<SEC-DOCUMENT>0001628280-24-007235.txt : 20240227
<SEC-HEADER>0001628280-24-007235.hdr.sgml : 20240227
<ACCEPTANCE-DATETIME>20240227162027
ACCESSION NUMBER:		0001628280-24-007235
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		151
CONFORMED PERIOD OF REPORT:	20231231
FILED AS OF DATE:		20240227
DATE AS OF CHANGE:		20240227

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Zai Lab Ltd
		CENTRAL INDEX KEY:			0001704292
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38205
		FILM NUMBER:		24687088

	BUSINESS ADDRESS:	
		STREET 1:		4560 JINKE ROAD
		STREET 2:		BLDG. 1, 4F, PUDONG
		CITY:			SHANGHAI
		STATE:			F4
		ZIP:			201210
		BUSINESS PHONE:		862161632588

	MAIL ADDRESS:	
		STREET 1:		4560 JINKE ROAD
		STREET 2:		BLDG. 1, 4F, PUDONG
		CITY:			SHANGHAI
		STATE:			F4
		ZIP:			201210
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>zlab-20231231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:ecd="http://xbrl.sec.gov/ecd/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:zlab="http://zailab.com/20231231" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns="http://www.w3.org/1999/xhtml" xmlns:srt="http://fasb.org/srt/2023" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>zlab-20231231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-36">false</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalPeriodFocus" id="f-37">FY</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-38">0001704292</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalYearFocus" id="f-39">2023</ix:nonNumeric><ix:nonNumeric contextRef="c-8" name="ecd:TrdArrDuration" format="ixt-sec:durday" id="f-49">367</ix:nonNumeric><ix:nonNumeric contextRef="c-71" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="f-496">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="c-107" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm" id="f-627">P1Y</ix:nonNumeric><ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="0" id="f-850">0</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="c-247" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" scale="0" id="f-1005">0</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="c-254" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" scale="0" id="f-1006">0</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="zlab-20231231.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dei:AdrMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-02-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dei:AdrMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-02-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">zlab:RafaelAmadoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">zlab:RafaelAmadoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">zlab:RafaelAmadoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">zlab:ZaiLabHongKongLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">zlab:ZaiLabShanghaiCompanyLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">zlab:ZaiLabAUSTPtyLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">zlab:ZaiLabSuzhouCompanyLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">zlab:ZaiBiopharmaceuticalSuzhouCompanyLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">zlab:ZaiLabUSLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">zlab:ZaiLabInternationalTradingShanghaiCompanyLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">zlab:ZaiAutoImmuneHongKongLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">zlab:ZaiLabTaiwanLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">zlab:ZaiLabTradingSuzhouCoLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-30</xbrli:startDate><xbrli:endDate>2022-03-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-29</xbrli:startDate><xbrli:endDate>2022-03-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">zlab:ElectronicEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">zlab:ElectronicEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">zlab:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ManufacturingFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">zlab:CapitalizedSalesBasedMilestoneFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:HuizhengMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="cny"><xbrli:measure>iso4217:CNY</xbrli:measure></xbrli:unit><xbrli:context id="c-81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:HuizhengMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:HuizhengMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:HuizhengMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:HuizhengMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">zlab:CollaborativeAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:HuizhengMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">zlab:CollaborativeAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>zlab:segment</xbrli:measure></xbrli:unit><xbrli:context id="c-86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">zlab:OneCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">zlab:OneCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">zlab:OneCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">zlab:ResearchAndDevelopmentExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="zlab:MajorSuppliersAxis">zlab:SupplierEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="zlab:MajorSuppliersAxis">zlab:SupplierFMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">zlab:ResearchAndDevelopmentExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:LenderConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">zlab:OneCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:LenderConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">zlab:OneCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">zlab:ForeignCurrencyRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CNY</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">zlab:CashAndCashEquivalentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">zlab:ForeignCurrencyRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CNY</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">zlab:CashAndCashEquivalentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">zlab:ForeignCurrencyRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CNY</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">zlab:CashAndCashEquivalentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">zlab:ForeignCurrencyRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CNY</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">zlab:CashAndCashEquivalentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CNY</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CNY</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:HKD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:HKD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:AUD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:AUD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:TWD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:TWD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">zlab:MacroGenicsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">zlab:MacroGenicsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">zlab:MacroGenicsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">zlab:MacroGenicsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">zlab:MacroGenicsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">zlab:MacroGenicsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">zlab:ElectronicEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">zlab:ElectronicEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">zlab:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">zlab:ManufacturingEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">zlab:ManufacturingEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">zlab:ZejulaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">zlab:ZejulaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">zlab:ZejulaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">zlab:OptuneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">zlab:OptuneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">zlab:OptuneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">zlab:QinlockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">zlab:QinlockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">zlab:QinlockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">zlab:NuzyraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">zlab:NuzyraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-137"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">zlab:NuzyraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">zlab:VyvgartMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">zlab:VyvgartMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">zlab:VyvgartMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-141"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">zlab:ZaiLabAUSTPtyLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">zlab:ZaiLabUSLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">zlab:ZaiLabTaiwanLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">zlab:ZaiLabHongKongAndZlChinaHoldingTwoAndZaiAutoImmuneHongKongAndZaiAntiInfectivesHongKongLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-145"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">zlab:ZaiLabHongKongAndZlChinaHoldingTwoAndZaiAutoImmuneHongKongAndZaiAntiInfectivesHongKongLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">zlab:ZaiLabHongKongAndZlChinaHoldingTwoAndZaiAutoImmuneHongKongAndZaiAntiInfectivesHongKongLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-147"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:KY</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-148"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:KY</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:KY</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:VG</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-151"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:VG</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-152"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:VG</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-153"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-154"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-155"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:HK</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-157"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:HK</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-158"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:HK</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-159"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-160"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-161"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-162"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-163"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-164"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-165"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:TW</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-166"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:TW</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-167"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:TW</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-168"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-169"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:HK</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-170"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:TW</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-171"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-172"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-173"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-174"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-175"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-176"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">zlab:NonVestedRestrictedSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-177"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">zlab:NonVestedRestrictedSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-178"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">zlab:NonVestedRestrictedSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-179"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:LimitedLiabilityCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-180"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:LimitedLiabilityCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-181"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:LimitedLiabilityCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-182"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">zlab:TwoThousandTwentyTwoEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-183"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-184"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">zlab:April2023AndLaterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-185"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">zlab:PriorToApril2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-186"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">zlab:April2023AndLaterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-187"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">zlab:April2023AndLaterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-188"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">zlab:ShareBasedPaymentArrangementTrancheFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">zlab:April2023AndLaterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-189"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">zlab:April2023AndLaterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-190"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">zlab:PriorToApril2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-191"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">zlab:PriorToApril2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-192"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">zlab:PriorToApril2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">zlab:ShareBasedPaymentArrangementTrancheFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-193"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">zlab:PriorToApril2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-194"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">zlab:ShareBasedPaymentArrangementTrancheFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">zlab:PriorToApril2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-195"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-196"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-197"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">zlab:ShareBasedPaymentArrangementOptionBatchOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-198"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">zlab:ShareBasedPaymentArrangementOptionBatchTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-199"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">zlab:ShareBasedPaymentArrangementOptionBatchThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-200"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">zlab:ShareBasedPaymentArrangementOptionBatchOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">zlab:ShareBasedPaymentArrangementOptionBatchTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">zlab:ShareBasedPaymentArrangementOptionBatchThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">zlab:NonVestedRestrictedSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">zlab:NonVestedRestrictedSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">zlab:NonVestedRestrictedSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">zlab:NonVestedRestrictedSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">zlab:NonVestedRestrictedSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-208"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:GlaxoSmithKlineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:GlaxoSmithKlineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:GlaxoSmithKlineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-218"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:GlaxoSmithKlineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:NovocureLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-220"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:DecipheraPharmaceuticalsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:DecipheraPharmaceuticalsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:GurnetPointCapitalAndNovoHoldingsASMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:GurnetPointCapitalAndNovoHoldingsASMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-224"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:ArgenxBvMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:ArgenxBvMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:AmgenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:AmgenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:InnovivaInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:InnovivaInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:BMSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">zlab:RepotrectinibMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:BMSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">zlab:RepotrectinibMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-232"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:BMSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">zlab:RepotrectinibMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-233"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:BMSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">zlab:AdagrasibMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-234"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:BMSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">zlab:AdagrasibMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-235"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:BMSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">zlab:AdagrasibMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-236"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:BMSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">zlab:XanomelineTrospiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-237"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:BMSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">zlab:XanomelineTrospiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-238"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:BMSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">zlab:XanomelineTrospiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-239"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:PfizerIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-240"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:PfizerIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-241"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:OtherCounterpartiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-242"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-243"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">zlab:MainlandChinaGovernmentPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-244"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">zlab:MainlandChinaGovernmentPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-245"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">zlab:MainlandChinaGovernmentPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-246"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">zlab:A401kPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-247"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">zlab:A401kPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-248"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">zlab:A401kPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-249"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">zlab:A401kPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-250"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">zlab:A401kPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-251"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">zlab:A401kPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-252"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">zlab:MandatoryProvidentFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-253"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">zlab:MandatoryProvidentFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-254"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">zlab:MandatoryProvidentFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-255"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-256"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">zlab:BankOfChinaWorkingCapitalLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-02-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-257"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">zlab:BankOfChinaWorkingCapitalLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-02-05</xbrli:startDate><xbrli:endDate>2024-02-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-258"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">zlab:BankOfChinaWorkingCapitalLoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-02-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-259"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">zlab:BankOfChinaWorkingCapitalLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-02-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-260"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">zlab:BankOfChinaWorkingCapitalLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">zlab:ZaiLabShanghaiCo.Ltd.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-02-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-261"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">zlab:BankOfChinaWorkingCapitalLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">zlab:ZaiLabShanghaiCo.Ltd.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-02-07</xbrli:startDate><xbrli:endDate>2024-02-07</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-262"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-02-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-263"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-02-06</xbrli:startDate><xbrli:endDate>2024-02-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-264"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">zlab:SPDBankWorkingCapitalLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">zlab:ZaiLabShanghaiCo.Ltd.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-02-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-265"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">zlab:SPDBankWorkingCapitalLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">zlab:ZaiLabShanghaiCo.Ltd.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-02-06</xbrli:startDate><xbrli:endDate>2024-02-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-266"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">zlab:ZaiLabSuzhouCompanyLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">zlab:NingboBankWorkingCapitalLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-02-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-267"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">zlab:NingboBankWorkingCapitalLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-02-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-268"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-269"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-270"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-271"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-272"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-273"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-274"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i8a977bbf870448998f9d0f718b7b41b9_1"></div><div style="min-height:45pt;width:100%"><div style="margin-bottom:17pt"><span><br/></span></div></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">10-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Mark One)</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:2.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:94.810%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentAnnualReport" format="ixt:fixed-true" id="f-2">x</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:114%">Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">For the fiscal year ended: <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-3"><ix:nonNumeric contextRef="c-1" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="f-4">December 31</ix:nonNumeric>, 2023</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Or </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:2.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:94.810%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="f-5">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:114%">Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 </span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">For the transition period from [ ] to [ ]</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Commission file number: <ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-6">001-38205</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________</span></div><div style="text-align:center"><img src="zlab-20231231_g1.jpg" alt="Zai Lab logo.jpg" style="height:53px;margin-bottom:5pt;vertical-align:text-bottom;width:159px"/></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-7">ZAI LAB LIMITED</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Exact Name of Registrant as Specified in its Charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.051%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.749%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:edgarprovcountryen" id="f-8">Cayman Islands</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-9">98-1144595</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(State or Other Jurisdiction of<br/>Incorporation or Organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(I.R.S. Employer<br/>Identification No.)</span></td></tr></table></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"/><td style="width:48.975%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.825%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-10">4560 Jinke Road</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine2" id="f-11">Bldg. 1, Fourth Floor <br/>Pudong</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-12">Shanghai</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCountry" format="ixt-sec:countrynameen" id="f-13">China</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-14">201210</ix:nonNumeric></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">314 Main Street</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4th Floor, Suite 100</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cambridge, MA, USA</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">02142</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">(Address of Principal Executive Offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">(Zip Code)</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">+<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-15">86 21</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-16">6163 2588</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">+1 857 706 2604</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Registrant&#8217;s Telephone Number, Including Area Code)</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(b) of the Act: </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.203%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.142%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:38.143%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="c-2" name="dei:Security12bTitle" id="f-17">American Depositary Shares, each representing 10 Ordinary Shares, par value $0.000006 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="c-2" name="dei:TradingSymbol" id="f-18">ZLAB</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="c-2" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-19">The Nasdaq Global Market</ix:nonNumeric></span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="c-3" name="dei:Security12bTitle" id="f-20">Ordinary Shares, par value $0.000006 per share</ix:nonNumeric>*</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="c-3" name="dei:TradingSymbol" id="f-21">9688</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">The Stock Exchange of Hong Kong Limited</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________</span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:23pt">Included in connection with the registration of the American Depositary Shares with the Securities and Exchange Commission. The ordinary shares are not registered or listed for trading in the United States but are listed for trading on the Stock Exchange of Hong Kong Limited. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(g) of the Act: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">None</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. <ix:nonNumeric contextRef="c-1" name="dei:EntityWellKnownSeasonedIssuer" id="f-22">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="c-1" name="dei:EntityVoluntaryFilers" id="f-23">No</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">x</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric contextRef="c-1" name="dei:EntityCurrentReportingStatus" id="f-24">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="c-1" name="dei:EntityInteractiveDataCurrent" id="f-25">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.: </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:21.172%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:46.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.506%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.992%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-26">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:114%">x</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Accelerated Filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:114%">o</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:114%">o</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="f-27">o</ix:nonNumeric></span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-28">o</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:IcfrAuditorAttestationFlag" format="ixt:fixed-true" id="f-29">x</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentFinStmtErrorCorrectionFlag" format="ixt:fixed-false" id="f-30">o</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b). </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityShellCompany" format="ixt:fixed-false" id="f-31">x</ix:nonNumeric></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">As of June 30, 2023, the last business day of the registrant&#8217;s most recently completed second fiscal quarter, the aggregate market value of the ordinary shares, including in the form of American Depositary Shares (&#8220;ADSs&#8221;), each representing ten ordinary shares, held by non-affiliates of the registrant was approximately $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-8" name="dei:EntityPublicFloat" format="ixt:num-dot-decimal" scale="9" id="f-32">2.7</ix:nonFraction>&#160;billion, based upon the closing price of the registrant&#8217;s ADSs on the Nasdaq Global Market of $27.73 on June 30, 2023. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">As of February&#160;21, 2024, <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-33">992,087,430</ix:nonFraction> ordinary shares, par value $0.000006 per share, were outstanding, of which <ix:nonFraction unitRef="shares" contextRef="c-6" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-34">758,101,320</ix:nonFraction> ordinary shares were held in the form of ADSs. </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE</span></div><ix:nonNumeric contextRef="c-1" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="f-35" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The registrant intends to file a definitive proxy statement pursuant to Regulation 14A within 120 days of the end of the fiscal year ended December 31, 2023. Portions of such definitive proxy statement are incorporated by reference into Part III of this Annual Report on Form 10-K.</span></div></ix:nonNumeric><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i8a977bbf870448998f9d0f718b7b41b9_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:17pt"><span><br/></span></div></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Zai Lab Limited </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023 Annual Report on Form 10-K</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:90.869%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.931%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a977bbf870448998f9d0f718b7b41b9_13">PART I</a></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i8a977bbf870448998f9d0f718b7b41b9_13">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a977bbf870448998f9d0f718b7b41b9_16">Item 1. Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i8a977bbf870448998f9d0f718b7b41b9_16">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:22.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a977bbf870448998f9d0f718b7b41b9_19">Item 1A. Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i8a977bbf870448998f9d0f718b7b41b9_19">26</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:22.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a977bbf870448998f9d0f718b7b41b9_22">Item 1B. Unresolved Staff Comments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i8a977bbf870448998f9d0f718b7b41b9_22">76</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:22.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a977bbf870448998f9d0f718b7b41b9_712">Item 1C. Cybersecurity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i8a977bbf870448998f9d0f718b7b41b9_712">76</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a977bbf870448998f9d0f718b7b41b9_25">Item 2. Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i8a977bbf870448998f9d0f718b7b41b9_25">77</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a977bbf870448998f9d0f718b7b41b9_28">Item 3. Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i8a977bbf870448998f9d0f718b7b41b9_28">77</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a977bbf870448998f9d0f718b7b41b9_31">Item 4. Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i8a977bbf870448998f9d0f718b7b41b9_31">78</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a977bbf870448998f9d0f718b7b41b9_34">PART II</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i8a977bbf870448998f9d0f718b7b41b9_34">79</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a977bbf870448998f9d0f718b7b41b9_37">Item 5. Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i8a977bbf870448998f9d0f718b7b41b9_37">79</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a977bbf870448998f9d0f718b7b41b9_40">Item 6. [Reserved]</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i8a977bbf870448998f9d0f718b7b41b9_40">80</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a977bbf870448998f9d0f718b7b41b9_43">Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i8a977bbf870448998f9d0f718b7b41b9_43">81</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:22.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a977bbf870448998f9d0f718b7b41b9_76">Item 7A. Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i8a977bbf870448998f9d0f718b7b41b9_76">90</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a977bbf870448998f9d0f718b7b41b9_79">Item 8. Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i8a977bbf870448998f9d0f718b7b41b9_79">92</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a977bbf870448998f9d0f718b7b41b9_82">Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i8a977bbf870448998f9d0f718b7b41b9_82">92</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:22.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a977bbf870448998f9d0f718b7b41b9_85">Item 9A. Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i8a977bbf870448998f9d0f718b7b41b9_85">92</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:22.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a977bbf870448998f9d0f718b7b41b9_88">Item 9B. Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i8a977bbf870448998f9d0f718b7b41b9_88">93</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:22.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a977bbf870448998f9d0f718b7b41b9_91">Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i8a977bbf870448998f9d0f718b7b41b9_91">93</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a977bbf870448998f9d0f718b7b41b9_94">PART III</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i8a977bbf870448998f9d0f718b7b41b9_94">94</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a977bbf870448998f9d0f718b7b41b9_97">Item 10. Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i8a977bbf870448998f9d0f718b7b41b9_97">94</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a977bbf870448998f9d0f718b7b41b9_100">Item 11. Executive Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i8a977bbf870448998f9d0f718b7b41b9_100">94</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a977bbf870448998f9d0f718b7b41b9_103">Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i8a977bbf870448998f9d0f718b7b41b9_103">94</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a977bbf870448998f9d0f718b7b41b9_106">Item 13. Certain Relationships and Related Transactions, and Director Independence</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i8a977bbf870448998f9d0f718b7b41b9_106">94</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a977bbf870448998f9d0f718b7b41b9_109">Item 14. Principal Accounting Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i8a977bbf870448998f9d0f718b7b41b9_109">94</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a977bbf870448998f9d0f718b7b41b9_112">PART IV</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i8a977bbf870448998f9d0f718b7b41b9_112">95</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a977bbf870448998f9d0f718b7b41b9_115">Item 15. Exhibits, Financial Statement Schedules</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i8a977bbf870448998f9d0f718b7b41b9_115">95</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a977bbf870448998f9d0f718b7b41b9_760">Item 16. Form 10-K Summary</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i8a977bbf870448998f9d0f718b7b41b9_760">98</a></span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-i-</span></div></div></div><div id="i8a977bbf870448998f9d0f718b7b41b9_655"></div><hr style="page-break-after:always"/><div style="min-height:45.36pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Forward-Looking Statements</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">This report contains certain forward-looking statements, including statements relating to our strategy and plans; potential of and expectations for our business, commercial products, and pipeline programs; the market for our commercial and pipeline products; capital allocation and investment strategy; clinical development programs and related clinical trials; clinical trial data, data readouts, and presentations; risks and uncertainties associated with drug development and commercialization; regulatory discussions, submissions, filings, and approvals and the timing thereof; the potential benefits, safety, and efficacy of our products and product candidates and those of our collaboration partners; the anticipated benefits and potential of investments, collaborations, and business development activities; our profitability and timeline to profitability; and our future financial and operating results. All statements, other than statements of historical fact, included in this report are forward-looking statements, and can be identified by words such as &#8220;aim,&#8221; &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;contemplate,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;forecast,&#8221; &#8220;goal,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;plan,&#8221; &#8220;possible,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;seek,&#8221; &#8220;should,&#8221; &#8220;target,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; or the negative of these terms or similar expressions. Such statements constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not guarantees or assurances of future performance. Forward-looking statements are based on our expectations and assumptions as of the date of this report and are subject to inherent uncertainties, risks, and changes in circumstances that may differ materially from those contemplated by the forward-looking statements. We may not actually achieve the plans, carry out the intentions, or meet the expectations or projections disclosed in our forward-looking statements, and you should not place undue reliance on these forward-looking statements. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including but not limited to the following:</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;&#160;&#160;&#160;&#160;Our ability to successfully commercialize and generate revenue from our approved products;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;&#160;&#160;&#160;&#160;Our ability to obtain funding for our operations and business initiatives;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;&#160;&#160;&#160;&#160;The results of our clinical and pre-clinical development of our product candidates;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;&#160;&#160;&#160;&#160;The content and timing of decisions made by the relevant regulatory authorities regarding regulatory approvals of our product candidates;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;&#160;&#160;&#160;&#160;Changes in United States and China trade policies and relations, as well as relations with other countries, and/or changes in regulations and/or sanctions;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;&#160;&#160;&#160;&#160;Actions the Chinese government may take to intervene in or influence our operations;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;&#160;&#160;&#160;&#160;Economic, political, and social conditions in mainland China, as well as governmental policies;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;&#160;&#160;&#160;&#160;Uncertainties in the Chinese legal system, including with respect to the anti-corruption enforcement efforts in China and the Counter-Espionage Law, the Data Security Law, the Cyber Security Law, the Cybersecurity Review Measures, the Personal Information Protection Law, the Regulation on the Administration of Human Genetic Resources, the Biosecurity Law, the Measures on Security Assessment of Cross-Border Data Transfer (the &#8220;Security Assessment Measures&#8221;), and other future laws and regulations or amendments to such laws and regulations;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;&#160;&#160;&#160;&#160;Approval, filing, or procedural requirements imposed by the China Securities Regulatory Commission (&#8220;CSRC&#8221;) or other Chinese regulatory authorities in connection with issuing securities to foreign investors under Chinese law;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;&#160;&#160;&#160;&#160;Any violation or liability under the U.S. Foreign Corrupt Practices Act (&#8220;FCPA&#8221;) or Chinese anti-corruption laws;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;&#160;&#160;&#160;&#160;Restrictions on currency exchange;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;&#160;&#160;&#160;&#160;Limitations on the ability of our Chinese subsidiaries to make payments to us;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;&#160;&#160;&#160;&#160;Chinese requirements on the ability of residents in mainland China to establish offshore special purpose companies;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;&#160;&#160;&#160;&#160;Chinese regulations regarding acquisitions of companies based in mainland China by foreign investors;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;&#160;&#160;&#160;&#160;Any issues that our Chinese manufacturing facilities may have with operating in conformity with established Good Manufacturing Practices (&#8220;GMPs&#8221;) and international best practices, and with passing U.S. Food and Drug Administration (&#8220;FDA&#8221;), China National Medical Products Administration (&#8220;NMPA&#8221;), and European Medicines Agency (&#8220;EMA&#8221;) inspections;</span></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:27pt"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45.36pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;&#160;&#160;&#160;&#160;Expiration of, or changes to, financial incentives or discretionary policies granted by local governments in mainland China;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;&#160;&#160;&#160;&#160;Restrictions or limitations on the ability of overseas regulators to conduct investigations or collect evidence within mainland China;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%">&#8226;&#160;&#160;&#160;&#160;Business disruptions caused by pandemics such as COVID-19, international war or conflict such as the Russia/Ukraine and Israel/Hamas wars, natural disasters, extreme weather events, and other significant disruptions outside of our control;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;&#160;&#160;&#160;&#160;Unfavorable tax consequences to us and our non-Chinese shareholders or ADS holders if we were to be classified as a Chinese resident enterprise for Chinese income tax purposes;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;&#160;&#160;&#160;&#160;Failure to comply with applicable Chinese, U.S., and Hong Kong regulations that could lead to government enforcement actions, fines, other legal or administrative sanctions, and/or harm to our business or reputation; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;&#160;&#160;&#160;&#160;Review by the U.S. Committee on Foreign Investment (&#8220;CFIUS&#8221;) in our investments or other delays or obstacles for closing transactions;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;&#160;&#160;&#160;&#160;Any inability to renew our current leases on desirable terms or otherwise locate desirable alternatives for our leased properties;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;&#160;&#160;&#160;&#160;Our ability to generate revenues from our approved commercial products;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;&#160;&#160;&#160;&#160;Any inability of third parties on whom we rely to conduct our pre-clinical and clinical trials to successfully carry out their contractual duties or meet expected deadlines; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;&#160;&#160;&#160;&#160;Any inability to obtain or maintain sufficient patent protection for our products and product candidates.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">For more information on these factors and other risks and uncertainties that may affect our business, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">. These factors should not be construed as exhaustive and should be read with the other cautionary statements and information in this report. Forward-looking statements are based on our management&#8217;s beliefs and assumptions and information currently available to our management. These statements, like all statements in this report, speak only as of their date. We anticipate that subsequent events and developments will cause our expectations and assumptions to change, and we undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as may be required by law. These forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date of this report. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Usage of Terms</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Unless the context requires otherwise, references in this report to &#8220;Greater China&#8221; refer to mainland China, Hong Kong Special Administrative Region (&#8220;Hong Kong&#8221; or &#8220;HK&#8221;), Macau Special Administrative Region (&#8220;Macau&#8221;), and Taiwan, collectively; references to &#8220;Zai Lab,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221; refer to Zai Lab Limited, a holding company, and its subsidiaries, on a consolidated basis; and references to &#8220;Zai Lab Limited&#8221; refer to Zai Lab Limited, a holding company. Zai Lab Limited is the entity in which investors hold their interest. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our operating subsidiaries consist of Zai Lab (Hong Kong) Limited, domiciled in Hong Kong; Zai Auto Immune (Hong Kong) Limited, domiciled in Hong Kong; Zai Anti Infectives (Hong Kong) Limited, domiciled in Hong Kong; Zai Lab (Shanghai) Co., Ltd., domiciled in mainland China; Zai Lab International Trading (Shanghai) Co., Ltd., domiciled in mainland China; Zai Lab (Suzhou) Co., Ltd., domiciled in mainland China; Zai Biopharmaceutical (Suzhou) Co., Ltd., domiciled in mainland China; Zai Lab Trading (Suzhou) Co., Ltd., domiciled in mainland China; Zai Lab (Taiwan) Limited, domiciled in Taiwan; Zai Lab (AUST) Pty. Ltd., domiciled in Australia; and Zai Lab (US) LLC, domiciled in the United States. As of the date of this report, Zai Anti Infectives (Hong Kong) Limited has non-substantial business operations. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We own various trademarks, including various forms of the Zai Lab brand (in English and Chinese), as well as several domain names that incorporate such trademarks. Trademarks and trade names of other companies appearing in this report are the property of their respective holders. Solely for convenience, some of the trademarks and trade names in this report are referred to without the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:139%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> and &#8482; symbols, but such references should not be construed as any indicator that their respective owners will not assert, to the fullest extent under applicable law, their rights thereto. We do not intend our use or </span></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:27pt"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45.36pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">display of other companies&#8217; trademarks and trade names to imply a relationship with, or endorsement or sponsorship of, any other company. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Disclosures Relating to Our Chinese Operations </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Zai Lab Limited is an exempted company incorporated in the Cayman Islands with limited liability on March 28, 2013. Any company that is registered in the Cayman Islands but conducts business mainly outside of the Cayman Islands may apply to be registered as an exempted company. We have substantial operations in mainland China. Below is a summary of certain risks related to our Chinese operations. For more information on material risks that may affect our business, ADSs, and ordinary shares, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;text-decoration:underline">Zai Lab Limited is not a Chinese operating company, but a holding company incorporated in the Cayman Islands.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Zai Lab Limited is not a Chinese operating company, but a holding company incorporated in the Cayman Islands. As a holding company, we conduct a substantial portion of our operations through wholly owned subsidiaries based in mainland China. Our investors do not hold direct investments in our Chinese operating companies. In July 2021, the Chinese government provided new guidance on Chinese companies raising capital outside of mainland China, including through arrangements called variable interest entities (&#8220;VIEs&#8221;). Currently, our corporate structure contains no VIEs, and the life sciences industry in which we operate is not subject to foreign ownership limitations in mainland China. However, there are uncertainties with respect to the Chinese legal system, and there may be changes in laws, regulations, and policies, including how those laws, regulations, and policies will be interpreted or implemented, that may affect our business or an investment in our business. If, in the future, the Chinese government determines that our corporate structure does not comply with Chinese regulations, or if Chinese regulations change or are interpreted differently, the value of our ADSs and/or ordinary shares (individually or collectively, our &#8220;securities&#8221;) may decline or become worthless. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;text-decoration:underline">There are significant legal and operational risks associated with conducting a substantial portion of our operations in mainland China, including with respect to changes in the legal, political, and economic policies of the Chinese government, relations between mainland China and the United States, or Chinese or U.S. regulations, that may materially and adversely affect our business, financial condition, results of operations, ability to raise capital or continue to offer our securities, and the market price of our securities.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">There are significant legal and operational risks associated with conducting a substantial portion of our operations in mainland China, including with respect to changes in the legal, political, and economic policies of the Chinese government, relations between mainland China and the United States, or Chinese or U.S. regulations. For example, geopolitical events, such as developments with respect to Taiwan, continue to cause heightened tensions between the United States and China. In addition, new laws and regulations, including the Counter-Espionage Law, Personal Information Protection Law, Data Security Law, Cyber Security Law, and Cybersecurity Review Measures, Measures on Security Assessment of Cross-Border Data Transfer, and regulations and guidelines relating to the multi-level protection scheme, have imposed, and may continue to impose, additional restrictions or obligations and compliance-related costs on our business. In addition, our business, or our directors or employees, may be subject to enforcement actions or penalties if it is determined that we, or they, have not complied with applicable laws and regulations. Such legal and operational risks may materially and adversely affect our business, financial condition, results of operations, ability to raise capital or continue to offer our securities, and the market price of our securities. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;text-decoration:underline">We are or may be required to obtain certain permissions from Chinese authorities to operate in mainland China, issue our securities to foreign investors, and transfer certain scientific data.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Chinese government has exercised, and may continue to exercise, substantial influence or control over virtually every sector of the Chinese economy through regulation and state ownership. As a result, we are or may be required to obtain certain approvals or permissions from Chinese authorities to operate in mainland China, transfer certain scientific data, and issue our securities to foreign investors. </span></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:27pt"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45.36pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">For example, we are required to obtain certain approvals from Chinese authorities to operate our Chinese subsidiaries. To operate our general business activities in mainland China, each of our Chinese subsidiaries is required to obtain a business license from the local counterpart of the State Administration for Market Regulation (&#8220;SAMR&#8221;). Each of our Chinese subsidiaries has obtained such a business license. Our Chinese subsidiaries are also required to obtain certain licenses and permits, including but not limited to the following: Pharmaceutical Manufacturing Permits, Pharmaceutical Distribution Permits, and Medical Device Distribution Permits to manufacture and/or distribute drugs and/or applicable medical devices. To date, no application for any such material license or permit has been denied.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Further, we are required to obtain certain approvals from Chinese authorities before transferring certain scientific data abroad or to foreign parties or entities established or controlled by those foreign parties. In addition, we may be subject to additional such requirements pursuant to the Security Assessment Measures, which may affect our Chinese subsidiaries or clinical trials. The Security Assessment Measures may require us to complete security assessments for certain cross-border data transfers, obtain prior approval from the Cyberspace Administration of China (&#8220;CAC&#8221;) for transfers out of mainland China of certain important or personal data, or obtain prior clearance or approval from the Human Genetic Resources Administration Office of China (&#8220;HGRAC&#8221;) for certain transfers of data derived from human organs, tissues, or cells of Chinese individuals that contain human genetic materials. If we are not able to obtain or maintain the necessary permissions or approvals, our ability to operate in mainland China may be restricted or prohibited, and the value of our securities could significantly decline or become worthless. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Although we are not currently required to obtain prior approval or permission from the CSRC or any other Chinese regulatory authority to issue our securities to foreign investors, the CSRC has promulgated a new set of regulations (the &#8220;Trial Measures&#8221;) and five supporting guidelines, which became effective in March 2023. Pursuant to the Trial Measures, we may be required to submit filings to the CSRC following the submission of future overseas listings and the completion of future offerings of our equity securities to foreign investors. If we are not able to complete the necessary filings for future securities offerings, our ability to raise capital may be adversely affected.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The central or local governments could impose new, stricter regulations or interpretations of existing regulations that could impose additional requirements, require additional approvals or permissions in the future, and result in additional related expenditures and efforts on our part to comply with such regulations or interpretations. Also, as there are uncertainties with respect to the Chinese legal system and changes in laws, regulations, and policies, including how those laws, regulations, and policies will be interpreted or implemented, our business and an investment in our securities could be adversely affected. </span></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:27pt"><span><br/></span></div></div></div><div id="i8a977bbf870448998f9d0f718b7b41b9_13"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I </span></div><div id="i8a977bbf870448998f9d0f718b7b41b9_16"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Business</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We are a patient-focused, innovative, commercial-stage, global biopharmaceutical company with a substantial presence in both Greater China and the United States. We are focused on discovering, developing, and commercializing products that address medical conditions with significant unmet needs in the areas of oncology, autoimmune disorders, infectious disease, and neuroscience. We intend to leverage our competencies and resources to positively impact human health in Greater China and worldwide. To that end, our experienced team has secured partnerships with leading global biopharmaceutical companies to generate a broad pipeline, including multiple commercial products and multiple programs in late-stage clinical development. We have also built an in-house R&amp;D team with strong product discovery and translational research capabilities and are establishing a pipeline of proprietary product candidates with global rights.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Mission and Corporate Strategic Goals</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our mission is to be a leading global biopharmaceutical company focused on discovering, developing, and commercializing innovative therapies that improve the lives of patients.  </span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">To execute on that mission, we have developed a corporate strategy with the following three pillars to help us drive innovation in China and beyond:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:13.8pt">Accelerate Medicines to Patients: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We seek to advance our product pipeline by continuing to invest in research and development, including internal discovery activities;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:13.8pt">Expanding Our Pipeline: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We seek to continue to expand and strengthen our differentiated product pipeline through synergistic regional and global collaborations and corporate development activities; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:13.8pt">Continue Our Commercial Excellence and Execution: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We seek to continue delivering strong financial performance, including by increasing access to our existing commercial products and driving further increases in our efficiency and productivity as we continue preparations to launch multiple additional products or new indications for existing products in Greater China in the next 2-3 years. Through our efforts, we seek to achieve overall corporate profitability by the end of 2025.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We also seek to build and maintain the trust of our stakeholders, including through our Trust for Life strategy, which includes three commitments: improve human health, create better outcomes, and act right now with ethical business practices and strong corporate governance. As part of our corporate strategy, and the actions taken in support of our corporate goals, we will continue to develop and integrate our Trust for Life strategy into our business and operations. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Our Commercial Products and Operations</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We have license agreements and have received marketing approval in one or more territories in Greater China for five products: ZEJULA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:139%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">, OPTUNE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:139%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">, QINLOCK</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:139%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">, NUZYRA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:139%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">, and VYVGART</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:139%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> (collectively, our &#8220;commercial products&#8221;). The success of our commercial products, and the scale and sophistication of our commercial operation, is crucial to our business.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We have invested, and will continue to invest, resources to strengthen our commercial infrastructure and to attract, retain, and train qualified marketing, sales, and other personnel in support of the sales of our commercial products. Our sales and marketing teams cover medical centers across Greater China, and our commercial team has capabilities that cover the product sales cycle, including medical affairs, market access, and distributor management. Our commercial team has a proven track record and experience from leading global pharmaceutical companies including AstraZeneca, Roche, Novartis, and Bristol-Myers Squibb Company (&#8220;BMS&#8221;), and we tailor our commercialization strategies according to our </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-1-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">individual products and their market potential. For example, we work to increase access for our commercial products, including through National Reimbursement Drug List (&#8220;NRDL&#8221;) inclusion or supplemental insurance coverage, increase brand perception and adoption, including through education and outreach efforts, and provide post-launch product support services for patients.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We rely on independent third-party distributors in Greater China to sell our commercial products, which is consistent with the pharmaceutical industry norm. This allows us to execute marketing strategies that are specifically tailored to each product and geographical location, including the hospitals located within our distributors&#8217; specific distribution territories. For more information on how we source and sell our commercial products, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Our Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Manufacturing, Suppliers, and Quality Control</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following table provides an overview of our partners and the approved indications and current geographic markets for our commercial products: </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.363%"><tr><td style="width:1.0%"/><td style="width:17.296%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.428%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:34.591%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.586%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.686%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.428%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Product</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Approved Indications</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Current Markets</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Partner</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="text-align:center"><img src="zlab-20231231_g2.jpg" alt="Zejula logo.jpg" style="height:71px;margin-bottom:5pt;vertical-align:text-bottom;width:96px"/></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> line and 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">nd</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> line ovarian cancer maintenance treatment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Platinum sensitive relapsed ovarian cancer maintenance treatment</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mainland China, Hong Kong, and Macau</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"><div style="text-align:center"><img src="zlab-20231231_g3.jpg" alt="GSK logo.jpg" style="height:30px;margin-bottom:5pt;vertical-align:text-bottom;width:96px"/></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><img src="zlab-20231231_g4.jpg" alt="Optune GIO.jpg" style="height:32px;margin-bottom:5pt;vertical-align:text-bottom;width:100px"/></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Newly diagnosed and recurrent glioblastoma multiforme (&#8220;GBM&#8221;)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mainland China, Hong Kong, Macau, and Taiwan</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><img src="zlab-20231231_g5.jpg" alt="novocure logo.jpg" style="height:40px;margin-bottom:5pt;vertical-align:text-bottom;width:96px"/></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><img src="zlab-20231231_g6.jpg" alt="Qinlock logo.jpg" style="height:37px;margin-bottom:5pt;vertical-align:text-bottom;width:96px"/></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> line gastrointestinal stromal tumors (&#8220;GIST&#8221;)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mainland China, Hong Kong, Macau, and Taiwan</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><img src="zlab-20231231_g7.jpg" alt="deciphera logo.jpg" style="height:36px;margin-bottom:5pt;vertical-align:text-bottom;width:96px"/></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><img src="zlab-20231231_g8.jpg" alt="Nuzyra logo.jpg" style="height:69px;margin-bottom:5pt;vertical-align:text-bottom;width:96px"/></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Community-acquired bacterial pneumonia (&#8220;CABP&#8221;)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acute bacterial skin and skin structure infections (&#8220;ABSSSI&#8221;)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mainland China</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><img src="zlab-20231231_g9.jpg" alt="NOVO holdings logo.jpg" style="height:54px;margin-bottom:5pt;vertical-align:text-bottom;width:96px"/></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><img src="zlab-20231231_g10.jpg" alt="vyvgart logo.jpg" style="height:41px;margin-bottom:5pt;vertical-align:text-bottom;width:96px"/></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generalized myesthenia gravis (&#8220;gMG&#8221;)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mainland China</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><img src="zlab-20231231_g11.jpg" alt="argenx logo.jpg" style="height:36px;margin-bottom:5pt;vertical-align:text-bottom;width:96px"/></div></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following sections include more information on our commercial products. Each of our commercial products has received approval and is currently marketed in regions outside of our licensed territory for similar approved indications to ours, such as in the United States. We are also evaluating other potential indications for our commercial products, as discussed in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Our Oncology Pipeline</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Our Autoimmune Disorder, Infectious Disease, and Neuroscience Pipeline</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">ZEJULA (Niraparib)</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">ZEJULA is an orally administered poly (ADP-ribose) polymerase (&#8220;PARP&#8221;) 1/2 inhibitor. PARP is a protein that helps repair DNA damage in cells. PARP inhibitors block PARP from repairing DNA damage, such as may be caused by radiation and/or certain chemotherapies, which may lead to cancer cell death and slow the return or progression of cancer. Tumors that are deficient in key DNA damage repair pathways, such as BRCA1 mutant tumors, are particularly sensitive to ZEJULA. As maintenance therapy, ZEJULA is for women who have had prior chemotherapy treatment but are at high risk of cancer recurrence. ZEJULA is intended to avoid or slow a recurrence of the cancer if it is in remission after prior treatment. In the maintenance setting, ZEJULA does not require the addition of radiation or chemotherapies to kill tumor cells. We have an exclusive license from Tesaro Inc. (now a subsidiary of GlaxoSmithKline plc (&#8220;GSK&#8221;)) to develop and commerci</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">alize ZEJULA in ma</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">inland China, Hong Kong, and Macau. We purchase ZEJULA from GSK for commercial </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-2-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">use in Hong Kong. We are not otherwise obligated to purchase ZEJULA or other licensed products from GSK. For more information on this agreement, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Overview of Significant License and Collaboration Agreements &#8211; GSK (Niraparib)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our primary market for ZEJULA is patients with epithelial ovarian, fallopian tube, or primary peritoneal cancer (collectively, &#8220;ovarian cancer&#8221;) in mainland China. Ovarian cancer is one of the most common gynecological cancers in China, with over 55,000 newly diagnosed cases and 37,000 deaths in China annually. We launched ZEJULA in mainland China in 2020, and have supported increased patient access through its inclusion in the NRDL since 2021, as a maintenance treatment for women with recurrent platinum-sensitive ovarian cancer and for adult patients with advanced ovarian cancer who are in a complete or partial response to first-line platinum-based chemotherapy, and since 2022, as a maintenance treatment for first-line ovarian cancer.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We also launched ZEJULA in Hong Kong in 2018 for adult patients with platinum-sensitive, relapsed high-grade, serous epithelial ovarian cancer who are in a complete response or partial response to platinum-based chemotherapy and in Hong Kong and Macau in 2021 as a maintenance treatment for adult patients with high-grade serous epithelial ovarian cancer who are in a complete response or partial response to first-line platinum-based chemotherapy. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">OPTUNE (Tumor Treating Fields)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">OPTUNE (&#8220;Tumor Treating Fields&#8221; or &#8220;TTFields&#8221;) is a cancer therapy that uses electric fields tuned to specific frequencies to kill tumor cells via a variety of mechanisms. TTFields therapy is delivered through a portable medical device. The complete delivery system for OPTUNE includes a portable electric field generator, arrays, rechargeable batteries, and accessories. We have an exclusive license from NovoCure Ltd. (&#8220;NovoCure&#8221;) to develop and commercialize any TTFields products in Greater China in the field of oncology. We purchase the licensed products exclusively from NovoCure. For more information on this agreement, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Overview of Significant License and Collaboration Agreements &#8211; NovoCure (Tumor Treating Fields)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our primary market for OPTUNE is patients in mainland China with GBM, the most aggressive form of brain tumor. We estimate that there are more than 45,000 patients with GBM in China each year. We launched OPTUNE GIO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:139%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">, the OPTUNE product for the treatment of GBM, in mainland China in 2020 for the treatment of patients with newly diagnosed GBM in combination with temozolomide (&#8220;TMZ&#8221;), a chemotherapy drug, and as a monotherapy for the treatment of patients with recurrent GBM. We have also launched OPTUNE GIO for these GBM indications in Hong Kong, Taiwan, and Macau. Further, we have improved patient access to OPTUNE GIO in mainland China through supplemental insurance coverage. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">QINLOCK (Ripretinib)</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">QINLOCK is an orally administered switch-control tyrosine kinase inhibitor (&#8220;TKI&#8221;) that broadly inhibits KIT and </span><span style="background-color:#ffffff;color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">platelet-derived growth factor receptor alpha (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8220;PDGFR&#945;&#8221;) tyrosine kinases, including wild-type and forms with multiple primary and secondary mutations. Switch-control tyrosine kinases KIT and PDGFR&#945; regulate kinase activity through a main activation switch and an auxiliary inhibitory switch that control kinase conformation in either an &#8220;on&#8221; or &#8220;off&#8221; position. Oncogenic kinase mutations predominantly function by disrupting one or more regulatory switch mechanisms, leading to dysregulated function and loss of normal, physiologic conformational control. Blocking the switch pocket region and the activation switch region locks KIT and PDGFR&#945; kinases in an inactive conformation by a dual mechanism of action that provides broad inhibition of KIT and PDGFR&#945; kinase activity thereby preventing downstream signaling and cell proliferation. We have an exclusive license from Deciphera Pharmaceuticals, Inc. (&#8220;Deciphera&#8221;) to develop and commercialize QINLOCK in Greater China. We purchase the licensed products exclusively from Deciphera. For more information on this agreement, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Overview of Significant License and Collaboration Agreements &#8211; Deciphera (Ripretinib)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our primary market for QINLOCK is patients with GIST in mainland China, where we believe QINLOCK is the standard of care. GISTs are the most common mesenchymal tumors of the gastrointestinal tract, accounting for about 0.1-3% of gastrointestinal tumors, with an estimated annual incidence of around 30,000 newly diagnosed patients per year in mainland China. We launched QINLOCK in mainland China in 2021 for the treatment of adult patients with advanced </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-3-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">GIST who have received prior treatment with three or more kinase inhibitors, including imatinib (&#8220;fourth-line GIST&#8221;). In January 2023, QINLOCK was included in the NRDL for this indication. We have also launched QINLOCK for fourth-line GIST in Hong Kong, Taiwan, and Macau. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">NUZYRA (Omadacycline)</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">NUZYRA, a novel tetracycline-class antibacterial with both oral and IV formulations, is a broad spectrum antibiotic. We have an exclusive license from Paratek Pharmaceuticals, Inc. (&#8220;Paratek&#8221;) (subsequently acquired by Gurnet Point Capital and Novo Holdings A/S) to develop, manufacture, and commercialize NUZYRA in Greater China. For more information on this agreement, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Overview of Significant License and Collaboration Agreements &#8211; Novo Holdings (Omadacycline)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our primary market for NUZYRA is patients with CABP or ABSSSI in mainland China. CABP is the most common type of pneumonia that is acquired outside of the hospital. It is one of the most common infectious diseases and is a significant cause of mortality and morbidity worldwide. ABSSSI are bacterial infections of skin and associated soft tissues, such as loose connective tissue and mucous membranes. ABSSSI are common and encompass a variety of disease presentations and degrees of severity. The World Health Organization has identified the worldwide development of resistance to currently available antibacterial agents as one of the greatest threats to human health. In 2020, the estimated incidence of CABP in mainland China was approximately 10 million patients, and in 2015, the estimated incidence of ABSSSI in mainland China was 2.8 million patients. We launched NUZYRA in mainland China in December 2021 for the treatment of adults with CABP and ABSSSI for both oral and intravenous (&#8220;IV&#8221;) formulation. NUZYRA was included in the NRDL for the treatment of adult patients with CABP and ABSSSI in January 2023 for its IV formulation and in January 2024 for its oral formulation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">NUZYRA is locally manufactured by Contract Manufacturing Organizations (&#8220;CMOs&#8221;) in mainland China. We have an exclusive promotion agreement with Huizheng (Shanghai) Pharmaceutical Technology Co., Ltd. (&#8220;Huizheng&#8221;), a subsidiary of Hanhui Pharmaceutical Co., Ltd. (&#8220;Hanhui&#8221;), one of the leading pharmaceutical companies for antibiotics in mainland China, which allows us to use Hanhui&#8217;s existing infrastructure for sales of NUZYRA in mainland China. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">VYVGART (Efgartigimod)</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Efgartigimod alfa fcab (&#8220;efgartigimod&#8221;) is a human IgG1 antibody fragment that binds to the neonatal fragment crystallizable receptor (&#8220;FcRn&#8221;). FcRn is widely expressed throughout the body and plays a central role in rescuing IgG antibodies from lysosomal degradation. Blocking FcRn prevents FcRn from binding IgG antibodies and rescuing them from lysosomal degradation resulting in a reduction in circulating IgG antibodies which may include pathogenic IgG antibodies that contribute to certain autoimmune diseases such as gMG. We have an exclusive license from argenx BV (&#8220;argenx&#8221;) to develop and commercialize efgartigimod in Greater China. We purchase the licensed products exclusively from argenx. For more information on this agreement, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Overview of Significant License and Collaboration Agreements </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">&#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">argenx (Efgartigimod)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our primary market for VYVGART is patients with gMG in mainland China. There are approximately 200,000 patients in China living with myasthenia gravis (&#8220;MG&#8221;). Approximately 85% of people with MG progress to gMG within 18 months, and of those patients, 85% are estimated to have confirmed AChR antibodies. We launched VYVGART (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">efgartigimod alfa injection</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">) in mainland China in September 2023 as an add on to standard therapy for the treatment of adult patients with gMG who are anti-acetylcholine receptor (&#8220;AChR&#8221;) antibody positive, and in January 2024, this product was added to the NRDL for this indication.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Our Pipeline of Product Candidates and R&amp;D Activities</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We believe research and development is important to our future growth and ability to remain competitive, and we are dedicated to discovering or licensing, and then developing and commercializing, innovative products that address significant unmet medical needs in Greater China and worldwide. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We have a deep and differentiated pipeline of potential </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-4-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">first-in-class / best-in-class products across our therapeutic areas of oncology, autoimmune disorders, infectious disease, and neuroscience. Our pipeline includes certain additional indications for our commercial products as well as new products for which we may seek regulatory approval and commercialization. Our pipeline includes both in-licensed assets as well as assets that we have internally developed. Our product candidates are in various stages of development, including several assets in late-stage development and various others in clinical and pre-clinical development.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following table </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">provides</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> an overview of our significant product candidates, including key indications we are evaluating for those products, their clinical stage and related studies in which we are participating, and our partners and potential </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">geographic markets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:13.293%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:36.021%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.839%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.963%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Product</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Description</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Potential Indications and Clinical Stage (Studies)</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Potential Markets</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Partner</span></div></td></tr><tr><td colspan="15" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Oncology Pipeline</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tumor Treating Fields</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Portable device for delivery of electric fields</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2L NSCLC &#8211; Phase III (LUNAR)         Brain Met from NSCLC-Phase III (METIS) </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pancreatic Cancer &#8211; Phase III (PANOVA)</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Greater China</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NovoCure</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tisotumab vedotin</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tissue Factor ADC</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2L/3L Cervical Cancer &#8211; Phase III (innovaTV-301)</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Greater China</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Seagen (now owned by Pfizer)</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adagrasib</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">KRAS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">G12C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> inhibitor</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2L+ NSCLC &#8211; Phase III (KRYSTAL-12) 1L NSCLC &#8211; Phase III (KRYSTAL-7)     2L CRC &#8211; Phase III (KRYSTAL-10)</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Greater China</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mirati (now owned by BMS)</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bemarituzumab</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Anti-FGFR2b antibody</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gastric/GEJ Cancer &#8211; Phase III (FORTITUDE-101 and FORTITUDE-102)</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Greater China</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Five Prime (now owned by Amgen)</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Repotrectinib</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">TKI targeting ROS1 oncogenic fusions</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ROS1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+ NSCLC &#8211; Phase I/II (TRIDENT-1) </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">NTRK</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+ Solid Tumors &#8211; Phase I/II (TRIDENT-1)</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Greater China</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Turning Point (now owned by BMS)</span></div></td></tr><tr><td colspan="15" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Autoimmune Disorder, Infectious Disease, and Neuroscience Pipeline</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Efgartigimod</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FcRn blocker</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CIDP &#8211; Phase II (ADHERE) </span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Greater China</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">argenx</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sulbactam-Durlobactam</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Combination of beta-lactam antibacterial and beta-lactamase inhibitor </span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HABP/VABP caused by susceptible isolates of carbapenem-resistant </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acinetobacter baumannii-calcoaceticus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Phase III (ATTACK)</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Asia Pacific</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Entasis (now owned by Innoviva)</span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Xanomeline-Trospium (KarXT)</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Combination of muscarinic receptor agonist and antimuscarinic agent </span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Schizophrenia &#8211; Phase III (EMERGENT) </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ADP &#8211; Phase III (ADEPT)</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Greater China</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Karuna</span></div></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* NSCLC = non-small cell lung cancer; Brain Met = brain metastases; CRC = colorectal cancer; GEJ = gastroesophageal junction; CIDP = chronic inflammatory demyelinating polyneuropathy; Asia Pacific = Greater China, South Korea, Vietnam, Thailand, Cambodia, Laos, Malaysia, Indonesia, the Philippines, Singapore, Australia, New Zealand, and Japan; HABP/VABP = hospital acquired bacterial pneumonia and ventilator-associated bacterial pneumonia; and ADP = Alzheimer&#8217;s Disease with Psychosis.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following sections include more information on significant late-stage product candidates in our oncology pipeline and our autoimmune disorder, infectious disease, and neuroscience pipeline. We will continue to evaluate the developmental possibilities of the programs in our pipeline. For example, our programs may have significant potential beyond those indications we are currently evaluating. We may in the future expand our research and development efforts to evaluate additional indications to those discussed below. In addition, we or our partners may decide to discontinue development of certain products based on a review of the competitive landscape and market opportunity or otherwise. In the fourth quarter of 2023, we decided to discontinue our development of margetuximab and odronextamab, and we provided notice to terminate our related license agreements with MacroGenics and Regeneron in accordance with their terms, effective on May 14, 2024 and December 20, 2024, respectively. In addition, our partner, Blueprint Medicines Corporation, has decided to de-prioritize its development of BLU-945.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-5-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We are also focused on building our global pipeline through our internal discovery efforts and business development activities. We have assembled an integrated drug discovery and development team with extensive experience in discovery, translational medicine, and pre-clinical and clinical development in China and worldwide that has been directly involved in the discovery and development of several innovative product candidates with global rights, including ZL-1218, a</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> humanized, IgG1 monoclonal antibody that binds to human CC chemokine receptor 8 (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8220;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">CCR8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">) that is in development for treatment of solid tumors and currently in a Phase I study</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">, and ZL-1102, a fully human V</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:139%;position:relative;top:1.41pt;vertical-align:baseline">H</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> fragment that binds to human interleukin-17 (&#8220;IL-17&#8221;), for which we are preparing to initiate a Phase II study in mild-to-moderate chronic plaque psoriasis. We also collaborate with external research partners, such as leading Contract Research Organizations (&#8220;CROs&#8221;), academic institutions, and commercial partners, such as for execution of our pre-clinical and clinical trials. With respect to business development, we will continue to consider opportunities to expand our portfolio through our regional and global collaboration efforts and corporate development activities. For example, we added ZL-1310, an early-stage next generation DLL3 antibody drug conjugate (&#8220;ADC&#8221;) program that is currently in a Phase I study, to our oncology portfolio in the first quarter of 2023 through a new collaboration with MediLink Therapeutics (Suzhou) Co., Ltd. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">DLL3 is an inhibitor of the Notch ligand that is overexpressed in small cell lung cancer and neuroendocrine tumors.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">For information on risks related to our potential products and R&amp;D activities, including clinical trials and reliance on third parties, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Our Oncology Pipeline</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Additional Indications for Tumor Treating Fields (TTFields)</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">As discussed in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Our Commercial Products and Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">, we have an exclusive license from NovoCure to develop and commercialize any TTFields products in Greater China in the field of oncology, and we have commercially launched TTFields in mainland China, Hong Kong, Taiwan, and Macau under the brand name OPTUNE GIO for certain GBM indications.  </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Significant additional indications for TTFields therapy that we are evaluating include solid tumor types in second-line non-small cell lung cancer (&#8220;NSCLC&#8221;), brain metastases from NSCLC, and pancreatic cancer. </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:14.5pt">2L NSCLC: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We participated in the Greater China portion of the Phase III pivotal LUNAR trial, which was intended for patients who had recently been diagnosed with progression of NSCLC during or after platinum-based therapy. The Phase III LUNAR trial met its primary endpoint, demonstrating a statistically significant and clinically meaningful improvement in overall survival (&#8220;OS&#8221;) for patients with metastatic NSCLC after platinum-based therapies, and a profound OS benefit from TTFields therapy was demonstrated in the immune checkpoint inhibitors (&#8220;ICI&#8221;) subgroup. TTFields therapy was well tolerated with no added systemic toxicities and few grade 3 (and no grade 4 or 5) device-related adverse events. Lung cancer has the highest total incidence of any cancer in mainland China. According to the World Health Organization, the incidence of lung cancer in mainland China in 2020 was 815,563 cases. Lung cancer consists of NSCLC in approximately 85% of cases and small cell lung cancer (&#8220;SCLC&#8221;) in approximately 15% of cases. In January 2024, NovoCure announced that the FDA had accepted its Premarket Approval (&#8220;PMA&#8221;) application seeking approval for the use of TTFields therapy together with standard systemic therapies for the treatment of NSCLC following progression on or after platinum-based therapy. We are preparing a similar submission for this indication, with a goal to submit an MAA to the NMPA in 2024.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:14.5pt">Brain Metastases from NSCLC: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We are participating in the Greater China portion of the Phase III pivotal METIS study evaluating the efficacy of TTFields therapy following stereotactic radiosurgery for treatment of patients with brain metastases resulting from NSCLC. We estimate an annual incidence of around 13,000 such patients in China.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:14.5pt">Pancreatic Cancer: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We participated in the Greater China portion of the Phase III pivotal PANOVA-3 trial evaluating the efficacy of TTFields therapy administered concomitantly with gemcitabine and nab-paclitaxel as front-line treatment for patients with unresectable, locally advanced pancreatic cancer. According to the World </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-6-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Health Organization, pancreatic cancer was the eighth-leading cancer type in mainland China in 2020, with an estimated 125,000 newly diagnosed cases. The current median survival of patients with metastatic pancreatic cancer is four to six months, and the five-year survival rate is 7.2%.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Tisotumab Vedotin</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Tisotumab vedotin is an ADC composed of Genmab&#8217;s human monoclonal antibody directed against cell surface tissue factor and Seagen&#8217;s ADC technology that utilizes a protease-cleavable linker that covalently attaches the microtubule-disrupting agent monomethyl auristatin E (&#8220;MMAE&#8221;) to the antibody. MMAE disrupts the microtubule network of actively dividing cells, leading to cell cycle arrest and apoptotic cell death of actively dividing cells. In vitro, tisotumab vedotin also mediates antibody-dependent cellular phagocytosis and antibody-dependent cellular cytotoxicity. We have an exclusive license</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> from Seagen Inc. (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8220;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Seagen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">) (a company later acquired by Pfizer Inc. (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8220;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Pfizer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">)) to develop and commercialize t</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">isotumab vedotin in Greater China. We purchase the licensed products exclusively from Pfizer. For more information on this agreement, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Overview of Significant License and Collaboration Agreements &#8211; Pfizer (Tisotumab Vedotin)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We are evaluating tisotumab vedotin for the treatment of adult patients in Greater China with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy. Tisotumab vedotin has already been approved in the United States for this indication. We are participating in the Greater China portion of the global Phase III innovaTV 301 study in recurrent or metastatic cervical cancer with disease progression on or after front-line therapy who received tisotumab vedotin, compared with chemotherapy alone. In October 2023, our partner Seagen and Genmab A/S announced that the innovaTV 301 study met its primary endpoint of OS. An Independent Data Monitoring Committee determined that OS crossed the pre-specified efficacy boundary at interim analysis. The key secondary endpoints of investigator-assessed progression-free survival and objective response rate also demonstrated statistical significance. The safety profile of tisotumab vedotin in innovaTV 301 was consistent with the known safety profile of tisotumab vedotin as presented in the U.S. prescribing information, and no new safety signals were observed. We have completed patient enrollment in the Greater China portion of the innovaTV 301 study. We estimate that there are around 110,000 new cases of cervical cancer each year in China.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Adagrasib</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Adagrasib is a highly selective and potent oral small-molecule inhibitor of KRAS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:139%;position:relative;top:-3.5pt;vertical-align:baseline">G12C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> for treating KRAS-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:139%;position:relative;top:-3.5pt;vertical-align:baseline">G12C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">-mutated solid tumors, including NSCLC, colorectal cancer (&#8220;CRC&#8221;), and pancreatic cancer. We have an exclusive license from Mirati Therapeutics, Inc. (&#8220;Mirati&#8221;) (a company later acquired by BMS) to develop and commercialize adagrasib in Greater China. We purchase the licensed products exclusively from BMS. For more information on this agreement, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Overview of Significant License and Collaboration Agreements </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">&#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">BMS (Adagrasib)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We are evaluating adagrasib for the treatment of KRAS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:139%;position:relative;top:-3.5pt;vertical-align:baseline">G12C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">-mutated NSCLC and second-line colorectal cancer.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:14.5pt">Second-Line+ NSCLC: </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We are participating in the Greater China portion of the global Phase III KRYSTAL-12 study evaluating adagrasib in previously treated patients with KRAS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:139%;position:relative;top:-3.5pt;vertical-align:baseline">G12C</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">-mutated NSCLC. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Adagrasib has already been approved in the United States for the treatment of patients with NSCLC who harbor the KRAS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:139%;position:relative;top:-3.5pt;vertical-align:baseline">G12C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> mutation who have received at least one prior systemic therapy. We seek to leverage the global data package for the FDA approval, the ongoing PK study in China, and the global confirmatory KRYSTAL-12 study to obtain regulatory approval in China</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> and are preparing to submit a New Drug Application (&#8220;NDA&#8221;) to the NMPA later this year</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:14.5pt">First-Line NSCLC:</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We are participating in the Greater China portion of the global Phase II KRYSTAL-7 study evaluating adagrasib in combination with pembrolizumab in first-line KRAS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:139%;position:relative;top:-3.5pt;vertical-align:baseline">G12C</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">-mutated NSCLC patients. In October 2023, our partner Mirati announced updated results from this study, which demonstrate a manageable safety profile and early signs of durability of adagrasib in combination with a checkpoint inhibitor in the first-line NSCLC setting.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-7-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:14.5pt">2L Colorectal Cancer: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We are participating in, and have completed enrollment for, the Greater China portion of the global Phase III KRYSTAL-10 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">trial of adagrasib in combination with cetuximab versus chemotherapy in patients with previously treated advanced KRAS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:139%;position:relative;top:-3.5pt;vertical-align:baseline">G12C</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">-mutated colorectal cancer. In February 2024, Mirati announced that the FDA had accepted its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">supplemental NDA (&#8220;sNDA&#8221;)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> for priority review for adagrasib in combination with cetuximab for the treatment of patients with previously treated KRAS</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:139%;position:relative;top:-3.5pt;vertical-align:baseline">G12C</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">-mutated locally advanced or metastatic colorectal cancer, with a PDUFA goal date of June 21, 2024.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We estimate that there are around 42,000 patients in China each year with these NSCLC and colorectal cancer indications.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Bemarituzumab</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Bemarituzumab is a humanized monoclonal antibody (IgG1 isotype) specific to the human fibroblast growth factor receptor 2 isoforma IIb (&#8220;FGFR2b&#8221;) that is in clinical development as a targeted therapy for gastric and gastroesophageal junction (&#8220;GEJ&#8221;) cancer patients whose tumors overexpress FGFR2b. We have an exclusive license from Five Prime Therapeutics, Inc. (&#8220;Five Prime&#8221;) (a company later acquired by Amgen Inc. (&#8220;Amgen&#8221;)) to develop and commercialize bemarituzumab in Greater China. We purchase the licensed products exclusively from Amgen. For more information on this agreement, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Overview of Significant License and Collaboration Agreements </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">&#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Amgen (Bemarituzumab)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We are evaluating bemarituzumab for the treatment of gastric and GEJ cancer. We are participating in the Greater China portion of the global Phase III </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">FORTITUDE-101 study of bemarituzumab plus chemotherapy, versus placebo plus chemotherapy, in first-line gastric cancer with FGFR2b overexpression. In addition, we are participating in the Greater China portion of the global Phase III FORTITUDE-102 study of bemarituzumab in combination with nivolumab and chemotherapy in first-line gastric or GEJ cancer. We estimate an annual incidence of around 126,000 first-line HER2- FGFR2b+ gastric cancer patients in China and around 76,000 of these patients have FGFR2b expression over 10%.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Repotrectinib</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Repotrectinib is a next-generation tyrosine kinase inhibitor (&#8220;TKI&#8221;) that targets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">ROS1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> oncogenic fusions. We have an exclusive license from Turning Point Therapeutics (a wholly owned subsidiary of BMS) to develop and commercialize repotrectinib in Greater China. We purchase the licensed products exclusively from BMS. For more information on this  agreement, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Overview of Significant License and Collaboration Agreements </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">&#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">BMS (Repotrectinib)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We are evaluating repotrectinib for the treatment of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">ROS1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">+ NSCLC and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">NTRK</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">+ solid tumors and are participating in the Greater China portion of the global Phase I/II TRIDENT-I study for the treatment of TKI-na&#239;ve and TKI-pretreated patients with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">ROS1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">-positive locally advanced or metastatic NSCLC and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">NTRK</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">-positive advanced solid tumors.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%;padding-left:14.5pt">ROS1</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">+ NSCLC: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In August 2023, our partner BMS announced updated results from the registrational Phase I/II TRIDENT-1 study, demonstrating that repotrectinib continued to demonstrate high response rates and durable responses, including robust intracranial responses in patients with ROS1-positive locally advanced or metastatic NSCLC. In November 2023, based on results from the TRIDENT-1 trial, the FDA approved repotrectinib for the treatment of adult patients with locally advanced or metastatic </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">ROS1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">-positive NSCLC. In August 2023, we submitted an NDA to the NMPA for repotrectinib for the same indication, which has been accepted with priority review. We estimate an annual incidence of around 14,000-21,000 patients in China with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">ROS1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">-positive metastatic NSCLC.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%;padding-left:14.5pt">NTRK</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">+ Solid Tumors: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In August 2023, the NMPA granted Breakthrough Therapy Designation (&#8220;BTD&#8221;) for repotrectinib for the treatment of patients with advanced solid tumors that have a neurotrophic tropomyosin-receptor kinase (&#8220;NTRK&#8221;) gene fusion who have progressed following treatment with TRK TKIs. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">NTRK</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">+ is estimated to be an oncogenic driver in approximately 0.5% of patients with a variety of advanced solid tumors. <br/><br/>This is the fourth BTD granted by the NMPA for repotrectinib. The NMPA previously granted BTDs for repotrectinib for the treatment of patients with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">ROS1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">-positive metastatic NSCLC who have not been treated with a </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-8-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">ROS1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> TKI; for the treatment of patients with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">ROS1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">-positive metastatic NSCLC who have received one prior line of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">ROS1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> TKI and one prior line of platinum-based chemotherapy; and for the treatment of patients with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">ROS1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">-positive metastatic NSCLC who have received one prior line of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">ROS1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> TKI and no chemotherapy or immunotherapy. These BTDs were supported by data from the TRIDENT-1 study.<br/><br/>In February 2024, BMS announced that, based on the results of the TRIDENT-1 trial, the FDA has accepted its sNDA for repotrectinib for the treatment of adult and pediatric patients 12 years of age and older with solid tumors that have a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">NTRK</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> gene fusion, and are locally advanced or metastatic or where surgical resection is likely to result in severe morbidity. The application was granted priority review status, with a Prescription Drug User Fee Act (&#8220;PDUFA&#8221;) goal date of June 15, 2024.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Our Autoimmune Disorder, Infectious Disease, and Neuroscience Pipeline</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Additional Opportunities for Efgartigimod</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">As discussed in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Our Commercial Products and Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">, we have an exclusive license from argenx to develop and commercialize efgartigimod in Greater China, and we have commercially launched VYVGART (efgartigimod alfa injection) in mainland China for the treatment of adult patients with gMG. In addition, a subcutaneous formulation of efgartigimod (&#8220;SC efgartigimod&#8221;) is being evaluated for the treatment of adult patients with gMG, and we are evaluating significant additional indications including the treatment of chronic inflammatory demyelinating polyneuropathy (&#8220;CIDP&#8221;).  </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:14.5pt">gMG:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> In July 2023, the NMPA accepted our supplemental BLA (&#8220;sBLA&#8221;) for SC efgartigimod for the treatment of adult patients with gMG. In June 2023, our partner argenx announced that the FDA approved VYVGART Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) injection for subcutaneous use in gMG in the United States.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:14.5pt">CIDP:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In September 2023, the NMPA granted BTD for SC efgartigimod for the treatment of patients with CIDP. This BTD was supported by data from both global and Chinese patients enrolled in the ADHERE study. The ADHERE study met its primary endpoint, demonstrating a significantly lower risk of relapse with efgartigimod SC compared to placebo (p=0.000039). Efgartigimod SC demonstrated a 61% reduction (HR: 0.39 95% CI: 0.25; 0.61) in the risk of relapse versus placebo, and 67% of patients in open-label Stage A demonstrated evidence of clinical improvement, indicating that IgG autoantibodies play a significant role in the underlying biology of CIDP. The safety and tolerability profile was consistent with previous clinical trials and the confirmed safety profile of efgartigimod. We participated in the Greater China portion of this study. We estimate that there are around 50,000 CIDP patients diagnosed in China. In February 2024, argenx announced that the FDA had accepted its sBLA for efgartigimod SC in CIDP with priority review, with a PDUFA goal date of June 21, 2024. We plan to submit an sBLA to the NMPA for this indication later this year.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Sulbactam/Durlobactam</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Sulbactam/durlobactam (&#8220;SUL-DUR&#8221;) is a combination of a beta-lactam antibiotic (sulbactam) and a beta-lactamase inhibitor (durlobactam). We have an exclusive license from Entasis Therapeutics, Inc. (&#8220;Entasis&#8221;), a wholly owned subsidiary of Innoviva, Inc. (&#8220;Innoviva&#8221;), to develop and commercialize durlobactam with sulbactam (the combination, SUL-DUR) in Greater China, Korea, Vietnam, Thailand, Cambodia, Laos, Malaysia, Indonesia, the Philippines, Singapore, Australia, New Zealand, and Japan. We purchase the licensed products exclusively from Innoviva. For more information on this agreement, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Overview of Significant License and Collaboration Agreements </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">&#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Innoviva (SUL-DUR)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We are evaluating SUL-DUR for the treatment of serious infections caused by </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Acinetobacter</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">, including multidrug-resistant (&#8220;MDR&#8221;) and carbapenem-resistant (&#8220;CRAB&#8221;) strains. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Acinetobacter</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> belongs to a group of bacteria commonly found in the environment, such as soil and water. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Acinetobacter baumannii</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> accounts for most </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Acinetobacter</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> infections in humans; the organism can cause infections in all organs, but bloodstream infection and pneumonia are most dangerous and associated with high mortality. In recent years, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Acinetobacter baumannii</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> has become multi-drug resistant. For carbapenem-resistant </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Acinetobacter baumannii</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> infections, treatment options are extremely limited because remaining antibiotics are either toxic or of limited efficacy. In mainland China, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Acinetobacter baumannii</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> infections are often seen in the hospital </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-9-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">setting. Based on the 2022 Annual Report of CARSS (China Antimicrobial Resistance Surveillance System), there were around 300,000 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Acinetobacter</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> infections reported in mainland China in 2022. According to recent surveillance data from China, overall resistance of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Acinetobacter baumannii</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> to the carbapenem class of antibiotics is approximately 53%, with some provinces as high as 70%. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We participated in the Greater China portion of the global Phase III registrational ATTACK trial evaluating the safety and efficacy of SUL-DUR versus colistin in patients with infections caused by </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Acinetobacter baumannii</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">. The ATTACK trial met its primary efficacy endpoint, demonstrating a reduced mortality rate with SUL-DUR versus colistin in the CRAB population. SUL-DUR also met the primary safety objective of the study achieving statistically significant reduction in nephrotoxicity. In May 2023, our partner Innoviva announced that the FDA approved XACDURO for the treatment of adults with hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia caused by susceptible strains of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Acinetobacter baumannii-calcoaceticus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> complex. Our NDA for the treatment of infections caused by </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Acinetobacter baumannii</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">, including MDR and CRAB strains, was accepted by the NMPA in February 2023 and has been granted priority review status. Results of the ATTACK trial were published in Lacent Infectious Diseases [Kaye et al.]</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Xanomeline-Trospium</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Xanomeline-trospium (&#8220;Kar XT&#8221;) is a combination of an oral M1/M4-preferring muscarinic acetylcholine receptor agonist and an antimuscarinic agent, which combination is in development for the treatment of psychiatric and neurological conditions, including schizophrenia and dementia-related psychosis. Xanomeline-trospium preferentially stimulates muscarinic receptors in the central nervous system implicated in these conditions, as opposed to current antipsychotic medicines, which mostly target dopamine or serotonin receptors. Xanomeline-trospium has the potential to represent a new class of treatment for schizophrenia and dementia-related psychosis based on its differentiated mechanism of action. We have an exclusive license from Karuna Therapeutics, Inc. (&#8220;Karuna&#8221;) to develop, manufacture, and commercialize xanomeline-trospium in Greater China. For more information on this agreement, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Overview of Significant License and Collaboration Agreements </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%"> Karuna (Xanomeline-Trospium)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We are evaluating Kar XT</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> for the treatment of schizophrenia and Alzheimer&#8217;s disease with psychosis (&#8220;ADP&#8221;).</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:14.5pt">Schizophrenia:</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In November 2023, our partner Karuna announced that, supported by data from its three positive registrational EMERGENT trials, the FDA had accepted Karuna&#8217;s NDA for KarXT for the treatment of schizophrenia, with a PDUFA goal date of September 26, 2024. We are conducting a registrational bridging study in mainland China.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> We estimate that there are more than 8 million people living with schizophrenia in China.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:14.5pt">ADP: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our partner Karuna initiated the Phase III ADEPT program in ADP in the third quarter of 2023. We are preparing to join the Greater China portion of the global Phase III ADEPT-2 and ADEPT-3 trials. We estimate that around 8 million people are affected by Alzheimer</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">s disease in China and around 45% of these patients display psychotic symptoms. </span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Overview of Significant License and Collaboration Agreements</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We have entered into various license and collaboration agreements with third parties, such as biopharmaceutical companies with innovative products in our therapeutic areas and external research parties, for the development and commercialization of our products and product candidates. We are generally required to make upfront payments upon our entry into such agreements and milestone payments upon the achievement of certain development, regulatory, and sales-based milestones for the licensed products under these agreements as well as certain royalties at tiered percentage rates based on annual net sales of the licensed products in the licensed territories. For a discussion of aggregate potential payments under our license and collaboration arrangements, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Note 16</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">MD&amp;A &#8211; License and Collaboration Arrangements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">These agreements may include intellectual property rights associated with the products or product candidates, including the responsibility for obtaining and maintaining patents as well as enforcement of those patents.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-10-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">These agreements generally remain in effect, unless earlier terminated, until the expiration of the last-to-expire royalty term for the last licensed product. The royalty terms generally continue until the latest of: (i) the expiration of the last-to-expire valid claim with respect to licensed patent rights; (ii) the expiration of market or regulatory exclusivity; or (iii) or a specified period of time, generally around ten years, after the date of the first commercial sale of the licensed product. These agreements also contain customary provisions for termination by either party, including in the event of a material breach by the other party that remains uncured; by us for convenience upon a specified notice period; for certain bankruptcy, insolvency, or other similar events; and by our partners upon challenge of their licensed patent rights. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following sections provide additional information on the license and collaboration arrangements for our commercial products and significant product candidates, such as the scope of the licensed products and licensed territories and any related supply arrangements. We have also entered into other license and collaboration arrangements that are not considered significant to our business at this time, such as because they relate to earlier stage assets. Such other license agreements may become material to our business in the future.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">GSK (Niraparib)</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In September 2016, we entered into a collaboration, development, and license agreement with Tesaro, Inc., a company later acquired by GSK, pursuant to which we obtained an exclusive sublicense under certain patents and know-how of GSK (including such patents and know-how licensed from Merck, Sharp &amp; Dohme Corp., a subsidiary of Merck &amp; Co., Inc., and AstraZeneca UK Limited) to develop, manufacture, and commercialize GSK&#8217;s proprietary PARP inhibitor, niraparib (ZEJULA), for the diagnosis and prevention of any human diseases or conditions (other than prostate cancer) in mainland China, Hong Kong, and Macau. We also obtained the right of first negotiation to obtain a license to develop and commercialize certain follow-on compounds of niraparib being developed by GSK in the licensed territory. Under the agreement, we agreed not to research, develop, or commercialize certain competing products, and we also granted GSK the right of first refusal to license certain immuno-oncology assets developed by us. In February 2018, we entered into an amendment with GSK that eliminated GSK&#8217;s option to co-market niraparib in the licensed territory. We have agreed to purchase ZEJULA from GSK for commercial use in Hong Kong. We are not otherwise obligated to purchase ZEJULA or other licensed products from GSK.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">NovoCure (Tumor Treating Fields)</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In September 2018, we entered into a license and collaboration agreement with NovoCure, pursuant to which we obtained an exclusive license under certain patents and know-how of NovoCure to develop and commercialize any Tumor Treating Fields (OPTUNE) products in all human therapeutic and preventative uses in the field of oncology in Greater China. We will purchase the licensed products exclusively from NovoCure. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Deciphera (Ripretinib)</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In June 2019, we entered into a license agreement with Deciphera, pursuant to which we obtained an exclusive license under certain patents and know-how of Deciphera to develop and commercialize products containing ripretinib (QINLOCK) in the field of prevention, prophylaxis, treatment, cure, or amelioration of any disease or medical condition in humans in Greater China. We will purchase the licensed products exclusively from Deciphera.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Novo Holdings (Omadacycline)</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In April 2017, we entered into a license and collaboration agreement with Paratek Bermuda Ltd., a subsidiary of Paratek (which was subsequently acquired by Gurnet Point Capital and Novo Holdings A/S), pursuant to which we obtained both an exclusive license under certain patents and know-how of Paratek Bermuda Ltd. and an exclusive sub-license under certain intellectual property that Paratek Bermuda Ltd. licensed from Tufts University to develop, manufacture, and commercialize products containing omadacycline (NUZYRA) as an active ingredient in the field of all human therapeutic and preventative uses other than biodefense in Greater China. Under certain circumstances, our exclusive sub-license to certain intellectual property Paratek Bermuda Ltd. licensed from Tufts University may be converted to a non-exclusive license if Paratek Bermuda Ltd.&#8217;s exclusive license from Tufts University is converted to a </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-11-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">non-exclusive license under the Tufts Agreement. We also obtained the right of first negotiation to be Paratek Bermuda Ltd.&#8217;s partner to develop certain derivatives or modifications of omadacycline in our licensed territory. Paratek Bermuda Ltd. retains the right to manufacture the licensed product in our licensed territory to support development and commercialization of the same outside of our licensed territory. We also granted Paratek Bermuda Ltd. a non-exclusive license to certain of our intellectual property. Under the agreement, we agreed not to commercialize certain competing products in our licensed territory. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">argenx (Efgartigimod)</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In January 2021, we entered into a collaboration and license agreement with argenx, pursuant to which we obtained an exclusive license under certain patents and know-how of argenx to develop and commercialize products containing efgartigimod (including VYVGART) as an active ingredient in all human and animal uses for any preventative or therapeutic indications in Greater China. Under the terms of the agreement, we are responsible for recruiting patients in mainland China to argenx&#8217;s global registrational trials for the development of efgartigimod. We will purchase the licensed products exclusively from argenx.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Pfizer (Tisotumab Vedotin)</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">September 2022, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">we entered into a collaboration and license agreement with Seagen (a company later acquired by Pfizer), pursuant to which we obtained an exclusive license to develop and commercialize tisotumab vedotin in Greater China. We will purchase the licensed products exclusively from Pfizer.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">BMS (Adagrasib)</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In May 2021, we entered into a collaboration and license agreement with Mirati (a company later acquired by BMS) pursuant to which we agreed to collaboratively develop MRTX849 (adagrasib) in Greater China. Under the agreement, we received the right to research, develop, manufacture, and exclusively commercialize adagrasib in all indications in Greater China, with BMS retaining exclusive rights for the development, manufacturing, and commercialization of adagrasib outside of Greater China as well as certain co-commercialization, manufacture, and development rights in Greater China. We will purchase the licensed products exclusively from BMS.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Amgen (Bemarituzumab)</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In December 2017, we entered into a license and collaboration agreement with Five Prime (later acquired by Amgen), pursuant to which we obtained an exclusive license under certain patents and know-how of Five Prime to develop and commercialize products containing Five Prime&#8217;s proprietary afucosylated FGFR2b antibody known as bemarituzumab (FPA144) as an active ingredient in the treatment or prevention of any disease or condition in humans in Greater China. We will purchase the licensed products exclusively from Amgen.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Pursuant to the terms of the agreement, we are responsible for (i) developing and commercializing licensed products under a territory development plan; and (ii) performing certain development activities to support global development and registration of licensed products, including the global Phase III registrational trial of bemarituzumab (FPA144) in combination with FOLFOX in front-line gastric and gastroesophageal cancer (the &#8220;bemarituzumab FPA144-004 Study&#8221;) in the licensed territory under a global development plan. If we enroll and treat a specified number of patients in the bemarituzumab FPA144-004 Study in mainland China, we will be eligible to receive a low single-digit percentage quarterly royalty on annual net sales of the licensed products outside of the licensed territory until the tenth anniversary of the first commercial sale of each such licensed product outside of the licensed territory. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">BMS (Repotrectinib)</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In July 2020, we entered into an exclusive license agreement with Turning Point (a company later acquired by BMS) pursuant to which we obtained an exclusive license to develop and commercialize products containing repotrectinib as an </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-12-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">active ingredient in all human therapeutic indications in Greater China. We will purchase the licensed products exclusively from BMS.  </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Innoviva (Sulbactam-Durlobactam)</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In April 2018, we entered into a license and collaboration agreement with Entasis, a wholly owned subsidiary of Innoviva, pursuant to which we obtained an exclusive license under certain patents and know-how of Entasis to develop and commercialize Entasis&#8217;s proprietary compounds, durlobactam with sulbactam (the combination, SUL-DUR) with the possibility of developing and commercializing a combination of such compounds with imipenem in all human diagnostic, prophylactic and therapeutic uses in Greater China, Korea, Vietnam, Thailand, Cambodia, Laos, Malaysia, Indonesia, the Philippines, Singapore, Australia, New Zealand, and Japan. Our rights to develop and commercialize the licensed products are limited to the lead product (Sulbactam) until such lead product receives initial FDA approval in the United States. We will purchase the licensed products exclusively from Innoviva.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Pursuant to the terms of the agreement, we are responsible for (i) developing and commercializing the licensed products in the territory under a mutually agreed development plan; and (ii) providing Entasis (or its CRO) with clinical and financial support in the territory for the global pivotal Phase III ATTACK clinical trial of SUL-DUR as set forth in mutually agreed development plans. We are also responsible for a portion of the costs of the global pivotal Phase III ATTACK clinical trial of SUL-DUR outside of the licensed territory. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Karuna (Xanomeline-Trospium)</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In November 2021, we entered into a license agreement with Karuna, pursuant to which we agreed to collaboratively develop xanomeline-trospium (KarXT) in Greater China. Under the agreement, we obtained an exclusive license to develop, manufacture, and commercialize xanomeline-trospium in Greater China. </span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Intellectual Property</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our commercial success depends, in part, on our ability to obtain and maintain proprietary protection for our know-how and innovation pertaining to our commercial products and product candidates as well as our core technologies; to operate without infringing, misappropriating, or otherwise violating the proprietary rights of others; and to prevent others from infringing, misappropriating, or otherwise violating our proprietary rights. We expect that we will seek to protect our proprietary position by, among other methods, licensing or procuring patent rights to inventions that are important to the development and implementation of our business. We also rely on trade secrets, know-how, and confidential agreements with third parties to maintain our proprietary position. Additionally, we rely on continuing technological innovation to develop and maintain our proprietary position. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Patents</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Patent rights are important in our industry to protect innovation pertaining to our commercial products, product candidates, and technologies. We hold patent rights to our commercial products, product candidates, and technologies, in part, through our licenses or other agreements. For our internally developed product candidates, we consider on a case-by-case basis whether to procure patent rights to protect certain innovation pertaining to our commercial products, product candidates and technologies. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">As with other biotechnology and pharmaceutical companies, our ability to protect our commercial products, product candidates, and technologies will depend, in part, on our success in obtaining and maintaining effective patent rights. For more information regarding the risks related to our intellectual property, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Risk Factors </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">&#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Risks Related to Intellectual Property</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The term of a patent depends upon the laws of the country in which it is issued. In most jurisdictions that we principally operate in, a patent term is 20 years from the earliest filing date of a non-provisional patent application. The laws of each jurisdiction vary, and patent term adjustment or patent term extension may not be available in any or all </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-13-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">jurisdictions in which we hold rights. For information on intellectual property included in our license and collaboration agreements for our commercial products, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Overview of Significant Licensed and Collaboration Arrangements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Trade Secrets</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In addition to patents, we rely upon unpatented trade secrets and know-how and continuing technological innovation to develop and maintain our competitive position. Such trade secrets and know-how can be difficult to protect. We seek to protect our proprietary information, in part, by executing confidentiality agreements with our partners, collaborators, scientific advisors, employees, consultants, and other third parties. These confidentiality agreements are designed to protect our proprietary information and generally include clauses requiring assignment of inventions to us to grant us ownership of technologies that are developed through our relationship with the respective counterparty. Such agreements may not provide adequate protection of our intellectual property and proprietary information rights. If any of the parties we contract with in this manner breaches or violates the terms of any such agreement or otherwise discloses our proprietary information, we may lose our competitive position and trade secret protection. For more information regarding the risks related to our trade secrets, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Risk Factors </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">&#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Risks Related to Intellectual Property &#8211; If we are unable to maintain the confidentiality of our trade secrets, our business and competitive position may be harmed</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Trademarks and Domain Names</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We conduct our business using trademarks with various forms of the &#8220;ZAI LAB&#8221; and &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#20877;&#40718;&#21307;&#33647;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221; brands, as well as domain names incorporating some or all of these trademarks. </span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Government Regulation</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Chinese Government Regulation of Pharmaceutical Product Development, Approval, and Marketing</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Since mainland China&#8217;s entry into the World Trade Organization in 2001, the Chinese government has made significant efforts to standardize regulations, develop its pharmaceutical regulatory system and strengthen intellectual property protection. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Drug Administration Law and related implementing measures established the legal framework for the administration of pharmaceutical products, including the development and manufacturing of new drugs and the medicinal preparations by medical institutions. The Drug Administration Law also regulates the distribution, packaging, labels and advertisements of pharmaceutical products in mainland China, including the use of patients&#8217; human genetic resources and derived data. These rules are highly complex and require significant resources, time, and expense for compliance. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%;text-decoration:underline">Clinical Trials</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%"> </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Clinical trials conducted both within and outside of mainland China, and the data derived from those trials, may be used to obtain marketing approval in mainland China, subject to various rules and regulations. We participate in clinical trials in multiple geographic locations, and compliance with the complex regulations applicable to the conduct of such trials and the use of data derived therefrom is critical to our ability to obtain approval for our products in mainland China and in our other markets.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Clinical trials on investigational products must be approved by the relevant authorities before their commencement. Following approval of a Clinical Trial Application (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">CTA</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">) approval, the applicant (i.e., sponsor) generally conducts the clinical trial at one or more institutions, subject to rules and regulations governing good practices associated with such clinical trial. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">With certain governmental approvals, companies may simultaneously perform clinical trials in different centers using the same clinical trial protocol through International Multi-Center Clinical Trials in China (the &#8220;IMCCTs&#8221;). Where the applicant plans to make use of the data derived from the IMCCTs, such IMCCTs shall satisfy certain requirements, including on-site inspections by Chinese regulatory authorities, in addition to other applicable regulatory requirements. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-14-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">IMCCTs are required to adhere to certain principles and ethical requirements and are subject to governmental supervision and disclosure requirements. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Trial sponsors may also use the data of foreign clinical trials to support marketing authorization in mainland China, provided that sponsors satisfy the authenticity, completeness, accuracy, and traceability requirements, and that such data is obtained in accordance with the relevant principles and ethics requirements applicable to IMCCTs. Clinical trial sponsors must be attentive to potentially meaningful ethnic differences in the subject population. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In addition, investigational products approved outside of mainland China may be approved in mainland China on a conditional basis without pre-approval clinical trials being conducted in mainland China. Applicants are required to establish a risk mitigation plan and may be required to complete post-approval trials in mainland China. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%;text-decoration:underline">Marketing</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We must obtain approval of marketing authorizations before our products can be manufactured and sold in the mainland China market. An applicant may submit an application for marketing authorization to relevant governmental authorities. The NMPA, which monitors and supervises the administration of pharmaceutical products, medical appliances and equipment, and cosmetics, then determines whether to approve the application following a technical review process. Accelerated review and approval procedures are available for certain types of innovative products, such as products with distinctive clinical benefits, which have not been sold within or outside mainland China, and products using advanced technology, innovative treatment methods, or distinctive treatment advantages, and in cases of public health emergency.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Domestic pharmaceutical and medical research and development institutions and individuals are eligible to hold marketing authorizations without having to become manufacturers. The marketing authorization holder is responsible for their products throughout the life cycle, including nonclinical studies, clinical trials, production and distribution, post-market studies, and the monitoring, reporting, and handling of adverse reactions in connection with pharmaceuticals. The marketing authorization holders may engage contract manufacturers for manufacturing and distribution, subject to certain requirements. We serve as the marketing authorization holder and thus have primary regulatory responsibility for the development and approval of certain of our products in China.</span></div><div style="margin-top:9pt;text-indent:22.3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%;text-decoration:underline">Drug Manufacturing Operations</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">To manufacture pharmaceutical products in mainland China, a pharmaceutical manufacturing enterprise must first obtain a Pharmaceutical Manufacturing Permit issued by the relevant provincial medical products administration where the enterprise is located, which is effective for five years. The grant of such license is subject to annual inspection of the manufacturing facilities, production premises and facilities, equipment, hygiene conditions, production management, quality controls, product operation, raw material management, maintenance of sales records, and management of customer complaints and adverse event reports. </span></div><div style="margin-top:9pt;text-indent:22.3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%;text-decoration:underline">Pharmaceutical Distribution</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">To distribute pharmaceutical products in mainland China, including wholesale and retail distribution, a pharmaceutical distribution enterprise must first obtain a Pharmaceutical Distribution Permit, which is effective for five years. Any enterprise holding a Pharmaceutical Distribution Permit is subject to periodic review and inspection by the relevant regulatory authorities. Additional rules and regulations govern the process of procurement, storage, sales, and transportation. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Coverage and Reimbursement </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Historically, most Chinese healthcare costs had been borne by patients out-of-pocket, which had limited the growth of more expensive pharmaceutical products. However, in recent years, the number of people covered by government and private insurance has increased. According to the National Healthcare Security Administration (&#8220;NHSA&#8221;), as of December 2022, approximately 1.34 billion residents in mainland China were enrolled in the Basic Medical Insurance scheme, representing a coverage rate of above 95% of the total population. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-15-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Under the applicable regulations, expenses of drugs listed in the Basic Medical Insurance Catalog, typically known in the industry as the &#8220;NRDL&#8221;, will be paid in full or part from the basic medical insurance fund in accordance with applicable provisions, and the drugs with the same generic names as those specified in the Basic Medical Insurance Catalog will be automatically regulated by the Basic Medical Insurance Catalog and shall also be eligible for the reimbursement by the basic medical insurance fund. The Chinese Ministry of Human Resources and Social Security, together with other government authorities, have the power to determine the medicines included in the NRDL. Admission to the NRDL depends on a number of factors, including on-market experience, scale of patient adoption, physician endorsement, cost effectiveness, and budget impact. Patients purchasing medicines included in the NRDL are entitled to reimbursement of the entire amount or a certain percentage of the purchase price. We currently have four products included in the NRDL: ZEJULA for certain ovarian cancer indications, QINLOCK for fourth-line GIST, NUZYRA for CABP and ABSSSI, and VYVGART (efgartigimod alfa injection) for gMG. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In addition to the NRDL, there is an evolving medical insurance system that makes innovative drugs more affordable and available to the Chinese population, which offers greater opportunities to drug manufacturers that focus on the research and development of innovative drugs, such as higher-cost cancer therapeutics. This system includes commercial health insurance and various forms of supplementary insurance. We have focused on increasing insurance coverage in the private-pay market for certain of our commercial products and indications, including OPTUNE for GBM. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Inclusion in the NRDL and supplemental insurance coverage can significantly increase the reach and visibility of, and potential market for, our products, and we continue to devote significant resources to increasing access to our products through NRDL listing and/or supplemental insurance coverage, which efforts may not be successful on our desired timeline or at all.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%;text-decoration:underline">Price Negotiations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%"> </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Chinese government has initiated several rounds of price negotiations with manufacturers of patented drugs, drugs with an exclusive source of supply, and oncology drugs since 2016. Once the government agreed with the drug manufacturers on the supply prices, the drugs would be automatically listed in the NRDL and qualified for public hospital purchase. In 2023, the average price reduction of the 121 drugs participating in price negotiations was 61.7%, and in 2022, the average price reduction of the 111 drugs participating in negotiations was 60.1%. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Regulations Impacting Purchases of Pharmaceutical Products by Medical Institutions</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Applicable regulations set forth rules for the tender process and negotiations of the prices of drugs, operational procedures, a code of conduct, and standards or measures of evaluating bids and negotiating prices for public hospitals in mainland China. Under the rules and related guidance, certain not-for-profit medical institutions owned by the government shall purchase pharmaceutical products by online centralized procurement. The centralized tender process takes the form of public tender operated and organized by provincial or municipal government agencies. Only pharmaceuticals that have won in the centralized tender process may be purchased by public medical institutions funded by the governmental or state-owned or -controlled enterprise in the relevant region. While participation in this process can increase the reach and acceptance of our products, it can also result in significant negotiated reductions in the price paid for the products by hospitals or consortiums of hospitals bidding as a group.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In addition, under the &#8220;two-invoice system,&#8221; there cannot be more than two invoices issued for drug products supplied by manufacturers to public hospitals. To meet this requirement, many drug manufacturers have reduced the tiers of distributors, or converted drug distributors into contracted service organizations. As a result, the system significantly limits the options for companies like us to use multiple distributors to reach a larger geographic area in mainland China. The reduction in distribution tiers resulted in a decrease in distribution mark-ups and an accompanying reduction in prices paid by public hospitals. Compliance with the two-invoice system is a prerequisite for pharmaceutical companies to participate in the tender and procurement processes of public hospitals, which currently provide most of Chinese healthcare services. Manufacturers and distributors that fail to implement the two-invoice system may lose their qualifications to participate in the tender and procurement process and may also be blacklisted from engaging in drug sales to public hospitals. The two-invoice system has been implemented in all provinces, each with its own regional implementation rules. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-16-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Regulation of Pharmaceutical Product Development and Approval Outside of China</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In the United States, the FDA regulates drugs and biological products under the Federal Food, Drug, and Cosmetic Act, the Public Health Service Act, and their implementing regulations. Drugs and biologics are also subject to other federal, state, and local statutes and regulations in the United States as well as laws, regulations, and rules in other applicable jurisdictions outside of mainland China. The process of obtaining marketing approvals and the subsequent compliance with applicable laws, regulations, and rules may require the expenditure of substantial time and financial resources. While we do not currently market our products outside of Greater China, we have certain pre-clinical and early-stage clinical products that are undergoing or will undergo testing in the United States and other jurisdictions, and we may in the future seek approval to commercialize our products in the United States and such other jurisdictions. As our business and the number of products we have in the trial and commercial stage grow, we expect that pharmaceutical laws and regulations in the United States and other jurisdictions will have a greater impact on us. Further, U.S. and other pharmaceutical regulations could impact the availability, reputation, and consumer acceptance of the products that we market and sell in our current markets.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Other Significant Regulations Affecting Our Business Activities in Mainland China </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We are subject to additional regulations that apply broadly to companies doing business in mainland China, including those described below.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%;text-decoration:underline">Data Privacy and Data Protection</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">: Since our subsidiaries located in mainland China operate computer networks as part of their normal operations, we are required to comply with the requirements of mainland China&#8217;s cyber security, data protection, privacy, and data transfer laws and regulations. In addition, in the ordinary course of our business, we collect and store personal information, including personal information about our clinical trial subjects, customers, and employees in mainland China. We may need to share such personal information with our subsidiaries, licensors, partners, or contractors located outside of mainland China. Mainland China&#8217;s network and data protection regime is evolving, and we continue to face uncertainties as to whether our efforts to comply with these requirements will be sufficient. Although we develop and maintain compliance protocols and controls designed to maintain compliance with these requirements, development, implementation, improvement, and maintenance of these protocols and controls is costly and requires significant effort, resources, and time. In addition, in certain cases, our CROs, licensors, licensees, partners, contractors, and other third parties with which we do business are also required to comply with these laws, and our agreements with them require them to comply with these requirements, but there is a risk that they may not fully comply with them.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%;text-decoration:underline">Foreign Investment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">: Chinese laws and regulations govern the establishment, operation, and management of corporate entities in mainland China, as well as investment activities by foreign investors in mainland China. To comply with these rules, we must periodically submit certain information regarding our Company and certain investment information to relevant administrative authorities.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%;text-decoration:underline">Competition Laws</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">: Under Chinese laws governing competition, commercial bribery is prohibited and subject to criminal liability. Further, under certain circumstances, a pharmaceutical company&#8217;s products may not be purchased by public medical institutions where that pharmaceutical company is involved in a criminal investigation or administrative proceedings related to bribery. These laws also protect &#8220;trade secrets,&#8221; meaning technical and business information that is unknown to the public that has utility and may create business interests or profits for its legal owners or holders and is maintained as a secret by its legal owners or holders. Unlawfully obtaining or disclosing trade secrets is prohibited. Additionally, a company whose concentration of business violates the anti-monopoly rules in mainland China may be subject to fines of up to 10% of the last year&#8217;s sales revenue, in addition to other remedial measures.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%;text-decoration:underline">Product Liability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">: In addition to the strict new drug approval process, certain Chinese laws have been promulgated to protect the rights of consumers and to strengthen the control of medical products in mainland China. Under current Chinese law, manufacturers, and vendors of defective products in mainland China may incur civil and liability for loss and injury caused by such products as well as revocation of business licenses.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-17-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%;text-decoration:underline">Tort Law</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">: Under the PRC Civil Code, producers and sellers of defective products are required to take remedial measures such as the issuance of a warning, the recall of products, etc. in a timely manner, and may be held liable under tort law for any failure to do so, or to do so timely. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%;text-decoration:underline">Intellectual Property Rights</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">: Mainland China has comprehensive legislation governing intellectual property rights, including patents, trademarks, copyrights, and domain names. We hold patent rights from third parties for some of our programs as described in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Overview of Significant License and Collaboration Agreements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">. Under certain of our agreements, we rely on third parties to file and prosecute patent applications, maintain patents, and otherwise protect the licensed intellectual property.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%;text-decoration:underline">Labor Protection</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">: Under applicable rules in mainland China, employers must establish a comprehensive management system to protect the rights of their employees and ensure manufacturing safety, including a system governing occupational health and safety to provide employees with occupational training to prevent occupational injury, and employers are required to truthfully inform prospective employees of the job description, working conditions, location, occupational hazards, and status of safe production as well as remuneration and other conditions. Employers are also required to contribute, on behalf of their employees, to a number of social security funds, including funds for basic pension insurance, unemployment insurance, basic medical insurance, work-related injury insurance, and maternity insurance. Additionally, manufacturers of pharmaceutical products are required to establish production safety and labor protection measures in connection with the operation of their manufacturing equipment and manufacturing process. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%;text-decoration:underline">Regulations Relating to Foreign Exchange</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">: Approval from or registration with appropriate government authorities is required where RMB is to be converted into foreign currency and remitted out of mainland China to pay capital expenses such as repayment of foreign currency-denominated loans. For more information, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Dividends and Other Distributions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%;text-decoration:underline">Regulations on Securities Offering and Listing Outside of China</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">: Laws in mainland China regulate overseas securities offering and listing activities by domestic companies. These regulations include the requirement to submit filing documents including the offering prospectus to the CSRC. Overseas offering and listing are prohibited under certain circumstances, including where (i) the offering and listing are expressly forbidden by applicable Chinese laws, regulations, and rules; (ii) the intended overseas securities offering and listing may endanger national security as reviewed and determined by competent authorities under the State Council; or (iii) there are material disputes with regard to the ownership of the equity held by the domestic company&#8217;s controlling shareholder or by other shareholders that are controlled by the controlling shareholder and/or actual controller. If domestic companies fail to fulfill the above-mentioned filing procedures or offer and list in an overseas market against the prohibited circumstances, they may be warned and fined up to RMB10 million. The controlling shareholders and actual controllers of such domestic companies that organize or instruct the aforementioned violations may be fined up to RMB10 million and directly liable persons-in-charge and other directly liable persons may be fined up to RMB5 million. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%;text-decoration:underline">Rules for the Regulations on Supervision and Administration of Medical Devices</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">: Laws and regulations in mainland China govern certain aspects of the production, distribution, and clinical trials of medical devices, including reporting, establishment, and maintenance of quality management and quality control measures covering the distribution process, self-inspection, and ethics review.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%;text-decoration:underline">Other Chinese National- and Provincial-Level Laws and Regulations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">: We are subject to changing requirements under many other laws and regulations administered by governmental authorities at the national, provincial, and municipal levels, some of which are or may become applicable to our business. For example, regulations control the confidentiality of patients&#8217; medical information and the circumstances under which patient medical information may be released for inclusion in our databases or by us to third parties. We are also subject to numerous additional national and provincial laws relating to matters such as safe working conditions, manufacturing practices, environmental protection, and fire hazard control.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%;text-decoration:underline">Anti-Corruption Laws and Regulations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">: We are subject to anti-corruption laws and rules in China and the United States, including the FCPA. These laws generally prohibit companies and their representatives from making improper payments to government officials for the purpose of obtaining or retaining business or to otherwise obtain favorable treatment or influence a person working in an official capacity. The health care professionals we regularly interact with </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-18-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">may be considered government officials under Chinese anti-corruption laws or the FCPA. In 2023, Chinese authorities increased their anti-corruption enforcement efforts with respect to the health care sector.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Our Customers </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We rely on independent third-party distributors in Greater China to sell our commercialized products, which is consistent with the pharmaceutical industry norm. This allows us to execute marketing strategies that are specifically tailored to each product and the geographic location of the hospitals located within the distribution territories of our customers across mainland China. During 2023 and 2022, our five largest customers accounted for approximately 35.0% and 37.7% of our total product revenue, respectively. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We select distributors based on their business qualifications and distribution capabilities, such as distribution network coverage, quality, number of personnel, cash flow conditions, creditworthiness, logistics, compliance standard, past performance, and capacity for customer management. We offer rebates to our distributors, consistent with pharmaceutical industry practice. We retain no ownership control over the products sold to our distributors, and all significant risks (including inventory risks) and rewards associated with the products are generally transferred to our distributors upon delivery to and acceptance by the distributors. </span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Manufacturing, Suppliers, and Quality Control </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">As discussed below, we manufacture or source from third parties our commercial products, product candidates, and materials. We have our own independent quality control system and devote significant attention to quality control for the designing, manufacturing, and testing of our commercial products and product candidates.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Our Manufacturing Facilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%"> </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We currently manufacture or have rights to manufacture our internally developed products and certain of our licensed commercial products and product candidates under the terms of our licensing agreements, including ZEJULA (other than for commercial use in Hong Kong), NUZYRA, and xanomeline-trospium.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We operate two manufacturing facilities in Suzhou, China, which support the commercial and clinical production of certain of our products and product candidates, including ZEJULA. </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">We have a small molecule facility that manufactures ZEJULA. The oral solids production line is cGMP-compliant and is capable of performing the entire production process, including blending, granulation (i.e., wet granulation process, fluidized bed process, and roller compaction), tableting, coating, and packaging for oral solid drug products. The facility has capacity to produce up to 50 million units per year for oral solid dosage form. We also have an early clinical manufacturing workshop for oral solids with additional capacity to produce approximately 30,000 units/batch.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">We have a large molecule facility for which we have successfully obtained permits and passed inspections to manufacture supplies for certain product candidates. The facility has a biological processing / formulation production line with an annual production capacity of up to 12 to 22 200L or 1000L clinical batches, respectively. The production line consists of a 1000L drug substance production line from Cytiva and a self-clean / autoclave automatic drug product production line from Tofflon Science. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our two manufacturing facilities comply with both the PRC and PIC/S drug manufacturing standards. We procure our manufacturing equipment from leading domestic and international suppliers. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We believe our two manufacturing facilities are sufficient to support our commercial and clinical needs and our business growth in the near term.   </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-19-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Contract Manufacturing Organizations</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We outsource to a limited number of external contract manufacturing organizations (&#8220;CMOs&#8221;) the production of certain drug substances and products to meet pre-clinical, clinical, and commercial requirements of our products and product candidates. For example, we have obtained the necessary licenses and engaged CMOs to locally manufacture NUZYRA and ZL-1102 in mainland China. By outsourcing a portion of our manufacturing activities, we can increase our focus on core areas of competence such as product candidate development, commercialization, and research. We have adopted procedures to promote compliance by our CMOs with relevant regulatory requirements and internal guidelines with respect to production qualifications, facilities, and processes. When selecting our CMOs, we consider a number of factors, including their qualifications, relevant expertise, production capacity, geographic proximity, reputation, track record, product quality, reliability, and proposed terms for the production arrangement. Our CMOs provide services to us on a short-term and project-by-project basis. Our agreements with CMOs typically specify requirements, including product quality or service details, technical standards or methods, delivery terms, agreed price and payment, and product inspection and acceptance criteria. Our CMOs procure the necessary raw materials themselves. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Suppliers </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our suppliers may consist of (i) third-party licensors from which we have licenses for commercial products and product candidates; (ii) suppliers of raw materials in our supply chain; and (iii) CROs to support our clinical trials. </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:14.5pt">Licensors: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We are dependent on some of our third-party partners for the manufacture and supply of certain of our commercial products and product candidates. For example, we source OPTUNE from NovoCure, QINLOCK from Deciphera, VYVGART from argenx, tisotumab vedotin from Pfizer, adagrasib and repotrectinib from BMS, bemarituzumab from Amgen, and SUL-DUR from Innoviva.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:14.5pt">Other Suppliers: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We are dependent on third parties for certain raw materials in our supply chain. For example, we obtain raw materials for our clinical trial activities from multiple suppliers who we believe have sufficient capacity to meet our demands. We also believe we would have access to adequate alternative sources for such supplies, if needed. We typically order raw materials and services on a purchase order basis and do not enter into long-term dedicated capacity or minimum supply arrangements. While we experience price fluctuations associated with our raw materials, we have not experienced material disruptions in the supply of our raw materials. We have suppliers in both China and the United States. </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:14.5pt">CROs: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We may depend on certain CROs to support our clinical trials.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Quality Control and Assurance</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We have established a strict quality control system in accordance with NMPA regulations. We monitor our operations in real time throughout the entire production process, from inspection of raw and auxiliary materials to manufacture and delivery of finished products to clinical testing at hospitals. Our quality assurance team is also responsible for our compliance with applicable regulations, standards, and internal policies. Our senior management team is actively involved in setting quality policies and managing the internal and external quality performance of the Company.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">For information on risks related to our manufacturing and commercialization activities as well as our reliance on third parties, including our third-party partners, CMOs, and suppliers, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Competition</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Competition in the biopharmaceutical industry is intense. There are many companies, including biotechnology and pharmaceutical companies, engaged in developing products for the approved indications of our commercial products and the therapeutic areas we are targeting with our research and development activities. Some of our competitors may have substantially greater financial, marketing, research and development, and other resources than we do. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-20-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We believe that competition and leadership in the industry is based on managerial and technological excellence and innovation as well as established patent and other proprietary positions through research and development. The achievement of a leadership position also depends largely upon our ability to maximize the approval, acceptance, and use of our product candidates and the availability of adequate financial resources to fund facilities, equipment, personnel, clinical testing, manufacturing, and marketing. Another key aspect of remaining competitive in the industry is recruiting, motivating, and retaining global leaders and top talent to support our research, development, and commercial activities. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Competition among approved products may be based, among other things, on patent position, product efficacy, safety, patient convenience, delivery devices, reliability, availability, reimbursement, and price. In addition, early entry of a new pharmaceutical product into the market may have important advantages in gaining product acceptance and market share. Accordingly, the relative speed with which we can develop products, complete the testing and approval process and supply commercial quantities of products can have a significant impact on our competitive position. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The introduction of new products or technologies, including the development of new processes or technologies by competitors or new information about existing products or technologies, results in increased competition for, and pricing pressure on, our commercial products. The development of new or improved treatment options or standards of care in our therapeutic areas could reduce or eliminate the use of our products or may limit the utility and application of ongoing clinical trials for our product candidates. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We also face increased competitive pressures from the introduction of generic versions, prodrugs and biosimilars of existing products and products approved under abbreviated regulatory pathways. Such products are likely to be sold at substantially lower prices than branded products, which may significantly reduce both the price that we are able to charge for our products and the volume of products we sell. In addition, in some markets, when a generic or biosimilar version of one of our products is commercialized, it may be automatically substituted for our product and significantly reduce our revenues in a short period of time. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We believe our long-term competitive position depends upon our success in discovering and developing innovative, cost-effective products that serve unmet medical needs, along with our ability to manufacture products efficiently and to launch and market them effectively in a highly competitive environment. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">For information on significant risks we face from competition, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Insurance</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We maintain insurance policies that are required under Chinese laws and regulations as well as based on our assessment of our operational needs and industry practice. We maintain liability insurance for certain clinical trials, which covers the patient human clinical trial liabilities such as bodily injury, product liability insurance, general insurance policies covering property loss due to accidents or natural disasters, and director and officer (&#8220;D&amp;O&#8221;) insurance. We do not maintain insurance to cover intellectual property infringement or misappropriation. </span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Human Capital Resources </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our employees are integral to our success, and we are committed to building and maintaining a strong and engaged workforce that is focused on delivering on our mission to become a leading global biopharmaceutical company and to positively impact human health in China and beyond. We seek to attract, retain, and motivate our employees through competitive compensation programs, professional development opportunities, and employee engagement. In evaluating our human capital management, we consider various factors, including employee performance, development, and our ability to recruit well qualified employees to support our business and operations. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">As of January 31, 2024, we had 2,175 full-time employees, of which 2,088 were located in Greater China. The number of full-time employees by function as of such date was as follows:</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-21-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.082%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">By Function</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Number of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employees</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and Development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">757</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,178</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Manufacturing</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and Administrative*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">170</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2,175</span></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* Includes finance, legal, human resources, information technology, and other general and administrative functions. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our management executive team is comprised of our CEO and her direct reports who, collectively, have management responsibility for our business. Our management team places significant focus and attention on matters concerning our human capital assets, with a focus on being an employer of choice as well as on diversity, employee capabilities and growth, and succession planning. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The competition for top talent in our industry is intense. To help attract, motivate, and retain well qualified employees, we strive to provide competitive compensation programs and benefits, including cash compensation, stock-based compensation, and other benefits to support the financial, physical, and emotional health of our employees. For our employees in China, consistent with Chinese regulations, we participate in a housing fund and various employee social security plans that are organized by applicable local municipal and provincial governments, including housing, pension, medical, work-related injury, maternity, and unemployment benefit plans, under which we make contributions at specified percentages of the salaries of our employees. For our U.S.-based employees, in addition to our health and welfare benefits and parental leave, we provide retirement benefits in the form of certain matching contributions to tax-qualified 401(k) plans. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We provide professional development and training opportunities to our employees to help enhance their competencies and capabilities. These opportunities include formal and comprehensive company-level and department-level training for new employees followed by on-the-job training; periodic trainings to promote awareness and compliance with our policies and procedures; and cross-functional trainings to strengthen and reinforce employee collaborations across different functions, groups, and departments that work together to support our day-to-day operations. We have a performance management and talent development process through which managers provide regular feedback and coaching to develop employees. This process also helps the Company identify our pipeline of talent as well as areas in potential need of additional resources or support. We also engage our employees through employee resource groups, such as our women&#8217;s leadership community and local diversity, equity, and inclusion committees.  </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We seek to bring together employees with different backgrounds and expertise to support our growth while also creating an inclusive culture. We are proud of the diversity, skills, and achievements that our employees bring to our business from various parts of the world. In addition, we are committed to being an equal opportunity employer, where everyone is treated equally and respected, regardless of their gender, nationality, marital status, age, disability, or religious belief. Our commitment to diversity is reflected in the composition of our workforce. For example, with respect to gender diversity, the majority of our full-time employees are women, and the majority of STEM-related positions are held by women.  </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our worldwide teams are united by a common mission to improve human health. We strive to maintain a good working relationship with our employees. We are committed to encouraging a culture of open communication where employees can ask questions, raise concerns, and contribute creative solutions. Our management team routinely makes themselves available to all employees, including in regular town hall events that encourage open dialogue. None of our employees are represented by a labor union or covered by a collective bargaining agreement, and we have not experienced any material work stoppages or labor disputes. Further, we have been able to recruit strong employees to support our business and operations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-22-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Risk Management </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We are committed to acting ethically, which includes identifying and responsibly managing risk. As a result, we have adopted a consolidated risk management methodology and program, which includes a three lines of defense risk management framework to identify, assess, evaluate, and monitor key risks associated with our strategic objectives on an on-going basis, and a risk governance structure that includes oversight by the Board of Directors (the &#8220;Board&#8221;), the Audit Committee of the Board of Directors (the &#8220;Audit Committee&#8221;), and management. Management oversight includes a Risk Coordination Council that is comprised of leaders of governance and quality functions along with operational line leaders and serves as a forum to discuss and monitor risks across the organization as well as other regional, divisional, or functional risk management committees or working groups, as deemed appropriate. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We conduct an annual enterprise risk assessment to identify our top tier risks and, based on that assessment, will develop an enterprise risk management strategy and plans to manage those risks. Our risk management strategy takes into account various factors including our corporate strategic goals and objectives, our risk tolerance levels and thresholds, and applicable legal and regulatory requirements. We also develop and implement risk strategies for new or evolving risks during the year, as deemed appropriate. Management discusses with the Board of Directors or the Audit Committee the results of its annual enterprise risk assessments as well as its enterprise risk management methodology and guidelines and key risk-related developments. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following provides additional information on our three lines of defense framework: </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:14.5pt">First Line of Defense: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our business functions are</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">primarily responsible for identifying and evaluating risks in their areas of responsibility and for developing and implementing a risk management program, including appropriate controls and procedures, to monitor, manage, and communicate to management key information with respect to these risks. Such risk management program should be consistent with our corporate business objectives and should adhere to risk policies, controls, and guidelines established by management and the Board of Directors or Audit Committee, including risk tolerance levels. Our business functions are also responsible for monitoring ongoing risks in their areas and communicating to management, as appropriate.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:14.5pt">Second Line of Defense:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> Our Legal and Ethics and Compliance functions oversee implementation of our enterprise risk management program and monitoring of business activities aligned with the risk outcomes identified during the annual risk assessment process. For example, our Chief Legal Officer, supported by our Chief Compliance Officer, is responsible for: developing and updating our enterprise risk management program and targets; reviewing and approving management or mitigation plans for major risk management issues; overseeing implementation of risk management measures; providing guidance and support on our risk management approach to the relevant departments in the Company; and reporting to management, the Board of Directors, and the Audit Committee, as deemed appropriate. </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:14.5pt">Third Line of Defense: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our Internal Audit function is responsible for evaluating the design, adequacy, operational effectiveness, and efficiency of our enterprise risk management program, including our risk governance structure, processes for enterprise risk identification and management, and risk control processes.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following provides additional information on certain components of our risk governance structure:</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:14.5pt">Risk Coordination Council: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Risk Coordination Council, which is co-chaired by the Chief Compliance Officer and another rotating member and is comprised of governance function leaders as well as business operations leaders, provides a forum to discuss and identify, monitor, and manage risks across the organization. Potential risks identified through this forum are escalated and managed both at the functional line level and through the Chief Compliance Officer directly to executive leadership and/or the Audit Committee, as deemed appropriate.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:14.5pt">Audit Committee:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> The Audit Committee is responsible for assisting the Board of Directors in its oversight of the Company&#8217;s risk management and internal controls; the integrity of our financial statements; compliance with </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-23-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">applicable legal and regulatory requirements; the qualifications, independence, and performance of our auditors; and our internal audit and compliance functions.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:14.15pt">Board of Directors:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> The Board of Directors oversees the management of risks inherent in the operation of our business and the implementation of our business strategies and is responsible for establishing our enterprise risk management and internal control system and reviewing its effectiveness. The Board of Directors performs its oversight role through several different levels of review. For example, management reports to the Board on our business strategies, operations, and corporate functions, and each of the Board&#8217;s Committees reports to the Board on the risks within their areas of responsibility.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Investment Risk Management </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">To help meet our liquidity needs without significantly increasing our risk, we have an investment policy, which was approved by the Audit Committee and provides guidelines and specific instructions for the investment of our funds. Our investment strategy aims to minimize risks by reasonably and conservatively matching the maturities of the portfolio to anticipated operating cash needs. We make our investment decisions on a case-by-case basis after considering a number of factors, including, but not limited to, our cash flow levels, operational needs, and capital expenditures; the macro-economic environment; general market conditions; and the expected profit or potential loss of the investment. In accordance with our investment policy, we may engage in short-term investments with surplus cash on hand. Our investment portfolio primarily consists of time deposits. We are prohibited from investing in high-risk products, and proposed investments must not interfere with our business operations or capital expenditures. </span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Dividends and Other Distributions</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Zai Lab Limited is a holding company, and we may rely on dividends and other distributions on equity paid by our Chinese subsidiaries for our cash and financing requirements, including the funds necessary to pay dividends and other cash distributions to our shareholders or holders of our ADSs or to service any debt we may incur. If any of our Chinese subsidiaries incur debt on their own behalf in the future, the instruments governing such debt may restrict their ability to pay dividends to us. To date, there have not been any such dividends or other distributions from our Chinese subsidiaries to our subsidiaries located in or outside of mainland China. In addition, as of the date of this report, none of our subsidiaries have ever issued any dividends or distributions to us or their respective shareholders in or outside of mainland China, and neither Zai Lab Limited nor any of our subsidiaries has ever directly or indirectly paid dividends or made distributions to U.S. investors. Zai Lab (Shanghai) Co., Ltd., an operating subsidiary of ours that is domiciled in mainland China, received $466.5 million in capital contributions via 24 separate contributions from Zai Lab (Hong Kong) Limited, its sole shareholder, domiciled outside of mainland China, from 2014 to 2023 to fund its business operations in mainland China. Zai Lab International Trading (Shanghai) Co., Ltd., an operating subsidiary of ours that is domiciled in mainland China, received RMB1.0 million in capital contributions via contributions from Zai Lab (Shanghai) Co., Ltd., its sole shareholder, in 2019 to fund its business operations in mainland China. Zai Lab (Suzhou) Co., Ltd., an operating subsidiary of ours that is domiciled in mainland China, received RMB166.5 million in capital contributions via ten separate contributions from Zai Lab (Hong Kong) Limited, its sole shareholder, domiciled outside of mainland China, from 2015 to 2019 to fund its business operations in mainland China. Zai Lab Trading (Suzhou) Co., Ltd., an operating subsidiary of ours that is domiciled in mainland China, received RMB1.0 million in capital contributions via contributions from Zai Lab (Suzhou) Co., Ltd., its sole shareholder, in 2020 to fund its business operations in mainland China. Zai Biopharmaceutical (Suzhou) Co., Ltd., an operating subsidiary of ours that is domiciled in mainland China, received $15.0 million in capital contributions via four separate contributions from Zai Lab (Hong Kong) Limited, its sole shareholder, domiciled outside of mainland China, from 2017 to 2018 to fund its business operations in mainland China. In the future, cash proceeds raised from our overseas financing activities may be transferred by us to our Chinese subsidiaries via capital contributions, shareholder loans or intercompany loans. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">According to the Foreign Investment Law of the People&#8217;s Republic of China and its implementing rules, which jointly established the legal framework for the administration of foreign-invested companies, a foreign investor may, in </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-24-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">accordance with other applicable laws, freely transfer into or out of mainland China its contributions, profits, capital earnings, income from asset disposal, intellectual property rights, royalties acquired, compensation, or indemnity legally obtained, and income from liquidation, made or derived within the territory of mainland China in RMB or any foreign currency, and any entity or individual shall not illegally restrict such transfer in terms of the currency, amount, and frequency. According to the Company Law of the People&#8217;s Republic of China and other Chinese laws and regulations, our Chinese subsidiaries may pay dividends only out of their respective accumulated profits as determined in accordance with Chinese accounting standards and regulations. In addition, each of our Chinese subsidiaries is required to set aside at least 10% of its accumulated after-tax profits, if any, each year to fund a certain statutory reserve fund until the aggregate amount of such fund reaches 50% of its registered capital. Where the statutory reserve fund is insufficient to cover any loss the Chinese subsidiary incurred in the previous financial year, its current financial year&#8217;s accumulated after-tax profits shall first be used to cover the loss before any statutory reserve fund is drawn therefrom. Such statutory reserve funds and the accumulated after-tax profits that are used for covering the loss cannot be distributed to us as dividends. At their discretion, our Chinese subsidiaries may allocate a portion of their after-tax profits based on Chinese accounting standards to a discretionary reserve fund. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Renminbi, or RMB, is not freely convertible into other currencies. As a result, any restriction on currency exchange may limit the ability of our Chinese subsidiaries to use their potential future RMB revenues to pay dividends to us. The Chinese government imposes controls on the convertibility of RMB into foreign currencies and, in certain cases, the remittance of currency out of mainland China. Shortages in availability of foreign currency may then restrict the ability of our Chinese subsidiaries to remit sufficient foreign currency to our offshore entities for those offshore entities to pay dividends or make other payments or otherwise to satisfy our foreign-currency-denominated obligations. RMB is currently convertible under the &#8220;current account,&#8221; which includes dividends and trade- and service-related foreign exchange transactions, but not under the &#8220;capital account,&#8221; which includes foreign direct investment and foreign debt (which may be denominated in foreign currency or RMB), including loans we may secure for our Chinese subsidiaries. Currently, our Chinese subsidiaries may purchase foreign currency for settlement of current account transactions, including payment of dividends to us, without the approval of the State Administration of Foreign Exchange of China (&#8220;SAFE&#8221;) by complying with certain procedural requirements. However, the relevant Chinese governmental authorities may limit or eliminate our ability to purchase foreign currencies in the future for current account transactions. The Chinese government may continue to strengthen its capital controls, and additional restrictions and substantial vetting processes may be instituted by SAFE for cross-border transactions falling under both the current account and the capital account. Any existing and future restrictions on currency exchange may limit our ability to utilize revenue generated in RMB to fund our business activities outside of mainland China or pay dividends in foreign currencies to holders of our securities. Foreign exchange transactions under the capital account remain subject to limitations and require approvals from, or registration with, SAFE and other relevant Chinese governmental authorities. This could affect our ability to obtain foreign currency through debt or equity financing for our subsidiaries. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> for a detailed discussion of the Chinese legal restrictions on the payment of dividends, our ability to transfer cash within the Company, and the potential for holders of our securities to be subject to Chinese taxes on dividends paid by us in the event we are deemed a Chinese resident enterprise for Chinese tax purposes. </span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Available Information</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We file reports and other information with the Securities and Exchange Commission (&#8220;SEC&#8221;) and The Stock Exchange of Hong Kong Limited (&#8220;Hong Kong Stock Exchange&#8221;). We make available on our website our annual reports on Form 10-K (and previously on Form 20-F), our quarterly reports on Form 10-Q, and our current reports on Form 8-K (and previously on Form 6-K), and all other SEC reports and amendments to those reports. Additionally, we make available on our website our securities filings with the Hong Kong Stock Exchange. We make this information available on our website free of charge as soon as reasonably practicable after we electronically file the information with, or furnish it to, the SEC and the Hong Kong Stock Exchange, as applicable. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We use our website as a means of disclosing material non-public information &#8211; including information on our products; business activities and partnerships; research; Trust for Life strategy, commitments, and reports; and other events and developments &#8211; and for complying with our disclosure obligations under Regulation FD. Our website address is </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-25-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">www.zailaboratory.com. We do not incorporate the information on or accessible through our website into this report, and you should not consider any information on, or that can be accessed through, our website as part of this report. </span></div><div id="i8a977bbf870448998f9d0f718b7b41b9_19"></div><div style="-sec-extract:summary;margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Item 1A. Risk Factors</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Risk Factors</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">The following section includes the most significant factors that we believe may adversely affect our business and operations. You should carefully consider these risks and other information contained in this report and our other filings with the SEC before deciding to invest in our securities. The risks and uncertainties described below are not the only ones we face. Additional risks and uncertainties not presently known to us or that we currently believe to be immaterial could also adversely affect our business and operations.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">This summary provides an overview of material risks that could affect our business, financial condition, results of operations, cash flows, and prospects, which should be read in conjunction with the more detailed discussion of risks that follows this summary.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">Changes in relations between the United States and China, as well as relations between China and other countries, may adversely impact our business, our operating results, our ability to raise capital on favorable terms or at all, and the market price of our securities;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">We are subject to extensive laws, rules, and regulations. Compliance with these laws, including China&#8217;s Counter-Espionage Law, Data Security Law, Cyber Security Law, Cybersecurity Review Measures, Personal Information Protection Law, Regulation on the Administration of Human Genetic Resources, Biosecurity Law, Security Assessment Measures, and any other future laws and regulations or amendments to such laws and regulations may entail significant expenses and could materially affect our business. Our failure to comply with such laws and regulations, as a result of uncertainties in the Chinese legal system with respect to recent anti-corruption enforcement efforts or otherwise, could lead to government enforcement actions and significant penalties against us, which could materially and adversely impact our operating results;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">We could be adversely affected by risks of doing business globally. For example, business disruptions or other adverse effects caused by economic, political, and social conditions, including market conditions, changing legal and regulatory requirements and government policies, political instability, trade policies and sanctions, public health crises, international war or conflict, natural disasters, extreme weather events, and other geopolitical events or significant disruptions could adversely affect our business, liquidity, and access to capital;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">We have incurred significant losses since our inception and anticipate that we will continue to incur losses for at least the next year. If we are unable to generate sufficient revenue from our approved commercial products, on the anticipated timeline or at all, at a level that more than offsets our expenses, we will be unable to achieve or maintain profitability;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">We rely on our licensors, CMOs, and other third parties for the commercial and clinical supply of our products and product candidates. Failure of our third parties to supply us with a sufficient quantity of products, in a timely matter or at all, will adversely affect us;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">Chinese manufacturing facilities have historically experienced issues operating in line with established GMPs and international best practices, and passing FDA, NMPA, and EMA inspections, which may result in a longer and costlier current GMP inspection and approval process by the FDA, NMPA, or EMA for our Chinese manufacturing processes and third-party contract manufacturers;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">We rely on third parties to conduct our pre-clinical and clinical trials. If these third parties do not successfully carry out their contractual duties or meet expected deadlines, we may not be able to obtain regulatory approval for or commercialize our products or product candidates, on the anticipated timeline or at all, and our business could be substantially harmed;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-26-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">If we are unable to obtain and maintain patent protection for our products and product candidates through intellectual property rights, or if the scope of such intellectual property rights obtained is not sufficiently broad, third parties may compete directly against us;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">We may not be able to protect our systems and networks, or the confidentiality of our confidential or other information (including personal information), from cyberattacks and other unauthorized access, disclosure, and disruption, which may materially and adversely affect us;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">The pre-approval of, filing, or other procedures with the CSRC or other Chinese regulatory authorities may be required in connection with issuing securities to foreign investors under Chinese law, and, if required, we cannot predict whether we will be able, or how long it will take us, to obtain such approval or complete such filing or other procedures;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">We may be exposed to liabilities under the FCPA and Chinese anti-corruption laws, and any determination that we have violated these laws could have a material adverse effect on our business or our reputation;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">Certain of our investments may be subject to CFIUS review, which may delay or block a transaction from closing;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">Restrictions on currency exchange may limit our ability to receive and use financing in foreign currencies;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">We may rely on dividends and other distributions on equity paid by our Chinese subsidiaries to fund any cash and financing requirements we may have, and any limitation on the ability of our Chinese subsidiaries to make payments to Zai Lab Limited could have a material and adverse effect on our ability to conduct our business;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">Chinese regulations relating to the establishment of offshore special purpose companies by residents in mainland China may subject our China resident beneficial owners or our wholly foreign-owned subsidiaries in mainland China to liability or penalties, limit our ability to inject capital into these subsidiaries, limit these subsidiaries&#8217; ability to increase their registered capital or distribute profits to us, or may otherwise adversely affect us;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">Chinese regulations establish complex procedures for some acquisitions of mainland China based companies by foreign investors, which could make it more difficult for us to pursue growth through acquisitions in mainland China;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">Our business benefits from certain financial incentives and discretionary policies granted by local governments. Expiration of, or changes to, these incentives or policies would have an adverse effect on our results of operations; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">It may be difficult to enforce against us or our management in mainland China any judgments obtained from foreign courts or for overseas regulators to conduct investigations or collect evidence within mainland China.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Risks Related to Doing Business in China</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Uncertainties in the Chinese legal system could materially and adversely affect us. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Chinese government has promulgated a comprehensive system of laws and regulations governing economic matters. Although such legislation has enhanced protections afforded to foreign investments in mainland China, mainland China has not developed a fully integrated legal system, and recently enacted laws and regulations may not sufficiently cover all aspects of economic activities in mainland China. In particular, the Chinese legal system is based on written statutes and prior court decisions have limited value as precedents. Since these laws and regulations are relatively new and the Chinese legal system continues to evolve, the interpretations of many laws, regulations and rules may not be uniform and enforcement of these laws, regulations and rules involves uncertainties. These uncertainties may affect our judgment on the relevance of legal requirements and our ability to enforce our contractual rights or claims. In addition, the regulatory uncertainties may be exploited through unmerited or frivolous legal actions or threats in attempts to extract payments or benefits from us. Furthermore, the Chinese legal system is based in part on government policies and internal rules, some of which are not published on a timely basis or at all and may have a retroactive effect. As a result, we may not be aware of our violation of any of these policies and rules until after an alleged violation has occurred. In addition, any administrative </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-27-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">and court proceedings in mainland China may be protracted, resulting in substantial costs and diversion of resources and management attention. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In recent years, the General Office of the Communist Party of China Central Committee and the General Office of the State Council have focused on enhancing enforcement against illegal activities in the securities markets and promoting the development of capital markets, which, among other things, requires the relevant governmental authorities to strengthen cross-border oversight of law-enforcement and judicial cooperation, to enhance supervision over Chinese companies listed overseas, and to establish and improve the system of extraterritorial application of the Chinese securities laws. There are uncertainties with respect to how soon legislative or administrative regulation-making bodies will respond and what existing or new laws or regulations or detailed implementations and interpretations will be modified or promulgated, if any, and the potential impact such modified or new laws and regulations will have on companies like us. It is especially difficult for us to accurately predict the potential impact on the Company of new legal requirements in mainland China because the Chinese legal system is a civil law system and, unlike common law systems, prior court decisions have limited precedential value. Uncertainties with respect to the scope and interpretation of existing laws, rules, and regulations in China, as well as future laws, rules, and regulations or amendments to such laws, rules, and regulations, may adversely affect our business and results of operations.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Changes in relations between the United States and China, as well as relations between China and other countries, may adversely impact our business, operating results, ability to raise capital, and the market price of our securities.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The U.S. government, including the SEC, has made statements and taken certain actions that have impacted, and may continue to impact, companies like us with a substantial presence in mainland China, including by imposing several rounds of tariffs affecting certain products manufactured in mainland China, imposing certain sanctions and restrictions in relation to mainland China, and issuing statements indicating enhanced review of companies with significant China-based operations or the possibility of legislation that restricts or prohibits U.S. investment in certain companies operating in mainland China. It is unknown whether and to what extent new legislation, executive orders, tariffs, laws, or regulations will be adopted, or the effect that any such actions would have on companies with a significant presence in mainland China, our industry, or us. We conduct pre-clinical and clinical activities and have significant business operations in mainland China. Any unfavorable government policies on cross-border relations and/or international trade, including increased scrutiny on companies with significant China-based operations, capital controls, or tariffs, may affect the competitive position of our commercial products and product candidates, the hiring of scientists and other research and development personnel, the demand for or our ability to sell our commercial products, the import or export of raw materials in relation to drug development, our ability to raise capital, and the market price of our securities. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">If any new legislation, executive orders, tariffs, laws and/or regulations are implemented, if existing trade agreements are renegotiated, or if the U.S. or Chinese government take retaliatory actions due to recent or increased tensions between the United States and mainland China, such changes could have an adverse effect on our business, financial condition, and results of operations, our ability to raise capital, and the market price of our securities.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">The Chinese government may intervene in or influence our operations at any time, which could result in a material change in our operations and significantly and adversely impact the value of our securities, including potentially making those securities worthless.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Chinese government has significant oversight and discretion over the conduct of our business and may intervene or influence our operations as the government deems appropriate to further regulatory, political and societal goals. The Chinese government has published policies that significantly affect certain industries such as the education and internet industries, and it may in the future release regulations or policies regarding the life sciences industry that could require us to seek permission from Chinese authorities to continue to operate our business, which may adversely affect our business, financial condition, and results of operations. Furthermore, recent statements made by the Chinese government have indicated an intent to increase the government&#8217;s oversight and control over offerings of companies with significant operations in mainland China that are to be conducted in foreign markets, including the United States, as well as foreign investment in China-based issuers like us. Any such action by the Chinese government could significantly limit or </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-28-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">completely hinder our ability to offer or continue to offer our securities to our investors and could cause the value of our securities to significantly decline or become worthless. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Because the majority of our operations are in mainland China and our auditor for prior fiscal years was located in mainland China, there have been concerns regarding oversight of audits of our financial statements filed with the SEC. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In recent years, the U.S. Congress and regulatory authorities have expressed concerns about challenges in their oversight of financial statement audits of U.S.-listed companies with significant operations in mainland China and with auditors located in mainland China. For example, inspections by the Public Company Accounting Oversight Board (the &#8220;PCAOB&#8221;) of auditors located in mainland China and Hong Kong have at times identified deficiencies in those auditors&#8217; audit procedures and quality control procedures, and limitations on the ability of the PCAOB to inspect or investigate auditors in mainland China or Hong Kong could deprive investors of the benefits of PCAOB inspections, which could adversely affect the ability of companies using such auditors to access U.S. capital markets.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">As part of the continued focus on access to audit and other information for companies with substantial operations in China, in December 2020, the United States enacted the Holding Foreign Companies Accountable Act (as amended, the &#8220;HFCAA&#8221;), which requires the SEC to identify issuers that have filed an annual report with an audit report issued by a registered public accounting firm that is located in a foreign jurisdiction and that the PCAOB has determined it is unable to inspect or investigate completely because of a restriction imposed by a non-U.S. authority in the auditor&#8217;s local jurisdiction (a &#8220;Commission-Identified Issuer&#8221;). Under the HFCAA, if the SEC conclusively identifies an issuer as a Commission-Identified Issuer for two consecutive years, the SEC is required to prohibit the trading of the issuer&#8217;s securities on a national securities exchange or through any other method that is within the jurisdiction of the SEC to regulate, including over-the-counter markets in the United States.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In March 2022, SEC staff conclusively identified the Company as a Commission-Identified Issuer because our former auditor, which filed an audit report with our Annual Report on Form 10-K for the fiscal year ended December 31, 2021, was located in mainland China.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In May 2022, the Company engaged KPMG LLP (&#8220;KPMG&#8221;), an auditor located in the United States that is inspected by the PCAOB, as our independent registered public accounting firm for the fiscal year ended December 31, 2022. In addition, in December 2022, the PCAOB vacated its determination that it was unable to inspect and investigate PCAOB-registered public accounting firms in mainland China. As a result, until such time as the PCAOB issues a new determination, the SEC staff has stated that there are no issuers currently at risk of having their securities subject to a trading prohibition under the HFCAA. Although we are not currently at risk of delisting pursuant to the HFCAA, if the PCAOB were to issue a new determination regarding limitations on its ability to inspect or investigate our independent auditor and we were to fail to meet the audit requirements of the HFCAA for two consecutive years, our securities may be prohibited from trading on a national securities exchange or over-the-counter market in the United States, and this could result in our ADSs being delisted from the Nasdaq Global Market (&#8220;Nasdaq&#8221;). Delisting of our ADSs would force holders of our ADSs to sell their ADSs or convert them into our ordinary shares. The foregoing could adversely affect the market price of our securities and our ability to raise capital. The market price of our securities could also be adversely affected as a result of anticipated negative impacts of such legislative or executive actions upon, as well as negative investor sentiment toward, companies with significant operations in mainland China and Hong Kong that are listed in the United States, regardless of whether such actions are implemented and regardless of our actual operating performance.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">We may be subject to additional approval, filing, and compliance obligations with Chinese authorities in connection with our engagement of KPMG, a U.S. auditor that is subject to PCAOB inspection.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In the first quarter of 2023, the CSRC adopted the Provisions on Strengthening Confidentiality and Archives Administration of Overseas Securities Offering and Listing by Domestic Companies (the &#8220;Archives Rules&#8221;). According to the Archives Rules, we may be required to complete certain approval, filing, and regulatory procedures if it becomes necessary for us to disclose or provide to KPMG, our U.S. auditor that is subject to inspection by the PCAOB, any documents or materials relevant to KPMG&#8217;s audit that are deemed to have a sensitive impact (i.e., be detrimental to national security or the public interest if divulged) or contain state secrets or governmental authority work secrets. Under </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-29-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">those circumstances, KPMG would also be required to abide by corresponding approval, filing, and compliance procedures. Due to the lack of further interpretation, we are not certain about the scope of materials that would be deemed to have a sensitive impact or contain state or governmental authority work secrets.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">We are subject to extensive data protection, privacy, and information security laws, regulations, and policies in China. Compliance with such laws, rules, and regulations, and any other future laws and regulations in these areas, may entail significant expenses and could materially affect our business and results of operations, including as a result of government enforcement actions and significant penalties.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We are subject to extensive data protection, privacy, and information security laws, rules, and regulations in China, such as the Data Security Law, Cyber Security Law, Cybersecurity Review Measures, Personal Information Protection Law, Regulation on the Administration of Human Genetic Resources, Biosecurity Law, and Security Assessment Measures. These laws, rules, and regulations require us to take certain measures to promote the security of our networks and data stored on our networks (including with respect to collection, storage, processing, and transfer), to monitor and manage related risks, and to disclose certain incidents to affected parties and appropriate regulators. Establishing and maintaining such systems and complying with such requirements takes substantial time, effort, and cost. These laws, rules, and regulations also impose certain requirements on, and may limit our ability to, transfer certain data, such as personally identifiable information of persons located within mainland China and de-identified or anonymized health data for clinical trials, outside of China, including to our third-party partners and foreign law enforcement agencies or judicial authorities without prior approval by the Chinese government. Certain violations of these laws, rules, and regulations could lead to enforcement actions, significant fines, and/or criminal, civil, or administrative penalties. If we are not able to transfer data outside of mainland China to comply with our contractual requirements or requirements of judicial or law enforcement authorities outside of mainland China, as a result of our requirements in China, it could materially and adversely affect our business and operating results. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Although we believe we are compliant with our material legal obligations in these areas, the interpretation, application, and enforcement of these laws, rules, and regulations may evolve over time or change. Our compliance with such existing laws, rules, and regulations, or any future related laws and regulations, could significantly increase our compliance costs, require significant changes to our operations, result in suspensions or delays of our clinical trials or impair or ability to initiate new clinical trials, or even prevent us from providing certain products in jurisdictions in which we currently operate or may in the future wish to operate. Any actual or perceived failure on our part to comply with such laws, regulations, or obligations relating to privacy, data protection, information security, or national security in China could result in investigations, fines, suspension, or other penalties by Chinese government authorities and private claims or litigation, any of which could materially adversely affect our business, financial condition, results of operations, and reputation. Further, legal uncertainty created by such laws, rules, and regulations as well as recent Chinese government actions could adversely affect our ability to raise capital in the U.S. on favorable terms or at all. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">The economic, political, and social conditions in mainland China, as well as governmental policies, could affect the business environment and financial markets in mainland China, our ability to operate our business, our liquidity, and our access to capital.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">A substantial portion of our operations, and all of our commercial operations, are conducted in mainland China. Accordingly, our business, results of operations, financial condition, and prospects may be significantly influenced by economic, political, legal, and social conditions in mainland China. Mainland China&#8217;s economy differs from the U.S. economy in many respects, including with respect to the amount of government involvement, level of development, growth rate, control of foreign exchange, and allocation of resources. While mainland China&#8217;s economy has experienced significant growth, such growth has been uneven across different regions and sectors. The Chinese government has implemented various measures to encourage economic development and allocation of resources. Some of these measures may benefit the overall economy in mainland China but may have a negative effect on our business. For example, our financial condition and results of operations may be adversely affected by government control, perceived government interference, and/or changes in tax, cyber and data security, capital investments, cross-border transactions, and other regulations that are currently or may in the future be applicable to us. Recently, Chinese regulators have announced </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-30-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">regulatory actions aimed at providing the Chinese government with greater oversight over certain sectors of mainland China&#8217;s economy, including the for-profit education and technology sectors. Although the biotech industry is already highly regulated in mainland China and there has been no indication of such actions or oversight in our sector, the Chinese government may in the future take regulatory actions that materially adversely affect our business, financial results, liquidity, or access to capital or the business environment and financial markets in mainland China more broadly. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">If the Chinese government determines that our corporate structure does not comply with Chinese regulations, or if Chinese regulations change or are interpreted differently in the future, the value of our securities may decline in value or become worthless.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In July 2021, the Chinese government provided new guidance on Chinese companies raising capital outside of mainland China, including through arrangements called variable interest entities, or VIEs. Currently, our corporate structure contains no variable interest entities and we are not in an industry that is subject to foreign ownership limitations in mainland China. However, there are uncertainties with respect to the Chinese legal system and there may be changes in laws, regulations and policies, including how those laws, regulations and policies will be interpreted or implemented. If in the future the Chinese government determines that our corporate structure does not comply with Chinese regulations, or if Chinese regulations change or are interpreted differently, the value of our securities may decline or become worthless. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">We are required to obtain certain approvals and licenses from Chinese authorities to operate our Chinese subsidiaries.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Chinese government has exercised, and may continue to exercise, substantial influence or control over virtually every sector of the Chinese economy through regulation and state ownership. For example, to conduct our business activities in mainland China, each of our Chinese subsidiaries is required to obtain a business license from the local counterpart of the State Administration for Market Regulation, or SAMR. Our ability to operate in mainland China could be undermined if our Chinese subsidiaries are not able to obtain or maintain required approvals from Chinese authorities to operate in mainland China. Each of our Chinese subsidiaries has obtained a valid business license from the local counterpart of the SAMR, and no application for any such license has been denied. The central or local governments could impose new, stricter regulations or interpretations of existing regulations that could require additional expenditures and efforts on our part to comply with such regulations or interpretations. If in the future our Chinese subsidiaries do not receive or maintain required approvals, such as because we inadvertently conclude that approvals are not required or because of changes in applicable laws and regulations or interpretations of such laws and regulations, the operations of our Chinese subsidiaries, and as a result our business, results of operations, financial condition, and prospects, could be adversely affected and the value of our securities could significantly decline or become worthless.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">The approval of, submission of certain filings to, or other procedures with the CSRC or other Chinese regulatory authorities may be required in connection with issuing securities to foreign investors under Chinese law, and, if required, we cannot predict whether we will be able, or how long it will take us, to obtain such approval or complete such filing or other procedures.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We are not currently required under Chinese laws and regulations to obtain prior approval or prior permission from the CSRC or any other Chinese regulatory authority to issue securities to foreign investors, and we do not believe we will be required to submit an application to the CSRC for our previous issuances of securities to foreign investors. Under recent guidelines, however, we may be required to submit filings to the CSRC following the submission of future overseas listings and the completion of future offerings of our equity securities to foreign investors, including for future securities offerings in the same overseas markets as our previous issuances. There remains uncertainty as to the interpretation and implementation of regulatory requirements related to overseas securities offerings and other capital markets activities. If, for any reason, we were to fail to obtain any approvals or to complete any filings or other procedures required by the CSRC or other Chinese regulatory authorities, future offerings of our equity securities to foreign investors may be delayed or prevented or we may face sanctions, fines, and/or other penalties; limitations on our ability to pay dividends outside of mainland China; limitations on our operations in mainland China; delays or restrictions on the repatriation of the proceeds from our public offerings into mainland China; or other actions that could have a material adverse effect on our business, financial condition, results of operations, and prospects as well as the value of our securities.  </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-31-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">We may be exposed to liabilities under anti-corruption laws in China and the United States, including the U.S. Foreign Corrupt Practices Act, and any determination that we have violated such laws could have a material adverse effect on our business or reputation. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We are subject to anti-corruption laws in China and the United States, including the FCPA, which generally prohibit us from making improper payments to government officials for the purpose of obtaining or retaining business. Although we have implemented controls and procedures to promote compliance with such laws, if we fail to comply, due to either our own deliberate or inadvertent acts or those of others, our reputation could be harmed and we could incur criminal or civil penalties, sanctions, and/or other significant expenses, which could have a material adverse effect on our business, results of operations, financial condition, cash flows, and prospects. In addition, the scope of the recent anti-corruption enforcement efforts in China have led to increased uncertainty in the healthcare industry, which have impacted and may continue to impact hospital and physician practices. Such uncertainty, and related evaluations and adjustments by hospitals and physicians and other market participants, may adversely affect our business and results of operations.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Restrictions on currency exchange may limit our ability to receive and use financing in foreign currencies effectively. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The ability of our Chinese subsidiaries to exchange currency is subject to significant foreign exchange controls and, in the case of transactions under the capital account, requires the approval of and/or registration with Chinese government authorities, including the state administration of foreign exchange, or SAFE. In particular, if we finance our Chinese subsidiaries by means of foreign debt from us or other foreign lenders, the amount is not allowed to, among other things, exceed the statutory limits and such loans must be registered with the local counterpart of the SAFE. If we finance our Chinese subsidiaries by means of additional capital contributions, these capital contributions are subject to registration with SAMR or its local branch, reporting of foreign investment information with the Chinese Ministry of Commerce, or registration with other governmental authorities in mainland China. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In light of the various requirements imposed by Chinese regulations on loans to, and direct investment in, China-based entities by offshore holding companies, we may not be able to complete the necessary government formalities or obtain the necessary government approvals on timely basis, if at all, with respect to future loans or capital contributions by us to our Chinese subsidiaries. If we fail to complete such registrations or obtain such approvals, our ability to capitalize or otherwise fund our Chinese operations may be negatively affected, which could materially and adversely affect our liquidity and our ability to fund and expand our business. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">We may rely on dividends and other distributions on equity paid by our Chinese subsidiaries to fund any cash and financing requirements we may have, and any limitation on the ability of our Chinese subsidiaries to make payments to us could have a material and adverse effect on our ability to conduct our business. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Zai Lab Limited is a holding company, and we may rely on dividends and other distributions on equity paid by our Chinese subsidiaries for our cash and financing requirements, including the funds necessary to pay dividends and other cash distributions to our shareholders or holders of our ADSs or to service any debt we may incur. If any of our Chinese subsidiaries incur debt on their own behalf in the future, the instruments governing such debt may restrict their ability to pay dividends to us. To date, there have not been any such dividends or other distributions from our Chinese subsidiaries to our subsidiaries located in or outside of mainland China. In addition, none of our subsidiaries have issued any dividends or distributions to us or their respective shareholders in or outside of mainland China, and neither we nor any of our subsidiaries have directly or indirectly paid dividends or made distributions to U.S. investors. Zai Lab (Shanghai) Co., Ltd., an operating subsidiary of ours that is domiciled in mainland China, received $466.5 million in capital contributions via 24 separate contributions from Zai Lab (Hong Kong) Limited, its sole shareholder, domiciled outside of mainland China, from 2014 to 2023, to fund its business operations in mainland China. Zai Lab International Trading (Shanghai) Co., Ltd., an operating subsidiary of ours that is domiciled in mainland China, received RMB1.0 million in capital contributions via contributions from Zai Lab (Shanghai) Co., Ltd., its sole shareholder, in 2019 to fund its business operations in mainland China. Zai Lab (Suzhou) Co., Ltd., an operating subsidiary of ours that is domiciled in mainland China, received RMB166.5 million in capital contributions via 10 separate contributions from Zai Lab (Hong Kong) Limited, its sole shareholder, domiciled outside of mainland China, from 2015 to 2019 to fund its business operations in mainland China. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-32-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Zai Lab Trading (Suzhou) Co., Ltd., an operating subsidiary of ours that is domiciled in mainland China, received RMB1.0 million in capital contributions via contributions from Zai Lab (Suzhou) Co., Ltd., its sole shareholder, in 2020 to fund its business operations in mainland China. Zai Biopharmaceutical (Suzhou) Co., Ltd., an operating subsidiary of ours that is domiciled in mainland China, received $15.0 million in capital contributions via four separate contributions from Zai Lab (Hong Kong) Limited, its sole shareholder, domiciled outside of mainland China, from 2017 to 2018 to fund its business operations in mainland China. In the future, cash proceeds raised from our overseas financing activities may be transferred by us to our Chinese subsidiaries via capital contributions, shareholder loans or intercompany loans, as the case may be. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">According to the Foreign Investment Law of the People&#8217;s Republic of China and its implementing rules, which jointly established the legal framework for the administration of foreign-invested companies, a foreign investor may, in accordance with other applicable laws, freely transfer into or out of mainland China its contributions, profits, capital earnings, income from asset disposal, intellectual property rights, royalties acquired, compensation or indemnity legally obtained, and income from liquidation, made or derived within the territory of mainland China in RMB or any foreign currency, and any entity or individual shall not illegally restrict such transfer in terms of the currency, amount, and frequency. According to the Company Law of the People&#8217;s Republic of China and other Chinese laws and regulations, our Chinese subsidiaries may pay dividends only out of their respective accumulated profits as determined in accordance with Chinese accounting standards and regulations. In addition, each of our Chinese subsidiaries is required to set aside at least 10% of its accumulated after-tax profits, if any, each year to fund a certain statutory reserve fund, until the aggregate amount of such fund reaches 50% of its registered capital. Where the statutory reserve fund is insufficient to cover any loss the Chinese subsidiary incurred in the previous financial year, its current financial year&#8217;s accumulated after-tax profits shall first be used to cover the loss before any statutory reserve fund is drawn therefrom. Such statutory reserve funds and the accumulated after-tax profits that are used for covering the loss cannot be distributed to us as dividends. At their discretion, our Chinese subsidiaries may allocate a portion of their after-tax profits based on Chinese accounting standards to a discretionary reserve fund. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">RMB is not freely convertible into other currencies. As a result, any restriction on currency exchange may limit the ability of our Chinese subsidiaries to use their potential future RMB revenues to pay dividends to us. The Chinese government imposes controls on the convertibility of RMB into foreign currencies and, in certain cases, the remittance of currency out of mainland China. Shortages in availability of foreign currency may then restrict the ability of our Chinese subsidiaries to remit sufficient foreign currency to our offshore entities for those offshore entities to pay dividends or make other payments or otherwise to satisfy our foreign-currency-denominated obligations. RMB is currently convertible under the &#8220;current account,&#8221; which includes dividends, trade, and service-related foreign exchange transactions, but not under the &#8220;capital account,&#8221; which includes foreign direct investment and foreign debt (which may be denominated in foreign currency or RMB), including loans we may secure for our Chinese subsidiaries. Currently, our Chinese subsidiaries may purchase foreign currency for settlement of current account transactions, including payment of dividends to us, without the approval of the SAFE by complying with certain procedural requirements. However, the relevant Chinese governmental authorities may limit or eliminate our ability to purchase foreign currencies in the future for current account transactions. The Chinese government may continue to strengthen its capital controls, and additional restrictions and substantial vetting processes may be instituted by SAFE for cross-border transactions falling under both the current account and the capital account. Any existing and future restrictions on currency exchange may limit our ability to utilize revenue generated in RMB to fund our business activities outside of mainland China or pay dividends in foreign currencies to holders of our securities. Foreign exchange transactions under the capital account remain subject to limitations and require approvals from, or registration with, SAFE and other relevant Chinese governmental authorities. This could affect our ability to obtain foreign currency through debt or equity financing for our subsidiaries. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Chinese regulations relating to the establishment of offshore special purpose companies by residents in mainland China may subject our China resident beneficial owners or our wholly foreign-owned subsidiaries in mainland China to liability or penalties, limit our ability to inject capital into these subsidiaries, limit the ability of these subsidiaries to increase their registered capital or distribute profits to us, or otherwise adversely affect us.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our shareholders that are residents of mainland China are required to register with local branches of SAFE or competent banks designated by SAFE in connection with their direct establishment or indirect control of an offshore entity, </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-33-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">for the purpose of overseas investment and financing, with such residents&#8217; legally owned assets or equity interests in domestic enterprises or offshore assets or interests, being considered a &#8220;special purpose vehicle.&#8221; If such shareholders do not complete their registration with the local SAFE branches or otherwise fail to comply with SAFE registration requirements, the Chinese subsidiaries may be prohibited from distributing their profits and proceeds from any reduction in capital, share transfer, or liquidation to the offshore company, and the offshore company may be restricted in its ability to contribute additional capital to its Chinese subsidiaries. Moreover, failure to comply with SAFE registration requirements could result in liability under Chinese law for circumventing applicable foreign exchange restrictions. As a result, our business operations and ability to distribute profits could be materially and adversely affected. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Chinese regulations establish complex procedures for certain acquisitions of mainland China based companies by foreign investors, which could make it more difficult for us to pursue growth through acquisitions in mainland China.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Chinese regulations establish certain additional procedures and requirements that could make merger and acquisition activities by foreign investors more time consuming and complex. For example, companies must notify the Chinese Ministry of Commerce (the &#8220;MOFCOM&#8221;) in advance of any change-of-control transaction in which a foreign investor takes control of a Chinese domestic enterprise, if (i) any important industry is concerned, (ii) such transaction involves factors that have or may have impact on the national security, (iii) such transaction will lead to a change in control of a domestic enterprise which holds a famous trademark or Chinese time-honored brand, or (iv) such transaction involves the concentration of business undertakings by way of mergers, acquisitions, or contractual arrangements that allow one market player to take control of or to exert decisive impact on another market player. In the future, we may grow our business by acquiring complementary businesses. Complying with the necessary notification and review requirements to complete such transactions may be time consuming, and our ability to obtain any necessary approvals, such as from the MOFCOM or its local counterparts, may delay or prevent our ability to complete such transactions. It is unclear whether our business would be deemed to be in an industry that raises national security concerns. If our business is deemed to be in an industry subject to national security review, our future acquisitions in mainland China may be closely scrutinized or prohibited, and our ability to expand our business through future acquisitions would be materially and adversely affected. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Completing the necessary inspection and approval processes for our Chinese manufacturing facilities, such as by the FDA, NMPA, and EMA, may be time consuming and costly. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">As part of obtaining required regulatory approvals for our product candidates, such as by the NMPA in mainland China, FDA in the United States, and EMA in the European Union (the &#8220;EU&#8221;), we will need to undergo strict pre-approval inspections of our manufacturing facilities or the manufacturing facilities of our CMOs, including those located in mainland China and elsewhere. Historically, some manufacturing facilities in mainland China have had difficulty meeting required standards. When inspecting Chinese manufacturing facilities, our regulator(s) might cite GMP deficiencies, both minor and significant. Our efforts to remediate deficiencies to the satisfaction of our regulator(s) can be laborious, time consuming, and costly and may be unsuccessful. If we cannot satisfy our regulator(s) as to our compliance with GMP, marketing approval for our product candidates could be significantly delayed or prevented, which in turn would delay or prevent commercialization of our product candidates. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business benefits from certain financial incentives and discretionary policies granted by local governments. Expiration of, or changes to, these incentives or policies would have an adverse effect on our results of operations. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Local governments within mainland China have granted certain financial incentives to our Chinese subsidiaries as part of their efforts to encourage the development of local businesses. The timing, amount, and criteria of government financial incentives are determined within the sole discretion of the local government authorities and cannot be predicted with certainty. We received government grants and subsidies of $2.4 million and $11.5 million in 2023 and 2022, respectively. Local governments may decide to reduce or eliminate incentives that we are receiving at any time. In addition, some government financial incentives are granted on a project basis and subject to the satisfaction of certain conditions, including compliance with the applicable financial incentive agreements and completion of the specified project(s). If we fail to satisfy the necessary conditions, we may be deprived of the relevant incentives. Any reduction or elimination of government incentives would have an adverse effect on our business and results of operations.  </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-34-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">It may be difficult for shareholders and regulators outside of mainland China to conduct investigations or collect evidence in mainland China.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">It may be difficult for shareholders to pursue claims or for regulators outside of mainland China to conduct regulatory investigations in mainland China as a matter of law or practicality. For example, in mainland China, there are significant legal and other obstacles to providing information needed for regulatory investigations or litigation initiated outside of mainland China. Although authorities in mainland China may establish a regulatory cooperation mechanism with authorities of another country or region to implement cross-border supervision and administration, such cooperation with authorities in the United States may not be efficient in the absence of mutual and practical cooperation mechanisms. Furthermore, under Chinese securities laws, no overseas securities regulator is allowed to directly conduct investigation or evidence collection activities in mainland China, which may further increase difficulties shareholders may face in protecting their interests. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">If we are classified as a Chinese resident enterprise for Chinese income tax purposes, such classification could result in unfavorable tax consequences to us and our non-Chinese shareholders or ADS holders.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Under the Enterprise Income Tax Law of the People&#8217;s Republic of China (the &#8220;EIT Law&#8221;), an enterprise incorporated outside of mainland China whose &#8220;de facto management bodies&#8221; are located in mainland China is considered a &#8220;resident enterprise&#8221; and will be subject to a uniform 25% enterprise income tax, or EIT, rate on its global income. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We believe that neither Zai Lab Limited nor any of our subsidiaries outside of mainland China is a Chinese resident enterprise for Chinese tax purposes. However, the tax resident status of an enterprise is subject to determination by Chinese tax authorities, and uncertainties remain with respect to the interpretation of the term &#8220;de facto management body.&#8221; If Chinese tax authorities determine that Zai Lab Limited or any of our subsidiaries outside of mainland China is a Chinese resident enterprise for EIT purposes that entity would be subject to a 25% EIT on its global income. If such entity derives income other than dividends from its wholly owned subsidiaries in mainland China, a 25% EIT on its global income may increase our tax burden. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In addition, if Zai Lab Limited is classified as a Chinese resident enterprise for Chinese tax purposes, we may be required to withhold tax at a rate of 10% from dividends we pay to our shareholders, including the holders of our ADSs that are non-resident enterprises. In addition, non-resident enterprise shareholders (including our ADS holders) may be subject to a 10% Chinese withholding tax on gains realized on the sale or other disposition of ADSs or ordinary shares, if such income is treated as sourced from within mainland China. Furthermore, gains derived by our non-Chinese individual shareholders from the sale of our shares and ADSs may be subject to a 20% Chinese withholding tax. It is unclear whether our non-China-based individual shareholders (including our ADS holders) would be subject to any Chinese tax (including withholding tax) on dividends received by such non-Chinese individual shareholders in the event we are determined to be a Chinese resident enterprise. If any Chinese tax were to apply to such dividends, it would generally apply at a rate of 20%. Chinese tax liability may vary under applicable tax treaties. However, it is unclear whether our non-Chinese shareholders would be able to claim the benefits of any tax treaties between their country of tax residence and mainland China in the event that Zai Lab Limited is treated as a Chinese resident enterprise. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">We and our shareholders may face tax consequences and other requirements in mainland China with respect to indirect transfers of equity interests in Chinese resident enterprises.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The indirect transfer of equity interests in Chinese resident enterprises by a non-Chinese resident enterprise, or Indirect Transfer, is potentially subject to income tax in mainland China at a rate of 10% on the gain if such transfer is considered as not having a commercial purpose and is carried out for tax avoidance. The Chinese State Administration of Taxation has issued several rules and notices to tighten scrutiny over such acquisition transactions in recent years and has provided certain factors and criteria that will be considered in determining whether an indirect transfer has a bona fide commercial purpose. Failure to withhold and remit required taxes may result in tax liability and a penalty of 50% to 300% of the unpaid tax. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-35-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">It is unclear how these rules and regulations affect future private equity financing transactions, share exchange, or other transactions involving the transfer of shares in Zai Lab Limited by investors that are non-Chinese resident enterprises or the sale or purchase of shares in other non-Chinese resident companies or other taxable assets by us. As a result, we may be required to expend valuable resources to determine whether we or our non-Chinese resident investors are subject to filing, withholding, or tax obligations for certain transactions, such as offshore restructuring transactions or acquisition transactions, and to otherwise comply with these rules and regulations. This may have a material adverse effect on our financial condition, results of operations, and ability to complete such transactions with non-Chinese resident investors. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Certain of our investments may be subject to review from the Committee on Foreign Investment in the United States, which may delay or block a transaction from closing.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The CFIUS has jurisdiction over investments in which a foreign person acquires control over a U.S. company, as well as certain non-controlling investments in U.S. businesses that deal in critical technology, critical infrastructure, or sensitive personal data. Some transactions involving U.S. businesses that deal in critical technology are subject to a mandatory filing requirement. Accordingly, to the extent the U.S. portion of our business decides to take investments from foreign persons, or we decide to invest in or acquire, in whole or in part, a U.S. business, such investments could be subject to CFIUS&#8217;s jurisdiction. To date, none of our investments have been subject to CFIUS review, but depending on the particulars of ongoing or future investments, we may be obligated to secure CFIUS approval before closing, which could delay the time period between signing and closing. If we determine that a CFIUS filing is not mandatory (or otherwise advisable), there is a risk that CFIUS could initiate its own review, if it determines that the transaction is subject to its jurisdiction. If an investment raises significant national security concerns, CFIUS has the authority to impose mitigation conditions or recommend that the President block a transaction. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In September 2022, President Biden issued an executive order to instruct CFIUS to consider national security factors when evaluating transactions, specifically a deal&#8217;s effect on critical U.S. supply chains, U.S. technological leadership in biotechnology and biomanufacturing, cybersecurity risks, or risks to U.S. persons&#8217; sensitive data. As a result, companies with significant operations in China will likely face heightened regulatory scrutiny from CFIUS in conducting acquisition of U.S, biotech companies.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Changes in United States and international trade policies and relations, particularly with regard to mainland China, may adversely impact our business and operating results.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The U.S. government has recently made statements and taken certain actions that led to changes to United States and international trade policies and relations, including imposing several rounds of tariffs affecting certain products manufactured in mainland China and imposing certain sanctions and restrictions in relation to mainland China. It is unknown whether and to what extent new tariffs or other new executive orders, laws, or regulations will be adopted, or the effect that any such actions would have on us or our industry. We conduct pre-clinical and clinical activities and have business operations both in the United States and mainland China, and any unfavorable government policies on international trade, such as capital controls or tariffs, may affect the demand for our products, the competitive position of our products, the hiring of scientists and other research and development personnel, and import or export of raw materials in relation to drug development or may prevent us from selling our products in certain countries. If any new tariffs, legislation, executive orders, and/or regulations are implemented, or if existing trade agreements are renegotiated or, in particular, if the U.S. or Chinese governments takes retaliatory actions due to the recent U.S.-China tension, such changes could have an adverse effect on our business, financial condition, and results of operations. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">It may be difficult to enforce against us or our management in mainland China any judgments obtained from foreign courts.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Although there are some protections with respect to enforcement in mainland China of judgments rendered by Hong Kong courts as a result of reciprocal recognition and enforcement of judgment arrangements, mainland China does not have treaties or agreements providing for the reciprocal recognition and enforcement of judgments awarded by courts of the United States, the United Kingdom, most other western countries, or Japan. Hence, the recognition and enforcement in </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-36-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">mainland China of judgments of a court in any of these jurisdictions in relation to any matter not subject to a binding arbitration provision may be difficult or even impossible.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Failure to renew our current leases or locate desirable alternatives for our leased properties could materially and adversely affect our business.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We lease properties for our offices and manufacturing facilities. We may not be able to successfully extend or renew such leases upon expiration of the current term on commercially reasonable terms or at all and may therefore be forced to relocate our affected operations. This could disrupt our operations and result in significant relocation expenses, which could adversely affect our business, financial condition, and results of operations. In addition, we compete with other businesses for premises at certain locations or of desirable sizes. As a result, even though we could extend or renew our leases, rental payments may significantly increase as a result of the high demand for the leased properties. In addition, we may not be able to locate desirable alternative sites for our current leased properties as our business continues to grow and failure in relocating our affected operations could adversely affect our business and operations. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Risks Related to Our Financial Position</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">We have incurred significant losses since our inception and anticipate that we will continue to incur losses for at least the next year. If we are unable to generate sufficient revenue from our commercial products, on the anticipated timeline or at all, at a level that more than offsets our expenses, we will be unable to achieve or maintain profitability.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We currently have five commercial products that are approved and marketed for certain indications in mainland China, and we are pursuing regulatory approval of new products and additional indications for our existing products in coming years in mainland China and other licensed territories and worldwide for our internally developed product candidates. Investment in biopharmaceutical product development is highly speculative because it entails substantial upfront capital expenditures and significant risk that a product candidate will fail to gain regulatory approval or become commercially viable. To date, we have financed our activities primarily through revenues from the sales of our commercial products and offerings on Nasdaq and the Hong Kong Stock Exchange as well as private placements. Although our annual product revenues have been increasing for the last few years and we continue to focus on efficiency and productivity, we continue to incur significant development, commercialization, and other expenses related to our ongoing operations. As a result, we have incurred net losses since our inception, including $334.6 million for 2023. If we are unable to generate sufficient revenue from sales of our approved commercial products, on our anticipated timeline or at all, at a level that more than offsets our expenses, we will be unable to achieve or maintain profitability.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">There are several factors that could impact our ability to achieve and maintain profitability, including the success and costs of our commercial products; our ability to obtain approvals for and commercialize new products or additional indications for existing products and costs of our clinical trials; our ability to build and strengthen our pipeline through internal discovery and business development activities and costs related to such license and collaboration arrangements; the costs and efficiency of our commercial and R&amp;D teams and other personnel; and our ability to overcome unforeseen challenges or absorb unforeseen expenses that may adversely affect our business. Our failure to become and remain profitable would decrease the value of the Company or our securities and could impair our ability to raise capital, maintain our research and development and commercialization efforts, or expand or maintain our business. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">We may seek additional funding, such as for our product development programs and commercialization efforts, which may not be available on acceptable terms, or at all. If we are unable to raise capital on acceptable terms when needed, we could incur losses or be forced to delay, reduce, or terminate certain programs or activities.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Since inception, we have incurred significant costs for our commercialization efforts with respect to our approved products, our research and development efforts related to our product candidates and related clinical or pre-clinical trials, our business development activities and related upfront or milestone fees or royalty payments in our license and collaboration arrangements, and other costs to develop the infrastructure and otherwise support our operations. To date, we have financed our activities primarily through revenues from the sales of our commercial products and offerings on Nasdaq and the Hong Kong Stock Exchange as well as private placements. We may require or seek to obtain additional funding in </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-37-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">connection with our operations through public or private equity offerings, debt financing, collaborations or licensing arrangements, or other sources. If we are unable to raise capital when needed or on acceptable terms, we could incur losses or be forced to delay, reduce, or terminate certain programs or activities. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Although we believe our cash and cash equivalents and short-term investments as of December 31, 2023 will enable us to fund our operating expenses and capital expenditure requirements for at least the next twelve months, we could use our capital resources sooner than we currently expect. Our future capital requirements will depend on many factors, including: </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">revenues from our approved commercial products and related product costs;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">the cost and timing of future commercialization activities for our products and any other product candidates for which we receive regulatory approval; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">the cost, timing, and outcome of seeking, obtaining, and maintaining regulatory approval for our products and product candidates; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">the scope, progress, timing, results, and costs of researching and developing our product candidates, including additional indications for our existing commercial products, and conducting pre-clinical and clinical trials; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">our ability to establish and maintain strategic partnerships, including collaboration, licensing, or other arrangements and the economic and other terms, timing, and success of such arrangements, such as with respect to any upfront fees, development and regulatory milestones that may be payable prior to commercialization or before we have generated any revenue from the related product, and sales-based milestones or royalty payments;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">the cost, timing, and outcome of preparing, filing, and prosecuting patent applications, maintaining and enforcing our intellectual property rights, and defending any intellectual property related claims; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">cash requirements of any future acquisitions; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">resources and costs required to promote compliance with applicable laws and regulations by us and our third-party partners; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">costs of our personnel; and </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">the costs of operating as a public company in both the United States and Hong Kong. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">We and our subsidiaries have entered into debt arrangements with certain financial institutions in China, and we may in the future consider additional debt arrangements, to fund our business or working capital needs.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:139%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Such debt arrangements may restrict our future operations.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We may, from time to time, enter into debt arrangements with certain financial institutions to support our business and working capital needs. As of the date hereof, we have entered into certain debt arrangements with Chinese financial institutions that allow certain of our wholly-owned subsidiaries to borrow up to approximately $164.5 million (or RMB1,171.7 million) to support our working capital needs in mainland China, and Zai Lab Limited has agreed to guarantee approximately $142.0 million (or RMB1,011.7 million) of this debt. Such debt requires us or our subsidiaries to dedicate a portion of our or their cash flow to service interest and principal payments and, if interest rates rise, this amount may increase. As a result, our existing debt may limit our ability to use our cash flow to fund capital expenditures, to engage in transactions, or to meet other capital needs. Additionally, our subsidiaries&#8217; debt service obligations may limit their ability to make future distributions to us. Our debt could also limit our flexibility to plan for and react to changes in our business or industry and may increase our vulnerability to general adverse economic and industry conditions, including a downturn in our business or the economy. This debt is denominated in RMB, and some bears interest at variable rates. As a result, increases in market interest rates and changes in foreign exchange rates could require a greater portion of our cash flow to be used to pay interest, which could further hinder our operations. We may also have difficulty refinancing our existing debt or incurring new debt on terms that we would consider commercially reasonable or at all. To the extent that we incur additional indebtedness, the foregoing risks could increase.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-38-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">We may enter into certain capital raising, business collaboration, or other arrangements that may cause dilution to our shareholders, restrict our operations, or require us to relinquish rights to our technologies or product candidates. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We may seek business opportunities or additional funding in the future through equity offerings, debt financings, collaborations, licensing arrangements, strategic alliances, and marketing or distribution arrangements. To the extent that we raise additional capital through the sale of equity or convertible debt securities, our shareholders&#8217; ownership interest will be diluted, and the terms may include liquidation or other preferences that adversely affect rights of our security holders. The incurrence of additional indebtedness or the issuance of certain equity securities could result in increased fixed payment obligations and additional restrictive covenants, such as limitations on our ability to incur additional debt or issue additional equity, limitations on our ability to acquire or license intellectual property rights, and other operating restrictions that could adversely impact our ability to conduct our business. In addition, issuance of additional equity securities, or the possibility of such issuance, may cause the market price of our securities to decline. Additionally, to finance any acquisitions, licensing arrangements, or strategic alliances, we may choose to issue our securities as consideration, which could dilute the ownership of our shareholders. In the event that we enter into collaboration or licensing arrangements to raise capital, we may be required to accept unfavorable terms, including relinquishing or licensing to a third party our rights to technologies or product candidates. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">We may not be able to access the capital and credit markets on terms that are favorable to us. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We may seek access to the capital and credit markets to supplement our existing funds and cash generated from operations for working capital, capital expenditure and debt service requirements, and other business initiatives. The capital and credit markets are experiencing, and have in the past experienced, extreme volatility and disruption, which leads to uncertainty and liquidity issues for borrowers and investors. That volatility and unpredictability in the financial markets has adversely affected, and may in the future adversely affect, access to capital and credit for life sciences companies, particularly for companies like ours with significant operations in China as a result of geopolitical tensions between the United States and China or otherwise. In the event of adverse market conditions, we may be unable to obtain adequate capital or credit market financing, obtain that capital or credit on favorable terms, or access such capital or credit in the market(s) or manner most favorable to the Company. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Our results of operations may be adversely affected by sustained periods of increased inflation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The global economy, including the U.S. economy, has experienced rising inflation in recent years. We source our products, product candidates, and key materials from third parties located in the United States, including our licensors, other suppliers, and CROs. For example, we rely on NovoCure for OPTUNE, Deciphera for QINLOCK, and argenx for VYVGART. Although we have not been materially affected by inflation in the past, sustained or increased inflation may result in increased product costs or other expenses. As a result, our results of operations may be adversely affected.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Risks Related to Our Business and Industry</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Our ability to generate revenues is highly dependent on the success of our commercial products and our ability to obtain regulatory approvals for our product candidates.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to generate product revenues depends on the success of our commercial products, including our five current commercial products as well as new products or additional indications for our current commercial products that we may launch in the future. Our ability to successfully generate revenue from our commercial products will depend on, among other things, our ability to: </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">maintain sufficient manufacturing or supply arrangements with third-party licensors or manufacturers; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">produce through a validated process or procure internally or from third-party manufacturers sufficient quantities and inventory of our commercial products; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">build and maintain sufficient internal sales, distribution and marketing capabilities; </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-39-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">increase awareness and education for our commercial products to promote acceptance from physicians, healthcare payors, patients, and the medical community; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">improve access to, and affordability of, our commercial products, such as through NRDL listings or supplemental insurance coverage in the private-pay market; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">maintain compliance with ongoing regulatory labeling, packaging, storage, advertising, promotion, recordkeeping, safety, and other post-market requirements; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">manage our growth and spending as costs and expenses increase due to commercialization; and </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">manage business interruptions resulting from the occurrence of any public health crisis, international war or conflict, natural disaster, extreme weather event, or other significant or catastrophic event outside of our control. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We have several product candidates in late-stage clinical development and various others in earlier stage clinical and pre-clinical development. Our ability to generate revenue from our product candidates is dependent on the results of clinical and pre-clinical development, our receipt of regulatory approval, and successful commercialization of such products, which may not occur on the anticipated timeline or at all. The success of our product candidates will depend on several factors, including the following:</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">successful enrollment of patients in, and completion of, clinical trials and pre-clinical studies; </span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">receipt of regulatory approvals from applicable regulatory authorities for planned clinical trials, future clinical trials or drug registrations, manufacturing, and commercialization; </span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">successful completion of all safety and efficacy studies required to obtain regulatory approval in Greater China, the United States, and other jurisdictions for our product candidates; </span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">adapting our commercial manufacturing capabilities to the specifications for our product candidates for clinical supply and commercial manufacturing and/or making and maintaining necessary arrangements with third-party manufacturers or suppliers; </span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">obtaining, maintaining, and successfully enforcing or defending patent, trade secret, and other intellectual property protection and/or regulatory exclusivity for our product candidates; </span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">launching commercial sales of our product candidates, if and when approved, whether alone or in collaboration with others; </span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the success of our marketing efforts and market acceptance of the product candidates by patients, the medical community, and third-party payors; </span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">effectively competing with any competing products or therapies; </span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">obtaining and maintaining healthcare coverage and adequate reimbursement; </span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">successfully enforcing and defending intellectual property rights and claims; and </span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">maintaining a continued acceptable safety, tolerability, and efficacy profile of the product candidates following regulatory approval.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We are not permitted to market any of our products or product candidates in mainland China, the United States, the EU, or any other jurisdictions until we have received required regulatory approvals. The process to develop, obtain regulatory approval, and commercialize product candidates is long, complex, and costly and varies among countries. The successful completion of clinical trials or regulatory approval in one country does not mean that clinical trials will be successful in, or regulatory approval will be obtained, in any other country. Our product candidates could be delayed in receiving, or fail to receive, regulatory approval for many reasons, including the following:</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">disagreement regarding the number, design, size, conduct, or implementation of our clinical trials; </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-40-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">failure to demonstrate to the satisfaction of the regulator(s) that a product candidate is safe and effective for its proposed indication, including as a result of safety issues, product recalls, or other incidents related to products approved and marketed in other jurisdictions; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">failure of CROs, clinical study sites, or investigators to comply with the ICH-good clinical practice, or GCP, requirements imposed by the regulator(s); </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">failure of the clinical trial results to meet the required level of statistical significance; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">failure to demonstrate that clinical and other benefits outweigh safety risks; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">disagreement regarding the interpretation of data from pre-clinical studies or clinical trials; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">insufficient data collected from clinical trials to support the submission of an NDA, PMA, or other submission required to obtain regulatory approval in Greater China, the United States, the EU, or elsewhere; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">failure to obtain approval of the manufacturing processes for our clinical and commercial supplies; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">changes in the approval policies or regulations; and </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">actions by our CROs or licensors that materially and adversely affect the clinical trials. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">If we are not successful in gaining broad acceptance of our commercial products, our business would be harmed.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Sales of our commercial products will depend on our ability to educate and increase physician awareness of the benefits, safety, and cost-effectiveness of such products, in general and relative to any competing therapies. The degree of market acceptance of our commercial products among physicians, patients, healthcare payors, and the medical community may depend on a number of factors, including: </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">acceptable evidence of safety and efficacy; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">relative convenience and ease of administration; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">prevalence and severity of any adverse side effects; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">availability of alternative treatments; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">pricing, cost effectiveness, and value propositions; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">effectiveness of our sales and marketing capabilities and strategies; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">ability to obtain sufficient insurance coverage and reimbursement; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">the clinical indications for which such product are approved, as well as changes in the standard of care for their targeted indications; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">the effectiveness of manufacturing and supply chain; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">warnings and limitations contained in the approved labeling; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">safety concerns with respect to similar or competing products marketed by others; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">our ability to comply with regulatory post-marketing requirements; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">the market size for such product, which may be larger or smaller than expected; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">entry timing and price for any competing products; and </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-41-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">our ability to manage complications or barriers that inhibit our commercial team from reaching the appropriate audience to promote our product(s), such as because of government actions or business disruptions caused by public health crises, natural disasters, extreme weather events, and other significant or catastrophic events. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">We may not obtain regulatory approval of our product candidates, on the anticipated timeline or at all, which could delay or limit our ability to realize the full potential of our product pipeline.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In order to market products in any given jurisdiction, we must obtain regulatory approval and comply with numerous and varying regulatory requirements regarding safety, efficacy, and quality. We have obtained approval for our five commercial products for certain indications in certain jurisdictions in Greater China. We may not obtain regulatory approval for our product candidates, including new products or additional indications for our current commercial products, on the anticipated timeline or at all, which could delay or limit our ability to realize the full potential of our pipeline. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">We have limited experience manufacturing our products and product candidates on a large clinical or commercial scale. We rely on third parties for our supply chain, and if we experience problems with any of these third parties, the manufacture of our products or product candidates could be delayed, which could harm our business and results of operations.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We currently manufacture, or have rights to manufacture, our internally developed products and certain of our licensed commercial products and product candidates under the terms of our licensing arrangements. We rely on our two manufacturing facilities in Suzhou to support the clinical development and commercial production of such products and product candidates, including ZEJULA. If our two manufacturing facilities are unable to meet our intended production capacity in a timely fashion, we may have to engage a CMO(s) for the production of clinical supplies of our products or product candidates. We may not be able to identify qualified CMOs or alternative suppliers that are able to meet our product production needs on commercially reasonable terms, in a timely manner, or at all. If we are not able to maintain sufficient quantity of our manufactured products and product candidates, our business and results of operations could be adversely affected.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">If our manufacturing facilities are damaged or destroyed, or production at such facilities is otherwise interrupted, or if any new manufacturing facilities are not approved by regulators, our business and prospects would be negatively affected.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We have two manufacturing facilities in Suzhou that have received required approvals from our regulators and, accordingly, we intend to rely on these facilities for the manufacture of clinical and commercial supply for certain of our products and product candidates. If either facility were damaged or destroyed, or otherwise subject to disruption, it would require substantial lead-time to replace our manufacturing capabilities. In such event, we would be forced to identify and rely partially or entirely on third-party CMOs for an indefinite period. Any new facility needed to replace an existing production facility would need to comply with necessary regulatory requirements and be tailored to our production requirements and processes. We also would need regulatory approvals before using any products or drugs manufactured at a new facility in clinical trials or selling any products or drugs that have been approved. Any disruptions or delays at our facilities or their failure to comply with regulatory requirements would impair our ability to develop and commercialize certain of our products or product candidates, which may adversely affect our business and results of operations.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">We have a limited operating history, which may make it difficult for you to evaluate the success of our business and to assess our future prospects.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We are a commercial-stage biopharmaceutical company with a relatively limited operating history. Consequently, any predictions about our future success, performance, or prospects are subject to significant uncertainty, particularly in light of the dynamic and evolving industry in which we operate. We will encounter risks and difficulties frequently experienced by companies in our industry as we continue to expand or enhance our commercial activities. In addition, as a commercial-stage business, we may be more likely to encounter unforeseen expenses, difficulties, complications, and delays. If we do not address these risks and difficulties successfully, our business will suffer. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-42-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">We may decide to pursue a particular product, product candidate, or indication and fail to pursue other products, product candidates, or indications that may later prove to be more profitable or for which there is a greater likelihood of success.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We may decide to focus our licensing, research, development, and commercialization programs to specific products and product candidates or to specific indications</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">for those products and product candidates based on our expectations with respect to the potential benefits of the therapies, patient needs and the potential markets, synergies with our existing business, the competitive landscape, or otherwise. We may incorrectly assess the benefits, costs, and risks for any potential product or product candidate. As a result, we may forego or delay pursuit of opportunities for other products or product candidates or for other indications that later prove to have greater commercial potential, and our resource allocation decisions may cause us to fail to capitalize on promising commercial drugs or profitable market opportunities. If we do not accurately evaluate the commercial potential or target market for a particular product candidate, we may also relinquish valuable rights to that product candidate through collaboration, licensing, or other royalty arrangements when it would have been more advantageous for us to retain sole development and commercialization rights to such product candidate. Such developments would have an adverse effect on our business, results of operations, financial conditions, and prospects.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">The market opportunities for certain of our products and product candidates may be small, such as when those opportunities are limited to patients who are ineligible for other treatment options or who have not responded to prior treatments, and our estimations with respect to these populations may be inaccurate.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The potential markets for certain indications of our commercial products and product candidates may be small, such as when we are seeking approval of our product candidates as a later stage therapy for patients who are ineligible for other treatment options or who have not responded to prior treatments or other approved treatments. We may consider such indications or market indications as an initial entry point for certain of our product candidates or as an additional indication for our current commercial products. We may not be able to achieve such regulatory approval or to generate sufficient revenue from such opportunities to recover related costs, without obtaining regulatory approval for additional indications. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In addition, as part of our evaluation of the commercial prospects for our products and product candidates, we periodically make estimates regarding the incidence and prevalence of our target populations, including with respect to the number of people who have the indications we are targeting, as well as the subset of people with those indications who may be in a position to receive our therapies and who have the potential to benefit from treatment with our products. We also make projections regarding sales, revenues, costs, and reimbursement for our products and product candidates. We may also use such estimates in making decisions regarding our product development strategy, including business development opportunities as well as our research and development activities and the focus of pre-clinical and clinical trials. These estimates and projections are based on our beliefs, internally generated analyses, and third-party sources, and they may prove to be inaccurate or based on imprecise data. For example, the actual size of the potential market opportunity and patient population for a product or product candidate will depend on a variety of factors, including acceptance by the medical community, patient access, product pricing, reimbursement, and availability of other treatment options. Further, new studies or market data may change the estimated incidence or prevalence of these indications. The number of patients may turn out to be lower than expected, such as because patients may not be amenable to treatment with our products and product candidates or new patients may become increasingly difficult to identify or reach. All of this could significantly harm our business, financial condition, results of operations, and prospects. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">The pharmaceutical industry is highly regulated, and such regulations are subject to change, which may affect the approval and commercialization of our products and product candidates, and any failure to comply with such regulations could have adverse legal and financial impact.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The pharmaceutical industry in Greater China, the United States, the EU, and some other jurisdictions is subject to extensive and comprehensive regulation and oversight by numerous regulatory authorities, including with respect to approval, manufacturing, distribution, marketing, and other activities related to new drug candidates and certain other therapies and treatments. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-43-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In recent years, there have been a number of legislative and regulatory changes in our industry that could prevent or delay regulatory approval of our products and product candidates, restrict or regulate post-approval activities, and affect the commercial prospects of our products and product candidates, including in our primary market of mainland China. We expect the evolution in the Chinese healthcare industry to continue. Any changes or amendments, or proposed further changes or amendments, with respect to applicable laws, rules, and regulation and supervision of the pharmaceutical industry in mainland China, including recent anti-corruption enforcement efforts, may result in uncertainties with respect to the interpretation and implementation of the relevant laws and regulations and may adversely affect the development or commercialization of our drugs and product candidates in mainland China. Efforts to comply with these extensive regulatory requirements may involve substantial costs. If our operations were found to be in violation of applicable regulatory requirements, we could be subject to significant civil, criminal, and administrative penalties, including, without limitation, damages, fines, imprisonment, and exclusion from participation in government healthcare programs or contracting with government authorities and the curtailment or restructuring of our operations, which could significantly harm our business.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In addition, the commercial success of our approved products depends, in part, on adequate insurance coverage and reimbursement by third party payors, including government health benefit programs and authorities. We expect that healthcare reform measures may result in more rigorous coverage criteria and in additional downward pressure on the reimbursement available for any approved product which could adversely affect pricing for such product. Any reduction in reimbursement from government programs may result in a similar reduction in payments from private payors. The implementation of cost containment measures or other healthcare reforms may prevent us from being able to generate revenue or attain profitability for our products or to successfully commercialize our products and product candidates. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">If safety, efficacy, manufacturing, or supply issues arise with any therapy or treatment that we use in combination with our products and product candidates, such as chemotherapy drugs, we may be unable to market such products or product candidate or may experience significant regulatory delays or supply shortages, and our business could be materially harmed. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Certain of our products are approved for treatment, and certain of our product candidates are being evaluated as a potential treatment, in combination with other products, such as chemotherapy drugs. For example, we have commercially launched OPTUNE or TTFields in combination with TMZ for the treatment of patients with newly diagnosed GBM, and we are evaluating TTFields as a combination therapy in gastric cancer, adagrasib as a combination therapy for colorectal cancer and NSCLC, and bemarituzumab as a combination therapy for gastric and GEJ cancers.  </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">If the NMPA, FDA, or another regulatory agency were to revoke its approval of any therapeutic we use in combination with our products and product candidates, we would not be able to market our products and product candidates in combination with such revoked therapeutics. If safety or efficacy issues arise with the therapeutics that we seek to combine with our products and product candidates in the future, we may experience significant regulatory delays, and we may be required to redesign or terminate the related clinical trials. In addition, if manufacturing or other issues result in a supply shortage of any combination therapeutic, we may not be able to successfully commercialize our products or product candidates on our anticipated timeline or at all. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">We face substantial competition, which may result in our competitors discovering, developing, or commercializing drugs before or more successfully than we do, or developing products or therapies that are more advanced or effective than ours, which may adversely affect our financial condition and our ability to successfully market or commercialize our products and product candidates.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The development and commercialization of new drug products or medical devices is highly competitive. We face competition with respect to our current products and product candidates and will face competition with respect to any product candidates that we may seek to develop or commercialize in the future, from major pharmaceutical companies, specialty pharmaceutical companies, biotechnology companies, and medical device companies. Some of these competitive drugs and therapies are based on scientific approaches that are similar to that of our products and product candidates. Potential competitors also include academic institutions, government agencies, and other public and private research </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-44-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">organizations that conduct research, seek patent protection, and establish collaborative arrangements for research, development, manufacturing, and commercialization. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Many of the companies against which we are competing or may in the future compete have significantly greater financial resources and may have additional resources or capabilities with respect to research and development, manufacturing, pre-clinical testing, conducting clinical trials, obtaining regulatory approvals, and marketing approved drugs than we do. Additionally, some of our competitors may successfully adopt or use emerging technologies, including artificial intelligence, to enhance their clinical or business operations before we are able to do so, which could leave us at a competitive disadvantage or with higher costs relative to our peers. Mergers and acquisitions in the pharmaceutical, biotechnology, and diagnostic industries may result in resources being further concentrated among a smaller number of our competitors. Smaller or early-stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large and established companies. These competitors also compete with us in recruiting and retaining global leaders and qualified scientific and management personnel; establishing clinical trial sites and patient registration for clinical trials; and acquiring technologies complementary to, or necessary for, our programs. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our commercial opportunities could be reduced or eliminated if our competitors develop and commercialize products that are safer, more effective, have fewer or less severe side effects, are more convenient, or are less expensive than our products or if they are more successful in their marketing and distribution efforts. Our commercial opportunities also may be adversely affected if the availability of competitor products limits or reduces the price we are able to charge for our products. Our competitors also may obtain regulatory approvals in our target markets before we do, which could allow them to establish a strong market position before we are able to enter the market. Additionally, technologies developed by our competitors may render our products or product candidates uneconomical or obsolete. We may also be adversely affected as a result of the expiration or successful challenge of our patent rights with respect to the validity and/or scope of patents relating to our competitors&#8217; products. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Clinical development involves a lengthy and expensive process with an uncertain outcome.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">There is a risk of failure for each of our product candidates. It is difficult to predict when or if any of our product candidates will prove effective and safe in humans or will receive regulatory approval. Before obtaining regulatory approval, our product candidates must complete pre-clinical studies and extensive clinical trials to demonstrate their safety and efficacy. Clinical testing is expensive, difficult to design and implement, and can take many years to complete. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The outcomes of pre-clinical testing and early clinical trials may not be predictive of the success of later clinical trials, and interim results of a clinical trial do not necessarily predict final results. Moreover, pre-clinical and clinical data are often susceptible to varying interpretations and analyses, and many companies that have believed their product candidates performed satisfactorily in pre-clinical studies and clinical trials have nonetheless failed to obtain regulatory approval of their product candidates. Future clinical trials of our product candidates may not be successful. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Before commencing clinical trials, we must finalize the trial design based on ongoing discussions with the NMPA for trials in mainland China, the FDA for trials in the United States, and any other applicable regulatory authorities. The regulatory authorities may subsequently change their position on the acceptability of trial designs or clinical endpoints, which could require us to complete additional clinical trials or impose unexpected additional approval conditions. Successful completion of our clinical trials is a prerequisite to submitting an NDA (or equivalent filing) to the NMPA, FDA, or other applicable regulatory authorities and to the ultimate approval and commercial launch of our products or product candidates. A number of companies in the pharmaceutical and biotechnology industries have suffered significant setbacks in advanced clinical trials due to lack of efficacy or adverse safety profiles, notwithstanding promising results in earlier trials. There are inherent uncertainties associated with the development of our products and product candidates. We do not know whether the clinical trials for our product candidates will begin or be completed on schedule or at all or whether the clinical trial results will be favorable. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-45-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">We may incur additional costs or experience delays in completing pre-clinical or clinical trials or ultimately be unable to complete the development and commercialization of our product candidates. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We may experience delays in completing our pre-clinical or clinical trials, and numerous unforeseen events could arise during, or as a result of, such clinical trials, which could delay or prevent us from receiving regulatory approval, including: </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">regulators or institutional review boards, or IRBs, or ethics committees may not authorize us or our investigators to commence or conduct a clinical trial at a prospective trial site; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">we may experience delays in reaching, or may fail to reach, agreement on acceptable terms with prospective trial sites and prospective CROs who conduct clinical trials on our behalf, the terms of which can be subject to extensive negotiation and may vary significantly among different CROs and trial sites; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">clinical trials may produce negative or inconclusive results, and we may decide, or regulators may require us, to conduct additional clinical trials or we may decide to abandon product development programs; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">the number of patients required for clinical trials of our products and product candidates may be larger than we anticipate, enrollment in these clinical trials may be slower than we anticipate, or participants may drop out of these clinical trials or fail to return for post-treatment follow-up at a higher rate than we anticipate; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">third-party contractors used in our clinical trials may fail to comply with regulatory requirements or meet their contractual obligations in a timely manner, or at all, or may deviate from the clinical trial protocol or drop out of the trial, which may require that we add new clinical trial sites or investigators; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">we may not be able to conduct a companion diagnostic test to identify patients who are likely to benefit from our products and product candidates in a timely manner or at all; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">we may elect to, or regulators, IRBs or ethics committees may require that we or our investigators, suspend or terminate clinical research for various reasons, including non-compliance with regulatory requirements or a finding that participants are being exposed to unacceptable health risks; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">the cost of clinical trials may be greater than we anticipate; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">the supply or quality of our product candidates or other materials necessary to conduct clinical trials may be insufficient or inadequate; and </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">our products and product candidates may have undesirable side effects or unexpected characteristics, causing us or our investigators, regulators, IRBs, or ethics committees to suspend or terminate the trials, or reports may arise from pre-clinical or clinical testing of other therapies that raise safety or efficacy concerns about our products and product candidates. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We could encounter regulatory delays if a clinical trial is suspended or terminated by us or, as applicable, the IRBs or the ethics committee of the institutions in which such trials are being conducted, by the data safety monitoring board, which is an independent group of experts that is formed to monitor clinical trials while ongoing, or by the NMPA, FDA, or other applicable regulatory authorities. Such authorities may impose a suspension or termination due to a number of factors, including: a failure to conduct the clinical trial in accordance with regulatory requirements or the applicable clinical protocols; a failure to obtain the regulatory approval and/or complete record filings with respect to the collection, preservation, use, and export of mainland China&#8217;s human genetic resources; inspection of the clinical trial operations or trial site by the NMPA, FDA, or other regulatory authorities that results in the imposition of a clinical hold, unforeseen safety issues, or adverse side effects; failure to demonstrate a benefit from using a product candidate; changes in government regulations or administrative actions; or lack of adequate funding to continue the clinical trial. Many of the factors that could cause a delay in the commencement or completion of clinical trials may also ultimately lead to the denial of regulatory approval of our product candidates. Further, the NMPA, FDA, or other applicable regulatory authorities may disagree with our clinical trial design or our interpretation of data from clinical trials or may change the requirements for </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-46-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">approval even after it has reviewed and commented on the design for our clinical trials. Our business will be adversely affected if we are unable to successfully complete clinical development, obtain regulatory approval, and successfully commercialize our products and product candidates. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">If we are required to conduct additional clinical trials or other testing of our products or product candidates beyond those that are currently contemplated, or if we are unable to successfully complete clinical trials of our products or product candidates or other testing, or if the results of these trials or tests are not positive or are only modestly positive or if there are safety concerns, we may: </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">be delayed in obtaining regulatory approval for our products and product candidates; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">not obtain regulatory approval at all; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">obtain approval for indications or patient populations that are not as broad as intended or desired; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">be subject to post-marketing testing requirements; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">encounter difficulties obtaining or be unable to obtain reimbursement for use of our products and product candidates; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">be subject to restrictions on the distribution and/or commercialization of our products and product candidates; or </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">have our products and product candidates removed from the market after obtaining regulatory approval. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our product development costs will also increase if we experience delays in testing or regulatory approvals. We do not know whether any of our clinical trials will begin as planned, will need to be restructured or will be completed on schedule, or at all. Significant pre-clinical study or clinical trial delays also could allow our competitors to bring products to market before we do and impair our ability to successfully commercialize our products and product candidates and may harm our business and results of operations. Any delays in our clinical development programs may harm our business, financial condition, and prospects significantly. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">If we experience delays or difficulties in the enrollment of patients in clinical trials, the progress of such clinical trials and our receipt of necessary regulatory approvals could be delayed or prevented.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We may not be able to initiate or continue clinical trials for our products and product candidates if we are unable to locate and enroll a sufficient number of eligible patients to participate in these trials as required by the NMPA, FDA, or applicable regulatory authorities. In particular, we have designed many of our clinical trials, and expect to design future clinical trials, to include some patients with the applicable genomic mutation with a view to assessing possible early evidence of potential therapeutic effect. Genomically defined diseases, however, may have relatively low prevalence, and it may be difficult to identify patients with the applicable genomic mutation. The inability to enroll a sufficient number of patients with the applicable genomic alteration or that meet other applicable criteria for our clinical trials would result in significant delays and could require us to abandon one or more clinical trials. In addition, some of our competitors have ongoing clinical trials for products or product candidates that treat the same indications as our products or product candidates, and patients who would otherwise be eligible for our clinical trials may instead enroll in clinical trials of our competitors&#8217; products or product candidates. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Patient enrollment may be affected by other factors including: </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">the severity of the disease under investigation; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">the total size and nature of the relevant patient population; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">the design and eligibility criteria for the clinical trial; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">the availability of an appropriate genomic screening test; </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-47-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">the perceived risks and benefits of the product or product candidate under study; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">the efforts to facilitate timely enrollment in clinical trials; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">the patient referral practices of physicians; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">the availability of competing therapies also undergoing clinical trials; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">the ability to monitor patients adequately during and after treatment; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">the proximity and availability of clinical trial sites for prospective patients; and </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">the occurrence of any public health crisis, international war or conflict, natural disaster, extreme weather event, or other significant or catastrophic event may cause a delay in enrollment of patients in clinical trials. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Our products and product candidates may cause undesirable side effects that could delay or prevent their regulatory approval, limit the commercial profile of an approved label, or result in significant negative consequences following regulatory approval, if any.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Undesirable side effects, including adverse safety events, caused by our products or product candidates could have a negative impact on our business. Discovery of safety issues with our products could create issues with respect to product liability, additional regulatory scrutiny and requirements for additional labeling or safety monitoring, withdrawal of products from the market, and the imposition of fines or criminal penalties. Adverse safety events may also damage physician, patient, and/or investor confidence in our products and our reputation. Any of these events could result in liability, loss of revenues, material write-offs of inventory, material impairments of intangible assets, goodwill and fixed assets, material restructuring charges, or other adverse impacts on our results of operations. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Furthermore, undesirable side effects could cause us to interrupt, delay, or halt clinical trials or could cause regulatory authorities to interrupt, delay, or halt our clinical trials and could result in a more restrictive label or the delay or denial of regulatory approval by the NMPA, FDA, or other applicable regulatory authorities. For example, side effects, such as fatigue, nausea, and low blood cell levels, are common in the case of oncology products or product candidates. If trial results for our products or product candidates reveal a high and unacceptable severity and prevalence of these or other side effects, trials of our products or product candidates could be suspended or terminated and the NMPA, FDA, or other applicable regulatory authorities could order us to cease further development or deny approval of our products or product candidates for any or all targeted indications. The product-related side effects could affect patient recruitment or the ability of enrolled patients to complete the trial or result in potential product liability claims. Any of these occurrences may harm our business, financial condition, and prospects significantly.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Additionally, our products and product candidates could cause undesirable side effects related to off-target toxicity. For example, many of the currently approved PARP inhibitors have been associated with off-target toxicities. Many compounds that initially showed promise in early-stage testing for treating cancer have later been found to cause side effects that prevented further development of the compound. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Clinical trials assess a sample of the potential patient population. With a limited number of patients and duration of exposure, rare and severe side effects of our products or product candidates may only be uncovered with a significantly larger number of patients exposed to the product candidate. Even after a product or product candidate receives regulatory approval, if we, our partners, or others identify undesirable side effects caused by such product candidates (or any other similar product candidates) after such approval, a number of significant negative consequences could result, including: </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">our revenue may be negatively impacted; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">our regulatory authorities may withdraw or limit their approval of such products or product candidates; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">our regulatory authorities may require the addition of labeling statements, such as a &#8220;boxed&#8221; warning or a contraindication; </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-48-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">we may be required to create a medication guide outlining the risks of such side effects for distribution to patients; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">we may be required to change the way such products or product candidates are distributed or administered, conduct additional clinical trials or change the labeling of our products or product candidates; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">our regulatory authorities may require a Risk Evaluation and Mitigation Strategy, or REMS (or analogous requirement), plan to mitigate risks, which could include medication guides, physician communication plans, or elements to assure safe use, such as restricted distribution methods, patient registries, and other risk minimization tools; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">we may be subject to regulatory investigations and government enforcement actions; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">we may decide to remove such products or product candidates from the marketplace; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">we could be sued and held liable for injury caused to individuals exposed to or taking our products or product candidates; and </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">our reputation may suffer. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Any of these events could prevent us from achieving or maintaining market acceptance of the affected products or product candidates, could substantially increase the costs of commercializing our products and product candidates, if approved, and could otherwise significantly impact our ability to successfully commercialize our products and product candidates and generate revenue. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">If we are unable to obtain NMPA approval for our products and product candidates to be eligible for an expedited registration pathway, the time and cost we incur to obtain regulatory approvals may increase. Even if we receive Category 1 drug designation, it may not lead to a faster development, review, or approval process.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The NMPA designates innovative drug as Category 1 drugs. To qualify for a Category 1 designation, a drug needs to have a new and clearly defined structure, pharmacological property, and apparent clinical value and has not been marketed anywhere in the world. Our CTAs for ZEJULA and NUZYRA were approved as Category 1 drugs by the NMPA. A Category 1 designation by the NMPA may not be granted for any of our other product candidates that will not be first approved in mainland China or, if granted, such designation may not lead to faster development or regulatory review or approval process. Moreover, a Category 1 designation does not increase the likelihood that our product or product candidates will receive regulatory approval. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Furthermore, despite positive regulatory changes in mainland China which have significantly accelerated time to market for innovative drugs, the regulatory process is still relatively ambiguous and unpredictable. The NMPA might require us to change our planned clinical study design or otherwise spend additional resources and effort to obtain approval of our product candidates. In addition, policy changes may contain significant limitations related to use restrictions for certain age groups, warnings, precautions, or contraindications, or we may be subject to burdensome post-approval study or risk management requirements. If we are unable to obtain regulatory approval for our product candidates in our target markets, or any approval contains significant limitations, we may not be able to obtain sufficient funding or generate sufficient revenue to continue the development of our other product candidates or to in-license, acquire, or develop additional product candidates in the future. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">We continue to be subject to ongoing obligations and continued regulatory review with respect to our commercial products, which may result in significant additional expense, and if we fail to comply with ongoing regulatory requirements or experience any unanticipated problems with any of our commercial products, we may be subject to penalties.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">After obtaining regulatory approval, our commercial products will be subject to, among other things, ongoing regulatory requirements governing the labeling, packaging, promotion, recordkeeping, data management, and submission of safety, efficacy, and other post-market information. These requirements include submissions of safety and other post-marketing information and reports, registration, and continued compliance with cGMPs and GCPs. Such post-approval </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-49-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">development and regulatory requirements may limit how our commercial products are manufactured and marketed, and could materially impair our ability to generate revenue. As such, we and our partners and any of our and their respective contract manufacturers will be subject to ongoing review and periodic inspections to assess compliance with applicable post-approval regulations. To the extent we want to make changes to the approved products, product labeling, or manufacturing processes, we will need to submit new applications or supplements to the applicable regulatory authority and obtain their approval. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Additionally, any regulatory approvals that we receive for our products or product candidates may be subject to limitations on the approved indications for which the products may be marketed or to the conditions of approval, or contain requirements for potentially costly post-marketing studies, including Phase IV studies for the surveillance and monitoring the safety and efficacy of the products. For example, we are collecting additional safety and efficacy data for post-market safety and efficacy analysis for OPTUNE and monitoring adverse effects related to skin irritation, and we continue to collect safety events for all approved products. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In addition, once a product is approved by the applicable regulatory authority for marketing, it is possible that there could be a subsequent discovery of previously unknown problems with the product, including problems with third-party manufacturers or manufacturing processes, or failure to comply with regulatory requirements. If any of the foregoing occurs with respect to our products, it may result in, among other things: </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">restrictions on the marketing or manufacturing of the product, withdrawal of the product or drug from the market, or voluntary or mandatory product recalls; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">fines, warning letters or holds on clinical trials; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">refusal by the applicable regulatory authority to approve pending applications or supplements to approved applications filed by us, or suspension or revocation of product license approvals; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">drug seizure, detention, or refusal to permit the import or export of the product; and </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">injunctions or the imposition of civil, administrative, or criminal penalties. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Any government investigation of alleged violations of law could require us to expend significant time and resources and could generate negative publicity. Moreover, regulatory policies may change, or additional government regulations may be enacted, that could prevent, limit, or delay regulatory approval of our products or product candidates. If we are not able to maintain regulatory compliance, regulatory approval that has been obtained may be lost, and we may not achieve or sustain profitability, which may harm our business, financial condition, and prospects significantly. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our future success depends on our ability to retain key executives and to attract, retain, and motivate qualified personnel. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We are highly dependent on the expertise of our global leaders, including Samantha (Ying) Du, our founder, Chief Executive Officer, and Chairperson of the Board of Directors, and on members of our research and development and commercial teams. Although we have entered into employment agreements with our executive officers, they may terminate their employment with us at any time following a reasonable notice of not less than thirty days. We do not maintain &#8220;key person&#8221; insurance for any of our executives or employees. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Recruiting and retaining qualified management, scientific, clinical, manufacturing, and sales and marketing personnel is critical to our success. The loss of the services of certain of our executive officers or other key employees could impede the achievement of our research, development, and commercialization objectives and seriously harm our ability to successfully implement our business strategy. Furthermore, replacing certain of our executive officers and key employees may be difficult and may take an extended period of time because of the limited number of individuals in our industry with the breadth of skills and experience required to successfully develop, gain regulatory approval of, and commercialize products. Competition to hire from this limited pool is intense, and we may be unable to hire, train, retain, or motivate these key personnel on acceptable terms given the competition among numerous pharmaceutical and </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-50-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">biotechnology companies for similar personnel. We also experience competition for the hiring of scientific and clinical personnel from universities and research institutions. In addition, our management will be required to devote significant time to compliance initiatives from our dual primary listing on Nasdaq and the Hong Kong Stock Exchange. Failure to succeed in clinical trials may make it more challenging to recruit and retain qualified scientific personnel. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">We may further increase the size and capabilities of our organization, and we may experience difficulties in managing such growth. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We may experience further growth in the number of our employees and consultants and the scope of our operations, particularly in the areas of product development, product commercialization, regulatory affairs, and business development. To manage future growth, we may continue to implement and improve our managerial, operational and financial systems, expand our facilities, and continue to recruit and train additional qualified personnel. We may not be able to effectively manage the expansion of our operations or recruit and train additional qualified personnel. The expansion of our operations may lead to significant costs and may divert the attention of our management and business development resources. Any inability to manage growth could delay the execution of our business plans or disrupt our operations and could have a materially adverse effect on our business.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">We may explore additional regional or global licensing or collaboration arrangements for the development and/or commercialization of product candidates, which may expose us to significant additional costs, such as upfront fees, milestone payments, royalty payments, and the costs of related clinical or pre-clinical trials, may divert management attention or resources away from our other products and product candidates, and may expose us to additional risks of conducting business in additional international markets. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The majority of our products and product candidates are in-licensed for development and commercialization in Greater China. We have and may in the future explore additional global or regional licensing or collaboration agreements, including in territories outside of Greater China. Efforts to enter into license or collaboration with third parties may divert our management&#8217;s attention away from other corporate strategic goals or objectives, business operations, or potential acquisition or development opportunities for additional product candidates. Further, these arrangements involve significant costs, including upfront fees; development, regulatory, and sales-based milestones; and certain royalties at tiered percentage rates based on annual net sales. Such milestone payments are contingent on product performance, and upfront fees, certain development and regulatory milestones, and costs of clinical or pre-clinical trials may occur before we have commercialized or received any revenue from the related product candidate.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Moreover, international business relationships subject us to additional risks that may materially adversely affect our business, including:</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">difficulty of effective enforcement of contractual provisions in other jurisdictions; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">potential third-party patent rights or potentially reduced protection for intellectual property rights; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">unexpected changes in tariffs, trade barriers and regulatory requirements, including the loss of normal trade status between mainland China and the United States; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">economic weakness, including inflation; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">compliance with tax, employment, immigration, and labor laws for employees traveling abroad; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">the effects of applicable foreign tax structures and potentially adverse tax consequences; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">currency fluctuations, which could result in increased operating expenses and reduced revenue; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">workforce uncertainty and labor unrest;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-51-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">failure of our employees and contracted third parties to comply with anti-bribery laws in mainland China, Office of Foreign Asset Control rules and regulations and the Foreign Corrupt Practices Act and other anti-bribery and corruption laws; and </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">business interruptions resulting from geopolitical actions, including trade disputes, public health crises, international war or conflict, natural disasters, extreme weather events, and other significant or catastrophic events outside of our control. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">These and other risks may materially adversely affect our business, results of operations, and financial condition.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may engage in future partnerships, in-licensing arrangements, joint ventures, or other types of future business acquisitions that could disrupt our business, cause dilution to holders of our securities, and harm our financial condition and operating results.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We have engaged, and may again in the future engage, in partnership or strategic collaboration opportunities or investments, including those that require acquisitions of, or investments in, companies that we believe have products or capabilities that are a strategic or commercial fit with our current business and corporate strategic goals. In connection with such partnership or collaboration opportunities, acquisitions, or investments, we may:</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">issue ordinary shares that would dilute the percentage of ownership of the holders of our securities;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">incur debt and assume liabilities; and</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">incur amortization expenses related to intangible assets or incur large and immediate write-offs.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">For example, in January 2021, we entered into a strategic collaboration with argenx BV pursuant to which we obtained an exclusive license for the development and commercialization of efgartigimod in Greater China in exchange for a combination of cash and ordinary shares.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We may form or seek strategic alliances, create joint ventures or collaborations, or enter into additional licensing arrangements with third parties that we believe will complement or augment our research, development, and commercialization efforts with respect to our products and product candidates and any future products and product candidates that we may develop. Any of these relationships may require us to incur non-recurring and other charges, increase our near- and long-term expenditures, issue securities that dilute our existing shareholders, or disrupt our management and business. Additionally, establishment of a joint venture involves significant risks and uncertainties, including (i) our ability to cooperate with our strategic partner, (ii) our strategic partner having economic, business, or legal interests or goals that are inconsistent with ours, and (iii) the potential that our strategic partner may be unable to meet its economic or other obligations, which may require us to fulfill those obligations alone.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We may be unable to find suitable acquisition candidates, and we may not be able to complete partnership or strategic collaboration opportunities or investments on favorable terms, if at all. If we do enter into partnerships or strategic collaborations or make other investments, such arrangements may not ultimately strengthen our competitive position or may be viewed negatively by customers, financial markets, or investors. Further, future partnerships, strategic collaborations, or other investments could also pose numerous additional risks to our operations, including:</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">problems integrating the purchased business, products, personnel, or technologies;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">increases to our expenses;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">failure to have discovered undisclosed liabilities of the acquired asset or company;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">diversion of management&#8217;s attention from their day-to-day responsibilities;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">harm to our operating results or financial condition;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">entrance into markets in which we have limited or no prior experience; and</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-52-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">potential loss of key employees, particularly those of the acquired entity.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We may not be able to realize the benefit of current or future collaborations, strategic partnerships, or the license of our third-party products and product candidates if we are unable to successfully integrate such products with our existing operations and company culture, which could delay our timelines or otherwise adversely affect our business. Following a strategic transaction or license, we may not be able to achieve sufficient revenue or net income to justify such transaction. If we elect to fund and undertake development or commercialization activities on our own, we may need to obtain additional expertise and additional capital, which may not be available to us on acceptable terms or at all. If we fail to enter into collaborations and do not have sufficient funds or expertise to undertake the necessary development and commercialization activities, we may not be able to further develop our products and product candidates or bring them to market and generate product sales revenue, which would harm our business prospects, financial condition, and results of operations. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">We may need to significantly reduce our prices for our approved products or our other product candidates and devices for which we may receive regulatory approval in mainland China and face uncertainty of reimbursement, which could diminish our sales or adversely affect our profitability.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The regulations that govern pricing and reimbursement for pharmaceutical drugs and devices vary widely from country to country. In mainland China, the National Healthcare Security Administration (&#8220;NHSA&#8221;) is responsible for administering mainland China&#8217;s social security system, including price negotiations with drug companies seeking to include their products in the NRDL. Such price negotiations have resulted in average price reductions ranging from around 50% to 60% over the past few years. The NHSA, together with other government authorities, review the inclusion or removal of drugs from the NRDL, and the tier under which a drug will be classified, both of which affect the amounts reimbursable to program participants for their purchases of those drugs. These determinations are made based on a number of factors, including price and efficacy. In connection with obtaining NRDL listing for ZEJULA, QINLOCK, NUZYRA, and VYVGART for certain indications, we lowered the selling price of each product in preparation. Although NRDL listing may increase patient access to, and demand for, our commercial products, the lower reimbursement rate could negatively affect our revenues or product margins and may not be sufficient to cover our costs, including licensing fees and research, development, manufacturing, marketing, and distribution expenses. We may also continue to experience additional pricing pressure for our products, including as a result of the centralized tender process or otherwise, which may further adversely affect our revenues or results of operations.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Prior to any potential NRDL listing, revenues for our commercial products will depend on sales that are self-paid by patients or otherwise covered by insurance in the private-pay market. Higher patient prices or lower patient access may reduce demand for, and sales of, our commercial products.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Companies in mainland China that manufacture or sell drugs and medical devices are required to comply with extensive regulations and hold a number of permits and licenses to carry on their business. Our ability to obtain and maintain these regulatory approvals is uncertain, and future government regulation may place additional burdens on our efforts to commercialize our product candidates.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The life sciences industry in mainland China is subject to extensive government regulation and supervision. In order to manufacture and distribute drug and medical device products in mainland China, we are required to: </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">obtain a manufacturing permit for each production facility from the NMPA and its relevant branches for the manufacture of drug and device products domestically; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">obtain a marketing authorization, which includes an approval number, from the NMPA for each drug or device for sale in mainland China; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">obtain a Pharmaceutical Distribution Permit from the provincial medical products administration if we were to sell drugs manufactured by third parties; and</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-53-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">renew the Pharmaceutical Manufacturing Permits, the Pharmaceutical Distribution Permits, and marketing authorizations every five years, among other requirements. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">If we are unable to obtain or renew such permits or any other permits or licenses required for our operations, we will not be able to engage in the commercialization, manufacture, and distribution of our products and product candidates and our business may be adversely affected.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">If we fail to maintain our licenses or other intellectual property-related agreements for our products or product candidates or if we otherwise experience disruptions to our business relationships, we could lose the ability to continue the development and commercialization of our products and product candidates.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our business relies, in large part, on our ability to develop and commercialize products and product candidates from third parties in accordance with our license and collaboration agreements and other intellectual property-related agreements. If we fail to maintain such licenses or other intellectual-property-related agreements that are relevant to our products and product candidates, we may be unable to develop and commercialize the affected products or product candidates, and our business, results of operations, financial condition, and prospects could be materially harmed. If we fail to comply with our obligations under such agreements or if our licensors or collaboration partners fail to comply with obligations under such agreements or other agreements from which our rights are based, we may be unable to successfully develop and commercialize the affected products or product candidates, and our business, results of operations, financial condition, and prospects could be materially harmed.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Failure to meet obligations under any of the aforementioned agreements may result in termination of same by the other contracting party. Even though we may exercise all rights and remedies available to us and otherwise seek to preserve our rights, we may not be able to do so in a timely manner, at an acceptable cost, or at all. Any uncured, material breach under such agreements could result in loss of our rights and may lead to a complete termination of our rights to the applicable products or product candidates. Any of the foregoing could have a material adverse effect on our business, financial conditions, results of operations, and prospects. In addition, disputes may arise regarding our rights under license, collaboration, or other intellectual-property related agreement, including but not limited to: </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">the scope of rights granted under such agreement; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">the use of intellectual property right under such agreement; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">the satisfaction of diligence obligations under such agreement; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">the ownership of inventions or know-how resulting from such agreement; and </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">the payments due under such agreement. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Such dispute may disrupt our business relationships or otherwise hinder our ability to successfully develop and commercialize the affected products or product candidates, which could have a material adverse effect on our business, financial conditions, results of operations, and prospects.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In addition, the resolution of any disputed contractual interpretation of any of the foregoing agreements could result in a narrower interpretation of the scope of our rights or increase our financial or other obligations and thereby may prevent or impair our ability to maintain our current agreement on commercially acceptable terms. Accordingly, we may be unable to successfully develop and commercialize the affected products or product candidates. Any of the foregoing could have a material adverse effect on our business, financial condition, results of operations, and prospects. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Reputational harm to our products, including product liability claims or lawsuits against us or any of our licensors, could cause us to incur substantial liabilities or loss of revenue or harm our reputation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We face an inherent risk related to the use of our products and product candidates anywhere in the world. If we or our licensors cannot successfully defend the reputation of our licensed products, including against product liability or other claims, then we may incur substantial liability, loss of revenue, or loss of reputation. Regardless of merit or eventual </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-54-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">outcome, the consequences to us from those claims (whether resulting from our sales in our licensed territories, or those of our licensors&#8217; sales elsewhere in the world) may result in: </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">significant negative media attention and reputational damage;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">withdrawal of clinical trial subjects and inability to continue clinical trials;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">significant costs to defend related litigation;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">substantial monetary awards to trial subjects or patients;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">the inability to commercialize any products or product candidates that we may develop;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">initiation of investigations by regulators;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">a diversion of management&#8217;s time and our resources; and</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">a decline in the market price of our securities.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Any litigation or investigation might result in substantial costs and diversion of resources. While we maintain liability insurance for certain clinical trials (which covers the patient human clinical trial liabilities including, among others, bodily injury), product liability insurance to cover our product liability claims and general liability and D&amp;O insurance to cover other commercial liability claims, these insurance policies may not fully cover our potential liabilities. Additionally, inability to obtain sufficient insurance coverage at an acceptable cost could prevent or inhibit the successful commercialization of products or drugs we develop, alone or with our collaborators. Any negative reputational harm to our licensors&#8217; products anywhere in the world may have an adverse impact on our ability to sell those same products in our licensed territories. If our licensors incur such harm or liability, it may also cause damage to our revenues and reputation which may not be covered by insurance.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">The research and development projects under our internal discovery programs are at an early-stage of development. As a result, we are unable to predict if or when we will successfully develop or commercialize any product candidates under such programs.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our internal discovery programs are at an early-stage of development and will require significant investment of time and resources and regulatory approvals prior to commercialization. Each of our product candidates will require additional clinical and pre-clinical development; management of clinical, pre-clinical, and manufacturing activities; obtaining regulatory approval, obtaining sufficient manufacturing supply; development of a commercialization strategy; and significant marketing efforts before such products will generate any revenue. We are not permitted to market or promote any of our product candidates before we receive regulatory approval from the NMPA, the FDA, or applicable regulatory authorities, and we may never receive such regulatory approval.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Clinical development of any product candidates from our internal discovery programs may not be successful. We may not be able to obtain regulatory approvals or to successfully commercialize or generate revenue from any of our product candidates. Even if we have success in pre-clinical testing, our clinical trials may not be successful, and the clinical trial process may fail to demonstrate that our product candidates are safe and effective for their proposed uses. Any such failure could cause us to delay or abandon further development of any of our product candidates. Any delay in, or termination of, our clinical trials will delay and possibly preclude the filing of any NDAs or other similar applications with the NMPA for approvals in mainland China, the FDA for approvals in the United States, or other applicable regulatory authorities for approval in other target markets, which will adversely affect our ability to commercialize or generate revenue from the related product candidates.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-55-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Potential cybersecurity threats are changing rapidly and advancing in sophistication. We may not be able to protect our systems and networks, or the confidentiality of our confidential or other information (including personal information), from cyberattacks and other unauthorized access, disclosure, and disruption.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Cybersecurity risks for companies like ours have significantly increased in recent years, in part because of the proliferation of new technologies, the use of the internet and certain technologies to conduct business, and the increased sophistication and activities of organized crime, hackers, terrorists, and other external parties, including foreign state-sponsored actors. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Like many companies, from time to time we have been, and expect to continue to be, the target of attempted cyberattacks and other cybersecurity incidents. Such incidents may include malware, ransomware, denial-of-service attacks, social engineering, unauthorized access, human error, theft or misconduct, fraud, and phishing, as part of an effort to disrupt operations, potentially test cybersecurity capabilities, or obtain confidential, proprietary, or other information (including personal information). Our cybersecurity risk and exposure depend on various factors, including the evolving nature and increasing frequency, levels of persistence, sophistication, and intensity of these threats, the outsourcing of some of our business operations, and the current global economic and political environment. The increase in remote work environments also may increase our cybersecurity risk if our employees, vendors, service providers, and other third parties with which we interact are working remotely on less secure systems and environments. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Because we are dependent on third parties for certain elements of our business and operations, we could also be adversely affected if any of them are subject to a successful cyberattack or other cybersecurity incident. Third parties with which we do business may also be sources of cybersecurity or other technology risks. We routinely transmit and receive confidential, proprietary, and other information (including personal information) by electronic means. This information could be subject to interception, misuse, or mishandling. Our exposure to these risks could increase as a result of our migration of core systems and applications to a third-party cloud environment. While we generally perform cybersecurity diligence on our key vendors, because we do not control third parties with whom we do business and our ability to monitor their cybersecurity posture is limited, the cybersecurity measures they take may not be sufficient to protect any information we share with them.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Although we devote significant resources to protect our systems, network, and information, the security measures we have implemented may not provide effective security. Our internal computer systems, software, devices, and networks &#8211; and those of our CROs, CMOs, and other third-party providers &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">may be vulnerable to cyberattacks and other cybersecurity incidents, business or supply chain disruptions, or other attempts to harm our business or reputation or misuse or steal information (including personal information). We routinely identify cybersecurity threats as well as vulnerabilities in our system and work to address them, but these efforts may be insufficient. Outside parties may attempt to induce employees, third-party partners, vendors, service providers, or other users of our systems or networks to disclose confidential, proprietary, or other information (including personal information) in order to gain access to our systems and networks and the information they contain. Unauthorized access or disclosure, or breaches of our security, also may result from human error. We may not be able to anticipate, prevent, detect, recognize, or react to threats to our systems, networks, and assets, or implement effective preventative measures against cyberattacks or other security incidents, especially because the techniques used change frequently or are not recognized until launched. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">A cyberattack or other cybersecurity incident could occur and persist for an extended period of time without detection. We expect that any investigation of such an incident would take time, during which we would not necessarily know the extent of the harm or how best to remediate it. Although we have not experienced any such incident resulting in a material impact to the company to date, our cybersecurity risk management program may not prevent such an incident from having a material impact in the future. We have obtained insurance coverage relating to cybersecurity risks, but this insurance may not be sufficient to provide adequate loss coverage (including if the insurer denies future claims) and may not continue to be available to us on economically reasonable terms, or at all. Further, any limitations of liability provisions in our agreements with vendors, customers, and other third parties with which we do business may not be enforceable or adequate or otherwise protect us from any liabilities or damages with respect to any particular claim in connection with a cyberattack or other security incident of a third party on which we rely.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-56-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The occurrence of one or more cyberattacks or other cybersecurity incidents could result in the unauthorized disclosure, misuse, or corruption of confidential, proprietary, and other information (including personal and other information about our employees and patients and company and vendor confidential data) or could otherwise cause interruptions or malfunctions in our operations or the operations of our partners, customers, vendors, and other third parties with which we do business. This could result in significant losses or reputational damage, adversely affect our relationships with our partners, customers, vendors, and other third parties, negatively affect our competitive position, or otherwise harm our business. We could also face regulatory and other legal action, including for any failure to provide timely disclosure concerning, or appropriately to limit trading in our securities following, an incident. We may be required to expend significant additional resources to repair or replace information systems or networks, modify our internal controls, and implement or enhance other protective measures or to investigate or remediate vulnerabilities or other exposures. We also may be subject to litigation and financial losses that are not fully insured.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">We are subject to laws and government regulations relating to privacy and data protection that have required us to modify certain of our policies and procedures with respect to the collection and processing of personal data, and future laws and regulations may cause us to incur additional expenses or otherwise limit our ability to collect and process personal data.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We are subject to data privacy and security laws in the various jurisdictions in which we operate, obtain or store personally identifiable information, including in mainland China, the United States, and the EU. The legislative and regulatory landscape for privacy and data protection continues to evolve, and there has been an increasing focus on privacy and data protection issues with the potential to affect our business. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We could be subject to regulatory actions and/or claims made by individuals and groups in private litigation involving privacy issues related to data collection and use practices and other data privacy laws and regulations, including claims under the laws described, as well as for alleged unfair or deceptive practices. If our operations are found to be in violation of any of the privacy laws, rules, or regulations that apply to us, we could be subject to penalties, including civil penalties, damages, injunctive relief, and other penalties, which could adversely affect our ability to operate our business and our financial results. We will continue to review these and all future privacy and other laws and regulations to assess whether additional procedural safeguards are warranted, which may cause us to incur additional expenses or otherwise limit our ability to collect and process personal data.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">We may face further restrictions (or even prohibitions) on our ability to transfer our scientific data abroad if Chinese regulators impose new restrictions (or change their interpretation of existing restrictions) on life sciences companies like us and the scientific data we obtain, generate, and maintain.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Scientific Data Administrative Measures promulgated by the General Office of the State Council provides a regulatory framework for the collection, submission, retention, exploitation, confidentiality, and security of scientific data. Scientific data is defined as data generated from basic research, applied research, experiments, and developments in the fields of natural sciences, engineering, and technology. It also includes the original and derived data by means of surveillance, monitoring, field studies, examination, and testing that are used in scientific research activities. All scientific data generated by research entities, including research institutions, higher education institutions, and enterprises that is created or managed with government funds, or funded by any source that concerns state secrets, national security, or social and public interests, must be submitted to data centers designated by the Chinese government for consolidation. Disclosure of scientific data will be subject to regulatory scrutiny. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The definition of scientific data is broad, and the Chinese government has not issued further guidance to clarify if clinical study data would fall within this definition. To our understanding, the Chinese government has not required life sciences companies to upload clinical study data to any government-designated data center or prevented the cross-border transmission and sharing of clinical study data. None of our clinical study or other scientific data has been created or managed with government funds or funded by any source that concerns state secrets, national security, or social and public interests. To date, we have received requisite permissions to transfer clinical study data abroad. We are closely monitoring legal and regulatory developments in this area to see how scientific data is interpreted, and we may be required to comply </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-57-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">with additional regulatory requirements for sharing clinical study or other scientific data with our licensors or foreign regulatory authorities, although the scope of such requirements, if any, is currently unknown. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Risks Related to Our Dependence on Third Parties</span></div><div style="margin-top:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">We rely on third parties, including our licensors, CMOs, and other suppliers, to support the commercial and clinical supply of our products and product candidates. Failure of such third parties to supply us with a sufficient quantity of products, in a timely matter or at all, may adversely affect our business.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We rely on third-party manufacturers to manufacture some of our products and product candidates. For example, with respect to our commercial products, we rely on NovoCure for OPTUNE or TTFields, Deciphera for QINLOCK, and argenx for VYVGART. We also rely on CMOs for the local production in mainland China of certain drug substances and products, including NUZYRA.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Such reliance on third-party manufacturers entails risks to which we would not be subject to if we manufactured product candidates or products ourselves, including reliance on the third party for regulatory compliance and quality assurance, the possibility of breach of the manufacturing or supply agreement by the third party because of factors beyond our control (including a failure to synthesize and manufacture our products or product candidates in accordance with our specifications), and the possibility of termination or nonrenewal of the agreement by the third party, based on its own business priorities, at a time that is costly or damaging to us. In addition, the NMPA and other regulatory authorities require that our product candidates and any products that we may eventually commercialize be manufactured according to cGMP standards. Any failure by our third-party manufacturers to comply with cGMP standards or failure to scale up manufacturing processes, including any failure to deliver sufficient quantities of product candidates in a timely manner, could lead to a delay in, or failure to obtain, regulatory approval of our product candidates. In addition, such failure could be the basis for the NMPA to issue a warning or untitled letter, withdraw approvals for product candidates previously granted to us, or take other regulatory or legal action, including recall or seizure, total or partial suspension of production, suspension of ongoing clinical trials, refusal to approve pending applications or supplemental applications, detention or product, refusal to permit the import or export of products, injunction or imposing civil and criminal penalties. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Any significant disruption in our supplier relationships could harm our business. We currently source key materials from third parties, either directly through agreements with suppliers or indirectly through our manufacturers who have agreements with suppliers, as well as through our licensors. Any significant disruption in our potential supplier relationships, whether due to price increases, manufacturing, or supply-related issues, could harm our business. We anticipate that, in the near term, our key materials will be sourced through third parties. There are a small number of suppliers for certain capital equipment and key materials that are used to manufacture some of our products and product candidates. Such suppliers may not sell these key materials to us or our manufacturers at the times we need them or on commercially reasonable terms. We currently do not have any agreements for the commercial production of these key materials. Any significant delay in the supply of a product or product candidate or its key materials could considerably delay completion of our clinical studies, product or drug testing, and potential regulatory approval of our products or product candidates. If we or our manufacturers are unable to purchase key materials after regulatory approval has been obtained, the commercialization or the commercial launch of our product candidates could be delayed or there could be a shortage in supply, which would impair our ability to generate revenues from the sale of such products. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Furthermore, because of the complex nature of our compounds, we or our manufacturers may not be able to manufacture our compounds at a cost, in quantities, or in a timely manner necessary to make our products commercially successful. In addition, as our product pipeline develops, we may have a greater need for clinical study and commercial manufacturing capacity or third-party supply of our products and product candidates. We may not be able to increase our scale of production or supply on commercially reasonable terms, in a timely manner, or at all.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-58-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">We rely on third parties to conduct our pre-clinical and clinical trials. If these third parties do not successfully carry out their contractual duties or meet expected deadlines, we may not be able to obtain regulatory approval for or commercialize our products or product candidates and our business could be substantially harmed.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our internal capacity to perform pre-clinical and clinical trials is limited. As a result, we have relied upon and plan to continue to rely upon third-party CROs to monitor and manage data for some of our ongoing pre-clinical and clinical programs. We rely on these third parties for execution of our pre-clinical and clinical trials, and we control only certain aspects of their activities. Nevertheless, we are responsible for ensuring that each of our studies is conducted in accordance with applicable protocols and legal, regulatory, and scientific standards, and our reliance on the CROs does not relieve us of our regulatory responsibilities. We also rely on third parties to assist in conducting our pre-clinical studies in accordance with Good Laboratory Practices (&#8220;GLP&#8221;), and the Regulations for the Administration of Affairs Concerning Experimental Animals. We and our CROs are required to comply with Good Clinical Practice and relevant guidelines enforced by the NMPA, and other applicable regulatory authorities for all of our products or product candidates in clinical development. Regulatory authorities enforce these GCP requirements through periodic inspections of trial sponsors, investigators, and trial sites. If we or any of our CROs fail to comply with applicable GCP requirements, the clinical data generated in our clinical trials may be deemed unreliable, and the NMPA and other applicable regulatory authorities may require us to perform additional clinical trials before approving our marketing applications. In addition, our clinical trials must be conducted with products or drugs produced under cGMP requirements. Failure to comply with these regulations may require us to repeat pre-clinical and clinical trials, which would delay the regulatory approval process.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our CROs are not our employees, and except for remedies available to us under our agreements with such CROs, we cannot control whether they devote sufficient time and resources to our on-going clinical, nonclinical, and pre-clinical programs. Our CROs may not perform contracted services to our standards, may not produce results in a timely manner, or may fail to perform at all. If our CROs do not successfully carry out their contractual duties or obligations or meet expected deadlines or if the quality or accuracy of the clinical data they obtain is compromised due to their failure to adhere to our clinical protocols, regulatory requirements, or for other reasons, our clinical trials may be extended, delayed, or terminated and we may not be able to obtain regulatory approval for or successfully commercialize our products or product candidates. As a result, our results of operations, and the commercial prospects for our products and product candidates would be harmed, our costs could increase, and our ability to generate revenues could be delayed or compromised.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">If we lose our relationships with CROs, our product or drug development efforts could be delayed.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We rely on third-party vendors, including CROs, for some of our pre-clinical studies and clinical trials related to our product or drug development efforts. Switching or adding additional CROs involves additional cost and requires management time and focus. Our CROs have the right to terminate their agreements with us in the event of an uncured material breach. In addition, some of our CROs have an ability to terminate their respective agreements with us if they can reasonably demonstrate that the safety of the subjects participating in our clinical trials warrants such termination, if we make a general assignment for the benefit of our creditors, or if we are liquidated. If any of our relationships with our third-party CROs are terminated, we may not be able to enter into arrangements with alternative CROs in a timely manner, on commercially reasonable terms, or at all. In addition, there is a natural transition period when a new CRO commences work and the new CRO may not provide the same type or level of services as the original provider. Any such developments could cause our drug development efforts to be delayed, which could adversely affect our business and operations. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">We depend on other parties to manage certain intellectual property rights that are material to our business. Any failure to effectively protect these rights could adversely affect our business and operations.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We depend on other parties to manage certain of our intellectual property rights that are material to our business. In accordance with certain of our agreements, we rely on other parties to manage responsibility for protection of certain intellectual property rights that we hold rights to for our products and product candidates. If such parties fail to procure or maintain intellectual property rights, the rights we hold may be reduced or eliminated, which could materially harm our business, financial conditions, results of operations, and prospects. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-59-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Pursuant to the terms of certain of our agreements, we may rely on others to procure, maintain, enforce, or defend certain patent rights we hold that are material to our business. Additionally, even if we are contractually permitted to pursue the enforcement or defense of a patent we hold rights to under an agreement, we require the cooperation of any applicable patent owners to enforce such patent, and such cooperation may not be provided to us. Furthermore, even if we are able to participate in any such legal actions, an adverse outcome could materially harm our business, financial conditions, results of operations, and prospects.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">We rely on third-party distributors to sell our commercial products, and a limited number of customers have generated a substantial portion of our revenue. If we fail to maintain an effective distribution channel for our products, our business and sales of the relevant products could be adversely affected.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We rely on third-party distributors to sell our commercial products, which is consistent with the general practices of the pharmaceutical industry. A substantial amount of our revenue is derived from sales to a limited number of customers, which are distributors. For 2023 and 2022, our five largest customers accounted for approximately 35.0% and 37.7% of our product revenue, respectively. Product revenue generated from our largest customer for the same periods accounted for approximately 19.9% and 22.4% of our product revenue, respectively. We have relatively limited control over our distributors, and they may fail to distribute our products in a timely manner or in the manner we contemplate. Further, while we believe alternative distributors are readily available, if any of our major customers significantly reduces its purchase volume or ceases to purchase from us, and we are not able to identify new customers in a timely manner, our business, financial condition, and results of operation may be materially and adversely affected. In addition, our major customers may seek to negotiate more favorable terms for them in the future. Under such circumstances, we may have to agree to less favorable terms in order to maintain the ongoing cooperative relationships with our major customers. If we are unable to reduce our production costs accordingly, our profitability, results of operations, and financial condition may be materially and adversely affected.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">The illegal distribution and sale by third parties of counterfeit versions of our products or stolen products could have a negative impact on our reputation and business.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Third parties might illegally distribute and sell counterfeit or unfit versions of our products, which do not meet our or our collaborators&#8217; rigorous manufacturing and testing standards. A patient who receives a counterfeit or unfit product may be at risk for a number of dangerous health consequences. Our reputation and business could suffer harm as a result of counterfeit or unfit products sold under our or our collaborators&#8217; brand name(s). In addition, thefts of inventory at warehouses, plants, or while in-transit, which are not properly stored and which are sold through unauthorized channels, could adversely impact patient safety, our reputation, and our business.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Our business, results of operations, and financial condition may be adversely affected by deterioration in the credit quality of, or defaults by, our distributors and customers, and an impairment in the carrying value of our short-term investments could negatively affect our consolidated results of operations.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We are exposed to the risk that our distributors and customers may default on their obligations to us as a result of bankruptcy, lack of liquidity, operational failure, or other reasons. As our business evolves, the amount and duration of our credit exposure may increase, as will the breadth of the entities to which we have credit exposure. Although we regularly review our credit exposure to specific distributors and customers that we believe may present credit concerns, default risks may arise from events or circumstances that are difficult to detect or foresee.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The carrying amounts of cash and cash equivalents, restricted cash, and short-term investments represent the maximum amount of loss due to credit risk. As of December&#160;31, 2023 and 2022, we had cash and cash equivalents of $790.2 million and $1,008.5 million, restricted cash of $1.1 million and $0.8 million, and short-term investments of $16.3 million and nil, respectively, most of which are deposited in financial institutions outside of mainland China. Although our cash and cash equivalents in mainland China, Hong Kong, Australia, and the United States are deposited with various major reputable financial institutions, deposits placed with these financial institutions are not protected by statutory or commercial insurance. In the event of bankruptcy of one of these financial institutions, we may be unlikely to claim our </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-60-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">deposits back in full. As of December 31, 2023 and 2022, our short-term investments consisted of time deposits with original maturities between three months and one year.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Although we believe that U.S. Treasury securities are of high credit quality, concerns about, or a default by, one or more institutions in the market could lead to significant liquidity problems, losses, or defaults by other institutions, which in turn could adversely affect us.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Risks Related to Intellectual Property</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">If we are unable to obtain and maintain protection for our products and product candidates through intellectual property rights, or if the scope of such intellectual property rights obtained is not sufficiently broad, third parties may compete directly against us.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our success depends, in part, on our ability to protect our products, product candidates, and technologies from competition by obtaining, maintaining, and enforcing our intellectual property rights. We seek to protect our products and product candidates as well as technologies that we consider commercially important through intellectual property rights, such as patents and trade secrets. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We do not own or hold an exclusive license to patent rights in all of the territories in which we plan to commercialize certain of our products and product candidates. Further, we cannot predict whether patent applications that we hold rights to or any of our other owned or in-licensed pending patent applications will result in the issuance of patents that effectively protect our products, product candidates, and technologies. It is also possible that we do not identify and/or secure patent rights to certain patentable aspects of our products, product candidates, or technologies. If we do not secure patent rights with respect to our products, product candidates, and technologies, our business, financial condition, results of operations, and prospects could be materially harmed.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The patent prosecution process is expensive, time-consuming, and complex, and we may not be able to file, prosecute, maintain, license, or defend all necessary or desirable patent rights at a reasonable cost or in a timely manner, and patents may be invalidated, in whole or in part, and thereby rendered unenforceable. In addition, our licenses may not provide us with exclusive rights to products and product candidates in all relevant fields of use and in all territories in a manner which we may wish to develop or commercialize products in the future. As a result, we may not be able to prevent competitors from developing and commercializing competitive products in all such fields and territories.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Furthermore, the term of a patent is finite and generally expires 20 years from its earliest non-provisional filing date provided that associated fees are timely paid. Given the amount of time required for the development, testing, and regulatory review of products and new product candidates, patents protecting such products and product candidates might expire before or shortly after such products or product candidates are commercialized. As a result, the patent rights we hold may be insufficient to protect our products and product candidates from competitors&#8217; products, including those that are generic. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Moreover, in the case of any patent rights that are jointly owned by us and another party, if we are unable to obtain an exclusive license or otherwise limit the other party&#8217;s right to license such patent rights to a third party, such patent rights may be licensed to third parties, including our competitors. In addition, we may need the cooperation of any joint owner of such jointly-owned patent to enforce it against third parties, and such cooperation may not be provided to us. Any of the foregoing could have a material adverse effect on our competitive position, business, financial conditions, results of operations, and prospects. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Our owned or in-licensed patents could be found invalid or unenforceable if challenged in court or before the U.S. Patent and Trademark Office or other foreign authority.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We or our licensors or collaboration partners may become involved in patent litigation against third parties, for example, to enforce our patent rights, to invalidate patents held by such third parties, or to defend against such claims. Further, third parties could claim that we infringed, misappropriated, or otherwise violated their intellectual property rights or that a patent we or our licensors or collaboration partners have asserted against them is invalid or unenforceable. In </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-61-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">patent litigation, defendant counterclaims challenging the validity, enforceability or scope of asserted patents are common, and there are numerous grounds upon which a party can assert invalidity or unenforceability of a patent. In addition to court proceedings, in certain jurisdictions, parties may initiate legal proceedings before administrative bodies to assert challenges to intellectual property rights, including patent rights. Such proceedings could result in revocation, cancellation, or amendment to the scope of our patent rights and could negatively affect our business. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The outcome of any such proceeding is generally unpredictable. Furthermore, even if we are successful in defending against such challenges, the cost to us of any patent litigation or similar proceeding could be substantial, and it may consume significant management and other personnel time. We do not maintain insurance to cover intellectual property infringement, misappropriation, or violation. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">An adverse result in any litigation or other intellectual property proceeding could put one or more of our patents at risk of being invalidated, rendered unenforceable, or interpreted narrowly. If a defendant were to prevail on a legal assertion of invalidity and/or unenforceability of our patents covering one or more of our products or product candidates, we may lack sufficient patent coverage of our products or product candidates to prevent others from marketing competing products. Any of these outcomes could have a material adverse effect on our business, financial condition, results of operations, and prospects. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">We may not be able to protect our intellectual property.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The extent to which intellectual property rights provide adequate protection as available under the relevant intellectual property laws is uncertain, particularly in light of possible challenges to any patents in a given jurisdiction. Any such challenge to our patent rights could have a material adverse effect on our business, results of operations, and prospects. Notably, the experience and capabilities of Chinese courts in handling intellectual property litigation varies, and outcomes are unpredictable. Further, such litigation may require a significant financial expenditure and could divert management&#8217;s attention from other aspects of our business and operations. An adverse determination in any such litigation could materially impair our intellectual property rights and may harm our business, financial condition, results of operations, prospects, and reputation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Many companies have encountered significant problems in protecting and defending intellectual property rights in certain jurisdictions, including mainland China. The legal systems, particularly in certain developing countries, do not favor the enforcement of patents, trade secrets, and other intellectual property protection, which could make it difficult for us to enforce our intellectual property and proprietary rights generally. Proceedings to enforce such intellectual property and proprietary rights could result in substantial costs, divert our efforts and attention from other aspects of our business, put our patents at risk of being invalidated or interpreted narrowly, and provoke third parties to assert counterclaims against us. We may not prevail in any lawsuits that we initiate, and the damages or other remedies awarded, if any, may not be commercially meaningful. Accordingly, our efforts to enforce our intellectual property and proprietary rights may be inadequate to obtain a significant commercial advantage from the intellectual property that we hold rights to. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Furthermore, many countries have compulsory licensing laws under which a patent owner may be compelled to grant licenses to third parties. In addition, many countries limit the enforceability of patents against government agencies or government contractors. In these countries, the patent owner may have limited remedies, which could materially diminish the value of such patent. If we or any of our licensors are forced to grant a license to third parties with respect to any patents relevant to our business, our competitive position may be impaired, and our business, financial condition, results of operations, and prospects may be adversely affected. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Developments or uncertainties in patent law could have a negative impact on our business.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Changes in either the patent laws or interpretation of the patent laws could diminish the value of patents, thereby impairing our ability to protect our products, product candidates, and technologies. Changes in patent laws and regulations in various countries or jurisdictions, changes in the governmental bodies that enforce them, or changes in how the relevant governmental authority enforces them may weaken our ability to obtain new patents or patent rights through our licensors or to enforce any patents in the future. We cannot predict future changes in the interpretation of patent laws or changes to </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-62-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">patent laws that might be enacted into law by any legislative body. Such changes could materially affect our patent rights and could have a material adverse effect on our business, results of operations, and prospects. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">If we are unable to maintain the confidentiality of our trade secrets, our business and competitive position may be harmed.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We rely upon proprietary confidential information, including trade secrets and know-how to maintain our competitive position. However, such confidential information can be difficult to protect. We seek to protect our proprietary confidential information, in part, by entering into confidentiality agreements with parties that have access to such information, including our partners, collaborators, scientific advisors, employees, consultants, and other third parties. We may not be able to enter into such agreements with each party that may have or have had access to our trade secrets or proprietary technologies. Further, we may not be able to prevent the unauthorized disclosure or use of our trade secrets or know-how by the parties to these agreements, despite their existence and any other contractual restrictions. If any of these parties breaches or violates the terms of such agreement or otherwise discloses our proprietary confidential information, we may not have adequate remedies for such breach or violation and could lose any competitive advantage such confidential information afforded us. Enforcing a claim that a third party illegally disclosed or misappropriated our trade secrets is difficult, expensive, and time-consuming, with the outcome being unpredictable. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our trade secrets could become known or even be independently discovered by other parties, including our competitors. If any of our trade secrets were to be disclosed or independently developed, we would have no right to prevent others from using that information to compete against us, which may have a material adverse effect on our business, financial condition, results of operations, and prospects. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">If our products or product candidates infringe, misappropriate, or otherwise violate the intellectual property rights of third parties, we may incur substantial liabilities, and we may be unable to sell or commercialize these products and product candidates.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our success depends significantly on our ability to develop, manufacture, market, and sell our commercial products and use our proprietary technologies without infringing, misappropriating, or otherwise violating the patents and other proprietary rights of third parties. The biotechnology and pharmaceutical industries are characterized by extensive litigation regarding patents and other intellectual property rights. We may become party to, or threatened with, litigation or other proceedings regarding intellectual property rights with respect to our products, product candidates, or technologies that could negatively affect our business. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Third parties may assert claims of patent infringement against us, regardless of merit, based on their existing patents or based on later issued patents. Even if we believe such claims are without merit, there is no assurance that a court would find in our favor on questions of patent infringement or counterclaims pertaining to the underlying patent(s) asserted against us. A court of competent jurisdiction could hold that a third-party patent is valid, enforceable, and infringed by us, which could have a material adverse effect on our business. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">If we are found to have infringed a third party&#8217;s patent rights, and we are unsuccessful in demonstrating that such patent(s) are invalid or unenforceable, we could be required to: </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">obtain royalty-bearing licenses from such third party to the relevant patent(s), which may not be available on commercially reasonable terms, require substantial licensing and royalty payments, or may not be available at all, and even if we were able to obtain such licenses, they could be non-exclusive, thereby giving our competitors and other third parties access to the same technologies licensed to us; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">defend against additional litigation or administrative proceedings in the same and/or other jurisdiction(s); </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">reformulate affected product(s) so that they do not infringe the intellectual property rights of others, which may not be possible or could be expensive and time consuming; </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-63-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">cease developing, manufacturing, and commercializing any infringing products, product candidates, or technologies; and </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">pay such third party significant monetary damages, including treble damages and attorneys&#8217; fees, if we are found to have willfully infringed their patent. </span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Similarly, claims by third parties that we have misappropriated their confidential information, such as trade secrets, could have a material adverse effect on our business. Even if we are ultimately successful in defending against such claims via litigation(s) or administrative proceeding(s), any such litigation or proceeding may be costly and could result in a substantial diversion of management resources. Consequently, any of the foregoing may have a material adverse effect on our business, financial condition, results of operations, and prospects.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Intellectual property litigation and proceedings could cause us to spend substantial resources and distract our personnel from their normal responsibilities.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Even if resolved in our favor, litigation or other such legal proceedings relating to our intellectual property rights may cause us to incur significant expenses and could distract our personnel from their normal responsibilities. In addition, there could be public announcements of the results of hearings, motions, or other interim proceedings or developments, and if securities analysts or investors perceive these results to be negative, it could have a substantial adverse effect on the price of our securities. Such litigation or proceedings could substantially increase our operating losses and reduce the resources available for development activities or any future sales, marketing, or distribution activities. We may not have sufficient financial or other resources to conduct such litigation or proceedings adequately. Additionally, some of our competitors may be able to sustain the costs of such litigation or proceedings more effectively than we can, for example, because of greater financial or other resources. Moreover, uncertainties resulting from the initiation and continuation of such litigation or other proceedings could have a material adverse effect on our business.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">We may be subject to claims that we or our employees, consultants, or advisors have wrongfully used or disclosed alleged trade secrets of their current or former employers or are in breach of confidentiality, non-disclosure, non-use, non-competition, or non-solicitation agreements with such current or former employers, some of whom may be our competitors or potential competitors.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We could in the future be subject to claims that we or our employees, consultants, or advisors have inadvertently or otherwise improperly used or disclosed alleged trade secrets or other proprietary information of current or former employers of our employees, consultants, or advisors. For example, many of our employees, consultants, and advisors are currently or were previously employed at universities or other biotechnology or pharmaceutical companies, including our competitors or potential competitors. Although we try to prevent our employees, consultants, and advisors from improperly using the intellectual property, proprietary information, know-how, or trade secrets of their current or former employers in their work for us, these efforts may not be successful. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Litigation may be necessary to defend against such claims, and even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management and research personnel. If our defenses to these claims fail, in addition to requiring us to pay monetary damages, a court could prohibit us from using certain technologies or features that are essential to our products and product candidates if such technologies or features are found to incorporate or be derived from the trade secrets or other proprietary information of another party. An inability to incorporate such technologies or features could have a material adverse effect on our business and may prevent us from successfully commercializing our affected products and product candidates. In addition, we may lose valuable intellectual property rights or personnel as a result of such claims. Moreover, any such litigation or the threat of such litigation may adversely affect our ability to hire employees or contract with necessary personnel. A loss of key personnel or their work product could hamper or prevent our ability to develop or commercialize our products and product candidates, which would have a material adverse effect on our business, results of operations, financial condition, and prospects.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In addition, while we require our employees and contractors who may be involved in the conception or development of intellectual property to execute agreements assigning such intellectual property to us, we may be unsuccessful in enforcing such agreements. The assignment of intellectual property rights may not be self-executing, or the assignment </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-64-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">agreements may be breached, and we may be forced to bring claims against our employees, contractors, or other third parties, or defend claims that they may bring against us, to determine the ownership of certain intellectual property. Such claims could have a material adverse effect on our business, financial condition, results of operations, and prospects. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">We may not be successful in obtaining intellectual property rights for acquired or in-licensed product candidates.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our business model depends, in part, on our ability to successfully identify and acquire or in-license product candidates to enhance and strengthen our product pipeline. For such acquired or in-licensed product candidates, we may be unable to secure intellectual property rights relating to, or necessary for, commercialization of any such product candidates from third parties on commercially reasonable terms or at all. In such event, we may be unable to develop or commercialize such product candidates. We may also be unable to identify product candidates that we believe are an appropriate strategic fit for the Company and/or obtain intellectual property protection relating to such product candidates. Any of the foregoing could have a materially adverse effect on our business, financial condition, results of operations, and prospects. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The in-licensing and acquisition of intellectual property rights for product candidates is a competitive area, and a number of other companies are also pursuing strategies to in-license or acquire third-party intellectual property rights for product candidates that we may consider attractive or necessary. These other companies may have a competitive advantage over us, for example due to their size, cash resources, and clinical development and commercialization capabilities. Furthermore, certain companies that perceive us to be a competitor may be unwilling to assign or license rights to us. If we are unable to successfully obtain rights to suitable product candidates, our business, financial condition, results of operations, and prospects could suffer. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">If we or our licensors or collaboration partners do not obtain patent term extension and data exclusivity for our products or their products or any product candidates we may develop, our business may be materially harmed.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Depending upon the timing, duration, and specifics of any regulatory marketing approval of our products or any product candidates we may develop, one or more of our owned or in-licensed patents may be eligible for limited patent term extension in a particular jurisdiction. For example, in the United States, a single patent (provided it claims the approved drug or method for using it, or a method for manufacturing the drug) may be eligible for patent term extension of up to five years, although it cannot extend the remaining term of a patent beyond a total of 14 years from the date of product approval. However, we may not be granted any patent term extension due to failure to meet applicable requirements, for example, failure to exercise due diligence during the testing phase or regulatory review process or failure to apply for patent term extension within the applicable deadlines or prior to expiration of the relevant patents. Moreover, any patent term extension approved could be less than the period we requested. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The China Patent Law provides for patent term extension and adjustments for patents and a patent linkage system. However, to be implemented, the patent term extensions and adjustments require further promulgation of regulations and detailed implementation measures. Additionally, in mainland China, there is currently no effective law or regulation providing for data exclusivity, although Chinese regulators have proposed a framework for integrating data exclusivity into the Chinese regulatory regime. Until the new provisions of the China Patent Law providing for patent term extensions and adjustments and the proposed framework for data exclusivity can be implemented, a lower-cost generic or biosimilar drug can emerge onto the market more quickly. Consequently, the absence of currently implemented laws and regulations on patent term extension and adjustment and data exclusivity or the cancellation of the previous five-year administrative exclusivity for domestically manufactured new drugs could result in much weaker protection for us against generic competition in mainland China. For instance, if we are unable to obtain patent term extension or adjustment or the term of any such extension or adjustment is less than we request, our competitors may obtain approval of competing products following our patent expiration, and our business, financial condition, results of operations, and prospects could be materially harmed. If we were to pursue patent linkage litigation, such litigation could take several months to conclude and require additional months thereafter for the decision to be made publicly available. We will monitor future administrative rulings / court decisions on patent linkage in mainland China. Any decision against our interests could adversely affect our business.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-65-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Obtaining and maintaining our patent protection depends on compliance with various procedural, document submission, fee payment, and other requirements imposed by government patent agencies, and our patent protection could be reduced or eliminated for non-compliance with these requirements.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Over the lifetime of any patent rights we hold, certain government fees will be paid to a patent office in the respective jurisdiction for any patent application(s) and on any patent(s) resulting therefrom. In some of our licensed matters, we rely on our licensors to pay these fees. In addition to the payment of fees, during the patent application process, the patent office of any given jurisdiction requires compliance with procedural and documentary provisions. In some of our licensed matters, we rely on our licensors to comply with these requirements. In some cases, an inadvertent lapse can be cured by payment of a late fee or by other means in accordance with the applicable rules of a jurisdiction. There are situations, however, in which non-compliance can result in abandonment or lapse of the patent or patent application, resulting in a partial or complete loss of patent rights in the relevant jurisdiction, which may have a material adverse effect on our business, financial condition, results of operations, and prospects. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Intellectual property rights do not necessarily address all potential threats.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The degree of future protection afforded by our intellectual property rights is uncertain because intellectual property rights have limitations and may not adequately protect our business or permit us to maintain our competitive advantage. For example: </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">others may be able to make products that are similar to our products or product candidates or utilize similar technology that are not covered by the claims of the patents that we hold rights to; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">patent rights we currently hold or that we may hold in the future might be from inventors that are not the first to make the inventions covered by such patent rights; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">patent rights we currently hold or that we may hold in the future might be from inventors that are not the first to file patent applications covering such inventions; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">others may independently develop similar or alternative technologies or duplicate any of our technologies without infringing, misappropriating, or otherwise violating our intellectual property rights; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">patent rights we currently hold to any patent applications that are pending or such patent applications that we may hold patent rights to in the future may not result in issued patents; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">issued patents that we hold rights to may be held invalid or unenforceable; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">our competitors might conduct research and development activities in countries where we do not have patent rights and then use the information learned from such activities to develop competitive products for sale in our major commercial markets; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">we may not develop additional proprietary technologies that are patentable; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">the patents of others may impede our ability to exploit our innovations and may harm our business; and </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">we may choose to maintain certain trade secrets or know-how, and a third party may discover such trade secrets or know-how through independent research and development, which may harm our business. </span></div><div style="margin-top:10pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Should any of these events occur, they could have a material adverse effect on our business, financial condition, results of operations, and prospects.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-66-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Risks Related to Our ADSs and Ordinary Shares</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">If we fail to maintain proper internal control over financial reporting, our ability to produce accurate financial statements or comply with applicable regulations could be impaired.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Pursuant to Section 404 of the Sarbanes-Oxley Act, we are required to file a report by our management on our internal control over financial reporting, including an attestation report on internal control over financial reporting issued by our independent registered public accounting firm. The presence of material weaknesses in internal control over financial reporting could result in financial statement errors which, in turn, could lead to errors in our financial reports and/or delays in our financial reporting, which could require us to restate our operating results. We might not identify one or more material weaknesses in our internal controls in connection with evaluating our compliance with Section 404 of the Sarbanes-Oxley Act. In order to maintain and improve the effectiveness of our disclosure controls and procedures and internal controls over financial reporting, we will need to expend significant resources and provide significant management oversight. Implementing any appropriate changes to our internal controls may require specific compliance training of our directors and employees, entail substantial costs in order to modify our existing accounting systems, take a significant period of time to complete, and divert management&#8217;s attention from other business concerns. These changes may not, however, be effective in maintaining the adequacy of our internal control. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">If we fail to maintain effective internal control over financial reporting in the future, our management and our independent registered public accounting firm may not be able to conclude that we have effective internal controls over financial reporting, investors may lose confidence in our operating results, the price of our securities could decline, and we may be subject to litigation or regulatory enforcement actions. In addition, if we are unable to meet the requirements of Section 404 of the Sarbanes-Oxley Act, our ADSs may not be able to remain listed on Nasdaq. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">We have incurred losses and have not paid dividends on our securities since our inception, and we do not currently intend to pay dividends on our securities. The success of an investment in our securities will depend on appreciation in the price of our securities.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We have incurred losses since inception and have never declared or paid any dividends on our securities. We currently intend to invest our future earnings, if any, to fund our business. Therefore, investors are not likely to receive any dividends on their securities, at least in the near term, and the success of an investment in our securities will depend upon any future appreciation in their value compared to their purchase price. There is no guarantee that our securities will appreciate in value or even maintain the price at which they were purchased. Further, investors may need to sell all or part of their holdings of our securities to realize any future gains on their investment. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">The market price of our securities may be volatile, which could result in substantial losses for our investors.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The market price of our securities has been volatile, and will likely continue to be volatile and subject to wide fluctuations in response to a variety of factors, including the following: </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">announcements of competitive developments; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">regulatory developments affecting us, our licensors and partners, our customers, or our competitors; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">announcements regarding litigation or administrative proceedings involving us or our licensors and partners; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">actual or anticipated fluctuations in our period-to-period operating results; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">changes in financial estimates by securities research analysts; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">additions or departures of our executive officers; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">fluctuations of exchange rates between the RMB and the U.S. dollar; </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">release or expiration of lock-up or other transfer restrictions on our outstanding securities; and </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-67-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">sales or perceived sales of additional securities. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In addition, the securities markets have experienced, and may in the future experience, significant price and volume fluctuations that are not related to the operating performance of particular companies. Broad market and industry factors may negatively affect the market price of our securities, regardless of our actual operating performance. For example, in the last few years, the COVID-19 pandemic, tensions between the United States and China, and other geopolitical factors have negatively affected stock market and investor sentiment and resulted in significant volatility, including temporary trading halts. Prolonged global capital markets volatility may affect overall investor sentiment towards our securities, which would also negatively affect the trading prices for our securities. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Fluctuations in the value of the RMB or Hong Kong dollars may have a material adverse effect on our results of operations and the value of our securities.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The value of the RMB or HK dollar against the U.S. dollar and other currencies may fluctuate and is affected by, among other things, changes in political and economic conditions. With the development of the foreign exchange market and progress towards interest rate liberalization and RMB internationalization, the Chinese government has announced, and may again in the future announce, changes to the exchange rate system. There is no guarantee that the RMB will not appreciate or depreciate significantly in value against the U.S. dollar. It is difficult to predict how market forces or Chinese or U.S. government policy may impact the exchange rate between the RMB and the U.S. dollar in the future. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The value of our securities may, therefore, be affected by foreign exchange rates between U.S. dollars, HK dollars, and the RMB. For example, to the extent that we need to convert U.S. dollars or HK dollars into RMB for our operations or if any of our arrangements with other parties are denominated in U.S. dollars or HK dollars and need to be converted into RMB, appreciation of the RMB against the U.S. dollar or the HK dollar would have an adverse effect on the RMB amount we receive from the conversion. Conversely, if we decide to convert RMB into U.S. dollars or HK dollars for the purpose of making payments for business purposes, appreciation of the U.S. dollar or the HK dollar against the RMB would have a negative effect on the conversion amounts available to us. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Since 1983, the Hong Kong Monetary Authority (&#8220;HKMA&#8221;) has pegged the HK dollar to the U.S. dollar at the rate of approximately HK$7.80 to US$1.00. However, there is no assurance that the HK dollar will continue to be pegged to the U.S. dollar or that the HK dollar conversion rate will remain at HK$7.80 to US$1.00. If the HK dollar conversion rate against the U.S. dollar changes and the value of the HK dollar depreciates against the U.S. dollar, the Company&#8217;s assets denominated in HK dollars will be adversely affected. Additionally, if the HKMA were to repeg the HK dollar to, for example, the RMB rather than the U.S. dollar, or otherwise restrict the conversion of HK dollars into other currencies, then the Company&#8217;s assets denominated in HK dollars will be adversely affected. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Significant revaluation of the RMB or HK dollar may have a material adverse effect on our business. For example, to the extent that we need to convert U.S. dollars into RMB or HK dollars for our operations, appreciation of the RMB or HK dollar against the U.S. dollar would have an adverse effect on the RMB amount we would receive from the conversion. Conversely, if we decide to convert our RMB or HK dollars into U.S. dollars for the purpose of making payments for business purposes, appreciation of the U.S. dollar against the RMB would have a negative effect on the U.S. dollar amount available to us. In addition, appreciation or depreciation in the value of the RMB relative to U.S. dollars would affect our financial results reported in U.S. dollar terms regardless of any underlying change in our business or results of operations. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Very limited hedging options are available in mainland China to reduce our exposure to exchange rate fluctuations. To date, we have not entered into any hedging transactions in an effort to reduce our exposure to foreign currency exchange risk. While we may decide to enter into hedging transactions in the future, the availability and effectiveness of these hedges may be limited, and we may not be able to adequately hedge our exposure or at all. In addition, our currency exchange losses may be magnified by Chinese exchange control regulations that restrict our ability to convert RMB into foreign currency. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-68-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Holders of our ADSs have fewer rights than shareholders and must act through the depositary to exercise their rights.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Holders of our ADSs do not have the same rights as our shareholders and may only exercise the voting rights with respect to the underlying ordinary shares in accordance with the provisions of the deposit agreement. Under our amended and restated articles of association, an annual general meeting and any extraordinary general meeting may be called with not less than fourteen days&#8217; notice. When a general meeting is convened, you may not receive sufficient notice of a shareholders&#8217; meeting to permit you to withdraw the ordinary shares underlying your ADSs to allow you to vote with respect to any specific matter. If we ask for your instructions, we will give the depositary notice of any such meeting and details concerning the matters to be voted upon at least 30 days in advance of the meeting date, and the depositary will send a notice to you about the upcoming vote and will arrange to deliver our voting materials to you. The depositary and its agents, however, may not be able to send voting instructions to you or carry out your voting instructions in a timely manner. We will make commercially reasonable efforts to cause the depositary to extend voting rights to you in a timely manner, but we cannot assure you that you will receive the voting materials in time to instruct the depositary to vote the ordinary shares underlying your ADSs. Furthermore, the depositary will not be liable for any failure to carry out any instructions to vote, for the manner in which any vote is cast or for the effect of any such vote. As a holder or beneficial owner of ADSs, you may have limited recourse if we or the depositary fail to meet our respective obligations under the deposit agreement or if you wish us or the depositary to participate in legal proceedings. As a result, you may not be able to exercise your right to vote and you may lack recourse if your ADSs are not voted as you request. In addition, in your capacity as an ADS holder, you will not be able to call a shareholders&#8217; meeting. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Under the deposit agreement, for the ADSs, the depositary will give us a discretionary proxy to vote the ordinary shares underlying your ADS at shareholders&#8217; meeting if you do not give instructions to the depositary, unless (i) we have failed to timely provide the depositary with our notice of meeting and related voting materials, (ii) we have instructed the depositary that we do not wish a discretionary proxy to be given, (iii) we have informed the depositary that there is a substantial opposition as to a matter to be voted on at the meeting, or (iv) a matter to be voted on at the meeting would have a material adverse impact on shareholders. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The effect of this discretionary proxy is that, if you fail to give voting instructions to the depositary, you cannot prevent the ordinary shares underlying your ADSs from being voted, except under the circumstances described above. This may adversely affect your interests and make it more difficult for ADS holders to influence the management of the Company. Holders of our ordinary shares are not subject to this discretionary proxy. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Holders of our ADSs may not receive distributions or any value for them if such distribution is illegal or impractical or if any required government approval cannot be obtained in order to make such distributions.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Although we do not have any present plan to pay any dividends, if we achieve profitability and were to decide to pay dividends in the future, the depositary of our ADSs has agreed to pay our ADS holders the cash dividends or other distributions it or the custodian receives on ordinary shares or other deposited securities underlying our ADSs, after deducting its fees and expenses and any applicable taxes and governmental charges. Our ADS holders will receive these distributions in proportion to the number of ordinary shares their ADSs represent. However, the depositary is not responsible if it decides that it is unlawful or impractical to make a distribution available to any holders of ADSs. For example, it would be unlawful to make a distribution to a holder of ADSs if it consists of securities whose offering would require registration under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;) but are not so properly registered or distributed under an applicable exemption from registration. The depositary may also determine that it is not reasonably practicable to distribute certain property. In these cases, the depositary may determine not to distribute such property. We have no obligation to register under the U.S. securities laws any offering of ADSs, ordinary shares, rights, or other securities received through such distributions. We also have no obligation to take any other action to permit the distribution of ADSs, ordinary shares, rights, or anything else to holders of ADSs. This means that you may not receive distributions we make on our ordinary shares or any value for them if it is illegal or impractical for us to make them available to you. These restrictions may cause a material decline in the value of our ADSs. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-69-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Rights of our shareholders in the United States to participate in any future rights offerings may be limited, which may cause dilution to their holdings. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We may from time to time distribute rights to our shareholders, including rights to acquire our securities. However, we cannot make rights available to our shareholders in the United States unless we register the rights and the securities to which the rights relate under the Securities Act or an exemption from the registration requirements is available. Also, under the deposit agreement, the depositary will not make rights available to our U.S. shareholders unless either both the rights and any related securities are registered under the Securities Act, or the distribution of them to ADS holders is exempted from registration under the Securities Act. We are under no obligation to file a registration statement with respect to any such rights or securities or to endeavor to cause such a registration statement to be declared effective. Moreover, we may not be able to establish an exemption from registration under the Securities Act. If the depositary does not distribute the rights, it may, under the deposit agreement, either sell them, if possible, or allow them to lapse. Accordingly, our U.S. shareholders may be unable to participate in our rights offerings and may experience dilution in their holdings. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Taxing authorities could reallocate our taxable income among our subsidiaries, which could increase our overall tax liability. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We are organized under the laws of the Cayman Islands and currently have subsidiaries in mainland China, Hong Kong, Taiwan, the Cayman Islands, the United States, Australia, and the British Virgin Islands. If we further grow our business, we expect to conduct increased operations through our subsidiaries in various tax jurisdictions pursuant to transfer pricing arrangements between us, our parent company, and our subsidiaries. If two or more affiliated companies are located in different countries, the tax laws or regulations of each country generally will require that transfer prices be the same as those between unrelated companies dealing at arms&#8217; length and that appropriate documentation is maintained to support the transfer prices. While we believe that we operate in compliance with applicable transfer pricing laws and intend to continue to do so, our transfer pricing procedures are not binding on applicable tax authorities. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">If tax authorities in any of these countries were to successfully challenge our transfer prices as not reflecting arms&#8217; length transactions, they could require us to adjust our transfer prices and thereby reallocate our income to reflect these revised transfer prices, which could result in a higher tax liability to us. In addition, if the country from which the income is reallocated does not agree with the reallocation, both countries could tax the same income, resulting in double taxation. If tax authorities were to allocate income to a higher tax jurisdiction, subject our income to double taxation or assess interest and penalties, it would increase our consolidated tax liability, which could adversely affect our financial condition, results of operations, and cash flows. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">A tax authority could assert that we are subject to tax in a jurisdiction where we believe we have not established a taxable connection, often referred to as a &#8220;permanent establishment&#8221; under international tax treaties, and such an assertion, if successful, could increase our expected tax liability in one or more jurisdictions. A tax authority may take the position that material income tax liabilities, interest, and penalties are payable by us, in which case, we expect that we might contest such assessment. Contesting such an assessment may be lengthy and costly, and if we were unsuccessful in disputing the assessment, the implications could increase our anticipated effective tax rate, where applicable. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">There is no assurance that we will not be a passive foreign investment company, or PFIC for U.S. federal income tax purposes for any taxable year, which could subject U.S. investors in our securities to significant adverse U.S. federal income tax consequences.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In general, a non-U.S. corporation will be a PFIC for any taxable year in which (i) 75% or more of its gross income consists of passive income, or (ii) 50% or more of the value of its assets (generally determined on a quarterly average basis) consists of assets that produce, or are held for the production of, passive income (the &#8220;asset test&#8221;). For purposes of the above calculations, a non-U.S. corporation that directly or indirectly owns at least 25% by value of the shares of another corporation is treated as if it held its proportionate share of the assets of the other corporation and received directly its proportionate share of the income of the other corporation. Passive income generally includes interest, dividends, and gains from certain property transactions, rents, and royalties (other than certain rents or royalties derived in the active conduct of a trade or business). For these purposes, cash is generally a passive asset and the value of a non-U.S. corporation&#8217;s </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-70-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">goodwill (which may be determined by reference to the excess of the sum of its market capitalization and liabilities over its booked assets) generally should be an active asset to the extent attributable to business activities that produce non-passive income. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Based on the current market price of our ADSs and our current and expected composition of income and assets, we do not expect the Company and its subsidiaries to be PFICs for our current taxable year. However, our assets other than goodwill are expected to consist primarily of cash and cash equivalents for the foreseeable future. Therefore, whether we will satisfy the asset test for the current or any future taxable year will depend largely on the quarterly value of our goodwill (which may be determined by reference to the market price of our ADSs, which could be volatile given the nature and early stage of our business). If our market capitalization declines while we continue to hold a significant amount of cash, the risk that we will be a PFIC will increase. Furthermore, we may be a PFIC for any taxable year in which our interest and other investment income constitutes 75% or more of the sum of (i) such interest and investment income, and (ii) the excess of our revenue over cost of goods sold. In addition, a company&#8217;s PFIC status is an annual determination that can be made only after the end of each taxable year. Therefore, we cannot give any assurance as to whether we are a PFIC for the current or any future taxable year. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Subject to the discussion below, if we are or become a PFIC, U.S. investors generally would be subject to adverse U.S. federal income tax consequences, such as increased tax liabilities on capital gains and certain distributions, and interest charges on taxes deemed to be deferred. If we are a PFIC for any taxable year during which a U.S. investor owns our securities, we will generally continue to be treated as a PFIC with respect to such investor for all succeeding years during which the investor owns our securities (unless the investor timely makes a valid &#8220;deemed sale&#8221; election), even if we cease to meet the threshold requirements for PFIC status. A mark-to-market election may be available with respect our securities, which would result in U.S. federal income tax consequences to holders of our securities that are different from those described above. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">If a U.S. investor owns our securities during any year in which we are a PFIC, such investor generally will be required to file annual reports on IRS Form 8621 (or any successor form) with respect to us, generally with their U.S. federal income tax return for that year. U.S. investors should consult their tax advisors regarding the determination of whether we are a PFIC for any taxable year and the potential application of the PFIC rules. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">If a U.S. investor is treated as owning at least 10% of our ordinary shares, such holder may be subject to adverse U.S. federal income tax consequences. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">If a U.S. investor is treated as owning (directly, indirectly, or constructively) at least 10% of either the total value or total combined voting power of our ADSs or our ordinary shares, such U.S. investor may be treated as a &#8220;United States shareholder&#8221; with respect to each controlled foreign corporation, or CFC, in the Company (if any). Because the Company includes at least one U.S. subsidiary (Zai Lab (US) LLC), certain of our non-U.S. subsidiaries will be treated as CFCs (regardless of whether Zai Lab Limited is treated as a CFC). A United States shareholder of a CFC may be required to annually report and include in its U.S. taxable income its pro rata share of &#8220;Subpart F income,&#8221; &#8220;global intangible low-taxed income&#8221; and investments in U.S. property by CFCs, regardless of whether we make any distributions. An individual that is a United States shareholder with respect to a CFC generally would not be allowed certain tax deductions or foreign tax credits that would be allowed to a United States shareholder that is a U.S. corporation. We may not assist investors in determining whether any of our non-U.S. subsidiaries are treated as a CFC or whether such investor is treated as a United States shareholder with respect to any of such CFCs. Further, we may not furnish to any investors information that may be necessary to comply with the reporting and tax paying obligations discussed above. Failure to comply with these reporting obligations may subject a U.S. investor to significant monetary penalties and may prevent the statute of limitations with respect to their U.S. federal income tax return for the year for which reporting was due from starting. U.S. investors should consult their tax advisors regarding the potential application of these rules to their investment in our securities. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Changes in tax law may adversely affect our business and financial results.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Under current law, we expect to be treated as a non-U.S. corporation for U.S. federal income tax purposes. The tax laws applicable to our business activities, however, are subject to change and uncertain interpretation. Our tax position </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-71-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">could be adversely impacted by changes in tax rates, tax laws, tax practice, tax treaties or tax regulations, or changes in the interpretation thereof by the tax authorities in jurisdictions in which we do business. Our actual tax rate may vary from our expectation, and that variance may be material. A number of factors may increase our future effective tax rates, including: (i) the jurisdictions in which profits are determined to be earned and taxed; (ii) the resolution of issues arising from any future tax audits with various tax authorities; (iii) changes in the valuation of our deferred tax assets and liabilities; (iv) our ability to use net operating loss carryforwards to offset future taxable income and any adjustments to the amount of the net operating loss carryforwards we can utilize; and (v) changes in tax laws or the interpretation of such tax laws, and changes in U.S. Generally Accepted Accounting Principles (&#8220;U.S. GAAP&#8221;). </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Our corporate actions are substantially controlled by our directors, executive officers, and other principal shareholders, who can exert significant influence over important corporate matters, which may reduce the price of our securities.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our directors, executive officers, and other principal shareholders could exert substantial influence over matters such as electing directors and approving material mergers, acquisitions, or other business combination transactions. This may discourage, delay, or prevent a change in control of the Company, which could deprive our shareholders of an opportunity to receive a premium for their shares as part of a sale of the Company and reduce the price of our securities. Such actions may be taken even if they are opposed by certain of our other shareholders. In addition, our directors, executive officers, and other principal shareholders could divert business opportunities away from us to themselves or others. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">You may have difficulty enforcing judgments obtained against us.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Zai Lab Limited is a company organized under the laws of the Cayman Islands, and a substantial portion of our assets and operations are located in mainland China. In addition, some of our directors and officers are nationals and residents of countries or regions other than the United States or Hong Kong, and a substantial portion of their assets is located outside of the United States and Hong Kong. As a result, it may be difficult for investors to effect service of process within the United States or Hong Kong upon these persons, or to bring an action against us or against these individuals in the United States or Hong Kong in the event that they believe that their rights have been infringed under applicable federal securities laws or otherwise. Even if shareholders are successful in bringing an action of this kind, the laws of the Cayman Islands and mainland China may render them unable to enforce a judgment against our assets or the assets of our directors and officers. There is uncertainty as to whether the courts of the Cayman Islands or mainland China would recognize or enforce judgments of U.S. courts against us or such persons predicated upon the civil liability provisions of securities laws of the United States or any state. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The recognition and enforcement of foreign judgments are provided for under PRC Civil Procedures Law. Chinese courts may recognize and enforce foreign judgments in accordance with the requirements of PRC Civil Procedures Law based either on treaties between mainland China and the country where the judgment is made or on principles of reciprocity between jurisdictions. Mainland China does not have any treaties or other forms of reciprocity with the United States that provide for the reciprocal recognition and enforcement of foreign judgments. In addition, according to PRC Civil Procedures Law, mainland China courts will not enforce a foreign judgment against us or our directors and officers if they decide that the judgment violates the basic principles of Chinese laws or national sovereignty, security, or public interest. As a result, it is uncertain whether and on what basis a Chinese court would enforce a judgment rendered by a court in the United States. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Investors may be subject to limitations on transfers of their ADSs.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">ADSs are transferable on the books of the depositary. However, the depositary may close its transfer books at any time when it deems expedient in connection with the performance of its duties. In addition, the depositary may refuse to deliver, transfer, or register transfers of ADSs generally when our books or the books of the depositary are closed, or at any time if we or the depositary deems it advisable to do so because of any requirement of law or of any government or governmental body, or under any provision of the deposit agreement, or for any other reason. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-72-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Substantial future sales or perceived potential sales of our ordinary shares, ADSs, or other equity or equity-linked securities could cause the price of our securities to decline.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Sales of our ordinary shares, ADSs, or other equity or equity-linked securities, or the perception that these sales could occur, could cause the market price of our securities to decline significantly. All of our ordinary shares represented by ADSs were freely transferable by persons other than our affiliates without restriction or additional registration under the U.S. Securities Act. The shares held by our affiliates are also available for sale, subject to volume and other restrictions as applicable under Rule 144 of the U.S. Securities Act, under trading plans adopted pursuant to Rule 10b5-1 or otherwise. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Divestiture in the future of our securities by shareholders, the announcement of any plan to divest our securities, or hedging activity by third-party financial institutions in connection with similar derivative or other financing arrangements entered into by shareholders could cause the price of our securities to decline. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Furthermore, any major disposal of our securities by any of our directors or executive officers (or the perception that such disposals may occur) may cause the prevailing market price of our securities to fall, which could negatively impact our ability to raise capital in the future. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">The different characteristics of the capital markets in Hong Kong and the United States may negatively affect the trading prices of our securities.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We are dual primary listed on Nasdaq and the Hong Kong Stock Exchange. Nasdaq and the Hong Kong Stock Exchange have different listing rules and requirements, trading hours, trading characteristics (including trading volume and liquidity), trading rules, and investor bases (including different levels of retail and institutional participation). As a result of these differences, the trading prices of our ordinary shares on the Hong Kong Stock Exchange and our ADSs on Nasdaq may not be the same, even after allowing for currency differences. Fluctuations in the price of our securities due to circumstances unique to the one market could materially and adversely affect the price of our securities on the other market. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">The depositary for our ADSs is entitled to charge holders fees for various services, including annual service fees. Dealings in the ordinary shares registered in our Hong Kong register of members will be subject to Hong Kong stamp duty.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The depositary for our ADSs is entitled to charge holders fees for various services including for the issuance of ADSs upon deposit of ordinary shares, cancelation of ADSs, distributions of cash dividends or other cash distributions, distributions of ADSs pursuant to share dividends or other free share distributions, distributions of securities other than ADSs, and annual service fees. In the case of ADSs issued by the depositary into The Depository Trust Company, or DTC, the fees will be charged by the DTC participant to the account of the applicable beneficial owner in accordance with the procedures and practices of the DTC participant as in effect at the time. Additionally, dealings in the ordinary shares registered in our Hong Kong register of members will be subject to Hong Kong stamp duty. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Exchange between our ordinary shares and our ADSs may adversely affect the liquidity and/or trading price of our securities.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Subject to compliance with U.S. securities law and the terms of the deposit agreement, holders of our ordinary shares may deposit such ordinary shares with the depositary in exchange for the issuance of our ADSs. Any holder of ADSs may also withdraw the underlying ordinary shares represented by the ADSs pursuant to the terms of the deposit agreement for trading on the Hong Kong Stock Exchange. If a substantial number of our ordinary shares are deposited with the depositary in exchange for ADSs or vice versa, the liquidity and trading price of our ordinary shares on the Hong Kong Stock Exchange and our ADSs on Nasdaq may be adversely affected. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-73-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">The time required for the exchange between our ordinary shares and ADSs might be longer than expected and investors might not be able to settle or effect any sale of their securities during this period, and the exchange of ordinary shares into ADSs involves costs.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">There is no direct trading or settlement between Nasdaq and the Hong Kong Stock Exchange on which our ADSs and ordinary shares are respectively traded. In addition, the time differences between Hong Kong and New York and unforeseen market circumstances or other factors may delay the deposit of ordinary shares in exchange of ADSs or the withdrawal of ordinary shares underlying the ADSs. Investors will be prevented from settling or effectuating the sale of their securities during such periods of delay. In addition, there is no assurance that any exchange of ADSs into ordinary shares (and vice versa) will be completed in accordance with the timelines investors may anticipate. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Furthermore, the depositary for the ADSs is entitled to charge holders fees for various services including for the issuance of ADSs upon deposit of ordinary shares, cancellation of ADSs, distributions of cash dividends or other cash distributions, distributions of ADSs pursuant to share dividends or other free share distributions, distributions of securities other than ADSs, and annual service fees. As a result, shareholders who exchange ADSs into ordinary shares, and vice versa, may not achieve the level of economic return they may anticipate. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">There is uncertainty as to whether Hong Kong stamp duty will apply to the trading or conversion of our ADSs.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We have established a branch register of members in Hong Kong (the &#8220;Hong Kong share register&#8221;) for our ordinary shares that are traded on the Hong Kong Stock Exchange, and the trading of these ordinary shares on the Hong Kong Stock Exchange will be subject to the Hong Kong stamp duty. In addition, to facilitate ADS-ordinary share conversion and trading between Nasdaq and the Hong Kong Stock Exchange, we have moved a portion of our issued ordinary shares from our register of members maintained in the Cayman Islands to our Hong Kong share register. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Under the Hong Kong Stamp Duty Ordinance, any person who effects any sale or purchase of Hong Kong stock, defined as stock the transfer of which is required to be registered in Hong Kong, is required to pay Hong Kong stamp duty. The stamp duty is currently set at a total rate of 0.2% of the greater of the consideration for, or the value of, shares transferred, with 0.1% payable by each of the buyer and the seller. To the best of our knowledge, Hong Kong stamp duty has not been levied in practice on the trading or conversion of ADSs of companies that are listed in both the United States and Hong Kong and that have maintained all or a portion of their ordinary shares, including ordinary shares underlying ADSs, in their Hong Kong share registers. However, it is unclear whether, as a matter of Hong Kong law, the trading or conversion of ADSs of these dual-listed companies constitutes a sale or purchase of the underlying Hong Kong-registered ordinary shares that is subject to Hong Kong stamp duty. We advise investors to consult their own tax advisors on this matter. If Hong Kong stamp duty is determined by the competent authority to apply to the trading or conversion of our ADSs, the trading price and the value of any investment in our securities may be affected. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">General Risk Factors</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">We are subject to the risks of doing business globally, such as from economic or political tensions between the United States and China and other business disruptions or other adverse effects caused by economic downturns, market conditions, changing legal and regulatory requirements, political instability, trade sanctions, public health crises, international war or conflict, natural disasters, extreme weather events, and other geopolitical events or significant disruptions outside of our control.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Because we operate in Greater China, the United States, and other countries, our business is subject to risks associated with doing business globally. For example, our business and financial results could be adversely affected by changes in global, economic, and industry conditions, including currency fluctuations, changes in interest rates, capital and exchange controls, inflation, recession, market volatility, and restrictive government actions such as changes in laws and regulatory requirements, intellectual property, legal protections and remedies, trade regulations, tax laws and regulations, and procedures and actions affecting approval, production, pricing, marketing, reimbursement, and access for our products or product candidates. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-74-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In addition, we, as well as our customers, vendors, partners, and patients, may be impacted by geopolitical events, including economic or political tensions between the United States and China; international war or conflicts, such as the war in Ukraine and the conflict between Israel and Hamas; and other instances of political or civil unrest, such as major hostilities or acts of terrorism. For example, as a result of economic or political conditions or tensions between the United States and China, the United States and other nations have raised the possibility of trade or other sanctions on China, Chinese banks, and companies with operations in China as well as legislation that restricts or prohibits U.S. investment in certain companies operating in China. Such actual or threatened sanctions on us or third parties with which we do business, such as customers, suppliers, intermediaries, services providers, or banks, and other geopolitical factors could adversely affect our business and financial results, including our ability to raise capital or raise capital on favorable terms and the market price of our securities. We, as well as our customers, vendors, partners, and patients, may also be impacted by public health crises, such as the COVID-19 pandemic, as well as earthquakes, hurricanes, floods, drought, wildfires, and other extreme weather or catastrophic events. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The occurrence of one or more of the events described above could disrupt our studies, supply chain, manufacturing facilities, distribution network, and sales and marketing efforts or result in increased costs or decreased demand for our products. Such developments could have a material adverse effect on our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">business, including our clinical development, results of operations, financial condition, ability to raise capital or raise capital on favorable terms, and the market price of our securities.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">If we or our CROs or CMOs fail to comply with applicable environmental, health, and safety laws and regulations, we could become subject to fines or penalties or incur costs that could have a material adverse effect on our business.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We, our CROs, CMOs, or other contractors are subject to numerous environmental, health, and safety laws and regulations, including those governing laboratory procedures and the handling, use, storage, treatment and disposal of hazardous materials and wastes. In addition, our construction projects can only be put into operation after certain regulatory procedures with the relevant administrative authorities in charge of environmental protection, health, and safety have been completed. Our development operations primarily occur in mainland China and the United States and involve the use of hazardous and flammable materials, including chemicals and biological materials. Our operations also produce hazardous waste products. We are therefore subject to Chinese and U.S. laws and regulations concerning the discharge of wastewater, gaseous waste, and solid waste during our research and development of our products and product candidates. We generally contract with third parties for the disposal of these materials and wastes. If we fail to comply with environmental regulations and contamination or injury from these materials results from our use of hazardous materials, we could be held liable for any resulting damages, and any such liability could exceed our resources or insurance coverage (such as workers&#8217; compensation insurance for injuries to our employees). We also could incur significant costs associated with civil, administrative, or criminal fines and penalties. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Furthermore, the Chinese or U.S. government may adopt more stringent environmental regulations. If this occurs, we may incur substantial capital expenditures to install, replace, upgrade, or supplement our facilities and equipment or make operational changes to comply with such environmental protection laws and regulations. If such costs were to become prohibitively expensive, we may be forced to cease certain aspects of our business or operations. We do not maintain insurance for environmental liability or toxic tort claims that may be asserted against us in connection with our storage, use or disposal of biological or hazardous materials. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In addition, we may be required to incur substantial costs to comply with current or future health and safety laws and regulations, which could impair our research, development, or production efforts. Failure to comply with such laws and regulations may result in substantial fines, penalties, or other sanctions. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Because of volatility in the price of our securities and the share price of biotechnology and biopharmaceuticals companies more broadly, we may be at increased risk of securities class action litigation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In recent years, our company as well as other companies in our industry have experienced significant share price volatility. As a result, we may be at increased risk of securities class action litigation. Historically, securities class action litigation, whether warranted or not, often follows a decline in the market price of a company&#8217;s securities. If we were to </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-75-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">become subject to class action litigation, it could result in substantial costs and a diversion of management&#8217;s attention and resources, which could harm our business. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">If analysts do not continue to publish research or publish inaccurate or unfavorable research about our business, the market price and/or trading value of our securities could decline.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The market for our securities relies in part on research and reports that equity research analysts publish about us or our business. If research analysts do not maintain adequate research coverage or if one or more of the analysts who covers us downgrades our securities or publishes inaccurate or unfavorable research about our business, the market price for our securities would likely decline. If one or more of these analysts cease coverage of the Company or fail to publish reports on us regularly, we could lose visibility in the financial markets, which, in turn, could cause the market price or trading volume for our securities to decline significantly. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">The increasing use of social media platforms presents new risks and challenges.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Social media is increasingly being used to communicate about our products and the diseases our therapies are designed to treat. Social media practices in the biopharmaceutical industry continue to evolve and regulations relating to such use are not always clear and create uncertainty and risk of noncompliance with regulations applicable to our business. For example, patients may use social media channels to comment on the effectiveness of a product or to report an alleged adverse event. When such disclosures occur, there is a risk that we fail to monitor and comply with applicable adverse event reporting obligations, or we may not be able to defend the company or the public&#8217;s legitimate interests in the face of the political and market pressures generated by social media due to restrictions on what we may say about our products. There is also a risk of inappropriate disclosure of sensitive information or negative or inaccurate posts or comments about us on any social networking website. Further, there is a risk that unmerited or unsupported claims about our products may circulate on social media. If any of these events were to occur or we otherwise fail to comply with applicable regulations, we could incur liability, face restrictive regulatory actions, or incur other harm to our business, including damage to the reputation of our products or Company.</span></div><div id="i8a977bbf870448998f9d0f718b7b41b9_22"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1B. Unresolved Staff Comments</span></div><div style="margin-top:9pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Not applicable.</span></div><div id="i8a977bbf870448998f9d0f718b7b41b9_712"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Item 1C. Cybersecurity</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Cybersecurity risks are a growing threat to us and other businesses, including our CROs, CMOs, and other third-party providers, which are vulnerable to cyberattacks, malware, and other system failures that may result in unauthorized access, damage, and other harms to our business or reputation.  Protecting the confidentiality, integrity, and availability of our business information, intellectual property, customer, patient and employee data, and technology systems is critical to our business and operations, ability to comply with regulatory requirements, and reputation. Accordingly, cybersecurity is an important and integrated part of the Company&#8217;s enterprise risk management function that identifies, monitors, and mitigates business, operational, and legal risks. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Accordingly, we have established cybersecurity standards, policies, and operating procedures, including our Global IT Policy and Information Security Policy and our incident response plan, for the purpose of implementing information protection processes and technologies; carrying out cybersecurity risk detection, identification, assessment, response, and monitoring; assigning responsibility within our organization for risk detection and oversight; implementing cybersecurity training; governing internal communications regarding cybersecurity risks; and making required public and regulatory disclosures regarding cybersecurity threats and incidents. We oversee risks from cybersecurity threats associated with our use of third-party service providers by requiring our vendors to agree that they have and will maintain appropriate cybersecurity controls, such as through standard contractual provisions, and by coordinating with key vendors with respect to integration with our systems. Our cybersecurity risk management program is based on the National Institute of Standards and Technology (&#8220;NIST&#8221;) framework.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-76-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Key components of our cybersecurity risk management program include the use of third-party service providers, as appropriate, to assess, test, or otherwise assist with aspects of our security processes. For example, we employed a third-party cyber risk consultant to assess our overall cybersecurity risk framework against NIST standards. We have also engaged third-party experts to perform penetration testing of our IT systems, and we have considered the results of such tests to enhance our cybersecurity systems and controls, as appropriate.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our management, including leaders from our IT, information security, legal, and compliance teams, is responsible for implementing our cybersecurity standards, policies, and operating procedures, under the ultimate oversight of our Chief Operating Officer. We regularly discuss and assess cybersecurity risks as part of our Risk Coordination Council, which brings together senior leaders across the Company to address various risk issues. In addition, our Global Compliance Committee, which is comprised of leaders from senior management, legal, compliance, finance, HR, and internal audit, discusses significant risk issues affecting the Company, including with respect to cybersecurity issues, as appropriate. Members of our information security team, which includes personnel in the United States and China, collectively have decades of experience with information technology and cybersecurity systems, implementation, and oversight in the jurisdictions in which we operate. Under our incident response plan and our related information security policies and procedures, our information security personnel are responsible for promptly notifying senior management, including leaders in our legal and compliance departments, about any new cybersecurity incident or threat that may require management evaluation or response.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our Audit Committee assists our Board in overseeing cybersecurity risk management and the integrity of our information technology systems, processes, and data. Periodically, the Audit Committee reviews and discusses with management, our internal auditor, and, in its discretion, third party vendors or other external experts, the adequacy of security for our information technology systems, processes, and data; our incident response and contingency plans in the event of a breakdown or security breach affecting the security of our information technology systems or data or the information technology systems, processes, and data of our clients; and any new threats or incidents that have or may impact us. The Audit Committee receives reports on the operation of such programs from the Chief Operating Officer, Chief Legal Officer, and/or the IT Department, as appropriate. The Audit Committee also reviews management reports regarding the evolving threat environment, vulnerability assessments, and specific cybersecurity incidents. Periodically, the Audit Committee reports on cybersecurity matters, incidents, and risk oversight to the Board. The Board also receives briefings from management on our cybersecurity risk management program.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Although we have not experienced a cyberattack or other cybersecurity incident that has materially affected us, we cannot guarantee that we will not experience cybersecurity incidents that may have a material effect on us in the future. For more information, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Risk Factors &#8211; Potential cybersecurity threats are changing rapidly and advancing in sophistication. We may not be able to protect our systems and networks, or the confidentiality of our confidential or other information (including personal information), from cyberattacks and other unauthorized access, disclosure, and disruption. </span></div><div id="i8a977bbf870448998f9d0f718b7b41b9_25"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Item 2. Properties</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We lease our principal executive offices in Shanghai and Cambridge, Massachusetts as well as various administrative offices in Shanghai, Beijing, Guangzhou, Hong Kong, and San Francisco, California and research and development facilities in Shanghai and a small site in San Diego, California. We also lease two manufacturing facilities, including a small molecule and a large molecule facility, in Suzhou to support production of certain of our products and product candidates. In addition, we are constructing a new office and research building in Suzhou. We believe these facilities are sufficient to meet our near-term needs.</span></div><div id="i8a977bbf870448998f9d0f718b7b41b9_28"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Item 3. Legal Proceedings</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We are, from time to time, subject to various claims, lawsuits, and other legal and administrative proceedings arising in the ordinary course of business. Some of these claims, lawsuits, and other proceedings may involve highly complex issues that are subject to substantial uncertainties, and could result in damages, fines, penalties, non-monetary sanctions, or relief. However, we do not consider any such claims, lawsuits, or proceedings that are currently pending, individually or in </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-77-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">the aggregate, to be material to our business or likely to result in a material adverse effect on our future operating results, financial condition or cash flows. </span></div><div id="i8a977bbf870448998f9d0f718b7b41b9_31"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Item 4. Mine Safety Disclosures</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Not applicable.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-78-</span></div></div></div><div id="i8a977bbf870448998f9d0f718b7b41b9_34"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div id="i8a977bbf870448998f9d0f718b7b41b9_37"></div><div style="-sec-extract:summary;margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Item 5. Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Market Information</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our ADSs are traded on the Nasdaq Global Market under the symbol &#8220;ZLAB.&#8221; Our ordinary shares are publicly traded on the Hong Kong Stock Exchange under the stock code &#8220;9688.&#8221; </span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Shareholders</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">As of February&#160;21, 2024, we had approximately 11 holders of record of our ordinary shares. Citibank, N.A. is the depositary for our ADSs.&#160; This disclosure does not include beneficial owners whose ordinary shares or ADSs are held by nominees in street name. </span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Dividends </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We have incurred losses since inception and never declared or paid dividends on our ordinary shares. We currently expect to retain all future earnings for use in the operation and expansion of our business and do not have any present plan to pay any dividends.  </span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Securities Authorized for Issuance under Equity Compensation Plans</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our equity compensation plan information is incorporated by reference in the information in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Performance Graph</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">This graph is not &#8220;soliciting material,&#8221; is not deemed &#8220;filed&#8221; with the SEC, and is not to be incorporated by reference into any of our filings under the Securities Act or the Exchange Act, whether made before or after the date hereof and irrespective of any general incorporation language in any such filing.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following graph compares the yearly percentage change in the cumulative total shareholder return of our ADSs with the cumulative total return of the NASDAQ Composite Index (U.S.) and the NASDAQ Biotechnology Index for the past five years. The graph assumes an investment of $100 at market close on December 31, 2018 and reinvestment of any dividends.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-79-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The shareholder return shown on the graph below is not necessarily indicative of future performance, and we do not make or endorse any predictions as to future shareholder returns. </span></div><div style="margin-top:10pt;text-align:center"><img src="zlab-20231231_g12.jpg" alt="Stock chart.jpg" style="height:319px;margin-bottom:5pt;vertical-align:text-bottom;width:619px"/></div><div style="margin-top:10pt;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.212%"><tr><td style="width:1.0%"/><td style="width:26.806%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.464%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.694%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.464%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.694%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.464%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.029%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.464%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.029%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.464%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.029%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.464%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.035%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12/31/18</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12/31/19</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12/31/20</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12/31/21</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12/31/22</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12/31/23</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Zai Lab Limited</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100.00</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">179.11</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">528.86</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">270.67</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">132.21</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">117.70</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nasdaq Composite Index</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100.00</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">135.23</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">194.24</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">235.78</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">157.74</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">226.24</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nasdaq Biotechnology Index</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100.00</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">124.41</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">156.36</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">155.37</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">138.42</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">143.60</span></div></td></tr></table></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Recent Sales of Unregistered Securities</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">None.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Issuer Purchases of Equity Securities</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following table presents acquisitions of the Company&#8217;s ADSs from employees by the Company to satisfy tax withholding obligations due in connection with exercise of option shares or vesting of restricted shares during the fourth quarter of 2023:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:20.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.445%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.445%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.445%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.447%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #b6b6b6;border-top:1pt solid #b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Period</span></div></td><td colspan="3" style="border-left:1pt solid #b6b6b6;border-top:1pt solid #b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Total Number of Shares (or Units) Purchased</span></div></td><td colspan="3" style="border-left:1pt solid #b6b6b6;border-top:1pt solid #b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Average Price Paid per Share (or Unit)</span></div></td><td colspan="3" style="border-left:1pt solid #b6b6b6;border-top:1pt solid #b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Total Number of Shares (or Units) Purchased as Part of Publicly Announced Plans or Programs</span></div></td><td colspan="3" style="border-left:1pt solid #b6b6b6;border-right:1pt solid #b6b6b6;border-top:1pt solid #b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Maximum Number (or Approximate Dollar Value) of Shares (or Units) that May Yet Be Purchased Under the Plans or Programs</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #b6b6b6;border-top:1pt solid #b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">October 1 &#8211; 31, 2023</span></div></td><td colspan="2" style="border-left:1pt solid #b6b6b6;border-top:1pt solid #b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,907&#160;</span></td><td style="border-top:1pt solid #b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-left:1pt solid #b6b6b6;border-top:1pt solid #b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24.00&#160;</span></td><td style="border-top:1pt solid #b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #b6b6b6;border-top:1pt solid #b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;</span></div></td><td colspan="3" style="border-left:1pt solid #b6b6b6;border-right:1pt solid #b6b6b6;border-top:1pt solid #b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #b6b6b6;border-top:1pt solid #b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">November 1 &#8211; 30, 2023</span></div></td><td colspan="3" style="border-left:1pt solid #b6b6b6;border-top:1pt solid #b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;</span></div></td><td colspan="3" style="border-left:1pt solid #b6b6b6;border-top:1pt solid #b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;</span></div></td><td colspan="3" style="border-left:1pt solid #b6b6b6;border-top:1pt solid #b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;</span></div></td><td colspan="3" style="border-left:1pt solid #b6b6b6;border-right:1pt solid #b6b6b6;border-top:1pt solid #b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #b6b6b6;border-top:1pt solid #b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">December 1 &#8211; 31, 2023</span></div></td><td colspan="3" style="border-left:1pt solid #b6b6b6;border-top:1pt solid #b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;</span></div></td><td colspan="3" style="border-left:1pt solid #b6b6b6;border-top:1pt solid #b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;</span></div></td><td colspan="3" style="border-left:1pt solid #b6b6b6;border-top:1pt solid #b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;</span></div></td><td colspan="3" style="border-left:1pt solid #b6b6b6;border-right:1pt solid #b6b6b6;border-top:1pt solid #b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;</span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #b6b6b6;border-left:1pt solid #b6b6b6;border-top:1pt solid #b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></div></td><td colspan="2" style="border-bottom:1pt solid #b6b6b6;border-left:1pt solid #b6b6b6;border-top:1pt solid #b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,907&#160;</span></td><td style="border-bottom:1pt solid #b6b6b6;border-top:1pt solid #b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1pt solid #b6b6b6;border-left:1pt solid #b6b6b6;border-top:1pt solid #b6b6b6;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #b6b6b6;border-left:1pt solid #b6b6b6;border-top:1pt solid #b6b6b6;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #b6b6b6;border-left:1pt solid #b6b6b6;border-right:1pt solid #b6b6b6;border-top:1pt solid #b6b6b6;padding:0 1pt"/></tr></table></div><div id="i8a977bbf870448998f9d0f718b7b41b9_40"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6. [Reserved]</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Not applicable.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-80-</span></div></div></div><div id="i8a977bbf870448998f9d0f718b7b41b9_43"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="-sec-extract:summary;margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">You should read the following discussion and analysis of our financial condition and results of operations together with our consolidated financial statements and the accompanying notes in this report. This section generally discusses year-over-year comparisons between 2023 and 2022. For a discussion of year-over-year changes in our financial condition and results of operations between 2022 and 2021, see Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2022, filed on March 1, 2023. In addition to historical information, this discussion and analysis contains forward-looking statements that involve risks, uncertainties, and assumptions. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of certain factors. We discuss factors that we believe could cause or contribute to these differences elsewhere in this report, including in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Forward-Looking Statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">.</span></div><div id="i8a977bbf870448998f9d0f718b7b41b9_46"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Overview</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We are a patient-focused, innovative, commercial-stage, global biopharmaceutical company with a substantial presence in both Greater China and the United States. We are focused on discovering, developing, and commercializing products that address medical conditions with significant unmet needs in the areas of oncology, autoimmune disorders, infectious disease, and neuroscience. We intend to leverage our competencies and resources to positively impact human health in Greater China and worldwide. We currently have five commercial products &#8211; ZEJULA, OPTUNE, QINLOCK, NUZYRA, and VYVGART &#8211; that have received marketing approval and that we have commercially launched in one or more territories in Greater China. We also have multiple programs in late-stage product development and a number of ongoing pivotal trials across our portfolio. For more information on our business, products and product candidates, and operations, see</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%"> Business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Since our inception, we have incurred net losses and negative cash flows from our operations. Substantially all of our losses have resulted from funding our research and development programs and selling, general and administrative costs associated with our operations. Developing high quality product candidates requires significant investment in our research and development activities over a prolonged period of time, and a core part of our strategy is to continue making sustained investments in this area. Our ability to generate profits and positive cash flow from operations over the next several years depends upon our ability to successfully market our commercial products and to successfully expand the indications for these products and develop and commercialize our other product candidates. As discussed further below, we expect to continue to incur substantial costs related to our research and development and commercialization activities. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">As we pursue our corporate strategic goals, we anticipate that our financial results will fluctuate from quarter to quarter and year to year depending in part on the balance between the success of our commercial products and the level of our research and development expenses. We cannot predict whether or when our product candidates will receive regulatory approval. Further, if we receive such regulatory approval, we cannot predict whether or when we may be able to successfully commercialize such product or whether or when such product may become profitable. </span></div><div id="i8a977bbf870448998f9d0f718b7b41b9_49"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Business Developments and Corporate Strategic Goals</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In 2023, we were excited to launch a fifth commercial product, VYVGART, for gMG in China. Sales increased for each of our commercial products, ZEJULA continued to lead PARP inhibitor sales for ovarian cancer in the hospital setting, and we were able to increase patient access for QINLOCK and NUZYRA from their new NRDL listings and for OPTUNE as a result of increased supplemental insurance coverage in the private-pay market. In 2024, we expect our product revenues to continue to increase, such as from the new NRDL listings for VYVGART and NUZYRA.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We also continued to make progress across our product pipeline. For example, the NMPA accepted NDAs for SC efgartigimod for the treatment of gMG, SUL-DUR for infections caused by </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Acinetobacter baumannii</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">, including MDR and CRAB strains, and repotrectinib for locally advanced or metastatic ROS1+ NSCLC. We also had several positive data readouts during the year, including for TTFields therapy in 2L NSCLC, TIVDAK in 2L+ cervical cancer, SC efgartigimod </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-81-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">in CIDP, and KarXT in schizophrenia. We also advanced our global pipeline, initiating Phase I studies for our DLL3 ADC program and for ZL-1218, a humanized, IgG1 monoclonal antibody that binds to human CCR8. And, we increased our pipeline assets through our business development activities with our strategic collaboration with MediLink for the license of a next generation DLL3 ADC program, which further deepened our lung cancer franchise. For more information on our commercial products and product pipeline, including status and developments in 2023, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Business &#8211; Our Commercial Products and Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Business &#8211; Our Pipeline of Product Candidates and R&amp;D Activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We also continued to strengthen our business in 2023 through key new additions to our global leadership team. For example, we promoted Dr. Yajing Chen to Chief Financial Officer on July 7, 2023. Dr. Chen previously served as our Senior Vice President and Deputy Chief Financial Officer, helping to oversee finance, planning and forecasting, accounting, tax, treasury, and procurement matters since joining the Company in September 2021. She is a seasoned finance executive with more than 20 years of experience in the life sciences industry as well as a Ph.D. trained scientist. Dr. Chen succeeded Billy Cho, who stepped down from his role and left the Company on July 7, 2023. In addition, the Company appointed Dr. Robert Brown as Chief Medical Officer, Oncology in September 2023 to help accelerate the growth and development for our global oncology pipeline. Dr. Brown is an oncology drug development leader, with more than 16 years of translational, research, and clinical development expertise in the areas of oncology, immunology, and neurology. Dr. Brown reports to Dr. Rafael Amado, President, Head of Global Oncology Research and Development at Zai Lab, and provides strategic leadership and support with respect to the clinical development of our oncology pipeline.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We further discuss in MD&amp;A below key factors affecting our results of operations, key components and primary drivers of changes in our results of operations in 2023, and our liquidity and capital resources. In 2024, we seek to continue advancing our mission of becoming a leading global biopharmaceutical company, driving innovation in treatment options for patients in China and beyond, by focusing on the following corporate strategic goals: accelerating medicines to patients through our R&amp;D activities, including internal discovery; further expanding our product pipeline through synergistic regional and global collaborations and corporate development activities; and continuing our commercial excellence and execution, including by delivering strong financial performance and preparing for the launch of multiple new products and obtaining overall corporate profitability by the end of 2025. We also intend to continue building and maintaining the trust of our stakeholders by further developing and integrating our Trust for Life strategy into our business and operations. For additional information on our Mission and Corporate Strategic Goals, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Business &#8211; Our Mission and Corporate Strategic Goals</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">.</span></div><div id="i8a977bbf870448998f9d0f718b7b41b9_52"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Basis of Presentation</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our consolidated statement of operations data for the years ended December&#160;31, 2023 and 2022 and our consolidated balance sheet data as of December&#160;31, 2023 and 2022 have been derived from our audited consolidated financial statements included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Financial Statements and Supplementary Data</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">. Our consolidated financial statements appearing elsewhere in this report have been prepared in accordance with U.S. GAAP. </span></div><div id="i8a977bbf870448998f9d0f718b7b41b9_55"></div><div style="-sec-extract:summary;margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Factors Affecting Our Results of Operations</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Our Commercial Products</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We generate product revenue through the sale of our commercial products in Greater China, net of any related sales returns and rebates to distributors. Our cost of sales mainly consists of the costs of manufacturing ZEJULA and NUZYRA, costs of purchasing OPTUNE, QINLOCK, and VYVGART from our collaboration partners, any royalty fees incurred as a result of sales of our commercial products under our license and collaboration agreements, and amortization of any sales-based milestone payments incurred under our license and collaboration agreements. We expect our revenue to increase in coming years as we continue to focus on increasing patient access to our existing commercial products, such as through NRDL listing or increased supplemental insurance coverage in the private-pay market. For example, in the first quarter of 2023, QINLOCK was added to the NRDL for fourth-line GIST and NUZYRA for the IV treatment of adult patients with CABP and ABSSSI. In the first quarter of 2024, VYVGART (efgartigimod alfa injection) was added to the NRDL for </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-82-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">gMG and NUZYRA for the oral treatment of adult patients with CABP and ABSSSI. We also expect revenue to increase in coming years as a result of our launch of additional commercial products, if and when we obtain required regulatory approvals. We expect our cost of sales to increase as the volume of products sold increases.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Research and Development Expenses</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We believe our ability to successfully develop product candidates will be the primary factor affecting our long-term competitiveness, as well as our future growth and development. Developing high quality product candidates requires a significant investment of resources over a prolonged period of time. We are committed to advancing and expanding our pipeline of potential best-in-class and first-in-class products, such as through clinical and pre-clinical trials and business development activities. As a result, we expect to continue making significant investments in research and development, including internal discovery activities.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Elements of research and development expenditures primarily include: </span></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:23.5pt">payroll and other related costs of personnel engaged in research and development activities; </span></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:23.5pt">in-licensed patent rights fees of exclusive development rights of products granted to the Company; </span></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:23.5pt">costs related to pre-clinical testing of the Company&#8217;s technologies under development and clinical trials, such as payments to contract research organizations (&#8220;CROs&#8221;) and contract manufacturing organizations (&#8220;CMOs&#8221;), investigators, and clinical trial sites that conduct our clinical studies; </span></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:23.5pt">costs to develop the product candidates, including raw materials and supplies, product testing, depreciation, and facility-related expenses; and </span></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:23.5pt">other research and development expenses.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Selling, General, and Administrative Expenses </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our selling, general, and administrative expenses consist primarily of personnel compensation and related costs, including share-based compensation for commercial and administrative personnel. Other selling, general, and administrative expenses include product distribution and promotion costs, and professional service fees for legal, intellectual property, consulting, auditing, and tax services as well as other direct and allocated expenses for rent and maintenance of facilities, insurance, and other supplies used in selling, general, and administrative activities. We expect these costs to continue to be significant to support sales of our commercial products and preparation to launch and subsequent sales of additional product candidates if and when approved.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Our Ability to Commercialize Our Product Candidates </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We have multiple product candidates in late-stage clinical development and various others in clinical and pre-clinical development in Greater China and the United States. Our ability to generate revenue from our product candidates is dependent on our receipt of regulatory approvals for and successful commercialization of such product candidates, which may not occur. Certain of our product candidates may require additional pre-clinical and/or clinical development, regulatory approvals in multiple jurisdictions, manufacturing supply, substantial investment, and significant marketing efforts before we generate any revenue from product sales. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">License and Collaboration Arrangements </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our results of operations have been, and will continue to be, affected by our license and collaboration agreements. In accordance with these agreements, we may be required to make upfront payments and milestone payments upon the achievement of certain development, regulatory, and sales-based milestones for the relevant products as well as certain royalties at tiered percentage rates based on annual net sales of the licensed products in the licensed territories. We had $19.3 million and $53.4 million of research and development expenses in 2023 and 2022, respectively, related to upfront </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-83-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">fees and development milestones. As of December&#160;31, 2023, we may be required to pay development and regulatory milestone payments of up to an additional aggregate amount of $303.5 million for our current clinical programs and $673.2 million for other programs that are contingent on the progress of our product candidates prior to commercialization. As of December&#160;31, 2023, we also may be required to pay sales-based milestone payments of up to an additional aggregate amount of $2,457.5 million as well as certain royalties at tiered percentage rates on annual net sales that are contingent on product performance. If these milestones or royalties do occur, we view related payments as favorable because such payments signify that the product or product candidate is achieving higher sales levels or advancing toward potential commercial launch. </span></div><div id="i8a977bbf870448998f9d0f718b7b41b9_61"></div><div style="-sec-extract:summary;margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Results of Operations</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following table presents our results of operations ($ in thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"/><td style="width:34.560%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.377%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.377%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.377%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.385%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Change</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product revenue, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">266,719&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">212,672&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54,047&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Collaboration revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,368&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,368)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 46pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">266,719&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">215,040&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51,679&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(95,816)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(74,018)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(21,798)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(265,868)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(286,408)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20,540&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(281,608)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(258,971)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(22,637)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gain on sale of intellectual property</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NM</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss from operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(366,573)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(404,357)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37,784&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39,797&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25,215&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">173&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency loss</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(14,850)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(56,403)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41,553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(74)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,006&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,113&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,893&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss before income tax and share of loss from equity method investment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(334,620)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(443,065)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">108,445&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(24)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share of loss from equity method investment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(221)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">221&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(334,620)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(443,286)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">108,666&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(25)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss attributable to ordinary shareholders</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(334,620)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(443,286)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">108,666&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(25)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">NM - Not Meaningful</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Product Revenue</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following table presents the components of the Company&#8217;s product revenue ($ in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"/><td style="width:32.739%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.833%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.833%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.833%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Change</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Product revenue &#8212; gross</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">298,911&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">234,009&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64,902&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Less: Rebates and sales returns</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(32,192)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(21,337)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10,855)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Product revenue &#8212; net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">266,719&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">212,672&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54,047&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our product revenue is derived from the sales our commercial products primarily in mainland China, net of sales returns and rebates to distributors with respect to the sales of these products.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-84-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our net product revenue increased by $54.0 million in 2023 primarily driven by increased sales volumes, the launch of VYVGART, and decreased negative effects from the COVID-19 pandemic, partially offset by an increase in sales rebates to distributors resulting from price reductions in connection with NRDL listings for certain products and the effects on hospital and physician practices from the recent industry-wide anti-corruption enforcement efforts in China in the second half of 2023. In terms of revenue growth by product, ZEJULA continued to be the leading PARP inhibitor in hospital sales for ovarian cancer in mainland China; increased sales for QINLOCK and NUZYRA were supported by their inclusion in the NRDL in the first quarter of 2023, and we commercially launched VYVGART for gMG in mainland China in September 2023. The effects of the COVID-19 pandemic had an adverse impact on our sales volumes for 2022 and the first quarter in 2023, due to decreased patient access to our products, such as through reduced hospital access during periods of lockdown or high infection rates, fewer newly diagnosed oncology patients, and delayed or interrupted treatments. The COVID-19 pandemic has not had a material adverse effect on our sales volume since the second quarter of 2023. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Sales rebates to distributors resulting from price reductions in connection with NRDL listings were $13.0 million for 2023, which increased from $5.3 million for 2022. These sales rebates in 2023 were driven by price reductions in connection with the inclusion of QINLOCK and NUZYRA (IV formulation) in the first quarter of 2023 and the inclusion of VYVGART and NUZYRA (oral formulation) and the renewal of ZEJULA as a maintenance treatment in the fourth quarter of 2023. These sales rebates in 2022 were driven by price reductions in connection with the inclusion of ZEJULA for certain treatments in December 2021 and price reductions for QINLOCK and NUZYRA in the second quarter of 2022 in connection with NRDL pricing negotiations.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following table presents net revenue by product ($ in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.545%"><tr><td style="width:1.0%"/><td style="width:27.058%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.251%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.251%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.251%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.257%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Change</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ZEJULA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">168,843&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">145,194&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23,649&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">OPTUNE</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46,969&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47,321&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(352)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">QINLOCK</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19,240&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,283&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NUZYRA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21,656&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16,456&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VYVGART</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,011&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,011&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NM</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">266,719&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">212,672&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54,047&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">NM - Not Meaningful</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Cost of Sales</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Cost of sales increased by $21.8 million to $95.8 million in 2023 primarily due to increasing sales volumes.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Research and Development Expenses</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following table presents the components of our research and development expenses ($ in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.748%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Change</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Personnel compensation and related costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">115,749&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105,561&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Licensing fees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19,291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53,441&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(34,150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(64)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CROs/CMOs/Investigators expenses</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103,333&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100,544&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,789&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27,495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26,862&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">633&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">265,868&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">286,408&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(20,540)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-85-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Research and development expenses decreased by $20.5 million in 2023 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">primarily due to:</span></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:23.5pt">a decrease of $34.2 million in licensing fees as a result of decreased upfront and milestone payments for our license and collaboration agreements; partially offset by </span></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:23.5pt">an increase of $10.2 million in personnel compensation and related costs primarily due to grants of share options and restricted shares and the continued vesting of option and restricted share awards.</span></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:23.5pt">an increase of $2.8 million in in CROs/CMOs/Investigators expenses related to newly initiated studies and progress of existing studies. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following table presents our research and development expenses by program ($ in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.748%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Change</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical programs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">112,158&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">155,792&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(43,634)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(28)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-clinical programs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,356&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,644&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,712&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unallocated research and development expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">136,354&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">123,972&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,382&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">265,868&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">286,408&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(20,540)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> Research and development expenses attributable to clinical programs decreased by $43.6 million in 2023 primarily driven by a decrease in licensing fees of $45.2 million. Research and development expenses attributable to pre-clinical programs increased by $10.7 million in 2023, primarily driven by an increase in licensing fees related to an upfront payment for a new business collaboration.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Although we manage our external research and development expenses by program, we do not allocate our internal research and development expenses by program because our employees and internal resources may be engaged in projects for multiple programs at any given time. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Selling, General, and Administrative Expenses</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following table presents our selling, general and administrative expenses by program ($ in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.748%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Change</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Personnel compensation and related costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">173,389&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">162,045&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,344&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Professional service fees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22,507&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35,414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(12,907)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85,712&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">281,608&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">258,971&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22,637&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Selling, general</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> and administrative expenses increased by $22.6 million in 2023 primarily due to:</span></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:23.5pt">an increase of $24.2 million in other costs mainly related to selling, rental, and administrative expenses for commercial operations in mainland China, Hong Kong, and Taiwan; </span></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:23.5pt">an increase of $11.3 million in personnel compensation and related costs which was primarily driven by grants of share options and restricted shares and the continued vesting of option and restricted share awards; partially offset by</span></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:23.5pt">a decrease of $12.9 million in professional service fees primarily related to legal and other administrative expenses. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-86-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Gain on Sale of Intellectual Property</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We had a gain on sale of intellectual property of $10.0 million in connection with our sale of certain patent rights and related know-how to a third party in the second quarter of 2023. We had no such intellectual property sales resulting in gains or losses in 2022. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Interest Income</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Interest income increased by $25.2 million to $39.8 million in 2023, mainly due to increased interest rates. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Foreign Currency Loss</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Foreign currency loss decreased by $41.6 million to $14.9 million in 2023, due to the decrease in the remeasurement loss due to the lesser extent of U.S. dollar appreciation against the RMB. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Other Income, Net</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Other income, net increased by $3.9 million to $7.0 million in 2023 primarily due to an increase of gain on equity investments of  $11.7 million, driven by the shift from a loss of $9.0 million in 2022 to a gain of $2.8 million in 2023 for our investment in MacroGenics as a result of changes in its stock price, partially offset by a decrease of $9.0 million in government grant income.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Share of Loss from Equity Method Investment</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Share of loss from equity method investment was $0.2 million in 2022 due to losses from our investment in JING Medicine Technology (Shanghai) Ltd., an entity that provides services for drug discovery and development, consultation, and transfer of pharmaceutical technology. There was no change on the equity method investment in 2023.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Income Tax Expense </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Income tax expense was nil in both 2023 and 2022. For more information on income taxes, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Note 11</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Net Loss </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Net loss was $334.6 million for 2023, or a loss per ordinary share attributable to common stockholders of $0.35 (or loss per ADS of $3.46), compared to a net loss of $443.3 million for 2022, or a loss per ordinary share of $0.46 (or loss per ADS of $4.63). The decrease in net loss was primarily due to product revenue growing faster than net operating expenses, increased interest income, and decreased foreign currency loss. </span></div><div id="i8a977bbf870448998f9d0f718b7b41b9_64"></div><div style="-sec-extract:summary;margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Critical Accounting Policies and Significant Judgments and Estimates</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We prepare our financial statements in conformity with U.S. GAAP, which requires management to make judgments, estimates, and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses, and related disclosures. Some of those judgments can be subjective and complex. Actual results could differ from our estimates. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our most critical accounting policies and estimates, including those that require the most difficult, subjective, or complex judgments and are the most inherently uncertain, are described below. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-87-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Revenue Recognition </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We sell our products to distributors (our customers), who ultimately sell the products to healthcare providers, primarily in mainland China. We recognize revenue when the performance obligations are satisfied upon the product&#8217;s delivery to distributors. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We offer rebates to our distributors to compensate the distributors consistent with pharmaceutical industry practices. We are required to establish a provision for rebates in the same period the related product sales are recognized. The estimated amount of rebates, if any, is recorded as a reduction of revenue.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Significant judgments are required in making these estimates. In determining the appropriate accrual amount, we consider our contracted rates, sales volumes, levels of distributor inventories, and historical experiences and trends. If actual results vary from our estimates or our expectations change, we will adjust these estimates accordingly, which would affect net product revenue and earnings in the period such variances become expected or known. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Research and Development Expenses </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We have a significant amount of research and development expenses, including with respect to pre-clinical and clinical trials for our product candidates. Such costs are expensed as incurred when they have no alternative future uses. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We contract with third parties to perform various pre-clinical and clinical trial activities on our behalf in the ongoing development of our product candidates. Expenses related to pre-clinical and clinical trial activities are accrued based on the Company&#8217;s estimates of the actual services performed by the third parties, such as CROs and CMOs.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Significant judgments are required in estimating the actual services performed by the third parties for the respective period and the related expense accruals. In determining the appropriate accrual, we consider a variety of factors, including contractual requirements with respect to services to be provided, related rates, and our assessment of services performed during the period and progress with respect to any contractual milestones when we have not yet been invoiced or otherwise notified by third parties of actual costs. If the actual status and timing of services performed vary from our estimates, our reported expenses and earnings for the corresponding period may be affected.  </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Share-Based Compensation </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We grant share-based awards, including share options and restricted shares, to eligible employees, non-employees, and directors. Such share-based awards are measured at grant date fair value. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Significant assumptions are required in determining the fair value of share options, which we estimate using the Black-Scholes option valuation model. These assumptions include: (i) the expected volatility of our ADS price, (ii) the periods of time over which grantees are expected to hold their options prior to exercise (expected term), (iii) the expected dividend yield on our ADSs, and (iv) risk-free interest rates. Since we do not have sufficient trading history since our September 2017 initial public offering on Nasdaq to cover the expected term of our share options, we estimate expected volatility based on movements in the share price of certain companies we consider comparable over the most recent equivalent historical period. Since we do not have sufficient historical information since to develop reasonable expectations about future exercise patterns and post-vesting employment termination behavior, the expected term is derived from the average midpoint between the weighted average vesting and the contractual term, also known as the simplified method. The expected dividend yield is zero as we have never paid dividends and do not currently anticipate paying any in the foreseeable future, and risk-free interest rates are based on quoted U.S. Treasury rates for securities with maturities approximating the expected term. If actual results vary from our estimates or our expectations change, our reported expenses and earnings for the corresponding period may be affected.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Income Taxes </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We recognize deferred tax assets and liabilities for temporary differences between the financial statement and income tax bases of assets and liabilities, which are measured using enacted tax rates and laws that will be in effect when </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-88-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">the differences are expected to reverse. A valuation allowance is provided when it is more likely than not that some or all of a deferred tax asset will not be realized. Significant judgements are required when evaluating tax positions in accordance with ASC 740, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We recognize in our financial statements the benefit of a tax position if the tax position is &#8220;more likely than not&#8221; to prevail based on the facts and technical merits of the position. Tax positions that meet the &#8220;more likely than not&#8221; recognition threshold are measured at the largest amount of tax benefit that has a greater than fifty percent likelihood of being realized upon settlement. We estimate our liability for unrecognized tax benefits which are periodically assessed and may be affected by changing interpretations of laws, rulings by tax authorities, changes and/or developments with respect to tax audits, and the expiration of the applicable statute of limitations. The ultimate outcome for a particular tax position may not be determined with certainty prior to the conclusion of a tax audit and, in some cases, appeal or litigation process.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We consider positive and negative evidence when determining whether some or all of our deferred tax assets will not be realized. This assessment considers various factors, including the nature, frequency, and severity of current and cumulative losses, forecasts of future profitability, the duration of statutory carry-forward periods, our historical results of operations, and our tax planning strategies. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Our estimates may be affected by changing interpretations of laws, rulings by tax authorities, changes and/or developments with respect to tax audits, and expiration of the statute of limitations. If actual benefits vary from our estimates or our expectations change, we will adjust the recognition and measurement estimates accordingly, which would affect reported expenses and earnings in the corresponding period.</span></div><div id="i8a977bbf870448998f9d0f718b7b41b9_67"></div><div style="-sec-extract:summary;margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Liquidity and Capital Resources</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">To date, we have financed our activities primarily through private placements, our September 2017 initial public offering and various follow-on offerings on Nasdaq, and our September 2020 secondary listing and initial public offering on the Hong Kong Stock Exchange. In addition, we have raised approximately $164.6 million in private equity financing and approximately $2,462.7 million in net proceeds after deducting underwriting commissions and the offering expenses payable by us in our initial public offering and subsequent follow-on offerings on Nasdaq and our initial public offering on the Hong Kong Stock Exchange. Our operations have consumed substantial amounts of cash since inception. The net cash used in our operating activities was $198.2 million and $367.6 million in 2023 and 2022, respectively. For information on these activities and related expenditures, see the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Research and Development Expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Selling, General, and Administrative Expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">License and Collaboration Arrangements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Results of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> sections in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">MD&amp;A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> above. In addition, as of December&#160;31, 2023, we had commitments for capital expenditures of $1.2 million, mainly for the purpose of plant construction and installation. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">As of December&#160;31, 2023, we had cash and cash equivalents, restricted cash, and short-term investments of $807.6 million. Based on our current operating plan, we expect that our cash, cash equivalents, restricted cash, and short-term investments will enable us to meet our cash requirements and fund our operating expenses and capital expenditure requirements for at least the next 12 months. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Although we believe that we have sufficient capital to fund our operations for at least the next twelve months, we may, from time to time, identify opportunities to access capital through debt arrangements on favorable commercial terms. In February 2024, we entered into three such debt arrangements with Chinese financial institutions that allow certain of our subsidiaries to borrow approximately $164.5 million (or RMB1,171.7 million) to support our working capital needs in mainland China. So far, our subsidiaries have entered into working capital loans with an aggregate principal amount of RMB390.0 million ($54.8 million), which are guaranteed by us. These debt arrangements will provide us with additional capital capacity that gives us enhanced flexibility to execute on our corporate strategic goals.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Although we do not currently anticipate entering into additional debt arrangements, we may consider, or we may ultimately need, additional funding sources to bring to fruition or research and development objectives or otherwise, and there can be no assurances that such funding will be made available to us on acceptable terms or at all.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-89-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> The following table presents information regarding our cash flows ($ in thousands): </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"/><td style="width:44.271%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.502%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.502%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.507%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31, </span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Change</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in operating activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(198,178)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(367,642)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">169,464&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash (used in) provided by investing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10,776)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">420,016&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(430,792)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in financing activities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6,433)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,730)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4,703)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,622)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6,274)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,652&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net (decrease) increase in cash, cash equivalents and restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(218,009)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44,370&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(262,379)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Net Cash Used in Operating Activities</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Net cash used in operating activities decreased by $169.5 million in 2023, primarily due to a decrease of $108.7 million in net loss and an increase of $105.9 million in net changes in operating assets and liabilities, partially offset by a decrease of $45.1 million in adjustments to reconcile net loss to net cash used in operating activities. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Net Cash (Used in) Provided by Investing Activities </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Net cash used in investing activities was $10.8 million in 2023, compared to net cash provided by investing activities of $420.0 million in 2022. This shift was primarily due to a decrease of $587.6 million in proceeds from maturity of short-term investments, partially offset by a decrease of $126.3 million in purchases of short-term investments, a decrease of $17.4 million in purchases of property and equipment, and proceeds of $13.9 million from a sale of intellectual property and a disposal of land use rights in 2023.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Net Cash Used in Financing Activities </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Net cash used in financing activities increased by $4.7 million in 2023, primarily due to a decrease of $3.5 million in proceeds from exercises of share options and an increase of $1.2 million in taxes paid related to settlement of equity awards.</span></div><div id="i8a977bbf870448998f9d0f718b7b41b9_70"></div><div><span><br/></span></div><div id="i8a977bbf870448998f9d0f718b7b41b9_73"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Recently Issued Accounting Standards</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">For more information regarding recently issued accounting standards, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Financial Statements and Supplementary Data </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Recent Accounting Pronouncements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">. </span></div><div id="i8a977bbf870448998f9d0f718b7b41b9_76"></div><div style="-sec-extract:summary;margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Item 7A. Quantitative and Qualitative Disclosures About Market Risk </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We are exposed to market risk including foreign exchange risk, credit risk, and inflation risk. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Foreign Exchange Risk </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Renminbi, or RMB, is not a freely convertible currency. The State Administration of Foreign Exchange, under the authority of the People&#8217;s Bank of China (&#8220;PBOC&#8221;), controls the conversion of RMB into foreign currencies. The value of RMB is subject to changes in central government policies and to international economic and political developments affecting supply and demand in the China Foreign Exchange Trading System market. The cash and cash equivalents of the Company included aggregated amounts of $25.1 million and $45.5 million, which were denominated in RMB, as of December&#160;31, 2023 and 2022, respectively, representing 3% and 5% of the cash and cash equivalents as of December&#160;31, 2023 and 2022, respectively. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">While our financial statements are presented in U.S. dollars, our business mainly operates in mainland China with a significant portion of our transactions settled in RMB, and as such, we do not believe that we currently have significant </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-90-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">direct foreign exchange risk and have not used derivative financial instruments to hedge our exposure to such risk. Although, in general, our exposure to foreign exchange risks should be limited, the value of your investment in our ADSs and ordinary shares will be affected by the exchange rate between the U.S. dollar and the RMB and between the HK dollar and the RMB, respectively, because the value of our business is effectively denominated in RMB, while ADSs and ordinary shares are traded in U.S. dollars and HK dollars, respectively. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The value of the RMB against the U.S. dollar and other currencies may fluctuate and is affected by, among other things, changes in Greater China&#8217;s political and economic conditions. The conversion of RMB into foreign currencies, including U.S. dollars, has been based on rates set by the PBOC. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The value of our ADSs and our ordinary shares will be affected by the foreign exchange rates between U.S. dollars, HK dollars, and the RMB. For example, to the extent that we need to convert U.S. dollars or HK dollars into RMB for our operations or if any of our arrangements with other parties are denominated in U.S. dollars or HK dollars and need to be converted into RMB, appreciation of the RMB against the U.S. dollar or the HK dollar would have an adverse effect on the RMB amount we receive from the conversion. Conversely, if we decide to convert RMB into U.S. dollars or HK dollars for the purpose of making payments for dividends on ordinary shares or ADSs or for other business purposes, appreciation of the U.S. dollar or the HK dollar against the RMB would have a negative effect on the conversion amounts available to us. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Since 1983, the Hong Kong Monetary Authority (&#8220;HKMA&#8221;) has pegged the HK dollar to the U.S. dollar at the rate of approximately HK$7.80 to US$1.00. However, there is no assurance that the HK dollar will continue to be pegged to the U.S. dollar or that the HK dollar conversion rate will remain at HK$7.80 to US$1.00. If the HK dollar conversion rate against the U.S. dollar changes and the value of the HK dollar depreciates against the U.S. dollar, our assets denominated in HK dollars will be adversely affected. Additionally, if the HKMA were to repeg the HK dollar to, for example, the RMB rather than the U.S. dollar, or otherwise restrict the conversion of HK dollars into other currencies, then our assets denominated in HK dollars will be adversely affected.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Credit Risk</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Financial instruments that are potentially subject to significant concentration of credit risk consist of cash and cash equivalents, short-term investments, accounts receivable, and notes receivable. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The carrying amounts of cash and cash equivalents and short-term investments represent the maximum amount of loss due to credit risk. As of December&#160;31, 2023 and 2022, we had cash and cash equivalents of $790.2 million and $1,008.5 million and short-term investments of $16.3 million and nil, respectively. As of December&#160;31, 2023 and 2022, all of our cash and cash equivalents and short-term investments were held by major financial institutions located in mainland China and international financial institutions outside of mainland China which we believe are of high credit quality and for which we monitor continued credit worthiness. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Accounts receivable are typically unsecured and are derived from product sales and collaborative arrangements. We manage credit risk related to our accounts receivable through ongoing monitoring of outstanding balances and limiting the amount of credit extended based upon payment history and credit worthiness. Historically, we have collected receivables from customers within the credit terms with no significant credit losses incurred. As of December&#160;31, 2023, our two largest customers accounted for approximately 18% of our total accounts receivable collectively. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Certain accounts receivable balances are settled in the form of notes receivable. As of December&#160;31, 2023, such notes receivable included bank acceptance promissory notes that are non-interest bearing and due within six months. These notes receivable were used to collect the receivables based on an administrative convenience, given these notes are readily convertible to known amounts of cash. In accordance with the sales agreements, whether to use cash or bank acceptance promissory notes to settle the receivables is at our discretion, and this selection does not impact the agreed contractual purchase prices. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-91-</span></div></div></div><div id="i8a977bbf870448998f9d0f718b7b41b9_79"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="-sec-extract:summary;margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Item 8. Financial Statements and Supplementary Data </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The financial statements required to be filed pursuant to this item are appended to this report. An index of those financial statements is in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Exhibits, Financial Statement Schedules</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">. </span></div><div id="i8a977bbf870448998f9d0f718b7b41b9_82"></div><div style="-sec-extract:summary;margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">None.</span></div><div id="i8a977bbf870448998f9d0f718b7b41b9_85"></div><div style="-sec-extract:summary;margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Item 9A. Controls and Procedures</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">(a)&#160;&#160;&#160;&#160;Management&#8217;s Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our management, including our Chief Executive Officer and Chief Financial Officer, performed an evaluation of the effectiveness of our disclosure controls and procedures (as defined in Exchange Act Rule 13a-15(e)) as of the end of the period covered by this report. Our disclosure controls and procedures are designed to ensure that the information required to be disclosed in the reports that we file or furnish under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC&#8217;s rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure. Any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objective. Based upon that evaluation, our management has concluded that, as of December&#160;31, 2023, our disclosure controls and procedures were effective.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">(b)&#160;&#160;&#160;&#160;Management&#8217;s Report on Internal Control over Financial Reporting</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Exchange Act Rule 13a-15(f). Our internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of our financial reporting and the preparation of financial statements for external purposes in accordance with U.S. GAAP and includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of consolidated financial statements in accordance with U.S. GAAP, and that receipts and expenditures of the Company are being made only in accordance with authorizations of our management and directors; and (iii) provide reasonable assurance regarding prevention or timely detection of the unauthorized acquisition, use or disposition of the Company&#8217;s assets that could have a material effect on the consolidated financial statements. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Internal control over financial reporting, no matter how well designed, has inherent limitations. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our management, including our Chief Executive Officer and Chief Financial Officer, assessed the effectiveness of our internal control over financial reporting as of December&#160;31, 2023 using the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in &#8220;Internal Control &#8211; Integrated Framework (2013).&#8221; Based on this assessment, management concluded that our internal control over financial reporting was effective as of December&#160;31, 2023.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">(c)&#160;&#160;&#160;&#160;Report of Registered Accounting Firm</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The effectiveness of our internal control over financial reporting as of December&#160;31, 2023 has been audited by KPMG LLP, an independent registered public accounting firm, who has also audited our consolidated financial statements for the year ended December&#160;31, 2023, as stated in their report which is included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Financial Statements and Supplementary Data</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-92-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">(d)&#160;&#160;&#160;&#160;Changes in Internal Control over Financial Reporting</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">There were no changes in our internal control over financial reporting (as such item is defined in Exchange Act Rule 13a-15(f)) during the fiscal quarter ended December&#160;31, 2023 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. </span></div><div id="i8a977bbf870448998f9d0f718b7b41b9_88"></div><div style="-sec-extract:summary;margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Item 9B. Other Information</span></div><ix:nonNumeric contextRef="c-7" name="ecd:MtrlTermsOfTrdArrTextBlock" id="f-40" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">On <ix:nonNumeric contextRef="c-8" name="ecd:TrdArrAdoptionDate" id="f-41">December 15, 2023</ix:nonNumeric>, <ix:nonNumeric contextRef="c-8" name="ecd:TrdArrIndName" id="f-42">Rafael Amado</ix:nonNumeric>, the Company&#8217;s <ix:nonNumeric contextRef="c-8" name="ecd:TrdArrIndTitle" id="f-43">President and Head of Global Oncology Research and Development</ix:nonNumeric>, <ix:nonNumeric contextRef="c-8" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-true" id="f-44">adopted</ix:nonNumeric> a new written Rule 10b5-1 trading arrangement (as defined in Item 408 of Regulation S-K), for the sale of up to <ix:nonFraction unitRef="shares" contextRef="c-9" decimals="INF" name="ecd:TrdArrSecuritiesAggAvailAmt" format="ixt:num-dot-decimal" scale="0" id="f-45">94,500</ix:nonFraction> of the Company&#8217;s ADSs, each representing ten of the Company&#8217;s ordinary shares. This Rule 10b5-1 trading arrangement is scheduled to terminate no later than December 16, 2024.</span></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Other than as described above, during the fourth quarter of 2023, none of our directors or executive officers (as defined in Rule 16a-1(f) under the Exchange Act) has <ix:nonNumeric contextRef="c-10" name="ecd:NonRule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-46">adopted</ix:nonNumeric> or <ix:nonNumeric contextRef="c-10" name="ecd:NonRule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-47"><ix:nonNumeric contextRef="c-10" name="ecd:Rule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-48">terminated</ix:nonNumeric></ix:nonNumeric> a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement (each as defined in Item 408 of Regulation S-K).</span></div><div id="i8a977bbf870448998f9d0f718b7b41b9_91"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Not applicable.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-93-</span></div></div></div><div id="i8a977bbf870448998f9d0f718b7b41b9_94"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III</span></div><div id="i8a977bbf870448998f9d0f718b7b41b9_97"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Item 10. Directors, Executive Officers and Corporate Governance</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The information required by this item will be set forth in our definitive proxy statement pursuant to Regulation 14A</span><span style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(the &#8220;2024 Proxy Statement&#8221;)</span><span style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">  which will be filed with the U.S. Securities and Exchange Commission not later than 120 days after the close of our fiscal year ended December&#160;31, 2023, and is incorporated herein by reference. </span></div><div id="i8a977bbf870448998f9d0f718b7b41b9_100"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Item 11. Executive Compensation </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The information required by this item will be set forth in the 2024 Proxy Statement and is incorporated herein by reference. </span></div><div id="i8a977bbf870448998f9d0f718b7b41b9_103"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The information required by this item will be set forth in the 2024 Proxy Statement and is incorporated herein by reference. </span></div><div id="i8a977bbf870448998f9d0f718b7b41b9_106"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Item 13. Certain Relationships and Related Transactions, and Director Independence </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The information required by this item will be set forth in the 2024 Proxy Statement and is incorporated herein by reference. </span></div><div id="i8a977bbf870448998f9d0f718b7b41b9_109"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Item 14. Principal Accounting Fees and Services </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The information required by this item will be set forth in the 2024 Proxy Statement and is incorporated herein by reference.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-94-</span></div></div></div><div id="i8a977bbf870448998f9d0f718b7b41b9_112"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART IV</span></div><div id="i8a977bbf870448998f9d0f718b7b41b9_115"></div><div style="-sec-extract:summary;margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Item 15. Exhibits, Financial Statement Schedules</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The financial statements listed in the Index to Consolidated Financial Statements beginning on page F-1 are filed as part of this report.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We have included Additional Financial Information of Parent Company - Financial Statements Schedule I for the years ended December 31, 2023, 2022, and 2021 on page F-39. No other financial statement schedules have been filed as part of this report because they are not applicable, not required or the information required is shown in the financial statements or the notes thereto. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The exhibits filed as part of this report are set forth on the Exhibit Index below. The Exhibit Index is incorporated herein by reference. </span></div><div id="i8a977bbf870448998f9d0f718b7b41b9_118"></div><div style="-sec-extract:summary;margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:8.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.398%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:87.672%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit Title</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000119312522178758/d362463dex31.htm">Sixth Amended and Restated Memorandum and Articles of Association of Zai Lab Limited (incorporated by reference to Exhibit 3.1 to our Current Report on Form 8-K (File No. 001-38205) filed on June 22, 2022) </a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1704292/000119312517275654/d358845dex41.htm">Form of Deposit Agreement (incorporated by reference to Exhibit 4.1 to Amendment No. 2 to our Registration Statement on Form F-1 (File No. 333-219980) filed on September 1, 2017)</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000119380522000555/e621481_424b3-zailab.htm">Form of American Depositary Receipt (incorporated by reference to Form 424B3 (File No. 333-220256) filed on March 30, 2022)</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000119312522145057/d357615dex41.htm">Registrant&#8217;s Specimen Certificate for Ordinary Shares (incorporated by reference to Exhibit 4.1 to our Registration Statement on Form S-8 (File No. 333-264800) filed on May 9, 2022)</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.4</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1704292/000119312517258641/d358845dex44.htm">Third Amended and Restated Shareholders Agreement between Zai Lab Limited and other parties named therein dated June 26, 2017 (incorporated by reference to Exhibit 4.4 to our Registration Statement on Form F-1 (File No. 333-219980) filed on August 15, 2017)</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.5</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="exhibit45-descriptionofsec.htm">Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act </a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.1#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1704292/000119312517275654/d358845dex101.htm">Zai Lab Limited 2015 Omnibus Equity Incentive Plan as amended on February 3, 2016 and April 10, 2016 (incorporated by reference to Exhibit 10.1 to Amendment No. 2 to our Registration Statement on Form F-1 (File No. 333-219980) filed on September 1, 2017)</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.2#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1704292/000119312517275654/d358845dex1022.htm">Zai Lab Limited 2017 Equity Incentive Plan (incorporated by reference to Exhibit 10.22 to Amendment No. 2 to our Registration Statement on Form F-1 (File No. 333-219980) filed on September 1, 2017)</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.3#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000119312522178758/d362463dex101.htm">Zai Lab Limited 2022 Equity Incentive Plan (incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K (File No. 001-38205) filed on June 22, 2022)</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.4#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828022029246/exhibit102formofrestricted.htm">Form Restricted Share Unit Award Agreement (incorporated by reference to Exhibit 10.2 to our Quarterly Report on Form 10-Q (File No. 001-38205) filed on November 9, 2022)</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.5#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828022029246/exhibit103formofrestricted.htm">Form Restricted Stock Award Agreement (incorporated by reference to Exhibit 10.3 to our Quarterly Report on Form 10-Q (File No. 001-38205) filed on November 9, 2022)</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.6#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828022029246/exhibit104formofnon-statut.htm">Form of Non-Statutory Stock Option Award Agreement (incorporated by reference to Exhibit 10.4 to our Quarterly Report on Form 10-Q (File No. 001-38205) filed on November 9, 2022)</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.7#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828023005832/exhibit107-nonxemployeedir.htm">Non-Employee Director Compensation Policy</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828023005832/exhibit107-nonxemployeedir.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828023005832/exhibit107-nonxemployeedir.htm">(incorporated by reference to Exhibit 10.7 to our Annual Report on Form 10-K (File No. 001-38205) filed on March 1, 2023)</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">+</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1704292/000119312517258641/d358845dex102.htm">Collaboration, Development and License Agreement by and between Tesaro, Inc. and Zai Lab (Shanghai) Co., Ltd. dated September 28, 2016 (incorporated by reference to Exhibit 10.2 to our Registration Statement on Form F-1 (File No. 333-219980) filed on August 15, 2017)</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-95-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:8.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.398%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:87.672%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit Title</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.9</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1704292/000156459018009692/zlab-ex43_533.htm">Amendment to Collaboration, Development and License Agreement by and between Tesaro, Inc. and Zai Lab (Shanghai) Co., Ltd., dated February 26, 2018 (incorporated by reference to Exhibit 4.3 to our Annual Report on Form 20-F (File No. 001-38205) filed on April 30, 2018)</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.10</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">+</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1704292/000156459019010185/zlab-ex1015_820.htm">License and Collaboration Agreement by and between Novocure Limited and Zai Lab (Shanghai) Co., Ltd. dated September 10, 2018 (incorporated by reference to Exhibit 10.15 to our Annual Report on Form 20-F (File No. 001-38205) filed on March 29, 2019)</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.11&#x5E;</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459020019745/zlab-ex1017_1525.htm">License </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459020019745/zlab-ex1017_1525.htm">Agreement </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459020019745/zlab-ex1017_1525.htm">between </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459020019745/zlab-ex1017_1525.htm">Deciphera Pharmaceuticals, LLC</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459020019745/zlab-ex1017_1525.htm"> and Zai Lab (Shanghai) Co., Ltd. dated </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459020019745/zlab-ex1017_1525.htm">June 10, 2019</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459020019745/zlab-ex1017_1525.htm"> (incorporated by reference to Exhibit </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459020019745/zlab-ex1017_1525.htm">10.17</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459020019745/zlab-ex1017_1525.htm"> to our </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459020019745/zlab-ex1017_1525.htm">Annual Report</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459020019745/zlab-ex1017_1525.htm"> on Form </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459020019745/zlab-ex1017_1525.htm">20-F</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459020019745/zlab-ex1017_1525.htm"> (File No. </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459020019745/zlab-ex1017_1525.htm">001-38205)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459020019745/zlab-ex1017_1525.htm"> filed on </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459020019745/zlab-ex1017_1525.htm">April 29, 2020)</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.12&#x5E;</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459020019745/zlab-ex1018_1523.htm">Amendment to </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459020019745/zlab-ex1018_1523.htm">License Agreement </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459020019745/zlab-ex1018_1523.htm">between </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459020019745/zlab-ex1018_1523.htm">Deciphera Pharmaceuticals, LLC</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459020019745/zlab-ex1018_1523.htm"> and Zai Lab (Shanghai) Co., Ltd. dated </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459020019745/zlab-ex1018_1523.htm">January 17, 2020</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459020019745/zlab-ex1018_1523.htm"> (incorporated by reference to Exhibit </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459020019745/zlab-ex1018_1523.htm">10.18</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459020019745/zlab-ex1018_1523.htm"> to our Annual Report on Form 20-F (File No. 001-38205) filed on April </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459020019745/zlab-ex1018_1523.htm">29, 2020)</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">+</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1704292/000119312517258641/d358845dex104.htm">License and Collaboration Agreement by and between Paratek Bermuda Ltd. and Zai Lab (Shanghai) Co., Ltd. dated April 21, 2017 (incorporated by reference to Exhibit 10.4 to our Registration Statement on Form F-1 (File No. 333-219980) filed on August 15, 2017)</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.14&#x5E;</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000119312521155749/d109144dex101.htm">Collaboration and License Agreement between argenx BV and Zai Auto Immune (Hong Kong) Limited dated January 6, 2021 (incorporated by reference to Exhibit 10.1 to our Quarterly Report on Form 10-Q (File No. 001-38205) filed on May 10, 2021)</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.15&#x5E;</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828022029246/zlab-20220930xexx101_seage.htm">Collaboration and License Agreement by and between Seagen Inc. and Zai Lab (Hong Kong) Limited dated as of September 20, 2022 (incorporated by reference to Exhibit 10.1 to our Quarterly Report on Form 10-Q (File No. 001-38205) filed on November 9, 2022)</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.16&#x5E;</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000119312521240435/d46351dex102.htm">Collaboration and License Agreement, dated as of May 28, 2021, by and between Zai Lab (Hong Kong) Limited and Mirati Therapeutics, Inc. (incorporated by reference to Exhibit 10.2 to our Quarterly Report on Form 10-Q (File No. 001-38205) filed on August 9, 2021)</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.17</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">+</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459018009692/zlab-ex411_534.htm">License Agreement by and between Five Prime Therapeutics, Inc. and Zai Lab (Shanghai) Co., Ltd. dated December 19, 2017 (incorporated by reference to Exhibit 4.11 to our Annual Report on Form 20-F (File No. 001-38205) filed on April 30, 2018)</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.18&#x5E;</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001704292/000119312521062279/d85279dex1021.htm">License Agreement between Turning Point Therapeutics, Inc. and Zai Lab (Shanghai) Co., Ltd. dated July 6, 2020 (incorporated by reference to Exhibit 10.21 to our Annual Report on Form 10-K (File No. 001-38205) filed on March 1, 2021)</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.19+</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000119312518265046/d605957dex1012.htm">License and Collaboration Agreement by and between Entasis Therapeutics Holdings Inc. and Zai Lab (Shanghai) Co., Ltd. dated as of April 25, 2018 (incorporated by reference to Exhibit 10.12 to our Amendment No. 2 to our Registration Statement on Form F-1 (File No. 333-227159) filed on September 5, 2018)</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.20&#x5E;</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000119312522061312/d261426dex1024.htm">License Agreement by and between Zai Lab (Shanghai) Co., Ltd. and Karuna Therapeutics, Inc., dated November 8, 2021 (incorporated by reference to Exhibit 10.24 to our Annual Report on Form 10-K (File No. 001-38205) filed on March 1, 2022)</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.21#</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1704292/000119312517258641/d358845dex1012.htm">Form of Indemnification Agreement for Directors and Officers (incorporated by reference to Exhibit 10.12 to our Registration Statement on Form F-1 (File No. 333-219980) filed on August 15, 2017)</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.22#</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000119312517275654/d358845dex1018.htm">E</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000119312517275654/d358845dex1018.htm">mployment Agreement between Samantha</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000119312517275654/d358845dex1018.htm"> (Ying) Du and Zai Lab (Shanghai) Co., Ltd. dated July 1, 20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000119312517275654/d358845dex1018.htm">17 (English translation) (incorporated by reference to Exhibit 10.18 to Amendment No</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000119312517275654/d358845dex1018.htm">. 2 to our Registration Statement on For</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000119312517275654/d358845dex1018.htm">m F-1 (File No. 333-219980) filed on September 1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000119312517275654/d358845dex1018.htm">, 2017)</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.23#</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459018009692/zlab-ex416_531.htm">L</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459018009692/zlab-ex416_531.htm">etter Agreement between Samantha (Ying) Du and Zai Lab (US) LLC dated December 11, 2017 (incorporated by reference to Exhibit 4.16 to our Annual Report on Form 20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459018009692/zlab-ex416_531.htm">-F (File </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459018009692/zlab-ex416_531.htm">No. </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459018009692/zlab-ex416_531.htm">001-38205</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459018009692/zlab-ex416_531.htm">) filed on April 30, 2018)</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.24#</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1704292/000156459019010185/zlab-ex1018_818.htm">Fourth Amended and Restated Founder Employment Agreement between Samantha (Ying) Du and Zai Lab Limited dated December 1, 2018 (incorporated by reference to Exhibit 10.18 to our Annual Report on Form 20-F (File No. 001-38205) filed on March 29, 2019)</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-96-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:8.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.398%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:87.672%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit Title</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.25#</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828023037358/ex101-zailetteragreementwy.htm">Letter Agreement between Yajing Chen and Zai Lab (US) LLC dated July 6, 2023 (incorporated by reference to Exhibit 10.1 to our Quarterly Report on Form 10-Q</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828023037358/ex101-zailetteragreementwy.htm"> (File No. 001-38205)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828023037358/ex101-zailetteragreementwy.htm"> filed on November 7, 2023) </a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.26#</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828023005832/exhibit1041-zailabxramad.htm">Employment Agreement between Rafael Amado and Zai Lab (US) LLC dated December 30, 2022 (incorporated by reference to Exhibit 10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828023005832/exhibit1041-zailabxramad.htm">41</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828023005832/exhibit1041-zailabxramad.htm"> to our Annual Report on Form 10-K (File No. 001-38205) filed on March 1, 2023)</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.27#</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459019010185/zlab-ex1022_816.htm">Second Amended</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459019010185/zlab-ex1022_816.htm"> and </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459019010185/zlab-ex1022_816.htm">Restated Employment Agreement between Harald Reinhart</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459019010185/zlab-ex1022_816.htm"> and </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459019010185/zlab-ex1022_816.htm">Zai Lab </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459019010185/zlab-ex1022_816.htm">(Hong Kong) Limited dated December 28, 2019</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459019010185/zlab-ex1022_816.htm"> (incorporated by reference to Exhibit </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459019010185/zlab-ex1022_816.htm">10.22</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459019010185/zlab-ex1022_816.htm"> to our </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459019010185/zlab-ex1022_816.htm">Annual</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459019010185/zlab-ex1022_816.htm"> Report on Form </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459019010185/zlab-ex1022_816.htm">20-F</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459019010185/zlab-ex1022_816.htm"> (File No. 001-38205) filed on </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459019010185/zlab-ex1022_816.htm">March 29, 2019)</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.28#</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828023005832/ex1039-sandlerseveranceagr.htm">Employment Agreement between Joshua Smiley</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828023005832/ex1039-sandlerseveranceagr.htm"> and </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828023005832/ex1039-sandlerseveranceagr.htm">Zai Lab </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828023005832/ex1039-sandlerseveranceagr.htm">(US) LLC</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828023005832/ex1039-sandlerseveranceagr.htm"> dated </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828023005832/ex1039-sandlerseveranceagr.htm">August 1, 2022</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828023005832/ex1039-sandlerseveranceagr.htm"> (incorporated by reference to Exhibit </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828023005832/ex1039-sandlerseveranceagr.htm">10.39</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828023005832/ex1039-sandlerseveranceagr.htm"> to our Annual Report on Form 10-K (File No. 001-38205) filed on March 1, </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828023005832/ex1039-sandlerseveranceagr.htm">2023)</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.29#</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459019010185/zlab-ex1019_817.htm">Amended and Restated Employment Agreement</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459019010185/zlab-ex1019_817.htm"> between </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459019010185/zlab-ex1019_817.htm">William Ki Chul Cho</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459019010185/zlab-ex1019_817.htm"> and </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459019010185/zlab-ex1019_817.htm">Zai Lab (Hong Kong) Limited</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459019010185/zlab-ex1019_817.htm"> dated </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459019010185/zlab-ex1019_817.htm">March 22, 2019</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459019010185/zlab-ex1019_817.htm"> (incorporated by reference to Exhibit </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459019010185/zlab-ex1019_817.htm">10.19</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459019010185/zlab-ex1019_817.htm"> to our Annual Report on Form </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459019010185/zlab-ex1019_817.htm">20-F</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459019010185/zlab-ex1019_817.htm"> (File No. 001-38205) filed on March </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000156459019010185/zlab-ex1019_817.htm">29, 2019)</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.30#&#x5E;</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828023037358/ex102-zaixletteragreemen.htm">Letter</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828023037358/ex102-zaixletteragreemen.htm"> Agreement </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828023037358/ex102-zaixletteragreemen.htm">between </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828023037358/ex102-zaixletteragreemen.htm">Wil</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828023037358/ex102-zaixletteragreemen.htm">l</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828023037358/ex102-zaixletteragreemen.htm">iam Ki Chul Cho</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828023037358/ex102-zaixletteragreemen.htm"> and Zai Lab </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828023037358/ex102-zaixletteragreemen.htm">(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828023037358/ex102-zaixletteragreemen.htm">Hong Kong</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828023037358/ex102-zaixletteragreemen.htm">) L</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828023037358/ex102-zaixletteragreemen.htm">imited</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828023037358/ex102-zaixletteragreemen.htm"> dated </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828023037358/ex102-zaixletteragreemen.htm">July 6, 2023</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828023037358/ex102-zaixletteragreemen.htm"> (incorporated by reference to Exhibit 10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828023037358/ex102-zaixletteragreemen.htm">2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828023037358/ex102-zaixletteragreemen.htm"> to our Quarterly Report on Form 10-Q (File No. 001-38205) filed on November </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828023037358/ex102-zaixletteragreemen.htm">7, 2023)</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.31#</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000119312521062279/d85279dex1030.htm">Employment Agreement between Alan Bart Sandler</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000119312521062279/d85279dex1030.htm"> and </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000119312521062279/d85279dex1030.htm">Zai Lab (US) LLC dated December 1, 2020</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000119312521062279/d85279dex1030.htm"> (incorporated by reference to Exhibit </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000119312521062279/d85279dex1030.htm">10.30</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000119312521062279/d85279dex1030.htm"> to our </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000119312521062279/d85279dex1030.htm">Annual Report</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000119312521062279/d85279dex1030.htm"> on Form </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000119312521062279/d85279dex1030.htm">10-K</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000119312521062279/d85279dex1030.htm"> (File No. </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000119312521062279/d85279dex1030.htm">001-38205)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000119312521062279/d85279dex1030.htm"> filed on </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000119312521062279/d85279dex1030.htm">March 1, 2021) </a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.32#</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828023005832/ex1039-sandlerseveranceagr.htm">Severance</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828023005832/ex1039-sandlerseveranceagr.htm"> Agreement </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828023005832/ex1039-sandlerseveranceagr.htm">and General Release </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828023005832/ex1039-sandlerseveranceagr.htm">between </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828023005832/ex1039-sandlerseveranceagr.htm">Alan Bart Sandler</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828023005832/ex1039-sandlerseveranceagr.htm"> and Zai Lab </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828023005832/ex1039-sandlerseveranceagr.htm">(US) LLC</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828023005832/ex1039-sandlerseveranceagr.htm"> dated </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828023005832/ex1039-sandlerseveranceagr.htm">October 25, 2022</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828023005832/ex1039-sandlerseveranceagr.htm"> (incorporated by reference to Exhibit </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828023005832/ex1039-sandlerseveranceagr.htm">10.39</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828023005832/ex1039-sandlerseveranceagr.htm"> to </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828023005832/ex1039-sandlerseveranceagr.htm">our </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828023005832/ex1039-sandlerseveranceagr.htm">Annual Report</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828023005832/ex1039-sandlerseveranceagr.htm"> on Form </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828023005832/ex1039-sandlerseveranceagr.htm">10-K</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828023005832/ex1039-sandlerseveranceagr.htm"> (File No. </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828023005832/ex1039-sandlerseveranceagr.htm">001-38205)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828023005832/ex1039-sandlerseveranceagr.htm"> filed on </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828023005832/ex1039-sandlerseveranceagr.htm">March</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828023005832/ex1039-sandlerseveranceagr.htm"> 1, </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828023005832/ex1039-sandlerseveranceagr.htm">2023)</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.33</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="exhibit1033-bochk_facili.htm">F</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="exhibit1033-bochk_facili.htm">acility Letter, dated as of Feb</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="exhibit1033-bochk_facili.htm">ruary 5, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="exhibit1033-bochk_facili.htm">4, by and betwe</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="exhibit1033-bochk_facili.htm">e</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="exhibit1033-bochk_facili.htm">n Zai Lab Limited and Bank of China (Hong Kong) Limited</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.34</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a102-bocchinaxworkingcapit.htm">U</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a102-bocchinaxworkingcapit.htm">nofficial English Translation of </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a102-bocchinaxworkingcapit.htm">Working Capital Loan Agreement, dated as of Februar</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a102-bocchinaxworkingcapit.htm">y </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a102-bocchinaxworkingcapit.htm">7</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a102-bocchinaxworkingcapit.htm">, 2024, by and between Zai Lab (Shanghai) Co</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a102-bocchinaxworkingcapit.htm">., L</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a102-bocchinaxworkingcapit.htm">td. and Bank of </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a102-bocchinaxworkingcapit.htm">China Pudong Development Zone Sub-branch (incorporated by reference to Exhibit 10.2 to our Current Report on Form 8-K (File No. 0</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a102-bocchinaxworkingcapit.htm">0</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a102-bocchinaxworkingcapit.htm">01-38205) filed on February 8, 2024)</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.35+</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a103-spdbankxmaximumguaran.htm">U</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a103-spdbankxmaximumguaran.htm">nofficial En</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a103-spdbankxmaximumguaran.htm">glish Tra</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a103-spdbankxmaximumguaran.htm">nslation of Maximum</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a103-spdbankxmaximumguaran.htm">-</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a103-spdbankxmaximumguaran.htm">Amount</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a103-spdbankxmaximumguaran.htm"> Guarantee C</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a103-spdbankxmaximumguaran.htm">ontract, dated </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a103-spdbankxmaximumguaran.htm">as of Fe</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a103-spdbankxmaximumguaran.htm">bruary 6, 2024, by and between Zai Lab Limited and Shanghai Pudong Dev</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a103-spdbankxmaximumguaran.htm">elopment Bank Co., Ltd. Zhangjiang Hi</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a103-spdbankxmaximumguaran.htm">-T</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a103-spdbankxmaximumguaran.htm">e</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a103-spdbankxmaximumguaran.htm">ch Park Sub-branch</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a103-spdbankxmaximumguaran.htm"> (incorporate</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a103-spdbankxmaximumguaran.htm">d by reference to Exhibit 10.3 to our Current Report on Form 8-K (File No. </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a103-spdbankxmaximumguaran.htm">001-38205) filed on February 8, 2024)</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.36</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a104-ningbobankxmaximumcre.htm">U</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a104-ningbobankxmaximumcre.htm">noff</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a104-ningbobankxmaximumcre.htm">icial English Translation of Maximum Credit Contract, </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a104-ningbobankxmaximumcre.htm">dated as of Fe</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a104-ningbobankxmaximumcre.htm">bruary 6, 2024, by and between Zai Lab (Suzhou</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a104-ningbobankxmaximumcre.htm">) Co., Ltd. and Bank of Ningbo </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a104-ningbobankxmaximumcre.htm">Co., L</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a104-ningbobankxmaximumcre.htm">td. Suzhou Branch (incorporated by reference to Exhibit 10</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a104-ningbobankxmaximumcre.htm">.4 to our Current Report on For</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a104-ningbobankxmaximumcre.htm">m 8-K (File No. 00</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a104-ningbobankxmaximumcre.htm">1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a104-ningbobankxmaximumcre.htm">-3820</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a104-ningbobankxmaximumcre.htm">5) filed on February 8, 2024)</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.37+</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a105-ningbobankxelectronic.htm">U</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a105-ningbobankxelectronic.htm">nofficial English T</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a105-ningbobankxelectronic.htm">ranslati</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a105-ningbobankxelectronic.htm">on of Electronic Commercial Draft Discounting Master Agreement Standard Terms, dated as of Feb</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a105-ningbobankxelectronic.htm">ruary 6, 2024, by and between Zai Lab (S</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a105-ningbobankxelectronic.htm">uzhou) Co., L</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a105-ningbobankxelectronic.htm">td. and Bank of Ningbo Co.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a105-ningbobankxelectronic.htm">, Ltd. Suzhou Branch (incorporated </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a105-ningbobankxelectronic.htm">by reference to Exhibit 10.5 </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a105-ningbobankxelectronic.htm">to our Current Report on For</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a105-ningbobankxelectronic.htm">m 8-</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a105-ningbobankxelectronic.htm">K (File No. 001-38205) </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a105-ningbobankxelectronic.htm">filed on February 8, 2024)</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.38+</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a106-ningbobankxonlinework.htm">U</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a106-ningbobankxonlinework.htm">nofficial English Translation of Online Working Capital Loan Master Agreement, dated as of February 6, 2024, by and between Zai Lab (Suzhou) Co</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a106-ningbobankxonlinework.htm">., L</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a106-ningbobankxonlinework.htm">td</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a106-ningbobankxonlinework.htm">. and </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a106-ningbobankxonlinework.htm">Bank </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a106-ningbobankxonlinework.htm">of </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a106-ningbobankxonlinework.htm">Ningbo </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a106-ningbobankxonlinework.htm">Co., Ltd. Suzhou Branch (</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a106-ningbobankxonlinework.htm">i</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a106-ningbobankxonlinework.htm">n</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a106-ningbobankxonlinework.htm">corporated by reference to Exhibit 10.6 </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a106-ningbobankxonlinework.htm">to our </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a106-ningbobankxonlinework.htm">Current Report on Form 8-K (File No. 001-382</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a106-ningbobankxonlinework.htm">05) filed on F</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a106-ningbobankxonlinework.htm">e</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a106-ningbobankxonlinework.htm">bruary 8, 2024</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000162828024003902/a106-ningbobankxonlinework.htm">)</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000119312522164558/d364438dex161.htm">Letter from Deloitte Touche Tohmatsu Certified Public Accountants LLP to the SEC, dated June 1, 2022 (incorporated by reference to Exhibit 16.1 to our Current Report on Form 8-K </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000119312522164558/d364438dex161.htm">(File No. 001-38205) </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1704292/000119312522164558/d364438dex161.htm">filed on June 1, 2022)</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">21.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="ex211-subsidiarieslist2023.htm">Subsidiaries of the Registrant</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></td><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-97-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:8.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.398%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:87.672%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit Title</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">23.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="ex231-consentletterfromkpmg.htm">Consent of KPMG LLP, an independent accounting firm, regarding the consolidated financial statements of Zai Lab Limited</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="ex231-consentletterfromkpmg.htm"> </a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">23.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="ex232-consentletterfromdel.htm">Consent of Deloitte Touche Tohmatsu Certified Public Accountants LLP, an independent accounting firm, regarding the consolidated financial statements of Zai Lab Limited </a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">31.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="zlab-20231231x10kxexx311.htm">Certification of Chief Executive Officer Required by Rule 13a-14(a)</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">31.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="zlab-20231231x10kxexx312.htm">Certification of Chief Financial Officer Required by Rule 13a-14(a)</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">32.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="zlab-20231231x10kxexx321.htm">Certification of Chief Executive Officer Required by 18 U.S.C. Section 1350</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">32.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="zlab-20231231x10kxexx322.htm">Certification of Chief Financial Officer Required by 18 U.S.C. Section 1350</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">97.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="ex971-zlabxdoddxfrankcompe.htm">D</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="ex971-zlabxdoddxfrankcompe.htm">odd</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="ex971-zlabxdoddxfrankcompe.htm">-Frank </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="ex971-zlabxdoddxfrankcompe.htm">Policy on Recoupment of I</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="ex971-zlabxdoddxfrankcompe.htm">ncentive Compensation</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">101.INS</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Instance Document-the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">101.SCH</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Schema Document</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">101.CAL</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">101.LAB</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">101.PRE</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">101.DEF</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Definitions Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">104</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)</span></td><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:109%">#&#160;&#160;&#160;&#160;Management contract or compensatory plan, contract, or arrangement</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">+&#160;&#160;&#160;&#160;Confidential treatment has been granted as to certain portions, which portions have been omitted and submitted separately to the Securities and Exchange Commission. </span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#x5E;&#160;&#160;&#160;&#160;Portions of this exhibit have been redacted pursuant to Regulation S-K Item 601(b)(10)(iv).</span></div><div id="i8a977bbf870448998f9d0f718b7b41b9_760"></div><div style="margin-top:18pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Item 16. Form 10-K Summary</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Not applicable.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-98-</span></div></div></div><div id="i8a977bbf870448998f9d0f718b7b41b9_121"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.657%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">ZAI LAB LIMITED</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Date: February&#160;27, 2024</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">/s/ Samantha (Ying) Du</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Name:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Samantha (Ying) Du</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Title:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Chief Executive Officer</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-99-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed by the following persons in the capacities and on the dates indicated below: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.354%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.354%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.780%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Signature</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Title</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Date</span></td></tr><tr style="height:9pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Samantha (Ying) Du</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Executive Officer and Chairperson of the Board of Directors</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 27, 2024</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Samantha (Ying) Du</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Principal Executive Officer)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Yajing Chen</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Financial Officer</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 27, 2024</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Yajing Chen</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Principal Financial and Accounting Officer)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ John Diekman</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 27, 2024</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">John Diekman</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Kai-Xian Chen</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 27, 2024</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Kai-Xian Chen</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Richard Gaynor</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 27, 2024</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Richard Gaynor</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Nisa Leung</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 27, 2024</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nisa Leung</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ William Lis</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 27, 2024</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">William Lis</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Leon O. Moulder, Jr.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 27, 2024</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leon O. Moulder, Jr.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Scott Morrison</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 27, 2024</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Scott Morrison</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Michel Vounatsos</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 27, 2024</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Michel Vounatsos</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Peter Wirth</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 27, 2024</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Peter Wirth</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-100-</span></div></div></div><div id="i8a977bbf870448998f9d0f718b7b41b9_124"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Zai Lab Limited</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Index to Consolidated Financial Statements</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:90.869%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.931%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i8a977bbf870448998f9d0f718b7b41b9_127">Reports of Independent Registered Public Accounting Firms (KPMG LLP, Short Hills, NJ, Auditor Firm ID:</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><ix:nonNumeric contextRef="c-1" name="dei:AuditorFirmId" id="f-50">185</ix:nonNumeric></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i8a977bbf870448998f9d0f718b7b41b9_127">; Deloitte Touche Tohmatsu Certified Public Accountants LLP, Shanghai, the People</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i8a977bbf870448998f9d0f718b7b41b9_139">&#8217;</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i8a977bbf870448998f9d0f718b7b41b9_127">s Republic of China, Auditor Firm ID: </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-11" name="dei:AuditorFirmId" id="f-51">1113</ix:nonNumeric></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i8a977bbf870448998f9d0f718b7b41b9_127">)</a></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i8a977bbf870448998f9d0f718b7b41b9_127"> </a></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">F-<a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i8a977bbf870448998f9d0f718b7b41b9_127">2</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i8a977bbf870448998f9d0f718b7b41b9_130">Consolidated Balance Sheets as of December 31, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i8a977bbf870448998f9d0f718b7b41b9_130">3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i8a977bbf870448998f9d0f718b7b41b9_130"> and 20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i8a977bbf870448998f9d0f718b7b41b9_130">22</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">F-<a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i8a977bbf870448998f9d0f718b7b41b9_130">6</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i8a977bbf870448998f9d0f718b7b41b9_133">Consolidated Statements of Operations for the Years Ended December 31, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i8a977bbf870448998f9d0f718b7b41b9_133">3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i8a977bbf870448998f9d0f718b7b41b9_133">, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i8a977bbf870448998f9d0f718b7b41b9_133">2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i8a977bbf870448998f9d0f718b7b41b9_133">, and 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i8a977bbf870448998f9d0f718b7b41b9_133">1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">F-<a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i8a977bbf870448998f9d0f718b7b41b9_133">7</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i8a977bbf870448998f9d0f718b7b41b9_136">Consolidated Statements of Comprehensive Loss for the Years Ended December 31, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i8a977bbf870448998f9d0f718b7b41b9_136">3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i8a977bbf870448998f9d0f718b7b41b9_136">, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i8a977bbf870448998f9d0f718b7b41b9_136">2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i8a977bbf870448998f9d0f718b7b41b9_136">, and 20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i8a977bbf870448998f9d0f718b7b41b9_136">21</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">F-<a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i8a977bbf870448998f9d0f718b7b41b9_136">8</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i8a977bbf870448998f9d0f718b7b41b9_139">Consolidated Statements of Shareholders&#8217; Equity for the Years Ended December 31, 2023, 2022, and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">F-<a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i8a977bbf870448998f9d0f718b7b41b9_139">9</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i8a977bbf870448998f9d0f718b7b41b9_142">Consolidated Statements of Cash Flows for the Years Ended December 31, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i8a977bbf870448998f9d0f718b7b41b9_142">3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i8a977bbf870448998f9d0f718b7b41b9_142">, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i8a977bbf870448998f9d0f718b7b41b9_142">2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i8a977bbf870448998f9d0f718b7b41b9_142">, and 20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i8a977bbf870448998f9d0f718b7b41b9_142">21</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">F-<a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i8a977bbf870448998f9d0f718b7b41b9_142">10</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i8a977bbf870448998f9d0f718b7b41b9_145">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">F-<a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i8a977bbf870448998f9d0f718b7b41b9_145">11</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i8a977bbf870448998f9d0f718b7b41b9_220">Schedule I &#8212; Condensed Financial Information of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i8a977bbf870448998f9d0f718b7b41b9_220">Registrant</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">F-<a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i8a977bbf870448998f9d0f718b7b41b9_220">39</a></span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">F-1</span></div></div></div><div id="i8a977bbf870448998f9d0f718b7b41b9_127"></div><hr style="page-break-after:always"/><div style="min-height:57.6pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Report of Independent Registered Public Accounting Firm </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">To the Shareholders and Board of Directors of Zai Lab Limited</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Opinion on the Consolidated Financial Statements</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We have audited the accompanying consolidated balance sheets of Zai Lab Limited and subsidiaries (the Company) as of December 31, 2023 and 2022, the related consolidated statements of operations, comprehensive loss, shareholders&#8217; equity, and cash flows for each of the years in the two-year period ended December 31, 2023, and the related notes and financial statement Schedule I - Condensed Financial Information of Registrant (collectively, the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2023 and 2022, and the results of its operations and its cash flows for each of the years in the two-year period ended December 31, 2023, in conformity with U.S. generally accepted accounting principles.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We also have audited the adjustments to the 2021 consolidated financial statements to retrospectively apply the share subdivision, as described in Note 2(a). In our opinion, such adjustments are appropriate and have been properly applied. We were not engaged to audit, review, or apply any procedures to the 2021 consolidated financial statements of the Company other than with respect to the adjustments and, accordingly, we do not express an opinion or any other form of assurance on the 2021 consolidated financial statements taken as a whole.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company&#8217;s internal control over financial reporting as of December 31, 2023, based on criteria established in Internal Control &#8211; Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission, and our report dated February&#160;27, 2024 expressed an unqualified opinion on the effectiveness of the Company&#8217;s internal control over financial reporting.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Basis for Opinion</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">These consolidated financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Critical Audit Matter</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of a critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.</span></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">F-2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:57.6pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Evaluation of accrued preclinical and clinical trial expenses</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">As discussed in Note 2 to the consolidated financial statements, the Company&#8217;s research and development expenses include costs associated with payments to contract research organizations (CROs) and contract manufacturing organizations (CMOs) for various preclinical and clinical trial activities.  Expenses related to preclinical and clinical trial activities are accrued based on the Company&#8217;s estimates of the actual services performed by the CROs and CMOs. As disclosed in the consolidated financial statements, as of December&#160;31, 2023, the Company recorded $113.0 million in accounts payable which included the accrued preclinical and clinical trial expenses. </span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We identified the evaluation of accrued preclinical and clinical trial expenses as a critical audit matter. Specifically, evaluating the estimate of services performed for certain research and development activities at year-end required subjective auditor judgment.</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following are the primary procedures we performed to address this critical audit matter. We evaluated the design and tested the operating effectiveness of certain internal controls related to accrued preclinical and clinical trial expenses. This included controls related to the estimation of the services performed by the CROs and CMOs during the period that are included in accounts payable at the end of each reporting period. On a sample basis, we examined contracts, purchase orders, invoices, and third-party confirmations and compared them to the Company&#8217;s estimation of services performed by the CROs and CMOs. We also examined certain invoices received and/or payments made after year-end and evaluated whether they were associated with services received prior to that date and whether they were included in the Company&#8217;s estimate of costs incurred at year-end.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">/s/ <ix:nonNumeric contextRef="c-1" name="dei:AuditorName" id="f-52">KPMG LLP</ix:nonNumeric></span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We have served as the Company&#8217;s auditor since 2022.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"><ix:nonNumeric contextRef="c-1" name="dei:AuditorLocation" id="f-53">Short Hills, New Jersey</ix:nonNumeric> </span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">February&#160;27, 2024</span></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">F-3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:57.6pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%">To the Shareholders and Board of Directors of Zai Lab Limited</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:130%">Opinion on Internal Control Over Financial Reporting</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%">We have audited Zai Lab Limited and subsidiaries&#8217; (the Company) internal control over financial reporting as of December 31, 2023, based on criteria established in Internal Control &#8211; Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2023, based on criteria established in Internal Control &#8211; Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company as of December 31, 2023 and 2022, the related consolidated statements of operations, comprehensive loss, shareholders&#8217; equity, and cash flows for each of the years in the two-year period ended December 31, 2023, and the related notes and financial statement Schedule I - Condensed Financial Information of Registrant (collectively, the consolidated financial statements), and our report dated February&#160;27, 2024 expressed an unqualified opinion on those consolidated financial statements.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:130%">Basis for Opinion</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:130%">Management's Report on Internal Control over Financial Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%">. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:130%">Definition and Limitations of Internal Control Over Financial Reporting</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%">/s/ KPMG LLP</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short Hills, New Jersey </span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;27, 2024</span></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">F-4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:57.6pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Report of Independent Registered Public Accounting Firm</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">To the Shareholders and Board of Directors of Zai Lab Limited </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Opinion on the Financial Statements </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We have audited, the accompanying consolidated statements of operations, comprehensive loss, changes in shareholders&#8217; equity and cash flows of Zai Lab Limited and its subsidiaries (collectively referred to as the &#8220;Company&#8221;), for the year ended December 31, 2021, the related notes and schedule listed in the Schedule I (collectively referred to as the &#8220;financial statements&#8221;), before the effects of the retrospective adjustments for share subdivision as discussed in Note 2(a) (the &#8220;retrospective adjustments&#8221;).  The previously issued financial statements, before the effects of the retrospective adjustments, are not presented herein. In our opinion, the financial statements present fairly, in all material respects, the results of operations and cash flows of the Company for the year ended December 31, 2021, in conformity with accounting principles generally accepted in the United States of America.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We were not engaged to audit the retrospective adjustments, and accordingly, we do not express an opinion or any other form of assurance about whether such retrospective adjustments are appropriate and have been properly applied. Those retrospective adjustments were audited by other auditors.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Basis for Opinion </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">These financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">/s/ <ix:nonNumeric contextRef="c-11" name="dei:AuditorName" id="f-54">Deloitte Touche Tohmatsu Certified Public Accountants LLP</ix:nonNumeric> </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"><ix:nonNumeric contextRef="c-11" name="dei:AuditorLocation" id="f-55">Shanghai, the People&#8217;s Republic of  China</ix:nonNumeric> </span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">March 1, 2022</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We have served as the Company&#8217;s auditor since 2017. In 2022, we became the predecessor auditor.</span></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">F-5</span></div></div></div><div id="i8a977bbf870448998f9d0f718b7b41b9_130"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Zai Lab Limited </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Balance Sheets </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands of U.S. dollars (&#8220;$&#8221;), except for number of shares and per share data) </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.508%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.881%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.005%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Notes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-56">790,151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-57">1,008,470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Short-term investments</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-58">16,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:fixed-zero" scale="3" id="f-59">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Accounts receivable (net of allowance for credit loss of $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="f-60">17</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="f-61">11</ix:nonFraction> as of December&#160;31, 2023 and 2022, respectively)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-62">59,199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-63">39,963</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Notes receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLossCurrent" format="ixt:num-dot-decimal" scale="3" id="f-64">6,134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLossCurrent" format="ixt:num-dot-decimal" scale="3" id="f-65">8,608</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Inventories, net</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="f-66">44,827</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="f-67">31,621</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Prepayments and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-68">22,995</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-69">35,674</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-70">939,606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-71">1,124,336</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Restricted cash, non-current</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-72">1,113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" scale="3" id="f-73">803</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Long-term investments </span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:LongTermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-74">9,220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:LongTermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-75">6,431</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Prepayments for equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="zlab:PrepaymentsForEquipment" scale="3" id="f-76">111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="zlab:PrepaymentsForEquipment" format="ixt:num-dot-decimal" scale="3" id="f-77">1,396</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Property and equipment, net</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-78">53,734</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-79">57,863</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-80">14,844</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-81">19,512</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Land use rights, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="zlab:LandUseRightsNetNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-82">3,069</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="zlab:LandUseRightsNetNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-83">6,892</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Intangible assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-84">13,389</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-85">1,511</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Long-term deposits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:DepositsAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-86">1,209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:DepositsAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-87">1,396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-88">1,036,295</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-89">1,220,140</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Liabilities and shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-90">112,991</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-91">65,974</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Current operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-92">7,104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-93">7,050</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">12</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-94">82,972</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-95">66,818</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-96">203,067</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-97">139,842</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Deferred income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:DeferredIncomeNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-98">28,738</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:DeferredIncomeNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-99">21,360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Non-current operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-100">8,047</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-101">13,343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Other non-current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="f-102">325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:fixed-zero" scale="3" id="f-103">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-104">240,177</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-105">174,545</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Commitments and contingencies (Note 20)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-12" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-106"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-13" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-107"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Ordinary shares (par value of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-13" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-108"><ix:nonFraction unitRef="usdPerShare" contextRef="c-12" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-109">0.000006</ix:nonFraction></ix:nonFraction> per share; <ix:nonFraction unitRef="shares" contextRef="c-13" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-110"><ix:nonFraction unitRef="shares" contextRef="c-12" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-111">5,000,000,000</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction unitRef="shares" contextRef="c-12" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-112">977,151,270</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-13" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-113">962,455,850</ix:nonFraction> shares issued as of December&#160;31, 2023 and 2022, respectively; <ix:nonFraction unitRef="shares" contextRef="c-12" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-114">972,239,070</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-13" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-115">960,219,570</ix:nonFraction> shares issued and outstanding as of December&#160;31, 2023 and 2022, respectively)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-116">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-117">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Additional paid-in capital</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-118">2,975,302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-119">2,893,120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Accumulated deficit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-120">2,195,980</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-121">1,861,360</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Accumulated other comprehensive income </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-122">37,626</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-123">25,685</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Treasury stock (at cost, <ix:nonFraction unitRef="shares" contextRef="c-12" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-124">4,912,200</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-13" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-125">2,236,280</ix:nonFraction> shares as of December&#160;31, 2023 and 2022,  respectively)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:TreasuryStockCommonValue" format="ixt:num-dot-decimal" scale="3" id="f-126">20,836</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:TreasuryStockCommonValue" format="ixt:num-dot-decimal" scale="3" id="f-127">11,856</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-128">796,118</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-129">1,045,595</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total liabilities and shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-130">1,036,295</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-131">1,220,140</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">F-6</span></div></div></div><div id="i8a977bbf870448998f9d0f718b7b41b9_133"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Zai Lab Limited</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Operations</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands of $, except for number of shares and per share data)</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.506%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.930%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Notes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product revenue, net</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-132">266,719</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-133">212,672</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-134">144,105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Collaboration revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" format="ixt:fixed-zero" scale="3" id="f-135">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" format="ixt:num-dot-decimal" scale="3" id="f-136">2,368</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" scale="3" id="f-137">207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 46pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-138">266,719</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-139">215,040</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-140">144,312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="f-141">95,816</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="f-142">74,018</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="f-143">52,239</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-144">265,868</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-145">286,408</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-146">573,306</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-147">281,608</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-148">258,971</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-149">218,831</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gain on sale of intellectual property</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GainLossOnDispositionOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="f-150">10,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:GainLossOnDispositionOfIntangibleAssets" format="ixt:fixed-zero" scale="3" id="f-151">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:GainLossOnDispositionOfIntangibleAssets" format="ixt:fixed-zero" scale="3" id="f-152">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss from operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-153">366,573</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-154">404,357</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-155">700,064</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InvestmentIncomeInterest" format="ixt:num-dot-decimal" scale="3" id="f-156">39,797</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:InvestmentIncomeInterest" format="ixt:num-dot-decimal" scale="3" id="f-157">14,582</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:InvestmentIncomeInterest" format="ixt:num-dot-decimal" scale="3" id="f-158">2,190</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency (loss) gain</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="f-159">14,850</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="f-160">56,403</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="f-161">4,661</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense), net</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-162">7,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-163">3,113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-164">10,201</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss before income tax and share of loss from equity method investment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-165">334,620</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-166">443,065</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-167">703,414</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="f-168">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="f-169">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="f-170">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share of loss from equity method investment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:fixed-zero" scale="3" id="f-171">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="f-172">221</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-173">1,057</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-174">334,620</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-175">443,286</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-176">704,471</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss per share &#8212; basic and diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-177"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-178">0.35</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-14" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-179"><ix:nonFraction unitRef="usdPerShare" contextRef="c-14" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-180">0.46</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-11" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-181"><ix:nonFraction unitRef="usdPerShare" contextRef="c-11" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-182">0.76</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average shares used in calculating net loss per ordinary share &#8212; basic and diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-183"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-184">966,394,130</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-14" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-185"><ix:nonFraction unitRef="shares" contextRef="c-14" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-186">958,067,140</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-11" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-187"><ix:nonFraction unitRef="shares" contextRef="c-11" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-188">929,921,120</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note: All the numbers of ordinary shares and per share data in these consolidated financial statements have been retrospectively adjusted, where applicable, as a result of the Share Subdivision that became effective on March 30, 2022. Refer to Note 2(a) for additional information. </span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">F-7</span></div></div></div><div id="i8a977bbf870448998f9d0f718b7b41b9_136"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Zai Lab Limited </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Comprehensive Loss </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands of $) </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-189">334,620</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-190">443,286</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-191">704,471</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive income (loss), net of tax of <ix:nonFraction unitRef="usd" contextRef="c-14" decimals="INF" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" format="ixt:fixed-zero" scale="3" id="f-192"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="INF" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" format="ixt:fixed-zero" scale="3" id="f-193"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="INF" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" format="ixt:fixed-zero" scale="3" id="f-194">nil</ix:nonFraction></ix:nonFraction></ix:nonFraction>:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="f-195">11,941</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="f-196">49,330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="f-197">9,121</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-198">322,679</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-199">393,956</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-200">713,592</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="margin-top:10pt;text-align:center"><span><br/></span></div><div style="margin-top:10pt;text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">F-8</span></div></div></div><div id="i8a977bbf870448998f9d0f718b7b41b9_139"></div><hr style="page-break-after:always"/><div style="min-height:44.64pt;width:100%"><div style="text-indent:27pt"><span><br/></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Zai Lab Limited </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Shareholders&#8217; Equity </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands of $, except for number of shares)</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.934%"><tr><td style="width:1.0%"/><td style="width:31.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.934%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.234%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.934%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.234%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.934%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.234%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.934%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.234%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.477%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.234%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.934%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.234%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.934%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.234%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.943%"/><td style="width:0.1%"/></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Ordinary shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Additional<br/>paid<br/>in capital</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accumulated<br/>deficit </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accumulated<br/>other<br/>comprehensive<br/>income (loss) </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Treasury Stock </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of<br/>Shares </span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total </span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Balance at January 1, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-15" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-201">878,110,260</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-202">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-203">1,897,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-204">713,603</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-205">14,524</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-206">1,169,345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Issuance of ordinary shares upon vesting of restricted shares</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-20" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="0" id="f-207">2,054,500</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="f-208">0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="f-209">0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" format="ixt:fixed-zero" scale="3" id="f-210">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Exercise of share options</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-20" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-211">12,353,400</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-212">0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="f-213">7,417</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="f-214">7,417</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Issuance of ordinary shares upon follow-on public offering, net of issuance cost of $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="f-215">839</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-20" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-216">57,164,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-217">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-218">818,035</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-219">818,036</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Issuance of ordinary shares in connection with collaboration and license arrangement (Note 16)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-20" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesOther" format="ixt:num-dot-decimal" scale="0" id="f-220">5,681,820</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="3" id="f-221">0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueOther" format="ixt:num-dot-decimal" scale="3" id="f-222">62,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueOther" format="ixt:num-dot-decimal" scale="3" id="f-223">62,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Issuance cost adjustment for secondary listing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="zlab:IssuanceCostAdjustment" scale="3" id="f-224">65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="zlab:IssuanceCostAdjustment" scale="3" id="f-225">65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Receipt of shares netted to satisfy tax withholding obligations related to share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="c-22" decimals="INF" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-226">382,930</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-227">4,279</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-228">4,279</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-229">40,714</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-230">40,714</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-231">704,471</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-232">704,471</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="f-233">9,121</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="f-234">9,121</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Balance at December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-25" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-235">955,363,980</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-236">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-237">2,825,948</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-238">1,418,074</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-239">23,645</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="c-29" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-240">382,930</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-241">4,279</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-242">1,379,956</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Issuance of ordinary shares upon vesting of restricted shares</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-31" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="0" id="f-243">1,940,680</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="f-244">0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="f-245">0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" format="ixt:fixed-zero" scale="3" id="f-246">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Exercise of share options</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-31" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-247">5,151,190</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-248">0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="f-249">5,870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="f-250">5,870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Receipt of shares netted to satisfy tax withholding obligations related to share-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="c-33" decimals="INF" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-251">1,853,350</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-252">7,577</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-253">7,577</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Share-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-254">61,302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-255">61,302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-256">443,286</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-257">443,286</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Foreign currency translation</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="f-258">49,330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="f-259">49,330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Balance at December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-36" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-260">962,455,850</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-261">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-262">2,893,120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-263">1,861,360</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-264">25,685</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="c-40" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-265">2,236,280</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-266">11,856</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-267">1,045,595</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Issuance of ordinary shares upon vesting of restricted shares</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-41" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="0" id="f-268">8,178,500</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="f-269">0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="f-270">0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" format="ixt:fixed-zero" scale="3" id="f-271">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Exercise of share options</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-41" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-272">6,516,920</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-273">0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="f-274">2,548</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="f-275">2,548</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Receipt of shares netted to satisfy tax withholding obligations related to share-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="c-43" decimals="INF" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-276">2,675,920</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-277">8,980</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-278">8,980</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Share-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-279">79,634</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-280">79,634</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-281">334,620</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-282">334,620</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Foreign currency translation</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="f-283">11,941</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="f-284">11,941</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Balance at December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-46" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-285">977,151,270</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-286">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-287">2,975,302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-288">2,195,980</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-289">37,626</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="c-50" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-290">4,912,200</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-291">20,836</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-292">796,118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements. &#8220;0&#8221; in above table means less than 1,000 dollars. </span></div><div style="height:44.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">F-9</span></div></div></div><div id="i8a977bbf870448998f9d0f718b7b41b9_142"></div><hr style="page-break-after:always"/><div style="min-height:0.72pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Zai Lab Limited </span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Cash Flows </span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands of $) </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cash flows from operating activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-293">334,620</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-294">443,286</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-295">704,471</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Allowance for credit loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="f-296">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="f-297">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="f-298">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Inventory write-down</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InventoryWriteDown" scale="3" id="f-299">973</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:InventoryWriteDown" scale="3" id="f-300">477</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:InventoryWriteDown" format="ixt:num-dot-decimal" scale="3" id="f-301">1,368</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Depreciation and amortization expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-302">9,029</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-303">8,227</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-304">6,487</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Impairment of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:TangibleAssetImpairmentCharges" scale="3" id="f-305">57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:TangibleAssetImpairmentCharges" format="ixt:fixed-zero" scale="3" id="f-306">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:TangibleAssetImpairmentCharges" format="ixt:fixed-zero" scale="3" id="f-307">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Amortization of deferred income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="zlab:AmortizationOfDeferredIncome" format="ixt:num-dot-decimal" scale="3" id="f-308">3,383</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="zlab:AmortizationOfDeferredIncome" format="ixt:num-dot-decimal" scale="3" id="f-309">2,602</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" sign="-" name="zlab:AmortizationOfDeferredIncome" scale="3" id="f-310">521</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-311">79,634</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-312">61,302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-313">40,714</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Noncash research and development expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="zlab:NoncashResearchAndDevelopmentExpenses" format="ixt:fixed-zero" scale="3" id="f-314">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="zlab:NoncashResearchAndDevelopmentExpenses" format="ixt:fixed-zero" scale="3" id="f-315">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="zlab:NoncashResearchAndDevelopmentExpenses" format="ixt:num-dot-decimal" scale="3" id="f-316">62,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Share of loss from equity method investment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:fixed-zero" scale="3" id="f-317">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="f-318">221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-319">1,057</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Gain) loss from fair value changes of equity investment with readily determinable fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:EquitySecuritiesFvNiGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-320">2,789</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:EquitySecuritiesFvNiGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-321">8,952</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" sign="-" name="us-gaap:EquitySecuritiesFvNiGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-322">14,617</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Loss on disposal of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="f-323">159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="f-324">560</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="f-325">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Gain on disposal of land use right</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="zlab:GainLossOnDisposalOfLandUseRights" scale="3" id="f-326">408</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="zlab:GainLossOnDisposalOfLandUseRights" format="ixt:fixed-zero" scale="3" id="f-327">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="zlab:GainLossOnDisposalOfLandUseRights" format="ixt:fixed-zero" scale="3" id="f-328">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Noncash lease expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="zlab:NonCashLeaseExpenses" format="ixt:num-dot-decimal" scale="3" id="f-329">8,708</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="zlab:NonCashLeaseExpenses" format="ixt:num-dot-decimal" scale="3" id="f-330">8,350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="zlab:NonCashLeaseExpenses" format="ixt:num-dot-decimal" scale="3" id="f-331">6,119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Gain from sale of intellectual property</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GainLossOnDispositionOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="f-332">10,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:GainLossOnDispositionOfIntangibleAssets" format="ixt:fixed-zero" scale="3" id="f-333">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:GainLossOnDispositionOfIntangibleAssets" format="ixt:fixed-zero" scale="3" id="f-334">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Foreign currency remeasurement loss (gain)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" format="ixt:num-dot-decimal" scale="3" id="f-335">14,850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" format="ixt:num-dot-decimal" scale="3" id="f-336">56,403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" format="ixt:num-dot-decimal" scale="3" id="f-337">10,679</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 46pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-338">20,040</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-339">4,330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-340">42,319</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 46pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Notes receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInNotesReceivableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-341">2,352</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:IncreaseDecreaseInNotesReceivableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-342">1,976</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:IncreaseDecreaseInNotesReceivableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-343">7,335</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 46pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="f-344">14,907</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="f-345">15,382</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="f-346">7,174</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 46pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Prepayments and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="f-347">12,246</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="f-348">19,258</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="f-349">7,086</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 46pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Long-term deposits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="zlab:IncreaseDecreaseInLongTermDeposits" scale="3" id="f-350">187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="zlab:IncreaseDecreaseInLongTermDeposits" scale="3" id="f-351">527</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="zlab:IncreaseDecreaseInLongTermDeposits" scale="3" id="f-352">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 46pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Value added tax recoverable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="zlab:IncreaseDecreaseInValueAddedTaxesReceivable" format="ixt:fixed-zero" scale="3" id="f-353">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="zlab:IncreaseDecreaseInValueAddedTaxesReceivable" format="ixt:num-dot-decimal" scale="3" id="f-354">22,781</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="zlab:IncreaseDecreaseInValueAddedTaxesReceivable" format="ixt:num-dot-decimal" scale="3" id="f-355">1,717</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 46pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="f-356">36,803</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="f-357">53,773</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="f-358">63,522</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 46pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-359">19,810</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-360">7,392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-361">30,142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 46pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="zlab:IncreaseDecreaseInOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-362">8,351</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="zlab:IncreaseDecreaseInOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-363">8,455</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" sign="-" name="zlab:IncreaseDecreaseInOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-364">5,385</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 46pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Deferred income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="f-365">11,181</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="f-366">1,379</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:IncreaseDecreaseInDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="f-367">11,149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 46pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Other non-current Liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" scale="3" id="f-368">325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" format="ixt:fixed-zero" scale="3" id="f-369">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" format="ixt:fixed-zero" scale="3" id="f-370">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net cash used in operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-371">198,178</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-372">367,642</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-373">549,231</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cash flows from investing activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Purchase of short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquireShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-374">134,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:PaymentsToAcquireShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-375">260,274</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:PaymentsToAcquireShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-376">445,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Proceeds from maturity of short-term investment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-377">117,700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-378">705,274</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-379">743,902</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Purchase of investment in equity investee</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:fixed-zero" scale="3" id="f-380">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:fixed-zero" scale="3" id="f-381">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-382">30,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Purchase of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-383">7,212</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-384">24,585</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-385">18,295</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Proceeds from the sale of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" id="f-386">122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="3" id="f-387">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" id="f-388">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Acquisition of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquireIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="f-389">1,279</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="3" id="f-390">399</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="3" id="f-391">653</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Proceeds from sale of intellectual property</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromSaleOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="f-392">10,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:ProceedsFromSaleOfIntangibleAssets" format="ixt:fixed-zero" scale="3" id="f-393">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:ProceedsFromSaleOfIntangibleAssets" format="ixt:fixed-zero" scale="3" id="f-394">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Proceeds from disposal of land use right</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="zlab:ProceedsFromDisposalOfLandUseRights" format="ixt:num-dot-decimal" scale="3" id="f-395">3,893</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="zlab:ProceedsFromDisposalOfLandUseRights" format="ixt:fixed-zero" scale="3" id="f-396">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="zlab:ProceedsFromDisposalOfLandUseRights" format="ixt:fixed-zero" scale="3" id="f-397">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net cash (used in) provided by investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-398">10,776</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-399">420,016</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-400">249,957</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cash flows from financing activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Proceeds from exercises of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="f-401">2,369</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="f-402">5,870</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="f-403">7,417</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Proceeds from issuance of ordinary shares upon public offerings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" format="ixt:fixed-zero" scale="3" id="f-404">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" format="ixt:fixed-zero" scale="3" id="f-405">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" format="ixt:num-dot-decimal" scale="3" id="f-406">818,875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Payment of public offering costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" format="ixt:fixed-zero" scale="3" id="f-407">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" format="ixt:fixed-zero" scale="3" id="f-408">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="f-409">1,837</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Taxes paid related to settlement of equity awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-410">8,802</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-411">7,600</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-412">4,253</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net cash (used in) provided by financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-413">6,433</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-414">1,730</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-415">820,202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="f-416">2,622</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="f-417">6,274</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="f-418">1,116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net (decrease) increase in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-419">218,009</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-420">44,370</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-421">522,044</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Cash, cash equivalents and restricted cash &#8212; beginning of the year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="f-422">1,009,273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="f-423">964,903</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="f-424">442,859</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Cash, cash equivalents and restricted cash &#8212; end of the year</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="f-425">791,264</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="f-426">1,009,273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="f-427">964,903</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Supplemental disclosure on non-cash investing and financing activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Payables for purchase of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" format="ixt:num-dot-decimal" scale="3" id="f-428">2,474</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" format="ixt:num-dot-decimal" scale="3" id="f-429">5,269</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" format="ixt:num-dot-decimal" scale="3" id="f-430">2,568</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Payables for acquisition of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="zlab:NonCashPayablesForIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="f-431">11,516</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="zlab:NonCashPayablesForIntangibleAssets" scale="3" id="f-432">163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="zlab:NonCashPayablesForIntangibleAssets" scale="3" id="f-433">191</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Payables for treasury stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="zlab:NonCashPayablesForTreasuryStock" format="ixt:fixed-zero" scale="3" id="f-434">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="zlab:NonCashPayablesForTreasuryStock" scale="3" id="f-435">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="zlab:NonCashPayablesForTreasuryStock" scale="3" id="f-436">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Right-of-use asset acquired under operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-437">3,668</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-438">14,801</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-439">2,183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Receivables for disposal of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="zlab:ReceivableRecognizedForDisposalOfPropertyAndEquipment" format="ixt:fixed-zero" scale="3" id="f-440">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="zlab:ReceivableRecognizedForDisposalOfPropertyAndEquipment" scale="3" id="f-441">64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="zlab:ReceivableRecognizedForDisposalOfPropertyAndEquipment" format="ixt:fixed-zero" scale="3" id="f-442">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Supplemental disclosure of cash flow information</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-443">790,151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-444">1,008,470</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-445">964,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Restricted cash, non-current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-446">1,113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" scale="3" id="f-447">803</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" scale="3" id="f-448">803</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total cash and cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="f-449">791,264</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="f-450">1,009,273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="f-451">964,903</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:4.14pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">F-10</span></div></div></div><div id="i8a977bbf870448998f9d0f718b7b41b9_145"></div><hr style="page-break-after:always"/><div style="min-height:108pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Zai Lab Limited</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to the Consolidated Financial Statements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Years Ended December&#160;31, 2023, 2022, and 2021</span></div></div><div><span><br/></span></div><div id="i8a977bbf870448998f9d0f718b7b41b9_148"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">1.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="f-452" continuedAt="f-452-1" escape="true">Organization and Principal Activities </ix:nonNumeric></span></div><ix:continuation id="f-452-1"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Zai Lab Limited was incorporated on March 28, 2013 in the Cayman Islands as an exempted company with limited liability under the Companies Act of the Cayman Islands (as amended). Zai Lab Limited and its subsidiaries (collectively referred to as the &#8220;Company&#8221;) are focused on discovering, developing, and commercializing products that address medical conditions with significant unmet needs in the areas of oncology, autoimmune disorders, infectious disease, and neuroscience.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company&#8217;s principal operations and geographic markets are in Greater China. The Company has a substantial presence in Greater China and the United States. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock" id="f-453" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">As of December&#160;31, 2023, the Company&#8217;s significant operating subsidiaries were as follows: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.596%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.237%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name of Company</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Place of<br/>Incorporation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Date of<br/>Incorporation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Percentage of<br/>Ownership</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Principal Activities</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Zai Lab (Hong Kong) Limited</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hong Kong</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April 29, 2013</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-51" decimals="2" name="us-gaap:SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest" scale="-2" id="f-454">100</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating company for business development and R&amp;D activities and commercialization of innovative medicines and device</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Zai Lab (Shanghai) Co., Ltd.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mainland<br/>China</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">January 6, 2014</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-52" decimals="2" name="us-gaap:SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest" scale="-2" id="f-455">100</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Development and commercialization of innovative medicines and devices</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Zai Lab (AUST) Pty. Ltd.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Australia</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 10, 2014</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-53" decimals="2" name="us-gaap:SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest" scale="-2" id="f-456">100</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical trial activities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Zai Lab (Suzhou) Co., Ltd.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mainland<br/>China</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">November 30, 2015</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-54" decimals="2" name="us-gaap:SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest" scale="-2" id="f-457">100</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Development and commercialization of innovative medicines</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Zai Biopharmaceutical (Suzhou) Co., Ltd.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mainland<br/>China</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June 15, 2017</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-55" decimals="2" name="us-gaap:SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest" scale="-2" id="f-458">100</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Development and commercialization of innovative medicines</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Zai Lab (US) LLC</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">United<br/>States</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April 21, 2017</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-56" decimals="2" name="us-gaap:SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest" scale="-2" id="f-459">100</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating company for business development, R&amp;D activities and certain business activities, including legal, compliance and communication functions of the Company</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Zai Lab International Trading (Shanghai) Co., Ltd.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mainland<br/>China</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">November 6, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-57" decimals="2" name="us-gaap:SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest" scale="-2" id="f-460">100</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercialization of innovative medicines and devices</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Zai Auto Immune (Hong Kong) Limited</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hong Kong</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">November 4, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-58" decimals="2" name="us-gaap:SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest" scale="-2" id="f-461">100</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating company for business development and R&amp;D activities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Zai Lab (Taiwan) Limited</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Taiwan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 10, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-59" decimals="2" name="us-gaap:SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest" scale="-2" id="f-462">100</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercialization of innovative medicines and devices</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Zai Lab Trading (Suzhou) Co., Ltd.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mainland<br/>China</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">October 27, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-60" decimals="2" name="us-gaap:SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest" scale="-2" id="f-463">100</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercialization of innovative medicines and devices</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">F-11</span></div></div></div><div id="i8a977bbf870448998f9d0f718b7b41b9_151"></div><hr style="page-break-after:always"/><div style="min-height:108pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Zai Lab Limited</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to the Consolidated Financial Statements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Years Ended December&#160;31, 2023, 2022, and 2021</span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">2.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="f-464" continuedAt="f-464-1" escape="true">Summary of Significant Accounting Policies </ix:nonNumeric></span></div><ix:continuation id="f-464-1" continuedAt="f-464-2"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(a) <ix:nonNumeric contextRef="c-1" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="f-465" continuedAt="f-465-1" escape="true">Basis of Presentation </ix:nonNumeric></span></div><ix:continuation id="f-465-1"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#8220;U.S. GAAP&#8221;). Significant accounting policies followed by the Company in the preparation of the accompanying consolidated financial statements are summarized below. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Effective as of March 30, 2022, the Company subdivided each of its issued and unissued ordinary shares into <ix:nonFraction unitRef="number" contextRef="c-61" decimals="INF" name="us-gaap:StockholdersEquityNoteStockSplitConversionRatio1" format="ixt-sec:numwordsen" scale="0" id="f-466">ten</ix:nonFraction> ordinary shares (the &#8220;Share Subdivision&#8221;). Following the Share Subdivision, the Company&#8217;s authorized share capital became $<ix:nonFraction unitRef="usd" contextRef="c-62" decimals="INF" name="zlab:CommonStockAuthorizedShareCapital" format="ixt:num-dot-decimal" scale="0" id="f-467">30,000</ix:nonFraction> divided into <ix:nonFraction unitRef="shares" contextRef="c-62" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-468">5,000,000,000</ix:nonFraction> shares with a par value of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-62" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-469">0.000006</ix:nonFraction> per share. The numbers of issued and unissued ordinary shares and per share data as disclosed elsewhere in these consolidated financial statements and notes thereto are presented on a basis after taking into account the effects of the Share Subdivision and have been retrospectively adjusted, where applicable. In connection with the Share Subdivision, the conversion ratio of its ADSs to ordinary shares changed from one ADS to <ix:nonFraction unitRef="number" contextRef="c-63" decimals="INF" name="zlab:AmericanDepositaryShareToCommonStockConversionRatio" format="ixt-sec:numwordsen" scale="0" id="f-470">one</ix:nonFraction> ordinary share to a new ratio of one ADS to <ix:nonFraction unitRef="number" contextRef="c-61" decimals="INF" name="zlab:AmericanDepositaryShareToCommonStockConversionRatio" format="ixt-sec:numwordsen" scale="0" id="f-471">ten</ix:nonFraction> ordinary shares (the &#8220;ADS Ratio Change&#8221;). The Share Subdivision and ADS Ratio Change did not result in any change to the number of outstanding ADSs of the Company. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> In 2022, the Company began to separately present foreign currency (loss) gain on the consolidated statements of operations. This amount was previously included in other income (expense), net. Additionally, the Company began to provide a breakdown of other income (expense), net in Note 17.  The Company also began to separately present the amount of foreign currency remeasurement loss (gain) on the consolidated statements of cash flows. This amount was previously included in changes in other current liabilities. This change did not have any impact on net cash used in operating activities. Corresponding amounts in the prior periods of the consolidated financial statements have been presented to conform to the current period presentation.</span></div></ix:continuation><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(b) <ix:nonNumeric contextRef="c-1" name="us-gaap:ConsolidationPolicyTextBlock" id="f-472" continuedAt="f-472-1" escape="true">Principles of Consolidation</ix:nonNumeric></span></div><ix:continuation id="f-472-1"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The consolidated financial statements include the accounts of Zai Lab Limited and its subsidiaries, which are wholly owned. All intercompany transactions and balances are eliminated upon consolidation.</span></div></ix:continuation><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(c) <ix:nonNumeric contextRef="c-1" name="us-gaap:UseOfEstimates" id="f-473" continuedAt="f-473-1" escape="true">Use of Estimates </ix:nonNumeric></span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"><ix:continuation id="f-473-1">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Areas where management uses subjective judgment include, but are not limited to, accrual of rebates, recognition of research and development expenses to the appropriate financial reporting period based on actual services performed, fair value of share-based compensation expenses, and recoverability of deferred tax assets. These estimates, judgments, and assumptions can affect the reported amounts of assets and liabilities as of the date of the financial statements as well as the reported amounts of revenues and expenses during the periods presented. Actual results could differ from these estimates.</ix:continuation> </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(d) <ix:nonNumeric contextRef="c-1" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="f-474" continuedAt="f-474-1" escape="true">Foreign Currency Translation </ix:nonNumeric></span></div><ix:continuation id="f-474-1" continuedAt="f-474-2"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The functional currency of Zai Lab Limited, Zai Lab (Hong Kong) Limited, Zai Lab (US) LLC, and Zai Auto Immune (Hong Kong) Limited are the U.S. dollar (&#8220;$&#8221;). The Company&#8217;s subsidiaries in mainland China determined their functional currency to be the Chinese Renminbi (&#8220;RMB&#8221;). The Company&#8217;s subsidiary in Australia determined its </span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">F-12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:108pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Zai Lab Limited</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to the Consolidated Financial Statements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Years Ended December&#160;31, 2023, 2022, and 2021</span></div></div><ix:continuation id="f-464-2" continuedAt="f-464-3"><ix:continuation id="f-474-2" continuedAt="f-474-3"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">functional currency to be the Australian dollar (&#8220;A$&#8221;). The Company&#8217;s subsidiary in Taiwan determined its functional currency to be the Taiwan dollar (&#8220;TWD&#8221;). The determination of the respective functional currency is based on the criteria of Accounting Standard Codification (&#8220;ASC&#8221;) 830, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Foreign Currency Matters</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">. The Company uses the U.S. dollar as its reporting currency. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Assets and liabilities are translated from each entity&#8217;s functional currency to the reporting currency at the exchange rate on the balance sheet date. Equity amounts are translated at historical exchange rates. Revenues, expenses, gains, and losses are translated using the average rate for the period presented. The resulted foreign currency translation adjustments are recorded as a component of other comprehensive loss in the consolidated statements of comprehensive loss, and the accumulated foreign currency translation adjustments are recorded as a component of accumulated other comprehensive income (loss) in the consolidated statements of shareholders&#8217; equity.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Monetary assets and liabilities denominated in currencies other than the applicable functional currencies are translated into the functional currencies at the prevailing rates of exchange at the balance sheet date.</span></div></ix:continuation><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"><ix:continuation id="f-474-3">Non-monetary assets and liabilities are translated into the applicable functional currencies at historical exchange rates. Transactions in currencies other than the applicable functional currencies during the year are converted into the functional currencies at the applicable rates of exchange prevailing at the transaction dates. Transaction gains and losses are recognized in the consolidated statements of operations.</ix:continuation> </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(e) <ix:nonNumeric contextRef="c-1" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" id="f-475" continuedAt="f-475-1" escape="true">Cash, Cash Equivalents, and Restricted Cash </ix:nonNumeric></span></div><ix:continuation id="f-475-1" continuedAt="f-475-2"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Cash and Cash Equivalents </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company considers all highly liquid investments purchased with original maturities of three months or less to be cash equivalents. Cash and cash equivalents consist primarily of cash on hand, demand deposits, and highly liquid investments with maturity of less than three months and are stated at cost, which approximates fair value. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Restricted Cash </span></div></ix:continuation><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"><ix:continuation id="f-475-2">Restricted cash mainly consists of bank deposits held as collateral for issuances of letters of credit.</ix:continuation> </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(f) <ix:nonNumeric contextRef="c-1" name="zlab:ShortTermInvestmentsPolicyPolicyTextBlock" id="f-476" continuedAt="f-476-1" escape="true">Short-Term Investments </ix:nonNumeric></span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"><ix:continuation id="f-476-1">Short-term investments are time deposits with original maturities between three months and one year. Short-term investments are stated at cost, which approximates fair value. Interest earned is included in interest income.</ix:continuation> </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(g) <ix:nonNumeric contextRef="c-1" name="us-gaap:ReceivablesPolicyTextBlock" id="f-477" continuedAt="f-477-1" escape="true">Accounts Receivable </ix:nonNumeric></span></div><ix:continuation id="f-477-1"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company&#8217;s accounts receivable arise from product sales and represent amounts due from its customers. From January 1, 2020, the Company adopted the ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Credit Losses, Measurement of Credit Losses on Financial Instruments. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Accounts receivable are recorded at the amounts net of allowances for credit losses. The allowance for credit losses reflects the Company&#8217;s current estimate of credit losses expected to be incurred over the life of the receivables. The Company considers various factors in establishing, monitoring, and adjusting its allowance for credit losses including the aging of receivables and aging trends, customer creditworthiness, and specific exposures related to particular customers. The Company also monitors other risk factors and forward-looking information, such as country-specific risks and economic factors that may affect a debtor&#8217;s ability to pay in establishing and adjusting its allowance for credit losses. Accounts receivable are written off when deemed uncollectible.</span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">F-13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:108pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Zai Lab Limited</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to the Consolidated Financial Statements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Years Ended December&#160;31, 2023, 2022, and 2021</span></div></div><ix:continuation id="f-464-3" continuedAt="f-464-4"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(h) <ix:nonNumeric contextRef="c-1" name="zlab:NotesReceivablePolicyTextBlock" id="f-478" continuedAt="f-478-1" escape="true">Notes Receivable </ix:nonNumeric></span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"><ix:continuation id="f-478-1">Notes receivable is equal to contractual amounts owed from signed, secured promissory notes issued from customers to the Company.</ix:continuation> The Company considers the notes receivable to be fully collectible. Accordingly, <ix:nonFraction unitRef="usd" contextRef="c-12" decimals="INF" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestCurrent" format="ixt:fixed-zero" scale="3" id="f-479"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="INF" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestCurrent" format="ixt:fixed-zero" scale="3" id="f-480">no</ix:nonFraction></ix:nonFraction> allowance for credit loss has been established as of December&#160;31, 2023 and 2022.   </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(i) <ix:nonNumeric contextRef="c-1" name="us-gaap:InventoryPolicyTextBlock" id="f-481" continuedAt="f-481-1" escape="true">Inventories </ix:nonNumeric></span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"><ix:continuation id="f-481-1">Inventories are stated at the lower of cost or net realizable value, with cost determined on a weighted average basis. The Company periodically reviews the composition of inventory and shelf life of inventory to identify obsolete, slow-moving, or otherwise non-saleable items. The Company will record a write-down to its net realizable value in cost of sales in the period that the decline in value is first identified.</ix:continuation> </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(j) <ix:nonNumeric contextRef="c-1" name="zlab:PrepaymentsForEquipmentPolicyPolicyTextBlock" id="f-482" continuedAt="f-482-1" escape="true">Prepayments for Equipment </ix:nonNumeric></span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"><ix:continuation id="f-482-1">The prepayments for equipment purchase are recorded in long-term prepayments considering the prepayments are all related to property and equipment.</ix:continuation> </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(k) <ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="f-483" continuedAt="f-483-1" escape="true">Property and Equipment </ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="zlab:PropertyAndEquipmentEstimatedUsefulLivesTableTextBlock" id="f-484" escape="true"><ix:continuation id="f-483-1" continuedAt="f-483-2"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Property and equipment are stated at cost, less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the respective assets as follows:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Useful life</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Office equipment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-64" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-485">3</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Electronic equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-65" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-486">1.25</ix:nonNumeric>-<ix:nonNumeric contextRef="c-66" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-487">3</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vehicles</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-67" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-488">4</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Laboratory equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-68" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-489">5</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Manufacturing equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-69" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-490">10</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leasehold improvements</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">lesser of useful life or lease term</span></td></tr></table></div></ix:continuation></ix:nonNumeric><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"><ix:continuation id="f-483-2">Construction in progress represents property and equipment under construction and pending installation and is stated at cost less impairment losses, if any.</ix:continuation> </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(l) <ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeLeasesPolicyTextBlock" id="f-491" continuedAt="f-491-1" escape="true">Leases</ix:nonNumeric></span></div><ix:continuation id="f-491-1" continuedAt="f-491-2"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company leases facilities for its offices, research and development center, and manufacturing facilities in mainland China, Hong Kong, and the United States. On January 1, 2019, the Company adopted the ASC 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> using the modified retrospective transition approach by applying the new standard to all leases existing at the date of initial application and not restating historical periods before the adoption date. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company assessed whether an arrangement contains a lease at inception. The Company&#8217;s leases are all classified as operating leases with fixed lease payments, or minimum payments, as contractually stated in the lease agreements. The Company&#8217;s leases do not contain any material residual value guarantees or material restrictive covenants.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%"> </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Operating leases are included in operating lease right-of-use assets and operating lease liabilities in the consolidated balance sheets. Operating lease liabilities that become due within one year of the balance sheet date are classified as current operating lease liabilities. Operating lease expense is recognized on a straight-line basis over the lease term.  </span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">F-14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:108pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Zai Lab Limited</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to the Consolidated Financial Statements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Years Ended December&#160;31, 2023, 2022, and 2021</span></div></div><ix:continuation id="f-464-4" continuedAt="f-464-5"><ix:continuation id="f-491-2"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">At the commencement date of a lease, the Company recognizes a lease liability for future fixed lease payments and a right-of-use (&#8220;ROU&#8221;) asset representing the right to use the underlying asset during the lease term. The lease liability is initially measured as the present value of the future fixed lease payments that will be made over the lease term. The lease term includes periods for which the Company is reasonably certain that the renewal options will be exercised and the termination options will not be exercised. The Company uses its incremental borrowing rate based on the information available at the commencement date in determining the lease liabilities as the Company&#8217;s leases generally do not provide an implicit rate. The incremental borrowing rate is reevaluated upon a lease modification. The Company considered information available at the adoption date of ASC 842 to determine the incremental borrowing rate for leases in existence as of this date.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The ROU asset is measured at the amount of the lease liability with adjustments, if applicable, for lease prepayments made prior to or at lease commencement, initial direct costs incurred by the Company, and lease incentives. Under ASC 842, land use rights agreements are also considered to be operating lease contracts.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company elected to apply each of the practical expedients described in ASC 842 which allow companies (i) not to reassess prior conclusions on whether any expired or existing contracts are or contain a lease, lease classification, and initial direct costs upon adoption of ASC 842, (ii) combine lease and non-lease components for all underlying assets groups, and (iii) not recognize ROU assets or lease liabilities for short term leases. A short-term lease is a lease that, at the commencement date, has a lease term of 12 months or less and does not include an option to purchase the underlying asset that the lessee is reasonably certain to exercise.</span></div></ix:continuation><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(m) <ix:nonNumeric contextRef="c-1" name="zlab:LandUseRightsPolicyPolicyTextBlock" id="f-492" continuedAt="f-492-1" escape="true">Land Use Rights </ix:nonNumeric></span></div><ix:continuation id="f-492-1"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">All land in mainland China is subject to government or collective ownership. Land use rights can be purchased for a specified period of time. The purchase price of land use rights represents the operating lease prepayments under ASC 842 and is recorded as land use rights on the consolidated balance sheet, which is amortized over the remaining lease term.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company acquired land use rights in 2019 for a term of <ix:nonNumeric contextRef="c-70" name="zlab:LandUseRightsLeaseTerm" format="ixt-sec:duryear" id="f-493">30</ix:nonNumeric> years from the local Bureau of Land and Resources in Suzhou for the purpose of constructing and operating the research center and biologics manufacturing facility in Suzhou. In 2023, the Company returned a portion of the land use rights and received cash in an amount equal to the respective portion of the original acquisition cost.</span></div></ix:continuation><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(n) <ix:nonNumeric contextRef="c-1" name="zlab:LongTermDepositsPolicyPolicyTextBlock" id="f-494" continuedAt="f-494-1" escape="true">Long-Term Deposits </ix:nonNumeric></span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"><ix:continuation id="f-494-1">Long-term deposits represent amounts paid in connection with the Company&#8217;s long-term lease agreements.</ix:continuation> </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(o) <ix:nonNumeric contextRef="c-1" name="us-gaap:IntangibleAssetsFiniteLivedPolicy" id="f-495" continuedAt="f-495-1" escape="true">Intangible Assets </ix:nonNumeric></span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"><ix:continuation id="f-495-1">Intangible assets mainly consist of capitalized sales-based milestone fees and externally purchased software. Sales-based milestone fees are capitalized based on contract terms upon achievement of the sales levels and are amortized over the estimated remaining useful life of the related product, which is generally based on expected patent life, the contractual period of the underlying license agreement, and expected commercial benefits of the products. Externally purchased software are amortized over <span style="-sec-ix-hidden:f-496">three</span> to <ix:nonNumeric contextRef="c-72" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:durwordsen" id="f-497">five years</ix:nonNumeric> on a straight-line basis.</ix:continuation> As of December&#160;31, 2023, the intangible assets, net consist of $<ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="f-498">11.2</ix:nonFraction> million capitalized sales-based milestone fees and $<ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="f-499">2.2</ix:nonFraction> million software. As of December&#160;31, 2022, the intangible assets, net consist of $<ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="f-500">1.5</ix:nonFraction> million software. Amortization expenses for 2023, 2022, and 2021 were $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-501">0.7</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-502">0.5</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-503">0.5</ix:nonFraction> million, respectively. Amortization expenses of the Company&#8217;s intangible assets are expected to be approximately $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="6" id="f-504">3.1</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="6" id="f-505">2.9</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="6" id="f-506">2.7</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="6" id="f-507">2.5</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="6" id="f-508">2.3</ix:nonFraction> million, and <ix:nonFraction unitRef="usd" contextRef="c-12" decimals="INF" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" format="ixt:fixed-zero" scale="3" id="f-509">nil</ix:nonFraction> for 2024, 2025, 2026, 2027, 2028, and thereafter, respectively. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">F-15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:108pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Zai Lab Limited</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to the Consolidated Financial Statements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Years Ended December&#160;31, 2023, 2022, and 2021</span></div></div><ix:continuation id="f-464-5" continuedAt="f-464-6"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(p) <ix:nonNumeric contextRef="c-1" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" id="f-510" continuedAt="f-510-1" escape="true">Impairment of Long-Lived Assets </ix:nonNumeric></span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"><ix:continuation id="f-510-1">The Company evaluates long-lived assets, which includes intangible assets, tangible assets, and ROU assets for impairment whenever events or changes in circumstances indicate that the carrying value of these assets may not be recoverable. Recoverability of these assets is measured by comparison of the carrying amount of the related asset group to its future undiscounted cash flows. The Company measures the amount of impairment, if any, based on the difference between the carrying value and the estimated fair value of the impaired asset group.</ix:continuation> </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(q) <ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="f-511" continuedAt="f-511-1" escape="true">Fair Value Measurements </ix:nonNumeric></span></div><ix:continuation id="f-511-1" continuedAt="f-511-2"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company applies ASC topic 820 (&#8220;ASC 820&#8221;), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Fair Value Measurements and Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">, in measuring fair value. ASC 820 defines fair value, establishes a framework for measuring fair value, and requires disclosures to be provided on fair value measurement. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">ASC 820 establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows: </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Level 1 &#8212; Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Level 2 &#8212; Include other inputs that are directly or indirectly observable in the marketplace. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Level 3 &#8212; Unobservable inputs which are supported by little or no market activity. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">ASC 820 describes three main approaches to measuring the fair value of assets and liabilities: (i) market approach; (ii) income approach; and (iii) cost approach. The market approach uses prices and other relevant information generated from market transactions involving identical or comparable assets or liabilities. The income approach uses valuation techniques to convert future amounts to a single present value amount. The measurement is based on the value indicated by current market expectations about those future amounts. The cost approach is based on the amount that would currently be required to replace an asset. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Equity investments with readily determinable fair value are measured using level 1 inputs and were $<ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-5" name="zlab:EquitySecuritiesWithReadilyDeterminableFairValueAmount" scale="6" id="f-512">9.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-5" name="zlab:EquitySecuritiesWithReadilyDeterminableFairValueAmount" scale="6" id="f-513">6.4</ix:nonFraction> million as of December&#160;31, 2023 and 2022, respectively. The unrealized gains and losses from fair value changes are recognized in other income (expense), net in the consolidated statements of operations. </span></div></ix:continuation><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"><ix:continuation id="f-511-2">Financial instruments of the Company primarily include cash, cash equivalents and restricted cash, short-term investments, accounts receivable, notes receivable, prepayments, and other current assets, accounts payable, and other current liabilities. As of December&#160;31, 2023 and 2022, the carrying values of cash and cash equivalents, short-term investments, accounts receivable, prepayments, and other current assets, accounts payable, and other current liabilities approximated their fair values due to the short-term maturity of these instruments, and the carrying value of notes receivable and restricted cash approximated their fair value based on the nature of the assessment of the ability to recover these amounts.</ix:continuation> </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(r) <ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="f-514" continuedAt="f-514-1" escape="true">Revenue Recognition</ix:nonNumeric></span></div><ix:continuation id="f-514-1" continuedAt="f-514-2"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In 2018, the Company adopted ASC Topic 606 (&#8220;ASC 606&#8221;), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">. Under ASC 606, the Company recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration expected to be received in exchange for those goods or services. To determine revenue recognition for arrangements that the Company determines are within the scope of ASC 606, the Company performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price, including variable consideration, if any; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the Company satisfies a performance </span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">F-16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:108pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Zai Lab Limited</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to the Consolidated Financial Statements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Years Ended December&#160;31, 2023, 2022, and 2021</span></div></div><ix:continuation id="f-464-6" continuedAt="f-464-7"><ix:continuation id="f-514-2" continuedAt="f-514-3"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">obligation. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration to which it is entitled in exchange for the goods or services it transfers to the customer. Once a contract is determined to be within the scope of ASC 606 at contract inception, the Company reviews the contract to determine which performance obligations it must deliver and which of these performance obligations are distinct. The Company recognizes as revenue the amount of the transaction price that is allocated to each performance obligation when that performance obligation is satisfied or as it is satisfied.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company&#8217;s revenue is mainly from product sales. The Company recognizes revenue from product sales when the Company has satisfied the performance obligation by transferring control of the product to the customers. Control of the product generally transfers to the customers when the delivery is made and when title and risk of loss transfers to the consumers. Cost of sales mainly consists of the acquisition cost of products, the manufacturing cost of products, royalty fees, and amortization of sales-based milestone payments. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company has applied the practical expedients under ASC 606 with regard to assessment of financing component and concluded that there is no significant financing component given that the period between delivery of goods and payment is generally one year or less. The Company&#8217;s product revenues were mainly generated from the sale of ZEJULA (niraparib), OPTUNE (Tumor Treating Fields), QINLOCK (ripretinib), NUZYRA (omadacycline), and VYVGART (efgartigimod) to customers. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In mainland China, the Company sells the products to distributors, who ultimately sell the products to health care providers. Based on the nature of the arrangements, the performance obligations are satisfied upon the delivery of the products to distributors. Rebates are offered to distributors, consistent with pharmaceutical industry practices. The estimated amount of unpaid or unbilled rebates are recorded as a reduction of revenue, if any. Estimated rebates are determined based on contracted rates and sales volumes and to a lesser extent, distributor inventories. The Company regularly reviews the information related to these estimates and adjusts the amount accordingly. </span></div></ix:continuation><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"><ix:continuation id="f-514-3">In Hong Kong, the Company sells the products to customers, which are typically healthcare providers such as oncology centers. The Company utilizes a third party for warehousing services. Based on the nature of the arrangements, the Company has determined that it is a principal in the transaction since the Company is primarily responsible for fulfilling the promise to provide the products to the customers, maintains inventory risk until delivery to the customers, and has latitude in establishing the price. Revenue was recognized at the amount to which the Company expected to be entitled in exchange for the sale of the products, which is the sales price agreed with the customers. Consideration paid to the third party is recognized in operating expenses.</ix:continuation> </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company didn&#8217;t recognize any contract assets and contract liabilities as of December&#160;31, 2023 and 2022.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(s) <ix:nonNumeric contextRef="c-1" name="us-gaap:CollaborativeArrangementAccountingPolicy" id="f-515" continuedAt="f-515-1" escape="true">Collaborative Arrangements </ix:nonNumeric></span></div><ix:continuation id="f-515-1" continuedAt="f-515-2"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company analyzes its collaboration arrangements to assess whether such arrangements involve joint operating activities performed by parties that are both active participants in the activities and exposed to significant risks and rewards dependent on the commercial success of such activities and therefore within the scope of ASC Topic 808, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Collaborative Arrangements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> (ASC 808). This assessment is performed throughout the life of the arrangement based on changes in the responsibilities of all parties in the arrangement. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">For collaboration arrangements within the scope of ASC 808 that contain multiple elements, the Company first determines which elements of the collaboration are deemed to be within the scope of ASC 808 and which elements of the collaboration are more reflective of a vendor-customer relationship and therefore within the scope of ASC 606. For </span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">F-17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:108pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Zai Lab Limited</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to the Consolidated Financial Statements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Years Ended December&#160;31, 2023, 2022, and 2021</span></div></div><ix:continuation id="f-464-7" continuedAt="f-464-8"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"><ix:continuation id="f-515-2">elements of collaboration arrangements that are accounted pursuant to ASC 808, an appropriate recognition method is determined and applied consistently.</ix:continuation> </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(t) <ix:nonNumeric contextRef="c-1" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="f-516" continuedAt="f-516-1" escape="true">Research and Development Expenses </ix:nonNumeric></span></div><ix:continuation id="f-516-1" continuedAt="f-516-2"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Elements of research and development expenses primarily include (i) payroll and other related costs of personnel engaged in research and development activities; (ii) in-licensed patent rights fees of exclusive development rights of products granted to the Company; (iii) costs related to pre-clinical testing of the Company&#8217;s technologies under development and clinical trials such as payments to contract research organizations (&#8220;CROs&#8221;) and contract manufacturing organizations (&#8220;CMOs&#8221;), investigators, and clinical trial sites that conduct its clinical studies; (iv) costs to develop the product candidates, including raw materials and supplies, product testing, depreciation, and facility-related expenses; and (v) other research and development expenses. Research and development expenses are charged to expense as incurred and have no alternative future uses. Liabilities related to third-party research and development expenses are primarily included in accounts payable on the consolidated balance sheet.</span></div></ix:continuation><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"><ix:continuation id="f-516-2">The Company has acquired rights to develop and commercialize product candidates. Upfront payments that relate to the acquisition of a new product compound, as well as pre-commercial milestone payments, are immediately expensed as acquired in-process research and development in the period in which they are incurred, provided that the new product compound did not also include processes or activities that would constitute a &#8220;business&#8221; as defined under U.S. GAAP. Milestone payments made to third parties subsequent to regulatory approval which meet the capitalization criteria would be capitalized as intangible assets and amortized over the estimated remaining useful life of the related product, which is generally based on expected patent life, the contractual period of the underlying license agreement, and expected commercial benefits of the products.</ix:continuation> </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(u) <ix:nonNumeric contextRef="c-1" name="zlab:DeferredIncomePolicyTextBlock" id="f-517" continuedAt="f-517-1" escape="true">Deferred Income </ix:nonNumeric></span></div><ix:continuation id="f-517-1"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Deferred income mainly consists of deferred income from government grants and the upfront payments received from Huizheng.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Government grants consist of cash subsidies received by the Company&#8217;s subsidiaries in mainland China from local governments. Grants received as incentives for conducting business in certain local districts with no performance obligation or other restriction as to the use are recognized as other income when cash is received. Grants received with government specified performance obligations are recognized as other income when all the obligations have been fulfilled. If such obligations are not satisfied, the Company may be required to refund the subsidy. The grant received before the fulfillment of specified performance obligation is recorded in deferred income. The Company had $<ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-5" name="us-gaap:DeferredIncomeNoncurrent" scale="6" id="f-518">2.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-5" name="us-gaap:DeferredIncomeNoncurrent" scale="6" id="f-519">0.9</ix:nonFraction> million of government grants in deferred income as of December&#160;31, 2023 and 2022, respectively. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In March 2020, the Company entered into an exclusive promotion agreement with Huizheng so that the Company could leverage Hanhui&#8217;s infrastructure to optimize an anticipated future commercial launch of NUZYRA in mainland China. In exchange for exclusive promotion rights in mainland China, Huizheng agreed to pay the Company non-creditable upfront payments of RMB<ix:nonFraction unitRef="cny" contextRef="c-80" decimals="-5" name="zlab:CollaborativeArrangementRightsAndObligationsPaymentOfUpFrontFeesForLicenseAgreement" format="ixt:num-dot-decimal" scale="6" id="f-520">230.0</ix:nonFraction> million, of which RMB<ix:nonFraction unitRef="cny" contextRef="c-81" decimals="-5" name="zlab:CollaborativeArrangementRightsAndObligationsPaymentOfUpFrontFeesForLicenseAgreement" format="ixt:num-dot-decimal" scale="6" id="f-521">90.0</ix:nonFraction> million was paid in April 2020, RMB<ix:nonFraction unitRef="cny" contextRef="c-82" decimals="-5" name="zlab:CollaborativeArrangementRightsAndObligationsPaymentOfUpFrontFeesForLicenseAgreement" format="ixt:num-dot-decimal" scale="6" id="f-522">70.0</ix:nonFraction> million in 2022, and RMB<ix:nonFraction unitRef="cny" contextRef="c-83" decimals="-5" name="zlab:CollaborativeArrangementRightsAndObligationsPaymentOfUpFrontFeesForLicenseAgreement" format="ixt:num-dot-decimal" scale="6" id="f-523">70.0</ix:nonFraction> million in 2023. The Company is amortizing the upfront payments through the end of the contract term. The Company had $<ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-5" name="us-gaap:DeferredIncomeNoncurrent" scale="6" id="f-524">26.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-5" name="us-gaap:DeferredIncomeNoncurrent" scale="6" id="f-525">20.5</ix:nonFraction> million in deferred income related to the upfront payments as of December&#160;31, 2023 and 2022, respectively.</span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">F-18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:108pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Zai Lab Limited</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to the Consolidated Financial Statements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Years Ended December&#160;31, 2023, 2022, and 2021</span></div></div><ix:continuation id="f-464-8" continuedAt="f-464-9"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(v) <ix:nonNumeric contextRef="c-1" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" id="f-526" continuedAt="f-526-1" escape="true">Comprehensive Loss </ix:nonNumeric></span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"><ix:continuation id="f-526-1">Comprehensive loss is defined as the changes in equity of the Company during a period from transactions and other events and circumstances excluding transactions resulting from investments by owners and distributions to owners. For each of the periods presented, the Company&#8217;s comprehensive loss includes net loss and foreign currency translation adjustments, which are presented in the consolidated statements of comprehensive loss.</ix:continuation> </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(w) <ix:nonNumeric contextRef="c-1" name="us-gaap:CompensationRelatedCostsPolicyTextBlock" id="f-527" continuedAt="f-527-1" escape="true">Share-Based Compensation </ix:nonNumeric></span></div><ix:continuation id="f-527-1"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company grants share options and non-vested restricted shares to eligible employees, non-employees, and directors and accounts for these share-based awards in accordance with ASC 718, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Compensation-Stock Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company estimates the fair value of stock options using the Black-Scholes option-pricing model. The grant-date fair value of non-vested restricted shares is the market value of the underlying stock on the award&#8217;s grant date. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> The Company has elected to use the straight-line method to recognize compensation expenses for share awards with graded vesting based on service conditions, subject to the minimum amount of cumulative compensation expense recognized is not less than the portion of the award vested to date. For share-based awards with service conditions only, the Company recognizes expenses (i) immediately at grant date if no vesting conditions are required; or (ii) using a straight-line method over the requisite service period, which is the vesting period, if vesting conditions are required. For share-based awards containing performance conditions, the Company recognizes expenses based on the estimated number of the performance-based awards expected to vest using the graded vesting attribution method. The Company accounts for the effect of forfeitures as they occur.</span></div></ix:continuation><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(x) <ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxPolicyTextBlock" id="f-528" continuedAt="f-528-1" escape="true">Income Taxes </ix:nonNumeric></span></div><ix:continuation id="f-528-1" continuedAt="f-528-2"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Income tax expense includes (i) deferred tax expense, which generally represents the net change in the deferred tax asset or liability balance during the year plus any change in valuation allowances; (ii) current tax expense, which represents the amount of tax currently payable to or receivable from a taxing authority; and (iii) non-current tax expense, which represents the increases and decreases in amounts related to uncertain tax positions from prior periods and not settled with cash or other tax attributes.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company recognizes deferred tax assets and liabilities for temporary differences between the financial statement and income tax bases of assets and liabilities, which are measured using enacted tax rates and laws that will be in effect when the differences are expected to reverse. A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized. </span></div></ix:continuation><div style="margin-top:9pt;text-indent:27pt"><ix:continuation id="f-528-2" continuedAt="f-528-3"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company evaluates its uncertain tax positions using the provisions of ASC 740, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Income Taxes</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"><ix:continuation id="f-528-3">, which requires that realization of an uncertain income tax position be recognized in the financial statements. The benefit to be recorded in the financial statements is the amount most likely to be realized assuming a review by tax authorities having all relevant information and applying current conventions. It is the Company&#8217;s policy to recognize interest and penalties related to unrecognized tax benefits, if any, as a component of income tax expense.</ix:continuation> <ix:nonFraction unitRef="usd" contextRef="c-14" decimals="INF" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" format="ixt:fixed-zero" scale="3" id="f-529"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="INF" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" format="ixt:fixed-zero" scale="3" id="f-530"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="INF" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" format="ixt:fixed-zero" scale="3" id="f-531">No</ix:nonFraction></ix:nonFraction></ix:nonFraction> unrecognized tax benefits and related interest and penalties were recorded in any of the periods presented. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(y) <ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerSharePolicyTextBlock" id="f-532" continuedAt="f-532-1" escape="true">Loss Per Share </ix:nonNumeric></span></div><ix:continuation id="f-532-1" continuedAt="f-532-2"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Basic loss per ordinary share is computed by dividing net loss attributable to ordinary shareholders by weighted average number of ordinary shares outstanding during the period. </span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">F-19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:108pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Zai Lab Limited</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to the Consolidated Financial Statements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Years Ended December&#160;31, 2023, 2022, and 2021</span></div></div><ix:continuation id="f-464-9" continuedAt="f-464-10"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"><ix:continuation id="f-532-2">Diluted loss per ordinary share reflects the potential dilution that could occur if securities were exercised or converted into ordinary shares. The Company had stock options and non-vested restricted shares, which could potentially dilute basic loss per share in the future. To calculate the number of shares for diluted loss per share, the effect of the stock options and non-vested restricted shares is computed using the treasury stock method. The computation of diluted loss per share does not assume exercise or conversion of securities that would have an anti-dilutive effect.</ix:continuation> </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(z) <ix:nonNumeric contextRef="c-1" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="f-533" continuedAt="f-533-1" escape="true">Segment Information </ix:nonNumeric></span></div><div style="margin-top:9pt;text-indent:27pt"><ix:continuation id="f-533-1" continuedAt="f-533-2"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In accordance with ASC 280, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Segment Reporting</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"><ix:continuation id="f-533-2">, the Company&#8217;s chief operating decision maker, the Chief Executive Officer, reviews the consolidated results when making decisions about allocating resources and assessing performance of the Company as a whole and therefore, the Company has only <ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="f-534"><ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="f-535">one</ix:nonFraction></ix:nonFraction> operating and reportable segment.</ix:continuation>  </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(aa) Concentration of Risks</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Concentration of Customers </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">One customer accounted for 10% or more of revenue, with $<ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-536">59.4</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-537">52.5</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="c-88" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-538">40.6</ix:nonFraction> million in 2023, 2022, and 2021, respectively.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Concentration of Suppliers</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueConcentrationOfRiskTextBlock" id="f-539" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following suppliers accounted for 10% or more of research and development expenses and inventory purchases ($ in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">E</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-89" decimals="-3" name="zlab:ResearchAndDevelopmentExpensesAndTheInventoryPurchases" format="ixt:num-dot-decimal" scale="3" id="f-540">165,431</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-3" name="zlab:ResearchAndDevelopmentExpensesAndTheInventoryPurchases" format="ixt:num-dot-decimal" scale="3" id="f-541">66,650</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">*  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Represents less than 10% of research and development expenses and inventory purchases for the period.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ConcentrationRiskCreditRisk" id="f-542" continuedAt="f-542-1" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Concentration of Credit Risk </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Financial instruments that are potentially subject to significant concentration of credit risk consist of cash and cash equivalents, short-term investments, accounts receivable, and notes receivable. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The carrying amounts of cash and cash equivalents and short-term investments represent the maximum amount of loss due to credit risk. As of December&#160;31, 2023 and 2022, all of the Company&#8217;s cash and cash equivalents and short-term investments were held by major financial institutions located in mainland China and international financial institutions outside of mainland China which management believes are of high credit quality and continually monitors the credit worthiness of these financial institutions.</span></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"><ix:continuation id="f-542-1" continuedAt="f-542-2">Accounts receivable are typically unsecured and are derived from product sales and collaborative arrangements. The Company manages credit risk of accounts receivable through ongoing monitoring of the outstanding balances and limits the amount of credit extended based upon payment history and credit worthiness. Historically, the Company has collected receivables from customers within the credit terms with no significant credit losses incurred. </ix:continuation>One customer accounted for 10% or more of accounts receivable, with $<ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-5" name="us-gaap:AccountsReceivableNet" scale="6" id="f-543">7.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-5" name="us-gaap:AccountsReceivableNet" scale="6" id="f-544">9.3</ix:nonFraction> million as of December&#160;31, 2023 and 2022, respectively.  </span></div><ix:continuation id="f-542-2" continuedAt="f-542-3"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Certain accounts receivable balances may be settled in the form of notes receivable. As of December&#160;31, 2023, notes receivable represented bank acceptance promissory notes that are non-interest bearing and due within six months. Notes receivable were used to collect the receivables based on an administrative convenience, given these notes are readily </span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">F-20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:108pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Zai Lab Limited</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to the Consolidated Financial Statements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Years Ended December&#160;31, 2023, 2022, and 2021</span></div></div><ix:continuation id="f-464-10" continuedAt="f-464-11"><ix:continuation id="f-542-3" continuedAt="f-542-4"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">convertible to be known amounts of cash. In accordance with the sales agreements, whether to use cash or bank acceptance promissory notes to settle the receivables is at the Company&#8217;s discretion, and this selection does not impact the agreed contractual purchase prices. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Foreign Currency Risk </span></div></ix:continuation><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"><ix:continuation id="f-542-4">RMB is not a freely convertible currency. The State Administration of Foreign Exchange, under the authority of the People&#8217;s Bank of China, controls the conversion of RMB into foreign currencies. The value of RMB is subject to changes in central government policies and to international economic and political developments affecting supply and demand in the China Foreign Exchange Trading System market.</ix:continuation> The cash and cash equivalents of the Company included aggregated amounts of $<ix:nonFraction unitRef="usd" contextRef="c-93" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-545">25.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-94" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-546">45.5</ix:nonFraction> million, which were denominated in RMB, as of December&#160;31, 2023 and 2022, respectively, representing <ix:nonFraction unitRef="number" contextRef="c-95" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-547">3</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-96" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-548">5</ix:nonFraction>% of the cash and cash equivalents as of December&#160;31, 2023 and 2022, respectively. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(ab) <ix:nonNumeric contextRef="c-1" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="f-549" continuedAt="f-549-1" escape="true">Recent Accounting Pronouncements </ix:nonNumeric></span></div><ix:continuation id="f-549-1" continuedAt="f-549-2"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In December 2023, the FASB issued ASU No. 2023-09, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Improvements to Income Tax Disclosures </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(Topic 740). The ASU requires disaggregated information about a reporting entity&#8217;s effective tax rate reconciliation as well as additional information on income taxes paid. The ASU is effective on a prospective basis for annual periods beginning after December 15, 2024. Early adoption is permitted. This ASU will result in the required additional disclosures being included in the consolidated financial statements, once adopted. The Company is currently evaluating the impact of this ASU and expects to adopt it for the year ending December 31, 2025.</span></div></ix:continuation></ix:continuation><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"><ix:continuation id="f-549-2"><ix:continuation id="f-464-11">The Company has not adopted any new accounting standards in 2023 that have a material impact on the Consolidated Financial Statements.</ix:continuation></ix:continuation> </span></div><div id="i8a977bbf870448998f9d0f718b7b41b9_157"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">3.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:CashAndCashEquivalentsDisclosureTextBlock" id="f-550" continuedAt="f-550-1" escape="true">Cash and Cash Equivalents </ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock" id="f-551" continuedAt="f-551-1" escape="true"><ix:continuation id="f-550-1" continuedAt="f-550-2"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following table presents the Company&#8217;s cash and cash equivalents ($ in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:Cash" format="ixt:num-dot-decimal" scale="3" id="f-552">789,051</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:Cash" format="ixt:num-dot-decimal" scale="3" id="f-553">1,007,423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents (i)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-554">1,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-555">1,047</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-556">790,151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-557">1,008,470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Denominated in:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">US$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-558">762,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-559">957,824</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RMB (ii)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-560">25,093</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-561">45,486</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hong Kong dollar (&#8220;HK$&#8221;)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-562">1,974</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-563">4,378</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Australian dollar (&#8220;A$&#8221;)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="f-564">587</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="f-565">598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Taiwan dollar (&#8220;TW$&#8221;)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="f-566">61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="f-567">184</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-568">790,151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-569">1,008,470</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:17.57pt">Cash equivalents represent short-term and highly liquid investments in a money market fund. </span></div></ix:continuation></ix:nonNumeric><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><ix:continuation id="f-551-1" continuedAt="f-551-2"><ix:continuation id="f-550-2" continuedAt="f-550-3"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</span></ix:continuation></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.8pt"><ix:continuation id="f-551-2"><ix:continuation id="f-550-3">Certain cash and bank balances denominated in RMB were deposited with banks in mainland China. The conversion of these RMB denominated balances into foreign currencies is subject to the rules and regulations of foreign exchange control promulgated by the Chinese government.</ix:continuation></ix:continuation> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">F-21</span></div></div></div><div id="i8a977bbf870448998f9d0f718b7b41b9_160"></div><hr style="page-break-after:always"/><div style="min-height:108pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Zai Lab Limited</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to the Consolidated Financial Statements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Years Ended December&#160;31, 2023, 2022, and 2021</span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">4.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="zlab:RestrictedCashNonCurrentTextBlock" id="f-570" continuedAt="f-570-1" escape="true">Restricted Cash, Non-Current</ix:nonNumeric></span></div><ix:continuation id="f-570-1"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company&#8217;s restricted cash balance were $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:RestrictedCashNoncurrent" scale="6" id="f-571">1.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:RestrictedCashNoncurrent" scale="6" id="f-572">0.8</ix:nonFraction> million as of December&#160;31, 2023 and 2022, respectively, and consisted of long-term bank deposits held as collateral for issuance of letters of credit. These deposits will be released when the related letters of credit are settled by the Company.</span></div></ix:continuation><div id="i8a977bbf870448998f9d0f718b7b41b9_163"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">5.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="zlab:ShortTermInvestmentTextBlock" id="f-573" continuedAt="f-573-1" escape="true">Short-Term Investments</ix:nonNumeric></span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"><ix:continuation id="f-573-1">Short-term investments are primarily comprised of time deposits with original maturities between <ix:nonNumeric contextRef="c-107" name="us-gaap:MaturityOfTimeDeposits" format="ixt-sec:durwordsen" id="f-574">three months</ix:nonNumeric> and <ix:nonNumeric contextRef="c-108" name="us-gaap:MaturityOfTimeDeposits" format="ixt-sec:durwordsen" id="f-575">one year</ix:nonNumeric>. The short-term investments balance were $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:ShortTermInvestments" scale="6" id="f-576">16.3</ix:nonFraction> million and <ix:nonFraction unitRef="usd" contextRef="c-13" decimals="INF" name="us-gaap:ShortTermInvestments" format="ixt:fixed-zero" scale="0" id="f-577">nil</ix:nonFraction> as of December&#160;31, 2023 and 2022, respectively. <ix:nonFraction unitRef="usd" contextRef="c-12" decimals="INF" name="us-gaap:DebtSecuritiesHeldToMaturityAllowanceForCreditLossExcludingAccruedInterest" format="ixt:fixed-zero" scale="0" id="f-578">No</ix:nonFraction> allowance for credit loss was recorded as of December 31, 2023.</ix:continuation> </span></div><div id="i8a977bbf870448998f9d0f718b7b41b9_169"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">6.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:InventoryDisclosureTextBlock" id="f-579" continuedAt="f-579-1" escape="true">Inventories, Net</ix:nonNumeric></span></div><ix:continuation id="f-579-1"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="f-580" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following table presents the Company&#8217;s inventories, net ($ in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="f-581">22,702</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="f-582">12,156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Raw materials</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:InventoryRawMaterialsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="f-583">17,655</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:InventoryRawMaterialsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="f-584">19,029</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Work in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:InventoryWorkInProcessNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="f-585">4,470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="3" id="f-586">436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inventories, net</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="f-587">44,827</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="f-588">31,621</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company writes down inventory for any excess or obsolete inventories or when the Company believes that the net realizable value of inventories is less than the carrying value. The Company recorded write-downs in inventory, which were included in cost of sales of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ProductionRelatedImpairmentsOrCharges" scale="6" id="f-589">1.0</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-5" name="us-gaap:ProductionRelatedImpairmentsOrCharges" scale="6" id="f-590">0.5</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:ProductionRelatedImpairmentsOrCharges" scale="6" id="f-591">1.4</ix:nonFraction> million in 2023, 2022, and 2021, respectively.</span></div></ix:continuation><div id="i8a977bbf870448998f9d0f718b7b41b9_172"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:InvestmentTextBlock" id="f-592" continuedAt="f-592-1" escape="true">Long-Term Investments </ix:nonNumeric></span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"><ix:continuation id="f-592-1">In July 2021, the Company made an equity investment in MacroGenics Inc. (&#8220;MacroGenics&#8221;), a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer, in a private placement with total contributions of $<ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-3" name="zlab:CapitalContributionsCommitment" format="ixt:num-dot-decimal" scale="3" id="f-593">30,000</ix:nonFraction> and obtained <ix:nonFraction unitRef="shares" contextRef="c-110" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" format="ixt:num-dot-decimal" scale="0" id="f-594">958,467</ix:nonFraction> newly issued common shares of MacroGenics at $<ix:nonFraction unitRef="usdPerShare" contextRef="c-111" decimals="2" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="f-595">31.30</ix:nonFraction> per share. The Company recorded this investment at acquisition cost and subsequently measured it at fair value, with the changes in fair value recognized in other income (expenses), net in the consolidated statements of operations. The equity investments with readily determinable fair value are measured using level 1 inputs and were $<ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-5" name="zlab:EquitySecuritiesWithReadilyDeterminableFairValueAmount" scale="6" id="f-596">9.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-5" name="zlab:EquitySecuritiesWithReadilyDeterminableFairValueAmount" scale="6" id="f-597">6.4</ix:nonFraction> million as of December&#160;31, 2023 and 2022, respectively. The Company recognized a fair value gain of $<ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-5" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="6" id="f-598">2.8</ix:nonFraction> million in 2023, and losses of $<ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-5" sign="-" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="6" id="f-599">9.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-5" sign="-" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="6" id="f-600">14.6</ix:nonFraction> million in 2022 and 2021, respectively.</ix:continuation> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">F-22</span></div></div></div><div id="i8a977bbf870448998f9d0f718b7b41b9_175"></div><hr style="page-break-after:always"/><div style="min-height:108pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Zai Lab Limited</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to the Consolidated Financial Statements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Years Ended December&#160;31, 2023, 2022, and 2021</span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">8.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="f-601" continuedAt="f-601-1" escape="true">Property and Equipment, Net </ix:nonNumeric></span></div><ix:continuation id="f-601-1"><ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="f-602" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following table presents the components of the Company&#8217;s property and equipment, net ($ in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Office equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-603">1,047</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-604">977</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Electronic equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-605">9,161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-117" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-606">7,416</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Vehicle</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-607">199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-608">202</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Laboratory equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-609">20,140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-610">18,726</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Manufacturing equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-611">17,680</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-612">17,055</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-613">11,371</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-614">11,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-615">24,272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-616">24,251</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-weight:400;line-height:114%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-617">83,870</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-618">79,927</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-619">30,136</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-620">22,064</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-621">53,734</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-622">57,863</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Depreciation expense was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:Depreciation" scale="6" id="f-623">8.4</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-5" name="us-gaap:Depreciation" scale="6" id="f-624">7.7</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:Depreciation" scale="6" id="f-625">6.0</ix:nonFraction> million for 2023, 2022, and 2021, respectively.</span></div></ix:continuation><div id="i8a977bbf870448998f9d0f718b7b41b9_178"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">9.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeasesTextBlock" id="f-626" continuedAt="f-626-1" escape="true">Leases</ix:nonNumeric></span></div><ix:continuation id="f-626-1" continuedAt="f-626-2"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company leases facilities for its offices, research and development center, and manufacturing facilities in mainland China, Hong Kong, Taiwan, and the United States. Lease terms vary based on the nature of operations and market dynamics; however, all leased facilities are classified as operating leases with remaining lease terms between <span style="-sec-ix-hidden:f-627">one</span> and <ix:nonNumeric contextRef="c-108" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm" format="ixt-sec:durwordsen" id="f-628">five years</ix:nonNumeric>. </span></div><ix:nonNumeric contextRef="c-1" name="zlab:SupplementalInformationRelatedToLeasesTableTableTextBlock" id="f-629" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following table presents operating lease costs ($ in thousands). Total lease expense related to short-term leases was insignificant for those periods presented.</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating fixed lease cost</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-630">8,691</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-631">8,774</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-632">6,263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:LeaseCostTableTextBlock" id="f-633" escape="true"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents operating cash flows related to leases ($ in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash paid for amounts included in measurement of lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="f-634">9,317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="f-635">8,084</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="f-636">5,840</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-cash operating lease liabilities arising from obtaining operating right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-637">3,668</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-638">14,801</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-639">2,183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">F-23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:108pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Zai Lab Limited</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to the Consolidated Financial Statements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Years Ended December&#160;31, 2023, 2022, and 2021</span></div></div><ix:continuation id="f-626-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="f-640" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The maturities of lease liabilities in accordance with ASC Topic 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> in each of the next five years and thereafter were as follows ($ in thousands): </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.778%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.022%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended<br/>December 31, 2023</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="f-641">7,444</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="f-642">5,143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="f-643">1,811</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="3" id="f-644">822</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="3" id="f-645">391</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:fixed-zero" scale="3" id="f-646">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="f-647">15,611</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="3" id="f-648">460</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Present value of minimum operating lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-649">15,151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="zlab:SummaryOfWeightedAverageRemainingLeaseTermsAndDiscountRatesTableTextBlock" id="f-650" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Weighted-average remaining lease terms and discount rates are as follows: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.051%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.962%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Weighted-average remaining lease term</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-12" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-651">2.5</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-13" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-652">2.6</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Weighted-average discount rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="number" contextRef="c-12" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-653">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="number" contextRef="c-13" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-654">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i8a977bbf870448998f9d0f718b7b41b9_181"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">10.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="f-655" continuedAt="f-655-1" escape="true">Revenue</ix:nonNumeric></span><ix:continuation id="f-655-1" continuedAt="f-655-2"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:139%"> </span></ix:continuation></div><ix:continuation id="f-655-2" continuedAt="f-655-3"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Product Revenue</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company&#8217;s product revenue is derived from the sales of its commercial products primarily in mainland China. <ix:nonNumeric contextRef="c-1" name="zlab:NetRevenueTableTextBlock" id="f-656" continuedAt="f-656-1" escape="true">The table below presents the Company&#8217;s net product revenue ($ in thousands):</ix:nonNumeric></span></div><ix:continuation id="f-656-1"><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Product revenue &#8212; gross</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="zlab:RevenueFromContractWithCustomersExcludingAssessedTaxBeforeAdjustmentsForRebatesAndSalesReturns" format="ixt:num-dot-decimal" scale="3" id="f-657">298,911</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="zlab:RevenueFromContractWithCustomersExcludingAssessedTaxBeforeAdjustmentsForRebatesAndSalesReturns" format="ixt:num-dot-decimal" scale="3" id="f-658">234,009</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="zlab:RevenueFromContractWithCustomersExcludingAssessedTaxBeforeAdjustmentsForRebatesAndSalesReturns" format="ixt:num-dot-decimal" scale="3" id="f-659">190,180</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Less: Rebates and sales returns</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="zlab:RevenueFromContractWithCustomersExcludingAssessedTaxAdjustmentsForRebatesAndSalesReturns" format="ixt:num-dot-decimal" scale="3" id="f-660">32,192</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="zlab:RevenueFromContractWithCustomersExcludingAssessedTaxAdjustmentsForRebatesAndSalesReturns" format="ixt:num-dot-decimal" scale="3" id="f-661">21,337</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="zlab:RevenueFromContractWithCustomersExcludingAssessedTaxAdjustmentsForRebatesAndSalesReturns" format="ixt:num-dot-decimal" scale="3" id="f-662">46,075</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Product revenue &#8212; net</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-663">266,719</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-664">212,672</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-665">144,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Sales rebates are offered to distributors in mainland China, and the amounts are recorded as a reduction of revenue. Estimated rebates are determined based on contracted rates, sales volumes, and level of distributor inventories. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">F-24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:108pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Zai Lab Limited</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to the Consolidated Financial Statements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Years Ended December&#160;31, 2023, 2022, and 2021</span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="f-666" escape="true"><ix:continuation id="f-655-3"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following table presents the Company&#8217;s net revenue by product ($ in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">ZEJULA</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-667">168,843</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-668">145,194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-669">93,579</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">OPTUNE</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-670">46,969</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-671">47,321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-672">38,903</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">QINLOCK</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-673">19,240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-674">14,957</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-675">11,620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">NUZYRA</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-676">21,656</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-677">5,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-678">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">VYVGART</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-679">10,011</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-680">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-681">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Product revenue &#8212; net</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-682">266,719</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-683">212,672</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-684">144,105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div id="i8a977bbf870448998f9d0f718b7b41b9_184"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">11.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxDisclosureTextBlock" id="f-685" continuedAt="f-685-1" escape="true">Income Tax</ix:nonNumeric></span></div><ix:continuation id="f-685-1" continuedAt="f-685-2"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Cayman Islands </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Zai Lab Limited, ZLIP Holding Limited, Zai Auto Immune Limited, and Zai Anti Infectives Limited are incorporated in the Cayman Islands. Under the current laws of the Cayman Islands, Zai Lab Limited, ZLIP Holding Limited, Zai Auto Immune Limited, and Zai Anti Infectives Limited are not subject to tax on income or capital gain. Additionally, the Cayman Islands does not impose a withholding tax on payments of dividends to shareholders. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">British Virgin Islands Taxation </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">ZL Capital Limited is incorporated in the British Virgin Islands. Under the current laws of the British Virgin Islands, ZL Capital Limited is not subject to income tax. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Australia </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Zai Lab (AUST) Pty. Ltd. is incorporated in Australia and is subject to corporate income tax at a rate of 30%. Zai Lab (AUST) Pty. Ltd. had <ix:nonFraction unitRef="usd" contextRef="c-141" decimals="INF" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="f-686">no</ix:nonFraction> taxable income for the periods presented; therefore, <ix:nonFraction unitRef="usd" contextRef="c-141" decimals="INF" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="f-687">no</ix:nonFraction> provision for income taxes is required. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">United States </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Zai Lab (US) LLC is incorporated in the United States and is subject to U.S. federal corporate income tax at a rate of 21%. Zai Lab (US) LLC is also subject to state income tax in Delaware. Zai Lab (US) LLC had <ix:nonFraction unitRef="usd" contextRef="c-142" decimals="INF" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="f-688">no</ix:nonFraction> taxable income for the periods presented; therefore, <ix:nonFraction unitRef="usd" contextRef="c-142" decimals="INF" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="f-689">no</ix:nonFraction> provision for income taxes is required. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Taiwan </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Zai Lab (Taiwan) Limited is incorporated in Taiwan and is subject to corporate income tax at a rate of 20%. Zai Lab (Taiwan) Limited had <ix:nonFraction unitRef="usd" contextRef="c-143" decimals="INF" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="f-690">no</ix:nonFraction> taxable income for the periods presented; therefore, <ix:nonFraction unitRef="usd" contextRef="c-143" decimals="INF" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="f-691">no</ix:nonFraction> provision for income taxes is required. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Hong Kong </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Zai Lab (Hong Kong) Limited, ZL China Holding Two Limited, Zai Auto Immune (Hong Kong) Limited, and Zai Anti Infectives (Hong Kong) Limited are incorporated in Hong Kong. Companies registered in Hong Kong are subject to Hong Kong profits tax on the taxable income as reported in their respective statutory financial statements adjusted in accordance with relevant Hong Kong tax laws. Under the two-tiered profits tax rates regime in Hong Kong, the first HK$2 million of profits of the qualifying group entity will be taxed at 8.25%, and profits above HK$2 million will be taxed at </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">F-25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:108pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Zai Lab Limited</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to the Consolidated Financial Statements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Years Ended December&#160;31, 2023, 2022, and 2021</span></div></div><ix:continuation id="f-685-2" continuedAt="f-685-3"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">16.5%. In 2023, 2022, and 2021, Zai Lab (Hong Kong) Limited, ZL China Holding Two Limited, Zai Auto Immune (Hong Kong) Limited, and Zai Anti Infectives (Hong Kong) Limited did <ix:nonFraction unitRef="usd" contextRef="c-144" decimals="INF" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="f-692"><ix:nonFraction unitRef="usd" contextRef="c-145" decimals="INF" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="f-693"><ix:nonFraction unitRef="usd" contextRef="c-146" decimals="INF" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="f-694">not</ix:nonFraction></ix:nonFraction></ix:nonFraction> make any provisions for Hong Kong profit tax as there were <ix:nonFraction unitRef="usd" contextRef="c-144" decimals="INF" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="f-695"><ix:nonFraction unitRef="usd" contextRef="c-145" decimals="INF" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="f-696"><ix:nonFraction unitRef="usd" contextRef="c-146" decimals="INF" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="f-697">no</ix:nonFraction></ix:nonFraction></ix:nonFraction> assessable profits derived from or earned in Hong Kong for any of the periods presented. Under the Hong Kong tax law, Zai Lab (Hong Kong) Limited, ZL China Holding Two Limited, Zai Auto Immune (Hong Kong) Limited, and Zai Anti Infectives (Hong Kong) Limited are exempted from income tax on its foreign-derived income, and there are <ix:nonFraction unitRef="usd" contextRef="c-144" decimals="INF" name="zlab:WithholdingTaxesRemittanceOfDividends" format="ixt:fixed-zero" scale="3" id="f-698"><ix:nonFraction unitRef="usd" contextRef="c-146" decimals="INF" name="zlab:WithholdingTaxesRemittanceOfDividends" format="ixt:fixed-zero" scale="3" id="f-699"><ix:nonFraction unitRef="usd" contextRef="c-145" decimals="INF" name="zlab:WithholdingTaxesRemittanceOfDividends" format="ixt:fixed-zero" scale="3" id="f-700">no</ix:nonFraction></ix:nonFraction></ix:nonFraction> withholding taxes in Hong Kong on remittance of dividends. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">People&#8217;s Republic of China</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Under EIT Law, the statutory income tax rate is 25%, and the EIT rate will be reduced to 15% for state-encouraged High and New Technology Enterprises (&#8220;HNTE&#8221;). Zai Lab (Shanghai) Co., Ltd., first obtained a HNTE certificate in 2018 and began to enjoy the preferential tax rate of 15% from 2018 to 2020 and further extended the certificate in 2021 effective for 2021 to 2023. Zai Lab International Trading (Shanghai) Co., Ltd., Zai Lab (Suzhou) Co., Ltd., Zai Biopharmaceutical (Suzhou) Co., Ltd., and Zai Lab Trading (Suzhou) Co., Ltd. are subject to the statutory rate of 25%. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="INF" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="f-701"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="INF" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="f-702"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="INF" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="f-703">No</ix:nonFraction></ix:nonFraction></ix:nonFraction> provision for income taxes has been required to be accrued because the Company is in a cumulative loss position for the periods presented. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="f-704" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following table presents loss (income) before income taxes ($ in thousands): </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cayman Islands</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-705">16,792</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-706">19,454</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-707">28,401</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">British Virgin Islands</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="f-708">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="f-709">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="f-710">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mainland China</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-711">253,274</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-712">290,056</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-713">340,865</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hong Kong</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-714">4,483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-715">53,425</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-716">243,400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-717">92,869</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-718">79,620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-719">89,374</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Australia</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="f-720">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="f-721">260</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-722">1,758</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Taiwan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="f-723">772</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="f-724">989</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="f-725">671</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-726">334,620</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-727">443,286</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-728">704,471</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">F-26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:108pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Zai Lab Limited</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to the Consolidated Financial Statements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Years Ended December&#160;31, 2023, 2022, and 2021</span></div></div><ix:continuation id="f-685-3" continuedAt="f-685-4"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="f-729" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Reconciliations of the differences between the Chinese statutory income tax rate and the Company&#8217;s effective income tax rate are as follows: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Statutory income tax rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-153" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="f-730">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-154" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="f-731">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-155" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="f-732">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax-exempted income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-153" decimals="4" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxExemptIncome" scale="-2" id="f-733">0.19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-154" decimals="4" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxExemptIncome" format="ixt:fixed-zero" scale="-2" id="f-734">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-155" decimals="4" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxExemptIncome" format="ixt:fixed-zero" scale="-2" id="f-735">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="number" contextRef="c-153" decimals="4" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="-2" id="f-736">2.08</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="number" contextRef="c-154" decimals="4" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="-2" id="f-737">1.40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="number" contextRef="c-155" decimals="4" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="-2" id="f-738">0.92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development super deduction</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-153" decimals="4" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="f-739">7.11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-154" decimals="4" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="f-740">2.51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-155" decimals="4" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" format="ixt:fixed-zero" scale="-2" id="f-741">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-deductible expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="number" contextRef="c-153" decimals="4" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" scale="-2" id="f-742">2.83</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="number" contextRef="c-154" decimals="4" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" scale="-2" id="f-743">2.31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="number" contextRef="c-155" decimals="4" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" scale="-2" id="f-744">5.78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior year tax filing adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-153" decimals="4" name="us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" scale="-2" id="f-745">1.32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-154" decimals="4" name="us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" scale="-2" id="f-746">6.33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-155" decimals="4" name="us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" scale="-2" id="f-747">1.50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effect of different tax rate of subsidiary operation in other jurisdictions</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-153" decimals="4" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="f-748">0.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="number" contextRef="c-154" decimals="4" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="f-749">2.85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="number" contextRef="c-155" decimals="4" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="f-750">4.60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preferential tax rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="number" contextRef="c-153" decimals="4" sign="-" name="zlab:EffectiveIncomeTaxRateReconciliationAtPreferentialTaxRate" scale="-2" id="f-751">7.12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="number" contextRef="c-154" decimals="4" sign="-" name="zlab:EffectiveIncomeTaxRateReconciliationAtPreferentialTaxRate" scale="-2" id="f-752">6.26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="number" contextRef="c-155" decimals="4" sign="-" name="zlab:EffectiveIncomeTaxRateReconciliationAtPreferentialTaxRate" scale="-2" id="f-753">4.30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expiration of deductible qualified donation </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-153" decimals="4" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCharitableContributions" scale="-2" id="f-754">2.28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-154" decimals="4" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCharitableContributions" format="ixt:fixed-zero" scale="-2" id="f-755">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-155" decimals="4" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCharitableContributions" format="ixt:fixed-zero" scale="-2" id="f-756">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="number" contextRef="c-153" decimals="4" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="f-757">23.89</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="number" contextRef="c-154" decimals="4" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="f-758">21.02</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="number" contextRef="c-155" decimals="4" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="f-759">10.90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-153" decimals="4" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" format="ixt:fixed-zero" scale="-2" id="f-760">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-154" decimals="4" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" format="ixt:fixed-zero" scale="-2" id="f-761">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-155" decimals="4" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" format="ixt:fixed-zero" scale="-2" id="f-762">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="f-763" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following table presents the principal components of deferred tax assets and liabilities ($ in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"/><td style="width:58.232%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.930%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.932%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation of property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" scale="3" id="f-764">131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" scale="3" id="f-765">98</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and experimental capitalization</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="zlab:DeferredTaxAssetsResearchAndExperimentalCapitalization" format="ixt:num-dot-decimal" scale="3" id="f-766">30,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="zlab:DeferredTaxAssetsResearchAndExperimentalCapitalization" format="ixt:num-dot-decimal" scale="3" id="f-767">22,476</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="f-768">3,422</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="f-769">1,787</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" scale="3" id="f-770">707</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-771">1,800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Government grants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="zlab:DeferredTaxAssetsGovernmentGrants" scale="3" id="f-772">467</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="zlab:DeferredTaxAssetsGovernmentGrants" scale="3" id="f-773">189</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="zlab:DeferredTaxAssetsDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="f-774">4,354</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="zlab:DeferredTaxAssetsDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="f-775">3,378</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Qualified donation</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="zlab:DeferredTaxAssetsPublicWelfareDonations" format="ixt:num-dot-decimal" scale="3" id="f-776">22,992</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="zlab:DeferredTaxAssetsPublicWelfareDonations" format="ixt:num-dot-decimal" scale="3" id="f-777">12,947</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="zlab:DeferredTaxAssetsLeasingArrangements" format="ixt:num-dot-decimal" scale="3" id="f-778">2,967</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="zlab:DeferredTaxAssetsLeasingArrangements" format="ixt:num-dot-decimal" scale="3" id="f-779">3,738</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net operating loss carry forwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="f-780">295,313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="f-781">241,397</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-782">357,956</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-783">284,072</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total Deferred tax assets</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-784">2,826</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-785">3,738</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" format="ixt:num-dot-decimal" scale="3" id="f-786">2,826</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" format="ixt:num-dot-decimal" scale="3" id="f-787">3,738</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets, net</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:fixed-zero" scale="0" id="f-788">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:fixed-zero" scale="0" id="f-789">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">ASC 740,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%"> Income Taxes,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> provides for the recognition of deferred tax assets if realization of such assets is more likely than not. The Company&#8217;s ability to realize deferred tax assets depends on its ability to generate sufficient taxable income within the carry forward periods provided for in the tax law. In assessing the need for any additional valuation allowance for 2023, the Company considered all available evidence both positive and negative, including potential for prudent and feasible tax planning strategies, recent losses, and forecasts of future profitability. As of December&#160;31, 2023 and 2022, the Company determined that the deferred tax assets on temporary differences and net operating loss carry forwards related to certain subsidiaries will not be realized, and as such it has fully provided the corresponding valuation allowance.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">F-27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:108pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Zai Lab Limited</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to the Consolidated Financial Statements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Years Ended December&#160;31, 2023, 2022, and 2021</span></div></div><ix:continuation id="f-685-4"><ix:nonNumeric contextRef="c-1" name="us-gaap:SummaryOfValuationAllowanceTextBlock" id="f-790" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following table presents that movement of the valuation allowance on deferred tax assets ($ in thousands): </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance as of January 1,</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-791">284,072</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-792">189,684</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="3" id="f-793">73,884</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="3" id="f-794">94,388</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance as of December 31,</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-795">357,956</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-796">284,072</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">As of December&#160;31, 2023 and 2022, the Company had net operating loss carry forwards of $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-797">1,804.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-798">1,483.2</ix:nonFraction> million, respectively. As of December&#160;31, 2023, net operating loss carryforwards related to the Company&#8217;s subsidiaries in mainland China, Hong Kong, Taiwan, the United States, and Australia and were $<ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-799">1,492.0</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-5" name="us-gaap:OperatingLossCarryforwards" scale="6" id="f-800">51.0</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-5" name="us-gaap:OperatingLossCarryforwards" scale="6" id="f-801">2.1</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-5" name="us-gaap:OperatingLossCarryforwards" scale="6" id="f-802">256.0</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="c-172" decimals="-5" name="us-gaap:OperatingLossCarryforwards" scale="6" id="f-803">3.8</ix:nonFraction> million, respectively. Net operating loss carryforwards in mainland China and Taiwan expire through 2033 and those in Hong Kong, the United States, and Australia do not expire.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Uncertainties exist with respect to how the current income tax law in mainland China applies to the Company&#8217;s overall operations, and more specifically, with regard to tax residency status. The EIT Law includes a provision specifying that legal entities organized outside of mainland China will be considered residents for Chinese income tax purposes if the place of effective management or control is within mainland China. The implementation rules to the EIT Law provide that non-resident legal entities will be considered Chinese residents if substantial and overall management and control over the manufacturing and business operations, personnel, accounting, and properties occurs within mainland China. Despite the present uncertainties resulting from the limited Chinese tax guidance on the issue, the Company does not believe that the legal entities organized outside of mainland China within the Company should be treated as residents for EIT Law purposes. If the Chinese tax authorities subsequently determine that the Company and its subsidiaries registered outside of mainland China should be deemed resident enterprises, the Company and its subsidiaries registered outside of mainland China will be subject to Chinese income taxes, at a rate of 25%. The Company is not subject to any other uncertain tax position. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">According to the PRC Tax Administration and Collection Law, the statute of limitation is three years if the underpayment of taxes is due to computational errors made by the taxpayer or the withholding agent. The statute of limitation is extended to five years under special circumstances where the underpayment of taxes is more than RMB0.1 million. In the case of transfer pricing issues, the statute of limitation is 10 years. There is no statute of limitation in the case of tax evasion. The income tax returns of the Company&#8217;s PRC subsidiary for the years from 2014 to 2023 are open to examination by the PRC tax authorities.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">For Hong Kong income tax purposes, the statute of limitations is six years after the relevant year of assessment. This can be extended to 10 years in the case of fraud of willful evasion of taxes. There are no provisions that govern the time limit for tax collection.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">For U.S. federal income tax purposes, the statute of limitations is generally 3 years after the due date of the return, or 3 years after the date the return was actually filed, whichever is later. The statute of limitations does not apply to fraud or tax evasion. Also, the statute of limitations is indefinite if no tax return is filed. For state income tax purpose, the statute of limitations is generally 4 years from the return filing date or due date for California, Kentucky, and New Jersey, subject to certain exceptions (e.g., fraud, failure to file).</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">F-28</span></div></div></div><div id="i8a977bbf870448998f9d0f718b7b41b9_187"></div><hr style="page-break-after:always"/><div style="min-height:108pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Zai Lab Limited</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to the Consolidated Financial Statements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Years Ended December&#160;31, 2023, 2022, and 2021</span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">12.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="zlab:OtherCurrentLiabilitiesDisclosureTextBlock" id="f-804" continuedAt="f-804-1" escape="true">Other Current Liabilities </ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:OtherCurrentLiabilitiesTableTextBlock" id="f-805" continuedAt="f-805-1" escape="true"><ix:continuation id="f-804-1" continuedAt="f-804-2"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following table presents the Company&#8217;s other current liabilities ($ in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued payroll</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-806">33,711</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-807">31,689</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued professional service fee</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-808">7,520</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-809">4,080</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payables for purchase of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="zlab:PayablesForPurchaseOfPropertyAndEquipmentCurrent" format="ixt:num-dot-decimal" scale="3" id="f-810">2,474</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="zlab:PayablesForPurchaseOfPropertyAndEquipmentCurrent" format="ixt:num-dot-decimal" scale="3" id="f-811">5,269</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued rebate to distributors</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="zlab:AccruedRebateToDistributorsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-812">16,926</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="zlab:AccruedRebateToDistributorsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-813">8,443</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax payables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:TaxesPayableCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-814">16,988</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:TaxesPayableCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-815">13,283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Others (i)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="zlab:OtherPayablesCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-816">5,353</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="zlab:OtherPayablesCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-817">4,054</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-818">82,972</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-819">66,818</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div style="margin-top:6pt"><ix:continuation id="f-805-1" continuedAt="f-805-2"><ix:continuation id="f-804-2" continuedAt="f-804-3"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span></ix:continuation></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt"><ix:continuation id="f-805-2"><ix:continuation id="f-804-3">Others mainly include accrued travel, business-related expenses, and other payables to employee.</ix:continuation></ix:continuation> </span></div><div id="i8a977bbf870448998f9d0f718b7b41b9_190"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">13.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerShareTextBlock" id="f-820" continuedAt="f-820-1" escape="true">Loss Per Share </ix:nonNumeric></span></div><ix:continuation id="f-820-1"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="f-821" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following table presents the computation of the basic and diluted net loss per share ($ in thousands, except share and per share data):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss attributable to ordinary shareholders</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="f-822"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="f-823">334,620</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="f-824"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="f-825">443,286</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="f-826"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="f-827">704,471</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average number of ordinary shares - basic and diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-828"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-829">966,394,130</ix:nonFraction></ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-14" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-830"><ix:nonFraction unitRef="shares" contextRef="c-14" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-831">958,067,140</ix:nonFraction></ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-11" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-832"><ix:nonFraction unitRef="shares" contextRef="c-11" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-833">929,921,120</ix:nonFraction></ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss per share-basic and diluted</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-834"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-835">0.35</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-14" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-836"><ix:nonFraction unitRef="usdPerShare" contextRef="c-14" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-837">0.46</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-11" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-838"><ix:nonFraction unitRef="usdPerShare" contextRef="c-11" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-839">0.76</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">As a result of the Company&#8217;s net loss for 2023, 2022, and 2021, share options and non-vested restricted shares outstanding in the respective periods were excluded from the calculation of diluted loss per share as their inclusion would have been anti-dilutive.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="f-840" escape="true"><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share options</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-173" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-841">104,584,050</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-174" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-842">91,181,420</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-175" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-843">81,015,590</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-vested restricted shares</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-176" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-844">31,279,600</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-177" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-845">33,433,890</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-178" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-846">9,567,360</ix:nonFraction></span></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i8a977bbf870448998f9d0f718b7b41b9_193"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">14.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="f-847" continuedAt="f-847-1" escape="true">Related Party Transactions </ix:nonNumeric></span></div><ix:continuation id="f-847-1"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company incurred research and development expenses for product research and development services provided by MEDx (Suzhou) Translational Medicine Co., Ltd (&#8220;MEDx&#8221;), over which an immediate family member of its Chief Executive Officer and Chairperson of the Board held significant influence. The Company incurred development expenses with MEDx of insignificant amount in 2023, and $<ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-848">0.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-849">0.7</ix:nonFraction> million in 2022 and 2021, respectively.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">F-29</span></div></div></div><div id="i8a977bbf870448998f9d0f718b7b41b9_196"></div><hr style="page-break-after:always"/><div style="min-height:108pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Zai Lab Limited</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to the Consolidated Financial Statements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Years Ended December&#160;31, 2023, 2022, and 2021</span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">15.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="f-851" continuedAt="f-851-1" escape="true">Share-Based Compensation </ix:nonNumeric></span></div><ix:continuation id="f-851-1" continuedAt="f-851-2"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company has adopted equity incentive plans, pursuant to which the Company grants share options, SARs, restricted and unrestricted shares, and share units, performance awards, and other awards that are convertible into or otherwise based on ordinary shares to employees and directors of the Company as well as to certain advisors and service providers. In March 2015, the Board of Directors of the Company approved such an Equity Incentive Plan (the &#8220;2015 Plan&#8221;). In August 2017, in connection with the completion of the Company&#8217;s initial public offering on Nasdaq (the &#8220;IPO&#8221;), the Board of Directors approved the 2017 Equity Incentive Plan (the &#8220;2017 Plan&#8221;). No new equity-based awards would be granted under the 2015 Plan subsequent to the IPO; new equity-based awards would be granted under the 2017 Plan. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company adopted the 2022 Equity Incentive Plan (the &#8220;2022 Plan&#8221;), which became effective in June 2022 following required approvals from the Company&#8217;s shareholders and Board of Directors. No new equity-based awards will be made under the 2017 Plan as of the effective date of the 2022 Plan. The initial aggregate number of shares available for issuance under the 2022 Plan was <ix:nonFraction unitRef="shares" contextRef="c-182" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-852">97,908,743</ix:nonFraction> ordinary shares. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> The share options granted under the equity incentive plans described above have a contractual term of <ix:nonNumeric contextRef="c-183" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="f-853">ten years</ix:nonNumeric>. Share options granted since April 2023 generally vest ratably over a <ix:nonNumeric contextRef="c-184" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-854">four-year</ix:nonNumeric> period, and share options granted prior to April 2023 generally vest ratably over a <ix:nonNumeric contextRef="c-185" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-855">five-year</ix:nonNumeric> period, with <ix:nonFraction unitRef="number" contextRef="c-186" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="f-856"><ix:nonFraction unitRef="number" contextRef="c-187" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="f-857"><ix:nonFraction unitRef="number" contextRef="c-188" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="f-858"><ix:nonFraction unitRef="number" contextRef="c-189" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="f-859">25</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>% or <ix:nonFraction unitRef="number" contextRef="c-190" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="f-860"><ix:nonFraction unitRef="number" contextRef="c-191" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="f-861"><ix:nonFraction unitRef="number" contextRef="c-192" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="f-862"><ix:nonFraction unitRef="number" contextRef="c-193" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="f-863"><ix:nonFraction unitRef="number" contextRef="c-194" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="f-864">20</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>% of the awards vesting on each anniversary of the grant date, respectively, subject to continued employment/service with the Company on the vesting date. The restricted shares granted generally vest ratably over a specified period on the anniversary of the grant date, subject to continued employment/service with the Company on the vesting date. The shares underlying restricted share grants represent shares not yet vested until they have met related consideration or vesting requirements, which are generally continued employment/service to the Company or satisfaction of specified performance conditions. The restricted shares will be released from the restrictions once they vest. Upon termination of the award holders&#8217; service with the Company for any reason, any shares that are outstanding and not yet vested will be immediately forfeited unless otherwise set forth in an agreement between the Company and the award holder.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Before November 2023, upon each settlement date of the share awards, shares were generally withheld to cover the required withholding tax, which was based on the value of a share on the settlement date as determined by the closing price of the ADSs on the trading day of the applicable settlement date. The remaining shares after the withholding were delivered to the recipient. The amount remitted to the tax authorities for employee tax obligations was reflected as a financing activity on the consolidated statements of cash flows. These shares withheld by the Company as a result of the net settlement were accounted for as treasury stock and considered issued but not outstanding. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">F-30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:108pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Zai Lab Limited</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to the Consolidated Financial Statements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Years Ended December&#160;31, 2023, 2022, and 2021</span></div></div><ix:continuation id="f-851-2" continuedAt="f-851-3"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Stock Option Activity</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="f-865" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following table presents a summary of option activity and related information in 2023: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of<br/>options </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted<br/>average exercise<br/>price<br/>($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted<br/>average<br/>remaining<br/>contractual term (years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Aggregate<br/>intrinsic value <br/>($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding at December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-13" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-866">91,181,420</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-13" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-867">3.05</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-14" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-868">5.89</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="f-869">115,969</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="f-870">24,102,740</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="f-871">3.36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-872">6,516,920</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="f-873">0.39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-874">4,183,190</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="f-875">6.68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding at December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-12" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-876">104,584,050</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-12" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-877">3.14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-878">5.97</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="f-879">83,424</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vested and exercisable as of December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-12" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="f-880">58,695,320</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-12" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="f-881">2.11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="f-882">3.93</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:num-dot-decimal" scale="3" id="f-883">83,266</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The aggregate intrinsic value of stock options exercised during 2023, 2022, and 2021 was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="f-884">20.3</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="f-885">14.3</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="f-886">170.4</ix:nonFraction> million, respectively. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Stock Option Valuation Assumptions</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="f-887" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following table presents the assumptions used to estimate the fair values of the share options granted: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.415%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.993%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk-free rate of return</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-183" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="f-888">3.5</ix:nonFraction>%-<ix:nonFraction unitRef="number" contextRef="c-183" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="f-889">4.7</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-195" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="f-890">1.4</ix:nonFraction>%-<ix:nonFraction unitRef="number" contextRef="c-195" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="f-891">4.0</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-196" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="f-892">0.9</ix:nonFraction>%-<ix:nonFraction unitRef="number" contextRef="c-196" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="f-893">1.4</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-197" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-894">6</ix:nonNumeric>, <ix:nonNumeric contextRef="c-198" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-895">6.25</ix:nonNumeric>,or <ix:nonNumeric contextRef="c-199" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-896">6.5</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-195" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-897">6.5</ix:nonNumeric> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-200" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-898">6</ix:nonNumeric>, <ix:nonNumeric contextRef="c-201" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-899">6.25</ix:nonNumeric> or <ix:nonNumeric contextRef="c-202" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-900">6.5</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated volatility rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-183" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-901">70</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-195" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-902">65</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-196" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-903">65</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected dividend rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-183" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="f-904">0</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-195" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="f-905">0</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-196" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="f-906">0</ix:nonFraction>%</span></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Options granted are measured based on grant-date fair value using the Black-Scholes option pricing model. The weighted-average grant-date fair value per share for options granted during 2023, 2022, and 2021 were $<ix:nonFraction unitRef="usdPerShare" contextRef="c-183" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-907">2.21</ix:nonFraction>, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-195" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-908">2.74</ix:nonFraction>, and $<ix:nonFraction unitRef="usdPerShare" contextRef="c-196" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-909">12.60</ix:nonFraction> per share, respectively. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Non-Vested Restricted Shares Activity</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock" id="f-910" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following table summarized the Company&#8217;s non-vested restricted share activity in 2023: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Numbers<br/>of non-vested<br/>restricted shares </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted<br/>average<br/>remaining<br/>contractual term (years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Aggregate<br/>intrinsic value <br/>($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-vested as of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-203" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-911">33,433,890</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-204" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="f-912">3.55</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-203" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" format="ixt:num-dot-decimal" scale="3" id="f-913">102,642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-205" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-914">9,001,740</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="c-205" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-915">8,178,500</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="c-205" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-916">2,977,530</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-vested as of December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-206" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-917">31,279,600</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-205" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="f-918">2.75</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-206" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" format="ixt:num-dot-decimal" scale="3" id="f-919">85,487</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">F-31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:108pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Zai Lab Limited</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to the Consolidated Financial Statements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Years Ended December&#160;31, 2023, 2022, and 2021</span></div></div><ix:continuation id="f-851-3" continuedAt="f-851-4"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> The grant-date fair value of restricted shares is the fair value of the underlying stock on the award&#8217;s grant date. The weighted-average grant-date fair value per share for restricted shares granted in 2023, 2022, and 2021 were $<ix:nonFraction unitRef="usdPerShare" contextRef="c-205" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-920">3.18</ix:nonFraction>, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-204" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-921">3.71</ix:nonFraction>, and $<ix:nonFraction unitRef="usdPerShare" contextRef="c-207" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-922">10.55</ix:nonFraction> per share, respectively. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Stock-Based Compensation Expenses</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="f-923" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following table presents the share-based compensation expense which has been reported in the Company&#8217;s consolidated statements of operations ($ in thousands): </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-208" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-924">48,017</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-209" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-925">38,118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-210" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-926">23,194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-211" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-927">31,617</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-212" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-928">23,184</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-213" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-929">17,520</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-930">79,634</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-931">61,302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-932">40,714</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"><ix:continuation id="f-851-4">As of December&#160;31, 2023, there was unrecognized share-based compensation expense related to unvested share options and unvested restricted shares of $<ix:nonFraction unitRef="usd" contextRef="c-214" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" scale="6" id="f-933">104.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-206" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" scale="6" id="f-934">104.1</ix:nonFraction> million, respectively, which the Company expects to recognize over a weighted-average period of <ix:nonNumeric contextRef="c-183" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="f-935">3.05</ix:nonNumeric> years and <ix:nonNumeric contextRef="c-205" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="f-936">2.75</ix:nonNumeric> years, respectively.</ix:continuation>  </span></div><div id="i8a977bbf870448998f9d0f718b7b41b9_199"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">16.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="zlab:LicensesAndCollaborativeArrangementDisclosureTextBlock" id="f-937" continuedAt="f-937-1" escape="true">License and Collaboration Agreements </ix:nonNumeric></span></div><ix:continuation id="f-937-1" continuedAt="f-937-2"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company may enter into collaboration agreements with third parties to license intellectual property. These agreements may require the Company to make upfront payments and payments related to certain future development, regulatory, and sales-based milestones as well as certain royalties at tiered percentage rates on annual sales of the licensed products in the licensed territory. These agreements generally remain in effect, unless earlier terminated, until the expiration of the last-to-expire royalty term for the last licensed product. The royalty terms generally continue until the latest of: (i) the expiration of the last-to-expire valid claim with respect to licensed patent rights; (ii) the expiration of market or regulatory exclusivity; or (iii) or a specified period of time, generally around <ix:nonNumeric contextRef="c-1" name="zlab:CollaborativeArrangementRightsAndObligationsSpecifiedRoyaltyTerm" format="ixt-sec:durwordsen" id="f-938">ten years</ix:nonNumeric>, after the date of the first commercial sale of the licensed product. These agreements also contain customary provisions for termination by either party, including in the event of a material breach by the other party that remains uncured; by us for convenience upon a specified notice period; for certain bankruptcy, insolvency, or other similar events; and by its partners upon challenge of their licensed patent rights. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Payments under these agreements generally become due and payable upon the achievement of such milestones or sales. These commitments are not recorded as liabilities on the consolidated balance sheet because the achievement and timing of these milestones are not fixed and determinable. The following is a description of the Company&#8217;s significant license and collaboration agreements as of December&#160;31, 2023, including milestone fees incurred in 2023, 2022, and 2021. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;text-decoration:underline">Significant License and Collaboration Arrangements</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">License and Collaboration Agreement with GSK (Niraparib) </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In September 2016, the Company entered into a collaboration, development, and license agreement with Tesaro, Inc., a company later acquired by GSK, pursuant to which the Company obtained an exclusive sublicense under certain patents and know-how of GSK to develop, manufacture, and commercialize GSK&#8217;s proprietary PARP inhibitor, niraparib, for the diagnosis and prevention of any human diseases or conditions (other than prostate cancer) in mainland China, Hong Kong, and Macau. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">F-32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:108pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Zai Lab Limited</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to the Consolidated Financial Statements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Years Ended December&#160;31, 2023, 2022, and 2021</span></div></div><ix:continuation id="f-937-2" continuedAt="f-937-3"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company recorded development milestone fees into research and development expenses of $<ix:nonFraction unitRef="usd" contextRef="c-215" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-939">4.0</ix:nonFraction> million in 2022. The Company recorded sales-based milestone fees of $<ix:nonFraction unitRef="usd" contextRef="c-216" decimals="-5" name="zlab:CollaborativeArrangementRightsAndObligationsSalesBasedMilestonePayment" scale="6" id="f-940">12.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-217" decimals="-5" name="zlab:CollaborativeArrangementRightsAndObligationsSalesBasedMilestonePayment" scale="6" id="f-941">8.0</ix:nonFraction> million in 2023 and 2021, respectively. The Company may be required to pay an additional aggregate amount of up to $<ix:nonFraction unitRef="usd" contextRef="c-218" decimals="-5" name="zlab:CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments" scale="6" id="f-942">16.0</ix:nonFraction> million in development, regulatory, and sales-based milestones as well as certain royalties at tiered percentages rates ranging from mid- to high-teens on annual net sales of the licensed products in the licensed territories.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">License and Collaboration Agreement with NovoCure (Tumor Treating Fields)</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In September 2018, the Company entered into a license and collaboration agreement with NovoCure, pursuant to which it obtained an exclusive license under certain patents and know-how of NovoCure to develop and commercialize any Tumor Treating Fields treatment or delivery system, including the device branded as OPTUNE, in all human therapeutic and preventative uses in the field of oncology in Greater China. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company may be required to pay an additional aggregate amount of up to $<ix:nonFraction unitRef="usd" contextRef="c-219" decimals="-5" name="zlab:CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments" scale="6" id="f-943">68.0</ix:nonFraction> million in development, regulatory, and sales-based milestones as well as certain royalties at tiered percentage rates ranging from low- to mid-teens on annual net sales of the licensed products in the licensed territory. The Company will purchase licensed products exclusively from NovoCure at NovoCure&#8217;s fully burdened manufacturing cost. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">License and Collaboration Agreement with Deciphera (Ripretinib)</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In June 2019, the Company entered into a license agreement with Deciphera, pursuant to which it obtained an exclusive license under certain patents and know-how of Deciphera to develop and commercialize products containing ripretinib in the field of the prevention, prophylaxis, treatment, cure, or amelioration of any disease or medical condition in humans in Greater China. The Company will purchase licensed products exclusively from Deciphera.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company recorded development milestone fees into research and development expenses of $<ix:nonFraction unitRef="usd" contextRef="c-220" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-944">5.0</ix:nonFraction> million in 2021.  The Company may be required to pay an additional aggregate amount of up to $<ix:nonFraction unitRef="usd" contextRef="c-221" decimals="-5" name="zlab:CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments" scale="6" id="f-945">173.0</ix:nonFraction> million in development, regulatory, and sales-based milestones as well as certain royalties at tiered percentage rates ranging from low- to high-teens on annual net sales of the licensed products in the licensed territory.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">License and Collaboration Agreement with Novo Holdings (Omadacycline)</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In April 2017, the Company entered into a license and collaboration agreement with Paratek Bermuda Ltd. (&#8220;Paratek&#8221;), a subsidiary of Paratek (which was subsequently acquired by Gurnet Point Capital and Novo Holdings A/S), pursuant to which the Company obtained both an exclusive license under certain patents and know-how of Paratek and an exclusive sub-license under certain intellectual property that Paratek licensed from Tufts University to develop, manufacture, and commercialize products containing omadacycline as an active ingredient in the field of all human therapeutic and preventative uses other than biodefense in Greater China.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company recorded development milestone fees into research and development expenses of $<ix:nonFraction unitRef="usd" contextRef="c-222" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-946">6.0</ix:nonFraction> million in 2021. The Company may be required to pay an additional aggregate amount of up to $<ix:nonFraction unitRef="usd" contextRef="c-223" decimals="-5" name="zlab:CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments" scale="6" id="f-947">40.5</ix:nonFraction> million in development, regulatory, and sales-based milestones as well as certain royalties at tiered percentages rates ranging from low- to mid-teens on annual net sales of licensed products in the licensed territory. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Collaboration and License Agreement with argenx (Efgartigimod)</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In January 2021, the Company entered into a collaboration and license agreement with argenx BV (&#8220;argenx&#8221;) pursuant to which the Company obtained an exclusive license under certain patients and know-how of argenx to develop and commercialize products containing efgartigimod as an active ingredient in all human and animal uses for any </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">F-33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:108pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Zai Lab Limited</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to the Consolidated Financial Statements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Years Ended December&#160;31, 2023, 2022, and 2021</span></div></div><ix:continuation id="f-937-3" continuedAt="f-937-4"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">preventative or therapeutic indications in Greater China. The Company will purchase licensed products exclusively from argenx.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Pursuant to the collaboration and license agreement, the Company and argenx entered into a share issuance agreement. The Company issued as an upfront payment to argenx of <ix:nonFraction unitRef="shares" contextRef="c-224" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross" format="ixt:num-dot-decimal" scale="0" id="f-948">5,681,820</ix:nonFraction> ordinary shares of the Company. In determining the fair value of the ordinary shares at closing, the Company considered the closing price of the ordinary shares on the closing date and included a lack of marketability discount because the shares were subject to certain restrictions. The fair value of the shares on the closing date was determined to be $<ix:nonFraction unitRef="usd" contextRef="c-224" decimals="-5" name="zlab:CollaborativeArrangementRightsAndObligationsPaymentOfUpFrontFeesForLicenseAgreement" scale="6" id="f-949">62.3</ix:nonFraction> million in the aggregate. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company recorded development milestone fees into research and development expense of $<ix:nonFraction unitRef="usd" contextRef="c-225" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-950">100.0</ix:nonFraction> million in 2021. The Company may be required to pay certain royalties at tiered percentages rates ranging from mid-teen to low-twenties on annual net sales of the licensed products in the licensed territory.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">License and Collaboration Agreement with Amgen (Bemarituzumab)</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In December 2017, the Company entered into a license and collaboration agreement with Five Prime Therapeutics, Inc. (a company later acquired by Amgen), pursuant to which it obtained an exclusive license under certain patents and know-how of Five Prime to develop and commercialize products containing Five Prime&#8217;s proprietary afucosylated FGFR2b antibody known as bemarituzumab (FPA144) as an active ingredient in the treatment or prevention of any disease or condition in humans in Greater China.  The Company will purchase licensed products exclusively from Amgen.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company may be required to pay an additional aggregate amount of up to $<ix:nonFraction unitRef="usd" contextRef="c-226" decimals="-5" name="zlab:CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments" scale="6" id="f-951">37.0</ix:nonFraction> million in development and regulatory milestones as well as certain royalties at tiered percentage rates ranging from high-teens to low twenties on annual net sales of the licensed product in the licensed territory. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Under the terms of the agreement, provided that the Company enrolls and treats a specified number of patients in the bemarituzumab FPA144-004 study in mainland China, the Company is eligible to receive a low single-digit percentage quarterly royalty, on a licensed product-by-licensed product basis on net sales of all licensed product outside of the licensed territory until the tenth (<ix:nonNumeric contextRef="c-227" name="zlab:CollaborativeArrangementRightsAndObligationsSpecifiedRoyaltyTerm" format="ixt-sec:duryear" id="f-952">10</ix:nonNumeric>th) anniversary of the first commercial sale of each such licensed product outside of the licensed territory. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">License and Collaboration Agreement with Innoviva (SUL-DUR)</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In April 2018, the Company entered into a license and collaboration agreement with Entasis Therapeutics Holdings Inc. (&#8220;Entasis&#8221;), a wholly owned subsidiary of Innoviva, Inc. (&#8220;Innoviva&#8221;), pursuant to which it obtained an exclusive license under certain patents and know-how of Entasis to develop and commercialize products containing Entasis&#8217;s proprietary compounds known as durlobactam with Sulbactam (the combination, SUL-DUR) with the possibility of developing and commercializing a combination of such compounds with Imipenem in all human diagnostic, prophylactic, and therapeutic uses in Greater China, Korea, Vietnam, Thailand, Cambodia, Laos, Malaysia, Indonesia, the Philippines, Singapore, Australia, New Zealand, and Japan. The Company&#8217;s rights to develop and commercialize the licensed products are limited to the lead product (Sulbactam) until such lead product receives initial FDA approval in the United States. The Company will purchase licensed products exclusively from Innoviva.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company recorded development milestone fees into research and development expenses of $<ix:nonFraction unitRef="usd" contextRef="c-228" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-953">3.0</ix:nonFraction> million in 2023. The Company may be required to pay an additional aggregate amount of up to $<ix:nonFraction unitRef="usd" contextRef="c-229" decimals="-5" name="zlab:CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments" scale="6" id="f-954">88.6</ix:nonFraction> million in development and sales-based milestones as well as certain royalties at tiered percentage rates ranging from high single digits to low-teens on annual net sales of the licensed products in the licensed territory. The Company is also responsible for a portion of the costs of the global pivotal Phase III ATTACK clinical trial of SUL-DUR outside of the licensed territory.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">F-34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:108pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Zai Lab Limited</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to the Consolidated Financial Statements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Years Ended December&#160;31, 2023, 2022, and 2021</span></div></div><ix:continuation id="f-937-4" continuedAt="f-937-5"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">License Agreement with BMS (Repotrectinib)</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In July 2020, the Company entered into an exclusive license agreement with Turning Point Therapeutics, Inc. (a company later required by BMS) pursuant to which the Company received an exclusive license to develop and commercialize products containing repotrectinib as an active ingredient in all human therapeutic indications in Greater China. The Company will purchase licensed products exclusively from BMS.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company recorded development milestone fees into research and development expenses of $<ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-955"><ix:nonFraction unitRef="usd" contextRef="c-231" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-956">5.0</ix:nonFraction></ix:nonFraction> million in each of 2023 and 2021. The Company may be required to pay an additional aggregate amount of up to $<ix:nonFraction unitRef="usd" contextRef="c-232" decimals="-5" name="zlab:CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments" scale="6" id="f-957">141.0</ix:nonFraction> million in development, regulatory, and sales-based milestones as well as certain royalties at tiered percentage rates ranging from mid- to high-teens on annual net sales of the licensed product in the licensed territory. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Collaboration and License Agreement with BMS (Adagrasib)</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In May 2021, the Company entered into a collaboration and license agreement with Mirati Therapeutics, Inc. (&#8220;Mirati&#8221;) (a company later acquired by BMS) pursuant to which the Company obtained the right to research, develop, manufacture, and exclusively commercialize adagrasib in all indications in Greater China, with Mirati retaining exclusive rights for the development, manufacturing, and commercialization of adagrasib outside of Greater China and certain co-commercialization, manufacture, and development rights in Greater China. The Company will purchase licensed products exclusively from BMS.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company recorded development milestone fees of $<ix:nonFraction unitRef="usd" contextRef="c-233" decimals="-5" name="zlab:CollaborativeArrangementRightsAndObligationsDevelopmentMilestonePayment" scale="6" id="f-958">10.0</ix:nonFraction> million in 2022 and an upfront payment of $<ix:nonFraction unitRef="usd" contextRef="c-234" decimals="-5" name="zlab:CollaborativeArrangementRightsAndObligationsPaymentOfUpFrontFeesForLicenseAgreement" scale="6" id="f-959">65.0</ix:nonFraction> million in 2021. The Company may be required to pay an additional aggregate amount of up to $<ix:nonFraction unitRef="usd" contextRef="c-235" decimals="-5" name="zlab:CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments" scale="6" id="f-960">263.0</ix:nonFraction> million in development, regulatory, and sales-based milestones as well as certain royalties at tiered percentage rates ranging from high-teens to low-twenties on annual net sales of the licensed product in the licensed territory.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">License Agreement with BMS (Xanomeline-Trospium)</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In November 2021, the Company entered into a license agreement with Karuna Therapeutics, Inc. (a company later acquired by BMS), pursuant to which the Company obtained an exclusive license to develop, manufacture, and commercialize xanomeline-trospium (KarXT) in Greater China.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company recorded an upfront payment of $<ix:nonFraction unitRef="usd" contextRef="c-236" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-961">35.0</ix:nonFraction> million and development milestone fees of $<ix:nonFraction unitRef="usd" contextRef="c-237" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-962">10.0</ix:nonFraction> million into research and development expenses in 2021 and 2022, respectively. The Company may be required to pay an additional aggregate amount of up to $<ix:nonFraction unitRef="usd" contextRef="c-238" decimals="-5" name="zlab:CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments" scale="6" id="f-963">142.0</ix:nonFraction> million in development, regulatory, and sales-based milestones as well as certain royalties at tiered percentage rates ranging from low- to high-teens on annual net sales of the licensed products in Greater China.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Collaboration and License Agreement with Pfizer (Tisotumab Vedotin)</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In September 2022, the Company entered into a collaboration and license agreement with Seagen Inc. (a company later acquired by Pfizer Inc. (&#8220;Pfizer&#8221;), pursuant to which the Company and Seagen agreed to collaboratively develop and commercialize tisotumab vedotin (TIVDAK). Under the agreement, the Company obtained an exclusive license to develop and commercialize TIVDAK in Greater China.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company recorded an upfront payment of $<ix:nonFraction unitRef="usd" contextRef="c-239" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-964">30.0</ix:nonFraction> million into research and development expenses in 2022. The Company may be required to pay an additional aggregate amount of up to $<ix:nonFraction unitRef="usd" contextRef="c-240" decimals="-5" name="zlab:CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments" scale="6" id="f-965">263.0</ix:nonFraction> million in development, regulatory, and sales-based milestone payments as well as certain royalties at tiered percentage rates ranging from mid-teens to low-twenties on annual net sales of the licensed products in Greater China. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">F-35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:108pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Zai Lab Limited</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to the Consolidated Financial Statements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Years Ended December&#160;31, 2023, 2022, and 2021</span></div></div><ix:continuation id="f-937-5"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The agreement will remain in effect, unless earlier terminated, until the expiration of the last-to-expire royalty term for the last licensed product. The agreement contains customary provisions for termination by either party, including in the event of a material breach by the other party that remains uncured, by the Company for convenience, for certain bankruptcy events, and by Seagen upon a challenge of the licensed patent rights.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;text-decoration:underline">Other License and Collaboration Arrangements That Are Not Individually Significant</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company recorded an upfront payment of $<ix:nonFraction unitRef="usd" contextRef="c-241" decimals="-5" name="zlab:CollaborativeArrangementRightsAndObligationsPaymentOfUpFrontFeesForLicenseAgreement" format="ixt:num-dot-decimal" scale="6" id="f-966">10.0</ix:nonFraction>&#160;million in 2023 for other license and collaboration agreements that are not individually significant. The Company may be required to pay an additional aggregate amount of up to $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="zlab:CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments" format="ixt:num-dot-decimal" scale="6" id="f-967">2,202.1</ix:nonFraction> million in development, regulatory, and sales-based milestones as well as certain royalties at tiered percentage rates on annual net sales under such agreements.</span></div></ix:continuation><div id="i8a977bbf870448998f9d0f718b7b41b9_202"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">17.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:OtherNonoperatingIncomeAndExpenseTextBlock" id="f-968" continuedAt="f-968-1" escape="true">Other Income (Expenses), Net </ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" id="f-969" escape="true"><ix:continuation id="f-968-1"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following table presents the Company&#8217;s other income (expenses), net ($ in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Government grants</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="zlab:GovernmentAssistanceNonoperatingIncome" format="ixt:num-dot-decimal" scale="3" id="f-970">2,433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="zlab:GovernmentAssistanceNonoperatingIncome" format="ixt:num-dot-decimal" scale="3" id="f-971">11,471</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="zlab:GovernmentAssistanceNonoperatingIncome" format="ixt:num-dot-decimal" scale="3" id="f-972">4,113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gain (Loss) on equity investments with readily determinable fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:EquitySecuritiesFvNiGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-973">2,789</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:EquitySecuritiesFvNiGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-974">8,952</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" sign="-" name="us-gaap:EquitySecuritiesFvNiGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-975">14,617</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Others miscellaneous gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherNonoperatingGainsLosses" format="ixt:num-dot-decimal" scale="3" id="f-976">1,784</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:OtherNonoperatingGainsLosses" scale="3" id="f-977">594</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:OtherNonoperatingGainsLosses" scale="3" id="f-978">303</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-979">7,006</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-980">3,113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-981">10,201</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div id="i8a977bbf870448998f9d0f718b7b41b9_205"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">18.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:RestrictedAssetsDisclosureTextBlock" id="f-982" continuedAt="f-982-1" escape="true">Restricted Net Assets</ix:nonNumeric></span></div><ix:continuation id="f-982-1" continuedAt="f-982-2"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company&#8217;s ability to pay dividends may depend on the Company receiving distributions of funds from its Chinese subsidiaries. Relevant Chinese laws and regulations permit payments of dividends by the Company&#8217;s Chinese subsidiaries only out of its retained earnings, if any, as determined in accordance with Chinese accounting standards and regulations. The results of operations reflected in the consolidated financial statements prepared in accordance with U.S. GAAP differ from those reflected in the statutory financial statements of the Company&#8217;s Chinese subsidiaries.  </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In accordance with the Company Law of the People&#8217;s Republic of China, a domestic enterprise is required to provide statutory reserves of at least 10% of its annual after-tax profit until such reserve has reached 50% of its respective registered capital based on the enterprise&#8217;s Chinese statutory accounts. A domestic enterprise may provide discretionary surplus reserve, at the discretion of the Board of Directors, from the profits determined in accordance with the enterprise&#8217;s Chinese statutory accounts. The aforementioned reserves can only be used for specific purposes and are not distributable as cash dividends. The Company&#8217;s Chinese subsidiaries were established as domestic enterprises and therefore are subject to the above-mentioned restrictions on distributable profits. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="INF" name="zlab:StatutoryReserves" format="ixt:fixed-zero" scale="3" id="f-983"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="INF" name="zlab:StatutoryReserves" format="ixt:fixed-zero" scale="3" id="f-984"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="INF" name="zlab:StatutoryReserves" format="ixt:fixed-zero" scale="3" id="f-985">No</ix:nonFraction></ix:nonFraction></ix:nonFraction> appropriation to statutory reserves was made during the years ended December&#160;31, 2023, 2022, and 2021 because the Chinese subsidiaries had substantial losses during such periods. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">As a result of these Chinese laws and regulations, subject to the limits discussed above that require annual appropriations of 10% of after-tax profit to be set aside, prior to payment of dividends, as a general reserve fund, the Company&#8217;s Chinese subsidiaries are restricted in their ability to transfer out a portion of their net assets. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Foreign exchange and other regulation in mainland China may further restrict the Company&#8217;s subsidiaries in mainland China from transferring out funds in the form of dividends, loans, and advances. As of December&#160;31, 2023 and </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">F-36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:108pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Zai Lab Limited</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to the Consolidated Financial Statements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Years Ended December&#160;31, 2023, 2022, and 2021</span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"><ix:continuation id="f-982-2">2022, amounts restricted were the paid-in capital of the Company&#8217;s subsidiaries in mainland China, which were $<ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-5" name="us-gaap:AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries" scale="6" id="f-986">506.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-242" decimals="-5" name="us-gaap:AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries" scale="6" id="f-987">456.0</ix:nonFraction> million, respectively.</ix:continuation> </span></div><div id="i8a977bbf870448998f9d0f718b7b41b9_208"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">19.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock" id="f-988" continuedAt="f-988-1" escape="true">Employee Defined Contribution Plans</ix:nonNumeric></span></div><ix:continuation id="f-988-1" continuedAt="f-988-2"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Full time employees of the Company in mainland China participate in a government mandated defined contribution plan, pursuant to which certain pension benefits, medical care, employee housing fund, and other welfare benefits are provided to employees. Chinese labor regulations require that the Company&#8217;s subsidiaries in China mainland make contributions to the government for these benefits primarily based on certain percentages of the employees&#8217; salaries subject to certain caps and other government requirements. The total amounts for such employee benefits, which were expensed as incurred, were $<ix:nonFraction unitRef="usd" contextRef="c-243" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" scale="6" id="f-989">25.8</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-244" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" scale="6" id="f-990">23.6</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="c-245" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" scale="6" id="f-991">17.6</ix:nonFraction> million for 2023, 2022, and 2021, respectively.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company&#8217;s employees who are U.S. taxpayers and who meet certain age and service requirements are eligible to participate in a broad-based, defined contribution retirement plan which is qualified under Section 401 of the Internal Revenue Code (&#8220;the 401(k) plan&#8221;). The Company makes a matching contribution equal to <ix:nonFraction unitRef="number" contextRef="c-246" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" scale="-2" id="f-992">100</ix:nonFraction>% in 2023 and <ix:nonFraction unitRef="number" contextRef="c-247" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" scale="-2" id="f-993"><ix:nonFraction unitRef="number" contextRef="c-248" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" scale="-2" id="f-994">50</ix:nonFraction></ix:nonFraction>% in 2022 and 2021 of the first <ix:nonFraction unitRef="number" contextRef="c-248" decimals="INF" name="zlab:DefinedContributionPlanEmployerMatchingContributionPercentOfEmployeeContribution" scale="-2" id="f-995"><ix:nonFraction unitRef="number" contextRef="c-246" decimals="INF" name="zlab:DefinedContributionPlanEmployerMatchingContributionPercentOfEmployeeContribution" scale="-2" id="f-996"><ix:nonFraction unitRef="number" contextRef="c-247" decimals="INF" name="zlab:DefinedContributionPlanEmployerMatchingContributionPercentOfEmployeeContribution" scale="-2" id="f-997">5</ix:nonFraction></ix:nonFraction></ix:nonFraction>% of the employee&#8217;s elective contributions under the plan, up to <ix:nonFraction unitRef="number" contextRef="c-249" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent" scale="-2" id="f-998"><ix:nonFraction unitRef="number" contextRef="c-250" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent" scale="-2" id="f-999"><ix:nonFraction unitRef="number" contextRef="c-251" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent" scale="-2" id="f-1000">5.0</ix:nonFraction></ix:nonFraction></ix:nonFraction>% of an employee&#8217;s eligible compensation. Contributions made by the Company vest 100% upon contribution. The total amounts for such employee benefits, which were expensed as incurred, were $<ix:nonFraction unitRef="usd" contextRef="c-246" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" scale="6" id="f-1001">1.0</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-248" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" scale="6" id="f-1002">0.5</ix:nonFraction> million, and insignificant in 2023, 2022, and 2021, respectively. </span></div></ix:continuation><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"><ix:continuation id="f-988-2">The Company also provides required Mandatory Provident Fund contribution for its full-time employees located in Hong Kong and provides social benefits contribution for its full-time employees located in Taiwan. The total amounts for these contributions, which were expensed as incurred, was $<ix:nonFraction unitRef="usd" contextRef="c-252" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" scale="6" id="f-1003">0.2</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-253" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" scale="6" id="f-1004">0.2</ix:nonFraction> million, and insignificant in 2023, 2022, and 2021, respectively.</ix:continuation> </span></div><div id="i8a977bbf870448998f9d0f718b7b41b9_211"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">20.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="f-1007" continuedAt="f-1007-1" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="f-1007-1" continuedAt="f-1007-2"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(a)&#160;&#160;&#160;&#160;Purchase Commitments</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company&#8217;s commitments related to purchase of property and equipment contracted but not yet reflected in the consolidated financial statements were $<ix:nonFraction unitRef="usd" contextRef="c-255" decimals="-5" name="us-gaap:UnrecordedUnconditionalPurchaseObligationDueInNextRollingTwelveMonths" scale="6" id="f-1008">1.2</ix:nonFraction> million as of December&#160;31, 2023 and were expected to be incurred within one year. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(b)&#160;&#160;&#160;&#160;Legal Proceedings</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company is not currently a party to any material legal proceedings. Each quarter, the Company evaluates whether there have been any developments in legal proceedings that would require an accrual. In accordance with the accounting guidance for contingencies, the Company will accrue for losses that are both probable and reasonably estimable. The Company will record any legal and other third-party costs related to its legal contingencies as incurred.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(c)       Indemnifications</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In the normal course of business, the Company enters into agreements that indemnify others for certain liabilities that may arise in connection with a transaction or certain events and activities. If the indemnified party were to make a successful claim pursuant to the terms of the indemnification, the Company may be required to reimburse the loss. These indemnifications are generally subject to various restrictions and limitations. The Company&#8217;s exposure under these agreements is unknown because it involves claims that may be made against the Company in the future but have not yet </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">F-37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:108pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Zai Lab Limited</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to the consolidated financial statements </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December&#160;31, 2021, 2022 and 2023 </span></div><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"><ix:continuation id="f-1007-2">been made. To date, the Company has not paid any claims or been required to defend any action related to its indemnification obligations.</ix:continuation> </span></div><div id="i8a977bbf870448998f9d0f718b7b41b9_217"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">21.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:SubsequentEventsTextBlock" id="f-1009" continuedAt="f-1009-1" escape="true">Subsequent Events </ix:nonNumeric></span></div><ix:continuation id="f-1009-1"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In February 2024, the Company entered into certain debt arrangements with the Bank of China, SPD Bank, and Ningbo Bank to support its working capital needs in mainland China.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Bank of China Working Capital Loan Facility</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">On February 5, 2024, the Company entered into an uncommitted facility letter with the Bank of China (Hong Kong) Limited (the &#8220;BOC HK&#8221;) pursuant to which the BOC HK will provide standby letters of credit for loans of up to $<ix:nonFraction unitRef="usd" contextRef="c-256" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="f-1010">100.0</ix:nonFraction> million for a term of <ix:nonNumeric contextRef="c-257" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="f-1011">one year</ix:nonNumeric>. In connection with this agreement, the Company paid a one-time, non-refundable fee of $<ix:nonFraction unitRef="usd" contextRef="c-258" decimals="-5" name="us-gaap:DebtInstrumentFeeAmount" scale="6" id="f-1012">0.7</ix:nonFraction> million. On February 6, 2024, upon the Company&#8217;s application, the BOC HK provided a standby letter of credit in favor of the Bank of China Pudong Development Zone Branch (the &#8220;BOC Pudong Branch&#8221;) for $<ix:nonFraction unitRef="usd" contextRef="c-259" decimals="-5" name="us-gaap:LettersOfCreditOutstandingAmount" format="ixt:num-dot-decimal" scale="6" id="f-1013">50.0</ix:nonFraction>&#160;million which are or may become payable by the Company&#8217;s wholly-owned subsidiary, Zai Lab (Shanghai) Co., Ltd. (&#8220;Zai Lab Shanghai&#8221;), and Zai Lab Shanghai subsequently entered into a working capital loan contract with the BOC Pudong Branch on February 7, 2024 for a loan of RMB<ix:nonFraction unitRef="cny" contextRef="c-260" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-1014">340.0</ix:nonFraction>&#160;million (approximately $<ix:nonFraction unitRef="usd" contextRef="c-260" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-1015">47.8</ix:nonFraction>&#160;million). The working capital loan has a <ix:nonNumeric contextRef="c-261" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="f-1016">one-year</ix:nonNumeric> term and is subject to a floating interest rate of approximately <ix:nonFraction unitRef="number" contextRef="c-260" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1017">2.95</ix:nonFraction>% initially, and is subject to adjustment every <ix:nonNumeric contextRef="c-261" name="zlab:DebtInstrumentVariableInterestRateAdjustmentPeriod" format="ixt-sec:durwordsen" id="f-1018">six months</ix:nonNumeric>.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">SPD Bank Working Capital Loan Facility</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">On February 6, 2024, the Company entered into a maximum-amount guarantee contract with the Shanghai Pudong Development Bank Co., Ltd. Zhangjiang Hi-Tech Park Sub-branch (the &#8220;SPD Bank&#8221;) pursuant to which the Company will guarantee working capital loans of up to RMB<ix:nonFraction unitRef="cny" contextRef="c-262" decimals="-5" name="us-gaap:GuaranteeObligationsMaximumExposure" format="ixt:num-dot-decimal" scale="6" id="f-1019">300.0</ix:nonFraction>&#160;million (approximately $<ix:nonFraction unitRef="usd" contextRef="c-262" decimals="-5" name="us-gaap:GuaranteeObligationsMaximumExposure" format="ixt:num-dot-decimal" scale="6" id="f-1020">42.0</ix:nonFraction>&#160;million) from SPD Bank to Zai Lab Shanghai over a <ix:nonNumeric contextRef="c-263" name="zlab:GuarantorObligationTerm" format="ixt-sec:durwordsen" id="f-1021">three-year</ix:nonNumeric> period. To date, Zai Lab Shanghai has entered into a working capital loan contract with SPD Bank under this debt facility for RMB<ix:nonFraction unitRef="cny" contextRef="c-264" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-1022">50.0</ix:nonFraction>&#160;million (approximately $<ix:nonFraction unitRef="usd" contextRef="c-264" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-1023">7.0</ix:nonFraction>&#160;million). The working capital loan has a <ix:nonNumeric contextRef="c-265" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="f-1024">one-year</ix:nonNumeric> term and is subject to a fixed interest rate of <ix:nonFraction unitRef="number" contextRef="c-264" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1025">3.45</ix:nonFraction>%.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Ningbo Bank Working Capital Loan Facility</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">On February 6, 2024, the Company&#8217;s wholly-owned subsidiary, Zai Lab (Suzhou) Co., Ltd. (&#8220;Zai Lab Suzhou&#8221;), entered into a maximum credit contract with Bank of Ningbo Co., Ltd. Suzhou Sub-branch (&#8220;Ningbo Bank&#8221;) as well as an Electronic Commercial Draft Discounting Master Agreement and Online Working Capital Loan Master Agreement (collectively, the &#8220;Ningbo Bank Agreements&#8221;). The Ningbo Bank Agreements permit Zai Lab Suzhou to utilize, including through discounting or working capital loan agreements and subject to the terms and conditions in related master agreements, up to RMB<ix:nonFraction unitRef="cny" contextRef="c-266" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-1026">230.3</ix:nonFraction>&#160;million (approximately $<ix:nonFraction unitRef="usd" contextRef="c-266" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-1027">32.4</ix:nonFraction>&#160;million), of which the Company is authorized to utilize up to RMB<ix:nonFraction unitRef="cny" contextRef="c-267" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-1028">160.0</ix:nonFraction>&#160;million (approximately $<ix:nonFraction unitRef="usd" contextRef="c-267" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-1029">22.5</ix:nonFraction>&#160;million). In connection with the arrangements described in the Ningbo Bank Agreements, Zai Lab Suzhou agreed to pledge interests in certain real property it owns in Suzhou. To date, Zai Lab Suzhou has not entered into any discounting arrangements or working capital loans under this Ningbo Bank working capital loan facility.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">F-38</span></div></div></div><div id="i8a977bbf870448998f9d0f718b7b41b9_220"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:18pt"><span><br/></span></div><div id="i8a977bbf870448998f9d0f718b7b41b9_223"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock" id="f-1030" continuedAt="f-1030-1" escape="true"><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Schedule I &#8212; Condensed Financial Information of Registrant</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Zai Lab Limited</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Information of Parent Company</span></div><ix:nonNumeric contextRef="c-1" name="srt:ScheduleOfCondensedBalanceSheetTableTextBlock" id="f-1031" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Balance Sheets</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands of $, except for number of shares and per share data)</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-1032">565,981</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-269" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-1033">944,649</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepayments and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1034">7,423</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-269" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1035">10,203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1036">573,404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-269" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1037">954,852</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investment in subsidiaries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="f-1038">224,954</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-269" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="f-1039">93,363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-1040">798,358</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-269" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-1041">1,048,215</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liabilities and shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1042">2,240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-269" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1043">2,620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1044">2,240</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-269" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1045">2,620</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-1046">2,240</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-269" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-1047">2,620</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ordinary shares (par value of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-269" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-1048"><ix:nonFraction unitRef="usdPerShare" contextRef="c-268" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-1049">0.000006</ix:nonFraction></ix:nonFraction> per share; <ix:nonFraction unitRef="shares" contextRef="c-268" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-1050"><ix:nonFraction unitRef="shares" contextRef="c-269" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-1051">5,000,000,000</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction unitRef="shares" contextRef="c-268" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-1052">977,151,270</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-269" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-1053">962,455,850</ix:nonFraction> shares issued as of December&#160;31, 2023 and 2022, respectively; <ix:nonFraction unitRef="shares" contextRef="c-268" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1054">972,239,070</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-269" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1055">960,219,570</ix:nonFraction> shares issued and outstanding as of December&#160;31, 2023 and 2022, respectively)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-1056">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-269" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-1057">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-1058">2,975,302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-269" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-1059">2,893,120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-1060">2,195,980</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-269" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-1061">1,861,360</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated other comprehensive income</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-1062">37,626</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-269" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-1063">25,685</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Treasury stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-3" name="us-gaap:TreasuryStockCommonValue" format="ixt:num-dot-decimal" scale="3" id="f-1064">20,836</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-269" decimals="-3" name="us-gaap:TreasuryStockCommonValue" format="ixt:num-dot-decimal" scale="3" id="f-1065">11,856</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total shareholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-1066">796,118</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-269" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-1067">1,045,595</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total liabilities and shareholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-1068">798,358</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-269" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-1069">1,048,215</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">F-39</span></div></div></div><div id="i8a977bbf870448998f9d0f718b7b41b9_226"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><ix:continuation id="f-1030-1" continuedAt="f-1030-2"><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Schedule I &#8212; Condensed Financial Information of Registrant</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Zai Lab Limited </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Information of Parent Company</span></div><ix:nonNumeric contextRef="c-1" name="srt:CondensedStatementOfComprehensiveIncomeTableTextBlock" id="f-1070" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Statements of Operations and Comprehensive Loss</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands of $)</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="f-1071">82</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-271" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="f-1072">178</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="f-1073">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1074">16,958</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-271" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1075">19,773</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1076">12,074</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Loss from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1077">17,040</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-271" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1078">19,951</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1079">12,080</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-3" name="us-gaap:InvestmentIncomeInterest" format="ixt:num-dot-decimal" scale="3" id="f-1080">30,840</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-271" decimals="-3" name="us-gaap:InvestmentIncomeInterest" format="ixt:num-dot-decimal" scale="3" id="f-1081">12,857</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-3" name="us-gaap:InvestmentIncomeInterest" format="ixt:num-dot-decimal" scale="3" id="f-1082">1,881</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1083">4,029</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-271" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1084">8,678</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1085">18,173</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Profit (Loss) before income tax and equity in loss of subsidiaries</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-1086">17,829</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-271" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-1087">15,772</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-1088">28,372</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity in loss of subsidiaries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-3" sign="-" name="zlab:IncomeLossFromEquityMethodInvestmentsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-1089">352,449</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-271" decimals="-3" sign="-" name="zlab:IncomeLossFromEquityMethodInvestmentsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-1090">427,514</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-3" sign="-" name="zlab:IncomeLossFromEquityMethodInvestmentsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-1091">676,099</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="f-1092">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-271" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="f-1093">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="f-1094">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1095">334,620</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-271" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1096">443,286</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1097">704,471</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive income (loss), net of tax of <ix:nonFraction unitRef="usd" contextRef="c-270" decimals="INF" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" format="ixt:fixed-zero" scale="0" id="f-1098"><ix:nonFraction unitRef="usd" contextRef="c-271" decimals="INF" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" format="ixt:fixed-zero" scale="0" id="f-1099"><ix:nonFraction unitRef="usd" contextRef="c-272" decimals="INF" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" format="ixt:fixed-zero" scale="0" id="f-1100">nil</ix:nonFraction></ix:nonFraction></ix:nonFraction>:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="f-1101">11,941</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-271" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="f-1102">49,330</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="f-1103">9,121</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-1104">322,679</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-271" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-1105">393,956</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-1106">713,592</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">F-40</span></div></div></div><div id="i8a977bbf870448998f9d0f718b7b41b9_229"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><ix:continuation id="f-1030-2" continuedAt="f-1030-3"><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Schedule I &#8212; Condensed Financial Information of Registrant</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Zai Lab Limited </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Information of Parent Company </span></div><ix:nonNumeric contextRef="c-1" name="srt:ScheduleOfCondensedCashFlowStatementTableTextBlock" id="f-1107" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Statements of Cash Flows</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands of $)</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1108">334,620</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-271" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1109">443,286</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1110">704,471</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjustments to reconcile net loss to net cash provided by (used in) operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of deferred income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-3" name="zlab:AmortizationOfDeferredIncome" format="ixt:fixed-zero" scale="3" id="f-1111">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-271" decimals="-3" sign="-" name="zlab:AmortizationOfDeferredIncome" scale="3" id="f-1112">234</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-3" sign="-" name="zlab:AmortizationOfDeferredIncome" scale="3" id="f-1113">312</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-1114">3,217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-271" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-1115">3,724</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-1116">3,435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity in loss of subsidiaries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-3" sign="-" name="zlab:IncomeLossFromEquityMethodInvestmentsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-1117">352,449</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-271" decimals="-3" sign="-" name="zlab:IncomeLossFromEquityMethodInvestmentsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-1118">427,514</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-3" sign="-" name="zlab:IncomeLossFromEquityMethodInvestmentsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-1119">676,099</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss from fair value changes of equity investment of readily determinable fair value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-3" name="us-gaap:EquitySecuritiesFvNiGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-1120">2,789</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-271" decimals="-3" sign="-" name="us-gaap:EquitySecuritiesFvNiGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-1121">8,952</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-3" sign="-" name="us-gaap:EquitySecuritiesFvNiGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-1122">14,617</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepayments and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="f-1123">2,780</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-271" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="f-1124">7,839</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="f-1125">439</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" scale="3" id="f-1126">379</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-271" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1127">1,648</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" scale="3" id="f-1128">376</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by (used in) operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-1129">20,658</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-271" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-1130">9,521</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-1131">11,447</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchases of short-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-3" name="us-gaap:PaymentsToAcquireShortTermInvestments" format="ixt:fixed-zero" scale="3" id="f-1132">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-271" decimals="-3" name="us-gaap:PaymentsToAcquireShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-1133">260,274</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-3" name="us-gaap:PaymentsToAcquireShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-1134">445,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proceeds from maturity of short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-3" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" format="ixt:fixed-zero" scale="3" id="f-1135">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-271" decimals="-3" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-1136">705,274</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-3" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-1137">743,902</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchase of investment in equity investee</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-3" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:fixed-zero" scale="3" id="f-1138">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-271" decimals="-3" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:fixed-zero" scale="3" id="f-1139">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-3" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-1140">30,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investment in subsidiaries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-3" name="us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates" format="ixt:num-dot-decimal" scale="3" id="f-1141">392,893</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-271" decimals="-3" name="us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates" format="ixt:num-dot-decimal" scale="3" id="f-1142">80,942</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-3" name="us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates" format="ixt:num-dot-decimal" scale="3" id="f-1143">884,342</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash (used in) provided by investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-1144">392,893</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-271" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-1145">364,058</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-1146">615,440</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proceeds from exercises of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="f-1147">2,369</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-271" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="f-1148">5,870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="f-1149">7,418</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proceeds from issuance of ordinary shares upon public offerings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-3" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" format="ixt:fixed-zero" scale="3" id="f-1150">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-271" decimals="-3" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" format="ixt:fixed-zero" scale="3" id="f-1151">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-3" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" format="ixt:num-dot-decimal" scale="3" id="f-1152">818,875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payment of public offering costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" format="ixt:fixed-zero" scale="3" id="f-1153">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-271" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" format="ixt:fixed-zero" scale="3" id="f-1154">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="f-1155">1,692</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employee taxes paid related to settlement of equity awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-1156">8,802</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-271" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-1157">7,600</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-1158">4,253</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash (used in) provided by financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-1159">6,433</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-271" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-1160">1,730</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-1161">820,348</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effect of foreign exchange rate changes on cash and cash equivalent</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:fixed-zero" scale="3" id="f-1162">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-271" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:fixed-zero" scale="3" id="f-1163">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" scale="3" id="f-1164">773</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net (decrease) increase in cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-1165">378,668</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-271" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-1166">352,807</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-1167">194,234</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents-beginning of the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-269" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="f-1168">944,649</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-273" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="f-1169">591,842</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-274" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="f-1170">397,608</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents-end of the year</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="f-1171">565,981</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-269" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="f-1172">944,649</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-273" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="f-1173">591,842</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">F-41</span></div></div></div><div id="i8a977bbf870448998f9d0f718b7b41b9_232"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><ix:continuation id="f-1030-3"><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Schedule I &#8212; Condensed Financial Information of Registrant</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Zai Lab Limited </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Information of Parent Company</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;Schedule I has been provided pursuant to the requirements of Rule 12-04(a) and 5-04(c) of Regulation S-X, which require condensed financial information as to the financial position, changes in financial position and results of operations of a parent company as of the same dates and for the same periods for which audited consolidated financial statements have been presented when the restricted net assets of consolidated subsidiaries exceed 25 percent of consolidated net assets as of the end of the most recently completed fiscal year. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;The condensed financial information has been prepared using the same accounting policies as set out in the consolidated financial statements except that the equity method has been used to account for investments in its subsidiaries. For the parent company, Zai Lab Limited records its investments in subsidiaries under the equity method of accounting as prescribed in ASC 323, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments-Equity Method and Joint Ventures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Such investments are presented on the Condensed Balance Sheets as &#8220;Investment in subsidiaries&#8221;. Ordinarily under the equity, an investor in an equity method investee would cease to recognize its share of the losses of an investee once the carrying value of the investment has been reduced to nil absent an undertaking by the investor to provide continuing support and fund losses. For the purpose of this Schedule I, the parent company has continued to reflect its share, based on its proportionate interest, of the losses of subsidiaries regardless of the carrying value of the investment even though the parent company is not obligated to provide continuing support or fund losses. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. The footnote disclosures provide certain supplemental information relating to the operations of the Company and, as such, these statements should be read in conjunction with the notes to the accompanying consolidated financial statements. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;As of December&#160;31, 2023 and 2022, there were no material contingencies, significant provisions of long-term obligations, mandatory dividend or redemption requirements of redeemable stocks or guarantees of Zai Lab Limited.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">F-42</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.5
<SEQUENCE>2
<FILENAME>exhibit45-descriptionofsec.htm
<DESCRIPTION>EX-4.5
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i466024eafd7d47f9a09ac27391bf6fc2_1"></div><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 4.5 </font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DESCRIPTION OF SECURITIES </font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 </font></div><div style="margin-top:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Zai Lab Limited, an exempted company incorporated in the Cayman Islands with limited liability (&#8220;Zai Lab,&#8221; the &#8220;Company&#8221;, or &#8220;we&#8221;), has two classes of securities registered pursuant to Section 12 of the U.S. Securities Exchange Act of 1934, as amended&#58; (1) our ordinary shares, par value of $0.000006 per share, and (2) our American Depositary Shares (&#8220;ADSs&#8221;), each representing 10 of our ordinary shares. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following description of our registered shares is a summary and does not purport to be complete. It is subject to and qualified in its entirety by reference to our amended and restated memorandum and articles of association for our ordinary shares and our deposit agreement for our ADSs, each of which are incorporated by reference as an exhibit to this report. We encourage you to read our amended and restated memorandum and articles of association, the applicable provisions of Cayman Islands laws, and the form deposit agreement for additional information.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Description of Ordinary Shares</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">As of February 21, 2024, our authorized share capital consists of  5,000,000,000 ordinary shares with a par value of $0.000006 per share. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our ordinary shares are listed on The Stock Exchange of Hong Kong Limited under the stock code &#8220;9688.&#8221;</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">General</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">. Our ordinary shares are issued in registered form, and are issued when registered in our register of members. Certificates representing the ordinary shares are issued in registered form.</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Dividends</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">. The holders of our ordinary shares are entitled to such dividends as may be declared by our board of directors. Our Sixth Amended and Restated Articles of Association provides that dividends may be declared and paid out of our profits, realized or unrealized, or from any reserve set aside from profits which our board of directors determine is no longer needed. Dividends may also be declared and paid out of share premium account or any other fund or account which can be authorized for this purpose in accordance with the Companies Act (Revised) of the Cayman Islands and any statutory amendment or re-enactment thereof (&#8220;Companies Act&#8221;). Holders of ordinary shares will be entitled to the same amount of dividends, if declared.</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Voting rights</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;In respect of all matters subject to a shareholders&#8217; vote, each ordinary share is entitled to one vote. Voting at any meeting of shareholders is by show of hands unless a poll is demanded. A poll may be demanded by the chairman of such meeting or any one or more shareholders present in person or by proxy and who together hold not less than 10% of the nominal value of the total issued voting shares of our company. Each holder of our ordinary shares is entitled to have one vote for each ordinary share registered in his or her name on our register of members.</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">A quorum required for a meeting of shareholders consists of one or more shareholders who hold at least&#160;one-tenth&#160;of all voting power of our share capital in issue at the date of the meeting present in person or by proxy or, if a corporation or other&#160;non-natural&#160;person, by its duly authorized representative. Shareholders&#8217; meetings may be held annually. Each general meeting, other than an annual general meeting, shall be an extraordinary general meeting. Extraordinary general meetings may be called by a majority of our board of directors or our chairman or upon a requisition of shareholders holding at the date of deposit of the requisition not less than&#160;one-third&#160;of the aggregate voting power of our company. Advance notice of at least 21 days is required for the convening of our annual general </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></div><hr style="page-break-after:always"><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">meeting and at least 14 calendar days&#8217; notice is required for any extraordinary general meeting unless such notice is waived in accordance with our articles of association.</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">An ordinary resolution to be passed at a meeting by the shareholders requires the affirmative vote of a simple majority of the votes attaching to all issued and outstanding shares cast at a meeting, while a special resolution also requires the affirmative vote of no less than&#160;two-thirds&#160;of the votes cast attaching to the issued and outstanding shares at a meeting. A super majority resolution will be required for important matters such as a change of name or making changes to our Sixth Amended and Restated Articles of Association.</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Transfer of ordinary shares</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Subject to the restrictions set out below, any of our shareholders may transfer all or any of his or her ordinary shares by an instrument of transfer in the usual or common form or any other form approved by our board of directors.</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our board of directors may, in its absolute discretion, decline to register any transfer of any ordinary share which is not fully paid up or on which we have a lien. Our board of directors may also decline to register any transfer of any ordinary share unless&#58;</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.636%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the instrument of transfer is lodged with us, accompanied by the certificate for the ordinary shares to which it relates and such other evidence as our board of directors may reasonably require to show the right of the transferor to make the transfer&#59;</font></td></tr></table></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.636%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the instrument of transfer is in respect of only one class of ordinary shares&#59;</font></td></tr></table></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.636%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the instrument of transfer is properly stamped, if required&#59;</font></td></tr></table></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.636%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">in the case of a transfer to joint holders, the number of joint holders to whom the ordinary share is to be transferred does not exceed four&#59;</font></td></tr></table></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.636%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the shares are free from any lien in favor of the Company&#59; and</font></td></tr></table></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.636%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a fee of such maximum sum as the Nasdaq Global Market may determine to be payable or such lesser sum as our directors may from time to time require is paid to us in respect thereof.</font></td></tr></table></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">If our directors refuse to register a transfer, they shall, within two months after the date on which the instrument of transfer was lodged, send to each of the transferor and the transferee notice of such refusal.</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Notwithstanding the above, transfers of shares which are listed on The Stock Exchange of Hong Kong Limited may be effected by any method of transferring or dealing in securities permitted by The Stock Exchange of Hong Kong Limited listing rules and which has been approved by the Board for such purpose.</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The registration of transfers may, on 14 days&#8217; notice being given by advertisement in one or more newspapers or by electronic means, be suspended and the register closed at such times and for such periods as our board of directors may from time to time determine, provided, however, that the registration of transfers shall not be suspended nor the register closed for more than 30 days in any year.</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Liquidation</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;On a return of capital on winding up or otherwise (other than on conversion, redemption or purchase of ordinary shares), assets available for distribution among the holders of ordinary shares shall be distributed by a liquidator who may divide our assets for distribution among our shareholders in his discretion. The liquidator also may vest all or part of our assets in trust. None of our shareholders may be compelled to accept any shares subject to liability.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></div><hr style="page-break-after:always"><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Calls on ordinary shares and forfeiture of ordinary shares</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;Our board of directors may from time to time make calls upon shareholders for any amounts unpaid on their ordinary shares in a notice served to such shareholders at least 14 clear days prior to the specified time of payment. The ordinary shares that have been called upon and remain unpaid are subject to forfeiture.</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Redemption of ordinary shares</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;The Companies Act and Sixth Amended and Restated Articles of Association permit us to purchase our own shares. In accordance with our Sixth Amended and Restated Articles of Association and provided the necessary shareholders or board approval have been obtained, we may issue shares on terms that are subject to redemption, at our option or at the option of the holders of these shares, on such terms and in such manner, including out of capital, as may be determined by our board of directors.</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Variations of rights of shares</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">All or any of the special rights attached to any class of shares may, subject to the provisions of the Companies Act, be varied with the written consent of the holders of a majority of the issued shares of that class or with the sanction of a special resolution passed at a general meeting of the holders of the shares of that class. The rights conferred upon the holders of the shares of any class issued shall not, unless otherwise expressly provided by the terms of issue of the shares of that class, be deemed to be varied by the creation or issue of further shares ranking pari passu with such existing class of shares. Holders of our ordinary shares do not have preemptive, subscription or conversion rights. The ordinary shares are not subject to further calls or assessment by us. There are no sinking fund provisions applicable to the ordinary shares.</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Inspection of books and records</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Holders of our ordinary shares have no general right under Cayman Islands law to inspect or obtain copies of our list of shareholders or our corporate records. However, we will file annual audited financial statements with the SEC. See &#8220;Incorporation of Documents by Reference.&#8221;</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%">&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Issuance of additional shares</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our Sixth Amended and Restated Articles of Association authorizes our board of directors to issue additional ordinary shares from time to time as our board of directors shall determine, to the extent of available authorized but unissued shares.</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our Sixth Amended and Restated Articles of Association also authorizes our board of directors to establish from time to time one or more series of preferred shares and to determine, with respect to any series of preferred shares, the terms and rights of that series, including&#58;</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.636%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the designation of the series&#59;</font></td></tr></table></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.636%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the number of shares of the series&#59;</font></td></tr></table></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.636%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the dividend rights, dividend rates, conversion rights, voting rights&#59; and</font></td></tr></table></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.636%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the rights and terms of redemption and liquidation preferences.</font></td></tr></table></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our board of directors may issue preferred shares without action by our shareholders to the extent authorized but unissued. Issuance of these shares may dilute the voting power of holders of ordinary shares.</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Anti-takeover provisions</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;Some provisions of our Sixth Amended and Restated Articles of Association may discourage, delay or prevent a change of control of our company or management that shareholders may consider favorable, including provisions that authorize our board of directors to issue preferred shares in one or more series and to designate the price, rights, preferences, privileges and restrictions of such preferred shares without any further vote or action by our shareholders.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></div><hr style="page-break-after:always"><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Exempted company</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;We are an exempted company with limited liability under the Companies Act. The Companies Act distinguishes between ordinary resident companies and exempted companies. Any company that is registered in the Cayman Islands but conducts business mainly outside of the Cayman Islands may apply to be registered as an exempted company. The requirements for an exempted company are essentially the same as for an ordinary company except that an exempted company&#58;</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.636%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">does not have to file an annual return of its shareholders with the Registrar of Companies&#59;</font></td></tr></table></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.636%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">is not required to open its register of members for inspection&#59;</font></td></tr></table></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.636%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">does not have to hold an annual general meeting&#59;</font></td></tr></table></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.636%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">may issue negotiable or bearer shares or shares with no par value&#59;</font></td></tr></table></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.636%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">may obtain an undertaking against the imposition of any future taxation (such undertakings are usually given for 20 years in the first instance)&#59;</font></td></tr></table></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.636%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">may register by way of continuation in another jurisdiction and be deregistered in the Cayman Islands&#59;</font></td></tr></table></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.636%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">may register as a limited duration company&#59; and</font></td></tr></table></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.636%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">may register as a segregated portfolio company.</font></td></tr></table></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8220;Limited liability&#8221; means that the liability of each shareholder is limited to the amount unpaid by the shareholder on the shares of the company.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Description of American Depositary Shares</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Citibank, N.A. acts as the depositary bank for the American Depositary Shares pursuant to the Deposit Agreement, dated as of September 20, 2017. Citibank&#8217;s depositary offices are located at 388 Greenwich Street New York, New York 10013. American Depositary Shares are frequently referred to as &#8220;ADSs&#8221; and represent ownership interests in securities that are on deposit with the depositary bank. ADSs may be represented by certificates that are commonly known as &#8220;American Depositary Receipts&#8221; or &#8220;ADRs.&#8221; The depositary bank has appointed a custodian to safekeep the securities on deposit. In this case, the custodian is Citibank, N.A.&#8212;Hong Kong, located at 9&#47;F., Citi Tower, One Bay East, 83 Hoi Bun Road, Kwun Tong, Kowloon, Hong Kong. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our ADSs are listed on the Nasdaq Global Market under the symbol &#8220;ZLAB.&#8221;</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Each American depositary share (&#8220;ADS&#8221;) represents the right to receive, and to exercise the beneficial ownership interests in, ten ordinary shares that are on deposit with the depositary bank and&#47;or custodian. An ADS also represents the right to receive, and to exercise the beneficial interests in, any other property received by the depositary bank or the custodian on behalf of the owner of the ADS but that has not been distributed to the owners of ADSs because of legal restrictions or practical considerations. We and the depositary bank may agree to change the ADS-to-ordinary share ratio by amending the deposit agreement. This amendment may give rise to, or change, the depositary fees payable by ADS owners. The custodian, the depositary bank, and their respective nominees will hold all deposited property for the benefit of the holders and beneficial owners of ADSs. The deposited property does not constitute the proprietary assets of the depositary bank, the custodian, or their nominees. Beneficial ownership in the deposited property will under the terms of the deposit agreement be vested in the beneficial owners of the ADSs. The depositary bank, the custodian, and their respective nominees will be the record holders of the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></div><hr style="page-break-after:always"><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">deposited property represented by the ADSs for the benefit of the holders and beneficial owners of the corresponding ADSs. A beneficial owner of ADSs may or may not be the holder of ADSs. Beneficial owners of ADSs will be able to receive, and to exercise beneficial ownership interests in, the deposited property only through the registered holders of the ADSs, the registered holders of the ADSs (on behalf of the applicable ADS owners) only through the depositary bank, and the depositary bank (on behalf of the owners of the corresponding ADSs) directly, or indirectly, through the custodian or their respective nominees, in each case upon the terms of the deposit agreement. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">An ADS holder will become a party to the deposit agreement and therefore will be bound to its terms and to the terms of any ADR that represents such ADSs. The deposit agreement and the ADR specify our rights and obligations as well as ADS holders&#8217; rights and obligations as owner of ADSs and those of the depositary bank. ADS holders appoint the depositary bank to act on their behalf in certain circumstances. The deposit agreement and the ADRs are governed by New York law. However, our obligations to the holders of ordinary shares will continue to be governed by the laws of the Cayman Islands, which may be different from the laws in the United States. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In addition, applicable laws and regulations may require ADS holders to satisfy reporting requirements and obtain regulatory approvals in certain circumstances. ADS holders are solely responsible for complying with such reporting requirements and obtaining such approvals. Neither the depositary bank, the custodian, us, or any of their or our respective agents or affiliates shall be required to take any actions whatsoever on ADS holders&#8217; behalf to satisfy such reporting requirements or obtain such regulatory approvals under applicable laws and regulations. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We will not treat ADS holders as our shareholders, and ADS holders will not have direct shareholder rights. The depositary bank will hold on ADS holders&#8217; behalf the shareholder rights attached to the ordinary shares underlying the ADSs. ADS holders will be able to exercise the shareholders rights for the ordinary shares represented by the ADSs through the depositary bank only to the extent contemplated in the deposit agreement. To exercise any shareholder rights not contemplated in the deposit agreement, an ADS holder will, as an ADS owner, need to arrange for the cancellation of such ADSs and become a direct shareholder. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The manner in which ADS holders owns the ADSs (e.g., in a brokerage account vs. as registered holder, or as holder of certificated vs. uncertificated ADSs) may affect the holders&#8217; rights and obligations, and the manner in which, and extent to which, the depositary bank&#8217;s services are made available to the holders. An ADS holder may hold the ADSs either by means of an ADR registered in such holder&#8217;s name, through a brokerage or safekeeping account, or through an account established by the depositary bank in such holder&#8217;s name reflecting the registration of uncertificated ADSs directly on the books of the depositary bank (commonly referred to as the &#8220;direct registration system&#8221; or &#8220;DRS&#8221;). The direct registration system reflects the uncertificated (book-entry) registration of ownership of ADSs by the depositary bank. Under the direct registration system, ownership of ADSs is evidenced by periodic statements issued by the depositary bank to the holders of the ADSs. The direct registration system includes automated transfers between the depositary bank and The Depository Trust Company (&#8220;DTC&#8221;), the central book-entry clearing and settlement system for equity securities in the United States. If an ADS holder decides to hold the ADSs through such holder&#8217;s brokerage or safekeeping account, the holder must rely on the procedures of his&#47;her broker or bank to assert his&#47;her rights as an ADS owner. Banks and brokers typically hold securities such as the ADSs through clearing and settlement systems such as DTC. The procedures of such clearing and settlement systems may limit an ADS holder&#8217;s ability to exercise such holder&#8217;s rights as an owner of ADSs. ADS holders should consult with their broker or bank if they have any questions concerning these limitations and procedures. All ADSs held through DTC will be registered in the name of a nominee of DTC. This summary description assumes ADS holders have opted to own the ADSs directly by means of ADSs registered in such holders&#8217; name and, as such, we will refer to ADS holders as the &#8220;holders.&#8221; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></div><hr style="page-break-after:always"><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The registration of the ordinary shares in the name of the depositary bank or the custodian shall, to the maximum extent permitted by applicable law, vest in the depositary bank or the custodian the record ownership in the applicable ordinary shares with the beneficial ownership rights and interests in such ordinary shares being at all times vested with the beneficial owners of the ADSs representing the ordinary shares. The depositary bank or the custodian shall at all times be entitled to exercise the beneficial ownership rights in all deposited property, in each case only on behalf of the holders and beneficial owners of the ADSs representing the deposited property. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Dividends and Distributions </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Holders of ADSs generally have the right to receive the distributions we make on the securities deposited with the custodian. ADS holders&#8217; receipt of these distributions may be limited, however, by practical considerations and legal limitations. Holders of ADSs will receive such distributions under the terms of the deposit agreement in proportion to the number of ADSs held as of the specified record date, after deduction of the applicable fees, taxes, and expenses. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Distributions of Cash </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Whenever we make a cash distribution for the securities on deposit with the custodian, we will deposit the funds with the custodian. Upon receipt of confirmation of the deposit of the requisite funds, the depositary bank will arrange for the funds received in a currency other than U.S. dollars to be converted into U.S. dollars and for the distribution of the U.S. dollars to the holders, subject to Cayman Islands laws and regulations. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The conversion into U.S. dollars will take place only if practicable and if the U.S. dollars are transferable to the United States. The depositary bank will apply the same method for distributing the proceeds of the sale of any property (such as undistributed rights) held by the custodian in respect of securities on deposit. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The distribution of cash will be made net of the fees, expenses, taxes, and governmental charges payable by holders under the terms of the deposit agreement. The depositary bank will hold any cash amounts it is unable to distribute in a non-interest bearing account for the benefit of the applicable holders and beneficial owners of ADSs until the distribution can be effected or the funds that the depositary bank holds must be escheated as unclaimed property in accordance with the laws of the relevant states of the United States. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Distributions of Ordinary Shares </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Whenever we make a free distribution of ordinary shares for the securities on deposit with the custodian, we will deposit the applicable number of ordinary shares with the custodian. Upon receipt of confirmation of such deposit, the depositary bank will either distribute to holders new ADSs representing the ordinary shares deposited or modify the ADS-to-ordinary share ratio, in which case each ADS holders hold will represent rights and interests in the additional ordinary shares so deposited. Only whole new ADSs will be distributed. Fractional entitlements will be sold, and the proceeds of such sale will be distributed as in the case of a cash distribution. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The distribution of new ADSs or the modification of the ADS-to-ordinary share ratio upon a distribution of ordinary shares will be made net of the fees, expenses, taxes, and governmental charges payable by holders under the terms of the deposit agreement. In order to pay such taxes or governmental charges, the depositary bank may sell all or a portion of the new ordinary shares so distributed. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">No such distribution of new ADSs will be made if it would violate a law (e.g., the U.S. securities laws) or if it is not operationally practicable. If the depositary bank does not distribute new ADSs as described above, it may sell the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></div><hr style="page-break-after:always"><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">ordinary shares received upon the terms described in the deposit agreement and will distribute the proceeds of the sale as in the case of a distribution of cash. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Distributions of Rights </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Whenever we intend to distribute rights to subscribe for additional ordinary shares, we will give prior notice to the depositary bank, and we will assist the depositary bank in determining whether it is lawful and reasonably practicable to distribute rights to subscribe for additional ADSs to holders. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The depositary bank will establish procedures to distribute rights to subscribe for additional ADSs to holders and to enable such holders to exercise such rights if it is lawful and reasonably practicable to make the rights available to holders of ADSs, and if we provide all of the documentation contemplated in the deposit agreement (such as opinions to address the lawfulness of the transaction). Holders may have to pay fees, expenses, taxes, and other governmental charges to subscribe for the new ADSs upon the exercise of such rights. The depositary bank is not obligated to establish procedures to facilitate the distribution and exercise by holders of rights to subscribe for new ordinary shares other than in the form of ADSs. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The depositary bank will not distribute the rights to holders if&#58; </font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:15.2pt">We do not timely request that the rights be distributed to holders or we request that the rights not be distributed to holders&#59; or</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:15.2pt">&#8202;We fail to deliver satisfactory documents to the depositary bank&#59; or</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:15.2pt">It is not reasonably practicable to distribute the rights.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The depositary bank will sell the rights that are not exercised or not distributed if such sale is lawful and reasonably practicable. The proceeds of such sale will be distributed to holders as in the case of a cash distribution. If the depositary bank is unable to sell the rights, it will allow the rights to lapse. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Elective Distributions </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Whenever we intend to distribute a dividend payable at the election of shareholders either in cash or in additional shares, we will give prior notice thereof to the depositary bank and will indicate whether we wish the elective distribution to be made available to holders. In such case, we will assist the depositary bank in determining whether such distribution is lawful and reasonably practicable. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The depositary bank will make the election available to holders only if it is reasonably practicable and if we have provided all of the documentation contemplated in the deposit agreement. In such case, the depositary bank will establish procedures to enable holders to elect to receive either cash or additional ADSs, in each case as described in the deposit agreement. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">If the election is not made available to holders, holders will receive either cash or additional ADSs, depending on what a shareholder in the Cayman Islands would receive upon failing to make an election, as more fully described in the deposit agreement. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Other Distributions </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Whenever we intend to distribute property other than cash, ordinary shares, or rights to subscribe for additional ordinary shares, we will notify the depositary bank in advance and will indicate whether we wish such distribution to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></div><hr style="page-break-after:always"><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">be made to holders. If so, we will assist the depositary bank in determining whether such distribution to holders is lawful and reasonably practicable. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">If it is reasonably practicable to distribute such property to holders and if we provide to the depositary bank all of the documentation contemplated in the deposit agreement, the depositary bank will distribute the property to holders in a manner it deems practicable. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The distribution will be made net of fees, expenses, taxes, and governmental charges payable by holders under the terms of the deposit agreement. In order to pay such taxes and governmental charges, the depositary bank may sell all or a portion of the property received. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The depositary bank will not distribute the property to holders and will sell the property if&#58; </font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:15.2pt">We do not request that the property be distributed to holders or if we request that the property not be distributed to holders&#59; or</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:15.2pt">We do not deliver satisfactory documents to the depositary bank&#59; or</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:15.2pt">The depositary bank determines that all or a portion of the distribution to holders is not reasonably practicable&#59; or</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:15.2pt">The proceeds of such a sale will be distributed to holders as in the case of a cash distribution.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Redemption </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Whenever we decide to redeem any of the securities on deposit with the custodian, we will notify the depositary bank in advance. If it is practicable and if we provide all of the documentation contemplated in the deposit agreement, the depositary bank will provide notice of the redemption to holders. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The custodian will be instructed to surrender the shares being redeemed against payment of the applicable redemption price. The depositary bank will convert into U.S. dollars upon the terms of the deposit agreement the redemption funds received in a currency other than U.S. dollars and will establish procedures to enable holders to receive the net proceeds from the redemption upon surrender of their ADSs to the depositary bank. Holders may have to pay fees, expenses, taxes, and other governmental charges upon the redemption of the ADSs. If less than all ADSs are being redeemed, the ADSs to be retired will be selected by lot or on a pro rata basis, as the depositary bank may determine. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Changes Affecting Ordinary Shares </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The ordinary shares held on deposit for the ADSs may change from time to time. For example, there may be a change in nominal or par value, split-up, cancellation, consolidation, or any other reclassification of such ordinary shares or a recapitalization, reorganization, merger, consolidation, or sale of assets of the Company. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">If any such change were to occur, the ADSs would, to the extent permitted by law and the deposit agreement, represent the right to receive the property received or exchanged in respect of the ordinary shares held on deposit. The depositary bank may in such circumstances deliver new ADSs to holders, amend the deposit agreement, the ADRs, and the applicable Registration Statement(s) on Form F-6, call for the exchange of holders&#8217; existing ADSs for new ADSs and take any other actions that are appropriate to reflect as to the ADSs the change affecting the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></div><hr style="page-break-after:always"><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">ordinary shares. If the depositary bank may not lawfully distribute such property to holders, the depositary bank may sell such property and distribute the net proceeds to holders as in the case of a cash distribution. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Issuance of ADSs upon Deposit of Ordinary Shares </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our ordinary shares have been and will be deposited with the custodian. The depositary bank may create ADSs on a holder&#8217;s behalf if such holder or such holder&#8217;s broker deposits ordinary shares with the custodian. The depositary bank will deliver these ADSs to the person such holder indicates only after such holder pays any applicable issuance fees and any charges and taxes payable for the transfer of the ordinary shares to the custodian. Holders&#8217; ability to deposit ordinary shares and receive ADSs may be limited by U.S. and Cayman Islands legal considerations applicable at the time of deposit. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The issuance of ADSs may be delayed until the depositary bank or the custodian receives confirmation that all required approvals have been given and that the ordinary shares have been duly transferred to the custodian. The depositary bank will only issue ADSs in whole numbers. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">When a holder makes a deposit of ordinary shares, such holder will be responsible for transferring good and valid title to the depositary bank. As such, the holder will be deemed to represent and warrant that&#58; </font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:15.2pt">The ordinary shares are duly authorized, validly issued, fully paid, non-assessable, and legally obtained.</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:15.2pt">All preemptive (and similar) rights, if any, with respect to such ordinary shares have been validly waived or exercised.</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:15.2pt">The holder is duly authorized to deposit the ordinary shares.</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:15.2pt">The ordinary shares presented for deposit are free and clear of any lien, encumbrance, security interest, charge, mortgage, or adverse claim, and are not, and the ADSs issuable upon such deposit will not be, &#8220;restricted securities&#8221; (as defined in the deposit agreement).</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:15.2pt">The ordinary shares presented for deposit have not been stripped of any rights or entitlements.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">If any of the representations or warranties are incorrect in any way, we and the depositary bank may, at holders&#8217; cost and expense, take any and all actions necessary to correct the consequences of the misrepresentations. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Transfer, Combination, and Split-up of ADRs </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Holders will be entitled to transfer, combine, or split up their ADRs and the ADSs evidenced thereby. For transfers of ADRs, a holder will have to surrender the ADRs to be transferred to the depositary bank and also must&#58; </font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:15.2pt">ensure that the surrendered ADR is properly endorsed or otherwise in proper form for transfer&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:15.2pt">provide such proof of identity and genuineness of signatures as the depositary bank deems appropriate&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:15.2pt">provide any transfer stamps required by the State of New York or the United States&#59; and</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:15.2pt">pay all applicable fees, charges, expenses, taxes, and other government charges payable by ADR holders pursuant to the terms of the deposit agreement, upon the transfer of ADRs.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></div><hr style="page-break-after:always"><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">To have the ADRs either combined or split up, a holder must surrender his&#47;her ADRs in question to the depositary bank with such holder&#8217;s request to have them combined or split up, and such holder must pay all applicable fees, charges, and expenses payable by ADR holders, pursuant to the terms of the deposit agreement, upon a combination or split up of ADRs. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Withdrawal of Ordinary Shares Upon Cancellation of ADSs </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Holders will be entitled to present their ADSs to the depositary bank for cancellation and then receive the corresponding number of underlying ordinary shares at the custodian&#8217;s offices. Holders&#8217; ability to withdraw the ordinary shares held in respect of the ADSs may be limited by U.S. and Cayman Islands considerations applicable at the time of withdrawal. In order to withdraw the ordinary shares represented by the ADSs, holders will be required to pay to the depositary bank the fees for cancellation of ADSs and any charges and taxes payable upon the transfer of the ordinary shares. Holders assume the risk for delivery of all funds and securities upon withdrawal. Once canceled, the ADSs will not have any rights under the deposit agreement. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">If a holder holds ADSs registered in his&#47;her name, the depositary bank may ask such holder to provide proof of identity and genuineness of any signature and such other documents as the depositary bank may deem appropriate before it will cancel the ADSs. The withdrawal of the ordinary shares represented by the ADSs may be delayed until the depositary bank receives satisfactory evidence of compliance with all applicable laws and regulations. Please keep in mind that the depositary bank will only accept ADSs for cancellation that represent a whole number of securities on deposit. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Holders will have the right to withdraw the securities represented by the ADSs at any time except for&#58; </font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:15.2pt">Temporary delays that may arise because (i) the transfer books for the ordinary shares or ADSs are closed, or (ii) ordinary shares are immobilized on account of a shareholders&#8217; meeting or a payment of dividends.</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:15.2pt">Obligations to pay fees, taxes, and similar charges.</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:15.2pt">Restrictions imposed because of laws or regulations applicable to ADSs or the withdrawal of securities on deposit.</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:15.2pt">The deposit agreement may not be modified to impair holders&#8217; right to withdraw the securities represented by the ADSs except to comply with mandatory provisions of law.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Voting Rights </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Holders generally have the right under the deposit agreement to instruct the depositary bank to exercise the voting rights for the ordinary shares represented by ADSs. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">At our request, the depositary bank will distribute to holders any notice of shareholders&#8217; meeting received from us together with information explaining how to instruct the depositary bank to exercise the voting rights of the securities represented by ADSs. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">If the depositary bank timely receives voting instructions from a holder, it will endeavor to vote the securities (in person or by proxy) represented by the holder&#8217;s ADSs in accordance with such voting instructions as follows&#58; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></div><hr style="page-break-after:always"><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%;padding-left:15.2pt">In the event of voting by show of hands</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">, the depositary bank will vote (or cause the custodian to vote) all ordinary shares held on deposit at that time in accordance with the voting instructions received from a majority of holders who provide timely voting instructions.</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%;padding-left:15.2pt">In the event of voting by poll, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">the depositary bank will vote (or cause the custodian to vote) the ordinary shares held on deposit in accordance with the voting instructions received from the holders.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In the event of voting by poll, holders in respect of which no timely voting instructions have been received shall be deemed to have instructed the depositary bank to give a discretionary proxy to a person designated by us to vote the ordinary shares represented by such holders&#8217; ADSs&#59; provided, that no such instructions shall be deemed given and no such discretionary proxy shall be given with respect to any matter as to which we inform the depositary bank that we do not wish such proxy to be given&#59; provided, further, that no such discretionary proxy shall be given (x) with respect to any matter as to which we inform the depositary that (i) there exists substantial opposition, or (ii) the rights of holders or the shareholders of our company will be materially adversely affected, and (y) in the event that the vote is on a show of hands. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Please note that the ability of the depositary bank to carry out voting instructions may be limited by practical and legal limitations and the terms of the securities on deposit. We cannot assure that holders will receive voting materials in time to enable them to return voting instructions to the depositary bank in a timely manner. </font></div><div style="margin-top:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Fees and Charges </font></div><div style="margin-bottom:12pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Holders will be required to pay the following fees under the terms of the deposit agreement&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.820%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.860%"></td><td style="width:0.1%"></td></tr><tr style="height:0pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Service</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fees</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20pt;text-indent:-15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#8195;&#8202;Issuance of ADSs (e.g., an issuance of ADS upon a deposit of ordinary shares, upon a change in the ADS(s)-to-ordinary share ratio, or for any other reason), excluding ADS issuances as a result of distributions of ordinary shares</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Up to U.S. 5&#162; per ADS issued</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20pt;text-indent:-15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#8195;&#8202;Cancellation of ADSs (e.g., a cancellation of ADSs for delivery of deposited property, upon a change in the ADS(s)-to-share ratio, or for any other reason)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Up to U.S. 5&#162; per ADS cancelled</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20pt;text-indent:-15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#8195;&#8202;Distribution of cash dividends or other cash distributions (e.g., upon a sale of rights and other entitlements)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Up to U.S. 5&#162; per ADS held</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20pt;text-indent:-15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#8195;&#8202;Distribution of ADSs pursuant to (i) stock dividends or other free stock distributions, or (ii) exercise of rights to purchase additional ADSs</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Up to U.S. 5&#162; per ADS held</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20pt;text-indent:-15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#8195;&#8202;Distribution of securities other than ADSs or rights to purchase additional ADSs (e.g., upon a spin-off)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Up to U.S. 5&#162; per ADS held</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20pt;text-indent:-15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#8195;&#8202;ADS Services</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Up to U.S. 5&#162; per ADS held on the applicable record date(s) established by the depositary bank</font></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Holders will also be responsible to pay certain charges such as&#58; </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.020%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">taxes (including applicable interest and penalties) and other governmental charges&#59;</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.020%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the registration fees as may from time to time be in effect for the registration of ordinary shares on the share register and applicable to transfers of ordinary shares to or from the name of the custodian, the depositary bank, or any nominees upon the making of deposits and withdrawals, respectively&#59;</font></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></div><hr style="page-break-after:always"><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.020%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">certain cable, telex, and facsimile transmission and delivery expenses&#59;</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.020%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the expenses and charges incurred by the depositary bank in the conversion of foreign currency&#59;</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.020%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the fees and expenses incurred by the depositary bank in connection with compliance with exchange control regulations and other regulatory requirements applicable to ordinary shares, ADSs and ADRs&#59; and</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.020%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the fees and expenses incurred by the depositary bank, the custodian, or any nominee in connection with the servicing or delivery of deposited property.</font></td></tr></table></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">ADS fees and charges payable upon (i) the issuance of ADSs, and (ii) the cancellation of ADSs are charged to the person to whom the ADSs are issued (in the case of ADS issuances) and to the person whose ADSs are cancelled (in the case of ADS cancellations). In the case of ADSs issued by the depositary bank into DTC, the ADS issuance and cancellation fees and charges may be deducted from distributions made through DTC, and may be charged to the DTC participant(s) receiving the ADSs being issued or the DTC participant(s) holding the ADSs being cancelled, as the case may be, on behalf of the beneficial owner(s) and will be charged by the DTC participant(s) to the account of the applicable beneficial owner(s) in accordance with the procedures and practices of the DTC participants as in effect at the time. ADS fees and charges in respect of distributions and the ADS service fee are charged to the holders as of the applicable ADS record date. In the case of distributions of cash, the amount of the applicable ADS fees and charges is deducted from the funds being distributed. In the case of (i) distributions other than cash and (ii) the ADS service fee, holders as of the ADS record date will be invoiced for the amount of the ADS fees and charges and such ADS fees and charges may be deducted from distributions made to holders of ADSs. For ADSs held through DTC, the ADS fees and charges for distributions other than cash and the ADS service fee may be deducted from distributions made through DTC, and may be charged to the DTC participants in accordance with the procedures and practices prescribed by DTC and the DTC participants in turn charge the amount of such ADS fees and charges to the beneficial owners for whom they hold ADSs. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In the event of refusal to pay the depositary bank fees, the depositary bank may, under the terms of the deposit agreement, refuse the requested service until payment is received or may set off the amount of the depositary bank fees from any distribution to be made to holders. Certain of the depositary fees and charges (such as the ADS services fee) may become payable shortly after the closing of an ADS offering. Note that the fees and charges holders may be required to pay may vary over time and may be changed by us and by the depositary bank. Holders will receive prior notice of such changes. The depositary bank may reimburse us for certain expenses incurred by us in respect of the ADR program, by making available a portion of the ADS fees charged in respect of the ADR program or otherwise, upon such terms and conditions as we and the depositary bank agree from time to time. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Amendments and Termination </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We may agree with the depositary bank to modify the deposit agreement at any time without holders&#8217; consent. We undertake to give holders 30 days&#8217; prior notice of any modifications that would materially prejudice any of their substantial rights under the deposit agreement. We will not consider to be materially prejudicial to holders&#8217; substantial rights any modifications or supplements that are reasonably necessary for the ADSs to be registered under the Securities Act or to be eligible for book-entry settlement, in each case without imposing or increasing the fees and charges holders are required to pay. In addition, we may not be able to provide holders with prior notice of any modifications or supplements that are required to accommodate compliance with applicable provisions of law. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></div><hr style="page-break-after:always"><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Holders will be bound by the modifications to the deposit agreement if they continue to hold their ADSs after the modifications to the deposit agreement become effective. The deposit agreement cannot be amended to prevent holders from withdrawing the ordinary shares represented by the ADSs (except as permitted by law). </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We have the right to direct the depositary bank to terminate the deposit agreement. Similarly, the depositary bank may in certain circumstances on its own initiative terminate the deposit agreement. In either case, the depositary bank must give notice to holders at least 30 days before termination. Until termination, holders&#8217; rights under the deposit agreement will be unaffected. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">After termination, the depositary bank will continue to collect distributions received (but will not distribute any such property until holders request the cancellation of their ADSs) and may sell the securities held on deposit. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">After the sale, the depositary bank will hold the proceeds from such sale and any other funds then held for the holders of ADSs in a non-interest bearing account. At that point, the depositary bank will have no further obligations to holders other than to account for the funds then held for the holders of ADSs still outstanding (after deduction of applicable fees, taxes and expenses). </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Books of Depositary </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The depositary bank will maintain ADS holder records at its depositary office. Holders may inspect such records at such office during regular business hours but solely for the purpose of communicating with other holders in the interest of business matters relating to the ADSs and the deposit agreement. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The depositary bank will maintain in New York facilities to record and process the issuance, cancellation, combination, split-up, and transfer of ADSs. These facilities may be closed from time to time, to the extent not prohibited by law. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Limitations on Obligations and Liabilities </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The deposit agreement limits our obligations and the depositary bank&#8217;s obligations to holders. Please note the following&#58; </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.020%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">we and the depositary bank are obligated only to take the actions specifically stated in the deposit agreement without negligence or bad faith.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.020%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the depositary bank disclaims any liability for any failure to carry out voting instructions, for any manner in which a vote is cast or for the effect of any vote, provided it acts in good faith and in accordance with the terms of the deposit agreement.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.020%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the depositary bank disclaims any liability for any failure to determine the lawfulness or practicality of any action, for the content of any document forwarded to holders on our behalf or for the accuracy of any translation of such a document, for the investment risks associated with investing in ordinary shares, for the validity or worth of the ordinary shares, for any tax consequences that result from the ownership of ADSs, for the credit-worthiness of any third party, for allowing any rights to lapse under the terms of the deposit agreement, for the timeliness of any of our notices, or for our failure to give notice.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.020%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">we and the depositary bank will not be obligated to perform any act that is inconsistent with the terms of the deposit agreement.</font></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></div><hr style="page-break-after:always"><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.020%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">we and the depositary bank disclaim any liability if we or the depositary bank, or our respective controlling persons or agents are prevented or forbidden from, or subject to any civil or criminal penalty or restraint on account of, or delayed in, doing or performing any act or thing required by the terms of the deposit agreement, by reason of any provision, present or future of any law or regulation, or by reason of present or future provision of any provision of our articles of association, or any provision of or governing the securities on deposit, or by reason of any act of God or war or other circumstances beyond our control.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.020%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">we and the depositary bank disclaim any liability by reason of any exercise of, or failure to exercise, any discretion provided for in the deposit agreement or in our articles of association or in any provisions of or governing the securities on deposit.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.020%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">we and the depositary bank further disclaim any liability for any action or inaction in reliance on the advice or information received from legal counsel, accountants, any person presenting ordinary shares for deposit, any holder or authorized representatives thereof, or any other person believed by either of us in good faith to be competent to give such advice or information.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.020%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">we and the depositary bank also disclaim liability for the inability by a holder to benefit from any distribution, offering, right, or other benefit that is made available to holders of ordinary shares but is not, under the terms of the deposit agreement, made available to holders.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.020%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">we and the depositary bank may rely without any liability upon any written notice, request, or other document believed to be genuine and to have been signed or presented by the proper parties.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.020%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">we and the depositary bank also disclaim liability for any consequential, indirect, or punitive damages for any breach of the terms of the deposit agreement, or otherwise.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.020%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">no disclaimer of any Securities Act liability is intended by any provision of the deposit agreement.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.020%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">nothing in the deposit agreement gives rise to a partnership or joint venture, or establishes a fiduciary relationship, among us, the depositary bank and holders.</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">nothing in the deposit agreement precludes Citibank (or its affiliates) from engaging in transactions in which parties adverse to us or the ADS owners have interests, and nothing in the deposit agreement obligates Citibank to disclose those transactions, or any information obtained in the course of those transactions, to us or to the ADS owners, or to account for any payment received as part of those transactions.</font></td></tr></table></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Pre-Release Transactions </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">The depositary bank has informed us that it no longer engages in pre-release transactions, and has no intention to do so in the future.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Taxes </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Holders will be responsible for the taxes and other governmental charges payable on the ADSs and the securities represented by the ADSs. We, the depositary bank and the custodian may deduct from any distribution the taxes and governmental charges payable by holders and may sell any and all property on deposit to pay the taxes and governmental charges payable by holders. Holders will be liable for any deficiency if the sale proceeds do not cover the taxes that are due. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></div><hr style="page-break-after:always"><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The depositary bank may refuse to issue ADSs, to deliver, transfer, split, and combine ADRs or to release securities on deposit until all taxes and charges are paid by the applicable holder. The depositary bank and the custodian may take reasonable administrative actions to obtain tax refunds and reduced tax withholding for any distributions on holders&#8217; behalf. However, holders may be required to provide to the depositary bank and to the custodian proof of taxpayer status and residence and such other information as the depositary bank and the custodian may require to fulfill legal obligations. Holders are required to indemnify us, the depositary bank, and the custodian for any claims with respect to taxes arising out of any refund of taxes, reduced rate of withholding, or of the tax benefit obtained for or by the holders. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Foreign Currency Conversion </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The depositary bank will arrange for the conversion of all foreign currency received into U.S. dollars if such conversion is practical, and it will distribute the U.S. dollars in accordance with the terms of the deposit agreement. Holder may have to pay fees and expenses incurred in converting foreign currency, such as fees and expenses incurred in complying with currency exchange controls and other governmental requirements. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">If the conversion of foreign currency is not practical or lawful, or if any required approvals are denied or not obtainable at a reasonable cost or within a reasonable period, the depositary bank may take the following actions in its discretion&#58; </font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:15.2pt">Convert the foreign currency to the extent practical and lawful and distribute the U.S. dollars to holders for whom the conversion and distribution is lawful and practical.</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:15.2pt">Distribute the foreign currency to holders for whom the distribution is lawful and practical.</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:15.2pt">Hold the foreign currency (without liability for interest) for the applicable holders.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Governing Law&#47;Waiver of Jury Trial </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The deposit agreement and the ADRs will be interpreted in accordance with the laws of the State of New York. The rights of holders of ordinary shares (including ordinary shares represented by ADSs) is governed by the laws of the Cayman Islands. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">By holding an ADS or an interest therein, ADS holders irrevocably agree that any legal suit, action, or proceeding against or involving us or the Depositary, arising out of or based upon the deposit agreement, ADSs, or ADRs, may only be instituted in a state or federal court in New York, New York, and ADS holders irrevocably waive any objection to the laying of venue and irrevocably submit to the exclusive jurisdiction of such courts with respect to any such suit, action or proceeding. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">AS A PARTY TO THE DEPOSIT AGREEMENT, ADS HOLDERS IRREVOCABLY WAIVE THE RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF THE DEPOSIT AGREEMENT, THE ADRs, AND ANY TRANSACTIONS CONTEMPLATED THEREIN (WHETHER BASED ON CONTRACT, TORT, COMMON LAW, OR OTHERWISE) AGAINST US AND&#47;OR THE DEPOSITARY BANK. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.33
<SEQUENCE>3
<FILENAME>exhibit1033-bochk_facili.htm
<DESCRIPTION>EX-10.33
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>exhibit1033-bochk_facili</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:965;"><!-- exhibit1033-bochk_facili001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1033-bochk_facili001.jpg" title="slide1" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">Exhibit 10.33    Ref: CCMC/CCE(CP)/219/23/100204/00/F/8851239    Combined Facility Letter 202308    1  23/F, Bank of China Centre, Olympian City, 11 Hoi Fai Road, West Kowloon.  Website: www.bochk.com  Important Notice:  This Facility Letter sets out the terms and conditions upon which the bank would provide banking  facilities to you. You are advised to read and understand the terms and conditions before accepting this  Facility Letter.    Date : 11 January 2024    Zai Lab Limited (incorporated in Cayman Islands with limited liability)  (the &#8220;Borrower&#8221;)      Dear Sirs,    Re: General Banking Facilities  Further to our recent discussions, the Bank is pleased to grant the following general banking facility(ies) (the &#8220;Facility(ies)&#8221;) to  the Borrower subject to the Bank's General Terms and Conditions for General Banking Facilities and Loan Facility(ies) (as  amended from time to time, the &#8220;General Terms&#8221;) and the terms and conditions stated below. Words and expressions defined in  the General Terms shall have the same meanings when used in this Facility Letter. Any appendix hereto forms an integral part of  this Facility Letter.    1.1 Facility(ies) Amount Interest Rate / Terms and Conditions  L/G / Standby L/C USD100,000,000.00 &#8226; L/G / Standby L/C shall be made available to the  Borrower against 100% margin payment from  time to time made to the Bank (the &#8220;Margin  Payment&#8221;).       1.2  Commitment:    Notwithstanding any provisions of this Facility Letter, the General Terms (if applicable) or any other documents between  the Borrower and the Bank to the contrary, the Bank may at any time without prior notice modify, cancel or suspend the  Facility/Facilities at its sole discretion including, without limitation, canceling any unutilized facilities, and declaring any  outstanding amount to be immediately due and payable.      2. Conditions Precedent / Collateral Security(ies)    The Facility(ies) shall not be made available for drawdown or utilization by the Borrower until the Bank has confirmed  receipt of all the following condition precedent documents in form and substance satisfactory to the Bank:-    &#61607; A duly signed copy of this Facility Letter indicating the Borrower's and the security providers&#8217; acceptance of the  Facility(ies) on the terms and conditions set out in this Facility Letter.    &#61607; For the purpose of the Margin Payment , Charge of Deposit(s) for the aggregate principal deposit amount of not less  than the aggregate limit amount made available under the L/G / Standby L/C Facilities (or if the charged deposit is  denominated in any foreign currency acceptable to the Bank, its equivalent in such foreign currency plus any deposit  margin (the &quot;Charged Deposit Margin&quot;) as determined by the Bank from time to time without any prior notice to or  agreement by the Borrower and/or the Deposit Chargor(s)) together with interest accrued or to be accrued thereon. A  list of the deposit margin (the &quot;List of Charged Deposit Margin&quot;) applicable to each foreign currency acceptable to the  Bank is attached herewith for your reference. Should the percentage of the charged deposit margin be changed, the  change shall be effective on the date another List of Charged Deposit Margin is issued to the Borrower and the  Deposit Chargor(s).  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1033-bochk_facili002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1033-bochk_facili002.jpg" title="slide2" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">    Ref: CCMC/CCE(CP)/219/23/100204/00/F/8851239    Combined Facility Letter 202308    2  23/F, Bank of China Centre, Olympian City, 11 Hoi Fai Road, West Kowloon.  Website: www.bochk.com  A Deed of Indemnity, Charge Over Deposit(s) and Set-Off to be executed by the deposit chargor in the Bank's favour  to secure general banking facilities from time to time and at any time granted or to be granted by the Bank to the  Borrower to such extent as the Bank may from time to time deem fit.  Name of Deposit Chargor:  Zai Lab Limited     In the event that the aggregate mark-to-market value of charged deposit is less than the amount specified in the above  Charged Deposit Margin, the Borrower confirms that it shall upon demand by the Bank immediately provide or  procure the same be provided to the Bank an additional cash margin or other security acceptable to the Bank.    &#61607; Legal Opinion to be issued by qualified lawyers practicing the laws of Cayman Island for the validity, legality and  enforceability in respect of this Facility Letter and the Deed of Indemnity, Charge Over Deposit(s) and Set-Off to be  executed by Zai Lab Limited together with any resolutions and such other documents in a form and substance  satisfactory to the Bank.  &#61607; Copy, certified by a director, of each of the following documents of your company:  &#61607; Certificate of Incorporation.  &#61607; Memorandum and Articles of Association or other constitutional documents (if any).  &#61607; List of directors with their specimen signatures.  &#61607; Current Business Registration Certificate (if any).    &#61607; If any of the Borrower / the guarantor(s) / security provider(s) is a limited company, the relevant shareholder and board  resolution and certified copies of the constitutional documents of that company.    &#61607;  Such other documents as the Bank may request including those as may be required to evidence any and all licences,  authorizations, consents or approvals necessary for the performance by the Borrower or the security provider(s) of their  respective obligations under this Facility Letter and the security documents.      3. Other Conditions:  &#61607; Utilization of the Facility(ies) is conditional upon the Bank&#8217;s prior approval.  &#61607; Throughout the life of the Facility(ies), the Borrower undertakes and procures with the Bank that:-  (i) its subsidiary company, &#12300;&#20877;&#40718;&#37291;&#34277;&#65288;&#19978;&#28023;&#65289;&#26377;&#38480;&#20844;&#21496;&#12301;, shall maintain its total available limit of foreign debts  with State Administration of Foreign Exchange must not be less than the total aggregate amount of L/G / Standby  L/C issued by the Bank.    4. Fees  &#61607; Handling Charge: USD700,000.00 flat payable upon acceptance of this Facility Letter.    All fees and charges shall not be refundable under any circumstances.    Currently, the Borrower represents that (i) the Borrower is not (or is not in any way related to) any of the directors, employees,  controllers or minority shareholder controllers of Bank of China (Hong Kong) Limited (&quot;BOCHK&quot;) or their relatives or BOCHK  within the meaning of Rule 85 of Banking (Exposure Limits) Rules (Cap 155S of the Laws of Hong Kong); (ii) the Borrower is  not (or is not in any way related to) (a) the senior management and key staff of BOCHK or their relatives, (b) subsidiaries,  affiliates and other entities over which BOCHK is able to exert control or (c) the controllers, minority shareholder controllers,  directors, senior management and key staff of the subsidiaries, affiliates and other entities mentioned in (b) above or their relatives  within the meaning of Hong Kong Monetary Authority Supervisory Policy CR-G-9 and (iii) the Borrower is not a connected party  to BOCHK and/or Bank of China Limited under the applicable rules of the Shanghai Stock Exchange, China Banking Regulatory  Commission, Hong Kong Exchanges &amp; Clearing Limited. If the Facility(ies) is/are guaranteed/secured or to be  guaranteed/secured by any guarantee or security from any third party, the Borrower also represents that none of such third parties  is so related or be such a party as mentioned above. The Borrower undertakes that if the Borrower or any such third party becomes  so related or be such a party as mentioned above, the Borrower will promptly notify the Bank in writing.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1033-bochk_facili003.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1033-bochk_facili003.jpg" title="slide3" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">    Ref: CCMC/CCE(CP)/219/23/100204/00/F/8851239    Combined Facility Letter 202308    3  23/F, Bank of China Centre, Olympian City, 11 Hoi Fai Road, West Kowloon.  Website: www.bochk.com  Please signify your receipt of the General Terms and your understanding and acceptance of this offer by signing and returning to  the Bank the duplicate copy of this Facility Letter on or before 8 April 2024, failing which this offer shall lapse unless otherwise  agreed by the Bank.    Should you have any queries, please contact our Ms. Kathy Chan at 398 27779 at any time. We are here to serve you better.    Yours faithfully,  For and on behalf of  Bank of China (Hong Kong) Limited            /s/ Lo Lai Fan and /s/ Chan Man Hin    Authorized Signature(s)      Encl. &#61607;  General Terms and Conditions for General Banking Facilities and Loan Facility(ies) [version no. 202307_revised   (LD/2023/7274)]  &#61607; List of Charged Deposit Margin [(all) 140515]  &#61607; Certified Extract of the Minutes of Board Meeting  &#61607; Deed of Indemnity, Charge Over Deposit(s) and Set-off  &#61607; Data Policy Notice  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1033-bochk_facili004.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1033-bochk_facili004.jpg" title="slide4" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  Ref: CCMC/CCE(CP)/219/23/100204/00/F/8851239  Combined Facility Letter 202308                4  23/F, Bank of China Centre, Olympian City, 11 Hoi Fai Road, West Kowloon.  Website: www.bochk.com      After due and careful consideration of the contents of this letter and the General Terms (as defined above), I/we agree to  (i) accept the Facilities and (ii) be bound by all the terms and conditions herein set out. If I/we have granted security in  your favour, I/we confirm that each security document executed by me/us in respect of, among other things, our  obligations to you is not (and will not be) discharged, prejudiced or affected in any way whatsoever and will remain in  ull force and effect at all times, notwithstanding any variations, amendments and/or supplements to the Facilities.          /s/ Xiaopeng Feng           Borrower: Zai Lab Limited  Date: February 5, 2024      Witness:                              /                        Name:  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1033-bochk_facili005.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1033-bochk_facili005.jpg" title="slide5" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">    List of charged deposit margin (all) 140515     23/F, Bank of China Centre, Olympian City, 11 Hoi Fai Road, West Kowloon.  Website: www.bochk.com      List of Charged Deposit Margin      The Charged Deposit Margin required for each of the following currencies acceptable to the Bank are set out  below:-    Currency Charged Deposit Margin  HKD 0%  USD 0%  CNY 12%  GBP, EUR, AUD, NZD, JPY, CAD, CHF 25%  DKK, SEK,SGD 34%    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1033-bochk_facili006.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1033-bochk_facili006.jpg" title="slide6" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">1  T &amp; C for GBF &amp; Loans Facility(ies) 202307_revised (LD/2023/7274)  (&#39321;&#28207;)&#26377;&#38480;&#20844;&#21496;  BANK OF CHINA (HONG KONG) LIMITED 1      Important Notice: These General Terms and Conditions for General Banking Facilities and Loan  Facility(ies) set out the terms and conditions upon which the Bank would provide /  continue / renew general banking facilities and loan facility(ies) to borrowers.  Borrower(s) is / are advised to read and understand these terms and conditions carefully  before accepting the general banking facilities and loan facility(ies).          General Terms and Conditions for General Banking Facilities and Loan Facility(ies)    These General Terms and Conditions for General Banking Facilities and Loan Facility(ies) (as amended and in force from  time to time) (&quot;these General Terms and Conditions&quot;) shall apply to all general banking facilities and loan facility(ies)  (the &quot;Facilities&quot;) which Bank of China (Hong Kong) Limited (including its successors and assigns, the &quot;Bank&quot;) may  from time to time grant to you as the Borrower.  1. Definitions   In these General Terms and Conditions and the Facility Letter, unless the context otherwise requires, the following  expressions shall have the following meanings: -    B Prime means the prime rate for any currency other than HKD, CNY or USD as may be quoted by  the Bank from time to time and subject to fluctuation;  Business Day means a day on which commercial banks in Hong Kong are open for business but  excluding Saturdays, Sundays and public holidays;  Base Rate means the HKD Prime, USD Prime, CNY Prime, B Prime, HIBOR, CNY HIBOR or such  other rates as may be determined by the Bank from time to time (as the case may be);  B/B L/C means a letters of credit issuance and inward bills facility on a &quot;back to back&quot; basis against  master letters of credit which is available on a &quot;direct shipment&quot; basis only;  Borrower means any party to whom the Facilities are granted or made available by the Bank;  CIRS means a Facility granted in connection with currency interest rate swap Transactions  pursuant to the Bank's Terms and Conditions for Treasury and Derivative Products, Terms  and Conditions for Foreign Exchange and Derivative Transactions or the terms and  conditions under the ISDA Documentation (as the case may be);  CNY means Renminbi, the lawful currency of the People's Republic of China;  CNY HIBOR means in respect of a particular interest period and in relation to any advance and/or  drawing under the Facilities in CNY, the rate per annum quoted by the Bank from time to  time at Reuters (Code: &quot;BCHN&quot;) and Bloomberg (Code: &quot;BOCH&quot;);  CNY O/D means an overdraft facility made available to the Borrower under current account(s)  denominated in CNY;  CNY Prime means the prime rate for CNY as may be quoted by the Bank from time to time and subject  to fluctuation;  Currency Option means a Facility granted in connection with currency option Transactions pursuant to the  Bank's Terms and Conditions for Treasury and Derivative Products, Terms and Conditions  for Foreign Exchange and Derivative Transactions or the terms and conditions under the  ISDA Documentation (as the case may be);  DDC O/D means an overdraft facility made available to the Borrower under current account(s)  denominated in HKD against uncleared cheque(s) which is/are due and which shall be  expressed as a percentage of the face amount of the relevant cheque(s) as stated in the  relevant Facility Letter;  Default Administrative  Charges means the amount of charges referred to in Clause 6.5;  Default Margin means, without prejudice to Clause 6.2 below, 6% per annum for Loan Facility(ies), 10%  per annum for HKD O/D, DDC O/D, USD O/D and CNY O/D, or the rate specified by  the Bank from time to time and displayed or posted in the Bank's banking halls or such  other rate as the Bank may designate and notify the Borrower;  D/L means a demand loan facility;  D/P / D/A means an export-bills purchase facility against export collection bills on Documents  Against Payment (&quot;D/P&quot;) and/or Documents Against Acceptance (&quot;D/A&quot;) basis with a  tenor and up to a percentage of the relevant bills as stated in the relevant Facility Letter;  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1033-bochk_facili007.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1033-bochk_facili007.jpg" title="slide7" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">2  T &amp; C for GBF &amp; Loans Facility(ies) 202307_revised (LD/2023/7274)  (&#39321;&#28207;)&#26377;&#38480;&#20844;&#21496;  BANK OF CHINA (HONG KONG) LIMITED 2          EID means an export invoice discounting facility with a tenor and up to a percentage against  invoice(s) issued by the Borrower for goods sold or supplied by the Borrower;  EFAC means the Maximum Funds in Use available for factoring of export bills pursuant to the  terms and conditions of a factoring agreement and its supplement(s), if any, from time to  time entered into between the Bank and the Borrower;  Event of Default means any one of the events mentioned in Clause 24 below and reference to &quot;Events of  Default&quot; shall be construed accordingly;  Facility(ies) means the various general banking facilities and loan facility(ies) granted or made  available to the Borrower from time to time as set out in the Facility Letter(s) and  reference to &quot;Facility&quot; shall be construed accordingly;  Facility Letter means the facility letter(s) containing the terms and conditions of the Facilities issued by  the Bank to the Borrower, as may be amended, revised or supplemented from time to time;  F/X means a Facility granted in connection with forward exchange Transactions pursuant to the  Bank's Terms and Conditions for Treasury and Derivative Products, Terms and Conditions  for Foreign Exchange and Derivative Transactions or the terms and conditions under the  ISDA Documentation (as the case may be);  HIBOR means in respect of a particular interest period and in relation to any advance and/or  drawing under the Facilities in HKD, the rate per annum quoted by the Bank in the Hong  Kong Interbank Hong Kong Dollar Market and known as &quot;Hong Kong Interbank Offered  Rate&quot;;  HKD means Hong Kong dollars, the lawful currency of Hong Kong;  HKD O/D means an overdraft facility made available to the Borrower under current account(s)  denominated in HKD;  HKD Prime means the prime rate for HKD as may be quoted by the Bank from time to time and subject  to fluctuation;  Hong Kong means the Hong Kong Special Administrative Region of the People's Republic of China;  IIF means an import invoice financing with a tenor and up to a percentage of the relevant  invoice as stated in the relevant Facility Letter;  I/L means an import loans facility with a tenor as stated in the relevant Facility Letter;  IRS means a Facility granted in connection with interest rate swap Transactions pursuant to the  Bank's Terms and Conditions for Treasury and Derivative Products, Terms and Conditions  for Foreign Exchange and Derivative Transactions or the terms and conditions under the  ISDA Documentation (as the case may be);  ISDA Documentation means the ISDA Master Agreement, the ISDA Schedule and any other documents ancillary  to such documents;  L/C means a letters of credit issuance and inward bills facility;  L/G means a letters of guarantee issuance facility;  L/I means a Facility granted for negotiation of export bills under letters of credits issued by  banks acceptable to the Bank (not conforming to terms of such export letter of credit);  Loan Facility(ies) means the Mortgage Loan Facility, Term Loan Facility, Demand Loan Facility, Revolving  Loan Facility and any other loan facilities made available to the Borrower whether or not  on the security of certain property(ies) or securities as stated in the relevant Facility Letter;  ML means a mortgage loan facility;  MML means a money market line facility;  &#8220;Obligors&#8221;  means the Borrower, any party to a Security Document and any party to a Facility Letter  (including by way of counter-signature), but shall not include the Bank and any other party  expressly excluded by the Bank in a Facility Letter.  ODB means a Facility granted for negotiation of export bills under letters of credits issued by  banks acceptable to the Bank;  Original Interest Rate means the respective applicable rate of interest for HKD O/D, DDC O/D, CNY O/D or  USD O/D as specified in the Facility Letter;  Payment Order means bills, drafts, orders and/or other instruments;  P/L means a packing loans facility which shall be expressed as a percentage of the relevant  export letter of credit as stated in the relevant Facility Letter;  POD means a payment order discounting facility against any Payment Order purchased or  discounted by the Bank from the Borrower;  PSF means a pre-shipment financing facility which shall be expressed as a percentage of the  relevant purchase order/contract as stated in the relevant Facility Letter;  R/L means a revolving loan facility;  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1033-bochk_facili008.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1033-bochk_facili008.jpg" title="slide8" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">3  T &amp; C for GBF &amp; Loans Facility(ies) 202307_revised (LD/2023/7274)  (&#39321;&#28207;)&#26377;&#38480;&#20844;&#21496;  BANK OF CHINA (HONG KONG) LIMITED 3          S/G means a shipping guarantees issuance facility;  Sanctions means the sanctions (including export controls) laws, regulations, embargoes or restrictive  measures administered, enacted or enforced by any Sanctions Authority. Without prejudice  to the generality of the preceding sentence, Sanctions shall include: -  (a) in relation to the United States of America, any sanction applied by the United States  (unilaterally or multilaterally) and shall include regulations imposed by the United States  Treasury Department&#8217;s Office of Foreign Assets Control, the US Department of State or,  to the extent applicable, the United States Department of Commerce&#8217;s Bureau of Industry  and Security, including but not limited to US Export Administration Regulations; and  (b) in relation to Hong Kong, any sanctions applied by the Government of Hong Kong  SAR (unilaterally or multilaterally) and shall include regulations imposed by the Hong  Kong Monetary Authority, the Hong Kong Financial Services and the Treasury Bureau,  including but not limited to the United Nations Sanctions Ordinance (Cap. 537), United  Nations (Anti-Terrorism Measures) Ordinance (Cap.575), Weapons of Mass Destruction  (Control of Provision of Services) Ordinance (Cap. 526) and Import and Export (strategic  commodities) Regulations (Cap. 60G).  Sanctions Authority   means any of the followings:  (a) The United Nations;  (b) The People&#8217;s Republic of China;  (c) The United States of America;  (d) The European Union  (e) The United Kingdom;  (f) Hong Kong; and  (g) the respective Government Authorities of any of the foregoing, including without  limitation, OFAC, the US Department of State, the US Department of Commerce Bureau  of Industry Security and the HKMA.  Sanctions Compliance in relation to a person, means itself and its affiliates. For this purpose, (i) &#8220;person&#8221; means  Group individual, firm, company, corporation, government, state or agency of a state or any  association, trust, joint venture, consortium, vessel or partnership; and (ii) &#8220;affiliate&#8221;, in  relation to a person, means another person that, directly or indirectly, controls, is  controlled by, or is under common control with, the first mentioned person.    Security Documents means such documents as may from time to time securing, guaranteeing or supporting the  Facility(ies) for the benefit of the Bank;  Standby L/C means a standby letters of credit issuance facility;  T/L means a term loan facility;  T/R means a trust receipt facility with a tenor as stated in the relevant Facility Letter;  Transactions means the transactions entered into pursuant to the Bank's Terms and Conditions for  Treasury and Derivative Products, Terms and Conditions for Foreign Exchange and  Derivative Transactions or the terms and conditions under the ISDA Documentation (as  the case may be) and has its meaning ascribed therein;  USD means United States dollars, the lawful currency of the United States of America;  USD O/D means an overdraft facility made available to the Borrower under account(s) denominated  in USD; and  USD Prime means the prime rate for USD as may be quoted by the Bank from time to time and subject  to fluctuation.  2. Availability   2.1 Subject to the Borrower's acceptance of and full compliance with the terms and conditions set out in the relevant  Facility Letter and production and where appropriate, execution of all appropriate documentation mentioned in  the relevant Facility Letter to the Bank's satisfaction and payment of all required fees and charges, the Facilities  set forth in the relevant Facility Letter will be made available to the Borrower for use until such time as the  Bank shall notify the Borrower in writing to the contrary.  2.2 The Facilities shall be deemed automatically drawn down by the Borrower and/or advanced by the Bank when  payment or liability is made or incurred by the Bank under the relevant Facilities. For the avoidance of doubt  and subject to the Bank's overriding discretion, setting up of credit limits in respect of any overdraft facility  and/or any other Facilities would only be effected on Business Days.  2.3 The Bank reserves the absolute right to (i) reject any application from the Borrower to be provided with or  utilize the Facilities and (ii) review and make adjustment to the Facilities at any time at its sole and absolute  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1033-bochk_facili009.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1033-bochk_facili009.jpg" title="slide9" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">4  T &amp; C for GBF &amp; Loans Facility(ies) 202307_revised (LD/2023/7274)  (&#39321;&#28207;)&#26377;&#38480;&#20844;&#21496;  BANK OF CHINA (HONG KONG) LIMITED 4          discretion.  2.4 Where a Facility (the &quot;First Facility&quot;) is said to be interchangeable with another Facility (the &quot;Second  Facility&quot;) as stated in the relevant Facility Letter, and any free unutilized balance is available under the First  Facility, the whole amount of such free unutilized balance can be made available to the Borrower for utilization  under the Second Facility, subject to any limit stated in the relevant Facility Letter, and the reverse shall also  apply. For the avoidance of doubt, any balance of any Facility which is withheld by the Bank shall not be  treated as free unutilized balance of such Facility.  2.5 In case of T/R being granted, it means that T/R and S/G are granted such that the T/R are interchangeable with  the S/G.  2.6 Unless otherwise stated in the relevant Facility Letter, whenever T/R are granted together with L/C, such T/R  are granted by the Bank as part of the L/C so that the utilization of the T/R is subject to the availability of free  unutilized balance under the L/C and upon utilization, will reduce the free unutilized balance of the L/C by a  corresponding amount.  2.7 In case of T/L or D/L, any advance under such Facility shall be made against a drawdown notice, except that no  drawdown notice is required if an application by the Borrower for opening a letter of credit has been accepted  by the Bank, in which case drawdown shall be deemed to have been made at the time when payment or a  commitment to pay is made by the Bank pursuant to the relevant letter of credit. If a shipping guarantee shall be  issued by the Bank on behalf of the Borrower, drawdown shall be deemed to have been made at the time when  the Bank pays the beneficiary under the shipping guarantee. Any payment by the Bank in a currency other than  the currency of the relevant Facility shall be converted at the spot rate of exchange quoted by the Bank for  buying the currency of payment with the currency of the relevant Facility.  2.8 If a drawdown notice specifies that the relevant advance shall be credited to an account opened in the name of a  third party (and not the Borrower), the Borrower shall remain liable for the repayment of the advance once the  same has been made to such account.  2.9 A drawdown notice shall be irrevocable once given. A drawdown notice shall be in writing and in such form as  the Bank may direct.  2.10 A notice for rollover or selection of interest period shall be irrevocable once given. Such notice shall be in  writing and in such form as the Bank may direct. The Bank may at its absolute discretion and subject to such  conditions as the Bank may think fit accept an instruction for rollover or selection of interest period be given to  the Bank by phone, facsimile or electronic mail.  2.11 Subject to the Bank's overriding discretion, a drawdown will only be effected on a Business Day (which in the  case of a Facility being denominated in USD shall mean a day on which commercial banks in Hong Kong,  London and New York City are open for business but excluding Saturdays, Sundays and public holidays).  2.12 The Bank is not bound to monitor or verify the application of any amount borrowed under the relevant  Facilities.  2.13 If, at any time, it is or will become unlawful in any applicable jurisdiction for the Bank to perform any of its  obligations under the Facilities or to fund or maintain its participation in any loan, the Bank shall notify the  Borrower of the same and the commitments of the Bank shall be immediately cancelled and the Borrower shall  repay the Facilities in full on the date specified by the Bank in the notice delivered to the Borrower.  3. Interest   3.1 All amounts advanced/drawn under the Facilities shall be charged with interest (before as well as after judgment  and subject to fluctuation), commission and/or other charges at such rates as specified in the relevant Facility  Letter or at such standard rates specified in any schedule of charges published by the Bank from time to time, or  such other rates as the Bank may from time to time determine in its absolute discretion. The schedule of  charges shall be made available to the Borrower at any time upon request.  If any Base Rate is below zero,  such Base Rate shall be deemed to be zero when calculating the applicable interest rate chargeable on the  Facilities. In addition, if the applicable interest rate chargeable on the Facilities is below zero (after any  negative Base Rate has been deemed to be zero), then such applicable interest rate shall be deemed to be zero.  3.2 Unless otherwise specified in these General Terms and Conditions or the relevant Facility Letter, interest on the  Facilities will accrue from day to day and be calculated on the basis of actual number of days elapsed and a  365-day year for HKD and Pound Sterling or a 360-day year for other currencies (including USD and CNY) or  according to the market practice as the Bank may from time to time adopt in its absolute discretion and any  change to a prime rate shall immediately apply to any interest rate calculated by reference to such prime rate.  3.3 All accrued interest shall be payable on demand, and if no demand is made, shall be paid on the due date of  each instalment payable in respect of a Facility or, in the case where the principal sum of the Facilities is not  payable by periodical instalments, at such interval as the Bank may designate in the Facility Letter or otherwise  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1033-bochk_facili010.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1033-bochk_facili010.jpg" title="slide10" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">5  T &amp; C for GBF &amp; Loans Facility(ies) 202307_revised (LD/2023/7274)  (&#39321;&#28207;)&#26377;&#38480;&#20844;&#21496;  BANK OF CHINA (HONG KONG) LIMITED 5          on the relevant repayment date or according to the Bank's customary practice as may be notified to the  Borrower from time to time and if not so paid, the Bank shall have the right to capitalize such unpaid interest as  principal advance so that it shall bear interest at the same rate.  3.4 Subject to the Bank's approval, if any Facility is drawn in a currency other than that specified in the Facility  Letter, the interest rate applicable to such Facility shall be such rate as determined by the Bank from time to  time.  3.5 In respect of HKD O/D, and DDC O/D, the Bank shall be entitled to charge the highest of (i) the Original  Interest Rate applicable to such facilities; or (ii) the overnight HIBOR; or (iii) the Bank's cost of funds as may  be quoted by the Bank from time to time.  3.6 In respect of USD O/D, the Bank shall be entitled to charge the highest of (i) the Original Interest Rate  applicable to such facilities; or (ii) the Bank's cost of funds as may be quoted by the Bank from time to time.  3.7 In respect of CNY O/D, the Bank shall be entitled to charge the highest of (i) the Original Interest Rate  applicable to such facilities; or (ii) the Bank's cost of funds as may be quoted by the Bank from time to time.  3.8 In respect of any overdraft facility (including HKD O/D, DDC O/D, CNY O/D and USD O/D), the interest  accrued thereon shall be payable on the last Calendar Day of each month.  3.9 In respect of Facilities other than overdraft facilities, if interest on any such Facilities is charged by reference to  prime rate plus or minus an interest margin or at a fixed rate, and if for any reason whatsoever, the prime rate is  not available, or if the Bank's cost of funds, as determined solely by the Bank, for maintaining such Facilities  exceeds the prime rate or the fixed rate, or if the Bank is unable to obtain deposits to fund such Facilities, the  Bank shall be entitled, without limiting the right of the Bank under Clause 3.1 to charge interest, commission or  charges at such rates as it may determine from time to time, to charge interest at the Bank's cost of funds or the  overnight HIBOR/ the overnight CNY HIBOR (whichever is the highest) plus the said interest margin or where  interest is charged at a fixed rate, an interest margin determined by the Bank.  3.10 If for any reason whatsoever, interbank offered rates (IBORs) include HIBOR (1) is not available, temporarily  or permanently, (2) in the opinion of the Bank ceases to be representative, or (3) in the opinion of the Bank is  no longer appropriate for the purposes of calculating interest hereunder, the Bank reserves its absolute right to  review and amend the interest rate for the facility(ies) without prior notice. The Bank shall notify the  Borrower(s) as soon as the interest rate has been amended.  3.11 If for any reason whatsoever, interbank offered rates (IBORs) include HIBOR or the amended rate as decided  by the Bank pursuant to Clause 3.10 (if applicable) does not reflect the cost of funds incurred, interest for the  advance shall be charged at interest margin over the Bank&#8217;s cost of funds as may be reasonably determined by  the Bank solely.  The Bank shall notify the Borrower such cost of funds as soon as it has been fixed.  3.12 In respect of a Loan Facility where the Borrower is entitled to choose the duration of interest periods, all  accrued interest shall be paid in arrears at the end of each interest period. No interest period shall extend  beyond the final maturity date as set out in the Facility Letter and if any interest period would otherwise extend  beyond such date, it shall end on such date. If the Bank receives no valid selection of an interest period from the  Borrower, that interest period shall be one month. If any interest period would otherwise end on a day which is  not a Business Day, it shall end on the immediately succeeding Business Day, if there is one within the same  calendar month, and, if not, on the immediately preceding Business Day.  3.13 In the case where the principal sum of the Facilities are not payable by periodical instalments and the Bank  designates in the Facility Letter that the interest accrued on the Facilities are payable monthly in arrears, the  first interest payment date shall be the date in the succeeding month corresponding to the date of the drawdown  of the relevant Facilities and thereafter subsequent interest payment dates shall be the corresponding dates in  each and every succeeding months provided that no interest payment date shall extend beyond the final maturity  date of the relevant Facilities set out in the Facility Letter.  4. Payment   4.1  All payments or repayments made by the Borrower to the Bank are to be made in the currency of the payment  or liabilities made or incurred by the Bank under the Facility Letter or otherwise in the converted currency if the  Bank exercises its rights under Clause 4.4 (the &quot;Applicable Currency&quot;), in immediately available funds  without set-off or counter-claim and free and clear of and without withholding or deduction of any or all present  or future taxes, duties, payments or other charges. In case any payment under the Facility Letter and/or Security  Documents is/are required for such withholding or deduction, it shall be increased by the Borrower to the extent  necessary equal to the sum of payment as if no such withholding or deduction has been made. The Borrower  shall immediately inform the Bank or pay such sum within the time prescribed. The Borrower shall also within  30 days of making such payment provide documentary evidence to the Bank showing the payment has been  made.  4.2  If any change in, or in the interpretation of, any law or regulation or directive or compliance with any law or  regulation or directive made after the original date of a Facility Letter:  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1033-bochk_facili011.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1033-bochk_facili011.jpg" title="slide11" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">6  T &amp; C for GBF &amp; Loans Facility(ies) 202307_revised (LD/2023/7274)  (&#39321;&#28207;)&#26377;&#38480;&#20844;&#21496;  BANK OF CHINA (HONG KONG) LIMITED 6          (a) increases the Bank's cost of making available or maintaining the relevant Facilities; or  (b) reduces the amount of any payment receivable by the Bank under the Facility Letter and/or Security  Documents,  then the Borrower will pay to the Bank on demand all amounts needed to compensate the Bank therefor.  4.3  No payment to the Bank (whether under any judgment, court order or otherwise) shall discharge the obligation  or liability of the Borrower in respect of which it was made unless and until the Bank shall have received  payment in full in the Applicable Currency , and to the extent the amount of any such payment shall on actual  conversion into the Applicable Currency fall short of such obligation or liability expressed in the Applicable  Currency, the Bank shall have a further separate cause of action against the Borrower.  4.4  The Bank hereby expressly reserves the right, at any time at its absolute discretion without giving any reason  therefor to the Borrower to: -  (a) convert all or any outstanding indebtedness, liabilities and/or obligations due, owing or incurred by the  Borrower under any Facility denominated in the currency specified in the Facility Letter for the relevant  Facility into HKD; or  (b) convert all or any outstanding indebtedness, liabilities and/or obligations due, owing or incurred by the  Borrower under any Facility denominated in a currency other than that specified in the Facility Letter for  the relevant Facility into the currency so specified for the relevant Facility or into HKD, as the Bank may  deem fit in its absolute discretion.  The aforesaid conversion shall be at the then prevailing rate of exchange as the Bank may determine  conclusively. For the avoidance of doubt, after such conversion, the Bank shall be entitled to re-determine the  applicable interest rate for the converted indebtedness, liabilities and/or obligations on the basis that the same  are denominated in HKD or (as the case may be) in the currency specified in the Facility Letter for the relevant  Facility.  The Bank may also from time to time, without actual conversion, determine the outstanding amount of any  Facility by reference to the base currency to which such Facility was originally denominated at the then  prevailing rate of exchange as the Bank may determine conclusively. If such outstanding amount under the base  currency exceeds the original base currency amount of such Facility, the Bank shall be entitled to request the  Borrower to repay such excess amount upon demand in the currency as specified by the Bank.  4.5  Any payment made to the Bank in a currency (the &quot;existing currency&quot;) other than the Applicable Currency  may at the Bank's absolute discretion be converted into the Applicable Currency to cover the obligations and  liabilities of the Borrower at the then prevailing spot rate of exchange as conclusively determined by the Bank  for purchasing the Applicable Currency with the existing currency.  4.6  All payments made by the Borrower to the Bank shall be accepted upon and subject to the Bank's practice and  terms and conditions and where applicable to the rules of any relevant clearing system for the time being and  from time to time in force, and shall be deemed not to have been made until such time as the relevant funds  have been cleared and received for value by the Bank.  4.7 If a change in any currency of a country occurs and such change relates to the currency or currencies in which  the Facilities or the transactions contemplated under the Facility Letter are denominated, these General Terms  and Conditions and the Facility Letter will, to the extent the Bank (acting reasonably) specifies to be necessary,  be amended to comply with any generally accepted conventions and market practice in the relevant interbank  market and otherwise to reflect the change in currency.  5. Repayment   5.1 Notwithstanding anything to the contrary contained in the Facility Letter and in these General Terms and  Conditions but subject to Clause 27.8 hereof, the Bank reserves the overriding right to demand immediate  repayment of all the outstanding indebtedness, liabilities and/or obligations (including interest and default  interest thereon) due, owing or incurred by the Borrower (actual or contingent) to the Bank under or in respect  of the Facilities.  5.2 Unless otherwise provided in the Facility Letter and/or these General Terms and Conditions and/or General  Terms and Conditions for Mortgage Loan Facility or agreed by the Bank in writing, in the case of the Facilities  being payable by monthly instalments, the first instalment shall be due and payable one month after the  drawdown of the relevant Facilities; in the case of the Facilities being payable by bi-weekly instalments, the first  instalment shall be due and payable two weeks after the drawdown of the relevant Facilities.  5.3 Subject to the Bank's approval, in the case of the Facilities being payable by the Borrower by monthly  instalments, the Borrower may designate a day of each successive month as pre-set payment dates for payment  of the monthly instalments to the Bank. The first pre-set payment date shall be the pre-set payment date which  immediately follows the date of drawdown of the relevant Facilities. If the first pre-set payment date does not  fall on or falls before the date falling one month from the drawdown date of the relevant Facilities: -  (a) the first monthly instalment shall be due and payable on the second pre-set payment date and the  subsequent monthly instalments on the corresponding subsequent pre-set payment dates;  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1033-bochk_facili012.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1033-bochk_facili012.jpg" title="slide12" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">7  T &amp; C for GBF &amp; Loans Facility(ies) 202307_revised (LD/2023/7274)  (&#39321;&#28207;)&#26377;&#38480;&#20844;&#21496;  BANK OF CHINA (HONG KONG) LIMITED 7          (b) interest on the relevant Facilities shall accrue on a daily basis for the period from the drawdown date of the  Facilities to the first pre-set payment date (the &quot;Extended Interest&quot;);  (c) the amount due and payable for the first monthly instalment shall be a sum representing the monthly  instalment payable (calculated as if the relevant Facilities were drawn on the first pre-set payment date)  together with the Extended Interest.  If the first pre-set payment date falls on or after the date falling one month from the drawdown date of the  relevant Facilities, the first monthly instalment shall be due and payable on the first pre-set payment date and  there shall be no Extended Interest payable by the Borrower.  5.4 If there is any variation in the interest rate resulting from a change in the Base Rate, the Bank may vary either  the amount or number of instalments or both at the Bank's sole discretion and will notify the Borrower  subsequently.  5.5 In the case of ML and/or T/L secured by mortgaged properties (the &quot;said facilities&quot;), the loan tenor specified in  the Facility Letter is subject to the confirmation of the solicitors acting for the Bank after their review of the title  deeds of the mortgaged property. Such loan tenor must not be longer than the term of the Government Grant  under which the property is held. In the event the term of the Government Grant is shorter than the loan tenor of  the said facilities, re-approval of the said facilities by the Bank is required. Such re-approval process may  result in the Bank's refusal to grant the said facilities or in repackaging the said facilities with different loan  amount and/or loan tenor and/or the terms and conditions of the loan.  5.6 In respect of ML, T/L or D/L where CNY HIBOR or HIBOR is used as the Base Rate and where repayment is  required to be made on an interest payment date or a repayment date only, or in respect of R/L, if a repayment is  not made on an interest payment date, the Borrower shall indemnify the Bank for any break-funding cost which  would have been incurred in the amount certified by the Bank.  5.7 Unless it is provided in the Facility Letter that the principal of the Facilities is payable by instalments, the  principal of the Facilities shall be repaid in full on the final maturity date set out in the Facility Letter.  5.8 If the Borrower shall anticipate or experience any difficulty in repaying or servicing the Facilities, the Borrower  shall inform the Bank as soon as possible.  6. Default interest/charges   6.1 Time shall be of the essence of any payment or repayment to be made by the Borrower.  6.2 The Bank reserves the right to charge default interest (before as well as after judgment) on a day to day basis on  any sum which is not paid when due: -  (a) In respect of HKD O/D and DDC O/D, at (i) the HKD Prime plus the applicable Default Margin, or (ii)  the overnight HIBOR, or (iii) the Bank's cost of funds, whichever is the highest, provided that the  foregoing default rate and method of calculation shall apply irrespective of whether the due but unpaid  overdrafts fall within the overdraft limit previously allowed by the Bank or otherwise.  (b) In respect of USD O/D, at (i) the USD Prime plus the applicable Default Margin, or (ii) the Bank's cost of  funds, whichever is the highest, provided that the foregoing default rate and method of calculation shall  apply irrespective of whether the due but unpaid overdrafts fall within the overdraft limit previously  allowed by the Bank or otherwise.  (c) In respect of CNY O/D, at (i) the CNY Prime plus the applicable Default Margin, or (ii) the overnight  CNY HIBOR plus the applicable Default Margin, or (iii), the Bank's cost of funds, whichever is the  highest, provided that the foregoing default rate and method of calculation shall apply irrespective of  whether the due but unpaid overdrafts fall within the overdraft limit previously allowed by the Bank or  otherwise.  (d) In respect of Loan Facility(ies), at the higher of (i) the applicable Default Margin plus the prime rate for  the relevant currency and as may from time to time be quoted by the Bank, and (ii) the Bank's cost of  funds; or such other rates as the Bank may from time to time determine at its absolute discretion.  (e) For Facilities other than HKD O/D, DDC O/D, USD O/D, CNY O/D and Loan Facility(ies), at (i) the  applicable Default Margin plus the prime rate for the relevant currency and as may from time to time be  quoted or determined by the Bank, or (ii) the overnight inter-bank offered rate for the relevant currency  and as may from time to time be quoted or determined by the Bank, or (iii) the Bank's cost of funds  whichever is the highest; or such other rates as the Bank may determine from time to time at its absolute  discretion.  6.3 (a)  In respect of HKD O/D and DDC O/D, the Bank shall have the right to charge default interest at the  higher of (i) such default rate and in such method of calculation as set out in Sub-clause 6.2(a) on any sum  which is overdrawn in excess of the applicable pre-agreed overdraft limit, whether such excess is allowed  by the Bank in the exercise of its discretion or upon the request of the Borrower or otherwise, or (ii) the  Original Interest Rate.  (b) In respect of USD O/D, the Bank shall have the right to charge default interest at (i) the USD Prime plus  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1033-bochk_facili013.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1033-bochk_facili013.jpg" title="slide13" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">8  T &amp; C for GBF &amp; Loans Facility(ies) 202307_revised (LD/2023/7274)  (&#39321;&#28207;)&#26377;&#38480;&#20844;&#21496;  BANK OF CHINA (HONG KONG) LIMITED 8      7. F/X and other Treasury and Derivative Products  8. Facilities granted to two or more Borrowers severally      6% per annum, or (ii) the Bank's cost of funds, or (iii) the Original Interest Rate applicable to the USD  O/D, whichever is the highest, on any sum which is overdrawn in excess of the applicable pre-agreed  overdraft limit, whether such excess is allowed by the Bank in the exercise of its discretion or upon the  request of the Borrower or otherwise.  (c) In respect of CNY O/D, the Bank shall have the right to charge default interest at (i) the CNY Prime plus  the applicable Default Margin, or (ii) the overnight CNY HIBOR plus the applicable Default Margin, or  (iii) the Bank's cost of funds, or (iv) the Original Interest Rate, whichever is the highest, on any sum  which is overdrawn in excess of the applicable pre-agreed overdraft limit, whether such excess is allowed  by the Bank in the exercise of its discretion or upon the request of the Borrower or otherwise,.  6.4 Default interest shall accrue on a day to day basis and be calculated from the date when payment is due up to  the date of final payment in full. In the case of the Loan Facility(ies) being payable by instalments, if any  instalment or interest payment is overdue, default interest shall be calculated from the due date of the relevant  instalment or interest payment on a daily basis up to the day on which actual payment in full has been made.  The provisions in this Clause 6.4 shall not prejudice or affect the Bank's rights to charge default interest under  Clause 6.2 above.  6.5 Apart from default interest, the Bank reserves the right to charge the Borrower Default Administrative Charges  of HKD500.00 or such other amount as determined by the Bank from time to time, on each time when the  Borrower fails to make a payment on its due date. In addition, if the Bank shall determine in its absolute  discretion that it is necessary to instruct lawyers to issue letter of demand to the Borrower or to take any other  recovery action against the Borrower after the Borrower has failed to make any payment on its due date, the  Bank shall have the right to recover all legal costs reasonably incurred by the Bank and the Borrower shall be  obliged to pay such costs to the Bank upon demand.  6.6 For the avoidance of doubt, in case the Original Interest Rate chargeable on the overdue sum shall exceed the  default rate specified in Clause 6.2, the Bank shall have the right to continue to apply such Original Interest  Rate notwithstanding the sum is overdue.  6.7 The Bank reserves the right to compound default interest at such intervals as it deems fit.    7.1 All F/X and other treasury and derivative products Transactions shall be subject to the terms and conditions  stipulated by the Bank from time to time and the market practices prevailing for the time being and must be  settled before 3:00 p.m. Hong Kong time on the relevant value date or delivery date for any particular  Transactions or such other time as may be required by the Bank.    8.1 If, under any Facility Letter, the Facilities are granted to two or more Borrowers severally, such Facilities or any  part or parts thereof may, subject to the Bank's prior approval, be utilized by any one of the relevant Borrowers  within such sub-limits (the &quot;Sub-Limits&quot;) (if they are expressly stipulated in the relevant Facility Letter or  otherwise imposed by the Bank) and upon such terms as the Bank may determine from time to time. In any  event, the Borrowers may not in aggregate borrow more than the amount of the Facilities. For the purpose of  this Clause 8, the Facilities that are granted to two or more Borrowers severally are hereinafter called the  &quot;Global Facilities&quot; and the facility limit in respect of the Global Facilities is called the &quot;Global Limit&quot;.  8.2 For the avoidance of doubt, unless Sub-Limits are stipulated in the Facility Letter or otherwise imposed by the  Bank, the Bank may allow any one or more of the Borrowers to utilize the Global Facilities up to the full extent  of the Global Limit, provided that unless the Bank in its absolute discretion agrees, the aggregate utilization of  the Global Facilities at any time by all of the relevant Borrowers in respect of each type of the Global Facilities  shall not exceed the relevant Global Limit(s) of such Global Facilities.  8.3 Where there are Sub-Limits stipulated in the Facility Letter or otherwise imposed by the Bank, all the  Borrowers acting together by themselves or through an authorized representative(s) may apply to the Bank to  vary the Sub-Limits allocated to each of the Borrowers by giving the Bank not less than three (3) Business  Days' prior notice. The Bank reserves the absolute discretion to determine whether to accept or reject any such  application.  8.4 Upon approval by the Bank of any application to vary the Sub-Limits, each of the relevant Borrowers shall be  bound by the variation and any condition imposed by the Bank in respect of such variation.  8.5 Notwithstanding anything herein contained, the Bank reserves the absolute right to re-allocate the Global  Facilities and/or the Global Limits and/or the Sub-Limits (if any) at any time and at the Bank's sole and absolute  discretion.  8.6 For the avoidance of doubt, all provisions contained in these General Terms and Conditions applicable to the  Facilities shall equally apply to the Global Facilities and insofar as the relevant Borrower's utilization of and  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1033-bochk_facili014.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1033-bochk_facili014.jpg" title="slide14" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">9  T &amp; C for GBF &amp; Loans Facility(ies) 202307_revised (LD/2023/7274)  (&#39321;&#28207;)&#26377;&#38480;&#20844;&#21496;  BANK OF CHINA (HONG KONG) LIMITED 9      9. Facilities to be used by third parties  10. Prepayment  11. Conclusive Statement      liabilities under or relating to the Global Facilities are concerned, each of the Borrowers to whom the Global  Facilities is granted shall be bound by the provisions contained in these General Terms and Conditions.    9.1 Subject to the Bank's prior approval, the Bank may, at the request of the Borrower, allow the Facilities granted  to the Borrower to be utilized by third parties (the &quot;Co-user(s)&quot;) upon the following conditions and other  additional conditions as the Bank may from time to time impose: -  (a) any utilization of the Facilities by the Co-user(s) shall be booked under the account(s) of the Borrower and  the Borrower shall be fully liable for the same to the Bank as if it were the party actually utilizing the  Facilities;  (b) in addition and without prejudice to sub-clause (a) above, the Co-user(s) shall, in addition to the Borrower,  be fully liable to the Bank in respect of their utilization of the Facilities as if the Facilities were granted  in their favour and utilized by them under their own account(s). In this regard, the Co-user(s) shall be  bound by these General Terms and Conditions and any other terms and conditions under which the Bank  has agreed to grant the Facilities to the Borrower, as if the Co-user(s) is/are the Borrower named therein;  and  (c) in case the Borrower has given any guarantee in favour of the Bank for the obligations and liabilities of the  Co-user(s) under general banking facilities granted or to be granted by the Bank in favour of the Co-user(s),  such guarantee shall for all intent and purposes cover the obligations and liabilities of the Co-user(s) under  sub-clause (b) above. For the avoidance of doubt, this provision shall not be affected in case the liability of  the Borrower under sub-clause (a) above is or becomes unenforceable or avoided for whatever reason.    10.1 Unless otherwise provided in the Facility Letter, prepayment under the Loan Facility(ies) shall be subject to the  following conditions: -  (a) where the principal sum of the Loan Facility(ies) is repayable by instalments, all prepayments (whether  total or partial) must be paid on an instalment payment date of the Loan Facility(ies), otherwise the Bank  shall be entitled to charge interest on the amount to be prepaid up to the next coming instalment payment  date;  (b) in respect of Loan Facility(ies) where CNY HIBOR or HIBOR is used as the Base Rate, if a prepayment  is not made on an interest payment date or a repayment date, the Borrower shall indemnify the Bank for  any break-funding cost which would have been incurred in the amount certified by the Bank;  (c) the Borrower shall give to the Bank at least 1 month's prior notice in writing of the Borrower's intention to  prepay whether in whole or in part the outstanding amount of the Loan Facility(ies). Such notice shall be  irrevocable once given. If the Borrower fails to give such notice in the prescribed manner, a prepayment  fee as may be specified by the Bank from time to time and displayed or posted in the Bank's banking halls  shall be payable by the Borrower on or before the prepayment;  (d) any partial prepayment shall be in the minimum sum of HKD50,000.00 or its equivalent in other foreign  currencies. In the case of any partial prepayment, the Bank may, at its discretion, vary either the amount  of the monthly instalment or the number of future instalments;  (e) amount prepaid shall be subject to the Bank's right of appropriation under Clause 17 below;  (f) any prepayment of the principal of the Loan Facility(ies) shall include all interest accrued thereon and  may not be re-borrowed;  (g) all or any sums or liabilities (actual or contingent) payable by the Borrower in connection with the prepaid  portion of the Loan Facility(ies) shall be paid or discharged by the Borrower on or before the prepayment;  and  (h) due payment of any prepayment charges or fees as may be stipulated in the relevant Facility Letter.    11.1 Any statement of account (including, without limitation, the monthly statement) relating to the Facilities signed  as correct by any one of the Bank's officers shall be conclusive evidence of the indebtedness of the Borrower to  the Bank and be binding on the Borrower, save for manifest error.  11.2 Any certificate relating to the Bank's cost of funds or any Base Rate in respect of any Facilities signed as correct  by any one of the Bank's officers shall be conclusive and binding on the Borrower.  11.3 Any opinion, determination or decision by the Bank as to any materiality, effect or otherwise relating to  anything herein mentioned or referred to shall be conclusive and binding on the Borrower.  11.4 Instruction given by the Borrower to the Bank through telephone, facsimile or electronic mail shall be binding  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1033-bochk_facili015.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1033-bochk_facili015.jpg" title="slide15" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">10  T &amp; C for GBF &amp; Loans Facility(ies) 202307_revised (LD/2023/7274)  (&#39321;&#28207;)&#26377;&#38480;&#20844;&#21496;  BANK OF CHINA (HONG KONG) LIMITED 10      12. Termination of the Facilities  13. Mortgaged Property(ies)      against the Borrower and the Bank may (but shall not be obliged to) act upon such instructions subject to such  conditions as the Bank may think fit. The Bank may at its absolute discretion take recording or keep record of  such instructions with or without notice to the Borrower. The Borrower consents to such recording and record  keeping and agrees to the use of such records for any purpose that the Bank deems desirable including for use  as evidence, in any proceedings, against the Borrower or any other person.    12.1 Notwithstanding anything contained in the Facility Letter (including any review date stated therein), the Bank  reserves the overriding right to:-  (a) review the Facilities at any time (if applicable, prior to the review date stated in the Facility Letter) and the  Facilities shall terminate forthwith (if applicable, even if prior to the said review date) as and when the  Bank has given to the Borrower notice of termination; and  (b) increase, reduce and/or cancel the Facilities or any part or parts thereof or to vary or amend the terms and  conditions thereof at any time at its sole and absolute discretion to be effective forthwith (if applicable,  even if prior to the said review date) by notice in writing to the Borrower.  12.2 A renewal fee shall be payable by the Borrower when the Facilities or any part or parts thereof are renewed,  extended or otherwise revised by the Bank.    13.1 The following provisions shall apply if land property(ies) is/are mortgaged to the Bank as security for the  Facilities:-  (a) the title of the property(ies) to be mortgaged to the Bank shall be approved by solicitors appointed by the  Bank;  (b) the mortgaged property(ies) has/have to be insured against fire risks. The relevant insurance policy  denoting the Bank's interest as mortgagee together with the premium receipt shall be lodged with the  Bank forthwith after the Borrower has accepted the relevant Facility Letter under which the Facilities are  granted (but in any event prior to the drawdown of the Facilities), and in the case of renewal of any  insurance policy, fifteen (15) days before the expiry of the current insurance policy, provided always that  if the Borrower fails to perform its obligation as aforesaid, the Bank shall be entitled (but not be obliged)  to take out or renew at the Borrower's costs and expenses the said insurance policy for the Borrower with  such insurance company, for such insured amount and on such terms as the Bank shall determine;  (c) where the property(ies) mortgaged is/are residential property(ies), such property(ies) shall, as indicated  and subject to the conditions imposed by the Bank, be insured against fire risks with an insurance  company acceptable to the Bank for an amount approved by the Bank. If the amount insured is the full  replacement value of the property(ies) and the Bank requires valuation of the property(ies) to be  conducted by the Bank's nominated surveyor from time to time, the Borrower shall be liable to reimburse  the Bank on demand all valuation charges, so incurred;  (d) where the property(ies) mortgaged is/are property(ies) other than residential properties, such property(ies)  has/have to be insured through the Bank's appointed agent upon such terms, for such amount and against  such risks as the Bank may require from time to time;  (e) where the mortgage of the property(ies) is given to the Bank by way of equitable mortgage, the Borrower  shall forthwith on demand by the Bank execute or procure the execution of a legal mortgage or legal  charge in favour of the Bank on such terms and in such form as the Bank may require;  (f) the Borrower undertakes that the property(ies) is/are self-occupied by the registered owner(s) thereof and  the property(ies) shall not be let to any other party(ies) unless with the Bank's prior written consent. The  Bank shall have the right to re-determine the interest rate, the loan amount and/or the terms and conditions  of the relevant Facilities at its absolute discretion upon giving the consent to let and such re-determination  of the interest rate, the loan amount and/or the terms and conditions shall take immediate effect unless  otherwise agreed by the Bank. All costs and expenses (including the Bank's legal costs on a full  indemnity basis) reasonably incurred by the Bank in giving the consent shall be borne and paid by the  Borrower;  (g) the Borrower undertakes that it shall not / it shall procure the mortgagor not to enter into any second  mortgage / further mortgage over the property(ies) without the prior written consent of the Bank.  Otherwise, re-approval of the Loan by the Bank is required. Such re-approval process may result in the  Bank's refusal to grant the Loan or in repackaging the Loan with different loan amount and/or loan tenor  and/or the terms and conditions of the loan; and  (h) on default in payment of any of the Facilities, the Bank may take possession of and sell the property(ies)  pursuant to the terms of the relevant mortgage or charge documents under which the property(ies) is/are  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1033-bochk_facili016.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1033-bochk_facili016.jpg" title="slide16" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">11  T &amp; C for GBF &amp; Loans Facility(ies) 202307_revised (LD/2023/7274)  (&#39321;&#28207;)&#26377;&#38480;&#20844;&#21496;  BANK OF CHINA (HONG KONG) LIMITED 11      14. Property valuation fees  15. Indemnity  16. Expenses  17. Appropriation  18. Set-off and Lien      mortgaged to the Bank.    14.1 The Borrower acknowledges that when any land property is proposed to be mortgaged to the Bank as security  for the Facilities, the Bank may, in its absolute discretion, elect to engage a property valuation agent or its  internal office or department, or both, to assess the value of the property concerned. Without prejudice to the  generality of the foregoing, during the availability of the Facilities, the Borrower will promptly deliver to the  Bank from time to time as requested by the Bank valuation report or reports (with the name of the Bank as the  addressee) in respect of the mortgaged property(ies) or any part thereof, which shall be dated not earlier than 30  days prior to the date of its delivery and prepared at the cost and expense of the Borrower by an independent  firm of property valuation agent acceptable to the Bank, as to the then current market value of the mortgaged  property(ies).  14.2 If any property valuation agent has been engaged, the Borrower shall be obliged to reimburse the Bank the full  amount of the fees charged by the agent and pay the Bank a handling charge in such sum as the Bank may  charge its customers generally for arranging such kind of property valuation. If the Bank has engaged its  internal office or department to make assessment of the value of the property concerned, the Bank may impose a  handling charge on the Borrower in such amount as the Bank may charge its customers generally for such  service. All such fees and charges shall be payable by the Borrower forthwith on demand.  14.3 For the avoidance of doubt, unless the Bank otherwise agrees, the Borrower shall be liable for the payments  mentioned in Clause 14.2, notwithstanding that the property in question may not eventually be accepted by the  Bank as security for the Facilities for whatever reason or that the Facilities are not eventually made available to  or utilized by the Borrower on whatever ground.    15.1 The Borrower shall indemnify the Bank on a fully indemnity basis from and against all action, suits,  proceedings, claims, demands, losses, damages, costs, fees, expenses and/or liabilities of whatsoever nature  which the Bank may suffer, incur or sustain, whether actual or contingent, by reason of or in maintaining or  enforcing the Facilities granted to the Borrower (including the Facilities used by Co-user(s) as mentioned in  Clause 9 above) or by accepting any instruction/notice given by the Borrower through telephone, facsimile or  electronic mail unless caused by the negligence or wilful default of the Bank.  15.2 Without prejudice to Clause 4.1, if the Bank is required to make any payment for such withholding or deduction  referred to in Clause 4.1 or incur any liability with respect to such withholding or deduction, the Borrower shall  promptly indemnify the Bank against such payment or liability.    16.1 Whether or not the Facilities are drawn or utilized by the Borrower, all expenses including but not limited to  legal fees, communications and other out-of-pocket expenses reasonably incurred by the Bank in connection  with the Facilities or any documents executed in respect of the Facilities or any enforcement, or attempted  enforcement, of the Bank's rights under the Facility Letter or other documents executed in respect of the  Facilities, are to be borne by the Borrower on a full indemnity basis.    17.1 The Borrower hereby irrevocably waives any right or power which it may have by way of appropriation and the  Bank shall have the sole and absolute right to appropriate either at the time of payment or at any time thereafter  any moneys paid to the Bank by or otherwise coming into the Bank's possession or control from the Borrower in  or towards discharging whichever part or parts of liabilities of the Borrower to the Bank as the Bank shall think  fit. Any such appropriation shall override any purported appropriation by the Borrower.    18.1 In addition and without prejudice to any general banker's lien, right of set-off or similar right to which the Bank  may be entitled, the Bank shall have the right and is hereby irrevocably and unconditionally authorized, to the  fullest extent permitted by law, from time to time and at any time without prior notice to the Borrower (any such  notice being expressly waived):-  (a) to set off and appropriate and apply any credit balance in any of the account(s) and/or deposit(s) of the  Borrower (whether in its sole name or jointly with others) in whatever currency maintained with any of  the Bank's branches or sub-branches (whether subject to notice or not and whether matured or not) and/or  any of the liability of the Bank (whether actual or contingent) due or owing to the Borrower (whether  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1033-bochk_facili017.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1033-bochk_facili017.jpg" title="slide17" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">12  T &amp; C for GBF &amp; Loans Facility(ies) 202307_revised (LD/2023/7274)  (&#39321;&#28207;)&#26377;&#38480;&#20844;&#21496;  BANK OF CHINA (HONG KONG) LIMITED 12      19. Authorization to debit account(s)  20. Debt Collection  21. Information      alone or jointly with others) against or on account of the obligations and liabilities whatsoever of the  Borrower (whether actual or contingent, future or existing) due, owing or incurred to the Bank; and  (b) to apply any credit balance in any of the account(s) and/or deposit(s) of the Borrower (whether in its sole  name or jointly with others) in whatever currency maintained at any of the Bank's offices or branches or  sub-branches (whether the credit balance was originally available in any account maintained with the  Bank (formerly known as Po Sang Bank Limited) or any one or more of Bank of China (Hong Kong  Branch), The Kwangtung Provincial Bank (Hong Kong Branch), Sin Hua Bank Limited (Hong Kong  Branch), The China &amp; South Sea Bank Limited (Hong Kong Branch), Kincheng Banking Corporation  (Hong Kong Branch), The China State Bank Limited (Hong Kong Branch), The National Commercial  Bank Limited (Hong Kong Branch), The Yien Yieh Commercial Bank Limited (Hong Kong Branch) and  Hua Chiao Commercial Bank Limited (collectively the &quot;Merging Banks&quot;) prior to the merger of the said  Merging Banks on 1st day of October 2001 (the &quot;Date of Merger&quot;)) (whether subject to notice or not and  whether matured or not) and/or to set off any of the liability of the Bank (whether actual or contingent)  due or owing to the Borrower (whether alone or jointly with others) including but not limited to any  liability of any one or more of the Merging Banks (whether actual or contingent) which was originally due  or owing to the Borrower (whether alone or jointly with others) prior to the Date of Merger, towards  satisfaction of or against the Borrower's obligations and liabilities, whether actual or contingent, future or  existing, due, or owing or incurred to the Bank, including but not limited to any such obligations and  liabilities of the Borrower originally due, owing or incurred to the Bank or any one or more of the  Merging Banks prior to the Date of Merger.  The Bank shall notify the Borrower promptly after exercising its rights under this Clause 18.1.  18.2 For the purposes aforesaid, the Bank may convert all or any part of the said credit balance or deposit of the  Borrower or such liability of the Bank to the Borrower to such other currencies at the applicable rate of  exchange quoted and determined by the Bank as may be necessary.  18.3 If any sum is due but unpaid under the Facilities and/or these General Terms and Conditions, the Bank may at  any time without further reference to the Borrower, retain all or any securities, valuables or any other property  whatever and wherever situate which may be deposited with or otherwise held by the Bank for or in the name of  the Borrower whether for safe custody or otherwise and sell the same or any part thereof at such price as the  Bank shall determine whether by public auction, private treaty or tender and the Bank may engage such agent or  broker therefor and apply the proceeds thereof in satisfaction of any or all sums owing under the Facilities  and/or these General Terms and Conditions after first deducting all costs and expenses reasonably incurred by  the Bank and the Bank shall not be liable for any loss arising from the sale or other disposition of any such  securities, valuables or other property unless caused by the negligence or wilful misconduct of the Bank.  18.4 The rights herein conferred on the Bank are in addition and without prejudice to any rights conferred on the  Bank under any Security Documents at any time and from time to time held by the Bank.    19.1 The Bank shall be entitled to debit at any time and from time to time all or any of the interests, fees, charges,  commissions, costs, expenses and other sums due and payable by the Borrower in respect of the Facilities from  any of the account(s) of the Borrower without prior notice to the Borrower. Such sums shall be deemed duly  drawn or overdrawn from the account(s) by the Borrower.    20.1 The Bank shall be entitled to employ debt collecting agent(s) to collect any sum due but unpaid by the Borrower  under the Facilities. The Borrower agrees, and acknowledges that the Borrower has been warned, that the  Borrower shall indemnify and keep the Bank indemnified on a full indemnity basis against all costs and  expenses which the Bank may reasonably incur in the employment of debt collecting agent(s). The Bank shall  be entitled to disclose to such debt collecting agent(s) any or all information relating to the Borrower, the  Facilities or the Facility Letter.    21.1 The Borrower agrees that it is necessary to supply the Bank with data/information related to the Borrower  (including for the purpose of this subclause, that of any party/ies or individual(s) who is/are related to a  corporate borrower in whatever capacity) or any information as required by the Bank for assessing the grant,  revision and renewal of the Facilities. The Borrower (which for this subclause refers to itself in the case of an  incorporated entity and its capacity as the duly authorised agent acting on behalf of the related party/ies and  individual(s) including but not limited to the Borrower's holding companies, subsidiaries, affiliates,  shareholders, directors and authorized persons, all these parties and individuals are hereinafter collectively  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1033-bochk_facili018.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1033-bochk_facili018.jpg" title="slide18" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">13  T &amp; C for GBF &amp; Loans Facility(ies) 202307_revised (LD/2023/7274)  (&#39321;&#28207;)&#26377;&#38480;&#20844;&#21496;  BANK OF CHINA (HONG KONG) LIMITED 13          referred as the &quot;Related Parties&quot;) authorize the Bank to use any data, information and documents relating to  the Borrower and the Related Parties , the Facilities, the Facility Letter or any other agreements or transactions  or dealings between the Borrower and/or the Related Parties and /or the Bank in accordance with the Bank's  Conditions for Services (as amended and in force from time to time) (the &quot;Conditions&quot;) (provided that in the  case of an individual, such use will be subject to the Data Policy Notice issued and/or revised by the Bank from  time to time (the &quot;Notice&quot;), and the contents and the receipt of which are hereby acknowledged by the Borrower)  and notes that such data/information/documents (including the Facility Letter or anything in respect of the  Facilities) held by the Bank will be kept confidential but permits the Bank to provide such  data/information/documents to the parties referred to in the Conditions or listed in the Notice (as the case may  be) or to any of its branches, subsidiaries and holding companies and the branches, subsidiaries and affiliates of  any of its holding companies (together the &quot;Bank&#8217;s Related Parties&quot;) or other persons including but not limited  to any person permitted by the Borrower, the professional advisers and any other persons providing services to  the Bank or any of the Bank's Related Parties (including, without limitation, credit reference agencies, debt  collection agencies, rating agencies, insurers or insurance brokers, credit protection providers), any actual or  potential assignee, transferee, participant or sub-participant or any subsequent chargee, mortgagee or  encumbrancer in respect of securities held by the Bank for the Facilities or to any person to the extent required  by or for compliance of any laws, regulations, guidelines or rules of stock exchange binding on or applicable to  the Bank or any of the Bank&#8217;s Related Parties or to any person to whom information is required or requested to  be disclosed by any court or governmental or regulatory authority to which the Bank or any of the Bank&#8217;s  Related Parties are subject to or to any person to whom information is required to be disclosed in connection  with, and for the purposes of any litigation, arbitration, administrative, mediation or other investigations,  proceedings or disputes relating to the Bank or any of the Bank&#8217;s Related Parties. The Borrower further  authorizes the Bank to contact any of the employers of the Borrower (if applicable), bank, referee, credit  reference agencies or any other source for the purpose of obtaining or exchanging any information and to  compare the information provided by the Borrower with other information collected by the Bank for checking  purposes. The Bank is entitled to use the result of such comparison to take any action which may be adverse to  the interest of or against the Borrower. The Borrower also consents to the data/information/documents being  transferred to another jurisdiction outside Hong Kong.  21.2 The Borrower undertakes at all times to notify the Bank in writing of any change of the particulars of the  Borrower including without limitation the Borrower's address, telephone number and facsimile number.  21.3 The Borrower agrees that the Bank may provide the following information to any Obligors in respect of any  Facilities extended by the Bank to the Borrower: -  (a) a copy of the contract evidencing the obligations to be guaranteed or secured by any Obligors or a summary  thereof;  (b) a copy of any formal demand for overdue payment served on the Borrower from time to time; and  (c) a copy of the latest statement of accounts provided to the Borrower from time to time on request by any  Obligors.  21.4 In the case of an individual Borrower, the Borrower acknowledges that the Bank has provided him with the  following information:  (a) the Borrower's data may be supplied to a credit reference agency and/or, in the Event of Default, to a debt  collection agency;  (b) the Borrower's right to be informed, upon request, about what items of data are routinely disclosed to such  credit reference agency and/or debt collection agency, and the Borrower's right to be provided with further  information to enable the making of a data access and correction request to the relevant credit reference  agency or debt collection agency, as the case may be;  (c) that, in the event of any default in payment, unless the amount in default is fully paid before the expiry of  60 days from the date such default occurred, the Borrower shall be liable to have his account data retained  by the credit reference agency until the expiry of five years from the date of final settlement of the amount  in default; and  (d) that the Borrower, upon termination of the account by full payment and on condition that there has not been,  within five years immediately before such account termination, any material default on the account, will  have the right to instruct the Bank to make a request to the credit reference agency to delete from its  database any account data relating to the terminated account.  21.5 The Borrower shall promptly supply, or procure the supply of, such documentation and other evidence as  reasonably requested by the Bank or pursuant to or in satisfaction of any law or regulation to which the Bank is  subject.  21.6 This Clause 21 shall also apply, mutatis mutandis, to any party who has entered into or countersigned the  Facility Letter in favour of the Bank, but is not otherwise a party to any other Security Document.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1033-bochk_facili019.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1033-bochk_facili019.jpg" title="slide19" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">14  T &amp; C for GBF &amp; Loans Facility(ies) 202307_revised (LD/2023/7274)  (&#39321;&#28207;)&#26377;&#38480;&#20844;&#21496;  BANK OF CHINA (HONG KONG) LIMITED 14      23. Representations, warranties and undertakings          22.1 The Bank may at any time, without consent of or notice to the Borrower, assign or transfer to any party all or  any of its rights, benefits, obligations and liabilities under the Facilities and these General Terms and Conditions  and the related guarantees, collateral securities and support documents provided that the Borrower, at any time  of such assignment or transfer, will not be liable to pay any greater amount than the Borrower would have been  liable to pay had no assignment or transfer been made. The Borrower may not assign or transfer any of its rights,  benefits, obligations and/or liabilities under the Facilities and/or these General Terms and Conditions to any  party except with the prior written consent of the Bank.  22.2 In addition to the other rights provided to the Bank, the Bank may without consulting with or obtaining consent  from any Obligor, at any time charge, assign or otherwise create security in or over (whether by way of  collateral or otherwise) all or any of its rights under any Facility Letter(s) or Security Document to secure  obligations of the Bank including:  (a) any charge, assignment or other security to secure obligations to a federal reserve or central bank; and  (b) any charge, assignment or other security granted to any holders (or trustee or representatives of holders)  of obligations owed, or securities issued, by the Bank as security for those obligations or securities,  except that no such charge, assignment or security shall:  (i) release the Bank from any of its obligations under the Facility Letter(s) or Security Document or  substitute the beneficiary of the relevant charge, assignment or security for the Bank as a party to any of the  Facility Letter(s) or Security Document; or  (ii) require any payments to be made by an Obligor other than or in excess of, or grant to any person any more  extensive rights than, those required to be made or granted to the Bank under the Facility Letter(s) or Security  Document.    23.1 The Borrower makes the following representations and warranties to the Bank on the date of its execution of the  relevant Facility Letter: -  (a) it is a company duly incorporated with limited liability under the laws of the place where it was  incorporated (applicable where the Borrower is a limited company);  (b) it has a valid and subsisting business registration certificate pursuant to the Business Registration  Ordinance (Cap.310 of the Laws of Hong Kong) (where applicable);  (c) it has the power and authority and the legal capacity to perform and observe its obligations under the  Facility Letter(s), Security Documents and any other ancillary documents executed in the Bank's favour;  (d) all necessary corporate and other action (including but not limited to any corporate resolutions required to  be passed by the Borrower's shareholders and/or directors) under all applicable laws and regulations  (including but not limited to the Borrower's Memorandum and Articles of Association) to which the  Borrower is subject has been taken to authorise the use of the Facilities and the execution, delivery and  performance of these General Terms and Conditions, the relevant Facility Letter, the Security Documents  (if applicable) and any other ancillary documents;  (e) these General Terms and Conditions, the relevant Facility Letter, the Security Documents (if applicable)  and any other ancillary documents constitute valid and legally binding obligations of the Borrower in  accordance with their terms;  (f) it is not in default of any payment of any principal of or interest on any indebtedness for borrowed money  and is not in breach of or in default under any other provision of any indenture, deed of trusts, agreement  or other instrument to which it is a party and under or subject to which any such indebtedness for  borrowed money has been issued or incurred and is outstanding and no event, condition or act which with  the giving of notice or lapse of time, or both, would constitute an event of default under any such  indenture, deed of trust, agreement or other instrument has occurred or is continuing which has not, in  each case, been properly waived and/or remedied thereunder;  (g) the entry into and performance by it of, and the transactions contemplated by, these General Terms and  Conditions, the relevant Facility Letter, the Security Documents (if applicable) and any other ancillary  documents, do not and will not conflict with any law or regulation applicable to it, its constitutional  documents or any agreement, or instrument binding on it or any of its assets;  (h) all information provided by the Borrower was true, complete and accurate in all material respects as at the  date it was given or as at the date (if any) at which it is stated and was not misleading in any respect;  (i) it is not subject to any existing litigation or arbitration or administrative proceeding or petition for  bankruptcy or winding up before any court, tribunal, arbitrator or governmental authority and is not  pending any litigation or arbitration or administrative proceeding or petition for bankruptcy or winding up  22. Assignment  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1033-bochk_facili020.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1033-bochk_facili020.jpg" title="slide20" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">15  T &amp; C for GBF &amp; Loans Facility(ies) 202307_revised (LD/2023/7274)  (&#39321;&#28207;)&#26377;&#38480;&#20844;&#21496;  BANK OF CHINA (HONG KONG) LIMITED 15          and it has no knowledge of (having made all reasonable enquiries) any litigation, arbitration or  administrative proceeding or petition for bankruptcy or winding up threatened against the Borrower, or  any of its properties or assets, which might, in each case, result in a material adverse change or effect on  the business, assets, condition (financial or otherwise) or prospects of the Borrower;  (j) there is no arrangement with any other financier to further charge the mortgaged property(ies) under  which the Bank is the first mortgagee except for those where prior written consent has been given by the  Bank;  (k) no Event of Default has occurred, or will occur as a result of execution of any of the Facility Letter(s),  Security Documents and other ancillary documents and/or utilizing any of the Facilities, which has not  been duly remedied or waived under the Facility Letter and/or these General Term and Conditions;  (l) None of the members of the Obligor&#8217;s Sanctions Compliance Group and their respective directors,  officers and agents:  i is the target of any Sanctions, or is owned or controlled by any target of any Sanctions; or  ii is located, incorporated, organised or resided in a country or territory that is, or whose  government is, the target of Sanctions, which currently includes the Crimean region, Cuba, Iran,  the Democratic People's Republic of Korea and Syria.  (m)  the above representations and warranties shall be repeated and deemed to be made by the Borrower,  where applicable, on each advance or drawing of the Facility(ies) and on each interest payment date, in  each case by reference to the facts and circumstances then existing.  23.2 The Borrower undertakes with the Bank that it will:  (a) promptly notify the Bank in writing on becoming aware of the occurrence of any Event of Default or  potential Event of Default or any other events or circumstances which has or might have a material  adverse change in or effect on the Borrower's operations, prospects, business or condition (financial or  otherwise) or the Borrower's ability to perform its obligations hereunder and under the Facility Letter,  other Security Document(s) or any other ancillary documents;  (b) duly pay or cause to be paid all taxes, duties and other governmental charges imposed upon the Borrower;  (c) from time to time (including in respect of the net exposure of one or more transactions under the Facilities)  upon the demand of the Bank provide or procure to be provided to the Bank further cash or security  acceptable to the Bank having current market value of not less than the then outstanding Facilities and/or  the net exposure thereunder;  (d) ensure that the Borrower's obligations hereunder and under the Facility Letter, whether actual or  contingent, are not subordinated to, and that they will at all times rank at least pari passu in priority of  payment and in all other respects with any other of the Borrower's unsecured obligations, except to the  extent that such obligations are preferred solely by operation of law;  (e) comply in all respects with all laws and regulations to which it may be subject, if failure so to comply  would materially impair its ability to perform its obligations under the Facilities and Security Documents  to which it is a party;  (f) promptly notify the Bank in writing of any change of the Borrower's particulars or the particulars of any  third party guarantor(s) or security provider(s) in respect of the Borrower's liabilities including without  limitation its/their address(es) and/or telephone number(s) and/or facsimile number(s);  (g) (in case of the Borrower being a firm, partnership or company) promptly upon the Bank&#8217;s request supply  or procure to be supplied to the Bank all information, books, documents, accounts, instruments, computer  or other records, orders, correspondence (whether original or copy) and other evidence (in whatever form)  relating to the Facility(ies) and collection and enforcement of the Facility(ies). The Borrower shall allow  any officer, employee, advisors, duly authorized representative or agent of the Bank, at all reasonable  times, to attend any premises of or occupied by the Borrower or where the Borrower carries on business to  inspect, check, verify and copy (at the Borrower&#8217;s expense) any of the above as the Bank may require  from time to time;  (h) promptly supply or procure to be supplied to the Bank such other documents or information reasonably  required by the Bank from time to time; and  (i) (in case of the Borrower being a firm, partnership or company) comply with, and (in any other case where  any third party guarantor(s) or security provider(s) is involved) ensure any such third party guarantor(s) or  security provider(s) to comply with, in each case in all material respects, with all environmental laws  (including but not limited to obtain and maintain all environmental permits relevant to the operation of  their business activities in the relevant countries) applicable to it or the relevant third party guarantor(s) or  security provider(s); and  (j) not directly or indirectly use, lend, contribute or otherwise make available any service or facility provided  by the Bank or any proceeds thereof, or permit the same to be used, lent, contributed or otherwise made  available, (i) to fund any activities or business of or with any person, or in any country or territory, that, at  the time of such funding, is, or whose government is, the target of any Sanctions; or (ii) in any manner that  would result in a violation of any Sanctions by any person in any capacity.  23.3 In the case where the Borrower is a firm, partnership or company, that it undertakes with the Bank that it will  NOT unless the Bank otherwise expressly agrees in writing:  (a) merge, or consolidate with or into any other corporation or take any step with a view to dissolution,  liquidation or winding up;  (b) make any material change to the nature of the Borrower's business as presently carried on;  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1033-bochk_facili021.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1033-bochk_facili021.jpg" title="slide21" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">16  T &amp; C for GBF &amp; Loans Facility(ies) 202307_revised (LD/2023/7274)  (&#39321;&#28207;)&#26377;&#38480;&#20844;&#21496;  BANK OF CHINA (HONG KONG) LIMITED 16      24. Events of Default  25. Liability of the Bank      (c) create, incur or suffer or permit to exist any charge or security interest upon any of the Borrower's property,  assets, revenues and rights, present or future, except (i) in favour of the Bank or (ii) being any lien arising  by operation of law and in the ordinary course of trading or entered into in the ordinary course of its  banking arrangements provided that in each case the debt secured thereby is paid when due or contested in  good faith;  (d) make loans, advance moneys, grant credit to or guarantee or indemnify the liability of any person, firm or  company, except for any trade credit extended to its customers on normal commercial terms and in the  ordinary course of its trading activities or as permitted by the purpose of the Facility(ies);  (e) [intentionally left blank];  (f) sell, assign or dispose any of its major assets or business (as determined by the Bank) to any third party  unless the proceeds of such sale, assignment or disposal are for the repayment of any outstanding under  the Facilities.  23.4 In the case where the Borrower is a firm or partnership, it undertakes with the Bank that it will promptly inform  all withdrawing, retiring and joining partners in writing of the representations and warranties in this Clause 23.    24.1 Without prejudice to the other provisions herein, all amounts (including principal and interest) due or owing by  the Borrower to the Bank shall, without any demand, become immediately due and payable by the Borrower  and the Bank shall not be required to make any further advances under any of the Facility(ies) upon the  occurrence of any of the following events of default: -  (a) the failure by any Obligors to pay any principal, interest, charges or other costs and expenses payable to  the Bank in connection with the Facility(ies) on the due date;  (b) the Borrower's failure to pay any money, debts and liabilities owing or incurred, due but unpaid to the  Bank in any manner howsoever or on any account whether as principal or surety and whether alone or  jointly with any other person, firm or corporation;  (c) any of the representations, warranties, undertakings, covenants or statements of any Obligors under the  Facility Letter and/or these General Terms and Conditions and/or the Security Documents and any other  ancillary documents or any information or document delivered by any Obligors to the Bank is incorrect or  misleading in any material respect;  (d) any distress, attachment, sequestration, execution or other legal process is levied, enforced or sued out on  or against the assets of any Obligors;  (e) an event occurs which, in the opinion of the Bank, has or might have a material adverse change in or effect  on the business, assets condition (financial or otherwise) or prospects of any Obligors or affect or prevent  the ability of any Obligors to perform its obligations under the Facility Letter and/or the Security  Documents;  (f) a payment default occurs under the provisions of any agreement or instrument evidencing or securing any  financial indebtedness of any Obligors or any such financial indebtedness becomes payable or capable of  being declared payable before its stated maturity;  (g) a petition is presented or proceedings are commenced or an order is made or an effective resolution is  passed for the bankruptcy or winding up of any Obligors or for the appointment of a liquidator, receiver,  official administrator or similar officer in respect of any Obligors or all or any part of its business or assets  or if any Obligors otherwise becomes insolvent or bankrupt under any court of law;  (h) without prejudice to paragraph (a) above, failure of any Obligors to comply with any provision contained  in these General Terms and Conditions, the Facility Letter and/or the Security Documents and any other  ancillary documents which is not capable of remedy or, if can be remedied, has not been remedied within  seven days of the earlier of notice from the Bank requiring its remedy or any Obligors becoming aware of  the failure to comply;  (i) any change to the direct or indirect shareholding of the Borrower or any guarantor without the prior  written consent of the Bank (except if the Borrower or such guarantor is a company listed on any stock  exchange);  (j) any governmental, tax, monetary or other approval required by any Obligors in connection with the  Facilities is withdrawn or revised in a way prejudicial to the interest of the Bank under the Facilities, these  General Terms and Conditions, the Facility Letter or any Security Documents or any other ancillary  documents;  (k) any present or future security on or over the assets of any Obligors becomes enforceable;  (l) it becomes unlawful for any Obligors to perform any of its obligations under these General Terms and  Conditions, the Facility Letter, any Security Document or any other ancillary documents; and  (m) the occurrence of any event which under the law of any relevant jurisdiction, has an analogous or  equivalent effect to any event mentioned in this Clause 24.1.    25.1 The Bank shall not be liable for any loss or damage suffered by the Borrower or any other person as a result of:-  (a) the withdrawal or suspension of any transaction of the Borrower or for any failure to effect or execute any  of the order or instruction from the Borrower whether it is attributable, either directly or indirectly, to any  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1033-bochk_facili022.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1033-bochk_facili022.jpg" title="slide22" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">17  T &amp; C for GBF &amp; Loans Facility(ies) 202307_revised (LD/2023/7274)  (&#39321;&#28207;)&#26377;&#38480;&#20844;&#21496;  BANK OF CHINA (HONG KONG) LIMITED 17      26. Financial Statements/Information  27. Miscellaneous      circumstances or events outside the control of the Bank; and/or  (b) (i) any mechanical, electronic or other failure, malfunction, interruption, inaccuracy or inadequacy of the  Bank's telecommunication and computer system or other equipment or its installation or operation; (ii)  any incomplete or erroneous transmission of any instruction or order of the Borrower or any error in the  execution of any such instruction or order (except negligence or wilful misconduct of the Bank's  authorized officers) nor for any delay, loss (including loss of profit or any economic loss), expenses or  damages whatsoever incurred or suffered by the Borrower as a result of (i) and /or (ii) above; and/or  (c) any delay, interruption or suspension howsoever caused by any third party, including but not limited to  service providers or equipment suppliers, which interferes with, affects or disrupts the performance of the  Bank hereunder; and/or  (d) any instruction / notice given by the Borrower through telephone, facsimile or electronic mail having been  acted upon by the Bank.  25.2 In the case of any POD, the Bank shall have absolute discretion to refuse to purchase or discount any Payment  Order without giving any reason therefor. In addition and without prejudice to the Bank's right under all existing  terms and conditions, the Bank has full recourse against the Borrower in respect of any or all of the Payment  Orders purchased or discounted by the Bank from the Borrower and the Borrower shall refund to the Bank on  demand at any time, whether prior to the maturity of the Payment Order or otherwise, the sum paid to the  Borrower by way of the purchase or discount of the Payment Order together with interest thereon from the date  of the Bank's payment to the Borrower up to the refund by the Borrower in full.    26.1 In case the Borrower and/or any Obligors is a limited company, the Bank shall be entitled, at any time and from  time to time require the Borrower to furnish to the Bank: -  (a) within ninety (90) days after the end of every six (6) months of each accounting period, copies of the  unaudited consolidated and/or unconsolidated financial statements of the Borrower and (if applicable),any  Obligors and the Borrower's subsidiary companies duly certified by the Borrower's director(s) and (if  applicable) the director(s) of any Obligors and/or the Borrower's subsidiary companies to be true copies  of the original unaudited consolidated and/or unconsolidated financial statements; and  (b) within one hundred and eighty (180) days from the close of the financial year of the Borrower, or (if  applicable) any Obligors and the Borrower's subsidiary companies, the original audited consolidated  and/or unconsolidated annual financial statements of the Borrower or (if applicable) any Obligors and  the Borrower's subsidiary companies for such year or copies of such audited consolidated and/or  unconsolidated annual financial statements duly certified by the Borrower's director(s) and (if applicable)  the director(s) of any Obligors and/or the Borrower's subsidiary companies to be true copies of the  original audited consolidated and/or unconsolidated annual financial statements.  26.2 In case the Borrower is a sole-proprietorship or partnership, the Borrower shall furnish to the Bank at the  request of the Bank copies of the Borrower's financial statements duly certified by the sole-proprietor or  partner(s) of the Borrower to be true copies of the original and such other information about the Borrower.  26.3 In case the Borrower is an individual, the Borrower shall furnish to the Bank at the request of the Bank certified  copies of the Borrower updated income tax return, bank statements and such other information as the Bank shall  from time to time require.  26.4 The Borrower shall procure that each set of financial statements delivered pursuant to Clauses 26.1 and 26.2 are  prepared according to relevant generally accepted accounting principles.    27.1 Subject to prior notice to the Borrower, the Bank reserves the absolute right to vary the terms of the Facilities,  to increase, reduce and/or cancel any Facility or any part thereof at any time and from time to time, including  without limitation, the basis of calculation of any interest, charges, commissions, fees or default interest payable  under the Facility Letter(s) and to vary these General Terms and Conditions (including without limitation the  Default Margin or the Default Administrative Charges), to impose a commitment fee on the daily undrawn  balance of the Facilities granted, and/or to impose any additional handling charges at such rate as determined by  the Bank at its sole discretion. Any variation, amendment or supplement shall be binding on the  Borrower(s) if the Borrower(s) do(es) not terminate the Facility(ies) after receiving any notice of such  variation, amendment or supplement.  27.2 No failure, delay or omission by the Bank in exercising any right, power, privilege or remedy shall impair such  right, power, privilege or remedy or be construed as a waiver thereof, nor shall any single or partial exercise of  any right, power, privilege or remedy preclude any further exercise of any other right power, privilege or  remedy. Rights, powers, privileges and remedies herein provided are cumulative and do not exclude those  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1033-bochk_facili023.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1033-bochk_facili023.jpg" title="slide23" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">18  T &amp; C for GBF &amp; Loans Facility(ies) 202307_revised (LD/2023/7274)  (&#39321;&#28207;)&#26377;&#38480;&#20844;&#21496;  BANK OF CHINA (HONG KONG) LIMITED 18          provided by law.  27.3 Subject to Clause 27.4, any notice, demand or other communication to the Borrower shall be sent to the  Borrower's last known address or such other address as may have been notified in writing by the Borrower to  the Bank and, if (i) delivered personally, shall be deemed to have been given at the time of such delivery; (ii)  despatched by letter postage prepaid, shall be deemed to have been given twenty-four (24) hours after posting;  and (iii) transmitted by facsimile or other electronic means, shall be deemed to have been given at the time of  despatch, provided that the Bank may give oral notice to the Borrower and if it consists of more than one person,  any one of them, whether personally or through the telephone, and any oral notice so given shall be immediately  effective and binding upon the Borrower. Subject to Clause 11.4, any notice or communication to the Bank  shall not be effective until actually received by the Bank. If the Borrower consists of more than one person, any  notice, demand or other communication shall be effective on the Bank only if given by each of them and on all  of them if given by the Bank to any of them.  27.4 The Bank reserves the right to notify the Borrower of any variation of these General Terms and Conditions or  any fees or changes in the standard charges for or relating to the Facilities, the Default Margin, the default  interest set out in Clause 6.2 above, the Default Administrative Charges or the basis of calculation of any of  them by notice displayed or posted up in the Bank's banking halls.  27.5 These General Terms and Conditions are in addition and without prejudice to the Bank's rights under all  existing or future security and/or legal documents (if any) held by the Bank.  27.6 If the Borrower shall consist of more than one person and any Facilities are made available to such Borrowers  jointly, the liabilities of the Borrowers to the Bank under those Facilities shall be joint and several and each and  every provision of the Facility Letter and the terms herein shall be construed accordingly. If the Borrower is a  firm (whether partnership or sole proprietorship), the Facility Letter and the terms herein shall be binding  jointly and severally on all persons now or for the time being or at any time hereafter carrying on business in the  name of the said firm or in succession to the said firm notwithstanding any change of members or constitution  thereof.  27.7 Save as provided for in Clause 27.8, in case of conflict between (1) the terms of the Facility Letter, (2) these  General Terms and Conditions and (3) any of the terms contained in the documentation mentioned in the  relevant Facility Letter, (a) the terms of the Facility Letter shall prevail over these General Terms and  Conditions and the terms referred to in (3), and (b) the terms referred to in (3) shall prevail over these General  Terms and Conditions.  27.8 In the case where mortgage/legal charge forms prescribed by the Hong Kong Housing Authority, Hong Kong  Housing Society or other similar bodies or authorities are used, whenever there is any conflict between the  terms of the Facility Letter, these General Terms and Conditions and any of the terms contained in the  mortgage/legal charge forms, the terms of the mortgage/legal charge forms shall prevail.  27.9 Any provision in the Facility Letter and/or these General Terms and Conditions which is or is declared by any  court or tribunal of competent jurisdiction to be illegal, invalid or unenforceable in any respect under applicable  law shall be severed from the Facility Letter and/or these General Terms and Conditions (as the case may be) to  the maximum extent permissible by such applicable law without in any manner affecting the legality, validity or  enforceability of the remaining provisions of the Facility Letter and/or these General Terms and Conditions (as  the case may be), all of which shall continue in full force and effect.  27.10 In the case where a facility is subject to a separate set of General Terms and Conditions, if there is any conflict  between these General Terms and Conditions and the General Terms and Conditions for the specific facility, the  latter shall prevail.  27.11 Unless contrary intention appears, words importing the singular number shall include the plural number and  vice versa and words importing the masculine gender shall include the feminine gender and the neuter gender.  27.12  References to any regulation includes any regulation, rule, official directive, request or guideline (whether or  not having the force of law) of any governmental, intergovernmental or supranational body, agency, department  or regulatory, self-regulatory or other authority or organization.  28. Third Party Rights   28.1 Subject to Clause 28.3, a person who is not a party to any Facility Letter has no right under the Contracts  (Rights of Third Parties) Ordinance (Cap. 623 of the Laws of Hong Kong) (the &quot;Third Parties Ordinance&quot;) to  enforce or to enjoy the benefit of any term of such Facility Letter and/or these General Terms and Conditions.  28.2 Notwithstanding any term of any Facility Letter and/or these General Terms and Conditions, the consent of any  person who is not a party to such Facility Letter is not required to rescind or vary such Facility Letter and/or  these General Terms and Conditions at any time.  28.3 Any director, officer, employee, affiliate or agent of the Bank or any of the Bank&#8217;s Related Parties may, by  virtue of the Third Parties Ordinance, rely on any provision of any Facility Letter and/or these General Terms  and Conditions which expressly confers rights on that person.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1033-bochk_facili024.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1033-bochk_facili024.jpg" title="slide24" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">19  T &amp; C for GBF &amp; Loans Facility(ies) 202307_revised (LD/2023/7274)  (&#39321;&#28207;)&#26377;&#38480;&#20844;&#21496;  BANK OF CHINA (HONG KONG) LIMITED 19      29. Language  30. Governing Law      28.4 This Clause 28 shall apply upon the commencement date of the Third Parties Ordinance (being 1 January  2016).    29.1 The Chinese version of the Facility Letter and these General Terms and Conditions are for reference only and if  there is any conflict between the English version and the Chinese version, the English version shall prevail.    30.1 The Facility Letter and these General Terms and Conditions shall be governed by and construed in accordance  with the laws of Hong Kong. The Borrower hereby irrevocably submits to the non-exclusive jurisdiction of the  courts of Hong Kong.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>4
<FILENAME>ex211-subsidiarieslist2023.htm
<DESCRIPTION>EX-21.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i536d33adb3af4940997215e4a004d36a_1"></div><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 21.1 </font></div><div style="margin-top:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Subsidiaries of Registrant </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.789%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.275%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chinese Name <br>(where applicable)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jurisdiction of</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Incorporation or</font></div><div style="margin-bottom:1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Organization</font></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Zai Lab (Hong Kong) Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'PMingLiU',serif;font-size:9pt;font-weight:400;line-height:100%">&#20877;&#21019;&#21307;&#33647;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(</font><font style="color:#000000;font-family:'PMingLiU',serif;font-size:9pt;font-weight:400;line-height:100%">&#39321;&#28207;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</font><font style="color:#000000;font-family:'PMingLiU',serif;font-size:9pt;font-weight:400;line-height:100%">&#26377;&#38480;&#20844;&#21496;</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hong Kong</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Zai Lab (Shanghai) Co., Ltd.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'PMingLiU',serif;font-size:9pt;font-weight:400;line-height:100%">&#20877;&#40718;&#21307;&#33647;&#65288;&#19978;&#28023;&#65289;&#26377;&#38480;&#20844;&#21496;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shanghai</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Zai Lab International Trading (Shanghai) Co., Ltd.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'PMingLiU',serif;font-size:9pt;font-weight:400;line-height:100%">&#20877;&#40718;&#22269;&#38469;&#36152;&#26131;&#65288;&#19978;&#28023;&#65289;&#26377;&#38480;&#20844;&#21496;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shanghai</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Zai Lab (Suzhou) Co., Ltd.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'PMingLiU',serif;font-size:9pt;font-weight:400;line-height:100%">&#20877;&#40718;&#21307;&#33647;&#65288;&#33487;&#24030;&#65289;&#26377;&#38480;&#20844;&#21496;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Suzhou</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Zai Lab Trading (Suzhou) Co., Ltd.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'PMingLiU',serif;font-size:9pt;font-weight:400;line-height:100%">&#20877;&#40718;&#21307;&#33647;&#36152;&#26131;&#65288;&#33487;&#24030;&#65289;&#26377;&#38480;&#20844;&#21496;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Suzhou</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Zai Biopharmaceutical (Suzhou) Co., Ltd</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'PMingLiU',serif;font-size:9pt;font-weight:400;line-height:100%">&#20877;&#21019;&#29983;&#29289;&#21307;&#33647;&#65288;&#33487;&#24030;&#65289;&#26377;&#38480;&#20844;&#21496;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Suzhou</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Zai Lab (Aust) Pty., Ltd.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Zai Lab (US) LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USA</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZLIP Holding Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cayman</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZL Capital Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BVI</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZL China Holding Two Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hong Kong</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Zai Auto Immune Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cayman</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Zai Auto Immune (Hong Kong) Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hong Kong</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Zai Anti Infectives Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cayman</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Zai Anti Infectives (Hong Kong) Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hong Kong</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Zai Lab (Taiwan) Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'PMingLiU',serif;font-size:9pt;font-weight:400;line-height:100%">&#20877;&#40718;&#21488;&#28286;&#21307;&#33647;&#26377;&#38480;&#20844;&#21496;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taiwan</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All subsidiaries are wholly owned, directly or indirectly, by Zai Lab Limited.</font></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>5
<FILENAME>ex231-consentletterfromkpmg.htm
<DESCRIPTION>EX-23.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="idfe33cb543cd46f2ba936eb83bedab5b_1"></div><div style="min-height:156.24pt;width:100%"><div style="margin-top:63pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 23.1</font></div></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Consent of Independent Registered Public Accounting Firm</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">We consent to the incorporation by reference in the registration statements (No. 333-221616, No. 333-239223, No. 333-258630, No. 333-264800, and No. 333-268054) on Form S-8 and No. 333-255340 on Form S-3 of our reports dated February&#160;27, 2024, with respect to the consolidated financial statements of Zai Lab Limited and subsidiaries and the effectiveness of internal control over financial reporting.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; KPMG LLP</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">Short Hills, New Jersey</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">February&#160;27, 2024</font></div><div style="margin-bottom:0.1pt"><font><br></font></div><div style="margin-bottom:0.1pt"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>6
<FILENAME>ex232-consentletterfromdel.htm
<DESCRIPTION>EX-23.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i1b20505854b74b0b8b916692be5ad249_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 23.2</font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">We consent to the incorporation by reference in the Registration Statement No. 333-255340 on Form S-3 and Registration Statement Nos. 333-221616, 333-239223, 333-258630, 333-264800 and 333-268054 on Form S-8 of our report dated March 1, 2022, relating to the financial statements of Zai Lab Limited appearing in this Annual Report on Form 10-K for the year ended December 31, 2023.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#47;s&#47; Deloitte Touche Tohmatsu Certified Public Accountants LLP </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Shanghai, the People&#8217;s Republic of China</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">February&#160;27, 2024</font></div><div style="margin-bottom:6pt"><font><br></font></div><div style="margin-bottom:6pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>7
<FILENAME>zlab-20231231x10kxexx311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="icdeb1fc9168d42fdb70f9520a2afbf41_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification by the Principal Executive Officer </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Exchange Act Rule 13a-14(a),</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">As Adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Samantha (Ying) Du, certify that&#58; </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this Annual Report on Form 10-K for the year ended December&#160;31, 2023 of Zai Lab Limited&#59; </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59; </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59; </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58; </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59; </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59; </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58; </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.  </font></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; February&#160;27, 2024</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; Samantha (Ying) Du</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Samantha (Ying) Du</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Principal Executive Officer)</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>8
<FILENAME>zlab-20231231x10kxexx312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="if4a420f88f694f84a40b10c0dfb47ac6_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification by the Principal Financial Officer </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Exchange Act Rule 13a-14(a),</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">As Adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Yajing Chen, certify that&#58; </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this Annual Report on Form 10-K for the year ended December&#160;31, 2023 of Zai Lab Limited&#59; </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59; </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59; </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58; </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59; </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59; </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58; </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; February&#160;27, 2024</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; Yajing Chen</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Yajing Chen</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Principal Financial and Accounting Officer)</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>9
<FILENAME>zlab-20231231x10kxexx321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="id9e2e02d82d544299bce888939d1036a_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification by the Principal Executive Officer</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to 18 U.S.C. Section 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">As Adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Annual Report on Form 10-K for the year ended December&#160;31, 2023 of Zai Lab Limited (the &#8220;Company&#8221;)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Samantha (Ying) Du, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge&#58; </font></div><div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and </font></div><div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:12pt"><font><br></font></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Date&#58; February&#160;27, 2024</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; Samantha (Ying) Du</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Samantha (Ying) Du</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Principal Executive Officer)</font></td></tr></table></div><div style="margin-top:12pt"><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>10
<FILENAME>zlab-20231231x10kxexx322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="ibb9e3802b62641009ad18f76134af202_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification by the Principal Financial Officer </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to 18 U.S.C. Section 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">As Adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Annual Report on Form 10-K for the year ended December&#160;31, 2023 of Zai Lab Limited (the &#8220;Company&#8221;), as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Yajing Chen, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge&#58; </font></div><div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and </font></div><div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; February&#160;27, 2024</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; Yajing Chen</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Yajing Chen</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Principal Financial and Accounting Officer)</font></td></tr></table></div><div style="margin-top:12pt"><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-97.1
<SEQUENCE>11
<FILENAME>ex971-zlabxdoddxfrankcompe.htm
<DESCRIPTION>EX-97.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i161025cc500643bf9b3da37c62b30f3c_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 97.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ZAI LAB LIMITED</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">DODD-FRANK POLICY ON RECOUPMENT OF INCENTIVE COMPENSATION</font></div><div style="text-align:center"><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">I.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:28.34pt;text-decoration:underline">Introduction</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Compensation Committee (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Compensation Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) of the Board of Directors (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) of Zai Lab Limited (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) has adopted this Dodd-Frank Policy on Recoupment of Incentive Compensation (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), which provides for the recoupment of compensation in certain circumstances in the event of a restatement of financial results by the Company.  This Policy shall be interpreted to comply with the requirements of U.S. Securities and Exchange Commission (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SEC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) rules and Nasdaq Stock Market (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Nasdaq</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) listing standards implementing Section 954 of the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Dodd-Frank Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and, to the extent this Policy is in any manner deemed inconsistent with such rules, this Policy shall be treated as retroactively amended to be compliant with such rules.</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">II.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:23.68pt;text-decoration:underline">Administration</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Policy shall be administered by the Compensation Committee.  Any determinations made by the Compensation Committee shall be final and binding on all affected individuals.  The Compensation Committee is authorized to interpret and construe this Policy and to make all determinations necessary, appropriate, or advisable for the administration of this Policy, in all cases consistent with the Dodd-Frank Act.  The Board or Compensation Committee may amend this Policy from time to time in its discretion.</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">III.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:19.02pt;text-decoration:underline">Covered Executives</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Policy applies to any current or former &#8220;executive officer,&#8221; within the meaning of Rule 10D-1 under the Securities Exchange Act of 1934, as amended, of the Company or a subsidiary of the Company (each such individual, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  This Policy shall be binding and enforceable against all Executives and their beneficiaries, executors, administrators, and other legal representatives.</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">IV.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:19.68pt;text-decoration:underline">Recoupment Upon Financial Restatement</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If the Company is required to prepare an accounting restatement due to the material noncompliance of the Company with any financial reporting requirement under the securities laws, including any required accounting restatement to correct an error in previously issued financial statements that is material to the previously issued financial statements, or that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Financial Restatement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), the Compensation Committee shall cause the Company to recoup from each Executive, as promptly as reasonably possible, any erroneously awarded Incentive-Based Compensation, as defined below.  </font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">V.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:24.34pt;text-decoration:underline">No-Fault Recovery</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Recoupment under this Policy shall be required regardless of whether the Executive or any other person was at fault or responsible for accounting errors that contributed to the need for the Financial Restatement or engaged in any misconduct.  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">VI.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:19.68pt;text-decoration:underline">Compensation Subject to Recovery&#59; Enforcement</font></div><div style="margin-top:12pt;padding-right:-7.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Policy applies to all compensation granted, earned, or vested based wholly or in part upon the attainment of any financial reporting measure determined and presented in accordance with the accounting principles used in preparing the Company&#8217;s financial statements, and any measure that is derived wholly or in part from such measures, whether or not presented within the Company&#8217;s financial statements or included in a filing with the SEC, including stock price and total shareholder return (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">TSR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), including but not limited to performance-based cash, stock, options, or other equity-based awards paid or granted to the Executive (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Incentive-Based Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  Compensation that is granted, vests, or is earned based solely upon the occurrence of non-financial events, such as base salary, restricted stock or options with time-based vesting, or a bonus awarded solely at the discretion of the Board or Compensation Committee and not based on the attainment of any financial measure, is not subject to this Policy. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In the event of a Financial Restatement, the amount to be recovered will be the excess of (i) the Incentive-Based Compensation received by the Executive during the Recovery Period (as defined below) based on the erroneous data and calculated without regard to any taxes paid or withheld, over (ii) the Incentive-Based Compensation that would have been received by the Executive had it been calculated based on the restated financial information, as determined by the Compensation Committee.  For purposes of this Policy, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Recovery Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the three completed fiscal years immediately preceding the date on which the Company is required to prepare the Financial Restatement, as determined in accordance with the last sentence of this paragraph, or any transition period that results from a change in the Company&#8217;s fiscal year (as set forth in Section 5608(b)(i)(D) of the Nasdaq Listing Rules).  The date on which the Company is required to prepare a Financial Restatement is the earlier to occur of (A) the date the Board or a Board committee (or authorized officers of the Company if Board action is not required) concludes, or reasonably should have concluded, that the Company is required to prepare a Financial Restatement, or (B) the date a court, regulator, or other legally authorized body directs the Company to prepare a Financial Restatement.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">For Incentive-Based Compensation based on stock price or TSR, where the amount of erroneously awarded compensation is not subject to mathematical recalculation directly from the information in the Financial Restatement, then the Compensation Committee shall determine the amount to be recovered based on a reasonable estimate of the effect of the Financial Restatement on the stock price or TSR upon which the Incentive-Based Compensation was received and the Company shall document the determination of that estimate and provide it to Nasdaq.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Incentive-Based Compensation is considered to have been received by an Executive in the fiscal year during which the applicable financial reporting measure was attained or purportedly attained, even if the payment or grant of such Incentive-Based Compensation occurs after the end of that period.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Company may use any legal or equitable remedies that are available to the Company to recoup any erroneously awarded Incentive-Based Compensation, including but not limited to by collecting from the Executive cash payments or ordinary shares or American Depositary Shares of the Company from or by forfeiting any amounts that the Company owes to the Executive. Executives shall be solely responsible for any tax consequences to them that result from the recoupment or recovery of any amount pursuant to this Policy, and the Company shall have no obligation to administer the Policy in a manner that avoids or minimizes any such tax consequences.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">VII.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:15.02pt;text-decoration:underline">No Indemnification</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Company shall not indemnify any Executive or pay or reimburse the premium for any insurance policy to cover any losses incurred by such Executive under this Policy or any claims relating to the Company&#8217;s enforcement of rights under this Policy.</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">VIII.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:10.36pt;text-decoration:underline">Exceptions</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The compensation recouped under this Policy shall not include Incentive-Based Compensation received by an Executive (i) prior to beginning service as an Executive or (ii) if he or she did not serve as an Executive at any time during the performance period applicable to the Incentive-Based Compensation in question. The Compensation Committee (or a majority of independent directors serving on the Board) may determine not to seek recovery from an Executive in whole or part to the extent it determines in its sole discretion that such recovery would be impracticable because (A) the direct expense paid to a third party to assist in enforcing recovery would exceed the recoverable amount (after having made a reasonable attempt to recover the erroneously awarded Incentive-Based Compensation and providing corresponding documentation of such attempt to Nasdaq), (B) recovery would violate the home country law that was adopted prior to November 28, 2022, as determined by an opinion of counsel licensed in the applicable jurisdiction that is acceptable to and provided to Nasdaq, or (C) recovery would likely cause the Company&#8217;s 401(k) plan or any other tax-qualified retirement plan to fail to meet the requirements of Section 401(a)(13) or Section 411(a) of the Internal Revenue Code of 1986, as amended, and the regulations thereunder.</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">IX.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:19.68pt;text-decoration:underline">Other Remedies Not Precluded</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The exercise by the Compensation Committee of any rights pursuant to this Policy shall be without prejudice to any other rights or remedies that the Company, the Board, or the Compensation Committee may have with respect to any Executive subject to this Policy, whether arising under applicable law (including pursuant to Section 304 of the Sarbanes-Oxley Act of 2002) or regulation or pursuant to the terms of any other policy of the Company, employment agreement, equity award, cash incentive award, or other agreement applicable to an Executive.  Notwithstanding the foregoing, there shall be no duplication of recovery of the same Incentive-Based Compensation under this Policy and any other such rights or remedies.</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">X.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:24.34pt;text-decoration:underline">Acknowledgment</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">To the extent required by the Compensation Committee, each Executive shall be required to sign and return to the Company the acknowledgement form attached hereto as Exhibit A pursuant to which such Executive will agree to be bound by the terms of, and comply with, this Policy. For the avoidance of doubt, each Executive shall be fully bound by, and must comply with, the Policy, whether or not such Executive has executed and returned such acknowledgment form to the Company.</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">XI.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:19.68pt;text-decoration:underline">Effective Date and Applicability</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Policy has been adopted by the Compensation Committee on October 16, 2023, and shall apply to any Incentive-Based Compensation that is received by an Executive on or after October 2, 2023.</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EXHIBIT A</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">DODD-FRANK COMPENSATION CLAWBACK POLICY </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ACKNOWLEDGEMENT FORM</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Capitalized terms used but not otherwise defined in this Acknowledgement Form (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Acknowledgement Form</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) shall have the meanings ascribed to such terms in the Policy.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By signing this Acknowledgement Form, the undersigned acknowledges, confirms, and agrees that the undersigned&#58; (i)  has received and reviewed a copy of the Policy&#59; (ii) is and will continue to be subject to the Policy and that the Policy will apply both during and after the undersigned&#8217;s employment with the Company&#59; and (iii) will abide by the terms of the Policy, including, without limitation, by reasonably promptly returning to the Company any recoverable compensation that is received on or after October 2, 2023 (regardless of when granted) as required by the Policy, as determined by the Compensation Committee in its sole discretion.  </font></div><div style="margin-bottom:41.75pt;margin-top:12pt"><font><br></font></div><div style="padding-left:234pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Sign&#58;&#160;&#160;&#160;&#160;_____________________________</font></div><div style="padding-left:234pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58;       &#91;Employee&#93;</font></div><div style="padding-left:234pt;text-align:justify"><font><br></font></div><div style="padding-left:234pt;text-align:justify"><font><br></font></div><div style="padding-left:234pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Date&#58;&#160;&#160;&#160;&#160;_____________________________</font></div><div style="margin-bottom:12pt;padding-left:234pt;text-align:justify"><font><br></font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>12
<FILENAME>zlab-20231231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:8edfc3fc-8768-4ea6-b2a3-bb613cc9a367,g:14e43acd-1532-4842-be1c-6094bb39150d-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:zlab="http://zailab.com/20231231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types1="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://zailab.com/20231231">
  <xs:import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/currency/2023" schemaLocation="https://xbrl.sec.gov/currency/2023/currency-2023.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2023" schemaLocation="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="zlab-20231231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="zlab-20231231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="zlab-20231231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="zlab-20231231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://zailab.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://zailab.com/role/AuditInformation">
        <link:definition>0000002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://zailab.com/role/ConsolidatedBalanceSheets">
        <link:definition>0000003 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://zailab.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>0000004 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofOperations" roleURI="http://zailab.com/role/ConsolidatedStatementsofOperations">
        <link:definition>0000005 - Statement - Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveLoss" roleURI="http://zailab.com/role/ConsolidatedStatementsofComprehensiveLoss">
        <link:definition>0000006 - Statement - Consolidated Statements of Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveLossParenthetical" roleURI="http://zailab.com/role/ConsolidatedStatementsofComprehensiveLossParenthetical">
        <link:definition>0000007 - Statement - Consolidated Statements of Comprehensive Loss (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofShareholdersEquity" roleURI="http://zailab.com/role/ConsolidatedStatementsofShareholdersEquity">
        <link:definition>0000008 - Statement - Consolidated Statements of Shareholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofShareholdersEquityParenthetical" roleURI="http://zailab.com/role/ConsolidatedStatementsofShareholdersEquityParenthetical">
        <link:definition>0000009 - Statement - Consolidated Statements of Shareholders' Equity (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://zailab.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>0000010 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandPrincipalActivities" roleURI="http://zailab.com/role/OrganizationandPrincipalActivities">
        <link:definition>0000011 - Disclosure - Organization and Principal Activities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://zailab.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>0000012 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CashandCashEquivalents" roleURI="http://zailab.com/role/CashandCashEquivalents">
        <link:definition>0000013 - Disclosure - Cash and Cash Equivalents</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestrictedCashNonCurrent" roleURI="http://zailab.com/role/RestrictedCashNonCurrent">
        <link:definition>0000014 - Disclosure - Restricted Cash, Non-Current</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShortTermInvestments" roleURI="http://zailab.com/role/ShortTermInvestments">
        <link:definition>0000015 - Disclosure - Short-Term Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesNet" roleURI="http://zailab.com/role/InventoriesNet">
        <link:definition>0000016 - Disclosure - Inventories, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermInvestments" roleURI="http://zailab.com/role/LongTermInvestments">
        <link:definition>0000017 - Disclosure - Long-Term Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentNet" roleURI="http://zailab.com/role/PropertyandEquipmentNet">
        <link:definition>0000018 - Disclosure - Property and Equipment, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://zailab.com/role/Leases">
        <link:definition>0000019 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Revenue" roleURI="http://zailab.com/role/Revenue">
        <link:definition>0000020 - Disclosure - Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTax" roleURI="http://zailab.com/role/IncomeTax">
        <link:definition>0000021 - Disclosure - Income Tax</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherCurrentLiabilities" roleURI="http://zailab.com/role/OtherCurrentLiabilities">
        <link:definition>0000022 - Disclosure - Other Current Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LossPerShare" roleURI="http://zailab.com/role/LossPerShare">
        <link:definition>0000023 - Disclosure - Loss Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactions" roleURI="http://zailab.com/role/RelatedPartyTransactions">
        <link:definition>0000024 - Disclosure - Related Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensation" roleURI="http://zailab.com/role/ShareBasedCompensation">
        <link:definition>0000025 - Disclosure - Share-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LicenseandCollaborationAgreements" roleURI="http://zailab.com/role/LicenseandCollaborationAgreements">
        <link:definition>0000026 - Disclosure - License and Collaboration Agreements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherIncomeExpensesNet" roleURI="http://zailab.com/role/OtherIncomeExpensesNet">
        <link:definition>0000027 - Disclosure - Other Income (Expenses), Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestrictedNetAssets" roleURI="http://zailab.com/role/RestrictedNetAssets">
        <link:definition>0000028 - Disclosure - Restricted Net Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeDefinedContributionPlans" roleURI="http://zailab.com/role/EmployeeDefinedContributionPlans">
        <link:definition>0000029 - Disclosure - Employee Defined Contribution Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://zailab.com/role/CommitmentsandContingencies">
        <link:definition>0000030 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents" roleURI="http://zailab.com/role/SubsequentEvents">
        <link:definition>0000031 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleICondensedFinancialInformationofRegistrant" roleURI="http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrant">
        <link:definition>0000032 - Disclosure - Schedule I &#8212; Condensed Financial Information of Registrant</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://zailab.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>9954471 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandPrincipalActivitiesTables" roleURI="http://zailab.com/role/OrganizationandPrincipalActivitiesTables">
        <link:definition>9954472 - Disclosure - Organization and Principal Activities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesTables" roleURI="http://zailab.com/role/SummaryofSignificantAccountingPoliciesTables">
        <link:definition>9954473 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CashandCashEquivalentsTables" roleURI="http://zailab.com/role/CashandCashEquivalentsTables">
        <link:definition>9954474 - Disclosure - Cash and Cash Equivalents (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesNetTables" roleURI="http://zailab.com/role/InventoriesNetTables">
        <link:definition>9954475 - Disclosure - Inventories, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentNetTables" roleURI="http://zailab.com/role/PropertyandEquipmentNetTables">
        <link:definition>9954476 - Disclosure - Property and Equipment, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://zailab.com/role/LeasesTables">
        <link:definition>9954477 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueTables" roleURI="http://zailab.com/role/RevenueTables">
        <link:definition>9954478 - Disclosure - Revenue (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxTables" roleURI="http://zailab.com/role/IncomeTaxTables">
        <link:definition>9954479 - Disclosure - Income Tax (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherCurrentLiabilitiesTables" roleURI="http://zailab.com/role/OtherCurrentLiabilitiesTables">
        <link:definition>9954480 - Disclosure - Other Current Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LossPerShareTables" roleURI="http://zailab.com/role/LossPerShareTables">
        <link:definition>9954481 - Disclosure - Loss Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationTables" roleURI="http://zailab.com/role/ShareBasedCompensationTables">
        <link:definition>9954482 - Disclosure - Share-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherIncomeExpensesNetTables" roleURI="http://zailab.com/role/OtherIncomeExpensesNetTables">
        <link:definition>9954483 - Disclosure - Other Income (Expenses), Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleICondensedFinancialInformationofRegistrantTables" roleURI="http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantTables">
        <link:definition>9954484 - Disclosure - Schedule I &#8212; Condensed Financial Information of Registrant (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandPrincipalActivitiesDetails" roleURI="http://zailab.com/role/OrganizationandPrincipalActivitiesDetails">
        <link:definition>9954485 - Disclosure - Organization and Principal Activities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesAdditionalInformationDetails" roleURI="http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails">
        <link:definition>9954486 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails" roleURI="http://zailab.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails">
        <link:definition>9954487 - Disclosure - Summary of Significant Accounting Policies - Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesConcentrationofSuppliersDetails" roleURI="http://zailab.com/role/SummaryofSignificantAccountingPoliciesConcentrationofSuppliersDetails">
        <link:definition>9954488 - Disclosure - Summary of Significant Accounting Policies - Concentration of Suppliers (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CashandCashEquivalentsDetails" roleURI="http://zailab.com/role/CashandCashEquivalentsDetails">
        <link:definition>9954489 - Disclosure - Cash and Cash Equivalents (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestrictedCashNonCurrentDetails" roleURI="http://zailab.com/role/RestrictedCashNonCurrentDetails">
        <link:definition>9954490 - Disclosure - Restricted Cash, Non-Current (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShortTermInvestmentsDetails" roleURI="http://zailab.com/role/ShortTermInvestmentsDetails">
        <link:definition>9954491 - Disclosure - Short-Term Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesNetScheduleofInventoryDetails" roleURI="http://zailab.com/role/InventoriesNetScheduleofInventoryDetails">
        <link:definition>9954492 - Disclosure - Inventories, Net - Schedule of Inventory (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesNetAdditionalInformationDetails" roleURI="http://zailab.com/role/InventoriesNetAdditionalInformationDetails">
        <link:definition>9954493 - Disclosure - Inventories, Net - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermInvestmentsDetails" roleURI="http://zailab.com/role/LongTermInvestmentsDetails">
        <link:definition>9954494 - Disclosure - Long-Term Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails" roleURI="http://zailab.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails">
        <link:definition>9954495 - Disclosure - Property and Equipment, Net - Summary of Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentNetAdditionalInformationDetails" roleURI="http://zailab.com/role/PropertyandEquipmentNetAdditionalInformationDetails">
        <link:definition>9954496 - Disclosure - Property and Equipment, Net - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesAdditionalInformationDetails" roleURI="http://zailab.com/role/LeasesAdditionalInformationDetails">
        <link:definition>9954497 - Disclosure - Leases - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesOperatingLeaseCostDetails" roleURI="http://zailab.com/role/LeasesOperatingLeaseCostDetails">
        <link:definition>9954498 - Disclosure - Leases - Operating Lease Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesCashFlowInformationDetails" roleURI="http://zailab.com/role/LeasesCashFlowInformationDetails">
        <link:definition>9954499 - Disclosure - Leases - Cash Flow Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturitiesofLeaseLiabilitiesDetails" roleURI="http://zailab.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails">
        <link:definition>9954500 - Disclosure - Leases - Maturities of Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturitiesofLeaseLiabilitiesDetails_1" roleURI="http://zailab.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1">
        <link:definition>9954500 - Disclosure - Leases - Maturities of Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesWeightedAverageRemainingLeaseTermsandDiscountRatesDetails" roleURI="http://zailab.com/role/LeasesWeightedAverageRemainingLeaseTermsandDiscountRatesDetails">
        <link:definition>9954501 - Disclosure - Leases - Weighted-Average Remaining Lease Terms and Discount Rates (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueSummaryofProductRevenueDetails" roleURI="http://zailab.com/role/RevenueSummaryofProductRevenueDetails">
        <link:definition>9954502 - Disclosure - Revenue - Summary of Product Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueDisaggregationofNetRevenuebyProductDetails" roleURI="http://zailab.com/role/RevenueDisaggregationofNetRevenuebyProductDetails">
        <link:definition>9954503 - Disclosure - Revenue - Disaggregation of Net Revenue by Product (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxAdditionalInformationDetails" roleURI="http://zailab.com/role/IncomeTaxAdditionalInformationDetails">
        <link:definition>9954504 - Disclosure - Income Tax - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxLossIncomeBeforeIncomeTaxesDetails" roleURI="http://zailab.com/role/IncomeTaxLossIncomeBeforeIncomeTaxesDetails">
        <link:definition>9954505 - Disclosure - Income Tax - Loss (Income) Before Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxReconciliationoftheEffectiveIncomeTaxRateDetails" roleURI="http://zailab.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRateDetails">
        <link:definition>9954506 - Disclosure - Income Tax - Reconciliation of the Effective Income Tax Rate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxComponentsofDeferredTaxAssetsandLiabilitiesDetails" roleURI="http://zailab.com/role/IncomeTaxComponentsofDeferredTaxAssetsandLiabilitiesDetails">
        <link:definition>9954507 - Disclosure - Income Tax - Components of Deferred Tax Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxMovementofValuationAllowanceDetails" roleURI="http://zailab.com/role/IncomeTaxMovementofValuationAllowanceDetails">
        <link:definition>9954508 - Disclosure - Income Tax - Movement of Valuation Allowance (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherCurrentLiabilitiesDetails" roleURI="http://zailab.com/role/OtherCurrentLiabilitiesDetails">
        <link:definition>9954509 - Disclosure - Other Current Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LossPerShareComputationofBasicandDilutedNetLossPerShareDetails" roleURI="http://zailab.com/role/LossPerShareComputationofBasicandDilutedNetLossPerShareDetails">
        <link:definition>9954510 - Disclosure - Loss Per Share - Computation of Basic and Diluted Net Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LossPerShareAntiDilutiveSharesExcludedfromCalculationofDilutedLossPerShareDetails" roleURI="http://zailab.com/role/LossPerShareAntiDilutiveSharesExcludedfromCalculationofDilutedLossPerShareDetails">
        <link:definition>9954511 - Disclosure - Loss Per Share - Anti-Dilutive Shares Excluded from Calculation of Diluted Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactionsDetails" roleURI="http://zailab.com/role/RelatedPartyTransactionsDetails">
        <link:definition>9954512 - Disclosure - Related Party Transactions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationAdditionalInformationDetails" roleURI="http://zailab.com/role/ShareBasedCompensationAdditionalInformationDetails">
        <link:definition>9954513 - Disclosure - Share-Based Compensation - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationOptionActivityDetails" roleURI="http://zailab.com/role/ShareBasedCompensationOptionActivityDetails">
        <link:definition>9954514 - Disclosure - Share-Based Compensation - Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationAssumptionsUsedtoEstimateFairValuesofShareOptionsGrantedDetails" roleURI="http://zailab.com/role/ShareBasedCompensationAssumptionsUsedtoEstimateFairValuesofShareOptionsGrantedDetails">
        <link:definition>9954515 - Disclosure - Share-Based Compensation - Assumptions Used to Estimate Fair Values of Share Options Granted (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationNonvestedRestrictedShareActivityDetails" roleURI="http://zailab.com/role/ShareBasedCompensationNonvestedRestrictedShareActivityDetails">
        <link:definition>9954516 - Disclosure - Share-Based Compensation - Non-vested Restricted Share Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationCompensationExpenseDetails" roleURI="http://zailab.com/role/ShareBasedCompensationCompensationExpenseDetails">
        <link:definition>9954517 - Disclosure - Share-Based Compensation - Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LicenseandCollaborationAgreementsDetails" roleURI="http://zailab.com/role/LicenseandCollaborationAgreementsDetails">
        <link:definition>9954518 - Disclosure - License and Collaboration Agreements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherIncomeExpensesNetDetails" roleURI="http://zailab.com/role/OtherIncomeExpensesNetDetails">
        <link:definition>9954519 - Disclosure - Other Income (Expenses), Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestrictedNetAssetsDetails" roleURI="http://zailab.com/role/RestrictedNetAssetsDetails">
        <link:definition>9954520 - Disclosure - Restricted Net Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeDefinedContributionPlansDetails" roleURI="http://zailab.com/role/EmployeeDefinedContributionPlansDetails">
        <link:definition>9954521 - Disclosure - Employee Defined Contribution Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetails" roleURI="http://zailab.com/role/CommitmentsandContingenciesDetails">
        <link:definition>9954522 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsDetails" roleURI="http://zailab.com/role/SubsequentEventsDetails">
        <link:definition>9954523 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleICondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails" roleURI="http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails">
        <link:definition>9954524 - Disclosure - Schedule I &#8212; Condensed Financial Information of Registrant - Condensed Balance Sheets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofOperationsandComprehensiveLossDetails" roleURI="http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofOperationsandComprehensiveLossDetails">
        <link:definition>9954525 - Disclosure - Schedule I &#8212; Condensed Financial Information of Registrant - Condensed Statements of Operations and Comprehensive Loss (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails" roleURI="http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails">
        <link:definition>9954526 - Disclosure - Schedule I &#8212; Condensed Financial Information of Registrant - Condensed Statements of Cash Flows (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="zlab_DeferredTaxAssetsGovernmentGrants" abstract="false" name="DeferredTaxAssetsGovernmentGrants" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="zlab_CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments" abstract="false" name="CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="zlab_ShareBasedPaymentArrangementOptionBatchThreeMember" abstract="true" name="ShareBasedPaymentArrangementOptionBatchThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="zlab_HuizhengMember" abstract="true" name="HuizhengMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="zlab_PrepaymentsForEquipment" abstract="false" name="PrepaymentsForEquipment" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="zlab_DeferredTaxAssetsPublicWelfareDonations" abstract="false" name="DeferredTaxAssetsPublicWelfareDonations" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="zlab_ZaiBiopharmaceuticalSuzhouCompanyLimitedMember" abstract="true" name="ZaiBiopharmaceuticalSuzhouCompanyLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="zlab_BMSMember" abstract="true" name="BMSMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="zlab_CollaborativeAgreementMember" abstract="true" name="CollaborativeAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="zlab_NotesReceivablePolicyTextBlock" abstract="false" name="NotesReceivablePolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="zlab_ManufacturingEquipmentMember" abstract="true" name="ManufacturingEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="zlab_GlaxoSmithKlineMember" abstract="true" name="GlaxoSmithKlineMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="zlab_NetRevenueTableTextBlock" abstract="false" name="NetRevenueTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="zlab_SupplierFMember" abstract="true" name="SupplierFMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="zlab_ZaiLabShanghaiCo.Ltd.Member" abstract="true" name="ZaiLabShanghaiCo.Ltd.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="zlab_RafaelAmadoMember" abstract="true" name="RafaelAmadoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="zlab_ForeignCurrencyRiskMember" abstract="true" name="ForeignCurrencyRiskMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="zlab_OtherPayablesCurrentLiabilities" abstract="false" name="OtherPayablesCurrentLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="zlab_DefinedContributionPlanEmployerMatchingContributionPercentOfEmployeeContribution" abstract="false" name="DefinedContributionPlanEmployerMatchingContributionPercentOfEmployeeContribution" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="zlab_LandUseRightsNetNoncurrent" abstract="false" name="LandUseRightsNetNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="zlab_CollaborativeArrangementRightsAndObligationsPaymentOfUpFrontFeesForLicenseAgreement" abstract="false" name="CollaborativeArrangementRightsAndObligationsPaymentOfUpFrontFeesForLicenseAgreement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="zlab_PrepaymentsForEquipmentPolicyPolicyTextBlock" abstract="false" name="PrepaymentsForEquipmentPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="zlab_AuditInformationAbstract" abstract="true" name="AuditInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="zlab_SummaryOfWeightedAverageRemainingLeaseTermsAndDiscountRatesTableTextBlock" abstract="false" name="SummaryOfWeightedAverageRemainingLeaseTermsAndDiscountRatesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="zlab_April2023AndLaterMember" abstract="true" name="April2023AndLaterMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="zlab_ResearchAndDevelopmentExpensesAndTheInventoryPurchases" abstract="false" name="ResearchAndDevelopmentExpensesAndTheInventoryPurchases" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="zlab_ZaiLabTaiwanLimitedMember" abstract="true" name="ZaiLabTaiwanLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="zlab_PropertyAndEquipmentEstimatedUsefulLivesTableTextBlock" abstract="false" name="PropertyAndEquipmentEstimatedUsefulLivesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="zlab_NonCashPayablesForTreasuryStock" abstract="false" name="NonCashPayablesForTreasuryStock" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="zlab_NonCashLeaseExpenses" abstract="false" name="NonCashLeaseExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="zlab_NuzyraMember" abstract="true" name="NuzyraMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="zlab_SignificantAccountingPoliciesTable" abstract="true" name="SignificantAccountingPoliciesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="zlab_ZaiLabSuzhouCompanyLimitedMember" abstract="true" name="ZaiLabSuzhouCompanyLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="zlab_MajorSuppliersAxis" abstract="true" name="MajorSuppliersAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="zlab_MandatoryProvidentFundMember" abstract="true" name="MandatoryProvidentFundMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="zlab_OptuneMember" abstract="true" name="OptuneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="zlab_ShareBasedPaymentArrangementOptionBatchTwoMember" abstract="true" name="ShareBasedPaymentArrangementOptionBatchTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="zlab_NovocureLimitedMember" abstract="true" name="NovocureLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="zlab_RevenueFromContractWithCustomersExcludingAssessedTaxAdjustmentsForRebatesAndSalesReturns" abstract="false" name="RevenueFromContractWithCustomersExcludingAssessedTaxAdjustmentsForRebatesAndSalesReturns" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="zlab_EquitySecuritiesWithReadilyDeterminableFairValueAmount" abstract="false" name="EquitySecuritiesWithReadilyDeterminableFairValueAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="zlab_AccruedRebateToDistributorsCurrent" abstract="false" name="AccruedRebateToDistributorsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="zlab_IncomeTaxesLineItems" abstract="true" name="IncomeTaxesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="zlab_ZaiLabHongKongLimitedMember" abstract="true" name="ZaiLabHongKongLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="zlab_ZaiLabHongKongAndZlChinaHoldingTwoAndZaiAutoImmuneHongKongAndZaiAntiInfectivesHongKongLimitedMember" abstract="true" name="ZaiLabHongKongAndZlChinaHoldingTwoAndZaiAutoImmuneHongKongAndZaiAntiInfectivesHongKongLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="zlab_SignificantAccountingPoliciesLineItems" abstract="true" name="SignificantAccountingPoliciesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="zlab_RestrictedNetAssetsAbstract" abstract="true" name="RestrictedNetAssetsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="zlab_DeferredTaxAssetsLeasingArrangements" abstract="false" name="DeferredTaxAssetsLeasingArrangements" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="zlab_WithholdingTaxesRemittanceOfDividends" abstract="false" name="WithholdingTaxesRemittanceOfDividends" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="zlab_OtherCurrentLiabilitiesDisclosureTextBlock" abstract="false" name="OtherCurrentLiabilitiesDisclosureTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="zlab_EquityAndCostMethodInvestmentsLineItems" abstract="true" name="EquityAndCostMethodInvestmentsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="zlab_RestrictedCashNonCurrentTextBlock" abstract="false" name="RestrictedCashNonCurrentTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="zlab_RestrictedNetAssetsLineItems" abstract="true" name="RestrictedNetAssetsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="zlab_GurnetPointCapitalAndNovoHoldingsASMember" abstract="true" name="GurnetPointCapitalAndNovoHoldingsASMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="zlab_MajorSuppliersDomain" abstract="true" name="MajorSuppliersDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="zlab_GovernmentAssistanceNonoperatingIncome" abstract="false" name="GovernmentAssistanceNonoperatingIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="zlab_BankOfChinaWorkingCapitalLoanFacilityMember" abstract="true" name="BankOfChinaWorkingCapitalLoanFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="zlab_ZaiLabInternationalTradingShanghaiCompanyLimitedMember" abstract="true" name="ZaiLabInternationalTradingShanghaiCompanyLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="zlab_A401kPlanMember" abstract="true" name="A401kPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="zlab_CollaborativeArrangementRightsAndObligationsDevelopmentMilestonePayment" abstract="false" name="CollaborativeArrangementRightsAndObligationsDevelopmentMilestonePayment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="zlab_EquityAndCostMethodInvestmentTable" abstract="true" name="EquityAndCostMethodInvestmentTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="zlab_ZaiAutoImmuneHongKongLimitedMember" abstract="true" name="ZaiAutoImmuneHongKongLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="zlab_AdagrasibMember" abstract="true" name="AdagrasibMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="zlab_CollaborativeArrangementRightsAndObligationsSalesBasedMilestonePayment" abstract="false" name="CollaborativeArrangementRightsAndObligationsSalesBasedMilestonePayment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="zlab_PfizerIncMember" abstract="true" name="PfizerIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="zlab_ShareBasedPaymentArrangementTrancheFourMember" abstract="true" name="ShareBasedPaymentArrangementTrancheFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="zlab_IncreaseDecreaseInOperatingLeaseLiabilities" abstract="false" name="IncreaseDecreaseInOperatingLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="zlab_LandUseRightsLeaseTerm" abstract="false" name="LandUseRightsLeaseTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="zlab_LaboratoryEquipmentMember" abstract="true" name="LaboratoryEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="zlab_IssuanceCostAdjustment" abstract="false" name="IssuanceCostAdjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="zlab_PriorToApril2023Member" abstract="true" name="PriorToApril2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="zlab_MainlandChinaGovernmentPlanMember" abstract="true" name="MainlandChinaGovernmentPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="zlab_ArgenxBvMember" abstract="true" name="ArgenxBvMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="zlab_CashAndCashEquivalentMember" abstract="true" name="CashAndCashEquivalentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="zlab_LicensesAndCollaborativeArrangementDisclosureTextBlock" abstract="false" name="LicensesAndCollaborativeArrangementDisclosureTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="zlab_WeightedAverageNumberOfShareOutstandingBasicAndDilutedAbstract" abstract="true" name="WeightedAverageNumberOfShareOutstandingBasicAndDilutedAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="zlab_DeferredIncomePolicyTextBlock" abstract="false" name="DeferredIncomePolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="zlab_DeferredTaxAssetsValuationAllowanceRollForward" abstract="true" name="DeferredTaxAssetsValuationAllowanceRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="zlab_TwoThousandTwentyTwoEquityIncentivePlanMember" abstract="true" name="TwoThousandTwentyTwoEquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="zlab_ResearchAndDevelopmentExpensesMember" abstract="true" name="ResearchAndDevelopmentExpensesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="zlab_SupplierEMember" abstract="true" name="SupplierEMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="zlab_CollaborativeArrangementRightsAndObligationsSpecifiedRoyaltyTerm" abstract="false" name="CollaborativeArrangementRightsAndObligationsSpecifiedRoyaltyTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="zlab_NonCashPayablesForIntangibleAssets" abstract="false" name="NonCashPayablesForIntangibleAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="zlab_ZaiLabTradingSuzhouCoLtdMember" abstract="true" name="ZaiLabTradingSuzhouCoLtdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="zlab_ShareBasedPaymentArrangementTrancheFiveMember" abstract="true" name="ShareBasedPaymentArrangementTrancheFiveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="zlab_GuarantorObligationTerm" abstract="false" name="GuarantorObligationTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="zlab_OtherCounterpartiesMember" abstract="true" name="OtherCounterpartiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="zlab_DebtInstrumentVariableInterestRateAdjustmentPeriod" abstract="false" name="DebtInstrumentVariableInterestRateAdjustmentPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="zlab_IncreaseDecreaseInLongTermDeposits" abstract="false" name="IncreaseDecreaseInLongTermDeposits" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="zlab_ReceivableRecognizedForDisposalOfPropertyAndEquipment" abstract="false" name="ReceivableRecognizedForDisposalOfPropertyAndEquipment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="zlab_RestrictedNetAssetsTable" abstract="true" name="RestrictedNetAssetsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="zlab_InnovivaInc.Member" abstract="true" name="InnovivaInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="zlab_RepotrectinibMember" abstract="true" name="RepotrectinibMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="zlab_IncreaseDecreaseInValueAddedTaxesReceivable" abstract="false" name="IncreaseDecreaseInValueAddedTaxesReceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="zlab_MacroGenicsIncMember" abstract="true" name="MacroGenicsIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="zlab_ProceedsFromDisposalOfLandUseRights" abstract="false" name="ProceedsFromDisposalOfLandUseRights" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="zlab_PayablesForPurchaseOfPropertyAndEquipmentCurrent" abstract="false" name="PayablesForPurchaseOfPropertyAndEquipmentCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="zlab_DeferredTaxAssetsResearchAndExperimentalCapitalization" abstract="false" name="DeferredTaxAssetsResearchAndExperimentalCapitalization" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="zlab_CommonStockAuthorizedShareCapital" abstract="false" name="CommonStockAuthorizedShareCapital" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="zlab_CapitalizedSalesBasedMilestoneFeesMember" abstract="true" name="CapitalizedSalesBasedMilestoneFeesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="zlab_ShortTermInvestmentTextBlock" abstract="false" name="ShortTermInvestmentTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="zlab_QinlockMember" abstract="true" name="QinlockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="zlab_IncomeTaxDisclosureLineItems" abstract="true" name="IncomeTaxDisclosureLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="zlab_AmericanDepositaryShareToCommonStockConversionRatio" abstract="false" name="AmericanDepositaryShareToCommonStockConversionRatio" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="zlab_LongTermDepositsPolicyPolicyTextBlock" abstract="false" name="LongTermDepositsPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="zlab_SPDBankWorkingCapitalLoanFacilityMember" abstract="true" name="SPDBankWorkingCapitalLoanFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="zlab_GainLossOnDisposalOfLandUseRights" abstract="false" name="GainLossOnDisposalOfLandUseRights" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="zlab_EffectiveIncomeTaxRateReconciliationAtPreferentialTaxRate" abstract="false" name="EffectiveIncomeTaxRateReconciliationAtPreferentialTaxRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="zlab_IncomeTaxDisclosureTable" abstract="true" name="IncomeTaxDisclosureTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="zlab_IncomeLossFromEquityMethodInvestmentsNetOfTax" abstract="false" name="IncomeLossFromEquityMethodInvestmentsNetOfTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="zlab_RevenueFromContractWithCustomersExcludingAssessedTaxBeforeAdjustmentsForRebatesAndSalesReturns" abstract="false" name="RevenueFromContractWithCustomersExcludingAssessedTaxBeforeAdjustmentsForRebatesAndSalesReturns" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="zlab_ShortTermInvestmentsPolicyPolicyTextBlock" abstract="false" name="ShortTermInvestmentsPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="zlab_ZaiLabShanghaiCompanyLimitedMember" abstract="true" name="ZaiLabShanghaiCompanyLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="zlab_ZaiLabUSLLCMember" abstract="true" name="ZaiLabUSLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="zlab_AmgenMember" abstract="true" name="AmgenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="zlab_NoncashResearchAndDevelopmentExpenses" abstract="false" name="NoncashResearchAndDevelopmentExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="zlab_NonVestedRestrictedSharesMember" abstract="true" name="NonVestedRestrictedSharesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="zlab_VyvgartMember" abstract="true" name="VyvgartMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="zlab_NingboBankWorkingCapitalLoanFacilityMember" abstract="true" name="NingboBankWorkingCapitalLoanFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="zlab_IncomeTaxesTable" abstract="true" name="IncomeTaxesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="zlab_SupplementalInformationRelatedToLeasesTableTableTextBlock" abstract="false" name="SupplementalInformationRelatedToLeasesTableTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="zlab_ZejulaMember" abstract="true" name="ZejulaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="zlab_CapitalContributionsCommitment" abstract="false" name="CapitalContributionsCommitment" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="zlab_OneCustomerMember" abstract="true" name="OneCustomerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="zlab_ElectronicEquipmentMember" abstract="true" name="ElectronicEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="zlab_AmortizationOfDeferredIncome" abstract="false" name="AmortizationOfDeferredIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="zlab_DecipheraPharmaceuticalsLLCMember" abstract="true" name="DecipheraPharmaceuticalsLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="zlab_StatutoryReserves" abstract="false" name="StatutoryReserves" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="zlab_XanomelineTrospiumMember" abstract="true" name="XanomelineTrospiumMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="zlab_ZaiLabAUSTPtyLtdMember" abstract="true" name="ZaiLabAUSTPtyLtdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="zlab_LandUseRightsPolicyPolicyTextBlock" abstract="false" name="LandUseRightsPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="zlab_DeferredTaxAssetsDeferredRevenue" abstract="false" name="DeferredTaxAssetsDeferredRevenue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="zlab_ShareBasedPaymentArrangementOptionBatchOneMember" abstract="true" name="ShareBasedPaymentArrangementOptionBatchOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>13
<FILENAME>zlab-20231231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:8edfc3fc-8768-4ea6-b2a3-bb613cc9a367,g:14e43acd-1532-4842-be1c-6094bb39150d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://zailab.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="zlab-20231231.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://zailab.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_1aa8bbc5-e527-4a9d-ab4c-dad1996ebc2b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_a19f857d-e164-4838-9ccb-f4aa1ad29f68" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_1aa8bbc5-e527-4a9d-ab4c-dad1996ebc2b" xlink:to="loc_us-gaap_AssetsCurrent_a19f857d-e164-4838-9ccb-f4aa1ad29f68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_256f918a-e793-413a-a261-c81031f2d88f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_1aa8bbc5-e527-4a9d-ab4c-dad1996ebc2b" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_256f918a-e793-413a-a261-c81031f2d88f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_3117b8d7-a9aa-4482-a8d3-bc89ea72dd4a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_1aa8bbc5-e527-4a9d-ab4c-dad1996ebc2b" xlink:to="loc_us-gaap_LongTermInvestments_3117b8d7-a9aa-4482-a8d3-bc89ea72dd4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_PrepaymentsForEquipment_7f14fef0-11ab-4e7b-a68c-0f00406cc48a" xlink:href="zlab-20231231.xsd#zlab_PrepaymentsForEquipment"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_1aa8bbc5-e527-4a9d-ab4c-dad1996ebc2b" xlink:to="loc_zlab_PrepaymentsForEquipment_7f14fef0-11ab-4e7b-a68c-0f00406cc48a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_a9501544-d33e-4812-939b-a313167d4ac7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_1aa8bbc5-e527-4a9d-ab4c-dad1996ebc2b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_a9501544-d33e-4812-939b-a313167d4ac7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_ea300ca8-f56b-43e4-82b0-95398eda3316" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_1aa8bbc5-e527-4a9d-ab4c-dad1996ebc2b" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_ea300ca8-f56b-43e4-82b0-95398eda3316" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_LandUseRightsNetNoncurrent_c5681274-7995-42a5-961a-7d66750bb618" xlink:href="zlab-20231231.xsd#zlab_LandUseRightsNetNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_1aa8bbc5-e527-4a9d-ab4c-dad1996ebc2b" xlink:to="loc_zlab_LandUseRightsNetNoncurrent_c5681274-7995-42a5-961a-7d66750bb618" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_2f274342-3658-4505-b663-c81fb0808118" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_1aa8bbc5-e527-4a9d-ab4c-dad1996ebc2b" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_2f274342-3658-4505-b663-c81fb0808118" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsAssetsNoncurrent_65e4b074-747e-48b6-b738-91ad4ee4018a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositsAssetsNoncurrent"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_1aa8bbc5-e527-4a9d-ab4c-dad1996ebc2b" xlink:to="loc_us-gaap_DepositsAssetsNoncurrent_65e4b074-747e-48b6-b738-91ad4ee4018a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_47402c81-52c3-45b6-97ba-23547eab4bd4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_1aa8bbc5-e527-4a9d-ab4c-dad1996ebc2b" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_47402c81-52c3-45b6-97ba-23547eab4bd4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_a5294909-ac57-435e-9d39-9988481922f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_a0b60efa-8cfb-4908-b28b-270bfac90d17" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_a5294909-ac57-435e-9d39-9988481922f1" xlink:to="loc_us-gaap_Liabilities_a0b60efa-8cfb-4908-b28b-270bfac90d17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_bae65d4d-a8e9-4dc2-a659-f12dde08e76e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_a5294909-ac57-435e-9d39-9988481922f1" xlink:to="loc_us-gaap_StockholdersEquity_bae65d4d-a8e9-4dc2-a659-f12dde08e76e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_1e83db8d-1477-434a-967d-47dbbc6b0375" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_0e504048-8aff-4f0c-9173-31456272ce11" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1e83db8d-1477-434a-967d-47dbbc6b0375" xlink:to="loc_us-gaap_AccountsPayableCurrent_0e504048-8aff-4f0c-9173-31456272ce11" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_46657bb0-c664-43a8-8c34-90e3bdec2776" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1e83db8d-1477-434a-967d-47dbbc6b0375" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_46657bb0-c664-43a8-8c34-90e3bdec2776" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_12a11751-b24e-4d9b-86cb-2d3161cfb8ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1e83db8d-1477-434a-967d-47dbbc6b0375" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_12a11751-b24e-4d9b-86cb-2d3161cfb8ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_3e439670-442a-4042-8304-c2620364ab8f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_31285f98-3f66-45a5-9159-9ef34deb7713" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_3e439670-442a-4042-8304-c2620364ab8f" xlink:to="loc_us-gaap_LiabilitiesCurrent_31285f98-3f66-45a5-9159-9ef34deb7713" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeNoncurrent_a12bd218-beee-45e3-a88b-b9b51ace0e9e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_3e439670-442a-4042-8304-c2620364ab8f" xlink:to="loc_us-gaap_DeferredIncomeNoncurrent_a12bd218-beee-45e3-a88b-b9b51ace0e9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_35380001-20b1-4f5e-b464-4320ae718db9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_3e439670-442a-4042-8304-c2620364ab8f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_35380001-20b1-4f5e-b464-4320ae718db9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_32e5038d-71d4-4455-8b2d-7d97940290f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_3e439670-442a-4042-8304-c2620364ab8f" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_32e5038d-71d4-4455-8b2d-7d97940290f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_c281f424-d54c-4cee-84ed-a2b0ea036dfa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7bc94e1a-021e-4798-908f-749eb8e97e6e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c281f424-d54c-4cee-84ed-a2b0ea036dfa" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7bc94e1a-021e-4798-908f-749eb8e97e6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_b9ce048c-13a4-4668-80bf-2ae471ea3865" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c281f424-d54c-4cee-84ed-a2b0ea036dfa" xlink:to="loc_us-gaap_ShortTermInvestments_b9ce048c-13a4-4668-80bf-2ae471ea3865" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_3fa82e33-c265-4b4e-a405-c649b55d8a9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c281f424-d54c-4cee-84ed-a2b0ea036dfa" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_3fa82e33-c265-4b4e-a405-c649b55d8a9a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLossCurrent_cb3f69a9-9e91-4a8c-9b47-c16b45be1c9d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLossCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c281f424-d54c-4cee-84ed-a2b0ea036dfa" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLossCurrent_cb3f69a9-9e91-4a8c-9b47-c16b45be1c9d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_24d40432-6862-4d3f-80fc-55995de20ef1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c281f424-d54c-4cee-84ed-a2b0ea036dfa" xlink:to="loc_us-gaap_InventoryNet_24d40432-6862-4d3f-80fc-55995de20ef1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_df007e22-7236-4cb8-b0d5-37e527e7654f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c281f424-d54c-4cee-84ed-a2b0ea036dfa" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_df007e22-7236-4cb8-b0d5-37e527e7654f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_b42c48bb-15fb-4278-a072-7a6446c5b496" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_94bc3d84-cf97-4571-b4df-0055084b5878" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_b42c48bb-15fb-4278-a072-7a6446c5b496" xlink:to="loc_us-gaap_CommonStockValue_94bc3d84-cf97-4571-b4df-0055084b5878" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_beb9fa9d-3ffc-420e-bd37-173f710daea7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_b42c48bb-15fb-4278-a072-7a6446c5b496" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_beb9fa9d-3ffc-420e-bd37-173f710daea7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_4c6c4a44-8b28-473c-b315-cfd0f6b3993f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_b42c48bb-15fb-4278-a072-7a6446c5b496" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_4c6c4a44-8b28-473c-b315-cfd0f6b3993f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3259e8ba-0681-4b90-965d-141ffc76a64f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_b42c48bb-15fb-4278-a072-7a6446c5b496" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3259e8ba-0681-4b90-965d-141ffc76a64f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_de524a89-14a3-4098-a732-9de7c7cea58e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_b42c48bb-15fb-4278-a072-7a6446c5b496" xlink:to="loc_us-gaap_TreasuryStockCommonValue_de524a89-14a3-4098-a732-9de7c7cea58e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://zailab.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="zlab-20231231.xsd#ConsolidatedStatementsofOperations"/>
  <link:calculationLink xlink:role="http://zailab.com/role/ConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_39253a15-582c-4b9d-8558-9556f6e18c0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2adcae65-7cfa-47cc-925a-8e2849d69187" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_39253a15-582c-4b9d-8558-9556f6e18c0a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2adcae65-7cfa-47cc-925a-8e2849d69187" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_b00c5029-5594-4e2d-a95e-a817454254d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_39253a15-582c-4b9d-8558-9556f6e18c0a" xlink:to="loc_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_b00c5029-5594-4e2d-a95e-a817454254d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_acd30112-9730-4971-82b1-ba4f0a66c76b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_07613415-9e67-4009-8dd2-d411311782d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_acd30112-9730-4971-82b1-ba4f0a66c76b" xlink:to="loc_us-gaap_Revenues_07613415-9e67-4009-8dd2-d411311782d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_8f3c21dc-5329-4dfd-88cd-7a2bd69aa148" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfRevenue"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_acd30112-9730-4971-82b1-ba4f0a66c76b" xlink:to="loc_us-gaap_CostOfRevenue_8f3c21dc-5329-4dfd-88cd-7a2bd69aa148" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_d70ac583-9067-4c39-9744-25c0a30c9cb8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_acd30112-9730-4971-82b1-ba4f0a66c76b" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_d70ac583-9067-4c39-9744-25c0a30c9cb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_4745ad5a-8484-4122-9398-d5f4533a1e75" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_acd30112-9730-4971-82b1-ba4f0a66c76b" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_4745ad5a-8484-4122-9398-d5f4533a1e75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfIntangibleAssets_29135403-9b6a-432c-9bbe-8d780662966b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnDispositionOfIntangibleAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_acd30112-9730-4971-82b1-ba4f0a66c76b" xlink:to="loc_us-gaap_GainLossOnDispositionOfIntangibleAssets_29135403-9b6a-432c-9bbe-8d780662966b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0574fa0e-0261-4452-a8ee-d9d22c9c185f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_9b107158-e1b0-42ed-9d44-863ac40f47c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0574fa0e-0261-4452-a8ee-d9d22c9c185f" xlink:to="loc_us-gaap_OperatingIncomeLoss_9b107158-e1b0-42ed-9d44-863ac40f47c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_2d7a41b0-c672-45ab-b533-89d6e7fd15ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0574fa0e-0261-4452-a8ee-d9d22c9c185f" xlink:to="loc_us-gaap_InvestmentIncomeInterest_2d7a41b0-c672-45ab-b533-89d6e7fd15ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_376a7ff2-0fce-4ac3-82b2-49806a31557e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0574fa0e-0261-4452-a8ee-d9d22c9c185f" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_376a7ff2-0fce-4ac3-82b2-49806a31557e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_6b27740d-446d-41d4-a293-04a0f5922ea9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0574fa0e-0261-4452-a8ee-d9d22c9c185f" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_6b27740d-446d-41d4-a293-04a0f5922ea9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f9fa81e6-6a75-4d2a-9c0f-5f1104877841" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_01cca8f5-a949-4240-bfeb-0321f4363edf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_f9fa81e6-6a75-4d2a-9c0f-5f1104877841" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_01cca8f5-a949-4240-bfeb-0321f4363edf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_2cbaa9a3-48ac-46c2-9a24-f75bf1179d9f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_f9fa81e6-6a75-4d2a-9c0f-5f1104877841" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_2cbaa9a3-48ac-46c2-9a24-f75bf1179d9f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_87eba42c-36c4-4beb-aff7-9453fac42ac4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_f9fa81e6-6a75-4d2a-9c0f-5f1104877841" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_87eba42c-36c4-4beb-aff7-9453fac42ac4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://zailab.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="zlab-20231231.xsd#ConsolidatedStatementsofComprehensiveLoss"/>
  <link:calculationLink xlink:role="http://zailab.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_ef469ba8-df73-49df-89bf-5ad8842039f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a86120c8-63a9-4c80-a7d3-9d4c949f1b5c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_ef469ba8-df73-49df-89bf-5ad8842039f1" xlink:to="loc_us-gaap_NetIncomeLoss_a86120c8-63a9-4c80-a7d3-9d4c949f1b5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_98d9f357-976b-404b-ba04-04698f46c313" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_ef469ba8-df73-49df-89bf-5ad8842039f1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_98d9f357-976b-404b-ba04-04698f46c313" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://zailab.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="zlab-20231231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://zailab.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7a9dfc54-13b9-409d-93ac-97a747e7c15c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments_d609edff-450a-4f61-95bc-5afc6670a999" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7a9dfc54-13b9-409d-93ac-97a747e7c15c" xlink:to="loc_us-gaap_PaymentsToAcquireShortTermInvestments_d609edff-450a-4f61-95bc-5afc6670a999" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_0533dd71-b5be-4aeb-99d1-376896ded72d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7a9dfc54-13b9-409d-93ac-97a747e7c15c" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_0533dd71-b5be-4aeb-99d1-376896ded72d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_74333037-ce3a-4c19-837d-c5115c766aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7a9dfc54-13b9-409d-93ac-97a747e7c15c" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_74333037-ce3a-4c19-837d-c5115c766aa9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_6da05b44-8ced-48eb-b280-999c49357a05" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7a9dfc54-13b9-409d-93ac-97a747e7c15c" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_6da05b44-8ced-48eb-b280-999c49357a05" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_3b8cbdd6-117e-462c-b822-ccae551c4271" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7a9dfc54-13b9-409d-93ac-97a747e7c15c" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_3b8cbdd6-117e-462c-b822-ccae551c4271" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_bb420938-7ec2-4244-9bd1-3b1c6fb3ebeb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7a9dfc54-13b9-409d-93ac-97a747e7c15c" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_bb420938-7ec2-4244-9bd1-3b1c6fb3ebeb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfIntangibleAssets_946da1fb-4de5-4d03-8cf8-ffc91bd35ae4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfIntangibleAssets"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7a9dfc54-13b9-409d-93ac-97a747e7c15c" xlink:to="loc_us-gaap_ProceedsFromSaleOfIntangibleAssets_946da1fb-4de5-4d03-8cf8-ffc91bd35ae4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ProceedsFromDisposalOfLandUseRights_47aebdce-9bc9-4f37-ab98-d9509bdc80d5" xlink:href="zlab-20231231.xsd#zlab_ProceedsFromDisposalOfLandUseRights"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7a9dfc54-13b9-409d-93ac-97a747e7c15c" xlink:to="loc_zlab_ProceedsFromDisposalOfLandUseRights_47aebdce-9bc9-4f37-ab98-d9509bdc80d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_ca18f2a7-0565-47ae-8762-a97b49d397ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7a9dfc54-13b9-409d-93ac-97a747e7c15c" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_ca18f2a7-0565-47ae-8762-a97b49d397ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5a3361c5-78fd-4d40-90b8-01870539ac54" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5290b501-cf26-4b67-90c9-42d475359e42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5a3361c5-78fd-4d40-90b8-01870539ac54" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5290b501-cf26-4b67-90c9-42d475359e42" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9046d7f6-2285-4976-bf02-43fbcaec97c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5a3361c5-78fd-4d40-90b8-01870539ac54" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9046d7f6-2285-4976-bf02-43fbcaec97c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f07ea1e5-ba18-482f-ae10-c7342023f218" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5a3361c5-78fd-4d40-90b8-01870539ac54" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f07ea1e5-ba18-482f-ae10-c7342023f218" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_761f572d-509a-400e-81e3-70bd4176692e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5a3361c5-78fd-4d40-90b8-01870539ac54" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_761f572d-509a-400e-81e3-70bd4176692e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2bca133a-e08c-4611-9c11-7db4ab598e61" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1078f70d-6315-492f-84d3-2ca16b40be23" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2bca133a-e08c-4611-9c11-7db4ab598e61" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1078f70d-6315-492f-84d3-2ca16b40be23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_d1924f6d-ad39-44ab-ba73-46b48e7435fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2bca133a-e08c-4611-9c11-7db4ab598e61" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_d1924f6d-ad39-44ab-ba73-46b48e7435fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f105b00b-488e-4f8c-96f2-be41a19e9673" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f6e96112-9950-4b26-afbf-88c9e5440699" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f105b00b-488e-4f8c-96f2-be41a19e9673" xlink:to="loc_us-gaap_NetIncomeLoss_f6e96112-9950-4b26-afbf-88c9e5440699" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_18ea57b0-4d7b-41be-8cb9-b6faacd78729" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f105b00b-488e-4f8c-96f2-be41a19e9673" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_18ea57b0-4d7b-41be-8cb9-b6faacd78729" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_e65a8ece-0650-4a60-8b67-57f92ba226ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWriteDown"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f105b00b-488e-4f8c-96f2-be41a19e9673" xlink:to="loc_us-gaap_InventoryWriteDown_e65a8ece-0650-4a60-8b67-57f92ba226ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_57111188-024f-4c08-82a5-df234bc1a5d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f105b00b-488e-4f8c-96f2-be41a19e9673" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_57111188-024f-4c08-82a5-df234bc1a5d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TangibleAssetImpairmentCharges_c304d8fd-e406-4815-972d-f134aeaed9c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TangibleAssetImpairmentCharges"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f105b00b-488e-4f8c-96f2-be41a19e9673" xlink:to="loc_us-gaap_TangibleAssetImpairmentCharges_c304d8fd-e406-4815-972d-f134aeaed9c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_AmortizationOfDeferredIncome_dffd5828-347c-4fae-b3bd-a6820bda179b" xlink:href="zlab-20231231.xsd#zlab_AmortizationOfDeferredIncome"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f105b00b-488e-4f8c-96f2-be41a19e9673" xlink:to="loc_zlab_AmortizationOfDeferredIncome_dffd5828-347c-4fae-b3bd-a6820bda179b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_10f34451-03a0-4875-be3f-a84b10ccf91c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f105b00b-488e-4f8c-96f2-be41a19e9673" xlink:to="loc_us-gaap_ShareBasedCompensation_10f34451-03a0-4875-be3f-a84b10ccf91c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_NoncashResearchAndDevelopmentExpenses_bc03d6a3-d3f3-4343-a520-96218a6d05f6" xlink:href="zlab-20231231.xsd#zlab_NoncashResearchAndDevelopmentExpenses"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f105b00b-488e-4f8c-96f2-be41a19e9673" xlink:to="loc_zlab_NoncashResearchAndDevelopmentExpenses_bc03d6a3-d3f3-4343-a520-96218a6d05f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_04edad81-3ef9-480d-832b-3710fc847ec6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f105b00b-488e-4f8c-96f2-be41a19e9673" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_04edad81-3ef9-480d-832b-3710fc847ec6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_0ca9941e-f9a3-459b-9fe3-b51b481355c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f105b00b-488e-4f8c-96f2-be41a19e9673" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_0ca9941e-f9a3-459b-9fe3-b51b481355c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_9dc038ec-fe03-4f6f-867b-3094af77f5bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f105b00b-488e-4f8c-96f2-be41a19e9673" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_9dc038ec-fe03-4f6f-867b-3094af77f5bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_GainLossOnDisposalOfLandUseRights_34bce161-ae0a-46a8-97de-886dbb23b91a" xlink:href="zlab-20231231.xsd#zlab_GainLossOnDisposalOfLandUseRights"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f105b00b-488e-4f8c-96f2-be41a19e9673" xlink:to="loc_zlab_GainLossOnDisposalOfLandUseRights_34bce161-ae0a-46a8-97de-886dbb23b91a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_NonCashLeaseExpenses_1d2e9ed7-b5d3-43e2-a01a-b8d83a43b188" xlink:href="zlab-20231231.xsd#zlab_NonCashLeaseExpenses"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f105b00b-488e-4f8c-96f2-be41a19e9673" xlink:to="loc_zlab_NonCashLeaseExpenses_1d2e9ed7-b5d3-43e2-a01a-b8d83a43b188" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfIntangibleAssets_47746895-bcb6-40f4-bea8-7833c4e06bdf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnDispositionOfIntangibleAssets"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f105b00b-488e-4f8c-96f2-be41a19e9673" xlink:to="loc_us-gaap_GainLossOnDispositionOfIntangibleAssets_47746895-bcb6-40f4-bea8-7833c4e06bdf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_54b411bd-ee36-4fb4-9780-5be580fdedad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f105b00b-488e-4f8c-96f2-be41a19e9673" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_54b411bd-ee36-4fb4-9780-5be580fdedad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_a00e910c-5da6-4070-b703-ed099d11b8ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f105b00b-488e-4f8c-96f2-be41a19e9673" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_a00e910c-5da6-4070-b703-ed099d11b8ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInNotesReceivableCurrent_d7324197-6061-495d-ab9f-6d9f9bbfd748" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInNotesReceivableCurrent"/>
    <link:calculationArc order="17" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f105b00b-488e-4f8c-96f2-be41a19e9673" xlink:to="loc_us-gaap_IncreaseDecreaseInNotesReceivableCurrent_d7324197-6061-495d-ab9f-6d9f9bbfd748" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_7a3f206d-bd8b-440b-b374-35dd857434d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="18" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f105b00b-488e-4f8c-96f2-be41a19e9673" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_7a3f206d-bd8b-440b-b374-35dd857434d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3aaa5bcd-00a1-4fa9-829f-3ce64aa4c9c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="19" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f105b00b-488e-4f8c-96f2-be41a19e9673" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3aaa5bcd-00a1-4fa9-829f-3ce64aa4c9c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_IncreaseDecreaseInLongTermDeposits_3d7a90e7-6fbe-45bc-8b9c-0eab1be5d466" xlink:href="zlab-20231231.xsd#zlab_IncreaseDecreaseInLongTermDeposits"/>
    <link:calculationArc order="20" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f105b00b-488e-4f8c-96f2-be41a19e9673" xlink:to="loc_zlab_IncreaseDecreaseInLongTermDeposits_3d7a90e7-6fbe-45bc-8b9c-0eab1be5d466" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_IncreaseDecreaseInValueAddedTaxesReceivable_29395e9c-db5a-4f82-b147-ddea7b302b4d" xlink:href="zlab-20231231.xsd#zlab_IncreaseDecreaseInValueAddedTaxesReceivable"/>
    <link:calculationArc order="21" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f105b00b-488e-4f8c-96f2-be41a19e9673" xlink:to="loc_zlab_IncreaseDecreaseInValueAddedTaxesReceivable_29395e9c-db5a-4f82-b147-ddea7b302b4d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_5dfbe666-62bc-47bb-8552-4df6dbf00e6a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="22" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f105b00b-488e-4f8c-96f2-be41a19e9673" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_5dfbe666-62bc-47bb-8552-4df6dbf00e6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_a81b620b-f3f9-4610-ae71-6a2cc7559e2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities"/>
    <link:calculationArc order="23" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f105b00b-488e-4f8c-96f2-be41a19e9673" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_a81b620b-f3f9-4610-ae71-6a2cc7559e2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_IncreaseDecreaseInOperatingLeaseLiabilities_fa25196c-d105-4ef6-bfcf-e294a5ae8eaa" xlink:href="zlab-20231231.xsd#zlab_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <link:calculationArc order="24" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f105b00b-488e-4f8c-96f2-be41a19e9673" xlink:to="loc_zlab_IncreaseDecreaseInOperatingLeaseLiabilities_fa25196c-d105-4ef6-bfcf-e294a5ae8eaa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_d729b74b-2c7b-4c3a-abca-81c602ff7339" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:calculationArc order="25" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f105b00b-488e-4f8c-96f2-be41a19e9673" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_d729b74b-2c7b-4c3a-abca-81c602ff7339" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_b181ddb8-ba23-47bf-9932-a113427da9ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:calculationArc order="26" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f105b00b-488e-4f8c-96f2-be41a19e9673" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_b181ddb8-ba23-47bf-9932-a113427da9ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1994d59c-ba9c-42bc-8564-76eb36f16433" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_89e7366c-ae98-4425-8625-03bee6a2e69f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1994d59c-ba9c-42bc-8564-76eb36f16433" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_89e7366c-ae98-4425-8625-03bee6a2e69f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_b15a6c71-5dd8-425c-9443-7135afdb935c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1994d59c-ba9c-42bc-8564-76eb36f16433" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_b15a6c71-5dd8-425c-9443-7135afdb935c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_64a81f4f-c827-4eef-9142-545bb24e5bcc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1994d59c-ba9c-42bc-8564-76eb36f16433" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_64a81f4f-c827-4eef-9142-545bb24e5bcc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_11ff3de8-1bed-40cd-b7a9-a831ddfaa88d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1994d59c-ba9c-42bc-8564-76eb36f16433" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_11ff3de8-1bed-40cd-b7a9-a831ddfaa88d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://zailab.com/role/CashandCashEquivalentsDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#CashandCashEquivalentsDetails"/>
  <link:calculationLink xlink:role="http://zailab.com/role/CashandCashEquivalentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_04e47d53-b2d0-4332-9728-c6da1cf8c705" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash_b2cae303-6186-406d-b2d3-786d375f3497" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Cash"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_04e47d53-b2d0-4332-9728-c6da1cf8c705" xlink:to="loc_us-gaap_Cash_b2cae303-6186-406d-b2d3-786d375f3497" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_784330c9-0db6-4aeb-bf09-326fdc008f5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_04e47d53-b2d0-4332-9728-c6da1cf8c705" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_784330c9-0db6-4aeb-bf09-326fdc008f5b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://zailab.com/role/InventoriesNetScheduleofInventoryDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#InventoriesNetScheduleofInventoryDetails"/>
  <link:calculationLink xlink:role="http://zailab.com/role/InventoriesNetScheduleofInventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_44d22cb8-a191-4ad6-8974-6a9bc8d0549c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_b025f8b0-7da7-4628-8d3f-25b1897bb7b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_44d22cb8-a191-4ad6-8974-6a9bc8d0549c" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_b025f8b0-7da7-4628-8d3f-25b1897bb7b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_396e4a68-29ac-4696-afd4-006337e38754" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_44d22cb8-a191-4ad6-8974-6a9bc8d0549c" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_396e4a68-29ac-4696-afd4-006337e38754" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_d222e5ce-92f2-474b-ae19-ac80123425ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_44d22cb8-a191-4ad6-8974-6a9bc8d0549c" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_d222e5ce-92f2-474b-ae19-ac80123425ff" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://zailab.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails"/>
  <link:calculationLink xlink:role="http://zailab.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_ecdeff64-5951-458d-9a7b-1718f5673041" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_67cb7ace-0bf7-4e88-8a9e-0df1ee8c0091" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_ecdeff64-5951-458d-9a7b-1718f5673041" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_67cb7ace-0bf7-4e88-8a9e-0df1ee8c0091" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_4e16d9e2-1276-4827-b6f1-e43c5300332a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_ecdeff64-5951-458d-9a7b-1718f5673041" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_4e16d9e2-1276-4827-b6f1-e43c5300332a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://zailab.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#LeasesMaturitiesofLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://zailab.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3e83ef2f-9ada-4000-80ec-c0c2404cc140" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_5205b7ae-db97-4d3f-89e0-570f3301fa9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3e83ef2f-9ada-4000-80ec-c0c2404cc140" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_5205b7ae-db97-4d3f-89e0-570f3301fa9a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_601618ef-b3d7-43dd-818c-48492da301d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3e83ef2f-9ada-4000-80ec-c0c2404cc140" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_601618ef-b3d7-43dd-818c-48492da301d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_ea368dde-8c16-47d7-ba2c-ca1c27216b3b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3e83ef2f-9ada-4000-80ec-c0c2404cc140" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_ea368dde-8c16-47d7-ba2c-ca1c27216b3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_397f4a98-85ab-4172-9553-7483359ec804" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3e83ef2f-9ada-4000-80ec-c0c2404cc140" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_397f4a98-85ab-4172-9553-7483359ec804" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_fe0648ea-087d-41c6-bf77-343d666da982" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3e83ef2f-9ada-4000-80ec-c0c2404cc140" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_fe0648ea-087d-41c6-bf77-343d666da982" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_71445634-e67d-45a0-b68d-48691628650f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3e83ef2f-9ada-4000-80ec-c0c2404cc140" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_71445634-e67d-45a0-b68d-48691628650f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://zailab.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="zlab-20231231.xsd#LeasesMaturitiesofLeaseLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://zailab.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f30c7908-41b6-450c-ae22-4815a66bfd43" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_724e5a36-f9e2-4d08-a758-4145f41b20a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f30c7908-41b6-450c-ae22-4815a66bfd43" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_724e5a36-f9e2-4d08-a758-4145f41b20a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_10a8f971-5d85-4010-ade8-06d974238c72" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f30c7908-41b6-450c-ae22-4815a66bfd43" xlink:to="loc_us-gaap_OperatingLeaseLiability_10a8f971-5d85-4010-ade8-06d974238c72" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://zailab.com/role/RevenueSummaryofProductRevenueDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#RevenueSummaryofProductRevenueDetails"/>
  <link:calculationLink xlink:role="http://zailab.com/role/RevenueSummaryofProductRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3a251002-2ca3-4eec-929a-5122ed27295d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_RevenueFromContractWithCustomersExcludingAssessedTaxBeforeAdjustmentsForRebatesAndSalesReturns_fee26d8a-30e0-4c62-8898-737238c16025" xlink:href="zlab-20231231.xsd#zlab_RevenueFromContractWithCustomersExcludingAssessedTaxBeforeAdjustmentsForRebatesAndSalesReturns"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3a251002-2ca3-4eec-929a-5122ed27295d" xlink:to="loc_zlab_RevenueFromContractWithCustomersExcludingAssessedTaxBeforeAdjustmentsForRebatesAndSalesReturns_fee26d8a-30e0-4c62-8898-737238c16025" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_RevenueFromContractWithCustomersExcludingAssessedTaxAdjustmentsForRebatesAndSalesReturns_3280acb9-d3b8-4b97-afdd-807fbe16e159" xlink:href="zlab-20231231.xsd#zlab_RevenueFromContractWithCustomersExcludingAssessedTaxAdjustmentsForRebatesAndSalesReturns"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3a251002-2ca3-4eec-929a-5122ed27295d" xlink:to="loc_zlab_RevenueFromContractWithCustomersExcludingAssessedTaxAdjustmentsForRebatesAndSalesReturns_3280acb9-d3b8-4b97-afdd-807fbe16e159" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://zailab.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRateDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#IncomeTaxReconciliationoftheEffectiveIncomeTaxRateDetails"/>
  <link:calculationLink xlink:role="http://zailab.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5c48cfff-dea3-49f1-a1cd-c78d819ad228" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_64a48bc1-719e-4684-9e96-7cd926315d01" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5c48cfff-dea3-49f1-a1cd-c78d819ad228" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_64a48bc1-719e-4684-9e96-7cd926315d01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome_e9604ac8-1dab-4d83-9e3a-7026e09574be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5c48cfff-dea3-49f1-a1cd-c78d819ad228" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome_e9604ac8-1dab-4d83-9e3a-7026e09574be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_81fa5bfd-e15c-4ff5-9a92-7f649bdb8c1f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5c48cfff-dea3-49f1-a1cd-c78d819ad228" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_81fa5bfd-e15c-4ff5-9a92-7f649bdb8c1f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_d9fc25bf-ad31-4ffb-8258-cc9a4a32cc60" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5c48cfff-dea3-49f1-a1cd-c78d819ad228" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_d9fc25bf-ad31-4ffb-8258-cc9a4a32cc60" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_6ffbb075-62c7-4424-8bb1-47cfe0d39b8d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5c48cfff-dea3-49f1-a1cd-c78d819ad228" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_6ffbb075-62c7-4424-8bb1-47cfe0d39b8d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_fdc18f9b-f62c-4b05-a4d9-638765bfa778" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5c48cfff-dea3-49f1-a1cd-c78d819ad228" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_fdc18f9b-f62c-4b05-a4d9-638765bfa778" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_0c20f55d-05af-4049-9b6e-97b7b280b172" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5c48cfff-dea3-49f1-a1cd-c78d819ad228" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_0c20f55d-05af-4049-9b6e-97b7b280b172" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_EffectiveIncomeTaxRateReconciliationAtPreferentialTaxRate_a008f0f1-26f4-4311-825c-0527a36d2258" xlink:href="zlab-20231231.xsd#zlab_EffectiveIncomeTaxRateReconciliationAtPreferentialTaxRate"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5c48cfff-dea3-49f1-a1cd-c78d819ad228" xlink:to="loc_zlab_EffectiveIncomeTaxRateReconciliationAtPreferentialTaxRate_a008f0f1-26f4-4311-825c-0527a36d2258" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCharitableContributions_315b016a-c133-4a9e-9b6d-1de587ea0fdc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCharitableContributions"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5c48cfff-dea3-49f1-a1cd-c78d819ad228" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCharitableContributions_315b016a-c133-4a9e-9b6d-1de587ea0fdc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_c7cdbad1-c122-481b-86dd-e048696d2d97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5c48cfff-dea3-49f1-a1cd-c78d819ad228" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_c7cdbad1-c122-481b-86dd-e048696d2d97" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://zailab.com/role/IncomeTaxComponentsofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#IncomeTaxComponentsofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://zailab.com/role/IncomeTaxComponentsofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_ebd6ba6c-29da-4911-83d4-8664f01f7457" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_84b566cb-ea5c-4e38-86da-025d08b4ced9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_ebd6ba6c-29da-4911-83d4-8664f01f7457" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_84b566cb-ea5c-4e38-86da-025d08b4ced9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_58f5b178-78f6-492f-8cac-4fe7594494f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_ebd6ba6c-29da-4911-83d4-8664f01f7457" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_58f5b178-78f6-492f-8cac-4fe7594494f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_cbb866fe-bae9-4aec-a83b-4a0827f1f7f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_3de5d7fb-4a09-4c21-91b6-620b8c50e2fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_cbb866fe-bae9-4aec-a83b-4a0827f1f7f3" xlink:to="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_3de5d7fb-4a09-4c21-91b6-620b8c50e2fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_DeferredTaxAssetsResearchAndExperimentalCapitalization_f73a25a5-00af-4301-ad2f-c1cd7d86c449" xlink:href="zlab-20231231.xsd#zlab_DeferredTaxAssetsResearchAndExperimentalCapitalization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_cbb866fe-bae9-4aec-a83b-4a0827f1f7f3" xlink:to="loc_zlab_DeferredTaxAssetsResearchAndExperimentalCapitalization_f73a25a5-00af-4301-ad2f-c1cd7d86c449" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_7f3b6b85-72e0-4d70-9410-529d13185f0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_cbb866fe-bae9-4aec-a83b-4a0827f1f7f3" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_7f3b6b85-72e0-4d70-9410-529d13185f0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_497feffa-3897-43df-8d79-63d0a5fbf236" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_cbb866fe-bae9-4aec-a83b-4a0827f1f7f3" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_497feffa-3897-43df-8d79-63d0a5fbf236" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_DeferredTaxAssetsGovernmentGrants_e17e7b4f-c513-4dfc-ba7f-969de6932f4e" xlink:href="zlab-20231231.xsd#zlab_DeferredTaxAssetsGovernmentGrants"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_cbb866fe-bae9-4aec-a83b-4a0827f1f7f3" xlink:to="loc_zlab_DeferredTaxAssetsGovernmentGrants_e17e7b4f-c513-4dfc-ba7f-969de6932f4e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_DeferredTaxAssetsDeferredRevenue_90f9d1a1-7473-4cac-96bf-37ba6219a693" xlink:href="zlab-20231231.xsd#zlab_DeferredTaxAssetsDeferredRevenue"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_cbb866fe-bae9-4aec-a83b-4a0827f1f7f3" xlink:to="loc_zlab_DeferredTaxAssetsDeferredRevenue_90f9d1a1-7473-4cac-96bf-37ba6219a693" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_DeferredTaxAssetsPublicWelfareDonations_e87c9641-c210-440a-9f79-07ccbb6fa6e2" xlink:href="zlab-20231231.xsd#zlab_DeferredTaxAssetsPublicWelfareDonations"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_cbb866fe-bae9-4aec-a83b-4a0827f1f7f3" xlink:to="loc_zlab_DeferredTaxAssetsPublicWelfareDonations_e87c9641-c210-440a-9f79-07ccbb6fa6e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_DeferredTaxAssetsLeasingArrangements_60751734-47c3-4345-87a9-49d18d454b06" xlink:href="zlab-20231231.xsd#zlab_DeferredTaxAssetsLeasingArrangements"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_cbb866fe-bae9-4aec-a83b-4a0827f1f7f3" xlink:to="loc_zlab_DeferredTaxAssetsLeasingArrangements_60751734-47c3-4345-87a9-49d18d454b06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_887559b3-ddef-4180-810d-f2b23dea3bc0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_cbb866fe-bae9-4aec-a83b-4a0827f1f7f3" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_887559b3-ddef-4180-810d-f2b23dea3bc0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_5df8b8fd-b0f7-4848-8536-8b449978505d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_cbb866fe-bae9-4aec-a83b-4a0827f1f7f3" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_5df8b8fd-b0f7-4848-8536-8b449978505d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://zailab.com/role/OtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#OtherCurrentLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://zailab.com/role/OtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_07983ecb-5a8f-4dd2-a670-b16efe34ef26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_7df52513-d4c2-4c9d-93f3-56ce1a8a86a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_07983ecb-5a8f-4dd2-a670-b16efe34ef26" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_7df52513-d4c2-4c9d-93f3-56ce1a8a86a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_83070b50-60fb-477d-b9e9-bcf7539e6f42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_07983ecb-5a8f-4dd2-a670-b16efe34ef26" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_83070b50-60fb-477d-b9e9-bcf7539e6f42" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_PayablesForPurchaseOfPropertyAndEquipmentCurrent_2853cd41-e246-44be-bbdf-15055db1a5c5" xlink:href="zlab-20231231.xsd#zlab_PayablesForPurchaseOfPropertyAndEquipmentCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_07983ecb-5a8f-4dd2-a670-b16efe34ef26" xlink:to="loc_zlab_PayablesForPurchaseOfPropertyAndEquipmentCurrent_2853cd41-e246-44be-bbdf-15055db1a5c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_AccruedRebateToDistributorsCurrent_da2f34b5-a8d6-4e04-bad6-ee81f5924b7c" xlink:href="zlab-20231231.xsd#zlab_AccruedRebateToDistributorsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_07983ecb-5a8f-4dd2-a670-b16efe34ef26" xlink:to="loc_zlab_AccruedRebateToDistributorsCurrent_da2f34b5-a8d6-4e04-bad6-ee81f5924b7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrentAndNoncurrent_38915e89-8dbc-4d7d-a7d5-c4d744c83bc6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxesPayableCurrentAndNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_07983ecb-5a8f-4dd2-a670-b16efe34ef26" xlink:to="loc_us-gaap_TaxesPayableCurrentAndNoncurrent_38915e89-8dbc-4d7d-a7d5-c4d744c83bc6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_OtherPayablesCurrentLiabilities_a3830223-07c4-4610-8dde-08625acf380a" xlink:href="zlab-20231231.xsd#zlab_OtherPayablesCurrentLiabilities"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_07983ecb-5a8f-4dd2-a670-b16efe34ef26" xlink:to="loc_zlab_OtherPayablesCurrentLiabilities_a3830223-07c4-4610-8dde-08625acf380a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://zailab.com/role/OtherIncomeExpensesNetDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#OtherIncomeExpensesNetDetails"/>
  <link:calculationLink xlink:role="http://zailab.com/role/OtherIncomeExpensesNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_90e8298d-d599-41fc-96a3-8857c2bf3f5a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_GovernmentAssistanceNonoperatingIncome_7474a876-5a7b-41d4-99b8-c9890b0b43a9" xlink:href="zlab-20231231.xsd#zlab_GovernmentAssistanceNonoperatingIncome"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_90e8298d-d599-41fc-96a3-8857c2bf3f5a" xlink:to="loc_zlab_GovernmentAssistanceNonoperatingIncome_7474a876-5a7b-41d4-99b8-c9890b0b43a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_4bbf6386-bfff-4763-9bcc-7f5d69671356" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_90e8298d-d599-41fc-96a3-8857c2bf3f5a" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_4bbf6386-bfff-4763-9bcc-7f5d69671356" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingGainsLosses_2fadbf0b-9192-4020-8209-08a0ea4034f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingGainsLosses"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_90e8298d-d599-41fc-96a3-8857c2bf3f5a" xlink:to="loc_us-gaap_OtherNonoperatingGainsLosses_2fadbf0b-9192-4020-8209-08a0ea4034f8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofOperationsandComprehensiveLossDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofOperationsandComprehensiveLossDetails"/>
  <link:calculationLink xlink:role="http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofOperationsandComprehensiveLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_713fb07d-3edd-4d19-8183-2679f17f5fbf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_0e08c838-c7b3-4b9e-8064-627bc41e9273" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_713fb07d-3edd-4d19-8183-2679f17f5fbf" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_0e08c838-c7b3-4b9e-8064-627bc41e9273" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_13bdfe13-6b0b-44cd-a37a-15648aa89776" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_713fb07d-3edd-4d19-8183-2679f17f5fbf" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_13bdfe13-6b0b-44cd-a37a-15648aa89776" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c2f8ee53-8142-4a42-9908-89ebbbcf87a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_f92264f0-c6f3-4d79-a4ee-c5713c6b032b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_c2f8ee53-8142-4a42-9908-89ebbbcf87a0" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_f92264f0-c6f3-4d79-a4ee-c5713c6b032b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_IncomeLossFromEquityMethodInvestmentsNetOfTax_bf9c045d-385f-437e-a3dd-a92bfa7080ca" xlink:href="zlab-20231231.xsd#zlab_IncomeLossFromEquityMethodInvestmentsNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_c2f8ee53-8142-4a42-9908-89ebbbcf87a0" xlink:to="loc_zlab_IncomeLossFromEquityMethodInvestmentsNetOfTax_bf9c045d-385f-437e-a3dd-a92bfa7080ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_3208efb1-7a55-4ddd-aa96-fbe87b0e423f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_c2f8ee53-8142-4a42-9908-89ebbbcf87a0" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_3208efb1-7a55-4ddd-aa96-fbe87b0e423f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"/>
  <link:calculationLink xlink:role="http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e8ed4e6b-2b7b-4892-be84-b451035f3adc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_fc31e67e-d806-42b0-b7a6-9ea8852da58f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e8ed4e6b-2b7b-4892-be84-b451035f3adc" xlink:to="loc_us-gaap_NetIncomeLoss_fc31e67e-d806-42b0-b7a6-9ea8852da58f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_AmortizationOfDeferredIncome_66aa7e5b-f923-4be9-bbb1-bf9912088c23" xlink:href="zlab-20231231.xsd#zlab_AmortizationOfDeferredIncome"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e8ed4e6b-2b7b-4892-be84-b451035f3adc" xlink:to="loc_zlab_AmortizationOfDeferredIncome_66aa7e5b-f923-4be9-bbb1-bf9912088c23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_4d1bd786-8e49-4cf4-9727-297eec588c0b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e8ed4e6b-2b7b-4892-be84-b451035f3adc" xlink:to="loc_us-gaap_ShareBasedCompensation_4d1bd786-8e49-4cf4-9727-297eec588c0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_IncomeLossFromEquityMethodInvestmentsNetOfTax_f07c21b8-b0dc-44a9-bb28-a8184dc7e02d" xlink:href="zlab-20231231.xsd#zlab_IncomeLossFromEquityMethodInvestmentsNetOfTax"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e8ed4e6b-2b7b-4892-be84-b451035f3adc" xlink:to="loc_zlab_IncomeLossFromEquityMethodInvestmentsNetOfTax_f07c21b8-b0dc-44a9-bb28-a8184dc7e02d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_b8cc498a-6bd0-4759-b787-973c96a57813" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e8ed4e6b-2b7b-4892-be84-b451035f3adc" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_b8cc498a-6bd0-4759-b787-973c96a57813" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_fe799937-c4ea-47c6-87db-36023ebbb3a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e8ed4e6b-2b7b-4892-be84-b451035f3adc" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_fe799937-c4ea-47c6-87db-36023ebbb3a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_9da50cb1-2a8c-4b09-8529-8a08ac2004ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e8ed4e6b-2b7b-4892-be84-b451035f3adc" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_9da50cb1-2a8c-4b09-8529-8a08ac2004ff" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>14
<FILENAME>zlab-20231231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:8edfc3fc-8768-4ea6-b2a3-bb613cc9a367,g:14e43acd-1532-4842-be1c-6094bb39150d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://zailab.com/role/CoverPage" xlink:type="simple" xlink:href="zlab-20231231.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://zailab.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_a14886a1-e2f8-499a-8766-50e4774f0d10" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_DocumentInformationTable_a14886a1-e2f8-499a-8766-50e4774f0d10" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_b34e7b70-bfeb-45d7-9ee8-6b38a0b000f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_a14886a1-e2f8-499a-8766-50e4774f0d10" xlink:to="loc_us-gaap_StatementClassOfStockAxis_b34e7b70-bfeb-45d7-9ee8-6b38a0b000f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_b34e7b70-bfeb-45d7-9ee8-6b38a0b000f9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b34e7b70-bfeb-45d7-9ee8-6b38a0b000f9" xlink:to="loc_us-gaap_ClassOfStockDomain_b34e7b70-bfeb-45d7-9ee8-6b38a0b000f9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_c6566e48-2ce9-404b-806d-a0756616ffc8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b34e7b70-bfeb-45d7-9ee8-6b38a0b000f9" xlink:to="loc_us-gaap_ClassOfStockDomain_c6566e48-2ce9-404b-806d-a0756616ffc8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AdrMember_bdcfe42f-1a68-4ae4-a102-1180e29f2894" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AdrMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_c6566e48-2ce9-404b-806d-a0756616ffc8" xlink:to="loc_dei_AdrMember_bdcfe42f-1a68-4ae4-a102-1180e29f2894" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_b30e1b2f-ad69-4b5b-a2c3-aa0cea28d739" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_c6566e48-2ce9-404b-806d-a0756616ffc8" xlink:to="loc_us-gaap_CommonStockMember_b30e1b2f-ad69-4b5b-a2c3-aa0cea28d739" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_8f2ed626-c2be-4c3b-8d57-0de0db7ce81c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_DocumentType_8f2ed626-c2be-4c3b-8d57-0de0db7ce81c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_24e7db3c-f181-4dbd-a9d3-c2b2100303c7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_DocumentAnnualReport_24e7db3c-f181-4dbd-a9d3-c2b2100303c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_8cd66df3-e7d1-4e1c-a78f-33ec958548aa" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_DocumentPeriodEndDate_8cd66df3-e7d1-4e1c-a78f-33ec958548aa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_c384f0a9-5e8a-4a9c-9eb9-ce24e32b39c8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_CurrentFiscalYearEndDate_c384f0a9-5e8a-4a9c-9eb9-ce24e32b39c8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_19b2a8fd-e57c-44aa-8502-bb3340bb0537" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_DocumentTransitionReport_19b2a8fd-e57c-44aa-8502-bb3340bb0537" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_926803e5-a609-4fb2-ae6f-b260b1986ea1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_EntityFileNumber_926803e5-a609-4fb2-ae6f-b260b1986ea1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_ab76430b-eba1-4048-8e12-8c4966807321" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_EntityRegistrantName_ab76430b-eba1-4048-8e12-8c4966807321" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_54eee8d3-968b-40ef-8f03-d13e9e097477" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_EntityIncorporationStateCountryCode_54eee8d3-968b-40ef-8f03-d13e9e097477" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_25b001c2-0eec-44c1-987a-8982028942ae" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_EntityTaxIdentificationNumber_25b001c2-0eec-44c1-987a-8982028942ae" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_2fcad205-05ff-4689-8721-cc031316ff50" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_EntityAddressAddressLine1_2fcad205-05ff-4689-8721-cc031316ff50" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_cdfae5f6-3b99-4da1-bd35-490ee548d1b8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_EntityAddressAddressLine2_cdfae5f6-3b99-4da1-bd35-490ee548d1b8" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_3b4bceb2-e2b3-4baa-a14e-c087880b70b7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_EntityAddressCityOrTown_3b4bceb2-e2b3-4baa-a14e-c087880b70b7" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry_a66187c4-2bbf-44e0-a0d3-92f1ccfe41c8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_EntityAddressCountry_a66187c4-2bbf-44e0-a0d3-92f1ccfe41c8" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_7b932fa4-06c5-4ae9-8101-3587af431c87" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_EntityAddressPostalZipCode_7b932fa4-06c5-4ae9-8101-3587af431c87" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_961a5d79-b8d5-4e7b-ace7-e2fa58560739" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_CityAreaCode_961a5d79-b8d5-4e7b-ace7-e2fa58560739" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_fa733fe1-fa07-4eb8-9935-7edf5a2c703a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_LocalPhoneNumber_fa733fe1-fa07-4eb8-9935-7edf5a2c703a" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_ab955c16-cde2-4438-87f1-9907d9e70cfa" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_Security12bTitle_ab955c16-cde2-4438-87f1-9907d9e70cfa" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_b163d33c-f647-4c9f-a959-06b2b7790cbc" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_TradingSymbol_b163d33c-f647-4c9f-a959-06b2b7790cbc" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_c243d043-f976-451a-89f8-2cd4a4183756" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_SecurityExchangeName_c243d043-f976-451a-89f8-2cd4a4183756" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_199f91ce-d253-4430-a8fd-64799ffb2027" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_199f91ce-d253-4430-a8fd-64799ffb2027" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_09840b20-ef90-4314-b44b-323e61587445" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_EntityVoluntaryFilers_09840b20-ef90-4314-b44b-323e61587445" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_bdb33488-9338-43ed-be68-f03f2cdaca9a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_EntityCurrentReportingStatus_bdb33488-9338-43ed-be68-f03f2cdaca9a" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_77e1aebb-be38-486c-ba54-b24c9610f2c7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_EntityInteractiveDataCurrent_77e1aebb-be38-486c-ba54-b24c9610f2c7" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_e05fc9bc-9f6a-42d5-8081-0c80b72f835d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_EntityFilerCategory_e05fc9bc-9f6a-42d5-8081-0c80b72f835d" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_e752a450-4936-491d-95bd-3a7af027dfaa" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_EntitySmallBusiness_e752a450-4936-491d-95bd-3a7af027dfaa" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_0e65d92a-fe72-4dc2-b654-739bdce77a50" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_EntityEmergingGrowthCompany_0e65d92a-fe72-4dc2-b654-739bdce77a50" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_e5e19497-d4fd-4c85-8a7a-52d54094186d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_IcfrAuditorAttestationFlag_e5e19497-d4fd-4c85-8a7a-52d54094186d" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag_8253bb4d-c3f3-41d9-b579-7f076a45ccf3" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_DocumentFinStmtErrorCorrectionFlag_8253bb4d-c3f3-41d9-b579-7f076a45ccf3" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_c750f0bb-316d-4922-ba8f-62a883b09dde" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_EntityShellCompany_c750f0bb-316d-4922-ba8f-62a883b09dde" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_7b0210e4-0062-464f-b5d6-1ea69f7e350c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_EntityPublicFloat_7b0210e4-0062-464f-b5d6-1ea69f7e350c" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_9578415a-c5dc-4602-9a92-f5dfa9e47c44" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_9578415a-c5dc-4602-9a92-f5dfa9e47c44" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_159fe702-8ec2-4e56-a23d-902ebe34d5eb" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_159fe702-8ec2-4e56-a23d-902ebe34d5eb" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_3ed9ae00-ce3d-472d-a163-2edd7c9c910f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_AmendmentFlag_3ed9ae00-ce3d-472d-a163-2edd7c9c910f" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_0e3ddc84-eb2e-492e-8dd2-7a7e8f4df104" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_DocumentFiscalPeriodFocus_0e3ddc84-eb2e-492e-8dd2-7a7e8f4df104" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_5ff11f66-054a-400c-845d-e4e1d623040d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_EntityCentralIndexKey_5ff11f66-054a-400c-845d-e4e1d623040d" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_974e60f0-dfd8-48c2-a3f2-1bc09f0f5a17" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_DocumentFiscalYearFocus_974e60f0-dfd8-48c2-a3f2-1bc09f0f5a17" xlink:type="arc" order="35"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://zailab.com/role/ConsolidatedStatementsofShareholdersEquity" xlink:type="simple" xlink:href="zlab-20231231.xsd#ConsolidatedStatementsofShareholdersEquity"/>
  <link:definitionLink xlink:role="http://zailab.com/role/ConsolidatedStatementsofShareholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_16105645-56e7-43ad-9f4b-8cf775ce90b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_db2c58f0-fc6e-4622-84b4-53f2624013d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_16105645-56e7-43ad-9f4b-8cf775ce90b3" xlink:to="loc_us-gaap_StatementTable_db2c58f0-fc6e-4622-84b4-53f2624013d4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_4b2ab51f-ea0f-4c0f-acd5-7b7fe30c381d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_db2c58f0-fc6e-4622-84b4-53f2624013d4" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_4b2ab51f-ea0f-4c0f-acd5-7b7fe30c381d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_4b2ab51f-ea0f-4c0f-acd5-7b7fe30c381d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4b2ab51f-ea0f-4c0f-acd5-7b7fe30c381d" xlink:to="loc_us-gaap_EquityComponentDomain_4b2ab51f-ea0f-4c0f-acd5-7b7fe30c381d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_dc353353-8ed4-4cf2-8b4c-f39eae496402" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4b2ab51f-ea0f-4c0f-acd5-7b7fe30c381d" xlink:to="loc_us-gaap_EquityComponentDomain_dc353353-8ed4-4cf2-8b4c-f39eae496402" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_b88096a6-2ca1-4ec0-a279-334ec4c41423" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_dc353353-8ed4-4cf2-8b4c-f39eae496402" xlink:to="loc_us-gaap_CommonStockMember_b88096a6-2ca1-4ec0-a279-334ec4c41423" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_52b6f298-4a35-43ff-8d66-09b4c466ad14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_dc353353-8ed4-4cf2-8b4c-f39eae496402" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_52b6f298-4a35-43ff-8d66-09b4c466ad14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_d4249b0e-bf4c-42a5-94c0-cebbcd88ab31" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_dc353353-8ed4-4cf2-8b4c-f39eae496402" xlink:to="loc_us-gaap_RetainedEarningsMember_d4249b0e-bf4c-42a5-94c0-cebbcd88ab31" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ba53a0b7-99e0-4819-91f2-f74332908271" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_dc353353-8ed4-4cf2-8b4c-f39eae496402" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ba53a0b7-99e0-4819-91f2-f74332908271" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_9531e5a6-6962-4444-b0fe-11f04c56f51c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_dc353353-8ed4-4cf2-8b4c-f39eae496402" xlink:to="loc_us-gaap_TreasuryStockCommonMember_9531e5a6-6962-4444-b0fe-11f04c56f51c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5594e4fe-e5d8-4c1f-a26a-e98cad24b2d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_16105645-56e7-43ad-9f4b-8cf775ce90b3" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5594e4fe-e5d8-4c1f-a26a-e98cad24b2d9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_1e60903a-66c0-4bea-8b4f-3c452a3c8f39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5594e4fe-e5d8-4c1f-a26a-e98cad24b2d9" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_1e60903a-66c0-4bea-8b4f-3c452a3c8f39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_766eb4b6-ae64-496c-8d08-2331dc641ae7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5594e4fe-e5d8-4c1f-a26a-e98cad24b2d9" xlink:to="loc_us-gaap_StockholdersEquity_766eb4b6-ae64-496c-8d08-2331dc641ae7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_06db7e01-6452-44ad-9644-1d14fc12ac23" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5594e4fe-e5d8-4c1f-a26a-e98cad24b2d9" xlink:to="loc_us-gaap_TreasuryStockCommonShares_06db7e01-6452-44ad-9644-1d14fc12ac23" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_9099edca-cf83-4ed3-b472-c4fc812aa501" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5594e4fe-e5d8-4c1f-a26a-e98cad24b2d9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_9099edca-cf83-4ed3-b472-c4fc812aa501" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_0c7aba5b-d64d-4194-abcb-517ea6e35392" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5594e4fe-e5d8-4c1f-a26a-e98cad24b2d9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_0c7aba5b-d64d-4194-abcb-517ea6e35392" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_9dc492bf-1f14-4ead-be67-c0970e46cf88" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5594e4fe-e5d8-4c1f-a26a-e98cad24b2d9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_9dc492bf-1f14-4ead-be67-c0970e46cf88" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_fcf24750-d1b4-4900-8adc-572b445aca3a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5594e4fe-e5d8-4c1f-a26a-e98cad24b2d9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_fcf24750-d1b4-4900-8adc-572b445aca3a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_118fd97d-0f4a-4a24-8b00-130fcd2f27d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5594e4fe-e5d8-4c1f-a26a-e98cad24b2d9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_118fd97d-0f4a-4a24-8b00-130fcd2f27d4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_7bef9555-8236-4900-8af9-cf36eac64922" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5594e4fe-e5d8-4c1f-a26a-e98cad24b2d9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_7bef9555-8236-4900-8af9-cf36eac64922" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesOther_168f0833-b8cf-4264-9ff7-159cc5fb4ba5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5594e4fe-e5d8-4c1f-a26a-e98cad24b2d9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesOther_168f0833-b8cf-4264-9ff7-159cc5fb4ba5" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueOther_8400d055-aaf5-483f-9185-896a9f7c3138" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5594e4fe-e5d8-4c1f-a26a-e98cad24b2d9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueOther_8400d055-aaf5-483f-9185-896a9f7c3138" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_IssuanceCostAdjustment_fb2d8f8c-9bc1-4b4c-925c-e5a89f476321" xlink:href="zlab-20231231.xsd#zlab_IssuanceCostAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5594e4fe-e5d8-4c1f-a26a-e98cad24b2d9" xlink:to="loc_zlab_IssuanceCostAdjustment_fb2d8f8c-9bc1-4b4c-925c-e5a89f476321" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_69098728-8f01-4d09-a047-d9e818205edc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5594e4fe-e5d8-4c1f-a26a-e98cad24b2d9" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_69098728-8f01-4d09-a047-d9e818205edc" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_bc8e7022-4658-42bf-b5f7-7ec38ca2ee0c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5594e4fe-e5d8-4c1f-a26a-e98cad24b2d9" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_bc8e7022-4658-42bf-b5f7-7ec38ca2ee0c" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_767c4e44-9b3b-4485-9de1-2e242098e3c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5594e4fe-e5d8-4c1f-a26a-e98cad24b2d9" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_767c4e44-9b3b-4485-9de1-2e242098e3c9" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3e4781cc-b5b0-47d2-a12f-d3ee2a81d726" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5594e4fe-e5d8-4c1f-a26a-e98cad24b2d9" xlink:to="loc_us-gaap_NetIncomeLoss_3e4781cc-b5b0-47d2-a12f-d3ee2a81d726" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_23ce4ba2-f962-4313-bb46-88818dafa145" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5594e4fe-e5d8-4c1f-a26a-e98cad24b2d9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_23ce4ba2-f962-4313-bb46-88818dafa145" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_ddfd52b9-2f1d-494c-8469-9c06388c8962" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_55eb7387-8958-4d73-b77f-86aaf0011908" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_88bb07b6-2740-4e28-8f8d-418a2d05e69e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://zailab.com/role/OrganizationandPrincipalActivitiesDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#OrganizationandPrincipalActivitiesDetails"/>
  <link:definitionLink xlink:role="http://zailab.com/role/OrganizationandPrincipalActivitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems_0916063f-56d1-42a3-93ea-1f8ac0eaa64b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipTable_175f6cf0-5057-4e74-81d4-f717dec60835" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems_0916063f-56d1-42a3-93ea-1f8ac0eaa64b" xlink:to="loc_us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipTable_175f6cf0-5057-4e74-81d4-f717dec60835" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_7b9fbed8-9aca-4edd-a367-1d77d118f857" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipTable_175f6cf0-5057-4e74-81d4-f717dec60835" xlink:to="loc_srt_OwnershipAxis_7b9fbed8-9aca-4edd-a367-1d77d118f857" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_7b9fbed8-9aca-4edd-a367-1d77d118f857_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_7b9fbed8-9aca-4edd-a367-1d77d118f857" xlink:to="loc_srt_OwnershipDomain_7b9fbed8-9aca-4edd-a367-1d77d118f857_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_6147aa3a-8235-44c7-8570-cb74269b07ca" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_7b9fbed8-9aca-4edd-a367-1d77d118f857" xlink:to="loc_srt_OwnershipDomain_6147aa3a-8235-44c7-8570-cb74269b07ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ZaiLabHongKongLimitedMember_e1a14650-97ae-48ad-af7f-853eec164292" xlink:href="zlab-20231231.xsd#zlab_ZaiLabHongKongLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_6147aa3a-8235-44c7-8570-cb74269b07ca" xlink:to="loc_zlab_ZaiLabHongKongLimitedMember_e1a14650-97ae-48ad-af7f-853eec164292" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ZaiLabShanghaiCompanyLimitedMember_157b2c9f-f588-492c-bbd4-14edf306bbab" xlink:href="zlab-20231231.xsd#zlab_ZaiLabShanghaiCompanyLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_6147aa3a-8235-44c7-8570-cb74269b07ca" xlink:to="loc_zlab_ZaiLabShanghaiCompanyLimitedMember_157b2c9f-f588-492c-bbd4-14edf306bbab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ZaiLabAUSTPtyLtdMember_0e7ae682-055a-4ace-bcda-1963f2e344e6" xlink:href="zlab-20231231.xsd#zlab_ZaiLabAUSTPtyLtdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_6147aa3a-8235-44c7-8570-cb74269b07ca" xlink:to="loc_zlab_ZaiLabAUSTPtyLtdMember_0e7ae682-055a-4ace-bcda-1963f2e344e6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ZaiLabSuzhouCompanyLimitedMember_9d0385d4-0a61-4a8a-95e1-1f3e57fa63ee" xlink:href="zlab-20231231.xsd#zlab_ZaiLabSuzhouCompanyLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_6147aa3a-8235-44c7-8570-cb74269b07ca" xlink:to="loc_zlab_ZaiLabSuzhouCompanyLimitedMember_9d0385d4-0a61-4a8a-95e1-1f3e57fa63ee" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ZaiBiopharmaceuticalSuzhouCompanyLimitedMember_ca5f61de-fbf5-4268-90de-cbe2697d0cc8" xlink:href="zlab-20231231.xsd#zlab_ZaiBiopharmaceuticalSuzhouCompanyLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_6147aa3a-8235-44c7-8570-cb74269b07ca" xlink:to="loc_zlab_ZaiBiopharmaceuticalSuzhouCompanyLimitedMember_ca5f61de-fbf5-4268-90de-cbe2697d0cc8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ZaiLabUSLLCMember_5f7d7567-e2d4-4765-980b-752edffc8d40" xlink:href="zlab-20231231.xsd#zlab_ZaiLabUSLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_6147aa3a-8235-44c7-8570-cb74269b07ca" xlink:to="loc_zlab_ZaiLabUSLLCMember_5f7d7567-e2d4-4765-980b-752edffc8d40" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ZaiLabInternationalTradingShanghaiCompanyLimitedMember_a3db5b58-179b-4073-bb37-77a70741c3e3" xlink:href="zlab-20231231.xsd#zlab_ZaiLabInternationalTradingShanghaiCompanyLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_6147aa3a-8235-44c7-8570-cb74269b07ca" xlink:to="loc_zlab_ZaiLabInternationalTradingShanghaiCompanyLimitedMember_a3db5b58-179b-4073-bb37-77a70741c3e3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ZaiAutoImmuneHongKongLimitedMember_3988bb8a-0ab8-40bf-990b-dbeaa4993674" xlink:href="zlab-20231231.xsd#zlab_ZaiAutoImmuneHongKongLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_6147aa3a-8235-44c7-8570-cb74269b07ca" xlink:to="loc_zlab_ZaiAutoImmuneHongKongLimitedMember_3988bb8a-0ab8-40bf-990b-dbeaa4993674" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ZaiLabTaiwanLimitedMember_c7f7a5b8-7a43-43ef-993a-3601dcd7636a" xlink:href="zlab-20231231.xsd#zlab_ZaiLabTaiwanLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_6147aa3a-8235-44c7-8570-cb74269b07ca" xlink:to="loc_zlab_ZaiLabTaiwanLimitedMember_c7f7a5b8-7a43-43ef-993a-3601dcd7636a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ZaiLabTradingSuzhouCoLtdMember_6b5dc826-1faa-49f0-b510-2f8948ccc564" xlink:href="zlab-20231231.xsd#zlab_ZaiLabTradingSuzhouCoLtdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_6147aa3a-8235-44c7-8570-cb74269b07ca" xlink:to="loc_zlab_ZaiLabTradingSuzhouCoLtdMember_6b5dc826-1faa-49f0-b510-2f8948ccc564" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest_bbaf83b1-6470-4a7b-bf9f-5235969c0fe2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems_0916063f-56d1-42a3-93ea-1f8ac0eaa64b" xlink:to="loc_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest_bbaf83b1-6470-4a7b-bf9f-5235969c0fe2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_zlab_SignificantAccountingPoliciesLineItems_546bc3d2-1751-4473-a4df-a3016e6768cc" xlink:href="zlab-20231231.xsd#zlab_SignificantAccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_SignificantAccountingPoliciesTable_261c5c9e-2223-4d8e-96c5-a49fa5a1457e" xlink:href="zlab-20231231.xsd#zlab_SignificantAccountingPoliciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_zlab_SignificantAccountingPoliciesLineItems_546bc3d2-1751-4473-a4df-a3016e6768cc" xlink:to="loc_zlab_SignificantAccountingPoliciesTable_261c5c9e-2223-4d8e-96c5-a49fa5a1457e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f80b162e-3e2e-4bed-b357-8fc4f906a12e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_zlab_SignificantAccountingPoliciesTable_261c5c9e-2223-4d8e-96c5-a49fa5a1457e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f80b162e-3e2e-4bed-b357-8fc4f906a12e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f80b162e-3e2e-4bed-b357-8fc4f906a12e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f80b162e-3e2e-4bed-b357-8fc4f906a12e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f80b162e-3e2e-4bed-b357-8fc4f906a12e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ed35336a-25f5-4a91-b91b-e68446f6a7fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f80b162e-3e2e-4bed-b357-8fc4f906a12e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ed35336a-25f5-4a91-b91b-e68446f6a7fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_b75e1df2-5e31-438b-a421-be7df9d80ba7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ed35336a-25f5-4a91-b91b-e68446f6a7fc" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_b75e1df2-5e31-438b-a421-be7df9d80ba7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_CapitalizedSalesBasedMilestoneFeesMember_f09852a7-297a-4a42-b765-c050f8ae5e6d" xlink:href="zlab-20231231.xsd#zlab_CapitalizedSalesBasedMilestoneFeesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ed35336a-25f5-4a91-b91b-e68446f6a7fc" xlink:to="loc_zlab_CapitalizedSalesBasedMilestoneFeesMember_f09852a7-297a-4a42-b765-c050f8ae5e6d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_33c11646-3d2e-4dd3-a83c-1aebfaa69e8e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_zlab_SignificantAccountingPoliciesTable_261c5c9e-2223-4d8e-96c5-a49fa5a1457e" xlink:to="loc_srt_RangeAxis_33c11646-3d2e-4dd3-a83c-1aebfaa69e8e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_33c11646-3d2e-4dd3-a83c-1aebfaa69e8e_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_33c11646-3d2e-4dd3-a83c-1aebfaa69e8e" xlink:to="loc_srt_RangeMember_33c11646-3d2e-4dd3-a83c-1aebfaa69e8e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c9116f77-6ad2-4e4f-9eab-85847f41b9c6" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_33c11646-3d2e-4dd3-a83c-1aebfaa69e8e" xlink:to="loc_srt_RangeMember_c9116f77-6ad2-4e4f-9eab-85847f41b9c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_290e30ca-0780-47f4-98d5-2ab645deca08" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c9116f77-6ad2-4e4f-9eab-85847f41b9c6" xlink:to="loc_srt_MinimumMember_290e30ca-0780-47f4-98d5-2ab645deca08" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_1b1c2e87-0054-4200-b9a5-d24ad2b1e2fa" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c9116f77-6ad2-4e4f-9eab-85847f41b9c6" xlink:to="loc_srt_MaximumMember_1b1c2e87-0054-4200-b9a5-d24ad2b1e2fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_696685f4-215e-483c-9cd2-664659ba5f43" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_zlab_SignificantAccountingPoliciesTable_261c5c9e-2223-4d8e-96c5-a49fa5a1457e" xlink:to="loc_srt_CounterpartyNameAxis_696685f4-215e-483c-9cd2-664659ba5f43" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_696685f4-215e-483c-9cd2-664659ba5f43_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_696685f4-215e-483c-9cd2-664659ba5f43" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_696685f4-215e-483c-9cd2-664659ba5f43_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6450ff46-f890-4e93-ab70-b328aee07171" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_696685f4-215e-483c-9cd2-664659ba5f43" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6450ff46-f890-4e93-ab70-b328aee07171" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_HuizhengMember_a5613cd3-9b67-4c39-a56e-e622fe4b7264" xlink:href="zlab-20231231.xsd#zlab_HuizhengMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6450ff46-f890-4e93-ab70-b328aee07171" xlink:to="loc_zlab_HuizhengMember_a5613cd3-9b67-4c39-a56e-e622fe4b7264" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_a53866ab-c6f1-4e28-91e7-86350aa83785" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_zlab_SignificantAccountingPoliciesTable_261c5c9e-2223-4d8e-96c5-a49fa5a1457e" xlink:to="loc_srt_ProductOrServiceAxis_a53866ab-c6f1-4e28-91e7-86350aa83785" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a53866ab-c6f1-4e28-91e7-86350aa83785_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_a53866ab-c6f1-4e28-91e7-86350aa83785" xlink:to="loc_srt_ProductsAndServicesDomain_a53866ab-c6f1-4e28-91e7-86350aa83785_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_7a372a2a-99be-43ff-8651-5a865e2ecb8f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_a53866ab-c6f1-4e28-91e7-86350aa83785" xlink:to="loc_srt_ProductsAndServicesDomain_7a372a2a-99be-43ff-8651-5a865e2ecb8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrantMember_6d870a54-7509-42aa-9ac4-a95b25fd9b76" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_7a372a2a-99be-43ff-8651-5a865e2ecb8f" xlink:to="loc_us-gaap_GrantMember_6d870a54-7509-42aa-9ac4-a95b25fd9b76" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_CollaborativeAgreementMember_63df887e-54fc-4bc8-8da7-f54bd7f6c364" xlink:href="zlab-20231231.xsd#zlab_CollaborativeAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_7a372a2a-99be-43ff-8651-5a865e2ecb8f" xlink:to="loc_zlab_CollaborativeAgreementMember_63df887e-54fc-4bc8-8da7-f54bd7f6c364" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2f06860e-8498-4ea5-89ff-cfda3204fb4d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_zlab_SignificantAccountingPoliciesTable_261c5c9e-2223-4d8e-96c5-a49fa5a1457e" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2f06860e-8498-4ea5-89ff-cfda3204fb4d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2f06860e-8498-4ea5-89ff-cfda3204fb4d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2f06860e-8498-4ea5-89ff-cfda3204fb4d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2f06860e-8498-4ea5-89ff-cfda3204fb4d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5f3eab59-301b-47c3-bb23-b3b41ff8cf3b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2f06860e-8498-4ea5-89ff-cfda3204fb4d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5f3eab59-301b-47c3-bb23-b3b41ff8cf3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_c01d51a4-99f0-4c91-935e-b3db1c3d50ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5f3eab59-301b-47c3-bb23-b3b41ff8cf3b" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_c01d51a4-99f0-4c91-935e-b3db1c3d50ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_1cf8dd8b-84ad-46c3-aa62-da30da4df8bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_zlab_SignificantAccountingPoliciesTable_261c5c9e-2223-4d8e-96c5-a49fa5a1457e" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_1cf8dd8b-84ad-46c3-aa62-da30da4df8bf" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_1cf8dd8b-84ad-46c3-aa62-da30da4df8bf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_1cf8dd8b-84ad-46c3-aa62-da30da4df8bf" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_1cf8dd8b-84ad-46c3-aa62-da30da4df8bf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_2de6dd41-2ed1-4aa3-be23-0abfb64b55d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_1cf8dd8b-84ad-46c3-aa62-da30da4df8bf" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_2de6dd41-2ed1-4aa3-be23-0abfb64b55d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_68ce1e64-3869-403f-b956-17b48bc958a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_2de6dd41-2ed1-4aa3-be23-0abfb64b55d9" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_68ce1e64-3869-403f-b956-17b48bc958a7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LenderConcentrationRiskMember_3c7643c0-628d-4c06-b406-9124ef4be219" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LenderConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_2de6dd41-2ed1-4aa3-be23-0abfb64b55d9" xlink:to="loc_us-gaap_LenderConcentrationRiskMember_3c7643c0-628d-4c06-b406-9124ef4be219" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ForeignCurrencyRiskMember_eabbec0f-e971-4543-96fe-788189b5a927" xlink:href="zlab-20231231.xsd#zlab_ForeignCurrencyRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_2de6dd41-2ed1-4aa3-be23-0abfb64b55d9" xlink:to="loc_zlab_ForeignCurrencyRiskMember_eabbec0f-e971-4543-96fe-788189b5a927" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_504abf3c-2ab2-48c7-8dc4-db37ee140343" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_zlab_SignificantAccountingPoliciesTable_261c5c9e-2223-4d8e-96c5-a49fa5a1457e" xlink:to="loc_srt_MajorCustomersAxis_504abf3c-2ab2-48c7-8dc4-db37ee140343" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_504abf3c-2ab2-48c7-8dc4-db37ee140343_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_504abf3c-2ab2-48c7-8dc4-db37ee140343" xlink:to="loc_srt_NameOfMajorCustomerDomain_504abf3c-2ab2-48c7-8dc4-db37ee140343_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_ad6d372d-8191-4eda-b531-4e5c1286c132" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_504abf3c-2ab2-48c7-8dc4-db37ee140343" xlink:to="loc_srt_NameOfMajorCustomerDomain_ad6d372d-8191-4eda-b531-4e5c1286c132" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_OneCustomerMember_0c5b63a9-c851-48f9-ad4a-c104d6d5d9e7" xlink:href="zlab-20231231.xsd#zlab_OneCustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_ad6d372d-8191-4eda-b531-4e5c1286c132" xlink:to="loc_zlab_OneCustomerMember_0c5b63a9-c851-48f9-ad4a-c104d6d5d9e7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_0aa11f30-ef0e-47dc-bd98-5d0637416145" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_zlab_SignificantAccountingPoliciesTable_261c5c9e-2223-4d8e-96c5-a49fa5a1457e" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_0aa11f30-ef0e-47dc-bd98-5d0637416145" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_0aa11f30-ef0e-47dc-bd98-5d0637416145_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_0aa11f30-ef0e-47dc-bd98-5d0637416145" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_0aa11f30-ef0e-47dc-bd98-5d0637416145_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_45e9d8cf-15ae-4c5b-8374-f3093dae199a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_0aa11f30-ef0e-47dc-bd98-5d0637416145" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_45e9d8cf-15ae-4c5b-8374-f3093dae199a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_d80f1773-7956-49d6-8991-1ef90c339a8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_45e9d8cf-15ae-4c5b-8374-f3093dae199a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_d80f1773-7956-49d6-8991-1ef90c339a8c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_9b626f2f-cacd-44e0-b549-6a3a908c3a27" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_45e9d8cf-15ae-4c5b-8374-f3093dae199a" xlink:to="loc_us-gaap_AccountsReceivableMember_9b626f2f-cacd-44e0-b549-6a3a908c3a27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_CashAndCashEquivalentMember_fa36c68d-ec7a-4693-8b66-2410c2bb2598" xlink:href="zlab-20231231.xsd#zlab_CashAndCashEquivalentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_45e9d8cf-15ae-4c5b-8374-f3093dae199a" xlink:to="loc_zlab_CashAndCashEquivalentMember_fa36c68d-ec7a-4693-8b66-2410c2bb2598" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_93609a17-6618-49ec-8cd3-8196517e7b52" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CurrencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_zlab_SignificantAccountingPoliciesTable_261c5c9e-2223-4d8e-96c5-a49fa5a1457e" xlink:to="loc_srt_CurrencyAxis_93609a17-6618-49ec-8cd3-8196517e7b52" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_93609a17-6618-49ec-8cd3-8196517e7b52_default" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_93609a17-6618-49ec-8cd3-8196517e7b52" xlink:to="loc_currency_AllCurrenciesDomain_93609a17-6618-49ec-8cd3-8196517e7b52_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_35b48070-01de-422f-b992-ad0ae2a585c4" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_93609a17-6618-49ec-8cd3-8196517e7b52" xlink:to="loc_currency_AllCurrenciesDomain_35b48070-01de-422f-b992-ad0ae2a585c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CNY_007fe4e9-fc45-4ef0-91bb-2bc081b6d40b" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_CNY"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_35b48070-01de-422f-b992-ad0ae2a585c4" xlink:to="loc_currency_CNY_007fe4e9-fc45-4ef0-91bb-2bc081b6d40b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_368c0ca3-1c40-4323-b6d5-e563565de358" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zlab_SignificantAccountingPoliciesLineItems_546bc3d2-1751-4473-a4df-a3016e6768cc" xlink:to="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_368c0ca3-1c40-4323-b6d5-e563565de358" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_CommonStockAuthorizedShareCapital_db79693a-9588-4dc0-bea5-1f806e8f4649" xlink:href="zlab-20231231.xsd#zlab_CommonStockAuthorizedShareCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zlab_SignificantAccountingPoliciesLineItems_546bc3d2-1751-4473-a4df-a3016e6768cc" xlink:to="loc_zlab_CommonStockAuthorizedShareCapital_db79693a-9588-4dc0-bea5-1f806e8f4649" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_06be48ed-3ca7-4ad6-8ec1-fdce11084149" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zlab_SignificantAccountingPoliciesLineItems_546bc3d2-1751-4473-a4df-a3016e6768cc" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_06be48ed-3ca7-4ad6-8ec1-fdce11084149" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_d158a46f-dcbb-42e0-8b54-d1811f665d7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zlab_SignificantAccountingPoliciesLineItems_546bc3d2-1751-4473-a4df-a3016e6768cc" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_d158a46f-dcbb-42e0-8b54-d1811f665d7a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_AmericanDepositaryShareToCommonStockConversionRatio_a80cf77d-0801-42a3-a789-aa936bad17a7" xlink:href="zlab-20231231.xsd#zlab_AmericanDepositaryShareToCommonStockConversionRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zlab_SignificantAccountingPoliciesLineItems_546bc3d2-1751-4473-a4df-a3016e6768cc" xlink:to="loc_zlab_AmericanDepositaryShareToCommonStockConversionRatio_a80cf77d-0801-42a3-a789-aa936bad17a7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestCurrent_240a2e88-06dd-4dc1-bab4-afa4f630e2fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zlab_SignificantAccountingPoliciesLineItems_546bc3d2-1751-4473-a4df-a3016e6768cc" xlink:to="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestCurrent_240a2e88-06dd-4dc1-bab4-afa4f630e2fb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_LandUseRightsLeaseTerm_e6d913ee-61fc-497c-8fe3-d4475e5d6381" xlink:href="zlab-20231231.xsd#zlab_LandUseRightsLeaseTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zlab_SignificantAccountingPoliciesLineItems_546bc3d2-1751-4473-a4df-a3016e6768cc" xlink:to="loc_zlab_LandUseRightsLeaseTerm_e6d913ee-61fc-497c-8fe3-d4475e5d6381" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_a46a25bf-2ac6-4aa8-b2cf-29324ab74f10" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zlab_SignificantAccountingPoliciesLineItems_546bc3d2-1751-4473-a4df-a3016e6768cc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_a46a25bf-2ac6-4aa8-b2cf-29324ab74f10" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_1dc2bbcc-a8bc-4c0e-a63a-4f2c257a33ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zlab_SignificantAccountingPoliciesLineItems_546bc3d2-1751-4473-a4df-a3016e6768cc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_1dc2bbcc-a8bc-4c0e-a63a-4f2c257a33ba" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_734e1c4b-45bf-4696-bd73-b4a6eb6334c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zlab_SignificantAccountingPoliciesLineItems_546bc3d2-1751-4473-a4df-a3016e6768cc" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_734e1c4b-45bf-4696-bd73-b4a6eb6334c5" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_f7caa328-ae41-4e6c-be11-2f16cfabf7f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zlab_SignificantAccountingPoliciesLineItems_546bc3d2-1751-4473-a4df-a3016e6768cc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_f7caa328-ae41-4e6c-be11-2f16cfabf7f5" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_f427e355-8de3-47e0-8c56-c1bbd39f1bff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zlab_SignificantAccountingPoliciesLineItems_546bc3d2-1751-4473-a4df-a3016e6768cc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_f427e355-8de3-47e0-8c56-c1bbd39f1bff" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_c554c51d-0e8c-4361-bb8c-b524477f305a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zlab_SignificantAccountingPoliciesLineItems_546bc3d2-1751-4473-a4df-a3016e6768cc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_c554c51d-0e8c-4361-bb8c-b524477f305a" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_fe74b0ac-3d9f-40f2-be34-a981c1de7e27" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zlab_SignificantAccountingPoliciesLineItems_546bc3d2-1751-4473-a4df-a3016e6768cc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_fe74b0ac-3d9f-40f2-be34-a981c1de7e27" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_d58cddb3-4700-4524-ba22-b8f6f0788045" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zlab_SignificantAccountingPoliciesLineItems_546bc3d2-1751-4473-a4df-a3016e6768cc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_d58cddb3-4700-4524-ba22-b8f6f0788045" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_f8fc7340-3ccf-4adb-95b6-35c1b3b5dcf9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zlab_SignificantAccountingPoliciesLineItems_546bc3d2-1751-4473-a4df-a3016e6768cc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_f8fc7340-3ccf-4adb-95b6-35c1b3b5dcf9" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_EquitySecuritiesWithReadilyDeterminableFairValueAmount_4ac8ef28-07e7-4086-9fa2-f3203ccb2b58" xlink:href="zlab-20231231.xsd#zlab_EquitySecuritiesWithReadilyDeterminableFairValueAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zlab_SignificantAccountingPoliciesLineItems_546bc3d2-1751-4473-a4df-a3016e6768cc" xlink:to="loc_zlab_EquitySecuritiesWithReadilyDeterminableFairValueAmount_4ac8ef28-07e7-4086-9fa2-f3203ccb2b58" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeNoncurrent_96f1d2bf-4af5-499c-8d10-dc24e5a61633" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zlab_SignificantAccountingPoliciesLineItems_546bc3d2-1751-4473-a4df-a3016e6768cc" xlink:to="loc_us-gaap_DeferredIncomeNoncurrent_96f1d2bf-4af5-499c-8d10-dc24e5a61633" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_CollaborativeArrangementRightsAndObligationsPaymentOfUpFrontFeesForLicenseAgreement_03ecaf6e-188b-43e3-9101-91468d9b3196" xlink:href="zlab-20231231.xsd#zlab_CollaborativeArrangementRightsAndObligationsPaymentOfUpFrontFeesForLicenseAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zlab_SignificantAccountingPoliciesLineItems_546bc3d2-1751-4473-a4df-a3016e6768cc" xlink:to="loc_zlab_CollaborativeArrangementRightsAndObligationsPaymentOfUpFrontFeesForLicenseAgreement_03ecaf6e-188b-43e3-9101-91468d9b3196" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_2df6b7bc-85db-43dd-8a19-aefde69418e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zlab_SignificantAccountingPoliciesLineItems_546bc3d2-1751-4473-a4df-a3016e6768cc" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_2df6b7bc-85db-43dd-8a19-aefde69418e9" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_435828a9-69ff-41c9-8ce9-9d30f68817b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zlab_SignificantAccountingPoliciesLineItems_546bc3d2-1751-4473-a4df-a3016e6768cc" xlink:to="loc_us-gaap_NumberOfOperatingSegments_435828a9-69ff-41c9-8ce9-9d30f68817b3" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_ed491490-ddf8-486d-88e7-d39f9bc16396" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zlab_SignificantAccountingPoliciesLineItems_546bc3d2-1751-4473-a4df-a3016e6768cc" xlink:to="loc_us-gaap_NumberOfReportableSegments_ed491490-ddf8-486d-88e7-d39f9bc16396" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3c934021-2f1e-4886-8660-e6d551de0107" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zlab_SignificantAccountingPoliciesLineItems_546bc3d2-1751-4473-a4df-a3016e6768cc" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3c934021-2f1e-4886-8660-e6d551de0107" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNet_ffd27e51-e402-499a-83aa-ec461ac992a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zlab_SignificantAccountingPoliciesLineItems_546bc3d2-1751-4473-a4df-a3016e6768cc" xlink:to="loc_us-gaap_AccountsReceivableNet_ffd27e51-e402-499a-83aa-ec461ac992a9" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_228c752c-560f-48fa-97e1-d3c40654a8ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zlab_SignificantAccountingPoliciesLineItems_546bc3d2-1751-4473-a4df-a3016e6768cc" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_228c752c-560f-48fa-97e1-d3c40654a8ab" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_5a3055a1-fda1-49fa-a02e-8ac9e70df674" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zlab_SignificantAccountingPoliciesLineItems_546bc3d2-1751-4473-a4df-a3016e6768cc" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_5a3055a1-fda1-49fa-a02e-8ac9e70df674" xlink:type="arc" order="25"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://zailab.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://zailab.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ad6df4a9-2f5f-4186-87be-4a4380f8a366" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_9052a571-319d-4438-81c2-de072c3c0507" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ad6df4a9-2f5f-4186-87be-4a4380f8a366" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_9052a571-319d-4438-81c2-de072c3c0507" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9e3711cd-12d8-489b-9272-92c101a44a7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_9052a571-319d-4438-81c2-de072c3c0507" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9e3711cd-12d8-489b-9272-92c101a44a7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9e3711cd-12d8-489b-9272-92c101a44a7f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9e3711cd-12d8-489b-9272-92c101a44a7f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9e3711cd-12d8-489b-9272-92c101a44a7f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b3637fee-fa2b-4ba8-9c62-ba2f9c947d40" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9e3711cd-12d8-489b-9272-92c101a44a7f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b3637fee-fa2b-4ba8-9c62-ba2f9c947d40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember_6816df50-6f33-4095-9bce-444b08aeddee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b3637fee-fa2b-4ba8-9c62-ba2f9c947d40" xlink:to="loc_us-gaap_OfficeEquipmentMember_6816df50-6f33-4095-9bce-444b08aeddee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ElectronicEquipmentMember_ed2197ae-76d3-4df4-bacc-f5b9419489f1" xlink:href="zlab-20231231.xsd#zlab_ElectronicEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b3637fee-fa2b-4ba8-9c62-ba2f9c947d40" xlink:to="loc_zlab_ElectronicEquipmentMember_ed2197ae-76d3-4df4-bacc-f5b9419489f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VehiclesMember_6c04a662-1a87-461a-8292-77effa98b84e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VehiclesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b3637fee-fa2b-4ba8-9c62-ba2f9c947d40" xlink:to="loc_us-gaap_VehiclesMember_6c04a662-1a87-461a-8292-77effa98b84e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_LaboratoryEquipmentMember_509497bf-a11b-4891-a655-7245ea8836e5" xlink:href="zlab-20231231.xsd#zlab_LaboratoryEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b3637fee-fa2b-4ba8-9c62-ba2f9c947d40" xlink:to="loc_zlab_LaboratoryEquipmentMember_509497bf-a11b-4891-a655-7245ea8836e5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManufacturingFacilityMember_d23d946e-4048-468a-a034-86a09f2e6ee3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ManufacturingFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b3637fee-fa2b-4ba8-9c62-ba2f9c947d40" xlink:to="loc_us-gaap_ManufacturingFacilityMember_d23d946e-4048-468a-a034-86a09f2e6ee3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_defb23d1-3fc9-4659-8891-978d39692e7f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_9052a571-319d-4438-81c2-de072c3c0507" xlink:to="loc_srt_RangeAxis_defb23d1-3fc9-4659-8891-978d39692e7f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_defb23d1-3fc9-4659-8891-978d39692e7f_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_defb23d1-3fc9-4659-8891-978d39692e7f" xlink:to="loc_srt_RangeMember_defb23d1-3fc9-4659-8891-978d39692e7f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_97e1d6cb-0b15-4ac7-a1b7-b507ed94fe39" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_defb23d1-3fc9-4659-8891-978d39692e7f" xlink:to="loc_srt_RangeMember_97e1d6cb-0b15-4ac7-a1b7-b507ed94fe39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d0632e93-6311-49c1-b124-0aaef55bf1e1" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_97e1d6cb-0b15-4ac7-a1b7-b507ed94fe39" xlink:to="loc_srt_MinimumMember_d0632e93-6311-49c1-b124-0aaef55bf1e1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3d50fb0a-b1a6-42ca-a2bb-89d3d102102e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_97e1d6cb-0b15-4ac7-a1b7-b507ed94fe39" xlink:to="loc_srt_MaximumMember_3d50fb0a-b1a6-42ca-a2bb-89d3d102102e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_a72c7243-147d-4201-91ce-941272f0904f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ad6df4a9-2f5f-4186-87be-4a4380f8a366" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_a72c7243-147d-4201-91ce-941272f0904f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://zailab.com/role/SummaryofSignificantAccountingPoliciesConcentrationofSuppliersDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#SummaryofSignificantAccountingPoliciesConcentrationofSuppliersDetails"/>
  <link:definitionLink xlink:role="http://zailab.com/role/SummaryofSignificantAccountingPoliciesConcentrationofSuppliersDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_7ab5827f-8eb0-461c-8642-4b0a65a12b94" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_1c09b9f0-c248-43a8-b7fa-f941de93d93a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_7ab5827f-8eb0-461c-8642-4b0a65a12b94" xlink:to="loc_us-gaap_ConcentrationRiskTable_1c09b9f0-c248-43a8-b7fa-f941de93d93a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_6acea769-34ec-4331-97ae-a52288104c8f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_1c09b9f0-c248-43a8-b7fa-f941de93d93a" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_6acea769-34ec-4331-97ae-a52288104c8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6acea769-34ec-4331-97ae-a52288104c8f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_6acea769-34ec-4331-97ae-a52288104c8f" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6acea769-34ec-4331-97ae-a52288104c8f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e176c30e-6a77-480c-aded-8b7b49568cd3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_6acea769-34ec-4331-97ae-a52288104c8f" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e176c30e-6a77-480c-aded-8b7b49568cd3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ResearchAndDevelopmentExpensesMember_3d114a87-0f67-43a1-87a7-43091243f657" xlink:href="zlab-20231231.xsd#zlab_ResearchAndDevelopmentExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e176c30e-6a77-480c-aded-8b7b49568cd3" xlink:to="loc_zlab_ResearchAndDevelopmentExpensesMember_3d114a87-0f67-43a1-87a7-43091243f657" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_ac9cd06f-07f3-4526-b865-6530aff5e794" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_1c09b9f0-c248-43a8-b7fa-f941de93d93a" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_ac9cd06f-07f3-4526-b865-6530aff5e794" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_ac9cd06f-07f3-4526-b865-6530aff5e794_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_ac9cd06f-07f3-4526-b865-6530aff5e794" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_ac9cd06f-07f3-4526-b865-6530aff5e794_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_f8d728e6-ed63-45f8-9634-e34c4ded6470" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_ac9cd06f-07f3-4526-b865-6530aff5e794" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_f8d728e6-ed63-45f8-9634-e34c4ded6470" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierConcentrationRiskMember_de46bdca-8677-463d-a8cc-4551a83bfdec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplierConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_f8d728e6-ed63-45f8-9634-e34c4ded6470" xlink:to="loc_us-gaap_SupplierConcentrationRiskMember_de46bdca-8677-463d-a8cc-4551a83bfdec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_MajorSuppliersAxis_d5f63338-43f7-4291-afe6-c4fcc7d5af24" xlink:href="zlab-20231231.xsd#zlab_MajorSuppliersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_1c09b9f0-c248-43a8-b7fa-f941de93d93a" xlink:to="loc_zlab_MajorSuppliersAxis_d5f63338-43f7-4291-afe6-c4fcc7d5af24" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_MajorSuppliersDomain_d5f63338-43f7-4291-afe6-c4fcc7d5af24_default" xlink:href="zlab-20231231.xsd#zlab_MajorSuppliersDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_zlab_MajorSuppliersAxis_d5f63338-43f7-4291-afe6-c4fcc7d5af24" xlink:to="loc_zlab_MajorSuppliersDomain_d5f63338-43f7-4291-afe6-c4fcc7d5af24_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_MajorSuppliersDomain_81c8d71e-b50b-4c3b-b04b-33ccafdfd591" xlink:href="zlab-20231231.xsd#zlab_MajorSuppliersDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_zlab_MajorSuppliersAxis_d5f63338-43f7-4291-afe6-c4fcc7d5af24" xlink:to="loc_zlab_MajorSuppliersDomain_81c8d71e-b50b-4c3b-b04b-33ccafdfd591" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_SupplierEMember_ca74fda1-53cf-48a7-9c00-c4eedbdcaaf6" xlink:href="zlab-20231231.xsd#zlab_SupplierEMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zlab_MajorSuppliersDomain_81c8d71e-b50b-4c3b-b04b-33ccafdfd591" xlink:to="loc_zlab_SupplierEMember_ca74fda1-53cf-48a7-9c00-c4eedbdcaaf6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_SupplierFMember_1bfbaa07-0bb7-4456-b41b-a5809e96ee62" xlink:href="zlab-20231231.xsd#zlab_SupplierFMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zlab_MajorSuppliersDomain_81c8d71e-b50b-4c3b-b04b-33ccafdfd591" xlink:to="loc_zlab_SupplierFMember_1bfbaa07-0bb7-4456-b41b-a5809e96ee62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ResearchAndDevelopmentExpensesAndTheInventoryPurchases_85d9c578-720c-4611-bcfb-1b88cf2cf7b6" xlink:href="zlab-20231231.xsd#zlab_ResearchAndDevelopmentExpensesAndTheInventoryPurchases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_7ab5827f-8eb0-461c-8642-4b0a65a12b94" xlink:to="loc_zlab_ResearchAndDevelopmentExpensesAndTheInventoryPurchases_85d9c578-720c-4611-bcfb-1b88cf2cf7b6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://zailab.com/role/CashandCashEquivalentsDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#CashandCashEquivalentsDetails"/>
  <link:definitionLink xlink:role="http://zailab.com/role/CashandCashEquivalentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsLineItems_b6e978a0-426d-4d12-922d-e59de31382a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_7b622a51-9285-49d2-826c-71048187df05" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_b6e978a0-426d-4d12-922d-e59de31382a8" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_7b622a51-9285-49d2-826c-71048187df05" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_85dea3b0-abe6-4fac-a85a-4ac26a3dd8cb" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CurrencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_7b622a51-9285-49d2-826c-71048187df05" xlink:to="loc_srt_CurrencyAxis_85dea3b0-abe6-4fac-a85a-4ac26a3dd8cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_85dea3b0-abe6-4fac-a85a-4ac26a3dd8cb_default" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_85dea3b0-abe6-4fac-a85a-4ac26a3dd8cb" xlink:to="loc_currency_AllCurrenciesDomain_85dea3b0-abe6-4fac-a85a-4ac26a3dd8cb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_527971c5-492b-4f18-b5db-1fb04ccff835" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_85dea3b0-abe6-4fac-a85a-4ac26a3dd8cb" xlink:to="loc_currency_AllCurrenciesDomain_527971c5-492b-4f18-b5db-1fb04ccff835" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD_1dc7bb36-468d-42a1-9f50-732572769e1c" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_USD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_527971c5-492b-4f18-b5db-1fb04ccff835" xlink:to="loc_currency_USD_1dc7bb36-468d-42a1-9f50-732572769e1c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CNY_3cb12c8a-81e3-4179-b5b8-ae017f5ed763" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_CNY"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_527971c5-492b-4f18-b5db-1fb04ccff835" xlink:to="loc_currency_CNY_3cb12c8a-81e3-4179-b5b8-ae017f5ed763" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_HKD_171ecc45-9c2d-4075-8765-d75d76f760a6" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_HKD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_527971c5-492b-4f18-b5db-1fb04ccff835" xlink:to="loc_currency_HKD_171ecc45-9c2d-4075-8765-d75d76f760a6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AUD_bf056ce6-471c-4741-a8cd-2701a33004fa" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_AUD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_527971c5-492b-4f18-b5db-1fb04ccff835" xlink:to="loc_currency_AUD_bf056ce6-471c-4741-a8cd-2701a33004fa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_TWD_dede77b2-3ac0-483c-92e8-f760976b9400" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_TWD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_527971c5-492b-4f18-b5db-1fb04ccff835" xlink:to="loc_currency_TWD_dede77b2-3ac0-483c-92e8-f760976b9400" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash_76e48f12-ac89-4d08-b2d8-2da3a4035e89" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Cash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_b6e978a0-426d-4d12-922d-e59de31382a8" xlink:to="loc_us-gaap_Cash_76e48f12-ac89-4d08-b2d8-2da3a4035e89" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_240d3bbe-8938-45ae-8aeb-3c3630e2916d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_b6e978a0-426d-4d12-922d-e59de31382a8" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_240d3bbe-8938-45ae-8aeb-3c3630e2916d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_cdee4a23-6285-492f-91cb-2f39ad6c4557" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_b6e978a0-426d-4d12-922d-e59de31382a8" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_cdee4a23-6285-492f-91cb-2f39ad6c4557" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://zailab.com/role/ShortTermInvestmentsDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#ShortTermInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://zailab.com/role/ShortTermInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems_845d6770-be1a-4af0-ba87-cbb9f1424649" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesTable_091ab17d-7f14-4dd6-90a8-33845f3bafdf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfHeldToMaturitySecuritiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems_845d6770-be1a-4af0-ba87-cbb9f1424649" xlink:to="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesTable_091ab17d-7f14-4dd6-90a8-33845f3bafdf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fc1db454-0592-43c1-ae39-8b73169fac53" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesTable_091ab17d-7f14-4dd6-90a8-33845f3bafdf" xlink:to="loc_srt_RangeAxis_fc1db454-0592-43c1-ae39-8b73169fac53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fc1db454-0592-43c1-ae39-8b73169fac53_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_fc1db454-0592-43c1-ae39-8b73169fac53" xlink:to="loc_srt_RangeMember_fc1db454-0592-43c1-ae39-8b73169fac53_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9aa21389-3e5d-4dd9-b761-52cac4e00d4d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_fc1db454-0592-43c1-ae39-8b73169fac53" xlink:to="loc_srt_RangeMember_9aa21389-3e5d-4dd9-b761-52cac4e00d4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_23b460a5-dfc8-40b4-b6d4-6e03b607463f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_9aa21389-3e5d-4dd9-b761-52cac4e00d4d" xlink:to="loc_srt_MinimumMember_23b460a5-dfc8-40b4-b6d4-6e03b607463f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_62b5b12d-7775-477e-8872-69fa06230ce9" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_9aa21389-3e5d-4dd9-b761-52cac4e00d4d" xlink:to="loc_srt_MaximumMember_62b5b12d-7775-477e-8872-69fa06230ce9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaturityOfTimeDeposits_3e34b2b8-72e4-4767-8b3a-5be441adb568" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MaturityOfTimeDeposits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems_845d6770-be1a-4af0-ba87-cbb9f1424649" xlink:to="loc_us-gaap_MaturityOfTimeDeposits_3e34b2b8-72e4-4767-8b3a-5be441adb568" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_b133a5b5-c8a7-46c7-98ea-499886186cab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems_845d6770-be1a-4af0-ba87-cbb9f1424649" xlink:to="loc_us-gaap_ShortTermInvestments_b133a5b5-c8a7-46c7-98ea-499886186cab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossExcludingAccruedInterest_96f118f8-5882-4713-9597-016075c0e8c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossExcludingAccruedInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems_845d6770-be1a-4af0-ba87-cbb9f1424649" xlink:to="loc_us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossExcludingAccruedInterest_96f118f8-5882-4713-9597-016075c0e8c1" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://zailab.com/role/LongTermInvestmentsDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#LongTermInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://zailab.com/role/LongTermInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_zlab_EquityAndCostMethodInvestmentsLineItems_19c0faa1-299c-4cc1-9cee-c60d6f6e43e8" xlink:href="zlab-20231231.xsd#zlab_EquityAndCostMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_EquityAndCostMethodInvestmentTable_7d69384f-d40c-4d10-b2e9-89a4aaa3ac3f" xlink:href="zlab-20231231.xsd#zlab_EquityAndCostMethodInvestmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_zlab_EquityAndCostMethodInvestmentsLineItems_19c0faa1-299c-4cc1-9cee-c60d6f6e43e8" xlink:to="loc_zlab_EquityAndCostMethodInvestmentTable_7d69384f-d40c-4d10-b2e9-89a4aaa3ac3f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d31b358d-2930-4c1f-92e8-c36af3e915ce" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_zlab_EquityAndCostMethodInvestmentTable_7d69384f-d40c-4d10-b2e9-89a4aaa3ac3f" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d31b358d-2930-4c1f-92e8-c36af3e915ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_d31b358d-2930-4c1f-92e8-c36af3e915ce_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d31b358d-2930-4c1f-92e8-c36af3e915ce" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_d31b358d-2930-4c1f-92e8-c36af3e915ce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_ba3b1735-7e05-4b09-9145-d2613eb4923b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d31b358d-2930-4c1f-92e8-c36af3e915ce" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_ba3b1735-7e05-4b09-9145-d2613eb4923b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_MacroGenicsIncMember_a064534e-9f07-48f6-825f-6dd91bc17540" xlink:href="zlab-20231231.xsd#zlab_MacroGenicsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_ba3b1735-7e05-4b09-9145-d2613eb4923b" xlink:to="loc_zlab_MacroGenicsIncMember_a064534e-9f07-48f6-825f-6dd91bc17540" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_07521136-5438-4fbb-807d-48618608b692" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_zlab_EquityAndCostMethodInvestmentTable_7d69384f-d40c-4d10-b2e9-89a4aaa3ac3f" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_07521136-5438-4fbb-807d-48618608b692" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_07521136-5438-4fbb-807d-48618608b692_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_07521136-5438-4fbb-807d-48618608b692" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_07521136-5438-4fbb-807d-48618608b692_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b21a4381-32c7-4b38-ad07-b897b9c9ee5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_07521136-5438-4fbb-807d-48618608b692" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b21a4381-32c7-4b38-ad07-b897b9c9ee5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_67dca79d-e437-44c9-b5cc-355ef706dd2f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b21a4381-32c7-4b38-ad07-b897b9c9ee5b" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_67dca79d-e437-44c9-b5cc-355ef706dd2f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_a2aa5aef-b014-4872-a3e6-0030f12467cc" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_zlab_EquityAndCostMethodInvestmentTable_7d69384f-d40c-4d10-b2e9-89a4aaa3ac3f" xlink:to="loc_dei_LegalEntityAxis_a2aa5aef-b014-4872-a3e6-0030f12467cc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_a2aa5aef-b014-4872-a3e6-0030f12467cc_default" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_a2aa5aef-b014-4872-a3e6-0030f12467cc" xlink:to="loc_dei_EntityDomain_a2aa5aef-b014-4872-a3e6-0030f12467cc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_d454289a-cbd0-41bb-b213-8418ca32fb01" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_a2aa5aef-b014-4872-a3e6-0030f12467cc" xlink:to="loc_dei_EntityDomain_d454289a-cbd0-41bb-b213-8418ca32fb01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_MacroGenicsIncMember_fc1b7940-b00a-4def-8bd9-f93e69b352e3" xlink:href="zlab-20231231.xsd#zlab_MacroGenicsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_d454289a-cbd0-41bb-b213-8418ca32fb01" xlink:to="loc_zlab_MacroGenicsIncMember_fc1b7940-b00a-4def-8bd9-f93e69b352e3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_CapitalContributionsCommitment_197af2ec-4d9c-4813-8e6b-a14c52fbc75c" xlink:href="zlab-20231231.xsd#zlab_CapitalContributionsCommitment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zlab_EquityAndCostMethodInvestmentsLineItems_19c0faa1-299c-4cc1-9cee-c60d6f6e43e8" xlink:to="loc_zlab_CapitalContributionsCommitment_197af2ec-4d9c-4813-8e6b-a14c52fbc75c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_e872c73a-05c2-4115-9500-0ccace42705d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zlab_EquityAndCostMethodInvestmentsLineItems_19c0faa1-299c-4cc1-9cee-c60d6f6e43e8" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_e872c73a-05c2-4115-9500-0ccace42705d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_4f904e7e-bbd6-4363-aa45-b2d1fa19175d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zlab_EquityAndCostMethodInvestmentsLineItems_19c0faa1-299c-4cc1-9cee-c60d6f6e43e8" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_4f904e7e-bbd6-4363-aa45-b2d1fa19175d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_EquitySecuritiesWithReadilyDeterminableFairValueAmount_6d21e44d-eda3-44b2-babf-d96837311e5c" xlink:href="zlab-20231231.xsd#zlab_EquitySecuritiesWithReadilyDeterminableFairValueAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zlab_EquityAndCostMethodInvestmentsLineItems_19c0faa1-299c-4cc1-9cee-c60d6f6e43e8" xlink:to="loc_zlab_EquitySecuritiesWithReadilyDeterminableFairValueAmount_6d21e44d-eda3-44b2-babf-d96837311e5c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_b287edc3-fb1a-45d1-9fbb-44f65d53176b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zlab_EquityAndCostMethodInvestmentsLineItems_19c0faa1-299c-4cc1-9cee-c60d6f6e43e8" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_b287edc3-fb1a-45d1-9fbb-44f65d53176b" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://zailab.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://zailab.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_495d2252-932e-46c9-9774-99d43a001df7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e126a7b9-516a-417f-aef5-ae815e2a3577" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_495d2252-932e-46c9-9774-99d43a001df7" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e126a7b9-516a-417f-aef5-ae815e2a3577" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_378d0f9e-ea1a-43b1-b257-0f4e9331f9bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e126a7b9-516a-417f-aef5-ae815e2a3577" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_378d0f9e-ea1a-43b1-b257-0f4e9331f9bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_378d0f9e-ea1a-43b1-b257-0f4e9331f9bc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_378d0f9e-ea1a-43b1-b257-0f4e9331f9bc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_378d0f9e-ea1a-43b1-b257-0f4e9331f9bc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_04dfbd41-79dd-4834-87c3-86fdfcb1698e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_378d0f9e-ea1a-43b1-b257-0f4e9331f9bc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_04dfbd41-79dd-4834-87c3-86fdfcb1698e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember_45a7d0c5-a15a-4f66-ba71-3b9ed0f8f261" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_04dfbd41-79dd-4834-87c3-86fdfcb1698e" xlink:to="loc_us-gaap_OfficeEquipmentMember_45a7d0c5-a15a-4f66-ba71-3b9ed0f8f261" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ElectronicEquipmentMember_0401a6c8-d267-466d-9ff3-2c3c09684eb9" xlink:href="zlab-20231231.xsd#zlab_ElectronicEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_04dfbd41-79dd-4834-87c3-86fdfcb1698e" xlink:to="loc_zlab_ElectronicEquipmentMember_0401a6c8-d267-466d-9ff3-2c3c09684eb9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VehiclesMember_2d57c3fb-794b-479f-86b6-caf7dc06cded" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VehiclesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_04dfbd41-79dd-4834-87c3-86fdfcb1698e" xlink:to="loc_us-gaap_VehiclesMember_2d57c3fb-794b-479f-86b6-caf7dc06cded" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_LaboratoryEquipmentMember_0a046ea3-c7ee-487d-a20a-3795fdc4c85d" xlink:href="zlab-20231231.xsd#zlab_LaboratoryEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_04dfbd41-79dd-4834-87c3-86fdfcb1698e" xlink:to="loc_zlab_LaboratoryEquipmentMember_0a046ea3-c7ee-487d-a20a-3795fdc4c85d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ManufacturingEquipmentMember_0551aa57-1d22-44a8-9cd0-f96ef926757e" xlink:href="zlab-20231231.xsd#zlab_ManufacturingEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_04dfbd41-79dd-4834-87c3-86fdfcb1698e" xlink:to="loc_zlab_ManufacturingEquipmentMember_0551aa57-1d22-44a8-9cd0-f96ef926757e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_85a6a326-2f65-4d7f-aa5a-b04a1c1eb896" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_04dfbd41-79dd-4834-87c3-86fdfcb1698e" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_85a6a326-2f65-4d7f-aa5a-b04a1c1eb896" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_72bd451c-69db-4986-8f7f-8b415e188bea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_04dfbd41-79dd-4834-87c3-86fdfcb1698e" xlink:to="loc_us-gaap_ConstructionInProgressMember_72bd451c-69db-4986-8f7f-8b415e188bea" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_8b27356e-c4ac-4c63-910d-08a838a926ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_495d2252-932e-46c9-9774-99d43a001df7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_8b27356e-c4ac-4c63-910d-08a838a926ee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_d951d1e6-11b1-48af-a722-9dd2a945f08d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_495d2252-932e-46c9-9774-99d43a001df7" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_d951d1e6-11b1-48af-a722-9dd2a945f08d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_0e670b18-1be6-4f0d-85d8-bab366c02165" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_495d2252-932e-46c9-9774-99d43a001df7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_0e670b18-1be6-4f0d-85d8-bab366c02165" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://zailab.com/role/LeasesAdditionalInformationDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#LeasesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://zailab.com/role/LeasesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_908d73aa-2040-441a-9d6e-af658e85ce9b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_42cba6d6-1607-4138-b187-9806f9bdc35b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_908d73aa-2040-441a-9d6e-af658e85ce9b" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_42cba6d6-1607-4138-b187-9806f9bdc35b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_71144490-a6c1-478c-b2e2-9d37d96c00c9" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_42cba6d6-1607-4138-b187-9806f9bdc35b" xlink:to="loc_srt_RangeAxis_71144490-a6c1-478c-b2e2-9d37d96c00c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_71144490-a6c1-478c-b2e2-9d37d96c00c9_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_71144490-a6c1-478c-b2e2-9d37d96c00c9" xlink:to="loc_srt_RangeMember_71144490-a6c1-478c-b2e2-9d37d96c00c9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b87bad9e-8fbb-48d1-b923-0eb82966c2a8" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_71144490-a6c1-478c-b2e2-9d37d96c00c9" xlink:to="loc_srt_RangeMember_b87bad9e-8fbb-48d1-b923-0eb82966c2a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ea074f54-f562-4137-a586-a03c6c8ae63c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b87bad9e-8fbb-48d1-b923-0eb82966c2a8" xlink:to="loc_srt_MinimumMember_ea074f54-f562-4137-a586-a03c6c8ae63c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_595d8df9-327b-4627-a606-8bd96a418f90" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b87bad9e-8fbb-48d1-b923-0eb82966c2a8" xlink:to="loc_srt_MaximumMember_595d8df9-327b-4627-a606-8bd96a418f90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_3354c4b0-3040-41e5-a90b-b25159b70866" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_908d73aa-2040-441a-9d6e-af658e85ce9b" xlink:to="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_3354c4b0-3040-41e5-a90b-b25159b70866" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://zailab.com/role/RevenueDisaggregationofNetRevenuebyProductDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#RevenueDisaggregationofNetRevenuebyProductDetails"/>
  <link:definitionLink xlink:role="http://zailab.com/role/RevenueDisaggregationofNetRevenuebyProductDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_8173e72f-cabe-432f-8b30-2e65cc7634dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_c8e57358-d47a-494c-89b2-e9635abf205f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_8173e72f-cabe-432f-8b30-2e65cc7634dd" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_c8e57358-d47a-494c-89b2-e9635abf205f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_021f7663-5ba5-4fbd-9015-202e73bdd59c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c8e57358-d47a-494c-89b2-e9635abf205f" xlink:to="loc_srt_ProductOrServiceAxis_021f7663-5ba5-4fbd-9015-202e73bdd59c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_021f7663-5ba5-4fbd-9015-202e73bdd59c_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_021f7663-5ba5-4fbd-9015-202e73bdd59c" xlink:to="loc_srt_ProductsAndServicesDomain_021f7663-5ba5-4fbd-9015-202e73bdd59c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_4e98fb77-2b95-4419-888e-dba277265c66" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_021f7663-5ba5-4fbd-9015-202e73bdd59c" xlink:to="loc_srt_ProductsAndServicesDomain_4e98fb77-2b95-4419-888e-dba277265c66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ZejulaMember_8953611b-6b86-4dbd-803a-8a58fe878d71" xlink:href="zlab-20231231.xsd#zlab_ZejulaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_4e98fb77-2b95-4419-888e-dba277265c66" xlink:to="loc_zlab_ZejulaMember_8953611b-6b86-4dbd-803a-8a58fe878d71" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_OptuneMember_5ff57e0c-72bc-44ed-973f-6e12e56a7942" xlink:href="zlab-20231231.xsd#zlab_OptuneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_4e98fb77-2b95-4419-888e-dba277265c66" xlink:to="loc_zlab_OptuneMember_5ff57e0c-72bc-44ed-973f-6e12e56a7942" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_QinlockMember_e760baa5-27b9-4202-9380-9672ea281413" xlink:href="zlab-20231231.xsd#zlab_QinlockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_4e98fb77-2b95-4419-888e-dba277265c66" xlink:to="loc_zlab_QinlockMember_e760baa5-27b9-4202-9380-9672ea281413" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_NuzyraMember_e3dc4e8f-569f-4164-ac65-2a4bd4ceb59e" xlink:href="zlab-20231231.xsd#zlab_NuzyraMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_4e98fb77-2b95-4419-888e-dba277265c66" xlink:to="loc_zlab_NuzyraMember_e3dc4e8f-569f-4164-ac65-2a4bd4ceb59e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_VyvgartMember_8d76ba0c-7177-4cd4-a631-8c8641a0aa41" xlink:href="zlab-20231231.xsd#zlab_VyvgartMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_4e98fb77-2b95-4419-888e-dba277265c66" xlink:to="loc_zlab_VyvgartMember_8d76ba0c-7177-4cd4-a631-8c8641a0aa41" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_12577a6c-863a-47df-985a-803f95fb6ce6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_8173e72f-cabe-432f-8b30-2e65cc7634dd" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_12577a6c-863a-47df-985a-803f95fb6ce6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://zailab.com/role/IncomeTaxAdditionalInformationDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#IncomeTaxAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://zailab.com/role/IncomeTaxAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_zlab_IncomeTaxDisclosureLineItems_0e1144df-504a-4a82-9138-7f79f6a369dd" xlink:href="zlab-20231231.xsd#zlab_IncomeTaxDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_IncomeTaxDisclosureTable_7f1f19ea-d86c-43fc-a7b0-36719c77fb00" xlink:href="zlab-20231231.xsd#zlab_IncomeTaxDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_zlab_IncomeTaxDisclosureLineItems_0e1144df-504a-4a82-9138-7f79f6a369dd" xlink:to="loc_zlab_IncomeTaxDisclosureTable_7f1f19ea-d86c-43fc-a7b0-36719c77fb00" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_66e5709f-1db4-4293-808e-41e34772682a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_zlab_IncomeTaxDisclosureTable_7f1f19ea-d86c-43fc-a7b0-36719c77fb00" xlink:to="loc_dei_LegalEntityAxis_66e5709f-1db4-4293-808e-41e34772682a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_66e5709f-1db4-4293-808e-41e34772682a_default" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_66e5709f-1db4-4293-808e-41e34772682a" xlink:to="loc_dei_EntityDomain_66e5709f-1db4-4293-808e-41e34772682a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_bb3ec4da-7a3e-4473-9390-6bfa554a5c88" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_66e5709f-1db4-4293-808e-41e34772682a" xlink:to="loc_dei_EntityDomain_bb3ec4da-7a3e-4473-9390-6bfa554a5c88" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ZaiLabAUSTPtyLtdMember_ca75738c-2cd8-49a6-8e76-5dfad296c4b2" xlink:href="zlab-20231231.xsd#zlab_ZaiLabAUSTPtyLtdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_bb3ec4da-7a3e-4473-9390-6bfa554a5c88" xlink:to="loc_zlab_ZaiLabAUSTPtyLtdMember_ca75738c-2cd8-49a6-8e76-5dfad296c4b2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ZaiLabUSLLCMember_6a83a546-0ca0-4e9c-ae34-8efbc3d342c0" xlink:href="zlab-20231231.xsd#zlab_ZaiLabUSLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_bb3ec4da-7a3e-4473-9390-6bfa554a5c88" xlink:to="loc_zlab_ZaiLabUSLLCMember_6a83a546-0ca0-4e9c-ae34-8efbc3d342c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ZaiLabTaiwanLimitedMember_3e35b86c-9507-4c28-a581-5d41f5d0d8ad" xlink:href="zlab-20231231.xsd#zlab_ZaiLabTaiwanLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_bb3ec4da-7a3e-4473-9390-6bfa554a5c88" xlink:to="loc_zlab_ZaiLabTaiwanLimitedMember_3e35b86c-9507-4c28-a581-5d41f5d0d8ad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ZaiLabHongKongAndZlChinaHoldingTwoAndZaiAutoImmuneHongKongAndZaiAntiInfectivesHongKongLimitedMember_177edef7-664b-43b5-af54-daf00ff8ef67" xlink:href="zlab-20231231.xsd#zlab_ZaiLabHongKongAndZlChinaHoldingTwoAndZaiAutoImmuneHongKongAndZaiAntiInfectivesHongKongLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_bb3ec4da-7a3e-4473-9390-6bfa554a5c88" xlink:to="loc_zlab_ZaiLabHongKongAndZlChinaHoldingTwoAndZaiAutoImmuneHongKongAndZaiAntiInfectivesHongKongLimitedMember_177edef7-664b-43b5-af54-daf00ff8ef67" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_0675614b-c180-4542-9939-93243ccea67e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_zlab_IncomeTaxDisclosureTable_7f1f19ea-d86c-43fc-a7b0-36719c77fb00" xlink:to="loc_srt_StatementGeographicalAxis_0675614b-c180-4542-9939-93243ccea67e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_0675614b-c180-4542-9939-93243ccea67e_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_0675614b-c180-4542-9939-93243ccea67e" xlink:to="loc_srt_SegmentGeographicalDomain_0675614b-c180-4542-9939-93243ccea67e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_37f26c2e-3251-409d-a675-9be204bb4653" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_0675614b-c180-4542-9939-93243ccea67e" xlink:to="loc_srt_SegmentGeographicalDomain_37f26c2e-3251-409d-a675-9be204bb4653" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN_c28b1d8a-f530-4f90-9136-fd6cea768f45" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_CN"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_37f26c2e-3251-409d-a675-9be204bb4653" xlink:to="loc_country_CN_c28b1d8a-f530-4f90-9136-fd6cea768f45" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_HK_c9386a8d-993d-4423-9a33-247b349e713e" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_HK"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_37f26c2e-3251-409d-a675-9be204bb4653" xlink:to="loc_country_HK_c9386a8d-993d-4423-9a33-247b349e713e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_TW_e40e4b6b-ef01-4e8a-9420-646a9e33e69a" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_TW"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_37f26c2e-3251-409d-a675-9be204bb4653" xlink:to="loc_country_TW_e40e4b6b-ef01-4e8a-9420-646a9e33e69a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_64b41e5c-638a-4215-9ee2-1122df03e0ca" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_37f26c2e-3251-409d-a675-9be204bb4653" xlink:to="loc_country_US_64b41e5c-638a-4215-9ee2-1122df03e0ca" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_AU_8cf3d81a-02e1-4418-a399-77321756e379" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_AU"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_37f26c2e-3251-409d-a675-9be204bb4653" xlink:to="loc_country_AU_8cf3d81a-02e1-4418-a399-77321756e379" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4749d609-1b8f-4162-9a9a-d8046daf03be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zlab_IncomeTaxDisclosureLineItems_0e1144df-504a-4a82-9138-7f79f6a369dd" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4749d609-1b8f-4162-9a9a-d8046daf03be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_247391b7-09a9-4b98-aff0-61276400e949" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zlab_IncomeTaxDisclosureLineItems_0e1144df-504a-4a82-9138-7f79f6a369dd" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_247391b7-09a9-4b98-aff0-61276400e949" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_WithholdingTaxesRemittanceOfDividends_4d83b920-b6a6-46b8-bab6-7bb52cc06b69" xlink:href="zlab-20231231.xsd#zlab_WithholdingTaxesRemittanceOfDividends"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zlab_IncomeTaxDisclosureLineItems_0e1144df-504a-4a82-9138-7f79f6a369dd" xlink:to="loc_zlab_WithholdingTaxesRemittanceOfDividends_4d83b920-b6a6-46b8-bab6-7bb52cc06b69" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_7b0194a7-d93f-458a-8441-b21aea072a6f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zlab_IncomeTaxDisclosureLineItems_0e1144df-504a-4a82-9138-7f79f6a369dd" xlink:to="loc_us-gaap_OperatingLossCarryforwards_7b0194a7-d93f-458a-8441-b21aea072a6f" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://zailab.com/role/IncomeTaxLossIncomeBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#IncomeTaxLossIncomeBeforeIncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://zailab.com/role/IncomeTaxLossIncomeBeforeIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_zlab_IncomeTaxDisclosureLineItems_b98d38c3-8f8d-41fd-94ae-aab9e5b1bedc" xlink:href="zlab-20231231.xsd#zlab_IncomeTaxDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_IncomeTaxDisclosureTable_fbb31eb5-46e6-495e-8cc0-bfdf45abfce9" xlink:href="zlab-20231231.xsd#zlab_IncomeTaxDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_zlab_IncomeTaxDisclosureLineItems_b98d38c3-8f8d-41fd-94ae-aab9e5b1bedc" xlink:to="loc_zlab_IncomeTaxDisclosureTable_fbb31eb5-46e6-495e-8cc0-bfdf45abfce9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_6f944b03-d5d6-4471-b1e0-9cee8ce542c3" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_zlab_IncomeTaxDisclosureTable_fbb31eb5-46e6-495e-8cc0-bfdf45abfce9" xlink:to="loc_srt_StatementGeographicalAxis_6f944b03-d5d6-4471-b1e0-9cee8ce542c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_6f944b03-d5d6-4471-b1e0-9cee8ce542c3_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_6f944b03-d5d6-4471-b1e0-9cee8ce542c3" xlink:to="loc_srt_SegmentGeographicalDomain_6f944b03-d5d6-4471-b1e0-9cee8ce542c3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_56825034-381c-46d2-ac6b-747ff34d56b7" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_6f944b03-d5d6-4471-b1e0-9cee8ce542c3" xlink:to="loc_srt_SegmentGeographicalDomain_56825034-381c-46d2-ac6b-747ff34d56b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_KY_3837b5b3-394c-4f88-a637-99c602fba12c" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_KY"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_56825034-381c-46d2-ac6b-747ff34d56b7" xlink:to="loc_country_KY_3837b5b3-394c-4f88-a637-99c602fba12c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_VG_a47f84b0-3099-4035-a227-4589c6a9e51c" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_VG"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_56825034-381c-46d2-ac6b-747ff34d56b7" xlink:to="loc_country_VG_a47f84b0-3099-4035-a227-4589c6a9e51c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN_f6328ac4-d644-47c3-b535-489e05e92ca6" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_CN"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_56825034-381c-46d2-ac6b-747ff34d56b7" xlink:to="loc_country_CN_f6328ac4-d644-47c3-b535-489e05e92ca6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_HK_dbd6413f-7ffa-4135-9755-ca1629beb968" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_HK"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_56825034-381c-46d2-ac6b-747ff34d56b7" xlink:to="loc_country_HK_dbd6413f-7ffa-4135-9755-ca1629beb968" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_c8974338-df87-4f31-a4d3-ffc5b81b2e84" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_56825034-381c-46d2-ac6b-747ff34d56b7" xlink:to="loc_country_US_c8974338-df87-4f31-a4d3-ffc5b81b2e84" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_AU_96cbbf20-12a3-4de2-a790-f303cee02a3f" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_AU"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_56825034-381c-46d2-ac6b-747ff34d56b7" xlink:to="loc_country_AU_96cbbf20-12a3-4de2-a790-f303cee02a3f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_TW_c921d5dd-e2b6-4fc4-a8b3-20ba3ba94d9f" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_TW"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_56825034-381c-46d2-ac6b-747ff34d56b7" xlink:to="loc_country_TW_c921d5dd-e2b6-4fc4-a8b3-20ba3ba94d9f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8ffa2b28-dfe7-446a-a59e-9494ae4790b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zlab_IncomeTaxDisclosureLineItems_b98d38c3-8f8d-41fd-94ae-aab9e5b1bedc" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8ffa2b28-dfe7-446a-a59e-9494ae4790b8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://zailab.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRateDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#IncomeTaxReconciliationoftheEffectiveIncomeTaxRateDetails"/>
  <link:definitionLink xlink:role="http://zailab.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_zlab_IncomeTaxesLineItems_7d12b0d0-6b7d-471f-8287-96a867830cc2" xlink:href="zlab-20231231.xsd#zlab_IncomeTaxesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_IncomeTaxesTable_5452c615-027e-492d-9847-662a2c823104" xlink:href="zlab-20231231.xsd#zlab_IncomeTaxesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_zlab_IncomeTaxesLineItems_7d12b0d0-6b7d-471f-8287-96a867830cc2" xlink:to="loc_zlab_IncomeTaxesTable_5452c615-027e-492d-9847-662a2c823104" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_8418d1c3-4405-4a19-a611-04423a73d17c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_zlab_IncomeTaxesTable_5452c615-027e-492d-9847-662a2c823104" xlink:to="loc_srt_StatementGeographicalAxis_8418d1c3-4405-4a19-a611-04423a73d17c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_8418d1c3-4405-4a19-a611-04423a73d17c_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_8418d1c3-4405-4a19-a611-04423a73d17c" xlink:to="loc_srt_SegmentGeographicalDomain_8418d1c3-4405-4a19-a611-04423a73d17c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_56b5f8d9-14ec-43d0-a456-0ca47d1d9e1b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_8418d1c3-4405-4a19-a611-04423a73d17c" xlink:to="loc_srt_SegmentGeographicalDomain_56b5f8d9-14ec-43d0-a456-0ca47d1d9e1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN_0ba8d58e-94b1-4dcb-8cc7-32db3bf28d67" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_CN"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_56b5f8d9-14ec-43d0-a456-0ca47d1d9e1b" xlink:to="loc_country_CN_0ba8d58e-94b1-4dcb-8cc7-32db3bf28d67" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_d2bdc1a3-04c7-422d-82f1-61c87e519cb2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zlab_IncomeTaxesLineItems_7d12b0d0-6b7d-471f-8287-96a867830cc2" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_d2bdc1a3-04c7-422d-82f1-61c87e519cb2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome_c73580ec-ce1d-4d68-8e9c-786940ff1f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zlab_IncomeTaxesLineItems_7d12b0d0-6b7d-471f-8287-96a867830cc2" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome_c73580ec-ce1d-4d68-8e9c-786940ff1f8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_6d07a3d0-78a3-4e88-b236-d176db0af8ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zlab_IncomeTaxesLineItems_7d12b0d0-6b7d-471f-8287-96a867830cc2" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_6d07a3d0-78a3-4e88-b236-d176db0af8ee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_02b328d8-7c1b-41fa-950a-32bd10f38eea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zlab_IncomeTaxesLineItems_7d12b0d0-6b7d-471f-8287-96a867830cc2" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_02b328d8-7c1b-41fa-950a-32bd10f38eea" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_866a04ad-f9b1-4682-a6df-a076fd36e985" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zlab_IncomeTaxesLineItems_7d12b0d0-6b7d-471f-8287-96a867830cc2" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_866a04ad-f9b1-4682-a6df-a076fd36e985" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_2f6bba4c-bc8e-4ad8-892f-0a95ae75b173" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zlab_IncomeTaxesLineItems_7d12b0d0-6b7d-471f-8287-96a867830cc2" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_2f6bba4c-bc8e-4ad8-892f-0a95ae75b173" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_1580e2f5-38ae-4bef-94e9-a0d13c14ef0f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zlab_IncomeTaxesLineItems_7d12b0d0-6b7d-471f-8287-96a867830cc2" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_1580e2f5-38ae-4bef-94e9-a0d13c14ef0f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_EffectiveIncomeTaxRateReconciliationAtPreferentialTaxRate_fceed441-6590-4593-a62c-8342be83dabf" xlink:href="zlab-20231231.xsd#zlab_EffectiveIncomeTaxRateReconciliationAtPreferentialTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zlab_IncomeTaxesLineItems_7d12b0d0-6b7d-471f-8287-96a867830cc2" xlink:to="loc_zlab_EffectiveIncomeTaxRateReconciliationAtPreferentialTaxRate_fceed441-6590-4593-a62c-8342be83dabf" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCharitableContributions_09a9dcb2-add9-4731-8e0c-0404ff788a27" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCharitableContributions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zlab_IncomeTaxesLineItems_7d12b0d0-6b7d-471f-8287-96a867830cc2" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCharitableContributions_09a9dcb2-add9-4731-8e0c-0404ff788a27" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_1610c60c-5a0b-449c-8755-b00cc9e9a794" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zlab_IncomeTaxesLineItems_7d12b0d0-6b7d-471f-8287-96a867830cc2" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_1610c60c-5a0b-449c-8755-b00cc9e9a794" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e6d3bb97-e27f-4a26-b53d-dbcde081654e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zlab_IncomeTaxesLineItems_7d12b0d0-6b7d-471f-8287-96a867830cc2" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e6d3bb97-e27f-4a26-b53d-dbcde081654e" xlink:type="arc" order="10"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://zailab.com/role/LossPerShareAntiDilutiveSharesExcludedfromCalculationofDilutedLossPerShareDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#LossPerShareAntiDilutiveSharesExcludedfromCalculationofDilutedLossPerShareDetails"/>
  <link:definitionLink xlink:role="http://zailab.com/role/LossPerShareAntiDilutiveSharesExcludedfromCalculationofDilutedLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1f974790-fabb-47aa-858d-4deb62141bad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_14f593e1-6e28-4df4-92fb-694ba3275efd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1f974790-fabb-47aa-858d-4deb62141bad" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_14f593e1-6e28-4df4-92fb-694ba3275efd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7a0895d4-5a8a-4900-931e-14ae38b510f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_14f593e1-6e28-4df4-92fb-694ba3275efd" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7a0895d4-5a8a-4900-931e-14ae38b510f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_7a0895d4-5a8a-4900-931e-14ae38b510f6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7a0895d4-5a8a-4900-931e-14ae38b510f6" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_7a0895d4-5a8a-4900-931e-14ae38b510f6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_219cf1db-ff5e-431c-8438-f5ce8b3726bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7a0895d4-5a8a-4900-931e-14ae38b510f6" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_219cf1db-ff5e-431c-8438-f5ce8b3726bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_080a3e2d-6f3d-4bd0-a413-4b785eaa6f2e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_219cf1db-ff5e-431c-8438-f5ce8b3726bc" xlink:to="loc_us-gaap_EmployeeStockOptionMember_080a3e2d-6f3d-4bd0-a413-4b785eaa6f2e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_NonVestedRestrictedSharesMember_ea3e5807-59ab-4427-a614-e9d2a63cc033" xlink:href="zlab-20231231.xsd#zlab_NonVestedRestrictedSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_219cf1db-ff5e-431c-8438-f5ce8b3726bc" xlink:to="loc_zlab_NonVestedRestrictedSharesMember_ea3e5807-59ab-4427-a614-e9d2a63cc033" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1665a052-efdc-4ef1-9033-b33d549270f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1f974790-fabb-47aa-858d-4deb62141bad" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1665a052-efdc-4ef1-9033-b33d549270f5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://zailab.com/role/RelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#RelatedPartyTransactionsDetails"/>
  <link:definitionLink xlink:role="http://zailab.com/role/RelatedPartyTransactionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_644c7da3-04c4-48fd-b33d-baab3b0e3879" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_acdbed6f-1f6d-4f9a-87b4-1696ea57ec4b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_644c7da3-04c4-48fd-b33d-baab3b0e3879" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_acdbed6f-1f6d-4f9a-87b4-1696ea57ec4b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_38afbb13-c90a-45ff-8e7a-20f9722b17ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_acdbed6f-1f6d-4f9a-87b4-1696ea57ec4b" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_38afbb13-c90a-45ff-8e7a-20f9722b17ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_38afbb13-c90a-45ff-8e7a-20f9722b17ff_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_38afbb13-c90a-45ff-8e7a-20f9722b17ff" xlink:to="loc_us-gaap_RelatedPartyDomain_38afbb13-c90a-45ff-8e7a-20f9722b17ff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_795487a4-5510-4479-9a79-a4e81cdd7b7e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_38afbb13-c90a-45ff-8e7a-20f9722b17ff" xlink:to="loc_us-gaap_RelatedPartyDomain_795487a4-5510-4479-9a79-a4e81cdd7b7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedLiabilityCompanyMember_b10726e9-ade7-4105-a46b-50125428ef01" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LimitedLiabilityCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_795487a4-5510-4479-9a79-a4e81cdd7b7e" xlink:to="loc_us-gaap_LimitedLiabilityCompanyMember_b10726e9-ade7-4105-a46b-50125428ef01" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_80d1dfe7-f196-4ff5-ac9f-51b4df6926d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_644c7da3-04c4-48fd-b33d-baab3b0e3879" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_80d1dfe7-f196-4ff5-ac9f-51b4df6926d5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://zailab.com/role/ShareBasedCompensationAdditionalInformationDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#ShareBasedCompensationAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://zailab.com/role/ShareBasedCompensationAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_da26807d-1991-4b02-bc80-cac2682510d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8036a077-edeb-4601-a272-cb1033bae5ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_da26807d-1991-4b02-bc80-cac2682510d0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8036a077-edeb-4601-a272-cb1033bae5ac" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_444d326e-d1ee-420b-8691-43720550d85f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8036a077-edeb-4601-a272-cb1033bae5ac" xlink:to="loc_us-gaap_PlanNameAxis_444d326e-d1ee-420b-8691-43720550d85f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_444d326e-d1ee-420b-8691-43720550d85f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_444d326e-d1ee-420b-8691-43720550d85f" xlink:to="loc_us-gaap_PlanNameDomain_444d326e-d1ee-420b-8691-43720550d85f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_b2844821-6146-4859-a83c-b67ca1ef4a2e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_444d326e-d1ee-420b-8691-43720550d85f" xlink:to="loc_us-gaap_PlanNameDomain_b2844821-6146-4859-a83c-b67ca1ef4a2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_TwoThousandTwentyTwoEquityIncentivePlanMember_6dffce85-47f4-462c-8320-3e502f35924c" xlink:href="zlab-20231231.xsd#zlab_TwoThousandTwentyTwoEquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_b2844821-6146-4859-a83c-b67ca1ef4a2e" xlink:to="loc_zlab_TwoThousandTwentyTwoEquityIncentivePlanMember_6dffce85-47f4-462c-8320-3e502f35924c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_694e0205-4a26-4e4d-8fca-39ccc85759e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8036a077-edeb-4601-a272-cb1033bae5ac" xlink:to="loc_us-gaap_AwardTypeAxis_694e0205-4a26-4e4d-8fca-39ccc85759e2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_694e0205-4a26-4e4d-8fca-39ccc85759e2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_694e0205-4a26-4e4d-8fca-39ccc85759e2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_694e0205-4a26-4e4d-8fca-39ccc85759e2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8edaa953-4755-42b5-babe-16efdf5d4064" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_694e0205-4a26-4e4d-8fca-39ccc85759e2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8edaa953-4755-42b5-babe-16efdf5d4064" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_72ea2fca-263c-47b6-b25b-89e1bcc106ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8edaa953-4755-42b5-babe-16efdf5d4064" xlink:to="loc_us-gaap_EmployeeStockOptionMember_72ea2fca-263c-47b6-b25b-89e1bcc106ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_NonVestedRestrictedSharesMember_06e00deb-21e8-4d6a-b32d-2df8cddd866b" xlink:href="zlab-20231231.xsd#zlab_NonVestedRestrictedSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8edaa953-4755-42b5-babe-16efdf5d4064" xlink:to="loc_zlab_NonVestedRestrictedSharesMember_06e00deb-21e8-4d6a-b32d-2df8cddd866b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateAxis_ce0beb30-45e9-4495-b977-fa19551a88dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8036a077-edeb-4601-a272-cb1033bae5ac" xlink:to="loc_us-gaap_AwardDateAxis_ce0beb30-45e9-4495-b977-fa19551a88dc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_ce0beb30-45e9-4495-b977-fa19551a88dc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardDateAxis_ce0beb30-45e9-4495-b977-fa19551a88dc" xlink:to="loc_us-gaap_AwardDateDomain_ce0beb30-45e9-4495-b977-fa19551a88dc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_346ec4c9-fe17-46d1-88e0-2ca29db21b5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardDateAxis_ce0beb30-45e9-4495-b977-fa19551a88dc" xlink:to="loc_us-gaap_AwardDateDomain_346ec4c9-fe17-46d1-88e0-2ca29db21b5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_April2023AndLaterMember_66c5161a-51c8-4e51-a2cf-ddb3cc81433b" xlink:href="zlab-20231231.xsd#zlab_April2023AndLaterMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_346ec4c9-fe17-46d1-88e0-2ca29db21b5b" xlink:to="loc_zlab_April2023AndLaterMember_66c5161a-51c8-4e51-a2cf-ddb3cc81433b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_PriorToApril2023Member_b8a93e19-4ca9-4826-b5e4-dc63a4e9d951" xlink:href="zlab-20231231.xsd#zlab_PriorToApril2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_346ec4c9-fe17-46d1-88e0-2ca29db21b5b" xlink:to="loc_zlab_PriorToApril2023Member_b8a93e19-4ca9-4826-b5e4-dc63a4e9d951" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_260f4741-1f3b-43ea-8f2f-5b1692a1819c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8036a077-edeb-4601-a272-cb1033bae5ac" xlink:to="loc_us-gaap_VestingAxis_260f4741-1f3b-43ea-8f2f-5b1692a1819c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_260f4741-1f3b-43ea-8f2f-5b1692a1819c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VestingAxis_260f4741-1f3b-43ea-8f2f-5b1692a1819c" xlink:to="loc_us-gaap_VestingDomain_260f4741-1f3b-43ea-8f2f-5b1692a1819c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_256411e4-f966-46ae-870a-9af78a9aed24" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VestingAxis_260f4741-1f3b-43ea-8f2f-5b1692a1819c" xlink:to="loc_us-gaap_VestingDomain_256411e4-f966-46ae-870a-9af78a9aed24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_facd6f67-8bf3-453c-9309-6d76fb3f61e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_256411e4-f966-46ae-870a-9af78a9aed24" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_facd6f67-8bf3-453c-9309-6d76fb3f61e4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_a4993110-a219-4174-8c8f-2cc28cbc59da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_256411e4-f966-46ae-870a-9af78a9aed24" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_a4993110-a219-4174-8c8f-2cc28cbc59da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_b5cdec7c-58d9-472d-acd6-debbcc3d858f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_256411e4-f966-46ae-870a-9af78a9aed24" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_b5cdec7c-58d9-472d-acd6-debbcc3d858f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ShareBasedPaymentArrangementTrancheFourMember_d23ef4af-5734-43e7-91a8-6e90978a55a6" xlink:href="zlab-20231231.xsd#zlab_ShareBasedPaymentArrangementTrancheFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_256411e4-f966-46ae-870a-9af78a9aed24" xlink:to="loc_zlab_ShareBasedPaymentArrangementTrancheFourMember_d23ef4af-5734-43e7-91a8-6e90978a55a6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ShareBasedPaymentArrangementTrancheFiveMember_db1d5907-faf2-4453-acbb-e12a41415625" xlink:href="zlab-20231231.xsd#zlab_ShareBasedPaymentArrangementTrancheFiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_256411e4-f966-46ae-870a-9af78a9aed24" xlink:to="loc_zlab_ShareBasedPaymentArrangementTrancheFiveMember_db1d5907-faf2-4453-acbb-e12a41415625" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_8f3c5776-60d7-4934-a5f0-1ddbd3bbff25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_da26807d-1991-4b02-bc80-cac2682510d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_8f3c5776-60d7-4934-a5f0-1ddbd3bbff25" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_0989fa00-318e-4ae5-8b09-448c74525e5e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_da26807d-1991-4b02-bc80-cac2682510d0" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_0989fa00-318e-4ae5-8b09-448c74525e5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_47ba4067-6669-4825-bd7b-ee4cb1cf49c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_da26807d-1991-4b02-bc80-cac2682510d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_47ba4067-6669-4825-bd7b-ee4cb1cf49c4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_da0d9e82-6122-4030-9226-df0000cf3404" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_da26807d-1991-4b02-bc80-cac2682510d0" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_da0d9e82-6122-4030-9226-df0000cf3404" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_f2f77391-a872-40d2-a3d6-274e81a4013a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_da26807d-1991-4b02-bc80-cac2682510d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_f2f77391-a872-40d2-a3d6-274e81a4013a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_356d9d0a-0c05-47d5-bb91-3a1a1f4c51d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_da26807d-1991-4b02-bc80-cac2682510d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_356d9d0a-0c05-47d5-bb91-3a1a1f4c51d3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_6b022d8e-ed26-403a-bd8b-081e345d2644" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_da26807d-1991-4b02-bc80-cac2682510d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_6b022d8e-ed26-403a-bd8b-081e345d2644" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_f2c7eac4-fa7c-4ab4-9883-1367f7f366f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_da26807d-1991-4b02-bc80-cac2682510d0" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_f2c7eac4-fa7c-4ab4-9883-1367f7f366f7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_ef270816-3c31-4d34-b9e6-68c5b25ca7f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_da26807d-1991-4b02-bc80-cac2682510d0" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_ef270816-3c31-4d34-b9e6-68c5b25ca7f0" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_01c4106d-fba5-4f08-abd3-47d3d9cc32c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_da26807d-1991-4b02-bc80-cac2682510d0" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_01c4106d-fba5-4f08-abd3-47d3d9cc32c7" xlink:type="arc" order="9"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://zailab.com/role/ShareBasedCompensationAssumptionsUsedtoEstimateFairValuesofShareOptionsGrantedDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#ShareBasedCompensationAssumptionsUsedtoEstimateFairValuesofShareOptionsGrantedDetails"/>
  <link:definitionLink xlink:role="http://zailab.com/role/ShareBasedCompensationAssumptionsUsedtoEstimateFairValuesofShareOptionsGrantedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9f078987-946b-40dd-a909-814592e13f71" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a41161c1-4805-408f-ae04-8fc5b439ac91" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9f078987-946b-40dd-a909-814592e13f71" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a41161c1-4805-408f-ae04-8fc5b439ac91" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_86d049c6-afeb-4ad3-a8d3-4f31a9047806" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a41161c1-4805-408f-ae04-8fc5b439ac91" xlink:to="loc_us-gaap_AwardTypeAxis_86d049c6-afeb-4ad3-a8d3-4f31a9047806" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_86d049c6-afeb-4ad3-a8d3-4f31a9047806_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_86d049c6-afeb-4ad3-a8d3-4f31a9047806" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_86d049c6-afeb-4ad3-a8d3-4f31a9047806_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_695128fc-8006-48a8-92bd-e0b15e02e32d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_86d049c6-afeb-4ad3-a8d3-4f31a9047806" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_695128fc-8006-48a8-92bd-e0b15e02e32d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_cf2032b5-49d3-49a6-ab79-aee7a271f9d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_695128fc-8006-48a8-92bd-e0b15e02e32d" xlink:to="loc_us-gaap_EmployeeStockOptionMember_cf2032b5-49d3-49a6-ab79-aee7a271f9d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ShareBasedPaymentArrangementOptionBatchOneMember_fa5d524b-06be-434d-b63e-da54a9e4d8b0" xlink:href="zlab-20231231.xsd#zlab_ShareBasedPaymentArrangementOptionBatchOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeStockOptionMember_cf2032b5-49d3-49a6-ab79-aee7a271f9d1" xlink:to="loc_zlab_ShareBasedPaymentArrangementOptionBatchOneMember_fa5d524b-06be-434d-b63e-da54a9e4d8b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ShareBasedPaymentArrangementOptionBatchTwoMember_7a71ad26-955d-4df6-9202-e0bc3e69cd2f" xlink:href="zlab-20231231.xsd#zlab_ShareBasedPaymentArrangementOptionBatchTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeStockOptionMember_cf2032b5-49d3-49a6-ab79-aee7a271f9d1" xlink:to="loc_zlab_ShareBasedPaymentArrangementOptionBatchTwoMember_7a71ad26-955d-4df6-9202-e0bc3e69cd2f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ShareBasedPaymentArrangementOptionBatchThreeMember_937fa965-8ef6-4677-bcf2-0a12e0c7cd16" xlink:href="zlab-20231231.xsd#zlab_ShareBasedPaymentArrangementOptionBatchThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeStockOptionMember_cf2032b5-49d3-49a6-ab79-aee7a271f9d1" xlink:to="loc_zlab_ShareBasedPaymentArrangementOptionBatchThreeMember_937fa965-8ef6-4677-bcf2-0a12e0c7cd16" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_4cf2249b-e0e8-402f-88c4-c2f26bde073f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9f078987-946b-40dd-a909-814592e13f71" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_4cf2249b-e0e8-402f-88c4-c2f26bde073f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_03d926ec-8d45-43af-93fe-58ffa524a1fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9f078987-946b-40dd-a909-814592e13f71" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_03d926ec-8d45-43af-93fe-58ffa524a1fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_8f9f5f5f-ab2b-4676-9974-7af9d8f8372e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9f078987-946b-40dd-a909-814592e13f71" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_8f9f5f5f-ab2b-4676-9974-7af9d8f8372e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_c3c389e2-c805-4f92-8e85-dfda233e399b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9f078987-946b-40dd-a909-814592e13f71" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_c3c389e2-c805-4f92-8e85-dfda233e399b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_0cedfb11-ffe1-4ece-bd85-46cdfe5b1529" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9f078987-946b-40dd-a909-814592e13f71" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_0cedfb11-ffe1-4ece-bd85-46cdfe5b1529" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://zailab.com/role/ShareBasedCompensationNonvestedRestrictedShareActivityDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#ShareBasedCompensationNonvestedRestrictedShareActivityDetails"/>
  <link:definitionLink xlink:role="http://zailab.com/role/ShareBasedCompensationNonvestedRestrictedShareActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a39e42e5-fded-4cf4-b4b8-1726aec08c09" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ec7532e0-470d-414b-bb07-23a2a1602c41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a39e42e5-fded-4cf4-b4b8-1726aec08c09" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ec7532e0-470d-414b-bb07-23a2a1602c41" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_41b59219-09b1-4eb7-b563-0fcfbc1b03ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ec7532e0-470d-414b-bb07-23a2a1602c41" xlink:to="loc_us-gaap_AwardTypeAxis_41b59219-09b1-4eb7-b563-0fcfbc1b03ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_41b59219-09b1-4eb7-b563-0fcfbc1b03ac_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_41b59219-09b1-4eb7-b563-0fcfbc1b03ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_41b59219-09b1-4eb7-b563-0fcfbc1b03ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9dd268cb-b445-4ae2-823a-8e9385007955" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_41b59219-09b1-4eb7-b563-0fcfbc1b03ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9dd268cb-b445-4ae2-823a-8e9385007955" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_NonVestedRestrictedSharesMember_53640b56-2274-46ed-b867-13a8b058fc3f" xlink:href="zlab-20231231.xsd#zlab_NonVestedRestrictedSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9dd268cb-b445-4ae2-823a-8e9385007955" xlink:to="loc_zlab_NonVestedRestrictedSharesMember_53640b56-2274-46ed-b867-13a8b058fc3f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_798a2457-5988-4e5e-a6e4-3337755ab05e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a39e42e5-fded-4cf4-b4b8-1726aec08c09" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_798a2457-5988-4e5e-a6e4-3337755ab05e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5a445d7b-6a30-4456-a360-2f13c2d41402" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_798a2457-5988-4e5e-a6e4-3337755ab05e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5a445d7b-6a30-4456-a360-2f13c2d41402" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_ffc4d17e-5b7a-4db7-832f-b278555acc27" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_798a2457-5988-4e5e-a6e4-3337755ab05e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_ffc4d17e-5b7a-4db7-832f-b278555acc27" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_eca252f5-0051-4549-9963-7ff8ece99aba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_798a2457-5988-4e5e-a6e4-3337755ab05e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_eca252f5-0051-4549-9963-7ff8ece99aba" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_22e7a336-aa58-4c72-9b93-6e7095d9f946" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_798a2457-5988-4e5e-a6e4-3337755ab05e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_22e7a336-aa58-4c72-9b93-6e7095d9f946" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_ee333a30-5a3b-4a43-b6e3-117fb40258d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_92932300-c4c4-4629-a16a-7e10d27ea478" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a39e42e5-fded-4cf4-b4b8-1726aec08c09" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_92932300-c4c4-4629-a16a-7e10d27ea478" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_592dc85c-2a68-477a-9702-9a5a0a3f2af3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a39e42e5-fded-4cf4-b4b8-1726aec08c09" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_592dc85c-2a68-477a-9702-9a5a0a3f2af3" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://zailab.com/role/ShareBasedCompensationCompensationExpenseDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#ShareBasedCompensationCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://zailab.com/role/ShareBasedCompensationCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_006101a4-e55c-4e2c-9382-963832a39fcc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1ac74218-2291-4d3c-a9e0-41db720b973d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_006101a4-e55c-4e2c-9382-963832a39fcc" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1ac74218-2291-4d3c-a9e0-41db720b973d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_371cb489-0798-4b89-b7d9-88616be7af25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1ac74218-2291-4d3c-a9e0-41db720b973d" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_371cb489-0798-4b89-b7d9-88616be7af25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_371cb489-0798-4b89-b7d9-88616be7af25_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_371cb489-0798-4b89-b7d9-88616be7af25" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_371cb489-0798-4b89-b7d9-88616be7af25_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8b05b8fc-12dc-41d9-8f92-f5d91c100752" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_371cb489-0798-4b89-b7d9-88616be7af25" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8b05b8fc-12dc-41d9-8f92-f5d91c100752" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_e1231d71-7c8b-4f71-b7c2-dab85bdb2f14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8b05b8fc-12dc-41d9-8f92-f5d91c100752" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_e1231d71-7c8b-4f71-b7c2-dab85bdb2f14" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_f3051ba5-217b-4a03-b9c3-59b56511883d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8b05b8fc-12dc-41d9-8f92-f5d91c100752" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_f3051ba5-217b-4a03-b9c3-59b56511883d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_05c5c25c-2920-4f82-8883-a0e2fe75af97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_006101a4-e55c-4e2c-9382-963832a39fcc" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_05c5c25c-2920-4f82-8883-a0e2fe75af97" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://zailab.com/role/LicenseandCollaborationAgreementsDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#LicenseandCollaborationAgreementsDetails"/>
  <link:definitionLink xlink:role="http://zailab.com/role/LicenseandCollaborationAgreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_12c963bd-e34d-47d3-9fb6-68ca392ea532" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_c0218d13-fa61-4317-81dc-31e83efd14a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_12c963bd-e34d-47d3-9fb6-68ca392ea532" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_c0218d13-fa61-4317-81dc-31e83efd14a9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_e9ef8fe8-94f8-4a96-8c23-8532a9541a9b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_c0218d13-fa61-4317-81dc-31e83efd14a9" xlink:to="loc_us-gaap_TypeOfArrangementAxis_e9ef8fe8-94f8-4a96-8c23-8532a9541a9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e9ef8fe8-94f8-4a96-8c23-8532a9541a9b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_e9ef8fe8-94f8-4a96-8c23-8532a9541a9b" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e9ef8fe8-94f8-4a96-8c23-8532a9541a9b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_94fa9a22-0d6e-4b62-b636-9a81b9f538c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_e9ef8fe8-94f8-4a96-8c23-8532a9541a9b" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_94fa9a22-0d6e-4b62-b636-9a81b9f538c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_b5204d6a-4d96-4c27-a0bc-04ae5c33b3f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_94fa9a22-0d6e-4b62-b636-9a81b9f538c0" xlink:to="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_b5204d6a-4d96-4c27-a0bc-04ae5c33b3f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_ccff4d9d-cdb2-4f76-9363-fb037218c468" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_c0218d13-fa61-4317-81dc-31e83efd14a9" xlink:to="loc_srt_CounterpartyNameAxis_ccff4d9d-cdb2-4f76-9363-fb037218c468" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ccff4d9d-cdb2-4f76-9363-fb037218c468_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_ccff4d9d-cdb2-4f76-9363-fb037218c468" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ccff4d9d-cdb2-4f76-9363-fb037218c468_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4deff456-9b6b-4979-a5fc-f40e7b0436f9" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_ccff4d9d-cdb2-4f76-9363-fb037218c468" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4deff456-9b6b-4979-a5fc-f40e7b0436f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_GlaxoSmithKlineMember_a1fcad19-9a9b-4b27-aa4e-1cf1cff0365d" xlink:href="zlab-20231231.xsd#zlab_GlaxoSmithKlineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4deff456-9b6b-4979-a5fc-f40e7b0436f9" xlink:to="loc_zlab_GlaxoSmithKlineMember_a1fcad19-9a9b-4b27-aa4e-1cf1cff0365d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_NovocureLimitedMember_601884d7-ebf0-4b73-8e7e-4d2958ec0548" xlink:href="zlab-20231231.xsd#zlab_NovocureLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4deff456-9b6b-4979-a5fc-f40e7b0436f9" xlink:to="loc_zlab_NovocureLimitedMember_601884d7-ebf0-4b73-8e7e-4d2958ec0548" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_DecipheraPharmaceuticalsLLCMember_7d9bc589-c217-45b1-acf7-0c2ed6368c79" xlink:href="zlab-20231231.xsd#zlab_DecipheraPharmaceuticalsLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4deff456-9b6b-4979-a5fc-f40e7b0436f9" xlink:to="loc_zlab_DecipheraPharmaceuticalsLLCMember_7d9bc589-c217-45b1-acf7-0c2ed6368c79" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_GurnetPointCapitalAndNovoHoldingsASMember_8b4dfc64-98e2-4491-b74e-fb65b4b69f7a" xlink:href="zlab-20231231.xsd#zlab_GurnetPointCapitalAndNovoHoldingsASMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4deff456-9b6b-4979-a5fc-f40e7b0436f9" xlink:to="loc_zlab_GurnetPointCapitalAndNovoHoldingsASMember_8b4dfc64-98e2-4491-b74e-fb65b4b69f7a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ArgenxBvMember_c9294563-50ef-4417-ad49-ffa7353d350d" xlink:href="zlab-20231231.xsd#zlab_ArgenxBvMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4deff456-9b6b-4979-a5fc-f40e7b0436f9" xlink:to="loc_zlab_ArgenxBvMember_c9294563-50ef-4417-ad49-ffa7353d350d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_AmgenMember_4c749202-48ec-4814-abb6-495894ac90cc" xlink:href="zlab-20231231.xsd#zlab_AmgenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4deff456-9b6b-4979-a5fc-f40e7b0436f9" xlink:to="loc_zlab_AmgenMember_4c749202-48ec-4814-abb6-495894ac90cc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_InnovivaInc.Member_c70282b0-b8b1-48c4-81a2-d23637f42496" xlink:href="zlab-20231231.xsd#zlab_InnovivaInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4deff456-9b6b-4979-a5fc-f40e7b0436f9" xlink:to="loc_zlab_InnovivaInc.Member_c70282b0-b8b1-48c4-81a2-d23637f42496" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_BMSMember_6fbbb2b5-8d65-4c7a-aa03-9729a1bd9778" xlink:href="zlab-20231231.xsd#zlab_BMSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4deff456-9b6b-4979-a5fc-f40e7b0436f9" xlink:to="loc_zlab_BMSMember_6fbbb2b5-8d65-4c7a-aa03-9729a1bd9778" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_PfizerIncMember_de954c8b-1028-4fbd-86f4-adebfdac015e" xlink:href="zlab-20231231.xsd#zlab_PfizerIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4deff456-9b6b-4979-a5fc-f40e7b0436f9" xlink:to="loc_zlab_PfizerIncMember_de954c8b-1028-4fbd-86f4-adebfdac015e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_OtherCounterpartiesMember_ccd19546-7e75-4f3e-a67f-418a9b64df83" xlink:href="zlab-20231231.xsd#zlab_OtherCounterpartiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4deff456-9b6b-4979-a5fc-f40e7b0436f9" xlink:to="loc_zlab_OtherCounterpartiesMember_ccd19546-7e75-4f3e-a67f-418a9b64df83" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_90bf6a7a-67cd-440d-a101-7ad4665f403e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_c0218d13-fa61-4317-81dc-31e83efd14a9" xlink:to="loc_srt_ProductOrServiceAxis_90bf6a7a-67cd-440d-a101-7ad4665f403e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_90bf6a7a-67cd-440d-a101-7ad4665f403e_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_90bf6a7a-67cd-440d-a101-7ad4665f403e" xlink:to="loc_srt_ProductsAndServicesDomain_90bf6a7a-67cd-440d-a101-7ad4665f403e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e53dc2bd-221b-4311-b2f8-b417c30406f6" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_90bf6a7a-67cd-440d-a101-7ad4665f403e" xlink:to="loc_srt_ProductsAndServicesDomain_e53dc2bd-221b-4311-b2f8-b417c30406f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_RepotrectinibMember_e5a3aca7-854a-4eae-a772-4095ee80740c" xlink:href="zlab-20231231.xsd#zlab_RepotrectinibMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_e53dc2bd-221b-4311-b2f8-b417c30406f6" xlink:to="loc_zlab_RepotrectinibMember_e5a3aca7-854a-4eae-a772-4095ee80740c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_AdagrasibMember_faab749f-9c8f-4fa1-a88e-88b81199c4cc" xlink:href="zlab-20231231.xsd#zlab_AdagrasibMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_e53dc2bd-221b-4311-b2f8-b417c30406f6" xlink:to="loc_zlab_AdagrasibMember_faab749f-9c8f-4fa1-a88e-88b81199c4cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_XanomelineTrospiumMember_59e93ede-7892-4d7b-8636-f55360b5cc43" xlink:href="zlab-20231231.xsd#zlab_XanomelineTrospiumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_e53dc2bd-221b-4311-b2f8-b417c30406f6" xlink:to="loc_zlab_XanomelineTrospiumMember_59e93ede-7892-4d7b-8636-f55360b5cc43" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_CollaborativeArrangementRightsAndObligationsSpecifiedRoyaltyTerm_872cdafa-f7ad-4f30-88ee-68b6c743ac9c" xlink:href="zlab-20231231.xsd#zlab_CollaborativeArrangementRightsAndObligationsSpecifiedRoyaltyTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_12c963bd-e34d-47d3-9fb6-68ca392ea532" xlink:to="loc_zlab_CollaborativeArrangementRightsAndObligationsSpecifiedRoyaltyTerm_872cdafa-f7ad-4f30-88ee-68b6c743ac9c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_ce0739d1-d40c-46c3-a0ce-59519ac1a979" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_12c963bd-e34d-47d3-9fb6-68ca392ea532" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_ce0739d1-d40c-46c3-a0ce-59519ac1a979" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_CollaborativeArrangementRightsAndObligationsSalesBasedMilestonePayment_08807dd7-b789-4a9d-9bcf-395debed14f7" xlink:href="zlab-20231231.xsd#zlab_CollaborativeArrangementRightsAndObligationsSalesBasedMilestonePayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_12c963bd-e34d-47d3-9fb6-68ca392ea532" xlink:to="loc_zlab_CollaborativeArrangementRightsAndObligationsSalesBasedMilestonePayment_08807dd7-b789-4a9d-9bcf-395debed14f7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments_10a5e468-3af9-425a-8211-6551c91aae76" xlink:href="zlab-20231231.xsd#zlab_CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_12c963bd-e34d-47d3-9fb6-68ca392ea532" xlink:to="loc_zlab_CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments_10a5e468-3af9-425a-8211-6551c91aae76" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_86e6b9e6-4771-4d53-a111-016333d74bb3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_12c963bd-e34d-47d3-9fb6-68ca392ea532" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_86e6b9e6-4771-4d53-a111-016333d74bb3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_CollaborativeArrangementRightsAndObligationsPaymentOfUpFrontFeesForLicenseAgreement_3925e295-6c57-49b9-beb9-64127d749323" xlink:href="zlab-20231231.xsd#zlab_CollaborativeArrangementRightsAndObligationsPaymentOfUpFrontFeesForLicenseAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_12c963bd-e34d-47d3-9fb6-68ca392ea532" xlink:to="loc_zlab_CollaborativeArrangementRightsAndObligationsPaymentOfUpFrontFeesForLicenseAgreement_3925e295-6c57-49b9-beb9-64127d749323" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_CollaborativeArrangementRightsAndObligationsDevelopmentMilestonePayment_070244cc-089b-46ad-bda7-243f316cca06" xlink:href="zlab-20231231.xsd#zlab_CollaborativeArrangementRightsAndObligationsDevelopmentMilestonePayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_12c963bd-e34d-47d3-9fb6-68ca392ea532" xlink:to="loc_zlab_CollaborativeArrangementRightsAndObligationsDevelopmentMilestonePayment_070244cc-089b-46ad-bda7-243f316cca06" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://zailab.com/role/RestrictedNetAssetsDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#RestrictedNetAssetsDetails"/>
  <link:definitionLink xlink:role="http://zailab.com/role/RestrictedNetAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_zlab_RestrictedNetAssetsLineItems_48545c19-ede8-4d63-8f89-aec736045879" xlink:href="zlab-20231231.xsd#zlab_RestrictedNetAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_RestrictedNetAssetsTable_1a1f6522-fcad-4750-95ec-0676fa5b401e" xlink:href="zlab-20231231.xsd#zlab_RestrictedNetAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_zlab_RestrictedNetAssetsLineItems_48545c19-ede8-4d63-8f89-aec736045879" xlink:to="loc_zlab_RestrictedNetAssetsTable_1a1f6522-fcad-4750-95ec-0676fa5b401e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_9dc0ad04-375f-47c8-ab02-0bc84710a298" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_zlab_RestrictedNetAssetsTable_1a1f6522-fcad-4750-95ec-0676fa5b401e" xlink:to="loc_srt_StatementGeographicalAxis_9dc0ad04-375f-47c8-ab02-0bc84710a298" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_9dc0ad04-375f-47c8-ab02-0bc84710a298_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_9dc0ad04-375f-47c8-ab02-0bc84710a298" xlink:to="loc_srt_SegmentGeographicalDomain_9dc0ad04-375f-47c8-ab02-0bc84710a298_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_0d433946-6256-40d4-94d4-81b4095d8ded" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_9dc0ad04-375f-47c8-ab02-0bc84710a298" xlink:to="loc_srt_SegmentGeographicalDomain_0d433946-6256-40d4-94d4-81b4095d8ded" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN_2b7619d5-009b-4033-bfc5-37f31c7b1481" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_CN"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_0d433946-6256-40d4-94d4-81b4095d8ded" xlink:to="loc_country_CN_2b7619d5-009b-4033-bfc5-37f31c7b1481" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_StatutoryReserves_cfdde950-5d4f-4fc9-acf2-06ecfe7f78b7" xlink:href="zlab-20231231.xsd#zlab_StatutoryReserves"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zlab_RestrictedNetAssetsLineItems_48545c19-ede8-4d63-8f89-aec736045879" xlink:to="loc_zlab_StatutoryReserves_cfdde950-5d4f-4fc9-acf2-06ecfe7f78b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries_6ec30ff1-e19b-4662-a6fd-c35fba4699ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zlab_RestrictedNetAssetsLineItems_48545c19-ede8-4d63-8f89-aec736045879" xlink:to="loc_us-gaap_AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries_6ec30ff1-e19b-4662-a6fd-c35fba4699ce" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://zailab.com/role/EmployeeDefinedContributionPlansDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#EmployeeDefinedContributionPlansDetails"/>
  <link:definitionLink xlink:role="http://zailab.com/role/EmployeeDefinedContributionPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanDisclosureLineItems_77dc50f2-72b1-466e-92a7-8bc7571ef123" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanTable_8143cb64-ec6a-4aa3-90e5-34c4a8d6103c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedContributionPlanDisclosureLineItems_77dc50f2-72b1-466e-92a7-8bc7571ef123" xlink:to="loc_us-gaap_DefinedContributionPlanTable_8143cb64-ec6a-4aa3-90e5-34c4a8d6103c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e81af527-6d9d-45e2-943e-b8cfbf3f2019" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedContributionPlanTable_8143cb64-ec6a-4aa3-90e5-34c4a8d6103c" xlink:to="loc_srt_RangeAxis_e81af527-6d9d-45e2-943e-b8cfbf3f2019" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e81af527-6d9d-45e2-943e-b8cfbf3f2019_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_e81af527-6d9d-45e2-943e-b8cfbf3f2019" xlink:to="loc_srt_RangeMember_e81af527-6d9d-45e2-943e-b8cfbf3f2019_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_19e7fad2-0886-46dc-b23f-d3c9d57d0ed8" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_e81af527-6d9d-45e2-943e-b8cfbf3f2019" xlink:to="loc_srt_RangeMember_19e7fad2-0886-46dc-b23f-d3c9d57d0ed8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_27d3489c-965f-4ffd-a12b-d154519f13a3" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_19e7fad2-0886-46dc-b23f-d3c9d57d0ed8" xlink:to="loc_srt_MaximumMember_27d3489c-965f-4ffd-a12b-d154519f13a3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_d08471f4-89ff-42d2-ac30-57ce11f1e7be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedContributionPlanTable_8143cb64-ec6a-4aa3-90e5-34c4a8d6103c" xlink:to="loc_us-gaap_RetirementPlanNameAxis_d08471f4-89ff-42d2-ac30-57ce11f1e7be" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_d08471f4-89ff-42d2-ac30-57ce11f1e7be_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanNameAxis_d08471f4-89ff-42d2-ac30-57ce11f1e7be" xlink:to="loc_us-gaap_RetirementPlanNameDomain_d08471f4-89ff-42d2-ac30-57ce11f1e7be_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_ba73fc47-7ade-48f6-a698-fcbd4018ace5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanNameAxis_d08471f4-89ff-42d2-ac30-57ce11f1e7be" xlink:to="loc_us-gaap_RetirementPlanNameDomain_ba73fc47-7ade-48f6-a698-fcbd4018ace5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_MainlandChinaGovernmentPlanMember_0a91e5c4-48f0-44d2-954e-a9737bcadcee" xlink:href="zlab-20231231.xsd#zlab_MainlandChinaGovernmentPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_ba73fc47-7ade-48f6-a698-fcbd4018ace5" xlink:to="loc_zlab_MainlandChinaGovernmentPlanMember_0a91e5c4-48f0-44d2-954e-a9737bcadcee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_A401kPlanMember_cf215cc5-10ea-4789-b65f-15ef741c6c87" xlink:href="zlab-20231231.xsd#zlab_A401kPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_ba73fc47-7ade-48f6-a698-fcbd4018ace5" xlink:to="loc_zlab_A401kPlanMember_cf215cc5-10ea-4789-b65f-15ef741c6c87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_MandatoryProvidentFundMember_b83f0a6e-f299-49c2-8108-560860ffde4c" xlink:href="zlab-20231231.xsd#zlab_MandatoryProvidentFundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_ba73fc47-7ade-48f6-a698-fcbd4018ace5" xlink:to="loc_zlab_MandatoryProvidentFundMember_b83f0a6e-f299-49c2-8108-560860ffde4c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_02859650-ea71-4b20-9da8-477118043965" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedContributionPlanDisclosureLineItems_77dc50f2-72b1-466e-92a7-8bc7571ef123" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_02859650-ea71-4b20-9da8-477118043965" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_cab63296-9630-414b-b4e4-30ea57c7f95b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedContributionPlanDisclosureLineItems_77dc50f2-72b1-466e-92a7-8bc7571ef123" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_cab63296-9630-414b-b4e4-30ea57c7f95b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_DefinedContributionPlanEmployerMatchingContributionPercentOfEmployeeContribution_fca0d975-246c-42a5-8779-1f808048a760" xlink:href="zlab-20231231.xsd#zlab_DefinedContributionPlanEmployerMatchingContributionPercentOfEmployeeContribution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedContributionPlanDisclosureLineItems_77dc50f2-72b1-466e-92a7-8bc7571ef123" xlink:to="loc_zlab_DefinedContributionPlanEmployerMatchingContributionPercentOfEmployeeContribution_fca0d975-246c-42a5-8779-1f808048a760" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_3e35e7ac-f7ba-4fbb-9532-b5c039034997" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedContributionPlanDisclosureLineItems_77dc50f2-72b1-466e-92a7-8bc7571ef123" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_3e35e7ac-f7ba-4fbb-9532-b5c039034997" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://zailab.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#CommitmentsandContingenciesDetails"/>
  <link:definitionLink xlink:role="http://zailab.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_75a83c22-cac7-416f-9cbb-60a7c79fbb03" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_e58d2381-9fd7-4f54-bf05-afc6c09f2897" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_75a83c22-cac7-416f-9cbb-60a7c79fbb03" xlink:to="loc_us-gaap_LossContingenciesTable_e58d2381-9fd7-4f54-bf05-afc6c09f2897" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_86a952c5-88a3-4b60-93aa-075aadef4b82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_e58d2381-9fd7-4f54-bf05-afc6c09f2897" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_86a952c5-88a3-4b60-93aa-075aadef4b82" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_86a952c5-88a3-4b60-93aa-075aadef4b82_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_86a952c5-88a3-4b60-93aa-075aadef4b82" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_86a952c5-88a3-4b60-93aa-075aadef4b82_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_ee24d9f2-d397-49e4-8098-7ae955fc5fd8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_86a952c5-88a3-4b60-93aa-075aadef4b82" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_ee24d9f2-d397-49e4-8098-7ae955fc5fd8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_7b935870-d6a0-4ce0-b13b-b4edae920679" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_ee24d9f2-d397-49e4-8098-7ae955fc5fd8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_7b935870-d6a0-4ce0-b13b-b4edae920679" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationDueInNextRollingTwelveMonths_17c91d87-e5bc-485d-959a-4e8bcfa078b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationDueInNextRollingTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_75a83c22-cac7-416f-9cbb-60a7c79fbb03" xlink:to="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationDueInNextRollingTwelveMonths_17c91d87-e5bc-485d-959a-4e8bcfa078b2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://zailab.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#SubsequentEventsDetails"/>
  <link:definitionLink xlink:role="http://zailab.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_1187d88e-86f7-43b6-af3b-d675d67e57df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_cdbe2fc7-d0c5-405c-9258-bbc4ad653f6f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_1187d88e-86f7-43b6-af3b-d675d67e57df" xlink:to="loc_us-gaap_SubsequentEventTable_cdbe2fc7-d0c5-405c-9258-bbc4ad653f6f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_0a6d44df-aa9b-495f-b977-7ee34c8530f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_cdbe2fc7-d0c5-405c-9258-bbc4ad653f6f" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_0a6d44df-aa9b-495f-b977-7ee34c8530f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_0a6d44df-aa9b-495f-b977-7ee34c8530f7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_0a6d44df-aa9b-495f-b977-7ee34c8530f7" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_0a6d44df-aa9b-495f-b977-7ee34c8530f7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_10f9b45a-483d-49a8-bf56-bf838433c42e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_0a6d44df-aa9b-495f-b977-7ee34c8530f7" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_10f9b45a-483d-49a8-bf56-bf838433c42e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_bd1f10e4-e521-46ee-a166-c41fd4c1afc0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_10f9b45a-483d-49a8-bf56-bf838433c42e" xlink:to="loc_us-gaap_SubsequentEventMember_bd1f10e4-e521-46ee-a166-c41fd4c1afc0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_984853fd-30a0-4904-a5b0-540c59e5c3ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_cdbe2fc7-d0c5-405c-9258-bbc4ad653f6f" xlink:to="loc_us-gaap_DebtInstrumentAxis_984853fd-30a0-4904-a5b0-540c59e5c3ac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_984853fd-30a0-4904-a5b0-540c59e5c3ac_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_984853fd-30a0-4904-a5b0-540c59e5c3ac" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_984853fd-30a0-4904-a5b0-540c59e5c3ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_cad4921c-9560-4e53-99c9-3d5ce50040e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_984853fd-30a0-4904-a5b0-540c59e5c3ac" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_cad4921c-9560-4e53-99c9-3d5ce50040e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_BankOfChinaWorkingCapitalLoanFacilityMember_51933de1-ab29-4e15-9d0f-9253ef5b82c3" xlink:href="zlab-20231231.xsd#zlab_BankOfChinaWorkingCapitalLoanFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cad4921c-9560-4e53-99c9-3d5ce50040e8" xlink:to="loc_zlab_BankOfChinaWorkingCapitalLoanFacilityMember_51933de1-ab29-4e15-9d0f-9253ef5b82c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_SPDBankWorkingCapitalLoanFacilityMember_ddb466c6-03bc-41b4-92c6-f545f93c59b1" xlink:href="zlab-20231231.xsd#zlab_SPDBankWorkingCapitalLoanFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cad4921c-9560-4e53-99c9-3d5ce50040e8" xlink:to="loc_zlab_SPDBankWorkingCapitalLoanFacilityMember_ddb466c6-03bc-41b4-92c6-f545f93c59b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_NingboBankWorkingCapitalLoanFacilityMember_28f9ab4a-3bd1-4094-84a9-cc7541e425a0" xlink:href="zlab-20231231.xsd#zlab_NingboBankWorkingCapitalLoanFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cad4921c-9560-4e53-99c9-3d5ce50040e8" xlink:to="loc_zlab_NingboBankWorkingCapitalLoanFacilityMember_28f9ab4a-3bd1-4094-84a9-cc7541e425a0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_c265b018-af8e-49a0-bb3d-6b6f66f75d7c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_cdbe2fc7-d0c5-405c-9258-bbc4ad653f6f" xlink:to="loc_us-gaap_CreditFacilityAxis_c265b018-af8e-49a0-bb3d-6b6f66f75d7c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_c265b018-af8e-49a0-bb3d-6b6f66f75d7c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_c265b018-af8e-49a0-bb3d-6b6f66f75d7c" xlink:to="loc_us-gaap_CreditFacilityDomain_c265b018-af8e-49a0-bb3d-6b6f66f75d7c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_4612f2c4-e540-44f2-aae0-5fcbad32d45c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_c265b018-af8e-49a0-bb3d-6b6f66f75d7c" xlink:to="loc_us-gaap_CreditFacilityDomain_4612f2c4-e540-44f2-aae0-5fcbad32d45c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandbyLettersOfCreditMember_cf7cc379-b73f-4637-b6e6-c30247c0e7f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StandbyLettersOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_4612f2c4-e540-44f2-aae0-5fcbad32d45c" xlink:to="loc_us-gaap_StandbyLettersOfCreditMember_cf7cc379-b73f-4637-b6e6-c30247c0e7f6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_bad32c49-e349-43eb-8694-f871e66e46fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_cdbe2fc7-d0c5-405c-9258-bbc4ad653f6f" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_bad32c49-e349-43eb-8694-f871e66e46fc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_bad32c49-e349-43eb-8694-f871e66e46fc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_bad32c49-e349-43eb-8694-f871e66e46fc" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_bad32c49-e349-43eb-8694-f871e66e46fc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_74ff1745-bc2e-4e59-8b03-ce45906cdfd4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_bad32c49-e349-43eb-8694-f871e66e46fc" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_74ff1745-bc2e-4e59-8b03-ce45906cdfd4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_412b2a69-fc5a-4002-add5-baa429501245" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_74ff1745-bc2e-4e59-8b03-ce45906cdfd4" xlink:to="loc_us-gaap_LoansPayableMember_412b2a69-fc5a-4002-add5-baa429501245" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_4bf2dd52-02bd-4484-a676-7cc9d9927a07" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_cdbe2fc7-d0c5-405c-9258-bbc4ad653f6f" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_4bf2dd52-02bd-4484-a676-7cc9d9927a07" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4bf2dd52-02bd-4484-a676-7cc9d9927a07_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_4bf2dd52-02bd-4484-a676-7cc9d9927a07" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4bf2dd52-02bd-4484-a676-7cc9d9927a07_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f01f0048-e93d-424a-aa23-b58f5f008784" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_4bf2dd52-02bd-4484-a676-7cc9d9927a07" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f01f0048-e93d-424a-aa23-b58f5f008784" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_98dca4e9-a0d8-40e6-a460-bfafcaf25388" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f01f0048-e93d-424a-aa23-b58f5f008784" xlink:to="loc_us-gaap_LoansPayableMember_98dca4e9-a0d8-40e6-a460-bfafcaf25388" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_2c4d6509-862e-475c-8a2d-65cdd9d90713" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_cdbe2fc7-d0c5-405c-9258-bbc4ad653f6f" xlink:to="loc_dei_LegalEntityAxis_2c4d6509-862e-475c-8a2d-65cdd9d90713" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_2c4d6509-862e-475c-8a2d-65cdd9d90713_default" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_2c4d6509-862e-475c-8a2d-65cdd9d90713" xlink:to="loc_dei_EntityDomain_2c4d6509-862e-475c-8a2d-65cdd9d90713_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_13cfafd7-30cf-4d3d-86ee-a8c1822fbf54" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_2c4d6509-862e-475c-8a2d-65cdd9d90713" xlink:to="loc_dei_EntityDomain_13cfafd7-30cf-4d3d-86ee-a8c1822fbf54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ZaiLabShanghaiCo.Ltd.Member_bbbc84d7-06f6-4c6c-9f29-153fd2187bd5" xlink:href="zlab-20231231.xsd#zlab_ZaiLabShanghaiCo.Ltd.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_13cfafd7-30cf-4d3d-86ee-a8c1822fbf54" xlink:to="loc_zlab_ZaiLabShanghaiCo.Ltd.Member_bbbc84d7-06f6-4c6c-9f29-153fd2187bd5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ZaiLabSuzhouCompanyLimitedMember_f5da70c8-27cc-47b2-8ed4-f8be29061f73" xlink:href="zlab-20231231.xsd#zlab_ZaiLabSuzhouCompanyLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_13cfafd7-30cf-4d3d-86ee-a8c1822fbf54" xlink:to="loc_zlab_ZaiLabSuzhouCompanyLimitedMember_f5da70c8-27cc-47b2-8ed4-f8be29061f73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_49b6368f-5b25-456f-8de7-a47b5d783fa7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_1187d88e-86f7-43b6-af3b-d675d67e57df" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_49b6368f-5b25-456f-8de7-a47b5d783fa7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_afe3d35c-f8fa-488f-b602-430e10fa6671" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_1187d88e-86f7-43b6-af3b-d675d67e57df" xlink:to="loc_us-gaap_DebtInstrumentTerm_afe3d35c-f8fa-488f-b602-430e10fa6671" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFeeAmount_16fbdade-ecc0-466a-88d2-75d45593f768" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFeeAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_1187d88e-86f7-43b6-af3b-d675d67e57df" xlink:to="loc_us-gaap_DebtInstrumentFeeAmount_16fbdade-ecc0-466a-88d2-75d45593f768" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_1453dbb4-4afb-4511-a67c-91f294b43d00" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_1187d88e-86f7-43b6-af3b-d675d67e57df" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_1453dbb4-4afb-4511-a67c-91f294b43d00" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_365d57a9-3247-4298-b6cb-fab83b3a6268" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_1187d88e-86f7-43b6-af3b-d675d67e57df" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_365d57a9-3247-4298-b6cb-fab83b3a6268" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_91cce23c-f07c-4da7-a3b5-87cc2dcd8148" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_1187d88e-86f7-43b6-af3b-d675d67e57df" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_91cce23c-f07c-4da7-a3b5-87cc2dcd8148" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_DebtInstrumentVariableInterestRateAdjustmentPeriod_bf2ae755-f467-474b-ac08-7a599a42304b" xlink:href="zlab-20231231.xsd#zlab_DebtInstrumentVariableInterestRateAdjustmentPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_1187d88e-86f7-43b6-af3b-d675d67e57df" xlink:to="loc_zlab_DebtInstrumentVariableInterestRateAdjustmentPeriod_bf2ae755-f467-474b-ac08-7a599a42304b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsMaximumExposure_6da2aec7-d3ee-4632-81ba-7d525271a6a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GuaranteeObligationsMaximumExposure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_1187d88e-86f7-43b6-af3b-d675d67e57df" xlink:to="loc_us-gaap_GuaranteeObligationsMaximumExposure_6da2aec7-d3ee-4632-81ba-7d525271a6a1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_GuarantorObligationTerm_cb3940bd-310d-43c1-a27c-0c24660dbfc5" xlink:href="zlab-20231231.xsd#zlab_GuarantorObligationTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_1187d88e-86f7-43b6-af3b-d675d67e57df" xlink:to="loc_zlab_GuarantorObligationTerm_cb3940bd-310d-43c1-a27c-0c24660dbfc5" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#ScheduleICondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"/>
  <link:definitionLink xlink:role="http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_c2019ead-d8e9-405f-a236-db9881297e6c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CondensedBalanceSheetStatementsCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedBalanceSheetStatementTable_1a0c7e42-6f75-44b2-b494-d99e3d06fba0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CondensedBalanceSheetStatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_c2019ead-d8e9-405f-a236-db9881297e6c" xlink:to="loc_srt_CondensedBalanceSheetStatementTable_1a0c7e42-6f75-44b2-b494-d99e3d06fba0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_721b3087-325c-4c78-89a2-74ad05c5d509" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_CondensedBalanceSheetStatementTable_1a0c7e42-6f75-44b2-b494-d99e3d06fba0" xlink:to="loc_srt_ConsolidatedEntitiesAxis_721b3087-325c-4c78-89a2-74ad05c5d509" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_721b3087-325c-4c78-89a2-74ad05c5d509_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_721b3087-325c-4c78-89a2-74ad05c5d509" xlink:to="loc_srt_ConsolidatedEntitiesDomain_721b3087-325c-4c78-89a2-74ad05c5d509_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_f39afbb3-527d-4b19-ba63-9ac72da7f1c2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_721b3087-325c-4c78-89a2-74ad05c5d509" xlink:to="loc_srt_ConsolidatedEntitiesDomain_f39afbb3-527d-4b19-ba63-9ac72da7f1c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_bc416e2d-1e67-427f-ae19-e07a49521db4" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ParentCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_f39afbb3-527d-4b19-ba63-9ac72da7f1c2" xlink:to="loc_srt_ParentCompanyMember_bc416e2d-1e67-427f-ae19-e07a49521db4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_5c69cf70-32fd-4217-bfea-6499cac4c826" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_c2019ead-d8e9-405f-a236-db9881297e6c" xlink:to="loc_us-gaap_AssetsAbstract_5c69cf70-32fd-4217-bfea-6499cac4c826" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_84142334-a463-486d-8c3c-869a02411c90" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_5c69cf70-32fd-4217-bfea-6499cac4c826" xlink:to="loc_us-gaap_AssetsCurrentAbstract_84142334-a463-486d-8c3c-869a02411c90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f7c38c96-162e-46b5-9a9b-b8c2ff2a3b52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_84142334-a463-486d-8c3c-869a02411c90" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f7c38c96-162e-46b5-9a9b-b8c2ff2a3b52" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_bb969b82-9648-484e-9156-c61cd93bba8f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_84142334-a463-486d-8c3c-869a02411c90" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_bb969b82-9648-484e-9156-c61cd93bba8f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_f8c12ea6-b5e8-4da1-b376-c2dfaf973fa1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_84142334-a463-486d-8c3c-869a02411c90" xlink:to="loc_us-gaap_AssetsCurrent_f8c12ea6-b5e8-4da1-b376-c2dfaf973fa1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_0abf41fd-8eda-49ab-b38b-9dc317b49ea2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_5c69cf70-32fd-4217-bfea-6499cac4c826" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_0abf41fd-8eda-49ab-b38b-9dc317b49ea2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_829677d2-22ff-4973-b778-2a0f91b113fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_5c69cf70-32fd-4217-bfea-6499cac4c826" xlink:to="loc_us-gaap_Assets_829677d2-22ff-4973-b778-2a0f91b113fa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8db7998d-c202-40be-bc3e-67f3888d99e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_c2019ead-d8e9-405f-a236-db9881297e6c" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8db7998d-c202-40be-bc3e-67f3888d99e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_cdb3faca-65f7-472e-adc4-7e2b6215600c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8db7998d-c202-40be-bc3e-67f3888d99e0" xlink:to="loc_us-gaap_LiabilitiesAbstract_cdb3faca-65f7-472e-adc4-7e2b6215600c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_a65c5630-8162-438b-84b2-153aa97877a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_cdb3faca-65f7-472e-adc4-7e2b6215600c" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_a65c5630-8162-438b-84b2-153aa97877a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_fc2989a1-c2f9-4f98-a88f-7956bfca062d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_a65c5630-8162-438b-84b2-153aa97877a0" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_fc2989a1-c2f9-4f98-a88f-7956bfca062d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_1239a97f-5e20-46d5-935c-5da338f926f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_a65c5630-8162-438b-84b2-153aa97877a0" xlink:to="loc_us-gaap_LiabilitiesCurrent_1239a97f-5e20-46d5-935c-5da338f926f0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_eae03754-885f-4413-8e4f-b94643ea172a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_cdb3faca-65f7-472e-adc4-7e2b6215600c" xlink:to="loc_us-gaap_Liabilities_eae03754-885f-4413-8e4f-b94643ea172a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_de63ae34-4de1-42b5-bce5-4bf8be933a68" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8db7998d-c202-40be-bc3e-67f3888d99e0" xlink:to="loc_us-gaap_StockholdersEquityAbstract_de63ae34-4de1-42b5-bce5-4bf8be933a68" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_6b0101c3-c78a-41d1-8361-c04e437324a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_de63ae34-4de1-42b5-bce5-4bf8be933a68" xlink:to="loc_us-gaap_CommonStockValue_6b0101c3-c78a-41d1-8361-c04e437324a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_d1601b96-eeca-4d81-b71d-5b07e8119237" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_de63ae34-4de1-42b5-bce5-4bf8be933a68" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_d1601b96-eeca-4d81-b71d-5b07e8119237" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_41d54fc8-b493-4b13-8102-e59e57d75bc1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_de63ae34-4de1-42b5-bce5-4bf8be933a68" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_41d54fc8-b493-4b13-8102-e59e57d75bc1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9108e470-b1de-4db6-9879-5103f2da095d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_de63ae34-4de1-42b5-bce5-4bf8be933a68" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9108e470-b1de-4db6-9879-5103f2da095d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_b5996b2e-ddaa-4d58-b45b-dcdb866fbfe0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_de63ae34-4de1-42b5-bce5-4bf8be933a68" xlink:to="loc_us-gaap_TreasuryStockCommonValue_b5996b2e-ddaa-4d58-b45b-dcdb866fbfe0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_734eab33-4f80-441d-b648-ec14743c7231" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_de63ae34-4de1-42b5-bce5-4bf8be933a68" xlink:to="loc_us-gaap_StockholdersEquity_734eab33-4f80-441d-b648-ec14743c7231" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_92dca2ea-4ca8-4794-b160-2fa14dc06609" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8db7998d-c202-40be-bc3e-67f3888d99e0" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_92dca2ea-4ca8-4794-b160-2fa14dc06609" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract_d5afd51a-712c-42c8-85b7-e7b711965d92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_c2019ead-d8e9-405f-a236-db9881297e6c" xlink:to="loc_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract_d5afd51a-712c-42c8-85b7-e7b711965d92" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_29787849-7ee7-481d-b549-46f4e5a013e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract_d5afd51a-712c-42c8-85b7-e7b711965d92" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_29787849-7ee7-481d-b549-46f4e5a013e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_7c3a1a8e-44dd-4a9e-831b-83b9a8f17d9f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract_d5afd51a-712c-42c8-85b7-e7b711965d92" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_7c3a1a8e-44dd-4a9e-831b-83b9a8f17d9f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_e147a036-5189-455a-909d-2bf5a8ae86af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract_d5afd51a-712c-42c8-85b7-e7b711965d92" xlink:to="loc_us-gaap_CommonStockSharesIssued_e147a036-5189-455a-909d-2bf5a8ae86af" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_6dcc8088-16ff-4106-ab1d-2df7e8b45bd5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract_d5afd51a-712c-42c8-85b7-e7b711965d92" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_6dcc8088-16ff-4106-ab1d-2df7e8b45bd5" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofOperationsandComprehensiveLossDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofOperationsandComprehensiveLossDetails"/>
  <link:definitionLink xlink:role="http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofOperationsandComprehensiveLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedIncomeStatementsCaptionsLineItems_ed9c4a60-ba78-4ae3-8635-770ac8c56eae" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CondensedIncomeStatementsCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedIncomeStatementTable_fac82f4c-39ab-4f03-a429-4515e1c58353" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CondensedIncomeStatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_CondensedIncomeStatementsCaptionsLineItems_ed9c4a60-ba78-4ae3-8635-770ac8c56eae" xlink:to="loc_srt_CondensedIncomeStatementTable_fac82f4c-39ab-4f03-a429-4515e1c58353" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_7b7f0526-a25b-41e7-96c0-7b97ab06173b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_CondensedIncomeStatementTable_fac82f4c-39ab-4f03-a429-4515e1c58353" xlink:to="loc_srt_ConsolidatedEntitiesAxis_7b7f0526-a25b-41e7-96c0-7b97ab06173b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_7b7f0526-a25b-41e7-96c0-7b97ab06173b_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_7b7f0526-a25b-41e7-96c0-7b97ab06173b" xlink:to="loc_srt_ConsolidatedEntitiesDomain_7b7f0526-a25b-41e7-96c0-7b97ab06173b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_66f2e296-07d0-432e-be8e-ae5ce05b8328" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_7b7f0526-a25b-41e7-96c0-7b97ab06173b" xlink:to="loc_srt_ConsolidatedEntitiesDomain_66f2e296-07d0-432e-be8e-ae5ce05b8328" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_b184b62a-d4f9-4a12-a611-bc87d2cd9a28" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ParentCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_66f2e296-07d0-432e-be8e-ae5ce05b8328" xlink:to="loc_srt_ParentCompanyMember_b184b62a-d4f9-4a12-a611-bc87d2cd9a28" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_4c80d5c0-e175-45ac-91b8-26264f41fbeb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedIncomeStatementsCaptionsLineItems_ed9c4a60-ba78-4ae3-8635-770ac8c56eae" xlink:to="loc_us-gaap_OperatingExpensesAbstract_4c80d5c0-e175-45ac-91b8-26264f41fbeb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_21f48415-dc47-452c-8489-ef1425f0ca73" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4c80d5c0-e175-45ac-91b8-26264f41fbeb" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_21f48415-dc47-452c-8489-ef1425f0ca73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_44bc2699-bb22-4e57-a1e5-0f729a45b0c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4c80d5c0-e175-45ac-91b8-26264f41fbeb" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_44bc2699-bb22-4e57-a1e5-0f729a45b0c5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_591f6709-be3c-45bf-b42d-cfbd3c80be8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedIncomeStatementsCaptionsLineItems_ed9c4a60-ba78-4ae3-8635-770ac8c56eae" xlink:to="loc_us-gaap_OperatingIncomeLoss_591f6709-be3c-45bf-b42d-cfbd3c80be8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_77aa22cb-a5d9-4a8b-81c8-c93f5a2c8365" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedIncomeStatementsCaptionsLineItems_ed9c4a60-ba78-4ae3-8635-770ac8c56eae" xlink:to="loc_us-gaap_InvestmentIncomeInterest_77aa22cb-a5d9-4a8b-81c8-c93f5a2c8365" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_d56e429d-6a62-4d9e-802c-d8d9fe108227" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedIncomeStatementsCaptionsLineItems_ed9c4a60-ba78-4ae3-8635-770ac8c56eae" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_d56e429d-6a62-4d9e-802c-d8d9fe108227" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_999dac77-06ac-4047-8e72-086260ffce0e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedIncomeStatementsCaptionsLineItems_ed9c4a60-ba78-4ae3-8635-770ac8c56eae" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_999dac77-06ac-4047-8e72-086260ffce0e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_IncomeLossFromEquityMethodInvestmentsNetOfTax_f22a1ecd-1bfd-47d6-b0b7-aed28b1efd3d" xlink:href="zlab-20231231.xsd#zlab_IncomeLossFromEquityMethodInvestmentsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedIncomeStatementsCaptionsLineItems_ed9c4a60-ba78-4ae3-8635-770ac8c56eae" xlink:to="loc_zlab_IncomeLossFromEquityMethodInvestmentsNetOfTax_f22a1ecd-1bfd-47d6-b0b7-aed28b1efd3d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_ce4e1e99-69bb-4790-a34d-f7862581856e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedIncomeStatementsCaptionsLineItems_ed9c4a60-ba78-4ae3-8635-770ac8c56eae" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_ce4e1e99-69bb-4790-a34d-f7862581856e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a8503e73-e2b9-4d16-86f1-fbf33ceb6e0d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedIncomeStatementsCaptionsLineItems_ed9c4a60-ba78-4ae3-8635-770ac8c56eae" xlink:to="loc_us-gaap_NetIncomeLoss_a8503e73-e2b9-4d16-86f1-fbf33ceb6e0d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_5f8eb434-2698-4838-93e0-aa6439ce9985" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedIncomeStatementsCaptionsLineItems_ed9c4a60-ba78-4ae3-8635-770ac8c56eae" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_5f8eb434-2698-4838-93e0-aa6439ce9985" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_c84be0d5-171a-4d1b-9fdc-3663000591a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_5f8eb434-2698-4838-93e0-aa6439ce9985" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_c84be0d5-171a-4d1b-9fdc-3663000591a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_883439b9-d23e-4bcd-a76f-7a370a644a92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_5f8eb434-2698-4838-93e0-aa6439ce9985" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_883439b9-d23e-4bcd-a76f-7a370a644a92" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_3e809d45-6e8b-42c0-a1a1-8161100251a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedIncomeStatementsCaptionsLineItems_ed9c4a60-ba78-4ae3-8635-770ac8c56eae" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_3e809d45-6e8b-42c0-a1a1-8161100251a5" xlink:type="arc" order="9"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"/>
  <link:definitionLink xlink:role="http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_00dc47e2-69c9-4eba-bbf0-809ed6a8db43" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CondensedCashFlowStatementsCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedCashFlowStatementTable_61a02e85-2fae-428d-ad35-a346a9d7f449" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CondensedCashFlowStatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_00dc47e2-69c9-4eba-bbf0-809ed6a8db43" xlink:to="loc_srt_CondensedCashFlowStatementTable_61a02e85-2fae-428d-ad35-a346a9d7f449" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_2124c053-0850-451b-8589-8ba3dd223591" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_CondensedCashFlowStatementTable_61a02e85-2fae-428d-ad35-a346a9d7f449" xlink:to="loc_srt_ConsolidatedEntitiesAxis_2124c053-0850-451b-8589-8ba3dd223591" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_2124c053-0850-451b-8589-8ba3dd223591_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_2124c053-0850-451b-8589-8ba3dd223591" xlink:to="loc_srt_ConsolidatedEntitiesDomain_2124c053-0850-451b-8589-8ba3dd223591_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_92bece17-746c-4c1e-9e7b-5ae3fa91febc" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_2124c053-0850-451b-8589-8ba3dd223591" xlink:to="loc_srt_ConsolidatedEntitiesDomain_92bece17-746c-4c1e-9e7b-5ae3fa91febc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_431d8216-338b-40ce-acba-9cc6b555742e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ParentCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_92bece17-746c-4c1e-9e7b-5ae3fa91febc" xlink:to="loc_srt_ParentCompanyMember_431d8216-338b-40ce-acba-9cc6b555742e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_185117ff-bb49-4bbd-a4f3-49a446be406d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_00dc47e2-69c9-4eba-bbf0-809ed6a8db43" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_185117ff-bb49-4bbd-a4f3-49a446be406d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c747957d-7f47-4538-9108-939f70fa688b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_185117ff-bb49-4bbd-a4f3-49a446be406d" xlink:to="loc_us-gaap_NetIncomeLoss_c747957d-7f47-4538-9108-939f70fa688b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_bd3b754b-6efd-4ebd-a448-014c733892d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_185117ff-bb49-4bbd-a4f3-49a446be406d" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_bd3b754b-6efd-4ebd-a448-014c733892d4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_AmortizationOfDeferredIncome_938e75ae-0681-48c7-b86d-d63a7f5fc9d2" xlink:href="zlab-20231231.xsd#zlab_AmortizationOfDeferredIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_bd3b754b-6efd-4ebd-a448-014c733892d4" xlink:to="loc_zlab_AmortizationOfDeferredIncome_938e75ae-0681-48c7-b86d-d63a7f5fc9d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_1eb2fbef-1329-4e00-8c6e-2310e7319655" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_bd3b754b-6efd-4ebd-a448-014c733892d4" xlink:to="loc_us-gaap_ShareBasedCompensation_1eb2fbef-1329-4e00-8c6e-2310e7319655" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_IncomeLossFromEquityMethodInvestmentsNetOfTax_8d160c5f-d450-479c-9ce8-009a98ed7565" xlink:href="zlab-20231231.xsd#zlab_IncomeLossFromEquityMethodInvestmentsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_bd3b754b-6efd-4ebd-a448-014c733892d4" xlink:to="loc_zlab_IncomeLossFromEquityMethodInvestmentsNetOfTax_8d160c5f-d450-479c-9ce8-009a98ed7565" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_e724ba60-85c1-44ed-a77b-e43146a9a2b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_bd3b754b-6efd-4ebd-a448-014c733892d4" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_e724ba60-85c1-44ed-a77b-e43146a9a2b4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_15503581-c8f4-4d07-9839-04f42f0c09a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_bd3b754b-6efd-4ebd-a448-014c733892d4" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_15503581-c8f4-4d07-9839-04f42f0c09a7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_ddb7b49b-ac58-495a-8979-843ef99471a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_15503581-c8f4-4d07-9839-04f42f0c09a7" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_ddb7b49b-ac58-495a-8979-843ef99471a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_437504dd-8d4b-41e0-99f4-73dd216882d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_15503581-c8f4-4d07-9839-04f42f0c09a7" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_437504dd-8d4b-41e0-99f4-73dd216882d7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7bf0ed4d-a0a9-434f-ba2c-3511b6cd3fed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_185117ff-bb49-4bbd-a4f3-49a446be406d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7bf0ed4d-a0a9-434f-ba2c-3511b6cd3fed" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3642c88f-d979-4311-93cd-ab510233e68a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_00dc47e2-69c9-4eba-bbf0-809ed6a8db43" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3642c88f-d979-4311-93cd-ab510233e68a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments_720ad3c3-2678-46b5-ba90-cf9164cae3d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3642c88f-d979-4311-93cd-ab510233e68a" xlink:to="loc_us-gaap_PaymentsToAcquireShortTermInvestments_720ad3c3-2678-46b5-ba90-cf9164cae3d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_f6f531b2-8dc5-434a-92ae-78ff3f4c7f73" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3642c88f-d979-4311-93cd-ab510233e68a" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_f6f531b2-8dc5-434a-92ae-78ff3f4c7f73" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_ebf07f2f-bf8b-4403-b490-a6693604f984" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3642c88f-d979-4311-93cd-ab510233e68a" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_ebf07f2f-bf8b-4403-b490-a6693604f984" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_eee76b3c-2801-41ab-9389-20fabb8b954e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3642c88f-d979-4311-93cd-ab510233e68a" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_eee76b3c-2801-41ab-9389-20fabb8b954e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a097f273-a8da-468e-b549-269c801efac2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3642c88f-d979-4311-93cd-ab510233e68a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a097f273-a8da-468e-b549-269c801efac2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_907d9573-327e-42fd-bd7e-709a2b12df90" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_00dc47e2-69c9-4eba-bbf0-809ed6a8db43" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_907d9573-327e-42fd-bd7e-709a2b12df90" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_28c29223-5dbc-4d2b-a0c0-9273adf44d3d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_907d9573-327e-42fd-bd7e-709a2b12df90" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_28c29223-5dbc-4d2b-a0c0-9273adf44d3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_3fa567e5-223f-4f15-8cec-4e954cd037ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_907d9573-327e-42fd-bd7e-709a2b12df90" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_3fa567e5-223f-4f15-8cec-4e954cd037ef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_fdf6b5f7-e93c-4fc2-88f0-0de1f1402500" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_907d9573-327e-42fd-bd7e-709a2b12df90" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_fdf6b5f7-e93c-4fc2-88f0-0de1f1402500" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_0b4e97b9-be00-4310-a516-ec30b67e0472" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_907d9573-327e-42fd-bd7e-709a2b12df90" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_0b4e97b9-be00-4310-a516-ec30b67e0472" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1f29b546-fd07-4bad-8940-74f22da9391b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_907d9573-327e-42fd-bd7e-709a2b12df90" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1f29b546-fd07-4bad-8940-74f22da9391b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3c3fc171-ffab-46aa-8967-44e65088b1e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_00dc47e2-69c9-4eba-bbf0-809ed6a8db43" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3c3fc171-ffab-46aa-8967-44e65088b1e7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_67b8a404-c7cb-44f3-b31f-b7ad7eeac160" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_00dc47e2-69c9-4eba-bbf0-809ed6a8db43" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_67b8a404-c7cb-44f3-b31f-b7ad7eeac160" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_79b886b2-46cf-4ab3-801f-b425bb83bfcf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_00dc47e2-69c9-4eba-bbf0-809ed6a8db43" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_79b886b2-46cf-4ab3-801f-b425bb83bfcf" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_6f6016b1-e704-47a1-8c6f-c3b2c9716ddf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/AwardTypeOnly" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#AwardTypeOnly"/>
  <link:definitionLink xlink:role="http://xbrl.sec.gov/ecd/AwardTypeOnly" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ShareBasedPaymentArrangementOptionBatchOneMember_52e39999-4278-4ab6-8449-584d5da3ba88" xlink:href="zlab-20231231.xsd#zlab_ShareBasedPaymentArrangementOptionBatchOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_zlab_ShareBasedPaymentArrangementOptionBatchOneMember_52e39999-4278-4ab6-8449-584d5da3ba88" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ShareBasedPaymentArrangementOptionBatchTwoMember_daf2c0cd-99f8-4b6c-9bdf-b98eadefe856" xlink:href="zlab-20231231.xsd#zlab_ShareBasedPaymentArrangementOptionBatchTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_zlab_ShareBasedPaymentArrangementOptionBatchTwoMember_daf2c0cd-99f8-4b6c-9bdf-b98eadefe856" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ShareBasedPaymentArrangementOptionBatchThreeMember_b3f43a07-40c4-4176-99ee-07a45486d8b8" xlink:href="zlab-20231231.xsd#zlab_ShareBasedPaymentArrangementOptionBatchThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_zlab_ShareBasedPaymentArrangementOptionBatchThreeMember_b3f43a07-40c4-4176-99ee-07a45486d8b8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_NonVestedRestrictedSharesMember_6f538819-2b39-4137-b4b8-4efd5a264d07" xlink:href="zlab-20231231.xsd#zlab_NonVestedRestrictedSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_zlab_NonVestedRestrictedSharesMember_6f538819-2b39-4137-b4b8-4efd5a264d07" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/IndividualsOnly" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#IndividualsOnly"/>
  <link:definitionLink xlink:role="http://xbrl.sec.gov/ecd/role/IndividualsOnly" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_RafaelAmadoMember_bfd6e8fc-6869-482e-8337-995531683d93" xlink:href="zlab-20231231.xsd#zlab_RafaelAmadoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_zlab_RafaelAmadoMember_bfd6e8fc-6869-482e-8337-995531683d93" xlink:type="arc" order="2"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>15
<FILENAME>zlab-20231231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:8edfc3fc-8768-4ea6-b2a3-bb613cc9a367,g:14e43acd-1532-4842-be1c-6094bb39150d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_zlab_MandatoryProvidentFundMember_bac2afe4-fe67-4ad5-9c37-453ac60dedef_terseLabel_en-US" xlink:label="lab_zlab_MandatoryProvidentFundMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mandatory Provident Fund</link:label>
    <link:label id="lab_zlab_MandatoryProvidentFundMember_label_en-US" xlink:label="lab_zlab_MandatoryProvidentFundMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mandatory Provident Fund [Member]</link:label>
    <link:label id="lab_zlab_MandatoryProvidentFundMember_documentation_en-US" xlink:label="lab_zlab_MandatoryProvidentFundMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mandatory Provident Fund</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_MandatoryProvidentFundMember" xlink:href="zlab-20231231.xsd#zlab_MandatoryProvidentFundMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_MandatoryProvidentFundMember" xlink:to="lab_zlab_MandatoryProvidentFundMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_c83f4ca3-8916-4f6b-871a-038d1819898f_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis" xlink:to="lab_srt_ConsolidatedEntitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_terseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Appreciation Rights (SARs)</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_label_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ManufacturingFacilityMember_8843d278-9a04-4821-a2f3-ea3b8ccef193_terseLabel_en-US" xlink:label="lab_us-gaap_ManufacturingFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing equipment</link:label>
    <link:label id="lab_us-gaap_ManufacturingFacilityMember_label_en-US" xlink:label="lab_us-gaap_ManufacturingFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManufacturingFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ManufacturingFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ManufacturingFacilityMember" xlink:to="lab_us-gaap_ManufacturingFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_NingboBankWorkingCapitalLoanFacilityMember_a6acf4af-6929-4847-a3ef-26d392516717_terseLabel_en-US" xlink:label="lab_zlab_NingboBankWorkingCapitalLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ningbo Bank Working Capital Loan Facility</link:label>
    <link:label id="lab_zlab_NingboBankWorkingCapitalLoanFacilityMember_label_en-US" xlink:label="lab_zlab_NingboBankWorkingCapitalLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ningbo Bank Working Capital Loan Facility [Member]</link:label>
    <link:label id="lab_zlab_NingboBankWorkingCapitalLoanFacilityMember_documentation_en-US" xlink:label="lab_zlab_NingboBankWorkingCapitalLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ningbo Bank Working Capital Loan Facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_NingboBankWorkingCapitalLoanFacilityMember" xlink:href="zlab-20231231.xsd#zlab_NingboBankWorkingCapitalLoanFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_NingboBankWorkingCapitalLoanFacilityMember" xlink:to="lab_zlab_NingboBankWorkingCapitalLoanFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PayVsPerformanceDisclosureLineItems_label_en-US" xlink:label="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_3191926b-a739-4c6e-96bf-65c6eca45bd2_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_761eb545-5aea-49c7-b4a3-ac37c7bb70b7_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_a4ae2025-9ea1-4566-85bc-dc6de1b531e7_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_d6ce5f3b-8a7f-4e1f-ad23-0298879f6522_negatedLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_11ffe950-fe98-4ea1-9b2a-a5abd6932abf_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expense</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1695c6d3-ae34-4a97-8220-67c488ea75ed_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_terseLabel_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underlying Security Market Price Change</link:label>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_label_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underlying Security Market Price Change, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:to="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_650737bc-8d95-4233-9fb9-150393e61316_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_a99fa87d-9d41-48a5-8546-cba9ba610f23_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted contractual term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfIntangibleAssets_49fa9470-954f-4a33-b17b-a285b3b32dc6_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of intellectual property</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfIntangibleAssets" xlink:to="lab_us-gaap_ProceedsFromSaleOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_MajorSuppliersDomain_d7c6b8cc-c15a-4a49-9eb5-bfeba378021f_terseLabel_en-US" xlink:label="lab_zlab_MajorSuppliersDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major Suppliers [Domain]</link:label>
    <link:label id="lab_zlab_MajorSuppliersDomain_label_en-US" xlink:label="lab_zlab_MajorSuppliersDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major Suppliers [Domain]</link:label>
    <link:label id="lab_zlab_MajorSuppliersDomain_documentation_en-US" xlink:label="lab_zlab_MajorSuppliersDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major Suppliers.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_MajorSuppliersDomain" xlink:href="zlab-20231231.xsd#zlab_MajorSuppliersDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_MajorSuppliersDomain" xlink:to="lab_zlab_MajorSuppliersDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2f445884-10f5-4045-a20f-ffebc8dbdef7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardGrantDateFairValue_terseLabel_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value as of Grant Date</link:label>
    <link:label id="lab_ecd_AwardGrantDateFairValue_label_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardGrantDateFairValue" xlink:to="lab_ecd_AwardGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_AccruedRebateToDistributorsCurrent_dc3f7bab-5eea-44c8-96e8-b768b45a1fb2_terseLabel_en-US" xlink:label="lab_zlab_AccruedRebateToDistributorsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued rebate to distributors</link:label>
    <link:label id="lab_zlab_AccruedRebateToDistributorsCurrent_label_en-US" xlink:label="lab_zlab_AccruedRebateToDistributorsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Rebate To Distributors Current</link:label>
    <link:label id="lab_zlab_AccruedRebateToDistributorsCurrent_documentation_en-US" xlink:label="lab_zlab_AccruedRebateToDistributorsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of accrued rebate payable to distributors.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_AccruedRebateToDistributorsCurrent" xlink:href="zlab-20231231.xsd#zlab_AccruedRebateToDistributorsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_AccruedRebateToDistributorsCurrent" xlink:to="lab_zlab_AccruedRebateToDistributorsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_b99f236d-617f-4450-ab50-b2eda5153806_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0c0abadf-e0fa-4185-be3e-bb5e2ec3d806_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-vested, Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_fa20d774-24aa-4976-847e-81bb70877bec_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-vested, Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_ed101c5d-ce40-4407-b845-3d2d53bf07b8_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease remaining lease term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_9a4a6a5b-eafc-4ff7-891f-32816c1731b4_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Transaction with Party to Collaborative Arrangement</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:to="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_c2954117-6859-4d85-aabf-336c8d3ac0ac_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_512c5174-31bf-459e-9bdd-8b7622e45321_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expenses</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueOther_1714a751-3636-44f8-9265-3b7d626a0fc5_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of ordinary shares in connection with collaboration and license arrangement (Note 16)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueOther_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LenderConcentrationRiskMember_e67b9d2c-c0a4-405b-9d23-323b68b9957c_terseLabel_en-US" xlink:label="lab_us-gaap_LenderConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debtor Concentration Risk</link:label>
    <link:label id="lab_us-gaap_LenderConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_LenderConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LenderConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LenderConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LenderConcentrationRiskMember" xlink:to="lab_us-gaap_LenderConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_terseLabel_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_label_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:to="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_CapitalContributionsCommitment_4a958a9e-3a55-47e1-8b9e-243c9261c6d7_terseLabel_en-US" xlink:label="lab_zlab_CapitalContributionsCommitment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital contribution commitment</link:label>
    <link:label id="lab_zlab_CapitalContributionsCommitment_label_en-US" xlink:label="lab_zlab_CapitalContributionsCommitment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Contributions Commitment</link:label>
    <link:label id="lab_zlab_CapitalContributionsCommitment_documentation_en-US" xlink:label="lab_zlab_CapitalContributionsCommitment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital contribution commitment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_CapitalContributionsCommitment" xlink:href="zlab-20231231.xsd#zlab_CapitalContributionsCommitment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_CapitalContributionsCommitment" xlink:to="lab_zlab_CapitalContributionsCommitment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_68c99b9f-9841-4524-88ff-3249fff7ab3f_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDateAxis_terseLabel_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Determination Date:</link:label>
    <link:label id="lab_ecd_RestatementDateAxis_label_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDateAxis" xlink:to="lab_ecd_RestatementDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_9143c6f9-e428-4f18-91c6-4cb376089367_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_05198761-66df-4ab9-bfa2-8018787928bb_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_MacroGenicsIncMember_e839409e-fb59-4b9f-81d6-26a1e09e6511_terseLabel_en-US" xlink:label="lab_zlab_MacroGenicsIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MacroGenics</link:label>
    <link:label id="lab_zlab_MacroGenicsIncMember_label_en-US" xlink:label="lab_zlab_MacroGenicsIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MacroGenics Inc [Member]</link:label>
    <link:label id="lab_zlab_MacroGenicsIncMember_documentation_en-US" xlink:label="lab_zlab_MacroGenicsIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Macro Genics Inc..</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_MacroGenicsIncMember" xlink:href="zlab-20231231.xsd#zlab_MacroGenicsIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_MacroGenicsIncMember" xlink:to="lab_zlab_MacroGenicsIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_36ec4e8a-3d3b-45d4-bb78-5328b1036ccd_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current Liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_40a00046-d95c-4b45-8e24-5119bb597a81_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_44a1ffc9-fc66-4ed3-8d1c-e01de95d0c8d_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies (Note 20)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_05abff8c-6927-49e4-bc9d-af0cc7803b34_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingPoliciesProcLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssuedPricePerShare_fcdf1e2f-ce80-44a8-8280-791cbc78e039_terseLabel_en-US" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issue price per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharesIssuedPricePerShare_label_en-US" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssuedPricePerShare" xlink:to="lab_us-gaap_SharesIssuedPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:to="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_IncomeTaxesLineItems_04373cd9-5e9d-4257-ba5d-8cea32f9c348_terseLabel_en-US" xlink:label="lab_zlab_IncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Line Items]</link:label>
    <link:label id="lab_zlab_IncomeTaxesLineItems_label_en-US" xlink:label="lab_zlab_IncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Line Items]</link:label>
    <link:label id="lab_zlab_IncomeTaxesLineItems_documentation_en-US" xlink:label="lab_zlab_IncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_IncomeTaxesLineItems" xlink:href="zlab-20231231.xsd#zlab_IncomeTaxesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_IncomeTaxesLineItems" xlink:to="lab_zlab_IncomeTaxesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_RestrictedNetAssetsAbstract_f8f5744e-91eb-4991-a326-c9e552081d21_terseLabel_en-US" xlink:label="lab_zlab_RestrictedNetAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted net assets</link:label>
    <link:label id="lab_zlab_RestrictedNetAssetsAbstract_label_en-US" xlink:label="lab_zlab_RestrictedNetAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted net assets</link:label>
    <link:label id="lab_zlab_RestrictedNetAssetsAbstract_documentation_en-US" xlink:label="lab_zlab_RestrictedNetAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted net assets .</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_RestrictedNetAssetsAbstract" xlink:href="zlab-20231231.xsd#zlab_RestrictedNetAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_RestrictedNetAssetsAbstract" xlink:to="lab_zlab_RestrictedNetAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_46a81fde-b073-4365-83ce-c827fc0d543c_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_99f54c43-1ae7-42fa-9c4a-7715018a7413_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_8eae3282-33da-4ab2-b4ed-ab8b1bb0af56_terseLabel_en-US" xlink:label="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Non-vested Restricted Share Activity</link:label>
    <link:label id="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested Restricted Stock Shares Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:to="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_terseLabel_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement does not require Recovery</link:label>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_label_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Does Not Require Recovery [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AdrMember_002e91fa-5132-47b2-a6c1-90b1cf416779_terseLabel_en-US" xlink:label="lab_dei_AdrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">American Depositary Shares</link:label>
    <link:label id="lab_dei_AdrMember_label_en-US" xlink:label="lab_dei_AdrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ADR [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AdrMember" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AdrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AdrMember" xlink:to="lab_dei_AdrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_b38ae9f4-4eb2-4dc7-adf7-3f592366b0db_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWriteDown_6838acc8-bcee-4296-8403-33893e6f0732_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory write-down</link:label>
    <link:label id="lab_us-gaap_InventoryWriteDown_label_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Write-down</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWriteDown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWriteDown" xlink:to="lab_us-gaap_InventoryWriteDown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_3d75bf9f-18b9-43c2-b41c-752f0eee6dc5_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_label_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract_7875d8f5-b429-4aaa-b3e8-e236bda2af25_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity, par value and number of shares</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Number of Shares, Par Value and Other Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="lab_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_ZaiLabAUSTPtyLtdMember_43e28333-e2af-468a-9b06-b3aee3def170_terseLabel_en-US" xlink:label="lab_zlab_ZaiLabAUSTPtyLtdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zai Lab (AUST) Pty. Ltd.</link:label>
    <link:label id="lab_zlab_ZaiLabAUSTPtyLtdMember_label_en-US" xlink:label="lab_zlab_ZaiLabAUSTPtyLtdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zai Lab A U S T Pty Ltd [Member]</link:label>
    <link:label id="lab_zlab_ZaiLabAUSTPtyLtdMember_documentation_en-US" xlink:label="lab_zlab_ZaiLabAUSTPtyLtdMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zai Lab (AUST) Pty., Ltd.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ZaiLabAUSTPtyLtdMember" xlink:href="zlab-20231231.xsd#zlab_ZaiLabAUSTPtyLtdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_ZaiLabAUSTPtyLtdMember" xlink:to="lab_zlab_ZaiLabAUSTPtyLtdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_b079b631-3587-48c9-836f-b70f1ed4e462_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_RestrictedCashNonCurrentTextBlock_6a5fd8e1-785a-4e3f-bbc4-fbfaac8d9a26_terseLabel_en-US" xlink:label="lab_zlab_RestrictedCashNonCurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Non-Current</link:label>
    <link:label id="lab_zlab_RestrictedCashNonCurrentTextBlock_label_en-US" xlink:label="lab_zlab_RestrictedCashNonCurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash Non Current [Text Block]</link:label>
    <link:label id="lab_zlab_RestrictedCashNonCurrentTextBlock_documentation_en-US" xlink:label="lab_zlab_RestrictedCashNonCurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash, non-current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_RestrictedCashNonCurrentTextBlock" xlink:href="zlab-20231231.xsd#zlab_RestrictedCashNonCurrentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_RestrictedCashNonCurrentTextBlock" xlink:to="lab_zlab_RestrictedCashNonCurrentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_PayablesForPurchaseOfPropertyAndEquipmentCurrent_5b065cfc-68d2-493e-934e-9500449c2287_terseLabel_en-US" xlink:label="lab_zlab_PayablesForPurchaseOfPropertyAndEquipmentCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables for purchase of property and equipment</link:label>
    <link:label id="lab_zlab_PayablesForPurchaseOfPropertyAndEquipmentCurrent_label_en-US" xlink:label="lab_zlab_PayablesForPurchaseOfPropertyAndEquipmentCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables For Purchase Of Property And Equipment Current</link:label>
    <link:label id="lab_zlab_PayablesForPurchaseOfPropertyAndEquipmentCurrent_documentation_en-US" xlink:label="lab_zlab_PayablesForPurchaseOfPropertyAndEquipmentCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables for purchase of property and equipment current.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_PayablesForPurchaseOfPropertyAndEquipmentCurrent" xlink:href="zlab-20231231.xsd#zlab_PayablesForPurchaseOfPropertyAndEquipmentCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_PayablesForPurchaseOfPropertyAndEquipmentCurrent" xlink:to="lab_zlab_PayablesForPurchaseOfPropertyAndEquipmentCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_a7b7e5ae-50fb-47d4-85c5-14d525891196_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_134e9d82-cd7e-423e-b83e-ddc7952a9417_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected dividend rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_ElectronicEquipmentMember_af664e3a-1347-434d-97ac-6eeec1e7abac_terseLabel_en-US" xlink:label="lab_zlab_ElectronicEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Electronic equipment</link:label>
    <link:label id="lab_zlab_ElectronicEquipmentMember_label_en-US" xlink:label="lab_zlab_ElectronicEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Electronic Equipment [Member]</link:label>
    <link:label id="lab_zlab_ElectronicEquipmentMember_documentation_en-US" xlink:label="lab_zlab_ElectronicEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Electronic equipment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ElectronicEquipmentMember" xlink:href="zlab-20231231.xsd#zlab_ElectronicEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_ElectronicEquipmentMember" xlink:to="lab_zlab_ElectronicEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_dbcc49ce-f6a7-4a7e-a53c-80e51ed300c7_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of ordinary shares upon vesting of restricted shares (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_109d0e7a-2b00-4e13-aa99-a459715925b9_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskLineItems" xlink:to="lab_us-gaap_ConcentrationRiskLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_d0508969-d4dd-463f-9af7-2eb0da9b888c_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of ordinary shares in connection with collaboration and license arrangement (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, before Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_ec328dda-6890-4895-9410-8d9721134254_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_StatutoryReserves_f2efaa47-9b3e-4cc2-9425-70a2c5c0f66c_terseLabel_en-US" xlink:label="lab_zlab_StatutoryReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory reserves</link:label>
    <link:label id="lab_zlab_StatutoryReserves_label_en-US" xlink:label="lab_zlab_StatutoryReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Reserves</link:label>
    <link:label id="lab_zlab_StatutoryReserves_documentation_en-US" xlink:label="lab_zlab_StatutoryReserves" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory reserves.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_StatutoryReserves" xlink:href="zlab-20231231.xsd#zlab_StatutoryReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_StatutoryReserves" xlink:to="lab_zlab_StatutoryReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_9762308b-6722-4f56-b179-95d7c9f3ede6_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_a9064578-24f4-484f-a0ac-6e09100f9140_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_a64517ee-3313-4840-a1d5-a862fa7b023f_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_HKD_b4a5c172-ffcd-40af-9449-265b5c04c510_terseLabel_en-US" xlink:label="lab_currency_HKD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hong Kong dollar (&#8220;HK$&#8221;)</link:label>
    <link:label id="lab_currency_HKD_label_en-US" xlink:label="lab_currency_HKD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hong Kong, Dollars</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_HKD" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_HKD"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_HKD" xlink:to="lab_currency_HKD" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_ZaiLabSuzhouCompanyLimitedMember_a8c72093-c7c3-4c0f-891a-7496ae9b11a9_terseLabel_en-US" xlink:label="lab_zlab_ZaiLabSuzhouCompanyLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zai Lab (Suzhou) Co., Ltd.</link:label>
    <link:label id="lab_zlab_ZaiLabSuzhouCompanyLimitedMember_e657080f-6cb4-45e4-800a-acbfe85bacb6_verboseLabel_en-US" xlink:label="lab_zlab_ZaiLabSuzhouCompanyLimitedMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zai Lab Suzhou</link:label>
    <link:label id="lab_zlab_ZaiLabSuzhouCompanyLimitedMember_label_en-US" xlink:label="lab_zlab_ZaiLabSuzhouCompanyLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zai Lab Suzhou Company Limited [Member]</link:label>
    <link:label id="lab_zlab_ZaiLabSuzhouCompanyLimitedMember_documentation_en-US" xlink:label="lab_zlab_ZaiLabSuzhouCompanyLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zai Lab (Suzhou) company limited.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ZaiLabSuzhouCompanyLimitedMember" xlink:href="zlab-20231231.xsd#zlab_ZaiLabSuzhouCompanyLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_ZaiLabSuzhouCompanyLimitedMember" xlink:to="lab_zlab_ZaiLabSuzhouCompanyLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_b20aef88-c522-4d23-a75a-fb20515d2446_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_75dced2b-99e5-4eae-8236-8ad6dd428be1_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss per share &#8212; diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_6ab6d253-787b-423a-9cb0-373ad7580256_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share &#8212; diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossExcludingAccruedInterest_726cf207-9c11-4a0d-b24e-782b8b9153c5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossExcludingAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for credit loss</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossExcludingAccruedInterest_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossExcludingAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Allowance for Credit Loss, Excluding Accrued Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossExcludingAccruedInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossExcludingAccruedInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossExcludingAccruedInterest" xlink:to="lab_us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossExcludingAccruedInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoTotalCompAmt_label_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoTotalCompAmt" xlink:to="lab_ecd_PeoTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1ad35a01-90da-41d0-bab3-8d5dd0c510a6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Property Plant And Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_a359375c-6717-4afa-900f-0ba4565934b7_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable (net of allowance for credit loss of $17 and $11 as of December&#160;31, 2023 and 2022, respectively)</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrByIndTable_terseLabel_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangements, by Individual</link:label>
    <link:label id="lab_ecd_TradingArrByIndTable_label_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrByIndTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="lab_ecd_TradingArrByIndTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_8188551e-71a4-487a-880b-dfa385005ac7_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_8ee8e7a2-b3d8-4030-a72f-b7183b20e3d2_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_c035dc3f-4f60-453f-95cc-ce8ce6e2f829_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CondensedCashFlowStatementTable_10fa0460-be27-4354-82d3-ad025b5ea659_terseLabel_en-US" xlink:label="lab_srt_CondensedCashFlowStatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Cash Flow Statement [Table]</link:label>
    <link:label id="lab_srt_CondensedCashFlowStatementTable_label_en-US" xlink:label="lab_srt_CondensedCashFlowStatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Cash Flow Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedCashFlowStatementTable" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CondensedCashFlowStatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CondensedCashFlowStatementTable" xlink:to="lab_srt_CondensedCashFlowStatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6ea10315-afdc-44a0-8664-17f99ec6d5eb_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c4447051-bdab-4d8e-984b-2cee9eda3c33_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_NonCashLeaseExpenses_45b43033-8760-431f-981a-8f634a2af38f_terseLabel_en-US" xlink:label="lab_zlab_NonCashLeaseExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash lease expenses</link:label>
    <link:label id="lab_zlab_NonCashLeaseExpenses_label_en-US" xlink:label="lab_zlab_NonCashLeaseExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Cash Lease Expenses</link:label>
    <link:label id="lab_zlab_NonCashLeaseExpenses_documentation_en-US" xlink:label="lab_zlab_NonCashLeaseExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash lease expenses.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_NonCashLeaseExpenses" xlink:href="zlab-20231231.xsd#zlab_NonCashLeaseExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_NonCashLeaseExpenses" xlink:to="lab_zlab_NonCashLeaseExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_f7a21cfa-81f2-479d-801b-8cf120cb5e1c_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of share options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_b7f507ed-075c-44c3-9e45-c3dd41ec76f5_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_0c614a1e-1141-4444-aeae-9e98075b8352_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of credit outstanding</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_24b97dd5-c37f-409e-bc43-7cf4688c42c3_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of investment in equity investee</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_bb7d19b0-ad95-4db2-9d60-38c564280214_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of investment in equity investee</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c52811be-ea55-4f4b-9c09-5f70d966434d_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_3421a1e7-4d1f-4f5e-a6e2-b14c32e121bd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1ed79bf9-53cd-4961-9477-515df9b8b63f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average grant-date fair value of options granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_736cb472-ec37-4ad8-8625-66191e4b7497_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_658197d7-182b-48f9-be4c-0f2e04b290e8_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_909aa41a-09c8-47f7-b5f5-eeddcb62a7c2_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets, Amortization expense, after year five</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_fba2a0f9-cef0-4f5e-a5fd-82f1476bf692_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_9a6a7626-efc0-49ce-be9b-f648b84e560a_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_label_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changed Peer Group, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:to="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureName_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureName_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureName" xlink:to="lab_ecd_CoSelectedMeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_622799f8-44f2-4a2e-8347-2a13005f2ba7_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_89ab9e16-0b80-459b-9506-7576b004ef6f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_AllCurrenciesDomain_b60add38-1246-42e3-a96b-b0d0c697592f_terseLabel_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:label id="lab_currency_AllCurrenciesDomain_label_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_AllCurrenciesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_AllCurrenciesDomain" xlink:to="lab_currency_AllCurrenciesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_73b636f7-7f20-4047-88fd-9942c4cdbe2c_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_ShareBasedPaymentArrangementTrancheFiveMember_d1bf8846-8705-4605-9fe5-837ddb34a747_terseLabel_en-US" xlink:label="lab_zlab_ShareBasedPaymentArrangementTrancheFiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tranche five</link:label>
    <link:label id="lab_zlab_ShareBasedPaymentArrangementTrancheFiveMember_label_en-US" xlink:label="lab_zlab_ShareBasedPaymentArrangementTrancheFiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Tranche Five [Member]</link:label>
    <link:label id="lab_zlab_ShareBasedPaymentArrangementTrancheFiveMember_documentation_en-US" xlink:label="lab_zlab_ShareBasedPaymentArrangementTrancheFiveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Tranche Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ShareBasedPaymentArrangementTrancheFiveMember" xlink:href="zlab-20231231.xsd#zlab_ShareBasedPaymentArrangementTrancheFiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_ShareBasedPaymentArrangementTrancheFiveMember" xlink:to="lab_zlab_ShareBasedPaymentArrangementTrancheFiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_MainlandChinaGovernmentPlanMember_0c929667-d279-4af9-b7d5-5136a6564475_terseLabel_en-US" xlink:label="lab_zlab_MainlandChinaGovernmentPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mainland China Government Plan</link:label>
    <link:label id="lab_zlab_MainlandChinaGovernmentPlanMember_label_en-US" xlink:label="lab_zlab_MainlandChinaGovernmentPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mainland China Government Plan [Member]</link:label>
    <link:label id="lab_zlab_MainlandChinaGovernmentPlanMember_documentation_en-US" xlink:label="lab_zlab_MainlandChinaGovernmentPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mainland China Government Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_MainlandChinaGovernmentPlanMember" xlink:href="zlab-20231231.xsd#zlab_MainlandChinaGovernmentPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_MainlandChinaGovernmentPlanMember" xlink:to="lab_zlab_MainlandChinaGovernmentPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock_d140528a-fb0c-423e-9eba-050333bf7747_terseLabel_en-US" xlink:label="lab_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule I &#8212; Condensed Financial Information of Registrant</link:label>
    <link:label id="lab_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Information of Parent Company Only Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock" xlink:to="lab_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_14856eb7-5fd8-4637-8802-3f1cb95f7759_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_RestrictedNetAssetsLineItems_40b02232-9716-405d-999a-925077fe7dcf_verboseLabel_en-US" xlink:label="lab_zlab_RestrictedNetAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted net assets</link:label>
    <link:label id="lab_zlab_RestrictedNetAssetsLineItems_label_en-US" xlink:label="lab_zlab_RestrictedNetAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Net Assets [Line Items]</link:label>
    <link:label id="lab_zlab_RestrictedNetAssetsLineItems_documentation_en-US" xlink:label="lab_zlab_RestrictedNetAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted net assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_RestrictedNetAssetsLineItems" xlink:href="zlab-20231231.xsd#zlab_RestrictedNetAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_RestrictedNetAssetsLineItems" xlink:to="lab_zlab_RestrictedNetAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_c540b0d4-f5a7-4f63-98b5-bc042655933b_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_a0fe980d-7188-4b47-a9c0-6d680316f06c_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of shares options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_ba5260df-1eca-4305-8be8-ef91791e23c0_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_ManufacturingEquipmentMember_f4245f67-49d9-48ef-abb4-fde41877ab89_terseLabel_en-US" xlink:label="lab_zlab_ManufacturingEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing equipment</link:label>
    <link:label id="lab_zlab_ManufacturingEquipmentMember_label_en-US" xlink:label="lab_zlab_ManufacturingEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing Equipment [Member]</link:label>
    <link:label id="lab_zlab_ManufacturingEquipmentMember_documentation_en-US" xlink:label="lab_zlab_ManufacturingEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing equipment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ManufacturingEquipmentMember" xlink:href="zlab-20231231.xsd#zlab_ManufacturingEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_ManufacturingEquipmentMember" xlink:to="lab_zlab_ManufacturingEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_6791d8f5-2797-4590-af72-ba2e934f1f1b_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Basic and Diluted Net Loss Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_35734e5a-dbae-43b8-9ad1-250aacc30147_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:to="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_795953a2-2804-4666-89a4-c943e88d67d5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_terseLabel_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Category:</link:label>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_label_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="lab_ecd_ExecutiveCategoryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_9608f890-30a3-4fbd-866a-15deb8c815e5_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepositsAssetsNoncurrent_4485359f-e3c1-4d6b-bfc6-398880e2a9b3_terseLabel_en-US" xlink:label="lab_us-gaap_DepositsAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term deposits</link:label>
    <link:label id="lab_us-gaap_DepositsAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_DepositsAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deposits Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositsAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepositsAssetsNoncurrent" xlink:to="lab_us-gaap_DepositsAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_c399b32b-96c7-44fe-80c2-cf422f31f4d2_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_ShortTermInvestmentsPolicyPolicyTextBlock_8fb2e093-cd3a-4b83-8858-0f692f39250a_terseLabel_en-US" xlink:label="lab_zlab_ShortTermInvestmentsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Investments</link:label>
    <link:label id="lab_zlab_ShortTermInvestmentsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_zlab_ShortTermInvestmentsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short Term Investments, Policy [Policy Text Block]</link:label>
    <link:label id="lab_zlab_ShortTermInvestmentsPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_zlab_ShortTermInvestmentsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short term investments policy.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ShortTermInvestmentsPolicyPolicyTextBlock" xlink:href="zlab-20231231.xsd#zlab_ShortTermInvestmentsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_ShortTermInvestmentsPolicyPolicyTextBlock" xlink:to="lab_zlab_ShortTermInvestmentsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_7ead6e02-3dc0-4c8a-90b2-db4cac7f962c_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_0b5d6812-e3da-4525-a217-87ea21edef93_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_d4eb5593-2728-4f12-bbae-812eacf5ad55_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureName_terseLabel_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_MeasureName_label_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureName" xlink:to="lab_ecd_MeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_8cc84e0b-c6eb-4aad-b3d7-cb3696cbb737_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryIndName" xlink:to="lab_ecd_ForgoneRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteeObligationsMaximumExposure_97d037b5-f825-4d75-8785-2dd47a86f552_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsMaximumExposure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum guarantor obligation</link:label>
    <link:label id="lab_us-gaap_GuaranteeObligationsMaximumExposure_label_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsMaximumExposure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Maximum Exposure, Undiscounted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsMaximumExposure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GuaranteeObligationsMaximumExposure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteeObligationsMaximumExposure" xlink:to="lab_us-gaap_GuaranteeObligationsMaximumExposure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireShortTermInvestments_9458c890-6e34-4e63-8573-b9f7ffbbfa9e_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of short-term investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_0bc2998c-7f73-452a-b729-01fa435f75c9_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_a3edbc0b-1928-4106-930f-a87418e5e2cc_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_label_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional 402(v) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Additional402vDisclosureTextBlock" xlink:to="lab_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CondensedBalanceSheetStatementsCaptionsLineItems_b4b3c8d1-6833-47cb-aac7-e28dd8b4d5d1_terseLabel_en-US" xlink:label="lab_srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Balance Sheet Statements Captions [Line Items]</link:label>
    <link:label id="lab_srt_CondensedBalanceSheetStatementsCaptionsLineItems_label_en-US" xlink:label="lab_srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Balance Sheet Statements, Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CondensedBalanceSheetStatementsCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="lab_srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_795498a7-edcf-45a0-872a-59c382c2d939_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Lease Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_0fa7e943-fdb4-45b9-90ee-ea8b784d72da_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_terseLabel_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underlying Securities</link:label>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_label_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Underlying Securities Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:to="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_07faf32d-b6b7-4e29-8e40-29fad8bc0a65_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_9e86fb4f-7ef6-438e-93ff-f6bcc77e0e88_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets, Amortization expense, year four</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_8c8ba7a5-254d-4f06-9d8f-1774bdf092fc_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_5a1614de-e47c-4c6f-a441-60543517bec6_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_d7b70b8b-dca5-4122-af80-919735bc9da2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency remeasurement loss (gain)</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss), Foreign Currency Transaction, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RecoveryOfErrCompDisclosureLineItems_label_en-US" xlink:label="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recovery of Erroneously Awarded Compensation Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_ZaiLabShanghaiCo.Ltd.Member_c4167656-bac3-46da-a4ec-214d71e0181a_terseLabel_en-US" xlink:label="lab_zlab_ZaiLabShanghaiCo.Ltd.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zai Lab Shanghai</link:label>
    <link:label id="lab_zlab_ZaiLabShanghaiCo.Ltd.Member_label_en-US" xlink:label="lab_zlab_ZaiLabShanghaiCo.Ltd.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zai Lab (Shanghai) Co., Ltd. [Member]</link:label>
    <link:label id="lab_zlab_ZaiLabShanghaiCo.Ltd.Member_documentation_en-US" xlink:label="lab_zlab_ZaiLabShanghaiCo.Ltd.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zai Lab (Shanghai) Co., Ltd.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ZaiLabShanghaiCo.Ltd.Member" xlink:href="zlab-20231231.xsd#zlab_ZaiLabShanghaiCo.Ltd.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_ZaiLabShanghaiCo.Ltd.Member" xlink:to="lab_zlab_ZaiLabShanghaiCo.Ltd.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_f3fbbe22-820e-4399-9d13-6650c9b74cae_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableMember_6402966c-987a-45a4-84ad-9a1ab88f875a_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableMember_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember" xlink:to="lab_us-gaap_AccountsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_9baa682f-a60c-4bb2-82ca-48fe9d288180_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_d39c070d-5ff3-4b4f-a744-0aa27e13a498_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument term</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_e651e565-c066-42f5-a61b-e6ed57882be3_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of public offering costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_09957e9b-091d-41ef-9d39-e9130358362f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of public offering costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Stock Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_68e7f384-35b9-43c3-b0d7-8cdddee0e447_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_9d404a60-d2d5-49d8-99ca-bddec7e24280_verboseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expenses</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_IncomeTaxDisclosureLineItems_56bf8fda-dd65-4506-95d1-d70dfeccfdfb_terseLabel_en-US" xlink:label="lab_zlab_IncomeTaxDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Line Items]</link:label>
    <link:label id="lab_zlab_IncomeTaxDisclosureLineItems_label_en-US" xlink:label="lab_zlab_IncomeTaxDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Line Items]</link:label>
    <link:label id="lab_zlab_IncomeTaxDisclosureLineItems_documentation_en-US" xlink:label="lab_zlab_IncomeTaxDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax disclosure.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_IncomeTaxDisclosureLineItems" xlink:href="zlab-20231231.xsd#zlab_IncomeTaxDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_IncomeTaxDisclosureLineItems" xlink:to="lab_zlab_IncomeTaxDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_df64f434-2083-42fe-a59e-7b7435ce2e35_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee defined contribution plan</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_CashAndCashEquivalentMember_54e264f0-284c-43e6-953d-e505b28d19d1_terseLabel_en-US" xlink:label="lab_zlab_CashAndCashEquivalentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_zlab_CashAndCashEquivalentMember_label_en-US" xlink:label="lab_zlab_CashAndCashEquivalentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Cash Equivalent [Member]</link:label>
    <link:label id="lab_zlab_CashAndCashEquivalentMember_documentation_en-US" xlink:label="lab_zlab_CashAndCashEquivalentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalent.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_CashAndCashEquivalentMember" xlink:href="zlab-20231231.xsd#zlab_CashAndCashEquivalentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_CashAndCashEquivalentMember" xlink:to="lab_zlab_CashAndCashEquivalentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_IncreaseDecreaseInLongTermDeposits_381d37eb-ccb8-4795-9546-35915aef484c_negatedLabel_en-US" xlink:label="lab_zlab_IncreaseDecreaseInLongTermDeposits" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term deposits</link:label>
    <link:label id="lab_zlab_IncreaseDecreaseInLongTermDeposits_label_en-US" xlink:label="lab_zlab_IncreaseDecreaseInLongTermDeposits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase Decrease In Long Term Deposits</link:label>
    <link:label id="lab_zlab_IncreaseDecreaseInLongTermDeposits_documentation_en-US" xlink:label="lab_zlab_IncreaseDecreaseInLongTermDeposits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase decrease in long term deposits.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_IncreaseDecreaseInLongTermDeposits" xlink:href="zlab-20231231.xsd#zlab_IncreaseDecreaseInLongTermDeposits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_IncreaseDecreaseInLongTermDeposits" xlink:to="lab_zlab_IncreaseDecreaseInLongTermDeposits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_db470fb9-a3e0-4a2f-964a-ccff24aeef2f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_5545c1be-05dc-40ec-b334-2f5a5ce16318_terseLabel_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_label_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_fd58091c-2136-4861-83de-20ae18f43e2e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development super deduction</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_ZaiLabTaiwanLimitedMember_4cfc8973-7e0a-4c13-9f52-a1c3fbd0d294_terseLabel_en-US" xlink:label="lab_zlab_ZaiLabTaiwanLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zai Lab (Taiwan) Limited</link:label>
    <link:label id="lab_zlab_ZaiLabTaiwanLimitedMember_label_en-US" xlink:label="lab_zlab_ZaiLabTaiwanLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zai Lab (Taiwan) Limited [Member]</link:label>
    <link:label id="lab_zlab_ZaiLabTaiwanLimitedMember_documentation_en-US" xlink:label="lab_zlab_ZaiLabTaiwanLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zai lab (taiwan) limited [Member].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ZaiLabTaiwanLimitedMember" xlink:href="zlab-20231231.xsd#zlab_ZaiLabTaiwanLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_ZaiLabTaiwanLimitedMember" xlink:to="lab_zlab_ZaiLabTaiwanLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_IssuanceCostAdjustment_30b26a2d-1167-45a3-aee6-1eff9e6b81b4_terseLabel_en-US" xlink:label="lab_zlab_IssuanceCostAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance cost adjustment for secondary listing</link:label>
    <link:label id="lab_zlab_IssuanceCostAdjustment_label_en-US" xlink:label="lab_zlab_IssuanceCostAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance Cost Adjustment</link:label>
    <link:label id="lab_zlab_IssuanceCostAdjustment_documentation_en-US" xlink:label="lab_zlab_IssuanceCostAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance cost adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_IssuanceCostAdjustment" xlink:href="zlab-20231231.xsd#zlab_IssuanceCostAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_IssuanceCostAdjustment" xlink:to="lab_zlab_IssuanceCostAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_f1461450-ba5e-454d-8c47-ca2e5f700788_negatedLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receipt of shares netted to satisfy tax withholding obligations related to share-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_GainLossOnDisposalOfLandUseRights_875324a6-39d8-4c3b-92d8-f042b2d0c8ab_negatedTerseLabel_en-US" xlink:label="lab_zlab_GainLossOnDisposalOfLandUseRights" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on disposal of land use right</link:label>
    <link:label id="lab_zlab_GainLossOnDisposalOfLandUseRights_label_en-US" xlink:label="lab_zlab_GainLossOnDisposalOfLandUseRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) On Disposal Of Land Use Rights</link:label>
    <link:label id="lab_zlab_GainLossOnDisposalOfLandUseRights_documentation_en-US" xlink:label="lab_zlab_GainLossOnDisposalOfLandUseRights" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) On Disposal Of Land Use Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_GainLossOnDisposalOfLandUseRights" xlink:href="zlab-20231231.xsd#zlab_GainLossOnDisposalOfLandUseRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_GainLossOnDisposalOfLandUseRights" xlink:to="lab_zlab_GainLossOnDisposalOfLandUseRights" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_EquityAndCostMethodInvestmentTable_1ebc2c4b-88d3-4021-9e8c-21736dfd8fe5_terseLabel_en-US" xlink:label="lab_zlab_EquityAndCostMethodInvestmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity And Cost Method Investment [Table]</link:label>
    <link:label id="lab_zlab_EquityAndCostMethodInvestmentTable_label_en-US" xlink:label="lab_zlab_EquityAndCostMethodInvestmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity And Cost Method Investment [Table]</link:label>
    <link:label id="lab_zlab_EquityAndCostMethodInvestmentTable_documentation_en-US" xlink:label="lab_zlab_EquityAndCostMethodInvestmentTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity and cost method investment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_EquityAndCostMethodInvestmentTable" xlink:href="zlab-20231231.xsd#zlab_EquityAndCostMethodInvestmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_EquityAndCostMethodInvestmentTable" xlink:to="lab_zlab_EquityAndCostMethodInvestmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_27f271c6-e699-44ae-87e3-89737318a21e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Maturities of Lease Liabilities</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_d8421850-e089-4b0e-9068-5ed40d3833dc_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance costs</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_PrepaymentsForEquipment_2bc7ae28-21da-4a4f-9e59-eff5e310b21e_terseLabel_en-US" xlink:label="lab_zlab_PrepaymentsForEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepayments for equipment</link:label>
    <link:label id="lab_zlab_PrepaymentsForEquipment_label_en-US" xlink:label="lab_zlab_PrepaymentsForEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepayments For Equipment</link:label>
    <link:label id="lab_zlab_PrepaymentsForEquipment_documentation_en-US" xlink:label="lab_zlab_PrepaymentsForEquipment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepayments for equipment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_PrepaymentsForEquipment" xlink:href="zlab-20231231.xsd#zlab_PrepaymentsForEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_PrepaymentsForEquipment" xlink:to="lab_zlab_PrepaymentsForEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanTable_b9bb51a3-5cf2-4232-bd15-7ad5126bbac2_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan [Table]</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanTable_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanTable" xlink:to="lab_us-gaap_DefinedContributionPlanTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_50bc1c4a-f460-46f5-9cd1-bb4aa557a54a_totalLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_50db4cea-e29c-4de9-9e02-bd7cec9e9885_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_c0bafada-dcfe-4743-83f8-a79b43835b8c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Anti-Dilutive Shares Excluded from Calculation of Diluted Loss Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesOther_00dae7b4-2773-407f-82d9-3dcdef16043c_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of ordinary shares in connection with collaboration and license arrangement (Note 16) (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesOther_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_label_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OtherPerfMeasureAmt" xlink:to="lab_ecd_OtherPerfMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_DeferredTaxAssetsPublicWelfareDonations_0b91716a-22da-4399-9e5e-315c6a560bc7_terseLabel_en-US" xlink:label="lab_zlab_DeferredTaxAssetsPublicWelfareDonations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Qualified donation</link:label>
    <link:label id="lab_zlab_DeferredTaxAssetsPublicWelfareDonations_label_en-US" xlink:label="lab_zlab_DeferredTaxAssetsPublicWelfareDonations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets Public Welfare Donations</link:label>
    <link:label id="lab_zlab_DeferredTaxAssetsPublicWelfareDonations_documentation_en-US" xlink:label="lab_zlab_DeferredTaxAssetsPublicWelfareDonations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets public welfare donations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_DeferredTaxAssetsPublicWelfareDonations" xlink:href="zlab-20231231.xsd#zlab_DeferredTaxAssetsPublicWelfareDonations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_DeferredTaxAssetsPublicWelfareDonations" xlink:to="lab_zlab_DeferredTaxAssetsPublicWelfareDonations" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_terseLabel_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Available</link:label>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_label_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement, Securities Aggregate Available Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:to="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_ae8b4112-b624-4da0-b678-fe68a7376d7f_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Cash Flow Information Related to Leases</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_f24b651f-89e6-4b36-8921-6464ec5c1bb4_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandbyLettersOfCreditMember_dbe75240-736a-47d9-9372-5092ebc74d78_terseLabel_en-US" xlink:label="lab_us-gaap_StandbyLettersOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standby Letters of Credit</link:label>
    <link:label id="lab_us-gaap_StandbyLettersOfCreditMember_label_en-US" xlink:label="lab_us-gaap_StandbyLettersOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standby Letters of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandbyLettersOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StandbyLettersOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandbyLettersOfCreditMember" xlink:to="lab_us-gaap_StandbyLettersOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_4327e864-a3af-4225-b7d0-a55b10b66203_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_71ff3485-9eb6-417f-98bd-4d0a5105f0d4_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_ZaiLabTradingSuzhouCoLtdMember_9cb064db-997c-4fc7-861b-dd434aedf6b1_terseLabel_en-US" xlink:label="lab_zlab_ZaiLabTradingSuzhouCoLtdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zai Lab Trading (Suzhou) Co., Ltd.</link:label>
    <link:label id="lab_zlab_ZaiLabTradingSuzhouCoLtdMember_label_en-US" xlink:label="lab_zlab_ZaiLabTradingSuzhouCoLtdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zai Lab Trading (Suzhou) Co., Ltd. [Member]</link:label>
    <link:label id="lab_zlab_ZaiLabTradingSuzhouCoLtdMember_documentation_en-US" xlink:label="lab_zlab_ZaiLabTradingSuzhouCoLtdMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zai Lab Trading (Suzhou) Co., Ltd.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ZaiLabTradingSuzhouCoLtdMember" xlink:href="zlab-20231231.xsd#zlab_ZaiLabTradingSuzhouCoLtdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_ZaiLabTradingSuzhouCoLtdMember" xlink:to="lab_zlab_ZaiLabTradingSuzhouCoLtdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_b0e5b4e4-f592-4ab7-8e02-6e7d0c1a3587_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_73de4dfc-89ce-44c2-9aaf-7bc05c779794_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive shares excluded from calculation of diluted loss per share</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_DeferredTaxAssetsLeasingArrangements_fb32fd77-4ca8-47dc-b427-a222b70694ae_terseLabel_en-US" xlink:label="lab_zlab_DeferredTaxAssetsLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liability</link:label>
    <link:label id="lab_zlab_DeferredTaxAssetsLeasingArrangements_label_en-US" xlink:label="lab_zlab_DeferredTaxAssetsLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Leasing Arrangements</link:label>
    <link:label id="lab_zlab_DeferredTaxAssetsLeasingArrangements_documentation_en-US" xlink:label="lab_zlab_DeferredTaxAssetsLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Leasing Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_DeferredTaxAssetsLeasingArrangements" xlink:href="zlab-20231231.xsd#zlab_DeferredTaxAssetsLeasingArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_DeferredTaxAssetsLeasingArrangements" xlink:to="lab_zlab_DeferredTaxAssetsLeasingArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_ebdd1329-f33c-4c53-8e6c-f94159dca074_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_7c787fa9-c681-4676-ad6d-8e4f67a8e5dc_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_5a95c2b1-82dc-4246-9512-a7c4b9c0d4be_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_label_en-US" xlink:label="lab_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Collaborative Arrangement, Excluding Revenue from Contract with Customer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" xlink:to="lab_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_0cfb957f-44b8-44a8-aec1-47bea24c3764_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized share-based compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_EquityAndCostMethodInvestmentsLineItems_ec693726-1c9c-4a36-b211-6b63ace44515_terseLabel_en-US" xlink:label="lab_zlab_EquityAndCostMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity And Cost Method Investments</link:label>
    <link:label id="lab_zlab_EquityAndCostMethodInvestmentsLineItems_label_en-US" xlink:label="lab_zlab_EquityAndCostMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity And Cost Method Investments [Line Items]</link:label>
    <link:label id="lab_zlab_EquityAndCostMethodInvestmentsLineItems_documentation_en-US" xlink:label="lab_zlab_EquityAndCostMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity and cost method investments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_EquityAndCostMethodInvestmentsLineItems" xlink:href="zlab-20231231.xsd#zlab_EquityAndCostMethodInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_EquityAndCostMethodInvestmentsLineItems" xlink:to="lab_zlab_EquityAndCostMethodInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_adef7116-33b2-4a8f-9ac5-7b5b9e586961_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_84a9c008-2ac4-47b3-b486-4d469f5c8e35_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_a2c8d8e9-8cf1-41c3-8ce8-330a935ff839_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_4f79d853-a271-4c4d-98b5-ea4b5ca2378e_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_32310194-7b4d-44bc-8d1b-791e3082863a_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining contractual term, Outstanding</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_RevenueFromContractWithCustomersExcludingAssessedTaxBeforeAdjustmentsForRebatesAndSalesReturns_08e4357b-c4a6-4ff0-ac58-e72b04526c22_terseLabel_en-US" xlink:label="lab_zlab_RevenueFromContractWithCustomersExcludingAssessedTaxBeforeAdjustmentsForRebatesAndSalesReturns" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product revenue &#8212; gross</link:label>
    <link:label id="lab_zlab_RevenueFromContractWithCustomersExcludingAssessedTaxBeforeAdjustmentsForRebatesAndSalesReturns_label_en-US" xlink:label="lab_zlab_RevenueFromContractWithCustomersExcludingAssessedTaxBeforeAdjustmentsForRebatesAndSalesReturns" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customers, Excluding Assessed Tax, Before Adjustments For Rebates And Sales Returns</link:label>
    <link:label id="lab_zlab_RevenueFromContractWithCustomersExcludingAssessedTaxBeforeAdjustmentsForRebatesAndSalesReturns_documentation_en-US" xlink:label="lab_zlab_RevenueFromContractWithCustomersExcludingAssessedTaxBeforeAdjustmentsForRebatesAndSalesReturns" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of revenue from contract with customers excluding assessed tax, before adjustments for rebates and sales return.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_RevenueFromContractWithCustomersExcludingAssessedTaxBeforeAdjustmentsForRebatesAndSalesReturns" xlink:href="zlab-20231231.xsd#zlab_RevenueFromContractWithCustomersExcludingAssessedTaxBeforeAdjustmentsForRebatesAndSalesReturns"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_RevenueFromContractWithCustomersExcludingAssessedTaxBeforeAdjustmentsForRebatesAndSalesReturns" xlink:to="lab_zlab_RevenueFromContractWithCustomersExcludingAssessedTaxBeforeAdjustmentsForRebatesAndSalesReturns" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_25603129-df60-4c10-a2bd-04bede63fd6f_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use asset acquired under operating leases</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_22e551f9-715a-4388-8dbc-b951f332cd7c_verboseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash operating lease liabilities arising from obtaining operating right-of-use assets</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrAxis_terseLabel_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement:</link:label>
    <link:label id="lab_ecd_TradingArrAxis_label_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrAxis" xlink:to="lab_ecd_TradingArrAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_15789b1e-415c-42d0-85c3-f2d6f2dfe657_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_e44f51fa-c084-4f5a-b766-e24992b96ab4_negatedLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_RestrictedNetAssetsTable_9171558f-2e00-4431-b0bf-c184c9cc71e1_terseLabel_en-US" xlink:label="lab_zlab_RestrictedNetAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Net Assets [Table]</link:label>
    <link:label id="lab_zlab_RestrictedNetAssetsTable_label_en-US" xlink:label="lab_zlab_RestrictedNetAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Net Assets [Table]</link:label>
    <link:label id="lab_zlab_RestrictedNetAssetsTable_documentation_en-US" xlink:label="lab_zlab_RestrictedNetAssetsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted net assets .</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_RestrictedNetAssetsTable" xlink:href="zlab-20231231.xsd#zlab_RestrictedNetAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_RestrictedNetAssetsTable" xlink:to="lab_zlab_RestrictedNetAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_913f5627-83c2-4775-95da-e29e3044bfd4_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_label_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoActuallyPaidCompAmt" xlink:to="lab_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_2a90db95-bdd8-42b5-b1db-8c4ded61902d_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables for purchase of property and equipment</link:label>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_label_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash or Part Noncash Acquisition, Fixed Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:to="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_d62e446d-2edb-40d8-b62e-3cdd16f9a44c_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_3b3dc8ca-84bd-42cb-a04f-be30eadb91b3_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_10a7e428-7a13-4c1c-bfd5-26b03ba374ec_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_ce4648ca-7739-4ee7-8acf-2a60cbebe61d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_e540463f-1a44-4b01-9e23-a2e5f2876ee3_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_0fecf739-4bc2-4468-971a-aaf6838bc2e9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_OptuneMember_c5caef9e-575e-4866-9675-e5ca5a2d7366_terseLabel_en-US" xlink:label="lab_zlab_OptuneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OPTUNE</link:label>
    <link:label id="lab_zlab_OptuneMember_label_en-US" xlink:label="lab_zlab_OptuneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Optune [Member]</link:label>
    <link:label id="lab_zlab_OptuneMember_documentation_en-US" xlink:label="lab_zlab_OptuneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Optune</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_OptuneMember" xlink:href="zlab-20231231.xsd#zlab_OptuneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_OptuneMember" xlink:to="lab_zlab_OptuneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_IncreaseDecreaseInValueAddedTaxesReceivable_95319553-08c8-4ebf-bed1-5f06c25d8131_negatedLabel_en-US" xlink:label="lab_zlab_IncreaseDecreaseInValueAddedTaxesReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value added tax recoverable</link:label>
    <link:label id="lab_zlab_IncreaseDecreaseInValueAddedTaxesReceivable_label_en-US" xlink:label="lab_zlab_IncreaseDecreaseInValueAddedTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase Decrease In Value Added Taxes Receivable</link:label>
    <link:label id="lab_zlab_IncreaseDecreaseInValueAddedTaxesReceivable_documentation_en-US" xlink:label="lab_zlab_IncreaseDecreaseInValueAddedTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase decrease in value added taxes receivable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_IncreaseDecreaseInValueAddedTaxesReceivable" xlink:href="zlab-20231231.xsd#zlab_IncreaseDecreaseInValueAddedTaxesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_IncreaseDecreaseInValueAddedTaxesReceivable" xlink:to="lab_zlab_IncreaseDecreaseInValueAddedTaxesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComputerSoftwareIntangibleAssetMember_c079d9d8-81f6-4baa-b4fa-7b41ef3f2cdf_terseLabel_en-US" xlink:label="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software</link:label>
    <link:label id="lab_us-gaap_ComputerSoftwareIntangibleAssetMember_label_en-US" xlink:label="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Software, Intangible Asset [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:to="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_InnovivaInc.Member_35fa8fc4-4455-4da9-b0e9-26c80cad8a03_terseLabel_en-US" xlink:label="lab_zlab_InnovivaInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Innoviva</link:label>
    <link:label id="lab_zlab_InnovivaInc.Member_label_en-US" xlink:label="lab_zlab_InnovivaInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Innoviva, Inc. [Member]</link:label>
    <link:label id="lab_zlab_InnovivaInc.Member_documentation_en-US" xlink:label="lab_zlab_InnovivaInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Innoviva, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_InnovivaInc.Member" xlink:href="zlab-20231231.xsd#zlab_InnovivaInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_InnovivaInc.Member" xlink:to="lab_zlab_InnovivaInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_SummaryOfWeightedAverageRemainingLeaseTermsAndDiscountRatesTableTextBlock_fed1f3f4-dc12-4b86-b4d8-982fdeb518ff_terseLabel_en-US" xlink:label="lab_zlab_SummaryOfWeightedAverageRemainingLeaseTermsAndDiscountRatesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Weighted-Average Remaining Lease Terms and Discount Rates</link:label>
    <link:label id="lab_zlab_SummaryOfWeightedAverageRemainingLeaseTermsAndDiscountRatesTableTextBlock_label_en-US" xlink:label="lab_zlab_SummaryOfWeightedAverageRemainingLeaseTermsAndDiscountRatesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Weighted Average Remaining Lease Terms And Discount Rates [Table Text Block]</link:label>
    <link:label id="lab_zlab_SummaryOfWeightedAverageRemainingLeaseTermsAndDiscountRatesTableTextBlock_documentation_en-US" xlink:label="lab_zlab_SummaryOfWeightedAverageRemainingLeaseTermsAndDiscountRatesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of weighted average remaining lease terms and discount rates.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_SummaryOfWeightedAverageRemainingLeaseTermsAndDiscountRatesTableTextBlock" xlink:href="zlab-20231231.xsd#zlab_SummaryOfWeightedAverageRemainingLeaseTermsAndDiscountRatesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_SummaryOfWeightedAverageRemainingLeaseTermsAndDiscountRatesTableTextBlock" xlink:to="lab_zlab_SummaryOfWeightedAverageRemainingLeaseTermsAndDiscountRatesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_d71d40eb-1c37-4383-bbb1-2736f7d79165_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_1509eab5-302d-4bd3-b24d-7c8bec2aa36a_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expenses</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_5a4bffc5-c708-4976-871a-43f032f924f5_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_731aa46c-6d2d-4400-ae61-b015ba60c987_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermInvestments_bca1c23a-c180-4f2b-89e3-9f643c240b74_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term investments</link:label>
    <link:label id="lab_us-gaap_LongTermInvestments_label_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermInvestments" xlink:to="lab_us-gaap_LongTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_176a3b69-1bb3-4fd2-9958-76a0281aa7e1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free rate of return, minimum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_A401kPlanMember_fded3322-f996-4a58-9cb3-fb6c38ac7a6a_terseLabel_en-US" xlink:label="lab_zlab_A401kPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">401(k) Plan</link:label>
    <link:label id="lab_zlab_A401kPlanMember_label_en-US" xlink:label="lab_zlab_A401kPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">401(k) Plan [Member]</link:label>
    <link:label id="lab_zlab_A401kPlanMember_documentation_en-US" xlink:label="lab_zlab_A401kPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">401(k) Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_A401kPlanMember" xlink:href="zlab-20231231.xsd#zlab_A401kPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_A401kPlanMember" xlink:to="lab_zlab_A401kPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_e93dfa74-3fdb-4c9f-a3e5-56ee717eac48_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_064283f8-5b0a-4307-ac1d-f1b4d3420ae1_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_857baef1-0eee-400c-aea9-ac19b8c10dea_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDeterminationDate_terseLabel_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:label id="lab_ecd_RestatementDeterminationDate_label_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDeterminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDeterminationDate" xlink:to="lab_ecd_RestatementDeterminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_country_AU_05c81a95-0aa0-4d2e-8345-942c74f6d223_terseLabel_en-US" xlink:label="lab_country_AU" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Australia</link:label>
    <link:label id="lab_country_AU_label_en-US" xlink:label="lab_country_AU" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AUSTRALIA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_AU" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_AU"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_AU" xlink:to="lab_country_AU" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_EffectiveIncomeTaxRateReconciliationAtPreferentialTaxRate_a5f3737e-0e60-45df-bcdf-54ebfad4f60e_terseLabel_en-US" xlink:label="lab_zlab_EffectiveIncomeTaxRateReconciliationAtPreferentialTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferential tax rate</link:label>
    <link:label id="lab_zlab_EffectiveIncomeTaxRateReconciliationAtPreferentialTaxRate_label_en-US" xlink:label="lab_zlab_EffectiveIncomeTaxRateReconciliationAtPreferentialTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation At Preferential Tax Rate</link:label>
    <link:label id="lab_zlab_EffectiveIncomeTaxRateReconciliationAtPreferentialTaxRate_documentation_en-US" xlink:label="lab_zlab_EffectiveIncomeTaxRateReconciliationAtPreferentialTaxRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate reconciliation at preferential tax rate.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_EffectiveIncomeTaxRateReconciliationAtPreferentialTaxRate" xlink:href="zlab-20231231.xsd#zlab_EffectiveIncomeTaxRateReconciliationAtPreferentialTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_EffectiveIncomeTaxRateReconciliationAtPreferentialTaxRate" xlink:to="lab_zlab_EffectiveIncomeTaxRateReconciliationAtPreferentialTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardDateDomain_a827bdc5-3acb-415b-add0-71917e348b74_terseLabel_en-US" xlink:label="lab_us-gaap_AwardDateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Domain]</link:label>
    <link:label id="lab_us-gaap_AwardDateDomain_label_en-US" xlink:label="lab_us-gaap_AwardDateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardDateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardDateDomain" xlink:to="lab_us-gaap_AwardDateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_ZaiLabInternationalTradingShanghaiCompanyLimitedMember_cc065220-61b8-4876-9c92-b37b6604fef3_terseLabel_en-US" xlink:label="lab_zlab_ZaiLabInternationalTradingShanghaiCompanyLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zai Lab International Trading (Shanghai) Co., Ltd.</link:label>
    <link:label id="lab_zlab_ZaiLabInternationalTradingShanghaiCompanyLimitedMember_label_en-US" xlink:label="lab_zlab_ZaiLabInternationalTradingShanghaiCompanyLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zai Lab International Trading Shanghai Company Limited [Member]</link:label>
    <link:label id="lab_zlab_ZaiLabInternationalTradingShanghaiCompanyLimitedMember_documentation_en-US" xlink:label="lab_zlab_ZaiLabInternationalTradingShanghaiCompanyLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zai Lab International Trading Shanghai Company Limited.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ZaiLabInternationalTradingShanghaiCompanyLimitedMember" xlink:href="zlab-20231231.xsd#zlab_ZaiLabInternationalTradingShanghaiCompanyLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_ZaiLabInternationalTradingShanghaiCompanyLimitedMember" xlink:to="lab_zlab_ZaiLabInternationalTradingShanghaiCompanyLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAbstract_936ee95d-10b9-4cb7-b624-1030b89d7b5a_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash, non-current</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAbstract_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAbstract" xlink:to="lab_us-gaap_RestrictedCashAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_3602282c-8d8e-4ab8-b9a3-8d2e27355bda_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:to="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_e0bc4e10-3a5c-4d70-9142-29502809e09f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByAssetClassAxis" xlink:to="lab_us-gaap_FairValueByAssetClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_OtherCounterpartiesMember_b260c65c-8112-43ec-a44b-59e87e39509b_terseLabel_en-US" xlink:label="lab_zlab_OtherCounterpartiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other counterparties</link:label>
    <link:label id="lab_zlab_OtherCounterpartiesMember_label_en-US" xlink:label="lab_zlab_OtherCounterpartiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Counterparties [Member]</link:label>
    <link:label id="lab_zlab_OtherCounterpartiesMember_documentation_en-US" xlink:label="lab_zlab_OtherCounterpartiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Counterparties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_OtherCounterpartiesMember" xlink:href="zlab-20231231.xsd#zlab_OtherCounterpartiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_OtherCounterpartiesMember" xlink:to="lab_zlab_OtherCounterpartiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_PfizerIncMember_014c734e-ccd7-44a2-95ce-660822aede66_terseLabel_en-US" xlink:label="lab_zlab_PfizerIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pfizer</link:label>
    <link:label id="lab_zlab_PfizerIncMember_label_en-US" xlink:label="lab_zlab_PfizerIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pfizer Inc [Member]</link:label>
    <link:label id="lab_zlab_PfizerIncMember_documentation_en-US" xlink:label="lab_zlab_PfizerIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pfizer Inc</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_PfizerIncMember" xlink:href="zlab-20231231.xsd#zlab_PfizerIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_PfizerIncMember" xlink:to="lab_zlab_PfizerIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_d3cf1d07-9f17-4eb7-8fb9-4f09b9e1c3b2_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_ZaiLabShanghaiCompanyLimitedMember_71858c92-19c6-4ccb-a7ee-4a417a43e02c_terseLabel_en-US" xlink:label="lab_zlab_ZaiLabShanghaiCompanyLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zai Lab (Shanghai) Co., Ltd.</link:label>
    <link:label id="lab_zlab_ZaiLabShanghaiCompanyLimitedMember_label_en-US" xlink:label="lab_zlab_ZaiLabShanghaiCompanyLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zai Lab Shanghai Company Limited [Member]</link:label>
    <link:label id="lab_zlab_ZaiLabShanghaiCompanyLimitedMember_documentation_en-US" xlink:label="lab_zlab_ZaiLabShanghaiCompanyLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zai Lab (Shanghai) company limited.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ZaiLabShanghaiCompanyLimitedMember" xlink:href="zlab-20231231.xsd#zlab_ZaiLabShanghaiCompanyLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_ZaiLabShanghaiCompanyLimitedMember" xlink:to="lab_zlab_ZaiLabShanghaiCompanyLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_BMSMember_0729b53b-4dd0-4b5e-9c23-486dd7e78552_terseLabel_en-US" xlink:label="lab_zlab_BMSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BMS</link:label>
    <link:label id="lab_zlab_BMSMember_label_en-US" xlink:label="lab_zlab_BMSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BMS [Member]</link:label>
    <link:label id="lab_zlab_BMSMember_documentation_en-US" xlink:label="lab_zlab_BMSMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BMS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_BMSMember" xlink:href="zlab-20231231.xsd#zlab_BMSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_BMSMember" xlink:to="lab_zlab_BMSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_ArgenxBvMember_7d433bc5-ddc4-46e0-8994-d4ce53b87bbb_terseLabel_en-US" xlink:label="lab_zlab_ArgenxBvMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">argenx</link:label>
    <link:label id="lab_zlab_ArgenxBvMember_label_en-US" xlink:label="lab_zlab_ArgenxBvMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Argenx BV [Member]</link:label>
    <link:label id="lab_zlab_ArgenxBvMember_documentation_en-US" xlink:label="lab_zlab_ArgenxBvMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Argenx BV [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ArgenxBvMember" xlink:href="zlab-20231231.xsd#zlab_ArgenxBvMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_ArgenxBvMember" xlink:to="lab_zlab_ArgenxBvMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_a308be9e-a06d-4ce3-b469-79a7d17c93ab_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Loss (Income) Before Income Taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_710f6900-bfe9-4ed1-b731-bb7f77351003_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_label_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Price or TSR Estimation Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansPayableMember_84ea2f0a-de80-4d46-8331-93617f9638e0_terseLabel_en-US" xlink:label="lab_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable</link:label>
    <link:label id="lab_us-gaap_LoansPayableMember_label_en-US" xlink:label="lab_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LoansPayableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansPayableMember" xlink:to="lab_us-gaap_LoansPayableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_893b9a90-1861-4b54-8013-cfc73ba257e6_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating fixed lease cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_e79f6a79-ca21-4a9b-98c6-13fae7aacc4f_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Long-Lived Assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_419dad65-ece5-4e21-96ce-b3bb13152366_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_487f8f3e-3ce7-4a9d-910a-0ff1f818b48d_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest_2fd5b6a6-b8fe-4c27-9cad-695dbb73515b_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Ownership</link:label>
    <link:label id="lab_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest_label_en-US" xlink:label="lab_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary of Limited Liability Company or Limited Partnership, Ownership Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest" xlink:to="lab_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_90c1c1f0-f00f-4751-ba1f-429daedd6570_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Assumptions Used to Estimate Fair Values of Share Options Granted</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_714bafd1-eeb3-4a9c-8f2c-8b879d76dd3e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock (at cost, 4,912,200 and 2,236,280 shares as of December&#160;31, 2023 and 2022, respectively)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_f66ba740-b07e-4f9e-93b1-73c411cd4548_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonValue" xlink:to="lab_us-gaap_TreasuryStockCommonValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_8d36369c-c62a-4deb-bcb3-847c5df3e318_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInNotesReceivableCurrent_b9ed4513-cb59-465b-92fe-561ed183772e_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInNotesReceivableCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInNotesReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInNotesReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Notes Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInNotesReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInNotesReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInNotesReceivableCurrent" xlink:to="lab_us-gaap_IncreaseDecreaseInNotesReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_51264598-b7e3-4a82-b742-a61d8af293ea_negatedLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6247b1f1-502a-436d-acf8-a25d308f4030_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_ec0d1047-6b58-4366-9264-12c918085961_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting percentage</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_26b1b370-ec31-429f-9f01-71b543d71171_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedAssetsDisclosureTextBlock_8ea20163-09f8-4a47-9637-9ef08b84ae4f_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Net Assets</link:label>
    <link:label id="lab_us-gaap_RestrictedAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestrictedAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_RestrictedAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_55984e00-678a-40b6-90c0-e96450a2c6ef_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer matching contribution percentage</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Match</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_SPDBankWorkingCapitalLoanFacilityMember_7dc5f887-0306-4bc1-a702-75d47fc1ff89_terseLabel_en-US" xlink:label="lab_zlab_SPDBankWorkingCapitalLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SPD Bank Working Capital Loan Facility</link:label>
    <link:label id="lab_zlab_SPDBankWorkingCapitalLoanFacilityMember_label_en-US" xlink:label="lab_zlab_SPDBankWorkingCapitalLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SPD Bank Working Capital Loan Facility [Member]</link:label>
    <link:label id="lab_zlab_SPDBankWorkingCapitalLoanFacilityMember_documentation_en-US" xlink:label="lab_zlab_SPDBankWorkingCapitalLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SPD Bank Working Capital Loan Facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_SPDBankWorkingCapitalLoanFacilityMember" xlink:href="zlab-20231231.xsd#zlab_SPDBankWorkingCapitalLoanFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_SPDBankWorkingCapitalLoanFacilityMember" xlink:to="lab_zlab_SPDBankWorkingCapitalLoanFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_e673253d-a993-482a-9ae5-2dd9bcc4eead_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognized over a weighted-average period</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_1a968184-6a38-4328-87ec-56f0624ad3e8_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_08637f04-f0d0-404b-8410-f302ed5ee1f8_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaturityOfTimeDeposits_4c279993-9493-4ac2-b980-ee79310a2b19_terseLabel_en-US" xlink:label="lab_us-gaap_MaturityOfTimeDeposits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Original maturities of time deposits</link:label>
    <link:label id="lab_us-gaap_MaturityOfTimeDeposits_label_en-US" xlink:label="lab_us-gaap_MaturityOfTimeDeposits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturity of Time Deposits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaturityOfTimeDeposits" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MaturityOfTimeDeposits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaturityOfTimeDeposits" xlink:to="lab_us-gaap_MaturityOfTimeDeposits" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_AmericanDepositaryShareToCommonStockConversionRatio_26ba8b8d-8934-4969-821c-062b98621683_terseLabel_en-US" xlink:label="lab_zlab_AmericanDepositaryShareToCommonStockConversionRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ADS to ordinary shares conversion ratio</link:label>
    <link:label id="lab_zlab_AmericanDepositaryShareToCommonStockConversionRatio_label_en-US" xlink:label="lab_zlab_AmericanDepositaryShareToCommonStockConversionRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">American Depositary Share to Common Stock, Conversion Ratio</link:label>
    <link:label id="lab_zlab_AmericanDepositaryShareToCommonStockConversionRatio_documentation_en-US" xlink:label="lab_zlab_AmericanDepositaryShareToCommonStockConversionRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">American Depositary Share to Common Stock, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_AmericanDepositaryShareToCommonStockConversionRatio" xlink:href="zlab-20231231.xsd#zlab_AmericanDepositaryShareToCommonStockConversionRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_AmericanDepositaryShareToCommonStockConversionRatio" xlink:to="lab_zlab_AmericanDepositaryShareToCommonStockConversionRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashEquivalentsAtCarryingValue_b7e03b57-8567-421d-99c9-b4e236926954_terseLabel_en-US" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_d3af810e-fb64-4763-8f7d-9d99c5c4f91b_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_ShareBasedPaymentArrangementOptionBatchTwoMember_49f52459-7497-4959-922e-75189a5beed0_terseLabel_en-US" xlink:label="lab_zlab_ShareBasedPaymentArrangementOptionBatchTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share options, batch two</link:label>
    <link:label id="lab_zlab_ShareBasedPaymentArrangementOptionBatchTwoMember_label_en-US" xlink:label="lab_zlab_ShareBasedPaymentArrangementOptionBatchTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Batch Two [Member]</link:label>
    <link:label id="lab_zlab_ShareBasedPaymentArrangementOptionBatchTwoMember_documentation_en-US" xlink:label="lab_zlab_ShareBasedPaymentArrangementOptionBatchTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Batch Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ShareBasedPaymentArrangementOptionBatchTwoMember" xlink:href="zlab-20231231.xsd#zlab_ShareBasedPaymentArrangementOptionBatchTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_ShareBasedPaymentArrangementOptionBatchTwoMember" xlink:to="lab_zlab_ShareBasedPaymentArrangementOptionBatchTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TabularListTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular List, Table</link:label>
    <link:label id="lab_ecd_TabularListTableTextBlock_label_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular List [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TabularListTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TabularListTableTextBlock" xlink:to="lab_ecd_TabularListTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_DeferredTaxAssetsDeferredRevenue_35a41d22-11ef-4903-b794-7d034240c4b4_terseLabel_en-US" xlink:label="lab_zlab_DeferredTaxAssetsDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_zlab_DeferredTaxAssetsDeferredRevenue_label_en-US" xlink:label="lab_zlab_DeferredTaxAssetsDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets Deferred Revenue</link:label>
    <link:label id="lab_zlab_DeferredTaxAssetsDeferredRevenue_documentation_en-US" xlink:label="lab_zlab_DeferredTaxAssetsDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred revenue.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_DeferredTaxAssetsDeferredRevenue" xlink:href="zlab-20231231.xsd#zlab_DeferredTaxAssetsDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_DeferredTaxAssetsDeferredRevenue" xlink:to="lab_zlab_DeferredTaxAssetsDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductionRelatedImpairmentsOrCharges_97a786fd-e6b0-44ff-b1d5-c4cfeddfadfd_terseLabel_en-US" xlink:label="lab_us-gaap_ProductionRelatedImpairmentsOrCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory write-down</link:label>
    <link:label id="lab_us-gaap_ProductionRelatedImpairmentsOrCharges_label_en-US" xlink:label="lab_us-gaap_ProductionRelatedImpairmentsOrCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Production Related Impairments or Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductionRelatedImpairmentsOrCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductionRelatedImpairmentsOrCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductionRelatedImpairmentsOrCharges" xlink:to="lab_us-gaap_ProductionRelatedImpairmentsOrCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_f00a85d4-000d-42f1-8367-dff6ba3ee449_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_4257d9b7-22ec-42b5-a485-79ae23729d02_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_e3265f20-fdac-4e18-b5eb-ae9cc5bfacaf_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_NonCashPayablesForTreasuryStock_023b72ce-4015-430d-9edf-e8ff9ad56aaf_terseLabel_en-US" xlink:label="lab_zlab_NonCashPayablesForTreasuryStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables for treasury stock</link:label>
    <link:label id="lab_zlab_NonCashPayablesForTreasuryStock_label_en-US" xlink:label="lab_zlab_NonCashPayablesForTreasuryStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Cash Payables For Treasury Stock</link:label>
    <link:label id="lab_zlab_NonCashPayablesForTreasuryStock_documentation_en-US" xlink:label="lab_zlab_NonCashPayablesForTreasuryStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non cash payables for treasury stock.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_NonCashPayablesForTreasuryStock" xlink:href="zlab-20231231.xsd#zlab_NonCashPayablesForTreasuryStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_NonCashPayablesForTreasuryStock" xlink:to="lab_zlab_NonCashPayablesForTreasuryStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_7fbfb439-1021-48c6-bc8e-6beed1e56d67_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_46acefca-e149-4417-8045-a6122e5be1e1_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_CollaborativeArrangementRightsAndObligationsSpecifiedRoyaltyTerm_a32a826f-b159-4482-8ca6-0f607b72f6c3_terseLabel_en-US" xlink:label="lab_zlab_CollaborativeArrangementRightsAndObligationsSpecifiedRoyaltyTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Specified royalty term</link:label>
    <link:label id="lab_zlab_CollaborativeArrangementRightsAndObligationsSpecifiedRoyaltyTerm_label_en-US" xlink:label="lab_zlab_CollaborativeArrangementRightsAndObligationsSpecifiedRoyaltyTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Rights and Obligations, Specified Royalty Term</link:label>
    <link:label id="lab_zlab_CollaborativeArrangementRightsAndObligationsSpecifiedRoyaltyTerm_documentation_en-US" xlink:label="lab_zlab_CollaborativeArrangementRightsAndObligationsSpecifiedRoyaltyTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Rights and Obligations, Specified Royalty Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_CollaborativeArrangementRightsAndObligationsSpecifiedRoyaltyTerm" xlink:href="zlab-20231231.xsd#zlab_CollaborativeArrangementRightsAndObligationsSpecifiedRoyaltyTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_CollaborativeArrangementRightsAndObligationsSpecifiedRoyaltyTerm" xlink:to="lab_zlab_CollaborativeArrangementRightsAndObligationsSpecifiedRoyaltyTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_95d87e6e-9cf5-4890-87cd-9c45da3e9d1f_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_OneCustomerMember_6d5c5962-09a6-45eb-8039-fe55ba2454ea_terseLabel_en-US" xlink:label="lab_zlab_OneCustomerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Customer</link:label>
    <link:label id="lab_zlab_OneCustomerMember_label_en-US" xlink:label="lab_zlab_OneCustomerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Customer [Member]</link:label>
    <link:label id="lab_zlab_OneCustomerMember_documentation_en-US" xlink:label="lab_zlab_OneCustomerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Customer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_OneCustomerMember" xlink:href="zlab-20231231.xsd#zlab_OneCustomerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_OneCustomerMember" xlink:to="lab_zlab_OneCustomerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_313e3bda-16ad-4d10-aaec-fc2dea967fa7_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7b193c37-3143-4970-9fa4-6eb65fe4758f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price ($)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_b964e010-800b-4f68-9b8c-942c6d35798c_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, allowance for credit loss</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_2b1c044c-55b6-4a6d-9a4c-8c74f3e85086_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_27e7c9fd-a47d-4d45-aa62-2f07a628384d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carry forwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_b22b9e6d-3e84-4369-b401-9ac25376224d_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_3c0dfc32-56d7-44eb-987a-599200f5f606_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash, non-current</link:label>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashNoncurrent" xlink:to="lab_us-gaap_RestrictedCashNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_6cc7b469-72f4-4aa4-85a5-76fa41f696dd_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_06590e1f-1de7-428e-8516-5859b4bc82fe_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_SupplierEMember_ce150c2f-5435-4a56-83aa-f459f75169e9_terseLabel_en-US" xlink:label="lab_zlab_SupplierEMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">E</link:label>
    <link:label id="lab_zlab_SupplierEMember_label_en-US" xlink:label="lab_zlab_SupplierEMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier E [Member]</link:label>
    <link:label id="lab_zlab_SupplierEMember_documentation_en-US" xlink:label="lab_zlab_SupplierEMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier E</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_SupplierEMember" xlink:href="zlab-20231231.xsd#zlab_SupplierEMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_SupplierEMember" xlink:to="lab_zlab_SupplierEMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_78e97fad-cce7-42ac-ae76-e46e7522ec2f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated statements of operations</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_c3c110b7-b97b-4f31-b5ea-7c01a163c47b_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_9112d123-dc3b-4c4a-a938-d56544d18420_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of ordinary shares upon follow-on public offering, net of issuance cost (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_78f2f2bd-ddab-4349-8f41-18147090da93_verboseLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpensesAbstract" xlink:to="lab_us-gaap_CostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_6919d2b4-5a51-4c2e-9a88-380c60a8efe0_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_6600099a-03db-42cc-b5e2-aef6f77c36d2_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_ForeignCurrencyRiskMember_e8a1c47d-d534-4835-951a-e93b70a9317c_terseLabel_en-US" xlink:label="lab_zlab_ForeignCurrencyRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Risk</link:label>
    <link:label id="lab_zlab_ForeignCurrencyRiskMember_label_en-US" xlink:label="lab_zlab_ForeignCurrencyRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Risk [Member]</link:label>
    <link:label id="lab_zlab_ForeignCurrencyRiskMember_documentation_en-US" xlink:label="lab_zlab_ForeignCurrencyRiskMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">foreign currency risk.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ForeignCurrencyRiskMember" xlink:href="zlab-20231231.xsd#zlab_ForeignCurrencyRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_ForeignCurrencyRiskMember" xlink:to="lab_zlab_ForeignCurrencyRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Investments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermInvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestmentsAbstract" xlink:to="lab_us-gaap_ShortTermInvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeNoncurrent_051b8bcc-f991-464d-a353-3bc17ecea468_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeNoncurrent" xlink:to="lab_us-gaap_DeferredIncomeNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_79c0d0f7-1ad9-4800-bd48-8458b1e1f248_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_fe44fe66-5d51-475e-8f10-b55756c0ab42_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_label_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAbstract_d69eec8b-c185-418d-a7fd-e414d9031256_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator:</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAbstract" xlink:to="lab_us-gaap_NetIncomeLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_12d62f85-1e6e-44f3-a9e9-976a55d624f1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_RafaelAmadoMember_label_en-US" xlink:label="lab_zlab_RafaelAmadoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rafael Amado [Member]</link:label>
    <link:label id="lab_zlab_RafaelAmadoMember_documentation_en-US" xlink:label="lab_zlab_RafaelAmadoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rafael Amado</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_RafaelAmadoMember" xlink:href="zlab-20231231.xsd#zlab_RafaelAmadoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_RafaelAmadoMember" xlink:to="lab_zlab_RafaelAmadoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ecef7bd3-612b-4bd4-9c2b-594f20a097e6_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_CommonStockAuthorizedShareCapital_3432b0c4-3be6-406f-8653-a5e9f9057f4d_terseLabel_en-US" xlink:label="lab_zlab_CommonStockAuthorizedShareCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, authorized share capital</link:label>
    <link:label id="lab_zlab_CommonStockAuthorizedShareCapital_label_en-US" xlink:label="lab_zlab_CommonStockAuthorizedShareCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Authorized Share Capital</link:label>
    <link:label id="lab_zlab_CommonStockAuthorizedShareCapital_documentation_en-US" xlink:label="lab_zlab_CommonStockAuthorizedShareCapital" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock authorized share capital.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_CommonStockAuthorizedShareCapital" xlink:href="zlab-20231231.xsd#zlab_CommonStockAuthorizedShareCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_CommonStockAuthorizedShareCapital" xlink:to="lab_zlab_CommonStockAuthorizedShareCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_704efc85-044e-4b5c-82ea-48b3bf5c51a5_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_ZaiLabHongKongAndZlChinaHoldingTwoAndZaiAutoImmuneHongKongAndZaiAntiInfectivesHongKongLimitedMember_73727e58-9481-47bc-bcef-c81e5dc7a3ab_terseLabel_en-US" xlink:label="lab_zlab_ZaiLabHongKongAndZlChinaHoldingTwoAndZaiAutoImmuneHongKongAndZaiAntiInfectivesHongKongLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zai Lab (Hong Kong) and ZL China Holding Two and Zai Auto Immune (Hong Kong) and Zai Anti Infectives (Hong Kong) Limited</link:label>
    <link:label id="lab_zlab_ZaiLabHongKongAndZlChinaHoldingTwoAndZaiAutoImmuneHongKongAndZaiAntiInfectivesHongKongLimitedMember_label_en-US" xlink:label="lab_zlab_ZaiLabHongKongAndZlChinaHoldingTwoAndZaiAutoImmuneHongKongAndZaiAntiInfectivesHongKongLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zai Lab (Hong Kong) and ZL China Holding Two and Zai Auto Immune (Hong Kong) and Zai Anti Infectives (Hong Kong) Limited [Member]</link:label>
    <link:label id="lab_zlab_ZaiLabHongKongAndZlChinaHoldingTwoAndZaiAutoImmuneHongKongAndZaiAntiInfectivesHongKongLimitedMember_documentation_en-US" xlink:label="lab_zlab_ZaiLabHongKongAndZlChinaHoldingTwoAndZaiAutoImmuneHongKongAndZaiAntiInfectivesHongKongLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zai Lab (Hong Kong) and ZL China Holding Two and Zai Auto Immune (Hong Kong) and Zai Anti Infectives (Hong Kong) Limited [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ZaiLabHongKongAndZlChinaHoldingTwoAndZaiAutoImmuneHongKongAndZaiAntiInfectivesHongKongLimitedMember" xlink:href="zlab-20231231.xsd#zlab_ZaiLabHongKongAndZlChinaHoldingTwoAndZaiAutoImmuneHongKongAndZaiAntiInfectivesHongKongLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_ZaiLabHongKongAndZlChinaHoldingTwoAndZaiAutoImmuneHongKongAndZaiAntiInfectivesHongKongLimitedMember" xlink:to="lab_zlab_ZaiLabHongKongAndZlChinaHoldingTwoAndZaiAutoImmuneHongKongAndZaiAntiInfectivesHongKongLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_be3808e3-9ed7-40a7-a61b-b01eaacc10d9_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_5476d319-d611-4410-a3c6-89230ad8d750_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_ba514f1a-77e2-4391-89bf-4fd98733f88a_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_NetRevenueTableTextBlock_16cec66d-dcfb-4c49-b058-945e2509b6fd_terseLabel_en-US" xlink:label="lab_zlab_NetRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Product Sales</link:label>
    <link:label id="lab_zlab_NetRevenueTableTextBlock_label_en-US" xlink:label="lab_zlab_NetRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Revenue [Table Text Block]</link:label>
    <link:label id="lab_zlab_NetRevenueTableTextBlock_documentation_en-US" xlink:label="lab_zlab_NetRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_NetRevenueTableTextBlock" xlink:href="zlab-20231231.xsd#zlab_NetRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_NetRevenueTableTextBlock" xlink:to="lab_zlab_NetRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_2cc24103-7226-40b6-a5c6-8465531cba42_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_26c37f31-7ae0-4774-b8fc-f0a2497d8293_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLossCurrent_bbd5b733-6653-4e87-ab0b-40bb4559468d_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLossCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes receivable</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLossCurrent_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLossCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Excluding Accrued Interest, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLossCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLossCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLossCurrent" xlink:to="lab_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLossCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_WeightedAverageNumberOfShareOutstandingBasicAndDilutedAbstract_2bec4013-380a-444b-b6e0-0e40ee4f3f33_terseLabel_en-US" xlink:label="lab_zlab_WeightedAverageNumberOfShareOutstandingBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator:</link:label>
    <link:label id="lab_zlab_WeightedAverageNumberOfShareOutstandingBasicAndDilutedAbstract_label_en-US" xlink:label="lab_zlab_WeightedAverageNumberOfShareOutstandingBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number Of Share Outstanding Basic And Diluted [Abstract]</link:label>
    <link:label id="lab_zlab_WeightedAverageNumberOfShareOutstandingBasicAndDilutedAbstract_documentation_en-US" xlink:label="lab_zlab_WeightedAverageNumberOfShareOutstandingBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of share outstanding basic and diluted.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_WeightedAverageNumberOfShareOutstandingBasicAndDilutedAbstract" xlink:href="zlab-20231231.xsd#zlab_WeightedAverageNumberOfShareOutstandingBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_WeightedAverageNumberOfShareOutstandingBasicAndDilutedAbstract" xlink:to="lab_zlab_WeightedAverageNumberOfShareOutstandingBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnAmt" xlink:to="lab_ecd_TotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_02b8bba4-a598-4953-bac3-ff4f7f534700_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment To PEO Compensation, Footnote</link:label>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment To PEO Compensation, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToPeoCompFnTextBlock" xlink:to="lab_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_5d9f4523-242e-45c3-a17d-3fa527c3ff1f_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_ShareBasedPaymentArrangementOptionBatchThreeMember_c5adcdca-9c65-43ee-bcd0-155de56a19fc_terseLabel_en-US" xlink:label="lab_zlab_ShareBasedPaymentArrangementOptionBatchThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share options, batch three</link:label>
    <link:label id="lab_zlab_ShareBasedPaymentArrangementOptionBatchThreeMember_label_en-US" xlink:label="lab_zlab_ShareBasedPaymentArrangementOptionBatchThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Batch Three [Member]</link:label>
    <link:label id="lab_zlab_ShareBasedPaymentArrangementOptionBatchThreeMember_documentation_en-US" xlink:label="lab_zlab_ShareBasedPaymentArrangementOptionBatchThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Batch Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ShareBasedPaymentArrangementOptionBatchThreeMember" xlink:href="zlab-20231231.xsd#zlab_ShareBasedPaymentArrangementOptionBatchThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_ShareBasedPaymentArrangementOptionBatchThreeMember" xlink:to="lab_zlab_ShareBasedPaymentArrangementOptionBatchThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_DeferredTaxAssetsResearchAndExperimentalCapitalization_e289ee8a-e309-463a-9f6e-f11979f3a952_terseLabel_en-US" xlink:label="lab_zlab_DeferredTaxAssetsResearchAndExperimentalCapitalization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and experimental capitalization</link:label>
    <link:label id="lab_zlab_DeferredTaxAssetsResearchAndExperimentalCapitalization_label_en-US" xlink:label="lab_zlab_DeferredTaxAssetsResearchAndExperimentalCapitalization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Research And Experimental Capitalization</link:label>
    <link:label id="lab_zlab_DeferredTaxAssetsResearchAndExperimentalCapitalization_documentation_en-US" xlink:label="lab_zlab_DeferredTaxAssetsResearchAndExperimentalCapitalization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Research And Experimental Capitalization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_DeferredTaxAssetsResearchAndExperimentalCapitalization" xlink:href="zlab-20231231.xsd#zlab_DeferredTaxAssetsResearchAndExperimentalCapitalization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_DeferredTaxAssetsResearchAndExperimentalCapitalization" xlink:to="lab_zlab_DeferredTaxAssetsResearchAndExperimentalCapitalization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_b62df5ec-d8f7-4f6e-8228-9078a5787f8e_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosure on non-cash investing and financing activities</link:label>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfCondensedBalanceSheetTableTextBlock_5b9263bf-b85d-4e42-9337-740b5979d447_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Balance Sheets</link:label>
    <link:label id="lab_srt_ScheduleOfCondensedBalanceSheetTableTextBlock_label_en-US" xlink:label="lab_srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Balance Sheet [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfCondensedBalanceSheetTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:to="lab_srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_81e87834-14b0-44ce-b17d-0323b6feae5d_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_ZaiBiopharmaceuticalSuzhouCompanyLimitedMember_967d94fc-c1e1-4435-b2eb-d565160f8a91_terseLabel_en-US" xlink:label="lab_zlab_ZaiBiopharmaceuticalSuzhouCompanyLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zai Biopharmaceutical (Suzhou) Co., Ltd.</link:label>
    <link:label id="lab_zlab_ZaiBiopharmaceuticalSuzhouCompanyLimitedMember_label_en-US" xlink:label="lab_zlab_ZaiBiopharmaceuticalSuzhouCompanyLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zai Biopharmaceutical Suzhou Company Limited [Member]</link:label>
    <link:label id="lab_zlab_ZaiBiopharmaceuticalSuzhouCompanyLimitedMember_documentation_en-US" xlink:label="lab_zlab_ZaiBiopharmaceuticalSuzhouCompanyLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zai Biopharmaceutical (Suzhou) company limited.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ZaiBiopharmaceuticalSuzhouCompanyLimitedMember" xlink:href="zlab-20231231.xsd#zlab_ZaiBiopharmaceuticalSuzhouCompanyLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_ZaiBiopharmaceuticalSuzhouCompanyLimitedMember" xlink:to="lab_zlab_ZaiBiopharmaceuticalSuzhouCompanyLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a2ce3b2d-9343-4f36-946e-d360739893fb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_e8c5ada9-a517-4e10-9329-a31043a1c670_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_AdagrasibMember_061781ec-155a-4b5e-9960-5ede23f29fa1_terseLabel_en-US" xlink:label="lab_zlab_AdagrasibMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adagrasib</link:label>
    <link:label id="lab_zlab_AdagrasibMember_label_en-US" xlink:label="lab_zlab_AdagrasibMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adagrasib [Member]</link:label>
    <link:label id="lab_zlab_AdagrasibMember_documentation_en-US" xlink:label="lab_zlab_AdagrasibMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adagrasib</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_AdagrasibMember" xlink:href="zlab-20231231.xsd#zlab_AdagrasibMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_AdagrasibMember" xlink:to="lab_zlab_AdagrasibMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_49ec9bc4-7715-48e9-9c82-0ae406363cc7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Income (Expense), Net</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Nonoperating Income (Expense) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_a53fcbd9-5d21-48aa-a882-e88b60bcf146_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureAxis_terseLabel_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measure:</link:label>
    <link:label id="lab_ecd_MeasureAxis_label_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measure [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureAxis" xlink:to="lab_ecd_MeasureAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8fc5155d-6aa3-4104-958f-93c3f7ff7547_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryIndName" xlink:to="lab_ecd_OutstandingRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_41374b04-2a21-452f-9453-b41454a0f97e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_670ece29-017f-4f50-bb66-8f472d924ce6_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_c9244934-7faa-45a7-be3e-f62c235b6b23_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_SupplementalInformationRelatedToLeasesTableTableTextBlock_3593416e-c058-4490-85d9-37eef6ccd4f3_terseLabel_en-US" xlink:label="lab_zlab_SupplementalInformationRelatedToLeasesTableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Supplemental Information Related to Leases</link:label>
    <link:label id="lab_zlab_SupplementalInformationRelatedToLeasesTableTableTextBlock_label_en-US" xlink:label="lab_zlab_SupplementalInformationRelatedToLeasesTableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Information Related To Leases Table [Table Text Block]</link:label>
    <link:label id="lab_zlab_SupplementalInformationRelatedToLeasesTableTableTextBlock_documentation_en-US" xlink:label="lab_zlab_SupplementalInformationRelatedToLeasesTableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of supplemental information related to leases.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_SupplementalInformationRelatedToLeasesTableTableTextBlock" xlink:href="zlab-20231231.xsd#zlab_SupplementalInformationRelatedToLeasesTableTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_SupplementalInformationRelatedToLeasesTableTableTextBlock" xlink:to="lab_zlab_SupplementalInformationRelatedToLeasesTableTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_156f636b-a99f-498c-a5b0-dd37b2980c38_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_ffeb0f50-3a8b-41b8-9e2a-77fbdc362166_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Deferred Tax Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_3eac1f67-e521-4b63-ba59-f7c5b32bda46_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_598898a7-857f-459f-825b-fec0e63ea37f_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_4a9acc55-0099-4aa5-b5cd-3072d8fa55b6_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from Operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_c75c9f99-f8f8-472a-ac38-f3dffc8a026a_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_6fafc1a1-a82b-4cd5-ab79-83f6af86d170_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Related Party Transactions By Related Party [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_SupplierFMember_15fa6aca-1275-4194-9657-eb6922c983b8_terseLabel_en-US" xlink:label="lab_zlab_SupplierFMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">F</link:label>
    <link:label id="lab_zlab_SupplierFMember_label_en-US" xlink:label="lab_zlab_SupplierFMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier F [Member]</link:label>
    <link:label id="lab_zlab_SupplierFMember_documentation_en-US" xlink:label="lab_zlab_SupplierFMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier F.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_SupplierFMember" xlink:href="zlab-20231231.xsd#zlab_SupplierFMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_SupplierFMember" xlink:to="lab_zlab_SupplierFMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_b1d0b720-e0d1-4905-a18c-4fe074759e81_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets, Amortization expense, year one</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_OtherPayablesCurrentLiabilities_23f90ef2-dd39-4c9e-b81e-a2d146fc87b0_terseLabel_en-US" xlink:label="lab_zlab_OtherPayablesCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Others</link:label>
    <link:label id="lab_zlab_OtherPayablesCurrentLiabilities_label_en-US" xlink:label="lab_zlab_OtherPayablesCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Payables Current Liabilities</link:label>
    <link:label id="lab_zlab_OtherPayablesCurrentLiabilities_documentation_en-US" xlink:label="lab_zlab_OtherPayablesCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other payables current liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_OtherPayablesCurrentLiabilities" xlink:href="zlab-20231231.xsd#zlab_OtherPayablesCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_OtherPayablesCurrentLiabilities" xlink:to="lab_zlab_OtherPayablesCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_07c1dff7-4714-4ce2-9b96-44d1da85a620_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for amounts included in measurement of lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_GuarantorObligationTerm_968c6d6c-d088-42ca-a012-e3dd3573e1e3_terseLabel_en-US" xlink:label="lab_zlab_GuarantorObligationTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor obligation term</link:label>
    <link:label id="lab_zlab_GuarantorObligationTerm_label_en-US" xlink:label="lab_zlab_GuarantorObligationTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligation, Term</link:label>
    <link:label id="lab_zlab_GuarantorObligationTerm_documentation_en-US" xlink:label="lab_zlab_GuarantorObligationTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligation, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_GuarantorObligationTerm" xlink:href="zlab-20231231.xsd#zlab_GuarantorObligationTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_GuarantorObligationTerm" xlink:to="lab_zlab_GuarantorObligationTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_fe88ce77-2407-48a1-801b-d2944b3c40eb_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_eb4dfdac-c42d-484a-934c-77a6b2ea0090_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_38126660-ff78-43ba-9f68-b963a6e2a37c_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_NonCashPayablesForIntangibleAssets_0e88e8fb-ae99-47ed-85db-d0f712f019c5_terseLabel_en-US" xlink:label="lab_zlab_NonCashPayablesForIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables for acquisition of intangible assets</link:label>
    <link:label id="lab_zlab_NonCashPayablesForIntangibleAssets_label_en-US" xlink:label="lab_zlab_NonCashPayablesForIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Cash Payables For Intangible Assets</link:label>
    <link:label id="lab_zlab_NonCashPayablesForIntangibleAssets_documentation_en-US" xlink:label="lab_zlab_NonCashPayablesForIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash payables for intangible assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_NonCashPayablesForIntangibleAssets" xlink:href="zlab-20231231.xsd#zlab_NonCashPayablesForIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_NonCashPayablesForIntangibleAssets" xlink:to="lab_zlab_NonCashPayablesForIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_CollaborativeArrangementRightsAndObligationsSalesBasedMilestonePayment_cd8ec5db-d3e3-446e-8dbd-1a8dbfa8d1e5_terseLabel_en-US" xlink:label="lab_zlab_CollaborativeArrangementRightsAndObligationsSalesBasedMilestonePayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-based milestone payment</link:label>
    <link:label id="lab_zlab_CollaborativeArrangementRightsAndObligationsSalesBasedMilestonePayment_label_en-US" xlink:label="lab_zlab_CollaborativeArrangementRightsAndObligationsSalesBasedMilestonePayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Rights and Obligations, Sales-Based Milestone Payment</link:label>
    <link:label id="lab_zlab_CollaborativeArrangementRightsAndObligationsSalesBasedMilestonePayment_documentation_en-US" xlink:label="lab_zlab_CollaborativeArrangementRightsAndObligationsSalesBasedMilestonePayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Rights and Obligations, Sales-Based Milestone Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_CollaborativeArrangementRightsAndObligationsSalesBasedMilestonePayment" xlink:href="zlab-20231231.xsd#zlab_CollaborativeArrangementRightsAndObligationsSalesBasedMilestonePayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_CollaborativeArrangementRightsAndObligationsSalesBasedMilestonePayment" xlink:to="lab_zlab_CollaborativeArrangementRightsAndObligationsSalesBasedMilestonePayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoMember_terseLabel_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO</link:label>
    <link:label id="lab_ecd_PeoMember_label_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoMember" xlink:to="lab_ecd_PeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems_d13707ff-4912-4d68-9cab-0509dfaf95ad_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary Of Limited Liability Company Or Limited Partnership [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems_label_en-US" xlink:label="lab_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary of Limited Liability Company or Limited Partnership [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems" xlink:to="lab_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_LandUseRightsLeaseTerm_39812ca7-b311-4e81-9420-749866f3f3ca_terseLabel_en-US" xlink:label="lab_zlab_LandUseRightsLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land use rights lease term</link:label>
    <link:label id="lab_zlab_LandUseRightsLeaseTerm_label_en-US" xlink:label="lab_zlab_LandUseRightsLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land Use Rights Lease Term</link:label>
    <link:label id="lab_zlab_LandUseRightsLeaseTerm_documentation_en-US" xlink:label="lab_zlab_LandUseRightsLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land use rights lease term.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_LandUseRightsLeaseTerm" xlink:href="zlab-20231231.xsd#zlab_LandUseRightsLeaseTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_LandUseRightsLeaseTerm" xlink:to="lab_zlab_LandUseRightsLeaseTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_e7dcfdfa-0ea4-4393-99e6-bf6ce4246eb8_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration of Risks</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_4ec8ca7a-3637-4137-b03a-f093e9661ed4_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_IncreaseDecreaseInOperatingLeaseLiabilities_22fc107b-199a-4450-b840-359daad59564_terseLabel_en-US" xlink:label="lab_zlab_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_zlab_IncreaseDecreaseInOperatingLeaseLiabilities_label_en-US" xlink:label="lab_zlab_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase Decrease In Operating Lease Liabilities</link:label>
    <link:label id="lab_zlab_IncreaseDecreaseInOperatingLeaseLiabilities_documentation_en-US" xlink:label="lab_zlab_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in operating lease liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:href="zlab-20231231.xsd#zlab_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:to="lab_zlab_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_OtherCurrentLiabilitiesDisclosureTextBlock_0c40eb12-7bd8-46f4-8ba4-4beba428a46c_terseLabel_en-US" xlink:label="lab_zlab_OtherCurrentLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities</link:label>
    <link:label id="lab_zlab_OtherCurrentLiabilitiesDisclosureTextBlock_label_en-US" xlink:label="lab_zlab_OtherCurrentLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities Disclosure [Text Block]</link:label>
    <link:label id="lab_zlab_OtherCurrentLiabilitiesDisclosureTextBlock_documentation_en-US" xlink:label="lab_zlab_OtherCurrentLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities disclosure.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_OtherCurrentLiabilitiesDisclosureTextBlock" xlink:href="zlab-20231231.xsd#zlab_OtherCurrentLiabilitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_OtherCurrentLiabilitiesDisclosureTextBlock" xlink:to="lab_zlab_OtherCurrentLiabilitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_d7a2d779-33af-48a2-8229-265e5be808ed_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanDisclosureLineItems_e4e71f67-bb16-48f9-aa97-ca140224a59c_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_e67ee8f3-27f5-4f27-b4ca-f63192b0b644_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_ZaiLabUSLLCMember_9e65cec3-a3fb-410a-b842-081b4e2201e2_terseLabel_en-US" xlink:label="lab_zlab_ZaiLabUSLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zai Lab (US) LLC</link:label>
    <link:label id="lab_zlab_ZaiLabUSLLCMember_label_en-US" xlink:label="lab_zlab_ZaiLabUSLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zai Lab U S L L C [Member]</link:label>
    <link:label id="lab_zlab_ZaiLabUSLLCMember_documentation_en-US" xlink:label="lab_zlab_ZaiLabUSLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zai Lab (US) LLC.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ZaiLabUSLLCMember" xlink:href="zlab-20231231.xsd#zlab_ZaiLabUSLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_ZaiLabUSLLCMember" xlink:to="lab_zlab_ZaiLabUSLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_69a45fd9-f03e-4ea4-b9ed-9039516ebc74_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_b1262527-af20-488e-8c63-bdd81a58dd00_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems_d1effd52-7e1f-4cdf-9b0c-f493ab4baaff_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Held-to-Maturity Securities [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Held-to-Maturity Securities [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_6d6acc86-60a9-4c6f-a94b-4cf2bf379a9e_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in) provided by investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_b31c73c5-bc2e-4a35-9d96-2370730e4cc8_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxesPayableCurrentAndNoncurrent_ece2703a-5bed-4b44-b69e-bf18eec8ccbc_terseLabel_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax payables</link:label>
    <link:label id="lab_us-gaap_TaxesPayableCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxesPayableCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_3bdd2aa2-0325-4b1a-8d83-7945879d546d_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_5d159502-98de-4ea3-a282-3c2a612d5a7b_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss attributable to ordinary shareholders &#8212; basic</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_ZaiAutoImmuneHongKongLimitedMember_c45bdff4-5c3b-405a-b719-76ad1e499dad_terseLabel_en-US" xlink:label="lab_zlab_ZaiAutoImmuneHongKongLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zai Auto Immune (Hong Kong) Limited</link:label>
    <link:label id="lab_zlab_ZaiAutoImmuneHongKongLimitedMember_label_en-US" xlink:label="lab_zlab_ZaiAutoImmuneHongKongLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zai Auto Immune Hong Kong Limited [Member]</link:label>
    <link:label id="lab_zlab_ZaiAutoImmuneHongKongLimitedMember_documentation_en-US" xlink:label="lab_zlab_ZaiAutoImmuneHongKongLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zai Auto Immune Hong Kong Limited [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ZaiAutoImmuneHongKongLimitedMember" xlink:href="zlab-20231231.xsd#zlab_ZaiAutoImmuneHongKongLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_ZaiAutoImmuneHongKongLimitedMember" xlink:to="lab_zlab_ZaiAutoImmuneHongKongLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_527f3259-37b2-487b-9172-a52cf44e3fb4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_393c79b8-4a2c-4070-aeeb-e26f0999e53f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of options</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_1ae7cc3d-0ceb-45ed-9edb-1c507e47fec8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingAggtErrCompAmt" xlink:to="lab_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_4f20a929-f215-400f-89e2-6fcf0dbdeb61_totalLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_NuzyraMember_b8cb4b2a-e05e-44e1-8ff4-cb93d48a4065_terseLabel_en-US" xlink:label="lab_zlab_NuzyraMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NUZYRA</link:label>
    <link:label id="lab_zlab_NuzyraMember_label_en-US" xlink:label="lab_zlab_NuzyraMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nuzyra [Member]</link:label>
    <link:label id="lab_zlab_NuzyraMember_documentation_en-US" xlink:label="lab_zlab_NuzyraMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nuzyra [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_NuzyraMember" xlink:href="zlab-20231231.xsd#zlab_NuzyraMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_NuzyraMember" xlink:to="lab_zlab_NuzyraMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_9196596b-e7aa-41e6-b9b1-9178cb0d712d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_61e2f074-0833-4abe-8886-4e02a1bf8b47_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of minimum operating lease payments</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_DeferredIncomePolicyTextBlock_418c6200-c51c-4755-9cbe-75e4a8b0db78_terseLabel_en-US" xlink:label="lab_zlab_DeferredIncomePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income</link:label>
    <link:label id="lab_zlab_DeferredIncomePolicyTextBlock_label_en-US" xlink:label="lab_zlab_DeferredIncomePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income [Policy Text Block]</link:label>
    <link:label id="lab_zlab_DeferredIncomePolicyTextBlock_documentation_en-US" xlink:label="lab_zlab_DeferredIncomePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_DeferredIncomePolicyTextBlock" xlink:href="zlab-20231231.xsd#zlab_DeferredIncomePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_DeferredIncomePolicyTextBlock" xlink:to="lab_zlab_DeferredIncomePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_eea81f12-1715-4db4-8405-a559a848459e_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments_42490b23-1066-4374-b327-60fd0da74f9d_terseLabel_en-US" xlink:label="lab_zlab_CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum additional milestone payments</link:label>
    <link:label id="lab_zlab_CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments_label_en-US" xlink:label="lab_zlab_CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Rights and Obligations, Maximum Additional Milestone Payments</link:label>
    <link:label id="lab_zlab_CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments_documentation_en-US" xlink:label="lab_zlab_CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount represents the additional milestone payments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments" xlink:href="zlab-20231231.xsd#zlab_CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments" xlink:to="lab_zlab_CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_75b53e06-1ed1-4b85-9b3d-9f828f9018ff_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_SignificantAccountingPoliciesLineItems_ad80a7e8-32d9-4f74-b314-7c689d28ca22_terseLabel_en-US" xlink:label="lab_zlab_SignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_zlab_SignificantAccountingPoliciesLineItems_label_en-US" xlink:label="lab_zlab_SignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_zlab_SignificantAccountingPoliciesLineItems_documentation_en-US" xlink:label="lab_zlab_SignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant accounting policies.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_SignificantAccountingPoliciesLineItems" xlink:href="zlab-20231231.xsd#zlab_SignificantAccountingPoliciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_SignificantAccountingPoliciesLineItems" xlink:to="lab_zlab_SignificantAccountingPoliciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_b495dbde-69b1-4ea8-85b7-89bf5d409aae_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated volatility rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_4e7050dc-7fb8-42a4-b753-56e78b90aa51_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization and Principal Activities</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholder Return Vs Peer Group [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_29acf20d-9ed9-471f-a0d4-1f5cc36fd925_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_ShareBasedPaymentArrangementOptionBatchOneMember_244c758a-d770-4eb7-b851-15941793a4f9_terseLabel_en-US" xlink:label="lab_zlab_ShareBasedPaymentArrangementOptionBatchOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share options, batch one</link:label>
    <link:label id="lab_zlab_ShareBasedPaymentArrangementOptionBatchOneMember_label_en-US" xlink:label="lab_zlab_ShareBasedPaymentArrangementOptionBatchOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Batch One [Member]</link:label>
    <link:label id="lab_zlab_ShareBasedPaymentArrangementOptionBatchOneMember_documentation_en-US" xlink:label="lab_zlab_ShareBasedPaymentArrangementOptionBatchOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Batch One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ShareBasedPaymentArrangementOptionBatchOneMember" xlink:href="zlab-20231231.xsd#zlab_ShareBasedPaymentArrangementOptionBatchOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_ShareBasedPaymentArrangementOptionBatchOneMember" xlink:to="lab_zlab_ShareBasedPaymentArrangementOptionBatchOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingDomain_cb6bed6a-fda1-4dd7-8da4-4369c12d1445_terseLabel_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:label id="lab_us-gaap_VestingDomain_label_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingDomain" xlink:to="lab_us-gaap_VestingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_a9ea5c36-1806-4a30-914a-974b3cc6283f_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepayments and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c8b70153-32c2-4563-8f2d-3d30db425040_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_AggtErrCompAmt_label_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompAmt" xlink:to="lab_ecd_AggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_f1010939-6c80-4d3d-8626-976751229378_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined contribution plan expense</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:to="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_9613efbb-28e2-4546-9568-88fb25146316_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfIntangibleAssets_9e2e8ad3-2a1a-4f1d-8ecd-b9e57720dcbe_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on sale of intellectual property</link:label>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfIntangibleAssets_42ea10d7-819e-4300-9550-06ef9a77d6d2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain from sale of intellectual property</link:label>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnDispositionOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnDispositionOfIntangibleAssets" xlink:to="lab_us-gaap_GainLossOnDispositionOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_terseLabel_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Executive Categories</link:label>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_label_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Executive Categories [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="lab_ecd_AllExecutiveCategoriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:to="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_e864d03e-a03b-4eae-8a60-dded6ea6d246_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_IncomeLossFromEquityMethodInvestmentsNetOfTax_d0346885-ddac-4924-86de-a8ea4f02de7b_verboseLabel_en-US" xlink:label="lab_zlab_IncomeLossFromEquityMethodInvestmentsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in loss of subsidiaries</link:label>
    <link:label id="lab_zlab_IncomeLossFromEquityMethodInvestmentsNetOfTax_5d92aeb4-e2d3-4712-a534-6f355064baf3_negatedLabel_en-US" xlink:label="lab_zlab_IncomeLossFromEquityMethodInvestmentsNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in loss of subsidiaries</link:label>
    <link:label id="lab_zlab_IncomeLossFromEquityMethodInvestmentsNetOfTax_label_en-US" xlink:label="lab_zlab_IncomeLossFromEquityMethodInvestmentsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Loss From Equity Method Investments Net Of Tax</link:label>
    <link:label id="lab_zlab_IncomeLossFromEquityMethodInvestmentsNetOfTax_documentation_en-US" xlink:label="lab_zlab_IncomeLossFromEquityMethodInvestmentsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from equity method investments, net of tax.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_IncomeLossFromEquityMethodInvestmentsNetOfTax" xlink:href="zlab-20231231.xsd#zlab_IncomeLossFromEquityMethodInvestmentsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_IncomeLossFromEquityMethodInvestmentsNetOfTax" xlink:to="lab_zlab_IncomeLossFromEquityMethodInvestmentsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_ff9d00a9-ff48-4842-93c8-1bb708f3ccf8_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_e3a9221a-a4ec-4582-a88e-db3378dcb977_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_c4c6d3d2-c43d-43b8-a519-db2f2a9b7f8b_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestCurrent_357f959a-26ed-495f-8103-ec972476d897_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for credit loss</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestCurrent_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss, Excluding Accrued Interest, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestCurrent" xlink:to="lab_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_a30e8c71-71a6-47ba-9373-4e6a51595e82_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_0c909c73-b598-4c4f-bb4a-677f3553ce47_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numbers of non-vested restricted shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_LicensesAndCollaborativeArrangementDisclosureTextBlock_8665010e-a0b9-4083-b84e-bbf958399a2f_terseLabel_en-US" xlink:label="lab_zlab_LicensesAndCollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License and Collaboration Agreements</link:label>
    <link:label id="lab_zlab_LicensesAndCollaborativeArrangementDisclosureTextBlock_label_en-US" xlink:label="lab_zlab_LicensesAndCollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licenses And Collaborative Arrangement Disclosure [Text Block]</link:label>
    <link:label id="lab_zlab_LicensesAndCollaborativeArrangementDisclosureTextBlock_documentation_en-US" xlink:label="lab_zlab_LicensesAndCollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licenses and collaborative arrangement disclosure.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_LicensesAndCollaborativeArrangementDisclosureTextBlock" xlink:href="zlab-20231231.xsd#zlab_LicensesAndCollaborativeArrangementDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_LicensesAndCollaborativeArrangementDisclosureTextBlock" xlink:to="lab_zlab_LicensesAndCollaborativeArrangementDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_1ff3d3fc-d23a-4aec-be5e-a476a0d5b7f1_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares (par value of $0.000006 per share; 5,000,000,000 shares authorized, 977,151,270 and 962,455,850 shares issued as of December&#160;31, 2023 and 2022, respectively; 972,239,070 and 960,219,570 shares issued and outstanding as of December&#160;31, 2023 and 2022, respectively)</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_8f3f9dc7-bcca-4562-8fd8-7a37cf34a1ff_negatedLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_country_CN_73ed7366-662a-4a08-9eda-338876b3d6d7_terseLabel_en-US" xlink:label="lab_country_CN" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mainland China</link:label>
    <link:label id="lab_country_CN_label_en-US" xlink:label="lab_country_CN" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CHINA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_CN"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CN" xlink:to="lab_country_CN" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_MajorSuppliersAxis_f3f35c6b-5884-4925-b9a7-6453d5e512a6_terseLabel_en-US" xlink:label="lab_zlab_MajorSuppliersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major Suppliers [Axis]</link:label>
    <link:label id="lab_zlab_MajorSuppliersAxis_label_en-US" xlink:label="lab_zlab_MajorSuppliersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major Suppliers [Axis]</link:label>
    <link:label id="lab_zlab_MajorSuppliersAxis_documentation_en-US" xlink:label="lab_zlab_MajorSuppliersAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major suppliers.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_MajorSuppliersAxis" xlink:href="zlab-20231231.xsd#zlab_MajorSuppliersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_MajorSuppliersAxis" xlink:to="lab_zlab_MajorSuppliersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_40c3b18a-7a06-4571-aba9-81a5d937260b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss) income, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_5f2e6dac-a457-4f6a-b3c4-ddbc8cc6409f_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization and principal activities</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_49484084-2eae-409e-a685-745ab273b7d5_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued professional service fee</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Professional Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_USD_6bfc2cb5-2c4c-48ed-a568-e9013cc95b9b_terseLabel_en-US" xlink:label="lab_currency_USD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US$</link:label>
    <link:label id="lab_currency_USD_label_en-US" xlink:label="lab_currency_USD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States of America, Dollars</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_USD"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_USD" xlink:to="lab_currency_USD" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_c2c61dee-a4a1-4313-bdcc-c84306d6b8fd_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_97407bb3-a91e-4880-901d-3b12af2d7dff_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LimitedLiabilityCompanyMember_2220216d-bbfc-4582-b2c8-ca3c31a784c2_verboseLabel_en-US" xlink:label="lab_us-gaap_LimitedLiabilityCompanyMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MEDx (Suzhou) Translational Medicine Co., Ltd.</link:label>
    <link:label id="lab_us-gaap_LimitedLiabilityCompanyMember_label_en-US" xlink:label="lab_us-gaap_LimitedLiabilityCompanyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Limited Liability Company [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedLiabilityCompanyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LimitedLiabilityCompanyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LimitedLiabilityCompanyMember" xlink:to="lab_us-gaap_LimitedLiabilityCompanyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_469645b6-fe08-41f7-acff-346b621bbe0e_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in subsidiaries</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_label_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:to="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_ResearchAndDevelopmentExpensesMember_b479ca97-ccdb-46b7-a8aa-5e02b0459dbd_terseLabel_en-US" xlink:label="lab_zlab_ResearchAndDevelopmentExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expenses</link:label>
    <link:label id="lab_zlab_ResearchAndDevelopmentExpensesMember_label_en-US" xlink:label="lab_zlab_ResearchAndDevelopmentExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Expenses [Member]</link:label>
    <link:label id="lab_zlab_ResearchAndDevelopmentExpensesMember_documentation_en-US" xlink:label="lab_zlab_ResearchAndDevelopmentExpensesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expenses.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ResearchAndDevelopmentExpensesMember" xlink:href="zlab-20231231.xsd#zlab_ResearchAndDevelopmentExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_ResearchAndDevelopmentExpensesMember" xlink:to="lab_zlab_ResearchAndDevelopmentExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNet_9a506b0c-36d0-41c8-bdc0-38ef7dcd82ca_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNet_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNet" xlink:to="lab_us-gaap_AccountsReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_83312a97-543e-4754-af90-f290425c9a7a_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllIndividualsMember_terseLabel_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Individuals</link:label>
    <link:label id="lab_ecd_AllIndividualsMember_label_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Individuals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="lab_ecd_AllIndividualsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_37c9849f-dee7-4134-a409-34c02f844405_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosure of cash flow information</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_b7ab4e63-e2ae-4103-9450-ef81fe572db0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_f335f0d4-d4f6-422a-8153-daa9687b3cdd_totalLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_d5a41953-25c6-49f5-8aaf-719c39cd2e0c_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_e56e81f7-e7e8-4d49-acbc-c394495a92a7_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanNameDomain_40bb5e62-9296-4abd-b0ab-14bc07fefce3_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanNameDomain" xlink:to="lab_us-gaap_RetirementPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_1b83d661-9548-4a58-82af-d6f2576a01d2_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain" xlink:to="lab_us-gaap_ShortTermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_fce42c34-6ce8-415a-b6ec-29cbf62f80ab_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_695f4f40-f551-4508-a5ff-bac1b06989ce_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_e7bc5670-47c8-48bb-8eb3-41e813de75c0_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCharitableContributions_19a31904-0023-4115-9bf7-80dab2073de0_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCharitableContributions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration of deductible qualified donation</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCharitableContributions_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCharitableContributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Charitable Contributions, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCharitableContributions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCharitableContributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCharitableContributions" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCharitableContributions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_b635cca4-c68d-4b71-829a-fc364633479f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Reconciliations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoName_terseLabel_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Name</link:label>
    <link:label id="lab_ecd_PeoName_label_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoName" xlink:to="lab_ecd_PeoName" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_IncomeTaxesTable_8c3f3551-0298-4a1e-8cf9-d3bd409cb9d8_terseLabel_en-US" xlink:label="lab_zlab_IncomeTaxesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Table]</link:label>
    <link:label id="lab_zlab_IncomeTaxesTable_label_en-US" xlink:label="lab_zlab_IncomeTaxesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Table]</link:label>
    <link:label id="lab_zlab_IncomeTaxesTable_documentation_en-US" xlink:label="lab_zlab_IncomeTaxesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_IncomeTaxesTable" xlink:href="zlab-20231231.xsd#zlab_IncomeTaxesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_IncomeTaxesTable" xlink:to="lab_zlab_IncomeTaxesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_fcb1fa40-6306-49c5-b48a-e233dcc60c04_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk percentage</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_79c9d96d-bd05-4223-b484-0b48db3d5d47_terseLabel_en-US" xlink:label="lab_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Information Disclosure [Abstract]</link:label>
    <link:label id="lab_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_label_en-US" xlink:label="lab_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Information Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:to="lab_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock_ae73ba60-c1a6-4bc5-ae5d-93bc681248a9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Significant Operating Subsidiaries</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Subsidiary of Limited Liability Company or Limited Partnership, Description [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock" xlink:to="lab_us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_e99a7c60-0da2-471c-a024-498597f00fc5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average grant-date fair value of non-option awards granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_8b0ec827-415e-432a-969e-0e7a88143906_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets, Amortization expense, year five</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock_ee987d09-7164-4d73-b005-38636521cedc_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income (Expenses), Net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income and Expense [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock" xlink:to="lab_us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_CollaborativeArrangementRightsAndObligationsPaymentOfUpFrontFeesForLicenseAgreement_37539bcb-6db8-4f51-bb60-52fe36d11c53_terseLabel_en-US" xlink:label="lab_zlab_CollaborativeArrangementRightsAndObligationsPaymentOfUpFrontFeesForLicenseAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront payment</link:label>
    <link:label id="lab_zlab_CollaborativeArrangementRightsAndObligationsPaymentOfUpFrontFeesForLicenseAgreement_label_en-US" xlink:label="lab_zlab_CollaborativeArrangementRightsAndObligationsPaymentOfUpFrontFeesForLicenseAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Rights and Obligations, Payment Of Up front Fees For License Agreement</link:label>
    <link:label id="lab_zlab_CollaborativeArrangementRightsAndObligationsPaymentOfUpFrontFeesForLicenseAgreement_documentation_en-US" xlink:label="lab_zlab_CollaborativeArrangementRightsAndObligationsPaymentOfUpFrontFeesForLicenseAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of upfront fees for license agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_CollaborativeArrangementRightsAndObligationsPaymentOfUpFrontFeesForLicenseAgreement" xlink:href="zlab-20231231.xsd#zlab_CollaborativeArrangementRightsAndObligationsPaymentOfUpFrontFeesForLicenseAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_CollaborativeArrangementRightsAndObligationsPaymentOfUpFrontFeesForLicenseAgreement" xlink:to="lab_zlab_CollaborativeArrangementRightsAndObligationsPaymentOfUpFrontFeesForLicenseAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_888d72ae-cd3d-4da9-ae97-c19b778d9b38_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_13fb262c-6781-431c-b54c-a0c1c5fd8bca_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_60c2df12-e2ca-49a2-b844-766f3acdde20_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value, Vested and exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_85703a53-2815-4e23-8d4a-13cef2fd9d9a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompRecoveryTable_terseLabel_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Erroneously Awarded Compensation Recovery</link:label>
    <link:label id="lab_ecd_ErrCompRecoveryTable_label_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompRecoveryTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="lab_ecd_ErrCompRecoveryTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFeeAmount_3ff7fc53-2321-4fb9-95bc-f5d9b80bb518_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFeeAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument fee</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFeeAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFeeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fee Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFeeAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFeeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFeeAmount" xlink:to="lab_us-gaap_DebtInstrumentFeeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_34e95b45-66e9-4ddd-95b0-c799a186c050_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization expenses</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_f0897f6e-d3e0-4866-9b7c-bb93b113a467_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing, How MNPI Considered [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_718c3342-817e-4044-805f-945c25db19d9_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated balance sheets</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_bc1c7801-8455-4ed5-a1b4-37cd1ca9dde8_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_6f8445f2-993d-42f6-a490-8634468d312c_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_5c436ec0-98ae-4e40-84e2-11b51c26fd03_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_DebtInstrumentVariableInterestRateAdjustmentPeriod_db740db2-49f4-46c5-a0a2-3c3ca73bd30d_terseLabel_en-US" xlink:label="lab_zlab_DebtInstrumentVariableInterestRateAdjustmentPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating interest rate adjustment period</link:label>
    <link:label id="lab_zlab_DebtInstrumentVariableInterestRateAdjustmentPeriod_label_en-US" xlink:label="lab_zlab_DebtInstrumentVariableInterestRateAdjustmentPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Variable Interest Rate, Adjustment, Period</link:label>
    <link:label id="lab_zlab_DebtInstrumentVariableInterestRateAdjustmentPeriod_documentation_en-US" xlink:label="lab_zlab_DebtInstrumentVariableInterestRateAdjustmentPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Variable Interest Rate, Adjustment, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_DebtInstrumentVariableInterestRateAdjustmentPeriod" xlink:href="zlab-20231231.xsd#zlab_DebtInstrumentVariableInterestRateAdjustmentPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_DebtInstrumentVariableInterestRateAdjustmentPeriod" xlink:to="lab_zlab_DebtInstrumentVariableInterestRateAdjustmentPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_d3b62bf8-ed28-46e6-90e2-0f7ceb834d29_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_ShareBasedPaymentArrangementTrancheFourMember_29335ff1-f33a-4843-9156-ab21b8f02e19_terseLabel_en-US" xlink:label="lab_zlab_ShareBasedPaymentArrangementTrancheFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tranche four</link:label>
    <link:label id="lab_zlab_ShareBasedPaymentArrangementTrancheFourMember_label_en-US" xlink:label="lab_zlab_ShareBasedPaymentArrangementTrancheFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Tranche Four [Member]</link:label>
    <link:label id="lab_zlab_ShareBasedPaymentArrangementTrancheFourMember_documentation_en-US" xlink:label="lab_zlab_ShareBasedPaymentArrangementTrancheFourMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Tranche Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ShareBasedPaymentArrangementTrancheFourMember" xlink:href="zlab-20231231.xsd#zlab_ShareBasedPaymentArrangementTrancheFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_ShareBasedPaymentArrangementTrancheFourMember" xlink:to="lab_zlab_ShareBasedPaymentArrangementTrancheFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_bfcce348-b648-4ad9-8406-ac850e8c3ba7_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_76d4d53a-0354-4107-8aab-31632a8c6d16_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance as of January 1,</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_b5ae8869-459c-4583-ba79-04a4abb6e594_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance as of December 31,</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_eaf0a78a-8a15-4ee3-a0eb-7028df25e776_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from maturity of short-term investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Maturities, Prepayments and Calls of Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:to="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_39d35106-b8b9-44cd-aadf-3847a890f04b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_NonVestedRestrictedSharesMember_eaf5d8dc-7be8-4bc4-b837-0d02d77bc253_terseLabel_en-US" xlink:label="lab_zlab_NonVestedRestrictedSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-vested restricted shares</link:label>
    <link:label id="lab_zlab_NonVestedRestrictedSharesMember_0853e439-1208-4e5d-8238-88b5aa3d34b6_verboseLabel_en-US" xlink:label="lab_zlab_NonVestedRestrictedSharesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Vested Restricted Shares</link:label>
    <link:label id="lab_zlab_NonVestedRestrictedSharesMember_label_en-US" xlink:label="lab_zlab_NonVestedRestrictedSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Vested Restricted Shares [Member]</link:label>
    <link:label id="lab_zlab_NonVestedRestrictedSharesMember_documentation_en-US" xlink:label="lab_zlab_NonVestedRestrictedSharesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-vested restricted shares.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_NonVestedRestrictedSharesMember" xlink:href="zlab-20231231.xsd#zlab_NonVestedRestrictedSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_NonVestedRestrictedSharesMember" xlink:to="lab_zlab_NonVestedRestrictedSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CondensedStatementOfComprehensiveIncomeTableTextBlock_738edb5b-13c8-45fe-b687-1171cf4cb6f0_terseLabel_en-US" xlink:label="lab_srt_CondensedStatementOfComprehensiveIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Statements of Operations and Comprehensive Loss</link:label>
    <link:label id="lab_srt_CondensedStatementOfComprehensiveIncomeTableTextBlock_label_en-US" xlink:label="lab_srt_CondensedStatementOfComprehensiveIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Statement of Comprehensive Income [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedStatementOfComprehensiveIncomeTableTextBlock" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CondensedStatementOfComprehensiveIncomeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CondensedStatementOfComprehensiveIncomeTableTextBlock" xlink:to="lab_srt_CondensedStatementOfComprehensiveIncomeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_country_HK_268fc2e9-ebe8-4bd4-804f-db6629639244_terseLabel_en-US" xlink:label="lab_country_HK" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hong Kong</link:label>
    <link:label id="lab_country_HK_label_en-US" xlink:label="lab_country_HK" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HONG KONG</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_HK" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_HK"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_HK" xlink:to="lab_country_HK" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_41efad86-34c0-4e1f-8e3d-1ac34e9040a3_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_PriorToApril2023Member_1bed7faa-3b79-445a-9222-6d2902ef4809_terseLabel_en-US" xlink:label="lab_zlab_PriorToApril2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior to April 2023</link:label>
    <link:label id="lab_zlab_PriorToApril2023Member_label_en-US" xlink:label="lab_zlab_PriorToApril2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior To April 2023 [Member]</link:label>
    <link:label id="lab_zlab_PriorToApril2023Member_documentation_en-US" xlink:label="lab_zlab_PriorToApril2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior To April 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_PriorToApril2023Member" xlink:href="zlab-20231231.xsd#zlab_PriorToApril2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_PriorToApril2023Member" xlink:to="lab_zlab_PriorToApril2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_d5528869-1836-469b-af13-7eb80dfa4c44_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_1aedaeb8-dafe-470c-8e3f-aa787240ee42_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected term (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d3a4bf92-1ad4-4ec7-a463-f71855436173_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxable income</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a4c320b9-2e0b-41a3-8015-32e7391ab969_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (income) before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_5eb8c0b6-9890-4a7d-b640-739fe2232e4a_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock_e5ecaf15-9761-4a27-aeba-d5d2209fff03_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Statements of Cash Flows</link:label>
    <link:label id="lab_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock_label_en-US" xlink:label="lab_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Cash Flow Statement [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfCondensedCashFlowStatementTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock" xlink:to="lab_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_336e93c1-16ed-45e5-98df-1be0fcfad392_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition of intangible assets</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_2f0e4b12-f061-46db-8869-974663f256c4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TangibleAssetImpairmentCharges_b2f14d78-de8f-4aac-b197-1bde23368fc1_terseLabel_en-US" xlink:label="lab_us-gaap_TangibleAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of property and equipment</link:label>
    <link:label id="lab_us-gaap_TangibleAssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_TangibleAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TangibleAssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TangibleAssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TangibleAssetImpairmentCharges" xlink:to="lab_us-gaap_TangibleAssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanNameAxis_855a2a05-3fa9-45e9-aa09-56d7c07b9b55_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanNameAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanNameAxis" xlink:to="lab_us-gaap_RetirementPlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_10f99b54-f3f0-4f6b-9511-3a5c34c3a1f4_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_c90e30b8-5bd6-4ed4-b10b-4e83b54ea1db_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_6610dd79-3a79-4109-b034-8b370630a2d9_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_LongTermDepositsPolicyPolicyTextBlock_70253195-a834-460f-bbe2-587d90d2dcd6_terseLabel_en-US" xlink:label="lab_zlab_LongTermDepositsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Deposits</link:label>
    <link:label id="lab_zlab_LongTermDepositsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_zlab_LongTermDepositsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Deposits, Policy [Policy Text Block]</link:label>
    <link:label id="lab_zlab_LongTermDepositsPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_zlab_LongTermDepositsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term deposits.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_LongTermDepositsPolicyPolicyTextBlock" xlink:href="zlab-20231231.xsd#zlab_LongTermDepositsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_LongTermDepositsPolicyPolicyTextBlock" xlink:to="lab_zlab_LongTermDepositsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CondensedIncomeStatementTable_67bc3843-39f4-4f9b-8b52-15fd6978ae94_terseLabel_en-US" xlink:label="lab_srt_CondensedIncomeStatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Income Statement [Table]</link:label>
    <link:label id="lab_srt_CondensedIncomeStatementTable_label_en-US" xlink:label="lab_srt_CondensedIncomeStatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Income Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedIncomeStatementTable" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CondensedIncomeStatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CondensedIncomeStatementTable" xlink:to="lab_srt_CondensedIncomeStatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1b1ee17e-8e76-4990-b73e-0a23d697ce82_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Named Executive Officers, Footnote</link:label>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_label_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Named Executive Officers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ParentCompanyMember_cd86462a-6a32-4112-9cae-2e5865dcc81c_terseLabel_en-US" xlink:label="lab_srt_ParentCompanyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent Company</link:label>
    <link:label id="lab_srt_ParentCompanyMember_label_en-US" xlink:label="lab_srt_ParentCompanyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent Company [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ParentCompanyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ParentCompanyMember" xlink:to="lab_srt_ParentCompanyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_825dc757-b562-49f9-aacb-fd5502eb0439_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_ee6667cc-07af-47bd-9061-8d613262bd8e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_11259662-c6ab-4244-99e8-3e93dac3c18e_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets useful life</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance Disclosure, Table</link:label>
    <link:label id="lab_ecd_PvpTableTextBlock_label_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTableTextBlock" xlink:to="lab_ecd_PvpTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_26d5bb8b-373f-4cc6-8155-c7705064d092_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_6186f16c-edc9-4108-a1ad-970f026025da_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndTitle_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title</link:label>
    <link:label id="lab_ecd_TrdArrIndTitle_label_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement, Individual Title</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndTitle" xlink:to="lab_ecd_TrdArrIndTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_68efcb28-8870-4488-9664-64fc0ef14bca_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, beginning balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2bd04a7e-61f4-4fce-b03c-6c548ab9d54b_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, ending balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_04749d18-0af2-4c20-909f-aa06dce3bd3f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationDueInNextRollingTwelveMonths_6f00d121-8a12-4e7f-9c64-32f8955b1f03_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationDueInNextRollingTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase obligation to be incurred within one year</link:label>
    <link:label id="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationDueInNextRollingTwelveMonths_label_en-US" xlink:label="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationDueInNextRollingTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecorded Unconditional Purchase Obligation, Due in Next Rolling 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationDueInNextRollingTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationDueInNextRollingTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationDueInNextRollingTwelveMonths" xlink:to="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationDueInNextRollingTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_5d57b516-1efe-4837-9356-6cd8ca354c4a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_IndividualAxis_terseLabel_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual:</link:label>
    <link:label id="lab_ecd_IndividualAxis_label_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_IndividualAxis" xlink:to="lab_ecd_IndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_cc3a0995-498f-4384-807c-38f04c4139ed_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_49587ab9-f3e2-4d8f-bb3b-50d682d8fbe4_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_8cb7a063-53a0-4cfd-ac0c-966670237502_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_c6e70b8e-091b-45fb-a9d2-7f2f6bc09492_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_11ab162f-e852-4ea4-b009-f85ef9830b67_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CondensedIncomeStatementsCaptionsLineItems_70ba2917-ef4a-42e7-9344-40f9dbcc9c3d_terseLabel_en-US" xlink:label="lab_srt_CondensedIncomeStatementsCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Income Statements Captions [Line Items]</link:label>
    <link:label id="lab_srt_CondensedIncomeStatementsCaptionsLineItems_label_en-US" xlink:label="lab_srt_CondensedIncomeStatementsCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Income Statements, Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedIncomeStatementsCaptionsLineItems" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CondensedIncomeStatementsCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CondensedIncomeStatementsCaptionsLineItems" xlink:to="lab_srt_CondensedIncomeStatementsCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_19a73967-42e4-4ea9-8361-462ecf8bc94a_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_30f12586-ba34-4094-ba64-cd3d2359c031_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock_18a5566c-cae3-4d52-872c-453959559304_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Related Costs, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:to="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsAbstract" xlink:to="lab_us-gaap_InvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_0c4231ab-eaa4-40f2-8a04-3ac117fcbf89_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits and related interest and penalties</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_7c72be9a-a5e4-41ce-a5c9-268b91ed6b83_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_a36e6a4b-6557-4cbe-91e7-a1eed3157157_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_969e2dd6-ed65-4bd6-901e-dbe81a6e06d7_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CondensedBalanceSheetStatementTable_eae32358-2c10-459b-a3fb-6d49b5fbac00_terseLabel_en-US" xlink:label="lab_srt_CondensedBalanceSheetStatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Balance Sheet Statement [Table]</link:label>
    <link:label id="lab_srt_CondensedBalanceSheetStatementTable_label_en-US" xlink:label="lab_srt_CondensedBalanceSheetStatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Balance Sheet Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedBalanceSheetStatementTable" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CondensedBalanceSheetStatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CondensedBalanceSheetStatementTable" xlink:to="lab_srt_CondensedBalanceSheetStatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_81539de6-d06d-48e8-bbb9-2639f985c28b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Option Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardExrcPrice_terseLabel_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price</link:label>
    <link:label id="lab_ecd_AwardExrcPrice_label_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardExrcPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardExrcPrice" xlink:to="lab_ecd_AwardExrcPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_April2023AndLaterMember_6f5c9e87-e47f-40d1-8798-228be9318c5a_terseLabel_en-US" xlink:label="lab_zlab_April2023AndLaterMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Since April 2023</link:label>
    <link:label id="lab_zlab_April2023AndLaterMember_label_en-US" xlink:label="lab_zlab_April2023AndLaterMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">April 2023 And Later [Member]</link:label>
    <link:label id="lab_zlab_April2023AndLaterMember_documentation_en-US" xlink:label="lab_zlab_April2023AndLaterMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">April 2023 And Later</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_April2023AndLaterMember" xlink:href="zlab-20231231.xsd#zlab_April2023AndLaterMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_April2023AndLaterMember" xlink:to="lab_zlab_April2023AndLaterMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_765138ec-fcea-4a06-a53d-2cb146860d25_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_NoncashResearchAndDevelopmentExpenses_dc5770bf-3808-44bd-b679-de7cde84265a_terseLabel_en-US" xlink:label="lab_zlab_NoncashResearchAndDevelopmentExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash research and development expenses</link:label>
    <link:label id="lab_zlab_NoncashResearchAndDevelopmentExpenses_label_en-US" xlink:label="lab_zlab_NoncashResearchAndDevelopmentExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Research And Development Expenses</link:label>
    <link:label id="lab_zlab_NoncashResearchAndDevelopmentExpenses_documentation_en-US" xlink:label="lab_zlab_NoncashResearchAndDevelopmentExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash research and development expenses.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_NoncashResearchAndDevelopmentExpenses" xlink:href="zlab-20231231.xsd#zlab_NoncashResearchAndDevelopmentExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_NoncashResearchAndDevelopmentExpenses" xlink:to="lab_zlab_NoncashResearchAndDevelopmentExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Cash_5736fcc4-d66d-47a6-83cb-bf2516b8dd4a_terseLabel_en-US" xlink:label="lab_us-gaap_Cash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_Cash_label_en-US" xlink:label="lab_us-gaap_Cash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Cash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Cash" xlink:to="lab_us-gaap_Cash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_0108056c-5594-4767-9e48-1cdf3c2addd0_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_652de7e5-2ed4-40f7-91bc-dc5bc996c335_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing MNPI Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:to="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_13f1970a-fc98-4460-adcf-3ac97e11cdb2_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency (loss) gain</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss), Foreign Currency Transaction, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipTable_ade8ea83-4ce8-4559-8c75-73532d566249_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Subsidiary Of Limited Liability Company Or Limited Partnership [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Subsidiary of Limited Liability Company or Limited Partnership [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipTable" xlink:to="lab_us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_b40ea2ea-2a81-46b9-8419-196caf51db56_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes paid related to settlement of equity awards</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNetAbstract_cb771f59-b86a-43ca-9275-479e99063ac4_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNetAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueConcentrationOfRiskTextBlock_2c6c88cd-abab-44b4-b738-b3ca092efe00_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueConcentrationOfRiskTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Concentration of Suppliers</link:label>
    <link:label id="lab_us-gaap_FairValueConcentrationOfRiskTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueConcentrationOfRiskTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Concentration of Risk [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueConcentrationOfRiskTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueConcentrationOfRiskTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueConcentrationOfRiskTextBlock" xlink:to="lab_us-gaap_FairValueConcentrationOfRiskTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_da078602-cfce-4df2-b722-56476889c965_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_7a09a5fe-324b-4cca-a6bb-730387a8bbcb_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in) provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_NovocureLimitedMember_ddccfd93-db56-4bab-9570-8da413fcdbe5_terseLabel_en-US" xlink:label="lab_zlab_NovocureLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Novocure</link:label>
    <link:label id="lab_zlab_NovocureLimitedMember_label_en-US" xlink:label="lab_zlab_NovocureLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Novocure Limited [Member]</link:label>
    <link:label id="lab_zlab_NovocureLimitedMember_documentation_en-US" xlink:label="lab_zlab_NovocureLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Novocure limited.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_NovocureLimitedMember" xlink:href="zlab-20231231.xsd#zlab_NovocureLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_NovocureLimitedMember" xlink:to="lab_zlab_NovocureLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_6f43c8c3-bb57-474e-a02c-bcb8dd413dab_verboseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_a49c0087-396f-44de-88b0-0448e6df69cc_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_56825a78-a989-46d9-8b5b-b338e76f6960_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in subsidiaries</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Interest in Subsidiaries and Affiliates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:to="lab_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_52b78b8f-91e5-49ac-8511-df144918179c_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_ShortTermInvestmentTextBlock_90ddcfdd-4c44-4700-aece-ad461b48f47d_terseLabel_en-US" xlink:label="lab_zlab_ShortTermInvestmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Investments</link:label>
    <link:label id="lab_zlab_ShortTermInvestmentTextBlock_label_en-US" xlink:label="lab_zlab_ShortTermInvestmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short Term Investment [Text Block]</link:label>
    <link:label id="lab_zlab_ShortTermInvestmentTextBlock_documentation_en-US" xlink:label="lab_zlab_ShortTermInvestmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ShortTermInvestmentTextBlock" xlink:href="zlab-20231231.xsd#zlab_ShortTermInvestmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_ShortTermInvestmentTextBlock" xlink:to="lab_zlab_ShortTermInvestmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_LandUseRightsPolicyPolicyTextBlock_f32b5cf3-21f5-4a1e-8783-5419316a0daf_terseLabel_en-US" xlink:label="lab_zlab_LandUseRightsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land Use Rights</link:label>
    <link:label id="lab_zlab_LandUseRightsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_zlab_LandUseRightsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land Use Rights, Policy [Policy Text Block]</link:label>
    <link:label id="lab_zlab_LandUseRightsPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_zlab_LandUseRightsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land use rights.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_LandUseRightsPolicyPolicyTextBlock" xlink:href="zlab-20231231.xsd#zlab_LandUseRightsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_LandUseRightsPolicyPolicyTextBlock" xlink:to="lab_zlab_LandUseRightsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_country_KY_fed1b816-aff0-4d0f-a7db-f6d9fb8effbc_terseLabel_en-US" xlink:label="lab_country_KY" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cayman Islands</link:label>
    <link:label id="lab_country_KY_label_en-US" xlink:label="lab_country_KY" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CAYMAN ISLANDS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_KY" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_KY"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_KY" xlink:to="lab_country_KY" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_28c0f4fd-6f3b-46db-978d-8eb215f7d023_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allocation of Compensation Expense Related to Options</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote</link:label>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentMember_8775c09f-2540-47ba-8743-82fde24cf9e7_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentMember" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_530b3199-8e30-4f58-84b1-60f51158da30_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_3feeee74-c034-437c-986a-a596ebcecebb_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock_74208434-30dc-4174-aafb-f2ce2ec1edd8_verboseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Defined Contribution Plans</link:label>
    <link:label id="lab_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock_label_en-US" xlink:label="lab_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation and Employee Benefit Plans, Other than Share-Based Compensation [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock" xlink:to="lab_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_e364d460-0589-449f-ac4e-62103fd688cb_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss per share &#8212; basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_ca88e385-c7e5-4f66-b4a9-4bf684b778a5_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share &#8212; basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_121159c5-e2d8-4e0e-8ce5-d89e91e873d1_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_63806ce2-9532-456c-890c-deb65cda0a55_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation expense related to unvested share options granted</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_3c547364-c97a-449e-b1b8-c3631637412d_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of significant accounting policies</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_label_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_3a99e5bf-3ea4-4ca0-830d-18e77d2be4f3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free rate of return, maximum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_label_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Erroneous Compensation Analysis [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompAnalysisTextBlock" xlink:to="lab_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_36533455-f17b-4b84-b96d-d3d25c9f8be9_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets, net</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_3d2117ad-5b14-4e44-9861-4191b701a9bf_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value of stock options exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CurrencyAxis_1f3f786c-bae8-4fe0-a082-2c3ad9a16227_terseLabel_en-US" xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency [Axis]</link:label>
    <link:label id="lab_srt_CurrencyAxis_label_en-US" xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CurrencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CurrencyAxis" xlink:to="lab_srt_CurrencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_78a6ca27-6963-4f12-8952-f6ee160b2dd7_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss attributable to ordinary shareholders &#8212; diluted</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrDuration_terseLabel_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arrangement Duration</link:label>
    <link:label id="lab_ecd_TrdArrDuration_label_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement Duration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrDuration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrDuration" xlink:to="lab_ecd_TrdArrDuration" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_05f2a9f2-df9f-494e-a1ce-aaa5dfa6baa0_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing MNPI Considered [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_PrepaymentsForEquipmentPolicyPolicyTextBlock_4de44649-24da-4c78-909f-1c09957ef09c_terseLabel_en-US" xlink:label="lab_zlab_PrepaymentsForEquipmentPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepayments for Equipment</link:label>
    <link:label id="lab_zlab_PrepaymentsForEquipmentPolicyPolicyTextBlock_label_en-US" xlink:label="lab_zlab_PrepaymentsForEquipmentPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepayments For Equipment, Policy [Policy Text Block]</link:label>
    <link:label id="lab_zlab_PrepaymentsForEquipmentPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_zlab_PrepaymentsForEquipmentPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepayments for equipment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_PrepaymentsForEquipmentPolicyPolicyTextBlock" xlink:href="zlab-20231231.xsd#zlab_PrepaymentsForEquipmentPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_PrepaymentsForEquipmentPolicyPolicyTextBlock" xlink:to="lab_zlab_PrepaymentsForEquipmentPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_1e0b1d03-6adb-4437-964f-ca2cb5729d60_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of options, Vested and exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable_e8c6901d-fe60-475d-ab50-d43b0b15dc60_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Cash And Cash Equivalents [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:to="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_9a1476a3-b710-42c1-bc83-48c5a3fc9f21_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principles of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_IncomeTaxDisclosureTable_7689b0e5-3ccd-4669-baab-234841f0f552_terseLabel_en-US" xlink:label="lab_zlab_IncomeTaxDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Table]</link:label>
    <link:label id="lab_zlab_IncomeTaxDisclosureTable_label_en-US" xlink:label="lab_zlab_IncomeTaxDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Table]</link:label>
    <link:label id="lab_zlab_IncomeTaxDisclosureTable_documentation_en-US" xlink:label="lab_zlab_IncomeTaxDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax disclosure.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_IncomeTaxDisclosureTable" xlink:href="zlab-20231231.xsd#zlab_IncomeTaxDisclosureTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_IncomeTaxDisclosureTable" xlink:to="lab_zlab_IncomeTaxDisclosureTable" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_CNY_fbf449ee-4896-450d-8dc0-b81b6e5cd006_terseLabel_en-US" xlink:label="lab_currency_CNY" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RMB</link:label>
    <link:label id="lab_currency_CNY_label_en-US" xlink:label="lab_currency_CNY" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">China, Yuan Renminbi</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CNY" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_CNY"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_CNY" xlink:to="lab_currency_CNY" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_01f78dd5-a241-4511-8c34-3f42384f69dc_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Predetermined</link:label>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_label_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Predetermined [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgPredtrmndFlag" xlink:to="lab_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_WithholdingTaxesRemittanceOfDividends_b3930299-3bfd-4b20-8f06-77f91dd1da0e_terseLabel_en-US" xlink:label="lab_zlab_WithholdingTaxesRemittanceOfDividends" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Withholding taxes on remittance of dividends</link:label>
    <link:label id="lab_zlab_WithholdingTaxesRemittanceOfDividends_label_en-US" xlink:label="lab_zlab_WithholdingTaxesRemittanceOfDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Withholding Taxes Remittance Of Dividends</link:label>
    <link:label id="lab_zlab_WithholdingTaxesRemittanceOfDividends_documentation_en-US" xlink:label="lab_zlab_WithholdingTaxesRemittanceOfDividends" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of withholding taxes on remittance of dividends.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_WithholdingTaxesRemittanceOfDividends" xlink:href="zlab-20231231.xsd#zlab_WithholdingTaxesRemittanceOfDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_WithholdingTaxesRemittanceOfDividends" xlink:to="lab_zlab_WithholdingTaxesRemittanceOfDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrTerminationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Termination Date</link:label>
    <link:label id="lab_ecd_TrdArrTerminationDate_label_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement Termination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrTerminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrTerminationDate" xlink:to="lab_ecd_TrdArrTerminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_7cb3e18e-9ea9-46bf-88af-5c2e3c78238e_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_b5c460a9-7972-4f43-9935-3eacb980dd3d_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationTable_8a3f8f5a-8df4-4e9d-acb5-2431d91a4cfd_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:label id="lab_dei_DocumentInformationTable_label_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_LandUseRightsNetNoncurrent_d821633b-2368-4cc9-8adf-ff32914cc191_terseLabel_en-US" xlink:label="lab_zlab_LandUseRightsNetNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land use rights, net</link:label>
    <link:label id="lab_zlab_LandUseRightsNetNoncurrent_label_en-US" xlink:label="lab_zlab_LandUseRightsNetNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land Use Rights Net Noncurrent</link:label>
    <link:label id="lab_zlab_LandUseRightsNetNoncurrent_documentation_en-US" xlink:label="lab_zlab_LandUseRightsNetNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land use rights, net noncurrent.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_LandUseRightsNetNoncurrent" xlink:href="zlab-20231231.xsd#zlab_LandUseRightsNetNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_LandUseRightsNetNoncurrent" xlink:to="lab_zlab_LandUseRightsNetNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_e10f2feb-17ee-47c1-8e29-93d505ae6393_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_ff466928-32a0-43e4-ab05-7b094af5f0ce_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Gain) loss from fair value changes of equity investment with readily determinable fair value</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_4cfa1f74-a48f-4b3a-9bd4-e5e42ba2e5b4_netLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains (losses) on equity investments with readily determinable fair value</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_d9932511-5211-4931-8a9f-9fe1c725f5c7_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on equity investments with readily determinable fair value</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_58da50dd-85c9-4229-8537-298a3c80dbe1_negatedLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from fair value changes of equity investment of readily determinable fair value</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_441f6a43-dc8b-4ed3-ae04-5b0124b8c2a2_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property Plant And Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:to="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCountry_a7f011e4-3a4a-4ef9-8188-c63a6c97bf7b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Country</link:label>
    <link:label id="lab_dei_EntityAddressCountry_label_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Country</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCountry" xlink:to="lab_dei_EntityAddressCountry" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_GurnetPointCapitalAndNovoHoldingsASMember_1260ff07-ad65-4d11-a550-3f2d9c8ace63_terseLabel_en-US" xlink:label="lab_zlab_GurnetPointCapitalAndNovoHoldingsASMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Novo Holdings</link:label>
    <link:label id="lab_zlab_GurnetPointCapitalAndNovoHoldingsASMember_label_en-US" xlink:label="lab_zlab_GurnetPointCapitalAndNovoHoldingsASMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gurnet Point Capital And Novo Holdings A/S [Member]</link:label>
    <link:label id="lab_zlab_GurnetPointCapitalAndNovoHoldingsASMember_documentation_en-US" xlink:label="lab_zlab_GurnetPointCapitalAndNovoHoldingsASMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gurnet Point Capital And Novo Holdings A/S</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_GurnetPointCapitalAndNovoHoldingsASMember" xlink:href="zlab-20231231.xsd#zlab_GurnetPointCapitalAndNovoHoldingsASMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_GurnetPointCapitalAndNovoHoldingsASMember" xlink:to="lab_zlab_GurnetPointCapitalAndNovoHoldingsASMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_60c9c986-76db-4edb-a7e6-e403ce55ded1_negatedLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_be440dd5-7db6-41ed-8049-9cbfd9d623dc_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c8be282d-4334-4b14-9db4-134fe6b8c46e_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net loss to net cash provided by (used in) operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_ce87e795-f2a9-4800-a24f-c70b660ab5f8_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllTradingArrangementsMember_terseLabel_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Trading Arrangements</link:label>
    <link:label id="lab_ecd_AllTradingArrangementsMember_label_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Trading Arrangements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllTradingArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllTradingArrangementsMember" xlink:to="lab_ecd_AllTradingArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplierConcentrationRiskMember_a931ca54-22d8-42fc-aa12-6274fc1707ef_terseLabel_en-US" xlink:label="lab_us-gaap_SupplierConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Concentration Risk</link:label>
    <link:label id="lab_us-gaap_SupplierConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_SupplierConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplierConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplierConcentrationRiskMember" xlink:to="lab_us-gaap_SupplierConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllAdjToCompMember_terseLabel_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Adjustments to Compensation</link:label>
    <link:label id="lab_ecd_AllAdjToCompMember_label_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Adjustments to Compensation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllAdjToCompMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="lab_ecd_AllAdjToCompMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgDiscLineItems_label_en-US" xlink:label="lab_ecd_AwardTmgDiscLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="lab_ecd_AwardTmgDiscLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_RevenueFromContractWithCustomersExcludingAssessedTaxAdjustmentsForRebatesAndSalesReturns_6e1309dc-465d-44e2-bc9b-675b6c34e4a6_negatedLabel_en-US" xlink:label="lab_zlab_RevenueFromContractWithCustomersExcludingAssessedTaxAdjustmentsForRebatesAndSalesReturns" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Rebates and sales returns</link:label>
    <link:label id="lab_zlab_RevenueFromContractWithCustomersExcludingAssessedTaxAdjustmentsForRebatesAndSalesReturns_label_en-US" xlink:label="lab_zlab_RevenueFromContractWithCustomersExcludingAssessedTaxAdjustmentsForRebatesAndSalesReturns" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customers, Excluding Assessed Tax, Adjustments For Rebates And Sales Returns</link:label>
    <link:label id="lab_zlab_RevenueFromContractWithCustomersExcludingAssessedTaxAdjustmentsForRebatesAndSalesReturns_documentation_en-US" xlink:label="lab_zlab_RevenueFromContractWithCustomersExcludingAssessedTaxAdjustmentsForRebatesAndSalesReturns" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of revenue from contract with customers excluding assessed tax, adjustments for rebates and sales return.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_RevenueFromContractWithCustomersExcludingAssessedTaxAdjustmentsForRebatesAndSalesReturns" xlink:href="zlab-20231231.xsd#zlab_RevenueFromContractWithCustomersExcludingAssessedTaxAdjustmentsForRebatesAndSalesReturns"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_RevenueFromContractWithCustomersExcludingAssessedTaxAdjustmentsForRebatesAndSalesReturns" xlink:to="lab_zlab_RevenueFromContractWithCustomersExcludingAssessedTaxAdjustmentsForRebatesAndSalesReturns" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_cd3ef559-d8d8-4945-bc53-4ea0a2667eb3_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents and Restricted Cash</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_DecipheraPharmaceuticalsLLCMember_747c1a4d-a2fd-4f00-9319-ed9fbe8d55c5_terseLabel_en-US" xlink:label="lab_zlab_DecipheraPharmaceuticalsLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deciphera</link:label>
    <link:label id="lab_zlab_DecipheraPharmaceuticalsLLCMember_label_en-US" xlink:label="lab_zlab_DecipheraPharmaceuticalsLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deciphera Pharmaceuticals L L C [Member]</link:label>
    <link:label id="lab_zlab_DecipheraPharmaceuticalsLLCMember_documentation_en-US" xlink:label="lab_zlab_DecipheraPharmaceuticalsLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deciphera Pharmaceuticals L L C [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_DecipheraPharmaceuticalsLLCMember" xlink:href="zlab-20231231.xsd#zlab_DecipheraPharmaceuticalsLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_DecipheraPharmaceuticalsLLCMember" xlink:to="lab_zlab_DecipheraPharmaceuticalsLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTextBlock_3e89a549-9870-404f-b41a-bcbb5f21803f_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTextBlock" xlink:to="lab_us-gaap_InvestmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_2823439c-f9bf-4312-a538-2402b6e0afea_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Subdivision ratio</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note, Stock Split, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:to="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Recovery Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryCompAmt" xlink:to="lab_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_ZejulaMember_ce717914-3d78-44d4-b938-ea6c0e087b4e_terseLabel_en-US" xlink:label="lab_zlab_ZejulaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZEJULA</link:label>
    <link:label id="lab_zlab_ZejulaMember_label_en-US" xlink:label="lab_zlab_ZejulaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zejula [Member]</link:label>
    <link:label id="lab_zlab_ZejulaMember_documentation_en-US" xlink:label="lab_zlab_ZejulaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zejula</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ZejulaMember" xlink:href="zlab-20231231.xsd#zlab_ZejulaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_ZejulaMember" xlink:to="lab_zlab_ZejulaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_4584b2c0-78ac-4889-a415-831434d7943f_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for credit loss</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_ProceedsFromDisposalOfLandUseRights_3069e5b4-c02f-4791-a5df-05d882138034_terseLabel_en-US" xlink:label="lab_zlab_ProceedsFromDisposalOfLandUseRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from disposal of land use right</link:label>
    <link:label id="lab_zlab_ProceedsFromDisposalOfLandUseRights_label_en-US" xlink:label="lab_zlab_ProceedsFromDisposalOfLandUseRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Disposal Of Land Use Rights</link:label>
    <link:label id="lab_zlab_ProceedsFromDisposalOfLandUseRights_documentation_en-US" xlink:label="lab_zlab_ProceedsFromDisposalOfLandUseRights" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Disposal Of Land Use Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ProceedsFromDisposalOfLandUseRights" xlink:href="zlab-20231231.xsd#zlab_ProceedsFromDisposalOfLandUseRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_ProceedsFromDisposalOfLandUseRights" xlink:to="lab_zlab_ProceedsFromDisposalOfLandUseRights" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_AuditInformationAbstract_label_en-US" xlink:label="lab_zlab_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:label id="lab_zlab_AuditInformationAbstract_documentation_en-US" xlink:label="lab_zlab_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_AuditInformationAbstract" xlink:href="zlab-20231231.xsd#zlab_AuditInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_AuditInformationAbstract" xlink:to="lab_zlab_AuditInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_ae61cbde-4894-4952-bb51-210384b5e262_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Leasing Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationLineItems_39931f95-67f0-41bd-b33a-82b39c9ff231_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:label id="lab_dei_DocumentInformationLineItems_label_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_261c898a-0503-44e7-9cb2-e00284c7ac08_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_a2abad52-e877-4b59-95d0-87f31703895d_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercises of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7ad7fe45-27dc-40ca-bdee-4fdb8190d018_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated statements of comprehensive loss</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_QinlockMember_bab289c0-bac0-4a56-8d63-89114d2fdf75_terseLabel_en-US" xlink:label="lab_zlab_QinlockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">QINLOCK</link:label>
    <link:label id="lab_zlab_QinlockMember_label_en-US" xlink:label="lab_zlab_QinlockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Qinlock [Member]</link:label>
    <link:label id="lab_zlab_QinlockMember_documentation_en-US" xlink:label="lab_zlab_QinlockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Qinlock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_QinlockMember" xlink:href="zlab-20231231.xsd#zlab_QinlockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_QinlockMember" xlink:to="lab_zlab_QinlockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_AUD_5176e648-d604-4b82-88b6-8833dffdc23c_terseLabel_en-US" xlink:label="lab_currency_AUD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Australian dollar (&#8220;A$&#8221;)</link:label>
    <link:label id="lab_currency_AUD_label_en-US" xlink:label="lab_currency_AUD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Australia, Dollars</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AUD" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_AUD"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_AUD" xlink:to="lab_currency_AUD" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_7fc96bd1-9211-4c64-a48d-ba09fdb5daf0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tranche three</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Tranche Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementAccountingPolicy_99ba4fb6-bf92-4686-8b6b-49d459771444_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementAccountingPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangements</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementAccountingPolicy_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementAccountingPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Accounting Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementAccountingPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementAccountingPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementAccountingPolicy" xlink:to="lab_us-gaap_CollaborativeArrangementAccountingPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_49745c8b-4166-4e63-8b50-bc1d1498c862_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis" xlink:to="lab_us-gaap_ShortTermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_fdfd1850-9ca6-41dc-ab52-dd7c2babe78b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_550ac153-e4b8-4bd0-8730-d818c9450767_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_7f639c82-586f-4683-964e-824b0a1277d3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_58b30cdf-ec66-4323-9cfc-6ea9448bfc3e_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepayments and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFinStmtErrorCorrectionFlag_dd60a9bf-0674-4feb-8f0b-cb78b8d2d084_terseLabel_en-US" xlink:label="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
    <link:label id="lab_dei_DocumentFinStmtErrorCorrectionFlag_label_en-US" xlink:label="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_GovernmentAssistanceNonoperatingIncome_183e9bd9-fafb-4ee6-b410-e56044db1325_terseLabel_en-US" xlink:label="lab_zlab_GovernmentAssistanceNonoperatingIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government grants recognized</link:label>
    <link:label id="lab_zlab_GovernmentAssistanceNonoperatingIncome_label_en-US" xlink:label="lab_zlab_GovernmentAssistanceNonoperatingIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Assistance, Nonoperating Income</link:label>
    <link:label id="lab_zlab_GovernmentAssistanceNonoperatingIncome_documentation_en-US" xlink:label="lab_zlab_GovernmentAssistanceNonoperatingIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Assistance, Nonoperating Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_GovernmentAssistanceNonoperatingIncome" xlink:href="zlab-20231231.xsd#zlab_GovernmentAssistanceNonoperatingIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_GovernmentAssistanceNonoperatingIncome" xlink:to="lab_zlab_GovernmentAssistanceNonoperatingIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_cc0e0e1c-6047-4462-b552-fdc0a7009711_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets, Amortization expense, year three</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_997d4f8a-0248-43df-9a36-24ec42e120b1_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_AmortizationOfDeferredIncome_9cd0d5a8-ecf1-4c5d-87b3-40086f46ae04_terseLabel_en-US" xlink:label="lab_zlab_AmortizationOfDeferredIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of deferred income</link:label>
    <link:label id="lab_zlab_AmortizationOfDeferredIncome_label_en-US" xlink:label="lab_zlab_AmortizationOfDeferredIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization Of Deferred Income</link:label>
    <link:label id="lab_zlab_AmortizationOfDeferredIncome_documentation_en-US" xlink:label="lab_zlab_AmortizationOfDeferredIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of deferred income.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_AmortizationOfDeferredIncome" xlink:href="zlab-20231231.xsd#zlab_AmortizationOfDeferredIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_AmortizationOfDeferredIncome" xlink:to="lab_zlab_AmortizationOfDeferredIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_b02fe24e-fddb-48f5-9da6-0255452dd510_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of employees eligible compensation the employer matches</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingArrLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingArrLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Arrangements [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="lab_ecd_InsiderTradingArrLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_ResearchAndDevelopmentExpensesAndTheInventoryPurchases_97248a54-9263-4612-8525-a8a9a84f5e79_terseLabel_en-US" xlink:label="lab_zlab_ResearchAndDevelopmentExpensesAndTheInventoryPurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expenses and inventory purchases</link:label>
    <link:label id="lab_zlab_ResearchAndDevelopmentExpensesAndTheInventoryPurchases_label_en-US" xlink:label="lab_zlab_ResearchAndDevelopmentExpensesAndTheInventoryPurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expenses and the inventory purchases</link:label>
    <link:label id="lab_zlab_ResearchAndDevelopmentExpensesAndTheInventoryPurchases_documentation_en-US" xlink:label="lab_zlab_ResearchAndDevelopmentExpensesAndTheInventoryPurchases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expenses and the inventory purchases.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ResearchAndDevelopmentExpensesAndTheInventoryPurchases" xlink:href="zlab-20231231.xsd#zlab_ResearchAndDevelopmentExpensesAndTheInventoryPurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_ResearchAndDevelopmentExpensesAndTheInventoryPurchases" xlink:to="lab_zlab_ResearchAndDevelopmentExpensesAndTheInventoryPurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b1124ec1-8abb-4895-a892-699784b4a9db_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0ff20f9d-2595-4aac-9f44-74f3e88005d6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value, Outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_SignificantAccountingPoliciesTable_31a14876-a836-4792-b944-32292c56bc7e_terseLabel_en-US" xlink:label="lab_zlab_SignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_zlab_SignificantAccountingPoliciesTable_label_en-US" xlink:label="lab_zlab_SignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_zlab_SignificantAccountingPoliciesTable_documentation_en-US" xlink:label="lab_zlab_SignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant accounting policies.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_SignificantAccountingPoliciesTable" xlink:href="zlab-20231231.xsd#zlab_SignificantAccountingPoliciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_SignificantAccountingPoliciesTable" xlink:to="lab_zlab_SignificantAccountingPoliciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_ce055fc8-c35c-4f9d-b32a-9629783868f7_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_terseLabel_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_label_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Terms of Trading Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Method</link:label>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMethodTextBlock" xlink:to="lab_ecd_AwardTmgMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_243160b7-edbb-42a8-a173-2b6fe6e28464_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of different tax rate of subsidiary operation in other jurisdictions</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_eebdaa56-f4dc-4fdb-b3b3-7fdd2d89e8b8_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets, Amortization expense, year two</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CondensedCashFlowStatementsCaptionsLineItems_8ce9d157-3c89-461f-8890-8b09c064b0de_terseLabel_en-US" xlink:label="lab_srt_CondensedCashFlowStatementsCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Cash Flow Statements Captions [Line Items]</link:label>
    <link:label id="lab_srt_CondensedCashFlowStatementsCaptionsLineItems_label_en-US" xlink:label="lab_srt_CondensedCashFlowStatementsCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Cash Flow Statements, Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedCashFlowStatementsCaptionsLineItems" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CondensedCashFlowStatementsCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems" xlink:to="lab_srt_CondensedCashFlowStatementsCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_b7ff7415-ef82-460a-ac9e-aae80d6d1e88_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Compensation, Amount</link:label>
    <link:label id="lab_ecd_AdjToCompAmt_label_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAmt" xlink:to="lab_ecd_AdjToCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_a3cca301-2f74-430c-b389-c557968309bf_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tranche two</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Tranche Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_9fde3236-ca8c-4feb-87f9-4674de8a4e72_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from the sale of property and equipment</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_EquitySecuritiesWithReadilyDeterminableFairValueAmount_ec0e98ae-e7f1-4121-94a6-07f531a0e77c_terseLabel_en-US" xlink:label="lab_zlab_EquitySecuritiesWithReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments with readily determinable fair value</link:label>
    <link:label id="lab_zlab_EquitySecuritiesWithReadilyDeterminableFairValueAmount_label_en-US" xlink:label="lab_zlab_EquitySecuritiesWithReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities With Readily Determinable Fair Value Amount</link:label>
    <link:label id="lab_zlab_EquitySecuritiesWithReadilyDeterminableFairValueAmount_documentation_en-US" xlink:label="lab_zlab_EquitySecuritiesWithReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities with readily determinable fair value amount.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_EquitySecuritiesWithReadilyDeterminableFairValueAmount" xlink:href="zlab-20231231.xsd#zlab_EquitySecuritiesWithReadilyDeterminableFairValueAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_EquitySecuritiesWithReadilyDeterminableFairValueAmount" xlink:to="lab_zlab_EquitySecuritiesWithReadilyDeterminableFairValueAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_9b7bf962-0cea-411f-9231-63533b2c9311_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_c5813738-acfd-4d90-8b04-e5692710233e_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_f34e8e8b-443f-4319-8db0-c4b4ff9d9079_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_edf08055-0ab6-479f-9cdc-2b52f892bed7_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_RepotrectinibMember_e50fe07f-7b37-423c-9acd-062bb743636a_terseLabel_en-US" xlink:label="lab_zlab_RepotrectinibMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repotrectinib</link:label>
    <link:label id="lab_zlab_RepotrectinibMember_label_en-US" xlink:label="lab_zlab_RepotrectinibMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repotrectinib [Member]</link:label>
    <link:label id="lab_zlab_RepotrectinibMember_documentation_en-US" xlink:label="lab_zlab_RepotrectinibMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repotrectinib</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_RepotrectinibMember" xlink:href="zlab-20231231.xsd#zlab_RepotrectinibMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_RepotrectinibMember" xlink:to="lab_zlab_RepotrectinibMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Net Income</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Net Income [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_label_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peer Group Issuers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:to="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrAdoptionDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adoption Date</link:label>
    <link:label id="lab_ecd_TrdArrAdoptionDate_label_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement Adoption Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrAdoptionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrAdoptionDate" xlink:to="lab_ecd_TrdArrAdoptionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_f956e04b-4117-468b-bd31-1da19e6bca1b_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_49fff56f-5c63-4bc1-bab2-c4609c6e76b4_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of ordinary shares upon vesting of restricted shares</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_542a6b2a-226d-4a0e-a1de-a87f884c1b6a_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_a7e59a9c-def5-4673-870c-5886fec05c87_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price, Vested and exercisable (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_c969db8a-3226-49ff-86dd-6d58e2f3c676_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonMember" xlink:to="lab_us-gaap_TreasuryStockCommonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_7fbfc9ff-e336-4bfd-8fd7-045143736ac9_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_e1e2c257-f522-4928-9c4e-f3d0980579d0_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on disposal of property and equipment</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_b281b777-b1b0-452b-875f-e8e56382bc6c_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:to="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_XanomelineTrospiumMember_7fb289fe-e4c8-4f98-bf3f-059aa6b995f7_terseLabel_en-US" xlink:label="lab_zlab_XanomelineTrospiumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Xanomeline-Trospium</link:label>
    <link:label id="lab_zlab_XanomelineTrospiumMember_label_en-US" xlink:label="lab_zlab_XanomelineTrospiumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Xanomeline-Trospium [Member]</link:label>
    <link:label id="lab_zlab_XanomelineTrospiumMember_documentation_en-US" xlink:label="lab_zlab_XanomelineTrospiumMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Xanomeline-Trospium</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_XanomelineTrospiumMember" xlink:href="zlab-20231231.xsd#zlab_XanomelineTrospiumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_XanomelineTrospiumMember" xlink:to="lab_zlab_XanomelineTrospiumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_12cc8b14-dce7-4c95-b614-4e330b02644b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_5ba1683f-11f9-4bdf-b639-e7d2050d68a8_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_950b449f-0689-44cc-964a-b2702308c231_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_DefinedContributionPlanEmployerMatchingContributionPercentOfEmployeeContribution_ba143c49-7302-48ef-99fa-d0390df4afac_terseLabel_en-US" xlink:label="lab_zlab_DefinedContributionPlanEmployerMatchingContributionPercentOfEmployeeContribution" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of employee contribution that the employer matches</link:label>
    <link:label id="lab_zlab_DefinedContributionPlanEmployerMatchingContributionPercentOfEmployeeContribution_label_en-US" xlink:label="lab_zlab_DefinedContributionPlanEmployerMatchingContributionPercentOfEmployeeContribution" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent Of Employee Contribution</link:label>
    <link:label id="lab_zlab_DefinedContributionPlanEmployerMatchingContributionPercentOfEmployeeContribution_documentation_en-US" xlink:label="lab_zlab_DefinedContributionPlanEmployerMatchingContributionPercentOfEmployeeContribution" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent Of Employee Contribution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_DefinedContributionPlanEmployerMatchingContributionPercentOfEmployeeContribution" xlink:href="zlab-20231231.xsd#zlab_DefinedContributionPlanEmployerMatchingContributionPercentOfEmployeeContribution"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_DefinedContributionPlanEmployerMatchingContributionPercentOfEmployeeContribution" xlink:to="lab_zlab_DefinedContributionPlanEmployerMatchingContributionPercentOfEmployeeContribution" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_CollaborativeArrangementRightsAndObligationsDevelopmentMilestonePayment_31d21e9c-86d9-40b9-a1f4-988879a2fa0a_terseLabel_en-US" xlink:label="lab_zlab_CollaborativeArrangementRightsAndObligationsDevelopmentMilestonePayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development milestone payment</link:label>
    <link:label id="lab_zlab_CollaborativeArrangementRightsAndObligationsDevelopmentMilestonePayment_label_en-US" xlink:label="lab_zlab_CollaborativeArrangementRightsAndObligationsDevelopmentMilestonePayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Rights and Obligations, Development Milestone Payment</link:label>
    <link:label id="lab_zlab_CollaborativeArrangementRightsAndObligationsDevelopmentMilestonePayment_documentation_en-US" xlink:label="lab_zlab_CollaborativeArrangementRightsAndObligationsDevelopmentMilestonePayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Rights and Obligations, Development Milestone Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_CollaborativeArrangementRightsAndObligationsDevelopmentMilestonePayment" xlink:href="zlab-20231231.xsd#zlab_CollaborativeArrangementRightsAndObligationsDevelopmentMilestonePayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_CollaborativeArrangementRightsAndObligationsDevelopmentMilestonePayment" xlink:to="lab_zlab_CollaborativeArrangementRightsAndObligationsDevelopmentMilestonePayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_5918f7d6-6c81-4cd7-82f4-3462c4c7e053_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-deductible expenses</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_CapitalizedSalesBasedMilestoneFeesMember_56861a3b-d9a4-407e-873f-ad4b71aa6593_terseLabel_en-US" xlink:label="lab_zlab_CapitalizedSalesBasedMilestoneFeesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Sales Based Milestone Fees</link:label>
    <link:label id="lab_zlab_CapitalizedSalesBasedMilestoneFeesMember_label_en-US" xlink:label="lab_zlab_CapitalizedSalesBasedMilestoneFeesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Sales Based Milestone Fees [Member]</link:label>
    <link:label id="lab_zlab_CapitalizedSalesBasedMilestoneFeesMember_documentation_en-US" xlink:label="lab_zlab_CapitalizedSalesBasedMilestoneFeesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Sales Based Milestone Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_CapitalizedSalesBasedMilestoneFeesMember" xlink:href="zlab-20231231.xsd#zlab_CapitalizedSalesBasedMilestoneFeesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_CapitalizedSalesBasedMilestoneFeesMember" xlink:to="lab_zlab_CapitalizedSalesBasedMilestoneFeesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_f6f0e565-2066-406e-a6dd-12435c626b5d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining contractual term (years)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_4d23ca33-d6f4-4fc4-a5f1-20e4be3197ff_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued payroll</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingAxis_973a428d-dfb4-4568-be7f-bdbd5ea990a3_terseLabel_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:label id="lab_us-gaap_VestingAxis_label_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingAxis" xlink:to="lab_us-gaap_VestingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_06b35430-b7cc-442b-b6a7-2c7c638330af_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndName_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_TrdArrIndName_label_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndName" xlink:to="lab_ecd_TrdArrIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAbstract_baab0bda-0c73-40ec-b842-d0ddc0e45b7d_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAbstract_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract" xlink:to="lab_us-gaap_CashAndCashEquivalentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardDateAxis_d7c07461-dc54-494f-846f-4e5a2365c613_terseLabel_en-US" xlink:label="lab_us-gaap_AwardDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardDateAxis_label_en-US" xlink:label="lab_us-gaap_AwardDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardDateAxis" xlink:to="lab_us-gaap_AwardDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_d311f811-edb4-47a5-bc5a-068c2a9e0ba9_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Disaggregation of Net Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_4fe0dd88-ea46-460c-897a-963f0eff649c_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of ordinary shares upon follow-on public offering, net of issuance cost</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_22d49c67-3e1e-4798-9425-1f6f81d33b40_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, Net</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_DeferredTaxAssetsValuationAllowanceRollForward_ea4aae16-662c-4824-8359-d46d700a3236_terseLabel_en-US" xlink:label="lab_zlab_DeferredTaxAssetsValuationAllowanceRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance [Roll Forward]</link:label>
    <link:label id="lab_zlab_DeferredTaxAssetsValuationAllowanceRollForward_label_en-US" xlink:label="lab_zlab_DeferredTaxAssetsValuationAllowanceRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance [Roll Forward]</link:label>
    <link:label id="lab_zlab_DeferredTaxAssetsValuationAllowanceRollForward_documentation_en-US" xlink:label="lab_zlab_DeferredTaxAssetsValuationAllowanceRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_DeferredTaxAssetsValuationAllowanceRollForward" xlink:href="zlab-20231231.xsd#zlab_DeferredTaxAssetsValuationAllowanceRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_DeferredTaxAssetsValuationAllowanceRollForward" xlink:to="lab_zlab_DeferredTaxAssetsValuationAllowanceRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_5991139d-e989-4e17-addf-3676b29dc7dd_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining lease term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_928fbe18-d266-4343-aff6-eff9890c017b_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product revenue, net</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6da6ddfd-fa0e-4b28-a7e4-0e5045f06256_netLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_bbd7f237-383d-4cb5-a1a5-1220f3cc42db_totalLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product revenue &#8212; net</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f37ecd49-e75c-4b23-8efe-1373fbcda667_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product revenue &#8212; net</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_91895dae-794a-4966-85d3-5fe40a63bcb5_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_82cf9038-2972-4390-89c7-6c86706240f1_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsLineItems_d7222b44-699a-4978-864c-c2f5cdc83108_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Cash Equivalents [Line Items]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsLineItems_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems" xlink:to="lab_us-gaap_CashAndCashEquivalentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_65fd832c-0f94-485f-89e7-3a47cdac4849_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_HuizhengMember_3a2fb433-a59e-417b-9d79-0b2c533496fe_terseLabel_en-US" xlink:label="lab_zlab_HuizhengMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Huizheng</link:label>
    <link:label id="lab_zlab_HuizhengMember_label_en-US" xlink:label="lab_zlab_HuizhengMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Huizheng [Member]</link:label>
    <link:label id="lab_zlab_HuizhengMember_documentation_en-US" xlink:label="lab_zlab_HuizhengMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Huizheng</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_HuizhengMember" xlink:href="zlab-20231231.xsd#zlab_HuizhengMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_HuizhengMember" xlink:to="lab_zlab_HuizhengMember" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_PropertyAndEquipmentEstimatedUsefulLivesTableTextBlock_3cb85855-3369-4fc5-a98c-1a9b11008d53_terseLabel_en-US" xlink:label="lab_zlab_PropertyAndEquipmentEstimatedUsefulLivesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Estimated Useful Lives of Property and Equipment</link:label>
    <link:label id="lab_zlab_PropertyAndEquipmentEstimatedUsefulLivesTableTextBlock_label_en-US" xlink:label="lab_zlab_PropertyAndEquipmentEstimatedUsefulLivesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property And Equipment Estimated Useful Lives [Table Text Block]</link:label>
    <link:label id="lab_zlab_PropertyAndEquipmentEstimatedUsefulLivesTableTextBlock_documentation_en-US" xlink:label="lab_zlab_PropertyAndEquipmentEstimatedUsefulLivesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment estimated useful lives.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_PropertyAndEquipmentEstimatedUsefulLivesTableTextBlock" xlink:href="zlab-20231231.xsd#zlab_PropertyAndEquipmentEstimatedUsefulLivesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_PropertyAndEquipmentEstimatedUsefulLivesTableTextBlock" xlink:to="lab_zlab_PropertyAndEquipmentEstimatedUsefulLivesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_5a3f6af1-4239-43c5-8cea-2d69c8e912cf_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_5803fa40-a385-416b-ba57-4dad51b94592_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_42d78d67-0080-435a-a42f-2dac39e65253_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate amount of cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_e90a193e-b257-4d1e-b28f-59c776290741_totalLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_98e634c1-9dcd-4af7-8352-95a6ded022b2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receipt of shares netted to satisfy tax withholding obligations related to share-based compensation (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_f14fa0db-2d95-45fc-b48a-78dacf3320f1_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average discount rate</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_country_VG_885c379e-8e02-4353-a0d0-4119776faa87_terseLabel_en-US" xlink:label="lab_country_VG" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">British Virgin Islands</link:label>
    <link:label id="lab_country_VG_label_en-US" xlink:label="lab_country_VG" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">VIRGIN ISLANDS, BRITISH</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_VG" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_VG"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_VG" xlink:to="lab_country_VG" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_be3ab97c-7fae-4c2a-b1df-e140ca013db5_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy_d89ef1db-e71d-4fdd-a217-893fc84e5d9e_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Finite-Lived, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:to="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_GlaxoSmithKlineMember_4129af7e-f05f-4e09-9918-a2a7049020e6_terseLabel_en-US" xlink:label="lab_zlab_GlaxoSmithKlineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GSK</link:label>
    <link:label id="lab_zlab_GlaxoSmithKlineMember_label_en-US" xlink:label="lab_zlab_GlaxoSmithKlineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GlaxoSmithKline [Member]</link:label>
    <link:label id="lab_zlab_GlaxoSmithKlineMember_documentation_en-US" xlink:label="lab_zlab_GlaxoSmithKlineMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GSK [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_GlaxoSmithKlineMember" xlink:href="zlab-20231231.xsd#zlab_GlaxoSmithKlineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_GlaxoSmithKlineMember" xlink:to="lab_zlab_GlaxoSmithKlineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_7c01982e-63d1-4b72-b167-ccc30a244df4_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Useful life</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_LaboratoryEquipmentMember_6923b7c7-63b6-4c26-8cef-207d0ffa941b_terseLabel_en-US" xlink:label="lab_zlab_LaboratoryEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory equipment</link:label>
    <link:label id="lab_zlab_LaboratoryEquipmentMember_label_en-US" xlink:label="lab_zlab_LaboratoryEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory Equipment [Member]</link:label>
    <link:label id="lab_zlab_LaboratoryEquipmentMember_documentation_en-US" xlink:label="lab_zlab_LaboratoryEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory equipment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_LaboratoryEquipmentMember" xlink:href="zlab-20231231.xsd#zlab_LaboratoryEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_LaboratoryEquipmentMember" xlink:to="lab_zlab_LaboratoryEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_ZaiLabHongKongLimitedMember_2f19ec38-7487-4d81-9ae9-fad77e4e569e_terseLabel_en-US" xlink:label="lab_zlab_ZaiLabHongKongLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zai Lab (Hong Kong) Limited</link:label>
    <link:label id="lab_zlab_ZaiLabHongKongLimitedMember_label_en-US" xlink:label="lab_zlab_ZaiLabHongKongLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zai Lab Hong Kong Limited [Member]</link:label>
    <link:label id="lab_zlab_ZaiLabHongKongLimitedMember_documentation_en-US" xlink:label="lab_zlab_ZaiLabHongKongLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zai Lab (Hong Kong) Limited.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ZaiLabHongKongLimitedMember" xlink:href="zlab-20231231.xsd#zlab_ZaiLabHongKongLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_ZaiLabHongKongLimitedMember" xlink:to="lab_zlab_ZaiLabHongKongLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Other Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_ac798c42-bb6f-4161-9f0d-58c2f9607ef4_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in valuation allowance</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_2cacf357-c624-4368-b1a2-d073a7c13cde_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4d3a1ecc-bb5c-48f2-8b96-fa41b74aa60a_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average shares used in calculating net loss per ordinary share &#8212;diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_30923524-3834-4310-8619-fee7050934f8_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of ordinary shares - diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfValuationAllowanceTextBlock_3562affe-7f09-4e3c-bb65-78dbe8fca208_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Movement of Valuation Allowance</link:label>
    <link:label id="lab_us-gaap_SummaryOfValuationAllowanceTextBlock_label_en-US" xlink:label="lab_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Valuation Allowance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SummaryOfValuationAllowanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:to="lab_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_VyvgartMember_299a3c5d-e4d1-4cd9-aba3-4836abd00321_terseLabel_en-US" xlink:label="lab_zlab_VyvgartMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">VYVGART</link:label>
    <link:label id="lab_zlab_VyvgartMember_label_en-US" xlink:label="lab_zlab_VyvgartMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">vyvgart [Member]</link:label>
    <link:label id="lab_zlab_VyvgartMember_documentation_en-US" xlink:label="lab_zlab_VyvgartMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">vyvgart</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_VyvgartMember" xlink:href="zlab-20231231.xsd#zlab_VyvgartMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_VyvgartMember" xlink:to="lab_zlab_VyvgartMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_7025ecaf-371e-454e-9ce7-7ae76baffeea_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_938b3241-a3c4-4b47-842d-011424769274_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_c721c67f-adf1-406f-a48f-4b768d04a49e_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureAmt" xlink:to="lab_ecd_CoSelectedMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_6d7bcf86-188a-4a99-9ffe-6444698d0fdd_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_d78d9be7-83fd-4578-9cc0-f71d17970bae_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_e0777af8-aa90-4591-b72d-7b8c61722e61_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfHeldToMaturitySecuritiesTable_8d871082-d629-4530-a6e8-83b6d52a9867_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfHeldToMaturitySecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfHeldToMaturitySecuritiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfHeldToMaturitySecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfHeldToMaturitySecuritiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesTable" xlink:to="lab_us-gaap_ScheduleOfHeldToMaturitySecuritiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VehiclesMember_35b89bb2-79ab-4d51-b40f-a0feb2cf75d7_verboseLabel_en-US" xlink:label="lab_us-gaap_VehiclesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vehicles</link:label>
    <link:label id="lab_us-gaap_VehiclesMember_73714a01-9fd5-48d4-b5a9-3b9204df35c2_terseLabel_en-US" xlink:label="lab_us-gaap_VehiclesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vehicle</link:label>
    <link:label id="lab_us-gaap_VehiclesMember_label_en-US" xlink:label="lab_us-gaap_VehiclesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vehicles [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VehiclesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VehiclesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VehiclesMember" xlink:to="lab_us-gaap_VehiclesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_9f8efe94-1749-4eb2-8eb1-a8071391055c_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash &#8212; beginning of the year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_c9a390e0-98a6-4622-ab87-0c97a6da399e_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash &#8212; end of the year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_ed2dda4c-e8e3-45e2-aeb9-1d1636dd2599_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash and cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_0be20dcc-313f-4cdd-9615-c5d6be18a1cc_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:to="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_c991fadc-02a4-45f7-bc90-24ccc820ff84_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share of loss from equity method investment</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_aea81dd6-1365-4d66-a35d-76cc06b108b6_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share of loss from equity method investment</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_b68fb7af-a032-4ef0-98b3-66d0a7573d53_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_8a12b58d-8c70-4eb5-a278-7f53fbd1aac0_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_9cf2e4d6-61d8-40b3-b4b7-b43edb174f4d_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining contractual term, Vested and exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome_349f34ef-202f-4950-b56c-dd1d26d802ef_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax-exempted income</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Exempt Income, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_e7fa61e1-7cef-4747-a883-6b8578ec4475_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_64dde281-bcdd-47cb-9f74-7372ce99bb38_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_fc395343-52af-424d-ab64-c3699bc4c919_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_DeferredTaxAssetsGovernmentGrants_c94ca3a7-5967-4143-bbec-7bc94fced243_terseLabel_en-US" xlink:label="lab_zlab_DeferredTaxAssetsGovernmentGrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government grants</link:label>
    <link:label id="lab_zlab_DeferredTaxAssetsGovernmentGrants_label_en-US" xlink:label="lab_zlab_DeferredTaxAssetsGovernmentGrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets Government Grants</link:label>
    <link:label id="lab_zlab_DeferredTaxAssetsGovernmentGrants_documentation_en-US" xlink:label="lab_zlab_DeferredTaxAssetsGovernmentGrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets government grants.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_DeferredTaxAssetsGovernmentGrants" xlink:href="zlab-20231231.xsd#zlab_DeferredTaxAssetsGovernmentGrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_DeferredTaxAssetsGovernmentGrants" xlink:to="lab_zlab_DeferredTaxAssetsGovernmentGrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrantMember_ee198483-c11c-4fc2-bf6f-98854282bb68_terseLabel_en-US" xlink:label="lab_us-gaap_GrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Grants</link:label>
    <link:label id="lab_us-gaap_GrantMember_label_en-US" xlink:label="lab_us-gaap_GrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrantMember" xlink:to="lab_us-gaap_GrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock_cbd71316-bab3-43e2-b2db-72af1891643f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Current Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_05c3b3ab-4fdf-4250-9747-c73121d72169_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonNeosMember_terseLabel_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-NEOs</link:label>
    <link:label id="lab_ecd_NonNeosMember_label_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-NEOs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonNeosMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonNeosMember" xlink:to="lab_ecd_NonNeosMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_dc728513-bc13-4814-803a-d6e7cee9c431_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestments_accb3e14-d95f-4fe9-ab35-c917a2f6ac07_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestments" xlink:to="lab_us-gaap_ShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_68f1da49-a052-4780-800c-daf9c2db27ed_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_ReceivableRecognizedForDisposalOfPropertyAndEquipment_129821bd-edc8-4cc4-b4c6-2e76905df7e2_terseLabel_en-US" xlink:label="lab_zlab_ReceivableRecognizedForDisposalOfPropertyAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables for disposal of property and equipment</link:label>
    <link:label id="lab_zlab_ReceivableRecognizedForDisposalOfPropertyAndEquipment_label_en-US" xlink:label="lab_zlab_ReceivableRecognizedForDisposalOfPropertyAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable Recognized For Disposal Of Property And Equipment</link:label>
    <link:label id="lab_zlab_ReceivableRecognizedForDisposalOfPropertyAndEquipment_documentation_en-US" xlink:label="lab_zlab_ReceivableRecognizedForDisposalOfPropertyAndEquipment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable Recognized For Disposal Of Property And Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ReceivableRecognizedForDisposalOfPropertyAndEquipment" xlink:href="zlab-20231231.xsd#zlab_ReceivableRecognizedForDisposalOfPropertyAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_ReceivableRecognizedForDisposalOfPropertyAndEquipment" xlink:to="lab_zlab_ReceivableRecognizedForDisposalOfPropertyAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_BankOfChinaWorkingCapitalLoanFacilityMember_81f4144d-3dfc-4e63-90bb-7e3c081f8fda_terseLabel_en-US" xlink:label="lab_zlab_BankOfChinaWorkingCapitalLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank of China Working Capital Loan Facility</link:label>
    <link:label id="lab_zlab_BankOfChinaWorkingCapitalLoanFacilityMember_label_en-US" xlink:label="lab_zlab_BankOfChinaWorkingCapitalLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank of China Working Capital Loan Facility [Member]</link:label>
    <link:label id="lab_zlab_BankOfChinaWorkingCapitalLoanFacilityMember_documentation_en-US" xlink:label="lab_zlab_BankOfChinaWorkingCapitalLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank of China Working Capital Loan Facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_BankOfChinaWorkingCapitalLoanFacilityMember" xlink:href="zlab-20231231.xsd#zlab_BankOfChinaWorkingCapitalLoanFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_BankOfChinaWorkingCapitalLoanFacilityMember" xlink:to="lab_zlab_BankOfChinaWorkingCapitalLoanFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingGainsLosses_88558daa-dd6e-428a-8a99-cc10f86076c4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingGainsLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Others miscellaneous gain</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingGainsLosses_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Gains (Losses)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingGainsLosses" xlink:to="lab_us-gaap_OtherNonoperatingGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_AmgenMember_3375b165-155d-4e45-af05-000fc11fc145_terseLabel_en-US" xlink:label="lab_zlab_AmgenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amgen</link:label>
    <link:label id="lab_zlab_AmgenMember_label_en-US" xlink:label="lab_zlab_AmgenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amgen [Member]</link:label>
    <link:label id="lab_zlab_AmgenMember_documentation_en-US" xlink:label="lab_zlab_AmgenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Five Prime Therapeutics Incorporation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_AmgenMember" xlink:href="zlab-20231231.xsd#zlab_AmgenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_AmgenMember" xlink:to="lab_zlab_AmgenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries_afc915bb-fa4c-490e-a100-9b5e8373ca14_terseLabel_en-US" xlink:label="lab_us-gaap_AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted amount by subsidiaries</link:label>
    <link:label id="lab_us-gaap_AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries_label_en-US" xlink:label="lab_us-gaap_AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of Restricted Net Assets for Consolidated and Unconsolidated Subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries" xlink:to="lab_us-gaap_AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsDisclosureTextBlock_35376497-f9f7-43ef-be96-2d6198ea0e67_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsDisclosureTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_154079bf-a94d-405e-b9f3-0b42cd82fe3f_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (decrease) increase in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_TWD_5c0cb2d1-1329-45ae-adc1-aed20561a918_terseLabel_en-US" xlink:label="lab_currency_TWD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taiwan dollar (&#8220;TW$&#8221;)</link:label>
    <link:label id="lab_currency_TWD_label_en-US" xlink:label="lab_currency_TWD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taiwan, New Dollars</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_TWD" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_TWD"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_TWD" xlink:to="lab_currency_TWD" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_db09012b-0ef5-40f7-9099-3e168d10ee61_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_25eda26a-678e-4a0b-822e-9f89aa5c105c_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss before income tax and share of loss from equity method investment</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoMember_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO</link:label>
    <link:label id="lab_ecd_NonPeoNeoMember_label_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoMember" xlink:to="lab_ecd_NonPeoNeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_76a7326a-4031-4b49-810b-5691727c74cc_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAxis_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Compensation:</link:label>
    <link:label id="lab_ecd_AdjToCompAxis_label_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="lab_ecd_AdjToCompAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_8f0058ea-9982-42c5-a6c2-f0bbab0b1113_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work in progress</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-GAAP Measure Description</link:label>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_label_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-GAAP Measure Description [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_1b1bcc0e-a026-4586-b013-1e4c84c114e1_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carry forwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c8ed5787-b48c-4d3e-9f5b-28d3d9e60c90_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average shares used in calculating net loss per ordinary share &#8212; basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_51775a35-e115-4e8d-8456-1ae9b7e574c8_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of ordinary shares - basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_7ed3f4d1-b1c6-44f9-8014-7ef2b92b1eec_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation of property and equipment, net</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_3706c588-e3ba-4a07-b0c4-0956a13028ad_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_country_TW_cb5c180e-08e3-4453-a584-c2851de28f4c_terseLabel_en-US" xlink:label="lab_country_TW" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taiwan</link:label>
    <link:label id="lab_country_TW_label_en-US" xlink:label="lab_country_TW" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TAIWAN</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_TW" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_TW"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_TW" xlink:to="lab_country_TW" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_2abd077c-acd4-4d81-9cde-bd916f6e48af_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_c79617e8-9fb2-46a2-ba15-1b1a6a722256_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_ac249be7-d78e-4050-a273-fecfc5d68ab3_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering_c5487dbb-dc82-42f9-b1fc-2f0c9da57fcf_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of ordinary shares upon public offerings</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance Initial Public Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OfficeEquipmentMember_530a86ef-97a9-4cf7-99ff-ae7a8a4277d7_terseLabel_en-US" xlink:label="lab_us-gaap_OfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office equipment</link:label>
    <link:label id="lab_us-gaap_OfficeEquipmentMember_label_en-US" xlink:label="lab_us-gaap_OfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OfficeEquipmentMember" xlink:to="lab_us-gaap_OfficeEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_8236aa92-f5f2-4107-a8f8-37c4486bc54a_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_8cb30a95-6198-4d68-b669-8811bca91b39_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value ($ in thousands)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_830f2d00-8951-46a0-8033-b100296897eb_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesDomain" xlink:to="lab_srt_ConsolidatedEntitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenue_5ca04949-a873-4286-a65a-5bfb41624265_negatedLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfRevenue_label_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenue" xlink:to="lab_us-gaap_CostOfRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_b36c4874-a6ad-4195-886c-75d61a6be5f9_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_NotesReceivablePolicyTextBlock_b5c507f4-573b-4d96-9988-16549c4f5ead_terseLabel_en-US" xlink:label="lab_zlab_NotesReceivablePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable</link:label>
    <link:label id="lab_zlab_NotesReceivablePolicyTextBlock_label_en-US" xlink:label="lab_zlab_NotesReceivablePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable [Policy Text Block]</link:label>
    <link:label id="lab_zlab_NotesReceivablePolicyTextBlock_documentation_en-US" xlink:label="lab_zlab_NotesReceivablePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes receivable policy.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_NotesReceivablePolicyTextBlock" xlink:href="zlab-20231231.xsd#zlab_NotesReceivablePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_NotesReceivablePolicyTextBlock" xlink:to="lab_zlab_NotesReceivablePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTable_terseLabel_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance Disclosure</link:label>
    <link:label id="lab_ecd_PvpTable_label_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTable" xlink:to="lab_ecd_PvpTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_85c3e10c-ab67-42b4-a9d1-08d6f4641553_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_TwoThousandTwentyTwoEquityIncentivePlanMember_05ae6265-e7fa-46a3-809e-783cdcb16321_terseLabel_en-US" xlink:label="lab_zlab_TwoThousandTwentyTwoEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Twenty Two Equity Incentive Plan</link:label>
    <link:label id="lab_zlab_TwoThousandTwentyTwoEquityIncentivePlanMember_label_en-US" xlink:label="lab_zlab_TwoThousandTwentyTwoEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Twenty Two Equity Incentive Plan [Member]</link:label>
    <link:label id="lab_zlab_TwoThousandTwentyTwoEquityIncentivePlanMember_documentation_en-US" xlink:label="lab_zlab_TwoThousandTwentyTwoEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Twenty Two Equity Incentive Plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_TwoThousandTwentyTwoEquityIncentivePlanMember" xlink:href="zlab-20231231.xsd#zlab_TwoThousandTwentyTwoEquityIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_TwoThousandTwentyTwoEquityIncentivePlanMember" xlink:to="lab_zlab_TwoThousandTwentyTwoEquityIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_0f5643a7-d3a0-4ada-940f-73beb872d3c2_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable" xlink:to="lab_us-gaap_ConcentrationRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_9bf81221-d868-46a4-9b30-d6f9fc246333_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_b3ab73fb-8150-4d52-895a-e466a26b5b55_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax of nil:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c704e8e4-ab42-43f0-afaa-14af012e558c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) , net of tax of nil:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_c6d298a0-d10a-4fc0-b394-18810c846efc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Disclosures</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" order="1"/>
    <link:label id="lab_zlab_CollaborativeAgreementMember_79f219fa-b018-4541-8a89-75e231e9fea0_terseLabel_en-US" xlink:label="lab_zlab_CollaborativeAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Agreement</link:label>
    <link:label id="lab_zlab_CollaborativeAgreementMember_label_en-US" xlink:label="lab_zlab_CollaborativeAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Agreement [Member]</link:label>
    <link:label id="lab_zlab_CollaborativeAgreementMember_documentation_en-US" xlink:label="lab_zlab_CollaborativeAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_CollaborativeAgreementMember" xlink:href="zlab-20231231.xsd#zlab_CollaborativeAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zlab_CollaborativeAgreementMember" xlink:to="lab_zlab_CollaborativeAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_8f1d9ff6-76a5-4f63-a5d8-1c422b36245b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tranche one</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Tranche One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_732eaf37-1175-4e7c-b93f-3bbcb955a7ba_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior year tax filing adjustment</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>16
<FILENAME>zlab-20231231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:8edfc3fc-8768-4ea6-b2a3-bb613cc9a367,g:14e43acd-1532-4842-be1c-6094bb39150d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://zailab.com/role/CoverPage" xlink:type="simple" xlink:href="zlab-20231231.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://zailab.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_ff42ccf0-7107-41bc-9369-0fa1d028f0fe" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_a14886a1-e2f8-499a-8766-50e4774f0d10" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ff42ccf0-7107-41bc-9369-0fa1d028f0fe" xlink:to="loc_dei_DocumentInformationTable_a14886a1-e2f8-499a-8766-50e4774f0d10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_b34e7b70-bfeb-45d7-9ee8-6b38a0b000f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_a14886a1-e2f8-499a-8766-50e4774f0d10" xlink:to="loc_us-gaap_StatementClassOfStockAxis_b34e7b70-bfeb-45d7-9ee8-6b38a0b000f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_c6566e48-2ce9-404b-806d-a0756616ffc8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b34e7b70-bfeb-45d7-9ee8-6b38a0b000f9" xlink:to="loc_us-gaap_ClassOfStockDomain_c6566e48-2ce9-404b-806d-a0756616ffc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AdrMember_bdcfe42f-1a68-4ae4-a102-1180e29f2894" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AdrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_c6566e48-2ce9-404b-806d-a0756616ffc8" xlink:to="loc_dei_AdrMember_bdcfe42f-1a68-4ae4-a102-1180e29f2894" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_b30e1b2f-ad69-4b5b-a2c3-aa0cea28d739" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_c6566e48-2ce9-404b-806d-a0756616ffc8" xlink:to="loc_us-gaap_CommonStockMember_b30e1b2f-ad69-4b5b-a2c3-aa0cea28d739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_a14886a1-e2f8-499a-8766-50e4774f0d10" xlink:to="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_8f2ed626-c2be-4c3b-8d57-0de0db7ce81c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_DocumentType_8f2ed626-c2be-4c3b-8d57-0de0db7ce81c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_24e7db3c-f181-4dbd-a9d3-c2b2100303c7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_DocumentAnnualReport_24e7db3c-f181-4dbd-a9d3-c2b2100303c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_8cd66df3-e7d1-4e1c-a78f-33ec958548aa" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_DocumentPeriodEndDate_8cd66df3-e7d1-4e1c-a78f-33ec958548aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_c384f0a9-5e8a-4a9c-9eb9-ce24e32b39c8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_CurrentFiscalYearEndDate_c384f0a9-5e8a-4a9c-9eb9-ce24e32b39c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_19b2a8fd-e57c-44aa-8502-bb3340bb0537" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_DocumentTransitionReport_19b2a8fd-e57c-44aa-8502-bb3340bb0537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_926803e5-a609-4fb2-ae6f-b260b1986ea1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_EntityFileNumber_926803e5-a609-4fb2-ae6f-b260b1986ea1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_ab76430b-eba1-4048-8e12-8c4966807321" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_EntityRegistrantName_ab76430b-eba1-4048-8e12-8c4966807321" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_54eee8d3-968b-40ef-8f03-d13e9e097477" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_EntityIncorporationStateCountryCode_54eee8d3-968b-40ef-8f03-d13e9e097477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_25b001c2-0eec-44c1-987a-8982028942ae" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_EntityTaxIdentificationNumber_25b001c2-0eec-44c1-987a-8982028942ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_2fcad205-05ff-4689-8721-cc031316ff50" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_EntityAddressAddressLine1_2fcad205-05ff-4689-8721-cc031316ff50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_cdfae5f6-3b99-4da1-bd35-490ee548d1b8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_EntityAddressAddressLine2_cdfae5f6-3b99-4da1-bd35-490ee548d1b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_3b4bceb2-e2b3-4baa-a14e-c087880b70b7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_EntityAddressCityOrTown_3b4bceb2-e2b3-4baa-a14e-c087880b70b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry_a66187c4-2bbf-44e0-a0d3-92f1ccfe41c8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_EntityAddressCountry_a66187c4-2bbf-44e0-a0d3-92f1ccfe41c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_7b932fa4-06c5-4ae9-8101-3587af431c87" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_EntityAddressPostalZipCode_7b932fa4-06c5-4ae9-8101-3587af431c87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_961a5d79-b8d5-4e7b-ace7-e2fa58560739" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_CityAreaCode_961a5d79-b8d5-4e7b-ace7-e2fa58560739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_fa733fe1-fa07-4eb8-9935-7edf5a2c703a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_LocalPhoneNumber_fa733fe1-fa07-4eb8-9935-7edf5a2c703a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_ab955c16-cde2-4438-87f1-9907d9e70cfa" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_Security12bTitle_ab955c16-cde2-4438-87f1-9907d9e70cfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_b163d33c-f647-4c9f-a959-06b2b7790cbc" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_TradingSymbol_b163d33c-f647-4c9f-a959-06b2b7790cbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_c243d043-f976-451a-89f8-2cd4a4183756" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_SecurityExchangeName_c243d043-f976-451a-89f8-2cd4a4183756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_199f91ce-d253-4430-a8fd-64799ffb2027" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_199f91ce-d253-4430-a8fd-64799ffb2027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_09840b20-ef90-4314-b44b-323e61587445" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_EntityVoluntaryFilers_09840b20-ef90-4314-b44b-323e61587445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_bdb33488-9338-43ed-be68-f03f2cdaca9a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_EntityCurrentReportingStatus_bdb33488-9338-43ed-be68-f03f2cdaca9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_77e1aebb-be38-486c-ba54-b24c9610f2c7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_EntityInteractiveDataCurrent_77e1aebb-be38-486c-ba54-b24c9610f2c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_e05fc9bc-9f6a-42d5-8081-0c80b72f835d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_EntityFilerCategory_e05fc9bc-9f6a-42d5-8081-0c80b72f835d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_e752a450-4936-491d-95bd-3a7af027dfaa" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_EntitySmallBusiness_e752a450-4936-491d-95bd-3a7af027dfaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_0e65d92a-fe72-4dc2-b654-739bdce77a50" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_EntityEmergingGrowthCompany_0e65d92a-fe72-4dc2-b654-739bdce77a50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_e5e19497-d4fd-4c85-8a7a-52d54094186d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_IcfrAuditorAttestationFlag_e5e19497-d4fd-4c85-8a7a-52d54094186d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag_8253bb4d-c3f3-41d9-b579-7f076a45ccf3" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_DocumentFinStmtErrorCorrectionFlag_8253bb4d-c3f3-41d9-b579-7f076a45ccf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_c750f0bb-316d-4922-ba8f-62a883b09dde" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_EntityShellCompany_c750f0bb-316d-4922-ba8f-62a883b09dde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_7b0210e4-0062-464f-b5d6-1ea69f7e350c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_EntityPublicFloat_7b0210e4-0062-464f-b5d6-1ea69f7e350c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_9578415a-c5dc-4602-9a92-f5dfa9e47c44" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_9578415a-c5dc-4602-9a92-f5dfa9e47c44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_159fe702-8ec2-4e56-a23d-902ebe34d5eb" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_159fe702-8ec2-4e56-a23d-902ebe34d5eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_3ed9ae00-ce3d-472d-a163-2edd7c9c910f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_AmendmentFlag_3ed9ae00-ce3d-472d-a163-2edd7c9c910f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_0e3ddc84-eb2e-492e-8dd2-7a7e8f4df104" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_DocumentFiscalPeriodFocus_0e3ddc84-eb2e-492e-8dd2-7a7e8f4df104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_5ff11f66-054a-400c-845d-e4e1d623040d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_EntityCentralIndexKey_5ff11f66-054a-400c-845d-e4e1d623040d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_974e60f0-dfd8-48c2-a3f2-1bc09f0f5a17" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1bac9fe6-d1fb-498d-8806-ecf3771e4c02" xlink:to="loc_dei_DocumentFiscalYearFocus_974e60f0-dfd8-48c2-a3f2-1bc09f0f5a17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/AuditInformation" xlink:type="simple" xlink:href="zlab-20231231.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://zailab.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_zlab_AuditInformationAbstract_cd18c04a-196b-4bfa-b49a-ab3096879127" xlink:href="zlab-20231231.xsd#zlab_AuditInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_ecd2c91c-fb8a-43d0-a8dc-af2cadbf4196" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_AuditInformationAbstract_cd18c04a-196b-4bfa-b49a-ab3096879127" xlink:to="loc_dei_AuditorFirmId_ecd2c91c-fb8a-43d0-a8dc-af2cadbf4196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_98e8503e-e00d-4b6b-a25f-e6fb3618c3d1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_AuditInformationAbstract_cd18c04a-196b-4bfa-b49a-ab3096879127" xlink:to="loc_dei_AuditorName_98e8503e-e00d-4b6b-a25f-e6fb3618c3d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_811d087b-c576-4b04-95fd-7b271bf3ddec" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_AuditInformationAbstract_cd18c04a-196b-4bfa-b49a-ab3096879127" xlink:to="loc_dei_AuditorLocation_811d087b-c576-4b04-95fd-7b271bf3ddec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="zlab-20231231.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://zailab.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_24ec7d29-eed6-478e-ae4e-60331139e697" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_36a55958-bf4a-495a-9fef-99bc89e89b4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_24ec7d29-eed6-478e-ae4e-60331139e697" xlink:to="loc_us-gaap_AssetsAbstract_36a55958-bf4a-495a-9fef-99bc89e89b4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_67f09708-4961-4d89-8690-d02fe33d2569" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_36a55958-bf4a-495a-9fef-99bc89e89b4e" xlink:to="loc_us-gaap_AssetsCurrentAbstract_67f09708-4961-4d89-8690-d02fe33d2569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_92888182-29ef-4551-a65c-02360836cf00" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_67f09708-4961-4d89-8690-d02fe33d2569" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_92888182-29ef-4551-a65c-02360836cf00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_9c76c16b-f39e-4c30-9526-54e82da6e176" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_67f09708-4961-4d89-8690-d02fe33d2569" xlink:to="loc_us-gaap_ShortTermInvestments_9c76c16b-f39e-4c30-9526-54e82da6e176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_ac0dd110-f6a2-494b-8b95-5f81e13a4acb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_67f09708-4961-4d89-8690-d02fe33d2569" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_ac0dd110-f6a2-494b-8b95-5f81e13a4acb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLossCurrent_3b154c21-041a-4764-a2c1-522332746b59" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLossCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_67f09708-4961-4d89-8690-d02fe33d2569" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLossCurrent_3b154c21-041a-4764-a2c1-522332746b59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_ede7369c-49b1-4925-9bcc-188b840ce526" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_67f09708-4961-4d89-8690-d02fe33d2569" xlink:to="loc_us-gaap_InventoryNet_ede7369c-49b1-4925-9bcc-188b840ce526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_26108e1f-d1cf-43df-bc66-b602d23eb0f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_67f09708-4961-4d89-8690-d02fe33d2569" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_26108e1f-d1cf-43df-bc66-b602d23eb0f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_b1120db8-8fbf-41e8-9680-862e33ac0e90" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_67f09708-4961-4d89-8690-d02fe33d2569" xlink:to="loc_us-gaap_AssetsCurrent_b1120db8-8fbf-41e8-9680-862e33ac0e90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_1992df44-63da-4618-8acd-6c5db5808458" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_36a55958-bf4a-495a-9fef-99bc89e89b4e" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_1992df44-63da-4618-8acd-6c5db5808458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_a5ff6794-1416-401b-b29e-1bab2c18deba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_36a55958-bf4a-495a-9fef-99bc89e89b4e" xlink:to="loc_us-gaap_LongTermInvestments_a5ff6794-1416-401b-b29e-1bab2c18deba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_PrepaymentsForEquipment_36d493b2-190c-4030-ac93-c78aaad109ff" xlink:href="zlab-20231231.xsd#zlab_PrepaymentsForEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_36a55958-bf4a-495a-9fef-99bc89e89b4e" xlink:to="loc_zlab_PrepaymentsForEquipment_36d493b2-190c-4030-ac93-c78aaad109ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_011bf5e9-e6a9-4a00-a289-2d0860ef0462" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_36a55958-bf4a-495a-9fef-99bc89e89b4e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_011bf5e9-e6a9-4a00-a289-2d0860ef0462" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_562d3d91-df03-4cb6-bed1-f609fba602fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_36a55958-bf4a-495a-9fef-99bc89e89b4e" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_562d3d91-df03-4cb6-bed1-f609fba602fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_LandUseRightsNetNoncurrent_e001b2e5-1103-4d88-8f0e-30b0ede55943" xlink:href="zlab-20231231.xsd#zlab_LandUseRightsNetNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_36a55958-bf4a-495a-9fef-99bc89e89b4e" xlink:to="loc_zlab_LandUseRightsNetNoncurrent_e001b2e5-1103-4d88-8f0e-30b0ede55943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_f7010fc8-7e62-4dd3-a59a-f7c7057418ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_36a55958-bf4a-495a-9fef-99bc89e89b4e" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_f7010fc8-7e62-4dd3-a59a-f7c7057418ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsAssetsNoncurrent_0815086b-2825-4f61-8dbb-b46e11d5edc9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositsAssetsNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_36a55958-bf4a-495a-9fef-99bc89e89b4e" xlink:to="loc_us-gaap_DepositsAssetsNoncurrent_0815086b-2825-4f61-8dbb-b46e11d5edc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_b79b94d6-98cf-4dd0-974c-d04a90c84c47" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_36a55958-bf4a-495a-9fef-99bc89e89b4e" xlink:to="loc_us-gaap_Assets_b79b94d6-98cf-4dd0-974c-d04a90c84c47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7a0a551a-00af-4326-a35a-f54241f57d7e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_24ec7d29-eed6-478e-ae4e-60331139e697" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7a0a551a-00af-4326-a35a-f54241f57d7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_611d9429-a1ea-4783-9f33-3596d62260ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7a0a551a-00af-4326-a35a-f54241f57d7e" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_611d9429-a1ea-4783-9f33-3596d62260ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_37083461-b49f-4024-9d57-ea85bdc75fe7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_611d9429-a1ea-4783-9f33-3596d62260ce" xlink:to="loc_us-gaap_AccountsPayableCurrent_37083461-b49f-4024-9d57-ea85bdc75fe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_0b66f62f-f6bb-4edf-8635-7e4f18bd297c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_611d9429-a1ea-4783-9f33-3596d62260ce" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_0b66f62f-f6bb-4edf-8635-7e4f18bd297c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_e697ccdc-850e-459f-9abc-22dc45d23b2e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_611d9429-a1ea-4783-9f33-3596d62260ce" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_e697ccdc-850e-459f-9abc-22dc45d23b2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_5cd62a57-d37a-47b0-a1e8-39cce0926474" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_611d9429-a1ea-4783-9f33-3596d62260ce" xlink:to="loc_us-gaap_LiabilitiesCurrent_5cd62a57-d37a-47b0-a1e8-39cce0926474" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeNoncurrent_c4342ef7-06a0-4f89-a720-638d5ea98a84" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7a0a551a-00af-4326-a35a-f54241f57d7e" xlink:to="loc_us-gaap_DeferredIncomeNoncurrent_c4342ef7-06a0-4f89-a720-638d5ea98a84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_8b5da5c4-458f-4ad9-b7c9-de0515010a3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7a0a551a-00af-4326-a35a-f54241f57d7e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_8b5da5c4-458f-4ad9-b7c9-de0515010a3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_221c6e7b-fcad-47c5-9bcb-e8b072204414" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7a0a551a-00af-4326-a35a-f54241f57d7e" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_221c6e7b-fcad-47c5-9bcb-e8b072204414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_2dbd3c4f-f9ff-4adc-b7dc-7fc642c0993a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7a0a551a-00af-4326-a35a-f54241f57d7e" xlink:to="loc_us-gaap_Liabilities_2dbd3c4f-f9ff-4adc-b7dc-7fc642c0993a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_3fbbf6f7-987d-47c3-b918-87757c0ff657" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7a0a551a-00af-4326-a35a-f54241f57d7e" xlink:to="loc_us-gaap_CommitmentsAndContingencies_3fbbf6f7-987d-47c3-b918-87757c0ff657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_2bbd8768-b029-44e9-b435-ee7ab0e379e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7a0a551a-00af-4326-a35a-f54241f57d7e" xlink:to="loc_us-gaap_StockholdersEquityAbstract_2bbd8768-b029-44e9-b435-ee7ab0e379e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_233d37e0-3c23-45e3-9625-26b5d9833854" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2bbd8768-b029-44e9-b435-ee7ab0e379e7" xlink:to="loc_us-gaap_CommonStockValue_233d37e0-3c23-45e3-9625-26b5d9833854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_0c657a6a-9f43-4d6f-8ae8-9b0681ad8cfe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2bbd8768-b029-44e9-b435-ee7ab0e379e7" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_0c657a6a-9f43-4d6f-8ae8-9b0681ad8cfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_7578bce5-a4d9-4cd3-bec0-8b71e25242a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2bbd8768-b029-44e9-b435-ee7ab0e379e7" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_7578bce5-a4d9-4cd3-bec0-8b71e25242a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d570aea9-70af-4aef-b805-d21ffe2b3002" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2bbd8768-b029-44e9-b435-ee7ab0e379e7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d570aea9-70af-4aef-b805-d21ffe2b3002" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_5dda79f3-4cdf-497b-bcfa-58d9ba39d3c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2bbd8768-b029-44e9-b435-ee7ab0e379e7" xlink:to="loc_us-gaap_TreasuryStockCommonValue_5dda79f3-4cdf-497b-bcfa-58d9ba39d3c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_385cc20b-8558-4379-87b8-fd45c015b597" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2bbd8768-b029-44e9-b435-ee7ab0e379e7" xlink:to="loc_us-gaap_StockholdersEquity_385cc20b-8558-4379-87b8-fd45c015b597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_1d03a832-ff9a-4377-b9af-fb40ee20b7d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7a0a551a-00af-4326-a35a-f54241f57d7e" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_1d03a832-ff9a-4377-b9af-fb40ee20b7d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="zlab-20231231.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://zailab.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_bca23a69-698c-4537-823e-b60b1fdcd60f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_dc6d0f1a-ba9b-47e5-950d-4d18f37a8a36" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_bca23a69-698c-4537-823e-b60b1fdcd60f" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_dc6d0f1a-ba9b-47e5-950d-4d18f37a8a36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_d8e2417f-ed70-4c22-9dd2-78fb2ef6339e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_bca23a69-698c-4537-823e-b60b1fdcd60f" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_d8e2417f-ed70-4c22-9dd2-78fb2ef6339e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_efa9e4ea-e2bd-4511-bc41-b0f5c6d287e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_bca23a69-698c-4537-823e-b60b1fdcd60f" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_efa9e4ea-e2bd-4511-bc41-b0f5c6d287e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_44dcf24f-ce5d-4b5c-a39c-19ce23905d1d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_bca23a69-698c-4537-823e-b60b1fdcd60f" xlink:to="loc_us-gaap_CommonStockSharesIssued_44dcf24f-ce5d-4b5c-a39c-19ce23905d1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_cb40ad42-311a-4234-8510-4599fed7afa8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_bca23a69-698c-4537-823e-b60b1fdcd60f" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_cb40ad42-311a-4234-8510-4599fed7afa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_31bd7e71-97d4-467d-bfb7-630aec10b51b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_bca23a69-698c-4537-823e-b60b1fdcd60f" xlink:to="loc_us-gaap_TreasuryStockCommonShares_31bd7e71-97d4-467d-bfb7-630aec10b51b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="zlab-20231231.xsd#ConsolidatedStatementsofOperations"/>
  <link:presentationLink xlink:role="http://zailab.com/role/ConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_da28fcde-aaf8-40cf-907f-64a1a2180b51" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_0e8cf9d4-fad6-493a-87c4-a3f0bd2c0292" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_da28fcde-aaf8-40cf-907f-64a1a2180b51" xlink:to="loc_us-gaap_RevenuesAbstract_0e8cf9d4-fad6-493a-87c4-a3f0bd2c0292" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_55b54555-c75d-408c-aea1-18eccc93d521" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_0e8cf9d4-fad6-493a-87c4-a3f0bd2c0292" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_55b54555-c75d-408c-aea1-18eccc93d521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_26f147c1-fb5d-4c69-ae22-2aece4a3a199" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_0e8cf9d4-fad6-493a-87c4-a3f0bd2c0292" xlink:to="loc_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_26f147c1-fb5d-4c69-ae22-2aece4a3a199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_b9d027d6-a481-4ceb-81a7-e5f639ca3bfe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_0e8cf9d4-fad6-493a-87c4-a3f0bd2c0292" xlink:to="loc_us-gaap_Revenues_b9d027d6-a481-4ceb-81a7-e5f639ca3bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_cc54733e-42e2-4c1a-85ca-a6e1fde133ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_da28fcde-aaf8-40cf-907f-64a1a2180b51" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_cc54733e-42e2-4c1a-85ca-a6e1fde133ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_7b95acbd-7cf9-4bf1-b043-51c021521ea9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_cc54733e-42e2-4c1a-85ca-a6e1fde133ae" xlink:to="loc_us-gaap_CostOfRevenue_7b95acbd-7cf9-4bf1-b043-51c021521ea9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_04cecc0b-1a84-41d9-a7a3-267fdad56c56" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_cc54733e-42e2-4c1a-85ca-a6e1fde133ae" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_04cecc0b-1a84-41d9-a7a3-267fdad56c56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_f633d6e4-ff19-46af-a2b9-71d28d3b1000" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_cc54733e-42e2-4c1a-85ca-a6e1fde133ae" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_f633d6e4-ff19-46af-a2b9-71d28d3b1000" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfIntangibleAssets_c16f0c21-ecc5-4753-83aa-74878ec7ef71" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnDispositionOfIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_da28fcde-aaf8-40cf-907f-64a1a2180b51" xlink:to="loc_us-gaap_GainLossOnDispositionOfIntangibleAssets_c16f0c21-ecc5-4753-83aa-74878ec7ef71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_4d04570d-3932-4c25-b6e0-d30827a00437" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_da28fcde-aaf8-40cf-907f-64a1a2180b51" xlink:to="loc_us-gaap_OperatingIncomeLoss_4d04570d-3932-4c25-b6e0-d30827a00437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_c5619f05-0ade-41e7-9f5a-4c4f681ed18b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_da28fcde-aaf8-40cf-907f-64a1a2180b51" xlink:to="loc_us-gaap_InvestmentIncomeInterest_c5619f05-0ade-41e7-9f5a-4c4f681ed18b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_420e70d1-e5a8-4a4d-8d8b-a07c81791b75" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_da28fcde-aaf8-40cf-907f-64a1a2180b51" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_420e70d1-e5a8-4a4d-8d8b-a07c81791b75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_7d9a7cbe-0719-48d5-a173-5f286e14cbf7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_da28fcde-aaf8-40cf-907f-64a1a2180b51" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_7d9a7cbe-0719-48d5-a173-5f286e14cbf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_421fed1f-595e-4e7f-8983-44d239221b0f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_da28fcde-aaf8-40cf-907f-64a1a2180b51" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_421fed1f-595e-4e7f-8983-44d239221b0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_a12be813-86a8-4aba-aed6-aa1642df047e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_da28fcde-aaf8-40cf-907f-64a1a2180b51" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_a12be813-86a8-4aba-aed6-aa1642df047e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_739c3224-3e6b-43ad-b652-9df179a049db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_da28fcde-aaf8-40cf-907f-64a1a2180b51" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_739c3224-3e6b-43ad-b652-9df179a049db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_34c52ac6-ba03-4af9-82f7-f93f1ada8c52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_da28fcde-aaf8-40cf-907f-64a1a2180b51" xlink:to="loc_us-gaap_NetIncomeLoss_34c52ac6-ba03-4af9-82f7-f93f1ada8c52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_230afa41-36cc-4ac1-bcfc-5fefac3c9031" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_da28fcde-aaf8-40cf-907f-64a1a2180b51" xlink:to="loc_us-gaap_EarningsPerShareBasic_230afa41-36cc-4ac1-bcfc-5fefac3c9031" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_9ba68d20-7ba9-46d7-a746-278421e9bab7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_da28fcde-aaf8-40cf-907f-64a1a2180b51" xlink:to="loc_us-gaap_EarningsPerShareDiluted_9ba68d20-7ba9-46d7-a746-278421e9bab7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f2d0552c-debb-4284-90b1-99afb2e33e52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_da28fcde-aaf8-40cf-907f-64a1a2180b51" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f2d0552c-debb-4284-90b1-99afb2e33e52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_16619ca0-c79a-4818-8d51-5cb583a00892" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_da28fcde-aaf8-40cf-907f-64a1a2180b51" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_16619ca0-c79a-4818-8d51-5cb583a00892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="zlab-20231231.xsd#ConsolidatedStatementsofComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://zailab.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_6ccd9ee8-5a80-4cea-b59a-5f9059c3342e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_45775b97-05a0-4de7-8bda-176a080211f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_6ccd9ee8-5a80-4cea-b59a-5f9059c3342e" xlink:to="loc_us-gaap_NetIncomeLoss_45775b97-05a0-4de7-8bda-176a080211f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_951af7a2-c9e4-4b7c-b442-2687b8a0c9d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_6ccd9ee8-5a80-4cea-b59a-5f9059c3342e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_951af7a2-c9e4-4b7c-b442-2687b8a0c9d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_ecffd718-85db-4916-9572-c03554bb0e4b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_951af7a2-c9e4-4b7c-b442-2687b8a0c9d5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_ecffd718-85db-4916-9572-c03554bb0e4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_2ce740b9-3966-47f3-862b-e9c396c94548" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_6ccd9ee8-5a80-4cea-b59a-5f9059c3342e" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_2ce740b9-3966-47f3-862b-e9c396c94548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/ConsolidatedStatementsofComprehensiveLossParenthetical" xlink:type="simple" xlink:href="zlab-20231231.xsd#ConsolidatedStatementsofComprehensiveLossParenthetical"/>
  <link:presentationLink xlink:role="http://zailab.com/role/ConsolidatedStatementsofComprehensiveLossParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_65543f4e-97d2-4a49-b527-947ee258ef2e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_7983dfa1-57cc-4508-9508-d5dfe632bf02" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_65543f4e-97d2-4a49-b527-947ee258ef2e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_7983dfa1-57cc-4508-9508-d5dfe632bf02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/ConsolidatedStatementsofShareholdersEquity" xlink:type="simple" xlink:href="zlab-20231231.xsd#ConsolidatedStatementsofShareholdersEquity"/>
  <link:presentationLink xlink:role="http://zailab.com/role/ConsolidatedStatementsofShareholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_badaaf9f-bd43-4733-9f93-f9bb004ab8b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_db2c58f0-fc6e-4622-84b4-53f2624013d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_badaaf9f-bd43-4733-9f93-f9bb004ab8b1" xlink:to="loc_us-gaap_StatementTable_db2c58f0-fc6e-4622-84b4-53f2624013d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_4b2ab51f-ea0f-4c0f-acd5-7b7fe30c381d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_db2c58f0-fc6e-4622-84b4-53f2624013d4" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_4b2ab51f-ea0f-4c0f-acd5-7b7fe30c381d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_dc353353-8ed4-4cf2-8b4c-f39eae496402" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4b2ab51f-ea0f-4c0f-acd5-7b7fe30c381d" xlink:to="loc_us-gaap_EquityComponentDomain_dc353353-8ed4-4cf2-8b4c-f39eae496402" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_b88096a6-2ca1-4ec0-a279-334ec4c41423" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_dc353353-8ed4-4cf2-8b4c-f39eae496402" xlink:to="loc_us-gaap_CommonStockMember_b88096a6-2ca1-4ec0-a279-334ec4c41423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_52b6f298-4a35-43ff-8d66-09b4c466ad14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_dc353353-8ed4-4cf2-8b4c-f39eae496402" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_52b6f298-4a35-43ff-8d66-09b4c466ad14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_d4249b0e-bf4c-42a5-94c0-cebbcd88ab31" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_dc353353-8ed4-4cf2-8b4c-f39eae496402" xlink:to="loc_us-gaap_RetainedEarningsMember_d4249b0e-bf4c-42a5-94c0-cebbcd88ab31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ba53a0b7-99e0-4819-91f2-f74332908271" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_dc353353-8ed4-4cf2-8b4c-f39eae496402" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ba53a0b7-99e0-4819-91f2-f74332908271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_9531e5a6-6962-4444-b0fe-11f04c56f51c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_dc353353-8ed4-4cf2-8b4c-f39eae496402" xlink:to="loc_us-gaap_TreasuryStockCommonMember_9531e5a6-6962-4444-b0fe-11f04c56f51c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_16105645-56e7-43ad-9f4b-8cf775ce90b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_db2c58f0-fc6e-4622-84b4-53f2624013d4" xlink:to="loc_us-gaap_StatementLineItems_16105645-56e7-43ad-9f4b-8cf775ce90b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5594e4fe-e5d8-4c1f-a26a-e98cad24b2d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_16105645-56e7-43ad-9f4b-8cf775ce90b3" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5594e4fe-e5d8-4c1f-a26a-e98cad24b2d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_1e60903a-66c0-4bea-8b4f-3c452a3c8f39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5594e4fe-e5d8-4c1f-a26a-e98cad24b2d9" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_1e60903a-66c0-4bea-8b4f-3c452a3c8f39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_766eb4b6-ae64-496c-8d08-2331dc641ae7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5594e4fe-e5d8-4c1f-a26a-e98cad24b2d9" xlink:to="loc_us-gaap_StockholdersEquity_766eb4b6-ae64-496c-8d08-2331dc641ae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_06db7e01-6452-44ad-9644-1d14fc12ac23" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5594e4fe-e5d8-4c1f-a26a-e98cad24b2d9" xlink:to="loc_us-gaap_TreasuryStockCommonShares_06db7e01-6452-44ad-9644-1d14fc12ac23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_9099edca-cf83-4ed3-b472-c4fc812aa501" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5594e4fe-e5d8-4c1f-a26a-e98cad24b2d9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_9099edca-cf83-4ed3-b472-c4fc812aa501" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_0c7aba5b-d64d-4194-abcb-517ea6e35392" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5594e4fe-e5d8-4c1f-a26a-e98cad24b2d9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_0c7aba5b-d64d-4194-abcb-517ea6e35392" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_9dc492bf-1f14-4ead-be67-c0970e46cf88" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5594e4fe-e5d8-4c1f-a26a-e98cad24b2d9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_9dc492bf-1f14-4ead-be67-c0970e46cf88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_fcf24750-d1b4-4900-8adc-572b445aca3a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5594e4fe-e5d8-4c1f-a26a-e98cad24b2d9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_fcf24750-d1b4-4900-8adc-572b445aca3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_118fd97d-0f4a-4a24-8b00-130fcd2f27d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5594e4fe-e5d8-4c1f-a26a-e98cad24b2d9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_118fd97d-0f4a-4a24-8b00-130fcd2f27d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_7bef9555-8236-4900-8af9-cf36eac64922" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5594e4fe-e5d8-4c1f-a26a-e98cad24b2d9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_7bef9555-8236-4900-8af9-cf36eac64922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesOther_168f0833-b8cf-4264-9ff7-159cc5fb4ba5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5594e4fe-e5d8-4c1f-a26a-e98cad24b2d9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesOther_168f0833-b8cf-4264-9ff7-159cc5fb4ba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueOther_8400d055-aaf5-483f-9185-896a9f7c3138" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5594e4fe-e5d8-4c1f-a26a-e98cad24b2d9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueOther_8400d055-aaf5-483f-9185-896a9f7c3138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_IssuanceCostAdjustment_fb2d8f8c-9bc1-4b4c-925c-e5a89f476321" xlink:href="zlab-20231231.xsd#zlab_IssuanceCostAdjustment"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5594e4fe-e5d8-4c1f-a26a-e98cad24b2d9" xlink:to="loc_zlab_IssuanceCostAdjustment_fb2d8f8c-9bc1-4b4c-925c-e5a89f476321" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_69098728-8f01-4d09-a047-d9e818205edc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5594e4fe-e5d8-4c1f-a26a-e98cad24b2d9" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_69098728-8f01-4d09-a047-d9e818205edc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_bc8e7022-4658-42bf-b5f7-7ec38ca2ee0c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5594e4fe-e5d8-4c1f-a26a-e98cad24b2d9" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_bc8e7022-4658-42bf-b5f7-7ec38ca2ee0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_767c4e44-9b3b-4485-9de1-2e242098e3c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5594e4fe-e5d8-4c1f-a26a-e98cad24b2d9" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_767c4e44-9b3b-4485-9de1-2e242098e3c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3e4781cc-b5b0-47d2-a12f-d3ee2a81d726" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5594e4fe-e5d8-4c1f-a26a-e98cad24b2d9" xlink:to="loc_us-gaap_NetIncomeLoss_3e4781cc-b5b0-47d2-a12f-d3ee2a81d726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_23ce4ba2-f962-4313-bb46-88818dafa145" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5594e4fe-e5d8-4c1f-a26a-e98cad24b2d9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_23ce4ba2-f962-4313-bb46-88818dafa145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_ddfd52b9-2f1d-494c-8469-9c06388c8962" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5594e4fe-e5d8-4c1f-a26a-e98cad24b2d9" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_ddfd52b9-2f1d-494c-8469-9c06388c8962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_55eb7387-8958-4d73-b77f-86aaf0011908" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5594e4fe-e5d8-4c1f-a26a-e98cad24b2d9" xlink:to="loc_us-gaap_StockholdersEquity_55eb7387-8958-4d73-b77f-86aaf0011908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_88bb07b6-2740-4e28-8f8d-418a2d05e69e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5594e4fe-e5d8-4c1f-a26a-e98cad24b2d9" xlink:to="loc_us-gaap_TreasuryStockCommonShares_88bb07b6-2740-4e28-8f8d-418a2d05e69e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/ConsolidatedStatementsofShareholdersEquityParenthetical" xlink:type="simple" xlink:href="zlab-20231231.xsd#ConsolidatedStatementsofShareholdersEquityParenthetical"/>
  <link:presentationLink xlink:role="http://zailab.com/role/ConsolidatedStatementsofShareholdersEquityParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_6b0fa013-aff8-4856-953f-2ef2f1f868d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_e28e3f38-2a50-4c9a-aa82-859b5b0b33a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_6b0fa013-aff8-4856-953f-2ef2f1f868d2" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_e28e3f38-2a50-4c9a-aa82-859b5b0b33a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="zlab-20231231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://zailab.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_78e0c21c-59b3-4053-ad6b-70a6e40a2754" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_97ad4244-da9a-40ca-a55b-c3ca4791cc2f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_78e0c21c-59b3-4053-ad6b-70a6e40a2754" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_97ad4244-da9a-40ca-a55b-c3ca4791cc2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_73195374-384f-44a1-8531-89e545fa1545" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_97ad4244-da9a-40ca-a55b-c3ca4791cc2f" xlink:to="loc_us-gaap_NetIncomeLoss_73195374-384f-44a1-8531-89e545fa1545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7bbf5806-8c35-456d-b6a1-829ad3f7b340" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_97ad4244-da9a-40ca-a55b-c3ca4791cc2f" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7bbf5806-8c35-456d-b6a1-829ad3f7b340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_7d235510-3cbf-4472-8987-78ebd8993db4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7bbf5806-8c35-456d-b6a1-829ad3f7b340" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_7d235510-3cbf-4472-8987-78ebd8993db4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_4be1be16-54b8-441a-9d58-148968228962" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWriteDown"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7bbf5806-8c35-456d-b6a1-829ad3f7b340" xlink:to="loc_us-gaap_InventoryWriteDown_4be1be16-54b8-441a-9d58-148968228962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_120d3da2-63d9-4a17-a8c9-b4e18f5eb72b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7bbf5806-8c35-456d-b6a1-829ad3f7b340" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_120d3da2-63d9-4a17-a8c9-b4e18f5eb72b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TangibleAssetImpairmentCharges_cffa6621-e247-45bf-b801-fe9a0df55931" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TangibleAssetImpairmentCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7bbf5806-8c35-456d-b6a1-829ad3f7b340" xlink:to="loc_us-gaap_TangibleAssetImpairmentCharges_cffa6621-e247-45bf-b801-fe9a0df55931" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_AmortizationOfDeferredIncome_5a1410f4-de08-4b8c-a5c1-0a295b57946c" xlink:href="zlab-20231231.xsd#zlab_AmortizationOfDeferredIncome"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7bbf5806-8c35-456d-b6a1-829ad3f7b340" xlink:to="loc_zlab_AmortizationOfDeferredIncome_5a1410f4-de08-4b8c-a5c1-0a295b57946c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_80df6f43-2f8e-4b39-bbd2-23666f1848dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7bbf5806-8c35-456d-b6a1-829ad3f7b340" xlink:to="loc_us-gaap_ShareBasedCompensation_80df6f43-2f8e-4b39-bbd2-23666f1848dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_NoncashResearchAndDevelopmentExpenses_7215db4d-6fbd-4aa3-9703-97560a829448" xlink:href="zlab-20231231.xsd#zlab_NoncashResearchAndDevelopmentExpenses"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7bbf5806-8c35-456d-b6a1-829ad3f7b340" xlink:to="loc_zlab_NoncashResearchAndDevelopmentExpenses_7215db4d-6fbd-4aa3-9703-97560a829448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_87f46491-3f80-49b5-bba6-57ca12cc59cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7bbf5806-8c35-456d-b6a1-829ad3f7b340" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_87f46491-3f80-49b5-bba6-57ca12cc59cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_c673c76a-b7c7-43a2-a96c-701e2f1e250d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7bbf5806-8c35-456d-b6a1-829ad3f7b340" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_c673c76a-b7c7-43a2-a96c-701e2f1e250d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_8376d3d7-2844-4681-8bc4-54fa48df6837" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7bbf5806-8c35-456d-b6a1-829ad3f7b340" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_8376d3d7-2844-4681-8bc4-54fa48df6837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_GainLossOnDisposalOfLandUseRights_8d8a3aa6-11db-4ca0-831a-4a30bd078d36" xlink:href="zlab-20231231.xsd#zlab_GainLossOnDisposalOfLandUseRights"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7bbf5806-8c35-456d-b6a1-829ad3f7b340" xlink:to="loc_zlab_GainLossOnDisposalOfLandUseRights_8d8a3aa6-11db-4ca0-831a-4a30bd078d36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_NonCashLeaseExpenses_5d77f75c-482a-4abe-82f3-5dbe6d327009" xlink:href="zlab-20231231.xsd#zlab_NonCashLeaseExpenses"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7bbf5806-8c35-456d-b6a1-829ad3f7b340" xlink:to="loc_zlab_NonCashLeaseExpenses_5d77f75c-482a-4abe-82f3-5dbe6d327009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfIntangibleAssets_26c2fc32-459c-4244-a3ee-454fc41656fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnDispositionOfIntangibleAssets"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7bbf5806-8c35-456d-b6a1-829ad3f7b340" xlink:to="loc_us-gaap_GainLossOnDispositionOfIntangibleAssets_26c2fc32-459c-4244-a3ee-454fc41656fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_c35ac59e-a784-4f51-a8fa-6e6d03b2040c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7bbf5806-8c35-456d-b6a1-829ad3f7b340" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_c35ac59e-a784-4f51-a8fa-6e6d03b2040c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_69cb7492-4559-4d4b-a0dd-f4d7e7e684fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7bbf5806-8c35-456d-b6a1-829ad3f7b340" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_69cb7492-4559-4d4b-a0dd-f4d7e7e684fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_71aed3c6-92ff-4a65-b0c5-f1628d1d616d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_69cb7492-4559-4d4b-a0dd-f4d7e7e684fe" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_71aed3c6-92ff-4a65-b0c5-f1628d1d616d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInNotesReceivableCurrent_bc9a0a75-aac7-49b6-8eb9-7ca3c894f6a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInNotesReceivableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_69cb7492-4559-4d4b-a0dd-f4d7e7e684fe" xlink:to="loc_us-gaap_IncreaseDecreaseInNotesReceivableCurrent_bc9a0a75-aac7-49b6-8eb9-7ca3c894f6a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_96909393-a805-4c9e-b9f3-778300d0fd3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_69cb7492-4559-4d4b-a0dd-f4d7e7e684fe" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_96909393-a805-4c9e-b9f3-778300d0fd3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_fe416bce-bb6c-4eb6-b456-f86a97cff0dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_69cb7492-4559-4d4b-a0dd-f4d7e7e684fe" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_fe416bce-bb6c-4eb6-b456-f86a97cff0dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_IncreaseDecreaseInLongTermDeposits_c6eb655f-5e95-46bd-8516-b9bdafd16e92" xlink:href="zlab-20231231.xsd#zlab_IncreaseDecreaseInLongTermDeposits"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_69cb7492-4559-4d4b-a0dd-f4d7e7e684fe" xlink:to="loc_zlab_IncreaseDecreaseInLongTermDeposits_c6eb655f-5e95-46bd-8516-b9bdafd16e92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_IncreaseDecreaseInValueAddedTaxesReceivable_6914ed0f-1cc3-457d-b3e5-a5c9b2111e24" xlink:href="zlab-20231231.xsd#zlab_IncreaseDecreaseInValueAddedTaxesReceivable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_69cb7492-4559-4d4b-a0dd-f4d7e7e684fe" xlink:to="loc_zlab_IncreaseDecreaseInValueAddedTaxesReceivable_6914ed0f-1cc3-457d-b3e5-a5c9b2111e24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_c78e3350-90cb-4aef-ab1b-65841017c197" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_69cb7492-4559-4d4b-a0dd-f4d7e7e684fe" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_c78e3350-90cb-4aef-ab1b-65841017c197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_2f024316-d033-4274-9415-681d95b67577" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_69cb7492-4559-4d4b-a0dd-f4d7e7e684fe" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_2f024316-d033-4274-9415-681d95b67577" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_IncreaseDecreaseInOperatingLeaseLiabilities_392b28f6-2034-442e-a743-f8bc339066ca" xlink:href="zlab-20231231.xsd#zlab_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_69cb7492-4559-4d4b-a0dd-f4d7e7e684fe" xlink:to="loc_zlab_IncreaseDecreaseInOperatingLeaseLiabilities_392b28f6-2034-442e-a743-f8bc339066ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_56c264b7-12ec-442a-96db-3396fb5f584f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_69cb7492-4559-4d4b-a0dd-f4d7e7e684fe" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_56c264b7-12ec-442a-96db-3396fb5f584f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_5c41fe41-9b51-42a4-8aa9-31a68a7d1e80" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_69cb7492-4559-4d4b-a0dd-f4d7e7e684fe" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_5c41fe41-9b51-42a4-8aa9-31a68a7d1e80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_75f8af7a-f326-4101-b500-f8afe18d6cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_97ad4244-da9a-40ca-a55b-c3ca4791cc2f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_75f8af7a-f326-4101-b500-f8afe18d6cbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4ed3bd21-9a6f-41dd-a725-991062de6401" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_78e0c21c-59b3-4053-ad6b-70a6e40a2754" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4ed3bd21-9a6f-41dd-a725-991062de6401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments_2eb48485-73b7-4a62-b7f6-3deda7396407" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4ed3bd21-9a6f-41dd-a725-991062de6401" xlink:to="loc_us-gaap_PaymentsToAcquireShortTermInvestments_2eb48485-73b7-4a62-b7f6-3deda7396407" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_dd2e3536-393b-4e6a-b98a-3d35712fb597" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4ed3bd21-9a6f-41dd-a725-991062de6401" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_dd2e3536-393b-4e6a-b98a-3d35712fb597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_40d81a3a-99d4-4044-b932-ac8e9d45b0cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4ed3bd21-9a6f-41dd-a725-991062de6401" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_40d81a3a-99d4-4044-b932-ac8e9d45b0cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_3b0f56cd-7f96-4103-93b7-1090e62c630a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4ed3bd21-9a6f-41dd-a725-991062de6401" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_3b0f56cd-7f96-4103-93b7-1090e62c630a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_53b8a87e-6c41-4049-86c4-dbe3f6ba6f4f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4ed3bd21-9a6f-41dd-a725-991062de6401" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_53b8a87e-6c41-4049-86c4-dbe3f6ba6f4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_6451ce16-ad71-40f5-af59-367e18fe1692" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4ed3bd21-9a6f-41dd-a725-991062de6401" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_6451ce16-ad71-40f5-af59-367e18fe1692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfIntangibleAssets_d5d498ad-e40e-4718-b507-72afafe718e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfIntangibleAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4ed3bd21-9a6f-41dd-a725-991062de6401" xlink:to="loc_us-gaap_ProceedsFromSaleOfIntangibleAssets_d5d498ad-e40e-4718-b507-72afafe718e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ProceedsFromDisposalOfLandUseRights_27ad3bbb-978c-44cf-a1ae-381f09b66b82" xlink:href="zlab-20231231.xsd#zlab_ProceedsFromDisposalOfLandUseRights"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4ed3bd21-9a6f-41dd-a725-991062de6401" xlink:to="loc_zlab_ProceedsFromDisposalOfLandUseRights_27ad3bbb-978c-44cf-a1ae-381f09b66b82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e1b5aec2-3b1c-4d9c-b36f-fb0e5f9c7056" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4ed3bd21-9a6f-41dd-a725-991062de6401" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e1b5aec2-3b1c-4d9c-b36f-fb0e5f9c7056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8f60205-94a6-4419-8126-163eea1551fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_78e0c21c-59b3-4053-ad6b-70a6e40a2754" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8f60205-94a6-4419-8126-163eea1551fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_16e1d93f-13ae-4ab9-842b-9c9af74c2034" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8f60205-94a6-4419-8126-163eea1551fa" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_16e1d93f-13ae-4ab9-842b-9c9af74c2034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_eccb1ba9-2df2-4fc9-beac-30d4ec396f4d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8f60205-94a6-4419-8126-163eea1551fa" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_eccb1ba9-2df2-4fc9-beac-30d4ec396f4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_4d6ebd08-3ef9-46c0-9d29-a0d73e3984e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8f60205-94a6-4419-8126-163eea1551fa" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_4d6ebd08-3ef9-46c0-9d29-a0d73e3984e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_72648240-282a-4e84-a323-667a2adf1cc7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8f60205-94a6-4419-8126-163eea1551fa" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_72648240-282a-4e84-a323-667a2adf1cc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_025b6dde-2e33-4082-9282-9c4c5ae45c79" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8f60205-94a6-4419-8126-163eea1551fa" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_025b6dde-2e33-4082-9282-9c4c5ae45c79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_64be21aa-f1e6-4972-84cc-f4c70ed49194" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_78e0c21c-59b3-4053-ad6b-70a6e40a2754" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_64be21aa-f1e6-4972-84cc-f4c70ed49194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c708e0a9-5730-46fa-b9db-261e06b1f56c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_78e0c21c-59b3-4053-ad6b-70a6e40a2754" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c708e0a9-5730-46fa-b9db-261e06b1f56c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_4b1f199b-2a8a-4f65-8f79-34cfbb9318da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_78e0c21c-59b3-4053-ad6b-70a6e40a2754" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_4b1f199b-2a8a-4f65-8f79-34cfbb9318da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_ab923972-0cfc-48a4-a38d-50fb1b69c157" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_78e0c21c-59b3-4053-ad6b-70a6e40a2754" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_ab923972-0cfc-48a4-a38d-50fb1b69c157" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_cc2e666d-41f1-44a7-be6c-3720414281a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_78e0c21c-59b3-4053-ad6b-70a6e40a2754" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_cc2e666d-41f1-44a7-be6c-3720414281a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_03359f9a-9402-4046-9df3-29aced17c6db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_cc2e666d-41f1-44a7-be6c-3720414281a3" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_03359f9a-9402-4046-9df3-29aced17c6db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_NonCashPayablesForIntangibleAssets_72ed3611-3e42-486f-b82c-e68e5af71052" xlink:href="zlab-20231231.xsd#zlab_NonCashPayablesForIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_cc2e666d-41f1-44a7-be6c-3720414281a3" xlink:to="loc_zlab_NonCashPayablesForIntangibleAssets_72ed3611-3e42-486f-b82c-e68e5af71052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_NonCashPayablesForTreasuryStock_42e72a6e-7483-4dd9-b0e2-be232f4c046a" xlink:href="zlab-20231231.xsd#zlab_NonCashPayablesForTreasuryStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_cc2e666d-41f1-44a7-be6c-3720414281a3" xlink:to="loc_zlab_NonCashPayablesForTreasuryStock_42e72a6e-7483-4dd9-b0e2-be232f4c046a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_c69d862c-d21e-4683-b969-b097f91c44c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_cc2e666d-41f1-44a7-be6c-3720414281a3" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_c69d862c-d21e-4683-b969-b097f91c44c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ReceivableRecognizedForDisposalOfPropertyAndEquipment_65722163-2d31-440f-b60b-478d0e8a0d55" xlink:href="zlab-20231231.xsd#zlab_ReceivableRecognizedForDisposalOfPropertyAndEquipment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_cc2e666d-41f1-44a7-be6c-3720414281a3" xlink:to="loc_zlab_ReceivableRecognizedForDisposalOfPropertyAndEquipment_65722163-2d31-440f-b60b-478d0e8a0d55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_2108eb14-8722-4bd1-b2fb-b3a26889bd8a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_78e0c21c-59b3-4053-ad6b-70a6e40a2754" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_2108eb14-8722-4bd1-b2fb-b3a26889bd8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ebacca4a-842d-4673-8aa3-e5567e90e5b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_2108eb14-8722-4bd1-b2fb-b3a26889bd8a" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ebacca4a-842d-4673-8aa3-e5567e90e5b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_9c5a2bec-e94e-45b2-84f9-30e0a70b4d3b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_2108eb14-8722-4bd1-b2fb-b3a26889bd8a" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_9c5a2bec-e94e-45b2-84f9-30e0a70b4d3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_e0d0be57-5d37-47a4-b011-13f947bfc72a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_2108eb14-8722-4bd1-b2fb-b3a26889bd8a" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_e0d0be57-5d37-47a4-b011-13f947bfc72a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/OrganizationandPrincipalActivities" xlink:type="simple" xlink:href="zlab-20231231.xsd#OrganizationandPrincipalActivities"/>
  <link:presentationLink xlink:role="http://zailab.com/role/OrganizationandPrincipalActivities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8dc993ae-0c66-4fcd-a147-1e550f9a40c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_e721f4d9-606a-4e48-b164-ef64f5139a6a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8dc993ae-0c66-4fcd-a147-1e550f9a40c2" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_e721f4d9-606a-4e48-b164-ef64f5139a6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="zlab-20231231.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://zailab.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_8fdaa402-fb6d-4381-80c8-b1c3ac86e421" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_4e7f1f5f-beae-4788-b591-8dbf0b0a79c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8fdaa402-fb6d-4381-80c8-b1c3ac86e421" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_4e7f1f5f-beae-4788-b591-8dbf0b0a79c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/CashandCashEquivalents" xlink:type="simple" xlink:href="zlab-20231231.xsd#CashandCashEquivalents"/>
  <link:presentationLink xlink:role="http://zailab.com/role/CashandCashEquivalents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_17807bd7-76ca-4a92-9511-0253439bf3a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsDisclosureTextBlock_f1782b73-c206-4e1d-9124-a17bca0a5f6c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_17807bd7-76ca-4a92-9511-0253439bf3a1" xlink:to="loc_us-gaap_CashAndCashEquivalentsDisclosureTextBlock_f1782b73-c206-4e1d-9124-a17bca0a5f6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/RestrictedCashNonCurrent" xlink:type="simple" xlink:href="zlab-20231231.xsd#RestrictedCashNonCurrent"/>
  <link:presentationLink xlink:role="http://zailab.com/role/RestrictedCashNonCurrent" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAbstract_713d73e6-7073-4501-95c7-3842001b0971" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_RestrictedCashNonCurrentTextBlock_d08fe63c-fa51-49a0-b9ae-737f89791d64" xlink:href="zlab-20231231.xsd#zlab_RestrictedCashNonCurrentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAbstract_713d73e6-7073-4501-95c7-3842001b0971" xlink:to="loc_zlab_RestrictedCashNonCurrentTextBlock_d08fe63c-fa51-49a0-b9ae-737f89791d64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/ShortTermInvestments" xlink:type="simple" xlink:href="zlab-20231231.xsd#ShortTermInvestments"/>
  <link:presentationLink xlink:role="http://zailab.com/role/ShortTermInvestments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsAbstract_cac88b25-5401-4bb5-a5d6-d397eac17f4d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ShortTermInvestmentTextBlock_5904289e-ce06-4760-84be-f6aac29e2532" xlink:href="zlab-20231231.xsd#zlab_ShortTermInvestmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermInvestmentsAbstract_cac88b25-5401-4bb5-a5d6-d397eac17f4d" xlink:to="loc_zlab_ShortTermInvestmentTextBlock_5904289e-ce06-4760-84be-f6aac29e2532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/InventoriesNet" xlink:type="simple" xlink:href="zlab-20231231.xsd#InventoriesNet"/>
  <link:presentationLink xlink:role="http://zailab.com/role/InventoriesNet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_41b62e26-b0b1-4514-9984-6899e556994e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_7b6965ed-e88e-4749-9873-f35c5c548be3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_41b62e26-b0b1-4514-9984-6899e556994e" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_7b6965ed-e88e-4749-9873-f35c5c548be3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/LongTermInvestments" xlink:type="simple" xlink:href="zlab-20231231.xsd#LongTermInvestments"/>
  <link:presentationLink xlink:role="http://zailab.com/role/LongTermInvestments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_96a860eb-18dc-4214-b5a5-cc05d6f0292a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTextBlock_d8ce86c3-8d14-4c8d-859a-2bb8d824449a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_96a860eb-18dc-4214-b5a5-cc05d6f0292a" xlink:to="loc_us-gaap_InvestmentTextBlock_d8ce86c3-8d14-4c8d-859a-2bb8d824449a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/PropertyandEquipmentNet" xlink:type="simple" xlink:href="zlab-20231231.xsd#PropertyandEquipmentNet"/>
  <link:presentationLink xlink:role="http://zailab.com/role/PropertyandEquipmentNet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_e822d9de-e814-4e81-9a5c-b4b507d750bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_0e7fbc1d-865f-4c40-a2bb-9ad50792a67e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_e822d9de-e814-4e81-9a5c-b4b507d750bf" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_0e7fbc1d-865f-4c40-a2bb-9ad50792a67e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/Leases" xlink:type="simple" xlink:href="zlab-20231231.xsd#Leases"/>
  <link:presentationLink xlink:role="http://zailab.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_bb54859b-cec1-4477-84b4-9f697faef6f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_3b067ed5-fbeb-4b36-8b0a-0a009729bf78" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_bb54859b-cec1-4477-84b4-9f697faef6f5" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_3b067ed5-fbeb-4b36-8b0a-0a009729bf78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/Revenue" xlink:type="simple" xlink:href="zlab-20231231.xsd#Revenue"/>
  <link:presentationLink xlink:role="http://zailab.com/role/Revenue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_6962cff2-cfe0-49f9-8f01-3aadb9d0db43" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_fc4f44e8-8003-45db-8ac8-4e7863721d34" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_6962cff2-cfe0-49f9-8f01-3aadb9d0db43" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_fc4f44e8-8003-45db-8ac8-4e7863721d34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/IncomeTax" xlink:type="simple" xlink:href="zlab-20231231.xsd#IncomeTax"/>
  <link:presentationLink xlink:role="http://zailab.com/role/IncomeTax" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_9dd8b18b-48a0-46b3-b788-cbdc065ba815" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_89b72d3f-b347-44b0-945e-c2e0d4051569" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9dd8b18b-48a0-46b3-b788-cbdc065ba815" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_89b72d3f-b347-44b0-945e-c2e0d4051569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/OtherCurrentLiabilities" xlink:type="simple" xlink:href="zlab-20231231.xsd#OtherCurrentLiabilities"/>
  <link:presentationLink xlink:role="http://zailab.com/role/OtherCurrentLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_402e08b3-b7c3-4d6f-9dc2-00472f86eda6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_OtherCurrentLiabilitiesDisclosureTextBlock_73ba4cc0-69e7-4936-b8bf-7511fb4dbaef" xlink:href="zlab-20231231.xsd#zlab_OtherCurrentLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_402e08b3-b7c3-4d6f-9dc2-00472f86eda6" xlink:to="loc_zlab_OtherCurrentLiabilitiesDisclosureTextBlock_73ba4cc0-69e7-4936-b8bf-7511fb4dbaef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/LossPerShare" xlink:type="simple" xlink:href="zlab-20231231.xsd#LossPerShare"/>
  <link:presentationLink xlink:role="http://zailab.com/role/LossPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_71af9ebe-f653-419f-9fe1-e42a9492457d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_7687725a-b3de-4507-98ba-173ff7215b07" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_71af9ebe-f653-419f-9fe1-e42a9492457d" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_7687725a-b3de-4507-98ba-173ff7215b07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/RelatedPartyTransactions" xlink:type="simple" xlink:href="zlab-20231231.xsd#RelatedPartyTransactions"/>
  <link:presentationLink xlink:role="http://zailab.com/role/RelatedPartyTransactions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_b75d86c1-ef28-47e0-997a-c55d3c957cd6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_6ce79f34-fcc0-4445-bee6-67c900bfb88a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_b75d86c1-ef28-47e0-997a-c55d3c957cd6" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_6ce79f34-fcc0-4445-bee6-67c900bfb88a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/ShareBasedCompensation" xlink:type="simple" xlink:href="zlab-20231231.xsd#ShareBasedCompensation"/>
  <link:presentationLink xlink:role="http://zailab.com/role/ShareBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c6f6d67e-57c9-4357-8303-7c990bc7abad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_431b560f-39a7-41a0-a1ab-6a2f42f20b43" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c6f6d67e-57c9-4357-8303-7c990bc7abad" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_431b560f-39a7-41a0-a1ab-6a2f42f20b43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/LicenseandCollaborationAgreements" xlink:type="simple" xlink:href="zlab-20231231.xsd#LicenseandCollaborationAgreements"/>
  <link:presentationLink xlink:role="http://zailab.com/role/LicenseandCollaborationAgreements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_da1b473c-4c2c-4131-9335-087a120a4b1d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_LicensesAndCollaborativeArrangementDisclosureTextBlock_3565f20c-7c18-4a27-932d-31ccd1f04bf4" xlink:href="zlab-20231231.xsd#zlab_LicensesAndCollaborativeArrangementDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_da1b473c-4c2c-4131-9335-087a120a4b1d" xlink:to="loc_zlab_LicensesAndCollaborativeArrangementDisclosureTextBlock_3565f20c-7c18-4a27-932d-31ccd1f04bf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/OtherIncomeExpensesNet" xlink:type="simple" xlink:href="zlab-20231231.xsd#OtherIncomeExpensesNet"/>
  <link:presentationLink xlink:role="http://zailab.com/role/OtherIncomeExpensesNet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_0d2f3753-8f1c-45a7-adee-3d4e67ffdcd1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock_ab203a1e-f5bb-4a43-8aea-6be8ed156d82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_0d2f3753-8f1c-45a7-adee-3d4e67ffdcd1" xlink:to="loc_us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock_ab203a1e-f5bb-4a43-8aea-6be8ed156d82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/RestrictedNetAssets" xlink:type="simple" xlink:href="zlab-20231231.xsd#RestrictedNetAssets"/>
  <link:presentationLink xlink:role="http://zailab.com/role/RestrictedNetAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_zlab_RestrictedNetAssetsAbstract_4df8a407-cfdc-4648-a06f-55ff89bf80ca" xlink:href="zlab-20231231.xsd#zlab_RestrictedNetAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedAssetsDisclosureTextBlock_cf3a6498-7ca0-4888-ae56-2ec9fde2b5c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_RestrictedNetAssetsAbstract_4df8a407-cfdc-4648-a06f-55ff89bf80ca" xlink:to="loc_us-gaap_RestrictedAssetsDisclosureTextBlock_cf3a6498-7ca0-4888-ae56-2ec9fde2b5c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/EmployeeDefinedContributionPlans" xlink:type="simple" xlink:href="zlab-20231231.xsd#EmployeeDefinedContributionPlans"/>
  <link:presentationLink xlink:role="http://zailab.com/role/EmployeeDefinedContributionPlans" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ccdcdf38-af28-4f47-b783-c985e36fe7a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock_98880707-1bd0-4c65-a8bb-352c9a03674e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ccdcdf38-af28-4f47-b783-c985e36fe7a3" xlink:to="loc_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock_98880707-1bd0-4c65-a8bb-352c9a03674e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="zlab-20231231.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://zailab.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c4b83053-cd6c-4def-8bd1-99aa1eb4f5ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_adaa9c6d-3759-483b-93e7-2485f8a4dca3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c4b83053-cd6c-4def-8bd1-99aa1eb4f5ee" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_adaa9c6d-3759-483b-93e7-2485f8a4dca3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/SubsequentEvents" xlink:type="simple" xlink:href="zlab-20231231.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://zailab.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_4c1603a8-92d1-4e78-90c0-0cc4b8319faf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_42ca25bc-14ec-4e12-a8f9-21fc69cc4481" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_4c1603a8-92d1-4e78-90c0-0cc4b8319faf" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_42ca25bc-14ec-4e12-a8f9-21fc69cc4481" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrant" xlink:type="simple" xlink:href="zlab-20231231.xsd#ScheduleICondensedFinancialInformationofRegistrant"/>
  <link:presentationLink xlink:role="http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrant" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_efdabd3e-b18e-4039-b479-f3e19736e9a3" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock_872a647d-bdf7-4670-8c1a-9328e7b270bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_efdabd3e-b18e-4039-b479-f3e19736e9a3" xlink:to="loc_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock_872a647d-bdf7-4670-8c1a-9328e7b270bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="zlab-20231231.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://zailab.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_ec2634c1-d152-4787-b751-2dc3c54d9165" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_af0fe097-18ce-490f-a370-92102afa4a64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ec2634c1-d152-4787-b751-2dc3c54d9165" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_af0fe097-18ce-490f-a370-92102afa4a64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_5ce3af7d-4939-4976-a8b2-5d407d6669c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ec2634c1-d152-4787-b751-2dc3c54d9165" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_5ce3af7d-4939-4976-a8b2-5d407d6669c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_5458bdc4-8e09-4fda-b614-e3f719d99749" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ec2634c1-d152-4787-b751-2dc3c54d9165" xlink:to="loc_us-gaap_UseOfEstimates_5458bdc4-8e09-4fda-b614-e3f719d99749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_56271cb2-80f1-464e-8c58-04137a9e016c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ec2634c1-d152-4787-b751-2dc3c54d9165" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_56271cb2-80f1-464e-8c58-04137a9e016c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_fb301d5d-dc13-45f0-bcb6-0169b5d85e6a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ec2634c1-d152-4787-b751-2dc3c54d9165" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_fb301d5d-dc13-45f0-bcb6-0169b5d85e6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ShortTermInvestmentsPolicyPolicyTextBlock_bc579634-2ef8-4090-a688-e2cd14313529" xlink:href="zlab-20231231.xsd#zlab_ShortTermInvestmentsPolicyPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ec2634c1-d152-4787-b751-2dc3c54d9165" xlink:to="loc_zlab_ShortTermInvestmentsPolicyPolicyTextBlock_bc579634-2ef8-4090-a688-e2cd14313529" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_472f3590-6138-49fc-b771-958d12456e1d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ec2634c1-d152-4787-b751-2dc3c54d9165" xlink:to="loc_us-gaap_ReceivablesPolicyTextBlock_472f3590-6138-49fc-b771-958d12456e1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_NotesReceivablePolicyTextBlock_c3303604-e99e-4875-90bb-c26319251d09" xlink:href="zlab-20231231.xsd#zlab_NotesReceivablePolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ec2634c1-d152-4787-b751-2dc3c54d9165" xlink:to="loc_zlab_NotesReceivablePolicyTextBlock_c3303604-e99e-4875-90bb-c26319251d09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_8a619fc6-0d9e-4fbc-8440-51a4842ace5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ec2634c1-d152-4787-b751-2dc3c54d9165" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_8a619fc6-0d9e-4fbc-8440-51a4842ace5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_PrepaymentsForEquipmentPolicyPolicyTextBlock_83f16805-d9c3-40e1-af2c-7e54c49cc2c8" xlink:href="zlab-20231231.xsd#zlab_PrepaymentsForEquipmentPolicyPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ec2634c1-d152-4787-b751-2dc3c54d9165" xlink:to="loc_zlab_PrepaymentsForEquipmentPolicyPolicyTextBlock_83f16805-d9c3-40e1-af2c-7e54c49cc2c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_65ed2acb-457f-4148-90d2-0405573d4f17" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ec2634c1-d152-4787-b751-2dc3c54d9165" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_65ed2acb-457f-4148-90d2-0405573d4f17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_118e6b70-c3d9-4ffb-b19a-4ea92d307c54" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ec2634c1-d152-4787-b751-2dc3c54d9165" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_118e6b70-c3d9-4ffb-b19a-4ea92d307c54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_LandUseRightsPolicyPolicyTextBlock_20715109-7a13-464e-b678-7a959ced8634" xlink:href="zlab-20231231.xsd#zlab_LandUseRightsPolicyPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ec2634c1-d152-4787-b751-2dc3c54d9165" xlink:to="loc_zlab_LandUseRightsPolicyPolicyTextBlock_20715109-7a13-464e-b678-7a959ced8634" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_LongTermDepositsPolicyPolicyTextBlock_2414ed92-24ac-48b4-8d41-daa067c2117f" xlink:href="zlab-20231231.xsd#zlab_LongTermDepositsPolicyPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ec2634c1-d152-4787-b751-2dc3c54d9165" xlink:to="loc_zlab_LongTermDepositsPolicyPolicyTextBlock_2414ed92-24ac-48b4-8d41-daa067c2117f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy_7c3c8810-0a78-4156-8133-f923760de277" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ec2634c1-d152-4787-b751-2dc3c54d9165" xlink:to="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy_7c3c8810-0a78-4156-8133-f923760de277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_6e66fe26-84d7-415e-9991-0cab7545db26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ec2634c1-d152-4787-b751-2dc3c54d9165" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_6e66fe26-84d7-415e-9991-0cab7545db26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_fed7ab8c-c078-4f28-b498-7129a177f8dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ec2634c1-d152-4787-b751-2dc3c54d9165" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_fed7ab8c-c078-4f28-b498-7129a177f8dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_dcc57db3-1ea9-4b13-906d-32b1cfe1bc44" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ec2634c1-d152-4787-b751-2dc3c54d9165" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_dcc57db3-1ea9-4b13-906d-32b1cfe1bc44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementAccountingPolicy_90a31c65-150f-416d-a1e9-247f0594ce01" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementAccountingPolicy"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ec2634c1-d152-4787-b751-2dc3c54d9165" xlink:to="loc_us-gaap_CollaborativeArrangementAccountingPolicy_90a31c65-150f-416d-a1e9-247f0594ce01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_3ab63e53-f712-429e-9c28-a4e612ff44d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ec2634c1-d152-4787-b751-2dc3c54d9165" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_3ab63e53-f712-429e-9c28-a4e612ff44d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_DeferredIncomePolicyTextBlock_3bb25747-18b6-40db-addf-16c2f1ccd1b2" xlink:href="zlab-20231231.xsd#zlab_DeferredIncomePolicyTextBlock"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ec2634c1-d152-4787-b751-2dc3c54d9165" xlink:to="loc_zlab_DeferredIncomePolicyTextBlock_3bb25747-18b6-40db-addf-16c2f1ccd1b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_cac4f59a-bcd7-489e-a77a-c5a29a0faba0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ec2634c1-d152-4787-b751-2dc3c54d9165" xlink:to="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_cac4f59a-bcd7-489e-a77a-c5a29a0faba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock_78e9bcff-5519-41d1-809e-9da460796aee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ec2634c1-d152-4787-b751-2dc3c54d9165" xlink:to="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock_78e9bcff-5519-41d1-809e-9da460796aee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_fcff39a3-0261-4787-8ab0-c3347582494c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ec2634c1-d152-4787-b751-2dc3c54d9165" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_fcff39a3-0261-4787-8ab0-c3347582494c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_17f83384-6469-4787-aecf-55bccdcd5291" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ec2634c1-d152-4787-b751-2dc3c54d9165" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_17f83384-6469-4787-aecf-55bccdcd5291" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_a15cb149-d4d7-48a7-bc8f-7d64e8068984" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ec2634c1-d152-4787-b751-2dc3c54d9165" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_a15cb149-d4d7-48a7-bc8f-7d64e8068984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_af5bb3ae-0a38-4358-b8fc-90eded1c84fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ec2634c1-d152-4787-b751-2dc3c54d9165" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_af5bb3ae-0a38-4358-b8fc-90eded1c84fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_a8c31cf8-2d91-4914-b7f1-45f1b8cf9175" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ec2634c1-d152-4787-b751-2dc3c54d9165" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_a8c31cf8-2d91-4914-b7f1-45f1b8cf9175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/OrganizationandPrincipalActivitiesTables" xlink:type="simple" xlink:href="zlab-20231231.xsd#OrganizationandPrincipalActivitiesTables"/>
  <link:presentationLink xlink:role="http://zailab.com/role/OrganizationandPrincipalActivitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_76832841-a027-4fa3-95c3-c9811eafd3c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock_83ce1a33-d2e5-4c45-9424-7183b4ede27c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_76832841-a027-4fa3-95c3-c9811eafd3c9" xlink:to="loc_us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock_83ce1a33-d2e5-4c45-9424-7183b4ede27c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="zlab-20231231.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://zailab.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_63e92444-2df2-4c8f-96de-37c795c41aed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_PropertyAndEquipmentEstimatedUsefulLivesTableTextBlock_36280350-7437-4d87-9875-adfd14c1aa94" xlink:href="zlab-20231231.xsd#zlab_PropertyAndEquipmentEstimatedUsefulLivesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_63e92444-2df2-4c8f-96de-37c795c41aed" xlink:to="loc_zlab_PropertyAndEquipmentEstimatedUsefulLivesTableTextBlock_36280350-7437-4d87-9875-adfd14c1aa94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueConcentrationOfRiskTextBlock_8abcc4b8-67ec-469d-8bb9-6d3d9941142b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueConcentrationOfRiskTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_63e92444-2df2-4c8f-96de-37c795c41aed" xlink:to="loc_us-gaap_FairValueConcentrationOfRiskTextBlock_8abcc4b8-67ec-469d-8bb9-6d3d9941142b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/CashandCashEquivalentsTables" xlink:type="simple" xlink:href="zlab-20231231.xsd#CashandCashEquivalentsTables"/>
  <link:presentationLink xlink:role="http://zailab.com/role/CashandCashEquivalentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_ab4b3223-1a0e-456b-8549-9f36d9c0b3e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_23c82550-893b-4047-a46c-a36187f67c53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_ab4b3223-1a0e-456b-8549-9f36d9c0b3e4" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_23c82550-893b-4047-a46c-a36187f67c53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/InventoriesNetTables" xlink:type="simple" xlink:href="zlab-20231231.xsd#InventoriesNetTables"/>
  <link:presentationLink xlink:role="http://zailab.com/role/InventoriesNetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_58e2cbfd-9e68-493a-bca3-2912ff0a674b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_f194aef6-feba-4260-ae62-efd055111907" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_58e2cbfd-9e68-493a-bca3-2912ff0a674b" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_f194aef6-feba-4260-ae62-efd055111907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/PropertyandEquipmentNetTables" xlink:type="simple" xlink:href="zlab-20231231.xsd#PropertyandEquipmentNetTables"/>
  <link:presentationLink xlink:role="http://zailab.com/role/PropertyandEquipmentNetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_bb879d65-b325-4c33-bac6-cf8f68b3376e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_78fbb736-7877-4351-af62-4f4bb1bdd0e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_bb879d65-b325-4c33-bac6-cf8f68b3376e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_78fbb736-7877-4351-af62-4f4bb1bdd0e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/LeasesTables" xlink:type="simple" xlink:href="zlab-20231231.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://zailab.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_71402ae7-51b8-453e-bcf1-449c26697a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_SupplementalInformationRelatedToLeasesTableTableTextBlock_d551126d-b182-4f97-96b9-f19cfbffbe24" xlink:href="zlab-20231231.xsd#zlab_SupplementalInformationRelatedToLeasesTableTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_71402ae7-51b8-453e-bcf1-449c26697a1f" xlink:to="loc_zlab_SupplementalInformationRelatedToLeasesTableTableTextBlock_d551126d-b182-4f97-96b9-f19cfbffbe24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_a147a68e-f907-442d-a039-423363a5c7a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_71402ae7-51b8-453e-bcf1-449c26697a1f" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_a147a68e-f907-442d-a039-423363a5c7a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_be0072cd-1a08-400a-a812-e213eac156a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_71402ae7-51b8-453e-bcf1-449c26697a1f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_be0072cd-1a08-400a-a812-e213eac156a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_SummaryOfWeightedAverageRemainingLeaseTermsAndDiscountRatesTableTextBlock_055812f6-6d18-42d9-888b-9e8b18df74ee" xlink:href="zlab-20231231.xsd#zlab_SummaryOfWeightedAverageRemainingLeaseTermsAndDiscountRatesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_71402ae7-51b8-453e-bcf1-449c26697a1f" xlink:to="loc_zlab_SummaryOfWeightedAverageRemainingLeaseTermsAndDiscountRatesTableTextBlock_055812f6-6d18-42d9-888b-9e8b18df74ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/RevenueTables" xlink:type="simple" xlink:href="zlab-20231231.xsd#RevenueTables"/>
  <link:presentationLink xlink:role="http://zailab.com/role/RevenueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f4dc0057-9469-4063-b7f0-adbc13fb6b98" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_NetRevenueTableTextBlock_4e7f4118-dcb1-4ac3-9b3d-e269f04cb81d" xlink:href="zlab-20231231.xsd#zlab_NetRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f4dc0057-9469-4063-b7f0-adbc13fb6b98" xlink:to="loc_zlab_NetRevenueTableTextBlock_4e7f4118-dcb1-4ac3-9b3d-e269f04cb81d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_da7118e7-00e8-4d9c-ba85-d5da4f7310ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f4dc0057-9469-4063-b7f0-adbc13fb6b98" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_da7118e7-00e8-4d9c-ba85-d5da4f7310ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/IncomeTaxTables" xlink:type="simple" xlink:href="zlab-20231231.xsd#IncomeTaxTables"/>
  <link:presentationLink xlink:role="http://zailab.com/role/IncomeTaxTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_70d77f41-9379-4d23-a84f-7915f1064f7b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_06a85866-1c84-49b2-8c14-fb6b7368fd4c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_70d77f41-9379-4d23-a84f-7915f1064f7b" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_06a85866-1c84-49b2-8c14-fb6b7368fd4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_ddf29edf-e53f-41c3-8160-c965568d8dcb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_70d77f41-9379-4d23-a84f-7915f1064f7b" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_ddf29edf-e53f-41c3-8160-c965568d8dcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_dca3841f-3fe8-453f-b541-98b0b09df0da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_70d77f41-9379-4d23-a84f-7915f1064f7b" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_dca3841f-3fe8-453f-b541-98b0b09df0da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfValuationAllowanceTextBlock_fa0ace4e-6b6f-4a78-98a5-c942a805e5e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SummaryOfValuationAllowanceTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_70d77f41-9379-4d23-a84f-7915f1064f7b" xlink:to="loc_us-gaap_SummaryOfValuationAllowanceTextBlock_fa0ace4e-6b6f-4a78-98a5-c942a805e5e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/OtherCurrentLiabilitiesTables" xlink:type="simple" xlink:href="zlab-20231231.xsd#OtherCurrentLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://zailab.com/role/OtherCurrentLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_e1fd590c-a9b3-4909-8fd6-28693ce65ac8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_486ee4c4-17d3-4fb7-bc5d-cdf98094ebd2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_e1fd590c-a9b3-4909-8fd6-28693ce65ac8" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_486ee4c4-17d3-4fb7-bc5d-cdf98094ebd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/LossPerShareTables" xlink:type="simple" xlink:href="zlab-20231231.xsd#LossPerShareTables"/>
  <link:presentationLink xlink:role="http://zailab.com/role/LossPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_83d0c887-ce17-411d-afdf-d3086582afa6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_961b55e1-ec48-4216-9e8a-0999f17ed5e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_83d0c887-ce17-411d-afdf-d3086582afa6" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_961b55e1-ec48-4216-9e8a-0999f17ed5e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_856014f0-72b0-498f-bc6c-328ddd8fc105" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_83d0c887-ce17-411d-afdf-d3086582afa6" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_856014f0-72b0-498f-bc6c-328ddd8fc105" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/ShareBasedCompensationTables" xlink:type="simple" xlink:href="zlab-20231231.xsd#ShareBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://zailab.com/role/ShareBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_377c269c-a76e-4446-b48f-5eec2d6a6a79" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_3e1e583d-7859-465b-b26e-97c9731334ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_377c269c-a76e-4446-b48f-5eec2d6a6a79" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_3e1e583d-7859-465b-b26e-97c9731334ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_e97e2bd1-1c02-47c3-97c8-8ac2481d8304" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_377c269c-a76e-4446-b48f-5eec2d6a6a79" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_e97e2bd1-1c02-47c3-97c8-8ac2481d8304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_c1a12b91-aae5-4124-a4fa-e54204c25f40" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_377c269c-a76e-4446-b48f-5eec2d6a6a79" xlink:to="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_c1a12b91-aae5-4124-a4fa-e54204c25f40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_2d434ab6-69e0-41e0-9d0b-90f1fb6b4658" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_377c269c-a76e-4446-b48f-5eec2d6a6a79" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_2d434ab6-69e0-41e0-9d0b-90f1fb6b4658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/OtherIncomeExpensesNetTables" xlink:type="simple" xlink:href="zlab-20231231.xsd#OtherIncomeExpensesNetTables"/>
  <link:presentationLink xlink:role="http://zailab.com/role/OtherIncomeExpensesNetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_9c4551c3-1aa9-458e-a49b-a5502217b1ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_70533135-d9fd-4619-84ed-637ed7206bc9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_9c4551c3-1aa9-458e-a49b-a5502217b1ac" xlink:to="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_70533135-d9fd-4619-84ed-637ed7206bc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantTables" xlink:type="simple" xlink:href="zlab-20231231.xsd#ScheduleICondensedFinancialInformationofRegistrantTables"/>
  <link:presentationLink xlink:role="http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_cb843ea6-78ae-4c9d-887d-faf4228bf43e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedBalanceSheetTableTextBlock_1f3e788b-d6cb-4d5f-9b47-84bf26b93667" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfCondensedBalanceSheetTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_cb843ea6-78ae-4c9d-887d-faf4228bf43e" xlink:to="loc_srt_ScheduleOfCondensedBalanceSheetTableTextBlock_1f3e788b-d6cb-4d5f-9b47-84bf26b93667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedStatementOfComprehensiveIncomeTableTextBlock_0e74af1c-5a2f-4320-a54b-a8b8b8767b15" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CondensedStatementOfComprehensiveIncomeTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_cb843ea6-78ae-4c9d-887d-faf4228bf43e" xlink:to="loc_srt_CondensedStatementOfComprehensiveIncomeTableTextBlock_0e74af1c-5a2f-4320-a54b-a8b8b8767b15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock_1ab212fc-96e5-4e50-bb33-9cd9fa9782c7" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfCondensedCashFlowStatementTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_cb843ea6-78ae-4c9d-887d-faf4228bf43e" xlink:to="loc_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock_1ab212fc-96e5-4e50-bb33-9cd9fa9782c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/OrganizationandPrincipalActivitiesDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#OrganizationandPrincipalActivitiesDetails"/>
  <link:presentationLink xlink:role="http://zailab.com/role/OrganizationandPrincipalActivitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f07c4b4a-863b-4bb3-bdec-1ad1f7e57901" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipTable_175f6cf0-5057-4e74-81d4-f717dec60835" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f07c4b4a-863b-4bb3-bdec-1ad1f7e57901" xlink:to="loc_us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipTable_175f6cf0-5057-4e74-81d4-f717dec60835" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_7b9fbed8-9aca-4edd-a367-1d77d118f857" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipTable_175f6cf0-5057-4e74-81d4-f717dec60835" xlink:to="loc_srt_OwnershipAxis_7b9fbed8-9aca-4edd-a367-1d77d118f857" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_6147aa3a-8235-44c7-8570-cb74269b07ca" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_7b9fbed8-9aca-4edd-a367-1d77d118f857" xlink:to="loc_srt_OwnershipDomain_6147aa3a-8235-44c7-8570-cb74269b07ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ZaiLabHongKongLimitedMember_e1a14650-97ae-48ad-af7f-853eec164292" xlink:href="zlab-20231231.xsd#zlab_ZaiLabHongKongLimitedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_6147aa3a-8235-44c7-8570-cb74269b07ca" xlink:to="loc_zlab_ZaiLabHongKongLimitedMember_e1a14650-97ae-48ad-af7f-853eec164292" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ZaiLabShanghaiCompanyLimitedMember_157b2c9f-f588-492c-bbd4-14edf306bbab" xlink:href="zlab-20231231.xsd#zlab_ZaiLabShanghaiCompanyLimitedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_6147aa3a-8235-44c7-8570-cb74269b07ca" xlink:to="loc_zlab_ZaiLabShanghaiCompanyLimitedMember_157b2c9f-f588-492c-bbd4-14edf306bbab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ZaiLabAUSTPtyLtdMember_0e7ae682-055a-4ace-bcda-1963f2e344e6" xlink:href="zlab-20231231.xsd#zlab_ZaiLabAUSTPtyLtdMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_6147aa3a-8235-44c7-8570-cb74269b07ca" xlink:to="loc_zlab_ZaiLabAUSTPtyLtdMember_0e7ae682-055a-4ace-bcda-1963f2e344e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ZaiLabSuzhouCompanyLimitedMember_9d0385d4-0a61-4a8a-95e1-1f3e57fa63ee" xlink:href="zlab-20231231.xsd#zlab_ZaiLabSuzhouCompanyLimitedMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_6147aa3a-8235-44c7-8570-cb74269b07ca" xlink:to="loc_zlab_ZaiLabSuzhouCompanyLimitedMember_9d0385d4-0a61-4a8a-95e1-1f3e57fa63ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ZaiBiopharmaceuticalSuzhouCompanyLimitedMember_ca5f61de-fbf5-4268-90de-cbe2697d0cc8" xlink:href="zlab-20231231.xsd#zlab_ZaiBiopharmaceuticalSuzhouCompanyLimitedMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_6147aa3a-8235-44c7-8570-cb74269b07ca" xlink:to="loc_zlab_ZaiBiopharmaceuticalSuzhouCompanyLimitedMember_ca5f61de-fbf5-4268-90de-cbe2697d0cc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ZaiLabUSLLCMember_5f7d7567-e2d4-4765-980b-752edffc8d40" xlink:href="zlab-20231231.xsd#zlab_ZaiLabUSLLCMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_6147aa3a-8235-44c7-8570-cb74269b07ca" xlink:to="loc_zlab_ZaiLabUSLLCMember_5f7d7567-e2d4-4765-980b-752edffc8d40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ZaiLabInternationalTradingShanghaiCompanyLimitedMember_a3db5b58-179b-4073-bb37-77a70741c3e3" xlink:href="zlab-20231231.xsd#zlab_ZaiLabInternationalTradingShanghaiCompanyLimitedMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_6147aa3a-8235-44c7-8570-cb74269b07ca" xlink:to="loc_zlab_ZaiLabInternationalTradingShanghaiCompanyLimitedMember_a3db5b58-179b-4073-bb37-77a70741c3e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ZaiAutoImmuneHongKongLimitedMember_3988bb8a-0ab8-40bf-990b-dbeaa4993674" xlink:href="zlab-20231231.xsd#zlab_ZaiAutoImmuneHongKongLimitedMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_6147aa3a-8235-44c7-8570-cb74269b07ca" xlink:to="loc_zlab_ZaiAutoImmuneHongKongLimitedMember_3988bb8a-0ab8-40bf-990b-dbeaa4993674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ZaiLabTaiwanLimitedMember_c7f7a5b8-7a43-43ef-993a-3601dcd7636a" xlink:href="zlab-20231231.xsd#zlab_ZaiLabTaiwanLimitedMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_6147aa3a-8235-44c7-8570-cb74269b07ca" xlink:to="loc_zlab_ZaiLabTaiwanLimitedMember_c7f7a5b8-7a43-43ef-993a-3601dcd7636a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ZaiLabTradingSuzhouCoLtdMember_6b5dc826-1faa-49f0-b510-2f8948ccc564" xlink:href="zlab-20231231.xsd#zlab_ZaiLabTradingSuzhouCoLtdMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_6147aa3a-8235-44c7-8570-cb74269b07ca" xlink:to="loc_zlab_ZaiLabTradingSuzhouCoLtdMember_6b5dc826-1faa-49f0-b510-2f8948ccc564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems_0916063f-56d1-42a3-93ea-1f8ac0eaa64b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipTable_175f6cf0-5057-4e74-81d4-f717dec60835" xlink:to="loc_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems_0916063f-56d1-42a3-93ea-1f8ac0eaa64b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest_bbaf83b1-6470-4a7b-bf9f-5235969c0fe2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems_0916063f-56d1-42a3-93ea-1f8ac0eaa64b" xlink:to="loc_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest_bbaf83b1-6470-4a7b-bf9f-5235969c0fe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_7528652a-a83b-4caa-8e95-e7c2e1b3c765" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_SignificantAccountingPoliciesTable_261c5c9e-2223-4d8e-96c5-a49fa5a1457e" xlink:href="zlab-20231231.xsd#zlab_SignificantAccountingPoliciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7528652a-a83b-4caa-8e95-e7c2e1b3c765" xlink:to="loc_zlab_SignificantAccountingPoliciesTable_261c5c9e-2223-4d8e-96c5-a49fa5a1457e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f80b162e-3e2e-4bed-b357-8fc4f906a12e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_SignificantAccountingPoliciesTable_261c5c9e-2223-4d8e-96c5-a49fa5a1457e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f80b162e-3e2e-4bed-b357-8fc4f906a12e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ed35336a-25f5-4a91-b91b-e68446f6a7fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f80b162e-3e2e-4bed-b357-8fc4f906a12e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ed35336a-25f5-4a91-b91b-e68446f6a7fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_b75e1df2-5e31-438b-a421-be7df9d80ba7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ed35336a-25f5-4a91-b91b-e68446f6a7fc" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_b75e1df2-5e31-438b-a421-be7df9d80ba7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_CapitalizedSalesBasedMilestoneFeesMember_f09852a7-297a-4a42-b765-c050f8ae5e6d" xlink:href="zlab-20231231.xsd#zlab_CapitalizedSalesBasedMilestoneFeesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ed35336a-25f5-4a91-b91b-e68446f6a7fc" xlink:to="loc_zlab_CapitalizedSalesBasedMilestoneFeesMember_f09852a7-297a-4a42-b765-c050f8ae5e6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_33c11646-3d2e-4dd3-a83c-1aebfaa69e8e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_SignificantAccountingPoliciesTable_261c5c9e-2223-4d8e-96c5-a49fa5a1457e" xlink:to="loc_srt_RangeAxis_33c11646-3d2e-4dd3-a83c-1aebfaa69e8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c9116f77-6ad2-4e4f-9eab-85847f41b9c6" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_33c11646-3d2e-4dd3-a83c-1aebfaa69e8e" xlink:to="loc_srt_RangeMember_c9116f77-6ad2-4e4f-9eab-85847f41b9c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_290e30ca-0780-47f4-98d5-2ab645deca08" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c9116f77-6ad2-4e4f-9eab-85847f41b9c6" xlink:to="loc_srt_MinimumMember_290e30ca-0780-47f4-98d5-2ab645deca08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_1b1c2e87-0054-4200-b9a5-d24ad2b1e2fa" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c9116f77-6ad2-4e4f-9eab-85847f41b9c6" xlink:to="loc_srt_MaximumMember_1b1c2e87-0054-4200-b9a5-d24ad2b1e2fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_696685f4-215e-483c-9cd2-664659ba5f43" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_SignificantAccountingPoliciesTable_261c5c9e-2223-4d8e-96c5-a49fa5a1457e" xlink:to="loc_srt_CounterpartyNameAxis_696685f4-215e-483c-9cd2-664659ba5f43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6450ff46-f890-4e93-ab70-b328aee07171" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_696685f4-215e-483c-9cd2-664659ba5f43" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6450ff46-f890-4e93-ab70-b328aee07171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_HuizhengMember_a5613cd3-9b67-4c39-a56e-e622fe4b7264" xlink:href="zlab-20231231.xsd#zlab_HuizhengMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6450ff46-f890-4e93-ab70-b328aee07171" xlink:to="loc_zlab_HuizhengMember_a5613cd3-9b67-4c39-a56e-e622fe4b7264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_a53866ab-c6f1-4e28-91e7-86350aa83785" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_SignificantAccountingPoliciesTable_261c5c9e-2223-4d8e-96c5-a49fa5a1457e" xlink:to="loc_srt_ProductOrServiceAxis_a53866ab-c6f1-4e28-91e7-86350aa83785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_7a372a2a-99be-43ff-8651-5a865e2ecb8f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_a53866ab-c6f1-4e28-91e7-86350aa83785" xlink:to="loc_srt_ProductsAndServicesDomain_7a372a2a-99be-43ff-8651-5a865e2ecb8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrantMember_6d870a54-7509-42aa-9ac4-a95b25fd9b76" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_7a372a2a-99be-43ff-8651-5a865e2ecb8f" xlink:to="loc_us-gaap_GrantMember_6d870a54-7509-42aa-9ac4-a95b25fd9b76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_CollaborativeAgreementMember_63df887e-54fc-4bc8-8da7-f54bd7f6c364" xlink:href="zlab-20231231.xsd#zlab_CollaborativeAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_7a372a2a-99be-43ff-8651-5a865e2ecb8f" xlink:to="loc_zlab_CollaborativeAgreementMember_63df887e-54fc-4bc8-8da7-f54bd7f6c364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2f06860e-8498-4ea5-89ff-cfda3204fb4d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_SignificantAccountingPoliciesTable_261c5c9e-2223-4d8e-96c5-a49fa5a1457e" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2f06860e-8498-4ea5-89ff-cfda3204fb4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5f3eab59-301b-47c3-bb23-b3b41ff8cf3b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2f06860e-8498-4ea5-89ff-cfda3204fb4d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5f3eab59-301b-47c3-bb23-b3b41ff8cf3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_c01d51a4-99f0-4c91-935e-b3db1c3d50ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5f3eab59-301b-47c3-bb23-b3b41ff8cf3b" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_c01d51a4-99f0-4c91-935e-b3db1c3d50ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_1cf8dd8b-84ad-46c3-aa62-da30da4df8bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_SignificantAccountingPoliciesTable_261c5c9e-2223-4d8e-96c5-a49fa5a1457e" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_1cf8dd8b-84ad-46c3-aa62-da30da4df8bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_2de6dd41-2ed1-4aa3-be23-0abfb64b55d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_1cf8dd8b-84ad-46c3-aa62-da30da4df8bf" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_2de6dd41-2ed1-4aa3-be23-0abfb64b55d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_68ce1e64-3869-403f-b956-17b48bc958a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_2de6dd41-2ed1-4aa3-be23-0abfb64b55d9" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_68ce1e64-3869-403f-b956-17b48bc958a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LenderConcentrationRiskMember_3c7643c0-628d-4c06-b406-9124ef4be219" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LenderConcentrationRiskMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_2de6dd41-2ed1-4aa3-be23-0abfb64b55d9" xlink:to="loc_us-gaap_LenderConcentrationRiskMember_3c7643c0-628d-4c06-b406-9124ef4be219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ForeignCurrencyRiskMember_eabbec0f-e971-4543-96fe-788189b5a927" xlink:href="zlab-20231231.xsd#zlab_ForeignCurrencyRiskMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_2de6dd41-2ed1-4aa3-be23-0abfb64b55d9" xlink:to="loc_zlab_ForeignCurrencyRiskMember_eabbec0f-e971-4543-96fe-788189b5a927" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_504abf3c-2ab2-48c7-8dc4-db37ee140343" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_SignificantAccountingPoliciesTable_261c5c9e-2223-4d8e-96c5-a49fa5a1457e" xlink:to="loc_srt_MajorCustomersAxis_504abf3c-2ab2-48c7-8dc4-db37ee140343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_ad6d372d-8191-4eda-b531-4e5c1286c132" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_504abf3c-2ab2-48c7-8dc4-db37ee140343" xlink:to="loc_srt_NameOfMajorCustomerDomain_ad6d372d-8191-4eda-b531-4e5c1286c132" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_OneCustomerMember_0c5b63a9-c851-48f9-ad4a-c104d6d5d9e7" xlink:href="zlab-20231231.xsd#zlab_OneCustomerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_ad6d372d-8191-4eda-b531-4e5c1286c132" xlink:to="loc_zlab_OneCustomerMember_0c5b63a9-c851-48f9-ad4a-c104d6d5d9e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_0aa11f30-ef0e-47dc-bd98-5d0637416145" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_SignificantAccountingPoliciesTable_261c5c9e-2223-4d8e-96c5-a49fa5a1457e" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_0aa11f30-ef0e-47dc-bd98-5d0637416145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_45e9d8cf-15ae-4c5b-8374-f3093dae199a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_0aa11f30-ef0e-47dc-bd98-5d0637416145" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_45e9d8cf-15ae-4c5b-8374-f3093dae199a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_d80f1773-7956-49d6-8991-1ef90c339a8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_45e9d8cf-15ae-4c5b-8374-f3093dae199a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_d80f1773-7956-49d6-8991-1ef90c339a8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_9b626f2f-cacd-44e0-b549-6a3a908c3a27" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_45e9d8cf-15ae-4c5b-8374-f3093dae199a" xlink:to="loc_us-gaap_AccountsReceivableMember_9b626f2f-cacd-44e0-b549-6a3a908c3a27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_CashAndCashEquivalentMember_fa36c68d-ec7a-4693-8b66-2410c2bb2598" xlink:href="zlab-20231231.xsd#zlab_CashAndCashEquivalentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_45e9d8cf-15ae-4c5b-8374-f3093dae199a" xlink:to="loc_zlab_CashAndCashEquivalentMember_fa36c68d-ec7a-4693-8b66-2410c2bb2598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_93609a17-6618-49ec-8cd3-8196517e7b52" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CurrencyAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_SignificantAccountingPoliciesTable_261c5c9e-2223-4d8e-96c5-a49fa5a1457e" xlink:to="loc_srt_CurrencyAxis_93609a17-6618-49ec-8cd3-8196517e7b52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_35b48070-01de-422f-b992-ad0ae2a585c4" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_AllCurrenciesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_93609a17-6618-49ec-8cd3-8196517e7b52" xlink:to="loc_currency_AllCurrenciesDomain_35b48070-01de-422f-b992-ad0ae2a585c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CNY_007fe4e9-fc45-4ef0-91bb-2bc081b6d40b" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_CNY"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_35b48070-01de-422f-b992-ad0ae2a585c4" xlink:to="loc_currency_CNY_007fe4e9-fc45-4ef0-91bb-2bc081b6d40b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_SignificantAccountingPoliciesLineItems_546bc3d2-1751-4473-a4df-a3016e6768cc" xlink:href="zlab-20231231.xsd#zlab_SignificantAccountingPoliciesLineItems"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_SignificantAccountingPoliciesTable_261c5c9e-2223-4d8e-96c5-a49fa5a1457e" xlink:to="loc_zlab_SignificantAccountingPoliciesLineItems_546bc3d2-1751-4473-a4df-a3016e6768cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_368c0ca3-1c40-4323-b6d5-e563565de358" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_SignificantAccountingPoliciesLineItems_546bc3d2-1751-4473-a4df-a3016e6768cc" xlink:to="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_368c0ca3-1c40-4323-b6d5-e563565de358" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_CommonStockAuthorizedShareCapital_db79693a-9588-4dc0-bea5-1f806e8f4649" xlink:href="zlab-20231231.xsd#zlab_CommonStockAuthorizedShareCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_SignificantAccountingPoliciesLineItems_546bc3d2-1751-4473-a4df-a3016e6768cc" xlink:to="loc_zlab_CommonStockAuthorizedShareCapital_db79693a-9588-4dc0-bea5-1f806e8f4649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_06be48ed-3ca7-4ad6-8ec1-fdce11084149" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_SignificantAccountingPoliciesLineItems_546bc3d2-1751-4473-a4df-a3016e6768cc" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_06be48ed-3ca7-4ad6-8ec1-fdce11084149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_d158a46f-dcbb-42e0-8b54-d1811f665d7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_SignificantAccountingPoliciesLineItems_546bc3d2-1751-4473-a4df-a3016e6768cc" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_d158a46f-dcbb-42e0-8b54-d1811f665d7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_AmericanDepositaryShareToCommonStockConversionRatio_a80cf77d-0801-42a3-a789-aa936bad17a7" xlink:href="zlab-20231231.xsd#zlab_AmericanDepositaryShareToCommonStockConversionRatio"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_SignificantAccountingPoliciesLineItems_546bc3d2-1751-4473-a4df-a3016e6768cc" xlink:to="loc_zlab_AmericanDepositaryShareToCommonStockConversionRatio_a80cf77d-0801-42a3-a789-aa936bad17a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestCurrent_240a2e88-06dd-4dc1-bab4-afa4f630e2fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_SignificantAccountingPoliciesLineItems_546bc3d2-1751-4473-a4df-a3016e6768cc" xlink:to="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestCurrent_240a2e88-06dd-4dc1-bab4-afa4f630e2fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_LandUseRightsLeaseTerm_e6d913ee-61fc-497c-8fe3-d4475e5d6381" xlink:href="zlab-20231231.xsd#zlab_LandUseRightsLeaseTerm"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_SignificantAccountingPoliciesLineItems_546bc3d2-1751-4473-a4df-a3016e6768cc" xlink:to="loc_zlab_LandUseRightsLeaseTerm_e6d913ee-61fc-497c-8fe3-d4475e5d6381" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_a46a25bf-2ac6-4aa8-b2cf-29324ab74f10" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_SignificantAccountingPoliciesLineItems_546bc3d2-1751-4473-a4df-a3016e6768cc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_a46a25bf-2ac6-4aa8-b2cf-29324ab74f10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_1dc2bbcc-a8bc-4c0e-a63a-4f2c257a33ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_SignificantAccountingPoliciesLineItems_546bc3d2-1751-4473-a4df-a3016e6768cc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_1dc2bbcc-a8bc-4c0e-a63a-4f2c257a33ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_734e1c4b-45bf-4696-bd73-b4a6eb6334c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_SignificantAccountingPoliciesLineItems_546bc3d2-1751-4473-a4df-a3016e6768cc" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_734e1c4b-45bf-4696-bd73-b4a6eb6334c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_f7caa328-ae41-4e6c-be11-2f16cfabf7f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_SignificantAccountingPoliciesLineItems_546bc3d2-1751-4473-a4df-a3016e6768cc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_f7caa328-ae41-4e6c-be11-2f16cfabf7f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_f427e355-8de3-47e0-8c56-c1bbd39f1bff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_SignificantAccountingPoliciesLineItems_546bc3d2-1751-4473-a4df-a3016e6768cc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_f427e355-8de3-47e0-8c56-c1bbd39f1bff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_c554c51d-0e8c-4361-bb8c-b524477f305a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_SignificantAccountingPoliciesLineItems_546bc3d2-1751-4473-a4df-a3016e6768cc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_c554c51d-0e8c-4361-bb8c-b524477f305a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_fe74b0ac-3d9f-40f2-be34-a981c1de7e27" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_SignificantAccountingPoliciesLineItems_546bc3d2-1751-4473-a4df-a3016e6768cc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_fe74b0ac-3d9f-40f2-be34-a981c1de7e27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_d58cddb3-4700-4524-ba22-b8f6f0788045" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_SignificantAccountingPoliciesLineItems_546bc3d2-1751-4473-a4df-a3016e6768cc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_d58cddb3-4700-4524-ba22-b8f6f0788045" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_f8fc7340-3ccf-4adb-95b6-35c1b3b5dcf9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_SignificantAccountingPoliciesLineItems_546bc3d2-1751-4473-a4df-a3016e6768cc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_f8fc7340-3ccf-4adb-95b6-35c1b3b5dcf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_EquitySecuritiesWithReadilyDeterminableFairValueAmount_4ac8ef28-07e7-4086-9fa2-f3203ccb2b58" xlink:href="zlab-20231231.xsd#zlab_EquitySecuritiesWithReadilyDeterminableFairValueAmount"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_SignificantAccountingPoliciesLineItems_546bc3d2-1751-4473-a4df-a3016e6768cc" xlink:to="loc_zlab_EquitySecuritiesWithReadilyDeterminableFairValueAmount_4ac8ef28-07e7-4086-9fa2-f3203ccb2b58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeNoncurrent_96f1d2bf-4af5-499c-8d10-dc24e5a61633" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeNoncurrent"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_SignificantAccountingPoliciesLineItems_546bc3d2-1751-4473-a4df-a3016e6768cc" xlink:to="loc_us-gaap_DeferredIncomeNoncurrent_96f1d2bf-4af5-499c-8d10-dc24e5a61633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_CollaborativeArrangementRightsAndObligationsPaymentOfUpFrontFeesForLicenseAgreement_03ecaf6e-188b-43e3-9101-91468d9b3196" xlink:href="zlab-20231231.xsd#zlab_CollaborativeArrangementRightsAndObligationsPaymentOfUpFrontFeesForLicenseAgreement"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_SignificantAccountingPoliciesLineItems_546bc3d2-1751-4473-a4df-a3016e6768cc" xlink:to="loc_zlab_CollaborativeArrangementRightsAndObligationsPaymentOfUpFrontFeesForLicenseAgreement_03ecaf6e-188b-43e3-9101-91468d9b3196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_2df6b7bc-85db-43dd-8a19-aefde69418e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_SignificantAccountingPoliciesLineItems_546bc3d2-1751-4473-a4df-a3016e6768cc" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_2df6b7bc-85db-43dd-8a19-aefde69418e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_435828a9-69ff-41c9-8ce9-9d30f68817b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_SignificantAccountingPoliciesLineItems_546bc3d2-1751-4473-a4df-a3016e6768cc" xlink:to="loc_us-gaap_NumberOfOperatingSegments_435828a9-69ff-41c9-8ce9-9d30f68817b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_ed491490-ddf8-486d-88e7-d39f9bc16396" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_SignificantAccountingPoliciesLineItems_546bc3d2-1751-4473-a4df-a3016e6768cc" xlink:to="loc_us-gaap_NumberOfReportableSegments_ed491490-ddf8-486d-88e7-d39f9bc16396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3c934021-2f1e-4886-8660-e6d551de0107" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_SignificantAccountingPoliciesLineItems_546bc3d2-1751-4473-a4df-a3016e6768cc" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3c934021-2f1e-4886-8660-e6d551de0107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNet_ffd27e51-e402-499a-83aa-ec461ac992a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNet"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_SignificantAccountingPoliciesLineItems_546bc3d2-1751-4473-a4df-a3016e6768cc" xlink:to="loc_us-gaap_AccountsReceivableNet_ffd27e51-e402-499a-83aa-ec461ac992a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_228c752c-560f-48fa-97e1-d3c40654a8ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_SignificantAccountingPoliciesLineItems_546bc3d2-1751-4473-a4df-a3016e6768cc" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_228c752c-560f-48fa-97e1-d3c40654a8ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_5a3055a1-fda1-49fa-a02e-8ac9e70df674" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_SignificantAccountingPoliciesLineItems_546bc3d2-1751-4473-a4df-a3016e6768cc" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_5a3055a1-fda1-49fa-a02e-8ac9e70df674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://zailab.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_8a6375a2-9813-4314-a2c6-2f059bc2bf6f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_9052a571-319d-4438-81c2-de072c3c0507" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8a6375a2-9813-4314-a2c6-2f059bc2bf6f" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_9052a571-319d-4438-81c2-de072c3c0507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9e3711cd-12d8-489b-9272-92c101a44a7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_9052a571-319d-4438-81c2-de072c3c0507" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9e3711cd-12d8-489b-9272-92c101a44a7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b3637fee-fa2b-4ba8-9c62-ba2f9c947d40" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9e3711cd-12d8-489b-9272-92c101a44a7f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b3637fee-fa2b-4ba8-9c62-ba2f9c947d40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember_6816df50-6f33-4095-9bce-444b08aeddee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b3637fee-fa2b-4ba8-9c62-ba2f9c947d40" xlink:to="loc_us-gaap_OfficeEquipmentMember_6816df50-6f33-4095-9bce-444b08aeddee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ElectronicEquipmentMember_ed2197ae-76d3-4df4-bacc-f5b9419489f1" xlink:href="zlab-20231231.xsd#zlab_ElectronicEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b3637fee-fa2b-4ba8-9c62-ba2f9c947d40" xlink:to="loc_zlab_ElectronicEquipmentMember_ed2197ae-76d3-4df4-bacc-f5b9419489f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VehiclesMember_6c04a662-1a87-461a-8292-77effa98b84e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VehiclesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b3637fee-fa2b-4ba8-9c62-ba2f9c947d40" xlink:to="loc_us-gaap_VehiclesMember_6c04a662-1a87-461a-8292-77effa98b84e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_LaboratoryEquipmentMember_509497bf-a11b-4891-a655-7245ea8836e5" xlink:href="zlab-20231231.xsd#zlab_LaboratoryEquipmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b3637fee-fa2b-4ba8-9c62-ba2f9c947d40" xlink:to="loc_zlab_LaboratoryEquipmentMember_509497bf-a11b-4891-a655-7245ea8836e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManufacturingFacilityMember_d23d946e-4048-468a-a034-86a09f2e6ee3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ManufacturingFacilityMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b3637fee-fa2b-4ba8-9c62-ba2f9c947d40" xlink:to="loc_us-gaap_ManufacturingFacilityMember_d23d946e-4048-468a-a034-86a09f2e6ee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_defb23d1-3fc9-4659-8891-978d39692e7f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_9052a571-319d-4438-81c2-de072c3c0507" xlink:to="loc_srt_RangeAxis_defb23d1-3fc9-4659-8891-978d39692e7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_97e1d6cb-0b15-4ac7-a1b7-b507ed94fe39" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_defb23d1-3fc9-4659-8891-978d39692e7f" xlink:to="loc_srt_RangeMember_97e1d6cb-0b15-4ac7-a1b7-b507ed94fe39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d0632e93-6311-49c1-b124-0aaef55bf1e1" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_97e1d6cb-0b15-4ac7-a1b7-b507ed94fe39" xlink:to="loc_srt_MinimumMember_d0632e93-6311-49c1-b124-0aaef55bf1e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3d50fb0a-b1a6-42ca-a2bb-89d3d102102e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_97e1d6cb-0b15-4ac7-a1b7-b507ed94fe39" xlink:to="loc_srt_MaximumMember_3d50fb0a-b1a6-42ca-a2bb-89d3d102102e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ad6df4a9-2f5f-4186-87be-4a4380f8a366" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_9052a571-319d-4438-81c2-de072c3c0507" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ad6df4a9-2f5f-4186-87be-4a4380f8a366" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_a72c7243-147d-4201-91ce-941272f0904f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ad6df4a9-2f5f-4186-87be-4a4380f8a366" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_a72c7243-147d-4201-91ce-941272f0904f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/SummaryofSignificantAccountingPoliciesConcentrationofSuppliersDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#SummaryofSignificantAccountingPoliciesConcentrationofSuppliersDetails"/>
  <link:presentationLink xlink:role="http://zailab.com/role/SummaryofSignificantAccountingPoliciesConcentrationofSuppliersDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_08c0ebac-ad37-44af-929c-acad68890a47" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_1c09b9f0-c248-43a8-b7fa-f941de93d93a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_08c0ebac-ad37-44af-929c-acad68890a47" xlink:to="loc_us-gaap_ConcentrationRiskTable_1c09b9f0-c248-43a8-b7fa-f941de93d93a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_6acea769-34ec-4331-97ae-a52288104c8f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_1c09b9f0-c248-43a8-b7fa-f941de93d93a" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_6acea769-34ec-4331-97ae-a52288104c8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e176c30e-6a77-480c-aded-8b7b49568cd3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_6acea769-34ec-4331-97ae-a52288104c8f" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e176c30e-6a77-480c-aded-8b7b49568cd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ResearchAndDevelopmentExpensesMember_3d114a87-0f67-43a1-87a7-43091243f657" xlink:href="zlab-20231231.xsd#zlab_ResearchAndDevelopmentExpensesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e176c30e-6a77-480c-aded-8b7b49568cd3" xlink:to="loc_zlab_ResearchAndDevelopmentExpensesMember_3d114a87-0f67-43a1-87a7-43091243f657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_ac9cd06f-07f3-4526-b865-6530aff5e794" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_1c09b9f0-c248-43a8-b7fa-f941de93d93a" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_ac9cd06f-07f3-4526-b865-6530aff5e794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_f8d728e6-ed63-45f8-9634-e34c4ded6470" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_ac9cd06f-07f3-4526-b865-6530aff5e794" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_f8d728e6-ed63-45f8-9634-e34c4ded6470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierConcentrationRiskMember_de46bdca-8677-463d-a8cc-4551a83bfdec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplierConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_f8d728e6-ed63-45f8-9634-e34c4ded6470" xlink:to="loc_us-gaap_SupplierConcentrationRiskMember_de46bdca-8677-463d-a8cc-4551a83bfdec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_MajorSuppliersAxis_d5f63338-43f7-4291-afe6-c4fcc7d5af24" xlink:href="zlab-20231231.xsd#zlab_MajorSuppliersAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_1c09b9f0-c248-43a8-b7fa-f941de93d93a" xlink:to="loc_zlab_MajorSuppliersAxis_d5f63338-43f7-4291-afe6-c4fcc7d5af24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_MajorSuppliersDomain_81c8d71e-b50b-4c3b-b04b-33ccafdfd591" xlink:href="zlab-20231231.xsd#zlab_MajorSuppliersDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_MajorSuppliersAxis_d5f63338-43f7-4291-afe6-c4fcc7d5af24" xlink:to="loc_zlab_MajorSuppliersDomain_81c8d71e-b50b-4c3b-b04b-33ccafdfd591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_SupplierEMember_ca74fda1-53cf-48a7-9c00-c4eedbdcaaf6" xlink:href="zlab-20231231.xsd#zlab_SupplierEMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_MajorSuppliersDomain_81c8d71e-b50b-4c3b-b04b-33ccafdfd591" xlink:to="loc_zlab_SupplierEMember_ca74fda1-53cf-48a7-9c00-c4eedbdcaaf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_SupplierFMember_1bfbaa07-0bb7-4456-b41b-a5809e96ee62" xlink:href="zlab-20231231.xsd#zlab_SupplierFMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_MajorSuppliersDomain_81c8d71e-b50b-4c3b-b04b-33ccafdfd591" xlink:to="loc_zlab_SupplierFMember_1bfbaa07-0bb7-4456-b41b-a5809e96ee62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_7ab5827f-8eb0-461c-8642-4b0a65a12b94" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_1c09b9f0-c248-43a8-b7fa-f941de93d93a" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_7ab5827f-8eb0-461c-8642-4b0a65a12b94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ResearchAndDevelopmentExpensesAndTheInventoryPurchases_85d9c578-720c-4611-bcfb-1b88cf2cf7b6" xlink:href="zlab-20231231.xsd#zlab_ResearchAndDevelopmentExpensesAndTheInventoryPurchases"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_7ab5827f-8eb0-461c-8642-4b0a65a12b94" xlink:to="loc_zlab_ResearchAndDevelopmentExpensesAndTheInventoryPurchases_85d9c578-720c-4611-bcfb-1b88cf2cf7b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/CashandCashEquivalentsDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#CashandCashEquivalentsDetails"/>
  <link:presentationLink xlink:role="http://zailab.com/role/CashandCashEquivalentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_c9eac0d0-9056-42a6-9c74-687173b1c660" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_7b622a51-9285-49d2-826c-71048187df05" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_c9eac0d0-9056-42a6-9c74-687173b1c660" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_7b622a51-9285-49d2-826c-71048187df05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_85dea3b0-abe6-4fac-a85a-4ac26a3dd8cb" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CurrencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_7b622a51-9285-49d2-826c-71048187df05" xlink:to="loc_srt_CurrencyAxis_85dea3b0-abe6-4fac-a85a-4ac26a3dd8cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_527971c5-492b-4f18-b5db-1fb04ccff835" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_AllCurrenciesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_85dea3b0-abe6-4fac-a85a-4ac26a3dd8cb" xlink:to="loc_currency_AllCurrenciesDomain_527971c5-492b-4f18-b5db-1fb04ccff835" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD_1dc7bb36-468d-42a1-9f50-732572769e1c" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_USD"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_527971c5-492b-4f18-b5db-1fb04ccff835" xlink:to="loc_currency_USD_1dc7bb36-468d-42a1-9f50-732572769e1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CNY_3cb12c8a-81e3-4179-b5b8-ae017f5ed763" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_CNY"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_527971c5-492b-4f18-b5db-1fb04ccff835" xlink:to="loc_currency_CNY_3cb12c8a-81e3-4179-b5b8-ae017f5ed763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_HKD_171ecc45-9c2d-4075-8765-d75d76f760a6" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_HKD"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_527971c5-492b-4f18-b5db-1fb04ccff835" xlink:to="loc_currency_HKD_171ecc45-9c2d-4075-8765-d75d76f760a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AUD_bf056ce6-471c-4741-a8cd-2701a33004fa" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_AUD"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_527971c5-492b-4f18-b5db-1fb04ccff835" xlink:to="loc_currency_AUD_bf056ce6-471c-4741-a8cd-2701a33004fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_TWD_dede77b2-3ac0-483c-92e8-f760976b9400" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_TWD"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_527971c5-492b-4f18-b5db-1fb04ccff835" xlink:to="loc_currency_TWD_dede77b2-3ac0-483c-92e8-f760976b9400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsLineItems_b6e978a0-426d-4d12-922d-e59de31382a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_7b622a51-9285-49d2-826c-71048187df05" xlink:to="loc_us-gaap_CashAndCashEquivalentsLineItems_b6e978a0-426d-4d12-922d-e59de31382a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash_76e48f12-ac89-4d08-b2d8-2da3a4035e89" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Cash"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_b6e978a0-426d-4d12-922d-e59de31382a8" xlink:to="loc_us-gaap_Cash_76e48f12-ac89-4d08-b2d8-2da3a4035e89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_240d3bbe-8938-45ae-8aeb-3c3630e2916d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_b6e978a0-426d-4d12-922d-e59de31382a8" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_240d3bbe-8938-45ae-8aeb-3c3630e2916d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_cdee4a23-6285-492f-91cb-2f39ad6c4557" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_b6e978a0-426d-4d12-922d-e59de31382a8" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_cdee4a23-6285-492f-91cb-2f39ad6c4557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/RestrictedCashNonCurrentDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#RestrictedCashNonCurrentDetails"/>
  <link:presentationLink xlink:role="http://zailab.com/role/RestrictedCashNonCurrentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAbstract_2629abf9-181a-406c-8629-e6d37e6533ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_3b373c25-ba4b-44af-ab44-b59f73de20ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAbstract_2629abf9-181a-406c-8629-e6d37e6533ea" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_3b373c25-ba4b-44af-ab44-b59f73de20ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/ShortTermInvestmentsDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#ShortTermInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://zailab.com/role/ShortTermInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsAbstract_0167b9fc-6c57-4644-9430-ed3f177b6ac9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesTable_091ab17d-7f14-4dd6-90a8-33845f3bafdf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfHeldToMaturitySecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermInvestmentsAbstract_0167b9fc-6c57-4644-9430-ed3f177b6ac9" xlink:to="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesTable_091ab17d-7f14-4dd6-90a8-33845f3bafdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fc1db454-0592-43c1-ae39-8b73169fac53" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesTable_091ab17d-7f14-4dd6-90a8-33845f3bafdf" xlink:to="loc_srt_RangeAxis_fc1db454-0592-43c1-ae39-8b73169fac53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9aa21389-3e5d-4dd9-b761-52cac4e00d4d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_fc1db454-0592-43c1-ae39-8b73169fac53" xlink:to="loc_srt_RangeMember_9aa21389-3e5d-4dd9-b761-52cac4e00d4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_23b460a5-dfc8-40b4-b6d4-6e03b607463f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_9aa21389-3e5d-4dd9-b761-52cac4e00d4d" xlink:to="loc_srt_MinimumMember_23b460a5-dfc8-40b4-b6d4-6e03b607463f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_62b5b12d-7775-477e-8872-69fa06230ce9" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_9aa21389-3e5d-4dd9-b761-52cac4e00d4d" xlink:to="loc_srt_MaximumMember_62b5b12d-7775-477e-8872-69fa06230ce9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems_845d6770-be1a-4af0-ba87-cbb9f1424649" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesTable_091ab17d-7f14-4dd6-90a8-33845f3bafdf" xlink:to="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems_845d6770-be1a-4af0-ba87-cbb9f1424649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaturityOfTimeDeposits_3e34b2b8-72e4-4767-8b3a-5be441adb568" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MaturityOfTimeDeposits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems_845d6770-be1a-4af0-ba87-cbb9f1424649" xlink:to="loc_us-gaap_MaturityOfTimeDeposits_3e34b2b8-72e4-4767-8b3a-5be441adb568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_b133a5b5-c8a7-46c7-98ea-499886186cab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems_845d6770-be1a-4af0-ba87-cbb9f1424649" xlink:to="loc_us-gaap_ShortTermInvestments_b133a5b5-c8a7-46c7-98ea-499886186cab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossExcludingAccruedInterest_96f118f8-5882-4713-9597-016075c0e8c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossExcludingAccruedInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems_845d6770-be1a-4af0-ba87-cbb9f1424649" xlink:to="loc_us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossExcludingAccruedInterest_96f118f8-5882-4713-9597-016075c0e8c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/InventoriesNetScheduleofInventoryDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#InventoriesNetScheduleofInventoryDetails"/>
  <link:presentationLink xlink:role="http://zailab.com/role/InventoriesNetScheduleofInventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_c21e2de1-a6eb-4fc7-990f-64b78c613dd4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_d44fac61-fa0d-4780-95e9-a18d36a218de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_c21e2de1-a6eb-4fc7-990f-64b78c613dd4" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_d44fac61-fa0d-4780-95e9-a18d36a218de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_fc28b128-f649-4722-9417-ecf5a034f6a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_c21e2de1-a6eb-4fc7-990f-64b78c613dd4" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_fc28b128-f649-4722-9417-ecf5a034f6a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_0bad117c-4906-496a-a77e-6845e7f8f420" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_c21e2de1-a6eb-4fc7-990f-64b78c613dd4" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_0bad117c-4906-496a-a77e-6845e7f8f420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_2fa5433e-1671-4394-a284-66e86634d98c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_c21e2de1-a6eb-4fc7-990f-64b78c613dd4" xlink:to="loc_us-gaap_InventoryNet_2fa5433e-1671-4394-a284-66e86634d98c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/InventoriesNetAdditionalInformationDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#InventoriesNetAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://zailab.com/role/InventoriesNetAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_2c04c08a-7825-4ef6-bb68-08bd06215e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductionRelatedImpairmentsOrCharges_75075c24-38a7-4898-acce-1cbfb63cb6ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductionRelatedImpairmentsOrCharges"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_2c04c08a-7825-4ef6-bb68-08bd06215e9a" xlink:to="loc_us-gaap_ProductionRelatedImpairmentsOrCharges_75075c24-38a7-4898-acce-1cbfb63cb6ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/LongTermInvestmentsDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#LongTermInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://zailab.com/role/LongTermInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_021169e7-7d33-4496-a513-555b6b087e2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_EquityAndCostMethodInvestmentTable_7d69384f-d40c-4d10-b2e9-89a4aaa3ac3f" xlink:href="zlab-20231231.xsd#zlab_EquityAndCostMethodInvestmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_021169e7-7d33-4496-a513-555b6b087e2c" xlink:to="loc_zlab_EquityAndCostMethodInvestmentTable_7d69384f-d40c-4d10-b2e9-89a4aaa3ac3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d31b358d-2930-4c1f-92e8-c36af3e915ce" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_EquityAndCostMethodInvestmentTable_7d69384f-d40c-4d10-b2e9-89a4aaa3ac3f" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d31b358d-2930-4c1f-92e8-c36af3e915ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_ba3b1735-7e05-4b09-9145-d2613eb4923b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d31b358d-2930-4c1f-92e8-c36af3e915ce" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_ba3b1735-7e05-4b09-9145-d2613eb4923b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_MacroGenicsIncMember_a064534e-9f07-48f6-825f-6dd91bc17540" xlink:href="zlab-20231231.xsd#zlab_MacroGenicsIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_ba3b1735-7e05-4b09-9145-d2613eb4923b" xlink:to="loc_zlab_MacroGenicsIncMember_a064534e-9f07-48f6-825f-6dd91bc17540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_07521136-5438-4fbb-807d-48618608b692" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_EquityAndCostMethodInvestmentTable_7d69384f-d40c-4d10-b2e9-89a4aaa3ac3f" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_07521136-5438-4fbb-807d-48618608b692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b21a4381-32c7-4b38-ad07-b897b9c9ee5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_07521136-5438-4fbb-807d-48618608b692" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b21a4381-32c7-4b38-ad07-b897b9c9ee5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_67dca79d-e437-44c9-b5cc-355ef706dd2f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b21a4381-32c7-4b38-ad07-b897b9c9ee5b" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_67dca79d-e437-44c9-b5cc-355ef706dd2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_a2aa5aef-b014-4872-a3e6-0030f12467cc" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_EquityAndCostMethodInvestmentTable_7d69384f-d40c-4d10-b2e9-89a4aaa3ac3f" xlink:to="loc_dei_LegalEntityAxis_a2aa5aef-b014-4872-a3e6-0030f12467cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_d454289a-cbd0-41bb-b213-8418ca32fb01" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_a2aa5aef-b014-4872-a3e6-0030f12467cc" xlink:to="loc_dei_EntityDomain_d454289a-cbd0-41bb-b213-8418ca32fb01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_MacroGenicsIncMember_fc1b7940-b00a-4def-8bd9-f93e69b352e3" xlink:href="zlab-20231231.xsd#zlab_MacroGenicsIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_d454289a-cbd0-41bb-b213-8418ca32fb01" xlink:to="loc_zlab_MacroGenicsIncMember_fc1b7940-b00a-4def-8bd9-f93e69b352e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_EquityAndCostMethodInvestmentsLineItems_19c0faa1-299c-4cc1-9cee-c60d6f6e43e8" xlink:href="zlab-20231231.xsd#zlab_EquityAndCostMethodInvestmentsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_EquityAndCostMethodInvestmentTable_7d69384f-d40c-4d10-b2e9-89a4aaa3ac3f" xlink:to="loc_zlab_EquityAndCostMethodInvestmentsLineItems_19c0faa1-299c-4cc1-9cee-c60d6f6e43e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_CapitalContributionsCommitment_197af2ec-4d9c-4813-8e6b-a14c52fbc75c" xlink:href="zlab-20231231.xsd#zlab_CapitalContributionsCommitment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_EquityAndCostMethodInvestmentsLineItems_19c0faa1-299c-4cc1-9cee-c60d6f6e43e8" xlink:to="loc_zlab_CapitalContributionsCommitment_197af2ec-4d9c-4813-8e6b-a14c52fbc75c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_e872c73a-05c2-4115-9500-0ccace42705d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_EquityAndCostMethodInvestmentsLineItems_19c0faa1-299c-4cc1-9cee-c60d6f6e43e8" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_e872c73a-05c2-4115-9500-0ccace42705d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_4f904e7e-bbd6-4363-aa45-b2d1fa19175d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_EquityAndCostMethodInvestmentsLineItems_19c0faa1-299c-4cc1-9cee-c60d6f6e43e8" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_4f904e7e-bbd6-4363-aa45-b2d1fa19175d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_EquitySecuritiesWithReadilyDeterminableFairValueAmount_6d21e44d-eda3-44b2-babf-d96837311e5c" xlink:href="zlab-20231231.xsd#zlab_EquitySecuritiesWithReadilyDeterminableFairValueAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_EquityAndCostMethodInvestmentsLineItems_19c0faa1-299c-4cc1-9cee-c60d6f6e43e8" xlink:to="loc_zlab_EquitySecuritiesWithReadilyDeterminableFairValueAmount_6d21e44d-eda3-44b2-babf-d96837311e5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_b287edc3-fb1a-45d1-9fbb-44f65d53176b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_EquityAndCostMethodInvestmentsLineItems_19c0faa1-299c-4cc1-9cee-c60d6f6e43e8" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_b287edc3-fb1a-45d1-9fbb-44f65d53176b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://zailab.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_e03d25f2-cf8c-4b37-a6b8-2786999ebc89" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e126a7b9-516a-417f-aef5-ae815e2a3577" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_e03d25f2-cf8c-4b37-a6b8-2786999ebc89" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e126a7b9-516a-417f-aef5-ae815e2a3577" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_378d0f9e-ea1a-43b1-b257-0f4e9331f9bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e126a7b9-516a-417f-aef5-ae815e2a3577" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_378d0f9e-ea1a-43b1-b257-0f4e9331f9bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_04dfbd41-79dd-4834-87c3-86fdfcb1698e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_378d0f9e-ea1a-43b1-b257-0f4e9331f9bc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_04dfbd41-79dd-4834-87c3-86fdfcb1698e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember_45a7d0c5-a15a-4f66-ba71-3b9ed0f8f261" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_04dfbd41-79dd-4834-87c3-86fdfcb1698e" xlink:to="loc_us-gaap_OfficeEquipmentMember_45a7d0c5-a15a-4f66-ba71-3b9ed0f8f261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ElectronicEquipmentMember_0401a6c8-d267-466d-9ff3-2c3c09684eb9" xlink:href="zlab-20231231.xsd#zlab_ElectronicEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_04dfbd41-79dd-4834-87c3-86fdfcb1698e" xlink:to="loc_zlab_ElectronicEquipmentMember_0401a6c8-d267-466d-9ff3-2c3c09684eb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VehiclesMember_2d57c3fb-794b-479f-86b6-caf7dc06cded" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VehiclesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_04dfbd41-79dd-4834-87c3-86fdfcb1698e" xlink:to="loc_us-gaap_VehiclesMember_2d57c3fb-794b-479f-86b6-caf7dc06cded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_LaboratoryEquipmentMember_0a046ea3-c7ee-487d-a20a-3795fdc4c85d" xlink:href="zlab-20231231.xsd#zlab_LaboratoryEquipmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_04dfbd41-79dd-4834-87c3-86fdfcb1698e" xlink:to="loc_zlab_LaboratoryEquipmentMember_0a046ea3-c7ee-487d-a20a-3795fdc4c85d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ManufacturingEquipmentMember_0551aa57-1d22-44a8-9cd0-f96ef926757e" xlink:href="zlab-20231231.xsd#zlab_ManufacturingEquipmentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_04dfbd41-79dd-4834-87c3-86fdfcb1698e" xlink:to="loc_zlab_ManufacturingEquipmentMember_0551aa57-1d22-44a8-9cd0-f96ef926757e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_85a6a326-2f65-4d7f-aa5a-b04a1c1eb896" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_04dfbd41-79dd-4834-87c3-86fdfcb1698e" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_85a6a326-2f65-4d7f-aa5a-b04a1c1eb896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_72bd451c-69db-4986-8f7f-8b415e188bea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_04dfbd41-79dd-4834-87c3-86fdfcb1698e" xlink:to="loc_us-gaap_ConstructionInProgressMember_72bd451c-69db-4986-8f7f-8b415e188bea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_495d2252-932e-46c9-9774-99d43a001df7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e126a7b9-516a-417f-aef5-ae815e2a3577" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_495d2252-932e-46c9-9774-99d43a001df7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_8b27356e-c4ac-4c63-910d-08a838a926ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_495d2252-932e-46c9-9774-99d43a001df7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_8b27356e-c4ac-4c63-910d-08a838a926ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_d951d1e6-11b1-48af-a722-9dd2a945f08d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_495d2252-932e-46c9-9774-99d43a001df7" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_d951d1e6-11b1-48af-a722-9dd2a945f08d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_0e670b18-1be6-4f0d-85d8-bab366c02165" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_495d2252-932e-46c9-9774-99d43a001df7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_0e670b18-1be6-4f0d-85d8-bab366c02165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/PropertyandEquipmentNetAdditionalInformationDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#PropertyandEquipmentNetAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://zailab.com/role/PropertyandEquipmentNetAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_396d8c2b-4673-45a3-b764-21a3e9f140e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_feb77139-8d7f-4d73-b8a0-1a27d877c40a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_396d8c2b-4673-45a3-b764-21a3e9f140e9" xlink:to="loc_us-gaap_Depreciation_feb77139-8d7f-4d73-b8a0-1a27d877c40a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/LeasesAdditionalInformationDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#LeasesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://zailab.com/role/LeasesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_a9ddd0da-4c5b-43fc-81ae-ba8a4c197457" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_42cba6d6-1607-4138-b187-9806f9bdc35b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a9ddd0da-4c5b-43fc-81ae-ba8a4c197457" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_42cba6d6-1607-4138-b187-9806f9bdc35b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_71144490-a6c1-478c-b2e2-9d37d96c00c9" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_42cba6d6-1607-4138-b187-9806f9bdc35b" xlink:to="loc_srt_RangeAxis_71144490-a6c1-478c-b2e2-9d37d96c00c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b87bad9e-8fbb-48d1-b923-0eb82966c2a8" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_71144490-a6c1-478c-b2e2-9d37d96c00c9" xlink:to="loc_srt_RangeMember_b87bad9e-8fbb-48d1-b923-0eb82966c2a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ea074f54-f562-4137-a586-a03c6c8ae63c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b87bad9e-8fbb-48d1-b923-0eb82966c2a8" xlink:to="loc_srt_MinimumMember_ea074f54-f562-4137-a586-a03c6c8ae63c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_595d8df9-327b-4627-a606-8bd96a418f90" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b87bad9e-8fbb-48d1-b923-0eb82966c2a8" xlink:to="loc_srt_MaximumMember_595d8df9-327b-4627-a606-8bd96a418f90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_908d73aa-2040-441a-9d6e-af658e85ce9b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_42cba6d6-1607-4138-b187-9806f9bdc35b" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_908d73aa-2040-441a-9d6e-af658e85ce9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_3354c4b0-3040-41e5-a90b-b25159b70866" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_908d73aa-2040-441a-9d6e-af658e85ce9b" xlink:to="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_3354c4b0-3040-41e5-a90b-b25159b70866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/LeasesOperatingLeaseCostDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#LeasesOperatingLeaseCostDetails"/>
  <link:presentationLink xlink:role="http://zailab.com/role/LeasesOperatingLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_0ca816f9-9702-4832-885f-5d5129f14ecc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_61c209bf-f659-484b-8717-8ca61060b98f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0ca816f9-9702-4832-885f-5d5129f14ecc" xlink:to="loc_us-gaap_OperatingLeaseCost_61c209bf-f659-484b-8717-8ca61060b98f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/LeasesCashFlowInformationDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#LeasesCashFlowInformationDetails"/>
  <link:presentationLink xlink:role="http://zailab.com/role/LeasesCashFlowInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_0e274e5a-4f46-40bd-a625-dda7a465d4d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_1bed5815-4de5-4793-bb15-37a626da5bc6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0e274e5a-4f46-40bd-a625-dda7a465d4d0" xlink:to="loc_us-gaap_OperatingLeasePayments_1bed5815-4de5-4793-bb15-37a626da5bc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_e9beaaf2-a0b4-4ea6-962c-d8b8fb050c43" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0e274e5a-4f46-40bd-a625-dda7a465d4d0" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_e9beaaf2-a0b4-4ea6-962c-d8b8fb050c43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#LeasesMaturitiesofLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://zailab.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_68f98938-efa3-4e8d-8a63-33a6061dcf29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c4827472-06bb-48cc-8211-6535f14bd653" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_68f98938-efa3-4e8d-8a63-33a6061dcf29" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c4827472-06bb-48cc-8211-6535f14bd653" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c23c401e-b3a9-462e-b43e-450d920631c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_68f98938-efa3-4e8d-8a63-33a6061dcf29" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c23c401e-b3a9-462e-b43e-450d920631c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_01e06d84-2626-454c-b62d-64198c391a54" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_68f98938-efa3-4e8d-8a63-33a6061dcf29" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_01e06d84-2626-454c-b62d-64198c391a54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_591aa738-a74d-477d-93da-309bb1e72703" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_68f98938-efa3-4e8d-8a63-33a6061dcf29" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_591aa738-a74d-477d-93da-309bb1e72703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_2fc20336-40dc-4978-a3f7-e8ba53e21eba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_68f98938-efa3-4e8d-8a63-33a6061dcf29" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_2fc20336-40dc-4978-a3f7-e8ba53e21eba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_08cacda9-306c-459f-9e60-b95e55861eb9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_68f98938-efa3-4e8d-8a63-33a6061dcf29" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_08cacda9-306c-459f-9e60-b95e55861eb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2a277599-d2de-4d18-b76d-5e515585decb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_68f98938-efa3-4e8d-8a63-33a6061dcf29" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2a277599-d2de-4d18-b76d-5e515585decb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_85b32043-1043-420b-86de-d1448bf23411" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_68f98938-efa3-4e8d-8a63-33a6061dcf29" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_85b32043-1043-420b-86de-d1448bf23411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_1ce7ee57-c897-4ce6-a4e1-d5dd6d46650a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_68f98938-efa3-4e8d-8a63-33a6061dcf29" xlink:to="loc_us-gaap_OperatingLeaseLiability_1ce7ee57-c897-4ce6-a4e1-d5dd6d46650a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="zlab-20231231.xsd#LeasesMaturitiesofLeaseLiabilitiesDetails_1"/>
  <link:presentationLink xlink:role="http://zailab.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://zailab.com/role/LeasesWeightedAverageRemainingLeaseTermsandDiscountRatesDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#LeasesWeightedAverageRemainingLeaseTermsandDiscountRatesDetails"/>
  <link:presentationLink xlink:role="http://zailab.com/role/LeasesWeightedAverageRemainingLeaseTermsandDiscountRatesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_9f871d29-94b9-4080-8892-47a68bc74852" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_e8946edb-ad72-436e-a079-52eba5839dc6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9f871d29-94b9-4080-8892-47a68bc74852" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_e8946edb-ad72-436e-a079-52eba5839dc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_4fcaa48c-10a4-4a15-8771-0658491e6177" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9f871d29-94b9-4080-8892-47a68bc74852" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_4fcaa48c-10a4-4a15-8771-0658491e6177" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/RevenueSummaryofProductRevenueDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#RevenueSummaryofProductRevenueDetails"/>
  <link:presentationLink xlink:role="http://zailab.com/role/RevenueSummaryofProductRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_6596d197-97e0-44be-a6ca-93d2d7afd685" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_RevenueFromContractWithCustomersExcludingAssessedTaxBeforeAdjustmentsForRebatesAndSalesReturns_4fbed24c-a6d1-462b-a880-d3151911449f" xlink:href="zlab-20231231.xsd#zlab_RevenueFromContractWithCustomersExcludingAssessedTaxBeforeAdjustmentsForRebatesAndSalesReturns"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_6596d197-97e0-44be-a6ca-93d2d7afd685" xlink:to="loc_zlab_RevenueFromContractWithCustomersExcludingAssessedTaxBeforeAdjustmentsForRebatesAndSalesReturns_4fbed24c-a6d1-462b-a880-d3151911449f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_RevenueFromContractWithCustomersExcludingAssessedTaxAdjustmentsForRebatesAndSalesReturns_3c4e6fb8-fb7f-470e-8430-7d2cc035f9e6" xlink:href="zlab-20231231.xsd#zlab_RevenueFromContractWithCustomersExcludingAssessedTaxAdjustmentsForRebatesAndSalesReturns"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_6596d197-97e0-44be-a6ca-93d2d7afd685" xlink:to="loc_zlab_RevenueFromContractWithCustomersExcludingAssessedTaxAdjustmentsForRebatesAndSalesReturns_3c4e6fb8-fb7f-470e-8430-7d2cc035f9e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3b69b769-39bb-463c-878e-8cc59f940818" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_6596d197-97e0-44be-a6ca-93d2d7afd685" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3b69b769-39bb-463c-878e-8cc59f940818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/RevenueDisaggregationofNetRevenuebyProductDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#RevenueDisaggregationofNetRevenuebyProductDetails"/>
  <link:presentationLink xlink:role="http://zailab.com/role/RevenueDisaggregationofNetRevenuebyProductDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_37654c0e-337b-4d2a-a474-17420300cc29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_c8e57358-d47a-494c-89b2-e9635abf205f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_37654c0e-337b-4d2a-a474-17420300cc29" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_c8e57358-d47a-494c-89b2-e9635abf205f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_021f7663-5ba5-4fbd-9015-202e73bdd59c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c8e57358-d47a-494c-89b2-e9635abf205f" xlink:to="loc_srt_ProductOrServiceAxis_021f7663-5ba5-4fbd-9015-202e73bdd59c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_4e98fb77-2b95-4419-888e-dba277265c66" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_021f7663-5ba5-4fbd-9015-202e73bdd59c" xlink:to="loc_srt_ProductsAndServicesDomain_4e98fb77-2b95-4419-888e-dba277265c66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ZejulaMember_8953611b-6b86-4dbd-803a-8a58fe878d71" xlink:href="zlab-20231231.xsd#zlab_ZejulaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_4e98fb77-2b95-4419-888e-dba277265c66" xlink:to="loc_zlab_ZejulaMember_8953611b-6b86-4dbd-803a-8a58fe878d71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_OptuneMember_5ff57e0c-72bc-44ed-973f-6e12e56a7942" xlink:href="zlab-20231231.xsd#zlab_OptuneMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_4e98fb77-2b95-4419-888e-dba277265c66" xlink:to="loc_zlab_OptuneMember_5ff57e0c-72bc-44ed-973f-6e12e56a7942" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_QinlockMember_e760baa5-27b9-4202-9380-9672ea281413" xlink:href="zlab-20231231.xsd#zlab_QinlockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_4e98fb77-2b95-4419-888e-dba277265c66" xlink:to="loc_zlab_QinlockMember_e760baa5-27b9-4202-9380-9672ea281413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_NuzyraMember_e3dc4e8f-569f-4164-ac65-2a4bd4ceb59e" xlink:href="zlab-20231231.xsd#zlab_NuzyraMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_4e98fb77-2b95-4419-888e-dba277265c66" xlink:to="loc_zlab_NuzyraMember_e3dc4e8f-569f-4164-ac65-2a4bd4ceb59e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_VyvgartMember_8d76ba0c-7177-4cd4-a631-8c8641a0aa41" xlink:href="zlab-20231231.xsd#zlab_VyvgartMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_4e98fb77-2b95-4419-888e-dba277265c66" xlink:to="loc_zlab_VyvgartMember_8d76ba0c-7177-4cd4-a631-8c8641a0aa41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_8173e72f-cabe-432f-8b30-2e65cc7634dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c8e57358-d47a-494c-89b2-e9635abf205f" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_8173e72f-cabe-432f-8b30-2e65cc7634dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_12577a6c-863a-47df-985a-803f95fb6ce6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_8173e72f-cabe-432f-8b30-2e65cc7634dd" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_12577a6c-863a-47df-985a-803f95fb6ce6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/IncomeTaxAdditionalInformationDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#IncomeTaxAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://zailab.com/role/IncomeTaxAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_3f66b96f-f606-4c52-96b4-8d880e8d63c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_IncomeTaxDisclosureTable_7f1f19ea-d86c-43fc-a7b0-36719c77fb00" xlink:href="zlab-20231231.xsd#zlab_IncomeTaxDisclosureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3f66b96f-f606-4c52-96b4-8d880e8d63c7" xlink:to="loc_zlab_IncomeTaxDisclosureTable_7f1f19ea-d86c-43fc-a7b0-36719c77fb00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_66e5709f-1db4-4293-808e-41e34772682a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_IncomeTaxDisclosureTable_7f1f19ea-d86c-43fc-a7b0-36719c77fb00" xlink:to="loc_dei_LegalEntityAxis_66e5709f-1db4-4293-808e-41e34772682a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_bb3ec4da-7a3e-4473-9390-6bfa554a5c88" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_66e5709f-1db4-4293-808e-41e34772682a" xlink:to="loc_dei_EntityDomain_bb3ec4da-7a3e-4473-9390-6bfa554a5c88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ZaiLabAUSTPtyLtdMember_ca75738c-2cd8-49a6-8e76-5dfad296c4b2" xlink:href="zlab-20231231.xsd#zlab_ZaiLabAUSTPtyLtdMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_bb3ec4da-7a3e-4473-9390-6bfa554a5c88" xlink:to="loc_zlab_ZaiLabAUSTPtyLtdMember_ca75738c-2cd8-49a6-8e76-5dfad296c4b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ZaiLabUSLLCMember_6a83a546-0ca0-4e9c-ae34-8efbc3d342c0" xlink:href="zlab-20231231.xsd#zlab_ZaiLabUSLLCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_bb3ec4da-7a3e-4473-9390-6bfa554a5c88" xlink:to="loc_zlab_ZaiLabUSLLCMember_6a83a546-0ca0-4e9c-ae34-8efbc3d342c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ZaiLabTaiwanLimitedMember_3e35b86c-9507-4c28-a581-5d41f5d0d8ad" xlink:href="zlab-20231231.xsd#zlab_ZaiLabTaiwanLimitedMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_bb3ec4da-7a3e-4473-9390-6bfa554a5c88" xlink:to="loc_zlab_ZaiLabTaiwanLimitedMember_3e35b86c-9507-4c28-a581-5d41f5d0d8ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ZaiLabHongKongAndZlChinaHoldingTwoAndZaiAutoImmuneHongKongAndZaiAntiInfectivesHongKongLimitedMember_177edef7-664b-43b5-af54-daf00ff8ef67" xlink:href="zlab-20231231.xsd#zlab_ZaiLabHongKongAndZlChinaHoldingTwoAndZaiAutoImmuneHongKongAndZaiAntiInfectivesHongKongLimitedMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_bb3ec4da-7a3e-4473-9390-6bfa554a5c88" xlink:to="loc_zlab_ZaiLabHongKongAndZlChinaHoldingTwoAndZaiAutoImmuneHongKongAndZaiAntiInfectivesHongKongLimitedMember_177edef7-664b-43b5-af54-daf00ff8ef67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_0675614b-c180-4542-9939-93243ccea67e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_IncomeTaxDisclosureTable_7f1f19ea-d86c-43fc-a7b0-36719c77fb00" xlink:to="loc_srt_StatementGeographicalAxis_0675614b-c180-4542-9939-93243ccea67e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_37f26c2e-3251-409d-a675-9be204bb4653" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_0675614b-c180-4542-9939-93243ccea67e" xlink:to="loc_srt_SegmentGeographicalDomain_37f26c2e-3251-409d-a675-9be204bb4653" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN_c28b1d8a-f530-4f90-9136-fd6cea768f45" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_CN"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_37f26c2e-3251-409d-a675-9be204bb4653" xlink:to="loc_country_CN_c28b1d8a-f530-4f90-9136-fd6cea768f45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_HK_c9386a8d-993d-4423-9a33-247b349e713e" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_HK"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_37f26c2e-3251-409d-a675-9be204bb4653" xlink:to="loc_country_HK_c9386a8d-993d-4423-9a33-247b349e713e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_TW_e40e4b6b-ef01-4e8a-9420-646a9e33e69a" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_TW"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_37f26c2e-3251-409d-a675-9be204bb4653" xlink:to="loc_country_TW_e40e4b6b-ef01-4e8a-9420-646a9e33e69a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_64b41e5c-638a-4215-9ee2-1122df03e0ca" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_37f26c2e-3251-409d-a675-9be204bb4653" xlink:to="loc_country_US_64b41e5c-638a-4215-9ee2-1122df03e0ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_AU_8cf3d81a-02e1-4418-a399-77321756e379" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_AU"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_37f26c2e-3251-409d-a675-9be204bb4653" xlink:to="loc_country_AU_8cf3d81a-02e1-4418-a399-77321756e379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_IncomeTaxDisclosureLineItems_0e1144df-504a-4a82-9138-7f79f6a369dd" xlink:href="zlab-20231231.xsd#zlab_IncomeTaxDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_IncomeTaxDisclosureTable_7f1f19ea-d86c-43fc-a7b0-36719c77fb00" xlink:to="loc_zlab_IncomeTaxDisclosureLineItems_0e1144df-504a-4a82-9138-7f79f6a369dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4749d609-1b8f-4162-9a9a-d8046daf03be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_IncomeTaxDisclosureLineItems_0e1144df-504a-4a82-9138-7f79f6a369dd" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4749d609-1b8f-4162-9a9a-d8046daf03be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_247391b7-09a9-4b98-aff0-61276400e949" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_IncomeTaxDisclosureLineItems_0e1144df-504a-4a82-9138-7f79f6a369dd" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_247391b7-09a9-4b98-aff0-61276400e949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_WithholdingTaxesRemittanceOfDividends_4d83b920-b6a6-46b8-bab6-7bb52cc06b69" xlink:href="zlab-20231231.xsd#zlab_WithholdingTaxesRemittanceOfDividends"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_IncomeTaxDisclosureLineItems_0e1144df-504a-4a82-9138-7f79f6a369dd" xlink:to="loc_zlab_WithholdingTaxesRemittanceOfDividends_4d83b920-b6a6-46b8-bab6-7bb52cc06b69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_7b0194a7-d93f-458a-8441-b21aea072a6f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_IncomeTaxDisclosureLineItems_0e1144df-504a-4a82-9138-7f79f6a369dd" xlink:to="loc_us-gaap_OperatingLossCarryforwards_7b0194a7-d93f-458a-8441-b21aea072a6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/IncomeTaxLossIncomeBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#IncomeTaxLossIncomeBeforeIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://zailab.com/role/IncomeTaxLossIncomeBeforeIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_ba7c5d49-1fcc-401a-8e60-49b0f1a7462a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_IncomeTaxDisclosureTable_fbb31eb5-46e6-495e-8cc0-bfdf45abfce9" xlink:href="zlab-20231231.xsd#zlab_IncomeTaxDisclosureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ba7c5d49-1fcc-401a-8e60-49b0f1a7462a" xlink:to="loc_zlab_IncomeTaxDisclosureTable_fbb31eb5-46e6-495e-8cc0-bfdf45abfce9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_6f944b03-d5d6-4471-b1e0-9cee8ce542c3" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_IncomeTaxDisclosureTable_fbb31eb5-46e6-495e-8cc0-bfdf45abfce9" xlink:to="loc_srt_StatementGeographicalAxis_6f944b03-d5d6-4471-b1e0-9cee8ce542c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_56825034-381c-46d2-ac6b-747ff34d56b7" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_6f944b03-d5d6-4471-b1e0-9cee8ce542c3" xlink:to="loc_srt_SegmentGeographicalDomain_56825034-381c-46d2-ac6b-747ff34d56b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_KY_3837b5b3-394c-4f88-a637-99c602fba12c" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_KY"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_56825034-381c-46d2-ac6b-747ff34d56b7" xlink:to="loc_country_KY_3837b5b3-394c-4f88-a637-99c602fba12c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_VG_a47f84b0-3099-4035-a227-4589c6a9e51c" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_VG"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_56825034-381c-46d2-ac6b-747ff34d56b7" xlink:to="loc_country_VG_a47f84b0-3099-4035-a227-4589c6a9e51c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN_f6328ac4-d644-47c3-b535-489e05e92ca6" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_CN"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_56825034-381c-46d2-ac6b-747ff34d56b7" xlink:to="loc_country_CN_f6328ac4-d644-47c3-b535-489e05e92ca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_HK_dbd6413f-7ffa-4135-9755-ca1629beb968" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_HK"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_56825034-381c-46d2-ac6b-747ff34d56b7" xlink:to="loc_country_HK_dbd6413f-7ffa-4135-9755-ca1629beb968" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_c8974338-df87-4f31-a4d3-ffc5b81b2e84" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_56825034-381c-46d2-ac6b-747ff34d56b7" xlink:to="loc_country_US_c8974338-df87-4f31-a4d3-ffc5b81b2e84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_AU_96cbbf20-12a3-4de2-a790-f303cee02a3f" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_AU"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_56825034-381c-46d2-ac6b-747ff34d56b7" xlink:to="loc_country_AU_96cbbf20-12a3-4de2-a790-f303cee02a3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_TW_c921d5dd-e2b6-4fc4-a8b3-20ba3ba94d9f" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_TW"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_56825034-381c-46d2-ac6b-747ff34d56b7" xlink:to="loc_country_TW_c921d5dd-e2b6-4fc4-a8b3-20ba3ba94d9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_IncomeTaxDisclosureLineItems_b98d38c3-8f8d-41fd-94ae-aab9e5b1bedc" xlink:href="zlab-20231231.xsd#zlab_IncomeTaxDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_IncomeTaxDisclosureTable_fbb31eb5-46e6-495e-8cc0-bfdf45abfce9" xlink:to="loc_zlab_IncomeTaxDisclosureLineItems_b98d38c3-8f8d-41fd-94ae-aab9e5b1bedc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8ffa2b28-dfe7-446a-a59e-9494ae4790b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_IncomeTaxDisclosureLineItems_b98d38c3-8f8d-41fd-94ae-aab9e5b1bedc" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8ffa2b28-dfe7-446a-a59e-9494ae4790b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRateDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#IncomeTaxReconciliationoftheEffectiveIncomeTaxRateDetails"/>
  <link:presentationLink xlink:role="http://zailab.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_40d5a8fb-a5ac-4846-ba88-179d757ac1cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_IncomeTaxesTable_5452c615-027e-492d-9847-662a2c823104" xlink:href="zlab-20231231.xsd#zlab_IncomeTaxesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_40d5a8fb-a5ac-4846-ba88-179d757ac1cf" xlink:to="loc_zlab_IncomeTaxesTable_5452c615-027e-492d-9847-662a2c823104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_8418d1c3-4405-4a19-a611-04423a73d17c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_IncomeTaxesTable_5452c615-027e-492d-9847-662a2c823104" xlink:to="loc_srt_StatementGeographicalAxis_8418d1c3-4405-4a19-a611-04423a73d17c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_56b5f8d9-14ec-43d0-a456-0ca47d1d9e1b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_8418d1c3-4405-4a19-a611-04423a73d17c" xlink:to="loc_srt_SegmentGeographicalDomain_56b5f8d9-14ec-43d0-a456-0ca47d1d9e1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN_0ba8d58e-94b1-4dcb-8cc7-32db3bf28d67" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_CN"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_56b5f8d9-14ec-43d0-a456-0ca47d1d9e1b" xlink:to="loc_country_CN_0ba8d58e-94b1-4dcb-8cc7-32db3bf28d67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_IncomeTaxesLineItems_7d12b0d0-6b7d-471f-8287-96a867830cc2" xlink:href="zlab-20231231.xsd#zlab_IncomeTaxesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_IncomeTaxesTable_5452c615-027e-492d-9847-662a2c823104" xlink:to="loc_zlab_IncomeTaxesLineItems_7d12b0d0-6b7d-471f-8287-96a867830cc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_d2bdc1a3-04c7-422d-82f1-61c87e519cb2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_IncomeTaxesLineItems_7d12b0d0-6b7d-471f-8287-96a867830cc2" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_d2bdc1a3-04c7-422d-82f1-61c87e519cb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome_c73580ec-ce1d-4d68-8e9c-786940ff1f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_IncomeTaxesLineItems_7d12b0d0-6b7d-471f-8287-96a867830cc2" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome_c73580ec-ce1d-4d68-8e9c-786940ff1f8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_6d07a3d0-78a3-4e88-b236-d176db0af8ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_IncomeTaxesLineItems_7d12b0d0-6b7d-471f-8287-96a867830cc2" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_6d07a3d0-78a3-4e88-b236-d176db0af8ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_02b328d8-7c1b-41fa-950a-32bd10f38eea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_IncomeTaxesLineItems_7d12b0d0-6b7d-471f-8287-96a867830cc2" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_02b328d8-7c1b-41fa-950a-32bd10f38eea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_866a04ad-f9b1-4682-a6df-a076fd36e985" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_IncomeTaxesLineItems_7d12b0d0-6b7d-471f-8287-96a867830cc2" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_866a04ad-f9b1-4682-a6df-a076fd36e985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_2f6bba4c-bc8e-4ad8-892f-0a95ae75b173" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_IncomeTaxesLineItems_7d12b0d0-6b7d-471f-8287-96a867830cc2" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_2f6bba4c-bc8e-4ad8-892f-0a95ae75b173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_1580e2f5-38ae-4bef-94e9-a0d13c14ef0f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_IncomeTaxesLineItems_7d12b0d0-6b7d-471f-8287-96a867830cc2" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_1580e2f5-38ae-4bef-94e9-a0d13c14ef0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_EffectiveIncomeTaxRateReconciliationAtPreferentialTaxRate_fceed441-6590-4593-a62c-8342be83dabf" xlink:href="zlab-20231231.xsd#zlab_EffectiveIncomeTaxRateReconciliationAtPreferentialTaxRate"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_IncomeTaxesLineItems_7d12b0d0-6b7d-471f-8287-96a867830cc2" xlink:to="loc_zlab_EffectiveIncomeTaxRateReconciliationAtPreferentialTaxRate_fceed441-6590-4593-a62c-8342be83dabf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCharitableContributions_09a9dcb2-add9-4731-8e0c-0404ff788a27" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCharitableContributions"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_IncomeTaxesLineItems_7d12b0d0-6b7d-471f-8287-96a867830cc2" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCharitableContributions_09a9dcb2-add9-4731-8e0c-0404ff788a27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_1610c60c-5a0b-449c-8755-b00cc9e9a794" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_IncomeTaxesLineItems_7d12b0d0-6b7d-471f-8287-96a867830cc2" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_1610c60c-5a0b-449c-8755-b00cc9e9a794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e6d3bb97-e27f-4a26-b53d-dbcde081654e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_IncomeTaxesLineItems_7d12b0d0-6b7d-471f-8287-96a867830cc2" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e6d3bb97-e27f-4a26-b53d-dbcde081654e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/IncomeTaxComponentsofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#IncomeTaxComponentsofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://zailab.com/role/IncomeTaxComponentsofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_7c2afa72-a4c7-44be-82f5-9f7df9b05217" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNetAbstract_7f4d78c6-bbf1-47d8-bf7e-b6779a9ff851" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7c2afa72-a4c7-44be-82f5-9f7df9b05217" xlink:to="loc_us-gaap_DeferredTaxAssetsNetAbstract_7f4d78c6-bbf1-47d8-bf7e-b6779a9ff851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_8478b907-9760-44f9-a5cf-62dd2fda1c9c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_7f4d78c6-bbf1-47d8-bf7e-b6779a9ff851" xlink:to="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_8478b907-9760-44f9-a5cf-62dd2fda1c9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_DeferredTaxAssetsResearchAndExperimentalCapitalization_a6d9a3ad-9492-46b1-8dce-2c43cc9c31bf" xlink:href="zlab-20231231.xsd#zlab_DeferredTaxAssetsResearchAndExperimentalCapitalization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_7f4d78c6-bbf1-47d8-bf7e-b6779a9ff851" xlink:to="loc_zlab_DeferredTaxAssetsResearchAndExperimentalCapitalization_a6d9a3ad-9492-46b1-8dce-2c43cc9c31bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_9b621d69-bf1d-4e5a-9ddf-5e1aceabab9f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_7f4d78c6-bbf1-47d8-bf7e-b6779a9ff851" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_9b621d69-bf1d-4e5a-9ddf-5e1aceabab9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_e06ca400-b833-4ec3-9455-cb0cb651b154" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_7f4d78c6-bbf1-47d8-bf7e-b6779a9ff851" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_e06ca400-b833-4ec3-9455-cb0cb651b154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_DeferredTaxAssetsGovernmentGrants_f533876a-d5b4-4ca0-913b-29852a591538" xlink:href="zlab-20231231.xsd#zlab_DeferredTaxAssetsGovernmentGrants"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_7f4d78c6-bbf1-47d8-bf7e-b6779a9ff851" xlink:to="loc_zlab_DeferredTaxAssetsGovernmentGrants_f533876a-d5b4-4ca0-913b-29852a591538" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_DeferredTaxAssetsDeferredRevenue_6c02d276-42e5-4a7a-b75c-3d6999e8fa31" xlink:href="zlab-20231231.xsd#zlab_DeferredTaxAssetsDeferredRevenue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_7f4d78c6-bbf1-47d8-bf7e-b6779a9ff851" xlink:to="loc_zlab_DeferredTaxAssetsDeferredRevenue_6c02d276-42e5-4a7a-b75c-3d6999e8fa31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_DeferredTaxAssetsPublicWelfareDonations_6d2526a2-93e7-485f-8ccc-d4bb4ad83042" xlink:href="zlab-20231231.xsd#zlab_DeferredTaxAssetsPublicWelfareDonations"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_7f4d78c6-bbf1-47d8-bf7e-b6779a9ff851" xlink:to="loc_zlab_DeferredTaxAssetsPublicWelfareDonations_6d2526a2-93e7-485f-8ccc-d4bb4ad83042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_DeferredTaxAssetsLeasingArrangements_209dff6e-dfda-42e9-b2ab-da8d8f2944a9" xlink:href="zlab-20231231.xsd#zlab_DeferredTaxAssetsLeasingArrangements"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_7f4d78c6-bbf1-47d8-bf7e-b6779a9ff851" xlink:to="loc_zlab_DeferredTaxAssetsLeasingArrangements_209dff6e-dfda-42e9-b2ab-da8d8f2944a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_ce16e067-b601-4329-b760-93156b4ec9e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_7f4d78c6-bbf1-47d8-bf7e-b6779a9ff851" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_ce16e067-b601-4329-b760-93156b4ec9e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_2ef899ed-a1b3-461f-ab8f-8d8136e93a4a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7c2afa72-a4c7-44be-82f5-9f7df9b05217" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_2ef899ed-a1b3-461f-ab8f-8d8136e93a4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_91aa323f-35d9-407b-ad9c-53d5b5a560ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7c2afa72-a4c7-44be-82f5-9f7df9b05217" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_91aa323f-35d9-407b-ad9c-53d5b5a560ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract_ca75e105-f13f-4aa3-a368-b859f6f28434" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7c2afa72-a4c7-44be-82f5-9f7df9b05217" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesAbstract_ca75e105-f13f-4aa3-a368-b859f6f28434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_639cd93b-5b10-42e1-afe7-9036c33a399b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_ca75e105-f13f-4aa3-a368-b859f6f28434" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_639cd93b-5b10-42e1-afe7-9036c33a399b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_609e2ee2-0b97-4d48-aaff-19e0fec0b6c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7c2afa72-a4c7-44be-82f5-9f7df9b05217" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_609e2ee2-0b97-4d48-aaff-19e0fec0b6c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/IncomeTaxMovementofValuationAllowanceDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#IncomeTaxMovementofValuationAllowanceDetails"/>
  <link:presentationLink xlink:role="http://zailab.com/role/IncomeTaxMovementofValuationAllowanceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0b3039f5-44fa-4431-bd04-5b1b65722491" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_DeferredTaxAssetsValuationAllowanceRollForward_c7fc9b1f-d595-44fd-9939-a80e5325ce0e" xlink:href="zlab-20231231.xsd#zlab_DeferredTaxAssetsValuationAllowanceRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0b3039f5-44fa-4431-bd04-5b1b65722491" xlink:to="loc_zlab_DeferredTaxAssetsValuationAllowanceRollForward_c7fc9b1f-d595-44fd-9939-a80e5325ce0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_b74eeaf0-086f-4fdb-afd4-07d951ab9d07" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_DeferredTaxAssetsValuationAllowanceRollForward_c7fc9b1f-d595-44fd-9939-a80e5325ce0e" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_b74eeaf0-086f-4fdb-afd4-07d951ab9d07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_a28e9d50-fb7f-461b-8002-fb7c884bac8f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_DeferredTaxAssetsValuationAllowanceRollForward_c7fc9b1f-d595-44fd-9939-a80e5325ce0e" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_a28e9d50-fb7f-461b-8002-fb7c884bac8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_58968b56-4d9b-4180-8876-159ea644c38d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_DeferredTaxAssetsValuationAllowanceRollForward_c7fc9b1f-d595-44fd-9939-a80e5325ce0e" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_58968b56-4d9b-4180-8876-159ea644c38d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/OtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#OtherCurrentLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://zailab.com/role/OtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_c0ac5e2a-7aea-4872-9a02-7ce45f52aec2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_0d54f547-b1cf-43da-a4f1-748048deae2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_c0ac5e2a-7aea-4872-9a02-7ce45f52aec2" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_0d54f547-b1cf-43da-a4f1-748048deae2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_fb2c2466-2bdb-4c3c-b8c2-05d084224ac8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_c0ac5e2a-7aea-4872-9a02-7ce45f52aec2" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_fb2c2466-2bdb-4c3c-b8c2-05d084224ac8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_PayablesForPurchaseOfPropertyAndEquipmentCurrent_0a03d53c-1bb3-4fd8-98e4-44b60188f593" xlink:href="zlab-20231231.xsd#zlab_PayablesForPurchaseOfPropertyAndEquipmentCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_c0ac5e2a-7aea-4872-9a02-7ce45f52aec2" xlink:to="loc_zlab_PayablesForPurchaseOfPropertyAndEquipmentCurrent_0a03d53c-1bb3-4fd8-98e4-44b60188f593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_AccruedRebateToDistributorsCurrent_e01ccd59-4b07-479b-adb3-a47fee3f82a4" xlink:href="zlab-20231231.xsd#zlab_AccruedRebateToDistributorsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_c0ac5e2a-7aea-4872-9a02-7ce45f52aec2" xlink:to="loc_zlab_AccruedRebateToDistributorsCurrent_e01ccd59-4b07-479b-adb3-a47fee3f82a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrentAndNoncurrent_feb58d86-8ffa-4b7f-a2a3-065e227bc259" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxesPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_c0ac5e2a-7aea-4872-9a02-7ce45f52aec2" xlink:to="loc_us-gaap_TaxesPayableCurrentAndNoncurrent_feb58d86-8ffa-4b7f-a2a3-065e227bc259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_OtherPayablesCurrentLiabilities_a732a823-157d-4c04-b6fe-a2671bc5b013" xlink:href="zlab-20231231.xsd#zlab_OtherPayablesCurrentLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_c0ac5e2a-7aea-4872-9a02-7ce45f52aec2" xlink:to="loc_zlab_OtherPayablesCurrentLiabilities_a732a823-157d-4c04-b6fe-a2671bc5b013" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_38d87845-a8fc-4184-bb09-ee691b947e13" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_c0ac5e2a-7aea-4872-9a02-7ce45f52aec2" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_38d87845-a8fc-4184-bb09-ee691b947e13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/LossPerShareComputationofBasicandDilutedNetLossPerShareDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#LossPerShareComputationofBasicandDilutedNetLossPerShareDetails"/>
  <link:presentationLink xlink:role="http://zailab.com/role/LossPerShareComputationofBasicandDilutedNetLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_ad6648b6-d830-44f2-93bd-5da8f9864c80" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAbstract_6ff69866-5bc7-4e03-970b-8ed8fcc7e3ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ad6648b6-d830-44f2-93bd-5da8f9864c80" xlink:to="loc_us-gaap_NetIncomeLossAbstract_6ff69866-5bc7-4e03-970b-8ed8fcc7e3ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_40a2c8dd-2e87-4a57-819d-53ee45f9b011" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAbstract_6ff69866-5bc7-4e03-970b-8ed8fcc7e3ae" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_40a2c8dd-2e87-4a57-819d-53ee45f9b011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_6c43df8e-0e2e-44cf-b4b8-d220f3bf6d74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAbstract_6ff69866-5bc7-4e03-970b-8ed8fcc7e3ae" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_6c43df8e-0e2e-44cf-b4b8-d220f3bf6d74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_WeightedAverageNumberOfShareOutstandingBasicAndDilutedAbstract_81460f64-adef-4ae6-acb5-6e9bf31a82ab" xlink:href="zlab-20231231.xsd#zlab_WeightedAverageNumberOfShareOutstandingBasicAndDilutedAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ad6648b6-d830-44f2-93bd-5da8f9864c80" xlink:to="loc_zlab_WeightedAverageNumberOfShareOutstandingBasicAndDilutedAbstract_81460f64-adef-4ae6-acb5-6e9bf31a82ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d4800485-dfab-48ef-b1dd-53be183f84fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_WeightedAverageNumberOfShareOutstandingBasicAndDilutedAbstract_81460f64-adef-4ae6-acb5-6e9bf31a82ab" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d4800485-dfab-48ef-b1dd-53be183f84fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b37b9276-5003-4a6f-8c1b-b37b6f79556c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_WeightedAverageNumberOfShareOutstandingBasicAndDilutedAbstract_81460f64-adef-4ae6-acb5-6e9bf31a82ab" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b37b9276-5003-4a6f-8c1b-b37b6f79556c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_e75aed07-879f-4056-ae26-646a33ee381f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ad6648b6-d830-44f2-93bd-5da8f9864c80" xlink:to="loc_us-gaap_EarningsPerShareBasic_e75aed07-879f-4056-ae26-646a33ee381f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_f4d99a7e-9123-4485-92cb-05c74efb9cdd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ad6648b6-d830-44f2-93bd-5da8f9864c80" xlink:to="loc_us-gaap_EarningsPerShareDiluted_f4d99a7e-9123-4485-92cb-05c74efb9cdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/LossPerShareAntiDilutiveSharesExcludedfromCalculationofDilutedLossPerShareDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#LossPerShareAntiDilutiveSharesExcludedfromCalculationofDilutedLossPerShareDetails"/>
  <link:presentationLink xlink:role="http://zailab.com/role/LossPerShareAntiDilutiveSharesExcludedfromCalculationofDilutedLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_f7e2bd13-da4a-4fa1-9403-5680c067c9af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_14f593e1-6e28-4df4-92fb-694ba3275efd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f7e2bd13-da4a-4fa1-9403-5680c067c9af" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_14f593e1-6e28-4df4-92fb-694ba3275efd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7a0895d4-5a8a-4900-931e-14ae38b510f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_14f593e1-6e28-4df4-92fb-694ba3275efd" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7a0895d4-5a8a-4900-931e-14ae38b510f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_219cf1db-ff5e-431c-8438-f5ce8b3726bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7a0895d4-5a8a-4900-931e-14ae38b510f6" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_219cf1db-ff5e-431c-8438-f5ce8b3726bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_080a3e2d-6f3d-4bd0-a413-4b785eaa6f2e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_219cf1db-ff5e-431c-8438-f5ce8b3726bc" xlink:to="loc_us-gaap_EmployeeStockOptionMember_080a3e2d-6f3d-4bd0-a413-4b785eaa6f2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_NonVestedRestrictedSharesMember_ea3e5807-59ab-4427-a614-e9d2a63cc033" xlink:href="zlab-20231231.xsd#zlab_NonVestedRestrictedSharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_219cf1db-ff5e-431c-8438-f5ce8b3726bc" xlink:to="loc_zlab_NonVestedRestrictedSharesMember_ea3e5807-59ab-4427-a614-e9d2a63cc033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1f974790-fabb-47aa-858d-4deb62141bad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_14f593e1-6e28-4df4-92fb-694ba3275efd" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1f974790-fabb-47aa-858d-4deb62141bad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1665a052-efdc-4ef1-9033-b33d549270f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1f974790-fabb-47aa-858d-4deb62141bad" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1665a052-efdc-4ef1-9033-b33d549270f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/RelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#RelatedPartyTransactionsDetails"/>
  <link:presentationLink xlink:role="http://zailab.com/role/RelatedPartyTransactionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_57ab3196-2e1b-4a76-a9e0-3153bcb77358" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_acdbed6f-1f6d-4f9a-87b4-1696ea57ec4b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_57ab3196-2e1b-4a76-a9e0-3153bcb77358" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_acdbed6f-1f6d-4f9a-87b4-1696ea57ec4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_38afbb13-c90a-45ff-8e7a-20f9722b17ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_acdbed6f-1f6d-4f9a-87b4-1696ea57ec4b" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_38afbb13-c90a-45ff-8e7a-20f9722b17ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_795487a4-5510-4479-9a79-a4e81cdd7b7e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_38afbb13-c90a-45ff-8e7a-20f9722b17ff" xlink:to="loc_us-gaap_RelatedPartyDomain_795487a4-5510-4479-9a79-a4e81cdd7b7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedLiabilityCompanyMember_b10726e9-ade7-4105-a46b-50125428ef01" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LimitedLiabilityCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_795487a4-5510-4479-9a79-a4e81cdd7b7e" xlink:to="loc_us-gaap_LimitedLiabilityCompanyMember_b10726e9-ade7-4105-a46b-50125428ef01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_644c7da3-04c4-48fd-b33d-baab3b0e3879" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_acdbed6f-1f6d-4f9a-87b4-1696ea57ec4b" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_644c7da3-04c4-48fd-b33d-baab3b0e3879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_80d1dfe7-f196-4ff5-ac9f-51b4df6926d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_644c7da3-04c4-48fd-b33d-baab3b0e3879" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_80d1dfe7-f196-4ff5-ac9f-51b4df6926d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/ShareBasedCompensationAdditionalInformationDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#ShareBasedCompensationAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://zailab.com/role/ShareBasedCompensationAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_626efe2d-a816-41ba-8d16-579b499bc207" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8036a077-edeb-4601-a272-cb1033bae5ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_626efe2d-a816-41ba-8d16-579b499bc207" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8036a077-edeb-4601-a272-cb1033bae5ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_444d326e-d1ee-420b-8691-43720550d85f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8036a077-edeb-4601-a272-cb1033bae5ac" xlink:to="loc_us-gaap_PlanNameAxis_444d326e-d1ee-420b-8691-43720550d85f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_b2844821-6146-4859-a83c-b67ca1ef4a2e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_444d326e-d1ee-420b-8691-43720550d85f" xlink:to="loc_us-gaap_PlanNameDomain_b2844821-6146-4859-a83c-b67ca1ef4a2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_TwoThousandTwentyTwoEquityIncentivePlanMember_6dffce85-47f4-462c-8320-3e502f35924c" xlink:href="zlab-20231231.xsd#zlab_TwoThousandTwentyTwoEquityIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_b2844821-6146-4859-a83c-b67ca1ef4a2e" xlink:to="loc_zlab_TwoThousandTwentyTwoEquityIncentivePlanMember_6dffce85-47f4-462c-8320-3e502f35924c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_694e0205-4a26-4e4d-8fca-39ccc85759e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8036a077-edeb-4601-a272-cb1033bae5ac" xlink:to="loc_us-gaap_AwardTypeAxis_694e0205-4a26-4e4d-8fca-39ccc85759e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8edaa953-4755-42b5-babe-16efdf5d4064" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_694e0205-4a26-4e4d-8fca-39ccc85759e2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8edaa953-4755-42b5-babe-16efdf5d4064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_72ea2fca-263c-47b6-b25b-89e1bcc106ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8edaa953-4755-42b5-babe-16efdf5d4064" xlink:to="loc_us-gaap_EmployeeStockOptionMember_72ea2fca-263c-47b6-b25b-89e1bcc106ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_NonVestedRestrictedSharesMember_06e00deb-21e8-4d6a-b32d-2df8cddd866b" xlink:href="zlab-20231231.xsd#zlab_NonVestedRestrictedSharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8edaa953-4755-42b5-babe-16efdf5d4064" xlink:to="loc_zlab_NonVestedRestrictedSharesMember_06e00deb-21e8-4d6a-b32d-2df8cddd866b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateAxis_ce0beb30-45e9-4495-b977-fa19551a88dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardDateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8036a077-edeb-4601-a272-cb1033bae5ac" xlink:to="loc_us-gaap_AwardDateAxis_ce0beb30-45e9-4495-b977-fa19551a88dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_346ec4c9-fe17-46d1-88e0-2ca29db21b5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardDateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateAxis_ce0beb30-45e9-4495-b977-fa19551a88dc" xlink:to="loc_us-gaap_AwardDateDomain_346ec4c9-fe17-46d1-88e0-2ca29db21b5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_April2023AndLaterMember_66c5161a-51c8-4e51-a2cf-ddb3cc81433b" xlink:href="zlab-20231231.xsd#zlab_April2023AndLaterMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_346ec4c9-fe17-46d1-88e0-2ca29db21b5b" xlink:to="loc_zlab_April2023AndLaterMember_66c5161a-51c8-4e51-a2cf-ddb3cc81433b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_PriorToApril2023Member_b8a93e19-4ca9-4826-b5e4-dc63a4e9d951" xlink:href="zlab-20231231.xsd#zlab_PriorToApril2023Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_346ec4c9-fe17-46d1-88e0-2ca29db21b5b" xlink:to="loc_zlab_PriorToApril2023Member_b8a93e19-4ca9-4826-b5e4-dc63a4e9d951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_260f4741-1f3b-43ea-8f2f-5b1692a1819c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8036a077-edeb-4601-a272-cb1033bae5ac" xlink:to="loc_us-gaap_VestingAxis_260f4741-1f3b-43ea-8f2f-5b1692a1819c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_256411e4-f966-46ae-870a-9af78a9aed24" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_260f4741-1f3b-43ea-8f2f-5b1692a1819c" xlink:to="loc_us-gaap_VestingDomain_256411e4-f966-46ae-870a-9af78a9aed24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_facd6f67-8bf3-453c-9309-6d76fb3f61e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_256411e4-f966-46ae-870a-9af78a9aed24" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_facd6f67-8bf3-453c-9309-6d76fb3f61e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_a4993110-a219-4174-8c8f-2cc28cbc59da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_256411e4-f966-46ae-870a-9af78a9aed24" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_a4993110-a219-4174-8c8f-2cc28cbc59da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_b5cdec7c-58d9-472d-acd6-debbcc3d858f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_256411e4-f966-46ae-870a-9af78a9aed24" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_b5cdec7c-58d9-472d-acd6-debbcc3d858f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ShareBasedPaymentArrangementTrancheFourMember_d23ef4af-5734-43e7-91a8-6e90978a55a6" xlink:href="zlab-20231231.xsd#zlab_ShareBasedPaymentArrangementTrancheFourMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_256411e4-f966-46ae-870a-9af78a9aed24" xlink:to="loc_zlab_ShareBasedPaymentArrangementTrancheFourMember_d23ef4af-5734-43e7-91a8-6e90978a55a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ShareBasedPaymentArrangementTrancheFiveMember_db1d5907-faf2-4453-acbb-e12a41415625" xlink:href="zlab-20231231.xsd#zlab_ShareBasedPaymentArrangementTrancheFiveMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_256411e4-f966-46ae-870a-9af78a9aed24" xlink:to="loc_zlab_ShareBasedPaymentArrangementTrancheFiveMember_db1d5907-faf2-4453-acbb-e12a41415625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_da26807d-1991-4b02-bc80-cac2682510d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8036a077-edeb-4601-a272-cb1033bae5ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_da26807d-1991-4b02-bc80-cac2682510d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_8f3c5776-60d7-4934-a5f0-1ddbd3bbff25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_da26807d-1991-4b02-bc80-cac2682510d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_8f3c5776-60d7-4934-a5f0-1ddbd3bbff25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_0989fa00-318e-4ae5-8b09-448c74525e5e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_da26807d-1991-4b02-bc80-cac2682510d0" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_0989fa00-318e-4ae5-8b09-448c74525e5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_47ba4067-6669-4825-bd7b-ee4cb1cf49c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_da26807d-1991-4b02-bc80-cac2682510d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_47ba4067-6669-4825-bd7b-ee4cb1cf49c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_da0d9e82-6122-4030-9226-df0000cf3404" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_da26807d-1991-4b02-bc80-cac2682510d0" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_da0d9e82-6122-4030-9226-df0000cf3404" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_f2f77391-a872-40d2-a3d6-274e81a4013a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_da26807d-1991-4b02-bc80-cac2682510d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_f2f77391-a872-40d2-a3d6-274e81a4013a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_356d9d0a-0c05-47d5-bb91-3a1a1f4c51d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_da26807d-1991-4b02-bc80-cac2682510d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_356d9d0a-0c05-47d5-bb91-3a1a1f4c51d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_6b022d8e-ed26-403a-bd8b-081e345d2644" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_da26807d-1991-4b02-bc80-cac2682510d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_6b022d8e-ed26-403a-bd8b-081e345d2644" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_f2c7eac4-fa7c-4ab4-9883-1367f7f366f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_da26807d-1991-4b02-bc80-cac2682510d0" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_f2c7eac4-fa7c-4ab4-9883-1367f7f366f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_ef270816-3c31-4d34-b9e6-68c5b25ca7f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_da26807d-1991-4b02-bc80-cac2682510d0" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_ef270816-3c31-4d34-b9e6-68c5b25ca7f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_01c4106d-fba5-4f08-abd3-47d3d9cc32c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_da26807d-1991-4b02-bc80-cac2682510d0" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_01c4106d-fba5-4f08-abd3-47d3d9cc32c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/ShareBasedCompensationOptionActivityDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#ShareBasedCompensationOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://zailab.com/role/ShareBasedCompensationOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c20a731c-f1af-4336-acc3-bc54523dfddd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2cd43f35-b7c7-4861-8aa3-34cbb1c4dd3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c20a731c-f1af-4336-acc3-bc54523dfddd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2cd43f35-b7c7-4861-8aa3-34cbb1c4dd3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_ba7d0ab9-cfc3-4621-affa-999d81f55650" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2cd43f35-b7c7-4861-8aa3-34cbb1c4dd3f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_ba7d0ab9-cfc3-4621-affa-999d81f55650" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_5a914375-7a25-43e8-8296-04aae0ae6b8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2cd43f35-b7c7-4861-8aa3-34cbb1c4dd3f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_5a914375-7a25-43e8-8296-04aae0ae6b8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_0a231cb1-e2f9-4572-925e-2492414e8b0c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2cd43f35-b7c7-4861-8aa3-34cbb1c4dd3f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_0a231cb1-e2f9-4572-925e-2492414e8b0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_5cba140f-321b-4d0c-8882-13836dce4e70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2cd43f35-b7c7-4861-8aa3-34cbb1c4dd3f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_5cba140f-321b-4d0c-8882-13836dce4e70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e4969fa3-8b71-4bba-ae78-4de200ee3977" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2cd43f35-b7c7-4861-8aa3-34cbb1c4dd3f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e4969fa3-8b71-4bba-ae78-4de200ee3977" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_abcedfcb-0d47-4a52-b208-7c1ae0bf06f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c20a731c-f1af-4336-acc3-bc54523dfddd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_abcedfcb-0d47-4a52-b208-7c1ae0bf06f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_225333e5-55a6-4e5b-ac5e-4edeb198cd3e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_abcedfcb-0d47-4a52-b208-7c1ae0bf06f5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_225333e5-55a6-4e5b-ac5e-4edeb198cd3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_10325587-bbc0-47f3-a192-a98c996fab3b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_abcedfcb-0d47-4a52-b208-7c1ae0bf06f5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_10325587-bbc0-47f3-a192-a98c996fab3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c0a75256-425c-499f-9411-a0e5e25893f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_abcedfcb-0d47-4a52-b208-7c1ae0bf06f5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c0a75256-425c-499f-9411-a0e5e25893f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_7d43ce41-d9a9-4cbd-89cb-929c04c7a7a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_abcedfcb-0d47-4a52-b208-7c1ae0bf06f5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_7d43ce41-d9a9-4cbd-89cb-929c04c7a7a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_dbf51a7c-0134-448f-89fd-a1ace70b279b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_abcedfcb-0d47-4a52-b208-7c1ae0bf06f5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_dbf51a7c-0134-448f-89fd-a1ace70b279b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_28aa6fb2-2309-4fbf-a904-4351a494b753" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c20a731c-f1af-4336-acc3-bc54523dfddd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_28aa6fb2-2309-4fbf-a904-4351a494b753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_f5564162-6d31-4a4d-b518-f022b5310f4c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_28aa6fb2-2309-4fbf-a904-4351a494b753" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_f5564162-6d31-4a4d-b518-f022b5310f4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_659f9c3d-0685-4786-8aec-7ba2caff3429" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_28aa6fb2-2309-4fbf-a904-4351a494b753" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_659f9c3d-0685-4786-8aec-7ba2caff3429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_19b54230-d970-4616-9185-811b60a6aa3e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_28aa6fb2-2309-4fbf-a904-4351a494b753" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_19b54230-d970-4616-9185-811b60a6aa3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_b43e07ef-6569-48d3-a1ca-ca9aee2c2d0c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_28aa6fb2-2309-4fbf-a904-4351a494b753" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_b43e07ef-6569-48d3-a1ca-ca9aee2c2d0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_63d5e5ca-f3a7-41ec-946d-55ffe26f7795" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_28aa6fb2-2309-4fbf-a904-4351a494b753" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_63d5e5ca-f3a7-41ec-946d-55ffe26f7795" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_98a991ba-24a1-45fb-b3a0-e08b19ae39e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_28aa6fb2-2309-4fbf-a904-4351a494b753" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_98a991ba-24a1-45fb-b3a0-e08b19ae39e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/ShareBasedCompensationAssumptionsUsedtoEstimateFairValuesofShareOptionsGrantedDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#ShareBasedCompensationAssumptionsUsedtoEstimateFairValuesofShareOptionsGrantedDetails"/>
  <link:presentationLink xlink:role="http://zailab.com/role/ShareBasedCompensationAssumptionsUsedtoEstimateFairValuesofShareOptionsGrantedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_31c57642-826f-4ac0-b625-912b901a515c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a41161c1-4805-408f-ae04-8fc5b439ac91" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_31c57642-826f-4ac0-b625-912b901a515c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a41161c1-4805-408f-ae04-8fc5b439ac91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_86d049c6-afeb-4ad3-a8d3-4f31a9047806" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a41161c1-4805-408f-ae04-8fc5b439ac91" xlink:to="loc_us-gaap_AwardTypeAxis_86d049c6-afeb-4ad3-a8d3-4f31a9047806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_695128fc-8006-48a8-92bd-e0b15e02e32d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_86d049c6-afeb-4ad3-a8d3-4f31a9047806" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_695128fc-8006-48a8-92bd-e0b15e02e32d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_cf2032b5-49d3-49a6-ab79-aee7a271f9d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_695128fc-8006-48a8-92bd-e0b15e02e32d" xlink:to="loc_us-gaap_EmployeeStockOptionMember_cf2032b5-49d3-49a6-ab79-aee7a271f9d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ShareBasedPaymentArrangementOptionBatchOneMember_fa5d524b-06be-434d-b63e-da54a9e4d8b0" xlink:href="zlab-20231231.xsd#zlab_ShareBasedPaymentArrangementOptionBatchOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeStockOptionMember_cf2032b5-49d3-49a6-ab79-aee7a271f9d1" xlink:to="loc_zlab_ShareBasedPaymentArrangementOptionBatchOneMember_fa5d524b-06be-434d-b63e-da54a9e4d8b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ShareBasedPaymentArrangementOptionBatchTwoMember_7a71ad26-955d-4df6-9202-e0bc3e69cd2f" xlink:href="zlab-20231231.xsd#zlab_ShareBasedPaymentArrangementOptionBatchTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeStockOptionMember_cf2032b5-49d3-49a6-ab79-aee7a271f9d1" xlink:to="loc_zlab_ShareBasedPaymentArrangementOptionBatchTwoMember_7a71ad26-955d-4df6-9202-e0bc3e69cd2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ShareBasedPaymentArrangementOptionBatchThreeMember_937fa965-8ef6-4677-bcf2-0a12e0c7cd16" xlink:href="zlab-20231231.xsd#zlab_ShareBasedPaymentArrangementOptionBatchThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeStockOptionMember_cf2032b5-49d3-49a6-ab79-aee7a271f9d1" xlink:to="loc_zlab_ShareBasedPaymentArrangementOptionBatchThreeMember_937fa965-8ef6-4677-bcf2-0a12e0c7cd16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9f078987-946b-40dd-a909-814592e13f71" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a41161c1-4805-408f-ae04-8fc5b439ac91" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9f078987-946b-40dd-a909-814592e13f71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_4cf2249b-e0e8-402f-88c4-c2f26bde073f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9f078987-946b-40dd-a909-814592e13f71" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_4cf2249b-e0e8-402f-88c4-c2f26bde073f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_03d926ec-8d45-43af-93fe-58ffa524a1fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9f078987-946b-40dd-a909-814592e13f71" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_03d926ec-8d45-43af-93fe-58ffa524a1fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_8f9f5f5f-ab2b-4676-9974-7af9d8f8372e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9f078987-946b-40dd-a909-814592e13f71" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_8f9f5f5f-ab2b-4676-9974-7af9d8f8372e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_c3c389e2-c805-4f92-8e85-dfda233e399b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9f078987-946b-40dd-a909-814592e13f71" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_c3c389e2-c805-4f92-8e85-dfda233e399b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_0cedfb11-ffe1-4ece-bd85-46cdfe5b1529" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9f078987-946b-40dd-a909-814592e13f71" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_0cedfb11-ffe1-4ece-bd85-46cdfe5b1529" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/ShareBasedCompensationNonvestedRestrictedShareActivityDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#ShareBasedCompensationNonvestedRestrictedShareActivityDetails"/>
  <link:presentationLink xlink:role="http://zailab.com/role/ShareBasedCompensationNonvestedRestrictedShareActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_14a9f2f7-31cf-4e8a-a816-278201d29f96" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ec7532e0-470d-414b-bb07-23a2a1602c41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_14a9f2f7-31cf-4e8a-a816-278201d29f96" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ec7532e0-470d-414b-bb07-23a2a1602c41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_41b59219-09b1-4eb7-b563-0fcfbc1b03ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ec7532e0-470d-414b-bb07-23a2a1602c41" xlink:to="loc_us-gaap_AwardTypeAxis_41b59219-09b1-4eb7-b563-0fcfbc1b03ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9dd268cb-b445-4ae2-823a-8e9385007955" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_41b59219-09b1-4eb7-b563-0fcfbc1b03ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9dd268cb-b445-4ae2-823a-8e9385007955" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_NonVestedRestrictedSharesMember_53640b56-2274-46ed-b867-13a8b058fc3f" xlink:href="zlab-20231231.xsd#zlab_NonVestedRestrictedSharesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9dd268cb-b445-4ae2-823a-8e9385007955" xlink:to="loc_zlab_NonVestedRestrictedSharesMember_53640b56-2274-46ed-b867-13a8b058fc3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a39e42e5-fded-4cf4-b4b8-1726aec08c09" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ec7532e0-470d-414b-bb07-23a2a1602c41" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a39e42e5-fded-4cf4-b4b8-1726aec08c09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_798a2457-5988-4e5e-a6e4-3337755ab05e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a39e42e5-fded-4cf4-b4b8-1726aec08c09" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_798a2457-5988-4e5e-a6e4-3337755ab05e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5a445d7b-6a30-4456-a360-2f13c2d41402" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_798a2457-5988-4e5e-a6e4-3337755ab05e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5a445d7b-6a30-4456-a360-2f13c2d41402" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_ffc4d17e-5b7a-4db7-832f-b278555acc27" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_798a2457-5988-4e5e-a6e4-3337755ab05e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_ffc4d17e-5b7a-4db7-832f-b278555acc27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_eca252f5-0051-4549-9963-7ff8ece99aba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_798a2457-5988-4e5e-a6e4-3337755ab05e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_eca252f5-0051-4549-9963-7ff8ece99aba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_22e7a336-aa58-4c72-9b93-6e7095d9f946" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_798a2457-5988-4e5e-a6e4-3337755ab05e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_22e7a336-aa58-4c72-9b93-6e7095d9f946" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_ee333a30-5a3b-4a43-b6e3-117fb40258d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_798a2457-5988-4e5e-a6e4-3337755ab05e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_ee333a30-5a3b-4a43-b6e3-117fb40258d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_92932300-c4c4-4629-a16a-7e10d27ea478" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a39e42e5-fded-4cf4-b4b8-1726aec08c09" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_92932300-c4c4-4629-a16a-7e10d27ea478" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_592dc85c-2a68-477a-9702-9a5a0a3f2af3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a39e42e5-fded-4cf4-b4b8-1726aec08c09" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_592dc85c-2a68-477a-9702-9a5a0a3f2af3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/ShareBasedCompensationCompensationExpenseDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#ShareBasedCompensationCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://zailab.com/role/ShareBasedCompensationCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ddb31d57-dc60-4db6-935c-cc7f217f21bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1ac74218-2291-4d3c-a9e0-41db720b973d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ddb31d57-dc60-4db6-935c-cc7f217f21bc" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1ac74218-2291-4d3c-a9e0-41db720b973d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_371cb489-0798-4b89-b7d9-88616be7af25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1ac74218-2291-4d3c-a9e0-41db720b973d" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_371cb489-0798-4b89-b7d9-88616be7af25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8b05b8fc-12dc-41d9-8f92-f5d91c100752" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_371cb489-0798-4b89-b7d9-88616be7af25" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8b05b8fc-12dc-41d9-8f92-f5d91c100752" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_e1231d71-7c8b-4f71-b7c2-dab85bdb2f14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8b05b8fc-12dc-41d9-8f92-f5d91c100752" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_e1231d71-7c8b-4f71-b7c2-dab85bdb2f14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_f3051ba5-217b-4a03-b9c3-59b56511883d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8b05b8fc-12dc-41d9-8f92-f5d91c100752" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_f3051ba5-217b-4a03-b9c3-59b56511883d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_006101a4-e55c-4e2c-9382-963832a39fcc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1ac74218-2291-4d3c-a9e0-41db720b973d" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_006101a4-e55c-4e2c-9382-963832a39fcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_05c5c25c-2920-4f82-8883-a0e2fe75af97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_006101a4-e55c-4e2c-9382-963832a39fcc" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_05c5c25c-2920-4f82-8883-a0e2fe75af97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/LicenseandCollaborationAgreementsDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#LicenseandCollaborationAgreementsDetails"/>
  <link:presentationLink xlink:role="http://zailab.com/role/LicenseandCollaborationAgreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_41752b42-17b7-4e95-b179-9a9c8b4b3c0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_c0218d13-fa61-4317-81dc-31e83efd14a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_41752b42-17b7-4e95-b179-9a9c8b4b3c0a" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_c0218d13-fa61-4317-81dc-31e83efd14a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_e9ef8fe8-94f8-4a96-8c23-8532a9541a9b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_c0218d13-fa61-4317-81dc-31e83efd14a9" xlink:to="loc_us-gaap_TypeOfArrangementAxis_e9ef8fe8-94f8-4a96-8c23-8532a9541a9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_94fa9a22-0d6e-4b62-b636-9a81b9f538c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_e9ef8fe8-94f8-4a96-8c23-8532a9541a9b" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_94fa9a22-0d6e-4b62-b636-9a81b9f538c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_b5204d6a-4d96-4c27-a0bc-04ae5c33b3f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_94fa9a22-0d6e-4b62-b636-9a81b9f538c0" xlink:to="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_b5204d6a-4d96-4c27-a0bc-04ae5c33b3f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_ccff4d9d-cdb2-4f76-9363-fb037218c468" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_c0218d13-fa61-4317-81dc-31e83efd14a9" xlink:to="loc_srt_CounterpartyNameAxis_ccff4d9d-cdb2-4f76-9363-fb037218c468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4deff456-9b6b-4979-a5fc-f40e7b0436f9" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_ccff4d9d-cdb2-4f76-9363-fb037218c468" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4deff456-9b6b-4979-a5fc-f40e7b0436f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_GlaxoSmithKlineMember_a1fcad19-9a9b-4b27-aa4e-1cf1cff0365d" xlink:href="zlab-20231231.xsd#zlab_GlaxoSmithKlineMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4deff456-9b6b-4979-a5fc-f40e7b0436f9" xlink:to="loc_zlab_GlaxoSmithKlineMember_a1fcad19-9a9b-4b27-aa4e-1cf1cff0365d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_NovocureLimitedMember_601884d7-ebf0-4b73-8e7e-4d2958ec0548" xlink:href="zlab-20231231.xsd#zlab_NovocureLimitedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4deff456-9b6b-4979-a5fc-f40e7b0436f9" xlink:to="loc_zlab_NovocureLimitedMember_601884d7-ebf0-4b73-8e7e-4d2958ec0548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_DecipheraPharmaceuticalsLLCMember_7d9bc589-c217-45b1-acf7-0c2ed6368c79" xlink:href="zlab-20231231.xsd#zlab_DecipheraPharmaceuticalsLLCMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4deff456-9b6b-4979-a5fc-f40e7b0436f9" xlink:to="loc_zlab_DecipheraPharmaceuticalsLLCMember_7d9bc589-c217-45b1-acf7-0c2ed6368c79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_GurnetPointCapitalAndNovoHoldingsASMember_8b4dfc64-98e2-4491-b74e-fb65b4b69f7a" xlink:href="zlab-20231231.xsd#zlab_GurnetPointCapitalAndNovoHoldingsASMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4deff456-9b6b-4979-a5fc-f40e7b0436f9" xlink:to="loc_zlab_GurnetPointCapitalAndNovoHoldingsASMember_8b4dfc64-98e2-4491-b74e-fb65b4b69f7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ArgenxBvMember_c9294563-50ef-4417-ad49-ffa7353d350d" xlink:href="zlab-20231231.xsd#zlab_ArgenxBvMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4deff456-9b6b-4979-a5fc-f40e7b0436f9" xlink:to="loc_zlab_ArgenxBvMember_c9294563-50ef-4417-ad49-ffa7353d350d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_AmgenMember_4c749202-48ec-4814-abb6-495894ac90cc" xlink:href="zlab-20231231.xsd#zlab_AmgenMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4deff456-9b6b-4979-a5fc-f40e7b0436f9" xlink:to="loc_zlab_AmgenMember_4c749202-48ec-4814-abb6-495894ac90cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_InnovivaInc.Member_c70282b0-b8b1-48c4-81a2-d23637f42496" xlink:href="zlab-20231231.xsd#zlab_InnovivaInc.Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4deff456-9b6b-4979-a5fc-f40e7b0436f9" xlink:to="loc_zlab_InnovivaInc.Member_c70282b0-b8b1-48c4-81a2-d23637f42496" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_BMSMember_6fbbb2b5-8d65-4c7a-aa03-9729a1bd9778" xlink:href="zlab-20231231.xsd#zlab_BMSMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4deff456-9b6b-4979-a5fc-f40e7b0436f9" xlink:to="loc_zlab_BMSMember_6fbbb2b5-8d65-4c7a-aa03-9729a1bd9778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_PfizerIncMember_de954c8b-1028-4fbd-86f4-adebfdac015e" xlink:href="zlab-20231231.xsd#zlab_PfizerIncMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4deff456-9b6b-4979-a5fc-f40e7b0436f9" xlink:to="loc_zlab_PfizerIncMember_de954c8b-1028-4fbd-86f4-adebfdac015e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_OtherCounterpartiesMember_ccd19546-7e75-4f3e-a67f-418a9b64df83" xlink:href="zlab-20231231.xsd#zlab_OtherCounterpartiesMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4deff456-9b6b-4979-a5fc-f40e7b0436f9" xlink:to="loc_zlab_OtherCounterpartiesMember_ccd19546-7e75-4f3e-a67f-418a9b64df83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_90bf6a7a-67cd-440d-a101-7ad4665f403e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_c0218d13-fa61-4317-81dc-31e83efd14a9" xlink:to="loc_srt_ProductOrServiceAxis_90bf6a7a-67cd-440d-a101-7ad4665f403e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e53dc2bd-221b-4311-b2f8-b417c30406f6" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_90bf6a7a-67cd-440d-a101-7ad4665f403e" xlink:to="loc_srt_ProductsAndServicesDomain_e53dc2bd-221b-4311-b2f8-b417c30406f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_RepotrectinibMember_e5a3aca7-854a-4eae-a772-4095ee80740c" xlink:href="zlab-20231231.xsd#zlab_RepotrectinibMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_e53dc2bd-221b-4311-b2f8-b417c30406f6" xlink:to="loc_zlab_RepotrectinibMember_e5a3aca7-854a-4eae-a772-4095ee80740c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_AdagrasibMember_faab749f-9c8f-4fa1-a88e-88b81199c4cc" xlink:href="zlab-20231231.xsd#zlab_AdagrasibMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_e53dc2bd-221b-4311-b2f8-b417c30406f6" xlink:to="loc_zlab_AdagrasibMember_faab749f-9c8f-4fa1-a88e-88b81199c4cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_XanomelineTrospiumMember_59e93ede-7892-4d7b-8636-f55360b5cc43" xlink:href="zlab-20231231.xsd#zlab_XanomelineTrospiumMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_e53dc2bd-221b-4311-b2f8-b417c30406f6" xlink:to="loc_zlab_XanomelineTrospiumMember_59e93ede-7892-4d7b-8636-f55360b5cc43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_12c963bd-e34d-47d3-9fb6-68ca392ea532" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_c0218d13-fa61-4317-81dc-31e83efd14a9" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_12c963bd-e34d-47d3-9fb6-68ca392ea532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_CollaborativeArrangementRightsAndObligationsSpecifiedRoyaltyTerm_872cdafa-f7ad-4f30-88ee-68b6c743ac9c" xlink:href="zlab-20231231.xsd#zlab_CollaborativeArrangementRightsAndObligationsSpecifiedRoyaltyTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_12c963bd-e34d-47d3-9fb6-68ca392ea532" xlink:to="loc_zlab_CollaborativeArrangementRightsAndObligationsSpecifiedRoyaltyTerm_872cdafa-f7ad-4f30-88ee-68b6c743ac9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_ce0739d1-d40c-46c3-a0ce-59519ac1a979" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_12c963bd-e34d-47d3-9fb6-68ca392ea532" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_ce0739d1-d40c-46c3-a0ce-59519ac1a979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_CollaborativeArrangementRightsAndObligationsSalesBasedMilestonePayment_08807dd7-b789-4a9d-9bcf-395debed14f7" xlink:href="zlab-20231231.xsd#zlab_CollaborativeArrangementRightsAndObligationsSalesBasedMilestonePayment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_12c963bd-e34d-47d3-9fb6-68ca392ea532" xlink:to="loc_zlab_CollaborativeArrangementRightsAndObligationsSalesBasedMilestonePayment_08807dd7-b789-4a9d-9bcf-395debed14f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments_10a5e468-3af9-425a-8211-6551c91aae76" xlink:href="zlab-20231231.xsd#zlab_CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_12c963bd-e34d-47d3-9fb6-68ca392ea532" xlink:to="loc_zlab_CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments_10a5e468-3af9-425a-8211-6551c91aae76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_86e6b9e6-4771-4d53-a111-016333d74bb3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_12c963bd-e34d-47d3-9fb6-68ca392ea532" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_86e6b9e6-4771-4d53-a111-016333d74bb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_CollaborativeArrangementRightsAndObligationsPaymentOfUpFrontFeesForLicenseAgreement_3925e295-6c57-49b9-beb9-64127d749323" xlink:href="zlab-20231231.xsd#zlab_CollaborativeArrangementRightsAndObligationsPaymentOfUpFrontFeesForLicenseAgreement"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_12c963bd-e34d-47d3-9fb6-68ca392ea532" xlink:to="loc_zlab_CollaborativeArrangementRightsAndObligationsPaymentOfUpFrontFeesForLicenseAgreement_3925e295-6c57-49b9-beb9-64127d749323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_CollaborativeArrangementRightsAndObligationsDevelopmentMilestonePayment_070244cc-089b-46ad-bda7-243f316cca06" xlink:href="zlab-20231231.xsd#zlab_CollaborativeArrangementRightsAndObligationsDevelopmentMilestonePayment"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_12c963bd-e34d-47d3-9fb6-68ca392ea532" xlink:to="loc_zlab_CollaborativeArrangementRightsAndObligationsDevelopmentMilestonePayment_070244cc-089b-46ad-bda7-243f316cca06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/OtherIncomeExpensesNetDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#OtherIncomeExpensesNetDetails"/>
  <link:presentationLink xlink:role="http://zailab.com/role/OtherIncomeExpensesNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_b302267f-5ea5-420b-b6ed-25e3d3604714" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_GovernmentAssistanceNonoperatingIncome_48e38842-9d0b-4773-b2df-2fa3371ad9d4" xlink:href="zlab-20231231.xsd#zlab_GovernmentAssistanceNonoperatingIncome"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_b302267f-5ea5-420b-b6ed-25e3d3604714" xlink:to="loc_zlab_GovernmentAssistanceNonoperatingIncome_48e38842-9d0b-4773-b2df-2fa3371ad9d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_19b58ddd-9f25-4447-9c6c-574b4736cffd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_b302267f-5ea5-420b-b6ed-25e3d3604714" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_19b58ddd-9f25-4447-9c6c-574b4736cffd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingGainsLosses_476a78b4-7724-4f4b-9036-d5769484b076" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingGainsLosses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_b302267f-5ea5-420b-b6ed-25e3d3604714" xlink:to="loc_us-gaap_OtherNonoperatingGainsLosses_476a78b4-7724-4f4b-9036-d5769484b076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_984ffc4e-9180-4fbf-a9e1-e63f073e140f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_b302267f-5ea5-420b-b6ed-25e3d3604714" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_984ffc4e-9180-4fbf-a9e1-e63f073e140f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/RestrictedNetAssetsDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#RestrictedNetAssetsDetails"/>
  <link:presentationLink xlink:role="http://zailab.com/role/RestrictedNetAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_zlab_RestrictedNetAssetsAbstract_9505ae3b-2425-41e1-8bc6-7cab67c147b7" xlink:href="zlab-20231231.xsd#zlab_RestrictedNetAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_RestrictedNetAssetsTable_1a1f6522-fcad-4750-95ec-0676fa5b401e" xlink:href="zlab-20231231.xsd#zlab_RestrictedNetAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_RestrictedNetAssetsAbstract_9505ae3b-2425-41e1-8bc6-7cab67c147b7" xlink:to="loc_zlab_RestrictedNetAssetsTable_1a1f6522-fcad-4750-95ec-0676fa5b401e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_9dc0ad04-375f-47c8-ab02-0bc84710a298" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_RestrictedNetAssetsTable_1a1f6522-fcad-4750-95ec-0676fa5b401e" xlink:to="loc_srt_StatementGeographicalAxis_9dc0ad04-375f-47c8-ab02-0bc84710a298" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_0d433946-6256-40d4-94d4-81b4095d8ded" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_9dc0ad04-375f-47c8-ab02-0bc84710a298" xlink:to="loc_srt_SegmentGeographicalDomain_0d433946-6256-40d4-94d4-81b4095d8ded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN_2b7619d5-009b-4033-bfc5-37f31c7b1481" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_CN"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_0d433946-6256-40d4-94d4-81b4095d8ded" xlink:to="loc_country_CN_2b7619d5-009b-4033-bfc5-37f31c7b1481" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_RestrictedNetAssetsLineItems_48545c19-ede8-4d63-8f89-aec736045879" xlink:href="zlab-20231231.xsd#zlab_RestrictedNetAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_RestrictedNetAssetsTable_1a1f6522-fcad-4750-95ec-0676fa5b401e" xlink:to="loc_zlab_RestrictedNetAssetsLineItems_48545c19-ede8-4d63-8f89-aec736045879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_StatutoryReserves_cfdde950-5d4f-4fc9-acf2-06ecfe7f78b7" xlink:href="zlab-20231231.xsd#zlab_StatutoryReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_RestrictedNetAssetsLineItems_48545c19-ede8-4d63-8f89-aec736045879" xlink:to="loc_zlab_StatutoryReserves_cfdde950-5d4f-4fc9-acf2-06ecfe7f78b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries_6ec30ff1-e19b-4662-a6fd-c35fba4699ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zlab_RestrictedNetAssetsLineItems_48545c19-ede8-4d63-8f89-aec736045879" xlink:to="loc_us-gaap_AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries_6ec30ff1-e19b-4662-a6fd-c35fba4699ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/EmployeeDefinedContributionPlansDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#EmployeeDefinedContributionPlansDetails"/>
  <link:presentationLink xlink:role="http://zailab.com/role/EmployeeDefinedContributionPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_22383f2e-6fc0-43b2-82d2-3378d227c27b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanTable_8143cb64-ec6a-4aa3-90e5-34c4a8d6103c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_22383f2e-6fc0-43b2-82d2-3378d227c27b" xlink:to="loc_us-gaap_DefinedContributionPlanTable_8143cb64-ec6a-4aa3-90e5-34c4a8d6103c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e81af527-6d9d-45e2-943e-b8cfbf3f2019" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedContributionPlanTable_8143cb64-ec6a-4aa3-90e5-34c4a8d6103c" xlink:to="loc_srt_RangeAxis_e81af527-6d9d-45e2-943e-b8cfbf3f2019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_19e7fad2-0886-46dc-b23f-d3c9d57d0ed8" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_e81af527-6d9d-45e2-943e-b8cfbf3f2019" xlink:to="loc_srt_RangeMember_19e7fad2-0886-46dc-b23f-d3c9d57d0ed8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_27d3489c-965f-4ffd-a12b-d154519f13a3" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_19e7fad2-0886-46dc-b23f-d3c9d57d0ed8" xlink:to="loc_srt_MaximumMember_27d3489c-965f-4ffd-a12b-d154519f13a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_d08471f4-89ff-42d2-ac30-57ce11f1e7be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedContributionPlanTable_8143cb64-ec6a-4aa3-90e5-34c4a8d6103c" xlink:to="loc_us-gaap_RetirementPlanNameAxis_d08471f4-89ff-42d2-ac30-57ce11f1e7be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_ba73fc47-7ade-48f6-a698-fcbd4018ace5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameAxis_d08471f4-89ff-42d2-ac30-57ce11f1e7be" xlink:to="loc_us-gaap_RetirementPlanNameDomain_ba73fc47-7ade-48f6-a698-fcbd4018ace5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_MainlandChinaGovernmentPlanMember_0a91e5c4-48f0-44d2-954e-a9737bcadcee" xlink:href="zlab-20231231.xsd#zlab_MainlandChinaGovernmentPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_ba73fc47-7ade-48f6-a698-fcbd4018ace5" xlink:to="loc_zlab_MainlandChinaGovernmentPlanMember_0a91e5c4-48f0-44d2-954e-a9737bcadcee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_A401kPlanMember_cf215cc5-10ea-4789-b65f-15ef741c6c87" xlink:href="zlab-20231231.xsd#zlab_A401kPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_ba73fc47-7ade-48f6-a698-fcbd4018ace5" xlink:to="loc_zlab_A401kPlanMember_cf215cc5-10ea-4789-b65f-15ef741c6c87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_MandatoryProvidentFundMember_b83f0a6e-f299-49c2-8108-560860ffde4c" xlink:href="zlab-20231231.xsd#zlab_MandatoryProvidentFundMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_ba73fc47-7ade-48f6-a698-fcbd4018ace5" xlink:to="loc_zlab_MandatoryProvidentFundMember_b83f0a6e-f299-49c2-8108-560860ffde4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanDisclosureLineItems_77dc50f2-72b1-466e-92a7-8bc7571ef123" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedContributionPlanTable_8143cb64-ec6a-4aa3-90e5-34c4a8d6103c" xlink:to="loc_us-gaap_DefinedContributionPlanDisclosureLineItems_77dc50f2-72b1-466e-92a7-8bc7571ef123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_02859650-ea71-4b20-9da8-477118043965" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedContributionPlanDisclosureLineItems_77dc50f2-72b1-466e-92a7-8bc7571ef123" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_02859650-ea71-4b20-9da8-477118043965" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_cab63296-9630-414b-b4e4-30ea57c7f95b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedContributionPlanDisclosureLineItems_77dc50f2-72b1-466e-92a7-8bc7571ef123" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_cab63296-9630-414b-b4e4-30ea57c7f95b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_DefinedContributionPlanEmployerMatchingContributionPercentOfEmployeeContribution_fca0d975-246c-42a5-8779-1f808048a760" xlink:href="zlab-20231231.xsd#zlab_DefinedContributionPlanEmployerMatchingContributionPercentOfEmployeeContribution"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedContributionPlanDisclosureLineItems_77dc50f2-72b1-466e-92a7-8bc7571ef123" xlink:to="loc_zlab_DefinedContributionPlanEmployerMatchingContributionPercentOfEmployeeContribution_fca0d975-246c-42a5-8779-1f808048a760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_3e35e7ac-f7ba-4fbb-9532-b5c039034997" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedContributionPlanDisclosureLineItems_77dc50f2-72b1-466e-92a7-8bc7571ef123" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_3e35e7ac-f7ba-4fbb-9532-b5c039034997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#CommitmentsandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://zailab.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_268e0711-6c28-4258-b8ed-9f2202e9e31b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_e58d2381-9fd7-4f54-bf05-afc6c09f2897" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_268e0711-6c28-4258-b8ed-9f2202e9e31b" xlink:to="loc_us-gaap_LossContingenciesTable_e58d2381-9fd7-4f54-bf05-afc6c09f2897" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_86a952c5-88a3-4b60-93aa-075aadef4b82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_e58d2381-9fd7-4f54-bf05-afc6c09f2897" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_86a952c5-88a3-4b60-93aa-075aadef4b82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_ee24d9f2-d397-49e4-8098-7ae955fc5fd8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_86a952c5-88a3-4b60-93aa-075aadef4b82" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_ee24d9f2-d397-49e4-8098-7ae955fc5fd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_7b935870-d6a0-4ce0-b13b-b4edae920679" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_ee24d9f2-d397-49e4-8098-7ae955fc5fd8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_7b935870-d6a0-4ce0-b13b-b4edae920679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_75a83c22-cac7-416f-9cbb-60a7c79fbb03" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_e58d2381-9fd7-4f54-bf05-afc6c09f2897" xlink:to="loc_us-gaap_LossContingenciesLineItems_75a83c22-cac7-416f-9cbb-60a7c79fbb03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationDueInNextRollingTwelveMonths_17c91d87-e5bc-485d-959a-4e8bcfa078b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationDueInNextRollingTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_75a83c22-cac7-416f-9cbb-60a7c79fbb03" xlink:to="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationDueInNextRollingTwelveMonths_17c91d87-e5bc-485d-959a-4e8bcfa078b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#SubsequentEventsDetails"/>
  <link:presentationLink xlink:role="http://zailab.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_ab563009-04d2-4661-994a-e88f164a7e02" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_cdbe2fc7-d0c5-405c-9258-bbc4ad653f6f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_ab563009-04d2-4661-994a-e88f164a7e02" xlink:to="loc_us-gaap_SubsequentEventTable_cdbe2fc7-d0c5-405c-9258-bbc4ad653f6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_0a6d44df-aa9b-495f-b977-7ee34c8530f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_cdbe2fc7-d0c5-405c-9258-bbc4ad653f6f" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_0a6d44df-aa9b-495f-b977-7ee34c8530f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_10f9b45a-483d-49a8-bf56-bf838433c42e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_0a6d44df-aa9b-495f-b977-7ee34c8530f7" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_10f9b45a-483d-49a8-bf56-bf838433c42e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_bd1f10e4-e521-46ee-a166-c41fd4c1afc0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_10f9b45a-483d-49a8-bf56-bf838433c42e" xlink:to="loc_us-gaap_SubsequentEventMember_bd1f10e4-e521-46ee-a166-c41fd4c1afc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_984853fd-30a0-4904-a5b0-540c59e5c3ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_cdbe2fc7-d0c5-405c-9258-bbc4ad653f6f" xlink:to="loc_us-gaap_DebtInstrumentAxis_984853fd-30a0-4904-a5b0-540c59e5c3ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_cad4921c-9560-4e53-99c9-3d5ce50040e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_984853fd-30a0-4904-a5b0-540c59e5c3ac" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_cad4921c-9560-4e53-99c9-3d5ce50040e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_BankOfChinaWorkingCapitalLoanFacilityMember_51933de1-ab29-4e15-9d0f-9253ef5b82c3" xlink:href="zlab-20231231.xsd#zlab_BankOfChinaWorkingCapitalLoanFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cad4921c-9560-4e53-99c9-3d5ce50040e8" xlink:to="loc_zlab_BankOfChinaWorkingCapitalLoanFacilityMember_51933de1-ab29-4e15-9d0f-9253ef5b82c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_SPDBankWorkingCapitalLoanFacilityMember_ddb466c6-03bc-41b4-92c6-f545f93c59b1" xlink:href="zlab-20231231.xsd#zlab_SPDBankWorkingCapitalLoanFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cad4921c-9560-4e53-99c9-3d5ce50040e8" xlink:to="loc_zlab_SPDBankWorkingCapitalLoanFacilityMember_ddb466c6-03bc-41b4-92c6-f545f93c59b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_NingboBankWorkingCapitalLoanFacilityMember_28f9ab4a-3bd1-4094-84a9-cc7541e425a0" xlink:href="zlab-20231231.xsd#zlab_NingboBankWorkingCapitalLoanFacilityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cad4921c-9560-4e53-99c9-3d5ce50040e8" xlink:to="loc_zlab_NingboBankWorkingCapitalLoanFacilityMember_28f9ab4a-3bd1-4094-84a9-cc7541e425a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_c265b018-af8e-49a0-bb3d-6b6f66f75d7c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_cdbe2fc7-d0c5-405c-9258-bbc4ad653f6f" xlink:to="loc_us-gaap_CreditFacilityAxis_c265b018-af8e-49a0-bb3d-6b6f66f75d7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_4612f2c4-e540-44f2-aae0-5fcbad32d45c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_c265b018-af8e-49a0-bb3d-6b6f66f75d7c" xlink:to="loc_us-gaap_CreditFacilityDomain_4612f2c4-e540-44f2-aae0-5fcbad32d45c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandbyLettersOfCreditMember_cf7cc379-b73f-4637-b6e6-c30247c0e7f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StandbyLettersOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_4612f2c4-e540-44f2-aae0-5fcbad32d45c" xlink:to="loc_us-gaap_StandbyLettersOfCreditMember_cf7cc379-b73f-4637-b6e6-c30247c0e7f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_bad32c49-e349-43eb-8694-f871e66e46fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_cdbe2fc7-d0c5-405c-9258-bbc4ad653f6f" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_bad32c49-e349-43eb-8694-f871e66e46fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_74ff1745-bc2e-4e59-8b03-ce45906cdfd4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_bad32c49-e349-43eb-8694-f871e66e46fc" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_74ff1745-bc2e-4e59-8b03-ce45906cdfd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_412b2a69-fc5a-4002-add5-baa429501245" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_74ff1745-bc2e-4e59-8b03-ce45906cdfd4" xlink:to="loc_us-gaap_LoansPayableMember_412b2a69-fc5a-4002-add5-baa429501245" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_4bf2dd52-02bd-4484-a676-7cc9d9927a07" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_cdbe2fc7-d0c5-405c-9258-bbc4ad653f6f" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_4bf2dd52-02bd-4484-a676-7cc9d9927a07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f01f0048-e93d-424a-aa23-b58f5f008784" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_4bf2dd52-02bd-4484-a676-7cc9d9927a07" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f01f0048-e93d-424a-aa23-b58f5f008784" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_98dca4e9-a0d8-40e6-a460-bfafcaf25388" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f01f0048-e93d-424a-aa23-b58f5f008784" xlink:to="loc_us-gaap_LoansPayableMember_98dca4e9-a0d8-40e6-a460-bfafcaf25388" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_2c4d6509-862e-475c-8a2d-65cdd9d90713" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_cdbe2fc7-d0c5-405c-9258-bbc4ad653f6f" xlink:to="loc_dei_LegalEntityAxis_2c4d6509-862e-475c-8a2d-65cdd9d90713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_13cfafd7-30cf-4d3d-86ee-a8c1822fbf54" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_2c4d6509-862e-475c-8a2d-65cdd9d90713" xlink:to="loc_dei_EntityDomain_13cfafd7-30cf-4d3d-86ee-a8c1822fbf54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ZaiLabShanghaiCo.Ltd.Member_bbbc84d7-06f6-4c6c-9f29-153fd2187bd5" xlink:href="zlab-20231231.xsd#zlab_ZaiLabShanghaiCo.Ltd.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_13cfafd7-30cf-4d3d-86ee-a8c1822fbf54" xlink:to="loc_zlab_ZaiLabShanghaiCo.Ltd.Member_bbbc84d7-06f6-4c6c-9f29-153fd2187bd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ZaiLabSuzhouCompanyLimitedMember_f5da70c8-27cc-47b2-8ed4-f8be29061f73" xlink:href="zlab-20231231.xsd#zlab_ZaiLabSuzhouCompanyLimitedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_13cfafd7-30cf-4d3d-86ee-a8c1822fbf54" xlink:to="loc_zlab_ZaiLabSuzhouCompanyLimitedMember_f5da70c8-27cc-47b2-8ed4-f8be29061f73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_1187d88e-86f7-43b6-af3b-d675d67e57df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_cdbe2fc7-d0c5-405c-9258-bbc4ad653f6f" xlink:to="loc_us-gaap_SubsequentEventLineItems_1187d88e-86f7-43b6-af3b-d675d67e57df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_49b6368f-5b25-456f-8de7-a47b5d783fa7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_1187d88e-86f7-43b6-af3b-d675d67e57df" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_49b6368f-5b25-456f-8de7-a47b5d783fa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_afe3d35c-f8fa-488f-b602-430e10fa6671" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_1187d88e-86f7-43b6-af3b-d675d67e57df" xlink:to="loc_us-gaap_DebtInstrumentTerm_afe3d35c-f8fa-488f-b602-430e10fa6671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFeeAmount_16fbdade-ecc0-466a-88d2-75d45593f768" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFeeAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_1187d88e-86f7-43b6-af3b-d675d67e57df" xlink:to="loc_us-gaap_DebtInstrumentFeeAmount_16fbdade-ecc0-466a-88d2-75d45593f768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_1453dbb4-4afb-4511-a67c-91f294b43d00" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_1187d88e-86f7-43b6-af3b-d675d67e57df" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_1453dbb4-4afb-4511-a67c-91f294b43d00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_365d57a9-3247-4298-b6cb-fab83b3a6268" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_1187d88e-86f7-43b6-af3b-d675d67e57df" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_365d57a9-3247-4298-b6cb-fab83b3a6268" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_91cce23c-f07c-4da7-a3b5-87cc2dcd8148" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_1187d88e-86f7-43b6-af3b-d675d67e57df" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_91cce23c-f07c-4da7-a3b5-87cc2dcd8148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_DebtInstrumentVariableInterestRateAdjustmentPeriod_bf2ae755-f467-474b-ac08-7a599a42304b" xlink:href="zlab-20231231.xsd#zlab_DebtInstrumentVariableInterestRateAdjustmentPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_1187d88e-86f7-43b6-af3b-d675d67e57df" xlink:to="loc_zlab_DebtInstrumentVariableInterestRateAdjustmentPeriod_bf2ae755-f467-474b-ac08-7a599a42304b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsMaximumExposure_6da2aec7-d3ee-4632-81ba-7d525271a6a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GuaranteeObligationsMaximumExposure"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_1187d88e-86f7-43b6-af3b-d675d67e57df" xlink:to="loc_us-gaap_GuaranteeObligationsMaximumExposure_6da2aec7-d3ee-4632-81ba-7d525271a6a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_GuarantorObligationTerm_cb3940bd-310d-43c1-a27c-0c24660dbfc5" xlink:href="zlab-20231231.xsd#zlab_GuarantorObligationTerm"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_1187d88e-86f7-43b6-af3b-d675d67e57df" xlink:to="loc_zlab_GuarantorObligationTerm_cb3940bd-310d-43c1-a27c-0c24660dbfc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#ScheduleICondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"/>
  <link:presentationLink xlink:role="http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_9d68d19d-76cc-4ef9-89bf-9cbb158aff98" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedBalanceSheetStatementTable_1a0c7e42-6f75-44b2-b494-d99e3d06fba0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CondensedBalanceSheetStatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_9d68d19d-76cc-4ef9-89bf-9cbb158aff98" xlink:to="loc_srt_CondensedBalanceSheetStatementTable_1a0c7e42-6f75-44b2-b494-d99e3d06fba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_721b3087-325c-4c78-89a2-74ad05c5d509" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementTable_1a0c7e42-6f75-44b2-b494-d99e3d06fba0" xlink:to="loc_srt_ConsolidatedEntitiesAxis_721b3087-325c-4c78-89a2-74ad05c5d509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_f39afbb3-527d-4b19-ba63-9ac72da7f1c2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_721b3087-325c-4c78-89a2-74ad05c5d509" xlink:to="loc_srt_ConsolidatedEntitiesDomain_f39afbb3-527d-4b19-ba63-9ac72da7f1c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_bc416e2d-1e67-427f-ae19-e07a49521db4" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ParentCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_f39afbb3-527d-4b19-ba63-9ac72da7f1c2" xlink:to="loc_srt_ParentCompanyMember_bc416e2d-1e67-427f-ae19-e07a49521db4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_c2019ead-d8e9-405f-a236-db9881297e6c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CondensedBalanceSheetStatementsCaptionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementTable_1a0c7e42-6f75-44b2-b494-d99e3d06fba0" xlink:to="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_c2019ead-d8e9-405f-a236-db9881297e6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_5c69cf70-32fd-4217-bfea-6499cac4c826" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_c2019ead-d8e9-405f-a236-db9881297e6c" xlink:to="loc_us-gaap_AssetsAbstract_5c69cf70-32fd-4217-bfea-6499cac4c826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_84142334-a463-486d-8c3c-869a02411c90" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5c69cf70-32fd-4217-bfea-6499cac4c826" xlink:to="loc_us-gaap_AssetsCurrentAbstract_84142334-a463-486d-8c3c-869a02411c90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f7c38c96-162e-46b5-9a9b-b8c2ff2a3b52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_84142334-a463-486d-8c3c-869a02411c90" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f7c38c96-162e-46b5-9a9b-b8c2ff2a3b52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_bb969b82-9648-484e-9156-c61cd93bba8f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_84142334-a463-486d-8c3c-869a02411c90" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_bb969b82-9648-484e-9156-c61cd93bba8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_f8c12ea6-b5e8-4da1-b376-c2dfaf973fa1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_84142334-a463-486d-8c3c-869a02411c90" xlink:to="loc_us-gaap_AssetsCurrent_f8c12ea6-b5e8-4da1-b376-c2dfaf973fa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_0abf41fd-8eda-49ab-b38b-9dc317b49ea2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5c69cf70-32fd-4217-bfea-6499cac4c826" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_0abf41fd-8eda-49ab-b38b-9dc317b49ea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_829677d2-22ff-4973-b778-2a0f91b113fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5c69cf70-32fd-4217-bfea-6499cac4c826" xlink:to="loc_us-gaap_Assets_829677d2-22ff-4973-b778-2a0f91b113fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8db7998d-c202-40be-bc3e-67f3888d99e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_c2019ead-d8e9-405f-a236-db9881297e6c" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8db7998d-c202-40be-bc3e-67f3888d99e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_cdb3faca-65f7-472e-adc4-7e2b6215600c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8db7998d-c202-40be-bc3e-67f3888d99e0" xlink:to="loc_us-gaap_LiabilitiesAbstract_cdb3faca-65f7-472e-adc4-7e2b6215600c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_a65c5630-8162-438b-84b2-153aa97877a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_cdb3faca-65f7-472e-adc4-7e2b6215600c" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_a65c5630-8162-438b-84b2-153aa97877a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_fc2989a1-c2f9-4f98-a88f-7956bfca062d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_a65c5630-8162-438b-84b2-153aa97877a0" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_fc2989a1-c2f9-4f98-a88f-7956bfca062d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_1239a97f-5e20-46d5-935c-5da338f926f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_a65c5630-8162-438b-84b2-153aa97877a0" xlink:to="loc_us-gaap_LiabilitiesCurrent_1239a97f-5e20-46d5-935c-5da338f926f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_eae03754-885f-4413-8e4f-b94643ea172a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_cdb3faca-65f7-472e-adc4-7e2b6215600c" xlink:to="loc_us-gaap_Liabilities_eae03754-885f-4413-8e4f-b94643ea172a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_de63ae34-4de1-42b5-bce5-4bf8be933a68" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8db7998d-c202-40be-bc3e-67f3888d99e0" xlink:to="loc_us-gaap_StockholdersEquityAbstract_de63ae34-4de1-42b5-bce5-4bf8be933a68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_6b0101c3-c78a-41d1-8361-c04e437324a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_de63ae34-4de1-42b5-bce5-4bf8be933a68" xlink:to="loc_us-gaap_CommonStockValue_6b0101c3-c78a-41d1-8361-c04e437324a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_d1601b96-eeca-4d81-b71d-5b07e8119237" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_de63ae34-4de1-42b5-bce5-4bf8be933a68" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_d1601b96-eeca-4d81-b71d-5b07e8119237" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_41d54fc8-b493-4b13-8102-e59e57d75bc1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_de63ae34-4de1-42b5-bce5-4bf8be933a68" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_41d54fc8-b493-4b13-8102-e59e57d75bc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9108e470-b1de-4db6-9879-5103f2da095d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_de63ae34-4de1-42b5-bce5-4bf8be933a68" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9108e470-b1de-4db6-9879-5103f2da095d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_b5996b2e-ddaa-4d58-b45b-dcdb866fbfe0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_de63ae34-4de1-42b5-bce5-4bf8be933a68" xlink:to="loc_us-gaap_TreasuryStockCommonValue_b5996b2e-ddaa-4d58-b45b-dcdb866fbfe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_734eab33-4f80-441d-b648-ec14743c7231" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_de63ae34-4de1-42b5-bce5-4bf8be933a68" xlink:to="loc_us-gaap_StockholdersEquity_734eab33-4f80-441d-b648-ec14743c7231" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_92dca2ea-4ca8-4794-b160-2fa14dc06609" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8db7998d-c202-40be-bc3e-67f3888d99e0" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_92dca2ea-4ca8-4794-b160-2fa14dc06609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract_d5afd51a-712c-42c8-85b7-e7b711965d92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_c2019ead-d8e9-405f-a236-db9881297e6c" xlink:to="loc_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract_d5afd51a-712c-42c8-85b7-e7b711965d92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_29787849-7ee7-481d-b549-46f4e5a013e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract_d5afd51a-712c-42c8-85b7-e7b711965d92" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_29787849-7ee7-481d-b549-46f4e5a013e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_7c3a1a8e-44dd-4a9e-831b-83b9a8f17d9f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract_d5afd51a-712c-42c8-85b7-e7b711965d92" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_7c3a1a8e-44dd-4a9e-831b-83b9a8f17d9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_e147a036-5189-455a-909d-2bf5a8ae86af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract_d5afd51a-712c-42c8-85b7-e7b711965d92" xlink:to="loc_us-gaap_CommonStockSharesIssued_e147a036-5189-455a-909d-2bf5a8ae86af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_6dcc8088-16ff-4106-ab1d-2df7e8b45bd5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract_d5afd51a-712c-42c8-85b7-e7b711965d92" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_6dcc8088-16ff-4106-ab1d-2df7e8b45bd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofOperationsandComprehensiveLossDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofOperationsandComprehensiveLossDetails"/>
  <link:presentationLink xlink:role="http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofOperationsandComprehensiveLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_3ce1d982-d5cc-4bb8-b58a-59c181b7dc73" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedIncomeStatementTable_fac82f4c-39ab-4f03-a429-4515e1c58353" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CondensedIncomeStatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_3ce1d982-d5cc-4bb8-b58a-59c181b7dc73" xlink:to="loc_srt_CondensedIncomeStatementTable_fac82f4c-39ab-4f03-a429-4515e1c58353" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_7b7f0526-a25b-41e7-96c0-7b97ab06173b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedIncomeStatementTable_fac82f4c-39ab-4f03-a429-4515e1c58353" xlink:to="loc_srt_ConsolidatedEntitiesAxis_7b7f0526-a25b-41e7-96c0-7b97ab06173b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_66f2e296-07d0-432e-be8e-ae5ce05b8328" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_7b7f0526-a25b-41e7-96c0-7b97ab06173b" xlink:to="loc_srt_ConsolidatedEntitiesDomain_66f2e296-07d0-432e-be8e-ae5ce05b8328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_b184b62a-d4f9-4a12-a611-bc87d2cd9a28" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ParentCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_66f2e296-07d0-432e-be8e-ae5ce05b8328" xlink:to="loc_srt_ParentCompanyMember_b184b62a-d4f9-4a12-a611-bc87d2cd9a28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedIncomeStatementsCaptionsLineItems_ed9c4a60-ba78-4ae3-8635-770ac8c56eae" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CondensedIncomeStatementsCaptionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedIncomeStatementTable_fac82f4c-39ab-4f03-a429-4515e1c58353" xlink:to="loc_srt_CondensedIncomeStatementsCaptionsLineItems_ed9c4a60-ba78-4ae3-8635-770ac8c56eae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_4c80d5c0-e175-45ac-91b8-26264f41fbeb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedIncomeStatementsCaptionsLineItems_ed9c4a60-ba78-4ae3-8635-770ac8c56eae" xlink:to="loc_us-gaap_OperatingExpensesAbstract_4c80d5c0-e175-45ac-91b8-26264f41fbeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_21f48415-dc47-452c-8489-ef1425f0ca73" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4c80d5c0-e175-45ac-91b8-26264f41fbeb" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_21f48415-dc47-452c-8489-ef1425f0ca73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_44bc2699-bb22-4e57-a1e5-0f729a45b0c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4c80d5c0-e175-45ac-91b8-26264f41fbeb" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_44bc2699-bb22-4e57-a1e5-0f729a45b0c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_591f6709-be3c-45bf-b42d-cfbd3c80be8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedIncomeStatementsCaptionsLineItems_ed9c4a60-ba78-4ae3-8635-770ac8c56eae" xlink:to="loc_us-gaap_OperatingIncomeLoss_591f6709-be3c-45bf-b42d-cfbd3c80be8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_77aa22cb-a5d9-4a8b-81c8-c93f5a2c8365" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedIncomeStatementsCaptionsLineItems_ed9c4a60-ba78-4ae3-8635-770ac8c56eae" xlink:to="loc_us-gaap_InvestmentIncomeInterest_77aa22cb-a5d9-4a8b-81c8-c93f5a2c8365" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_d56e429d-6a62-4d9e-802c-d8d9fe108227" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedIncomeStatementsCaptionsLineItems_ed9c4a60-ba78-4ae3-8635-770ac8c56eae" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_d56e429d-6a62-4d9e-802c-d8d9fe108227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_999dac77-06ac-4047-8e72-086260ffce0e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedIncomeStatementsCaptionsLineItems_ed9c4a60-ba78-4ae3-8635-770ac8c56eae" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_999dac77-06ac-4047-8e72-086260ffce0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_IncomeLossFromEquityMethodInvestmentsNetOfTax_f22a1ecd-1bfd-47d6-b0b7-aed28b1efd3d" xlink:href="zlab-20231231.xsd#zlab_IncomeLossFromEquityMethodInvestmentsNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedIncomeStatementsCaptionsLineItems_ed9c4a60-ba78-4ae3-8635-770ac8c56eae" xlink:to="loc_zlab_IncomeLossFromEquityMethodInvestmentsNetOfTax_f22a1ecd-1bfd-47d6-b0b7-aed28b1efd3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_ce4e1e99-69bb-4790-a34d-f7862581856e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedIncomeStatementsCaptionsLineItems_ed9c4a60-ba78-4ae3-8635-770ac8c56eae" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_ce4e1e99-69bb-4790-a34d-f7862581856e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a8503e73-e2b9-4d16-86f1-fbf33ceb6e0d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedIncomeStatementsCaptionsLineItems_ed9c4a60-ba78-4ae3-8635-770ac8c56eae" xlink:to="loc_us-gaap_NetIncomeLoss_a8503e73-e2b9-4d16-86f1-fbf33ceb6e0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_5f8eb434-2698-4838-93e0-aa6439ce9985" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedIncomeStatementsCaptionsLineItems_ed9c4a60-ba78-4ae3-8635-770ac8c56eae" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_5f8eb434-2698-4838-93e0-aa6439ce9985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_c84be0d5-171a-4d1b-9fdc-3663000591a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_5f8eb434-2698-4838-93e0-aa6439ce9985" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_c84be0d5-171a-4d1b-9fdc-3663000591a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_883439b9-d23e-4bcd-a76f-7a370a644a92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_5f8eb434-2698-4838-93e0-aa6439ce9985" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_883439b9-d23e-4bcd-a76f-7a370a644a92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_3e809d45-6e8b-42c0-a1a1-8161100251a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedIncomeStatementsCaptionsLineItems_ed9c4a60-ba78-4ae3-8635-770ac8c56eae" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_3e809d45-6e8b-42c0-a1a1-8161100251a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails" xlink:type="simple" xlink:href="zlab-20231231.xsd#ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"/>
  <link:presentationLink xlink:role="http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_c4056378-479a-4857-bb0d-b2d75cf9fd14" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedCashFlowStatementTable_61a02e85-2fae-428d-ad35-a346a9d7f449" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CondensedCashFlowStatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_c4056378-479a-4857-bb0d-b2d75cf9fd14" xlink:to="loc_srt_CondensedCashFlowStatementTable_61a02e85-2fae-428d-ad35-a346a9d7f449" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_2124c053-0850-451b-8589-8ba3dd223591" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedCashFlowStatementTable_61a02e85-2fae-428d-ad35-a346a9d7f449" xlink:to="loc_srt_ConsolidatedEntitiesAxis_2124c053-0850-451b-8589-8ba3dd223591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_92bece17-746c-4c1e-9e7b-5ae3fa91febc" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_2124c053-0850-451b-8589-8ba3dd223591" xlink:to="loc_srt_ConsolidatedEntitiesDomain_92bece17-746c-4c1e-9e7b-5ae3fa91febc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_431d8216-338b-40ce-acba-9cc6b555742e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ParentCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_92bece17-746c-4c1e-9e7b-5ae3fa91febc" xlink:to="loc_srt_ParentCompanyMember_431d8216-338b-40ce-acba-9cc6b555742e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_00dc47e2-69c9-4eba-bbf0-809ed6a8db43" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CondensedCashFlowStatementsCaptionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedCashFlowStatementTable_61a02e85-2fae-428d-ad35-a346a9d7f449" xlink:to="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_00dc47e2-69c9-4eba-bbf0-809ed6a8db43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_185117ff-bb49-4bbd-a4f3-49a446be406d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_00dc47e2-69c9-4eba-bbf0-809ed6a8db43" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_185117ff-bb49-4bbd-a4f3-49a446be406d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c747957d-7f47-4538-9108-939f70fa688b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_185117ff-bb49-4bbd-a4f3-49a446be406d" xlink:to="loc_us-gaap_NetIncomeLoss_c747957d-7f47-4538-9108-939f70fa688b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_bd3b754b-6efd-4ebd-a448-014c733892d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_185117ff-bb49-4bbd-a4f3-49a446be406d" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_bd3b754b-6efd-4ebd-a448-014c733892d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_AmortizationOfDeferredIncome_938e75ae-0681-48c7-b86d-d63a7f5fc9d2" xlink:href="zlab-20231231.xsd#zlab_AmortizationOfDeferredIncome"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_bd3b754b-6efd-4ebd-a448-014c733892d4" xlink:to="loc_zlab_AmortizationOfDeferredIncome_938e75ae-0681-48c7-b86d-d63a7f5fc9d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_1eb2fbef-1329-4e00-8c6e-2310e7319655" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_bd3b754b-6efd-4ebd-a448-014c733892d4" xlink:to="loc_us-gaap_ShareBasedCompensation_1eb2fbef-1329-4e00-8c6e-2310e7319655" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_IncomeLossFromEquityMethodInvestmentsNetOfTax_8d160c5f-d450-479c-9ce8-009a98ed7565" xlink:href="zlab-20231231.xsd#zlab_IncomeLossFromEquityMethodInvestmentsNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_bd3b754b-6efd-4ebd-a448-014c733892d4" xlink:to="loc_zlab_IncomeLossFromEquityMethodInvestmentsNetOfTax_8d160c5f-d450-479c-9ce8-009a98ed7565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_e724ba60-85c1-44ed-a77b-e43146a9a2b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_bd3b754b-6efd-4ebd-a448-014c733892d4" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_e724ba60-85c1-44ed-a77b-e43146a9a2b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_15503581-c8f4-4d07-9839-04f42f0c09a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_bd3b754b-6efd-4ebd-a448-014c733892d4" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_15503581-c8f4-4d07-9839-04f42f0c09a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_ddb7b49b-ac58-495a-8979-843ef99471a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_15503581-c8f4-4d07-9839-04f42f0c09a7" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_ddb7b49b-ac58-495a-8979-843ef99471a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_437504dd-8d4b-41e0-99f4-73dd216882d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_15503581-c8f4-4d07-9839-04f42f0c09a7" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_437504dd-8d4b-41e0-99f4-73dd216882d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7bf0ed4d-a0a9-434f-ba2c-3511b6cd3fed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_185117ff-bb49-4bbd-a4f3-49a446be406d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7bf0ed4d-a0a9-434f-ba2c-3511b6cd3fed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3642c88f-d979-4311-93cd-ab510233e68a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_00dc47e2-69c9-4eba-bbf0-809ed6a8db43" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3642c88f-d979-4311-93cd-ab510233e68a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments_720ad3c3-2678-46b5-ba90-cf9164cae3d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3642c88f-d979-4311-93cd-ab510233e68a" xlink:to="loc_us-gaap_PaymentsToAcquireShortTermInvestments_720ad3c3-2678-46b5-ba90-cf9164cae3d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_f6f531b2-8dc5-434a-92ae-78ff3f4c7f73" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3642c88f-d979-4311-93cd-ab510233e68a" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_f6f531b2-8dc5-434a-92ae-78ff3f4c7f73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_ebf07f2f-bf8b-4403-b490-a6693604f984" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3642c88f-d979-4311-93cd-ab510233e68a" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_ebf07f2f-bf8b-4403-b490-a6693604f984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_eee76b3c-2801-41ab-9389-20fabb8b954e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3642c88f-d979-4311-93cd-ab510233e68a" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_eee76b3c-2801-41ab-9389-20fabb8b954e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a097f273-a8da-468e-b549-269c801efac2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3642c88f-d979-4311-93cd-ab510233e68a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a097f273-a8da-468e-b549-269c801efac2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_907d9573-327e-42fd-bd7e-709a2b12df90" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_00dc47e2-69c9-4eba-bbf0-809ed6a8db43" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_907d9573-327e-42fd-bd7e-709a2b12df90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_28c29223-5dbc-4d2b-a0c0-9273adf44d3d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_907d9573-327e-42fd-bd7e-709a2b12df90" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_28c29223-5dbc-4d2b-a0c0-9273adf44d3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_3fa567e5-223f-4f15-8cec-4e954cd037ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_907d9573-327e-42fd-bd7e-709a2b12df90" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_3fa567e5-223f-4f15-8cec-4e954cd037ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_fdf6b5f7-e93c-4fc2-88f0-0de1f1402500" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_907d9573-327e-42fd-bd7e-709a2b12df90" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_fdf6b5f7-e93c-4fc2-88f0-0de1f1402500" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_0b4e97b9-be00-4310-a516-ec30b67e0472" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_907d9573-327e-42fd-bd7e-709a2b12df90" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_0b4e97b9-be00-4310-a516-ec30b67e0472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1f29b546-fd07-4bad-8940-74f22da9391b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_907d9573-327e-42fd-bd7e-709a2b12df90" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1f29b546-fd07-4bad-8940-74f22da9391b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3c3fc171-ffab-46aa-8967-44e65088b1e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_00dc47e2-69c9-4eba-bbf0-809ed6a8db43" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3c3fc171-ffab-46aa-8967-44e65088b1e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_67b8a404-c7cb-44f3-b31f-b7ad7eeac160" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_00dc47e2-69c9-4eba-bbf0-809ed6a8db43" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_67b8a404-c7cb-44f3-b31f-b7ad7eeac160" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_79b886b2-46cf-4ab3-801f-b425bb83bfcf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_00dc47e2-69c9-4eba-bbf0-809ed6a8db43" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_79b886b2-46cf-4ab3-801f-b425bb83bfcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_6f6016b1-e704-47a1-8c6f-c3b2c9716ddf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_00dc47e2-69c9-4eba-bbf0-809ed6a8db43" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_6f6016b1-e704-47a1-8c6f-c3b2c9716ddf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#AwardTimingDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ShareBasedPaymentArrangementOptionBatchOneMember" xlink:href="zlab-20231231.xsd#zlab_ShareBasedPaymentArrangementOptionBatchOneMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_zlab_ShareBasedPaymentArrangementOptionBatchOneMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ShareBasedPaymentArrangementOptionBatchTwoMember" xlink:href="zlab-20231231.xsd#zlab_ShareBasedPaymentArrangementOptionBatchTwoMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_zlab_ShareBasedPaymentArrangementOptionBatchTwoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_ShareBasedPaymentArrangementOptionBatchThreeMember" xlink:href="zlab-20231231.xsd#zlab_ShareBasedPaymentArrangementOptionBatchThreeMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_zlab_ShareBasedPaymentArrangementOptionBatchThreeMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_NonVestedRestrictedSharesMember" xlink:href="zlab-20231231.xsd#zlab_NonVestedRestrictedSharesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_zlab_NonVestedRestrictedSharesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaap_AwardTypeAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_EmployeeStockOptionMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardExrcPrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardExrcPrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardGrantDateFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#InsiderTradingArrangements"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_zlab_RafaelAmadoMember" xlink:href="zlab-20231231.xsd#zlab_RafaelAmadoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_zlab_RafaelAmadoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrByIndTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TradingArrByIndTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_TradingArrAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllTradingArrangementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrAxis" xlink:to="loc_ecd_AllTradingArrangementsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndTitle"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndTitle" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrAdoptionDate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrAdoptionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrTerminationDate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrTerminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrDuration"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrDuration" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ErrCompDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompRecoveryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompRecoveryTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_RestatementDateAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonNeosMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ecd_NonNeosMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDeterminationDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDeterminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompAmt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#PvpDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_ExecutiveCategoryAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="loc_ecd_AllExecutiveCategoriesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_PeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_NonPeoNeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_AdjToCompAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllAdjToCompMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="loc_ecd_AllAdjToCompMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_MeasureAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoTotalCompAmt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TabularListTableTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TabularListTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_us-gaap_NetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_OtherPerfMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAmt"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoName"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureName"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_MeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#InsiderTradingPoliciesProc"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>exhibit1033-bochk_facili001.jpg
<TEXT>
begin 644 exhibit1033-bochk_facili001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MXPU#6M*LY;#3KNT1)86A: 33[B3)Y; $$+P20,Y^M '84444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MXKRUO[AIYXBLBNV,[3QC\Q^M=[0 4444 %%%% !1110 4444 %%%% !1110
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MA5E"D,3Z$Y7]:T_',AB\)7I4X+;$_ NH_K5+Q_/:GP^-/GNH[=[N540N^T
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MUA=BENJA99 0#DG@A<C/N: .\N/$VBV:%I]3M5QU'F G]*TH9H[B%98F#QL
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MKDXP#.<>_ JK\1;A3#96V1OWF0CVQC^M'_+L$G]<T[DOPZ<_8KU.PE4_F/\
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M_P"V:5M7-O%=6[P3QK)$XVLK#((K+\.Z#%X>M)[6"5I(Y)VE4MU ( QGOC%
M&S1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M:3(KG=$U*XU37=39WD6WA$8@CR,%6!^<\9YQ^50Z:;^[NO$-H-1EW12B*!W
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^0@KVQV':E;0X?[8_M6*66*Z:(12%<;9 .FX$=1ZUB?\+#L?^?&Z_-?\:/\
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M\K_\51_PL#3/^?>[_P"^5_QHYX]P^KU?Y3K**Y+_ (6#IG_/M=_]\K_C2_\
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M%EO"MKOA#[81(L(VYXY(9\D'[PK0UOQ'?#Q/X-\.07#PC5HYIKJ>,#?MCA+
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M (X4"K4WAC6=3OK'6]1.FPZ[IMG<0VTEJSF.261=H9LKE5'/R_-]X\^O:T4
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M1,@9QDGVKKJ* $551 BJ%51@ #  I:** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MD$5#]MM#=?9OM4/VC_GEY@W_ )=:JZ!_R+FE_P#7I%_Z *Y:_F-G\4[^[C$
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MDGA0:!(T,KLX? RX!0 KQZ@T =MHWBO2]<N1;VCRK*]LEY$LJ;3+ Q(61?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ H(R,'I110 4444 %%%% !1110 4444 %
M%%% !1110 48HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L#6/%
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MA5;/8C S76Z[$T^@:C$B%Y&MI BCJ6VG&/?.* -"BO*['5K>_GTK[/?-)O\
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M,\TEU<Q/:R11Q%1',S*5FR,D@ Y&#QR!7(-8S6OB^^T40N]AJYCOEDY(B$9
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M%H[<)&6A7D'!&X#'!WDDYKU(   #H* //?C=_P DLU+_ *ZP_P#HQ:]-M_\
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MW]IJ=HMW8W$=Q;L659(SE25)4X/U!%6*\QT"]UC2-%TB\@NXI+&XUJ>SELC
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ME=V P^4C*G R#D''(J_10!CVOA;1K$V1M;0Q?8E=+;9,X\L/]['/?C\A3/\
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M,J/FZ<#\AZ5J44 8R>%-%CM4M4M&6W2#[,(A/)M,62=C#=AEY/!SP2.E;(
MP.!110!YY\;O^26:CSC][#_Z,6O3;?\ X]HO]P?RKS+XW?\ )+-2_P"NL/\
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M_H8O#O\ X#M_\37I]% 'F']A_%S_ *&+P[_X#M_\31_8?Q<_Z&+P[_X#M_\
M$UZ?10!YA_8?Q<_Z&+P[_P" [?\ Q-']A_%S_H8O#O\ X#M_\37I]% 'F']A
M_%S_ *&+P[_X#M_\31_8?Q<_Z&+P[_X#M_\ $UZ?10!YA_8?Q<_Z&+P[_P"
M[?\ Q-']A_%S_H8O#O\ X#M_\37I]% 'F']A_%S_ *&+P[_X#M_\31_8?Q<_
MZ&+P[_X#M_\ $UZ?10!YA_8?Q<_Z&+P[_P" [?\ Q-']A_%S_H8O#O\ X#M_
M\37I]% 'F']A_%S_ *&+P[_X#M_\31_8?Q<_Z&+P[_X#M_\ $UZ?10!YA_8?
MQ<_Z&+P[_P" [?\ Q-']A_%S_H8O#O\ X#M_\37I]% 'F']A_%S_ *&+P[_X
M#M_\31_8?Q<_Z&+P[_X#M_\ $UZ?10!YA_8?Q<_Z&+P[_P" [?\ Q-']A_%S
M_H8O#O\ X#M_\37I]% 'F']A_%S_ *&+P[_X#M_\31_8?Q<_Z&+P[_X#M_\
M$UZ?10!YA_8?Q<_Z&+P[_P" [?\ Q-']A_%S_H8O#O\ X#M_\37I]% 'F']A
M_%S_ *&+P[_X#M_\31_8?Q<_Z&+P[_X#M_\ $UZ?10!YA_8?Q<_Z&+P[_P"
M[?\ Q-']A_%S_H8O#O\ X#M_\37I]% 'F']A_%S_ *&+P[_X#M_\31_8?Q<_
MZ&+P[_X#M_\ $UZ?10!YA_8?Q<_Z&+P[_P" [?\ Q-']A_%S_H8O#O\ X#M_
M\37I]% 'F']A_%S_ *&+P[_X#M_\31_8?Q<_Z&+P[_X#M_\ $UZ?10!YA_8?
MQ<_Z&+P[_P" [?\ Q-']A_%S_H8O#O\ X#M_\37I]% 'F']A_%S_ *&+P[_X
M#M_\31_8?Q<_Z&+P[_X#M_\ $UZ?10!YA_8?Q<_Z&+P[_P" [?\ Q-']A_%S
M_H8O#O\ X#M_\37I]% 'F']A_%S_ *&+P[_X#M_\31_8?Q<_Z&+P[_X#M_\
M$UZ?10!YA_8?Q<_Z&+P[_P" [?\ Q-']A_%S_H8O#O\ X#M_\37I]% 'F']A
M_%S_ *&+P[_X#M_\31_8?Q<_Z&+P[_X#M_\ $UZ?10!YA_8?Q<_Z&+P[_P"
M[?\ Q-']A_%S_H8O#O\ X#M_\37I]% 'F']A_%S_ *&+P[_X#M_\31_8?Q<_
MZ&+P[_X#M_\ $UZ?10!YA_8?Q<_Z&+P[_P" [?\ Q-']A_%S_H8O#O\ X#M_
M\37I]% 'F']A_%S_ *&+P[_X#M_\31_8?Q<_Z&+P[_X#M_\ $UZ?10!YA_8?
MQ<_Z&+P[_P" [?\ Q-']A_%S_H8O#O\ X#M_\37I]% 'F']A_%S_ *&+P[_X
M#M_\31_8?Q<_Z&+P[_X#M_\ $UZ?10!YA_8?Q<_Z&+P[_P" [?\ Q-']A_%S
M_H8O#O\ X#M_\37I]% 'F']A_%S_ *&+P[_X#M_\31_8?Q<_Z&+P[_X#M_\
M$UZ?10!YA_8?Q<_Z&+P[_P" [?\ Q-']A_%S_H8O#O\ X#M_\37I]% 'F']A
M_%S_ *&+P[_X#M_\31_8?Q<_Z&+P[_X#M_\ $UZ?10!YA_8?Q<_Z&+P[_P"
M[?\ Q-']A_%S_H8O#O\ X#M_\37I]% 'F']A_%S_ *&+P[_X#M_\31_8?Q<_
MZ&+P[_X#M_\ $UZ?10!YA_8?Q<_Z&+P[_P" [?\ Q-']A_%S_H8O#O\ X#M_
M\37I]% 'F']A_%S_ *&+P[_X#M_\31_8?Q<_Z&+P[_X#M_\ $UZ?10!YA_8?
MQ<_Z&+P[_P" [?\ Q-']A_%S_H8O#O\ X#M_\37I]% 'F']A_%S_ *&+P[_X
M#M_\31_8?Q<_Z&+P[_X#M_\ $UZ?10!YA_8?Q<_Z&+P[_P" [?\ Q-']A_%S
M_H8O#O\ X#M_\37I]% 'F']A_%S_ *&+P[_X#M_\31_8?Q<_Z&+P[_X#M_\
M$UZ?10!YA_8?Q<_Z&+P[_P" [?\ Q-']A_%S_H8O#O\ X#M_\37I]% 'F']A
M_%S_ *&+P[_X#M_\31_8?Q<_Z&+P[_X#M_\ $UZ?10!YA_8?Q<_Z&+P[_P"
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MI7]G7MS<:@LC0F#RMO[L MDNZXX(H VZ*R-,\16FI:E=:88I[34;90\EK<J
M^P]'4@E67/&5)P>#BM>@ HHJKJ6H6VDZ9=:C>2>7;6L332MC.%49/'>@"U16
M3::W)<7\%G/I5Y:M/"TT;R&-D(7;D$JQPWS#CZX)Q5ZQGFN;**:XM'M)G&6@
MD969#Z$J2#^!H L4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=!)'(O1E(R#4KKO1EW,N1C*G!'TIL$$5K;QP0H$BC4*BCL!0!)1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !7*^)_&+^'->T+2ETY;E]8E:&&0S[ C#;G=\IX^8=,UU5>8
M?$[3[O4/&G@=K>VOWAMKR1[F>U@=O(5O+ 8LH('0_E0!U7A_QA#K6OZOH,UH
M]IJ>EE/.C+AT=6&596&,C&.H!Y%;R7EK)'+(ES"R1$B1ED!"$=<GMBO'M%TK
MQ#H]OXX\/RV-W-K=Y#)+9Z\(G/VT%#M5I.BN,\#( )/IDWO#.G6$GA&[O[W2
M]>GD70TL+_2Y+0PJ_E _*@VJ7?E@&!/!YP<4 >L(ZR(KHP9&&0P.01ZURVC>
M,9?%$E])X>T^.YT^TF-N;RXN3$LT@Y/E@(Q*C(^8X]LUJ:-;VTOA*RMK6SGT
M^V>R1([:4$20*4P%.23N X_"N \ P:AX'\%ZGX<U""YM]2M)9I+6:*W:2.Y!
M&49"%())X*]10!Z%I>L"]T@W][;-INR62.2.Y=04*.4R2#C!QD<]"*NM>6J;
M-US"-Z[ERX^8>H]17D%_<^,;WP[X,UW7+._WP:B\NI6UM:9>%<E8W\K!)P/F
MY!.33[_PS%!K/P]MK6QU2^TJUNKN21[RT9C$CX*AP$&Q<YP& ( Y% 'KGVRU
M^R?:_M,/V;&[SMXV8]=W2E^UVV8Q]HB_>C,?SCYQZCUKP;2]/U_3/!'AR1M-
MU2.TT[7Y9KNV2T;S4B))201LOS*N2>AYK:UCPO$+GP+:6EGJU[I<>I3S2FZM
M6S'$Y!(<!1L0DD;6 XZC% 'KCZC8QP1SO>VZQ2'"2-*H5C['/-8U[XJ6R\<Z
M9X9:T+-?V\DZ7 DX78"2"N/;UKSWQ_H9M;J?1]!\.7RP?\(_/#'+;0O)#S(7
M$2J/E5\C<6.2> !D@U8TFTU!_&OP[NI;"_"6VA&&ZEDMI (I3%C:Y(X.0>O]
M: .R\3^,9/#OB#0](73EN9-8D>*"0W&P(R[<[OE/'S#IFI/"WC.V\27&L6;V
MLEE>Z//Y%W&[AE!YPRN.H^4^G2N5^)EC/?>./ \D=EJ$UK:7,SW4MI#*?)5O
M+P2T8R.AZ'/%<U'I>KZ?X<\;P0^']3NM!ENHY-.@,;Q7<SF0%G)QYK*#@Y;)
M('U( /;4O[.6W-Q'=P/ #@RK("N?3.<57OM6@MM-OKJ!XKE[.%I7B249X4L
M<9QD#TKQF33=8DT'XFPR:9J3R:@8)K5?L,B>>2.2B@'GIQDD8YY!JWHVD75C
MXBU-H=(O(+:;P@D)*V4BJ]P%7*_=Y?KQUZT >G^&O$]KXB\.Z?JV%M?ML?F)
M!)("P&2/QZ4[0M>;5+!KB^M!ILAN)(8XI+A',@4X# CCGT__ %UYE\-CKNA7
M6@6NN:/<RV4NG&*UF%A('TZ0.=Z2<';O^4[N,X7L*PH]"U%_ .DV4NB:@73Q
M@+F6%K&3(M_FRY&W[N".: /?4O+62W:X2YA:!,[I%D!48ZY/3BE@N[:Z7=;W
M$4RXSF-PP_2O"+_3OL'AKQG]NCNM+L%\31W5OOM'6&2/S !D8_U?<D XP.#P
M#W7PTN-#O]3\2ZII>KV=[<W]V)Y8;=6'V=<8 RRJS9P23@#- &BGC>YG\;:K
MX8M]+A^T:=;K<O/->%(V0A2/X#@_,.OH>:Z"SU=7TZ&XU-(]-FD=HS#-,O#*
MQ7 ;@-G&1CUKS%O#<^M_&7Q4UQ!J=M8W>GQ107D:2Q1O(HCR-P 5AP<@Y!P:
M?\4;2_OM9U&VL=%U*=YM DC^U11/+'(?,W")5'RJV1DL<DC  R0: /5Y[NVM
M0AN+B*$.VU?,<+N/H,]37+Z[XUGT-=>F?1VEM-)MXYA.+E0)]WWE P2I7WZ^
MW&>#^QW#ZUHR^)=(U2\T+4/#,6GGR[65VMYP59PRJ-RDE1SCT[ XK^(](OVU
M?X@BUTC43%=:1:P6N+61_-950%0P!W$=\$]#0!Z;8^+A=7J":Q%MIQTM-0>^
MDN4VQEL$QLO48!SNZ41^,(K[^PY=)M#?6FIN0TPF5#;IC(9E/)SZ=?Y5YJ-$
MU&\UZ]5=)O"LW@862-):NJFYPI$>2,;N.GM2V.F70M?A:(]&OXFL9F^W$V,B
M^4VQ5+/\O'(QD]<4 >TK<P/</;K/&9T&YHPXW*/4CJ*2WN[:[#&VN(I@IP3&
MX;'Y?2O&O#&B7$T5W;:_%X@CUC3KB_D;[/;X2X292&<2E<-D8 &[.0N!@<=+
M\+K'5]*GU73K]?M-G;1V\5EJ+VS0231@-B-U8#)0''MG&3V /1J*** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"AJND6NLVT<%
MV'Q%,D\;(Q4HZG*GT/T.1[4VPT6TL+R>]4-+>3HL<EQ)C<R*257    +'H.]
M:-% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M4Q,$B2)Y2Q(W?-PJJ!D8!ZG'/1^'-;FU8ZG:W<*1WFFWC6LQCSLD^575USR
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M#:VTA/E4H 2"W)S@4 >B4A(4$D@ <DFN&MO&FI/)/$\%G)*-'?4D\O>(U=&
M:/?R)!R/G7 X--B\0ZAJD0L=4M;(P:EH$FH1B(,2A 0,K;N"#Y@(Z8P1SUH
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M6AM_C%X'CFM!JTZV$ZRIY<:&Y98GY(.%'/..@[4 >R AAD$'Z4M<'%>2>'=
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M;VTG^T0ZB9@;@.5VGDC:05X*[<8[5?T70K;0H[M;>:XE-U</<RM.^XEVZD8
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MVFL_VHMQ<O<&T2S(D<$%%)89XSG+,<Y[^F*?J6B0ZE?V5_\ :+BVN[(2"&:
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M^[N+.YMX9()BHCB:14"E,D';\P)[DGMV -:[\)V%]/JTMU+<R_VK9K97*EE
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MKW4[G/D6D#SN!U(522![\5FVVKS6>FZ:U[#<76H:@AE,-NHPAV;F4%B%55'
MR<GW)- "2>#]-DEO?WERMM?NLEY:!P8IW4 ;FR"V2%4-@C=CG/-=!7.Q^,]-
MN;*TN;.*YNOM5F;Y(HE42>4,9.UF&3DXP,G]*Z*@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH *PK[1[U_%MCK=I+;[8;.:TEBE!R0[QN"I'?,>.?7/.
M,5NU4O-3T_3RHO;ZVMBXROG2JF1D#C)]2/SH Y'3?!=_:VGABUN)K5X])CGC
MG*,P,HD0I\O'&,YK2\+:/K^C6UOIVH7]E<6%E'Y5O)#$RS2H!A?,R<# ].I
M.1R#KW>NZ18-(MYJMC;-'MWB:X1"N[.W.3QG!QZXJ6WU33[N[GM+:^MIKFWQ
MYT,<JL\>>FX Y'XT 5O$FG3ZQX9U/2[9HTEO;62W#R$[4WJ5SP.<9Z5@W/A/
M4=6A\.VM_-:06VC7$-SNMRSR3/$N% ) V*>_4GI71#7M',-Q,-5L?*M\&9_M
M"8CSTW'/&?>I;;5-/O7N$M;ZVG:V;;.(I58Q'T;!^4_6@#EH?!=RFDGP_)/
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M8V*Q;?,F97F9F"G  ( &X<]^:T-(UN^GLAJ&K0V=II[V<5TEPLYPNX$LK[@
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M1GI[UUD&HK<ZM)%#>6$ML+990D<NZ8$D_,0#C81C!]<T]-:TJ6&>:/4[-HH
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MK'UJD^O:/%<K;R:K8I.TOD"-KA QDX^3&<[N1QUY%:% !1110 4444 %%%%
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M:]!\/6$&EZ#:6=K8M8P1J?+MFD+M$I)(!))YYYY('0$BM.D9MJ,V"<#.!U-
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M(MUOJ=K%<:I;W%K=V<?SQ%;=%,H4@[@'4J1CD'H:]!DECA4-(ZHI8*"QQR2
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M,7'V6ZM6WLC0W,>QU*D@]R"..""01R#0!;HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *XS45M8OBUI,MQ.T1?2;A8\SLBNXFAPH&<'J>._?I79U%-' R
M^9.D9" _,X'R@CGD].* /*/",LVGV/@>6SN[AWOK6[CD@:X8Q2;$+( F=H(8
M=0 >3DFMCP3J"ZQ<:3J"^)O/O'M&6_TT;RWF8&XR(SGRRC@C(50=V.F*[BTC
MTVYABN;-+26(_-%+"%9?JI']*=9&PF$EU8FV<2N1)-!M.]E)4@D=2""/;!H
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MJ0N99YKF63;'.2C1PEPZ[0%,@ R 2O3-=-X=@)\+6UO-JDFJ QLGVWE&F7)
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MOB'@Z#8J9#'NU>P 8'!'^D)R*Z;[%:E%0VT.U3E1Y8P#ZBGRP0SJ%FB20 Y
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M^'VAZS_;FJ->7>HV<$LK7[D%?M>TC&<?=)!XYQSFO5DM+:-Y72WA5YO]:P0
MO]?7\:3[%:>6(_LL/E@[@OEC&?7% 'EVMO-I]IXV:WU;4E_L>XMYK,-?RMY3
M/'&S DMEE))^5LCDX S6[=:A>6GC8-+(]YITVH1P1O:W3*]I(8A^ZEBSM=#]
M_(Y&[)'&:[,V-HV[-K =QRV8QS]:5;*U2<3I;0K,!M$@C 8#TSZ4 8'B[4(+
M271K>:[DM_M-V5 \_P B*3$3G$DG4+QD <D@#IFN-\/WTVLMX0MKC6;N43#4
MH+D0WKJ91&^$W$-G(7'.=V#UKU66&*8*)8TD"L& 90<$=#]:C-E:E@QMH<C)
M!\L<9.3^I- &!\/[N:]\%64MQ<R7,BO-%YLC[V8),Z+ECR3A1R>M<E+>7+^9
M$-6O5 \8"T!6[?/E%5S'G/3V[5ZA%#% FR&)(USG"* ,_A47V"S_ .?2#KG_
M %8Z^O2@#RV^*?89[:YOKE[73O%]O#')->2$Q1'RFP7+9P"[8)/%:$>I_P!I
M:]>6\OB8:=J%EJ:"WM<NSS0878%3S )%=2<G:3DDYX&/0Q9VH5U%M#M<@N-@
MPW?GUIQMH&N%N&AC,ZC:LA0;@/0'KB@#S>*^FU+7OL)UQ5O(=>E$K)J0C#VH
MW 0B(.&W [5QMZJ3D@\QB>.#2?$NJW>M:LOV35Y;*,QWS;8T:2)0IR<*,G&X
M\J"2.@KI8?!C>:\=Y?07EHTK2?O;%/M'+%L&7/J>H4''0@\UTHL[58Y(Q;0A
M).'4(,-]1WH \JO]4\_PQXPM)+^.9+75K/R5%R9A&C&V;"LQR5W%O;.<8Z5W
M/CZ::W\ :]<6T\T$\-C+)'+#(49652001SU%;C6=JRE6MH2IP2"@YP,#\AQ5
M+Q#H_P#;OAN_T=)Q;+>0- 9/+W;%88.!D=J .$U2YDT*^U&>'6M4DTR?07NK
MJ1;CSF@F+JL<D98X0L&?@87Y,\8K/U/6IDT[QA#!K31_9S8S6WV;4&D\K>55
M]KDY(/?MD]*]5M+"&UL_(\F#YA^]\N((LAQ@DCGK[YIYL;0KM-K 5P!CRQC
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M2",IPX'///&/>@#U"BO+8?%&MZUX]\&QPW,%M9W^C?VB]N82XWLO()W#. 2
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M/'Y4C;05D!7.3D\D\8Q@"I=.\>WD.E6NG:1965JNG^%4UB171W0D(NV%/F!
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MA0^S C=ACJ% !'3.>M6['P'H^FW>H2V;WL4-^[R2VBW#" 2.,,ZIV//T'''
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MUZ\FNIHH YN'P-H]O=Z+=1?:5GTBW^RVSK,03%C 1L?>''^.:Z2BB@ HHHH
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M^R;?Q"NB.I4^81M^:4-G'#=!CIWS0!Z=17,>,_%$GAR'2(;9$:[U74H;"$R
ME8][<N0",X';(Y(KF/\ A9]QY!L/)@_M8>(_["W[3Y>-^/.VYS]W^'/7VH ]
M.HKF/!?BB3Q''K%O<I&MYI.I36$IC!"R;#\K@$G&1VSU!KIZ "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MT_3;F599K>$(S*25'L,]AT'L*R-4\.:G>:KXCN83:>7J>DI80[Y6!5E\WYF
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MFWMG;= ?XAQ['/IC'7BL"Q\%:]I%MHLULNCW=U9VKV=S;W3OY3H7WJZ/L)#
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MW,4VDG')V]OI7EDU^-&U#Q,8;J6(OXCMDO#]I?=#:/';[Y,$_*,G;OZ@'@C
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MQ*ZB6=) H#2*Z'>$&1D\G)Y(%>D>'UD70+%9;]M0=85!O&389\='Q[CGWZT
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%8GB3Q7I?A2UAN-4>95
MFE6&,1PL^YVZ#(&!WZD=#0!MT4V21(8GED8)&BEF9C@ #J37+Z%\0-&U_7[C
M1((K^UOX8_.6*]M6A,L><;U#<XY'4 T =5115>]O;73;&:]O9T@MH$+R2R'"
MJHZDT 6**YF+QK:3:2-7&F:HNEN T=TT Q(IZ,$W;PI]2H&.3@<UTU !1110
M 445F:CK<&F:CIME+;W<DFH2M%&\,)=$(&<N?X1_GL: -.BH+:]MKQ[A+>9)
M6MY3#+M.=C@ E3[X85/0 4444 %%0/>VT=[#9/,@N9D9XXL_,RKC<?H-P_.I
MZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<DOC::Y\1K.WU&8VR:"EU$&NF?;-Y.=ZDDD')!R.^/:O:O*C.<HO/M1Y4?\
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M8[8Q6CL48^4<=..E"JJC"@ =< 4 +1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M5=/-]]A%];&[Y_<"5=_ !/RYSP""?J*CM-<TF_G6"SU.SN)6#%4BG5R0I ;
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M"K-E)97(Z$'..3SWVG''-<_8^$];M;;3+^TLI(CH&A31VD+D"2ZOYD_>$C/
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M=J.M7<P6/0KZ_74+.) 4=$7;#&'(R#O(P>X#$]A4EQXA\5V/AC4?$^HZ@EM
MFB>;%;!8CFZD.49!@D(N0@W$ECDD=* /5:*YSPC:^((K$7.O:I]K>XMX"D'D
M+&8&"_/DCJ6)!/8$8'%<#K'CW5M2O)TTG5!9&77%T>RC5$8A$YGG?<#QZ=,
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M &,-E<#&=N/>L/5?$&JZU\,O#%GJSR:C>:S?/=3PQJBNUI"3*5P,#.T(?QH
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M2K*5;UD>Z#P*WGE?NE\CYL8XSTI+KPYHE[?P7UUI-E-=0($BF>%2R*.0 <=
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MK4;_ %M-/61)'B8QKAI)8V&"R;>,XYY]C6M/\1+&*^@MK2RN+J&;4AI44Z,
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M-(D<:]7=@ /Q- &%XS\,#Q?X8N-&^V&S,SQOYPCW\HX;E<C(X]:YRZ^%HO\
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M1Q<:M)/+<7WD\EY3\QVY]/EZTL?@%$U+2+MM28_V3ICV-H@A $3L-IE'/&%
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M4F385W-@  \[0H'7U-<'H^@2>.+#^T(;!A+K'B ZC+>R0E1!9Q-A%5B.6.,
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MYI.-K*/NY &%[#'&<X[*B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MHDFPA1O' ;)&!G/X5YKX3CN!J^@_9$(M1X<D&N[A@>;\W$N?^6F_/7YL9[4
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M-F]HP/X@<Y(Y&3ZFNNM;2W?XX6&H7EFLD=UX>C:&=H=P>X$@Y!Q]X*.O8>U
M'I6HZE'IWV0,C2275REO&B]26R2?H%#,?935#Q#XIL/#ALX9TFN+Z^E\JTL[
M=0TLS=\9(  SR20!3)0=0\<6\>"8=+M#,?3SIB47\0B2?]_!7'>.;*[TSXJ^
M%/%\L,LVCVL<EK<M&A?[,6#@2,!T7YQD]MOTH [FWUN9]3M]/N]*NK66>-Y%
MD9D>/"XR-RD_-\PX(]<9Q6A?70L;"XNVC:18(VD*)C+ #.!GC-8&N:Q_:OAK
M5H_#-RMWJ L9FMYK4[U63;A0''&\D\#.:\U\/K<QWFGMIX9+-?"3#6"!A?M.
M&XD_Z:[L]?FQF@#OM.^)&EZE)X96*RO5'B%9C:LZIA/*SN#X;CIQC/6NRKP/
MPPK(_P (E9&4V_V\3 @YC+<+N],G@9ZTOAF\DD\?>$;RVAU**VDN-1@N)+N%
M_/<$$J)Y H5CN.0.=HQDGL >X6>IV>H37D5I.LK6<WD3[>0DFT,5SZ@,*MU\
M_I8WNF^"?B'%I6GR0ZLFM3'$,!67[&7C)"D#[I4'@'IDBK?C"WMY?AKJM]H]
M^]S;WU]:S6\,%HT"6[<!Q&I).<#+ =#GWH ]UK"\1^*;3PU/I,=W;W$HU.]C
ML8FA"D)(_0MDCCKTSTKC?%6EZ-X>DT."RM;V2/4=3>>3!>YMY':,*7F7#%\C
M&%&,G)R.M<1ISW3?#SX?0W8N//L_$Z>8LRL&BC61N3GHH!'L.* /<-:U^VT6
M6PMY$:6[U"?[/;0J0N]L%CDD@  #^0 )-3Z;J;7\EU%)9SVLULX1UFV_-E0P
M*D$@KSU^O Q7,_$/2M"U^"PTC71-!',SRP7T)VFUD0#!+8PH(8C)XSCOBO.K
MZ;Q=IOA.\M+C4)=:T;3M9M =16,N;FSP6E5L'+JK; >3GYAG X />J*\4U7;
MI'_"/7374VI^#Y]6N9KS;:LL$0D0>6H3D^4K,Y'8'W J34K*QT+Q9X)-JU[+
MHRV%[;+/<([M)E&V*>,G.["C'(QB@#V>LRXU=X/$%GI0TZ]D2YB>0WB1Y@BV
M_P +MV)[5X7I4$D_@OX8P7!G20:K,MT=S*Z1F5LACU4$$<\=176:AH-AH_Q1
M\,Z1IUKLTY=,NXVB+,ZG>'(5BQ.<DM@&@#U#3=3L]7L_M=A.L]N9'C$B<@E&
M*-@]QE3S3=5U6UT>Q-W=N0FY8T51EI'8A511W8D@ 5X=HGA?[;\!X9K*S\CQ
M%I$TEV<P%79XY7/EOD?-E/X3_LUTNN13S2^!]9FM/LRZEKL-W=QX^X[1XA#>
MX  _WB?6@#T2SUB2ZUNZTQ]+OK<6\,<OVF1!Y,A8<JK \D=ZU:\,\7?VNGBC
MXC?V'YXN7TRU\KR,Y;!3S=F/XMN[..:L7NG0ZIX8DOM#U^*W2[O+6X@MY;(Q
M64<T<3YC<,2 &VC=G(W!?6@#UR75K>WUBWTR?='-=(S6[-C;*5Y90?[P'.#U
M'(S@XOUX[=W%YJ'A?X;S1Z=_9]_+KT<AMDSA8QYID*YYV%?FQV4BO8J "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@#*UC0TUF:S>2^O;=;9F+1V\NU)U92I20$'(P?8CJ"#5O4-.M-4L7L[R
M$20/CY<X((.001R"" 01R"*M44 -C4I&J%V<J "S8RWN<<4ZBB@"F^F6TFJQ
MZC*IDN(8S'"6.1$&^]M'8G R>N!BKE%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MO<:A96C!;F\MX6(W 22JIQD#/)]2!]2*1-2L9)6BCO;9Y%5F*+*I("G!.,]
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M7,8S]T-[5BZ=IVIZ1ILR)H]T=)_MY9;%&B,EQ:PD$M,4'S-\_3?DC=E@<8H
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MO:@#TI=9TMD1UU*S*O+Y*$3KAI/[@YY;VZU++?6=O<16\UU!'/+Q'$\@#/\
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MUOY<K )&V-PQG!)VJ<G)XJQI>EVN@:1'8:?%)]G@4^7$9"S=<X!8^OJ:OT4
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MYA\H*'=CGD=.^)-J.OMK.MN]^EM+!X=ANA#$HD2&5O.W;3WY0<GKQ0!Z)17
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M#K(649!XPV.HR0#JZ*Y#P[K6N:PVD:D8H?[)U&U,L@8H#$Q4,@C(8EAC(;<
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MZ1@1R@VK@J)'B(_C520"#N&1P0!P.:V* "BBB@ HHHH **** "BBB@ HHHH
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MR1@G>57@;FZM_0UL/KMC:ZUJRSZC/BSMX'EMG@PD6]G"LK;<N6(QC)'RCUH
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MS.A"M@D':1N&54X.>0#52T\):-8C3!;V\JC3"YM ;F0B/<"&ZMSD$CG-;=%
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M\1K;P-?Z1:3Z?+='4G95:.0+LVE1SD<_?_2NVIKQ1R$%T5B.F1G%.H ****
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MV:F?+QY7!R?D^]\HYZ<=*TM&TF+0]"L])MYII(;2!8(I)=I?:HP,X &<8[4
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ML=E_;%_/8Q +'!,4)"#HI<*&('3DY]2: .1TW5[GP[=^(9H+*W?3V\3)!/\
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M>"*)BTR1L\L@1(E9L%SDC./[HY)P*Y^T\:R7-C9DVBQW-SJ\NE;FW"-&3?\
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M@8,\?WN"<#&[ .*9J>E:]JM[X@O[/1[BW:X73I[>.XFCC,[6\C.\9*.2I(P
M>GN* .U/B;0UA\U]6M(U$WD'S)0I$G780>0<'./3GI5RTU"SOM/2_M;F*:TD
M3>LR-E2OKFN$O-)NM0AM+ZV\+W=K-)JUG<7*7%PDDS+"3EV)D(P!@ 9R<=!Q
M7H8 48  'H* .-E\=V\YT"]L)[<:9?WLUO</.I5D5(Y6# Y&W/EC@CH>U='%
MKFESZ;'J,-]!):2DK'*C;@Y&00,=3P>.O!KA]*T368++PC:SZ/,#I6IS27#>
M9$5V%)E5Q\V2,R+[]>.*A71]>L?*U!-(NYD@UF^GDLH;E8Y9()V)61"' R/[
MI(ZF@#T>SO+;4+2.[L[B.XMY1E)8F#*P]B*Q-$UJ_P!0\3>(--N!;"#2YHHD
M:-&#/OB63)RQ QNQ[XJ[X>LH['25CCT[^SU=WE^S%][(68D[B"06).3@D9/4
M]:Y_2EU72_%OBJ^DT&_EMK^X@DMWB>#YPD"H>#(".5/6@#I-5U,:>]N"Z(C%
MY)W<9$<**6=OSVC_ (%69I.J:WKVBQZQ:)96T%RGFVEM<1LSO&>4+N& 4L,'
M 5L9[T[^S;C7[?4!JMNUHMU8FS6+<&:-9%)DP02,_,BGWCXXQ6'#9:Q!\.)_
M"U]I,MQ?06#6-O-"4:*?"%8W!+#8?ND[L8(.,T =Q9R32V5O)<QB*=XU:2,?
MPL1R/P-06UW)<:E?1 +]GM]D8..3(1N;\-K)^.:AT"R?2O#6FV4J*LMM:1QR
M*G(WA0&QZ\YJ31K>6VTN(7"[;F4M-,N<XD<EF&?0$X'L!0!CW?B.=_%\WAZU
MN+&TN8[5+B);Q&8W6XL"$PRX"[1D_,?FZ<<V;;Q+"M[I6E:B%M]7O++[3)"N
M=L9&P,N3_M/@?2L[Q1I5OK[W%EK'AV>]M8PKV5W;%!+&^.0IW!D((!ST/?I6
M?IVD>)+"^\-W-] =1NH-(N+.ZF,JX65FB9=Y)!880@D DD>] '61^(M&E69T
MU.UV0Q><[&4 "/.-^3P5R"-W2G6&OZ1JEPUO8ZE;7$R1B5DBD#$(>C8]*\_L
M='U[S(IYM!N8F;P[-8/&)(%2.8E"$1%?"Q\$+WQU]:FD\-:U<VNFVL-G)9R+
MX5GTQYRZ8AN'$6T'#$XRC<@&@#;OO%TA\1PZ?I=S93P2:9<W>XHS$/&4"G(8
M H=YZ?W>M6O#7C/3-9T6REGU*Q&HMI\5Y=P1R#,6Y S'&20 3^'>L."SUG4-
M5T2:30+BR%MI%U93EY(MJ2,(=N-KDE?D;!Q^%2Z!H%ZP\&?:=/>RDT"S:*X>
M0I\[F$1%%VDY4GY\]/E'?H =A#J^G7$-I-#>P217AQ;.K@B8X)^4]^ 3QV!K
M,\::W>>'?#$^J62022PR1+LF4E6#R*G8C&-V?PK-\)Z//8:QJ-JSH^EZ9.\>
MG!3R@E"R,I'^QG:I_NL15GXAV%_JO@RZL=-LY+NZEDA*QHR+PLJ.>6('13WH
M Z>,.(U$C*SX^8JN 3],G'YURS^*;F?5+/2;&*%KV_,TT;.#L@M8VV^:P!RV
MXXV@$9W=1CFY=ZEJ]U');V>C7EJ[Q,!<7#Q81CA5P%<DD%MQXQA3WQ6;J6A7
M6E>*])\0:39M=0VUBVF7%I&RB00DJRLFX@$J5Y!(R#Q0!OVKZNFIF"\6VEM3
M"76XA1D._(&TJ2<<'(.>>>F.<[Q!K.H:?KV@Z=9FU":I-+"SS1,YC*1M)D ,
M,YVXQ[UKV=W/=L7:SEMH0.//P'8_0$X'UYKG/%VD3ZMXD\+O_91OK"TN99;O
M<(RBJT3(N58\_,0> : -BWU-[2&5M7N[(AK@Q6[VZE?-PO(VDL=P(?(!/"Y]
M:L/K>EQV,-Z;^ VTZ[XI%<,)%QG*XZC'/%8FL:9-82Z)!H^CA["&XE:7[*(U
MEMPZM_J]Y 4$L02O(!XKFM!TSQ%X=CT&[ET&XNX[>TN;"YM(IHC)'OE#K(NY
MPK*=N#D@]#0!W(U6.ZU:V@LM4T]TFLWG6$?/(XRNV1<-C9R<\<Y&#63X?\37
M&JZ/X>NKN\TZVNK]I#+;D$-,%#\1 MD8V@DG/ -,BTR\M_&&BW<6D+;V-MI5
MQ;NMN4$<+.\3+&!D$X$9&0,9K(T71-8M=/\  T4^ES(^FW4[W8+QGRE:*5 >
M&YYD7IGO0!T,7BVPU2PBN-.U*S@#:@+3_2P?WA$I0JHR#N;:=OX'%:\NL:;#
M?1V4M["ES(^Q8V?!+XSM_P!['..N.:X;^Q=:C\.QZ?\ V3.TMOXD%[N62/#P
M_;#-O7YO[A'!P<\8JQ9Z/?IKEW8:EH-Q>P-JC:A:7_VO_1T4OO&Y-X(=,D#"
MG.!R!DT =G!JMC=79M8+J.2<!FV*>2%(5B/4 D XZ'BH=6U4:>]E;1@/>7\_
MD6Z'IG:69C[*JL?? '&:YSPUI.J:;KRM%'=0Z3)#,TMI>%)/LLI=2! X)8HW
MS':<@8'0\5<\26TB>+?"FJ'_ (]K>XG@E/9#+$50G_@0"_5Q0!M7&L:=8S+!
M=WT$4QV@AFQ@L<+GTR>!GKVJ-_$6C1ZD-.?5+07ID$0@\Y=^\@D+CUP"<5R6
MI:%JLEKXST@V+72:XQDL[K<NQ"\*1X?)RNPH&'!R.G/%:N@:5>67B[7)[FUD
M,$T%I'#=N4/FF-&5CP21R>X% &UJ]]]ABML7UG:/-<Q1*;KD2;F **,CYR.!
MUY[5CR>(KJ_\3WNC:3/8I+8"!I!<JS>=O+;U!4C:55>N#R:F\9V5Y?Z;I\=E
M:/<R1:G:7#JC*-J1S*['YB.P--TFTO8?'/B"\FLI8[2ZBM5@G+(0YC#AN <C
M[PZ@4 :.J>(-/TC4-.LKN79-J$K1Q#' VHS$D]A\N/J:RO#WBV&]FN++5+RR
MBU!=1N+2"%#L,JQL0"%))R0">O8XZ5+XELKZ76_#5_:6;W4=E>2-.D;JK*KP
M2(&^8@$ L,]\=C7-KHFKBT4?V1.'_P"$J;42-\>?(,A;?][^Z>G7VH [HZQI
MHU!+ WL(NG)58B_+,!DJ/4@<D=<<U9N+F"T@::XE2*)< LYP,DX ^I) KA=$
MT>^AU$:=JFA3W!M=1EO+;4VN]UOM:1W#A-^1)ARN-N.IS@UM^,K34I[33;S2
M[;[7-I^H1W;VH<*9XPK*R@G W#?N&3U44 1:OXLBM9M$FLKNRDL+O4&L[J1^
ML>V*1SSD;2#'@@COVK7CU_29K"&^BU""2VF<QQ.C;M[C.5 ')(VMD=>#Z5S=
M_8WNH7.@7D'AYK1$U@WMQ%^Z#JODNGF28;!<LPZ%C@#OQ5"UTW7+28-_8DS0
MOKUW<L\;0^?'%(K;'C+-A=Q.&.0P!./6@#KKCQ3H%I;0W-QK-C'#/$9HG:=<
M.@ZL.>1[U)/XBT6V($^J6D0+!=\DH5=Q7<%W'C)7D#.<<UQ'A[0=7M)/"$=Y
MH\R+ISWRW#-)&X02$[&^]D@Y^OK4$W[K4=2>72]5FT2/6O[2^TVJPR('BVAC
MN\P.%#H<J$)X(!H ]#DUC38;^.RDO8$N9&V)&7 );&=O^]CG'7'-8VN^*5L-
M4T>SL;BUD>ZU%;.XC8%F *L3M(( 88&1SU[5CV6CWT>N7.GZEH4]Y!_:K:A:
M:A]K_P!'13)Y@+)O!#ID@ *<X'(&35&STK7X-+T#2;C1KB6?2]:^T37:R1>7
M-&3*?-!+@Y.\$@C.<^U 'I4TT5O \T\B111J6=W8!5 ZDD]!7.:;XH%[XJUF
MQ:XM?[/L;2WN!* 49"YDW!R3C@(".!P:E\;:=J&J>%YX-,19;I)89UA9@HF$
M<JN8\G@;@I'/'/-<OJVE:]K=_KU[9Z1<6C7-C8FW%S+&ADD@G>1HR4<E=P(7
M/OUH [0^)M#$9=]5M(PLP@/F2A")#T4@\Y((/TYI]GXAT:_T^2_M-3M)K2)_
M+DF24%5;@;2>QY''N/6N!UR'.GVNIR>'+JQGN-8TU98[J=99YRDW3.]EVC.%
MR1GG( Q5O4O#6JSZM?Z_8VC*'U.QN_L3,JO<) I5SUP&.[(!(_U8SC- ';QZ
MSILMK)<QWD311R>4Y!Y5^!L(ZAN1QUY%59-:MIKS3%M=4L!'<R2J8W.9)@BM
MN$?(P59?FR#P".#7,WOAV>_U'6=2EL[^.'4);3RUMI5CN(6A5O\ 2!SC.648
M/)"]#P*6TTSQ";WPK+J%NURUC?W;S7*K'&?*>.1(W=0<;FWJ2%SU/>@#J="U
M^P\163W>GR;XTEDB.1@Y1V3./?:2/:@ZI%'K-Y#)J5B(+:V262#.)822V7<Y
MP%( QP.AYK/\%65]IFCW%A?6;P/%?73HY=6659)Y)%9<$G&&'7!SGBLW6=(N
M[SQ1K4TFDW%UI]SH\-H/+F1#(RRR,RJ=P((5P03@9'6@#KK2_M;]9#;3+)Y3
M^7(!P4; ."#R#@@\^HJQ7.>$K35K&*_AU&>:YMQ.#:3W2*MPZ;%!\S;PQ!&
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MMB=P@=BJ%RH(4%@0"<#@^E9W@V]O+JRU*"]NGNGLM2N+5)I H=D5OEW;0 2
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M(5MI*GH1Z9JG9^/(KK2H]3;2+Z"TGD2"W>1H_P![,\QB"8#$CYL$D\8SC/<
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M<Y9?0G)Y'J:M:AIUEJUE)9:A:PW5K(,/%,@96_ UP/BCQ%J-WH?B^(136?\
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MR2,#![8&.E!T/2V$ :P@;[/*9HBR E)#U<$\[N3SUYJ6#4[.XTB/58YU-C)
M+E9CP/+*[MWY<UC1>+X7FTY);"YC35(&FL&RI,VU=^PC/RN5^8 \8!Y!&* -
MJTTVQL);B6TM(()+F0RSM%&%,CG^)L=35JL/PSXB;Q+I\=^FEW5I:30QS02S
MLG[T,#D *Q(Q@=<9R,9K<H **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=N />NDT^_BO[6.1)(S*8T>2-7!,989P?2IH+JWN@QMYXI@C;6,;AL'T..]
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MLY;J%+FXW>3"S@/)@9.T=3@#-6* /)O"FD;KCPQ_:FAW16V\/2VUP;FP<A9
M\6U3E>N%? _+J,S>%UO],_X1=M8TS4'L5T+[%M-G)(;>XW#<'0*2H9 H#$8^
M7&>:]2)"@DD #DDU176]):%IEU.R,2Q+,SB==HC;.UB<_=.#@]#@T <GX!L[
ML>'=$MIK2XM#I]BV$N(63$KLRC@CJJJWX2"LW2M-OY])\)6LEE<P:QI=Z3J$
MTD+ %-KB8[\8<2$J>"<E@>QQZ1;W-O>0+/;3QSPMRLD3AE/T(IMK>6U]$TMI
M<1SQJ[1LT;!@&4E67CN""#0!RGPZTBVL-",K:5]DOOM-VI>6U,4GEM<.Z#)
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MUS2;AML&J64K<\)<(W09/0^Q_*K%G>6NH6J75G<17%O)G9+$X96P<<$<'D4
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MXM)KMYRH8X1D4*H/&27R<]A[Y%B+PQI$-Q8SQ6K1RV*NL#)*XX=@SAL'Y\L
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MNG+]F9%TU]]J(YG01M@@G@C)PS<G/4^M7;_3[35;":QOK>.XM9EVR12#(84
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M7\=M",EIR7!CWY^925P#@=:H?\)-KSVE[=V5S:7%I#H?]H&>2U)"7&&/E<.
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M):*PVY3-NKY&X@9.S R>I'7H>NT"75Y+2X36%B6>.X=(F0C+Q<%"X!(5L'D
MXXSWJ&X\':%=V5[:3V;/#>W/VN8-/)GSN,.IW91N!RN.E:.FZ9:Z39K:VBN(
MP=Q:25I'<^K.Q+,?<GL* .%T/7]3@M+.UGO3/<:GKMY9+<21C]TD;S$D=B2(
MPH'09[XP>F\.ZM>7>I:WI=]L>;2[E8EN$7:)4>-9%)'9@&P<<<9XSBI&\(Z(
MT,\7V1PLUU]MXGD!CGW%MZ'=\AR2?EQU/K6E8Z?;:<DBVZ$&5S)*[,6:1\ 9
M9CR3@ ?0 =!0!YKK\U_/H/CL7-Z9XX-4@BAC9  @Q;, ,=AN/\ZVKGQ7JFCW
MFMV=Y)!=/;3V*6\J0^6%^TOL^8%L$*02,D9Z$]ZWKSPCHM\]^UQ:R'^T&1[E
M5N9$61DV[3@, #\B\C&=HS3[GPIHMXVHFZLS/_:420W8EE=A(J9V\$X!&3@C
M!H -#EUDW-_#JJ)Y*.K6CDJ)60CD2*I(!# X(ZCMD&MFL[1]$L=#M3;V2S;6
M.6>>=YG;'0%G).!V&<"M&@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@#DO'.JW>D'0'M]3:QANM5CM;E]L9'ELCD\
MNIP<J.:JZ5XMVZ[K\<FIIJ.A:9:)</J 128I/F+Q$H 'PH#<#(S@YK4\6:-J
M.L2Z(]@+4_V?J,=ZXGE9-X577:,*W7?U]JR[[PIKE]KFJZ]!>6FFZC-I1T^U
M6W9G ;=N\R1BHR1T&%X&>M &K<>,]+L[/4;B[2Z@.G"-KB)H=SJLGW&^7(P>
M>_&#G%9?BGQ9O\)^)3I4UW8ZEI=L)<RP;& 8$HP#@Y4[6'KP>E9]UX)UNYMO
M$*1II5N=6M;:,(L\C>6\9;<68IEL@YW$9)Z^IN^(/">KZN_B8PFQ0:OIT%G'
MOF?]VR&0DG"=/WGZ>_ !UMKJ,5Y=W$$*2,+=MCS8'EENZ@YY(Z'T/%5-2OX+
M?7M%LY+NZAFN9)1'%'&#'-MC9B'8CC &1@@Y [54\-:/J6@RW=DSV[Z.7\VS
M3S6:6W+<O'RH#(&)VG.0./I+K&DWE]XB\/W\!@\C3IY9)A(Y#,'B:/Y0%(.-
MV>2.E %K3=<MM5>/[-',8IHC+#.5&R5 0,@@^XX.#[4:IKEMI4L<,D<\T\D4
MDRQ0IEO+CQO;D@<;EXSDYX!K$\-^%[O1];>_Q;V4,]NRW5I:3.\,TY93YRHR
M@1G ;('7=[9-KQ)H^JZK?VOV:2UDT_[/-%/;7#LHWMMV2X ._;AOE.!SG.0,
M "+XOAN-<LK*SLKBZM[O3#J,<\8&&3*!0 2#R&YSCM[XCTKQM;ZAH6FZ@]C=
M)-?Q//#;(H+&- "S9SC #*.N23P*J:#X7U?2KOP[/*]B_P!AT?\ LNY"N_8Q
MD.GR_-GR\$';C/?&#4T_PGXBL]&T/2I)=-FL[&"6VG@,LFR3(41RD;?F(PWR
M' ^;KD @ Z.3Q9IGV"&\M_.NXY;/[>%@CRP@QG>0<?@.IP< X-84WB\:=XIU
M.:>>\NM(72+:^C2&WW>4K-+O?@ XVHIYY]/2H-'\*>)O#_\ 8]Q92Z7-/#I4
M6F7D,TD@C(B)*2(P7)/S-E2!UZ]ZO:CX9U>\OM=F$MF_]H:*FFH[NRGS!YN7
M90I !\WH">GO0!K:GXMTK2H))YGDD@AA6>>2%=PAB;.';N1P3@ G SC%8WCG
MQ2UIX5UB31Y[C[59Q(6N;9%=86;!4-NSU4@\ X# G&0:AC\*Z[8:HEU9IH]Q
M'<V<$%TEX&;R9(EV[XR%^8$=5.WH.14.J>#==>Q\3:7I\UA+9:VPG66XD9)(
M)=B(PVJA#*=@(Y&.>#0!WER&-K*$D:-]AVNH!*G'49!'YBN1\%>,(]0T+0H-
M2DN/[0NM-6Z-Q-#LCF*JOF$-P,C<">W/%=;()GLV 2/SRA^7>=N['3.,X]\?
MA7$67@G4DL/#-C=26GDZ9ID]A<M%*VYO,14W)E/]G/..M &T_C?1XFD$K7$8
M6S:^C)B)\Z%<;F0#)XR." <'.,5);^+K&Z@22&VOMTO,$;P&-IUV!BR;B 5
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ME8LRNSR2)(65<$8RAXSW]N>CUJ[TJTTF=M:N+>"PE7R96N'"H0_R[23ZYQ0
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M9EC\^<D#T]ZD@T77],\1ZI+IT]BVEZI.MS(TQ;SK:38J-L4 JX(12,D8/KW
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MKR^DN-2ED0^%8KD!;QU7SLR?. & SPI_(^] 'K5%>2ZKKL+6VG?VEK%NHO\
MPVOD&>Z$(BNC_P MMY(&<]URR[.GS5-J%W9QW4&D:OKXBL+C2(?L&HEWD$TV
M7$KQR;O]9S&5Y)QC'<$ ]4J&[N/LEG-<F-Y!$A<HF-S8&<#) S]33; .NG6J
MR22R.(D#/,NUV.!DL.Q]17G<=^]MK]Y'--;7UM,U\8[V&8K+;E=Q:*X0\%5^
MZK=L*,#/(!W^CZE%K.BV&J0HZ17EO'<(KXW*KJ& .._-2:C>KINFW5\\4DJ6
M\32LD>-S!1DXR0,\>M>5:!=6VD6WA2:"ZN?](\+3-=1PSEW=HXX2NU22 X_>
M!1CU%+INK6Q?58X+^)K.X\,+,J),7!D'F!F9CPTF,!FP.< B@#T&S\3V]YJ&
MDV:VMPC:G8-?12-MVA1LRIYSN_>+VQ[U9\0:U%X>T2XU2>":>*  LD.W=@D#
M/)'K7&:)<V[>(/ BK/&2?#LP ##K_HW'_CK?D?2MWXCHTGP]UI5#$^1GY1DX
M# DT =317EFJM/I=SKEYX7NKJYTPV$,MR8KA[@"7SAO:,EB=_D[R0IS]T]2#
M73>#'TVYGU&]TC5_M]G<>6VR%"+>%P"#LR3AB,%AVX. 30!UM4-3U6+36M(3
M&TMS>2F&WA0@%V",YY/  5&.?:N<\<:FNFZAHHU"=+;19FF2YFFC+1+)M7RA
M)@C"GY^O&<>U84UKIL5]X#AFU![Z+[9<B.XNGPTD7D3;.IR5R5"GN-O)S0!U
MUMXK^URI%#H^H&5'BCNXRJ![4R=-XW<@#!)7. 0>><=#7EEW,ME?_$&ZTGYK
MV&6V;$#%I!'Y4?FE0#G(&_ISD=C23ZG96VF7&L:-K$M[HTUY:'4!:(PAMX=Q
M$A7DD$C;O [<D#/(!ZA-<0VZHTTBH'=8UW'JS'  ]\U'!<2RW5U$]I+$D+*$
ME<KMF!4$E<'/!..0.17G&N1^'Y+'2+ZSNS<:3_PD$4IG>7-O$&0AA&W0)G'L
M&8C/4">2QDUVZ\=:?87LGVJ*>WELLSL?+D$",%Y/"EL@CIR10!Z117G6HZQ<
M7'A >*E@N+6&[EM?M";&+P6BL/,)48/4MDCDICTK?\&BR:"^GTS53J%C/.)(
MS&/W$1V@,L7)XR,D9P"3CN  =-17(Z_=K'XUTNTU9E31)[.<*9&VQ/<ADP'/
M3.S>5![YQR!CE=,$MQJWAFSU>^N'MY%U-$$ETZF>V60"!G^89RG0]2.N: /6
M*S]3U*UL;2[>5#<-;0&Y>W3:7*#)R 2!_"<9/:L;X=737?@73W:X:X9#+%O9
M]YPLC*H)ZGY0.M8&O"PM/&_B:2<QQ33^'$:(NV"Y!N Q'K@;0?3(]: ._P!.
MO4U+2[2_C5ECN84F56Z@,H(!_.K->16<\^GQV2Z%<N]]=>$)94B$YD\RX01^
M60I)&X9< #Z=!72^"KG2]2U-M1TG6'N4DLU2XM8T8)&X8$-(&)(EY(.>2 <]
M!0!W%9FEZU%JMYJELD$T4FG7(MI/,V_,2BN",$\8<=>?:LCQSJ#Z=;:0\SM%
MI<FHQQZC*"0$A*MC<1T0N$#'I@X/!-<=#J6C6-QKZ172BRF\16P1DN L&UK:
M,CS&Y_<Y4C X) 7(% 'J\MQ# 8Q+(J&5Q&@)^\V"<#WP#^525X[!/:7%IH3Z
MA<)+#8^*KNW,CE@L496XV+R25!^3 )_NCTK6TB]AU/Q$L-[JTMKX@L]5FWV<
M<;"66'>P53DX:'RRISC QGKU /3**RO$UTMCX6U:Z<W02*TE8FT.)@ IY0]F
M]#VKRO4]5B31_&<5KJ<:PG2;.XM19W#!-Y,JL4;(W$X0,P !/49H ]IJ.>>*
MUMY;B>18X8D+N[' 50,DG\*\NUR]ETG5?$T.B74\D1L;"ZE6.X:5PIG<3NG)
M(;R@"2/8^E,\60I=:=XMCTAUN=#?0?/9(7WQ+<@L5*8X!*#) ]%)Z\@'HL>M
MPR>)9-$\B83):+=^:=NQD+%<#G.<@]0*TZ\LU4:-?^(KX17:&U7PSOB,-R5&
M1(Y!!!&?4?@?2J[ZS%J$5A:Z_K'V*"^T*U>RNV#'=.0WFF-P1B8'9CJ?3OD
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MRNW.,'*GIZ'TH ];DABE*F2-'*G*[E!P?:H=1O5TW3KF]DBDD2WC:5ECQN(
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M6BB@ P/2BBB@!"H/4 _6EHHH **** $ "C   ]!2T44 %%%% !1110 4444
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M<O%\P56# ]%;:<CG (]F2^%+?[)IVCVZ%=.M[W[?.S$9D<2&4* , 9D(8X
M P!SQT]% %6SLS:-<DW5Q/Y\S3 3N&\O( V)@#"C' YZFK5%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MV2%6QE<]#T..M>?:CI>LZK<>*A8V>IR/J&DVOV>:]A\H3-&\A>,C "D@A=I
M/.<8YKHKR^'B'P[K-Y%X9O[2\DTJ6V9[JS*3LQ4[8E&-S+DDY^[R,9YP 79]
M:OX/$7A*TCO8+BRU*"9IY%AVF4I$&#J<_*"3G'ZTZ7Q=8:3I%QJ%UJ\&I0OJ
M/V:%K:/ 0LX41D@D';GEOZ\5D06]T-3^'KFQO MI:2I<L;9\0L8%0!^/E^8$
M<_RK+FT_4'\(ZX$TV^,@\3B^6+[.X>2$7*/N12,M\H)P.>* /1;76],O;V2S
MMKR.6YBC662%?O*IZ$CL#VJ>VNX=1LA<6,Z21R [)5&5/;\>:Y#Q5:ZC'JVD
M:[HB&*]NU.F3I)\K>5("R.1ZQL-V/0M786\$&FZ?%;PH5@MX@B*H+$*HP!@<
MG@4 <_X"UO4O$/AS^TM3>V,K7$T06WB**!'(R=V.2=N:V-0US2]);%_>Q6_
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M%JEU!;66I132W"L\(4'$@7[V#C!(ZXZXYZ4 ;-%9MCK^EZE="VM+M996C,J
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MY"D1Y9WS@G'  )X'O@=]10!Y[=^']9?^V)8M/9F?Q%:ZG#'YL8,L48A#8^;
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MNPPV@]2/>N[HH XNUT/4[;Q<M_917%G:RW4S7T$DR26TRE6"RQKDLDA.S.
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M'G;UV_WOEQ^.?:@!O@#6YKWPWIELWVB^G$;FYNFD#>4=YVAV8Y+$<@#)P.<
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0H **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>exhibit1033-bochk_facili002.jpg
<TEXT>
begin 644 exhibit1033-bochk_facili002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MMM<B[2*.YA8?+&" 5/0\D]P:ZV@ HHHH **** "BBB@ HHHH **** "BBB@
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M+>&:S:=@@++%C+8/IP,^V:S8[BUM/$^L-_:-M:*+I2D:V8EDD4*O"G' [<4
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M_P" &/ZT?\NQ*ZQ>G<D^'4A.GWD9Z+*"/Q'_ -:NUKB/ATN;.^;MYJK^0_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@#$\4Z8=4T*:%,^8F)$'J1VKSS
MPOJC:3K4;N0L,I\J4-Q@$]?P->ND9%>9>,/#;V%TU_;1EK65MT@'_+-CU_ U
ME43^)'=A*B:=*74[S5],AUO2Y+.1R$D *NO.".0:\XN_ ^M03.L423QC.'5P
M,CZ$\5H>&?&']GQK9:@6:V48CE R5]CZBO0(;N"[M1-;RK)&RY#*<@T6C/42
ME5PKY>AX8$9I!'C#%MF/?./YUT5MX)UN650]LD*$\NS@\?@:Q$.=14?]/ _]
M"KVV2XBMH#)-(J1J,EF.!40@GN=F)Q$Z?+R]2EHNDPZ%IJVR/NP2SNW&3WKS
M;Q7JAU3792C!H(?W<>.0?4_G6QXG\8K?0-9:8Q\E@1)*1@M[+[>]5/"'AQ]2
MN5O;F,BSC.5S_P M&!_E52=_=B848.DG7J[G:>%-+.E:)#&^?-D_>2?4]JW:
M11@"EK5*R//G)RDY,*:Z)(A1U#*PP0>A%8/C*]N],\.W%_9W+0RP[2/E5@06
M .01[U3L-;DG\616-IJD-_9M:F63&S=&V0!RN,YSTIDG4I''&BHBJJJ,  8
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M:M-IEAY2RVT:O<32J2JELX  (R>,]>/>@#;&!2URXUS4I+'5(5A@35--QO#
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M)/I3 @G(MVXQ]#7(-_:6ERE";FU<'D E?_K&O4CXNT8=;AO^_;?X4QO%>AR
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MSBTMK2&\AA^2*Z\\)\G;<N,\#TJY_P )GH7_ #^'_OTW^%+_ ,)EH7_/X?\
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MUOXBF2 Q6ZLDD#-T(RS;P,\\"@#TVBLZ?7M*MM173YKZ%+IF1/+)Z,^=BD]
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M!L ZL54ODD##* "<T_Q)\0+[2/ FC^([72HF_M'[.&CGE(,)E&>@'S8^H[4
M=]17%>)?&5YI_B=] TR"W-U%I,NJ-)<!F5@IPL8 (P20<GG'H:FTWQJVM^'/
M#VIZ;: S:LYS QR45%8RX.1W0J">,LN: .OHK@]&\6^)1X_F\,:_I5@F^Q-]
M;2:?*S[4#;=KEL9.<C. ,_6I]*\2^(V^(4WAW5;#3_LQLOMB364CL8 6VA9"
MV,DX/0#I]< ':T5PGB?QSJ.A^$=<\0VMA;7-O979MX \C)E598F8X!W?O2XP
M-O"]:O:MXMGM=7\,Z+:)"+_6UD?S)5+)"D<6]CM!!.3@#D=_2@#K:*\VTGXG
MOX@M_"UO86\,.I:VUPL@E!=+?R%);@$%LD#'(X/M4D'CKQ!X@^'MOXB\-Z9I
MYG$4LEVE[,P1#&2&1 O+$X)&2 !C- '>7FGVNH1K'=0B5%.X YX-4O\ A&=&
MSG[!'^9_QKD[/XB7.K0>$+>ULXK;4/$,,LQ$X+I L:$DX!!;<0,<CCFKFD_$
M2VU#X;1^+&M6$ABDS9QMEFE3=N4'T^4MGLO)Z4 =!_PC.C$Y-A'GZG_&@^&-
M&/\ RX1_F?\ &L;3?%EW?^"O#^JF&W6_U9X5$8!\M=QW2$<Y^6-7;KVK%T;X
MH-J-UH%Q/;PQZ9KMQ=06Q (DB\HX4N2<-NYX &,CK0!V7_"+:+_SX)_WTW^-
M'_",:-_SXI_WTW^-<=H?Q.DU2\\/32VT*:=K]Q=06NT$21&)L*6.<-NYX &,
MCK2^-?B!JGAS2;W5+&VLYK:'5$T^-9E;+_)EVR&'1\KC'\)H [#_ (1?1>?]
M 3G_ &C_ (T?\(QHW_/@G_?1_P :@AU'4;:^NVO[G3YM-M8':>:")HWAD4*V
MU@78$%&)_"N(O?BEJ%G<W5E<V]E9W]MI4>H)!<*^;MW&[RH_F&" =O\ $2V>
M,"@#NG\)Z+(Y9K%,GOO;_&D_X1#0_P#GP3_OMO\ &N.UKXH7-AJVH:>+6WLK
MFTTR*^BMKT,7O'8!C$A!&"/N]&).>.#4OB+XA:G;:[9:/HXT2&]EMHYIK?5K
MIHG5Y.1&N.I Z_48I<J-%5FOM,ZO_A$-#_Y\%_[[;_&C_A#]#_Y\%_[[;_&L
MOQ%XLU+0?$'A?2FLK61=7N/(EG$C?(0 6VICWX);\*I^/O%OB;PBJZI::387
M.B0RQQ3AY6^T2;R!E . ,D#G)SVQS2Y8]@]M4_F9T'_"'Z'_ ,^*_P#?QO\
M&C_A#M"_Y\%_[[;_ !K&\<>)O$GAHVEYIVG6%S8O=16S0RR-]HG9SC]V!P/3
MG/0G&!6=XA^)%YIM[XH%C9V\D'AM;5KE)<[[CS3\VP@X7:.Y#9/I1RQ[![:I
M_,SJ?^$.T+_GQ7_OMO\ &C_A#M#_ .?(?]]M_C6O97<5_86]Y 28;B)94)'.
MU@"/T-3T<L>P>VJ?S,PO^$/T/_GQ'_?;?XT?\(AH>/\ CQ'_ '\;_&MVBCEC
MV#VU3^9F%_PA^A_\^(_[^-_C1_PB&B?\^0_[^-_C6[11RQ[![:I_,S"_X0[0
M_P#GR'_?;?XT'P=H9_Y<O_(C?XUNT4<J[![:I_,S!_X0W0\Y^Q_^1&_QI/\
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M\8944@Y<E@H/7@$]OPFGT:];0-3T#2/#TVG0:G;7#3RR/"L:2M!L"JJ.3DL
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQK9VNJWD4=JUA-"3>R,\32'#X9F)P<=,XYZ5-KEQ)IUK\0[2VU.\5+73(;N
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M;%8HV-L6(.[A,ESZ Y(Z5H7.IQ7VN:EI\WB3^S+NVN;=]-4,[230;(RIC'F
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M8(HQ*91&GF'JVT9_.D6"%9#(L2!SU8*,G\:YJ^\37.G^+KNSN8X(])L]*-_-
M-YAWXW,"<;>VP\9[Y]JLVOB<OJNFV-[8M:G5(&GLW$F_=M 9D<8&U]I!XR.#
MSQ0!MO;02MNDAC=O5D!-2 !0   !T K,U_6[?P_IGVZYVB+S8XB\C;$0NP4,
M[8.U1GDXK/F\5-'';1+9QM?7$<LR1"<F,QHX4,'53D-E2OR]#SC% '01P0PH
MR111HK$EE50 2>I-(MM;K;_9U@B$&,>6$&W'TZ5S</C"2_M"^G:/=2W<=BM[
M/9SGR98PQ8+'@@Y<E'P.!QU&11>>,OL<.ON^G29T>RBO71I "Z.KMMZ<,/+/
M'(SWH Z:.*.$8CC1 >RC';'\@*1X(9)4E>)&DC^X[*"5^A[5SK^*YSK\NEP:
M1)(L$%O<S7#3HJI#(7!;!Y.W83COS[972?%O]J:C9P+ILZVM];FX@N5#,J@8
M(63Y0$)!R.2#@C- '0^1#YOF^4GF?W]HS^=$D$4V/-B1\=-R@XJCK6L1Z-!;
M.\9DDNKJ.TA3. 7<X&3V'4YYZ=ZQXO&J,MTDU@\-Q#J/]FHIDW++,$WG! SM
M"?-G&?;/% '2&TMCG-O$<]?D'-#6MN[*SV\3,J[5)0$@>@]JY9?&\Q^Q1'0K
MI;BZOY+ *SA%WK&T@=68 LA"]<#OQD8J6V\:QW%G%NLS%J$EW/9FV:0E5>$G
M>=ZJ25X&"%S\PXZX .F:")Y4E>)&D3.QRH)7/7![4TVEL<YMXCDY/R#DUR8\
M<74HTV&W\.WC7M\+@+!+(L6UX>HRPY4\$-C!!'TJXWBXPZW9Z?=:>T'VN[:T
MCWS#S-PC9]^S'^K.Q@&SZ<<T = ;2V))-O$<]?D%'V2VY_T>+D8/R#FN<\#L
MYM]<5Y99!'K-TBF20N0H88&22<"J&J7VHV'Q&N&TZQGU%SHRR?9?M0C3(F8$
MC<< D #@<]_6@#KKRT>:REBLYA9W)C*17"Q*YB)[@'@_2HK#3?L6GM;O<//-
M*6::X=5W2.W5B,8] !C   [5S=W\0K>'P]'KL%A(]@UC]M9YI!$2,G,2<'=(
M-K97([<\U+JWC:73KC68X=&EN$TJSCOII//5 T3!R2!R<@1G [^W< Z>SM(;
M"TCM;=-D48PH_K]<\TKVMO).D[P1-,GW9&0%E^A[5Q,&MBU^(.L1P-)<S7EC
M8O:6;S$;R3.6(SD* H!)QCCU(SI7^N1:=XBOS)ILSWEKH_VMG2Y^1XPYRBJ<
M#.0?F(!H Z5K:!V+/#&S-U)4$FC[+;D8\B+[I3[@^Z>H^E<S8^-1/.JWNFR6
MD4FEG5(G\T2%HEV[P0.A&Y<=<@]CQ4VE^*WU'5K"Q.G-&+[3QJ,4JS!@L60,
M,,##99>!D<]>* -NZL8KFUN84+6[SQM&9X,+(NX8R#CJ.H]ZQM+\+-:7%M+>
MW<%TUH<P-'9)"P.TKEB,Y.">F![4WQ]J%]IG@G4[K3R%G6/;YF\J4!(!92 >
M>?;U[5GWNLP^"TO9GTUXX#Y=Q,#>$H6<["L 8?,0%W,!M^\/6@#L8X(HF=HX
MD1I#N<JH!8^I]:=)''-&T<J*Z,,%6&0?PK#G\12FYNTT_39+Z*RNH[6Y:-P'
M5V"D[5Q\P4.I/([XSBN7\1:A%<>&?%+6L-U9W%IJ\$4K?:F)D?-O\PP<*I5P
M-HX]LF@#T.**."-8X8TCC7HJ* !^ IP4#. !DY..]<1K_B-M);QA<V%@?[1T
MW3H9S)-<$QR*1+M(3D#;M;L-V0#CK5V?7;:Q\1HVIVCPS0Z-/>27*7!:-8D=
M-Z[.,GD')&>,#K0!THM;=49!;Q!7;<P"##'U/O4JJJJ%50% P !Q7)2>.1;)
M=R7>E7$4$%G]L6=-S1[=P!1VV@*PR"0-PQD@G%;VD:D=4M&N-D/E;\12P3B:
M.9=H.Y6 &1DD=.H- %M+6WC8,D$2L.ZH :=+#%<1F.:))$/574$?D:Y+Q-+=
MW7B_0]&,"2Z==074DT9G9"Y4(.P_AWDCGKSQ@&H=+\9&+1XY'TFZ2SBE.G0R
MS72R237"S^0J'N<D9+GT/X@&W<>'ENO%4.LRRQ/'%:-:BV>#<""ZONW9Z@J.
MWK6O-!#<($FB210<@.H(!]>:Y74_'']CQ:NEYIK_ &W3(HKAH8I@5EBD)575
MB!T((((R".])>^-+VRFUF!M!=IM+MEO7'VI,/ P?D''W_P!VPV]./O4 =5);
M03,C2PQNR'*EE!*GU'I2^1#O9_*3<PPQVC)'O26MPEW:0W,6?+FC61<]<$9%
M<-/XFN+C0-;N=7TT26MKJZV:QVMTR, LJ*I+ *<;B"<'G)&,4 =C+IL+W]M>
MQ_NKB!#$&4<-&<90CTR 1Z$>F09'LHQ!-';!;5I?O21( WU^N.A-<QJWCF32
MY-</]C2RP:*8VN9//528W7=N4=R >AQG!Y%6)/&*V5WJEMJ>GR6KV5O%<H%D
M60S)([(@XX#;UQC)'(YH Z*SM(+"SAL[6)8K>!!'&B]%4# %+]F@Y_<Q\DL?
ME')/4_C65HVNRZG?WUG/I\MN]L$991N:*96!^ZQ5>0001CCCKFH-8UC4+/Q5
MH6F6L$#V]]YS2N\A5L(N< ;3_>!_#'% &X+6W4J5@B!7D$(.*%MH$E,JP1K(
MQW%@@!)]<USD7C2&2/2[TVA&E:G=?9;:Z$F3O)(0LF.%8KP02>5R!GC1\4ZG
M<Z+X4U75+2*.6>SM9)U21BJG:I/. ?3IW]1UH U7C252LB*ZG@AAD4V.WAB@
M\B.&-(L8\M5 7'TKF8]6)\0Z7%=:=(VHR:5/<))'<GRR T6Y=O ).Y#DCCD"
MJUAXZN=171FBT*0+K-JT]F6N5^\JABK\?*,'.1D\=* .O6WA2%85AC6)>B!0
M%'?I4E<I:^-HKW3K"2&S*WUV+@_9I9" GD2>7)EE5N-Y ! YSVK;T35/[9T:
MVU VEQ:&9<M!<H5DC()!!'U'7N,&@"V+6W6X-P((A.1@R!!N(^O6E:"%I/,:
M*,O_ 'BHS^=<]>>+18ZU;V,]BR)/>BRC9I0)')3<) F.8\@KNSU'2JMIXXDN
M)[0R:/+#:W&IRZ69C.I*S(SJ#M'524/.>,CKUH ZN."*'/E1(F>NU0,T[8N_
M?M&_&-V.<>E<%K^N3:LN@7=C$ZZ>=?BMUG6X*F3;(R-E ,%"RD#)/0''-=MJ
M%VUCIUS=I;3730QLX@@&7D(&=JCU- $L4$-N&$,4<88[B$4#)]>*)H(;A0LT
M22*#D!U! /KS7%:MXYN8M%UY[&VMC?:8T"L5N?,B(EP P8+R0<Y4@<CK7;1&
M1HE,J*DA'S*K;@#[' S^5 "2P13H$FB2100=KJ",^O-25S,'B[S-=MM+ET]H
MI;H7'DH91YH\H_QI@;0XY4Y.1CI571_'$FJR:/G1Y+>'5HY3;.\ZGYXP6*L
M. 0#SSTZ4 =6+6W'F8@B'F'+X0?.?4^M.$,0D$@B0.!@-M&<?6N?TKQ2=5M+
M*1;'RKF>\EM)K9I<M;F/=O+8';;^.Y>>:F\9ZO=Z#X0U/5+&..2XMX2R"1L
M=L]#G'7'?VH V8X(8598HHT5B68*H )/4FD%K;K;_9Q!$(",>6$&W'TZ5S=S
MK*VGB:59],E-]#I#W.Z.Z)C9 XR@4X&<_P 1 /:H+3QI>7LVF11:"X?5-/\
MMUGNNE ( 0LKG'RX\Q<$9SZ"@#K/(AV,GE)M?[R[1@\8Y_ "AH(FE25HD,B
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MB>61@L:*69CT '4US=OXP65M&EEL7CL]:4_89O,!+-L+JKK@;"R@D<GI@XH
MZ)[:WDB6)X(FC4@JA0$#'3 K);P\LOBU]<FEBE5K1+9;=X,[=KLX8,3URQ[5
M%X8\17/B2U6\.DR6EFZL8Y7G5BS*[*5VCD?=SGWINI:Y?6GC33=*2&W^PSV<
M]S-*\I##RVC!XVGH'SUY]L<@&]+!#.4,L22%#N7>H.T^H]*1[:"25)7AC:1/
MNNR@E?H>U<]:^,8YFT6:6S:+3]:.VRN/,R2Q4N@=<?+N4$C!/H<4SXCN\?@+
M4Y8I)8Y(U1E:*0H<[U[@C\NE '2_9X/G_<Q_/]_Y1\WU]:DZ5R;>-ULKR_L]
M7TN:QN+>*.>%/,607"22>6N".C;R%(/3(Y(K3T77)-5O+^UFL);:2T*8D^9H
MIE8$@HQ5<D8((QQQZT :8M+98S&MO$(RVXJ$&,^N/6C[+;X8>1%AAM;Y!R/0
M^U9VI:X;/5K;2K:V^T7L]O+<JKR>6NR,J#\V#R2Z@#'J>*PXO'D][;Z*^GZ#
M<3R:O:2W5M&]PD?"!3AB>A(<4 =<UM;L,-!&<XZH/3'\JP]1\.7%WJ[WT&I*
MD<L:1O;W%HDZ*%S@IG!4_,<]1[5$?%WEZ]9Z9<:>T)N[F6VBW2CS<HC/O*8^
MXVQL-GGCCGBMI_CB2]?3'DT>6"UO[V>P25IU8K-&9!RH_A/E-SV/8CF@#HK3
M2;.TL8+-8$>* [DWHO#9)) Q@'))X  [8JUY,7F^;Y:>9_?VC/YUQ^D^,;N7
M33-J-K MS/J=S96T<4K%3Y3R [CLR %C/.#G/05;L_%[7_V6T73)H=3N)9XQ
M;SL8U"Q8W2!]N2AW)M(7G<.!S@ Z62*.8 21HX'(##-,-I;'.;>(Y.3\@Y-<
MS\.Y9YO"\C7!D\P:C>J1)*9&7%Q( NX\G &,^U9ESK&H:+XT\4SVFG7.I10V
M5G/)$+D+Y:CSMQ0,>I ^Z, XZCC(!WVU=NW:-N,8QQBHOLMN>MO%TQ]P=/2N
M?M_&5M/>F,PB*TDTL:I;7+R8$T6 3QC@KD9Z_>'7-;]E--<6,$T\!MY9$#/"
M6W%"1G:3ZB@!QM;=EC5H(B(SN0%!\I]1Z&GNBR*5=0RGJ",@UYKJ6NZKJ>E)
M=7$(A>U\40VD<=K<'YU2X"%3D*"#COQSVQ71Q>,T$5W'=V)M[^WU :?]G\W>
MKR-&)5(8#[NPY/&1@\'C(!TL=O#$<QPQH?55 H,$)<N8DW,02VT9)'0_A6=H
M.LOK-M</+8S6<MO.T#+(#M?&"'1B!N4@CG [CM7,:U-Y?Q0L[>:74VM)-'FE
M:WM)IL&194 ;;&>N"1GWH [;[';8Q]GAQG/W!1]DML$?9XL$YQL%<-X1\1WG
M]A:A-)Y]XL>KR6UO'<R8EM(.,?:&.2N/F.6R<%<U?B\=BXM=,DM],DFDOM0G
MT["3KM66(29(8_>4^62#CH?PH ZN6V@G*F6&.0H<KO4':?:I&574JRAE/!!&
M0:\[UKQ1'=6N@:I=%],%IK[VEZAN#L7RXY@V2,!ERH(R*[K3KFYN[43W%I]E
MW$E$+[FV]B1@8)'..V>>: )A;0*% @C 5MR@(.#Z_6GB.-4"!%"#D*!P.]<W
M?>(;NR\9_P!GR1VZ:9%IDE]-,TAW *Z@G&WL,\9YS[4^T\5B:]TB&ZL6MXM8
MB:2RD\S<20F_8XP-K%,D8+#@C/3(!OS00W$?ESQ)*F<[74,,_0TLD,4H421H
MX5@R[E!P1T(]ZQ/&.L7NA>&Y;ZPBBDF$L,7[URH4/(J9Z')&[I_^H\S<Z]>>
M'_$WBW4&LI;N&UL;*YN(A=?+"H$Q?9NZG S@  X[4 =^+: %2(8\I]T[!Q]*
MEKE]3\9QV4MR+6PGODLY(X[D0!C("X5OD0*=V%=6/(X/&:ZB@ HHHH ****
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M7EM)M\NXA?<"R[7!R/44 8G_  CET^K:/J,^JF>:P$WF%X,><9  <8.$  &
M ??/6J'_  A$_P#:*7(UI]D6K-JD:&W4MEE92C,3R '(4XX  P<#'5-=VR6_
MVAKB)8/^>A<!?3KTK)N?$(M?%%II<D<*VMQ8S78NS-C;Y;1K@C&,'S <Y[4
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M"8,DC.1@>[&JUYX9FGU?4KVVU'[.NIVL=K<H8=[!4W@-&V1M.)&ZAATKH:*
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MF"$C("]2<5TE% &7XCT8>(-"GTTW!MS(T;K*%W;61U=3CN,J.*Q[[P;-?CQ
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M/E[94)_Y9N.0>W(/2NAUJTU*YOK&:RMX)5M7,RF2]:'#E63D")\C:Q'4=>G
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MD1+DCAC]XYZ<=Z-83Q#=Z5+:Z9I<%HD0B\N.25,R 2*65<95"$4X)[D=,9H
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M=P"@<$N2I& ,=.:SM7\=7$&B^('L[2 ZAI21%@+@/'^]R <@<E2#E2!R.O-
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M6FVFKV$EC?0^;;R8++N*G(((((((((!!!R"*BT[1K33"6A:ZED(V^9=74D[
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M#XF\4W?V"YMK:\N8)8'F@,7F 0(I(!P<Y!SD4[Q;9&?6_#-W+8R75E:7<K7
M2$S; T#JI* $GYBO0''6NKHH \VD\-3V'A+5=0M8%M)[35)=8TN%QL$2*!E"
M/X1(!)D=A)S@BNWT.VE@TU9;E-EW=,;BX7J5=N=N>^T80>RBG:CHMCJMQ:37
MD;R-:L7C42NJ$G'WE! <<#A@:L/?6T=_%8O*!=31M+''@Y95(#'\"R_G0!S^
MNQ7$?C;PYJ"6EQ-;0PW<,KPQE_+9Q$5W8Z#Y&Y_QKEM TBZM8?!;#3+F"XM[
MN\-TYM6!C5TE"ESCH2R?IZ5ZC10!YYX,L',NCQ:IHNJQ:QH\3PR74[L(#E=K
M,C9Q)O(!QCCJ<$<]9XJ227PEK$,,4DLLME-'''&A9F9D(  'N:UZ* /*UT.X
M>T\&OH^GZA'K-@]NMS+=)((H8M@$P(E^7)&0-G/H0*FC@OW\2Z1</HE]!%;:
MU>M<0QV^8@DD<RK)N/+[RRDD':,XP,#/IU% 'EN@:1-8V_@M_P"R;F"6UO[Q
MKHBT8-&CI,%+8'0EH_T].)?!,.K:+?V_]H:==S6EV]TL3-;,'L&,[O@C'W)%
M93NZY&#P!M]-HZ#)H 9+L\I_,7<FT[EV[LCTQW^E>8^'='GA3P&+O2;A38VU
MU'<^9:M^Y) VAN..1Q7H^GZE9ZK;M<6-PEQ"LC1ET.1N4X8?@0119:E9:B;D
M6=RD_P!FF,$VPYV2  E3[X8?G0!YOI6CS6NE^%]ND7$4]OK]S--BT8,D#?:
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MZT <7H6I7NGN^DPW(\^_\07\9N9"J$[,M@?*RAC@?PXX. .,;%CJNN'6]/\
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MU%B(+38+%VDM@)7Q$S9W$<]\G/U/K4=IX1T"QNKNYM-,B@FN@PE:,E<[OO8
M/RY[[<9H K>")]4O_#.GZKJFH_:GO[*WG$8@6,1,8P6QCKDD'GIVP.*Y^[\9
M:CH\NJMJ*W"7-O:WES:P-&C6UVB?,C1R*,Y50-RL<\D]J[NPL+;2["&QLHO*
MMH5"11AB0BCH!GL/2JT&@:7;RF1+4$GS %D=G5=YR^U6)"[N^ ,T <IJ6MZ]
MH%C<:G<:A8W&G300>0[.&>-WF2-I!M1 8@L@;DDY'7!JWKMYK6A0F0:PMPCZ
ME8QQJ\*>8L4LJQNKX !!^8J0 1ZG%:UCX/\ #VFV-U96FDVZ6MTNR:(@LKKS
M\N#G"\G@<<TZ+PEH,&BRZ1'IT8L92"\99B6((*G<3NR,#!SQ@8H Y?6_$6M6
MB^)UM;Y5;3]2L8+<O"K;4F\G<IX&?]8>>O3FM-I]9LO%.GZ-/K#W$5SIUY,T
MHMXT<.DD80C QPLA'3!QDBM,^#] ,5Q'_9R;;EXWGP[ R-'C86.<DC:#]1GK
MS5]])LI-2@U%X2UW!&T4<I=LJC8R.N.<#/K@>E ' Z'JNIZ3X(\(:W<:I-+I
MTBQ+J8E6,[5E7"ONVY $A7.3G#$YXKN=#FN;K3%N[F5G^TNTT090I2)CF,<
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MQ'Y>#C !:0 D]NW'.E?ZYJVC+*+^VMI1+/;P64L&1YCR'#!D))&WKU^;..*
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MI&H&%522 /PKDM1\2^)$T+4[V*PBAA72);V"[,9VPRJN[RR"WSY'(88''(H
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M.V%@/$<$,(9"9<).8R^[.!EE/RXZ$<]J /2**RO$6M+H.D&\,8DD>:*WB0G
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MCQ-:-E)H'G$3+U/5&!*G.& [B@#N**H:U>S:=H]U=VZ0O+$F5$THC0<]68\
M#K^%<G<>-]0@L=5>.TMYYK#4[6SW.LD*R)-Y6&VG)4CS<>G&?:@#NZR['28+
M35;N[-[<W5S(20MQ*'%NC'.Q  -JD@>I.!SQ7/MXQO;.;4;"^M[9K^'4+:RM
MS"S"-S.JE2V>1MRV?7;QC-.\+130^._%XN! 9";-BT"% ^8VY().#^)Z4 =6
ML,$$\D_"R3;59V;DXS@#/;D\#U/K4^<]*X;Q=:ZE:^(8=;AT>'7].2T^SW.G
M':9H@6),L2MPQ(X*\$[1BDTGQ+:-I>EV'A93)'/:S7,1FB9O*59 NQER#D,Q
M4G/&WOF@#LKZRAU'3[FQN Q@N(FBD",5.UA@X(Y'!ZU0T_0C921/<:KJ&H>3
MS"+MH\1G!&1L1<G!(RV>M8%EK^MS^*K%-12/3;?^QGO+JR==[1N)%5OG#8.,
M<''0GCGBGXI\3VFLP:%9:5?&2RO]8AL[V2/<N4*L_EYX(W;0#CMD=Z /0%='
MSL96P<'!S@TUIX4F2%I8UE<$HA8!FQUP.]<3XQBC\/77AO4='MXK6X?5K>QD
M2! @F@DRK(P'4#[PST*Y'>LNX@O;N+QY=W$EG+/I]R9+61H&+0NEK&RE#N^7
M 9OQ8GOB@#N+S3;76;Z"8ZA<-':,1):PS#RI&R"/,4#)(('&1[Y%:U<_X1TV
M&VT.QO#!;"\GLH$DFABV%T5?D#<G.-QYK"TCQ1JB0&.]FM[B[O==N-.MB(F1
M(Q&TF6(W'("Q\ 8)/?G- '>TT2(9&C#J74 LH/(!Z9_(_E6+H6MSW^I:OI=Y
M%&EYIDR([Q9"2HZ!T8 Y(."01DX(ZURUU/JNF>,_&%YHEI8RO%96<\R7#,GF
M;1,<#:/O$#J>F!P>P!Z+17$GQIJ&IVLD_A_2S=-#;V\YMY!\TOFH)-@;("$(
MPY(.3Q@8S7:J=R*Q4J2,X/44 +1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% &-KWAJUUZ2SG>YN[.\LV9K>ZLY DB!A
MAEY!!4X&00>@IL?ABVAU*UOX[N\6>VM9+9"75MRR,&=FW*26+*#GVK2O+^UT
M^(274PC4G"C!);C)P!R> 3QV%51XBT9FMU74K9C<0M<0[7!\R,#)=?4 =Q0!
MGVG@RRLH-#AAO+T)HN[[*"R'[RE#N^7GY6(J1/"&G1R3JLEQ]CFNQ>O8[E\D
MS!@^[IN'S@-C=C(Z=:OW&N:9:V<=W/>1I!(AD1^3E!R6_P!T9&3T&1276O:5
M91)+<ZA;QQN@D#E\KL/ <D<!3_>/'O0!2'A'36L-9L;EI[FVU>5IKF.5A]YE
M"G:5 (X5?IC-0-X)L9]$FTR^OM2OA)LVW-Q<9FB*'<A1E VE3SG&3WS6I-KV
ME6Z7;S7\$:V;*MR6;'DEN1N],Y&,^M0P^)=-FUK4=+$X6;3XTDG9_E50P8]3
MQP%R3TY]C0!2;P;;/%9&35-4DO+.?SX[YYE,Q.QDP?EV[=K,,!1U)ZDFFVO@
MBPL4L_LE[?PR6<\\T$OFJ[)YQ+2+\RD%23W!/O6K%KNE3174J7T(6TQ]HWMM
M,61D;@>1D=/7M6;H/B"75_$NO6.^%[:P\CRBL;(XWJQ8.&/48'8<=J )CX4L
M,::(Y+B/[!=/>(5929)F#!G<D').]\].OL,0R>#+&2SNK5KR]\NYU!=1<ADR
M)597&/EZ;D4X]JD\6ZS<Z%IMI>6[6ZH]_;6\QG4D".2548@Y&" V<G(J:+Q9
MX?FL6O8M7M'MEF%NT@D!"R'HI]">,#OD4 0SZ>=#O-1UK3[2^U"YOGC,UG%-
M&JE@%3>-Y4 [5&>>W ZU/X9T2+0-#BLXH8X69WFD2,Y57=BQ4'N%SM'LHK16
M[MWO'M%E4W$:+(\?=58D GV)!_(^E,U WOV0C3_)%R74!IE+(J[AN) ()PN<
M#(YQ0!6O-$AO-;L]6:XN([BTBEBB"%=H$FW<2"IR?E7\OK5"P\&V.G#15ANK
MPKHX=;8.R'(<8(;Y>>/I532?$&J7WBJ_L3+83Z5IJ;;R]2!H@)^OE*3(P.T<
ML>V0/IJR>(=-GT^]EM=4M(VMX/-,LQPD:L#LD8$C*'&00<'!P: )M8T6'6A9
M>=//%]DN4NH_)*C+KTSD'CD\51OO"%E>ZX^K)>7]I-.BQW4=K/LCNE7[HD&.
MP)&00<<9K9LI3/86\QECF,D2L9(QA7R <@$G /4<UB7FM7\/CO3M$C^S?9+J
MTEN79HV+CRV08!W8YW]<<8[T 3R^';4W<-Y--=7 M;A[N"!MA6.0JP.WY0V,
M,W&<<UB^"/"\EKX8T)=86Y^U:?&VRUG*%(9""I(VCGY68#). QKK+R_M;!(V
MNIEC\QMD:X)9VP3A0.2< GCL":YS4_&-O8:UHC"_L?[$O[:XF:X)SRFS;M;.
M"#OZ8SD4 3:;X%TO3;::R$]]<Z:\;Q1V%S/OA@1P0RH,9Q@D#). 3C%%OX(L
M(M#N](N+[4KVUN+9K0?:KC<T,1&-J$ 8[<G)X&2<5O6-]:ZE917EC<17%M,N
MZ.6)@RL/8BL77]:O].\0>']/M/LWE:G<20R-+&S,FV-I,C##KMQ^- &W;6HM
M[)+9Y9+@*NUGG(9G]<X 'Z8K(TWPE8:8+*..:YEMK!V>RMY65DMB05^7C<<*
MS ;B< U=UR^&G:3+<?;[2Q8%56>[&8P2P&",@DGH.>IJ&[\4Z#8330W6KV<4
MD#*LJM*,QENF[T_&@"31M$AT1+M(+BXE%U<R73^<5.'<Y;& .,]JKZAX8M-0
MU.XOVN+J&6YLOL4PB<!7CRQ&00>1O;'U]A4K>(=+G@U 6NK60ELXRTSNX*PY
M!PS<CY<@]^Q&:KVGB:R?4M/TB2Z2>^N;$7?FPH1&X^49&<XW%B0,G '/;( 6
MOA2UM+JQN(KR\$EE8&PA)*']T=O7Y>3\B\^WUJ"+P590Z)%HZ7U\+!+/[$T1
M:,B2+GALIU )&1@UJV^N:7=W$EO!?0O+''YI7=C]WG&\9ZKG^(<5DV?B?[?X
MX&DVLUO+8G33=@JC!]WF*H.2<%2"2"!SZF@#>>T0V!LXF:&/R_+4QXRHQCC(
M/;UJGH^@VNC>'H=$A>:6SAB\E/-8%@F,8R /\:LZIJ5MH^EW6HWCE+:VC:61
M@I)"@9X ZU43Q'IATVVOI;E(HYXO.4-DD* -Q('9<C)Z"@#*M/A_I5NL"2W-
M_=Q0V#Z:(KB8%6MVQ\A  Z;1@]?4FIK?P7:0Z'=Z3+J6IW,%Q;-:;[B<.\4)
M&"B';@<<9()X'/ K7N-8TZUABFEO(A'+&98V4[MR  EQC/R@$$MT&143^(='
M2Q2]_M*V>U=6998I!(I5?O,"N>!W/0=Z (8?#D$&JV^HI=W7VB"R-BF2F/+R
M#DC;][*@Y]NE5;3P7I]E;Z-%!<WH_L@O]G?S%W%7&&1OEY!_ \=:=>>*[+[9
M<:;8W$;WRV!O8V*EXRI!V\@C<#@G@]/K1X5\4V>O:3IV^\M6U273X;NX@B;[
MNY5+$#/0$X]N,T ,T/3WNM<N_$EYI+Z;>3VZ6@ADD5WV*S$LQ0E>20.N<(/H
M-+7]$M_$>B7.DW<LT=M<KLE\D@,5],D'%1/XHT*..XDDU6UC2WC$TC/(% C/
M <9ZJ3P",@U<T_5+'58Y9+"[BN4BE,,C1-N"N,$J??D?G0!17P^'DC-[J=]?
M1(K*()_+$9W*5.0B+G@D<GO5*P\#Z?8Z9<Z8U[J5U936[VJ0W5QO$$3#!1.
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M=M)<7,T<,$:EGDD8*J@=22>E9UOXGT2[ADEMM3MYUC*JWE-N.67<H '))7G
M]#Z&@#/E\$V+ZA%>Q7^I6TP@2WN/L\X074:?=$@ Z@$C*[3SUK?N;5;FREM0
M[1)(A3='C*@C'&01^E4V\1:0ME%>_P!H0-;2QM*LJ-N78OWF)'11T)/ /6I+
MO6M-L9A%=7L,3_+G<V NXX7<>BY/ SC/:@#(A\#Z>FCV>C7%U>W>EVBHL=G,
MZ"-@GW0^U5+@8'#$@XY!J:^\(65[K;:K'=W]G-+&L5S':3[([E%SM#C'8$C(
M(.#C-1MXC:S\5ZO9:C-;0Z;96$%V)BI4IO:56WMDC \L'.!UK0O_ !%I6FPW
M<EQ=H#:6WVJ5%Y<1=F ')!QCZT 4AX.L(]<GU."ZO[=;EUDN;**?;;S.  &9
M,9S@#." <<@U6/@+3MY6*^U&&U^W+J"6D<J^5'.&W[ERNX MDE<XY. *OVFN
MP:A?:8+:_M$2ZM7G-HXS,X^7#+SP%R0>#G(JU#KVE7$K117\!98S+R^ 8QP7
M!/#*.Y&0* 'ZQI%GKNE3Z=?(S6\P&=K;64@@JP(Z$$ @^HJDWAFWEAOA<7=U
M/<WML+26Z<H)!$-WRC"A1]YCTZGV&)K'Q+HFIW,=M8ZI:W$TD1F1(Y 2R#&2
M/7J/S'K5FSU6QU"1TM+A965%D(&>4;.UAZJ<'!'!Q0 [3K%-,TVVL8Y))([>
M-8D:3&[:HP,X ["L.?P187%KK=O)>WQCUF0277S(#D +\OR<<*!^%=!=7=O8
MV[7%U,D,*D NYP,DX ^I)  [DU1;Q)HJ6R7$FIVL<;S&W!DD"'S1U0@\AAW!
MZ4 4M0\&Z;JLVHR7\MS/_:%K':S*651MC8LC+M4$,&8G.>OT%0-X&T^Y:[;4
M;V_U%KNQ6QF-S(OS1JS,I^15PP+'G\>O-:]OK^DW6GO?P:A!):I)Y32*_ ?(
M&W_>R0,=3D>M9WAG7YM;U#7XG>%X;"^%O"T4;(2IB1R&!)^8%B#TZ=!0!'_P
MA-M)I1L+G5=6N_WL4GGW$ZO(/*<.BYVXP& )XR<<DU)?>#;'44UM)[N\VZS&
MD=T%9!\JKM 7Y>..*V[J\M[)%>XDVAVV( "2S8)P .2< GCL">U5HM=TN9@L
M5]"[&W^T@*<DQ9QO'JN3UH S;SP=9WPU@7%Y>M_:]LEM=89!E%! Q\G!PS?G
M]*EE\*V5Q>75S<7%U*UUIXTZ5&90K1?-Z*"#\S<Y[U;EU_28+&&]>_@^S31>
M?'(K;@T> 2XQ_" 02W09%8LWC&WT_P 57MIJ5_8PZ6FGV]W!.3@DR/(IRV2"
M,1@Y '!H 9J&@&\MK#PQ)I]S=Z; 89FU&YF0@>6^=F 0VXA0O"@88\]CN7&G
MW,OB"ROXKVXC@AC=);<2?NI<],IC[P.#NSQC&#DXT@0RAE(((R".]4KW6M-T
MZ39>7D4) #-O;A 3@%C_  @G@$X!- #-:T2RUZS2WO%<>5*LT,L3E)(9%^ZZ
M,.A'^(/%1KHK-;O%=:G>W;-&R+)+Y8*9&"0$15SCN0>_J:H:OXK@MI=8T^RD
M3^T["P^U@2QL4.0Y X(S]PYP>]6/#_B6PUFQMP+ZV>_%I'<7,4;?<W*,G'IG
M(]NE %4>!]--M86SW%X\%EI\FFQHSJ,P.JJP)"@YPB\\=/K47_" Z>T,\<NH
MZG*9]._LR1WF7+0<X'W<9 9AG'?/7FM1_%&A1P7,TFJVL<=JBR3-(^W:C?=;
MGJIP<$<'M5RPU.QU2.62PNHKE(I6A=HFW!7'5?KR/SH Y7Q3HUY*-'M88=5N
M+*U1PTUA-")@^ J[DDPC+C=R!D''09J:/PC+JFGVC:GJ.JPWMG,TEE=B6);J
M%&4 HY1?+;.#D8(QCJ1FNBU'4K;3XL3744,KJQCWJ6Z#EBHYVC(R> /45C^'
M?%,=[X/TC5M5FAAN+VU$[)&#CIEBJ\G:,\GMWH W;*TCL;..VC:1U3.7D8LS
M$G))/<DDFLU?#4%O+=M87MY81WDAEGBMF3:TA^\PW*2I/?:1SSUYJW/K6F6U
MI%=R7L/D3(9(W1MP= ,EAC.5 Y)Z 4W^W])*S,-0MRL,"W,A#@A8FSMD_P!T
MX//3@T 07'AC2I_##^'1;^5IS1>6$C8@KSD,#UW _-GKGFF:SX6L=9CL?WUU
M8SV#9M+FRD$<D((VE1D$%2, @@CBI+KQ3H-EG[1JUI&5A6<@RC(C/1L>AZU-
M::]I-_?-96FHVT]RL?F^7'(&)3CYACJ.1T]10!6A\,VL.IZ?J"W5VTUC#+"F
M]PP<2%6<N2,DDJIZCIQBK6N:/!K^BW6E74LT=O=(8Y3"0&*GJ,D'%0OXHT*-
M+AY-5M8TMXA-(SR!0(R<!QGJI/&1D9J*X\7:%!8ZE=C489DTV+S;E83O9%P2
M.!US@_D?2@!/^$7M9IK*34+J[U 63"2WCN&4(CC@/M15#,.Q;..V*B3PA8PZ
MY<:I!=W\*W,HGN+*.?%O+*,?.5QG/ S@@''(-7(_$6F-:P3O=*@FC63!R=H8
MX&[CC)R 3C)'%:M '$^%_#4KVUU_:R7<:#6;B_BM)"GEG,S/$_ )[JV">HZ5
MKQ>$-.ADD5)+C[$]Y]N-B64PB;=OW#C<!O ;;NQGM4B>(+"WDU"2]UK3C;Q7
M:VZ;6VF)BJ_NW)8@N22>,<$<5>T[5]/U=)7T^\AN5AD\N0Q-G:V <'\"#]#0
M!23PU;B_AO9+N[FFMVF>V,A0^09<[MIVY(Y( 8D ?056L_!FGV$.B1P7-XO]
MC(\5LWF+EHV RC?+R/E7T/'6MR[O+>Q@\ZZF6*/<%!8]6)P /4DD  <DTEE?
MVNHV_P!HLYTFBW,A93T93AE/H0000>10!B:3X<?3M*31TN)[>WL[AI;.>W90
M?+9F(0A@?N[BO3! !ZY CNO"D$FGP:- C"Q>^%]>2.1F5A)YNW Q]YPN< #:
M#5OQ1XA3P]86\F4\VYNH;:/>"0N^15+$#KM!)QWQBBSUJ.TC$.L:G8M<-( D
MD*E%VN?W6[).UF&!@GD]* +FMZ/;:]I$VFW3RI%*5;?"VUU96#*P/J&4'\*Q
MY? MA-]M,E_J+->SP7,[&526DAV[6^[@<HI(Z<8&!Q6C<>*= M;UK*XUBRBN
M5?8T;S*"K;2V#Z' )YIB>+_#LF-FLV;9A%PN)!\T9Q@CUZCIZCUH JWW@K3=
M1?4GN9[MGOY89F=756ADB $;QD+E2,#UJYI/AZ+2M1O=0^W7EU=7JQK.]PR?
M-L&%.%50#@]A6C97MMJ-G%>64\<]M,NZ.6-LJP]C4&H:QIVE8^W7<<.4:3#'
MD(N-SG'11D98\#(S0!#=:-Y^IOJ$&HWMI.\*P-Y)0JRJ6(^5U89RYYK+G\":
M6UOIZVEQ?6%Q8&0Q7=I,%E;S#ND#$@A@S<G(Z],5I7OBC0M.=X[S5K.)TC$K
M*THR$/1L>AY/T!-&LZY:Z=IDLRWENLQMWFA+@NI4#.XA3]SD9.0.1S0 Q/#5
MG%JMGJ,4UTD]K;M;\2Y$R%@QWY!).X9SD$G.<YJYJVDV>M6#6=[&7CW*ZE6*
MM&ZG*NK#D," 014'AO4)M7\+Z3J5P$$]W9PSR!!A0S(&.!Z9-6+C5;&TN5MY
M[E$E8H-ISP7;:@)Z#<>!GJ>E %5- A>_MKR]N[J_EM,FW^T; L3$8+ (J@M@
MD9.<9.,9-5_^$5M?)UN+[9>;=99FN>4X)01G;\O'RJ!W_/FKJZ]I3(CB_@VO
M<_9 =W_+;./+]FSQCK6'HGC.UFOKW3M8U"P@OEU.6SMHE.PR*N-O!)Y.3WY(
MXH Z33[-=.T^WLHY))$@C6-6DQN( P,X '2L1_!.FM%.@GO%+WYU&%ED&;:<
ML6+1\=RS9#9!R1TXK4DUS389GB>[0.F_( )R5&6 ..2!U Y%4K'Q?HU[HMIJ
MHNA%!=1F6-7!W;0 Q) YP 02>@SS0!?T[2H-.>YE1Y);BZD$D\\N-\C!0HS@
M  !5    _$FJ5YX8M;S4;V\^U7<)OH$M[N.)U"S(N[ .5)7AV&5(//TJ6Z\4
M:%9$"XU:S0F#[0!YH),1QAP!U!R.:FN=<TNTM([J:^A6"6,S)(&W!HP 2_'\
M(!!+=!D<T 9EUX+TZ;55U"VN;ZP8PI!/%93>7'<1IPJN,=@2 5P<<9KH@ JA
M5   P .U4+O7=*L5C:YOX(TD"L'+_*%8X5B>@!/ )X-:% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ')>*[/4UUS
M2-7L;"XU&WMXI[>YM;:Y\B4"0QD.I+*#@QX()Z-[5FZSX6N=0T&RT_3](CTY
M[!)+RV(=75923BW/S9(<,0_\)!P">W?T4 <%J4&N3:Q8:S-X>O+B"YT_[)=Z
M?!?(DEO)NW9R) KH<D'GL#CM38-)U/1-7NH(_#<6H:3J-C;VZP1RQ^7:-&&4
MQN)",QX;.0">OR\UV]Y>PV%G/=3E_+@0R2"-"[ #GA5!)^@%3J0RAAG!&>1B
M@#S?Q)H>N2CQ=:6>DO=?VO!;FWFCDC2,,B!64[F!!XXX(YZBK.M:#K=]>^*!
M:6;1_P!I6MH]M,\RJN^+),38;<">!D#&">:ZVXU_3;74$L99G\YY5A^2)V5)
M&&55F PI(Z9(ZCU%:= 'G-]H^JZGIO\ :=IX;FL=1ANK2>6VNKQ9);Q89-YC
MW[V4*/X2Q&3V'?<\.V^H'Q9K^I7.EW%G;7L=MY)F>,L2BL&!",<'D5U)(7J0
M,G'-+0!SWC/3KO4M$@2SMS<207]K<M"&4%TCF1V W$#.%.,D5G'PNNKW7B:Y
MOX6L[;6+>"W5&*[U,:MB4X) ;+#'.1L'TKLJI:GI&G:U;+;:G907<"R+((YD
M#*&'0X- &5X,COY-!BU'56C?4;U$>5X_NE0H5,9Z @;\=BYJ;Q9-KD6@3)X=
MM#/J4Q$2-O0" 'K(=Q .T<@=SCMFML%5(08!QP/84M '&6EE>Z/X7&AZ-X=G
M8"WF#2:A)"4ED*,<R;9"6+R8SQC!/3%8\.BZ[))JTS:-=K]M\.I9J)9X,^>I
ME^3:K[5'SKC&%QGH>*])9U098_@.2?H.]5=+U2SUK3H[^PE,MM(6"N4*DE6*
MG@@$<@T 1Z##-;>'M-M[B)HIXK6..2-B"58* 1D$CMV-8&K6NII\0]+U:WTF
MYNK*WL)X))(I(@0[M&1@.ZG^ _I77UG7^NZ?IEY:VEU+(MQ=;A!&D#R&0J,D
M#:#D@<GVH PM5DUR_NM-G70)DMXKMQ(!)!]JC3RB ZMOVJ"S%3M;=M^O&)H.
MAZSI4?A2:YTB8G3!?0SQI+&[+YK HXRW(.#WSSR*[W3]5L=464V5PLIA?RY4
MY#QMUVLIP5/L15R@#!\(Z/+HND313(L3W%Y<78@4@B$22,X08XX!&<<9SBJ/
MBJSU*;Q)X8O;+3)[R#3[F6:X,4D2E5:%T& [KDY8?A6_JFK6>C6BW5](T<+2
MI$&$;-\SL%4' .,D@9/'-7: ..\5)K.O^%]4LK?0[B-V\D01RRP[Y2) S'B0
MJ  !U.2<\5G:[H>KWR^.A!I4K'5=/B@LR9(AYCB-U(^_Q@L.N*]"HH X>^TK
M5)M<U"YBTN;R9O#PLD/F1#,VYSLQO_VAST]ZK6_A_65FTA39R1!O#;:7-*)8
M\VLW[OD_-R/E."N>0.G6O0:* /,#X:UC6?"=UITVA/IVL0Z:]DM[/>^:DA(
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M^48LJ,QG&5]N,C\JDHH Y2_MM4LO'L>K0Z?+?V%QIPLV6%T#02"0ON(=ERK
M@$C)^4<5A>$]$UW0#X>N[K3)G2'1O[.N+9)(R\$@<.''S8*MT.#D87(]/2**
M /-=)T#7/"DVE7":6^J6YM+BVN+2"6,/;&2<RKMWL%90#L//\(/(JSJNC:M#
M?Z@;/1 T-]X=73XTM7C6*WD4RD(<D';B0 $#MT%>@T4 <#9Z/JT>HQSRZ3,%
M7PVE@3YD1_? DE/O_KT]ZJ1>&=9EL/"]D;*2U:U\/7&G7,WF1D03/'$HZ-D\
MQL<C/:O2:* /,)M$U;4_"&I6TWA::WUE=)EL%FEOEE$K,H&(B7.$) 8[MN,
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M@>.-Q*W1'9B&$? .%ZD<\5VE% 'GEOHVL&XDEDT>9=WAA-/&98B?.!;*??\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MIMQKW]DPR,\@M%N_-528S&V=I#8P00I.<XJ:/Q)H\@E(OXE$4/VAC)E 8O\
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MA\L=K*V2" <X X[4 ;\_C*WL/%5S!?7]HFD#3(;V"95))WNZDY!.Y<(#D
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MO'S#!QVS5J@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MN5#,O0L&WI@9& 3Z<R_VG>_\)!X9@U31[*.]N8;DM()/,:!D49"''1ACO[4
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M^RE\J.>3@@D$<'I0!WU%<#H?B?65TK1Y[][:Y.HZU<6#%8V0HHDGP1\QX'E
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M5M))T5/*F WAUS][&Y2,X .#R>*M1^+-,L(;V>2;4[A3JXL2LD.XQRL$ 10
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MS-%'N7[0<?)C.<Y.,XQGC- !I_A#3].6TABFN7M+*9IK.UD93';L0P^7Y=Q
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M-,R,_F%#G(0XQL_'/:F:MH^N:S:VWGM81RP:G;W:QI(Y18XF5MN[;DL2#S@
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MJ2.HS@''!].:Y:+Q_<KX//BB[T>*/38YGCG$5X7E15E,18*8U#<C.,@X]^*
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M3;Z1<6,^F27UFMQ!-#<[S#-%++Y@(8+E64@=CGFNZ>]M8[I+5[F%;B092%I
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MT\L:NSJLL4HD4Y(!*L!(. "/EZ\\.T[PAK%G=Z5++/8R"SU:\OW*EUW+/Y@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MW,%XC%'CW;E92IR&4D\="#VJ/_A'=3L]:OM1LKNWF;4K.."Z%P"NV2,,%E4
M'(PQRG'0<T 23^-M/67R[2UO;\M8+J,;6L:E9("?O*68#/L<?GQ3K3QII]Y/
M;I':WRQW=DU[:2O$ MQ&H4MM&=V1O7A@,YXR*H6/@V?2;N$64D+6D&B+I<0E
M8AR0<[S@8Y]*BA\-7NEVWAZ:XN+00Z'I,UG,V]AYFY(UW#(X_P!4#@_WO;D
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M)^X3CKQG90!ZO17E$ZNK64,EW,-+;Q1LL"+AE#6QB)8 @\QB3<!Z<8XQ74^
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M@ ZF$P'G^'AB>0: /4Z*\AU,6PL/$UX+R475KXDM_LTGVI]T:DVX?;\W0CS
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH R_$&BIK^DG3Y+AX(S+%*6C4$YC=74<\=5
M'X5IJ"% )R>YQ2T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:V,,3S0^60UMNW_,S9^;=C@8XV^]3+XHT:2WDGBO/-2-W1O*C=VRH!8A0"2
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MUKX?UF.QTB)]-</;^(Y]1E_>Q_+"[S$'[W)Q*O'L?Q]!1Q(BNOW6&1QCBG4
M>?6GA;5CH-AX=N8"%L=66\741(I62)9S,"!G<'.=I&,<DY-0W'A#6+I=4M+
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M?Z1=2MX:6&6.UU-K?^S-0@$@9C:M'N?E>C*4!4] 6////H"JJ*%4!548  X
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M.1P>* /.)M1UHR16']J7<<$7B8:?'<(5WS6[1%]I)!R58E<_[/.2#77ZY*-
M\$WCOJES$;:U*B^D5990<8#$<!FSCK@9ZUI/I.FR101/I]HT=NV^%&A4B-O5
M1C@_2K$\$-S!)!<1)+#(I5XY%#*P/4$'J* /+M3US5+2T\5P0ZG+;-936#0
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M !C+?-SG)4'K6UJ.J7]CXP NO/DTR6]@MX;FTGR+=V1/W,T7'#$[@XR1O .
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MN[6^_MR&VN(]0GM[NQ+EF8!G41>5T5E 5@P&< DY!-=D-#TE551I=D%67SE
MMTP)/[PX^][]:>FD:;'J,FHII]HM](NQ[D0J)67T+8R10!YW87VK:C#X9MI-
M;OD^V:KJ=K/)&RAW2/[1LYV\$;%QCIBO3+>(P6T4)EDE,:!3)(<L^!C)QW-5
M$T/2(C$8]+LD,3F2,K;H-C'JPXX)]:OT %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 5AZYXC.C7]C8Q:7=WUS?+*85@9 "
M47<5)9A@X_#W[5N5C:GHL]_XBT;5([J.)-.:4M$T18R;TVG#;AMQ]#0!0D\;
MV4=Y##]GD96NULY"CHSQ2G@Y0'.T-\I8=#ZCFE'C2V?3;_4H;.:XLK.*XDD>
M%T+ PMAD921M8\D ]@>AXHLO#>J:;K5X]GK*)H]W=&[DM7MLRI(QRX23=@*Q
MY.5)&3@C.:Q/$'A0VFF:WK4TUO\ ;#I%W;2-:P&)KPNOR>8,D,PQ@=R3VZ4
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M)8:;)8;5M&4/N,9#?ZPXQY:\<YR>G&  M_$NGZK?^&+J**_ U*VEN+9A)MC
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M$J?<9Q5B@ HHKE?%'C#^Q=;T?0+&W6YU?5I"L2R-M2*,<M(V.2 ,X ZX/(H
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MH3<1&:#?.H\U ,[EY^88]*/^$ET0V%K?#5+5K6[SY$JR K)C)8C'I@Y],<T
M:M%4(M;TN:_BL(K^W>[FMQ<QPB0%WB/1P/3WJ_0 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !7'>-+1?$-O>>';WPW=7EK-;%[>\C9"JS<@#E@4(X.3P<_GV-% '*^
M'4US1!HGAVXL&N[2#3%%QJOGC F7C9M/)^O^!KJJ** "N!\8^%]0E\<^&_&&
MF0&Z?3"T-S:JP#M"P(W)D@$C<QQGGBN^HH \]U'P]?>*_B9H>MR6LMII.B1N
MZO. KW$S=E7J%&%))QGH/6N6F\(>(U^$WBSPV-'F:_NM4::WQ)'MF0S1L"#N
MX^52><=J]KHH \<U'P;X@U+4O&HMK*2VCU/2+:"TD=U57>-%W)P>,X*\\5)J
M7AG4=6^'&L^1X=U&WUZ^LK:UFCN+A#YK1L/NC=M"@;L$X//2O7Z* ,OP_IT&
MG:+9QQV<=M+]GB6550*V50##$=<8Q7$^!=$U/X>W.M:1/IUS>:9<WC7=E=VH
M5^& !1UR"I 5><8//->E44 <'KVEZO=>-?"?B8V,IM=/^U)<6B.KR1"1"J/@
M'!/0$ G'N.:Y'2/ _B+3++P#%<6+RMI^I3W=VJ.I%JCG*KUY(Z_+GG->U44
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MA2/E.?7)'; -:^I75WX?U+PMHNE0Q-9W$LD#^?.Y;:D+L!N(8_P@Y// '?-
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHKG?%/CGP]X,-K_ &[>M;?:M_DX
MA>3=MQG[H./O#K0!T5%16MS%>6D-U VZ&9%D1L8RI&0<'V-2T %%%% &+J&@
M&XUVWUNRNS::A% ULS-'YD<L18-M9<@\,,@@@\GKFHKWPM'J6A:GIUY>S/-J
M(_?7*JJE2  NU>@ P..>^22<U7\8:QK.@:1J>KV:V1M+&T\X),C,\K@ME<AA
MM& O.#U/I5;5]<U[1;.UN[A]->":\LH=XB=<)++LDX+G! *D'IR>.* -+_A'
M)3K+:H^HO).VGFQ.Z)<$%MV_C'.>W3'YU5LO!_V%/#ZQ:B__ !)+9[: F(?.
MK($RW/4!1T[UI)XGT)[(WBZO9?9A/]G\SSE \W(PGUY''O2CQ-H;64=ZNJVK
M6TBLRRK("NU3M9LCHH/!/04 9%OX):'0KK2&U:<P78F-U,D86:=Y596=GSU^
M;(X_A Z#%1/X"2XAU&.\U>ZF_M#3$TV;;%&@"KOVLH"\$;SQ72-J^G).\+7L
M E2'[0R;QD1?W_\ =]^E,EUW2H;6&YDU"W$$T/GQR!P5:+ )DR/X!D9;H,CF
M@#,E\)I>7ZW.H7KW:G39=.FC>,*)8Y""QXQ@_* ,=O?FBS\*&W6P^T:@]TVF
MV[V]D\D8!0,H7<^#\[;1C/ P3QDYJM<^,K:U\3V\,FH:?_8DVFRW8N0V?G25
M$P'#8(PQX SQ6]/K.FVUM#<RWL AF3S8G#9#I@$L,=5P0<]!F@#&TSP>NF-X
M>V7[NNB6KVL0,8_>*P526.>N$7I[U=O- ,GB!=;LKQK6]-M]EFS&'26/=N7(
MR,,I)P<]SD&KJZQIKS+$E];M(T'VE55P2T7'SC'5>1R/452_X2O1VU33;"*\
MCFDU"%I[=XSN1T!49##@Y+#% %:'PA;VDV@FRN&AAT99%BC9 WF;UVL6/'/)
M/&.3^%7=8T,:K>:7=K=RVT^GSM-&T:JVX,C(RD$'J&//:B\\06-IKEIHKS!;
MZ[B>6(%20 I4<_4L./K6;X1\76^N:99)>WEFNKSK*S6T38.%=EX4DGH >O?-
M #%\%X@2+^T6^75SJV?)',A8MMZ_=R3[^]3Z7X4DTC49FMM9O!I<D[W*Z<53
M8DC,6;#XW;-Q+;<]?;(K6AUC3;B_-C%>PO=;681!N6"G#$>N#P<=#UK.GUJX
MM_&\>E2-;K8-IDMXSL"&5DDC7ELXVX<GI^- $NJZ =3US2-3^UF)M,>22.,1
M@ARZ%#N.?0G&.].UC0FU34-,OHK^:TFL'=EV*K!@Z[6R&!&<=#VY]:R;OQ:M
MEI>@AM0T^XN=4F$0NX5/D ;'<R*N[)'R8'S=2*UK'6$A^S6&K7]A_:KL8V6
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MS8S3"$7!1)U)\O&=W7I@@Y]Q1;>*=!O%D:VU>SF$:HS>7*&P')"=.NXCCUH
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MG'^C.-Q8>K*RX'^^:ZFB@#A=.\/:M9^"=8T^ZC-S=):3:=8*KC,ENH<1$DG
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M4<3'_OM77_@-1>-=)@U&W@1+?SM1N98[:!I-S)$N\/(V <+\BMEA@G 7/(H
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MS6"3PW\-TTMO>1;L"3:Q_=N<\CH>QP*?XA$4/Q+T*=I&65M-O!"AN&C620/
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M3D/D-D_<3(/![@\4 >GUG76LVUIK5AI4B3>??+(T3*OR?(,MDYXX-,-[=?\
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MXYPO&!UKT&B@#@M<\,^)=8N;EY#ILJ_:K.ZM/,N)!Y B>-GC V$<E6/F=3D
MC'1U[X3UJYL/$$"_8-^I:M;WT1,[@*D?DY#?)P3Y/;/WO:N[HH \^U#PEX@:
MPU_2[,Z?+::E?K?Q333NCQ,71W0J$((RAP<C@]*NWWA;5+M_%%IFT%IX@V;Y
MO-;? /)2)P%VX8X4D'(Z\XQSVE% '$7EAI^J>-K!-,U")I+2(P:K;Q,')B1E
M>)7Y^5@^, ]5:2NWIJQ1HSLB*K.<L0,%C[^M.H **** "BBB@ HHHH ****
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M"$N$YQ-GD,#D[6XS6AJFKRWFJZU=>'GGN&D\/0.C6RMF0B63?L.,%]G (YR
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 445D>)_$5GX5\/W>KWNYHX$)6-/O2-CA1^7X $G@4 :]%5=,O1J6DV=^(_
M+%S DP0G.W<H.,]^M6J "BBN5\7>,CX5OM%M?[/^U'5KI;2)A-LV2$@#=\IX
MYZC\J .JHK)L-5NY;J]BU"QBM(K=$=;A+D21R9+AADJN"I3G([BM!KRV2V%P
M]Q"L#8Q*7 4YZ<]* )J*BDNK>*1(Y)XDDD^XK. 6^@[U+0 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MO*Q5A^!!'X58H **IW^JZ?I8B-_>P6PF<1QF9PN]ST49ZD^E6P0RA@<@C(H
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M'/6F:;IU^^K2ZIJ\=BMRB-;6PM2S;8BVXEF8 Y;"9'0;>#S0!E?$'_4^&O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MBIR!@8SUY(!Z917E/A[4(-1C@NKK7)[77K2WN%U.UAB82JVQMS2@DY56 *'
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MR*JV'B$76OZKIDT<4*61@\N;SL^=YJDCC P>.G- &W14;SPQR)&\J*\G"*S
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MD=>O09KG-*T>]M;7PL-,TVYL]1;PS<VUQ-]D>/9<%(?+$K%>"&5\9]*]9HH
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M&S8Q4L,8[E5.?:@#SG1O"P6]\)66KZ1)<P1V5_'()[5I$CC>5&@CD8@@$)P
MQX(J[I5H)];^PZM9:O\ VK9:M-=P2QV^V!XR[%7$P3[OEL%*%L\;<<#'HMS=
M6]E;O<74\4$"#+R2N%51[D\"I>HR* /(TL]<AT&[M;"VGO[>.Q@>"5[0P7@B
M69"]I(&&V1C&'P<>N1\W-C5=/L-2T:XU#3],UB9KO4M/DE^T6+HV8YEWLL00
M%<1@AG P>F3BO49IHK:%YIY4BB099W8*JCU)/2D^T0"V^T^='Y&W?YNX;=N,
MYSTQ[T >6ZQI!6W\806FCW M1J6G7,$45DX5U0P^:T:A<-PK9VYZ&M6>*ZC\
M7I<:=;RSVD][;F>QN[)T\K]T@$\$F!M"K@,IXR&'!.#WT,T5Q!'/!(DL4BAT
MD1@RLI&001U!I] '+?$*T>[\).([1[EHKNTF,<<1D;:MQ&SD* 2<*&Z=LUR'
MB72_MZ^.9HM%NY)9-/MAIY^P2$[U1N(_E^\"5Z<C\*]8HH \M\3F>YU#4'AT
MG4$ECO\ 3+@21V4LAN$5XRSAL$*%!<;%PV02>I%=)X5MOLGB?Q4KV$L#SWRW
M$4K6Y5'C,$(X?&#\RMD ]0<UUU% '*+')%\6999<^5/HBK 3TRDS&0#_ +^1
M_I6+;1+9>!_':RV<UO"]S?O&DENT8D1DX*@@9!/3'6N^GM(;EX7D3]Y"^^-P
M<%3C'!]QD$=ZBU+["ML)M1EBCMH6$A:9PL8(.06SQP>1GO@]0* (="M9H/#&
MF6=\-T\=G%%.&YRP0!L_CFO.-"TPG3O =E=:-=A;2>=;Y)+"3:K>3(N7^7!&
MXJ 3P?6O4UNK=[I[5;B)KA%#M$'!=5/0D=0*FH \FLUO-*L=+DET_4X](MM3
MU))8H+$L\*R3,8)!$R$E-I895> ]>@^%K&VTWP[:VMG#=0VJ[S%'=<2*I8D9
M! V]>%P,# P,8K8HH \H73;>[M?&\6H6GB!#>:C*]NMM!=*)D,4:J0H&Q@6!
M'S#!QSQ6AI$.K6U_H[^*]/WV\FA"V9(;;S(X9]V70H@(7<FP<#'R$#L*]'JM
M;ZA97<\T%M>6\TL)Q+''*K-'_O 'CH>M 'FFC>&6;4O"EIKNE27:QZ7>13&>
MU:5$#2QM#'(V"N0@(P3P0::?#TC^&?%LVFZ*Z:I_:4[0%K4Q226[.A=(RP'R
MNH<<<$GWKTQ-3T^601QWUL\A. JRJ23],U:H X-]"MO$?B'4&BMI(M%OM%^R
M72O T0>4O\A"L!\R+NYQQD#MQD66F>(IKS3KZZL2DNH6S:'J("@%5CS_ *23
M[[9@.V&C]:]3J%;JW>Z>U6>(W"*'>(.-ZJ>A(Z@4 >=:M8I)XAUC2-4L-5>V
MNWMWTQK&VS'M1$ 02!#Y)616;DJ!NSZUK>%=&LU\5>);V72?+G74_-M;B6T*
M?*UO&K-&Q X+!P2.O>NUHH Y3Q);L_C+PA<I:32>1=S^9-' SB)&MY%&Y@/E
M!8J.:S?!\%[::Y'#Y;W.G&SD:*XN;5H+FT)D4^1(2 ),Y)!QGY2><Y/:#4+)
MKXV(O+<W87<8!*OF >NW.<<C\Z==7MK8QB2[N8;="<!I9 @)],F@#E/$.FV]
MY\0?#\UQIC7-NEG>+/(;5I(QDQ% QP1V8@&N>\,0WM@GA>34]/N_[+ALKJU,
M4EJ^;:8R@HS(1D Q@J#C SCO7I9O[,20QF[@#S';$OF#,AQNPHSSQSQVI\US
M!;>7Y\\<7F.(T\QPNYST49ZD^E 'FFF:-=:==^%9;O3[B2UAOK\0K]G:1K>!
MRQMU< $J,8ZX"\ XQ72_$&.1M!LYER8;;5+*>X'_ $R6="Q/L."?I75TR6*.
M>%XI462-U*NC#(8'@@CN* ./U*+9XUU ZS937>DWFEI#;%+=IE5@S^;&0H.&
M8,A]]H':L+P_X;E;7M @\1:8UW-%X?\ *N)I[8R1B82(RJSX*EPH/4]CZUZ9
M!"MO D2%BB# W,6./J>342ZA9/*L27ENTC %4$@)(/(P,T <_P#$>U>]^'^L
M6\5I)=3/#B***$RN7R,84 G-96HQWJ^+Q=6$4MU#->6OVFRN[-Q@ )B>"7 V
M[ ?F4\?*PX)Y[>&\M;B5HH;F&21?O*D@)'U J>@#E/B-:&]\&SPI:2W4OVBV
M9(X86D<8F0D@*"1A0W/I7+ZGIMU;:KKXTO2KA=.%YIMS-;PVC(MQ"A_?!!@!
MS@+E1R0,<UZG10!Y=XCTB>^M_%=YI]E-)IUS#9ND(MVS+.DA,CHA&2?+V D#
MG&.<5Z3"T$EBI2$K R<1M$5.W'0H1D<=B,^U+)>6L,RPRW,*2M]U&D 8_04L
M=W;33/#%<1/*GWT5P67ZCM0!Y9H>CJT'@:*[T6YV6TM\LZS6$F(D8/L#@KP"
M2N,\=*[#X?026OA7[-);3VPBO;L1Q30M$5C,\A3 8#Y=I7'M74T4 >73B=_$
MUE.FD7\'V?Q'*TRI9RN&1H9$\TR$'*M\G"D*H(!Z9JOIVD"UM]&N(=%NH;F/
MQ1<.76PD5TMF>?!)VY$95U]N:]7=TBC:21E1%&69C@ >YIU '"66BRV?BZ\T
M*.VC_L.6=-9! &$<D@Q8[9E59 ?9A72>*-$7Q#X;OM,)59)8R87(SY<HY1OP
M8 TFC66EZ7+/;VMZ]Q=2.3(;B[,\O!.%RQ)"C)P.@R?4UIO<P1W$5N\\:S2A
MC'&S@,X7&<#J<9&?K0!YSINGZS?:W%>W>EF"U\26L;:C R#_ $9H<</Z^8I9
M?4<>E0ZB)W\1121:1?P-;>(TED$=I+)YD?E;/.\S!!4C VJ0%'6O4:BFN8+;
MR_/GCB\UQ''O<+O<]%&>I.#Q0!Q-KHLMGXON]#CMHSHEQ,FLY &$D!PT6/>1
M4D'T<5H?$>T:]\":A EI-=2MY9CCAA:1\AU.0%!.0,\UM:5HMMI F,$ES-),
MVYY;FX>9R,DA=S$D*,G ' R?4UHT ><Z[86>F:]'$^E7:>'KZP:$+IVGB4),
MSDOOC",R[U*\X'*\TR]M)K'49DAT?4KN"+PJ]LD+;RTC!LB(S*,;ROH<^E>A
MV]U;W:NUM/%,$<HYC<-M8=0<=#[4Z6>& 9EE2,8+9=@.!R3]!0!Y!J%A<WEC
MXI2#3;Z9+K1[)[<?V=)$K-&TFY45AG(!4 $EC[BM?5XH;O7-1L]3T[6&TO4K
M: 6'V2Q)&%!S&3LW0MN^8$E0,Y)&*]#;4;%%9GO;=0I ),JC!(R._<<_2I(+
MJWNE+6\\4RC@F-PP'Y4 >5>(8;IM(\8:;J&EWMUJ-Q<Q364B6CSB2$"/8%=5
M(!4J^1QR2?XJ],U6'[=H5Y$D9D,UNX5&7!)*G P?ZU+-J%E;W*6TUY;QSR?<
MB>50S?0$Y-32RQPQ-+*ZQQJ,LS'  ]S0!YKX?CDM)/"TM]IER-*31/LCQO9/
M^YN\1[BZ;<C<JLH8C!P1GYN4O-+O[7X46NENLBW<NIPK8QOG?$AO \2GN-L8
M''8#':O1(]3L)8#/'?6SPC/[Q95*\8SSG'<?G4,L^EN\%]-=6Y6,D0NTHV*Q
M&"1SC=@D9ZX)]3D H^-"1X2OL:?)J (0-;QAR6&]<G"?,P498J.H!'>O/[^R
MFN;?Q!&VFZA<+-KFG7<+'3I%W)^X\QU4+QPKY[@#GD\^K+?V;S"%+N!I2,A!
M("2,9Z9]*1=0LGB>5;RW:-" SB52%). "<\4 <(GA>#5;CQII$=D]E;3S036
M4GV4QQI,L*XD3( )#J,XZXKH/![76I:?_;VI6JV]_?1HK1@@[$08 !'4%B[C
MV<5HZC:66N6ZVCWTR 2[O]#NVB<E#AE)0@XYP16A#%'!#'#"BI%&H5$48"@#
M  H XW4H=OC+5?[9L9KO2[W3(X;4I;M*JD%_-CPH.&;<A]]H_NUF:;I=];:G
MX#CU>TGN+RVTZ>.[G^SM(L;E8]@>0 C/!&2>H)KTBB@#EOB#:-=^%#LM'N6A
MO+28QQQ&1MBW$;.0H!)^4-T[9KD/$NE_;T\<S1:+=R2O8VO]GG[!(6WJA_U?
MR_>!V].1^%>I7%U;VBHUS/%"KN(U,CA=S$X"C/4D]JFH \TU2#[;X@U?3]8L
MM8EBOWMY].DM;8E6"HF$,FPF%ED5FY*@;L]S75>.8=1G\%ZG'I<<DMT8UQ%&
M?GD3</,5?<IN ^M;D]S!;!#<3QQ!W6-#(X7<Q. HSU)/05+0!YC=I:ZEK6O7
M-EH]Y]DNO#0A4'394#R!I,)M*#+ %1CVXZ5)I&B6U[XET$ZCHLDD2>'(XI&N
M;%]BS*Z$*Q9<!Q@XSR*]*HZ#)H \NT6RN+ORK:ZM=6A\3Z<USMG>WV0;G##S
M?." .K9!V[B<]N,B;3;:VU?PF\ \/7T.N6VBRV,YN+=XP'*C*@GY92SJ&!&?
M7(SSZ-;75O>0B:UGBGB)*AXG#+D'!&1Z$$?A4M 'G&D*8=1T6:_TRY_L=]"%
MJJ/9/^ZN 1Y@>/;E=ZX&2.=I'<9HZ1X99M1\)VFN:5)=QQZ=>Q3&>U:5$1I(
MS!'(V"N0@(P3P17J$%S!=(SV\\<R*[(6C<, RG##CN"""*EH \^TP7>E^)WE
M2":\TSS+V9A-9.ES9-N+,%8#$L;M]T=?NX) X[;3=0@U738+ZW$@BF7<%E0H
MZ]B&4\@@Y!%6F4.A4YP1@X.#^8IL44<$211(J1H JJHP /2@#S30+..ZGMK?
M6]/U=M9TZ6X,S-:8@=7W!G\P)B17!'RY))QQQD4_#V@Q1P^ !<Z%.KQV<T=_
MYE@_!\L;5ERO]Y1@-W Q7K5% 'C]C8V<3^#[?5-,=88]1U2/R;BS88B)E:,;
M"N=F"I'&.GI5^UTBYTVST:*&QNULAXIDNK:!+=S]GM2L@!( ^1=S9 .,!A7:
MWL.D7^M:?>2:FBW5@[^3&DZ ;F&ULCJ<@X_^O6S++'#$TLKK'&HRS,< #W-
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M!Y;F::> 6SW$LNZ3RAG"@]NIYZG.22:MZ9IT&DZ9;:?;%_L]M&L40=MQ5%&
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MIS<1/YI),A4J68G[WRL1SV/L*K#P?I@B6/=<[5OSJ0_>G_CX)W;OIDDXZ>U
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M>;D2:5_QZ31SE)$XQ]X8)&!C!Z]\UO(NU%7<6P,9/4T +1110 4444 %%%%
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M<QR.56)E1]C$$*<;<@8)7.0.:N6?BK2H+""6[UF.X^U74\,$BV[)N96?]V%
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M8U"#QHD%ESJ\,"6I:5!DJFT[N>.: .LU#Q'I.E/,MY=B/R%1IB$9A$'.%+D
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MPQ1L'@[<5F:)IVH>%M-DMK'3)+FREOG>"S%RH:S@91\HW':1O#':&X#<$XH
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M&+2R^U)9ZI%>3J7108T5@0-QY/S#CI[T ,T_Q3(OB35M-O[BSGLK"S2[?4(
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M?6@!WB?5M2T[6?#]G836\<>I7;V\IEA+E0(G?(PP_NX_&JVA>,#+9:]<:P\
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M3_!YB"-%..YRY_X : -+6?$-MHM[I=K/%</)J$YAC,4+.%(1G).T'LO3KWZ
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M444 %%%% !1110 445R&L/J%SXZM]*AU:[M+2;29YV2 ("'66)0P)4G.&/\
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MVI%$@55'H . *EKS:#Q#=Z\XTVPU=[5_[(BNK:YNG$$KR%I%>1TVD-L**"O
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M&;JQ*#D_7K^-8QU6_A\7I::BUTMG=W<D5G=VL@:!\1M^YD7K&X*LV[G)7KV
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M74([&;3);D36<ZQ/OWQJKAMP.%#-P1R3T(%8<6IRW.D7>LZM-X@A6RU9[/\
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M </D@GC(!'(SBL_Q3XBDGM[%M+^V+#'KMK9R74+A48^>J2(><E?O(>,9X]Z
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M9 "KCY\LN&!X!/M4-]XX;3+[Q']KTJY:RT:**1I(3&S-N4L3@L.V,#V.>N*
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M%%% !1110 4444 %<CXI\)W_ (@N;SRM0MX[6ZTR2Q\J> R>2[;@9$PP )#
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MCBQ,?LXDSGY-FX GC[I]#7>Z'##8^"UCAOKZ>VCAE,5S./WNS+$$<= /NY[
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MA(.H^?A<\8Z<5V?BVY:WUGP]]LP-#>XE6]9_]6'\L^5YG;9NSUXW;?:NKHH
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MS'\QD#!@V$Y&&.,8HM_!-I;I8JNH7["RU&748]QCYEDW[@?D^[^\?@8Z]>*
M+GAG69]:L+E[J".&ZM;N:TE6)RR%HVQN4D X(P>:X?4]0U+5=(-Q?I;2RVOB
MR""V"9&W9<J@&3T&!U]S7?Z+HD6B)>+#<3S?:[J2Z<S;>'<Y8#:HX^N:RY?!
M%I(LZ#4;](I=274Q&ICPDP</QE"=I8 D'/MB@"M'XSN(3>VE]9Q)J$&IIIZ"
M!GDC<O$)@W"[N$)R,<E>V>-K0=2OM1M[DZA8/:20SM$C%659T !$BA@" <XP
M>A!ZUFWO@:PO_P"TVEO;]9KZ[BO1-&Z*]O-&JHC1D+QA5 YSGGUK:TK3FTVU
M,4M[<WLS-NDN+DKO<XQT4!0,#H /S)- '*?\)KJ^Q)_[)L_)_MEM)91=-NW;
MRBN#LQC.,]\$\<<V(O&=Q%]KM+ZTB34(=373D$!>2-RT(F#8"[N$)XQU'49R
M+?\ PA-I]F\C^T;_ &_VI_:N<Q9\[?OQ]S[N[MU]Z;>^!K&^&HM)?7Z37MY'
M?+-&Z*]O,B!%:,A>/E4#!SGGUH 9'XDU<VR?:=,2T<WDEOY\Q(1D"%DD2,X=
MBQPNP<@YZ@<U++QKJ.J1^'19:9;+)K%K/-F:X8")X]H(X7)'S=>OL.M:;>$5
MDDT^XDUG4VOK*1Y/M9:/?+O4*P9=FT#  &U1C'J23'IG@BTTI]):#4;]O[+2
M:.W$C1D;92"P;Y,G&!CZ<YH S[7Q-_;#>#[N?2+8RW\]P@=I"6M94BEW%/EY
M!V,,\<'I2Z?XTU*Y;2IKG3+6*TOM3GTTF.X9W22,R@, 5 *GR2/7FM"S\%6E
MC'HR1ZA?,-)GEG@W&/YFD#A@WR<C$C8QCK1!X*M(+:P@74+\I9:C)J,9)CR9
M7+E@?D^[F1^!CKUXH IIXSO)KBQ-MI\,D5WJL^F>4\K))$8M^9&PIX(C8[<#
M *\\UN:QK/\ 9][IFGPHKWFI3-%#O.%4*C.S'UP%Z=R1TZUQVD:7K:ZN]TAU
MFSO9+IY9XKB&UDM]K29($NWS&7;@##9X'  P.SUG0[?6?L<CRRP7-E.)[:XA
M(WQO@@]00002"".0: ./\2^([^]\*:U:K%%;7UAJ-O970#DJZ221893CHR2#
M(/3)'/4]!J>D6>G^#=;CBL[>$SV\T\R1#Y#+Y?+ 'I]T?CSUIUYX/L[W2KNR
MDN[M&O+I+NYN(]@DDD0H5ZJ0 /+08 Z#ZUKZA8#4=*N+"2>5%GB:)Y8]N_!&
M"1D$9_"@#RW4Y3)\'_#T;:1<1KC3#]H8Q;26DB#'ARWS G/&3GFNSU#Q1/;I
MKK:99PS0Z"J_:(V<JTI\L2,J8&!A",$YR>.,9J:Z\&VMWX4LO#KZA?+:6?DB
M.13'YA$14H"=F."H[#-/NO"-K<7>HSK>74*ZG"L-_'&5VS@+MW<KE6*_*2N.
M,=P#0!AWWCV_C@UJ\L=-M9;+3+.WO]\EPRM+#(C.0!MX;"^N/Z7M>\93Z8VM
M&ULHY?[)LX;QXY7*-<"0M\J$ XQLZX.2<8'6K-WX(L+N/6HOM=Y%#JUK':31
MQ>6%CC12H"90XX8CG-86K:3J4OBB64'78C%'%%:3VD-I/'*JC)8^:I\MMQ(.
M-HX!^@!U>NAKCPAJ/VJ&,.UE(SQ@[U5MA/!(&<'O@5PW@"?3_$=AH^G:E;B&
M;2K"VG@LID :XW1+FYST=220 .AY;G 7T!K&XO\ P[]@U"X9;B:V\JXF@"@[
MBN&*Y! []JQ;CP%8S:;H=JFH:A;S:*%6SO86C6<*J[=I;805(QD8YQS0 :EX
MLN((M?N;"TBGM]".+I7<J\I$8D<)V&U&&,YR<CCK5#4?'6H0IKEQ8Z;:S6FE
M64%_ODN&5I8G5V( V\-A..W]->?P=:S3:B_VV\2/5(ECU")2@6XPNS<?E^5B
MORDKC(QT/-)>^"[*]_MI3>7D4>KVB6<\<7EA8XT#* F4XX=NN>M %37?&<VF
MG6#:V<<O]E6$5\Z3.4-PKE_E0@'& AYP<D@8[UL:T&N?"-_]K@C5WLI&>,'>
MJG83P2!G![X%<GJVD:C)XG=P==C$,,,-I<6D-I/'(%&2Q\U3Y;;B0<;0=H.?
M3LOL-S>^'A8ZA<,MS-;>5<30!0=Q7#%<@CU[4 <7X8U6[T;1[_PM)*9-4L)$
MAT]I3N,L,W,+GU"?,&]HS4'@;45T3PM8V40,]]J&LW=I%),V2VR24EW;J<(A
MX[G XZCM!X:L/[7L]6??)J%I:M:QW#;<[6QR0!C(YQQ_$WK6=!X$L+?2H;)+
MZ^+V]\VH6]RQC\R&9F9F(P@!!WL""#P: *5SXWO;62>S.FP/?VNJV^GS+YY5
M"LVTI(IVGJ&Y!Z$'D]YHO&=Q&+JUOK.)-0BU0::@@+R1L6A$P;A=W"$\8ZCM
MG(O7'@ZSNEW27=V+AK^+4)9UV!I98]H0'*D!0%48 '3U))AO/ UC>KJ)>^OT
MFO+U+]9HW17MYT145HR%X^50,'.>?6@#-NO$GB%[C18?L4=DT^KO9R&57 N(
MQ"\BNH(!53MY!&<C'3FKW_"67:>)+33);. "[NKBU15EW-&8T9U9V&5&\)G;
MPR@CK5N7PG'<6MBEQJNH27=I=B\6\+1^8S["F"-FT+M8C 4>O7FJT/@6UM[N
MVGBU74E%K?37MO'NC*QM*'\Q>4R0?,;J21V(H S(_&FOOX4/B5M(L5L$^:1%
MN7>1$65DD?&P A5&[KR >E=98:@]]?WJ1B)K. HB2J<EW*AF'I@!EY]R.U9D
M5@OA/PS%IEI8ZAK4+2-'Y7[HN!(68EB=B[,D@]^>]7_#>BQ>'O#ECI472WB"
ML02<MU8Y/.,DT <]\0KB>YL?[)L-0%E>K&;Y9,XRT9!B0_[T@'X(U6_^$R$_
MA30]>LX$DBU&XMH'C9B#&99!&WXJQ(Q[5NV>F"SO[Z\-U/,]VRL5EVXC"C 5
M<*#MZG!)Y)/>L)/ =G%I%YIT>I:@(KB^_M"-LQYMIO,$F8QLP!N&=I!'7UH
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M4K Q# 8.,D*&8+DG&>^!B-/!-HEG#;#4;_9%J9U16)CR92Y<@_)]W<QXZ^]
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ML]PBSN8W+L_EQJQ4$$JF2Q& 2!@]I!X*M!X730/[0O\ [,ER+D2YC\S<)?.
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M/DV\..X- $$GBB^M-0U?3KNUMUO+6"*:R5';%WYAV <CC]YA#UQD'O74IO\
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MCR>E 'J>I7$MIIEU<PJC20Q-(JOG!P,X./I7*0>-;Q-%\.:Q>Z?;BTUJ2WB
M@F)DA:893Y2OSC)YP01UP:Z/47DF\.73"WF\R2U8"';E]Q7 &!GG)KS:#PU>
M'PKX2@TO2+NU\1:?]F$ES*NR. * )MVXX<$;AA03R* /4/[4T_[=]A^W6WVO
M)'D>:N_@9/RYSTY^E1Q:YI$]U%:PZK8R7$N[RXDN$+/MR&P <G&#GTQ7"75I
MJTNOVDHT2[C2U\1-<,L")Y31&*11-N)RS-N&>PZ8'>.UTB[ALM/VZ7<)*GBJ
M:]?$!!$#22D.>.FUU]^<8XH ZW0?$@OK:Z?4GM+22/4I[&)?,P)#&Q QNZD@
M$X%7+?5X UVUWJ&FB);O[/"8YQD$JN$?)_UF2?E'8K7$^'[76-'\37&H3Z?=
M7&GW>I7:^483OM \C.DZ>JN#M8?>&%]Q3;[2+N6UUJ(Z7<.L_BBVO47R"0\"
M_9][].G[M^.OYB@#T&WU?3+NSDO+;4;2:UC)5YXYE9$(Z@L#@8I]KJ-C?,ZV
MEY;W#)PXBE5RO;G!XKSO6K*XC/BF1;.[47&K6%Q9".(?OFC$()"DC> T9)7(
M)"\>M=!X/>!]3UJX>WOK>_O9DN9H[JT, "[%C79R<_<Y.>I[<4 %YXFU6+Q!
MK.FVMC92KIMG'>!I9VC\P/O^7[I"D;#S[UJZ1XDL=4\,6.O2.MG:W<*RC[2X
M7;D="3Q_C7'ZWX5N/$7B[Q$I2ZMHY["VCM+IE;R7EC:1BKKT=/F4$,"""<5-
M?7&KSP>'M3F\/7Z"P,D-_IUFQ1XRRA5DBVL Z@J1@'.U^E ';OJNG1VD5V]_
M:K;2C,<QF4(XQG(;.#P":2+5]-F=$BU&TD=U9T59E)91U(YY [UP5S;C0KW0
M)M)T6_A\J&]8V:K]J:..5D)+H9,@EL'@D#YE[\&EV:Z;_P (?-IMAJ5Q9Z9'
M<V<ZM;[)HY'5,%T., E3ST (YQS0!U-_XB,6J>'HK$VMU9:I<R0-.DF[&V*1
M\J1P>8\&M,:QIC2S1+J-H9859Y4$RED53AB1G@ ]?2N"T;3-3@L/!B7&F743
MV6J74MP"F?+1UG"L<9X)D7W_  HT2TU8^(O#UU/HEW:);_;HIXE1%AMS(RD;
M3G+*<9+'.2>/0 '::?XFT?4]'CU6#4+<64APLCR*HSV!R>"1S@\XJQ+K6E6\
M$4\VIV<<,REXI'G4*Z@;B5)/( !.1V%<!X=L-8TNU\'3W>FW:P:9;SV=Y"$W
M-&[!=LJJI)9?E*Y'.&SC&:=;>'+JWU#1'FT^1[7^W;V^\HQ;A;021R! 1T&6
M8-CMN]C0!WL.MZ5<PS30:G92Q0+NF=)U98QC.6(/ QZU<1UD171@R,,JRG((
M]17%ZKHDT7C""+3TB73]9MQ%J,0XVK 00P'<,C&(]."GI7;4 %%%% !1110
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MCCTH Z*H;J[MK&V>YN[B*W@C&YY97"JH]23P*FK$\9?\B-X@_P"P;<_^BFH
MMRZ[I$%G!>3:I91VMP0(9GN%"2$] K9P<^U7P0RAE(((R".]>7ZT^HGP#X36
M>VM5M_MFE8=)V9O]9'CY2@'ZUL:GXEU-K+Q;?V,Z0'P\Y"6SH"LX2%96+D\@
M-N*C:1C&>>E '<T5YOK'B?7XX?%%[:WD5O%I5C;WT$#6P).Y&=HW)/0[<$CG
MTQWT/$6OZY!=ZQ;Z<#'<6UG!-IT*PB07<CLP96X_V0, C'+'CH =Q37=8T9W
M8*BC)8G  IL D6"-9G#RA0'8+@$]SCM4E &:/$.B-IW]HC6+ V._9]I%RGE[
MLXQNSC.>,5HJRNBNC!E89!!R"*\>\ :K]EM-$M-?A$6ERR3?V5.#F%[CSY,K
M+QQ)_<SQUQ\W3O;K4[V^\6W>@6ET;(VVGI=B41JYD=W=1PP(VKLYQR=W48Y
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M+_;S1):K*A1WD,963.%*L""&YP,'/-6]/TNTTR-EMEDRV-TDTSRNV.@+N2Q
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M7,37D48DDA5LLBDX!([9P:LUPFJ6VIW/Q(OUTK48["X&A0$2O )02)IL @G
M'KW],4 =99Z+I]A?W=];6^RZNVW32%V8L?;).T<=!@5?KSC2_%GB'Q7IW_$K
M6"SU"/3;:[".5V/)*&/S!@3Y?RX^7!Y//2O0K:1I;6&1]FYT#'RVW+DCL>X]
MZ ):*** "BBB@ HHHH **** "BBB@ HHHH **** "J&IZ-I^L+"+ZW\QH'WP
MR*[))$W3*NI#*<>A%7ZS=1URSTVX%O)YLEP8'N3%"FYA$F SX] 2!CJ<\ T
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M31-$=T,SD! X[ [EPWW3D<U,OB6P=M055N"]A<);3IY1W"1]NT =\[UY''-
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M9B7+*B@H"@R/D[XZUG6W@S7]/TSP\8X='O+K2()+)[:YD8Q7$+%#O#%"4<%
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MFYL#KQ0!R>A^$]:TY_"_V@V#+I1N_/*3/EA*3@J"G49Y!/XU-I_AG5=.U^\
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M<JS;V&0#@ >IJE!X.UN!0B1Z8D:^(%U5529P!'MP4^YUST['KQTKT$    8
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M47$$4P4Y D0-@_C0!Q>K>$=3U%M4O8A:1WE_=V,GEO,P1(K:17&6"G+-\W;
MR.>*L:OX>U4^*WU>PM-(OH;NVC@N(-0)!A9"Q5T(5LC#D%>,X'-=C10!QEQX
M4O7\2V^J6WD6<\,T(:[MIF0W%NJJ'CEB VMD[@ISP".1C!C\,>&=8T)$L);3
M1I+6S#BVO4!%Q,F"$5QL^4C(RP)SCIS7;T4 </H?A35]-7P>DYLF71;26WN"
MDS$N655!0%!G[N><=:J1>"=1;PMI6C7UM8ROI\<J0W5O>2131/QY<B.$RO\
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M8);:QN[/19(+*17,F9IHT =LJ,*-@XYR3[<T[OP5K]W:Z^@BTR%]6TF*S/\
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M;CE&8]5]AC.*BU#4+ZR\9$RM+=Z;+?P6Z/:W3*]G*T:XBEB^ZR-G=N'(W<\
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M.W1HQA&6( K]..* .&^(.K_97U*"#4Y[>\M]$FNXT%R8$5LG:Z[>9'RN-IX
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M>=J\$$AAE*;T;=E3Z]!7)W4MU8Z;K]Q%J^I%M)\06\%J)+V1@L;M;ED?)_>
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MH&.3GMH+6WMM_P!GMXHMYRWEH%W'WQUI)[.UN9(I)[:&62(YC:2,,4/J">E
M'!Z.=1UGQ;:QZI?7]M*-#L;^:TAN&C1;@R/ORH[': 5Z'OVK6\7ZA%#J>FV+
M7\MN\\-S($%R;>-@H4;F<?-E=W"CKDDXQFNG%K;BY-R+>(3D8,NP;B/KUITM
MO!.\;RPQR-&VY"Z@E#ZCT- 'F7A^\N/$=QX5CNM8O62\\-R370M[MH]\JM -
MQ*D$,-S<C!ZCID4NGZUJ-CX9\)>+KJYO;R"2T6UU"%9&8.S@".79G!;> I/_
M $TSVKT8:;8#;BRMAM78O[I>%]!QTY-49M$DEU*W9+M(=*BVO_9\5NJAI5;<
M'+]<9VG:!U4<]00 C@N--\)R)<7[1W26KO+=2,9/+?:26^;)*J>@] !7 W>K
M:E9Z/?1WKW5EJ-E/IDDDT.H/-;RPO<!#(C$Y 9=X96[ 'GK7JK*KJ590RL,$
M$9!%5TTZRCMI+>.SMU@DSOB6)0K9]1C!H \YU+Q0]GJ?B0Q:H[:?%J.GI-(D
MY<6UNX42LIR=HSD$CIDXP15C75LY+;34L=;GOK:7Q%:E'^T>:("1RB2')/KR
M3C=7H"65K'&\:6T*HZA758P P P 1W&./I3!IMB((H!96WDQ?ZN/REVI]!CB
M@# \%RR[O$-D]S/<16.K200&>9I76/RHGVEF))P7;J37%:FEM%H?C:,74BW'
M_"06_P C7#,54R6A#;6)'4]<>@Z#%>LPVMO;L[0011,YRY1 NX^^.M,EL+.<
MN9;2"0N07+Q@[B.!GUQ0!YMKUW>:9I/Q!M;;5+Y5L8(+BV=KIVDA9X\MM<G<
M 2,XS@9.*UYA<W'CK7Q'?7[BQL;2\MK.*Z94>3,W!4'E6VJ".A_*NP.FV#;]
MUE;'?]_,2_-]>.:?%96D,OFQ6T,<F-N](P#CTSZ4 >9:3J%IJ&K?#W4VU1KB
M\NHYS<A[DD>:8#N&PG"$-E< #TKI/%(DG\7^&K#^T;RUM[P723);W#1>9MC!
M R.<]>1S73QZ=90SM/%9VZ3,Q<R+$H8L>ISCK69J_AT:OKNDZA++ 8+#S=UM
M+;^8)=X Z[L#&!V- '$6.J7"6MGIE_K%T^+G48[2::[,(N((F"J\DH^9F7=@
M ?>ZGIFC0KNY\2S>$8KG6[\"]\/R2W/V6[,9>9&@^8[3PWS-GOU!XR*]-:TM
MF$(:WB(A(,0*#]V1Q\OI^%,33[*)XWCM+='C&$98P"H]!QQ0!YK964_]A^))
MM(O+LZGI^N3W(MDO9,S(DF3&R[NCKD9]<>E=OX:NO[6M9M;22<VVH.)+6.1F
MPL(4!2%/ W8+<=F'I5C5-+N;M NG7XTUI),W,D=NK/*FTC )^ZW3#<XQTK0@
M@CMK>."% D42!$4=%4# % 'E5]%<Q0>,=1T[4KR#5;77%-I!#.0DKM'  C1C
MAP_3G/MCFM-=2EU/Q#>PS>)5TS4;'5@B61#EI8>-JB/S KJZG[VTD$DYXX[\
MV5J;L79MH3<@;1-Y8W@>F[K2M9VK7:W;6T)N57:LQ0;P/0-UQ0!P&C:S_:5L
MM[_:]P/$5M<W:2Z4)_\ 6,I<+$T1Z* $(8 'C.>32:3J%Y<P^"KZTU"ZN)M4
M1DU.)YF((\EFD?:3B,I( OR@8W;?2O0%M+9+I[I+>);B0!7E" .P'8GJ:;'8
MVD4DTD=K DDW^M98P#)_O'O^- 'F&B27=S:^"IY=9U-WU.XNK:Z)O'Q+&J3,
M!C. 047YAAO?I3[?7KBUM[*PO=7>#3O[9U"Q:]NI78@1NWDQO*'5N1GDMD[0
M.:]*73;!=FVRMAY9RF(E^4^HXXH.F6!MY+<V5L8)#EXS$NUC[C&#0!YUJ$^I
MV&B0/;ZV^NVMK:W+W!@N6MKAHM_$T3;B)3& 5^8\\'.3SZ7;S+<6T4Z!@LB!
MP&&#@C/([&HI-/LIA$);.W?R@!'NB4[,=,<<59H **** "BBB@ HHHH ****
M "BBB@ HHHH **** "L'5?$T>G:S'I,<44EY);_:(XY9_*,PW$%8\@[V&,D<
M=1ZUO5SOB;PM_P )-'+;7-S$+.2)5"/;[WA<$GS8GW#8^"!G!^Z/<$ AO_&<
M-E:ZAJ M&ETS3;G[->7"R89"-H=E3'S*I89Y!X; ..='Q)KH\.Z(^IFUDNE2
M2-#'&P!^=P@//NPK+F\%)(FKV2WI&DZM/]HNK5HMS;CCS C[N ^T9!!ZG!&>
M-3Q)HK>(-#DTU+D6P>2-S)Y>_&QU<#&1W44 9=WXON;-9H9-&?\ M&" W,MH
M)]Q\LLZIM95(+/L8@''3!(JDFK.OC6\U&*"_FB;P[%>+98;S"QD<[1&3A7(
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M!!;/2K_ARUUA[.:.+48T@\^*9;G^R6MGE^8F5&21B3D!?GX^\>N* .PHHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M31=.N'M[O5+6*=(O/:-I!N"9 W8ZXR1]:Y3R+S3]5\8VVHZ==7<6K*LMI)!
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M9-X</@$8[ $ 'I"$M&K,NUB 2N<X/I3JBM?/^R0_:=OVC8OF[.F['./;-2T
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% $=P\L=M*\,7FRJA*1[MNYL<#/;/K7)VNJ>)=-\8:?I6L2:?>VNI
MPS21R6D#1-;/&%)!RS;E(8#/!S75W,XM;66=DDD$:EBD2%W;'8*.2?:N0T+7
M'U+75N;GP_K4-[.IB5[FS,<-K$/FV[B>I(&2.IVCH!0!VE%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MRM'2XL-+M4BBEFC,<\T;.7C<;NA#\-V8 CISV/B'3;KQ+X+U'35#6-U?6CQ
M2,#Y;$=&*D@CL<=JW** .3M]/U*_\0Z3K=YI[V4FGV$T,D(D1C-)(8^%*MC:
M-A(W8^\.!S5OP-I][I/@W3M/U"W,%U;QE'0NK#J3D%21WKH:* .-\,:=JGA"
M"XT5=,EOM.6YEFL[BWEC!5)&+E)%=E.06/(R"/3I5F:QU1O&UEJLECO@BTNX
MMY&BD7 D>2-E4;B">$(S@<XZ=NIHH \^T#0-8T^/P0MQI[@Z38SP7966,[69
M%5<?-SG;_*F:-X?UJSM?!R2:<4?3)[I[G,L9""1)%4\-SRXSCWKT2B@#S[PW
MHVOP>(=%U#4-,$'DZ=<6ET5N$\M'9XF!CC7A8\(0 !G^]ZG6U32+^R\;V_BC
M3;;[:KV1L+RU5U1R@?>CH6(4D$D$$C@]>*ZNB@#E?$UGK&NZ"?L=DL,]O/#<
MQ6MU*H,YC<,49D)500, Y///&*R[K1=0O;:RNH?#4=A<'5;6ZN(5GC>0I$>6
M=\X)QP ">![X'?44 >>W?A_67_MB6+3V9G\16NIPQ^;&#+%&(0V/FP&_=L<'
M':KC>'M2U%O&\$L!LQK42QV\Y=6&?LXB.<'. P/4#BNVHH XG33JMA97&KW7
MA*UMM2M;0Q'_ $R,FXY!(63HD?!/S<]...=7Q)HH\9>";G37+VCWL".AD7YH
MI 0Z[A[,!D?6N@(##! (Z\TM '(:]9ZUXH\+R:#/IQLI;Q%AN[HRHT2)D;S'
M@EF) (7*KUYQC%/M]&\CQ1K4EY:*NC76FVUFCR2+M8(90RD9S@B0#D>M=95>
M^L+/4[.2SO[6&ZM9,!X9D#HV#D9!X/(!H X33M#U*?X>ZY:F07]U-:3Z98.&
M WP)OCB+$D#)W$D]QCKQ6A#I>IIXBMKTZ=)Y*:$;)CYD>?-W*VW&[V//2NQC
MC2&)(HD5(T 5548"@= !V%.H \R\/6]_HGB#PS8W.FRRW=KX8:WEBCDC)5ED
MB!()8 @D>O<5=TOPKJFC/X5AAMDD73K>\\]PZ^7&\V&50"0Q4'(X'0"NV.F6
M3:DNI&UB-ZJ&-9]OSA#U7/I[5:H \RL- \1"X@N;G2"DAT&>PF47,>U9B4(V
M(#M6,[2 !C ZX/77T/1=4M-7\+S3V+1Q6&AO8W#>8AVRDPX'#9(_=-R/4>^.
MVHH Y35]'O[7QI9^*=-M_MC"S;3[NU#JCM$7WJR%B%W!LY!(R#UXI_B>WU77
MO!FM6-OIKQ375G)!##+)'O9V!&20Q4*,^I)]L<]110!RMO87EMXRGU*XM%&G
M7.DP6\LDDJ#RFC:4LK#/.1(.1D<'GUJ>$M.N=*L]2D1DOK?3S+::2H?&85);
M;N/ .[$>>G[D&NON[2WO[26TNX(Y[>52DD4JAE<'L0>M+!:V]M:I:P01Q6\:
M[$B1 JJO3  X ]J *^D7TFIZ1:WLMLUM)-&':%F#;#Z;AP1Z'N.:RO#MA>VF
MN>)+BZM6AAOKY)X&+J=RB&./H"2#E#U[8KHJ* .=T&QO;7Q+XEN[FU:*"^N8
MI8'+J=P6%(SP"2.5/7M57Q9H]UJVO>&I4TX7=G97;S76XQ[0IB=!\K$9.6!_
M"NLHH \_U/PA<W?B?6!86"6-A?Z"^G+<Q>6H68LQW%0<XPPYQVJ]9:5J=YJ7
MAV_OK!K.31K29)5$B-YSNBIM3!^[\I;YMO\ #QUQV5% '/>"=/O-'\%:;87U
MN8KJVB*/&'5N<D\$'%9_@KPXVGVUS+J>E1P7PU*ZNH96V,VV1W(^92?X7((K
ML:* //+71O$)\1Z/?76EJOV+4KMYFCN$6(Q2+($:.,'_ &@6)&XL3U[=%X,T
M^\TS1KB"^MC!*]_=3JI=6RDDSR+]TGLP_&NAHH \T'@O4I[C7-4CLDL]935V
MU+2KB1D8.OEHGEOM)(5MK CMN!'(K<2#6E\5V_B%])F,<^FBSN+-9HB\$BN7
M# E@K*=Q!YSPO'IU]% 'F#^$->LO#\>B0VD=Q ^DW,/F0SK&8[B1V8(S'#&(
M!L #@D?,.F+,>C>(K+^T_P#B5&Y35=&AM<)<1@VLL<;IM;<1E3OSE<X.>.]>
MC44 <WX?NM0L?[*T&[TPQ"+2HV>Y$ZL!(FU&0J.?0ANAZ=C3_&NBW6M^'6CT
MYD34[6:.[L7?HLT;!AGV(ROT:N@P 2<#)ZFEH XNV\&36'C*QOK:4?V:+)$O
M%/6:>'(B<^I(D<D^J"H+[0M2'B76$DT&VU;3-6DCF6::=0MNRQI&5D0\LO[L
M,-H/4CWKNZ* .+M=#U.V\7+?V45Q9VLMU,U]!),DEM,I5@LL:Y+)(3LS@ 'Y
ML^^EX'L+_2/!FG:9J-KY-S90B J)%??MXW CL>V>?7%=%10!Y;;>#=:LEU77
MM-M&LO$:ZG<W-MF2,I>6\DFX0RX;&/KRIY&:Z)H-;E\2:3XB;295*6<UE=V/
MGQL\1=D<2(VX*PRF#D@XP<=J["B@#@AX1U.T\.VKV!A36+;5I=1@1V^2)9I6
MWQ$CMY<C XZD<=JT/#/AF[T'4[]'E,VFQ.TFGAFR^Z4*TV[WWJ2/]]JZVB@#
MSK1/#VN:2OAN^>Q=WL/ML%S:"6/=LFDWK(AW;21M4$$@X)].9+/PMJVE:O8:
MU# 9\:A?7%Q8I(H9$N2,%22%++L!(SCYFP3W]!HH \_A\,:G;:AIUVMH65_$
M$^JSQB1/W$;PO&!R>6RRL<9Y+<GOJ^';;5M(BNXY-*9OMFM7$Q)GC'EP2,S"
M3@G/8;>O-=710 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5R/B^XN=)UKP[JRW5P
MFG_;!:7T*RL$(E!6-R,X^5]O_?7/2NNK+\1Z+%XB\.W^D2OL6ZA*+(!DQMU5
MA[A@#^% '%Z1K5Q'<>,-)>ZNY9UN VF//,Q)CD8PH%.<[5F5AGK@@FN@U+Q5
M8^&HI;1O/O'L(8VN/WJM+M/<!CEVP-Q [?@*D_X0VS77-#U-)'#:5:O;!?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
**** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>exhibit1033-bochk_facili003.jpg
<TEXT>
begin 644 exhibit1033-bochk_facili003.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MX\1W>KQ7EK?W#3SQ%9%=L9VGC'YC]:[V@ HHHH **** "BBB@ HHHH ****
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MLL3!XV *L.017&:7>W<OBBWL)= L;"V>!IB,*TA .,Y48'.*[955!A0 /04
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M HMM$U:STVPM(]2@D-FV5>6 DNH! !PWH3^E9X^(MF?^7"X_-:3_ (6+9?\
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MTFM:%>ZK?Z3=QW$$36$GFX:,D.WY\"J'_"Q+'_GPNL_5?\:/^%B6/_/C=?\
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MWR$%>V.P[4K:'#_;']JQ2RQ731"*0KC;(!TW CJ/6L3_ (6'8_\ /C=?FO\
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M^4ZVBN2_X6#IO_/K=_\ ?*__ !5)_P +"TW./LMW_P!\K_\ %4<\>X?5ZO\
M*==17(_\+!TW_GUN_P E_P#BJ3_A86G?\^EW^2__ !5'/'N/ZM5_E.OHKD/^
M%A:</^72[_)?_BJ</B#IG>UNQ_P%?_BJ.>/<7U>K_*=;17)_\+ TO_GWN_\
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ME;:.Y@:5D=AAG]-W8>@SZG/<T4 <=K?AO6O$6GZCH.J2Z=-H]TL:Q7 #"XB
MP22I!5FR"0<C&>AZ4_Q)X)M_% M;&\BM8M,@*;RJ;KB9%((CWD?(F0,XR3[5
MUU% "*JH@15"JHP !@ 4M%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M9,523,.U7RN/X7QG^M=3\0[(W_AF.%;*6[<7]H^R*%I&"K.C.< $CY W\N]
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M-YJR,8F(<#^#[W;T.>+=OXVNA-I]Y>QPQ:9JFD"^LPL9,@F"AVA)W88[6RN
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M.@NH]L#,REI)58MM!.T! <X &>: -[3M"L]+OKZ[M?-1[Z02SIO.QGP!O"]
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MHR<E&*$$KD9Q^6*+CPMID]T]PB2V[2VXM)A;R%!-",[48#TR0",$ D9K:HH
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ME/I%G+ US-,'G>51-,TIC#'[H9N2.I_'TJI=>$-*O?[6^T"=QJNS[4/.(R4
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M#IG.1SD=Q10!YAJ=I>WNKZK:P:8;A)M,M[/58K:_B1@<.VUO,''R/]Y>S'N
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M>1-LR0<8XV?K[57TW1O$\&BOINH:EIETL,'D0-]F;]^!@9F!)'W1@A>N2<T
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M"VNM.-]YLJA&7YU4 J2",9.>,YQCC)K3OM;BL[[[#%;7%Y>" W#06X7<L8.
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MY!K2K)L;34[*ST>U62T\JWB$5YE6+.%3"F,\8^8 G(/'YUK4 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %<GXPU/5/#\^GZS'<M_8D,P35(5
MB4LD9X$H.,X4D;AZ=,8KK*H:Y:S7V@ZA9VZ1M-<6\D2"1MJY92.3@\<^E %&
MTU![B\OM6;40FA01[4!";&*Y\R3?C.P=!SU5CTQ3AXJTP-*DC3Q21VIO!')
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M=JNEZ796<!TPPLCN)#YD.U?D^7&"O&,YSDBMB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M<[8D"C/T%>7_  ]\=RP_#&VU[Q'>7-[>75\;2)1C?*Y;:B*.%'<YXZ&NCO\
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M\/\ B+5;_P"+FI:;<"[MK%=)CN5LK@H?+D+J,@J3V/3/K7HE !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<;XP\(W_B+Q!X<U
M.TN;:%=&N3<;)0Q\TDKQQT^[UYZUV5% 'F\GPVU4MXIU*V\0"TUO70BB6VB*
M1VZ*1P.<DD#&[@\D@5%%\,+^"R\76RZC8!=?MX8@(K9HUA9%*D@;CQR>,Y]Z
M]-HH \\T_P"'^H66MC4#>VKA?#RZ*$"L.5 _>9],CI^M5?"7PQU#P?J&D7FG
MZE;AX;=K;4TVMLO$WED8#^%ESC//0>]>FT4 <OKWA::^\5:1XDL)HEO=.CFA
M,4V0DJ2*1U&2""<]#GI[USMO\+IM/T;PEIUG?Q.-#OOMTTDJD&X<MD@ ?=')
M]>U>E44 <YXV\'VGC;PZ^E74KP.LBS07"#+12+G#8[]2"/0]JLZ?#XB\NWBU
M&YL!Y6/-FMT8M/C_ &6X3/?EN^,=1M44 >6WWPMU*[M]7B&HVB_;]<75P2C'
M8 3^[]^HY^O%7M3^'FH:A?\ C2X%];(/$=O#"JE6/D>6H7)_O9&3VKT2B@#S
MRP\ :M8ZTVI0ZK!#,/#RZ-$Z1DM&Z@8F&>#R/N_K2^$_A[J7A_Q5;ZY=ZI:W
M3C2_L-P$@97E;?O\PL6.6)')/7T';T*B@#C]1TB6Q^)VG^)U1GM9]/?3+DJ,
M^4=XDC<^Q.5)[<5!H'@[4M$\3^*-9-Q:2_VVRLL0W#R2H8 $X^;[WH.E=O10
M!Y?IGPIN;+P)8:!-J$#W6FZFFI6MPJ$*SJV=KKZ8)&0>^>W,FK_"ZYU7P_XE
MMOM\$5_K]]'<S/M+1PHC J@Z%CQUXZ].*],HH \M\3>%+[3;;QSKLAL[H:S:
M01+:O$SK&T8" GU'.<\;<9/ )JQ\/[F]3Q%=076AV,;7%JKOJ5GJ)N\^7M1(
MW8YQP20,\X)P>37I5% '$ZOX(GU;XCV/B2:2T>RM[)[*2SD4L94<.&)/3^/I
M@].O/&9HGPTOM,T77?#4NJ1R^'-1$HM[?#&6SW9QM8\,.G!QR,]SGTFB@#SV
MR^'EVEW'>WEY;M<VN@C1;81AMI&"#*V>03G[HSCGDU7T/X<WVB7_ (5NY;ZV
MFCT&TGMW58VS,)-W('; (XYS7I5% 'B'@BXO[&_T*6X\/:5-&))(XY+:_8R6
M2RDM(XMS_JA_>& 0./:O0/!NC3P:WXE\0W$;Q'6;M##&XPPAB78C$'D%N3@\
MX(SSQ77T4 <-8^$-7TWX@ZYXI@N;%QJD4<7V=PX\L(J@'<.N=OIWILG@W6KO
MQ1X=UV]U&TEN-+DNI)55&42>=E0J]=H5=HYSG%=W10!Y;8_"W4K/3]#MCJ-H
MYTS6FU4L$8>8"0=GMWY^G%%Y\+=2NO#^NZ9_:5HK:IK1U42;&(C!.=F._0<_
MI7J5% ' W?P[EOM9\67$M_&MGXCM8HI8Q&2\+I&4!4Y (R<\CMCWJK+\-K[4
M_A]/X:U2\TY)O)CB@NK.UV$F,@JTF3R3M (&.YYXQZ110!Q>B>$M7M?'4_BC
M4[^SDDGTY+)X+>)@ 5(.X$GU'IWKM*** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MBXN/"&F7NMW!N-2O[B>".."(#>T;R#"@=!MC)R3^-:O_  FFBM%ISQRW$O\
M:*.]JL5K(S/L^\,!>&'IU_"@#H**I:5JEIK>EPZA8R,UO,#M8J58$$@@@\@@
M@@@]Q7&Z3XK=]'\2?VAKT$=[9WUW;VP=HD95B)"?+CDG'.1SVQ0!W]%<=H6O
M276D^#YM0U2X%]JEN)S&EL"EPQ@+LI(7"A>HP03CO6A8^-=%U"XLX8)+G_3)
M98(9)+61$:2,MN3<0 &^1C@^E '0T444 %%%% !1110 4444 %%%% !1110
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M$25XF(!&'1BK#GT((H X;5O$EUJ%J1#JFC6VV>%O(2_?]]$"3(#((P4)^4#
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?)TN $VYM27RY,1ZH2Q.1V^G'2@#CF@OE\0V_P!DU2:"XC\+^8+CRHV?(D!
MP5VXZ#IG'OS6CHGB'5/$[QVJ7G]G3C0[2_#QQHWF2S!B3A@?D4J!@8/S'GI7
M20>%]&MF#060C(MS:@K(X_=$Y*=>F>?K1_PC&C>5:QK9!!:PFWA*2,I6(_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MYOG4J"/X3D>_ !V%1/=6\5Q%;R3Q)/+GRXV<!GP,G ZG K@]&\:ZM)!X?O\
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MUX0\:V]J;>.UTR$P.)8RSR,8ED8@Y&T . .#R">E 'HDT\-O'YDTL<<?]YV
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MNWZ4 %%<+?\ BK6K&^\33M]@.G:$0S1^4XEF5H!(!NW84AF )P01G@8YGO\
M5/&5K9ZI+!86<GDV@N;5Y(P#(ZD[XMBRL3D8*MD<G!!ZT =?<7$%I;R7%S-'
M#!&NYY)&"JH]23P!4@.1D=*XG7?$]Q+X0UC6M-^PW5A;Z>DT:W$!=979=Y!&
MX?+L9./5O:K-WXHN+/Q5'I5T8[*.66);1Y[=C'=J5!=5E!VK(#D!2.<#KG@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MF1AMOTSTH \W\17<E]!XQB6ZO&M6\+17<4+RLI1R)^=H/!(5,COWKK9&MO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M:KL6:>:ZAS(8]^X+_%'G*[@>HZ8YJII7@JZTQ/#D9U>.6/0S(L8-IM,B,A0
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M 8EVSCEE 'OV )K?7PI!%XCO]>AFV7MY:I"P*DQAQD&3;GJ5VKUZ+UYK(M/
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/+(0%55'J:Q/$R3^)O 4'A?3;.[:ZOHH(999;9XX[9 5+NS, ,@*<*.2<<4
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M6:07-S)<OYI!^=SEL8 X)[5HT4 %%%% !4$5G#!<33Q+L:<AI #PS 8W8]<
M#/? ]!4]% $$MI#/<0SRKO: EHP>BL1C=CUP2,^Y]34]%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !3)8UFB:-\[6&#AB#^8YI]% &-:^%
M-"LX[>*'3(!%;D-!&V62(CH54DA3[BG:AX7T/5KF:XO],M[B6:(0R,Z_?09(
M!]<9.#U&:UZ* ,BY\+:%>&<W&E6TAGA6WERGWHU^Z/P['J*GT_0M+TJXFN+&
MQA@FF"K+(@^9PHP,GO\ UK0HH HVVCV%GJ-U?V]OLN[K'GR[F)DP,+NR><#@
M>E,N]"TR_NS=7-FCS-'Y3MDCS$SG8X!PZ\GALCDUHT4 4)=%T^>^DO9+?-S)
M!]G>0.P)C_N<'IDDU3N?!_AZ\M;*VN-*MY8;$;;96!/E+TV@YSMQ@;>G XK;
MHH Q)M,O;S6H/M*V(TBS=9K9$5C*9 I7YL_* ,DC'/ Z=]2\LX+^SEM+J/S(
M)5*2)D@,IZ@X[&IZ* *\MA:W%H+6>%9H 5(63YN5(*G)YR" <^U5IM!TNXOG
MO9;-&GDV^8V2!)MY7>H.&QVR#CM6C10!E7?AO1KZ:\EN=/ADDO8Q%<L0094'
M #8ZC&!]!3;CPMH=UJ-OJ%QIL$MY;J$CF<$M@'(!/\6#R,YP:UZ* ,E_#&B/
MKO\ ;;:9;G4N/](V_,2!@$]B0.A/(K6HHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M-E8ZE;7%R(A,8HW!;8<<_3D?3/-<;J]E>?VUXQVV=[,MQX?CM89%MG832@3
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MXA\.?VEJ;VQE:XFB"V\110(Y&3NQR3MS6QJ&N:7I+8O[V*WX!8N>$!. 6/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQ+?QF&2 W*O&#(/)&,R':#A!D?,>.>M5_$?B&#2M&O)H+F/[6EH]S%^Z:50
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@#E_$,VM2ZBEM!X>DO\ 38PLC%;J*/SG!R 0
MQSM! /N?8?,WQ#9W/B'29M(OO#:SBYM.)FEB:*&9@01DD.-IP=RJ?:NJHH Q
M].L+BTN&DGWS_9K6.U@8D%I,#+OUX+':.?[E8_@'PV=(\.6<>I:7%;ZG;RSL
M9/D9B'D<CYE)S\K <_TKL** ,W1=3N-4MIY+FP:SEAN'AV&59 P7HP9>#G/3
ML01VKB8_#5RT7BI+[PHMY+J5]+/:O(\& IC15RV[<I!4G@$CMS7HX 50%  '
M0"EH \QU#POXI;P[_8LJ#4G;P^UF;Q)UC9KDAAB1CAV3!7:.A.2PYR+UUH>L
MW+Z^YTQE-]X>BL(1YT9S,!-D'YN!^]7GIP?;/H%% 'F5_P"&O$4FM6FK65HZ
M7%AI=JD44LT9CGFC9R\;C=T(?ANS $=.>Q\0Z;=>)?!>HZ:H:QNKZT>("1@?
M+8CHQ4D$=CCM6Y10!R=OI^I7_B'2=;O-/>RDT^PFADA$B,9I)#'PI5L;1L)&
M['WAP.:M^!M/O=)\&Z=I^H6Y@NK>,HZ%U8=2<@J2.]=#10!QOAC3M4\(07&B
MKIDM]IRW,LUG<6\L8*I(Q<I(KLIR"QY&01Z=*LS6.J-XVLM5DL=\$6EW%O(T
M4BX$CR1LJC<03PA&<#G'3MU-% 'GV@:!K&GQ^"%N-/<'2;&>"[*RQG:S(JKC
MYN<[?Y4S1O#^M6=KX.233BCZ9/=/<YEC(02)(JGAN>7&<>]>B44 >?>&]&U^
M#Q#HNH:AI@@\G3KBTNBMPGEH[/$P,<:\+'A"  ,_WO4ZVJ:1?V7C>W\4:;;?
M;5>R-A>6JNJ.4#[T="Q"D@D@@D<'KQ75T4 <KXFL]8UW03]CLEAGMYX;F*UN
MI5!G,;ABC,A*J"!@')YYXQ67=:+J%[;65U#X:CL+@ZK:W5Q"L\;R%(CRSOG!
M..  3P/? [ZB@#SV[\/ZR_\ ;$L6GLS/XBM=3AC\V,&6*,0AL?-@-^[8X..U
M7&\/:EJ+>-X)8#9C6HECMYRZL,_9Q$<X.<!@>H'%=M10!Q.FG5;"RN-7NO"5
MK;:E:VAB/^F1DW'()"R=$CX)^;GIQQSJ^)-%'C+P3<Z:Y>T>]@1T,B_-%("'
M7</9@,CZUT! 88(!'7FEH Y#7K/6O%'A>309].-E+>(L-W=&5&B1,C>8\$LQ
M(!"Y5>O.,8I]OHWD>*-:DO+15T:ZTVVLT>21=K!#*&4C.<$2 <CUKK*KWUA9
MZG9R6=_:PW5K)@/#,@=&P<C(/!Y - '":=H>I3_#W7+4R"_NIK2?3+!PP&^!
M-\<18D@9.XDGN,=>*T(=+U-/$5M>G3I/)30C9,?,CSYNY6VXW>QYZ5V,<:0Q
M)%$BI&@"JJC 4#H .PIU 'F7AZWO]$\0>&;&YTV66[M?##6\L4<D9*LLD0)!
M+ $$CU[BKNE^%=4T9_"L,-LDBZ=;WGGN'7RXWFPRJ 2&*@Y' Z 5VQTRR;4E
MU(VL1O50QK/M^<(>JY]/:K5 'F5AH'B(7$%S<Z04D.@SV$RBYCVK,2A&Q =J
MQG:0 ,8'7!ZZ^AZ+JEIJ_A>:>Q:.*PT-[&X;S$.V4F' X;)'[IN1ZCWQVU%
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M%93N(/.>%X].OHH \P?PAKUEX?CT2&TCN('TFYA\R&=8S'<2.S!&8X8Q -@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M$3!6S@[E'4C@G/-+=>#Q=Z]9ZBSVT9LITDMIHH2DZ1*H!@+9^9"<GGL<8[T
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+ 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>exhibit1033-bochk_facili004.jpg
<TEXT>
begin 644 exhibit1033-bochk_facili004.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M4KQYF_'MG->A0_$2TW!9+*=5[LI!_2HARZW.K%0JOE=/H<OKOAR[T.<,P:6
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M %B2<#U)ZT 5[C5+*U29I[J*,0_ZS<V-O&?Y$5%!KVESVOVI-0M_(W%?,,@
MR.W-<7KNG6-WKFN37T"&*.:S$DVW+1QD?-CT!P 3V&3VK.2&PM?$FKO)/HMK
M##=*%^UQ!WVA5X09Z4 >E6&J6>J1O)97"3QHYC9DZ;A5VN9\#^6WA\W*;?\
M2;B6;"CH"YQQVX KHY76.,NY 5022>PH 9<W,=K;R3RDB.,98J"2!]!3;*\@
MO[2*ZMI1)#*NY&'0BN9\/WDVH7U_KDMR8M,G=8;:)^ V"%#\^IX'K4^D2'1M
M>GT:0*EG,#/88[#^-/P)R!Z&@1T]1R3Q1?ZR5$_WF I^>*Y?6[*VU:^"W7AN
M6\>'Y4E=T52.O!W9Q^% S:EUK2X/];J5HGUF4?UI-.UJPU:6=+&ZCG\@@2%.
M0,C(KG+#0XDU&-1X6TJWMU^^3*'D [$#;BM'PU#'%?:X(XTC OL *H QY:4
M=%1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=O\ 2M2G-EJ,<6ER3>:+4P[B"?O -GCFMO4(KJ73YH[*98;ED(CD==P5O<4
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M+UC3X(T5K9I%6[;'^K#Y5/IE@?RJ;Q)=:K9VL4VE)'-,9 I@=?OC!)P<]>*
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MN[:WU%-/&Z<QEV*!F8?*> 3M^H- '0?\(=HW/[A^?^FAI?\ A$-'_P">+_\
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MTM%')'L'MZO\S.:_X0;1C_RSE_[^&@^!=&/\$W_?PUTM%')'L/ZQ5_F9S/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MX6-RZ@1W! +84YR"5!(W 9 XH\.Z ^D:#+I=Q.\L+R2>7&96D\F)CQ&';YB
M.A/]*RM,\(WT-AX?TR_GMY;30IQ+;S1D^9.$1DB#+C"X#\X)R5[9H 7PW>:A
MX@U2]OIY+^S6QU&>W$.Z/RI(U&T(R@GY@?FW#OQDCBL_Q)XKOY=$\4"TANM/
MDTBZBA6X4H=^?*8]R>1)Q@=.X/%=)X9TF\TA-36[,!^UW\UVGDN3M$ASM.0.
M1ZUBZMX0U2\B\3V]O<6?D:Q<0W$9D+!HV58E(. 1C]UQ_O=L<@%W4?%=A)H_
MB 3#5+%M-@W7!CB F2-E)62/J.@8C/3!R!6E_P )!;+>?8HHKFXDC\@3,@4^
M7YIPA89!]R0"!6)J_A74]2;Q65>T0:WIT=G'F1CY159%+'Y>1^\/_?/OPNI>
M$KO4M2M+TK:6UY:M 8;^WE=9HT4J9(B H$B-AAAC@;NE %[QA>7=DNB/:W4D
M/FZO;0RA,8D1FP5.1G'TQ3Y_&>DV^I06;NY\Z[-DDRE2GG\C9C=N!R"N<8R,
M9J7Q+I%UJ\6FK:M"IM-0ANW\UB-RQG.!@'DUGZ1H&N:1JES!%=V#Z++>27B,
MT;?:8_,<R-&/X2NXGYNH!Z=" "I#X]N9M+L+L:%<@WFJOIZKOCX"R2+G[_WL
M1GVSW(ZZUQXTTFUU"&TE=\2W0LA,-I43G@(1NW=?ESC&>,UD)X/U:#2[:TCN
M;)FLM:?4K<L' ='DD<J_H?WI'&?N^_%O2] UW2=6NXH;O3Y-(N+Q[T,\3?:(
MV=M[QC^$J6)P3R QZ\4 :.B^*+77KB2.TL[]8XVE1IY8-L8>.38R9S][//TS
MZ$47GBFQLM0-K+%<[5NH;1YP@\M)90"B\G)SN7D @;AD]<'A;2+O1=.N;:[:
M%FEO;BZ4Q,2 )96DP<@<C=C\*P]:\):UJFIW-P+NPDC&H6MY:/<!R\*Q,A:(
M <*"58Y')+8/J #2;QQIJ7,L1MK\1PZ@NG33F#$<<K;0N23G!+J,@'KS@8-4
M/&?B62+1[C^R7NU>VU"VMIKJ$)Y:LTL8="2<_=;!*C@G&>M,N?".JS6.K6XD
MLMU[K4.I(QD8!5C:([3\O4^3_P"/>W,-YX-ULV.L:7:7-@;&^U)-2CDF+B2)
MO.25XR ,,,J<'(ZXQW !TGB?79/#VF0W<=G)=-+=P6VU"HV^9(J9.2/[WYXZ
M#)'/#Q:^C>(O$CZG]OEL+8VC +&K"S5TRQ;&!@$\XW'Z@5T'BC1[G6]#6UMI
M8DN8[FWN4,N=A:*5),''(!VX_&L+5O".K:E;^*H_.LE;6H88T;<X$91-I)&W
MOU S0!L:MXSTC19I4NG?R[>2.*YE0J5@9\;=P)#'[RD[0<!AFF^,=>GT+3+1
M;,(;[4;V'3[5I!E$DD.-S#N  QQWQBJBZ#KUGXAO[JPNM/%AJ;I/<).C-+;R
MA%1C$>C A%^]C!YYZ5I>*?#L?B;25M3<-;7,$\=U:7*KN,,R'*MCOZ$>A- %
M:_\ ^),^GF;Q)-')+<HA6[V8NN>4 "C#$9P%QTZ4^7QII$.I06;.Y$]TUG',
MNTH9QG*8!W Y5AG;C(QGI5?4]%UG79-%%\+"W73[^.]DD@E=S*4##:%*C;G=
M_>./>F:-H&NZ-?W%K'=6$FC-=2743-&WVE-[F0Q?W<;F/S=<'IT( )]/\;Z;
MJ,]A'';7T<=_-+;P32P[4,L>_<A.<YQ&Q'&.,9SQ1_PG.CF^@M0TK?:1*;:1
M K+,8P2P4 E@< D9 !QQFLVQ\(ZI:V6@0/)9DZ;JL]](5D;YUD\[Y1\O4>=_
MX[[\3:#X=\0:+9G26NM.FTRV5UM)-C+.Z$'8DAP0-N1\PR3@<#F@"Y8>-;+4
MK6TN+;3]3*7OE_9-T 43[T9_E)..%1LDD=L9R,TKKQ"=2O?!][IEU/'9W]]-
M#-"R@;PL,Q*MWR'C['''>D@\,:S;>&/#6EQW-F_]F*D5W Y?RKI%C*#.!G@X
M;:1@D8/K4.F>#M4T^U\.V[SV,BZ3J-Q=$IN3>D@E  &#@CS2?3C'O0!U&J6E
MW<E)(-3N+..)'+K L9,C<;<EU;@8/3'6N8\'ZG>MX+TOQ1K6NW$L4ECYES')
M'$$WDC#+L0'/!&,G.[Z5V=RLC6TJPA#(5(4.Q S[D _RKD[+P==+\,8?"EQ=
MQQ7,-NL4=U#EE#HP9'P0.X&1^M $\OQ T>WBOVG2Z22Q>%9HE19& E;:C HQ
M!!/'7(/45+_PF=O]K%G_ &3J_P!L-O)<K;&V =D1PAQEL=P1SR/<@52U#0O$
MNL^&9[*_ETE+MY8&46P=8@(Y%D+$D$DG:!CH/4UISZ3?OXQAUJ/[,8H].DM/
M+:1@Q=G1\_=Z?)C\<^U $>G^-=+U*:P6*.[2&_MFN;6XEBVQRJH#,!SD$ YY
M !YP36AI&MPZR@DMX)TA>&.>*5PNR5'S@J5)].0<$9%<UI?A#5=/M?"D/G69
M;1+66!W#M\Y:/8"!M[8S@U?\,>%Y-"U.ZND2WLX+F%!)8VDC- 9@26E56 "9
M! P/QH LP:V+O7-94R%+'1@J2E1G?*4\QLXY(52N .Y/H*:GC/3!'=-<1W-J
M;:UBO&6=5!:*0D(PP2!DJ1@D$=\53@TJ[L=7\46MO<&U?60+FRNMN1'+Y(C8
M?52BOCN#QT.*-GX/UB"[N+J0:.YN=,ALYX&5W69D=BQ<L,MO#G)(S]>M '96
M-[]M6;-M/;M%)Y;+,%Y^4-D%201AAR#ZUR>O^)9)KG0SI;W:VLNM1VDEP@3R
MI@"P=.N[&5(S@ D'D\5K^%?#[^';:\MU?9:RS^9;6BS-*EJFU045F ."P9L8
M &<"N?M_!NN6EEIVDQW5@]AIVJB^MYG+^:T>]G\ME QD;R-V><=!0!O'QGI(
MU.VL=[G[3.]M#,"I1Y5SE/O;@?E8 D ''!Z9Y=M;N+ZQU'6=1O-;TV"RU22T
M*V9B(9!((U0CYL$, 2W'4C)'3=T'0-<T6ZDLOM=A)HRW$D\#^6WVD*S%_+/\
M. 6(W=<<8!Y%.;PCJLWA76-*,ED)K[4GO4?S&*JK3"7:?EZC&/QS0!I:CXXT
MW3+C48IK:_8::T8NY4@RD2N,AR21E?7&3['FIM7\9Z3HLTR7;OY=O)'%<RH5
M*P,^-NX$ACPRD[0< @FLC6/".J:G%XLC22S3^VX88XB9&/E;$VDM\O/KQ5I=
M!UZT\0W]U876GBPU-TFN$G1GEMY0BHQB/1@0B_>Q@C/M0!7\8>)9(]+?^R7N
MU:WU.UM9KF$)Y89IHP\9).?NM@D#J<9ZBNIU+4H=+MTFE260R2I#&D2Y9G<@
M >@Y/4D 5QMWX-UO[%JFEVEU8-87>J)J<4DQ<21GSTF>,@#!&5.#GOC'<=+X
MDT[4M2TV"'3KB*.5+B.26.4LJ3Q@_-&2N2 ?QZ8.030!S^K>*VEOO#US8-?+
M$=5N+*[LDC!=W2&4E"!G.&12"&QW)]-BR\9:;?VD<D,=T+E[I[/[%)&%G$RJ
M69""<#"C=G.,=^16)9^"]5L7MYHYM.9K769M2BA56C1DDC="F<';C?Q@'[OO
MQ8?P9=QZA!K=M<0?VLFI27TD;DB%U>(0M%G&1A%7#8Z@G'.  :1\9Z:((I3#
M= M?C3I4**&MYR0 LGS8 .1@C(.1SR*MW7B*SLWF299%9+@6R E1YTA3?A26
MQPO))P.#69)X.6\T?Q#;W<BK=:U*9W:(DB!PBK&5/!)78K9P,G--U+PQJ4NC
M:0UE>VXUG3KC[7YLZ$PW$C*RRA@.0K>8V,=.* &7?C*U;0QXALI'^RVEX+2_
MMY ,IF01MT)&Y2P;()!&>N01U]<=XBTS4-7\+?V%=M;M?:C/$)5ME(CAB#JS
MD9Y("J>3U9@.,@#>TZXU.74]3BO8K<6D<B_9)(@P+*0=P;=U(('*\<XZ@T 8
M^DW]]+\0?$=C<7\CV-G;VLD,+*@5#()"W(7)^Z.IJ:P\1A)H+6X@NY+J]MY=
M0@ 5<-$&&$7)'S!63(]R:KMX:U)_$/B&],EJMMJ\%O;X#MO1(]P<_=QDJ[8Y
MX(%7_$GATZV-.>"X^RSV=QN$BCDQ,I25!Z91CCT(![4 %KXNTVZTNSU-?-2R
MNK22\\YPH$<2 %F?!R.HX&3^M/TOQ1I^JZM-I<8DBO(H%N/+DVG?&3C<"K$=
M1@@X(XXYK*M_ D,6C^(=*-T5M-2\V.V6-<?9(GRQ51[2.Y^FT=JU/#]KX@@3
M_B>SZ<[HGEJ;*-E\T_WVW=#Q]T<<GD\8 %U/Q38Z3<31W$5RR6YA$\R(-D7F
MMM3.2">>NT''>H]2\7Z;I;7OFI<RQV,L4-U+"@98GDQM4\Y/WDZ XW#/?&/X
MG\):SKMUJ6RZL7MYUMVM?M(<M;-&P9E4#@!L9+=>V",8P-2N1+XHUE%GT&0M
M<0>;I]Y<RVTMQ)$B%6$8#%\L."!R !@X% ':'QC8#5+JP-K?AK0K]JF,&(X%
M9"X9VSPN!U]:9%XZT5KB>":22W>*U^V#S-I\R+(7*[2><D#:<-R.*AB\-W-]
M<>)GO_+AM==MDBV(Y,D0\HQL#QC//8U5_P"$8\0ZGX9N='UC4;!'$"QP7-G"
MVYW5E9)7#=""HRHX.3STH W=(\2V.L7]Y80B2.[LPC2Q2%3\KYVL"K,"#@CK
MD8YQ5!?&$<>L:U:W=G-!;Z:\,*RY5C+)(!M4 -G+%E &/KBM#0H-;CB9];?3
M_.P%5+!&"<=6);G)].@]3FL#6/!=_J.I:O<07MO$MU/:7MLS*Q:.>#;@,.A0
M[>>_/2@#H]/UNVU"_N[#RYK>^M C2V\X 8*V=K J2"IP>0>H(.*TZQ-.T>=?
M$5UKU\(4NY[6*T6*!RZHB,[9W$*227/88 %;= !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %5+W4(K)H(V!>>YD\N")>KM
M@D_0  DGT'K@5;KD]2$@^*.@M+G[,=-O%B]/-W0D_CM!_6@#:N=4DLH[V>YL
M9H[6U8'S@RMOCV@LX4'.%.00>>"0#QG01TDC61&#(P!5E.00>XKD- D@'B7Q
MLDLNZW6YB8AW+ +]G3?C/;=N_'-6/AY]IA^&N@&[60S+81G:1\VW;\H^NW%
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MR?#F\OHUD86ES"TTB%F\S"%5)Z[LAB._6@#U2SGGGCD:>T>V99715=U;>H.
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MP_N[@NW/'*[>HH ]1HKR72]0BCC\*V3S.+RTU^[AND^;=$A%SM5O0'Y" >N
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M&52>*:VV[<!E<%>GO7E_A^#3+FQ^'=I(D8C6RG2ZCY3]YY"!@_3/((.>I!%
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M.^TQ+(,$8"[UR1C(!]ZZWPM;Q67AJS@AN[NYMT5O*GO.)&3<=N>!QC&,]L4
M2^']:CU_21?QV\D"F::$QR$%@8Y&C.<$CJIK4KR/15MK:+PS?PR;+N3Q'>Q2
MN)#DPN]R=I&<;23&?3)![U-H5_;77BK0WBWK#=C4(+J&5&:4L6!"3MT+=2%(
M^4=R.: /5J*X'PY8WT+76B/ S?V#-,UI/*,B?S!N@.X]=JNRM[A357P++8ZC
M>Z=>)?7PUF"T,.IVA@\O$F!N,Y(Y8.#M.<G)QD9P >D45Q?CC4;;3-5T&XU"
M>/\ L_?.L]O-Q'(2GRL3C;E3T!Z[B1TKF-/T_3+N3P;I\VJIJ<$\=ZER\-X[
M)(2HPI.<\?='0G% 'K=%>42W]M'XHL7MFEA>#Q"]M<"0.\_E^3(HRW:)B%V+
MSG .<Y AT];:W32+Z.=_M0\57,'F-.S'[.TDPV\G[A!0^G0T >KP74%UYOD2
MK)Y4AB?:<[6'4?45-7D,<T&BZ;>A(3;V<7B:X&J>3;;BELQE,99<<IN,9^GM
M5Y9[#3)M#_TZ>X\*7-[<O)/<KMMT=D4Q*. !#N,F,\;@/04 =YH6M)KMK<SI
M;RP>1=S6K)*03NC<J3P2.H]:U*X[X<?9UT;5(K88A36+W8,$#:9F*XSVQBL:
M6>^@\4W L/LNI23W%T+>1?DNK*81/A91T>'*X4G&-R=>* /2J3 SG SZUY%:
MW O/#MYJ7AZ]U)]?BTEXKJS2'RV63 +>;D9,P(8*<[CD]15[6)=#U#P=K6J>
M&OM+ V\#RB)75(F1P2=N.)=I;=CG &>V0#U"J\L\Z7MO"EH\D,@<R3AU BP!
M@$$Y.<GH#C'->4^)M2M;W_A-9;.[<P2V>GR6\D+,JNV^0,4(X;@C..OX5TEU
MI^G:=XW\,VUEQ;7$=Z\D9F9T?>JG)!)!R2V/QH [6VNH+R 36\JRQ%F4.IR"
M5)4_J#4M>2Z18Q6OPWTW5]/M@-0T"X>XG@1-ID5782QL.[;.1Z%5KT7P_;M'
MIQNI8S'<7LC74J$8*[N54^ZKM!]P3WH NPSSR7=S%):/%%$5$4Q=2)@1DD '
M(P>.<58KR?Q+(@C\>(MS("+NQ,>V9@0<1[MO/3.[(''6NG\,+;VGCCQ-96;X
MM?*M)DC$A8;V#AV&2>3A,GZ9ZT =C1110 4444 %%%% !1110 4444 %%%%
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M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KGO%%C<:Y"-";2O/T^\
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MMBNG#[J!R&0[MX(;J"&P0>V!27'A33[VRU""^DN+M[^!;>>XD8"0QKG: 5
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M"#[8J#4M4L](L6O;^;R;9" TA4D#)P,X![D"H&U_3%EOXFN&#Z?&)+I?*?\
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M6"V!C,ZQ;H0V3M8 8?#.0>F2 >*T;/Q;H>H0&:SOA.F(ROEQ.2^]2R[1C+'
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MDC<  3T7WQ->^'KN\U3Q$]UI4LUG?SVCQ>5<K'*/+0 NC!AM96 (Y&<5W5%
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M?G"JW&>HPXYK0H X33- U&TUJXM+S0;&\M/[2DO[;5))5)C#R&3!0C=YBEB
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M1QW8:Z19%CE$>QAF-S]TY(R00=N0#S7,Z)X<UNP?PVEQIX"Z;J5_/*R7"O\
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M5Z-Y$/VC[1Y4?G[=GF;1NVYSC/7&>U1S6%G<R&2>T@E<H8RSQAB4/5<GM[4
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M-85"O]1CFK= !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MKESH.MZI;2P"REL)+KPV^G%Y)85C@F!!"*J,=L?\(P,XZ^M>D?\ ",Z!_P!
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M+,W$7DLY>,B(.<YX(R?\]:UK7P986EI;VBW-V]M:[S:12,A%N7# E?ER2 S
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* *VH7BV%A-=%"Y1?E0'!=CPJCW)('XU9K+U$&ZU/3[+'[L,;J7T(CQM'UWL
MK#_<-:E !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>M):M'&D-NR#,17.YM_5MV1UZ8]ZMT44 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MF17%:?X=\067Q*M+F;5#/90Z48C*M@D<>/-7$(P< ]\]<"@#T*BBB@ HHHH
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MENZ^:J1JXRWF\$[L9P?H>E '?45A1>+-.32+*^U!VL7N+-+R2"169H$(!)?
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M7,<4)B!!*M$DGS9/)^?'&.E0>(M:U'3-?\.V5HUH(-2NG@F,T3,RA8V?*D.
M/NXY!ZT =)17-+KE_P#\+"ET1GL_[.33%O=WE-Y@8R%,%M^,<9^[6G;>(-+N
MYC%#>(7$/V@!E*[XO[ZY W+_ +0R.1ZT :5%9NAW9O\ 0;6Z74(;XRQY%U%$
M423D\A<G _&N;T#Q#KFLV4DC7VCQ7"ZC/:) ;5P91%(P.#YO!*H3T('O0!VU
M%9L7B#2IK\64=XAG9I$4;2%=H_OJK8VDKW .1@^AHT*^74=/:X34(;]#/*JS
M0Q[% #L-N,G)7&TGOC- &E17G%[XVUZPTKQ+J;MI<D>C:E]D2V\B1'N5VQG
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MD9*LLD0)!+ $$CU[BKNE^%=4T9_"L,-LDBZ=;WGGN'7RXWFPRJ 2&*@Y' Z
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
3 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>exhibit1033-bochk_facili005.jpg
<TEXT>
begin 644 exhibit1033-bochk_facili005.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M4KQYF_'MG->A0_$2TW!9+*=5[LI!_2HARZW.K%0JOE=/H<OKOAR[T.<,P:6
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M %B2<#U)ZT 5[C5+*U29I[J*,0_ZS<V-O&?Y$5%!KVESVOVI-0M_(W%?,,@
MR.W-<7KNG6-WKFN37T"&*.:S$DVW+1QD?-CT!P 3V&3VK.2&PM?$FKO)/HMK
M##=*%^UQ!WVA5X09Z4 >E6&J6>J1O)97"3QHYC9DZ;A5VN9\#^6WA\W*;?\
M2;B6;"CH"YQQVX KHY76.,NY 5022>PH 9<W,=K;R3RDB.,98J"2!]!3;*\@
MO[2*ZMI1)#*NY&'0BN9\/WDVH7U_KDMR8M,G=8;:)^ V"%#\^IX'K4^D2'1M
M>GT:0*EG,#/88[#^-/P)R!Z&@1T]1R3Q1?ZR5$_WF I^>*Y?6[*VU:^"W7AN
M6\>'Y4E=T52.O!W9Q^% S:EUK2X/];J5HGUF4?UI-.UJPU:6=+&ZCG\@@2%.
M0,C(KG+#0XDU&-1X6TJWMU^^3*'D [$#;BM'PU#'%?:X(XTC OL *H QY:4
M=%1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=O\ 2M2G-EJ,<6ER3>:+4P[B"?O -GCFMO4(KJ73YH[*98;ED(CD==P5O<4
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M+UC3X(T5K9I%6[;'^K#Y5/IE@?RJ;Q)=:K9VL4VE)'-,9 I@=?OC!)P<]>*
M-ZDXKEY/$;7WA]-1TZ5(I%ECBFAD3)C8NJLI'8C)I=3U^72_%,-I<7$4=@UJ
M]P[,OS+CC&?K0!T^ :,8K,TMM0G:6XNF18'8FWB\O#JG8L<]?:H;[4YO[=MM
M(M HEDC,TTC<B.,<<#N2: -JD(%<_+J5[INOVME>212VEZ"L,JIM99!SM;GD
M$5FVVO7T]YK-I-J%K#+9S"&WWQ@>86Z9&?4@<>M '9XI*K^<;>P,]T53RX]\
MI!X&!D_AUK)L+C5=3TL:A'+!$9@9+>$QY&W^'<<]2.>.F: -^BN5OM6U2SL-
M'GG:&VFNKF.WN(W3(3(8D@Y_V:-8\026NLZ/:V5S;RI>3>5*!ABH]1@\4 =5
M2<5S4NKWL?CJ'1]\9M9+4SYV?,,$C&<].*J_\)3-IWB&ZLM7V+8F80V]RJX&
M[:K;7YXX8<^U '7.B2(4=0RD8((X(J.VM+:SB\JU@CAC'.R- H_(53MGNCJM
MU%+.KPQHC(NS!&XGJ<^WZUG6>O3R^++G39HE2U:(M:R?\]"AP_Z_RH Z.DP,
MTR218X7D<X5%+$^PK&BU.]?PL^JJD7G-$UPD;YVA.H!([[<?C0!N8%&!7-3^
M(+I=)T^YA^PR7%S)&CQ>:<+YA &._&>:N3:M/+J3Z;81Q/<PQJ\[RDA(]W0<
M<DF@#: Q17-#Q!>2V&H[+)%U+3C^^MW8[6&,@J?<<BI8-??4+2VGL4C#&<07
M,4V0T+=Q@=Q0!T%&!6&-7N+[4+NTTM(&-FP2>28G;O(SM&/3N>U7M.NKB[MF
M>YM#;2J[(8RV[H<9![@]: +N!0 !6#/KLMKKUS97*0);QVZSK(&)9BQVA<8Z
MY';VIW]KWT4-M%=6T":A=.5A@64D8 R2QQVYS^% &[01FL2#5KQ=5.F7UM''
M.\1EMY8V)CD QD<\@C(_.J6D^*)]2M;B*2UBMM216DB@>0E94!(W XZ9!'M0
M!T^!FEK!36KI[?3XE@A.H7D7G"+>=B+P22<9[@?6KEK<:A)/+;WELD15,I/$
M^Y&SVP1P10!H\4N*S](GGN+,BZ4"XBD>*3 X)#$ CZC!_&H+;4KJ3Q'=:9-#
M"L<4*S+(K$E@Q( (QQ]TT :]%8MSJ]Q;^*++2O(C,-U$\@EWG<NS&1C'N*:F
MNLGBA]&N8HTW0":"0/DOR001C@\$T ;E%8]AK)U'6;ZTA5/(L]J-)DY9SG@#
M'08JO:ZSJ%R^L1+9Q--8MY<2I(?WK$9&<C@<B@#H**YJVUC6IM1NK0Z?9DVK
M1>9MG;)5^XRO89/-1OXCOQJVI6*6MGNLC& 9;@IYN\94#Y>O;ZT =328%8-]
MK=[!K]GI<%I [74+RJ\DI7;MQD$!3ZBKFEZJU]-<VT]O]FO+9@)8=VX $95@
M>X(_E0!IT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/_?8_P *7_A M,_YZW/_ 'V/\*ZNBCECV#ZQ5_F.4_X0'2_^>EQ_WV/\*/\
MA =+S_K+G_OL?X5U=%'+'L'UBK_,<I_P@.F?\];G_OH?X4G_  @.F?\ /6Y_
M[Z'^%=911RQ[!]8J_P QRG_" Z9_SUN/^^A_A1_P@.F?\]KC_OH?X5U=%'+'
ML'UBK_,<G_P@&F?\]KG_ +Z'^%'_  @&F9SYUS_WT/\ "NLHHY(]@^L5?YCD
M_P#A =,S_K;G_OL?X4O_  @.EC_EK<_]]C_"NKHHY8]@^L5?YCE#X!TL_P#+
M6Y_[['^%-/@#3?\ GO<_]]+_ (5UM%')'L'UBK_,<E_PK_3?^?BY_-?\*/\
MA7^G?\_%S^:_X5UM%')'L/ZS5_F.2_X5_IN/^/BY_-?\*/\ A --_P"?BY_,
M?X5UM%')'L'UFK_,<E_P@&F_\_%Q^:_X4?\ "O\ 3>UQ<_FO^%=;11R1[!]9
MJ_S'(GX?Z<?^7BY_-?\ "C_A7VG?\_-Q^:_X5UU%')'L'UFK_,<C_P *_P!/
M_P"?FY_-?\*3_A7NG?\ /Q<?^._X5U]%')'L'UFK_,<?_P *]T__ )^KC\Q_
MA0/A[IX_Y>;C_P =_P *["BCDCV#ZS5[G'_\*]T_.?M-Q_X[_A2_\*]T_'_'
MS<?^._X5U]%')'L'UFKW.//P]T\_\O5Q_P"._P"%-/P[L#_R]W'Y+_A7944<
MD0^LU?YCCE^'EB'!-W<%1VPO^%3+X"TU)%<37&5(/+#L?I75T4<D1/$U7]H*
M***HQ"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M"2W0,P)ZBM_7;O6]8M=6L+?0[R&S?2;A%:8Q@SW#@*BJ QP -V2<#GVKLZ*
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M4%LJEGDN@$8G'"J@))/J3@>F>WB'_"#^*O\ A6HTG^PKC[=_PDO]H>7YD?\
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M+YS8,?'R[<XQP.U 'DND_#3Q!I7A7PC<RVY>\TS6?[0NK%'!98F9,[><%E"
MXS_$:UXO ]U>GQI?:OH]Q<6>O7T(BLT=4G6)&/[X9. PW;@"<_*01SBO7J*
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MC+D*!DG H O45D'Q)8+JFEZ<?.%QJ<336_[H[2JJ&.6Z9P1QUYK7H ***0G
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M85DV8<^1%\QPH.>W&![5O:;X5T[2VL_*-Q+'8@K9QSREUM@1C"9YZ< G) R
M0":GTK0+31[N^N;5YS)?2^?<>9)N#R8 W8[< #C XH YV\AGD^,=@!?W21#1
MII!$I79Q-$",$'@\9/7@<BN6TRZU/2/#::K::G-'&OB>6W>T$:>7)')>%&W$
M@MGYN"",8''<^EWOA^PO]9M-6E$R7MK&T2213,F48@E6 .&&5!P?2L__ (0?
M2/[*_LW-W]E^V?;=OGG/G;]^[/7[W..F: ,*34/$VOQZQ<Z'>6]K-IVI/;1I
M/,!"%B8!A(OEDG<,G.1C(QC'/:ZG&\VD7*I,\+&(D218R.,\9!'Z5C3^!-$N
M-<EU8K=QSS[3=10W3QPW17@&6-2%;\>#WS7075NMU:RV[NZ+(I5BAPV#UP>U
M 'F/A;4KK3_"?P_TB*]F0:S& \S!,PI'"7*)\O!8@#)R<9[XQ-K^I:@FD_$+
MP_=SO=P6>D&YMKAP-X26*3,;$  X*'!ZX/.<5UH\&:0-!LM'"3_9K!UDLV\T
M^9;LOW2C]>.>N>#CIQ4TOA?3KC3=1LI_/E&I+MO)FD_>3+MVX+#H,<8& .?4
MT <W/_R-WP\_Z\KO_P!$QUG2^*=7F^&TGCFVO76:*=Y?L!5?*,*S&,Q$8SNV
MC.[.=WMQ7;'PS8F]TJ\+W)FTJ-H[4F4_*K !@1_%D #GT]:A3P=I,<DX1)EM
M)[C[5+9"0^0TN0V[;_O $C.TGDB@#G-7U76;'7-=TO\ M6Y22]L$NM$/EQ9C
MEW>6T7*X;YVCZYX;KQFKOAC6;SQ18:?<17]S 8; _;@%C)^TDE,'*\%"DA(X
MZKQBNGN]'L;[4K#4+B!7NK!G:W<_P%UVM^E,LM$L=-AO8[*(VXO9Y+F9HS@F
M1_O-]>* //\ 3]?U^_\ #?@"Y_MB6.?5IS%>.(8SY@,<C9P5X(*C&./4'I5A
MM>U_3O#WBZ**[FO[C2-02**YDC0RK RQ.[$*H#%%=R..PX/2NFM_!.DVMGI%
MK";I8=(D,MDOG$^6V"/^!<,1SGK6;XD\+>5I.HG3;*[OGU*\AGOXDN_+E8*5
M):(D@!P$4 9 XH GT.XU*Y\9:BD6I7%UH$-M$T+,J%#,V[>@?;N; "MP>"V#
MZ"QJ.ISW/C>V\.)=26D3:?)>N\6 \A#J@4$@X R2<<].V<TO"^DWEOJ:W4;^
M(X+0(RR0ZS?"?>3C&U=SE<<\Y'I@YR-C7_"NF^(I;2>[^TPW=HQ-O=6D[0RQ
MYX8!E.<'N* ,+[9KFE^(/!^FWFLK>/<R7<-ZT<2*LVR)G0D8RK#"YP0,CI6-
M?>(->C\.ZY-#J\BSV?B5+&%VBC/[EGA781M&1\YY&#[UVEYX1TN\L]/M\7,!
MT^0RVTT%PZRHQ!#'?G)W!CNSG.3GFJK> =#-E=V86[6&[NUO9E%T_P TH((;
MD\'*J??'.: ,2_M_$%MXMTO08_%E\8;^UO)GF:W@\Q"ICV;<(!QO(Y'3T."$
M^V>*-<@U?^QM1BBN],O3:1M/(JQMY87<94$9)WY8\$8!&,8)/7SZ!:7&MV6L
M2R3F\LXVBA8284*V-P*]#G _+C%9]YX%T2\UV75V6ZBGG"BZC@NGCBNMO \U
M%.'XXYZ]\T <Y?7NNW>K^,H(M?N+:+3K&WNK401Q'8[1R,1N*<IE1[GCD=[6
MCZ]?^*;RVTXWSV$AT&VU!F@50TDLP.2,@_*NT<#J6YKHI/"VGR7FK71>Y$NJ
MQ+#=D2G#(H(4 ?PX#,,CGFJ5QX T6XCTT*U];S:; +:WN+:[>*40C_EF74@L
MO'>@"E-?:U8^)/!EA<ZLEQ]J%S%?^3$JQSO'"QW=,J=PY ...E4M.U'Q-X@L
M;37=-O+:&(7SB:&>8"+[.DC(R%?+)#X .=W7V.!U4OAG3I+W2KH++&^E!A:+
M'(0J;EVMD?Q9''.?SJG!X%T2UUR;58$NHFFF^T2VR73BW>;KYABSM+9YZ=>>
MM &-:^(;V#QE%IFM37MC++?3"T;8K6=[#A_+C5@/DD VD@D$E3UR!6]XFO)K
M>32X(+YH#<76QH84W3W*A&.R//"\@$L<  'D5+'X8L4N8Y7>YECBNGO(H)9=
MR1S,6)8=_P"-L#.!G@5+K/AZPUV2RENO/2>RE,MO-;S-$Z$C:0&4@X(."* .
M*TWQ9JCZ?8V-U=.D]SXBN-*-U(J>8D49D(!P-I<A F<=\]:T]4OM5\/36NGS
M:P)UU35XK:WF:-?-M871F()QAB3&RJ2._?%7W^'_ (>DTN\TY[><P75T;PYN
M7+1S9SOC;.4.23D>O.:FF\$Z-=:#)H]VES=12N)7GN+EWG,B_=?S"=P(P,8/
M'2@#*U>^U?PX%M6U9+H:CJ<%M:-*%62VC=6)#-@@Y9&"DJ>O?%9OB*Y\7>'_
M  WKUR^K1(L<ML]@0RS3(KR*DB29C *Y)*D<^_%=._@G1;C0)]'O([B]@G(:
M66ZN'DF9A]UO,)W C'&,8_$UA>+?"/V?X?:AI6DQ:AJ-W=/!EYKAIIG"2JV"
M[G@!0V!D#TY- $.H3Z]I'BBXTB?7+J\L]2TFXN8Y#'&DEK+%MSL*J,*0X SD
MCUSS3/#T]U;>"O!5NNK7!-Y:([VR*IN)@( 0D;8 55."68^@W<X/9VFB6:S/
M>2F>YN)H/(,ET<LL778!@8&>O&3QDG K-B\ Z)!;Z9#$;Z,Z86^RR+>RAXU8
M!2@;.=F !CVH XN;4=2USPKX0EN[IA?#Q.UO]H**6&PW" D#Y2V%'MGM4GB"
MZU:ST7Q]X>U#49=3M[?2!=VUS,B+(@D60%'V  \ID' XKLH_ NAPZ:MC#'<Q
MQ1WAOH66Y?=#,2QW(2>/O-QTY.<U:G\*Z;=:7J%C<":1=1&V\E:0^9,,8P6'
M08XP, <XZT 8,FHZEJ&LCP_83FV\C2(+D,DHC=F<LN1E&R%V#CCEN<UTNA+J
MK^';:/6;BW;5!&8[B:S.4+@D;ER.O'(Q@'(Q5#5/!&DZL]C-,][#=V,?E0W=
MK=/#-Y?="ZD$CZ_U-;MI:06-I%:VR;(8EVJN2>/<GDGW/)H \M\-ZO?:5X%\
M/QKJ%P\VL:U+9-/-M8P@SS%F4D<LVW'S9Y.>V*ZS3-0U"S^(%[X=N+B2[LVT
M]+^WEE WPG>8VC) &X$C(SSU'-65\#:$NE3Z8()C:RS_ &E5-PY\B3>7#1'/
MR$,2>,=:T[#1[>PN)KH-+/=SJJ27$[;G95SM7L !D\ #DD]30!S.IPSR?%W1
ME6_NHXO[+N7\I"NSB2+(P0>N>3UX&"*Y:UNM3TCP_JFLV6IS1+!XJFC:T6-#
M'*DEX$8.2"V<,<$$8Q7I=_X?L-1U:RU.83+=V:ND;Q3,F5;!*L ?F7*J<'TK
M/;P/I#Z5<::QNS:W%W]MD7SSEIM^_=GK]X XZ9% &)/?^)?$!UQ]"O(+6XT[
M4&M85EE B'E[2WFKY;$A@3SD8!&,8)/9WS%]&N6.W)MV)VG(^Z>AK&NO FBW
M>MR:LXNX[B<*+I(;IXX[K:,#S44@/QZ]>^:W[NV6\LY;9W=$E4HQC.&P>N#V
MH \8\G6YOV>[-5^QMI8L%>[50RS_ &=3N?83E=V!W'ZUU6J:Y-/IRS:+J-RE
MN-!%Y;6L"+YL1()265GXVX  7.2=W!QQMIX!T1=&BT9S?2:7$ JV;WDGEE0<
M@$ C(]CQ5F^\&Z-?Z@;V2*:-WM/L<B03O$DL(SA652 0,G'UQTH YN/5M:U7
M5?!T2ZM+:1:OH\ES=+#%&<2!(CN0LIP<N>N1[=ZQ-0UF_F\(:-/?--J-SI_B
MO[.&1%$MP(I9%7@8&X@ =N:[ZS\':783:7-;M=A]+@:WM2T[/M1@ 0<YSD*O
M7I@8Q42^!M(6WB@#78CBOSJ2#SSQ<$EM_P"9)QTYZ4 2^$KYM9TA-9_M)KJ.
M]S(L("A+;_IF/E#$J1@EN<YX'0<_XUUG4[%?$$NGZG+YFG::MS%!:QIBW<!V
M+S%^&#8 "CG )QWKJ]+\/6.C7U_=V7G1M?2F>>/S"8S(>K!>BD]\8SWS5+4O
M!.C:M>ZA=7*7(;4+<6]VD5RZ),H! +*#@D D T 8=W<ZWJWC.TTNVUVXT^WN
MM#-X1##&QCE$B#*[E/KWSQG&,Y$=KJ'B?7[%M6TJ^MX#;ZC+$\=Q,%B\F*5D
M9'41DABJ[L[N">PXKI[3PKIUEJEKJ,+W7VBUM?L<9>=G'E9!*G/7) .3S58>
M!=$37IM6C2ZBDN)1-/;QW3K;S2#^-X@=K'H>1UYH N>*)M4M_#]Q+HT1FO5:
M,K&K*K.F]=ZJ6X#%-V,]\5Q\/C)I[*WAL+V[,][K*V+Q:@@AGL<PE_*;*D9)
M0X)#??ZG%=[J6G0ZK9FUG>5%WI(&AD*,K(P92"/<"LJ]\%Z-J>GWMI?PR7)O
M94FGG=\2F1  C!EQM*@ #&._J<@'&^+[?Q%:^#];CU+5/W"WEF]GY,P:81/*
MBNDIV+E<YQZ]#G%=[K%^_A_POJ&H$R7;V-I)/\^-TA12V#@ =NPJG_PA>DMX
M?N=&G-Y<PW)4S37%T\DS%2"I\PG(VD @#@?B:VHK.&*R%H0TL.PHPF8R%P>N
MXMDG/?- '#3:OJ^FV?A#5AJ,EY'K%Q!;7D#(NS]\A(DCP,KM(Z9.1UR>:HW'
MB+6XO VL7ZZG+]KLO$#6<<ICCR8?M21;2-N#\K'G&:['3O"6F:9]D2'[0\%D
MQ:S@FE+I;$@CY >> 2!DG ) Q5.[^'^A7OV])A>>1?7 NI8$NG6,2AE8NJ@\
M$E1DCWQC- %+0H9V^*?BMGO[IXXH;+;$Q4IAEE.WID ')&".2<YKMJRHO#NG
MP:\^M1B=;R2%(9/W[[9 @(4LN<,0&(R?6M6@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ KF-2\1S:9XWM-.NI[.'2I=/FNI)9?D9&1XU
MY<MC;\_I73UPGB1;"/XEZ%<ZNENMB-.NHQ+=*/*$I>(@9;@,0&Q^- '9?VC9
M&Q%]]LM_L94,+CS5\L@]#NSC%8'BOQ+)IWA0:SHEQ97*?:((]_\ K497E6,[
M2K 9&[WZ5P20S>&;6TU-DN[7PROB"ZN$^SQ9-M \>V.0(5.(]^\]. X([5=U
M]-&C^'VJW>CS7$MOJ&JVMP9YOE$\GGQ%V1<#C"\D#'!]* /3KS4[#3MGVZ^M
MK;?]WSY53=],GGJ*5]1L8KI;:2\MTN'7>L32J'*^H&<XX/-<5!>VMEX\\3IX
M@DA2SU"UMS8RSD>7- $(DC4G@D,6)7J=V<5C6NFZIH'@/PAKL]M<3:CHTFV6
M#&96M)F*>7@_Q*K1'!Z%* /2EUC2WM3<IJ5FUN&V&43J4#>F<XS[5/%=6\\T
MT,-Q%)+ P65$<%HR1D!@.AQSS7GWAK2]3L/$EYX=O8=UB9TUOS%'[L,^2T(^
MDZEQ[+S74>;;W<FMV_AR2SM=9CEC6ZFELV9=^U2-^-N_Y. 0W''TH WZ*H:1
M#JL-D4UB[M;JZWDB2V@,*[>,#:6;GKSFK] !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Q_C?7;RTO] \/Z;,;>
M[UNZ,1N% +0PH-TA7/&[! &>F<UV%<EXV\.WNJ3:-K.D"-M5T6Y,\,4K;5G1
MAB2/=_"2 ,'U% %R\\, 6L?]FZAJ%M<QRQR;WO99!*%<,5<,QR& (SUY_"A_
M&%C';:[,UK=_\2,_Z8FU-P&P297YL$;3GKFK%KJVHWZHBZ)>64A(WO>-'MC]
M?N.2Q],<>I%<?JVD:[%<^/+2UT:6ZCURWWVMRLT:Q@_9A&4;+;@V1Q@$'(R1
MR: .@O?'>GV=S:VR6&J75Q=V1OH(K:VWM(@VD@<C+88<?K20>.[*ZU:738-*
MUB2Y@F@BG M.(/-7<K/S\J@'D_SP<9FFZ7K,?BKPO>3:1-';V>C/9W,GG1$1
MR-Y?8/DCY#R >HJ[HVEZ@OC#Q?/=6,UO9:D8/L]P9(SN"0^6W 8D<],B@"XW
MC;34N-.62&Z2TU*7R;.]*J89G()4##;AN .TE0#V[52;XD:2EM-=FPU06EM>
MFRN;@VX"6[APF6RV<;B!P"1W XK(\'Z7K&EV]CH>H>$;)9=.*QC6 8C'+&A^
M5U'W_,( '/0\D]JJ7GAWQ!/X \5:8FBS_;-0UB6ZMHS/#\T;3*X.=^!PIX/-
M ';ZKXHM=+:^5;6[O&L(1/=BU53Y"$$C.YADX!.U<G';D9;:>+;"]UVUTF&&
MZWW=D+ZWG9 L<D7'().<_,,C&1GTYK 6/Q%X?\::O?6FA2ZGI^M"&8;+B.-[
M69(PA5]S<J0 <KG&.]6?&^GZB^DZ1JMG+ GB#3[J+R&P?+D:4B.2/UVD-G_@
M(H Z?3-3CU2.>2*&:-(IY(,R!?G9&*L5P3QD$?A5VJNF6,>F:9;6,1+)!&$W
M-U8CJQ]R>3[FK5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5PU
MIJ$_BWQYK>FM<3PZ1H8BB,4$K1&XG<%B692&VJ!C;G!)R<UW-<.ND:GX7\<:
MKK6GV$FHZ7K*QM=0P.@FMYD!4.H8@,K \X.<]J +FLZ'+96FIW-MJ-\MG_9D
MZ^0;N0F.48971L[AP".N.F.IS1\&>+8/[&\*:3=V]^L]]IT7DW<T?[J:1(0S
MKN)W9P"<D8.#@FMO49=2U/0]22+3)HA):21Q02L@EE=EP/XMJCZG)SVQSS%M
MHFMQVOP[C;2)PVCJ%OOWT/[K_1S%_?\ F^8YXSQ^5 '0Q^-M-DN;51!=BVN[
MY]/AO"B^4\ZE@5^]N'*, 2N./I26WC>RO-8GTVVT[599+>[%I<2+;?)"Q7<&
M<YX7!ZX_"N/N-)\57PTFXO\ 0II]3L-=6YGG-U%Y;P!GV^2N[Y5"LF00I.,_
M,<XZ?PS9WVGZUXKNM2L6M+2\O!<Q2RRQE601(ASM8D?=)Y XH E/C[2Q!IUR
MMK?O::E,8+.X2)669QG  #;AD*Q&0,@5/JWC33M'AN;F>"ZDL;280W5Y$JF.
M!B0#D%@Q +#)53C\#C@]#\_3]*T9M5\,:V-)TV5KVV\J:WE@@!W;7X82,J*Y
MP#SZ@X &K:Z/J^CZ[J]B_A.TU>VOKV6[M-2=H@L0E.XI*&^;"DGH#D=* .C\
M1:_;MI^L65I#?74MM:%[B2Q8*8-REE^;<IW8^;"Y.,<<C,O@*22?X>^'I9I'
MDD?3H&9V8EF)09)/K7/1:;KNA:QXHMH])EU"RUG_ $BVN;>2-1%(8@C)(K,"
M -HP1GBND\$V=YIO@?1K"_M6M[NULXX9(BZMAE4#JI([>M ',^%K%M6\2>,(
M+S4=6>.TU 16X74YU$2F,-@ /CJ3US4N@>)KK1?$?B'PYK]^UU#ID*7MM>R*
M/,:!OX7VCYF!P 0,M3_#D&MZ-KWBF[G\.7SQ:C?">W,<]M\RA O.91CD50O/
M 6KZU8^*-4OI+:'6]7CB2U@5M\=M'$P9$9L?,6*C<<8]* .GE\;6%K>W-E?6
M=]:74-FUZL4D:N9HE.&*;&8$CN#@]\8JM9?$72;R\TF$VFI6T.K(IL[NXM]L
M,CLNX1[L_>Q[8)'!-9L/V^Y\/ZG->>#[;09(M/G65]T3M(^P\1E.=O4Y..PP
M>2*>CZ==^)?!G@*U^PRV\-A]BOI;B5DV[8HLJ$P226)'88&<X/! .IO/&NG6
M5O<WKP7<FFVLYM[B_C13%$P.ULC=N(4\$A2!SZ'$]YXHM;6:[CAMKJ]^QQ)+
M<-;!&$:N"5X+ G@9X!XKD;;P_K=CX*U[P:=/>?[4]REG?>8GE&*<L=SY.X,I
M<Y&#G QFDU[PE=L2=(LKZUUJPMH8--U:UG15G54 V3J6Y4-G.5Z=,]" =,=2
MT]?&][;PV^H2ZO#IBR&,-MBDBWG;L#,%W%LC/'3K4G@GQ#<>*/#%KJUQ9/;&
MX!=02I4J6.,8)/ P.0/I5.#3M3'Q0EU26R?["VC1V?VD.FTRK*SG"[MV,,.U
M+\.;#4M'\%V.DZI8-:SV2F$DR(XD^8G<NTGY<$=<'KQZ@'/^(-6U#PS\3;?4
MC>W+:!(D%M?6\DS-'"\[2!)0"<* T:@X['WI_P 7]:U*R\.2V^D7DUI-!Y5Q
M=3P.4=8VE6-4!'(+$L<^D;#O6WJF@OXAOO$6GW^GS1Z=J%C#;)<,T9!9#*=P
M 8L,%U(R!R*YG5_"GB6?X43Z;/;G4O$=ZUN;AHY8U4")TP-SL/X$SQU9F/>@
M#MM0\16FBW)TU+:]O+B&S:\>.$AV2$'&XM(PR20<#)/%5KKQWI5NNC-'!?70
MUF$S67V>#=O 3?CDC!([>_.!DUG:_;Z_J.NO"=)GN=(GTXI#&+B-%BN26R9Q
MNRPQMQC<!SQGD9>D:+K\$?P\$^B3I_8T,D=YB>$^7F#R@?O\\\\9X]^* .I_
MX3*T9&\O3]1>XBLEO;BU\I5EMXVS@.K,/F.UOE&3Q],T;KQ-H>JP^&KUX]2\
MJ^OD^P/&&C5I"C%2_(RI7<<'/3I63X@%^OC?4Y])TG4+I)+"*UNY=.G@#%B6
M(#K*1AE4@@CL_/:EFLY=0TCPA#H>@WL-MH^JQF>VF>-7MTCC="#E_F/S@Y!.
M?K0!LWOQ!TZS?6$&G:K.=(8?;/*MQB-2N_?RPX"\^OH#S746]Q%=VL5S X>&
M9!(C#NI&0?RK@I]&UEW^(9729R-8B"6/[V']Z1;"+^_\OS#/../RKK_#D%Q:
M^&=+MKJ!H+B&TBBDC9E)5E4 C*D@].QH TZ*** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ K-U+P_HVL2I+J6E6=Y(B[5:
MX@5RH] 2*TJ* ,#_ (0?PI_T+>E?^ B?X4?\(/X4_P"A;TK_ ,!$_P *WZ*
M,#_A!_"G_0MZ5_X")_A1_P (/X4_Z%O2O_ 1/\*WZ* ,#_A!_"G_ $+>E?\
M@(G^%'_"#^%/^A;TK_P$3_"M^B@# _X0?PI_T+>E?^ B?X55'PW\'#4FO_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %9V
MHZ!HVL21R:GI-C>O']QKFW20K]"P.*T:* ,R\\-Z'J$T4U[HVGW,L( B>:V1
MV0#I@D<=!THN_#>AW]W'=WFC:?<7,>-DTULCNN.F"1D8K3HH RQX:T(:@^H#
M1=.^VOG?<?94\QLC!RV,GBH(_!OA>%R\7AS2$8G)*V48)/\ WS6W10 BJJ*%
M4 *!@ #  I:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "JLVG65Q<+/-:0R2C;AV0$_*<K^1)(]#TJU10!%):P33PSR1J\D))C
M)YVDC!(]\<9]"?4U'>6%M?HBW,0<(2RG)!4D$'!'(R"1]"15FB@".""&UMX[
M>WB2*&-0B1QJ%55'0 #H*DHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH *BN+F"SMWN+J>."%!EY)7"JH]R>!4M<;\5=;&@
M?#76;D-B66'[-%Z[I/DX^@)/X4 ='::WI.H02SV6J65S%%_K)(;A'5/J0>*8
M_B'14TTZDVKV L VW[3]I3R]WINSC/M7,^$=/?P;\)+&".,"\2S\S81]ZXDY
M"GWWL%_*N=^)OA_4-,T?PSJ^A0K>0>%91)-9?WU 3YR!W 7GN-Q- 'I5IKVC
MWX<V>JV5P$4N_E3JVU1U)P>!]:BM_$^@7DZP6VN:9/,QPL<5W&S$^@ -<SI_
MB/P_/X7U7XC:;&%>:P'GA@ VZ$.0C?[66VY[@+7GFCZ%:V?[->KZAJL:-/J'
MF7P=Q\RR%@L1![9(!_X$?6@#WZBN2^&-W?WWPUT&XU)G>Z>VY>3[S*&(0GUR
MH4Y[UUM !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!4-U>6UE%YMU<101E@H:1PH)/0<]ZFKB[29]9^*FIF8_Z)X?M(HHD/3SYUWL
M_P!1&%7V#'UH ZMM1L4LTO&O(!;/C9-Y@V-G@8/0Y[5-#-%<0I-!(DD3C*NC
M9##U!%>7^$;34=6TW2?$4,)N;6.]U.[M[0N$&Z65O*?GC !D]QOR :U]-/\
M97ANTTJYOR;9)3%=7<(.Z[N)'+-#!CG&YF!8= ,#!!*@'<07$-S'YD$J2)N*
M[D.1D'!'X$$5)5/2[JRNK%38!5@A9H/+5=OELA*E,=L$$?A5R@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ME(*VZX*PKV&?XF]3T].F2 7:*** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH *\T^,G@W4_$^C:=?Z+'YVHZ3.9D@S@R*<9 ]P54X[
M\]Z]+HH YNR\96U_8QO!IVJ?;W49L7LI(W1_[K,RA5 /\1./>I#+%/XON+6:
MUG>.73UC9GMG,+?,^5WE=IX/3/>N@HH \I\*> KWP3\4Y18-*_AF\MI9H8\Y
M6";* H?3CH>X'?;5;X\Z3=ZIIFBOI6F7MWJ5M>;P]I;2.T<94Y^91Q\P7WXK
MU^B@"&T\G['"+:,QP*H6-/+*;5' &T@$?2IJ** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "N.\5M)J/BCPSI(MKM[2.]^VW4R6[
MM&IC0F)2X&WERIZ_PUV-% '->)_$K:1)#90V>J223J6:XM-/EN%A7I_"I!<]
M@>G4]@;&G3Z?%X52;^SKF"S8'%M<PDS2$L>60\EG)SSR2W/.:W:* ..UFSU2
MT\-7FI6D*1:FD6RR@B0,EBK$!F '#.%)8GVP..MCPPMS_;6KF)IVT:-((+5Y
MG9C/(H8RR@GD@[D&[H2I-=310 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M*,-$T;%75@,\@J1QG/;-:%M,UQ:Q3-#)"TB!C%)C<F>QQGF@"6BBB@ HHHH
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MN1MFG-U*WF#C@@MC'RCMVH J>#_#FD_#OP[:Z&NH(6FF)$EPZHT\K8SM7/H
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MD #C% 'F7PZ_Y-OU_P#Z][__ -%FK_P?M=:E\&>%7$]O)H>^[$UNL)$FXM*
M68L0RYSQ@<D=:[ZP\!^'M,\/7.@V=K/#IESN$MN+N7#!AAADMD CK@U?\/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **"0.IQ10 4444 %%%% !129'J.*4D 9)P* "BD!! ((P>E+0 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%&: "BBC(QG/% !110"#TH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\K^/Z*OPY^T*H$R7D060
M<,H.<@&O5*X?XI^%-5\:>$QH^EFU21ITE:2YE90 N>!A3GK0!Q'Q"$G@CPGX
M9\6^'6^PWBO##<Q0_+%=*T9;]X@X;E>O7GV%0?$R_LT^(W@35)8&%M<(MQ<1
MI&7:1=RL 5 RQP>E==KG@+5_&5CH6DZW)9V>D:<4DGCM9FEDN75=H&2BA%P6
MYY/-+XO\$ZUK7C[PSK>GI8)9:,P+1RSLKN-P.  A P!ZT 6/#%SHGQ,,/B:1
M(9H[.1XK:S91F YZR_WF(P0/NC/&3S7"^,]3T_PY^T#9:C>0.UE!IC7,T4,6
M\NX27#;1P3D#D],9)&,UTT/@#Q!X:^)5QK_A,Z=%H]Z!]LT^>=T#L>6*@(0N
M#R/0DCH<5:O_  3K=]\8+'Q<T6GG3H+4VLD#SL7<%74G&S'\?3/:@#4\*1:3
MXQ%MXUD%O<W,L>R!%7Y;4 \J<\M(#U8_\! '7M:\M\+^!/$G@GQMJ4^AM8-X
M6O9-WV":Y</'Q]Y?D(!!R,9Y& 3D CI/!EWXGFU'7K;Q%/97,=O<J+6:T7"@
M'),9X'*C9Z_>QDT <7\0M;N?"GQ"AU?7]";5_"\MFL$9V"1;63=ECM;Y=Q]\
M9& #P15C6Y=!U#X*^(]0T&Z^U6,FZ>'?DO;/A 4^;E2,<#L" .,5V\MMKL6M
M:FS6UGJ&CW839;O+MD0A K<%2I4XZ9'0GG-<E'\-;VQ\ >)=&T]+**ZURX>8
M0>:P@M58C:@.TDX ]!^0H QOA_9:#XD\,:+HSZ;LU)-/-Z]^;5HW#K* A60@
M>8.N<$C@#-0_%B6TT_XK>#;JXB)MR2]RL<1<RA7!Y4#+?3FNKT70/%^@>"+'
M2+*ST;^U+2V>VCOGO9"J!FR6"^5ST7C/44SQ;X)US6O'WAG7++[&;31B"XGN
M&$DOS G&$([=S0!8\,7.B?$LP^)Y$AG2T=XK:S91F YZR_WF(P0/NC/&3S71
M^,8-5N?!VK0:&Y34WMG%N5;:V['0'L<9 /KBN(@\ >(/#/Q*N-?\)G3HM'O0
M#>:?/.Z!V/WBH"$+@\CTR1T.*T';QU>Z[XBTT7FF^2!#/ITB XMCY@(20@<D
MJ"2.?P#"@#D_!/BOPQK%WI6AWVF-X<\2V,T0VF/RQ<NI&48\$EN3M?\ B(()
M-7/#=ZWQ#^+7B)-8'GZ3H1,%I82<Q;PY7S&7HS?*QYSC(]*Z;Q%X/NO&&HZ)
M/J.G65E-IUVES+>PS>8[JG/EI\H."<'+8QC@&FQ>";[PWX^OO$_A[R)[?5%(
MO[":0QD/G/F1M@C.<G!QU//3 !K)X>T*W\26>H:?-;6CQ"2*6SA<+%*6& 3&
M#C>.F<9()![5YOX$T73=6^*?C^POK.*:VBF(B1A_JLNWW#_"?<8KJ]/\$:G)
M\6I_&MW'9V\!MO)CM0^^0MM"[B=H Z>IJMX;\'^*O#OC7Q/KR0:3,NKN7AC:
M\D7ROF)&[$1SU[4 5O@_XAU.76/$WA34;N:]71KIDMKB9MS[ [)M9N_W01]3
M[5ZQ7&^ ? B^#HM1NKJ[%[J^J3F>\N%3:N<D[5'H"S?7-=E0 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 5YS\5-,T./0;C4K^*Y%^S(MOJ,<4LAL""/GW(/D4?>/3/O7HU<]
MJD>OZBNIZ7]@T];&YB,,5TURS$*RX8M'LY(R>-V#ZB@":^OGN8+73],N=]Q>
M1!_M28/E0X&9?3)SA?4G." :X+PW97=U\+O"HACDN+2'56DOH@#(TD(GFZCD
MOABC$<YQ78R?#_PW<PV:75@9WM+6.TCD,SJWEQC"@[2 >I_.HO /A,>#/"RV
M;11M>EI'F,,C,LAWL4 W8Q\I [<_G0!GZ&U]8>&QI,LC63S3W,ZM(=IL;#S6
M*DY^Z=I 4'IZ80BNNTF?3I;!(]+EA>V@ B58FR$P!A3Z<$'GL0>]8.L>%[O6
M/!NKV3S1IJVJ19DD).Q6'W8\]=@ V].<L<9)JUX?TN]M]<UW5[R,6XU*2$QV
MV\,4$<80DD<9)ST[ ?0 '14444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4BJJ+M50H'8#%+10 4444 %%%%
M !2*JKG:H&3DX'4TM% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 9?B.\N=.\-:G?V
M;1K<6MK).GFH64E5+8(!'''K3?#%[=ZGX7TS4;YXFN+NUBN'\I"BJ70-@ DG
MC/K3/%JR2>#]9ABBEFEELIHXXXHR[,S(0  !ZFL?PYK3V/A'0]._LO5#?QVE
MO;-$]A,BQN%526<J%"@Y).>@XS0!L6>K6WGZM+)K5I<V]O.J;(U ^RG:H\MF
M!.YB>>Q^8#%0:GXRT?3+2&X>XWB6]BL=JJ0RR.R@AACY<!@QS_,BN8FT[[1/
MXV2]L-5%M=ZC:20R6L+K+A5A7S8SMY*.I;@'[O0U6NK7Q"^A#[;%<:DMCX@L
M[B.Z2S,=Q<P(T99VB R67E<@<A<XH ],^T0BV^TF15AV;S(QP N,Y)/08JE;
M:[I=VTRP7L3O#&)9$Z,$/1\'DJ<'!'!K*\<Z?J&N> M1M-,C87DT2.D+D*7P
MRLT9[98 KZ<U2*2:WXTT/7;:TO+6"QLKD79N+9XF;S-FV+# %B"K-QD<#U%
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M*\HT],PDQ2[I7(/.2Q!SW:I[G2-0T[2?&VB06<\\VMW$T]C(D;&,_:(U1MS
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MYU4%@#TZ?7%4?".C#1;&^6. VUM=7TMU!:D8\A&Q\N!P,D%L=MV* .AHHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MN9?Q%):^+[^TNYX%TJ#2X;U75#N!:1U.2"<CY1C '6NB%Q%]F^T,VR(+O+2
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MS=(TD5K'N\M>KL2 JCZL0/QH U:*Y/6=8UOPWX?.NZ@;2>&W"R7MI#$RE$)
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MQ_:TM'N8OW32J  <,P7HN>Y('OQ0!NT50T.[EO\ P_IMY.09KBUBE?:,#<R
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M!!!!H MT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MGM2DD1S(\LBR-)D-Q\R],=SS0!)I/C:VU:XTA4T^\AM]6A:2UGEV ,RKN9"
MQ((&>2,'!]B>HKCM*\&7>FQ>%XSJ,,BZ&)5)%N09PZ%?[WRX!]Z[&@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
4B@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>exhibit1033-bochk_facili006.jpg
<TEXT>
begin 644 exhibit1033-bochk_facili006.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MY)4MU^7.2/:O7K;Q9HU[JRZ99W,ES<')S#!(\8QUS(%V#\Z -NBBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MP"15Q(9-I?)P>G;..>E<SX?\9>(KOPCX$:XO9<ZWJ$T-_J!4;E"R,$C'&%+
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MP$A<E<;_ # -P&,#C(QT]JVY]1U&'P1J^I/>75K?1Z3-/;Q22JY<I"KB=?\
M@38(Z= 17:?V5IWV'[#]@M?LG7R/)7R_^^<8IBZ+I2*ZKIED Z>6X$"_,G]T
M\<CVH \ZTOQ-KD%W\/0EY)??V[9[]0MY%5BN(U;SE(&5P2<CH>@ ->IU6M=.
ML;'/V2SM[?("GR8E3@=N!5F@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KGAJ-\/B&=+
M:=38-I9N5B$8!#B4+DMU/'TKH:P3I-\?':ZSBW^Q#3S:8\QO,W&0/G;MQCC'
M6@#>HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBL/4-+UVYO9);+Q']CMVQM@^Q1R;>!GYB<G)R?QH W*1E5U*LH93P01D
M&N;_ +$\3_\ 0W?^4V+_ !H_L3Q/_P!#=_Y38O\ &@"_+X7\/SOOFT+3)'_O
M/:1D_J*N6FFV.GKMLK*VMAC&(8E3^0K$_L3Q/_T-W_E-B_QH_L3Q/_T-W_E-
MB_QH Z6BN:_L3Q/_ -#=_P"4V+_&C^Q/$_\ T-W_ )38O\: .EHKFO[$\3_]
M#=_Y38O\:/[$\3_]#=_Y38O\: .EHKFO[$\3_P#0W?\ E-B_QH_L3Q/_ -#=
M_P"4V+_&@#I:*YK^Q/$__0W?^4V+_&C^Q/$__0W?^4V+_&@#I:*YK^Q/$_\
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M_L3Q/_T-W_E-B_QH Z6BN:_L3Q/_ -#=_P"4V+_&C^Q/$_\ T-W_ )38O\:
M.EHKFO[$\3_]#=_Y38O\:/[$\3_]#=_Y38O\: .EHKFO[$\3_P#0W?\ E-B_
MQH_L3Q/_ -#=_P"4V+_&@#I:*YK^Q/$__0W?^4V+_&C^Q/$__0W?^4V+_&@#
MI:*YK^Q/$_\ T-W_ )38O\:/[$\3_P#0W?\ E-B_QH Z6BN:_L3Q/_T-W_E-
MB_QH_L3Q/_T-W_E-B_QH Z6BN:_L3Q/_ -#=_P"4V+_&C^Q/$_\ T-W_ )38
MO\: .EHKFO[$\3_]#=_Y38O\:/[$\3_]#=_Y38O\: .EHKFO[$\3_P#0W?\
ME-B_QH_L3Q/_ -#=_P"4V+_&@#I:*YK^Q/$__0W?^4V+_&C^Q/$__0W?^4V+
M_&@#I:*YK^Q/$_\ T-W_ )38O\:/[$\3_P#0W?\ E-B_QH Z6BN:_L3Q/_T-
MW_E-B_QH_L3Q/_T-W_E-B_QH Z6BN:_L3Q/_ -#=_P"4V+_&C^Q/$_\ T-W_
M )38O\: .EHKFO[$\3_]#=_Y38O\:/[$\3_]#=_Y38O\: .EHKFO[$\3_P#0
MW?\ E-B_QH_L3Q/_ -#=_P"4V+_&@#I:*YK^Q/$__0W?^4V+_&C^Q/$__0W?
M^4V+_&@#I:*YK^Q/$_\ T-W_ )38O\:/[$\3_P#0W?\ E-B_QH Z6BN:_L3Q
M/_T-W_E-B_QH_L3Q/_T-W_E-B_QH Z6BN:_L3Q/_ -#=_P"4V+_&C^Q/$_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M3?JM\FH:D\:1S72P^7O5 0HQD]RQ^K&DM_#EG:ZE?W$2(;?4'$US:R1AD:8
M#S!Z$@#/7. >#G(!XZ]XUWK/A;2=8O[:UTJ[\)1K:S7J[H1<,@#.#N4"0 <$
MGCCUIWBF'4=#N+35VO;?Q/8VVGV]G?Q2+LN$5FPD\.22"Q(Y!.3UR.GMTFF:
M?-#%#+8VSQ1'=&C0J50^H&.*?+86<]PD\UI!)-&<I(\8+*?4$C(H X+5FE'Q
MZ\.?9\C=I$XN<?\ //)*Y_X'BO1:R[/0X;?6[O69G\^_N$6$2%<"*%22L:CL
M,DDGN3Z8 U* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M(?\ P;S_ /Q5=#10!SW_  B$'_09\0_^#>?_ .*H_P"$0@_Z#/B'_P &\_\
M\570T4 <]_PB$'_09\0_^#>?_P"*H_X1"#_H,^(?_!O/_P#%5T!(52S$ #DD
M]JA@O+6Z#&WN89@GWC&X;'UQ0!B_\(A!_P!!GQ#_ .#>?_XJC_A$(/\ H,^(
M?_!O/_\ %5MP7=M=!C;W$4P4X8QN&Q]<5-0!SW_"(0?]!GQ#_P"#>?\ ^*H_
MX1"#_H,^(?\ P;S_ /Q5;DES!#)%'+-&DDI*QJS %R!G '>I: .>_P"$0@_Z
M#/B'_P &\_\ \51_PB$'_09\0_\ @WG_ /BJZ&B@#GO^$0@_Z#/B'_P;S_\
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M:* .>_X1"#_H,^(?_!O/_P#%4?\ "(0?]!GQ#_X-Y_\ XJNAHH Y[_A$(/\
MH,^(?_!O/_\ %4?\(A!_T&?$/_@WG_\ BJZ&H;>\MKOS?LUQ%-Y3F.3RW#;'
M !VG'0X(X]Z ,3_A$(/^@SXA_P#!O/\ _%4?\(A!_P!!GQ#_ .#>?_XJNAJO
M=ZA96 4WEW;VX<X4S2!,_3)H QO^$0@_Z#/B'_P;S_\ Q5'_  B$'_09\0_^
M#>?_ .*K>CECE&8W5QZJ<]L_R(I] '/?\(A!_P!!GQ#_ .#>?_XJC_A$(/\
MH,^(?_!O/_\ %5T-0_;+;[9]C^T0_:MAD\G>-^P$#=MZXR1S[T 8G_"(0?\
M09\0_P#@WG_^*H_X1"#_ *#/B'_P;S__ !5;EK=6][;)<VD\4\#C*2Q.&5OH
M1P:2*ZMYIYH(IXGF@($L:N"T9(R P[9'/- &)_PB$'_09\0_^#>?_P"*H_X1
M"#_H,^(?_!O/_P#%5T-% '/?\(A!_P!!GQ#_ .#>?_XJC_A$(/\ H,^(?_!O
M/_\ %5T-% '/?\(A!_T&?$/_ (-Y_P#XJC_A$(/^@SXA_P#!O/\ _%5LWE_9
MZ= 9[Z[@MH1_RTGD"+^9J:.1)8UDC=71P&5E.00>A!H P/\ A$(/^@SXA_\
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M,^(?_!O/_P#%5T-% '/?\(A!_P!!GQ#_ .#>?_XJC_A$(/\ H,^(?_!O/_\
M%5T-% '/?\(A!_T&?$/_ (-Y_P#XJC_A$(/^@SXA_P#!O/\ _%5MR7EM#<PV
M\MQ$D\Y(BB9P&DP,G:.IP 3Q4U '/?\ "(0?]!GQ#_X-Y_\ XJC_ (1"#_H,
M^(?_  ;S_P#Q5;4]]:6KJEQ=00LPR!)(%)_.I@00"""#T(H Y_\ X1"#_H,^
M(?\ P;S_ /Q5'_"(0?\ 09\0_P#@WG_^*KH:* .>_P"$0@_Z#/B'_P &\_\
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M>X0M(2</@G(7"MQGMUYXAUO0[NP\?^ ;.SEN?*TVTE@:]6WW+&!'M3?QMYP
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M[RXEENM>(-W<(H3:%^X$7G 'OG/<T <I->S07/PQ74[6PU"6Z \F=DD1[?\
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M !1110!Q_@K_ ) $_P#V$]0_]*YJZ*N=\%?\@"?_ +">H?\ I7-714 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %9?B+5VT#P_>ZL+<7
M"VD33/'YFPE5&3@X/-:E<S\171/ASXA+L%!L)0,G&25.!0!=LM4U2X:PDETF
M);6[&3+%=%S$"A8%E*#@X X/4BMFN6T:QCLM%M]6_M"]N8AI@!C\S?@;5;*8
M[\8_+TKB-%U&WCUC19M%N+19+O0;D11I('D>4>6T:S/T>7))/ ();KUH ]@K
MG=1\0:AI5II4EYID*RWNHI9.B7.X1!W(5P=OS< ''&,US_@Z?PSJT.AW=O<;
MM;CM&CO(TDQ+N*CS3<+U/S#@MW/'6L2PG@7X?^% )DVCQ. "7_Z>Y?Z8H ].
MDOI;26_FOHX;?3K:-9$N3-DL,$ON7'R@8'<YS5R*59X8Y4Y1U#+GT/->7>((
M;::?XGPA(Y3_ &5!)Y9^;#B*4Y [$'!J_J46G:9I>@>,=)@@D@TT!+H6J A[
M=QM=@%ZLC'=^##N: .YU/4H=,MTDD!>261888EZR2,<!1_,GL 3VI8Y;XZ@(
MI+6);7R QF6;)\W/*;<=,8.[/X5PT]A+8^)?!,D\(B^U7MY<W2@<"X>!V53Z
M[064?2I-8>>'Q_K9TPYU$^&6>%%.291(^WCUX7]* /0*@O)I;>U>:& W#(-Q
MB4X9@.H7U/H.,^HKS'3&\.:E8#5+#Q$UO=#29X[Q;5%62)3'\SS@?-N1AD$\
MDGOFM_P4\]OK&H:=>6-@ETEK!)]MTWB"YBRX0E?X'^]D<Y&,< 4 =?97MOJ-
MC!>VDHEMYT$D;KT92,@U/7(?#02#P:F[/D_;+KR,_P#//SWV_AZ>U1^-8KB3
M4;&2SDTZXN(;>=SIFH\1W,>4W%6_A=<  X(PQZ#- '9U7-];?VB-/\U3=&(S
M>6.H0$#)].3^A]*\K;4-'U.X6RUZY72=.N]&MGTU;]5^5"K;]KMP) 2O(Y.%
M/:MC3;;3K3XE6 N"LD[Z!"(9[Q%$\TBR$;CQDOMQGN* /1**J:JUVFCWK6"[
MKQ;>0P ]Y-IV_KBO.;'[/<Z5X'OM(*_VO+<117Y'^MDC\MOM(F[G##)W=&QW
M- 'J-5[>^MKN>ZA@E622UD$4P7^!BH;!]\,#^->2/?:?:^'%M)+B".YM/%N3
M$6 :&/[9UQ_"NTCGI@BNK\&1Z;!XK\7111VL=[_:.]515$GE-#$<\<[2W/H3
M0!V%_?6VF6%Q?7DJQ6UO&9)';HJ@9-9SZY)'XQ@T(VJ^7-8R7:W'F<_(Z+MV
MX_V\YSVK+^)\"3_#770\2R;+8NH9<[2.<CW'K65<6VA:I\0M)M42RGTUM%N2
ML,97R7'G1?PC@CJ?3(SVH ]"HKQK1M5MH]&\*PZS>PQ:));WD"S7*K) )EFP
MBN6^4?NPP4GWKTGPA:6MCX;M[>QOI[VS0OY$\Q!W)N)&TCJ@Z*?0#'&* -2:
M^MK>\MK2255N+DMY4?=MHRQ^@'?W'K5BN(\4Q:<GQ$\)W%]%:A6CNX_,F5>6
M"H47)ZG.<#USBL#1Y-,U>\MQJ6K&V\36>JN9+:-%6Z<^8WRY/S-"4(SCY0H[
M8H ]6HKR&WTG1Y? 7C+4C'&]W:RZK%#-YI)C7<Q51STX4@5H0:5HY\6>%XO)
M@:/4-&F-VA;(N=HA*>8,_/C+8SG]* /3J*\FTF.2Z\*Z7;:=>Z>9[74;Y;:R
MO_G@N(TE=1&3U!"D%3S@#IBN]\'W45[X3T^>&R:RC:,@6[-N\O#$8#=UXX/<
M8- &Y17FWCVZTV74]5LIVA6\CT-Y(S=ME<$OCR4X)DRO+ \87@]H=.CTS7O%
M>@?;6AO8[CPRS3+))N65@\0.X9PW\77N/:@#T^L;P[K<FMQZB9;5;=[.^ELR
MJR;PVS'S9P.N>F*\Z\/:I"+#P3;ZM/&VBR17<>^=@8FG1]L2N3QP@;:#W]P*
MZCX;M8BV\0P6#PF&/6KC8L3 A5.W;C';T[4 =M17(>-]0CTZ\\/R:BP70WO6
M2^=_]6"8V\KS.VS?CKQD#-8MY)I5BVB+ILOF>%[C6)#>/OWV^YHSL53]WRO,
M(X^[N&* /2:*\@\1V\=M;>)XH'$>C1ZEIIM C[4CF:1//"8Z#!!('0D^]3:X
M[:#>>.(= 4PXT^SN&BMC\P+.ZRR*!_%Y?)/7@&@#T"36Y(_&-OH1M5\N:RDN
MUN!)SE'12NW'^WUSVJ>#4WBM[%=6CAL[Z[D,26Z2^8"P#-@-@9^52>G%<5:2
M>&W^)>EOI,MA]GN=$G0_9W4!_P!Y$0#COMS[X'M6#I::6WASX>W5^MJ]LM_<
MQR2W 5E *3X4D^I X]<4 >N02WCWMU'/;1QVR%?L\JR[FE!'S97'RX/'4Y]J
MLUY5K%Q<VDGQ&?26<W"&S9EA8[UC*+YI7'(.TN>.]7=6AL!KD,N@FW73;G1K
MI]0%L0L10!?)<XXW9+ 'J0#Z4 >D45Y3X>@L;&\^'-U;%([F]TR2.YD#_/,!
M;JP5CW 8<#MT%:/@MWL]<L;26.ROXY]/DDL]8L^'FB#1Y%PO]_)7YLG)SWS0
M!Z+161XK@^T^$-9B\OS&:RFVKC.6V'&/?.*XC3=1TN^\1>!UBN[>8RZ//#,4
MD!W-LAPA([_>XZC)]: /3J*\8T#3;1_"W@G5=,;.NG4(XFE24L[P[V\Y&Y^X
M$!)';\>;DSO>>!M1N3M3QE;:HZHW2=9O/_=HO?88RHQT*YH ];HKR+Q!8Z;/
M_P ++EF6-YK2&*: E\^3*+<,&7GAMW<<UZIITWVC3+68N',D*,6!SG('- %F
MJNI73V.EW5W'$LSP1-((V?:&P,XS@XZ>E</XFTM;;Q5-#':"2#Q/9&R;"9$=
MPG(D/I\C.QQ_SR'>HM#$EWX6NY=1MDAN-#L)],+E H,J@B1Q[%5C((_O,* .
MXT/43K&@:=J9B\HWEK%<&,-G9O4-C/?&:FL9;R6%VO;:.WD$KJJI+Y@*!CM;
M.!@D8..U>:>'K>QLK_X=3VWEQSWVD/'<NK_-,!!&0&.<G!' [=!BJUGJ,&G>
M';)YY!_8:^)KN._8'<BQEY1'O_V-_EDYXZ=J /1/$.N2:&NG.EJLZ7=_#9L3
M)M,?F,%W 8.<>G%;->9:[%H*:-8C1[D/87'B2U<M'-^Y#%UW"(@X"CK\O )/
M?.-KPA%:V/C#Q=IMBL<-K%-;2);Q8"HSPC<0!TR1S[T =7?7UMIME+>7<JQ0
M1#+,WZ#ZD\ 5G1:Y(_C&XT%[556*R2\6<29W!G9,%<<8*GN>U9'Q0A@E\ 7[
M3Q1NL3PR9=0=F)4R>>G&>?3-8]W9:%JOCN]MWCLY]/'AU"D2D>5CSI>0!QQU
M![=10!Z117C^G:M;2Z?X3B\17\$6EW6AJL<]XJO"UP" X<MP&V@8)_VO6O2/
M"MM#9>&;&VMKRXO;>-"L5Q<'+R)N.TY[C&,'N,4 0:SXAN-+U[2-*AL(YWU-
MI5BD:X*!#&F\[OE/;IC-2:;XB6\UV[T.ZM7M-1MHEG*;PZ21,2 Z,,9&0000
M#7.^-I(!X[\%)+>_9?WUV3()%4K^Y]3QR>/QK&2ZATOQAXID@NKG5K!M&:>\
MOXG#SVSKD"%)%^4?+E@N,@\F@#U:D8G:=H!;' )QFO)-.N=-&N74$%S8+:W/
MAK=Y5K)\I96.-S _.X4G+8!QVJ;PY#8V-W\.+JW,<=S>Z;)'<R!_FF46ZL%8
MYY 8<#MVQ0!WWAC6W\0Z%'J+VPMF>6:,Q"3>!LD9.N!G.W/3O6Q7D/@K4+9)
MM,AUQ+=]/FN;L:5,2"BW'VB4NKY_C*D%3TQD#GKZ]0 45Y/K.AW"7&O>&=.L
MD,IF77-/D:/*H,9:/TYDC"[?[LGH*NZM?M=>%8O%,=NT%KJ5[9M>?+ATL RA
M@V.=IY)_V6]!0!Z737+B-C&H9P#M#' )]S@XKS'Q%9(+KQ5#H\<3:7)X<>66
M*  QK=?-Y;*!P'* GCGA3Z5;TW5=,N?'?AN6VO;:3S-#F1WCD!#,#"0I(ZD#
M)QU H Z[POK9\1>&[/5FMQ;FY5CY6_?MPQ'7 ST]*;H.MR:Q/J\4MJMNVGWS
M6GRR;P^$1]W08^_T]J\YT+48(?#O@**_DC&ASR72W+R$>49@6\E7/3!)8@'C
M('I74?#UM/2\\5P:>\'DKK#.B0L" IABY ';(..W% ';T5QGQ'2 Z=HKW$AC
MC&M6@9Q(4VJ9.>01CCOVKC?%.E6NE:=X[@TP"+1Q802&-'/EQW9+;@O/!*["
M0/[PH ]EHK@+RQTS2_&6C6IMX5T/4$N)6+G?%->$)M+EB0245L9ZG)ZUF?V)
M<WOA77&LXQ,NE:N]WH@;Y@4CVL8E]4+"1 .GY"@#TJ_DNH;">2QMTN+I4)BA
M>3RU=NP+8./RJ1VD$#,B*9=N0A; )],X_7%>=>)VM=5^&/B+Q&8?+.H6?F0%
MQM<1*N(\_4Y;_@0':K4M]IT_CJYLO$#VWV(Z7"^FBY(\I\EO.92>-_W!ZX%
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MC=?;;*&Y,$L!D7<8I@ Z>QP2,_C5B@#@_A+C[=XWQ_T,-S_Z$:]*KS3X2_\
M']XX_P"QAN?_ $(UZ70 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110!Q_@K_D 3_P#83U#_ -*YJZ*N>\%?\@&?_L)ZA_Z5S5T- !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6%XNT2ZUS15BT^XC@O
M[:XBN[5Y02GF1L& ;'.#R/QK=JIJ>IVFCZ?+?WTC16L*[I)!&S[1ZD*"<>]
M'-:KHGB#Q'H0^W-8V.HV]Q!=6<4,C2Q+)$VX%V*@D-TP!Q[TW5?#>I:U-J6H
MRQ6T%Y-H\FF6\/GEE!D.69FV],A<  ]#ZX&W!XFTF>>UA%P\3W?_ ![BX@DA
M$W&<(74!CCG YK7H Y*UT#5(]:\-7<BV@BTS3Y+6?;,Q)9Q&,J-O(_=]\=:S
M+7PEKT'A70-(9=/+Z5J,,Y<3OB2*-RV?N<,<].@QU]/0** .&U+PMK%[;^-(
MHQ9C^W%5;8M.WR8A$9+_ "<=,\9J>XT+6TUZ2_M8K)TN])2PG$D[ PNA<AE
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M%HW*E21DCH>1TH X8^"=<2UOFM6TVVN8]935[!49C&2(U0Q.-HPN PR,YSG
MK7UW2?$7B'P?>V5Q'I\%]<M'L@6=C%$JN&)+[,L3C^Z!T]R>OHH YO\ LK4Q
MXVGUH16IMWTM;14\YM_F!V?GY<;?FQG/;I6-I_A+6M/T7P?$GV%[S0Y&\U3,
MPCD5HGCRK;,Y&X'&.W6NZED6&)Y&#%5!)VJ6/X <G\*K:3JEIK>EV^I6,ADM
M;A=\;E2I(]<'D4 <C>^$-6OAXE*SVMM-?7MO?6$H=GV20K'MWC:."8^V>#[5
MHFT\1:EHMQ%JNGZ,9)-D9LA(SPRIN'F%F*9!*YVC!P>I/;J:* .>\):!-X>M
M;RVWNME)<>9:6C3&7[-'M4% QYQN#''09KH:0,#G!!P<'':EH \^O_"OB.\O
M6FD&FW$D.LQWUO<RSN',"N"(<;#L"CT)!(SC))I^H^$M:O-%\7V2"Q$FM7(E
M@8SMA!LC3YODX/R9XSUKOJH'6+(:ZNBEW^W-;M<A#&P4QA@I.[&#RPX!H YB
MX\/Z];ZMX@FL8[*:UUR!3(LT[(UM,(O+.,(=ZD >G(KH_#EC<Z9X9TS3[SRO
MM%K:QP.8F+*2BA<@D \X]*TBP! ) R<#/>J.FZQ9:M+>QVCNS64YMYP\;)M?
M:&Q\P&>&'- %URP1BBAG X!. 3]:X'2O!VL:5IWA696M'U#1%FAEA$K>7/%+
M][#;<AAA2,C'!'O7H%% '#W?A?6?,N]0M'MOM5_J45S>6C3,D<END?EB(N%)
M[!CQ@\CD=::^#M<CTZZM$CTQ5?7HM4C"3.JB-71BF-G!^3 _/CI7HE(S!5+,
M0 !DD]J ,#2M)O[3Q?KFJ3K;BUOTMUB"2$N#&K [AM YW=B>E=!110!SUQI6
MH/X\L]9C2W-E#8RVK9E(DR[HV0NW&!L]>]<[9^$_$0U'1+R_&FS7-C=3M=77
MGN9+E)$= WW/EVAAA,X]"!7H=% '(>$](\2Z%:6VB7+V#Z98Y6&[1V,TL0SL
M0H5PI' )R>!P.<BA+X2UN3PSJ.G!;$3W.M_VBA\]MHC^T+-@G9G=\N.F.:[Z
MB@#E+OP_J-YXGU6^;[-':WND+8*1(2ZN&<Y(VXQ\_KVK,U.R-O\ #JUT/5+J
MRMM:MK>+[ L$^]VGBVB-D#!227 & /XL9[UWU5YK.TDN(KR:UBDN( ?*E,09
MT!Z[3C(S[4 <IKNA2V>E>'[I"9I=(OTN[IE',@;<)GQ]9&?\#5V_T2ZU'Q?;
M:FI@;3?[,FLW(E/F'S&1MRC;C&%]>];&D:O9ZYIZWU@[/;L[Q@NA0Y1BK<$
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MX5LZQK%EH6G-?W[NENK*A9(V?!8@#. <<D#)XYH76+)]=?1@[_;DM_M+(8V
M\O=MR&(P>?0T 9^A66N:58Z3I]S-#>110NMW<RRL9=V?W87CYN#@DX)QFM^B
MB@#@OA+_ ,?WCC_L8;G_ -"->EUYK\)3F^\;_P#8PW/_ *$:]*H **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH X_P5_P @"?\ [">H?^E<
MU=%7/>"O^0#/_P!A/4/_ $KFKH: "BBB@ HHHH **** "BBB@ HHHH ****
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M19S*[![FZN)+JY=>C2.<G'L!A1[**;=>&M,O;^[O9XI6GN[4V<S"=P&AY^4
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M$,,19)&:0'!93Q\@R#D^A%)H7B2_\17.A:?)<M:O/H4>IW,D*J&D=B% &00
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M;71--&;23=&GFRMN(V\##+S[T =I'XRT1[S5()+Z&%=-<)/)*^U02 3R>PW
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M ,A#QU_V,5S_ #KTRO,_A'_R$/'7_8Q7/\Z],H **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH X_P %?\@"?_L)ZA_Z5S5T5>=";X@^&[B\
MTW3?!UMJED+N>>*[748X]ZRRM+C:V""-^T^X]*=_PDGQ0_Z)U!_X-H?\: /0
MZ*\\_P"$D^*'_1.H/_!M#_C1_P ))\4/^B=0?^#:'_&@#T.BO//^$D^*'_1.
MH/\ P;0_XT?\))\4/^B=0?\ @VA_QH ]#HKSS_A)/BA_T3J#_P &T/\ C1_P
MDGQ0_P"B=0?^#:'_ !H ]#HKSS_A)/BA_P!$Z@_\&T/^-'_"2?%#_HG4'_@V
MA_QH ]#HKSS_ (23XH?]$Z@_\&T/^-'_  DGQ0_Z)U!_X-H?\: /0Z*\\_X2
M3XH?]$Z@_P#!M#_C1_PDGQ0_Z)U!_P"#:'_&@#T.BO//^$D^*'_1.H/_  ;0
M_P"-'_"2?%#_ *)U!_X-H?\ &@#T.BO//^$D^*'_ $3J#_P;0_XT?\))\4/^
MB=0?^#:'_&@#T.BO//\ A)/BA_T3J#_P;0_XT?\ "2?%#_HG4'_@VA_QH ]#
MHKSS_A)/BA_T3J#_ ,&T/^-'_"2?%#_HG4'_ (-H?\: /0Z*\\_X23XH?]$Z
M@_\ !M#_ (T?\))\4/\ HG4'_@VA_P : /0Z*\\_X23XH?\ 1.H/_!M#_C1_
MPDGQ0_Z)U!_X-H?\: /0Z*\\_P"$D^*'_1.H/_!M#_C1_P ))\4/^B=0?^#:
M'_&@#T.BO//^$D^*'_1.H/\ P;0_XT?\))\4/^B=0?\ @VA_QH ]#ILB%XV1
M7:,D8#KC(]QD$5Y]_P ))\4/^B=0?^#:'_&C_A)/BA_T3J#_ ,&T/^- '9:%
MHUOX?T:VTJTDF>VMUVQ^:06"^F0!FM&O//\ A)/BA_T3J#_P;0_XT?\ "2?%
M#_HG4'_@VA_QH ]#K&U'PW;W^IC4H[V_LKORA"\EK/M$B D@,I!4X+-@XSR>
M:Y7_ (23XH?]$Z@_\&T/^-'_  DGQ0_Z)U!_X-H?\: .[L[.*Q@\J+><G<[R
M.6=V]6)Y)X'Y =!5BO//^$D^*'_1.H/_  ;0_P"-'_"2?%#_ *)U!_X-H?\
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M:I)>+")DD #C/52>AR*]"H **** "BBB@ HHHH **** "BBB@ HHHH ****
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MEM;23N&*1J6(12QP/0#K7F[+?7&IFQG\1WUS&GAS[1]HMI&MQ-(KD"8!3QD
M'@X/N#BET[79=9-I9ZOJ$MNLGAFWOHV2<P^?*ZGS7R",[<+QT&XDCI0!Z!I6
MI6^L:39ZG:[OL]W"D\6\8.U@",CMP:-3U&#2-+NM1NM_V>UB:63RT+-M49.
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MGSY7F^=Y9\OKC;N_O=\>E6*X;Q!>7</BC68(K^YBB7PX]RB)(0(Y [#>!V/
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M73Y4_9(VSR?7\AP,"@#U6BN'59(/&%GH=SJ.HM8WEC->)(]TRM+/N0%%=2"
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M"FKC4XMUMDK^_,^P_,,_,<9XX[=Z6]\%SW=GKMO_ &G&@U6^BO"WV8GRB@C
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M]CO+>X\LX?R90^T^AP>*JZUK4&BP6YD4R7%U.MM;0*<&61N@SV  ))[ 'Z4
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M7T4# JK9WY:PCEOWLX9F+Y$4^]/E)Z,0,\#)XXY]*L->VJ6@NVN85MB 1,9
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MW$=RJQ^7<1SZ)-:R0*1N8"1FVCYP,JJ@,><#J/0?[1L0CN;VWV( 7;S5PH/
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M[![>_H:AU/1O%%S?^#7TB"\M+VV\-M ]S):.5AF\K&QCCY6)!&>V<^E>X44
M8'@N_DU#PI8//I$VD3QQB.6RE@:(1L.#M!'*]Q]?7->8^*/#OB&>3QO9Q6=W
M-J&JZA8RZ9<I&Q01HP.?, PFP @Y(_6O;:* //-(TVZB^-FKW\MC<"VDTN*)
M+LV["-Y01NPV,9_&E^+'AG4]=TK2;_2(3<W>D7R7?V4$ S*.H&>_ X^M>A5
MU[:K>I9-<PBZ=#(L!<;RHZL%ZXY'- &?8^((=1,*VUCJ(:3EQ/9R0^4.^XN
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ML!NV,_Q8[UZ%10!YQ>Q?V9?:3>6^BZI%H,D5U&T%K;F66&25U<.\1#,%;#C
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M3V?V&42RLRO#R=I4G'4DYZ\]:DT3P[8>'X&BLC<L& 7=<W,DS*HZ*"Y)"C/
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M86CBMV4Q/&KLK ESD?)C&._6MV+P1H<%S#<117*/!<R74(6[EVQ/)NW[5W8
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MH *PM:UVWT8237M_#:6ZD -*P49QT&>I]JW:\<^/<$+>&(YS$AF6^A59"HW
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M0!8^VW'_ #T_04?;;C_GI^@JO10!8^VW'_/3]!1]MN/^>GZ"J]% %C[;<?\
M/3]!1]MN/^>GZ"J]% %C[;<?\]/T%'VVX_YZ?H*KT4 6/MMQ_P ]/T%'VVX_
MYZ?H*KT4 6/MMQ_ST_04?;;C_GI^@JO10!8^VW'_ #T_04?;;C_GI^@JO10!
M8^VW'_/3]!1]MN/^>GZ"J]% %C[;<?\ /3]!1]MN/^>GZ"J]% %C[;<?\]/T
M%'VVX_YZ?H*KT4 6/MMQ_P ]/T%'VVX_YZ?H*KT4 6/MMQ_ST_04?;;C_GI^
M@JO10!8^VW'_ #T_04?;;C_GI^@JO10!8^VW'_/3]!1]MN/^>GZ"J]% %C[;
M<?\ /3]!1]MN/^>GZ"J]% %C[;<?\]/T%'VVX_YZ?H*KT4 6/MMQ_P ]/T%:
ML+%H(V)R2H)K"K<M_P#CVB_W!_*@"2BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ KD?&'@ZW\7Q?9+\W)M5D64)"X7+ 8!SC/<UUU
M% '&7_@Z'4M4TG4;O[4]SI;,T#"0*&+  [@, ]!Z5M?8[C_GD:V:* ,;['<?
M\\C36LKAE(",I(QD8R/SK;HH \YM/AC86<&H6\4FH_9]1<R7D7V@ 3$YSD@
M@')R 15O5?A]I>K:/9Z8UG):PV+B2T:T?RW@8=U/^?7K7=T4 <'J/@"VU6PL
M[2\DOI%M;A;I9&F!=Y0,!F)'.!VZ>U.D\!V\NM7^K,UY]KOK4VDS!UP8R ,
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MYY&C['<?\\C6S10!C?8[C_GD:/L=Q_SR-;-% &-]CN/^>1H^QW'_ #R-;-%
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M$12S,=ZG  Y/ )I?$-G;:=X4U>\B%_J,-Q#&K1"XDD8J&P2#RVW#$L!V!]:
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MQI%O=7%AX9Q$\7BBUU+_ (FC%")#'E_.+GO&PP5/0DICI39#_P 22Y&U\_\
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MY4;2-I(S\QS]*VM>\5W^DZBXB2TDMX[NS@,81G<K,ZH69@=L9!?A2"3C/?@
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M::K)#NO+2%X8I"3D*^W.?4_+^I]:S_\ A#],77IM6C>\B>=UEGMX[AE@FD4
M!VC'!/ ^N!G-;]% &?J^C6NMP0171E7[/.EQ$\,A1D=<X((]B1^-9TW@W3I[
M>^@>:[\N^NX[V8>8,F5-FT@XXQY:<?[/N<]#10!@+X/TR/7)=5CDO(WGD6:>
MWCN&6":08P[1C@MP/8X&0:O:QHUOK<$$-S),BP7$=RGE,%/F(P9">.Q .*T:
M* ,.Z\*:==W=[.[3H-0C6.^B1P$NE48&\8ZXX)7&1P>*?<>&K*XOKV\:2=9+
MRS%E*$8!1$-V !CC[[<^_P!*V:* ,"/PC80/:R6TUW;S6]H+'SHI &D@'W4;
MC!QV/##)YY-6YO#NE36FF6C6B"WTR6.6TC7@1L@*KCZ UJ44 9</A_3[:UU.
MWMHS"NI2R37!0\L[@!B/3.*K6GA2RLI[.:">Z5[.Q.GPG>#MA^7CIR?E7GK\
MOUSNT4 <!J/A:YL;C2K33K75Y-,L+,V]O)I^H)%-&2PR'#E0RX5,$9/7/:NM
MT>TO+;1H[:]NII9QN_>R,K2*I)V@L  2 0,X[=^M:5% '/V?A#3[!-'2"6Z"
MZ0'%H"X.T,"I!XYX)'-02^ ])ELH;<37T4EO=2W<%S#.4FBDD),FU@.C%CD'
M(Y^E=/10!SEUX(TBZ8%VO%)M'LI2MTX,\3$L0YSECN+'/7).<CBGIX.T]#*5
MGO,RV"Z<Q:7<3",X&2.OS-S[_3'044 8 \(V >!A/= P:>VFH=X_U#8R.G7Y
M5YZ\5%+X6CL[6";3&D>]T_3I+*Q2>7:FT@85B!G&43GK\OUKI** ."\/^&[^
M,0VTG]O6=FL+07$%]?Q3)(AC*@)L+$$'!!^7I^%=$WABU=;IGN[XW-S#' ]V
MLVR81QL650R@8Y9N>ISR36W10 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MHJJ,DGZ 55TW5EU*2=!9WEL8@C W$6U9%89!5@2#[C.1W H T**** "BBB@
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MOJ=H)!!."4$B[6X)'(^HH OT444 %%%% !1110 4444 %%%% !1110 4444
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M%+9X!?@<#'I72W7B^.RU'5K.:T.^R>UCB*R9\][ABJ#H-OS 9Z\<TR_\&)J
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MMK6XCO6^RLOEED  <X[D=_2H?"8M6N_#0O[?48AIJ316DT^G2;9C*1L+RX*
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M LK21D J 2,JK<D8[9YK%T32;_PU>>%'NK"[EBALKVV98(S*8#)+')%&Q&<
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MHXSZT :NFZ79:/9BTL(!#"#G&2Q)]2222>G)/:J9\+:.8VC-HVUKL7I'G/\
MZ_.?,^]USS7-:-XBU;4=(?0[B[,/BRWN?L]R1&A" '=YP7&#&4P1QR2%SGFN
MKUB2XL_#E]-#<N+B"U=TF*J3N5202,8[>E "#P_I0OI+P6@$LDHG<!VV-(,8
M<IG:6&!\V,\#GBHY_#&CW2:@DUIO74'5[L&5\2D  $\]@ /H!Z5Q^B^,-2%]
MX62:^74XM6TQKR^1(5,EFRQJ^X",?=+$K@@G/0GI6TWC/2M3L+.XM+W4+6">
MXM1%<"Q?9-YK_*@9DQAL;21TSU!Q0!I7_A'0M4N)9[RP$DD\'V>9O,=?.CZ
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M?, <X*#&??K66?$^K+X,\%:K/J_D2:M=01WDICB50LD;L<97"X*C% 'I5%<
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MP5P,*,Y]?;B@#TZBN'@\7&V\37UHFHQZMI-IIKWMS<QA"]JZGA&9,*=RY(&
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MI(KAC=DE[65!@E5VD.,\CD=!R,<^C444 %%%% !1110 4444 %%%% !1110
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MI>H+,7\.E[9IW)_TIFP8WSW/E8+9_B?VKLKN!Y[.:&&=[:61&5)HP"T9(^\
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M+?25^TJRW%RS3S(6SL9R6*#V7.T?2O+=+33%TOPMI_FI%*GB6[2XC64HZ?\
M'V #@Y7@KZ?>'J*]D) !)( '<T$A022 !R2: /)(=:33["*&>^"Z#!KU[:SS
M2EIHX4^;R5D.[/EY..3C[O:N_P#"<<%OX>00:E+?V@=VAN9NA0L2 I)R4'0$
MD\ <D8-;A 8$$ @]0:6@#Q%I+2[^'OBB-?$121M3OI(].1HV%U^^8K'M \PA
M^!\K#KZ5H>*-;VV=VTC-INK6NGV$_P!GDE(\@[LL(%&" ,D.^2,* 1BO7J3
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M&0Q<#CU%>LY&<9&1SB@,IQA@<C(YZB@#@O ]WIVJ:A#J&GZS)/,;(1WEFB,
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M4$ G<K?WCQ5.7X=Z5<ZI?:I=W5[=ZA>1I!)/.R96$,"8U55"A6"X/&<$\\T
M>?>+;.2SU#X<M=6AEN[Z_EGO8%VYE:1DD:,[B 0"Y !..*W_ (57#KXA\76,
MUQ);,EX'BT65BS62?-R#]W#9'"$@8'K76>(_!MIXEU72-1N;^^MY]*E,UL+<
MQA0YQR0R-G[HJ30O!^G:#JFHZK%)<W6I:BP-S=W+ NP'10% 4 >@ Z#TH XO
M7(T/[1/AR/8/+DTN21TQPS#S<,1W(P.?:NV\73L=#DT^"3;<Z@Z62;3\RB4[
M68?1-[?\!-5M1\$VNH^,;3Q0=3U"#4+2 V\0A,7EA#NSPT9S]X]ZL6OA6*#6
M$U.XU*^O9UE:8?:3'A6,?EC 15  4OC_ 'V)S0!P_AIH_%_Q0\46VKQ++8:!
MY=K8:?(,PH#N!DV'@M\G!.<!OI7HNF:):Z1<7DEIN2.Y96\G)V1D#&$'\([X
M'&<^M9USX-M&\2OXBT^[N=-U.:,17#V^PI<*,8WHRD$C P1@UM65F;.-P]S/
M<R.VYY9F!).,<  !1QT 'KU)- %FBBB@ HHHH **** "BBB@ HHHH **** "
MN(UGQIJ>FOXB>+2[62WT,Q/(6N6#2QLH8[1MP&P>_''?/';US6H>"[/4DUY)
MK^^5=:5%N AC&P*NT;,H<<#OF@"K<>,;G2[W5K;5+&%6M+>WN8/L\K.)!-(T
M2JV5!!WJ.0#P?:I?^$CU>);X3Z4J)#) (KN1C#"R2-AV(DP<IU('WN,=>)]0
M\&6&JW5_/?7-W-]NLDLI4+(JA49F5EPH(8,Q.<]>U1/X+$^FQV]WKVK7-S#/
M%/#>2O'YD9C.5  3:1R<Y4D]SP, %!?'%[)9VSPZ;#)-)K+:2^^5HQD9(< J
M2 0.0>1[TYO',MKI<\^I6\-JUKJCZ==7";Y((0$WB5L $*<HO.,%N3BKD?@:
MTC8-_:>HG&I_VIRT9_?8P?X/NG)./Y59@\*I:274EMJE\C7-\U[(&\ME9F38
M4(V<IC!QUR!S0!<34[AO#3:G'!#<W MVF2*"X4QRD D!9#Q@\?,?6J/A[Q')
MJ^JZEI\J0EK.."59X2=DBRANF>N"AY!(/!J7_A$].'@^7PPIE2PEA>%BC!7
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M"0,'DB778TE^"-X)$5@- + ,,X(@R#]0:T]3\'V^H:C?7L.H7MD^H6OV6]2
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M:WG_ +,LQF> R9.9L8PPQ]2#]/4 [JTNH+ZSAN[:0203()(W'\2D9!J:O/\
MQAKE]ICZL^EW[*=-BM7,"(JQP%Y#G>3DN77   X SD$BKT6IW>KZEK:IK/\
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M[& C(4DKR1TS[<YJ&\NM2N;06=QJUV_V/Q;!9I-\BN\?[MP'PH!P6XX[#TH
M]1JG?ZK9Z6UJ+R4Q_:IUMX?D9@TC=%R <9]ZY"'5=8U6_O9+/5+>V_LW51;2
MQ32##1 J-K)LSEP<JP;J1CTK)N=1N-?TG0-8FO)%=O$J1-:#;LB"3NBH1C.X
M!02<Y))[8  /4:*YWQ#JD]MKOA_2HY&@AU*>5)9UQD;(BX0$]"Q'7KA3CUKE
MY-8U^2]M],_M6>)4\1/IGVI(H]TT!MFE&<KC>IPN0,<<@\T >E45RWC&XU#1
M/AY?3VFI3"^M+9<7;(A=V& 2PV[>><X ]L5BZO<:U;:GXGLXO$%ZJ6>DQZE
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M5A;I+%#]GC<1C*Q?W!Z+[=*R/ &H76I^$H[J]FFFF-W=H6G #[5N)%4$#@$
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M\=,\UVM47U'S+=)M/A-ZIN/(?RW5=F'V.Q)(SM(.0.>.*O4 <)/\/&=9O(U
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MK#0M%)JCBYV.,,L9 $8(['8 2/[S-7!C4;=O%^FW$32P$:[=VUV) YFVF*4
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MB9%DD1&D.U S %CC.!ZT^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJ@X(#8YS5NQT6"PU74=1BEF:;4&1YE<@KE5"K@ <?* * -!PQ1@A"O@[2PR
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "LN\\1:587/D7-UL<2I"S>6Q1)'QL5G VJ
M3D<$CJ/45J5R%GINOZ7X@U:"&SM+K3-2O!>)=2S8:W8JBLI3!W8V K@CW(H
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M*# !.3U'2J=EH?B$W-C/<:;!$MOH$NFL@N@S&0F/!'&,'8>_0^O% '01^-]
MF,:Q7<TC36XNH56TF)FC..8QL^<C<,A<D=P*MCQ+I+Z;;7\5RTUO<Q&:(P0O
M(S(,9;8H+8&0#QP2!UKGM)T+5;*[\(R2VGRZ3I$EG<[9%/[PK$!MYY'[H\\=
M1[XRK#PMKVDVNB7 TFRU&2U@GM+JQN)E P\OF+)&Q!&1T(([T =9+XV\/1*A
M^WF4/:B\3R())=T)_C&Q3D>N.G.>E.'BW3GUVTTR+S9%N;$WRW*QL8O+RH4[
ML8P0Q.>@P,]:R4T"_M]<^T1:=;16PT5[-8K4JB)*S[]JCCY1TS@9/855TKPY
MKVFG09(H+;SK7P^=,E\V7Y8Y1Y9#8 .Y24/O]* -]_&>BBPNKN*::9;:S^W%
M$MY TD)SAT! W*<=1QZXIMGK\&H7VC;;R2V>\M))Q8R6S R@!<G>P&-N?QW#
MVKF+7PKX@G>=[JU@B>Z\/R:=*[79D(F.>0 N I)X"X '8=*T/[ U:\N?#AN;
M5;=+33+FSN6CG#%&D2-05Z9QL)_$=: .B@\2Z3<W,4$5T2\Z-) 3$X6=5^\8
MV(P^!S\I/'/2H=.\8:%JMS:V]E>M(]VKM 3!(JR;/O ,5"EAC)7.<<XK"TWP
MYJAL_"MG?VZ1GP\V6GBD!%SLA:) @ZC(8$[L8QCGJ(=&\-ZQ90>$(Y[10=*N
M;F2Y(E4@+(DBKMYY_P!8,_0T =3J^K&TOM-TR#'VS4961"1D1HBEG?'? P![
ML.V:5O$>DQWXL6NSY_V@6N?+8IYQ7>$+@;0VWG&>]9GB"T>/Q?X:UD_\>ULU
MQ:S'LGG*NUC[;D5?^!BLC4] \1WNLB=K6VE2WUJ*\@?[444P!0,; OWQSECD
MGL2,  '86VM6%W>?98)7>0^9@^2X1MC!7PY&TX)QP:J77B"&/Q+'X?2.<74M
MH]R)A S(F&51R!@_>.><# SUK(T7P_?Z?XG-];QRV-G,9VO;3SQ)!*[-E)(E
MR2C'DMT'UZU>O=.U!/&]IK%M;QSVPTZ6TE'F[65C(C@@$<YVD=1S0!3\%>,(
M-;T71X[ZZW:M=V?VAAY#(DA&-^UL;"1D9 )([UMVGB'2[V_2R@N2;B2(SQ*T
M3H)8P0"R,0 XY'*D]1ZBN/TSPGJT6G^$K*Y@$8TVQN+6[D253M,D80%>>>F>
MU:7A#1M2L%LX-4T+2;>;3X?(74+<AGN!@+E1M!3( +9/7C'H ;^J>(-,T82&
M^N3&(HO.EVQ._EQYQO?:#M7@\G X/H:9+XFT>"]%H]X/-,L<)*QLR+)( 44N
M!M!8$8!/<>HK(O=/UVP\7WFHZ=96NH66IVL4$R3S^68'C+X/W3N0ASD#G(K+
MUSP_XDU"_G/V>VGCBU&RN[607/E*8XFC+J4 /SY5OF.>" .F* .Q37-/DN_L
MRS,7WO'N\I_+W)G<-^-N1@YY['T-,LO$&F:A??8K>X8W/DB=4>)TWQDXWJ6
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MU_96[N9[%UCN%:-EVLR[AC(&>"#D<<UP&OZEJ]M)XQNH=9O$_LFYM7M8AL"
M,D;,K#;RIW$8]_7%,UA+R+4O'VI6.KW-A<6 @N(EBVE)'6V4A7!!+ XVX]_7
M% 'I"7D;W\MD$F$D4:R,QB8(0Q( #8P3\IR <CCUJ=F5%+,P50,DDX %<GI>
MK78\8:K'J5V8K6+2K.Z,,I54MW=I@_/''R#J>U+\23O^'.LO',Z#[/N#Q.5R
M,CN.Q'YB@#>BU>SFUJ?2$=_MD$*3R(8V ",2%()&#RIZ9Z5>KS77X9D\4>()
M+/4KJWDM?#4<J2Q."Q=)+@C)(.0".1WI\NNZCK,\]B-6ATNZ32K:\MYGF\L;
MG5BTNW&)%! !4G _'- '<ZMJ]GHFGM?7[NENK*A98V?!8A1P <<D#/2KU<AX
M^9G^'=P\C*SL;8LRJ5!/G1\@'D5EZWKUU!KAEL]2D:.'7;.QD5F$:1JXC#Q!
M.?,)#EBY QD $[30!Z'4%[>V^GVCW5U((X4QEB,\D@  #DDD@ #J37G&NZOK
M&E76L6$-U>7%S9W$>JP!7P9-/QF6/IS@HZC'.63GK5OQ4?[4\&C4Q=W!M[O5
M;*2V D(40FYB52/9@-X]-P]* .WT[4X-4BED@69##*T,B31-&RN,9&".>H.1
MP<TU-7LWUN71U=_ML<"W#(8V V$E00Q&#R#T/:N'U_5K[3(O'446I3Q_V?I4
M%Q9EY,M'(4EY!/7+(O!XK7LG\SXFLY;);0(23Z_OGH Z^BN)GU234=<\0V4F
MM/I4^ES6YMPN"/**(Y<H?O[R73G.,#&#US;K7+^WL-4/]HRK+;^*;>SAW.,B
M%W@RG/4;7?KS0!Z117G,TNK2P^-KT:_J$;:3-.+6-/+V ?9(W (*<@,V1_\
MKI_VZ\LI/#UG<ZQ<2)K5N\[RW-P(@)5CBVQ(ZKE0=SMCJ2O7J" >AT5Y[:G6
M)]=T/2;KQ+/.DVFWAGGLPJ"1HY8U5@=OW@&()'4@D8S5;0/$=WK4&@:?JFJ2
M6K7FBO<BY1A&T\ZN$)SQRH^;:.#NY&!0!Z717!7NJZAH&H:;<RZA-JEGJ=E]
MDA8#8C7H&48 ?=$HS[ @8ZUJ^)[^\\->"5ECNI))XVMX)KQP"RJTB))*1TR
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MTI):$2%%C\K&,LNU@^2<GTXH [^BO+K&^UW^S-&U@:Y>7,TFNR:?+:N$\N6
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M)6.;G+HRGH<\J1]"*ZZB@#SY_A@B>!]9T*#40;_6IC/?:A+#G>Y8,2$!X''
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M'O#EKI<]RER\&[]XD90$%BW3)]:U!=6[$@3Q$A=Y <?=]?I3A-$S*JR(2PR
M&'(]: ,34]#NKWQ)8ZM#<PQK:VEQ;B)XR2QEV<Y!&,>6.,<Y-9^D>$+O3'\+
M[K^&1-#LI+0XA(,P947=][Y<;!QSU-=2+JW+;1/$6VE\;QG:."?I3XY$EC62
M-U=&&593D$?6@"MJMH^H:1>64<BQO<0O$'9<A=P(SCOUKG)_"FIQV7A^73=4
M@@U31[<VPDDMR\-Q&5565D# C.Q",-P174O<P1RB)YHUD89"%@"1TZ4HN(2
M1+&03M'S#D^E '/W'AW4+G5='OY=31I;&*X65A#@R-* "5Y^4+C@'=QU/>LK
M2_ M_:3VKW6K6THCTR;3IC':%7F#E3YI8N<N2F6)ZY_&NU,\*SK 94$K#(C+
M#<1ZXJO:ZK8WMS>6]O<QR26<GE3A6'R-M#8/X,* .<L_"-[$/#2W.H6TR:-
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M.SF,A0% )SDBN;&B:??^+O#XN=#,EG_8LT4OFV#>6)"\)57RN ?E<@&O1**
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M.6AD_=ROM*@_+T.]>>G(YK(U>PU_7-"2:73;2UOH+VUNTLUN=^_RI5=@9-H
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MK%5F6ZC:<PMN8+L.X DJ,-E1UR.N*YK0O#WBCPXFB7$-C97;Q:3'I=W:M=E
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MYJ1&WHK%2N0#M;J/8UYEK4[Z:GQ L[;4[Q4M]&BO("U[(SQ3%9LLK%LC.Q.
M<>W-&L.;K5=91M5O4CB\,17D:PWTD86;,OSC:PP?E7V/&0: /3Z8)8VF>$.I
ME10S)GD YP3]<'\J\C\1>)6;1)[B/5Y8M1@T>RN@7N?+4,Q+%HD7&\G!W$\
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M1H_N@95<8Z8[G-=310!AKX<,>NV.JIJ-P9K>U>UEWJK&=697))Q\IW+V&,'
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M 45!>7MKI]L;F\GC@A#*IDD; !9@JC/N2!^-3T %%%% !1110 4444 %%%%
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M-MGS%9 Y1CN[\C(YZ=._H=8UUX5T>]_M(7%J[C4PHO!]HD E"C & W'''&*
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MD\J;.Q\_W?E.3_\ 7Q!J^A:Q_P )0NM:-)IT@FM4M;JWOU;;A&9D="H)R-[
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M-J&GK=6US<*H,R!5)+$8^?YE) '?TI]QXNL+>S2X:&X9GA:X$*[-_E*<;^6
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MD6[9G)Y ;D C!P>1G!K,M=%OH?'E_KCFW^R7-E%:JJNWF HSMN(VXYWXZ]J
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M@O4WVCIY9(C<9^5"6<J1P& QGI6?KU\MWX:FC&FSV%\GAXRVT<@>8*P9\"#
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M\2[I-.ET"-(FN%+(;P'$BM_TTVA<9Y^]CDFNL^&G'PXT)"KJ4M54AU(((^M
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M;BPF:"WN8%D,]C)&T<\)#@(>3B1",G<HQT]: .I) !). .IIL<B2QK)&ZNC
M,K*<@@]P:X_5;J_N/&5_I4DT#:8-%,YMVA)+%G93D[L$_*.W3(]ZR/"WB:[T
M3PYX<@U"&W;3W\-_;(VAW>8OD11%@V>#D/G@#!&.>M 'I-%<YHNKZW?:C$+O
M3473I[03I<IA?+DR/W9!8EP0<A@!TZ<TEWK>J7&HZK9:)!:RSZ8L)>.X)'G,
MXW;0P/R?+CYB#R>G'(!TE%<AJ/BN]L-<BMC%;- ^I0V.Q-SOMD0$2,X.U#N/
MW",D#.>14#>/!;7.KK>B*%],BN9Y;"2-DG:.,G9(C$[9%8#.0.,@4 =M16!I
M&I:Y<ZL\%_IR+8M;"6.Z0!0),X,97<Q;@@AN!UX%9NM^)=:L]4UVTL8+#;IN
MFQZ@CS%R9 3+E"!C'^JZ]L]Z .QHKCK;Q7JC:AY,UI9E+G1GU2U192A4J5'E
MN[<<[U^;  YX[U##XKUJZ36[>RM[2ZOK&Q@O+?$4B)/OWY0 G)YC.&!P<B@#
MMZ:)(S*T0=3(H!*@\@'H<?@?RK%T77?[=FAFLGBEL&LXIVD"D$N^2%'/& ,D
M'D9%<U>MJUGX_P#$EQH5O8-<+I5G-(MR6 DPUQP-O<@8W'I@<'L >@T@96&5
M(.#C@]ZX>/QMJ6LV!N/#VEB>9+&WNS;R]9#*N\1[MRA.!]X@C)Z<<W[F_EL/
M'>CQ1H8X]9M)Q-"Q^[+$$96..,[6921UPOH* .JHJMI_VW[!!_:0MQ>[!YWV
M8L8]W?;NYQ]:LT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MBL*Y\6Z59ZM=Z?/,R/:6?VV9RAVK'\QSG&#PC'\*GM=90:7;7NHD6[72>;'
M%+,B$9P<9R0/O'H* -:BL<ZVD6LV%J[(]MJ<;/9S)W95#%3ZY7+ _P"R?;.Q
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M:1*OVCPU%I\8,L1)F'FY7[_^VO/3@\UV6A0S6WA_3K>YB,4\5M''(C$$JP4
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M<G'\/'7'4W4;36DT2XW.C*,^I%2U";J$78M=^9RF\H!G"],GT!(.,]<''0T
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M]E3!CSG81C[N3G'K0!QNN^(-5\,77B(+J$UVD6EVMY&;A5/D/)-)&S  #Y0
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M6><NV22=N\Y.!G ] !7!0>(M4U;_ (0C5WMY%FO+JYS:V]P0DJ^1*5!!PO!
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M=U#<D X88Y'2NCB\0>+=1\?:[X;L)]+2+3%M9?/G@?+*ZAG7 ;J<G![8QWR
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M.8Q&5D(4$D;3@@\=^E<X?%L\7B73Y)C=_8+G19+MK..U+N)5DB&0 N[HS>U
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MX8-&I!V\@FNUHH XV+0=:TWQ':ZQ90::ZRV/V.ZM%D,*0D2-(K1D(<@;V4Y
M)X/M5_PQH=[IG@&ST.^,"W4-H;=FA<NF<$9R0#6K<:M;0:@FGKOGO'3S/)B&
M2J9QN8GA1G.,D9P<9Q4FH:A#IEFUS.LK@$!4AC,CNQZ!5')/^>E '':'X:UW
M19]$OC'9RS6FDKI-S;K<-M*IM*2(Q3KD'((Z$<G'/0>'-$D\/^&4T\,DLX,L
MK8)";Y':0@''W06P..@Z5-H?B&Q\00W#V@GCEMI3#<6]Q$8Y87P#AE/J""#T
M.:DT_6;;4K[4K.%)EET^989O,7 +% X*\\C#"@#E=!\+:SI9\)><EFPT;3I[
M2?9.WSLXC *Y3I^[YSCK6KX>\.2VW@0>'M76)M\4T,P@D+*R.S="0#T;TKIJ
MSM-UFVU2ZU&V@299-/N!;S>8N,L45P1SR,.* ,GP_9^(=%T>VT6:*RN4LXQ!
M!?><R[HU&%+Q[>&  R V#CJ,\4]4T#Q!)JNOWNFS6L4E[86UM;RO(0VZ)Y&;
M< OR[A(0",X/.*[.B@#SNX\&ZU-;>(1'#I\+7\UG=6\8N7?YX3&2KL4SSY?W
MN3\W2K<GAK5;ZZUZ;4M-TRXMM4:U)M3<OPL:X8;M@PPZJPQR.W6NYK-O-<LK
M/48=-W/-J$R&1+:%=S[ <%F[*N>,L0,\=: .-_X1#7K(Z;>0M:ZK)9M<PBSU
M28M_HTK(RKYNUCO4H.2#P2,G&3TU_P"'O[7\%W>@W/D6QN[=XF^RIB.(MDC:
M.,@$^V<=LTR\\:Z)8ZW_ &3/<.MPLT$$C!,I%),&,2,>Q8*?8<9QD5K#48&U
M9M-3<]PD(FDVCY8U)PNX]B<-@?[)H Y_^Q]7EU.VUN2"S74;'39;6&)9FV32
MN4.6;;D(#&,<$_,>F.;.KV6KZW9WVCW5E8II]Y;^4UP+AF==RX?"%,$@YVG/
MH3CI7144 9=M=WW]OW-B]K#_ &?% C13I(2^[NK@C ]1@G@<XR*U*** "BBB
M@ HHHH **** "BJVH7]MI>GW%]>2>7;P(7D;&< >W<^U1Z?J)OVN$:RN[1X)
M/+9;F,#=P"&5@2K#GJ#UR#@T 7:**R]9UZUT,V?VJ.=OMEPMK#Y2;LRMG:IY
MXS@\]* -2BD!R 2"/8]J6@ HHHH **PAXIM7U#4+&&ROYKC3RJW*QPAMNY=R
MXYYR#GC-;%M.EU:Q7$6?+E0.N1@X(R.* ):**QKWQ';Z=;B>ZM+V-#?)8KF(
M?,SN$5QS]PEAS^E &S1507Z":\66*6"*U +3R@+&X*Y)4YY []*MT %%5YKV
M&&[AM22T\P++&O)VC&6/H!D<^X%%G=&\@:4V\\&)'39.NUCM8C=C)X.,@]P1
M0!8HHJM%?0S7DUH"5N(0&:-A@E3G##U!P1^!H LT45CZ5XHTC6]6U'3-/N3-
M<Z=L^T@(0%+YP 2.?NGI0!L45@:=XRT75-0@L[:X8M=&86LA7"7/E';)L/?:
M?IGJ,CFFZ5XUT36=5_LZSN&:9Q*869,+,(VV2;#WP?IGJ,CF@#H:*J66HP:@
M]T+?<RV\Q@:3'RLX^\%/?!X/N".QJW0 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 >6?'5U3PYX>W,!C7;<\
MGL$DR:@UM;C5_CKI5]H2BX&DZ9+]LFC.4#,LFR)B.-Q+#CWSVKU2:TMKD@SV
M\4I'0N@;'YT^.*.% D4:H@Z*HP!0!X[X&O[SQ%HL5]=^( T[6=W%JEB;B3SG
MDW$ARN1Y6WH",## >@K-\+ZG;:1\*_ Z/J<UM]MOY5>$S%(I_G=2LDA/[M!P
M?EZGL22:]P6RM%:9EMH09O\ 6D1C]Y_O>OXT+9VJ*JI;0JJMO4", !O4>_O0
M!X/9^)-5?X6^%;V36;L30^)4MKF<7+!O(W/\LASRN-OWNV*K^(]5EU'X<?$H
M/J,MW;Q:W&EKYDYD"Q^<A 3).%],<5] -9VKP- ]M"T+G<T9C!4G.<D?6D:P
MLVW;K2 [CELQCD^IX]S0!YGI$5L/CUJIGGD5FTJW>W4W#@.>,@#.&'7CD#KB
MNE\;:):^)E70KET4WEC<K%N/(<&(JP'?! /X5U:V\*NCK#&'1=BL%&57T'H/
M:D>V@DF69X8VE7[KE06'T- 'SQXG;5;OX"QW.NQ&*\M)H]-B5S\Q6*0AF^I*
MJ#_USSWKI/B=XB:TN[ZTM-:N([F/1%N(H%F,*1,) 1)&RG,DA'&W& H)SVKV
M*:UM[@ 3012!<D;T!QGKUH^QVN,?9H<;/+^X/N_W?I[4 >375U>:_P".O"%@
M=<OX+74M!:2Z%G=%/,;8?F&#@-GN!GBJ_B&WUK^V/$6BV6O2O<I;6$.E2MJ?
MDFTQCS#+EE)9@"Q(#$@^X%>P_8[;S$D^SP[T "ML&5 Z8/:N.USX::7KVL7^
MHWL=G</>*J[KFU+O" H7",KKCIGD$Y/7&  #F-3O;VR\<^+-.35+T6]MX4,T
M:?:Y"$E4#YURQ(;@<]??FJ/@34[\>+_!RR:K?7 U+0'ENEN+IY1(X9L-AB0"
M,8X]#[UZY8Z)I^GV%M9QVZ.D$"0*\JAG954*-QQR< 582QM(W5TM8%9/NLL8
M!'TH L4444 %%%% !1110 5Y7XGN+F,>/KF+5;^*33$MY[18[QU6%S$&^Z#@
M@G^$Y'/2O5*KM8VCERUK Q?ER8P=WU]: /.];U&]\/ZIXDCL+V\EC72;6\82
M3/.8RTTB2R("?E_=C.%P/E& *=+J5E:VES=6_BU[ZRO+JS1$M9SY<+L_W3,S
MN45P/F&<@#(&6Y]$2TMHY/,CMXD?&W<J ''IFFK86:6S6RVD"P,<F(1@*3].
ME 'ET&JSW5I;VXUJ;*>*_LF8+QB?(8$A-V<LOH3Z<8J[;SZF++4+'3]0\^2S
M\0R06]M>WL@-S&(-_D>=DL""S,"<_< /%>BM96CG+VT+'=NYC!Y]?KP/RIK:
M=8NC(]E;LK'<RF)2"?4\>YH QO"VO6%]I.G0"=XKR:%I%M+N</<;5<JQ)R2P
M!&-W?K6=XMDNM,US3[V.2]DM+Z*739+>&X=0LS#="X /RDE2F[MO'I74-IMJ
MU_;WAC7S+="D6% " \<<9Z<>E6F56QN4'!R,CH: . \.2ZA>:%<PZC<WBW6B
M6TUA<3>?(OGSC/[S.>3L5'![>:?2L_0)HI]=\"7M_>RF>X\-$^9)=./-ES;'
M!^;YB<DD=^^<5Z:T4;JZM&A5_O@J,-VY]:8+2V"(@MX=J9VC8,+GKCTS0!Y5
MX2EFL+3P1-:7=P[7R7D4D#7#&*0*CNH"9V@AE'(&>3DFM#2=1OKS3O!VHV]]
M<RZC?7)@U2W:9BN/+<S93.$,;J,8 QP.]>AK86:%"MI I0Y4B,#:?;TIT=K;
MQ3R3QP1)-)]^14 9OJ>] 'F6D:\[1>#H9M8E-RVK7EM=H]VQ9E N JR GGE4
MQGG@8KH/AJELGANYABG9YH]0O%E1IV=H_P#29<9!)VDCGMGKS76K9VR2F5;:
M%9"^\L$ );&,Y]<<9IZQ)&'\I$0N2Q(7JWJ?6@#RJP:_;3],U.UUG49M13Q'
M+9- ]X[I);_:9%9&0G!VQC=N(R HYP!3UNKFQ\-:YKBZIJ,CVFL3V<C-<R2I
M!:?:U#G9NY*QAL-]X GGICN?#?AQ- M98WDAN)WGFF\];?RVQ)(TA7J20"Q[
M^E:\5K;P*RQ011JWW@B  _6@#S?4YS!X9U>\TSQ0]_"UY9/$;69RMN6E1702
M>8Q8,#DJ3QGIR*B\3:W)I\?CF$ZO/;S036LEFANV5D#1QEM@SG:3OR!QUKMM
M2\.#4%BLUFB@TD-&\EG';@;G259 0P(P"5 (P<C/0\UK26=M+*99+>%Y"NPN
MR G;G.,^F>: /*?&>JPZGH7CVWO[]HKBS15LK<7)16@,2,KA00'W,7R>>@':
MM3Q%KE[8:OXIGTV\GE2+1;2YC2.0R"/=+*))$7D [ #P.PKT&6RM;B4236T,
MD@4J&>,$@'MD]J<+:!9C,(8Q*PP7"C<1]: //]6UFQL-)NM3T3Q!/=6$LUF+
MIQ<-<1V<1?#N&SN7<"-PW9 YX)S71>$Q'MU!K?7EU>T></$8V+I!E1E%<NQ8
M?Q8SQNK=BM+:" P0V\4<+9S&B *<]>!3H8(;:%88(DBB7[J1J% ^@% 'E5K?
M+I$-_'#=RQQR^*V@OV^TN6AMV8X8Y/R!FV*6X.&ZUV7AM[N/Q'XCL?/EGTRW
MEA-JTLAD*.R9DC#$DD#Y3@GC?BNC-O PE!AC(E_U@*CY^,<^O%$,$5M$L4$2
M11K]U$4*!] * .)\%S)I?B/Q;INI2K%J$^JO>Q"5L&:V=%$;+G[P7:5..A%6
M/$=Q:SZYX0EMV0H^LM\Z]'(M9AD'OV&:ZNYLK2]"BZM89PARHEC#8/MFG26T
M$I0R01N4^X60';]/2@#S33M?2X\5Z)Y.KS/;WMY?P3)->'S'QOVJT8($>&4!
M,?-CT)(IGA_7WD/@:*;6)7N9+B[@O$>Z+%L)+M60$\G<HQGG(XKTU;6W5]ZV
M\0?>7W!!G<1@GZX[T)9VL<AD2VA5RQ<LJ $L>"<^OO0!Y8?$&K:7H]V9I99Y
MUL([F/4[6X>>&YMC,BR3>63F.0(S' XZX/''8^$V@EN]1GLO$2:M9S")TCB9
MI([=L'.'9W/S<$KGCKCYJZ*"SM;;?Y%M#%O^_P"6@7=]<=:6"V@M8O*MX8X8
M\YV1J%&?H* /+Y_[4L$\9:K:7T\6O1:NGDVQVE9XL1K"A4C)5E) P>#G&"#7
MH-_XAT?3K>[GN]0M46R95G!E7,;L,JIYX)!&/K6@UO \ZSM#&TR#"R%064>Q
MILEG;2[_ #+:%][!FW(#N(& 3ZG'% &#X5GTR[GU2^M-0L[R]O)DGN_LLRRK
M$-H2-,J2.%3\3D]"*XW6X&^V^/KRUU*]M=3M)X);)+:X9-\OV:+8I0'$FY@%
MPP(].:]1AMH+8$00QQ \D(H7/Y4C6MN]RER]O$TZ#"RE 64>@/44 >=3ZI-J
M&N:G97_B)=&U6TNX&MK<;MSQ[(R B>8%E#MO4C:QR<=AB*\U2;3M0\320RM%
M;R>)+.&]F1L&&!H( S9'W1G"D]@2>,9KTM[:![A+AX(VFC!"2% 64'K@]12"
MTME\S;;Q#S?]9A!\_P!?6@#@;ZVUBXE\6:?I-]>-%:1V]U8,+ER5N,,SP[\Y
M*L%3*D\>9QVJ#3M6O-4U]TB?4%T[Q)#%=6#M/(# D9'G@<_)N!!7&/O#Z5Z/
M!;PVT*Q6\4<42]$C4*!^ IRQQKMVHHV#:N!T'H/R% $%KJ%E>2W$%K=PS26K
M^5.B2!FB;&<-Z''K7AFM7>N:1K_C_6+2\N(-<MKZQ%I  &%S [;$3:1\P(/;
MN/6O<K;3[>UN[FZC3]]<D&1\ 9 S@<#MD^_-2O:V\DZ3O!$TT?"2,@++]#U%
M '%>(_"NC1WDGB&ZBN7O)[BUF-C%(-MU=1!EA'(S_%S@@87)X!K#U3Q?J7@K
M4KRS^QPW=RD5O?7TK*V^[DFF6(K%SPJ+@+D'A0/4GU-X8I'C>2-&>)MT;,H)
M0X(R/0X)'XU'-96MQ/%/-;0R30\QR/&"R?0GI0!QWQ?N[JP^%^L7EE=7%K<P
M^28YK>5HW4F5 <%2#T)%<5=:WK&EZWXD3PY?W5];+X92]8O<-<"*Y) #*6)P
M2F6P.#CIQ7IWC3PU_P )AX4O-"-W]D2ZV;I1'O("N&X&1W45J:?816%JD2)"
M)-H\QXXPGF,!C<1S_,T >.W.I79^&6MZS8>)3)')I5M(L5O=R-+;3@@,Y?.5
M9NA7N0>O->D>"]+-IH\&HR:E?WMQJ%K;RRFZN#(JL(QDH/X<YY_"MU-/LHX&
M@2T@6)FW-&(P%)]2,=:FCC2) D:*B+P%48 H \+U/Q;*GC>T-IKUQ((O%0M+
M@RS>64A8 -%Y6<>4,$!S@DYXXR:/BW5M2MG^(-W#K6HQRZ7J5E]B5;V0)%O)
MW +NQ@\\=*]^-K;DDFWB)+B0G8.6'1OK[TQM/LF+%K.W)8Y8F)>3ZGB@#QKQ
MQ?7A\8>,84U;4(H;7PZMW!%#>R1HDP9<, K 9]NAS4UWX@O4UKP?<7FKW,-O
M?>&))9R;IDCEF\G.[&0-^3UZ]*]@;3[)B2UI;DD $F,<@=NGL*4V5JPB#6T)
M$1S&#&/D/MZ4 >'VVL:G<^ OAE+)K.H">^U<074RWCJ\R&5P0S9R>@'/2L^X
MU34++2M4N(=9U'?IOC,V=KNO9&"P;C\ARWS _P"UGI]:]_\ L%GM5?LD&U#E
M1Y8P#[<4G]FV)!!LK?!.3^Z7D_E0!S/Q/2-_AYJK2NR!%1@1(4YWJ.<$9'/0
MU4NYA+XDUK2+V_NK*UMM,BGL)%NW0D'S/-EW;LL5(0<DX&/4Y[:6WAGC$<T4
M<B#D*Z@C\C3)+*TE$0DM87$1S&&C!V'U'I0!YWHC:CKGB#1XM9OK^WN)/#\%
MY/;0W3PCSA*,L5!&,C@CIS@UL?$2:*!?"[RR)&H\06I)=@!T>NN^S0>?Y_DQ
M^=T\S:-WY]:2:UM[G'GP12[>F] V/SH Y;QEXFBM-$E_LZ\1Y$D@:[DMW#-;
MVS2JLCY'W?E+8/L3VK&UK4GT?4-<A34KT:,;2SD\U+@LT$\DQ3:LC$[%9=I)
MS\H.X8SSZ%%:6T 80V\48?A@B ;OKBD2RM(K8VT=K"ENV<Q+& ISUXZ4 >5R
M:Q</:ZK;1ZS(K6_B6QBB^SWK/LAD\C<H8G+)EGZ\=>.U=AX3=X==\4:8+JXG
MM[.]B\A;B=IFC#P1NPW,2V-Q8X)XS72-8VC@AK6!@2"08P>@P/TXIT=M!"[/
M%#&CO]YE4 GZT <%I=I<WWQ!\:K9ZK+:LD]D66-4(<"!<@Y!(S@C@CK5/Q5K
MZVVMWK6^K2PS66J:?%(DMT8PB.T>]4C'#(5<EF;OD#H"/2([2VAE:2*WB21N
MK*@!/XT/:V\CL[V\3.P 9F0$D Y&?H>: .&TS5K75=8NH[W6[BTU>TUEDCLX
M[C:980<1KY1X:-D(8MCU.1CC+N[IY?#NH+-=R3"'QA!$AFE+E%6ZAPH)/0>E
M>G?9H/M/VGR8_/V[?-V#=CTSUQ4?]GV14K]CM]I.XCRQ@GUZ4 >9^+96GL_'
MUO-=W#P6SV+HAN&Q$"%+8YX'4XZ?E6SJ\]SHNN6]QI]S=W=CK5L;&W!N9)DA
MNADQN,L<*R[LD?W >]=L+.U!D(MH<R##_(/F'H?6J"Z3<-K?VV>_:2SAP;2R
M$*JL+;-I;<.6X+8!X&X]>, &%H$+P?$'7[6:6:06VG6$5N\SEG:/]]N;<>22
MP.3["N<M->F@TO28K_5FAT^XU;4;>:]N97(!2:00HT@=2 0#CYOX0*])FTV*
M34XM00[+E(S"S 9$D9.=K#V/(/8Y[$@R&PLS;O;FT@,+G+1^6-K?4=#0!YOJ
M$^H6&B0/;:V^NVEK:7#SB.Z:VN'AW\31.&(D* %?F//!SD\[VJW@3QYX5NXV
M,44MA>M<&3Y<0A8FR^>F&V]>F375R65I-Y?F6L+^5CR]T8.S'3'I4 TR)M0G
MOI3ON)(O(5B!B./.=H!]3R?7 [ "@">SO+;4+2*[LYX[BVF4-'+$P96'J".M
M>:^%,S_%/XEQ02*)9%M%0@]#Y3#/X&O2;&R@TZSCM;9 D29P/<DDG\22?QI8
MK*T@D\R*UAC?^\D8!_.@#P;P?87;M\++-(W2YL)]4:[3^*$+)AMWIZ?C7?2>
M#M.T'5[6+1)+@:G.)TM0[!DL89'#32@8R<9 7<3RRCIDUWJ6T$<TDT<,:2R8
MWNJ ,V.F3WIPAB$YG$:"9E"&3:-Q4$D#/IDG\Z /-_#WC2>+Q-:>&X-,BBTX
M:C>Z7&HW&6,6\:.)6).#N+'/'<')[^EU ME:I=O=K;0K<N-K3",!V''!;J>@
M_*IZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH *X'5_B-=:=J_B2P@T%;D:#;QW4\AO-F^)EW':-A^8#MTX//3/?5Y
M)-X:U'7?B5XYM1)<V%AJ5G;VYN6LV9)5$85PC' W#D9R1R>#V -V_P#BGIL(
M0V-M]J_XEB:HZO,(W,;D;41<'?)C)V\=.O-27'Q!O7\2W>AZ1X<EU*YBLXKV
M,BZ6(/&Y7KN'RD;NG.?SQ*OP\CT_7-/U30=6GTU[:P33I4\I91-"F-N<]&&!
M\W/3IUSHV7A,6?CB\\3"^9WN;1+0P-'T5<$'=GDY'IWH UM8U%M)T:[U!;.X
MO&MXRXM[9-TDA'91ZUR-K\24N!XGC.G)]HT*T6[98[G<DR&,N5W; 588(((X
M-=3XBT@Z_P"'K[21>36?VJ(Q^?#]Y,^G\C[$UREG\,4L_P"VBNM3R'5M,33I
M=UN@"!8_+#*%P/N]!^>: '>'_B-)K>LV&G2:-]E.H:2-3M7-T'RN<;6 7Y>A
MY&>.P/%5/#_Q6.MW'AL2:&UK;:Z]Q%#+]J#LCQ=<KM'!XYSGKQW-_2/AV-(U
M?2-1CU4R/IFE_P!F1HUOPZ9)#'YNO(_*JFD?"R+2%\,I'J[R+H$\\T.Z  R^
M:<L&^;MSC% #/^%J@6OGMHQ&/$7]@N!<YP^/]8/DY'7CBEUSXHS:/>>)H5T'
MSX_#YMS<2?; N])<8*C8?F&1QTX//3*3_"A))YO*UN:.V?7!KB0&W5MLW<%L
MY*^G3'OUJQJWPS35IO%4CZL\8\1"!9@( ?*$6-NWYN<@<YH TM!\:MK'BN\T
M&?33:R0V<=[#)YXD\R)\8W  ;6&1P"P]Z=XXO+ZVMM(ALTC:.[U.""8/*4W*
M6SLX4\-C!]N,'-&D>#/[+\6R>(#J!EDDT^.Q:'R=HVIC#9W'G(_6M/7]%DUH
M:>$NA;_8[R.[&8M^]DZ+U&!SS0!A)X@M?#ND:G)96$DNEZ1<%+QOM+.T9.'D
M\M6!W*@<<97H0!QSHVOB:ZOO$EWI=KI)>"TDB$UT;A0 DD9=6"XR>PQ[U#<>
M#$F.LVZ7ICT[67\R]MO*R2Q4*Y1L_+O50#D'U&*T=,T,Z=KNJZB+E72_\K]R
M(MOE^6NT8.>>/:@#%^(LTEMIVC2QS741.LVD;_9I'5GC:0!EPI!((XQ5>^O?
MM7Q,\-P1'4(('M+QI8I#+$DA01;"5) ;&YOSKH/$F@OK\-C&MV+;[)>Q7@/E
M;]S1MN4=1QGK3;[0);SQ1I>M_;41M/BFB6'R<AQ)MW$G=_L#'X]: .$\/:J-
M0UC6/"L^H7L$EQJMV5N);B0,T,<@ A@<GA@.N#\JG(&3D=%XP@\G5/"%K#<7
M<4,NI>1*([J13(GDR-AB&RW*@\^E+)\/HKC1-4T^XO@\MY?R:C!=)"4DM)W;
M.Y"&SD=N?KFKEYX8U*_717N=;CEN=*N/M"3-9X\YMC)\X#@=&/3'- %&XGN?
M#GQ$T+3[>[N9M.UN.X1[:XF:7R9(D#AT9B6 (R",XZ5:\::I=6]WX?T>UF>W
M_M:_$$T\9PRQ*I=@I[,V ,CD9..<&M&U\.J-?&N:A=/>7\<1A@^0)%;H3EMB
M\X+8&223QC@5/KNA6^O6L$<SO#/;3I<VUQ'C=#*O1AG@]2"#P02* .>\1RMX
M4U7PY=Z<\HAOM3CTZZMFD9TD60-A\$G#*5!R.2,YS5+QO+-)H%_J<-S<0'^T
MK2TA>"9XSY:SJCCY2.K-*/H!732:!-?ZC9WNJWD5R]BQDM8HH#'&LI4KYC L
MQ9@"0.0!D\9P1!K/A7^U/#%MHD=[Y"0O#(TQBWL[1NK@GD=67)^IH R?$SS^
M$]4\/ZAIUW=FWO-2ATZZLYKAY4D67(#J')*LI /&,C.:[FL&3PXU_JUEJ.KW
MGVMK%C);6\<7EPI)C'F%<L68 D#)P,G SS5O18M3ABNQJ=U]I+73M;L8EC98
M3C:I"\<'=@]2,9YS0!S8M1>_%34[.:YO?LRZ3;S+#'>2QJKM)("P"L,$A1^5
M<_JVIZE9Z)\0M#?4+N7^Q;9+FQO#,PF198V8(7!!)4J<$\D'G-=J_AV]7Q5=
M:];:E#')<6J6AB>U+A41F8$'>.<N?;IQ5:X\#6\OAW6=,2]E-SK.XWU_,@>2
M0D;> ,  #A0. .U &1XN,_A7PE!XFTR]O5FLC TUO+=22QW,;LJLA5R0#\V0
MPP<BKWA^9O%6N^(KB_>4VNG:@VG6MJ)&5%V*I9R 1N9BW!/0 8QSG1N/"SZH
MMC#K-_\ :;.S=)%M88?*CE=/NF3)8L 1G (&>H-/'AN:QUR\U31K]+0WY5KN
MWF@\V*1U&!( &4JV, \X.!QGF@#2TS3SIL4T7VF>='F:1#/(79 <?+N))(!S
MCVKF/#LS>*]6\1W&HO*T%AJ3Z=;6RR,J(L:KE\ C+,6)R>@ QCG/7VT+P18D
MF>:1CN9VXR?8=A[?S.360GA^2QU:^U#2+N.U:_*O<PS0F6-I ,>8H#*58@ '
MD@X'&>2 <_HVM7_D^)M$>XDEGT^_6RLKESN?;,JE-Q/+%-QR>I"\\Y-+I>G1
M7/Q \2Z?)<7PM+:ULO(B2^F18]RR;BH5AC.U?RKH-,\,6^F21R+,\LIN)+RX
MD<#=/.Z[=YQP %) 4#&,>G,">'+ZW\1ZKK%KJD4;ZC'%&Z/:[O+6,,%VG>.?
MF.<@CIQ0!2\%:E?-J?B+0;VZDO/[(NT2"YEY=XI$#JK'NRY(SWXK:\4;AX3U
M=D>2-TLIG1XW*,K!"001R#FLT>&[G1M*:+0KZ5;^XO1<W5U.B2-<L3\V_. J
MX 'R@8 P!71W%O%=VTMM.N^*5#&Z^JD8(_*@#DHM\GPBMYFN+GSSI"3&;SW\
MPN8@=V_.[.>>M4?%%Y+H7B%KS6;/4+CPT]K'''=64LF;"0%M[.J'=@@K\XR1
MMQWK;L?#%Y:Z1;:)+JPFTFW58E0VV)GB7&U&DW8(P "0H)'IUJ]/IFH_;[JX
ML]3CCCN54-!/;>:B$#&Y<,IR>^<C@<>H!R=VL<^N> ;:#5;JZL[BWG62:*[D
M4702 %7;:PW'//XU>@N;K0OB5;Z&EW<7.F:G8R7"17$K2M;RQL 2KL2VU@W0
MDX(XQTJ>+P.+%O#O]F7X@30XY$@6:#S/,,B[6+89?<X&.3^%:FG^'8[;6Y];
MN[F2\U.6(0"5E"I#$#G9&HZ GDY))/>@#+\5:E<GQ3X9\.PS200:I)/)<RQ,
M5<I#'NV!AR-Q(R1S@'UJ'5IW\,^,/#D=B\GV+59I+2YMF=F7(0NDB@GY2"I!
MQU!YZ"M[6M"AUAK*X\UK>]L)O/M;E "8VP001W5@2".X]#@U7E\/37FHQZE?
M7R27MM#)'9&*#9';LXPTFTL2S8XY.,9  R30!S/BAY9[?2[Y+FYB6^\16T \
MF=X]UON,>W*D95MI;_@=7-8EN/"WB[PZUE=W4ECJMRUE<V<\[3 -L+)(A<DJ
M05P0#@@],\UKZWX8_M.PTFSM;M;2/3+F&YBS%YF3%]Q3\PX]>_TJ5/#GGZ];
M:SJEVUY=6BLMK&L?EPP%AAF5<DEB.,ECQTQ0!=U;4)--M$FCMC.6E5#E]B1@
M]7=N=J@=3@UST7CHSVNFRV^EM-)>:C-INU+A=JR1B3D,1\RGRR<X'!Z=JV?$
M&BR:W;V:Q7K6LMK=QW2-Y8D5BN?E921D<YZ\$ ]JQ[;P1);2VC#5WD%MJTNJ
M*)(%R6D#@J<$<?O&Y^G QR 367C(7<-O";'R]4FOYK 6IFRH>+<7;?C[@5<Y
MVYY Q47@*2X>'7Q<AUD36KA=C3&7: $X#'DCTZ?04P^!9%=;J#5C%J$.IS:C
M;SBWRJ&4$21LI;YE(..H/3FMCP_H4FAC4#)>M=/>W;W;$QA C, " !VX[F@#
M%L;F3Q'X[\065W)(+#1A!##;(Y59'D3>SO@_-U  / P3C-,\3>'KN+29$TO6
M+ZUNIM0@>UE:X=A 243:03\T9VYVG(^8UKW/AR2/Q#+KFDWPLKNYC6*[22'S
M8K@+G864,I# $@$-TZ@U8NM)N[JWA5M0'FK<1W#LT.5.P@A57=\HX]2?>@#G
M=.U]M?NM(M[Y)++6;+4&M]1LTE90&^SS,#@'YHV*AE)R./:H)9[SP=XNN+8F
M[O['71_Q+A+.\GD70',)))VHP^<'MM;T%=->^&+"\\3Z;XAP8[^Q#IO3_EJC
M(R[6]<%LCTY]:37- DUC4=(NUO%@_LVY^TJABW[VV,F"=PP,,?QH N:/I@TG
M3(K3[1/<.HS)-/*SL['J<L20,]!T%<UHT[^)_%/B1;YY#9Z9<I96UJKLJ@[
MSR, 1N)+<9Z <=3GM*PSX?>UUR[U;2KI+6>^5!=QRP^;'*R#"O@,I#8XSG!
M''&: ,#2M;OK._\ %NA^<\[:7- MA+,Q=O\ 2$!CC9CRVUSC)YP1FFV>FHWQ
M'OM*>ZOS9V^C6K1QK>RH Q>12V%8<D*O/M706'AB"QG^T&=YKF6[-Y=3.HS/
M)L**/0*HQ@=MH[Y)B?P[>KXIN]=MM3ACDN;6.U,3VI<*B,S @[QSES[=.* *
M'A&_O8_$WB7PW=74MY#I<D$EM/,VZ3RYD+;&;^(J0<$\D'FNEU;4[;1=(N]3
MO&*VUK$TTA R<*,\#N:PG\-7>DZ1?'1+^8:U>W"SSWT\:2-,XP,,#@*FT;<
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MU!?>([R#Q.-#L]':ZD^S)=&4W"QJ(S)L;@CJ.3COBKNBZ=J-A"W]IZQ)J<Y
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M=$))ODCV2*X"L0&89! Z$<BJ-\ESK7C;6=.O;<2V5G86TT"Q7;QR(S/,=ZD
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MV( #Y#X)]_6M3166Y\7>&[NWT:_LXH='GM)O.L9(A"^Z$K&25 XVO@]#S@T
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M1SG&>(K"PU#3/ 7AC68-/F76-%(MVMKA?*>:)V\MXN?JI7W48ZT >EOJ%E%
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M'R]>!@ ]5;(4[0"V. 3@9KBD\>72^&+OQ%<:-&MA97$L5P(KS?*JQR%&95*
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M#O#DJ<J=@R!@8&8M#TAK&T\(RIHUS!<0:Q>-<,+%U=(6%P%W';D*=T?MT]*
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M-;R^9H4FI1S>0?*\U&4?N^59HCNX+8)P""0:=8:]K%TUI;ZC/;S0ZGX>DO\
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M)&^"N0RD'HQ'H0:DL--@TZ-A$TTCOC?+/*TKMCIEF)..3QT&3ZU<HH ****
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M2--9!=R);,5B#C(8GNN#U&?;.#0!;O\ PKHVI3WTUU:NS7\ M[H+/(BRH,@
MA6 S@D9ZX)&<4Y_"^CRW$L\MJTSS6@LI!+,[J\'/R%2Q!ZGG&>:BC\6:8TU_
M%-]HM7L8DFD%Q"4+1N2%=1U()4C'7/&*C7QEI?F74$@GCN[:2&)[9E!=C,=L
M6W!*D,>,YXP<XH ;%X&T"'2)=*%K.UI*4WJ]Y,S80Y10Q?<%!Y"@X]JW9;>.
M:V:W?>8V38<.0V,8^\#G/OG-8;^--*BMHI9%NU:2^;3S$(&9DG&<J=N1VX()
MSVS3[;Q;I]W;*\<=P)VO&L1:R($E\]5+E.2!]T%LYQC\J 'GPEHO]GZ;9+;2
MI#IA!L]ES*KP_*5P'#;L;21C.,4V#P=H5M%9Q06;1I9SO<6X6>0>6[YW8.[[
MIR<K]WVJ[)K-I!H<NL7'FP6L432R>9&=Z*N<Y4<YXZ4FFZU;ZE=7EHL<T-U9
ME/.AF4 J'7<IR"001GH>QH JZ?X2T72]5FU&RM&BGE=I"HF<QAV^\RQD[%8Y
M.2 #R?4U-J7AO2M7O([N]MW>>.%X-R3/'NC;&Y&"D!E.!P<BL'QIXFDMM%NO
M[)EN5FM;RW@FN(45D1FD0-&Q;G[K\D#@D<@UKWWBS2]/NQ#.\@C^TI:/. #'
M',V-JMSGG(&0" 3@D4 $?A#18K>.V6WF^SI#'!Y+7,C(R(255@6PV"3UZ]#Q
MQ5_5-*L]9LOLE]$TD/F)(-LC(RNK!E8,I!!! .0:QCX[TA6YCOO*^VFP:7[(
M^U9@<!3QGD\# ZX]14\7B[3I8)W\NZCG@NTLGMI(MLOFN%*#&<8(8'.<8ZD4
M .G\'Z'<Q:A'+:RLFH%#=#[5*/,V !>C<8  XQTI9O"&B3ZT-7>T?[;A [+/
M(JS;?N^8H;:Y'8L#4+>--*2WMI66[W7%Y)8+&MNS,LZ;MR'&1GY#W.>V:EMO
M%FG75BEQ&MP)7NFLEM7CVS&=<Y3!.,@ G.<8&<XH NZSHMAK^GM8:E$\MLS*
MS(LSQY*D,,E2#P0#^%0Q^&M)2^%Z]N\]RL31+)<SR3E$;[P7>QVY[XZUF^"]
M3O-377C>2SN;?5I8(EG55:- D9"_*,<$GGG/7)ZU!X?U^2*VU+^TKJ6ZF_MJ
M>RM5VKODP?E0  #@ G/' ))H N6_@7P]:K&(K2<>7;/:(3>3$K"V,Q@E_N\#
M [=L597PGHR&V*V\P-M:-90D74ORPMC*?>_V5YZ\#TIJ>*].DA)43FY6[^PM
M:;,2K/C=L/.!\OS;L[2.<U"/&NDF'3Y%6[=K^:6WAC2W9F\V+?O0XX!!1A^&
M>G- %FQ\*:-IMW:75G;2136EJ+.%A<2'$(.0A!;# =MV<59GT6QN-6CU22.3
M[;' UNDBSNN(V(+# ..2 <XSP/2C1]9M=;TW[=:"4('>)XY$VNCHQ5E8=B""
M*Y/3/$5S>W<NHW4VH6ZQ:K-I\5DD:%+C!**GLP*EBV1W&<4 =!!X0T.VBTZ*
M*TD$>FAQ:H;F5A&&!##!;Y@02.<U7A\):;HD<=YHVGE[^RMGALTGO9=NTX(C
M)8MA,J,#!"]@*LV_BFPN[:"2V2>6>>66%+4*!+OB8K(""0!M(P23CI@G(S6@
M\06&K:II M;V_B-[:3RQ0^1M1PI4,7W+PR'H,]SD$8H O:%ICV4=W=W,%O#?
MZA/]HN5@.Y0VT* &P"V%5><#)R<#-+J/AS3-4U"#4+B&07<,9B6:&=XF*'DH
MQ0C<N><'(KFO#.OR7.D>%CJ.H7TE_>-<8$<2[+DH)"0YVX& N0 1R!VJ_H_C
MBWU&TTR:YL+JU.I74MM;[E4KN1GP"P;@[4)]R"!F@">3P'X=DM=.M_L<L:Z<
MABM7BNI4D1#U3>K!BO'0G%7W\-Z7)(6:W;86B8PB5Q$3'C9\F=O&U>W89Z4X
M:W"TRQI;7C@W9M-Z0EE# $EB1T48QD]^.M:= '(Z]X35]/DBTJR647-^M[>P
MR7TT32D#[R2 DHV0AXP"%QQUI=,\(126DL.J)=_9FEAFBM)-5GN#%)&Q8/YA
M((YV_*"1\@/>NMHH PKKP?HEY+=2S6TQEN9X[F2074JMYL8PCJ0V5( Q\N.*
M0>#="$#PK:2*CW8O25N90PF'\8;=D'DYP><G/6MZB@#$C\(Z)#KDFL16;1W<
MC"20),XC=P,!S'G86']XC-6M2T/3]7GM)[R)VFM&9H)(YGC9=PPPRI!((Z@\
M&M&B@#"LO!^AZ>]DUI:RQ&Q61+;%S+B,28W@#=CG Z],#'2F#P5H26UC!':S
M1"Q=WMI([N59(BYRX#AMV&[C.*Z"B@"AI6C6.BZ=]@L(GBMMSOL,KM@L2S$$
MDD9))X]:IVOA+1;-=.6"VE0::[R6@^U2GRV<$,>6YR&/7/4UMT4 9-EX9TG3
MYHY+:V*"*1Y88C*YCB=L[F1"=JD[FZ ?>..IJ'_A#]$\D0BUE$0O/MRHMS*
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M$;MQ+'.!U'4BMZLZ]UFWL=7TW398YC-J#2+"ZJ"@*(7.XYXX!]:T: "BBB@
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M#DXS0!-17-Q>.-(;3K/4IUN[73[P(8+N> B(A\;2S#.P'(Y; YKI* "BBB@
MHHHH ***9++'!$TLKJD:C+,QP!0 ^BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \K^.TB)X;\/[G5?\
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MLK5(/(2VA6+.?+$8"Y]<5)Y,?R?NT_=_<^4?+QCCTXH ?7G&BZPFI0BY.JW
M\46MS=K+I:W'^L8%PL;1'I&!L(8 = <Y)SZ/4:P0K.TZQ1B9P T@4;B!V)H
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MVD6UELY%AV$212$$CYE.#E1R,&@#*?QEJ-S/!%INE6[^?HZZK&T]T4P"1\A
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MF,(D"[ "F[&>0>>G'.O%X22UURZO[75;^"TNYA<7.GH4,,DN!ELE2RYP,A2
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M#'#++L5-ZQ[MI(4 %OF.3]   *M:QI=OK>C7FF76?(NHFB8KU7(ZCW'4>XH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M6&W$LJ^<".3QCS%Y.._I6UIUE<IX\DO?L,L5FVC06PD*@#S%DD8KC.> P]J
M+>I^*+.VO;[2K>XA.J6]DUT(Y.G0D#J"<[2<#M3O#7B6SU[3+(_;+1M2DLH;
MFXMH9 3'O4$_+DD#)QS65J]CJ \7:G=PZ?-/;7>ABU26,KA95>4[2"0>=ZXX
M_+%8B>'-6GL]$LXK.6TD3PM<:;+,< 0W#K$%!P?5&.1D?G0!Z#::MIVH320V
M=];SRQJ&=(Y Q"GH<#L<'GIQ45QK^CVEZ+*XU2SBNBZ((7G4/N<X08SG)P<>
MM8'A.VEGO(KZ]\.7FFZA;VGV66:ZN?-#<@E(L.V4R,Y(';'?$W]FW$OQ$U"]
M:T=;:328+>*Z*@@2+)(Y YSQN0],9'M0!MC5[&XGFL[2_M7O41F$6\,1@X)P
M#D@'@X^E9>@^*8+SP;I6MZO/:V;WELLSC=M0'&3C)S@5A>$M-NK>+3(=5\.W
MD6HZ-;M!]MDNO,B<;-I,(WDG?A3@J /J!69I6DZUHVF^&9+K1-0O((=*.GW=
MI:3A)8)-RG=C>H93C!Y[ T >CQ:MILUV+2*_MI+@Q"<1)*I;RST?&<[3Z]*A
MD\0:/#%%+)JEFL<J[T<S+AESC=G/3/&>F:YJ^\-WMI'H%SH-JEE-;1M830K)
MGRK64?WCG<8V",/7!QUJAXVT;5+N'5]-TW19'MY=%%O:RVQC7>ZE_P!W(S$,
M%7*E0."6;.>P!V5WXDT.PFDAN]8L8)8F59$DN%4H6SM!!/&<'\J(O$&G3>(;
MC0TN%-]!$DKIGLV[ 'J<*2?3(KC-8TG4K_\ X31TTBXWZEHD-K:A@F7E"2@K
MD' P73G...IQ6WI-I?V_C:XO);&;[+=Z5:Q"8E<1O&TI96&<Y^=>@/Z4 6-5
MUK4K?QAIFB6HM1'?6T\_FRQLQ0QE!C 89SO_  QWJ[%K*65D)=:O+"!F9C')
M')A)(QSO&3GH>?3UQ6)KVCMJGQ"T*XN-*^UZ;;6ES'-))&KHKN8]O!Y/W3R!
MQ3=?TN[AN=.L-,TAWL(].GM4FMO+$D1(0+&6<C;&0O)7G*KT[@'3W6L:98P)
M-=7]M#%(N]'>4 %>/FSZ<CGIR*HWVKRQ7&HK:7NG2&VL?/6WR6E5_F.Y\-]P
M@#' .<\UQVC66M:0NG?;O#EUJ%G=Z#:Z;/;JT3-!+$&#*X9PNQP_7)Z#(K6N
M-,OE\2:G-'IK+ _AZ.SC,(&PRJTA\M>AP ZX. * -/2O$+7MGH=S<WFG0-=Z
M:+RYMR2).41MR#=P@RV<Y[<U8TGQ;H>L6]G+:ZC;[KTM]GB>0"23'7"YSG&#
MCL#7/:/IFHP7_@=I;"=%T_1Y;:[8XQ%(5A 4\\\QMR,CIZU2ATC4;'X7Z:9+
M-[36O#Y$UNLK+^]="0R J3\LBLR>OS#CI0!Z'!=6]T91;SQRF)S')L8-L<=5
M..A]JQ/#&MWNM7&M+=);HFGZA)8IY2L"^U5;<<DXSNZ>W6M/2+-[#2XH9B&N
M#F2=EZ-*Q+.1[;B<>V*Y3PW)J.B3>)&GT'4I!=ZM-=V_E",^9&R(!U<8)*G@
MXH ZV[U;3K"5(KR^MX)'("K)(%)R<#KZG@>IK'O/'6@V2:NTMXF=*8).H/S%
MR =JCO\ >49Z9/M7/WVF:C-K>J0:KX>NM3LM8C@=/L]WMBA=8U5HY1O7Y0R[
M@P#=3QGBFZUH>KSVOCBT@TV60W\D%Q:R!TVRA8H5*C+9W9C;J,=.>: .WGUS
M2K98FGU*UC6;!C+2J P)P#GW/ ]Z8WB+15OOL+:M8BZWLGD^>N_<J[B,9SD+
MR?:N/U&POKC7M36_\-W^HZ;K,,/EI'=!%A95VM',HD "_P 61NZGJ:U=%L;B
MR\2>*;V;39"DTD$EL^%S,$MU0A23G.0P&<=?>@#I[2[M[ZTBN[2>.>WF4/'+
M&P974]"".HJ:L_1+Y-1T:VNH[22S5UQ]GD !C()4K\I(X([<8K0H **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@"E_9-D-8.K>4WVXQ>1YOF-]S.=NW.,9YZ
M=:NT44 %%%% !5+^R;+^V/[6\IOMWE>1YOF-]S.=NW.,9YZ=:NT4 %%%% !1
M110 4444 9$OA;19M0EOGL$\^8[I2K,JRG&,NH.UC@#J#6OT&!110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !5"\T73M0U"SOKNSCFN;
M,DV\CC/EDXR0.G8'VQ5^B@ HHHH **** "D90RE6 *D8(/0TM% "*JHH55"J
MHP !@ 4M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 45BV%_=S>*]9L9I%:WMX;:2
M%0F"N_S-V3W^Z*VJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MTW_Q-3/X@TQ+M;9[G:[2M"K%&V&15+%-^-NX 'C/8^AJL/%^B&$2_:I-I:%
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M9U9MZ[B%/0C.>:MZSJVM0:9J&HZ:MAY%GYK@7*N3*(QAD&TC:2RN-W/\/!H
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MC_A)+;_GPU;_ ,%TW_Q-;-% &-_PDEM_SX:M_P""Z;_XFC_A)+;_ )\-6_\
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M )\-6_\ !=-_\36S10!C?\));?\ /AJW_@NF_P#B:/\ A)+;_GPU;_P73?\
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MM?"OV*R\+Z1$[O;:,RSR3MG]XRQ,B@9)QEG+8S@!<=Q75T44 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
# ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>exhibit1033-bochk_facili007.jpg
<TEXT>
begin 644 exhibit1033-bochk_facili007.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MY)4MU^7.2/:O7K;Q9HU[JRZ99W,ES<')S#!(\8QUS(%V#\Z -NBBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MP"15Q(9-I?)P>G;..>E<SX?\9>(KOPCX$:XO9<ZWJ$T-_J!4;E"R,$C'&%+
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MP$A<E<;_ # -P&,#C(QT]JVY]1U&'P1J^I/>75K?1Z3-/;Q22JY<I"KB=?\
M@38(Z= 17:?V5IWV'[#]@M?LG7R/)7R_^^<8IBZ+I2*ZKIED Z>6X$"_,G]T
M\<CVH \ZTOQ-KD%W\/0EY)??V[9[]0MY%5BN(U;SE(&5P2<CH>@ ->IU6M=.
ML;'/V2SM[?("GR8E3@=N!5F@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KD-2D\1Z9K^
MDSC5$N;>^OOL\NG?9U"QQE6;>CXWY4+DY.#SP.!77URL5OXM.O-=SVFB>27\
MM)/M<K/#!D9"IY0&X@9/S<D#L!0!U5%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 445AZAI>NW-[)+9>(_L=NV-L'V*.3;P,
M_,3DY.3^- &Y2,JNI5E#*>"",@US?]B>)_\ H;O_ "FQ?XT?V)XG_P"AN_\
M*;%_C0!?E\+^'YWWS:%IDC_WGM(R?U%7+33;'3UVV5E;6PQC$,2I_(5B?V)X
MG_Z&[_RFQ?XT?V)XG_Z&[_RFQ?XT =+17-?V)XG_ .AN_P#*;%_C1_8GB?\
MZ&[_ ,IL7^- '2T5S7]B>)_^AN_\IL7^-']B>)_^AN_\IL7^- '2T5S7]B>)
M_P#H;O\ RFQ?XT?V)XG_ .AN_P#*;%_C0!TM%<U_8GB?_H;O_*;%_C1_8GB?
M_H;O_*;%_C0!TM%<U_8GB?\ Z&[_ ,IL7^-']B>)_P#H;O\ RFQ?XT =+17-
M?V)XG_Z&[_RFQ?XT?V)XG_Z&[_RFQ?XT =+17-?V)XG_ .AN_P#*;%_C1_8G
MB?\ Z&[_ ,IL7^- '2T5S7]B>)_^AN_\IL7^-']B>)_^AN_\IL7^- '2T5S7
M]B>)_P#H;O\ RFQ?XT?V)XG_ .AN_P#*;%_C0!TM%<U_8GB?_H;O_*;%_C1_
M8GB?_H;O_*;%_C0!TM%<U_8GB?\ Z&[_ ,IL7^-']B>)_P#H;O\ RFQ?XT =
M+17-?V)XG_Z&[_RFQ?XT?V)XG_Z&[_RFQ?XT =+17-?V)XG_ .AN_P#*;%_C
M1_8GB?\ Z&[_ ,IL7^- '2T5S7]B>)_^AN_\IL7^-']B>)_^AN_\IL7^- '2
MT5S7]B>)_P#H;O\ RFQ?XT?V)XG_ .AN_P#*;%_C0!TM%<U_8GB?_H;O_*;%
M_C1_8GB?_H;O_*;%_C0!TM%<U_8GB?\ Z&[_ ,IL7^-']B>)_P#H;O\ RFQ?
MXT =+17-?V)XG_Z&[_RFQ?XT?V)XG_Z&[_RFQ?XT =+17-?V)XG_ .AN_P#*
M;%_C1_8GB?\ Z&[_ ,IL7^- '2T5S7]B>)_^AN_\IL7^-']B>)_^AN_\IL7^
M- '2T5S7]B>)_P#H;O\ RFQ?XT?V)XG_ .AN_P#*;%_C0!TM%<U_8GB?_H;O
M_*;%_C1_8GB?_H;O_*;%_C0!TM%<U_8GB?\ Z&[_ ,IL7^-']B>)_P#H;O\
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M7^-']B>)_P#H;O\ RFQ?XT =+17-?V)XG_Z&[_RFQ?XUT%LDL5K%'/-YTRH
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M3Y8EV \X&6![TW6IY+:/54AU&6+1EUO3ELI([IE5=SQ^>BL#R@SG'(!+=,<
M'JAGB%RMN9%\YD+A,\[00"?IDBH[RYDMHD>.UFN2TJ(5B*Y4,P!8Y(X&<GO@
M=*XFRTW2]'^*4-O&63S-''V?S9WD:1O.<L 6)+8#=.<"M+Q_<"UTS2I?M3VY
M&L6(RLI0,IG3<#@C(VYR#Q0!UE%>1WES##%KFH+J<_VFS\56\<#->N0D;-;A
MUP6P5(,@(/& ?2NBEMKFU\97NBKY\EEK:QW<4N]B(!&0)T!S\H(V$8Q@R'%
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MB@ I."2.,]Z6N'U;Q*=$O?&%Y!H]JUSIEE;3M+YQ5KE")2 QV\;=IP.>O44
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MW,3?;GV!(WC7#?N\@D2=L\^U '4VD'V6TBA+*S(H!8+MW$#KBI0JJ,!0!G/
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M0 8'I2%58$$ @]012T4 )@   # Z4M%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 45Q_Q$\7W?@O2;&_M
MK6"Y%S>I:%)"5V[@QW9'IMZ>]6YM7UFWCU*5XK":"VM9)4FB+X\V/[T; ]..
MX)[^E '2T5PGA3QAK?BCPYI&LQ6>GJ+Z4[[7>_F)$LPC=U/0XR&Q@=:U-?\
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M0/'&V-V,+C<<+DD?PC@51'@6" Z7)8:OJ5E<V%FMA]HA,9:>W7HCAD*Y'8@
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M7LMQIXEPTA0^>9  Q?Y?88"[0,<"M.]U33]-V?;KZVM=^XIYTJINP"3C)YP
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ME1UP%&:[RB@#S31;368M=T"_N=!O+=+6"^BN(8A$(H"[(RB,!LE3M/)R23^
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MLF%6YCC2 ,F>V[RF7G'7TKT4D $D@ =2:6@#S?Q3HVH:XGB+4;&PN4%YH/\
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M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\UO\
M5KO0M7\:ZBM]*P@EL8E69EV0I($!;[IP$#LWIU)!KTJJ,FC:9-=W%U+I]J\]
MS%Y,\C1*3)'_ '6]1[&@#B]:N_$6E:=>2KKD6U[RP^S!"LSQI+,L;AB44%6R
M2O?KSBI[A-:A\2R:*/$M^T(TB2Z$QB@\SS/-P#D1XX! Z=NU=%!X3\/VVF_V
M=!HUE'9F03&!8@%+CHQ'<C P>V!5R71].FNVNY+.)KEH3 92OS&/^YG^[[4
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M#CD<5UT>AZ7%/',EA;B6.#[.C;!D1?W/]WVZ57M/"GA^P=7M-'LX71&C5DB
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MC.1FO-?"UQ<6OA'P[;1ZG<^;>W=R!;JB;Y54S$A7( 0 X8DY/&!UQ7I"PQ)
M($C5(@NP(HP N,8&.E9O_"+Z$;."T.D69MK>3S88C$"L;G.2H[9R<^N30!R'
MA[Q+J.LIX?TV]U!H);VSNY6N8PH::2*4(JCC'W26. ,X'09!9=7FHZ=XDCO)
M-5EU*:R\-W$Y$2*D=S(DB X3!QN(&<'TP<<5U\_A+P[<V"6,VB6#VJ2F98C
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MVVI/&(?#)U&(!(SLF!;YN5/!VC@\>F*[&WT+2K5'2&P@5'C:(ILRNQOO* >
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MJLJK( P C)#,P4@E1V]3Q3;WQY!9S:D#I5\\&FSPPW4X,855D"E7 W9(PX.
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M7DS2W=T]BLC&1\O(V,\L>Y]35'2O!%_H<NDSV&K0>?:::FF7'FVI*3Q(<HP
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M-N&W!,,1\I/53U'L17")=PMXQTNZCAG@*ZY>070>&1I=IBE \R3&-C$(57H
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BN(^)WBS5/!VA6.H:8
M+5WGOH[5UN8V888,<C##D;:TH]:N+&XO+O4]6TV71[53'+-'"T;13@IA2=[!
MLA\8 SD8H Z6BL6'Q9H4UGJ%T-02.+3GV7GG(T;0MZ,K $9[<<]LUBZYXXMA
M96[Z-JEC%*-4BLKD7\$R[2?O1[0N5<CINP#S0!VE%>777Q"U>*/Q<C7.DV;:
M1J,-K;7%S#+Y95CSYFPL<X& 1@9KI3\0-)C\3:MH\JW*#2H%EN9_LTC*I(+'
MHIP H!W'@YXS0!UE%8@\6Z(^F1:DEX6LY;:6Z241/M,48R[9QP!QUQG(K!_X
M2[4)HO"MUY^GV4>MW 86]S'(7,#+E55EROF8()S@<X[9(!W-%9$?BG1);YK-
M-0C\X&5>00A,8!D <C:2N>0#D<^AJA>>+K:70;O5-&;[6+*W6]>)X7C\Z AC
ME"P&<A6VD9&1[T =-15;3K^WU73;74+1_,MKF)9HF]589'\ZLT %%%% !111
M0 4444 %%%% !6))X8M7UJYU=;N]BN[F)896CEV@HI)50,<8W'D<\]:VZQ+O
MQ?H%A/<PW.I1I);.D<XVL1$6Z;B!A1R.3P,B@!DW@W0YM!DT?[(R6TDOGETE
M82^=G=YOF9W;\@'<3FDD\(V,VE1Z?+<WTJ+<)<M-)<%Y9)$(9"S')X*KQTXJ
MW;>(](NWO%AOHR;)0\^X%0B'.&R0,J<'##(.#S35\3:04N";O8UO)''+%)&Z
M2*SG"#80&)8GC Y[9H HWO@C2;^YNYYGO0UW-#<3+'<LBF6+;MDP. WR+^7K
M1>>"-(OIKQY7O52\FBN)H8[EE0RQ[-KX'\7[M 3[>O-7'\5:'';17$FHQQQR
MW!M5\P,I\T=4((R",="!3[?Q'I-W9K=6]T9(VF:W"K$^_P U024V8W;@ 3C'
M09Z4 5KKPCIEX-7%P;AUU946Y'FX^X,(5(Y!&!_7-;4$(MX$B#R.$&-TC%F/
MN2>M-M+J&^M8[FW??#(,JV",CZ'FL[6_$-KH<VG17$5P[W]Q]GB\J%WP=I8Y
MV@]E/'4_@< %R_L%OQ;DSSP/!+YL;PL 0VUEY!!!&&/!!K-M?">G6-W;75JT
M\,MM#+#&588Q*^^0D$<DL WU'''%9VB>+XFO]1L=8O85N$U9[*U"1,JD;4**
M3R 220,GD]*W9=>TR"_CLI;H+-++Y*91MADQG9OQMW8_ASGVH QT^'^B1VT%
MNAO%BALFL,+<LN^!CG8V,9 ).._/>KUKX7LK.[MKJ":[$UO9&QC9I=V(L@\Y
M!R<@'/MZ<5MUFC7M-+ZBGVD[M.&;L>6V8AC=D\<\<\=N: )-&TFVT+2+;2[,
MR?9K9!'$)&W%5'09[U2TSPKINE+:1P^=)#9!ELX9GWK;AA@[>YX)&6)(!(!
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M/H:T: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M=QXKDM[NZ8D")# "N2""H+A%)R,9KTJ.PLXKM[N.T@2YDX>98P';ZMC)IO\
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M*X 'IS7J=5(M*TZ&X:XBL+6.=G+F185#%CU.<9S[U;H **** "BBB@ HHHH
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M&@V6IQ:;M$Z3F7S[@1QPO$VTH7P<L6!"\<X)XHT[P/'I5WI<UG=I$EA+=2K
ML&(\SG+*HW?(H[#FH;7P)+:)IRQ:RX-H+I3_ *.I#K</O; )(5@<@-SP<8-
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M$5O"TAP,Y)P./QH ]%A:1X4:5%20C+*K;@#[' S^54Y];TNWL[N[EU&U6WM
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M.6W>XCNX'A0D/(L@*KCKD]!7G6NZ5>_VKKXT+3)XUGT:UVK';F))W29V>/)
M7<8SMY_O8ITRV\MG/K%EH.LR/<W5G]I-Y;2*Z&-\B00* 7\OC.!@\?> - 'H
MJWEJ\*3)<PM%(<(X<%6/H#WIOV^S^R?:OM<'V;_GMY@V=<=>G6O+4TN>:.*&
MYTF_F">*S<[IK%CF!U)+X"X"G// '//>KL6F3QQ:E';KJ.ER)XBDN+&>+3V>
M- 8,;FCV_-&Q\Q3C'+ Y% 'I:2)+&)(W5T(R&4Y!_&N:O/&5H([&73#!>PSZ
MFFGRNLV/+)8J6  .[E2.HJ_X6-VWAFR^WV45G<["'@B4JB_,<$*>5!&#M/(S
MCM7!C39AI,&GRZ1>$Q>*WGF7[&[(T+7$CAL@89-K#GISB@#TU;RU>U-TES"U
MN,DRAP4&.O/2I(9HKB)989$DC<95T8$$>Q%>7RVFH:?_ &A/:Z9J'V"W\2_:
MI+>VMB'>W-N$WQJ5PX$IW8 /W<^E=KX3L[2UTR=[*UO+>"ZN7N MXI1V9L%F
MV$ H"<_+@>N.: (KSQ)*VNW&D:5#:W-U:1PRS)+<>7N#LP*KP?F 1F.?8=\C
M=@O+:Z1GM[B&9%.&:-PP!]#BN%U*WE7Q!XTG31+B\$VD0QPQB%T6Y=1/O19
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MHE4< $ @=.,]<<=*V*Y^^\::'ITU[%<SSJ;%T2Z(M92L.\9#,0N N#G=T]Z
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M]1GG2>W:V+.ZK#(R8^4DG*K]WOQS0!OOX+\/RV=]:3:?YT5\ZR7/FS2.TCJ
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M<!D#D8^O->D$ C!&10%4#  QZ8H \FT2<VO@[P?JDE]=RVVI2V\6KW,EV[@
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M(ZUC:QXEO='\67_GM$=)L-&:_>-0?,8AF!]L_)@?4UOZ-I#Z3 RS:E>ZC,^
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MCDAA$;M+"PR\;H2'3W(((]^/6G>$M??Q%H2W=Q;BUO8I9+:[MLY\F9&*LO\
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MYLM8T[4)Y(+2\BFEC4.R*W.T]&QW4X.".#BH+[Q-H>FRSQ7NJVD$D"JTJ/*
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MJ2",C@CM6C0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M!GC..N,>_-9VJ>(=4DL/&-_:7IM9O#\A$-L44K*J0I*2^1D[]S 8(P ,<YH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "N%U/P3JLUOK^GV.HVB:?J]R+S]_$S202Y0N!@@,IV CIC)'-=U7/?\
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MF/Q4^@6^F":9;,7OF&X"J4+E,?=^]D?3WJQH?B*VUN2]MA#-:WUA(([JTN
M\1(RIX)!5AR"#S0!7_L2[_X3S_A(/-@^S_V?]A\GG?\ ZS?OST]L?CGM65-X
M0U&;3_%]K]IM1_PD#,5;YOW&Z(1<\?-PN>U;WB37/[ \,WVLQVXNUM8C*8Q)
MMW =><&B+6VD\67&AM;;?*LH[M9_,SN#.RXVXXP5/>@#";PAJ-GJ>FZMHUU:
MV=\D*P:DI5FBO44 +E1C##LW4=.15R'0]8MO%6J:W#+8C[?;P0>4X=O+\O?S
MD8W9WGCCIUKIA(C*65U*CJ0>*CN)FBM99HD65D4D*6P"1VSSB@#EX]"U+P]I
M]Y=:;<0WNMZA>+/=S7$#;9>@V*JGY%"@ $DXY)S6KXGT:?6]*BM[:>.&X@N[
M>ZC:12REHI5?! (.#MQ3/"WBBT\4^'DU>!'MUW.DT,Q :%U.&5OY_0BF>%O%
M,/BG3KJ_AMGM[:&YDMU,S?,VPX+$?PC]: ,C4_!VI:C;^)HS=VJMK0@ ?:V(
MO+55)([YVYQGC/4]:N1:!KEEK]]<Z?J=K%IVI2+/<PRPL\D,@148Q-D#Y@H^
M\#@\X/2NIWKM#;AM/0YX-9.G:V;_ %[5],-N(_[/$)$HDW"42*6!QCC&/>@"
M/Q)H]SK$6G+;211FTOX;QO,S\PC.=HQTSZ]O0UB^(_!VJ:W=ZDR:C:""Z6W,
M N(6=K8QL&*J0P 5B,D]>WICM"ZAE4L 6Z GK5>VO[6\FNHK>99'M9?)F"G.
MQ]JM@^^&7\Z .5U'P7?7\^NLNJ10#47MKJ*1(#O@N( FUN6P5S&IQUY(S70:
M-#K$<#/K5U:37#8 6SB9(U [_,223GGMP!CN='>N\)N&XC.W/.*7>N[;N&3Q
MC- 'G&EZ:_B1/%^D^=;?8+C6R9F#$R; L1( Z?-M(W9XYX.*W[#0-;TO6;T6
M>IVO]C7=TUXT4D#&>-V.YT5L[=K-DY(R,GV-:/B#7?["M[246XG\^\@MBOF;
M2@ED6/=T.<%AQ3M:UIM'N-)C^S><M_>K:%O,V^665F#8P<_=/I0!%X7T>YT/
M3)K2YEBD9[NXN0T>< 2RM)CGTW8SWQ6'J'@[5KW59;O^TK-@-3AOH'FMV:1$
M3;^YSN "C!(QU)Y]:[;('4B@.I7<&!7USQ0!Q;^$-1:UGB%Q:YDUU-7!^;@*
MZOY?3K\N-WOTI9_"&H2VFH0"YM0;K6XM54_-\H1HVV'CJ?* S_M=..>S#*RA
M@00>A!ZTN1ZT </=^#-5EDO(H-0LX[2?6(=53?"S.&5HV9#A@,93CZ]L5)>>
M#]0N=/UVU%S:J=3U2&_5B&_=A#%\I'?/DCG_ &O;GL]Z[MNX9/&,T,ZHI9V"
MJ.I)P* ,73='N;3Q-K&JRR0F+4$@58T)RGEJ1R<<YW?ACO7&>-M%U#1O#GBJ
M:*_M3I6HN+HPRQGSDE.Q656S@J=H/(R.1[UZ8SJH!9@,G R>M9^MZL='LX;@
M6TEQYMU!;;4."OFR+&&^@+ T <UKW@_4-7;Q +#4;2.TURWB5FDC9V1D7:"I
M!P5(P?\ ]>1//X1O67Q!:PWD'V+7US<Y0AH)&C$<C(.00RJ, GY3W/2I#XU?
M[%I5Q_94B_VCJ4FFJCR@&-U>1=QX^Z?*8\<\BM*37V3QA#X?^R9:6S:\$_F\
M!%94(QCKEA^'>@#%O? TUP^M0V^H);6E_%;>25B+26\L 'EMG." 54X[]*DO
M_#GB#6=)A_M'5+%-4M+J&ZM&M[=A"'C)^^"Q8[@2#@C'&/?KPZEBH8%EZ@'I
M0'4MM# GKC- &!H6C:C8ZYJ^IW]Q:N=1\D^5!&P\LHFW[Q//Y?X53OO"EY=7
M7B*-+J%;+7E19V*GS(0(A$P4=&RHX)Q@GH>E=6'4L5# L.HSR*QM9U]M)U72
M+$6GG'4YV@1_,V[&",Y)&#QA3T[T 8EW8:;K/C'3H=/FE672 8K]%C8(8AM>
M.-F(P3O$;#'8/ZFMSQ1HTVNZ+]DMYTAG2X@N(WD4LNZ*59 " 0<';C\:ETW5
M9=3N[H16@%C"^R.[\S(G/?:,= <C/3(XS6F'5B0&!*]0#TH XO5/!^I:E!XG
MC:[M5;6X(8@X5@(BB[2<=\]<9XZ9/6K:Z!KMGK][=Z=J=I#8ZFR2W<,L+.\,
MH149HFR!RJK]X'!&<'I74AU)P&!.,X!H#JS%0P)7J >E &%XQT.Y\2>&Y]*M
MIHH6FDB8R2@D*$D5^@ZYVX_&JEYX9OM7\1Z9K%_>00'3(YA;1VL9)+R)L+,S
M'H!T7'7J:OZMK[:9KNCZ8+3S3JDDD<<GF;0A1"YR,=-H.,=ZV=Z[MNX9/;-
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M"VD=M+'C83O<&2-#_$JX Z*,]L=MJFFV^KZ;-877F>3*!DQR%&!!!!##D$$
MU!I^C+8R"62]O+V90522ZD#% >H   [=<9]Z .:FNDM/BU-=3).+<:(D/FK
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M3C(C*[LD<$9KLO%TD:ZAH2364LL;7$G[\0O,D)\M@-T:_>+9(7/ //L>JHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M$A1P.GH/2K.NZ6^KV"VT=S/;.LJ2"6&9HV7:<YX^]_NG@]Z -.BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M5VJSY)VYZ+NP1DCC.:Y&X\&7K?".TT.+1X/[:CAMXF.8Q\R.A9M^>A"GWYH
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M/P"V3COZ\\$<5K^));C23=6<.O7\URNG75_LEE6/RSE0LF]0.%((6/!!W'/
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MBP\T7,1O[EK6!9;9U)D7=D'(^7A&()QD<BN=\,ZF^N0V&IR:Y)!>M=7$%U8
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M\'+<O%M^[+O+$;?8YX]JZ;PW++-JC7$6NPWVGW-HDD=NLIF(;/\ K Y^Z&!
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MV8TFP%K<8\Z$6Z;),=-RXP>@ZU;M;2VL;6.UM+>*WMXQM2*) BJ/0 <"IJ*
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MD<<LT:/(<(K, 6/H/6@"2BD9E12S$*H&22< "H4O;61%:.YA96.%*R @GVH
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M.D]NY.V1#D'!QFK= !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MF8Y^[GRRC?3!-3W-K>Z=+K$EEIE\NG0>(HKJ2WMK0@R6_P!F56:-"N'Q+AL
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M&T?5M/NY8FM75KFV2./S JD?,<C)7J<8QSBG^(M(N+RW\5WMA8SOI]R+&2.
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M?-]7-<5?:=(FDZ]8_P!DW9ED\2P7&([-R'@\^%]P(7#+M5B<=,'..*]4551
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MW/AK9O6W:(2S[\[6<@#>06Z\\UZC10!R'A)+&\U&XU:TL=6MII;:."<7UO\
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M0Z?HUGILIEA$KS&-8O-GE:5]BYPN6)..3]>^:)=%LIM:AU=TE^VPQ-#&XF<
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M+.,952VUB,X. >U &S15"#5K7[%8S7=Q;V\EW&C(CR!=S$ X7/7K4PU"R)G
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MT56CU"RFE$4=Y;O(69 BR@DLOWAC/49&?3-6: "BBB@ HHHH **** "BBB@
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M!SP/0\Y%7QI<X?6HXH]3TUCX@^U65S;6;.(_]&5?,*;<.A8.I'^UGCK7I-%
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MUA:R.SZ;-;6\$$98DF,JJ@#\!6DFBV,>M2ZN$D:\D0(6>9V50!CY4)VJ<=2
M":T* .6LM3FET"QTNTL]0BOGM5A\R:SEB2!A'RS,R@<$8&,Y./K7*V>E2:IX
M8F@?0-6M]<M-%N+ M<DK%EH]NR,YQ(&8 CJ!UR#P?4Z* /-9;/5+JY@>SL;V
MWENO#$MC!*\)3R;C(QO_ +GJ"<=.*SM3TU=;\':K+%X:UB'5QH[6&RYC; ;(
M*QQJ.' 8$AP, =QFO6Z* , /H^G:II%O%HK1RW?FF"XCL@JPML!8.V 49E7\
M=O/2M^F-#&\J2LBF1,[6(Y7/7%/H **** "BBB@ HHJO:7]I?K*UG=0W"Q2&
M*0Q.&"N.JG'<9'% %BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M*.S(QW=]N,C_ /7W]8UWX5T>];5&N+>5_P"U(UBO!]HD E100!@-QP2.,=:
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M%C4G)5 S$(N>RX' ]!4U[H&GZA<R37,<KF5466/SG$<@0Y4,F=IP3Z<]#D4
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M/T;5]2UGQ;H=R]UY5O=>'EO6M50;0[M'GGKWZ]L>YK?M_"&BVI0PP3J4L_L
M/VJ4X@Z[?O?KU]ZDMO"^D6<VG2V]O(CZ=;_9K8B>3Y8N/D;YOG VC&[.,<4
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MX:L)OLRP68O+RY50S@,VU(T# @$X))(/  '7(N^?<Z++=3ZIJ/GZ>5A2W+1
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M,[81E0JV[Y.GS<8ST[4 7/'?B9M*\,:VVF7$Z:A8V^]I881((6(RH;((Y^G
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M&T@L05QL//L?2F1:I97UOX9GU"Y1?$,7B';?Q228DB.91M*YX0#;M[8QCJ:
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 445PS6D)^,%^R".&4^'HV$P491C-(-WUP
M!^5 ';C9N.W;G/./6G5Y?X?,>B:SH>C>)M%2SU2!V2RU>V7=#J#&-U.]_O!V
M#%BK=2,U<\(>'-'U(>+([K3;9S_;MS&L@C"N@VIC:PY7!)(P1B@#T2D(##D
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MLVC&#@MGYNP'0YI)O%GB!KEK6/2+2TN$T<:B\=U,S%'W$-&=HP>00#GOGVH
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M(!QD XY%+110 A4$@D D=#Z4M%% " !>@ [\4M%% !1110 @ 48  'M2T44
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M[N_MX8G7>KM(-I7CYL_W>1STY% %'0/"\'AY0D6HZC=QQIY4"7DP<0)Q\JX
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M*CFJUKX.\2RP_$*.?3IDDUNPMQ:/-/$=\B1,&5MIPIR>PVCUQBO9** /*_[
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MF-N2 ,@<TZ]TFXO;>SO;3PU=VTDNL6EU<QW$R/,RQ=7?,A' P  2>.E>AT4
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M8./,561@YYR<8Z<UZA10!YEJGAO4WT_QG:6NCM_INE6UI9"-TVNR1LI4%FR
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M7,:*4D5<=]WR%@05W8S[5C_\(5J;ZM;W<VIVDH@U26]#/;,99(Y$D3RV;?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MI:-$)CDC$J9C;:#A".#P1CL>E '545Y'+_9DF@:QJ>G74$Y76K.\:&V#,;.
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MRER/GF"%AOX.X] :V=?;0+_P3KU_X?AG5;B& ,%C>*/S%;@*A ^?!.[ [#-
M';#7Y9=7UG3+?3I);G3K:*=%,JJ+@R>9M4'^'F,C)]:TXKV&2Y-H75;M8EFD
MASDHK$@$_B"/P->=>)6CFN_B#M;=YN@6X@*'[[A;@@+CJ<LG3^\/6IK72-+U
M+QE>6][9HR:CH%JL<PAY9@9@Y#@<, 4YSG[OM0!Z/17 ^'8VDTJYD\16P6/0
M[2739'$9_?*O^LE4+R0T:QXQR"7%=CH\EC-HMD^F$&P,"?9\ C]W@;1SST]>
M: +M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 45Y5\>
M8HV\*:,[(I?^V8$W$<[2LF1]#7HVJ:A;:%HUS>2!5BMH7=8UXW;5)VJ/7CI0
M!>!!Z$'MQ2UXKJVCKIWQ+^&UI<Q1O<O'</=MM!\R8@NQ/K\[,1]:]JH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHKAM;\8ZOIK^)9(+&R:#
M0Q%*V^1MTT;)N(&!@-CZCCOG@ [FBN.N_&%YI%]JUMJ=I;L;:T@NK?[.[?-Y
MLC1!&)'4,H^8#H>G%3-K^N6Z7PN=.A2**2 0WDI\F-E=MKDHS$[DZX!^?( P
M: .KHKAE\;:C)9P-#8VSS-K9TES(7B!')#A2"5R,9!Z>].;QK=VFEW4^H6\4
M1LM5;3[NZAB>6*%!'O$I0?-MY13SP6SG H [>BJ6D7AU#2K:[:2WE\U-PDMG
MWQL.Q4]P17/Q>*[S_A)['3)X+?R[RZN;8+&2QB\I6969QE265<E."NX9H ZV
MBN1^*$:2?#+Q!O16V6CLN1G!'0CWIEO$FG0WNJVWA>WLKJSL,P.TD4(GW9+*
MSJ<!040Y/3- '8TUW2-=SLJC(&6..2< ?G7&1^-Y4EU&UEBBFFAN[2UMI51X
MDE-Q@*2K9( .3D$Y XZU-KVI:E9:6QU72M/NHUU6TAB9C\DB/+&!($.2K*S=
M">JYSVH ZQIHD#EI$41C<^6 VCU/I3Z\VU.YCTJY^)%XNGVMVD5O;S26TX_=
MR@0$L&&#G/ZUL?VEKK^,-5L;)[-H;?2K>XMK>2-@"[M*,%@W&2@&<<#MZ@'8
MUG:QHZ:Q! C75U:RV\PGAGMG"LC@$=""I&&/!!%9GA_Q)+K\>ER0K$%EM#/>
MKM(:"3=L$?7@[Q(.?^>9JYK^LOI TY(XU+7UZEH)'^Y%N#'<WK]W:!D9+"@"
MUI^F_82\DMW<7ERX"O<7&S<5&<#"*J@#)Z#O5ZN%_P"$RUG[%%(NG63-)K1T
MI7,SA7 9E\P#;TRO3)QSUQ4NJ>*]7T11]OMK R0M:I+';L\GF>;($9@>L:@G
MC>/F((% ':T5PVH^,M7LIM<D6QLC:Z1?06\F96+RQR"(Y'& P\W//'&/>E?Q
M/J.G:SXG>[>*>VLKFTM;6!$*G=,$VY.3_%)R<=N.F* .XIH=69E# LOW@#R/
MK7)/XIU6RD:VOM-5)9[V&TL+@J8XYS("22A)9=@5LC/S<8(SPSPA%+#XL\9+
M.L D^VP%C A56S;H<X).">_)YS0!U\LL<$9DED6-%ZLYP!^-.!! (.0>A%<?
MXG%W/XT\,6:O;M9S?:6>&:,N&*QXY&<'AB!]3UJMIWBD6>A:%?6=E;QZ#>7:
MV$$,>1) C.8XGSG!!(&5P,;NIQR =U17->&=:UG6[B[EN;6Q@LK>YN;0^7*[
M2%XI=@(R -I /OG%.U?6=4M_$]AHVGV]FWVRTGG6:=V^1HVC'*@<C]YZ_E0!
MT=%<38^-KS5]-TW[#9HNH76GM>.A1I44AMFT8(."V?F[ =#FG7?C'48(6633
M8[&\AT9M4EANWR"RDAHE93CC'+<XW+QS0!VE%<I:>)-3U2X^P6EK;0:A'IT5
M],DY9E!D+;(NQ!^0Y;MQP:S]&\5ZAXB\1:++9F.#3[S1Y;MK:5"6$@EC0@L#
MV)(!QZ\'(P =RCI(H9&5E/=3D4ZN%TGQ%<CPOI<UEI^GV*W#768XU+(C([85
M(UPSEB"21TP212Z7XEU76]?\-RP&""RU'0Y+^2V92QW[H>-V>V\@''KP<\ '
M;HZ2+N1E9<D94Y''!IU</H'B8SV.C6%G86=C=:C-?$)&I,,2PRL';:,%BS%?
M3EB>V")XUU*>2QM(M/M1=OJTVE7.^5@BR1Q/('7 R5(4'GD9Q[T =Q5;4+0W
M]A-:K=7%J95VB>W8+(GNI((S^%9WAC6+C6=.N'O(HH[JUO)[27R22C-&Y7<N
M>0" #@UGZCXGO%EU\:9!!*-#C5IXY20T[&/S"BD?=^4C!(.2<8&,D W+>UM-
M*TU+0SLL9)!DEEP[NQ))+<?,22>.YXJU##';01PPH$CC4*JCL!7"%QXI\:VJ
M3+;W&C7F@BX6WGB)^21USGG 8X'/;'XUU&N:N-%@L8HHMTUY<+:P#:6"G:S9
M(')PJ-QW.!D=: ->BN+O?%&O:7H$NK7VE1Q0V5YY=UD'=):Y'[^-<Y! /*'G
M@X)XS/=^(]8@3P\L-K82RZQ,Z*3*P6-?*>1#QG=PG.#CL/6@#K:*XC3?&M[=
MW,6C7-I;P:T=1FL)"I9H0(HA*9%Z$@JR87(.6Z\4V7QKJ:E;2.PM3?QZR-*G
MWR,(_F3S$D7@G!4@D'D<CGK0!W--9U5E5F +'"@GJ<9X_*N4T'4->N/&6J6.
MJ367EVME:.8;=&*AW\W<58G)Y7N.@'IDP^,$F'BSP?+916[7HNKE(VF)"@&U
MESD@$X[X[X[=: .Q9T3;O95W':,G&3Z4AFB4.3(@"'#DL/E/OZ=17"CQ3<WL
M%A'J6D6+WEOX@73;C+%TCD"[EEBR,_=8$9P1D]:Q-8MH!X>\>J(8PJ:];NHV
MCABEJ<CWY/YT >L45R[>*6'C!M"D:"VE$JB**X1E:ZB,88R1/G:Q#$J5&2-I
M/M5_Q3K$^@Z$^HP1QR-'-"C(^<$/(J'!'0C=G\* -FBN+UOQC?Z4/$@BM+:8
MZ2+9H]S,N]9>N>O(_#/M2S^,KW3;S5;'4+2V:ZMY+-+40R-MD-RY1%8D<;64
MY..1V[4 =B'4N4# LH!*YY /3^1IU><Q:E+X>\8^+;NYB@EGDCTN)/(0H)'E
M>6-2PR2.6&>3P/PK1OO%.OZ=;R--I$)QJ-K:P3R%HEG29U4D+\Q5E)P<G'0C
MTH [6FJZOG:P;!P<'.#Z5!IYOC8Q_P!I"W%WSY@MBQCZG&-W/3'XUPGA[51H
M]O=V%I OG7OB&_BA58RRH%9G)VC&>%Q@$=?:@#T2BN&.N^))]9\.6T]O#IS7
M%S=1SQNA83+'&Q1Q\V0K#!VGD''IS'H_BG5%L56]>*XO+S6+NRM_+A;"")I<
MDKNR1MCX (Z\GJ: .]HKB9/$_B19=*LFT>U@O+ZZN;8-<2,J,(XV=) !DA6"
MC@G(Y'O5JQ\57$WB@:'>&UM;Q7PUM(KJTR>5N\V%S@2#?Q@#(&2<4 =9163K
M^M#1K>S"HKSWMY%9P!CA0[GJ?8 ,<=\8XSFN3\5>(M2/AGQIII,4&H:78^:+
MB(,%DBDC;:RC.48%6'4] >_ !W\4T4X)BE20*2I*,#@CM3ZS=(TNWT^)IDM[
M:*YN%3SWMX]@DVC"\9/08%9NF:YJFL)::A8VEM)IEQ--$0SE9(U0LJR$]#N9
M<;0,C<.3@T =)17"Z;XSU>YT;3]2N[*SC34YA:VJ0L[NLNZ3<6&!E=L9( .2
M>.,\7(/$VJFYL]+N]/2UU&\NYH8)'!\MX8TWF;9G(SD+L)Z]\4 =69HAUE3[
MVS[P^]Z?7VI]>7Z/<MIFF2I-IUA<>9XO:!E*_+$S2@"2-<<$'D<\>]:D'B;5
MK*#Q+>WA2XM[+5Q:KY-L[FWBV19<J"2RJ&)('.<G@= #O*:'1G9 REEQN /(
M^M9^@ZD-7T:&^6XM;A)2^R6U;,;J&(4CDX. ,CL<CM7.W'B%].U'Q3+'I,/F
MV+V@DFMXVDDEC<#,C@ %MBDG:.P(S0!VE%<3<>.D@TRQOS=V+6%U)*HU2-'>
MV3;C8'P<QELD$L<*5(/45)=>+;^VC\0?N+1WTS2(=20J25D++*2F0>G[KAA_
M>Z4 =E37=8T+NP55&2S' %<C=^+-3F^TIH^FB[N;2W@FD@*G]ZTB[MBMD!/E
MZ,<Y)Z#&:Q?'.K3:]X+\3K;P0+:Z=(EO()U)=I $=BI!PNW>!T.2#TX- 'I5
M-1UD0.C!E(R"#D&H[N-)K.:.5%>-T8,K#((QT(KSCP9KFLZ;X;\&V,MK9?8=
M2L5M[6978O'*L)=?,& "K!&Z=/>@#TVBN6T'Q-=ZS!IJ-#!%>M).FH08)^SF
M([6 .>NXH!GJ&SVQ74T %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% '/^+/"%AXRL;>SU&XNHX;>=;A!;LJG>
MH(!)*GIN--O/",6I7D%QJ&K:E="';MB=HECXD1^0J#.2@!]B1WKHJ* .>U;P
M=8ZQXFTS7Y[J\2\TW=]F$;($7=PV05.<_6NAHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ KG;_P=9:B-<6:[O NLHB7*JR#"JNT!?EXXX[U
MT5<A%XTM;'Q)K>G:YJ-E;1VUS#%:D@H2'C5OF))[MC/ Z4 7[[P=IVIW-[-?
MRW-P+RR6QFC9E"F-26!&U00P9B<@]?H*@/@FWDTU+6XU?5[F:*:*:&\FG5IH
MFC.4Q\NW&<YRISWS@8UIM=TRWOA92WD:SF1(MIS@.XRJEN@8CH"<GC%5_P#A
M+- ^UBU&JVQG-Q]EVA\XEXPA/0$Y 'J>.M %%/ ]C&VY;[4/^0B-3^:16_?
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MG9TB5&SO9,[@#TR-IX]B:L#7-,-\EG]LC\YW:) <[7=?O(&Z%A@Y4'(P>.*
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MXBTGPY#%-J]V+6*5Q&CLC$,YSA<@'G@\>U:2.)$5P& (R-RD'\CR* '4444
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M/)&7AEVA7A?#98#:-K#. 0O85<:VDM/B@+^0'R+[21;1MV\R*1G*_4K(2/\
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M]I>P3K/&J%4$ =<%MP8>4QZ8QWSQ7?V-_9ZG9I=V%U#<V\GW987#*?7D58H
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M2N+5)I H=D4C;NV@ D XSCM6'H\6J2^.?&7]GW=M"@U"S,JRP%V9?(B+!6#
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MT9O4C Y/H* ,KP_<WJ>*_$&E7-_->06JVTT+3A-R^8K[A\J@8R@(XXR:K?\
M-9?^Y?\ _;BNF@TRQM;R:\@M(8[F956694 =P.@)ZG':JUUX=T6^O3>W>E6<
M]T4V>=)"K/M],GG'M0!E:GK#S>,=,T&*Y:"">&XDEEB(#-)&(\1@D<<2%CCG
M@>]85GKVJWL,.GSZC)]KCN=0@!B14:ZC@?8LS/T0*2-P .3T& 179_\ "/Z/
M]CBM!IEJMO#(98HTB"B-SDEEQT)R>1ZFG3:#I%RMHLVF6<BV9)MPT*D19Z[>
M.* .(T;5M9\03^%XI-9N+==2\/O=W/V>.,'S@8!N&5.#^\/MZ 5U/@K4[K6/
M!.C:C>N)+JXM4>5P -S8Y.!P,]:M6_AS1+0PFVTJSA,,;11&.%5V(W)48' /
M<5;M-/L]/LELK.UBM[5 56&) JJ/0 =* .'^'L&IRZ0&2YM?[.&K7YF@-N?,
M8>;*!\^['WMI^[VZ^K+;Q'J U[29(;Z2]L[V;4$.55%F$6XH(TY(V[=FXD%C
MDXY!KN=/TNPTJ%H=/LX+6)F+LD*! 6/4X'>JL7AG0H+H746CV*7"S&<2K;J&
M$ASELXZ\GGWH PO#=[=ZSI&D:R/$!_XF%BS36RQHP\X@',?'R>6=RX(.>,\\
MG(TB_NM5;X;7][,9;JYM9Y)9" "S&WR3@<5VUIX<T6PN+NXM-*LX)KO/VB2*
M%5,N>N2!SFG1:!I$'V/RM,M(_L0(M=L0'D ]=G]W/M0!P'VS4=2M_#CW6JW1
MD'B>[M&D78NY$^TA<@+C@1KVK774=4M_$5]X9GU"X>ZN;B*YL+G:F5M#S(.%
MQE2CKD@_ZQ/6NF/AW13:"T.DV1MQ-]H$1@4KYN<[\8^]R>?<U%IVG7_]IS:A
MJTUI+,H>&U%M$R".$MN.2Q)+':F>@^48H U4DCDW!'5BAVM@YP?0^]<EI?\
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MI'F[Q(-N-_RX\UN>>@XH JR^*7L[:633+"Z>27Q"NGS+=W&XJQ90Q3D@*1P
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M+S-H# _=R/3UK*N/!\\C:[##J*1V6NK_ *9$8261S&(W:,[N-R@<$'!&>>E
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MHY?M&(Y"(HBX<;OF8DK@L.,GGK2:;XI;5M(\+W^I6-U#)J-\5A^S7&$5MDA
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M<W46I>8K*X88:+S?WC#;NW$94<=ZZ#Q7H$_B/3(;."]CM#'=0W)=X#+DQN'
MP&7J5JG>>#CK6MQ:EK=['<B"TGM88+> PJ!,NV0L2S%B0,#H!0!/;^+8I;G3
M8I;"XB7586FL&+*?-VKOV$9^5RO(!XP#R",5FP?$'S])L=4'A_4A9W\L$5M)
MOBR[2L5QC?D8(';N.W-6]/\ "ES;KHRWFH1W0T6-DLF\@JQ)3RU:3YN2$)'&
M,DYXZ5!#X+NH/">AZ(NJPEM*NH9Q.;4XD$;[@NW?QGH3D_2@"V?%D@ANO^)/
M<FZL;=;B]MA)&7A#;B%!!(9R%+8!Z8YR<4Q_&]IF9K>UEGA&E#58)%90+B'O
MMR>&'&0<=1ZU+<^&KD:WJ6HZ=?QV_P#:=LD%U'+"9!N0$+(GS#!VL00<@X'I
MRV;P98M'X?A@DDABT8")5')FAV!3&Q]"5C)]=N.] #_^$OLAIL6HM&WV1[**
M\\Q74X$AQ&GU8\#MP<D52N/'UO:6]])+IMS(UG-;QM]G9)$<3,%5E?(!P3@C
MJ#VQS3X_ EK%X5U'0DO)DCNIFEAF4#=;#?OB5?9"!@?7UI+WPSKFK: ]CJ>O
M6\MRTT$@FCL2B 12+(/D\S[S%1DYQCH!W .ALKJZN=/\^?3Y;2?+#[/+(C-P
M2!RI(Y !Z]ZP;'QO;7KZ(OV.:'^UI)H4\QU!ADBW;D<9Z_*>F>174C.T;B"<
M<X%<???#^UO/[49+V:%[N]CO+=T'-HX*ERGN[*2?K0!5OM:O)/&'AZYM+:[D
M2ZLKXBT6X 2;8T.Q\$A1PS$'KAA]*TH_'-C<Z7875M"3->6K726\TJQ%54@$
M$DXW;C@ =<'D#FKMUX?DD\1:5J=M<PP1:=:S6Z6Y@+9$FSG.X8 \M>,>M85G
MX%U/2;;27TO788M0L(9+9Y)+,O%<0N^_#)O!!!Y!#>OK0!-#XKFUO5HK*VLI
MXK"YT@WOF.YBF0EMN".JE<$<'J?;FKX,\6E/#WAVUU6&Z1KC1Q=K?3R*XF\M
M$,A/)8'YP<GKS6U)X;O/[;AU2+5%,HT]K*?SK?>9,MO#C##;SGC!XX&.M9]K
MX$>*VT"UN-1CFMM*TZ;3W46Q4SI(BH3G>=IP@]>IH E;Q]:I'<2&PN)(X[!]
M0C,+H^Y%Y96.<(^#G!/(S@Y&*W-$U2;5[,W4FG3V4;;6A\YT)E1E#!@%)QUQ
M@X/%8-MX4UM?#=WH=[XBCN;=K-[.V?['M=59=H:3#_.P7@8VCN<GITVF6LEC
MI=I:2RK*\$*QF14VAMHQG&3CIZF@#$N/&5I;PO>FWE;2XKW[#+>*1A)-_EEM
MO78'.TGU[8YJ;2?$TFL:I=6L.CWD<%K<RVTUS(\>U70*<8#$G.[L#[^U >"3
M]DO=*-ZK:-=WWVYH#$?,4F02M&'W8VEQGID D>A&KH&BS:-+JK2W<=P+Z]>[
M 6$IY>X*-OWCG[HYXH 9JOB)].UNUTF'3+F[NKJWEGB,;HJGRRH()9AC[X[?
MG5:P\8V^KVU@=-M)9KJ\LS>"W=E0QH"%(8],[C@8ZX/('-6[W1+BZ\4:?K,=
MY'&MG;3P"%H2V_S"ASNW#&/+'&.YK%T;P/=:$VEW-IJD+7EG:/92L]L?+GB9
M]X^7?E65N^3D$C'H 2V7C1M7US0X-.LV:QU"UN)W>1@LD;1.B,A7L5+'//)'
M%=?7*6/@S^R[[1;FRO@IL$N4G$D.[S_/=9'(PPV'<O'7@XKJZ "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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ML$B\[#Y9.%YV]\9JK<:)ID[Z!):Z7J%Q93ZZ]S+]JLF^X\$@=BFP>7&7*\$
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MG/-7Z\6U<#_A+?@_P/\ CV/_ **CKV831F<P!QYH4.5[@$D _H?RH ?1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%<!KWBC7[!O%<UM+8"'0Q
M#-&CV[$S(R;V4G?P>HR!Z<>H!W]%</J'BS4]!O\ 6;>_-K<K;V5M=6[11&,(
M996BVMECD @'.1QGI5F?5O$5BMV+P6<,)FMUM9YP/,8.P61?+1FW./X .I(!
MZ<@'7T5Y^OBW7)+.W$8M4G/B Z4YF@.3'@D-@/PV,9'0^W:5?%6LP:7>O<0&
MZ:PU=[*ZGLK8LX@$8<2"+<22"R @$\9.* .[HKGTUQY? [ZU;7VG3O\ 97EC
MN7+1V[$9P6ZLH]1U'(J+PWK=[J&M:SIUV-R60@>*1H3$[+(I)W*3QRIQD X/
M(H Z6BO/M5\4^(+-/$=S%)IYBT?48(%B:W;,T;K"2"V_Y2/-/.#T' J:]\7:
MIHMSKMI>M:W,MJUB+:5(6C4&Y<QC>-QR%*YZC(XH [NBN!\1^*]:\/C7[0&U
MGGL]+&I6L[0D*1N*,CJ&ZY&01V/0XYLSR^(8?&V@6EUJELT%PMW,T4-L57:@
MCP#ER20'89X'?% '2:9HMMI4ES)%+=32W#[GDN9VE8#)(4%B<*-QP!P,UHUP
MVD>)]:U34-'1%MD%U)<C4+9H2SV0B8@ D,,$XVY8').0,<4[2?%6J7&M6EK*
MMO=QW>G7%VIMD(0R1N@"QN?OJ1(/F(P2,@XX !V]%<!I_C'59DM+U_L\UD='
MDU&_CC@;?;2J!^YSN^4G+#Y@3^[;UXV="U+7KV]MIKJ"$Z7=68F$@VJR2G!
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M4:X5+%8S*TT@*!5'4G/(QCO26&KV6IR7$5K*S2VY431O&T;IN&5RK '!'0T
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M+DAAADTVS>*!]\*- I6-NNY1C@^XJ1-/LHKV2]CL[=+N10KSK$!(P'8MC)%
M'#:;JVH7%KX+U&&_FN3K:F/4(M_RY,+.SJ/^6>QEV\8ZX.3@UFKXDU+2);0W
M]W=S)HE_)::TY8X>*1L6\I '/#HW';.>U>DVVE:=9W$EQ:V%K!-(27DBA568
MDY.2!SD\U*]G;.)0]O$PF(:3* [R, $^N,#\A0!P]Y?7Z:K8Z%=:@;.2[T^6
MZ626Y,9\XN,HK@<^6",+W')S2:?_ &MJ'BNTL+GQ'<R1)I$%T\EFJ1I/()2"
MP!4_*P7D=\\$"NSU'2--U>)(M3T^TO8T;>B7,*R!6]0&!P:>NG6*WOVU;*W%
MWL\OSQ$OF;?[N[&<>U $L%Q!=1"6WFCFC)(#QL&&0<$9'H>*\^N=>N4\1V4E
MMJ<DD$FO26$Q=PBA%B?=$L?((5E!WG!)]0:[;2=(M-&M7M[.&.)'E:5EB0(N
MYNN%' '^3DY-(V@Z.]R]RVDV+3O(LSRFW0LSK]UB<9+#L>HH X*RU'5D_LZ]
MDUF\F9O$UQIKQN5V-#YDJ@$!1R-JX/;%:>G7>HIKUSX5N;NZDN8KP7J7+.=S
M6)Y'/3AQY1'I\W7FNJ&@Z.J(@TFQ"I+YR@6Z863^^..&]^M0Z1IM];S37FJW
M<%U?2*(@\$!B1(U)( !9CG+$DYYXXXH S_'MY>6'A22ZL;R2TG6YME\Q I^5
MIT1@<@\88USUY?ZCH>KZUI<VN7LUFPL9()Y%1Y4EFF9&@#?*!O"\$XV;L^E=
M9XLT27Q%H$FF1/"GF30R,TREEPDBOC'?.W'XU<.C:8]A)92:99&UF(:6 P*8
MW/'5<8/0=1V% 'GQUG5GLY[=-5EA>#Q3#8 QRB4B%_*)0NRY;!=N3]#G%7H=
M'E7QWJ>G+KFI>=_8D'DW$MQEPYDG&[& IQ@'&.W-=@?#^BD$'1]/(+K(0;9.
M6485NG4   ]A3M1T[SP]W91V<6K)$8[>[GMQ(8P>W!!V^P(H Y[P?JEYK9@^
MTM-'-I<+6FH1ECM>[#;6^N NX>TJ^E+XHC#>-?".^YFBC,MSN"RE%)$#$$CI
MGK^&:Z+2K!M/M"DTJS7,KM+<3*FP.YZD#)P , #)P !D]:FN;&TO3";JU@G,
M,@DB,L8;RW'1EST/N* . M==U6YT+1M>BN9C?W&L_8[JR+901F9HVCV?PE%
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M;;'FB3 R?GXQM%5[?P'=V$&ER:?KGV?4;#ST%Q]E#)+%,_F,CH6[-@@@C&*
M%DU"YN?&OARZ$%U:O<Z3>2265Q(5VLK08#*,@$;F&0.]7;#QK;WL6@3M:M#!
MK%I)=*[R#]R$4,0W'H>H]ZM'P]*=>TO5'U!I#8VTUNRR19:7S2A9BP( Y08
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M)(I)Y8=T<\<F"R% PP 54K@\8YSDY (M/\:P:C=:7!%9R(]]+<V[K(X#6\T
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MP+-MB;(PPSW QUQCGZUC6'BR&TT^Q^R:/=M]OU:ZLA&]R&*3*TI8EF)X)C;
M' 'Y5O\ AG19/#OAZUTEKS[4EJ@BBD,80A!PH(!.3CJ>_M61;^"YX(]/7^U$
M;['JTVJ#_1B-[2>9E/O\ >:W/T_$ GL?&"WL,$(L3'J<M[-8_96E&U7BR78N
M!]W SG&>0,50U#4+N\UWP=<26UU82O?W,,MK)*0K;8)NH'#*2H()'0CI3Y/
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MC9:<?[6.O@VEPEL?W)'DMO$F,*%^8D9'?CD9 /5A>VIN!;BYA\XDJ(_,&[(
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M)G9HCO PQ0[>>.?2B^MWO;4ZYIFBZWDW=F^I07<126XAB<DHL7&\KD'('(&
M3V .TT7Q#_;&M:S9(D!AL'B6.:&;S!*'3=GI@8Z8Y^M)I_B1+C7=7TV\%O:F
MRN8X(29\F??&KC ('/S8P,UG>%@9/%WB>\2QNK>VO&MI(I)K9X1+B(*QPP!S
MGU&:P=?T 7][XVMIM&DN+S4EB_LV;[,6&_R%0,)<83;(,G)!&,T >C"^M"TJ
MBZ@)AYE'F#Y/][T_&J^IZSI^D:3+JE[=1QV<:;S)N&&ST ]2>WK7)ZKHM[:^
M([5+7;)%KMLMCJC9P<QC/G>N3'YB9]2E:WCVQFO? FJ6MG;-/*81Y<,2Y8X8
M'"CN<#I0!+%XHA/B:\TV=K6*TAM(+F*Z^T#$GF/(N.0 .8^Q.<ULSWEK:O&M
MQ<PPM*VV,2.%+GT&>IKSW7K :KJWB:X_L>ZECG\.)!:F2R?F7,YVJ"O#?.G'
M49]CBO/:SRW,EGKFDZS>6&IZ7:PQFUA)PRJ0\4G&8SN.X,<#D\C% '>^)-6?
M0?#FH:NENMQ]B@>=HC)LW*H)(!P>>/2LT>*I[:]T6#4M.CABU<[+>6"X,NV3
M87"N"BD @'D9Y'.*7QG;SR_#K6+*""::YETZ2".*)6E=G*$ <#)Y[US#Z3-)
MJ_A&[T2TU,7UK(B7LM\DWE16Q3$H'G=')P!LY]>* /14O;62Y>V2YA:>,9>)
M9 64>XZBFK?VLSF*VNK>6<H76,2C)&<9XR<9XSBO.--BNW\0Z%/+HM_;00W.
MH)<V_P!D8QP^86()<@EPY^8L"5Y  '2H_#6E2:=%X&E_LBZMY;9[L7C"R<,B
MM&X7?A<X)V8_#TH [CPUXBCUS0-/U"Y$-K<7BL5M_-ST8C S@GIZ5HW=Q/#<
MV20_9MDLI67SI2K;=K'Y!@[FR!QQQDUYY\/(M4T9["WU73;N2*XMV6VG:U<-
M8D/\T3C'RJW#AN_(/W5QTGBJU>;Q!X4GCM)9OL^HN\LD<+/Y<9@E7)(' +,O
M^10!T2W]F\Z0+=P-,^[;&) 6;;][ SV[^E/N+F"UA,MQ-'#$.KR,% _$UY?9
M:.]M;:9+%HUQ%/'XJGN"RV3JRV[238;[N0FUU]N:[#Q6\L=WH;I83S(MXQ:Y
M@A:9K7]TZA@B]<[MN2"%W9(H Z))%EA$L+)(K+N1E;(8=N1VKE]*\4:MJ]I>
M7%OHUIBUO9K-D-^VYS&Y5BO[K!S@D D?A3OA[#<67@NVM;RUN;>:"6=6CGCV
MMCS7(P!U&",8X]*S/!&@QLVH7EY:WUO<QZW=W4(F\V-61W;:P1L*058]J .U
M6]M6NVM5N83<J,F$2#>!ZXZ]Q0EY:R7+VR7,+3QC+Q!P64>I'45YQ#%?OXHT
M>X71[^U6VUN],T:6S&-%DCF593(?OAR58D':N0,# S?\'Q[['3++6/#]XNKZ
M5%+%<74T+>6=PP[H_27S" <#)Y.>G(!N'Q#>P7OARUN+:S=M5EEBEDM[@ND9
M2)Y!M^4;@=F,\8]ZLR>(;;3H@VKW5E 9KUK:W$4^[?S\N<@8;'+#MZFN+\/V
M-Y;:=\/8I-.O(S93W'VA6MG'D@PRH-W' RRC\:9'IMS!IT3KI5V(K?Q;+=F-
M;1]P@9GPZIC)7YAT% 'I"ZC9-%)*MY;F.(XD82KA/J<\5G>*]>;PUX7O=;CM
M5NUM(_-:(R^7N7V.#_*L&XTBX@\:R65M"HTG6U6^O%R!Y4D)4/QW$@,2GZ-Z
MU=^)5M<7OP[UJSM+:>YN9[<QQ10QEV9B1V H Z>!I7@1ID1)",LJ-N /L2!G
M\JJ7&MZ7:6EY=3:A;+#9J6N&\T'R@/[WH?:LR^U:74]/FT_2K?4([RXMI52>
M:SE@2%MAVL6=0,[MHP.?RKCX=-_MCPSJ)CT+5[?68]!GT]ENT\M Q3B-.@D!
M89!&0!W&<4 =Y;^)M'NKZULH;^!KFZMS<QQB0$[ 0.>>N6Z>Q]*O)?V<C3*E
MW S0?ZX+("8_][GC\:X06U[-K6FW-K87D!G\/S6<4SVS+Y,^Y"-_'R="<MC.
M..:S8-/34O"]T9M UF+5K719K"1+F$A,E,!(P!B7+@$$9 ZY!Z@'J$%U;W(8
MV\\4H0X;RW#8.,X./8@_C4M<[H"VNCZ1H]O#I4T,MY&BS&*T*['6+EIN 1]W
M&3WP*Z*@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** &R21PQ-)*ZI&HRS,<
M #U)JO::GI]_N^QWUM<[ "WDS*^T'IG!KS?XMS3R>(/ VERD_P!CWNK*MXO\
M,A#)L1O4'+<>WM1\3Y9].\<> KS3,IJ$M^;9@G!D@)3>K>J@'\,YH ]"37M'
MDF\E-6L6EW;=@N4+9],9ZU->:G8:>5%[?6UL7^[YTJIN^F37D'ABQLM0U7XN
M6U_'&]LUR=^\<+Q*=WL1US[5S$M_J>H?"'P#/?%IIT\01QPO,QRZ*7"Y/)QQ
MC// H ^B;2]M+^(RV=U#<1@X+0R!QGZBIZ\H\%,+7XS^+(-07[)JMW!',MI;
M'=;&(!1OW\%GY&<JO5NN:]7H **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBO/]>\3Z_8-XLFMIK$1:&D,\:/;L3*K)O9&._CN,CVX]0#T"L_3-'M=)
MDO7MC+F\G-S-O?=F0@ D>G ' XXKEM1\6:GH%_K,%\UM=+!8V]W;F.(Q[#+*
MT6ULL<@$*<Y'>K,^J^(;!;L7AM((&EMUM9IP/-(=PLBB.,MN;'W,=20#TY .
MPHKSY?%FN/9PJGV9)QX@.E.T\!),>,AB%? 8<9QP?:IE\4:U!IE^TT+7C:?J
M[V5S-8VV9! (@XD6(DY(+*"!GC)Q0!W=5[ZSBU&QGLYS*(ID*,8I&C8 ^C*0
M0?I570-035=#M+Y+N&[692PG@4JK\D9"GD>X/(.17.P>)M2/BC3;1I+>>TO;
MV[M6,*'8@B5V3:YP6?Y,-@%021D$4 =-$FGZ!IB1&6.UM(N-\\O<G)+,QR22
M222<DDTZUU;3;Z8PVFH6EQ*%W%(IE=L>N >G(K ^)O/PS\1?]>,G\J6:YU.U
MTN]U*ZM-*M9;2P!LYY+AG0,0=V]MBD+\L? !SZ^@!U50W5W;640ENKB*",NJ
M!Y7"@LQ"J,GN20!]:X@^,K^TN-4M)E5FBO+&VM9IX?+(%R0-SJ#T4Y('RGH#
MCK5W7M0US1M,DDGFT^X4:G:1PDQ$N89)8T.Y<@*X8M@C(P!QF@#HWU?38UO&
M?4+55LANNB9E_<#&?GY^7@$\U<5@RAE(((R".]>=:K?W&DW?Q&U&T6 SVUI;
MS*L\>]&VPL<$9&<XK26XUNY\<:I;6FH1(J:/;S6\4L.Z-)':4<X(/5!GVXXH
M [2BN5\,^(KO7UL.8TDBMF.J1%.8K@-L\L<\?,DOKPH]:O\ B75KC28-/:$*
ML5Q>QV\]PPR+>-@?G/;J%7)X!8$^E &W17 /XD\2KI]M-OL1Y^N#3H9&M7Q)
M!N*B4?/SG&>  >W4&GZQXCUS0TE$EW97DMF]FDP@MR WFR!',F3\APPVJ"3W
M((/ !UEMHME::K<ZG&)FNKCAFDG=PHXR$4DA =HSM S@>@K0KS_5?%&OV4WB
M.>.:Q^SZ-?6T0B-NVZ:.18F(+;^"/,/.#D@<#N7'B#4=(UCQ;=37(N(;6YLK
M:WA9 !'YP0 YR. 9"3DC/J.P!Z!4$%]:74T\-O<PS2V[;)DC<,8VZX8#H?8U
MR-SX@U[2IOLM]#"OVV_M[2PGD"[@) Q<R(C$?+L;;@C.0.QJ7PG'-%XO\8I<
M3+,XNK;YPFW(^SIC(]<?Y% '4W=[:V$!GO+F*WA'5Y7"CUZGZ&GP3PW,$<]O
M*DL,BADDC8,K*>A!'45RGB1;M_'?A1(KE8XF-T=C1[N1%UZ^A(]N:H6WBF[B
M\.Z;KEG#;)I<NI"Q^P1Q;3'$9S I4@_?!P2,8P2.V: .^HKEO#&HZYJU_J,M
MY=67V.TOKBS$,5LP9]C *VXN<<9R,'Z]A)KFI:M#XIT?2=/N+6&&_@N6>26
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M"E]K+M)Z 9P?3'M0!SC^*[ZW=+'3=%MW$>C)J*>9>%%"=-GW"<C'![^U;O\
M;+W7A!=<LH5WRV(NXHYF( RF\!B*HIX2"77GC4)=W]EC3,&-<>6.=W^]^GM6
MGI^C16/ANWT0RO+!#:BT#G 9D"[1G'&<4 <-;WVJWFL>"-1^S6\NI7>C7+L&
MG*1N2MNP9B%X^\> IQG\:V[3QPVHZ;ITEGIQ:^O+1[HP,798]K!"NY$8G+9
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@#D?B%XNN_!FD65_;6L-R+B\CM
M&CD8KC>"0P(]-O3WINB^./M7B?7_  _JMO#:3Z.B2R7239A>-E# DL!L(!&0
M<]^>*S/C!HVI:_X:TZRTNQFNYDU**=UBXVQJ&R<DCU'O5[Q7X=MH/ FM1Z'X
M<M[Z[O55WMGRC7#;AR[9#$KRV"<\8[T = /$NA_8[F[.KV2V]LXCGE:=0L3'
MH&)/RDY'6I7UW2(H?.DU.S2+R/M.]IE \K^_G/W>1STKSKPOX9OGUKQJOB2Q
MN8=.UJWM4$UTT0W?NRC [&(#9;C'3'7IE^BZ#KB_"'6=.OT^U:F+*XTNT6/D
MO'&9(X_S)//H%]* .W'C+PR1*1X@TPB*(3.1=(=J'HW7IR/S%7'UO2H]/@OW
MU&V%I/@PS>:-LF1D;3WX!/'I7DVG^%]8@U;PY/)HTXCL_"KV,QV#Y+@JWR]>
MIR>1QSUJ+3_#?B72=#^']VVF7TG]C_:H;^TMRGG1B4D!U!.&X/Y'ZX /6+KQ
M-H5EY/VK6=/A\Z+SHO,N47S(\9W+D\C'<50U;QUX?TFVTNXDU&WDCU.9(K5X
MY 5<$X+[N@51R3^%<9+X3N+#Q9X,?3]'NUTG3+*\1Q(PE:'S%;8I.3DY/;(&
M>N.:R-)\)>(K+P5X CETBX:YT;5VFO+=2N](S(S!ADX(P1T/>@#TGQEXRM/"
M.APW[1&\GNI4@L[>-@//D;H-W8=\U3UKQ?=^$KK1_P"WX+8V6I3BV:XMBP^S
M3$94$-]Y3@_-QC'2JOQ.\*:AXGT?3;K2T5]1TJ\2\BMW<*)0.J9Z ],'IQ[U
M2\=:-??$/^P=*M["ZM;*&]6\OKBZC\OR@JD>6H/WF.X\KD#'6@#LW\3:#'<M
M;/K-@MPLZV[1&X3<)6SM0C.=QP<#VKG_ !+\0+71]6T>QT^:ROI+S5(].N8U
MF^> L>6X[CN#ZBJ'ACPS(OQ$\9:EJ>DCR;JXMY+">>)6!V*067.=I#;3V/ /
M:N,L?"OB6UT/POH\NA7<MUI'B07EU<J4V21;RWF*Q;G(/Z<]J /:O[8TW^T#
MI_V^V^V#(,'F#?D#<1CUQSCTYJO:^)M"OKF"VM-9L+B><N(HXKA69R@RV #S
MCO7GWAKPSJ%MXCU"TUO3-1F\K7)-6LKZ*51 0W&YCG=NQD;<'.<=!FM/X5^&
M9-(TB\DU725M]1.I7$T4DT:EPCXP5;G (R,9H ]#HHHH **** "BBB@ K-G\
M0Z+:S-#<:O812K((F22X12'/12">I]*TJ\V\1:+?WD7C]8-,FDDU&W@CM"(Q
M^^98]IP>V&]<>M '>VVKZ;>-<K:ZA:SM:G;<".96\D_[6#\O0]?2FQZUI4UO
M-<1ZE:/# P6619E*QDXP&.>"<C'U%<1XBT75-0U766TNQD59M&MHH=P\I)9(
MYG<Q9[94A<]/FZ\4L]O-<64FK67A/4(;N6XM!<?;9!+<;8WSO1&=@3'G*D]2
M>A P0#M/[=T@01SG5+(0RN8XW,ZX9QU4'/)&#D=J6'6]*N+%;Z#4K26T9BBS
MI,K(6'8$'&>#Q7GL6C:F46*?2+PJOBD7Y,P1R82O+G:2.#U^O&<'%LZ-=2#5
M0\.J63OX@>\M+RT0%X0;<*)=F#O4D.I7&?GSCO0!UVNZR;+PCJ.MZ:UO<_9K
M.2YB);=')L4MU7J#CM18>(M-U"RE:'4[!KFWA#W*+.I$#$9^<9RHSZ^E9;V&
ML:A\+[_3[NWB&K7.GW,/EQ 1J[LKA3C.%+9!(S@$FL^'1Y;G4;'4H--EM$LM
M%FLYE:+8\SOLVQA>X78QSTRPP3S@ UDU^^&K>'+(M87$>IVDLTD]N6*%T5#F
M,Y^X=W!.>*D\/>)DO_#D6I:M+:6DCW%Q#]_:A\N5TXW'T3)_&L#1-,U"U;P"
M)K"X3^SM+D@NR4_U+F*-0#ZY*-TS^M5+/1M13P]IZ!=4TS4K>YOY8KJ"$2B/
MS)F=5DCYWHZL#[%>HH ]*BDCFB26)U>-U#*ZG(8'H0?2L#QAXEB\-^'=1O8Y
M[/[;;VSSQ07$F-^ <#&<\D8'O3M"U2[#V.CZCI<EI>KIT<\CQA?L^X;5>-""
M3\I(_#N:Y7Q'I^L;?'-C_95U>C6;4&PGA"LHQ!L\MLD;2&!8>NXXYXH [8:_
MI2S16T^IV4=VYC3R&G4/O<':NW.<G!P.^*EAUK2KCS?)U*SD\E-\FV=3L7GY
MCSP.#S[5S&GZ?='Q9K%]+I#$2Z7:1P&=5VM+'YI9-PSCEDYZ?E6=X6M-4MO$
M.FWUUH][;0)H9M9%*1JD$BNI\M%5B=HP0O4GU/6@"]I7C^"\DTJ[N;S38]/U
M4.EO&)")H9!E@'.2I&P<GY<$@8.:ZZ/4K&:\-I'>6[W(W$PK("XVG#<=>"0#
MZ9K@-+TK5;/PUX$WZ7<M/I5T?M< "AT!@E3/) (RZ\@]ZNZ9:ZKI.NRW-I;W
MTVF$7<TUA<1J6@D+%A]GDXW"0\["2!GG;TH [LD*I9B  ,DGM5&/6])EAGFC
MU.S:*W :9Q.NV,'H6.> ?4UC:\EWXM^'-ZFF));W5_9GRHI\*03U1L$CGE<Y
MQS6/K.G7NN75QJMOIUS;8T"YLI()$P\LLFTI'CN%(;YNGS<'K@ Z^/7]'F@D
MFBU6RDCC<1NZSJ0KD9"G!X)!Z5F>'/%$>IZ)<:C?SV<,<=]<6R2QR8C=8Y&5
M2"3SD+FL4V%_IK^#=1ATJ:2VLK=X;VVA0>;'(T2(LFWC=MVLIQSAN,BLJWTW
M6M/6VU!M#U"2V@UC49)K.WE"3&*:0F.5 KC..A&>C'&: /0)O$FAVT$<\^LZ
M?'#)'YR.]R@5DSC<#GD9(Y]ZL1ZI82W?V2.]MWN.?W2R@MQUXSGBN,MM!2+Q
M#X9:#09;;3X8;XR12_O?),Q0C>23RV') ) SBI]*T_4K/Q:'M%NAI<MU=27-
MK>1@K;L2Q$L$GI(3DIDXWGIB@#J[K5=.L94BN[ZVMY'QM2655)R<#@GN>/K4
M-QXAT6TG:&YU>PAE5UC9)+A%8.WW5()ZGL*XOQWI^KZB^O6MIH]Q(MQIT*P3
MVP3_ $AE=R5D9B"-N1M4==QZ]!%X@T?4-0B\=M%I-QYNI:?!%:!D&7<(P*Y!
MP,,5[XXXSB@#J_%_B2+PWX=U&]CN+,7MO:O/%!<28\S:#@8SGDC ]ZOMJ+_:
M=/A 0&:)IYBW18U49Q[[G3KVS7"Z]9:P\/C:T_LB[O!K5B#82QJI"X@V>4^2
M"I#98>NXXYXK6UG1M5UOPGKD4$36]]<6B6MO%*P&51=Q4D$@;F9U)SC&* .F
M37-)E@GG34[-HK<!IG$Z[8P>A8YX!]34MEJ=AJ8E-A>V]T(FV2&"4/L; .#@
M\'!%<3K>G7NN7-YJMMIUU;Y\/W-B\$B;7EEDP4CQW"D-\W3YN#UQTVE6#IX0
MM[2&/[%=-9+$3LVM'((PN3CN"/TH NQZOILL\D$>H6KRQJ7=%F4LJ@X)(ST!
MX/I7.2^.K2=]"NM/N+233+^[FMYYI'P8U2.1PW7"Y\O/S=C6=I&CZC/;>"[:
M6QELKO025O)6'RE5A:(JC?QAV*MQV'.#@54TK2=3BL/!UI=:3<J=+U.9[DLJ
MLJJ4F"N,$Y&YTQW[]J ._36-,DTY-1CU"U>RD^Y<+,IC;MPV<'H?RJ&;Q)H=
MO;QW$VLZ?'#+&98Y'N4"LG]X'/(]ZX)--UBP\F_&DW\]M;ZU?S2VENYBF,,S
M,4E3#+G&?NY!PQK1M]!2/7_#+P:#-;6$2WSRQ2GS?),VW&\DMRQ#$@$@9YH
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MT<4\*2HCC!56 (! Z'FK- !1110 4444 %%%% !1110 4444 %%%% !1110
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MJ,]>] 'I5%1P(\<"))*TK@<NP )_( 5)0 4444 %%%% !1110 4444 %%%%
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M#:QSGJR@D @$X)&#BI>>.+2W?5(H--U*ZDTTNMQY<&U%*Q"7EF( !4\'_$9
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M'K3EHF1BQCS L7S @?W,\'OCWKJ** ,W0K2]T_P_96=W]G:YMX%B/DL=AVJ
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M@ HIBS1-,\*R*94 9D!Y4'."?K@_E4.H:A::5837U].D%K N^21^@']?IWH
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MR(P9& *L#P0>]>2WBSR6GB&ZL]6OSK5CKXBL(?MLC#DQ?NS'NPRD%NH. #T
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MPV]K?W3[;B,1EO),F2P(W,RYSRHXXKT[R8O^>2?]\BFM;0.A1X8V4]05!!H
M\XT*YLKOQIX>OI1<VS7&ARK$EU<LSLZS(-N[/[SC)SSD?-7;^)KQ-/\ "VK7
M<DES$D-I*YDM0/-0!3RF>-PZC/%:FQ<J=HRO3CI2D9&#TH \9U/6A'I'C.*V
MUD*B:5:7-K]EOF8*Y,BNROD;B=J;B, D\C)YZ;[ M]XH\2^'[75KR*.YTNVN
M(Y%O79XIF:8&1#NR/NQD@<<#CFN]$,0&!$F, 8VCH.@JKJ-E-<V,D5C=G3[E
ML;+F.)'*8()X8$'(&/QH Y_P=>7FMJ-1OHIK:6TB&GR0%V"F="1,P&<,,@!3
MUX;UJ+XK2)'\,-=+NJY@ &3C)W#BNIL+)-/LH[:-W?;DM(^-SL22S''&222<
M>M3LBN,.H8>A&: .(\1:99Z99:KXMO-3O9;EK!;-)[5EC\F$N#\A XRQ!+G.
M ,C&*R;-+C7U\7Z3IVKA;B&2"YT_[+=N4C;RE; ;.3&6!!Z Y;@&O3=B[-FT
M;2,;<<8JEJ=A<W=H(K#4'TV7>I::&%'8J.JX<$?CCB@#@-;U6;5/ &H^)Q+>
MZ:9_LT4$9G>(Q!9%#Y&0,EVD4^JJM5]=2&"?QW#%JEZB6.E17ULHU"7]W.4F
M^8'=GJD?'3VYKTZVLH+2RAM(T'DPH$0-SP!CG/4^]2^3%S^[3G_9% 'F.HZP
MFHZG=V&I^(1I,KVEK-ILPW!I,J"S0X<!WWY!7!)&!@CBJNO7+0_\)K>?VM=K
M/IMW9O;#[:ZK$Q2(L-N[&"2WRG(Y('>O6##$2A,:$I]PE1\OT]*##$<YC0YZ
M_*.: .-\/+9Q?$CQ6HEQ<2?9I$C,Q)9#$,L%SR,\9QQTJ7XE65U>>%8Y+6*2
M<6=];7<\$8W-)%'(&< =^!G'M77A%!R% .,9 [4M '"?$&>#Q%X2ATK1[F*Y
MOM1N;<VAA<,5"RH[2\=%55))^@ZFLBYENHX?'FIZ=>7MQJ6E74GV*(7;NL8:
MVCS^[SAL$L0"" 5XQ7IT<$,3N\<2(SG+,J@%OKZTY4122J*">I ZT >3WVI6
M<6OW%[X6OA>73>%KA[?9<&9GD#H00"3E\<D=3CFFZOJ%C-X0U_5M%\5//&VF
MJQBM)I%$$H;Y79C(S)(02"IQG'(XKUB."*+_ %<2)_NJ!0L$*JRK$@5CN("C
M!/K]: *VEV%O86K+;2S2QRN9M\T[3$ENN"Q.![#CTKC->@M+WQ[J%AJ.KWEI
M9G1$N L=])"$<2R R###D +[<#(-=^      .PK&.@!_%DFN2S1R!K1+40-#
MG:%=G#;L]<L>W3% 'GUGJ]_;6^->U":WN[KPI'*$DG:,O<!GRRKG_68V9V\]
M*NZ*T6N^(="@N-5O)$D\.0731Q7\B[Y5=?F.UN3QSZ]\UZ6\4<A!>-&(R 6&
M<9ZTHC0,&"+N'?'- 'GWA'5K#5187-WJ]Q'XA@-PNH6(GZ-\VX2QG[J+@;3P
M!QSS@X?A&YBTRR\#3Q7UQB[TNY6XC6=G#A$5E"QD[000<8&>O7)KUP0QAW<1
MIN<88[1EOKZT"&($$1H".GRCB@#R32M<BEF9+?Q#]GM[OPS)*)WNC,\<JD?O
M9.0/-"L2P4#'3. #5B;Q!>:?:F._1+"&+4H(M2N8)WGM/*>%RCH<AD4N(]RY
M&,\Y#'/J8AB48$: 8(X4=^M(L$*1&)8HUC.<H% !SUXH \V348-/N]$MI->-
M[X=O+ZZ+7GF%80VP&* 2;CF/<7QECRNWMBMOX;O;'2-6CM9Q-''K-X WF>8<
M>:2,G))R,<GK77&")H1"T2&( #85&./:GJJH,*H R3@#O0!R>MWF/&^EZ=J,
MC0Z1<64Y0^88UDN0R85B".0F\@?4]0,<K9FZU&Z\+:?JFJ7ODW,NI0J5O'C>
MZMT)$+L5())7!#=2.YR:]4DBCF39+&KKUVL,BE,:%@Q121T)'2@ C01QK&I8
MA0 "Q)/'J3UIU%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %><^/M5DUGP?XGAM8('M=-E6VE>4G<T@V,Q7TV[QU
MZG/3J?1JY34_ =IJ#ZNJ:E?VEMJQ5[RV@,>QI  -XW*2I(49P<' H BN]>&F
MZ]XFD31XWN+&QM93-!EY)T9I0 P"YPFUC@9X)^E2V?B\7XL(K*6QNY-0GD2V
MN()"8C&D8=G8=0P)V[.N>]77\,*VIWVH)JE]'<WD,$3NGEC:(6+*1\G7+-G.
M0<]*I7/@*PG+7$5Y=6FI&]-\M[;;$=)2@C.%VE=I48((.>IYH EB\0:E+?66
MCRV$-KJ\\$]Q(KR[XXXXW"!@5Y.\LI XP,YY&#5TOQK+J5[I-M]A2%[N6[MK
MA3(28)K?(8 X^921P>.*T7\*P&YL+V.^NTU&S$BB\)5GF5\;U<%=I!(!  &,
M#&!Q4;^#K0)IQM+R[M+BQGEG6XBV,\C2Y\TMN4J=Q8GIP<8QTH S+7QIJ-[%
MH0@TRV\W4[J\MCON&"QM 91G[O(/EY_''O4">+-8U"3PUY$-K;O=:G=V5Y&6
M9@6A28':<?=)CSTST'K6M8>"+33SI9AU&^(TVYN+F%7*'+3;]X8[<D?.V.<\
M]:(O!-I##:)'J-^LEIJ$VH13 Q[@\N_S%^YC:?,?MD9X/% $5OXNNKNXMKBV
MTUYM+EN)89)51PT*H6'FDD;2I*8P#D9!YY QYM2FUWQ#X!UG[-!':7=S/);G
M),JHUK*5W=OF&"0.AXYZUT&G^#K?3=0GE@U&_P#[/FF>X_LQG4VZR,26(^7=
MC))V[MN3G%5[#P';:=)I0AU;43;:3.TME;L8RL09&0IG9N*[78#)R!CF@"#Q
M<LZ^+_",UE!!)>>?=+'YS%%_X]WZL 3COTJ.U\;W["S-[IL%NJZHVE:BZS%E
M@EQ\C*<#<CDH,G&"XZUT>K:)'JEUI]V+F:VNK"5I()(MIY92C A@0003[^]8
MNM:*B:++X<MM-O+P:N96GO=R;8I&()ED.0003E0H_@ &.* -_2KZ;4+>:X:-
M%B\^1("I)WHK%0Q^I!QCM@]Z\[NM0U/5M(TJ\OX[6:ZA\5>1!L)4#9-(F,D'
M PHYYKTZVMHK.TAM8%V0PHL:+Z*!@#\JYS_A"+4*L::C?K$FIG5(XP8R$E+L
MY493.TLS'GGWH KV_C.<QR6UU:1IJ*ZJ^F*L)>2,LL7G;\!=Q&SMCKW Y&WH
M.H7NI6,KZAI[V<T<[Q88';*HZ2*" 0&!Z$9!R/>LNZ\"V5U#>@ZA?QSW&H#4
MH[B-T5[><($RF%QC:,$-G()]:W=-L&T^S\E[RXNYF.Z2XN"N]VZ9PH"C@ 8
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MKVN:(R6A3<UJ3'Y08MM\S<QPS#;A?KUXK4A\0:/<1WDD6IVCI9'%RPE&(O\
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M<;4+#67@N(GE>)DMV6-$*3 MT4H&&T-U..: +GB/Q)=Z7H7B6_T^]TVYETQ
MT<&PL8B%!*RX;J3DC&,#'6M.^UZVTV^OWNM2LQ:V5F+B:W4%IX^3\QP?ND8
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M110 5D6OA?0[&[-U:Z9!%+O,@VC"AB<E@O0'/<#-:]% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !17G/Q@U>_T/1=%NM.OI[1YM6AMIFB<C=$RN6!'_
M  $<]:3PKK]_J7Q)U2TTJ_EU+PK!:KOGE.]8;K(^1)",MQR02<>U 'H]%>.^
M(]=U=;_P=>6^IW<-OKNN%&C24A6M2Z+& .V4 ;(P<N:]A P !GCU.: %HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "JD&F6-M=W-W#:0QW%UCSY
M50!I<<#<>^!ZU;KE=3\=6VF2ZL)-+U"2/27C%Y*@CVHC@,'&7RPP<X SUXH
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M")F+R@P+^\8]2W')/O4]UX=T6]U.WU*ZTJSFO;8 0SO"I=,<C!QV/(]*TZ*
M,Z;0-(N7O'FTRTD:]4+=,T*DS 8 #<<XP.OH/2HY_#.A7-Y:7<^CV,EQ9J%M
MY&@4M$!T"G' ';TK5HH H?V+IRI?>596RM? BY)C!$V1CY_[W''TXI^E:;;Z
M1I=OI]JNV"!-B#&,#V'8>PZ5<HH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MO5CL#!^I*@ @'[PX- '0?\));?\ /AJW_@NF_P#B:/\ A)+;_GPU;_P73?\
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M4D1XBDD!^\HZICGUH G_ .$DMO\ GPU;_P %TW_Q-'_"26W_ #X:M_X+IO\
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M<A=2-H;)(:,CJ.&![8H N_\ "26W_/AJW_@NF_\ B:/^$DMO^?#5O_!=-_\
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MFC_A)+;_ )\-6_\ !=-_\32WFL2#4;NPM!'YMI9BZF:12P&[<(UP".NQR>>
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M&OULY[B*Y-M:BU5D69@@)^\6X!W GML:@"W_ ,));?\ /AJW_@NF_P#B:/\
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MX+IO_B:/^$DMO^?#5O\ P73?_$ULT4 8W_"26W_/AJW_ (+IO_B:/^$DMO\
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M$3Q3>9N3#KC=@*>,X P12VWAB^MK#4=,75T;3[CSS!&;;YXC*6)#-N^=06;
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>exhibit1033-bochk_facili008.jpg
<TEXT>
begin 644 exhibit1033-bochk_facili008.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MY)4MU^7.2/:O7K;Q9HU[JRZ99W,ES<')S#!(\8QUS(%V#\Z -NBBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MP"15Q(9-I?)P>G;..>E<SX?\9>(KOPCX$:XO9<ZWJ$T-_J!4;E"R,$C'&%+
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MP$A<E<;_ # -P&,#C(QT]JVY]1U&'P1J^I/>75K?1Z3-/;Q22JY<I"KB=?\
M@38(Z= 17:?V5IWV'[#]@M?LG7R/)7R_^^<8IBZ+I2*ZKIED Z>6X$"_,G]T
M\<CVH \ZTOQ-KD%W\/0EY)??V[9[]0MY%5BN(U;SE(&5P2<CH>@ ->IU6M=.
ML;'/V2SM[?("GR8E3@=N!5F@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KD+O4+^R\>:
M58C7[>5;TS&;3)$C79$J$JZ'[Y;=M!!)SEB  ..OKG+K2M0UN]L6U2TLK>/3
M[[[5#+!.TCN%#!1@HNW.1GD]".^0 ='1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%8>H:7KMS>R2V7B/[';MC;!]BCDV\
M#/S$Y.3D_C0!N4C*KJ590RG@@C(-<W_8GB?_ *&[_P IL7^-']B>)_\ H;O_
M "FQ?XT 7Y?"_A^=]\VA:9(_]Y[2,G]15RTTVQT]=ME96UL,8Q#$J?R%8G]B
M>)_^AN_\IL7^-']B>)_^AN_\IL7^- '2T5S7]B>)_P#H;O\ RFQ?XT?V)XG_
M .AN_P#*;%_C0!TM%<U_8GB?_H;O_*;%_C1_8GB?_H;O_*;%_C0!TM%<U_8G
MB?\ Z&[_ ,IL7^-']B>)_P#H;O\ RFQ?XT =+17-?V)XG_Z&[_RFQ?XT?V)X
MG_Z&[_RFQ?XT =+17-?V)XG_ .AN_P#*;%_C1_8GB?\ Z&[_ ,IL7^- '2T5
MS7]B>)_^AN_\IL7^-']B>)_^AN_\IL7^- '2T5S7]B>)_P#H;O\ RFQ?XT?V
M)XG_ .AN_P#*;%_C0!TM%<U_8GB?_H;O_*;%_C1_8GB?_H;O_*;%_C0!TM%<
MU_8GB?\ Z&[_ ,IL7^-']B>)_P#H;O\ RFQ?XT =+17-?V)XG_Z&[_RFQ?XT
M?V)XG_Z&[_RFQ?XT =+17-?V)XG_ .AN_P#*;%_C1_8GB?\ Z&[_ ,IL7^-
M'2T5S7]B>)_^AN_\IL7^-']B>)_^AN_\IL7^- '2T5S7]B>)_P#H;O\ RFQ?
MXT?V)XG_ .AN_P#*;%_C0!TM%<U_8GB?_H;O_*;%_C1_8GB?_H;O_*;%_C0!
MTM%<U_8GB?\ Z&[_ ,IL7^-']B>)_P#H;O\ RFQ?XT =+17-?V)XG_Z&[_RF
MQ?XT?V)XG_Z&[_RFQ?XT =+17-?V)XG_ .AN_P#*;%_C1_8GB?\ Z&[_ ,IL
M7^- '2T5S7]B>)_^AN_\IL7^-']B>)_^AN_\IL7^- '2T5S7]B>)_P#H;O\
MRFQ?XT?V)XG_ .AN_P#*;%_C0!TM%<U_8GB?_H;O_*;%_C1_8GB?_H;O_*;%
M_C0!TM%<U_8GB?\ Z&[_ ,IL7^-']B>)_P#H;O\ RFQ?XT =+17-?V)XG_Z&
M[_RFQ?XT?V)XG_Z&[_RFQ?XT =+17-?V)XG_ .AN_P#*;%_C1_8GB?\ Z&[_
M ,IL7^- '2T5S7]B>)_^AN_\IL7^-']B>)_^AN_\IL7^- '2T5S7]B>)_P#H
M;O\ RFQ?XT?V)XG_ .AN_P#*;%_C0!TM%<U_8GB?_H;O_*;%_C1_8GB?_H;O
M_*;%_C0!TM%<U_8GB?\ Z&[_ ,IL7^-']B>)_P#H;O\ RFQ?XT =+17-?V)X
MG_Z&[_RFQ?XT?V)XG_Z&[_RFQ?XT =+17-?V)XG_ .AN_P#*;%_C1_8GB?\
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MBBB@ HHHH **** "BBB@ HHHH S-5UVUTJZL;-TEGO+]V2VMXMNZ3:NYCEB
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M@E2\>XX.<Y*@8 .>0 <GK0!8TGQ FLRQM;65T+.:$SP7K!?*E7=C'!R">H!
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M;23RXS.X\X$J9&V9P>1QGH.G H Z*BBB@ HHHH **** "BBB@ HHHH ****
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M =G@8QVI  .@ JI974]YI4=UY< FDCW*J3;XR>V' Y4\<XZ'I7G5KJNJ:P/
M.L3V]N^H7,]RRJLI5&!MY3@G;\H'T;@=Z /4 JABP49/4XZTN!Z5R%GXU>[L
MK-?L(34KB:ZA:!6>1$-NYC=LJA8C=MQ\H^][5O:'J-QJNCP7EWI\UA</N$EM
M,#N0@D=P,@XR#@<$<"@"&_T,7^OZ9JC3A18+*HA,>0_F !LG/^R,?UHU'0QJ
M&N:5J1N @T\R;8O+W"3>NTY.?3I[^M8VF^-I-6TFZO[.SMYV@B#/;+=!)8),
MX,<RL!LVC))YZ''09BE\>31V-_-'IT5Q)9:G;V#>7<$+()O+VNI*_P#34<'C
MCKB@#M<#THP/2N2C\8S137UE?:?%'J-O?PV,<<5P7CE:5%=#O*@@ $Y^7^$X
MSFH]8U_Q#:?V=%_9MO;23ZPEF6:?<LT14N&0A25!P0<C(P>N<T 78?"CIYMO
M-J]S<Z=)(\AMIHHB?G8LRF3;N*Y)]_>KNKZ+/J-W:W=KJ<]E/;JZ *B21NK[
M<[E8'GY1@C!'/J:PQXEMM,U37@=,CCO1J-K9@I,3]JEE1!&6)7Y0 P!X. IZ
MT:KXWN-'36(;C3(WOM-2"?RTN"$FAE;8&4E>"&!!4CMUYH Z73M,BT^"1-QF
MDED\V65U4%WP!G"@ <*HX';UYJ[M'' XY%<C/XSN-/\ [=34=-2.32Q;R$P3
M-*IBF8@.WR C;M8M@'@<9K>T34_[7T\7BM;/$S$12VL_FQR)V8-@?EV(QS0!
MH8 ["C ]!ZUP']M+>_#K7_$]Y9)?Q2"[Q:R2%%^S1.R! 0#C(0L?4M],7]5\
M7:AIUWJEK9Z/;S+IVF1ZB6>[*!XSYF5 "'#?NSCMZD4 =C@>E(55@5(!!Z@]
MZYI_%%U=_:5T33!>RVMM#<21/.(F?S065%X(W;1G)('('KC#OM8;PWXB\;:S
M':"<VNF65PT#2;-V//SS@X.!Z4 >@E59=I4%?0CB@JI()4$CD$CI7,ZKXQCT
M;4=5M[NT_=6-C#>+(DF6E,CO&J;2!@[EQG)^]VK$N)KN#QSK,][86SL/#HD:
M&.X8I*!(^025X/&,XY&/H #T+K2;5#%MHR>"<=:X>V\5WL=O8V6E:':[#H4>
MHQ+)>%%1, >7]PGCH#W]JLMXX,UI#-96(9GT0:R5FEV#RR,A 0#SUR>@X]>
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M[73Q!9VL%T==.EW:&<LORY/R-LZ, .2,C.,=P =/<Z1)=:Q#=RZA<&SB52+
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MHDZV]G9?:TFC#A'.<&,ET7##@YP1@D]L5%JGC:_TG^W1+I5O+_9%K%=.R7;
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MZ[7MY;7LI9(_]9#LVXPHX/EKD>U6?%7BB/0K>$6T]F]XUY;0-;RO\VV614.
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MK,\9F7< OWCC/;OZ5FV?BBRUF#2KK2]1L/(O)2-D[_O)%"L<( ?O_=.#T&:
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MMT(1FS(Y"JIP#C)(Y/'- '!W^G7FHV!UC3O#>H6MTEY9S7=O>7 ::\CA?<4
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MH;"!)+:(P0LJ<QQG^!?1>!QTX%-TKP]H^A&<Z5IEI9&=MTI@B";C[X^IX]Z
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MK>9;(S$C"X(9ESP<KCC@XY )F\6M!K>O6L^G7(M=*MX93+&%=I"X<\*#GG
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M9&C9P1G?@$"-B<D#T)JM8^$-1M+30(6N+5CIFIW%\Y!;]X)/-^4<<$><>?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "J2ZC')JSZ="/,DAC62=LX$8;.T>
M['!X[ 9/49NUQ&E6DDVI>/;.XC$DT]TKHK#(>-K9%3KVRK#Z@T =O2!@3@$$
M]:\IT.2">?PB)+.XQ!X<GL[QI+1P%D58 4<E>Q5^O'YTOA/3[>PF\"RBT\F:
M31IH=1=HR&)"1;5E)'8JP ;T(% '<3^(+FRN-$@O--$<NIW3VS!;@,(2J.X.
M<?-D1^V,UN[ER1D9'7GI7EFB1M%H?@*,PRH8-6N&D4QL#&I2X +#'RC+IU_O
M#UI-%,<_BG0IAIMS!'*^H074,EI(Q4NV=LTC#Y\D$^@&/J0#TVSO[6_LDO+6
M9)+9\[9%/RL 2,@^G'6IR0.I KQW2A'I?AOPLM[8WD&EQ)<0:D(]/W^7<DJ$
M:1&1MPP'7< <%AS6I;>&]'E\1>'=/ELKFZTT:5=QC^T(R6(,L31*_ QP&*J0
M" !P"* /3MPR0""P&<9KE(/&AFT_3KHZ:R_:]6?3&7S@?+99'3=G'(^0G'O7
M+Z?*#XQT2[CL+NU(U2_BN5-K*SKN63!DE(^8,0K #Y5&WTS2VH8:!HZF.4,O
MBR:9@8SE8S<3,'/'"X93GIR* /4Z*X!="-GXNN]!BL8SHVJ2IJS$(-L;1D"2
M,C_:<0D#T:3TK>\<)J,G@S4ETE))+ORU(CB^^Z!AO5?<IN QW- '0!E()!!
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M #ZD\XP>1\0ZSJFH^&-4M)I(8KK3=<M+.61(CMG5IX&5@-WR_+(-PR>AZ9X
M/0;;4;*\MFN;6\MY[=25:6.0,H(Z@D'''>HH]:TJ:58HM3LWD<X55G4DGT S
M4]K:I:QMMCA665O,F>*,()'P 6(]3@=2>@KS_P"',-W<>$=(@DTVSDTX7ERY
MF,I,BE9Y60[-H PX'.X]!QSP >CT5PL'C'4)M)T77U2!]/U/4%M#;",^9$CR
M&-'W9Y8$#<,=SC&.8H?%>O1Z=>:G=/8/!%J<FEQPQ6[*QD^TK"DA9I,  $DK
MQG^\,\ '=7-U;V<)FNIXH(@RJ7E<*N20 ,GN20![FI:X;5]9\1:=HVH37UG9
ME(;VT6W:>-298I)41MR*Y"LK$D-G!P.*75_%.L0W^I6MBENEU:WUM;6]I+"7
M:XBEV;I1A@2!N?IP/+;)] #N**\_U;Q3X@L)/$<J2:>8-%N+8;#;ONG218V8
M9W_*1O///;@=_0* &[T\SR]R[\;MN><>N*=7F&H:N;/Q=I_B[==BSDN#IDX:
M"00K:.0L<F\C9_K0&R#RL@':NCUWQ-<Z3XB@LYRMG93&%8;N6!GAD=G(>-G!
M_=MMQMSP2>_2@#K**X2?QS/IUYJJ:BGV>6QAN[A;*2!E-S#$"R/#+DJ^5 W#
MJ">@QS!XAUCQ5!X8URZ A@MUTB2Y@NU5 Z2@9*JHD;*E3D-V/KQ0!Z%17%ZE
MXEO]%U"RM+Z6.WMIHX1'?O:LT$DK.0T;L&/EG;MVD\$D\]JL_$O4+W2OASK5
MYI[O'<I" )$^\BLP5F'H0I)SVQ0!=U:'2=9NH(O[9-M?V3LT;6MTJR1DC!!4
MY!X/0@UIV&GI8HW[Z:>9\>9/.VYWQTS@  >P ')XY-5!H6DOH$&F+;Q?V?"J
M-" !A=N"K@^H(!SZUS=SXQOUT2Y\0P) UA:ZF;.2T*'S&C680LP;/#Y^8#&,
M<=>: .ZHK@+CQ5K\!U*Z+Z>;73]=ATYHA;N&EBD,(SNW_*P\[.<'..@JO=:_
MKVF6WC*_BN[:<V.IQ0P130':JM'!P"&X_P!8>QYY[XH ]'J![RUCNXK1[F%;
MF4%HX6<!W ZD#J<5S<>IZT_B!_#SWED+V.S:]:Y6U8*5:0I&H0OVVG<<\\8Q
M6/8:T_B+7/ ^JS6X@GEBOUDC!R%= $;!],J2/;% 'H=075Y:V,(EN[F&WC+!
M0\KA1D]!D]S4]>5ZY<ZE=>'/&@N[M+B.WURWA@0Q[=@!M6 !R>/F].N3WH ]
M4HKAIO%FJ:;?ZIIMW]FN;B*\LX+:2&(QC%QGAE9^2NUL?,,Y XKH="N-9E-[
M%K%O''Y<W^C2*5#21$#!959@I!W#KSC/% !K5MIGB'3[S0+B_53<QF.6.&5!
M+M/48.<<>U7H;NT57@%[%*]NO[TF1=RX[L!T_(5S%LH'QCU$X )T*W(]_P!]
M+_\ 6I-9TEM:MO$]C!=QVD\UQ;!)G7<OF*L;*K#N"<*1W#4 =3::C97Z[K.\
MM[A?6&57_D:+K4+*R*B[N[> M]WS9 N?IDUR?AG5YKGQ5/8Z]HRZ;XC2S#-+
M P>"[@5P-Z-UX9ONGD;N]/\ ':*^I>#@RAA_;L?49_Y8S4 =;!<P747FV\T<
MT?3=&X8?F*EKSSQ+)#X=^(V@W^GQ^6]Y;WG]I10C'G0Q1;U=@.,JV &Z_-BK
M#^)/$PT6364M+3[$^DR7J/(%PDH3>J@+(2ZE<\\$8SWP #NZS;+1H;+4;J^^
MT7=Q-.Q(^T3%Q"I()2,?PKD#CV'H*Y1?%'B"PO+5=0;2Y(-1TF:]MG"M"MO)
M$JL5D8L<H0X^; Q@\57O?&>M6>F>)G3[,\VF:=;WL$DMLZ!]_F;@5+ XS'P3
M@\\@]P#T6BN)N9O$<7C30;.YU2T,5PEW,8X;5E7""/:#E\D@.PSP.^/2E9>*
M?$EQ9Z#=O+INW4M2N-.>,6S_ "%3/MD!W]O)'R]\]1V /0Z*X6T\7:FXBTV9
M(I=1?5;G3Q-#&%5EB0ON",X&XC QN]3SC%/_ +;\5)J&BZ;=1Z?:W-[+=12.
M8S)\L:EHW 63 )&,KD\]\4 =O17G=IX@UO5I_![M=P0-<7U];W2QPG9*T*S)
MG&[(!V9QG@GOBNK\3ZTVA:7%/&BM-<74%I%OSM5I9%0,V.PSG'&<8XS0!LU5
MM-2L;]Y4L[VWN&A($JPRJY0GD9P>*X[7M9U6.W\5Z)++%YUMHYOK>[CB(RC+
M(I5ANX8%#@@]"...>B\,6BPZ%83R+ UR]G"C31P["R!?E4\DG&3W[GIF@"\V
MIZ>MX;-KZV%T,9A,R[^>GRYSW%6Z\PN6NO"A>+6K&+5?"TVI_;(=3M\&:SE:
M;>OFJ?O .<;UZ#C':M.'6-7MK[Q=*VH6C+:ZC!;VZW$;!8U>.$X&TDL<.V%
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MEA\T^7(4(*DK[$#IC. #D5F>'O%EEK-I:6!NY4U:2P2X)DMFC$F5&YXRRA7
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M<XNKJ.\D;[7+N$R;=KJV[(;Y%R1UQS3_ /A#M'&MMJR1W$<\A0S1I=2+%,R
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MG*^]:M95GXBTS4+/3[NUG>2#4'*6S"%QO(#$Y!&5X5N3CI6K0 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ML1W(S2"&(8Q&@QR/E'% '!>"M4T_5HM*O)=7N?[=C@D34[+S^DG\9FC/W K
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MA2.:4,ICB\S<=RJIDVY8YVCKM%>D-%&Z,C1H5?[RD<'ZT-#$Z!'C1D&,*5!
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MBTK6)XI.4@5\>;N'(5EV MQ]YNA%>JA$5BP503U('6D\F+##RTPPPPVCD>]
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M.ZQ>PW>D>,;1KZ*6V@EL+F&."Z9XXE+)O*MGE>.3P,Y. :V=?U6\L]8\0?\
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M)[#7#=S)+9120QPJJ[&63;NSQG/RCO5&X\%65[=Z]+>7$\\6MPQPW,)"A5"
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M@,\ 46_@VUT]]*FTRZGM9].LA8)(=K^; ,85P1R00"",8.>QQ0!4T_QN;]M
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M,EK=1F*10<'!]#V/?-4;3P\8;E+RXOYKJ]AM3:0W$J*"B$@L< 8+$JN3_LC
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MF>%]5=?$%]I>OQ+!XD8EU?.8[FW!.TP$_P *YY7J#DG.<T =G17GEUXFU9M
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MV!)B([KTPWL1-J/B+5[;3O$TD>HL'T_6K6WMV,<?$4GV?<A^7D?O7YZ].>*
M/0Z*XF$:_J_B+Q+:0>([BSCL+A([94MH6 WVZOAMR'(#MD=^,$GM/X2UN^U_
M[+YL\B2V$#0ZI$53YKO=M*Y"\8V.W&,AT/2@#H]3U6QT>U^U:A<+;P;@OF.#
MM!)P 2.F20!3;36-/OKE[6WNXVN8U#O 3MD53T8J<''OC%<W\4MW_" W6P@-
M]JM,$C(S]ICK/O\ [;!\6- &J21.;JRNH+&2R788V 5Y#(K;LC &TYP#U'-
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MBY";@PP&(&"#Z#'..G2@!X\)Z"--73AI=N+-)O/2$+A5D_O#T/)Y'J?6G_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MVU[:PSW6J+J%S;_9R;:0"/9Y90,">SY)Y89QZ+I_@N_L9M+9M2MI4L-3NK\
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MOH6^.$BU822Q&/RU#'?@,%QR!V]Z[2HUGB=]BRHSXW;0P)QG&?SJ2@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N0
MU;0[7Q/J>L6%PMQ"PBMWMKM8V4PS(9"'C<C!921T/?'>NOIK2(CHC.H9\A5)
MY;'/'K0!YLKZU#H-RWB#2FGO1KL DD@BDDCVI'$!<A$Y=<H#MZ GGH:SX;&0
M6-F;C2[V6*T\5RS,)+!RWD.),,$"_=)92<# )YKT^35=.AN3;2ZA:I<#K$TR
MAA^&<U<!! (.0: /+KZSO8[OQ+)9Z=<FT_MZRNKB%+=A]HMECB$NP8^?YE.0
M,YP1SGF/Q+I4EU;^)[FRLIY-.NVL&AACMG)>X63][(B 9'R; 6 YP?2O5:*
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M;)(D2%Y'5$'5F.!0!Y1>6.H2:%?0W5DFHQVMYILL=_;V#1R7$2SJ7#Q8^^B
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MZ6=K$1:YI4EVD:0-_H\B)&PR=_S@[SQQT'-=*WAVP:_^W-]H-S]E-GYGGO\
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MF_.<]O3'&,<42^%M+FBA1XY28KL7H<3,&:<='8@Y8]L'C  Q@"@#'T*;6_\
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M+WMRPW!B,] 0,G%<]9^$EO\ P/JO@V[E:"6*ZF>"8#)"M,9H90.X!(!]U84
M=&=/UV.UMY%UHRW8DC:>-H(Q"R[@9%0!=R_+N )8X[YI8?%>ESWL=LCS$RO/
M'#((F*RO"2)%7')((/;G!QFGV$GB&2**+4+:PAD7 EN()V<-CJ50H,9]">,_
MQ8YYNU\->(O^$@TK4KXZ?,]E>7+R7'GN7EAD5PN%V83:"HV@X."<^H!L:9XZ
MT+5KRQMK:6X'V]&>TEEMI(XYMHR55F !8#G'U[@UTE>;>"-)NM9\(>"Y9TAB
MM=-/VM720L\K;'15Q@8'SDGG^$#G.1W]@;V2Q0ZE%!'=$MO2!RZ 9.,$@'IC
MMUS0!R_A_P 8P>(+])FOOLMM<RR1Z=;^5C[4L9(9R[+@DX)"J00O)SGBGI_B
MZ^FTO0/$$LNZSUG4?LOV78H$4;LZQ,#C<6RJ9R2/F; &!5C3O!MU;:;H.CSM
M ;/1+W[3#.KG?(BAQ&I7'RGYQN.3]WC[W"V/@RYM[/1='E>'^S-'OS>0R*Q,
MDBJ7,2%<8&TN,G)SL'J< $_A[5KOQ7IUQKBZD]AIC32QVB0I'DQQL4,DC.K<
MDJ3@8 &.O6EE\0R:=X;M];DU.TU&VAN!%=RVI4QM&TNP.NW.&4,I(R> PZX(
M7P_H>I^$H;G3;"*WO-*,\DUH'F,<D&]BQC/RD%0Q)#9SSC'>LBX\+75G\+;;
MP<TD<M]=.(28L[55IO,D;D X52><#)P.I H ]#HJK:M?&>[%U% D*R 6QC<L
MS)M&2X(&#NSP,\8JU0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M$4I#JNUF).'7)QG'R9'4U7UG4+W3+ZYO=+7S+Z#PAYD( W$$2?> [XZX[XH
M]1HK@YH[B[URTT_2-7O7T_5-'FEDF%T[F!P4\F96)RI;>W P#MZ<&L6Q\0ZN
MUSIEVZWFV[MFT6:-YI"L>I)GYL9^[\K M[>W(!Z<+O.H/9^1.-L2R^<4_=G)
M(VAO[PQDCT(JQ7FOB:XO-+N?$]K;ZK?JMIX76YA)N6+)*K2C>#G[QV+D]Z+R
M\U'2[K68[/69E=_#0OUDO9S(D4X+CS #D*,8R ,<#B@#TJDP,@X&1QFO.(9[
MR]&J7FG:Y]EMCI\$<"76H>>$N68ABQ1V*J047=G@Y(]3J:'>QWD4D&JS7NDW
MMIJJ(UO)J!=9)?*5EC20G,D; [MAYR3QQ0!VE-=%D1D=0R,,%6&013J* (X+
M>&UB$5O#'%&.0L:A1^0J2BB@ HHHH *3 W9P,],TM% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 0W%G;7:[;F
MWAF7&,2(&&./7Z#\J;]@LQ;);"T@^SH05B\L;5(Y! Q@58HH K/IMC*KK)96
M[J[^8X:)2&;^\>.3[TL=A9PN[Q6D".XVNRQ@%AZ'CFK%% %:+3K&"T:TBLK>
M.V;.Z%(E"'/7*XQ2K86:SI.MI )4 59!&-R@#& <<<58HH K1:?90-,T-G;Q
MF?\ UI2)1YG^]@<]3UIJ:5IT;(R6%JIC.Y"(5&T^HXXJW10!7M["SM)'DMK2
M"%Y,;VCC"EL=,D=:<MI;)</.MO$LSC#R! &8>YZFIJ* *L>F6$/F>58VR>8I
M5]L2C<#U!XY%+!IUC:LC6]E;PLB[%,<2J57T&!P*LT4 5#I>GF-(S8VNQ"61
M?)7"D]2!CBG)IUE''+&EG;JDW$JB)0'_ -X8YZ]ZLT4 51IMB+06@LK;[,IR
M(?*78#ZXQBG2V%G/'''-:02)']Q7C!"_08XJQ10!FZMI<E[87::==#3=0GC"
M+?1PJ[I@Y'!ZCMCWJQI]G]AM?*+!Y&9I)9 NW>[$ECCL,G@9.!@9JU10 444
M4 (RAE*L 5(P01P159=,T]/+VV-LOEG<F(5&T^HXXJU7+V>KRWNK>([L0RW$
M6CO]EM[>+[TD@B61R!T+'>J#/3';)H W3I>GM;26QL;8P2'+Q&%=K'U(Q@U(
MUC:/Y.ZU@;R1B+,8/EC&,+Z<<<5@Z9K:>)9M4TF6-;>:UCA<RVMSY@'F!L%6
MP,,I0YX[#Z5:\(:S+K_A6PU&<*+B162;:,#S$8HY'MN4T :/]F:>,?Z#;<)Y
M8_=+]WIMZ=/:D&EZ>'B<6%KOB&(V\E<ISGCCCGFG7]DFH6;6LKRHCE2QBD*,
M0&!QN&",XP<=C7$^'])BO/%?BNWDN;X1V-_;?9@+R7]V/)C<@?-R"V<@]<F@
M#NI[:"ZC\NXACFCR&VR(&&1T.#49TZR+AS9VY8.9 3$N0QZMTZGUK@_"VO7&
MDQ1VLMFTME=:_>V*W+7&71_.E*#:0<KA<9+ CT(YK>M/%[WNH6:6VDW,VGW4
MTD*W<:.?+*[@'<;-H0E3@ACU&0,G !=U'0GNDCMK&ZCT^R<L+R&&V7-PC#&
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MN9<2. ?D!Z9)&*B_MY]-T74=8UB:R.G6RF6*YLW+"1 .1M.?FW948)SQTZ4
M;]%<^-3U[^RTU'^R;?YU5S:>>?-C0XY)VX+ ')4>F 3W;H7BB/4;B]M;Z2TM
M;N+4)K2" 3#=*(\<@'!)YYP* .BHK-M]40277VN\T]8UNA!#Y<^3DJN$?/23
M)/RCL5]:FCU?3);(WL>HVCVH;89UG4H&SC&[.,YXH N45634;&1+=TO+=DN3
MM@82J1*<$X7GYN 3QZ&K- !1110 4444 %%%% !1110 4444 %%%% !1110
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M9%>*PMFW& 2(2^<=-H;_ ":](DO;6&]@LY)XUN9U9HHBWS.%QN('?&1^=3T
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MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *X1-?DLO\
MA/->EB,KZ5(8(8C_ '(H%D ]@6D8D_X5W=9*:+'%JVH7"I'):ZFBB[A<9!=5
MV;L=]RX4@_W1[T 1V4%[-+-#J%[:W^GW5JI1-@5BQR).!P8R"N.IY.2>*J>
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MR;&>1A^Z^PR$+&^<]/,"R9QTD([5N:[J^N1Z_K-C97T%O#::.E_$3;;VW[I
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M[WV Y;&.%.,#KS0!9O/&>F6*7S7"70^Q7D5E,%AW$22;"A&,\$2+^?KQ3_\
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M:)E9PJ@$*'*YW#GG&" ,/OO"6KW=EXAA$EB'U34+>[1O,<!!&(001MZGR?\
MQ[VY -#Q_J%_I?AM;O3KR2UG%Y;1%D1&RLDR(PPRD=&-:.LO<PRZ2D%[-")+
ML1R[%0F1=CM@Y4]U'3%-\4Z&_B/PY/IRSBWG9HY8I"-P22-U=<CC(RH!]J1;
M75[^\LI=1ALK>.T<S;;>=Y3*^QE ^9%VJ-Q/<YQ^(!5L_'&EWL]G''!?)'=W
M,MI'-);E4\Z,N"A/7)\ML<8XQP>*32O$=BUJH@FO[V>XO;F**&95$I:-VWJ
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MU..5%=#:R95AD'Y37EVH,)/@9HD+:-,B>1IK?:&\G829(=S<.6^;)[9YY[T
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M;"22)()$C$3HX!8K@2(V&RQZ8SW!K"C\9:L9EEET^S6T76SI,@69F?EMBN.
M.I&?7/;'.?K&J2^(8O"^KQQ6PL&U^-(,@F4*K.F_=T^;:?EQP".>U 'H%G9Q
M6-JMO%DJ"S%FZLS$LS'W))/XU8HHH *#R.N*** (K:VBM(!#"I"Y+')R2222
M2?4DD_C4M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M!/;M0!UU%4;G6=-M((YY[Z!(I4,B/O!#( "6'^R 1D]!D4X:MIQG6 7L!E:
MW*H'!+1#'SCU7D<^XH N45BIXKT>75K'3H;V*:6^MVN8'C;<C(&51AAP<EN/
MH:VJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH *X>WMX]/D\>6VH9\FXD-Z"7V;X7MU3ACTPT;KGMBNXK$O-0T2]EU
M6SNH?M,FG6^Z[B:V9SY4BL=H&/G#!#P,YP.^* .;\("XAU>Q;5M,U2UO5TU-
M/ADGAB6)E3YR"4D?+'&<D*.. ,UK^!K:2+3=3NV!$5_JMU=P9[Q,^%;Z,%W#
MV:M+3= T:SMLV5BL<<T>"'#9V'G;\W('^SQ]*U0 J@   < #M0!E>*;&?5/"
M.M:?:J'N;JQGAB4G&79" ,GIR:YN&QU.;Q#:7\NC7,<2Z!):,':(E92ZD+PY
MZA3ST]Z[&ROH;^SANHO,6.8?()HVC?OU5@".A[59H \NT[1=:TNUT47N@WNH
M6KZ'!IMU:VUVJ/!+'NSN'F*K(P<@G)QM%>CZ;;+9:7:6J0I"L,*1B*,DJ@"@
M;03R0,8I9KZ&":UC;S&-S(8XS'&SJ"%+'<0,*,*>3CGBK- '$R:#?WNI>.(Q
M;-:_VI;I%9W;%<%A 8\\$L,,>X%4K?2I]4TJ9M2\)7T%ZEFMI,QOPTCC>I(@
M;S#@#:7!.WD*/7'H=% 'E][;ZK8-X?35/.OXT\2H;666-%N)8OLDO,@& 64@
MC/!(4<9Q4UUX=U>SO9]=LM.FEB?6FO6TR&<0RM$UOY)=2& #ELOC(R#@X/%=
M?K+Z+)?V<6H"2:\MV^TV\4*R2/&1E?,VQY(')&2.Y'>I9_$VCV^BRZQ+> 6$
M)*RRB-CY1!P0Z@94@\$$#'>@#E/[/U'1]5TO7=-\.7!M2+I+K3DG1KA#,T;>
M:=S[2Q:/Y@&Z-WYK0ATR]LO%FBWT&BK#9)IMQ:O#:F-5M2TL;J",CLI^[GGV
M.:Z&UUJRN[T6<9N%G:-I56:UEBW*" 2"Z@'!9>GK4Z7]I+J,VGI.C7<$:2R1
M _,JN6"D_7:WY4 <+:^'=67X>6B1V30ZYI=]+?6D,CK\S><[;-P)&'C<KU_B
M]JNZWI6J6,F@W]K9SZD+0SB_M[2X\F1VFPS2(2R@X8'Y21PU=1>ZO8V%Q%;S
MRL;B4%D@BC:21E'5MJ@G R.<8Y%.L-4L]3\\6LI=K=_+F1D9&C; ;!# $'!!
M_&@"#P_91Z?HT,$6GC3T+/(+7?O,>YBW)R06.<G!(R3@GK6)?:3?Z;X^7Q-9
M6[7EK=60LKR"-E$D>UBR2+N(##D@C.>A&>E=:S!5+,0% R23P!5.+5K.;6+C
M24D;[9;Q)-(AC8 (Q(4@D8.2K=,]* .#UOPMJ>OZAXINK.T^R+?:7%;6S3[5
M,DJLS/D D@,-JDG&?PK=@TVXUCQ7;ZS=:?)9VZ:7)9W$$Y4F5I'5MGRD@JNU
MN>AW<=ZZRHKFXCM+:2XF+".-2S%5+$ >P!)H X:T\*:RW@O5]&GF47$=K-IN
MF2L^<P<[&8]BP**W_7,&J6JZ5J.N^%-8=?"EW::Q/8?8R+F\65Y#N!VHQD(\
ML')R<=>!UKN(?$&F7&@_VW%.[Z=Y9F\X0OR@&=P&,D8YSBB?Q!IUO(D;O.TK
MQ";RX[:5W5"<!F55)4$@]<=#Z&@#(NK*Y;QWI&IQZ9*;.#3;F.1QL&R1VB*K
MC=G.$8<<>]87AK1-7L)/!?VK2IH_[,T^[@N3NC/ENYCVCAN<A#T]J] L[RWU
M"RAO+242V\Z"2.1>C*1D$5D_\)AHF;O_ $F?;9R&*YD-I-LA8 $AFV87 (/)
MZ$4 <IH^A:M:V'@Z*32IHGT_4;F:ZPT?[I'2=5/#<Y,B],]_2I/#6D:A:VUE
M9:IX>N6OM'BDCCU![L212@H4#1*7R&<8R"H YYZ5Z!;W$-W;QW%M-'-!*H9)
M(V#*P/0@CJ*DH \\\/:'JMDW@5)],EB_LW2YK:\;='B)V6, <-SDH>1GM6_X
M"L[W3?!6EZ=J%F]K<V<*P.KLK;BO&X%2>#V[^U=)10!A:M;7>IZU8VH2Z@LH
M UPUU$8\&4<(N&R<8+'[O4+S7.6F@:M8R^+]#AMIY-,U.*2>SNY7C $\D961
M2 00"V&!V@<FN_#!LX(.#@X/0TM 'G5EIFM7E[:/)HUS:QKX<ETYFFDB^68E
M, A6/RG:<']!4^CZ=JJ:CX.GN=&N(DTW2)K6X+/$2DA6$#HQSGRVZ>HSC-=]
M10!YMX7T;6]"?P[>7.FSM%;Z=/87%LK(SV[-*KJX ;!!"A3@Y''OB72?#&HZ
M;J?AKS+!G@M[C4)Y0&0K:K.Q*)UYP#@[<CKVKT,,"2 02#@X/0TM 'G6M:%J
M]VGC3R--E;[9<V<UJ-Z#SUB$6['S<'Y#C=CM4NOZ)K.M:OK<EK926PO-"BMH
M9)9$"^<LDCF-MK$C(8 D<<GDUU^J:W8Z.N;IY"WEO+Y<432/L3&YMJ@G W#)
M]Q4MUJME9V4=W/-MAE*B/"EF<M]T*H&23Z 9H XQM+;6=.N;FZ\+:I8W<H@B
ME;[>K7.4D#!HG\PC;&<L,X)]/7H_"D&JVVDR1:O)YTHN)/*F:-4DEBS\K2!>
M Y[X]L@'(J[8ZQ8Z@;A;>5M]MCSDEB:)H\C(W!@"..?I5^@#F-1M=0M/'5IK
M4=M+=V#:?)9R)$1OA<NKA\$C(;&#CIA>W3#L_#FJ:79^$;<64DHLM4N+RX6-
MTQ;QR+/M3EAG;YJCC/0UZ$&!8J",CJ,]*6@ KS?2].UU-?T*^N="G@%I)>I.
MD+PK#&)#E3&H;E3C))&XD\^WHY(52S$  9)/:J2:O9OK3Z0LC?;4@%PR&-@/
M+)V@AL8//H: .&\.Z%JUC!X&CGTJ6(Z:+E;SYH\1;T('1N<DCIFM7P]H\]EX
MHU&T#HVCV,[7-F@/,<LZY=/;;ER/:?VKL)(TEC:.10R."K*>A!ZBJ5AIVG>'
M]+%KI]HEK9P@D101DX]>!DD_K0 FO6,VJ>'M2T^VF\B>ZM988Y?[C,I /X$U
MS.GZ9J-YJ/A>\N-.EL7T:TECN5+*0[-&J>6FTG<N1NSP/E7OTZ.S\0:9J&B?
MVS:3O+I^PN)EA?E1U(&,D?04DGB'38Q!^\G=YXO.2.*VE=_+_O%%4LH]R!0!
MG^!;.\T_PO%:7]I):W"7%PY1V4\/,[J<J2.C"CQ+97TNM>&[^TLWNDLKV1YT
MC9595>"1 WS$ @%AGOCL:W+&^MM2LHKRSE$MO*,I( <,,X[UEGQ=HPGO(O/N
M"UDVVY(LYBL)QGYFV8'!!Z]#F@#DUT35Q: #29Q)_P )4=1(W1Y\CS"V_P"]
M_=[=?:K.BZ/?0ZB-.U30;BX-KJ4M[;:FUWFWVM([A]F_(DPY7&W'4YP:[FUN
M[>^M8KJTGCGMY5#1RQ,&5QZ@CK4U ",<*3@G Z#O7G&FZ+KEGIOAZY;3IM^F
M:K=SW%F70L\4S3!77#8)42 XSGD]Z](HH \YNO#FI&[:]BT^5X[KQ)!J/V8,
MF88DC5&<@MC)92V!D\COFIK_ $:]_P"$BUFSNM GU32]5DBE@DCN]D,16-$*
M3)O7Y08PP*ACSZUWX8-G!!P<'!Z&EH \OO@5U36M^EZI/HIU:._DN+189%\R
M%8]V&,@8 -$ 5V$C:0#S@6[_ ,/ZM=:1XKT)K227^U[PW-I>AEV*KA,%LG(,
M97TY 7'MUP\+Z&-0DOAIL N)'\R0@$*[_P!XK]TM[D9K7H \X\1Z%J]XOC>.
MWTV:;^T;*UAM&WQCSF0,&ZL,8W#KBG>)]-GFN?%,\^GSK8WVBV]I"1+&ADF#
MRX0<G#9D0#(P3Q7H@8$D @D'!P>AJ"^L+34[*6SOK:*XMI1AXI5#*W?H??F@
M#B]*U"ZM=4U34[O1-6_M>:Q3;%+'#$DR0D\*5E<!LRDDL1P1CI7:V5T+ZPMK
MM8WC6>)90D@PRA@#@^_-8LJ>'O"T#)]FVF2-I&1(GGD:-,;CCYF*KN'MR.YK
M7FU&SM]..H3W,<5F(Q(9I#M4*>A.: .$\6:'J^H3^,A::9-,-1TBWM;5@\8$
MDBM+N'+#&/,7DX[T[Q)H.LZIJFN2Z=8-$)]*M([<RLBI)+%,\AB.#D JP7.,
M<FNPB\0:=+<VUMOGBFNF*P+/;21>80I8@;E&?E4G\*TZ .$UZWU+Q!X0UAH/
M#$MEJ%Y'#'Y4C0B>8JV?F96QM49QDYZ\#C-+Q3I&LW+>,8+/2)[D:UIL26TB
MO&JJZHZLKY8$'D8P"#GJ.:](HH \WUK3==9?&5NNC7-TFN6 %FZ21?NG$'EF
M)\L,8;Y@1D'<>]6;_2M6GU"_F72I]LWAK["OSQ\SY8[/O?[0YZ>]=_10!YM<
MZ5<V\5O+?:;+%80^%9K"Y;S8TVR'9\F<G!PK $ C)%7/"AN(]<LY-7TS5+6^
M_L]+"*2>&)8F"9<_<D?YC@G)P.. ,UV]U:V]]:RVMW!'/;RJ4DBD4,K@]00>
MM5--T'2]():QLTB8C;NR6(7T!)) ]AQ0!8U"Q@U/3;JPNDWV]S$T,B^JL"#^
MAK@+'POXD-QI5U?.C32PMI6IC?D-:IRLGNS%']QY_P#LUZ16-)XJT>.ZO;9I
MY_-L<?:@MI*1"",@L0N ".<^E '.^(-#U34=4\7"WLG,=_X?6RMI2Z!7F'G_
M "]<C_6+R1CK2QV.IS^(;>_ET:YCB&@/:$.T1*REU(3ASU"]>GO7:VUS!>6L
M5S:S1S02J'CDC8,KJ>A!'45+0!YWX9TK6M"FT6YO--GFA'A^#39X49&>WGB)
M)XW8*MG&03]T9XZ)HGA[5O#-UX:8V,MZMOIES9S""1/W#R2QR*"6(R@"E<C/
M0<5Z+10!YSX4T76=+F\(276E3*+72)K&Y DC/DNSQ,"?FY4A&Z9/M7HU%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %>>:M<7%GJ_P 0[NSN'M[FWT6VFBE0 E65+AAU!'45Z'5&71=*GDNI)M-M
M)'NT$=PSPJ3,HZ*_'S#V- '%W-UJMYJ\UJNLWEO#_P (['>@0[ 5EW,-V2I/
M.!_^KBGZ#J6JSZIX8>XU2XE&M:))<W$;*@6.51"0T8"\?ZQNN<\9KKQH6D!R
MXTNRW&'[.6\A<^5_<Z?=]NE":%I$30-'I=DC6\9BA*P*#&AZJO' /H* //M&
MN[S5)_ %Y?ZC<O+-#>/,V\*'95X) &,XR/IFK>DZW>7FNZ/&NJS7%CJMG>N9
MB0AE*.FQT09\L ,0.<GN,BNV30='CAM84TJR6*TD\RW06ZA87_O(,?*?<4VW
M\.Z):3I/;:180S1NTB21VR*RLWWF! X)[GO0!P?AB]O;;PY\.A%J-PR7S[+J
M-V#!P;:1\$D9X90>M6+3Q!JMSH6AZ_%<RF[N]7%I=61QL$;3-&4V_P +(!NS
MU^4YR#7:Q>']&@$ BTFQC$$AEA"6Z#RW/5EXX)]14L>D:;#>O>Q6%LET[%VF
M6(!BQ&"<^N.,T >?VNIZQ&UI>R:S=38\3S::T3A CP>8Z $!1R !@^WUSZ3%
M-%.&,4J2!&*-L8'##J#[CTJ@/#^BA%0:38A5F^T!?LZ8$O\ ?Z?>]^M.TO1[
M323>-:PQQF\N&N91&@0%R "<#N<#)ZDY- '->%Q)#\1?&<=YD7,KVTL!;^.W
M\O:NWV#;P?<^]<CXG21K#XK7,/\ R#GCMT0C[K3K&!+CW'R ^X]J]9O-,L=0
M9&N[2&=H\[&D0$KGK@]1FF2Z/ID^G#3IM.M)+$<"V:%3'_WSC% %6T%[8BZO
M=7OK62VC@5D:. Q"(+N+DY9NVWG/;I7#7#7NA>(=)\7W=C);)>3-:ZG(\BG$
M4S 0;@#QY9$:Y]V]:]'FTZRN+ V$UG!)9E=IMWC!C(]-IXQ3;O2M.U"Q%E>6
M-M<V@QB":)73CI\I&.* .3T-FB^+/BN.].)YK:S>QW_Q6ZJP?9["0G/N176B
M:RAN9#YD*3.ZQN2P!9\?*ONV.W7&*CN]%TN_B@CN].M9TM_]2)(@?+[?+_=X
M]*AO?#^FWUI:6KVENL%K<)<1((E^1U.05_NG/<<X)]<T 9'Q*W_\*]UADFDB
M(B!W1MM)&X @GT(ZU@:_%<P^)_$<UGJ=U;S6GAN*9)8RI9G22Y(W$@Y&1R.]
M>BW-M!>6TEM<PQS02J4DBD4,KJ>H(/!%4O\ A']%&_&DV/[R$0/_ *.GS1CH
MAXY7VZ4 <;+KFJ:U<W-C%JD&F746F6UW!*\WE@%U):4J5(D4$;2"<#'J<UW$
MHDN-&<'#RR6Y^Z" 6*]@>:@N/#FB71M#<:/82FSQ]FWVZ'R<=-F1\O;I6G0!
MP'AZ:,_ FU(8<:*8B/\ ;$97;]=W&/6K6N:1J3^(I-4\+ZK#!K<%K%'=6-TN
MZ"ZBRYCW8Y4YWX8>XKHT\/Z/'>&[32[-;@R>;Y@A4'?_ 'NGWO?K3[O1=+OY
MC-=Z=:SS%=ADDB!;;_=SUQ[4 5/".JIK?A33]02S-F)8SFWSD1D$J0#W&0<'
MN,5C>#)8H;[QK+,Z)$FMR,[N0%4""'))/:NPBBCAB2**-8XT4*J(,!0.@ ["
MLT>&=!$DDG]B:=OD?>[?94RS>IXY/O0!YKX2U&ZLK'3M-C?[+I.K:AJ,VGEY
MC!F$.IA16VDJ&#.P'&=H[<'<5M;FU?P[H]QXFE87-I?"XN+)8U\QHI(PI!*G
M# ,03TX. *[?4=)T[5[/[)J5A;7EMD-Y5Q$'7(Z'!'6L;4/"T=YXCT:\%O9C
M3]-MIX%MRF,>9Y>"H PNT1X_$]* .3M=>U:YT2&VN=5E>_@M]1.Z,"'SU@E\
MM+AG[ 8^Z =Q;)&!5W3+W5O$&KZ'"^N7=M%=>'XK^5;98QF;?'DC*G@Y((_+
M%=K-H>DW/V7S]+LI?L@VV^^!3Y(QC"9'R]!T]*2UT+2+&:&:TTNR@EAC\F)X
MH%4HG]T$#@>U 'G>GW%_9Z%:_9=7NXY)_%4MK*697)C-S*N/F![ ?EZ<5+=W
M^L6-AX@G37+USH^M000+)L(>.3R"RR?+EA^]8#ICCTKOF\/Z,[N[:38EWG^T
M,QMTRTO]\\?>]^M$GA_1I4G232;%UN)!+,&MU(D<=&;CDCU- ')C5M2U75M1
M^SZK!8RZ9JBP-#)+UA^7Y3%MY\P'(;.<D8Z8JA%J>LQM'>OK-U+Y?BAM.\IA
M&$: R;,$!1R 1@^WUSWCZ%I$FJ1:H^F6;:A$NV.Z,"F11TP&QD4W_A'M%V;/
M[)L=OG?:,?9TQYO]_I][WZT 87@=&6?Q&SW4\S_VQ.@$LF[  3'Z8'TQ4.H:
ME>WVL^*+);^6P;2K.*:T*$ $LCL96!'S+E=N#Q\I[FNL@T^RM;FXN;>T@BN+
MDAIY8XPK2D# +$<GCUIEWI&G7\Z3W=A;3RHI17EB#$*>2,GMGM0!Q.D2W.J^
M.?#^I7C36]S<^'#<2P*V%1S)"2N/3)Z5T/B[2X-8L;*T;4I=.O?M:O8746"8
MYU1R.#PPVAP0>H-:[:98/J"Z@UE;F]5=BW!B'F!?0-C./:G7EA9ZC$L5[:PW
M,:MO5)HPX#<C.#WY- 'E^MZEK$WAKQ-I6N)%%JM@MH7OK!RD=U"\A"Y'53P^
M5]_2M/Q+K=Y83W[:?JLTC:?<V$+*Q"K%YDBAE;KYK.KY.0 HZ'(-=NFBZ6EE
M/9+IUK]EN,^=$8E*RY&/F&/FX ZU!+X9T&=BTNB:=(6B6$EK5#E%^ZO3H,#
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M"T19XV9!'(4;./F4#J#@\\]* *M_/<ZYXWET0O>1:>-,CN(Y[2Z\IE9I&'F
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M#=::\2-;.Z;Y3(!LVX)&&)P.>H([50TCP9>Z8OAE'U6":/0TDB4"U*F5&38
M3O." ,YYR>PIXM++7?'D6I6HNE_LV.2WO-\+QQS2*P\M?F W[29&!7(&1ZB@
M#2\6MJZ^&+E]&A>2]4QL8HG"R/&'4R*C'HQ3< ?7IS6'H'BC0WM]3U:VU6^^
MS6L*K=:;?2.9[60$]5D.X%L@=<9''>NLU6TN[RR$=E>"TN%ECD65H]XPK E2
MN1D$ @\CK7.ZAX(&MW>I7FI74<=S=V L5>SC*; 'WAR23N8,%(] ,<YH GC\
M;V1FNH);>03PM"D8B=9%G,K;45'!QG=P0<8Z].:FE\5&UEABO-*O('DU!-/R
M0-I9UW*ZMQN3L2.001BJ=UX6UK5]#-KJVOQO?PRQ36EU;6GEK%)&P979"QW$
MD<C(&. !UJ:_\.ZOJ>EVWVO5K9M4MKR*[BD2U*P*8SPOE[RV""<G=G)] !0
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M#Y!A)+B3;D[MW&-@[52E\)WDFH^)KI=1@ UNVCMPIMB?("(R YW_ #<,3VH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M&DV1BE2TEE:<HQ;:IP5CV')(P&)(]!D ]1AU*SN-0N;"*='N;94:9 <E-V<
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M9E5F/)SC()Z9KG+C0R6LUFTZ6737\4&>UA-LS"*V:(AR5Q\L;2%C@X!!'8T
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MO9'@:XMG4!FP22NT>4I8G (&2>.M.UJ.1?B-X6N&S]F,%[ #V$K*C#\2J/\
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MAO L%Y97T]K(BW5FEE"L&H-:M;S;5+!89E/!=02<C'7D#-=S0 4444 %%%%
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M2:E>N=.G2T35X=2>UN8EC;:L*C>) -V<,A0@],N!76T %%%% !1110 4444
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M"Q*R#:3R >F< \XSS7J5% !1110 4444 %%%% !1110 4444 %%%% !1110
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M%_?3*C>ONN10!%_PB-FUO9QRWNH3R6MTMV)YI@\CR*"%W$CH 3P,#D]ZBN?
M^EW=O=1RS7@>>^&H+,DH22&X "[XV XX &.1CZFM^TNHKVS@N[=BT,\:R1L5
M*DJPR.#R.#T-4!XDTDZBMB+K]^T[6R_NWV&55W%-^-NX $XSG@^E &3K&B2S
M:2/#<5A->V=^K"[O[BY!:,Y7YFR=S-C[NT8!51P.G4Q1I#$D42!(T4*JJ,
M= *Q+;QCH-Y=06T%ZS23SO;QDP2*IE3.Z,L5VAOE;Y203CC-9_B'Q3]FO-(@
MTVY.9M6BLK@_9V9&!)#H),;0PQ@X.>".H- &SJ&A6U_J5KJ0EFMK^V1HX[B
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MF#%NI8EVS_*LF?X?V6H1W!U2Z>XN)K);-KF.,12,%9761R,[I RJ0>@P>.:
M%U;QI/HG]KP7FF1F\L=.;4XTCN24GA4D.-Q0%6![8[CGKC0TKQ#<WFOW&DWF
MGI:R+:1WD+)/YF^-V9<-\HVL"O0;ASUJO?\ @_\ M:TU!=0OVEN[VP.G-<)"
M%V0G);"Y/S$G)/3@8 Q4Y\-S_P!J3:C%JCPW,FFBP5TA7]W@EA( <@L&8G!X
M]J .@HID*/'!&DDAE=5 :0@ L<=<#CFGT %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110!7O+^TT^)9;RYB@1F"*9
M& W,>@'J?:BSO[34(FELKJ&XC5MC-$X8!L X.._(XKC_ (@:-J^IW>C7?AO4
MH;;7M.::XMH)QF.X0A4D!_!E'_ CTZCE(_B/J-MH[)-HHTG7I]?@T_4@FUE5
MG09D3<=N2B #)(Z')% 'L=%>:7?BGQ)I^HZ%H6J$6,VJ:I<P)>_NGD^SHH:+
M(&4$C%U4\=C@<BI;C6O%.D^*?!&AZGJ%M)-J27:7[6T0V.8TW(RY&0>1GMD=
M,4 >C56GU&RM;RVL[B[@BN;HL+>%Y 'EVC+;1U.!UQ7D%O\ $#Q//\._"VL)
M>0G4-0UU=/F+0+L>,LXY ''W1R,=ZVM5DUC2_'_@>PU._M=2FNY;[-R;"-&C
M4("NSJ5." <'G _$ ]-!!S@].M+7BWAR]\52?#?Q1K>FZS/-JL&I7$@6:*-Q
M((]NX8VYR5' ' P  *]%\(:XWB?3UUJ&XD:PGAB$43*O$@7,AR ,\G;[%&H
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M$Q*^-RKEOE7C@#@=L5,/"VCC18-'%HPT^!U>*$3284JVY<'=G@@$#/45L44
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MF.6(  'OW&,TU/$=DMA?WEZDUA'8R^5.+H $-M5AC!(;.]<8)R3B@#7HHHH
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MSM^[")&GS?+W\O/'K[58U7PM?:M?^()7EMX8M5T9=-7#,S1L/-^8\#(_>_\
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MXEN2L@'/J=AR>^#D]ZQ]&U/3[+PQX0@OKB&VT6736AN99(RT2W@$8VR<C:V
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#G/%^D6=YI-]J%Q'YD
MUKI]P(0Q^525SNQ_>&T8/;FN-^&4=C:?"O2?%5V'-W9V]U++,&.Z50\G#?WN
M ,9Y&.*]+U.Q&IZ7=6+2O$EQ$T3/'C< PP<9!&<'TK!TGP19Z/X0MO#,-Y=2
MV$$RR R[2[*)?-*$@ $$\'CH<4 <!-I\NG_%CP!8W1S+/9W$U\N?EEG*R.Q(
M[X<G&>G%>S;E+%<C<!DC/('^0:YC5_!5OJ_B[3O$AU*\M[W3XVCMUB$90!@0
MV0RG.0Q[UJZ9I#V%[>7<VHW5[-=; 3/L C5<X50J@ ?,3]30!IT444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\;V&F0W"):W.FW4Q4Q E9$:(*V?3YSQ6!X;U_7;_ /X122]U(2)KFFRR2K'
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M92QV2A[*#[/;DLQV1<?)R>0,# .<8XK5KS36];O[3Q#XN@7Q!<6AL;&WGT^
M+&^Z5Q(2H4J2^2JC YYXQ0!UEIX)\.6%K>6MKID<4%XC1S1J[X*-]Y!S\JGN
M%P#4VH>%=%U6RM+2^L1-%9D&W)D</%QCY7!W#CCKS69IOC&5VL=.U#2;\:P]
MG;7%W'#""D/FY4DDMPJL&SW&.^#5ZW\7:=<3:>-EQ';:D66RNW5?*G(!; (.
M1E02-P&0.* )KGPMHMU):226"*]I$886B=HRL9ZH=I&5_P!DY'M5[3M.M-(T
M^"PL(%@M8%"1QJ20H';GFN2O?$LM]XD\)OIWVU=.O;B<;_D$5TBP2,I'.[J
M1G (YK8M/%^GWL>D21PW*IJL\MO 65?E>,.6#<\?ZML8STH T;C1[&ZU&._F
MB8W4<3PI(LK*51L;@,'O@?D/2J]KX9TBS;3S;VAC_LY&CM )7Q$K<$ 9Z$ ?
ME5>+Q5;7$D MK*^FBN4E:VG2-?+F\OJ =WRYYP6V@]C5+1_&R:AHFDW<VGW
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M SETVL0<$$$9R./44 2V?@SP]I_VO['ID< NU9)0CL!M;E@HSA >X7&:M?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M5!S@^F: .)TKPGKMG)X9BN;VPDM]!+QQR(C[YXC$8UR.BL 1GD@]?:NXHHH
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MYD!^Z< !ADC.>363XGFALO%FKBX#+'>^'BD("$B:57DR!@<L 4]\8["O0J*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M44PMY4L;HQV.I8Y(V$9R <C@5-K7B;7+.^URWL4TU8],TF/4D,T;L7SYN8R
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M*5)]>O)WMII+B/RXHY<C<^UBV0#G !H ]%\+^(+7Q5X:L=;LU9(;N/=L;JC
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M+2+Z34](M;V6U:UDFC#-"SAMA]-PX(]".HP:NT %%%% !1110 4444 %%%%
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MNY&0W<ZV\.(V8-(W0$@8'?KBN(N+XV.O^+V6\>UDEO\ 3H4:.,.[ETC&Q<D
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M #J*XV'Q_'_PC">)+K2YX=*\UHY95D5VAQ(8RS+Q\NX=LG'.*['(R!D9/04
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MZG;ZOJMK>Z<6N+>WM9F>78RKN;9M7D#DX;CMCG&17144 >*6GAW^R-<T;7/
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M _P[LUQ<#S6UWX>U*_TVW@2SUBYBGN=/A9H95>V=5E10"0K.0.XW#KS7J5%
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MF:[\_3W=XYO/)>0N,/O/?/X8P,8%5(_ ^F1W$$JW-^([>_?4((!/B.*5M^[
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_GI^@JO10!8^VW'_ #T_04?;;C_GI^@JO10!8^VW'_/3]!1]MN/^>GZ"J]%
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M (I]% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M;)$9&5@5\I2<$@@ XS7K5 !1110 4444 %%%% !1110 4444 %%%% !1110
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M1B'[5:I<.@.0F5R0/6L*U\8W<MKX=U66W@.F:Y,L,:(#YL!=6:,L<X;.W!
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MNMLTKO'&3&^QW0$LJOC:6&#\H.>#Z&FZ1XFTC7G9-,N_M!5/,)$3JN-Q7J0
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MW-T(=*DBDMR&7<3&,)N.WD <>]5H/ ^FV]Y;7$=U?C[+>RWL$7G_ "1O)O\
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MY+$K.RLLD3D%PWR\Y*KZ=,=*;9^$K*SAMX5N;N5+2%X+/S75C;(PP0IV\G:
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ML69' S@-P,UW]!( ))P!U)H P_#EK+&EQ=7&AV>D37!7?# RN[;1C+NH /7
M'. .O.!AR>&=3O=(\8V)1+:35+QKBTD=@RD>7&JA@#D#=&<CT/X5VT<B2QK)
M&P9' 964Y!!Z&LN?Q!;0ZE]ACM[JX=)HX9WMX]ZP,XRN_G(&""2 0 03B@#E
M=0T+5=9\(:U!_P (SIVEZG>61M5$,J,TI/<N ,(.H!R>3P.\M[H6IGQ'J,IT
M#3M4T_5EB8F\=<VCJ@0AE(.]"%!^7OGUS7=TQY8XRBNX#.=J GEC@G ]3@$_
MA0!S5YX<N7\8P:C;/&EA<0*FHQ="[0L&A(_$L#[ "L?5M"\17NL--]B@E2#6
M8+R!Q=>6C0*%!!0#EQ@Y9LG& #C KL-&UBVUW3_MMHLJQ>=+"1*NU@T;LC<?
M535J[N/LEG/<^3--Y4;/Y4*[G? SA1W)["@#A9/#NL-9W$8L?G?Q+'J:CS4_
MU"R(Y[_>PIX]Q6_X;TV_TS4M>6Y@06]WJ#7<$RR9+!D08VXX(*G/X5OHV^-7
MVLNX X88(^M.H Y*UT":7QSK]_?Z=')I]];6\$3.4;F/?NR,Y .\8^G:LWQ?
MH/B#6)]7@M[2*:VFBMS:,+D1 ,C[G#C&68]LY4#T.<]9J.NV6FM9B4O)]KNU
MLT,2[@LASPQ[=#6G0!QNGZ?X@TW6]3M_[.M+G3]1NUO5NGG'^C,50,I0C+8*
M94C';.*HZEX<UBYTKQ9;Q68,FI:G#=6V94 **(0<\\']TWYCWQZ!10!PNN>&
M]4U6?Q@(K=8TU;2(K2V>21?]8HER&P3@?O!S['\7>(;2?4)]#>VN(;#70QMI
M8%E#N+:53Y@X[@*'!Z;DQSGGK]0OHM,TZYOIU=HK>-I7$:[FV@9.!4-A'I]Z
M(=;M[2)9[NW0B<Q*)3&1N"ENN.>F: 'WD!CT>:VM(,X@,<42$+VP ,\ 5SGA
M:'7M&\*Z+HLFD!9K6&*WFG-PA157 9@ <DXS@8ZUU]% '#>&_#^HZ;=QV%_H
M6F2Q6=Q)+!JY96D9"S%<)MW"3#;2<XZG)Z56TWPYKMCIGA6-K*!I=&OI3(HN
M !)&\<J!P<<?ZQ3CKC->A4T2HTK1AU,B@%E!Y .<9_(_E0!P^@Z!J6G7GV*]
MT'3;F&UNY+FWU4LK2,K,S ;",B3YMN<@=\]CM>"M-O-(\*VMA?0B*XB>7<H<
M,"&D9@01[,/UJWJVOVFC75C;W,=PTE](8K<11[M[A2VWVX!//I5FPU*._:=%
MAN(7@8*Z3Q%#R,@C/4>X]_2@#C=:\*ZS?W/BA+9846_FM+RUF>7 +P"/]VR@
M9 )CZ^A[]*W+#3+JX\72>(;FV:S_ .)>EDL#NK,QWEV8E21@9 '.>6X%=%5:
M:\\F\AMOLUP_F1N_FHF43;CACV)SP.^#0!S]]I>I#QC>:E!;)-:W6D+:9\T*
MR2(\C8P>N?,'?L:PX/"6JRV'AJQFA,"V>@W&F74RR*=DDD<2!EP<D?NR?Q'O
MCKM.\16VJZ=87UG;7<D%Y,\2GRN8]I8%GY^5<H1GU(]:U4E23=L=6V-M;!S@
M^E ')^$],U&!H&U7P]I=C=6EOY!O+=U=I^G*84%5.,D'G./3-+KNE7MUXXT?
M5$TS[7965K<12 O'DM(8\8#$=-ASTZUUM9=SKUI:Z]::-(DYO+N-Y(0J95E7
M&X[N@QN'7UH XZ'PQK^GIK%U8VUO##?:E;SQZ5%*!Y,*8$A1B-J2.?FXZ8X.
M>:2V\,ZW (D:P0(GB3^T\K=!SY)4@\M@DY(Z]>?;/HU->5$9%=U5I&VH"?O'
M!.!^ )_"@#SG4?">JW]K?6KVDJ1W/B);_?%<*CB#:JD@@Y#_ "G'X<UU7AN'
M5[71&T[58(FFM-T,$ZE0MQ&.$8J/NDC&1T]/0;B2)*&,;JP5BIVG.".HIU '
M(>$-!O\ 1;V0*L]KI36R!;"><3"";/(A;)(CQV)^@%,U70=1G\4C4]-CFL[D
M7$ >X2<&"Z@7;O6:,GE@-X4@9^[R*[*B@#S_ $W0O$0\0Z+?WUE!NLY[L7$B
M77R%),[6CC PHQCC@D]?6DLO#FMV_AGPSILMDGFZ5J:32LDZD-$I?YAG'7<,
M#Z]*[>6]\J]%M]FN7S"TOFI'E!M(&W/]XYX'?!K*LO%^FWZ:(\*7.W6=YM2T
M> -JLYW<\<*: ,O2]"U'3_$[7]K#/:6<KW$EY:&=9()F))22)2<H[=6^Z.3]
M:IZ9HGB&P\/>'+$V*'[)-+]MC6X5'PV[84D'(&6&[&">G(R#U^M:S;:#IC7]
MVLK0JZ(?*3<068*/PR16A0!YKHGA_P 3^'4T2[BTZWNI+6VN+&YM!=A3L>42
M+(K$8[8(],=^!T,>EZI;^+['5/LENT']F-:S)#(%$+>8' 4$#<,< \=.<5U-
M% 'GF@>&];T0>&[UK7S9+&UN;*[M5E7.V217#H20I(* $$C@^W,UAX5U'3]5
MT6Z$ =(]2OK^Y5)%Q")PX5%R1G&X9Q[XKO:* .?\':=>:5HLUM>P^5*U]=3@
M!@WRR3/(O0^C 'W%<[IVB>(TU[1M1OK"$O9R7BW#1W0"LLGW3''C"C  QP2>
MO]ZNR_MFV_X2'^Q-LHNOLINLE/D*!@O7UR:T* /.]*\+ZQ!8>$;6:W,3:;'<
MQW4B2J=GF1LBE>>>2#2Z/H7B*W_X0ZTNM-@5- =XIKA;E=LT?D/$KH,9YR"0
M0.?SKT.B@#D/%LDD7BKP:\4#3L+^?]VK $C[++G&2![]:HQ>'=:LKM;FWM8W
MAOM5N+V[MUG$<D0= B8D'3[N7VG))P,C.>TN-.LKNX@N+FS@FGMSNADDC#-&
M?52>1^%0W>J)927(EMKHQV]M]H:58\HPR<J#W88SCT(H X/^Q[[2_ FB6+2V
MEIXDTRX5[%/-W[R9"A! P2K*[ ^G!/3CH9=#N;7Q%X;EM8&EL]-MKB*:4NH9
MF<( <$\DE"2?>MBP_LW68=/UZ.TB:66V62WGDB7S4C=0V,]1P>0#3H=9MI]>
MNM'591=6T$<[EDPI1RP&#WY1J ./TWPYK%OIWA:"6RP^G:K<75QB5"!&XG Q
MSR?WR\>Q]LO\,:!J>E1VUC?:!ILATP.L&J(Z-).N"%VJ1E'((#$G'7KGCK3K
M-L/$*Z(5E^U-:M=!MGR;%95//KEA6A0!P6@>'-6T]?!*7%H!_9%E-;W;"52
MS(JC;SR,K^HK<\$:;?Z-X2L=+U&%(Y[1/)RDF\. >&Z<9]*WWE2-D5W56D;:
M@)QN."<#\ 3^%.H X"P\*:HNAZ1X?NHQY>EZHEVM^) 1+&DAD7 SN#G(4@C'
MWCD]*W?#>GWMCJGB&6ZMC%'?:A]I@;>K93RHTYP>#E"?H17022)%&TDC*B("
MS,QP !U)J@FM6K^('T4++]J2V%UN*_(4+;1@]SF@#D/$FA>(=3U"^\JSAEA%
M]975HXN1$I2)XV=67'S/E6Y;(QC&,8)K7AS6+^S\;PQ6:[]8$(M<RK@[8D0Y
MYXY4GZ?E7H%(QPI(!.!T'4T 8WBFSNM6\&ZO86L)-U>64L$<;,!AG0J,G.."
M>?ZUB:QI&K?:]"U6UTJWU VMH]I<Z?<2JI ?RSO1CE<@Q_B#6C'XYT9]/DU%
M_M<-C%,T$ES);L$C=6V,&(S@!N,GCWKI 00"#D'H: .'@T;6-$UZ.^L-)L#9
M7.G+:RVMO*(DLV621P5^7YE/F$' !)&<<XK+\'Z?J2:3X)UBQM$NHET$V4JF
M81F,OY+J_/4?NR#CGD<&O2I(TFC:.1%=&&&5AD$>A%16EG:V%JEM9V\5O;QC
M"10H$51[ <"@#AM"\.ZSIUOX*6YLE+:1;31W0CF4X+1A5QDC/(Y_F:9'X8UJ
M'P%H-JEE;R:EI%W]H:SGD'EW"XD4KN&0,K(2"1P0*]#HH X230]5AOM&URQT
M.RMI+:XG>YTRWD16=98U0OOP%:0%0?H<9XK9\(:=J&G6VJ#4+>.%KG4KBZC5
M)=_R2/N&<#@UT5% '!ZCX:U?4!XO2*&.%]1N;:YLGF<,CF%(AM< D@,T6/H?
MPJ.]\/ZMJ6E?;8/#>E:;J4-S!/\ 9/,5OM8CW91Y%7&,.=N0<'DXS7::CJ<&
MFK!YH=Y;B7R8(4QNE?!;:,D#HK'DC@4[3KU=1L(KM8+B 2 GRKB,QR(0<$,I
MZ=/\* .0NO#LFHV$+3>'$TZ1[@S_ /$KN4CN;=PFU9/,&U68\@CD;<=>E;=O
M::VG@?['--;3ZV+)HQ)(@\MI=I"[@!C&<9XQUXK>HH \PNO"WB&[M=>']G*K
MZGH"6(\R]#L)@9<YXP!^\!XX ' [5=\1^%M9UN[U![6);?SM(M[>)Y9%P9HI
MC+M8 D[3PN?K7H5% '*:7:ZQ<>-9-:O=,6RMY=+CMBK7"R,LBR.Q'R\$?-U_
M_4&7MAKECXOO;^PT^VU*QU2UB@E2:<1F!XR^"<@[D(<Y R<CIS7744 >>ZUX
M:UF]M?&,,5JKOJL5NELWF*JL40*Q(S\HR,CVI==T/Q'J>I7$JV$3QIJ=E>VQ
M^U",>7&T;.K* =TF5;YCGC !XP?0:JRWZ(;;RXI;A9YC#O@7<L9 ;)8YX *X
MSZD"@#C;FPDT[PUXX;5K6)+?4)YIHA), DBO"D05F7E<LOZBLX:1J6JP7VG7
M]C/;:I?Z3]CM[V6YAFCVQY(#+'@X+-DM@YZ<< ]UI^IV/B"'4(4A=H[:X>SG
MCGC&&8 $C!ZC##K4VG:-I>D(Z:9IMI9*YRXMH%C#?7:!F@#DO[%N]4T>Y_M+
MP?IUM/(L4,L=M<+YDP$BL6210NT+@LH)SNQTQDV](?6_#\5E87<<NHQ7-[(B
M37%PGVB"# V;\#]XP.<D'A<9)-=?2' YQTH Y_Q3IM]?2:)<6$*3/8:DMS)&
M\FS<GER(<'VW@_0&N?G\.ZQ)8ZE$ME\\_B.'4H_WJ<PH\3'O][$9X]Q[X['1
MM8MM=T_[;:+*L0FEA(E7:P:-V1N/JIJ]+(D,3RRNJ1HI9F8X"@=230!P^F^'
M]1L];N;6ZT+3;RS;47O[?4Y64O$'D,FTH1G>I)"L#CH>V#I^.-*O=9TJRMK*
MV$[1ZA;7,@9U4;(Y [#D\D@8 K?^U?\ $Q%G]GGYB,OG[/W?7&W=_>YSCTJQ
M0!SVOZ=>#2 NAV4(E>[AFN(@5C9T!7?M;HKX48/;'!!P:Y:#PSXDTZ4:A:V5
MO)/::U-?1VK7F[[1#+$8V&\CAQG()Z\_CZ510!R5]INJWUYX<NVT^&$VNHO=
MW$44BD1(T4B=>-S9D!.!Z]<#.9-X=UA](U"W6R_>3>(H]20>:G,*S1R'OUPA
M&/4BO0** .!UCPYK-S8^.;."TC==:4/:R><!\Q@CBVL#TP4)SZ8QGL^\T'5/
M^$BOYCH&G:K8:K'$6^V2*#:2*@0AE(.]" #\O?/KFNX>6.,HKN SDA!GEC@G
M ]> 3^%4M%UBVUW31?VBRK$998L2KM8-&[(W'U4T <W%X?U"#Q;'J5A'+8HU
MT3>JLRM;746PJK"/)*2_<&0!P#DGI7:444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >=7&J
MZM8:].0)+])Y[M=/N+:Z8J)4BD/V>: G QL.&7K@9P3SE_:8M9\):C?VWBDW
MOGZ#.;BPB>0L) F=[9D)C8-E2 %!SC'%>I)96L5PUQ';0I._WI%C 9OJ>M+%
M9VT#2M#;PQM,=TA1 "Y]3CK^- &?X8:W;PQIIM9O.B^SI\_FF3G:,_,2>_;M
M7!7MQ+HS?$+4-.EN/M$%[;!F$SN8XFA@\Q]I)&54N0<<8]!BO4(HHX8ECB18
MXU&%51@ >PID=I;12/)';Q([_>94 +?4]Z /./%%U>:>OB5-+U*[.GKX=>]6
M1;IW,%P"WEE'))&Y03C.#MSW.;%YI]I8>+?",\^HWLBW!N9#)<7TA&\Q)@+\
MV "03M'')&,<5WD>G645NUO'9VZ0,<F-8E"D^N,8J0VMN4C0P1%8CF-=@PA]
MO2@#RW17>RAT*]M[ZY5KCQ/?6DD0G;RFB:2Y.#'G:3E5.2,^^.*[CQQ-+;^!
M->N()Y8)H;":6.6)RC(RH2""/<"M8:=8J% LK<!6W+B)>#ZCCK4TL4<\9CFC
M21#U5U!!_ T >;:L\]UJNK1G5=0BCB\,Q7J+#>/&%FS+\XVD?W5]CW!KN]!N
M9+[PYIEU,^^6>TBD=AQDL@)/ZU8_LZQR3]CM^5VG]TO(].G2IXXXX8UCB141
M> JC 'X4 >0VL=L-!L+5+N43#Q?)'(/M+,\8^TSA?O$[21WZGK[U>;6[C2H;
MJTFU2:+3(?$K64MW<S/(8(3;AT5I-P8+YK*-Q;@'&<5Z4]A9R$E[2!B6WDF,
M'+>OUXZT?8+/RY8_LD&R;_6+Y8P_U'?\: ,GPFACTN=1K7]KP_:9##<#)"H<
M'RPY9BX4DC<23V[5S=Q]ND\2>,9[6^OY;C2X8KBRLTN7\OS# YVE,X(+8X/&
M:[^**.")8H8UCC085$& !Z "FI;6\<SS1P1+*_WG5 &;ZGO0!YO:7D&H:%J.
MHVGBE=0AGT*8S62EGV/M_P!8VZ1O+;DJ5P,^GRU!_:?G16.CWGB!-$A?P_:R
MV-P\C1AG(82,K"1 67$?RG/';!->F)86<:S*EI JS'=*!& )#ZMQR?K0]A9R
M)$CVD#+"VZ)3&"$/JO'!^E '$WDVI:5KMHAO;RZCUVP6UB<EU6&[49+A,_NP
MR%G('3RC6;XLUD:;=:C'::O<QSZ;+IZ$3WA78&D7(5,_O-R,2S/^N./3RBL5
M+*"5.5)'0XQQ^!-0R6=K-(TDMM"[LNQF:,$E<YP3Z9YH \QUJ\N8QXPOX-8O
M@=-U&S:T"7C^6@=("PV@X93O;Y3D<\ 5T7AQ+>+XA^+D\]_/,MNRQ-.QRIA4
MDA2<8SWQQT&*ZIM/LG+[K.W;><OF)3N/J>.:E6"%)#(D2*Y4)N"@':.@SZ4
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MG=CROG*@_+P1C(KTYT61&1U#*PP589!%10VEM;6_V>"WBBAY_=H@5>>O XH
MY_PGL,^I26WB%-7M)'C>-8F,B6Y*_,HD+N3G ;;GC/H16;K:/=^.;JQ?4;Z&
MV.A-/Y4%V\0#B3 <;2"#CT_&NSM[:"TA$-M!'#$.B1H%4?@*;)9VLLIDDMH7
MD(VEFC!)'IGTH \UTG5;FU7PGJ5QJM\[:EH$]Q?%IC(&9(HG#K&?E##<W0#/
M?-9Y\57UA;:C-IFHO<N?#:7<*/=?:7,@8YD(.0'VG<57CCO7K*V%FC(R6D"L
MG"$1@%?IZ4L-G:V^WR;:&/:I5=D8& 3D@8[9YH \PU348-/\17E_X?U![VX_
MX1>66W)N3<,S"12&4,3DXYQWQTKI_"<UO=ZG->:?XG35+.>U1C:QL\BQ-GAR
MS2.4+ XV\9VDXR#73V]A9VAS;6D$)Y'[N,+U.3T]Z=;VEM:*RVUO%"KL681H
M%!/J<=Z .-\<:FD%Z+-=1FMI_P"S+F=$^TFWCR"H#[E^9G!X"].23CC-$:Q>
MVD/A;Q&+FXOK?4K!;.>%)F,9NG0-&^T' )=6C)QP6'I7H,EO!,Z/+#&[QYV,
MR@E<\''I2K!$D21+$@C3&U HPN.F!VQ0!YEXUU"31K#4;*#6KM=0T_0Q<*TM
MXT8W[GQ(O.97)3!!^4#'KBM:YU!I_$^LQI>O+:2>'$N!&)BT88O*"RC.!D*.
MGI7:RVEM.^^:WBD?:4W.@)VGJ.>Q]*:;&T9BQM8"S+M),8R5]/I0!Y-?ZS]E
M\#V<-MJD]O>6WA**[B071@16V?*Z[>9'RF-IX ^N#JWD=KJ_BO5)YM8N+-/^
M$=M9UN+.Z,)R))SORIY /;ISR#Q7HGV"RPH^R08161?W8^53U XZ'O1)8VDS
M0M+:P.T/^J+1@^7_ +OI^% 'FR:CK27>GW\T1;7E\&W$QB*_,TX:(@%?4MV_
M"MOP?=0:AJ,=_8^*5U&WGL09+)2S['W#$C%I&,;<E2N!GGCY:[$VT!N!<&&,
MS 8$A0;@/KUI(+2VM3(;>WBA,C;G\M NX^IQU- ')>+4MU\9>$)KF=X8_M%R
MI;SVC7/D,1T(&<_GTK&M-5U*ZT72=5CN[@:VVN?9+NS,S;=IF97B,>=H"Q_,
M#C.%W9Y.?29(8I=GF1H^Q@R[E!VD=QZ&F+9VRW372V\(N&&UI0@WD>A/6@#G
M?B1'YOPV\1#+C%A*PV,5/"D]NWMTKF]2@M;SQ/="UU"Y$4?AHR1S6UZX;(E?
M!\P-N.#[X[&O2V574JRAE(P01D$57_LZRSG[';_=V?ZI?N],=.GM0!YI_;LV
MJ165GJGB--'-UH%K=6UT[M'OF8-YKJRN@+*?+.TYX/3!->F6!D.G6QEF,TGE
M+OE,?EES@9.W^'/7':AM/LG2)'M+=EA;=$IC!"'U7C@_2IV4,I5@"I&"#WH
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M'-'D';(H89'0X- 'FECJFIWVF-_9M^NH2P:Q?K]BEOWB>YA21@JI*#D%5*D
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M CKR"<GGFK5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 9>LW&L0QHFBV-M<SL&9FNIS%&H&.,JK$L<\<8X))[
M%N@ZW_;GAJUU@6DL+31%VMR0S*PR"H/?D'![U!XEU2ZL8(K>TT_4;EK@E9);
M*(.T*=R,D#<>@].O;!73=12VT^P@AT/4;6W,$GEQ&('R$CP K@,<%A]T#.>^
M* *VFZ]JY\3#1M9TRVMFGM7N[:6UN#*-J,JLCY5<,-Z\C@YKI:Y30=3GU'6G
MN;K0=5M;F6/9YMS$JQPQ*<A =Q)))R>.?HHKJZ .3U+Q%KFGZQI=BVF6.-3N
MYK>!FN7RJHKN&8;.ZIT'3-.'BFYL?$$%AKD=AI\#6,]U).;GY5*3)&OS,% !
M#@\\\XIOBBWN9O%?A*>&UGEAM+R66X>.,L(U:%T!)'^TPI-3LFE^(5I>2V,D
MUI%I%Q"9?)+J)&DC(7IU*JW\N] '17.J:?9VZ7%U?VL$$@RDDLRJK#V).#5A
MRS1$PE2Q&5)Z'\J\JTO3M2TW3M 75-$U6\LFT--.G@M"PDMY5)W!E#+E&! S
MR/D%>E:9;QZ9H=I;I;O!%;P(BP!FE:-0  N>2V.G>@#!\.>)-7\0:%IFKKI]
ME'%>/AHOM+;U4.58C*X8@ G''%=%!J5A=7$EO;WMM-/&"7BCE5F7!P<@'(YX
MKD/AQX<CT[PMI4UWITEKJULDJ2"0%6^9CP>Q!&WD5S]KI>NWDFG>5I5YITQT
M?4+(C8J0V<SF,H%.=Q7*D[CG/;T !Z3)J]E)!=_9-0L7GMXRS!IQMC/."^#E
M1D?H:S4U^Y7Q'I.FRK:/#>:;+=O<0R$KN0Q [>VP^9D'VK#M$?4O#%PLWA:Y
MLM1@T=[!VEB7).T 11X)WKN&<].GOA^EV=W%K7A*6:RN5BM="EMKAC"V(Y#Y
M&%/'7]V_Y>XH W(?%%C NEV^HZAIYO=09UB^RS;HVV[CD$]N /\ >.*NVFIH
M;:[N+N\T_P F*X=%DAFRJJ",!R> _/(KAM!TS4K"R\$R2:7=_P"@S7:7$8CP
MT7F!PA(...1ST&:B.GZK9PR7L6E7TT%OXCN;N6U@S%++!(C*LD?(R06!QG)Y
MH ]#.KZ8MI'=G4;06TN?+F,Z['^C9P>E6UD1HA*KJ8R-P8'@CUSZ5YW=:,8[
M2VNM%M-6T:Z9KJXB=HVN0S2%"Z3Q'=@2$9P",;<Y!.*ZQX9I_!307^GGSWTX
MI/96S_Q&/#1H?KD T 5M>\416&EQWFF2V=[B\MK>4+,&V++*J9^7O\V><5K1
M:OIEQ9R7D.HVDEM&Q1YDG4HC#@@L#@'D<5YW>Z9K4VBW=C/'<ZK:B\TYK>XG
MLREP\:3AY$E7 W;%7.[ SN(Y-6KZTOK?5?$$]OHL\\$VJ6,T;" DJJ(@>6-3
MC<RLO ]LX(&" =/K7B,65EIMWIQM;R"[U&"S>19=P DD"$J5X)&?6IM(UFXU
M#7->T^:&*-=-GCBC9&)+J\2R9.>_S8KB8]-U1=,FBDTS4-X\517P,D8+-#YJ
M.S_)QP 2<=^!75>'[>XB\6^*IY;>:.&YN8'@D="%D"P(A(/LRD4 .'BJ&V\4
MZIIFISV5E;6L5L\$TLX0R-*9!M.[ S^[X K:NM2L;%XTN[VVMVE($:RRJA<Y
MQ@9//-<;K&E;_$_B*2[T:2]AU'2H+>U*P^8KNIFW(6Z)]].6P/?BLI=!O-/D
M;1]<TG4M:L[S3+6U$UG,P0O&FUTD^9=H+?,&/]X]Z /4"0H))  Y)-<]9>)X
M[_Q?=:3;R6<UG#8I="XAFWG<SE2K8X& ,_C2>,M.U"^\"W]CIB;[QH5"Q;_]
M8 REDW'^\H9<GUYKE=9M-5U_4]6NM,T>]M_M.@QP)]IC\G?(LS,8CDY&5.W/
M3GTYH ]"@U73KJ&::WO[6:*'_6O',K+'QGYB#QQSS34UG2Y($G34K-HGD\I9
M%G4JS]-H.>3[=:X&^L)]2TRXUC2_#NKV]Z)+5[J&\N&2:Z2&3>8TRYY49(;C
M)P!FG7VDPWMM:7UEX?U&'[1K5I<W*W@:25PG#NR$MM 4 >IQTZ$@'<1^(-%E
M6!H]7L'%Q(8H2MRA\UQU5>>3["K$NI6,%Y'9RWMO'<R_ZN%Y5#O]%SD]#^5>
M=:KHUT]AXR$&E3F:[U:UGM=MN<R(@@W,IQV*2'_]8S:_LZ6;7]2T_5="U.]2
MXU%+ZSNXIF6WP A4N0PV,A7&,9( QF@#HO$WB>/1/L44$EG+=37UM;/!)-AU
M2614+!1R2 V:WIIXK:%IIY4BB099Y&"JH]R:\QN+/5UTV;2[C1KVXOHO$D=^
M+B.,,DT/VI9 X?. 0GR[>HV^E=GXP%R= 'V;3C>L+FW9HPF]D42J3(JY&YEQ
MN ]1WZ4 :::MILL<4D>H6KI-)Y4;+,I#OTV@YY/L*JZAXFT;3+=9[G4+<(UT
MEIE95.)68#:>>",Y/H.:X,:;JL5K?3/I>HN(?$\&I?/&IDEAVQAF55/)&"2
M/UXJ6>PU26#6+D:1>J#XEM-01"@WR0J(-Q4 \D;&XH ]"?5-/BGB@DO[5)9L
M>5&TRAGSTVC/.?:F3ZWI5K*8KC4[**0.L922X52';HN">I["N%U'2M3N=+\8
MZ//87$EUJ\_VC3Y]N4&Z.-4#.,A#$R9Y(Z KFH-=T.\GMO'L::=///>V<$5M
M(+<YG=8\'!Q_>Q_.@#T2+5=.N/M7DW]K)]D)%QLF4^2?1\'Y>AZU3OO%&BZ?
MI4NI2ZE;-:QR"(O'*K9D. $X/7D<?CTKD-=L;L:MK5Q8:$]W!+H5O D+0%4D
M=97)7'&2J.#C(STS5*^TS5[JU\6LFFZE*;J?3[J%IHT5YEC,9?"C'S80\8SP
M,\T >AV^H"XU26..ZL)+5;=)%$<NZ4$DY9ATV$;<'OS4D6KZ9-!-/%J-I)##
M_K9%G4K'_O'/'XUPOB+2M5U75?$4FG6,T;WFAP0Q&5=BR2++*S1%NF2K*.N/
MF]C5K49Y=2TJ;4[7PC=17,DMHLXN81YVV.4-N5 ?G\ODCL3CJ 10!N:[XD%A
MI%MJ&FM:WL4E];VKLLNY0))5C)!7J1NZ4EKXE4:YKEGJ3VEI;:<\"QS/+M#^
M8F[DM@ ^U<>VFZI_8VL0-INH%Y?$MM>QF2-2TD0>!F?Y.. C$\#TZ\5NKH0U
MC6_&5G?VTR6.I1VZ1RM&0&VQ;2RD]U;!'N,T =>MU;M<?9UGB,VSS/+#C=MZ
M;L=<>]4M<UB#1M,GN))[6.98G>)+B81B0J,X]?3IZUE^"UU&XTTZEK'EF_E
MMBT9RK)$2H<?[[;W^CCTK+UF'4+;Q/KCS:;=7UGJ>E);VDD$?F"-U\S=&P_A
MW%U.3P<<GB@#>TOQ-87.B:9>7][96MQ>6D-PT+S*N#(%P "<XRV!6@NKZ:TT
MT2ZA:&2%6:5!,N8PIP2PSP >N:X?PWHTO]N:"^H:/(JP>'(K61IX 0DRLAVD
M\C.%)_\ K\5!H=IJC>(O#MS/HEY:QP+?0SPB-1#;F1E("G.64X)+'()Z8Z
M[^+5M-FDACBU"UD>==\*K,I,B^JC/(]Q44FOZ-#&9)=6L$0(9"S7* !0=I;.
M>@) SZG%<"/#GB/3!;/IT"EM!OV@TU6/$]K.?FW?[,:N@'_7(^U;<NC):^-]
M*?[#)-96FC3V[3F N-Y>(@$@<L55_P _>@#LHY$FB26)U>-P&5E.0P/0@]Q7
M/ZIXGCL_$.BZ7;2V<[7MT]O.HFS)%B)WSM'NF.?6F^!;2[LO &C65S%);W<%
MFD3I*N"C 8Z5R6DVFJK:^"[*YT6^6^TB^<7TQC!0YAF4RAR<,&9@Q(]>><9
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MSALC(&T$^F*MM:ZI)XCTZ<Z)>0QVNOW$LB0QKY7E/%*HEW$Y8MN4D]!G&!W
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M0W ^T7^O:DC7+%49MC%L#*E0QZ_=Q@' ].Z\/G5/[*6/69K::^CD='DMCE6
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M-1TRYG74WV(JLB_ZOC'RAU='!]%89K.L?$NM27 C-[YR7&@RZA'.8$5#(C(
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MQ_:2-X$H7Y%0Y3E<]^#GBMGPKJR:SH[7"W,\S+/)&XN8!#+$P/\ JW4  ,O
MXZ]>] &C?ZC9:5:M=:A=PVMNI :69PBC/3)/%1VNLZ9?7)MK6_MYIPGF&-)
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MNHH S(/#^EV]X+P6HDNA&8UFG=I75#U4,Y) /<#K52W\%>';7R_(TR.,Q1/
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MCS;:5YHG+,6#N"K,23EB02,G-5X?$EK=7\EK:07%R(I?)DEBV%4;R_,&1NW
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MH?#]O8VLG]BW;+YL9\M<W$3?=7!(R3QD8S[8/5ZGH-OJFI:;?S3W"2Z=(TL
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M[U9'1D5PRL 2%<8)P&&#@G(SBLJ'6-=O?%FJ:9;1:<EKI[0EGDWEW61&;C'
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MQX?@UJYL+B:YN89+";SX#"5&U]I7)RISPQ&.G- '!6^O)X4\1^+[FXLO[/\
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M!)[UK4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M2!S7#G3K^RM=-@O;98II?%K72QI('/EN\L@)QTX/Z5/<^']>5[FTATU9(O\
MA(XM52X-PBJ\7F(Y '7<,$<@>Q- '92>(--B>1#-(QC\S.R!V#&/.\*0,,1@
M@@9.01UK/L?&VC7>FZ;=R3/;OJ$'GP021/YC+M#' Q\W!'3.>V:R[7P]J</B
M2:YLXY[*SN9;EKRWDF62WE+;MDL0R61V)4MP!RW?&:^B:)K5I_PA2W6FE/['
MLY;:Y*SHW/E(@(YYR5)^F._  .EL_%N@ZA/9PVNHQRO> ^1A6PY )*YQ@, "
M=IYXZ5,?$6DB]6T:\59F$FS<C!9-GWPK$;6*X.0"2,'TKD;'P_K$.E^'+=]/
M99+'7)[V?]['A8G,Y!'S<G]\O'L?;,OAG0M3TQK>QU#P_9S'37D:#51*K-*O
MS;2JGE9"" <D#KR<T =%8^+M"U*6**RU!9WFA:>()&Y\Q%^]M./F(R,@<\]*
MF\/:];>)-'BU*TCF2&4MM$L;(2 2 >0.H&>/IVKD_#_A[6+"+P3'<6!4Z5!/
M'=L)4(4LFT8^;D9]*W_!&G7^D>%;73=0MUAFM=T>5D#AQN)##'0$$=>: )K?
MQ7IT]]J]LQEA72Y%CFEEB95+%5. 2,'[Z@#J<\9&#6A8ZK9:D\\=K-NEMV"S
M1.C(\9(R-RL 1D<CCFN*U;PSK=Q?Z]):01XEU*SU2U9I@%F,*Q Q,.HR8SR>
M/N^^-_2]+N7\6:AX@G@>T6XLX+5;=V4L=C.Q=MI(_C ')Z'UH M7GB"WM?$-
MIH>R;[7=023(XA=D4*57D@8ZN._'?&1G*\'>,(-9TO3H;^[B.KW*2L42,JK;
M'((4],@8.W.<<U:U2PO_ /A-='U:VM1<6T-I<VTV) I0NT3 X/7_ %;#ZD=N
M1S^C^'-8MK7PA#/8O&=-GNFNF66,[%D215(PW/+@\>AH [&#7M,N=02QBN@;
MB1&>)2C*)54X8HQ&'QD9VDXS69XRUJ_T.VTN6QDM4^U:E!9RFXC+A4D;:6&&
M7!'6LOP=H>HZ<NG6>J:!8QRZ5$88]4657,RA=@*+]Y"PQNSCH1SGC0\<:5>:
MQ:Z3#:67VH0:I;W4ZED \N-LL/F(R2.U %RWU9K4W,VHZI87%H)(X(6MH65O
M.;.4QN;<3E, <\FK<>OZ9-9+=QW6^-YF@551BYD4D,FS&[<-K9&,C!]*S=?T
MRYBTR!-#TZ')O8IKF%-D;E!PQC)^57X7GCC."#@US%IX=\2Z5+!J-OIT<TEG
MJ]W<_8S> F>"<$9#M_$N1][&?FZ=P#KAX@L;ZZT<V.L0".\DE"Q>46:XV(VY
M0>-A4@DY'\)%96F^([F?3W;4-3MK6===DL(V^SDB95FV",+G@L!C=DXSFI;K
M3=3N=7\,7G]F10I:7<\]S'#(F(0\3H.XW-EP3@>O7OD_\(_K/]E>3_9S^9_P
MDW]I[?-C_P!1]H\S/WNN.WK0!M7/B^RGL-=\J\;3#ID_V9KNYM79%;:C9VD#
M/W\8SD]>A%:]_KVF:9)LO+H18**S%&*1ECA=[ 83)Z;B*X_5O#NM3:-XTTZ"
MQ64ZK=?:+603* P:.)<$$\8,;9S[8SVFO-"U(^(]5\SP_9ZIINKM%,)+F51]
ME<1I&RR(<[U^0,-N><CWH ZY=8L7OELUF)F9VC&(VVEU!)7?C;D 'C/8U+?:
MA:Z='&]U+L$D@BC 4LSN>BJH!)/!. .QKE;70M2MO%ZZA917%E;2W4K7T+3+
M);3H58+(BY+)*3LS@ 'YLY[ZOBB#4YX]-.G6RW"1WBO<HKJDHCV,,QLWW3DC
M)!!V[@#S0 V;QAI:3:.D+37":I-)%$\,+L%*([-G X(*%2O4<^AK8O;VVTZT
M>ZNYEBA3 +-ZD@ #U))  '))K@M+\-Z[I\.@LVGQL^G:S>SO&+H'=%-YX5PQ
MZX\U<Y^;@\9XKJ_%4&I7&A.FE01SW/G1,8WV@E!(I;:6^4/M!VD]#@T .?Q5
MHD5M]HEU".*/[2+0^:K(5F./D8$94\CJ.A!Z4U?%NAM:?:A??NOM0LR3$X*S
M'&$*XR"<C&1SD>M<@/#>N(MX@TQMDOB*UU-,W:R-Y2"+=DL<[AY9'7K[<UI2
MZ&LT7C&'6MMC9:K<K+;W#RH-NV"-0XP>&5HBP^@H [".\@EO)K1')GA56D7:
M> V<<XP>AK+E\364?B"ZT5O.CFM[1;F29H6\M58L!SC!^X><X[=<X;X1@OD\
M/P7>JE6U.]5;BZ*J0-Q4   ],*%&/4&JMQIVHQ>-[S4XK03V=SI,=MN650RR
M(\K8P>N?,&.W!S0!-:>*=*@T[31=ZO%=7%S:"XCDB@8&X0 9=8QD\Y!QR>:L
M67BO0]2N;6WL]1CFDNXS)!M5ML@ R0&QC<!R5SD>E<UX?T'5].E\&FXL& TK
M2)K.Y*RQG$C"(#'S<C]T>?<>^(M(\.ZQ:V?@Z&:P9&TR[N9+HB6,[%DCF52/
MFYYD4_@?Q .QAU[3+C4$L([H&XD5FB4HP$H4X;8Q&'QWVDXJ>^U*TT[R1<RE
M7F8I%&B,[R, 6(55!)P 3P.@KD/!VA:CIHTZQU30;%9-)0Q1:J)5<S+MV HO
MWD8C&[/OUSQM>([?5)[W26L;47%M',YN@DHBE4%"%*N>5&3\VTAL=,\@@#F\
M7:6;_1[:W:6Y&JH\D$L,3LFQ1R20/4@8[9R<5;U^_33M'EN'U&+3\,BBXEB\
MQ5)8#&W(SGI^-<?H/AS7-,C\)--81EM,^UP7"K< [5D(VOGN..G7D>^.C\;:
M=>:MX2O+&P@\ZYE:/:FY5Z2*QY) Z T 2)XJT]M8U33G\Z,Z<D;32O"X3+Y(
M .,'H,>I.!G%:=G?V]^LK6[.?*?RY%>-D96P#@A@#T(/XUR5]H=]-J_B1I=(
M%[8:K!:X3[0$8[,JZ]00P!R#G''6M;PGI^IZ9:7D%_<W$\/VC-F;ME>X$6Q>
M)&7AB&#8.2<8R: -)M8L4OA9F8^<9!%@1L5#E=P4L!M!V\X)S@BHXM?TN>]C
MM([M3-*76+*L%E*?>",1M8C!R 3C!]*YVZT'4CXN.HZ<ES9>;=)]K83JUM=0
MB, L8R25E& H( ^Z,DCI4TOPOJHT;PUHE[;B/^P[U9FO5D4K,D8<)M .X,VY
M<@@8^;D\9 -GP]XAEGTZ^FU69#)#JES9Q^3$<N(W8*%09).%)XST)K<T[4;/
M5;)+NQG6:!B5#+D8(.""#R""""#R"*X!O#FO00)>Q:7'<2V^MW=Y]AEG1?M$
M$Q?&&!(#@,#@^XS7;:#:?8].(.FV^G-+(TK6T!!VENI8CAF/4D>O?&2  \0Z
M4VH+8B\7SVE:%?E;:9%7<R!\;2P )(SG@^E5[7Q=H-[=06UMJ,<DMQ(\46%;
M#.F=R;L8W#:W&<D#(KF)M%\13Z]97<NG(19ZY)<ATN52-K=HY%4A!_%\X+%A
MN)SC(Z%KX?UF/3]'B?3F#VWB*?4)?WL?$+O,P/WN3B5>/8^V0#7U_P 4_9-0
MT>VTZX1C<:JEG<9@9E(P=RJ_W0P(Y')Z],&NDO+RWT^SEN[N9(;>)=SR.< "
MO/;70/$5MIFCZ,^FB8:7K(NOMOVA D\.^1MV,[@_S\@CKT)KLO%$&HW'AN\B
MTJ*&6]95\M)@NUOF&?O KG&<9XSC- &5XC\5K:Z*U[IEW$K6VHVMM=K<0LK1
MK)+&K AL%3M<$$CI6I:>*=%O[>XGMKY9%MY5AE4(P=7; 5=A&[)R,<<]JXZ?
MPQKDR:\R:?M%U?V%] DMX)'<0F(NA))^;]VW4XR0 <<UHZAX:FU.^U;4[K3)
M2E^+2$6L=PL<Z"$NWG!U; <,XQANB#GG  .F_M[3OL\4PF<B5WC1!"YD9D)#
M )C=Q@YXXK*U/Q&QN?#,VE74$UAJ5\8)6"[BR^5(_!SP0T>",9^E9&G:'XCT
M[5=)U6Y:74A:K=VKQ2/&)_(D=6C<G(1G'E@-SR#GD]2'POJ5FVC.EMOVZ_<:
MK<(LBX@2590%&2,D>8N<=]WMD ZJ/Q'I,L=O(MV"MQ<M:1DHPS,I(*'CALJ1
M@XZ&JVF^*].U*&^F43Q1VMTUJ3+ ZEW!QA01DG=D8&3Q[URZZ!K\3P6BZ:K0
MV_B234_M!N$ >%WD?@=<C?@@XZ<9[)<^&]>CMKHV]A!/);:_+JD,,DX5;R*0
M."F?X6 D/WN,@=N: .[T[4[/5K=I[*<2HDC1/P59'4X*LI *D>A&:MUD>'K0
MVUE+(^DV^ER7$QF>WA96.2 ,NR\%CCJ,\8YXK7H **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=CHFM65O:MIFHM;*;=PQGQ-C+!@<#9N)*X.0K'(H U?^$DMO^?#5O_!=-_\
M$T?\));?\^&K?^"Z;_XFLG4/%MQHM_K(OGL+B"PTYK_R;9BLT>"0J,"3NW8^
M\ ,=QR*LC5=;EU&YT:(:>NI0P077FR(_E>7(74C:&R2&C(ZCA@>V* +O_"26
MW_/AJW_@NF_^)H_X22V_Y\-6_P#!=-_\34OAZ\O=0T6*ZOOLYED9]K6ZE4=
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M?FN!<JY,HC&&0;2-I+*XW<_P\&@"[_PDEM_SX:M_X+IO_B:/^$DMO^?#5O\
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M #X:M_X+IO\ XFC_ (22V_Y\-6_\%TW_ ,36S10!C?\ "26W_/AJW_@NF_\
MB:/^$DMO^?#5O_!=-_\ $ULT4 8W_"26W_/AJW_@NF_^)H_X22V_Y\-6_P#!
M=-_\36S10!C?\));?\^&K?\ @NF_^)H_X22V_P"?#5O_  73?_$ULT4 8W_"
M26W_ #X:M_X+IO\ XFC_ (22V_Y\-6_\%TW_ ,36S10!C?\ "26W_/AJW_@N
MF_\ B:/^$DMO^?#5O_!=-_\ $ULT4 8W_"26W_/AJW_@NF_^)H_X22V_Y\-6
M_P#!=-_\36S10!C?\));?\^&K?\ @NF_^)H_X22V_P"?#5O_  73?_$ULT4
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
/"BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>exhibit1033-bochk_facili009.jpg
<TEXT>
begin 644 exhibit1033-bochk_facili009.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MY)4MU^7.2/:O7K;Q9HU[JRZ99W,ES<')S#!(\8QUS(%V#\Z -NBBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MP"15Q(9-I?)P>G;..>E<SX?\9>(KOPCX$:XO9<ZWJ$T-_J!4;E"R,$C'&%+
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MP$A<E<;_ # -P&,#C(QT]JVY]1U&'P1J^I/>75K?1Z3-/;Q22JY<I"KB=?\
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M/S$Y.3D_C0!N4C*KJ590RG@@C(-<W_8GB?\ Z&[_ ,IL7^-']B>)_P#H;O\
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M_8GB?_H;O_*;%_C0!TM%<U_8GB?_ *&[_P IL7^-']B>)_\ H;O_ "FQ?XT
M=+17-?V)XG_Z&[_RFQ?XT?V)XG_Z&[_RFQ?XT =+17-?V)XG_P"AN_\ *;%_
MC1_8GB?_ *&[_P IL7^- '2T5S7]B>)_^AN_\IL7^-']B>)_^AN_\IL7^- '
M2T5S7]B>)_\ H;O_ "FQ?XT?V)XG_P"AN_\ *;%_C0!TM%<U_8GB?_H;O_*;
M%_C1_8GB?_H;O_*;%_C0!TM%<U_8GB?_ *&[_P IL7^-']B>)_\ H;O_ "FQ
M?XT =+17-?V)XG_Z&[_RFQ?XT?V)XG_Z&[_RFQ?XT =+17-?V)XG_P"AN_\
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M?_H;O_*;%_C1_8GB?_H;O_*;%_C0!TM%<U_8GB?_ *&[_P IL7^-']B>)_\
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MOB=X U6[@@MEU'3[FX6."1C\AB)57R!D@$<^YX&.?8J "BBB@ HHHH ****
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M,TH CD.,*WH3D<'U'K0!F-X2$DNG74FM:DU]9R2/]J)CW2[U"L&79M PHQM
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MXY>4P)%8G<2<=0,8Q4.O>*DLK"SO=.N;.6%M3@LKHR9/EJ[JKYY&U@#GG\J
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MBE;SQO%I-K<6DUB^F27A=,[PRR1J#G."A#D@XYQUH DTGPC%HU_));:GJ'V
MS//'IK.I@BD8DDK\N[&22%+8!.<=,=%64?$VAK#<S-JUFD=LH>9FF "*?NL<
M]CC@]#VJW8ZE8ZI'+)87<-RD4AB=HG#!7'53CN,B@!FK:;'J^ESV$LTT*3
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MW8!94)8+G#&N\HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MJ:U\0WUI-%I=[J4IMF\13:<U[*5$@C$)D1"P  +-A<]<>^#7:#P[HBD%='L
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M6/2;%%MY#+"%MT C<]67C@GU%:- !1110 4444 %%%% !1110 4444 %%%%
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ME#1M"Q64LP)&T$ 9&<[E]:KP^#'M[[3+N*^C$EMJ%QJ-QN@/[^29'4@?-\H
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MW[Z-G8NR"3=C9N)/W<X.,U<LO#D-CXHU'68YFQ>*I^SX^5),!7<>[*D8_P"
MGUH K6_B^&?5(;!]/NHIKBWFN((WVK(RQ,%(9204)W KG@CN.E0:3XXBU=],
M$>E7D*:I9O=6;RLF)-H4E#AB5.&')X//XT],\$ZGI]YIER^M6\\EBES'O:S(
M><3%3N=O,Y?*#)[^@JQI'@VZTO\ X1A3J4,J:';26YQ;E3.'4+G[YVX"CUH
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M+//^Y.X-M9%R< <YX!/'UJ:Y\%W=QIFKV8U.!3J&JQZB'^S$^7L:-MF-_/\
MJEYXZGBGZIX,FU0^)O,U&-%UJUB@4+ <P&,, WWOFSNZ<?6@#1'B5(];ETN\
MLY;25+(WHDE=-CH#AL$'JIQGTR/6M2RN&OM.@N7@EMS-&',4APZ9&<''0URF
MLV4/B#6=*TN:29]3T^42W<T-L\<1@=#O3<V5*O\ *NT,3W_A-=F<X.,9[9H
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M,<^9R^4!8]\GIUJ6/P'(UIHMG=:A'+;:?I$VE2*D!5IDD1$+ [CM.(QV/4T
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M;/+W#;G!)QC-;L6@2ZUI_B^U:&6VNFU@WFGSSP,@61(XO+D4L.1O0@X[9]:
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M75_%#'<+#)!+=0QE_(,H4G R >I'Y5-;3)<6T<L:NB.H*K)&48#W4@$?0BN
MAAO[3Q#<>1#<7>FR37SLEQ9.LUDYWDM'(!B2.1NB\GYA@D+P ==X=UN/7M"T
MZ_Q'%/=VD5R]NLFXQAU#8]<<]<5->ZK%#I=]=V;074EI&[M&LP RH)VD@''3
MTKSC1M-FTVW\(RPZ%=_:(_#MQ!>HML\3/+LAVQN^!@ED8#)XIVEQ7(NKF5-,
MU&.";PPMNB?V?+&L<B%_W0!&XD!@!N))R2,B@#L+#Q3->:AX?MFLD1-7TQ[[
M>)23&5$9*8QR/WHYSVZ5T<DB11M)(ZHBC)9C@"N!T:"Y35O Q>RO$6WT.:"=
MGMG BD*P *Q(^4_(_!]/I6O\1K1[[P%JEO%:2W4SHOEQ11&1BVX<@ $Y]Z .
MECGAF+B*5',;;7VL#M/H?0U4NM:TVSTJYU.:]@%E;*S2S!P57'49'?VKSW7-
M*O!?>*X]#TN>.*>RT]UCCMFB2X"2N9D4D %C&0N.ISBI?$NDW.LIXGO-)LKC
M[+=>'C 86MVC,]R"Q3", 2RKQG'\0';  /289HYX5EB<.C#(93D&L;0O$(U5
M[Z*YCAM9[:^EM$C$VXR; #N&0#WZ8XK1TR6.;3;>2*&2&-D!$<D1C8?52 1]
M"*\VN_#OVV+7;9=*E77)==%S979MF!C3?&PD$N,!0 _ /J,9.* /3S<P"Y%L
M9XQ.5W"(N-Q'KCKBI:\XL[1[CQ#/I^L6&KO>P:R]]:3QPX@:,N2C^<%XVQG8
M5+9.W&#G%>CT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 (1D$9Q[BJ&D:/;:)9/:6CRF)Y9)
MCYC;B'=BS'IW8D_C7#3ZYKNF6'C#4(;Z*:2TUF*WBCGARJHRVXP,$8P'/KZ\
MYK5N=4\1)J-UH5O/%<ZG!9_;$FCMT1'WR2+&K*TF0HV88@DG(Z=P#I-(T>VT
M6WFAM6E9)IY+A_,;<=[L6<_B23BEU;1[;6K>."Z>Y6-)!)B"X>+?P1M8J02I
M!.0>#7(ZQXKUFP@:YS:>9 +'SK6 >:J&9U602.< ?>^3:2>Y&#4<FOZCI.K>
M*[B:Z^T1PZC9V=O$R +%YRP@'.1PID)P2,^HH ] 5510JJ%51@ #  J"WOK2
M\DGCMKJ&9[=_+F6-PQC;&=K8Z'!Z5R5QK^NZ9<1V5]'$IOM1AM+&>0+O5'1F
M<R(C$9'EL%P1G(R.#F;PA'-%XG\8I/,)I!J$/[S:%R/LT6,@<9QC/\ATH Z^
MBN*O?$VI6NOV\22P36TFKKI[I$A*(C1D_,YP?-# Y R .#@\U/HGB2ZN_$TN
MEZBS6ET%F9;26#"S(''ER0R#AUV?>&<Y/0 8H Z:]O[33K<SWMS%;PC^.5PH
MZ9[^P)_"I89HKB".>"1)8I%#HZ,&5E/(((ZBN2\0)=/\0O#"1W02)H;P[#'N
M&0J9[]P<>WXUE6/B/6;/0WOY9+#[,FHOI,%K;VGEA6%UY*/DO@ *#\O SCYA
M0!Z+17%3:]KVFW$5C?0*3>WZV]E,/+\WRS$[G>N[9NS&R@YP<@XR"#OZ!+J\
MME<)K"1)<1SND;1D9:+@HS $A6P>0#CC/>@#6HKA;/Q3JLVGZ#.[P%[S6[C3
M9_W7!C1IPK#G@_NE_,U!IWB?7Y!HUW=7%F\%YK-SI<L,=N5.$:<*X8L<$>4.
M,'J: /0:@NKRVL8//N[B*"+<J;Y6"C<Q"J,GN20/QKC+;Q3JKV6E3.\!>;Q!
M/I<O[O :)'E4$<\-B,>W)XJA#K.LV7AK5K][V*ZDC\0_9,3P9 C^U+%Q@C!
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MWF9QSRA\L$#KR>:GM->UC73/::;-:6U];:9:W?[Y"4EEF5C@]Q&-N..>?;D
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M(BXLQ_Q*ENEN=LJG_6 A=O//OTHTOPWK5C%X<D-I"9=.U"]EFC:<#]W.92K
M@'.-XR/KBO0** .%\-^']3TF:.QO="TN>*QFDDM]5#*9I$)8J I7*R8.TDMC
MK4%OX:UZS\$^'(K>"#^U=$NQ<&V>8".=<2(RAQG!*R$@D<$5Z#10!R-[I^L:
MA?\ AZ]ET^& VNH/=3Q13*WEH87C W<;FR^3@8QD9..<ZUT/Q#:L@2SC-O)K
M%Y=SQ_:1&YCE+&,AQDC!/S <GW&0>_HH \^\/>&]:TQ_"HNK*(+I45Y',8IP
MV?,(V$9QZ'/ID>X&='8:GI$?AFPCM8FUNT:]G$:WB1MY+N<[=RLK [TR#@Y7
MCC->I53U#2=-U:-(]2T^UO$0Y5;B%9 I]0&!Q0!P-MH][]GT:\TK0H9UTL7%
ME<Z=>W*-Y@D9',B2@%2P9>>!U8<8J?7/#.N7FGW.G6FFZ=#97&D301P6LWD)
M!<.7.#A1O7##' &X,2!GCT"**.")(H8TCC0;51% "CT '2GT <,FAZU%<:NQ
ML8)/[5TNWM!B<%(9$613OR 2OS@_*#T-07G@F^F:?3H'VVA\.+I,5V[#/F*3
MAF7KMQC/X_6O0** .;\,V=\LK76I>']+TJZ6(0L]HRNTW.20P4%4SR%.3SVQ
MRWQ!X<GU37-/O;:1$B:*2RU%6ZRVS8;:/?<H7V$C&NFHH X>W\*ZG:?#_6-'
MDD6ZO9K2:PM&+8Q  R0!B?0-N/U/6I#HFKQ:P+R.TC>*70EL'4S -'*I8_0@
M[NN>U=I10!Q&AZ!JEE>^$7GM@J:7HSV-RPD4_O"(0".>1^Z/YCWQV]%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% 'D&KBU@TCQ]%]I9+G^VK=O+:<DA#]D.[:Q(ZDX./;H,
M5H:GJMSH%WXI@M[^Z-E;3Z=)(\LTD[6T4K8F8$MN VC/!&.2,5Z3):6TI8R6
M\3EL;BR YQTS0MI;(S,EO$I8;6(0#(]#0!@>$O*+ZC)::^FK6<DJ/&(F,D=N
M2OS(KEW)S@-MSQGWKE=>0Z4==\2^%]7B5H97_M71;LAX;EUX.!U21@!C'WLK
MQ7I<,$-M$(H(HXHUZ(BA0/P%,>RM))TG>UA:6,Y21HP64^Q[4 <7XLL]0\2^
M%O$AT^-UNS8?9+>+^+<0))5'NV53ZI2:YXHCB^$\VM:'<11R06R!(F16VOPI
MB=#W'((X.17=JJH,*H4$D\#')Y-0'3[)KH736EN;@=)3&-_YXS0 VWO+=KAK
M$7<<MY#&CRQ[AO"MG#%1TS@]NU6J:(XQ*TH11(P 9@.2!T!/XG\Z=0 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/ICGF_ ^MW6FZ5X>TZ2RB^PW]W>6\<XF.]75YI.4VXVX1A][/3BNRU'0DO\
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MVY^4Y*KR1VQ6!+X,EN] GTK4/$.I7OF[%%Q*(]Z(C!@!A0"20,L02<5U*@A
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MFA6<UM'<2SK+<S7):0 $-(Y=AP!QECBJ7_"+R)XBO]:MM8NX)[V..*1%CB9
ML>[;C<I.?F/?O0!:UJ3S+BRM I8;S=RJ.I2+##'OYAC_  S7/>!+6#Q+X/M-
M>U>-;N_U(/.\KG)A!8A4C/5 H  VXY&>IS73:9I T^1YI+N>[F>,(TLVW)^9
MF)X  R7[ #"J.U4-/\+G1C+#I6IW%II\LC2BT"(ZPLQRWEDC*@DDX.0,G&*
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M!I=Q+IT4=UF348S+:J8V4R*!DGD<<>N*MV=[;ZA TULY>-9'C)*%?F5BK#!
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MB,=M$$!.6.268^I)Y)]S4%[HNFZC<+<7=G'),J&+S.A*'JA(ZJ?[IX]JOT4
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M+ EC\N,#'7/.>U:%(S!5+,0 .I)Z4;EP#N&#T.>M "T4@92 0P(/3GK2YS0
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M0$J><8!7KQ6UX(TC3TU+7;[^ST2[35;GR)FB*L(GV_<)'W3@]..M=E;W,%W
MD]M-'-"XRLD;!E;Z$<&I: .*U*X2V^*^GW,J3?9X](GB>58695=I8R%) (R0
MI./:J)M+_4_&&K>((;:YM;:>QBT>T,D9CDE+2%GFVG! 4,<9 SM/:O0R0!DG
M J.WN(;NWCN+::.:&10R21L&5AZ@C@B@#BM7EAT_XEZ#*8I5M+?3;F%GB@=T
MC+-%M4E0<9"G'TK=/BK3E\EG6Z2&>[6RBD:UD :1AD?P\+D@;CQFMRHIK>*?
M9YJ;@C!U!/&X=#CO@\C/< T <]XSE2*#21+9R3QMJ"9D$3RI =CX=T3EQG
M/&XJ3TKA]%T^&>X\+VM]I\S1VVIZI'*+FT956)C+Y88%0-IRN!T[>U>O44 >
M56NF&W\"0:O;6>+WP[J5W=6T3Q[2;83R;HUST4PM\O;(7TKT'0;(VFG>9+"L
M5W=NUS<@ 9$CG.T^NT87/HM-U73K&_U#3Q>7TT;*S>7:+<E$N2,,0R?QXVYQ
M]<\$UK4 >0:<]X^I:7<Z5I]W9W<FGZE#Y3VL@,4[,C(LLC#YVW!CN)QZ>]O1
MDL+W6/!A72KA98[&YMM1$UDX*R&- RRL5P26W<DG.<]^?5*B@NK>Z\S[//%+
MY;F-_+<-M8=5..AY''O0!P6AZ5<Z=87VFW.FRS6WAX7"Z?L&&N0Z[H]C=0RH
MWEY]6]17-&%9=/UI(;"X$%UX3$<<26$J)YR^9M3YAEG&Y1N/))X]![$ES!)<
M26Z31M/$%:2,,"R!LX)'49P<?0TRVU"RO7E2TNX)VA(618I Q0GL<'C\: /+
M[S3[FWGOE\.VCPW5SX8 )A0H99PV<%O^>NTM@D[N:O7\EC>^'KW5/#.CZA$Y
M%H+V%+5X6>*.4%XEC<!7<(7!P#D?+DYQ7I5% '+^#H-,SJ-_I)OS;WDB2.;F
M#R$,@7!V1E$QP%R<8)[Y!KC_ !!%]GC\86'V"Y:>?5K*\MTBM'<,F+<,ZD+C
MJK@XYSGUKUBB@#R/Q!IMO*?&]W'I[-="\M)K)Q;MO#A(MS1<9SN#9*\\'-'B
M0_:=-\6VFHZ?<3ZI)?136#K:/+OM@8_+\M@#P,/D#N3_ 'J]<J*6ZMX)8HII
MXHY)FVQ([@%SC.%!ZG'I0!YQ=107WB;4K'68M76\DOHKK3)+>UX>,*A3;+L)
MCVL&# LHY/J:U?!6D:>NK:]?'3T2[CU:X\B9HBK")U3[A(^Z2#TX.#790W,%
MQYGD31R^4YCDV,&V,.JG'0\CBI: //\ Q/%<1^*1>6B1WK!K19=.N;<Y<+)N
M62WE'1E))8<C R<=:QKB,6WGV'V"Z^T0^+HKP+':.P6$RHV\$+C&,]/?T->L
MU%!<P747F6\T<T>YEW1L&&0<$9'<$$'W% ' Z,;6;6)K+6M-O&UZUU>:YAN!
M#(JM$6;RY/- V[!$P7:3_#C&<5DZ38Q0)X;ODLG2_'B.\\V;R&$BP.USC<<9
M$9W1GTY!KUFB@#C/B/'Y^G:+"$G8?VU9R/Y ;<L:R LV5Y4 <Y[4[Q'9V^D:
M)&$@N[V&XU."5VD>6X$/*X=P"6= 4'RYQR.@KK(;JWN'E2">*5H6V2*CABC8
MS@XZ'!'%2T >26,T^F1027=C?2:+;:_>-=1_8GPJ.&,4GE[>4#'. #@D'&16
MTUE86^L>"GTRPN(+.._NG7S(WS'&\,O)#<HI=A@''4<#I7H-1?:K?[7]E\^+
M[3L\SR=XW[<XW8ZXR1S0!Y?)#OT@LUM*73QD+A<PMD1_:@QD''W=N3NZ8J]#
MX6L]8D\;:1/8BWN;F^\^VN#:X"_N8BCJ^,'$@8X![-GO7H]4-7L(]1L##->W
M5G&K"1I;:<PM@=BP['O0!C^#FN-3M6U_4;);6_NHT@,8 ^1(\@@$=C(9&![J
M5]*QITGMO'@N8$CO8);\>=!<6Y6>T;R=OG12=&BVC!!XR2 <\5VEC<:<L45I
M8W%N4B0(D<4@;:H& .OI5R@#R;P[81VA\%WB6+QWG]HWJ74OD,)!$RS[0Y(R
M%+&/ /&2*E\+RA?$^@7J6%W91/87L5Q&UI*/)?S(G"RR,/G;[Y+$X].O/JE%
M 'EOAY)8]/\ ARLD$Z-;W%QYX:)@8LP3*-W'RY+*.?45T7C:TAN=2\,R7MMY
MVG17\ANMT9=%5K>51O 'W2Q4<\<\UV%% 'DPLI]!ABE-K>1^%O[9N)$A@M_-
M-O"T8"-Y15CY?F"0@;> P([5WGA6QLK#PXD%F+O[ 6D>(7B[6V,Q/W2!M7DX
M4@8&.*W:* /(-*T:R&F>$'?3-LXUBZCN2UNP86[?:,*_&1&=T?!X.1ZU:LA#
M9)'9G39A9IXBNS PMI'AMD*-M/E*/F5BS!?X03GM@^FW=_9Z?&LE[=P6R,=J
MM-($!/IDFK% 'DGAF22S'AR/6K&[;2(K:\M@LUF[+%<^?\FY=O>/*J<8Y('6
MH-)_XE^B>'5U.RU"/0Q'>V\BI8&7R96FRA>-D8[2FX!@.Y&>37L5% '/65LF
ME> _L]K!J%Q%;V3B&&9R+F10IVKG (8C '&1QW%>>JA^RZU]E2]L[>X\+QJK
MVUA*@1T,F5&0"S $#).3GC'0>QU3U73+?6-.EL;HRB*0J=T4A1U96#*0PY!!
M /X4 >8M/I%S'XBU**S6:[FTR*'^S+6">)BB$B1U+1HQ'SJ"%'W4&<Y $&J0
M--H?CN!+2>5+E+:>U"6$D22-Y:@F-".N1[GC/O7J&GZ.MC)YLEY>7LP4HLMU
M(&*J<9   '8<XSQUJXES!)/+!'-&TT6/,C5@63/3(ZC/:@#R[Q1I=I?7?CV;
M^S_/D?2(&LW$!;=.$FP8^.7!*<CD9%7[T7)\26][;*E^)9K-;BRNK=A(OW<3
M6\GHN<LIX^5NF>?1Z* ./\ VD5C#K=L+$VTRZM=,V;<QAD:9VCP< ,-I!&,X
M!KG+IRWBJTN(M.O();?Q(WG8M)7=HS"Z>89,$;&^3"C@#&>G'J=(S*BEF(50
M,DDX % ')^,II;?4_#UQ<02S:+'=O]N"1&0*3&1$SJ 25#GTP#M/:N,33[26
M"&$Z9*+;_A+WE"/:.J^0RG)P5'R= >W8UZY!<0W4"3V\T<T+C*R1L&5A[$=:
MDH \F\26MO9W=_::=I%Q:FPN],:#R;223?$DD9+1L 0B*"X*KR2&SUP;?B+P
MO>7.IZSINF62+!JB1ZM!<-$-L%U#P5Y[NPAX]&DKTZB@#SG46NFT?2->N=,F
MCM[_ %*&ZU6V2$NZ0>65C#J!DJK"-F'.#GWK,$<D4^K2V.GW T@^);>YNHUM
M'59+8V\89@NWYE$@#$#/ )Z5ZS1T&30!YM=>&Y=4M_%;:;"HM#-!>:0I3""Z
MC4,S(.RLP4$C@G=[T:3IE[=>(I&FTKRM,\1+%J<T;1 ?9VB(_=O_ +3CR20>
M_F5Z#:7]G?J[6=W!<K&VUS#('VMZ'!X-6* /(QIMM LMY%8%+J+Q<DD4JP'>
MD!E3<RG&1&5W9(^4C-=;X^M8KJ+05D@,P76+=FPA;:F3N)QT7'4]/6NOI&94
M4LS!5 R23@ 4 >5I;2V!O8K:QD71K?Q2LMQ;10';]E,"#<J <QB;YC@8^4GL
M:35]))BU6YBLFET,:[IUS;Q+ 7"J'C^T.B 9V'G.!@X8]Z]-CU"RF^S^7>6[
M_:03!ME4^:!R2O/S8]JLT >7ZO#=)?\ C&32+"<^9;::_DQ0E#/&CL9D7@9;
MRR5('/(%3ZK)8R:3)J^@:;J"V$E];2ZD(K5U,L:J5)2%UYV_NRV%P<=R#CT2
M&ZM[DRB">*4Q/Y<@1PVQL [3CH<$<>]2T <=H%[HFAV8DM6U(6FJZCB%I[5D
M7S7 ^Z@1?+0D=2 "Q)[Y,OCJ2>WMM*N?*N9=.AO@U^MM")7$9C<!MA#;E5RA
M(P>F>U=/-;Q3F/S5W!&#J"3C(Z''?!Y&>AYH:ZMTN4MFGB6X=2R1%P&8#J0.
MI% 'G%UX?LKOP_:VV@"[BU!KY[[2KJ[A\L6[#YV.TH-D9.X!"HSG(&.0?VE;
M16'A2].C74&AP^=%?VGV9Y#;SE0$=T )<9\P;\'.\'O7IE% 'F&H06&GSZ7;
MW%CJ<'A>:QF@@5;1K@Q2-)G#HR.R[D(V\9&-O'2J[Z-X?_X2F33M7LY9[7_A
M'( B7B&25B))5!.!S+MP!_%QQ7J]9J:+"GB.76Q/.;B2V6V,9*[-BL6'&,YR
MQ.<]Z .'\+Z7=Z=XE\/-K5F[WQ\/I"]P8"^)U<9#. 0&"G&2:V=<MH(_B1X>
MOY[(R1"SNHO/%N7"2;H63) .W@.03C&#78T4 >2^&K&.R/@F[2PDCO/M-ZEU
M)Y!63RRLNU7)&0I;9@'C.,4F@Q"YU?2V32[J&&YT:\MYK>2SEPDA>-@DKN/G
M?[^6/&<XZ\^MT4 <MX!BMXOAYH\#6AM_+L8H[F.6 QGS%C4/N# 9Y!!/?%<9
MX9TU;*/P//;61M[[-Y%<RM RLJE)-BR'&0N[9@'CIBO7** /,-%M+F>S\(^5
M;30>(+.[(U9WC*OLV.)C(V/F5VVD=<D@CIQZ?44EU;PSPP23Q)-,2(HV<!I"
M!D[1WP 3Q4M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M&LA*ML/M;D1+)C<H!.-O X]A5BR\):;I_P#9'V<W 724>.T4R9"*PPP/][@
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M7#W,OF-NS(WWB/3/ITH X"XU+6- O?'6KZ6MBUM87T=Q<6\T;;ID%K"7"L&
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M&\;22.R<X(4C8F ?F)ZGCI@]1!(+JTBE*C$L88J>>HZ5D:OX2TK6[N:YNUN
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M]36;/X2TRX.H[A,JZA:+97"(^%,*A@% _AX=AD<_-]*T9-,MIM'?2IU:6T>
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MI5U99&<8&""#NQU&,5B:#X7UC2U\(+/%;L-'LY[>Y*3$[F<*%*\<CY><XZT
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M]<$/#OB.7Q#IU_=1V4ILM6GN/.-RP+6[I(BA4V80J'7(!^8KDGO7>T %%%%
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MDQ%D97."0>AQ69X%OKAM36TN9([TM8+/#J=K.6CNH]P :6,_<EYYZ@\_W<
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M?5)GEU'2I_MAGO&<2%4C()#' (.[D 'K[T >CZ%K$&OZ)::K:I*D%U'YB+*
M& ]P"1G\:T*\H^&&K0M;Z/8ZI*L<IL0VE;)L13H#^\!'>56Z@YPI&/XL]%XM
M6&;QGX:M+N]N(+2ZCNTFCCNWA67"H5!VL.>3R.>W3B@#M:*\JTF]GTNX\-R:
MCJ<PTP:AJ-K#=75P0LUN _D;V)PV<?*3U !'6JNEW,.K-X7LKG5KHQW&HZK;
MS1K?2(SH&EV*<,#D#;COC H ]?HKSNVFDMO&$-K)(NHV,]Y+;Q30W3B>V98F
M!BF0GYDPI(;/!P3UR<KPYX@1E\"K)JDLMRMO=17J"<NY=8SA9!GE\@X#<YH
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MV.<>E C02&0(N\C!;')'UKC)O$L&D7GBBY;2XX7L[NVCN+B-F?S%=$Q*X"Y
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M ,JD @@$="* BC&% QTXKD+;QM-.VG[].2)9=2ETJ\9IR?L]PH;;CY?G5B
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M68*<!7'RXR2,#K5>#QQ<265E>/IT:V[ZL^EW4AF8>2P<HL@!7)5F"C!P06%
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M%B&2Z+NDD?FX.-@!4B$\YSSTKM: "BBB@ HHHH **** "BBB@ HHHH ****
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MT=M=W.GW.F,#9W5L07C^7:00P(8$<$$<UK6%H;&S2%KF:YD&2\\Q&^1CU)P
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M?:+M$22,CS Y P),KEA]WG'%=]97D&H6%O>VK[[>XB66)\$;E89!P>1P:GH
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MT33)M1U"5HK6 ;I'$;/M'T4$T 5-=M)Y/!^H6-I;F:>2QD@BBC(&6*%0 6(
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M:?J-W-=?O(CY:2+.%/#<Y,B],GK7HU%% !1110 4444 %%%% !1110 4444
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MQ0-;)LC/<@8P*FO?#^CZC)#)>Z7:3O ACB:2%244]5''3VH K>#?^1&\/_\
M8-MO_12US,6O7S^)])\G4Y)[*]U.\M)&*JB%8XY"%1.3\C1@%SC<<\$$5W=K
M:6UC:QVMI!%;V\2[8XHD"JH] !P*HCPUH2W1NAH]@+@S_:?-^SKN\WGY\X^]
MR>?>@#&^' D_X1,/+=37#M>7>3,X8C%S*.O7G'>J6J+(?B!JVZ\G$2^'PZPE
MALR7D4\8]@?K78V>G6.GF8V5G!;F>0RR^5&%WN>K''4GUJ.ZT?3;VZ6YNK"V
MGN%C:(2R1*S!&ZKDC.#Z4 ><:-JVJ:!HV@-#=37D,WA.2\6SD5=JR0QPE N
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M9?E^_P 8\YN>>@XJ*3P/>J)+FTUI(-275)=1MIQ:Y1/,7:\3H7^92.X(/0T
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M73*EGVAAQUSQZU<GNK>/Q/9/;130/;^(3;S!XI'F,?DN@)?M$V%VISG@YSP
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MC9MFC<?>'.YU('1^1S6[X_MK60^'+B[M4FA@U>,RLT/F;$:.0'/!X+;1]<4
M;FBZVNL2ZG&+:2!K"]:T8.P.XA$;<,=L.*U:\BO8K55UW4DP+V#Q3;/;R D,
MD9-NKE1V!42 ^H4YZ<6+J^A;Q9:7$$<T4T7B-H;C=$[S&,PNN2X&!$QV[4Y!
MX.>P /3[:[M[M9&MY5D6.1HG*G(#*<,/P/%96L^);72=/FNTC:[$%W#:3+$P
M'EO(R*,Y]/,4\9ZUD?#RWM;.TUFVAM4MYX]6NQ(JP[/D,SF/G'(VD$>Q%<GJ
M5M96NC^+;46RP7+^(K>3"1%&,1EMVR& Z<.W![,>QH ]>HKRF_<Z5<^*(=,2
M4:;%?V,\\-JN\B$JOGLJ\[N@+  YYSU-=?X,ATQ+>^N-'N[JXL;F82KYD8CB
M5MH#")=JX' )XQDGOF@#IZRO$>MKX=T&ZU5[:2X2W +1QL <$@9R?K7GRV _
MLGQAJ6G0S3:I;:E,(3"[&00,(O,$8SW4/CW''2F:JNCS>"/$U]H=W=SP7<,(
M:,P"*%9 W\"!%^<C[V/09H ]9HKS'67L[_Q/JNGZQ=:A;SRRP3:/+:0AF>,(
MA_<R;3M;S ^>1PW/%:DNE2VOC.^TJ.T+Z9KJI>/(%RL+1$"93[./+Q[LQH [
MJBO*M0O81XIAF@BF@FM_$21S;HG>8QF(KG<!\L3<!4Y!ZYSP*]O#:6_V>_C8
MBZC\72(DID)98&E8$#)X0J?H1@T >KV]W;W33+!*LA@D,4FTYVN "1]>14U<
M;X$MK2SN_$EO':I!<#5IV8+#L/ED@ISCH<DC\:YV]OHO^$LM[B&.:&>#Q'Y4
M^Z)WF,9B9<EP.(F^7:G(/!SV !W^M:TNC/IRO;22B]O([0,K ",MG!.><<=J
MU:\@6ZM[FWT0ZC"W_"26_B,&^!B8RJ/,DP>!DQ[=FW^' 'I7266DR6GBO4-
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M-LQNQ_LYH ["BO+/'EW'_:&LK''+'>VL=E)'(\;R,5$NXM#C_5@9.YN<]#C
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M8U<Q_NC)VVYW=> VWVH ZRBO(GMHXM1T>/4)6719/$%VEF'E94^RFV?"]?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M''6JNIZU>/XFO-"6V9+9=*:Z-PDVU\EBH(QR,;3TYY]J .IHKA/"/BX1^']
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MFDDTRYAMYTMY$<9EVA2#D9&6 (QD$'BIT\8P*^HPWEA<VMU9SP0"!F1FE:;
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MR=OXV]-\*7?AR:PU6\UA+F/2K.XBE\NQ;S)T<HY<X=BTF8QD@'=G@ \UW%%
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MG(P?P[5L?V=8^48OL5OY;($*>4N"HY QCH/2IH88K>)8H(DBC7[J(H4#Z 4
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M9!?,;5-^VW.<2'IP<' ')P< X-)<>+M+MY2I:9HE:!))UC^2,S$"(-GGDD=
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ML<[H&23.,A20RXSU9:Z@7UYI7A"?4]0#SW4%K)=21$*""%+^7\H X^[GOC-
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M][$L[EE56. S*,LH;H6 Y(SD"H]-\1Z-K$[0:;J5O=2*GF%8GW?+N*Y_,$4
M:E%5+W4K/3@OVJ8(7!*J 68@=2%&3@9&3VJE>>*_#]A!#-=:Q9QQSPF>)O-!
M#QC&6&.HY'- &Q13#+&L)F+J(PNXN3P!USGTJE'K>FRQS2+=*%A"%]ZE2 W"
MG!&3NQQCKVH T**Y?6?%'EV>GW.CW%O,DFK6]A<AT)9 \@5EQD%'&>X_"MF7
M6]-AOX[*2\C2XD?RD4]"^,[,]-V.=N<X[4 7Z*S)/$.DQW+6[7L?F@2$* 3N
MV??"X'S%>X&2/2L^P\46FLQ:%=65_!;QZ@S,MO/&?-G7RRV$Y&".&)P1@$4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MU*+6M1THV\9E, CE6,, !LE8 [ILDL0.>.F*N77A[5FTKPQ=6"BVU6QA6SN
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MO.MS#+ ^UTD7."#]"1@^M9L/@G3+=XFBGO1Y6H-J*!I]_P"^8,"?F!X^9O\
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M4EVAO;3['<I#.466,%BN1ZC>V/KSF@"K=^*I;;Q6FCS&&S$LD0M3<POMNU8
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M2YAO);Q)E=0P>7F09V\JQ/*].GH*U-:T>WU[2I=.NWE6"4J7\I@&."&'.#W
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M=?C!TB]&@7]@T)&FV'F;)F8E_,C"%AO4H-V.J<T >@27-O%*D4D\:2/]Q&<
MM]!WJOI^K6.J-<BRN8Y_LTIAD*,#AQC(_#./J#7!W&G7NG:A9'3+>ZE6,6,,
MVFW\#2JZ(RE9$G'"O'DELDCY>>N3N^"K8V4VOV\EE+;R'5;B4,T!17C9LH5;
M&&&/3..^* .G:ZMTD6-YXE=FV!2X!+8SC'KBAKF!)T@>:-9G&4C+ ,P]AWKR
M?5-%LM4E\>V-OIOF:L]_%]@ECMSF*4V\)5ED PF&^9CD<=:U)+-Y_$.HZ7K=
MEJ\\TFH17=C<6T'[EU54V'S@O[LH5(()''3.[! .^NKP)!.+9[>2[2-VCBDE
M"@L!T8\D#)&3@XS3A>1QV\#W4L$+RA1CS1M+$=%)QFO.8O#]H_A?QP[:$QO)
M)[X6I>P;S'1T&WR\KD@L/X>,\U;M('BU*4:UIUU<:;>:%;V]N/LKOY;*&\V)
ME RK-N4\@9VCTH [G4KY-/L99V:'>JDQI++Y8=L9"YP>OT-4M+UF74_!]EKB
M6RK+<V*78@,G +(&V[L>^,X_"N%TNTU726M[3Q-9W=\)O#T5I%(ENUPJ3#?Y
ML;;0<,P,?S'@[.O%=;X2@G3X:Z/:R0317$>EQ0O%+&4=76(*00<'J* -#P[K
M<6O:%I]_^[CFNK2*Y>W60,8]ZAL'OWZXK0CN8)I)(XIHW>,X=58$J?<=J\MT
M3PY,VG>%7TC3Y-.U>QTV2&_N'MF@.XV^P(Q(&\^;M8=<;2>XSL^"8(+FZL+J
M73=7M=5LK+[)<_:H/)C3IE0P4"7+#(()P,G(SR =U-<06X4SS1Q!CM4NP7)]
M!FH)[F:*^MT"V_V5TD:61YMKJ1C&U<?,.3DY&,#KFN*\:3"W\3*7AN;B.YTB
M>TD1;.6X2,.ZX;$2L03@Y! ! '/%1Z7I]C%KG@O^R[>6>QMM,NK62Z%FR G]
MT )/E&UBRR$AL'.?6@#OUNK=E0K/$0YPI#CYCZ#UH2ZMY)9(DGB:2+_6*'!*
M?4=JXSP[H=_83WFCF 16&DS2R:7,P^5O.!*8_P"N>Z1/H1Z5A:38Q7VB(M]I
M&LC6=/TN:TN%GM2(R63# ,%Q/N=0PP6/?@]0#U".Y@F<I%/'(P4,0K@D ]#]
M#5>?5K&VU.VTV6YC6\N59XHBPW,JX!/YD#\:X7PMIIL-=\*21:9/;?\ %//!
M>2?9'0>;F A9#M^]\LG7W]:V?$%K+_PGGA^\2TDD06EY!YZ0&18I6,)CW$ [
M1\K')P.#0!U*7,$D[P)-&TR#+QA@67ZCM4M>::-I]]/I_@Z#['<VVM:7=G^T
M9I(67Y-CB8ER,.)&VD8)R2#V./2Z "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BO,?$FKZGJ
M7ASQ8EW%$L>G:M!!;F"8[L9MVQC SG>3DGOC&!FNC/C)[:75;;4-.6&[LI[:
M*..&8RK-YYQ'SL!!SG( .,<9H ZNBL?0]8NM3EOH;O2YK)[60*CLK^7.I7(9
M"RJ3CD$8X([UQ;-&GB[QNDNG:I?10"V:*.QD(:,F#)"88%23S\O>@#TRBN!T
M'Q5?VW@+0[N9[?5)I;.1YKUKCRT+ITCSM+&0],;>J,3[WE\:7EY-8Q:9H\<S
M7ND#5(C-=^6 ,I\C81L'Y^HSSZ=0 =A17F\GBBUD\5^'-=563^T]!E:WMGDP
M9)7DMRD8[9RQ&?J>E=Y();C2)%O(DCD>)A)'%*6 XZ!L*3^0H N45YSX+\2Z
MC9^'O".G76E+Y.HZ<B6=V;K)>98=^V1=OR!@K$$%NG(!XKH=&\52ZQ:Z:RV"
M175Q--%=6QGRUKY1(<D[>2&VC''WQSB@#I:*Y_6_$%]IVMV&DV.EQWD]]#-+
M&TESY2J8]N0WRL<'>.1GZ5RS>()]=UWPGJ5K8-%?"2_MIK.:XVK'+&I5E9@#
MD @\A2<=J /2:*Y33?&9U6WTJ.WL574;\7!-O)/A(A _ER$N%)(WX ^7G/;%
M5X/'4]W<:?:6ND*UW<W5S931R76T03P*2P)VG<IP"& S@],\4 =G17(V?C8W
MMA8%-/*ZC=-<J;;>[K&8)/+D.Y$)(W%<';W[5O:'J4VKZ-;WUQ87%A-(#OMK
MA2'C()!'(&1QD' R"#0!H45R/C">].M>&=/B@MYK2\O9%GBFE*K*%MY6"L-I
M^7(#=^5''>F6&OQ:-JFG>'4T[[/;27$UI!ONS)*@1&=692#A&"MMRV<8X] #
ML:*YJS\3W=]:VNHP:-)-I5U;RSQSQ3!I JC*;HR!]\=,$X. ?;)O_%]MJG@?
M4M4:PL]0T^.*-FC@OC\Q9OF1OD!1E^7(([T =W5#5M(M]9MH[>YDNDC202?Z
M/</"6P"-I*$$J03D=*Y_6/&5[IMQX@C@T>.=-%M8KN5VN]GF1,'8[1L/S 1G
M Z'U'>0^)YY;K4-/NM)10--^WP 76?.B)*E7^4;&Z=-PYZT =2B)'&L<:A44
M *JC  '84ZO/;>]M?[9\$:E'$;2TDT*YF,/F%Q'&$@8#/?:"1G&:WM'\3W6J
M:C:Q-HUS%9W=L;B*Z"N53H0DFY  2#D8+#@CT) .DHK"O?$$ZZG?Z=IEBEY<
MV%LEQ.KS^4/GW;$7Y3EB$8\X XYYXR[7QO<:M>V$.BZ2MU%>Z>FH))+=>5M0
MN%8$;3\PR>_..U '8T5DZSK8TN>SM8X#/=W9?RTPV J#+,=JL<<J.!WKF)-2
MFU7Q%X+OKFPN=.G:>\CEMIMPV[87&>0,@XR#@<$=* .]HKCX/'0DCM[Y]*N1
MHT]I+=B^1)"(D1-X,@*!1N7IACSQWI=7\3:W:>'=3U&/1HHEATI[^"=KG>@8
M#/EN-H(8#GC(/(R.M '7T5R*>)M8&I66DQZ/!<74U@MXTGVW:NW>J-UCZX;/
M3V]Z<GC96M=.U+[$#I&H7OV.*X$V7#%RB.R;<!688^]D;@2.N #K*JZE80ZK
MIEUI]P7$%S$T4NPX)5A@C/;()%<M;^-[N6>W,VC)':2:M)I+RB[W.LBLRA@N
MSE25[D$9Z&GV/B.WMI]3CBTQ8;R77#8*GGDK/-Y*/YA)'RC8#P ?N]R: .JL
M[9+*SAM8V=DA01J7.3@# S4U4=,N[V[@F-]IYLYHIGC"^:)%D4='4X'!'J 1
MS7+P^.;^6*QG.A1B"ZU*;3,B]RRS(TB@XV8*$Q\G((ST..0#MJ*Y6V\6W4UC
M</+ID45S:ZB;"Y'VO]S%A0_F&0J#MPRC[N<L![U43Q1;ZO:>&KZ;2@WVK59+
M5?\ 2#_H\T8F7>/E&\$1OUQ]X<4 =K17*^"1MF\3("Q5=;F RQ.!Y<?K754
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MB2?[,TD2E_*VAB, 9VMW'3\[-OX/AM+S2KFWNW#V$EQ,V] 3/)/DR,V,=R2
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MSG SUZ4$!E*L 0>"#WH \<N+K3H!KRV.I^3"?%.GE7@NRN8V6W#8(/*XW>P
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MY:M(YCB35;%I) VWRT%PF6W?PX'.>U<M>W-QH#:W)IUY<OX:2\LC),TDEPL
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M&U.C75Z]]L:)C/&SMN>,'.W:6R<D9 )'H1FV7@W6[;4M.OI=3L9+BT-T'N#
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M8;M;R%C'.))#*6 4Y4AV8@9/!Q[UH7/A[4I=>CU(W-O*5TJ6Q8N"I9W96WX
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M51HK@!-[J1M!7(S@J1@XZUNGPS=3:_?:[)'96][/I[6*QPLQ5\L#OD;:"2,
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MN+(<,2#A&(.,''7/%9UMX/UF'6M/U&:_L9Y+.^N)S*\+>;/'(K@*S9X*A@H
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MW,=GI/\ 9SJI;+'<AWCCI\G3WZ\<@&WJ.IP::MN)%>26YE$,$,8&Z1\%L#)
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M$\=K;27$I(CC4NQ52Q '7@<G\*X#5-?U1])\7:G;7<EO>:'=F.WM< HZ(B,
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M8PHQ*J.@&2,>@YYR: /3**\[T34=5U+58]-&L7 COM!6[CN6";S+O $RI@A
MP;.S)& . <U/I&M:MJ^C3%+S[+J.DV,T%ZT^/+^VC*@MQ]T;"_'\,BT =[5>
M]O;;3K1[J[E$4*D L><DG   Y))(  Y)(%<YX6UI[B:_M=36[LKVV:)9;2]D
M5PA<':8Y!PZL0<=\@C X%7O%FFVNKZ*ME<WLMB\EQ$;:ZB(W13A@T9&>#\P'
M!Z]* +UAK-CJ5Q/;VTC^? JM+%+"\3H&SM)5P#@[6Q]*OUY=J.N^)-)TOQ/8
MZH8!K=AI'VRVU:Q7"SQJ7"[T.0K!MW'(.3CI5OQ7KVIV<_B9;'5)(A:^'4OH
M0@1O+FW2@D9!ZA5X_+% 'HU4EU:S;67T@2-]M2 7#1F-@/+)V@AL8//'!KA-
M:\1:MX8N->(OY;Q8]'@O8_/12()'E>-F 4#Y  &P<_=Z\FFZK,-%\6:K>#6I
M4"^&Q(EW,@G\MO-(#A1C=DX..F?04 >E45YZD_B#4'\5Z58W\]O>6<=O-8B1
MTD=&9"Q1S@C#%1GKC=P>E68M<U'Q!H-SK6AS%$:.WAM[:X<1AI=ZF5=Q!PYW
M>4#V=30!W-%8'A+5/[4TVY=A>QS073PS6]Z!YMNX"G82.&&""&YR".]<WI&N
M7]WX@T9(]5EGLM4MKUO/*HOF%'3RW2/!V !BHR?F[C- 'H=4I]6L[;5;33)9
M&6[NU=H$\MB&"#+?-C QD<9[UYSH_B+6[;3/#&JW&HW&H/J&E7,]Q;.J!7>.
M,.I7:H().1U.<_2KEA-)?^(? 6JR:A)=/>V5S-)R-F]HD)V@#Y0,D8]AGG)H
M ]'HKD_$<FH2^+]"TNVU:YLK6]M[HS"!8]Q*",J5+*<'YCZ_3/-8GAW6]:FU
M;0[*_P!0>5'DU.UEEVJHN1!(%CDX'!QNZ<'% '=3ZM9VVJVFF2R,MW=J[PIY
M;88(,M\V,<9'&<\T7FK6>GW=C:W,C)-?2F&W'EL0[A2V,@8'"D\XZ5YQI\][
MXAE\$RSZG.EQ,NI*UW"$\PA6VC&5*C@ 9Q^O-3V]YJ%W_P (LFI7!NI;7Q-<
MVJ714*;A(XKA5<@<9XP<=Q0!Z+:WL-X9Q#YG[B5H7WQLGS#&<9 R.>HX/K5@
MG )]*\ZB\27\,QM+S4'$,_B673FNF"J8HA$71 0  68!<XS\Q[X-=GHL<T%M
M/!-J9U!H[APLA0*R*3E8R1]XJ"!N[]^: )M+U6SUFQ%Y82F2 R/'N9&0[D8H
MPPP!&&4C\*N5Y;X?N+[3H-#N(+^807?B.^LY;4A?+*-+<MGINW;D!SGVJ[:^
M(=6N="T7Q!%<R&XNM7%G<V) V"-IFC*8QD,@ ;/7Y3G@\ '81^(M-FMKFXBD
MFD2VNQ9R[;>0LLN5&-NW.,NO.,=\U8U75K/1-/>^OY&BMD*AG$;/@DX'"@GJ
M0*\_>]O-.T;Q)=65T]O*OBJ*,E0IW(\ENC*<@\$,>F#4?BK49M;\,^+GENY8
M3INHQVJ6RD "-6B.6&.=Y8G/IC'0Y /4:*\^U;7KZ'75DL]2>2%-=MK"12%2
M.-75 \6.2[?,6+\8R ,X(JQ;7^IQ:_>>%[B_N7NWNTN[6Y(7/V$_,PX&.&1H
MR>OSH>] ';2R+#$TC!BJC)VJ6/X <FB&:*X@2:&19(I%#(Z'(8'H0:X[2]8U
M!/%RV&JFY7[1+<_9)XF62UN45B0O',<B*,$'@X8Y/%3^";HJ-?M9'"PV^N7$
M-L&.."%D*CZ,[\>WM0!UM%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !16;K$.KW$21:1=
MVUFYR7GF@,V,=%"[EZ^N>,=.<B#PIJEWK/AFRO[^&.*ZE5A(L6=A*L5W+GG:
MV-P]B* -FBN?TS5=1NM:\1V4@MY/L$D2VH52F[?$'PQ)/.3C/Z57TF]U^W\6
M2Z/JMQ:7L$EE]KCGM[<PF%MX4QL"S9!SD'.?E:@#3E\,Z#/=2W4VBZ?)<38\
MV5[9"SXZ9.,FI9-"TF:"V@?3;0Q6J[($\I0(EQ@JOH,<8'%<YJ>H^(K'Q'H.
MFG4+/;JLUPK8M"?*5(V=0#OY/ !-))XDOM#\4)9:Y>1/:C3)+EOLUHY8LLP4
M,%7<WW#D@<#GZT =0^D::]Q'<-86QGBB,,<AB7<B'JH..![56?PSH4EK;6SZ
M/8&"U8M;Q_9UVQ$]=HQQGOBBY\2:3:64=Y)=%K=X/M(>&)Y?W6,^8=H.%QW/
M%:4,T=Q!'-#(LD4BAT=3D,I&00>XH H#P]HRVD%HNE6:P0.7AC6%0(V/4K@<
M$Y.3WS4IT?3#+;RG3[7S+9#' WE+F)3U53CY1["N;NM=U!/'=[HQU.SM+2+3
MHKR-YX@3N9W4@DL,@; ?7GK4_ASQ@FH>';2_U15AGN+B6WA%O&[BZV%L/$HR
MQ4JI;O@=^] '0V6GV>G6HM;&UAMK<$D10QA%!/)X''-48?"OAZW"B'0].C"J
MZKMMD& _WATZ''-1-XOT)8K&07V\7T;26HCA=VE"_> 4*3D?W>OM5"?Q-]IU
MGPQ)IEY%)I6IFX\P^7@L$B9AR>5P1R,9XYH W(M#TF"2WDBTRTC>WC,,++"H
M,:'JJ\<+[#BH;+PSH6FSQSV6CV-O-'N\MXK=59-W7! XSCM5RQOK?4K-+NU9
MVAD&49HV3</4!@#CWJI?W\=OK6DV9U 6\ER\FVW,);[2%C8XW?P8QN]\8[T
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M\MDA,\@6-G\N,'!=MH.U<]S@<'T- $5[X7TF]T\V36-NL+2)(W[H$Y7H0>Q
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MJQC;9YI&0F_&T,?0G-1Z;XGT?6+U[2PNFFF3S-P$+@ HVQP6( R"1QG/.>E
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%*HEW$Y8ON4D]!G&!W;HNCW5I9^$?^)5<0S6NLW<UR1;D&.-Q<!2QQT.^/\
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M\^7R,@8SG)YDN--.K>$M6<>%]5M=8&AS:?BY=G!<K\L<8W$,NX9#8 ''/)H
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M+@UJMTVERW5U)<6U[!_QZN2Q\R&7 RLC'.S)QO[8KN* "BBB@ HHHH ****
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M)RV>>, 9QVJ:"_:[\7V%EJ.B6T%U<:+)/([2"22/]Y$'AR!@KEASGG'2@#J
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MFZ,^6_F&3:,I]W<Q/.3VS5R3Q+;?VIHUI;QM<0ZJ)3%<HPV (A;ZG...U;=
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MCU^7VI+RVL_L&LW8+"[A\4P^1*)6#QQM)"'*G.0I7S,D=@?3CU^B@#RB^?\
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M&H(/N""*\]\+:5Y>G>#Y]$5H]<@B>+4P7;Y(Q"XV3*3QB3R]H/3G' ->OT4
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M>!GI@CH*NBZL;SPK>ZCX8M]0&J)IR17<42.C#:ZEU8$#=/CS,'EO?D9]0HH
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MT'[P+W&"!TIMG<PK'XA2V*K:7/AB-XUAA=8S(!,IY(^=^54MP2<# /%>O44
M<!H\L9\6^%"'! \.2H>>C%H,#Z_*W'^R?2N_HHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
MY8^-HEN-4\S2KR.STN9X;NZ9H]J%8UD&!NR=VX 8[D9QFH;KQ_:V,.H//I]R
MYLUBD)MW25'21]@(8'&0?O+U&1C(J8^#O/LO$MG>7V^#6YS-F&(QO 3&B#!+
M')'EJ>@YK%\6V&N6WP_U!-6UB+4+HF".$P6GE XE0EF7<VYL#)Q@  X Y- &
MW%XSS=:C97&BZC!J%FD<JVN$D>>.1MBNI1B,;@0W/RX-1R>.K:+3KV[-E(Z6
M%^EC=M%*K)$6V$2;L\H/,7)ZCGCBFZIX2N-:%[>-J<45]=0001R10DQ+%')Y
MA5EW98.20W(^7 ]<P2Z7;^'K36O[:G:_M==G"&VM-/<G>85C* *6PI$?&<8S
MR30!U-M?_:=0O;586"VI16ER,,S*&V@=<@%3_P "%<)XJ\0ZC=:'XR@$<MF-
M)DBCAG@G*N25C?G:0>0_3ICBNP\+Z3)HOARRLKB5YKI(P;B5VW,\AY8D]^>/
MH!6-JW@JZU$>(XHM5B@@UIHG96M2[1.B(A.=XR"(QQ@8)/)H M_\)E;02ZK%
M?V<]E+I_D$I(R'S%F8K%@AL E@5P2,>N*N:)XABUFZO[40-%-9L@=@P>.0,,
MAD<<'H01U!'TK*U7P5+JUYK%Q+JGE'4+>UCC,,&&MY;=VD20$L<_,V<8[#FM
MO1K35;:!CK&I0WMRV #!;^3&H'^R68Y.>3GTP!B@#C9-1CA\;^*K>_GUF6VM
MH;62WBM9+DK&71R_,9PN2!]X@#!]ZWK_ ,2Q^&HH[:[@NYX;;[-;R7DI ,K2
M$("N?]80<%L=,]^E6=.\/SV/BK6=9>]BECU)(4\@6Y4Q^4& ^;<<YW'/ K+U
M[P7?:Q>:I+'J\445Z+<HLMH9&@,+JVU6WCY&*Y*XZD\T :S^) ;MTM=/NKNW
MAO%LIYH &\N0XR=O4JNX;CVYZX-<QKVJ+-X:UZ:Q;4;2XM-<MX)#)<MG<9+<
M-MPQ C*OC;TY/&:V[+PQJ>FZU>36FM*FF7UP+JXMFMLR"4@!]DF[Y5;&2"I(
MYP1G(KW7@JZN=,UJS&JPK_:>IQZAO^R$^5L,1V8\SYL^4O/'4\4 0:]XG_L=
M?%UU96=T]_IMI!(PGG_<L&#[61<G&,'/ )X^M:%QKUG9>(W.H0W=K)!I$MY*
MYFW0")77=\H/+CUQG'&:AU3P9+JC^)?-U)$36[.*V 6W.82@8!L[_F^^>,#I
MUJ2]\(S:MJ$ESJ>H12Q3Z3+IEQ%#;E-PD()96+G;TX&#]: &/X]L;<WGVJWD
MB6WM5NA(KJ\90N$PS X5@2,@\ '.2 :Z#3;Y[^!Y&@\H*^U65PZ2KM!#HPZJ
M<_H:Q+'0O$,6EO:7WB"WNY$18H7-CA64,"3*N\[R0-O&T8)]:N>&O#D/ANWO
M(;<HD5S<FX6WA4K%!E5!5%). 2I;TRQX% &1%XLM-/AO9DT_4Y"^N#3W1Y5<
MK*VP97+X5.1@#\ADUN:'K@UG[?&]I+:7-C<FVGAE96(;:K@@J2""KJ:Q'\%7
M;I.HU:$>;K::N#]D/&TJ?+_UG/W!\WZ5LZ/HLNEZGK5Y)=I,-2NEN BPE/*Q
M&D>,[CNX0'H.IH Y?5-3NI_$/B3[7'?+9Z+:V]U%]DN_*88\QV. <-N"@8/&
M!CC-;[>((;^Y&F+#<1O<Z6;^.57VX3(&,@Y# L.GYTR7PM)<:EXBN)KY#;ZS
M:):M$D!#1!5=<[MQR?G/8=*J:=X3U2VO[:]N=7M99(-+;30J6952,J0_^L)S
M\HR,X/;% &/X>O;R8?#B22\N7:ZTN1K@-,Q$S"%"&89PQR3R>>:[74-82SO[
M33HHC/?72R21Q!@H")C<S'L,LHZ'EA[D8NF>#KC3O^$6']IQ2+H5L]OC[*09
MPR*F?O\ R\*/6M'5M"EO-;TW6;*Y6"]LEDBQ)&726*3&Y2 00<JI!SVZ'- &
M='X[M[F33X;73+V:YO);BW,.8U,,T(.]');@\=1D8YST%;.@ZU'KVBQ:C#!)
M#N:2-H9,;D='9&7(./O*>:QK;P8UIJ>FWT5_&)+:ZNKRX#6Y/GR3@AL?/\@&
M< <\ <]ZU/#6BRZ!I!L9;I+DFXGG$BQ&/_62-(1C<W0L1G- '&R>)=3U.U\,
M:F]M/!))KUQ:FWM[CB9%%RH4C(!P8UY;N,\5T<'C6TFL8Y)(&M[M[N6R-M/*
MJ[98\[LOG&W SD9ZCBJEMX*N[9=-A&K0FWT_59M1B4VAW$2&4E"=_4><WS8[
M#CKEC^![^,&YL];CAU*/4YM0MYOLF442C#Q.F_YE(/4$'@&@#H=#UN'7-*^W
MI#+;A7>.2.8 %60D'D<$<9!'!!!KF+K7IM5\2^#+NS2ZBTV]N9RD@FPL\8MY
M2I9 >^ RYSP.<'BNNM+2==.,&HW(NYI ?.=4\M3GC"KD[1CC&2?<FN6T[P3J
M5A_8$#:W#+::',YM0;0B1HC&\85VWXR%? ( Z#B@"]!XR2>]^Q_V=/%<RV4M
M[!#*P5RL;!2'7K&3N4C(/!]1BJVF>-C/X=T>ZNK>-=0O[$7@A,ZHI7:I)#$\
M9+  ?RP34>D>![[3[O3)KC68K@6=M<6KE;0J\ZRE"79BY_>909;'.>@ZTVU\
M$ZMIMIHC:=KT$>H:7:FQ\R2R+13V_P N%=/,SN!0'<&'.>,&@#H(?$5I-X4/
MB+RKA+06K731O'B55522I7^\,$8K.N?&<=KI\%ZVGS7$%Q<06\,MI*DJ2>:V
MU2K9&0#P??VYK;>TNO['DM4OC]L:%E%T\8;#D'YMN0, G.W/3BO/_$'AE=!M
M%GM'MH)+[6M/F,%O 5@B:.4%I-F[C/5L$<*/J0#HH/'5H?ML%]93V&H6EQ';
MM:SNGS&0$QL'!*[2 QSGC:?QEL_&5O>E;>.TE%^UV]HD!8;794WEU?H8]O.[
MKGC&>*K:CX+DU(WE^-2^S:Q-<07$%U%%E(3""$7:3\PPSYR1G>>E/OO#&L7\
M6GWKZY"FNV,YFBN%M#Y&UEV-&8M^=I'?=G/.>@ !(VO176I>'5NM.U2TN+JY
MN(XT=_+5'2.3/F*&^=2%)4X(Z'BN8O=1>[T[Q-J^L1ZND.E7\D:KI]^8B(Q&
M@V8# $98L3USTZ8KK9_#U]=7^A7MQJB23Z;<27$O^C'$Q>-HR%&_Y  YQ][H
M,YY)HW/@JZN= \1Z6VK0C^V;EY_-%H?W.X*",>9\W"]<CK0!;UCQG9:1-=1^
M2]Q]C:-;E8G7S%W@'Y4SE\*RL<=CQD\5D>-O$$MQX=U Z6MR$L[^WMY;N&?R
M]K^;'N4 '++AMK>YZ'!QIR>&M6A\076HZ=K:6T&HB,WT#6N\ET4)OB;<-A*J
MHY##@'FJ-]X%OIK?6+&SUB&'3M2O%OC'+:F1XI=Z.VU@X!4E,X(XR>: +WCZ
MXFM-!M+BWDN$D34[(8@D*EU:X164X(!!!(P>.:@F\>I:6FJO>:->V]QI31-=
M6[-&2L,F=LP8,05X.<'(VGTK9\0Z*^NZ0MHMRL$T<\%PDICW+OBD6097(."5
MQU[]:S[JVLM&_M'5M<+W4FIK%:2K;VDDB^6 P6,(NYL$N^2?[W;B@#:M]0%Q
MJ=Q9I$2L$:.TP8%2S9^7Z@ $^S+ZUQ7BSQ!J,^F>.;*.*2U32M/#P7,,Y5]Y
MC9PV5((Z#CVYZXKI?!^C-H7AFTLY7E>?:&E:9MSYP JL1U*J%3/^S6?K'@VY
MU.3Q&(=4C@@URT6WD5K8NT;!"FX'>,C!Z8Z]^U $L7C&WM6O8-2M+BS:RLXK
ML-(R-YT;DJ",'@[E(P<=15[1_$<6K:C>6/V=HYK94?>KB2.16SC:XXR""".W
M'4'-9>I^"7U>[O9;K4@J76F1V&(8"K1LCEUD#%SR&.<8[#FMC1++6+6(G6M5
MBOYL!%:"V\A<#N5W-ECW.0/0#G(!RMY>I%\1=8M+RZU@V<>F03QQ6;7#['9Y
M Q"Q9QD*O!XX^M6/"7B>^G\':;=W@:_GN9ID6?<H6.-"Y4SNORHVU0#_ +1
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MMY#=QN\7F+NC;."H*D@].HH Y:W\2S:%KGBB2ZM[ZYL8=2MHV?S@RVJR0P]
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M,= .X!T6GW-Q=V:S7-C+92EF!@E=690"0#E21R #U[U:JKY5[_::2FZB^Q"
MJT'E?,9,C#[L\#&1MQWZU:H **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M[%_NC\J-B_W1^5 'FGB'PI?7WBG3?$FCW\-KJ%G&T#I<1%XY8CDX."",9/\
MD57\5^";GQ59?9+VYLY08E"S/ 5DMY=Q+/'@]""!L)_A&2>_J>Q?[H_*C8O]
MT?E0!YK:^$)['QT_B&WU!3%-9):30RQEG.W;@ALCKM&<@]_PZNM_8O\ ='Y4
M;%_NC\J ,"BM_8O]T?E1L7^Z/RH P**W]B_W1^5&Q?[H_*@# HK?V+_='Y4;
M%_NC\J ,"BM_8O\ ='Y4;%_NC\J ,"BM_8O]T?E1L7^Z/RH P**W]B_W1^5&
MQ?[H_*@# HK?V+_='Y4;%_NC\J ,"BM_8O\ ='Y4;%_NC\J ,"BM_8O]T?E1
ML7^Z/RH P**W]B_W1^5&Q?[H_*@# HK?V+_='Y4;%_NC\J ,"BM_8O\ ='Y4
M;%_NC\J ,"BM_8O]T?E1L7^Z/RH P**W]B_W1^5&Q?[H_*@# HK?V+_='Y4;
M%_NC\J ,"BM_8O\ ='Y4;%_NC\J ,"BM_8O]T?E1L7^Z/RH P**W]B_W1^5&
MQ?[H_*@# HK?V+_='Y4;%_NC\J ,"BM_8O\ ='Y4;%_NC\J ,"BM_8O]T?E1
ML7^Z/RH P**W]B_W1^5&Q?[H_*@# HK?V+_='Y4;%_NC\J ,"BM_8O\ ='Y4
M;%_NC\J ,"BM_8O]T?E1L7^Z/RH P**W]B_W1^5&Q?[H_*@# HK?V+_='Y4;
M%_NC\J ,"BM_8O\ ='Y4;%_NC\J ,"BM_8O]T?E1L7^Z/RH P**W]B_W1^5&
MQ?[H_*@# HK?V+_='Y4;%_NC\J ,"BM_8O\ ='Y4;%_NC\J ,"BM_8O]T?E1
ML7^Z/RH P**W]B_W1^5&Q?[H_*@# HK?V+_='Y4;%_NC\J ,"BM_8O\ ='Y4
M;%_NC\J ,"BM_8O]T?E1L7^Z/RH P**W]B_W1^5&Q?[H_*@# HK?V+_='Y4;
M%_NC\J ,"BM_8O\ ='Y4;%_NC\J ,"BM_8O]T?E1L7^Z/RH P**W]B_W1^5&
MQ?[H_*@# HK?V+_='Y4;%_NC\J ,"MRW_P"/:+_<'\J?L7^Z/RI: "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MD(#*58 @C!![T 9NF^(=)U>ZN+;3[^*>>W ,B*3D ]&&>JG!Y&15F\U*RT]K
M=;RZBA:XE6&%7;!D<G 4#N:YZ-;RV^)I-S#;2V]UIC"VGB4J\"Q2+N1\D@AC
M*"",?=QBG^-2&M-#8$$'6K(@C_KH* .HHHHH @N[RVL+5[F[F2&!,;I'. ,G
M _4BHM4U2RT73I;_ %";R;6(9>3:6VCZ $USOC"S7Q$3X>>SN+JT:!I;M8&0
M%2P*Q9WLH^]N?CH8U]:YZ^U>YU;X(:LNH C5+&%[&^4G)$T;!23_ +PPW_ J
M /0X]4LI=6FTM)LWL$2S21;2,(Q(!SC!R0?RJY7*V_\ R5;4?^P);?\ H^>L
MSQ5X@U&PN]0ET_4&86,]BCPK&@CB\R10RN6R79E<$;<;1CD'J =[17FVNZSK
MMJ/%]S;ZS,@T>[MS;1>3$597CB=D?Y<E?G;H0?<U)J_B/5O#=SXEA:_DNTMH
M+&:&6>- ;<SRO$Y^50"JA0PSGH<F@#T6BO.O%.MZWH+>(;6UU":1(-$.I6]P
M\<9>"56*E3\N"K8SR,\-SCI/XDU[5;*[\31VFHO&MIX=74( (XV\N;,N3RIR
M"$7@Y]L4 =]0"" 0<@UYMJVH:Q!#KUF^L7,BOX:;48W"1HT,HW@A"J@A3@=<
MD8ZU)?:OJ6@Z7I\LES>-I*:="TUW;+$\EJYS\\L>W)BV@#*\C:V>Q !Z+16)
MXDOI+2/3HH+MX);J\6()%&K23C:S%$+<*<+DL>@![D5RVC>)]3OVT'2KN[,<
MUY=ZC%+<J$WLMM(RJ@XVY(P20.0AQC/ !W&G:I9ZM;O/8S>;&DKPL=I7#H=K
M#! Z$$5<KR[3[K4=#\,76J0W\QM[#Q'=G41Y:$S6YN&5V/R\%<A_EQP#^'17
M&I7CG3C'J<P_M.[D>WMXHTWR0+&Q4(Q "CA9"6R<':.U '7T5YOI.MZYK$7A
M!)-7D@.HQ7BW;PQ1$N8N%894@'\,>U2Z!XDU'5!H&EWFH/#+>0WQ>[1$5YW@
MF$:J,C:"5)<X'\/89H ]#JO?WUMIEA/?7DGE6T"&263:3M4<DX'-<6^HZ[=:
MA_PCL&M6YU"+2UN%O5"Q">7S)$9MA1P0I1<@8^_],4-6U:_UO0O%UC/J"Q/I
MNC(S"T"E)WDMV=G^8$E#]T=.A[XP >AB^MF2U<2?+=D" X/SY4O^'R@GGTJ-
MM4LEU=-*,V+Z2%KA8MIYC4@$YQC@LO?/-<I<ZK)IWAV75XH?/_L71?-1.S3-
M&&P?3"JOX2&J,HND\8:;=KJTUQ)+X;NY4FVQX5M\!W* N,'(X.1Q0!Z+17GV
ME7^KR:'X9N+G7[F>ZUF&*4VR01*S?Z.68(V %&2K,6STP,9Q4%GXFU6/P]X8
MU[4=29;&:26TU(I&F,DNL4N=O'S*H., [AQVH ](HKA/"VK:SJT9TV^OKB'4
M]-DF&H-Y<6XYY@R-N!E6#<#JA'-5?"NMZU<2^#KB]U62Z76=/EDN(7BC5%=%
M1@R[5!!Y.<DCGH* /1:*YN\O[R/Q[:::MX\=E<:5<SLFU/ED22)0P)&<X=N.
MGM7-:)K&N:VO@^.36IX?[4TBXGNGBABW&1#%AERA /SGL1[=Z /2&8*I8] ,
MFJNFZE9ZQI\=]83":VEW;) I&<$J>" >H-</X;\3:EKK>']-NKUH);G2YKN:
MXB1%:=TD6, 9! ZEB /3MD'/\)ZE?+HWA_0+>[$#W-O?3"<NL;2NEQC"DHPR
M Q8C'IV!! /4Z"0.IK@;6;Q'>>(M.TFY\0B-_P"RFGN)+*&,H\T<RH2N],@$
M9!'UQBM'Q>)VU_PBD5[<6Z2:DZN(BN&_T:9@3D'/3]?7! !T.GZI9:K'.]E-
MYJP3-!(=I7;(OWEY Z9JY7EUG=ZAID]U>VM_)'%)XN-K);!$*2))(J,22"V1
MG(P1TZ&MG3=5UO6;E=0M]0M;>"WU:6TNK65P1Y:R-&$V[,B0X1@=_.?0X !U
M.HZUI^E26\=[<>4]PVR$;&/F-C.T8!R< G'M4ECJ=GJ/G"UFWM"P612I4H2,
M@$$ ]#7*^/1,VJ^#A;O&DQUD;6D0LH_<2]0",_F*N:A<:E90Z9;W-_&NHWE[
M)&PLX 'N(P)&5%W$A,*%)))X! Y(H ZFJTU_;P7D-I([":9'>-0C$$)C=R!@
M?>'7KVKA= \3:CJJ^']-O;XP37T=^7N8P@>5H)O+5!E=N=I+' 'W>PS6G!?:
MK:^)?#6GSZNMZEQ:78NGCA5%FDB,8#X&2#\S @''M0!NVWB#3+RTL[JWN3)!
M>3-! ZQ/\SKN!!XX^XW)P./<5;O+ZWL+?S[ERL>](\JA<[F8*HP 3U(^E>=Z
M!?WECX<\)+:W+117>MW5M/&%4B1"]RW4C(Y0="*9!?:GIGA?5[V#5KEIU\2F
MWS*(VS&;Q8B.5[JV/; QB@#T^BN'_M76]5U'47L-0M;1=,U-;>6&9Q@Q#;D,
MNPMEP25(8<X]\RZ/K>H'Q7_9VK-<Q/,;AK4JJ/:W48<%2C@;E=5X*MUY/- '
M9U3L-4LM4-T+.;S3:SFWF^4C9( "5Y'HPZ<<US'BG6]0T?6!)(US'HPCB#W-
MHJ2&VD+G<9D(W>6PVC<O3!^M8(N]0TN;7M2L[^2)4\50PO;A$*2K)]FC;<2"
MW1^,$8([T >HUC_\)1HWV<S_ &T>4+P6!;RWXG+!0G3U(&>G/6N:G\0:BGB*
MQ-OJ#3V<VN/I\H\M%B"B)R8P/O%E9.6R!G(Y'3)N/^0#JG_8YP_^E4- 'H]_
MJEEIAMA>3>5]IG6WA^4G=(QPJ\#C/O5RN2\?H\ECHJ1R>4[:U9A7 !VG?UP>
M*Q)/$.M:-J-[HUSJ)NXEU2VM8=0N D;(LT3.48JFW(*JH.W_ ):"@#TBF32I
M!"\TAPB*68X)P!["LGP^NJ0P7L.JWD%W)'<MY31'+)&0&5'(506&>N!P16)X
M<U*^UW2-)UUM858KV&7S[ Q*5WX)"(1AE*;6!SG.#F@#J]/O[75-/M[^RE$M
MK<1B6*0 C<I&0<'FK->7^"[^^TO3O!43ZDS6%]HDCR0R1H(X3$D95E( ;HS9
MR3GVJ>S\0ZR[NG]IS21S>'7U&*=XHUW2JRXD1,':C!N%;)P!D YR >DT5P5M
M?:Y!I'AN[GU2YNX]6DA:[*0)YD*FW9L1JJY(+@$G!(&3P.0R'5O$%K'I-CJ-
MW(L^IWUS''+<;(6\I-QB7B,[7=0&P03P1QT !W[$*I8] ,FJNFZG9ZQ81WUA
M-YUM(6"N%*Y*L5/! /4$5R-AJ>LG7=.\-:EJD9G:WNKB2[M0NZ;9(JI'DKC<
M%?+84<J.@R*M_#F-_P#A +6,S,7\VZ4R@ '/VB3YL8QGOTQ0!UU5YKVW@O+:
MTD9A-<[O* 1B#M&3D@8''KC->;Q>+]4TV73_ .T]1F=-,OI;+76\J,* S$6\
MIPN0&RAXQP36^UYK%MKOABTGU"8#4$NFN8FCCRI";E&0O\.<>^.<T =+=:K9
M65W9VMQ.$FO9#%;KM)WN%+$9 P.%)Y]*N5Y+IL=U/X?\$%]1N'GFURX)FDVL
MR'R[K)'')ZGYL\^W%=QX-OKR]TV^COKEKJ6SU&YM%G=55G1)"%+;0!G&!P!T
MH VK2]M[Y96MV9A%*\+Y1EPZG!'(&>>XX-6"0.IQ7G']MZY):VRKJTBR-XHF
MTUI/)C): ,X QMQD;1R/QS5:[O-4NK2&TGU>Z=K3Q7'9"<"-7DC^5UW@+M)!
M;TQP,@T >H45PMOJNMZM>W4UEJ5M;QZ=JOV6>&9QAHE(7!41YW."&4AAR1QC
MBL]==UJRT35-9N=:DD2WU:730DL421QQF[6(2LP3.57//3IE3@Y /2J,@$#/
M6N(NYO%.GQ72I<PZAFYBDBMH9D^T^04;>BLR*I.5W+D9P&&>AJCIVHR:OXM\
M+W,6JW[0265^7CGC2-M\<T2E73;@,,E3C^[QC/(!Z!<7,-K&'F<*I8*.Y)/0
M =2?:H-/U2RU5;AK*;S1;S-;R_*5VR+C*\@=,BL&^GDF^)^CV,F1;PZ;<W:#
MLTN^.//U"NP_X&:Y5I]6TNS\2:UINI2(;7Q P^P^4C1W(9HE*DD;MQW<;2.>
MQH ]4K-GU[3+?48["6YQ<22B%0(V*B0KN"%@-H8KR 2"01ZUS-IJNMZQ?375
MIJ%K;0V6L/9W%O*XP8E?9MV[,AV&UE.[JP[<5D0:C=Z!;>*KR.]F=I/$<5HT
MDJH5A$BVR&4X4<A6X[<#B@#T^BO./%&N:YHG_"2V=MJ,K"UTV"_MKIXXRT+-
M(R&-OEP0=F1QGKSTQH7EQK,6O_\ ".0ZR[7$UG)>17$QCB<DOM"J!&00G7&,
MG<,DXH [>BN?NM1NK'P)-?WNI6D5Y%8EI+V.,R0B0+]]5ZL,\@=ZY^/6/$7G
M^([&W=Y;BT%C);173Q)(1(3YB;@-H9@IVYR 6'..  >@45@>%M4_MG2+A_.O
M5FCN)(9$NXE2:W< ?(P VDC((/(((ZUQR>+M5TV6Q&IZC*ZZ7?R6>N-Y<:KL
M=L6\IPN5#;HSQCC/I0!ZA5&36+&+4SIKSXO!;M<^5L8GRP0"V<8ZD<=>:Y67
M4=;EU.ST(7QM[RZL)+T/(R1N&+@",?NV!\L$9&,G@D]:-->[D\>Z.U]/;SW?
M_"/S":6WSY;N)H067/8F@#KM.U&TU;3H+^QF$UK.F^*0 @,OK@\U:KC? MPM
MI\)M*N6F2%8=.\PRR E4 !.X@=0.M9EGK?B![F]LX+SSII-$@N[5KP1Q[IF=
MDW#:,*&P,*V<<9[B@#T6BN<\):N^J0WZ7'VZ.[MK@)+:WR()+?**0NY.'4\L
M&YR&]JQ+;7]1D\4:0L6H-<V%]J%[;.WEHL96-)"H08W90QX+$X)S@$8P =8^
MOZ9'J<>G/=8N9)#$HV-MWA=Y3?C:&V\XSG%:5>23PW4/A+Q#(FJWH8>)EC)'
MEC(-S$ISA>X;ITXZ8R#T%QJ>N7]_K5MIVJ6]K+HUQ"G^DNH#Q^7&[/(HC)(;
M<XRI7&W@#!R =W5<WUN-16P+M]I:(S!=C8V @$[L8ZD<9S7->')-5U#Q!K;W
M.L3O:Z?J3V\=KY485D,,; ,0N>"Y(P1[YHUC4M1@\7RV4%[)';-H=Q=+&J(=
MLJ21@,"5)Z,>#D>U '6U3EU2R@U2WTR2;;>7*/)#'M/SJN-QSC'&1W[UPT?B
MS4[:VT"^DN&N1/X8GU*XMPB#S9HTA8$8&1G>XP./;BEMI+FY\5>"]1DU!KQ[
MO2[N;!"B,,R0M\NT9 YQ@D\ =\D@'HE%<'X>O?$>KSZ'/)=WD<$UE+)J7[A%
MC2;*A!$Q0[E.7QM)!"J<\_-G:+JWB"^M_!\TVO7!;61/%<@00@+M1W#I\G#?
M)CG(YZ4 >FT5YSIWB75IUTS29KT-//?:C:_:Y&6)Y?L\A5%R$*ABO/"\[#TJ
MQ%/XC;6M!T>\U\![BUO?M4UE'&=S1/&$8%DX8!R&XQD' '8 [[(&,GKTHKS/
M1]1U+6=0\"W=WJ4XDFM;QIQ&$5)'CVKN*XQD@G..F3C%>F4 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %-DC26-X
MY%#HX*LK#((/4&G44 9]EH>F:=:O;6EE%'"Z>6R@9RG/R\]N3QTYH?0]+DL;
M2R:RB-M9[#;Q8PL13[I7T(QP>U:%% !1110!6AT^TM[R>[A@5+BXQYT@ZOCI
MGZ52;PQHCI>HVF6Y2^;==*5XG/J_][\:KZCXKM-,OOL\]K=^6+J"T:X"*(Q)
M+C8!D@L/F7)4'&?8XJ2^.;.&XN4?3=1$-IJ":?<3[(]D4C[-K'Y\E29%' )'
M<"@#=BTJQAU W\=NHNS$(3-R6*#HI/<#D_B:JWOAC0M2N9KF]TFTN)IU5)7D
MB!+A3E<_2N<\;>(Y/[!OAI7VU6L[VWMY;NW955',L>Y>NXC#8.!U..QQU^I:
MA;Z3I=UJ-TQ6WM8FFD(&2%49/\J *DGAO1I8[N.33H&2[*FX0KQ*5P%W#O@
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MP.?,/^UG!SUX%8Y^(.E#S_W%TWEV+WZ;/+;S8D^]C#\, 0=K8./Q VM&U?\
MMFU-R+"[M(SM,9N54>:K*&#+ACQSCG!R#Q0!9OM/L]2M?LU[;QSPY#!9!G#
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M3RRD @$<@9SD  V3X;T4ZY_;1TNU_M/&/M7EC?TQG/KCC/7%/30-)2*\A%A
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M2,JP625I,-DG)!?'&.GO6C>:E9V%B][<W$:6Z=7W<9)P /4DD#'K5DD 9)
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% &%_PDJ2:_<Z1;0I+<6KQI,AF"R
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M@@D5B^+KAK?QMX5B:XU!+6Y^UK/#:2S#S-L8*Y6,Y.#[5NZ%IFKV$>-7UO\
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M^;L)4MDKG'1L8)]/K5.P\11:++J>G#3;Y;#2'9[R[N+I9! C1F;*Y.YE&0H
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M8%< )CD$$Y.>,#UKF_"$>G7-]>:KI\&J1-<11QS_ &VU^S#<N< 1[%RP!(+
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MR%QG9+NW8!P" ,9)S533_%.JSZ?X;N)7A+7^KW-A< 1X!2,W 4CG@_N5_,T
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MV Y,F>I.![Y&HFO>);IQH_E6\.MPZ<+J7R"CQM(9'0#YF&$S'\P&2-P&1CD
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M9(D+A@K-MW$8'7'4X[5U&@2ZK)IS+K*0+>1S.F8B/F3.49@"0K%2,C)&>G%
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MAL-36>:UFA+&X46T&Y0X8;3CIP>:O76LMH?B7Q;?I&"[?V7"N_HIE9HPQY'
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M'')<732V?VZ,6ML\HDAR!N4@8/45LV-[;ZC86]]:2"6VN(EEB<?Q*PR#^1H
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MKK,ETELFJ>7*)U.S(A,9)?(+!=X!)!P,UZO4(L[9;HW(MX1<$8,H0;R/KUH
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MV,="V!T6O1P !@# ]J6@#R[PS>VNJW5I+?:S+;Z[:B=-3LHPT<AR&#><=W"
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M3D#I@ !@# '84  # &!Z"@#R"]U2SN[2!M5N$37[7Q3#Y\4DFUXXA=#9A?\
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M .>M*!@8'2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M=RW$,.1"954%%SD+P!G'J:9X?T#^P1J(%VUP+Z\DO7W(%VNY^8#'\/''?W-
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M])DD%WN=9 Q4,%V#*DCG)!&>AING>+[]8]0?4+:%I#K$FG6D<#NV2HS@X3.
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M22.&)Y975(T4LSL<!0.I)["N:LO%<5SXHU:R:ZLCIUE907/VA6P4+M(&#DG
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M-NQ6D )W'"_F>!ZGI7F[>&=:T[08]&CTEY%DTF\B$MJT>Y))9&=8&9B"(U#
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MA-TH[QR( <8QDHO![;'C.PO]1\,3PZ8GFW<<L,Z0^9Y?G>7*LA3=VW!2,^]
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M)\IKN9/+VHCC(<9?) '8#/7BK&L>,;/1SJ9:VN+A-*CCDO&BV_NQ)G& Q&2
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M& %+=?N\UT% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%6X,@? SCY.4QGGK6X)!A Y578<+G^7K0!RFL>$+O49_$GD:A#%#KEBMJZO
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MQVMGI0#1F"73EAMCA9?+7<T( X;<HR5YR.:G\2Z9:7TGQ F&G^=+)IT#V3"
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M*+I&CG,'G1*P!(\U>Z'&">,$@Y&*W)KJWMY(HYIXHWF;9$KN 7;T /4_2IJ
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M-<A5DWOE0%SM '8#)Z>IK)?P5I$EIJUJWVGR-6E,UX@G(#N<9(_NYP,XQTH
MK6R@?%?4B  3HML3CO\ OIZO>(=4O;&>T@LI+9&F65B'C:61BJC:%0$9&3\S
M$@ 8]<BY#HMM#K3ZN'F:\DMTMG9GX,:DD#'3.68Y]Z9J?A^QU6_M+VX\];BU
M5TC>&=HR4?&Y3M(R#M7\J .=TKQ7J?B*UL8=/6SMK^?18M3;ST9T+R9"H ""
M%RIR>3@BK7]MZYJ%QJ-EIJZ='?Z;#;M+',6:.661=[*'&"J8X#8))[<8,@\
MZ''!IT<'VZW;3XC;P307LB2>4>L;,#DKP..V.,59NO!NCW6I1W_EW$$JPK;R
M+;7#Q)-$OW4D52 P&3U[''3B@#*DUSQ%+J_B&*VETM+32"K#?;N[2JT'F 9#
M@ AB.>X[#O'_ ,)M>6\.F7=U# UM<>'IM7F2-&#AXUB8JI+$;3YAX(SP.:Z6
MWT*RMK[4KM1(SZEM^TJ[Y5MJ[1@=OEXXK/L?!&C6$EJZK=3?9;9[2)9[EY%$
M+[<QD$X*X4#!]* ,F[\5Z[H^G76JW^GP2:<+)9H9 50^>S*JIQ(^4.X'=@8P
M>N14MA%>1?%6X^V302NVB1D-#"8_^6S9!!8YYZ<]/S-^S\":'9Z;<Z:8[FXL
MIX3!Y%U=22I%$?X(PQ^0<#ISP.>!5K3/"UAI>HIJ$<U[/=I;"U$EQ=/)^[!R
M 03@\]S0!%XBU">QU;PY%'%;217FH&!S+&6=/W,CAD.>#\F.AX)K!M?%>O&2
MTGN/[/:U?79M(DBCA<.RJ[HL@8N0#E!E<'//(KKM1T>UU2YL)[@R[[&?[1!L
M? #[2N3Z\,PP?6J"^$-,6&.(-<[8[\ZBO[T_\?!)8M^;$XZ<]* .=TWQ)JUK
M#="YFCN[B[\03Z=;XBV^7L#GH7 (VQX R.3U.:LW&N^++9]+M)[?3[:YO=3E
MLE>5"X:+R7D27:DAVGY,%<G..HS6M=>"=$N[:^@EBGV7=S]L;;<.#%-G/F1D
M'Y&SSD?RJ9?"FGJMAF2\DDL9S<QRRW#.[2E2FYV.2WRDK@\8XQP* ,<>(/$E
MPUTFGV=M=2Z;=16MT %1)3LC:5E9I 4P')4%6^[R3GA!XJOI=9OM)EEAL+Z,
M7!A@N+5OWL:Y\N6)]VV08P67J,XXQSKS^$-*GUU]8Q<QW$VW[1'#<ND5QMX4
MR(#AL#CGMP<BIT\.6*W:7$AFF\N266))9-RQ-+G>5[\AF&"2 #QB@"OX(N+R
M\\#:'=7UP)[B>P@E:0*5)W1J>>3D\\GCZ"LV+Q+/<^([C1+[RK27=,$MI[=A
M]HA4';)%)G:_8LN,C)],GHM&TBUT+2X=.LO-%M H2-996D*J!@ %B>   ![5
M6/AJR:X69Y+ARDLLT*O)D0R2!@[+W'#L,9(&> * .,\$:SJ>GZ+X/L)C9O97
MVBM)$NUD>)HDC(W.2000QS\HQCO5^U\27^J&]TV^6VEBET/[:)(8F1=YRK*I
M8G>G3#8&>O.:VXO!FCQ0:= $F:'3[:2TMXVE) B<!64^N0 .>>*;:>"-(LF1
MXGOBZ69L0\EW(Y\D_P /)QQV]/KS0!S6@J/MWPU; W?V!,,]_P#56U;7C]9#
M9:(81'YPUJT\LR#(!W]\<XK4M?"^GV<VDR1&<'2K=K:T!D)"QD*"#_>X51D\
M\"KFJZ1:ZS:I!=A\1RI/&\;E621#E6!'<'\* .17Q?K%C?W>BZA%:SZBE_!:
MP7%M&4CD66-Y 2C/PP$;#&_DE:Z;0+C6)[>Y76K6.":.X98FC(_>Q<%6*AFV
MGD@C)Z9[U#>>$=)U#3;BRNXI)?M$RW$DYD*S&5<;7#C!4C QC  &,8J_I>EP
M:3:?9X'GERVYY;B9I9)&Z99F))X 'T % '(:SXD\3077B?\ L[^RS#H<<=P$
MFA<M.AC,C)D. IP#AL'MQ3M1\9W\#Q7-NEJUJUQ8IY&QG=4N&0,9'! 1AO&%
MY) ST/%F'PU->^*?$LVH0W":;J"P(%$R[+A$3:RL 20"?ID'!]*OWO@C1;^Y
MNYI4ND-W+#-*D5R\:&2+;L<*" &&Q1GV% %)_$>JP:OJVC3_ &,:@LD+:9B%
MMLL,AQN8;\L4(?=@CA<]ZCO/%&I6FO6UM_H<MO+JJV#K%&S;%:,L"9,X#[A]
MS!P,9ZYK2MM.N+_Q,FJ:CID-M_9RS6]E)YPE>57*Y<\?+\JC@Y/S-^*2>"=&
MENWN"+M6:]%_L2ZD5%G[L%!P,]_J: .0TG5=7T#3[J_MQ92:2/$ES;3VYC;S
ML27C1AU<-@8+#Y=IR,\^E[3]7?1KW7X[:$-/?>)OLL0P,*QM8W)P64'A#W')
M%=3!X6TVWN7D59C$UTU[]G:4M$)R2QD /?<2<= >0 :AN?!FCWEKJ%O<1SNE
M]<B\D;SF#),  )$88*$!5Z>GUH M:!<:Q/;W*ZU:QP31W#+$T9'[V+@JQ4,V
MT\D$9/3/>L/4O%.HB#Q-=::EMY>@'#PS(Q:X*Q+*^&!&WY6P#@\C/(XKI=+T
MN#2;3[/ \\N6W/+<3-+)(W3+,Q)/  ^@ JE=^%M,O+R\N725?MT:QWL:2$)<
MJHP X^G&1@D<'(XH Y?4_&6N)#XAO+#[ MKI>GV^HQI/ Y>1'1W*-AP <)][
MMZ&NWN]0BLM)GU&4-Y4,#3N!R=H7<?T%9UWX3TR^;53-Y^-5@6WNU60@/&H(
M"C^[PS#C'6M9;:,6@M7'F1;/+(DYW+C'/KQ0!Y]/J5W+XA\'Z[?FW,4UA=W7
ME01D-&#"K[=Q)W<'&<#D9[X&A%XB\32Z8-56QM183:8]VDCA?W4H0.B_+(3(
MI&1G"D8SWP-.P\#Z/I\]C)";QEL ZVD4ET[)"KC!0 GE<<8.>/PHL/ ^CZ;:
MW-K;&\%M-&\2P/=.\<"/]Y8E)(3/MSZ4 95CKWB6^U'2[(3Z7&=4T@W\<GV9
MV\AE,8((\P;P?-']W&.]5_\ A-=5N/"ECJL*V4<\NDRWKPB-Y6:5,<!01MC^
M]EB>X'7KU%OX9L;6YL;B%[A9;&T-E;MYF=L1VY'O]Q>3S\HJBG@#0H[>"!$N
MUCAM7L@%NG7?"QR4;!^89)(SZT 9=WXHUZ>ZFCL#I\*#0H]50SP/(0Q+90X<
M9'R]>,>AIEQXDN_$NBZK;VBVUN(=$BNYQ-&9-SSQNP0<C  7KSR1Z<[\7@_3
M("3&UUDV T\EIV8^0,G;SWR3SUYJ%O VCGR?+-W"8[,6#-#<LAE@ PJ/C[V,
M\'K[T 7?"7_(F:%_V#[?_P!%K2:[J-W9SV$%K);H;F1U;>C22'"$@)&"-W.,
MDD #/U#+#PW'IFJ6DUI<7*6EK8"S2W:Y=U8 @J2K'&0 1NZG.. .;.IZ#9:M
M=V5W<>>EQ9,QAD@F:-@&&&4E2,@X'Y"@#E=.\6:[K*^&%M_[/MGUC3YYY6DA
M=_*DCV#Y0'&0=_0GCU-3:'XNOM?31K)5MK>^O+&:[N9#&70".0181=P/S,<\
MG@#'.<C7T_P;I6EOI[69N8SI\<L5MF=F"+(06'S9S]U?ICBHX_ ^CPPZ<D'V
MN%]/+_9IHKAED57.70MW4GG!S[8H K_#0,O@*Q5]F\2W(;8,+GSY.@]*R]?U
M2_DTGXAV\?V6!["S)CFCA(=U-L7^8[N6'0'MCIVKL-%T:ST#35L+ 2BW5V<"
M25I#EF+'EB>Y)JI<>%M.NAK(E-P1K"!+P"4C>H79@?W?EXXH GT&R6WTVWG>
M.V-U+;Q+)-##Y9=5'R@\DG )[]STS7*P^*]>$L4\YT]K4:^VD21I X=EWE%<
M,7(4@XR,'//(KN+6W6TM8K=&=DB4(I<Y.!TR>]8W_"'Z9Y7E;KG;]O\ [2_U
MI_X^-V[=],\XZ>U &-_PF5\VBVGB*..W;3)M2^Q-;[#YJQF<P!]V[&[=ABN.
MAQU&3T/B;6O[ T.2^5%>4R101*QPN^1UC4M[ L"?84R'PKI<%PTD:2"%KK[9
M]F\P^4)\YWA>QS\V.F><9YJ]JVE66MZ7/INH0B:UG7:Z9([Y!!'(((!!'0B@
M#A+G4[KP[XR\27UR8+B8:=IR1F./RP3)/+&I8%CT9L]1P/QJ_JGB#Q3I%A>S
MW%G:*D=W:1VTDJ@&5)95C<%5D;:5+9#9P<].*U?^$(T:07GVL75Z;RU6TN#=
M7+OYD:DE<\]06.#U'7KFE7P7I@THZ?)-?SQM)%(TD]V\DA,;!HQN8DA58 @#
MC\S0!S^J>*?$FF0>)V,FER'0A'<;OLSKY\;)NV8\P[2,,-V3GCBK^N^*M1TO
M4F$(M)+>.]L[=HE1G<),ZJQ=\@(P+C:O)(&>AXUKOPEIE\-6%P;AAJR+'> 2
MD;U48 &/N\<<8J"Z\#Z->S7,LWVS=<R0S2A+IT#2Q;=DF 0-WR+S[4 8MYXK
MUZV;6+G.GFUTO68+%H_(??+%)Y/\6_"L/.SG!!QT'>GXPU6ZUWPKKKP-;I9V
M&J169C>,L[E)HMS;LX7YCP,'@>_'5S>#]+GM[Z!S<F.^NDNYQYQ^:5-NTYZC
M'EIP/[H]ZBO? VC7TM\TGVM$OW26ZAAN7CCED4@ARH/#?*,D8SCUYH Z"X,@
MMI3$4$@0[2ZY7..XR,C\:\]3QM>6GA/0=0EAMM/MKW3A*;H6KO;03$#:CA6S
M&G)^8\>XQSZ$\0>!H=SJ"NW<#\P_$]ZPX_!VF0Z9'IL3W26:6GV(PB8D/!S\
MC9]B1G[P!ZT :][-)'IL\]LT?F+$SQEAN4D#(S@C(_&N*TSQ+XDU!_#:F72X
M_P"W-+:[4BV<_9W58V/_ "T^<'S#Q\N..3W[B2UBDLFM "D31^7A.,+C&!Z<
M5DVOA73K-]*:!KA3I5NUM:?O<[(V !!SUX51DYZ"@#GX/%^K7?AS3KU/L,=U
M-;73RHL;R,TD+;!L0$$(2"2Q;Y>!G)S4UMXFO/$=NEI:K;6\CZ)#J,_G1F12
MTP.U ,C@;6R?<5HQ>!-%A2U6,7:BVCFB4K=.I:.5MSHQ!!92W.#2Q^!]'@%B
M;<WD+V=K]C22.Z<.\':-SGY@.WIVQ0!S/AG7-5'A+0]'T6W22\@\/6MWF159
M6+J55>9$P,QG)&>H_'T*PEGGT^VFNH!!<21*TL2N'".1RH8<'!R,U@-X!T00
M:;'#]NMGTZ'[-!-;WLD<GD_\\V<')7CIV[8K1M=%%IKKWT,TJ6YM5MUMO.9H
M_E(P0AX4@ CCKDYH SO%OB*X\/-:R;?)L9$D\Z^:V:>.W<;=GF!2"J'+9;M@
M=,YKF+_5-1TO6?&&MZ7)8%K;2;*\D\R-I%F"K,Q"E6&,@'YN>W!KO=1T>#4Y
M%>6:XC(B>%A%)@.CXW*1T[#GJ.Q%4)/!FD21:A#LF2&_M$LIXTD(4PH"JH/3
M 9AQSS0!E:_XLU#3)I9;<6DD$,EF#"$9WVS2*K%V! C/S#:.2<9QCIA^)HT^
MR_%+Y%_Y!\3=._V=N:ZR[\"Z->O=--]L_P!*$/G!+IT#M%MV.0"!N&U1GV%6
M+GPEIEVNK)-]H9=6B6&['G'YT5=H [CC(R.3GF@#8@ -K&" 04&0?I7F?A#5
M]7T/PWX3,@LI='OI&L_*2-A/"Q\QE?=NPP^0@C:,9')KTZ&,0PI$&9@BA06.
M2<>M9&G>%M,TPVP@69HK1F>UAED+I;ELY*@]\$C)S@$@8!- &7X?U_7=:DTG
M4!81#1]1MS,S$HK0$J&CP1(2^1D'Y1@\\<BKOBG5M2TN;18M-^R;K^^%HYN$
M9@H,;N&&".FSIWSU'6GZ/X0TK0KMYK 7*)N9H[9[EV@@+?>,<9.U<Y/0<9(&
M 35?Q?I5[JL^@"TAE9;34UNII(I%0QH(Y%R-QY.7''/&?H0#,L_%&M%KK3KX
MZ>E_9ZH+*6>.)R)HVA\U6CBR6+X*@KD@#+9P*;IOBF_U(>$I[FVLPU_>W=M/
MF([D:)9ANC.X[<^7R.>"1FMZ;PCI<XA9Q<"XBNC>"YCG9)6E9=C$LN.J_+CI
MC &,"F6G@W2;$V/V<7*BQN9;JW4W#,$>3=OZD\$.PQ[GOS0!RUUJMUXB3P7K
M9:W6SN=:W0PB,^8B^7,%)?/4@<C'4CTY['Q-K1T'2!=(BO++<0VT0?[H>614
M!;V&[)^F*I1>!=%@EA,0NTAM[LWL%NMTXBBE.[)50> =Q..G)]36SJFEV>LZ
M;-I]_")K:88=<D'@Y!!'(((!!'((H X[Q#XNUG0!KUJ5LYKJQT^/4+:8PL$=
M&<HR.N[A@5X(/(/3CG<TC5=2?Q5JNC:BUK(+>W@NH9+>-DPLAD4HV6.2#'UX
MSGH*DNO">FWUA>VMXUQ<?;8DAN)GE/F/&I)5-PQ@#)Z8ZD]2:N6^BVUMK,^J
MJ\S7<\"02,SY#(A)7CIP68Y]S0!D:W=:BGCGPY96]W''9W$=R\T31%MY0)U.
MX=G./0\\\8YOPEJFHZ38:#"IM&TV_P!7OK,Q>6WFJ?-N) X;=C&8\;=O0]:[
MO4-$L]2OK&]G\U;BR9S"\4K(1N # X/(.!P?2J4'A#3+:&PBC-SLL;M[RW!E
M)VRONW$^N=[\'CYC[4 9VA^(=<UJ72]0AL(CHUZ',C,55H5YV$'S"6.1@C:.
MOMSJZ_K,FFSZ596X3[5J=W]FC>0$K& C.S$ C/"$ 9ZD5'I?A#2M'U&2\LA<
MH&D:5;8W+F")VSN9(R=JDY/0=SC&:N:UH=EKUI%!>K)^YE6>&6*0I)%(O1E8
M<@\G\S0!PVF:GJ&A7FME3:2/<>*X+28^4P!22*!<J-W#8.><C/:M>3Q??0WN
MHV30PO,FLQZ;:M&F.&@6;+!G )P6'49.*TCX)TAK6\@)O"UW<QW<DING+B9-
MNUU.?E(V+T]/3BFR^!=#GM+^WEBN7%[,EQ*[74A<2HJA9%;.58;1R.: +V@7
M&L3V]RNM6L<$T=PRQ-&1^]BX*L5#-M/)!&3TSWKB_'&JW6M^$/%R6S6\=IIL
MHM&62,L\C 1N[9R-OWP!P?ND]^.]TO2X-)M/L\$D\N6W/+<3-+)(W3+,Q)/
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MSQG Y.*P-4\7QQZAX;NK*\+:5>7%Q#<(MNS.QCBD.T+C>&#IC:!G(Q2OI?B
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MCUUM3AM;F0>7<1- (61C@[6QN(." <>^.QT*UDM;!C+IUGITDTAE:VM,%5)
M'+ #<QQDG'MSC) &S>(]*M[Z.TENBLDEP+56\MBGG$9$>_&T-CMGVZTRV\4Z
M-=SB*&\&6BDF1VC94D2-MKLK$ , 2,X/?/2LC1M-U_2-4O[#[-9SZ7/J$E]%
M>M,=\:R/O:,Q[>6!) .<8(/;!R++PYXF&H:9?7UE8RW%O:7EO<EKHE)6DV%2
MJ;<*GRXVC'7GU(!V4?B'39(I)!+*JQK&Q\R"12PD)";05RVXC  R<\5-INKV
M6K"X^QRLS6TIAFC=&1XWP#AE8 C@@^X.17"/X*UA-.N(=-_=6L,EM<V>F:A/
MY\:RQLQDC#\D1,I  .<')P*['P]:SPV\T]SI%CI4T[ M;VI#]!C+N%7)_#@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MS:]9VD]RJ+]MB#P".%Q\P'[U#G/W"0NXX!).!Q0!I?\ "26W_/AJW_@NF_\
MB:/^$DMO^?#5O_!=-_\ $TQM8N;OQ-<Z+I_DH;*WCGNIYD+@&0L$15!'.$8D
MYXXX.>+37US8:)<WNI1(9;=979;<$AU4G:0.2"5 )ZX)- $'_"26W_/AJW_@
MNF_^)H_X22V_Y\-6_P#!=-_\35'3?%,:Z>+S5KJ%%DABN,1VLB_9T<8S(3G
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MFLR"!;JXL$N]JH=BEHP^,9R1SCK0 _\ X22V_P"?#5O_  73?_$T?\));?\
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MC>!SUH M_P#"26W_ #X:M_X+IO\ XFC_ (22V_Y\-6_\%TW_ ,35.#4/$?\
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M !-'_"26W_/AJW_@NF_^)K9HH QO^$DMO^?#5O\ P73?_$T?\));?\^&K?\
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M?\^&K?\ @NF_^)K9HH QO^$DMO\ GPU;_P %TW_Q-'_"26W_ #X:M_X+IO\
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M* ,;_A)+;_GPU;_P73?_ !-'_"26W_/AJW_@NF_^)K9HH QO^$DMO^?#5O\
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MYF8GCQG<,<2$]#T%:U% ',:]X5N=9NQ)'J4<-NHMS'!);>8(GBF\S<F'7&[
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M?]62V7/7G.(^/]CWJ[10!BZ-IFKV-Q+)J&J6EVLF6;R;(PLS\8+,9&R !@
M4T^%K&XTRVM;W?--"')FCD>(L\AW2-\K#JW.,FMRB@#E+7PK]BLO"^D1.[VV
MC,L\D[9_>,L3(H&2<99RV,X 7'<5U=%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
E10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>exhibit1033-bochk_facili010.jpg
<TEXT>
begin 644 exhibit1033-bochk_facili010.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MY)4MU^7.2/:O7K;Q9HU[JRZ99W,ES<')S#!(\8QUS(%V#\Z -NBBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ KF?'_ (J'@WP;>ZP%1[A ([='Z-(QP,^PY)]@:Z:O&?VCGN%\
M'Z4B?\>[7W[P_P"T$;:/_0ORH X+X4^!G^(OB.\UWQ!-)<65O*&FWMEKF8\[
M2?[H')_ ?3UWQQ\5]$^'T\.D0V+7=XD:G[- RQI"G8$X...@ Z>G%0_ :.W3
MX7VS0_ZQ[F9IO]_=@?\ CH6O%_BHH;XWZBK %3<6P((X(\J.F!E_$7QI!X]\
M1Q:L+.2Q\NV6W\K>)<X9CG/'][ICM7H?A_\ :!M=&T+2]*D\/32+96L5LTRW
M8!8(H7<%V]\9QG\:]S3P]HD?W-'T]?I;(/Z5Y%^T186=KX3TE[>T@A;[<5W1
MQA3C8W''T% '6:]X=\.?&+P9#J-FP6=XR;2\VXDB8'E']L\$?B/6O)_@QXKO
M_"GC9_">H*PMKR<P-&QY@N%R 1]2-I_ ]J]1^!'_ "2VS_Z^)O\ T.O&O'JP
MV_Q[G-FS C4;9R1P1(0A;'XYH ^KZJ:IIT&KZ3>:;= FWNH7AD .#M88/\ZM
MT4@/F"YLM;T==6T'QM!K6H6%C8S'2V0LUON .UV[' .>3\N,8KC?AQHFJ^(O
M%B:7I5Y]D,T3"XD.=ODC!96 (R#P,=\U]A:Y8?VKH&H:>,9N;:2(9Z992/ZU
MY7\%O"MII&K:SJ%K'.87BCBAEE0@$$L6 )'.,+GZ ]Z8'KUM!':VT5O$BI'$
M@1510H  QP!TKDK+6(;;QAXTN[P!(--@M SJI9B@B>0\=2<N>!795PVH>$M:
MD^(5UK.FZC'8V5[IZVT[QHK2"12<-M8$'C SU&!2 X[0)]7@\1WNNZ=)J&W5
M7,EX^I#RX;5<$1[D(#84;3NXR!@9&6'9:@!/'X)>*ZFFQJ^1<3<O*H@GR?HV
M,_3%4;WX?^(6B?R_%]W=@@YMY=ULKG&,EX2K9^N:F\)>%M6C.E-JUI;Z=:Z2
MTIM[2.X-R\LC9!E:0X[%L#GKU[4 =?K.KPZ-9+-(K22RR"&"%>LLC?=4>F?6
MO,V\8G1OBG!H,FIO#:11>9?EK=%6XN'Y9W=B-J*A7!_V HS7K,\9EB95*K)C
M*.R[MK=CBO+IO .N7WBZ6YEV_9UA,#7UU.)&N<D,6,0&"H/ C)"C //2@#C_
M !P]KXB^)6L+/?+ L,4-A$?[3CM%:(H9'+%C\REF48 /!)P<5['HNMZ>T5AI
M.DQQW*PP(LALF#V]L@7 'F=#TP .>^!7'67@*^MY]8TJ[T33M4M;R[:>'5M2
M=97C5D52"F-Q8%> "HYZU9LOA?JN@3(WAOQKJ%E -N^WN(5N(S@8. 2,=.G:
M@#TB21(8VDE=4C499F. !ZDU\HW%G!=_%)(_ATMQJ]TC,\EQJ.R>,MGE\L/N
MC^\>YX[5].W.CC5/#T^DZQ-]K6XB:*>2-?*W@^@!../>O/?$?PG^R>&=.LO!
M'E6%]:7BSO=.<32+R#F0 $XSG'3B@#IM0CN]2^RVUQX=MM2O[##F[N4$5K'*
M5&6C!W,W7L/QR*@\,3ZQXP\-V^J7&KRV"S&13!90(@&UBO#-O/;KQ]!6QXAU
M'5]'TZYO;33DU2*--QMXF,<H&.<=0WKC@_6N9^"D6JP?#U(M5LYK1ENI3!',
MA1O*8A@<'G&6;% 'H4:>7$B;F;:H&YCDGW)]:';8C-@G:"<#J:=10!P$MQ._
M@"'5)YK^>YU=$NI?LT)F$:LF\(HW*L:*N!N)&<9)R:\M;[5-JPOVNM)DT_[(
M6\F9PY(W#KG*>9CGJ5QQNKWJVT%+/3;[3H+AQ9W <0Q, 1;AP<JO^SDD@'IT
M'& ..C^$<$>DI8'6IR%@$.[[-'_=QG_)H L1W-S?_#I@D=RJ(T8!FE_LQHXO
ME(,<B%E..,$':>GM7G_BN?4-3UK6S;:DTEJNF3VIN8[F:6$$MG9O6 @X"_,,
MX'=Z]AN_"L-[X?TO1IKJ7[+8O;LX4 "X6+&%<?W25!./2LW7OA_9ZUK?]I;K
M,?Z*MKY%S81W"*%9VRH;[I.\YQZ"@#'\.ZG<ZYX%N;I=0D@U&P'VF/?<.TD+
M!,A95,:90C(Q@@@D@]",SXA^)Y9M$DBTG5-5%]>PP1S6<$2/!9K/M4&5A$S@
MG?PJDL<\"N[3PQ+)H8TJ]U6:XMWES,JQ+&'AQ@0 #[L?0'N1D9YJSXC\/P>(
M]'_LR=E2$SP3.#&&#B.17VD>AVX_&@#SC1]3UB#4M%T-[W6[6VN7^RQ.!M\L
M+$S#_7:?&&X3&-V>_K4WBV+/BS4IKJ>Y^QV)TIKB5)F5HHFDE#LH4@9)5 W^
MSDCI77MX!T>/Q#I6J:?:66GBPD:7R[:S1&E8HR8+C!QALX]0*=J?@FRU75=1
MU&X=7FNHH$B$D6Y87BWE7P3A^7Z'CB@#QL7,_P#8GS?N[GS#<_:)8=A,0N2I
M83&Y /0C'EYZ#'(->P^)[K5K\KI>E&6PLY(A->:T6"K!#U(B/>0@'GHHY]*H
M0_#*WBL[-#KFH/=:>[26%P8X0;9V8LQ4!/F!)Y#$CZ8!&]KGAL^(=%33+W5;
MV*-H_+N3:;(_M (P0V5; // QUQ0!SDFNZC=-HGB'1A-()[5_,T*YN%6:YM]
MP(GC4G&\<'GJ&P2#BI?&TTLMIHUTBW43W4GD1VW[]92[*7 (BGC&0$;.2?:K
MMUX!L[QK.2;5]8:XLI5EM9OM S"P_N@+MP1D$8Q@UMZSH.FZ_%;1:G;^?';S
MB>-"Q WA67)QUX8\4 >47T5Y_8?B8O<7UI>:7IK7.PW%Y'(I97\M@3<NIY0\
M$=J]DMR3:Q$DDE!DGZ5S.I^!-.GT?4K#21%I9U.(07<J1&0O%AA@ L #\YYK
MJ8T$<:H.0H % #J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KC_ (G>
M%I/%_@2^TZV7=>)B>V&<9D7M^()'XUV%% 'S3\$?'L/A?4[KPUK<AMK6ZES$
M\N0(9_NE6S]T' Y[$<]>/0/B3\'$\9ZK_;6EW\5GJ#JJS+*F8Y<# ;(Y!Q@=
M\X'2I?B7\'K3QE*^JZ9+'9:QMPY8?N[C'3=CH?\ :Y]QZ>86/C'XE_"V/[!J
M=A+-8QD*@OHVDC4=,1RJ<8]LD#TI@<UXVTCQ%X%UN/2M0UR2>9X%G#6\SE=I
M+#'..?E-=CI?P2\2^)=(TS4KCQ';FVNX([A5E\R1HU=0W0\9P?7\:X;X@^-C
MX]\00ZL]@+)H[5;<QB7S <,QSG _O=/:NWT_X[:Q:>'=,T'0]!B-S:VL5LLL
MCM,7*(%R$4#T/&30!ZX]QH/P=^'\4$MPSI K>4KD>9=3'D@#MDGZ 5XI\*-!
MU'QQ\3&\1W@S;VER;VYE(X:4DE$'OGGV"_2KVD?#3QQ\2M5&J^+KNZLK;'$E
MTG[PC/W8XN-@_ #O@U]"Z#H.F^&M'@TO2K98+6$< <ECW9CW)]: -*D(W @Y
MYXX.*6D(#*58 @C!![T@/$M!\9>(1%X:O+W4Y_L]WK<UC<2N%D$J[B$CV 9!
MX^^.G?-==X@\8W>@^*=*N-@7PPTSV%W)Y1 25B-LN[&-H8%.O][KQ796^C:7
M:2+);:;9PNN<-' JD9Z\@4]]*TZ2S^QO86K6H.[R6A4IGUVXQ0!QGB.\\3Z-
MK5SK>ER2:EI-J52]T@ ;_+**QEA/7<,GY<X(Z5C:UXKU2"3P+=:/+=WD.J&X
MD>V#A6NE";XU);[O7VKU&"SMK9F:"VAB9P QC0*3@8&<>E1OIFGR20R26-LS
MP?ZEFB4F/_=../PH P_!>N6WB339=3AO)I)V?9<6DHV&SD'!CV=001U).>V!
MP,+1=:U+7)?&DFI7\NGOI5U);VT49""WB5,K,<CYMW7YLK@<"NYM]-L;2XEN
M+:RMH9Y>9)(XE5G[\D#)HN-,T^[D\RYL;::3&W=+$K''7&2* /);/QEXEU.7
MX>2W"W$<NKP7S7=I PB^T>4F8V!;[N>&X(Z^F*[_ %6_U+0/ %]J4$<UYJ$%
MJ]PD4WS,&/S;3C&0N?J0OK6Y+I]E/<Q7$MG;R3P_ZN5XE+)]#C(JS0!RGAH3
M:EX4T;5)=>N)+F[CAGFFW+LE+8+1A,;5'5>,,/4\UY[>^+O$4'@#QW?QWET;
MG3=;EM;2ZW)B&-9(U"[3UX8\D'K[5[%!I6G6TQFM["UBE))+QPJK$GKR!4?]
MB:3Y,L/]EV7E2MOD3[.FUV]2,<GWH X[^U-0/Q5TG1OMT_V"?0S<R0[OO2AM
MN[/7I[XK-M=;\2Z'<:;I^N7%Q?Z=K$]L;'5(E"O$[LI:"7:,8(+8;_*^C?V5
MIWGK/_9]KYRIY:R>2NX+_=!QT]JF2TMH[=+=+>)88R"D:H JX.1@=!@@&@#B
M/&OB_4/#U_8ZA;1L^B65TL6JD0LQVN,;@V, (2I(SR6QV-;/C#7Y='\.PW>G
ME'EN[FWMH9OO*GFN%\ST. <CMG%;3:;8-;R6[65L8)6+21&)=KD\DD8P33+K
M2;"\TIM,FM8_L3*%\E1M"@'(VXZ$$ @CH0,4 <4=6U2+XMWNB)-=7%A'HBW"
MP"15Q(9-I?)P>G;..>E<SX?\9>(KOPCX$:XO9<ZWJ$T-_J!4;E"R,$C'&%+
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MP$A<E<;_ # -P&,#C(QT]JVY]1U&'P1J^I/>75K?1Z3-/;Q22JY<I"KB=?\
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MS#)!.TCR;"3'\I0;#TSR>A'?( .@HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBL/4-+UVYO9);+Q']CMVQM@^Q1R;>!GY
MB<G)R?QH W*1E5U*LH93P01D&N;_ +$\3_\ 0W?^4V+_ !H_L3Q/_P!#=_Y3
M8O\ &@"_+X7\/SOOFT+3)'_O/:1D_J*N6FFV.GKMLK*VMAC&(8E3^0K$_L3Q
M/_T-W_E-B_QH_L3Q/_T-W_E-B_QH Z6BN:_L3Q/_ -#=_P"4V+_&C^Q/$_\
MT-W_ )38O\: .EHKFO[$\3_]#=_Y38O\:/[$\3_]#=_Y38O\: .EHKFO[$\3
M_P#0W?\ E-B_QH_L3Q/_ -#=_P"4V+_&@#I:*YK^Q/$__0W?^4V+_&C^Q/$_
M_0W?^4V+_&@#I:*YK^Q/$_\ T-W_ )38O\:/[$\3_P#0W?\ E-B_QH Z6BN:
M_L3Q/_T-W_E-B_QH_L3Q/_T-W_E-B_QH Z6BN:_L3Q/_ -#=_P"4V+_&C^Q/
M$_\ T-W_ )38O\: .EHKFO[$\3_]#=_Y38O\:/[$\3_]#=_Y38O\: .EHKFO
M[$\3_P#0W?\ E-B_QH_L3Q/_ -#=_P"4V+_&@#I:*YK^Q/$__0W?^4V+_&C^
MQ/$__0W?^4V+_&@#I:*YK^Q/$_\ T-W_ )38O\:/[$\3_P#0W?\ E-B_QH Z
M6BN:_L3Q/_T-W_E-B_QH_L3Q/_T-W_E-B_QH Z6BN:_L3Q/_ -#=_P"4V+_&
MC^Q/$_\ T-W_ )38O\: .EHKFO[$\3_]#=_Y38O\:/[$\3_]#=_Y38O\: .E
MHKFO[$\3_P#0W?\ E-B_QH_L3Q/_ -#=_P"4V+_&@#I:*YK^Q/$__0W?^4V+
M_&C^Q/$__0W?^4V+_&@#I:*YK^Q/$_\ T-W_ )38O\:/[$\3_P#0W?\ E-B_
MQH Z6BN:_L3Q/_T-W_E-B_QH_L3Q/_T-W_E-B_QH Z6BN:_L3Q/_ -#=_P"4
MV+_&C^Q/$_\ T-W_ )38O\: .EHKFO[$\3_]#=_Y38O\:/[$\3_]#=_Y38O\
M: .EHKFO[$\3_P#0W?\ E-B_QH_L3Q/_ -#=_P"4V+_&@#I:*YK^Q/$__0W?
M^4V+_&C^Q/$__0W?^4V+_&@#I:*YK^Q/$_\ T-W_ )38O\:/[$\3_P#0W?\
ME-B_QH Z6BN:_L3Q/_T-W_E-B_QH_L3Q/_T-W_E-B_QH Z6BN:_L3Q/_ -#=
M_P"4V+_&C^Q/$_\ T-W_ )38O\: .EHKFO[$\3_]#=_Y38O\:/[$\3_]#=_Y
M38O\: .EHKFO[$\3_P#0W?\ E-B_QH_L3Q/_ -#=_P"4V+_&@#I:*YK^Q/$_
M_0W?^4V+_&C^Q/$__0W?^4V+_&@#I:*YK^Q/$_\ T-W_ )38O\:/[$\3_P#0
MW?\ E-B_QH Z6BN:_L3Q/_T-W_E-B_QH_L3Q/_T-W_E-B_QH Z6BN:_L3Q/_
M -#=_P"4V+_&C^Q/$_\ T-W_ )38O\: .EHKFO[$\3_]#=_Y38O\:/[$\3_]
M#=_Y38O\: .EHKFO[$\3_P#0W?\ E-B_QH_L3Q/_ -#=_P"4V+_&@#I:*YK^
MQ/$__0W?^4V+_&C^Q/$__0W?^4V+_&@#I:*YK^Q/$_\ T-W_ )38O\:/[$\3
M_P#0W?\ E-B_QH Z6BN:_L3Q/_T-W_E-B_QH_L3Q/_T-W_E-B_QH Z6BN:_L
M3Q/_ -#=_P"4V+_&C^Q/$_\ T-W_ )38O\: .EHKFO[$\3_]#=_Y38O\:/[$
M\3_]#=_Y38O\: .EHKFO[$\3_P#0W?\ E-B_QH_L3Q/_ -#=_P"4V+_&@#I:
M*YK^Q/$__0W?^4V+_&C^Q/$__0W?^4V+_&@#I:*YK^Q/$_\ T-W_ )38O\:/
M[$\3_P#0W?\ E-B_QH Z6BN:_L3Q/_T-W_E-B_QH_L3Q/_T-W_E-B_QH Z6B
MN:_L3Q/_ -#=_P"4V+_&C^Q/$_\ T-W_ )38O\: .EHKFO[$\3_]#=_Y38O\
M:/[$\3_]#=_Y38O\: .EHKFO[$\3_P#0W?\ E-B_QH_L3Q/_ -#=_P"4V+_&
M@#I:*YK^Q/$__0W?^4V+_&C^Q/$__0W?^4V+_&@#I:*YK^Q/$_\ T-W_ )38
MO\:/[$\3_P#0W?\ E-B_QH Z6BN:_L3Q/_T-W_E-B_QKH+9)8K6*.>;SIE0!
MY=H7>V.3@=,^E $M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%>:Z[/YUWXQMM1D>'48XDDT0
MJQ5]OE#:8.Y;S0P.WD\ \8K+UM#*OC-]1N7_ +0MM!M9T5+E@$N@DQ)0 XR&
MV8QZCUH ]>K,U?7+;2-/U*Z96N'T^U-U-!$1O\O#$'D@<[&[]C5NPF^TZ=;3
M[P_F1*VX'(.1UKS;Q%'8VNM?$ RQQ1W-QH,;0$KAI/W<ZL1Z\[0?<J.XH ]+
MM+@7=G!<JI598UD /49&:FKR:62?3I[Q/#\LK74_A<3B..8NTDRM@,H)/S[2
M<8]O2NE\&2Z1?:C<ZEHFIRW,$T"+-!'%Y<,;@G!(/24@D'V SVR =I17)?$E
MUC\'.QN'@87=KADE*''GINY!&?EW?ASVKGM=CTK3=;DT/4+N33]'NK '3IB'
ME G:20R['))$OS1E>_IZ4 =U%K4<OB:YT/[/*LL%K'=>:VW8ZNS*,8.>J'J!
M6I7F&KW%];:UK/\ 9TMQ-J,?A>W"YQ]H9A)*6X'_ "TVG.!W(]JGL=+TCQ7I
MFL?V%K$TB7EJJ@0QF*&VG7)1\=1)S\P'4#YNHR >D45YU<:I]K\$7'B/4[.Y
MM&F6WM'BC;RC$%D59-QP=J>87#''***P7O(F^U6AO]L2>*;0Q"W=X8Q"\<1.
MP;N$)WGKCJ10!Z]<7,-K&LD\JQHSI&"QZLS!5'U)('XU+7D&H0V*66KVS;'L
M-.\5V4B*[;U@A/D&0Y.<+DR9[?>]Z]<A\LP1^4 (]HV #'&..* 'T5YA+;/-
M>^/+S37GGU:QE+Z>J7#L49K1 VQ<X)W%AC!&1[5FZM<:1=^%=7U?1-8NVC:"
MW$\4"M#'$XF7EQU\TAF!'<#GM0![#17E>I?9-'N_$$^GSW4OA^2UM#.8;MF1
M;EIR&/F'=A=FTR8S\I]Z?8V,NN:;XKL;"XC:[L]22[TX1*R1 B&)U4 D_NW8
M,",X.YB* /4:*\RUNZ&I>"O^$CD$]E)J5_8/%&9#&Z0B:-<'!&<KYC'V(]*S
M/$$%G;6WCU;6X=#8QP7-BJ7+_NIS'DL@W?>+ ?C]30![!17F&K7MKJ'B75-.
MU34[BSNFE@FT>2WBW221;$/[ANF3('##N#SQTHZDUO%%XFOUNY/M=GXDM3:N
M;ECY:G[,'V@GH1Y@/L".U 'K$=S#---#'*K20D+*H/*$@$ _@0?QJ6N+\*16
M5OXV\81I'&ER]Y',H"X)C:WARWT+[OJ0:N>/+V:PT2UF'F"Q^WP#4'CSE+;=
M\Y..=O0'_9)H U-/UJ/4-8U735MY8I-.>-79]N'WKN!7!/&/7!J_/<PVPC,T
MJIYCB-,G[S'H![UY0^H:+::OXC:VD0Z?/J.G;7@EVVX!09+L 1Y61\P'!SC(
MSFH5>TGL+ WQCEM[#Q;(A9XRJ0PLLFT -G:A)7 SW'M0![%17F6GW-OJ'B9K
M;4-0N;77[/5W>.".$B66WWGRQD]83$5SV&">M>F-NVG;C=CC/K0 M%>6Z1/<
M7=AX7GBE9/$BWYCUA"V)-F'\X2C^Z, J3P/DV]16W\.+*S?2I=2622:\%W>6
MYD>X=\1_:7*C!)'3:0>O/O0!V]%<WXWO;>RT6W:Z,BPR7L",P?9&N7!S*<']
MWQ\P[YQD9S7#66MK8P1+J$S-H4&OW45XPC8111LK&$,ISMBW$'!X'R]J /7:
M*\UN+_2-*O=&BNYIV\)7$5T(YKHLT7GLZE 2>B;3($SQZ9X-/A-C'K)TS6I[
MD:,=(C&F37\A#,0SB1MQP?-QY9'\0'IS0!Z/69K&M1Z/+IR26\LHOKM+163;
MA&8$@MDYQP>@->?:':3:KK_A^T\2S7#WC^'_ #)X6N'0F598RI8 CY\#)'J#
MZ53CU&SO(/#TFHR*OB.#Q$!?QN2)8_FDP".OE[=FW^'&,4 >L6L\T[7 FM)+
M<1RE$+LI\U< [Q@G .2,'!XZ58KR2>>%_M,37\H4>,D7BZ<'RRJ9&=V=O!^F
M.*DEO(M,T?7HHKT16%CXEA_<M(2C6Y$):/=SM0L7Z\9!!ZF@#U>HKBYAM45Y
MY5C5G6-2QZLS!5'U)(%<IX"DL+B/6+JPU2WNXY[UI$A@N?-%K&0-L>,X7D,V
M!Q\V.<4GQ%@M7TO2)[R.-H(-8M'D>096-/, 8D]A@\F@#L:*\JO[B>XTSQ#&
MKM%XG@U('2ER5D\K*>3Y8ZF,KD,!Q]_/>O5>W- &-K?B.UT73+J],;W0M9HX
M9HX2NZ-G*XSDCLZGUP>E;->/ZU'86FF>/;<K'!=OJ]O( !M8QL+8Y'L6#GZA
MO0U<U&Z?2;WQ9#I<LQLXI-.N)HX7:5EB9O\ 2&49).4 W8_F: /5*R?$'B"'
MP[9PW5Q:W-PDUQ';@6X0D.[!5SN9>"2*S/!@TUUU"[TC4I+VQN9%D4(FVWB;
M;AA$.V< L.F3ZYJE\4)8T\-62O.(2VJV9#Y *@3*2PSQP.?3CF@#?M?$-O/K
M9T:>VN;._P#(^T1Q3A?WL8."RLK,#@D C.>1Q6O7F,T_V?X@27]C>7.N6YT>
M<75Q'M=[(+\RK$R )N<_PX+94'.*Q3J,!T_7%M+P+;S^%!-$+>1QF9?,&2XQ
MOE^Z&; ). 1VH ]<U74%TG2+S47ADF2UA:9HX\;F"C)QD@=!ZU5N]>@L_"DO
MB&2&9K>*S^V-%& 7V[-Q Y SBO/KI[2REU6*WNL17?A-I90TY<22\@-R3\V#
MCZ8K3\#7=K>[],UJ.%M3:QB$7.8Y[,IA=@[$?,''7/?;@  ]"C?S(D?:5W '
M#=1]:=7GWVF2W^($;!K;48)K]DPC%+NQ?R2I##H\. 3VP6!YKN;\W*Z==&S
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M$BATD7@G!5AD'ISU[SQ>(_$"ZY<Z;=66EQBQM;>[O)DGD(\MVD#[!LSD",D
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M.0,4 =92,RHI9F"J.I)P!7$7OC/5K235Y?[/L_LFEZG!9R_OF+R)((OF7Y<
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M# JP(8]1[C!KGH];;5=,&D:?9V<>S18KN>*128E612$B4#H/E;GL .#GC3\
M_P#)._#7_8+MO_1:T :FG::;)I)IKJ6[NI557GE5%)5<[1A   "S=L\]:NJR
MNNY6##U!S7,ZA?:B?'^FZ4DEO_9T^GW$TL3QDERKQ+R<XZ.<<=SG/;F_ NMW
M>E:)X7L)K:V&G7L=RD;HY\Q&CWODC&,$*1@>WT !Z717+:)XEU+5[K39UTQC
MI>H6QG$P5E-OP&0,3P^X'JO0CN.:R_&4$#_$#P>9-.6]WB]#1!4)<")2,[R
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MP'=N$( \R9V!PJKD]CDE1U/#8?%&H7U]"^GZ:US8&_DLIB$8-&J.T;2[C\I
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M2-:VS7(CDR X SC(Z5C^(/&%[HTNMK%9V\WV#1UU./<Y7=EG!4\'^YG\<>]
M'945Q&I>,M5TE==%QI]F\MAI2ZI (YFPR9<%&)7J-G88.>W6I&\6:S9ZG<6-
M[I5HTDFF2:A8^5=;5?85#1R,X 4_,IW=,$^E '9,RQH7=@JJ,DDX %!( ))
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M[MTMI87VF/8A8K@;<_QMW[U1LO%.EPZ;927FN6MS)=M+Y$L<903;&;(5<D\
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M1%!.%)SM3D\8Q[GIUH ;:^"M/TU[:32[B[L)(;3[&7@9/WL8)8!@RD9!)((
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M_9RSQK%=QVLH5+I5SM#@@G(!(RI4X/6JT_@:QENIIA?ZC$CWZ:B(8Y$").H
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MEO<QW,$,T98+-&)$5U*M@@'E3R.HX/2@"6BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I&QM.[&,<YI::Z)+&
MT<BJZ,"K*PR"#U!% '+)]LM_B49)_LL]I=Z8QAEC0J]LL<BY5CN(8-YF<\?<
MZ<5A?$V]NI_#NL)_8][=::FF2/#=0-"8=[(P+MF0-A5Z84_>)YP*[JRT;2].
MM7MK+3K6W@==K1Q1*JLOH0!R.3Q4O]G67]FC3?LD'V$1>3]F,8\OR\8V[>F,
M<8H 6PG>YL()I+:6V=T!,,VW>GL=I(S]":L4 8&!10!PNM:=JMMKVIZ[X3U&
M!KR-434M+O/]3<;4!4ANL;[" #T/?H:KZ?X@DOKNWDMI)K'3KGPR+Z*V9@/)
M8, "#CL"!Z=\5V5UH.D7LSS76F6DTL@ =Y(5)<8Q@G'(QV-.N]%TN_EMY;S3
MK6XDMLB!I858QYZ[21QT'3TH \]TI;SQ%JWAR:75KJUNKGPFDTUU;;!(SLT1
M)Y4@<G/ _2K.D>(=<G'A*>ZN'E>ZL;UYX4156Y:+'ER=,C<#G ./FZ5VK>'M
M%>&WA.DV/E6ZE(4^SKB-3U"C' /<=ZJIHMU-XBM]2O9;?R[%9H[..",J=LFS
M[^2>0$(XX.>V* .-B\1ZPOA9/%-IJEM<A](FGDLO,,OF3JFX%5"CR]A#!ESC
MMUY,WBXEO FN75IXDGNK>XT@3)&&&[(ZR!QT5@0"N .#CN*[BST+2-.NKFZL
MM,L[:XNN9Y88%5I?]X@<TVT\/:+86ES:6>D6,%M=9\^&*W54ESP=P P>#WH
MN01A+58UF=\ CS&;+?GZUYIX9U&YM=+\-:<;VY\K5-2ODN)WDRPV/,RH&/(+
ME>O4[3CK7IEO;P6EO';VT,<,$:A4CC4*JCT '2JAT'2#;S0?V79^5-+Y\J"!
M0'DSG>>.6SSGK0!F>$[V_G?6K.]E:X2PU%[>WN' W21[$< XZE2Y7/?;SSFN
M7UY&_M3XAE[J<A=!CV1-)\O,5QP!Z<9X]Z]&M[:"T@6&VACAB7.$C4*!DY/
M]ZK76BZ7?3O/=Z;9W$TD7D.\L"LS1YSL)(Y7/;I0!Y_+K6J>'(KLPWDUVB^&
MA?I%,JD12*0N5  ^7!R1S]VNH\/O=MJDLIUB"\T^YM4EAA6;SF5L\R!]HPK
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MT=;B*XAG*2!W68[N,$<QC@'M[X$NE>,8[.Q2WU6UGMA;Z.FH"=W5_-C4 ,<
MY#9QP>N1WXJ[JGA2>^U'6+J#4E@35=.6QFC:WW[=OF!7!W#M*W&.H'/8UI_
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M[-!X=OW@M9Y;9F5XV8RI((]NT$G'));D *:J7WCB8Z=+)I]I"]Q;ZS;:9/\
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ML2;CDD =3[GK7.2> X[N>[N+V[B-Q=Z=-I\\UM;>2TZR #?)\Q#,H'!XZGZ
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MO;W.FF*(XMQ,Z&3"*&3:J@[B<9^HH ](TG2++0].BT_3XWCM8AB-'E:3:.@
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M+'/)+;LEK]L3S4QYL.0-R_B0,'!Y'%7?[;C"9>ROE<726K((-Y5F"D,=I(V
M,,MG Y]* +ME;FSL;>V,KRF&)8_,D.6? QDGU-9,G@_1)6F+6TH\Z\6^95N9
M57SU(8. &P#D \8!(R:U+^_MM,L9;R\E$<$0RS8)[X  ')))  '))K(N_&.E
MZ?!J4E\MS;R:= +BX@>+=((CG#@+D,O!&0>"#G% #[KP?H=]#J,5S9M*NHRK
M-<[II"6D4 *RG=\A 5<%<=!6AI>E6NCV8M;19-F=S-+*TKNWJSL2S'  Y/0
M=J73=2CU2&26*"ZB5)#&/M$+1E\ '<H/53G@US4OB6.Z\(:OX@GO;JSTY3-'
M!+:1AY(XXV*&0 @Y)92>1@#'N2 ;E[X<TV_U:'5)TN!>PQM%'+%=2Q[4;!(
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MQ)I2+)<*4_A8$J5Y^;(!Z>F.O%1ZAXLTS2RQNS*D44D<5Q*%!6W>3;M5^?\
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MGW;0CGH"3@#&>H]15H>*M/;48[-5G+2W$MI%)L^1YHU+/&#G.0%;D@ X.#0
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MUR'5HY))7#D*\;-&5"$#[APV3G(X'6N]J*2Y@AGA@DE599R1&A/+8&3CZ 4
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M'(&[DY[8*V&EZQX4TZ2+35AF@EOX_(L)[F246\!4!UC<KG.06 /RJ,\UV=%
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M?!C:25]H^3[W[W'IQ[U;%A?:+I_BJ:5()9=3NGGLXH7+,[-"D:H05&#E,]P
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MA&A$OS!<9P?*S@\C./>M(>!=,2*/R;B]ANTOSJ!O5D!FDF*E"6W*5(*L5QC
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MO@FHWD=[-M:/B1-FW;\G _=IQ[>YH S;SQ-_8][XKN!I=L);%K13+']Z82
M/*<=$!R>N #S65XRU2\U/PUXLT^[M;62+3&MQ'<QYQ([%''RG.T@'!^8]CWK
M;\1>&YEM-7NK#[?=7&J/;BZCAFC1UCC(!,>0!NV@C#'!SSGH:UAX6N=2TF[T
MR]O-:BTJX11Y5Z+5958,&RGE+@+QSNR3VQW +$OC"\TZZUFTU&TMS/9M9B#[
M.S%7^TN8T#9&<AAR1U';M1=^*M6TNTO)M2TQH[:"XB1;]('9/*8$M(T0)<;"
M-IY[@],BK]]X,T[4Y=4>]FNIO[2@BAF4NJA?*):-E*J"&#,3G/7Z5+:^&?LM
MM&G]M:M-<)(LGVN:5&D8!64(?DVE<,W\.<G.<T 8\.O:G?>)O#D=O>V$EA>V
MMU.[6X+K*(WC"L&W=U?IV.<Y[=3JVI0Z/H][J=R&,%G \\@7J552QQ[\5E6W
M@W3;.XTV>UEN89+!YV0QLH$GG.'D##;C!8 X7&,8&!Q6Y=6T-[:36MS&LL$R
M-')&W1E(P0?J#0!S</B+4$U72+*\AM@-9MI);:2+<1#*B!RCY/S#:?O#;]T\
M#-4_A]9_;-$M]8OX[>:_$]V$N1&1( UP^X$DG(.T?0 5LZ=X7MM.:S;[7=W+
M6,+069N&1C C8!QA1DX51ELG ]SFSH.B0^']+73[>>>:%7=U,Y4L"[%SRH'=
MC0!F:Y>O+XNT#0O^7>Y6XN[@?WUB"A4/MND#'_='8TVT,.KZ[XHTN:QM[=HC
M IN8.)9=T>5<M@$,O&/3'6K^L:2]QJNE:Q;KNN=/>0>7G'F12+AU!]<A6'^[
MCC.0G]D-IUYJVJ6#S37VHA,QRLHC1E7:IX ( '7DG\: (_!6L3Z_X-TO4KK'
MVF6'$Q P"ZDJQ ]"5)_&L77+O4+GQ'KVDS26[Z7'H0G$+1$DES*IR<X)R@[=
M/SKI]!T>'P_H-CI-NQ>.UB$>]NKGNQ]R<G\:K7_AFUO]5FU$W5W#-/9?8I1"
MZA7CRQ&05/(+MCZ\YH Y30?%5SH>AZ9!J5M!]AC\-?VE&\#$R!84C#*V>"2'
M!&.F".>M=-I&JZQ=ZJ8+S3@MD]L)DND4J$?.#$0QRW!R&& <'@5'%X,TY#9"
M2>ZGBM-.?3%BE*%7@<*&#84$G"+R".GUJ?0/#,/A] D>HZC>(B>5 MY,)!!'
MQ\JX XX')R>!S0!F?$6_NK31],M;>5X4U+5;6QN)HV*LD,C_ #D$="0-N?\
M:JGXYMH/#6EZ=JVBVL-I>6U_;Q*MN@3SHW<(T3 ?>!#9QV(!'(KK]5TNSUK3
M9K"_A$MO*!N7)!!!R"".000"".015/\ X1V*:YM)K^]N]0^QN)8$N-FU9 ,!
MR$5=S $XSG'7KS0!@MXBUF]M/$<CZ9ICV&F27-O+%+,Y,VR)6'\.,'<0<_\
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M?M4VQF5F"JI9BJ_>; !.!D9/09%9&C7VK6KZ1I.K6"M</8;YKR%D"+(N 4V
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MDN]Z?-)NB(."V[I&>W<5>\5V-]>SZ UE9O<"UU2.YF*NB[(PCJ3\S#)RPX%
M$NGZ_!!I<CZKJ=K)-;7'V:XFBB:-5=B-@93DJ2K)[9;CJ*EF\5Z!;W;VLNJV
MRS1S+ Z;\[)&QA6].HZ^HKD=;T/77'B>SM-)>X34=1M+Z"<3QJI5/(#J06R&
M'E,>F".^>*?K.@:S>6_C)8=+D9]3N+62U_>Q#>(TB5B?FXP4;K[4 ;?C3Q2-
M!T6ZDLKB#[="T0*21,ZKO<##$$!6(.1D\^AK<.K6*WZV1G'GL_EA=IQOV[]N
M[&-VWG&<XYK@=5T3Q"=,\4:5%I$EV-3OEOK6Y6>)5 )CS&X9@0R[, @$$8Y%
M:W]CZJGB]=3T^"ZLXY;L->Q2RQR6T\?EX\P+N+)+PJY7&<<Y'- '4W^JV6F!
M/M<XC+ABBA2S,%&6(4 G '4]JBEU[2X88IFO$:*6(3+)&"Z^6>CDJ#A3V)X-
M9/B6TU2YU;3OLEA]HL_)GCFEBD2.6-F"[/G8AA&<'=LY.%X(X/*P^&=?C\-Z
M.EM97=AK=CI,-JLR7$3PRLN0T4Z%L-'T((!(#''/% 'HVH:G8Z3;"YU"ZBMH
M2ZQAY6P"S' 'U)K-;QGX<1)'?5[91%((I,L1L8XQGT'(^;IR.:B\;:?>ZIX8
M:SLK8W%PUS;/L5E7Y4F1V.6('136!KV@ZO?IXZ6WTQV.K6,4%H3+$-[K&RG/
MS<8+#K0!V%QKNF6EX+2>\C2;>B$'.%9SA%8]%+'H"1GM2+K^EO%?2K=J4L'*
M71VG]TP&2&XZX(/T.:XKQ#I'B'4IK]8]%<H;FPN+=HIXHQ(L;QM()/F!>0;6
M W97 &"#UU+S299?'D+6LL0L[^!9M4@!R=\#+Y;#W)8*<]0GM0!I^+]9N=#T
M!=1M'A3%U;1R&="1Y<DR(W<8(#9R<].E6[+Q)HNHVUS<6FI6\L5L^R8JWW&[
M CKSV]>U5/&FFW>K>&I+:RA$TZW-M.(MP7>(YDD8 G SA3C) S7/:[X9U?4[
MS5-<LK3R;E_L)BL99@AN/L\C2-O9"0I8-M4YXVC..P!VUAJ=GJ:2M9SB3R9#
M%*N"K1N.=K*<%3@@X([BH+KQ!I5E<B"XO41S*L/()42-C:A;& QR,*3GFJGA
MNU9$NKR71/[*FNF4R1R3++*Y48W.RD@\8 Y/ _ <3JMOJ^E:/-IE]IS& ^([
M>ZBU 3(4E26^1P"N=X<;MN",8'7M0!Z!_P )!I7E^9]MC"BZ%F201MF) "'C
MALD#!]:?-KFF6]X+66\C24R+#SG:)&&50MT#$$84G)R..:XB]T/75.I6<.D/
M,DGB&WU2.X$\01X@\3, "V[<-C<$ >A/2I+GPSJ]QHFO>'I+9F34-3-W!J D
M3:D;RK(=PSN#I@@8!!PO/7 !U-GXHTV\O-5MUD:/^S91#,\B%5W;5;@D?[8'
MOVJQ'K^ERVLUPMXFR"40RA@5=)#C"%"-P8Y&!C)R,=:X_5/#VNR2>)19V0<S
M:G;:G:LTX1+@1I"#$2#N4DQ-R0!]WGT+K1M4F6PUNR\.&TNK?48KJYL'N4:>
MZ58WC)+[BA90X*@M_#U'  !O^%M>GUN[UY)7B>*QU#[-"4B:,[?*C?#!B3N!
M<@].G053T;QI:MJ%_I^LZC90WB:I)9VJ*"F]0%V@Y)Y))')Y/2K/A6SU"WU/
MQ%<WNGR6D=]?K<P!Y$8E?(C0YVL<'*'_ .O6)=>&=2O+#Q#HKV)5-2U87<=[
MO0QI'F,[L;MV\;#@;>N.<9( .O37]+D@O9DNU,=C)Y=RP4_NG&,J>.O(_,4W
M7=>M/#^EB_O!(8VDCB4(A)+.P5>@XY/>L&ZTF1_'ZFTFC-A?1+<:E"#D^9 P
M$3#T+$@'U$6/6M+QKIUYJGAF6WL(//N5N+:=8@P4N(YTD(!8@9PIQDB@"C%X
MRM[7Q)K%IJU[:V]E MJUJQ0HV)0Q._)/<#G  R,UO7NMZ;ITJQWEVD+$J"6S
MM0L<+N;HN3P,XSVKB]<T+6M1B\;>5I4@?5M/@AM09HOF=4<$$[N,%AR?0U)=
M:)J;:]JD=SX?&IZ;J_E2JTETJI;.(T1DE3=\RY0,"H;J: .@\;:U>>'?"&H:
MO8K T]J@<).A96&X#'!![U!)KU_I_B_2M$NS:7:ZE%,ZO;1M&\!C4'+*6;*G
M. <CG YS2_$'3+[6? VJ:9IUJ;FZN8PB('51]X')+$#'%9<GAVYG\7Z+J6DZ
M,-$CM=YO9LQ(;F,KA8BL3-N^;!RW3''- '30^(]'GD=(]0ARD339)VJT:G:S
MJ3PR@\$C(%5XO%&E:E')%I6IVLUTUJ;F$<L&3 PV.,CD9P>,CI7(Z5H_B*/4
M](O;O1'B>#3KRUN$CGA$2.[1E?*0-A4.P@=_[WK4NF:#K-G;^#E?2I=VF://
M:7066+Y9&2)0!\_.3&>?<4 =+X7\0KJ^@Z)+=R)_:-]I\5V\<:''S*"3WP,\
M<FD\2>(AI%[I.GQMY<VHW#1>:8F<1*(W<L .IR@&/?/:L#X?Z-K_ (8AM-/O
M;*26TFLH?,E:6,O:SH@1HR0V6C.W*XSC)'?C=\0V5]<^(?#5S:V;SP65W)-<
M.KH-BM!)&.&8$\N.G;- "Z5XJTV2$6M[K>FS:A"DAN&MSMC_ '9P[<DX R,\
M^M76\2:.EM=W$M_%#'9J'N/.S&8E/(+*P! /8XY[5R<OAK6+OPGXFL$MOLMY
M=:J][:^;(FV9?,2102I.-VS:<^M+XBT'5=>&MZC#ILUO/<Z!)ID5K)+'ODD<
MDY)#%0%Z9S_$W'J =))XQ\.Q?:-^K6X-NH>09)(4YP0,9(X/(R.#Z5IRZA:P
MZ8VHF4-:+%YWF1@N"F,Y&,YX]*Y1]+U)O$<EZ-,E\DZ#]C!\R+/F[BVW&[WZ
M]*T]!TV\M_A]I^DW,7DWD6F):R(S [7$84\J2,9% "67B:UU4:%<V]_!;1W\
M33?9)XSYLJ^7N^4Y&-O4G!!J:/QCX<E:%4UBT;SM_ED/P^S.X ],C!XZ\9KG
MM+TG68D\"^?I,L9TBW>&[_?1'8?L_E@\-R"WIGCKCI4&GZ!K$.D^%X)-+D62
MPUN>\N!YL1V1/]HVG[W/^M3@<\'\0#LH-?TNZTY;^WO$EMVD,2E 2Q<$@H%
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MW+YC(67( XR,CCC-=AX2U(ZQ;75W/+,E\)VBN;&0\6;K@>6!WXP=W\6<C (
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MH88F?!)8'@=>U '=T5Y=IWB+6M?M;6PN]0BTR_ET2&\BF:7R=\C-(&EV[2&
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MVFRW4EC96]M)=2F:X:*,*97/5F(ZGK4 U_3VU1-/5Y6F>1X0ZPL8_,5=S(7
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MCQ'I<3:C)=6=_H\MWOE(!F<21A9!'SY0(=L*#TQD BMGX;?\DV\/?]>,?\J
M-FXUO3[76+;2II76]NE9X8Q"Y#A<;CN QQD9YXR*T*X[6^?BGX4&<'[#J'(_
M[8UB:5J>KB/P]?3:S=SM=:[=Z?-%)LV/$&N O 4?,/+7!]L=* /2PRMG:0<'
M!P>AI:\KTO59=)TNW@-\XCOO$5[:337-R1L423E%WX)4L549_EU%^4ZTNHZ%
MI4GB65TNKZ[@DEM-I81B%W12[+\SKP-WMR,T >BT5Y[!J.I7VH7L46MQVMQI
M6I);LMQ+EI(@%X:(* QD!)##G)XZ8J&XU745FU*RU*6\B>XM+U[*[M9]UO<*
MOS+C',4B+\N,<\G)- 'HZLKJ&4AE(R"#D$5EWOB/3-/U-=.N))_MC1&98HK6
M60E 0"PVJ> 2 ?J*@\&JJ>"]%"RM)FQ@)+-N(S&IQ^M<WXG;54^)%D^BBV;4
M%T&[:%+E24=O-BPIP1C)[T =OI^HV>K6,5]87,=S:RC*2QMD'L?UXQ5AF5<;
MB!DX&3WKSG0[G3]/\!:5'IFH7<<EYJ0CG1T43O<.[-+"W($1R&!(Z <9)&:*
MWUWJ<.@B\U";=!XHN;,M'<=8E6?:"V!NQM #$9X]: /5:*X#3-6U'6;\7<>K
MP6KVNKRVMS:O*6W1+(R+'Y>.&*[7#YS^' [^@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ IKHDD;(ZAD8$,K#((/
M8TZB@"E9Z-IFG6SVUEIUI;0.NUHX8516'H0!R.34L=A9Q0VL,=K"D5KC[.BH
M (L*5&T=OE)''8U8HH **** *3Z1IDEZ]X^G6C73IY;3M"I=D_NEL9(]J;#H
MFDV[6S0Z991M:@BW*0*#"#U"8'RY]JR]6\6+I&HI;W%DZP-=06@E=PID:4J
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MKJQU5=.M!J++L-V(5\TCIC?C/2N&T?Q/<:"FJ/=V-Y<Z8NO36TE\UP'^SAI
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MPN;_ .S&Z:-I/+58PVT9.#R3D 8[')% %VPT^RTNS2TT^T@M+9/NPP1A$7Z
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M&P*LW) \Y1@] /89EU#QR;"XU56T>X:WTJYA@NIO-0860(0ZC.3PX./3/TH
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M8QFWTBPB,2-''Y=LB[%;JHP. >XIL_AK0KFQAL9]%TZ6T@;=% ]LA2,^JKC
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MD0XV,0ZD#)&,\U6LO&(UN"QADTVYLXM7TR2\M)O/&XA50L/E.5($BD'OSTH
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MOD=!D=<$XI=5\1?8-4.G10PO.MD]ZWGS^4NQ3@X.TY/KZ<>M &[15>QNUO\
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MVFUIO+VF1PH/W3D9/- &;X8\%2>%I[8V6I+Y"V<=M=0?9\+<-&-JR_>^5]H
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M$JE >G7.* +-%9SZ]I::C:6!OH#<W:-)"@<'<JD G\R![FM&@ HHHH ****
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MDET^0"-L0XC.5PP^5\8R#SCK7HMC?6NIV<=Y8W$=Q;29*2QME6P<<'OR*L4
M>8:1IJZ1X1\&D>'YHKL>2E[<1V3M-;.L#KN9 ,L<LR@L"J[\XJ+3+&ZCT#PA
M;7&E7XDLM=G>=9+-B8XO]( 8X&-OSIR..>.!7JE% '*^%K>2S\0^*8I;*:(S
M:B+B*4PD1O&88E&U\8/S*W Z8YQQ2>+[=I]6\+,MG-.L&J>;,T=NT@2/R)5R
MQ .!N9?SKJZ* /,)H[V3Q'82QZ/J%O\ 9O$4SR)':NR%&BE03&0@[@Y*_=(5
M00"!C)T/!\:R6>FV6L:!>KK&EI-'<7,T#",[L[W5_NR^80#@9/.3TKMK;4;.
M\N+F"VN8II;5Q'.J,"8V(S@^AQVHAU&SGO[BQAN8I+JV56FB5LM&&SMW#MG!
M_*@#SK0+&\M]+^'T3Z=>QFSNIS<*UJX\D&*906X^4991SZU&FFSPZ:CC2;L1
M6_BU[HQK9ON$#,V'5-N2O(Z"O4J* .&N=(N(/&<EC;0*-)UU5O;Q>!Y4D)4/
MQW$@,2GZ,>]=9J]O-=:)?VUL=L\MO)'&<XPQ4@?K3-/T6STV[N[J#SVFNG+R
M/-.\N,DG:NXG:N2?E&!6A0!YO+ ;SX7>$!!9332V\NF,4C@9VA\MX_,R "1M
M"L#]"*HZMHS-!XNFAT:X-S)K5I/:.ED^YE7[/N="%Z923)'I[UZ/:SZ;%J=U
M86LT0NP!<3VZ/DKN)^8KVW$$^YR:OT <#9JQUW4]-UC0[ZZFEU5+^RNA"WDE
M %\MC*.$,>""IYXX!SBLZ[L[P6FLW']GWK+#XKMK_:+9RSP*8-SHN,OC:WW<
M]*]&U#4;/2K&6]U"YBMK6(9>65@JK^-6: /++R/4GN]:OH-*U!K(Z_9WLT)M
MF#W%JL$88JI&6PZABO7Y<$9XJ/6;*34+#QT]MH]\RWL]I-:@V$BF4A(PS*I7
M.00<\9KU>B@#RSQ+HWVV3Q]+%HT\LUUI\ LW%DY,DH1\[#M^\"4SCV]*/%(C
MNM4URQGAU)[;5=.M899DTZ:X^SE2Y^4(IP<-G:VT@X/->BW.LZ99W!M[G4+:
M*90&9'E *@]"1V'N:H#P_I5]>2:M;7-VOVO:\IM+Z1(IR%"AB%;!. !D=0!0
M!J6$EK)IMM+9;?LC1*T.Q<#9CC QQQVQ7!:#I.[2_%DMU;:O#)+J=Y-"BFXB
M\U&^XRHI ;/T^M=U;WFGB[?2K:>#[1;1*S6T9&8D/"Y Z#CCZ5<H \CN=#FU
M/P/X T>[L-400M''?"*WE1X%^S/&Q) ^7YF _P 175^&M5U;3;N;P[KEI=W!
MLP!;:K#9N8KF/' ;:,+(!P>Q[>E=C5:'4;.XOKBQAN8I+JV56FB5@6C#9V[A
MVSM/Y4 <)X3OKW2/ +6:Z-J4NJ>==F*U>TDC#%YI&3<[@*JX8$DGI[\5TW@O
M09/#'@W2M&FD$DMK %D9>A8DEL>V2<5O4R::*WA>::1(XD&6=V "CU)/2@#C
MO#D$OA/4?$-I?6]R]O>ZE+J-M<0P/*KK* 60[ 2&5@1@]01C/-0>']$O5U"]
MNKJWDA75]5;4&B8<Q0Q*HB#=@Y8(V/3([&NHM?$FA7TD4=IK6G7#R\1K%=(Y
M?Z 'FM.@#B--N&T[Q_XKO+BRU'[/<)9B"1+&9UD*(X;:0I'!(J/0O/\ #C:O
MX@UBQNH7US4T*VT,?FM;1[0B-+MR%X&6/(&0.M=W4<L,<X42H'"L' /3(Z'\
M#S]: '2.(XV=@Q"C)"J6/X <FO-O#DVH67PGMM&AT?4'UAK:6!;>6U>)59F;
M!=W 4*,@GGZ9->ED@ DG %4;'6-.U.6:*RO(IY(0ID5#RH894X]",X/0]J .
M%L=)E\,^(_"%J\-Y<6^F:--:SW,-I+(GF'RL<JIZ[6^F*K^)/"6I>.+[Q#?I
M#)8Q2Z.-,L1<#8\["42EV7JBY55&>>IQ7J%% &#I?B%KRRA233-0@U#:%DMI
M;5T5'[CS,;"O^T"<CID\5>U[3?[9\/:EI?F>7]LM9;??_=WJ5S^M3WFHV>G^
M0+RYB@-Q*L,(=@#([' 4>I-6: .)LKV]M?A_%H\NE7AUF&Q%E]G6!BCR!-@8
M28V;#P=V> ?7BKGA/19-"L;2SN"\BZ3I\=FL@0_.Y :5E&,E>(P/]TBNJHH
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M@@9XYJG>6=_J7C&;Q#9P7$,-OIITZU>2)D:2:609?:1G8G!)(&>2.!FN[HH
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M 8IG:6 _BQGWH RM U35=?L=-UJ'4+>*UNS,LMK)&#LP6"!",$N"OS9.#\V
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M4C&">OX]: .#UO\ M*S\8:U/8ZCY5S:^&XYO.DA5RY66=@".  <<\?3%6_\
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MR)D.K1M@;3DKD$ '!/IFN@TV3^R/!<5^^ZYD@TY922JAG58]P7@#W ^M6_\
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M?.8HH^<EF?;GK)T Z+[\ %_PQ]ON]-34+G4;J1;RVB80S0HAADV_,RD#H<C
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MS3NCQDRI(\;*$.1E3@YZ'IQ0!T,OC31X;^]M'-V&L687<GV23RX-L?FY9MN
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M1]U+;<6PI[C>S@'NJI6A+I-\WCNVUE1;_8H].EM&!D(DW-(C@A=N,?)CKWH
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MGGI5BO,VAL]/TSP1=VUW,)+[4+=[AVO'82_Z.P;(+8QD+VP#BLMVMA9R7?\
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M*8HKG<CW$1C#^;&3PP#':5'(P2?2@#JJ*YOP-J6HZOX9COM2DA>:2>< QJ0
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MI#;O;Z9;&*=ILDM(8PYV^FU64Y.<G(XQFMIO%)B\2IH9\B";]UY4=SN0W4;
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MKH"O0;U)!/KZ<MO/$\ND-XGN;;1K,7%IJ=K;RLLI4W E6$*[';RP$BC'MUH
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MJLD+LFU$&'?<5)&!P 2:99>)!K%_X1O/[)MO,U/3IKF&623+V[;$+(#MZ'<
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]4@65;!K1Q,S^479$8MRH&#NP<[3Z\ &G<>#K">;4MLUQ%::F5:]LXROE3$
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MRPU'ROMUC;77DMOC\^)7V-ZC(X-66574JP#*1@@C((H \TU>YO;31=1NM/\
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M>>0:V&TG37@F@;3[5H9I/-EC,*E9'Z[F&,$^YJQ#!%;0K#!$D42C"HBA5'T
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M'4>^*](J#[#:?;?MGV6#[5MV^?Y8W[?3=UQ4] !1110 4444 %%%% !1110
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MHO,0AE*NC)D9!![$$8'- '-^&M??3K?4X[L.UW/KMS;P137#.%VH&/SD$[
M<<=QP*N)XQU"]U/0;>VTOR%O+FYAN5N7*L#$C'Y/E^93PP;N,# R<(W@2Z$4
MDT.NM#J8U-]2@NDM1MC9UV.A0L=R%<C&0?>M*;PW>7%SH][+J[/?6$TDCRF
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MCYE4L 3D'AL XYVM6U6#2-/-W,&<%XXHT3&9'=@B*/JS 5@R>"5>'5K$7_\
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M<&L/XA0RW_P^U$VJ2,56*X*;"&*)(KL-IYSM4\4_Q39WLLNCZYHL*7-[:3;
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MEU;NRY5%9E4)A=WF J,@G!R>!Q0!V$^HV=M>VUE-<Q)=71800LWS2;06.![
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MT0ZG8Z?.8H%6/][Y:OYF>1(2Y8!"0HVYZU6LM:U#3EU,O?2W$MWXD;3XVFV
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MVJW]S'=Q:EI5Q=2VR0!-KQ1JX*D<Y/(.>.F * /2ZK#4;,ZF=-%S$;T1><8
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M'@A1][,TA;<&ZJ5C"@<=2?3$/A?Q!=7^FZ?KEY=7C/J$+A=-$*;6;.X-&>"
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MI:7)C)LAJ4]PBLA)W;W(().W@ #Y1UK4N?"VCW8U 7%JT@U%56[!GD_>A1@
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MJ^C>$]8T^+PC',;$_P!CF?[04F<[@Z,HV909^]GG%=U2,RHC.[!549))P *
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M8D5LX<#<$R68[NP R/2CQ?X7U[Q VJ0126,EG<VD:6HN)77[-*K$L=H4AMW
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MJ.BY[XZ9//KGK3+BR@OYK>65O,CMY/,2,$;?,&0&/J1S@=CSU P 9OC:3R?
MNO2B=X&CL)F21)#&RL$)7# @@YQ7$7LMI?ZI=1SZG,8AX5CN B7SJHD!;YP
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MI#C]XK#(!!K%T"_@LM!LK2^?R[:37[F."^ED,4&H+L=O.G)SNW$G"@@,RKC
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M.5)# $C*D''T&,:/P_-)XUU58_MECIDFE6UG&\"J%?89=R@D$C =<$8ZGTX
M':7XOU37]5@ATS3[-;62PL]1+W$[!O*F+@K@*?F&PX[>_/#='U^<^'[&2STZ
MQL!<7MY#($.Y(V260?*@PTC.RY^4=R:W;#PU9Z9J[ZA:2SQYLXK);<;?+2*/
M=L &W/&YN_>J%OX'L[46!@U+48Y+&>XFCD5X\GSV+2*?DQ@DYX ([$4 9=AX
MLU+6-1\)W$8@MK+4M/GN[B%@6(9/+!&[CCYSCCZUI:)XFU'6+K3)X],8Z7J%
MN9Q,$93;<!D#$\/N!ZKT/'(YJ2P\$6&FIHRV][?_ /$I62. M(I+QR;=R/\
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MM[*&>1FA2=)2!O"D%E()((/ID9Z4ZX\3ZY$+NU@TR"ZU/3TC:XM[<2,DSO\
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MGY,D ,<=^>IXJ)_ -C]DMXX=2U*WN;6ZFNH+R&1!+&TS%I%^YM*L2>"#V]*
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MQAK&K7>ER65M>VEJD8EEC9PT9DW A&(_C'>@#H[N[M[&TENKJ9(;>)2\DCG
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M,6[# Q[YK"O-(DTOQ#X1O6?S(;;[3:W,N.LLZAO,/IND0CZN*J:UX<UJ^O\
MQ--:6RJUP]A/9F650D[6[!V1L'*@XQDB@#K(O$.ES)*R766BE$#Q>6XE60C(
M7R\;LD<].G/2JUWXAAMGTV[5UDTZ]N!:;]I5HY6)"DY[%AL(QD$CWK FT*35
M-/:6X\+RZ=//<1,YM+U!=QE%<"42!@IP2% R>"V1SBH]2TW5[GPGHFBZC+YV
MIS:I$[2!5#>5'/YN]]OR[O+4;B.-S8SR,@'?UD/XGT=$D=KP!8KH6;GRW^68
MXQ&>/O'(X]QZUKUPVO\ @R\U;5M6C@G$&FZG;)-(RMAEO(@5C8#T_P!6Q]X1
MZT =!JNM6T $*:G#9S+=P0,9H2P9G93Y8Y'S,#@$9QN!K#\0>-O)TC7WTG*7
M>D31Q2-<6[[#DINQG Z2#'/O@CFC4M&UBZ\):='):B;5GU"TOKU8W4!2DR2.
M 6(!VJNT>NT51UKP_K4]KXPM+?3C,NJ74%Q;2"9 & 2%64@D8(\MNOMC/8 [
M"W\1:1=17LL-_"4LC_I#,=HCR,@G/8CH>A[4Q_$VCQ6UW<2W@BCL]OVD21LK
M0@]"RD9 /8D8KE-=\-ZSJFH^(I[6V\K[3'I\MJ99%"RO;R-(R-@D@'(&<8_J
MOB+PQJ?B-=?OHK5K2>[T46$-O/(FZ20.SY8J2H'(4'/=N@Z@'3:QXITS1;34
MYIY'>33;<7,\*1L7"'.T@8Z$J1GH,'/0UJ6EREY:QW$8<+(N0'0J?R(!K@M6
MT37=>E\3R_V4;0:IH"V<"S7$982J9OE;:2!_K!R"1COU [K3WF?3X&N+<V\V
MP;HF8,4/H2./RH HZIXGT31IV@U#488)EB,QC.2VP$#. ">_\_2HKGQCX=M(
MX))M7M@D\'VF(JV[?%D#<,9R/F%9.HS20?%2R>.SENC_ &)."D10$?OHN?F(
M'MU[U3\.>%=1T/5?#:M:A[>RL+N*:1'7;%)-*D@502"0-K+G'I^ !TMGK5J4
MU.>75;:X@@O/('EQE?);:F(CR=[Y8=.NX#%.D\4:)%9O=S:C#%#'.+>0RY0I
M*2 $92,J>1P1T(/2N3G\.:VTNH7<-H1)'XDCU6&%I4'VF$0I&R@YP&X8C=@9
M"_@NM>&M4OCK>H06#^;J-YISK:M)&&5+:169V.[;D@$  G[J_@ =QI^HVFJV
M27EC,)K=RRJX!&2I*GKSP01534?$NC:3<M;7M_'%<+"9S%@L^P'!; !/?^O:
MM0'(!((]CVKF+_3[]O' U*.R>6T72);7>KH,R-(K 8+ ]%/- &O-KVF06T%P
MUVKQ3Q>?$8E,A:/ )<!03MP1\W3D>M57\5::NLZ=IL;O,U_;M<Q31(SQF,%1
MG<!C!WCG/ ZXR,\QX9T+7/#\VB7<UA).L>AQ:9<V\<L>^&6-LAAE@I5LD<'/
M"\>DFA^%M4\/WOA<K MS%9V=W;W)CE $)FECD&,XW*-K*,>@X'8 Z33=<M6T
MB.[EU2&]6:>6.*6WA8>85=AL5!N+%0I!QUVD]*E/B32/[.BU!;U9+69&D1XE
M:3*+]YL*"0%Z$XX[XKC+'1/$>D6^C:A!I9GFL;W4#/8^?&K217$K.KHV=NY?
MEX)'5A5W4=*UB'5[#5(= @O+>2UDMKC3H+A8C 6DWJP)PK=2&]^1F@#M[>XA
MNK>*XMY4EAE4/'(C95E(R"#W!%25E:5'<6(MM-72H;6RBM5(>WD'EQOG'E*O
M7 '.[ !]!TK5H Y+Q?K&OZ#83ZC:RZ=]G%U;P0Q2VSNQ$CHC,6$@'!<X&.PY
MYINKZUK.@WVCKJ%WI[6MWJ1MWDCMV0^5Y#N.KMAMR$=\@CIWL>/--O\ 5_#8
MLM.M6N)S=VTNT.J@+',CMRQ'934GB.QO;_4O#4]M:/(EGJ/VFX^=!L3R9$[G
MDY<=,]#0!H0>(-+NM.CO[>[$MO([1)L1BS."05" ;MPVG(QD8/I5JPU"TU2R
MCO+&=)[>3.UT/&0<$>Q!!!!Y!%>?-X>U^V(U"+2OM+0:U=W1L6N$0SP39PRL
M&P''!P2.XKM]!LQ9Z8%_LZ'3C)(TK6T1#;"QR=Q'!8]21W/?J0#.\6ZSJ&C-
MHHL&M0+_ %**RD-Q$S[5<,=PPR\C;^M0V?BF2'Q+JVDZG+9M!86:7CWT ,<<
M2DL"D@+-M8!=W7D=A3?'&E7FKKH:6VG&]CM=4BN[A-T8!C57!&'8 GYAQ6)>
M>&=9_M76M2T/2K73[>?2S;KI\QC*7=QNSYCHN8QA<J"<YSSQ0!V#^*-%AM;F
MYFOTACM65)_.5HVC+8*@JP!YR,<<UD^(_%\47A36K_0;RWEN].4;U>,L%SC'
M&1P0<@\@^]<[?^'->NK;Q.(])G_XF<5D81/>1N^Z-OG#?-@'OP<=,>USQ)H&
MLZB_B_[-ILC#5+&TAMB98QN>,ONS\W'WQ^1H [J&_MKB\N+2*0M-;D"4!#A2
M0"!G&,X(.,U)<7$-I;R7%Q(L<4:EG=N@%<_X5M=5THW>EWMO))9QRF2TO7="
M\BO\Q64 Y+J21N_BZ]>NGK]H+_0KNT:R^VK,FQK<2;"ZDC(#9&#C.#D<XH Q
M]?\ %/V(:9-97$20/JD=E>BXA960,A<_>QM.-IY!X-:L/B72+BQ2\BO5>%YS
M;J%1BYE&<ILQNW<$XQG STKD1X?\0)'80R"ZO;:UUN&ZA:[EB-PD"QX;S&#8
M<AB0.IP.:>NDZ_;3W;QZ47AGU][QPLL0E\AH0@:-BV$;<.>0VTG')H V=2\1
ML9O#<VE7$$UCJ6H&UE8H22!'(W!R-I#1X((SUZ8JSX8U6\U,ZRMZT3-9ZG+:
MQF)"HV*J$9!)Y^8UR^F>'=;M=,\.VLNFD-I^NW-W*5N$?]RYG*MDD$_ZY??@
MYQ72>%;"]L)==-Y;-"+K5);F$EU;=&RJ >"<?=/!H UM2U6PT>V6XU&ZBMH6
MD6,/(< LQP!^9JO;>(M(N[2YNH;Z-H;63RIB<J4<XP"",Y.X8]<C&<U2\::?
M>:IH"6MC;&>;[;:S%0RKA8YTD8_,1V4_C7/:KX<UJ[U;6KZVM-I_M*PO[9'E
M0"Y$"J&0X)VDX.,\9 H Z/4O&&E:=H]YJ)DDE%I(L4L*1/YB2-C:K*1E<Y')
M'0YJ9=:MSK%P@U!&CBLTF:R6W;SDRQ^<]\$8&W;G@FN8UWPSJ>KIXBU&WM&A
MGOH+.*&TDD0,Y@D+EF()4$[MHY[<]:UDM-2/C6ZU=]-D6WDTB.W4"6,GS%D=
MROWO1P,],YY[T 5O#'BQ]6&E7EW>Q1Q:O;[K>R-JZNLN-Q"OT90AY]QG..!U
MEM>079F$#EC#(8I/E(PPZCGK7!/I%W8?"O2+2X5+37='AAEM%>16W3Q  *-I
M.0^2GT>NWTFR;3],AMY&#S8+S..CR,2SM^+$F@"MK?B"TT$V*W*3,U[<K;Q"
M*)G^8Y)S@'' )]\5CZ1XPA.IZK8ZQ>V\<T6J_8K0+&5RICC9 W)P27(!)&3P
M/2KGBS3[Z]71I[&V^T/8ZG%<R1!U4E KJ<%B!D;@?PKG;S0-:FT[7HDTUS+=
MZ_;7\.)H^8D: L<[N#^Z;@^H]\ '9S:[IEO?1V<UVJ322B%<J=ID(R$W8VAB
M.0N<GTK1K@[+0]2@UR\M+S0;>^LY=1:_M]1DG4K$&??AHR=V]3D*0,=.17>4
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M2GAT&SN+.9YO+^9D;=)CI(%*J"IX_/- 'HFKZM::'I-SJ=^SI:VR&25DC9R
M.^ ":M*D9D\X(N\KMWXYQUQFO*_%&I3:UX5\=0WE])'+IEHB111,8U96@5S(
M5/4.S,N#G 48P<FO4(+B&0^2DT;2HBLR*P)4'H2.P.#^5 $]%%% !1110 44
M44 %%%% %4Z;9-J:ZD;:,WJQF)9\?.$/)7/IGG%6J** "BBB@ HHHH ****
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ME"$W;QF/Y,A<#!8G)YSU;W=M';"YDN(E@(!$K. I!Z<]*E#!E#*001D$'@T
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M#N&=@(&?Q)X]<'TH PHO"5S!;7MH+^UGLKK4)KM[:YLO,1DE+,T;?/\ -\S
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M$D XP&'2FRV]]8C5KFWTF\DLXO%*WL]M':L#/;>0BET4@>9B0!L#.=E>I44
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M6I=7@LA'>3.9'(D?87(P7\O.S=C^+&?>@#&\-ZUKFM_V-JZF#^RM0A9YHG9
M8F*[D$6.21@A@WH2,8Q5KQ?K5[HGV:9$N5TXQRFYN;6$3/;L-NQF0Y)C^_N*
MC(P.E7M,\)Z)H^H37VGV(@FE9F($CE%9OO%4)VH3WV@9JY?Z/9:E+'+<K*72
M-X@8YWC^1\;@=I&0=HZ^E 'GFH:EJ%MJ?BW6]*O[</;:%97N_P GS%GVK<.
M.1A6P>>O(QBM;Q!XIU*Q-Q=6<\;I;M99MXXPP02R*'$S'&"0PVA#D=2,&NAD
M\)Z)(MXALB$O;9+2=$F=5>%00J8#8  )'&.I]:AN?!/A^\>9I[%W,Z1I+_I$
MH#^7C82 W++@8;[WO0!R7B7_ %7Q1_[!,7_I/)7<:C_R*=W_ ->+_P#HLTR;
MPMH]P-1$MJS+J42PW8\^0"5%& N-W QD<8X-:2VL*V@M=FZ#9Y>UR6RN,8)/
M)X]: /-M,U[6?#&B>'9;B:&^TVYT1I5MT@\MX&AMQ(,-D[@0-ISW(QUQ74Z#
M>:Y<W]O/<RP2Z7=V8F4DH'$O!_=A>L94]R2,#DYK2L/#NEZ8J+;6S8CB,$8E
ME>7RXSC*+O)VKP.!@<#T%1Z)X5T;PZTATJS\C>",>:[A 3DJ@8D(N>RX' H
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M"GAN,;5Z8Z"HIO!F@7%S+<2V+-)+.ER_[^0#S4QB0 -@-P,D#)[YH XNVO\
M6=$LM9U>RNH&M(?$<L<UDT&6F62=4.'SD,-P(X[<YS5YIM4M)O'EYH[?Z7;:
MC#-Y6P,946U@+H,_Q%<X]\5U\?AO28KR2Z2V(>2?[2R&5S&9?[_EYV[N^<9S
MSUJ&YTV?2S=7>@6-O+?7UPKW/VJZD5&XV[NC<@!1@ <#VH 70M5_MR6XU"TN
M1+I3)&ML0HP[;=S,#Z?,JX[%6_#F_%>J76JZ?XWTV"X%M%I6FD,H0,9FDA9S
MNST7;@#&#G//:NPT;2X=%T>UTZW51' FWY5VAFZL<#IDDG\:IZEX3T75[R:Z
MO+1S-/ ;:9HYY(O.B.?E<(P##DXSG&>* .;AUC6[R";3M",276FV5JR"7;LD
M9TW?O,_-LP,?+@@@\GI4$FOW^E:EXLU"6\,R036,$,3[3'$)@@SG RJF0GJ,
M]ZZ:Y\%>'KNXM;B;3\RVL0@C832*3&.B/AOG7V;(JS<^&=&N[B^GN+%)6OXA
M#=*[,4E4# RN=N0.,XS[T <UK&J^*='LKIVGM=GVZRCM7G57E*2RK&X<)A1@
MG@CJ,CJ,T^XN_$L.O3:*=:MR4TI[P7 L0&WB4@<;B.F!^!]>-F+P7H,.E_V<
MEG)]F\U)<-=2LVY""GSEMV%(! S@=JO3:%I\^HO?R12&Z>W-JT@G<9B)SMP&
MQUYSUH Y;0O$6M7E[X9DNKFW:+7=*>Z,*P;1!(JQ,"#G+ ^8<@^@QBJNE^(]
M>U*U\)H+RVA?5?M:W#BVS@QAB"HS@=.GYYZ5UMOX8TBU;3V@MY$.G0M!:8N)
M/W4;  J/F] .OH/2F6WA31K/[!]GM9$_L\N;7%Q(?+WYW=6YSD]: .9TGQ5J
MVJ0Z9IK2!;^=+XR7$*(I<V\_DC:KY7G.XCVXQU%JRUC6]1OO[#O)[:TU"VTL
M75U); 2+)*SN@"[OX1Y9+#KE@,C'.K/X'\.W%C!9R6#>5;SO<0LMQ*LD<CDE
MRKAMPR220#@U8G\*:+<36DS69CEM(C#"\$SQ,(SU0E&!93UPV1F@"E\.O^2;
M^&_^P=!_Z *Y+PI?:UI/A_PI(EW#+IM_=/8O:B##Q[C(1(KY.2"O((QCZ9KT
MC2],L]&TV#3K"+R;2W0)%'O9MJCH,DDU4LO#>EZ8Z/9VI4Q%VA1YG9(F;.=B
MDD)G)^Z!P3ZT 86C:[J=W>?V'=W*_P!L6E_(MV5C4!K8#<CJO8,'B'U+>E=G
M6'HFGW@O+G5]6M;.#4[F..!DM7,BK&A8@;RJDDEV/3T'.,UN4 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 <3XD\572VGBZRL8[FTN-(TW[1'=A4(WE)&'!SQ\@'(]>G!K5T[
MQ9ITL4T5R\\$UI9I=3-<0L@>,@C>O'(RI'_ZQ6;K7A?5KVY\5?9'LC#K>FI:
MJTLC*T<BI(G("G*_.#G.>,8YR(=4\&ZEJ]Q<B6:UMXI]$73PZ2,[)*K[PVTJ
M 5SCOS0!TFG:_9ZCJ-SIR"6&]MD25X9EPQC;.UQ@D$$@CKD$<XKF]0UV6U\?
MWVF7GB,Z=IZ:7'=Q[O(7#M(ZMRZ'(PHXK;\.6>KP(TFKVNDVTP4)MTX,5D/=
MB64$>R\XYY/:H^D:S#XZN]>MX;"6WFT^.S6.2Z=&RCN^XXC8<[\?A0!!X8\6
MS7GANPNM2C:6ZO;F6"S\B/:;M$WE9 I.%RB%N2!Z=0*O#QKI#Q::\/VN8ZDD
MCVR16SLS;/O*>."#QC^G-86G^#-:TBSBCM[FRF2?5)[^^L2[Q0%9 0(T(4G:
MIP=I #'.<4_0_".LZ6_AL2G3V326O-_ERN-ZRD[=HV=L\C/YT 6;CQ0MWJOA
M6]L;YXM*O6NA<1RHJ#]W$Y^;<,J593GG'%=587BZA9QW20SPI(,JLR;&(]<=
M1^->?O\ #W4;W3-&T^^>T6&SN;R:62"Y<./.9V1D.P?,I<'GCY?>NWT)-7CT
MB"+7&M9+]%VR2VS$K)C^+!48)[CI0!7C\4Z:]J]X[21V2P/<K=.O[MXU(!((
MR>XX(!]J@OO$,<UIJEG ]Q8ZI!8M=(DL:A]F#AUSE2,C!'4=P,BN;F^'EY=V
MFHP+-!I:7UHRSPVDSR0/=;T=)A&0 G*G('7=[9.S<>']3U.]EU2\2SAO1I4M
MA%%%,S(6D(+,S% 0,JN!@]30 ^P\506GA/3+O4&FN+DZ7#>W1B0,RH4!:0CC
MJ0W Y.#@'!JN?$C1>*[N<74UUHPT.+4(XX8PW61@77 W'*@'&3[51A\):[IT
MVE75I'H]W)'I<&G7D%XS[ 8L[9(V"$_QME2!GCFM8V$FC^))=?U"YL8M,BTF
M.TDE9_+VLKLQ8KC:J_-C&Z@#8M=;M;UM/$ D87]N;F%@!CRQMY//'WU_.M&N
M.\&:2;#3+^XL+A+FW=Y$TKS.$2W#,R+D9RN]FPPZH$]!75VAN39P&\6);HQK
MYPA)*!\?-M)Y(SG&: )JXKQ--K6EWVBB+7;E%U+5Q:O&D,.V.%DD8!<QDY&Q
M>23WKM:YSQ1HVH:O=Z#)9?9MFGZBEY+YTC*6 1UVKA3S\^>?2@#-OM1U30?%
M>BVESJ%YJ%O<6]Z[1);H7D*-$4X11R Y'8< ULIXLTV?3+2^M?.N5NX&N(HH
MD_>%%QN)!QC!(&.N>!FFZCI-]<^+](U: 6YM[*VN8G5Y&5V:7R\8 4C \OU[
M^U<O9>"]>TJUT6>V72+J[LX)K6XMKIW,,D;R;U97V$JP/^SR": .XLK^VUO1
MH;_3KHM;740DAGC S@C@X8=?8BO-=,\;ZC)X1\-ZC'KL>H:WJ$T4<FF%(OWH
M9\/@(H9-JY;).!CG.:]-MX;BVTQ(ML#W"I]U!Y<>[T& <+^9K@E\"ZW<_#G3
M_!UVVG0I!Y0DOHIG=U".&W1J47#<8SNXSWH ZZ;Q1IT&H_8W,W%VEDTP3Y%G
M90ZH3UR01SC'(&<U63QOI#W2P 7@!OO[/:5K9U1)\@!22.,D@#\/45CZKX6\
M0:AJS7#2Z?.D.JP7MI+-*X9(4VYB"A2%Y#'<"=V><=0LGA/66M+B(&PW2>(8
M]67]^^/+61'VGY/O?)CTYH N:#K\XN]8MKV:>\E769;6U1$7<L8BC;H,#:-Q
MRQ]1D\UT5_J4&G" 2AFDN)1##&N-TC[2V!D@=%8\GM7&VGA'7--\2W>O64MD
MMS<Z@[RQ-._ES6K*HVM\G$BLFX$?WB#Q72>)='_MS38;.6QM+N S!IHIY&C(
M4*V&C=02KAMI!XXSR* ,:\\33P>+],*?;GL;C3;J1K)+?+F6.2)0< ;@<,PY
M.*TI/&>D#3[>^A:>XAGLFU >5'DK;KC<Y!QTW#CKUP.*S=)\,ZWI^JZ/=W%W
M#>BQL+FU=YIV,C&21'09V?-M5 I8\GKCM67%X)\1)X;L=$DFTZ:VBTJ6RDC:
M:38DS?=F V?/QQ@XV]0: -XZE<W/CJ"TM[^3^S[G19+F-55<!_,0*XRN<X;H
M<CVJ?P5J5SJ/@/1]2OY6GN9K199I G+MC).%'Z 53TSP_J]GK6F7\PL66UT8
MV#JDSY,FY&!'R?=^3&>O/3M6EX2TF\T#P?INE71@>YL[<1$Q.2C$=#DJ"/RH
M ATOQKI&KW%A%;?:E%_&\EM++;LB2;/O $]P.?S]#4\'BK3;B>SC0S!+X-]B
MF*?N[DJ"2$/K@$C.-P&1D5SVF>#=5MK/PM:W+6132EN$N3'.^7$B,@V?)U^;
M/.*GTSPEJ,>G^'-+U"2V:VT&<2Q3Q.V^<(CI&"I4!.'!/)^[[\ $EIXN@U;2
M=+OIOM^FBZU/[/$J1*WFD2.H1SA@ 0O/(YZ&JE[XDNGUK77EEU&SLM#>"1OL
M\"R!X]N^3>#DD$'C'( R.<TL'A+6H-$TO3=U@PT_6/MH?SG&^+S7DZ;.&^?&
M.G'7GC3AMCH6K>)-9UJ>PM]*OFA82/.?D"H(\/N4 9/N>N* -J#5;>XN;:"-
M9&:XM_M*L "H3CJ0>#R,>O..AK(U/Q%*NN7NA007$4L6FF[%VJJ0I)(7 .>A
M4]1UQ47@32?[-T=W%PUQ"[M'9.PY6S1F\E?<8)(/<,*DU+0]2E\47&IVAM&A
MN-+-BZS2,K*P9F4C"D$'=@],8[T 5O"7B^WOM&T>#4)9UOY=(CO9)YXC&DP"
M)YC*V #@L,_7CBM>P\2Z?J&J?V<GG1W+6_VJ)94V^;%G&]?Q(R#@C(R*YJ/P
M3J,MGH5E=R6JP66A3Z3<O%*Q8F1(TWH"@X'EYY(Z^W.MX5TO6]/2./5X=(4V
M\7E+-8J=]QT^=LJ-G ^Z"<D]1B@"CJ^M3VGQ"BTRXUXZ=ILFE/=<^2N)%D5>
M&=3V)./:I/"WBR2\T"6]U*19HSJ,EG87$4>#?(#A'5>F3\WH/E+<"K-WH^KC
MQ['K]K%8R6Z::UEY<MR\;DF17W<1L,?+C\:QH? 6HVXDU"*YM5U(ZV-72V0L
M+=?D,;1YQG)5F)?;UQQ0!T$WC32+:VEEN&N(WAO([*:$P,TD4KD!0P&>#N4@
MC@YX)IB>-M.>]BLA9ZJ+N1%D,!L) Z(TACW,,<#(.3TQS67J7A#4KV6]OX_L
M:WM[J5C=/&TS;$CMF0A=P3)8[6YP,9'7'.RND7O_  G,FL,+?[$^G+:8$C>9
MN#E\XVXQ\V.M $D?BK39)[5 THBO)&AM;@IB*>1<Y56]?E;&<!L<$U%!XPTR
MX2P=$N0M[=R641>+&)D+!E;)^4_(W7KCCMG'TSP;?V^DZ'HEW+;/8Z->K<0W
M".WF2I'N,:E=N%/(R=QSM]^$U;P)<7EQK,UK>QQ>=*E_IRL#BWO!M+.?8F-.
MG]^3UH Z)_$5HHPL5Q),9)42%%&^3RCM=ADXV@G&21R0.I%9Z^/=$F%F;3[;
M>&[MC=0K;6DCED#A&X Z@MR.V#5;6?"^H+<Z-?:,+&YFT^"2VEM]1R$GC?82
MVX*Q5]R YP<Y-6;70M3B\5:=JD@L1!!I\UK*L)9,/)(C_(NW&T;,<D$YS0!M
MW^IP:>]M&ZO)-<R&.&*/&YV"ECC) X52>3VJC'XGL9)C"([D2_81?A&BP3%G
M'?H0>,'FF>*-$&O6MO:RV5M=VZR%W669HGC(!VO&Z@E6!^G!-8<?A?Q!:SV4
MXO+6^G_LA].NIKJ5@P);<KC"G?W!SM)ZYH W'\6Z8--AOHA/<12V2ZAMACRR
M6Y&0[#M].IP< X-87_"9)IOB+7YKVYN[C28;2SN8O+M]P@1Q(7<X (7A3SD_
ME3-*\,>)= DTFXL'TR:6/2;?3+V&>614_<YV2HP4D_>;*D#KUJ75?">L7R^*
MU66R<ZSID5E%(\C*0ZK(I9E"$ 'S,X!/2@#K[V_MM/L9+VYE"0( 2V"<Y.
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M^V0[" DD6W:6!*X;)("]>U &OJNH06NLZ-:R7=U#+<SR".**,%)R(G8J[$'
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MC<%.1GOCVIU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_/$3D#T'W>G% 'J5%>8RM>HNH0V6I6BZ>FM*-,2_<FWN1]G+20%@>$#[RIY
M9,8XQ5-];MKH6-MK,[Z+IEYIA%JUT[2!+@2R+)ME##+ >648\D<CJ<@'K59&
ML>(K31[)[IDDN%BNHK6582I,;R,BKNR1Q^\4\9.#TJYI2NFD622333NL"!I9
MUVR.=H^9AV8]2/6O*-1&G6FB^+;8R1P7)\26[,GF8<(9K=@W7C/S$'O@^AH
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M)Z<\>_$/A_Q?J-QH&B_:UBEU+4XY[A62*1U5$89RJ@GJZ@#T[\8(!WG6D
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M <8\O&&!(.?_ *YNV?B&XNP-/T:RMO/M-,@NWBD<J@\P-LB7 XX0_-VXX.>
M#J\4B[=HVXV]L=*XN#Q<GBO3C#I5K$XETI;V=;LG"B3<JQX'<E'R>@P.#GC2
M^'__ "3KPU_V#+?_ -%K0!T1 .,@''/-&T8 P,#IQTK$\96L-WX,UF.>-7"V
M4SKD<JP0D,/0@]ZY![Z>PMF\'>)&%S<QRPOIUY,,_;H!*@Y_Z:J#AAW'/<T
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MM#8&<9P<?D:XZW\>WMN-+NM9TR&WT[4]->]@EMYS(Z&.(2LKJ5 Y7)&">F*
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MVJVY%Y!5@1DY!QM((H H6W@6UL&TZ2QU/4+::RL5TXR*8R9[=?NJX*$9'9@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MH\+75E;6X>8V;0QPQ$*"=FT ;B !]36I5&75K.'6+;29)&%Y<Q/-$GEMAE3
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MVEMHVGPVUT<W$,=L@27_ '@!@_C5T65JL<$:VT(2W(,*A!B,@$#:.W!(X]:
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M!(TO;2"Y6*02QB:,.$<=&&>A'K5;_A']%V%/[(L-IF^T8^S)CS?[_3[WOUH
MY+2M6U+6;U+U-5@M7MM6FM;JU>4MNC61D6+RMORM@*P;.>O8X'?5071-*35F
MU9=,LQJ3+M-V(%\TC&,;\9Z<5?H **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH X#4;E8OB?>6E
MU<:PUE_8L5P(+.6Y8"0S2*6"Q'@D*!^%.\'^*IY?#=@+J8WM[>W]Q;64<CJ)
M0B%F G(^ZRHOS<9Z<9-;4WA[4/\ A+Y_$%KJ=M&\MDEF(9;-G 579P<B1<G+
M&L^W^'\5G'#<VVHN-7CU.74VNWB!5Y9%V2*8P1A"O& <C .: )I?'4<483^R
M[E[U-373)K=77]W*PW*<DC*L""#[\XYI\'B^\DU9]-E\/7,,]O#!<79>YBVP
M1R%P6R&^;;L)XY//XMN/!CSR+<+?QI>/JD>IW$IMR5D:-0BH%W_*H50.I[GO
M6@GA\_\ "2ZGJDURDD%_:16CVWE$$*A<YW;N<^8V>/2@"K;^,(YFTB1K)X[7
M65)T^=G'SML+JKC'R%E!(Z].<'BH;/QQ#=/HJO9- =4N)[7$DHS!+$6#(PQU
M^4@8[X]1E^F>#VLH-&M+K4!=V>BN7LD,.U^$9$WMN(;:K$< 9X/:HK_P#9WI
MU9A=SPO?7,=U"R=;21=A+1^A9D!- %B?Q>D<<:QVJO<RQ27$<33A0\2MM5@V
M.K]5&.G4BH8/&LE]J%I9V.@WTLEQ9Q7I$K)"8XV?:VX,<@KSD=\<9ZU8U;PQ
M<S:G8ZEHFIC2[JU@-J0UN)HI8200I3<N"",@@^O6I[7P_/;^)TUA]1\X"P%F
MR/%\S_.7W[@V <D\!<8Z4 ;M>:ZMK^J:CH\]Q+"UN;/Q+;VD:VMP<NJW$:%3
M]T'.3UXY]J[?0DU1+*1=6N%N)?.<QR"$1$QY^7*@G!Z]^F,X.16%/X)N)(KN
M"/5D2";5TU5%:UW%&619"I.\9!91SQ@$]>H +<'BN2:/4(VTF=+VRO([26 .
M&5=ZJZR%QP$"N"3CC!ZUGS>-[BYMM+DTVSB<W.L-ID^Z<%5*!R2C '<&V<'C
M@],]);WP7=W5YJ-U'J\<;W>H6]\$-J60&)%0(Z[_ )U(4'J.1FFKX(N4A 76
M09DUAM6B=K4$!F#!D(##.=[<Y&../4 U?&%];Z=X5O;J[M[B>! OF);3&)\%
M@,A@01SCI6?J_C@Z5<:T@T>YFBT>**>YE$J*/*<,2RC.20%/'?!Z<9UO$VBO
MXA\.W6DK="W-P%4RF/?@ @],CT]:R=3\&W&I_P#"2!M3C0:Y:1VKXM2?*"JR
MY'S\YWG]* %E\6RVGB'78KR"--+TRR@N/-5\NV_S.V.IV  9_'GB.]\>+I]K
MJ4L^DW#FRCBES X>.17;;PY ^93U7KR,9S4M]X+_ +1NM3:XU B#4]/BL[F.
M.+:P:/?MD1MQV_?)Q@\@<]0677A36=3\-76E:IXC6YFF5$6<600*JL&R4#_,
MQP,G('H!SD FNO%TMH)(9M*:._CB>X-J]PF3$&(4@KD%FP<+[')'&7V_C&WO
MM0@L[2V8S20V\[03OY4XCE/WA&1DA!G=SQC'-+JOAS4+G6[;6=+UA;"^6W^R
MW&ZV\Z*>/.X?*6!4@EB#GN1S4>I^#SJTUL;N]25+::&:"9[?-S$R%2VV4,,;
M]O/R]S^ !8\+:U?:T-5>\MHH5MK^6UC$<F[A#MYX'IG\?:L[5/'C:;+K!_L*
M]FMM'E1;V9)(_DC9%?>JYRV%;..N >E;.AZ))HL^IG[8)H+R\DNTC\K:8V<Y
M8%LG=STX&/>N7@TFXUO7_&^GM<>187\L,4F8"6DC^SHC['R!V9<X.#0!L7WC
M:UMII?L]M)>003QP3M <R N%.Y4 RP =2>1CG&<&JESXN:]TO7F?0;XV%@MU
M#<RI<QHV8U&0N&!!()((/&/6K<?A2\LM<NKG2]::TTV]=9+FR^SACO"A"8WR
M-F550>#TR,&EC\*3IH?B'36U&,_VQ+/)Y@MB/)\U=I&-_P V!TY% #X_$B^5
M]FTRQDNYK6PBNYHC-AE1P=BACG<Y"-UQTY(S5>;Q9;:UI<BZ+')=&73!?,RS
M&$QQN&"#(Y#DJV!QC:<D<9DM_"EU87XOK#4XXKB6QCLKK?;%TE\O.R0#>-K#
M<PZD$&JT'@3^R;B%]"U$6<7]G)IUQ%/!YPE1,['!#+M<;FYY!STH O>$[UH_
MAQHM_<M+,RZ5#-(W+N^(@2?4DU@^)?$+ZOX%FU&R)2(364D-Q9W>X2![A%9,
MKCD#AE/'S"NJTC1IM)\)6NB)?;I;:S6UCNEBVD;5VJVW)Y& >M8%S\/_ +1%
MJ1CO;:UGU!K5YS;V92)FAD\S?LW_ 'V. 3GH!WYH THO%<KG5('TBY6]L)X8
MF@1E?<LN-CEAT4 DM_="D\UB:YXB&M>'5N+5Y+>6SU^TLY3!<$HY^T1 X9<;
MT*N.H[].*T-2\&75_=ZK<KJZ1/?36LH3[*60& \*XW_.K=QQ3'\#W3VE] =8
M0_:]5AU0L;3[KH8VV@!^A,8^@]3S0!:T"20^-O%D333/&CVI1'D9@F8LD*">
M!GG K*N]9O\ 1O&_B66VL+S4X8M/LYW@2X $0S/N*ASU(4?*O7%=+INB2V'B
M#5]4>[25=1,1\H1;?+\M=H^;<<Y^@JM>>&[F76M1U"TU%;<:C:1VDZM!O90A
M?#(=P /[QNH8=/H0"G=>/;);,W>GV\E]$EM#=.D;8D,<@W*$7'S-MYQQU')/
M%;NJ:S:Z1HTFJ7&\PJJD*H^9RQ"JH!QR20.<=:PD\&7&FZE'/X?UAM-M6M8;
M6XMFMQ,&6(;49"2-CA>,G(.!D<5L:_H4'B#P_<:3/++&DJKME4Y='5@R,,]2
M&4'GKB@#*U/QJNC+JL=_IT@N]/L3J'E0RAEFA!()5CCE2,$$=QC.:=_PFD-M
M<:A%J5A/9_9;2.]3+J_FQNS*,8/#;EQ@GN.:CU3P=/K5KJ1OM1B-]>Z:=-$\
M5L52.)B2Q"%R2Q)'\6/E''7)J7@HZO=7DEYJ'[NZTQ-/9882C(5<N)%8L<$,
M<XQV% &EH_B#^U-1O+&2S>&2W5)!*C;XI5;/W7P/F!'(QQQUS6?JWC)],N]:
M@CT>XN/[)M8[R=Q*BAHF#DE<GJ!&W'?VK4T33]5LHC_:^L#4IL!%9+80* .Y
M4$Y8]SG'' '.<[4?"<U_=^(9AJ,<:ZQIZ6)4VY8Q!1(-V=XR?WK>G0?B 1OX
MYM;2:[_M&RGM((=/_M&*4LKF6'.T\ \-DK@=\BI;OQ=_9D]S;:AILL=S'8/?
MPQQRJXFC3[Z@G #KD9'3G@FJM_X$756V7]^'MVT@Z6Z1P%&(+*WF!MQP05!
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MOW;.P<ONY)+MG@=J ,[1/$MHVG64-E:7"W-_>7<<-O<W!8@Q2/YC,Y+84$<
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M\^[U.YEM8H8+E5F!"[#MQY9!8?Q<$=>* /3K/5K&^L8;N&X3RI8$N!N8 A&
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MM*%L\8QZ>CT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MS7/6/B&\/B_^RM2::TDDGF%LC0J8+J)02ICD R'  +*QSUP,4GB;_DH'@?\
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M],TJ1Q=22+%%+'#/.L9,<+OC:'/;.Y?IN&<9%:=Q<0VEM+<W$JQ00H9))'.
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M\F=!(F]2I*GD'!Z<5@IX]T)[N*#S+I1)=M8^<]I(L2SAMOELQ7"L2, '^HH
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M]!JJ(MPX 1!'N3_5]<IP>^<\=*]#HH XW4/#NK)XKN]1L;72+VTU".-9EO\
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M]8R4+)LV_>^3 .['.>V#OV&OB_\ L+#3;Z&"]3?#-((RA!7>,[7)7(]0*V*
M.$U7P?J]_<^(+B*2Q22ZO;6]LA*S.C-"B+LE7:,*VT]"<9]JZ30+6\@MI)+Z
MQT^RFD(S!8G<@ [EBJEB?IQQUZU?OKE[.SDN([6:Z= "(8-N]N>VX@?K5'^W
MHCK.HZ4EI<O<V5JET0 N)5<N%"?-URC#G% %&\TO5(O%\NLV,=I,DVG+9E)I
M60HZR.X;A3E3O]CQ[\<[=^'K"W@\-^&M.U:/^UM.06TRHP\UK1T(FW*#E00
M0>@8)7?0W:2B!7!AGFB\T02$;U QG(!/0L <>M,L)!=0+>O8R6D\BX9)E42
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M*J(T+,I^3K^ZP#WSGCI7H#%Q&2J@OC@$X&?K4-]=K8V%Q=M')(L$;2,D>-Q
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M\5K"L?CK3+>[FN+=_#\=X(FN6E_>YFRPR3C(5,@<=.*]8V*>JC\J0A$!8A5
M')/'% 'F&JZII\^J2Z7<:_'IFGSZ=$^EW7F.0[;G#M%(' ,@.S@Y.,8&"<V(
M(YKKQ+XF,5]>7.H:?96MQ:0&Z=1Y_E2=8PV.6QE2,<]*]',<;;<HIV'*Y'0^
MU+M .0!GUH \LTV_L]2TF?4+'Q?Y,[Z68KM%5\6TA('F3AG)1PV1GY21GTR*
M]]<)/96BZM;1V;67B*V%Q+#>,]KAHQ\T;'&Q2-O!Z%CZUZR$B5F 5 S_ #$
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M(6(($66R1D8'/2O6V.!U )X!/K6/X=T--"LYK<3I<,UQ-,9/+"L#)(TC+U/
M+''MB@#A-+UNVNO%>B>3J4AAO+G4+>XCFN29G.6*K*!@)@C"+C(4#GK6OX>C
MO8=4?P]>-=R)H=Q)=?:GD=FN87!, +9RY^9P1ZPCUKN9(@T;A#Y;L#AU494D
M8SSWJEH^ER:9;.+F^EO[R4AIKJ5%5G(  ^50   .@'J>I- 'F.CZU#=WUJ+7
M4GF@U#P_>,8I+CS9995:,KYN./-VL^5 ^49'( K0\)1);W/@^XTK4)Y4FTK_
M (FL9NFEB5%B782I)5"'^48QQN'8UZ:$1>BJ.O0>O6A8T3=M15W'+8&,GWH
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MD4 <SX,GO=5"3ZA%+#<:7$=.E0LP62=3B1\?Q+A4*G_;:IO&MU]EN_##"[>
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M(#*=C';P 48@<]>U6-1\ V%^=52*_O[.VU6$17EM;LFR3"[ PW*2K;0!P1G
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MH59(\;)%.-P88'?''2M"PT:.SOI;^:XFN[Z6%(&GF"@B-22% 4 #EB3QR3[
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MW1()#$XQ&W(!ZBCPC%>V>IZ/_;&CZC;W,>G_ -G6MP[P-%M #D-L<L6(C')
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MF>UO="NKLS,5<Q21*A25200 V_!7ITP!5=;O4P3;RZM>S)>^%WO7W. 4F78
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M]!Z5<U/7;ZSTWQ28]3E5[+6;2&U9G!*QR+;DKSU!WR=<]?:@#TDG:I)S@#/
MS4%G>PWMG;W48D1)T#HLR&-\$9P5;!!]C7)V*ZCJ'BSQ(CZY?QP:=<1BWAC\
ML* ]LK$'*'(!;(]P,YK$T.XN-5O_  !>7VH7)FNM$N)9F$Q4.X\CG XR=QH
M]/HKA] O=2EU0^&[R[N9+[3+N2:XN6.#/;$9A)QQ\V]00/\ GD]=Q0 4444
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MD&KOJL,/V4%@SEV9&;=R,N<$ 8'7/;:T+1'T634@+SSH+N\DNTC,>TQF1MS
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MD,6TL048L, EOF&.<#D5-'X5O[77+N^L]=>"VU H]];"W!+R*H0O&^?W>Y5
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M#\Z/[3;_ )Y#\Z -&BL[^TV_YY#\Z/[3;_GD/SH T:*SO[3;_GD/SH_M-O\
MGD/SH T:*SO[3;_GD/SH_M-O^>0_.@#1HK._M-O^>0_.C^TV_P">0_.@#1HK
M._M-O^>0_.C^TV_YY#\Z -&BL[^TV_YY#\Z/[3;_ )Y#\Z -&BL[^TV_YY#\
MZ/[3;_GD/SH T:*SO[3;_GD/SH_M-O\ GD/SH T:*SO[3;_GD/SH_M-O^>0_
M.@#1HK._M-O^>0_.C^TV_P">0_.@#1HK._M-O^>0_.C^TV_YY#\Z -&BL[^T
MV_YY#\Z/[3;_ )Y#\Z -&BL[^TV_YY#\Z/[3;_GD/SH T:*SO[3;_GD/SH_M
M-O\ GD/SH T:*SO[3;_GD/SH_M-O^>0_.@#1HK._M-O^>0_.C^TV_P">0_.@
M#1HK._M-O^>0_.C^TV_YY#\Z -&BL[^TV_YY#\Z/[3;_ )Y#\Z -&BL[^TV_
MYY#\Z/[3;_GD/SH T:*SO[3;_GD/SH_M-O\ GD/SH T:*SO[3;_GD/SH_M-O
M^>0_.@#1HK._M-O^>0_.C^TV_P">0_.@#1HK._M-O^>0_.C^TV_YY#\Z -&B
ML[^TV_YY#\Z/[3;_ )Y#\Z -&BL[^TV_YY#\Z/[3;_GD/SH T:*SO[3;_GD/
MSH_M-O\ GD/SH T:*SO[3;_GD/SH_M-O^>0_.@#1HK._M-O^>0_.C^TV_P">
M0_.@#1HK._M-O^>0_.C^TV_YY#\Z -&BL[^TV_YY#\Z/[3;_ )Y#\Z -&BL[
M^TV_YY#\Z/[3;_GD/SH T:*SO[3;_GD/SH_M-O\ GD/SH T:*SO[3;_GD/SH
M_M-O^>0_.@#1HK._M-O^>0_.C^TV_P">0_.@#1HK._M-O^>0_.C^TV_YY#\Z
M -&BL[^TV_YY#\Z/[3;_ )Y#\Z -&BL[^TV_YY#\Z/[3;_GD/SH T:*SO[3;
M_GD/SH_M-O\ GD/SH T:*SO[3;_GD/SH_M-O^>0_.@#1HK._M-O^>0_.K\;[
MXE?&-P!Q0 ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ KSGXE:Q=6FCZS!IDPBNXK)YY9AUA3:<8_P!IB"!Z $]AGT:O.O'/P^T7
MQ1+J$\MG$-4F@\N*[8M\AVX4X!P<4 2^!G,G@/079BS&PA)).23L%=!7'Z1X
M3U/0;+P[8:7JD5O96(;^T(A#N^UL0,D$\KSD_C[5V% !7+_$;*_#_695)62*
MW+QNIPRL.X/8UU%8WBO2)]?\,WVDV\D<3W<?EF23)" ]\#K^E 'FOAN/6;F^
M\$W.AKJ*Q?90VL32B18)5X_O?*[?>Y7/45U<?Q%1M6TFUFTJ6"'4[F6VB,KE
M9D9#@,\9485CW#&NA\,:5/HGAJPTJXDCD>TA6$21YPX X.#T^E<3;_#765O-
M+O+K7;:YN;+4FO6E>V;?,&Q]YMW) 4 #@ 4 ;EEXXENK[7M.?2EAU#2F11 U
MS_Q\;SA2IV< Y7'^\,XJOJ?Q NK#6-<TR+1!/+I%F+R5_M>U&3:&./DSG!].
MW:F65EI'B7X@P^)=+N6<6EO+;7B!2H:17 0,#UZ,?^ *?2G7_@>^N_$'B;4D
MN[94UG3S8JA#9B^4+N)[]"<?K0 _3?B']OU?0+5])>"VUR!Y;:9IPS*57)#*
M!P/0Y].!1:?$G3[R_M(XXD^R7=^UA#*)P9"X'#&/'",00#G/3CFJUCX!O[6]
M\(SM>VS+H$3Q, K9FW#&1Z8'UJYX4\(ZKX5N+JRM]1M9-%DN6N(D:$^>F>J;
MLXQP.<$]>F> #,?XJO'9S7LFA,+2VU3^S9Y!= D-_>4;?F^AQV]\:%OXDUBZ
M^*UYH2V\ L;.S#D><03N9#O^[R0#@+QU/-8T_P ,-2F\/ZAIG]HVBM=ZO_:?
MF;&(7C[F._;G]*Z>'PM=V_Q!N/$T5W"(KNT6WG@:,E@5(^ZV1UVCJ* .IHHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *W+?\ X]HO]P?R
MK#K<M_\ CVB_W!_*@"2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HP/2BB@!,#T%&!Z"EHH 3 ]!1@>@I:* $P/048'H*1W6-&=V
M"HHRS,< #U-0V-];:G807UE,LUM.@DBD7HRGH10!,L:+G:BC)R<#J:7 ]!56
MUU.ROKFZM[6ZCFEM'"3JASY;$9 /OBK= "8'H*,#T%+4"WMLU])8K.ANHXUE
M>+/S!&) ;'H2K#\* )L#T%&!Z"L^;7-.@O[BQDG(N;>W^U2IY;'$6<;LXP>0
M>G/%6;&]M]2T^VOK23S+:YB6:)\$;D89!P>1P>] $^!Z"C ]!2T4 )@>@HP/
M04M% "8'H*,#T%+10 F!Z"C ]!1D9 SR>U+0 F!Z"C ]!2T4 )@>@HP/04M%
M "8'H*,#T%+10 F!Z"C ]!2T4 )@>@HP/04M% "8'H*,#T%!('4XI: $P/04
M8'H*6B@!,#T%&!Z"EJG/JME;:G:Z;--MN[M7:"/8QWA1EN<8&!ZF@"W@>@HP
M/04M4SJMDNL)I)F(OG@:X6+8W,:D*3G&."R\9SS0!;P/048'H*6B@!,#T%&!
MZ"J=WJUE8W5G;7,^R6]E,-N-C$.X!8KD# .%)YQTJ[0 F!Z"C ]!2G@9K$'B
M[0ML[M?JD=O*89I9(W2.*0<%68@!3R.">] &U@>@HP/04 @@$$$'H12T )@>
M@HP/04M% "8'H*,#T%+10 F!Z"C ]!2TF1G&>?2@ P/048'H*6D) QD]>E !
M@>@HP/054TW5;/5[>2>QF\V..5X')1EVNAPRX(!X(Q5R@!,#T%&!Z"J.I:S8
M:/Y'VZ<Q?:)!%%^[9M[GHHP#R<' ]J=8ZM8:C+-%:W*/- 0)HCE9(\]-RG!&
M>V10!<P/048'H*6JFJ:G9Z-IL^HW\ODVENA>638S;5'4X )H M8'H*,#T% (
M90PZ$9%+0 F!Z"C ]!2T4 )@>@HP/049&<9Y]*6@!,#T%&!Z"JESJME9ZA96
M,\Q2YO69+=-C'>54L1D# ^4$\^E7* $P/048'H*6B@!,#T%&!Z"EH)P"3VH
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MC ]!2T4 )@>@HP/04M% "8'H*,#T%+10 F!Z"EI"0,9/7I2T %%%% !1110
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MC_WF]3[T3:98W%_!?36D$EW;@K#,R N@/4 ]N@H Y#3=9U/[3X/N1?->P:Y
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M.81/YD98<HW]Y3U!Y/(]:KWGA_1]0TL:9=Z;:S6(.X0/$"H.<Y [')//7DT
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M8',GF)MX/;'7OGVK%M_!U_#8:9;&[MB;+69=39@C?.'>1MGMCS2,_P"R..:
M-2#Q;9RZK;6,MM=6QNA.8))U50PA;#DC.Y0>H)'(%8UQXAEU#Q5X2GM1>P:;
M>_:7#LX6*XC$+,I*@Y]&&X=/0TVW\"ZC]MLI;W5+6=8'NA-)]G82W$<P(^9M
M_P!X# '& !^%/T_P9J\'_"/V]WJ=G/::*)(8R+=A)-"T1C ;YL!@IZCTS[4
M:NF^--,U/5+2Q@63_386FM9LHRR*N"<A6)0X((# <9[@BK]]K<=KJ!T^"UGO
M+P6YN6A@V@K'G )+$#)(( [X-9OAC0];T."#3KS5K>ZTVR3RK79;E)F0#"B1
MMQ!VCC@#. ?8SWFAW2^*EU_3IX1,]G]CN(9P=KJ&+(P(Y!4LW'<'MUH I_\
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M@;3U.3P15R[2'4=7O;'7[?6+2>Y%K/I8MK<.R@1H?+27RVV.LH?.2H^;/3-
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M.4)S[D5YUISZ7/KUA;ZA=Q)<66M74AGN+>59;G<\BI&Q9-F-S+@[C_JTP >
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MI=>'8HFNX;-\AO-<$X*_,0"..X!% 'IVX8SD8]:7K7D[SWUI9HU]9QMID&K
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MLI7$9*%QDA<8('!Z'MFLW3_%]L!X=LXY+S4QJ=L\Z7QM]I=4 Y*J!@DL.,#
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M-"-N_<KJP5N0<Y&.0:UM/UF#4=1U.QCBFCFTZ58I?,  8L@<%<$Y&&'7%:5
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M(:0(-BW8EO('E:'SHRK @.JD@[BI/'(!'?FYIFLP:K=:E;Q131R:?<_9I?-
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M*2N0.<$YQVH Y_4-!U^37+;6A8:-J$TUI]EN[.ZD*I%B1G1HW\LYP'*G*C.
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M1% T"!FR&SLW8!P>!D=JOG4H=/FTM%\0?;?#M[JKB>[CD(AA_<DI"LFXG89
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MO51#$.D2#DG[HZGK^=(+>$8Q%'P<CY1Q0!R7CJ.&74/"B7,SPP-JQ5Y%E,9
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MGEA6;=:C:7?A#7-7TGQ5),W]A2,]O;RR*89E&5=R9"R29RN.-W/!Q7K8 !)
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MF-"0,#*C@4 >3Z)<PW<W@"]U"^>1L7UN)Y+ELN5.$4G/+$#ZMCG->MTP0Q*
M!&@ .1A1P?6GT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 <7KGC'5-,NO$26^EVLL6BVD5Z[
M/<LIEC82%@ $X;$9QV]ZL:CXMNDFO8](TR2_DL?*\V%4?=(74/M4A2JD(P/S
M'D\<=:M:AX/MM2EUUY;Z\0:S:+9W"ILPD:A@-F5R#AVZYZU%)X,B_M7[?;:O
MJ5H\L,<-XD#H%NU084ME3M;'&Y-IQZ4 2Q:_J%_<S-I>GQW%K;7XLIPTNR3C
M'F2#/&%)^[U.#C'&:]GXKO-0O+22STN2XTZXN)(&D1'#1!2P$A)&TJ2N, Y&
M1UY L0^$(+;6[F_M=1OH+:[E$]SI\;+Y$LH &[E=PS@9 8 XY[BDT[P?#I>H
M3RVVJ:@MA),]P-.+KY$<C$DE?EW 9);;NQDYQ0!EV?CTW>B7FIQP12?98T:X
MM8]YGM'+ .LL>-WR#+9 ^8*<#UNQ^*)[FPM+JS.G7%O<S/&EY%/NC*A,KA1\
MS.S?+L&2,'KCF:/PA&D_VLZG>&_%O';+> 1B78CAQNPN&)*@'(Z9QC)S$G@:
MSAOH;ZVO;NUNTNI;IY(!&!(TJ*C@J5( (1>@SG)SDF@"A;^-M5U.#P__ &9I
M%J9M8L)KI1<73*L31[,J<(3CY^#^@J]!XIO6FU.PFLK>/5+2\BMXH!*2)HY,
M%9<XSC&\D8./+:GZ3X)M=(ET9X=1OI!I,,L$"2&,ADD*E@V$!.-JXQCIWHL[
M$:MXN_MV?2KFR>QA>TC:X*@SDM]\!6/R@;MI//[UN* -?6]6CT31Y]0F0N(M
MH"+_ !,S!5'?JQ'8UAMXLOK22>&\TI@SW$%O8S8>..X>4D8.]<KLP23@Y'3G
MBM[6-)M-<TBZTR^5FMKE-C[6VL/0@]B#@@^HK$E\$I=Z.UE?ZWJEY.LD<D%[
M*Z"6W:,Y0IM4+D'J2"3WSQ@ J7WC*_TT:VD]C;2/I4MHA*2L!*L[ 9Y'RD9'
M'.<=>>+UQXGNH;[7K2.RA=M,%LR.UP(U992<LQ; 4( 2>3D#CFL>U\+RZAJ?
MBO3]2FU!X+U;3R[]T5&D>-<[EPH7*L%XQCCOS6E<>!(+IK^6?6-2>YO#;.\V
M8@5D@;=&P 3'7J,8/IGF@##\0:U_;_A'4/.MT673==L[8.H(#_OH&#J&&5RL
MF,?7D@UV^O7=QI_A[4;VT$9N+>VDEC\W.W*J3SCZ5C2>!;:6UU&W?5=1*W][
M#?2L3%D2Q^7@CY,8)B0D>W&*Z.\M([ZPGLI]QBGB:*3!P2&&#_.@#F-)\1:C
M=Q:;IB);2:I)I27\TDKL$VMA5' SEB&R>V.];/AO7(_$?A^UU6.%H/.W*\3G
M)C=&*.N>^&4C/>L^V\'16<NGW-OJ=ZM[96OV(7+",M+#P0CC;MX(!! !SGKD
MYV=+TRVT?38+"T4K#""!N.222223W)))/N: /.=5U#4M5T9Y[^.VDDM/%=O!
M;A"1MV7**!DCCCO[GZ5T4?C*>%KVTOK*)-0M]233T6!WD1R\2RJWW=W"$Y&.
MJ^_%B;P1:RK<(-2OTBFU)=3$:F/"2JX?C*9VE@"02?;%%[X&LK\ZF\M]?+-?
M745X)HW56MYHT5$:,A>/E4#G.>?6@#2T'4K[48+G[?I[VDD$[1(Q#!9TP")%
M# $ YQ@]"#UZUG_\)47\62Z"HMH;B.0!8;ABDDT9CW>;'GAP&.TJ.1@DGM6Q
MI6G/IUJ8YKZYOIV.Z2XN-NYCC'10%  '0 ?F2:I7/AJ"]U*&ZNKJ>9(+L7D,
M+A,12!=H"MC<%[XSR>^.* ,O3O&5Q?0>')38Q)_:]S<6SJ)2?*,:RD$''(/E
M>V,U4MO&VKSV^EW)TBS$-]J,^G!1=MN61&E"M]S[O[HY[\].U7[7P+;VD]@\
M>JZAY6GW<MU:0DQ[8C('#+]S++^\;J21Q@CO)!X*MH+33[9=1OBECJ#ZC&3Y
M>6D<N2&^3[N9'X&#SUXH N^&]9N-8MKX7=O'#=65Y):2B)RR,5P0RD@'!##K
M5#4O%5Q#_;KZ?9QW$>AJ#<J\A5I3Y8D94XP"$(Y/4G'&,UJZ/HD6C/J#17,\
MQOKIKN3S=ORNP (7 ''RCKFJ=YX3M;J^U.XCN[FW358EBOH8BNV8!=H/()5M
MIVD@],=P#0!@W3+XH\:V=K/!;W6BW6B-<+#-GE7>/YL8X?' /;U%=!XBUFXT
M"#3$LK*.Y-U>1V062<ILW X.=ISTY_KTJ:/P[;P^(8=7AN)HVAL_L26RA/*$
M>X-_=SG('>L[QO:75[%HB6B7!:+5H)W>"/>8T7=ECP1QD4 5[7Q=J3?;[.\T
MZVM]0L+V.VN&%SF!8Y%W+*"P4MQQL SFF6_C:YETW2]0DL(H[2?4I-.O)#(P
M\AED:)7 *_=9E YP5+CK5^Y\&VUTZW/V^[BOQ?+?&[CV;C(L9C VE2NT(2 ,
M>_7)K/O_  \NGZ!=>&[:TU'4HM8DN&,\ACV6C2-O+,?E( 9BPP&.5^E %J]\
M4ZA;RV @T^WFBO\ 5'L(7:<KPJ.=Y&T\$QL/I@C.<52B\:ZJL:2W.EVBQ0ZP
MNDW1CN6)WM(J*Z#;T^=202#U].=Z[\-6MS'HL:3SP1Z1,LT"QE3N*HT8#;@2
M1M9NF.M4G\$VTEK/ =1O@LVIKJC$>7D2JRN /D^[E5XZ^] #$\5WEU?1_P!G
MZ7)=69OWL9657#1[&9&EW;=NT.I!&<XY]JIZ?XTU*Y;2YKC2[:*TO=3GTPE+
MEG=)(S* P&T J?*/OSTK3M/"$5CK%Q>6NJ:A%:7%P;J73PZ^29B<EQ\NX9;Y
MBH;!/4=JC@\%6T%M80+J-Z5LM1DU*,GR\M*Y<D'Y/NYD?@8//7B@!_@W4]2U
M6POYM2,!:/4;FW3RL\".5DQ@^RBH->\67&B7[(UG$UND]M%CS<R2+,X0N ,[
M I8?>QN((!'&=?1M#BT0WH@N;B2*ZNI+KRY2I6)I&+L%P <%F)Y)K*U/P/;:
MG=ZC.=3U"!;^6WGEBB,>T2PE=C#<A/\  O&<>U #[/Q5]L\4SZ*!;Q302LCV
M\S%)C&%)$J C#J3@<=,\GL)O%UY'96.GO-I\%[')J=I%ME;'ELTJJL@&#DJ2
M#VJ3_A&()-2M+VYN[BY:SN)+FV$H3,;.K*0&"AMN&/&?3T JSKFB1:[:V]O-
M<3P+#<Q72F';DO&X=0=P/&0* .:ALVUSX@:]:ZI;6UQ:6D5FT 9FW1',CJR<
M<$D#.#V'6MG7-<OM.UK1]-L[*"=M1:5!)+.4"%(R_("G(X_^MWJU9Z''9Z_J
M&KK=W#RWR1))$^S8HC#!=N%S_$>I-+J&B1ZAJ^F:DUS/%+IS2-$D>W:Q=2IW
M9!/0GH10!B:9XRFU.+2K9;6&+4[Z2[C9"Y:./[,Y21@< L"VW X^][5K^'-<
M.N6=TTMO]GNK.[DL[F,-N42(>JG RI!!' ZUGV_@>TM$LV@O[Q;JRNI[F"Y.
MPLIF8M*A&W!0ENF,C P>*VM+TJWTFWDB@+NTTSSS2/C=)(QRS'  ]N!P !0!
MC1>*FN/%4^AH+:&XBD*^1<,4E>/R]PF0'AUW87 Z<DGM5;3?&LM[!X:GELHX
MH]8$_F8E)\DQHS<<?,#M]JU9O#4%SJ5M>75U/.+6Z:[MXW"?NG*E<!@-VWYB
M<9Z]\<5GV'@2UL)]-==3OWATR:62T@?R]B+(&#(?DRPPQZG/3GU $35[_7=$
MCNCID+:/J6GR3B3S06A!4&,.I^]N4YX^Z1CGK6=X%UN\AT[PIHUU:0K;W>AI
M/;31REG_ '21!@ZX &1(",$]*UM*\%PZ1:264&K:B]@$=+6UD9"MJ&R#L.W)
MP"0-Q; J73_"-MIUQHDL=]=O_8]FUE K[,-&P0'=A02?W:<C'3WH L^(-9GT
M1]-D%O'):7%Y':W$K.08=YVJV,<C=M7M]X5FZ1XLN-5EGM5MK=;R#4WLGC$C
M$>6J[_-SCH5P1QC) SWK=UG2K?7-'N],NMXAN8RA9#AE/9E/8@X(]Q5:R\-Z
M=I^M/JMM&R3M:1V> ?E"(21QZ\@9]%% ')?V_?1VML-+L+*P:X\2RV-RJL6$
MA#.6?.!RQ3).._XU#I^KW7AR]\2W$%C;O8GQ'%%<?O2KKYL=LF44+@X+@G)&
M:Z/_ (0FU^QF!=1OE<:HVJ),/+W),Q)('R8V_,>"#UI)_!%K/:ZC;MJ-\$O[
M^._E(\O*R1[-H'R=/W2=<GCKS0!ST.KW/AO5O%MY;6-O)8IK=LMQF0HX$D5N
MA**%()!?<<D9K;U'QG+:V&LZI;6:3:?HUR8+H%R)'VA3(R#&/EW=#][:>G&9
M[OP3;7D&K12:C?!=4NHKN8KY>5>/9M"_)P/W:=<]/>I)O!ME-)J2_:;A;/5'
M$E[:+M\N5\ ,>F5W!0&P><=N: ,(ZO;:!XJ\8:IY0=3;Z;L1?E\V20R(@SVR
MS*,]JKWLL]CXK\77-Y865P4\.PRO KE4N%#7&0Q()!P"O0Y '3.!TFH^"M/U
M2;67NKBZ9-5BACE1651%Y1)C9"%R&!.>2><5&W@M9I+^:[UK4;B>^TX:=-(P
MA7]V"YR $ #?O&_.@"B_BC4H7CL-,TFRVIHJ:BGF7#(H'39@(<8Q@?TQ@SOX
MTDGM[5[.TC5YM%.L8N'(4KA?W8('7YN6[<<'/%Q/"$"7(G&HWF\::-,Y\O'E
MCG=]S[WZ>U<WJOAVYM;S3-/B.MFQT^P2VM;FV@MK@.0<$.LBG:0%3Y@!GG)X
MH [C1+^75=#L=0GMA;274*S>2'+; PR 20.<$9XZUST?C5WLM+U<6D9TC4KT
M6<;JY\Q-SE(Y",8(9@,CJ-PZ\BNBT=+Z/2H%U*4RW0!WN556(R=NX+\N[;C.
M.,YQQ659^#;&S6&V2XN&T^WNS>6]DVW9%)N+#!QNVAB6 )X/L * $\-Z[JVN
M7-T\VGVEO96US<6C.MRSR&2*38"!L VD G.0?:I]1U62;6GT"S@@FG^Q&ZF^
MT$[-A8HJX .=Q#<]@.ASBK.AZ)'H4-U%%<SSBYNI;IC-MRKR,68#:!QDFH-0
M\-QWFO0:U;WUU8WT<!MI'@V$31$[MK!U(X.2".1DT <CX0\0SV?@?0--L+7S
M[U=(2Z*LCL",E57Y%.,D-R>F.]6=?U^YU[PIXBLXM-2&2UTGS;R&[;YHY)(F
M?RQ@=5 SN]2/<C0A^'UM96VE+I^LZI9W.G0&U2ZB:,O)"3G8X*%2 >1QD5/>
M>!K6>>]DMM2O[,7]F+.]2-D<7"A2JLQ=2=X!(W C- %*S\37%A8SV2VD3_V?
MH$&HQL9"/,R'!0C''^K///7I5R/Q1?ZC%*NCZ=%<7=O807DL$DVS>TH++$K8
MP#A3\QXY''7"W/@>WG(V:I?Q;M-&F3;3'F:$;MN[Y."-S<KCK2#P/!#=VMU9
M:QJ=G-%:1V4[PO&#=1)]T/E,!AD@,N#R>: *-UKFIM?^,(;JTM;BQT^PC=;1
MW*[@T;LRL<$<X(/;@?6KEAXAGNTBT[1K&V$]OI<%X\4CE442 ^7$N!Q]QN>W
M'!SQ<N?"5K/=:I-'>7<"ZG:+:3Q1E-N%5E##*DAMK$=<>U-B\(PVMS;75GJ%
MW;W45DM@\J["9HE^[N!7&Y><$ =3U% &5:^.;W69+(:-IMNR7FDMJ,;75PR%
M2KJI1@%/0G&0>?:NFT'55U[P[IVK+$8EO;:.?RR<[=R@XSWQFL^V\'V-C>6L
M]E<7%NMKIYTZ*%-A18R0<\J26RH.2:T=#TF+0=#LM)MYI98;.%88WEQN*J,#
M. !T]J .&\+ZO=:'%';I96YTV[\1WMEN64AT9II2I"[<;1MQU[^W.[!XMN3X
MCM-,N+*)?M4ES&%CEWO$8LE=Q'RY=1G;D%<C.:EC\$VT<%O$-1OB(-4?5%)\
MO)E9F8@_)]W+MQU]ZCM/ EK9W-C+'JNI%;&>>:WC9H]J";=O7.S)&6/))/O0
M!-X4\4CQ*LCI]G7RXU,T"L1-;2G.Z*1& ((Q][H>>..<S6A?1?$VRETFUM9;
MU]%N!_I$AC4@30]2JDG\N];VF>'(=/U/^TI+F:ZO?LJVGGRA S1J<_-M W-G
MN?PQSE]_H2WFLVVK0WMQ:WD$#VP:,(P:-RK$$,IYRBD'V[T 8%GX[FU;3[8V
M&G%=0DM9)Y;>0/($9)&B*913U='&[@8&<'.*EF\8ZA)!*+'1)FO[:UBN)[&1
M7+[W!/DAE4@, /O'CD>Y%B?P-9AM/ETN_OM*N;&)H5GM60M+&S;F5PZL&RWS
M9(SDDT^Y\&0OJD>H66K:EI\WD+;W/V>13]J122-^Y3\W)^<8;D\T 9FJ>.-3
ML?[=E32(#;Z.D$TOFW!$CQNNX@ +@,!G@G''4YX[#4+B2TTVYN8HUEDBB:14
M9]H8@9QG!Q^1K!OO!%G?1:Y$]]>1QZQ%'#.J%/W:HNT!,J<<>N:W[BU^TZ=+
M:/-(/,B,;2J!NY&">F,_A0!R-AXNUJ_ET6)-+L5;6=,-[;,UTV(RHC+!_DZ?
MO!C&>GXA5\;7<_ANPU6*P@B-Q:SS.))MP$D1QY2 #<V[YCN P N2*T[/PC;V
M,VBR17]X3I%FUE;AO+PR,$!+?+R<1KTQT]ZI6_P^L[6&TBAU74E%O;3VA(:/
M,L4K;V4_)QR."N#[T ,F\2-X@T^:TL+2%F?1X[^X6X8[5696V1\#DG:V3VP.
M#GC-\/>)+FT\&:+I^F6?VN]MM M+IHRKD/N0A$!53M)\MN3P..#DXV(/ EO:
M&U>SU;4()8;!=/ED7RR;B%<[0X*8RN3@@ X)IL?@&"U73&T_6M4LKBPLUL?/
MB:,M/ OW4<%"IQS@@ C)H Z>SG>ZL;>XD@D@>6-7:&3[T9(SM/N.E<S\0-)L
MIO"7B#4Y;=)+N'29Q#(XR8BJ.P*^AR>HYX'I706NGFUNVE2[N&@\F.%+9V!2
M/;GY@<;LG(SDGH*;K>E1ZYHE[I4TTL,-Y"\$CQ;=VQ@0<9!'0^E '!^(M$T^
MS^'=K?VME$ES(=-+; %#L)XL'_>^9AGT/-;G_"97%K+J=IJ%E$MY:WEO;1+;
MR-(DGG %#]W=QDYP.W'6M._\,PZAX;M]$EO;I883"1,FSS&\IE9<_+CJJYP*
MJ7_@BQU*35I+B\O=^HO#(71E1H)(<>6\9"Y!& ><T :&A:G?Z@;V._T][8V\
MVR*7:RI<(0"&4, PZD$'N.IS7*:G! ?BU,KZ,VI(VA+(846(_-Y[#=^\91G'
M&>M=EI.F2:;;%)]0NM0N'/SW%SMW$#H,* H ]AW-4;CPR)O$KZ]%JM[;W36H
MM-L:Q%!&&+=&0G.2><T <KX,\2R6^B6]@96FO[O6+FS@M;AV+6*J&D\J1CRQ
M1%]\Y !QS6E<^-[VW:6T_LR%]0M]6@TV=#.50B4*R2*=IX(89!Z<]<<WD\":
M9#:*D,]TMZM^=1^WEE,QN",%CQM(*_*5QC'85+<^#K6Z4,]Y=+<-?QZA+.FS
M=++& $!RI 4!5& !P.N<D@%./Q)KXUU]*N-+TV-[:U@N[J5;QRBQN[JVW]WD
MD",D \'U%+;^,9Y(= OI+.--/UUA';.')>)F0O%O&,$,%.<?=/'/6ME-"A3Q
M'<ZT;B9Y+FU2U>!@OE[$+,/X<YR[=^]4M-\'V>FI86XN;F:STV5I;*VE*E82
M0RCD#+!0S!<G@'N0" #+MO'4[2Z/'=V=O ]WJ$VGW:"5F-M(A('\/S!CL /'
M^L7KFKC^*KIF@MH+6-KNXAENHL+(ZF%7"H3M4D%\@^@]^AGO_!.D:C_;)F64
M'53&\Q1\%'CV[63^ZV44D]RH]*EUGPM#J=W8WMK?W>EWMDC113V90'RVQF-E
M964K\H/(X(XH S+3Q5KM_J]KIT6@PVLTEC%>S)=W15H@TA1TP$/(P2.Q[XZ5
MV-8MIX;AL]=75DO+MY1:"T,<C*RLH8MN)V[BQ8DDY[]*VJ "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** *<VJ6,%TMK)=Q)<,P0(S?Q'H/J>PZFL+PQXM@U2/[+J-Y8QZHUY=6
M\=O&VTR+%*Z A22<X3/YU2U'2M47Q<U_I4=W#YEW;_:HI2DEK=PA4W28)S'(
MH& 1C)1>".1FVFAZM%8Z0C:3,LD/B:XOY?FCRL+O,0Y^;GB1>!SUXXH [F+6
M=.N;LV=O?6[W6'P@8$DJ<-CUVG@XZ'@XKEK'Q;JMQI/AR[E2SWZCJTUA<!8V
M "JTP#)\W!_<C.<]:H:7INN#Q#H5Y<Z'-;K:3WJSK$\*P1K)DJT:ALD'J21N
M)/Y%AHNL0Z'X8MY-+G66SUV:[N%WQ_)$S7!#?>Y_UJ<#)Z^E ';:U??8+%9!
M>V=F[S1QK)>?<;+@%0,@EB,@<]<=:CG\3Z%:SO!/K%C'*DHA=&G4%7.,*>>#
MR/S'K5'QS8WFH^&6M;&U>YG-W:R!$*CY4GC=CEB!]U37-Z]H6JWMKX[2#299
M&U0VXM/FC'F[8T4]6XP5/7% '9#Q-H1M[RX&KV7DV1 N7\]=L6>FXYXSV]:C
ME\6>'H5N3)K5BHMB!-F=?D)SC//L?R/H:Y/Q1HNK:C<>+#9Z5,Z:AH45G;?-
M&H>4&;*\MQ@2+R>.M7KS2[^7Q)J%W'I4I@E\/BSC;,?,NYSLQN]&'/3WH ZF
M\UK3-/B26[O[>&-UWJ[R #;_ 'L_W>1STYK*\8^)X_#WAO4KRWN;07UM:M<1
M1398-@';D @@,1@'/)]:Y.UT;5[%;&._\/WNI65WHEKI]Q!!=K&8)8@ZLL@\
MQ59&#GD$XP>.:75=#UNUT_Q?I4.C27<>K6"K8R6\B%(BMN(O*;>P( 9<@\YW
M'OF@#MXM7C_M*5)M1T]88;))YH-V)8B227<[L!,8QD=CS46H>+M%T_1[S4GO
M8Y(K3 D5#E@S?=7'49R,9XQSTKF]6TW6IM2U2ZMM#6?S?#J6D<5T8VCDF#NQ
MC8;N>&'L?6LZ^T'7+ZV\6^7I5[G4;.T:W-S-#OD>,MN4A6PK>@&%^E 'H-QK
MNE6JQ-<:A;Q+*%*L\@ PQPISV!/ )ZGBLJ+Q.MKKVOVVK7-G:V&G"V,<[G9C
MS0QPY)QU  Z5A:AINH3Z_J7VWPY>:CINL11;$6\5%@95VF.9=X&W@-E=W4CF
MM.WT![S7_%4&HV+_ -F:E:V]NDA9=L@5&5\<DC&X8R* .H6]MFNEM1.AN&C\
MT1Y^8IG&['IFJ4^JPV^MFWEU+3XH8[1IY8';$RX91YA.[ 0 D'(ZD<UE^"+?
M4/[*-YJTR3WC8M4F4\20PEE1_JYW/_P,>E1:O87\GC0WL-A++:C1+BU\Q63!
ME9T95P2#T4\XQ[T ;-IXCT6_D:.TU6TG=8!<E8Y0Q$1 (?Z<CGW'K6-H?BJ3
M6(QJOVO3H])\R:%XFW"9&64I&0V<-N"D[< \C&:S= T?4[&Y\%--I<T:Z;HD
MEI=D,GR2E8<#AN<F-N1D=/6JVG:+KEIHGAR=M.F$NEZK<W%Q9%TW/%*TP#*0
MVTE1*&QGU[T =L_B'1H[2*Z?5;-()9#"DC3* S@X*\G[PYR.HQS54>,_#)MS
M.-?TXQ*J,SBX7"AL[2>>,X/Y&N5OO#NI/=SWT6GRO%>>(;2_%KE 8HHD17D8
M%L98J3@9/3OD"SK6BZA/J/C)H-,D>._T2.SM64H!)(!,"O+<?ZQ>3@=?2@#K
M[36=-O[R>SM+^WGN;< RQ1R!F0'CD#W!'X57N?$%E#K\6A"=4U">V>>,,,J
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MY'YBM.O./#NA:M8P>!HYM*EB.FBY6\^:/$6]& Z-SDD=,UZ/0 4444 %%%%
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M;0L8'WL-F1@X ..1P:YD->1^,(O#<^K7SP2V,U\L[,BR/)YBKL4JHX0'./\
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M?<P!SG.,<CEVD:KJFMW$-_'JT%J8M2GM;JU:;<2@=T$7E;/E< *P;)SR3P>
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M#2;$0Q3>?'&+=-J2?WP,<-R>>O-6KRRM=0M7M;VVAN;>08>*9 ZM]0>#4]%
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M :5%,AD$L$<F,;U#8^HI] !1110 4444 %%%% !1110 4444 %%%% !1110
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M'%9=A''>)<P6UF[07OA9T$"VLF#,IX5V8?O)1D@L<$GL#7LE(S!5+,0 .I-
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M4_0^AKTJBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MVD=,D*%^]G.,Y &TD5T\B%XV19&C)& ZXR/ID$4 <=\*8XX?AAH91%0&!F;
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M2QAPD19RNR0$DMT)!&W.#P*6QUG5$M-0;4%LY[B*Y-M:BU5D69@@)^\6X!W
MGML:@"W_ ,));?\ /AJW_@NF_P#B:/\ A)+;_GPU;_P73?\ Q-5=,\22SZ;X
M:N[R.-!K5O'_ *L$".=HC+CD_=(5@.X('7/'1T 8W_"26W_/AJW_ (+IO_B:
M/^$DMO\ GPU;_P %TW_Q-;-% &-_PDEM_P ^&K?^"Z;_ .)H_P"$DMO^?#5O
M_!=-_P#$ULT4 8W_  DEM_SX:M_X+IO_ (FC_A)+;_GPU;_P73?_ !-;-% &
M-_PDEM_SX:M_X+IO_B:/^$DMO^?#5O\ P73?_$ULT4 8W_"26W_/AJW_ (+I
MO_B:/^$DMO\ GPU;_P %TW_Q-;-% &-_PDEM_P ^&K?^"Z;_ .)H_P"$DMO^
M?#5O_!=-_P#$ULT4 8W_  DEM_SX:M_X+IO_ (FC_A)+;_GPU;_P73?_ !-;
M-% &-_PDEM_SX:M_X+IO_B:/^$DMO^?#5O\ P73?_$ULT4 8W_"26W_/AJW_
M (+IO_B:/^$DMO\ GPU;_P %TW_Q-;-% &-_PDEM_P ^&K?^"Z;_ .)H_P"$
MDMO^?#5O_!=-_P#$ULT4 8W_  DEM_SX:M_X+IO_ (FC_A)+;_GPU;_P73?_
M !-;-% &-_PDEM_SX:M_X+IO_B:/^$DMO^?#5O\ P73?_$ULT4 8W_"26W_/
MAJW_ (+IO_B:/^$DMO\ GPU;_P %TW_Q-;-% &-_PDEM_P ^&K?^"Z;_ .)H
M_P"$DMO^?#5O_!=-_P#$ULT4 8W_  DEM_SX:M_X+IO_ (FC_A)+;_GPU;_P
M73?_ !-;-% &-_PDEM_SX:M_X+IO_B:/^$DMO^?#5O\ P73?_$ULT4 8W_"2
M6W_/AJW_ (+IO_B:/^$DMO\ GPU;_P %TW_Q-;-% &-_PDEM_P ^&K?^"Z;_
M .)H_P"$DMO^?#5O_!=-_P#$ULT4 8W_  DEM_SX:M_X+IO_ (FC_A)+;_GP
MU;_P73?_ !-;-% &-_PDEM_SX:M_X+IO_B:/^$DMO^?#5O\ P73?_$ULT4 8
MW_"26W_/AJW_ (+IO_B:/^$DMO\ GPU;_P %TW_Q-;-% &-_PDEM_P ^&K?^
M"Z;_ .)H_P"$DMO^?#5O_!=-_P#$ULT4 8W_  DEM_SX:M_X+IO_ (FC_A)+
M;_GPU;_P73?_ !-;-% &-_PDEM_SX:M_X+IO_B:/^$DMO^?#5O\ P73?_$UL
MT4 8W_"26W_/AJW_ (+IO_B:/^$DMO\ GPU;_P %TW_Q-;-% &-_PDEM_P ^
M&K?^"Z;_ .)H_P"$DMO^?#5O_!=-_P#$ULT4 8W_  DEM_SX:M_X+IO_ (FC
M_A)+;_GPU;_P73?_ !-;-% '+6VH6\5V+FY77KR5"_DF;3''E!CD@;8QGH!D
MY.![G/30RB:&.55=0ZA@KJ589]0>0?:GT4 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %9/B'1I-<L(;6.Y6W,=W!<[FBWY\J19 ,;AU*
M@9K6HH R?$6CS:YHYLX;S[+*)8IED,>]28W5PK+D;E.W!&1Q65I7A2^TG7KC
M48-4@$5X_FW5L+0[0Y(+&$ESY>_ +9W9(SQVZNB@#$GT.:/Q#)K6FW<=O/<0
M)!=1S0F1)50DHPPRD,-S#/((/3O5ZZLIKO1[FR>Y7SIXGC,ICX4L",A<]!GI
MG\:NT4 <B_@IVM+JU_M%?)O]-CTZ]'D??5%90Z?-\A*NPYW#H>W.UH^D-I5Q
MJDAN%E2]NOM"J(ROE_NTCVYR<\1@YXZUJ44 <I+X.E30=7T&SU!(M,U$3@1R
M0%WM_.SO"$, 1EF(!'&>I'%.G\)W3W&LO%J5NL6IVT5JR2V9<HJ*RYSO )(8
M]1CI74T4 <[IGA4:7JMO<1W?FVL&EQZ:L,L>YV5#D,SYY)[C;4^NZ'<ZK>:;
M=6UY%"]E)(QBG@\Z*4.A0Y4,IR 3@Y[D=ZVZ* .:\+>&+KPPLEHFIK<:;G=%
M$\!$D?  3?N.8UQ\JXR!@9..7Q:#JEKJNLWMIJMM'_:4J2;7LBQB*QK&,'S
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
:444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>exhibit1033-bochk_facili011.jpg
<TEXT>
begin 644 exhibit1033-bochk_facili011.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MY)4MU^7.2/:O7K;Q9HU[JRZ99W,ES<')S#!(\8QUS(%V#\Z -NBBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MP"15Q(9-I?)P>G;..>E<SX?\9>(KOPCX$:XO9<ZWJ$T-_J!4;E"R,$C'&%+
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MP$A<E<;_ # -P&,#C(QT]JVY]1U&'P1J^I/>75K?1Z3-/;Q22JY<I"KB=?\
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M_P"4V+_&@#I:*YK^Q/$__0W?^4V+_&C^Q/$__0W?^4V+_&@#I:*YK^Q/$_\
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M_L3Q/_T-W_E-B_QH Z6BN:_L3Q/_ -#=_P"4V+_&C^Q/$_\ T-W_ )38O\:
M.EHKFO[$\3_]#=_Y38O\:/[$\3_]#=_Y38O\: .EHKFO[$\3_P#0W?\ E-B_
MQH_L3Q/_ -#=_P"4V+_&@#I:*YK^Q/$__0W?^4V+_&C^Q/$__0W?^4V+_&@#
MI:*YK^Q/$_\ T-W_ )38O\:/[$\3_P#0W?\ E-B_QH Z6BN:_L3Q/_T-W_E-
MB_QH_L3Q/_T-W_E-B_QH Z6BN:_L3Q/_ -#=_P"4V+_&N@MDEBM8HYYO.F5
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M&1B[1@YV[=Q)SC."1Z$ %J/Q?ITDED?+N%M+Z<VUK>%5\J609 48.X9VM@D
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M@O+1;*YTQ[)(;B)F^SR'=^\0 XR0P!/4;1CN*ANO"&JW=MXCCDN;/?K&EQ6
M9=P$919%+8P<C]X>,_P^_ !LV?B&6[\7WVBK8R""VM8)Q<[EPWF&3MNSCY,#
MC.<YP,$X>L:O):?$4V-SJE[;Z:=(^U&.!"V)!+MSPI/W>W2MC3]"OK/Q1)JI
MGM_(N+""VGBVL6#Q&0@J>!@^9W';WX=_8EY_PGW]O[X/LW]G?8?*R=_^LW[N
MF/;'XY[4 5Y?$D&@:2'NO[0U!8K1[^6X\M 4@W$C<<J"P!QA<D[2<>MR^\4V
M=D)S';7=XMM'')<&UC#^4K_=)&02<<X4$@<XY&<OQ5X4U'7IKJ."[M%L;C3)
M+)8;B-F$$C;OWJ $#)! YY&..I!;;>&O$&FZO+>6&I6*QWT$,=ZLL+$QR1KL
M#Q<]UP,-W /M0!%XDU<II?C86-YJ,%_I^G";+,HCC/ENR&+KC.WYOPJ[+KL5
MGJ3!AJ,]W!HQNS K*(9%!&2,G[^>,GMFH=3\*7]\WBP)/;JNMV26D18MF+:C
MH6;CG[Y.!Z>^1._AJ\GUD7<LL"1-H[::X4DL&)!WC@<<=* &:?XB349/"TUY
M'?6EUJ-L\Z11LOD/^Z#-OP2<#.5[^M.3X@Z$UPB-+(L4MM+=0SC8RRQQKN;
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MX P?[WJ0#KX_$&F36=E=QW):WO4+V\@C;#J%W9Z<#'/-4H?&WAV?R?)U$/\
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M@D 9V@DUV5<#H_AC4ETKPUIE];+;C1+LW,ESYBLLN!(%$>#G!W@G<!P".<T
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MD(WF)1D$#DX7@@8JQX;T+6=-N?#\EWIV!8>'FTZ7RYD;][F(C'(X(C/YCWH
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M&OZ9I3E;VZ$04J'?8Q2/<<+O8#" GH6(KG/#\&MZ&^OEM"FG-]JDUY;[+B(
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MKMQ;S6K21I;+;.2 C1Y\PX]?,++GN(P>] '11SQ2R2QQR*SQ,%D /*D@'!_
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MCUR<X !UV ,8 XZ>U(44N'*C<!@-CD"L"W\1W"Z[I^EZC8I;OJ-L\]L\4WF
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M@AUX.,8(/44 =D5!() )'0^E&U1_"/3I5.QFU&6TD>]LX+>X#L$C2X,BLO\
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M';G&*S;?Q9</<Z*EQIR11ZU"SV3B<L0X3S DGR_+E<G(W<@CT) .F5%4L54
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MABC\UPL@.$_O_P"[P>>E8_AC7[SQ($U&"6P.F/YJM"H;SXF60JA)R00R@DC
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ML=_'<QK&IMYTC5 R@+C!5<$'((./>NFDU&RBN_LDEU"MSY1F\HN ^P8!;'7
MR.?>J<GB;0HH8I7UFP6.:(S1L;A</&#C<.>1D@9H HOX7FG.ERW6L7-Q<V-W
M]L,TD:#S7V-'@J  J[6/  ]<YSG2US1K7Q!HUQI=YO$,X'S1G#(P(964]B&
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M@BBMGBTV*\BDY+$Y928SN(!R1G:#GICL(-?TBYLI+R#4[26VBD\EY4E!57R
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M=.U#3HX D07,4B,[%"I(X?S,YZ9'..*ZVH(+RVN9KB&"9))+9Q',JG)C8J&
M/X,#^- '"6_A#5],T3PK':NCW]G;MIUZ^[@6\J_,03][8RH5'?';-%OX2UE?
M!NM:-O42PPR6&E,[D[K?)9-Q[9!6,^T8->A44 >::OI=YKGA?5IHO"E]:ZI<
M6T=LRW5TLLDNV0-M4F0C8/F.3C.>!7I$041@K'Y889VXP1GU]ZSW\0Z8G]IY
MN&)TP W:K$Y,>1N' &6XYXS6D"" 1T- 'G/BG1-5OIO&BVVF33#4=/M(+4@H
M!*Z&3<.3QC>.N.]=#IMG=)X^U2_-E+%97&G6L4<AV@%T:4L, YX#KV]:Z8G
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M  E9U$_<SY!D)W_>_NGIU]J])HH \WNM(UV*75+^UTR64Q>(X]22V+HINH!
MD;;><;@06 ;'*BM#4+&ZU"?0;NW\//:(NM?;KB(B,.%\ET,D@5B-Q9EZ$G '
M?@=Q4%[>V^G6,][=2>7;P(9)'VD[5').!S0!A>#[.[LH]9%W:R6_GZK<7$0?
M'S1NV0PP3UYX/-&I65W+X_T.]CM9&M+>RNXI9QC:C2&(J.N?X&Z#TK?M[B*[
MMHKF!MT4J"1&QC*D9!Y]JE!!&0<B@#F_ 5I>Z=X+TW3M0LY+6YM(A ZNRG<5
M_B&TG@]N_M5;Q)X>NM0U^UN+1%-K?VLFFZIEL?N#\X8>X^=!Z>;GM76U3O\
M5;+3/L_VR?R_M$Z6T7RELR.<*O .,DCK0!Q<.CZ_9^!;F*YLH]1U2(Q6L<;;
M6,EO#* LF&^4N5W2#/<KGIBJL>A7\TVMK=Z=K$$=UJD-W;WD,\?GQ8MT7S
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MG-JEG;ZI:Z;+-MN[I7:&/:?G"C+<XQQD=^]7* "BBB@ HHHH **** "BBB@
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M5/)B(.8PS*_R<J3GI@\]:["UTR^?6C>:@UD;>UWII\5O&P**V 2Y)^]@8&W
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M97(F8XRS#N>!SUX%1CPKH*P7$ TBS\NY18YU\H?O57H&]1]: ,R+_DJ]U_V
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MTFW;$WRY.,Y*KN&XCISUP:CD\-ZG!XEOM1TO5X[:TU/RS>026Y=U=%";XF#
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MHVHZAX;6QL)#::O!-.SR,H>/9M!4C/4%N3[<9INC^#KS27\.$:C!*-%T^6R
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M'3;BY^PZAI]Y*8"Y4,5\K&Y,XW*68?UJYH?B2TETC3DL8+Z:>]>Y,,%U,&E
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M]GZ9'=S,TFZ$Q;I#E$!/S?*P)P"<"C_A,(X[RYM9M*OQ-!8#4"L023=$<X
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M9)M0_,7Y"X!(QD8J];>"]2@UBQOGU>WE^R:C/>!FM#YLJ2JZ[7??R5#[5.
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M6R7P^R)#=0&=PHF&T. "=VTX&>F<"LZZTK4[7P?_ &-<Z7?/>_\ "-2Q13I
M\[,2SE;?(RB%0$R3R> #Q0!["\\,;A'EC5R0 I8 G/3\\&HVO[-(YY&NH EN
M"9F,@Q&!UW>GXUPNFZ;;WOC>ZU"ZT.:7_B46<D,EQ9LH-PC2DX9EP) "G/4?
M@:Q]&M+BXO+39I%]!%-X<N+0V[V4B)!*&C*Q%G&6(^;YV.&.2.N* /3;;5K"
MZTRWU&.ZB%K<(KQR.P4$,,CKWYZ5=KR>W#VUCX=^WZ9JRZ2^BBRF2WTYG>&X
MPH</$4+ ,!C<!U7T.:Z_4M,O8_AG<Z9HJ7$=TNGF*UCFES*,+@*6_O8XSG@]
M^] '2)=6\B2/'/$ZQDARK@A2.N?2D2[MI$1X[B)TD.$97!#'V]:X"^N-.OM!
MN]3T_P *Z@)'2U@N8I;6:(JJ2@@>4,&01Y9CMZ@;<D=,M[6[2VU:9K#49(X/
M$UGJ(9K)U9H<0;G1 N3T<D 9&#GF@#U1KF!8WD:>,1Q\.Q<87ZGM2/=VT< G
M>XB6(G D9P%)^M><&VEN[OQ$Z)J>FF?68+FTNAI[LHQ;1@.R%?F3<I!'!!(S
M@CB#=J$+Z;-KFDW<>G36]U:R+I=DTR+*TQ.\Q%6=4E7D<<=.] 'JE0I=6\BR
M,D\3",X<AP=I]#Z5SE_I5['\,[G2M#%Q!=C3FAM%FDS*ORX52W9L8&<\'OQF
MLZTMX[SQ'I.IV&G3VEE#I4L.H0R6CIGE/*B*$?,RD2= <<_WAD V_#WB"Y\0
M)#>PV<0TJX@,L,ZW&7!W8"NF."5^;@G'(]"=I+B"29X4FC:6/[Z*P++]1VKF
M_AS:M9^ -'MY;26UN([=5FBEA:)PX'.00#^-<=8Q:C/J6D2V.F7^GS_9M2M_
M+:TD"6TKE63=(PRV6!;?G:>V* /4)M2LK>&YFFNX$CM5+3L9!B( 9RWI4-OJ
M+7LUE):K!)8W,#2F4RX<'Y=H"8Y&"<G(Q@>M<)96UOK'A">&/P[?6^M6^ARV
M,WVBW>,!]OW 3\LI+C<&&?7(S@D-I<S:EX?FTS3[JUN/^$>NK;SWLGB$<Q$.
MP.2HV_,KGGT/J,@'H\=Q#+))''-&[QG#JK E?J.U(ES!))Y<<T;/MW;5<$XS
MC./3->>Z58R71\'O'IUQ:SZ=;20ZJLMLPRGDE6C;(Q)NDVL,9S@M5'PGI+Z?
M_P ('(NCW5M<1Q7,=ZYLG1D!0A1(=O R%QGT% 'J,]Q!;('GFCB0G :1@HSZ
M<T2W$,"JTTT<:L<*78#)]!FN1\8AI=7L(?[.N95DL[J-;N*!YMC,$'E;1E5+
M#^-Q@!2.Y(Y1)Y+32_#?VRTOW=_#)L+B":PGD$3$1@L51&8$E6!R & X- 'K
M$MS!!L\Z:./>=J[V W'T&>M1&><:GY)C@%KY&_S#+^\W[L8V8^[C^+/7C%>5
MZG9VQ\,_V7H]A=W,/_"-36T%[%8R,9Y!N5HBN-L3[UW,6&XDX!!%:=Y:O=ZK
M=SMI5XZW'A8PNS6,A\R7<2$/R\O['F@#T>.X@F8K%-&[* Q"L"0#T/XU3N]<
MTRQM5N9[Z 0M*D*L) <N[!57ZY/\Z\\L])2VDTX?V3J$,4OA.>WO6MK-TD:7
M]UA2=O\ K,"3&><_6F7EEJDNC7D=W9_VC':W^FS1WT-@\<MQ$DREPT.,ET4<
ME1R#C'!  /2M1U2RTG39=0O;A(K6-=QD)X/H!ZD\ >N:SX/$2R>)K_29DABA
MMK:"XCN?.R)/-:10,8&#F/U.<U1\>6CZA\/[^*ULY)G\N-XX%B)? 920%QG.
M >!SVKFO$&FQ:I?^+)AHMU+%+X=CBLMVGR<RCS^$!7AQO3@<C/;F@#TN2XAA
M9%EFC1I#M0,P!8^@]:S_ !)K#>'_  [?ZN+<7"V<+3/%YFPLJC)P<'FN!O('
MNKZ>RUZPUJ>SU+3[9+=K6T+_ #*OSQN2I:)M_P P)*CG.1BNK\=03R_#G6K2
M&"XN+F6PDACBB1I7=RA 'RC)Y[XH D'BB6VU'2+34K!8%U;*VTT$_FJ'";]K
M@JI&0#@@$<=JWQ<0F<P":,S ;C'N&X#UQUKSB7397\0>$KS1+;57N[=PEXU_
M'.88K8IB0@S#Y7R !LP3R#Q4=GIVHW&CZ58RVEQ'XBLM<\^>Y,+ %/.9I)/,
MQ@JT1(QGN%[< 'I)N[9693<1 J"6!<< =2?ID4/>6L<9D>YA5 VPLS@ -Z9]
M?:O*+SPY;R^ ?&#)X>E.HO>W@M?^)>_G,CR[D\OY<[3@'CBNDET^VTOQG;S_
M -D[=!N=.D15ALRRI<,X+ET"Y!= HR1SMQWH [5IX4;:\L:MC=@L <>M"W$+
M[-LT9WYVX8?-CKBO-[70=7TGP]X9U&.R:YU*RDEM&MY!EOLD[L$1_9,PD^@5
MJETCP[K-IH&KZ-&A672;>YM-'N2 OF&5=Z./0J"J9'^U0!Z"MU;N)2D\3"(X
MD(<'8??TI\<L<H8QR*X4[3M.<'TKR>\L;76/"&MW-OHNM#4CHDED]O<6)0*^
M,I&J*@$C!LD,N<#N,UZ!I8T_28K"TL]-DMS?@R,8K1E4.$&6E.!M8@ 9;DD8
MH VZ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M2I+#(H=)(V#*RD9!!'4$5Q5EKVMZ[IMIJ L83HNHV4LDA;8&ARA:/!#DOW#
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M@\_=L9^NWY<;NO//2NDT"XU>>RF&M6T4-S'.Z(8R,21]4<@,VTD'D9/(]#0
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M%LQ6%HPI&Q0XX^;I[=>U 'H5%<-8>,+^ZTOP[)<_9K4Z@]Q%<WA4^5&\6X
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MD,2 R_?R">IXXKI?#]C=Z?IODW=Q/*Q<L@N)_.>-2!\I? +<Y/MG&3C-:M%
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M JG&0OS'GMCG2U_1]4E\0V>M66EV&I(UH;6YL;V0)L^;<KJVUAP201CD8KL
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M1''=6C!+>"6+YR84651=.%!!R,R+D<XCR#S7H:Q1HVY453TR!BG!0!@  >E
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MS)(@D3*S1'[DBY"@CCJ..E:?C74VTTZ&)IFM],N-16*^G#% B%'*AF'W5+A
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M 4444 %%%% !67XE17\+ZJ&&<6<I'L0A((]ZU*JZG9?VCI=U8^:T0N(FB9U
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M*Y4!FQ@ X!X':M*+P5'#H^FZ<FI3^787YOXW*+N=][/M;C&W+MTP<8YJ2_\
M!=IJ<NM/=7=P1JJ0!Q'A#"T)S&Z'J&!YYSR!0!#_ ,)?=0O);W>D217#WD5I
M9,V](KDR*6R"R C:%?<,'IQG-1>#Q,OBCQBL\4<4@OX<K$Y9>;>,Y&0.N<D>
MI/7K5BX\&O?:7'!J&NW]S?P7$=S;WY6-7A>/.W"JH4CYF!R#G<<GIC0T;0#I
M.HZG?/J%Q=3ZB\<DOF*BJ&2-4& H'91W_P 2 4]0U!8/&MO;+ID,MU_95Q/#
M=-,5("O&&C(VG )*G//3I570/&5WJUSH0NM+BMH-9L&O+=TN3(RE0A96&T #
M$G!!/3D#/&M>Z +O7XM7%W)'+%9RVBH$!7;(5)/KG*+BJ>F^#XM-?0#'?3.N
MBVKVL"LB_O$8*#N]\(O3'>@!_B[5=1TJ#2O[.2 M=:E!;2&5B/E9N0, ]<8S
MV!KF(-:NO#FL>+;N.PBFLTU>U6Y_?E6020VZDH-IW$%]QR5_P[77=$CURTMX
M6N9;:2WN8[J*6(*2KH<CA@01^%9-WX)CN[?6(7U*X U6YAN9F"+E6C"!0O'3
M$:9SGOZT +<^+;@7TL=AI,U[;V]ZMG.8E<N.FYUPA4A2W(+ \'VS>\8*#X+U
MPGJEA.ZGNK"-B"/0@]ZK1^$C;ZY<W]KK%];VMY()KNPCV>5+(  6!*EES@9"
MD9K7U?3QJ^CWFG-,T*74+PNZ %@K @XSQG!H Y+PPD?]E:7>+H-Y%=6^F+<+
M-O0?:F,8!7ACDG.?FQR0?6IH_'RQ_P!HK>6D8>TM;>X7[//YBNTSM&(]V ,A
MUP2,CGV(K>708CX3/AZ6XF> V9LS,N%DV;-F<CC=COZUB/\ #ZUNDN4U#5+V
MZ6YT^.PD&(X_EC9F1UVJ,,I;(]_6@!?$NK7MKX<UIM7T"">UMQ$5 NOW=RK$
M9Q\NX%3C@CGC!]*E](EGXS\63_94N$70+>62!W*"7#7&03@XR!CI6I<>$9K_
M ,.W>E:CKM]>/<JB/<ND:LJ*<@*JJ%SGJ2"3^6)[KPN+K4-3O7OI5DU&P6PD
M"HN%1=^&7W_>-UR.GI0!DZ=KNIRZWI5AI]E9QV$F@B\C@:9EPQ* #=M/ Z#Z
MD^@K1T3Q3+K5MI;)8I%<7+3"[@,Q)M?*.UP?E^8ARJXXZYZ4L?AN/2IK#4X;
MJ\EETS3C9^5$B$W,:X8#!'WLJ.A&<T>&-,CCO-5US[#/92:K*LGV>? =%5 ,
ME02%9B"2 ?3/- %+XHC'@&]D4E9$FMMKJ2&7,\8.".1D$CZ&NCU._M=!T2[O
MYDVVME TK+&O\*C. /PJKXFT!/$VB2Z5+=2VT4KHS/$JEOD<.,9!'51VJ*X\
M./J,<UOJNIW%[9RP20/;%$C4[QM+$J <X) YQSZXH P/$/B_7+'0=<EATGR)
M;6P^TP7;"3RLYPR'>BG>O!'8^V,5:N_$^HZ9XGOX]1BMDTVPT?\ M"812LS?
M>?)&5&3^[P!QU_"K"^"VF\/7NC:EKNHZA!<6S6L;S>6&AC/H54;FX'S-GI[G
M-BX\(P7M\]U>7US<>?IYT^[C8(%N(R6/.%^4_.WW<=J *-WXPU.RL]5N9=!<
MQ6>G-?I+ND2-]N2T19HQAL<C (/MBM_1KN_OK,SW]G#:ER&A6.?S=T94$%OE
M&&R2"!D<=36-%X,E_P"$?O='N_$&HWL$]JUG&TXCW0Q,,$#:HW-C W-GI]<]
M)9P&ULX;<R&0Q($WD8+8&,G% 'G^KW<)\3>*+G7[6*?3-(L[6YCVRMYD6#*X
M,> ,.Q4 X(Z 9(K=N_%=YIMZ+.^TV%9YK"6]M?+N"5<Q %XV.S@@,"#@@\],
M<V+CPE:WE]K<UY,\\&L6Z6UQ;E0%"(& VD<@_.>?ITIH\)B2)/MFHSW4\-E)
M8P3NBAHXWP&8X&"Y"KSTXZ#)R 6O#>JZAK6EPZA>6$-I%<0Q36XCN#(Q5T#'
M=\HP03CC-<?XOU/4;[3/B!I]Q';_ &*PTT&$JYW!C$[AL8Y.<=^,#KUKO-(T
M\:3H]GIRRM,EI"D"R. &95&!G'&< 5C:KX-AU.77&_M"ZACUFU6VN8T"$8"E
M=RDC(.TD=<=\4 5?^$QETN2_MM4T](OLEA#>0F&8R&579HPK#:-K;E'3(^;K
MQ6MH^L7U_J-Y:7>ERVR0JCQ7(5Q'*&SE1O52&4CGCH0?84[[P7:ZI<W<E_=3
M2I=:<NGR1J N$5BP<$<AMS$YZ=.*T-$TBZTN(B]UB\U27 19+E44JH[810"?
M4G)- %+5=?U.V\30Z)I^EV]U)+9O=K)+=&( )(BL"-A[/D?TZU#9^+)]2O;,
M6VDS3:;=S20FX17S$%W .V4"[6*XX;(R/?&I)H@D\40:Y]ID$D-J]J(0HVE'
M96))ZYRBU0TGPD=&O93:ZO??V:9GGBTYMABB=B2<-MW[<DD+G&: ,#PEK0TO
MPQIVGP0F6ZN;O46B4ARJI'<ODG8K'JR#IWK8M/%MZ]UH4=_HK6$>J&6)C/*0
MT,R D)M*C(8*Q4Y&0.@-1_\ "!1Q:?8Q6NKWEM>V%S/<6U[&J%U\YBTB,I!5
ME);H1V'I6GJ/A>UU;08]*OKBXF"2I.;DL!*75]Q;(  SR.   <# H H:AXLO
M;+2X[[^S8!');37*,]S@.$P40#;N+NIW8Q\H!SFJMSXVOV>4:?H\$JIH\>KJ
MTUV4RC;LH0$.&^4X['U%:VL>%8M6U%+Q;^YM3]CEL9$A"%7B<@D?,IVG('(J
MG;^"$MU<?VI<R%M)72B71,^4N[#< ?-\Q]NG% ":?XBO]3\86=M#%"NF3Z0E
M^ SD29=@.>,9&,8SW)SVKK*Y^P\*QZ?J.G7D5_<;[.P73RN$Q-&IRI;C((]L
M9KH* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ JCK-U-8:)?7EOY9EMX'E42 E254G!
MP1Z5>K-\0133^'-2@MX7FFEM9(XXTQEF92 .2!U- &;H>JZMJ-AHVH7$NG>1
M?6JW4T*QLCQ(T>[()<AL,R@\#KFM6TUK3+X2FVO[>411B5]KCY4.</\ [IP<
M-T.#7.^'_#JZ7X)MO)T.UAUI-)%K)%(B*)I!&,K(5X8%AUSW/K7,S>'/$6HQ
MWHBTRXMI+G08;93<R1!!-'(S&+:C$*A!"C Q@G/N =W?^(K#^R+^>SUC389;
M91NENFS'$6Y4N,@X/;GGM4$VO7,'BO4=,FELX;.WTN.]2>4%=C,[J=Y+8VC9
MGMUK%U^WU+Q'X+UWRO"\MEJ5Y:+;B.5H?.F89P-RMC8N3@D\Y/ [V[^QU"?Q
M7J]ZFG3M;W&A):QME/FE#RL4QNZX<<].O- &C!XLTV.YT_3[N_MGN[BP^V--
M#E864;!N7)/!W9 R>!6G#K.FW-O:W$%_;R0W;;+>1) 5F."<*>_ )X]#7):#
MI6JZ?J?A2>;39=EOH)T^YPZ?N)083\WS<CY&Y7/:K/AC1Y['7]1M"Z-I.FSN
MVGJ#RC3 .Z$=MFXA?]F7':@#H;^_%MJ6G6POK* W$CAH9_\ 63*$8XCY'((!
M)P> :CM_$VA7=U#:VVKV4T\Y<1)'.K%RN0V,'G&T_D?2J'B*SO+GQ%X8N+>T
MDFAL[V26X=2O[M3!(@/)!/S..F:YNST35HM/T9#I,R20>);B_F&Z/Y87><A_
MO<\2+P.>O'% '7:;XJTC5+2ZNH+R,06UPUN[.<?,&V]/=@0/6M*SOK74(#-9
MW$<\88H61LX8<%3Z$=P:X"/1-=MEBD73I6&G^)+C4&B$B?Z5!*TN&3YNJB0-
MAL<C YKI?#NEW%MK7B#5)(V@AU*XBDB@;&0$B5"Y X!8@\=< 9YX  :5K5_?
M^*_$&DRBV6'3?(\IUC;<YD0M\WS8XQCCK[5@GQKK \%2Z[Y5CYR:G]A\KRWV
MD?:/(W9W=?XOT]ZMZ=H(F\<^)]0U30TEM;D6WV6:>..3?LC*L ,DCG'4#-<\
MWAS5S\,9]$_L.;[0^K_:!;;HL>3]K$O][;C9V_"@#O++4+_4=48VK6S:3$NU
MK@QMNFE!PPC^;&T?WN>>!G!(R]+UKQ#JUQKT=NNF;M,OFM(XW21?.PB/DL&.
MW[^/NGI5;1K/6?"6L+I-G876H>&9DWV[>8GF:<V?]4=S O'Z8R5Z<TN@+JVC
MWOB>5]!O93>ZFUS;!9(0'0Q1J"27^7E#U&<=NU &KH'C#3]:TJVNIBMC<S7+
MV36L[C<MRF=T8/\ $?E)&.HK;N;JWLX?.N9DBCR%W.<9)X 'J2>U<AH5C<^#
M]+MDO[,WMYJNJO<7DEL5,=M+.W4;B"5&0N0,]36CXIL;^6^T'4K*%KE-.O3-
M/;*0&=&C>,LN2 2N_.._..: -)_$.C1VD5T^JV:02R&))&F4!G!P5Y/WASD=
M1BK=E>VNI645Y97$=Q;3+NCEC;<K#U!K@+[P[J3W<]_%I\KQ7GB&TOQ:@IF*
M*)$5Y&!;&6*EL#)Z=\@>BJH50%  '84 +1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M+<&=7)C("8*DI@$C(W=33;CQC+-X8E\26-P5L62T@43!0L4DDB"21CMS\@D
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M.(SIYK-YBA]C^6J89& 7<#AB.QJF?$^IS:8EW9#5;B*&YFCO[80PI?VVU4(
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MF,84$]#\Q'L>E=W-$D\+PR#=&ZE6&<9!KB7\02VOCN6?4%O+'3HM"DNY(IY
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M0/([MEG8QJ223U)-8]EXML[6PM6CL]7N/MNJ7-DBRLCNLRM(2I)?A<HP7!P
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MNT3_ %5QO#JR@]AM4>X!]:L:5X0M=)UR]OH)6-O<0)&+<]%<*$=\]RRI$/\
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M<[F7VKKGU=+)'?5/(M5:\6UM\3;S+N("<8&&)/W>< 9S6@)8R"1(A Z_-TH
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M]*TJWN=.:YDMWN)+T1M'LE\MF*;3D'#%<')P,XSQTAEC$HB,BB1AD(3R1]*
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M[;<.4^:2/8S991MW;<Y&#UJ"72[ZVOX[/1H=0BD3PM<VMG+<!BR2%U,2M)C
M? S@G(Q[5Z;10!YUH6C:+XFAN@]AJL37&F_8;V*[M/LZ1<C"XV*'=3N(89QZ
MC(IJ6^H/X#U"ZUG1I+J^M;-M,%O&&5IT1MKR+M^;:^ <#J$&.M>CT4 >/:I:
MR75EXLC%A>SK<SZ=<6Y73I(PY!0.R+MR,!3[X')[U:U[1U\GQQ;6&DR"V>*R
MG@BBM&".RY\PH N&; &<<UZO10!7MY8%L$EBC:* )E4\HH0O^YC(^F,UQ/PS
MT18/"6D74\>H07MN)E>"XDE4#<[?\LG.!Q@Y 'ZFN^HH \@L$U":[TZ72].O
MK"ZETC4;=8VM95%O.S1LBO*PRS;MQWDX)Z8[Z]DFE:GX7NY(= OH-0BT5[.Z
M2:TE3#8SY>TC$K;LD%0WU&[GTBB@#S[2HI!K/@TS6EP(HO#\T,Y>W?:C$0?(
MV1P3L?@^E9.AZ=Y%CX$EN=)N/+MI[R*56LG+1;@_E[EVY49Q@G@5ZO10!P>F
MZ&]EXJN_#ZVD?]AK<+K,9 &U68D>41VQ*ID!]!CM6MXXCO&TBSDMH)+BWAU"
MWEO88E+M);J^7 4<MC@D=P"*U=(T6WT:*1(9;J=Y&R\UW.TTC>@W,2<#)P.G
M)]36C0!Y3XDTIKBU\37%I93R:9=7&G/;Q16[DM,LH,TB*!D?)MRP'.#Z&O3+
M&PL=.LA;V-I#;6N6<111A%RQR3M'J2:M44 >2V&E1R67AF";29C'#XBOF='L
MW 2!S<;=PV\(=T?7@Y%.CTY8K.PW:3.;.S\67#B(63MY=NXEVE4VYV%F7H,<
MBO6** /+[BPO[K2=4L'M9T\2#6_M%I<^2W^K,RE)%?&-BQ94C/ 4KWP>S\:J
M\G@;7H8HY)99=/GBCCB0NSLT;   #)))K=HH \QUG2PGA'PI)!#JLL\=]I\D
MD1:XD\M4=2Y:,YV@8/4#%-UC1+_5_B/J5]ILUQ:7=I9VLME-- YMII4,NZ-\
MC###CD<KG(Z5ZA10!YKXFUV?Q5\*-54:-J=KJ;Q+&]B]G*7W[QG9\OSKQD$=
MNN*TO&22^+K*RT+3;6Z*RWD,US=2V[Q);Q1N')RX&6.  HR>><"NXHH H:?J
M]KJ5Q>P0"99+.8PRK+"R9/JN1\RGG!'!Q7GOBCS)-<OFBTR]CFM]6TZ;S([2
M68SQJT6Z17 (50"Z[%YR&)ZD5Z;%!%"TC1IAI&WN>I8].3] !]!4E ' :=%=
MP>-HVAC-Y8SWMR[K<VK1W%@^ULN).CQ,1@ _WEP3CC1\8VJ/K7A6\EL7N8+?
M4'\XQVYE**UO*JY !.-Q7GH#BNNHH \G_LX M?#3+C[:OB[S5F^R/Y@@,@W,
M#MR(RI;)Z<FKVDVRW.OBTU>VU<:U9:M-=12);;8I(V=MK^>$Y3RV"E"^>-N.
M!7I5% ''_$Z*2Y\$3VT,%Q/+)<VQ"6\;N^%GC9B-HR,*"<^U9,EI-'\0K+4=
M$M=3NK;[#<1Z@UXLI"J%S&L,DO*LS]0IQCDC@5Z-10!X[9P&6.3;I5ZEO/X6
MDM_L_P#9\H5)5(*Q$LNYV&2-Q^\<XZXJ_8V"V%W8O;Z;/#YOA62*Y9+1P7G_
M '>U7^7E_O\ !YZUZG10!YU\._M5D;2SUC3YC>'3K<VM\;5U"Q! #;L2/W;H
MP;(XW9SUK5\56$-YXO\ ";36)N(HY[@3-Y!=50P. '(! !8J.>]=A10!Y+8Z
M5':6>ES0:3-%<0>*9C&ZV;AXK4RRXQ\N5BVL/]GFK&G!Y?%6AS_V3>VR+J&H
M17,+6<K!/,WX,DK [PYPV0=H! [ UZE37021LA+ ,",J<$?0]J .&\.:++8Z
M]-H#VJ?V3I%PU_9/@8_?;MB8_P!@F;\/+-=W5#2-(M]&L_L\$EQ,6;=)-<S-
M++(V ,LS<G@ ?05?H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "LCQ/K8\.^'+S5/+$
MC0JH1&. 79@JY/8989]JUZJZCIUIJVG7&GW\"SVMPACEC;HRG_/6@#@M3U*Z
M\.>--7U.\DANGAT&%DV1^6,F=@ ?F/&X]<]/IDZEYX@U_1VF^WV<30SS6\%E
M*0BMYDCA&#()""!D$'<,YP?6M*+P5HR/*TZ75XTUG]AD^UW4DN^').T@G!Z]
M>OXTV+P/H::+<:3+%<W5I<*J,+JZDE954Y559F)4*>1C&#S0!EWVN^*--2)+
MB"S3S=6M[6&25,M)#*0"2J.=K!LC.2".PJI=>*/$=C:ZU-+-ITHT;4H;>3;;
M.OVB.01'CYSL($IY^;) Z=^C7P?I8LK>V=[V;R+A+I99KN220R)]PEV)) [#
MI[4MSX0TF[BU**9;@IJ4Z7%T!.PWNFT*>#QC8O Q]T4 0_$!YX_A[XA>WE$3
MKI\YW;23CRVSCD8/OVJC'+<V7BC1;)4T[S;_ $V=GNEM-LH:+RP@SNY7$G3V
MZ\UTNJ:7;:QI-QIE[YCVMQ&8I55RI=2,$9'/(J :!9?VC87Y,[7%C$\,#-*3
MA&QN!'0YVKR?04 9OP^N[Z_\#:7>ZA<BXN+B+S6DV;3SSSR<G.>F/I6+#XFU
MD6EEY"Z='+<>(KC3)2+=@NU6EPX ?[W[O)R3G/4=:[#1M%LM!T];'3UD2V4D
MHCRL^P'L-Q. .P'%44\'Z3&L*J+C$-\VHI^_;B=L[GZ\YW-QTY/% !X5U6]U
M.UU"/4&A>YL;^6T,D*%%D"X(;:2<'##C)Z5RVKZWJ[6.LK!/;6LMKXCM+/S(
M8"#)&YM_O?-R?WF">X&.*[C3-'M-(-V;42 W<[7,V^0MF1L9(STZ#@<<51F\
M(Z3/!J$,B3E=0N4NYR)W!\Y-NUU(.5(V)TQ]T4 9S>);NW\71Z/?NEH))E2V
M>2V;RKQ/+!;9("0L@?/R'L.,YS6CX@U*\L[FRM[.6!&G$I(9#)*Q51MV(,#&
M3\S$@ 8]<B8>&[#[2LS>?($G6X6*29G02JH57P3U 'TSSUYJ34M L-5OK.\N
M5F%Q:!UB>&=XSM?&Y3M(RIVKP?04 <+9:CJOB+7_  UJEC)9V5_?>&Y9G>6%
MI8T)D@) 4,I//J>/>ISX]U,:!I^H7D,=A'+%/'/>"!IK>*YCE,8#X.Y(V*DA
MCZCD8YZ:U\&:18PV$=F+JW-C"UO!(ER^X1,02A))R/E7Z8&,5--X6TN6V%LJ
M2PVWV;[(\$4I5'B.<JP[]3SUY//)H P]0\6ZA_9GB75=.%L;?09BC02*2;A4
MC220[@?ER&(7@],G.<#,U36;C2M7\9ZYIZQB>#0[*ZC6="0<?:#A@"#^M==-
MX4TB:YN93 Z+=JBW4*2%8IP@PN]1P> ![@8.1Q3[GPSI=Y<ZE/<1/(=2MA:7
M2M(VUX@& 7&>,;FY'/- '.^*?$.K6H\2V=K-##]DT#^T8)5B)=')D!')P?\
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M=N]MN%!W+AB<'/6N;U[POXCOTO+13;7D*_8FM)I[EHR/*9&DWJ%(+L58[CG
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M<8'4<'FN0TG2+O2M7N=6UV.PMK"?2H;2Z>:],A\Q7?.XLH!#>8!UP.![5H>
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MWLS2,5)!(*' .W.,@T >N45YGJVIP76M:EI+^*!I"1VT,FF3F9V,BG.YT/F
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MC\9WS0&\&@74MF^GO>Q/"LF054,(FR@&6!X*D\@CG@D Z]$6- B*%51@ #
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M?6WV/2IKBPEO)+1YD5]T>QF0RGY=I3<A'#9 (/J!K:QJXTO[#$L8DN;ZY%M
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ML4&0G"AF"DCCKSQ_D4 ;'V"S!&+2#@8'[L<#T_4T"PLQMQ:0#;]W]V./IQ7
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MB($@BD#%"1D9QTR.16;XK\0Q>'M U"[6YM%O8+62>&&X? <J"0, @\D8^IH
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M2S2S!P 5,@PP7 Z#MW'K2:EX2M[[1M.L8KRZM+C3G66UO8F!E20*5+'<"&W
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M/6@#.TOPK%IJ::KWDUR-+@-O8^:JCREVA=QP!N;:-N>.,\<DU7LO!<-C;:%
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MIXGFAP)8U<%DR,C<.V16)I.MWM_XKUW29DMU@TPP!70'=)YB;N><#'3OGVH
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MJ)K5X/[2N,/JHU8G8F1*'#[>GW<@>_O6W+K.EP(SRZA:HJR&)B95X<#)7KU
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M]:-&5B.X.2/SXJ?7+6\_X3#P[J,%G+<6]NMU%,T17,?F*FTD$CCY3TS7344
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M"F83(5*$_-]W"GIFO2*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MCDGAVD>3(O1AD@Y).   ,\T +HOC)]2T.POI=)NQ->O-Y4,6P@*A8Y+%@HX
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MO6 N--ET<Q+YD+.C2"4G:, _/@Y Z^E '>45YA'I&K>'=$\,:_\ 8_M.M6T
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M'T-4O!=OJ-KX,TF#5FD:^2W D\TY<?W0W^T%P#[@USVMVL$'CW5;J2Q):?0
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MUS$?WTP9"/,./F?'F=>>M 'H5G/-+8P37<*VT[QAI(1('$;8Y&[C./6IRRJ
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ML +G<"0"O4=P,59_X2G2&T^VOHKAIX;JW-S$(8F=FB !+[0,@#(SD=2!UXH
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M^?2@#5UW0[3Q#IIT^^:7[.SH[+$^TDJP9>>O! /X4G]B6YUV+63-<&\CMS;
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MI4AAQP,HO'3CZUSR>'];?5;V0+JUE<S73RK<V^IJ;3&?E8Q-EL[0N5VX)!Y
MZ:WB#Q!-HOB[1X9)IC87-I=/+;PVQF=WC,>TJ%4N?OMP/3/:M*'Q3I-UIMM?
MVEP]U#<H\D*P0N[LJ'#G8!N&TX!R."0.I H L:QHEIKD-O'=&96MIUN(9(9"
MCI( 0""/9F'T-9T'@O2K9X&A:[7R+Y]0C!N&<"9@P8_-G^^W'^T:V=/U"TU7
M3X+^QG6>UN$$D4B]&4U0_P"$HTD7D5J9Y/,F$A@/D.5F\OEPAQAB!S@=1TS0
M!7;P?ISV\L)ENMDM^-1;]X,^>&#!NG3*@XZ<=*E_X133/M-Q(%E$-S<+=SVH
M?]U),""'*^N54D X)&2#4>G^,]$U22W2SGGD-S;M<VY-K(JS(N-VPE0&(R,J
M.>>E4K'Q=:ZS8:#?)<W6GC4+DK%"]J3Y_P CD1EBN%X&[(/\) )YH LWW@G2
M-0N+V68W:K>3Q7,T4=RR(98RFUP >#^[4'Z>O-/N/!^FW4.I12R71349X[BY
M E^\Z;0I!QD8V)T_N_7.-J?C*:\\/W%]I?GVCVNL0V+^=!]]3<I$X^88YRW3
MD<9Q71W?B32[&Z6"XG9-TZVQD\IC&LK8VHS@8!.1U/<>HH EM=$M+/6+S5(C
M,+F\">?F4['*J%#;>F< #..U4=6\':5K-S>SW)NE^W6HM;I(9V19D&[;N ZD
M;FP?>L_Q)XH,$^EQ:9<R R:Q!93NL!:-@7PZ;R, CD<'@@CJ*VO$FN1^&_#M
M]J\L,DRVL1?RXUR6/8>P]^U %:;PCITQU#?)=8O[-;&X!F)W0J& 7)R<X=^>
MOS'GI4-SX(TJYD>0R7D3RV8LK@PSE//B (4.!P2 3@]>?2KMUXETVR1VF><&
M.'[1*JV\C-%'DC<Z@94?*W7K@^AK3BN(I[9+F&198702(\?S!E(R",=<B@#G
MI? VCR7%I<1M?6\MO;K:EK>\D0S0KT20@Y8#GKSS6G8:):Z;J-_?6YE$M\R-
M,I;Y?D4*N!CC"@#CTJE8^,]$U&,R6L\[QCHYM95#'>8]JDKRVX8VCGVJ>'Q1
MI-Q \D<[ETN3:- 8F$HF SLV8W9Q\W3&.>G- $U[HEI?ZI9ZE(9H[NS5TBDB
ME*_*^TL"!PPRBG!]/K5*S\'Z;8KI2PO<A=+DDDM0TF=I<$-GCG(9ASZU)#XM
MT><1[9Y5,EZ; ![>12+C&=ARO''<\>]3Q^(M,FCG:.9V,%T;-XQ"^\S !B@7
M&2<'.1QC)Z T 5=&\(:7H-RTMB;M8MS-%;/<N\,!;[WEH3A<Y/TR0, FKFH:
M);:AJ%MJ!DG@O+9'CCFA?!V/MW*0<@@[5[9&.,57@\5:3=0K);S2RLSRQF%(
M',JM&0) 4QN!7(SQW'7(IEEXHM;_ ,1R:1!#<$K9Q78F,3!663=MYQQPAY/?
MCJ#0!'/X+T69K<K%/ (;9[3;!<.GF1.<LKX.6R><GDDG/4TJ^#M-6R2Q\R[>
MS$,4#V\DQ=9$C.5W9R>OH1D8'0 5/J_B&'2-6TC3Y()Y'U&5XU:.-F"!8V?)
MP#S\H&/J>U8OASQ<C2SV.K7<LERVKW-C;R_9B$.QV"(75=@8JO0G)_$4 :L'
MA#2[76Y]4@-U&T\OVB6V6Y<6[S?\]#'G;NX!SZ@'KS6]62WB32TU""S:=E>X
MF:WAD,3>6\JYW('QMW#:W&>JD=0:UJ "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .2@TSQ!I?
MB35OL45E<:9JMPEUYTTQ62U?RT1ODVG>,(I'(YX/K67J'AC7W.K6EK!9O!=:
MU;ZI%-)<%20K0ED*A3@CRCSSU'%=--XEBCUZ?1H]/OI[N"W6Y81A,>6Q*A@2
MXSRI&.O%7=(UBRUS3TOK"4R0LS(=RE61E)#*RGD$$$$&@#FQH.J_8?&<)@A#
MZQ([VO[WCYK=(OFXXY3/?@U%J/A[5_LWAN]M;*PO+K3+9K:YL;J3"2JZH"5?
M:<,&C4@D<@GI7;T4 <C;Z'J%OXCT?4%L;*&"TLKJ*6&U8*J/*\;@*,#(&P@M
MQDG.*Q]%\->)O#L>AW5I;65U/;V#:?=VLER8UQYF]9$?:>G(((Z&O1J* .'\
M0V*ZGJ^C6T&I6R:RFZVOHH",FTD3,JE0<J/E4JQZ''K7:O$K0M$/E4KM^7C
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MX<X^7 Q[\,/A;4+N+5DU32[::"^U87JK#>,LT*B!4#(X"[9 R#'/0G\>^HH
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M;*VIZ'%I\0$^0LJB4$D[1\O[T<XSP>*ZJXUB&RM=3N[Z&:UM=/!9YI -LB!
MQ9,$D@9(Y .0:AL=;FO-4>R?1=3M0BEC<3HGE'[N &5SDG<?IM.<<9 ./O\
MPCKT^N0:S9^5!>V.GVT5KNGRCS1F3>LBXY1ED*YZCJ*]!A::2T5IH5BG*_-&
M&W!6],]Q4U9HUJ ^)#H9AF%P+7[6)"!L*;@N <YSD^E '"S^"-8_X1[6-.T^
M-;.WOK#R1ISW1D@BN"V6>(D$I'C/R]R>@Q6MJ^B^(;C5]:U#34MX9+O3K6WA
M,DO.Z.5W<'@XRLA ;G!&:Z1-:@?Q'+H?DS+<1VJW7F$#8R%BO!SG.0>HK2H
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M[6+1+>X!-U)"99%F.)"BL,$@+D=\\BO1'C250LB*X!R PSS2[%W;MHW>N.:
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MH:7I,UE<7%S>:C-?W,IVK)*B)Y<>20BA0!WY/4\9Z"M*2..5"DB*ZGJK#(H
M\VTG6H#KFB37<US865[I%W&8+N[+!IEGC  ;.';&[:PY*G/>LW0?$-M<:5X;
MM_$>L/!I]WH.4NY;HH'NMV'W29_U@7!&3U)[UZV8HVV913L.5R/N_3TI##$R
M*AC0JI!4%1@8Z8H \NU>*UFUS4T?4+PFW\*1.DKW#13,RO*5=RI4[NAP>YZ5
MT]YJFH'X5_VI9,\U^VEI,'C&YBQ0%F '4]2/>NK,:$DE%)/4D4H 48  'H*
M/.()-%U+3=6N;7Q7+-8W=M&F-/F=?L\Q)"%6,A*RL2!LR,X&1SS437[VR\'Z
MN+VXF&O6%U;QZPD4C,8[?>@:2)0?E4PY;(YR6/45Z@L,2*56-%4G=@* ,^M+
ML7).T9/4XZT ><ZMJ^FV&GC4-'UF2?1;C4H!?3K*9[>UC,; [64@A2XC+C=Q
MN.>I%1N98]/@.C:_:ZM$UY/-#;7$[10W$>Q=T44P9ON$DJ22 <CC;QZ2L,:Q
M>4L:"/&-@48Q]*1K>%HQ&T,9C7HI48'X4 >8OK,I;2M2A,MU8&"P\RRDN62^
MM26!5P.DH?(##@M@\GI75^,]0MK*/28[JX>!+B^6,%IA%"Q$;MME;'W..@ZL
M%'0FND,,;2+(8T+K]UBHR/H:<RJXPRAAG.",T >2Z-J/V^/PC;3ZO.Y.K:C:
M3A+MT+HHGV*WS9X 3&>0".>:+.Y6UM-.NH]5N6DM_%,FGQ%[UV'V?SG7RR"V
M&&W')R>!SP*]9\M/[B]<].])Y4?_ #S7\J /,AJ-]<Z0;I+J5/%,&O>0UMYI
MY0W&WRRF<&/R#NZ8XW=>:@NM:6SCN[675I(KJW\6PJ(VNF#I;M+%P1G(C*L>
MOR\UZIY4?F^;L7S,8WXYQZ9H\J/>7\M-QQEMO)QTH \HN[H0Q:WJ"ZM=>?9>
M*K>&#-\Y5(V:W#KMW8*D,XP<X&>F*Z;P<MI#XJ\80K)BZ_M,2>4923Y;6\!W
M;2>A.>?P[5V/E1_\\U_*G!5!)  )ZG% 'E7B?6/[/7QQ;/JDMO<1W%I-:1_:
M65U0I%N*#.0N=^<<=<TFO!+N[\<LFLWT=W9)!/IB0WT@VRM &78@;#!GP-N"
M.< <UZHT4;/O:-"V,9*\XSG^=9-AH(L]?U357F29K]XW"&+'E%$"#!R>H'-
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MF/)D*9P'WA48XS^\YZ5Z2\4<A4NBL5.5W#.#ZBLZXTF:ZUF*[FU&9K*(*RV
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M ,6+Q3<W%E#?PZ/*^GW-F]Y;W'F\;5 91(,?(64Y'WO?%)!XO6XDTQ4L'/\
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M47=K&G)82D6WW H<;A\W7]ZW'T]#D ?JGC..R-S]CL)K_P"R)&\Z0Y\S#@,
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MHZY7PU86]UKNI>)8+:\M8[U45(;J-HFW  22;#@KNVQKSU\K/0UU5 !1110
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MKMZ YP37GMOINIVTB7D>GW)M+7Q//>36PA(:2!U95D5<?-M+!L#GCID"DO\
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M[@1P'+'C/ ]ZSK34M6O];;P_)JRQ7-MI<=P]Y;0IB>5G="P5PP"J4Y [MU%
M'9T5YII7B+Q!XB>P']HG3OM.A27CK#!&V)DE";E+@_*>N#G@_C5W1O$6J>)H
M["RCOQI][/X?M]2$J1(WF2RY!.U@?D4J,@8/SCD4 =FNIV3ZK)IBW"F]CB$S
MPC.50G )_&K=>=ZI=W5OXCU.^AND^UQ>%!.L\*#:75W;< V1@D=#G@U;&NZS
M)?P06]U"9+CPT]\B3*JQBX!0*Q.,A?F.><4 =#'9:/X92\OPI@%S,&GE=WD)
M9WP!R20-S\ 8 R>E;%><7/BK4AX>U*:.YOK34[*ZLXY[2^MXM\(DE5#AE7:Z
M,"Q##T[=*U+W5]4L/%-_HTE\Y.H6Z2:.WEI^[;=LE7[OS;-R/SGY2?3- '9U
M4L]3LK^:[AM;A99+27R9PN?D? ;!_ @_C7)3:IKVH7^KQZ7?VENVD7D43I=.
MH5X]B.S2 1D_,&;!5E' XX.:;_VLDWCRXT29DOK?489D145O."VL):/Y@>6&
M0#ZXH ]$J&[N[>PLYKNZE6*WA0O)(W15'4UD>'M6_P"$@,VJVETTFE2I&MJN
MU<,=N7?.,]6"XSP4:L+Q%J5UJDGB[28KM[2/3-+#A41"9FDCD8EMP/R@*!QC
M^+GI@ [:WN(KNVBN8'#PRH)$8?Q*1D'\JDKS?3M3US4-._LS1;VUL[C3M+LI
M(_/<!7+Q[BS@HQ*<;?E*D8//3#9]:OM'U#Q?J;7[R"&6PA19&7R85E" L#MS
MM7S&;\\@T >E45P&M7OBG1[&[D?5K4AKVQ6U("RR+'+,L;JX\M 5.25(&>O/
M%2W#^((?$,VB_P#"1SE5TA[L7'V6$2>8)2%_@VX P#QSCL3F@#NJKV-];:E9
MQW=I)YD$F=KX(S@D'@\]0:XG0-<UF[O?"LMUJ)ECUW29+F6$0HJPR*D3!D(&
M[^,Y#$CTQTJMI6NZ]J=MX05M6:)]3-VEU(EO&2WEARI7*X!&!VQZ@T >CTV1
MUBC:1V"HH)8GL*\]TKQ-K&H6^B::]XBWEXVH(UV=D;2FVF\M0!L9=Q4[B-O\
M)QBKVF:IK=WK-MX=U#4H(KZ'37NKBYL55A,_G-$,;UP-NW+ #[S < <@'66.
MHV>I:=%J%G.LMI*F^.4=&7UYK.DM-$\7V-I?*[3Q1NYM[FWFDA=""5;:Z%6'
M((/.#BJ'PUS_ ,*WT#)R?LB_UKE?#ESK.E:%X=N[;43)9W>JRV4M@8$QM>>7
MYU;&[<I&[KC Z<4 >EV5A;Z? 8K=7P3N9I)&D=STRS,2S'  R3VJS7$Z5J^J
MR:K-X;N[^1M5M;XR23>5&-]EC<CXVXP<K&<<[LFK?Q :X70+0V]W-;,=4LD9
MHMN65KB-2#D'CG/X<Y&00#H+74[*^NKNVMKA99K-Q'<(N?W;$9 /X'-6Z\MU
M*[U+1]1\:ZI8ZB\;V5U8LR&)&%Q^YB#!\C@$$_=VD'OVK<FU;7M3U'5QI=[9
MVHTJ^2%X;AP%:(*C,7'EEOF#-M(8=!Z'(!UU]?VNF6<EY>SI!;1C+RN<*@]2
M>P]ZKVNN:7>W"V]M?V\D[IYBQ!P'9?[P!Y(]Q65\0_\ DG'B3_L&S_\ H!KF
M-6>]M=:\!76J"![$7*P0_9 1*)Y(BJ[L]8\;LX]NU 'IE(S!%+,0% R2>U<'
MI_B#5+GQ%I,*Z@UQ9:B;Y?-6%%B/EGY#%QO^4<$MD-U&1@U7\-:]KMP_A&YO
MM3-RFL)<)<0F"-%4HK,K*0-P/RX/..>@H [O3M1M-6L8[VQG6>VESLD7.&P2
M#U]P:M5YM\-=5DN[:VTHW$MF+..658"B_P"F*TS_ #@D'Y5.5(&#D\X&,^DT
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MNTTD("&991%Y0^;)<L0!Q@^O!H N6WA#P]9R7LEOI%K$UZCI<;5P'5_O#'0
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MN19"33H/]"4K;;!M,:G@J",?*>XZ'O6M10!5TW3++2+"*QT^VCMK6(82*,8
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MM+8:YI.F-;2.=1:55F# *A1"_(ZG(%:M !1110 4444 %%%% !1110 4444
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MN&X$^X K)GL1%LSZEV]*Q?#^G:>__"!BXB4M=:1)'J D8_O=L<>U9<GD!@V
MWH17J&F:='IEDMNDLTS9+233-NDE8]68\<_@ . , 5:DECAC:25U2-1EF8X
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M+A\?>QZ+FN;\1Z98W>M>,UNXY?[0D@@DTH(S+(THA(5H<'E@^!D=._%>IT4
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M@9. ?E#8J'[?+8_VSL22728M;M9[I+:U=(_LC0)O94Y^3?@D#.X!CR":]=)
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M\^/4V>)O-6<V[!_-XSDOG&?7CBO6:8TL:.B,ZJ[DA%)P6P,G'KQ3Z "BBB@
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MYO!?KMEQY%P"#YD?'!R,\Y'4="16II^E0Z?+<SJ\DUS=,K3SRXWOM&U1P
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MUI:SM<VMH[ Q02-NY7C=@;FP"2!G@# Q;TG1(='EOI(;BXD-[<-<RB4J1YA
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M32GGC#"%0ZHXD()R.'"XS]XCGFMCPSJ]]JZ:BUY% J6M[):Q20YQ,$."XSG
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MHK*APQC11MYY&5/YBJ%IX8U[3;;1[M=(MK^2T:^BN+&:9!NCGG\U71CE=PP
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M/[*2Y6Z*RH<;QA=O/-%GX=UB'2M MWLL266O3W\W[U,")WG88YY.)EX]C[9
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MD/:WUQ<1S_Z.VV0)#(V4D(VG#*/NYK8B\1:3+?)9K=@32(\D>]&5)53[Q1R
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M)HX%5T1MPR!C /%<-IWA?5XK#PI;3VIC.G7%VUTR2IE%ECE12O/)_> _@?Q
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MIVM_;07$B[+E8X5C=&QG:3AL$CTH [73=6LM6BEDLIO,$,IAE5D9&C<=596
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M:2,*-T04$949&UL]B.E\2WYL/#MQ=17JVC_(L<YC\S!9U4 +W8DX&>,D9XH
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M6>KV$=]83":VD+!) ",X8J>#SU!JW7E_A"[U#3[;PBL=_(UGJ-Y?6TMH8TV
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M#A3&VUD"N5W?,% SE3Z@];IMRNI>'K2ZM[PRBXM4D2Z5 I?<H(?:1@9SG!%
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MVY^\@.>O)YK3T?5]>U@6>LPWUC'8-=30W-K-(/E4,RJH CW"0$+G+$'G@<8
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MJ%I#<QQ2"5!(N=KCH1Z'D_G7#:[X@U[2O^$ALH;XLU@]A+;W4D*$[)Y=C1N
M #C!(( ."/J;3ZIXAMKGQ)I]M<MJ-Q92VDEOO$44C))S)&IP$)PK;=P[C)-
M'8:?I=AI,4D6GV<-K')(TKK"@4%F.2>*KQ>'-&@UJ36(M,M4U&3[]RL8#DXQ
MG/KCC/7%5O"NK+K&CM<">YE=)Y(Y%NX1%-"P/^K=0 ,J"!D=>#6;I6J:CK;2
M:A%JD=K':ZO-9SV;Q*RF-',87.-PD;Y6!SCYL8- &];:'IEG=-<V]E%'*7:3
M*C@.WWF Z GN1R>]5QX5T$71NAI-IYYN#<[S&,B4YRX]#R?Q.>M<K9^*-6N=
M$\/>($N"Z:GJ*VL]B8UVQH[L@VD#=N3 )R2#AN!QB*RUW7@=.O)]5::.3Q#<
M:7);F"-5>(/*JDD#=N&Q>00/4'K0!V2>&]&2.*-;"()#<&YC4$X68Y)<<_>Y
M//7D^M))X8T21Y';3+??+<"Z<A<%I1R'X_B!YSZ\UQ6F:OJ&G6TD9U&6634/
M$MS8":Y9%$04R%<$(>6\M4&01R, 5?FO/$]E>Z+I]WJ]OONM6FM7>!%=C!]G
M>5-^44"0;1T !X)!R10!T<^G7]]KL4EVUF=+M76>VC5&,S2A2N7).,#<2,#.
M<>G.SU&#7F\&MZ_#!;W$NL/.(/$7]DNC6\0$\1FV;GPN0X!'*[1QT-1W6N>)
M8-/U/6(]6$J:;K?V3[$;:,+/"943:6QN#?/P1CGKG/ !V6BVWA^.ZNXM(BMQ
M+9N8)5C!Q 6PY10>%!R"0O'2I-/\,:%I(NA8:39VXNLB8)$ '!Z@CTY/'3FN
M36^DL=;\7-#=BVEFUFRA4B,.[[H( 40'C<1D G@=3P*I3ZIJVI6EC%<:A<PO
M#XI^Q$H(PSQC+*'PI4D''08X[T =O:>%=!L=,N=-M=)M(K*Y&)H5C&V0>A]O
M3T[52O-#\(Z>([:[L+*(ZBR6JJR9,Y&65#W/.3SWYK-M=5U[5KR6ZL;ZSAM[
M+5VL[FWG<8,2/L(P(]PD;AE^8#Y@,8K(EU*Z\0Z=X2UR6[<)<:^ +0(FR, R
MJHSC=N 7G)ZD\=, '?7.B:;>2"2XM5D?RA"2Q/SQ@YV-S\RY)X.14]_I]IJE
MC+97UM'<6LHP\4BY5N<CCZ@'\*R/&6HWFE:+#=V4YBD%]:1-\JL&22=(V!R#
MV8],5SNN^(=9M!XJ6UU#8VGWMBEN6A1MJR^7O4\<CYS[^] '4_\ ")Z!B0#2
M;5?-=)'VIC<R8V$XZD8&/<9J%=/\-:E>ZQIWV>VN;B01G48G4MNR#L+YX)PO
M'<8[5SE[XFU71+O6[":_-SY=[80074T2*8%N6"L2% !"\D9'H"356[U&Y\-^
M)?%ES]K,SL-*A$]P%41+)))&68JN,+N)SCTSF@#O-.T+2])FEFL+&&":8*LD
MBK\SA1@9;J:=)HVG2WK7<EJC3LR.S'.&9/NDCH2N!@D<8XKC]6O/%.D1;9=6
MMOWNJV,4!55DD6&60(ZR?(@QG.T@9Z\\9KL;>UNH=)^S7&HRW%P$8&[\M$<D
MYP< ;<CCMCCI0!DW.D>%(M<@CN;&Q_M&^F-Q$K1Y:21!DOZ @#)/<CUJ_%X;
MT6#5YM6BTRVCU";/F7"H YR,$Y]2.,]:\[T-+R[T_P"&[MJ5Q]HN(9Y#<,J,
MZ9MSG&1@GKRP;D\YK4TKQ-K&H6^B::]XBWEXVH(UT2D;2&VF\M0/D9=Q4[B-
MO\)QB@#KX?#FCVRV@AL(D6SD:6W"YQ$S9W%1V)R<^N3ZFL_5-5\(ZUI]Q::I
M<6-U:12;9TFY6-U]?[K#\"*T] .I'1+==7GM9]03<DTMJ3Y;,K$9&0.>.1C@
MYKC_  G#J4UWXH2V:T-FWB*99XY8R69-L>\ YQT]1ZT =@GA_28OL7EV$,?V
M$'[+L&WR<_>VXZ9R<^N>:@_X1/0,0@Z3:L('>2/<F=K/RY&?[QY/J>:YVX\0
MZE'XALO(OC<6<VMMI\BK$@B5?*<[ 3\Y=63);.WJ/87/#>I:EK^GZ3K8U9(X
M+SSEFLFB0A6^;:J'&X,FTYR3G#<#C !-90^$(#I9LHK:$W*26=CY:LA91DNB
MCC ^4D_3-95_X5LM6NX!IEAH]YING(UD+2Z62+[-(&RVQU!R"-HVXQ\O!Y-4
M[34KS5K'P!>W\WG74FKSAY-H7.(;E1P..@%-OM1U6_M(XYM4G0P^+$LPT2(N
M8@PV@_*0<'GW/7- '4Q^"]&FT:TT_4["WO4M79XA*I81%B250L20O.,9Z 5M
M7(M+;3I%F"QVD<>& &%5 ,=N@ KD;C5]6L/$.H:!/J$CW-\(I-(F,4>50G;*
M,!<,8^7.>JD5UFHC&D78))(@?D]_E- &9:Z5X:USPQ%8V]I:7>B$#R8PNZ+
MZ%/8=B*MIX>TB.*QBCT^%([%B]JJ# B8YR5QW.3S[GUK)^'\B0_#3PX\C!5_
ML^ 9/J5  _.J&C:IK^NK8ZM#J%K#837$T-Q;LZED +*H0>7D2*0,[F(//'3
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M#3;J.UG;0Q=)*S*I=MVWC<C@A>I&,_,.: /3[:V@L[:.VMH4A@B4)''&H55
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MX?AMKLFF[Q="V/,?W@F1O(]]FZH_$VJ6NC_#9K_2[6UNM.2WA6*!\B-X6*H
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M@#&* .BC\+Z/%%;1I:$);7#74*^<^$E;)+CGJ=S?]]'U-0_\(;X?^UFY_LU
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MN<%\=\9QWJ?PGJL^N>$-(U6Y"K/=V<<T@08&YE!./;-< 3?SZ;:/-J,D\_\
MPF#0QO.BD($ED4'"@9X XZ<<8H ] ?PMHTEE<6;VA-O<7'VF9#,^'ER&W'GK
MD _4"K#:)ITE])>R6PDN)+?[+(TCLP>+^X03@CD_F:Y"W\4:I$6TRXG6:Y.N
MR:6EUL6,E!!YP./N[S]T<8[X[5U/A]M6^Q3QZR]O)<Q7#JCQ,"6BX*%P  'P
M1D#CN.M $%EX-T#3K"6RL].6&"5D9@DC@@HVY,-G*A6&0 0!5UO[,\/:=<7,
MLD=I:J3-/--)U)ZLS,<D\ <GL!7(7?B+7+*;Q9J#WL#66@R,4M1;?ZY3;)(
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MT6*:6U@PT2RM(ROM;KC*#WXQ0!NW/A71KP:@)[5W&HLK78\^0"4J %SAN,
M<>E17_@W0=3GN9KNQ9WNHEBN<3R*)U7A?,"L Y'8MDCUK,\9Z_J.D1W[Z?<1
M;[/3);T0+'O<LN2#)GA8\*1P0Q.<=*HZOXAU\7>MK97=K!%9:)%J<0:VWDL?
M-RA);H?+'/H?QH W]0\->&DO1KM_;0Q2VT:A[F29D78G3S/F"N!_M9Q33X2\
M-ZDSWZVGF)>21W;&*XD6.20899=BL%W< [L9-8>HZ]=^(-.\06=O*MHMGHT<
M[C8',CS1.V#G^ !<<8))/(QSH-K9\.?"BWUA8A*UII44BH>A;RU S[9(S[4
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M,;][LSQVDEG!;PR(-D?FA0"<8.%,A)YYYYKH;+4[^W\:2Z#=2"Z@>P%[#<%
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M1(F(;U_UAP1CH*FN-5\12ZWXDBMM0LX;;2 DD:-9ES(&A+[2=XQ@XY'7'04
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M%0"V".!U]!Z54E\#>&YM-MM/;30+>UD,EOMFD5X2>#M<-N48XP#C  Q70T4
M9L.@:9;7]O?06WEW%O ;:)ED8!8R02NW.,9 /3J!38/#FE6UV;F*U*N9VN-A
ME<QK*V=SA"=H8Y/(&>3ZUJ44 84/@W0(+F*XBL-DL,[W$1$TF(W?.XJ-V%!R
M20,#/.,T^'PGHUO%8QPVLB+8R/); 7$O[IG!#$?-WW-^9]:VJ* ,2V\):)9O
M8O;V;1O8&3[,PGDS'O.7&=W()Z@Y%;=%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &1=>%]
M(O)-3>XMY'.IQ+!>?Z1(!*@! 7 ; &"1QCJ:CNO".B7S2FZM'F\VT^Q/ON)"
M##G.W&[UYSUSSFMNB@#GG\$:!+'=)):3/]KCCCN&:\F+2A#E=S;\DCUSGI5V
M\\.Z7?W:W5U;O+*ML]H"TSX,3XWJ1NP<X&2>>!6I10!SUQX(T"YM;"WDM)MN
MG@K:NMW,LD2D8*B0-NVX &,XXJ^N@Z9'J5MJ$=MY=S;P"VC*.RJ(QR%*@[2
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M[4L)@#>8VW82&(VYVYR!SC-6J** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBN+\9>,=-\)31-J4MP/M#$1I#&7)P!DX';
MD?G0!VE%<GHVMQ:[I,&I6AG6WG!*><I1B 2,X/TJ]YC_ -]OSH WJ*P?,?\
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M0L%-PT;E2RCOG /'KQU%=74<_A.RN;FQN9K&U>:PS]E8K_J<C'R^G0?E5_\
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M=/ZI^=']G3^J?G0!4HJW_9T_JGYT?V=/ZI^= %2BK?\ 9T_JGYT?V=/ZI^=
M%2BK?]G3^J?G1_9T_JGYT 5**M_V=/ZI^=']G3^J?G0!4HJW_9T_JGYT?V=/
MZI^= %2BK?\ 9T_JGYT?V=/ZI^= %2BK?]G3^J?G1_9T_JGYT 5**M_V=/ZI
M^=']G3^J?G0!4HJW_9T_JGYT?V=/ZI^= %2BK?\ 9T_JGYT?V=/ZI^= %2BK
M?]G3^J?G1_9T_JGYT 5**M_V=/ZI^=']G3^J?G0!4HJW_9T_JGYT?V=/ZI^=
M %2MRW_X]HO]P?RK._LZ?U3\ZTHE*0HIZA0#0 ^BBB@ HHHH **** "BBB@
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MJ.A:??3!5EN;:.9P@P 64$X]N:JOKEI:7VIF]U;3([.SCB+J9 KP%MV?-);
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M94((SNXP3WX],U/>:5>RZ]K%K?\ A^\U/3]6DBN()5NMD41$:*4F7>,!6C#
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M/%!=O<V^FSW%O%;7,$<<D.YMN8IN"Z,Q;"MT^9>G.;/Q)_Y)OK__ %Z-6P-
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M-)TZ"T\TY?RAC/M[#D\#CFK.H:59:HD2WENLAAD$D3Y*M&_3<K#!4X)&0>]
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MS;'==_F%-I&5[>7S_O>W(!N0>*K#4+&PFL1<7$FH0M-!#&@$@1<!F(8@+M)
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MVC&[&X$Y Z G-0Z7X7\0VDGAF.YFTV2'01)$LB.X:XC,1C4E=N$8#&>6'\J
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M*^XR"/SKB?"VO->:-X+;4;^^:_U"W=_D4>7.PC);S#CL.0!CG':NWDW>6VP
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M(XH Q;_Q:)M9\-7NFS7D]C=&[CFLX8<N\D:?=*D9#*V002 ,?C4E[XG&J?\
M",7NDW5Q#!<:P;.ZMWC"-D1REHW!&5(9!T/Y\4L'@^]TZZTS4+22VENH+V\O
M+B*1V1':XSD*P4D;<@#(YQVIQ\(7D?\ 9LD4MNTT>M/JUV69E!+JZ[$X/0..
M3C.WWX +MGXCTZ&'49FNKV;&J?8A'.@#"9@@$48P/EY!!/J23BI8O%^GRK<!
M8+SSK>\6Q>$Q?-Y[=%!SMZ$'.<8(YKEO$&GS:+I-]]MN-.A;4=?2\MIYI76.
M$@*PWR8'EG]U@-SRP'>I=.M=6U73IXM/;2=WV^.\N9[6]DF@U $,)(WDV JP
MVID $8VCH2* -JY\:Q!=+:RL+F<WNHR:?(IV*T,D8<NI!;D_NVQ@D=\],SVW
MB'3X9=8D:ZO9&AU!+0PS(!MF9(]L<0P"0=RGGN2<XK%MO!FKVEM:K%-IPDM-
M=EU.)%5U0QR"0%>G!'F\ <?+UYXEN_!NI7,^IW2W%M'</K$&K6?S,5W1QI'L
MDXX#!#R,XW=\<@&K<>-=+LXKDW,=W%-:W,-M/;^3NDC:4@1D[205;(P03W'4
M8J2+Q?ITD=UOBN89[:ZCM'MYD"2&20 IC)QA@P(.?KBLC5?"&H:G)?WVZTCO
MKVXL6:/S6,:1VT@D W;<EF.[L,9'IS+=>%KVZO\ 7I+BVTR[L]4G@=K:X=B"
MB1A""=G#9 8$="* .IL;L7UJ)Q#+#\[H8YE 8%6*GH2.HX(/(K,N]5>7Q7:Z
M# Q0_96O;EQUV!@BH/3<Q;GT0^N0_P ,:1/H>BK8SW+S[)9&B#RM(8HRQ*Q[
MVY8*,#)JE=6+V7Q MM;;_CVN=/-A(W:-UDWQY] =SC/KM'<4 11>+-,L8KR>
M2?4IU.K_ &';)!N,<K; $4  [.1C.3DGKQ5RV\6Z?<6\[F.YBGANQ9-:RQ@2
MF8@,J@9P<JP;.<8R21@XQ9?"6K/'=*'LLR^((M67,K_<0H=A^3[WR?3GVIM_
MX/UB>[U*_M;JSAO&U:+5++>69,I"L)23@$!E#<C.-WMR 6-9\0S7":/+8275
MF1KD=C=P21A2W7<IZY'0@J<'/6M3_A+M.$)E:.X55U(:8^4'R3%@HSSTRPY&
M:J:EHVN:K:Z4US)8_:;;4HKV1$9A&J("-BG;ECSG) Z]*S;KPAK;2W<%O-I_
MV236XM6C>1GWG:Z,T9 &!RAP<G.>@H F\7>)9([%/[*DNE,.K6MI-<Q*ICR9
MD5XR3ST8@D#&>,YR*N3^*=-TJ?7KFXGU&1+*X@BGB,.5A9U4+Y8 !VG())SR
M>*R;CP=KJV-]I5K/I[V,VK)J<,LSN)$_TA9GC*A2",@X;/?&.]3ZMX1U6_7Q
M*(Y+)?[5N+66(M(WR"((#N^7OL[>OM0!L#QCI@BU)[A+FV;3WC26.>+:[>9@
M1E1WW$X'?/7%7-.UZVU+4K[3DAN(KJQ*B=)4P%W ,OS D'(.>#_*N/\ %VFS
M6</B+4+Z2QCMM5%E!&TKOMA9'/S.P V#YLA\_*5!YZ5I^#+F::]U!Y%TNY>X
MVRRW^G7K7 =@ H5R54 A0,!<]\@9R0#9\3W]OINB/<7-S>6T7G1)YMHH+J3(
MH Y! !) .>Q-4K_QQI>G7.H0S07Q&GR1I=RK;G9$' (8GNO(Z9/MUJUXMTBZ
MUWP]+I]FT*RR2PONF8A0$D5ST!Z[<?C6'K'A+5=2A\5QQO9I_;2PK"6D;]WL
M0*=WR^V>* -0>+(X];UNSNK66WM=*CB9[EBI#%P3P <\\ #&2<^U13>/M'MH
M[XW"W,<EB\*3Q",2,!*VV-AL)!4GCKP>#5/5O!^H:I=:^1=V\$6JP6Y1P"SP
MSP\KQ@!ESM.>#P1CG-%_H'B/5_#4UG>_V/#>/+;L%M=ZQ8CE60L25W9.W&,8
M'J: -"Y\::?9V<D]Q:WL;0Q-/-!)&$EBB5F7>59AD':Q &20.!5J'Q/874P2
MS6:[CS"&EA *IYH#(2"0V"&4YQCGZUG:KH6LCQ.-:TA]-<7%JEK=V]\K%1L9
MF5T*C.1YC @X!XY%0WWA*[N]>M=25K:"ZMI8"FH0.T<SPJ%\R*1 NUU8AL9/
M&[CIR :WAG7Y/$-I=W#V,MH(;N:V D*G/ENR'H3SE>>W/&>M7-1U:+3IK: P
MSSW%R6$44*@EMJ[B<D@#CU-4?#.CWFBQ:A;W$D$D,M_<74#1YW;99&DPV> 1
MNQQGIGVHU_2]2U"^TR2TEMFLX7D^U6MR6"2[@ K<#YMIR=IX.>H(!H @7QOI
M<RZ:;6&]NFU*U:ZM5AMR2Z+MR.< $;AU-3P>*;#4+&PFL!<7$FH0M-!#$@$@
M1<!F(8@+M) Y/4@<UA^'_".KZ._AHS2V,JZ197%JVQW7?YA3:1E>WE\_[WMS
M%H_@_6]"DT6\M9K":ZL[6:RN89)'6.2)Y!(&5@I(8$=",$=Q0!L^ =0NM5\%
MV-[>SRSW$C3;I)5 8XE<#( &#@ 8Q6CJ6K16T_V"-;B:\>!IA';*I=$'&_YN
M.IP!R2>@.#5?PAH]WH/AN#3KV2"2:*25M\.=I#2,XZ\_Q56O]%U2/QC'KVER
M6KK+9"RN8+EF3"JY=70J#R"S J<9]10!F^'/&"0^!=%N]3EFO+^;3Q=S!-N\
MJ/O.02HZ]AR>< X-.OO$$FMZ[H^FZ9+=IIVI:=->+>6I56/,01AN.0%\PD@C
MDXX(R*HZ9X+\0:);:)+93Z5/=6E@-/NX;D/Y3HK%E=& R&!+<$8(/:M]M$U+
M_A*=,U/S;5HK6PFM)#RC,TC1L650" !Y?3/?KQR &G^+;*6*&$B\ED:R>[BE
MDB53=1QD*[J >#EE."%^]P*M6OB6QU"73((#.C:K9->6LFP<Q@)GKG!'F)P1
MWKG-*\':W#J>GWFHW-A)+%8W%E=SIO:6X,A0B0D@<_)]WHN>"1P)=#\+Z[87
M?AN2[DTXQZ-ITUAMB=R901$%?)7C/E<CMZGL 0^%O%M\^G^%K.[@N+VYU.*>
M26[)0<1L0>,CGE>W3IFN^KA]'\(:MID?A@F:R:325N8IAN8ATE(.Y>!R,#@_
MG7<4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 5X)YI;JYBDM)(HXF41RLRD3 J"2 #D8.1R!
MTI;R:VMK22XNVC2")2[M)T4#O7EWB.X18_'*+>RKLU&P,>VX8%<B+>!STSOR
M.@Y]*B\1V]HMGX[L(/WMK$EE=)$7,@5L_O'&2>P!)_&@#UT    8 [4A .,@
M''->7:O=Z;=Z[?Z7?:A+80RQ0/HDMM"2SH%R?L[ 8W[\].2"O44][62XU+QU
M=:?)//J]B=^GJ+AB4D-HH.U0<$[BPQ@C(]J /3ZBFN8;=HEFE5&F?RXP3]YL
M$X'O@$_A7F5O-H^HZ7J&H:-XAEMUFMH8IP;<B""3S5VF93@[SDJ_.2N<]C5>
M1[>Y_L"YU33;2W%KXA>&:2W;S;9PUJ^&B)'",Q08[.".M 'JMS<PV<#3W$JQ
MQ+C+,>.3@?J0*H66M1WNNZGI0MY8Y-/6%G=RNV02!B"N"?[O?%8OQ+@AF\%2
MO/$KI#=VDI++G8HN(]S>P"[LGTS7'^)5L)7\=7-M+MDMM+M);$Q2E-CJDA4J
M 1R#MQ]<=Z /7J*\OU>^M=0\1:EI^K:G<64TOV>;1Y;>+=)(FQ2?(;IN\P."
M!U!&<CH26SRS^.[W3GN+C5K&=FL%2X=F0M:QAMB[L$Y+@<'D>U 'J%%>3SWE
MK+H>I:QX6U&[N8WCMUO;>UA,:Q1B5?,;'43>67!QS@9/."4\5LBZ?XKET2Z
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M88"H65=B8/ 4@YSB#0WM[:W\)WZ7;_:GUV]MY7>Y9B8"USA2"?N_ZL_4@]Z
M/2M!UJ/7M.>\B@E@"7$UN8Y<;@T<C(>A(ZJ>]:=>3^$-2@AUE8=6\IK"?4;\
MZ;,&^19_M,C,)!ZLI4H>G7O@GK?'THM=)TZ^9S%%:ZK9R339P(XO.4.2>RX/
M/;'6@#JZ*\BU._M[A/$)AO9%A_X2/3FA,<K1CRV%OO*X(^4_.<].I]ZEOKW^
MQ[CQ#:V<L@TB'6;)KM8Y&?RK9XT,Q')(4L/FQV+>] 'HEAK4=_K.JZ:MO+%)
MIS1J[/MP^]=P*X)XQZX-:E>0W&H6MG?>*KG17#:;]KTZ6X:S7S%^S;1YK(%Z
MKZA>VZIKN/27CTF33]8GN--O-=B/[N0Q0*IB<.D8!'R9"D]@S'&#D4 >L45S
MWB&VO-*\!:C;>'8Y!=6]BZ6:*Q=P0O&"<DMZ9[XKD[R6TEG^U>'[G&F2Z'<M
MJ'E2D!7 3R2Q!R)<EP<_,0#GI0!Z;5>WGFEN+F.2TDA2)PL<C,I$PV@[@ <@
M DCG'2L+P+8VEOX4TZ[MR[S7=I ]Q(TS/O<1@'J3@\8P,=*XO7;A!;>,4%[*
MI37;#R]MRP(4_9]X!ST_UF1T&#Z4 >LT5QWA3R+;Q;XIT^TE_P!%CDMY8XO-
M+A6:/YR,D]2!GWJG-9V]_P#$S5XVD>66#3K2XMH3<N%$ZO,<[0V./DR.F#R.
M: .]HKR;1+FPU+2FO/[<O[36(-*GAU2.* K)"^SYI)@>KJP)4]3GCC.(+R[<
M:9Y5W]FM_L^L:<LE]I5RR6MQ&T@!8 'Y&"_>&3C(.><T >P45Y-=-)H3:S)I
MTT[>%EU&T:1D+3I&A1O/*\DE WE%@,C[X]14[7VG:3'IMVFH37?A.XU*5[J9
MD_T:(M%\B@ ?ZG?_ ,!#'VH ]-DN88IX8'E599L^6A/+8&3CZ5+7FPM-&M_%
MG@^> 22V31WT=O/<@L6):-HU4D9VCY]@]!QQS7I- !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !2%@" 2!G@9[UR%]XU>UT[4=8BM(Y-+TV^-I<_.1*0K!))%&,?*Q/R]PI.1
MP*KQV;:Y\0M<L]4M[:YL[6WLGA5F;=$=TS!DXX8E1D@_PCK0!W% ((R#D5RU
M]?W\WCK^Q66V;3&TIYY(W!+,3(JG/;V ]S^'/>"?$EQI7AGPM9W]K"MA<:*T
M\<\<I:0>2B%MRX P0W&">GOP >E45S>C>(=0U/4+97TMUL;JU^T)<JK@1-QB
M-MR@-D'(9>."/0UB^)XH3\3/#X?2SJ"R6%V7@58SO*M%M)WD*<9/?/- '?45
MQ\FI2^'M&M&LM*BM$N+>6\>&:3_52[5;R51<L226Y4$+M)]!4MOXLN]7MU_L
M6PCENQI<&I-#-+MSYP8QQ XQD[&RQX''!SP =5D9QD9]* P.,$<C(YZUQFIW
M<=WJ^N6-SI%O%/\ V LS3EP[LC&0>6W&,*RL>">N:K:#>^6G@JS&GVTEQ-H#
M/;W<CG=&5CAW+C' ;<N3GMTH [PD#&3UZ4M>>Z1K]WJ&B>"[[5["SNI]2O#L
MF#$&!S%*P95QUPK+UX!'6M>R\67FH7-G-9Z5+<:;=/*AD1'#1!=VUR2 I#%<
M8!R,CKS@ Z:XA^T6[P^8\8<8+1G# =\'M]:6WMX;2VBMK>-8H8D"1QH,!5 P
M /PKG_"GB@>)8Y9$-L!&B&2%&(FMY3G=%(C $%<#GC//'%=)0 4444 %0VUM
M%:0^5$"%W%B2<DL2223ZDDFIJ* "BBB@ HHHH YZ+PL8S<PG6;^33KB2222R
MD$3*=[%F7?LW[22>-V?>NAHHH **** "BBB@ HHHH **** "BBB@#,DT<S:V
MFHS7]T\48!CLB5\E' (W_=W$X8]3COC(&-.BB@ HHHH **** "BBB@ HHHH
M**** "JMS80W-S;W+92XMR3'(O4 _>7W4X&1[ ]0"+5% !1110 4444 %%%%
M !1110 4444 %%%% %/5=.CU?2[BPEEFA2==IDA;:Z_0\C\P0>]5K#1Y;>=)
M[[4[G49HP1$TZ1H$SU("*O)]3^&,FM6B@ HHHH K"QA_M$WSY><1F)"W_+-"
M02%],D GUP/059HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "LK7=$77(+6)KF2 6UU%=J44'+1L&4'/;(YK5HH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M#?7-K^Y4JI$4K(#@D]0N>M4/%^MZWX?TJ^U6W6Q-K;M"D<<L;L\F]U4DD,
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M=G&.IQCK4]G>P7]E!=V[,89T#QET*,01D?*P!'T(H ;IR>7IULI@,+")0T9
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M:62.06<EO+;/$@G\N0,_F$L&+#!"C[N/>N]DO8(KZ"S<OY\ZN\8$;$$+C.6
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MVL$]JUK+"C6[+L:,CY2OICTJFV@Z2UG;6G]GP""U(-NBI@0D#'R8^[QQQVH
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M)]#R/0T <#XFU*XUWPMXGFDNY(?[/U2*T6U3;MV+)%RV1D[BQ(/'&,=\]/\
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M8-WRHR.17<52&CZ<+YKT6</VAG$C/MY+A=H8_P"UMXSUQQ5V@ HHHH ****
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M(H=8O;ZS6!HYK/868,'CD5P2"KC@]"".H/U!JKX\U.]TCP?>W=@K>>-B!U8
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MJ%O;1^5;[+;RG*C !D.X[F &. !U)R>@!JZE>_V=I\MW]FGN3&!B&W3<[DD
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M.WUZ]!0!O^'=:37_  _IVIB-87O+6.Y,&_<8PXSC/&?KBM))8Y&=4D5F0X8
MY*GW]*\FT+2;FSM/!QT_3YK34FT&YM[F8VS(5E\N+8)6QQAE.-WIQ6YX(AM+
MJ\LKS['J]MJMK9?9;M+JV\B-.A*DA )3N&006XR<C/(!WK2QHP5G52<8!.,]
MJ:TRGS$B:-YD&?++XY[9ZX_*N-N-&L[[XIW,USIBRJ-+@,<TML6C$Z2NP.XC
M;O *]\XK,\&0Q27&ER:C:ZQ%KVE0R17AEMO+CR5P[&0(!*&8!@-S')SV- '9
M>'M>CUOPQ8ZU+&MHMU&)/+:0$)DXQNP,UK>8FXKO7<.2,\UY'I0GT_0O"O\
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M[?1+B**+6#:2W$CVPC<';($0[6< 9!!8 DC. >] '7K?6C7[6"W4)O%C\UH
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M>6[R>'VN;J1+B5=1OO+=HP&0_:90Q!Z\US>H3:C<^']7>YO?M#Q^*K:&+>@
M0+<P!>G;&./ZF@#T75M'@UF"*"XGNXXTDWLMM<-%Y@P05;:1E2#R*OJJHH50
M%4#  ' %<*WBO4]/N=2TV[>*YN8M5M[&">.(1_+-&LG*EL9&6 YY.W/OTF@R
MZNRWD6KI&&CF/V=P5#O$0,%U4D!L[AQP< \4 :]5[V^M-.MS<7MU#;0@A?,F
M<*,G@#)[FN&'BC7;;3]8U:ZN;)K:QU&33T@2V*EB98XTD+%^ N\DCOZCLSQ9
M+K)\):_#JB)]F5[5[1VV"4@RKN#JA(X(X(Z@^U 'HE%<==:]K=[?:JFC0QDZ
M7>1P/'-L$<B[$>0NQ;<IVN=I Q\O.<\+'KFJ)KFJZ%<3Q"^%Q"U@PBP'MI!D
ML1GDKLEST^ZO3- &_J>BV^K36KW,MT$MV)\F*=DCESCB10<..!P>.OJ:T:XF
M?Q+J<'B&SA2:">VN-6?3V$<>8XU$3L,N<$RAD^8#*CIP1533/$^ORC1+N[N+
M-X+W5[G3)88[<J<(9PKABQP?W(X]">: /0:S9/$6B0NZ2ZSIZ/&<.K72 J??
MGBLCP)/?7.E7\M]>M=.-3NXE9D ("3N@Z>P'';%8VE-J?_";^-([&SM)XGOK
M-9C/,5(0P1!L+M(;Y<]2* /05974,K!E(R"#D$4M</JOB&_TG5$@LWMWM(=2
MLK#R8D++''*44^8QQB0%\@*3@;21\U7]-U;5-:=KZSN+2*U@U26RFMIE.?+C
M=HR0PY\PL 0.!@@=>: -HZWI0 )U&U -S]D&9EYFSM\OK][/&.M6(KRVGN+B
MWAN(I)K<JLT:L"T9(W ,.V00:\]U#4KK4]$B:\\CS+;Q?!;*88]@*I=( <9/
M/KS3_$NMZM]A\70174=N;&\LXHI(8L,8Y1%N#$DY/SD9]!VH [\7EL;YK(7$
M1NEC$K0[AO"$D!L=<9!&?:JNEZ+;Z4]Q)%+=3RW#[GDN9VE8#)(4%CPHW' '
M3-<SK/BB]T#5]96?[//#9:-%=QL(MC%VD=/F.?NY4'MC)^M376I>*;"*_D%G
M]KA"0R6X41BY(W@3!4#%6PAW+SUX.>,@'8T5C>&-7CUO2#=QW?VD"9X\F$Q.
MF#]R1" 5<=#^?0ULT %%%% !1110 4444 %1SP1W,+PS+NC<89<\$>A]O;O4
ME% !C P**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MX@U=- \/7^K20R3)9P/,8XQRP49_R: *A\':$8[>-K1WCM[)]/C1[B1E%NX
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MVF74F1[H/-(=[( %8?-\I  P5QT%7M*TFTT:S^S68EV%MS/-,\KN>F6=R6/
M Y/0 4:QJ]GH6DW&IW[NEK;IOD9(V<@?10368OC;0]^HI+//;M80BXE6XMWC
M+1$X#H",NI(QD9Y^HH M)X7T=-/U&P-H9+749'ENHII7D$C/]X_,3C/MBJT?
M@O0TT:723!<26DQ0R>;>3.[;3E1O+;MH/09Q2S^,=*M(;F2Y^TQ&UN([>X1H
M26B>3&S.,C!W+\V<<\D5:O?$%AI\TT5PT@>(PI@1D[GE;;&H/=B>,=NIP.:
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MC_9]*[2[@N-)\*7$.E*TMU:V3BU#G<SR*AVYSU)('US3CI#OKG]HSZA<RPH
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MCD$B--V>6PHP.IQWKUVFJZ2#<C*PR1D'/(X-.H **** "BBB@ HHHH ****
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M7\O[3M9!C8 %V_)QP!ZTV;3I-9\3V4M[I4L<6C.SPWDSH?M#,@'RJIZ9^8Y
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MW#E02 0,YXP2* (/&>H:CI]EIATZ:*)Y]4M;>1I$+91Y "!@CKT/MGZU1O\
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MA#%I8L]1U2SGTZV%G'<6\RK)) .D;_+A@.W&1ZUTR6RQ6:VT#O$B($1@<LH
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M*\+G3]4O+9+?9)=QRRRD-GE]V-@R<9.3D\#OH^(M+EO/$NF364J1/?Q-8ZG
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M$_N9NF2![]:S7T+6+;4KC4K;2]T5_K NIK:-XA/!$+?RMZ,QVJS,,L5.[:Q
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M(W2S$$,P8.H!&,8X&#4\GAG5Y]!U7PY-;,5NM6-Y#J D3:L;3K,21G<'7E0
M,$A><9P =G+K>FPW\=E+=HD\DGE("#M,F,[-W3=CG;G..U/MM6L;NZ^S03AY
M=K.!M(#*I"L5)&& ) R,]:X_3]#U&#6[FRO]!2]M3JCZA:ZD]T#'&&D,F#&6
MW"122 0,=.15GPSHNJ:7KBO'%<VNE202F6RNI8Y5@F+J1Y# E@A^8E3QTX[
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MYVG7S?D20VTNY50\+L/R\#ZY- 'JE%>8Z/=W7_"+Z+J%[K^I2W6I7GV41-*
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MZ=I#:BS$[PMPD6ST^]UK00LT:EEVL0"5SG!]* '4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% %,Z3IS27$AT^U+W*[9V,*YE'HQQ\P^M,&A:
M0L+0KI5B(F18V06Z8*+R%(QT&3@5BV6N2W<WB/4A!<7,.E3O:6]K;C<\C(BL
MY [LS,5'H%'3)S-::O\ \)&NKZ="1;7U@RJ)K>82('9-RLK8&<'@J1V(.0:
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M02%4L0HR>/05Y[XC\2G7OASJ6HV),<(A@FAN+6[).6D ,;;<%6 &&4Y'S=Z
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MCN9,95&"L5;)R,<#- '2T5Q>B^-+FZT*QN;ZV@2]OYKA8(EF.S;&[ EFVY
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M7< .F!B[-X1N9[JXN&U1"T^D?V8V;7IR3O\ O^K'CZ<UT$FIV$,[02WULDR
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M[>3I!;0H7DE<X55'>N?3QG:R:W8P^9:II5UIDE\+QYP-I5XUVM_"/]9Z]10
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M[.[DECMKN":2$@2K'(&*$]-P'3\: ,/X@(\OP^U^&*-Y)9;":...-2S.Q4@
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MBBB@ HHHH **** "LGQ-;)>>';NWD2[9) JG['_K5^8?,HP<E?O8P<XK6HH
M\TDM]<2'3[J_MI;Y;#7TG:Z@LFCFN8?L[)YK0CG<&8*<#D+D#%0G3+V:W\VY
MT:[\B/Q6U])$\&\F HPWA!DL,D= :]1HH \V;P]-%+?W=F+_ $J*ZU=;K3VM
M+4N;=A;[&D>'!^5VW@K@'Y@>.T AU1)[637M!O9[*^TO['+%I:-B*02R%MR9
MRJR(R'G[I7!QBO4** /+-6ANM%T[Q597.CWK6ESH:QV4JCSDACCMV5HGD)X*
MMN;)^]NXR:FO;:]C:^>+3;RY34?"D5K UO"74RJ)B58]%.)%(SUZ#)XKT34+
M"WU33KBPNE9K>YC:*55<J64C!&1R,CTI]K;1V=I#;0[A%"@1 S%B !@<GDT
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MW M@?.>>#63)X>NXY-4BOK"6\N?^$4ALC<"V9Q-<J)0P#8Y)W+S_ (&O4:*
M.<>TNKOX;/9+#)]LDTDP^5("K>88MN"#WS6!I]J]QKWAVXN])NQ;V^@S02>?
M:,=DI:'"D8."0C_Y(SZ%10!Y+I-GJ.FZ7X>75='U>YL&T4:?/#:HQDMY0WS!
MTX.UEP,CCY!78ZQHUVWPUN-'T>W:"X%AY-O;O-N( 7B,N3U(&W.>_6NIHH \
M\U>.XU_0[C4=+\.7EI=AK0W4-S$(I+F.&4.T"J3R NX9X!R ,\XI^+=(NM7B
M\4:A8V%TUO>Z7;VZ0&V=7GN%=SNV$ C:A4;B!^E>GT4 <1<Z%82^/]*E31$-
M@=-N5D;[%B,2.\14-\N 2%?KT_&J.AZ?*VH16&KZ+JCZCI^HSW4-[O9;9@SN
M1('!P24?!3&<]1CD>BT4 >-ZO8W]GX%UJVEBN+C28M)7[,U]:F*YM6#C$!8@
M"0 9PP'&.ISFM;Q#X:N]0N=9O/#FGM;1R:3%;M"83;BZ=9@Y3:0/^689,GC]
MX!G@X]!U?2;/7-,FTZ_1Y+6<;9$61DW#TRI!JVB[$5020!C+')_.@#SCQ-IM
MQK?]O:E8Z?=B&X\.2V1@DMF1YKAB3&-A&24Y&[&!OX/!Q7UG1=2N)-1BT2PF
M@DG\-);(PA:)6E#DF/=@ ,5)'/3->HT4 >>@MJ?B=M0CT*_@M'\/R6K":S9-
MK[P1%@CG SC&1Z53T#2'CN_#K7^D3[;;PO\ 9)S)9L=LP,?R'CKA7_R:].HH
M \ELQ>Z5IOA42Z?J$EU%H$EC=0?8VG\K/E#E!\P.4//1@I&>X[;P[;V-OX!M
MK.P2YFMK>T-OLDB:&9R@*L"I *L2#5[4/#FG:EJ"7\PN8KM8Q%YUK=RP,R D
MA6,;#< 22,],FM&WMXK2!(($V1KT&<^Y))Y))Y)/)- 'F%SI6MGPUJ]A'%=:
ME:Q063VDT]H8;LK'-O,## \PJH)# #);')J36K'4-8'C&2WTB^\N]AL&@$L.
MPS"-LN IYSCL>>V,UZA10!YU?Z!#=:EJVI6=E?66G7%I:0?Z);F*9ITGWB98
MRN3Y8V]5Y (YQ5<KXAM9-/U'4;&[O[:VO+F.:33[=HIYU=$$=P8<Y!!#H0.Q
MR!@UZ;10!YWIEI)X>\06#PZ!J/\ 8TU@\%M"H,S6TK3,[;P2=@<%>IP-N#C%
M9_A%+BUL/ >IK8W5Q;)I-Q:N;>(N4=VB*;L= =C#)X'<BO4G4.C(20&&,J<'
M\ZJ:3I5IHFEP:;8(T=K NV-&=GVCTRQ)H \ST>TU/2M+\.2:CHNK2V*Z=-93
MP6J$RP2-(&RR Y*LHQGM@9K07P]!:ZRT<>ASI9Q^'#:Q+)$T^QMYVQE^<L%(
M'4^F37I-% 'GWAJTO[/5_#$]S8784>'5LI7,1_=3*T9*OG[O0\GKCC-6O$L=
ME_PLCPX]Y9_:$:PO@0+<S'AH,$J 3CD]N]=O5";1[.XUFVU:19#>6T;Q1,)6
M 57QN&W.#G:O4=A0!YYH?A5K35?#4%]I+26D<6I922W\Q+>.:56AC8X(&$R,
M=N15W2M.D?5O[-U?1=4EO+35I;ZVO ["V*M(S+)N!QD(^W9WQC&.GHM% ''Z
MMH^J'27BU'6KV[9KB%X)[&R59+5U8L'VC=O&=N01TS6"HUVSGTN^U;2[N[M%
M%Y;3'3(61R7E5EG:'.X!PK;AV)]#7IU% '"Z1I+:-XJT7[+I-W!IRZ1+:QJ2
M9?(/G(X5V)./E![D<8!/%/\ $L=E_P +'\-O>6?VA#8WP(%N9CP8,$J 3CD]
MN]=O5"?1[.XUFUU:19#>6L;QPL)6 57QN&T'!SM7J.PH \XMM$U+3-,L].&D
M72QRVNHB"2",2/ DLNZ.W.?E0%=N21_#M!%7C8ZI8^'_  EK&GVS0:Q#:1:7
M<0W VLR2*J_,/]B0*^/0-ZUZ16>VBV#ZVNKO$[7JQB-6:5RJCGD)G:#AB-V,
MX)&: .9?1;>S\<Z:1ITDMC:Z)-;&4VYD&[?'M!.#EBJO_DUA:%HU];6'@:./
M3[BTNK:SN8;F3[,R^2[1;5WG']X#\J]3HH \IMM+:^\*O!=^&]6CUG3](GLF
M:;<T19H]N(\$B4,RJ1Q@=<@];L.CW O;>.VTR:(2>%I+1S]G*+YY*D(QP!G[
MW7^M>DT4 <WH\5]-\/+:U@BFLM0731!&)UV,DHCV@D=1AOY5RFGI>R3^#RGA
MV_CGTRPN;:ZCE@**DGE*H7S#P59E.&!(Y]:]/HH \IT[3M3N) %TB^@2;PQ)
M8K&]N(HX)1C$0SS@= 6))ZY(JP([N(Z1)J&B:Q<:7/HJ:?)%;1GS(91]\.@(
M(5P0,_[ SQ@UZ=10!YS-I-_IU_9G1K:[C\H64,NFW433V\L:%<,LW\$D8)YW
M$'8.#FNQT>]L[FYU.&VT^6SD@NF6?S(!'YSX'[P$?>!&/F/)Q]*U:9'#'%O\
MM%7>Q=L#[Q/<T /HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HKE-$\5+JNJ+YS2V\
M%U-/#I\?E?+.(B0S%_[QVLP''RCN0<=70 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 445SOB?5-5T>**ZM&L_(DN;6V"2Q,S;I9EC+9#
M@8 8$#'.#S0!T59EWK<%G<O ]IJ,C+C+0V4DBG(SPP4@U9ADN8+!Y+]X&ECW
MLSQ HA4$X.&)QQC//7-<]X3\7-KUG:3W*HOVV(/ (X7'S ?O4.<_<)"[C@$D
MX'% &E_PDEM_SX:M_P""Z;_XFC_A)+;_ )\-6_\ !=-_\33&UBYN_$USHNG^
M2ALK>.>ZGF0N 9"P1%4$<X1B3GCC@YXM-?7-AHES>ZE$AEMUE=EMP2'52=I
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MK2J2R!LD?NP0.,9Y)K0B\5Z:]]<VDOVB%X;\6"L\#[7E**X (&!G=CD]O<4
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M )\-6_\ !=-_\31_PDEM_P ^&K?^"Z;_ .)K9HH QO\ A)+;_GPU;_P73?\
MQ-'_  DEM_SX:M_X+IO_ (FMFB@#&_X22V_Y\-6_\%TW_P 31_PDEM_SX:M_
MX+IO_B:V:* ,;_A)+;_GPU;_ ,%TW_Q-'_"26W_/AJW_ (+IO_B:V:* ,;_A
M)+;_ )\-6_\ !=-_\31_PDEM_P ^&K?^"Z;_ .)K9HH QO\ A)+;_GPU;_P7
M3?\ Q-'_  DEM_SX:M_X+IO_ (FMFB@#&_X22V_Y\-6_\%TW_P 31_PDEM_S
MX:M_X+IO_B:V:* ,;_A)+;_GPU;_ ,%TW_Q-'_"26W_/AJW_ (+IO_B:V:*
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MO_B:V:* ,;_A)+;_ )\-6_\ !=-_\31_PDEM_P ^&K?^"Z;_ .)K9HH QO\
MA)+;_GPU;_P73?\ Q-'_  DEM_SX:M_X+IO_ (FMFB@#&_X22V_Y\-6_\%TW
M_P 31_PDEM_SX:M_X+IO_B:V:* ,;_A)+;_GPU;_ ,%TW_Q-'_"26W_/AJW_
M (+IO_B:V:* ,;_A)+;_ )\-6_\ !=-_\31_PDEM_P ^&K?^"Z;_ .)K9HH
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M4MYIRJDYP ,\\C)K?HH Q(= ;[=)?7,\3W,[0FX\F$QHXBW%!@L2"&;.<G@
M5>:Q9M6:_,H++;^1"I7_ %9+9<]><XCX_P!CWJ[10!BZ-IFKV-Q+)J&J6EVL
MF6;R;(PLS\8+,9&R !@  4T^%K&XTRVM;W?--"')FCD>(L\AW2-\K#JW.,FM
MRB@#E+7PK]BLO"^D1.[VVC,L\D[9_>,L3(H&2<99RV,X 7'<5U=%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
' %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>exhibit1033-bochk_facili012.jpg
<TEXT>
begin 644 exhibit1033-bochk_facili012.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MY)4MU^7.2/:O7K;Q9HU[JRZ99W,ES<')S#!(\8QUS(%V#\Z -NBBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MP"15Q(9-I?)P>G;..>E<SX?\9>(KOPCX$:XO9<ZWJ$T-_J!4;E"R,$C'&%+
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MP$A<E<;_ # -P&,#C(QT]JVY]1U&'P1J^I/>75K?1Z3-/;Q22JY<I"KB=?\
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M_*;%_C1_8GB?_H;O_*;%_C0!TM%<U_8GB?\ Z&[_ ,IL7^-']B>)_P#H;O\
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M:.4+]I8*)07PP .-WW3^1IL$KR:K8:C"$EUBZ\) VDK+N:6Z7T/=@3SZ<YH
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MW#'!Z@8Z&@#N 00".1V-("",@YKA]%UN_N-7\-6=E;6EMIESH'VP6P)&PYA
M4''10V!QW/M1H?BB/^Q=+MK'3(;.XO/MDBV\2O)'$(IBKGY%R<LRGH.I/;!
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M /- &K29!)''TKSR/7-57P!H^OVYA^W:O?6C3M)D[8YIU 1<= %8+],GJ<U
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BLNVU=+S4]0AB*+;:<1%<2MWE*ARH/0!5923_ +6.,&D?
M68;JSNI=(F@O)[4!W@5N6&,@>VX=#T^M &K574K)=2TRYL6EDB2XB:)GCQN
M88.,@C.#Z4NG7]OJNFVNH6DGF6US$LT3>JL,C^=0:YK-IX?T6[U6^<K;VT9=
ML#)..P'J: (;70+>V\+)X>,\\MHEI]C#N0)/+V;.J@#..^*QA\/;"6.2.^U"
M_O8Y=.&FR+*8U#1*25/RH,,I)P1^.:?-XRMK+Q1+;7M]8PZ3_9R7<=PYVG<9
M&0@L3@CY2>!Z^E;U[K6F:=&DEY?V\,;KO#NX V_WL]EY'/3F@#&E\&B[\.WF
MCZAK>IWJW40@:XE,?F)&/X5P@7/JQ!)[G@8MS^&8KC5;K47O[L37-@+!P!'M
M" L=P^7[V6;V]JW 00"#D&J(UK3&OOL0OH/M.YE$>\9+*,LH]P.2.H% &79^
M$;>QFT>:WO[Q9-+LC8H<H?-A^3 ?Y>H,:\KC]:I_\(#:Q:=IT%IJVHVUUITL
MTEM>QF/S%$K%I$(*;64D]"O8>E:R>*_#TCQHFMV#-('*8N%PVS.[!SVVM^1]
M*L0:YI5SIW]H0:A;R6F_R_-60%=^<;?][/&.N: ,^^\*1:AITEA/J%V]K/;F
MWN$DV/YN227.5X?+'D8 ].!B[K&AVVLZ!-H\KRQ6\B*@>(C>FT@J02#R"!US
M3TUS2GAAE74+8QSS?9XV\P?-+G&S_>SQCK39/$&CQ*[2:I9H$N!:MNF48F.,
M(>?O<CCWH SY?",+W=Y<QZC>12:A;K;WQ79_I 4$!S\ORO@D97 QVX&-.[T>
MSN_#\^B%#'8RVK6FR,X*QE=F!Z8%4+OQEH5KI7]I+J$,]M]I2TW0N&Q*S!0I
MQT^\"?;FMR-TEC61&#(P#*PZ$'O0!S\'A)(;V&\;5;Z6>*P:PW.(N4)!W$!!
M\V0/;CI5./P#;VJ:6=/UG4[&XT^T6Q%Q"T9::!>B.&0J<=B ",FK'B+Q2NF7
MFF6ME<6DDUQJ4-G/&X+$*YYP01A@,'!SP<XK677=*9$==1MBKW'V53YHP9LX
M\O\ WL\8ZT 32V*2:6U@DDD49A\D.IW,HQC.6SDX]<UCP^$+>"V\/P+?WA70
M\?9B?+RX$9B ?Y>?E8],5JMK&G)J"6#7L"W3L56(N,LP&2H]\<XZXYJXS*B,
M[L%51DDG  H PK'PPNG:5)8VNIWJ;[Q[P3'R]X=Y#(R_=P5))X(Z'K5>+P38
M026<UO<W%O/;7LM[YD(10[RJ5<%2I 4@XX /&<YYK1_X2;0Q:W%RVJVBP6ZJ
M\LCRA0BM]UCGL<'!Z'M4UKK>EWK7:VNHVLQM/^/C9*#Y7!/S>@X//L?2@#$\
M96EW>7WAK[(MQ_H^J">66&+?Y2"&5<G@C&64?0GZU/-X.M9O)<WETLZ:B-2D
MF79F:8+M&[*D;0H"@#' '.>:;I_B4ZCXUNM)MYK::RBL([I7C4[PS.RX)S@C
M !' ZUN7NH66FPK+?7<-M&SK&K3.%#,3@ 9ZDGM0!C7?A&*?7YM5MM4U"R-V
MJ)>V]NZ^7<A1@;MRDJ<<94@X'6MJ]M?MEC-;+/+;F5"@EA(#IGNN01D>X-4[
M7Q)HE[937EKJUG-;0/Y<LL<RLJ,2 %)'<DC [Y&*</$.CE8#_:5J//F-O$#(
M 7E'5 .NX>G6@#'O/ =A>BYF>[N8M0GN(KH7MOMCDCEC4JK* -O0L#D'.X^V
M+4OA1)X].:;5;^2\L;DW0O"8]\CE&C8$;-H!5B,*HQP>O-:4NL:= TJR7L*M
M%(L3KN^8.PR%QUW$<XZXK$U7Q=!8ZGH4D=[8'1K\3F6Y9N%V(2"K9QUXQCVH
M 3QM:75X= 6T2X+0ZM%/))!'O,2*K@L>",98?G4MQX-MKB5+H7]W%J"WPOFN
MX]FYI!&8L%64KM"':!CCKG.234O$V!X>N=(N+2[L=3OUM7E7YP5*.V48'&04
MQSGK[5L?VQIQU!;#[;!]K8L%BWC<Q49('J0.2.HH Y6^\-K::%+X4M[;4KZW
MU.667[6[1[+-FD\PL6!5LAF++P22,9]-^Z\.VUQ=Z-.DTUNND.6MXHMNPYC,
M>&R"<;6(X(K4GGBMH'GF<)$@RS,> *Y;P[XIEU;3[76KFZT^/3+R$&.%0PFC
ME/S!"<D/\G)P <CICH 3#P3;"V2#^T;[":H=5!_=Y,Q<N1]S[N2>.OO4FG^$
M(M,U*>>UU34$L99VN?[.WH8$E8Y++\NX#<2VW=MR>E7YO$FAV]K;W,VKV207
M 8PR-.H$@4$MMYYP <^F*T+>XAN[:*YMY4E@F021R(<JZD9!![@B@#G;/P5:
MV4.CQ)J%ZRZ5<RW4.[R\LT@<,&PG(Q(_3'7VK2T+0XM M9K6WN;B6!YY)D28
MJ1%O=G95P <;F/7)]ZP=3\<P&R-QI$UO((-7@T^Y\Y3]UY41V7D8QN.">./2
MNBMM=TJ\LI;RVU&VEMHG,<DJ2 JK\?*3Z\CCW'K0!A?\(#:IB&#5=0@L4U :
MC%:)Y92*4/O.TE"=I8D[<XY-/MO UM:WMI<1ZIJ.VSOIKV"(M&51I=_F+G9D
MJ?,;J21V(KH;'4+/4H#/97,<\:N49HVSM8=5/H1Z&L?Q%XC32+_2]-2>"&YU
M&5D$DPW+$JQN^XJ",Y*A>HZ^V* *;^ ;06$-O;ZIJ-O+:W<EW97$;)OMF<L6
M5?EPRG>V0P.1WX%=%8V(L[$6[SS73')DFG(+R$]2< #\   . *Q]*U\0V,\F
MO:SHAECNA;%K-RL:2%5_=DLQR^3G'H0/>K\7B31;B&&:'5+62*8@1ND@*G+%
M!R/5@5'J010!CVGA)3X4B\-7$L\,5A-&]I=0E=VV.021'Y@1E=JJ01SCWJ2[
M\#VMY!K$,NIW^-6DADG8>7D&-55=OR>B+G.:U-)\0:?K5Q?P64P=[*X-O)[L
M I)'MEL9]C5F]U73]-:);Z]M[8S$K&)I N\@9.,]< $T 8__  B$2:Y<:C;Z
MKJ%O%=LLEY9Q,GDW#J NXY7*D@ ':1G'-='61#XIT"X>V2'6+)VNG,<"K,N7
M8$C:/?((QZBK4FL:;#>K9R7T"7#.(Q&S@'>1D+_O$<@=2* ,CQ7X,M/%TFFO
M=WMY;G3KA;F#[,4'[P="=RMGZ58'AZ;[3<7+Z[J3320&"-L0@0 D%F0",#<2
M!R<]*G;Q-H2W0M3J]EYYG^S"/SUSYO'R=?O<CCW%8?B#QO%:Z5KKZ1+!)?:0
MZ)*DRDJ2=N< $'@..?6@!UC\.M)T\Z]'#<W@M-;B,5U:;D$8RNTLF%R&()R<
M\Y^E0R_#:Q;3M"@BU74H;O0SBQOD:/S47:%*$;-I7  P1]>ISI:UXIMXO"VN
MZEHE[97=SI=O)*R;O,565"P5@I!Y ]:TK/6;*YD%K]K@-\D"330*PW(K#.2O
M4"@#)O/!-K?:[I>L2ZC?F[TZ"6&)MR$/Y@(=FRO7GM@# P,<5G6OPOTJQTC0
M[*SU#4(I=$GDFLKO,9D3S"2ZG*;2ISZ5V=M=07MK'<VLR302J&CD0Y5@>A![
MBLMM=L[6\U-KW5]-2UM/*!7?M>!F!XD);&2>@P#]: .=/PJT8Z%=Z6;_ %(^
M?J/]J)<^8@E@N?[Z$*/ISFM+4O!$.J1:7)=:MJ#:GIMQ]H@U#,?F;B ""NW9
MM( X"CIZYSL0:]I%TET]OJ5K*MHP6<I*#Y9/3/U[>M5+SQ;HUE)9(]XA:[N3
M;)C^%PI9@WI@#OZB@!GA?PG:>%%U(6MW=W']H7;WDQN&4XD;J1M4>@ZYZ5!;
M^"[6U\:7WBJ/4+W[?>6XMY$/E^6$&W&!LSD;1WK836=-EOOL,=] UT2RB,.,
MEE^\!ZD=P.1WK&T+Q7%/IKS:W>6-K/\ VA=6<?S>6)/*D=<@,2<[5R>: ,W2
M_A9I.DIH"0:CJ3+H<\L]J':,[C(06#?)R/ICK5F3X;Z--:^(;.6:\>SUV8W%
MQ 77;'*2"70[<@Y4'DD>U;,/BK0+AK98=8LG:Y<QP@3+EW!(VCWR",>M69-8
MTV&^2REOH$N7;8L;. 2V-VWZXYQUQS0!SM_\/X-7\'R>'-3UO5;N"3RP9W:,
M2;8SE5&$QU R2"Q[FKWB7PA:>)K33TGN[JVN]/F6>UO+<JLD;COR""#W&,5=
MM_$VA7=U#:V^KV4T\Q<11QSJQ<KG<!@\XP?R/I2Z+X@T_7TNGT^82+;SO _8
MY4D$X],@X^E &9K/@N#7M+;3]0U.^F@EB\J?S!&WF\YWX*85QV*@8STJ6S\'
M6&G^*GU^TGNH9I+5+62 ,IB=$&%SD;L@8Z$=*V+S4;/3U5KNXCA!!(WGL.I^
M@[GH*YX>,;>T\3ZI9ZI?6%MI\%M:SVTSML+&4R @DG!^X#P!UH Z.]DN([.0
MVL0EN"I$2DX7=VW'L/7VZ9/%8.D^&KC1$T"SLM0N!9Z= \=S'\NRY)7[Q&,[
MM_S<$ <UL7.LZ;9W*V]S?012ML&UW QO.%SZ;CP,]3P*YK5O%.J6(\9>4MH3
MHME'=6VZ-CNS&[D/\W/W,<8H [.BHK65IK2&5L;GC5CCIDBN9LO&5K%K^KZ7
MK-_I]J]O?);68+^6TH:*.09#,<G,F.,=J .KHJE<:QIUI=QVMQ>P13R,J*CN
M 2S?=7ZGL._:KM !15&TUG3;^X:WM+Z":4)OV(X)*YQN'J,\9'&:M3W$-K T
MT\BQQ+]YF. * )**H1ZWI<TL,27\!EFD:*-"X#,ZC+* ><@<D=14;>(]%6*.
M1M6LE225X4)G4;G3.Y1SU&#D=L4 :=%9$/BK0+AK98=8LG:Z<QPJLRY=@2-H
M]\@C'J*UB0H))  Y)/:@!:*R;?Q/H-VSK;:Q8S%(S(WESJV%#;,\'IN&/K0?
M$^A+"LSZO9(C2-$"\RK\ZC++@G@@<D=A0!K45D)XIT!["&^76;$VL[F.*7SU
MVNPZ@'/48.1VI_\ PDFB^1;S_P!J6GE7(5HI/-&U@QPISVR>!GJ>* -2BJG]
MJ6'VX67VJ+[26*"/=R6"[BH]P.<=<57_ .$AT;=.IU2T7R(S-+NE "Q@X+Y/
M\.>,],T :=%9"^*="DCNI(]5M91:P^?,(Y Q2/\ O8'/^<57M/$EIJ9T>XM=
M1LHX+V%IVMYC^^==@;Y<-QM_BR#^% &_1679^)=$U"ZBM;/5K.XGF5GC2*96
M+A>I&#SBGG7](6Z2U?4K59I',<:-*!O<'!5<_>(/! Y!H T:*CN+B*TMI+B=
MPD42EW8]@.M<B?'5O+=^'KJ"XM4T?4[>::628$/&51649S@?? (QF@#LJ*H'
M7-+&G0ZA]O@-I,NZ*57!5QC.1CKQD_A5NWN(;NWCN+:5)H)5#QR1L&5E/0@C
MJ* )**RKSQ-H6GRS17>KV4$D!43+),H,>[.W=SQG!ZU-;ZWI=W<75O;ZC;2R
MVHW3HDH)C'/)]!P>?8T 7Z*S5\0:0\-Q,-2M1';())F:4*(T/1CGHI['H:B_
MX2G0C#>2IJMK(MG#Y\XC<.43UP.>WY\4 :]%<<?'%O\ VOI#M<VD6CW^FS7C
M2R\/&Z&(!=V<?\M.F,Y%7K[Q$T.N^'XK6:UETS4TG=YAECM2/>K*P.,'Z&@#
MHZ*H0:UIES:VUS!?V\L%T_EP2I("LK<\*>YX/3T-7Z "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** //?[$O[G1?'6AV[*M_<WLES;^8<+(DJ(5S_LDJZ'_ '371:7J#O!>:SJ.
MA-H[+ OGM.8S*^P,3RA.47)P2<G)X'?=,,;3+,47S5!4/CG!ZCZ=*)88YU"R
MH'4,&PW(R.1^O- '/^ M-N=)\":-97:%+B.V4R1GJA;YMI^F<?A4OC73KK5_
M!.M:?91^9=7%I)'$FX#<Q' R>!GWK>J.XGCM;:6XE)$<2%W*J6. ,G ')^@H
M XF^L-3OM?U&_P#[&N$CN/#YM(P[1$^:7<[#ACV9>>GO69!H^K636B7_ (?O
M=3LKW1;6QG@@NU0P2QJZLD@\Q59&WGD$XP>.:])@F2X@CGC),<BAU)4J<$9'
M!Y'T-24 0V< MK&W@"(@BC5 B$E5P,8&><5Y\=-UR3Q%IMU)H<R+9ZY<3/Y#
MPK"87CE59%&X%F.]2Q89R3@=J]&!!) (R.M5-1U6RTF*&6]F,233) AV,V7=
M@JC@'&20,GB@#@[30M532-#ADTB826WB2>_F4M'\D+23,K_>YXD3@<]?2E&B
M:W#J,FHII\QCM_$DE_\ 9MZ9G@>#RMZ_-C<I);!P>/7%>CT4 >=:AX>U/S=0
MUBWL9G6;7+/4$L591(8XE178 G;N;!.,] ,\\5#<Z/K5TNJLVB7 %SXCL[]%
M:2(YA00;R?GZCRVX_+->ETA( R2 />@#SK5=$U>=O$\D&F3,)]7L+VW4/&#,
MD/D;]N6X/[MOO8SQ7HD;,\2,Z&-F )0D$J?0XXIU% 'F46E:_#I>GZ1-HMS<
M3V.OB]>\22+9/$9WD\P$N#NP^"".WTI\^DZW&\]G'HUQ*%\31ZF)UDC"/ 9%
M<XRP.X#.00.G7IGTJB@#@-*TB^BU9].U30;BZ6'5);^UU%KO-N%:5I Q3?D2
M#>5P%Q[X-=EK*7$FAZ@EI;PW-RUM((H)O]7*^TX5O8G /L:=JFIV>C:;/J-_
M*8K2W0O+($9MJCJ<*":DN;R"TLI;R=RMO$AD=@I.% R3@<T >6:CH.OWUCK@
MCT2]WZAX>ALXQ++ ,3*TF5VJ^U1AQC'& >_74\3Z!K.K7^NMIU@T2W.CVL,)
MD=%622.9Y&B.#D95@N2,<GFO0+.[@O[*"\MGWV]Q&LL3X(W*PR#@\C@U-0!R
M&E+J-YX\DUB;1KNRM9=)CMRT[1Y61978J0KD]&ZT[XD_\B?S$9?]/L?W8Q\_
M^E1<<\<^]=1'<PRSRPQN&DBP) !]TD9 )Z9Q@XZX(]14&I:79ZO;+;WT/FPJ
MZR!=[+\RD%3P1T(!'N* .*U31]3;5M7URPTDNMT]@GD.L?FL(9"SSJKG;O4,
M N[NF<=,P)H%[_PC'BA;N"73YTU%]4L+FXE5RKJB,C$JQZ%"&]B0,UW=UJEE
M87EC97$Q2>]<Q6ZE6.]@I8C.,#Y5)Y/:DU#1M-U66UEO[*&Y>TD\V R+G8WJ
M* .8N;/5TTS1;@Z69[N>]^UZAY/EF:W+QL/W9D('RY6/=UV@XYY&3HNB:OIT
M?AN:YTBXVZ9J&H-,@D21PDK2%''S<CYA[^U>E$@ D]!533-4L]9L%O;";S;=
MF= ^PKRK%6&" >&4C\* .(7PWJ5HFF/%8.0_B235)8(V3_1H621<'G!/S D+
MGDG&<9J30-(OH;Z/3M5T&XFDLK^6ZM]3>[W6Y5G=@X3?D28<J1MQU.<&N^)
M(!(R>E+0!'<,RVTA5&D8*<(N,M[#->>Z+HVM:7I_@BYFT^8_V3:26E]:*R%T
M+H@$BX;#8*8X.<,<5W1U6S764TDS$7SP-<+%L;F-6"D[L8X++QG/-7* /.H/
M#>I6VH:5<?8)'A/B&YU.2(,G^C1212(N?FZ[F#$+G!8^E>B !0   !P .U+1
M0!YO=:)K!L-0LAI$TN[Q+%J"N'CVR0>>DA(RV>%4Y! YZ9HU31==;4-=OK/3
M9G']KVM]#")UB-W&D"QNJL&^5L@D9Q]T5W0UBQ-G/=F8I!!*T+M)&R_.K;2
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M<R+R<=_2J6O>&=9U=IX+.S>W\WPX+)9'9 GG"16\ML'." 1G&.:]+I"0!DD
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MQ3_9^KM<QR3)</:LFQ[6[C#J59& W(RKP5/7.>>M= _AW1I=936)-+M&U)
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MN[R&:!HXQ''' 4*N,[SG<<@\8';'4U=H **** "BBB@ HHHH **** "BBB@
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M3P1;P7%UI4MU::O#KNG6SV]X)[;RHP2!O+2! )0S*&7YF/.?6@#T5F"J68@
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MYANQ?!Q*P9Y\8WL?XCCC!XQ@8P!531_&-KJNA66I"VNE>[C:6*V6(M(47&2
M.H *Y/3) ')% \=Z#(;46\US=&ZMA=0BWM)9-T>X+GA>Q;D=1SG% $\GA#2)
M8;F)TN,7%ZM^["X=6$ZXPZD'*_= P..*2?P=I%Q#J$,J7!CU":.>Y'VA_G=
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M,2!)U73"YM 9V.S>"&SD_-D$CG/6DN/&.DVEI?W%TUQ"+!HQ=(T#%H@XRK$
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M=JMA(\EI$;N0QP%@00J[L;<$\=.:Z.BB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **HZMJD6D67VF6&XG
M)8(D-M&9))&/95'7@$_0$U+87GV^QBNOL]Q;^8,^5<)LD7G^)>U %FBLV+7;
M&;Q#/H<;LUY! MQ)A?E52< 9]>^/0CUK2H XK6_#.KWEQXL%H+-H=;TU+:-I
M9F5HY DB<@*>/G!SGMC'>H=6\':GK%Q=!Y+:WCGT1+!9 Y<I,K[P=NT IG'?
M/M7366OV]]KNHZ1'!<+<:>(VG9PH0!P2N"#SD ]N,<XIND^((M9D0VUG>"TE
M@%Q!>,B^3,A..""2#T.& .#]< ',WOAS7M5\*WUG+I>A6%_,L<8%I(VR3:ZL
M69O+! ^7A<'KR?2[KN@ZK+XFM]:L;'2[]9+06ES:7[E0F&+*Z.$;H78$8Y&*
MV]8\06FC6;7,JR3HES%:R"#:3&\C*J[LD<?.OO@UJT 95]ITDWAI].%M97+M
M"(F@E79!(. RX .U2,@<''%<K%X/U>WALX+>4-96VL17L%M=7;2-;PJF&17*
MDGYB2 > ._IW]% '#?\ ".^(K>6\>W^QF*YUMKZ6#[2\?FP-$$VEPA*D,H8@
M @CC/7,6G^$M9M-/T.U9-/ T[6Y[]O+F8 Q.9L!1LX/[X<=/EZ\\=Q=SM:V<
M]PD$MPT4;.(80"\A SM7) R>@R14D;%XU8JR%@#M;J/8T 8?AK2KW2YM::\$
M(%[J,EW#Y4A;Y&50 V0,'Y??K6-<^$]1N[7Q!I$@MOL.KZ@+HW D.](R(]R[
M-OWOW?!SCG/;![>B@#BK'PUJFG^(+U?L6CW.FW-ZUZE[,/\ 2(-S;F3;L(;Y
ML[6W#&>AQBM?Q)I5[J=SH<EH(2MCJ*W<WFR%24".N%P#D_/WQTK>HH X&+PE
MK-OJJZM']D-Q;ZS<7T<'G-ME@FC$;*3M^5QC(ZCMGG-='X?T:33)]6O+@H+C
M4[PW+QQME8P$5%&<#)P@)..I/I6W10!R%AH^M6.M>);MK'3[FWU:=)$C:[92
M%6)8R&'EGKMSWZTWQ!X>UK7[2W>1[.#4+!$NK&9')47@Y.[*Y\L#Y>Y(8DC(
M%==*YCB=PC2%5)")C+>PSWIMK,US:0SM!) TB*YBE WH2,[6P2,CH<$T <KJ
M'A[5=5UA;N=;2**[T>73KP),Q,+.P.Z/Y?G'4<[:S[?PSKTOA74-*NM/T*"[
M;3I;&*ZMF(-PS)M#M\@,8[D#=D^F.>Z>XC61XE.^9(_,,2D;B.<<>Y!'X4EI
M.UU9P7#V\MNTL:N89@ \9(SM;!(R.AP30!PNM>"M5UH2Q&6VMTDT-; 2"1F*
MS*ZN#C:,IE<'G/M2ZCX7U_Q'=WDVHQV%C]JT9K F&X:4I+OWA@"@RN1TSTKO
MZ* .!N?#&NZKX?DCFLM#TO4X9()H39DM'/)%(L@+G8I5"5QMYQG.3C%;&BZ=
MK">*]3UC4+:T@BO;2VA$<-PTC(T9D)SE%!!\S]*WK2Y>Z64O:SV_ERM&!,!\
MX!QO&"?E/49P?858H YB?1M3/CYM<CCMFM!I3605IB'+F0/G&TC'&.M9VA^%
M=7TT>#DG%H5T6REMKDI,QW%D504&WD?+WQUKI-<UZTT+2;_4)UDF6QA\^:*#
M:7"<\X) ['OVK35@R!AT(S0!YM9^#?$&F6&@.EIH]]/I=O+8RVMQ*WESQ,RD
M2*QC.QP4'&T\$\UT-EH6HVWBRQU)HK%+6+39+61(&*[7>19/E7;@J-N,Y!/7
M%=35<7+G46M?LLX01"3[1@>6221LZYW<9Z8P>M ''>'_  SJ^CNUA)8Z+):V
M\DCVVHXS<.K$E49-F 1G!;<<@=,G(I/X$U+^P]8L+$PV-O>6J"/3_M+RV\=P
M'W,T9*YC0X P![X&.?1B<#)ID,T=Q!'/"ZO%(H='4Y# C((H YKQTTQ^&/B%
MKE(XYCI<^]4<LJGRSP"0,_7 ^E4+[0=;U7_B:VDEM8ZA%I#V=H=Y<%Y"C,Q.
MW@#8 ."?F)QQSV<]O#<Q&*XACEC/5)%# _@:='&D4:QQHJ(HPJJ, #V% '#V
MFD)I%SKUYXC_ ++LM(U6W@AD#WI;#!61E9W5=V[=]XG)_6C3-$UQ? &RTOA+
MJL[1,LTY,1DMT90JE@"49HEY.,AG8\&NSN_LOV8F\$1A!!/F@%<YXZ]\XQ[U
M/0!YZ/!VLJFH,D.GQ^9K5KJL$27#D$1K$&0L4X/[L_-@Y)Y JUK/A/4M3LM?
MGC%LE_JKVH$32G9'' P(RP4Y8_-T&.0.V:[BHVFB2:.)I%$DF2BD\MCKCZ4
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M2\UBTU>"YDM;^VC>$2( PDB;!*,#U&0".A!'U%4V\'VJP:3#!=3PKIMXU\I
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MO>SWL%Y&$WHTS%I$*E2K(2>A'8<\5TUC:&RLT@:XEN'&2\TQ!>1B<DG  _
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MI775BV7AV.RU]]62\N))'LX[-HY,$%49F#$XR6)=B3GOTK:H **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M9OAFU&[_ %XQGY/[W'/':O.)[^[U;P#JWAG4&9[W1+6X34G(_P!8L49,#?\
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M P+;QLRF4R;X]S \83KU!_$&AX<U/5+;PEX8=KVYEBO[R9;RY*+)+&/WK#:
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M8RV44"08'0 '@XYQ0!W%W=P6-G/=W,@C@@C:21R"=J@9)X]A4D;K+&LB'*L
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MHQJT<;$8WG:F=V"5 4<Y (-6G^(FO:9IGC^5_,G?1A:M9"ZC021^>,'?L !
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MF](V'!(9@6. 20N3Q[C-N7Q5:*[FVM;R\@BFB@FGMHPZQO(%(R,[B '0D@'
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M,.""",Y'XT 6%\.:.ND7&E&PB>PN&9I;>3+JY8Y8X)/)//UYZU OA'0%T?\
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M%K,B%7:23+GYCN4B,* 5/?(&<U>U/7;E?$QT"*TF$;Z;+=&ZC= 5(95&,G(
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MRA@I8 GH,]:-RAL%AD]LT <3;>![E;/P_975Q ]OIFES:;-LW!I5D1$W#CC
M3ISU]N=;PUIGB#38(K35]3M+NWM8Q% T$#))*!P&D)8C.!T'&3FN@) ZG%('
M0[<,IW=.>M '+^)_"DOB&]23-M&8EC-K>+N6YM) Q+,C#[P(P-I(''.:K2>"
MIWLM6T8W,3:/J5\;Q]P/FQ[G#R1CL06!PW&-W0XKLLCU%->:.,.7D10@RQ+
M;1UR?2@#C]7\'WVI6_BV%;FW0:ZD:1L0Q\D+&$R?7(&>U63X?UNV\27NHZ;J
M-I#;:HL1O8I8F=HI$0)OB(('*@#YAU //2NCLKR#4+&WO;6026]Q&LL3C^)6
M&0?R-3;UW;=PSZ9H X_5?!UYJ?\ PE ^UP1C6$@$)VEC$8A@;O4'';I[U,WA
MO5(M3U6]M[NU+:Q;)%=JZ,!%(BE!(@R<C:0"IQG:#D=*ZK<N[;N&[&<9YQ5>
MTO[6^:X%M,LOV>4PRE3D*X )'X9'X\4 8.C^%GT778KBVEC^P0Z3!IL49R9
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M!?E92PZ$8YQ7IE% 'EVBVYN[Z-+E-4C\5V%Q<MS;!(FW;P':79AXF!7 +'D
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M$,<TUQ \$HFAFMY2CQN 1D'H>&(P01STI^GZ:E@'8W%Q<SN 'GN'#.P&<#@
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M>H[6Q9&*I(R$E6#+R"#P0#^% &"_B6YA\9+I%X191RSA+4RP$QW<?EY(24'
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MD9"2K!EY4@\$ _A52X\+:5<W=U<20R9O%1;N,2L$N-HPN]<X/'!]1P<CB@#
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M5'S#S!Q[=:[+7-,&M:!J.E-*8A>6TEN9%ZKO4KG]: *]MXETRZN$MXY)1+)
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MED0N^8C(RJ?-VIP1P">>>#3D\(ZM=1Z=;W0@@CC\.3Z1/)%,6*22",!E! R
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M:X>0 +YOR@;$(R!SR>U90\)^(I8[Z2:VLA/>: ^FR,;QG8SG=\Y)0?*=W0=
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M!T6\D7;(58''W I^LK5V= !1110 4444 %%%% !1110 4444 %%%% !1110
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M-Z^4^23AF4OGUVY/2IO'&I1Z4^A7%U>Q0:>;\I=12S+$LRF*3 +,0N P#8)
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ME8*!R .#BNF\9-<C3[);.\M(+AKQ0D-XQ6&Z.QSY3,.1D D'GE1P: .CJO\
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M10 FQ?[HZYZ4GEIYADV+O(P6QSCTS3J* &I%'&6*(J[CD[1C)IQ (P1D444
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M3KE+*>RMH++;$2)/+B="J_0D#GK5SPC=WVF>$= TF71K];R&V@MIM\8"1D*
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M/@L+B.5O()V.[1E1CKG"MTZ5UUEJ=EJ+W26=PLS6LQ@FVY^20 -M_)A^=6Z
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M5WXET6PNY;6[U*W@GB3S)$D?:43^\<]%X//2@#/\ 6=UI_@K3[.\LY+2>+S
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M\-:EJ]WX>T/0-(NHK2XC\-VMW%([*"[,"O1D?*J47(&#\_6NU/A#P^8[./\
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MN#<PJ';"2G.7'/4[FY_VCZFK5EI5AITMS+9VL<#W4IEF*#&]SR2?Q)/U)]:
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M],UJVMI82(L2")$,?,9)&\R!N20=O;L16GH_A4P:OK=[J<-O(+W4%NX529V
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MA*]LRAE28IC(Y"MC]>:X2X^'T\UAJT5M)9V$FI01QS16RL(&E5]S3;/X6/3
M_$F@#?7Q=;[M4BET[4(KC3O*9X#&K/*LI(C9 K$8)!')&,<XK'\3>)#>^%-5
MDL)+JRO--U"WMI@' 8,9(LC*D@J4D]?RQ5G5?"NJWU]K5W;7\%K)J%O:1* &
M;;Y+LQ5B,$JX=E.,$#US52;P/J,FG:Y:K>V"+J=W;72K';LBPF(1 J!N.0?*
M '3KGVH U=)N;EO'_B.UDN9I+>*VLY(HG;*QEO.W;1VSM'Y4^^UNUL/$ETDB
M:B\UMI;71C1E\EXP_)52P^?/'..*L6&CW-KXJU75Y)(C%?06\0C7.Y#%OYSW
MSO/IC'O575?#MY?:]=ZA%/ L<^E/IZHX.06;=O/L.F/UH ;9^.=.N&4W-M=V
M,#Z<=3CGN50(\ V[B-K$@KN7(('7C-9S>(I4\=V\UT+VQTP:%<7DB7#+LPLD
M7S[5)PP4MG//--N? 4^H6EE9W=W$+>'0Y=(D,8.YMXC_ '@STQY8X/KUXY?)
MX-U;59XSK>HV<D?]DW&ES?9H65I%EV9<$MA3\@.,$?T +,_Q#TNWCU!I+:[+
M65D;]DC,3EX0<,05<@$=U)!Y'6II_&L<%S=VO]B:J]Q;VPO!&JQ9E@)(WJ2^
M!@J?E;#=.*JS>'/$NI>$]1T75=8L9WGLWLXIHK=DR&&#)("QRV.RX')]1BU/
MX=OYM9N=0\ZV FTD:?L^;AMS-OSCI\V,>W6@!9O&]H)(H[33=0O6FTX:E%Y"
MQ@/"<=V<8//0X]LTZ/Q!8W^L:');_P!H-]OTZ6\M0C!898\1D[U)^^-RXSP-
MQYJEIOA+4+"6Q<W-L_V70QI.,,-Q&,2>P^4?+[]:DTGPI?:;-X8=KBWD71=-
M>P8 ,#-N$8W#^[_JAQS]X^G(!D:7XDE\B+Q#JD>LHIU2>P*Q31FW"M.T4>]"
M^%"[5!8 ')ZD&NZMM02ZO;VV2&4?9'6-Y&V[68J&PN#G@,,Y ZUR4FGV>@>#
M;O1?$,HGBU*XN5C%M$[-(TSO)L4 '##)P?4#I71^'--GTK0+2UNYC/>!-]S,
MW625N7/YDX]L4 <AK_BF_N] UZ6*&ZL&TS6+>U26*09=?,@# [2221(W&,8(
MYS71)XRL534?MEO<V4UC/%!)#<>6&9I,>65(8KAL]R,8.<8K-O\ P;J%Q:ZY
M:0WUL(-2U*&_3?$VZ,H8F*D@X(/D@#@?>]N5U+P;?:C>:S=QW\5K<7<UK<VD
MB(7\B6#[NX'&X'N..#0!N:%XCL]?:]CMUDCFLI1%,CE6Y(# AE)4@@]CZ@X-
M<C+K M_%/B^"_P!7U2WM+%+=[<VZO)Y.Z+<QP%8'GG#9'X5VND1:K';L^L7-
MM-=,1\MK$R1(!Z!B22>Y)]...<:VT+6++Q'KNJVUQ8?\33R=J2H[>5Y:; 3@
MC=GKCB@"MH7BR\'@[1[W5;62ZO[JS>YE:SV&/:F,L6W! 2"O&>I/8'%MO&UK
M)):1V6FZA>O=Z=_:4 A5!OB^7CYG&&^<<''XGBLJR^'UUI>GZ586>J12VUK'
M<+.EU;ED>25@WFH@8!64[@ <X#'OULZ+X2U+2IM)EDN[28V&C'2\*C)O.4(?
MO_SS QWR3QTH @?Q1#+XHT34X;JY.EWVASW26^?]8V^#R\)W<[RH'J<5V<,\
MDMFL[6DT3E=WD.4W@^G#%<_CBN!/PWN)K'1+6XO(<Z3I;64,\6Y9%ES&R3*?
MX2IB''.<GMP>ZTY;^/38DU"2":]5 ))(@421L=<'.W/IS0!Q?A_7)+J&WUK4
M'U-+J?4+JR@M$F0Q7.)9%50FX@%$BR6^7H3ELUL3^.+"WA<R65]]HBOX]/GM
ME1#)%+(1L)^;!4A@003U^M4+?P7?0:1IT0O(!?Z;J<VH6\H5MC^:\C/&PZ@;
M967(/H<=JEO?!UU=RS7JSVZ7USJEK?S9#% L&W9&O<YV\L?[QX[4 = -6":%
M)JMU97=L(XGEDMG0-,H7.1M0D$\<8)SD5CW/CJQLK;5)+FQODDTT0&XA"HSA
M9N$(PV.N01G(QTK:UNQN=3T*^L;2\>RN;B!HX[E.3$Q& PZ?TKCKGP'J=Q!J
MZ"\TV$:E;6L1CAMF58FA=FR/F.0=WZY[<@&Q<>-[:TM=9FN-*U)'TA4DN(0L
M9<Q."1(N'P5PK9YR,'BMJ#4X[C439QQ2,1;I<&4%2@#DA1D'.3M)X&..M8=Q
M;PZ%JVM:_K,\"Z??P6UL\81WVE2Z\X'(8R8Z<8]ZG\$Z,=%\.QQ,\[M(Q9//
M&'2$?+$A]"L80$>N: ,>Y\27&A^,/$K2VVJ:C96]I:3^5;[7%NI\[>P#,/[H
MX&2<=.*UU\9VD^JQV%G87UWO@M[KSXE3RQ!,2%D)+ [1M.>,XY /--O?#M^^
MM:O>6=W;I'JMG%:R>8A+0;-X#+CALB0\''0<GI1IGA3^S-:DFC>,Z<=*@TR.
M$YWJD1?!)Z<AR/PH BC^(&CRS(BK<,DMK)=P21A9/-2,;B J,6#%3D!@"?J"
M*SO%GBEKGPCXFBL_MNG:EIMI'.WS*KJ) 2A!5C_=8$<$8^AJQ8^%O$MMX<GT
M ^(H4M8;5K:PN8;<K<*-NU#(=V#M']T G .1WI7/@+4[FSUR 7FFPC5K""T9
M(;9E6)HR_P P^8Y!WGKU/IW .SLM32_N+A(()C!"VP7)V^7(W<)SDX/!.,9!
M&>*Q/%^JW=E>:#8V]O<O%?WWDS-;R*C,HBD?:K%E()* YXX!YYHTSPD+6'4-
M*NUM;GP_<N)8K!U+"W8D,R@G@IOY P,?H'WGA5(Y-!CT>*TL[32KQKKR I ;
M*.A48Z?ZPG//TH AL?$UGI>CND@U6Y6RU)=+DEN3&\OF.R!22&^9?WJ#/7'4
M$\T^?QS9V\]VCZ;J(BL[^.PN9]L>R)WV;&/SY*GS%Z D=P.]&_\ !FJ7#ZG#
M;:C:1VEWJL&J+YD#,ZNC1$J<, 1^ZX[\T^]\'ZA=6>NP"ZME.IZE!?*Q5OW8
MC\KY2.^?)'/^T?3D B\9^(Y&T6X_LK[:IM=2MK:6[@9517,T8=#SN(PVTX&,
MG'8XN7?BJQT>Y\1W4T6J2_V>UN+B/*LBAU^4Q+NX!R">^>U4;OP3JSV>JZ;:
M:E:)87^HIJ*^="S20R>:DKIP0&4LI(/!YQ[B?5O!U_J0\2*MW;)_;'V<*2K?
MNO* !R.^<>V/>@#1/C.Q@36&O;6\LVTI(Y)DF52SI)G8R[6(^8J1@X((YQ5S
M3_$$=_K=[I)LKJ"YLXTDE,FS;A\[<%6.<X;M_"?;/->*=)N+:W\3:I<- T.J
M6=M9[! TPAVLXWL!@E?WI)(Y4+GFK'@N:>34+I]^EWL,T0:2^L7F<[DP%1FD
M+9X+$ -Q@Y'S9H VM3\2P:=+=QQV5Y>M9QI)<K:1AS&K$XXR"QP"<*"<#W&8
M+[QA86$=[</#<R65A,L%Y=1JI2!B%)R"=Q"[EW$ XS['$%SX?U>#Q1=ZKH^I
M6T$&HQQI>17$!D*L@($D9# 9VG&#D< ^U5;CP7.]MKVEQW<?]E:W,9IMX/FP
ME@HE"GHVX+P3C:2>O2@#9C\1P7&ISV-K;3W#6\WD3/$4Q&_E^8,@L" 1@ XQ
MD^G-,\):[/XCT"+4I[)[4R/(%0LI& [*,$$]@ <XYSVJA-X2:X\36NKG[-!-
M:S[DNK<%)I(-I'D28X9<G.3T P!GFM#PKHMSX?T5=-GN8ITBDD,3)&5.QG9A
MNR3D_-V]* *8\<6/EPN]C?1[]4.E,'$8,4_;=\_W3V(SG(XY%4?$&N7"ZUX>
MDM$OUB_M::TDAC90+H+!*>!NP0'4#YL8*G.,9J76? D6K7FM3_:VC74($,<8
M'$-THP)Q_M +&!_NGUJ[=^')Y)?#I@GC*Z3<&>1I =T[&)XR>.A)D+$^M %:
M7Q38ZA8Z7<M%J=L9-6%DT<;*K1SJ[*4EPQ!3(.<$@\5H+XE@FN8HH+.]FMI;
MI[,7D,8:-9%W!LX.X*&5EW8QD?C6.O@_4!;11?:K;*:\VKDX;D%V?R_K\V-W
MMTJWHWA[6-$O;FV@U.V;19+J2[CB:$^>A=B[1[\[=F\DYP3@D>] &9X/\4NF
MGZ;8ZC'?S/>7]Y;17TI5D9TEF*H26W?<0X.W'&,UWE<79>#[^VL]$@:ZMF_L
MW59]09@&'F"3S?E [8\X\\_='KQVE !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !17F'B+PU?
M-J>MZ7IEBA2\,>LVL[1@I'<1<-'_ ,#9(N/1Y*N7WVB2PT;7)K!X[/4-22YU
M2 QY9(#$RQ"0#^%3Y;,#T.3TS0!Z'UK)\1ZU_P (_H[:@;9KA5FBB**X7&]U
M0'GT+"N!O[-[3[9?01-_85OXALKFU,<9*Q1X3SW0 <1[R>G'WCTJ+4)%ET+Q
MD(8)U2;7+.6$&!UWK_HQ)4$<_=<G'H2: /0_$NMCP[X?N]5-LUR+==QB5PI(
MR!U/UH\2ZW_PCOA^ZU4VS7*VZAC&KA202!U/UKSCQ8Z76G>-+35+.2;4VE23
M36^SM)OMML>SRB >C!\@=R<]:[+XB'S_ (=ZJ(U=FEA4(@4[F)8< =<^U '5
MT @C(KR[4ULM+U'Q<EK8O)83VEA(8K7<%D<R.)'.T$MA2A?&25Z]:2TT0ZYI
M_C'3($VRB]BO-.<VC0Q"001,K(K# 4NI!&>03G.: /4J3/&1S]*\[U2:\N?"
MD7B1].NH3>W-M+?6\4(>>.T7@KMP=V#\Y&#P2*Z#P;;:;#9WD^D2WLEE=7!F
M4W$7E(&(&[RTVKA<CTP3F@"_X?UL:[8S7/V8V[174]LT;.&.8I"A.1ZE:ULC
M..]>2V^B12Y:UMGC\30^)998Y-K+)';FZ+,2?^>31%C_ '22.I-7-&BAO=:2
M._;4X?$]C?SR86W"I(A9]K&79\T)0KP6[ #D"@#T[(SBC(KR?08=/OK"*:[&
MJQZ]9Z?-!J4,ML(T+%,,97V#S 7 *_,3SGUJSX1M+>PU;P7);P>3-/X?>.^8
M*0S2*(-JR'^\")  >1@@=* /1Y9KA;ZWB2UWV[JYDG\P#RR,;1MZG.3],>]6
M,CUKD-<2#_A8OAZ255V?8KU)F(^4 ^7M#'ISA\9]ZX_PS9+9P>"+BS@\G49+
M>[AN)64A_P#5ML60GG&\+@'OTH ]?S17F.A1:=K'AY(_[,O!XC@TN6UOUEA=
M,RE1N\PD!9"SKE>2>21WJMI=S;W=UH3&&<QKX6GMKEWMW $H\CY&)'4;6Z]^
M* /5LCUI<CCGK7D-IH&DKX=\ .]@@GN);==0+*=S!;61&$GL&*J0>.@JY<V&
MGC7K_0]234[62.>!]%-G; CR42,(L4NQMFUU8,"P&&)/!)H [SQ!K8T&QANC
M;-.LEU!;D*X7;YDBQAO?!85>OIKB"T>2TM?M,P*XB,@3() )R?09/X5Y3JKI
M-9:C%J=E,^O0>(X9E;[,[N;<74?ELA /R"+CCOGN:[+XCHLO@FY 0N_G6[1@
M*2V1,A.!UZ9_#- '69%07M[;:=8SWMW*L-O A>21CPH%>5>*+"UG?Q[=);"2
MZ1+66Q=5+$2A!\T7^UNZE>:[+XB6PU+X=:PD,'VHM;&2-43>3C!! [G'/% &
MI;:W]H\3W^BM;-&;2WAN!,7!$@D9U QVP8S^=:V0*\H\066EZE>^+'CLT> >
M'8OL2F$J!*#<$;%('S@LA&!D;ACK3M0:VU'4)+/Q$^IK%>V%L=.GM;;S"6"_
M.J-L8I*'YZCMZ4 >JT9&,YXKFO&,JVWA1?M%M/<1F>W64 D[1YBY>0)RR#JP
M'49' .:X01(]G-;2Q2[(_%L$L8^S/"JPL(V9E!'RI]XGGC.3US0![!D>M&><
M5X_JFEV%K8^+C:621O::O;2Z<(H_]3E8"[0@?=RPDSM]#GI6AK$4UW;>+K:Y
MB<Z\UP)=$E5?G9/+3R?);L X;=CIEB>#0!ZA1D>M>2>*%:VA\<64UO*UW=Q6
ML]NL5NS"0A%#.N!C[P/X_6F^);*TN#X[NTM2]TGV2:Q;RVWK*$7+1C&0P;KC
MGJ#0!ZM'>VTM[/9QRJUQ J-*@/*!L[<_7::GSBN-T2"UA^)'B&;[(%DNH+66
M"<0'#KL8,0X&.N,\^E9^M/92>+-7T[Q'97<UO=V\']EO#"[YQG>L;(/DDWX.
M<CC;S@4 >A9&<5!=WEO86<UW=3)%;P(9))&. J@9)-><W$5O>^*-0L-;_M6'
M4Q?QW&FM;6X;?&%39LEV': 0P8%@.6)ZFJ%SX>L+_P (^/9X]-6?4%GOA:GR
MRS[612-@]"5XQW'% 'J?VB<WT4:6VZU>%G-QY@&ULC"[>IR"3GMCWK%M?$E_
MJ4EO-INBFYTV>9XOM7VI4,827RV9D(SCAB,$D@<XS6-;+IS^.]+EM[=$L9-!
MN(V!A*(098B%(( &0'.#U&3TKG["UM(/ 7AUH[5(ITU^*23;%M=5%VQW,,9
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MV>&?2OW3#SA(VS#_ #?POM!QCA@: .H6>%YW@65#-& SQAAN4'."1V!P?R-
MN(3<-;B6,S*H8QAAN ]<=<5QFI>*9-#U7Q(\]I:2-96EDT<D:%'F>9Y$57;)
M^4,!CT#'K6??:C<^'?'&MZE>"VN)4T2V*^1&8@[-/(@#98_Q'KGI]* /1ZC2
M>&2:2%)8VECQYB*P+)GID=LX-<C=>)=>TEI4U+3H5%Q<VUKI\YVH'DE?8P=!
M(YPOWLY&1QP>:/#$4\7C[Q:+EH'D*V1W0QE WR/U!)Y_&@#KI9X8#&)94C,C
M[$#L!N;K@>IX/'M4E<_XFU"2PO- 5;>UF2YU-+=C,FYH\HY#H<\,-I&?>L.+
MQ;K@E2>:/3_LBZ\=(DC2-][*7V*X8M@$'&1@Y]10!WE1M<0I.D#2QK,X)2,L
M S =2!WIEXTJV4[0.J3"-BC.NX XX)&1G\Z\STJ;5M1N?A_?-<VKZG=:1<R&
MYEA8@92 _,H8%CDGH5'/:@#U.BN&TWQEJFL6&E0VEI"-3N[.:YEPH=%,<@CX
M5I$."QS][( QSG(ZO1[B^N]'M9]3LUL[YXQY]NL@<1OW 8$@B@"8WUHI(-U
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MZTU))18IID=RL4UL8F5VD9<_, 2" /U[U>NM;M++7;F*XU&15MK W,MH+9B
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M&*,O@72G33/*GO[:;3K<6D,]M<M%(8!C$;,N-R\#KSWSFM&+Q)I<UN\R3O\
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M2NY8@+M/<XSSQCGI5#_A,;#R#(MIJ3O&%,\"VK&6 ,[("R=<%D;[H/ STYH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M':X+9<K$20I.$.=W  '&,<5Z95*'1]+MY3)#IMG'(Q8ED@4$EOO'('? SZT
M>;HSZKX3\#W%_>74T[ZUY;2FX=6;F<=01S\HP>H[5LVUG&GCOQ@\=Q<I)'I]
MHRL+ESM)$_."<?3/3MBNO_L?3/*CC_LZT\N-MR+Y"X4^H&.#3SIM@999396Q
MDE&V1_*7+CT)QS0!YWI.NM?6OA_3]9UF:RCN_#45U'=&Y,32W! #L7R,LHVM
MC./F)(..)M1U::RN-=A;69RB^&8;JWEDE,9>;,P,BCC:3M3(&!TXYKO)-(TV
M6"&"33[1X86W11M"I5#ZJ,8!^E/N-.L;N5);FSMYI$5D5Y(E8JK## $C@$=?
M6@#@5E.H:[82-.\CS>$I6:2.0AB2\62&4YSGN*K:;=?V%X*\'>(H+VZETZUM
M8(M3@2X>10DD2@/MR>48J< =">.!7I"V%FDZ3I:0+-&NQ)!& RKZ XX'M6;=
M:')-<6T-O<PVNCQ_-+8Q6P'FL&##YL\+D<C'//K0!8T>VN$T9!=R3"YGW2R!
MI"QB+DG8">RYVCZ5P&AWFH:K;>!H[C5[_%_:W?VHI.5:8J 021SGGJ,$=L5Z
M@RJZ%'4,K#!!&0151-)TV,QE-/M%\K/EXA4;,]<<<4 8W@6ZN=0\%VKW5S+/
M,'GA,SMEV"3.BDGN<*.:XZQU*\L?!6C:U=ZY>LM_>+:WMQ<S%HX(_,E ;@C9
ME@B%LC@]17I\%G:VT!@M[:&*%LYCCC"J<]>!34TZQ2S>S2RMUM7SNA$2A&SU
MRN,&@#SZ<WD-SHEI'XKGN[6ZUN2 R6SD;8FMY'$.\LQ?# 8;.1G'44RRU&ZM
M)CH]YJ]Y-"FMSV]G)+<&,W$2P;RDD_W@$8L,C))0#IG'6:OX6AU&71$@%I;V
M>F7)N/LIM@R29C=-H ("CYR>AY K8;3K%X(H'LK=H86#1QF)2J$="!C /TH
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MG!&0<#@^E:&F>%)M*U.=[;6KL:5+</=?V<43:LC-N;#XW!"Q+;?7VR#:\1:
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M-C_W6_*MZB@#!V/_ '6_*C8_]UORK>HH P=C_P!UORHV/_=;\JWJ* ,'8_\
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M*C8_]UORK>HH P=C_P!UORK:@XMX_P#='\JDHH **** "BBB@ HHHH ****
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M.0"<=A5)=3DOM#BBFO5N&M?%]O#'^_,I6/[0I4;CRPY.">PH ]&L-8M=1O\
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ME-(\DMG;O)(NUV:)26'H3CD5P\^HW^A^-?$DFG:9+J,4.FV4K0?:M@109\[
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MOHUNWFAN;N6Z1&0#RC(Y=AD=?F8_ABLK4/!;WXUP'4A&-6N;>X;$&?+\G9M
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M%;>UN<J98XC$[D. H7<6C*J<8.>02.>A?P[I5Q87=I<V2SPWJ@7*SNTIDP.
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M:C(@C>>.>1"RCH" P!%00^#=!@M!:+8L]H',GV:6>22(L3N)*,Q4\G/(Z\T
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M2M(1?3K;#2)9?LX"["WG1@]L\\=^W&.<\KX,U?4=%\/^#T>X6>PN])F<VPB
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M.!QCL/2J^B^%]%\.F0Z58K;>9P0'9@HSG"AB=JY[+@4 8WB/_DHO@G_>O?\
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MRR>=@+\G4>=W_N^_%WPSHOB#0(1I3W%A-I5L\C6TH+B>1"25C<8VK@G&X$Y
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MX6TUT;-+O9^Z,X)79G.1\P*YQC(QG-.M_$UG<P7LD<%SNL[P64L10!Q*2H
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MT6]DM&?3)-)6YDG@N-C?:@K.7\LC&W@L1NSG'8'D=?0 4444 %%%% !1110
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M'>Q6XLK NZW=KXMEW1!6W10M)(5S@<(5*X[$#CI0!Z!I_B6UO1J)FC:T6RU
M:>?.8?/(0FW&">ID4"MJO)-2CM;BQUV6XBCEB@\7VT[ED#!(LVZL_P#NX# G
MV/O7IUW]G.BS=([?R#CJFU=OX8XH NU#+=00300RRJLEPQ2)2>7(4L0/P!->
M6Z3%IEAX-\'W$T;F?4! EU/.[O#YB0. )EYW8)("\?,%Y^45#H@MY4\#W&H0
MF7[->7]J\DT#90YD\M/F&1T7 ]@.M 'KU%>9^%)+;4-8LFO+R^B\364TRWML
ML&TN#N!\QMOS18P5YQ]T#TKIO&UW;VNFV'VI7,,M_"C,21$G4@RXZID=.,DJ
M,CK0!TU%>/Z88KFYT&RN99/+B\0ZA"T9WQ*(2DVQ=I/"\H I[$#O4VGZA'8Q
MZ7;W;_\ %-PZWJ,,Y<EHHU#O]F#_ /3/GC/'W?:@#T;0]:37(+N1+>2 VUW+
M:,DA!):,X)X)&*U*X[X="W33M9CM5VP+K%T8QM(&POD8SVQTKF_%-O:SWGQ!
M9W9IH=,@EM?WK92<)+@H,_>#;.G(R/7D ]5J&ZNH+*V>XN95BA3EG;H/3]:\
MQU%I[+4]5_L!I&N;GPZMPRP2%GFF#G+#GF383@]>E5-7M]"U/PKJVI:1/<7E
MNWV1YH3:A(862=26V[1B386#8[#GMD ]+L];2\\0ZGI MI(Y+".&1I&(Q()-
M^,8/;8>M:E>1^)(-.NIO'$T(4&#1+9['RV*;9%68J4 Q\P)3'<;AZ\Z-_<QW
MMYXABUESF33H9-'D!Y/[H[C"1_RT$O\ =^;[GM0!W^K:@-)T>\U%H9)EM87F
M:.,@,P49.,D#M4EA=K?Z=:WBJ46XB24*3R P!Q^M>6:A=3-9ZU8>, /M[>'X
M38B1?E>7R6\[R\<>9YG7'. O85Z-X=<OX5TMH^OV*( ,".=@ZT :M8L6OM=:
MH]M9V$MQ;PW1M+BX1U'E2! ^2IZK\P&1SGMCFN'T9[BZL_"TL)9/$T=_LU=3
MQ*4P_G>:/[G *YX^YM[5O> 8+".[\2M:Q6Z/_:\P!C4 ^7M3&,?PYS[=: .T
MHK@_$UY8Q^+WL?$8D72+O3!'9R!&*B?>PD"E0<2;3'M/7@X[U@^*KV**6^6+
M[5#>V0TUT>Z#R3;!(A+1D?< !(=LG<<@XXR >C6&MI?ZYJNEBWDB?3O*W.Y&
M)/,4D$8/3CO6I7E^LWUQ#JGC&YLA-(%?3'G2 'S&MP1YP4#G.S<#W&?6I=6D
MT3^R$UG0WE_L]=8L;F:9 RP1*)$60H,#:-H!? QR<\YP =OXAUM/#VCR:E);
MR3HCQH5C(!&]PH/)Z985J5Y+J]Y#/HWCGR78PMJEF\/RD*RE;<DKGL2&/'7D
M^]2^(-2@/B.:>$R17%KKEB)&=7>0PGRP60CA(2&(QSN);IG% 'H\^H_Z-=M8
M0F^N+:01/!&ZJ=^%.,L0 0K U>KR'4H;.S\-^.HHX1;W@U82*$0QL4;R2O(Q
MD'YCCOSZ&M/6Y1<S^,(+]F74!$DNANI.\KY(V?9SU+>:&SMYR1GC% 'I=%>0
MZY;><GC1]0<MJ,&AVLL>V5L+=".7)0 XW!MN,=,CUY]3AG$ND)<>86#0!RZ<
MD_+G(H K>(M;3P[H5SJLEM)<);@%DC(!P2!GD^]:E>+WDDD7@S7[&3[)>*=.
M@,6IV>5^T+YF LR?PS=2<$Y]L5K:G/8Z1J/BZ*$3-8/:6$ICMYFY=I'61RW)
MQC87(!)7KUH [[Q#K2>']'?49+>2=$DC0K&0"-[A >3TRPHL];2[\0ZEHXMY
M(Y+&*&4R,1MD$F_&,'ML/6O,[RY0>&_&-JLJ&)=4LY+=8H6CBV-]G8F-3G"D
MASP><$UV>CRQO\2O$>UU.ZQL=N#UP9LX^FY?S'K0!UM%<3XWGMFU33[&XC;,
MUI=&)I49X2V$&T(/O2G/R\C W=<XKE]*.EZO=^'$\073M!/X64SBXG>-7E5H
MPQ/(RV=WXC/44 >O5EWFMI9^(-,TEK>1FOUE9)@1M7RU!(/.<\CM7FFE6<3W
M_AVR\67$OERZ#<"1;N=H]X$\?E[^1\VPCKSD>HJ]HL-Q'/X#M=6:223RK],7
M/+F)AB(/GG)3:.>: /4:KWT\]M9R2VUH]W,N-L".J%^?5B /7GTKB_#&GW$&
MK-X?N8&-KH5P]Q!</SYR2@F$9[E0T@;W1#WK1^)) \!ZB0[*X\O9M8@D[U].
MO&>* .KHKS^WL=+U'Q[XEENY/,2WAM9X2;A@J'9(&88..A&?3/O6!IR6^E>
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M&AA#;,'Y3\Q.3N^G>@#TVBN2N/$>M7%[>#1M,2[AL;Y;69&*JSC"&1@Y<;2
M^0"ISMZ\\:FO:TVER:9:PJAN=2NQ:Q-("53Y6<L0",_*AP,C)(H V:*X6_\
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M=Y?BT6U-FT;3!@\.,!#N!Z#@$8(YYY-:M]I-M?:)-I#;XK2: V["(@$1D;2
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M0KD':9",A-V-NXCG;G/M6;XSUJ_T'1X+RP^S;WO(+=A<1LXVR2*F1AEY&[-
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MO,-V!P*[#P]:?9;&5SI46F/<3-,]NKAVR0 6=AD%CCL3QCFM571F8*P)0X8
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M?^S9-DGAQ+!?WL?,P+DK][I\PYZ5UVG:1IND1-'IUC;VJ-RPAC"[O3..M7:
M.:\-W5_9)I6@7FER0^1I,3-<><C#S$VHR%021V(/0\^AIMS8ZE8^-YM8ALWO
M[*[T]+5XXW0/"\;NP.'(!5@YZ'.0./3I@H#$@#)ZGUK/U+6[+2A;_:7<_:+J
M.T3RT+8D<@*&Q]WJ.M ')^%/"VH^']9T=)H/,M[31GM)+A74JLK2K)M )W;0
M 0#CL*U/%MK(-4\-:L.8-/U',_HJ21O%N/L&=<^@)/:NII&570JRAE88((R"
M* .1U+2M2F\4:W>16+O;W.B)9PN)$&^4-*V,%L@?O!R?>J-YI=W)X>\#Z+)"
M8[VVNK.6=-P/EK;KN=L@D8R%7/JX]:ZW3M5LKZZOK*T#A].E6"96C*!6*!@!
MGJ-K#GI5T11B5I0BB1@ 6QR0.@S^)H P?%VGWM]!I4MC;&Y>SU*&Z>(.JED7
M(."Q SSGD]JYS4- UJXT_P 31IICF6_UFUO( )H\-'']GW');C_4MC/J/?'9
MZGK-MI6Q)$FFG>-Y4@@3?(R)C>P'?&X>_( R35V"9+FWBGCW>7*@==RE3@C(
MR#R/H: .'L-#U*#6[JTO= AO;1]2:_MM1DN%*Q!G\S#1YW;U)(4@8Z<BM/Q]
MI=[K.@06=E8F\;[;;S21[D V1RJ[9WD Y (Q74U0N=8M+35['2Y3(+F]$AA
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M7??V-Y#S'^V(VEM"8B RJNXY/0'';K6W0 4444 %%%% !1110 4444 %%%%
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M3+9?8I-,LGM-^_R&MT*;O7;C&?>GOI>GRSQSR6-L\L0"QR-"I9 #D '' !H
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M;8^SZ99Q8WX\N!5QNQNZ#O@9]<4 >9:1J7E>"M LXM0EAE.E7=P(EG,"':P
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M5--)TV(P&/3[1#;Y,.V%1Y>>NWCC\*N4 %%%% !1110 4444 %%%% !1110
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MX:MKYU19(W^T2IYC$)(K*O4= B)UZ+2:EX).IW.L3R:F\,M^;:2*2&+:UM+
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M0P_9@N^&10NUFW'+ #&1C/H.X!H:3XL&J:E:VXT^=+>\MC<07"Y90!@[9/E
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M2_$OVK6=6TF_MX[2ZTU(Y9'2;?$T;@E6W$*0?E.01QZD5IIJNG26YN$U"U:
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M4Y_PH ["ZO;2PB$MY=0V\9.-\T@09^IJE=^(-+L]1LM/EO(!=WRLUO&9 -X
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MLOX>\8V3WEU&;32[>YAF>.-)?WGF!QA1PIV<9 89/3MZ=!&T4"(\SS,!S(X
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MK_\ V#;C_P!%M7*6&B:G<6^@^)#+:V@TO0FC@$1,CS,\2_?R% 4;<A>>3UH
M[Z[OK6Q$)NIEB$TJPQ[OXG;A5'N:L5Y];ZQXAB\.>&=6N-5CF.K7-@LL0M54
M(LBC> ?<G.>W;%17GB#Q##:ZO?)J40&GZ_%8I";5=LD4C0+ACG/'FD@@@\<Y
M[ 'HU%<!/XGU32;O6-.N+M+EH;^SMH+F1%C\M;@#.<#'!R 2.XSFNFT+^V8Y
M+Z#5Y[>8+*&MF1@9/*(Z2 *HSN#8('(]Z -FJO\ :-F=3_LT7,9O?*,Y@#?,
M$R!NQZ9(%<GJ][XBN/$^LZ9INK0V<=KIL-Y"6M5<[V:4%6)/W3Y8SW],5F6F
ML7.J:SINM;?LUU<>$I+K"@'8Y>)N <\9]: /2:*X6R\1ZO</X>VS0L^H^'I;
MYTD4*GGJL)4Y'(7,C9YK1\(ZY/JD][:WSWD-_;1Q>?97D*))"QW9960!71L<
M$9^Z: .G=TBC:21@J*"69C@ >IJ&QOK74[**]LITGMIEW1RH<JP]17.7;73?
M%+3H5OITMO[)GE,"A=A82PCG*YY!]>W&.<\OX-U34=(T;P@AN1-8WME<!K41
M ;#&I=2K=23@@YXYZ"@#U.BN/\-ZEKVJ'1]5DN;-]+U"T\R2(N-R2%0R^5A0
M2!\P(8D\9[&M37[ZX@N],M+:Z,3W,C@QQ(K3RA4)^3<"@ ."2W&..I% &Y17
MG.F>(?$.N)X5A348;1]4T^YEN)%ME<B2)HP&4$XYW'CI4>E>(/$VKWFD::^H
MP6LTRZC#<7$=J&WO;3+&)$!.!G)XZ=: /0)]1L[:]M;*:YC2ZNBP@B+?-)M4
ML<#V )IUI?6M^LK6LRRK%*\+E?X74X93[@UY[8:K?ZO?>"IM3\MKV'5;^UED
MC7:DIBBGCW@=L[<_7-7;#Q1J,\]KIUS=(DMWK=[8BY6-5V1PARH4'(W':!SG
MO[4 =[54:C9G4SIHN8S>B+SC &^8)D#<1V&2*Y:_U#6;)(+!]7BFOA%=2-]D
MA7SG5"OEL0PV* &&_IDE0O7%8]E<:IXB\0:'>VU^FGWMYX76>29(!(%9GC8@
M*QQC)[YX_.@#T&34;.'48-/DN8UO)T9XH"WS,J]2!Z#-6J\TLM=NM3O_  9K
M-]"OVK[!J+2I$.'9/+!*^S;<CZUN>&]1U[4WTG5);JSDTO4+3S)(]XW+(5#+
MY6%!(QN!#$G@<]: .CU#5=.TF))=1OK:SC=MBM<2K&&;T!)ZT6>K:=J+R)8W
M]K<O'C>L,RN5SZ@'BN;^(W_()T?_ +#EA_Z/6JOC=1%XO\&7%B -6?43$VS[
MS6FQC,#ZJ/E//0XH [JJ":UILFIC3EO(S=L&*QY^]MX8 ]"5SR!R.]<QX?U;
M7]>CTG5X[JVCTR_23SX6==T1(.P1?)G>I&&#$C@G QBLOPS/=6?A33-FI.9[
MO5[R,*8D:9@)K@L(OEP&)4$EN  W3B@#TJJMUJ-G8S6T-U<QQ2W4GE0(S8,C
MXS@#OP#7%:)XFU>^;PM]HG ^W7-_;7*^6HW>290K<=&^09QQUXJLVI7>K:=X
M6N+V02S)XHF@WA0N5C-RB\#C.U10!Z155M3L$U%-.:]MUOG0NEL9 )&4=2%Z
MD>]<]X':ZD379+J^GNF&KW,2^:%X"-M&,*.P ].*ROB!87,FJ6>L:<A?4]&M
MGOK=1UD"NHDC_P"!(6'UQ0!VUYJ5CIWD_;;RWMO/D$47G2!/,<]%7/4^PJU7
MEVMW\'B36/"'B"V<O8G688;)O[RF&5I&_%@J^QC/K6Q-XCU*/Q%8I%=K/:7&
ML2:>X2)1"BB)VV@GYS(K)R1E>HZC@ [FH+R\M]/LI[R[E6*W@0R2R-T50,DF
MN#@UOQ,/"^KZY]NCN6M;BZM4MEM5&!'<E/-R#DE45CM[\=^LNI:SX@L](\7W
M\%YNL]/M/-T^>:V7,CB/>_8!@",9QCG')!H [U65T5U(*L,@CN*6O/-9UW7X
MY_$OV74XX$TS1H-1A7[,K$N1,2I)_A/EC/?TQW[RRG-U8V]P0%,L2N0.V1F@
M">BN?UG5IXO$FBZ)!*;?^T%N)&G506 B53M7<",DMGD'A3ZY',1>(O$5[?Z?
MI:WT5O*=6O-,FN1;!O-6.%G20 \ \#(Z9![<4 >CU3GU2QMMOG74:;IUM@2>
MLK'"I]22.*K:Q=W.D>$[^\#B>[L[&27?LQYCI&3G';)'2N<%[>:-X+\(M93K
MFYN;&*Y9T#&42E?,.3W)8DGU- '6)JMA)--$MU&7@F%O(,_<D*A@I]R&'YBK
ME<C;7%SK<'C+3=0E62*VN6MH2J!-B&WC<?B"YYK2\&ZE<:QX*T74;K/VBYLH
MI)3ZL5&3^)Y_&@#2O-1LM/-NMW<QPM<2K#"';!D=NBCU-6J\G/VZ;0H'FU&:
MXF_X3#RD>=5.S9<NH.%"YX XSCCC%;$?B?5;9Y],GNEGG_M_^RX[ME6,A#;B
M<9P-N[/R#C'(XH ] HK(\/G5UM;F+69K>:>*X98GA;+&(@%?,P  ^#S@8Q@]
MZY_4_$.IRQ^+9[&Y6V?P^!Y<#QJRSXA$I+Y&0&SM&TC&,\T =O17#MXCU*'5
MWMYI61=6TZ.XTE&108YB0KQL<<X+QMSVW>E.N]6U^\OM8M=(NK:.?1Y88S]J
M9524&-)&:3Y"0"&8 KC!7//2@#MJ1F5$9V("J,DGL*X*;5?$3CQ==1:M%'%H
MLLRPP_9%.\"V2103G/#-^/.>V)M,UC6SJL5K<:A',+S0O[00FW51#*"H.,=0
M=^<$GD>G% '8V=Y;ZA907EI*LMO.@DBD7HRD9!%,;4;)=3336N8Q>R1-,L&[
MYB@(!;'IDBN+L?$NJWFD^&)+BX:W34=':ZFNX8 [&X"1D+MP0 =S'IR0 ".]
M2 :]J'B+PH^H7 L-7GT2\>=D@4F)B]N2H4Y&0?7/>@#TFBO.-&U?4]=U7P/>
M7%]+&;O3;F:XAB51&\B&(9P03SN;OQVQSGT>@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#'C
MT&WCN=41HHIM/U0^9<V\@R/,*A&XZ$,JC(]03SNXCA\-6>F:+/INBQ+9K.NQ
MI"[.R*1C(+$DD#H"<#]*W** (+*S@TZPM[*UC$=O;QK%$@_A51@#\A4]%% "
M$9!'KZ&L4>$M$6TEM1:-Y$MR+N1//D^:;=NW_>Z[@#]0#6V2 "3T%<AX4O[_
M ,7Z&NOMJ%Q9P7<DAL[>!4Q'$K%5+;E)9CC)[<@ <9(!T5II5E97MW>6\3+<
M795IW,C-O*C R"<<#BA])LI-7BU5HF-[%$84E\QAA"02N,XP2 >G8>E<9K6K
M>)?"][I5U-<-J=E%9N^K0)$@.U&13/%A=V1NW%22,9Q6Y'<7&LZC>C3M<E2T
METZWGM)84B=4:1I1O&4.[A%X)(ZT 6X/">A6NKSZK!IT4=Y.S-(ZEL%F&"VW
M.T,1G+ 9.3SS65XD\'17?A2^TW2+>,7,\"6R-<W#D)&K [03N(7CH/;TK.T3
M7=7U32_^$=N+^6#Q5:W'DWTRQQ_+&I#&8 IMV.A 7Y>K>Q-=ZBE(U4NSD#!9
ML9/N<<4 9RZ#IKVMS#/9K*MY$(KD3NTQ=0#A"S$DJ,G Z<D]ZJQ>#/#T.BS:
M.NF1M838\R.1F<G'W?F8EN.W/';%8VB>(3_PD'BBRU;7U1+2\6&U28PQE$,2
M/D?*,\L>N:Q+7Q%KT_PX\.ZL=:F-[>ZK#;S3"&'YHWN#&0!LP/E[@=: .Y_X
M1;13IL.GFQ4VT,PG0%V+"0=&+9W$XXR3TXZ5ISVT%U:R6T\*2P2H4>-U!5E(
MP01Z8KB]2UF>T^(<VEW7B*6QTX:0ETHVP#$AE92<LA/11Q6?8^-M6NO#VCHK
MQM>:OJLEC:7QC #VREC]HV= Q1>!TR0<8XH [>TT#3K*)XX(9%#1"'<T[LXC
M'1 Q)*J,G@$5/INFVFD6$5C8Q&*UA7;''O+!!V R3Q[5SFM:E>^%=3T.1[V:
M\L=1ODT^:.<)N1Y =DBE5'\0P0<C!XQCGF+_ ,4ZQ:CQ0EOX@DEU6RU'R-+T
MTP0N;@>7&^S8J!V'S-E@1@#.>#0!Z'?:!INHWL=[/ RW<:[%N()GADVYSM+(
M02N>Q.*>^C6$D=O&T3[;>3S8]LK@[_[Q(.6/)Y.>M6X&D>"-ID"2E070'.TX
MY&:YS4_'>E:3<:A#/;ZA)_9VPWDD-JS+"K#.\G^Z!SD?K@X .@ELK:>[M[J6
M!&N+?=Y,A'S)N&&P?0C^0]*KW>BV%]J-IJ%Q"SW5F6-O()67R]PPV #CD<'U
M%<Y/XB;3O%FLSSW4T^D6NBP7XCC"D("\NYEZ9^5 >I]O2M>X\5:9:33QW#21
M""P_M!G9?E,.<9'/7/:@#;K/NM%L+N[^UR1.ER4\LS03/"[+U"ED() R< ],
MFI;&_%]YP^S3P-$P4K*%YRH8$%201@]0?6L[4]>DLO$NEZ*EE-)]OCED,Z%<
M($V@\$]?G!Z=/7L :%MI5C9I;I;6T<26X;RE08"[OO''<GU//)]3523PSI4N
MH7-^89UNKE56>1+J5/,49P" P! R<#IR:Y[P=XL,VG:99:H]Y->7ES=PQW<D
M0$<CQRRD)D8&=B=AC@CKQ6U;^+]*N=5M+!'<->^9]DE."DY098+@Y' )&0,@
M9&: 'ZAX7TV\T6#28K:*VM894EC6$%/+*G(9=I'S9[GOR0:U+RSM]0LI[.[A
M2:VG0QRQN,AE(P0:CU+48-*L)+RYW^6A481=S,6(50!ZDD#\:R)O&NEVUO+)
M<1W<;PWZ:?+%Y)=TF?:5!VY!!#J<@GKZ\4 2IX-\/QI<(--C87-L+2<N[.9(
MAG"L223C)YZ^];%M;16=M';P+MBC&%!))_$GDGW-<V/'VCK;7$D\5]!+;7<5
MI/;RVS>;&\A C)49^5LC![_7BLWQ%XP%YX1U]]+EO=.U/3#&)8YH0DJ!B-IP
M01M89P1Z=J -V'PO9C3+W1KB)9M(N)7E6#<RE=[%V3CJNXDCGOC'%6ETA9-=
MBU.<AC:P-;VJ;BVT.5+L2>K':H]@#R=QJG+KNGV>OZJMS>W<?V*QBFFBD3]R
MB%GPZ<99B00<9^Z .:D?Q39PK>BYMKR"6T\G?$\66?S6VQ[2"0<MQUX[XH T
M-2TNRU>T^RW\ FA#K(!N*E64Y5@00001U%4I?"FBSQWL<EF2EZZ/<+YS@2%
M N<-V"J!CT'I6#X@\4L]G9W%A+=VSVVNP6-[;B,,YR063 W9RK*1M/.?PINO
M^+?MOA74)]+FO-/O["\MH;B&:()*F^6,8(.?E96R"/SH Z"7PIH<^M)K$FGQ
MMJ"A09MS?/M^Z6&<,1V+ D8%;! 92K $'@@]ZPM2\7Z5I5PT=R[^7'/';S3K
M@I#(^-H;G/\ $O(! W#)%;K LA 8J2,;AU'YT 9-EX9TG3B!:6SQ1*V];<3R
M>2ISG*Q%M@YYX'!J[;:?;6EQ<W$*NLERX>4F1F#, %S@G X ''8"N*\-R^)=
M:\%R:G%X@F;4UGNDB2:WA,+^7,Z*K!4#8(49(8'G/M5[2OB%I]_X4L-9D@E\
MR>S-W-;P[2T2J2K'YB,C<K  <G!P#@T =3:V-K91R1VL"0I+(TKJ@P"['+'Z
MD\U!IFC6&CK<+80F(7$K3R@R,VZ1N6;YB>3W]:YF^UV;6_$.GZ5ITUW%I][I
M<E['>VI0$DM$$<;C]U0Y)!')(X(K0LO&%A+ HVWCM]@-_&[Q*IN(5(#2*,\=
M0<':?F'% &[?6-OJ5C-97:&2WF0I(@8KN4C!!((."*9%IEI#I2Z9'&RV:Q>2
M(_,;A,8P#G.,<=:HVWB&RU&YLK.!IXY-0L#?6\FP?ZOY 3SG##S%X([]ZYOP
MOXMOI-*\(6MW;SWMUJMK)+-=90?<'/&1S\P/3ITH Z@^'-*.GV-@;9OLM@Z/
M;1B5QY13[N#G/';TIDGA;1Y8;F%[5C'<W*W<R^?)\\H((<_-U!5?^^1Z"M"_
M\S^SKDQ2M#((V*R( 2IQU&01^8KC_!WBR[F\+WO]OOYNK:4<7&Q IG5U#PNJ
MC ^=6  '\0- '0W'A?1KL:@+FQ6==155NUE=G$H7[N03P1V(Z59TK1[#1+/[
M)IUOY,.=Q!9G+'IDLQ)/  Y/0"N3\(>)-1.B7=QK]Q)=WIUB?3XHH(D #*Y4
M*N ..#RQ[=:UG\;Z6EK9S"&]=KNYELXXHX"SB:/?N0XXSF-AUP?IS0!%+X9D
MO?&VH:G>Q(UA<:?#:*J7+JS;7D9@RK@%2' P2>G3FMHZ+IYU%-0^S 7*0&V5
M@Q $1Y*;<[<<#C'85EW7C73+.UGN)H;Q8[5(6N_W/S6QE **ZYSNY&0 <9YJ
M.Y\3:?IVH:S<W$^I;;#3XKJ>V,/R1QDR'<HQDL=K \X^4=.: +%OX*\.VHC$
M6FJ/*ADMX]TCMMB< ,@R3A>!@=!VQ6E9:59Z?(\EO&WFR(J-))(TCE5SM7<Q
M)P-S8'3D^M5-,\26>J:E-81PW4-Q' EPHN(MGF1,2 R^V01S@UL4 4;O1M/O
MKZWOKBW#75NK)%*&9656QD<$9Y //0@$<U6M?#&CV?\ 9_V>T*#3MWV0"9R(
MMPPV!GN..:BO/%>FV)G>7SC:6]PMM<7:J#%#(<8#'.>K*"0"!GDC!PMOXHL[
MO79](@M;]Y[>;R)Y!;GRXF\OS 6;L"",'U(]10 _2O"NAZ'>376FZ?';2S$E
MBA; R<G:I.%R>NT#-6=1T33M6EM9;ZV$LEJY>%]Q4H2,'D$<$<$'@]ZK^)=9
M.B:1]HB57N9IHK6V1NAED<(N?8%LGV!J%[V&U\2V&G2WM^]R;*:41[!Y4P5D
MW,W'W@2,!>/F/'2@#+E\%Q0^(=#DTZUCM]*T^&Z5EBN9(Y TI0@KMYP-A_B'
M7VJ:^\+&7Q-H5Q:P1PZ9IUM<1$1W#Q2!I#'@KMY/W#G)YW5'I^NV%Q:>&FCU
M+5I%OKF58'EC4&<JLA*R_+@ !20!@_*/>M32-5>37-5T2X??/8^5+'(>LD,@
M.W/N&5U^@!ZF@"S_ ,(_I>[3V6U"'3R6M=CLHC)!!. >202#G.<GUJK/X0T&
MYTZ6PGL!);RW!NF5I')$Q.3(&SE6R3R".IK</ ]:\]O/%][?:=IFH0Q7=A&-
M?%E+$%1S-&LCH5XW'.4[8Z]Q0!U+^$]"D6S5M.C(LU=(?F885_OAN?F#$9(;
M.3R:2/PEHD$-I%!9&%;2$P0F&:1&6,]4+*P++P."2.*CM_%NG7%D\^R>*5+M
MK(VTJA9/. W;.3C[OS9SC'.:N:)KEEK]G+<6;/\ N9GMYHW&&CD0X93C(].0
M2"",&@!QT333=V-T+54EL8S%;;&*K$A !4*#C& .W8>E5])\*Z'H5U-<Z9I\
M=M++G=L+8&3DA5)PH)Y(4#.*Q/$6KW-CX[T:P;6Y+#3KNSN9)5"Q8WH8]N&=
M"1]X]Z9X9\727&FZE<WDS7]G%J?V+3[J.(![H,549 PN0[%=WRJ0,\4 =/JN
MC6&MPQ1:A"TJ12+*@$K)M=3E6^4CD'D>E%IHNGV5V]Y#;YNW78UQ*[22E?[N
M]B6Q[9Q68_C72X[>&5X[P-+?-I_E+ 69)USE3MR.QY!.>U9>K>*&O;32;G3I
M[FSVZ[%8WD$J*K#GYD;KVP<@]#0!NV/A30]-U*XU"RT^."ZG+,[HS ;F^\RK
MG"D]R "::/"&A"R@M!9'R;><W,(\Z3,<AR2RG=D9W-GGG)S4<U[?ZM)I=QI)
MF@LUOC]I>1%Q/ (Y.5ZG:7V8(QG((XJWI6NV^L+%):PS^1-")X9V V2H>A!!
M/Y'!&>10!7_X0_0!:16J:<D44-PUU$(G="DC9W%2I! .XY XP<8I\7A31((;
M>&&P6..WN6NXE21U"3'.6&#U^9O;DU=O]2@T\0+('>:XD\J"&, O(^"V!G X
M"L220  :H0^*;*YBM_)ANGNIY)8TM#&%EW1'$F=Q"@ ]\X.1@G(H O66DV&G
M7-W<6ENL4MW(99B"?F<]3CH,]\=:>=/MCJ2Z@5?[2L9B#>8V-IY(VYQV':LR
M#Q;IMW#;-:":XFN#,%MU4+*IB.)%(8C!4D CKSQD<TRP\3&_\43:2FGW"11V
M4-WY[[1D2%\9&<C[F.F<Y[<D M2^&M'F@L(&L@L.GN)+2.-V186 (! 4CG!/
M/N:A;P?H#79NCIL9F-U]LSO; F((+@9P"<G..O?-:6HZC;:7:&YNG*IO6-0!
MEG=F"JH'<EB /K6%JOBY+;0_$$UM;3#4M)MFFDM90H9?D+(QPV"AP>03T(ZC
M% "ZOX6C;PU=:7I%O;A;BX$\L-U+)LES('<;N2A;GY@#@G/7FJVD^#H5M[N&
M^LQ;VEW"89K&/4Y[F.0$CDE]N.,C"CD$Y)X U/#<-T;,7MS=WL@NHHW\BZV'
MRFQ\S*5[-P<9P,<8Z5C:UJE_=^*[K1(6U"TAM]-6[6XM?+W;R[#<0QY4!,;2
M.<G(Z&@#=?POI$OVO?;.WVNW6UN,SR?O(ER A^;IR?S/J:+3P[9V6N'4X%*/
M]D6TVAV;<@((W9)!QC XSR<DYXAMO%>G70TOREN&&IV37MJWEYWQJ%)&!R&P
MZ\8[U#I/C;2]8FL$@CNXDU"W:XM9IX=B2JN"P!SU (/IZ$T :VH:59:H(?MD
M.]H)/,A=79'C;&,JRD$<$C@\@XJ#_A'=*\RRD%KA[*1I8"LC@J[9W,<'DG<V
M2<DY.>M<]<>)9;SQ9X7^Q27<>EWPN7+,BB*Y18BRL#]X=B,XR#G!KHM)URWU
MA4DMH9Q#+"MQ#,X&R6-NA4@G\C@C(R* -&2-)HGBD4/&ZE64C((/45B6OAFU
M72++2KU?M%MISHUFWF,K*$_U9."/F7@9[XSQ6[7.CQEI_EHY@NU#:C_9C!D4
M%)\X ;YN <\'H>/49 +-SX?@%KJ45@#;2ZFQ^U3>8S-RNTL 21NV@ = ,#KC
M%:=I:PV-G!:6T8C@@C6.-!T55& /R%<IXBU^>WU30S:/=I#_ &NUG<1)&K"X
M'D2-@8R3AE7N.<YZ<69O%&GWUAI]RLVHVGF:HEF8TB <3*^TQ29! 4D<X/(Z
M&@"^WA31&=W^P[6>Z%ZVV5U_? YW\'@Y)/U)/6BX\)Z'>6M];7-@LT-_*)KA
M9'9M\@  ?D\,  ,C'0>E#^);(7D=NJ7+1R71LA<QQ[HQ, <J>_!!&<;01@G-
M8'A/Q83:6MGJLEY-<W.HWEI%=R1 1LR32[4)&!G8G&!CC'7B@#K=-TRSTBR6
MTL81%"I)QN+$D]22223[DU7NO#VE7MY+=SV@::9%CF(=E691T6100' R>&!Z
MFJ0\8Z6VHV]FGFLUTTB6LB[=D[H"65?FR#P<%@ <<$U/I_B6RU2PL+VVCG,5
M](\<>Y0"A7=N+C/R@;"#[\=30!HSV%K<W-K<S0(\UJS/ Y',9*E21]02*S[W
MPKH>HZO'JUUI\<E]&H42Y8;@#D!@#A@#TW XJD/'.C><L9,X$MJ]W;N$#"XC
M0 L4"DG(!!PP!P<UHZ'KL&OVOVJUMKR* HCQO<0E!*KJ&!7U'.* #_A'M+$>
MI1_9VVZD2;L><_[TE=ISSQ\H XQP *1/#FE1S1S);N)([4VB,)Y,K"?X/O=.
M!^0J&^U2TM?$UG:SW=W%(;.>?R@H\AT4IN9CC.Y<C&#_ !'-6M+UB+5@6A@G
MC0Q1SH\@7;(CYVE2"?[IXZC(]: .9UCP89+K3H['3+*YTRRM3;PP27\UM)!E
M@25D0,67"J-IQC'Y;&E>%K2S2UEG$LEY;QR1QR?:I7,4;MDQJS-D@<#)Y^4=
M, "37=??1K_1[5+&6Y.HW1M]R%1LQ&[]R.?D^G7V!PM"\5FUN[^UU62]N-VN
M2V,-R8AY<>=HC0D #D\# /7G&: .@@\+:+;IIR16*JNG%OLGSL?*W8R!D\@X
M'!XX'I6Q6#+XOTJ#4;>T=WVSW1LHYQ@QF<9'E]=P.01G&,C&<UO4 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 5RGA_0M7\*VC:1IXL;K24E=[0S3/'+ C,6V$
M!&#@$G!RO''O75$X4D DCL.]9N@:U%X@T>/488)8$>26/RY<;E,<C1G."1U4
M]Z &"QOO[=M;J1H)((K62&1RQ5V9F1LA<8Q\F.O>J'AOPC'X9UC5IK.<_P!G
M7@C,%H>EL0TC.J^B$OD#L2:W;2>:X64S6DEL4E9%#LIWJ#@.-I. >N#SZBJ>
MLZU'HIL/-MY91>7D=HK1[<(SG +9.<?3- %&RT6^M_'6J:W)]F^R7EK#;JJN
MQD7RRYR1MQSO]>,5T5%% '-Z#HVHZ7J_B&]F%JRZE=+<0JDK97$:IM;*_P"S
MG(SUK"@\%:U#X(T70_,L#/I^HQWCR>:^UU28RX'R9R<X_6N\^TP_:OLOFKYX
M3S#'GD+G&?IG^52T <M+I&LIXYEU^WBL)(GTY+(127+HP(D9]V1&?[V,>U9=
MM\/)8=.:7[;$FK#6&UF%HXSY,4C<&(+G)0KD$\')S[5WM% '.7NB7NO:EI<V
MK+;06NFW NT@MY6E,LP!"%F*KA5R3C!R<=,<XY\#WEVNO&YFM[>YN]1&I:?=
M6[LSVLJHJ*2"HS]SGU#$5W=% %73C?&QB_M);=;L*!)]G9F0GU&0"/IV]37#
MFVNM6\5>.M*M'M-MW;VT$DDDAW1;H64L% .[ /0D<CKSQW-E<37-DD\]G+:R
ML#F"1E9EP3W4D<]>O>J?A_5;?7=+&I06KV^^6:(I(%W@QR-&<X)'5">M &#=
M^#+B>XU:&*6&.QN]!32(B6+2)M$F&(Q@C]YZ]O>HX?#?B![]KV[&D,QT?^SS
M;Y>2-F#9^;*C*D=1COCGJ>SGE,-O)*(WD**6V)C+8[#) _,U3T/5HM=T&PU:
M"-XXKR!)T1\;E##(!QWYH S?"OAV3PZM]$K"*RFD5[>R2=I8[8;0&",P! )Y
MVXP.W6I-6TB]NO$NBZM9O;XL4GBECF+#<LH3E< \C9T/K4VO^([70-)U&^='
MN380B::"$KO"G.#R0.Q_*MB@#A]/\(ZM:VGAV&1[(G3-2N+R4K*_SK)YV OR
M=1YW?^[[\6O"OA[6M!$.G7$VFRZ99[EMIXXV^TR1\A5?(VC (^8$YP.!DUU-
MQ<PVD#3W$BQQ+@%F/&2<#\R0*EH RO$EEJ.HZ'-;:5=+;7;,A5W9E#*'!9"R
M\J&4%<CD9K@=<T:]\/VLLTATV-+_ ,1Z?<P0Q%D5&!B0J21T&SJ!SG.!TKNM
M4\1VNFK;,$>Y6:_BL&:$KB*1V"_-D] 3SC-:[QI)C>BMCIN&: /./&.F36%I
M=ZS</;)>:AJNEJL8D/EJL4Z;06(!)RS$G' QUQDZ>M>$+_5[3Q#,'M([[5HK
M>W5?,8QQQQ$D$MMR22S=O0=LUVCQI( '16 Z9&:S=4UA=.GMK2&W>YO;E9'@
MMT8+N$8!;D\#JH^K#MD@ P-<\(7VNZCK4KW$%M%?Z;!:Q/&Q=XI8I'D#$%0"
M-SCO_#[\6+K3_%VHZ!+%<7FG6^H;XL):M((I%5P7#/C<N]05X'RYZG/'2VLY
MN;.&=H98&EC5S%* '3(SM8 D9'0U-0!P,?@K58HKWRWTV,OK4&K00Q[E3Y%C
M#1DX^7[G# 'KG Z5:U;PC?ZE8ZS*KVJ:AJD]J[*9&\N*.!E(7=MRQ.UN<#[W
MMSVE% '(0^'M;LO$-_+:2Z8^F:A.+F0SHS3VS[55PG&U@=H(SC!/0]*ZYMP0
ME "V. 3@$_6H+V>:VMQ)!:273[T7RXV53@L 6RQ P 2?PXJQ0!Q6C>'O$FE>
M%9-#BGTZWDDEG?[:DCR&,2R,Y*QE5!8;\#+8XS[5&G@F]T"[TZ3PR;![>"P3
M3YK?40V&5&9ED5E!^?+OD8P<]J[FB@#FCH>ICQ59ZFLUL8H-,DLF?E7+LR-O
M";<8&SIGO6+IG@S6DOK:YU&XL&D.E3Z==SQEWDG9RA\TE@,D[/NGA>@R.G6:
MMK4>DW6EP26\LG]H70M4=-NU&*LWS9.>B'H#6G0!Q.A^&M>L-1T.ZNWTTKIF
ME2:<4BD<F3/E;7R5&,^5R,<9ZM3='\(ZKI=OX3'G632Z-%-!/\S%720 ;EXZ
MC:.#CKUK?LO$']H7XBM;&XEL_.F@-XI78DD1*L&&<@9# 'N1]"=F@""]266Q
MGC@"&5T*J'8JN2.Y /\ *N7A\&/_ &WI&K2S)');62V]W;QL3'<M&086)('W
M6W'.,]/2MO5M:CTBYTR&2WED_M"[%JCIMPC%68%LG.,*>@-7X;F&X:40R*YB
M<QR;3G:P )'UY% '$VWA7Q!::5-;Q3V(:76Y=1EB\YPD\,C,QA9@N1@L#T(.
MW!&":2P\&ZO9-IB[].,5EK=QJ.(RZ9CE$HV@;3@CS>G3Y>O/'>44 >6:W<1S
M^+=;CCFT(QO)!'<6-_>R6TEPT:AE.P*Q<9( ( SMQ@@<[FJ>&]6UHZ_=*EM;
M_P!LZ)'8)'+(VZ%\29+87''FGI_=]^.PAFMKHM)"R2&)VB++SM8'##/L>*GH
M Y*32-9L]8EUB#^SQ(FC+9QK))(P\U6+ D!<E<G''-=)ITMS/IEK+>0K#=/"
MC31*<A'(&X#Z'-6:* .)N/!E[-8:]HOG6[:3K%XUTTC,PFA$A4R(%QALD'!R
M,;NAQSLZ+I%YI^O:_>SF#R-1N(YHA&Y+*%B2/# J!_!G@]ZM>(=:C\.Z%=:K
M-;RSQ6ZAF2+;NQG&>2/6M.@#GO&>ESZGHL+VJ&2XL+VWOHXQUD\J0,5'N5#
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M!IL:+*S1Q(!)\Q;:"3F0_P /11785#=W'V2SFN/*>7RD+[$QN; S@9(&?J:
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQ?\ 3,'..P.0*S/$$-B_Q-\,F5(&F^RWGW\9W?NMF?QW8_&NS66-W=%=6="
MZ@Y*Y&1GTI1(C2-&'4NH!90>0#TR/P- 'EVD7%Q=V'AB:*5D\2K?F/6(]V)-
MF'\X2C^X, J3P/DV]152T\NR\&G6XI;F4QZM/!?3"62<I9_:W/*9.5QL)XR5
M)[$UZ]10!Y==76G:=H,&H6.M-<:-)K,4LBN-ELZ%#NBC/0)D!\'Y=P*YY(J*
MTNX(=/LKJ#5(;S1+C79#?^1<F6.U@97\J)SG"H&,>X<#D#D=?0M8T=M4:TEA
MU"ZL;BTD,D4D&PC)4J0RNI4C!/;([&I]/TX67F227$MU<RX\R>4*&8#H,*
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M25Y YINBZG':/X<N+V\\NVMM8U*SFEEW(B*3-Y4;;N@^[M4GC@>E>N$@ DG
M'4U&MQ"_E[9HV\T;H\,#O'7(]10!Y78WL4FB^&@\Q_=^++@ 2$@J@>Y"C!Y
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M::\B11M)(ZHBC+,QP /4F@#R&\NY!I;179MK?[/JVF"2_P!*N62VN(VE +
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MZ5U>%(+H!UY1 5&/EX.">?>@#(U?Q7X@MKGQ'_9]AITD.B)'.PED</-&8R[
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M"3WK7H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]*8HGAAN$WR+N^9FD"XVJ"2%ZGGIFNJH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZ?=#[.%CCF=C*&.W&=C; 2/?KP* .\JO>WMOIUH]U=2".%,98C/)(  '<DD
M#N36'XEU*:VUKP[IWF/#9ZC=213S(Q4Y6)F2,,.5W,.W/RX[UR&N27EUX8UF
MSO;F>6'3_$-I;VLYD(9XS/;MM8C[Q4NRY//R^H)H ]'T[4H=3BE>*.>-H96A
MD2>(HRL,>O48(((R#GK3/[6MF2!XEFFCFG\A'AB9US@_,2!PO!&[IGO6=XQF
MN=,\ :W-8O)]HM]/F,3EB6!"'YL]21UK-U.:73-/\&1:?<O!;O>V]LR1XVR1
M&%R >.GRCI0!U=M=PW:R&%\F)S'(I&&1AV([<$'W!!'!%/EF2%27)R%+[5!9
MB!UP!R>HZ>M<Q;221?%;4;>//V>;1[>>4=A()9%4_4KD?\!'I45W&G_"V;)I
M+B91_8\K*GG,$+>=$/NYQSD9]>/04 =)I.J6NM:5;:E8NSVMR@DB9E*DJ>G!
MY%7*\F\(75]I6D>"VMKNYG2]TNXWVC,#&3'&'3: .#G(SU.>:W_"&H7&K2:1
MJJ^((9X[NR)N;(.9"\N 2P'_ "R*G*D 8Y ZXH [JBN/\8ZB\5ZEG!?RPS#3
MKFY\E)/)7Y=@$K2#GY22 H!!+<X K%T^ZU'Q+J.EVTOB"]MH[OPW%>2&U=$(
MF+*&8';QR>?RZ9! /2JHRZO9PZU;:0[.+RXA>:-?+;:50J&^;&,C<.,YYKSK
M0+O6_$MQIUMJ.NWMF;C0!=.UL4C)<2E1*/EXR-K'Z^G%6M OK_5M6\#7FI/_
M *;/HUZTDBJ!O^:##XZ<C#>G- 'H-E>)?VB7,<<T:L6 6>)HW&"1RK $=/RY
MJQ7FFA>(;FXM_#-CJVI3)!J"WY>Z,OEM-+'+M2/>,8^4L<#&=@'3(IOB#5KF
MRT:ZAM?$4]Y=V.ARW2SAA I968+,2/ODE-H7!4X))&1D [^#5[.YUB[TJ-G^
MUVD<<LJM&R@*Y8*02,'[C=/2C^U[/^W?[&W/]M^SFYVF-@OEA@N=V,'D]!7
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M.6-W3[4BXW ,< GHQ ^4GN1ZYKC+6\NX]!U/5+WQ%J0=-6GTZ)1L*E?M815
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MF2WFORVC2_9;#4HM/N)C.N1YGE[75>_,JY'''<]* .D.D::;%K$Z?:&T8Y:
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M-#%^]<J%#R*F1P<D;NG_ .HY]]XACTK5]<GETN5KS3]'CO)2EUE)(P9#M4'
M!!5_FP">/:@#H;+34M;R[O6;S+N[*^9)C&%485![#)/U8GO4MQI]E=S1S7-G
M;S2Q!A&\D89D### $CC(X/K7-CQA?O>FRBT!FN)+ 7]N#=J%>/.&#''RD$C
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MKL?OVC9P6A ?A<AE#G'/?.00*[>"(06\<*L["-0H9V+,<#&23R3[T 24444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !7(P>"9;>WT^V35<P6&J/J,*M;@GYC(=A(8
M9YE;GV''7/75RUEXN74]5D2RDT]K&"\:SF:2Z"R9"@AU'1@6.W'?KGM0!6F\
M#3,DLUOK+VVH#4WU*VN8X ?*9UVLA4L0ZE<C'%=/IUK<6EH$NKQ[NX)W23,H
M0,?91PH]OSR<FGF_LU$I:[@ B8+(3(/D)Z ^AI8;VUN$E>"YAE6)BDC)(&",
M.H..A% &)_PBD<T_B/[9<>=;:XH66%8]AC B$7#9.?E [=:KQ^%=3D\/7VDZ
MCXCEO1<6CV<4KVRJ8T8;2S 'YWQ_$<?3DYLZ;XGBU#Q!K%B&M?L>GP03+=1S
MAPPD\S.X]%QY?J>M;":A92I&\=Y;NLK^7&RRJ0[8SM'/)P#Q0!SA\(7T&I0W
MVFZ])92M:Q6MXJVRNLZQYVL Q.QP"1GD>U:5_P"&K6_UC2=2>259=.#+C.?.
M0X(5SU.'1''NOO6O--%;Q-+-(D<:C+.[  ?4FHA?V;6\=P+N P2$*D@D&UB3
M@ '.#S0!S&J^"9M2OM1G367ACO+FUNMAMU<QO 4*@,3]P[,[>Q).>2"MUX*E
MN;/5[<ZHH&I:A#?LQM\E&C\O"_>Y!\E?S/MCJ$N[:6U%U'<1/;E=XE5P4V^N
M>F*CBU*PG*"*]MI#(Q5-DJG<1R0.>30!1TW0WT[7=5U%;PO'J+I*\!C VR+&
ML>0V<XP@X^O6JVL^&[B^UNTUG3-5?3K^&%K>1O)$J30L0VTJ2.01D$'CGK6S
M]OL_LSW/VN#R$.&E\P;5/H3T%9&H>)4L]9T6WC^S26&HB9FN_.X01QE\CC!!
MQUS0!6U'PC-=WYNK?5Y(6ETXZ?<F2$2-*F20P.0%;+-G@@YZ#BGZ1X5ETK4[
M"[_M$3"STM=-"-!@NJD$-D-P>!QBNBAFBN(4F@D26)QN1T8,K#U!'6HEOK1[
MI[5;J!KA!EHA("ZCU(ZB@#FQX)#^&+G1Y-2D$CWKW\%U#'L>"4S&8$ D@X8_
MEQ[U+-X8U&]@T\W^N_:;JTO8[LR?90BML! 4(&^4?,23DD_0 4RZ\;6;QZ?-
MI3VU[!<:FNGS2";_ %>2P+  '(RAQR/7FNA34+*6S-Y'>6[VHSF=95*<'!^;
M..M '+W'@62;[3-%J[6]\VJ?VI;7$< _<2&,1E2I8[U*C!''4TOB*SDET ^'
M[HW^H:AJ08QW<5N1'#*I4JY(^6(*=K#)YVGJ>O2G5-/6WCN&O[402*620S+M
M8 9)!S@@ &IGN8(H5FDFC2)L8=F 4YZ<^] #;*TBL+&"TA!$4$:QKDY. ,<^
M]<OJ7@F:_O[ZX369(H[J]MKX(;=79)(2A"[B>4^3.WC!).>2#T9U;30D3G4+
M3;,2L;><N'(."!SSSQ]:CAUS39]:N=(CNXFOK:-))8@XRH;=@?7"DD=@1ZT
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MXC'EN^X8&"/W9!Y&*U1J5@;-;P7ML;5ONS^:NP_1LXH YN3P7-):7<!U1?\
M2-6CU4L;;E61D8)][D9C7GZ_A#<^ YY(;^SMM9,&GWFH)J/D-;!VBF$JRL%;
M</E9ES@C@GKCBNJEU*Q@@CGFO;:.&7_5R/*H5_H2>:SK_79+'Q1IFEM#%]FO
M+:XG:X:3!0Q;.,8QCY^N>U %W5],BUG1+[2[ACY5W;O [#J RE2?UK%&B7FJ
MZ-H4%W-]ENM)N(I9<Q%UE>-2ORG(^5LYSUY .""*Z :A9'9B[M_G0R)^\'S*
M.K#GD>]4[#Q'I&I:4=3M]0MS9!F4S-(H488CKGC.,CV(H S&T6[TNT\0O:S?
M:;K6)FEB3RBHBD:)8QDY/R@(I)^N,D@5LZ+I<6B:'8:5 2T5G;I K'J0J@9/
MUQ5R.1)HEDB=7C<!E93D$'N#6%=^)4A\5Z7HUN;:<7?G"9EGR\)1=P!4#O[G
MMTH H?\ "$RI$L,>J_N(]8.JQHUN#M8R-(4R&&1N<\^F/J67/@:6:2[N8-8>
MVOWU/^T[:XC@!\ES$(BI4DAU*#!''4UT%KJ:KIRW.I7-A"6D= \5QNC.&8 !
MCCG Y'8Y':K$NH64'D^;=V\?GX\K?(!YF>FWGGJ.GK0 W3;6XM+0)=WK7EP3
MNDF9 @)_V5'"CCI^9)R:Q_\ A';^+Q1?ZY:ZG!')>016YCDM"X18RQ4@B0<_
M.?TXK;-_9BY%L;N 3EMHB\P;B<9QCKG'/TJE?>)-'T_2[O4IM1MC;6@_?,DJ
MMM/9>#]X]AWH P[3P$NG?8)+'59DN+>\GO)Y)8E<7$DPP[%> K#^$CISP<FG
MZ1X)ETA]#9-5\X:3!/#&)+<#>)2IYPPZ;5_7VQOQ7S3ZFD<,MG)9O;F0,DV9
M2VX#(4#!3'?/7BIX;^SN#*(+N"4P_P"M"2!MG^]@\=.] ''CX<PRV&EV%[>Q
MW5K8I<QF-K<CS1,<GG?\I7L1W&:Z"STO4K?PXFG2ZPT]Y&@1+YH0&..A9<X8
M\<],UH0:A974IBM[NWFD"+(4CD#$*>C8!Z'L:L4 8N@>'8-!EU"6'RE:^F$T
MD=O%Y42L%"Y5,G!.,DYY-5;[PQ=2>(Y-8TS69=/>YA2"\B$*R"94)VLN[[K@
M,1GD>U=)10!R]QX-#RZS';7[0V6LQA;V!H][9V>6S(^?E+( #D-R,T^\\(17
MVHVD\L\7D65S%/:*MOB6W"*H\M9-WW&*\C'.XCTQTM% &1X?T-M!MKFV%XT\
M$EU-<1*T84Q^9(TA&?XN6//'&./6I=^%W?5]2O[&_P#LO]J6ZP7D;0^9N*@J
MKH<C:VTD<Y' XXYZ*B@#G[?PNEEK>EWMG<+%;:=8-816QBS^[)0_>W=1Y:]O
M6N@HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **89HQ,(2Z^:5+!,\X]?I1+-'"%,KJ@9@
M@+' )/0?C0 ^BBB@ KS&YT^]D\)^)%CTV[,O]OK>QQ?9V#RPK/$Y* CYOE1L
M <\5Z:2%4DD #DD]JRU\3: Y 37--8E_+XNXS\V<;>O7/&* //\ 7K.ZU6+Q
M?(FC7[I>3:?);"2T;,@39N(&,C !SG!'0^E3:WI=^+WQ.=*TJ<VSMILWD1P%
M!=1Q.3,B9 !)3 ([CBO3Z* /-;FW_M/6O$MV-/UFVM;VVTXQ7$5F\<HDCE<E
MPK+DE,H2".0IXQ6II5W-96=O_P )%IANIWU;RK:]AL"H8LH5+AT/,1))0GUY
M'!KJ[[5-/TP1F_O[6T$C;4,\RQ[CZ#)Y-,MK[2]6<_9;NTO&MV#$12K)Y9(.
M"<$X/7'XT 8_BZ&]^U:!>P02W-G9:@);R")"[%#&ZJX4<MM9E; R>,@<5RNI
MZ%/+<75T-.GDL+KQ':7<-O\ 9F)2-5032%,94,P8D$#.,XYKU"J\U]:VUU;6
MTT\<<]R66&-C@R%5W''K@ F@#+U_3K7_ (16XL(K>>&V(5533X\/'\X.Y% [
M'YL8.<'BN0>'6TBTZ[U"TEO!8:^LSW=M8NDMS";9D\UH0-P(9@IP.=N0,5W:
M:[I,MO'<1ZA;/!+<?94D60%6EW;=@/<Y&*L7M[:Z=9R7=[/'!;Q@%Y)#A5R<
M<GZF@#S6!-6L9EU1M&U"2TM_$=U=3VJP$RM%(C*DJI_'M8YP,GN.E:DNFP2Z
M[X7EM]"GM[!;F\N)(WMV;89$)#N,$(6<D@'ID=.@[ZB@#F/ -M-9^%!;36TM
MLT=W=;8Y8BA5&GD9, @<;67%<WI>E:G-HWA?3I[2YAUG2M3\V[N6B8(R OYC
MB3&&$@;H"3E^1P<>ET4 >7+IMT=(LM/GTF[8P>*9+B8&V9D:%IY7#\ @KM9>
M>G./6B6SU*P:^NK;2[][.W\2M=O;6T)622!K<)OC4@;L2'=@>F?2O2(-0L[J
M[N;6WNHI9[4J)XT8$QEN0&]"<59H \U70+&77/#TT.@W@L9;V[N)Q>0,Y'F1
M$;G4@[ S_P )^N!FM[Q_IPN_!_V.WL&N"MU:%(88"Y55G0M@ < (&_#BNLHH
M \Q\;Z9,\.MZ?I6@SQK/HQ$$EE:Y$[[Y&,9XVI@G=C 9BW!XP9]7L=6N[_Q1
M]AT^Z$VI:1:_969-JN4\W?&S=%8A@,'GYO8X[ZSU"SU 3&SNHK@0RF&0Q,&"
MN,$J<=QD59H \Y:RM-7L;S48M,\1Z==3"VCDGDB831O'(&C*Q8(<(>2<8(X&
M>W3^$?[3&CRC5(8Q<+<R@2QPF'[0N>)3&>4+<Y'KSWK?J*YN8+.W>XNIXX((
MQEY)7"JH]23P* /+-.MKV2\TF:;0=3@@72;^UGM(X"BP,S1L(U<_,V=K8<DA
MC]WT'5>#8-3M;R]M[MI+NS2"!;6^N+0V\[J-_P"ZD4@;B@Q\P SO]<UOR:[I
M$5C%?2:K8I:2D".=KA!&Y/3#9P:>FKZ;)>FR34+1KL)YA@693)M_O;<YQ[T
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MW$;&9\(4:3RNJC[H/ )P3C')=:6,D^N7&G:SHVK33IJYU"TN4R+<H6W(QD'
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M# ,IP1D=P: +-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MB2C,5/S$GD=>: *OPYGO[GX=:%-J9=KM[12S2?>9?X2?<KM-5_BC_P D]O\
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MDWXUN:%RWWA"JKY(_P!W:<CZFLOPV973Q)HT>?[/GU^2UMA_"L94/.J^B\2
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M@9M2>66^2(?([2<,,\$X7"YP"<9[TD'A^&6PTVWU/-S)ICJUM,)&4DJNU78
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MC!?9G;N(_BQGWK9H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MS]EX2UBVTKPY:.;$OIFJRWTQ69\,C>=@+\G7]]WQ]WWXM^'M$\1:)#)I NK
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MZX+9/H.#GVG@[7M*AT*:T72+NXL]+CTR[M[MG\MEC^[)&P0D');((Y!Z\9H
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M224 W8Z_4TDMYIUFEK?Z?J,]SX9N]4B;4'6/9;0KY3@!0 ,(9!&7_ASUZL*
M/0=(UJ/5Y]4A2WEA;3[LVCB0CYB$1]PP3QAQ1::TEWXAU+1Q;RQR6,4,K2,1
MMD$F_&W!SQL/7%<_X -D+WQ4E@4^SG5S)%Y?W2I@AP5[;<@XQQQQQ61XBL=,
MN?%WB5=5>2-I-*M6LMDKQN\BF?F, C>ZDKC&2"P]>0#TA(8HY&D2)%=_O,%
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MF0L2,=]H'"Y[ 5YTIL;O2O'D$OB&6R,^J7!2"!T)F'E(!A<%V#$%?E(S@@4
M>LVEW!?V4%Y:R"6WN(UEBD7HRL,@_B#4U>-:Y?3-X56VO+(Z;J\?ACSHK?:V
MR-P&PL"#E9%V@DYRHV\'DBWKAL]2N/%MP]S)(5\.P7%O^_< 3@3D,HS]X'RR
M,>H]>0#T:'6HYO$UUH?V>5);>UCNO-8C:ZNS*,8.>J'KBM2O(=8U61?$_P!N
M8K=:=_8MB=46)OWK1>9,6*$=2"RLP')4\8.*]*L=;T>>^32K&[A:?[*+I(8A
MQY).T,#C&,\4 :"6\$<K2I#&LC?><* 3]34E<EXFN1#XJT*/4@HT*6.X69I?
M]5]HPOEB3/&,>9C/&??%<G%:M/=^'++4KB=K"35[^*V5[AU+V?ERB($YR5)P
M%)Z@KZT >L.ZQHSNP55&2Q. !6?!JCW=O97-I92S6UU)@2;E79$5)$I!.<'
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MLHY5MW8#'7GM6!KZZ3I&KV=M=S&W\/7]M,XN'W3Q-=,RY+,2=K%>5/KNQR:
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M* PY/W2I.>V/I6SH=WI^HZN]IJS7*^)K35)V:-0P9X2SB//&#!Y3+QTR/7J
M>B45P6B:=<6OB";PQ+ [6%A='4X;AN0\4F[RXR>N5D\S_@,:CO7>T %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 5E:MHBZK>Z7<M<R1'3KG[3&J $.VQDPV1TP
M[=*U:XJR\7:E/JT-C)#9LUS8W-RGE!BD3Q.B[/,R5D&'Y*XP01] #M:8TL:2
M)&TBAWSM4GEL=<#O7"Z9XXU P:-?:M!9I9:GH\NHXM@V^$QI&[ DG!!#G P,
M8ZGK4:W%YJ/C3P7JETEJHN[.ZE1(D.^,-&C!2Q)W<'J .<\<T >@T5G:Y?3:
M;I,MU;B#S%9%!G?:BAG"ECZX!)VCDD8')KF!XWNX]+OKJ>V^2QU4V-Q<1VDC
M"*+RUD$K0YW@?,JD9XSNZ<4 =Q15#1;[^T]'MKWS[:X$REA+:G,;C)P5Y/;\
MJY/5_&&MV!\1S16VGM!HEU"C*^_=-&Z1L0#G"L!)UP1QT[T =W17(/XEU:UO
M->L;F+3C/86]O<PR!S'&$E9UPY8\E=A.1C=P, U4F\8ZLFDZ[=16\$C:+>(D
MQ-O(ADMS''(SA"=P95<G!/.WMF@#NJ9++'!$TLTB1QH,L[L  /<FL_3=1?4;
MV\:)X7L(BB0R(#EV*AF.<X*_,HX[Y]*Q/&C7O]J>%HK:XBCCEU4*RR1%PQ$,
MK#.&&0"H./4 YXH ZN*6.:)98G5XW&5=3D$>H-/KSV+Q+>:#IVOSQZ=ID&C:
M%=30F"#<KR$QI(NW^%<O+R<=_;G2U3Q-JFBWUQ8W4-I/,VES7]K+&K(FZ+&^
M-@23_$I##'<8% '845Q-IXC\17FHV-BD>EH^HZ5_:$,A60B$J4#*PS\^?,&,
M%<<]<<]!X7UAO$'A?3=6DB$+W=NLKQJ<A6(Y /IF@#4DD2&)I)75(T!9F8X"
M@=232@A@"""#R"*X'4-9U6$^/9+@V5[::7;@Q6<T!V,GD>85;YCG()!XYXZ#
MBK5YXCUF.^N;'3X-.C6#1H]11I5<C)+ IM!&!\G'/&>_2@#M:*X:+QO>V_V:
M\U&VMA87>B2ZO&D&XR1")8V9&)X;(DX( P1CGK6QHVIZ[=ZF$O=.C73Y;43)
M<IA=DF1^[(WL6&#D, .AXH O+H__ !/'U.:^NIUX\BU<KY4#;=I90 #DC/4G
M[QQC-:=<SXOOM2LY= CTZZB@%WJ<=O-OB+[E*.W9AQE.1W]1WH7GC2Z@TB_U
MV&&"33=/U!K.:$JWFNJ2"-Y%;. 0Q)"D'('49X .UICRQQLBO(BM(VU Q +'
M&<#U. 3^%$PD,$@A94EVG8SKN /8D9&1[9%>?:'KNHW&A^![K4H[*^FU2<YF
M>(AX6,$C[EY.#\K#(QPV,4 >B45P*>,->:*WN#:Z:8GUJ726CRX8D2.BN&[<
MJ,C!SGJ*LV_C#4/-ETRX@MWU-=5?3D>!#Y; 0"??L9L_=.,;NO.: .UI@EC:
M5HA(ID0 L@/(!S@D>^#^59V@W>J7=A(VL6*VEU',\8"L"LJ _+( "=N1_"22
M.:Y"[DU:P\<^*[K0X+!IDTZRFE6YW#S,&?@;>Y QN/3 X/8 ]#J'[-$;L71!
M,H0QJ2?NJ2"0![D#/T%<:GC/5-8LFN/#NEBXDCM+:Z-O+C,AF02"/=O79\I'
MS889/3CGLS.J6IGE!C54WL#R5&,GI0!+17&VOBG4[J;PO<".T6RU\N4C*,9(
M5\AY4);=AB0HR,#&3UZTFF^+[Z\MO#4TL%L/[4OKBTF"AOE\L3$,O/?RAP<]
M: .R(# @@$'@@]ZKV-E%IUHEK 6$$?$:$Y\M>RCV':N3M_&EU-IVAZT(8&TO
M5[Q;5(U5O-A#L5C<G.&R0,C QNZG'-71O$VK+8HEU+%=WM[K%W90;("HC$32
MDG!?D;8P ,C&>IH [:]L8=0A$%QEH-P9X^TF#D!O49QQWZ'C(J:.6.92T4BN
MH)4E3D9!P17*6OB+69;RQT:]L(+/5+I[EM[_ #QF"+;B0(K9RV]/E+<?-R<#
M*?#=&B\+SQNL:NNJ7RLL0P@(N9.%'8>E '7T5RVH>)+XW6OPZ7%;,VB1(\J3
MALSNR&38""-GRX^8AN3TXYK6'BG5M;UV"WTR"R2QDT^SU+?<;_,\J9F#+@<;
ML+QVS]> #LJ8)8S*T0D4R* Q3/(!Z''X&LWQ'K2Z!HDM^8Q(X>.*)"<!I)'5
M%!/8;F&3Z9KCIM1G\.^-_$>H7:6TTW]F6"IY$9B#L\\L:[LD_P 1 )ST H ]
M&HK@?$&M^*;72+XO!%9B.\LXX+SRQ^^2694==@D)4KGKGD'C!Y%^Y\1ZV]S?
M1:3IT=\VFW,=M<( $\XE$=RK-(-F%DX!#9QUYH Z^BN&F\4>(1;>)KV&VTS[
M-HDMQ&5<R;Y=D"2KTX'WL'^F.9(_$/B.?5$T^./2EDN=+&H0R,LA$>" R,,_
M-DL,$%<<]<<@&M+H9369YX-?OK7[<WFR6BF)@Y554E=Z%@,!<X./IFMNWMXK
M2VBMX$"0Q($11_"H& /RKC;'Q+-J]YX2NETZR#ZKI<UTDD@+/ X2,E5;LIW#
M/KMJ#1O&^IW$.@WNIV]FEGJUA-<[;?>7B:-0YY)P003QC@CJ: .]IAEC$PA,
MB^:5+!,\D# )QZ<C\ZXH^,]5L],.N7VE!M%.FM>F2,JK1,%#+'RYW[@<!@%P
M1R.>"T2]_P"%J6$U]]D\V70)SFWC*X/G094DD[@,\'CJ>!0!VLDL<0!DD5 S
M!06.,DG 'U)I]<C\0D+:7I#QQQO.FM6)B\S@!O/4=<$C\*H77B[Q!IT6MQW5
MI8O<:,\$]P\".4DM),Y=5)R'0*Y()(.WWH [VBLW3=0DU"\O6C:%[&)ECAD0
M'+MM!8YS@CD#CN#Z5E:U>:DGC?P_I\%S"EC=0W,DT3PEBY0)WW#C#G''!YY[
M '212QS)OBD5TR1N0Y&0<']013Z\T\&:K?:1IGA^T$-I_9E_J=]:*JAA(C"6
MXD#9^[CY"NW'H<]JW]%\1ZQK,^F7D&F*^C7ZNQEX5K=<91B=YW[L8("@@GOB
M@#JV95&68 >YH5E895@1[&N5^)L:2?#3Q$'16"V,C#<,X('!KG;@C3_&?@^8
MZ8NBV\I>!KF/:1=.T?R0,$[9^8%NZ\4 >FT5QUEXJU"?Q!9:=)%:$7B7>WR@
MQ6%H6 4&3)63(/.T#:1BJWA_Q;JNK-X<;4+6Q%KKMK*WEQ!BT;(H;DDX*D9&
M,<>IH [>*6.:,212+(AZ,IR#^-/KSSX7ZJUYX?LM-LF@2+3XRMVLB'?N9B4"
M#(^7&?FP1G@9P<>AT %%<KJ'B6^^T>((]+BMF.AQ(\L<X;,[&/S"JD$;/EP
M2&Y/3CF#3_$^K:WK\=MIL%DEBUC9ZCON-_F&*8ON7 X#83CM^? !V-1F>$2+
M&98][DA5W#+$=<#VK!\<ZK<:-X/O;JT<QW+&.WBD'\#2R+&&_#?G\*COIDTS
MQ+X:TR"QM&AE6X6.61<R0E(\_*>V>A/>@#H!=VQ56%Q$59_+!WC!?.-OUR",
M>U2JRNH92&4]"#G-<!;ZZS:1I4S:1IB^;XBDLW18_EC832+YJ#^^2I.?5C6S
M:7CV?Q%O='3_ (]KK3TU!5[)*)"CX_W@4/U!/4F@#IZ8DL<I<1R*Y1MK!3G:
M>N#Z'D?G7.>+[[4[.Y\/Q:?=10+=ZFEO-OB+[E\MW'1AQE.1W]1SGF=.U2]\
M/W.NW%K!9FP;Q.EO/&0P<^<($RN.!@L#SG//3N >F4A(49) 'J:Y2/Q'K%]?
M!],TQ;BPBU)[&<'"NJHY1Y0Q<=&!.W;DCO6_K$:2Z+?1R(KHUNX*L,@_*: +
M:NK_ '6!^AIU>*6Q%CX$\"7_ /9BZ;##)9M/K$>W<B$ $$+\Q$A(4YXYYKO+
MOQ5?6GB"VLVBM6@GU/[!LC#,R*8BX=I =H;*_P"K(S@@T =?3(Y8Y=WER*^U
MBK;3G!'8^]</:^,-9>6UFN+:P%I)K<ND2)'OW_*[JK@DX'*#(P<YZBJW@S4]
MNL:QH.G&WBFCU:[N9EEC.!"9"H\L C)W#GL._) (!Z&K*XRK!ADC(.>1P:6N
M$U"__P"$"MTL8FAM[:ZEN[E;ZZA=H!-)*72)V4CRP=^-S<?+7<F15C,A/R ;
MLCGB@!U%<C;>*=0?0H/$TMO;'1);"6^D5"1- JKO0=2')7.0 ,'UH'BC4[:\
MT>.YM+>==8M));=+?*M'*D?F>6220P*Y ; Y'3G@ ZZBO-[_ ,9ZAJ'A*_N]
M/O[6&Z@DM(IHC;/'/;M)*$D1T9LJ0",-WYQZUZ+&)!$@E96D &YE7:">^!DX
M_,T /J)KJWCN4MGGB6>0$I$7 9@.I ZFN/@\:74NG:-K8@@;2M4OEM%C4$2Q
M!W*1N6S@Y(&5P,;NIQRGAFSDU'7_ !++J9M;O[+K"F'-N0T;K;P[64EC@ ,>
M,=23GG% ':22)%&TDCJB*,LS'  ]2:;#-%<PK-!*DL3C*NC!E(]B*Y;QVUX(
M="2UN(XDEUBV20/&7W?-D9PPX!7.._'(K/F\03^']/\ $Z6=E81_V1>0@+'$
M467SEC=R0&X.93S[4 =[3)I(XH7DED6-%!+.Q "CUR:X?6O&&M:;-XDDAMK!
MK;1# [!]Y>:-U#,!@@*V#P>1QTYR*GCW5)]9\(^,[2U2V%MI<)AE\Y"S22>6
M)&*\@+M#+@X.3GIUH [31M(&E0.'OKJ_N)"#)=714R.!]T?*  !Z =R>I-:5
M<G-XIDMO%,>BS-!:%WB%L+F)@+Q"H+F.3.W<"2-A&?ESWXZR@ HHHH ****
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M8 .2*T&UZQO)-$ELM7MUAOY6\I/++&Z4(Q*J<C801DDC^$B@"WK6C6VNZ?\
M8[EYHU66.9)(7VO'(C!E8'U! ZU0MO"-K933S6M_J,4L]V+QW\X-F3R_+/#
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MEU?IJ$GSIGSD*E2/EZ91./\ 9]SF:3Q7HUA&D=YJ<;3K:K<OLB8EHS_'M )
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M"XAGN)&OY_M$PD*D;]JKD8 QPJC'M2W'B#2[6^%E-=JL_F)"1M8JKO\ <5F
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !7GFH>#=86749-.EB46M^-3T>-FP/.<AIE?T4GS /:9J
M]#JA?ZQ:Z;?:=:7'F>;J$Q@@*H2NX(S\GH.%- &'<Z+=P>(?#$MO;O/;:=%<
M+<3;E!+.@&[!())()/UK(TOP]K%M9^%8I=/96T[5;JYN/WL9VQR"<*1\W/\
MK5X]C[9[JSNQ>1.X@GAV2O'MFC*$[6(W 'JIQD'N,58H XSPK8Z[I-K!I%_I
M,$D6G/*8=1$R,9D)8KM7JKD, <X'7DYK,TCPQK$%AX/M9[-X3IUO<PW<BRH?
M+,D952,-SSSQ7HU-DD2*-I)'5$499F. !0!Q7A#1=0M$L+;5O#MC!/IL!MQJ
M"RK)YXVA<QCJFX %LXZ8P>H2P\'7T?AS6]$FN$2%H)[#2Y <F*WD!(S[@L$Q
MZ1+ZUV"W8;4)+/R)P4B63S3&?+.21M#="PQDCT(]:L4 ><7&A:QJGA/5H)O"
M]G9:M+I<E@LL=PCM,S #Y6_ACR,D-STXXY]!M-PLX0\9B<( 4)!*G'3C(J:B
M@#S[_A&KV>ROH;S3;L&77)KV&:TNDCG@5E(65&W8SG@J>S'@UUOAV#4K;0+2
M'5Y5EOU4B615 W<G!('&[&,XXSG%:E% 'GFD^'];M+7PE;3Z=C^R+^>2=UF0
MAD:.9 PY[F13CKP?;-?_ (1S7K7RK^/24NG@U>^N&L)+A$,T%PY8,K9*AUXX
M..XS7I=% &;H=G]ATI(QIUO8%F:0VMN00A8D\D<%CU)]2>O6N/L_#^L16&BQ
M/I[![7Q#<:A+^]CXA=IR#][DXE7CV/MGT*B@#S._TZ_LK*6-[(_VA<^)3?:?
M']HC5G &[(R2N=JOD-C@]<XJ0:??7EF;6+1;N#4$URVU2]6:>%@P\P,2I5\?
M=CP%Z\#/7)[W4-,L-6MOLVHV5O=P9#>7/$'7(Z'![^]/LK"STVV%M8VL-M #
MD1PQA%S]!0!P6I>'-<EN]7OK6P21QK4.HV]O-,JK=1K;K"Z9!.T_>(SZ+5JY
M\.R7UE _]@3:7.\[W ?3+J-+FVDV*H=FR%<L 01R,;>M=W10!Q>E:9X@L=>L
MM1OK>&ZD.B1VES)%(L:K,CLQX]#NQP,9]!72:)J$VJZ/;WMQ9FSFD!WP&02;
M""1PPX8'&01U!!J^0""",@]0:6@#S[3_  MJPT/1- NX"!I&II=?;Q(I6:.-
MV=2!G<';(4@@#EN3QG?\':?>:;I]_%>VQ@>;4KJY0%U;<DDK.I^4GG##-=%1
M0!QFNZ'J5QXC&I:5%<6MXKP+]H29#;W$2L"RS1L<DJ"VUE&>1S69_8&O1O':
M)I@>*'Q(VIBX-P@5X7=WX&<Y&[!! ]L]O1J* .,\.6&N:4S:1=Z5!-:6]Y-<
M0:D9E;<CN[C"?>$GSE2>!U.3T-#2/#VL6MKX2CFT]E;3=0NI[G][&=J2+,%(
M^;G_ %J_D?Q]"HH YWQ/IE_<WNAZGIZ>>^F7AFDMMP7S4:-XVVDX&X!\C) Z
M\BL&]\,:H\MYJL%KF:XURTU#[%YJAECB5$/.=N\[2W7'3G->@44 >>:IX?UJ
M[L_%B1Z<3)J5_:SVX$T>"L:PAN2>.8FQGU'X3QZ#J4>OZC;W.@6FH6%[>"\A
MO9YE_P!'R%RKQGDE2N5V\'CD=:[RB@#G?">GWFGC61>6I@^TZI-=19=6W(^,
M'Y2<'CH:!I]Z/B))J?V4_8FTM;43;U^^)&?&,YQ@CG'6NBHH \[T;0O$0UK1
M+V_TY(7@M+NVNF6Y7RU:1HRICC7A4PAP ,_WO4UK'P_XATS3O#$S:)%?/IM@
MVFW5D;I%8C]WB5&/R]8^A.<$=^*]-HH \^U+POJ -M)HNG_V5?06J)#)93(+
M;!D=F@FC8C?& V<A<Y9B,=*Z?Q5#J5QH+QZ5!'/<^=$QC?;DH)%+;2WRA\ [
M2>AP:VJ* /.8O"^H/#JL%YI5UY-UK"WT$UMJ ^T0#[.J!U<L/G5EP03R&/4=
M>Q\-V^I6N@6T.KS":^7?ODPH+#>=I;;QNV[=V.,YK5HH \\L/#^MV^G^'+.7
M3O\ D%ZS-<RR+,A#1-Y^& S_ --5XZ\'CIF%_#FO0$W\6EI<O#K=U=_89)T3
MSX)@1E6R0''!P<=^:])HH S-!L_L>FX_LVWTYI9&E:V@((4L<G<1P6/4D=SW
MZGBXO#=T8?%27OA9+R74[^6>U>5X<*K1HJ[FW%E(*D\ D9XYKT>B@#S+4/"W
MB@^'?[%E"ZDS: UF;M;@1L;DAO\ 6,?G9,$!1T)SN'.1=N="UFY?7G.FE3?>
M'HK"(>=&?WRB;(//3]XO/L?;/H%% 'F=_P"&?$,FM6FK65JT=SI^EVL<,<DJ
M&.>:-G+1N-W0A^&[, 1TY]#66:73_->UDCF:/)@+*6!Q]W(./UJS10!P&A>'
M]7L(O Z3V# Z19RPW9$L9VLT:J,?-R,BH-/T+Q#:6.FVCZ8#"LNH&?;<(DB&
M68O$=X.0F"=P7G('! Y]&HH \V.CZC8^#O"<$<D%EXETQ8;6-#()-R.HBD!
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M5O+$;W,(:1!T1QPP'L&!%:]8_A313X=\+:=I+2"22WB D<=&<G<Q'MN)K8H
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MI&15F4NW ) "@\UR>IZ.?LWBN:'1;@W3Z]:7%HZ6+[RBFW+.A"],I)DCW]:
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M8U6[>&.2%HQY32LRE00/E(.>*YK4M,,E_'KOARSU/2O$LETBW$"6\BV]VOF
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M))([4RSQCS%4LR1$OT[#@$_E7)Z]HT4_CJRU/4K WVEMILUF5\@S"*4NK@E
M"<,H(SCJ!ZBIO"LEUH/AO3--U.&_EF\N>17$32^5$KED1R,G=L95 ZDJ0.E
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M=M?P-#:^(XM-\@6P DAD>).6R2"/,R".XYST'4>)M8FTJ+3HH,"2_O4M%D)
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M*.#N'WAG'3DCI6&_B?6[6W\4I''+<2Z;;VT]O]HB428D#;R53&0 I8# ;L:
M._HKSS6-?\16.F^)+VSO$DLK)(#97$UL,R,V/,&1@';G&0/XL=0:T+J^U]-8
MD\/PZBDM]]C>]CG6%(\[G*HNUMP*KCG')W+R.X!V=5M0U&STJRDO+^YBMK:/
M[TDK!5%<:=;\2ZF]Y86+V4.JV%I;R.%=6@DE<$MDL-WE\8&W!'/)K*\6ZO=^
M(/!?C!EN5MX=.9;7R$57$OR1NS$D9P=^%QC[N><XH ]0HK$\6ZW)X>\,W6I1
M(K2(T<:;QE5+R*@9O8;LGZ5C:A?^(8-9U+0;"[$URVEF_L;B6),K*K[3&X
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M#M!U6YNKB[L=[W<:QW(2:1%G5?N[U5@&([$@D4L_BS2[:_@M9'D"S77V))P
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M;@\@X;<,;NG'.UIVDWUKXOUG5)?L_P!EOHK>.,+(Q=?+#\D;<<[_ %[5O44
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MAB,@$\F@#.L9]/3P[%/:M#'8B'<K* B 8ZCIQFO*_"D1T[1/!6K:M))>:+!
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M0 ZBFM(B;=[JNX[1DXR?2G4 %%%% !1137D2)"\CJBCJ6.!0 ZBBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110!YEKUP-;\"_$&^ND5S ;NS@5AD1I"F./<N&;/N/05T=EJ=_<Z_-X<UR
MRM#%<6)NK=[=V8% P1D?('S LI!&,Y[8J=?#$)37M,GC,FEZRSS/M;:49T"R
M+Z\XW CNS=,#-R#21ISR7RO<:AJ'D"!)+AD5M@.0ORJH R<DXR?? % %7P3J
M=QJOA>"6[<R7,$LUK)(>KF*1H]Q]R%!/N:Z&LSP]HZZ#H=MIX?S'3<\LF,;Y
M'8N[8[99B:TZ  C(P:\OTC47\-:%XKU'3[*V>1?$SPE'^0;7EBCZ@=M_2O4#
MTZXKF#X'L3IM_8F]OC#?7POYCNCSYH=7X^3@;D4X]J +.A:Q?7NKZSIFH16Z
MS:?)%M>W+;721-PR#SD<CW]JS+KQ3JEOK&O*UK9#3=$19[AR[F5XC$TAVC&-
MW Z\5OV.BPV.KZAJ:3SO-?B/S5<KM&P87  &./>HHO#MFFH:M=R/-,-514N8
M92IC*JNT   'H2.M &,?$GB"&&ZN7T-KBV%C]IB>!#D29&8MNXE^#N! &=I&
M 2*KGQK=3VFFSZ6^F:C'?:G]A256>()^Z+_.AR58,K @\XQQS6GIW@NVTRQ:
MTBU75I(U4);F6Y#FU4,&"QY7IE5^]N.!CI69K_A>1+S2I=/6[EGDUF.^O;I/
M+#*%A:/=C 7^Z,!3GGK0 6GC74#<2Z/>V4*:U'J)LB8 SQ,OD^>) I()^3 V
MYZ]ZN6?B/5[B[M-)N;"*QU2<7,F^4%HS%$R@2!0V?F\Q?E)R/FSG S9O?!6F
MW]F\4DUVETUV+W[?%($G6<+M#@@8'R +C&,<8I+OP797<5BQU#4H[^R=GCU&
M.<?:"7 #[B05(( &-N/E&,8H I6^J>()?&>C65Y]FM%ETN>XN;5 9!YBRQ*<
M/D9X;CCC)SGMKZGK,L.O6&B6GE+=W<,L_F2J66-(]H/R@C))=1C(XR>V"H\-
M6:ZCIU_'-=)/8Q20JPESYJNRLPD)!)RR!LY'/L<5+JFA6^IWME?&6:WO;)F,
M%Q 5W*&&&4A@05( R".P/!% '&ZKK]_K>DZ4$$-K/%XA33[V(J71I(Y#R#D9
M0E0V#ZCTYM_$72[*Q^$^NV]O:01(L+3;8X\*)"VYF [<DFMV;PE8RVEG;K-<
MQ"VO?M^]&7=+/N+%G)4YR6)P,#\ *U;^PMM4TZXT^]B$UM<1M%*C?Q*1@]*
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BN<A76(?%4$$NL&XM
MGBEGEMQ;(JQKD!%##YNI."3SL-='0 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 445SOB?5-5T>**ZM&L_(DN;6V"2Q,S;I9EC+9#@8 8
M$#'.#S0!T59EWK<%G<O ]IJ,C+C+0V4DBG(SPP4@U9ADN8+!Y+]X&ECWLSQ
MHA4$X.&)QQC//7-<]X3\7-KUG:3W*HOVV(/ (X7'S ?O4.<_<)"[C@$DX'%
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M;_A)+;_GPU;_ ,%TW_Q-'_"26W_/AJW_ (+IO_B:V:* ,;_A)+;_ )\-6_\
M!=-_\31_PDEM_P ^&K?^"Z;_ .)K9HH QO\ A)+;_GPU;_P73?\ Q-'_  DE
MM_SX:M_X+IO_ (FMFB@#&_X22V_Y\-6_\%TW_P 31_PDEM_SX:M_X+IO_B:V
M:* ,;_A)+;_GPU;_ ,%TW_Q-'_"26W_/AJW_ (+IO_B:V:* ,;_A)+;_ )\-
M6_\ !=-_\31_PDEM_P ^&K?^"Z;_ .)K9HH QO\ A)+;_GPU;_P73?\ Q-'_
M  DEM_SX:M_X+IO_ (FMFB@#&_X22V_Y\-6_\%TW_P 31_PDEM_SX:M_X+IO
M_B:V:* ,;_A)+;_GPU;_ ,%TW_Q-'_"26W_/AJW_ (+IO_B:V:* ,;_A)+;_
M )\-6_\ !=-_\31_PDEM_P ^&K?^"Z;_ .)K9HH QO\ A)+;_GPU;_P73?\
MQ-'_  DEM_SX:M_X+IO_ (FMFB@#&_X22V_Y\-6_\%TW_P 31_PDEM_SX:M_
MX+IO_B:V:* ,;_A)+;_GPU;_ ,%TW_Q-'_"26W_/AJW_ (+IO_B:V:* ,;_A
M)+;_ )\-6_\ !=-_\31_PDEM_P ^&K?^"Z;_ .)K9HH QO\ A)+;_GPU;_P7
M3?\ Q-'_  DEM_SX:M_X+IO_ (FMFB@#&_X22V_Y\-6_\%TW_P 31_PDEM_S
MX:M_X+IO_B:V:* ,;_A)+;_GPU;_ ,%TW_Q-'_"26W_/AJW_ (+IO_B:V:*
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MO_B:V:* ,;_A)+;_ )\-6_\ !=-_\31_PDEM_P ^&K?^"Z;_ .)K9HH QO\
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M9EGDG;/[QEB9% R3C+.6QG "X[BNKHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
D* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>exhibit1033-bochk_facili013.jpg
<TEXT>
begin 644 exhibit1033-bochk_facili013.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HK@?B%\5=)\"Q&U ^VZPR@I:*V @/1G;L/;J?UKQN+4_BM\49B]D]W
M#8,=N;=C;6RCN-V1N^F6- 'U \D<>-[JN>FXXS3J^+O'/A?5_!NN1:=J]^EU
M=2VZW!>*1V !9AC+ $GY?2NSTSX9?$>UT73];\/ZN72ZMH[F.*VOGBD574-@
MAL*>N.IIV ^GJ*^=/"WQPU[P_J(TKQM9S31H=KS-%Y=Q%[LO 8?@#[FOH'3=
M3LM8TZ'4-.N8[FTG7='+&<AA_C[=J0%JBBD9E12SL%4#)). * %H!!Z&JU_>
MP:?IUQ>W#A((8VD9B0. ,U\T?!CQIXGMM:N-)M+>75[:6)IC!+.$$39&7WM]
MT>O7KTH ^H**YOP=XEO/%%E=W=QI:V4,4YAAD2X\U+@+P64[1\N>,XYJ]JVI
MSQ)=66EQ+<:LML9XHGX0<[1N;H.<\9YVF@#6) &2<4@(8 @@@]Q7D\OB[0KG
M2KFZF\/ZIXAGL6VW)EC\P*=^WY0>.1AAM4<'K72Z3Y&@Z[IL5E;O9:5K4#,M
ME(-OV>X50P"KT7*;LJ.Z_6@#M***X'QUJ>LWCSZ5X?NY;,6,(N[^]@C\QT Y
M2%%R,NV,XST^HR =]17*S^,([4Z)IPAEEU;5(#)'%,OE&,*N6>4?P <\>V!6
MCX:FO+K3YKN[O4N_.G<Q-''L0(IVC;R<@E2P.>C4 ;-%%>;_ !1^*5GX*T][
M*QDCGUR9<1Q#D0@_QO\ T'4_2@#TBBO!O@-=:^EUK5]KD]PFFW"JXFO7*AYL
MY)4MU^7.2/:O7K;Q9HU[JRZ99W,ES<')S#!(\8QUS(%V#\Z -NBBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MP"15Q(9-I?)P>G;..>E<SX?\9>(KOPCX$:XO9<ZWJ$T-_J!4;E"R,$C'&%+
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MP$A<E<;_ # -P&,#C(QT]JVY]1U&'P1J^I/>75K?1Z3-/;Q22JY<I"KB=?\
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MY7!^[\PKS<:G#:^.M:?4#%)H$NKQK*Z-_JYOLT(C9_6/*NIQT;KD9QT?C)!
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M YKNJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MK(5;)W+D'/0@]L5>&K:K<ZJ^@3V^FB^^S/=2_,\D7DERD:X(!);#9/08Z'-
M'3JRNH92&!Z$'-+7F'@S6]8M_#OA;1-+LK%WN-&>Y62YF90IC>-2"%4\8?\
MSWZ&+Q7>MXCL],EM[=?MDUU H0ES"8@2I9P=K%E7)08*Y - '0:OIB:QIDMB
M]Q/;B0J1+ P#J58,",@@\@<$$$<$8J+3])DM9UN;S4;C4+A4*)),D:;%)!.
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MZ\#)C;YCQR.#SAP\7RGQ!!I4\46GW$PA:.WO 5:=64%_+?.TLA)!7D_*3W%
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M01.6DMV"RC:1M) 8#.,'@@\>HKG=;\6K;#Q!8V 9=1TO3_M8>6W=HLE9& [
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M,UQ($0$#.,DDG   Y))(  Y-9H\4Z*8H9/MRA9KG[&N48$3YQY;#&5;V.#0
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M0 4444 (PW*1DC(QD=JX#2_#&K#1?#>B7MOY9T2_6=KT2*4F2,/M*@'=N;<
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M3PF>0J9-S2@DIG&2 "0._-:MY=S7_CB?09;J>TMTTM;J!H)#&SR&1E9LCKL
M3CI\_(/%=']@L_M45U]D@^T1)Y<<OEC>B?W0<9 ]J;>:;8:CY?VVRMKGRR2G
MG1*^W/!QD<4 >=V-Q=Z[=?#W4-4DE6\N$N3(8G,8?$38< ' W#!X[''2M_QY
M&';PWNGFB0ZS"C>7*R @J_7!]0,5TLVFV%Q/#/-96TDT'$,CQ*6C_P!TD9'X
M4^[LK6_@\B\MH;F+<&\N:,.N0<@X/<4 >93S75@?$^JV6H7$3P>);5!&C#RY
M%=;1&##'S95CWXZBM2+5;W5=9O2NMPZ?=:?JX@:V>0DO"" J>5T/F*<ANN3P
M>,5V+Z'I$BRJ^E6+"9Q)(#;H=[CHQXY/O3FTC3&U)-2;3K0WR+L2Y,*^:J^@
M;&0* .9^) <Z7H@B=4D.NV(5F7< ?-&"1D9^F16%JU]J6A_$+4;N3RM4U'_A
M'9Y+,6\9C%N(VW;'3+$[VVX;=VP!WKT:]TRPU-$2_L;:[5#N59XED"GU&1Q1
M::;8:?O^Q65M;;_O^3$J;OK@<T <7#?WRWOAQK'4[BYMM7TZ:2Z=G#[2L:NL
MR9!"_,VT@#;\PXXK+LY=7;PCX/U)O$6IFXU>>R2YRZ;<-&Q;;\O!/&?4@5Z+
M!H^F6JRK;Z=:1+,")1' JAP>2#@<]3^=(=%THV\%N=,LO(MVWPQ^0NV-O51C
M /TH XN:ZO5;Q5I[:O>PS:%91/93R2C<P\HOYS\ 298%3D8^3H"2:AO]0UOS
M+9))[JVN?$&D(+2-7(%I?@ L!UP,/N.<\1-7>W.EZ?>7$=Q=6-M/-&,))+$K
M,HSG )&1SS5AXHY'C=XU9HSN1B,E3@C(]#@D?B: /.CXIO'\&2>(E>:V$*VM
ME<+(Q(A?S56YD.<YVAB-W."AHU6XU.RLI'M/$OF0RZIIZQ+;R>:8$EE5'4R-
MDL&Z@'I]"*]#^RV_D/!Y$7DR;B\>P;6W$ELCH<DDGUR:I1^'M%BL5LH](L$M
M%?S%@6V0('_O!<8S[T 9?B.XO/"W@#4KFRGN+RZL[=W2:X(DDZYW'  .T'/3
MHO-8FMWVH:;>7D.F:G<RV4^@7%Z)3)YC0RQ[=DBLV<!PQXZ?+D <UZ 54KM(
M&W&,8XQ5*+1=*@M9;6'3+..WE&V2)(%"./0C&"* *7A6WGCT.VNKC4+N\ENX
M8IF-PP(0F-<A< 8'?'/)KDK#7-4N]#\.:['<S&^O=5%I>V9;*!&=U=-G\)C"
MYR,'Y#G.37HD%O#:P)!;PQPPH-J1QJ%51Z #I4$>EZ?#>/>16-LEU(27G6)0
M[$\'+8R: /+;> '2]/B6\N/-/C&:,LTQ=T EG (W9P<=^]:$7B"]LI?[+NM1
M?[)_;\]A]KN9BK!!")$C:0<@EC@'KP!GFN^;0])>5I6TNR:1I?/+FW0DR?W\
MX^][]:'T/2);:XMI-+LF@N6WSQ-;H5E;U88PQ]S0!Q#+JSZEX?TE_%%Q+%<S
M7L4D]F5#%%0L@WD'<R9V[O;IG-0:]=ZWI5SK.CVEW?7-ZHBU/3R93EX$'[Z(
MD>\9'KF9.1V] 71],0VI73K0&T&+8B!?W(]$X^7\*M&*,S"8QH954H'QR%."
M1GTX'Y"@#A=6U>YG\,)X@T^_N8H+W4[+[.-W!@::.,C!Z!LLW&."*6YUG4]/
M\3M]ICN+BVFN94L9[6?=$[+$W^CRQ?PD%6(8 Y('(KLIM,L+BTBM)[&VEMHM
MOEPO$K(FWI@$8&.U)'I>GPW9NXK"U2Y8EC,L*AR2,$YQG.* ..\)ZG/J1TK6
M#XAMY+>YL6:[M3(7W28!+X/^JV'<"!QR!UQ7=1R)-$DL3J\;J&5U.0P/0@]Q
M5.'1-*MI+J2#3+*)[O(N62!5,V>N\@?-U/6K<,,5O!'!!&D4,:A$C10JJH&
M !T % #Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M7.L7#:J89KY[::"2&##6TL'*,,L0W/4$#BMW2+/4;6W;^U-26^NFQEXX/)0
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M@UAY9NDA/SC?R%1?XF"X8CC@CDGBIM.T5K?5[K5[R>.>_N(8[<M'$8T6-"Q
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M8:]Y%[I<LQM)S:!E\J0Y:.1-WS9XY!7[H( H E7QW)<#38[/P_?S75_!/+'
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MJI&0Q /0CO7EVGVMX]QI\\^BWMK;C0[VUFMWMBL5LY:-A'EN6&%8[B2&/3N
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M6U]&EX?#4S?:)(-__+6 CY<CGIW]: .\TO3;;1M+MM-LU9;6VC$42LY8JH&
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M.LD;J&5U.0P/0@]Q56UU73[VYEMK6]MYIX0#)''(&90> 2!VX//L:CU2-H-
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M[@IYY&#@D8..,UB>!_%PU+1M#M=2DN7U*]M6E$\D&U)F7[P!  R 0>!CTZ4
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M&L<?E.C3>2N<\A@?FR#R3CIT .W.@Z;]FU*W%L$BU)V>[",5,C,H5CD'(R%
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MPAHMA]@^S6TL?V!Y'M@+B3$9DSOP-V.<GCISQ3T\364C:@BQW'F6%S':S1[
M&\Q]NT 9Y!WJ<].?8TV3Q5ID6H6]J[R!;BY:TBGV_NVG&<QYSG.589QC((SG
MB@!$\(Z-'!;PI;S".WO&OHA]IE^6=B27^]SDLQP>.3Q6Y7&:IXFDGUWPRNF3
M7*V5YJ,D$D@C7R;A%BE)P3\W#(,'@'DC(KLZ "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH *X74O =S<3:M-:7T<+O=I?Z7E21:W&4:1CZAF3\G?UKN6)"DA2Q
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ME/:WX95549F1T*JW(WL",<C'-3VOAV]3Q'?W=P]L;2ZTN"QS$Q5PR&0E@NW
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MS"L!(/XB#CM7H%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0RZAJ#O9W2W@G9T,DLJ\ N2N,8XP !5:;P-837<D_P!OU%%>_741$DJA$G
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M:[L@^6"N>A( 8L!GB@#.T[Q=J]UINC7%S:6<<FM0QRVBP;Y3&/*,CEUXSVP
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M(=HNW&?[/@QG_KFM<)9WMY8V$^MSV=A?WT?B26TAED#(\?F7'D'#<\;2 !V
M'7%>CZ;81Z7I=KI\,DCQ6T2PHTA!;:HP,G'7'M6)_P (39G39+$ZA?\ EOJ
MU(MNCW";S/-X^3IOP<?TH BBUW6Y[N_TR.'3SJ>G6J3W !<Q2-(7\N-2<%<J
MF2QS@MT-4K7QKJ.M2VHT>SM$BN]&_M.)[IVRIW %&"CWQP??V._=^&[>YU9]
M3AN[NSNY;<6T[V[*/.C!)7<&4C().",'D\U%%X3L+:]BN;26XMA#I_\ 9T4,
M938D.01@%2<\#DF@#,T/Q=?ZE>^'S<V=M%::YI[7<(CD9GB951B&) !!#]NF
M.]7/%NH:G8W/A^+3IX8EO-36WF\R,ME?+=QT(P,ISZU)8^$+/3WT1HKN\(T:
MW:VME=D(*, "&^7)X5?3I5[6=$@UN.T$TT\+VERMU#) P#*X!7N",$,PZ=Z
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M:,KN9X^A;<#G)Y/J:AN_!=E>0:M#)>WH35+F.YGVM'D.@0+M^3@8C3UZ>YH
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MM]_KA#QUZ5/IVB:E;ZS<65_H*WEL-3?4+747N@8T#2&09C+;A(I8@$#'0Y%
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MYMB@5O,\W&=FS&[=CG&,XYZ52\8Z?J-]I%O)I4:37=E>0WBV[N$$XC;)3<>
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MB:-I2RL,Y.1(.F1UYK$T_P ,7MUX2\0Z2+A9HX[:YTG29,](?FQD^H)6,_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M1GM[O3R[,SJ&=1%Y6<*0 K!@,X!)R":W?%6JR66I>'K$S-;6FHWQ@N+A6VD
M1NRH&_A+LJC(YZ@=: -;3-7M-7-Y]D:0_9+EK67?&4(D4 D8/.,,.:DU+2K#
M6+3[+J5G!=V^X/Y4\8==P.0<&O-;&YDTR6\%K?S ?\)DL$K&8DM&\<8*L>_8
M9//'7-3MXGN(;R[MI-3"V+^)'LFN))B%AC^S*ZIO!RH,G&<]\9H ]- "J
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M&')!YRHQ_C6*E_>7>I:A9CQ$MC>:3?Q0HEQ(6>6$*F-T8P)/,RWS8SD\= *
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M6+7C7ALK<W3+L,QB7>5]-V,XKF6\>6T%OJ[W,,*G3)+=)9(KCS(<3$ ,7VC
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ML&.T].0>N* .AN+.UO/+^TVT,_E.)(_-0-L<=&&>A]ZK#1-)"JHTNR"K)YH
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M+0W4 N3TA,@WGC/W>O3FJUGJ(_LPW>H7-C&HD=3)#/NB #D+\QQS@#(['(H
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M(Z3>7.G7>GR20!EW37 $*..SL,[??O5J2_M(9X[>:Z@CGDQMB:0!FSTP#R:
M.*@T>YUGQ%XULI9);?3M0D@C<M:L#+']G1'\MS@=F4G!Q5R\\"O<7=U)#K$D
M$,U];7R1^0K&-X=FU=QZIA!A>Q)Z]*WM?URV\/:2]_<J\GSI%%#'C?+(Y"HB
MY[DD?SJ%K[6X#:M/IEJR32JDOD7+,8 >YR@W#/<8Z],4 9EK96^L^-EUM;.^
MMSI\+VKM<1&(7$FXA6 /W@H,F&Z?O>.AP7?@N2[L]:MO[2"KJE_%>L?L^3&4
M\O"CYN1^Z3]?48NZ%XD74-)N;W4OLUCY%]<6AS-\F8Y&3.YL==N:UUO[-FC5
M;N F2/S$ D'S)_>'J/>@#F]2\$C5+G5YYM1>-]0%LT;P1[6MY("6C=22<\G)
M!%27'A?4+ZQM(]0UUKFZ@O(;LS&V"J?*;<JA%( !/4Y)/MQC=?5-/CMDN7OK
M98)#A)6F4*WT.<&G2ZA902PQ37EO')/@1(\J@R?[H)Y_"@#G+GP6]Q)J$HU/
M9+=:G!J<;"#(BDB"* 06^8$1CTY)K=U;2+;6]#NM)OMTEO=0F&4@@,01C([
M]ZFU"_M=*TZXO[V98;6WC,DLC=%4#)J'2KR[O[5;JXM!:)( T<+/ND /3?V4
MX_A&<>M &1)X4FNXP^H:D+F[BL);&"?[/MV+(%#NPW'<YVKSP.#QS3].\+O8
M:GI-X;X2?V=IIT\)Y./,4E#N)W<']VOZ_A+XK\2KX9TP7"VYN9V=%6(-C"EU
M4N3V W#\2!WK>H QM8T.74]3TN_@OWM9+!Y"%\L2*X==IX/1@.C<XR>#FG^&
M=$_X1SP_::2+I[E;9=B2.@4[<\# JIK_ (GBTW1C?Z<UI?;+FWAD59P=@EE6
M//RYY^;...E:\>I6,MO+<1WML\$3%9)5E4JA'4$YP"* .5_X0.6.(6=OK3Q:
M;'J:ZE!;FW#-$XD\PH'SRA8DXQD9ZFI8/!$T&HVER-:E9;74IK^)# I8^:KA
ME9NK8#D ]@ ,'C&CKGB(:?IME>V M[R&XO[>T9UFX422K&2, Y(STR*ETK69
M[_7]<TV6WCC73I(D1T<L9 \8?)X&.O3]: ,L>"Y!8QVW]IKE-8.K;OL_5S(9
M-F-W3)/OBG6UE;ZUXW&MK9WMM_9\4EJ[7$31+</N(5E!^\%!DPW3][QT..AN
M=3L+(L+J^MH"H#-YLJK@$X!.3W/%.N;^SL]GVJ[@@\PX3S9 NX^V>O44 0ZU
MI<6N:%?Z5.[QQ7EN\#NF-RAE()&>_-8=_P"#6U:SN%U#4F-W)8-813V\/EB)
M&(+':6;)8JN><8& !DYV6UW35UU=%-W%_:#0F;R=XR%R ./4Y.![&K=Q>6MH
M ;FYAA!!(\QPN0!D]?0 F@#G+?PG>VU[?WJZUF>]2W613:+Y?[K/&T'[K*2N
M,]SSTQ';^!H;-=.6UND@2SU-]2\J.#$>]D9"B+N^1<.3CGGGVKHCJFGK;Q7!
MOK402@M'*9EVN "20<X. "?PI3J=@)8(C?6WF7 #0IYJYD!Z%1GD?2@#'LO"
MP@\00:S<W,<UY#!);B6.#RWE1BI E;)W[=HQTZDU9UO0Y=4O=+OK:]^R7>GR
MNZ,8A(K*Z%&4C(['@YX([U8@U$"ZNH[NYL$47 AMQ'/ECE5.UP<8?)/ SQBK
M0O;5DF<7,)2 D2L)!B,CKN]/QH X&;P]=Z'J_A6SM+J>X\O4;VY>Y>T+I$)4
ME.'VX !9\9R.M=IHVD1Z1!<*LAEFNKA[JXEQMWR-UP.P   '/ ')/-8UOXJF
MOYO$,5H=- TV2)()Y+H^3('0,2S ?+C.,#/(KHIKZTMYXH)[J"*:4XCC>0*S
MGV!ZT <[J7@B'4Y];,M_,D.JF&4HB*&AFB"A)%;VV*<8ZY]:T[#17AU:35KZ
MX2YOVMEM0\<7EHL88MPN6Y).2<]AP.]]K^S2\6S:[@6Z<96 R .1ZA>M2RRQ
MPQ-+*ZQQJ,LS'  ]2: ,K4M#>]U[3-6AO&MYK%)H]OEAQ(DFPD'/3E%Y^OU&
M58^"WLH-"B_M)9%TFZFN5S;X\WS!("#\W&!*WZ?CTBZE8O;K<)>V[0.X19!*
MI5FSC .<9SQBI+>Y@NX%GMIHYH7^[)&P96[<$4 <_P"'?"UUX?*6RZW<7&E6
MY;[)9O$H,2G.%9QRZJ"< XQQUP*M:_X?;6+C3;VVO&LM0TZ8RV\WE^8N&4JZ
M,N1E2#Z@\#FM!-5TZ5)GCO[5U@YE*S*1'_O<\=.]<=%\0O,L+#4_^)>+#4VC
MCMB;G$D,CN!B1>X"'><$8^[W#4 6XO ]Q#,EPFN2?:%U.34>;=3&6="C+MSV
M!R#G@^M4[WP^MCX83P>&U&]ENI9)K:\CM]JVK>;Y@=G PI0MN&>3M('85U.G
MZHQCA@U2:PAOY6;RXH;@,)4R=K*#@\@9QSCU-6VU&Q2Y:V:\MQ.BEVB,J[@H
M&22,YQB@"2UMHK.TAM8%V0PHL:+Z*!@"N:F\%12+JUF+PC2=5N?M-U:&++;S
M@N%?/"OM&00>IP1GC;T?6M/UZQ%[IMS'<6Y9E#HP/0D?KC(]B*Q-8\;6=KIF
MHW&ER6U[/I]Y%:W$1EQM+M&I(QG./,'IR",\4 -U#P6]_%K\9U((-8N(9WQ;
MY\KRU10!\W.1&OZ_AU:YVC<06QR0,5!#?V=Q%++!=P2QPL5D=) P0CJ"0>"/
M>G6MW;7L/G6EQ#<19*[XG#KD=1D4 <NGP^TQ(H(Q+-^XU)KZ,Y^ZK%LP#_IG
MAV&WW-7=1\,27VKZC?B^6/[;IO\ 9Q3R<[%RQW9W<G+G]*8_B'4G\77F@VNF
M6KM;V<=V)I;QDWAV90,",X.4/<U/H?BFRUC01JDQ6Q59I+>59Y% 21&*L W0
MC(.#W% %%?!4<DEJ+J\$UO%H[Z1)$(MOF1/MRV=W!^0?K^#$\'7[^&+S0[WQ
M%/=Q36;644CVZJ8XF&TEL'YWQ@;CCZ<G/22:E80Q)++>VR1NAD1VE4!E R6!
MSR,<YK,O?$#0:]H5E;I!/::IYQ^T++G 2,N-H P0?7- "V>@26WB)=7>\61A
M8)8F(0[00K%MV=QYR3Q3=:\.2:MJUK?1ZC);&*WFMGC\M7#))MR5S]UAMZ\\
M$C%2R:\IUO3[.U2*XL[F&XEENTF!6+R]G''!SO\ 7C%:5M>6MZC/:W,,ZJ<%
MHI P!].* .3M/ MUIC:;-IOB">VN;:PCTZXD^S(XN(8_N?*>%9<G#<]>0:OW
M/A".YO\ 4IC?3"WU'3ET^XA*AF8*) &WGG.)&SZD#W!VWU&QCN!;O>VZSE@H
MC:50V2"0,9SG )_"J]GJ2C2(+O4KFPB9QAGAGW0D\_=9L9Z?SH YM_ 5S<QR
M"\U^=W?26TO?! L6$)&&').>!GGGGH.*?+X&GG@UI)M9).K:<EA-LM554"AU
MW(H/'#GC/7UZ5I:EXE2QUO1K5#;/97YF\RZ,W^K\N,O],<=<U;N?$FCVDVG1
M2ZA;@ZBQ6V(D4B3"EB0<],#&?4@=Z +T"&TL8TE?>8HP&94(S@=0.?RKA_!'
MAZXO/"/AW^U))8QIQ:6*V:W:&1)2'4%BQR=H=L<#J#SBNWCOK2:Y>VBNH'N$
M!+1+("RXX.1U%5KS7=-L-4L]-N;N*.[O-WDQ,P!( Y/TS@>Y- '.:=X3D\,M
M8ZG)JES>+I-A-;"&*T4O-&2K]!DL^4&3_$?3G-C0-"C^SZY?013V?]L2L\<5
MPA#0H5Y^0XV[G,CXZ_/S@\5TB7UG)=M:)=0-<H,M") 7 ]UZ]Q4LLL<$32S2
M)'&HRSN< #W)H YNP\)2V$WA^1-05_[&L7LHP8/]8K!!N/S<']VO3W]>*,'@
M.YL+;2VT[79+6_L!-$+@6RLLL4C[V1T)YPV""",8K5U3Q*EE=Z']F-K<66HW
M36[W(FXC"Q2/D8X/^K(//%:O]J:?]B2]^W6WV1_NS^<NQOHV<4 9!\,3?VN-
M1_M-GD_LY[$^;%N+;FW%R01SGL !C@5#I7@]M*N-#FBU)BVEZ>=.8>2/WT64
M([G:?W8R>^3TK=EU33X(4FFOK:.)TWH[S*%9>N02>1[TZ34;&*989+VW25AD
M(TJAB.O3- %+Q!HK:Y:6T"W(M_(NX;H-Y>_)B<.!U'!*C/M63>>"Y+NVUF Z
MDJC5+^&^8_9\^6T?EX4?-R#Y2_K^'2-?V:7:6CW<"W+C*0F0!V'LO4U++-%;
MQ-+-(D<:#+.[  #W)H CNH9+BRE@614DDC*;RN0"1C.,_P!:YN+P=-;:=X=@
MMM5\NXT-/*AF-N&$D?E^60R[NN,'(/4=.U6]"\2IJTFMF4VL5OIUY]G6>.;<
MCIY2/N+< ??Q^%/UKQ3I^E:7;7B75M*MW<16\#"9=C%W"%LYY5<Y./2@#/M?
M!+VEGI5LNJM(-.U*745:2 9=G,A*G!&!^];GZ?2M;0]%;1Y-3=KD3_;KQ[LC
MR]NPL "O4Y'RC]:=INJEPEOJ4^GQWSN?*C@N WG1\[7 /(R!G'./4U<&HV)5
M6%[;E6D\H$2K@O\ W>O7VZT 8>I>%'U&\UR?[>(QJVG+I[+Y.?+0;_F!W<G]
MZWZ>G.??> 9KV*\B_MN2-+NVMH7'V=6VF$Y4J2>%/4KZ\Y%73XRM[*ZU\:OY
M%I;Z7<Q0)(),F7S(U=>H'S'>!C]>]=()HWM_.BDC:,KN5PWRD>N?3WH P)_"
MOVS6++4+V\2=[*X\^WD^SA9E^4@IY@/W"221CVZ5>U_1?[;LX(EN#;RV]U%=
M0R;-P#QMN&Y>,CU&1]:?;:M"FF6T^I7NGQ3/ )9#%< Q8XRRLV,KD]?>DG\0
MZ3;:A86,E] +B^4O;H)!\Z@?>'/0Y 'J3Q0!D:AX*348KF=]0DAU>:YBNDOH
M8P/*DB&U J$D;0"P().=[<\\%[X3OKZVLIV\03IK5G,9HK]8%VC<NUD\KIL(
M[9SGG-="NH63W,MLMY;M/$NZ2(2J60>I&<@4Q=6TUXI)5U"T:.(*TCB92$##
M*DG/ /;UH RO^$<N6U72=1EU5IKBP28,9(1^]:4 $\$!0-HP!^.>M6_#>BGP
M_HD6FFY^T"-Y'$FS9]]RY&,GNQJV^J:>EK'<O?6RV\O^KE,RA'^AS@U!;Z]I
M=UK-QI,%Y"][!&DDD:N"0'W8_'"D_0CUH Q;GP7)<V.KVO\ :2JNI:E'J#-]
MGR49#&0H^;D?N4_7U&$U+P7+J%WJ=T-5,,E[+:S +;Y56@.5# M\ZGN.*Z=[
MNVCF,+W$2RA#(49P&"CJV/3WJ%]5TZ.%9I-0M4B9#(':90"HZMG/0>M ',/X
M"D)FN$UJ9;[^TQJ=O.8%Q%+Y8C92HQN5ER,9'7KGDDO@.6:.]E.MS1ZA-J*:
MG!<Q0*H@F6,1\*2=RE0003T/XUU4^H6EO9K=275ND+@&.224*C9&1\W3FLGP
M_P")H=3\*VNM:B]M8K,TBG=,-@VNRC#'&>%S0!9MM-U.&.T\W6GFE68RW3&W
M4"==I78!_P LP#M/&3Q[FM:JLVIV%N5$U];1EE#+OE49!( (R>A) _$5:H *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH Y'Q3#/+XL\(S16MQ+%:WDLD\D4+.L:M Z D@?WF I
MNK60N/B%:7-Q823VD>CW,1D-LTB"1I(R%S@\E5;^7>NDN]6L+&=(+BZC29UW
M+%G+E?[VT<X]^E1)K^D226D<6HVTC7DC1V_ER!O-902P&/0 Y^E 'FVEV>H:
M?IGA]-6T?5[FPDT)-.FBM8F,D$H)W*Z<':RX&>GR#ZUZ)#8PVOA-+$6QBABL
M_*$$K^844)@*6.=V.F>:UJCGA2YMY(7+!)%*MM8@X/N.E 'EOA/2+>\TSP)J
M%GISQ?8M.9KZ;[*RB6-K?;LZ?O-SD,,9^Z?49DT71+K2_"W@N[32)4:PF7^U
M+=;8B8CRY$5BN-SA&?=@9ZY'2O1]+TVVT?3+;3K)62UMHQ%$C.6*J!@#)YX%
M6Z //I?"]YJ&F^*);5&MS<WZ:AI"2(5,<\:(=^T\KOE5L@XX)/>I/$%E>7_@
M9;F;39CJ=Y?6EY);I$9'AQ-&=O X*QI@^X/K7:W%]:VDD4<\Z))*2(X\Y9\=
M=J]3CVI;R]M=.LY+N]N(K>VB&7EE8*JCW)H XL6NH0>,5N+)+F:RGOF>[M+R
MU)2(^45\^&7 QD  H<_>.,5EZ)8ZEIT/ANZ?3[L6-EJ&H_:;<6[;X_-D<PRA
M,9( ;' .!)[&O0],U;3]:LQ>:9>P7=L25$D+AAD=1QT/M5R@#S >'YX[O2WD
MTZ62T?Q-/?1Q&W+?9[9H77YACY09"&P<?>Y P<.M]+NUM;A8!J>EW$>MWES9
MW$5BTB(K9QOBV_-&P9NF,'N*]#L=2LM329[*YCG2&5H9&0Y"NO5?PS5J@#*\
M/?:O^$8T\:C916MP+95EMHE.Q,#& .H&.W;I7 Z/H\JP^#4N='N MIJ=^\RR
M6C8BC?S_ "R>. 2\>/\ ZW'J=% ',>!;:6ST:]@EMI;8#4[QXHY(C'^[>=V0
M@$#@JP-<QK6GWQTOQC8?V7>2O=ZO;W,)2 NLL?\ H^<$=?\ 5OD=L<]1GTZB
M@#R_Q%I$\]IX_M[32;ADO;&W6T1+5@LL@C93MXZ@[?\ (K4U*WU'_A)Q>Z6E
MVZS7-I]JL;JT8P3(-O[Y),#RG09R">2G3)Y[RB@#EO'FBWNL:+:2:=&)KS3;
M^#4(H"P7SC$V2F3P"03C/?%:MGK:Z@(Q!8WZ.<>8MS:O#Y8[Y+  GM\N<GVY
MK4HH \TT^*^M$L]VD7P!U[4)OM"VS-);K(TI1U0C'SA\;B"%!.0.HAT"TU'2
M[?P;<76DZ@%L?MUM.BP%G0R$;"57HIVXW=.G;FO4:* /*;33-4B\+:5Y,.HZ
M?JMLE^%1[(SPR*\P;R94 )PXVD,",;3S5B:PN[B_U#3]>\/ZG/#J<=M+ +)R
M88V6) 8G<']WLD4L&/\ >)'->G44 <WX\TBYUOP;>V-I'YTI:*40YQYH217*
M<\?,%(Y]:SK&U72?$.K:]IVF7<6E-I\6^S@M2CSW 9B62(X^8(5!/&<@<X-=
MK10!Y]XW\.>(;W3=4N+#48I5NGM]MH; M*J+(A"A_,Z [G/R]S78WT,C>';F
M"Z#W<AM&240+L:8["#M&3M)YP,G&:T** /*K[3M9?P]J.GRPW.J6WFZ=]FNI
M+!H[B2-+@,\<BX&[8JYW8 .[')JW?VMS::IXCDMM#GFM9;[3I8]MJ^%";=\J
M(,;RA4' ZX'! Q7I5% 'E@L=2&D:A"^G:DSMXIM[Q3);Y9X?,B=GP@QP%8G
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M/.X!)R[G<QY]2:M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MKNT,[HKV\<7EA/,52=V<,<#!^[R.M;2_"&M6#Z,K+IOE:?K%W>D1S.,Q3"4
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ML67BCQ/>P7=YK%DVA,T^HVQ7SK5E)VPQ.@"#(+/C;D$9.: /6*S?$&LQ>'M
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0.CKGD9!Y'."#R:CUK6K^QU_2=*LK2VD.H).1+-*R[#&H/0*<CGU_P : -_
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MV[P.<Y(/3@G=O?%-]]LO$TK37O5L;M+::)4;?)D(SE6QM&T.#@]<'IQD ZH
M#H**X:R\5:C;OK+7WDRD:W_9UHD:-\N4C(SC)( +-QR3GIGB2X\6:];-9V[Z
M+")KG4S8Q2S2/$DBF)I%D"E2P'RD$'D8XSF@#M2,C!I#@#)P *X6_P#&.O:?
M!KQETO3C+HEG#=W 6Y<K(&1F=4.P?W#C/MZ\7)O$=]]JU;3KW3;.0)I7V^%!
M,Q62,EE,<F5Z\=0".: .N&UE!&".H(I:X>S\2ZDZZ3IVE:581+/H2ZA$'F94
MCQY8\L*%Z#?@?TQS)#XWN-3TVSDTNPW7L^E1:D875W'[S.V/*CC)5AN/3 X.
M> #M*0,I) ()!P<=J@L+B2[T^VN9K9[666)7>"0@M$Q&2IQW'2N,NO$\ND_\
M)+<VVC68GM=5M;:4K*5,_FK" [';RP$BC'MUH [ND+*N,D#)P,GJ:P]"UF\O
M]4UC3;^W@BN-/DC :!RRNDB;AU .1R#]*9XGO4M+K0%DT^WNEGU..)7E/,#E
M'(=1CDX!'48S0!T   P**X*V\7:E9:;J]_J?E-!!K$EF98XG9;:->-[*.2HP
M,^[9.!77Z/?'4M*@O#);2"7)62VDWQNNXA64^A&#^- %ZD# D@$$@X/M7*:[
MXKNM&U(QM:PM;K=6L&W?NDD69U0R?+G8%+8 8?-@X-<Y!K-_X6/B_4K33K6;
M2[76S)=KYI24(88-Q10N"1G=R>>: /3\ =**Y0>,8QXCNM,G:"W-JSM)!/N2
M9H%C+>='GAU)&,#IW/:FVOBRXD/AZ>[LXEL-?&("C$O"S1F1%?LVY0<D8P>.
M1S0!U@(89!!&<<4M>=^#]5?2=+T+3H;>(P:AJ^HVW7!BVR7$@('0CY,8]ZGG
M\5:Q=G21:K;0&77I],G!W-O$0EP1Z F/)'X4 =[@9SWHKE+?Q3?7U[;O8::]
MS8/?26<K*C!HPC,AEW$;2NY?NCG!!SU ZN@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#GU\*
MB'5]3U.VUG4H+C4O+\[9Y) V+M7;NC.,"HK?P/I=A!I:Z:]Q9S::9/)GC8,[
M"3F0/N!#;CR<CJ!C%1>+_%(T:P_T"XA-XEY;02(\3.H$DB*5W# 5]K;@">G;
MFM*+6+9;_51+JEM+%:O%&88XSO@9A@*Q!.YF)&  #R!S0!73PA8Q76FW$5S=
M))87$UT""G[Z64,)&?*\YWMTQC/&,"I4\+V/G:X\\D]S%K.!=02E=F/+$>%P
MH(^4 <DU:_MS3OLRS^>2K2-$JB-B[.N=RA,;B1@Y&.,&J<WC/PY;PPRR:S:!
M)X?M$9#[MT>0-PQVR1_D&@!^F^&X-/GLYI+NZO9+&!K>U:Y*DQ(VW/W5&20J
MC)R<#W.:S^!]%>*2-H7VR:D-2/S=)<Y('HIRV5_VV]:TGU[3$OELVNU$[EE0
M;3AV4995;&&8 '*@Y&#Q63:^+;+5[#3;RSOTLTNKXP(MU VZX 9EV(#C!. <
M\X[B@"?4_"D.H:VFKP:EJ&G7?E""9K.15$\8)(5PRGH2<,,$9/-6M/T"WTW6
M;W4H9[@O=QQ1/"Y4HJQ@A=ORYZ,>I-3/KNF1WJVCW:+,TODC(.TR8SLW8V[\
M?PYS[56'BS0&O%M5U6W:8W'V7:&SB7CY">@)S@>IX'- %[4[!-4TNZT^262*
M.YB:)WBQN"L,'&01G!]*PI_ ]I.+<?VEJ*>5I[::^QXQYT!QPWR<'CJN#6MX
M@UNV\.Z%=ZM=B1H;="Q6-2Q8]AQZGOT'>L*?QE#I_BN[MM1NX(-*33HKN)FB
M97!:216W9YP F>@QW]: -"R\*06%[97<>H7S36=@=/C+F,@QDJ<GY/O95?;C
MI5:+P1:0:#%HB:C?&P2T:S:*3RF$D9]<I]X9.",=>]:UWX@TFQ<)<WT:$HCD
MC)5%<[59B.%!.0"< X-1V?B"SO?$%_H\0E^T6*QF5FC8+E@3@'&. !SWS[&@
M#2MX([:VBMXEVQQ($09S@ 8%<ZW@BP,4J+>7JDZ@=2MW#)FUG9BS%/EY!+-D
M-NX)%:5YJ4=OK=G:G4((RT,LKVAC+2RA<?,I!X"\YX.<BCP_KMKXCTB+4K,2
M""4G;YB%20"0#R.XYH ETW28=-DNYE=YKF[D$MQ/)C<Y"A1T   50  /U)-1
MWVB17VM:=JCW-Q'-8"01)&5V-O #;LJ3T Z$5#;:S;>?J;2ZI;W$4%TL CAC
M.Z%BJ_NS@G>Q)SP.X&.*TK2\@OK87%M)OB+,N<$8*DJP(/((((_"@#!@\%6=
MO:Z;;K?WY33[][^+<8\F1RY(;Y.5_>/P,=>O J*P\"6FG3Z?+!JNIG^SC,+5
M6>,A%EY9?N9(S@@G)XY)'%:,'BS0+F[BM8-5MY)I96@15;(,BYRN>F>#QWP<
M59.N::-1CL#=H+B1F2-2" [J,LJMC!8#.5!R,'B@#&TGP)IVBS64EI>7H-M:
MFT<,8R+F+.0LHV?-MR<$8(R?6K/A_P )0>'BL<&I:C<6D(*VMI<RJT=LI[+A
M0QP.!N)P.!5^'7M+GO1:1WL9F*NZ@Y =4.&*D\,%)P<$X[TR+Q'I$K3JM\@:
M&,3.K J?+)PKJ"/F4G@$9!/2@ US1(M<M[:.2YN+:2VN4N89K<KN1USCA@01
M@D8(-)H>@P:#'>)!<W,PNKE[E_/8':[G+8P!P3D\YJ0:YIQC+B9\B4P^7Y+^
M9O"[B-F-V=ISTZ5%-XFT:".*22_C$<D23A\$A8W.$=B!\JD\ M@=?2@#(U#3
MKVY^(]I=PM=V]NFES0-<Q1J5WM(C!3N!'12<XZ@?0NF\ :8\:Q075]:PG3WT
MZ6.&1<31,23N+*3NRS'(()SSFM*Z\5Z%9WSV,^IP+=1L$>(99E)!(! 'H#_D
MU:M]:TZZM[&X@N5DAOCBV=5)$O!;CCT!/T&: ,"711?:GI&F3:==O;:'*EQ'
MJ-PZ8F(C("KM.2<D9RH'R?2M.\\,V][JE]J#WEVDMY8BQ=4*;5C!8Y7*DYR[
M<DGK4NL^(+/1+C3H+D2E[^?R(O+C9@#M+$G /93QW_.IGUW3(KU;1[M%E:7R
M1D';YF,A-V-N_'\.<^U &8O@O3]UB)KBZGBM-.?3!%(4VR0.%#!L*"20B\@C
MI5>+P);KH-WHUQK.KW5K/;-:)YTJ%H(6X*J=G/  RVX\<&MO7;U-.T.\NWOX
M+#RXF(NKA-R1''!*Y&?IFJMYXKT+3'EAO=5MXYH(UDF7G**V<,0,X'!^@ZT
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M-2U$V2%VMK*253%;%LYV?+NP,G 8D#/2MNPM6LK""U>ZGNFB0(9YR#))CNQ
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MWRC4KN&\FVF/Y7BV; N4X'[M.N>GN:V;+5++47GCMIMTL#!9HF4H\9(R-RL
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M">JZ3;S"&:[M7A1ST!(P,^W8^U8-UHNJ:_?VE_/8G3IK;2KJT='D1O-DF"
M%"?D783DX/(XZUVB.LB*Z,&1@"K*<@CU%.H X31]*UB'4/"=Q<Z3+$NF:3-:
M7'[Z)BLA$(&,-SGRFZ>H]P,K3/#VOZ/9:#,^B/?B"RELKNR2[2-XR9-ZR*=V
MUAC@C.>GI7IS.J8W,%W' R<9/I5+2M8M-9@GFLS(4@N)+9_,C*$.APPP>>M
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MN%DD$BX4+G!R<#&.>/:FZ3J5Z]SX,O+6_GO(]8MG-^CR%E.(=_F =$(?"X7
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M %%%% !1110 4444 %%%% 'FSWD<7C#QE%>3:_-!;);/!%8RW+F/=$2VP(<
MDX.#Q5_P_P"*M0C\"Z+>WPAU"ZGM))9[L3JD*[#PK2 $>8<@8QR0W3%:L/AS
M4K37]9U6TU:V1]3\K<DED6\ORUVK@^8,\'N*H6GP^33(-+AT_598TM([A)?.
MB$AE,Y#/(.0$?.<'! !(Q0!.GC9KN2PCTW1Y[E[_ $K^U(=\R1C9E/E/)P?G
M'X_F,F3Q3;S>)_#FLQ23K;ZEHD\L-HTA_>2,\&Q N<;_ )B,@>O85K:/X-N=
M(ETN1=528Z?I)TM-UKC<N4(8X?MY:\?7GTH?\*UCET_2[*YU%98M.TU["(BW
M*ODE&64$/\KJ8D(Q[T =O;//);(]Q"L,K#+1J^_;[9P,UQVH>)EUWPOK_P!B
M&R.&RN\S0W)$L$L>0%=1@HQY(Y/ -=7IL%W:Z=!!?7BWEQ&H5[@1>7YF.Y7)
MY]<?I7-7/@8WD]Q=37T(O9K":Q:YBM-C2I)@9E^?YRH''3DDT )HGBF:.UAL
M+K2[HS1:.E_#Y;"5[E% # *.CY(P,G.X=.E4]?\ $O\ :GA/QA9*K6M[INEM
M.7MKHMM+1N5PRX(8%""/YYJ[<^")KI0#J[18T9M)WPP%6 ;!\P'=P<J./K4;
M^!KF:WUF.76(\ZKIB:?(([((D84.H9%W<#;(>,]>^.* 'V$DO_"PK-#-,8WT
M#>8S(Q3=YJ#<%S@''>G^*I[FV\5^$WM5FE=[BX0P),463_1Y"-P)QP><D$CM
MZ5H6OA^:#Q%;:L]ZC^3I_P!A,0@*[AN#;L[CCD#C!J;5-%DU'6M'U%+I8O[-
MEDD$9BW>87C9",[ACACZ\T 9]MXO:\TBVO(M-9'DFG@F$\P2*W>%F1@\@!'+
M+A>.<]J73_&<6H/X>9+)X[;7(&DAF=P-CJNXQD8^]C)'/.T^G-6U\$W5I+8R
MQ:R ]K>7=T0;7*-]H8LWREN&4D[6YP"<@Y-/C\"Q_P#"%:?X=FU&5C821O!=
MQH$=-C=AG@E<J3G^(_2@"Q-XMV10K'9J]U-#)<QQ&8A6B5L*V[:>7R"HQ]2*
MV-.U$ZIHMOJ,%M-$T\(D6"Y4QNI(^ZPP<'/!Z_C67K'AJYNM4LM4T?5/[+O+
M6%K8_P"CB:.6$D'84R.A ((/'/6MVUA:WMHXGF>9U&&ED^\Y[DXX_ <#M0!Y
MQ!K^JZM_P@^KRV["XO+FY_T:"Y(21?(E(# X'! Y()XSU.*Z*V\:PW5A:N+7
MRKZXFN(/LTLN C0.4DRX!X!  (!SN' YQ#IW@F?3DT"(:LLD6BS2R0AK;!=7
M1D"DANH#GGN<<"H_^$%NX88)K+7/LVI6U]<W<-R+4,FVX<M)&R%OF7)&.01@
M4 ='H>K?VWHT.H?9+BU9]P:"==KJRD@CW&1P>XP:Y2_\8F^\*:S?7/AZ]_LN
MVCN8YG2[6-V:*0QLH*L&'0G</0CTSV=C;S6UFD4]TUS.,EYF4#<Q.> .@]!Z
M?G7.-X,E?P;JWAY]27&H2W$AG%OC9YSL[#;OYP6..: )M9\81:0=5$=F]PND
M6<=Y>8D"D(^[ 3/WCA&)R0.G.>F'=Z]>:5XOUC4([&ZN8H]"MKR2U:Y $0#S
M;B,D@-M4<#J1VZU!K]O=7'BRX$D[V[+;PP*)="ENX;H#+D@QL!C<V-K$X*Y]
MZW'\,:AJAO[Z]O(8+K4](33YXDMR1$1O)8'?SS(W'L.3W )[/Q%>7WC)=.AM
MXO[..F17JRF0[R)&8#*X[;<8SWS[5+K>LZA8^)= TVTMH9(;^2;S7>0J0$C+
M8 VGV.?;'?-)I_AF6PUJSU%=0#>3IT>GS1^1@2A"2K [OEY8Y'.?:K6KZ(^I
M:II.H0WGV>;3I7<9CWAU="C#J,'!X/./0T 4%\9P-%87IM6_LJ_O/L4%V'R=
MY8HK,F.$9EP#DGD9 SQH>(]='AW2A?M:2W2F>*$I$R@@R2*@/)]6%9=EX)2T
MM+;3&O?,TBTOOMMO;&'#H0YD5"^[E5<Y'R@\ 9]=3Q)HKZ_I(L4NEML7$,^\
MQ;^8Y%D QD=2H_#- &3=^-)[.&X$NC2F]M(A-<V:3!W"EF"B/:"'8JN[;QU
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M4N+@0R>'EE55F=0K&20;E /RG '(QTJ[XC\'S:_>7TJZJ;>&]TQ].DC, DV
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MX2>3[1&#NB . ,YP03R,XQ2R>![EKAA'K(2T&KC5HXOLH+"0MN92V[E22<8
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MWX4@N#T.<=JU].UG5M987MB;%;&/4IK.:&8,)!'&[1E@P/WRR@A2,8.,YYH
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MCJFE+';E(6$EM(EN'4L2V'!"G. N#B@#TFHKBYM[2+S;F>.&/<J;Y'"C<Q
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M<8D<+O8]%&>I]JFKS/5-<_X2#3=*F@NH99H?$-K&J26SPR0''*RQL<A@2>F
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MQ/I4%P(I)W"?:1:&?RV\I9CP$+XP#DX],\9SQ6G<W,-G:RW-S*D4$*%Y)'.
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MCSV+W:7@D$I#I*H 4JPY4  <#^IIH\7:,%U%I)Y8?[/5))Q-;NAV/D(R@C+
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M7%M#+",8CDC#*,=.#Q0!R&N^%]1UM/$-VL<$-WJ&D?V7;Q-+P!ER7=@/5^
M>%]\"/7;&#5-7T2SM[^"+5X5-M?V\4@=OL;QYD5@.0"53:Q'4CUKN54*H50
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MZ[ ,\XKU.FE%9@Q4$CH2.E '->-[V>QLM+D#-'8/J4,>H2*2NR [N6(Z+OV
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M3R3%4\H.Y=53/!(  SUY(Q5O3/!46E6DMC%K.IOIXC>.UM9'0K:JP(PIVY.
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M+M5>XBTO^T&#Q/*9&.-D2A.03G[QR!D<&@#T/[?<?WA^5-;4ID0N\B*H&22
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M G@^V*6_^'2S:IJMY87T]@FJV?V2[A2$.K +M5ES]TXX_/H>:]0HH \L?X;
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MW&_*CRI/[C?E6[10!A>5)_<;\J/*D_N-^5;M% &%Y4G]QORH\J3^XWY5NT4
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M>GI6A7*6C*?BOJJ[AG^Q;3C/_3:X_P 175T 4=7UBQT.R6\U&=88#+'"&/\
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MG/X@CT-[>[M[^2W-RJ3QA08Q@$ALX)!(! R145Q:7$=I;Z5<7LEY)>79+RR
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MUK28XM7GFM-3TR]+I+>DRR.'C*%E! C?#. J\@<=L  ]+:_3S+,0Q2W$=TQ
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M0%MJEN#ANO%=CX;>ZC\3>(K(3RSZ7 \#6S22&0QR,A,D88DD@?(V,\;_ $H
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ML&5/DGG(()Z8Y.=J^M2ZY-X3U&VMU33I=;"0S"<[W4+*,E,8VL5R.2>!QR<
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MFVGS(\;E*L&!Y!'515&6V&B/=:[=QW6IWTL<5NPL[?)$88X"1Y/&7+$Y/Y
M0ZSXH2#5M/T?3[RP6\OX99HI;AM\8"A=HP&!.XN,8/0'K6K9ZO:RM%:7%[9?
MVEL_>P0S!L.H^<+G!(!]L^N* *?A'0H_#^@K;1Q-"99'G:)FW&(,?ECS_L+M
M3CCY:GU70QJ6J:7J*7<MM/I[R%=BJP=77:RG(^G-/@\1Z)<R/'!K%A*Z1M*X
M2X0E45MK,<'H&X)]:M66H6>HQ/)974-PB.4<Q.&VL.H..A]J .>@\%^1;:?
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MHP/2NHO[^VTO3[B^O)1%;6Z&21SV45F6WB&UOYM-EM=1T];:YMGG>&20&8@
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M**GRGV"*1GN*Z/I7,Q>*HKCQI%I-M<V4UBVG2WCRQOED97C49.<;2')Z=NM
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M>"4"XYX(&>E=3X8MH<WNH1Z-=Z:]XR-*+V7?-*RKMW,-[  # '.>.G2N@HH
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M&EKM .UEC9#$X)^49;<">/F;G-=A>WUOIUG)=W4A2&/&]@I8C) ' !/<58H
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MBO0Z* (;6$6]G!"%5!'&J;5)(&!C )Y/XUPNIZ/J;KXUTR2PDNUUM-UC.,%
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M& [*%SGMFNE\V3^^WYU\\77FV?PT\%ZEJQ2[T*"Y.;2W'E3;]SD$N2P885N
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M_OM^='FR?WV_.F44 /\ -D_OM^='FR?WV_.F44 /\V3^^WYT>;)_?;\Z910
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MTQ%3^Q4E&KQ@'E)I-RF/']W>KRCT.*[6@ HHHH **** "BBB@ HHHH ****
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MEV '>I).#D>J@US4FH:GHM[XLU.SN8A'!KUJDL+P[C,'CMHV^;/R\-D8'44
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M,'702W^@_P"H_P!%:3CY_F^9<]!^7% 'H5%<!=^)]7CT'Q'JD-Q$TGAZ8PO
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MF@A5Y+=7A1CM 4@_,QY8'W-;&I>,]*TNXU&"=;QWTZ%)[KRK5V$<;;OGSCD
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M1CE]_HMCJ<HDNDE+")H3Y<[Q@HV-RD*1D' ZUROB;Q7=QZ7XNM-/6ZM+G1K
M2I=E5;<Y1G[Y&, =O7IQ6Y:>*]-E-W%,\\$EG;I<2^?"R;HVR ZY'S E6''.
M1TY% !?^#- U*29KFPR)[=;66-)I(XY(USM#(K!3C)P2,CL:FE\+Z1-<2S26
MSEIHTCF7SY-LRKPHD7=A\#CY@>.*ET[7K/4K^[L$$L5Y:JCRP3+A@CYVL,$@
M@X/0\$8.*J^(5UUIK,Z-.(X]EP)P45LMY3>4>1QA\?6@"M:Z#-J6JZAJ.NV=
MJJWEA'8/9I(9D**\K$DE5R#Y@XQQBIH?!/AZ'1;C2!I_F6-P%$B3322$A>5
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M"QLPP6_WL$C/8$^IJTZ+(A1U#*1@AAD&@#R/^UFDL[NV&LLOD^++6&/[/>,
ML$@A)4'.2A+28SQP<8QQ8EUA](OM0TXZA.-'B\1PV]Q-)<N[6\#VR/@R$EE0
MRX!)/&XCO7J1@A;.8D.3DY4?2@V\)5U,,95QA@5&&^OK0!QW@5[+^W/&$5E<
MI-&-31UQ-YGRFVA[Y/&00/3&.U5/$NI+I_BK6H9]0DMHIO#_ )EO&;AD#3!Y
M 3&,_?QL^[STKODCCB&(T5!Z*,>W]*1X8I65I(T<J" 64'&>M 'E5F]OK5['
M#J&O7T5M)X7M;O?'J,D>)<N&E!#=1@9[$CD$U:T/4+[4'@L?%UW/9.V@6\\+
M^<T!,AW>=)D$?O%_=_[N>V37:#P\I\5RZW)+%(KVD=LMNT/W C,P8-GKESV]
M*UY(8IMOFQ(^T[EW*#@^HH \LTZ6^U:\TR'7[Z\AN)O##7%S"EV\/[P.N'*J
M1M;')QCWKN?!-[-J7@70;RXF,T\VGP/+(3DLY0;B??.<UM-#$[;FC0MTR5&:
M<J*B[44*/0#% 'E$U]J"Z=K,#3R74LVCWUS8:E87;XDVD$>9'G,<JDJ 1QU'
M&,4^_P#$UP;J[FT/4FN[C_A%S/''%/Y@,P8995R07"\],],UZC'!#$SM'$B,
M_P!XJH!;Z^M$<$,( BB1 !@;5 XZT >8>);S0KSP)X@OM%UN6\@FL(@\?VGS
M8HFW<,=V2LC9Y!/.WD5TF@.MMX^\0:;#>336XM+2Y6.6X:7:[&4.1N)QD*G
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M+WG6<;QY7^JQ&(ACGGY5'7O^50_\(DJ6N@>3>LE]HD?E6]R8P0Z% C*Z9Y!
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M:,SVR)- ET6_>QRGDC(X4@C'!YYQV]IX6TZSU6/48U/GQRW,H/\ M3LI<_\
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M:RMQIH1++<+<QS2(R!NJ[@P)4_W2<>U:+:#IIO\ [:+=DN/LWV0,DKJ!%_=
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M!+(L9*122D"-6/OD>PR,XS5>R\6VUS=ZS%-;SP1Z;=K:[W0_O698R ,=R9
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M7+C<"DC(<X)'53WK2H Y>_\ #EW%>^']0TZ2.6?2C*LL<S%!<+*H$C9 .'W
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M[8ZG-=%_PD7EWVBV5UIUU;7&J+(55RA$)1-Q5R&/./3(]ZOQ:@/+9[N![/\
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M++^=2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MY)YSGCZTV#6K.U\,3JTR7M_+K5]:Z?'<W)*9,S8>1B?N(F#DGIP.2*]5=TC
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MJ01SL^V!8GW!XR2%(<(%& <GZU9\)ZS:/K^GO#?C[)=Z#*[J\I=VE1XSF9^
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MQ))1<9'))P20,\ 5':>"K&RM-)M8KR^\G2K@SVJLZ':=K*%/R\J%=AZ\]2:
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M\^P],UWH 4  8 X%946@6T/B :Q%-.DHM5LQ -HB$8.X #;GJ?6M:@ HHHH
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MC^\[L&VD]  "3@#GL-/PQ87MC?\ B.2[M6ACO-3-S 2ZG>ABC3/!..4/7U%
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M2Q26'DLC,3EAP/F;@'&>TH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+;00W0\@]*OUY9IGVWQ+K-A<ZG?W6EW<_A>&>>2U<1,&,C'=R.!WQ^!JG?\
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M9MH8@9P3@X_(UY[;ZWJVH7G@75&MV>ZO].GE>VBN2L4A,4;!F!P!@L>Q(]Z
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MV$MK-IFHR3I)=-+@Q".)GSCH =N>2.#TH J0>!+RPM=,;3M>^S:C8&=1<?9
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M:,*Q5=A.TXV\$9!)/.17J58TGA;2I-0FO0ES'+.V^9(;R:..5L 9:-6"L<
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MS2P6YMKJ[A,#(28^-SQLR= -VWID59&BVQU;PW<VNA7L5JVJ7%Y.+F-I'7?
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M1H@2=C*#AEY/!!')H PD\07T7C&*QU"2X@M+BY9+*6.-)+6Y3RS^[+@;DE#
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M&[74-[AD61WC96')*;V7G&X>AK6M] NU\37]_<S12VUWIT-DQ!(D)0R$L1C
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MCRW0CCG.),_A6-_PA=T=+OM!>>!]'NM0^VB3+"5%,HF:+;C!^8$!L\!NF1R
M=3J6HQ:7:K/+'+)OE2%$B7<S.[!5'H.2.20!W-9UOXKL+F -'%<?:#>/8BU*
MKYAF0$LO7;PH+9SC'>I?$NG:AJ>EI!IUS'#*L\<CK*6"31JP+1L5Y 8<<?3H
M37+Q^!]9L\W=C>Z=%>V^JR:A:((F6$I)'L>-P#D#!X(Z8'KP =)#XHM;B* 0
MVEZUW,TRK9F,+*/*.V0G<0N 2!G.#N&"<U4N?'>D6VFK>E+EE^RB\DB**DL4
M62,LKLIS\K<#).TX!XJ&_P!"\0RZAI>MVM[8?VM;)+#/#*CBWDBD*DJ",L"I
M12#W.>F<!+C0/$5OKR:OIU_I\DUQ:I;7T=W"VPE&=E>/:<C'F,-I/(QSGF@!
MUW\0M)MA=O%:ZC=Q6D$5U-+;6VY5AD4L),DC*X4D]_0'!Q;T_P 3_P!I>*9]
M+M[.1K2.R@NTNPR[767?@XW9Q\G'&<YZ#!/.Q0W=YXT\6Z7:W%I))-IMG!++
M*V&4E95+[%'S=<E>.W/-;ND^&)M%\0I<VDT1TX:9;V!CD!\P>27VD'IR'Y^G
MOP :M]K$-G>1V20375Y)$TRV\&W=Y:D L2Q  RP'7G/'0XR)/'FEF'3Y+2WO
M[TZA#++;I;6^YF\OAU()&&!XP>XJQJ&BW@\5VOB#3GA:5;1[.>WG8JKQE@ZL
M& .&# ]CD'M6=IO@ZYTO4M"FAF@>*Q^V/<%B5:22X8.Q48( !Z GI0!O:WKE
MKH&C/JEY'.;="@811[F&X@#CZD5FW7C6QLK=Y+BSO8I8XWE>VD5$E6-6(WX9
MAD'!P 23CI5KQ;I%SKWANYTVT>))9FC(>4D* KJW8'^[C\:I:KHNM_\ "20Z
MYHUQ8++):+:7=O>*S(55F964K@[@7<<\$'M0 L?B?2)-6:Z%_=BW&D"_RPQ;
M>03GS!QG?_3MFG1^.=':XN[>5I8)[>&.;RVVL9$=MB[=C,"2^%P<')''-84N
MG0>+=>U&WAOUN+670#837L&,+,96!X' 8%2=M7[GPYXDUKPY-8:OJ6GQ7B>4
M]M/9PM@RQNLBR.&]T'RCCD\GC !9U;QF;"VD,>D7IN8K^VLY(I0BX\YU 8-N
MVL,-C@G!X..36]?:C%INE3:A=)*L<4?F.BKO?Z #.3VXK U'1/$&M:"(K^YT
M]-0CNK:YB2%7\@&&59,$GYOFQC.....I.MKMCJ.H^'+FSL;U;2_EC 6=00H;
M(ST.0#R,@Y&?6@"A<^-=.LK74)KJVO8WT^XBM[B'RP[JTNW8?E8@@[QT-,G\
M<6%K:ZC/<66H1'3I8X[F-XU#(LF-DGWL;#GKG(YR!@UC7'@?59;?6HXWTN%=
M2FLYEBB5U6(PE"1TYSLZXYSGC&#H7MI9Z3?>(-1\13VD>EZRD%KL+,3D(R%3
M\O.[<>E '2Q7Z3:E/8K%)O@C21Y.-GS9PN<YS\I.,=,>HJK-K]O'J<EA'!//
M+"T2S&(*1%YAPI8%@<=R0" /H:J^#=+GTGPU:Q7DTLUY(H>:288<_*%4,/4(
MJ*?<&J6M>%9]6UZ'44%M;W%O-$]O?Q.R7$<:D%XF &)%;###' W'CB@"Y'XO
MT]X8)?)NE674FTSE5^2=6*D'#=,J>1FI1XEM)KN&"*&[:&XN)+6.\CC#1>:F
M[<.N1@JPR1MR.M8#>#]9$WDQ75@+1-=.K1LRN9"&<NR$=!@L0#DY]L<Z&@Z%
MKNA3S6,=[9R:*+F6X@RC?: '<N8B?NXW,?FY..,#J "AX,\5M+INDV6I_;9K
MJ]GNHHKR5!LD>.20[,YSG8OICC&<C%=S7$Z;X1U.SMO#D4DMHQTK4+B[D*NW
MSK()1@?+U'G?^.^_';4 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%>57-Q&_BRSN(K6XAEB
M\1217&;>1Y3&89%W&3&/+;Y=J#C&#GCBEH.EV=UI_A^XTP'^VX-<G65T9BZV
MHN)?,5O2,I^&XCN: /8OYUA:7X@GU>T:>WTQ\QZC+93(TR@QB-RC2>_(Z#UK
MSOP_IEI<6/AVZTL'^W(-;F$TB,Q=;43R^8K>D>SIVW$8Y-6H]ALK-\'<OC*:
M4'!XC::0[O\ =(*G/3I0!ZO4<LD5O%)-*Z1QHI9W8X"@<DDUYWH4]G/<F/4[
M&^;Q387MU))Y43J\B%GVG?C:T9C*A03C(4 9 KG[2..]AFBMK*4Q7OA:=/(^
MRR',ZE2JR.P_>2C)RQQS]: /7([V2XGM&M[?S;*XA,IN=X&W[NT;3R=P).>V
M/>KE>5JK?:=!;0(A#=GPW>1Q8B,8$Y$)C!! Y+!SSUPU2VL,%S_PC]SIT1AV
MZ=.FMHRE6QY0 6;//F>;C&>3\Q'&: /3Z*\K\)P6^FWG@BXCB,4TN@RI?N =
M[,JPE5D[Y!#@ ],$"O3+&]@U&P@O;9F:">,21ED*$J1D9! (_$4 6**** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!, '.!GUI:** "BBB
M@ HHHH ,8HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 9++'!&9)9$
MC1>K.P 'XTY6#*&4@J1D$=#7)^-VO(I-%N-,2.ZU&"[9X=.D.%NAY;!QNZ(5
M4DACP#QWJQX*NK1O!\5U%))L\R>29)(RC02&1FDCV<[0C$J!SP!UH Z,N@=4
M+*'8$A<\D#K_ #%.KR^P\2Z9JGQ,T2]&H*TMS97<2P_-^Z!>'RTQC&XX8D^O
M&< 5ZA0!&)HI2T<<R%\?PL"16;X?TFUT72CIUE>RW$:R22;Y&1F4R.SG[J@?
M>8GD5A>%X8H_B'XX98T5C/9Y( !Q]G7^N:AN-2N]"4_V7;69>_U\VK^:"!\P
M^]\O?*T =-H.BP^']+73[>>>:)9)) TY4L"[EV^Z ,98]JTZX2#QGJD-_+H>
MHP68U<:G'8QSPJP@9)(C,)-I.00JL-N[KCFB^\9:M92WMC]FLY+VRU2SM'<A
MUCEBN&4*P&258;B#R>F><XH [NBL'P[JU_?7VM:?J(MC<:;=+$);=&19%>))
M%.UB2"-^#SVK-\1^*K_1;V?RDM'@@FM(S%M9Y&660(Q9@<18W?*&!W8/X '8
M45Y_JWC#Q#8P^([Z"UTV2ST&["S1MO\ ,FA\N.1MISA6 <\D$'&,#J6ZGXS\
M06EMXAU&"UTV2RT.["RQL'$LT/EQR':<X5@'/4$'&,#J0#T*BN(N?%NK6E[X
MCN)(K'^RM"Q)* K^=-&;<2@+S@-D@<C&,]*M-K^LP:GINGRK8O)JUG++:R)&
MX6*9%5BCC=\RD-PPQTZ<T =;39)$BC:21U1%&69C@ >I-<IHWBB]U?1[6[CC
MMEG2SEEOH7R@BF0E/+W%OE&]9!DYX0FLF\\0W.KZ-XFTN^CMI4301>)+%"Z*
MV]900 Q.X QY##@Y_&@#T%9$>,2*ZM&1N# Y!'KFDBFBN(EEAD22-AE71@0?
MH16?H*+)X7TQ'4,C640*L,@C8*X'P5K&LZ3X9\&P21V+:7J48M(BBOYL,OEN
MZLW.&4[#D #'J: /4:*Y+1/$FHZF+:RG2UCU6*]F@U")4;;&D?.Y<MGY@T."
M?^>@XXJ?QG>ZC9Q:,NGW4<!N-5MX)2T9?<I;..&'''/J..* .BCGBF,@BE1S
M&VQPK [6P#@^AP1Q[U)7F5GJ>H>'KGQ)>6L=D;,>)88;B-D;>XE2VC)3! 7!
M<'G=GGIU/0+XCUN]OV?2M,2XL8-1:RN Q56"*VUY QD&"#D[=IR!UYH ZJ26
M.(9D=4!XRQQ2QRQRC,;JX]5.:X_XKHK_  PUW<@;$*D COO6LR\8V/Q.\-R2
MZ<FCPS1SP"6$JPO'*Y6%]N,!<%@6[\#'- 'HM(2%!)( '))KBK'Q=J=QJL-E
M)'9,;FPN;E&B5RD;Q.@V^9G$HPXR5QR/R9H7B?5=5D\/IJ=O8&UUW2GNQ'"C
M9B95C)!+$AE(DZ8&,8R>M ';131SQ++#(DD;C*NC @CV(I]>??"O5WU+PKI5
MG:R0K!I]E#%<I(A\TR,@8;1D83!^\0<G..F:Z?6=9DLM6TC2;81BZU*20+)*
MI946-"[' (R>@ R.I/;! -AW2-&>1E5%&69C@ >IIEO<P7<"SVT\<T+?=DC<
M,I^A%>=ZWKNIZII(M6:"WNK'Q):6%R5C9DF_?1.C ;@0I#*2I)[C/>NTN470
M]"O[FRM[-)UCDN7!(@BDEQDLQYV@D<DY^M &K17G]YXWU6UT[Q')'%:33:5'
M;31.\$D2R++D$%2Q/!4X.><BKTVO>)$G\26$$&GW&H:=;0W=JJQN%E63S/W9
M&[.[]V0&& <C@4 =E16'HFN_V[,D]E)%)IQM(I3($(8R.-VWKQA<$C&1N'-9
MWC#Q-?Z!%>36BVC+:Z>]YL=6D>0J3E<*1L7 ^^<C)]N0#K:*X74?%'B,W6O)
MI=MIA32[2"\5;C>6E5T=BF00 ?DX/0>ASQ$WB_Q!J)U%]&MM-6.VTRUU*);H
M.6=95D8QG! !^3KV]#G@ [LW$(F,)EC$H7>4W#=M]<>GO2PS17$*30R))$ZA
MD=&!5@>A!'45P=AJ"ZIXQ@UBU@2-KWPNERJ2#/WI P#8ZXSBI]!\27NJ:7I%
MEI=OI]I>3:)'J)1HF\E-V%2-%# A<YYSP .#G@ [BFR2)#$\LKJD: LSL<!0
M.I)["N*U[Q;J^BVLL\EO8B2WMK:::W0O,Q9W*R#<I C48^5F!W'/'!J*]U;5
M8KWQRTDEI=6NFV:-#:30'81Y+.5;YN<\@\<\= ,4 =VK*Z!T8,K#((.012UR
M-KX@O]1FFT_28[*&XLM-M[IQ-&Q1GE#%8U 8;5 0\\_>''%9]MXTU?6S:MI,
M-C!%=:)_::&Z1W9'# %"%89'49X]?8@'?45FZ%J3ZUX:T[5 BPO>VD=QM/S!
M"Z!L=L@9KD?#7B;59M+T&UN;F";4-7N+LK,\+!8TB9RWR[OF_A  (P#WQR >
M@45A^&M:GU=-2@O(DCN].O7LYC%D)(0%974') *NO&3@YY-4!XBU)-8U?1YE
MM%OH9(#8 1MB6*7C>1NR=I60'&,!,]\4 =717'7?BK4+/7[:T9+22";5%L"D
M:NS*K1%@YDSM5LC[F,X(.:K0Z_XNOM+UF^LK?27.GSW5O';^7(7F:)\#!W #
M(##'KB@#NJ0D*I9B !R2>U8NBZY_;LZSV4D,NFFTBE\P(0QD<;MO7C"[21C/
MS#FLV^N=0F\?MIC7$)TW^QWF:W:$G<3(%.3NP3QQQP,\<YH ZJ*6.>))89$D
MC<;E=&R&'J".M/KS'P=XBOM%\-^%;>]2V?3;C0GN$\I6\V,P1H3DDX;<&/
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M" Q5F)()&>$/&1DXYK)77/$,4446H6=I9SO>R0K(P\PRQ!"R.D*.6+$\%=W
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MN4V+CK@=<L,@].^.*?INOV1TXW#ZFUX)+V:"(BV9'+JS?N@@&25"D$XZ*2:
M%U?PGIVM7LEU<O=(\UFUE,(9RBRPDD[6 ]"21]3G(XJ$>"].$5Y']HO"MY8I
MI\VZ4,3"H8 9(R#\[\_[7L,6'\7:'':P7#7I$<]R;1/W+[A,,YC9=N5;@\$
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M9?/O_,\DJF5^1=QR>W K0H **S[K6;:TUFPTJ59?M%\)&B(3Y/D&6R>W%:%
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MAA4C<3@_*<%A@<F0>YJM:> GLTTJ*+7KWR=(,GV%3'&3&K1L@5FVY8*&P.G
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MZIJ%UX:\;Z=>O,\=G%;-#]H6,2*' )#>6 O49'?FNHM?^2JZI_V!;3_T=<4
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MOZBN,FU_5;?6K%(]2:[MVUH:=,1!&L6/*.5Z;S(&7)(.WG'; U/!7^O\3_\
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M.Q5?;B@#L9/"^BRQ743V"&.[='G3>P$C+@*2,]@%QZ8'H*5_#.BRZRFL2:;
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MPH+?,,?-M'0$BN\HH XK7O"VN:\+A)KRP$%QI\]IY#H[I;NQ;;(G3+;2JDD
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MX+IO_B:/^$DMO^?#5O\ P73?_$UCP>*=1M])\.ZKJ$=K+9ZN;>.3R$9&MWF
MV=6;>NXA3T(SGFK>LZMK4&F:AJ.FK8>19^:X%RKDRB,89!M(VDLKC=S_  \&
M@"[_ ,));?\ /AJW_@NF_P#B:/\ A)+;_GPU;_P73?\ Q-9=[XOGMGU&<6R)
M;:6;5;M) 3(3+M+ $' V*ZGH<G(XZU<&HZY#XDBL9X;*2VNH)I81%N5X"A4#
MS&)(8'>.0!@^O6@"Q_PDEM_SX:M_X+IO_B:/^$DMO^?#5O\ P73?_$U3TKQ!
M<RP:V;J6PNVTV;RD>R.T2'8K;"I9BK;FV]>?;I2O>>([?6K&WF;3)+>XD8,D
M<;^:$5"2^2V!E@HZ<;P.>M %O_A)+;_GPU;_ ,%TW_Q-'_"26W_/AJW_ (+I
MO_B:IP:AXC_M2]TV6+37F%JEQ!+&'"1%G*[) 22W0D$;<X/ I;'6=4CM-0:_
M6SGN(KDVUJ+5619F" G[Q;@'<">VQJ +?_"26W_/AJW_ (+IO_B:/^$DMO\
MGPU;_P %TW_Q-5=,\22SZ=X:N[R.-!K5O'CRP0$G:(RXY/W2%8#N"!USQT=
M&-_PDEM_SX:M_P""Z;_XFC_A)+;_ )\-6_\ !=-_\36S10!C?\));?\ /AJW
M_@NF_P#B:/\ A)+;_GPU;_P73?\ Q-;-% &-_P ));?\^&K?^"Z;_P")H_X2
M2V_Y\-6_\%TW_P 36S10!C?\));?\^&K?^"Z;_XFC_A)+;_GPU;_ ,%TW_Q-
M;-% &-_PDEM_SX:M_P""Z;_XFC_A)+;_ )\-6_\ !=-_\36S10!C?\));?\
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MC_A)+;_GPU;_ ,%TW_Q-;-% &-_PDEM_SX:M_P""Z;_XFC_A)+;_ )\-6_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
L0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>exhibit1033-bochk_facili014.jpg
<TEXT>
begin 644 exhibit1033-bochk_facili014.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MY)4MU^7.2/:O7K;Q9HU[JRZ99W,ES<')S#!(\8QUS(%V#\Z -NBBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MP"15Q(9-I?)P>G;..>E<SX?\9>(KOPCX$:XO9<ZWJ$T-_J!4;E"R,$C'&%+
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MP$A<E<;_ # -P&,#C(QT]JVY]1U&'P1J^I/>75K?1Z3-/;Q22JY<I"KB=?\
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M_*;%_C1_8GB?_H;O_*;%_C0!TM%<U_8GB?\ Z&[_ ,IL7^-']B>)_P#H;O\
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MH \NT+O;')P.F?2@"6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M5);:VBN3(VW:ZNSJ,8.>J'KBM2O*)+.&[U=U\7220W<OAJSW%9FB9[A6F+[
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M 4HB1&:%_D!)PGWFZXQSTH ]>HH!R,BB@ HHHH **** "BBB@ HHHH ****
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M* /0**XC6_&&K:;-XC%MI]D\&B6L-VQ>9@TL;*[,H 7@X0X[?7/%K4?%5_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** ,G3_  _!IVNZGJ\=U<R3ZCY?G)(4
MV#8NU=N%!''O6=J7@BRU.[U"=[_4(1?RP3RQ0R($$L)78XRI.?D48S@XZ9YK
MIZ* .=M_!]I::S<7]O?:A%%<RBXGL5E'D22C'SD8W9. 3A@#CD&F2^"[*:RO
M;5KZ^"7>H+J,A#1Y$JLK #Y/NY1>/;K72T4 <[>^#K&__MO[1<W;#6(HXYP&
M0;-@PI3"\$>^:?-X2LKN]EN;ZXNKLS6#:?-',4VRQ,<L3A0022>A ] *WZ*
M.<L/"*V&GM:C6]7G("K#-/,K/ JL&"K\N#RHR6#$@8)K2TK1K;27O9(6=YKV
M?[1<2.%!=]JKG"@ <*.WOU-:-% &#!X7BM'N'MM3OXGN+YK]V!C/SLFPK@I@
MJ1C@]P#FK-GI::#X>>QTF'>T22O%&[A-\C%GY(&%RS'H,#/ XK5HH \^\*:)
MJME-;"*;7K5 NV[34%M"C?*1\K("[-NP022.N2>AVX_!5G!HFD:9!?W\0TF8
M2VEPK)YBD*RX.4VD;78<KWKIJ* .9L_!%C8RV+PWVH$65[/>PJ\B, \N_>#E
M<D?O'[YYZ]*5?!-DD$,:WU^KPZC)J4<H= RRR;]X^YC:?,?C&1G@BNEHH YV
MQ\'6>GZK/=V]]J"VLT[7+:<90;<2L<E@N-PR><;MN><56LO 5E8-IRP:EJ0M
M=-N6N;*U+QE(2592@.S<5P[#!)QV-=710!0U'2_[0DC?[9<0;$>-DC",LBOC
M(975@>@Q^/K6/%X&TVWCEBM[F\BBDTM-*\M60A8%W8QE2=WS-R2>M=/10!R-
MS\/=.N;>XMSJ.I)#<V<-G.B2(/,6+/EL?DX89[8![@U?G\)VMQ/JDTE]>E]3
MLDLI_F3_ %:A@"/EX;YWYYZ_2M^B@"@NDVXT'^QY&DEMOLWV9BY 9DV[>2 .
M<>@K/@\(V"VZ07LL^H1QV;V,8N=OR0L &4;%7DA5!)YX^N=^B@#$T#PU'H"!
M%U/4;Y43RH1>RA_)CX^5<*,]!RV3P.:+WPS;W>IW=\MY=V[WMNEM=)"RA98U
MW8Y*DJ?G894CKZX-;=% '/2>#]/^TSRV<UQ8I<VJ6EQ%;%0DL: JN05)!"DJ
M"I!Q]!AFH>"M/O9G:*YN[*.73QILL-JRJCP#=M'*DC;N;&".N#D5TE% '.+X
M.M$D>07]]N?35TPY:/\ U0S@_<^]\QY_2H1X&LHGMY+74=0MI([%=/E>)H_]
M(A4$*'!0C(R<,H!Y/-=310!EVF@VMKX8C\/EYIK-+7['F1AO,>W;@D <XXSB
MJ<.AQZ+;I>K]MU6YL+1H+2-S&'"8&57 5=S;5&3Z#GKGH** ,'PUI*V1U'4F
ML397.J7'VB6!F#-&, !202,G!8X.-SMR>M6K[0H;W6K+5A<W,%U:1R1*867#
MHY4E6!!XRBGC'3TXK4HH YNQ\%V-@FC)'>7KII#R/;AS&=WF!@P;Y.1ACTQU
MI^@^$+7P](!:W^H26<9;[-93S!HK;.>$X!Q@D#<3@'BNAHH Y*]TR^N?B/'=
MQ/>6UJ-*:W-S"J%=YD#;?F![#.<>V>U:%EX4L-.U+3[RTDN(A8V;644(92AC
M8JS;LC<22BG.>WN:W:* .>M?!^GV?EQ1S7)L8KLWD-DQ4Q12EBV5^7=@,2P&
M< _A5]=#L5\1/KH1A?/;"U9L_*4#%AQZ\GGTXK2HH P8?"\5M-=S6^I7\4EU
M??;G93']_9Y97!3&TJ!P<] <YJ.U\&Z=9SZ9+!+<)_9[W$D<8V;7:8DR%AM[
MECP, =JZ*B@#GM/\'V&G)9P1SW+V=A*TUE;2,I2W8A@-OR[B%#L &)QGV&&6
MW@NSM;?3(4OKXIIMY)>P[FCR9'W[MWR<C]X_IU]A7244 8MAX;M[+4;>_DNK
MF[N;:V:UADGV;EC8J2"54%ONKR<]/<YAU#PE:WNN'5XK^_L;B6)8;E;24(MR
MBDE0^03D9(#*0V#UKH** .>N/!VGSSZBR37,%MJ:JM[:Q%1%/A=O.5)4E0%.
MTC('KS3;[P98Z@-;62[O$36($@N$C* *B J GR<<$CO71T4 <UJ/@JPU22_>
M>\OA]OM([6X6.15#[-VQ_N\,-QZ?+Z@U'/X%L[N#5X[G4]2E.K0)!=NSQY8(
M, @!, D<<#'H!74T4 <Y>>#;2^&LB>^OC_:]JEK<X,8^10P&WY.#AF_.FS>"
M[635CJ,6I:E;R2Q)%=QP3*J7:H,+Y@V\''&5VG%=+10!RE]X"L+QM21-0U"U
MM=1F2XN+6!T\LRJ5.\;D)4G:N<'!QTK9US18-?T.XTFZGG2"X39(\14.1]2"
M/TK2HH YV\\'VE^VLM-?7O\ Q-[1+.YVF,?NU# ;?DX.';\_I6E>:/;ZAX?G
MT:Z>62VGMFMI&R Y4KM)R!C./:M"B@#GT\)P+=B[;4M0DG^P&P+N8^8R<Y^Y
M][/X>U5!X"LHO[,:SU35+.>PM%L1/;RHK30+]U),J0<=B ",GFNKHH PKCPK
M:74B":XN7M8YX;B.U8J41XMNPJ2NX?<4GYN>?4YCTGP?::-?/-:WVH?9#*TT
M>GO,#;Q.Q))48W8R2<$D G(&<5T-% &7K&@V>M&UDG,L5U9R>;:W4#;9(6Q@
MD$@@@C@@@@CJ*KCPO;2ZK_:5_<W%]/\ 9'LP)@@41.07&$49SM'7/MBMRB@#
ME;7P+:6VC76DMJVK3V<UL]I$DTZM]FB88*I\OIP"VX@< BK$W@S3KJ9FNYKF
MXC?33ICQ2%-KPGGG"@[O<$5T5% '*GP+;RZ)+I5UK6KW<<@15EGF1I(T5@P5
M3LQU49)!)P,FK&L>#K/6[JXGGO;Z(W6GG3[E874":([CSE3@@LQRN.N#D<5T
M5% &-9>&X++5XM36\NY9X[);+$C(59 =V3A0=V?0X]JE\1:%;^)=$N-)NYYX
MK>? D,!4,0"#C)![@5J44 8^N>'+?7["WM[FYNHI[:59[>\MW"312 $;@<8Y
M!((Q@@]*A7PK!]JTNZDU"_EN-/E>999'0F9W0HQ?Y?[IQA< =JWJ* .;O?!E
ME?QZU'+>WH76)(Y+@*T8VE%50%^3@851SGI4\WAB*74[S45U*_BN;J*")WC:
M,;1"Y="!LZY9LYR"&(Q6[10!GZ3HUMHXNS 6:2\N#<SNP +R%57.%  X5>@]
M^I)K&L? MEI]Q82P:EJ7_$O>8VJ-(A6-9>67[F2,\C.3QC)'%=310!S-KX'T
MZTM]'MQ=7DL.E+*D*2&,AUD4JP?Y.1@D<8IFG>![739]*>/5-3DBTHN+*"5X
MRL2,NTIG9N90.!DDCUKJ:* ,O6M!M-;%L\SS075I)YMK=6[!986Q@E20000<
M$$$$=14<_AVWU#3KFRU:YN-1BN(6A?S]BX4]<!%4 ].>O'%;%% '/OX2MI[:
M>.[O[VZEELFL!<2E/,2%OO 80#)P,D@G@5')X*TV=T^U375Q$--;2VBD*;7A
M;&<X4'=\HY!'2NDHH YJP\'1V-]:WAUG5+B>UM'LXFG:(XB8J<'$8R047DY/
M'.:6R\%V-A%H:6]Y>J=&B>&W;>F7C;;E'^7D?(O(P>.M=)10!S,?@FPAMX%C
MN[U;BWOI;Z"ZW)YD<DI8R ?+@JV]@00>#[#$TGA&RD^S-]INEEAO_P"T6E4I
MNFGVE<O\N,;3C QP!Z5T%% &!;^%8K1[B2WU._C>>\>\D.8R"SKM92"F"N,<
M>H'-6-*\/6^BBTBLKFY2UMH&A6VW#RV+-N+D8^]G/3  )XK7HH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MG_CHH V**Q_MUQ_ST_\ '11]NN/^>G_CHH V**Q_MUQ_ST_\=%'VZX_YZ?\
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M>HOKWAW3]26WD77=.^V1M#&4,+[2^WDG*[?QS5;XH"0ZSX)$+(LO]LQ["XR
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M<[=P!/4 C/3IQ4MMX(CBUVQU>XENKJYL8Y([=I(U!4/P06"@L ,@9Z GJ>:
M-^BI/(F_YY/_ -\FCR)O^>3_ /?)H CHJ3R)O^>3_P#?)H\B;_GD_P#WR: (
MZ*D\B;_GD_\ WR:/(F_YY/\ ]\F@".BI/(F_YY/_ -\FCR)O^>3_ /?)H CH
MJ3R)O^>3_P#?)H\B;_GD_P#WR: (Z*D\B;_GD_\ WR:/(F_YY/\ ]\F@".BI
M/(F_YY/_ -\FCR)O^>3_ /?)H CHJ3R)O^>3_P#?)H\B;_GD_P#WR: (Z*D\
MB;_GD_\ WR:/(F_YY/\ ]\F@".BI/(F_YY/_ -\FCR)O^>3_ /?)H CHJ3R)
MO^>3_P#?)H\B;_GD_P#WR: (Z*D\B;_GD_\ WR:/(F_YY/\ ]\F@".BI/(F_
MYY/_ -\FCR)O^>3_ /?)H CHJ3R)O^>3_P#?)H\B;_GD_P#WR: (Z*D\B;_G
MD_\ WR:/(F_YY/\ ]\F@".BI/(F_YY/_ -\FCR)O^>3_ /?)H CHJ3R)O^>3
M_P#?)H\B;_GD_P#WR: (Z*D\B;_GD_\ WR:/(F_YY/\ ]\F@".BI/(F_YY/_
M -\FCR)O^>3_ /?)H CHJ3R)O^>3_P#?)H\B;_GD_P#WR: (Z*D\B;_GD_\
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MAIT:RB:P,8E++A3O7<-I[\=:OT %%%5[ZY>SLI;A+6>Z9!D0P %WY[9('ZT
M6**** "BBB@ HHHH **** "BBLW1]:@UJ.[>&&:(VMU):2+* #O3&<8)XYH
MTJ*CFFBMXC+-(L:# +,<#DX'ZU1LM:@OM9U+2TAF2;3_ "C(S@;6$@)4K@GL
M.^* -*BBJ6L:I#HND7>IW,<KV]K$TTOE %@BC+'!(S@"@"[16'#XILGN=/@N
M8+JS;41FT:=%VS';NVAE) ;'.#@G'%;E !12,2J$A2Q SM'4^W-9^A:Q!K^C
M6^J6T<L<,^[:DH 888KS@D=1ZT :-%%% !1110 4444 %%1Q313AC%(KA6*,
M5.<,."/J*SM;\06FAZ9<WTRR3I:NB3)!M+(6( R"1_>!^AH U:*** "BBB@
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MZ_RI] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M!&ZX5>_3DDX[8R<Y^C>!=/TG4K>_EGFO9[73TTRV,X7$<"G(& .6/=O;H.:
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MT666%@'MIT5DW#/9E(.><,OO52[\$_8=-\1#2\RZIXAC%O/.R)&D8VE/,*J
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M0G;:FY?+4*"ORXR0!G(/MBIF\([==N-2MM8O[6.\*-?6D6SRKAU4+NY4LA(
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MV\*4WC*Y!VD]\>U)%X22UNX;RRU&XM[D626,TBJA\Z-/N,01@.N3@CU.0>,
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M8C@@_P )Z5L'7-3L[K7--GU?>]M?V<5O/) AE99@I:)54!2WW@I(P,Y;(!-
M'8WVIV6F+"U[<)")YD@BW?QR,<*H]R31:ZG97MU=VMM<)+-:.$N$7K&Q&0#[
MXKSV]U2^U+P^4OV9I+/Q7:VR%PH?8+B(C=L^7(W8X]*Z/P]_R._C#_KO:_\
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M(A)<2;0S;5 4LSG!.%4 DG )P!V-8E_J=U<>,X?#T%S)9HVG/>&:-5+NPD5
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MO5+I9&M[2)II1$NYMJC)P/I6-%XYTMKB[@GM[^U>WLS?*)[<CSX!U:, DG'
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M]]P=O^L;:%RWK\J@?A65?^*8=.N[:WFT^^+75U]EMRBQGS7YR0N_=M&"2<8
M&>E4(O%FG6$5[.[:I.IU@6#+)&&,<K! %0#GR_F&.IR3UH NV_@GPW:6%U8V
M^D01VMUQ-$I8!QG.WKPN?X1Q[5NI&J1",9*@;?F);CW)ZU@1>,-/>TN9I8;J
MWFMKU+![65%$IF?;L48)!W;U(.<8/.,&KNDZ];ZO=7]M%!<136,ODSK,H&U\
M!@ 02#\I4\=B* *UOX,\.VIC-OI4$9BC>.,KD%$?&Y0<\#CIV[8JQ#X;TB!K
M0QV:C['"UO;@NQ$<38!0 G&T@#CV'H*KZCKTUKXJTS0X[*9UO8)I3<*R80(4
M!P">V\$\?0'G&'X+\5M+IFD6.I_;9;N]DN8X[R5!LE>-Y#LSG.=BYZ8XQG(Q
M0!OV'A+0=,N;>XL]-BBEME=8&RQ\I6QE5!/RC@<#@=JVJYVS\::1?:O9Z="[
M[KY7:TERA2;8,MC#%AQR-P&1TKHJ "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K,\1:
M4VN>&M4TE)1$U[:2VXD(R%+*5!Q^-:=5-3O?[-TNZOO*,HMXFE9%(!8*,G&>
M^!0!SH\/:P^K?VA,]B6.D-I[*CN!O+;MW*GCM^OM5&P\)^(-$;2YM+O--,L6
MF0:;>Q7*.T;B'.R5",'/S-\IX.>O>M_2M?N-5M],NETBXCM-0C65)C(C>6K1
M[UW@'(STXSR16Y0!'"CQV\:._F.J@%R,;B!UP.F:XRV\,:Y;Z7XAT\-IFW6+
MNXG\UV=_)64!2"FT;\ >HS77WLUQ!;&2UM?M,N]1Y?F!."P#')] 2<=\8K*C
M\03W%]KMC:Z:\MUI8CV(9E7[073< #T7TYH R]*\'W?AJ]M)](N8KA$TR+3I
MDNV9=WE$E) 0#S\S K[CD8Y=H7@^;0-6TB2WFBDL[#2Y+%BQ(=V>1)"X&, 9
M3IG^+VYZ-]00R75M;A9KZW@69K8. ?FW; 3T&2C#/M5B!Y)+>)YHO*E9 7CW
M!MAQR,CKCUH XX^#+RY\,:KID]U!#<7&IOJ5M-%EQ&YF\Y P(&0& !]1Z5JV
M^@/=ZU=:MJT=OYL]@M@;>%BZ>7N9FRQ )W%L8QP!WS7044 </IWP_>RET2>7
M4FFN++=#=2%>;F ;3$A_W3%$??Y_[QJZF@ZY8>(M0GTZ^LAI>I3+<3+/$QF@
MDV*C>61P00H/S=#Z]*ZNB@##\/:1=Z5<:R]RT#+?7[7<?EL25!1%VG('/R9S
M[^W*>)M#&OVT-K-9V=Y: DR17+,A#8^5T=02K#GD>M;M% '%6WA+5K>;?+?0
MWC?V&-,,TSMO=\D[VX/'..N>,UG7_@/6[[0?[)>^L'A_L6/3T$JNP@E0$&1!
MP/G&W)/(QQFO1J* .4N/#NJ7&KZI?-)9_P"FZ0FG@!F&UU,AW=#Q^\/'M[\;
M>A64VF>'].L)RC2VMM' S1DE6*J%R,@=<9K0HH XV7PA>7$&LZ9--;G3=4U#
M[9)*"PE5<H6C"XQSLQNW=^G%3Z;H.N:5K%Y';WUDVC7-X]Y^\B8W$3.V]XU_
MA*EB3D\C<>O%=710!7OXI9]/N(8=GFR1LB[R0,D8YP#7*6_A;5K.P\)"":R-
MWH4'V9Q(7V2H8A&6! R#\H./PSWKLZ* .(L?!^J6EAH-L]S9RMINJSW[L-R[
MUD,WR@8//[X_]\X[YIEYI]CH^AZ]9>([B%;?7+Z9X%AW,[,Z#"*,??&S(QWQ
M7=44 97AO3[G3= M8+Z8S7Y3S+J4]7E;EC],\#V J#4=(N[KQ9I&K0M!Y%C#
M<1NCL0S&79TP".-GZ^W.Y10!P]EX2UJSTS2+/[58R16ES<R7-O)O:*82NSJ2
M,#)0L?E/!ZY!QA-&\(:OHD?AV1)[&YFTFUN+1HR7C5TD9"&#88Y'ECC'?VY[
MFB@#C[;P?<V-UH$D$\,@L;NZO+IFRIE></NV@ X ,A(!/0 >]2^%M!US0(H-
M+N+ZRFTFR!2U=(F%P\?(1'S\HV@CD=<#ISGJZ* ,7Q=I%SK_ (4U'2;5XHY;
MN(Q!Y2=JY[\ Y^E5'T74[?Q-/KEBUJ9+VS2VNK>9VVJT98HZL%R?OL"I SQR
M*Z6B@#D-!\'S>']6TI[>6*2QL=*.GDL2)'8NKE\8P.5Z9[^U;VOZ8=:\.:GI
M2R")KVTEMQ(1D*70KG'MFM&B@#DH?#^L#5X-0G>Q9DTAM/94=P-Y8,&&5/'R
M@?K[50T[PCX@T-=(FTR\TYI[?2X=,O(KE':.18L[)$(P0PW-P>#GKQFN\HH
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M.<$CMG!_*@"2BBD)"@DD #DDT +13(I8YXDEAD22-QE71@0P]013Z "BBB@
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M_*-R,CY>HQUJPO@'1TMK:W22]6.WL6T\!+@KOMS_  -CKCL>OKFI)/!&F2+
M!/?IY5C]@8I<$&6'LKGO@DD8QUQTXH S)?&US$VD?:1;V,>H6=M-%<3PNT,L
MLA^>(2!@(V QC=UW>U6[?Q'K>HWL<VFZ8D^FKJ,EE/N*JR(CM&TH8R=F7.W9
MD@]:NGP=IS6*6#37;6(@BMWMGE#)(D9RN<@G/J01GCT%+!X/TVUUN?4X);R/
MSYOM$MHMPPMWF_YZ&/INR ?3(!QF@"OXMO76]\/Z0IQ'J>H>5.?6)(WD9?\
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M;/VB)-VT,2"0?F;E2IYJ2X\*Z=+>/<P&:S>6V6TF6U8(LL*YVJ1@XP"0",,
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MLTJ]:2_AB6U_T-R9B+94PIV_-AP1Q]?>@#NQXFTQO%#>'Q.OVY(!,RDXZG
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M)7D"M(TI4!HU(^=5+*&.1CG@XKDO$<L\>F?$C9=W2_9Y(&A(N'!CS!&Q"G/
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MS&21R[L,CCYB<#MQ6NEU;RQ&6.>)XP=I=7! /IFG)+')'YB2(R<_,#D<=>:
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 5SGQ &?AUXES_ - RX_\ 1;5T=5-3TVUUC3+G3KU&>UN8S%*B
MN5W*1@C((/(H Y#_ (2#6-,N-2L9KG36\G1X[^UDF1HHXF+,FUR"2P^53D8)
MY]J5?%&M :_#%:2W<FGRVIB"P!9WAD +D1D\L &*C@] 1GKN7G@_1;\S&ZMY
M93-:"RDW7$G,0.0.O4'G/7/>DC\':1%-/.BW@GG\HR3&]E+L8SE&)+=1Z]QP
M>.* )O#.KQZWHPO([Q+I3+(F]8C$RX8C:Z-RK@8!'K[&L.?Q-J4'B*R@#VTU
MK<:L^GNL2$K&HB=A\YQF3<AR " ..#UZJPTZVTV&2.V0CS)&ED9B2SNW)8D]
MZR3X*T,W9N?L\X?[:;\ 74H59SG<P4-@9W'( P<G- &-#XFUN\U&SAMQ;I-)
MJL]G=6;P%VMX$WE920P/(5.3Q^\&!QS!'XIUZ'3M0U2ZFL7@M]3DTR.".V*D
ML;E84D+&3  !)*]_[P[&E^%M7BO@\L=W97'VIKB6>WUF5K9]TA=ML!XYR?E(
M YZGOTZ^%-&&E7^EO:F6RU"1Y;F*65W#NYRQR3D'//&,'D4 8EQK^O:7*+:^
MMD/VN^BMK&7]V)-KH[-O0/MR#&P4Y .X<<$%8M>UV+4=/T34(X(+R^NYUBN
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MU@E9]H\J-"IRJ]TZ^_:NAH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH KB\A:^:S0EID0.X7H@.<9^N#CZ&B\O(K"
MU>YGW"&/F1P,A%[L?8=SVK@5U'4+#P[X_P!2@#G4(-2FP57<R(L404@>T>&
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MD\G[/<W=QY+7!M[5 \GEJ0&;!(SRPX&2>P.*T//B"Q%FVF7A%88+'!.,'G.
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MAGL54X['ZT >KT5YIH.JR:K<6U]+XH6VU.">XCO=,"NS\;P4:,R8 7 8,$'
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M-HC)IT:VFK)/)'(UP0T*1==Z[.N.V>#QGO2VWC.\O$M[FWT.:2QNK-[J&?\
M>*$PH95D)CP-RG@J6Y&.>#0!UD-O#;)L@ACB3.=J*%&?PJ)M/LG+E[.W8N<N
M3$IW'U/'-<I8^.Y72QN=3TU+2SO='?5HI([@RLJQJC.K+M&.) 003G'.*6Y\
M:ZC:V6H7;Z!*8+;37U!)2TB(VP9:)F:,8;'((R#STQR =6;&T+%C:P;CM!/E
MC)V_=_+MZ4L=G:PSO/%;0I-)]^18P&;ZGJ:YN;Q-J]M9Q7%SI%K")E>2)FO<
MKM"*RJ?DSYC$L-J@XVDY/&:$.HQZSXO\%ZO%&T2ZAH]U/L)R0&%NP!]<;C0!
MMZWX>N=4U*"\@O;=1'$8FM[RS%S$03G<!N4JW &<XP!Q5S3-"L=-M8XDMX&9
M':0.(57#,<DJ ,*,]A^IYKG/$#7L'Q&T:33+6&XNWTN\ 2:<Q(<208W,%8\9
M/0'K^-*OCN>;0(=3CTI8B8KDSQW%R%"30MM:%2 2S$AL$#&%S[4 =H$4.7"C
M<0 6QR0,X'ZG\Z@^PVGFRR_98/,F&V5_+&7'HQ[CZURTOC._FGCBT[2(9O-T
MA=51I[LQ_*<?(<(<'\_PK('B6W/C73=5AB'GZOX?C:TM7DVF61W#*A/0<=3C
MH._2@#T!+"SC=&2T@5H_N%8P"OT]*DDMX9G1Y88W>,DHS*"5SUQZ5S=UJ3P>
M+X()=*MVOAI$]PDZW+<!9(PT7W.A)4[L=NE5]$\:76I3:,;O2DMK?5]-:^MV
MCN#*ZE A967:.T@P03G'('2@#I_[.L>/]#M^%V#]TO"],=.GM5";199=3@D^
MVB/2X0KC3XX%53*K$AR_7&<';ZJ#GJ*RM)\8W&JWNAQIIT2V^L6;WL4GV@EH
MD7;D,NW[W[Q>^,Y&>!EOC":\;6_#.GQP6\UI=WLBS132%5EVP2L%8;3E<@-W
MY X[T =3>0&ZLI[=9I(&EC9!+$</&2,;E/J.HKGM)\(_8KJUGO);"=[0Y@>W
MTY8),[2N7;<<\$]-O]*J:?K\6CZKIOAR/3EM[62XGM(5-T9)(A&C2*S#G"L$
M. 6R!CCL-'2O$%_JZ6%Y:Z4KZ9?PO+%<?: #& ,Q[UQP'']W..] &U%8VD+[
MXK6"-]S-N2, Y;J?J<#--&G6(0(+.W" $;?*7&"<GMW(!KS^PN;:_D^'5[:6
M*V,4MS<A;=)"XC7[//QGC/(STJ?_ (2*\@M8/[*TVUM&N/$DEC<JT[,'8,Q9
M@=O&XJ<\< ]/0 [S[':[8E^S0[83NC&P80^H]#3!I]D-N+.W^5=J_NEX'H..
MG)KEE\26VFZIX@W:8L=W'?6UJ6BD9_M4DD:;"<+D84@$ '[IQFEG\;RZ?:O+
MJFF-8(M\MK]JN-Z6^QD++*69 0N1L.1@,1SCF@#JDL[6,1A+:%1&2R!4 VD]
MQZ&ECM+:&>6>*WB2:7_62*@#/]3WJK'J970#JES"HV0-.Z0/YH( )^5N-V0.
M#QFL"U\8WMS<VT2:7;LMSI)U5'%V<!./D/R=<LO/U].0#J8+2VM3(;>WBB,C
M;G\M NX^IQU-))96LTADEMH7D(VEFC!)'IFN7L/%FJWFC:=JDVCVUM;:@D4D
M4KWV5C5XBY+_ "@YW * ,YW#ITJ.T\;WFHPZ ;/2(C)JZ3X$MT5$3Q9R"=A)
M4D=<9]J .K2QLXW1X[6!6081EC *_3TZTZ:TMKAU>:WBD9?NET!(^F:XRW\7
MZGJ=QX5:VL[>&/49[J.ZB>8DAH5=2H;;R-RD@XR<#IS5RV\:/<SVMPFESMI$
M_FYO%23]RJ D.^4"[6VGHQQD>^ #IA9VHD,@MH0Y?S"VP9+8QNSZXXS4P10Y
M<*-Q !;') S@?J?SK@'U&XU?Q=X(U-K1(+:\2YEA(F+/L: LH=<  X(/!.#D
M>]=3J.LM;ZS9Z/:PI+?74,LX$CE$2-"H)) )R2Z@#'KZ4 :*6=M'<O<I;PK/
M(,/*J ,P]SU-(+&T$K2BU@$C.'9_+&2P& 2?7!(S[UQZ>.[V\>PMK#1HY+VY
MFN[66*:[V"&>W!W*6"'*G'##U''II^+-7U/2M)TZ:SB@$]QJ-I;RK)(<*))5
M5@#CWQG'0YQVH WX+:"V!$$$<08Y(C0+G\J2:TMKB6.6:WADDB.8W= 2A]03
MTKF;_P 926MCK&H0Z>D]GHTOE7I68A\JBO)Y8V\A0XZD9P>G=OQ%=)_A]>SQ
MY<9@DC*G!.94QC\#^M '4&TMC<?:#;Q&;_GIL&[\^M/DABFV>;&C[&W+N4':
M?4>AKD9?&UQIM]?V&LZ6MO=0I#+;"WG,R7"RR^4@SL!!#D C!ZY&:V-$UB\U
M*YO[>[TR6T^S,GES%7$<ZL,Y7>JG((((QZ<\T 7QIMB H%E; *=PQ$O!]>G6
MI%M+9+I[I;>);AQM:4( [#T)ZFN6O_&D\#W1M--2>.VU6+2F$DYC<R2!,/@*
M?ES(ON1D^Q6'Q5K%Q+K/D:!%+#I<\MO)LO0'D98DD7:"@'._!R1CWH ZB>SM
M;H@W%M#*5Z&1 V/SI4M;>*%H8X(DB;(**@"G/7BN.N?'TEO8:W.EA!<OI;VX
M/DW)V3)+C!5BO4$GV..M1:]XPU>STCQ-&EC;6^HZ7'"Z,)S(ACER WW!\PVM
MQC'3DT =E_9UD4V?8[?9M"[?*7&!T'3H,G\Z1M-L6)+65L<@ YB7D#\*Y[4_
M%MY9RWD%IH[WUU8K&;B& R,26&=J$1D$A<'YMN<@>]8OCK6I-7\'>($LK5&M
MK":.WEEDE*/YF49MJX_A#@<D9.X=N0#OX[.VBE\V.WA23&W>J ''IGTH:TMG
MG$[6\33#I(4!8?CUKF?B2!_P@MZ^TLR20,N#@Y\Y!_4C\:K7OC35M-;6+>ZT
M")K[3[5;Y(H;PLD]L20S!O+R'7:<KMY[&@#KDLK6.>2=+:%9I1B201@,X]SW
MIT%O!;(4@ACB4G)$:A1G\*HV&K?VC?R1VZ1R6:6\4OVE),AF?)"@8_N[6SGH
MR\5PWC'5-1O]%^(%C<QP"TT^U00%)#N!,>\$C').?7C '/6@#T:6TMIV9I;>
M&1F4*Q= 20#D ^V:2.SM8I/,CMH4?;MW+& <>F?2N9D\8R:==:I;:IIZPO9V
MT%Q#Y,QD\U9G:-%/RC:V]<$#<.>IK3T76;W4;Z^M;O2Y;5;?8T5QM<1S!@<@
M;U4Y4C!&.X/?@ U+>UM[.,QVUO% A)8K$@4$GJ<"B6SMIYXYY;>&26+_ %<C
MH"R?0]J\]98?^$_\7I+I-YJ,4=K9R)':LH:-F63<5RZD,V!RO/%6/"GB2_C\
M":)+)-%J,\HE2:ZGG*B-E+;8WRN]I.B?=SE2?J =U)9VLMQ'<26T+SQ_<D9
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MXTG69PF5+H#N5FY!&.ASS0!V$D,4VWS8T?8P9=R@X(Z$>]0#3;$  65L #N
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MFSSD^P &CHVF76G0,+W5;G4[AL S3HB84= %0 #J<GJ<]>@&BDB2QK)&ZNC
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M>;3K:XOI91+ [D-(J[QB($Y+952<YXS6V-6LKB:6UL[ZTEO45B(1*"05.#D
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M<<U_?C[?I\EK;QQOB*7,D60Q)DYP 0 1TX!H 30=%70=.DLX[AYU>XFN-SJ
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MAU*UNWB0,(;>='=R7\M0 #W?"YZ9H T[73[.S@@AM[:-$@C6.(!>551@ 'V
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MFPN,=,GTKJZSI?$&BP2I%+J]A'))LV(UP@+;_N8&>=W;UK1H **** "BBB@
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M- U.6^UZ]M-1N='BU"^CGA"0QLQ5851F*NI"[F&>@/RC/4BNRI&94&6.* .
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MB]K6&<(FZ-%CDP ,8)&3R0??-=[/X>TBYLFM+BPAF@:43,)!N+2#&')/)8
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MUM%<V[D%HI5#*2"".#Z$ _A5.3PUHLJ722:9;,EV%%PI3B4+PH8=P!P/2@#
MO]3UM?$7B2QL;M&:'3[26SBFV(JR2/*I ;;U;8H&[.#CM6GX2U9M4MKX3?;H
M[FWN?+FM;Y%$EL=BG9E>'4YW!N<AJOR:!I,TD\DMA!(]Q&L4S,N3(BG*@GN
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MDL89+6<YFCD7<)#QRV>2>!R?0>E67LK66Q-C);0O:-'Y1@9 4*8QMV],8[4
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MM1F>:\TBRGD>$0,TD*DF,=%^@R<>E2QZ'I<-T+F*QA24,'RJX&X+M#8Z9"@
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MW.,X.['&*L_\(UK-GK]S?Z9K$*PZA%$E\+FW+OOC7;YD9# !BN!@@C(!YZ4
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M+4%M6\R1?M:V;RQLA$<C8 RN[=@$@$@8!^AP]?%%K=:E!I;6U[;M>FXCMY7
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MN+^5'EI_<7\J ,&BM[RT_N+^5'EI_<7\J ,&MRW_ ./:+_<'\J=Y:?W%_*G
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M?:O*\[R\'.S.,_G33J5D-533#<)]N>%IQ!GYO+! +?3+#\ZY#6O$>I^&]3U
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M++:_]B_-_P"E$=7=7UF4>*=)T&VN#!]K2XDEG0*64QJA"#<",GS W(/ ]\T
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M5Z)&@(1![#+'/JQ]A3I=$TZ>\:[DM]TKNDC@NVUF3&QBN=I(P,$CC ]*T**
M,<^%]',90VAVFZ^V$>:_^OSGS.OWL\YIJ^$= 2[6Z72X!.MR;I7Y^64YW,.>
M,Y.<<'K6U10!D#POHP@6 69\M;K[8!YK\3YW>9U^]GG/KS5W4-.M-4M&M;V!
M9H20VUNS Y!!'(((!!'((JU10!F2^'M)N-,N=.N+*.>UNCF=)B9#*>,%F8DD
MC P2<C ]*FTO2;#1;(6FG6RP0 [MH)))]23R3P.3Z"KM% &=!H>FV]U]HCMO
MWF^20;G9E5G)+LJDX4G)R0!U/K56R\(:!ITUO-:Z9#');JZ0L<MY:MC*C).!
MP..@[8K;HH Q%T.+1X$?0M/M?/CQ'''<3NJ1Q$C<J'#;!@=%&.!Z54M/!.EM
MX9L='U:VBO1;.TRN<@I(S%B588(Y8CZ5TU% &+>^$M U&.SCNM+MW6R&VW !
M7RU[J,8^4]QT/>KG]CZ=_:D>I"TB%Y%#Y"2@8(3G"^F!DX],GUJ]10!3N=)L
M+O4+:_GM4DNK4,(93U4'!(]QD \]P#4-CH&EZ;*LEG:+$4W>6H8E8MQRVQ2<
M)D]=H&:TJ* *=_I-AJC6[7MJDQMI/-A+=4;!&1^!((Z'-5!X7T=8TC%H=J71
MO%'FOQ.3DR=?O9).?>M>B@#(@\+Z);:W+K,&FP1ZA*2SS*#RQ&"V.FXCC.,\
MFM>BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M<222IY3,&*E)&0\C_=S0!J4457OIKBWL9I;6U^U7"*3'!Y@3S#Z;CP* +%%
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M.2$7:NV,'.!CZ<8K#LM3L]/^)_B66ZG$44EG9HCL#M9E\W< >F1N&1[UW=%
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MVUE<>))]-U,ZG;ZM:ZF); 6]N/GMQCR]LNPXCV?*PW <-GDUZA2$9!&2/<4
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M'E< KZ8'7K6M-XJOK?Q'9V3QVKV]SJ;6)6)69HP(F=6,F=N[*<IC(!'XWO\
MA"]-%K]F2>\2$7XU!$$N0DHD,GR@@X&\EL?TXIG_  @^E_:Q<":^79J#:C'&
MMR0B3,&WD#T;<V1[G&* .=M(?*\%^,I;7$,]GJ=]<VSJ,>7(GS*1[9&".X)'
M0UUDNM3-X);7;:*/SCI_VQ(Y,[<^7OP<<U5NO"ZKHFJ:5933;=7ED:YED8'R
MQ+Q(5P!R1G Z XK9N=,M[C1Y-*PT5J\!M\1G!5"-N!GVXH Y2S\1>([W4;"Q
M4:4CZCI7]H0R&.0B$J4#*PW?.#Y@Q@KCGKCF30O%]]K,_A]3#;Q+JVE2WC?*
MS&*5#&,#GE3YAXX/'6MBW\,6MK>65U%<W0ELK(V,)+*<1';U&WD_(O/M]<UH
M/!.FVL&DQ6]Q?1?V7&\,#QS;6,3XW1L0.0=J^_ P: ,$^/[U?#FCZG<I;627
M]J[F[EA=[9)@0$C=@P\L'GYFXK:T2^U*[\:^(K>>[ADLK46X@B6(C:&0MG.[
M'<Y..>.F*DM_!.G6ND)I4%S?)9BV:U>(RAA)&Q)(;<#ZGD8(R<5?L_#]CI^K
MSZC:^=')/%'$\0D/ED(-JG;Z@<4 <QJ2:JGQ+OGT-+!;QM$A8F[5BKD328!V
MD')X&<\>AHL_&^J:_IJ2:#IB->#38;UH9<,"\A<"/.],#,;?-SU''%=->^'K
M:\U4ZDMQ=6URUO\ 99&@D \R+);:<@XY)Y7!YZU2N_!.E7%U9W-L]WITMI;B
MU4V%PT.Z =(VQU4=NXSP: +.N:O>:9X+O]:2UC2[M;%[HV\S;@K*A8H2O7H1
MD5@MXJUVQU%K:_M=-87.E2ZA9-'*T:JT>W='*S<8^=3OX'7BMOQ7I\UUX'UC
M2].MC+-/I\UM;PHRKRT951EB !R.]5H_"-EJ&C^3JPNII9K 63^=(N^&,X+*
MI3C.0"3R3M')Q0!BZAXMO&T/Q<LUK8W?]E6,=RHFMG2*='1R59&))'R'G.""
M*D\3:M/JVB^*=+M$M%CT_2]T_G1E][21,X50"-H"@<G/)Z<<ZTG@?39HM32:
MZU"4ZG:K:7;R7!)D1<CTP#AB,@?3%/O?!>G7MQ<3FYO89+JT%G=F"4*+F, @
M;QC&0"<$8/..G% $D.J1:)\/XM5G5GBL],6=U7JP6(' _*LR[\4:KIL]E%<Q
M6<O]HV$US;M$K 12QH'*/DG<I!X88^[TYXZ:+2[2/1ETED,UF(/LY24[]R8V
MX)/7BLR#PE8PVR0-<7<RPVSVENTL@9H(F #*IQR<*HRV3@=>M &;X?\ $^K7
M^IZ-!J$5D(=5TC^T(_LZL&B9?*W*22<@^:".!C&.>M7O$^N7VD$"S^RC_1)Y
M_P!ZC2NS)MPHC4@[3DY?HN!GK5BR\+V5A=:9<137);3;0V5N&92/*.W(/')^
M1.?]GZY=JOABQU?4([V>2ZCF6W>U?R)B@DB<@E6QVR >,&@# ;Q7K=[<01:?
M#I\0GT-=55KA7?:Q(^0@$9'.,\>O/0]/HFI-K/AS3M46,1O>6D=P$)R%+H&Q
M^&:S[3P=8631-#<WN8M/_LY2T@;]SG..1USW_I6KIFFPZ3H]KIEL\GD6L*PQ
M%R"P51A><<X % '%Z1XFU2:P\,0V-EI=K_:KW:.JQL$A,>\@JH(SG;DCOSR,
MYIX\=7D/A^PU"_BAM8WGNK:[O5MY)8()(I#&I90=RHQ4G<20N,'KFMRR\'6%
M@-*$%Q=@:6\KVVYU.#)G?GY>?O'Z9I;;PE:V=LL%M?7T:!KACAT.[SFWR @J
M0<MR..,G'% &-%KNL_\ "1ZLXNK":VMM$M[V*'.R)G?SLGS2V I*#YB"-N.G
M4Y^O:[/K'A+QQIM['!(+/1_/CE2!XP_F12'[KDG@QY#=\BNDG\":'/$\/ESQ
MV[Z<NF-#',RHT*A@@/J5W-@^_P!*1_ ^FRQZDLUUJ$K:E9K9W3R7!8R1C</3
M .&89 [\8/- &=>^(=;M;R]T^P33PMGHT6H(\Z.Q8DN"A 8=?+Z]L]#3%\;W
MUHT=WJ-O;&QN-#EUB-( WF1B,(2C,3ALB08( QCOUK=?PM:27-Q<-<W9EN+%
M=/D.Y?\ 5#) ^[URS<^_TIL?A#3E>R+O/,EI8OIZ1R,I5H&"AE88YSL7GV^N
M0#&U+Q-XGTS2-5U&32[4VUMIC7L,[85?,7DQ%1(Q8$<AAMZ<BH=9\3:]9VGB
M.V9K**YMM$_M.UFAC8[/]8"C M\Q&SAN!S]WCG6@\!Z9#HMUI)N]2FM+B!K4
M+/=&0PPGK&F>@P /7@<\"K<_A2PN[BZFN9;B8W6G_P!G3*S@!H>>. ,'YFY]
MZ +EC)=KX>ADDDBFNOLX;?M*JQVY&1DGZ\UR6C^,M=N/^$8NM0L]/^PZ];DQ
MB N'@E$1E&XL2"I"MVX]3780V7]G:+]D@-Q<^5$43S'#._'')P/Y"N:\(^$O
M(\)Z+;:W'<-=6=C]G^SS2(RPEDV/M*=<C(!)) ) QDT ,TWQ3K6I7CZ?$E@U
MW)I(OH'6-_*$N[:8]V[]XG(PZX'?!J6Q\67NJ:-#>V:6WF)ILES>1R1L/*F4
ME1'][CYTE!Z_<]ZL6_A6W\/+'J6G)J&H7ME9&UMX)+O'F1Y!5/FPO&!@G\<G
MFK&D>'XX],U/S[86<^KS23W4<+ E"XVXSR,X&3CC<6(ZT 8]AXE\17]UHMN%
MTN,ZQI1OHG\N0^0RB+<&&[YP?-& "N/4]S3_ !GJ>LZ?IB6-G$-2NK![N0;=
MZ*5?R\ %T."V><\#'!SQNVOA:SLY],FAN+H/IEHUG;993B-MH(/R\GY$Y_V?
MKFB? &E+9Z=#!<ZA;2Z=O6WN;>XV2A'.60L!\RD]B.U %"3Q-XF>[^QBPT^Q
MNET?^T)([@M+Y<H8JR?(P!''4'OGGI3])U[4]8\5Z*Z3Q0V%YH(OVMO++$,S
M1Y^;<.1G ...>.:VCX6L?MC7237*.UD;' <']T3D]026R2=Q))-)9>%-/L+C
M3)X)+H2:=:?8HCYN-T/RD*^!SC:/RYS0 NHZM,?$5KH%GY"W$]K+=R23H758
MU94QM!&22_KP :X_PMJM_I/@72H;86:,QOW;<C2'<D[X5(U(8KR<MG"@#/6N
MUU7P[::K?V>H--<VU]9[EBN+9]K;&QN0Y!!4X'!';(Q6=;^ M(M5M%@FOT^S
M+.@8739=)F#NC'T+ 'C!]Z ,FU\5:C>:SH^H/-'#IL_AQ]4FM1$6.<Q$@-N&
M2 < XXYX.>-C0]9UW4;VSEN-,C72[NT\\3H5!A<X(0_.2X()^8!>G3GB6S\&
M:78_V9Y371_L^U:SCWS$^9"=IV/ZCY5XXZ>E/T'PG8>'3BSN+Z2% 5MX+BY:
M2.W4_P ,8/0=N<D#@<4 %[K%W)XE;0=.-O'<QV/VQY;A&=<%RB* &7NK$G/&
M!P<\<N^N7WB6Y\#7T)AM%N;JY$MO)&9 LL<,RMR&7<N0V.!V/M797V@VU[JD
M&J)-/:W\,30">!@"T;$$HP8$$9 (XR#TQ4'_  BVGH^D- TUNNDEC:I&PP"R
ME6+9!+$AFZ^I/7F@#.\6-/H'AFRAT(P6$8U"TMPBPY4(\Z*0 ",?>Y]LCC.1
MSMYJ>H^'-:\:ZK9QV3K:_8YKI7C8></+^8+@_*3R<G=Z8/6N_P!9T>VUS3FL
MKLR+'YD<JO$VUD='#JP/J&4&LRZ\&:=>1:M%-<7C)JJ1QW0\P$LJ#:N"1D<=
M^IH J7WB/6I;W48]#TQ+Q=-NH[>6)BJF7*H[X<N-F%DXRIR5]^'?$U%?X9^(
M@ZA@+&0C(S@@<&K4_@[3I]:?5?M%]%-.J+=QPW!2.[VC"F51P3CCC&1P>.*T
M=;T>WU_1[G2[MY5MKE#'*(F +*>HS@XH %N+?2O#XN74);VUMYA5!C"JN< ?
MA7/VWBK4!)X<FNX+9K37HR8A$&#6\AB,JJS$D."H8$@+@C.,'C8A\/1)+ T]
M_?7<< (2&>12G*E>0%&[@GKFH++PAIEG#;V^;B>UM$>.U@FDW+;JXVD*<9^Z
M2H))(!(&* ,*V\::I(]Q$\5E)(-&?4D:-7$:NI *!\D2+R,.N <>_%[0/$FJ
MWVLZ=::A%9B+4=(_M&/[.K QD&,,I))W ^:".!C!'/6I;?P%I=LD2I=:BQBL
M7T]"]R3B!L?+C&. !CC\SS5^R\,V=C?6%W%-<F2QLS8PAF4CRB5.#QR?D3GV
M^N0#G_'$*R>,/!9%G%=2?:[D".3 ##[.YQD@_7\*O+//H]K;&VTZQTN;4+R0
MW$>TR8*J0I2-,&1BL:9QC R>U:^I:#;ZGJFG:A--<)-ISM);B-@%#,I5B00<
MY4D4NJZ#:ZM=V-U++<0W%D[-#)!*4.&&UE/L1^/'!% '/Z+XOO\ Q!;:7!:Q
M6MOJ%WI\E[(959XUV.(P H(/+'/7@#OFK4.HW<OBS2K#4]-L$GN-)FFF9/WC
MQNKQ*\:N>J$OTQSM%"_#_2(K73XK:XU&VEL#)]GN(;HB54<Y9">ZGCC';/7F
MM-?#MI'JEIJ$4MQ'-:VKVL0#A@$8J6SN!))*J<DYR/<Y .+\)7S6?A_P%:K:
M6DD=U)/$))4R\)$<K IZ?=P?8D5/8>)->LO"?]M7EQ:7-O%JT\-XQMV#16XN
M7C+K\_10 <=E!ZXYZ.T\'Z?90Z/%#/=[-(D>2U#.IP6#*=W'/#,/Q^E5[O17
MTG3;K3](TV2_AU2:;SDGN0(K?S=S,VT\E"S'(7)Y^E %'7=:N[F:QL5:,66H
MZTM@KHI#/"B,\H)SW:-H^ .,^M3:SXC70?$6IO+8VK166B?;%E1<3, Y'EEN
MRY&?QS6A>>%X?[!TNPL<))I$L,UF7/!:,8PQ_P!I2RD_[1/-3W'ARQU+4)]0
MO8Y6:ZL3936\C*4,1))4@=\D\@T 95QKOB:PBOY9]%\^"*&.6&6",;LEPLB^
M4)&9]JG>,$9QC@U1UGQ#]K^'M]XELKRUNI=-D^T6\]LK)PA!9&5B2I(W(RGU
MK;L?!UI8:>UI'J&J2 ;!%+-=&1X%1@RJA(P!E1G(.0 #D"F:AX5AN=*N=)B#
M&'4KD3ZA.Y&Z097<,  98(J\  #)Z]0#HT<21JXZ, 1FN7U#Q'?M=>((=+CM
MBVB1(\B3JQ,[M'YFT$$;!MP-V&Y/3CG7L=-GM=:U*]:\N)(+H1^7;R2ETB*@
M@E ?N \<#N,]^(+SPQ8WFH75X)+B"2]@%O>+ X5;A!D -D'! )&Y<'!Z]* .
M3N-:O-?N-7_?1G2)O#,-]%:R0G</-67J=V-WR#G'M@=2:1XJO=!T>RBU&*VD
MLHO#/]IQ>0&$BB%8PR,2<-D."" ,<CGK7577A33KB\DN5,]NTEB+!D@DVH81
MNVC;C'&]L?7V&&1^$--22U,C3S);Z>VFK'*RE6MVV[E88YSL7GV^N0##UCQ1
MXHT?2=4U"32[5K>WL1<PSMA5\P, 8RHD8MP<AA@=<BK]UK6N:1JUA!JKZ7'9
MWS3QK/'&^(G5-\88EAG*J^>GW>V>'1^ =+31+G2'O-3FM)HO( GNC(8HL@^6
MA/W1P/?@<\5LZEHMGK%A%9Z@AN(XI8Y@6X)9&!!./7&".X)'>@#"\,^)M1\0
MV%FVRVBNPDXOX6B<>3(C;%3!;(R<GGJ >E8\'C::Q\(Z#>FULM,MKVS9Q/\
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M)'(&6X8Q>4-F.0I!+'=@@@#!ZUI:]IU[+K^A:K:0"X2PDF\Z(.%<B2/:"N<
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M[_2=-U5$34=/M;Q4.4%Q"L@4^HW XJY10 V.-(8ECB14C0;551@ >@%.HHH
M**** "BBB@ HHHH *1E#*58 J1@@C@BEHH KV=C::?!Y%E:P6T.2WEPQA%R>
MIP.*FDC2:)XI45XW4JR,,A@>H([BG44 16]O!:6Z6]M#'##&-J1QJ%51Z #@
M5+110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !117.RWS7_CDZ-DBVLK%;N4
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MI)+V]>Y@:VDN53R9X,[T9L$$9'!_2KA\92M=QI!H]S<0?;!93O"KNT3YVLV
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M!V%%<59^,;_5M1\,BTLH8;;4H[E[A)9CO1H2%900I! ))!XS@=._:T %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %84NF/:^,TUJ)"\5S9BRN HR5*N6C;'I\S@^F5[9(W:*
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M7%W;W1A1MHG8M)&RX 8'/MT&,8K6?PY+)J6C7LFHR2RZ:96)DC!,S2+M8G!
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M.>,^]22ZG80JK2WUM&K1F52TJ@%!U8<].1S0 ^QM(M/L+:R@!$-O$L48/95
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MX:ELUD188+P23&U>6)=XBVAB, 9VG'(Z5T&L:U8:#IS7VHW"00!E0%B!N8G
M4>Y-95KXLMW\1:G87<UE;VEO':M;7!N!B<S!\#)P,_)P!F@!MMX/CL[[2;J"
M\(:QFN+B3='DSR3Y,C$Y&.2< =..M+;>%9[#6KNZM-:NHM-NK@W<VGB-2#*<
M%BK_ 'E5B,E>_/3-;EQJ%E:310W-Y;PRRG$:22JK.?0 GFHM9OI-,T6^OXHD
ME>V@>81N^T-M4G&<''3TH X_POH4^HZ9/%J)FBM(]<N;U;:6U:)WQ<-)&=S=
M4SM?I[9QQ5VW\%OIES97O]KW4R:;=7-W%$($+N)=Q92>K-\Q /X=>:='XRNH
MK/P[>W^FPQVFMO#%&T%R7>*25-R!E*#([$@\>E=,-1L6O#9B\MS=#), E7>,
M<GY<Y[C\Z .?\-:;%)J>J^(8K2ZLSJ)4QP7:%&7"*&<QGE2Q501U/E@]Z;8^
M#&L;;0H1J.\:1<RW"$P8,A<.I!^;CB1NGM^._%JVFSSI;P:A:2SR*S1QI.I9
M@I() !R0""#Z8K,\/>)%U/3C/?FVM)S>W%HD8EX<Q2LGRDX))VYZ4 9K^!)!
M&);;69;748M1GOX+J.$'89L^9&4)(9#GZ\#GBM'_ (1N<ZKI6HRZH\UQ8),"
MTL0_>M* &/! 4#:, ?K5OQ'KMMX:\/WFK71!2WB9U0N%,C 9"@GN:BLM9,:R
M/JM[I202./LD\-P )EP,\,>"&XX)S[=* ,W3_!1T_P#L5H]4D\S2Y+@JPA7]
MXDS;F4@DXYQ@CM^==956?4]/MIQ!/?6T4I*@1R2JK$L<*,$]SP/6K5 !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 !Z5YE::5=KI96,:GI=U'K-]<VMS#9M(L:O
M(Y7?%M^9&1NW(..E>FT4 9.@?:AX6L!J=G%;7"VRB:VA4E4P,;0O)QCMSZ5P
M6@:+>VEEX(CCTV>TN;:.[2YD^S$>27C8*6..[;?R%>IT4 ><Z/I6HSZ=X,LW
MLKBTU+1)_P#3IG0A=@B='P_1Q(Q0\$]<G!%;_@*"YLO#*V-Y:3V\]O<7 82K
M@-F9V!7U&"#GIS]:W)-3LH=3@TV2X1;R=&DBA_B95QN/T&15N@#R[6=%FGL/
M&JQZ1.\EWJ=M+;8M23(JK!N*\= 4?_)&;.K6EU!JWB::TT.6YMYX]-\M!;L%
M;RY&WLJ\;F0%6VYYV@=C7I%-DD2*-I)&"HH)8GL* /+#9:U!+?72Z9J4]M'X
MD@U&6-XE$EQ;_9T7<JK@,5<!MH&?E]>*?=VFJM>:YJ5GHVH-;?VU:WQ@5##)
M<PK;HK; 2"6#?-@X.5]:])L+^UU2PAOK*99[6==\<B]&'J*EGGBM;>2>>1(H
M8U+N[G 4#DDGTH Q?"UK:PVMW<VFFWEBEY<FX=+QF\R1RH!<JQ.W.,8XZ9QS
M7*:EI&J7.D>*]$EM+AK^_P!1^TV%VL9,>T[/+;S!PACVXP2#A1C.17>Z?JME
MJGGBTFWM;R>5,C(R/&V <,K $<$'IR#5R@#R[7-%N)8_&[0Z5/)/=75H]JZV
MIS+L2+<5..S(Q_#/>NU\6B:7PCJ MM._M&1HAMM64_.,C/RY!.!D[<@G&.]:
M]S<PV=M+<W$BQ0Q*7=V/"@=35:WUBPNI+2."X5VO+?[5  I^>+Y?FZ?[:]>>
M: /-=3TS4+RV\4*^EZE<"]O-.N('GMAF14,6\[5'! 1N, X&#R>>O\/VCVWC
M+Q+*MI+!:W M3"QA*(Y6,JV.,<<"NIHH XG7+&63QI<W L)I8'T">W,BP%E:
M0NI5,@<G -9FB:1<VUSX45--F@:+P[-:73?9R@68B'"L<=<H_P#DC/I-% 'E
MFGPZEIVF>%);W1-7FL[;23IUS!;*1+#-B/YB@.60["N?8'H:T]*\.VMMXPTZ
M,:%)%I\.BF"-9T,RQ,)0RHSG(W!1ZG'0'I7H%% 'FFA:;(T=O9ZOX?U635=*
M-P?M1F802;@P+QL&PQD#?=QD$\],U6N-)US_ (1C6-/ABN]1M%M;4VDEQ:^5
M=@)+N,#<#S-J@D,!_%CFO5*J:AJ=EI4,<U]<)!')*D*%OXG8@*!]20* *NLL
MMUX6U!GA95>SD/ERKR/D/45Y_I>D&[TGPOJ6E:.3)9Z%*MRK1&$71>!0L);
MW;G^;(R!@G/(SZ/K,EC%H]TVI2&.R,969@6!VG@\KSW[5+I]C;Z7I]O86BLM
MO;QB*)6<L54# &223@>M ' Z!I4U_KLR:CI=Z-.O= ALY!/;B)$*O)NC Z@
M. ,Y/?)'-1C2]5O?A]X@AU"(WE[;V%SI%D8U\QIPFY1)@=&=@@/H8\UVTC:5
MXFLK_3Q,;B&*7[/<B&5XRC@*VW<I!!P5/![U?M;6"RM8[:VC$<,2[44=A0!P
MHTI/^$E6<Z3)]G_X1W[/N^R-CS-V=G3K@G\R*R;"QOK.RT>'6-$U>]L+GP_;
MZ=+%:AM\$R;A(DBY!VL& W=/D';FO5J* /+]1\/LO_"50Q:+-B7PW!9V@\II
M<RJDP*!R#N(W1_-GGKV.-[1H+R#QJMU+977D7.B6L(F,>%62-Y2RMGD'YU^N
M?K7954M=3LKV[N[6VN$EGM'"7"+_ ,LV(R ??% '/ZX;VR\;:/JC6=S=Z6EK
M/;N+>,R-!,[(5D*CD@JK+D XSV!KEM)L=2M=(T>S?0;V#"ZE'YJ0JTD7F3;D
MCP3M174C+$?PXXSFO2;?4[*ZO[JQ@N$DN;0(9XUZQ[L[<_7!_*BWU.RNK^[L
M8+A)+FTV>?&O6/=G;GZX- 'GNAZ=K$*^&,V%Y;RCPU)IS2,G^HG_ '."_/RC
MY&.?;UK1\&68DFTV2\T#4[+5=-LS:2S7,K>4HPH*Q_,1(I*@CC  ['@]Y10!
MRVK1WEIXYTO57MYKC2Q93VKB&,R&"5F1@Y50200A7(!QWX-<UIOAF:VU#PQ%
M>Z8\MK'<ZBYC:#S$MH92QAC8X('! QV_"O3JJ7>IV5C<6EO<W"1S7<GE0(>L
MC8)P/P!- &9XO24>%+I+331?,IBQ;!2?E$BY(4$;MHRP7(SMQ6=X.@O(-9\2
MO<VUZD5U>1W$,UU&J&1?(C7.!@9RIXQQCG!KKZ* .&.B27?BOQ;(EEY4UQ:0
M+97<D!"B54D!96QP067D?TKG[FRBN? VKW%WX=U*QU*Q\/7-I+)>.?+7$>=D
M?S$.-R[@0,#'8G%>LU5U+3[;5M-N=/O$9[6YC:*5%<IN0C!&00>10!YS=Z,]
MQ&FIZ/H)D6/P[-:W%L\)A%V[["D6."V,.21Z@ \U;T_0I=;U+Q-:ZA::@EEJ
MFGVBQ7-Q L6&02#(4?=925(!Y&!GL3W&D36<^D6LFG2&2S,8$+DL25' Y;G\
MZ-4TJTUFR^R7JR-#O5\1S/&<@Y'S(0?UH X"_LM6UOX8ZK=:A9_:-7O(4MTC
M@7S-PB;:&7'9F\R0'T<>E6-8T@3ZSXJEATF1H;GP_';VY6T;#RCSLJ..N'C_
M ,@X]!BBC@A2&%%CBC4*B*,!0.  /2GT >7M87!G:UUG0M7U#3]3TJUMU%J6
M&QT4AXI1N79RV0QXY/-1ZYH-Q):^.$ATB=Y[FWM4M&6!G,C+& =KD9.& Y]L
MUZI10!R^DQ7,/CS7)WL[@6U];VKPSE,(=BN&!)Z$$CCKS46I_;++X@6]_-8W
M-WI<VFM:HT$1E\F;S-S;E'(#KM&[I\G.*Z*SU.ROYKJ&UN$EDM)/*G"_P/@'
M!]\$'\:?#?6UQ=W-K%*&GMBHF3!^7<,C\QZ4 >46FFZO'X/T[3&T&^AF/A^X
MM?-2$-(9"?\ 4MDX12 #DC)X (Q@Z-QI>M72R1VUC=PSWOA5;&*1UVB.=2^5
M<Y^4G</S]17IU5M0U"TTJPFOKZ=(+6!2\DC]%'K0!QVE7=O;K<^(SX7URWO(
M+)8)XY<M(P#9$<:%L. 2QW<<=#R0.LNC_:.@SFV!;[3;,8PPP3N7C.>G6K3)
M#=V^UU62&0 X89##W%24 ><:/97#W/@4W>DW:)IVDS07'G6Q(CDV0J.QZE'
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M80*03SD@GA2<*"<#IR,\Y'X,UH^"K_PQ+/IRPWTMPTES\\A199&<@(0!N&[
M.[J <5>3PC>:;=:E_9=S"]MJ5E%;2BZ+%XGCC\L2# ^?*XRIQRO7F@"\_C*Q
M.JII]K9W][(\$-RLEM$&0PRL563)(^7(.>^/7FHK+QSI]]9K=I9:C'!(XBA>
M6$*)I3(8Q&OS<MN'?  Y)X.$T?PQ-HFNI<6S1-8PZ1;Z;"C.?,_=%R&/&.=^
M/PS[51A\&7R^$-.TUKJW34--O_M]M*NYHV82,^UA@'!#LIQ]?:@#2N/&NGVD
M%Z\]M>1RV,\4-U 53?#YA 1S\V"AR.03CG.,'%C_ (2BU^TZK;"UNC/ILD4<
ML>$RYDQLV?-SG(ZX].HQ58>%4OWUZ?5!'YFLVZ6LL4+%ECB16 PQ ).78YP.
MP[9-33/!4MGJ^F:G<Z@9[F.U\O46V_\ 'Y*"#&Q]D)?'_ ?2@"[<^-M(M-1B
MM)&?$EV++SE*%5F/ 0C=NZ_+G;C/&:GT7Q1;Z]<RQ6MA?I'$TL;SS0A8Q)')
ML9,YZYY'&, \Y!%4=-T'7=)UB\CMK^R;1KF\>]Q)$WVB)G;>\8.=I4L2<GD;
MC[5>\+Z1=:+87=O=M"S37UQ=*8B2 )9&DP<@=-V/?% $QUZWDU.?3X8;B5X)
MD@GDC"$0NZ!UW G=C#+S@CGZUS?@_P 5-_9^G66I_;II[R^O+:*]D4>6SI-,
M50G(.=B<87'&,YXJ]J'A6>^\4PZPHM;>>"X1X[R!V29X HW0R ##J3GDG@'@
M<<U;+PCJ=M9:';O+:$Z=JT^H.P=OG60S':/EZCSC_P!\^_ !LVGBBSO]0M[!
M8;N![M)GMI9$51((F"N0,DCJ"-P&17*:1J^J2Z5X(FEU&XD>[U.X@N=Q'[Y0
MEP1NX[%%]N*OZ7X0UJSUG2M1N[VPN)[+[2DTVQ_-N1(00S-G@C:!CD =..*?
MI_A#4[33O#5L\UHS:1?RW4C!FQ('648'R\']Z?\ OGWX .GU'5K?39;.&17D
MN+R4PV\,8&YV"ESU(  56.2>WKBL*3Q7I^HVEA.O]J6R/JJV0V*JGSE<J4?D
M_)N!!QUQQ5?X@W*0-H@^U65G*MVTR7-\6CB0K&PQYJD;&.\8!^\ P]:JV&E7
MNL:'80VT6F11V6K1WHFMIY)(KD ^8S*S+DL69LGD9[GH #HH?%%K.NH[;2[$
MNGW26DL+! [.VW;M^;!!WJ021UJ&X\:Z1;:E#9R.Y$MV+$3*4*K.>-A&[=U^
M7.W&>,T^3PV#XR77$GV0O %GMP.))4R(W/T5W'_?/I533-!US2=7NXK>_LFT
M6YO'O0'B8W$;.V]XP<[2I8DY/(#'V- %W7=?FTC5-$LHK"6Y_M&Y>$LC(-@6
M)W_B8<_+], ]\ I)XNTZ-XW9)_L4EV;);T*OD^=N*;3SNQO!7=C&>].U_1KO
M4KW1;RRFACFTZ\,Y$RDJZM$\9''<;\CZ5CQ>"[E-*?P_)/"^C?VB+U'R?."^
M<)_*(QC[_&[/W3TSS0!L^)M>ET&WL'AL9+IKN^AM<(RC;O8 GYB.<9Q[XSQ7
M/VOBM](UWQ(NI#4+BS@U&WB5PJLMHLD,1 ;D<;W/W=Q'4^M=!XGT>YUFRM%M
M)8H[BUO8+M/.!VMY;@[3CD9&:P]1\(:I>VWB2(3V8?5[JWG1MS ((EC4@C'?
MRL]>-W?'(!JZCXUTC3+TV\[N52Y2UEF4H5BD?& PW;L?,N2%(&>3P<5?B%J%
MWI7AZ"[L[V6T<7]M$[Q@',;RJK#!![$TMKH.O:=KM\]E?60TK4+C[5*DL;--
M Y #B,_=(.W()'!/0]*M^,-$O-?TF"SLW@C>.[@N2TQ('[N17QP#UVX]J ,C
M3O$4G_"=W&F6VI27^F0Z<;FY\Z,![>0, H4A06##=D8.,#GG%:7_  F^GK;7
M<TMI?1&VT]=2,;QKN>W.?F #'GY3D'!]JKWOAC4M6\1P:W<7EO93V=E/;VBV
MH+D/*,;W9@-P7 (7'7G-9*>!M9,-YYESIHEN]$;3)2BR9:0[OWI8\L3N).>>
M,>] &IJ'BR.^TG5[:T2_L+R/2GOK>66-5+IM.'7D]" "& //XUH^&M8.H:=8
MQ;)YY%LX7GNOE*>8R E2<Y+=R,<9&>M95SX5U.>=Y!)9C=H3:5@NW#G'S_=Z
M>U3>$_#.H>%Y?LT4UNVE20H7MPS$Q7 &'>/C[KX!*GH22.O(!HZUXJLM":X^
MTP73QVL*7%Q+$@*Q1LQ4$DD9Y5N%R<#IR,I8Z_->>+=5T8V$J16,4#>>63#%
M]YZ;LX^48X]<XXK'\7>$-5\12:G''>V9M+NQ%O"MRC,;:0%B60#CYL@$]1M'
M7I6MI^C7]IXJO]5DGMGAOK:!)45&#+)&''R\XVG?GGGC\: *=SJSZ=X]O?M=
M\Z:9!HHNWC;[D9$A#-@#/0>]2IXYTIIKRW:.Y6YMH8Y_)4)(TB.VQ2NQF'WN
M""1C.3@<U#KGA*;7-9U&66>.*SO-).G90GS$8L6W@8QP3TSVIDNC^+K[P]/:
M7FJZ='>@1K'):QNBRA74MYASD;E4KA>FX]>, &@OB[3RDP>*>.XAOAI[6\FP
M-YQ4. #NV\J0<[O;KQ43^*9CXBTG2TTFZ5;Z*>1WD* Q^4ZH1C=ZL#D9XQC.
M>,J'P7>(FKP7$&C75CJ-Y'<2631,B;1"L94'!VD,BL"!V[5/IOA'4--N] GC
MOTF&G)=0NMP7D(AF=6558\G8$5 6ZCGVH O^/+V]TWP7J-]I]T]M<P(&61%5
MOX@"/F!['ZUT1.%)P3CL*QO%ND7.O^&+W2K5XHY;E0F^4G:HR#G@'/2MA2YC
M!95$F.5#9&?KC^E '+P>/=/N$L9$T_4Q#?3RVT$A@7#31EP8_O9R?+;!QM]2
M.<6[7Q=875I'(L%TES)>/8BR=5$WG("67[VWA5+9W8QWK(L_".IVVG:#:M+:
M$Z;JTVH.P=OG5S,=H^7@CSC_ -\^_#4\&ZC%>#48[BV6^@UB;4K==S%'25-C
MQ,<9!VGA@#SVH TY/&^F10*[07OF_;QITD B#20SGD!@#C!!!!!(((Q5:\\<
MJFGQSVFEW;3_ -K1:9/;R^6KPNS+G/SX.58$8)'(SCFHKGP?>37)ODDMA=SZ
MQ!J5PI9M@6) BQJ<<\*.2!R3Q3+CPAJ4J:BZ7%HLTVMPZM &+%?W8C&QN.XC
MZCU]J (;?Q6^D:]XE&I#4)[*"^MHU8*K+:+)#$?FY'&]_P"'<>YXYK9BU&[T
MC4KNWU*26[DOKYSIL*; ?)$*$J,E1PP?J<\UEZEX0U6^MO$L8GLPVKW%O*C9
M8!/+6-3D8[^7GKQGOCG9\2Z$?$%M!;7%E97=L-QDAG=D*O@;7CD5258<\C'6
M@"W?:Y;Z=X;EUVXAN%MHK;[3)&(_WBKMW$%<]0.O-97_  GFFK+>Q3V>HV\E
MK9&_598 IG@'WGCYYQQD'!YZ55\3VLNE?"#5;*]OFNIX-'EA>YE.#*_E$9.>
MY/XU'-X=N_$%B+Z26T69M&ET^U\IV9/WP7=(QQ_LKA1GOSSP 6V\3VM]+H[M
M!K-DES>K';L8U1)R86<;N3E",^AROM5UO%VG*\#%)Q9SW9LH[W:ODF8,4V]=
MPRP*@XQD=>1FM=>'[^XL_#$0>V#Z3<1S3$LV'VQ-'A>.^_//ICWJE;>"[F+2
MDT"6XA?1X=1%[%)D^=L$WG"(C&/O\;L_=[9YH V-*\46^L:C/:6UAJ $$LL$
ML\D($:R1D J3G.3GCCL:JZIXVL-)N=4AELM0E_LN*.>Z>*$%4B?<=^2PR!M.
M0.?0'G%KPWI%WI U0730M]KOY;M/*8G:'Q\IR!R,=:RM8\*ZAJ,WBLQRVJIK
M6G1V499FS$561=QXY_UA.!Z>_ !K:AXHLK WF(;FZ6QA6>[:W4,(48$@D$@G
MY06PH)QVY&:B>*_M/B"YTZ&SGDLX].COENX60[UDW[2HW9Q\A XSGT')J_\
M"+ZG;W>K2VD]KLUBTCAN5E+?N)4C\O>F!\X*X^4[>5Z\U):>%+C2=52;3IH#
M9+H\.F"*;=O'E;]AR..=_/';WX )=.\362Z!IKVBZEJ+2Z<MXBL%:X:$ ?.^
M2!N.1P.2<X'!I=1\=Z/IMI]JE\]XUMH[J4*JJ\43\@LC$,3@$E0"1CIR,Y.G
M>$-=T1-#N-,O; W=EIB:7=1W"N8I8T.5=<8(8'/'0[L9[U?ET#Q!9^()-1TO
M4K%TO8(HKU;R%B0Z @2QA2.H/*GC@<T :7B;5+2R\)WFH33WB6@A#F:QQYJJ
M<?,I/%5=4\;6.E7.J02V6H2G2X8[BZ>*)2J1/N^?)89 V'(Z^@/.+/BK1KC7
M?"5]H]O,BS7,/E"6;H.F2<"LG5/"VI:C)XI826B#6]-CLDR['RBJR L?EY'[
MT_\ ?/OP =!K.MV^B:)-J\\<TUK"@D<P@$A/[W)' ZGVJJ_BBTCO=4M&M[GS
MM.MTN9!A/WB/G;L^;YLE2.W(QZ5H+8K/HPL+V-'1X/)F0'*L"NTCZ5RNF> I
M+*YT2ZFU)I[FS0Q7DA7!NT7:8@?388XS[X;U- &JGBR";6+G2XM,U-Y[5U2=
MDA4K$6CWJ2=W0CCC/)%9NE>+%8^%[.QMM0O;75+22=;NY=/-V(%^\-P^;YP3
MQTZ9/35T[2+VQ\0:_J+&W>/4&B:% [94I&$PW'?&>.GO61I'@_4M+A\* 75H
MTFBV\MK-D,1*CA/F7I@_(.#ZT 3V?BW3[2R@<+JUS]LU2XLHQ+&&=9E9R4X/
M"C8P7V S5ZW\8:?<6,5QY-U'-)?-IXM)%42B<9RG#;>BEL[L8'6LBW\(ZI%'
M8*TMF3;:[/JS8=N5D,IV#Y>H\T\_[/OQE:_83:'8[;NZTZW>\UYM0AN;AG6&
M#Y20&D&-C9  /?)&,$T =QHNNV^N)=-;PW$1M9VMI5F4 B13AAP2#CUZ<U5G
M\7:=;$R.D_V);O[$]Z%7RDFW;=IYW8WG;G& >]5_!<DAT^Y0Q6!C,QE%U83O
M+'<,^2S;G&2V>I!(Y SP0*/_  A=R=-O]":XA?1[O4/MH<D^;&IE$S18Q@Y8
M'#9X#="10 ^*[O\ 7/&>K:>SZA90Z:ULT,D$D84YW,V\9.X.,#D' '\)JSJG
MB"Y_M^^T*&UGB$>F&[^V(R<$E@" 3G *D="<]L<FWIFD7EGXHUK4Y6@-OJ'D
M^6J,=R>6I7GC'.<^WO4&I:#?S^)9]4M)K;RY],-C)'*&R"&9E(([?,<_2@"A
MX3\7PSZ+HUOJ8NX[F31TOFN[E0$G543S6!SG(+ G(&<Y&16KI?B_3=6U?^S(
M?,2Y:V^U1ARA$D>0"1M8X()&0V#STK$C\$7<EKHEG=S6YM['19M)G,;-N<2)
M&I=<CCB/H?[WMSL^&[#Q#8PQP:U?6-Q';QB*-[:)E:;& 'DR>#@=!QDF@#)U
MS5)K7XB6-A+JUS::?/IDT[I&%(\Q9$4')4D<,?:D\*^+7N-$O+N_N6O(!JCV
M6G3*BK+=KD!<J, -G<,X487) '-:5_HNJ/XVM=>M/L;106,EIY4LC*S;W1MV
M0IQC9C'O61_P@%UNN]1^WPC5IM6BU5 D9$"-&NP(1G)#*6!;KDYQQB@#7N?&
M^FV=M>27$%Y'+97,5M<V_E!I(VE($;8!(*MN&""?S!%(/&D/V^*P.BZR+QXO
M.\@VZ[E3S/++'YL8SSUZ<^U4=5\'WVI)J=T'M8[_ %"YLI'7>QCCCMG#JH.W
M+$D-S@?>'ISK_P!D7A\;)K1: 6PT\VA3<=^XN'W=,8XQ^OM0 U?%VG-)9GR[
M@6EY<-:VUX57RI)02-HYW#)5@"0 <<'D9BC\:6$D=JYM;Q!<:BVFX=4!CG4D
M8;YN =IP><\>HSGV'@NYMM+TW0YYX9-+TV_6[MY03YK*CEXXV&,##$98$Y"]
M!G@UCP'_ &E=:W-%>>4+U8Y[5-O%O>* //\ K^[BZ?[?K0!KW/BNRMCL>*8S
M&25(XMT:F41$!V4LX& Q Y(.3TJC#\0-+O!9?8+34;TWMHUW"+> $E%=48')
M&"I;GZ'O@$U+PUJ<-QI%_H5Y;+>6$,EM(EZC&.YCDVEBQ7D-N0-D=\YJQ!HF
MI+XKL-8N+BVE$-A+:S;04):21'RHP<*-@ !.<'D\<@$.GZQ<Z/:+IVJFXU#5
M46>ZD$(3=Y'G,$."1GY<# R>.??1\57\&F>%M2O;J2\B@B@9I)++'G(N.67/
M&16;XM\+2^)&PJVJ-'%BTO-S1W%G-D_O$91DC[ORY .WWK0\4Z/<:[X2U'1X
M)46:\MV@$LN<#<,%C@?I0!4U/QI9:3<ZC;26.HSOIULEW<-#$I"PMN^?)89Q
ML;(Z^@-#>+HX_$5Y92VSQZ?:Z<FH/?%EV[&+_-C.<80]LY[ <FIJ/AC4[^Y\
M0S![1/[5TA-/4;V/EL!)EC\O(_>GC_9]^(KKP7=WTUPD]U EM>Z(FE7(0,70
MIYF'0\#_ ):=_3WH L7'Q#T>UCU S170DL;47CQJ$=GA)V[EVL1P>""01QQ2
MZKXXBL-,UZ:/3;S[7I-H+OR)U5/-C8-M<?-]W*-D'##'3-5[WP_XHUCPCJ.D
M:K?Z8T]Q;&VCD@B=5;.,R/G/.!]T<<GGIA^L^$K[6;K7G>:VA35-&73EPS,8
MW!D.X\#(S+^GOP 7AKEL/$%O'>-?6<PTN6[>*0H(!&KH&9L$_,,C&#C!-2P^
M*[*6YMH'MKN%[RW:YL_,1?\ 244 D+@DAL$':V#@^QQGWGA6]U;4HYM1EMO(
MDT:XTRX6 L#^]*$LN1V"8YZYSQTIUGX:U+=HDFHRVLLNB021V[Q%AY[M'Y8=
MP1\GRYR!NY;KQR 6-'\::?K5QIT<-K?0IJ5LUS:2SQ!4E5=NX##$@@,#R #V
M)JQJ>OS6'B;1](CL)9EOUE=IE9 $" 9&"P/\0)]NF3TQ]%\):CI@\)I)-:NN
MB6DMM*59LR[E505&./NYP?6MC5]&NKWQ#HVJ6TT*BQ\Y)4E4G<D@4$C'<;1^
M= #8O%VG2RV/R3K:W\S06EXRKY4T@SA00<C.UL$@ XX/(SO5Q>F^#+JVTS1]
M%N;B&33M'O!<V\JD^;(J%C&C#&!M+#+ G.WH,\=I0 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !12, RE3T(Q7C_A^QMI[#PW=Z;-(=:BU>9+AA,S,+432^8K@
MGA-N,9_B(QR>0#V&BO([2UCM/!5UJ]K%<23Q:K-%=O"6DE%E]L+, ISE=@#8
MQRI/J:=J$.BKI]A=Z?J-Y+I=UKULS,<P0)E2'$84+A> 6[9)YSG !ZU17E/E
M6VCO?0Q)(?#LVMP+9$LS6T3&',A8<[HMXQMX&_C(I+*"7_A"3JT,<DE[X=U:
M[N$B:)DW0+,^Z(*W0>4<J.Q"T >KT5E>'[9HM/:ZEB\JYOI&NI5(P5+<JI]U
M7:I]P3WK@-=T?4+6]UG3]-L?,6WGCU^SD*94X'SVX/JSQ\#IM<^@H [_ %?6
MUTBYTN%[:24:A=BT5U( C8JS G//13TK5KSK6H(+FV\-W=Q"8FU/7([N5&^1
MEC,,@4-CIA=@/;)/K60MTNF6,D3&5/#]MXBN([@11^:L,#1DQDI@_NO,/I@'
M'I0!ZM-=P6\T$,LJK+<,4B0GER%+$#\%)JCH&M)KUC-=);R6_E74ULT<A!.Z
M-RA/''537!+INDVFJ>$;F/[1>::+V[\J>[@SM#QED1!M!";N%&.PQD8JI8QV
ML#:9J,1"WA\672&4.<^0\DV1_N$%3Z'(- 'KE%>8:";/4-8A&IW>H0>([*[N
M#=0K"$WQDN,O)M^:'85(^; PH'( K9^&6G6<7A6TU!$8WLJ/%/([LS$+(Y (
M)XQG]: .NCFG>^N(7M&2"-4,<Y=2)2<[@ .1C Z]<\=*L5Y3XNVEOB+&COO?
M2[4Q*KG)D EX7WR5X'J/6NBT..UL_B+JD%@P%K<:7;3L%<LLDWF2AFR3RVW9
MD]2,9H [3K6?KNJ+H>@W^JO!).EG \[1QD!F502<9XZ"N7\6Z9*GB&TNK>T-
MPFK6TNE7*A<A&8;XY3CH%VN">N"/05B_9KI_AMKW]I6VRZTS2KG28F*8,S*K
M R+ZA_W>/?=ZT >FVTPN+6&<#:)$#@'MD9I+NX^RV<UP(VE\I"^Q",M@9P,D
M"O++Z.ZL9]5C\,[Q=W/AE)0(7):28,?F!SS)L)QWZ5L1M:/KJWN@,B:0^C3?
M;U3A!)E?*W#M+@R YYP.>U '9Z+J::UH6GZK'&T:7MM'<*C')4.H;!_.KU>/
M6T]JNB^&;+7II[?2)_#T,$4JP>8J7(&'4_*VV3&W:>""& YKO[^+4K?X>7$6
MD27<NI1Z:RVKW.//:01_*6_V\X_&@#HJ*\S_ -$N+G3[K1&\NR?1[@:JJDK@
MA4\L2^DH;=U^;[U=%\/=.M+7P;I-U!&1=7-A;?:G9V9F=8P#G)X(Y&/;':@#
MHK>:>6XN4EM&ACB<+%(75A,NT$L .1@DC!],U8KR;7/+-OXQC$L@QKM@T6V5
M@<?Z/O*D'./]9G'3#>E=3X4CM[/Q;XILK/"6BR6\L<2ME0S1?.1]2!GWZ\T
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M<9('0>M>8W,5JD.L:A&S"[M_%5NUO(7;<D9:W#E03PI7S ?8'/3CNOB R_\
M"O/$*Y!:33IT0#JS%" !ZDF@"]8ZS->26N[2;R"&YCWI.[1LHXR VUB02/;'
M%:U<5]F33O M]J:W.I7R2:0J^3#-\Z[4;/ED#Y6^;KSC:/2N3:^N+8>(SI:O
M+;&WTVY\NP@D17A$C"X\OU;RQ@L,$X]1P >LWLT]O:M);6C74H90(E=4)!8
MG+<< D_A6:FOO-JNM:;;Z?+)<Z;!%*JF15^T&0.553G Y3&3CK7&:\VAS>#M
M3OM!:86]Q>V<@*;HXMXE0-Y:\8^4$M@8ZYY!P[7WCDO/B)MDY;18/**,06<)
M-C:1U.67IZCUH ]#CO8FN$M78)=M#YQ@SEE7('./<X]\&K%>=65AIMWXXMOM
MEI%(M[X=AC20Q9WL&8-A@.H4CG.0,5'IEAJDFBZEI3P-]J\.VEQ96<^.;B1T
MS$X_VA&4SZLY]* .VBU=[RSCN]/M'NH))UC5Q(J[DW8:49ZJ.2.[ <=1G3KS
MB[> ?#KP/)$VQ%N=*9=K$80-'NS[ 9SGI4-L;:_\536NJ76H6^O6NKM-;I#
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M"3D9VY&<5Q5KX[U*VL=-U+5X+-K.^T&75MEJC!XVC2-V7+,001)QP,8QD]:
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MEO3OMG0[A)&JN"P&Y<,W3B@#4T[PQ8Z<;;:]Q<+:0M;VJW#[O(C;&54XR>%
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M.T@X)[CUJ_0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M )9"NH/B[3EN=2@,-\7TU@MWLMF?RLJ&'W<D_*0>,UH6::5J+P:Y:16L\DT
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M8DMJTT#6N94&0D<:G//'*']*?K_AK5]7U/7I[6!(?M5G8_9FG=2K2V\S2E'
M).T[@N?K[9[ZB@#!\-VLZ?:+RZT"ST>><(KQPNLCOMSRSJ ".>!VY]<5SVK>
M%M:N[CQ(+:.%1=7]IJ5I(\N%D:%8?W3#&1DQ'GW'7FN]D=(HVDD8*B@LS,<
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MO-[J?(1?O-_$K1ELYZCC(&:[ZJ]YI]EJ,<<=[:07*1R"5%FC#A7'1AD<$>M
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MAP7$$\K-"6E.\2/PZ NN(R4;/7I@FNJ\:W-W:?##4+N.^GCNXK)9!=1 PN6
M&6QU7/IVKJ)[.VNFC:XMX9C$VZ,R(&V'U&>AK.\3Z*WB+PY>Z0MR+;[5'Y9E
M,>_:/ID?SH XK6+F;P]JNM!=;U-]*DTI+B60S^:]O.\P12C-P@<%N!@#;D8Q
M1;MJ.LQ^+M,T[5W6\LYX9[!8;]Y I\I&*;R0Q1FRISP-QQBO0H+"VAM6MQ;6
MP20?O4CB"HY(YROO[YJMJ&F3R6H32+N+3)BR;YDMED+(O&W!P.G0]O2@#D9M
M?34/#I\1-=7]C;7\]I:V\0E,>/G4,&SQ'N<NC..=J@C)ZX;7[:E9Q6L^IEQ;
M^+DA1X[HR-%$4)4!VYQEF )_#&*]3ATZUATR+3S"LEM'&(]DH#!@/7/4]Z>U
MC:/%+$]K T<O,B&,$/QCD=^@_*@#S'5!<VNBZ]8O>W-WIMKKNG)9S74IE<9F
M@:1-[<L%8D<DD<C/%7WU*34O$.H6\WB5=+U&QU1%AM#N+2PX7:HC\P*ZR GG
M:2"3SP,=\UC9O;I;M:0- GW(S&"J_0=!2FSM3<I<FVA-Q&NU)3&-RCT!Z@4
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M%FR1D 9R *]5A@BMXA'!$D48Z*BA0/P%,%E:K=F[%M"+EAM,PC&\CTW=: .
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M%A9J7(M( 9%V.1&/F7T/'(]JC72[1=22_6)1/'!]G0A0-J$@D<#/8?3MC)R
M7**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQ!.3]E)\KRP@ ^_SD1CTZF@!VK>./[+EUL?V/=31:,D<MU()$&8V4L649YP
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MCJNSS$V;#QDXR/>J&G>%I[9](:^U%+PZ/$\=FWD;&R5V!G.X[B$R.-H.2?3
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M%O>0R2VTT#!LA%W .. FX<KD\]#@\5'8>"I[*#08CJ<<@TF[GN<_92/-\P2
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M'S,8QL#+MSR3C%71X?N&\->*7L=&*ZD=5EF@#P>4\T'F(S(C,!PZJRXZ<\T
M>BQ:E83P>?#>VTD6_P OS$E4KNZ;<@]>1Q2QZC8S6KW45[;O;QDAY5E4HI'4
M$YP*\Q\06^G76@W&L#1M3A:YU+3//_M")A)*5N$7 C/<*=N0/FSCG%6[S2I+
M+4=9U/3M$E.FW5UI^(4MG!1XW)>X6$89MN8^,<E<X('(!Z"-3T\QPR"^MBDQ
M*Q,)EPYZ84YY_"GM?6B2-&UU '5U1E,@R&;H"/4]A7GEMHEY=>&?$2O#<6M_
M:ZO)J>GW%Y&$RX"NC<8&#@AL#HQ[YJSJVGSZCH.BWUUIDDEW>:Q;7]S"L)E,
M,>1\K8'\,853ZD'UH [9-6TV18634+1EF<QQ%9E.]QU5>>3["I9+ZTBNH[62
MZ@2XD&4B:0!V^@ZGH:\RU;17^Q>,OL^C3^;-JMK-9F.S;+*H@W,F%Z!D<Y'I
M[U>:RDN/$&I:=J^CZM<^?J,=]97,.Y8"H";"SC_5LA7!!YP. <XH [T:C8FX
M2W%[;^<[,BQ^:NYF'4 9R2.]0:;KFFZO/>0V%W%.]I,89@C@X8 $].W./J".
MU>=C1WBMY98M'N$G'BU+I66S8-Y E4EQ\N=NW=^9]:W-,U!O# \33WVF:@8C
MJSSAX+8N#$ZH X/=1AB<=,'/;(!U6KZO8Z%ILNH:C<)!;QXRS$#)/  ]23VK
M+M_%,#^)-0TZX>TAM+>WMIH+DW Q-YID '. #^[X )SFF^/;.XOO!6H06MO)
M<3?NW6*-=S,%D5C@=S@'BN8\0:<^J7GC*?\ LBZD^U>'XX+,O9L2TN)_E7CA
MLO']/P. #T2>^M+62*.XNH(7E.V-9) I<^@!ZU2\1ZM)H7AS4=6CMUN#96[W
M!B:39N"*6(S@\X'I7#7=I-/J%Y9ZUH^L7UAJME;+";5&P"BX:*0\&,AOF!.!
M\QYXKJ_&D$TWP_UNS@@FFN)M/F@BBB5I&9VC*@<#)Y/6@"(>*[BVN]#BU'3H
MXH=8(C@E@N3+LD*%PK*47@@'D9YZXK?2^LY+I[5+J!KA!EXED!=1[CJ*\[;2
M)I-3\(W6B66HK?VDB+>RWB2B**V*8E7]]P&/ &SG\*9I\-Z_B+0IY=$O[:""
M[U!;B 6I,4(DW$-N.2X<_,6!*Y. !TH ]%CU&SGE\FWO+:6<H76-9@25!QG
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M.H'WAST.0!ZDUIUYCX;L+ZR7P-)/IEXJVD%Y;3*8&S"7*;-P(^5<*>>E>G4
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M0 4444 %%%% !1110 4444 %%%% !3'ACDDCD=%9XR2A(^Z2,9'OCC\33Z*
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M%95IX;TFQN%FMK784E>:./S',<<C9W,B$[5)W-R /O'U-:M8%KXQTJ[/R?:
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M[J:6W2!;1S*LT:EGC9<<-A3Q_3FK,_C#2[81//\ :(X6EBADE>+:()) I5)
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M.,D'IGB2'PWK%EXCU"2V72I],O[D71EN$)N+9B '51M*N#MR,D8)/7&#V5%
M'FVDZ5<>(M.\0:7_ *.MB_B.626;S"7"QS)(5"[<9)4#.>,Y[8-\^%O$$NOV
M.H7,NGS-9ZK-<K.\CF1[=TD14"[<)L#CY0<-C)(.<]K#;06^[R(8XMW78H7/
MY5+0!P*>$-<MI+?4+>2P-]::S=:A'"TS^5+%/N#(S;,JP#<$ C(]ZWO"^DZA
MI;:P^H"V#7U^]V@@D9]H95&TDJ.1MZ]\]JZ"HY[B&UA,L\BQQ@@%F.!DG 'X
MD@4 <*W@K41)J4UH+2Q>_LKB"ZAAN'\BYEDP$E*;<(P^8DJ"3G'/6II/"_B
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M?M>QV+>61MVY!8C?GH.F>0_1M \1V_AEO#FH7.GFS@LWL[>YAW&29=A1"ZD
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ME;)8J,DESVX"CUK1U_PCJ6MKK-VOV.*^OK:WM(HS,Q1(XI#(69@F226(QC@
M<UU4-Q9ZJ9X)(5:6VDV2PS*"4;&0?3!!!!'K]15T *H   '  [4 <YJVC:I>
M^)=-U.UDMH!:V-U 69RS+)+Y>& VX(4Q]R,YK!M/!FN/+++>OIZ27.B2:;<R
MQRR2N\I_Y:DLHSG/0].@SVZ^UUJ*Z\0:AHX@F2:RBAF9WV[760N!MP2?X#G(
M%:= '&+X8U6YG\/&]^Q+%8:?/9W(AG<D^8B)E,H,_<SSCK[9)IOA74TL_#EC
MJ#VCQ: ^Z&:)VW7&R)HH]RE?D^5LG!;D>]:-]XPM; >(#)97;?V' EQ.%V9D
M1E9LI\W8*>N#6_#*)H(Y5! =0P!]QF@#B=)\):Q8P>%8Y38G^R+FXFG*3.=Z
MR+(HV_)U'F9YQTK8UK2=2G\2:-K&G"U<V<=Q!+'<2,GRR^6=RD*<D&,<<9SU
M%;-I<27 F,MI+;^7*T:B0J?,4='&">#VS@^U6* .%T/PEK.F-X8\YK!QI,5T
MDQ29QO\ -(V[1L[8YS4.E>$=>T631;ZW;3Y;NR6[MYX'G=8Y(9I?-!5]A(92
M%XVD'U%=;JNM1:3=:9!+!,_]H70M8W3;M1RK,-V3G&%/0&M.@#SJW\&:_86V
MEW,']DW%]937H>WN&<PS0W$WF_>V$JZD+V/>MVVT+4X_%.EZI(+$0V]A/;3)
M$63#22(_R+MQ@;,<D$YS6KK6M1:)'9R3032K=7<5H#'M^1I&"@MDCC)[9K3H
M Y[Q-X?GU:?2]2T^:.'5-*G,ULTH)C<,I5XVQR RGJ.1@'GI5^!M7F0M<V]G
M;D(<1Q7#2;VQP"Q1=H^@)/MC!TJS->UJ+0-,^WSP331"6.(B+;E2[A 3DCC+
M#..?:@#CHO!GB&/PYIFBO-ITUK!I+V,L3ROL68@!9@-GS\<;6QCJ#5@>%=>A
M^SO$=.:1]"&E7&Z5P(V7)5T^7YQ\Q!!V_P!*ZFSUJ*]UW4M)6":.:P2%W=]N
MUQ)NQMP2?X#UQ5NXN)()K9([2699I-CNA7$(VD[FR0<9 '&3DB@#AY_!.I7%
MAI,?^AV^HZ=96]O!J=M<.DL3(<.,;?WD9 'RMQDGUS5[2_#>L:7K=W&JZ5-I
M4U])>I<R(?M46]S(T>-N#\Q.&W @'IQ795'%<0SF012*_EN8WVG.UAU'UYH
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MNKG<\DNYB?(G'))R3D@?4BJ\LEE<:;;S7ER)K>U\8R*TTTY<1QEG RQ/ ^Z
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MIVIZ:O'I*7<#W4AT&U\3-#=GS6<0V[0!E#')(C\XC/;J#QD5ZQ00""",@]J
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MH?Q%I*V,-[]NC>VFA,\<D8+@QC&7X!PHR,D\#-7I[F"UMGN;B5(H47<TCG
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ME<WH5CK.GW=QI-YHT5Q:KJ4U[;ZF\J,H221I/ND[Q(-[*.,=\]C0TWPSJ_\
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MV7@:WBOC%:S^&Y)'C< QAXXX-KGC/&]N] 'HMK:P65K%:VT8C@B4)&@Z*HZ
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MC0!8HJA?:UING:?>7US>PI;V:DW#;P?+P,X/O[=:MPSQ7$*S1.KQL,AE.0:
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MT^[U2ZTV"ZCDN[4*9HU8$INS@'WP,_B/6K$EU;Q3QP27$232?<C9P&;Z#J:
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ME;*(B!0'*DMAP" ._/'K-% 'F'B+19)YO&4&EZ3,L-YX=C2%8[5D66=3-P.
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MY,=F5=9%BY,IP" "&&3QDCUKL** "BBB@ HHHH **** "BBB@ HHHH ****
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M_P#ST_0T 3T5!]MM_P#GI^AH^VV__/3]#0!/14'VVW_YZ?H:/MMO_P ]/T-
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MB-^]",HHY)/W2![BMBTBEL/B+XY>ZTZ\FAO+.-X5BB;]^JQ'<%<# /;KU]Z
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !6Y;_\ 'M%_N#^58=;EO_Q[1?[@_E0!)111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 55FL4FE:0N
MP)]*M44 4O[-C_OM1_9L?]]JNT4 4O[-C_OM1_9L?]]JNT4 4O[-C_OM1_9L
M?]]JNT4 4O[-C_OM1_9L?]]JNT4 4O[-C_OM1_9L?]]JNT4 4O[-C_OM1_9L
M?]]JNT4 4O[-C_OM1_9L?]]JNT4 4O[-C_OM1_9L?]]JNT4 4O[-C_OM1_9L
M?]]JNT4 4O[-C_OM1_9L?]]JNT4 4O[-C_OM1_9L?]]JNT4 4O[-C_OM1_9L
M?]]JNT4 4O[-C_OM1_9L?]]JNT4 4O[-C_OM1_9L?]]JNT4 4O[-C_OM1_9L
M?]]JNT4 4O[-C_OM1_9L?]]JNT4 4O[-C_OM1_9L?]]JNT4 4O[-C_OM1_9L
M?]]JNT4 4O[-C_OM1_9L?]]JNT4 4O[-C_OM1_9L?]]JNT4 4O[-C_OM1_9L
M?]]JNT4 4O[-C_OM1_9L?]]JNT4 4O[-C_OM1_9L?]]JNT4 4O[-C_OM1_9L
M?]]JNT4 4O[-C_OM1_9L?]]JNT4 4O[-C_OM1_9L?]]JNT4 4O[-C_OM1_9L
M?]]JNT4 4O[-C_OM1_9L?]]JNT4 4O[-C_OM1_9L?]]JNT4 4O[-C_OM1_9L
M?]]JNT4 4O[-C_OM1_9L?]]JNT4 4O[-C_OM1_9L?]]JNT4 4O[-C_OM1_9L
M?]]JNT4 4O[-C_OM1_9L?]]JNT4 4O[-C_OM1_9L?]]JNT4 4O[-C_OM1_9L
M?]]JNT4 4O[-C_OM1_9L?]]JNT4 4O[-C_OM1_9L?]]JNT4 4O[-C_OM1_9L
M?]]JNT4 4O[-C_OM1_9L?]]JNT4 4O[-C_OM1_9L?]]JNT4 4O[-C_OM1_9L
M?]]JNT4 4O[-C_OM1_9L?]]JNT4 4O[-C_OM1_9L?]]JNT4 4O[-C_OM1_9L
M?]]JNT4 4O[-C_OM1_9L?]]JNT4 4O[-C_OM1_9L?]]JNT4 4O[-C_OM1_9L
M?]]JNT4 4O[-C_OM1_9L?]]JNT4 4O[-C_OM5M%"1J@Z*,4ZB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MUT^J64C+J<-]%));,9%5  8L[^$&"0!W//.277'@O4C%>FTU6"&<:L=6L9#
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M!^;=@.=A., ^W-3^(]&N-8BTYK6XB@GL;Z.[4RH75MH8$$ @]&/Y5C#P5/\
MV=?:(]W$^CW=_P#;3E2)4!D$KQ#L07!PW4!B,'K0!L>+-<F\/>'Y=0@M#<R+
M)%$%# 8WNJ;CDC."PX_EU'.2^*)M#\3>)KF\M]2N+&VL[.X>%&1A:*1+YC8+
M =AD*23CC.*Z;Q1HTFO^'KC3H9T@E=HY$D==RADD5QD C@E<?C6+J/A'4=1'
MB;?>6H;6]/CLMP1@(BJR*6QDY!\P\9[#DYH NZSXXTG1'G$Q>5;81FX,3)F,
M/@@[2P9N"&.T'@_A4WC6YFM/ VMWMI.\-Q;V,T\,L;8*LJ%@??D=*HKX<UVR
MUN>\TS5;2&WOXXA>Q30-(4D1 GF1$,,$J ,,". >>E;'B72YM;\,:EI,$J1/
M>VTEOYD@)"!U*DX'7&: ,+1]3M_LPO\ [=K$C65@MS=PRPR$2AE8_*K*"6RA
MQM^G<5H1^,;#.H)<P7-M/8B R0R!2S&8XC5=K$;BPVX..?;FK-QI-Y-X1DTJ
M*]%I?-9_9DNX0?D;;M##H??K^/>N9E^']]=+J6_4+*T:[M[01?8[4J()[>1I
M$<98Y&3R#R?:@#5UGQ' FDWYO;+6+,6MS;Q2-#M1CO9-K(X;#+DA6P<CD$51
MN]3DLM:\;&[N+][&TTVWF\NWDP\(*S;VBR0%;"@_@*NZGH.NZWX9GL=1O['[
M9-+"V8(66)!'(K\ L22Q7!.0.G''*:AX6O;VX\3R+<6Z#6M/2R4$,?)*K(NX
M^O\ K"<<=!Z\ $EMXEF?Q%'I$6GW,ENNEI>"8NA=]Q(&<L/[I'N3V')@T_QA
MI=MX;TJ6%KRY^TV9N(4NIH_/:-<<NSL 6)(&,\_@<6;;P]?VFNVNIQW5L=FE
MI831,C?,48LK*V> 23G(-95AX+UK1;30Y-*U2S6^TZS-C,+B!FAN(B0P. P*
ML",CGN: ->T\::=J)@&GPW%T9;:&ZV(%5TCD8J"59@3@J=V <8K5U?5[;1;1
M+BZ/RR3)"@R!EW. ,D@#\37/ZWX0N=;EMVN9[9IX!&T%^J&.XMY V7*$=588
M&TG [[JW=<T]]4T_[*(K2:)W'G07<>^.9.<J?3L0>Q'>@#/GUF&35]!BGM]3
MM9KJXN(XH]RJA9$?(E 8[@0I9<9[&FIXTLII]/6&SO)8=0N9;6VG0)M=XRV[
MJP('R.1QSM/MFC8>#+C3GT#RKM#!I5U<7 B<L^U)%=5B1CSA _!/7';MSGAJ
MXE?5+::U.E7+?;9)A8M'/%<V@E<[R8RQ2-E5CD[0#SS\Q) .LL_'-G=SV:?V
M;J$,-U>RV"W$JQ[%GC+@H<.3SY;8(!'3G-21^.=(DU2ULU9BEU+)#%<!D*%T
MSD$!MR@[6P2 #CW&:$'@^_BM-/@-U;$VNM2ZJQ"M\P=I&V#TQYIY]NG-3Z1X
M8U?3HI](EU2WET M*8D$!%P$<D^67W;=H+'G&2 !0!4G\0S:EXK\(RV2WL6G
M7S7#!RRB*Y00LRDJ#GT89 X]Z[BN)TKPAK5E+X;CN-3LY;;02\<3"!A)-$8C
M&H;YL!@I'(STS[5VU !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% #?,3S/+WKOQG;GG'TH$B,Q
M574LO4 \BO+[AF;Q59W$6FWL$EOXD?SMMI*[,AAD3S#)@Y1ODPJ\ 8STXT_"
M<5S:^)418UO+*2WG=+J2W,5U:$R*QAF/1\GE3P3M)Y'- '>LZ)C>RKDX&3C)
MH9T5E5F4%CA03UKA?$+6R^+[RV\0:==WFDZAIJ06C0VTDRI)N?S4^0$H[!HR
M&X^Z.>*H:E:.\WBJRU2PN'DN;*+^R#L:5@!#@(CC.)%E!;KGD-TYH ])+JI
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MJS-;+=>)=0T[78]6-^;^*YT^:UM<I(BJFTK,$/E[2&# L!R>NXT >F$@ DG
M'4FD\V/R_,WKY>,[L\8^M<QXYDN+>RTNZ6VFNK"WU".34(88S(S0;7&=@Y8*
MY1B #]VL6:*U@O\ 0[VQTZY3PV]]<S72R0R8\R1/DE,;#*IOWCH "0V #F@#
MT+<N =PP>ASUI/,0Q^9O79C.[/&/K7E;:*1)I23V3OIQ\3RRVD1A8B*T:%P0
M1CY8S(3P<##+VIMMYFD+&[:=<MH%IXANVGMXK5F"1.K>5((P/FC#G/ (!P1T
MH ]!U/7#I^L:)9"W$L>ISO#YPDQY96)Y,XQ\V0A'4=:UMPXY'-<#+:V<-_X.
M&F:?=0:>NIW,P22*3Y$>"8;BK#,:EW  .,9' Z5BV4?V>+0=/_LZ[%SI_BBY
M>4+9N1%$[7!4A@N-I#(>.,4 >K&0'>L95I%'W=W?W]*BLIII[*"2ZA2"X>,-
M)"DOF!&(Y ; W8]<5Y_H]O+!JMQ$\"7^G36=VWGS6K1W-IN=6:&7C$@8_=.,
MG:3R.:KV6FW=AX/\$^(+/3'FU33+:&TGMS'MD:.1!&RG(R"K[6]@&]: /3FD
M1%W,ZJN<9)P*=7G.NV,.C:EIEMJ,-V^B264L,DMI9"=1<NP+LZ!'(W@G! ZY
M'>NAFL+RW^',^GZ,;M;Q-->*S^TO^^#;"$W'LW3Z&@#HQ(C;MKJ=IP<'H?2F
M7$DD=M*\$:RS*A:.-GVAVQP,\X!/?%>?:/HF@^*K>^"VFJ1?:].^Q7D5W9BW
M2(Y^4;?+4-(I+889QZ\BGP65Y?\ @/5;G6M. U"+3)=-5/*W%S&&4N@ SAW
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M\\AC X#\<G';\*\]\/:5!,O@&/4M,9UAT:XANUN+9BJ-B+:L@(QU5\!NX.*
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MIU>9Z'9SSQ>#&M[6>VUFQ<IJ[21%6V>4PE\QL?-OEV,.3DG<.A->F4 %%%%
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M1L8$'W(H ]%ZT5Y?X7UN>V\ :!;Z5?&0I97 <3P[K@R0D+M"9*B-6R"Q;H$
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MS.,]ZX9)]4O?#WAZ>YO4N+EO%$J1R21<+MEN%Y /(P!P,<#'O0!ZM2$A022
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M^?\ =M@C&<CC@Y;#XQNKK6[^QM;B"2.XMH9='E\GB0N0'S\WS!"Z$XQP3W%
M'=T5QO\ ;VNWUY=-I5O%)#8:C]DG678JLB[?,8MOW*W)(^7&,=<Y%GPQJ.N:
MM?:A->75E]CM+ZYLQ#%;,K/L8!6W%SCC.1@_7L #J:*S]<NKVRT2ZN=.MOM-
MW&F8X1C+<C. 2,G&<#(R>*YFT\53:C:VYLM1B<RWSV[I);,EW&%BW>7Y1&/,
M#=2<*%YH [:BN#L?%VJR:3X7UB\-M%8WT[6M_B,CRY"66-@=WRJ74*<Y^\.:
MNOK^IR76GZ?$/](U""XO(W2)=R1*R"-=KN 6Q(I;GL1CG( .OJI'JFGRW[6$
M=[;O>*I9H%E!< '!.W.>#Q4&D2ZI=:# ^IQP6VIM&5F6$[XTD!(R.>G&<9]L
MUP?A/4;B#3/#-F[P/>:G<7P2Z> %H45Y'DP2>68A?;KD'% 'IU%>?R>+->+1
M6,9LDNX]>.DS3/ S+(AB,JR*-PP<;<KDY.>16YXFU+5?#_@&_P!12>UFU.RM
M#(TC0$1NRCDA-V1GZG'O0!TE%<-J.L^)+;5M9T^.]T\&VTM=2AD-HQV\R*8R
M-_(_=@[O<\>E;6?&FIVVA'5K0VN8]*M[\VRH7;+DEA(> B8&%P=Q.[@[: /0
MJA6[MGO)+1;B)KF-%D>$.-ZJQ(!(Z@'!_(UPNO>*-?T^7Q3-;S6(M]$\B5(V
MMV+2HRAF4G?P>O('IP.^I=:G?OXB\1:<CV\2V^EP7$$JPG>"QF!#'=\WW..F
M,T =#;:II]Y<RVUK>V\T\(!DCCE#,@/ ) /'0_E5NO-_#=_=V^A^$].MD1[^
MZT%)Q<I F]8D2(!/F<;N7R>>W3G(MWOBO6M+AL?[;BATWS+=1)=Q1F>V2YWL
MK)(P.8U("X)X!8Y/RX(!WM%<MX6N-0N-?\4K=WOG0V^I"**/R\;%\B%@ <]/
MF/X\U7NM?UR\OM331;:-QIEZEO)'-L"2+M1Y"S%PRG:YVX4CY><YX .QHKS^
MY\0^)ETSQ7J<5WIJQ:))=(D36CDRA(4D7)\P8ZD'KG/X5H6^L:S_ &OINCW-
MY:^?J,$MZ)HK<J(HD6,>6 6.YMSD[O0=.> #L**\]A\5^(+^?2["%K&VNIM1
MO=-N96MV=2\*.PD0;QP=H.T]^,UWT E6WB6=U>8(!(Z+M5FQR0,G SVR: )*
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HK!T34[V\\
M0>(;&[>)H["XB2#RXRORM$K\Y)R<MU_2C0]3O;S7_$5C=O$T=A<Q1P&.,K\K
M0H_.2<G+'G]!0!O45A^(TUQK:272=2M+!8(6E+SP>;YC#)VGD;5XY/)Y[8YN
M:%?3ZIX?TW4+JW^SW%S:QS20_P#/-F4$K^!- %*[\'Z+?-J!GMYB-0D26Y5+
MF1%=TVX; 8 'Y$R1C.T9IUUX2T6].I?:[5IQJ4:178DF<B14^YQGY2,\$8.:
MH^-/$]QX;MK:>UMQ.D<BSWWK':!E61Q[C>"!Z!O2MC4M>TW2$M'O;@HMW((H
M"L;.'<@D ;0>2 <>O:@!=(T6TT2U,%H9WW'+27$[S2-Z99R3@=AT%5#X3THW
M]]>K]M2XO]OVEX[Z9/,VC:OW7&,#CC%-C\8:));6\XN9E2>[^PJ&M90RSYQY
M;*5RA_WL5JP7UO<W5S;Q,QEM6"2@HP"DJ& R1@\$'C/44 9)\&:"$L4BLC E
ME"\$*V\SQ#RWP61MI&X$@$@YR>:6R\'Z-I[6S6T5PC6UF;&(_:I3MA)!V\M[
M#GJ,#'2K'_"2:5_:$-E]I/FSS/!$WEMY;RH"60/C:6&&XSU!'4&HCXKT83B(
MW3AGA>>(F"3;-&F-S1G;A\9!^7/!STH @C\$Z#'#!"+20Q063Z?&CW$C*+=\
M;DP6Y!VCKSP*T[;1[*UT8:2D;O9"(P^7-*TA*$8VEF))&..M8,GQ!T9AI[6:
MWERE]/%%'(EG*%PZ&0,"5^;Y5/ R<_0X9J_BM-)T/Q3J=O=27LNFE@MLUJRB
MWD$2L$) RRDD-N/&&QF@"W'X$T".(QB&Z8-9FP)>]F8F _P9+=.H'IGBK1\*
M:.THDDMGE(LC8;99G=3 >J%2<'IU//O5#3KZ:+Q&EO=>(9YTGM9+B&RN-/\
M)8*I168R;5X4G@8!P_.>#5W_ (2_0AYQ>^$2Q6AO2TL;HK0 X,BDCYEZ=,]1
MZB@!-,\(Z3I-[;WEL+LSVT#6T+37DLFR(D'9AF(Q\J]?05:O= L+_4%OY1.E
MT(3;F2&=XRT9.=IVD9&>?4=C6=JGC73=.TC4;U5N99+!D26W\AU=6?&S((R%
M.1S]>_%7+[Q/I.FQ&6[GDBC4(TCM!)B$,<*9/E^3/^UC'4\4 0W_ (-T34);
M*5[:2WDLHO(A>SG>W(B_YYDQD93CH:T[S3+*_P!*ETNYMT>REB,+PCY04QC'
M'3CTIFK:Q8:'8&^U&?R;8.J&38S %B%7. < D@9/'-47\6Z/'8->/+<B%$>2
M3-I+OC16*LSKMW*N5;D@9P<=#0!,OAS3OL]S%(L\QN8/L\LLL[M(8N?E#DY
MY/3USUJ.'PKI,$T,L44ZO#9?8(S]IDX@X^7[WL.>O'6LX^)/L_BV_%SJ$0T2
M'1HM05]HVJ"\@+;AR1M0&I]4\:Z9IVD:E?(MQ-)8;!+;^0ZN"^-F01D*<]?K
MWXH <O@C0HQ9"&"X@-G;?8XFBNI48P=HV(;+*.P.<5/:^$M(LCIQMXIT.FV[
M6MJ?M,A\N-@ 1RW/W5Z],#'2HY?$-C;ZM<M-J,Z16^GBZEM'LW!1-Q_>YV[C
MZ;>V#Q4UAXKT;4IWAM[I@RVPN\RPO&K0G^-68 ,H[D$X[T 10>$M+L(=.%C
MZ2:6CK8![B0K'N&"#\WS#MSGVK \-^%M3L)K(O'>V+VY7SB-9EG@EQ]X)"W
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MSI8MLT3(?DD9,\CG.W/&<9P>: +<NF17.E)I]S)-*BJ@,GF,DA*D$-N4@@Y
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MV:"19 I!*G:5R5.#R!C@^AJMX3N[_4],MM7NK]Y(+NTBD-O):^5Y,I7<VQL
ME.1C.>GWC0!T=%8<'B[1+E'>*[<HMJ;P-Y$F'@!P9$^7YE^F>H]13+?QIH5R
MKM%=3$+9_;@?LLHWP<9=/E^<#(SMSC/- &_16?;:WI]XM@UO,\@U"(SVQ$3X
M=  =QX^489>N.HK \2ZY<Z9XOT/3_P"U(K*QOX;EI7E5/E:,)MP6]=YSGTH
MZ^BN?M]?MK&RA>^U-;W[5OFM'M[=F:2%0"6VH#TSU'!R.YQ5BX\4:/;V,5ZU
MT9+>6V^V*T,3R?N, ^80H)"X/4T ;%%<]-K,5QJ%S%8ZMF3^RQ=10"WRNTD[
M9@Y&&STQG'%4M"\0O=Z=X5EOM2D6\OM,^U26Z6NX7)\M&9@P7Y2I.=HZ[AQT
MH ZZBN4LO%UIK.GZ-?1W-SIZWMZ8HXY+1CY^-^(R2N%R!NR#_"1GK6LWB/2E
MU"&R:Y*R3RO#$YB81O(N=R!\;2PPW&>Q'8T :M%9^GZU8ZFX6T>1PT2S(S0N
MJO&>C*Q # ^W]11-K5C#>FT:20RK(D3[(794=\;59@, G(ZGN/44 :%%8-CX
M@L5MKNXEU1KA!J#6JAK<HR29 $(7&6()ZX]?2D;QIH*1-*]W*B)=K9.6MI1M
MF)P$/R\'/]/44 ;]%9%KXFTJ\M)KF&>3;#/]FDC>"1)5EX(3RV4-D@@CCH<T
M0^)])N+;SHKEF/VEK3RO*?S?.49*;,;L@#/3ISTYH UZ*YOP9K%UK5CJ<US,
M9?)U.XMXBT/E$1HV "N 01[\U>A\2Z3/J26$=R6GDFD@3]TVQY(P2Z!\;2RX
M.1GL?0T :U%9]CK5CJ4JI:R2/OB\Z-S"ZI(F0-RL1AAR.A[@]"*BU/Q'I6CF
M7[=<F,0JKS,L;.L*L<*SE00H)!Y/H3T!H U:*R;SQ)I.GRRI<W)00ND<T@C9
MHX6;&T.X&U<[EZD8R,]14$_C#1;?4I]/>><W5NP69$M)7\LE2XR0I !4$@]#
MVH W:*PK'Q?HNI6RSV<\TL;B,Q$6LH,N]2R[ 5^?@$G&<8.<8J6+Q3I%Q9PW
M4%R\RS&0)''"[29C.'!0#<-IX.0,$@=Q0!L45SUKXQTV_P!;L-/LO-N([VQ:
M]BN8XG,97<JCG'^T<YQC !Y-=#0 4444 %%%% !1110 4444 %%%% !1110
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MY>WAP7(W9QCFJ.@>'-8T_24TV\T72/,L+5[>#486'F7(V%%."H,9(QN.X].
M<\=_10!Q/_"/:NGA7P?:QP0->Z+-;M/$\VU7"0M$VU@#_>STZ"H-5\-:Q>Z5
MXXM8K>+S-;<?9290 !Y"1$MZ<H3WX(KO:* .1UG0;[6M=MIVB\BU;2+NQF?>
M"\;S>7@@#J!L/YBJ\%GXQD\)3:;);:9;7]O9?9H)UF\Q;AP  V"GR*0.ASR1
MQ@<]M10!YQ=>$=<NK;Q,J6MM"=3AM6@5[UI6\R(Y*NQ7/..O/;K5VYT#6/\
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M&( [6D<(I.2.,L* .=F\-7P\5QZEIZ263BXB$\Z7&8KRW5 ")8SUD&"%8#@
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M4DJV#T==S8/3GD'BF:=X4M=*U:SO+*9XX;33QI\5MM!41@@@YZ[L@<__ *Z
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M);O(4$H!N-PS@XR!CI5R_P#A_%?PW<)UB]BCN["*RG5%C.X19V,,J2/O'(&
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M#(X 9'4]0< ]000.: .<7QEJ&HZEH,%G:0PF;4+JROX993E)(8W)4,%Y7(#
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M6>E2&2PAD _=$JRKENK;59@OUYR0#724 %%%% !1110 4444 %%%% !1110
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MGE&.1GMZTV72M0U3PIJJ2>%;NUUG^QIM/#S7:R^8[K@)$?,(V9&<MMQQUYP
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M+2ZCFDM7$<ZH<^6Q&<'WP16%X=_Y'+QA_P!?5M_Z31T>'?\ D<?&/_7W;?\
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MGZMK=L]]BV35K&S29E3_ $6.9$+G.,=20"V<$CKC%.\207\#Z7;-K]Q,K:_
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M03G)!QG!&?6K5OJNLZQ?W4]IJ5M:)8:P;2>"60$&(-MVE-F=S@AE.[J1VXH
M[KI5/3=4L]7MGN+&;S8DE>%B49<.C%6&" >""*\]@U;Q&EA::Q_;<UR4\0/I
MLEFT,02:$W30]E!W@8.00,+TZDLT>ZO]--K<V]_*L%SXKO+.6UV)Y;(\TV23
MC=N! (((''3K0!ZC17G<?B35I_#]GXAAN7,SZS]CFTXHNWRS<F#9TW!P,-G/
M7/;@1+K&N1N;QM9GD6+Q.--\AHH@CP-(J8;"YR W!!'3O0!Z317#:;JNLZS=
M+?P:C;6\5MJTMI=6LD@(\M9&C";-F0Y 1@=W?T.!VZ.DB[D967)&5.10!GW6
MOZ99WT=E/<%9Y)4A $;,JN_W59@,*3V!(SD>HK2KS>.>;2[[QU=C6)H&74+>
M))&B23YG@MPN%P,M\VT9..03GDTH\4ZE9W%]8W5TT48UZWL$GE*,]O%)"DF"
M0-I.X[<G.-_4X% 'H]5VO8%U!+$L_P!H>)IE'EMMV@@'YL8SEAQG-<IJ<^NZ
M7!LM;R;6%BO)'FAMO+CND@V A%S\KLI93V)!7\:UCKMY?:KIB6NKSRV=UX>E
MN@[0HC&97B42$%>&^9LJ>/:@#I8/"^B6UZUW!IT,<K2&4A<A-^<[MF=N[/.<
M9S5^XO8+6XMH)6<27+F.(+&S L%+') PO"GDXKS[1=0UV^_X0_SM?NL:WI+S
M7.V*(;'5(F#1_)P3N;.<CG@#C$VD:_J]S:^#))K]W-Y?W5I=_NT'GK&D^TG
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MHLD,5QB.UD7[.CC&9"<X&X-AC@8&>@)K5M-=L+[4KC3[9YGN+9F2;_1Y B,
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MJ-?$=B;R0F]40"V@F6-K:17_ 'KLJ-N/4,<*% R"#GK0 [_A)+;_ )\-6_\
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M #X:M_X+IO\ XFC_ (22V_Y\-6_\%TW_ ,36S10!C?\ "26W_/AJW_@NF_\
MB:/^$DMO^?#5O_!=-_\ $ULT4 8W_"26W_/AJW_@NF_^)H_X22V_Y\-6_P#!
M=-_\36S10!C?\));?\^&K?\ @NF_^)H_X22V_P"?#5O_  73?_$ULT4 8W_"
M26W_ #X:M_X+IO\ XFC_ (22V_Y\-6_\%TW_ ,36S10!C?\ "26W_/AJW_@N
MF_\ B:/^$DMO^?#5O_!=-_\ $ULT4 8W_"26W_/AJW_@NF_^)H_X22V_Y\-6
M_P#!=-_\36S10!C?\));?\^&K?\ @NF_^)H_X22V_P"?#5O_  73?_$ULT4
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M?_$ULT4 8W_"26W_ #X:M_X+IO\ XFC_ (22V_Y\-6_\%TW_ ,36S10!C?\
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M2U\*_8K+POI$3N]MHS+/).V?WC+$R*!DG&6<MC. %QW%=7110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
$0!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>exhibit1033-bochk_facili015.jpg
<TEXT>
begin 644 exhibit1033-bochk_facili015.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MY)4MU^7.2/:O7K;Q9HU[JRZ99W,ES<')S#!(\8QUS(%V#\Z -NBBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MP"15Q(9-I?)P>G;..>E<SX?\9>(KOPCX$:XO9<ZWJ$T-_J!4;E"R,$C'&%+
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MP$A<E<;_ # -P&,#C(QT]JVY]1U&'P1J^I/>75K?1Z3-/;Q22JY<I"KB=?\
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MO\: .EHKFO[$\3_]#=_Y38O\:/[$\3_]#=_Y38O\: .EHKFO[$\3_P#0W?\
ME-B_QH_L3Q/_ -#=_P"4V+_&@#I:*YK^Q/$__0W?^4V+_&C^Q/$__0W?^4V+
M_&@#I:*YK^Q/$_\ T-W_ )38O\:/[$\3_P#0W?\ E-B_QH Z6BN:_L3Q/_T-
MW_E-B_QH_L3Q/_T-W_E-B_QH Z6BN:_L3Q/_ -#=_P"4V+_&C^Q/$_\ T-W_
M )38O\: .EHKFO[$\3_]#=_Y38O\:/[$\3_]#=_Y38O\: .EHKFO[$\3_P#0
MW?\ E-B_QH_L3Q/_ -#=_P"4V+_&@#I:*YK^Q/$__0W?^4V+_&C^Q/$__0W?
M^4V+_&@#I:*YK^Q/$_\ T-W_ )38O\:/[$\3_P#0W?\ E-B_QH Z6BN:_L3Q
M/_T-W_E-B_QH_L3Q/_T-W_E-B_QH Z6BN:_L3Q/_ -#=_P"4V+_&C^Q/$_\
MT-W_ )38O\: .EHKFO[$\3_]#=_Y38O\:/[$\3_]#=_Y38O\: .EHKFO[$\3
M_P#0W?\ E-B_QH_L3Q/_ -#=_P"4V+_&@#I:*YK^Q/$__0W?^4V+_&C^Q/$_
M_0W?^4V+_&@#I:*YK^Q/$_\ T-W_ )38O\:/[$\3_P#0W?\ E-B_QH Z6BN:
M_L3Q/_T-W_E-B_QH_L3Q/_T-W_E-B_QH Z6BN:_L3Q/_ -#=_P"4V+_&C^Q/
M$_\ T-W_ )38O\: .EHKFO[$\3_]#=_Y38O\:/[$\3_]#=_Y38O\: .EHKFO
M[$\3_P#0W?\ E-B_QH_L3Q/_ -#=_P"4V+_&@#I:*YK^Q/$__0W?^4V+_&C^
MQ/$__0W?^4V+_&@#I:*YK^Q/$_\ T-W_ )38O\:/[$\3_P#0W?\ E-B_QH Z
M6BN:_L3Q/_T-W_E-B_QH_L3Q/_T-W_E-B_QH Z6BN:_L3Q/_ -#=_P"4V+_&
MC^Q/$_\ T-W_ )38O\: .EHKFO[$\3_]#=_Y38O\:/[$\3_]#=_Y38O\: .E
MHKFO[$\3_P#0W?\ E-B_QH_L3Q/_ -#=_P"4V+_&@#I:*YK^Q/$__0W?^4V+
M_&C^Q/$__0W?^4V+_&@#I:*YK^Q/$_\ T-W_ )38O\:/[$\3_P#0W?\ E-B_
MQH Z6BN:_L3Q/_T-W_E-B_QH_L3Q/_T-W_E-B_QH Z6BN:_L3Q/_ -#=_P"4
MV+_&C^Q/$_\ T-W_ )38O\: .EHKFO[$\3_]#=_Y38O\:/[$\3_]#=_Y38O\
M: .EHKFO[$\3_P#0W?\ E-B_QH_L3Q/_ -#=_P"4V+_&@#I:*YK^Q/$__0W?
M^4V+_&C^Q/$__0W?^4V+_&@#I:*YK^Q/$_\ T-W_ )38O\:/[$\3_P#0W?\
ME-B_QH Z6BN:_L3Q/_T-W_E-B_QH_L3Q/_T-W_E-B_QH Z6BN:_L3Q/_ -#=
M_P"4V+_&C^Q/$_\ T-W_ )38O\: .EHKFO[$\3_]#=_Y38O\:/[$\3_]#=_Y
M38O\: .EHKFO[$\3_P#0W?\ E-B_QH_L3Q/_ -#=_P"4V+_&@#I:*YK^Q/$_
M_0W?^4V+_&C^Q/$__0W?^4V+_&@#I:*YK^Q/$_\ T-W_ )38O\:/[$\3_P#0
MW?\ E-B_QH Z6BN:_L3Q/_T-W_E-B_QH_L3Q/_T-W_E-B_QH Z6BN:_L3Q/_
M -#=_P"4V+_&C^Q/$_\ T-W_ )38O\: .EHKFO[$\3_]#=_Y38O\:/[$\3_]
M#=_Y38O\: .EHKFO[$\3_P#0W?\ E-B_QH_L3Q/_ -#=_P"4V+_&@#I:*YK^
MQ/$__0W?^4V+_&C^Q/$__0W?^4V+_&@#I:*YK^Q/$_\ T-W_ )38O\:Z"V26
M*UBCGF\Z94 >7:%WMCDX'3/I0!+1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !17E=QJUO_ ,)=
M9S03R12Q^(Y+:Y64LTY0PR* 2,!8B0NQ,'/!!SD".QOK"\\16EC=:[;1:C;:
MW<M-*]T8I;J(M(J0[<@G#%  >,1@C.<4 >L57LIYKFV\R>TDM9-[+Y4C*QP&
M(!RI(Y !_&O,M)U:VE\7:)-!/)&D]UJ$%RDC,9\Y8JLS# '(RJD?*H&":KZ4
M\%U9>#H9KR5D;6M1CE'VIANCS<[0W/(.4Z^H]: /7:B^TP_:Q:^:OGE/,\O/
M.W.,_3->5VLS_P!AI;V>HV'^AZM?K;VFI.3;SPK(P6,OG*D*P*'GCMBM+PX;
M*3QSIMY)8M:2W7AVW,$=Q\T@97<$;OXF"E<GTQ0!Z#+=0P2PQ22*)9B5B3/+
MD DX_ &J6@:U'K^E_;HH)8%\^:$QRXW QR-&<X)'53WKGO%,-DGCSPG=WD4>
MP&ZB$CKGYBBE%SZD@X%<MHS6MM'X<OX+C;=2>);V&1A,>86>Y.TKG&TGRSTZ
MD'O0!Z[61KWB"'P^MB9K2ZN/METEI&+?9Q(^=N=S+QQUKBO"ES;ZGK%DUWJ-
MS%XDLYYEOK-(2KN"6!\TG[T7W2IZ#Y0/2M3XERQ):^'5DNA;_P#$\M7,FY04
M4%LMSQ@>IXH Z*Q\06UYK,^D207%IJ$,(N/(N N7B)V[U*E@1D8ZY'I6M7E-
MVVI1^+/$%SX<N9-:GET&39?,%<VTRD^7#&R@(=Q);;C.0"35L36L]SIUUH=R
M5L9='N#JNR4C:0J>69#G*R[BPR?F/S9Z4 >ET5Y'#8:<GA7P)<&YG$VH7%HM
MZQO)/WF+9PP8;L#!P#TQP*N:C'#:_P#"5:5<M);W%I:Q_P!@CS&,@00C9Y!)
MW,_F@@XR3\H.1B@#U"BO-=8TG4Y+U+*5'\_Q'I:V\TJ9VVMW&,M("#\N59SQ
MU,0'>FRW^I3>"'\02V<UM<(;:TNXXHR62&*4"X*J.<9\P<=544 >F45Y/?G2
M3IEO=:9K4\VGW>N63?NG,,$?S@2"/&.,#+=@3G@YKT"\@M="\(WD=K'=+;6M
MI*R);N6FP%)PA8D[O3WQ0!L45XK=:A#_ &5XGCM+Q5@F\,13VXM9'"F8><,[
MN-[_ ' S #)P",\5IZO<7&EWFO+X=FF>>;P_#<;(IC([2>8X9UR3\_EG/'/"
M^U 'H:ZU&?$[:$;>42K:?:Q,=NQEW[<#G.<^H%7I;J&*9("X,\BL\<0(W.%Q
MG&?J/S%<'H%SH5Q\25GT.:"2VFT,8:%LJ6$O?_;QUSSQS5[7([&'XG^'KN\C
MB4/87<:2NO60/"RC/J!O(_$^M '1>']9B\0:);ZI##)#'/NQ'+C<N&*\X)':
MM*O(?"Q@M%\$7-M/MN;F>]@GS,<,FV5E4C. -X3'N?4UI^![FUU.^TNXDU&Z
M77[:!XM4LQ"48R$?,9\]0'&5/OQQD  [+6?$46C7^FV;V-W<2ZC*T,!@\O&\
M*6(.YUQPI-2:9K]KJ>H7NGB*>VOK+89K>=0&"N"58%25(.#R">G.*YKQ[- G
MB+P<LM\+3;J$CM+O4&-?(D&?F! &2!R.]<[+<C3]1\:7*37FJ:9+9P/+JD3[
M91)NV^2LBC;L53N)5?E!.<F@#URLOQ!K4?A[1Y=2FMY9XXW166+;D;F"@\D<
M9(]Z\OU"^B_L[Q3!%?(L*ZCILML+-GBB"N80YCP?ND;LXX.":G\0/;6=CXWT
M^UN%6W6:PDAC:4N [,A<C)SSM!- 'KM%<GX+U"&[;4(;Q43Q!#-B_ ;(?@;7
MC_Z9%=I'IWRV2<3Q+#9W7C#7H;J=C$OA]9!&;A@JR!Y>0,X! VG\C0!Z/17E
M%I>Q6,^CWJW-W)+>>%[B>]\B<M--*JPE2,D_O/\ 6;?Q'04_0(K/7-5U#2([
MM19:AH5L\?V5FPLFZ52X?^*1?ERX R0 1GB@#U2JEWJ$5K/;6Q!>XN6(BB7J
M0!EF/HH&,GW ZD \WX,>\U-5O-3M?(NM.B.FE<85Y4;$LB^JG"[?3YO6GMY@
M^+<1DSY1T)_(STW>>OF8_#ROTH V=#UJ/7;2XGCMY8/(NIK5DEQNW1N5/0D=
M1ZUIUY'#81M]JDL)I4\2Q>)I6AB2=@PA:ZR^Z/./+,19B<8/'M3I]2@M!-8O
M<F.[M_%T;>3D[HK=I4(..T94_0T >JPW,,[S)%(KM _ER@'[K;0V#[X8'\:E
M/ Z9KC/ \-G:ZQXJ@CBCBNAJTCLH7#>6R1E2?8G)'KS[U1U:ZDM?'&]6MM0@
M>]MHI+?<4N[-B%PT?]^'!W,.,?.<\' !UV@ZU'KVGO>102P!+B:W:.7&X-'(
MR'H2.JGO6D3A20"2.P[UY'IC6MN-&U"&XVW3^*KR)G$QYA>2<D8SC:<H>G<&
MK&C:O;R>+M"GMYWC2>XU"&Y24LT^[)*K.W SD952/E4#DCF@#K[;QI;7-CH]
MV+"Z1-4OI+% Q3,3H9!\V#W\INF:Z:O)]-N8/^$;\'#SH\CQ-<$_,.!ONN?_
M !Y?^^AZUU7Q%94\/6I,[PG^T[,;DE,9V^>F[D$<;=Q]NO:@#KJBN;F&SMWN
M+B58XD&6=CP*\NNKE]+N_$-I822?V5!K-B]TD<C/Y=LR(9B.2=NX?-CMN]ZC
M\2VT<NF^*3:^7/X?1]/G@V?/%'*)1YQCQP $VDXX!)]Z /3=7U%=(T:]U)X9
M)DM(7F:.+&YE49.,D#H/6IK*Y6]L;>Z52JS1+(%/4 C./UK)\0I'/X#U9+%-
M\;Z;,L"Q+G<#&VT*.^>U<$MO<0017O@V>::X?P_.;P13M*IG")Y/!) EW;P!
MUP".E 'K5%<1X+FTC4-3EU+1M2GF22U6.XMEB*1QN#D&0'GSN2#W('/:C5YK
M9_&E_9>(9!%ILFFQFP>1MJ;]S^:5/_/4?N\8Y ''>@#HTUJ-_$\VA_9Y5ECM
M%N_-.W8RLQ7 P<YR#U HFUJ.'Q-:Z(UO+YES;2W*3?+LPC(I'7.?G';%>;V-
MHEY?Z</&TLD4LOAN(2-+,T3/()')Z$9D ()')!/2M+0VO(]=\'1:Y,POQH%T
MMP97Q("6@QN/4-A3GOD'TH ]"L9YKFSCFN+22TE;.Z&1E9EY(Y*DCWZ]ZL5Y
M'8:Q;V/A3P==:C?(]@)KI+F&XD^64_/M+,W!*\<,>=V>HI8+VTTO1O#BWVLP
MWFAS"Z6[O0[74"W!93$CL3T"[U&<#(!P#0!ZS(Q2-F5&<@$A%QEO89P/SK/T
M#6(O$&@V6K012117<8D5),;E!]<<9KA;.>RL-8TG3-8OKBXT-],<6-SJ)VB:
M;S3D$G&6$>S9GG!..2:W_AH4D^&NA(/F M0C _CD&@#J+>YANXC+;RK(@=HR
MRG(W*Q5A^!!'X5#?ZA%IL<<UR"MNSA'E[1EC@%O;) SVSSQDCRW0I;?3=(T*
MW:-(=+36+V'5P%VK&=\WD++Z+DKUX^YG@BM6973P!X\1Y#)I %U_9Q+;AY9@
M!(0_W1(7"_3 XQ0!Z117.ZC<3V7PZN+B^%X;B+2R9_LK8FW>7\VP]FSGGM7
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M9I41E1E4JI8 N=Q' '.!SQQ7E)EM;NSM3<2NMA#XPG\QV=HQ%$8Y@N3QL7)
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M]^V.:&OZI+X@LM#U.&*W^P+XD@AA+ F7Y+@QEP>@RRD;<=,'/:@#T4,K%@K
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M_A,]J0#B5  25.,< C\Q0!EKX+LU@2+[??834SJ@.8\^<6+'^#[N2>/UJ$^
MK$,4AU'48+3[>NHQVD;Q^7%.'WY7*%@"W)7..3P*M:GXHM/[+U$Z9>PM?PV,
MMW )(V*R*H/S+TWKG RIQR*D\.>);+6K2VA6[CDU#['%<3QJ"/O 9([$;LCC
M.#Q0!#<>#+*YM]5B>\O1_:5W%>NZL@,4L>S84^7''EIP<]/>ENO!NG7TVIO>
MS75RNI6D=I<1R,N-L>XJP(4$,"S'.>OT%7]3OTM;_2[<ZC!:O<3E1#)'N:X
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MUP-.,P-NDK')91C<.23MSMR<XZ5._B[0$NVM6U.'SEN1:LHR=LIQA2<8&=P
MSP2<=:N#5[$WZV0F)G:0Q !&VEPI8KNQMR%!.,YXH K^(- @\16,5I<7-S!'
M'/'.# 4!+HP9<[E/ (!JK/X0L;Z^:]U*YN[^X^S26L;3,JB&.08?8$50"1_%
MR:U;S4[/3YK6*ZF\M[N7R8 5)WOC.W('7 )_ ^E5X?$&F7$+S17)=$N?LK$1
M/\LN<;",=<\4 8J^ ++R9(Y-5U24R::=+=GDCR8.<#A ,@$C..^3D\U:F\'6
MD\C.U_?!FTTZ8<&/_5'J?N?>]_TJ)_%UE86WG37PU!9]4-E$;6V;$9+ ;&QG
M)49YXST J'3?&$*:UK-CK%[!&8-22UM-L;+E7BC90W7!+.1DXR>/:@#0TGPG
M::+J/VRSN[M2UM';S1$ILF\L85V 4?.!@9&,@"K=]HD-_K&G:F]Q<1S6'F>4
ML97:=XVMNRI)X]Q5^>>*UMY)YY4BAC4N\CMA54<DDGH*S6\2Z.D%Y-+>K"MG
M&);@3*T;1H<X8JP!VG!P<8.#0!0A\%V<%II]LM]?%+&_?4(LF/)E<N3GY.F9
M'X]_85!;^"[31S9WEM=:I<MI?GR6EMYL>,2<M$,J,@GH6.?4XK>TS6-/UB.6
M33[E;A(G\MV4' ; ;OUX8'/O58>*-&9$<7GRO=&R7]T_^O'6/I][V]C0!5\-
MZ8(KO4];ETY["ZU61)'@D8%T54"C=M)4,2"3@]QGFKVLZ)!K0LC+/<026=R+
MF&2!@&#A67N",%78=._:H=0UJV2>W@CU.&UE^W1VSK+"S&5B,^4O3!((.[D"
ML+6?' &DW]SI9\IM/U2"RG:YMW"LK21(Y!. ,>8?7IG&"#0!H_\ "%6?D-%]
MOO\ !U,:IG='GS@P;^Y]W(Z?K1<>"[*Y74%>^O@+Z^BOY=K1\2Q[-N/DZ?NT
MX]O<UHV_B/2+JUN;F&^C,=M*(9L@J5<XPN",Y.Y<<<Y&,YI#XDT@6\D[7@2.
M*=;>7>C*8I&("JZD94DLN,@9R/6@#/OO!=G?MJC2W]\/[2F@GF"&,8:';LV_
M)P/D7/TJ_H_A^WT.XO7M+BX\F[F,[6SE?*C<_>* *"N3R1G&23CFH-8\6Z7H
M]CJ%Q(\DKV+)'-#'&Q97?[@/' .1STK7:[@2S-W(_EP!-Y:0%=J]<D'D4 49
M]#BG\16VM&ZN5N+>![=(U*>64<J6R"N<Y1>_:LY?!5DEE!;K?7ZF#47U*.8,
MF]97+EOX,;3YC\8[\'@5>T[Q1HFK7$<%CJ,4TDD'VE ,@/'Q\P)&#C(SCIGG
M%/A\1Z5.[)%=;W$)N%41MF6(=7C&/WB].5SU'J* +5G9M:-<DW=Q<>?,90)F
M!\H$ ;%P!A1C.#GJ>:IZYH$&O"Q$]S<PBRNDNX_(*C,B?=SN4\<]*H6'BJTU
MJ#0;NUOEM$U%V9+:>!M]POELVU2<8QPV[D<$5J)KVF2:@EBMVAN)"ZQC!"R%
M/OA6QABO< DC!STH 9>:'%>ZU8:JUS<)/8QRQQ*FS:1( &)!4G/RCOVK&'P_
ML8[/3HK74]3M;G3VE\B\AD02A9&W.C?)M92<'!7L*W+37=-OKW[';W2O/Y7G
M*A4KYD><;T)&'7..5R.1ZU%J/B&TTW6=-TN5)VN+\OY92)F50HR22 1UP,>^
M>E %^VM4M+-+:-Y"$7&]VW,3W8D]23S7.1^!;5-)O=*_M;5&L;V666YAWQ+Y
MAD8LXW",, 23T(ZXK937M,DO8[-;M?.D=XX\@A9'7.Y5;&UF&#D Y&#Z&F:]
MKUKX>L8KJZ25UEN(K=1%&S'=(X49P#@<_P!.I H R+_P!I=Z+R..ZOK2VN[>
M&WDM[=U"8A_U9&5)!'3&<'N#4UYX)LKZ'68IK^_VZNL:W.&CR BA1M.SC@<Y
MS56W\906OB/6K35[V"&UMY+9;4^4RD"1 ?GZXY(&3@=.E;U[KNF:?.L-W=+$
MQ=$+%3M1F.%#,!A23TR1G- &3?\ @:PU&ZO+J>]OA<W+P2B9&C5H7A^X\9V?
M*>2#UR"16[=60O-,FL99Y<31&)Y1M#X(P3TQG\*K>(KVYTWPWJ=_:&+S[6UD
MG02J64E5+8(!![>M<W'XLU.V'A:2Y:PNQKC1QM;V\31RQ;XRY<9=MR+C!X&,
MYSVH V+7PI;6=SI=Q%>WF_3+)K&#<8R#&VW.[Y.3\B<^WN:H0_#W3K>WMH(M
M0U)$ALY;%L2)F6&1MQ5OD['H5P?>MU]>TR.]6T>[596E\@$@[#+C/E[\;=^/
MX<Y]JH3^-_#5L\Z3:Q;J;<NLO4A"@!8$X[ C_(- &?)H"W,^CZ%)IUW)8Z-)
M%<1ZC<R)B38A 5=IR3D@$%0,9]JZNYMX[NUFMI03'*C1N <'!&#S6=%XFT>>
M(R07@F E:+;%&SLS* S84#) !!R!C!%.C\1:3,]DD-ZDIOHVDMO+!82JHRVT
M@<X[CK0!DV?@.PM3'OU#4;D)IS:9MFD3#0'HIVJ.1V/7US6[I.G+I.EV]@EQ
M/<) @C62<J7( P,X '  '3]:BM->TR^M[6XMKGS8;N1HH'6-L.RYR.G;:WY'
MTJ(^*-$4S;]0C010&Y8N"H:('!D4D89>G*Y'(]: *(\%60LTMUOKY634GU1)
M@R;TF8L6Q\F-IWMP1WJW'X:MAJEM?S75S<R6DTTULLQ0^4TN0P!"AB,,0 2>
MWH,6]+UO3M:CE?3KI+A(F"N5!P"5##J/0BG:@NI.(%TZ:VA/F?O7N(FD&S:>
M  R\YV\YZ9H K:IH$.J:G8:@;NZMKBR$B(UNZC>DFW>K9!X.U>1@C'!%9UAX
M(M-+BTM;'4=0AETVV>TAFW1LQA8J2K!D(X*+@@ \=\G.3I7B'Q/J7@^;7O/T
MI?+^V!HA:2#'DM(JL#YISDHN1CN>>*W?#GBFPU?3[57O86O_ +#%=7" %0 5
M&YAG@@'(."<'@T )/X/L9=,.F1W%U#8/;-;2VZE&656))9MRD[B68[@<\TV7
MP7IKO?K'+<P6FHHJ7EI&R^7.%4)SD%@2H"G:1D#UYK4LM;T[4;J2UMKD-/&B
MR-&R,C%&Z. P&5.#\PR*R-?UG4['Q3H&EV<EFD&I&=9'GA9V0QQ[QC#J.>E
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M>TR]NTMK>[5Y9$,D0*D"5 <%D)&' R.5SU'K5F[OK>Q6,SN09&V(JH79S@G
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MEU)AYL?$#22,#][KAQQ]:[NSO$OH&ECCF0+(\>)HFC.58J3@C.#C(/<<U8H
M\_A\,ZNEU?)91SV=E>VUVMQ:7$Z2PB9_NO#@ED#$DLO YZ9JQH^E:O'K'A:Y
MNM,:&/3])ELYSYT;;';R<=&Y'[INF>H]\=Q10!YS/H.O(\UI%I?F1#Q(FJ+<
M?:$"O#YBN0!G.X8((('L36IH%AK>F7<^DW>E03V:ZC->6^I/*K#9)(TF-GWO
M,&]EST[Y['LJHZGJ]GI M3>,ZBZN([6+;&S R.<*"0..3U- '$Q>'];B\.Z?
MIK::6>SU_P"V%UF3#P_:GFW#)'\+ 8/.<\=R^?POJT^BZWX<D@+17VJ&[AU
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MYY9-@\O)RBM@$[L8P!@]1Z-10!BZ7]OL-'T.S.FL2(DANCYR#[.%CZ]3N^8
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ML<#T Y/X4 <=9:'>6'B33[J'1HK>R@TFXMS#:NFR.225) @!(SPIR< 9-4-
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M\BC8"2 N[)7=D;<Y[5Q\.OZE'I6I(U\NVU\1I:.!<;Y!;$1ED1S@L<LW/WL
MXY KT2[L[6_M7M;RVAN;=^'BF0.C=^0>#6'KGA6&_M(XM/ATVVQ.LLT,]BLL
M-R%0J%D4%2<9!!SP5'7% ',W4NN6]C%,=9O(X+KQ%#!:_,C,+1F P203DDM]
MXDXVY[BGWES>C4M5T%?$C6-QIMO#):75Y/\ .RD%C*R@ 2C.4(/ VCH3D]%I
M'@W2[".4W&F:27E9',5K8K%"K+G#!"3\WS'+9R<#IBMBZTG3;ZZ@N;S3[2XN
M+<YAEFA5VB/JI(R/PH XD:M?:KJNHH-;ATZ\T[48XQ"[,-T.$.WR?XA)N.#U
M!/'3%7-'U2_C\6K9ZGY[+<O<FSNX)_,MKA%;(1DZQ2(HV],'!Y)KJI-)TV;4
MH]1ET^T>^B&V.Y:%3*@] V,BEM]+T^TN'GMK&VAF<DM)'$JLV3DY('<\F@#F
MO$T:MXY\)&2XFCCW71(69D4D19!(!QGK^&:Q[+7-4NM#T#78[F8W]WJXM+RS
M+90(971X]G13&HW9&#\A)SDUZ#<65K>-"US;0SF%Q)$98PWEN.C+GH?<5''I
M>GQ7KWL=C;)=.<M.L2AV.,<MC)XH YWXC)N\,0GS98PNI6.3'(4X-S&#G!Z8
M/\CVKEM>DN+&Z\<ZGI^HW,$MA;6<\)BD!#E8R1O)!W CC'0Y^E>H75I;7UL]
MM=V\5Q!(,/%*@=6'N#P:K/H>D2"8/I5BWG@";-NA\P#H&XYQ[T <;J.JWNH:
MWKMG'K<.E76FSP&W\R0\Q%$<L8^D@9BZ^V!C!Z[OCZ[N=/\  ^JWMG/)!<6\
M7F))&V"I!'/TQFM:71M+FN[:[ETVS>YMAB"9H%+Q#T4XROX5;FABN(7AFC22
M*12KHZ@JP/!!!ZB@#A]0U/4'\2>)+#3M2B5X[&R>W2:;"++))(K+D9*E@$7(
MZ$@U03Q1,T]EI]P;K3/.U"6VNX[ZY/[F584=(EG4Y*MNW @@GI[5W$?A[1(H
M3#'H^GI$8Q$46V0*4!W!<8Z DG'K4DNBZ5/8-83:;9R6;G<UN\"F,GU*D8S0
M!5\,K<IHB1W>IIJ<L<CI]J0?>4,< G^(J/E)[D>N:X^WUS5+G0=+UV*YF_M&
M36OL=S9%ODV&=HVBV=%*IAMW7Y<DD$UZ)!!%;0)!!$D4,:A4CC4*J@=  .@J
M!-+T^.^:]2QMENV.6G$2AR<8Y;&>G% ',^$K5(O%OC%Q+,Q&H1KAY68<VT)Z
M$]>V?3BHO%^J7^E:F]T?/ETF*WC,YLI]LUDQ=OWK1\"1&  (SD;#@<UUMOIU
MC:3RSVUG;PS3',LD<2JSGU8@<_C39]+T^YNENKBQMI;A0 LLD2LX .0 2,\'
MGZT <!?ZY>VNG:^?[2E2:T\2VUM!NEY6)S;;DYZ@AY.OJ?2M*PU0ZOJ5^TVM
MO8WFGZS]G%L&X:$$!4,??S <[L$@G@X&*ZF?0M(N;F6YN-*LI;B4*LDLENC,
MX4@J"2,G! (],"GG2=-.I+J1T^T-^J[%N?)7S0OH&QG'M0!YQI\MWI\B7MM?
MW""7Q?<VLD 8>4T;S2!@1CD]#GMCBNM\?75W9>$IKFQO);2=;BV421XSAID0
MCD'C#&M8:%I 4*-*L0HE\X#[.F!)_?Z?>]^M6;RQM-0@\B]M8+F'(;RYHPZY
M'0X- '"ZC+=0:[<^&CX@FMB-/^U6EW=W.QVD:23<<@ .(\)\IXP><]01:O-J
M=YJUE>^(387>GPVDEO/$-BR*T:NTHC)^<,VY=ISC  P>O:7NCZ9J0@%]IUI=
M" [H1/ K^6?5<CC\*6XTG3KN]@O;G3[6:ZM_]3/)"K/'_NL1D?A0!P=_KNJ2
MZ'XBU>VN9H]4TK5C;06@;Y&0.BK&R=#YBMG/7+C!X HOM1U:R?QOJL6I7L[:
M'*S6EIE?*.;1'PX"Y*AG+8R.GUKO6TO3WOA?/8VS78QB<Q*9..GS8SQDTZ'3
MK*VFGF@L[>*6X.9G2)5:0_[1 Y_&@#SZ<B+Q;#<V&M%I9O"UU+%=W,OF(K;X
MB)?8=R!QQP*Z'PCJ-S<W.I65_;7EI?VOE>=;3S^?& P;#Q29RRMM/!P00>*U
M8/#>A6H86^BZ=$&5D81VJ+E6^\.!T/<=ZN6EC:6"%+.U@MT8Y*PQA 3C';VH
M XW44>W^)=W>0>?+<1: TT< E;#L)#A<9Z' X]:KZ=J>H3Q^#;VVU*>X_MN%
MEOUW!@"8#(9%!R$*.-N ,?-@@G%=S_9UB;_[?]CM_MFW;]H\I?,V^F[&<4R'
M2--MWF>'3K2-ILB5DA4%\\G=@<Y[YH YWX=?;+OPEIVKWVJ7E[<7UI$TBS,I
M12,\J !@G///.!61KFO7$&NM+::G(4AURSL9%>3RTC5P@>()SYF0Q8N0",@#
M.VN^M+.UL+=;>SMH;>!?NQPH$4?0#BJ\VB:3<7$MQ/I=E+/+M\R1[=&9]I!7
M)(R<$#'IB@#@)M0U6)=0OQK-XYM/%$-G'&67RS"[PJR$ <C$AQZ=1SG.I-=:
MA9>)[[PY)=W;G5)([G3IRYS%",>>@/;9MR/7S%!S75MH6D,LBMI5B5DD\YP;
M=,,_]X\<M[]:@L-,O4U2:^U*\AN67?':)#!Y8AB9@2#ECN8[5!/ ^7IR: ,_
MQ]=W6G>!]1N[&[DM9X44K*F,CYP#USV/UKE?$UUK6@/XG@M=9OKB"+1UU".6
M5@7MI][+@%0!M8*3M(Q\IQ7;^*]%E\0^&KS289HX6N0JF212P4!@>@Z],5=M
M],LH+22W2QM8XYEQ-''$ C\8((QR,<<]J .$\4ZW>V]UXR2PU66,6GA^.\A$
M;AO+ES-DC.<9")_/O5F\M=0B\1Z!IH\1ZIY&IQW4L_[Q V52,@(=ORCDGVR<
M>W5IX=T..$PIHVGK$8Q"4%J@78"3MQCIDDXZ9)JAJ?AB/4->T6[\NS^PZ;',
MGV5X<AO,"CCLNW;Z=^U '+>'-9U6]U73] U6]N'M2=02.]5O+DO3!,$3YEQR
M$+$XQG;GURQ=9\1-HD,S^=J$5I+?PS+;3B"YGBBE")<IT5RH!!7@,6!YXKT.
M;2]/N;6*VGL+66WA(,<3PJ50C@8!&!CVIL^D:9<I"D^G6DJPJ4B#PJPC4XR%
MR.!P.!Z4 <$^NW.M7&I0VNOQZ;+9QVL]G+.S*7A>))/,:+I(&)=2#G&.,'KT
M'Q*#'X:^(2KR(RV,C9C<J>![=O4=ZW;C2-,NKRWO+C3K2:ZMO]1-)"K/%_NL
M1D?A5J6&.XA>&:-)(I%*NCJ"K \$$'J* /.]9MR_BW4OLFHW<)@\-^8DT,V7
M+++(1ECDG!'Z8]JH:[XIOSX8FU&WU21;^VT&UOF0.(DBD?)W_P#30OC&PC:
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MI+JWL+6&XD)+RQPJK,3UR0,G.*C;0])>SGM&TNR-M<-OFA-NFR1O5EQ@GW-
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M;YMX4]<?*..N2Z\)W^IZ*;74_$$\U^DD<UM>PP+%Y$D9RK!.023G=D\CCB@
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M,UN/G:0R$KPPP/WK<_2EA\%S16MG#_::'[-J\FJY^S?>9V=BGW^!F1N?I^(
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MQ9#C<N&4LW.2,'I5;2_!\6C:IIMS976VVL-/:P6%X\LZLRL7+9^]E0>G<_@
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MG+J-O<QVX(C:0;7C9"Q#J0<=0:T#X;NY-4T;4+C5C//I[2M(7@QYQD7:< ,
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M N?VE-_=3\C_ (T?VE-_=3\C_C5.B@"Y_:4W]U/R/^-']I3?W4_(_P"-4Z*
M+G]I3?W4_(_XT?VE-_=3\C_C5.B@"Y_:4W]U/R/^-']I3?W4_(_XU3HH N?V
ME-_=3\C_ (T?VE-_=3\C_C5.B@"Y_:4W]U/R/^-']I3?W4_(_P"-4Z* +G]I
M3?W4_(_XT?VE-_=3\C_C5.B@"Y_:4W]U/R/^-']I3?W4_(_XU3HH N?VE-_=
M3\C_ (T?VE-_=3\C_C5.B@"Y_:4W]U/R/^-']I3?W4_(_P"-4Z* +G]I3?W4
M_(_XT?VE-_=3\C_C5.B@"Y_:4W]U/R/^-']I3?W4_(_XU3HH N?VE-_=3\C_
M (T?VE-_=3\C_C5.B@"Y_:4W]U/R/^-']I3?W4_(_P"-4Z* +G]I3?W4_(_X
MT?VE-_=3\C_C5.B@"Y_:4W]U/R/^-']I3?W4_(_XU3HH N?VE-_=3\C_ (T?
MVE-_=3\C_C5.B@"Y_:4W]U/R/^-']I3?W4_(_P"-4Z* +G]I3?W4_(_XT?VE
M-_=3\C_C5.B@"Y_:4W]U/R/^-']I3?W4_(_XU3HH N?VE-_=3\C_ (T?VE-_
M=3\C_C5.B@"Y_:4W]U/R/^-']I3?W4_(_P"-4Z* +G]I3?W4_(_XT?VE-_=3
M\C_C5.B@"Y_:4W]U/R/^-']I3?W4_(_XU3HH N?VE-_=3\C_ (T?VE-_=3\C
M_C5.B@"Y_:4W]U/R/^-:,3%XD<]64$XK"K<M_P#CVB_W!_*@"2BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KG]<@EN4NX(72.21"
M@9U+ 97&< C/YUT%% 'F'A[PEJ7AOP._A^SUB$7"[_)O/LQ_=[F))V[N2,G'
M-0>'_!WB'1XIHKGQ:UU$+5X;5%LUC$,C8Q(<'YB.>O7)KU:B@#C]"LKW3M%M
M;34=0;4+R-2)+EDVF0Y)Z>PP/PK!\1>#KG7/%FBZW'J$4 TIRR0M 6\S)!.6
MW#'3TKTZB@#S;Q7X3GUV^TG5-/OUL=4TN1GAD>+S$=6P&5AD'!QZ^OK46O\
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M'A^26",WR@W;,P79#D L?]HA=J_GT4UT$5Q!,=D4T;D(K[58$[3T/T.#CZ4
M0Z9J=GK%BM[83B>V=G19 " 2K%6Z^A4C\*MUR_P^_P"127_K^OO_ $JEKJ*
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M->^'?M*FTP)#>$)AF [<\9^7.<]J[O0X[^'0;%-5G,^H"!#<O\O,A&6QM &
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M8PK(I;"KAUR!SDDXJRWC2WMH-8>_L+FUETMXE>%BC&02X$>"IQR3CD\'VYH
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MC' E_I@L)8WMS(1M,A5P=P_YZG(QS@<BM<WKR7UHML]I+:RK(7?S_GR,8V*
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ME>3Y8 _UGS9\L<\=357Q1HEQ:6GB*_>X$Z:NMM Z1Z>TOV=5.TNRAB77#$G
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M*BAN(+D.8)HY0C%&*,&VL.H..A]JQ-;\66>FVFMBT>"ZU#2K,W<MJ9MO&UF
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M[7;?:OLOVB+[3MW>3O&_'KCKBIJ "BBB@ HHHH **** "BBB@ HHHH ****
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M$.XSHQ5PR\;9#]_&,$^M:]4[NYT_2DDOKR>"U5RJO-*X7)Z*N3]>!ZD^M '
MZS8:5=^.O$]O>Z4;TSZ+;;42U,I+EIQU .UCP 3CIUXI_ACPV;?Q.BZUIOVF
M:#0["-KF6U+HUS$9"Y#D8+#*<YS7836>F:1J-[XBNKK[.TD"1W$LTH6,1H25
MZ\#!9OSK61UD170AE89!'<4 >7Z)9W^G0>&YWTZ\73K/4M1^T6XM7W1^;)(8
M91'C)4!B,@<;_8X:_A^03Z89M+FELG\3S7<,)M6;R+5H7!W+CY%,AW;3C[PR
M.N/4Z* .=\7:7YWP]UK2].LU).FS0VUM"@ SY9"JJCIV %8$*,=7U&34=*O9
MM+U'2(8;5?L;L4V^8)(F0#*%BRMR!G\*]!HH PO#VGW]IX'T[3]3?SK^.Q2*
M<L=V7"8()[^F>]<7H6GN]O\ #^"[T>["6%G+%=K-9/MCD$*+\V5Q]Y3@GKC(
M[&O4:* /)M,BU#2-.\/S7.F:L=.@^WVTT-M:,TL!>?=$_E%22A0%<@<!O<UW
M.GZ;:V'@@:?#93QVB6SK';3@RR!#G"D<G."/E[=.U:T>HV4T5Q+'=P-';.T<
M[AQB)E^\&/8COFBQU&RU*)Y+*ZBN$C<QN8V!V..JGT/L: /-K33)]%\(^#KZ
M#1KQ/LT<2ZK%:6F+K<(2@<H5W/L9CV)PQ(K2N=#^Q>';#6- TN\%SIM\U[!:
MSC$TL<A(F3:?N;E9F"]B%X'0>@U!>7MKI]I)=WEQ';V\0R\LK!54>Y- '(:O
MI4EO>^#R+62>X@U-I[J:&!G";X9=[$@?*I=UZ^WI6=X;LFGO[.TUC2]6_M?3
M;J>3[0\96V8.6S()0,.'5ONY)R>1QD>CT4 >6?V'K^DF!]/L#(/#FH/'8)C_
M (^[:X(W+GL(U<#/JA]*]"2PELO#[65E(!<K RI*PQF4@_.?<L<GZUHT4 >6
MZ2+@S>!P="U&.\TR&>"]\RT==LA@*D^81M8._.X$@YR346C6=[/>6171[^WB
MD\.7%GY#VCI';R[D(BW.-QQAOF8G<<D=2!ZO5>YO[.SEMXKFZAADN'\N%'<
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MV8GJ69B2Q]R2: .;OO$=W9>+ETZ\:2SMIKB*.SF,(>"X!4%D9QDI+NW8!P"
M,9)JMI7B35+GQ#IEH\\$]OJ%O=OYL<?[E6B= OE$X9EPV"3P3RIQ722Z!ITU
M\]W)%(\CS)<,K3.8S(@ 5MF=N0%7MU /453L_!6@Z?/:S6MI+&]IYGV?_2I2
M(@_WE4%L!> =O0'D 4 8/A_Q3J&KP^']/>6*"[U""ZN9YXH@ %BD"!44Y )+
M \YX4]SD:/PW61?!X65E>07]\'95P"?M4N2!VJ[_ ,(7H2V=C:I:S1I82-):
MO'=2K)$6^]B0-NP<\C.#6CI.CV.AV9M-/B:* R/*5:1G^9F+,<L3U))_&@#F
M+K7-:BU_Q%BZMET_188KHPK;$O,AC=F3=NX.5'.#]/62TO/%-_")K>6U$%YI
M_G6\LH3Y+C *A0K'=$0><G<,=>:Z&'1;"WU*]U".%OM-ZJI<%I797"@A1M)V
MC )Z#O5;1/"FC>'7=M+M7A# J%:=W6-2<E45F(09YPN!P/04 9&D^([S6]"3
M4+65$:'3F>Y26+<%NN04(!'W2CY&>Z_C1L?$NL:M8:;9V 2/49=!M]2+(B;6
MDD! &UB,("ISCGYAR._7Q:+I]O:7EM#;B**]DDEN!&Q4N[_>;(.03[5FW'@?
MP_<V^G0O9RJ-.C\FU>*ZE22./@;-ZL&*X X)(H Q-1\0^(+*=[:62VCN[S21
M<:>D:!T-XI"O%NS\P+/'@\<%O2MGPMKDGB*"*_BES:?9(MZ% &%P1N=3Z%1M
M!'J?:M:72;":2PD>UC+6#;K7C'E'84X_X"2/_P!5/L-.M-,@>"R@2&-Y9)F5
M>[NQ9C^))H R]7U::+Q'I&AV\GD/?)/,\^T$JD07Y5!XW$N.H/ /'IRGAF\O
MK31XK.*\C$\^L:F)/*CS-*5GDYC4Y4#=@DL< 8&<D5V^K:#I^M-;/>Q.9;63
MS()HI7BDC8C!VNA!&1P1G!JC'X)T&(P&.TE5H)Y;B-ENI0P>4YDYW9(8]5/!
M]* .9TK7]4UC4O!M_-=&*.\TFYNKBWAC&QG0Q9(SSR&('/%:WAW6=<UDZ/J9
M2$Z3J-J9)D<H#$Q4,@CVDEOX@P;GC/'(K4M?"&AV2Z:MM:/&--W_ &7$\GR!
ML;E^]\R_*ORG(X''%)IWA/2-"GGN])L?+F?<RQ&=_*1F.3M0DK'D]=HH I^!
MKJ26PU6Q<DQZ;JMS9P$]HE8,B_10P4>RBJ7B3Q+J6EWUT]K-#)%:W-G$T$<>
MX*LLBJ_FL<88AP5"DD<$C!KI=$TE-&T\VZOYDLLLEQ/+C'F2R,6=L=AD\#L
M!VJG?^#M"U.ZN[FZM)&DNS&T^RYE17:,C8VU6 W#:,-C.!C- &=%XCNT\9+I
M5^TEF);AUM0\(,%W$(R1LE'20,,E6(X!P.];/B&^FT_2Q+!<002//%$&E4L2
M&< A% )9R"=HQC.,\9I8O#VFPW27"PR%HYFN(U>9V1)"""RJ3@'#-T'<^M3:
MMI%CK=F+2_B:2(2+*NR1HV1U.5964@J01U!H XL>*M=:S14>".9?$0TMFN(
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MQ8W32%DTM&FV"5&@+,\?(W$R94XSP .AY]!MEBOO",2J1+%+8@#8WW@4[$4
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M,IMP!E&8D88-C'R]"1U'-;.MW\VFZ>)X(XF)EC1FFD")&K, 7.2,X!SM')/
MZT :&Q>?E'/7CK0JJBA44*HX  P!7 S^+M6OK7339K!!(VOMIEP71QO5=Q!
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M<=O:N6U;Q7=:7K4=L]K"8&O[>S"A]TC++M'FG;D( S8"L 6VD@]*YS2-9O\
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M\CI7'>(YHO\ A+M;.N0V]UHUCH:73P,I)"^9*25]')C7GV% 'H0C0*%"*%'
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M$T]ZL;7!CCGV803!@ZY"ABN&( )/'K@8?IWA:WT\V1-Y=W)T^%H+,SE"8%8
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M710!A1Z)=VVHZ7+!JE\\5OYINA-(I%UN7 +@+]X':1C  !&.U;M%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M152ZU2QL[VTL[BY2.YO'*6\1^](0I8X_ $_A0!;HK'U/Q5HFCWT5GJ&H)!-(
M5 W*Q52QPNY@-J9/3<1FM*[N[>QM);JZE6*")=SNW0"@":BLW1]?TO7X99=,
MNA,(7\N52C(\;=<,K ,/Q%:5 !15>\OK6P2)[N=(5EE2&,N<;G8X51[DU8H
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MV&0X=/-S@!MPQO4C@=*SM)T+5)H/!UM=V#64N@<3S!T*R!86B 3!R0^5;D#
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MW;W=OI]M%<.Q=I$B )8]3]3W/>@#D?#VK:MK<NGZJNIV\,1NYH+NS:7<6P6
MC"; 4=< YR<@$G(/&MXUO+ZSLM+-A?/://JEK;NR(K;D>0*1\P/K6K#H.D6V
MK2ZM!IEG'J,PQ)=)"HD8>[8S5+Q7H<VOV5E;1BW*0WT-U(L^<.L;!BO /7I_
MC0!S"ZGJFFZEJFBW.M74\4>HVD5I.T:&>;S4+O;[AM4'"YW=0K>N*BBUS68O
M#S:S+?RO#H^LW$-]$A5_,M%E9"2=H)*##9&,A#GK7<RZ#I-Q8FRGTVTEMC()
M6BDB#*7'\1SU;WZU0O\ P\YC-EI$>G6&GWA?^TE6V_>2A@!\A4@!B,@D@]1Z
M4 9<NHW4YTPC4IP=5NII8+5 %,D 0E ).-B@;9">6YVCTKG]-N+[Q+<^!YKC
M4YH;N?3]0$MU;A YPT(R,J5!.!SCZ8KTB\TC3=12!+VPMKE;=@\*S1*PC8#&
M5R..*@_X1S1/(B@&DV2Q0NTD2K H",WWB,#@GOZT <-8WVH7MQX.;4IOM,\&
MM7ULMSM"_:$CBN$5\#CD*.G%:/A35=5UP:)K+:I;+;W:2+=V9EWEI-I.Q5V#
MRV0@@\G(SG)P:Z]])TZ1K1GL+9C9\VQ,2_N>,?)Q\O''%16F@Z18ZE<:E::9
M9P7UQ_KKB*%5>3G)RP&3S0!A>.XWF?PS''.\#MK40$J %E_=2\C((S]0:Q9+
MOQ'::?KXAU.ZO1H&HQR)(53S+NW\M))86(7!90S $ '( KO[W3[/4H!!>VL5
MQ$&#A94# ,.A&>A'K5&_TZ^2RAL]"ELK"(N1,7@+$(0<E " 'R<Y.1ZT )X?
MO&U6&YU6.X>6RNI<V:GH(E 7<./XF#-]"M<UJRO_ ,)SK^Z[G\L>'D=82_R9
M+3*<#_@(/UKM[6UALK.&TMT$<$$:QQH.BJ!@#\A4%UH^F7MR+FZT^UGG$1A$
MLL*LWEGJN2.A]/>@#SG3-7U3P_I6E-!=37D;^$I+Y+215VK+"D.P+@ X(<@\
MG/%=/X;GO[G4(+PZQ;W6G7EB)4A$WFLS@C,JD(NU2&P5Z9QC'-;T.B:5;2V\
ML&FVD4EO&88'2%08D_NJ<<#V'%-TS0=(T5IVTO3+.R:=MTIMX53>?? YZG\Z
M .;\=B9M8\'"WDCCE.L?*TB%U'[B7J 1G\ZYG4M9U#PSXG\974WE7>JKI,%S
M%<VZ%8880Y0*\9)(8%F?ECD#L*]-OM'TS5'B>_T^UNFA.8S/"KE#ZC(XI;72
M=-LHYH[33[6!)_\ 6K%"JB3C'S8'/'K0!QFOZEJND7FHVUCJ<\ML^@7%_',V
MQV@FBQA@2N-K[NA&/EXQ43IK1O/#-M_PDVHA=8CE><A(<H1;AAL^3C#9/.>O
MXUV<6@Z1!9RVD>F6BVTR".2(0KM=!T4CNHR>.G-/_L;2P]H_]G6FZR&+4^2N
M8!T^3CY?PH X6]U[5QX>\1ZK;WLWV[1-0-M#;,%VRHFP;77')D#$Y&,;AC&*
M7Q'JFO:??ZWIEG>7,E]+'%J&E(-O,:Y\Z'.WML/)Y_>*,UW4FCZ;+?\ VY["
MW:Z.TF8QC<2OW23W([>G:K)@A:X2X:)#,B,BR%?F56() /H2J_D* .&O/%$K
MZ;8ZO:7973=7U"*VADE<1K%%Y;'=NVG:6D7;DYX(Q@\U#=R:_:SZ182>(6_T
MG6I+5FMMCLD)MY)%1F9.74J,''0C(-=O-I.G7&E_V9-8V\EAL$?V9X@8]HZ#
M;TP,5#%X=T6&WM+>+2;)(;-M]L@@7$+>J\<'D\B@"PMI*NE+9F]G:80B/[4=
MOF%L8WGC;GOTQ[5YM9^,-3LY-(N-0GN)H[7S=,U=%"X-Z-PC88&<L8SP#C]]
M'Q7J=5S86C!P;6$AY5G<%!\TBD$.?]H;5Y]A0!P=[8WW_"80V\FJW,5Y'X<D
M:2YAV[V<2J3C*D 9]NPJ*R\1:OX@@TVP6_CL[RY\/V^H1S&41;YGW!W V,&"
M%5.W@?/SGC'>S:3IUQ=M=S6%M)<M$83,\2ES&>JYQG;[=*JW/A;0+RUM;6YT
M73YK>T_X]XGMD*Q?[HQ@#V% '":GJNO"T\4W \02A],T:UOX3;1QB-I3'*S8
MRN2C%!P><'K7I<;&YLD8L4,D8.4ZKD=JJS:%I%P]R\VF6<C72".X+P*3,HZ*
MW'S >AJ[%%'!$D42*D: *JJ,!0.P% 'D^B137&D_#P'4+CSIKRY9IBP9U)M[
MC.,@\GGDYY-:5CXDU(QZ9I5Q>[S/J6H6?VJ:40O)Y$C+&A<*0&(YX )V>YSV
MT7AW1('B>+2+%&BE::,K;J"DC?>8<<$]S39O#.A7&GR:?-H]@]G)(9G@:W78
MSGDL1C[WOUH 3PX+Y=%BCU*^AOKJ-W1[B(<-AB!G@ L!@$@#D'I7*Z##JDWB
M_P 7_8;NVAB&KVYF22 NSH(82X#;@!E<C[IKN[:V@L[:.VMH8X8(E"1QQJ%5
M0.@ ' %0VFE:?87$]Q:6-M;S7!W3211!6D/JQ Y/UH XG5M=O+;6U>QU!W@B
MURUT]TVJD42.J!X0O)=OFW;N,9 !X(J[HNIW.N?\3 ZT;26WU:>TGL]BLI17
M=%BQU#$;'W<GKVX'03^&]#NKJ6ZN-'L);B9E:262W1F<KC:22.<8'Y"I$T+2
M(]8?5TTRT74G7:UV(5\TC&/O8STXH X*:]O+[1+%KVY>YDA\7BW61PH.Q+EE
M4?* . !VIOB2]O[C3_%EO+J-SY=GK-A'!M*J4C<VY9. ,C]XW7\<UWO_  CV
MBB$1?V38^6)OM 3[.N!+G._&/O9[]:=)H6D2I>))IEFRWI!N@T"D3D="_'S=
M!UH X_7?$.HZ%J?B/R[R2>WLM(M;B)9 I$3-)*COD+S@*&.<]#]*L32>((;7
M4'L=5L[L3+;2VEL;H,V"X#@2[  )%R%R#ANG'3JTT?3(IWFCTZT65XA [K"H
M+1C@(3CE1Z=*KVWAC0;*PDL+71K&&TED$CPQP*J,X((8@#J" 0>V!0!6\):F
M-4TJ:1OMJ30W,D,L%ZH$L#C!V$CA@ 1AAG(([US6J:_JCZ3XNU.VNY+>\T.[
M,=O:X!1T1$8!EQEO,W'GMD8P1SWMM:V]G#Y5M"D4>2VU!C)/))]2?6H)='TV
M>^^VRV%N]U\O[UHP6.TY7)[X/3T[4 <WI#ZGJ/C76DGU:[CM;"6W:.T58]I#
MPY9&.W) )R.0>.IK2\1WCQ7>D64-W)%+=SNOD1 !IU6-B1O)^0 X8D9)Q@#F
MM6#3K&VO)[R"S@BN;C'G3)& \F.FXCDX]Z2_TK3]46)=0L;>Z6)_,C$\0<(W
MJ,]#0!Y]H^LZSK$7@^.369X_M\=ZETT*QYD,60K9*\'].^ :DM=<U:W\*:'X
MBN]2FDM+2\FM]4!50)(!,\*RM@<%"$8XQD;J[:'P]HMN\+PZ38QO"SM$R6Z@
MH7^\0<<$]_6J5[X?=HHM,TU-.LM$E#_;;=+;#R!B"0F"%&[Y@Q()Y]: +FA-
M<3:8MU<R2,UR[3HD@ ,<;'*)T[+C/OFN%US4->1/&E[:Z_<Q-H<Z26D'EQE'
M'D1R&-QMRP)8@8(//4\5Z;7-:=X72+Q%K6J7T%I-]NN8IXN"S1[(T0 Y'/*;
MAZ$_C0!@ZEX@U!-7CGMK^0QKK=K8S1D*D<2NJ;X<<EV^8L7XQD '@BLK6FU6
M]\"^-+ZXU^_86<M[;1PIY:(44C;DJH.0 1P1P?KGT2?PWH=U=2W5QH]A+<3,
MK22R6Z,SE<;221SC _(5-'HVEPVUU;1:=:)!=EC<1K"H68MPQ<8PV>^>M %B
M!?*M542/,5'WF(+-^5<!IWB#5;K1O"NNQW<DDNJWPMKRT(&Q5??D*,94QE.O
M<*=V:] MK:"SMH[>VACA@C7:D<:A54>@ Z56AT;3+>[>ZAL+:.>1F9I%C )9
MOO'ZGN>_>@#G_ S:C?64NI7^L75T1<W=L(76,( EPZJWRJ#NPN.N,'I4>K?V
MGJ'CI]&M]<N["U;23< 6Z1Y602[<@LIXZ9'\N:ZFRTZRTV%H;&T@M8F8NR0Q
MA 6/4X'<^M8EWX9%_P",UU>[BM9K,6!M!&^2V2^XGIC!Z8__ %4 <5-XLUJY
M\%'4/[1=-4M] :_>.)%C17#,%F8G.X/LX0#'7.,BNC@DU/5_&UY9_P!MW=O:
M0V-G=K% L8&YVE#+DJ3M.P9[^]=+=^']&OY4EO-*LIY$A,"M+ K$1GJ@R/N^
MU26NCZ98W'VBTTZU@G\M8O,BA56V#HN0.@["@#SK0[S5[3P-H<]HUYJ*LL\U
MY;PSJ+HKO(WQ[OO[2<E2>2PZ]#Z#I%S'J?AVQN8;J2:.YM4=;@KL=PR@[L=B
M<YQ3!X;T15"II-D@#O(-D*KAG^^>!U; SZUI1QI%&L<:*D: *JJ,!0.@ H \
MFT2*:XTGX> ZA<^=->7+-,6#.I-O/G!(/)YY.>36E8>)-2:/2]*N+W>9]1U"
MS^U32B%I/(D98T+A2 Q7G@ G9[G/;Q>'=$@>)XM(L8VBE::,K;J"DC?>8<<$
M]S3)O#.A7&GR:?-H]@]G)(9G@:W78SGDL1C[WOUH Y'.ORZKH&C3^)I<W-O?
M+<7%DD>6:)XPA!9/O ,5;C!(/ -3:;JNK:O=B\BU2"W^R:O+:75M)+G=&LC(
ML?E[.'(VN&W=3Z<#KTT72HY;26/3;19+-/+MF6%085_NH<?*/84P:#I"ZR=8
M&F68U,KM-V(5\W&,?>QGIQ]* .+T_P 0ZK=:+X7U^.YD>;4]1%M=V1 V*C,X
M90,94Q[>O4[3G/;4\#V[1:CXJ<W,\N-9D3#D$?ZJ'G@=>U=)#H^FV]X]Y#86
M\=P[%VD6,!BQZM]3W/>GVFF6%A),]G96]N\[F25HHPID8_Q-CJ?<T <AXYUB
M\LAJ:Z?J,D=Q9:-+>K"@51&P)VR,QSNR5*A,$'G..#1%=ZKJ/C":%=6NX[:#
M2[/4!;0+'AY"\H9,E2=K! #WYX(KJK[0])U.X6XOM,M+J98VB62:%78(W5<D
M=#Z4MKHVEV-P+BTTZT@G$0A$D4*JPC'1<@?='I0!RGA/4M4UD:)K+:M;-:WU
MLWVFU$OF%I=H;Y!L'EE"&4C)XZ\\G0\6SWZ:KX<M+/4I[*.^O9+><PJA)7R)
M7R-RG!!08[>QK8LM!TC3;ZXOK'3+.VN[G_730PJKR<YY(&3SS4]UIMC>S037
M5G!/+;MOA>6,,8V]5)Z'W% '$+J&L7=WJ=I;ZU%;W&C7<,):ZE&9(@D9+21A
M/F\S+8((YQC&.:KZKK41N[TZS<N+;Q/%8+"4C"- [Q(5;"Y. YP<CH*[J?0=
M(NM5AU6XTRSEU" 8BNGA4R)Z8;&:1O#VBLDB-I-B5DF%PZFW7#2CHYXY;WZT
M <I9:KJNLW\MS#J=O:?8M9DL[BW>7.8A(4">7LX9AM<-NZGTXK,NO$FK:1*T
M%U?W$KZ+JA;4G(4"33Y"/+<X7@J)%Z8SY4E=_P#V!H_]LC6/[+L_[2"[?M?D
MKYN,8^]C/3CZ59EL+2?[1YMM"_VF,13[D!\Q!G"MZCYCP?4T <=<:MJ U+1]
M->Z:)=7BNKI&EF\E@0R&.%6"-@A')(QDE>N,@LTW4=3O-8@\/:CK"M-!I1N6
MNK,!/M,GFM'N&1_ %&0!@EN1C KKM4T;3-;M1:ZKI]M>P!@PCN(@Z@CN >],
MN= T>]6U6YTNSE6T&+</"I$0QC"\<# ' ]* ,7X<31CX>>'(C(GFMI\;!-PR
M0 ,G'XUU=8\7AC2;:_L+JUL+6V-@C);B&%4*A@01D?P\GCUYK8H **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH YJ?QKI\.I1VJQO*CWGV$R1NI*2YQRF=VT-\I;'!]N:?IWBV+
M4M7GTI-.NXKVVG:*XBDV Q(%!$IPW*-N 7')YXX.(=/\.:MI>L79M-8B&C75
MTUXUL]L3,CLVYU23=@(S9)RI/) QUI!X7ODUZTUR/4HEU -(EZWDL4N8"?DC
MV[OEV8&#SSD_Q&@"'3?&IEM+J?4;3[*PU.73[9#*F'9"P(+$X& C,2?PSW=%
MX\MI_L21:9?2375Y-9!$\L@2QHSGYBV"I"Y##CGG%5YO!%^()_LFL1P7,>K2
M:K82_9L^6\F_>D@W?.I$C+QMX-7Y?#^JWEYHE[>ZG;R7.GW3W,H2V*H^Z)HM
MB#>2H 8GDL2?RH ?9^,+:^M+0QVDZWUS=36BV;E0ZR1%A)D@D;1M)R">HQR<
M5B^&?$OV/3KX:A).;B76;NWMX;JX!9 A)VEV; 50/4]L=:FC\#W]M-;7UKJD
M"ZA:ZE=7L3-;DQLEP27C9=V>XPP/8<4T>"-5A3[7:ZU;QZI%J<]_!+]D)BQ*
M,/$Z;\E2.X((P* -2Q\8VFK0VL=G:7#7ET)O]&8A&C$3!78MG&W)4 @G.X8X
MR1'\/KR>Z\#VMS>33M)YUSN:YDW. L\@ 9B3T  Z]J2?PUJS:MINMQ:M!_:M
MO%)!<%[8^3-$Y5BJH'RNTJI'S'OG.:O>&] DT;PY_9-Y<QW8,DS%TB,8(D=G
M(QN/]\C- $%OXQM)WTMS:W"6FK9%A<-MVRG:64$9RI902N>N.<'BI?#GB4^(
MXOM$.E7MM:$/MGG,>&99&1EPK$Y^7.<8]ZH:=X.GM;+1=/NKZ.XLM$E\VS_=
M%7;:C)&'.<?*KGH.2 >.AU/"VBS>']"CTV>YCN&CEE<2)&4!#R,^,$GIN(Z]
MJ *VH>,+.PBO[HV\\MAITP@O;F/;B)L*2<9RP4,-Q'3G&<''-^+?$NH7&D^,
M+:&*>T72HX?)NH)]K$L V<J<\ANGH.>N*V+GP9)+'KMA'>HNE:W*9KB)HR9(
MV8!9 C9QA@O<?*23STJ+6/!-UJ'_  D,5MJ4$%MK$<*E&MB[1-&H7@AQD84<
M8Z]Z -#_ (3&TAEU2*_M+BRDT\0LRS%#YBS,5C*D,0,L"N"1CO527Q_9P17;
M/87;O:W5O;N("DBGSF"HRL&PPR<$#D$=.])JO@N?5[W6+B74E@-_;6L<;0Q?
M-!+!(TB2 DX/S-TP.G6GWOAS7M7T5;74M8LWNA=6\X>&S98P(9!(!M+D[F*\
MG.,=!QR 2_\ "8M%//;7>B7]K=16,E\(9'B)D1'VL%(<@MT/7&&'/-.E\46M
MYH#7L5K>26LVEF_9K>1 Z1D< '<,.1NQ@_PGGBK6N>'(];O-*NGF:)[*5F?8
M/]=$RD/$?]EB$)_W:IV7@]=-\.ZOI5K=?\?QG6)Y$R+>-]VV,#(RJ[FP,]Z
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MM0!Z/_:4G]Q/UH_M*3^XGZUY5XF\>:[:>"]0U>VT(V47DP&UNI[A6+"7C<$
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M/[2D_N)^M4J* +O]I2?W$_6C^TI/[B?K5*B@"[_:4G]Q/UH_M*3^XGZU2HH
MN_VE)_<3]:/[2D_N)^M4J* +O]I2?W$_6C^TI/[B?K5*B@"[_:4G]Q/UH_M*
M3^XGZU2HH N_VE)_<3]:/[2D_N)^M4J* +O]I2?W$_6C^TI/[B?K5*B@"[_:
M4G]Q/UH_M*3^XGZU2HH N_VE)_<3]:/[2D_N)^M4J* +O]I2?W$_6C^TI/[B
M?K5*B@"[_:4G]Q/UH_M*3^XGZU2HH N_VE)_<3]:/[2D_N)^M4J* +O]I2?W
M$_6C^TI/[B?K5*B@"[_:4G]Q/UH_M*3^XGZU2HH N_VE)_<3]:/[2D_N)^M4
MJ* +O]I2?W$_6C^TI/[B?K5*B@"[_:4G]Q/UH_M*3^XGZU2HH N_VE)_<3]:
M/[2D_N)^M4J* +O]I2?W$_6C^TI/[B?K5*B@"[_:4G]Q/UH_M*3^XGZU2HH
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M1RJ\"$I!Y?W ,\M[GBM/5O#6OZ_X)N]%U34[(W5PD<?FPPL$ 5@Q8Y.2QQ[
M5ZCM7T'Y4;5]!^5 'FWB#PC+K_P__P"$<>Z2&80Q()@I9=T94].#@[?PSWK(
M\5V=IKME9^$[J_5/$,)@NX'@C9=H#[2R9]%W9YSQFO8-J^@_*D\M-P;8NX#&
M<<T >7>(=$-EXC\,Z_:Q$VVEE[:X11DK"Z;0_P!%/)]B3VJCJ/PZ?6M4\475
MQ?1"VUV")$$:DM"8]NQO1N5!(XKV#:OH/RHVKZ#\J /-K/1?$(\-C3=1O]-N
M942.%1]F)CEC!&[S 3R64$<8 R3SVP)O"$GA_P $ZUH>GA7NM;G<6UI&S-'
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M/Y4_:OH/RI: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MX/DV)#R!0P&V7CY0!^E '845S'BR\U*VU#P];:??FT6^OVMIB(D<E?)D?(W
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M[QV#QF[%L4R!AD5696(.  2N._4 [07$+7+6PD'G*H<H>#M]1ZBI&8(A9C@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M\2^%CJ?ABZTS3H;=9KJ:&29[F5COV.C'<V&9N$VC/:M5M!TV6PN;2>S62*[
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M(;G[664%3YW/S\?Q<GGW/J:UJ* ,B?PMH=U97=G<:;#-;W<OGSQR L'D_O\
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M'-+G@2$!M@]<*02>V0.><%_J<=CIDFHJ!/;0@O*T;9*QC[S#'WL=<>@..>"
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MO/!_&N-C\>2CPY=Z_<:05TZSGEAN#%<!Y$$;E&<*5 (!!/7..W:@#LZ*B%S
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M>*2&)+5(D=)O.RS,2VX%<< 8'.><GTH M457N;^TM+6XNKBYBC@MU+S.S#"
M#.3Z<4L=Y;R6T-P)4$<P!0L<9ST'UH GHK+\1:P-!T"_U/RTF>UMY)Q"TOE^
M8$4L0#@\X![4S5=:?3?"=UKB6PF-O9M=F R;=P5-Q&[![ ]J ->BJUI>1W5I
M'/N12R*S+NSL) .#^=3AT.,,.>G/6@!U%4YM2MH=0CT[SH_MTT+S10EL%E4@
M$^PRP%4_#.NKXAT&SU$PK;R7"%_(\S>5 8KUP,].N* -BBF++&\C1K(I=/O*
M#R/J*?0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110!YO LEMX)\60W%A+?3+K-SYMO'O+,KRJZ
MMA?F($;JQ ZJ,=ZM:"XM8O&SW,5PEHTOVE7FM6@1T-K'N*@@#&5;CKQSSR>W
M6TA2\>Z1=LLBA7(/#@=,CU'/-%U:0WL/DSKOBW LG9L=CZCV[T 9/@JVN;/P
M-H-M>!A<Q:? DBMU4A!P?<=*W:** $95=2K ,I&"",@BO)M,TU/[&\):?-I%
MPIM];G-[&UDX4+LN "WRX*_.@ST.0/6O6B0 23@#J:IQZOILTHBBU&TDD)P$
M6922?3&: /,HDN=+M(G^PW\>BVNO7IEBMK,L8HG+>5(L10[HP2?N@XW9'2N]
M\*6%I8^'T@LH[M+-I'DB2[7:^UF)^X0-BY)PN!@=ATK<HH \F@TX0>&-/MO[
M)N$N[3Q0)9,63@JGVQW#@A>5$9!W#C!J35[!X=!^(5I%I=S]KN;SS8/*LW/F
MQM' !M8+\WS*W Z8.:]/AO+6YEFB@N899(&VRHCAC&>N& Z'ZU-0!YIK,$=[
MXEUBPUBWU=XKU[>;3);2UW*RJB802["8F616;DJ!NSZUTWCF*^E\-?Z%#)<"
M.ZMY+F"(;GFMUE4RH .N5!X[C([UTM% 'F^K:?\ :1XQN["TD;2KO1E1(1;M
M^^O L@W(F,D[3&"0.N!U7CL_#T$*>&=/A2W$2&V0/$8MG.T;@5('.<YS6K10
M!Y+I6FI_9'@^PGTBX7[-J\_VU'LG"@>7<*"WRX*_,@ST.<>M$*W.EVD#M8ZA
M'HMKKM]YL5O9EC%$[,8I%B*',8R>@.-V1TKUJB@##\*Z?9V7AV.VLXKI;)FD
M:..\7:^UF)^X0-J\G"D# QP.E>=>%]&LKK2/"=SIED(]3MM1E:ZN%A*D6P,H
M=7;'*D;5 ]<8Z''L# LI 8J2,9'4?G5#1-'M]!TJ+3K625X(BQ3S2"PW$L>0
M!W)H \UL=#-MX%AO+31G6YBU9C?1BU99Y;(7C.4 (RR[=K;1P1D=\4GBRQC,
M>NZC# ZZ--<Z4R*(F7=.+A1(\:XSG844D=3QU%>MUG:UHUOKM@+.YDF2(2QS
M?NB 2R,'7J#T90?PH \[U'1YK"XUZ^\.Z?,FBN]A)-:6< 7SRCL9S%&1@_)L
MR,88@CGFEO\ 2]+N[.SO+"QU*XM[K7;6XE^T63)T^61A$$4HN  QP W/6O4P
M,  DGW/>EH X.'PWI4/CS4=/;1(UTV[T>"&(1VG[GAY_,7<!M4X9>X/(K-@T
M?5;KPAK>GRP[KO1M.N=)T^4 9F)3AQCH2GDK_O;Z]&OK1;^QGM&FGA65"ADM
MY#'(N>ZL.0:2PL8--LH[6WW^6F3ND<NS$G)9F/)))))/K0!Q6J+'>>'/ ]S;
M6SS*E[93*T4)?RX]G+' .T8(R>E4])MEN=?%IJ]MJXUFSU::ZAD2VVQ21EVV
MOYX3E/+8*5+YXVXX%>AVMI#91M';KLC9BX0'A2>3@=AGG'O4] ' ^"8;NUUA
M(#']JL/L):&\FMF@N;?YU_<39X<\DAN#\ISUR=+X=12+X-C,@_=375U-"I_Y
MY/.[)^!4@CV-=/<0)=6[P2%MCC#!3@D=QFGQQI%&L<:*B( JJHP !T % 'E6
ME6L^G)I(DTN=+&TUN^.HH+1@,.\WD28Q\Z+N4Y&0-RGMQV'@VQFLAK1"/%IT
M^HO+81,I7;&57<0I^ZIDWD#WSWKIZ* /*+OP^EXNN0IILB^(6UX7%C<FW8/&
MF^,^8LF,!-H?.#@\CJ<5=LK9;KQ++9:Q;:O_ &I;:P]Y:R16V(I(MY*/YX3[
MHC.PJ7YQMQT%>E44 <CX[LTO$T -:/<"/5X'?9"9-D?.XG .%QUSQ7)7VBP0
M:9XG:UT>19XM?MIK#RK-MR)FW+M%A>!E922O'!KUNB@#S#5;*]O-/\5V$UK.
M=<GOQ/I5P(FY7">2R28PH0@AN1CDGKS-%X=M+V_\<R2:.LMV9"UG)):D;BUH
MB,8R1CE]P..IZ]J])HH \I:YMM/M?"TKV5QY/]C36TMI-I\Y16(B#,52-F#9
M!&2N""W/K!+9V4?ARQTK3K6XO8QH-S;)?I8R-YLO :/R\8C<LN2SC.!CWKT;
M4/#UO?ZDFH+=7MI=+$(6DM9RF] 20K+R#@D\XSSUK1M;6*SMU@A#! 2<LQ8D
MDY))/))/<T >5:I.C16T=ZEV1?>&DM)!<6%Q(+=V)&_"(Q#$@Y#;<[%P?2:Z
M@T_[1'8W4>HW/AZ]TF*ULY[&Q\T%U+B16 C9HW8E3GY>1R<KQWEWX;MKG57U
M&.[O[6>5%2;[-<%%E"YQE>1QD\C!]ZU;>WBM8$AA7;&@P!DD_4D\D^YY- 'D
MGB"VG_L3QEI6I:9?7-]/;QG37:W>X+Q+"@50Z@C<L@<GIRV>]>@>+;9M4\ Z
MU;P6[S2SZ;,(HC&=S.8SM&TC.<XXZYK?HH \[LU@_MJ!M2TR5M#N=%2&V5[)
M]L<@9O.0IMRK."A&0-VWBNE\'6-]:^"=+LM8W272VP259CN..RMZD+@'Z5OT
M4 >2Z#IJ'3? =E<Z1<*MK/<+?1RV3A5;R9%R^5P025&3P:2T%SI>GZ6T]EJ,
M>BVVIZE'+'!9&0P*\S&!_**,2FW< 0O <5ZW10!B^%[*UTOPU;6]HEW':1AV
MB6Z!$@0L2,K@%1SPN 0,# QBO,O[*%S\/M8M_LNM_P!JOJ%W/:6RP7!CE<SL
MT6^-AY90_*3N&,<]:]GHH \F\4B_N(]12XTJY34TM].D>2VM9)A.R.&;RV *
MHJ$MP/F)Y^K=?TJ.X'CB[BTB=KE[BTFLG%D^_<$CW-'\N<[@<D>G->MT4 >6
MZE]LB\<ZOJ,FFW%]H?GVGVFV%H[&7Y %E08_>>6^"5&>N>JBNY\210WGA6[B
M+W4<4T87?;1%Y$!(&0F#G'4KCD C%;-% 'EDEO?746G6VHZ?%<*GB*)Y;JSM
M'6*[C\@@RLG.T<JC?PD@^]%I&+"X-M_9%REHOB*Y>"1;.5H[9&A.&6)1A@Q9
MP#@J"<UZG10!Y;X?ANHK'P)#+97R-9:A=K,)+9U\I?+G52>,!?F4 ].>*ZGP
M0DB6VM"2&:(OK%W(HEB9-R,^589 R".]=310!Y1JGA]+X>*8!IL@UZ;5EGTR
MY-NP:,;(=LB28P%!5LX/8@]0*NK;+=>)[RPUFWU?^T$U87EC+!;?NI(P04;S
M@AVA5^5E+#@$8.<5Z510!S7C.416VE%K&6Y3^T(]TB122BWPK$2-&G+C.!CH
M"P)Z5P-G:6J-X7MM6L9?*BUW4XREU:E<Q,MPRC;MP4(*DX&W\C7L=9U_HT&H
MZEIU]++,DNGR-+"$("[F4H<Y!S\K$?C0!Y@=%L].GT5+NR"Z3+XFN6LX)(3A
M+9K:3Y=F,B,N&;&,;3D\5*GAN&*\TZ(Z4[:0_B6::V@^S,RQ6K6S*V1CY(VE
MSP< @@]#7I6HZ-!J=[IUU-+,DEA,9X1&0!O*LA)R#GY68?C6C0!YCJ6E-':^
M+]'ETV3[1+&G]AF& [0BPJL*1,!A"DBDGD8SNZ'-:5_H=_:>(K:6&W$PURR6
MPU6:-0 DB#=YI/NAE7Z[*[RB@#S/6;*&3Q'JVDZM9ZK]FNOL[:6UC:ADVHB_
MNUD"'RF616;)*@!LU1U99GTW6K/4-,O)M837X;F&1;.27?;BXC,;(ZJ1@1@K
MC.1@C'->M44 <Q\0+:6^\#WT5O!+.Y:%_+B0LY5949L <\ $\<\5AIX.TS6=
M3U^"SLEM=!U#3XH6"0^6C709SYJ(0.54I\P')XZ@UZ'5/4].35+%K1[BZMU9
ME;S+6=HI!@@\,O..,'VH P?!@O=0MVU?5[:.+4 @L3M P1"Q5V'H&DWD>P6L
MO7X;N/Q;]KLH_M@-Q:)/87-LQW!6!6:"4?=*9)8'(^4YQGGN;:VAL[6*VMTV
M0Q($1<YP!P*EH \OBL+^XTB"RDMID\3VVO>>UR8F&8S<%C)OQ@QF E<9QP%Z
M\4S6+26?0O&2&PNI))->MY[=?LKL74"W!=..0-C\CT->IT4 >?#R)?$FL:=K
MFDWMU<3W\-WIL\<$A1HU5-@$JC$>QU8D$CJ>NXYR]6TTO8^+PFES/'_;]E=H
MJVC'?&IMO,=!CYONR9QGH:]5HH \RU.TDN8?&%G=:?</<7D*/HK+;L/E$*B-
M$./W;)*"2#C&[)XYJQ8:)!)XLU^?5=-:XN(["S=+E;<C=.B2"1HF(QOR5Y'/
M(KT6B@#B? T-Y9WUW:RI'=6J6D"P:B+5K>1U!<"*5#QO4'J,?>Y K%\9"6;5
M-7$.F7JSPW6G2I+%:RS&X5)48LK@$*J@N-J_,2">^*]0HH \>U'1['5?^$XM
MK:PW:T=3C;3I%@(>*4P0$,K8^3#<L1CCKVIVKZ-8:E=>/;-+ 2ZP;F$Z>\<)
MW).;:(JR,!\AWX+$$<<GBO3M-T:#2[S4+F&69WOYQ/,)""-^U4R, 8^55'X4
M:?HT&G:CJ-[%+,\NH2K+,'((W*H08P!CY5 _"@#@M4L;V:S\8:=J%K//J]RR
MR:5<)$QW8B01>6X&%*2JQ/(QDL>#FHO$>FSR-XXC>QEN)KGP];QJ\=JS">X4
M39VX'S,"R=.1D>E>IT4 >6ZKHZM<>(K;3M*D"7GA;;M2U8+-<#S" 3C!D^8=
M?FYIMVML]Q;0:E8:HNA7^CQVT'V;3B^R7<_FHR>6S1LVY"&P,[>O ->J44 >
M3ZW;RQ67B[3=2TV^N'N-&1-)9[=K@E5MR"F]00'$N6/3.0:[/68)[[X9ZC;6
M\$S7$VD2QQPF,JY<PD!=IYSGC%=+10!YUI?AO3;_ %NSELM,$6GRZ/);:L&M
MS$MP[%-BL"!N<8D)/49Y/(K0\%6%XK^3J4*EM!5M,M9L#]ZN0?,X]8Q$/]X.
M*ZV^M%O[&>T::>%94*&2WD,<BY[JPY!I+"Q@TVRCM;??Y:9.9'+LQ)R69CR2
M2223W- ',ZO;QQ?$K1=0FL9)(?[/N8?/2W,@23S(67<0#MX#D$XZ&N5\-Z6]
MHG@F>'39K>^!O([J9K1U90R/L$A(R!NV8SQTQ7K-% 'G'@BWAN+K2I+RUUB'
M7M-MWM[P36_E1@D .3($ E#, P^9CSGUKT>BB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "O'98;^?P/X[AM]+M+J ZO?EG:7]Y$-V2ZH5P64?,/F&2.U>Q$9
M!&<5SJ^"-&%K>VI^VFVOIGFN8OMDH65W.7)PPX/<=* .=O?&-W8^'X[[3+J&
M\M8-/L[A/,C9I95<X9ICD"/*XV\DD[N"!BI=8\5:]83>)987T_[-HMS;@1M;
MN6FCD5&*D[_E(WGG!S@<#ON7O@;0;XW DMI8X[BWCMY8H+AXHV2/[GRJ0,KV
M/:I)_!ND7,.I0RK<LFI&,W0-R^7V !><Y& H''7'.: .9M-7>T^)7B#2;5XH
M+N^NX&26XC+1E4MHRRC!&7(/ ST!/.,'N[=+Y;VZ:XF@>U;9]G1(RKKQ\VXY
M(.3TP!CWK)NO!>CWCW4EPEP\EU/%<R2?:&#"6( (RD'*D  ?+BKECI!L]:U"
M_P#M$[+=I$OE/,SJ"@(W 'A2>.!Z9.<\ &I1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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ML9&*Y_=E)0%&W&-VWTK-T"X2T\)>#!::A,DC:UY%Q&MVY!!\[*,N['55./\
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M@[<L,9R"P..,B\+Z>RAT'2=<\1QP0W6EN[:BUTYCFNLJ&Q*)%Y Y'..N!P,
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M_P"$,:6:XCO+Z"[LII7D99K%#. S%BOFYZ#.!\N0,8(P#6!X,OE73O#5V]G
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M%U:&ZMFTN-[^TU*VL9HA<$*5G*^7(K;><AN0<8(/)[@'9(BQHJ(H5%& JC
MIGV6W\PR>1%O9@Q;8,EAT.?45RZ>)-?_ +>71Y=%L%N$M8[N=Q?L46-I61L?
MNP20%W 8 /J.Z0>-'EM]$U!K)!IFLS""VE$I+HS!C$77'1MO8_*2.O8 ZB&T
MMK=W>&WBC=_OLB %OKCK3IK>&X $T,<@!R Z@X_.N.B\=S Z:MUI\$#W&J2:
M9=)]I+&V=20K?<^96^3!X_UB^M7I/%4_F06T-FC75RL\T !D=3#&ZJKG8A(W
M%E(XQ@]>Q -\V%FV[-I =QRV8QR?>G-:6S2QRM;Q&2(8C<H,H/0'M7)P^+M:
MO+^PL;?PZL-U=6#7CQ7ET8VB*R(C(1L/][(/?C@5)X_!%GH<B1B25-;L]@)Q
MD^8.,]J .J2W@CE:5(8UD;[SA0"?J:Q-8\.2W]U;7%G>0VPA1T-O/:+/ ^X@
MEMN5(;CJ#W-4[?Q7>R6M^)M.MXKJQU$6,Y%U^Y12B.)=S!21M<#&,D\>]55^
M($0TFTO+J&&S$U[<64DUQ(RP1O$[*-S[<KO*\;@,<YY&" ='IFB6FFVPC6*%
MW,IF9A"J#>0 2J@87@ <?B2<DY^J>&9KS4H[JTO+>*)8! ;6YLEGB !)W(,J
M58YP>2#A>.*U5O)_[$%Z;7?<?9_--O%(#E]N=BL< \\ ]*YB+QZL8U);NUB+
MVEO:S(;>;>DC3NT:IN( X=<%AD<Y[$4 ='9:+8V6FPV(MXI(HG:0!XEP'9BQ
M8 # Y)Z#BKDMM!-)')+#'(\1W1LZ@E#Z@]JP;GQ!J&G.T-_ID:22W4-M921W
M&8[AI 2<\;EVX;.1SCCK@-F\1WUFT5K>Z8(;VXNI(+<(YE26-4W^;\BE@.VT
MC.?;F@#I:A>TMI(I(GMXFCD.71D!#'U([UR0\7ZS)/I=DOAY8KV^-R@6ZN&B
M56AQ\W^KR48$$'&>V.]5;7QGJNJ:AX?AALH;5YKZ[M-0MY)2Q62%'RJL%Y7(
M# XYX''- '1ZWH4FIQV8M+Q+0VCEEB>W66%P5VX9#CH#Q@C%2:9H%M86UQ'+
M';RO=$&?9;K'&V!@ (.,?4D^_3&1;>,Y;F:UN8],E?2)S*&NE63]RJ!B)&RF
MW:=IZ,2,CKSC+?4;C6/%G@;56M(H;:\6YFA(D)D"-;EE##&,D$'@\'CGK0!W
MOV>'9&GDQ[(\%%VC"XZ8]*C%A9  "TM^#D?NQP?7I6)XEU74M/U?P[;6"P&.
M^O6AF\UB"0(9' & <<IU]L=ZYK0M9N=!GU!4L(GT^X\326;OYQ5T:1E52J;2
M" 2,\CZ<4 >A?9+;SGF^SQ>;(NQWV#<R^A/<4^*&*!-D,21KG.U% &?PKF8O
M%ES=7UO]BTJ:YL)+Z2RDE17W1[&9#*?EV%-ZD?>S@@^H%WQ)KEUHITM;6QCN
MGO[Q;0!YS&$9E9@3\IR/E.>X]#TH VV56&& (R#R.XY%(8XV#J44A_O@C[W&
M.?7BN1G\7ZE$EPL6B-=75B\45[;VQDD.]E1V$;!-IVJX/S$9Y''4TK;5(="\
M3>+Y_*+M+?V4,4:@_-))$@'0$]22< GKP30!VXM+945!;Q!4)*@(,*3W%-6P
MLUV[;2 ;3N7$8X/J*Y:Z\8ZE86%S=W>AF."UO8H9IW=XT,#E1YRADR=I;YE(
M&,$Y-:=YKMU;K<216<+01W:6PG>X"( 0-[MD=%/RX&26XXH WB,C!Z57^P6?
M'^B0<+M'[L<#T^E<G!XXN[NVTAK?2HFEO]0N=/97N"@CDB$OS<IDJ?*/8$9Z
M&H!XOU>\N-"CAM+6"2;5[G3[R,S,REH4E/RMM^Z2@.2,]![T =HUE:-''&UK
M"4C;<BF,84^H'8U/7'?%/Y?AWJ<J@^9&8BC*<,#YJ#@]N"1^-2H8]-_M#4[/
MPW-9W%M $6%Y8XEF#$$L2K%0%V]2<@;N.F0#0\/^'$T5KV222&XGN;N:Y$H@
MV,GF,6*YR3@$UKQ6\$&[RH8X]_WMB@9^M<K;^-Q*;JW-M&UU'J46GPE)#Y<S
M21K('R1D *2>A^[QG(I=6U6ZCAT\:OH,)8ZU#;1$W&5Y8;)TP,]S\IP00>M
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M% ''ZYI=X^KZ/=6!\J34X/[,U!&.UO)VE]X_VDPX'_72NW1%C1410JJ,  8
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MKN+W4+;3M.FU"Z<QVL$9ED?8S;5 R3@#/3VJ6WGCNK:*XA;=%*@=&QC((R*
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M&38-T:GJJGL#@<#TH X;0?$=_?Q^&]/O]1D5M1^WE[H!5>5H9=J1C P/E)/
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M>1AD<YR0-V.E=/\ \(MH AGB&C6'ESJJ3+Y"XD5?NAN.0/>M$VEN9()#"A>
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M>G5F1^'=%A2U2/2;)%M)&EMPL"CRG/5EXX)K3H **** "BBB@ HHHH ****
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MW.V(1C)S\W SVJJGA&Y@TKPPL-[$-1T!%CBE,9\N9/+\ME9<Y&Y<'.3@@=:
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MD;(?+D; Y7=N*@D D#C\#B&'QU;2W,:'2]0CA;4FTQIW$>U)P2H! <D@D8R
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MT<2P/O1<9!;+;LGCJ/3G<U?2GUGPS?:3<7"I)>6DEN\R1\*74J6"D^_3/XT
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MD#'D'K\I/(YH [*;4[:+4$TT31&_D@>>.!GP2JD#)ZX&6 Z>OI5/PSKJ>(M
ML=2,2V\EU")C;^9N*#)'7 STZXK(U*W2#XF:9J$UC+)"VF3Q"=+9I LGF1,,
MD [3M#8)QT.*Y#0=)N;2P\&/9Z;<6NI?8[R&XF:T=&1C&=@E8KP-P7&[T&*
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M?]*^F5DQV(9/6K.L6$+>(=5T?5++5?L=TMN=+-A:ADVHBCRQ($/E%9%9LDJ
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MGCA<IL7'7C@Y89!Z=\=[D7B32IK^*R6ZQ-,CO"7C94E5/O%'(VMCKP3QSTH
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MN+2 R66FVEQ#(Q<!B7$87@]3\AR?>N;LO"FNZ5:Z)<C2K#49;2*XMKFQN)E
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MR.V=&)8]-QPPP,C[O/7'9S7Z1QQ20PRW2O.(#]G ;8=Q5F;D8"D'/<8Z5;H
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MR66.")I975(U&2S' % 'GNC^&M?T0>'+U+6&>:PBNK6ZM?/ RDT@<.C=,C:
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M0F19["&".X3P^=/1IG5E$VY3TY!7"D9(/)'&*[^JIOE6ZN8989HHH(EE:YD
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MK.>UN'2YW!RPB 9!MZ'R\X.,9]N>XHHH **** "BBB@ HHHH **** "BBB@
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MX2Y*"0MN*D",LN2/F[9KT1E5U*LH92,$$9!%4+[3YY-.%KI5X-+<,I62*!'
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M\QY(<XW@DDL,]ZMBSM1TMH1QC[@Z5&-,M1?178B420H4C 4 *">3P.O^>YH
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MYNY@FJQP(RQ (T#0DF-T;U!.><\@5IZ-IEWIT#?;M6N-3N&P#-,B)A1G "H
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M-;P7'_'QM\Y9-_'W?E(V>^<]JIZ_XQU6PTSQ1$NGV]OJ&EV"7D#?:#(K1OO
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M6@C". D>[806!(^\<^M6KWP8+]-=2;4Y6_MFTCM)V,2Y545ERN,#)#MGC'3
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M++!&C+-%G=M*N",@Y(/;)ZU5O?!"37-]+9ZK=6BZC9"SO4VK)YP52JOEAD.
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MDA&< MY;-CKT[G  .Z.KZ:+\6)OK<71;8(?,&XMMW;<>NWG'7'-*-6TYK\6
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M6-!TRYU">T@U"]B>06Z/MW!6()52<D #FM,ZWI8L$OO[0M3:.2$F64%6(SD
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M!G!)QG%/3P_JVBSV^JP:7=7%HVHWL\NG6DXCFACG*;&7#*"04)*Y_P"6A]*
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MTK@$\<ZI#X(D\5W5K926T%Q)%-;1ED<JDQBRC$D%CC(7 STS7?LVU"V"<#.
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MTV]1V7:PA:69)$B'/.%!7CCCWKI/ =E=Z;X&TBQOK=[>ZM[<1R1.02I'T)%
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MM(I%A&EWMLUVN-L4DOE;.^?X&/'M6+I^D2WNB&'5/"5_'?6FG-92NUZ")5(
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/\DK_(.%]=VW)]<=ZP-5UV^L=:\4P-JOV:WMK"SEMG>!7\F25Y4.  "Q)50
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M#[8[F@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M<A94\PJR=0&8%V.UC@<_B1FQ?>/;6S75)$TN_GATR&*YN)4$8'DNI;> 6!.
M"<8S[4 ;-GX;T73M4N-3L]+M8+VXR99XXP&;/)Y]^_KWJ6_T73=4F@FOK..>
M2W),+.,F,G@E?0^]9?\ PE\*7.H6\VF:A'+:68O41461KB(D@%%5B<Y7&TX/
M(_""Z\=6EE:ZO+/8W)DTJ6&.YBB*.1YN-I!W<C)P1U&#P: -;_A'-%^Q7=G_
M &7:?9[S_CY3RA^^]"W]X^YJ+_A$_#^V51I%H!*4,F(P-Y3[I/K@@'Z@&J@\
M96L;ZE%>65W:W-E)!'Y#[&:8S'$6S:Q&6;(P2,8YXYJMX=O;RX\<^)X+D7,<
M<,5F8X)9MZ(6$F2G) !P/3I0!LS^&]'NC<F?3X9#=%&N-X)\TI]W=ZX[9Z58
MMM*L+.]N+VWMDCN;G;Y\J_>DP,#<>^ ,<UEZEXKM]+OQ;W%G<B+[5!9F<@*I
MDEP%V@G+@%ER1TSWP<<EXAO;Z#3?B(8M0O(S9RP-;,MPX,.8(V(4YX!+$X'K
M0!W]IHVG6,WG6UHD;@,%(S\H8Y;:/X<D G&,D<TZ;2K&XODOI;=6NDC:)9N0
MRH>J@]@<#\A3-:U,:+HUWJ36L]TEK&TKQ6X4N5 R< D \=LU4F\20QVS7$5G
M=7,:V2WG^C*)"5;[J@ Y).#CMP>10!,/#>C+:VMLFGPI%:9^SB,%3#GJ%(Y4
M'N!P:E.BZ:9[68642R6B&.W91M\E2,$+CH" .GH*Y+Q5XE-[X/\ $J6CW-E?
MZ4T:2-%-@AFVL"K(>1AL$<<@\5LZCXQM=-77VEL[IO[$A2><)L^=&#,"F6[!
M3P<4 7XO#FCPQVT<6GPHEK*9H% XB<YRR^A.3S[GU-(OAO1D*%=/A!CN#=*<
M'B8]9/\ >.3SUY-4]4\6VVDSD7%G=?9UEMX7G("KNF8*NW)^?!(W8Z9[\XQ]
M4\6-]B\6I?V%]%9:3(L)ELIU24@QH^0VX$'Y\\=AZ\4 =$_A;0I5VR:7;./M
M!NL,F?WI&"_/<C@GOWIT?AG0XHH(H])LUCMYVN(E6( )(V<L/<YJMJ7BFWT]
MM2$=I<72:7&LEZT.W,0*[L $@L0OS$#L1U)Q5&^\>6MJ]_\ 9]-OKR*RL8]0
M>6$Q[6MW#G>NYQGA&XZGL* -BU\-Z+9:O/JMKI=K#?SY\VX2,!FSU.?4]SWJ
M*T\)^'[&ZBN;72+.*:%V>)EC'[MFZE?[N?:K=WJ]G8Z-)JT\A%HD7G%@,DJ1
MD8'<G(P/>N4\9:Y>'POJZK:ZEIMU9_9Y4F5L!U>0#"NAP2!D,O;(ZY!H ZZ\
MTNRU"2*2Y@#R1!@C@E64-C< 0<X.!D=\54N_#&AWSQO<Z5:R-' ;9,QCB+^Y
M]/0=NU4X_%J,VJ0R:5?I=:>T(:V"J[R"4X1EVL1C.<Y/&"3Q5=_'5G'9RS?8
M;J1X=432Y4A*/ME<IM(.[E?WB].>V!0!MVVB:997:W5K8PPSK"(%>-=N(QT0
M8_A'I5E+6".YEN4A19Y@JR2 <N%SMR>^,G\ZYRY\;16EK>RW&E7L<NGV8O;Z
MW)C+P1DN!T;#'$;-@'H.N2!1J7CJPTV!Y'MYG:&!+B>%9(_,1'S@!=WSM@9P
MN>/<@$ OIX;T[3);_4-%TS3[;5KE&_?M%@,YY^;;S@G!..M3Z-I\UG#/->M
M]_=R>=<O A5"VT* N><!54<]>3QG%5[7Q-;7VJRV-G#)/Y,JQ3.K+F(M&) S
M*3NVD$#..I_&MN@#.M-!TJPW?9+&*$%60!!@(K'+!?[H)Y(&.:L6&GVFEV4=
MG8VZ6]M&,)%&,*H] .U8<'C73YM)DU<Q2C35A:47"E6!(8+L(!R)"2/E/\\@
M7K/7X[C6Y-'N+6:TOEMQ=(DA5A)%G:2I4D9!P".V1U!S0!-)H&E2RWLLEE$S
MWR!+ICG]\H& &]1@D8/8TLNB:;-:6UK)9QF*U(-N!D&$@8&PCE>#C@].*S;[
M6+>R\4R0M!J#SPZ7)=;8Y!Y+QJZ@X4L!YF>Y XSSS4%AXYLKMK=KFSNK&WN=
M-.IPSW&S:T2A2_W6)!4.O4<]J -HZ)IA:S;[%"#9$M;;5QY1/!*XZ$@G/KDU
M"/#>C"-8QI\.Q;C[4JX.!-G/F?[V><]:SKOQBMC87=]<Z-J26]O8'4 X12'C
M'5<[L!P.=I/3\<27_B^UT^:_CDLKN0V>FC4V\O9\\62"!EA\PVG@XH V+_3;
M+5;86]_:Q7,(=7"2J& 8'(/U%59O#>C7 NA+IT#B[*FX!7B4K]W<.^,#'I@5
MC/XX=9+.(>'-5,M\':T7,/[X+&),_P"L^7(/\6.A[\5-+XXT^*\A@,,I#W:V
M;LKHS12GC#(&W;0WRE@, ^W- &K+H&E3O=/+91NUW$(;@MDF6,=%;U')X/J?
M6H;KPKH%[<6<]UI%I--9J$MWDC#&-1T )[#TKG=>\0R7TWA^?31=I92:VEL;
MF.4*DP!=6!4')0E2 2.=OH03V-G=2W1N1)9S6WDS-$IEV_O5 'SK@GY3GO@\
M=* 'W=I;WUI-:7<*3V\R%)(I%RKJ>H(JC)X;T:3RMVFV_P"ZB\A<+C,><[#C
M[RYYP<BM2B@!K(KH4904(P5(X(]*S(/#6BVPM!;Z;!$+,,+?RUV^5N&&VXZ9
M''TK5HH RX?#FCVZVBPZ?#&MFS/;!1@0L<Y*^F<GIZGUJ.?PIH-UI\MA<:5;
M2VLLQN'B=,@RDY+_ .\>>>O-;%% &/\ \(UIBZAI5U#:P0G3%=;811A2@9=I
M4'^[@YQCJ!SZW;[3+'4Q +ZTAN/(D$L7FH&V. 1D>^"1^-6Z* ,H>&]&"!!I
M\.T7'VH#!_UV<^9_O9YSUI8O#>BPZV^LQ:7:IJ4GWKE8P'/&,Y]<<9ZXK4HH
M I:CH^GZNL2ZA:1W*PN)(Q(,A''1AZ$>M)::-IEC)-):V-O%). LLBH-T@'0
M,>I'UJ]10!FVWA_2;.!X;>QBCB>,Q%5' C_N#^ZO^R,"C^P-)^S65M]AB\FQ
M8/:ICB%@, KZ8' ]!6E10!0NM$TR]N_M=Q90R3E C.1]]0<A6_O 'D YQ5J2
MU@FGAGDA1Y8"3$Y&2A(P<'MD<5+10!4;2M/?3I=/>R@:REW^9 T8*-N)9LCI
MR23^-4H/"F@VVGQ6$&E6T=K%*)TB5, 2#H_^\,#!ZC K8HH ANK6"]M9;6YB
M2:"52DD;C(93U!JD_A[29$5)+*.3;*LX+DLWF+PK9)SD #![=JTZ* ,F?PQH
MERLPGTRWD$TZW,F]<[I0,!_]['&?3CI0GAC0XU58]+M8U2X-TH2,*!-_?&/X
MN3S[UK44 5;33;.PEN9;6W2)[F3S9F7_ ):/C&X^IP ,^PJ&70]+GOFO9;&%
MKA]N]]OW]OW2PZ,1VSG':M"B@#+NO#>BWVKP:K=:7:S:A  ([AXP77!R.?8\
MCT[5;O\ 3K/5+1K2^MTN+=B"T<@RI(.1D?7FK-% &9<>'=(NVNFN=/@F-W$L
M-P9%W>:B_=#9Z@=O2HU\+: L5Q&NCV02Y55F'DC]X%^[GW& <^H!K7HH SI-
M TJ73Y;"6QBDMIF#2QN"WF$8P6)Y8\#KGH/2H[GPSHEYJEOJ=SI=K-?6X BN
M)(PSJ!R.3UP>1GH:U:* *]]8VNI64MG>V\=Q;2C#Q2+E6'7I567P]I$TJ22:
M? 62(0C"X!C'(1@.&4=@<BM*B@"&ZM8+VUEM;F-98)5*21MT93U!]JHWOAO1
MM1TJ'2[S3;>>RAP8H9$R(\=-OI@<<=JU** ,\:%I:O9NMC"C62&.V*+M\E2,
M$+CID<<5'%X<T>!+1(M/A1+21I+=5&!$QSDKZ$Y/YGUK4HH RCX:T8Q&/^SX
M0OGFY! (82GK(#U#')R1R<U)<Z#I-WI\=A<:? ]K$XD2(IPK@D[AZ')//N?6
MM&B@#)7POH:!!'I5J@2X^TKLC"XE_O\ '\78'M5AM&TYKYKUK1#<,ZR,W.&=
M0 K$="P  !QD8J]10!EVGAO1;'5I]5M=+M8;^?/FW"1@,Q/4Y]3W]>]:E%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !15.WU&.[O[JU@&\6I"329X60@-L'J0I!/IN'7G%
M!O$#C7=2TM+"21[*UANMR."95=G&%'J/+/!//M0!MT5#:7<%_9P7=K*LMO.B
MR1R+T92,@_E4U !7&6_@N^M[73;4:G;M!I^K2:C%FW(9E9I6V$[NO[T\X[#B
MNSHH XF3P3J*^;=V>K0P:DFJR:E;2FW+1CS$V-$Z[OF4KW!![]JZO3X;V&R
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M>TU[O[.;<I<SVYC9PQS%(T9.1ZE<T )KVACQ'X:N=(O)O*:XC ,T(^XZD,K
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M=EX/NH+?R[V+6;FW>4J=Z6W^D!4)ZB/'E8'3E?6O6&GA2=(6EC660$HA8!F
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M2)&@\NV$W^CYY(DVCJWS=<XZ<9 -6[FRANVA>0$20/OBD4X9#C!Q]02".X-
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M!([]:I6%OHVHZ5>7EG/K5E<OIZVMZ#9!%@;>N/,3RU\QP=V>3\N[/49]4HH
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M*DF57'(#1%AD>O2N;@\6:IX8L+ :M;VD^GR:+)=VYM0RR(8(U8HY8D-D$88
M8/;O7?W%E;W5A+8S1 VTL1A>,?*"A&"..G'I67;>%M.AA$5QYMZJVK62"Z8-
ML@; 9!@#@@#).2<#).* (](OM?FU9X=1L(EL&MEEBN8]JD29P4*B1RPP00W'
M<8J'4-1N(?&UK81V]F?,TNYGCGDC)D1D>(;<Y^Z=X)'^R*MZ#X8L_#R;+6XO
MIU5/+B%W<M+Y,?\ <3/0<#WX'/ J:[T*WN]8BU1IITN8K:2V0HPP$<@MP0><
MJIS[?6@#F-"\7ZW??\(]+=V]B\>M:9)=QPVZLKQR(J-C<S$$-O\ 08]34 \>
MWCZ!?7\;V?VNS:U6>QFM9(9H'DDV.KJSYQ@@JPX.#UKH(?!FFP0Z9"DMUY>F
MVTEK;*9!\L;J%8'CG@ 9]J=<>#]-O;:[BO9+FY>YMTMFGDD D6-&+( P Y#'
M.3DD]2: ,C7?%VJZ8_B-;>&SD.F&S,/F*PWB9BI#8;J.Q'Y5/<ZWXDBO+C2+
M>"QN-5@M/M>8XCY;J[NL2X:52#^[.YLG!(XJS-X%TNX2^$UQJ$CWZPK<R-<$
ML_E'*>PYYX ].G%6M6\*6.KW]KJ$EQ>V]];QF(7-I<&%WC)R48KU&>?8],4
M<UX@UO4-<\->*+ 6UM:/8:2&O(9QYQ\V2%G**58 ;1CYN<D]..>JM'FB\&V\
MENZ),E@K(SKN (C&,C(S^=5+WP3I-Y/<2JUU:_:K06=REM,46>( JH8=R 2
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M>[R,I0LY(.[Y21CH!TQ@8 #PKJ]UK&E3R7RPBZMKRXLY3 I5',4C)N4$D@$
M'!)^M94GBK4(?$EE8LEH]O=:C+8XB1V,86)W5C)G:6.SE,9&>O'/0Z1H]OHL
M-Q%;/*ZW%Q)<OYC GS';<Q& .I).*RU\#Z2MVEPLEZICOGU")%N6"1RN&WD#
MT;>Q(]SC% &'!XN\0RVVFW31Z7Y=UJ\^E-&(Y 05>55D#;O^F8RN#GU':S9^
M,-0DNH](N%M/[3?5YM.6=(V$6V.'SB^PL3G:0NW=U.<XXK6C\':?%;6MNL]W
MLMKYM0CRZY\YF9B3\O(R[''3GZ8&\&Z8_GN9+GSI+X:@LP<!XI]H7<AQQ\H
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M)P/E_>#GV/'3-"+PSK-C>6\HT;2]5@N=.M[2YBO)0#;R1*5+ [&W(0>1UXH
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MLJ#!#@X'K@CL016G0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110!72\ADO9;2,EY(E!E(Z)GH"?4CG'IUQ
MD9+V]AT^W^T7!*P@@/)CB,'^)O0>I[=3QDCSZ'4[W3O!/BO4E9UNDUNX\^0*
M6:.(3JA8 <_+" 1[ 5K:4MK<:9X@*>(8M7TZX@W!(V:2.WS&P8!V=R=PP=N>
M/^!4 =G16#X)FN;CP)H$UX6-R^GP-(6ZDE!R?>MZ@ HI&4.C*<X(P<$@_F.E
M>4MJNJ:++$;B?49X_#FHO%J3M-(WVBVF/[ER,_.0LBL>N-A'>@#T>XUFVMM=
MLM(D67[3>122Q,$^3"8W9/K\P_.M"O/[[36D\6>$[2^N+I99K74))METX<,W
ME,45P=P49P,$< 5CZ;X@GGTOPW::MK?V2TNK.Z7[;<2NOFS1RA%5I%=#N" D
M9/)SU(% 'K%%><V%M<7OBG2],N/$>H7D0T7SS/!.T N'2=0LFT'N.XX8'WI/
M"VI2:SJ&G7DOB58]3CGGBOM)&XNQ&X%&0R80+@$,%' 'KR >B/+'&45W"LYV
MH">6."<#U. 3^%4M&UBVURP:\M5E6-9I8")5VL&C<HW'U4USGBE+=?'7A&6Y
MG>)-]TN[SVC7/E9 X(&3^O2N;T=WLDT>^M[VY1Y_%5[:21B=O*:)I;@E3'G:
M3D Y(S[XH ]7HKSCPUJ4FL:E8W4OB58=4BNYXKS2AN+M@L/+:,R84* &#!1P
M.O)SM^)S(_BWPM:+>74$-U+<QS1P3M&)%$#,,X(Z$=1R.QH ZRBO*].N;JWM
M-%N_[6OY94\2S:8/-NW=7MQ+,@1E)PYPJ_,P+<#FIX=5U*YT.TU2.[N!KRZ[
M]DGL_.;;L-P4,1CSM $.&SC.!NSUH ]+DD2&)Y9'5(T4LS,<  =2:=U%>1:O
M9O?^!?'=Y/J6I3O9S7\$41O9#&J *0"N<'&._8D=*U?$6J+%J$EE:ZR/L\VC
M,;'9J8C9+C>P$C,SC>#@ '+8V,,<\@'I%%>3^+M7FTS2;^&'7)_[2L-%AN Y
MO&1#(6<^9'SF4L5P0>  /4BKOB;5I[C5M9L;77(HII;.U?3)(]06%8&);<S#
M<-P. <@-E>/J >ET5YKJU^TVNZMH\WB?^QIK1+=].=V<O+'L4[U'F*)27WJ0
M0V>!WKI?&VI7.E>'8[B%VBB-W;QW<Z<&&!I5$C@]OE)Y[9SVH W[NZ@L;.>[
MN9!%;P1M++(W1549)/T JKINK+J4DZ"RO+8Q!&!N(MJR*PR"K D'W&<CN!7
M>*O/33O'=@EU<3:3'HHN(R]P[>5.R2@H&)R055&*DD?,.,-7<"UC_P"$3:WC
M>9D:T.&\YV<Y7/#YW?K0!))KME'J^GZ<#(\FH122P2(N8RJ $_-_P(?G6GUK
MR;08+.^@^'%M'>2E'TJ<2F&Z8.&\F'*A@=R?12,>U+IWB">73/#=IJNM?9;.
MZ@O(_MMQ*Z^;-',$16D5T(;8&(RW)SU(% 'J5K:6UC;K;VEO%;PK]V.) BCZ
M <5-6#IJ3+X)1)-5DU"1;5@+]5\MIL X<8)ZC'(//7O7&>'3?/\ \(3>1:SJ
M%T=5TUO[326[9UVB $2 9^1EDVKN&"=W.3S0!ZC5>ZL;2^5%O+6"X5&#J)HP
MX5AT(ST->8Z->7=OX3\'ZC<:IJ$T6L2V\.I7$MV[!!LDV@'/R;I-BDC&> >3
M4FHW6HP:E+8+JM['IL?B.VM8+@7+;BDD6Z2(N3\P#G SDC..U 'J5%>5SZG?
M>'[F^L9-6N/[ CUN*W-_=RO*8$>W+LC2;@VT2[%W%N-Q!-3R1R?:?#UE'XIN
MKVTN]7N(?.MKAT'E&WD;R@^]BX5@ &R2#QD$4 >EB5&E:(.ID4 LH/(!S@G\
MC^5*S!5+,0% R2>@KS>ST2.XU[QGI%KJU];7S1VRVT_VZ3S0?(7#GYLM\PY/
MU'>J>MZMJ&M?#?6]6*W5J\%DMA/;F1P%D#@7+8S@@ E0W7Y6H ]&BU6.<63P
M6]S+#=L0DR1_(JA2P=CGA3C /<D>M7ZY;7YY+7Q9X/B@N)(H9KJ>*2%)"J2*
M+:1@"O0X(4BN9T#5I-4CM-2D\5K;:E''<K?Z>%9V1PK;@T9D(01L 00HR,#^
M*@#T>]O8=/M6N;@E8$YD<#(C7NQ]AW/;KTS5@$$9!R#7$>$[FYEFU'2]9B<W
M"64+O,EXUQ;7,3>8!*A8Y0M@Y4^@Z]:O?#R2XNOAMH+7;.9'L4&XDABN,*<]
M<[<'- '0V-U]MLX[C[//;[\_NKA-KKSCD=JL5Y1:ZGJTO@K0[V*[DU K9W<E
MW;&^>&XF02 >;'(#RR>C<?-VXKM=;OYO^%>7NHZ?=_9)O[-::&XN1@QGR\AF
MZX/Y\T ;\TODP22['DV*6V1C+-@= .YIMO-]HMHI_+DB\Q _ERKAER,X8=B.
M]>?6UP]Y'K^H6FJS)9)I*F* :H)GBG"N7?*.V!]P9SU!/?)<VHWVDV?A+Q 9
M[V[MKJPCL[J#SG8--)&IBDVYQN+C83_TT![4 >B45YSK-P]GJ\7A[4O$1TR%
MM)$D%[//(OFS[V$K!_,7YE_=D*2>&/&*I:FUX[^(EDUW47:S\-6]Y')%.]OF
M<"?][L!^7.Q25Z>H- 'J=-CD2:))8G5XW4,K*<A@>A%<]JKMJ'PXNY9&9I)M
M*:0M&Q4EC%G@CWKFM!O(KJ]T/1WOIETR305GA>*\=?,G!42#>&SE%VD+GC<3
MC@8 /2*S+K7;*UU'3;)C([ZA+)#"\:Y0,BLS!CVX1OQ%4/!=Q?:EX*L9-5D>
M2XD1U,N=K2H'94?(Q@L@5LCUS7 Z!%:W&C?#^V2[EW-?W"S;+EBZ'R)P5!SE
M#],'G/!YH ]@I"<*2 20.@[UY7;:]/:VFG6-]J[0::=7U&R:]NI7./+D80QO
M('5N5SR6YVCK7>>%4>/P_!&VKG5@K.$O2N/,7<<<Y.[ XW9.<9H J)XYT=K"
M:_D%W%903O;S7#V[;(G5MK!B,X /!/3WKHU8,H92"",@CO7BTH,GPR\5N-;C
M@A&IW[-:.%Q< 3,?*R/F&_[O!SSQ6CXC\1O'874T%W/IM[:66GR_9)+HQ"V+
M-N*H@QYA(R&+< *!SR  >LUGV>LVU]J^HZ9$LHGL/+\XNF%.\$KM/?H:\Z\1
M7EPO_";W]OK%\O\ 9IM+BS$=XXCC+1JQX!P5.?NG(YZ5+J6J'3_B%K?VEY(-
M'E>Q2^NX)BCP$HWEY(P51FX9L\9'8D@ ] UO6;;0-*EU&[65H(BH;RDW'YB
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M=D"G/O0!Z=17G?@K43K$^D:C_P ).);Q[9UU#3 '+>9@;MZ-(?**.",A5'S
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M]K;?V3IL%NUSXBEL;E9;EFRP9BS [3@,4/;@'@>@!W4=I;1+(L=O"BR??"H
M&^OK6!J/A::ZU4W4%W9BW:)(C:W=@LZ1A<_ZOYEVYSSG(KGM.UVYT"^\1RFR
M-Q8_\)%'!-*UR=T7FQVZ#:I!W ,^2"5X/&>@]"N+B*UMI;B=PD42%W8]E R3
M^5 %.ST73[*RBM4MH62.-HP6C7[K'+#@8 ))X&![8K(O?"DUUJUS=?;;22VN
M"NZ&[T])VB 4+MB8D;1QG!##))[TV#Q?(\FC&;3A%!K49:QD\_)W[/,5)!M^
M4LH)X+<@CTS!H/C:?5YM#,^DBUMM9MI)K=Q<[V5D )5EV@ $'@@GIR!0!TEO
MI5C;V]G"MM$PLHUCMV= 6C   P>W [5;95=2K*&5A@@C((K/UO5X=$TQKR9#
M(3(D,4:G!DD=@B+[99ASVZUR$&L2Z/XS\4W>H0;2+73DCAAF:4.\DDJ+C*@C
M+%0<#MGF@#N$L+..V^S):0+;YSY0C 7\L8J:...&,1Q(J(O15& /PKD+CQK>
MVF]9_#]PK+?VUHKEF2.43,%#(SHN2IX*X&..>:BN?'-_90ZK)<Z'$/[)NHX;
MW9>[AL<(5>/Y 6.'!*D+TX)H ZT:?9#;BSM_DR%_=#Y<]<<>YH;3K%[?[.]E
M;M!NW>48E*Y]<8QFL'4O%K:9K$5G-8 12WT-FCM.!(_F 8D5,'*!CM))'(/I
MS4_X3>Z6>0OHRK:0ZPNE2R_:LL&8JJNJ[>1EQD$C';/8 ZN[@:XLIK>-UC:2
M,H&*[@N1CID9_.L[P]X>M]!T"TTS;!,T%NEO),L 0S!5V@L,G/'O7*^+]:EU
M71O,LH!]CM=<M;5KC[058NMS&KX0#!7=E.3ZG'3/;ZJ@DTB]4D@&!_NL0?NG
MN* )?L=J+9K86T/D-PT6P;3]1TK(UWPVFKV^F6\,D%M;V5VESY1M]ZOM!&S
M( !W'UKF?"?B?4;30O"NFW&D9%_I4?V&Y-V#YTJ0!RL@V_)D D'+=.<'BNAT
M7Q0=;M=(EALU1[U)7GB:8[K;RSM<'Y>2'(4CCG/7% &X+2V%J;46\(MR-OE;
M!LQZ8Z4W[!9[8E^R0;81B,>6,)]/2LCQIJU]HGAB>^T](6G62*/]ZQ 4/(J9
M'!R?F_ST/,76M7WA_P 4>+M26P6Z2UTVRNKF+[60J*HG+["5.3@<#"@XY(H
M[C4K*XN;67^S[I+&^<*!=>0LI #9P0<9&,CKQG-+;Z7;PZ2=.E'VB%T99O-
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M(]I':^7GY<)GYO=B-HSZ**S_ /A"O]#\H:G(LJZLVK1RI$ORR,6++@Y!7YF
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M-(D+%696.1DXR%(]LUU1UW3(X[=KB]@MFN$22..>0(^&X7@GN3CZ\4 <]<>
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M)&V]-T;_ 'D;(R#P>10!RO\ PA%PFEZ3##K]U%?Z2S"SO?*5F$3#!C=6R'7
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MS&"%+;L8ZL._>KM !1110 445FVVOZ;=ZE]@@N"]P4=U'EL%<(VUMKD;6PQ
M."<4 :5%%% !15.\U6SL+NRM;F8QS7LABMUV,=[A2V,@8'"D\^E7* "BBB@
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M7:PM;EVA,<87RR_WB,=,]_6H9O"/AVXTN/3)=%LGL8G\R.W,(V(WJH['Z>M
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MS/\ :?,\E=WF\_/G'7D\^]/C\.Z-"END>FVZ);RF>%0F!'(<Y=?0G)Y]SZT
M<'!J%QKT'@+7I[UV:\U5G:V 7RXB8+C"CC.5P5Z\\Y[8]/K'7PIX?2[^UKHU
MD)_/^T!_)7(EP1O'H>3S6Q0 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "$D*2
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M*-@*LW&XC)(4CT_3//Z3XGDTJ_UJ._CU"ZMO[?%FEP65DMA(D(13N8';O?\
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MH HF3GY&*@!ASG [C- &AI6N/;K;Z-<)/>:E9PVT5](K(65W5?G(W E<G)8
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MO(NB)*CD(P,P=2N1S\N,Y[Y]J .DU'5(M/DM8"CS7-W(8X(8\;G(4L3DD
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MP]K.D:I<Q6^JVYT2:[>\$+6Y,\;.Y=XU?=MV%B3RI."1[CJ* "BBB@ HHHH
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M RD((<*L/&5=903@8(R#TK8\:VUW+\)+^VO4-QJ!TX*X1=Q>;:,[0.IW9Z4
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M8O8[/%Y#XKMY;:01'>D6^#>R<<*0),D<$ YZ5->6[Z>WBQK73;@/_;4%S/\
M9K3+RV92 OL)4AP2&)7G.&XZT >JA@1D$$>M&Y>.1STYZUY3>Z=HTUC87&G+
M?7%C=:];3OY]N8D'&)"B!%*I@#<<8)S[U+JVF:;!KE_H.HV^HVMC)%!_8_\
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M7"*/Q-<CX.MIKK4?$<FH/;77DZTYCS;\I(L40#*2QQA>!W]ZP/$USJ-SHOQ
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M-K:OJ$UK?VQ-U ;:<+*HP4+;3D%<,1R".:MV&G)8JQ,\]S.X DGG8%V S@<
M  9/  ')]37,:MXCNM!UN\-W':W,5IH4VH%XX2DC,CCY<ECA3Z>M.EUCQ5;1
M7DXTV.[@^R+- 8P@D,FX!U5!(V\;3N'(Y&.XH [&BL3POK<>O:=-=1W<=RB3
MF,8A:%X\ 921&Y5P2<^V#WK%M?$^J3>(M/L6>T>&^>\CWPQL4B,1.S:Y(WG
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M&"IP3CKR#WM7WB_4]$N=?MK_ .R7$EHMDUJ\431KFYD:(*^6.0K*"2,9![4
M=FEY;274MJEQ$UQ$H:2)7!= >A(Z@'!J:N-T>*ZB^*&M"ZFBF<Z39D-'%LX\
MR?J,GG.?PQ]:FU7Q-<Z=XIBTVX*V5O/)"EK/-;L\5P6/SIY@.$D_N@CGWSP
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M+'((!&,<<<FFV_BS6;F22V,MINFT2:_CN(86,:2(RC"%C^\3#C#8 .,C(.
M=W)=6\5Q#;R3Q)-/GRHV<!I,#)VCJ<#DXJ6N"TG6=0@@\$+>/;7*WU@\LLK0
M'S5*VX?(;<>3WXY]JEM/%VI2V'AK5W2W:QUV98?)5#OMS(K-&=V[YL;<-P.N
M1C&* .XHK@=)\5Z[<?V!=7C6#6VHZC<Z?)%# RLIC\[:X8N?^>."N#UZUWU
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MRB.6*T:U%F]O%(5CDA&?D(_X$>1SR>:@?QMH<;SQF:Z,D,(G,:V4Q9HCGYT
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MTLR260DG8JCN"#N[D'<1SGKQ5)?$SWGCG1[*RGE.GW=A<7#*]L4#[6BV.K,
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M(K61FW8DC$G++Z9D'Y&NEHH \XM?"?B":2:2\@M(I+K09-.FD-VTC><?XL;
M-I)Z#  Z>E3'P]KUO=Z;?_V/I6H'^S(]/N[*YN.(S&6*R*Y0Y!WL&&/3KBNW
MU._CTO2[K4)8Y)(K:)I76( L549.,D#H/6GV5VE_86]Y$&$<\2RJ&Z@, 1GW
MYH S-.N+VWU9=(:QMDLX;)&6>V? 5P0"GEX^0?W>>BFH?$&EW]WK'A_4+%(9
M/[/NI'E260IE'B>/(.#T+ XJ]#K,$WB&YT413+<6]O'<EV V,CLRC!SG.4;J
M!6E0!P*^&=8%I%&;>+<OB1M5/[X?ZDR,^/\ >P>G3WJ?0?#NIZ9J#65SI6DS
MV<5Y)<P:HQ!GVL[.%*;?OC<5W;NG/7BNWJ">ZC@)4_/+Y;2+$I&]U7&< GW
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MMG:$1.''\0 4$8^G'6NWK&_X2.)[C6+:&PO9KC2S&)(HU7=+O7<-F6YX]<4
M<QJ'A'4WM/%=G:QQM'J6E06%H\DO.Y$="7XX'S@\9Z&K5UX<U&?Q#;ZI:1-I
M]XDMOYEQ#<?N[B!0OF1S1]&;[X4@9'R\C%=M10!E^(K#^T]#N+(V4-ZDI0/;
MRN4#KO4MAAT8#)!]0.E<O:>&=;M[C1#)-+=6UAJLMRGVJ</-';M T:HS?QL&
M<GK]W R<5WE4]0U.#3K6YGDW2&W@:=XH\%R@SR 2/0_E0!QUKH'B*T**D%NU
MM)J]Y=W$/VDQEHY2S1_.%)&"?F4=?<<%NA^%]9T^'PA%<06V-'EN//,4V05=
M'52N0/[V2.P]>E=MI]['J6FVM_"K+%<PI,@<<@, 1GWYJS0!@>$],O-*L;Z*
M]C1'FU&YNDV/N&R25G7/N <&LS5]$U\ZUK]YI'V0'4=,A@AEF?F.6,R\%=I!
M!\P<]L'@UU5_>)I^GW%Y)'(\<$9D=8P"VT#)QDCM6/;>,=.GBTN>6&ZM;?5=
M@LIIXQLE+KN1<J3M)'0-C/3K0!RM]X1UZ[M?$J1V5M'_ &M;6J1AKYI&5XR=
MV]BN3P>OT'N+DOA;7&\-:CX?C>!K>*>*YTJ>Y?>?DD67RIQW 92N[))!YY'/
M?44 8?ARUNHHY[B\T;3M*FFVJ8;-@Y;;GEG"KGKP,''KS@0:AIE])XTL]6AA
M1[:#3KBV;]X Q>1XV&!Z?NR,^XK2T768-<M)KB"*:(0W,MLZ3 !@\;%&Z$C&
M0:=H^K6^MZ<M]:K*L3221@2KM;*.R-Q]5- ')Z)X:U;3H_!:301'^Q;26"Z*
M2@Y9HU0%/497/..M,T?PSK%E)X<,UO%C3K^^N)RLP/RSF4IMXY(\P9Z=#C-=
M]6;::S!>:YJ.DI%,D]@D,DC.!M82;]NT@Y_@.<@4 <G#X9UA-/LH3;Q;X?$4
MNJ/^^&/):61P!Q][#@8Z<'FGZ-X7U.RDDTN[TS2GM(YY9(-6!!N-CLS ;-O$
M@W8W;NE=W10!Y]I'A[Q':CPC:W-I9>5X?=XWG2Y/[^/R'B5E7;D'# D'OW[U
M)9Z!XBL[:UA6"W:'^U+RYN8?M)C+QS.[QX<*2,;_ )E'7W'!ZO6-9@T2*UDN
M(II%N;J*U4Q ':TC!5)R1QDCIFM*@#S_ $/PMKFEQ^%3)#9EM+%U!.JW!QLE
M(PZ_+SC;]WW'-6?"'AW4]&^QZ??Z5I!BTT%(=4C(,TZ8*K\NW*-@C<=QS@]<
MY';T4 <WXPT>^U.#3KG38K6XNM.NQ<BUNSB.=2CHR$X.#AR0<'! JA>Z'J5S
MIVE>1I5A9RQZM%?SVULX"HB]1NVC>Y]< =L\9/9D@ DG %,BECGA2:)U>.10
MR,IR&!Y!% '(ZEX:OM6UGQ)O"P6>K:0FGQS!P61AYN6*^G[T=^U9\OAC7-7\
M.75M<:7HNE:HD4:Q7-L=XGDCD20$X0%(R8QE>3\WMSZ#10!QVKZ?XB\0>&)D
MN+"QM+T3VLT=LMR7#>5,LC;I-HQD+@#!QW//'71^8T*^:JK(5&Y5;< >X!P,
M_E3Z* //= \->(-.?PK'<6EH(=#AGMY'6Y):8,@564;>,XZ$^O([RZ+X9U>P
MA\'QSP0YTAK@W)24$$.CJNWCG[PSG'XUWM% 'G">$]<M+'3;F.QL+NZLKZ]E
M>RN)?W<T-Q*S\-M.UURO48X-6]7\*7M]9P&WTZWT_4(H9&M;C3+CR?LDS-G:
MW $D9^7=D<D'Y>>.EU#Q!#8WCVD=G=WMQ%''+-':(':*-V*JQ!()Y5N%R<*>
M.E:<\OD6\DVQGV*6VIC)QV&: ./_ .$;U(>*8=5@S:7'GH;R>&;]S>PB, ^9
M$?\ EIG@$#@ <]J[2L"Q\76.H'0?*@N@NMV[7%LS*N%4('(;YN#@CIFM^@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** $.0IP,G' KS'2=1OKS3/"U]%=SG79M1
M,&J6YF;[OS^<K1YPH3 *\#&!C[W/I]1K%$)6E1$$C<,X R<>IH \@LUL$\/Z
M19K=%)5\6RQS(+@[X_W]Q@<G*DC'(P><^]7/[;?2[:YMWU)TTBW\2R6D]Q/*
M\H@A,.Y%=MP8)YK 9+<=#QD5ZH88CUC0\YY4=:3R865T\N,JW#KM&#]: /,F
MBA>_\,V*>);J]L+S4+Q!+!=O&KQ&!V$:L')=5;@-DD= >*?K]AJUG?ZIH&E7
M.HO+?VT5]ILKW<K>4\/$J%MV=K8CXSR937I?DQ *!&F$&%^4<?2G8&0<#(XS
M0!YQK6IM>^ )O$T=Q>67VVYLGMT-P\9CC\V-"",@?,"Y/J",]*L7&H7EKXUW
MAUU"TFOO)A,%RRRVLOD']U+%G#QG&_(Z$Y([UWQC1D"%%*CH".!35A@$QE6.
M/S0-I8*,@>F: ///!&H1ZQ=:3>GQ"7U1;=X]2TU0V_S,#<9D9SLVN" 0JCG
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MBW1R^4I)D'$CX.V,XPQZX..];\4,4*E8HTC4G)"* ,^M*Z+(A1U#*>H89!H
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MB\H%$>3<"4$I=<ENJ@'BKD,<1UCPM8?\)%=W]E<F^'FI=/&LT8 *@$/E@N2
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MEQ D=\X6";R\G"AL8W=CQ[<UZRC!T5U((89!!X--:*')+1ISU)4<T_Y47L%
M_ 4 >7^,==BMM7U,P:I);W5C>:>&66YV;$:2/<(T&/D*N=S-D'D8X!'J"L'4
M,I!4C(([TTQ1LQ9HT)( )('(ZT^@#S74X(CXM\;&VGG%XFAPO$(KEPPDQ<=
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M>2VY.-N.O4XR?88 M7'AJ&ZOX+N[N[BX6VNOMD,3JA\N0+C"D+NV]\9Z^W%
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M10V(UCQC%J\^E7-HVEI-;12SE1]H+$890K'* !L%L'Y^G6@#HIS(MK(51))
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MFO(%@N9(P\D*MD(2,[<^W2O-[[4=2U72;2ZOX[:6XMO%B6]OL)4#R[@IC)'
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQ7!/KTND6^GW\\D)B\R>-$,2I(&*OG=G;\OIGGI6Z[%(V8(SD D*N,GV&>*
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M@ 9YSD\B@#>U'2[+5K=;>_MTGB6195#9^5U.001R"*KGP]I)O7N_L2"5V1Y
MI(1V3&QF0':Q&!@D9&!Z"L:3XA:5#%?,]O=E[*6".9(Q'(<3,%1@5<@C<<'!
MR/2M?2->BU>ZO[7[)<VEU8R*DT-P%SAE#*P*LP((/KG@Y H U:P[3P;X>L!>
M"TTJ& 7BLDPCR 5;[R@9^4'N!@&M'4M1M]*L7N[IB(U*J HR69F"JH'<EB /
M<UFMXIMHC/'<V5];W$=Q';)#)&N9GD&5$;!BK#&<G/&#G&* +4/A[2H)X)H[
M0![>W-K$2[$+"<93!.-O X]AZ53G\$^&[FQM+*728&@LR3;C+ QY&#A@<XP
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MJTAEB\/Q6<)OIF>]DN7=OO+@NJ\AFZ<' ('6I/%>N2^'M!?4(;1KEQ+%$%#
M;=[J@)R1T+#C^0R1SLOBJ;0_$OB:XOH=2N+"VM;.X:%-C"T4B3>V-P'89"DD
MXXSB@#MK*S@T^PM[*U01V]O&L4:#^%5& /R%5KS1-.O[EKBYM_,=XUB<;V"R
M(I)"LH.&&2>"#U-9>L^-](T-YQ<&21;;R_M#1%#Y0?&"5+!FX()V@\&ND!!
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M.H1W5NM]#K$NIV_WBA61/+>)N_*Y^8=#V]9;OP?=SSM>I-;B]GU>#4K@'=L
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M7\DOG,8P[RSQ2-C&2,L6('/"D>]=CXFUY/#6AS:K+;27$,+(KI$0&^9@HQG
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M#@!9 48J2@ 4XSP?6O4M#@2Q\/V4 ENWCA@55DO3^^*@<%^!SCKD ^O-:-%
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M:&.[!&6*@X7()/L"1KZP)/"TEWKL$+SO?SPK?20VS2F&-(ROF"-3N8 @9P>
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MLB _*^ S;<C'RY.*P?!:(OB7QJ54 G5ER0.O^CQ'^I_.NHT[3X=,LUMH6E<
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MN NDJZ6BF3(56&&!X^;CCF@ \0ZO>:/>Z/(GV?\ LZYNQ:W3NA+1EP1&P(8
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M">%H903@NK#!Z>H/:L*;P-I,S6,@FU&&XLX?(2YAO9$E>+.=CL#EESV[=L4
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MA95+(01@X'<=JY/6=;EUJ7PM?VD)33I=<6..87!#2*!(,F,#&TE21R3TX&>
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M38GU6/4)3ODAC:*!<8$0;&XCU)P.?08'?-VBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBL6^O[N#Q9I%E'(HM;F&X:1-G)9-FTY_
MX$: -JBN,T7Q/>WMQH-Q,P:#6C<[8=H'D[,M'@]3\BD-G/)&,=*[.@ HHHH
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MW"2;EVY7:Q .0*K>)=<GT:]T6))K."&_NFMY9KE21'B*20'[RCJF.?6@"?\
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M #X:M_X+IO\ XFC_ (22V_Y\-6_\%TW_ ,36S10!C?\ "26W_/AJW_@NF_\
MB:/^$DMO^?#5O_!=-_\ $ULT4 8W_"26W_/AJW_@NF_^)H_X22V_Y\-6_P#!
M=-_\36S10!C?\));?\^&K?\ @NF_^)H_X22V_P"?#5O_  73?_$ULT4 8W_"
M26W_ #X:M_X+IO\ XFC_ (22V_Y\-6_\%TW_ ,36S10!C?\ "26W_/AJW_@N
MF_\ B:/^$DMO^?#5O_!=-_\ $ULT4 8W_"26W_/AJW_@NF_^)H_X22V_Y\-6
M_P#!=-_\36S10!C?\));?\^&K?\ @NF_^)H_X22V_P"?#5O_  73?_$ULT4
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M?_$ULT4 8W_"26W_ #X:M_X+IO\ XFC_ (22V_Y\-6_\%TW_ ,36S10!C?\
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I%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>exhibit1033-bochk_facili016.jpg
<TEXT>
begin 644 exhibit1033-bochk_facili016.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MY)4MU^7.2/:O7K;Q9HU[JRZ99W,ES<')S#!(\8QUS(%V#\Z -NBBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MP"15Q(9-I?)P>G;..>E<SX?\9>(KOPCX$:XO9<ZWJ$T-_J!4;E"R,$C'&%+
M8SC/!QSS7KBZ58B8SO:027+)Y;SO$OF./0G'-*FE:=%9&SCL+5+5CDP+"H0_
M\!QB@#AK_6M5M?'.M>'[:YFDTY-#-]YV<O93Y8 ;^X( ;#9_+BDTK5_$.E^*
M-/\ "OB-YKF22:22RU2%=B7L2QNQ20#A74A>.X'Y]VNF6"6\MNEE;+#-_K(Q
M$H5_J,8-3^3%B,>4G[HYC^4?(<$<>G!(_&@#S;PYXIGOO NI>*/$FH7=E+#<
MRQRQ6PQ]@"MM"^7@[B."=P8\^E7?B-K=_I'PEFUC2[^:*\CCMVCN=H#-N=%)
M*G(Y!/';-=G/I&FW,KRW&GVDLCXW/)"K%L=,DCFI+JQM+VW\B[M8+B'C]W+&
M'7CIP>* .,TSQ7)J-]J\$D5U:ZUI4$ACT:5^;A0,I)N&?,W8 R.F<'/!K D\
M4ZU'\&H?&":F\FMM(K>5M!C=C-L,'EX],CCYLC.:]/.EZ>;N.Z-A:_:8U"I-
MY*[U Z '&0*!I>GBY^TBQM1/OW^;Y*[MWKG&<^] '#:QJ7BK2-0F\0VHFO=*
MAV)J&C  R0J8T=I(FZEE+'*YY'3VA@\2ZAJ'B7PCI,=U/#I.IZ:U\UT>)+I\
M9$08_=P,,<8.#VKT6.V@AEDEBAC224YD=5 +GU)[TR6PLY[=+>:T@D@3!6-X
MP57'3 / Q0!Q=_XB6#3?%D^DZG=2W.A1>:]O<IE(G16<IN/+JX&.I([$<8G\
M=Z]>6WPHO=>TV62SN_LL5Q$PQNC+%>#G@\,1S71W&@Z9<V,MB;.*.UF8-/%$
M@19O9L#D'OZ]#QD5<N;.UO+<V]U;0SPG&8Y4#+QTX/% '.:WJDEG\/[N>*\9
M-171Y;N)]WS[DBSO_!BOMR!7)7NK>)_^$ \-Z_IE_-+>Q:<-1O8&P1>HOE%U
M/'!P['Y<>GI7I"Z+I2APNF60#IY; 0+\R?W3QR..E20Z;8VYC,-E;1F-"B;(
ME&U3U P.![4 >?IXFU+4_B7X;CBNIX=&U33YKE+0J$+*JY5FXR"<D]>F/>F>
M$-2U76/!>MZE=ZM=M/97EZD95@,J@^0'CH/U[YKT-]-L)+F.Y>RMFGC7:DIB
M4LH] <9 I(=+T^WMY;>&QM8X9<F2-(5"OGU &#0!Y@=:UI?@4?%0UB[_ +3:
MP$A<E<;_ # -P&,#C(QT]JVY]1U&'P1J^I/>75K?1Z3-/;Q22JY<I"KB=?\
M@38(Z= 17:?V5IWV'[#]@M?LG7R/)7R_^^<8IBZ+I2*ZKIED Z>6X$"_,G]T
M\<CVH \ZTOQ-KD%W\/0EY)??V[9[]0MY%5BN(U;SE(&5P2<CH>@ ->IU6M=.
ML;'/V2SM[?("GR8E3@=N!5F@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#GH]1OO^%A3Z
M6\ZM8C3$N4C$8!5S*5)+=3P*+;4;YOB!?Z7+.K64>G07,48C *LTDBG)ZGA!
M3UTF^'CM]9(M_L3:>MH!YC>9N$A?.W;C'..M$.DWR>.KO66%O]CFL(K50)&\
MS<CR-DC;C!WXZ]J -ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH ***P]0TO7;F]DELO$?V.W;&V#[%')MX&?F)R<G)_&@#<
MI&574JRAE/!!&0:YO^Q/$_\ T-W_ )38O\:/[$\3_P#0W?\ E-B_QH OR^%_
M#\[[YM"TR1_[SVD9/ZBKEIIMCIZ[;*RMK88QB&)4_D*Q/[$\3_\ 0W?^4V+_
M !H_L3Q/_P!#=_Y38O\ &@#I:*YK^Q/$_P#T-W_E-B_QH_L3Q/\ ]#=_Y38O
M\: .EHKFO[$\3_\ 0W?^4V+_ !H_L3Q/_P!#=_Y38O\ &@#I:*YK^Q/$_P#T
M-W_E-B_QH_L3Q/\ ]#=_Y38O\: .EHKFO[$\3_\ 0W?^4V+_ !H_L3Q/_P!#
M=_Y38O\ &@#I:*YK^Q/$_P#T-W_E-B_QH_L3Q/\ ]#=_Y38O\: .EHKFO[$\
M3_\ 0W?^4V+_ !H_L3Q/_P!#=_Y38O\ &@#I:*YK^Q/$_P#T-W_E-B_QH_L3
MQ/\ ]#=_Y38O\: .EHKFO[$\3_\ 0W?^4V+_ !H_L3Q/_P!#=_Y38O\ &@#I
M:*YK^Q/$_P#T-W_E-B_QH_L3Q/\ ]#=_Y38O\: .EHKFO[$\3_\ 0W?^4V+_
M !H_L3Q/_P!#=_Y38O\ &@#I:*YK^Q/$_P#T-W_E-B_QH_L3Q/\ ]#=_Y38O
M\: .EHKFO[$\3_\ 0W?^4V+_ !H_L3Q/_P!#=_Y38O\ &@#I:*YK^Q/$_P#T
M-W_E-B_QH_L3Q/\ ]#=_Y38O\: .EHKFO[$\3_\ 0W?^4V+_ !H_L3Q/_P!#
M=_Y38O\ &@#I:*YK^Q/$_P#T-W_E-B_QH_L3Q/\ ]#=_Y38O\: .EHKFO[$\
M3_\ 0W?^4V+_ !H_L3Q/_P!#=_Y38O\ &@#I:*YK^Q/$_P#T-W_E-B_QH_L3
MQ/\ ]#=_Y38O\: .EHKFO[$\3_\ 0W?^4V+_ !H_L3Q/_P!#=_Y38O\ &@#I
M:*YK^Q/$_P#T-W_E-B_QH_L3Q/\ ]#=_Y38O\: .EHKFO[$\3_\ 0W?^4V+_
M !H_L3Q/_P!#=_Y38O\ &@#I:*YK^Q/$_P#T-W_E-B_QH_L3Q/\ ]#=_Y38O
M\: .EHKFO[$\3_\ 0W?^4V+_ !H_L3Q/_P!#=_Y38O\ &@#I:*YK^Q/$_P#T
M-W_E-B_QH_L3Q/\ ]#=_Y38O\: .EHKFO[$\3_\ 0W?^4V+_ !H_L3Q/_P!#
M=_Y38O\ &@#I:*YK^Q/$_P#T-W_E-B_QH_L3Q/\ ]#=_Y38O\: .EHKFO[$\
M3_\ 0W?^4V+_ !H_L3Q/_P!#=_Y38O\ &@#I:*YK^Q/$_P#T-W_E-B_QH_L3
MQ/\ ]#=_Y38O\: .EHKFO[$\3_\ 0W?^4V+_ !H_L3Q/_P!#=_Y38O\ &@#I
M:*YK^Q/$_P#T-W_E-B_QH_L3Q/\ ]#=_Y38O\: .EHKFO[$\3_\ 0W?^4V+_
M !H_L3Q/_P!#=_Y38O\ &@#I:*YK^Q/$_P#T-W_E-B_QH_L3Q/\ ]#=_Y38O
M\: .EHKFO[$\3_\ 0W?^4V+_ !H_L3Q/_P!#=_Y38O\ &@#I:*YK^Q/$_P#T
M-W_E-B_QH_L3Q/\ ]#=_Y38O\: .EHKFO[$\3_\ 0W?^4V+_ !H_L3Q/_P!#
M=_Y38O\ &@#I:*YK^Q/$_P#T-W_E-B_QH_L3Q/\ ]#=_Y38O\: .EHKFO[$\
M3_\ 0W?^4V+_ !H_L3Q/_P!#=_Y38O\ &@#I:*YK^Q/$_P#T-W_E-B_QH_L3
MQ/\ ]#=_Y38O\: .EHKFO[$\3_\ 0W?^4V+_ !H_L3Q/_P!#=_Y38O\ &@#I
M:*YK^Q/$_P#T-W_E-B_QH_L3Q/\ ]#=_Y38O\: .EHKFO[$\3_\ 0W?^4V+_
M !H_L3Q/_P!#=_Y38O\ &@#I:*YK^Q/$_P#T-W_E-B_QH_L3Q/\ ]#=_Y38O
M\: .EHKFO[$\3_\ 0W?^4V+_ !H_L3Q/_P!#=_Y38O\ &@#I:*YK^Q/$_P#T
M-W_E-B_QH_L3Q/\ ]#=_Y38O\: .EHKFO[$\3_\ 0W?^4V+_ !H_L3Q/_P!#
M=_Y38O\ &@#I:*YK^Q/$_P#T-W_E-B_QH_L3Q/\ ]#=_Y38O\: .EHKFO[$\
M3_\ 0W?^4V+_ !H_L3Q/_P!#=_Y38O\ &@#I:*YK^Q/$_P#T-W_E-B_QH_L3
MQ/\ ]#=_Y38O\: .EHKFO[$\3_\ 0W?^4V+_ !KH+9)8K6*.>;SIE0!Y=H7>
MV.3@=,^E $M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 44C8VG<<#')SC]:\?TZ
M.T;2_"UP;N7[1+KUU;2R?:WW- 6N?D)W?=/[L_B/6@#V&BO*+.]^QE+4RY\/
M6_B6X@NAO+)%"8R8@QSQ%YI&<\=!TINH QYB^V2+HI\36RV#+<,JF$JIE52#
MS&'+ =ASC&* /5!<PFZ:U$BF=4$C1YY"DD _0D'\C4M>:MIFGZ)XRUVVL\6,
MIT"(V<^UI'1E-P&=2<LQ4;,_\!'I69I.K:7<PW.I0:F/,MO#Y26PT^]S<2S!
M27E50>6 X#,"<G) P,@'KM%>0)J&VV\61Z=J<=O$^@V]S;R6H<QJP\X.P(ZG
M 56< <XX!%3'4H+FW\2:KX=OX7E^QVX73+&Z\R2)5;]_($4X!*D $<Y4'@F@
M#UFLO3M:CU'5M5T];>6*339$C=GVX?>@<%<$\8(Z\UYW<W^GPV+:KHNJ3W6B
MW-_:#4Q!$4M[>$%MY '*D_() .W7K70^"GTX^*_%HTQX6M7GMI(S"<H08%R5
M(XQG/3B@#LH;F&=YDBE5V@?RY0#]QMH;!]\,#^-2UY*SII0\1+;1>5M\2QOJ
M(B4AULF$19CCG83G/J-_H:Z[PR"OBC7?[/D5]"9+=K?RVS$LY#>8(\< 8\LD
M#C)]<T :>M>([71M-N;WRWNA;7$=O,D)7,;.4 SDC_GHIXR<&MFO']7CL+32
M?'-OMC@NWURWDV@;6\MC:G/T)#G\&/8U;U"[;2+OQ7#IDLQL8;C3YYXX6:5E
MB8_Z0RC))^4 MCMGUH ]5KF$\:P21:M,ND:H8=*G>"[<+$=I50S$ 298!6!X
M&?:D\&+IS1ZA=:1J4E[8W,JR)M3;;Q-MPPB'8< D#C)/?(KBHWL;NS\?0R^)
M)-/$^IS;(H)(\RCR8QP-I=@2"ORD9Q@8- 'JUG>6^H6-O>VDHEMKB-98I%Z,
MK#(/Y&IZ\2U;4YAX2>.XM#I6L6OA^WEBMB&Q$59R/LZ#E6 4;V). %!'!-7M
M?FM)1XVU"&]D:6UN;.:R<7+_ +MBD9)09]=WZB@#TO2]:CU34-5LUMY89--N
M%MY/,V_.3&K@C!/&''O6I7DQU2"W\=ZW+?-%+X?EU6%971_N3?9H1&[^L60R
MG'0XSD9KTZRU&ROWN8[.=)3:R"*4*.$;:&Q^3 \>M %NBBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH J:GI\>JZ7=:?-)+''<1M&SPMM< C'!JI8:
M+-;S137VJW6HR0Y,)GCB0(2""?D1<G!(Y]>E:U% %'5],36-,DLGN)[<.582
MP, Z%6# C((/('!!!'!%1:?I,EK.+F\U&XU"Y5#&DDR1IL4D$@!%4<[5ZYZ<
M8K3HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ IC31*<-(@([%A3ZY[7+M;!;JZ:*
M658EW%(ERQP,\4 ;OGP_\]8_^^A1Y\/_ #UC_P"^A7$>$_$D/BSP_#K%O;R0
M13.ZJDA!;"L5R<>N*BTSQ;9ZMXLU/0K1"[:?$K2SY^4N3@J![>OK]* .\\^'
M_GK'_P!]"CSX?^>L?_?0K".<' !/;)K@?^%F%4U^5M$D:'0IQ#>&.X!8_,5W
M("!D?*>I% 'K?GP_\]8_^^A1Y\/_ #UC_P"^A7,:9J-MJ^EVNHVCEK>YC66,
MD8.",\CUJSO4*&+#!Z'/6@#>\^'_ )ZQ_P#?0H\^'_GK'_WT*PZ0$,,J00>X
MH W?/A_YZQ_]]"CSX?\ GK'_ -]"L(,&&5((]1574M3L](T^XO[Z=(;>W3?(
M['H/\3T [T =/Y\/_/6/_OH4>?#_ ,]8_P#OH5@0RK/!',N=LBAAGK@C-/H
MW//A_P">L?\ WT*//A_YZQ_]]"L.D+*I + $\#)ZT ;OGP_\]8_^^A1Y\/\
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M>?#_ ,]8_P#OH4>?#_SUC_[Z%8=% &YY\/\ SUC_ .^A1Y\/_/6/_OH5AT4
M;GGP_P#/6/\ [Z%'GP_\]8_^^A6'10!N>?#_ ,]8_P#OH4>?#_SUC_[Z%8=%
M &YY\/\ SUC_ .^A1Y\/_/6/_OH5AT4 ;GGP_P#/6/\ [Z%'GP_\]8_^^A6'
M10!N>?#_ ,]8_P#OH4>?#_SUC_[Z%8=% &YY\/\ SUC_ .^A1Y\/_/6/_OH5
MAT4 ;GGP_P#/6/\ [Z%'GP_\]8_^^A6'10!N>?#_ ,]8_P#OH4>?#_SUC_[Z
M%8=% &YY\/\ SUC_ .^A1Y\/_/6/_OH5AT4 ;GGP_P#/6/\ [Z%'GP_\]8_^
M^A6'10!N>?#_ ,]8_P#OH4>?#_SUC_[Z%8=% &YY\/\ SUC_ .^A1Y\/_/6/
M_OH5AT4 ;GGP_P#/6/\ [Z%'GP_\]8_^^A6'10!N>?#_ ,]8_P#OH4>?#_SU
MC_[Z%8=% &YY\/\ SUC_ .^A1Y\/_/6/_OH5AT4 ;GGP_P#/6/\ [Z%'GP_\
M]8_^^A6'10!N>?#_ ,]8_P#OH4>?#_SUC_[Z%8=% &YY\/\ SUC_ .^A1Y\/
M_/6/_OH5AT4 ;GGP_P#/6/\ [Z%'GP_\]8_^^A6'10!N>?#_ ,]8_P#OH4>?
M#_SUC_[Z%8=% &YY\/\ SUC_ .^A1Y\/_/6/_OH5AT4 ;GGP_P#/6/\ [Z%'
MGP_\]8_^^A6'10!N>?#_ ,]8_P#OH4>?#_SUC_[Z%8=% &YY\/\ SUC_ .^A
M1Y\/_/6/_OH5AT4 ;GGP_P#/6/\ [Z%'GP_\]8_^^A6'10!N>?#_ ,]8_P#O
MH4>?#_SUC_[Z%8=% &YY\/\ SUC_ .^A1Y\/_/6/_OH5AT4 ;GGP_P#/6/\
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ME $C(^.FZ/.* /$==6WF^(.IZ)J-_9Z5I\NE1QZ7+-$/+B7@DQ?,H5MPX/\
MLCT%5K@-?>+]=T;7=<CLYGL[/^S[VZ@(<J@#%HLL-KE^2.23D=J]U?0H)#&7
M$3&(YCS$#L^GI2OHD,DJ22>6\D?W&:,$K]#VH \4LA=Z5\1H'=K;6++4=2<+
M.%"W5G<!"K*1U";0>#QMP>#U]?JV-#@6;SAY8EQC>(ANQUZU+_9G_3;_ ,=_
M^O0!GT5H?V9_TV_\=_\ KT?V9_TV_P#'?_KT 9]%:']F?]-O_'?_ *]']F?]
M-O\ QW_Z] &?16A_9G_3;_QW_P"O1_9G_3;_ ,=_^O0!GT5H?V9_TV_\=_\
MKT?V9_TV_P#'?_KT 9]%:']F?]-O_'?_ *]']F?]-O\ QW_Z] &?16A_9G_3
M;_QW_P"O1_9G_3;_ ,=_^O0!GT5H?V9_TV_\=_\ KT?V9_TV_P#'?_KT 9]%
M:']F?]-O_'?_ *]']F?]-O\ QW_Z] &?16A_9G_3;_QW_P"O1_9G_3;_ ,=_
M^O0!GT5H?V9_TV_\=_\ KT?V9_TV_P#'?_KT 9]%:']F?]-O_'?_ *]']F?]
M-O\ QW_Z] &?16A_9G_3;_QW_P"O1_9G_3;_ ,=_^O0!GT5H?V9_TV_\=_\
MKT?V9_TV_P#'?_KT 9]%:']F?]-O_'?_ *]']F?]-O\ QW_Z] &?16A_9G_3
M;_QW_P"O1_9G_3;_ ,=_^O0!GT5H?V9_TV_\=_\ KT?V9_TV_P#'?_KT 9]%
M:']F?]-O_'?_ *]']F?]-O\ QW_Z] &?16A_9G_3;_QW_P"O1_9G_3;_ ,=_
M^O0!GT5H?V9_TV_\=_\ KT?V9_TV_P#'?_KT 9]%:']F?]-O_'?_ *]']F?]
M-O\ QW_Z] &?16A_9G_3;_QW_P"O1_9G_3;_ ,=_^O0!GT5H?V9_TV_\=_\
MKT?V9_TV_P#'?_KT 9]%:']F?]-O_'?_ *]']F?]-O\ QW_Z] &?16A_9G_3
M;_QW_P"O1_9G_3;_ ,=_^O0!GT5H?V9_TV_\=_\ KT?V9_TV_P#'?_KT 9]%
M:']F?]-O_'?_ *]']F?]-O\ QW_Z] &?16A_9G_3;_QW_P"O1_9G_3;_ ,=_
M^O0!GT5H?V9_TV_\=_\ KT?V9_TV_P#'?_KT 9]%:']F?]-O_'?_ *]']F?]
M-O\ QW_Z] &?16A_9G_3;_QW_P"O1_9G_3;_ ,=_^O0!GT5H?V9_TV_\=_\
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M!81QM@$A0  !@%CQDCN15N/QMHLMVENKW7S7IL#(UK(J+/T",Q& 2>!^'J*
M.BHK&D\4:7%<)&\KB-[G[&MQY9\KS\X\O=TSGY<],\9SQ4)\8:2(RY:X 6_&
MG-F!OEG) "GC@$L,'IR.>: -^BN5\2:Y/"U@NGW$L+)K-M9W(,0VR*Y!902#
MV8<CZ5I3^)M,M[V"VEDD43W/V1)O+/E&?G]WNZ9X(],C&<\4 ;%%<=K7B=FU
M7P]'I=Q.+>YU4VLT@A!BF4))N4,1G(9!R,9P<9P<:K^+M)2XAB,DS+/=/9PR
MQP.Z23)G<@*@\C:W)X^4\\&@#<HK'/BC2TO[>T>5T^TRO#!,T9$4DB9W(&Z9
M&UO8X.,XJ?3=:M=5*FV6;8\*SQN\9"R1M]UE/?..G4<9 R* -&BL"]\0;?$I
M\/QPW*3-8O<_:50%4^8*,9R/7)(QTZUF>#/&,&I:%HL6I3S?VE<Z:MV\LD!C
MCEVJOF%6P%."PR!ZT =E17-OXVTO^S[J[B6YD\BP_M%(Q$0TT!SAUSV..^".
MX%:VE:C_ &EHUK?F&2,S0K(8RI!!(S@9_2@"]16%:^+])O!IAA><C4I9(;8M
M RY>/=O4Y'RD;&X..AK+U/Q-)!XGT/[/+=&PG^V1S6R6^YI7BP!M 7<<'=T.
M#C/3F@#L:*QH/$^FW6FVE[:&:X6[C>2&*.(F1E0X?*GD;20#GN0.I%5!X[T*
M18&MI;FZ^T6AO8A;VLCEX@0I(PO4$X(ZCOB@#I**KV%];:GI]M?V<HEMKF)9
M8G QN5AD'GV-95KXNTF[D5(I)B)+>2YA;R6(FCC8*[)@9."1QU.00"* -VBN
M>L/&FCZF]NMJ;IC<VAO+<M:NHGC&TML)'S$;ER!SS5NQ\1Z=J-GIMW:M+)#J
M1(MSY9!. 221U484]?IU- &M17.^++^\T\Z(UI<M")]5@MYE"J1)&Q.0<@D=
M.HQ5F/Q3I<NI1V2R2EY)Y;:-_+.QYHP2Z ^H"M[':<9Q0!LT5SUCXUT;4;BR
MBMWN<7DLL,$DEK(B-)&6W)N8 !OD8X/I6?K?B=CJ?A^/2[B<07&K?9)I!"#%
M,H63<H8CJ&0<C&<'&<' !V-%9^L:W8Z#:QW.H2/'%),D"LL3/\[L%4':#CD]
M364/'FA"RO+F66ZA%G/';W$4UI(DD32$!-R%<@-D8)XH Z6BL+_A+=.\AI!%
M?;HXVFEA-I(LD4:LR[V0C(!*MCC)P< X-17?C?1+1U19+FZ9[07J"TM9)M\)
MZ."H((_E^5 '145AR^+=(334U"&:2YMGMOMFZWC9RL']\@<@<'CKP<#@XC/C
M31VOELX&N[J9HX91]GM)) 8Y<['R%QM./O=!0!T%%<OHOCBQU:VTIY+>ZMI-
M4>1+5)(3AMFXX+= =JYZ]CC.*W[.^AOUF:$/MBF:%BRD LIP<>HSD9]C0!9H
MKG[?7[*.[U;=?W$YAO8[7[.\&SRI&1-L:< L#D-DDCYNN!6Q97L=_:BXB615
MW.A61"K JQ4C!]P?K0!8HKFH_'F@RW<$ ENE$UTUDLSVDBQB<,5\MG*X#$@@
M _U%21>-M%EDN@)+I8[1I5GF>TD6.-HR REBN-W(P.I[=1D Z&BL&Y\8:18P
MZA)>O/;M80"XN(I(&WB(YPX !RO!&1TQSBDM_&>B3W%] ]Q+;O90?:I?M4#Q
M P_\]%W ;ER,9']10!OT5BGQ3I<;W4=S)+:R6UM]KDCN(F1C#_? [C/&!R#@
M$#(J;^WK4(_F1W$<JS" 0O$=[N5W@*.C?+SD' P<D8. #4HK$@\5:7=V\;VT
MDLDLD\ELMNL9$HE3.]2IZ;<<D\=.>1FKX&U2ZUC09[F[GDG=;^ZA1Y8Q&VQ)
MG5 5 &"% [4 =+17.67C"SN)-8^T0SVT6G7HL][QG]ZQ6/ 4#J2T@ 7J>/6M
M/3]9M-2N+JVB+I=6C*L\$J[7CW#*G'<$=",C@^AH T**XS4?%+:'XVU""]EO
M)M.CTN&Z6&"U,IB8R2*[?(N[;A 3D_SK8NO%FD6MA]N$[SVHMEO'EMXS($@;
M.)&Q_#P3Z\'C@T ;=%5;C4;6VTN34GD+6B1><9(U+Y3&<@*"3QSQ6-'XWTB:
M2.*)+YY9K47<"+9R$SQ\9*<?-C<N?J* .CHK%B\4Z9<VEI<6;RW8N[<W4,<$
M19S$,98KU&,@8/.> ":K3^.-#ACLGCFN;H7MN]S;"UM9)3*BXW8"KU&X9'4=
MP* .CHKFK'QG97,>J33PSVT-E??8E,D9S*YV  #U+/@#KTSBK \7Z3_I:,]P
MDUI<1VLT30.")G("(#C:Q.Y>A(P0>E &[16-'XGTR2T$XDD#&[-B(2A$GV@'
M'EX]>,YZ8YSCFDMO%6EWD4K0-.SQW)M#$8'5S,,YC&1AB I)P2 !DG'- &U1
M6'!XKTN\@C-K)+)/)-);BW6,^:LD?^L4J>FWN3QR.>1FOX$U2ZUGPK'>WD[S
MS-=72>9)&$8JD\B+E0!@A5 Z"@#I**YRP\86=U_:CSPSVT=E??8E+QG,K_(
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MLKNXDC(5L#,K@KCICFNATK1+^Q\67FH2BT^R3:?;6J^42K!HC(2=FW 4^9P
M3C%=)02 "2< =30!YM<Z7)I/@6T\/WM]80:[;2^;H_ES;GFE23*,%(!YW!6
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M5;Z7JEI_9\%C.FI$HT;1;L2H0K9!WG*\=!S7H=% &=J-C//X<NK"#RC/):M
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M-SL5DY88XS@^E=L(XU((101T(%"1QQ[BB*FX[FP,9/J: .+^*4D:>%+=7N!
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MY##X(UV99Y('CL)G26.0QLK!"5(8$$'.*XOS;-/$Z7<VI&UEG\*J\5UYI)W
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MH \EU99I8/&,UOJU\NLZ?JL?]FPI?2':[10E4";L,K,67!!&,XQS6B^HB_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MNA<*"20N=WR+R,=.E-7P-;XNS+J^I3/=Z:--F=S$,QC=@@!  P#L/3G)!/-
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MDK$5D,6SY>N75QGL%S@YQ56Q\6WVO:QX:%M#%!97]O>-=6\N699(72-UR."
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M;5&N@R%6=G!$9;*RX<KTQU.>Q .C@\8>'KK=]GU>VEP%.(VW$[GV* !U)88
M')X]:J:SXE:.TTFZTB>WEAN=5ALI]Z$D!GVN.HVL""#D<>E8MCI.NZ?X#TVR
M32-UW!J)DGAW0F01&9W+Q$ML#X8<D@CG&#@U6@\/ZY%IR0'2I<IXF&HC-RCD
MP>9OW9+9)QQSR3GZT =)>>*[+28=4N[G4(;N&WNX[98K:(EH7<( CD$Y.YLY
MP, @=:U(=>TR=[M([I2]F@DN%VL#$I&06!'&0":X[5?#^LW,'BWR=.<M>:G9
MW=JIEC'G)%Y&X#YN#^Z;&['45=UW2YKWQ/IDUJR0MJ,)L]5MBV2;=?WF3CN,
MF//_ $V^E '90S)/ DT;;HW4,IQC(/2J-OKVEW4_D07B/(8S*B@']X@X+)Q\
MZCCE<CD5-JMF^H:/>V4<IA>XMWB60=4+*0#^&<UR6F:+JEQ)X2-[8-9R:#$Z
MS.)$99CY/E!8\'.TYW?,!C '7H 7_#FNWWB.X>^MYH$T^*XN+>2W>!@^$=D1
MU?.,DH21C@''!',VJ^*8;>\U/2K0XU*TL#=@RPLT?1BH.,9^X>X_.CP58WNG
M:)-;W]H]M*;ZZG"LZ-E9)WD7E2>S"J.L:7JC>)]7NK:P:XM[[1%M$D25%VRJ
MTQP0Q!Y\Q<'IUSB@#1\->*+'6M.LU:]MVU$V,5S<1(<;=RC<1[ G'MT-:-EK
M6G:A<R6UK=))-&BR&/!!*'HX!ZJ<'##(/K7#/X5UB\MM.LS:O:@>%I])EG,B
M$13.(@. Q)'[MN1GM6YX6M+U[I;W4_#JZ;?16WV>2=[H3M)R#B,AB1'D9^;!
MSCCK0!;\2>(1I%WI-@C;)M1N##YIB9Q$HC=RV!U/R 8]\]JL6>M16ZV]EJNH
M6C:B7$$CPHR1-*>0H)R Q&#M)SS57Q%97UUK_AJYM;-YX;*]DFN'5T&Q3!)&
M.&8$\N.G;-<_)X9U>;0M4\.2VS%;C5C>0ZB)$VB)K@3$D9W!UY7&,9QSC. #
MJX_%>@RWDEHFK6C3Q^9O42#Y=@!?)Z# //X^AJ:/Q!I4L5W(+V-1:$"X$F4:
M//W<JP!&>W'/;-<HWAW5[GP]XMLX[86MU?:DUW:-+(NV4#RRH)0D@$QD'/8U
M4U>REN?#=Y<7'AQM-U*ZEM88HWO4DGFE24,F'W%2%/(!(SSG:.: .UC\0Z1+
M]J"ZA &M/^/A';:\/^\IP5ZCJ.<BJ]_X@L?[%U*XM]5MK-[1"));I#BW<C*E
MT)5NX..,]JX^?3M2U6+4RFEWEIKDEY::F\5T\0BN5@9 (U,;N%X3^(\DYSCI
M;\0>'M3UF'Q3?VUA+%-J6C)IT%H\D8:20>8=[$,5 'F #G/!]L@'3WGBO0M-
M>6&^U:UCF@C6292W**V<,1S@<$^PJQ>Z[I>G9-W>Q1!8Q*[$Y"1DX#L1PJD]
MS@<'TKE-3T;5KN_\0S1Z7(5O?#\=C#F2+YIAYV5/S<?ZQ>>G!K'O;"_ENKRP
M@T>]N4N-%MM/U1+6>W+H0'^7YW4*VUS@@L"'!P,#(!ZA!/%<P)/!(DL3C<CH
M<AAZ@U#>W]M8HGGRA&D)6-0I=G;!. HY/ )X["LS2M<-W?6UG%IEQ#9R6"W,
M-Q(ZGN 8V4$D$9'/0\X)Q537+35(/%^CZW9V3W]K!;SVL]O'(BO'YA1A(N\J
MI^Y@\@X/&: $\(^*TUG1;.6_N;?[;=RW0A6%"JRI%,Z90$G^%5)Y/6K\WB[P
M_;VL%S-JUJD,XD,3%_O^7G?@=>-I'U&*Y'2=$UW3%\/74FCRR/8WNHF:".:+
M<$N)'9'!+ $#(R,Y]C3M$T#6K5_"OVK2F7^S[^_FN"LT;!%E\W8P^;)_U@[9
MZ\4 =.GB;3(I-2NY]<L&L(!"<*,&#>N1N;)W%N"  ,>]7+?Q%H]W'>R0ZC;M
M'9<W+;\"(8SDD]L G/0XKC_$/A_6+X>,UM]->0:DEJMJ?-C DV##=6X_'%-\
M3Z9<O+XLN;FQD6UU'3K2UMB9XT+SJ\@"CDX.Z5 ,C!/'2@#MK36M-OKR6SM[
MN-KN)0TENV5D0'&"4." <CG%0:CX@M-.UC3])D+_ &N_#F+$;,JA1R21[D#&
M>]8OAB2X_P"$COIM3TJ_L]3O;="9)C#Y3QPG: HCD?!S*2<]<\=,5<URQOW\
M5>']3M;1KF&U%Q'.%D52GF*H5OF(R,KSC)YZ4 0>$?%\&L:?9PZA>6HU>=IQ
MY,0*AO+D=> 2>=J@XSG'-;<6MZ;-J L([N,W+!BB<C?M.&VGHV#UQG'>N+TC
M0-9M;3PE'+IDB/I^IW=Q<_O8CLCD$X4\-S_K5X'H:G\'Z'J-@=.L=5T)?.TD
M-'%JKW0D65=I4-&NXLK,,;@0!UZ\4 =I>7]KIZ1O<RA/,<1QJ 69VP3M51R3
M@$X'8&JL7B'29VL5BOHG-_N^R[<GS=N=P'N,'([8YJEXGAU&6326L;'[5#'=
M[KGRFC6:-#&ZAHV<@*<D D$-M)Q7.6GAG68O -M;I:+#K>E:A+>V2O.&$A\Y
MVQN!Z/&[+S@\\T =E-KVF0+F2Z /F/$%",6+(,L H&3@=2.E0-J]O<:EI26>
MK67EWD+S)#MWM<)M!5T(;A1U/!SGM65J6F:G;W&AQ6ME]LMT687D\3I',)'
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M.>#GL1CO6G!K^E7$_DQ7T1?RVE7)P'1>KJ3PRCN1D#-<C/X4O+WQ0+O2M/\
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M.5Z8ZG/8][0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MN+;HP^2,=PWKQBH]:\80Z5/=QPVDEXUD$-S'$W[SYN<(N#O8*0Q&1P1@D\4
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M( H/IG/6@#SC4M#N=!M]"TD:E.L=H;B6._\ [*>= SM@(1$P96PS\[@#SQT
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MEDG*["P()YW'D< =-->6MN<3W,,1X&'<+UZ=?7!Q]*62ZMX9!'+/$CL0 K.
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M+@VUL]PJ&3:KA5+8W 'J!Z4 8%YX+GN[76H/[4C0:IJ$-\3]E)\LQ^5A?O\
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MNKCNK>:%I8IXGB0D,ZN"%(ZY/M6/I'B-=4U?6K0+ +?3C%LN(YMZR*Z;LG@
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M,K*@!!!YZBNAI'=8T9W8*JC)). !0!YCHD=U)XE\/3MHU_:11G4(9X&M'\N
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M[0KK8N&6W\W)8?+D)M)]N31/%>_V<MA?:3?RZK;^)H[V2=+.219(OM(995<
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MY@174988!VD<XKU2B@#RG6++2G@TO45TW4/)O?$$$DPOK9A)*QC96(AV@@$
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MBTJ"58L"*-X8WR1GEN6 )[D=N*Z >#]!6 0+IZK&+LWJA9'&V8YRP(.1G<W
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M $ X))!/()R,4 8^H>(KRR\416EXT]I93S01VEPL2R6\I;&Z.1@"T<A)(7.
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M,G/S_*[9'/S1#UH [>63RH7DV,^U2=J]3["JFBZM;Z[HMGJMHLBV]W$LT8D
M#!2,C(!/->>^$M>BN/$FEB/5VFM+W1)9BL]WYCR2+)&0T@SM63:SY51P 1R
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MKK[1?27CSQJ^<P1-*)!CY,@X;!9>_6K.G7\46M:?HVJ^();G2SIDLMI?/,T
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M7G&@W\FL)X+@N-8NY/.^WP7(CO'4R^7G:&PV<@8YSNYZU3_M34SI'A">P?\
MM#4H;S4XX%FFW/(L8F0#<?O-L QGJ<9/.: /9*R]6U^STB!)IA)*INXK1O)
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M(R=R@-;$#D?[9YSW(Z5T1\93V<^JVNHV$27=G<6T,2V\K2++YYPG.P$$'.<
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MMTM[F&YGM9HT?>H>*1D)4D#(.W/3O0!JO#%(RM)$CLO0LH)%(T$+3+,T2&5
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M;V<%O/!Y$QD\T32-&BM\HPV]>< \'OBM31=6O[^^OK:\TV2W2#8T-SM=4G#
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M66L_:IHYK2"6".-0I0B0J6)R,Y^1>_:I+C7])M1$TVH6Z)*$9'W@KASA"6'
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M!]!HV&FV6EP&&RMHX$)R0@Y8^I/4GZTZ_OK?3+"XOKMV2WMXS)*X0MM4#).
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MDD#\S7&Z5I.LZ6_A"^DT^61;#2#IMY:K(A>%RL7[Q?FVL,Q;3@YP0?6N^HH
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M+<@>:N<G=UX/>270-<$M[>16#YA\3+JB0&6/-U!Y2QG;\V P.6 ;'*BO1:*
M/.M8\.:I>R:QJ%OI\K'4-1TV5;4O&&"6[H7D;+8R0",9S\H_#8L8M4TSQ%XD
MOQH\\T5[=6I@"RQ#>HC2-V^]QMP3@X) XKK:* "N"ATC5UM_'BMI<P;5)':S
M'FQ?O0;=8Q_'\OS*>N.*[VB@#.T&*>W\/:=!<PM#/%;1QR1L5)5@H!Y4D=O6
MN?U?3=3/BK5;JWT^2XM[W1%M$D22,;95:4[2&8'GS%P>G7.*[&B@#S8^%]9N
MK32K,6;VA7PM<:5+.9(\0SNL07[K$D91CD ]JW/"MM=RW27NI>'9=.OX;7[-
M)//=B<OR"5C(=ODR,\X[<=:Z"\U6ST^[LK6YD9);Z4PVX\MB'<*6QD# X4GG
M'2KM '-?$#3K[5_ FKZ;IUJUS=W4!BCC5U7D]R6(&*QIO#MU+XIT/4-%T/\
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M8P75I#-=L]];3R1R6TB>60)H^2R2?=4@8SSD8YKMJ** "BBB@ HHHH ****
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M;."V$SF200QA-[GJQQU)]: /./&6HSZSX9\>1R7<MO\ V41;QVR$ %/+1][
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M1C#+&CAD^3Y3DD$\]>W&)=/UW4;[0]*@DU:9KUDU#<J!4:58)3&LKR=%"\9
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MGPVDDWSE%C*';'SQN/3UYJMX;\5^1'K\ES<W%Q90:G'::?!<<7>YPJA'5L,
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M\C/C&X]"Q'6J.L^%#K>J0W5Q<0 6]S%<6TBV^+BWV%2R+(&^ZV#D8_B/7C
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M=]<M@;H;?R8U ]%W-R<\G/IP,4 <YXQNGMO%OA.,W-_':W4]Q'<16LDH\P+
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MV0\DR%_+QYGJQ&?TJ.V\&7MEJ-C?2:RDJV-]<7@S9DR2K*K@J[;_ )F ; (
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M_LS=/*$C,GEB0$OV4@XY'7 [TUO$U\/%&FZ<^G""VN+*XN9FEE&Y/+DC7Z8
M;.<\Y'IS'!X1O(HM2CFU"SNX]0O_ +9<0W%CNC=3$(VC(W],JK ]L<YIECX%
M&GOI'DW^8;&VN;26*2(L)(9G5RBG=E NT*,[OEX]Z +EOXP@F?29'LYH[36
M?L$Y8?O#M+JK#^$LH)7KTYP>*I6OCW[7'I<J:'>B'4Y9;>W8R1Y\U-YVD;N
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MPWIU_;W;R7]M(8KV64/YKIRP/);IW/7!]L]_7(:3X+N-,3PTAU2*5=$$J_\
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M/MWA\\I/*TD7S $$H=N#CKZ$&@#L=?\ $J:7H+ZG8"VOECN(8'"S\+OD5,Y
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M->E+.X66;9;36[*9X5)V2129VOQ@L.HR>F.>LH **** "BBB@ HHHH ****
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M(8BZN6YQR#@<Y-6KO7;*PUV]6YU"X5;33Q<S6HMBRJFX_O0P7+'@C )QCI0
MVX\&:3<S),?M44JVGV)WAN&0RPCHKX/S8R<'KSUJO+\/O#\UL]L8KI89+)+"
M1%O)0)(DSL#?-\Q7<<$^M7]+\4:7K%Z+2TDF\YK=;I!+ \8DB) W*6 ##) X
M]1536];N5\3:7X;T]UBN;R.2XGN"NXPPI@?*#P69F &<@<G!Z4 33^#]*N4U
M-)?M+KJ=NEM=[KAB9(U! &2<CAFYZG)S23^#=)GU1=1872W'E)#-Y=RZ+<HO
MW1*JD!\>_;@Y'%5]=_MO2M*U2Z@U5I((=-GECDDAC\Q)U *GA0I7 /&W\3D8
M='XNT^PTJU?4KAS,MC!=73I$6$2/P'; X!8-T]">@H L?\(AI(UZ76$6YCGF
M=9)HH[EUAFD7&UWC!VLPP.2.PK2U/3;/6--GT^_@$UK.NV1"2,CZCD$'!!'(
M(JC>>*M)L$U5KF:1!I2+)>?N7/EJP)#<#YA@'IFIY-<LH[UK7,KNDB12,D99
M8W?!56(Z9!!].1ZB@")?#MEY%VDCW$TEW +::>24F0Q#.%#=A\S=.>2>O-7M
M.L8=,TZWL;<OY%O&L48=MQ"J, 9[X [U13Q+ICZE;6(E<2732);NT;".9DSN
M56Q@D8)]\'&<5'XQO[S2O!NL:CI\D<=U:6DL\;21[QE5+=,CTH K7G@;1;V:
M]>1;I([Z5)[B"&Z>..252I#[0>&^5<D=<9Z\U9D\*Z5+=74QCE"7;(]U )#Y
M<[KC#,O<\ '^]@9S5JXU!K;3()0GG74X5(8LX\R0C./8=23V )[51\%:G>:Q
MX2LK_4)$DNI#()&1-JG;(RC [< 4 -U#P5H^IW-]-<K=8OFC>XCCN71'>/;M
M?:#]["*,^P[\U/+X5TR:[NYW68K>%&NH?.8QSE %4L#UX4 ]B!SFLNZN/$FF
M>)=',NH07=IJ-R\$MBMN%^SKY;N'5^IV[0#NX.[@#(%==0!@ZEX6L[R34[F(
MW$5UJ$*Q2M'=R1 [>%;Y3P0.,CG'%;%K"UO9PP/*\S1QJAD?[SD#&3[GK6(_
MC71$NI(&EN 8KQ;&5S:R!(Y6V[0S;< $NH!/!S5F[\3Z592R+/.ZQPS+;S3B
M-C%%(V-JLP&!]Y?89&<9H J6_@C1K:XMIHA=J;6XDN;9?M3[87<-NVKG !WM
MQTY].*EM?"&EV<>F)#]H"Z;-)/:@S$['<,&)SUR';KG[QJL_CC3K:\UF.\AN
MH(-+FCAEF-N[ LX4@\ X'SK_ #Z5HMXDTU)]3@9YO-TU5>Y7R'RH8$J1Q\V<
M'[N>E %*?P/HMQIQLG6Y"B[>^CF2X998IV)+.C@Y4DL>.G/2K+>%[ VZ0++>
M*@A>"0_:&8S(YR^\MDL3_>ZCL169JGBVVT:+Q#>^?=WC:>L.ZR^S[!"S#Y<-
MM!(;@DY..WI5>Y\7?V5XMU-;^:[.EQ:7!>+$MHS-#EY0[$*NX* @)W=* -P>
M&-.$R,%E\E)8YUMC(3$LD:JJ,!VP%7@<9&<9J[JNEVFM:7<:=?(7MIUVN%8J
M>N001R"" :KR>(+".X6%7DE)\G<T49=4\UML>2.@)_(<G K.LO&EC=)?/+#<
M0+;ZA]@C#Q-NFDX  XZDD\=AR<4 6)?"6F3-?-(;IC?VBV5P6N&)>(;L#)YS
M\[<]?F/-17'@G1[F\M[LB[CFA@6V9H;J2/SXEZ))M(W@>]/;QEHJ6]K,TT^+
MFYDLXU%M(6\Y-VZ,@+PPV-QWQQFIK?Q3I=UI\=W%)*1)<-:+"T++*9E)!CV$
M9!&TD^@!/3F@#79 8RBDH,8!7@CZ5SD7@30X])CTEDNI=-1]_P!DDNI#&QW;
MOF&?F&XYP<CVK(TOQ-+/97TE_JMW %\0BQMW^R#=MW1@1,-F%!)*ECCKUZ5M
MR^-=$ANIH'EN 8+M;*9_LLFR*5MNT,VW !+J 3P<T )>^"=%OKJZGE2Y4W4T
M5Q*D5U(B&6/;L<*I #?(HS[4^7P?I4UO>P/]I,=[=I>3CSF^:5-NUL]L>6G
MX^45+?\ BO2=-><7$TNRWFC@GDCA>18Y'QL0[03D[EZ?WAG&14OB'7(] \-7
MVLO!+,EK TWEHIW-@9Q[>^>E %.X\&:1=2W$LHN#+/=QWK2"9E83(H564C[O
MR@#C&16[)#'-;M!,HEC="CJXR&!&""/>N.N?%C:?XMD%U)=G3/[(%W]G2T9G
M1Q(59L*N_&!WX_,5L7OB_1;&$32W+-$+5+QY(XV81P,<+(V!PIP??@^AH ET
M[PUIVF&W\E9I%MHF@MEFE+B",XRJY[< 9.3@8SBH++P=I6G?V;]E^U)_9@=;
M0-<,XC5@%(^8G(V@ #MCBIK3Q#%=^*=1T-;:=6LH89#*8SM8R;^_H @Y/4D^
ME-O-?C@\46F@"&X\VZM99Q.D9*IM9%]"/X\Y/ P/6@"I+X$T62PM+11=Q?8Y
MI)[:>&Z=)HFD)+[7!SAB3D=/R%:$'AS3[;4K6_A$RSVMNUM&3*Q&QB&;=D_,
M2P!).22.M87@KQ>FIZ3I%MJ5Q-)JEY%(PE:W*1RE&.X*P4(2!C@>A]#6Y;>)
M=,NM1M[&.5Q+=1-+:L\;*EPBXW%&(PV,@^X.1D<T .O/#>E7\^H37-HKR:A:
M"SN&[O$-W'M]X\^P]!3KS0;&]CTZ.1'2/3I5FMEC<J$9057Z@ D8/'-1:KXF
MTW1KV*RNC<M=31/+%#!:R2M(JD!MNU3DC<..O.>E4F\>:!]CL;F*XN+A+^*2
M6V$%K+(T@C^^  N=P[KU'IQ0!<'A?3&<&=)+E%694BN'WJ@E_P!8!GL1Q@YP
M.!@4:%X8T_PZA2R:[=0NR,7-T\WE)V1-Q.U>G ]!GH*'\4Z3'(JO-(L;7 M?
M/,3"-9CC"%L8!R0.>,\=>*IS>/- @N7ADN+A1'=_8Y93:2B.*4XP'?;A<E@
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M/W1UK/\ "F@:GX5\.6&G1E+J4W3-=--=.PCC8L<QY!Y^[\O R6.?7K*#T]:
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MPE_9I,5;DL#YB]HP-I0\ ?+@Y.#F:9?QS>'_  *\M[YS_P#"03C?+-O8@"Z
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M^202*,L#P"%'3H,4R_\ !-O?W5_=-J5]'/=SVUQNC\O]U) 04*@J0>G(;(-
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MBL'S'_OM^='F/_?;\Z -ZBL'S'_OM^='F/\ WV_.@#>HK!\Q_P"^WYT>8_\
M?;\Z -ZBL'S'_OM^='F/_?;\Z -ZBL'S'_OM^='F/_?;\Z -ZBL'S'_OM^='
MF/\ WV_.@#>HK!\Q_P"^WYT>8_\ ?;\Z -ZBL'S'_OM^='F/_?;\Z -ZBL'S
M'_OM^='F/_?;\Z -ZBL'S'_OM^='F/\ WV_.@#>HK!\Q_P"^WYT>8_\ ?;\Z
M -ZBL'S'_OM^='F/_?;\Z -ZBL'S'_OM^='F/_?;\Z -ZBL'S'_OM^='F/\
MWV_.@#>HK!\Q_P"^WYT>8_\ ?;\Z -ZBL'S'_OM^='F/_?;\Z -ZBL'S'_OM
M^='F/_?;\Z -ZBL'S'_OM^='F/\ WV_.@#>HK!\Q_P"^WYT>8_\ ?;\Z -ZB
ML'S'_OM^='F/_?;\Z -ZBL'S'_OM^='F/_?;\Z -ZBL'S'_OM^='F/\ WV_.
M@#>HK!\Q_P"^WYT>8_\ ?;\Z -ZBL'S'_OM^='F/_?;\Z -ZBL'S'_OM^='F
M/_?;\Z -ZBL'S'_OM^='F/\ WV_.@#>HK!\Q_P"^WYT>8_\ ?;\Z -ZBL'S'
M_OM^='F/_?;\Z -ZBL'S'_OM^='F/_?;\Z -ZBL'S'_OM^='F/\ WV_.@#>H
MK!\Q_P"^WYT>8_\ ?;\Z -ZBL'S'_OM^='F/_?;\Z -ZBL'S'_OM^='F/_?;
M\Z -ZBL'S'_OM^='F/\ WV_.@#>HK!\Q_P"^WYT>8_\ ?;\Z -ZBL'S'_OM^
M='F/_?;\Z -ZBL'S'_OM^=;4!S;QD]=H_E0!)1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 5SNO\ _'M?_P#7%O\ T&NBK(U/2SJ'
MG12(QAE&U@LA0D8P>00: /)?AYI\FK?!"/3XKX6+7(GB-P4W; 96!XR.HR.O
M>KOAO_A)O#'BQ=$UV^@U/3[FUDG@OA&(WC\LKN#^WS#J3U'/45V,7@#28= F
MT)--7^RYOOVQF8KUSQELCGGC'-3VO@VRM-/DL8[1GMY(3;LL\[RGRR,%-SL2
M%]@<4 3V]S!=VZ7%M-'-#(,I)&P96'J".#7E'@YWC\5?$]XW9'67<K*<%2#,
M017K.E^&X=%TN'3=.M5@M(5*QQJY.T$DGDG/4DYJA:^ M,LI[^>VL6CEU $7
M;"YDS-G.=WS=>3S[T >4^'_$FOM_P@%[<:S=7!U>:YANHI-NQE5]J\ #GGK6
M?XDU2_\ $GPX\6:K>WLX,&K"UBM 0(TC5TP"N.N3G/7CTXKV&'X=:-;KIRQ:
M:$7379[,"X?$+,<DCYNYIEY\-=!OY;R2YTE'^V.);A!.ZI(X.0Q4,%W>^,G)
M]30!Q5UK6N:GXJU'P_I<TD,UGI44MF$D" RL%/F/G[RC(7'(Z\5'?ZGKEQXZ
METN35KBTB/A_[9+':N"HG'!*L0<#/I_6N_O?A_I&H7EK=W.FAKFUC$44JSNC
M!!_"2K#</8YJ67P1ITVIOJ3V/^EO;FV,BSNO[HC&P -@#Z4 >3Z/XFU][3P!
MJ4VKW,KZI=R6MS$VWRW17V#@#[W?/7-1ZYK^O1)X^F@UR]B&C7-M]DC0KA=[
MD$'(R1CMFO5(_ASHL,.GPQZ9MCT^0RVBBXDQ"Y.25^;U&:6;X=Z-<#41+IH8
M:DRO> W#XF*G*Y^;L: ..75]1NOB;I%B;R6.VO=!^T21ICB0[OF7(XZ#VXKG
M/"-MK5S\&;S4]*U6^CU599IUP^X.58EA@CDL,_CBO7(O!.GPZI;:FED1>6T(
MMX93.Y*Q@8"\MC')JDWA:Z\-VJ#PIH]G^^NU:ZAEG91Y1SO*9.%.<<=.O% %
M'P9K'_"364.MQ2S"W:VCA\EG)43 9D//7&57/L:ZFH=$\.'1='MM/MX8T2)>
M1'PNXDEB!Z9)J_\ 8+C^X/S% %:BK/V"X_N#\Q1]@N/[@_,4 5J*L_8+C^X/
MS%'V"X_N#\Q0!6HJS]@N/[@_,4?8+C^X/S% %:BK/V"X_N#\Q1]@N/[@_,4
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M:MRW_P"/:+_<'\JS/L%Q_<'YBM2%2D**>H4 T /HHHH **** "BBB@ HHHH
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M:VGCFB)(#QN&4D'!Y'O4M !1110 4444 %%%% !1110 4444 %%%% !1110
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M3XSCL]*N'CO=.LX[94MF DD0R;@..H#)_D5ZA10!YSK6ERRW7C-;32Y_(O=
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MKH&C)R58 C<"2<YSG)]:?8:';:?K6HZE H22^6)9$4G;^[! ."< X(' ' %
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M;YKLSP7&R2WO8!%/;_(IV.% !YR0PX((YXIUIX*\.V$=U'::9'"ER")%1W
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MCF0R  !]^=VX   YX QTIW_",:1Y$,"VK1QPQ/"HCF=,HYRP;##=DC)SG)H
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M16 !7.<LI 4;3D8 &.!4EGX5T73WL'M++R38(T=KME?$:MC<,9P<X&<^@]*
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MBLITC""6*7S$PK$$KM;>F2"<JU:4_B:TANS"EO=SQI=)9RSPQADBE;& W.[
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M '>.ZQHSNP5%!+,3@ >M8=OXML;B>PC\BZC348FEL99$&VY 7=A<$D$K\P#
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M26V0IYD1.&&2<X(XZT -U'Q78:;]N>2*YEM]/*B]GA4,EOD!OFY!.%(8[0<
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?J]W?V]XUS#/I$EK"&:2()&1Y,FTX^<.&&0,,<\&O2;F6.&VEDE=415)9F.
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M3P_-HT?V$NFR'S=S>=C@8D(*$=\ D=Z /2*Q-9\2VNDV,ETD;70AO(;.98F
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M3X>>(([/=YYL)0H7J1M.0/?&:S_$<D'G^"98'VQG44*[6('E&"3J/3.S\2*
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MBYAM8H]6OT8_;+?Q9 8)#(Q9(R\ ?;S]TKY@/8@'/3@ ]=I&944LQ 4#))/
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MCC9X Y0YR%*^9DCL#Z<6;Z0Z1<^)X--25=+AU"QFN(;5=^V$JOG,J\Y&0"P
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MQ8Z+;1W&H3^3#)*D*OL9AO<A5!P#C)(&3Q66_CGP_&L[274\?V>80SA[.93
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M/BC1Q$\INF"1WJV#DP2#;.Q4!#\O&2R\].>M3IKFGO>?9EE<OYCQ;_*?R]Z
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MT+R2(ZC!B^YCY<>H(Z'/.:9_PB&F>9;2@W"W$%U)>"=)-CO)("KEL8&"#C
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M2   .222  .237-:-XF:?6_$J7EPXL[&X@B@1[=D=2Z [=N-S$L0!QSD8ZT
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M.Q)YSWK6HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$ =,5TEWXMTFQMKV>YDN(A90?:;A&M9 ZQ\_-C;R.#R..#6TCB2-77[K $4
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M3=SGG ]2?SI]Y8VFHVS6U[:PW,#<F*:,.I_ \4 <W\06MSX&\2#Y#<KI-QG
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M81T+<<X]Z .-N=5O=2UO6+>/7(=,N],OXEBBD<\P[4;!BZ2"3+ 'KD\=*O\
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M;B]L/LKV=NAA5&CC9=HW,/OL%X!X'J">:W-'L)=,T>UL9[G[2\$2Q>;Y83<
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MKM4H0Z9Y#*2#@CU&*M2^$K:ZTO7+6[E\R?6<FYG5-N#L")M&3C:%4CD\\YH
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MX*CG@DY KCKK2==/AW5+-$NM3M8182VDT]MY5VRQ3AWA8<>845<AL#)8CDT
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MOV>(&)KF%($1_+/&6#C<!D9*#U% '?#6M*:".<:G9F*4L(Y!.NURH);!SS@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MZ ,JBM7^SH?5_P Z/[.A]7_.@#*HK5_LZ'U?\Z/[.A]7_.@#*HK5_LZ'U?\
M.C^SH?5_SH RJ*U?[.A]7_.C^SH?5_SH RJ*U?[.A]7_ #H_LZ'U?\Z ,JBM
M7^SH?5_SH_LZ'U?\Z ,JBM7^SH?5_P Z/[.A]7_.@#*HK5_LZ'U?\Z/[.A]7
M_.@#*HK5_LZ'U?\ .C^SH?5_SH RJ*U?[.A]7_.C^SH?5_SH RJ*U?[.A]7_
M #H_LZ'U?\Z ,JBM7^SH?5_SH_LZ'U?\Z ,JBM7^SH?5_P Z/[.A]7_.@#*H
MK5_LZ'U?\Z/[.A]7_.@#*HK5_LZ'U?\ .C^SH?5_SH RJ*U?[.A]7_.C^SH?
M5_SH RJ*U?[.A]7_ #H_LZ'U?\Z ,JBM7^SH?5_SH_LZ'U?\Z ,JBM7^SH?5
M_P Z/[.A]7_.@#*HK5_LZ'U?\Z/[.A]7_.@#*HK5_LZ'U?\ .C^SH?5_SH R
MJ*U?[.A]7_.C^SH?5_SH RJ*U?[.A]7_ #H_LZ'U?\Z ,JBM7^SH?5_SH_LZ
M'U?\Z ,JBM7^SH?5_P Z/[.A]7_.@#*HK5_LZ'U?\Z/[.A]7_.@#*HK5_LZ'
MU?\ .C^SH?5_SH RJ*U?[.A]7_.C^SH?5_SH RJ*U?[.A]7_ #H_LZ'U?\Z
M,JBM7^SH?5_SH_LZ'U?\Z ,JBM7^SH?5_P Z/[.A]7_.@#*HK5_LZ'U?\Z/[
M.A]7_.@#*K<M_P#CVB_W!_*H/[.A]7_.K2*$15'0# H 6BBB@ HHHH ****
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M3F9M+M([P 3 &XB8L,ID=05((]<>HI^J^+UTS3;C4$L3=VT$4$A>"4$$RM@
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MR!DY ] ,FNE-[:"V-R;J$6X&?-\P;<?7I67J^OG3Y=%^SQ17,&I7JVIE$OW
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MS1WUQ9K'YV[>8I"F02!G.,].] %73_"]_I>J736FN.NDSW+W?V$VX+)([;V
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M'1<]#GJJ@2]M)9EBCN87D8%@BR D@'!./8\5/0 4444 %%%% !1110 4444
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MMJYCC$BRXD,C#YPY(;<#L&0,# SZ=5>ZOK6R\G[3.D7GRK#%O.-[MT4>YP:
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M.%!*+'&7PN<C<3CJ#P&XKFI/$NOL\5@ES#'/%X@.E27)MPWFQ&$RJ^,@!@"
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MGV@N.-C;U^<#<,9P5.<4 ;,OBTZ3XHUR2^>_FTR#3K2[6)+;)MU8S>8Q  (
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MX@EM+A;62":/9)YC!2@ _P!H,"#TQUQ@XM:/KMGK:77V4NLMI,8+B&0 -&X
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MIK'5+?2HH;QO+O8;1FVB'!R%8J"S,3@YQ@=.>: -+_A(;,627)24++.UO I
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MZD[HQN8B[F1X\8VD;B<-G(!Z5V% !1110 4444 %%%% !1110 4444 %%%%
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MG$IB\UO,#=S%Y7*_P\)CG%9]Y86+^ O%^HI)*U]%>WL,$HN7+",S JH&>0<
MB@#V.BN!N;;3-,\665M=)&OAR[LII4>>0O"]VSJ269B1N*9*Y_VL<FLV"UU/
M3_#_ (>URYMKB^EM;F:S>&0%I)[.9V2'=GJ1F+D\X+9ZF@#U"BO-M"T_6+;2
MM2TKR-U]H$=PEE/MXN)94WQ,">NU6VG/<CTK),FDW_A+6M1T[4+\7HT*:*ZM
MO+,(28+E?-X!,V_(!R2>>HH ]?HK#T"PMK'PZLFEJ#)<Q+.6:1G$DI0#)))]
M!G%<7HSR75KX1GMG=-=28QZXK';)L\M_.\X=<>8%VD],KMX- 'J%%>1^'%M[
M9/!E[',PNI=4O8)W:9F8PD7!56R?NY\LCW(/4UU_C"YM$U70[6\3Y+AY@K3*
M7MPP3HZ#[[G/RC(YR>HP0#K:Q=-U]M5ND^RV$SZ>[3(MX&7:'B<HP9>H!(."
M,YQSBL_X?W!O/AQI!O':5A:".<S@Y) P0V[KZ&N+TS[#I_@OP]J$2Q0);^('
M:[F0!=D1FF +D=%P4Z\8(H ]*U[6TT&R@N9+>69);J&V_=D#89)%0,<GIEAT
MS1I^MI?ZUJNF"WEB?3FB#.Y&)-Z[@1@],>M>=7-W#)H.MA781CQ9:O$&4J/+
M\VW;(!_AX8_@376^'Y4?Q]XM"NIS]D(P>N(B#^M '2)/.VH2P-:.L"QJRW!=
M=KL2<KC.01@')&/F]JG95;&Y0<'(R.AKS+Q:ZKJ7CI%G<,?#D;1A96!\X>?@
M+SU_U? ]1ZU4U)[G3;G5QX<:0W4_AM)]L,A=I)@Y!<9)S)L)QWZ4 >B_VTG_
M  E/]A&WE$GV,W8F)&PJ'"X'.<Y/?%:E>27EU9RZW?7?@X!YI/#,HA-J#N,@
MD!Q[2X]?FR!FH]6?1KSP=X@U/0]1O7$MBB20I&8(TE#?+D  ^;@D$<\ 9[9
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M;@@ '7:.I)_7.G110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 5F7>CB\U:"]EOKOR85&+(,HA9PVY788W%@<=\<
M#CBM.B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M$\?]A7VI:-9S:NUK,8/)MCS(P(#;3SD#/Z&@#N_/B_YZI_WT*//B_P">J?\
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MHH W//B_YZI_WT*//B_YZI_WT*PZ* -SSXO^>J?]]"CSXO\ GJG_ 'T*PZ*
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MZ_\ CO\ ]>C^S#_SU_\ '?\ Z] &?16A_9A_YZ_^._\ UZ/[,/\ SU_\=_\
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M16A_9A_YZ_\ CO\ ]>C^S#_SU_\ '?\ Z] &?16A_9A_YZ_^._\ UZ/[,/\
MSU_\=_\ KT 9]%:']F'_ )Z_^.__ %Z/[,/_ #U_\=_^O0!GT5H?V8?^>O\
MX[_]>C^S#_SU_P#'?_KT 9]%:']F'_GK_P"._P#UZ/[,/_/7_P =_P#KT 9]
M%:']F'_GK_X[_P#7H_LP_P#/7_QW_P"O0!GT5H?V8?\ GK_X[_\ 7H_LP_\
M/7_QW_Z] &?16A_9A_YZ_P#CO_UZ/[,/_/7_ ,=_^O0!GT5H?V8?^>O_ ([_
M /7H_LP_\]?_ !W_ .O0!GT5H?V8?^>O_CO_ ->C^S#_ ,]?_'?_ *] &?16
MA_9A_P">O_CO_P!>C^S#_P ]?_'?_KT 9]%:']F'_GK_ ..__7H_LP_\]?\
MQW_Z] &?16A_9A_YZ_\ CO\ ]>C^S#_SU_\ '?\ Z] &?16A_9A_YZ_^._\
MUZ/[,/\ SU_\=_\ KT 9]%:']F'_ )Z_^.__ %Z/[,/_ #U_\=_^O0!GT5H?
MV8?^>O\ X[_]>C^S#_SU_P#'?_KT 9]%:']F'_GK_P"._P#UZ/[,/_/7_P =
M_P#KT 9]%:']F'_GK_X[_P#7H_LP_P#/7_QW_P"O0!GT5H?V8?\ GK_X[_\
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M$T#[HYGQL5AC@-N&&Z'/6KL^NV-L\Z2O(&AF2 CRV.^1P"J+Q\QP0>.@/.*
M-*BLB/Q-I<D$\GG.KP3BVE@:-A*LIQM39C))!!&."#G..:BC\6:5,JB)YGG:
MYDM!;B(^9YR*6=<>RC.>F,<\B@#<HKB;[Q@BZ[X>N[.ZN9](U"SNI3!!:F1Y
M&3R]N%"[\_,V1[<]*GN/$XO]1\)76CWQ?3=2NIXID$8^<+!*V#N&Y6#ITXZ8
M- '7T5CVGB?3+VP6]@>=HFNC9@&!PXE#;2I4C(P0<DCC&>E6;[6+/3KVQM+E
MI%EOI#%;XC8JSA2V"P& < GGK@T 7Z*R+/Q+IM_!'+;M.RO=M9 &!PPE7.Y2
M",C&ULD\<4RQ\5:5J,Z0VTLK&6W>YA/DMB:)6"LR<?-@D<=3D8!!H VJ*YS1
MO$VG2VFB6_\ :%S>RZG$SVUS);%//"@EB<*%4XYQQ5YO$%D(]R+<2N6E58HX
M6+MY9VN0N.0#QGIDC'44 :M%8<7BW1[FUBN;6=[F&2!;G?!$S;8F)5688R.5
M8>VTYQ@UHZCJ5KI5F;J[D*1;TC&%)+.[!54 =26('XT 6Z*P9/&.C16RSRS3
M(#>_8"GV=RRS\?(0 <=1@]#D8S31XST8V@N6>Y1/MHL'5[60-'.2 JN,97.Y
M<$\?,.>: .@HJM#?07%[<VD>\RVVT290A06&0 >A./3ID>M8LOC'29'O[6*:
M]62U,L4\L=C*P@9$#DD[".C C/7'&: .CHK!A\2:?;Z78L]W/>/+8"\WK#^\
M>$*N9651QG<. .IP!Q61-XN7_A)]*FMKBZGT>]TJXN4ACLV9Y&62(*RKMW\J
M[>Q'/O0!VM%<Y'XQL;G5M%L[..:XAU6U>[AN4C;9L&P#MD??&<].]:]]J5M8
M-!'*6::X8K##&I9Y"!DX'H .2>* +E%<_)XUT..UM)_/G=;N:2WB2.VD9_-0
M,6C*A<AQM;Y3SQQ5R^\0:?INA)K-X\L-DRHVYX'W+OQMW+C*\D Y QWQ0!J4
M5@VWC'1;D:AFXE@?3PK7$=S;R1.%;[K!6 +!N@P#D\=:+GQ?I%G;ZA+=23P'
M3T66YC>!]\<;='V@9*\'D9 P<XP: -ZBLA_$FFI=7]L[S++86RW4X,+<1'.&
M!Q\WW6Z9Z&FWOBC2]/\ FN9)8XUDCBEE,+;('DQL60X^4G<O7IN&<9% &S16
M-9>*=,U'59=.M3=23PS/!*?LL@2-T4,0S%<#AAC/7M4EUXAT^SU&:PF:;[3%
M:F\9%@=LQ X)4@?,02.!S[4 :M%<GXB\41_\(5>:CI%U+'<2:5-J%G,(,C:B
M!@3N! SE>#R<U9MO%5A=65U"UQ<PW-M9+<RN;5PVQ@?WJ K\XR#T!'% '1T5
MSZ>)M.LM$M+B:[GNP;!;QY5@)<P[03*ZJ/ESUQCUP.#60_C*+3?$^KM>7D\V
MCQ:=:WD/DVQD$2N9=[DHN=N$4Y/2@#MZ*@GN(TLI+CS&\H1E]\:ESC&<@ '/
MY&N<TWQ9;O<>'M.C>[O_ .TK W27S0;?,5=@W$   G>"> !0!U5%9NJ:[8:/
M-9PWCRK)>2&* 1PN^]@I;'R@\X4X'4]JS[?QOHERUL$DNE\^Y-GE[611'/DK
MY;DKA6)&,'U'J* .BHK&3Q1I<FHI9)+(9))Y;:-A$VQY8P2Z XZ@*WY''2EL
M_$VF7^GP7MN\S0S7)M$!@<-YH8J05(R,%6SD<8)Z4 ;%%<SXKU:YTB_\.O%<
M2);W.HFWN(DB#F1##*X &"V=R+C;5J#Q9I5S:6\\+S,]Q<26L<'DL)3*FXNA
M4@$$!&)SCI[B@#<HK%MO%>D7<FE)!/(_]J!S:'R7 ?8"6!)'RD '@X/!J9M?
ML@F4%Q)(7E18HX6+OY9PY QR >,],D#J10!J45G0:G;:QH U'2[O=!/"7AG1
M>1P><,.H/8CMS7.>$?'%KJ.BZ+!J$URVJW6G)<%FM'1;E@@:3RSM"N1GD+0!
MVE%9-EXDTW4;+3KRUDED@U%RELWDL"Q 8G((RO"MUQTJ:[UFSLM4M-.F,HN;
MM7:!5B8A]@RPW 8!QVH T**Q[/Q/I=]8VEY!+*;>Z>2.-VA9<%-V_<",J!M;
MDXZ5!'XRT>2WFG62XV16:W__ ![N2]NV<2* ,D<=.H]* -^BL^WUFSNGL5A9
MW^W0&Y@(C.#&-O)../OKU]:6^U>UL)TMW\V6X>-I5A@C+N47&YL#L,@>Y.!D
MT 7Z*Y'6/%L3_P#"/)I<TTEMK$[+]JMH2Y$8BD?Y<J1NR@!!&0,\>FR;S^PM
M*M5U6^:[N&D6W640A6GD8X4!5XR?P'!/ H U:*Y]_&FB1V]K*TT_^DW$MK&B
MVTC/YT>[?&0%.&&QACOCC-11^/- EMK:=9[@FXN)+5(OLDOF"9%+-&R[<J^
M?E/)[9H Z6BN;3QWH+V%O=K/<;9[IK-8_LLOF+.H),;)MRK<'@\GMFIY?%^D
MPVC74CW"PQQ)-<,UNX^S*XRID&,KQR0>0.3@<T ;M%<WJ'CO0=,FNXKB>Y)L
M]AN6CM)76%7&0[,%P%Q_%TJP_BW25U9M,1KJ:Z7RBPAM)'4+)G8VX+C:=I^;
MI0!N45S6F^)]/71[*7[?=:B]V9S"QMMLLBQLV_Y HP%Z= 3QU)I\?C"QN-9T
MJRM(Y[B'4;%KZ*YCB8J4!0#MG^/)]./6@#HJ*Y[2O$-B^CVDXU"XU!KJ>>.
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M U[:ZM>:=>Q:W))J26ACU&P5&#"3C<9PS'#*P(!P,Y(''3T7 SG'-(%4$D*
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M0C'!KOO&E_:V&C6CW,LD4,M[!'N\WRH^6SB5B#B,XP?7IWKI!M.0,'!Y^M!
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MSDZKJ#%]335#N,?^N4 ?W.AV@D?EB@#GO$>O&^T99M6MX+:;1O$MI#,\;ET
M#QOO4D _=<9&.QKNM&OY]3L5O7CB2WG^>VV/N+1'E6;L"1@X&?K63-X)M9WN
M6;4+T?:-3BU1@/+XEC"!0/D^[^[7CKQUK0T'0(?#T-Q;VES<-:23-+%;R;=E
MON.2L> "%R3@$G':@#B-,UN]\,6^N7D6FV\NCQ>()H[EEF*RQAW1=R)MP0"P
MSR">?3GI4\4WGVK5["6R@34;.ZAAMX?-)$\<N-DF<<#[^< X\MJG'A"T\R[1
M[JX>RNKT7TMHVW8TN0W7&[;N53C/;TXJ*VL1J_C!=;GTJYLWTZ*6UCDN"H-P
M2W#J%8_* &P3@_O#Q0!HZUK/]EOIULD:R7>H7(MH%8X4':SLQ]@J,<=S@<9S
M7/W7C>]M9Y;#^S(7U"WU2"PE7SRJ%9@&CD4[3P0>0>A!Z]^CUO0[?7(;999)
M89[2X6YMIXB-\4BY (R""""001@@FLZY\'6MTPEDO+H737T5_+.@0-))& $!
M!4@*  ,#\\DF@"SJ.MSZ%X6?5=6MXA<Q*H>&WE+(9&8(JAB <%F7DCC-8?B/
MQ;J>D6VN61@MDU&VTB34[696+1NJ9# @C(93CV.1TY%=3K.D6FO:/<Z7?*S6
MUPFU]K88<Y!![$$ @^HK-F\)6U];WJ:E=W%Y->6+:>\[;5986SG;M  ))R3C
MJ!V&* .:GN-3MO&L5[;6MI+J!\.M))YDK(C8E4\D*23^%:?_  FTU]802:5I
MYFNI-+AU(P,';(E#;(P44X)V,-QX''!R<:$7A-$O4O'U2^EG73SIY9Q'RA.=
MV @^;./;VJHG@*"V&F-I^LZG8W%A9I8>?"T9:>!?NJX9"I(YP0 1DT $'B76
M[_7I=-M-'MHO*M;6ZD-W<LKHDV\%2H0_.I0\9QP>:K6/CN6>;0([JS@MO[1F
MN+6X!F)-K/$6!0_+SDJ0"<=NN:W['P]!8:Y<:I%<W!>>VBM3"Y4H$CW;<'&[
M/SMR2<YJC>>!M&ODU194EQJ5U%=2[7QM>/:1L_NY*DGUW&@"O_;#7&O^&C=:
M5;-)>17,L%P)"7A4*#@ KU92N>>.G/6JUC\0(KK29M0,<#&,PQ/:J[">"XDD
M$8BE0C<,%A\P'/.!QST-]H4-]K.G:FUQ/')8+*L<<>W8PD #9R,] ,8(K*N/
M >G7\,ZZC<W5U--:):?:2524*C!U;<H&7#!2"?3IUR :.B:I?W]U?P7NGO M
MNR>3<;&5+A6&> X!!4@@CZ'/-5[;7K_4;CS=.T^.>PCU![&9C,%D4(2KRX/&
M ZD;>I'/M5[1M)ETN!EN-4O-2G? ,]UL#;1G  15'<\XR<\FJ%IX1AL=9N;V
MVU*^CM+FX-W+IX9/),QY+YV[QDC) ;!/;M0!1C\:N]EI6KBT0Z1J5Z+.-U<^
M8FYRD<A&,$,P&1U&X=>:K#QMJQ2*<Z1:>2=8DTEE%VV[>'9%<?)C;D#/?!Z<
M<ZUGX-LK)(;9+BX;3K>[-Y;V;;=D4FXL,'&[:&)8 G@^P J,>"K86RP?VC>[
M5U0ZKG]WGS2Y?'W/NY)XZ^] &7J7B:6;0-575-&L[B33M5M[.>'SB8VW-"R2
M+E<DCS5."!RIYJ75?&NI:=/KI72[9[71IX%F8W+;I(Y%5LJ-GW@&Z$XXZG/&
MA=>"K6[@U6)]0O574[V*]FV^7E7CV;0OR]/W2=<]/>B_\%6NH1ZXDNH7JC6&
MB:XV>7\GEJ%&SY>.%&<YH K:YXRN-,DUK[-8QSC23;+)')(4:8S8QLP#@#([
M')!'&.;_ (QO?L'@;5;RZTZWO5BM&>>TDD/EN /F7=MY'7L,^U<WJ6F:K/XK
MO+D'6K><-&EK)!;6L\+HJC#;I%)C.XMD94=QUKKM4T<Z]X8FTC49VC-W;^3<
MR6V <D8;;N!QW[4 86L>+=3TZ[UJWL]+M)(]*TV/4"TERR[T/F94 (<-^Z..
MWOVIEQXON;/7]1N+D1C1;/1(]2*C/F88R9]B?D Q6I=>$(+R;5)9=0O-VI:>
MNGS8\L8C7?ROR\-^\?U'/3BD?P9837'F3W%S+')IHTRXA8ILGB&[&["Y!&]O
MND=: "W\174>NZ;IFHVD4?\ :=L\]M)#(6"L@4M&V0.S AAUP>!WCO-0OY/'
MT.C;;=M,DTN6>1'SECYB+SQCH< >YSVJYIOAJ*QGLIY[RYO9+"!K>U:XVYC1
MMN2=H&6(51D]A[G,MYH,=UKUOK"7ES;W,-N]L1%L*NC,K8(93T*@\8]\B@#B
M/!/B6?1O"WABUOK6)=/GTJ29)TE+2+Y*!FW+C&""<8)Z>_'5:-XAU#4M1@CE
MTMTLKFU^T)<JK@1-Q^[;<HR2#D,O'!]B8;3P+86MOHUN;N[F@TF"6WBCDV$2
M)(NU@^%&>..,5:\/>%QX?58EU?4;VVA3R[6"Z=66W3T!"@M@< L20.!WR <_
MKL,+?%;3EDTLZ@KZ/<,\*K&<L)8P&(=@,@$C.<\U7\(ZW=6FCZN ,-#K+0BS
MO)]K:;"VW <L?F'5@%)!W  ^G5WOAM;OQ)#KJ:E>6]U#;-:HL0C*;&96/#(3
MG*CO5!O =CY;O'?WZ7[WZ:A)?;D,KRJI49!79M"D@+MP/K0!4B\;WMQ:Z8T&
MF0M-=ZK/I;AYV0*\8D(< IG!\OD'D9[UCZ_XDBN-.T75=7AAM'TKQ$]O<O&2
MZJ(TEW,IP#@@ XQ_*NEM_ ]K;R6[KJ=^WV?4Y-30.8S^]<,&!^3[OSO[\]>!
M0? ]HP4/?WCJ-4;5"K",AI6!!4_)]S#'CK[T 3O976LMH^K72)"UC</=1PPR
M[_,1HI$4$CC=\ZGC(&",GK3?"GB@>)HY94-L!&B&2)'(FMY3G=%(C %2N!SW
MYXXJYHGAZ+0M)DTRWO+J2TRWDI*RG[.K9^1" #M&>,YP,"DTWP[#I^J/J<ES
M+=7K6R6IGD559D4DC=M W-D]?R YR 86K^,M9L9_$/V31;6XM]#"2SEKLJ\L
M1C\P[!LQN SP3CCJ<\6+CQG)+9:Q?Z79I<VND1I).'<J\N8A*P3C (1AUZGC
MC&:JPZ#/JGB?Q;%=->6^G:AY$9 C"K.@B".%8C([J<=NGK6M<>#K*6YU%X+B
MXM8-3A6&]MX=NR4*NP$9&5.SY20>@'<9H JQ>-(;K7H=-@\B-IEAE@2Y8QO<
MQ.H8O$2,-MR05Z\'IQFO!X_A>WU&YE2$"PCD,]IO*W,,@<*B,A'1LYW#CZ]:
MUKKPK:WEQ$9IY6M8;F&ZAMMJ;87B"A=AQN4?*"1GGGL2#6N/ VG7X(U.>>^/
MV.2Q#R;5?RG*DY90"2-HP3TZ]3F@"O=>+M0TZ#4)KW2)1;6PA=+M(I?+VN^U
MRRE0W[L?,< Y'ISA+GQO'::;IUY+-8+:WLDB)J"RE[4;?N;G ^4O[\*01SCF
M_9^&;BULO)D\0ZK<SJR>7<SM&715.=N @!!QAB02?7IAL/A"VMK:2&VNY8DF
M>>2XC$<9CF,N-V4*X&-HQCWSG)R 9UYXFMM*UJZO=1TR!'MM!^W274,F^0H&
MYB' &-V<')SD=*LW/BF^TZ^AM+VP@\V[L9;NU,<QVEH@"\3';QPP(8#GG@=Y
M$\"Z4A6-GN)+0:4-(-L[ H8!ZG&[=[YJ:+PG"(HUN=0N[J2"S>RMYI=FZ*-P
M QX7!8A5&XCM[G(!3T'Q9?:GJ.DP7NGP01:KI?\ :$#13EV7'E[E8%1_SU&,
M$]#6C>:U<'7I-%TV&&2\BLQ>2&=RJ@,Q5%X!Y)5N>V.AS4>G^$[?3[O1[B.]
MNG.E6+6,*OLPT9V9W849/[M.1CI[U8O?#\=SKD6LV]W/9WRVYM7DB"L)(B=P
M5@P(X.2#VR>H.* .?M?'&H:S)I*:-I-NS:C8S70%W<E/+>*1$=&PAZ%B 1UQ
MT%='JNKFQO=.T^!%>[U"1TBWG"H$0NS'')P!C ZDCIR:JV7A*QT[4=,N[2:X
MB73K62UBARI5E<JS%B1DL2@.<COZU-X@\.PZ\EH_VJYLKRRF\^UN[8J'B;!4
M_>!!!!((((- %.+Q#J3WMEI$VGPVVKW$4\[H\V^-(HG"!P5Y.XLI X(!.>F#
MG6_CB]OIM*MK72X!=7=U=64Z2W) @F@#;AD(=RG;D'K@CCTUY/"L37&GWJ7]
MV-2LO, O&*L\H?&]7&W:0<*< #&T8P.*;%X0LX+K3+F&YN4DL)Y[@?</G2S;
MO,9_EZG<>F /H* ,2+Q;J^HR^%S!!;6YO+^[M;R(N6!:%9@0K8^Z3'NZ9Z>]
M2KXWU%+/4-0NM+M8[.TO)+ !;IC)).)EBC &S 4EN3U'H>^A!X)M;>&P2+4;
MY9+*^FOHI08]VZ7?YBGY,;3YC=LCC!J3_A#+!]#U32;BXNI[?4+E[IV9E5XY
M&??E"JC&& (SGI0!D>*-8DFTGQ1X>U*UB$Z:)->PR1DLDB;64\'E65@/7J#Q
MT'012SP>"XIK79Y\=@K)O.!D(*AN/"D-[;Z@M[?7,]S?67V"2YPBNL/S9"@+
MM!.XDG!YQZ #2&F@:(-+%Q+M$'D>=A=^,8STQG'M0!Y_H%W>:9I_A62RT>PF
MU;6M+4-=/<NF_9") 9,(<DEB2W)R??-;EWXVFMM*U#6!91/I^F7?V6["RGS/
ME*K(Z<8(5B>#]X*3QP*T+3PC;VAT#9?WC#0XC#;AO+^=2@3Y_EY^4#IBDD\&
MV,DFH1BXN%L-1N!<W5D-IC>3@L02-P#;1N&>?;)R 9>I^-M2L#KLJ:5;26^C
M74,4I^TG?*CK&V5&S&[$G0G''4YR-K1];O+O7]4TB_M((9K..&=&@E+JR2;P
M <J,$&,_F*K7W@NUOXM;BDO[Q5UB6.6?9Y?R%%50$RO PB]<UHVFAQVOB"\U
MC[5/)/=P102(VW8!&6*D8&<_.W?O0!PGC;4-0O\ 2?'MC=K;M96%K#Y"C.Y2
MR[\\]^?PP/K713^,;C3;S6+;5+&))+.*VFA\B5G$@GD:-%;Y00=Z\X!X/%6-
M6\%6FKR:R7O[V&/5X8XKF*(IM^08##*D@XXZX]LT[4/!ECJMSJ4U]<W4O]H6
MD5I*H*J%$;,R.I"Y#!F)SGKCCB@"WHNJW]]>WUO>Z>\"0%##<A'5)PP.0 X!
M!4C![<@^PXWR8/\ A//&:OX?FU54@LW2.#R@R$QOG:792I; Y7GCUQ7;Z+I$
MNE0L+G5;W4IF 7SKLIN"C.  BJ.YR<9/<],4U\+&+6]3U6VUB_@N-16-9@BP
ME5$8(7;NC., GKF@#GO!?B6XE\->&],6]34-5NX)WDGF9\1K$V&#Y 8LI9$Y
MQG!.?6ROCC4+EM/MK32;<WUQ?W.FSI+<E5BFAC=\@A#N0[ <\'!Z9K1M_ NF
M:?!I@TZ6XM;C3GE>*Y#!W<R\RB3<"&#'!/3! QC%2KX/LX[G3KB.ZN4ELKN6
M]W#9^^FE5E=G^7N'88&,<8Z"@#-/C'5;>YU@WVF64-IHB+)?R)=L[;3!YI\L
M;!N.<#!Q_A;_ .$EU&+4-/L9["W$VJ6DD]F4F)42(H8Q.<>AR&'H>/6\GABS
M^U:Y+<2S7$6LJ%N8)-NS:$\O"X /W>.2:33/#,-A-8RS7ES>MI\#06AGVYC1
ML Y*@;FPH&3V^IR 8NG^/A=7&ABX@@MX=2LY9I',A)MYHP=T3#&/X9.<C/EM
MQ5BY\5ZDL<D%MI0EU.WLH[R:U D;)DW[8@RJ<-\AY; !QUY(LR^!=&FBN(VC
MDVSZBNHGYONN#DJ/1&R^1_TT?UJ75/"J7^MQZO:ZI?Z;>>2+>9K1DQ/$"2%8
M.K#().&&",F@"M9^(]7U#Q'/IL&DV\4-M':SS/<7!614E#Y&T(?G79TSCWJQ
MKMY';^(_#<$FGP7!N;J5(IW?#6[B"1LJ,=P",Y[]ZM6'A^#3M;O-3AN;AFNH
M88&A<J458MVW'&[/S'J3G-/U+1(]3U+2[Y[F>*33IFFB6/;M9F1D.[()QM8]
M,4 <[8>-=1N7TR:YTNVBM+W4Y],8I<L[I(C2@,!L *GRCW!YZ<5VU<Q#X*MH
M+:Q@74+TK9ZC)J2$^7EI7+D@_+]W,C\#!YZ\5T] !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M.0>, 'I%(&#9P0<'!QVKS?0]3USQ-J.AK<ZI=Z>+O0EOI8K9(Q^]$J#(W*2
MP/0YX/:JNDZK<:5IMO ;Z0I?^(KVTEFN;C;L59)R@W[25+%%&<>PQU !ZF3@
M9JEI>JV>LV9NK&1I(1+)"2R,A#HQ5AA@#P017'V^HZG!KFD^'=0U99DNI;QS
M<0MARL80I 7P,L Y)8 $[![UH?#E#'X:N8S*TK+JM^ID;&6/VF3DXXR>M '6
MT5YK:>(-0FU33#!J\LMKJ-I?R"=@B^88V7RW2,@A ,E1G[W<9INBW^O[/!UX
M^N75T-;T]OM<3I'B)A;^8)4PO!#<'.0=P]J /3**\PT'4-?DM_!6H2:Y=77]
MMV[1WD+)'M3]PT@E3"\$,N#G(.[IT%+HVKZLOAWPC>7NL7<QU^2"&YD<(%A_
M=R-A,*""[!5))/M@XH ].HKS74-7URVO;K3(M4G2&VU^SM(KK8C,T4RHS1L2
MIR5W<'J01G/.8KW4=?TV35=-36[J2.TUC3H8+N1(S(4G=-\3';@XW9Z X8=J
M /1S>Q#45L2)?.:(S ^4VS:" ?FQMSDCC.:L$@ DG '4FN&N[V]T#Q"]G/KU
MR]E#H-U=O-=1HY1TD3$A"JN[:K$8[@>M<_K&J:D^A^++&6_N?*7PW'>Q%I1Y
MOF,)@QROW=P124!( Z$9Q0!ZB;V$7\=E^\,LD32J1&Q3:" <OC:#\PXSDU8K
MA+[5M0T?6H8[6YFO((_#MW=K:OM/F31O%MY R3\Q7K19ZEJ)N_"DEOJ<US!K
M=G(UTQVG8PA$BS(,87#?+C[OS#C- '=U2DU:SBUF#27D87L\+SQIY;89%(#'
M=C'!9>,YYKA/">K:O,_@NYN]6N+K^V-/F>YBD5 FY41E90%!!Y.>><_2M3Q'
M9R7_ ,0M MX[VXLRVFWV9K?:' WV_0L"!^5 ':45YK:Z[K%CH6C>(=4U&62P
MM;R:RU%PH59H?->.*Y( XP0A.."&)[5W&C)=-I"27DDWGW&Z4J^-T(<DJG_
M00/J* )+G6+&SO[&RFE(GOI'CMP$8AF569AN P" IZGM5ZO(]&@EFT[P,O\
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MF2&^O+-8I?+6(*DY5&.%!W +CKCGI78T %%%% !1110 4444 %%%% !1110
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MJ2C3+(2)$8$?R%RL9ZH#CA?;I5^B@#*;PQH#+"C:)IQ6"-H8E^RIB-&ZJO'
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MR/8Z/IT5U^\:*06ZJ5=QAFR!D$]S5?PWX:3P_P"&K.R2WM#?VUFML9T7:),
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MCT72HM-DTZ/3;-+&3.^V6!1&V3DY7&#DU/:65K8Q&*TMXX4)W$1J!D],GU/
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M.<'J.F:M:MXBM-%N-.@NVGWZA<"VA\M"PWGUQT% '945@[V_O'\Z-[?WC^=
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MB4I"BGJ% - #Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M&FQ6ELD1.9P)(F;=GS,G"@X&WUPU75O;1[B6W6YA:>%0\D8D!9%/0D=0#@T
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M.AGA@EO[5)I\>5&TRAI,]-HSSGVJ,:[HYN4MAJMCY\DAA2+[0FYG !*@9R6
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MNGZE/96DUOJ'V.U0S!6GS%'(,!CRW[S&!6IK6M6/A_2Y-0U&=8H$(&2>68G
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M<:Y;JU@VP, 3 (_*<C(C*N-V2<?,2#G-;^N6E]#X!FLTM%U:]CM$C:*09$[
M ,<9&>YQD9Z5T=% 'E.IZ5JEY;>*5;2M1G%_/I\T+3Q)NE"&/?E5X! 4\8'
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MFGZK:6ZQ&"9D5&1-K13#>NT;OFW<_>/>N]U35++1M.EO]0G$%K$,O(5)P/H
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M/#-QNDNY(- OY0& #.1]G8+\H ]NE13^)->TWPPWBD7]G>V4FDM<+;[PQ,V
M0R;44A!DA@2<8'.<Y[:W\/Z3:2VDMO8Q1/:1F*W*#'EH?O >QP,^N!45AX6T
M'2WNVL=(LX#=@K.$B #@]01TP?3I0!S]G#)!\3[9Y=2DO%?09&$D@0#_ %T>
M2-H'!ZUVK#S(R%<KN'#KC(]QGBL./P;X?@AD2WTBS0M;O; M'NQ&PY3KG;[
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M[D6:X#$XE=<;6;GDC Q]!Z"K,.E6%OJ,VH16D2WDR*DLX7YW X&3WZ#\AZ4
M<?XX\0:EIBZQ+IFH,)-.T^.Y,"1)MC8NW,C,#D,%P%7G@DXR#57Q)K&NVT_C
M*6TUF6"/1[&"\MHEAB8;BLC,K$J25.P>_H178ZAX:T35KA[C4-+M;F:2'R'>
M2,$M'S\I_,_3)H;PSHKI=(VG0[+J)89UP0)8U&%5AT( R /<T <9XHU6ZUK1
MO'=F+M[6/2],P(8U4^;OMS(6;<"<'.P8QT)ZXQWE@I?1;55<H3;H RXR/E'(
MSQ5.\\*Z%J$@DN]+MYG\C[,6=<EHO[I/<>F>G:M..V@AM5M88EB@5-BI&-H5
M<8P,=* /-XO$^OMX+T75I9;J:&6PDDO[BQCB::%\C;*8F&&08;(7GV-=EX@F
MCN? ^J3Q.)(Y=-E=7'\0,9(-2+X8T6.WAMX]/C2&&-HD1"5 C8Y9, _=/=>A
M]*T+BTM[JSDLYXE>WD3RWCZ KT(^F.,4 ><0:]JOARP4B[>]A7PL=1CMY(U"
MQR1!  NT!MI#<@DGCK5G7=1\1Z9X<U?5;?7;=[<Z7]JM&4I+()%(RZ_NE4QD
M,."#@].M=I#H.EP3Q3QV<8DA@-M&W)VQ?W!G^'@<=.!Z54MO!OARSL+JQMM&
MM(K6[_U\21X60>A'IR>.G- &+=W.LPZ_%X>CUEFGN;6:\CN)?+B;.Y5")B-@
M0N2<$9.1DX!SF1VNLZCXOV-KD=GJ(\/1>=>6,2.CR":09 D4C;GDC /H17:Z
MGX;T;6K:WM]3TZ"[CMSF$3+N*'IP>O\ C3KCP_I-T\3RV$!:*+R%*KM_=?\
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M'M>X%VPR>9@<B3K][(!SUX% '.:3JNN:U-!J<&H6D-K%J<UK=6DK@_(LC1A
MHCW+)PC<O@Y/&",=Q67'X:T6'6WUF/2[5-2?[UR(QO)QC.?7'&>N*U* "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=W[L)Y7RD8Y)\D<_[1].=G3=(N;3Q/K&JRO"8K^.!5C0G*&,,.3CG.[\,=Z
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M #_.IR3CGK6A/HEX/%TNM6UQ!Y4VGK:20R(<Y5W92&!X'S\\'I[UEZ-X1O\
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MR1RQ+@HP/)# @GI@[B.,9KH/#VBQ^']$ATY)/,*,\CR8QN=W+L0.PW,<#L*
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% #2Z"01EEWD$A<\D#J<?B*&=$*AG52QVJ"<
M9/7 _(UQ6EZQ<OHWB77%:W%TNHSVT1NF*QQQPOY2@XYQPS8'4L?6I[74;GQ%
MI?B?3[P!)+&4PPS+$T3<PI*C[22592XQ] < T =A161X5U236_"6D:I,H6:[
MLXII !QN903CVSFM>@ HI&#%&"$!L<$C(!^E>?>&?$FJR:7X?L[FZAFO]7GN
MR+AX3B-(F<MQNY.=H X 'KCD ]"HK"\,ZU<ZM'J4%['&MWIM\]G*\0(23 5E
M=022,JZY&3@YYJC=>)[BU\7KH]R8[))9HUM&G@8I=H5!8)*#M60-N&TCH!US
MP =76#!X4M;>64)?:@;.61Y7LFGS"6=BS=1NP222N[')XQQ65I7B'Q!K<6GZ
MA:6<":5?PR/YCA=UO\I,9_UF7Y&"-J_ABM#P%=WVH>!='O=0N%N+BYM8Y6<)
MM)W*#SR<G.>>/I0!T=5[G4+*R>)+J[MX&E;;&)9 I<^@R>37'ZCXROH-(UO7
M+6.W:RT>^:VEMG0^9*D959&#;L*>20,'@#UX(;6ZU+XA>([:XDLYK8:?9;8;
MBU,B@%K@KP7QPPR?7 Z8S0!NWEKIFLZW8D:D/MNE2&X6"&5"5)5HR77!.,,P
M[=?6MNN-^&UN9O!ND:A=BWFNS X2<0XD56?<P+$DG+ $].@XHU+Q3J-CKL5N
MHM)+9M5AL62-&8JDB [FDR%5]Q^Y@_+@]\T =E44]U;VJHUQ/%"'<1J9'"[F
M)P%&>I)[5PR^+->64SR_V>;6+Q -)>-87#NC.J!PV_"D%@<8.?:JGB'5;K7]
M&M[Z,VZ6,/B2VMDC,9,A$=VD9;=G )8$XQ]WWH ])K.AT:"+69]4:XNYII!A
M(Y9BT<(P ?+7HN=HS^/J:77+V;3M$O+NW:V6:*,LANGVQ@^K$=OY]*X^[\9Z
MQ;6>M&**UDFT^_LX(VF@>+S(YS&.5W94@N>?0#B@#T"BO/-3\7>(]%;6[.Z3
M39[RQ%I/;RQPND<L4\IB*LN\E64@\Y.?2C5_%WB30I-9LKE--GNK2&VN[:6.
M%TC>*64Q%&7>2&!!P<D$=J /0Z*Y6/5=;?7I/#[7.GB_BLS>-<"V?RRK2,D:
MA-^>-IW'/IBLG3O%^O>(9M)@TY-/LWO].N+AS<Q/+Y4L,J1L!AEW*2QQT['G
MH0#T"HHKF">26.*:.1X6V2JC E&P#AAV."#@^HK@;#Q=XCUI="@M(]-M+K4+
M>]\[SHGD6.:VD6,[<,,JQ)XZCU/0WX_$%]%+KZ!=-AEMM7AM1+Y3#>CQQ,3M
M!)DDP^ !C.!0!UMU9PWJ(DZEXU</L/W6(.1GUP<''M4]><S>)=;U&VTKRYX;
M67_A(GTZ;]P<2H@<J2N_*_=&1GKW XK7MO$.N:E>)/IUA%+I\>I265P'VJ51
M':-I WF9R&7.W9R#CKS0!U]%9>O7\^G:<LUN]NCM/%'NGR0 S@':J\NV"<*.
MIQ7*KXPUJ6SMO+CLUG;7FTF0RPN 4P2K[=V5; &1D_A0!WU1075O<F403Q2F
M)_+D$;AMC8!VG'0X(X]ZXRT\7:B733+C[(VI2:U)IB3I$RQ;4B\TOL+$YV\8
MW=?:K'@6.:*]\6).T32#6FRT2;%/[B''&3CCKSUH ["BN-\2^*=1T:[N6@%I
M)#;R6BF$(SN5ED",78$"/AAM!R3@GITH:OXK\264?B>\MDTQ[70+E=\3Q/ON
M(?*CD8!M^%8!SS@@X' [@'H-1)=6\MQ+;QSQ//$ 9(U<%D!S@D=1G!Q]*X/5
M?%?B2!?$]U8IIC6VA%)3%+$^^>(PK*RY#X1@&/.#D@<"GK/J#>*_%5WH<<'V
M]M(L9H([A"5=LSD*P!!R>F<\4 =]17/>'_$#^(6M[FT>)K$V4<LQ\LAA,_\
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M)=VZ74@RD#2 .P]ESDU.S!5+,0% R2>@KB_"-K->:IXDDU%K6Z\C6V:/-O\
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MS1V\CJB2 E7+*I&P@?>Z#N:N:CXDTG2F<7EUY8CV&5Q&S+$'.%+L 0H)]<4
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M;LF:-HU:$=9%+ !E'<C.,CU% ##X5TQ)+&2T22RELH#;0R6S[6$1QE#G.X9
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M9-<N[C=DG#L=PQGCGBO-O#]]?V]KX-O+>_N[N^U'1;EIH[BZ>19Y$C1D^4G
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M]3MC,Q&WY_.1H\X79@$<#&!Z\^D"TMEQBWB&TY&$'!IRV\*3O.L,:RN,-(%
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M259!;W VN@"*"2N2%9B"2.^%SS0!HZSK*:2+*,1B6YOKE;6WC+;07(+$DX.
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M &0D$MGLV5'MUXK&O_#X'A[3_!9CU*]14A\K4-BHMLL3+@[UQAPJ\8&2?J<
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MYWGBLXA%'(X 8J.F<<9JK-I;VWC&/7(4+I<6@LKE5ZKM<M&^.X&YP?\ >!Z
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MWJQV!@_4E0 0#]X<&@#H/^$DMO\ GPU;_P %TW_Q-'_"26W_ #X:M_X+IO\
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MA-ZH@%M!,L;6TBO^]=E1MQZACA0H&00<]: '?\));?\ /AJW_@NF_P#B:/\
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MV_Y\-6_\%TW_ ,31_P ));?\^&K?^"Z;_P")K9HH QO^$DMO^?#5O_!=-_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
-10 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>exhibit1033-bochk_facili017.jpg
<TEXT>
begin 644 exhibit1033-bochk_facili017.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MY)4MU^7.2/:O7K;Q9HU[JRZ99W,ES<')S#!(\8QUS(%V#\Z -NBBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MP"15Q(9-I?)P>G;..>E<SX?\9>(KOPCX$:XO9<ZWJ$T-_J!4;E"R,$C'&%+
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MP$A<E<;_ # -P&,#C(QT]JVY]1U&'P1J^I/>75K?1Z3-/;Q22JY<I"KB=?\
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MO\: .EHKFO[$\3_]#=_Y38O\:/[$\3_]#=_Y38O\: .EHKFO[$\3_P#0W?\
ME-B_QH_L3Q/_ -#=_P"4V+_&@#I:*YK^Q/$__0W?^4V+_&C^Q/$__0W?^4V+
M_&@#I:*YK^Q/$_\ T-W_ )38O\:/[$\3_P#0W?\ E-B_QH Z6BN:_L3Q/_T-
MW_E-B_QH_L3Q/_T-W_E-B_QH Z6BN:_L3Q/_ -#=_P"4V+_&C^Q/$_\ T-W_
M )38O\: .EHKFO[$\3_]#=_Y38O\:/[$\3_]#=_Y38O\: .EHKFO[$\3_P#0
MW?\ E-B_QH_L3Q/_ -#=_P"4V+_&@#I:*YK^Q/$__0W?^4V+_&C^Q/$__0W?
M^4V+_&@#I:*YK^Q/$_\ T-W_ )38O\:/[$\3_P#0W?\ E-B_QH Z6BN:_L3Q
M/_T-W_E-B_QH_L3Q/_T-W_E-B_QH Z6BN:_L3Q/_ -#=_P"4V+_&C^Q/$_\
MT-W_ )38O\: .EHKFO[$\3_]#=_Y38O\:/[$\3_]#=_Y38O\: .EHKFO[$\3
M_P#0W?\ E-B_QH_L3Q/_ -#=_P"4V+_&@#I:*YK^Q/$__0W?^4V+_&C^Q/$_
M_0W?^4V+_&@#I:*YK^Q/$_\ T-W_ )38O\:/[$\3_P#0W?\ E-B_QH Z6BN:
M_L3Q/_T-W_E-B_QH_L3Q/_T-W_E-B_QH Z6BN:_L3Q/_ -#=_P"4V+_&C^Q/
M$_\ T-W_ )38O\: .EHKFO[$\3_]#=_Y38O\:/[$\3_]#=_Y38O\: .EHKFO
M[$\3_P#0W?\ E-B_QH_L3Q/_ -#=_P"4V+_&@#I:*YK^Q/$__0W?^4V+_&C^
MQ/$__0W?^4V+_&@#I:*YK^Q/$_\ T-W_ )38O\:/[$\3_P#0W?\ E-B_QH Z
M6BN:_L3Q/_T-W_E-B_QH_L3Q/_T-W_E-B_QH Z6BN:_L3Q/_ -#=_P"4V+_&
MC^Q/$_\ T-W_ )38O\: .EHKFO[$\3_]#=_Y38O\:/[$\3_]#=_Y38O\: .E
MHKFO[$\3_P#0W?\ E-B_QH_L3Q/_ -#=_P"4V+_&@#I:*YK^Q/$__0W?^4V+
M_&C^Q/$__0W?^4V+_&@#I:*YK^Q/$_\ T-W_ )38O\:/[$\3_P#0W?\ E-B_
MQH Z6BN:_L3Q/_T-W_E-B_QH_L3Q/_T-W_E-B_QH Z6BN:_L3Q/_ -#=_P"4
MV+_&C^Q/$_\ T-W_ )38O\: .EHKFO[$\3_]#=_Y38O\:/[$\3_]#=_Y38O\
M: .EHKFO[$\3_P#0W?\ E-B_QH_L3Q/_ -#=_P"4V+_&@#I:*YK^Q/$__0W?
M^4V+_&C^Q/$__0W?^4V+_&@#I:*YK^Q/$_\ T-W_ )38O\:/[$\3_P#0W?\
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MV@#B$OSR",8)Z@CUH ]7HKR"RU>*TT70X]3N]N@BYU*UFFF4S1QNLY%N)/\
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M?/.D+-*RQ,1Y[*,DGY0"V.V?6@#U6BO)[_\ LDZ=:7.F:U//I]WKMFW[IS#
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MAB,K>8KCO%Y7*]L!<<XJ!=2AM_LUBUR4N[;Q<X:+)W10-*Y4'T0J5QV(Z=*
M/6JBAN8;AYDBE5VA?RY I^ZV V#[X8'\:\G5[:'-^MY)]IA\7B%)&N6;;"TH
M##D_=*DY]A[5U7@:&SM=4\4V\<4<5T-6E=E"X81LJ%2?8\D>O/O0!V=4-4U6
M+2TM@ZEYKJ=;>",'&^0@G&>PPK$GT'>N?\07*1^-=,@UC8NA364X4S'$)NMR
M8#D\9V;]N??'-<L\(;2?!ZZRRS;=>E6![HY=K3;<"(L3R05\OD^JYY- 'IVG
M7<M]81W$]G-9RMD-!-@LA!(ZJ2"#C(/<$50E\1VJZII%G%&\Z:H9?)N(ROEC
M8I8YYR<XXP,>]:LT,<UM)!(BO&Z%60C(((QBO(?#D6F3:9\.[)S&H"7"7488
MH?,%N58-C'.< C\* /8J*\@LM7BM-%T./4[O;H(N=2M9IIE,T<;+.1;B3_9\
MO< 3Q]T^AKT?PM;I:^&[."*\NKR%%(CGNO\ 6.FX[2?;&,9[8H V*R]*UJ/5
M;W5;5;>6%].N1;R>9M^<F-7!&">,./>N!U6XNKBR\31M(T7BF#4\Z6-V)#'E
M/)\L=XR,A@./OY[U6URQAGO/&NR6:+7Q>12Z4D4[)(TGV>$(R(#\P+ @G!&
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M<*[F2-5$A1 NW!.[!/\ LCL30!H:EH<M[J<.H6NK7EC/'$82(1&Z.A.>5=6
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M;EE4J"0"QP 3U/6EKR[4?%-O(_@WQ+JL,=L\%[?PSF/Y@#''-$=I./E+)GG
M&>3QFN]ADUIK:Q=X[ R/*#= .P"1;3]PX.YL[>N!C- &I167K>HW&G16I@6'
M]].(GEE;B,%6.0@(+DD!0J\_-GM7-V?C34]1@\/?9M/M1)JLMU YEE=1&\.\
M9 VYP=F<'GM[T =Q2*RMG:P.#@X/>N/TSQA<ZI#I5G]G@BU.]ENXY,DM%&+9
MRCL!P6R=N!D?>Z\<N^'"-%X>OHWCCC9=7OE*1?<4BX?A?;TH Z^BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BN-\0>*+V+P[XCU/2GA1=)W0HTL>\22J
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M+%XATN>TGNH[K=#;S_9I6$;Y67(79C&<Y(&/>KMU=065NT]S*L<:D#<>Y)P
M/4DD  <DG% ',#X?V,-GIL5IJ>IVEQIWF+!>02H)=DC;F1ODVLI.#@KQ@5HM
MX7M?[1M[^&[O(9X;5K0E9%;S49MV7W*26W#.>,G.<CBG/XMT&*!9I=2BC4W!
MM=KAE82@9*%2,AL<X([CUIQ\5:(MM!<F_003K&RR[&V*'.$+G&$R>F[% %*T
M\$Z?9IH\8N;N6+2;:2U@CD*%7C<!6#_+SPH';I4-MX"L[;1KK2/[5U:6QFMW
MM8H9IU86T3#!6/*^G +;B!P"*/%OBG^R;6-=/N(S="_M;:56A9U DE167</E
M5]K;L$YQVYJ74/%=GH\>M7D]\MW%9RQ1?9K>!B\#L  K,,YR3G.!@&@#?M;5
M;6QAM!(\BQ1B,.^-S #'. !GZ"N:LOA]IEF+)&O+^Y@L[6:RCAGD0H;>3;F,
MX4$@;1@YSZDBM3Q%J=Q8^#]4U6P95GM[*6XB\^)L95"P!7@]JKZ3XNT;4+9E
M_M.W-S;6JW%T"=H1,<OSP5!SR,@4 0V?@FSMM%NM)FU#4KVSFM7LT2YF#&"%
MA@JA"CMCELG@<TZ7P=!+-:S?VIJ2S0VC64DBO'NN(F(.U_DXP1P5VFFZ[XHC
M3PIKM]HUS&;W3;-KC9/"PV_(74E3M.& .#T^N*O-XCTVTCA2]O$CF,<3R_*2
M(_,.%+D#"!FR!G&<4 8[_#K36L?L8U#4E@;2QI,JK(G[V!=VS=\G5=QY&,]\
MUL6?AV"SUI=5%Y=RW LTLB)"A5D4E@3A0<Y)/7'/2FW7B[0+.ZFMKC4X4F@D
M2*9>3Y;-]W<0,*.1R>.15F\U[3-/G$-U=K$VY$8D$JC.<(&8#"Y/ R1F@""\
M\/07.L_VM!=W5E>M;_9I9+<K^]CR2 P92,@DX(P>34>G^%;#2]4MKVR>>);:
MQ6PBMP5\L1 Y';=G/?-6Y==TR&_CLI+I5FED\E,J=IDQG9OQMW8YVYS[4W6K
M]+&*TW:C#9--=PQ*98]_F[G \L#(P6Z ]LYH AU[PY;:\;.5KFZL[RRD,EM=
MVCA9(R1AA\P(((X(((J(^%;5;RTOH+R\@O[>)X3=*ZL\R.VY@^Y2#\WS#@8/
M3 XJ1O%V@)=FU.IP^<MR+1E&2%E.,*3C SN &>"3CK6E>WMMI]L;B[F6*(,J
M[CW9B H ')))  '))H R8/"5C:7>F7%K-<PG3H98844J5/FD%V;*DEB5!SGK
M]:@L_!5C81Z.D%[?!M*:7R7+IN99.71OEP0>.F#QUJZ_BG0XK9+B748HHWN#
M:CS,H1*.J$$9!^HI$\5Z)):Q7*WRF*6Z^QJ?+?/G9P(R,9#=.#UH IQ^"[.-
M8%%_?'R=3?5%R8^9G+$Y^3[OSMQ[UEZ_X9FM;%H;$:K=07NIF]O#;20^;&2I
MQM5P%9=P7(.>F0,].RBO()KJ>VC<F:#;YB[2-NX9'/0\55N]>TNPG:&ZNUC9
M6178J2D9;[H=@,*3D8W$9R/6@#F[7PI-JVC_ &34KW58XX)DGT^:4P1W5LZ@
M@D&)=F,'&"">6SVQK+X5@\_3+B34;^:XT^9YUED="TKLA0E_EQ]TD87 %4]2
MUV]N?%,OA[2YA:W,5FMR)IK5Y$=V<@*W3"X4\@]2,'@@ZFI>(;73=8T[2I%F
M-S?[_+*PLRJ%&220/7 QGOF@"BG@FRC@MT2^OU>WU&748Y0Z!A))OWC[F-I\
MQ^V1G@BM+1["[L6U W-[<7*3W3S0K.X8Q(0/D! &%SG YP,<UB^$?&$.JV%G
M;ZC>0?VM<2W*".-"JMY<KC ZC.U0<9SCFMR+7=,FU%+!+I3<R!S&I5@)-G#;
M&(PQ'< G'>@#/F\'V-S'KT=Q<W<L>N#%TC,H"_NQ&"F%!&%4=<]*A;P19SG4
M&O=1U&\?4-.&G7+3.@WQC?@@*@ ;YSTP/;.2=G4-8L-*V"\GV,ZLZHJ,[%5&
M6;:H)P,C)Z#(]:BNO$.DV=I'=37J>1)#]H5XP7'E8!\P[0<)@CYCQSUH SI_
M!T$\T$YU34EFCLVLI9%>/=<1$YP_R<$'H5VFI-)\)6NCWMG=07MY(UI8+IT:
M2LA4Q*<C.%!SP.<U=N_$6D6*JUQ?1JA5',@RR(KG",S $*">A) -.N=>TRSN
M3!<7:QN)%B9BIV([8VJS8VJ3D8!()R/44 9^C>#[30[MGM+[4#9B1I(;"28&
M"!FSG8,;L<G )(&>!5S4-!@OM5M-42XGM+^V1XEG@*Y:-L%D8,"",@'IP1QW
MI9O$6DV\=X\UXJ+92+%<DHW[IF *[N.,@CGIR*AN_%V@6-U/;7&IPI- Z1S+
MR?++?=W$#@<CD\#(H C@\)6%M>:5<V\US&=-$WEH&4B1I3F1GRN26//!'-6M
M?T&U\1:<MI=23Q&.59H9[=]DD,BGY74]B.?S-4;KQII=E=ZU!.)U&CVRW%Q(
M86VD$,< XP3A1CGDG Z&KJZNME8P2ZLXAN98S,T,:,_EJ -WW020N0"QXR>V
M0* (K?PY%&ENMQ?WM[Y3M))]I9&\]RNT%P% X'0+@=\$U3@\%6=OI6FZ:FH:
M@;?3;I;JV#/&2I7.U,[/N#) 'IQG@5?.LB#Q!:Z=,5:+4(7FLY ,9*8+(?P8
M,#Z!O3FUJ&K66F>6+N;8T@8HBHSLP498A5!. .IQQD4 9_\ PBMI)?175U<W
M-TT)G\E9BG[H39W@$*&Q@D $G ^@Q#9^#K6R71 FH7[_ -C*R6V]HSE2GEX;
MY.<+P,8]3D\U:G\6:#;>3YFIPDS6WVJ()ES)%Q\RA021\PZ5)<:_IRV$-Q#>
MQL+J SV[I&TH9, []J\E1D9/ Y'(S0!GVO@NSM(-*BCOKYETR[DNX-S1\O)O
MW;ODY'[Q_3K["N>T'2-;BU%+G&MV5X]QYEW'/]DDM2K/N=0X!E9<9"\YZ9QV
MW?#^OWNK>$?#E[*8_MVIK$TA5<*!@NY [#:I ]R*UX?$&E3W:6T=XADD#F/(
M(64)][8Q&'QWVDXH @TK2FBUK5-9N%VW%]Y<:IG)CAC!V@^Y+.Q^H':L_5?
MMAJDVK-]NO[6'5XA'?06[ILF(7:'^925;&!E2,X&<UJ:7XET?6IFATV_CN75
M#(0@/W0Q7.<8Z@C_ /765XY\4CP_X9U:XLKB,:C:6QF57A:55)SMWXX7."!D
MC/O0 NI^!;+56U#SM1U&./4;=(+N.)T FV A7)V9#8/8@'N*EF\&VLFM2:G'
MJ.I0/<(B7D,,RK'=[1M!D&W@XX)4KQQ6E=Z]IMA,D-W=+$Q=(RQ4[$9ONAF
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M=3W,%VC1^8AF8M*N"FTJQ/0@]O2M70M#AT"UGMX+BXG6>YEN6:<J2'D8LV,
M<9)J73=:T[5WN$L;I9GMG"2J 05)&1P1T(Y!Z'M5*^UVVT[5+SS]10Q6E@;F
M6RC@9Y5 ;_69';'&W'OF@#<HK$MO%6F3:3:W\KR0K/;BX*-"Y,:$#);"\#G[
MQX.*U;JZAL[=I[B0)&I SC.22   .222  .230!-16=_;FG>0)?/;!E,*IY3
M^8T@&2H3&XD $X Z FLG6/$C"#0KK2+FWEM;W4X[29BA8[3N# <C:P*X((R.
M1Q0!T]%9S:[IB:A%8O=*L\LABCRIVO(!DH'QM+8!^7.>#Q6C0 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M33Y6<!?^6BD<HWMN5&_X *R_^$&MX?"=_H-G>S0)=7#3++M#>6/,#K'M/5
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M3(90<^:D3D-+[%R%R/5* -37=9FTBYT>..WCE2_OEM'9G(,>59L@8Y^[ZBM
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M *122!68GL >37#>+M)M=6NK^\CL-5L/$-E\FG:C802;I_D#*"R@JR[B5(?
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M^@->@^(+:\O/#FIVNG2^5?36DL=O)G&V0H0ISVYQS0!9AO[.X>5(;N"5H?\
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MMG'' ;5P\UPDC%I A&X80HN<#./:O2+.UM+2W"6=M';Q,=^R.(1C)Y)(P.:
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M:)" 2!R>M %7P<2/#T< M;6"*%V2,VD[30RK][>KL 6R6.2>I!Y/6H)-!O\
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MS</YCQ)(""_=@.Q/&?SZDD@'%>*HHXI_!\XU.XN8_P"V89")'5E5/+D!?@#
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MZ\$$-TZ9 XZ<4 8%WXL\0V%OK4LW]F2#1=0A@FV02+]HCD$3?*-Y\M@)>IW
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M1YY6^9YG= 6D+=2Q))SUS534?%]]%IGB'5;&*VDM-"N&AFAD4^9.(T5Y"&!
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M)5M0;IB(EDQE0#QC@8SZ#.10!BZ-XWU::WT"_P!3BLOL>K:?-=-';1N'A:-
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MU_O?3 !R\^IW/B"Z\":XPMDM+O4W>&-8SYJ*;>?;E\X.0,D8'./3GTBN8MO
MFD6DEIY,EZL%E=&[M;87+".!R&!"C^[\[<9P,\8&173T %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:0133(/G"J,L#G"_*>1D^U '0Z%XWCG\)Z1J7B"!M.U"_BD<62Q.[MLR694
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M/ '/88'B#PWK-V/&D%K:Q2QZU;1K;R&8+AQ'Y9# _3.?2@#J+3Q+I-V;Q4O
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M.V10PSUP1FGUYUINJ2WFBZU#<ZBVEZY!;JBK).Q@AB(Q%*@! *L#R^,@YZ8
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M Y4L-QSP,*:T:\CAU:WU2S\(ZE?:@PU8Z^4N[>2Y($+@3#88R<+M^4#C//\
MM'/KE !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M'I7]JQO'/YK-&#AE(VC#9(P 2#GJ*GOO%=[83FSN=-AANY]/EO+/_2"\<AC
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MJ.QTBYOX[.Z2VN# LA<%@I8H A5MH<$Y8'@^@R =&UK;M<K<M!$9U&U92@W
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M&GK"T%I!,B'[.C K@L "^T' R<#T.!C>T?3_ .R=%LM.\XS"T@2!9"N"RJ
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M='>K9/?6RW3-M6$R@,6QG&/7'./2JLGBC0(97BEUO3DD0NK*UT@*E0"P//&
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M+:Y@O+:*YMIHYH)4#QR1L&5U(R"".HK/LM6A>UN[FYU'3I(([EXUEMY/E09
M56))^?G!QW/2@"QK&GC5M%O=-,IB6[@>!I N2H8%20/7!-8LW@Y;B6)Y=0E
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MKQ18:II^J)*^GWUO=K$YCD,$H<(WH<'@U+=7EM91"6ZGCA0G:&D8*"?0>IH
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M%W([3* PSC(.>F>,U?H Y$>"[J7PY>Z+>^(KV\@GM6LXWEC0-%$PP?N@;WP
M-S?ER<V;WP@FHW-_+=7K%;[2O[*E6.,+A/F^8')^;+M[=*V!J^FF^^Q"_MOM
M62/)\U=V0,D8SU Y(]*A@\1:)=7,5M;ZO833S!C'''<(S.%)#8 /."#GZ'TH
M R[K09[Q]!L)YY)X-,G6[FN'0*9'16$:@#CJP;VV8ZFNGJC%K6E3V@NXM3LI
M+8R"$3).I3>3@+NSC=GC'7-7J "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 1@2
MI .#C@^E>9:5I^MQ6/@_3KK1+LW6CZDQO+@%#&ZF*9?-5BV2&+JQ[YSGG&?3
MJS(?$.EW%JES#=;X7NOL:LJ,?WV[:5Z<?,",]/>@#AK/3-8@31+ Z-=DZ?XB
MN+J68%-C12&X974EN1B5<^G3K5OPQI5U%=65CJ^@WK7NF7$LD>IO=%K=@Q;]
MX@WYW,&P5V\9.:] )"J23@#DU5TW4K/5[%+VPG$UN[,JN 1DJQ5NOH01^% &
M5XVTZ_U3PK<VVFJ'NA)%,L18*)@DBN8\G@;@I'/'//%<OXJT74-<C\1ZC8V%
MRGVS0A81V[J%>:;<S D$\;0<9/\ >..!7:R^(=*@C\R6Z"+]K%CED89F+!0O
M3U(&>GO5N&^MI[JYMHY"9K4J)E*D;=PR.2,'CTH 6S2-+6/RH!"&4$ILVD<#
MJ/7M7%:GI6HB\\8VDMA+>0ZW;J+*1,%0?)\LQN2?DPPW9/'S'OQ7>44 <)J'
MA&_>YT^W5_/MK[2QI6L2EL%D0 K(/4G]ZF>WF ]J@GT37)OAAK5I?P&YUJ>Q
M>PC5""9%C5HXVST^8EG]M_M7H59UAKNFZG=/;6ET))DC6;;L9=T;9VNI( 93
M@_,N10!QVJZ7>W>H^))TTR=UN_#D=E QC&7E_?93V_UB=>/RK+U"UN7EO+(:
M=JDL=]H=M87YMH(YC&P$F5 ,BE'"N3T8'<IQQ\WJU9-UX9T>\U%M0FM/]*<
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MLTIC50,;02/F.!_"<8JO!K?B&_O],TLZJ]LS:G?Z=+<QP1DS+%&S)( 5(#9
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MM[BQ\/6]P)1'&S2,C7+ ,"NW:<<X /H15Z;6]=UNZO[32KVUL+FTL[:X3SG
M4F1=Y9@48E/X>",8/.<8Z@^&M&/GC[!%BX@%M,!D!XAG"'GE>3Q[GU-1W7A/
M0+Z:SFNM)M9I;- D#R)DHHZ+GN/8\4 1^)HTN_"D\=PD<B3")9%ZJP+KD<]J
MX[27G&G7GP_N2[OICLKR-_RTT\#=%D]#G*Q$>@;TKT:]L;;4;8V]W$)8202A
M) )!R.GO2/I]I(92\"EIHEAD?^)T&<*6ZD#<WYGUH \Y\*ZI>IX6\$:):3+;
MM>Z0\PE,@1F:,1@(I*.,X=FQC^'ZUH6\_B>YU[2]'N?$$<4SZ7/+<RV4,;HT
ML4\:97>G&0Q!&,=<8X(Z6X\(^'[K28-+GTJVDL;=@T$++Q$?]G^[^%6HM$TR
M"[M[J&SBCFMH?(A9!M\N/CY !P%X''L* .4CU+Q)?ZC''!-<1R+K4MO<(ENI
MA6S4-M8.5(W<)GG.YF&!CBK>:]K<=IJYBU-EDMO$]M81,T,9Q!)]GRA&.?\
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MB>4:AX:DU D11H8)D\H90A>_F'.<\CC%=G!X=TFVM9+:&RC6&2+R&3)/[O\
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M)(%+KPVW ;Y@Q' X]:VO"E[?37.OV%]>/>'3]1\B*>1$5V0Q1R -L &07(R
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MFK6%C8&]N+J);?<J"3<""Q(4 >I)(%/2XG;4)8FBB%HL2.DPFRS,2V05QP
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MF3S3)@@JWR@*N !U]HM-\/I)!IJP:;)!X@M?$$L\EP;=D=+?[3([9<CE&B.
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M7(89'[OC&,9/6F7WC#4]"N-574?LEPD.F0W\'E1M&$9Y&CV,2QR 0IW<=^*
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M/O<=>F,<^DT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M8)!X(R<'C@X )CX*T5K:^@:*Y(OIHKB=C=2%C)'MV.#NR&&Q3D<G'-;JQ*D
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MA&3&)FZ(6[$Y ],\9SQ6O0 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7!IX4U
MM=+@MRMCYD?B%M5;_2&QY1F:3:#L^]AL8Z>]=X3@$XS["LC0O$EAXA:_2S\U
M9K"Y:UN8I5VLCKU[G(]".#@T <TWAKQ%-K]A?W/V"8V6KRW*S-</N:W=)$5
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MVX^5OF&[DC@XSGC9\,Z5?Z7/K37J6X6]U&2[B\F4N0K*H ;*C!^7MGK7044
M8/BC2KW4XM+DL! TUCJ$5V4GD**ZJ&!&X*V#\V>G:L"\\*:W<6&NP*MCOO\
M6;?4(B9V "1F D'Y."?)/K][KQ7>T4 <58^&]5L-?O1]CT>YTZZO6O4NYL_:
M("QW,@780WS9VMN&,]#C%=K110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%  3@
M9/2O+%EN=%UF'Q!HL0O%U2[O-,NHXCN7SOM$K6\C8[ EE)[*PKU.FJBJ,*H
M]A0!Y/'+)H-[\0(]*F:6ZM;6Q)9/FE;Y&\U\#DM@LWUHUB]LCX6UC4](\5FX
MMY6LR/L<SK';N95!^8NQ#,I.Y#Z9(YY]8$:*VX(H/J!35@A1-BQ(%SG:%&,^
MM 'GGB*:Q\/:M:V,NJ;-/N-/NFBBN=3\MA.SJ1())7&>I PQ*]0.M26CFTUC
MP1:3:V]V9M.N1<S)?.Z7#A$RX);GYB^#V'3&,#IM3\/W%YJHO[;4VM\PK"\$
MENDT9 ).5#<JWS<D'!P,C@5HZ?IEMIUFEM"@*J6;<5 )9F+,<  #)).  .:
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M*ROTFBENBTTC!XROF@$!7 + *!E1D9QT]650HPH 'H!2".-3E44').0.YZT
M>.Z#J]G9^%_!UI=:G#::3<:<\=Q//(YB6["QXC=@Z["%WX!(&<\9 QWT+:A8
M_#J5M.O9M5OX+"4VMS,GSW#A6\LX[Y^7GOU[UT;0Q/'Y;Q(R9SM*@C/7I3Z
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MH)!N/'0 =30!UN1ZBER,XSSZ5Y!JNE6-M8^+S:6*(]KJMM+IPBB_U1VP%VA
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M8/*D,+:YIES 8[22"/8?)\QT'\(P'R0>Q/O6N/#-OJ3>,=*TZ"&W\F\@N],
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MRV74?[5B\2V-Y.TRK;A4=69OF:79\T14K@%NR@=!7IE !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% $(O+4OL%S#OSC;O&<U-7FJV[R>./'2PZ#:ZJ6CM,PS.B!R83\OS ]:=X
M&\02/X?\,Z%97OVB[ELYWFN;N)CY?DN$:/;N!)#.%'/1,]Q0!Z117 Q>,=<O
MI=,LK6WL(;V>_O-.N3,KM&LL".0Z8(.T[0<'GG&>]/D\5ZY8R^(;B]336LM
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MX/H<$5)7F:ZG?^']2\6ZA9)9_9(M=MEGB=&+R"2*V0[2" I&_.2&SZ#K7IE
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M=V6GA:^A$%XD+[5N4 ( ;CK@D97!P<9J >-M"+M&L]R\@@%RL:64S-)$?XD
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MZFGW@2221E3&20, *57   X]SFX-%MQX@&M>;,;K[-]EQN&PQYW8QCKGG/\
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M9[O"AXXWD6-FC1I,; S@%5SE>I_B'J*5_$>EQW\-F]PRR3S-;Q.8F\MY5SE
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M;-;:)Y7 R6DFD+N['J68\D__ *NE0/HUN_B"/6C),+J.W:V"AAL\LD,1C'J
M<^U:-% '-V/@C2=.NK&>"2]!L9)7MD:Y8I&)/O*!_=SV_IQ43^ ='.G6=G%)
M?P?8I6EM)X;IEEM]W54;LI'&.AKJ:* (+*SBL+2.VAWE$'61R[,2<DECR222
M23ZUG7OANRO-2EOQ)<6]Q/!]FN&@?;Y\8SA6X/3)PPPPR<&MBB@#)3P[91:M
M9ZC 987L[8VD$49 C6(E25VX_P!A?RK6HHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***H7>L6=EJFGZ=,T@N;
M]G6 "-BI*H7.6Q@<*>,YH OT5DWWB*QT^6Z68R%+-%DNY$7*VZMG!;\ 3QG
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M@K\A![\]#70R/Y43R%6;:"<*,D_053T;5;;7=&M-4M XM[J,2Q^8,-M/3(H
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MXGDC>386C#@NJO@[6QT;MV(.#3AXCMI'U>.&UO)IM*=8YHHXLNY90XV#//#
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M*0[7965E+$9(PQ ]!@<X&'Q>"VCMK2'^T21;ZL^J@^3]YW9V*]?NYD;WZ?B
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M%+&Q5UR.N"#SW&*X74-9U75=*M[J\@C62V\516T26\Y^8)<;-IR%&..IZY/
MZ5Z!H^DP:+8?98"S[I9)Y9&QNDDD8N[''JS'Z=*PG\$_(\<>J2B$ZN-62-HE
M.R3S/,*Y&"06/Y<>] "P^,V\NYAN]/$6HPZE_9PMXI6E1W,0E#!@F<;"2?ER
M,$5K:#JUQJ]K/)=:;/8307#0E)5;;(!@AT+*I92#UP.<CM6/>>!UO/[1D&J3
M075SJ":E!<0Q@-;3)&(Q@'(92JX(/7)]>.@TNRN+*TV7=_+?7#-NDGD54R<
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M:%81)MV[@HP"1ZX%<X/ [+?17":U<A8=4DU.*,Q(<.ZNK*6(R1AR!Z# YP,
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MW4)X4</:LOGQBWC1]CG Y(93P?;'6MV+PO!]MUR2XE$UKJ\20S6WE[0J*FS
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MOFP%/EMSGTSUH [&37=(AM8KJ35+);>92\<IG78ZCJP.<$#(YJ/_ (2'3/\
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M]<WJ^@:G+>ZMKVF:?*8Y;JQF^PJ_DR72P[M[#D;6.]<9P<QCVH ] L[ZTU"
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M+)-0;]WSY#2.1(?^ L..O;%6M!TJY34(M.U;0;Z6ZL=0FNH-2:Y/V8JSNPD
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MGMIK&"YCNG$?^H9XBJDXZY;'3/K0!Z'!JNGW5Y):6]];2W,8W/"DJEU&<$D
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MGW%_>2&.VMT,DK[2VU1R3@ GBN"A\5ZK#9^'+QK@W+7/AF?4+BWV*!-,D<+
M\#(R7<8''MQ4NIS7-WX"U+46UT7EM?>')Y?LYC7F3R\F1&&,* VTKSU'.<Y
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M>HRWG_"OKV35?*2\.G2>=L&U=Y0] 2<9],GTYK;FO+>"TFNGE7R859G93G
MR:S="U>\UB)+J33D@LI[>*XMYEN Y8.,[&7 *L!CID<]: .?T30[G5]"T"_G
MFMMUII)@MA'D@O)&JL[>F N-H]3SZ7#X4O?^$7\.:0+J#S-'EM7:0H<2B
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MJN+F-(3(L0;<,%V8*%'N20*>D]PVHR0F",6HB5TF$N69B3E=F.   <YYS[4
M1Z38G3=*M[1Y3+*BYEE(P9)"<NY]V8D_C7-V7@J6VTZST66ZBDTFQOQ>V_RG
MS<+(9$C;M@,1\W<#&!UKKTECD#%'5@IP2#G!H61')".K$8R <XSTH Q_#>CW
M&BP7\=Q-%*;F^GO%,8(V^8Y;:<]<9Z]_2LO5O!L^IWNNL-16"WU6" #;%F2&
M6+)1P<X(SM.,=NM=<2 "2< =36?J^LVFC:#>:Q.V^VM8&F;RR"6"C.![F@#!
MOO#_ (AUGP[+8:IJE@]T\L#*T%NR1@1R+(206)+,5 Z@#L/6'5?!5YJEYJ]V
MM_%;SW4UI<VC*A;R9;<Y7<,C<#W'%=+IUUJ%P]PM]816RHP\J2*X\U95(R3T
M!!!X((^A-7?-C\WRMZ^8!G;GG'KB@#B;OP7JNIS:O=76JVUO=7JVCP/;0,?L
M\UNQ=&^9OF&3R,<CTJY=Z!K^J6E@=1U&P:ZMK^&[(@@=(ML9)V@%B<MGDYXX
MX]>I\V,L%WKN.<#//'6E\Q",[UQTSF@#.\0Z==:MH%Y865Z;.XF3:DX!.TY!
M[$'!Z'!S@URUQX%U*>#6(UO=/B74GM)/+AM61(3"5. -W0[ /QS[5WE-21)-
MVQU;:<-@YP?0T <9JW@J]U/4=3OTOX;>XFFL[JT(C+B*6WSC<,C<K9(/3'O6
MKHFBZC9:]JNJW]U:R-J"0*8H(F4(8U(^\6.0<^E;R2))G8ZMCK@Y]Z&EC1E5
MW56<X4$X)/M0!RNK^$[V^N_$4EO?01PZUIRV;K)$2T;!9%# @],29QCJ.M07
MW@F?5)I1=7D<<,NC#3#Y(.]6#;A("?0@<?K5^]\4RV=]K]J-/5SI-A'?*?/Q
MYRMYGR_=^4CRCZ]:V]-N_P"T-+M+W9Y?VB%)=F<[=R@XSWZT 4-#M==@C/\
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MTN;>\M4FM;F.YA.5$L;A@Q!P>1QU!!]Q3;K4+*QV?;+RWM]_"^=($W?3)YH
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MU6X<0,@>8.A <XY?&_KSUKNTNK>2YEMDGB:>)5:2(."R!L[21U .#CUP:EH
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M2(8TC:\E86ZD@[8LM^[&0/NX/ ]*UK#2[?3Y;F:/>]Q<LK332'+.54*N>W
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M%Q;JJ[XYH\89L[@I[#!R,8H NVOCO0+RZLX(I[@?;)G@@EDM9$C:52P,>]E
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M[/.3U''II:+I7B'1M3OK-!8RZ3<7TEZERTK>=&)&WO%Y>W!^8L VX8!Z9&*
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MR.];% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M \A[2"WN+QS>*5ACDW[B,#YMOEG@=1GIWB_X3Z."$WE[I=W#IK637J72([
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MJ8^95+8/(/#8!P,U[_QQ-93ZKG1F:VTJ[AM[F;[0H.V0(0ZKCDCS!D$CZ]J
M.M\B'=N\J/.<YVBG,B.5+*I*G*DC.#[5P.M7)N/%VM0ZRBC1]-TJ&\WQ7+K)
M#\\S&1-J@[SY8'48 ZG)%7KWQS<Z?9ZG<3Z!=;+.P-\KJ6$;J#\R%V0!7'7
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MP]Y]ITTZ=)Y5NL.5W;@_4_,#SZ9[=JZ5-8TR22:--1M&>%2TJB=24 ."6YX
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MF_I6N6]Q!'!>W^E_VF$8S0VMT' VG#$9P<#C.1QG%6DUG2WMIKE-2LVMX/\
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M0!GT_.N>O;?49?%6IW,+7,%X;A3!!/H37$4GEJ C"9<* 2"1N;*[CR*],HH
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MED'BBTU%$6/!DA00!V4'&>4?CKQGO6C%9ZG%XPCN[&.[6VGO2]Y97D(:./\
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MO_>/Y4?;[?\ O'\J +-%5OM]O_>/Y4?;[?\ O'\J +-%5OM]O_>/Y4?;[?\
MO'\J +-%5OM]O_>/Y4?;[?\ O'\J +-%5OM]O_>/Y4?;[?\ O'\J +-%5OM]
MO_>/Y4?;[?\ O'\J +-%5OM]O_>/Y4?;[?\ O'\J +-%5OM]O_>/Y4?;[?\
MO'\J +-%5OM]O_>/Y4?;[?\ O'\J +-%5OM]O_>/Y4?;[?\ O'\J +-%5OM]
MO_>/Y4?;[?\ O'\J +-%5OM]O_>/Y4?;[?\ O'\J +-%5OM]O_>/Y4?;[?\
MO'\J +-%5OM]O_>/Y4?;[?\ O'\J +-%5OM]O_>/Y4?;[?\ O'\J +-%5OM]
MO_>/Y4?;[?\ O'\J +-%5OM]O_>/Y4?;[?\ O'\J +-%5OM]O_>/Y4?;[?\
MO'\J +-%5OM]O_>/Y4?;[?\ O'\J +-%5OM]O_>/Y4?;[?\ O'\J +-%5OM]
MO_>/Y4?;[?\ O'\J +-%5OM]O_>/Y4?;[?\ O'\J +-%5OM]O_>/Y4?;[?\
MO'\J +-%5OM]O_>/Y4?;[?\ O'\J +-%5OM]O_>/Y4?;[?\ O'\J +-%5OM]
MO_>/Y4?;[?\ O'\J +-%5OM]O_>/Y4?;[?\ O'\J +-%5OM]O_>/Y4?;[?\
MO'\J +-%5OM]O_>/Y4?;[?\ O'\J +-%5OM]O_>/Y4?;[?\ O'\J +-%5OM]
MO_>/Y4?;[?\ O'\J +-%5OM]O_>/Y4?;[?\ O'\J +-%5OM]O_>/Y4?;[?\
MO'\J +-%5OM]O_>/Y4?;[?\ O'\J +-%5OM]O_>/Y4?;[?\ O'\J +-%5OM]
MO_>/Y4?;[?\ O'\J +-%5OM]O_>/Y4?;[?\ O'\J +-%5OM]O_>/Y4?;[?\
MO'\J +-%5OM]O_>/Y4?;[?\ O'\J +-%5OM]O_>/Y4?;[?\ O'\J +-%5OM]
MO_>/Y4?;[?\ O'\J +-%5OM]O_>/Y4?;[?\ O'\J +-%5OM]O_>/Y4?;[?\
MO'\J +-%5OM]O_>/Y4?;[?\ O'\J +-%5OM]O_>/Y4?;[?\ O'\J +-%5OM]
MO_>/Y4?;[?\ O'\J +-%5OM]O_>/Y4?;[?\ O'\J +-%5OM]O_>/Y4?;[?\
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M>E?V3>"^&K&=863YI$RO*_WNAZ?AFNLU&UOK_P"*7AS4XK"^BM(["6.29H&
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M7YT?V=!_M?G5NB@"I_9T'^U^=']G0?[7YU;HH J?V=!_M?G1_9T'^U^=6Z*
M*G]G0?[7YT?V=!_M?G5NB@"I_9T'^U^=']G0?[7YU;HH J?V=!_M?G1_9T'^
MU^=6Z* *G]G0?[7YT?V=!_M?G5NB@"I_9T'^U^=']G0?[7YU;HH J?V=!_M?
MG1_9T'^U^=6Z* *G]G0?[7YT?V=!_M?G5NB@"I_9T'^U^=']G0?[7YU;HH J
M?V=!_M?G1_9T'^U^=6Z* *G]G0?[7YT?V=!_M?G5NB@"I_9T'^U^=']G0?[7
MYU;HH J?V=!_M?G1_9T'^U^=6Z* *G]G0?[7YT?V=!_M?G5NB@"I_9T'^U^=
M']G0?[7YU;HH J?V=!_M?G1_9T'^U^=6Z* *G]G0?[7YT?V=!_M?G5NB@"I_
M9T'^U^=']G0?[7YU;HH J?V=!_M?G1_9T'^U^=6Z* *G]G0?[7YT?V=!_M?G
M5NB@"I_9T'^U^=']G0?[7YU;HH J?V=!_M?G1_9T'^U^=6Z* *G]G0?[7YT?
MV=!_M?G5NB@"I_9T'^U^=']G0?[7YU;HH J?V=!_M?G1_9T'^U^=6Z* *G]G
M0?[7YT?V=!_M?G5NB@"I_9T'^U^=']G0?[7YU;HH J?V=!_M?G1_9T'^U^=6
MZ* *G]G0?[7YU:10B*HZ 8%+10 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 5R_BJ6>#6?"K0W,\:RZKY,J)(0LB&
M"5L,!UY53SZ5U%8^M:+)JUYI,Z72PC3KO[4%,6_S#L=,9W# PY_'% '+^(M4
M\K6_$-MJE]/I\<.FI-I4B2M&&8!S(RX.&<,$X.> .,$YZSPW?7&J>%])O[M-
MES=6<,TJ@8P[(">/J:-8T?\ MR$V5U/C3GQY\"+AI@/X&;/W#W  )'&<9S:6
MWN4U+S1= 60@$:V@B PX.=^[KTP-O3B@#"\%RSR#7TGN9Y_)UB>.,S2%RJ )
MA03V&>E=#>6_VNRGMO-DB\Z-H_,B8JZ9&,J1R".QK-T'19-&;4B]TL_VV\>[
MXBV;"P (^\<C@5L4 >?VNE"[\>Z_I)U'5DM8=/M7@"ZE/F)W,H+#Y^3\J]?2
MF:?X@GT+4?$3RVMQ=6(\01V[S/<9, EC@5=H;)(#/R., \9Z5T]IH$MKXNU#
M73>*XO8(H#!Y.-HC+%3NW<GYSGCTK-NO!<US:ZM!_::*-1U*+42?LV?+:,QD
M*/GY!\E>?<^V ">?QBB:@(;>PFNK<7HL9980S.CYP6VA<%%;@G((P3C'--^(
M\TUM\.]<N;:XGM[B"U:2.6"5HV5AT(*D&GVGA:]L-:NKBTUR6+3+NX^U36/D
M*3YIP6V29RJL1DC!ZG!&:O\ BC1#XD\-WVC"Y%LMY&8GE\O>54]<#(YH Y3^
MU&MO'/ANSL)]2MX;J.7[6NH/+Y4X"958_-/,@;!^7MG.:V[;Q?YVLP:9+ISQ
M3W,,\L,1E'FCRF Q(AQL+!@5Y/'I3[CPO-J>HZ3=:MJ"3QZ7+Y\$%O;^4K2A
M2H9B68G )P!CWS5'3? ]WIUUI<XUPRG3A<I'OM1F19B"2YW99LJ,MQGT!YH
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M<'GUEU/PRFIZZ-0>Y*PR6,EA<VYCR)8G(/#9^4\8[\'MUJ'3/"CV;:.+R_\
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M_9WN&:-'('RJQ'RKD9X'<G%</:Z[JVJR^!-7D@W7-]%<2&VAN2L<@,&X%@0
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M0UNMN"DJ 6QP"<9-<C_PB5W:3W&K0:BBZRUB;075O9*&E.Y2'D4MM=QMP"<
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M10S#R6'RB0(#NW<<$]:Z'QG:7VI^#;^#2X_-NG172$G;YH#*S1\]-R@KSZT
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M[7C'TX[''J% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !17#3>(]2C\16*17:SVEQK,FGN$B
M7R441.VW)^<R!DY(RO4=1Q4L?$.OYTR[N-0CEBFU^XTJ2 6ZJ&C5YE5L]0P\
MM?;USUH ]$HKBK+6M4.K7?ARYO2=5COE>.41(-UD1O#XQCHK1D_W\=CBMKQ=
MK4GA[PS=:C"JF1&CC4N,JA>14W'V&[)^E &W5"SUK3=0NI+6TO(I9XT61D4\
M[#G##U4X/(R.*YN_O]3M]8U;0I+V66%M(:^@NMB+)$P8HR'"[2#P0<9^][8T
M? L'E>!M!9Y&E=M.M\,RJ"J^6N%& .![\T ;%_J-EI<"SWUS';QLZQJTC8RS
M'"J/4DFK5>4ZJ;R7PWXL::_FG*>([:*,2JI5 );7'0 \=,9[>N36O/XGU32;
MK6-/N+I+EX=0L[:"Y>-8_+6X SG QP<@$CN,YH [^BL;0O[922^@U>:"8+*&
MM65@9?*(Z2 *HR&#8('(]ZY_Q1XCU+3+N^DLKI9$LYK)&@CB4J@ED56$K-SD
MJWRA#D<$]>0#MI8HYXS'*BNAZJPR#3ZY.TU34M8NM0GM-0AM8].U7[));RQ@
MJ\2[=^X_>#MN)4@@?=X/.6:1K.I:O90:['?1):"ZN(KBQ:,'Y$9T55/WO,RJ
MDY.#D\=* .OHK@K+Q+JL^F^%-8^T"6#7I5AFME1<6YDC=U,9QG*;,'=G/)XI
M-&\2ZM>P>#I)KE"VJ2745R/*7#;(Y64CT.4'2@#OJCN/)%M(;@H( I,AD(V[
M>^<]J\_T7Q#KTX\-75WJ,<L>IWUW930K;J@ 03E7!Z[AY0'I@],\UGZ3=WTU
MCX8L[N^GN8[_ ,07OGM*%Y$,EPZKP!U9$./]G P.* /4HRAB0H,)M&T8QQ]*
M;#/%<PK+#(KQMT93GV/ZUR>H^(+VP\6)97C7%K8S7$,5I<1Q+)!(6 W12G!:
M.0DG;T!!7WJ;1KB2+X@^)--7_CV,%K>*!T21PZ-^?EJ?KD]Z -_4].MM7TVX
MT^]1GM;F,QRHKE-RD8(R"#R*;+<66C6$2S2F.%!Y:;BSLV 3@=2QP">YP":R
M+S4[N[\8-X>MKIK+9IWVWSD169V:0H  P(P,$GC)W#D=^8M=2O\ Q%J/@34;
MF=[6>5KQ98X579OC1U+KN!.&P>I. ?QH ]%M+NWO[.&[M)XY[>9 \<L;95U/
M0@U&FHV<FI2Z<ES&UY%&LLD(;+(I) )';.#6!\0VFM/AWK+V4[VKQVQVM" "
M!T(Y' (XXY],5A:X-1M/&&LSV.I-#<6OAN.;SGA1V<K+.P!& N..<#Z8H ]&
MILDB11M)(P5%&2Q. !7##Q!KNO--:Z/)!:WL.F6UX@D*['DE5F^8%23'\H'R
MX/7GI7;6LCRVD,DGE[W16;RVW+DCL>X]Z *%KXDT.^:%;36=/G,QQ$(KE&\P
M^BX//X5J5X?NOD^!FF33Q6XTBWG2>YDB<FY6-;DG,8("AL@=^F>]=MJ'B;4I
M[+Q9?Z?<K;G0#F.WDC!$X6%9F,F1N ;<5&",8SSTH [JBN*L-2UW6O$VHP0Z
MBEE:6T%I<I"UJKMB5'+(Q)]0.?;ZYSM'\1Z[+HGA>[OM21Y/$+Q196V5!;?N
MY'8J><LVU0 1@')]J /1J*\^OO$6N6$&NAK@R+H%_ TTPB7,]FZH[@C& Z*S
M'( S@<<U/IGB2_OM;U#1_MK^:]W'+83>6F'LSG<PXY&8Y%W?[49[\@'=45Q6
MF:OK^M/;:G9SVL=B;Z:VN8)F7"HKM&NW"[O,W!3@M@Y/3BK?@>[UC5M(CU74
M]22=9O-C$"6ZH%*2NN[<#DY  Q_D@'55'/-';6\D\SA(HE+NQZ*H&2:Y3Q)J
M^HZ3KR0"\,=K?V,J6>(D8K>)@JO(^;<I.!ZJ?48J:;XCU+5?"T^HPW/E7-CI
ML@NT>-6 O%W!E( &-I0\=PZGZ@'9I>6TEBMZLR&U:,2B4G"[",[L^F.:+*]M
MM1LH;RSF2:VF0/'(AR'4]"*XG2;S4-1\7Z+-/J$VR;PX+IX55 A=GCW'&W//
MU[<8YK'\'ZQJ.B>'O""O<?:;&ZT6:0VJQ %##&K*5;J202#GCI@"@#U6BN&L
MO$&JNGA*]>Z$\'B!-LT21J/L[M"TJM&<9PNTJ=V[L?K%HOB75K^W\&O-<C=J
MHN4NML:C)2-V4CC@Y4>U '?45ROP[>YF\'6]Q=WDUU++-.S/+MSGSG'8#Z__
M %JQ-;USQ+ ?&%U9:G;1QZ R310-:@B9/(65D9LY'4C(YS^5 'HM5[&^M=2L
MHKRSF2>VE&Z.1.C"N6TV_P!=U?Q5JENNI):V=G]FD6 VJLQ$D1)5B3G@X.?:
MJ/AWQ1J>N1^';">Z\BXO]-FO9[F*-06*.J!$# J/ODG@\ >M '?T5YQ;>(_$
M6J3:-8)>PV<\]W?V-Q.ML'#M!N"R*">,E<X]<UU_B.ZO-,\':I>6\Z_;;2QD
MF65HP071"<[?<CI0!:U71[/6K5+:^1WB25)E"2LGSHP93E2#P0#^%7@, "O.
M;SQ;K&@)?7%U,FH(N@?VI'%Y(0)*#MVC'.TY!.<D8/TJ[K&JZOIMX+ :D]Q%
M?Z1<W,=RD:*]O+"$.Y<#&QMXQD$@CJ<T =#K%GHVH:AIMOJ9#7&]Y+6$RLHD
M*CYLJ" X QPV16Q7 Z7JVHZ=;^"K<W3W%M>::\DZO&I=BD"LH# #U^I[DU)#
MXCU1?"$'B_[;;W%K+I4MY)8E ,2B/S%2-@,\896W9Z9XH [JBN<T.77'U19+
MN[M;C2[FS$L1WKYGF9&2FU0#&58=22#CDYJKKDETGQ!\/1I>W"6S6EW*]O&%
M*NR>5CJ"<D.1U^F.: .MHK@K#Q1JDVF>%=<\Y9K?6[E8)[,(N(1(KLI1@,Y3
M;ALDYYZ5J?$.2YA\'3R6MW+;/]HMD+18RRM,B,IR#P0Q_P#U9H T+BVT/7=9
M5)76YOM)(<Q+,V(B_*[U!P?N9 8'&,ULUYCK5SJ>DZSXVU+3]0\N?3]*L[@E
MX5<S%%G.UNP!P<X //!&.=B]UO7=2OM7M]$FMK>?3/((2X=1&X>-9"9,J6VD
M$J"I&"I/- '9S31V\+RS2+'&@RSL< #U)JA:>(M$OGA2TU>PG:;_ %2Q7",9
M/]W!Y_"KTIS;.3CE#_*O%1+>P?!?PK>7D4 T:SDM)[B6!R;E5$@VE 0 #N(!
MYS@G% 'MU%<%J?BC4_[)\4ZO93K%_8-TT2VC(I698T1WWG&X%MS8((Q\O7FI
MH]1U^_U_7XXM4CMK;31%)'";16+!X"VUB3GAB#GVH [>BO/M)U_6Y+'PF;W4
MU>3Q''&YD2V5/LV+<RL%Z@LQ ZCCYL#H 7'B76K.VU*6:X#1:'J\<%W,(E_?
MVCJC%CQ@.@D!.,#"G@9X /0:*X;1?$6H:CJU[H[WC_:5O5FMY/+0;[ @E9 ,
M<@E63/J5/M3]%U?7]<73]6MKBUCT^XEFCGAE9?W8!94V87=O#  AFP>>G% '
M;4UW6-&=V"HHRS,< #U-<OX$O-8U;P_:ZOJFHI<?:X 1"ENL8C8,P)R.3D8X
M[8K7\1V%MJGAS4=/N[AK>WNH&A>93R@88S^M $EGKFE:C/Y%GJ%M/,4\P1QR
M L4X^8#KMY'/3FK]>?V&HZYI^OV^C^)K:![]K2==.UFS "S*H5G5XS]QOE4]
MU..*2S\7ZF+#PK?3N)EO]$GOKJ%4 WR1QQN-O&1DN1CZ4 =W=W=O86DMW=SQ
MP6\*EY)9&PJ@=R:=!-'<P1SPN'BD4.C#H01D&N(N[G4K[P5<ZG-JEO/9W^@S
M3-!Y8!65H]P\LCG9@L"&R>!SUJ3PK?ZE!J^F:5<7:W%I/H4=VB>4$\EE*)@$
M<D$,.N>1^% ';TR6-9H7B8L%<%3M8J<>Q'(K \5ZIJ&E1VDUK!=2VFYS=FR1
M))XU X948'<H)^; )Z8K#'B>_E_M(VVII<01^'(=2M[A(E :4^;E@"/NGRP<
M'IDT =EI6EVFBZ9;Z=8HT=K;H(XD9V?:HZ#+$FKE<!_;.O7]\EO#J:6JOX?C
MU#<ELK,)2<'KD8XZ8Z?G1IGB+799O#\\MU;RC6M$EO?(:(1QP2HD3+ANNT^8
M0<D],C'2@#OZ*Y7PCKEQJ=S>6E^]W#J%M%$9[*\A1'B8[LLK(-KQL1P1G[IS
M4/B;Q!>Z-K2"=KBVTEDB"WL,2RQQRER&6<8+(I&T*PX!)R: .FLM1LM1^T?8
M[F.<6\I@E,;9"2  E3[@$?G5JO,([_4M(N-?U"SNU2%?%,4$MN8@1*LHMXVR
MQY& V1C'(YSGC6G\1ZE%XBL5BNEN+2?67T^18XE$2*(G;;N/SF0,G)&5ZCJ.
M #IO^$CT;R?.&I6QC^U"S#!Q@S$@;!ZG) JY>7EMI]G+=WD\<%O"I>261L*H
M'<FO,KC_ ) .J?\ 8YP_^E4-=WXO_P"1*U[_ +!UQ_Z+:@#6AFCN((YHF#QR
M*'1AT((R#3Z\S?Q#K?A.RLY9[B/4;.;0IKR. 0",P/!&A R#DH0X!SR#W[5U
M6BR:V=5+7EW;7&F7%JLL)WJ9?,!&2NU0#&0P/.2#W.: .A9E12S$!0,DD\ 5
M7L+^TU2RCO+&XCN+:3.R6,Y5L$@X/U!K'U#5+B7Q?:>'K>X:U#V,M[),JJ7;
M:ZHJKN!'\1)X[#UKD/"&IWZZ%H6@VDXBGGMKVX,Z[59F2XVX4,&'\9)&,]/>
M@#U"BN#35_%%_-)HJ7%C!K5KIL=P[P.#%),SR)_$I)0&,9 P06QG@57U'7?$
M>/$ACU*V@;3-&M]1C6"%9$,A29F7<WWD)C'/!QC&.X!Z)17GMYXLU;19KVXN
M)X[N(Z"VJ1Q&(((9%8#:".2GS G))XZU/JFN:_X?M;F\N+FTN+.X6W2T>1E+
MQRR2K&SD(J@Q .K>N>,\B@#L8M1LY]0N+"*YC>[MU5YHE;+1AL[<^F<'\JLN
MZQHSNP55&2Q. !ZUQ^B036_Q,\0)-=R7).FV)5Y%56 WW'!V@ \Y[=ZOWVJ7
M-QXQB\/6]RUH!I[7KS(JL[?.$51N!&!R3QG[O2@#:L;^UU.RBO+*=)[:49CE
MC.589QD&FSZC9VU[:V4US&EU=EA!$6^:3:I8X'L 37GW@;4+VWT_P=IBW&+>
M]T^\>4!%X>-TVLIQQ]\\<CI3[+4[K6G^']_>R!KF6\NP[JH7.()U!QTZ 4 >
MD45Q>DZUJD^HR>'KN\)U>UOV,T@C0;[/&]) N,88%$/<-GTQ7:4 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 8;>#] :[:Z;34,QNOMF=[8$V""X&< G)SCKWS4B>%M&2*&-;
M5@D-T;R,>?)\LQ))?[W4DD_B?6L'QCXDD729?[*:\5K;4K6UENH=GEAC-&'0
MDG<>&P2!U.,\&M)_&EBE[J-O]AU(KISNMW,MON2+;$)<\')RI&, G.!QD9 +
M.DZ??MJ<VK:Q#9)>F+[-$+5F<+$&+<LP!RQ(R,8&T>IK5N[2WO[.:TNX4GMY
MD*212+E64]016!<>-K&TM-4GN+*^C;3$BENHBB%UCD!*OPQ&.#GG(P>*LOXH
MM([W5+1K>Y\[3K=+F083]XCYV[/F^;.TCMR,>E %J'0--@MIX$AD*SQ"&1GG
M=W9!G"[RQ; R>,]SZU:L+&VTRQALK2,QV\*!(TW%MJ@8 &2> *Y^\\=6%C-?
MQS6.HXT^2)+R01*5A$@!#$[N1\PSC)]L5NZEJ-MI-A)>7;E8D*KP,EF8A54#
MN2Q 'N: *-QX5T2Z>[:6Q!-W*DT^V1U#NN-K8!X.54\=2H)Z"G7'AC1KM=06
MYL5G7455;M979Q*%X7()X([$=*I7WC;3M,M]4>]MKR&;385N)[8HID,39 =<
M,59<@CKP1SBM:SU-+JSGNI;:YLXX78'[6@0E5YWCD_*1SS^(% !I.CV&B6?V
M33K?R8<[B"[.S'IDLQ)/  Y/0"J=_P"$="U.ZN;F\T])9;D()CO8!]ARA(!Q
MN&.&ZXXSBH[?Q997%Q90BVNXSJ$+3V+2*H%T%&XA?FX;:0<-M./H</T[Q/9Z
MII^GWMO#<"*]=T4.%#1[-VXN-W !4@^^!WH ?_PBFA_VT-7&G1"^PN9%) 8J
M,*2H.TD=B1D8&*6V\+Z+9ZS-JUO81QWLS%W=6;!<C!;;G:&(ZL!DY/-99^(6
MB!L8G96M)+R%D"-YT: %MH#$@X(.&"G'T-6K7Q=:WD=L8[#4%DNR!:Q21*K3
MKL#EURV-H!Y)(YXZD9 +UGX>TK3YUEM;01E'>2--[%(F;.XHA.U"<G[H'4^I
MJK!X.T"VNHKF'3U66&9YX3YCXB=\[B@SA0=QX&!STKG?#WC!K/25.IQZE=W%
MUK%[9VZ^6K2 H\A6-L$ ':A''''IS6Z?&-FDL*365_")+B"U9Y8@HBFE561&
M&[.?F4$@$ G&>#@ M0>%]'MH[-(K1E6RF:>W'G2?NY&SN8?-WW-_WT?4U!<>
M$].$ ^P0K:W$=X+^)QD@39)/!/"MN<$#'WV(Y.:BE\:6$,4TDEK>*(-13390
M50%)6V[2?F^Z=ZX/O4VH>*[339UBFM+U]]ZMBC11A@\I3>,8/3'&?4$=J +A
MT.PFNC>36Y-P\B32+YSF,R( %;;G:2-JX.,_*#VHTS2A9WE_J$I5KR^=6E*]
M%55VH@]@,G/<LQXS@&B:W!KEK/+##/ ]O.]M-#.H#QR+U!P2#P0<@D8-<A>>
M(YEU+Q%?W_\ :MK9Z!<1,!:M&0\8B1W1TW$-NWGGL ,%3F@#LK[1K#4;F"YN
M(6^T0!ECFBE:-U5NJ[E(.#@<=.!3&T#2VGL)A:A'T]2MIY;L@A!&"  0.G'T
MJI'XGAEF6W33=0^V/YC1VS1HDCQIMS(-S !<NH&2#D].#BNGC?3)UTS[)!>W
M3:B)?(2*( AXL[T;<1M8$$<\9[XYH W;ZQM=3L)[&]A6:VG0QRQMT93U%4/^
M$7TC?*_V5MTUM]DD/GR9:+D[3\WJ2?7))[FJ%CXXT^_;32EG?Q0ZA,]M'-+$
M%1)UW[HF^;.[]VPR 5R,9JUKVOS:/J.BVD5A+<_VC=- 61E&S$;O_$PY.SZ8
MSWP" -NO!GAZ]:R:XTU)&LHA# Q=P1&/X"0?F7_9;(K<>-7B,9R%(Q\K%2/H
M1R*X?0O%3V=U?6NIF_N4?79;&&Z9%,<1) C0G(.">!@$#/.,UL2^-=(BU2WL
M6=SY]V;))E*%//&1L(W;ARI7.W&1UH D@\&:!;VL%HE@6M('#Q6TL\DD2,#D
M$(S%<YYZ=:MW/A[2KR]ENY[0--,BI-AV59E7[HD4'#@?[0/I2ZIK,>F20Q&V
MN;F:99'5(%'W4 +$EB%'4=^<_6J0\7Z?-86]W90W5Z)[(7ZQ6Z#>(".&(8CD
M] .I(.!P: -!-&L8K^[ODB=;F\18YY!*X+JN=HZ\8R<8Z9-0#PUI"Z+#I LQ
M]A@96ACWMF(J<J4;.Y2#T((Q5:Y\6V,$$D\5M>W4<,,<\_D0Y:%).5+*2&SC
M)*@$@#D<C*W_ (MT_3EO99([B2UL)%CO+F-04MV(!^;G<<!E)V@X!YZ' !I1
M:58PV<]HL ,-QN\\.Q<R[A@EF))8XP.3T ':B#2K"VGMYX;6*.6WM_LL3*,%
M(L@[![?*/RK*O?&&GV,.L2RPW)723']IV*IRK@,K+\W(P?K[5%J?CC3]*N-3
MBFLM0D&F+')=R1P@K'&X)#Y+#(&#G'/H#S0!=A\*:';ZS-J\.GI'?3,7>1&8
M L1@OMSM#$?Q 9YZU=TS2[/1[);.PB,-NK,P3>S8+')ZD]22?QKGM1\;#3+_
M ,0I<:?+]DT>QCNS,&3]X6$AQ][/.P <=<YP,5H)J[:9!86U\);K5;R)YC##
MM&2H4N$#,!@;E &<]^>30!JW5C:WKV[W,"2M;2B:$L,[' (##WPQ_.H?['T_
M['>6BVRI!>.[W"H2OF,_WB2.<FLR;6FL_$6D0N7^R:S&XC608:*5$W@?1D#9
M'8J,=35/Q)JUWI?C#0!#]MG@GANO,LK903*RJA4\XY&X]2!0!KCPUI >S=;3
M#V<!MX'$CADC./ESG)' QGH0",46OAG2+(Z>;>T*?V<C1V@$KD1*W! !/0C
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M&ZDJRG!(R".H)'<&O.)?%E[9>%_$%Z_B&Y&J66J75K9Q/$C))LE*QQL-G0\
MG(/?- 'ID.D65O?WE]%$Z7-X%$\@E?Y]HP.^!@=,8Q55/"NC16=E:Q69CCL2
M3:F.9U>'/4*X;< >XS@U'/XDCM$>.2TN+B[M[1+J\BM K^0K9]6&<[7P!DG;
MTZ9KOXVT]KVWM;.UO[]KBUCO(GM(0RM"[!0V21TSD^U &B/#^EB:PE6U"O8;
MC;%'9?++?>. >2<G).<Y.:MWUE;ZC8SV5W'YEO.ACE3<1N4\$9'."*P+/QSI
M][:"Z6RU&.W9_*BDEA $LOFF(1K\W+;A],<DC!P^Z\:Z?96^H/<6UY'+I\D2
M74!5-\2R?<D^]M*'U!.,'.,' !H)X=TI+A9_LNZ1;7['^\D9P8?[A!)!'UI;
M+P_I>GQF.WM?D\GR ))&DVQ?W%W$[5_V1@<#TJLWBBT6[U6U^S71GTSRO-3"
M9D\S[FSYN<^^.>.M07?C;2++4([65GP]TMFTJE"J3-T4C=NZD#(! /?K0!<M
M?#&CV;6#6]H4.GJRVN)7/EAA@CD\\ #G/  Z"FZ=X4T+29[B:QTV*%KC<)%!
M)7#'+!5)PH)Z@  TS1O%%OKEY-!:V&H(D,DT4D\L(6-9(WV,F<]<\CC& ?2M
MR@#)T7PQHWAT2#2K%+82=0&9L#KA=Q.U?88%6;S2+"_O+2[NK=9+BS9F@DR0
M4SC/0\@X'!XX'I5VB@#,M/#VE6%P)K:T$;+(\J)O8I&[9W,B$[5)R<E0.I]3
M5G4=.M-6L);&^@6:VE #H21G!!'(Y!! .1Z5:HH QY/"NC2K>J]F2M["MO<C
MSGQ+&H("GYNF"?S/J:9=>$-!O;^WOKG3DDNK>,1)(7;+(.BOS\X'HV:VZ* &
M31)/"\4F[8XP=K%3CZCD5C6_@_0K:"UMTL2UO:,&MX)9I)(HB.A5&8J".W'%
M;E% &9-X>TJXOI;R2T!FFV&;#L%F*?=+H#M<CL6!Z4]=#T]+F_N%A<37X"W+
M"5_W@ P._&!QQBM"B@#*/AS23I-KI9M/]$M"K6R"1@T)7[I1L[E(Z#!X'%3C
M1[ :;<:?]F5K6Y#B=&)8R[QAMQ)R21W)S5ZB@"K%IME#>+=Q6T:7"P"W615P
M1&#D*/;-9]MX3T.RU6XU.VT](;RX+-)(CL!N889@N<*QYRP /)YK:HH RH?#
M>DV^G6FGQ6FVTM)EG@C\QR(W4Y!'.>#VZ5>O;.WU"SFL[N)9K>92DD;=&4]0
M:GHH SK70]/L[M;J.*1YU0QH\\[RE%.,A=[':#@9QC.!Z54L?!^@:=/;3VNG
M*DEKO$!,CMY0?&Y5!) 7CA>@[ 9K<HH PK/P9X>L+>[M[334AANT:.5%=\;&
MY95Y^13W"X!JW;:#IMI>6]W! RSV]O\ 98G,KG;%P=N"<8X'Y"M*B@"G>:9:
MW\L,LZR>9"&$;Q3/&P#8R,J1P<#\JH7/A'0;OR?-TZ/;%;?9$5&9%\G^X0I
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M<$;E.#D'G&.XTAX<U=8O%?D7\-K<:P_F6T\18M PA2($\#^X#D'C/MFNKHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHJG/?^3,T?EYQWW4
M 7**S_[3_P"F/_CW_P!:C^T_^F/_ (]_]:@#0HK/_M/_ *8_^/?_ %J/[3_Z
M8_\ CW_UJ -"BL_^T_\ IC_X]_\ 6H_M/_IC_P"/?_6H T**S_[3_P"F/_CW
M_P!:C^T_^F/_ (]_]:@#0HK/_M/_ *8_^/?_ %J/[3_Z8_\ CW_UJ -"BL_^
MT_\ IC_X]_\ 6H_M/_IC_P"/?_6H T**S_[3_P"F/_CW_P!:C^T_^F/_ (]_
M]:@#0HK/_M/_ *8_^/?_ %J/[3_Z8_\ CW_UJ -"BL_^T_\ IC_X]_\ 6H_M
M/_IC_P"/?_6H T**S_[3_P"F/_CW_P!:C^T_^F/_ (]_]:@#0HK/_M/_ *8_
M^/?_ %J/[3_Z8_\ CW_UJ -"BL_^T_\ IC_X]_\ 6H_M/_IC_P"/?_6H T**
MS_[3_P"F/_CW_P!:C^T_^F/_ (]_]:@#0HK/_M/_ *8_^/?_ %J/[3_Z8_\
MCW_UJ -"BL_^T_\ IC_X]_\ 6H_M/_IC_P"/?_6H T**S_[3_P"F/_CW_P!:
MC^T_^F/_ (]_]:@#0HK/_M/_ *8_^/?_ %J/[3_Z8_\ CW_UJ -"BL_^T_\
MIC_X]_\ 6H_M/_IC_P"/?_6H T**S_[3_P"F/_CW_P!:C^T_^F/_ (]_]:@#
M0HK/_M/_ *8_^/?_ %J/[3_Z8_\ CW_UJ -"BL_^T_\ IC_X]_\ 6H_M/_IC
M_P"/?_6H T**S_[3_P"F/_CW_P!:C^T_^F/_ (]_]:@#0HK/_M/_ *8_^/?_
M %J/[3_Z8_\ CW_UJ -"BL_^T_\ IC_X]_\ 6H_M/_IC_P"/?_6H T**S_[3
M_P"F/_CW_P!:C^T_^F/_ (]_]:@#0HK/_M/_ *8_^/?_ %J/[3_Z8_\ CW_U
MJ -"BL_^T_\ IC_X]_\ 6H_M/_IC_P"/?_6H T**S_[3_P"F/_CW_P!:C^T_
M^F/_ (]_]:@#0HK/_M/_ *8_^/?_ %J/[3_Z8_\ CW_UJ -"BL_^T_\ IC_X
M]_\ 6H_M/_IC_P"/?_6H T**S_[3_P"F/_CW_P!:C^T_^F/_ (]_]:@#0HK/
M_M/_ *8_^/?_ %J/[3_Z8_\ CW_UJ -"BL_^T_\ IC_X]_\ 6H_M/_IC_P"/
M?_6H T**S_[3_P"F/_CW_P!:C^T_^F/_ (]_]:@#0HK/_M/_ *8_^/?_ %J/
M[3_Z8_\ CW_UJ -"BL_^T_\ IC_X]_\ 6H_M/_IC_P"/?_6H T**S_[3_P"F
M/_CW_P!:C^T_^F/_ (]_]:@#0HK/_M/_ *8_^/?_ %J/[3_Z8_\ CW_UJ -"
MBL_^T_\ IC_X]_\ 6H_M/_IC_P"/?_6H T**S_[3_P"F/_CW_P!:C^T_^F/_
M (]_]:@#0HK/_M/_ *8_^/?_ %J/[3_Z8_\ CW_UJ -"BL_^T_\ IC_X]_\
M6H_M/_IC_P"/?_6H T**S_[3_P"F/_CW_P!:C^T_^F/_ (]_]:@#0HK/_M/_
M *8_^/?_ %J/[3_Z8_\ CW_UJ -"BL_^T_\ IC_X]_\ 6H_M/_IC_P"/?_6H
M T**S_[3_P"F/_CW_P!:C^T_^F/_ (]_]:@#0HK/_M/_ *8_^/?_ %J/[3_Z
M8_\ CW_UJ -"BL_^T_\ IC_X]_\ 6H_M/_IC_P"/?_6H T**S_[3_P"F/_CW
M_P!:C^T_^F/_ (]_]:@#0HK/_M/_ *8_^/?_ %JO1OYD:OC&X XH =1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5S'B73Y]4CEM(
M;^XL1(0))K8@2A<=%8YVG..<=,_6NGKC_&<.MW.GW5OX?EM8;Z7"":Y=E6-2
M.2-H)W>GY]J /+K'6]?\,^!_&=S)J5Q?P:?=FVTV[N3O<G?L8Y/4 E?;(-;'
MAW6KRR\?:;HDEU<3VM_H45VPGE:0B?G+ L21D Y XS5JT\'^(-2\)ZGH'B*Y
MTN.VEMTALTTU&VQ$$MN;< 2<A/U]:ETWP?JD.LC6YY+2/4+71ETVS569T\P
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M8W\)&W /ONX]^USP+X=\1>%+0Z)<2Z?/I,$KO;W"L_G%&).TIC .23G)^AH
MYJ;QQ=:Y\--6UB_CU&PMOM>Q+C3Y4$D:[U 5<D$GID\9W''I787?C:SL)YK*
M&WN;V:RT\7]T0R@QQ  \Y(RY'./UKEA\.=>C^&VH^$DGTTM-=>;#.TK@%=ZM
M\PV<'Y<8&>O7CG2O/!&J)J6JWUDUHTFK:0+"=))6 BD"! X.WYEP.F >/?@
MU9_B!8+?Z-:V=E=7QUB!IK1H=@#  D@[F&#Q6EX5\36OBS1%U*UAEA'F-$\4
MN-R,IY''![5R]KX O],UKPC/9S6LMIH=O)%*99&5Y6<$$J I &3GDUK?#WPU
MJ'A30)[#47MGD>ZDG5K=V88;'!W*.>* .MHHHH **** "BBB@ HHHH ****
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MD $DX JO9WUIJ-L+BRN8KF LRB2%PRDJ2",CT((_"@"3R(?^>2?]\BCR(?\
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MJQ+-;NLSJ$+##< @'(XY!I+C0=/NM3;4I8Y?M;6S6I=9W7]T3DK@''7G.,T
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MQD=JBC\%:#%=1W,=K,LD5T]W%BZE"QRONWE5W84-N;( P<\B@#GM'\3Z]/\
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MC]B2'R%B=V?]WC&W)))&..M '):%JVHW/]CZ"E[LG;0X[][IH@S,20JK@G!
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MV9V0,?D9%"J#QU?)]A[Y&?;:OK-]J[:"US9V^HVNFQW,\T*&2.29G=,*&YV
MQG/?D#(QSLZUX;TS7VMGOX9#-:L6@F@G>&2/(PV'0A@".HSS22^&M+EFMIE@
M>":VA-O');S/$WE'JA*D$C(SSWYZT <GI>M2>(O$/@?5IH!!-<Z=?F2,'(5@
M8 <>V0<>V*K^%=8N;;0M#T:S5UFO6U&;S$"%@([@C"AR!D^8#WX4\<Y';#P[
MI:W=A<QVQCDT^%H+412,BQ1L "H4''\*]1V%49? WA^;2[;3S:3+#:S-/;NE
MU*LL+L26*R!MPR2<C..: ,VSUGQ!?W2:'.]G9:Q'IK7<KQCS$>3S6C0 9.%^
M3+#DC< #QDMMKK69/&]W%+J$&(]#@G\E(]\(E9I0Q7D$C* ^I&!Q6Q>>#=#O
MA9&2UE1[)2D,L%S)%(%/WE+JP9@3R<DY/-6G\.Z6]^E\+=H[A+;[(#%*\8\H
M9PNU2 <9.#C(SQ0!R6D^(==U6/PG!!<65K_:VC27<K"U+>7(@B^Z-P&/WAX[
M8[U+I_BW4;_2_#4MT\-DFI6\[7-X$^1)8P-J@-P-WS-S_=P.3FNBM/">CV+:
M>UM!-&=/MVMK7%S(?+C;&5&6Y^ZO7T'I7/ZKX-,,FEV^F:<\NF64,L<:1:K/
M;3Q,[*20X.67Y>A/7U[ &_X:O]4O?"EIJ&M1PV]]+#YLD8C:)8_0$,21QR<_
ME7/:7XJUF2\:%DCOF?1&U&(11[$EF5@-L1/S&,Y&"PSWR0:Z?1M*DL]%-C>R
M27"ON!2:=IRJ-_ 9'^9Q[GUK)N/ ^GVFFR_V-!LOTL9+*U:ZNIG148<(<L?E
M&!@8..PH R8_&&K0VL^J;H;W3;?0SJ5P5@*LLX!/DA@<+TS@@L,<]14FM:[X
MHTG0]7U-#:M;1:8;NWEF12WFKRP"HYRA!!!)R#USFK/A_P +36TZ&:VNK.U$
M;136L^L37L<RE2NW8_R@<YSP>,8P36A;^!/#UMI5UI<=I.;.YC\IXGNY6VQ_
MW%);*+[+@4 <_P"(]<UVSLO%EBU_$)+;0QJ-M/!!L:(GS04Y)S_JQ@]>3[5H
MZ3<7%SX\6RNIO-33]'BFC)7 :29V!;'J%C"@^[>IK;F\+Z3<SW4T]O)*]U9_
M89_,GD8/!S\I!;'\3<]>3S4</AZ+3M5L[_3]P,5L;.599&<R1;MP.YB264YQ
MD\AF]J ,OP_X@N-4UF;2M5W6]V(9&EL)X,!UW@*\3CB2/!P>2<D9QTJQX$O)
M[OPW+!*Y9[&]N;%)&Y+)%*R(3Z_* /?%:,&@VFF[)[&%GN8(6AMOM$[N(E8@
ME06)P,JN<=E [5/H>DQ:'I$-A$Q?86>20C!DD9BSL?JS$_C0!Q/AK7]3&FZ#
M8SWQENM7O[Y#<O&,QK$\K' Z%CM '8#/'&*Z?PQJ]YJ+ZO9WRH;C3+YK4S1K
MM65=BNK8[':X!'J/?%/'A#1%MA;I:R(BW1NXRL\F89222T9W93EFX7 ^8\<F
MM.QL+;3H6BMHRH=S(Y+%F=CU9B>2?K[4 <[I6LZGK%M#K,%Q:I8"\GAGM9%.
MY8XW>,;6'/F%E4X/&&QU&30LO%FI2Z?X7UIC%)9ZY<+ ]LJ<P>8K,A5NY7;A
ML]<DC&,5T%KX4T:RUF;5;:V>.XFD,SJ)W\HR$8,GEYV!S_>QG\Z?9>&=)T^:
M-[:V9%BD>6&(RL8X7;.XHA.U2=S=!QN.,9- '!(!_8D/_8[M_P"EC5T=KKNM
MZK=BZT^*+['#JDME<QRE HB21HRP;=N\S(# 8P0<8[G5'A#11;+;BWF\M;W[
M>!]JE_U^[=OSNS]XYQTSVI8_"6BQ:[+K$=JZ7<KB20+.XB>0# <QYV%O]HC/
M?K0!FZ'JNKZ_IVG:S;WEI%97R2[X63YX>OE[#_$P(^8'CKC&,5/\/KB[N_ 6
MCWE]=-<3W%LLK2, #DC)SZ\YYJYIOA/1M)U"6]LK9XI)':3R_/<Q([?>9(R=
MJDY.2 .I]:MZ3HUAH>G+8:?"T=JN=L;2,X4'L-Q.!Z#H* .2T_Q1J\^J6UN9
M[69+S3+F[29(281)&Z >6<AG3$G4XS@$'!IN@^(=>OY?#@NKNU(US1WNAY=N
M1Y$JK$<_>.X'S#D<=!6Y:^!M LC;FWM9T-M%)!#_ *9,?+C?&Y!EN%X&!T&,
MC%2KX9T_3HK*;3K1FN=+M7@L(WNY JJ0/D))/!VJ,D'&!Z4 9OAOQ!J.L?8K
M.=XTU&U>9-714X1D.T!?3<2K*><J#WIWBWQ%=Z%>1[R]KIS09^WB#S8HIMV
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MS%H/,8GT&U@!CN"3D<5I^/?^25ZI_P!>2_\ LM:6H>#-$U2XN9KFWFWW=O\
M9KGR[J6,3Q@$ 2!6 8@$@$Y-:5SI-C>:.^DW,/FV3Q>4T;NQROINSG\<YH Y
M:XU'Q7!K6IZ)'=6-Q=OIIO["86Q14</M,3KN.021AL@]>N*TO#>OOXC-O=VL
MG^AK9H9U9!N%PW5">Q4 [A_M+5R33GTFTN+K2+,7NI,J(/M=V^9%!^Z9&#$
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MY/X"M[4O%6F:5*ZW+R"**:.">=5RD#OC:&YSSN7D @;AG%<_JGA+6]1MO%2
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MDZM<0[=*ETI[R2\CN60FZCWN9&CQMP?F) ;=D#MFNRH **** "BBB@ HHHH
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M."V3G'!Z9KS]KNQTMM:L&9AIZ>(H$B4RGR(5:"-B9.O[K>'RO +<9')J&TO
M=%TN"6;/V;Q<R*&5D"1B60J &^ZH!&!V!% 'HVDZU'JUUJMNMO+"^G7?V5_,
M(^<[$?<,$\8<5<O)YK>.-H+1[EFE1&5&5=BD@%SN(X YP.3CBN;\(R(VO^,
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M.[(6=Q@;A@D+CY!T)'-5_#)^RP>"+JUE9M0N;6[BG,DS$R$1DHKY/]\#'O\
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M.L4;1S>'[:4Y0?,?+N2"??@?D*UD\1ZA%IZV.C6(N[JQTVWF:)E)\YG4XC#
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M=9TFO:9%?Q64ET%FED,*95MC2 9V!\;=V ?ESGCI6C0 4444 %%%% !1110
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M5#1]<L->MY9].DDDBBE:%V>%X\.IPP^8#.""*T: /.T\*:N8M3M;-)K&RO\
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MFP%N98R999MO<,1L7;U)!^;IQ5G1](U*W\2Z/=S631P6^A_8I7,B';+NC.,
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MG2>&QMHY4C$22)$H94'100.![=* .)2XO9K6\N=(\4VD\=W91FWB>9I )2X
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M$N[K(Q92 A&.N<9&9&UO^U]3U>SN==;2I;2VMIK22.0*"&7<\FW.)/F!0@Y
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MC<WJ?SI** %W-ZG\Z-S>I_.DHH 7<WJ?SHW-ZG\Z2B@!=S>I_.C<WJ?SI**
M%W-ZG\Z-S>I_.DHH 7<WJ?SHW-ZG\Z2B@!=S>I_.C<WJ?SI** %W-ZG\Z-S>
MI_.DHH 7<WJ?SHW-ZG\Z2B@!=S>I_.C<WJ?SI** %W-ZG\Z-S>I_.DHH 7<W
MJ?SHW-ZG\Z2B@!=S>I_.C<WJ?SI** %W-ZG\Z-S>I_.DHH 7<WJ?SHW-ZG\Z
M2B@!=S>I_.C<WJ?SI** %W-ZG\Z-S>I_.DHH 7<WJ?SHW-ZG\Z2B@!=S>I_.
MC<WJ?SI** %W-ZG\Z-S>I_.DHH 7<WJ?SHW-ZG\Z2B@!=S>I_.C<WJ?SI**
M%W-ZG\Z-S>I_.DHH 7<WJ?SHW-ZG\Z2B@!=S>I_.C<WJ?SI** %W-ZG\Z-S>
MI_.DHH 7<WJ?SHW-ZG\Z2B@!=S>I_.C<WJ?SI** %W-ZG\Z-S>I_.DHH 7<W
MJ?SHW-ZG\Z2B@!=S>I_.C<WJ?SI** %W-ZG\ZV[?_CWC_P!T?RK#K<M_^/:+
M_<'\J )**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MY-'N]H\4+J&9)(W)AVC+G#'D'J/7IF@#J-6\4HMEI=[HUS9WEO=:G#92N#O
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M93)PS']<YJ#6_$?B#PH\UP=0?4X;C19+T)+"@%K*C1KN&P F/$F<$D_+UZT
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M3O8?]^T'X5H^'-:U";Q!_9VL-<Q73V\LT0PCVMW&'7$D+J,C 8 JW/S \]:
M.R5@ZAE(*D9!!X(I:Y7X?3R2>';BW<DQV6HW=I 3_P \HYF5!] ,+^%)XIU2
M[T/6=,NY+Z:+2+E9;6=(T0E)BI:)P2I.3M9<="67B@#IKFYBL[66YG;;%$I=
MVP3@#J<#FFV5Y!J%C;WMK)YEO<1++$^"-R,,@X//0BN%T35M5U;0;FVU&ZD^
MWZ7;7,.J+M0"2;D)T7H5!?Y<?>7K6=HVLZIX>T;0V2ZEO;>3PG)>K9LB +)!
M'"5"$ -R'(.2: /4J:[K'&SMG:H).!G@5QEAJVI1ZKX5/VYKZUUJT=YPR*!&
MPB$@D3:!A3G;@YZKWZ]7J32)IET\,K12K"S)(H!*D X.""/S% $EI=0WUG!=
MV[%H9XUDC+*5)4C(X(!'T-*US$EU';%OWTB,ZK@\JI4$_P#CR_G7G4GB;6H/
M"VB:M<S7364NC07%[=V2QM);2NH)FDB(^:,\_=Z8;CIC=U:_,=OJ>JQ7OV4^
M;!86LPC$A;]XH8(#QN9G*<\ H">!0!UM%>:S:_KHL[Z)=0E@EMO$EM8(S)&[
M>3)Y)*-\N"1YC<CGW/6KL]SKTFHZGH%EKBI>:=:131W5VT:-)O+GS'41D,@P
M%.-O0]R" #O:*CMW:2VB=RA9D!)3.W..V>U>>W&M:U96WB[5VU>:2+1KR2*&
MV:&/84,$3 N0NXA"Y;@CH<YH [O5-4L]&TV?4-0F\FU@7=))M+;1ZX )JV#D
M CH:\W\5C55\%^*3=ZG;W=A/I)EMD$@DD4X.YMRHH*,",=><XXZ6?$^OZC8S
MWTNGZ@[?89K%'A6-!'%YDBAE<G)=F5P1C&T8Y!Z@'?Y&<9Y]**\TN=7N]#U'
MQC?"_E94U.RME,[+Y<"2I &?.TX"AVQU'<@\U?O=4US1;J&RN]3@>+4M3M[>
M"56#RVL;HY8,=BJ=S1D*2#][O@4 =A9ZI9ZA<7EO:S;Y;.40W"[2-CE0P'(Y
MX(/'K5PD#J<5R'A"%X/$WC&)YY)V&HP_/)C=@VT1 . .@X_"G>.1.S^'%AO)
M[<2:Q#&_E%?F&UR,Y!S@J#Z?I0!UM%>=WOB75FT#7-<M;IQ/I6JM:I8[%*2Q
MI(J;6XSN<'<"".67''7T2@ HK@;/Q!J,GBC1A'J#75A?WM] S&-$C98PY4(/
MO?*4VEB?F.3@@@COJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** ,I-$@BO=0=55K74</=0,.#
M)M"%A]5501[ ^N71>'M)@>%XK"%&A@-M$5&"D1_@'HO3CIP/2JW_  DJ27:I
M;6%W<VWVTV+W$*!E209#$C.=@8;2W8^W-0+XRLC]BN#;S#3KV[-G!>?*4:7<
M5&1G(5F4@'')QT!!H LW'A'P]=V=I:7&C64MO9G_ $>-X@1%GJ%]![=*O'2K
M W_VXVD7VKRO(\W;SY?]S_=]NE<S+\08X;#4-0;0=4^Q6$LL,\P\KB2.01E<
M;\GDYR,C ]>*L_\ "<V=O<:E;:G87NGSV4*7"Q3!&,\;ML4IM8C)?"X)&"10
M!I67A;0=-DBDL](LX7B1DC98AE5;&0/0' _ 8IMIX3\/V$T<MII%I#)$'6-T
MC ,8;[P4_P (..U4=0\:V^E)JBWVGW4=SI]E]O:!2C&6#D%D.[!P1@@X([9R
M*+CQ@]K:RW$^AZA"D<4MQNE,:JT2!#D-N(#-OPJD@_*V<8H TX/#FCVWV3R-
M/@B^QAA;;!CR0WWMOIGOCK6%KO@J&[^PQ6.G:1+86QE8V-W&RIO<@^8K+DJ>
M&XQ@[B>M3#QB'U^.$6Q72CI']IM=,P!"$C!(SD  '/4Y/MS<TGQ9:ZKJ_P#9
MR02)(UM]JC?>CHR9 ()4G:XR/E/8\9YP 6O#VC)H6FFUC"(K2&3RHBWEQ9 &
MU-Q) XS]23@9Q5FZTNQO;NWN[FV22XMB3!(WWHR1@E3VR.#7.>)[^\L/&/AP
MVD=Y<^:ET&LX)0HF*HI7(9@O&2<G_"K6G^-+/4X+1;6UN/M]Q)-$;*7:KQ/"
M<2!SG "DJ,C.=PH UET33$OVOELH1<N_F,X7J^,;R.F['&[KCO4EEIEEIS7#
M6=M'";B0RS%!CS'/5CZGWKGCX\M6BLOL^F7\]Q=74UE]G41AXIXE9FC;+  _
M(<$9'?-*/',:W-['<:/J%M'IRJ]_-*8MMLK1>;DX<EN./ER<_AD Z2]LK74;
M.6SO8([BVE7;)%(NY6'N*I'PWHS"X!TVWQ<0B"8!<"2,=$([J,GCIR?6J1\5
MK'=I:3:9=QW4]H]W:1$H3<*F-R#YL!QN7@G'/!/.([#QK8W]UI4*02QKJ=@U
M_!+(R!=B[=RGYLAAN&1C'7G@T 7KKPMH-[<6=Q=:1:336:A;>22(,8U'0 GL
M.PK7KEKWQS9V5F9GM)S+':I>36V^,2I&V< *6^9\*3M'IZD S6WBU;[7)-,L
M]*OIA%Y#2W'[M42.5697Y;./EZ8S[4 1Z!X6%A>:G=:A!;22W.HO>Q&-V8+D
M#&00!N&.#[UH3^%M!NKN:ZN-(LY9YG621WB!+LN-I/N,#\AZ5'XGO[>PLK-K
ME+TQRW]M"&M)=A5FE4+N.02F2 1SD'I6?<^.8+:>^5]*O_(L+Z.RNI_W>V,R
M;-K8W9*_O%Z#([B@"WK7AJ&Y\.:YI^E06]O<ZK!)')(Q*AG="N]L Y('\@*N
M:7HEI8V"Q-:0"1H%AFQEPR@8V L/N<G"X Y/%7+^Y:RL+BZ2WEN&AC+^3%C>
M^!G"Y(&?QK"L_&MA>7=C L,B)>Z:=2AF=T"&,8R/O9W#<,\8Z\\4 :</A[2(
M+.6TCT^ 6\L8B>,KD&,=$Y_A&3A>@S23^'='NM/GL+G3H)[:X(:9)EW[R, $
MDY)(P,'M@8KD[CQ)=V'BV[O?L.I36_\ 8,5Z]AYJ_N3YDFYL,VT-M4# .21]
M36QJ?C:STRQ^WM:74EBMM#=/<;0J[)"0H7<1N8 $E1T&/4"@#>L+"TTNRCL[
M"VBMK:(82*)0JCN>/KS3;[2['4FA:[MDE>!BT3GAHR1@[6'(R.#CK6"WBYK7
M7M?M[VU,-AI<,#^<'4EB^[MGN0H _,C-17'CZTM;75)Y+"Y?^S5CDF\AHY%,
M3_QJP;!"X.X9R,9Y% &_)HFF2M9E[&'-E_QZX7'D\8^3'W>...U7ZQK_ ,26
MNG/,)T8)'Y2B0.NUY)#A4!)X/<YP "#FLH^/K18QC3;R2;^T%T\I"8V!D9=R
MLK;@&4CN.ASG% &R?#6B&1I/[+M0[7'VHLL8!,W_ #TX_BY//N?6E?PYHTD<
MR/IT#)-.+F4%>'E&,.?5A@<]>!Z5:M;QI=-CO+NWDLB8]\D4S*6BXY!*DCCV
M-9$7BM985N?[)U$VDMD]]!-'#O$B* =N!RKL""JGD^Q!% &G%HVG0WANH[2-
M9O,,N[_;(P7QTW$$C/7!Q5JXMX;NVEMKB)98)D,<D;C(92,$$>A%<O<^/+2R
MM=8EN+"Z$NE1PRW$,91F"RYV_P 74$$$=1CC-2IXTC%YJ-E<Z/J4%[:0+<I;
M%%=[B)FVADV,1][@@XQWH U'\/:1+8SV4MA#+;W&T2I(-V_;]W)//&./3M3%
M\,:$L-S"ND68CN=GG#R1^\V@!<_3 QZ8S5*'QC92?;(GAD%U:WJ6)@1E;S)7
M564*P.,8;G.,;6STJ#4/$$;06GVW3]5M'&KPV8"-Y8+EAM;=N&^(Y'3.>01Q
M0!MMHFF/IT^GR6,$EI<?ZZ*1=XEZ<MG[QX')]!Z5#'X9T2+38=.CTRV2SAD$
MT<*IA5<'(;_>!YSUK!_X3B:UMO$%[>Z3<?9-+U#[*6A="539&2[98< N6..@
M]<&MRZN9=0DO=/LS+#<6\*2)=*P*"1LE5(SSC )!&,,/6@ ?PMH,ET]T^CV3
M3O,+AI#""3(/X_K[T-X6T%KQ[MM(LVG><7#.8@291_']??UYIWAK6D\1>&M.
MU=$\O[7 LC)_<;^)?P.1^%46\8V2K;W)@F_LV>\-BEZ-NSS=Y0$C.0A<%0WK
M['- &I;Z)IEK(SPV42DAQTR '.7 !X&X\G'7O6<?!7A^/1K[2[/2;&VMKW'G
M(D VM@Y&1WP>0.@/:ET?Q,=9U&YMH=(OHX;:>6WEN93&$62,CC 8DYSP0"/Z
M3ZYKZZ(I+64\X6WDN7=<*B(FW(+L0-QW#"]\'IB@#4@A6W@CA3.R-0BY.3@#
M'6J%WX<T:^FNI;K3+662[14N&>,$RJO0-ZC@?D/2L:X\=0(S+::3?W>--35
M8_+4-"V?[SCD8/'7TSUJ];>*K2ZU6TLEMYT2\L/M]O<R;5CDC^7('.=PW*2,
M=#0!:N/#FC79N3<Z=!,;F)89S(N[S$4Y4'/4 \CT-,_X1;0?(N81H]EY=T$$
MZ^2N)-F-N?7&!CZ5=TV]_M+3+:]$$D"SQB18Y<;@#R,X)[5S$'BRSL+>XE2R
MU64RZTVGLDDBNR3$@<9? 3T Z>U '7QQI%&L<:*B( JJHP !T %4GT33'OVO
MFLH3<LRL[[?O,OW6(Z$CL3R.U<MKWC"Y?P7K5W8V5S:WUC<_8ID=DW0L=GS
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M;?3;*348]0>VC:\C0QI,1\RJ>J@^AP./850M?"7AZQCNX[71;*%+S_CX6.$
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M9,:QB02-D;LL'P 1D?+Q[UMV^K#4$TRZT_R)K&\4NTK2[652FY=JX^8GN,C
MYJ^MQ"\SPI-&TJ8+H&!9?J.U '$S^ KZ9K^==7MX+J6[MKZU:"SVI!-#&L8&
MTN=R%5QCCJ>:T[_P]JVJ6%BM[JELUW!J$-Z[1VS+'B-@0B+O) ..I)/)]@.C
MAN(+@$P31RA3@[&#8_*HK^>XM[-Y+6V^TS@J$B+[ 22!R<' &<G@\"@#G)+.
MU\-C7)]5N?/TO5[O?]G2SDD</)&L94[-V5.SCY1UZ]*F\/6$WACP7#$RSW5]
MY>[;(0TDDFT!$)'&0H1,],+D]S4=GXHU:[U75+!-$MV?3)H8K@I?$DB15?*
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M@9=H8G+ ]LUW NK<D@7$1(QG#CC)P/S/%!O+54C<W,(20[48N,,?0>M $P
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M_$4 9.@:+/H\NK/-<QS"_OGO%"1E?+W*J[3DG/W1SQUK%U_P9J&LWNIR1ZM
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M^R)).L=K(]N3#>)Y8)"R _++OW?*>PX!SFM2;PEHT]OJ$,D$I2_N$NKC_29
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MNT*3SMZGIT_"L2ZT*2?[!H"Z;;_\(_:""43RW!DD!B;*QA"">JI\Q;ID5T]
M'%1^)M3/B;3K/S;>6UO;V[M"T,9*1B-'9-KG&Y_DPW!4$D9!%1:7XJU6[M/"
MTLIMMVIWUU:7 $1 Q&LY4K\W!_=+GKU-;4/@K0X+N&YBMYUD@NGNX0+J7;'(
M^[?M7=@!MS94#!STHA\%:);W4%Q'!<!K>Z>[@7[5+LBD?=NV+NPH.]L@<'-
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MV[:_+I,D,=NRED#NBN&+G!&T<8/?GTU_!5QJ%TNMR7UY]I*:K<0I\FW:J-M
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M;6TL@B4Q3JL<A8!B,\,@P1@'!QD59M_%FEVEO+--?7URLNJ/9)OM&W)+G_5
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MMVX+;@0&W=#G&1@[>@:3?:5JFN-,;=K2^O3=PLCMO^:-%*LI&!@H>03G/;%
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M*1(I"*0"5YJ1?#-[!XJ&MVRVUB_G2M=-!<.$O8MK",21[=H<'82XR?E/7.
M=C4=Q<16EM+<SN$AB0R2.>BJ!DG\JI:%=7]YHUO/J=O#!>-N$B0LS)PQ *E@
M#@@ C([U9OHY9M/N8H%B:9XF5!,,H6(.-P],]: ,N3Q580)&\\5U"DDD$:,T
M603,VV,Y!/!/'MWQ63XJ\3F#3[@Z==3V]SIVJ6=M=KY0.5DDCRO(.04?/R\\
M_A6<? NHV^G74.FF"V@%Q9W=IIKW3R012PR^8X5RN41P%  ! (SCG FNO">N
M7O\ ;LTAT])K[4+&_A19G*@P"+*,=G&?*(# 'KG Z4 ;MMXRTFZ2Z ^TQ7%M
M/'!):SP-%+OD.(\*V.&['IUZ8-+-KEK-?Z+&;F^M)+FZFB2 P<3-&DFY')!P
M!M+#!&<#&16;?>%9]3N-3O;ZRL+E]06W@DLI96\L0Q%CG>%SOW.2"!QM7GO4
M5IX4UBV?P\'NTN(M,U">X/VBX=Y$A>.1$C#%<N5#]3CICWH DUOQ,[ZEX?72
MY[A;:XU;[)+*L2F*=0LFY0Q&>&0<C .#@FKUEXCL$BNG^V7EVSZH]E%%)"$8
M2[<^4@POR@ G+>_-8-CX2\0V5AH>DYTZ6TT?4Q<Q7)G<22PXD #)L(#C?_>(
M.*M+X;\16Z7/D/8E+C6WOIH/M+H)K=DQL9PF5(8*V "#C!.": -5_&^CI:V,
MX^UR?;I)HH(X[5W<R1!MZ$ <,"C#'<CTYI;3Q%8-?ZK*][>!;>*V:2VN+<QB
M R [0HVAF9C@$<\X ]*P])\(:SITFA*XT[RM,U2\NV\N5UW1S>:%"C9P1YO3
M./EZ\\3ZSX/U+5;SQ'(DUI"+];-[-F+/MDMV+CS%V@;2< X)XS0!M1^+--DE
MN+;]\E[!/';O:.H$F]U+(!SM((!(.<<'TK5LKM+ZU6XC21%+,I61=K JQ4@C
MZ@URLGAZ_P!2T9K;5=%T+$LJ>=:6\CJNU0WSK*$#!]Q4CCC'7G-6=%AUW1#I
M.DSR1W]LWG^?/+,[SPKEFB&2N' &$+'!)P<=: .IK'U?Q+I^BO(ESYS-#;-=
MS"*/=Y<*G#.?8>@R>#QQ6Q7'^+_#VM:]+=V]M)9OI]SIDMJL5Q*Z^3.V<2[0
MI#\$#DC;C(ZT +K&LW5WXHM-!LIKNVBN-/FNA=VT2LVX-$J$;@1M&\D\<G'O
M6+%K][>:=>:G?:SJ>FPV.HO9R>19HRRJ'$:\%6VL6&2>@W$>F-^ST35HO$VE
M:G,MEY5KI3V4JI,Q;>SQME<IR!Y>.<9ST%9TWA/6IO"6LZ5_H N+W5'O8F\]
M]@1IQ+@G9G.!C@4 6KG69[77O%L5YJ-Q'I]EIMO<1M%"KO;;A-O90%);[@/.
M>GI6A/XMTO3;5#/-<2K%:PW,\WEY\N*0E5=\8ZD-PH.,'@"J&H^&]5N[[Q3-
M&+,)JVEQV4&Z9LJZK*"6^3I^][9Z>]9>N>#_ !'JVE7&FF33I+>32X;: 2SR
M!;>=,[F"A,-N^7YC@KC@=<@'1IXKMQKNL6$]O-!!ID44DEPZ_*Q<,>,<]@!W
M)SQTS(OBW3/.N;:3SHKRW>)&MI$P[&4XCV\X(8Y&<\8.<8K%U7PCJNJW'B#,
MUG#'JUK;;9 S,T,\.2!M*X9"<<Y!P",<U*- U/4-%EMM6T7P_F5D26TMV<1R
MJ#DMOV!E;."H X(^]SP =58WB7UMYZ1RQC>Z%)5VL"K%3Q]0>>AZU8KD]'MM
M<\/C2]+9X[ZUDGG\UIKAY)K>'DQ ,5^<#H2V.H S764 %%%% !1110 4444
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M)VR+MX'3YSC&: /2Z*\POM2:]A\5"]GNK*^AM(I]&1G,<JJ8 RE #\SF7<K
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M G<<Y63[V3P>/:H-)O+FT\%>#O%2S75Z+8""^C65I#*DI*!B,_,ZN4//."U
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M('6E(##! (]#2T4 )M7T'Y4A1&4J54@]01UIU% " !1@ #Z4$ D$@$CI2T4
M-,:'&44XX''2EP#V%+10 FU1V'Y4@1 6(506^\0.M.HH 3:N,8&/I1M7^Z/R
MI:* $V+OW[1NQC..<4@1 Q8*H8G)..:=10!5U.S.HZ7=V0D\K[1"T1?;G:&&
M"<?0TS2-/72M)M;$.)/L\21>9LVEPH !(]< 5=HH :$09PJC)R<#J:&C1L;D
M4X.1D=*=10 A1696*@E>A(Z4;5/\(_*EHH ;Y:;@VQ=P& <<BHK6TBM!+Y0.
MZ60R2,>K,0!D_@ /H!4]% "%03D@$T;5]!^5+10   # &*0@'J :6B@! H!R
M /RI!&@! 10"<D8ZTZB@!OEQ^7Y>Q=F,;<<?E3J** ,BST(6OB+4M7:<2-?+
M$IC,>/+\L$*0<^C'/]*UBJDY*@GITI:* $  .0!1M7C@<=.*6B@!H106(4 M
MU..M*J*@PBA1UP!BEHH 0@'&0#CI1M7^Z/RI:* &E$( *J0#D9'0TH
MZ 4M% "%03D@?E1M4'@#\J6B@!HC1<[449SG ]:7:,8P,4M% "$ G) S2!$#
M%@J[B<DXYIU% #=B!BP49)SG'?I2[5_NCUZ4M% #6C1AAD4C.<$4ZBB@!-JY
MSM&>O2@ #H *6B@!%544*JA5'0 8%!4$Y(!I:* &F-&7:44C.<$4N!G.!GUI
M:* &A%#%@HW-U..32[5_NC\J6B@!-J\?*..1Q1M7CY1QTXI:* $*@@@@$'KQ
MUI B@ !0 .@QTIU% !2;5WE]HW$8SCG%+10 T(H8L% 8]3CDTNU?[H_*EHH
M38N_?M&[&,XYQ0%4,6"@,>IQR:6B@!-J^@_*EP,YQS110 FQ=Q;:-Q&"<<XK
M,U;2)-4>!/[0GM[-=PN;:)$VW2G'RL2"0.#]TC()K4HH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH ***Q;Z_NX/%FD64<BBUN8;AI$V<EDV;3G_@1H VJ*YZT;68/%8MI[Y;
MRSEM'FE3R53[*^]1&%(Y(8&3[V3\F<]JZ&@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHKG?$^J:KH\45U:-9^1)<VML$EB9FW2S+&6
MR' P P(&.<'F@#HJS+O6X+.Y>![349&7&6ALI)%.1GA@I!JS#)<P6#R7[P-+
M'O9GB!1"H)P<,3CC&>>N:Y[PGXN;7K.TGN51?ML0> 1PN/F _>H<Y^X2%W'
M))P.* -+_A)+;_GPU;_P73?_ !-'_"26W_/AJW_@NF_^)IC:Q<W?B:YT73_)
M0V5O'/=3S(7 ,A8(BJ".<(Q)SQQP<\6FOKFPT2YO=2B0RVZRNRVX)#JI.T@<
MD$J 3UP2: (/^$DMO^?#5O\ P73?_$T?\));?\^&K?\ @NF_^)JCIOBF-=/%
MYJUU"BR0Q7&([61?LZ.,9D)S@;@V&.!@9Z FM6TUVPOM2N-/MGF>XMF9)O\
M1Y B, I(+E=N<.I SR#D4 0?\));?\^&K?\ @NF_^)H_X22V_P"?#5O_  73
M?_$U0MO$-YJ>C7NLV<VGVMC')-';M> XD\MBA=GW (I93C@X&#WP,[5/&TVG
MW6N#[7I:1:?:PW-NDN=USO5CL#!^I*@ @'[PX- '0?\ "26W_/AJW_@NF_\
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MS22LR, B1.$8 <9)8X';ACSC!KQ>*],@T:*_O-01XV1Y6FBMI% 16*EBIR5
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M_G/F'CM@<FFZOH<L5GK%NIFN6UBY6:W\B#!M9UC0+(S[L!0T2L#C@\<UV%%
M'/IHAT_7M.O[?=)''9/8RYY;EE99#Z\JV?\ ?![&LVW\$W=D;%[75;?S88I(
M)S-8^8LD;2&0%5+_ "NI8X.2.>0:[*B@#G(/#[:9K=SK<3AY9(Y%:"WC,?V@
MDKL\SYMI90-H? .#R<"BS\/W^G^#;+1;'48;>YBC59;AH&D5N[X =2,DGG.0
M/?D='10!S@\.7N^UNSJ-LFH06\MH)(;/9$(7VD*(]Y(*E%(.X]_7AEOX;U'3
MY;"'3]3M(M-L88[>""6R:21$4!6(?S -Q QN*G'IUSTU% '.WWA8:V)O[;GA
MG+VD]DIMH#%B.4KNSEFR1L7'09R<>DL6@W"OJ-W)?AM2O+1+07*1;1&J!]I"
MY/.Z1F//H.U;M% &?]KL]*CBLDANA'#&J((;2610H& ,JI'05CW?A@ZK%K,@
MOVB&IO;SPDVQ5H'BVE"0Q^;E%)! [BNHHH YRX\,2:AI5O;WMY$MW#<K<">S
MM_)4<;755W$@-&74DD_>)[ 4[4O#)U#4;VY,UL8;JSAM&MI[7S$VI(SG/S#.
M0Y'08X.>*Z&B@#C[;P5<V-S;RVFK*0(3;3K=6YGS$)'=!&6?*E!(R@G=QC(.
M*FL?"5U8W]BRZG&]E8WMQ=0PM;'S,3!]R%]^#@R-@[>F <]:ZJB@# FT>9?$
M.HW<+ 1ZG8QV[N5W>5)&9,$C(R")#_WS[U'I_A_4[+0+31CJUL]O;60M59;)
ME9\1[%+?O#]<#&3CD5T=% '+0>$9_P"SM%L+W48Y[;2!$T,<=N8_,DB7$;/E
MVR 0&P,<@<]JM7NBZF]O86^GZE:PPVJC>ES9M-YKC&&.)$Z$9QSSSV%;]% '
M-77A(7DEUYUX#%?FW>^7RL&5X2.5.?E#!5!&#P.,=:FM]*UV+4+FY?6+!Q*&
MVC^SF#+P=BEO-.54G. !GGD9-;]% &)#H#?;I+ZYGB>YG:$W'DPF-'$6XH,%
MB00S9SD\ "KS6+-JS7YE!9;?R(5*_P"K);+GKSG$?'^Q[U=HH Q=&TS5[&XE
MDU#5+2[63+-Y-D869^,%F,C9  P  *:?"UC<:9;6M[OFFA#DS1R/$6>0[I&^
M5AU;G&36Y10!REKX5^Q67A?2(G=[;1F6>2=L_O&6)D4#).,LY;&< +CN*ZNB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
-HHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>exhibit1033-bochk_facili018.jpg
<TEXT>
begin 644 exhibit1033-bochk_facili018.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MY)4MU^7.2/:O7K;Q9HU[JRZ99W,ES<')S#!(\8QUS(%V#\Z -NBBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MP"15Q(9-I?)P>G;..>E<SX?\9>(KOPCX$:XO9<ZWJ$T-_J!4;E"R,$C'&%+
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MP$A<E<;_ # -P&,#C(QT]JVY]1U&'P1J^I/>75K?1Z3-/;Q22JY<I"KB=?\
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MHY-O S\Q.3DY/XT ;E(RJZE64,IX((R#7-_V)XG_ .AN_P#*;%_C1_8GB?\
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M_P IL7^- '2T5S7]B>)_^AN_\IL7^-']B>)_^AN_\IL7^- '2T5S7]B>)_\
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M_8GB?_H;O_*;%_C0!TM%<U_8GB?_ *&[_P IL7^-']B>)_\ H;O_ "FQ?XT
M=+17-?V)XG_Z&[_RFQ?XT?V)XG_Z&[_RFQ?XT =+17-?V)XG_P"AN_\ *;%_
MC1_8GB?_ *&[_P IL7^- '2T5S7]B>)_^AN_\IL7^-']B>)_^AN_\IL7^- '
M2T5S7]B>)_\ H;O_ "FQ?XT?V)XG_P"AN_\ *;%_C0!TM%<U_8GB?_H;O_*;
M%_C1_8GB?_H;O_*;%_C0!TM%<U_8GB?_ *&[_P IL7^-']B>)_\ H;O_ "FQ
M?XT =+17-?V)XG_Z&[_RFQ?XT?V)XG_Z&[_RFQ?XT =+17-?V)XG_P"AN_\
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M$]?#5]&+QTA_<@*QN8PC"14/9@,X([\=P0 >YZ-K%CK^D6VJZ9.)[.Y7='(
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MM9#*7)PB[6D!/$@D^7)YY8=N/0J "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!#A02<
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MQ!H\<L8ESMRL(/./I7.03ZI<>(_"5\D-I+JESH%PS/(Y56YMR"Q"D]SP!WH
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M"K+QQN!((.<8/7@U1?5[SPUKWC+4H+&VE@AN;.2[4RE#AH4#; %.3R3SC]>
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MU=(]A/-<C&P^?+-N\QGRO?<W3&.W2M"?7]*MITAEOH5=O+ YR!YAPF2.!N/
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M2@/0MCG;G..U9&@^)6N-.N9M7F@29-3N;&(0QL/-\N1E&U,L2=JDD#/0GH*
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MBZ+4](GNM0$5N\%_+8!HB72X=&QNBXRP/H,G@]<9K1;Q1H:0VLS:K:JEWO\
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M9Y-X?)<*Y/.X9Z],XS4P\/WUMJ\S6VBK%:?\(^;&)()(]B2%V;RQE@< $#)
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MC:?>VQM[JUM(X98RRMAE4 \J2#SSUK>JCJ.KV>E264=TSJUY<+;0[8V8%SG
M) P.AZT <1!I6OMXBTF]GT5T%EJMW)+Y,T20^5(DH1T0-DD[E+%ANW$]1T-*
MT#6;:Q\*12:5+&]AJUU<W/[V([(Y!.%/#\_ZU>!D\&O1:HW>KV=EJ>GZ?.SB
MXOV=( (V*L50N<MC X4]30!P.GZ1XAM=,\+Z9<:+-))HNIF2>Z2:(I/'LF7S
M%RX;)WJ2" <YZUMZCHVJ+:^';^"'S[FPOC>WEHKJ#(94D63:20"5,A(R1P.M
M=C10!YW?^&]4EN[K4(=.D87FO6=\;7S(P8HH516<Y;&YMI. 3V[YQU_B:PGU
M3PGK&GVJ@W%U8S0Q G +,A Y[<FM.1Q'&TC!B%!)VJ6/X <G\*JZ3JEKK6E6
MVI6+L]K<H)(F92I*GH<'D4 <?'INL3:O]LDT6>-#X>-EAI821+NSMX?T[]/>
MLZST+6]-33!=:!-J5M-HEKIUW;1WB1M!+$'!W?.%>-@YS@D\=.:]%L;Q+^T2
MYCCFC5R0%GB:-Q@D<JP!'2K% &)JMA/_ ,(3=Z;9VBM.=/:VBMX& 4,8RH"E
MB  /<]*Y?0O#>I^&9M'U.PTK+3V,-EJ]B'B#JR)@3(V[;P<A@#\P(/45U_\
MPD%B=42P3SGD:5H/,2)FC64+O*%@, [>>>.V<\5J4 <#I&BZC!JCV&I:";F&
M+4I;ZVU)[L&)5>1I 3'NR)%WE>%QWS45II>O6:19T61HVUV]NI=DD/GI#*9"
MC1L6PN=P#8(;!.*]#HH \XT'0=<TV+PFTVEONTZ>]CN$%Q&Q592VR3);E>1G
M^+VI-&\-ZM_9ZZ-?Z.8[NQCGBM]:>[#IAD95DC3=N5R&&00!UYZ"O0KN[@L+
M.:[NI5BMX$,DDC=%4#))_"J^GZK!J+W,<<5Q%);N$D2>%D/(R",\$$'M^/-
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M*\=.OOP,=;-I6G7%S'<S6%K)/$ L<KPJ60 Y !(R.>:?'86<5Y)>1VD"74H
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M'>7]C/*ZSV$9$Q&US')M#,?0[6)]JZ9M$TEX(('TNR:&W4K#&;="L2GJ%&.
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M7Q"RWMQ%(-&MGB F. Q:X!VJ<C^$'&.N378V>GV6G1&*QM+>VC/)2",(#VZ
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M'IFK3HDL;1R(KHPPRL,@CT(JE8Z'I&ER&33]+LK1R""T%ND9QZ9 H \C\/\
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MP&" ,@CMP15N^\)OJ>M6FHWEU;O):7,=Q!)':[)HPJ@-&)-WW&()((Z,1Z$
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M341 \@C?RF!VJ.N7.& '3Y3DCC+[7PM?0:G:7\NJP2RV^F/I^!:%0VYE;?\
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MQ!X:O-'2Y^S?:8_+,K)YA4?3(R?QJAJ7A-]6U:UOKRZMV:UNHKFWD2VVS1;
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M"R>R^VK>6[6F,^>)5*=<?>SCK4L,\5S"DT$J2Q.,JZ,&5AZ@CK7F'V74M/\
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MD\+@"MBUM8K*UCMH PCC&%W.7/XL223[DYJ:LS4M<M]-N8[8PS7%S)#).L,
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M!@7/@GP]>/9/-89>SA$$+B:16\H=$8ALNO\ LMD5O !0   !P *6B@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@#G-*T.\M/%GB#4[D6KVNJ" (BN691&A7Y@5P<Y]>/>LKQ'
MX3UO6KW4&2YL9());6:S-QOW6_E.C,@ & &*D[ASS@@@ CH_$.M+X?TL7SVS
MSIY\,)",!M\R18P3GL"PZ5JT <II>AZ_I&L7R6]Y8MI%[=F]9F5O/B9L&1%'
MW2I(."3D;CP:I7/A'59M*U>T62S#WNM1ZDA,C85%>)]I^7K^ZQ_P+VY[*VN[
M>[\W[/*L@BD,3E3D!QU'U%,U"\%A8RW)0R,N D8."[D@*H^K$#\: .3U?PAJ
M.J?\)6!-:Q#6+>". [F;8T8(^88'!)[5)JOA2^UW4KN6]EMH8+S1GTZ0P,Q9
M'9MVY01R!TY(S[=*ZFVFN)7N!/:F!8Y2D3%PWFI@'?QTY)&#SQ[U%J^IV^BZ
M1=ZG=EA;VL32OM&20!G ]Z ,"VTGQ%-HT]MJZZ'/*8Q#Y<<3>5<KN&XR9'&5
M!& " 23SQC-N?#5SIO@G6O#]K)SJI>"QM!,TRVJ2(J, S '8OSOT &<#W[#3
M[N]N7N4O-/-H8G 1Q*)$E4@'*G@C'0@@<CC/6KU $5K;I:6D-M'G9%&L:Y]
M,"L_Q/ID^M>%M4TJV:-)KVUDMU>0D*N]2N3@'IG-:M% '$ZIX-OM8NKLS7$%
MO'/HZ6 >-B[1RJY</@J 1G'&>U/O] \2:WX/U32]2ETF.[N[8VZ&U5Q'SU=B
M1G/HH&!SR<\=;/=V]M+;Q32JDEQ)Y<*D\NVTM@?@I/X4VVFN)7N!/:F!8Y2D
M3%PWFI@'?QTY)&#SQ[T <?JOA76YY_$GV&:Q\CQ!9"*=9W<&WF$1BRI"_,I&
M.#@C&?:NOTZ"6UTVUMYF1I8HE1BF=I(&.,U9J.>:.VMY)YG"11J7=CT  R30
M!7U>Q.J:+?Z>)/+-U;R0AR,[=RE<X[]:YZWTJ33O[-U;7I[2WAT*PDB5HI&9
M3E5#2,2HP J?=YZGDX%:>L^(#HOA*;79[&5S#;B:2V5@&7@9!)],UM<$<C@T
M <EX*TN"V.HW]I<--IUQ<-_9P(PL<!.]MG^R9&<CU4)VQ76T44 86KZ/>W?B
M/1=5LY(!]A$\<L<V?F60+RN.XV#@^M8MCX1U2ULM @>2S)TW59[^0K(WSK)Y
MWRCY>H\[_P =]^.WHH Y+POH&MZ"(M-GN=/ETFT+"VE2-OM#Q\[4?/RC;G[P
MZX' YKK:*ANKNWLH1-<RK%&76,,QZLS!5'U)('XT 8?BO1;_ %EM':Q-L#8:
MC'>L)Y&7?L##:,*<9W=?;I69?^$]8U'6]2UQ;^WT[49=*;3K06VYQ&2V[S'<
M@$D'I@#'/4UVM0S7=O;SV\,LJI+<N8X5)Y=@I8@?@I/X4 <%<>!]7N+/Q'$K
M:7;_ -LZ=#:[(C)B*1-X+%B,MD/G)&2?S-[7/"NJZM<:Y(C6<8U+15TQ0TK'
M8V9"6/R\C]Y^GOQVM0W-W;V:QM<2K&))%B3<?O.QP /?- '/^&-!U'P]/<6H
MDMVT>3$L,(D8O;R'F15RN"A;) XQD]N!TU96D:VNK7>K6XMG@;3KO[*V]@=Y
M\M'W#'08<5JT 8/B/PX=<N=,N([CR)+29A*<9\RW=2LD?_ OEY[;0:J:5X3D
MT?2-8LH)TD%T94LU;*K!"Q9ECX!X5I'_  (':NIHH Y#3O#.I65WX6E=[1ET
M?39+*4"1LR,RQC<OR]/W0Z_WO;G4\):1=:%X=ATZ[:%Y8Y)6W0L2I#R,XZ@?
MWL?A6W5*?4!Y=\EB@O+RT3)ME<*2Q7*J6/ )XZ^H- %VN,@\(7IM&TJZEMCI
M_P#:[:GYJ,WF.//,ZQE2,+AL MN.0.@SQV2$LBEEVL1DKG./:EH Y+0- UO1
M;I[(W.GR:,EQ)-!)Y;?:0K,7\L_PX!.-W7'8'D=;110!S'C'PLWBHZ5!(L+6
M=M<M+<*\C*S*8GCPI ."-^X'U45GS>'?%$MCI$[7^GS:QI4CJDDX8Q7<+#:1
M)@95\!3D9Y'3G%;IUZ275YK*QT][J.UN4MKN19 IA9D#Y"G[R@,N<'// .#6
MU0!P6HM?VWCGPG'*]C)?M;7Q>(.8HQGRL!>">,=2.<'IT%JV\'7EA=Z/>6UQ
M;-/;WMW=78<,%8W));9C^Z2  <9 [5V)12P8J"PZ''-.H *Y_P 3Z+J&HR:9
M?Z1<01:CIMP9HEN03%*K(R.C8Y&0W!&<$5;N-:6W\36.BM;.6N[>:=9]PVCR
MR@*XZY^<5?>[MX[N&T>51<3*S1QYY8+C<?H,C\Q0!SEQH6L2:OI.N_:+1]2M
M4FAG@RR0O%)MRJM@D%2BG)!SSTR,5;;P?=V>IZ5>Q26[-#J=UJ-V"S#+3HZ;
M4X/"AQR<9V]L\=G5>XFN(I[9(;4S1R2%97#A?)7:3NP?O<@# ]<]J ./'A+5
METF"T#V7F1Z\VJD^:^"AG,VS[O7YL9]L^U.UOP;?ZS=>(7^TP6XU&"S%NZDL
M8Y;=V=2PP 5+,._0>_';5#<W=O:"+[1*L?FR+%&"?O.>@'O_ (4 <5J'A#6]
M>N]1N=0N;&SDN]-AM5-J7E\N:*5I%?Y@N5R1Q^'O5B_T'Q)K/AJ:ROY-(CNW
MEMV M@ZQXCE60L203D[<8Q@>IK>T76UUB75(Q;/ VGWK6;!V!WD(C[ACH,./
MRK5H XG5_".I:FWB8K-:1'5%M3!EF;8T)!PWRC@X[=*FU/P[KM[JFI7]M>VM
MG<76D+8Q2QLQ,<H=WW=.GSXSG/&?8;^L:U:Z);PO<"226XF6"W@B +S2-T50
M2!V)))  !)-,CU:X6_MK.[TR: W&[9*KJ\8(&=I(.0V,\8QP>: .2G\$:M/9
M>)H5;2[<:U816XCBWXB=59222,L,-G.,D^G4][ '6",2!0X4!@IR,^QP*DHH
M I:S8'5=#U#3A((S=VTD <C.W<I7..^,USR>%;N_2R.J/;Q-8Z;+8PBW=G#&
M155I"2%QP@PO/4\]*V;S6EL_$6F:0UL[&_29UF##:OE@$C'7/S"IX-1_=VBW
M\0LKJZD>..W:0.6*AFX(X/RJ6]J .5TOPIK<5WIDM_/IZQV>CRZ4P@WL6W>7
MAQD#_GGT[9ZFNA\+Z=>:/X8T[3+YX'FL[>.WW09VL$4*#SW.,_CCWJ_:S7$Q
MG\^U-OLE*1Y<-YB#&'XZ9YX//%6* $)"@DD #DDUYOX,TR;7_">A>8]L+&QU
M*:\#QR%G=DEEVKC&%Y8$G)X'3GCTD@$8/(I%54&%4*/88H Y'PWX?U_0K=-,
M>XTV?3;,,MI($99Y$P0B2'! QD?,,DX' YJ&W\)ZG!X1\,Z1YEHTVD7%O+(^
M]@LBQ>GRYR?T]Z[6B@#B-0\):I=V/B*W22S!U34H;R,M(WR+&(@0?EZGR?\
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M]Z[4RQB41&1!(5+!"W) ZG'IR/SHBECGB66&19(W&5=#D$>H(H \VT%7N/\
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MKZ:]BTZ1;*2[_P"/AF"G83P/FZ8R >F><UTHEC,K1"13(H#,@/(!Z$C\#3Z
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M=CDX]GHH \VE^V6</AWQ-IUNUS<W]BFFW2R(<EW4>5*P.#@.,,>ZMGG KO\
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M:]:ZQJMSJPB%P(VNVV2^5(Q*8']]05/X>E 'H][=BQM'N#!/,%*CRX(R[G)
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MKH2S&4?*(RDHR?E)+E2!@'/3B@#MJ*** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** (39VI>9
MS;0EIU"RL4&9 !@!O48]:+6TMK*$0VEO%!$#D)$@5?R%><>)-7U/4O#GBM;J
M*)(].U:""W,$S;L9MVP1@9SO)Y/?&,#-=%_PF3VTNJ6VH:<(;NRGMX4CAF,H
MF\\XCYV @YSD '&.,T =#)IMC-,\LME;/+(%#NT2DL%.5R<<X(!'I36TG36#
MAM/M"';>X,*_,WJ>.3[U3T/6+K5);Z&[TR>R>UD"J[*_ESJ5R&0LJDXY!&."
M.]<_XT(3Q?X0!CN)(YKBX26&!B#*H@9@",@$ @'F@#H['2KN+5)[Z^OUNC\Z
M6D:P",6\3$$KP3N/RJ-W'W>@YS%XGT)_$.G06:W$4*QW<-RWF0^8'\MP^W&X
M<';@URWA[7+JVU7Q<L,5Y)#:/ UKI5W*1-'E<.^6)VQ,<$<D *V .E:$GCTI
M8WTZ:<D[V6I6]@X@N@R.)O+VNC%1G_6C@@=#SWH ZN.QM([1K5+6!;=@0T2Q
M@(<]?EZ<U&-)TT00P#3[00P',48A7;&?51C _"N%\5Z]+?>&M:M[ZV6QNM)U
M*R5S%<ET*O+"P;=A?X6(((XYZUVND:F^KVYO$@C6QD^:UF$NXS1XX?;@;0>W
M)./2@"R=/LC>?;#:0&Z_Y[>6-_3'WL9Z4)86:7CW:6D"W+C#3",!V'NW4U1U
M'63:ZO9Z3:P)/?744DRK)(8T6--H+$@$]74 8[GTK!7QW<7']G0V6C>;>75U
M<V4D$ET$\F>!6+*6VG*G9][T(..U '4#2-,"A1IUH%#^8!Y"\-_>Z=?>L_Q)
MH#:__9B^?#''9WBW3I+!Y@EVJPV_>& =Q]:V(7E:VC>:+RY2@+QJV[:V.0#Q
MGZUR4'CB62>XMY-+1+B+3'U 1+=!F780&BD^7".,C@;N_P"(!U)L+,V1LC:0
M&U(P8#&-A'7&W&*:-,L%\C;8VP^SC$.(E_=#_9XX_"N<TWQ??ZA<6UO_ &+'
M'+>Z4=2LU^V9WXV H_R?(<R+@C=D>G2KFB^)SK=MI$T%HJF^@DFG0RG-ML(5
ME/R\L'.W''0]<4 :KZ5ITGF[]/M6\UMTFZ%3O/J>.32MI6G.9"UA:DR*%<F%
M?F Z \<C@57UG6$TE;-/+\VXO;E;6WC+;0SD%N3@X 56/0]*Y3Q1XKOF\*>*
M;>W@%IJNF*L<VV<D!)%!62-PN3D'T!!!]!D [=;*U22.1;:%7B3RXV$8!1?[
MH/8>U12:3ILMK':R:?:/;QMNCB:%2B'U Q@&HM(TJWTQ)GAM8[5[E_,EBAE9
MHPV ,J" !D 9P!DUP.LZQJFI:?=274$2_8?%-I;0+;SG) FA&TY !SD\D]6/
M  H ]&N=.L;UXWN[*WG:+/EM+$K%,]<9'%31Q1Q1+%&BI&HVJBC  ] *Y>/Q
MFT8OK>]T\1:A;7Z6*P0S-*DC/&LBL&" XV$D_+D;3UK5T'5[G5H;HW6FSV,M
MO.T6)%;;*, AT+*I*G/H,$$4 32:6EOI]S#HZVVG7$JG;-';J0K]F*C&[\Z?
MI=@VGVA26<W%S(YDGG*A?,<]3CL   !S@ #)KDO%A5/B%X60Q7,T4]O>^=#
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MBFR=U)W@#J!R O0# H_X3>Z$[F31E6TBUA=)EE^UY8,S*JNJ[.1EQD$C';-
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MS3KV/4M,M+^)66.YA29 W4!E!&?SJOK&K)I45M^[\V>[N$MH(]VT,[9/)P<
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M@C@>G%9_A_PY:Z)H%IIC16LSQ6R6\LRVX3SPJXRPYSGW)ZUS?B7Q-J\G@_Q
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MEU35DM9[4ZI<>>+>?AHUQW7^$LQ=R/\ ;YYK8.JZ<MC'?&_M19R %+@S+Y;
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MVTUG2Y$G=-2LV6!=TS+.I$8]6YX''>G_ -I6)CB=;VV*S(7B/FKB10,DKSR
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M'(Z5UR7D6J>'1>QPR^5<VWF+$Z?/AER 5&>>:ONB2QM'(H9&&&4C((I0%10
M J@8 '  H \W\.Z3<VUSX):]TN<?V?H4MM<L]N3Y4N(0%/'7Y'Z?U&<^UT;5
MH/"&DI;07]GJUIILD A>U\VWN 6.;>5,< X7# C )YKU&.^MY+^:Q20FXA1)
M)$VGA6R%.<8/W3T]*+Z^M]-LY+N[D,<$8!=@I;'..@!/>@#S?Q'8:P\7C&V7
M1[N:?5;>UD@,"AHR515==Q(Y!7IU((-:ZZ-/?>(_%LJV+6\UY9P+974L.-LH
MC=20W8J67D?AG%=S10!Y<NF/J/A74-_A?5+76(=$FT\FXD9U+,F!'$-Q#J6
M(;   [5IZGI$J:9HTNE1WFFZA#9.%E@L_,C+;8P89XL<AMHYXQLZUWU&><4
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M95C)5L<?-N&?<FNSL-'LM,N;VXM(W26]E\ZX+2N^]\!<X8D#A0.,=!5[/.*
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M<?)YB2$1/$3Z9*,/=!7IM4)M%T^XUB#5IK??>P)Y<;EVPHY/W<[<\GG&>>M
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MFD+D,1UY0Y_J*[JB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%5MN=N0  #C(P*PM?\'QW=G!;Z=8Z?) MVUW<6EX7"3NRD;MXR5;+$YP<]Z
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M/N VL1GE21DX]:M^)=#O-4.GWFEWL=GJ6GSF6!Y8S)&X92K(Z@@X(/4'((%
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M(:-2DX^;CY02R=?44 >J9&<9&?2J.LZE_9.B7^I+#]H^QP/,8@X4L%!)&>W
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M'J=X/L=A=01P9C *B2)&"C:,L2SX'4G(%:2>)=+=;K,[I):R1Q30O$RR*\A
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M/2]0L]/N[6=Y(-1<I;,('&\@$G(*Y7A6Y..E7KR\M["U>YNI1'"F-S'GJ<
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M!K07J_9[:67= ?XQM4Y'KZ=\4 :$^AV5QJUOJCB87D$+0+(DK+E"0<, <-R
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MY:'<TH=F"KN"@(I);@4 ;VF>&].TIK<VZS-]EB,-L)I6D\B,XRJYZ#Y0.YP
M,XJUJ6EV6KP1PWT"S1Q31SH&[.C!E/YC\1D56OO$>F:?YAGG=A%"+B4PQ-((
MHCG#MM!P#@_D3V-07'B[1K?4([ W$LEQ)''*BP6TDH:.1MJN"JD;<_Q9P.]
M%M="T^,:GY4/EMJ;;[ID)!<[ G7MP!T]SU-5;?PGI5L]@RQRL+"T:R@224LH
MA8 %"#]X$*O7/05FCQA:6=K:/]HN]2%[JDMDDBV;*8B&<E"H7/RA2HXR<9]3
M6M%XGTJ:VOKA)IBEC<?9K@&VD#)+\N%"E<G[R] >HH ;8^%]-TY(4@$^VWA:
M"V$DS/\ 9XVQE4STZ 9Y( QG'%1VGA+2K$:4+<7"#2D:.S'G,?+5A@CG[W''
M.:V9I5A@>9E<JBEB$4LQQZ <D^U86D>+[#5=#T_4MEQ&U^A>&W\ES(P W'
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MC%Y-#<6EH)YG:U?*HP.)4!7YURK<KD<4 7H-"L[;4K[4(?.2XO8TCF(D.-J
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M<-"SSM,PES$VZ+##!&T\C'J<YS5S3M:L=4N+NWMI'%Q:,JSPRQM&\>X94D,
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M;K<)'@!]K*& ZXS@^M8^E^.=)U0Z9M6ZMTU52UC)<1;5GP,D @G!QS@X)[4
M<^?"GB"T.FWJ+!K+64ES$MGJDP+FVE*%09=K R*8QR0<@D9XR=&#0M8TKQ':
M:M96.GM#+8?8[BRAD\I+<^:TBLAV_,/G(;@$X!QVKM*9)-%#L\R14WL$7)ZL
M>@'O0!B>"M+O=$\&Z7I>H+$MS:P")_*<NO'N0*S=0T'5'U3Q*;>&WD@UJTC@
M21Y,"$JC(Q=<<C#9&,YQ@XZUU%O<M//<QM:SPB"0(KR ;91M!W)@GCG'..0:
ML4 <%>:)9R:_HFGZ9J,3RVUM]@U.$,&=[1%5@' /!W!5Y[2M7>U%':V\,\L\
M4$2338,LBH SX&!N/? ]:EH \^TSP]XEBUC2=2O[>SEN+6WNX+F1;MCYID*%
M61=F%7Y.%&,9_.31O#NIZ3%X.:\2W2+1+":"\D\X8!*( RY'(^0DYQUKO:1T
M61&1U#*PP5(R"/2@#CO"6FQ+K6JWEG>17.CK.YT\1$,D;2A7GVL."N_&,="7
M%:WB[2+S6M >WT^6.*^BGANK<RYV&2*19%#8[$KC\:V(((;6!(+>)(H4&$CC
M4*JCT '2J.L:S!HL=H]Q#-(MU=Q6BF( [7D<*I;)'&2.F: ,#4],\0:U9Z??
MRVMG9W]A?Q7D=FMP9%D"JRNK2;1@E7.."!M'/)Q4U/PIJ5W<:AK,$40O9]0L
M;M+1Y< I;$<%@" S?-ZCA>:[2^NFL[.2X2UGNF7&(8 "[9('&2!QG/7M5B@#
MSVZ\,^(+E=7=K6S#7NLV6H1JMR3A(A#N4DJ.?W1 ]<]JZ)],OU\>1ZQ%'"UG
M)IPM9=TA#QL)"X(&#NSG'4=*Z"F1313JS12*X5BA*G.&!P1]01B@#%\7:-=:
MWH8@L94CO(+F&[@\PD(SQ2*X5L=CMQ[=:Y_Q%X6U37HM<OH[>*"\OM.AL(;=
MYA@!9&=G=@".K8&,\#WP.ZCFBE:18Y%9HFV. ?NM@'!]\$'\:?0 U"S(I9=K
M$9*YS@^E>9:V#=^(_$2P6MI=6#M;QW\7]II;EVC4-\ZNA(X*C*LH('KFO3ZJ
M2Z7I\]XEY-86LETGW)WA4NOT8C(H Y%]$U6X7Q&;>!&M?$ENCK]H?:]I(T B
M99%[C 4\=\CWJY?>$)#>:$]E<!8K6W_L^^\SK/:X!V_7<@'T=JZIIHEF2%I%
M$KJ65">2!C)'TR/SI] '$ZCX>U-?%6H7<&E:3JEAJ:1[S?'#6KJNPG&UMZD
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M62*W6]D\N-FA^<; V"N2>#QZ8KMFBC:596C0R+PK%1D?0TH1%8L$4,>I Y-
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M.HQS) =/G>?8(L^:SQM&<G(_A8_CB@#@M$UP'_A"[>75Y&NUU2\MKR-[IBV
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MA$F@Z)ID=].K:*\<EI.54DE$:,!QC!&UB#C'X477@^WNK4QF[F6>34(M1GN
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MV;W30,798]K;-N41B<MD X' S[&]9^$ULKC19H[^9FTFQ>QA#(N'1@@RWO\
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M,@0AL =%48Q^.:73O!UMI\.GVOVN::RTR5I;""4 ^2Q5E7)ZL%#L%ST[Y(!
M!GZ3XVOK^31)+G288+35+FXM%=+HNZ21^8?N[ "I$3<YSD]*T/#?BI?$4\JQ
M);H(@PGA\T^?;2!@ DD9 ()&3GIP?J8[/P7%9P:/"NHW#+I=Y+>1%D7+M)OW
M!N.G[U\8QV]*23PD\;27R:C<MJB6+64-W&D:S;"5.6)&&8%1@GISQDYH ZFB
MH+%+B*PMH[N437*Q*LT@& [@#<<>YS4] !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &1-XK\/
MV]V+676K!+@S?9Q&;A<^9P=G7KR./<5)_P )%HO]I#3O[5L_MID,7D"9=^\+
MN*XSUQSBN"O--EUQOB%HL%BTDU]?11).0NR,_9H,,QSD;/O?RR:UW\.ZC>3^
M.(!"]L=4A2*SO'*G<1;B/=P2PPV>H'7B@#K+36--OYVAM+V":54$FU'!)0\!
MAZK[CBFV^N:5=/*D&H6SM%'YSXD'$?/S_P"[P?FZ<5QE[X?U;Q%;Z9_HLFDW
M-GI-U:2N[+CS)8EC"J5)RH(W9]E[YPLUAK6O>$I[4^'5TS5X+%;<2S21_O61
ME;RXW1B1&VTY)QU''7 !V4.MZ7<1W$D5_ RVQ F^<#R\]-P/3/;U[41ZWI<U
MG)=QWT#01R>2[;ONR9 V$=0V2..O(KB+W2=2U/2Y=3LO#=U9:E'-;2RV]W?9
MFO!$^XQB0.P4#)VDD<]@.KKC2[_SM-U[3_#MU 8=2%S=V,UPKW%PODM%YA)<
MJ67<,#=G"]C@4 :6F^+);^VU61]0TNW^S:RMA;RR*P21,1$K@MDR'>RCWQQP
M:W)/$^A0W7V635[)9Q,+<QF9<B0XPAYX/(X]QZUQ<^CZS<:7KBKHMRCW?B*V
MOX4:2+)B5H"Q^_@$>4W'TZT_6=#U:YMO&0@TF9Y-0OK26U^>,>8D:PACRW&#
M&W7% ';WFNZ5I\K1WFHVUNRE58RR!0I;E02> 3V!Z]J>-7T\WB6@O(3/(VU$
M#9W-MWX!Z9V_-CKCGI7GFI*[ZKKRG2M5N-'FU&"[GEM!#)^\A6(MAC(&7!C5
M67:WW3@Y.!LQ:;J2>+H]2TQ+N&VN+PO>07!1[>2/RR!/'D[HW^ZI QGG(QS0
M!V]9\.NZ3</(L6HVS&./SF_> ?N_[_NO^T.*77+&;4_#^I6%O-Y$]U:RPQR_
MW&9" WX$YKE+32]2O+GPS=3Z9+9RZ-9S1W";D/F,T0C\M"&Y4D;LG ^5>_0
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M,!3G..<8S4\FCWQU_5;*_P!!N-1L=0O$O+>Z%WMACPJ<2IO!RA0$$!L\=,4
M=I'JMA+>?8X[J)KC+ (#R=O#8]<'@^G>KE</IFF:MI_B9[FS@O$TV2:ZEN;*
MY:-T5R6*R6[YRID)R5)P-QSM-=C93RW5C!/-;26LLD:L\$A!:,D<J2"1D>U
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M!-L9 8FD:%E+ L,C]VW3/.* #PCXNM]=TRR6\N[)=7G61VM8FP<*Y&0I)/0
M_CFM?^WM(%Q) =2M5DC1I&#2 853ACD]0#P3V[UQ&BZ#J]K:^#8Y=,FA>PNK
MM[HAXSY2R)*%/#<Y+KTS3O#NCZA!IUI9:EX<N?[0TBUDMTOGO!)%*"A0&$%\
M@N,$@JH'//2@#M]-UO2]8\S^S=0MKORU1G\F0-M#C*DX]1R*OUA>#+&?3?!>
MBV-W:FVNK:QA@FC.TD.J 'E20><]^];M !1110 4444 %%%% !1110 4444
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M#J<?VRVU:35;6=;<A4D=W8HR[SN4B1EX(.#76)>6TL*S1W$+Q,VU75P5)SC
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MBP<&1(AMN4.7<X5>#U)Z#O0!C_$*TDN_ UW!':2W4^Z$QQQ1-*^X2*<@ $\
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MITW09G_L]\@[A*H9![&-&9/<.#5OQ';LOC/PQ?FRFG@A^TQR/% 9-C,B[-V
M<#(/)X'K70:7I=MI%BMI:^:4!RSS2M)(Y]6=B2QX'4]@.@J2&_M+BZN+6"ZA
MEN+?;YT2."T>[.-P'3.#UH \ST+2Y+:/PA<#2+N*[BU>]:ZD-E(KK$XN-I<[
M<A3NCZ\=/2KO@ZT:6[TJ+5=.U=-<TGS4FFEBV0$L"'<2!0) YP<9)R<GIFO0
M!>6S7S60N(C=+&)6AW#>$)(#8ZXR",^U)>7]IIT GO;J&VB+! \KA06)P!D]
MR>U '(>+X#/XT\*2O;:C):VS733RVD4Q\O=%A<M&,C)XZU@"PO=/3Q4]KHU[
M=Z'<7-I+"EU%*T[R[U\V3'$TB+A3M8\[<#BO5J* /([C3Y[B+4XIM+U&X5_$
M]G>1M)8/\T.(-[@!>!A7SQD=#R:FU;3;E(/$]II^G7D$<NNZ?/;"&Q<KM7[.
M9)%4+@@%')^GO7JU% ',^"YKA=/GLM0L);?4K:9EN9S"ZQWC?\]E<CYMPP<9
MRO3H!6+JFGW]SXG\7?V;;30W=SHD4-G=&!E0SCS\[9,8S\Z<Y[^U>@57M[^T
MNI[B"WNH9I;=@DR1N&,;$9PP'0X[&@#@?L)U&XT6[M=+N;:&UTBXM]0@DM'7
M(*($AVD?.0X8C&1P?[PSO?#_ $N#3?!>CXTX6=ZUA;QW>Z#RI6D1 "'R 3@[
MNOX5U%% ' >'0!.EAK&AWSZQ8:C<W(O# _E,'9\2K*.&S&P79R> , #(Q_#N
MDW%I%X)DCTJYMKR,WB74K63JT>Y'"^8=O W;,9]!7J]5[2^M-0C>2SNH;A$<
MQLT3A@&'5<CN* /,--TV]U'P^MO'8:Q:^*=/TNXM!-.GE1+(T>TLL@ $H9PK
M Y./O'!ZVM2%OK'@769+#PUJ5KJ1T1K!D>TD1MV#MA5<?/@EOF4$#UYKTVB@
M#SJW6Z;P_P")M*U/2[FXOI+:1H[P64A6\C9#Y:_=X=,A2G8C(ZFJUMI$<^JV
M$EYHL\B+X6$$AEL'($H*_(<K]_&>.M>G44 >2*\]AIOAL7=GJ$LK>&C8W4#V
M$TWDL1&"65%+ Y5@<@!@.O%>@^$8+"U\):9;:;(TEK! (5=H3$S,GRL60@%6
MW Y!&<YI]]X<LK_4AJ)EO+>Z,:Q.]K=/%YB DA6"G!P6;!ZC)YK2MK>*TMU@
MA7;&N< DDDDY))/)).22>230!+1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!YYK7B/Q-:
MCQ9=V=SIX@\/R+(('MFS/%Y*2LI;?\IPQY .3C@=Y=4\6ZK:V'BRX@:('2Q;
MR6PDBYQ)&K%7YY^\1QBM"Q\+F?Q%XCNM3MI#::A<0R1Q^>=DBI$B8= <?>4G
M!Z@\^E:&I^#M$U>YNY[VVE<WD:QW*+<2(DH7[I958 D=CC(H S6U+Q!=>*=;
MLK:^L8+735@E57M&=I Z.2I.\8Y Y'Y#OB6WC37[#3?#VM:FUK=V.K:=)/);
MV\!1X9$MS/D-N.X,%8$8&,BNT_L.TLI=0OK."9KV[A6.0M<.WF;00HPS8&,G
MGW-9OA#PM'I7AS1X-0@9KZRLEMF$DQE1#M ?8"2 #C\N.!Q0!3B\1ZM!/X=>
M1K>ZBURVD?8J[!!*(?-7#9Y0@$'//0Y[51M_'-TEG,ER9(]4$MI;26-U;B*2
MWEED*LPY"O&>-I!ZCD\UU5IX5TBRB6*&W?RHXGABC>9W6&-_O*@).T=N.@X'
M%-F\(Z+=6=Q:W=JUU%<0I;R?:)GD8QJ254,3D8)SD'.><T 8MWK'B;2[6=[N
MSDGMTNU_>6J(]T+8HQ+&($@L' '&<KD@9%='H&H)JNA6E]'=Q7:3)N$\2%%?
MDC[IY4^H/0Y%5[;PKI=I:0V\(NQY,OG)*UY*TN_:5R7+%F&TD8)(]JL6F@Z?
M83V\MK$\;6\3Q1@2OMP[!F)&<,Q89W')Y//- &)\1[>(?#[Q-<"-?.?39$9\
M<E0&('X%C^=5/&5LB^&-,N(8XUN7O],3S".N+A-H/L"Q_,UU>JZ59ZWID^G:
MA&TMI.NR6-9&3<OH2I!Q45YH.GW^GV]A<QRO;V\D<L2^?("&0@H2P;)P0#R>
MU '+'Q7JEA<:CIMT\5S=1:M!803QQ"/Y98ED&5+8R,LHYY.W\>DT"76'CNX]
M82(/'.?L[J5WO$0"I=5) ;.1QP< \5%=>$-#OH]2CNK-I5U)TDNM\TAW.@ 5
MA\WRD!1@KCH*OZ7I-IH]G]FM%EV;MS/-*TKN>F6=R6)P .3T % 'GL4>J7$G
MQ$MM.TVQO/-O2NRYG*9)MHQC;L(;\6&3W'6BQ\33VW@#2Y=$OS/';Z$]P@FB
MW7$CQ +F0$[5C^5@?FR3PI..>R_X0_1@]\PCNU-^_F706_G42M@+D@/CH /H
M,4EQX,T"Y\H-8>6D5H;)8X)7B0P'_EFRJ0&7V.: .?O_ !'K\UW>1V5S9VT<
M6@QZHFZV+D.2^5/S#(^0<^A_&LZ\\2M!XOTW4"$MYM3T*WC29U+16[RRDAG_
M -G/ Z9) R,Y'9IX0T6/?MMY\O9"P8FZE.8!G"_>]SSUY/-,?P7H$L31R6;R
M1M8C3RKW,K VXZ)@M^O7WH UW6>.Q8+,K7"H<2.G!;'4J"./;->?CQEJ4/A+
M0M4N5^RVMWIBS37L%MYD-O.0-HD099(NO(].H[]_#8P6^GK8QF7R%3RQNF=G
MVXQ]\G=GWSFLN/P?HT5A%8Q0SI:QVWV01+=2[6AY^0_-R.3UY .* '^)-;.C
MZ1#=0!9'N+F"WB;@J#(ZJ&Y('0Y'(R<<US^H:SXITQ8HY?LB";5K:V@DF0-(
MT$IP=ZHV P8,,CJ/0UUNHZ18:OI4NEWUK'-92H$>$\# Z8QTQ@$$=,5G1^#]
M&CLH+0PW,B07"7*/)>2M)YB?=)<MN..P)P/2@#E-1UK7);*>TDU!$GLO$MI8
MF>&$+YL3M"X!!)Q_K,'!Y ]S3O%>M:O%IWCBVCNHH6T^QMWAGAAVOAU?=DDG
MGC@C&,\<\UUDWA+1IX[U)+>4B]N4NYB+F4,9DV[74ALJ1L7[N.@ITOA31I_[
M2\ZU=QJ4"V]V&GD(D100HQNXP">1@\T <UK6HOH/C"ZU28?:7LO#,\[ #;YF
MR56Q[=*DU#Q)KVAV-WJ-U%;S6+6T1MWDV*1.\BQ]$8YB_>*V<Y&",G(-=(OA
MK2EO%NV@DEF%J;,M-/)(&B)R58,Q#9/))R352S\#^'K+3+G38[%I+.YC\IX9
MYY)56/\ N)N8[%[X7'('H* ,[3(;F'XIZDMS<BX8Z+;%7\L(0/.FX./?/X8Z
M]32UCQ!?:#XD\5Z@\[7%IIND6]S%:;0!N)G&,]1RHR?\*Z?3?#&F:5?_ &ZW
M6Z:Z^SK;&6>[EE)C4DA3O8YP6-2W'A_2[O4I=0GM?,GFMOLLN7;9)%\WRLF=
MK??;DC/S&@#,AU74;+Q9I^DW<T5W;ZC92SI+''L,4D93<.#RA$@QGD8Y)SPZ
M]U>^A\73:7')&+<Z2]XA*999%<+U[C!Z?K6CIN@Z?I3H]M'(7CB\B-IIGE,<
M>0=BEB<#@?7 ST%)J7AW3=5OH;RZBD,\,;1!HYGCW1M@LC!2 RD@'!R.* ./
M;QKJ,6@Z'J=\?LEK?:7!</?1V_F01W#@$K*!ED3D8;IDG)XYTDU[6]2O;B;2
MX8C;6>IFTGCE*!#$I =MV[<'YW#C&,#OFM1/!VBQV*6203BT2U6S,)N9"CPK
MG","W(^8]>QQTXIY\(Z*=>?61:NEY(RO)LG=8Y&7[K-&#L9A@8)&>!Z4 4?&
MD]]#+X>2SO&MEN-6BAE 0'>NUV /ME1]:YN/4M3T6Y\2:A:3P?9T\2P0S0/"
M295E6VC;#9^7 ?(X/(KO]4TBRUF"&&^C=UAF6>,I*T;(Z]&#*01U/?O5&3PA
MHDL%W"]M*8[NZ2[F474HW2KMVM][C&Q>!Q\H]* ,F/7M<U*^EFTR&(VMIJC6
M=Q'*4"^4C;7;=NW!_P"(<8Q@8YS5_P 6:GJ>G2:+%ILMO&;[4%M)&FB+X5HW
M;(PPZ%.G?VJ<>$=%&NOK*VKK>2,KR;9Y!'(Z_==HPVQF&!@D9XSUJ]J.CV6K
M/:/>1N[6<XN("LKIMD (#?*1G@D<YZF@#E7UKQ),^HVE@;>XO=(EAAF9T2**
MX)C21V;+[D!#G;C."O)/03+XDO3XHDTB\D>PF>686J26^Z*YB5"5:*0<%Q@%
ME//7 XS6O>>$M%OM:&KS6K_;"JI(T<[HLRK]T2*I"N!_M U8CT#3H[Q+H1R,
M\<[W$:R3.Z1R.&#,JDX!(9NG]XXZF@#G-"\4ZEJ)\&O.8-NLZ?+<7*JF,.J(
MPV\\#YCP<]JPO#TU\EEX)M[6]:""?4=0$L80$/M^T$9_P_'L*[.Q\%:'IL]G
M-:V\Z/9"06V;J5A"KXW*H+8"\?=Z"I(_"&B0VEE;1VTJQ64[W%OBYEW([;MW
MS;LD'<V5)P<GB@!-=UB6RU31-+@(CEU2X>+SF7/EJD;2' Z%CM &>.2><8KD
M/$&K:GJ&BZAI]Q,B3Z;K]C:M-''\LZ-- Z$C/! <9 X..P.!W^IZ19:O#%'>
M1%_)E6:)U<H\;CHRL""#R1]"1T-5+CPOI-U8?8IK>1H3<+=-B>16>52&#LP8
M%B"J]3V'H* #5FN]*T"ZN-,M%N+X;79(T56E8E0[ 9 +[<X!/) %<]9>+I[N
MZT3[)>+<07FIRV4Z3VQBFA"V[R;'4XVN&7GC!!]Z["\L(+^R-I<"0Q$JV4E9
M&!5@RD,"""" >M9UQX4TBY@$<L,V\70O/.2XD27S@NS?O4AL[?EZ].* ,&P\
M57]W=VVERRQ1W%SJM]9K<"/I'!NQ@'@N0![=3CM4&HIK$GBCPG#<W=DNI*+]
M&N(8RR ;5VG:2/FV[<C. ?45NR^!_#\M@UD;.18C=M>JR7$BO',2271@V4/)
MZ$5<3PUI4<]A,L$HEL%=;=OM$F5W_?)^;YB>Y;)- %?PGK-SJWA*WU&^"&X_
M>I*8EP&,<C(2!GC.W./>LBV\2ZF?"]OXM>6TETV339;V6S (D0A/,1(V[G 8
M-GN,C'2NHTK2;+1+!;&PC:.W5F<(TC/@LQ9N6)/))/XU0TWPAH>D33R6=FR+
M-OS"TSO$F_[VR-B53/?:!0!BR>(=8L[C1E::VN$UBQFE5A"<6\R1"08P?FC(
MR,$YSCGFJFE:_P")+]_#"O?62C7-*:Z8BT.8'58FR/F^;/F'@],#Z'J+3PMI
M-E"L,,,OEQPM;Q*UQ(WDQMC*IEOD' Z8X '0"BW\+:1:-IK002H=-@:WM/\
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MMSTS6!K'A#4-3TWQ0Z&TBU#7(8K<(96,<2(I );;DG+,>@[#MFNBUK2?[?\
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MA7D>6>*3E2%V\$ 8V D#L>U8_@Z6;=HXA_L2[5(7CM#9ZD99+-9>6(A*< 8
M(+G:!@'L0#N++Q9INI,(X?M*^;9F]@8PD^=!D#>@&3U(X(!Y'%4K#Q?IL.FZ
M-"LVI:C-?6)N;9S;$R3HH7).T!0WS#CCKVK/T3POX@LM8LM3O3ILMS'IDME=
M2+/(SW$A9&$A8IW*?=_ASQD<"30O"FKZ4_A4RFQ<:-IDUE+MF?\ >,WEX*_)
MT_=]_7VY -A/%^F3V%M>6HGN4N+5KQ8XH_G$2X#,5)!R"0,#)SVJ33_$)O\
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M/51=ND4C0M8R!HTD<H&;C@ J<GH*L0^*]-GGLXT\X1WVX64Y3$=R5!)"'/7
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MQSH]DEZ;O[5"UI:?;F1H26>#.-Z@9X!X(.",C(%;&FZG%J<$LT4%S"B2%/\
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MEK:I>2B&V9L0MNPV>A VMGZ>O%2VWB[2;B[D@\R:%5M#?+-/$4CD@&-SJ3U
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M,.B# )[;CG@]L \UB^!_%XO="T&VU,W9OKVS:87<T8$<S)RX!]0#GH!CH>*
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M]TD$$2*<@GKZ\4^/QCIS07CS175O-:W4=F]M-&!(99-OE@ $@[MZX.?KC!H
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!7-:O9^)Y]96>P_L=K2%08$NVER'QRY"C&><#T&?7CI:* ,'5](OK_4?#]S&
M]N1IMT;B8NQ4OF%XR% !Q_K,]>V/>K.HKK["^73FT]0T2"T:;?E9,G>7P""
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBD+
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M0V%U;S6"I,V(9#'&6:,9X)8'./<>M6?$%E8WFK>-#))*NI/%!-I/DS,DCRB
M!&B /S'> ,C/H>*]7HH \LO)1=:[?:5XBU"[L]5WVTNG/;0Y>11'&3Y#X(SY
MHD##T//'35\.1:7%K?BK5[N9V;3M2ED21IG811&WBWD+GD9#]CROM7?44 1P
M3QW-O'/"VZ*5 Z-C&01D&I*"<#)Z4R*:*>,20R)(AZ,C @_B* 'T444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 5QGCCPQ8:M92.D ;7;ADCT^YS^\MG!&&0]55<%VQUYZY KLZY
M_4O"O]HZH^H#7=8M)&C$82VF1511V&4)&3R>>>/08 *GBB)?^$H\&R\F0:E(
MF<]C:SD_R%=+=6T5Y:R6\Z>9%(,.F>&'H?8]".]4+[0H+ZYTN=[BY1M-E\V
M(RD%MC)\VX$GY68=>]/N])DN9+N1-5U"V:XCC1?)=<0E"3N0,I )S@YSD 4
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M=/E,T'D;,!RI4DAE.>&(_&J-UX&TR_74GO)[RXN]0B2*6[>0"1$1MR*F%"J
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M\N8YU0%Q,B1.48?-\H( .TY(..>.=O6-9:PU'2M,@5#=ZG,\<;2 E45$+LQ
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MEQ^]C.V.3S]I'S<G]\O'L?;(!V$>O:9+J,=@ET/M$N_R@48++L^^$8C:Q'<
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MP/7- &U+XQ\/0R0(VJPLT\231"/+[T<A588!X)(K3LM0M=169K282B"9X)"
M1MD0X9>?0US.E:'=6'BZSNDTN"UL(M)-KMMF41Q.90^U1P2 .,X&3V%=+93W
M4Z3&[L_LI29TC'FA_,0'Y7XZ9'..HH M45F6&C?8-0GN_P"T]1N/.S^YN)]\
M:9.?E7'&.GTK3H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MK#<69E#NHB\HG"D *P<#.!DY!- 'H=%>8>']0U0#PA>RZM>W3ZA>7EM<1RR
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MX]X^E6+73L&:8VZ%V(Z$MC)(J0:5IPOY+\6%J+R1=CW A7S&7T+8R1[5;HH
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MS)9VZRI%Y*NL2AA'_<!Q]WVZ59HH I6VCZ996LMK:Z=:06\Q)EBB@54?/7(
MP<^](NBZ4FF-IJ:99+8-UM1 HB/.?N8QU]JO44 5K33K'3PPLK.WM@^-PAB5
M-V!@9P.P %(=-L&OOMQLK8W> //,2^9QP/FQGO5JB@"O!8VEK+++;VL$,DQW
M2-'&%+GU)'7\::VFV#W@O'LK9KH8_?&)2_'3YL9XJU10!4CTO3XM0DU".QMD
MO9%VO<K"HD8>A;&2*6VTS3[.>>>UL;:":X.Z:2*%5:4^K$#)_&K5% &?#H.C
M6Z!(=)L(U 882V0##?>' [X&?6I'TG39=._L^33[1['&/LS0J8_7[N,5<HH
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MVH:-<79MK.WN;>UT=5*7-FEL,RKD$*K9 52 01M.03TZULT4 %%%% !1110
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MRO ;176=8@0CJ"WR. 2,_,/:NR) &2>*@BO;2>!IX;J&2%,[I$D!5<=<D<4
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MGV2.$Z>Z*DJ[]L04C=E2P W$D]02.:MW^CZCFXCT+3Y[6YG\+&!9%MVB!GW
MA2Q  ?!;&3D$UZK10!P>C21WGCS3+^UT>^LK8:)):L9K&2$1.)8V6,EE'0!L
M=O0U;U:UN)?B';36]M*I&CW,*W7V=FC29I(BF6QC/RD_A78T4 >;:3IUW<V7
M@R(Z?=6M_I.Y-3:6!@#&(665=Q&)/,DV-P3GKVK9^'&D0:=X4M7;3/L=]^]2
M4R6QBE*^:Q4'(!(P1CM7853.K:<-233C>P"]?.V R#>V!D@#U (./0YH \^;
M3-3N=#GTB6TN5UZ/7OM45YY+;"AN XE$F-N!"2F,YXVXZ5M+HMW:^-+RUAML
MZ)J;1ZC,X'RI/'A67_@9$+>^UZ[.B@#SBTLWGUZXT[6=+U:6ZAUA[^UN(XS]
MG:,N2C^:!@;4.PH3D[<8.:SXM"F@\$WD]GH4@NX]9EDGA%H8YI[+[9YC1ID
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MXJNDLKJWM[N>WEA>:V>$2_N%#$!@#G(.>]=?10 444V21(HVDD=41 69F.
M.Y- #J*AM+NVO[2*[M)XY[>5=T<L;!E<>H(ZBIJ "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+K4_ $.KHXMKNYTQ;H,B@B-VCW< YZ$]ZLMX;TMKIKHPS&9K7[&7^TRY,/\
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MD'=YFY1P1@Y(&."8K/Q)JEX/".H"YB%MK\C>9;B('R4,$DJ!6Z[AM ).03G
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M,UM1E@CA\2Z@E],+JT\1VOV9FNG_ ':L;8. ">A!D!&.@([4 >MNQ6-F52Y
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M3A5\PJ&Z<<'B@#URBO,[FRO9=.\2SZ6[S66FWT-]I*HY*N41'FB0]XV.Y<=
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MY+:!42>&]NDGC48*'[1)M!'8[<<>A'K0!T6J:S;:78W]PP:=[&V-U+!$1O\
M+^;D9('.QN_8U:LKI;ZPM[M%*K/$LH4]0& ./UKSGQ MC:>)?'#3".*XN/#\
M;PEN#(0MPK$>O\ /U [BJ0EN-.=TT":1[RX\)F=8TF+F2=2H4@$GYP"V,>F.
MU 'K58^K>(HM(U33=/>RN[B?47=(/(\O&Y5+D$LXQ\H)K!\%SZ3J&I3ZEHVK
M/<PRVR)/;QQ%(HW!X+@DD2D$@]R!SV)B\<3P1^,/!@EU 66VZN&:;<@*#R'
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MN;G9"JB>Z&)9 !PS#U(YYY]>:T* "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M(EQN$)C1I"Q7.[Y%^;Y<<CMWQ6%X:\43:OI'AZYN]3LXKF_DN,P)"2;E4\S
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M()  P<CY&\S.1D@YXKGM1\-^)KOPJ^D?V0-S>'X;.-HKB-,3H&#+*V=S#IM
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MD_*1@G)XQWSQ707\<FJ^&[F*.,Q2W=HRJDO!5G0X#>F,\UH,H888 C.<$4M
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M4!Q_O!]QQW##'0XTX-+ELK]M;U&9;N\BM/LL:VT!0!=P8X4LQ+,P7O@8'N2
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MI;8N9EDB  ,7FJ0"PSD$#U&><5%/X*\V+6;!;X#2=7N#<7-NT.75FQY@1]W
M;;W!QDXZ\6X_#5Q'<^(YA?Q8UC;M7[.?W&(A$/X_FX4'MS0!!8^,6OH=.;^R
M9X)=4"M8)+*G[Y3%YC,<$E0HX.1GD8'/ GC:!A;AK*9&.I_V7=!F'^C3?PY]
M5;(P1UW+TSP#PC+'I_AP0Z@BZAH2".&X,!V2IY?ELK)N[J!T;@@'VI\_@Z&Y
MT#6+"2Y(NM4G-U)=(F/+F&WRV5<G[FQ,#/\ #[T /T[Q6FI"9(K,B>'4VTV2
M+S02'4;F;/IM&[UQ[\5%;>-K:\O;2*VLY;B"]60V\T+JV2@)^<<; P!VDGTS
M@U8TWPG::7X@EU6"63]Y:QP&)N077(,I]7*[03[>]5M!\+ZIH2_8HM=$NDP%
MS9VSVOSQ@YPCN&^=%SP, \#GB@"K8ZQ?^+(-&UFVM;W3=-B=;QV:9?\ 2HC#
M*"A522<-Y9P1@]1TK:\/>($\16HN[>%?LDD22Q31S"16W9RAQT=<#<.V1R:/
M#VARZ%X4M-$^VB9[6#R$N%BV=!@';N//XU6T/PNND:S=ZJTMO]INX4CG6U@\
MF.5U))E9=Q&\YQG^= #IO$TR^)IM$MM&N[F6!()995DC51'(S+NY;)QL/'4^
ME4=&\36?]DZ6EI:W0FU*]NH((;J<NP>-Y3(6<EL#Y&P!GJ ..FK!HDT/BR^U
MO[9&4NK2*V\CR3E?+9V#;MW/,AXP.U<=J^C7.@Z3HVF'4"!'?W-Z+\:9)+'&
MS,[!&$;[E),K88,!A2#Z$ L:CXFEU9O#.H6=K?P$:W+9R6WG*OG%(IPRD!MI
M =."V.F:O3^-;N6VTMK/3-LUQJ[:9<Q2RC,3H') (R#G9P?0TS3-#U#4K32'
MEN+2"+2M0-S 8=/DA%PIC93E'?<AS(_)SD@'OS/_ ,(5<K"-FK1"=-:?5XW-
MH2H+!@4*[^1ASSD=N* -+Q?K5WH/A]KZSMTFE\^&'#OM"B214S[XW5#?>+5L
MXM2E6PDGCTE%;4/+<9BR@<A1_&54ACTX(QD\5>\2:*VOZ#+IRW/V>1GBD28Q
M[PK1R+(,KD9&5&1D5E3>$+AIM9,.IK'#K4*I?(;?)#[/+9XSN^4E<#!#8(!Y
MY! +/B^Z$WP[UN]L[F1?^)7-<03P2,C B,LK C!'8U0M/&T5BHM=9L+JQ\O3
MC>Q3RLCBXC0*'QM)PPW+\IYY%;U_HEO>^&+K04)@MIK-[-2O)1"A3C/H#6/<
M>"UU:U,6M7:SLNGR:?$;:(Q"-7V[WY9OF.Q,=ACOF@"_I/B-=3U:XTYK5XI(
MH5G65'$D3JQ(QO' <$<K[@@D55U#6[;3_$]VK6=[)<6VDM=928>7)&'Y"H6Q
MOS_$0#CC-7="T[6+&/&L:TNI.B^7&R6P@&/[S#<=S' YX'H.:K:GX:GO]<NM
M12_CB$^F/IXC-N6V[FW;\[QGZ8_&@"/2O%YU2\MK7^RIX'O-._M"T,DB8E0;
M 0<$[3F1>O8]NE87A;5I)K/2=5O!<OJ^IO<00PB[/E3 ,SEF7HH14P"!G!QS
MFMS3O"MSI^H:/=C4HG.FZ6VG!?LI'F F,[_O\?ZI>/<\^E2S\#SV6EZ)%'JB
M&_T>>26WN?LQ"NLFX.CIOY!#8R",$ T 2R>.H8XHU&F7<EW_ &E_9<MNK)F*
M;;N')(RK#!!]#SCFH[GQS/:IJ8F\.WJ3Z9917MU$9HCM1@Y."&() C;ZU+-X
M,>62*X2_C2Z.K+JEQ(;<D2,J;%11O&T!0!U/3/>I-2\)SW]WXBF748XUUG3T
ML=IMBQA"B0;L[QN/[UN..@H 4>-;6&YNDOK.>TAAL/[1CE=E;S80<$X!X;)'
M!]1]*8?'%K ]XEW:2H;>*.2-H6$J3&1]BQJPP!)N(!4_W@<D<U'=^!_[1E(O
M=05K=]';2I$B@*,02#Y@;<<$%1@8-)<>$=5U7P_-INM>(C<SCRS;7,%J(C&\
M;AUD9=Q#MN49Z#&0 ,YH -#N;V7XB^((;I98D2PLW6$W!EC!9ILLF>F< '@<
MKWZGHM8U :3HU[J31&5;2!YV13@LJ@D@>^ :YUM UZVNM4U=-9MSJ5W8PVR^
M3IYVJT;.0P5I#G/F$8)QWSBN@NK!]4\/SZ??,$DNK5H)VBZ LFUBN?J<4 9-
MQXQAMI'4V,[A=).JKL9<M&,97DCYN?7%4T^(5I#(AU73KK3;:;3WU"WN)61E
MEC10SC"DD, P.#U'H>*HZAX7U#3]+O-1O-5ANI(-!FTT116AC#@C*D?.QW$@
M#'.<\ 5+9>$8_$GAO2_[9N%EB72&LXXX8C&4\U%5V))/S * .F#GCT -:7Q:
M+.Z%M?:;/#/+927MLBNK><J8+IG( <;E)'3G@FDT7Q>NKW]A;/IMQ:"_T_[?
M:R2.K!T&S<" <@CS%Z]1Z=*8?"MW=+;R:CJ45Q=6EC+9V\RVQ4#S H:1QO.6
MP@X! Y;UX73/"D^G7V@W#:C'*NDZ:VG[!;%3*#Y?S9WG:?W2\8/4T 6=<\22
MZ3J=EIUOI-S?W5[%-)"L4D: F, E2688/(Z\56/C2V-_!#':R2PR7AL6>-PS
MQR@E260<[ P*EL]>V.:O:AHDU[XETG5DNTC33TF0PF$L9/,"@_-N&,;1V-4=
M.\,ZCI>KW36NME='N+IKQK(VX,B2,VYU67=PA8DD;2>2,B@!?^$P1CIDT-C)
M)8ZE=FTMK@2 ;FPQ#%>R$(V#R>G S1:^,H;FUTFX^Q2HNHZA-IX!8$QR1F0$
MGU4^4WYCBN;NM O/#;>%]..I"ZTRVUI6M8OLVV2&+RY?OON(8*6"@X7J,YXK
M7A\$7L$EE&FL1?8['5I=2MXOLGS?O#*61FW\\RG! ''4'L 6X?&UG/?6L<5O
M)+:W32I'<0D.5* G+J.55MIVGG/&<9JC?^.9F\&7FNZ79Q31K#%)!*+@,G[Q
MMI#8'#IQE?<#/6KFC>%M3T;S+*'7BVD*TCVMO]F EBW$D*9-WS(I.0, \ 9Q
MP:5Q\/ENK?5]UY!;W6IVT<,LEI:^7&\B-N$K)N(+$X'4<9Y] #M(F=XE:6/R
MW(^9-V<'ZU@>)/%<?AN.XFGLI7MK:!9YIBP12"Q&V,GAW 4DKD<8]:MV<>LI
MKDGVJ[BGL/LR@JMMY>V;/)4[B2",\'I@<DYK(\2^#+GQ!<ZDR:LL$%_I_P!B
M:.2V\UHN6.Z,[AMSN&X8.=HY&!@ S9_$%YH?BSQ7<)87^I6EO!:SR)'."($V
M.7*J[=>,[5ZX/MG;G\96QM[RYT^UDOH+&VCNKEHV"D(Z;P$!^\VSYL<<$<Y.
M*CF\*WDEYJDR:K&JZK:Q6UW_ *-\PV*R[HSNPN0QX(;!QUZ%O_"&&TN-0_LF
M]6TM=1M([6>%X3)M\M/+5T.X8.S Y!' /J" 22>-+7R]3D@MWGBLM,CU19%<
M 30N'(VYZ'$;<'VYI;'Q)=WWB]=-2S5;)M,BO1(9!N_>,P&1CMMQ^.:IWW@5
MV-Q%I>HI9VESHZZ3)$]OYK!$#A&5MPP0)"#D'/MUK0L/#5Q8:Y::D-11_+TV
M.PGC^SX\P(S,K*=WR\L<C!_"@"W?ZX;'7K'2S:,S7L4K0S%P%+QC)0]P2#D>
MP/I69:>*(O$7AZVN;2"5%O[:X<E9]KP"/Y3DKWW$#@]:TO$?A^+Q#9V\$D\D
M#P7*3I+']X8X8#TW(SKGMNS5>P\*PZ9+K<EI/L_M-RZ(R92WRN&"C(ZMN8\C
MK[4 8?A#Q7*F@^'[*_L;UI9]$6[BN"PE:Y,:1^8, EMQWJ1GKFI]1\=R6^DZ
M\\.GA=1TS35O_)>8$!6#X#8&5=2ARN/3!YS2KX$N5L='M5UKR_[-TF;3%EBM
MRKD2(B^8#O\ E8>6I'7G-1CP!<2V]_#=:M"4O=&&DNMO9>6% W[74;S_ ,]"
M2.Y[@<4 ==:3SRZ;%/- 1,8]QC5@<G'0'@<UQ^D>*)'3PG;:78S?8=32=R;N
MY+RHJ \$G))R<YSVQ7864%S;Z;%!/<1S7*)M,JQ%%)]=NXX'MG\:YG3O!5QI
MMMX<2/54:71C*N\VO$T<@P1C?\K=,')'M0!8M?&UM>7UI%;6<MQ!>K(;>:%U
M;)0$C>.-@8 [23['!JM8^/&U!=(>'0[O;J]NTUF3+'\S* Q5N?E&#G/L>.F;
M&@^&-4T%?L4>NB728"YL[9[7#Q@YVH[AOG1<\# / YXJ'2_!=QID7AF,:I%(
MNAQ21#-J09@R;?[_ ,N!]: )+?QS:W-GIKK;^5=7[SQI!<3+'^\A?8\8;D%M
MWW1W )XQ6Y=ZM;Z=H4NKWX:W@AMS/,&'S( N2,>O;'K7-KX&E.A'1[F\L;RT
M>6ZEEBN+$E6,TAD!'[S*LA+8(/0]CS6U<>'+:\\'GPW=S33V[68M'F9OWC +
MMWD_WN,_6@"*+Q&_]K1Z7<Z>]O>7%JUU:JT@*RJI 921]UUW+D<CG@GFLOP"
M+C5=&LO$-Z]R+RXA<2#[26CE!?(;9T!7&!CH.*TK3P]=B_LM0U&_BNKRPM9+
M:WD6W*#+[=SL-QR3L7H0.OKQ8\+Z+)X=\.VFDR72W7V92HE6+R]PR3R-Q]?6
M@#FO$^O2W]MITVG+.MI'K]M:-<QSE-Y6=4D!4?>3(9>>XZ8YK:?Q9'%KMKIL
MUC-%]KN9;6!I&"NS(C-NV'GRSL8!N<\<#-9;>!;V.!K&UUF*/35U1-3@BDM"
M[Q.)1*4W!P"A;/;(SU-2IX)O4U2WNSK2,MOJLFHINM,R,'1T*,^_G:'PIP,
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M:J@9)P.3R>I/L!GWGA0W_B&TU6YN(#):7/G02QV^V=4VD&(R;N4)))!'M[T
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M99@N?6/-4+BQ?5+G3;VUTNZM8;;1KBVO8);1T+;E01PA2/GPP8C;D#'7YAD
M[Z"[MKK=]GN(IMH!;RW#8R,C./4<UC^(O$B:))80Q"VFGN;VWMGB:?:Z)(X7
M>%P2<9]JB\"Z9#IW@[25%@+2[-C ET&@\N0R*@!WY )(.>M<;)#?C38=.O=(
MU"75+;Q-'>RSI:.Z2Q?:=PE60#;@1D+C.0%QC% 'IK7ML+K[(+B#[65W+ 9
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MQZ)/;7)GLF.QP8=JGC_9?'Z=1D ]-N+ZVM[07$ES D;#Y'DE"HQ(X^;WK/\
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M1D9Z4 7X9H[B".>%UDBD4.CJ<AE(R"*BO;^TTZ#S[RXC@C_O.<9X)X]> 3]
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M9Y)&"JH'4DGH*+>XAN[:*YMY%E@F021R*<AE(R"/8BN3UO5+K4;_ ,0Z-:W
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M7GRZIXJ9O#4?]KV0.N!B3]AY@_T8R<?/\WS#/;KZ<5;@UGQ!?S7#6+P.-.U
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MR[21V8K@D>O3BK.AZSK^OQ:5JEN\46FZA%(95DV9A)4F/R\<LP(PP;W(QC%
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M6K/936\R\-$AVL<]1(2<KT&" 0>M '545QNBZWKFM/IVJVXA&F7$\L=Q%*4
M1 S*FP@[MX8 $-P<G&*[*@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M;+4I[.:[B9Y+.7SH")678^",X!&>"1SZFG:EJ,&E6$EY<[_*0J,(NYF+,%4
M>I) _&LY?%>G&&=G6>.:&]6P:W=1YAG8*548)!R'4YSC'4C!H 5O"6BM#)"U
MM*4DO!?./M,O,X((?[W7(!].!4?_  A>@"Z%R+)Q(+IKQ<7$H"3,"&95W87=
MN.0!@YY!I8?%^F31W1VW$<EM=?8WBDCVL9\9V D[2<<Y!P <YQ59/'FCR+!L
M6[:66\>P\E(2[).BERAVY'W1D$$@YSTH MV_A#0[5[)X+21'L7EDMV%S+E#(
M<OSNY#'D@Y%*OA+155%%M+A+PWZ_Z3+Q.<Y?[W7D\=.33;3Q987UI#)!%<M<
M2SRVRVA0+,)(R=ZD$X&,=2<=.>126?BW3[VZTRWCBNT;45E: RQ;!F,D.IR>
M&&.G?J,CF@#.U_PDLEJ$TNQCF26_^VWD,M]-"TK;"NY) 248':>,9 QD5I>&
M='FTF&?S#-&DI4K;27\MWY1&<D22<\Y' X&/<UIV%]'J-L9XDD5!(\8W@#<5
M8J2,$\9!P>_6JVJ:W!I4L4+PW$\\L<DJQP*"=D8!=LD@<;EXSDYX% !?:!IN
MH7HO+B%Q<^28#+%,\1>,G.QMI&X9YP<XR?6E?0=-?4+*^^SE9[&,Q6Q21T6-
M#C*A00N#M';L*JCQ7I\L4,EJL]TLMG'??N5&5@?.UR"0<'!Z D8YQ3_$^NMX
M>TE;U+.2Z+W,-N%0J-IDD5 3DCNWYX[9( +FJZ39:U8-8ZA"98&97P'9"&4A
ME(92""" 00:CTS0M.T>6ZEL8&C>[<23L97?>P4+N.XGD@#)[XR<FN6_X2YM&
M\1^(VU1KZ2PMEM'"K$K"T5T)8L5XP#C/)/U K<U;Q?I6BR3"[=_*MW1+F5 "
ML!?&W=SG^)2< X!!.!0!/J7AC2=6OUOKJW?[2(3 9(IY(B\9ZHVQAN7V.15.
M7P'X;F@\A]/8P_8Q8LGVF4!H!G:C#=\V,G!.2.Q%;&H:C;Z; DLY8F218HD4
M9:1V. H'K^@&2< $UG1^*;24(B6MX;IKI[,6IC ?S$4NPR3MQM&=V[!['/%
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M\4GVF3SEDQC?YN[?G'&=W3CI0G@_0T@\E;679]L%\<W4I)G!R'SNSG/-;M%
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M689'3-5+W2_$FH+ITL\^G-LG9[NQW.(70IM4;L9?:?FPP .>V :ZFB@#SI?
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MD[=Q//3.,@'J!6I0!Y%I.IV%]?\ @*]6\276B;A;Y99<2"X-LX99%)^4[\@
MC@<#BM#P?>6>LR:?<W.MM_:<5K)%JU@%9&W[?G,X+';M<':V!UP..!Z6$126
M"J">2<4*$8;TVD. =P_B_P : /)?#MYI5MX,\&V\ERL8NS*"9)\6Y<*PQ(/X
MFYRJ C)&<\5)X;UM G@>ZU'4SY,VGWEK<RSS$+)*IBV(V3R^ ^,\]:]7VCT'
MKTI!Y;J"-K '@CG!% 'E7AV_CO!\/O/N_-E9[]&,DI+GY' !).<]!72?#%;2
M+PB(+<J)H;JY2>,-DQL)Y,*1V.,<>A![UV$CQ0Q[Y&1$7NQ  IXQVH \H\37
MXB3QZBZG-&T,]B8]MVP,9(3<!SP,DY7I[5TWAIX;?QSXETZVNGDMU@M)TC>X
M:7#L) [#<2>=J9_#UKL-H]!2*48;D*D=,B@#@=?@T^\^(-Q8ZMJ5Q;V3Z*)=
M@OGA4.)6&\88<@?RR<XKE-4U>]3P?Y6IWMQ#KT'AL7*&XE*L6!<J\:##&;"C
M>V?E&.#DUZH=#SXK.N-<!B;06OD&/@*&+ALYZY/Y?G6L0#U /:@#@-3:ZM==
MCEL'FN+3Q-:K:I(CEUMYP"?,7L%,9=CCJ8AZUE^(8[5+_P ;0?;[A%L=#@FM
MD%[(/*E59\,/FZY"?B1ZUZ#%I$@UN74;C4;BY3_EVMG5!';Y #%< $DXZL3C
M) ZUI8'H* /*[J_NK*^NFT:[FGOKOPNUWY8G,K23AAAU4D_-AFP![#M5;5[[
M3;CP?K^K:+XDDEC>QCW16KO&D4H<89B7)$I!(*YY Y'KZ[@>@H"* 0% !.3@
M=Z /)/%4=N(/'NFVUQ)/;G18+Q8FN&E_>9FW.,DGHJ$_@:]&TS6=%FGBTRPO
MX)9OLPN4B23<3$6QO![C/>M7 ]!4'V: Z@+DX,Z1>6O/W%)R>/<J/RH Y?7+
MV#3OB#HS7MT+>SNM/NX6$DFU)9 T)5<="V"^!UZXKD?#-Q;ZL_@^"^U.>2.?
M1;O[2AO77>RR18W8;KC?[\'TKUTJ#C(!P<C/:D^0,$^4-CA>^* /+- U,W<7
MPWEFO%GN3'=+NDDRS$1%1D]2> *;H&HP:G8PWLOB.:TUJWL+A-4MXHF\V-]A
MWO,I8_<<94X'8#@XKU;:/04!5!)"C)ZG'6@#RV"[O'L;RP>YTVUO8Y+0I=I.
MTFGWP.\JK<YC+;2&&3U4\YY[3P;>&^\-QR-:/:NLTR/$TWFJ&$C ['_B3.=I
M],>E;OEH%*[%VGJ,<&G    # '84 >.*--M](:S$ZPRKXRVRH)BK(GVIBO?*
M_*<@]<<U;EU8Z/%J]O'>.-(M/$:17+.[S"WMGMU;YOFW;/.(SSCEATR*]7VC
MT%&T$$8&#UXZT <_X.2V72KAK+5&U*SDN7DAE',:*<'9$<G* YQR<<CM7&7&
MN6P\664L&H/&Z>(I+2Y6:8F7889!M(& L195V*0<\$'->I@!0   !T HVC.<
M#- 'D,$L!L=/NO[5N?./BJ>S\S[>^3;F:5=GWNA7;SUZ'/2K$&I&QO+BQ%TY
MT.#Q.8+DF<MY,+6RLBLQ.1&9CSDX[=,BO5MH]!^5!52""!@]1CK0!Y9=W4VG
M7CW O730;7Q';K;W+3'8D3Q#S5WYQY0D..> >.W%>;4X;B*Z5-5E2(>+X8TV
M7;)^Y98L@8(^0_,1V[BO6MBE-FT;>F,<4+L==R[64]QR* /(M1^QK9:K;2W)
M>QTWQ99%3+<,PMXF,!<EB<A=S2<D\9->C>(7B3P;J<D<S11K8R,DB2%"N$.T
MA@01VK8P/04T21L%PZD/]WG[WT]: /+;=[74M1TR"[U&9H9/"@F=!>NJEP4^
M;AASU_+GI79>$;^ZO?AUH]Z)/M5X^F1.69LEY?+&<GUW=:Z$[%QNVC)P,]S3
M@,=* /(M)U.POK[P%>B\236B\ZWZRRXD%P;:0,LBD_*=^0 1P.!Q6AX/O;/6
M9-.N;G6V&J16LD6K6 5D;?M^<S@L=NUQ\K8'7 X.!Z6$4,6"@$\DXINZ%2S;
MD!+!6.1U[ ^_- 'D_AV\TJV\&^#[=[E8UNVF!,D^+8N%88D_O'G*H",D9SQ4
MGAO6T6/P1=:CJ9$,UC>6MS+/,0LDJF/8CY/+X#8!YZUZOM'H/7I2#RW'&U@I
M[<X(_K0!Y5H.H1W5M\.VGO/,D-[>JS2RY?\ U,Z@$DYSRH_$5TGPT2SA\/W=
MM;E1/#J-XDT88DQ_Z1+M!';Y<'Z$&NQ78<A=IVG! [>U.QB@#SC4+HG7/&=O
M'K2VC*-.\M[B5GCC8L05(S\J,<*V,<,:Z/P5>27>EW8FLQ:30WCQ2)'/YL+,
M N6B8_P'/3L<CM71[0<Y YZT*H50J@ #H!0!Y3K45N;KXEO8R'[?#8QR1>3*
M?,5_)8DC!SD'\JN7.N6-[KFN-:ZG'-:2>&1("DVZ-GW2@L.<$XV@D>F#7I(*
M;RH*[@,D=\'_ /4: BJ,!0!C' H \XTF2UN=9\"P--&RR>')T(63!.1;#'!S
MGAOR/I5_PI#>_P!H#0[W[0P\/RR?Z3(Q_P!*#\P,3_%\C-N!_B4&NUGB:6WE
MCCE:&1D*K*@!*$C@C((R.O-5=(TPZ9:,DMW->7,C;Y[F8*&E; &2%  X & .
MWXT <WXV,7]N^%8[B\FMK6>^EAFV7+1*ZFWE(!P1W ]_2N<L[F+3U@T^\OIF
MTV36KF/39;NX)@:$1?=D8Y,@#EPBY&2HYX%=]K&C+J6IZ3>O=+$-.G:549 1
M(SHT>"<^CG\<?2M9BB("Q55&,9X ]* /*_#NKO<0_#UI-2EDG:6[@F5[AOG*
MQ2 !@3R00HYR<U6L-5LK]?!5W>W:#7AK#IJ,4DN)(Y#%."K(3P <!>. 1CK7
MKVT>@I-BABVT;CSG% ')?$)8FT_13/(8K==8MC+*'*;%R03N&-O7KD=:Y>YN
MI] %^;>\F/A5=8@1IY7>=(HFA/F8;=N,0F\L'G RPZ9%>K$!@00"#U!HVKMV
MX&W&,8XQ0!Y9JL6ECP[I;KJXO[.3Q';-!*SE8U1I4+)$=QR@YYR<<CM3]5O)
MGL?%L37,D&O65P#HZ)*0YC\M/(\L9^8.VX-UR20>E>H!5  "C Z#'2@JI8,5
M&X=#CI0!YMY<]UK_ (RFM[F>?5M.@BFL;=+MRB3FW;@)NP1N.,$$>U7_  3=
MZ=J>HIJ&FZVUR7L0EU9QJP6-P1\TNYF*R_>'."1GKBN[P,YQ2!57.T 9.3@=
M30!Q>L+8V_Q5T.YO&2+S-,NDC=W*AG$L!"CGDXW''ID]JY7PG-%9P^!IK.[/
MVB\%Y#*AN24D 1V52N<##!>@[^]>OX!ZBFJ4897:1G&1ZT ><>![ZWU>\TN[
M.M2'6(K9X]3T]8V5_,P-QG!8XVN#M.!UP..!H^,]4ALO$&F6VK7D5EHMS;3+
MY]PK>3Y^4VAF#+M.W<5)/7/?&.W"J"2% )ZG'6AE5QAE!'H10!Y;KB/8Z5IE
MS8:K?7]Q863-J)>3;)/8'Y3(5SQ+CE&ZG#5:O6T/5_%\4,NK2KHUQH(FB\O4
M'B0XDP'!##D#^7/2O2,#TK(.A!O%7]N&<'%I]E$!CXV[M^[.>N?T_.@#B="N
MKU=1\&1:U?SK<S:-=_:5EG9"P!BV,PR,/M+'/7KZ5#H6BR:E\+K#6=.NKNXU
MQ(8KD,][(XG>)BWE,-V,,,J>.X)Z5ZF0#U K.UC3Y=1BAMX=5N-/!?,GV<)N
MF3!!3+ XZYRN",4 5/"\_P#:=G)KNR6-=399H8Y,@I"% 3CMD M_P+VKD=<O
M993XTAN[F6WU>T DT94D*OM\I3$8A_$6E#!L9SG:>,"O2(HD@A2*) D:*%55
M&  . !3BJE@Q4$CH<=* .$LD@?XJH;LQ#4/["B>5%DZ2^8<X&?TKO*:2@< E
M0QZ#N:=0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %8?C'6IO#OA#5-5MXP]Q;PDQ*W
M3>2%7/MDC-;E5M1T^UU73;G3[V(2VMS&8Y4/=2,'Z?6@#S37-9O/"OAS6M,:
MU\K7!I)NTU-9O-:XRPCD=F*J5968$+R ,8X&*Z&VBCT3XC6&EZ?&([.YT>1Y
MHT& 6BD0(Y_VL.P)ZGC/05LCPQ92K-]O>;4&FM#9.UR5)\D_>7Y0.O&3U.!Z
M5+IV@V^GWGVQI[BZNA;K;+-<%2RQ*<[1M ZGDGJ>,G@4 5=1U26XUN7P_9Q6
M[S+8FZG-R"R%&8HJ8']XJV3V Z'-<?H/B*\T'X8Z')!!;LD.B&Z_>,6:1HP#
MY:HOS 8R2^"%XSUKM=0\-P7VMP:Q#>7=E?1PFW>2V9,2Q$[MC!E88!R01@C)
MYK)B^'.FPV4-I'J.IK%'IS:8X$J?O8"2<-\G!!)P5P?7(H F?Q9);:M%'>Q1
M06%SIC7UM-RS,R %XR/4 AN.HSZ5%<>++NRU6PTS4$M+*[N8H'43AA'.[L1)
M'')G:&0 <'EB1@"EN-$%]>:3HTVFW4EEH\L5RFHW$B8D*H0%7:<DY(!!4+C/
MM6IJOANWUEY5N[JY:UF,9DM?D,9*-N!&5W GC)!'3M0!6\?7%W:> ->N+*41
M3QV,S!^<K\AY&.A]#61:37^F^)AI6EZ3I*3W-A%=W%QO>,.JN(\;0IY"GCU[
MXQBNJUO2(=>T6\TJXEFB@NXFBE:$@-M(P0"01T]JKP>'HH-=BU<WMW)<1VGV
M/:^S8R;MV2 H.<^A% &+#XTFDL-'UD6T3:3JMZ+2,*3YL>]BD;D]""0,C V[
MNIQ59/&FM-'!<'3;'R7UB32607#[MP=D5P=O3*C/&<'VYVK/P=I]D(88YKEK
M&WNC=V]DY4Q0R$D_+\N[ 9B0"2 3[#$:^"K-;:. 7]_MCU,ZH#F//G%RY_@^
M[DGC]: +/AO6;O5#JMO?0PQW6G7IM7,!)1QL20,,\CB0#'J*XKQC>7^H:)\0
M;2]:WEM+!(DMT$9RN8TD!R3U^8\_2N^TO1(=*N]2N8KB>5M0N/M,HE*X5]BI
M\N%&!M11SGI6=J?@JQU1M9\R\OHH]81%NHXG0+E5"AERI(.U0.N/;/- %.X\
M87>EWFLVVIV<'F6<=K+!]GD8AQ<2-$BMD9R'7D@=#TK7T74=3N[R^M[^P,44
M)0V]T$*+.&!R-C$E2I&#V.015:_\&Z?JEQJ4M]/=3_VA:1VDR%E4!8V9D9=J
M@A@S$YSU^@J]HNC'2(6634K[4)6 4SWLBL^T9P/E '<\XR<\DT <9\0=4EUC
MP;XQM;6&W:VTR(P3&8$L\FQ7.W^[M#+@G.3D<8S6UK?BN[T?4?+-M UNMU:V
M^W<6D=9G5#)\O$8!; ##YMIP:DU7P+8ZI-JS?;[^UAU>,)?6]NZ;)2%VA_F4
ME6P /E(S@9S27G@2RO9KR1]3U-!=S6]S(B2)CSH=FR093K^[7(^[[9YH HV_
MBC4;2Z\0->M%,D.L1:?9Q1HP(+QPE<\G(&\D]R<XQP*Z'0]0U*]:]CU&Q,'D
M2A89PI5;A" =P4\J0<@@^F0>:HWG@?3;U=526XO1'J4L=PZI*%\F9 @66,XW
M!OW:'DD<=.3G5TC2O[*MV1[Z[OIF(WW%VZL[ =!\H  'H .I/4T 8R>*7F\6
MRZ%NMK:X20JL%RK+)+%Y>X2QG($@W?*5'( ))%5M,\:7%[;^&;B:UACCU<3B
M4!B?*,:.V1Z@[*V)?#=O<:A!=7-U<SBWNC=P0R;-L4A4CY2%W8^8G&>M4+'P
M+96%QITD>H:@\>G32RVD#NFR,2!@R<)DKACU)(]: *LVJZAKWA9KUM/MGT?4
MM+FGR6^> %,QA@>'W \X VD8YZU%X+UJ^CC\/:+=V]NL%QH4=U;R1.2P\L1*
M0X(QSY@/'3!'/6M#3_ ]GIME/8P:EJ1L622.WMGE5DM5<$'R_EST) W%L \5
M:L/"MKI][I=U'>7CMIMB;"%7*8:([?O84$GY%Y&.GUH ?J&K2-KT&@6B0FYF
MM9+J1YU+(D:LJ ;01DL6]> #[ \AX+UJ>R\(Z+I%G!&+V2"ZN,>6\B(J3E<8
M7!Y+8SQ@#Z"NQU3PY!J6K6>JQW=U8W]JC1+/;%,O&V"R,'5@5R >F01Q64OP
M^L(;/3HK34]4M;C3VE\B\AE02A9&W.C94JRD\X(.,"@#-NKC4M;\2^%H=2L(
M;:*ZL+N2YTZY'F!6'E*P.#@\.P!]&/K5K2O$EQ#?V.B)9VL,<EG<&%(V9UMS
M R*$+@[7^5AG:05(P:W!X:MQJVFZBMW>"73XI(HU+JP<2%2Y<E2225!SFJ&F
M>!;'2[C398M0U&1=-26*VCED0JL<F"4.%!(!48.<\<DCB@"+2?%D^JGPN);2
M%8M=T^2Y=<DF(JJ-M]P=^/P]ZYWPM?:C9:5X+T_3Y((K6ZO+Y)49"<A#.P'!
M&!Q^8'X]1IG@:TTN?2Y(M3U*0:7')#:)(\96.-P!LX09 "C!//J33[;P396E
MII4$5]?@Z9<27$$N]-_[S=O4_)@J=[=@1V(H OZ]K/\ 9"6$:(KW%_=I9P!C
MA0S L2?8*K''? '&<UBGQE-;ZC=:-<VT7]IQ7L%I$ZDB*03*SK)@\C 1\KD\
MKC/.1O:UHEKKMI%!<M)&T,R7$$T1 >&53E67((SU'((()!%9U]X+T[4;2ZCN
M9[IKJXGCN3?(ZI,DD8 C9"  NT#@8QR<YR: $;7-4M[RTTN[M;>*_O+J6*WE
M#%HWAC3?YNW.0>VS/7G.*9;Z]JZZUI>E:A8V]O/>V]U(Q1RX0PL@4CU#!PV.
M".E.N_!EM>V5JDVIZE]OM9_M$6I+*HN%?;M/\.S!7@KMQCMGFIIO"D$LVFW"
MZC?QW=CY@%RKJ9)A)C>'W*1SM7H!C QB@##M_&>M:C;>'Q8:=8_:=7AN7!GG
M<)&\78X4G!]>O\ZD_P"$QU:%-;N[K3[%+'1[E[>;9.YDD;RHV3;\N.6D .>Q
M]N=+3?!5EI;Z.T%]?L-)$H@5V0AA)]X-\F3^8J=?"6GFUUNUN))[FVUF5I;J
M*4K@,R*AV[5!'RJO<],T 9UQXKU+33<+?:9N5Y+>&QG"M$DTLS^7Y;!LD;20
M2W(([9&*C\-Q3Q?$3Q7]H%OYC6]BQ>!"H?B;D@DX/;J>GX5;/@:SGT673+_5
M-5OPVSRKBYG!E@V,&0HRJ "" <D$G SD<5'<^#YUBU.XM-=U7^T[^&&)KGS(
MD(,;$J?EC 'WB#@<@GOS0!J>++Z[TSPAK&H6+1K=6ME+/&TB[@"J%NGX5R+/
MJ<7C.QN[:.REU)_#<CO)+N56Q+&1G&23VZ]R?:N[U#3X=4TFZTV[+-#=0/!*
M5."592IQZ<$UDP>$H8+R&[_M/4))XK%K ,YC.8R0<GY/O9 ]N.E &9%XUNM3
MT^T?2K$->S:3#J9A=6<'S=VR/*],E&&X]..#GCI0QU#0@]Y9F%I[<-+;388H
M2N2I['!X_"L)? %E!'I?V+5-4LY].M19)<02H'E@'2-\H5('8X!'K72&S0:?
M]CBDDA01^6K*0648QU;.3]<T >+V,JV/PV\'W\>FR:84EM6N-<&P"-"PW;MC
M%V#_ '<,,?-SBO0-1\93VVGZWJUK;12V&BW)@N8V)$DH0*9&4]!M#< @[MIY
M&:EB\ Z>N@V>A7%_J%UI-H4VVDK1A'"$%0Y5 S $ XSSCG-6I_!^GSSZB?.N
M4M=3=9+VS0KY4S  $G*Y&X* V",X^M %'_A)=:N=8UBWLK#3VM=,*,SRW#JT
MJ/#Y@QA#@YQG/;UJ'2_%NK7T6A+<6MC!-KL*SVFR1W\M!%OD+C R<E0 #_%R
M>.=R/PY!%>ZQ=)>70?5559AE,)M38-GR\<>N:KKX/LDTS1K2.ZNTET8 65T&
M3S4 79M/R[2"O!!'/UYH S%\:7@1#-9PQBVU@:5J+;B5C+8V2I_LMOC&#TW]
M\<SZ-XKNM5FGM EL+R#4VM'4!L&%5WB49YPRXP>F2!D]:TI?"VGSZ%J&E2^:
M\>H,\ES,6 D>1L?/D# 887&!QM'I4UIX=TVQUE]4MH?+N&M([/@_*(T)(X]>
M0,^BB@#&TWQ3JFK/875EI8FTV^BD=9"&C\C"YC+L>&#8P=H^4GOUJYX.UG5/
M$.B6VK7UK:6]O>6T4T"0RLS@L"6#9 &.F,$]3FFZ5X,M=&ED%GJ6I+:;G>"R
M:56AMF;.2@*Y[G 8D#/2M/0M'A\/Z)::3;2S2V]K&(HFF(+;1T!( 'Z4 8Z>
M)EN_%<WA^<6T3"1D-K<J5DGA\O/FQD_+("WRE0#@9)]*Y_X?ZU?6.A^$-,EM
M;<V=_8R"%T<^8K1@-\P(Q@@GZ8_+KI_#,%S>PW,]Y=2>1<M=6Z-L(AD92N5.
MW./F)P21GVXJG:^!M/M;?1[=;R^>+2HI88%9D^99%VL&(0$\>F* *6G^)I]8
MO)-(O[2V(N-*>[81$ND9#!&B+<K)C</F7C((Q6'X:C3'POEV+YG]D2KNQSCR
M(^,UU&G>!K339;26+5-3D>UL6T^(R/&<0G&!@( 2NT8/YYJ:Q\'V=@="\J\O
M2-%A:"V5BA#(RA2'^3G@ <8H H>.$D&K>$9K6&%[M=698S*=H&;:?() )QP#
M^%16GC6\>5M+O+**'64OWLG$(:6+"Q"7S% PQ!5E^7@Y/7BNDUC18=8^Q.\\
M\$UE<"Y@EA*Y5]K+T8$$%78<CO6;>^"M.O;-8_M-Y!>+=F]74(9 LXF*[2V<
M;?N_+MQC  Q0!HZ#?7^H:;YNI6!LKI9'C*9X< X#KW 88.#R,XKAK&YBTO2+
MX#3;2Y@?Q=Y/ERC B+W"*'48^\I((Z5Z%IUB-/M%@\^>X?.YYYV#/(WJ2 !^
M   Q@"L1O!5FUG+;&_O]DNIC5"<QY$P<.,?)]W<H./;K0!7NO%5U:^(+:QFM
MH#!<:C]@V*Q=U!B+K(S#*J25QL.#CFN=\.ZSJ'AS2E=+"T;1'\075G(4D(EC
M\R\=%8+C;M#$#&<XKIV\#637GGC4-151J)U-(5D38DQ!#8^7.&W'@DXSQBK%
MMX1LK>0K]HNI;07K7ZVDA4QK,SE]V0NX@.2P!) /T& #G=%U2/0YM=A@A'FW
MOB62WA54)56-NDA)"\GA&.!U..1G-=;H-_J%_:3MJ5@;2:*=XE/(69!C;(H/
M*@@]#R"#6;<^!M/NK6^A>\OP]U?C45G215DMYP H:,A>. !@Y[^M;6EZ=_9E
MIY)NKF[D9MTD]RP+R-@#)P !P ,  <4 <C9^*M1MGU8WK03.^O+I=E&JE0I9
M8\9.3P 68]R<],C&_I&MSW.NZIHE[%&MU8+%*)8LA)HI VUL')4@JP(R>@.>
M>*]QX*TZY&HA[B\"WEVM\ KJ/L]PNW$D9VY!^13SD=>,$@ZFGZ1#87-U=F66
MXO+K8)IY=NYE0$*N%   R>W4F@#A]2U&\\/>*O&VK:=:6L@M=.L[JX65BA=5
M$Y(&!]X@=3Z#K6SKOB^ZTB9I%MH&MD:U 0L6DD6:0(6^7_5A=PQN'S$$#%7M
M0\(6>HRZV\MY>*-9M4M+E4*8$:A@-N4)!P[<G/7Z55O/ 5C>F\WZEJ2+>"W,
MR))& SP[=C_<X/R+D?=/IF@!P\27RZIK&ERPVZWMK)!]C7YL3QRG"N><\,'!
MQTV$\TUO%&HSWSC3=--W;V]_]BG548-@$!Y WW1M)/RGD@=1G%;$N@V,VNV6
ML.KF\M('@C?=U5L<MZD8./\ >;UJBO@^TBUVXU*"_P!0@CNI1-<V,<H%O-(
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MGY!)VK]YL#G:,C)Z#/-<CX-TC4+8:;;ZMX?,%WI,!MUU![L2I(-H7,*[B5W
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M7)0&14R3M!Z@<G\S5VB@ HHHH **** "BBB@ HHHH **** *EGIEG83W,UK
M(Y+I_,G8,3YC8QN.3UP ,^@'I5NBB@"E)I&G3:M#JLME ^H0QF**Y9 713U
M/;J?S/K5VBB@ HHHH **** "HYX(KFWD@GC62&52CHPR&4C!!'IBI** *VGZ
M?9Z58Q66GVL5M:Q#"11*%5?P%6:** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MN6<\PMI;:6WN)+:>&4@E)$.",@D$=""/6L73?&C26EU/J5JMLW]J3:?;(9E
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M LWS D;0H+9]/?BJ5_XWD2**.ST]_MB:O%IMW!*Z@Q%B#D<X8,I&T^^3C&*
M.RHKE?'MS/:>'+:Z@DN(I4U&R&()"K,&N(U9#@@$$$C!XI8O'%HC7\&HV5QI
MU[9R0QM;7#QY<2DB-E8,5(.#DYXVG- '4T5RT/CFPD21)(_*N5N_LBH\J^7(
MVPON63.TIM!YZY&,9P#%!X\ANI+&"WTB^DN;N2XA5 8P \/+#<6P01@AAP0?
M7B@#KJ*S=!UF+7]&@U*&*2%9"ZM%+C<CHQ1E."1PRD<5I4 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 <6WA,7-AXE\/3R20P:G=/?6US&,["^UC_ ,"612<=P1[XNV>DZGI^
MN3:_JFH6]U(=/2T>&ULV0L5=F!&7;DE\8KIZ* ,3PEH\NA^'(+2XQ]I=Y+B?
M:<@22NTC 'N 6QGVJAJWA*YO[W7Y;?4HH8M9TY;*5'MRY0J)%# [AQB0\8Z@
M<UU5,EEC@0O+(D:#JSL * .1O?!=]=O(Z:T+9VT8Z6'A@(93D'S =_MT_6J\
MW@.[NK;6XI=4M8QJEG!;[;>R*)"\1;:5&\_+\WW?U%=F+RU+,HN8<JNYAO'
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M1MJ!W"[CZ#/4UAZIXCEAUE]'TNWM[K48[87+137'E!@6VA <'YCACSTP/7@
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M"$;9@[P@PG )QS6?=:=%:VUK8Z?HNIQVL]A?"":2W>5U,C*3$4QMBWGYLN.
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M22>@K&T*/1--2WMK"]:>2_B-U$\]RTTDT8Q\P9R25 =<#H,^YH J_$6S>_\
MA[KEK#:R74\MHZQ11Q&1F?'RX !.<USVIZ+:2^)-;>/0W:UF\/JJ8L'VO-NE
MX'R\OM9??G%>D44 >.ZU!J%UX6GLQHVI+?-X<M465;21WGD3<6C.1MC*'G&
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M0W,SM(V)'V!V^\P0G:K'N0 3D^M7]3TRTUG3I]/OXC+:SKMECWLNX>A*D'%
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M*UMU988EVJ&=G./=F))^I- ' 3:]J&C:AXMN6O'G$>J6EE;I,J^7")D@PQP
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MMR !SCWZUJ4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=S';7,@MGV0L^W:6./NG>O/OZ<U:_P"$FL1)K$;).KZ2H:Y4QX."I8%>?F!
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M>"Q&_=T[9Y%>S\,>(;.SL;;?I\ENFH7=Q=6S3R!)DFD=TR0G)0O]TC#>HXH
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MW=DRK<02@!DW#*G@D$$9P03T/I6?:^+8);_6H+BUGMXM,N$MO,< ^8[*A4
M]29% '_ZJM>'[74H(9)-4M=,M9WVCRM/R4XS\Q8JI.<],<8ZG-<_JG@[5;V7
MQ#Y%Q91K?7EOJ%H\FYMLT2Q#9(F,;#Y74$GYNG'(!JR>.='@$JS_ &F.>&[B
MLY8/(+NDDF-F=N1@@@@@D'IUXIDGCK3(A,KVFJ+-!:B[E@:Q<.D1+#)!'^PW
MY52N_#^NZAIMF);;1K6YBU&VNGAMI'$>V)PQ^?9DLWN ![\YM:EH&IW7B#5K
M^'[)Y-WI L(P\K!@X:0Y("$ ?O/4GB@"]9^+-,O[T6D'VK<]J;R!VMV"SQ#
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M",T >GT5YU>ZFP\7Q7$4UMJ=G/=VL9CCE*75FS*A5D'22%@0S#CJQYQQZ+0
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M  ]=O.>U5]+LFUGQOXB&JP6UPEA=VQMF.=\)$2.NT]N6)/J2>U ';@ = !0
M ,  #TKE?%?BRY\-BZF%I#)!;6R7&&DR\^7(955<E=H .YAC+ >M5-;\9ZII
MD_B+R=,M9(-$AAN9&>X8-+&P9B -O#84^WY\ ';4A (Y (]ZYBY\4W%GJ^JV
M%Q;1*T-FMW888DW8)*[<=F#[5QS]]3WJYXHC,W@?6$NDC9SITQ=1RN[RR>,^
M] &WA67H"I_(T$ C! (]*X*Z\67/AKPG9W"VD,D%KI$%T=TF7GXPR*JY*[0
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MQ;1VUR<QY"HI4%?DX)#'/7KVKIJ* .6FTW^V?$NGBYTRZ2/1'+I>SE MP2@
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M< -NRI/8="*U** .=MO"$%EK=Q?VVI:A%;7,_P!JET]9%\AINI?[NX9(R0&
M)ZCM7-:+I>MIJOVI3K-G>R732W,5Q!:R6X5I,LHE"^8R[>!AL\#@ 8'H]% '
M*IX&M8YX&35-06&VU)]2@MP8]D<C[RP'R9*DR,>22.Q%.;P1;;_-CU34(IQJ
M;:FDJF/*2LA1@ 4(*E6(P03[UU%% '+V_@:SM8;)(=1U!6LKZ:^ADWH64R[]
MZ<IRI\QO]KGKQ3G\$V,D5T&O+SS9M1&IQS90-!. !E/EQC QA@<@GUKIJ* .
M<N_!UI>Q2^=>77VB>\@O)KA=@=WA*F,?=P%&T< >O/)J_IVB1:=JNJ:@ES/+
M)J,B22K)MVJ50(-N%!^ZHZDUJ44 <Y?>"].U&;6&N)[LQ:KY;S0JZA4DC"A)
M$.W<&&Q>Y''2M"PT9+2_EU":XEN[Z2%(#/*%!$:DD* H '+$GU/L !IT4 9N
MIZ'9:M>:;=72L9=/G\^$J<9.TC!]1D@X]5%9[>#-,_X1O5-"A>>"UU*29YS&
MPW#S22P7(( P<#C@5T5% '/W'A."YO+NZDU"\\RZTX:=)CR\",%CD?)][+-[
M<]*K-X(MTN;&YL]6U*RN+:T2QDE@>,&XA7[JN"A&1SAE (R>:ZFB@#FKOP79
M7?\ ;(-Y>1QZM9I93(A3"1(& VY4D'#MR2>M:]SI4-YH4VD7#R/!-;-;2-D!
MBK+M)X&,X/I5ZB@#G;;PE';WMO>?VI?RSP6#6"L_E<QL0<D!!\V57VXZ=:IQ
M^ +6UBTK^S]7U2RN-.M19+<0O'OE@'1'!0J<=C@$9-==10!7^R*M@+2*22)1
M'Y:N#N8#&,Y;.3]<US47P_L!X=L_#]QJ6HW.D6VS%I*8@L@0[E5RJ!B,@'&1
MG'-=;10!RT_@:UGO)IQJ>HQI)J*:D(4:/:DZ@#()0G! Z$D#MBG'P3:F!XO[
M1OL-J@U7/[O/G!@V/N?=R!QU]ZZ>B@#E8_ EG#?)?1:C?QWB7TMZLZF,-F3[
M\9^3!C.!P>X!SQ6OKVBP^(-'ETRXGGABE9"SP[0WRL&'W@1U [5IT4 8=QX9
M@O;^*YN[NXG2&Z2\BB<)B.15"C:0NX#C)&>I/;BMRBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHK&U3Q7HFB
MWD=KJ-\()'*C)B<HFXX7>X!5,GIN(H V:*IW6JV-E?6=E<7"I<WKE+>/!)<A
M2QZ=.%)Y]*N4 %%5++4K345=K.4S1J2/,5#L;!P=K8PW/H35N@#A5T#55\1S
M36,=S:6=U/<_;;>>5)+=MRN$FBY+H[$KD<#EL]LY^EZ'K[1^&8+C1Y+9=.T6
MYTV=WGB(\QDA56 5B2A\LX/7U [];-XPT6"Z2V>:Z\V29X(PMC.PDD3.Y4(3
M#8VMTST-3V7B72]0U"*QMII6N)8)+A5>"2/Y$<1MG<HP0QQCK0!SFAZ#?LWA
M WEBUDV@V;0RM(Z,97,(BVIM8_+P6R<=%XZXY_PYINJPZ#X7U.WTF35;*32!
M:SVT5R(7C);>KC<RAE()!&?0\UZ/JD.FWT]II^H69N3(QFAW0LZ(R8Y+ 84_
M-QDC/.*T(XTBC6.-%2- %55& H'0 4 <%:Z/JVB:M>00^';6]TK4K6"-88Y4
M$5FT:E3&ZORT>"#E03U^7FM*S@UC1M;\3W2:0]XEY/!/;F.:-!)B**)E^9L@
MC:QYXP!@DUTM[?6NFVDEW>3I!!'C<[G Y. /<DX '<U33Q!ISW$5N6N(YI@Q
MBCEM)8V?:"QVAE&< =O;UH U**IZ5JEIK6F0:C82&2UN%W1N5*DC..AY'3O5
MR@ HHHH **1F5%+,0J@9))P *Q]*\5Z+K5_+8V%YONHT\TQ/$\99,XWKN W+
MG^)<CWH V:*IV>K6-_=WEK:W"RS6;JEPJ@_(Q&0,].GI5R@ HJC?ZO9Z;<6,
M%T[I)?3>1!B-F#/M+8) P.%)YQTJ]0 451O-6L["_L+*X=UGOY&CMP(V(9E4
MN06 P/E4GD]J-,U:SUB.XDLI'=;>=[>3?&R$2)PPPP!XH O4451_M:S_ +;&
MC^8_VTVYN0AC8#RPP4G=C!Y8<9S0!>HHHH **** "BBJ-WJUG8ZA86-Q(ZW%
M^[1VX$;$,RH7(+ 8'RJ3R: +U%%% !1110 444BLK#*D$9(X/<<&@!:*0LJD
M D L< $]34%I>17L<CQ+*HCE>(^;$R$E3@D;@,CC@C@]J +%%%% !112,P52
MS$  9)/:@!:*.HR** "BJ>J:G:Z-I=SJ5\[):VT9DE=8V<JHY)PH)IT6H0S7
M@M467>8%G#&)MFTD@?-C&>.F<T 6J*** "BD5E894@C)&0>XX-+0 4444 %%
M%% !1110 44C,J*68A5 R23@ 4M !1110 451U'5K/2WLTNW=#>3K;0XC9@T
MC= 2!@=#UQ5Z@ HHJC<:O9VNK6>F2NXN[Q7:%?+8A@@RWS8P,9'&<\T 7J**
M* "BBB@ HHI%974,I!!Z$&@!:*** "BJ-SJUG::I9:;,[K=7N_R%\MB&V+N;
MYL8&!V)JU<3+;6TL[ARD2%V"*68@#/ ')/L* )**C@F6XMXYT#A)$#J'4JP!
M&>0>0?8T_<H8+D;B"0,\D?Y(H 6BBB@ HHHH **** "BBB@ HI-R[BN1N SC
M/.*6@ HHJO%>137MQ:JLHDMPA<M$RJ=V<;6(PW3G!..] %BBBB@ HHJC9ZM9
MW]_?65N[M/8NJ7"M&R[69=PQD#/!!R.* +U%(652 2 6.!D]35+2]6L]8AFF
MLI'=(9WMWWQLA#H<,,, >#0!>HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH *YKQ5'8ZG8W/A^26",WR@W;,P7
MRX> S'_:(7:ON,]%-=+63>^%_#^I73W5]H6F75P^-TL]I&[M@8&21D\4 97B
M5TDU[P6\;*R-J;E64Y!'V2?&*/B+=RQ^!=8CL[CR[@1(LI1OFBB=PKOZC";S
MGV/I70W&FV-W+!+<V5M-);G="\D2L8SZJ2./PIWV&T^TS7'V6'SYT$<LGEC=
M(@SA6/<#)X/J: .?T22^T_Q3=: 9A<Z9!807%L_EJA@RSIY?R@ C"9'&>O6N
MHJO:6-I81F.SM8;=#C*Q(%!P,#I[<58H X[Q6%7QCX("@ ?VA/P/^O:6H=:L
MVN_B/9P0W<]GG1+HF2V(5_\ 70]"0<<\UUESI>GWMQ#<7=C:SSP',4DL*LT9
M_P!DD9'X43:7I]Q=_:YK&UDN?+,7G/"I?8>J[B,X/I0!P^BZ_JE[_P (+<3W
M[8U'2II;I-JA))%C0AS@9ZL3@''M6AX.U2_EU&73M86Y345LXY2?-$UM<KD@
MSQ,.FXD90@8XP*Z./0M(A-N8M*L4-LI6 K;H/*!ZA>/E!]JELM+T_3018V5O
M; J%(AB"<#H..PR>/>@#D_'S-#JWA&ZN#C2H=64W3'[J.481,WH Y')XR178
M3?9S/;B7890Y:$'J#M()'X$C\:?/!#=0/!<1)+#(-KQR*&5AZ$'J*JV>C:9I
MT;1V6GVMNCKM98HE4%?0X'3VH \VT34)8O!&@V=M?RQ3#2;JY\B-O+'RL )6
MDZ@*21M .XMSP*U-,UZ^O+BP>XU!ECNO"RWTN&"J)\IEQZ=?I78#PYH82V0:
M-IX2U)-NHMDQ$3UVC'RY]J5O#NB,EHC:18%+,$6R_9TQ#GKLX^7\* .";Q%J
M\?AC1M7NI;FXL6T:WGO9[.0">UD89,[1\"1#@Y Z;6('IHPZMJ.K:K>/#J\%
MC+I^K_9W@DE)W0@@!#%CDR Y#9SD\<#%=8OA_1D$072;%1"@CC"VZC8H.0HX
MX&><>M2/HNE2:LFJOIMHVHHNU;LPJ90.F V,T 7)$1XV2159&!#!AD$=\US=
MLUCJ_BNWUA;F K!;R6MD XW3;RK2.!U*XC 7U^8]"#71S0Q7$+PS1I)%(I5T
M=0593P00>HK.L/#6@Z5<_:=.T33;.?!7S;>U2-L'J,J <4 9/A[_ )'CQA_U
MVM?_ $G6M?Q"]ZFA71TZ:&*\(586F;:I8L %S@X)S@''!(JU!IUC:W4UU;V5
MO#<3\S2QQ*KR?[Q R?QJ2YM;>]MWM[J"*>!^'CE0,K=^0>#0!YI=7\FK?V+!
M)_:%C>0>)$AF@N6622V;[*YVJ_(=2#N#'/WJN6&KWC1II<^JW,LJZ[<V<2D@
M27,2(S!6E&-@7()89)"XP<UVIT322(@=,LV$,GFQ[H%.Q^FX<<-[]:C?P[HD
MD9C?1]/9#-]H*FV0@R_W\8^][]: .%TS4[G5K3P!=WEP)[@ZK=1O)D'=LAN5
M&2 ,\*.<<UT?@?\ U?B#_L.7?_H0K:30M'C,132K%3#*TT9%N@V2-]YAQPQ[
MD<U/::?96 E^QV=O;>:YDD\F,)O8]6.!R?>@#D_&NJ7%M-=06>H2Q7$&D7%X
M(481A"I&V5G[X(("8()/..*J1WTUSXIT^^^T11W$GA664S./D1S)$=Q'H#UK
ML[S2-,U">*>]T^TN9H@5CDFA5V0'J 2.,TQ-"TB,H4TJQ4I";="+= 5B/5!Q
MPOMTH X%O%&J:? UE>I>V.H?:;""[,LHFBCBED96N(I/1L%>0-IQQ74Z+<WL
M7B_6](DFDN+"WAMYX))3N:)I-X:,MU;[@89R1N],5KQZ-I<5K+:QZ=:+;S*$
MDB$*[74< $8P1[5/:65K81&*TMHH(R<E8D"@GIDX[\"@#$\27C)J.DV$=Y)%
M)=-*WD1MY?G*B9),F<HJD@G )/ QC-<EHNJ:OX@'A&";7;J :CI-S)=-;^6&
M:2-H@&!VG#88Y_0"O1;W3+#43";ZRMKDP/YD7G1*_EMZKD<'WK!N?!]K)XBT
MJ[ALM/CTZQ@N(_LHB RTI0E@ , C9^.X_B <OI.H:]JMQX<T^\UN[B%PNI03
M30+&K7 @E"1R E3@D?AW&.M.T^\U"]G\'#4YVN9K?7;ZU6Z("F=(X;E%?CC)
M"]1]:ZO4_#"7_B'1;P06?V'389HA;LG_ #T" ;1C V[/U[5KMI.FO]EW:?:M
M]D_X]LPJ?)XQ\G'R\>E '):7>ZD-<N/"UU>7,EY;WGVL7+'!DL3\R\XQ][]T
M1[$]:[6&>&X4M#*DBJQ0E&! 8'!''<&LS1]-O[>6:\U:ZM[G4)56+?;P&)%C
M4DJ "S'.6))SZ>E6-*TBTT=+E;2&.(7-PUQ((T"*78 $@#Z#ZG)[T 86K->W
M/CVQTJ/5+NVL[C2[B5XX"H(=9(0&!*D@X<U@^'-5U:Y_X0NZN]5N9SJ\$\5U
M&VU4.R(LK* !ALKUSW/MCT"73+">[6[FL;:2Y5#&)GB4N$/5=Q&<'TJ&+0M'
M@^S>3I5C']E)-OLMT'DD]=F!\N?:@#B-#UW4;J'P.)]2D:74)+N*Z!89E")*
M1D8Z@J.15?PU=-%X=T*S&J737%[>WI: R_-,$DFSF4G* '#$C))&,'FN]B\.
MZ)!<_:8M(L(Y_-,_F+;H&\P]7SC[W)YZ\FA_#NB2+M?1]/8>>;G!MD/[T]7Z
M?>]^M 'G^B7]UK-[X#O;[49FEDMKSS627:KLFT D# )QU..AJ[;ZIK\VD2M!
M)+J<EOK5[%+;B=8)YX(W=5$;  97Y3CC..OKVR:%I") B:79*MO*9H0+=0(Y
M#U9>.&/J.::/#^C! BZ38JHD,H"VZ##GJW ^\>YZT ,\.7T6I^&].O(9IYDE
M@4^9<)MD8XP2P[-D'..,UPVNZEK%NGC&ZAUJ[1M)O;8VJ )L :.)BK#;\R_.
MW'OZ\UZ5%%'!"D,,:QQ(H5$08"@=  .@JE+H.CSBY$NDV,@NF#7&^W0^:1T+
M<?,1[T <)X@U/5='C\900:M=R&RT^UO;>60J6B=VE#XP -I"#C&!S2>-M0N9
M8O'5C'?S"WM]!BN(TCDQL=O.W8(Y (1,CT^M=^=&TLR3R'3;/?<1>3,WD+F2
M/&-K''*X['BHK?P]HMK&T=OI%A$C0_9V5+= #%R=AXY7D\=.30!P_BS6KK3+
M+56TS5IWETRP@F"EPJPLTC<L>?-+@;=I& %/()%-\3:EJ\,GC:YMM:NXETFT
MM[JTCCV; Q1V(/R\J=O3W^F.X?PSH,@0/HNG,$A^SKNM4.V+^X./N\GCIS3V
MT#1G$X;2+!A<*J3 VR'S%7H&XY [ T <)XMU&76-(^(%G-=RVXTO3]L,$;[=
MRM;[R[#^(,24YX&WC!YK1N;_ %1-<O[*SU)8E_X1Z.>V$^!%%,790Q(&<<#K
MG^E=1=>'-$OI$DN]'L)W2(PJTMNC$1G^ 9'W?;I3VT+2&9V;2K$L\/V=B;=,
MM%_</'W?;I0!B^%M:\XW]MJ*W5A>PW$<;VE[,) C,@VB.3/[Q6P2.^<C XKJ
M)$\R-TW,NX$;E."/<'UK*O/#6E7=I':M8VRPI<)<8$*YWKT(XX;H,]0.!CMK
MT >7>$=1G32O!FDO>7'DZG%<RSRF4[V=.5C#=1G+-QR=AYZUU_@Z^O[NQU&&
M_E:<V6HSVD-PP ::-&^4G'!(R5)'4J:TO[!T?[*;4:59"W,OGF(0*%\S^_C'
MWO?K5R""&VA2&")(HD&%1%"JH]@* ."\?:Y>6":T^G:E*EQIVEK=")2$2%B[
MX=CSYA;;M"8P,')!857\1ZCJJW'C6:VUN[A32]+@O;5(MFU9-LS$'Y>5)09'
M>NZO-$TG4;C[1>Z99W,WE&'S)H%=O+/5<D=#D\>]-.@:,1,#I%@1-&L4H-LG
M[Q!T5N.0.P- '+ZMJVHZ-KD,KS336NM6?D6<6?DAO>H7(Z!P<Y.<>6?6NSM8
M6M[2&%YGF>- K2R?><@<D^YK,32+MM9CDFFM!I5H0]E:0VY1D?84)9MV" "V
M %'4>E;- 'EU]?Z\FG:_JUMKMV]QI>MB"WM2L?ES(3$/*8!<G.\@8(P<=\YO
M7&O7:^([&2VU.26WEUZ2PF+D(@18GS&L?.=K(,N<$GU!K?T+PNFGW^J7M[!9
MS3W=^UY%(J9:/*@!<D=1CK_M'IWTF\/Z*]R]RVD6#3O*LSRFV0LTB]')QDL.
MQZT >;ZH-1O?A_XAU&[U[49#!>75HL0=$38MUM!.U0<[1CKC!(Q71ZSJ%[X<
M\01#[5<W=EJELUK9H[Y$=ZOW5)'0.,\GH4/K74QZ-I<5G/9QZ;9I:W!)FA6!
M0DA/7<N,'/?-4TT>Z.KQ-)+:+I%GM:RM(;<HR.$*?,V[! !; "CJ/2@#4M('
MMK.&"2=YWC0*TLGWG('+'W-><:_JVM:7=ZWIT%U=SW=O+%JMJH?!>R S+'T[
M&-U'?,B<UZ;49@A:;SC$AEV%-Y49VGG&?3VH X#79FU6PT348;N46]]KUL]H
MW!V1895901CYL%QD'[P]*BAU[4;27^RYKZ>2 ^)CIANY"/,2$PB55W =2Y"
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MB(Y([AR[QLN_/!(PP/\ ".#S4[>"WC-E<6U^D=]!JDNIRRM!N25Y$=&4+N&
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M(5)8'S-C%21[9!'/I7.:-XRFN[!)+VQ\NZN=2GL;2".0'>T;R Y/8*L9)/Y
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MK#Y_D/R<_>SD]*Z'3XKN'3X([^YCN;M4 EFCB\M7;U"Y./SH LT444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M."&_NFMY9KE21'B*20'[RCJF.?6@"?\ X22V_P"?#5O_  73?_$T?\));?\
M/AJW_@NF_P#B:CM_$EG%!;B^OH)))Q&Z2VT+^68Y9"D+'KMW' Y/7/:I;KQ'
MIT2W$:W>R5(IG$AMW=/W7#XP/FVD\@'/7T. !/\ A)+;_GPU;_P73?\ Q-'_
M  DEM_SX:M_X+IO_ (FLR3Q/-%/J@FN[:.UMM.L[N*Z^RR, 96E4ED#9(_=@
M@<8SR36A%XKTU[ZYM)?M$+PWXL%9X'VO*45P 0,#.[')[>XH ?\ \));?\^&
MK?\ @NF_^)H_X22V_P"?#5O_  73?_$TO]O0W&KP:=9G?(RS22LR, B1.$8
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M4 8W_"26W_/AJW_@NF_^)H_X22V_Y\-6_P#!=-_\36S10!C?\));?\^&K?\
M@NF_^)H_X22V_P"?#5O_  73?_$ULT4 8W_"26W_ #X:M_X+IO\ XFC_ (22
MV_Y\-6_\%TW_ ,36S10!C?\ "26W_/AJW_@NF_\ B:/^$DMO^?#5O_!=-_\
M$ULT4 8W_"26W_/AJW_@NF_^)H_X22V_Y\-6_P#!=-_\36S10!C?\));?\^&
MK?\ @NF_^)H_X22V_P"?#5O_  73?_$ULT4 8W_"26W_ #X:M_X+IO\ XFC_
M (22V_Y\-6_\%TW_ ,36S10!C?\ "26W_/AJW_@NF_\ B:/^$DMO^?#5O_!=
M-_\ $ULT4 8W_"26W_/AJW_@NF_^)H_X22V_Y\-6_P#!=-_\36S10!C?\));
M?\^&K?\ @NF_^)H_X22V_P"?#5O_  73?_$ULT4 8W_"26W_ #X:M_X+IO\
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M0!D^(M'FUS1S9PWGV642Q3+(8]ZDQNKA67(W*=N",CBLK2O"E]I.O7&HP:I
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M\F$QHXBW%!@L2"&;.<G@ 5>:Q9M6:_,H++;^1"I7_5DMESUYSB/C_8]ZNT4
M8NC:9J]C<2R:AJEI=K)EF\FR,+,_&"S&1L@ 8  %-/A:QN-,MK6]WS30AR9H
MY'B+/(=TC?*PZMSC)K<HH Y2U\*_8K+POI$3N]MHS+/).V?WC+$R*!DG&6<M
MC. %QW%=7110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
5%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>exhibit1033-bochk_facili019.jpg
<TEXT>
begin 644 exhibit1033-bochk_facili019.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MY)4MU^7.2/:O7K;Q9HU[JRZ99W,ES<')S#!(\8QUS(%V#\Z -NBBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MP"15Q(9-I?)P>G;..>E<SX?\9>(KOPCX$:XO9<ZWJ$T-_J!4;E"R,$C'&%+
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MP$A<E<;_ # -P&,#C(QT]JVY]1U&'P1J^I/>75K?1Z3-/;Q22JY<I"KB=?\
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M$\3_ /0W?^4V+_&@#I:*YK^Q/$__ $-W_E-B_P :/[$\3_\ 0W?^4V+_ !H
MZ6BN:_L3Q/\ ]#=_Y38O\:/[$\3_ /0W?^4V+_&@#I:*YK^Q/$__ $-W_E-B
M_P :/[$\3_\ 0W?^4V+_ !H Z6BN:_L3Q/\ ]#=_Y38O\:/[$\3_ /0W?^4V
M+_&@#I:*YK^Q/$__ $-W_E-B_P :/[$\3_\ 0W?^4V+_ !H Z6BN:_L3Q/\
M]#=_Y38O\:/[$\3_ /0W?^4V+_&@#I:*YK^Q/$__ $-W_E-B_P :/[$\3_\
M0W?^4V+_ !H Z6BN:_L3Q/\ ]#=_Y38O\:/[$\3_ /0W?^4V+_&@#I:*YK^Q
M/$__ $-W_E-B_P :/[$\3_\ 0W?^4V+_ !H Z6BN:_L3Q/\ ]#=_Y38O\:/[
M$\3_ /0W?^4V+_&@#I:*YK^Q/$__ $-W_E-B_P :/[$\3_\ 0W?^4V+_ !H
MZ6BN:_L3Q/\ ]#=_Y38O\:/[$\3_ /0W?^4V+_&@#I:*YK^Q/$__ $-W_E-B
M_P :/[$\3_\ 0W?^4V+_ !H Z6BN:_L3Q/\ ]#=_Y38O\:/[$\3_ /0W?^4V
M+_&@#I:*YK^Q/$__ $-W_E-B_P :/[$\3_\ 0W?^4V+_ !H Z6BN:_L3Q/\
M]#=_Y38O\:/[$\3_ /0W?^4V+_&@#I:*YK^Q/$__ $-W_E-B_P :/[$\3_\
M0W?^4V+_ !H Z6BN:_L3Q/\ ]#=_Y38O\:/[$\3_ /0W?^4V+_&@#I:*YK^Q
M/$__ $-W_E-B_P :/[$\3_\ 0W?^4V+_ !H Z6BN:_L3Q/\ ]#=_Y38O\:/[
M$\3_ /0W?^4V+_&@#I:*YK^Q/$__ $-W_E-B_P :/[$\3_\ 0W?^4V+_ !H
MZ6BN:_L3Q/\ ]#=_Y38O\:/[$\3_ /0W?^4V+_&@#I:*YK^Q/$__ $-W_E-B
M_P :/[$\3_\ 0W?^4V+_ !H Z6BN:_L3Q/\ ]#=_Y38O\:/[$\3_ /0W?^4V
M+_&@#I:*YK^Q/$__ $-W_E-B_P :/[$\3_\ 0W?^4V+_ !H Z6BN:_L3Q/\
M]#=_Y38O\:/[$\3_ /0W?^4V+_&@#I:*YK^Q/$__ $-W_E-B_P :/[$\3_\
M0W?^4V+_ !H Z6BN:_L3Q/\ ]#=_Y38O\:/[$\3_ /0W?^4V+_&@#I:*YK^Q
M/$__ $-W_E-B_P :/[$\3_\ 0W?^4V+_ !H Z6BN:_L3Q/\ ]#=_Y38O\:/[
M$\3_ /0W?^4V+_&@#I:*YK^Q/$__ $-W_E-B_P :/[$\3_\ 0W?^4V+_ !H
MZ6BN:_L3Q/\ ]#=_Y38O\:/[$\3_ /0W?^4V+_&@#I:*YK^Q/$__ $-W_E-B
M_P :/[$\3_\ 0W?^4V+_ !H Z6BN:_L3Q/\ ]#=_Y38O\:/[$\3_ /0W?^4V
M+_&@#I:*YK^Q/$__ $-W_E-B_P :/[$\3_\ 0W?^4V+_ !H Z6BN:_L3Q/\
M]#=_Y38O\:/[$\3_ /0W?^4V+_&@#I:*YK^Q/$__ $-W_E-B_P :/[$\3_\
M0W?^4V+_ !H Z6BN:_L3Q/\ ]#=_Y38O\:/[$\3_ /0W?^4V+_&@#I:*YK^Q
M/$__ $-W_E-B_P :/[$\3_\ 0W?^4V+_ !H Z6BN:_L3Q/\ ]#=_Y38O\:/[
M$\3_ /0W?^4V+_&@#I:*YK^Q/$__ $-W_E-B_P :/[$\3_\ 0W?^4V+_ !H
MZ6BN:_L3Q/\ ]#=_Y38O\:/[$\3_ /0W?^4V+_&@#I:*YK^Q/$__ $-W_E-B
M_P :/[$\3_\ 0W?^4V+_ !H Z6BN:_L3Q/\ ]#=_Y38O\:/[$\3_ /0W?^4V
M+_&@#I:*YK^Q/$__ $-W_E-B_P :/[$\3_\ 0W?^4V+_ !H Z6BN:_L3Q/\
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M\W#>G/ [9K&U+Q9J0T31M?L9=1OM ,,WVPQ2!+J!C(0KN!PP7! S\IVG/44
M>G?\)'9?\)'_ &!]HD_M'[/]I\O:V/+SC.[IUK2\R3^^WYUY:FN:M+X]-MI5
M\]U'-X:^UVR2\+),?N,0>F>.,]S3?#5QXCU+4?"[?:M3>&2WEEUEI,J@<$[
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M9)_?;\Z/,D_OM^=-HH =YDG]]OSH\R3^^WYTVB@!WF2?WV_.CS)/[[?G3:*
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MC[!/_='YUK44 9/V"?\ NC\Z/L$_]T?G6M10!D_8)_[H_.C[!/\ W1^=:U%
M&3]@G_NC\Z/L$_\ ='YUK44 9/V"?^Z/SH^P3_W1^=:U% &3]@G_ +H_.C[!
M/_='YUK44 9/V"?^Z/SH^P3_ -T?G6M10!D_8)_[H_.C[!/_ '1^=:U% &3]
M@G_NC\Z/L$_]T?G6M10!D_8)_P"Z/SH^P3_W1^=:U% &3]@G_NC\Z/L$_P#=
M'YUK44 9/V"?^Z/SH^P3_P!T?G6M10!D_8)_[H_.C[!/_='YUK44 9/V"?\
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M0X^7"\<8&.U<+I/@W6;75--O;^]L9I;>TN;6YG5',MSYA0B0D_Q?)TZ#MD<
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M:LQMW#F0X[OR">,'CB@#T?6-:M=%CM_-226XNIA!;6\0!>:0Y.!D@# !))(
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MQVQDB9M#3Q+??;5VDJ(V,GDLP_YY[BIST^Z>@IMY8;6C3:W]CMXGA>P4$@+
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M"LJ&5 &9 PW*#T)';.#^5/KS;4[O5-%\5>*]2L18-<6FB6MU.98F"R[#<$@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110!S1\#Z4;O[0)KY<7YU%(UN6"),P;<0/1MS9^IQBGIX.L(X8(A<
MW>V#4&U),NO^O8LQ)^7IEFXZ<_2KMQXCTJTN##-=;2LRV[R>6QC21L;49P-J
MDY'!/<>HK'EUF^U7Q;J&BV%W+8M81V\@=K(R)*7:3>') PNU  0RY)."<8H
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M<1^8=[%<*-F3DD9QQ0!!I_@G3],LI+2"\U,P[1' )+MG^RJ""%BS]W! ZY/
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MLH$NY@.F<;??- #'\':=)I&H:;)-=M#?77VR1O, =)MX?<I &/F4''3BHY?
M^F30:E"]Q?D:C+%+<L;C)9XPH!&1Q]Q<_3 P.*Q]"\2ZO?0>!99[A"-7MY7O
M%$0&]A"7!'ISV%=;JFN:?HS6JW\YB-U)Y4($;-O?!.T;0>< X'?'% %B\LTO
M=/FLY9)0LL9C9T;:XR,9!'0UB7O@K2]2AN1=O<R7,\L4QO%D$<R/&,1LK(
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M,TO4IIG:2[@6>Q^P31V\VQ9(1NV@C_9WMCZ\Y'%.'A*Q6:65;B[#26"Z<<R
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M(8[R2WAN(EMKF2W/G1,F2C%2>0.X/'4<9Q0!/?Z+;ZA?:;=R22I)ITIE@$9
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MQE:1UUZWM(HEU6"<*'(=BT<\? D3!!X4Y);&*C\2:;<6T'BF6ZAA5=6O[/[
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** /+/$5TUM:_$R>WNY+>>%K9TDAF*,I^SQXY!!J3Q?KZ6VJZBUMJ
MTL-Q8WNG*RR710(KR1[A'&,!D*.2S-GN.W'I)L[5BQ:VA)<Y;*#GZT&UMR<F
MWB^Z%^X.@Y ^@H \JU*)RGC2^T[4KN#5[?58WL(K>Y91)(T$&P&,'#AS\OS
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M@<U8L]4U&[T?1]1CNYQKYUO[->6AF;&SSF62,QYP%6+Y@<9 4-W.?1OL-H
M+6# .1^['6GBW@6X:X$,8F8;3(%&XCTSUH YWQ?J%O:3:-;SW<EO]INV4 S^
M1%)B)SB1^H'< =2 .F:XNSUC4KKP?I-S!J"ZC);PWPN[0WSPS2QI*!YB2 _?
M1=O#=0^<YYKUB2*.4 21JX4A@&&<$=#]:CDLK25562UA<*VY0T8.#G.1[YH
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MU#"!'G#B0E@<@Y)([#&MHD#7WCSQ"UQ?WI-A/;O%;+>/Y:%X!N!3."I))P>
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M3W/FR33H4:/>GW5?E@$4<#(^GK8LK5=N+:$;3E<1C@^M.2W@C8,D,:D$D%5
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M&GV<=K;ILBC& /U)_$DF@">BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MI=PXWQ,1@]005(."#P13+K0#JVF75AK5V;R&YA:!TC3REVL,$@9)W>^>.P%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MYB3P2#P#TH ZY-3L)//V7MNWV=0\V)!^[4C<"WH".>>U1Q:SID\$T\5_;-%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %*PTFRTR6ZDM(F
MC:[E\Z<F1FWO@#=R3S@ <>@]*NT44 %4(]%TZ+6)M72TC&H3((WN,98J.@]N
M@Z>@J_10 4444 %%%% %*\TFRO[RTN[F)GGLW,D#"1EV,003@''0D<]B:NT4
M4 %%%% !1110 4444 %4]3TNSUBR:SOXC+;LRLR;V7)!R/ND=" ?PJY10 BJ
M%4*,X QR<FEHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MA_P@DDZ3V%WI$TGV=8MK(8D5P0V<DD$@YXZ8H ]3JC=ZSI>GW"6][J5G;3R
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M"JJ^I)XQ3H)XKFWCGA</%*H='7HRD9!%<#JTM[+K_BN.2^E:VC\/1RK;E5V
MN+@'MG^$'U_# JSX2U#4H-1T;2;BYCGM+G04NXU$6TPLAC3 .>00_?N.V<4
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MHO;VUTZSEO+V>."VB&7ED.%4>YKAM2\2ZW:VWB%H;BV$ECK=I9Q$V^1Y4OD
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M.".XH J:]X162Q6'2[*&:.6_^VW<$]Y-$96VD;DD&XHV=IXQG&.*DTKP?;K
M!J$,ZQI-'<06O]IW%P(9$SAP[D')R..@V^YJ8^-M/5;TM9Z@K6MF+XH8,-+
M<Y=!GG&#D'!]C6K;:Q;W<]G%"DC?:K;[4CC:55.,9(/4[AC&<\^AH K2^%-&
MFBNXY+5RMW<K=S'SY,F9<;7!W94C:O*XZ"IHO#VF0W*W"6[[TE\]%:9V19,%
M=P0G:#@GH.]0^*M<?PYX<N]4CM7N6A  C4@<DA03DCC)&<<U4N/$%I9ZW=FX
M;4HY;;3!=2VA16C6,,?F&,Y?@C@D8% ">(-$N=5\2>'[I(\VMC),\[+.T3C?
M&4&W;@]3SR./6M#_ (1O2=UBPMF#6,K36Y69P5D;.YC@_,QW-DMG.XYZUG1>
M-[*>:*"'3M4>:>T%Y;1BW&9X^,E><#&X9W8ZC&<BI&\::2=+M;^ RW"75J;N
M..,*K^4,9)#$<Y.,9R3G .#0!=N/#>DW5]/>2VF9;@()P)'5)MOW=Z [7QT^
M8'CCI5RXT^TNKRTNYX$>XM&9H)".8RRE6Q]0<4FG:A:ZMIMMJ%E*);6YC66)
MP,;E(R..U4+SQ-96=Q+&8KF9()X[>XEACWK"[[=H;G)^^I. <!@3B@"6X\.Z
M5=7=Y=7%H)I+VW%M<>8[,LD0SA2I.W'S-V[FJUKX.T*T=F2S>0M:FS;[1<2S
M9A/_ "S.]C\O/2L/2/%;6-_J]OJCWMQ&-=^Q0W'E QP!TB$:,1C +-C@'&><
M9S6Z?%-BNI16;17($MVUDDYC'EM,J%RG7=T5N<8R.M $<'@?PY;:1<:4FFAK
M*X"B2.2:20X4Y4!F8E0#R ",'IBKFF>'M-TBZGNK.*47%PJ)-++<22M(%X7)
M=B3C/6LR'QWI<MO=71M[^.UM3(DEQ);%4\Q)!$8P?[Q8C [_ (&K(\7:<EQJ
M%O<)<6TVG^7YZRH.#)@1@$$@EB0!@]?I0!<G\/Z5=7]Q>SV:23W,'V:?<25E
MCYP&7.T\,PR1G!([T[3M$T_2F#6L3AA&(E>69Y65!T4%R2![#BH='\166M7%
M]:V^^.YL75+B&3:2NX;E.5)4@CT/8UK4 9]WHFGWNHPZA/ QNX8VB25)60A&
MP2#M(R,@$9Z$ C!JM:^%=&LCIWV>U=!IJ-':#SY"(E88( +<@CCG-1V_BS3[
MB^@MMEQ$+CS_ ")I$ 27R3B3'.1CW R!QFD3Q;8/I_V]HKB.V=('AE<)MF$S
M;(]I#8R3C[V,9&<4 2Z/X4T30+B6;2[$6[29X$CLJ G)"*20@)ZA0!P*FO\
MP_IVIZA;7]U',;JU#+!)'<R1F,-@-C:PZX&?I5&]UNW-SI*3_P!I64DVH&W2
M-47$CA'.V0\C80"1@\X%++XQTV*:)?+N9(I;UK".>./<C3KG*=<\%6&<8RIY
MZ4 2OX1T*2RN;1[ ,ES*L\SF5_->12"KF3._<,#!SQ3!X-T%2Y6R92]TEXQ%
MQ(,S( %?[W7@?4\G)J"/QQIDETD(M[Y4-^=.:=H,1I/G 4DG/)X! ^N,BNEH
M Q9?">BS/.TEM(3/=)>2?Z3*-TR8VO\ >ZC:N/\ ='I5>^\&:5<V=W;P120?
M;+D74K)<2C$H.?,4!L!L@>V<9!QBI8_%NFR368Q.MM?2M#:794>5-(,_*"#D
M9VMC( ;'&<C+M$\46FOS.EG:7ZQH95:>6 I'OCD*,F?[V1G'I]"* -'4M-M-
M7T^:POX1-;3 !T)(S@Y'(P0<@'(K/D\)Z-*+T26LC"^MUMKG-Q+^]C4$!3\W
M^TWO\Q]35[4=3M],CA,VYI)Y1#!$@RTKD$A1GCH">2  "36!J/C>&WM%:UL;
MB:Z34X-.N+9MJO \C*/FRV#E6!4@D'(YQG !>NO!N@7M[;WEQ8;[BWB$*OYT
M@+1CHKX;]X/9LUI:GIEIK&G3:??1&6UG4I+&'9=ZGJ"5(.*Y"'Q8VD^(/$BZ
MH;Z:RM[NV1"(E9;19(D/S$8XW/VR?PYK;U/QCI.DW+Q7+OY<4\=O/,NTK#(^
MW:&&=W\2\@$#<,XYP 6(/#.DP75K<_9Y)9K08MVN+B2;R>,94.QVG'&1S4%O
MX+T"UG@G@L3');R22PD3R8B9\[MHW84'.<#C/.,U2E\?Z;%!J%P+#59+;3VE
M6YF6U^2,QD;@22/7/T!K0?Q191WNH6CQ7 EL;1;V3A</$V[!3YOF^ZP_#W&0
M!;?PGHUHFGI!:R(NG[_LH%S+^ZW AL?-W!/7UI+;PCHEF]@]O:/&]@9/LS"X
MDS'O.7&=W()YP<BJH\1V%IJ>LR7$]\C6L=KYMO.JB.,R%@@3W8\$DXX'(&:N
M3>([:W0":WN(KAI6B2V?8KN54,2"6VXP1SNQVZ\4 7+W2;+4;FSN+J)GELY/
M-@82,NQ\%<X! /!(Y[$U2/A/13"T1MI=C7@OB/M,O^O!W;_O=<C/I5K1-:LO
M$&E1:E8.S02%EPPPRLI*LI'J""*@U3Q'::4UPC0W-PUK +BY6V0.88R2 Q&1
MG.UN!D_*>* (%\&Z#'=+=1V&)H[IKR/]])M25@=S*-V%#;CD 8.>0:=HFGWO
MVRXUC5[:S@U.XB2 I:N9%6-"Q WE5))+L>GH.V:C/C#3_P"UY].6WOG>W\LS
MRBW/EQ(ZLP=F/1<*>?\ Z^(1X[T423)*T\7EV;7R90-YL*]64*2<C(^4@-R.
M* -Z_L+75+">QO85GM9T,<L;=&4]138].LXM0EOX[=%NI8DA>4#DHA8JOX%F
M_/V%<]J_C:/3])U:>+3[EKW3FB26VDV J9<;&)#8*\]CG@U9U7QGIFC)*]ZL
MT:VX1KK&P_9@_3< V3ZG;NP.>E %C_A$M$^QBT-HWDK=F]4>?)E9B22X;=D$
M[FSS@Y/K0_A/17BGB:UDV3W2WDB_:)1NF4@A_O<$%5Z>@]*V000"#D'H:QHO
M%%A*DTY$J6423NUXP7RL0MM?D$D$'/! S@XH E;PWI+7LMV;7]Y-(DTJB5Q'
M)(N-KLF=I887DC/ ]!5>^\':%J5U=7%W9-))=-&\X$\BJ[)C8VT,%W#:HW8S
M@8SBH4\;:1]HNK>=I;>>WA2<QR!6,B.VQ2NTG)+87;UR1QR*DD\6V=N[QW-I
M>P21WD%FZR1CY7F($9R&(*DL!D$X[XH T;?1K"UU2YU*"#9=W*JLS[V(?:
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M=9%^8JR.IRK*P(*D'N"#5:7PYI4UD]I):EHWF6X9C*_F&5<;7\S.[<,#!SD
M =JYO1?%;65[J=MJCWMPAUUK&&Y,0,<6X((T8C'5CC@'KSC-;-QXQTJVU&&T
M=G(FN_L2S+M*>?R-G7=G(*YQC/&: +<WAO2;C3IK":U+P3RK-*6E?S'D4@JQ
MDSNW#:N#G(VCTJK+X*\/3S22R:?EI)8YV GD"^9'C:X4-@,-H&1R0,'-<Y=^
M+[Z_TW2-1BAN[!#KQLI8E".9HU>1"ORECG*#.,<^HYKH[?Q?IT]BUP4GAE6[
M:R-M,%63SE&XKR=OW?FSG&.] $LWA/1;A;M9;61A=W"7,X^T2#?*F-K<-QC:
MN,?W1Z"EN?"FC7BZB+BUD<:CL^U@W$G[W:,+GYN, =L5G+\0-(DBMC##?337
M%Q-:B"*#>ZS1*69#@XSA>,$@Y!SCFNFMY?M%M%-Y<D?F('V2+M9<C.".Q]J
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M:W.X),I7"DXZ[3SM/!]L UAZ-X.U;2H_#6;FQ=])^TQ2 !P&CE(P5_VAM''
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M]*Z^"Y@N?-\B59/*D,;[3G##J/J*1[B"">&!Y$66<MY:=V(&3C\* )JXG5O
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M= ()73H%8>A$8!!]P:YC79C-<>,K;47>+4XXUDT0J2'*^2-GD=RWFA@=O))
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ML*1D87.P?B!WJ?Q'86ZQ^/M*MD:6*+P_;""W9VEPR+/]T,2<CY/?H>]>L44
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M-X/L#K<VJ)<WT;W&PW4$<^V&Y91@,Z@<G  ., @8((H YF+5)?#U]XMNK.&
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MX"EQ<M:1DHPS,I(*'CA@588..AK.O/&>AR6=_':ZY;P3P0S$SM$SK"4X9B.
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M?9K:Y#3&(3*C(R%XR<;UW ;E]QD<CUKF_$7AO4M6UW6! H2UU30O[/\ M/F
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ML?D/$KH,[N=P)! /UZUZ+0 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M2=3 \WV5XX[I(W7S8RX4_+']Y\!U)QV/&2"!:_X23S;H+::=<W5J+TV,EQ$
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M")%+,9?+'D1'"DG[I)) XZ]!TIWCZXFM-%L;BWDN%D75;(;8)"ID5IT5E."
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M#"('W6DP 7SRN.!(%P>,C@]VKNI[JWME9IYXXE5&D8NX7"KU8Y[#N:(;F"Y
M,$T<H*JX*,#\K<@\=CV- '">'K>[:"/2=0T2Z76+"ZN9(]2DC_<YD+XF63^(
MLKXV]<GD #-95EIZW'AAEU+0=3M]4TO2+BUFFNB?('[O#;#G$@9E##KCKD'K
MZK4%[9PZA8SV=P&,,Z&.0*Q4E2,$9'(XH \XT?1%OU\-7VEZ>UL8-#EBNY3
M8O.,D:!$)(&_Y@S9&0,9SR,]-X9@N&^&UA8R6D]O=1:8ELT4Z;&\Q8@IX/;(
M(SWZ]*Z"QLH=.L(+*V#""",1QAF+$*!@#)Y/%6* /-M'L9I)? 0N](NU33M*
ME@N1-:L1')Y<*C/'<H^/IZ$9H:?9:E!X?TBP;1;Z-QI]];B9+<EXRT@VPD-\
MJ*R@'<1_" ".:]2NKJWL;:2YNYXK>",9>65PJJ/4D\"I497171@RL,@@\$4
M>?\ ABVO[76/#-Q<Z;>(O_".K9R,\7^KF5HR0_\ =X!//7'KQ4VNZ4+GQGJE
MP^ER3Q/H#0++]F+AI=[_ "@XY.TBN[HH \YT&VO;"YLY-8TZ\N+*Y\/6UGM%
ML\ABE0-YL;J 2-VX<G@[>O K5L=&NK3X5V^CZL+N:=+%89A:MNF7MA3SDJ/K
MG;78T4 >9S6VN+:6\]];S:@ECKMO<_:X;)HY[F$1;2[0@9++D*2HY"Y XJ(1
M:O:S7&J+HU_);0>)7O9K41?O)H&@V!U7/S;7(;'7CU%>E?;;4WWV$7,/VOR_
M-\C>-^S(&[;UQD@9]ZGH X&YT^*YUCPS<6^@W%O9_P!IW-W/');DD;X7'F2+
MSM)D8<'GH3CG%_PG8WD/A35;*.*6RF:]OC;"2,Q[%>5VC8 CIA@:Z^J=QJ^F
MV<WDW.H6D$N,[)9E5L?0F@#A-/CDN_"!MYO#-]:ZO8:-+8/))"1\Q0 I&1GS
M S*#D9'J0>M8:9=6OV5K;09I\>$YK66W,+1++-^[(B9L#!.'_,^M>G1R)-&L
MD3JZ,,JRG((]C3J /(-4TW4;W3_%:KI6I3#4-"MH[;S+/9F5#,"@4<KC<H .
M3CG)'-;^O"#2-?T>\TW2YV#6=RLMO;V+2* _E#<T:_,&RHY(Y (..*[F>]M;
M62&.XN88I)WV0K(X4R-Z*#U/TJCJ/AW3]3OH[Z87,5TB>4)K6ZE@8IG.TE&&
MX9).#0!P%E:QZ3;Z#]EL=7U#1(=.DTZ86]LR3Q3;EW&2$X8!@I!ZXP.QS7::
M'<VNEMI_AN'3KZU5+$2P^;F2-$4[?+,F3EP",CD#(Y-;$45MIMGL7;%!$"S,
M[].Y9F/4]223[FF6=SI^H[KRRGM[G!,)FA</@@\KD=.>HH \_P#&EOJ%U=ZY
M!;:1>Y;[#)'+;0;Q=B.0,Q9CG!3G"KAN_(/%[[-J4/BP75C#=RVD]ZSW5C>6
MQQ"?)*^?#,!@9 "E<G[QQBN]HH \HDTK5?\ A$->TI+:[O[)]$,-B;JR,=U$
M^&"6[< 2;<Y# <=SSFI_$:M)J5]:_9-2EAU'0HK.X:*P>X\C)DP0J\JP#,2"
M!GY3G@UZA6/=>&=-NM3?4#]KAN90HE:VO)H!+M&!N", V!QD\XH XR;3+2\U
M:]N;/3)I[&3PT+>"5K-OFDW/\O*_?P1D=>U+IFE.VI6$U[I4[!?"Z6TK26C'
M]\,90\?>QFO1XHHX(4AB14C10JJHP !T I] 'EFFZ)J$5EX.BM;&>TO8M"N;
M6XF^SLGE3-%&%WMC^^K'\,]Q1%IPU+PM>>;X;U>#5[;1)K!A<*Q3)3 CC )$
M@+@$$# QG(KU.B@#S8:-<?;/+M-,FB$OA5[0D6Y13.2"$)P!N^]U]?>M6YLM
M3U3X1OI]A!-;:BVF+ L4Z^4Q8( R\],X*Y/KGIS783SPVT+37$J11+]YW8*!
M^)IMI>6U_:QW5G<17%O(,I+$X=6'L1P: .!UJPFUJXN-2L]-NH(/^$?N+2>"
M6U9&DD;:8HPA'S;2'Y&0,\'FNJ\+V,%AX9L%CLA;2FUB$R>5Y;EP@!W< YXQ
MDUJ1W=M+<S6T<\3SP;?-B5P6CW#*[AU&0.,U-0!Y0-*\0)H-S9:?!=7EG%9V
M[VRW<!@NHU29&:T+D 2 HK -CV).<U<O+:66W_X2#2=!UC=_:%K<7]O=@B>Z
M2(,"%B8]4RC#IN*\9P*]+HH X'4X R:/K%CH5[! FN?;;F,6[&9@T+QM*8AE
MA\S*",9P,XK)_LNYN%@^TZ)=X'BR2[*R6Q;$#!OG.,_+R/\ Z]>FVM[:WRR-
M:7,,ZQN8W,3A@KCJIQT(R.*A?6-,CBNI7U"T6.S.VY<S*!"?1SGY3]: .*UG
M0Y6UKQ-!IVF-'#<>&A:0>5!LC>4&;" XQG#I_D4_4H+^'3/#OB#2K1HM4MXT
ML'@N5\MI(Y=J88'GY9-C_16]:[^L^31;&76H]7DCD:\CC\M"97**.>0F=N[Y
MB-V,X)&: *&KZ5;Q>#9-+"WCPK$D6ZUYF'S#YQP<L/O'@YP:Y+[#K%S=Z/'J
MEHU\EOKWG->+8M&9XOLK()98\?*0S*F<#.W(&.:]'N;F"SMI;FZFC@@B4O)+
M(P544=22> *D5@RAE(*D9!'>@#S/3[>]L;N)!HUZD)UN_D2XCM27MT?.PHA&
M 'W$;B"!SG&<A/"]CJ%JO@5+G3;V$V%O=Q7&^!OW9( 7..@.#CZ>F*].HH X
MKP?$+/P_H]M?Z/=-="]NC&SVO-L6DE<.2W* J<9'][%=K110 445!=7MK8HC
MW=S# KN(T,KA0S$X"C/4D]J )Z*** "BBH([VUENY;2.YA>YA4-+"K@N@.<$
MCJ,X.,^E $]%%% !15";6])MIFAGU2RBE3AD>X12OU!-7(I8YXDEBD62-P&5
MT.0P/0@]Z 'T452FUC3+=;AIM1M(UMG$<Y>90(F(!"MD\$@@X/J* +M%0K=V
MSW<EHMQ$US&BR/"'&]58D D=0#@X/L:FH ***K3ZC96TZ07%Y;Q32?<CDE56
M;Z GF@"S1110 4444 %%-:2-&17=59SA03@L<9X]>*'ECCV^8ZKN;:NXXR?0
M>] #J*** "BBB@ HJI-JNG6]U]EGO[6*XQN\IYE5\>N"<U;H **** "BH;JZ
MM[&UDNKN>*"WB7=)+*X55'J2>!4W6@ HHIDLL<$32RR+'&HRSN< #W- #Z*I
MVVKZ9>R^5:ZC:3R?W8IU8_D#5R@ HHHH **** "BBB@ HHHH **** "BBB@
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MC6.[!F?#JHPN!GY<>HQ2MX8TYR1)]IDC9HWDCDN'=9&C(*,P).2"H.>^!G-
M&S7"R^,=0_L)_$<*PM81:H;.2T*'S#$)_(W!L_?W?-C&,<=>:[JL=/"^E)=R
MSK"X66Y%V\'F-Y33@@B39G&[(!],@'KS0!PT.IZSH-MXCU>Q>T>QMM?D%Q:/
M"QDE5FC5BKAL*1NR!M.<>]3ZEJ-QHY^(NH6B6[2P3VSA+B/>C?Z-%D$9%=DO
MAC2UNYI_*D*S7 NI(3*QB:88PY3.,Y /ID XR,U'=>$=(O8]52>*=DU9E:\
MN''F;0 .A^7@ <8Z4 8OB3Q1JVGWFL6]C'"EQ96L,UE#+&7-\[LP91@@G&T+
M@<@G)XXI-?\ $VK:/),RRV<_V5[-)(HH6Y\V14<N2<1_>&U06/<Y'1FJ>'-2
MN?$EW<_9KUHY5CC@N;+6I;7"*O25!U.XN<@-P1QUSIOX&TJ\AD.HFYN+FXB@
M6[D6YDC$\D07;(55@-V5'..U &#?ZQK-C#\0KS[5;W"Z8 ;>"XMRR!1;I)M(
M##CYF'N3GVK7FU_4KR[UNTTQ[>&72+2&7$T9832.C/@X(PF !D<Y)],'2N?"
M.CW9U/S89BNIQ"*[5;F0+(H4)T#8!V@ D<X'6GS^%],N+@SLDZ2O;BUE:.=U
M,T0SA7P?FQD\]1D\\T <B_C/7=0M;Z\TYK*V@BT"WUF))[=G;+B0F-B'&?\
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M)<-D99B$#*..$ ;)/7I0!V#,$4LQ 4#))[5@V_C+1KB*28S210K9?VBLDL9
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MCHQM88YG_LB\RCR;./-@Z'![X_#- &A_PFVB/IUO?6\\ES#/:R7J^3$21"A
M=R.HP2 1USVX-.E\8Z3'J,=C']LN+AXHIU6WM))!Y<APKY ^[D<GH.]<V_@G
M6H-*BTJ":RGLI+.Z6>*65T6.YFD+^8 %.]1N( .,8!ZUJ^'?#^KZ=KD%[>K9
M")-&M]/80S,S;XV<D@%!P=_KVZ4 2Z3XXLM0L-/N9[6ZM?[0NY+6W#Q$@LKN
M "PX!(0GKU! S706M]#>2W4<0?-M+Y3EEP-V >#WX(_EU!K@[O3%TCP%+X?U
M>^L[>^,TTNE-#-F6682F6(HK '>&9!M&?KS7;Z19/I^EP6\KB2?!>>0# >5B
M6=AZ98DXH SCXJMH_$.J:9<1200Z=:1W4UU(,1A6\PDY[ "/KZY]*MV6OV5[
MJ/\ 9X$T-V81<)%/&4+Q$XWKGJ,X!'49&0,BN?U_P?>ZSJ6OJ)H(['6-,BM#
M+N/F0R1F4@[<893Y@SR.A&.:T+31]1O/$&FZSJR6T,]A9RVX2WD+B1Y"FYLE
M1A1LX'^T?3D U=0U:VTV6VAD$DEQ=,RPPQ+N9]JEFQVX [G]36;_ ,)KHS)I
MY@>ZN#J-LUS:K#:R,947&<<=1N&1U'?%/\06&K7M]IC6)MI+*)W^V6T\K1B4
M%<*<JIW '.5/!SSTK!\/>$];TE_"_GBP9=(L[FVD\N=\N9"FTJ"G_3/GZ]\<
M@'067BS2=0GTR&VDE8ZG T]JQB8*RK]X$GHPSRIYK3L;Z'4;<SP!_+$CQY=<
M9*L5./;(//>O/IM(DT_PKHOA]]2LK;Q3:7*SV(@E\QOFD8,P4A6*;'<-QC )
M[5Z)9VL5C906D (B@C6- 3G@# H S+OQ1I=E)()I)!##.MM-<A"8HI6QA6;M
M]Y1GH"0"163_ &GJ&L>,-3TFVNKJP33A;.CI K+(6+EP^X="J@#!'<U5N?!V
MH3:;K^A;[=],U>]:Z^T-(1)"LC*TB[=N"00=ISWYZ<[6F:5?VGB_6]2F6W^R
M7T=ND6R5BX\L,#N!4 9W=B>E $NN>(%T:^TBU-I/.VHW)@#1KD)B-G_/Y>GU
M]*Q-"\6B&[OK/5KFYF<ZU+8V\QM_D3H(T9E4*">@[\C/45K^(])OM0N]#N[#
M[.9-.OOM#I.Y0,ABDC." >1OSC'..HK!?PIK36L\8%CN?Q$FK#_2'QY2R*^W
M[GWOEQZ<]: .DE\3Z9!?06TDDBB>Y-I'/L/E-.,YCW>O!'ID$9SQ6Q7%Z/X;
MU;2M7N(&MM(FTUKV2\BO7!^TH'<R&,KMP3N8@-NX';-=I0 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110!@)XI6;5M3TRVTC49[C3BGG[/) ^==R[=T@SD5M6LXNK2&X5'C$L:N
M$D&&7(S@CL:X#3K8:K\1/&<4&KS6Q_T/Y;=D(?$7.<@G /!P1UJAXRU>WAUK
M4S%=M!>V-[IQ)FD.\1F2/<8@,;8MK$,QR&.00.* /4ZQ-3\1?V39/=7>FW:Q
MB^CLUP4.X2.J+)][[NYQ[\=*Y:PU'3]0\17EGJUU<PZ];ZOYEI%&Q622WX\O
M:.\14_..F=Q.#67>W<7_  C.OHUWY@3Q7;A3),7(43VYZDYP &/L ?2@#TM]
M0$#WK7<#VUK:H'^U2,NR08)8C!R-N.<@>V:NUY-XL,5U!\1(#*UPD4-G,L;2
M%PF 2Q R< =>.!6WJX?2M9LM3T-/M-GK%N=."H2\<<IR8I@.FPC<&(Z@*: .
MYNI_LMK+/Y;R^6I8HF-QQZ9('ZU2T'68?$.B6NK6T$\5O=()(A.%#%3T.%)Q
M2S0V^E>'9(!)L@M[8IOE?G 7&23U/O7)_#_Q'H]K\/O#EH^HVS7AM88!;)*I
ME,AP-NW.<YZ^G4T =[59=0LW6%EN(RLTK0Q$'[[KNRH]2-C?D:\Z\/W-OJ^L
MP1WVIRP^(;6\G6[L4B(DDC)8;9"3@P[2I4XP,+@YX./HT.D0Z+X%DF2%%MM4
MN(+IC_RR<Q3@(WH20@QUZ>HH ]FJ"\O(-/LY;NZD$<,2[F8\_IW/H!UKSC1;
MRWU/6TCO]6EM?$%GJ$_VBTC1EE>+<X 8DX,.PJP. !@8.>N78VD3^"_#^J)/
M//))KEO#>R27+R#REO&V @D@?,4YQGGWH ]?A=I(5=XVC9ADHV,K[''&:KVN
MH0W5Q<VPREQ;,!+$W4 \JP]5(S@^Q'4$#B?%]W+9^)!<(]O?1)%;B73FD,=S
M'F5L2VYZ,23AEQR% SVK5'F?\+;/EY\K^PAY^.F[SSY>?_(N/QH ZRBN"UBX
M@E\4Z[8Z[.;>V_LZ)]+<R%.?G\UHS_ST#;.GS8VXZUG:);S:KXJTJV\0SW!O
MO^$?MKB>W%T\>+A9,DE588;@9'3U% '>ZGK$.F26D!BEGNKR0QV\$6W<Y"EF
M.6(  4$DD_J0*=IFIC4Q<C[)<VLEM-Y,D=PJ@[MJMD%201AAR#6+XTM-%U&*
MPLM8N9;%VE:2TOX9?*>WE4<$/T&02.>#TZD5R+:]K-IHLR:G?QW^F6.KQ07&
ML0P?+/;&(DLZH<':Y17(., @]#0!ZO3719$9'4,C##*PR"/0UY@=0T_2!I4T
MFJO=^%+F_N&FN'&+:-FC'EH#S^YW;\9RH; [5=^T:;I&N^%72_G_ +(FM[Z!
M9[R4XF)9&C4D_>&-X3/)'3/< ]#551 B*%51@ #  JF=0$+7K7<+VUM;%<7$
MC+LE!4$E<'(P3CD#D<9KRS1C;:S!X)L[V^N'CN4OXIXOM<B%P"=H;# Y]._:
MI/$:V\ECX[MVE::&TO;"15DE:3RE A+D9)P!\^?3F@#URJFJ:@FE:5=:A+%+
M+%;1-,ZQ8W;5&3C) Z#UKB]6BETS78)](1IK'Q!;"P4H2R6\P!*2@'@*8]Y.
M.OEKZUT'BA(+#P%J\(81Q1Z;-&F]O^F9 &3U/\Z (1XULHK&QO[ZROK"PO?+
M\JZG5#&-^-F\H[;,Y'+8'/6NEKS#5KZVU?X06GA_36CO]4OM-M[6*V@8.48J
MH+/C[BK@DDXQCUINHR2I;>*['4;J1-9LX8SHSARLC 0+L:'N290P;'4D \8%
M 'J-%>:_VA!<:YJ6E^*;F>UU;=:RZ<(&*NZB-"P@]291(&QU!P>!5#6=4BL;
M;Q/927AAO(?$-G-!%YA#I S6V64=0AS(,].2.] 'K-%>1:_)!Y/C>[2_F$]G
MJ5J]HXNW_=$QPYV_-Z[QCZBK6J7CZ-J/BR'2)YF@CATZYDCCE>9@AE<7#J,Y
MSY0!.#GH>M 'J=17%Q#:PF:>18XP0"S' R3@#\20*\LU"73&T9KW2=>DGLKG
M5]/(^RNT-O$?-42"/![KRPZ \\'-0:W'9QV/BJR\P/8V&N:=.BO*7$*DVYE;
M))(&2Y/8?-[T >OT5B:9<:&^NWD5A<JVH"V@,T(E8A8L'RR%)P.&/(]1GM7-
M:U<Q2^(O$=EK<[6\8L(GTES(4/W7WM$1_P M ^WISC;V- 'H%%>::-;2ZIXQ
ML;?7YYS?IH-G<SVXNG0+=+(Q8[58#/ R.GJ*]+H *",C!HHH B@M;>U5EMX(
MH58Y(C0+D^O%2T44 %%%% !1110!#%:6T$CR0V\4<DAR[(@!;ZD=:FHHH **
M** "BBB@ HHHH **** "BBB@ HHHH 8T4;NCO&K.ARC$9*_3TI]%% !1110
M4444 %%%% !1110 4444 %%%% !1110 5"UI;-<+<-;Q&=1@2%!N'X]:FHH
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MIUI':7>JSZ6WESLSJZ-* PRH!7]USWYH [>BN5L?$][<M<64MM;QZK!J0LC
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M%L)Z.PRJ$] Q'('4B@#&73CJWBNTO;K2[F :,LL4-U<,F;DN% *A6.5P"?F
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M3YM4M%O2\<?D&0;]SYV#'J<'% &9/X(M)KF:Y74M0BN)-174A(C1YCE$?E<
MH05*<8(/KUJ*/P!8P-;S6VI:E#=VUW/=07*NC.GG'=*F"A#(Q.?F!/3GBMVW
MUO3+J[>U@O87G5#+L#<E <%AZJ#QD<5CVWBC[;XY@TFTGMYK&339+O<J-OW"
M2-5(;."A#'! YQUH @;X?V0M(DAU34X;J"\FO8+V.1!+&\K$R*/DVE3DY!!K
MI;*R6RLDMA++-C.Z69MSN2<DD^I)[  =@!5/4?$-AI>K:=IMQ(1<7[.(@%.
M%4DDG\A^/L:F76M->^6R6]A-PS,BIN^\R_>4'H6'<#D=Z ,S3O"EIHMM8JDU
MW>Q:4C?88)2G[K*E>,!<MM)4%CT)^M)X<TX/J>H^(9M,ET^ZU'RU,$S*7544
M#<P4E0Q/7!Z*F>>!)XLUJXT*TT^YA>W2*74;>WN&G4X6-W"L0<C! [G(JY9^
M(='U"PDOK/4K:>VB?RWD1P0KY VGWY''4Y'K0!5UCPM;:QJ*WKWEY;R&TDLI
M5@=0LL3D$J=RDCD=5P?>JMOX(M+=7 U+4'W:8NEDNT9/DKNP?N?>^8\]/:MZ
MQU&SU.!IK*X2:-7,;%3RK#JI'4$>AYJC-XIT&WN&@EU>S65)A;NIE'RR'&%/
MH>1U]10!9M-)MK;0X=(?=<VL=N+8B< ET"[<-@ 'CCI67_PB%LVE1Z1-?7LV
MDH HLY&4JT8Z1LVW>4& ,$Y(&"2.*OP>(M&N8+N:'4[5XK0@7#B08CSTS]>W
MKVJ2/6M-ELYKI;R+R8)/*E9CM,;\?*P/(;D<'GD>M %*[\+V]SJ5W>QWEW;&
M\MDM;F.$H%DC7=MZJ2I^=AE2.OK@A1X8M(M52_MY[BW,=A_9\<,>SRTBSD8!
M4G(P.^/:J>B>)_M^H^(5N9[<6>G74<,,BH4.&C1L,"2=P9MN..1TS6[8ZC9Z
MG TUE<),BN8W*GE''56'4$>AYH X75_#$UBNB:5;+K<FF:=9F&&XM!;2ONRH
M"R)(N.%488+GDC([[MGX;N+@:?J-]?W<>K6BRQ)<A8A(T+G/ERA5,9Z*?E'!
M''?.Q-K6FV]XMK->PI,76/:S<!V&54GH&(Z \GM42>(]%DU0:8FJ6CWQD:(0
M+*"^]5W%<>H7F@"I!X1L;:\TJY@GN8VTXS,B@H1*TIS(SY7))))X(ZU=UK1+
M;7+6&*=Y8I+>=+FWGA(#Q2KT89!'<C!!!!(JS=W]K8A/M,RH9"0B\EG(&3@#
MDX )..PK.D\8>&XK:.Y;7=.\F169'6X5@P49;&#V% $%WX0LKVSNXIKFZ^TW
M5S#=27BE!*)(BIC(^7: -@XVXZYY)-17G@FSOH=9BFU"_*ZNL:W!#1Y 10HV
M_)QP.<YK43Q!I,ES';IJ$#22-L3#<,VW?M!Z;MOS8ZXYZ5';^*-"O+J&UMM7
MLYIIV=8D24'>5SN ]QM/Y'TH I2>#K=M<FU.'4]1M_M03[;;0R*(KHJ H9AM
MR#@ $J5R!6AI.B1:1<:C-%<W$IO[DW4JRE<*Y55^7"CC"KUSTJ#3?%6E:I:W
M=S!<8BMKAK=BX()<-MX'4Y8$ =35E-=TN6Q2\BO8G@D<Q(R'<6<9R@4<EA@Y
M7&1@^E %:_\ #=O?:P^I_;+N":2S-E(L)3:\>21G<I.06.,'OSFJ/_""Z>UM
M8V[WE\\-EILNEHI9!NAD55;)"@[L(O(QTJQX/UR?Q!I%Q>3O Y2^N+='@4JC
MI'(R*P!)Z@ ]:FL?%.E7[:GY=RJ)IUP;>9Y/E&X!22,]LMCW(X[4 9,OP\LK
MBWN(;C5]5E^T:<--E9GB!:$$D=(\ C<1G'?UYK:MM!BM]?;6/M=S)<-:)9LK
M[-A1&+ X"@YRQ[]^E7++4;/45D:TN$E\I_+D4<-&W7:P/*G!!P?6LC5/%%M;
MWVH:3:R+_:=M8F[ D0E.C;0<$9^Z>AH DO/"UM=:E>WT5U=6LE_ MO>+ 5VS
MJH(4G<I(8 D9&.#[#$MGX;M+#6SJ=M+,A^Q1V*VXV^4D49)4 ;<Y&X]Z@\,^
M)[+7-,LLWMLVI/8Q7-Q!&WW-R@DX] 3CV[UHV>L:=J%Q);VEY%+-&@D9%/.P
M]&'JIP<$<&@"+5-$AU6\TRYEN)XFT^X^TQ+$5PS[&3YLJ>,.W3'6LQ/!5FD$
M,0U"_*Q:FVJ DQY,S,S$'Y/NY9N/?K3M<UG4K+Q3H6DV;6BQ:D)]SS0LY0QH
M&XPXSG.*;H_BKS[K7;35#;PG1YTBDNXV(AEWJ&&,_=89 *Y/..3F@"_X@\/6
M_B&VMTEN+FTN+683VUU:N%EA< C()!!!!(((((--3PY 8X([J\NKQ(P_F+<E
M&$[,-I=QMZ@9  P #TJ5O$FBI;B>34[:.,S_ &;,CA")<_<(/(;D<'FLK6?%
M<:Z-!J&AW=I=)_:=O93$@N 'E1&'!&& ?/.>W'- #/\ A [5=-TJVAU?58KC
M2BPL[U9(S-&C#!C.4VLN !@J>@]*GO?!EO<W-E>6VJ:E8WUK&T)NK>5=\R,V
MYEDW*RG+9/3@GC%;MO?6UW+/';S+(\#^7*%_@;T/O4$VMZ9;&]$U[#&;)%DN
M0S8\E#G#-Z#@\].#0!GW?A.TO4$$]U=/9AX9/LSE64-$05(8J6!.T9.>?Q-2
MV_AJWBU6VU":ZN+J>T$HMS-LS&)#\PR%!( X )/'J>:?>>*M L&D2[U>SB:-
M%D=6E&55L[21V!P3]!FF^(->M](TBZG2ZMTN4MGGB$@+J0H^\P!!VYP,Y YZ
MT .OO#\-WK,.KPW5Q9W\<#6YE@VGS(B<[6#*0<'D'J#GL2*KKX1L8GT4VT]S
M;II#.UND94AF=2K%]RDDD,W<<G-.LO$MFGAW3-0U6[@MY+FSBN),G"KN4$D_
MW5R<9/'O5D^)-$&I+IW]JVAO6D$0@$H+;RI8+CUP,T +I%C>64FH&ZO;BY2>
MZ:6!9V5C$A ^08 PN<X') QDYJ@/!U@'NHQ/<BQNKL7LMCE?*:4,&)^[N +*
M&*YP3[$@W=4\0V&DZCIMC=2%9M0D:.(!20-J,Q)/X8_'ZUE>'?%T-[+/9:I>
MV4>H#4;FT@BC^3S%C=E& 2>2%)Z]CCI0!KZ5HD6D76I3Q7-Q*=0N?M,JR[<*
M^U5^7"CC"KUSTKE_$VF7]]XJ$WE:U'#';HEM-IZVTJ%MS%MRS [#]WD 9QR>
M !UO]LZ;_:"6!O(A=.65(RWWF49*@]"P')'4"LSQCK5[H&C17MD+=G:[@MV6
M9"PQ)(J9&&'3=GWQ0 [2]!G34K;6M0OKB745L_LDBXC",F[=D@+][ID@XSG
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M.FFYG:=H'D#R;FQEI""P+$C)P3VYSFN7;P]J]SX>\7VL5I]FN[W4GN[1I9%
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M13S'<S*0Z^F -[X_Z;"NRJEI>D:?HEBMEIEG#:6RDD10H%&3U/UJ[0 4444
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MUQ[*&YED+R0PDC^(Y/MGMNKHM+M(K'XZ-!!//-&-"!#33-*WWQ_$Q)]^3WH
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M03Z58\*ZU?S^-Y;)KNYDL;CP^MUY<\[2;I/E'F8+-L+ D[03U&>>@!Z-X?\
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M-S>I_.DHH 7<WJ?SHW-ZG\Z2B@!=S>I_.C<WJ?SI** %W-ZG\Z-S>I_.DHH
M7<WJ?SHW-ZG\Z2B@!=S>I_.C<WJ?SI** %W-ZG\Z-S>I_.DHH 7<WJ?SHW-Z
MG\Z2B@!=S>I_.C<WJ?SI** %W-ZG\Z-S>I_.DHH 7<WJ?SHW-ZG\Z2B@!=S>
MI_.C<WJ?SI** %W-ZG\Z-S>I_.DHH 7<WJ?SHW-ZG\Z2B@!=S>I_.C<WJ?SI
M** %W-ZG\Z-S>I_.DHH 7<WJ?SHW-ZG\Z2B@!=S>I_.C<WJ?SI** %W-ZG\Z
M-S>I_.DHH 7<WJ?SHW-ZG\Z2B@!=S>I_.MNW_P"/>/\ W1_*L.MRW_X]HO\
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M]*LUL)&#/!CY7(Z;O7H.OI4UOX.L+6_COX+&W2[CB$*3#.Y8P,!<^GM7444
M<@? &B-9SVAT;3_L\\@EEC\H;6<=#C'N?S-36_@K2[22Y>WTJPB:ZC$4^R(
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M1E:(D< ;'WD#H1[5I^%?#]_HE_>6ETQETVRD>33Y#RSF8!I,J.A5MX&.TA%
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M>G.MJ\>HV7CK3=72QGOM.^Q36C+!@M!(SHP?:2."$VDCI@9XH F\/>++>_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MW+,IC<@GAB,Y'!!QD'T(JEK6M_V.$_T.:?,4DS."%C14 R&<\ G< H[\^AH
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MC'FGGGH.*[!)8Y-VQU;:=K;3G!]#098P2"ZC'7)Z4 <MHWA.^TJ*72WU9)]
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M/!.TX]=IJ:#P:]K/HLL-\FZPOKB^G+0G]_),) ^/F^4?O#CKT KK** .%M/
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M8GD8R6/!S4D.CP#6/&-[=Z(U]>0PQRVY6%D::06VU_)?'#,V02O.2/:O2J*
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M?ZM;1:]IKS>9X4M!)%/:N7,H:13\I&?,XP#U]*]4MUL].6"PCE2/((@A9QG
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M%( PP5 [KC@ Y]*Z2@#B['Q3J=QK]CI\@LF2]BNV5X8W*1/$RA0'+8D&&^;
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ML-4FU==.O(A&UM?7B32]>2&7.T$8'#'/MW )[_Q1<67BQ-(G,-DDTL2VDEQ
MY2[!QO"RA@JN.0$(R<#KGC#L?$?B*WT:*=KFRNIKGQ#+IV98'4(GGR)D8?L%
M&!_/K77S>'+2YN#+<37,R-/%<-"[@HTL>W8^,9!!13@$ D<BJQ\&:7R$>[C7
M[?\ VBJ+.2JS[BV0#D ;F8XZ'//; !CZOXHUS0XW^TG39Y;9K19DMXI#O\V0
M(Y)W?NN"-H;<3@_A5U'6=7M8OB!<2RV=W!I: PVUQ;DH5^SI)M/S<@[F!]2<
M\#BNAU+P5I.JW5]/<&[4WWE&=(KED5FC(V/@'[PV@?@*?=>#]+N_[6WFZ"ZK
M"(;M5G;#@($S@]RH SUXH HR^(=1NKG5[32EM$ETFTAF=9XV82NZ,X088;5P
MH&>>3TXYS&\9ZSJ0>;2DL((&T&+6(OM43NP+;OW;;77/W>HZ9Z&NEF\+6$UR
MUR)+F*:6V%I</%)M-Q$,X5^.HR<,,,,GFB7PKISW,TZ&:+S;$:>4B8!%@&<*
MHQQU//7F@"_I-]_:>C6-^4V?:K>.;9G.W<H./UK,U'5[Y]?DT32S:QW:6!O-
M]RC.K98HBX!!QE3D]N..>-;3[*+3=.MK& N8;>-8H]YR0JC !/?@"L[6/"]A
MK-_;7\LEW;WENK1I<6EPT+F-L$H2IY4D X['IB@#'NO$7B*>2\L]*TZVEU&P
MMX'GA+!D>5U+% Y="JX& V#SVXP6_P!M^([W5];M;5M-MH--6-LR0O)(0\)?
M'#A<AL<]",]*T[SP7I-WJ,-\IN[6:.%;=_LER\0FB7[J.%/S 9/OSUJ[:Z#9
MVFH:A>1F0OJ 59T9AL(5=J@#'&%XXH Y70M8U)K/P#]M-I=OJ=L6DG>$^:A^
MS%\J=QY.,$]\]!62TUW;:!XEU2\ATO49+37F\M;JS+!6W1Q[AESC"G ],=37
M:V?A#3;%=(6"2[VZ3N^R!YR^T%-F#G.1M^4#M]>:;)X.TZ73=0T]YKMK>_N?
MM5P/,&6DW!B0<<#*KP../K0!$-:U;4;S4UTA;'R]-ODM98[G<&E&U'D8,#\F
M%?CY3DK[\4V\4ZC'XEL;%A9O;76HS61\I';RPL3NI,F=I;Y#N0#C.,Y'.I)X
M0TR37)-6WW:3S!/M,<=PR17)084R(.&(''N.#D5$G@C2([R.Y1KQ3%?/?Q(+
MIPD<KAM^%SP&WL2/<T 8.@^)=872;**>6.\OM0U.]@B80XV+%),3P9 &X0 #
M(P/7'/6Z#<ZK<Z:3K5I';7J2NA6-@5=0?E< ,VW(P=I)Q6=/X%T6>Q>T_P!+
MC4W;7L+QW+J]O,S,Q:(Y^7)=NG][Z5MZ?80Z;9K;0M*X'+232&1W8]2S'DG_
M /5T% &1XFU?4]-OM$M=.6T)U&[:V9KA6.S]U(X8;2,XV=._J.M8EGXPUH7-
MM8WT-E]JCUTZ3=-$CA)%,)F61,M\IQM!!W=ZU?%>EWVIZGX<:TAG,=GJ!N)Y
MHI$4QKY,B C<>>7'&#QGZ5:N/">FW-BMNQN$D6[^W"YCEVR^?TW[O7!*XQC'
M   % &#-XMUKRML*6'F_\) =)R\;[=F.'QN^]^A]JL/XGU.PUVUT?5I+.UN)
MFA2*8VL@@O"V-XCDW81QR C9)P.N>-!/!.E1J%C>\7%__:.3<%CYXZ-\V?R[
M]\U=NO#UI>7;S3R3O&\\5RUN7!C,D>W8V,9&"BG (!QSF@#G[?Q=J<EGIDTD
M=INGUZ;2I@L; %$>50R_-P?W8ZYZU);>*=2D\26&GN+-XKV6[A!AC=A$8LE/
MWF<.2!\P &#QGCF\?!&D&Z$^Z\VK?G4$B%RPC28Y+,H!XR6)/U/8D46W@?2+
M.YM9X'O4:SGEGME^U.5B,F=P"YQM)8G!_EQ0!C:'XMUV_?PY+=KIP@UEKB'9
M%$^Z)XU=@V2^""$(*X[]:U_ 5YJ.H>%8KO4KI+B:2>?YEC*$8F<8ZGTXQC P
M*GL_"&G6*Z4D,ER%TJ222U#2 [2X8-GCG(9ASZ_2KVCZ+::%;26UEYPA>5Y0
MDDI<(68L0N>@R2?QH RO&MYJ-G::3_9UTENT^JVL$A:,MN5I!QP1QZ^HXXK.
MU#QAJ$&D:]K%K':R6NAW303P,C!YQ&%,K*V["'YCM!!^[R>>.HU?1[76[-+:
M[\P+',D\;Q.49'1@RD$>XJC)X2TN2>[?$RPWK(]W;"3,=PR@ ,P/.<* <$;L
M?-F@#<1@Z*XSAAD9KSCQ/<ZA=)\0[2XN8I+&UT93% 83\I:*8Y!W8SD<G'.!
MTQ7I%8>H>$]-U*YU&>8W*-J-J+6Z6.8JLB ,.1TSAF&??UYH Y[_ (2W4- 2
M[AU".UGAM]'BO[<0JR%26V>6[%B#SM.X!>_%=#I%WKTFJ74&J64268C1[>X3
M:A9N0R%!(_3@ALCKCMRDGA+3+B>22Z$MP)+'^SY(Y6!5X.NT@ <YYSUJ;0_#
MMIH$1CMY[VX^4(K7ERTS(@Z*I8\#^?&<X% $GB-0WA?5E8 @V4V0?]PUYAND
MM/#'P[O;C3X["UA>R,FIP.&D ,8 C90 0LA(#') ]#7K5_9IJ%A/9RLZQ3QF
M-RAP=I&" >W%8T7@S2DMM.M9FNKFUTXH;6WGG)CC*#"$@8W8[;LT 94WBW4X
M;'4)O+LRUIK\.F8\M@'B=XES][AAYIYZ<=*M6_BBYF\62:)<-#93^;((8+BW
M<&XB"DK)%)NVOS@E0,@9],FS=^"-)O;B[EE:\5;JYCNY(8[ED3SD*D. .A^1
M<_3UJXOART%Y%<-+<2&">2Y@21PRPRN&#,N1GH[<$D#/2@#E=)\3:O<V/A>*
MT@TNV.JM=I(! ^R(Q[R"JAA_=Y&>?459T[QAJ>HVFF6JV\']J71O1(\<>8Q]
MFE\HE5:13\Q*G&[@9ZUL6?@_3K :6();H#3&E>VS(#M,F=^<CG.X]>F>*@E\
M":1)8V]L)+V)[:YENK>YAN"DT3R$M)M<8X8L<@\<^PH R[KQAK.F16*ZW:6V
MD2SPX:>6-IK?S][+Y;2(V(@5"L"V?O8SE3G0M_%$\GC!M$NC%9R><XB@G@<&
MYA"$AXI=VUCG&5QD#/IDWI_">GW%N]L\ET;66 6\\+3%EG3<S'>6R227;+ @
MG/6IU\/68O8KEY)Y1!</=0Q2."D4K!@67C/1VXS@9Z9H UJ\0G@2\MM2T=;6
M.SDO_%=PD.LM@"UD617 4CY@[ %5Z DXSV/MYY!&<>]<^G@W21I6IZ9*LT]K
MJ4SW%PDKY/FL<EU(P5.0",=".,4 5M8UW6#JFH:9H-G%/=V5K'.5E (D9R^U
M,F1-H^3[WS=>G'.=K7C+5;+^TT@M+:&[L[6VFAM)P9'NVD)W*A5AG!&WC//M
M6O=>"].O+NUO)+K44NX(?LYN(;MXY)HLYV2,N-PSWZ^]8VHZ#J4GB2[EBM=5
MAA<1QVTVF:FL,0C5< 2(QR"&+?=5AC'&<Y +EYK.IV?B'5;:*PM+N[M]%CNH
MC#$5DE<O(NS);E<J2!_M=>]9=[XKOM3T:TN-+U2V!;7+2TD M'CDC5G3=')&
MS95MV<^J],9S72CPO#/(;N]N[F2_EL8[.>:-]FX(=V1@#:=Q9LCU^E.N/"6F
MW<-PMPUQ)//<17,ER)-DIDBQY9!4 #&T=!Z^M &4FN^(9-6U^%6T@6NCL QE
M5XS*&MQ(,L6(3#,,D@\9Z8YQM9\7:RWA[Q5%%-!%<6&EPW<%U';/'GS!(& 5
MFSP8SM;WZ''/7GPIICQZQ'-Y\T6KH$NTDE)# ((Q@]0=H SGMGKS5;_A!M'=
M+U9VO;C[;9+8W!FNG8R1C=C//4;CS0!2U/Q%-H6O3&_AM)XK70I[]YH82DI\
MMUR@)8X4@]/4"G-XCU:UOM)M[E;.1=6LY98'BC8"&5$#[6RQW*03R-IR/?C6
M'ABP-\EW*UQ<2+9O9,)Y-XDB8@L&SUR0#^G3BDL_"UA910QI)<N+>!K:U,LF
MXV\;8RJ$CT &6R<#&<4 8?ASQ5K.H77ALZ@ECY&N:8]VJ6\;JT+H(R<L6(8$
M2'C QCJ>M=O6%9>%-/L)-(:![C_B4P-;6BLX(6-@ 0>.>%49/I]:W: "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH "0 2>@KD?#VJ:IXOT(Z[:7PL8;AY/L,/DJ
MZE%8JK2YY)8KG"E< @=>:ZXC(P>E<EX?TC5?"6B-H=E:Q7EM \AL)FFV!49B
MP67C/REB,J#D <"@"+2?B-I5UH5A>:@LUM>7(F4VT4$DQWPDB0+M4YQC..N"
M#2^+?%8L])+Z5<RK<QWMK [BV+(/,D0,C$KA3L?/J..Y%5]*\&W6A7GAA+<I
M<0Z?]J>]G9MC/)/R65?3=GC/ QUJI>^%_$2Z;K.D6T%I<6]WJZ:E;W,ER4(4
MW"2M&R[3R"I ([8[C! .AF\3:;IMSK<][JDI@L7A2:(VK 6I9>.0N6#<'/(&
M>M6%\6Z,T5_(US)$+!D%PLUO)&R[^$(5E!8,> 0#D]*YS6_#&LZ@OBP0P09U
M4VOV<M-@#RPH;=QQTXZ_A4^J:+XADU77[_3HX(VO8+)(=\V"1$[&1<X.TE7(
M5AG!YXXH VY/%^BP6SSS7,D:QWBV,@:!P8YFV[588XSN4Y/'(YJ2W\4:3=6M
MQ<)/(@MIQ;2QRP21R+*<;5V,H8DAE(XYS7(MX3UP+J*I:6BI<:Y9ZD@%VSD)
M%Y)<$E1EOW1Y[D_C4^I>%]<GU+5M2LEMUN#JMMJ-G'++\LHBA6)D<@';D!L'
MGJ* .H@\2Z7<P/)#-([)<-:M"(7\T3*-Q39C.0.?3'/2K6F:K9:Q8+>V,WF0
M,67)4J5920RL#@@@@@@UR^M:3X@U./3-6_L_36O;.X>1M,EFW1R1.FT@R;/O
MYP0=N!TYZGHM*L7BTAH9[.TLGFW,\%G]R/=VS@;CZG YH YVY\:2IX6M];MH
MTD?5KQ+/2H'X4EW*([D<\@%S[8'7).Z;36K=[5X]3%T/-7[4DL"*"G?R]N"N
M#@_,6X&.O-<I9>%KC4OASI>B"9+?6-!N(VA:0$JL\#?(6 YVNN#]'S77VESK
M-RJ+<:?#9,/]8WGB4$^B8 R/<X^E %>W\7:+=$^5=.R_9WND;R'Q)$A"LZ<?
M, 2.GJ#T--TOQEH>L7T%G9W4C37%O]I@\RWDC6:/ )*,R@-C(R 21WZ&N4M_
M#WB&VFMM3U.&T,D&DW=K>2K=,Q=FV,'5=@"K\AP@P!G\[7A32[O4])\$:E+
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MY$#RC"1VT@<EB.-Q^88&?X>>N*GBC3KBVC\2W-W';)'JMQ8I9&6Y\O\ >(5
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MMTQWK)]UD39A0 /NC\?4@'16'CGP_J5Q!!:W<K/<VYN;<M;2J)T !/EDKAR
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M\]59EQSD0<@^PK>L7T2[TG79],U1[_3YX2T@$_G01?NR&5#S@D#+#)Y.>,T
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M2V03NP@=EQU]>:[3P7>2W5EJ$=S9M:W-O>&*:-;@SP[MB',3G^ @@X[$D=J
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MRYPFXC&3@$'O>UK5+K0[G6?[(OKJ5GT&WNW7[0TS*QF*R2H"3@B,D\<?*.*
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MP!ANI&#GFH[34;V3PKI;VU_#>O;2:BC65U>M&]S#'.5!68'(D1=N">S$\=:
M/6:*HZ/.EYH-A.BSJDUM&X6?B0 J#AO]KU]Z\WLM<$=OX>M9=7D%Y%XFNK:X
MC>Z8N(M]QM23)SC CP&]!B@#U:LW5]9@T;[#Y\,SB\NH[1#& 0KN< MDCCZ9
MKS>QNQ"NFWZZM=//_P )7/9 R7SNI@,DJ["I;!& O)!/ YZ5%-JUI?V6DW.I
MWPCUN'Q.B74$EP5,*B=@J["<! FP@XQWZDF@#U^BO--(U!-6UI5O/$'V36[3
M4YTGT]-XFDBW. A4O@Q>658,%XP#G.<ZWPV@BN/#\>JM?7=W=2/<0.\MV\J[
M5N)-HVDD9QCGKCO0!V,D\<3I&S#S'!*)D9; R<52T/68-?TB'4K:.6.*5G4)
M, &!5RAS@D=5/>N<\0+:0_$SPQ<74OE;[2\16:4H&<-"57K@G[W'?WQ7+^%Y
MH[2+P7<VU]('O-1OK>5/M+>6Z?OV"[,[?O*ASC.?K0!ZY17FO@O45UB^TJZE
MU_&LQ)+'J6F(&\PO@[O-4N=H5Q\K!0.0!P<5Z50 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!
M4AT^*VO[FZARAN<-,@^Z[@!0_P!=H /J /2DO--@O=/>P8!+60;98T& Z'JO
ML#T/L3]:N44 ( %4*H  & !VI:** "FB.,# 1<9SC'>G$ @@C(/45YAX9M;>
M\;6K6?1;B=6U^[MUO49 += _R@'=O &, !<<CM0!Z<0&&" 1Z&FB*,$$(H(]
MJYE_%LT/B.TTR>QC1+J]DM%Q/ND3;&TBR, , ,$. 2#C!]0)]*\0:AK"6%[:
M:6CZ7?)(\<_V@!HP/N%U(Z/_ +.2O&<]@#?$,07:(T"XVXVC&/2ECC2) D:*
MB#HJC %>;VES;7\?P^O;;3X[!'U&X5;>-]PC'DW&0#@9R1GI5A_$-Y;VH.E:
M;:6<DWB4V-R#,S"0[OF<';P6QSQP/6@#T!D1CEE4G&.1VH$<:D$(H(Z$"N8_
MX2J[CNM9L9].ACO[)X1;0BY)%TLIPC9V?*-V5/!P5--^)6X?#;7I?NRQV;NC
M*>48#@@]C[T =0D4<>[RT5=QW-M&,GU-96L:%_:^HZ3=-.J+I\[3"-HMXD+1
MM&0>1QAS^.*M1R6VEZ&)F BMK>W\QMHZ*%R?ZUR]UXQU8:7>75OHQ6,:7)?0
M7#B3RT=5W>7)E!R0<@J2#@CCJ0#LS%&T7E&-#'C&PCC'IBE"*$V!0$QC;CC'
MI7$V?B36$UO1X+Q;46<FAR7URPD8L2K1 M]WJ QX]SSP*G7QGJ#6S7B:%(]H
M^GO>Q2DR(JE5#"-RR8!93P5W#((]"0#L,#.<#/3--\J(.S^6F]QAFVC)'O7$
M?\)#JFK7?ARPN[.&R@UEC<?NK@R,T"0B0JWRC:2[*"!G*YYYK5C\3QS>*9O#
MZQ6R20R!&AFEV2/$8]WFQJ1AUS\N >,$GTH Z1551A5 'H!2-&CG+(K'!&2,
M\'J*YWP[?N->\0:$Y+1Z;-$\!)R1%*FX+_P%@X'M@=JL>+[/4[_PS<P:0R?;
M-T;K&[E%F575FC+#D;U!7/O0!LF*,YS&O/M2-!"^W?$C;00N5!QGKBO/]%\4
M:)9?VO>C3KO2-1M+:,76C2ILVG<0KQ@?*0S,!N4<\9[5L-XNN[66>&\TB1&,
MUO#9RC>D<[RMMVDN@*E3R>#QR.>* .LIHBC!R$4'.[('?UKF[KQ'JFFRVT=_
MI$:"?4X[%)%N<JZ.N1*HQG@Y!4XZ=:J7/C6[ACN3'I44DD&N1Z1M^U$;MXC(
MDSL_Z:=/;J: .N6&)&++&@8DDD*,Y/4T>5'_ '%ZYZ=ZXVXUF^M]:N/M&C6,
M6L0Z')<B=;EI%PLG^K^X#MSAL_AQ4FD>*-16#PLFJ6D'E:O:J3>+.>)O*#A2
MNP#+#<1SV(],@'7&&(HR&-"C<,I48/UH\J/:J^6NU1@#' JGI-X^JZ5'=S6Z
M1I/N:-0^\-&2=K'('WEP<=LXKB/!V@6FL>$;[S'F@NCJ%ZD=Y#*R2Q;9W"88
M'.% ''3C&* /1-B[MVT;O7'-9DVD2SZQ#=2:A*;&%5,>GB-!&)!G#EL;CU'&
M<9 -<IX*\:ZCX@\/Z/!Y,,VL36#W4[RN8T*I*8E;@'ERI/ P.?8'1TWQM)KU
MM$ND:>'OC:/<RV]Q-L\MED:+R\@')+HXSTP,]\4 =?3/*CW%MBY)R3CJ?6N7
MG\6W=O-J<$NDK'-9:/'JGEO<<DMYF8F(4@$&,C(R#FH9?&&I27/V>QTFVD<Z
M0FJ*9;LJ,$X*'"'GC@]_:@#KO)B_YYI_WR*/)B\PR>4F\XRVT9..G-<A:^.G
M+6%Q?Z>EMI]_I4FJ02)/OD5(U1F#KM !Q(",$]*2X\9ZE;6-]>MH+M;P:8^H
M)*6D1"4&3$S-&,,1R",@X/3J0#LZ9Y,0Q^[3@8'RCI7&77C'5(H-4C.FVL-S
M%HYU2U;[09%*C(*N-HP00#@9!SC/>E7QC<64.DV=Y':)?7EBD\33SF-+ESQY
M:.5QOZ'!Q]X 9Z@ [%H(G4*T2,H.X J" ?6I*S]9U"73;#[1# DI\Q$8R2B-
M(U9@"[,>R@YXY.,5S2>.;F6SM9(=+BDEEUA]*8&X**&&XAQE,[2%Z$9&>] '
M9&*,JRF--K###'!^M9.L:%+J,MG-:7[6;VH=5C\E98G# #YD/<8X(((R?6LJ
MT\9S3(EI-8Q)JKZI)IBPI,6C+(GF,^[:#MV#/3.>/>F^ UE6X\5K-%'%(-<D
MRL;%E_U$/() Z]?QH W],TB#389%^66667SI9/+5-S[0N0J@ < #^IJ]Y48Q
MA%XZ<=*YB7Q;/;^(;739;")5NKV2S3]_F1=L;2+(P ("ML. 3G&#Z@5=,\;7
M]ZVC2SZ3!!:ZG=W%DK+=%W26/S<'&P J?)/.<\]* .TJ,00K$(A$@C'1 HQZ
M]*YO3?%5U?1>2^GPQ:DFI-836OV@L$"@L7W;!D&,!QP,Y SFM+5M9^P7^FZ=
M#&LEYJ,CI"';:JA$+LQ.#T  P.I(Z<D #-9T :O>:7/YR1+871N?+,6X2L8V
MC(/(XP[?CBM;RH]BIY:[5QM7' QTQ7#WGC+4YC:6UI:P07D>N+IE[')*2/N&
M0%&V_=9=IR1D9(QWJCH^LW.@76L,EA#)83>)OLLK^>5>,R^4@*KM((#,,Y(X
MZ4 >C-#$Z;&B1DSG:5!&<YS2E%+!BHW#H<<US \6W,]]&MCI,UU9_;WL99$5
M]T95BC2'Y-NT.I!^;..?:IO#.OZGKYEGFTRWM;*.6X@WK=&1S)%,8_N[!\I"
MDYSG(QCO0!>U+1Y=1N+<#4)8+!<_:+..--MSR" S$9 X.0.H)!K5KEM6\6S:
M5K$=K)8Q^2][;VBDS_O'$N!YH4 X4,VWYL9P<=LTW\;7\4MS(^D0"SM-8CTN
M:079+_.8U5U79SS(,@D>V: .TVKNW8&[&,XYQ38XHX@1'&B!CD[0!D^M8,'B
M"^O[@OIVFK<V,=^]C-)YX61-A*O)M(P55@1C.2.1Z5RNJW,%]H4LB:=%9R6_
MBRWC<1R%]\@N8@TF<#EL],4 =GKVAG6SIP^T+$MG=I=X,6_S"H("GD<?,:U?
M)B\GR?+3RL8V;1MQZ8KB+6[?2O$OC2YMK99F6>R^1I1&HW1J&=F/  R6/T/>
MI#XZN38M+#ID4TL>M)I+ 7!16+["LBDKTPXX_4T =GY48"@(N%X7CI]*41H&
MW!%W>N.:Y6/Q7J%GJ%S8ZYIMM9S1:>U]$T-TTJS;20ZC*+ROR^OWQ6OJ6M#1
M?#,VKZG!Y;00B26&)]_SG'R*Q SR0,\4 :*PQ(&"1(H<Y;"@;CZFE\J/ &Q<
M#IQTKSZ]U=]!\=:CK&KV\4:6_A[SF%M(7WXF^[R!SG SWXZ=MC4?&9\/W4L.
MN6:PC^SY;Z)[>4R!Q'C?'R!\PW+@]#GMB@#J?)B_YYI_WR*?7*ZQXEUG0M+U
M&_N]$A:&U@CG1X[OY7);#1_=R&7@YQ@Y[5%KWC.XT5_$"+IL<YTFS@NU)N"O
MFK(SKC[IP1Y9]<Y[4 =8(8@H C0 #& HZ4HC13D(H/J!7'W_ (MUFRO-8LQH
MUFTVGV2Z@I-ZP5X3Y@P3Y>0^8SQC'/7UDNO&DSPR-I&ERWTL-I#=O" ^YO,!
M98U*HP#8'<@<CW( .KCABA&(HD08Q\J@?YZFE=$D0I(JLC#!5AD&N)U3QU?V
M']N2IHL36^CQP3S&2Z*.T<B[CA=APX&>"<<=:FG\3ZG9:_XG$MK'/8Z7:6\L
M<<3,9#N$A)P%.<XYQT"\ F@#KS%&T7E&-3'C&PCC'IBD:"%XA$\2-&!C85!'
MY5F^']977;![R*6TFM_,VPS6LWF)(NU3GH-IR2"IZ8K+@\6W5[>6QLM)EN+"
M>[DM3,BR9CV%E\QODV["R8X;(!!]0 #IVAC<*'C1@I!4%0<$=Q2[%#;@HW>N
M.:YK1/%%[JNLW>E3Z7':W-A(RWH^T%@B'!B=#L&\.,GMC:<\\55M_'#RQVVH
M'2YSHL]M+<F[1'_<HB%U+Y4+AE!Q@G!P.<YH [# !)P,GJ::L4:.SJBJ[_>8
M#!;ZUR]YXGU>RT6\U>71(FM(=+?44=;ONHW&)OER&*\@@$=1]6:MXMO+;^T(
M+6RA\Z'1#JD4DDI(SR-K*%[8SG//M0!UK*KC#*&'N,TACC;.Y%.1@Y'4>E<?
M'XKU"/3K:WCL5O-5&FQWLJ*9&#ALA "L9P6*-U  ]ZJ^(_$$VM>%O$-I:Z<$
M:VTGSKN.Z<H\3R1,XC  /S*!DGIG ]2 #NHXTB0)&BH@Z*HP!2/%'(R,\:LR
M'*EADJ?:L$SBV^'8G:V2Z2/2P[P.^P2*(LE2<'&1GM67%XHOH_L6GZ7HUJ0V
MBIJ$0DNRBHHVCR^$)XSP>_M0!V3Q1R,C/&K,ARI89*GVI3&A.2BD],D5E6NL
MOJ/A"#7+.%5>YL5NXHI6X&Y P#$?6N)M;_5=0U#P%JC6]M+J=WI=Q(29BB/F
M*%LL0N1R3P >OXT =CJN@37U_!>6FHFU:.)HC"\"2Q,I().T]&X'(-7M-TJW
MTVV$2 .Q<R,Y15)<]3A0 /3@5SMEXW?4=.TUK:PQ?WEO-.T)+ND?EN(V&40D
MY8X!P.,GT!W;"Z?6?#L5S>Z?+9R7$.9;2X'S1GNI]>>] &CY<8 &Q<*,#CH/
M2FM!"\?EO$C)UVE01^5>+6%])9_#CPEJ"6]WI]RTUN9M:=QY00OAO-VL696'
MRC<,9(R17HFH>+9M/UR&REL8Q%+?QV2_O\R$.N1+M ("[LK@D$X)]J .G,:,
M02BDCID4QK>!U"M#&P!R 5!P:X]/&U_YX:72($M%UG^R9'6[+.&+!5=5V $9
M(SD@_7%5/"FJ"#7?$&CV$4,UV=9FGEC>78(H=D8W]"3EN ![\B@#T"F"&(.7
M$:!B=Q.T9)QC/Y5QMQJ2^"&6SFEA+:G=7=U'/>3-'"'9PR0[\$*2&XSQ\IQF
MNAUR[N[;PO?W=LJ+=1VCR*&; 4A2>H!Z?K0!H^3%_P \T_[Y%'DQ>89/*3S#
MC+;1GCIS7GFGWI\-^'[+58])M1=76DK-<3FZ(%PT:*57;C+2,&8EMIP!R3Q6
M_%XNSJ>G17%I';V.H::U]!<O,<Y4*S1E=O!"MNSGD \<4 =)Y4?F&3RUWD;2
MV.2/3-.5%0850H]ABN;C\1:A<W1T^VTZ'^TXK%+RX@EN"JIO+!(PVW[QV-DX
MXP.N:KZ1XV&MW-FEG9 17FE/J$;2RE65E=4,; *<<MU!/3I0!UC*K8W*#CID
M=*:(HQC$:<<CBN,M?&NJ:FNAKIVBVSRZMI9U%%FO2@CVF/*$B,_\].#W/8=:
MZRSDO)&N1>6\4(68K 8Y=_F1X&&/ VG.>.>G6@"=8HUD:144.V-S <GZFGT4
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%9MGJR7U[?I%M%M8OY,LK'K* &8#V4$9/KD<8
MYRK;Q/+J'B+5M.T[[%=Q6=G!<Q-%-N\QG:0%"1PI^08_W@: .GHJIIFHVVKZ
M7;:C:,6M[B,2(2,'![$=B.A'K5N@ .<'!P:Q_#^@)H"7ZI=RW O+R2\?S%4;
M7D.6 P!QZ?SK8JE'JEG=F:&QO;2XN8U),:S!BO4?,!D@9&* ,%/ T4=]!<+J
M]^$@U*34HHL1D*\@<.N2N2#YC=3D#I4^A^$AH#F*UU:]?3XV=[6QDV&.W+9S
M@A0S 9. 20,^P(HZ1XPO=1B\(2O:VZ)KD,DDVTMF,K$7 7VX[UU%WJ5C8,BW
ME[;VY<,5$TJIN"@EB,GG !)] * ,&S\%PV5KH=NFH7#+H]Q)<0EE3+EPZD-Q
MTQ(W3':AO!4+6DL/]HW2R/JG]JI*JINCESG !4@KVP0?K6X-6TTZ>FH#4+4V
M3C*7'G+Y;?1LX/2B75]-@LX[R74+2.UE&Z.9IE".,9R&S@\<T 845@FL>,8-
M4ETV\MCI,<ULL]QA?M)8C!4 G<H 8@D#EACO6KXBT6/Q'H%YI$T\D$-W&8I'
MB W;3UQD$58N=5TZS6)KJ_M8%EQY9EF50^<8QD\]1^=/?4;&.[6T>\MUN6("
MPM*H<DC/ SGI0!FKH$TGE1WVK7-W:HC(UN\<:K)E2OS;5!/!/&<9^E4M.\%K
M9:5/I5QK6HWNGM;/:P0SE/W$3+MP&"@L0. 6S@5N+JVFNTRIJ%HQA4O*!,I\
MM1P2W/ 'J::-:TIK<W"ZE9F!9!$9!.NT.>BYSC/(X]Z ,F'P?%'<:9/)J-W-
M)96;V+[UCQ<0L4)5@%X^XO3!ZU!8>"C8Z3/I1UW49[ P/;6L,WEG[-&PVX!"
M@L0#@;B<"MRTUS2=0E$5EJEE<R%2P2&X1R0#@G /0$$5:M[F"[@$]M/'-"V<
M21N&4XX/(H YZY\-O;1>'9[5VN)]#.Q-V TT)C,;#L-V,,.@)7'&:L7/AN*^
MU&WOKNYEF2VNOMEO&T8W1/MQM5L;@O<KU)[XXK3M]5TZ[69K:_M9E@&93',K
M",8SEL'CIWI@UK2C:378U.S-M <2S>>NR,_[1S@?C0!S[^']3==8U&TNY;'4
M]3NHI$:,(?+CC4*BON!!!P6;'/S$#I70ZKIYU.R%N+J>U82I*LT&W<I1@P^\
M",'&#D=":A?Q'H:)([ZSIRK$6$A-T@"%2 V>>,9&?3-6'U33X[*.\>_M5M90
M#'.9E".",C#9P>.: ,:[\&VFK/?2ZO/)=S7=G]B+*HC\N+=N^7'\6[!R2>5&
M,5#)X*^VZ))I^J:[J5]+NC:"[<HDENT;!D9-J@;@0"202>];D^MZ5:PQ37&I
MV4,4J&2-Y)U574#)8$GD8YS3EU?37NDMDU"T:XDP4B$REFXW<#.3QS].: ,>
MY\*27NEQ076LWDU]%<QW27S)&&5T/R@(%";>HQCN>]5_^$&BV3@ZM>LTVJ1:
MHS,L9_?($Q_#T.Q<C\L5K:?XFT?5(;R:UU"W:&TF,,LAD4 $'&>O3.0#WQQ6
MA:W=M?6ZW%I<17$#9VR1.'4XX.".* ,NZ\.0WFNRZI+<RYEL&L&A  7RV.XG
M.,[L_A[5AZCX?$FB:?X-:WU*]A186747"(D"1.O&Y<$/M7 P.<\GK75IJNG2
M73VJ7]JUQ&&+Q"92RA?O$C.1COZ4RVUO2KVY6VM=3LIYV3S%BBG5F*9QN !S
MC/>@"YL"Q;(\( ,+@<#TXKE[/P5]CT>XTE=;U 6=Q+++*J"-';S&+.NX+D E
MCTP?0U/?>*(X?%>C:/:36<XO))H[@++NDB*1LWW1TY7!S6[<W=M9Q>;=7$4$
M><;Y7"C/IDT 8I\)V=M>V%YI3G3IK*U-D@B4,C09!",I]" 0>N<]<FJ9\"6U
MO-87&DZG>Z9=6L+P--"(W,\;OO8.'4J27);('!)K5O?$^C6!T[S]0MPNHR;+
M9Q(I5\*6)SG&,#KZD#O5+P_XJBU*2XM;^>RMK]+ZXM8;=9ANE6)BNY0>3TR<
M"@!NI>#8;ZZEFBU*\MA/IW]G3JFUO-B&XJ26!(8%VY!YS2P>$([>X69-1N69
M=,73!O5#^[!R&X ^;GZ>U;1U33UO?L1OK87>"?(,J[\ 9)VYSTYI+35],U"4
MQ66HVES(%WE(9E<A<D9P#TR",^HH PX?!-HB:/%+=S3P:9I\FG)$ZKB6)U56
MWX'7"+TQW]:CM_!#1:#=Z-/K^I75G+:O9PB;RR;>)AM(!"C<V. S9Q^>>B?4
M[".]6R>^MENF("P-*H<DC. N<] 32/JFGQWGV-[ZV6ZP3Y)E4/P,GY<YZ<_2
M@#&D\(03W+RSWL[K)I9TMT 4 Q'JW3[WZ>U17/@M+W11I%YJ=Q=636J6LJ31
MQG(4G#KA1L?!QD>@/7FK-OXIL-6LK:ZTG4=/9)+S[.WVB7&\!RA" 'ECC*^N
M16L^I6$=ZMF][;+=,<+ 95#DXSPN<].: *FNZ&FN65O!]JFM7M[B.YBEBVDA
MT.1D,""/8UDQ^!XHG1AJMZ^S5?[5&]8SF7!!'"CY3DG\L8K<.NZ0+E+8ZK8B
M=Y3 L1N$W-( "4 SDM@CCKR*75]4@T;39;V<,RJ51$7[TCLP5$'N6('XT 8,
MW@6"3S94U*ZBO#J1U."X14W0RE=C #&"A7@@YZ]:U-#T$:)+J,OVZXNGO[G[
M3+YJH 'V*AP%4=D%2&_EAU*"WN;K3HQ]F>:>(RD2@@KAE!_@&2"Q[XZ5-:ZS
MI=]<?9[/4K.XG\L2^7#.KML/1L YP<CGIS0!@CP-$EY%.FKWZK#J<FI0Q8C(
M21PX=<E<D'S&ZG('2I+7P7%:6VDP+J-PRZ9?2WT194R[R>9N#<=/WK],=O2M
M6YUFU-M>_8;NTN+NVA:0PB8$C&?O 9(&1BH-"\06^IZ%IMY<W%K#=W.GQ7LL
M D **R*2<$YV@G&30!1T*Q2_\1WGB=],N]/EGMTM5BN@%=MI)9RH) S\J@]<
M)Z8K3UG0HM7FL+H326][83&:VGC )4E2K*0>"K*2"/U%37.KV$%@MT+^R6.5
M"T$DDZK')QD8;N/I6/X?\2S:SI.@7\TNGVYO[0W$\#2$2?=!'E@]0.<DT /G
M\'6L]NH%Y<17?]HKJ372!-S3!=O0@C&WY0,= .IY,3^"8GMKF ZE<XN-4CU1
MFVID2HR, ./NY1??KS6U;:WI-Y<I;6NIV4\[H9%BBG5F90<%@ <XSQFG_P!K
MZ9]J%K_:-I]H+%1%YR[BV<8QG.<\4 8]IX2^P:S<W=KJ]]%97-P;N73AL,1F
M)R6!*[P"WS%0P!/L2*OZ!HBZ#8RVL=S).LEQ+<;I  0TCEV' '&YCBJNN^(&
MT76=$MY?LT=E>RS)//,^WR@D+R9] /EY)K3AU?3;A+9X-0M)5NL_9RDRD38Z
M[,'YNAZ>E &!?>!XKR]O)QJU]"ES?0:@8D$9"31;,$%E)QB->"<4Z7P5%-:W
ML!U&Y"W>IQZFY")E9$*$ <?=S&OOUYYK1OO%6B:>EJ\VI6VVZN/LT1652"X^
M\,YP,8Y]/J16C<WMK9K&US<PP"1Q&AED"[F)P%&>I/I0!AV?A);#6;F[MM5O
M8[*ZN/M<VGC9Y33'!+!MN\ D E0<$^Q(J%_!43V5Q:G4;@+/JBZH6")D2!U<
M*./N[E'O[UNV^KZ;=V3WMMJ%I-:(2KSQS*R*1U!8' Q52_\ $^C:=I7]I3:A
M;M:^:L DCE5@9"P4*"#C.3SZ<YZ4 9U_X*BO[C4YSJ5U%+?7%M<YC5,120%2
MA (((^49#9S[5$? L9,Q_M>]8S:G%JC%EC_UR!0.BC@[!D?EBM7Q)K$FD^$=
M2UJQ6&X:UM'N8PS?(X52W4>H%.75E6]43WFGQ6XLQ/*C2XE0Y'S$$X"8/4]Z
M ,W5;%/$'B;3X)M,NT32+@77VUP%CERAPB$'+?,5)!&/D^E;.M:1::_HUWI5
M\K&VNHS&^PX8>A![$'!'TJ,^(]"59F;6=."P(KS$W28C5ONEN> >Q/6EFU-!
M?6"Q7NGBVGC>1@\W[R1 N5:/L1U)/I0!BMX%AO99GUC5;S4?/T\Z=*LBQH'C
M)SD[5!W9YR#UJP_@ZUO8&BUBYFU(_87L%>4*I$3XWGY1]\[5RW^R, <YNZ=X
MGT;4]*_M.WU&W^Q[V3S7E50"&(YR>,XR,]B*M2ZM816*7AO[18)1F*9YE$;\
M9&&S@].U &(/!OG^'KO1]2UO4-0CG@^S)+-L5XD[8VJ 6X!W-DG J"\\!KJ*
M:I]LUJ^EEU.SBM+A]D2Y5&8@J N ?G(]/J>:U/"FN2:]X6M-7N5AB:8.6$;?
M( KLN03VP*DTWQ-H^JZ6VI6VH6YM!(T9D:10 0Q7GGC.,CU!% %6[\++>7^H
MWDE_,)+_ $]=/D"HN%0%SN7C[V9&ZY'3CBJH\$?9[NUNK#6]0L9H[2.SN# (
MR+F*/.S<&4@, 2-RX/-=-;7,%Y;I<6L\<\+C*R1.&5OH1P:A&J:>UX;-;ZV-
MTN<PB9=XQR?ESGC(_.@#!O\ P1;W\6NPM?7"1:S#'!,JA?W:HNT;21UQUSFK
M4GA@MJMYJ,.JWEO/>00QR^4$P6B)*N,J>?F(QT/I5^'7=(N;B.W@U6QEFD5G
M2-+A&9E4D,0 <D @@GM@U)'J^FS6JW,6HVCV[R")95F4H7SC:#G&<]J *VCZ
M%;Z/-?SQD&>_G$\Y1 BE@H7A1TX7)ZDDFJ&G^$?[+U*>6TU>^33Y9WN1IQV&
M))6.XD';O"[CNVYQG\JWKFZM[.'SKJ>*"('&^5PHS]34,FK:;%9QWDFH6J6L
MHS',TRA'&,\-G!XH R8?"44&K6.J1WTZWMNDB3RA5S>*YR1+QS@C(QC';CBH
M=+\$P:9%+8_VG>W&C$2+#ILI3RXE<$,H8*'*X8@ D@9]@1M7.MZ591I)=:G9
M0(\?FJTLZJ&3^\"3R/>F#7]&-Q%;C5K S2R&*./[2FYW !*@9R3@CCW% &18
M^#$M]$N='O-8U"_L9+1[**.<H##"R[2 54%FQ@;FR>/<Y;#X)C\V26]U>]NW
METPZ9)N6- 8CGG 7@\]?SSVZ!]2L([Q;.2]MENG.%A:50Y.,\+G/3FHO[;TG
M[2;;^U++[0"RF+[0N[*C<PQG/ ()] <T 83>"&233[FTU_4;6_M+86;W,:Q$
MSP@Y"LI0KP<X(&1D]<TZ]\#PW%Q?R6NIWEFNHV8L[Q%VN)E52BN2X)# $@D=
M1[\UI7WBG1+#1[K5)-2MI+6VXD:*57^8CA>#U.1@>]6Y-9TN%86EU*S03X\D
MM.H\S)P-O///'% $+Z,K>&FT3[3,8S:_9?.8+OV[=N> !G'M6=;^$4MKF"=-
M0G+0Z9_9B@HN#'P=QX^]P/;VK>NKNVL8#/=W$5O"#@R2N$4?B:JMKVCI:_:F
MU:Q%OO9/--PFS<IPPSG&1W':@!NE:-%I7ARTT599)H+:V6U5WP&**NT9QQG%
M96G>#4TYM#9-4NI?['MWM[<2HG*,JKAL*.@1<?CG.:W9=3L()HX9KVVCEEV^
M6CRJ&?<<+@9YR>!ZT'4K 7HLC>VWVL\"#S5WGC/W<YZ<T <RG@&.VM--6PUF
M^M+W3S,(;R-8RS1RMO='4J59<X(XXP*Z:.S:'3OLB7$I;85\^3#.2>K'MDDD
M],>V.*R=)\1BYOM9M]1>UM19:B+* ^9CS<QQNOWNK$R8P*M:GXFT?2+*>ZNK
M^W"0RK X6125D8@*A&>#SW[<]* ,6/X?6O\ PC-IX;NM4O;C2+;8#;D1KYRJ
MP8*[!<D9 Z$9Q4MQX&BGO)YUU>_B234DU,1*(R$F4 <$J200HX)XK9M=26YU
M&[5+S3Y;6*&*11%+ND3=N)9^P4@#:>^&J1-:TJ2VFN4U*S:"#_72B=2L??YC
MG _&@#$;P5$T#Q?VC<8?51JV=B9$H8,%Z?=R![^],'@6!-0.HQ:C<Q7OV][Y
M9T5 PWJ%>+IS&P5<@\Y .<UOP:OIERUR+?4;24VO-P(YE;R>,_/@_+P#UJ:U
MO;2^1WM+J&X5&V,T4@<*V <''0X(./<4 9^M:'_;430R7;+;R0/!- T2ND@;
M'S8(^\,<'IR<@U-/I$4GAY]&BEDB@-M]E5Q\S*FW;WZG'K3TUK2I;DVT>IV3
MSC=F)9U+#;C=QG/&1GTS3X-5TZZ@FGM[^UEA@.)9(YE98^,_,0>..>: ,"7P
M1%(EFHU6]C^SZ<VF,4$?[V$A>N5.&^4<KBK,GA"RN-&T?3KJ:><:4\;PS,0K
MML4KM;  VE25([@UHIKNCR1O(FJV+(C*C,+A"%9N%!.>"<' [TS4=6@@L-0:
MVO\ 3DN;5/F-S,!'$Q'R^9@Y4&@"&\\/K-KHUFTO);.]:W^RRLBJRRQY++D$
M?>4DX/N<@BJ0\%VEM+ICZ;>7-B+&T>RQ'M;S86*DABP/.Y0=PYY-:[ZSID%P
MEM/J5E'<LR((FG4,6?[H )SDX./7%2PZG87-W):07MM+<QC+PI*K.HSC) .1
MSQ0!AZ/X,AT:?1I(M1NI1I5BUC$LBI\\;%"=V .?D7&/3O6GI5K?VUQJ+7EY
M+<0RW)>V64+F),?=&T#Y<],Y/J><#/7Q/'/XTM-%M);.XMYK*:X>2*7>Z,CQ
MJ 0. #O/Y5H7>OZ99:U9Z1/=QI>W:,\43, 2 0/U) 'KSZ4 :=%58M2L)KQK
M2*]MI+E<EH5E4N,'!RN<\&K5 !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'FQTK4Y?!7BS2K.
M,RZBNL3S>26VF>-YEFVY/'SQMM].<5LZ,\\_CG4]7?3+RSLI]+MD$MS&(_G1
MYBP(SG(##\O3&>L^SQ"Y-P$ F*;"XX)7.0#ZXR<>F3ZFB>"*ZA:&9 \;<,AZ
M,/0^H]N] '-_#RUFM/ ^GK.K*TK2W"JPP5225Y$'M\K"NHHHH :Y81L44,P!
MPI.,GTKS;PQ:ZI!K^BWMSHM[:PQ:-<6LT0B01VTF^)A&@!+%?E;!.2W\O2F8
M*I8G  R:JZ;J5GJ]A'?6$PFMI"P20 C.UBIZ\]010!P7A[3-0M;3X>Q3V%S&
M^GPRI=YB/[DF$H,_5JZ#Q)927/BGPK.+-YX;6[FDF<1;A&# ZJ3_ ,"*_P ^
MU=110!Y;;6.JZ;'8WO\ 9&HSV=MJNHM-:VQ,<RQS2EHI47*Y '! .0'/'!J[
M#83>']4TZZMO#5])HLUE/;&RC832VSR2^9E@S=''7!(! '2O1:* /.+W2I+;
M5)K2\\-7UWHVH:;!:Q6^GS86WV;P87 =0%PXPW3K5H:9J5EXHBDTR.Y6%[J
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M0CO-#6R2!X2CSS[F(.T\_*#C<>/FX/%>E53N]5LK&YL[>YG$<MY*88%P3O<
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MFI1>&M'L9=*NQ/9>(O/D/E[AY7VF20NN"<C:P/X\9YI]QHFJW.AZQH,MM/\
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M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KACXBCO/ %WXFO3?\
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MC\JX"?5OL$?C=[^?4Y;.UU"%$%M.1)"K0PMA"6&T;F/ ]3Q7?1"184$S*\H
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M!Y_V2!YS%NV[@H)(SVX%<'K5GHMWI=IJ.EZ3.UBVN6MS.6M),$9"NRQ,N0N
MN<* 3GK77^*P&\#ZRD4;9?3IDCC5#DDQD!0O7.2!B@#3L+L7UA;W04*9HDD*
M9SMW ''ZU.'5E+!@0.I!KRI[>'3)IY+/2KB5)_"C"XBM5:-[B8$84N!GS,%N
M>6ZTD$*23^(X4DNK.UNK;39(+BWTV18E99&!;RV'*C"!@3DJ#V' !ZN&##*D
M$>HK)TC7/[3U#5[1[?R'TZ[%MDR;O,S&D@8<#'#CCGI5+P4UTVDW2W=G:P2I
M=NOF6:E8;D87]ZBGH#T(YY!Y-<9KVA07]SXSB:P=M<FNXI='E\MA(K^1"JR1
MOC@!U.X@]%YH ]6+*&"DC)Z#/6C<N[;D;L9QGFO,YK>*[\3:AI^NKJHU+[?%
M<Z?+:VV5D153;LEV'8 0P8%@.3ZFC28+:\UT6^L1ZHFO66ISS@K; 1R1,[[6
M\[9@Q&-@-I?^$+C@4 >F;E)P&&?3-07M];:?"LUW,L2/(D2ECU=V"J![DD"O
M+/#VG0647@VZAL6AO%U:\CGD\DAU@;[1M#'&0A)C(!XR0:Z_XAVB7/AVV=[0
MW*6^I6<TBB$R%8UG3>=H!)&W.<=LT =7N7<%W#<1D#/-96AZV=9.I!K;[.UC
M?/9D>9NW[0IW=!C.[I7GVKR(^N&:VTR[MWMM<LG.+*5W:';&N\-C"1[25V+W
M#9ZD4NG226WBR^GU*Q-UHLVM3",&!F,$Y1=DY&/F0@,N[&%(SWR #U7<N[;D
M;L9QGFC<N<;AGTS7FEE!;WOB22UU>/55UFVU>2ZMVCML)+ 7)1O.V?ZORB%9
M2_\ #C&<"J&E:=;VD'AZ[AL3%>)XEN@THA(=+9GN, G&1&0R'^[R#WH ]3OK
MZVTVSDN[R98H(P-SL?4X ^I)  ]ZG+*" 6 )Z<]:Y;XC6GVSP/>H+4W+(\,@
M18]YPLJ%B  3]W=T[9KGM1@AGN?%-M?6,ACN;*(Z)BW8':(B-D7&4<2Y;'!Y
M4]N #TND#J<X8'!P<'I6;9B]MO"]N+]7N+^*R7SQ$?FDE"?-M/J3G%>86%J;
MQ9X;73IUCO/"LD"P?8Y%43*?E1F8?.ZY(W'J3QC.* /7Y)8X8GDE=4C12S,Q
MP% ZDGTK%'B:&36]*L881);:E927D5UOP J;.-N.XD!SFN(MA'JU_;^187$J
MR>%)+5V>S<!I04PA++U&#U[C'6G:58Z=>77@J"XTT&SBT6X2YBGM66,2$0<.
MK #)*/UZE2>U 'J)95&2P ]2:"P498@?4UY3X65XHO#B:[:N^D#2);9!<PED
MBN!+]UP1\I,8 4GL"!UY33O#XN+WPC8Z]8M<Q_9=0C=;F-FQ"TBFW24GN$Z!
MN01ZB@#T^">X:>[6XMTABB<"*02AO,7:"6(Q\O)(QSTSWJ<NH7<6 7U)XKS2
M2R0W'BJWBE?3EDUJWEMYOLIDARL$7+KT:/>K GL><C&:J>?+$NE'7M,>UT=D
MO+>3^S[0W$'GF8$2;"C$)(NXJ<<9(S@\@'K%8%[XIMX?[*DM$6[M]0U V'FI
M)@1N-X)Z<@&-A5OP_9167AVRLX_M3010A$^V',I3MOX'.,<$9'0UYM9:?;QZ
M#H.GOIKQ21>)IC=QFU91Y?F7&TL<8*;73GD88#O0!ZYO7;NW#;USGBE!! (.
M0>]>2J'TNTE"VETFA6OB.<SPVMKO\N!HSL=8RI#1B0YX!]1TKO/"-G966B%-
M.-Y]BDGDEA^U)L(#')VIM4HF2<# ]N"* -[(]:3<N[;N&[TSS7D^L1BVM_$V
MG_8;DW+>(K.]@2*T=AY1:VRZD+C^%P<<]:T9(K^/Q9))IRQ7OVBZN-JW%N8[
MFPE\EU$@?H\)P!STW* 3C  /1PRDD @D=0#TH9@JDL0 .I->>>!HK&ZO+"[$
M6K0:S:V9MK^*>V\E%;C<';8!(=PRIW,>2>YK8\3F2/Q1X?FO(3+H@%PEQE-R
M1S%5\IW'I@2 $\ M[B@#;UC5XM(M8977>]Q<16T*9P&>1@HR>PYR3SP.].M+
M^?\ LV2ZU6V33VB+^8#.'0(I/SAN/E(&>0".X%><7&E>7H6FQ7=F9;0>)Q)9
M1R0%C#9&7/0C*IC)YX"E:[WQ/9K>>#=6LX;=9=]C*D4*IG)V': /KC% #(_$
M<<OB*STR.#,%WISW\=T7P-JM&N-N/^F@.<]JVV95&68 >I->8V-CI=_K'AZ.
MXTT'3U\/3I+'-:LL?F%X#AE( R=KGGKC/O698,5T7PY!XCBU'^RYM$%H62S,
MYBN <,KJ49E)7: <?PF@#V%L[3M )QP"<5S.E^*KS5[&6\MM%9H8KJ2U=1<
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M#(A[;U6/![$-61J]KI&I^#]?O])M=5,\]@D,MO+9&!5D5LJH01KND&6&Y<X
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MM.N(-VR-B\5OF-@P#EW/(P2N>,YQ\U=1!IT5M?W-U"=@NL--'CAG "A_8[0
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MDF$RV\2R@;0X0!@/3/I3+&P@T^%HH%P'<R.< %F/4\<?_JH \HU%;2#0_&$
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ME$C*Y61749 ",N2<@DBJ$UM#_P )%JD5UJ%Q<74_A:$I(TKPM<L//#-Y8;T
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MAB)'$:$@L![D@9/^R/2K= !1110 4444 %%%% !1110 4444 %%%% !1110
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MYFX-[?O7QCV].<?7?#]QIME;6D4NH2V\VISZA/<6UDEQY3ON8*T1#%EW.2"
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MT =S>:QINGQI)>7]M CKO5I)  5X^;/IR.>G(HN=7TVSGCAN;ZWAEE*A%DD
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M<'!.*P(K[4H/$6BV2ZE+>6>KZ?-*TNR,-"Z",B1"%Q@^9C!!&=OOE_PSB=/
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M-S?WNH^+]0T*&^DT\6VG17$4D:(6D=V=2WS Y5=B\>K'/:N=L;^^\1:I\/\
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M8XP?D?GBNWH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M34+F.;7KFQBO'*LD9WD1H<MNQQC(4@=S77ZGJEOI4$4DX=FFF2"&- -TDC'
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M"$6Y2WOX;J43.R[E0YP, \G]*O2:!I4UJ+:6QBDB$PGP^23(.0Y)Y+# Y//
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MFBULK^XDOY)H8XD1 T<L0.^-]S#:P*D>GOCFM?0]9@U_28]0MXY8E=GC:*8
M/&Z.493@D9#*1P2* )HM,L8-1GU&*TA2\N%"RSJ@#N!P 3WZ#\AZ5'=Z)IE]
M=?:;JRAEFV>6SL.73.=K?WESS@Y%9K>,-/4P2F&X^P3WALDOL+Y1EW%,?>W
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MWFGW<VI6,\]K:W-M+(;=P]R92A\QVW'YOD&?T]N[IH=2Y0,"PY(SR* .)M_
MUS]BT"QNKF%[?3=+GTV8ID-*LB(A9?[N F<<]?:I=+\*ZW;7OAZ2]U*REBT6
M*6!62!@\Z,BH"?FPK849ZC\^.R#J3@,"?3-*2 "2< 4 8NO:/<:K>Z+/!+$B
MZ??"[</G+_NW3:,=/]83GVK/TOPI)9^)AK;FV@N&BDCN6M 4%Z6(*M(G0,H!
MYY))[#BN@N]1M+&WCN+F=$BDD2)&)^\[L%4#UR2*HZ=KGVW7-7TR2W$)T^2)
M!)YF?-\Q-PXP,?3F@".[TB[E\7VFM120>7;V,UKY3D@L9&1LYQP!Y8'XGTK$
MT/P9J'A_^QKFVN[:6[L=/.G3HX98YXMVY6!Y*L#GL<@D<=:[4NJLJE@&;H">
M32[UW;=PW>F>?\\B@#D;/P9+IESH,UG>Q;M/-T;CS(B?.-PP=RH!^4[AP#G
M/?'.KXCT>XUA--6WEBC^R7\-XWF9^81G.T8Z9]>WH:TK^:XM[">:TMTN+A$)
MCB>7RPY]"V#CZXJ8NJ_>90>.I]>E '&S^#]0EM-0@%S:@W6MQ:JI(;Y0C1ML
M/J3Y0Y_VNG'.YXFT:37]!EL(IU@E,D,J.R[E#1R+( 1D<$KC\:UBZ*P4LH8]
M 3R:@M-0M+Y9FMITD6&9H'93P''!&?8\?6@#EM:\(7FMV^JSR3VT6HW\,%L"
M S1PQ12&0#L6)9FR>.H].;FJZ'K+>((-<T:^M+>Y:U%I=07432Q.@8LK+M*D
M,I9OJ#VKI0RL,JP(/<&D9T099E48SR<4 <1KO@O5M7>_4ZM;2)<0VZQ/<VY9
MX7C8,VW#  .1DX&>WIB_9>'=:TS6[Z2TU2U&F:A.+JXC>W8RQR[5#^6=V K;
M0><XR>M=2&4L5##<.2,\BD$B'=AU.W[W/3ZT <8/!^H_9A%]IM<C7CJ^?FZ;
M]_E].O.-WZ5M^)=#?7+2S\BX$%W8W<=Y;.R[EWID88=U*LP./7/:M.YO;:SM
M9[JXGCC@@0O+(S8"*!DD_A4D,J3PI+&<HZAE/L: .1U7P?<ZKIOB/,]O%?ZY
M#';NPW-'#&BD*!T+'YF.>.OMST5_IRZOH5UIE\ $N[=[>;RFZ!E*G!(]ZF2_
MM7U&73TF5KJ*-99(P>55B0I/UVG\JG5U?.U@V#@X.<&@#EK7PSJ!;29-0N;:
M:;1[:2&V>,,OG.R!/,<?P_*#\HSR<Y[5J>%])FT'POIND3RQRO96Z0>8@(#A
M1@'!Z=*UZ,CUH XO5?!]_J'_  D82ZMD&KSVTJ%@Q\H0A!@^N=GMC/?%;.FZ
M1=6GBC5]6EDA,=_% BQIG*&,,.3CG._\,=Z?8:[]LU_5M+DMQ#_9YA"R^9GS
M?,4D<8&.GO5]9KDZC)"UN@MEB5DF\W+,Q)!79C@  '.><^U '+ZMX3U*?4-?
METV^MDM]=LQ!<QW$;,8Y%C,8=""."I (/IGVIMIX6U[2=0\[3=8LUANK>&*]
M6:U8D/&@0218;@E0!ALC@'VK;\1Z[_8.ARZG' MTL4D<;()=OWG"9S@]"PXK
M75E;.U@<'!P>AH Y>[\-ZE/JNOW=OJ"6IU+3X[.&6/)D@9/,VR>YS)TXQCK6
M4_@&^N;;689KVPA74]+CLBMM;,!'(AD(89;D9DR<\GVKM;Z:Y@MM]K;I/+O0
M;'E\L;2P#'.#T!)QWQCO1!?VMS=W-K#,LDUJ5695.=A(R ??&#^(H Y:;PMK
M-[<ZS=W=]8^=J6D+IQ2*%PL; R?,"3DC]X>,<^U7+#PW>V6MZ;J NK?;!IBZ
M?<1^626VL"&4Y&,\]0:W;^:YM[*26TMTN)UQMC>7RP>1GYL'&!D].U3ET#["
MR[L9QGG% &'K>C7M[K.D:II]Q;QSV!E5EG0LK)(H!Z$'(V@^_/2LC2?!VHZ8
MWA_?>VLXTJ:ZE;",AD$V[COTW=>_H.M=K35='+!65MIP<'.#0!P]GX*U33FT
MN\M+ZT^W6%Q>,5=&,4T-S*9&4]P5.,'GITYX;#X*UNQCM;NQU:S74[6^O+A-
M]NWDR17$F]XV&[/7:00>-O?K7>$@ DG %('5LX8'!P<'H: .=AT/4_\ A)M-
MUBZO+>9K>SFMI@J%-QD='RHYP%\L  DD@\G-6?$FDWNKVEI'97441ANDFEBF
M0M'<( 08W (..0?JHS6PLB,F]74I_>!XJO\ VC:'45L!.ANFB:81@Y.P,%)/
MIR<?GZ4 <E9>#-2LY-/W7MG(EGK-QJ8"Q,F1*)!LZG&/-/Y >]5]3TRWTSPW
MJVC:I-YESK5Y<7%DEM&Y?S6.] #C 96VD,<#C/&*[_(HH I:38G3=*M[1Y3+
M*BYEE(P9)"<NY^K$G\:YK_A"IC87^B-<Q-HUY?\ VTY!\V,&42O$.Q!<'YNH
M!(P>M=@LD;(75U*CJ0>!2AE;.U@<'!P>AH XO4?!NH7-MK]K!?6H@U34(KY-
M\;;HV7RL@D'!'[D8X_B]L%VI^#;[4KW6;M+^*UGNWM)[21%+F"6W.5+ X# G
MJ..*V[37?M7BB^T80*!:VL-RLZR[@X=G7&,<8,9[GK6Q0!R=]H6OZK8V/V^^
ML&N[>_@NR(8G2(+$V[:,DG+=R3QQQQSJ^*W5/"&M%V"C[#,,D]RA K6) !)(
M '6@,K9PP.#@X/0T <)I_A^YU[P[H]W--:AX-&>UM?+)(+2QJK.WI@+C:,]3
MSTQHGPM>1V_AFXAN81J.AQ&'Y@?*GC:,(X/=<[58'G!'>M/3-=_M'7=7TWR%
M0:?Y)$RR[A*)%)SC'&,>]:RR(R!U=2IZ$'@T <Q+X-2X\.:U82SA;O5;A[MY
MD'$4WR^6R_[FQ/J5SQG%2ZIX<N+K2-)LK>XCWV5[!>2RR@_OFC?>W3H6;)SV
MSTKHU8,H92"#T([TA=0P4L S= 3R: .6C\*S#Q5'KW^BQ74;S%Y;?<C7<3!@
MD<H'!VY4[N3\@X%4](\%W^BIH5S;W=O)?:9!-:R!@RQW$,C!L9Y*$,%(.#T/
MKQVQ=0P4L-QZ#//^>*6@#C[7P=/8ZEI-W#<0NUM>W=]=;@5\V2X#!@O7:!NX
MZYP/K6MX7T>XT/29+.XEBE9KJXN T>0,2RM)CGTWX_"MA71U#(RL#W!S65K6
MMMI%QI48MA,E_>K:%O,V^665F#8P<_=/I0!B6_@J:+3%T*2YB?1HM0%]%P?-
M"B7SA$>V-_\ %G.WC'>M;1]'N]/U[7+^:2%HM2GCF54SF/9$D>#GKD)G\:TK
MNXGCMEELH([EC(BD-,$&TL S9P<X&3COC%6"ZAPA8!B,A<\F@#C?%/@[4O$%
MQJ?EZC:K;WEFD$2W$#.ULZDDE,,  V1DXS\HZ]FZEX.U+4;;Q-$UW:*^M+
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M5"UU;K=):M/$+AU+K$7&]E'4@=2* .:^(\'VGP/>QK \\OF0M&B1EVR)5.0
M">F?PS65<QW$7CL7-HB7T$U_%YUM<6Y66W/DJOGPR]XPOW@>,[@#DXKT"B@"
MO?NT>G73K#),RPN1%$<,YP?E4]B>@KSWP3\GBJSDAL[BWMIM"BCV_8Y8D1T<
M_(S,,LR@XW,>23CTKT6XN8+2 SW,\<,2D R2.%4$G Y/J2!^-2T <E\3DC?X
M<ZSYB;@L(8<9((8<CWKFM6TRTL;W7K_1M)DETB;3(8[NWMD=%FG,WWL*,L50
MDOCDC@\FO0M<T>WU_1[C3+J25+>< 2&(@,1G.,D'TJ^BE452Q8@8+'&3[\4
M>/ZA;>=9>)839W4D<NL:=<P;;"2)2O[CS&C7''"OG'. <^M=)_PCVD6/Q"M8
MH]#A73I])DC01V>8MYFW,"0,+D,3SC@UWM17, N;6:W,DD8E1D+Q.5=<C&5(
MZ'T- '$^$-(FMKYM(NK939^')7BL9B ?,$@#(?9DC;:?7=FNB\6.4\(ZN193
MWO\ HD@^S0,RO("I& 5Y!^G/I5O3M/M]&T_R4EE95R\D]S*7=SW9V/4X'X
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?G41^^/^O+%BWYDG'3GI4+^!=%:=W NXXFO%OOL\=TZ1+.&W;PH/&3R0.,T
M8UWXGU2R@UV6WATX36NO6UC_ *EE$L<H@&6(;[X\WKSPHXJ:;Q7J^G6OB)+I
M+6YN-+N[>(3Q0LD8BE$9+NA8G"!V)P>0O;FMF?P?IEPMXLAN<7EY'?3 3$9F
M3;M8>F-B<=/E%4?$/AAWL[^7389KBXU"Y@EO$^UF%V6(C!C8<*PVKCH#CGF@
M"YX>U74=2U/6(KAK:6QM)EBMKB",@3916)SN(.TMM..X_ 9VK>*=1T_6UAC^
MR26W]IVUDT:(S,J2A06=\@*X9N%P3M )^]D7_#&F7UB\\MQ+J202* MOJ%X+
MEU8$Y;<,[1CC&XY]NZW7@G1KR[N+B07:M<74=XZ1W4B()DVX<*#@'Y5R?:@#
M#?Q7KT4ES<.=/-K:Z_'I;QK X>2-VC4,&WX5AYF>ASCM5/Q!JMUX@T>TOXVM
MTL8O$MM;)$8R9"([M8RV[/!+*3C'W3ZUU;^#],D@N(6:YV7%\NH2#SCS.I4A
MO;E5XZ<=*AF\"Z+--.Y%VD<]TE[)!%=.D9G5@WF!0>"2 3COSUYH G\7:M?:
M)HL=Y8+;M*;RV@*SJ2"LDJ1G&",'YLYYZ=*Q)/%^I:?<ZCIU[]DFO(M4M+"W
MGCB:.,BX52"REB?ERW1N<#IFNJU?1[76[);2[,OE++', CE3N1@RG/LP!_"J
M-QX1TJ\;4FN4FE.HO').3*00\>-C*1C:5P,$8Z4 -TC6+R7Q+JNA7ZQ/):10
MW$5Q$A4/')N&&4DX8,C=^1CI6??>(-<GOM4AT.QBG.F7,<$D<NT"7*)(_P Y
MD!3Y9./E(ROOQT5AI=O82SSH9);FXV^=/*V7<*,*#V '/  ')/4FLZ[\(:5>
M:XVKL+F.YE55N%AN7CCN0OW1*@.'QTY[<'(XH H#Q#JJ:UJ^BS&S%\DL#:=B
M%L20R=68;\L5*R9P1PN>]-7Q!KM_>2OI5E#+:6NHFSN%DVK\BG;(X8R @@\@
M;>1WYR.BETFRFUBWU:2!3>V\3PQ2]U5RI(_\='TR?4UG?\(AI2Z[+J\8NHII
MG66:&.Y=899%QAVC!VEA@<X[ ]: .?L?%>O2-IES=?V>UM<:U<:5)%%"ZO\
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M<+!L\]UC9EA#G"ER!QD_IR>.:6Z\2Z997:6\\SKON%M?-\MC&LS8VH6Q@$Y
M^I ZUC)IGB+3_$VI7=A%8RV6K^5)*9YF5[25(Q&2%"D2 A5(&5Y!Z9S4%IX<
MU2Q\0WR?V=I%WIUW>F\2]G_U]ON(+)LV$,<YVG<,9[XQ0!VU8\'BC2KBYMH8
MYW_TL.;5S$P2XVC+;&QAN.1CJ.1D<UJ7$(N+:6!BRK(A0E3@@$8XKB]-\+:H
MNF^&=,OQ;^7X?F$B7$4AS<".-XXP%Q\N0P+9],#.<@ Z#1?$^F>(&(TYKB1
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MIJ,KP21,&BEVY7>N,A>0<]".AJYXJT>[U:VT^6P>,7>G7T5[''*Q5)=N04)
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M6FQ:A8R,]O+D LA4@@E6!!Y!!!!![BK$\RV\$DSARL:EB$4LV!Z <D^PKDM
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M..ULH[R2Y="(]C;^<XP  AY/T[5=L==L;_49M/C:6.\AC69H9HFC8QL2 X#
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M]JKW6MV5G=M:R&5I4$9D$<3/Y8D8JA; X!(/TQDX%6[2UBL;."T@7;##&L:
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M#*>H7)'<^IZ;86VFV8@M&E:$LT@,L[RDECD_,Q)QSZT /M[EYY[F-[6:%89
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M#)\OS8P0.G6ND@\77-W>6[VFF2SZ=)=R6LDJHX:((S*922NPKN0C ;(!!]0
M#J0J*JJ%4 =!CI2[%VD;1@]1CK7G=WJDNO:MX%UA+:&.RNM0D:W?<3+L-O-M
MR,8^8#=CM@#GMT/B75-2L-9\.6MB(/+OKUX9O,)!($,C@ @' RN?P% '1!$
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M1H!@(H'IBEVKG.!D>U+10 W8H<OM&XC!;'.*!&BL6"*&)R2!R:=10 4U8T5
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ML(G!)'!YP<@$$<X[@\T :5%4])U.WUG2K;4;4MY,Z;@&&"IZ%3[@@@^XJY0
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M#*J07<QBWQ $$#[F"#CYB06(_ 5L:UH\.NZ+/IEW)(D<R@-)%@,""&!&01U
MZ@U<BN(+BV2YAFCD@==ZRHP*LOJ"."*R[/7[)=/@FU#5])WS-+Y<D%P!'(J%
ML[23SM5?F]"#0!6O?!UEJMM?)J=Q/<W%Y#'"UP"(WC5&WIY>T84ASNSSS[
M0S^#!?:/]DU#6]2NKM98YH;\LB2P/'G85"J%XRV<@YW'/;%ZY\6:';+ICMJ5
ML\>I2&.VE252CX4L3NSC VD9]<"KYU33UOA9&^MA=L=H@,J[R<9QC.<XYQZ4
M 9+>%?.&FO=:O?7-S8W?VSSY!&#*^PH 0% "[6(PH'KUR:NZ-HL>B+?>7<33
M?:[J2[?S ORN_4#:!QQ[UH33Q6T#SSRI%%&I9Y)&"JH'<D]!5,:[I!A$W]J6
M?EF80!O/7'FG&$Z_>Y''7F@#E?"_AZ6ZLKI=3-U' NMW-_':RQ; W[]I(FR1
MDK]U\>HY]*UO^$,L9-%U;2KFXN;BWU*Y>ZD+%5:.1F#90J!C# $9SR*UK?6=
M+N[&6]MM2LYK2)BLD\<ZLB$=06!P,5FZ!XA;6M:UVT5K:2WL)HHX98&W;PR!
MCN.<9!../2@#%\9>&II/"FLRH]UJ6KW-DMG&PC&[:&W8"J,#)Y)]AT  K7N_
M"5CK,%XVIS7%S)>6JVWF$")HHPV\;0 -K;L,2>X' QBM*^\0:-I;NFH:M8VC
M( 76>X1"H/ )R>,U+=ZOIMA%'+>:A:V\<@RCRS*H8<<@D].1^= &'+X-:[T5
M]/O]>U*\=I87^TR>4' B<.B@! OW@"3C)[GIB_?:2HUF#Q!YEU+<6-G+"EM$
M$Q*K;688(^\2BXY JQ+X@T:WNC:S:M8QW 8*8GN$# D$@8SG. 3^%8NB>*VU
MD'4H[O2TT=99H90TN)HBLA2-B<E2'VDX(7&1@M0!8\,Z8D=YJFN&PFL9M5E2
M0V\Q&]%5 N6 )"L2"3@^F>:T-=T*S\0Z>MG>A_+6:.8%#A@48'K[C*GV8T]M
M=TA+:.Y;5+)8)7*1RFX4*S#J <\D8/%0'Q7X=$'GG7M,$6$;>;N/;A\[3G/?
M!QZX- $:^%=.1]=9!*G]M#%SL;&W]WL^7T.,G/J:S[?P-%"79]8U"5WTP:8S
M,(A^Z&<' 0<C<?ZYK>AUC3+FXN;>#4;26:U&;B-)E+1#U8 _+T/6HQK^C&UF
MNAJUC]G@QYLOVA=L>1D;CG R.GK0!2N/"5A=Z#IFDW+S2Q:<T+0R$@.?+&W!
MP ,,N5/J&--U7PL+_6XM8M-5OM,O!"+>9[4H1/$"2%8.K#().".1DUJ6VKZ;
M>&Y%KJ%K-]E.VX\N96\D^C8/R]#UI(M8TR>":>+4;1XH2%E=9E(0G& QSQG(
M_,4 8.H>!+6[DU/[/J5[9PZI:"UO88BC+* FQ6RZDAMO!(/( [\UJ:EX?AU3
MPS)H<]S<")XEC\]2HD^7!!Z8SD#M@^E:%G>VNH6XN+.YAN(22OF1.&7(.",C
MN#7/VGBZWC\1:OI>K7FGV?V:ZB@M-\P1I]\2OCYCR?FQQ0!#<>!(;M=2\_6-
M1=M1>WDG8B(9:$J5( 3 SM7(J;4?!%EJDNJRW-Y=^9J!@?<A53!)"<QO&=O!
M!YYR*VQJVFM)=1KJ%H7M!FY43+F$8S\XS\OXU86>%K<7"RH8"N\2!AM*XSG/
M3&.] &!:>$A!JTVI7.JWEW-<>1YRR+&J.8=Q0X51C#-GKV%37GAB&?5;S4+>
M\N+26_MUM[M8MI$JKD*W(.& 8C(['IP*CMO%-C$-(M;_ %*PDOM1#&-K23]T
M^W.2I)Z9P!SR3Q6]--%;0O-/*D42#+.[!54>I)Z4 8^G>&;32M9;4+265$^Q
M0V*6V%\M(HBQ3'&<C<W>I]0T2/4-9TO4VN9HY-.:1HXT"[7WKM.[()Z>A%0Z
MKXHTS3?#>H:TMU;W$%G'(Q$<R_,ZJ3Y>>S'ICWJ30[N_OHI+BYFT^>UD"M;2
MV9;GCYE8$D<'C(//H,4 4H?",=MKES?VNJW\%K=S"XN-/1D\F27C+<KN7. 2
M 0#WXR*B_P"$*M_LH@_M&\P-5_M7.(\^;OWX^[]W/;K[UT%W?6EA&LEY<PVZ
M,=JM*X4$X)P,]3@$_A56;Q#HMO$DLVKV$<;P^>C/<H T?'S@YY7D<].10!D7
MO@:TO?[1=M0O8Y[R]COTFB95>VG1 BLGR]-J@$'.<GUI\_@\3G3[I]9OSJUE
M*\B:@?+WMO4*Z%-NS:0%X"CH#UR3LS:M8164=VU_:K!,N897E4))D9!!SR,<
M\=JH^$=:F\0^%[/5+A(DEGWY$.=GRNRC&?8"@"C%X(MXK>"+^T[Y_*U5M5#,
M(\F5F9B#A/NY8^_O4UAX0BTW5+B>WU2_&GS3M<MII9#")6.YB#MW@%LMMW8R
M>G:JFK^.+:/3;V?1YK6YEL=0@LKA';^_)&C$ '/'F=>F5-=!;:SI=Y:S75KJ
M5I/;P,4EECG5DC8=0Q!P#R.M '/V7@*"P.F10ZOJ'V/2[HW-E;'RR(LJZ[-Q
M3<5P[ 9.0.];.LZ'%K$NGS-<W%M-87/VB&2#;G.QD(.X$8*NP]:NV=_9ZC"9
MK*ZAN8PQ0O"X8!AU!QW'I6>WBG14U6_TZ74;>&:QB26<RRJBH&W=R>P7)],B
M@#//@FW,#Q?VC>8;51JN<1Y$H8,%^[]W(''7WJ6R\(IIVK7%S:ZK?QV4\[73
M:=N0PB9CDL#MW@%OFVAL9]N*T!XCT,Q/*-8L#&CF-V%PF%<#<5//! Y(["EN
M?$.BV2[KK5["$>4)LR7*+^[. &Y/W3D<^] &5_PA%D?"[:$][>&,7+7<-R&5
M9H93(90RD*!D,3CCIQ3I_"375A:QW.MW\U_;727<=\PCWAU4J!M"[-NUF&,=
MR>M;,^K:;;)&\]_:Q+*H>-GF4!E/0CGD<CGW%!U73A?"Q-_;"[+;1!YJ[R<;
ML;<YSCG'IS0!@Q^![>,*/[4OV*ZI_:N6\LYEQC'W?N\]/RQTHG\"VLPGD74;
MR.Z?4O[3AN$V;H)MH0[1MP5*C!#9SDUNMJ^FI=M:-J%JMRH8F(S+N 49/&<\
M#D^@K,M?%-CJ]KI]UI6I6'E7-T8B+B3#R*-P(0 YWG (!['I0!1E\ VT]O>"
M35M1^U7%\FHI=*8U>"=4"!DPN.5&""""":NKX5S=Z5>7&K7UQ=:?,\_FR"/]
M\[H8SN 4 #:< *!Z\GFM8ZKIXOA8F^MA=DX$'FKO)QG&W.<XY^E0+XAT5[J.
MU75[!KB20Q)$+A"S..J@9R2/2@!+"TOH-8U.XGO9IK.<QFW@DVXA(!#;<#.T
M_+U).0:TZJIJ=A+>&SCO;=[D9S"L@+\=>.O&1GTJ2YN[:RB\VZGB@CSC=(X4
M9].>] $U%4GUC3([**\?4;1;649CF,R['&,Y!S@\<TVXUW2+1(WN-4LH5DC,
MR&2X50R?WAD\K[]* +]%8\_BG18+K2[<ZA;LVIY-LR2*5=0I.[.<8/ 'J2*M
M_P!L:9]K>T_M&T^T(K,T7G+N4+]XD9SQW]* +M%92^)M!<D+K>G$B+SR!=)Q
M'_?Z_=Y'/3FGMXAT5+6"Z;5[!;>=&DBE-R@615!+%3G!  ))'3% &E17.ZKX
ME$,>A7.E2VEY9ZE?I:M,C[UVL&.Y"IP3E<5JC5]-:[:T&H6IN5W;HO.7<-OW
MN,YXR,^F: +M%8^F^*-&U32CJ5O?P?91(\9=Y .58KZ\9VY'J*M/K&G+81WH
MU"T^SS#]S,9EV2<$\'.#T/3T- %ZBL3PCK4WB'PQ:ZI.L*R3-*"(22F%D901
MGV4&J>B^+K>ZO[^PU2\T^UO(]1DL[6#S@KS*JJ00K')/S=J .GHJBNLZ6\-S
M,NI69BM6V7#B=<0MZ.<_*?K5T$, 000>010 M%8.I>*+*UO;W2[>X@;5;>S:
MZ$,C8'0D ]R3M)P.PS3_  WXCM->TNR?[7:-J,EG#<W%K#*"T6] >5R2!D]Z
M -NBJ,.M:7<>?Y.I6DGV==\VV=3Y:^K<\#@\^U*-7TUK9[E;^U,$;^6\@E7:
MK<?*3G@\CCKS0!=HJ&UNK>^MH[FTGBG@D&4EB<,K#V(X-8EIKEUK>IZC;Z2+
M=+73YC;374ZE_,F !9$4$<+D L3UR .,T =#16;:ZA-%92S:REO8M'*T>?-R
MC+GY6#$#J,<=CQSBAO$.BI!#.VKV"Q3(SQ.;E KJOWB#GD#!R>U &E15%M:T
MM=/CU ZE:"RE&8[CSE\MQUX;.#T/Y5'/XBT2VV>?K%A%OC65-]R@W(2 &&3R
M"2 #[B@#2HJG'JNGSW;6<%]:R7:AOW*RJ6^4X;@'/!(!]*H^$]8N-=\/17]U
M'%',TT\3+%G;^[F>,8SST44 ;5%<EK&OZ[I>H:9;FTL-FI:@UG#N=R44*[*[
M8]0G0=,ULIJHL-/677[BRL9=S@DS (5#'# MC^'!/IF@#4HK.G\0:-:S+#<:
MM8Q2L4 22X16._[O!/?MZTQ/$N@R.B)K6G,SH\B@72$E5SN8<]!@Y/;!H U*
M*HQZUI4UA'?1:E:/:2L5CG692C$9R V<$\'\C5J">*Y@CG@E26&10Z2(P964
M\@@CJ* )**HQZUI4LDL<>I6C/"I>15G4E%!P2>> #P3V-)9ZYI.HW/V:RU.S
MN9_*$WEPSJ[>6<8; /0Y'/N* +]%<W<>*(_^$OTG1[.>RN(KM)S/LDW21F,#
M'0X SD<^AKI* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** /.Q9>5X2\>Z9>+(9)+R[<)&X1Y$
MF0-'M)XYW;1[@BK_ (7G\SQ'=W>H6NH6VHW%E%&3<68@B:.$G)&'<;LR\Y/3
M&.A-=1?Z38:I%)%?6D4Z2Q^6X<?>7.0#]#R/0\BH;3P]IEE#)%% [+(-KF:9
MY25_NY<D[?\ 9Z>U &5\/K:6V\(0M*I47-Q<74:GM'+,[I_XZP/XUU%'2B@
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MZ?!/:6B075\][.I8F:1%1F!8D9"@#@8' [5FP>#O#UMI9TV#2X8[,R+*8ER
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MDUM=9?3+=M24 ?:"OS'' )]2.Q/(K0N[2WOK26UNX4FMY5*212#*NIZ@CN*
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MTH TY'>STYG8O</#$6)P TA ] ,9/L*XFP\0ZM-8^#]5^VFXBUYA%<6ZQIB
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M/K0!S?B>[UG0O#>NWMOKWG-'!%-:[H(S)%SALD#:RMVXXYY/:+5_^1P\4_\
M8M1?^AW-=#!X1T"VTB;2H=+@2QF(,L(SA\= ><D#TZ58DT'39;B>XDMMTUQ
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4.55\<@>V<UQ=WX(U1K75--L]3M4T^]U)-23SH&:2)_.65TX8 J64D=^<>]
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ML;1G'WE SC% '>6=[;:A9QW=K,LMO*-R2*>&'J/:K%>.:%I&G7.F^ ;&[TO
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MVLAD!WC/(#9H ]-R/4<TM<%H]U81:7;_ /"0Z?:Q2#60EK-91.UO-/M&R9
M=@.2,GC<#SS7>T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 13W5O:H7N)XH4"EBTCA0
M.IY[4\R1J@<NH4XPQ/!ST_.O.-3N3J_@?XB7UR [1_;;.(,,[(X8RH _X%N;
MZM]*WM(O[VZUBZ\/ZK'9S6YTV"YC\J-AA'+HT;Y)W?<^\ N<]* .KHKG/ VH
MW&I>%8'NG:2>WFGM'D8Y+^5*T88GN2%!/OFNCH *1F"J68@*!DD]J6N,T3Q/
M?:IKEOIE]'9R0W>FRW>ZWC;8K)(BE ['$JXD'S  <>_ !U:7]G)Y'EW<#_:
M3#MD!\P 9.WUX]*DDN(87B26:-'E;9&K, 7;!.!ZG )_"O+_  NB_8OA:^T;
MOLLXW8YQ]G/%=IX@U"6SUSPW L%K+'>7KPLTL99XR()'#(<\'Y2#[$T =!5>
M2^M(;J.UENH$N)?]7$T@#O\ 0=3T-<59>+=<=]/N+E-/-K/K4^DR1QQ.'^1Y
M560,6('^K&5P>O4=*H'4)=.N?%FH:BEG?&#6K:*V22 C9,T5ND;@ECM"[\G
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M91IE!'!''KZC(XSFJ#Z]XC?4_$$,+Z4MOHQ!9G@D+2AK<2# #X!#$#OD>G<
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MSQD@?6+3=4U.^\>M$;F-=/.CV]VMOY9RID=P?FW=<H.<=.,#J0#KF8*I9B
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MMV2VMWY@5)8YT>)RC(Z,&5@1W! J&T\/65G=:E.K32'40HN%E?<&VH$'O]T
M>_?)YK!G\916WBF+S+ICHTNDO=H%M)&D+"15W8 +D;23TQCGWK:&LVEQK.EQ
MV^JIY=W:R7$< A+"Y3Y"'#] %!Z=]XH J6/@?2+*2U?==W'V:U>RC6XN&=1
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M=3EO+1KM$>5IA:&Y8V\<C9W,L>< G)]N3C%7K_1K?4-1T^^EDF6:P=I(-C
M,RE3D8Y^4D?C4&G>(;;4]<U32XH;A9-.94D=X6568J&X)&.C#'//4<<U'?\
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MR<)@KYB$D>K$G 'KP *NKXIT9DE/VM@\5PML\+0NLHE895?+*[LD<CCD<]*
M*Q\':>;=H?.N]K:@-2/[P9\\-NW=.FX XZ4ESX,TR[N+FXDENQ//>1WID2;:
MR3(FQ67 X^3Y<="/?FKT?B+2IK&&\BNB\4TK01A8G+M(I(9-F-VX;6R,<;3G
MI7.:+XHEOM.6:]U5;=WUV6RA;[(?WR+(56(KU0D#J>1@T :B^"=(2 0H;Q0M
M^=05A=/N28[@2#G(R&;/^\:DM_!^F6FLSZE;O>1&>7SY+9;EOL[3?\]/+SC=
MW],@'&>:<OC'06NQ:B^/FFZ^QG]Q)M6;C",VW"DY&,D9Z#-37GBC1["5X[B[
M*E)UMV*Q.RK*P!"%@"-Q!'&<\CUH K_\(AII\-7&@&2Y-A<.[R R?-EW+MAL
M< L2?QJ*]\$:3?W%W-/)>[KN2&:81W+(K2Q;=DF!@!OD7VXZ9K0\07\>G:-)
M<R:@-/7<BBY,)E"DL!C;[]/QJM>^,=!T^YN;>ZOBDMJR+< 02,(M_P!TL0N
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M<2HUP(?LD@VN^<,P.\@D]-H)J>Y\(ZK!<'6K6QM;NX?59KV73)Y JM%)$L>
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M"NYFQGZ #N2>*CT[43?BX#65W:/!*8F2YC"[N =RD$JRD'J">XZB@"[1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110!Y_82SCPMX\N'FDANDO[YO-1RCILC41D$<C"*F*EU
M.>=]*\ 7,<C/=/?VP+YRSJUO)YF3W^7<3]*ZU=*MTOKJX51MNPIN(F4%9&4
M!L>N  ?4*/2@Z7;M?V]TRKBU5A;QJH"QEAAFQZXXSV!/J: +U%%%  1D$>M>
M21S1W-AX6N=0U"X9(O$M] 9Y+QQA!]J"@MN]%4 YZ<=Z];(!&#R*@6SM438M
MM"J;@^T1@#<.A^M $]>:PW6J36-_'8Z@)[F+Q'<11VUW=NGVF-8R?($@R5('
MS#M\G/&:]*JLVG6+QM&UE;LC'<RF)2"?4C% &?X4O4U'PQ8W2)=('0@I=/OD
M4AB""V3NY!^;N,'O7,^(UDN/%^JVIU*_A@3P^;I8H+QX@L@=P'&TC!X'L<<Y
MKOE544*JA548  P *A>SM99&DDMH7=A@LR DCZT <!I&JS:U=6MIK.H3VT,O
MAVVO()8KAH?,D8'SI-RD9*_N^.V<]ZK>&KBXN_%7AB^UV:2+4;GP\Y.Z9H_,
M?S8L?)D#)!R5Q^'%>CO86<D<<;VD#)&=R*8P0A]0.U2M%&TB2,BETSM8CE<]
M<'M0!!J<GE:3>2"Y^S%8';S]N[RL*?FQWQU_"O,KO5=2L]$U".\>YM+^RDTR
M5[FWU"26VFA>X"F56)RH90^Y6[ 'GK7JS*&4JP!4C!!Z&H$L;2*"2".U@2&3
M.^-8P%;/7([T >7^)-4CO8/&<$>IF6WAO-+>+$^]8@98BY7)( SG..,BIM>^
MW:38^-X=.U749+"WTI+J*5[QW>WNB)"520G=RH1BN>-PZ UZ:MK;I&T:01*C
M *RA  0!@ _AQ61K/AX:II_]EPSQ6FES1/#=6T=N/WB-C[I!&P]><'KTH Y/
M6]3:[U_5=*O/$@T.:&*WDT]R7#.I4$N@#J)#OW*5(;H!CFK%IJMOJ.MZC:ZG
MK5S8ZM9:JBV]K'/L:2'"%%$1.'5P6R<$\GD;1CNY+6WEDBDD@B=XCF-F0$I]
M#VH-M URMR8(S.J[1*4&X#TSUQ0!R/@!+:&3Q%#'.[3IK%R'C>=G*KN^4E23
MC/KWI?B"D!C\/2W,SQ1)K, =Q.T04$-R2",=N>U=>L4:.[HBJSG+$#!8].?6
MB2*.9-DJ*ZY!VL,C(Y% 'F=]JNH3Z+XBO8+RXCUW3M5$5G;B=@K)N00IY><,
MLB'.2#DL3G@8]/J)K6W:Y6Y:"(SJ-JRE!N ] >M2T >8+X@1O%NEO!J\OE3:
MW=V=PD]V0Q41R@(8ONHH=%"G[QX/&>8M'N;F.#PQ?G5K^6:XUZ\L9!+>.Z/#
MNN<*5)P<;$P>O YQ@5Z=]DMM[/\ 9XMS-O)V#);&,_7'&:8-/LEVXL[<;3N7
M$2\'UZ4 <;I@OX?$-SX5GN+^18;L:C'=O<2%FM#DK'OSG(D&S;GE1FN[/3BL
MO1]*N; S3W^HMJ%[* K3M$L0"*254*O QN)SU)/T U* /-/"FHKK;:9?7/B?
M9?>5,FJ:8KNKA]IWAP9/W01APP5>H'<5;\&W,J:U/I6J:C?3,(&ETJ2>=\W5
MHSL?,;YOFD&0,G!"[3@9-=S]CM1)+)]FAWS#$K;!EQ_M'O\ C0;*U)4FVA)1
M=JDQCY1Z#VH \PL]1U67P;HEW!>-J#K!>R7-H]\\,]Q&LN/,24'ED'9N/F[8
M%7M)ELYO%FNW/VJZADN=#L9X!+<NDC I.2=N[J!C/H<],UWS:;8.BHUE;%%.
MY5,2X!]1Q4SV\,C%I(8W8KL)9025]/I[4 >::')-J\W@NWN]4OS'>^&GFN1'
M>R(97'V?#$J0=WS-R"#UYQFH=/\ $4K:'X.FU752]O=:;/YZ_;5@EEE78%D+
MLR[L<C&<Y8'!QD>F#3[(8Q9VXP"!^Z' /;I[FL;5?#,EY?07-E=6UND<1B-K
M<62SPG)R6"Y4JW &<]AQ0!-X/ANH/">FK>WPOKLP@S7"SF4._?#9Y&?3BL_6
MRI^(WA9"V"UK?C&<'I#6]I.EP:18BU@"@%F=BJ! 68Y)"C@#V'ZGFK,EM;RR
MK))!$\BC 9D!('UH \JL9TNK?P/>:CJ$[*NKZC$UQ+=N. +D*"V[K\J@>W'0
MXJ[-JUU::5KTAU5UAM_$Z0OYUUM;R#Y.Z)'8_)U/<#KR.M>CK9VJ($2VA5 V
M\*$  ;U^OO67K7A\:C;1)9SQV,D<XF/^CK)',0"-LB'&X?-GJ,$ YXH XY;]
M+73;BZFUN9[>^UN.*S5-2#JD>,B.20,PC4D.3M.<%5]JRTOH;ZTT-[[5&D2S
M\57-N9A>N D6V?8"^[..% ).<=^:]%TKP[;6*W#W$=I-/<A!+Y5JL49"$E<)
MST+$Y))K5-M 5*F",@OYA&P<MZ_7WH \WO-:O;&?7E%[<&R3Q):V]Q*9F)MK
M9XH2^&SE%W'&1C&XXQ4?B&ZU"QB\306NI7:6%M<:<UM,+EBT4DDJK+&'))*[
M2IVG(&_Z5Z6MI;+YFVWB'F\280?/]?6FBQLQ;K;BT@$"G*Q^6-H/L.E '-^&
M6>W\6^)],%W<36UNUM+&EQ.TQC,D9+8+$D E<XZ#G%3^-=1N--T[3WCD>&UF
MU*WAO9T8J8H&;!.X?=!.U2>P8].M=!':V\,C2101([#!94 )_&GNB2(R.JLC
M##*PR"/>@#S#Q!=7]C#XD@MM3NX["VO=--K.+EBT3R2H)HPY))7:5.TY W^E
M>CZ=81Z;9K:Q37$J*S,&N)FE?DDX+,22!G SVQ3A8V8MUMQ:0>0ARL?EC:/H
M.E3@!5    X ':@#S/QWKOV2[UG[+JLT%W8PVCA'NC$L>9"?W:#_ %FX?>+<
M  #GG%L1#4_$7BY_[3O98K*.*6V@CO'\H;[8D_*#@J2<X/&>E=Y):V\SEY8(
MG8KL+,@)*^GT]J5+:"*5I8X(TD?[SJ@!/U- 'FWA2"6W?P6;#4KR>&]TG&H0
M-=,\:(L*[75<XC(?"_+C.3W!JGHTZ7@^'M[J-_.[R)>*T\EVX+M@XR=W)/3W
MZ5ZG%9VL(E$5M#&)3F0(@&\^_K2K9VJHJ+;0A5;<JA!@'U'O0!YE8W"6_A*?
M5KO6]5,KZM+8*WVYM@3[<556).$& %+_ '@K''852FOH[[3REYJ?F167BV%%
M9+UR(H6V$?/NSMR6P3^&*]9%C:"%X1:PB)_O((QM;ZCO3C:VY5U,$15R&8%!
MAB,8)]>@_*@#S?5M:O-.NO%C6M[<-:P7.G!V\YG^S6\FWSG3).WY2QR.G7M4
M7BV[OM.@\5Q:=J5V-.BTN"ZCF6Z<FWN&=AM5\YPR!25SW!_BY]-6UMU=W6"(
M/)P[!!EOKZTQ;"S2W^SI:0+!G/EB,!<^N.E '-:&SVGC[7--6\N9K;[%:72I
M/<-+MD9IE8KN)V@A5X&!Z 59\<ZC<Z5X;^TV[O'']JMTNID.&AMVE42N#VPI
M//;KVK>CM+:*3S([>)'QMW*@!QZ9J5E#*58 @C!![T >7>*[N^TX>)(;#4[M
M-.BMK*>.9;IB;>=YBK(KDDX*!6*DD<@XYKT?3K"/3;7R(IKF92[/NN)VE;YC
MG&YB3CT':GK86:VXMUM(! #D1B,;0?7&,5.JJBA5 50,  8 % 'FGQ#UPV<N
MMK:ZI-;WMEIT,\:-<F)48NY#1J.9&.W#9X  ZY(JEXPU>WU31_'MO>Z@8WM;
M1380I<E%DA:$,' ! ?<Y8$\\ "O5)+6WF<O+!$[%2A+("=IZCZ>U-ELK2=U>
M:UAD=5**SQ@D*>H&>U 'FVM3O<3>,I(=6O5CL]#M[VU^SWKHL<NR<AEVMT^5
M>.A[@\5>MYYHO$,D/]I7C)>^'3>RA[ISB4,!O3G"<,?NX'3CBN[:QM'9V>U@
M9G&&)C!+?7\J3[!9YS]D@SMV_P"K'3TZ=* /.=$>;6+CP;;W>J:@8[SPP9KD
M1WLB&60?9_G)4@[OF;D')YR<9IWA[5[V[C^'D]QJ,[O=V5Q]HS*<3%(AAF7.
M&(.3GK7H8T^R&,6=N, J/W0X![=/<TJV%FA0K:0*4^Z1&!M^GI0!Y%J]U>3>
M"->L=2>:XF_L7[5#?VUZ\EO>1AO]9M)S&YSRO0C/85U*107_ ,0FM8=8OVL(
MM*@NXXX-0D96<3N"V=Q+ A0".A[]J[6*RM($D6&UAC63[X2, -]<=:5+2VCE
M$B6\2R ;0RH 0,8QGZ4 >6Z-K::AJNG11:O//::GH]XS+)>EI97#QE&90<1O
MAG&U>@X[<3>&+E(]+^&D5IJ$QCGA,=S&MVS*S"S)*D;L<,!QV/I7ID=I;1,&
MCMXD8%B"J $$]3^/>D%E: H1:PYC.4_=CY3G/'IS0!QNA_;DUV[\,W-S?2?8
M;PWRW+SR$R6K@F)"Y.3ARRX/!$1]:H^%-3;6;_3;N7Q((]4CEGCOM)&XNS?,
M"C(9"$"D A@H[?WN?1MJARP4;B "<<D#I_,_G4:VUNEP]PD$:S2 !Y @#,!T
MR>IH JZV6&A:@R2/&ZVTA5XV*LI"D@@CI7GNC_; WA2ZM]9U"Y74]&DDU)9+
MQW4!85*RKS\A#D+D8SGGG)KTC4+9[W3;FU201M-$T8=EW!<C&<9&?SJEH6A6
M^BZ':Z:5@E,4"022K"$\X*NT%AD\X'J: ."T>YN+;PYX*O+C4]0EM]9^SIJ5
MQ+=NP#>0Y10<_)NDV@D8R0 >2<RS:W>:3J$MK>WTX\-KKPM3?/,VY(VM]^PR
MYR$$Y"[B>.5)KTC[);?9FM_L\7D-P8M@VG\.E!M;<VOV8P1&WV[?*V#9CTQT
MQ0!Y]?:I;:?<Z39?\)$YT.\ENQ]ON9V*>;E#'%YRLIV@&4 ECRF.2*JR:@89
M+#1=2\7!+.737:UU:9GA%Q()6!(=9%RRIY9!+'<"6[UZ7)9VTML+:2WA>
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MM8KIXU%P7DWY0'H=H!7ISR.E>CU$+: 3F<0QB8]9 @W'\:EH **** "BBB@
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M4_M73TL)@D(^5%+G*Y/4^8W7/;TY (;OQ;JMO?ZA8KH4#3VUDNH1YOL*\)+
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M(XSMDVE2-Q&2,' ]/? I&\#9N 5UBY2V353JL<"Q)\LA)9AN(R02QQZ9[\8
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MB7%F+VWM7N(H;A\;]H.!@$'DC ]ZYOQ[IVKZFVMVEGI$TJ7.C^5!<6WE@RR
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MKZVCN'8*L3R@,2>@QZGL.]8W@M=0GT==3U<QMJ%TJHSQG*M'&-JD>S'=(/\
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M@O1Y=&T:XBEB\A;B^N+J*WX_<1R2%E3C@<$' Z$D5T5 !1110 4444 %%%%
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M%7C;&,JRD%3@D<&K]% %:QT^UTV#R;6+8I.6)8LS'U9B22?<FK-%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M$40AF#1))EB21_%C@=J '?\ "26W_/AJW_@NF_\ B:/^$DMO^?#5O_!=-_\
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M?_$ULT4 8W_"26W_ #X:M_X+IO\ XFC_ (22V_Y\-6_\%TW_ ,36S10!C?\
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MB@$@D\)G/&,YZ$UV$,HFACE574.H8*ZE6&?4'D'VI]% !1110 4444 %%%%
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M\JV?]\'L:S;?P3=V1L7M=5M_-ABD@G,UCYBR1M(9 54O\KJ6.#DCGD&NRHH
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A** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>36
<FILENAME>exhibit1033-bochk_facili020.jpg
<TEXT>
begin 644 exhibit1033-bochk_facili020.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MY)4MU^7.2/:O7K;Q9HU[JRZ99W,ES<')S#!(\8QUS(%V#\Z -NBBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MP"15Q(9-I?)P>G;..>E<SX?\9>(KOPCX$:XO9<ZWJ$T-_J!4;E"R,$C'&%+
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MP$A<E<;_ # -P&,#C(QT]JVY]1U&'P1J^I/>75K?1Z3-/;Q22JY<I"KB=?\
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M\IL7^-']B>)_^AN_\IL7^- '2T5S7]B>)_\ H;O_ "FQ?XT?V)XG_P"AN_\
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M<]M.V%D.Y]C,6X)7/1CSOR.10![%17DD%Y::9I'AN/4=:AO-#GBN4N;[>UU
M+DLGEJ[$] N]03CD9P#7HOABW6U\-V4$=W=W<:(1'/=C]Y(F3M)_#&,\XQF@
M#6JCJNJ0:3:QS3!F,LT=O$B]7D=@JC\SU[#-8/BRZ-OKOAY;W T.2:9;QG_U
M8DV?NA)VVD[NO&[;[5R-]#'_ &/:I?,DM@OBJ)=-:9MW^B^8F0">J [P#TV@
M=L4 >GZ;>3WMJ9+BQFLY5=D:*4J>AQN!!(*GJ#^@HNM0BMKJVM<%[FX)\N)>
MNU<;F/HHR,GU('4BK,:HL:+& $  4+TQVQ7*CS!\6W,N?*.ACR,],B<^9C\X
ML_A0!LZ%K4>NVEQ<1V\L'D74UJR2XW;HW*-T)'4'O6G7D5FUK ]GJ,-QMNF\
M7W,>\3'_ %+RRY&,XVD$'WX/I4^G:G;3^+]%DAE=5GO]0MKJ*;<\Q)#E4F/
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MH!52>FW"NX"DKS@&@#TZBN(U/QKJ&EIK%L]C;S7VFSVBDAV2.:*X<(K 8)#
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M79LJSD@@H6^[P1D[LC&,Y[9JM?\ C'2K*Q2Z#RS*U]'8,D<+[XY795PRXRN
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M-RUM+-+;K*4Q$90P8 A0V,,0 2>WH,:&GZI9ZK%))93B012&*0;2K1N.JLI
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M_$&@ZS8Q&Y2P>9)[9756=)4"[E+$#*D#@D<$UA3>&=4BM?,ALVDDN?$B:M)
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MC<?56 (/UJQ0!P\D?BB^\+W"/X>LK;5(K58%\R6*7SR&7.P\@+@,0'_B*Y&
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MGD'8<8SVSBM/Q/I][?7OAY[2V:9+/4UN9R'4;4$4B=R,G+CIZ&NBI&944LQ
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M4B*.3R<LK'&>2V">,]-XMTNZUGPO?6-BZ)=NJM#YA(4LK!@K8[';@^QK:HH
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M+ISHVG:E=7%S^]C.U)%G"D8;G_6KP/0_CZ%110 4444 %%%% !1110 4444
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MZ4 </::_</XKT5H=4DFL[[4;ZWD:60*'6-9"JK%R%",BJ&X9L$D?-6YX _Y
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MM[@6NY%\[.^-T+_,I!]0> :TO^$=O9-7T;4KC55FFL!-YN;? F,@ .W#?(
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M7$C6D]O$3 X:.03.$5D<[<X)P1C(..QS4NI>"AJ=UK4DVH.D>I6UO"HCCQ)
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M<0202KNCD4HR^H(P: .6O=?GU/0KAX]/O(+2\TN6[M;V.0C: N5#D8,;$$,
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MT.8:5<I=1^)[JYF?[(X=8':XPS'&=I#I^?L< 'I2WUH]XUFMU UTHW-") 7
M]2O7O4]>=>&+"1[^QM-7TC5O[6TNZGD%VY*VQWELRJXX;>&^[R<GD#&:]%H
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ ) !). .]9D?B30I9/+CUK3G??Y>U;
MI"=_]W&>OM6G7D#Q:I<>!?'MO:6EE+;OJNH>:TTIWJF?F*IMP6 Y7+#G% 'K
M]%>:WGBZZM?#B7^C7C3VUMIUE/'$\89]KG!-P6Z;EQ@(=V=Q.1BI]:\1Z_93
M>*)X;VW$&C7-MY</V;/FHZQLRLV?]L\CGI]* .ZMM0L[RXN8+:YBFEM7"3HC
M F-B,X;T..U6:\X@U9[;XE:]I4<QM)+^\M]MTR!D^2VC)C&>-[#.,]@3SC![
MVWAO([VZDGO%EMGV>1%Y04Q8&&RV?FR>>@Q0!:HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *Q+/PGI5A+NMUNEB#[UMFO)6@5LYX
MC+;1SSC& >E;=% ".BR(R.H96&"#T(K'TWPMIFE&,6PNS%%CRH9KR66*+'3:
MC,5&.W'';%;-% !1110 4444 %%%% %#2M'M-&CN([,2!;B=[B3?(7S(YRQY
MZ9/..E7Z** "BBB@ HHHH **** "BBB@ HHHH **** "J%]H]IJ-[87EP)#-
M8R&6W*R%0K%2I) Z_*Q'/K5^B@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@"KJ6G6FK:?+8WT7FV\N-R[BIX(((((
M(((!!'((J#3M%M-,8O$]U-)MVB2ZNI)V ] 78X' SCK@9Z5HT4 %%%% !111
M0!!>VD5_8SV<^_RID,;^7(R-@C!PRD$'W!IMA86^F64=I:(4ACS@,Q8DDY)+
M$DDDDDDG))JS10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !17%:UK]Y<^'/&&
MH:==/:C2(IX;=T526FCCWLYW \!CMQ_LL>XQO6M^=3MY;6VDF2>*-=UT$!02
M$ X]SZC^5 &O165X<UD:]H-MJ'EB.1]R2Q@Y"2(Q1U'L&4UJT !&01ZU@#P7
MH0@N8/LLY@NI6FN(6O)C'*['+%E+X.>^1S6\S!5+'. ,\#)_*N>TWQKI.JW%
MA%;K=JM^9%MI9;=D1VCSN7)[X5C^![C% $M]X-\/ZC),]SIRGSX$MY421XT=
M$^X"JD#*]CC([&G2^$=$GBOHI+21H[\H;E?M$O[S8 %S\W&  ./2B'Q5IDUQ
M9QAI5AOI&BM+ED_=3NN<JI]?E;&0 V.,U%XXO[S2O!.L:C87#6]U:6KS1.%5
MOF49&0P(Q0!)<>$-#N_M1GM))&NI8YIF-S+EI(\;&!W9!&!@C'2K%CHD%AK6
MH:E$SA[Q(E=3*[ [ 0&.XD9P0.,=.<DUEZ5J*W%U:^1XBEU"46YGGM0L# K@
M#@HBD'<1C)]:T-/\2V.IV%A>VJS-#?.R1%DP05W;MP)RN-K=>XQU- &Q17-R
M>.-&A/[UIT1[62\@?RBPN(D +,F,DX!!P0#@YZ<T)XVTV6*X:*WO6>*Q_M!(
MV@*&>'N4W8!P2!SCJ.W- '245G:#J;:SH-CJ+V[0-<P)*8V[;E!X]N:JR^*M
M,AF4.THMS=?8OM>S]T)\[=A/7[WRYQC=QG/% &W17'V>H:AKGBS5;1)[RQBT
MJY@5 J(4E4QJ[J^<GYM_!'0 $8.<R^++[4;76_#5K9:C-:17]ZUO.(XXV)41
M._&]6P<J/PH ZNBN0DUN_P##_C.PT?4[Q;O3M3@FDMKF1%22&2)0SJY4!2I4
MY!P",'.:T(_%VGS7+VL<=P;G[*;R&-D ,\0(&Y>>Q(R#@C(XH WZ*X3PYXCN
M)-,TK5[^XOYI]4L/._L]8D*Y50[R1GC"@,%P3SQQGKT-IXHTZ^GM8K4RRF[L
M/[1MRJ8$D.5&1GH?G7@XZT ;5%<>_B)[_7O"EUIMU,VEZG;7,QAV >8%160\
MC(/)XSBM?POKQ\2:''J7V26V61W"I)C. Y Z$]AS[YH V:*XB+Q9_9/B/Q)#
MJL]W-96UY;1Q.L&Y+99(D/S%0/EW/U.3^5;L_BC3K?439OYWRW4=D\P3Y$G=
M0RH3UR0R\@8Y )H VJ*S+77+:]N_)@CF=#)+")PH\LO&2KKG.0001R!G!QFI
M[_4K?3O(67<\US)Y4$,8R\KX+8';@*22<  4 7**Q8?%.FW%N'B:5IS=-9_9
M=F)1.H)*8/&0H+9SC'.<<TD'BBPN8(6MX[F6>9Y46U$>)<Q';)D$@ *<#.<<
MC!.1D VZ*P[+Q7INH2P1VHN':XLFOH@8BN^-6"GKC# L!@XJJ/'>D2"Q^SQ7
M]RU[9B]@2"T=V:(E1G ';>"1V_*@#IJ*YRW\;:3<M<;$O1%;R2123/:NL8D1
MQ'Y>2/OEF "]34L?B_2W^UQL98[JUGCMY+5E!D+R<QA<$AMW8@XX.<8. #>H
MKE_"VJWFHZ[XGAN9+CR[2]CCABG15:)3"C%?EX(W,<'G(QR:Z*[N[>PLY[RZ
ME6&W@1I)9&. J@9)/X4 345AMXKTZ%YX[E+JVEAM3>^5)"=TD(ZNH&<XXR.H
MR,@9JSHNN6^NVQN;6"[2'",CSP-&)%90P*$_>'/44 :=%<_>^,--T]=5:X2Y
M4:6T8NL1YVA_NL.>5]^WX'">(==M+/3;X3SWUF+<0E[BVB#LA=A@#AAGL<C@
M'W!H Z&BN(U75-3@U?QA!#J$J)9Z-#=VH"(?)D/GY(RO.?+7KFNHT2>2YT#3
MIYG+RRVL3NQ[L5!)H OT5B)XJTQ[BU3=*L%W.UM;713]U+*N<H#Z_*V"0 <<
M$TZ/Q/ITM[;VZ^=Y=R\L<%SL_=2-&"7 ;MC:W) !P<$T ;-%<[)XTTN*%YW2
MZ$ LWOXY/)^6:!,;G7GL"#@X)!R :GG\5:;;22I*9P8[#^T"5B+9AZ$C&3GV
MH VZ*S=&UNWUVV:XM8+N.'"E'G@:,2*RA@R$_>'/457G\4:=;ZB;-_.XNTLF
MF"?(L[J&5">N2&7D#'(&<T ;5%9EIKEK>W?DP1S,ADEB6<*/++QL5=<YR"""
M.0,X.,BI=0U6#3GM8G266>ZD,<$,0!9V"ECU( PJDY)'3UH O453TK5+76M+
MM]1LG9K>==R%E*GK@@@]"""/PK*C\::5)<7<02]"6<DD5Q.UJXCC9 I(+8ZG
M<,#J>W49 .AHK 7QAIGG7-M)YT5W;O"C6T@ =C*<1[3G:0QR.O&#G%3Q^([1
M[VSLWAN8KB\,PB22/&6B.'!YX]CT(/!H V**XZ^\1M?3^%;S2[J:.SO=4EM9
MXF0#S D<V0<C(P\78_G6MX;\0'Q#!>R_8IK9;>[EM@)<<F-RAZ$\Y4_F* -N
MBLC4?$=EILETDBSS&TA$]UY$>_R(SG#-W/W6.!DX&<5C:MK<]_XCTO1K":YB
MM;ZPFNA>6@0DX,01E)R-H\PD\<\=1F@#L**I3WD>E:?$][.97&R+<% ::0X
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M^^Z$_P /7GC<\,Z1>Z,NIP7+6[0SZA<7<#1LQ8K+(SX8$  C=C@G.,^U;U%
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M\2'O7=2(7B= [(6! 9<97W&>]4-'TD:3:M&UW<WL\C;I;FY*F20@ #.T #
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MPZ<MGCFL^7[-"+V_6Y?[5;^+H4BD:X8E(FDB#@9/W2I?/L/;CUVB@#RQ(+2
M^*[6&YM=-OGUU9$>>#,3(8X659<8_=NP89SUSZ&NR\%W+W/AQ3)9)9NEQ,C)
M%)YD3$2-EHVP,H221QP..U=#10!Y7J6J0#Q5%-#))#/!XB2&<2!FF\LQ%>H^
M["W&U>03SG/ K6_V6 6]_'<O]IC\720I(UPS$0-*P*\G[I4_3I[5Z[10!X_=
M7]I=6UK_ &H0OB*V\3Q&X1P?,2(7/R$#KY7E[,'[N>>M=+KUQ<IH:ZM&)#9W
M>K0O>E <BQ#!,\<["%5C[.W;-=W10!Y+X@"QQZVUE=%-#:^TMK4P3%8UE,R^
M>(RIQMV;20. <GKFO3]/T^STVP2SLH]EL-Q52Y<?,2QY))QDFK3.J#+L%&0,
MDXY/ HW*&"Y&XC(&>2/\D4 >36.H0Q0^'K%IV%[:>)[F*>/YMT4;&Y*JWHI'
MED \$ 8Z<1*ME8>%[V*$+:W,'BP;U3,9$?V[(!QC*^62<=-O->OT4 >5^)IH
MS!\3/+G*R_9(#'Y<A5BPA(&,')YP,?A5SQ#-H^L:['I7VFVMX0D=UJ=_)*%;
MR]HV0Q,3D%L9)7HN>["O1BZAE4L S= 3R:=0!Y)XEN(C;>/A!<RH/LEDT"B9
M@5.UN%&>.HR!5O52EC>>-[?2M0>UC;1H+E)$D:3$O[[>X().2H3)'/(->H51
MU?3$UC39+*2>>W#E6$MNP5T96# C((Z@<$$'H0: .2\&7>DZEXGU2^T[4+/;
M);0JFG6]SN\HKD/(4' R2@SC^$9P3BK'C6YM?[5TNQN@09X+GRS,"T!8!1MV
M#EY3GY1D8^8\GBN@T_29+6<7%WJ-SJ%PJ&-))UC78I() "*HYVKUST[5I!U;
M[K \XX/>@#R;0&M-:NO"RZK<R31R>&'%T)IW4-(&A^]R,GAS^!/:IM.GN[/P
M=X/\71QS7UU:VT=I>PAMSRI( @//\:OMYZX+5ZI69=Z/]MU:"\EOKKR(0/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% ",H92K %2,$$<$5YCX0UK4M"\/Z
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MG921,S0<85SM[8X*[3[U-;^%K;21I=S;37UQ)HUB]I:PEX_WB$+\I)4<GRT
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M8TC W' (+'+*,9'4GM@YUCX$L=.ETWR=1U(V^ESM-96SR(4AW*RE =FXKAB
M"21V-:VJZ%;ZK=6-VTLUO>6+L]O<0%0R[AAE^8$%2.H([#N* .83QMJUU<V-
MA:Z=9B^EU"ZTV?SIF\M)88FD#+@9*D!3Z\X]ZWO$6JZCHGA6754@@EN+5%EN
M8QN90@QYA7H3M&6&>N,<9IJ^$;&.[T^YCN+I)K*YENPP*?OI9 RNSY7G(8C
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MM@-<7L@=R!T'R@# R>V>><T <,+6#_A8/C+;X<AU0B*S8*R1D(3&^20W//?
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MPRJ<A681ABOJ,\CB@"M:>)]4U*YM9M/TWSM.GN9;=WV$-"J%E$I8G# LO*@
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MP5F)3YL'OQNQFI[SP_J<VM1-!916MO<:)-I[-:NH2S=F#+QP2 ,@%1U'0 \
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MQCUB#2;FUM+:XMY))2H 9=S2;,8D7=E2"<#'8G- ';:OJ]GH>FRZA?NZ6T>
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M6DB@$328<; N\LA4'&,'.,CFUX%CDBG\4QRSM.XUR7,C* 6_<PXR  ,X] *
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M'[XZ-,(M26%GMR4#!G R%(/8]/QH TZJV^I65W>75G;W,<MQ:%1/&IR8RP)
M/UP:X2V\;7-[J86UNI#::IIZ'2V>-,+=_+O0G'.!+&3GIMD].*FLW>IZ-J?C
M?5+"_P#+ET^ULYV#0JWGE8VRK9' (S]T \\$=* /4**XG4?$&ISMXL:QNA:O
MH,:M%$T:LLQ\D2DOD9VG.T;2,8)R>T3>*[\:K8/>K<V%A?&U^SRI&DL(:0*6
MAF.-\;DMA3P.5]\@'=T5Q6@ZOKVMMINL17%HNF7$TL=Q;22#*@%E4)A,[P5
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M8IMO+JG_  ES:#IFHV]MI5EI]G<1*+82%D+R(4W;NA6,<]N/Q -6RT;P[?\
MAZ/3K.-)M*AF.R..9RJO&YXSG/RNO3L15J;PYH]Q<7L\]A#+)?1"*Y+@L)5
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M$%QJ3V]HPCN4UG[&]L8-ZK:;<^=G@YQALYQSMQF@#I=-MM&CU34Y=.6$7AF
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MGORT(F8%25RQ4,06''/)]:T/#^DP:'HEOI]JY:"+<4^=F #,6P"Q)(&<#)/
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M.FB$UH\9B>.4EPR$8();)/'K7/KXZLI!8+#I]]+-=W<UD855 T,\:LS1OEL
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M+OOY4."K*>A!]?6NDO=<^Q^(]*TD6XD%^)?WHDQY91=V"N.<_6M<D $DX H
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\M& !'+'(PJ@9Z8&*@E\":%)865HL5U$+&1Y+6:&[D2:(N<OMD#;L,3R,XH
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M:TU)0[I+,%$HC2:5G$?F_?VY/&>GL.!@4 <WH^JZG&G@BWFFMI_[1L'>262
MF166!6!#;N^>?7VJ/0O%.NW<GAJ>^DL6M]6N+FVDBA@92C1B5E<,6/\ SRQC
M'?K71VWA+2K0Z885N0=,1DM"UU(WEJR[2.2<_* .<X XI+?PCI-G%IR6\<RC
M397GM ;ASL=PP8G)YSN;KGJ: ,/3O$^M:EJ6E1Q+;(;F[N8;ZU: L]G'$6VD
MD,,$[5&3P2X(&.#W->?Z#X8U>VN;=IDOK*>.82SR1ZQ)+:R$ON<)"W #9/!
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MSQE<"6Y&X&<^C%7<?C["@!R^.=)?5+:QC\R0W4LD,$J,A5Y$SE<;MPSM;!(
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MNET>.ZU"(1:A>G[3<H/X'8#"?\!4*O\ P&@!;OQ!8VVO6^AM.J7]S \T889
M"E5&?4DL.,]C6=X0\76^OZ58"[N[)=7N(6E>UB?! #$9"DD],?G3M2M+Z/QY
MI.J0V4MQ:)87-M*\;(/+9GB920Q!(PC=,\XKFM$T#6+:S\&0R:;/;O8-=BZ8
M-&?)\Q'53PW.2P/&: .]@UC3KF^:R@O8)+E5+>4K@L0#@D>H!X..AXK-\::W
M=>'/"E[J]I'#)+:A6\N4'# L%QP1CK6%X-TJ\@_LJVU;P_/#?:/ ;<7\MWYD
M3C:$S"-Y(W *2"H QCJ!6I\1-.O=7\"ZGIVGVCW5U<*J)$I49^=2<EB!T!H
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MV5"NU7DB<%L$@X+OV!P*S-?T#5;[_A.$MM/<B_M+9+,ET F:-3N YXZ@<XH
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MQVNG2/'ICZ=]IG>X:"63?)N;&6<AF&XGDX)_/- %J]UC3M.<)>WL$#8#'S'
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MFMQ@V,RX* F$1['.?DVLN[/3!XYXH ZB+5- TR9-)BO]/MYE=8UM1,JMO?)
MVYSN."?4\UJDA022 !R2:Y#P_H]S9>+]3EO+=Y8S864,=Y(H(E>(2;R.X.64
M^_X5K^+=-N]8\(ZMIU@ZK=7%J\<6XX!8CH3Z'I^- !>>(+ Z5?SV.KZ8LMO%
MN,L\P,41(^4O@@[3]>>U3MK^D0W26<^JV*WC,D?DF=0Q=\[0%SG+8.!WQ7*:
MQ'>^(O!NO,GA:>QU.YTQK/;,(_-E<AMJ*58Y12QY)'7@58L]*NKCQ5K-PUG)
M ESI-K!;W4B#Y94\TMCN""Z'\/:@#I?[>T@/.IU2S!@0R2YG4;%!P6// !X)
M[&GG6-,5MK:C:!O(^TX,Z_ZKC]YU^[R/FZ<UQND6.H7WA5-)O/#9L]3LM*DT
M_P"US&,HQ*!,1,"258JK'( &/6JMC9ZO+=Z?-)H=[#'#X;FT^3S/+R)LQ8&
MW(.P@'^G- '9#Q3X?(D(UO3L1Q+._P#I*?+&V,,>>AR.?<>M6)-;TJ&SBNY-
M2M%MIH_-CF,R['3 )8'."O(YZ<BN-T72+RTO?!$DVF2H--T66VNFV ^5*5A
M''7)C?D9_6LNVT#5X?"NF1PV^HV&KVEK<I&R(DL4FZ0D02H<@JPVX;C&#R*
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MMTFV><MO(IV!QC&_:[CT,F*W?#%O$6O=131KS3)+PIYHO9M\TK*,98;V  &
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M'(K,68]"G("C![\@\0:WI%S<P^-Y(='N#/>W-H]KBW.Y]B1;B"!V96[]L]Z
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MQABA>)PP# X(R.X-35DKJ%II^J6>E0Z=/$EXCRI-' %A# 9*MT(8@$].U:U
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MN\A25*XP2.&.*YZVT37+6.QO#H\S26GB.[OVMDFBWM!,)@&4EPN1YBD@D=Z
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M60HRDKD,IP>G;Z5QFC:3K\$?@RRNM$D0Z%,\=S<+/$8Y$\AXED3YMQR64D$
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M(/MT4D*E)(V=1O=1@D$!6()(R?P-=!J$MK%8S&\E$5NR[&;<5/S?* ".<DG
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MLUS-J,,,<$JPR^=F,H[8VJ5;!!.01QR#2+XHT1[1;I-1A>$B1MR9;"QG:[$
M9"J>"3P*X>^\/:[<VWB5(]'N6&HW-A/")[J)G81F,N&R^ 1L;C..0!QTTO%
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MVE++)&TA>&X B903ED+')4=S5UM6TU+&.^:_M1:2@&.<S+L<$9X;.#P*\_\
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MU?3/#.E+<7DD=M:HR0QJ,*,L0JJ!_G ^E/&O:.;A+<:K8F:1E5(Q<)N8L"5
M&>20"1ZXK*\:V%U=^#WM[.W>XGCGM9?*C.698YXW;&3R=JGZUFP6$\OB;Q3?
MMHK2-<6=N;5;F, 22(C@INYP<LH)SWXSB@#IUU[1WAFF75;$Q0*&E<7";8U/
M0L<\ X/)I\&L:7=&Z%OJ-I*;3_CX"3JWD\9^?!^7H>OI7EUSI6L75AJ>-%U
M&Z\+&QC1HD54F!;$:J#D*"P SD]R2.:V[W27FU>ZW:5>M8R^'XK1A;H8VWB0
MDJI[,JMD=NU '5WTWA_5+-9;RZLI[:WN%(<SC:DPPR\@\,,@COTJXVJZ<EC'
M>M?VPM)/N3F9=C?1LX/0UPL<'B&W-NMS:S:G!'J@:/4A:K'=B/R"N\QM@;@3
MY9<C[N3CH:IZ)::YH$>A7LVAW\]O9R:C;W%LFQI4\Z??'*J[L,,#:3G@,<<4
M =VWB?1EU>UTS^T+<W%U;M<Q8D7:R J 0<\YW<>N#Z4^QU:$Z1'>WU_IQ5I'
M43V\W[EL,P #$\G P?<&N>MM.FT_Q9H5W;Z(]MIZZ9<VIA@"D6Q>6)U# ' ^
M5&SC// SQG)T/3-6TR/PQ>2V%S]FLKC4$NK<1DO'YTC-'*%'+ #CC) <^] '
M>OK6E1PP3/J5FL4ZEH7:=0L@ ))4YY  )X["A=9TM["*^34K1K.4XCG$RE'Z
M]&S@]#^1KA+?P]>6^H:/,]C*UN?$5UJ(B\O=]FA>*15R.V78-CMN]C38-'O?
MLDH5=4TRZ36+ZZM+NWM_,$:NY*[XB#N1PQXQD$=NM '>WTFF7.C2R7L]NVF3
M19DD>4")XV'=LXVD'Z$&FQ7ND:?!]E2]M(8[: /Y9G4>7%T#')X7T/2L>YL=
M4U'X7W&GSVD,.J7&DO ;>(@(LAB*A1S@#.!UX]:YNXMM3U&:[G&B7\<4GAA[
M)1+&H)FR<)C.?\YZ<T >@6FKZ;J$\L%EJ%K<S1!6DCAF5V0'H2 >,UD1>*([
MKQK!HMI-9W%J^GRW3212[W5DDC4 X. "'/Y5R=YH.JW,4=OIUI-:S/X4EL%E
M,914N"4(0GL>'YZ#/7FDU&PU?Q!/&;'1+S3Y&\.7>GDSJL:Q3,8BJ9S]WY6&
M1QSQWP =^-?T8P3SC5K'RK?'G/\ :$VQYZ;CGC/O4\.I6-S;S7$%[;RP0LRR
MR1RJRH5^\&(/!'?TKSG5]-DUWPGK5Q!X6U2TU:;3?L1%W,9&=MV0B#>P*@[C
MN..HQU./2K6.".!?L\"PHWS;!'L[=QZT <LWCJSN+G09[&>T?2M1EG2:XDDP
M8A'$\@/7"YV@\]CTKHQJ^FG3X]0&H6ILI!E+@3+Y;?1LX/0UY]H>E:C#:>!;
M:\TFZC.E3SBZ+QAE3]S(JL,$\;F7!_'IS45K8:MID.G7ITC49[2VU+4O.M+9
MC',L<\Q>*5 &7( X(SD!SQQ0!Z9'/'=VBSVDT4L<B[HI5.]&!Z$$'D?2N8\.
M^(]9U_0[#55L["-+F=HVA\YMP59&1BI(P2 I;'M6MX>L[?2O#\4-OI\MA I>
M1;5G,CH&8MSRW)SG )P3BN>^'?AN*Q\.:?-?:8UKJUO+<%C(FU\/(Y&3T(*L
M* .M@U33[FZ>U@OK:6X0$M$DJLP .#D YX/!]ZB;6-/D2Z6WU&Q::",NX,RD
M1]1E\'@9&,^QKSNUTO7;N\TEAI-WI\B6FHVKA518;227;L*8.XKD9W<Y/3T&
MQI"3W7AU8;OPO/9ZC8Z4UB\LB(=QV@;(BI)925!SP.!0!L+X@NTUO0;&3[%+
M#J%A+<RW$#DKNC$9RA_N'S,@GM4D7BJPMDTN+4=2T]KG4998X6M9<Q,$WG.2
M>P4*?]HXK T>POK>\\#--8W*K8:-+;W1,9Q%(4A 4_C&W3T]Q5/1M+U.RL?"
M$KZ7=$V&HWIN(E4!HUE$P1L$@8^=>>V: .WM=1AEMKZ6\O-.>VBN&B#Q2@JB
MX&%D). ^3R/<5-_;.E_8X[S^TK3[+(2$F\]=C$9S@YP<8/Y5P$NFZO;QWE[!
MI=Y-'!XDDOGM8F,4EQ;M"8]T9R,D$[L9&=OTJU<:-_HT%WI-GJ^AW4DUQ=1S
MA3<L'<(&$\1+9$A&< \;0<@DT =>=9CCUBTLI"C17\;26<R'(<J 64^^T[@1
MU /3'.I7#7EM?W=YX"@GMH[:_MY#=W44/W(52W9'4>V^15_&NYH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH C>WB>>.=D!EC!"/W /4?0X''L/043P1W,+0S('C<893T8>A]
M1[=ZDHH  ,# Z4444 1O<0QS1PO-&LLF=B,P!;'7 [U$-0LC$)1=VYC9BH?S
M!@D=1G/7@US_ (PCF2^\-Z@EK<7$-EJ?F3BWA:5T1H)4W;5!)&YES@5QD]JJ
M?V4VIZ5.@D\8W,@CFMBS/&\<[ A0#N!X/&<XH ]46_LWL_MB7<#6N,^>) 4Q
MT^]TI5OK1H(YUNH##*0L<@D&UR>@![UYO#HE_I>IIJ=I83C0QX@:[-A'"=ZQ
MM;^7YHBQG ER^T#/0XI+_09Y+F6X_LZ>2PN?$MO=P6YMF8QQ!%$TA7&5#.&)
M! SU[T >EVUU;WD(FM9XIXB2 \3AE)'7D53O=<T^PU"TT^>ZA2]N]WD1.X4M
M@=?IG ^IK'\'VKV=_P")D-I+;0RZJ9H T)C5D,,0++D $;E;I_6CQ!#,GC/P
MU?K9SSV\*W44KPQ%]A=4V[L=!\IYZ4 6_"_B2/7])MKB?[/;WLQE)M5FW,%2
M5DR,X)'R]<5KQWMI+=26L=U"]Q&,O$L@+J/4CJ*\TT+2I[6'P=+_ &5<PW,.
MJ7CW3FT=62-UG"ESCH2T?7V].+O@ZRD>XTB'5=(U9-9TA98Y+J;*VYW AG1^
MD@<X..2"<GI0!Z(2%4LQ  &23VK!TOQ*FI^)=5TV/[,UM96\$R7$,^\/YAD!
M!XP,>7ZGK47CNVO[KPI.FGP/<R+-#)+;1_>GA616DC'KE0PQWZ=ZY+58-0U/
M4O$U]I.DWX%S9:=(BRVS6YN?)F=I8_G ^8I\N#USZ4 >CQ:E8S0>?%>VTD._
MR_,652N[.-N<XSD]*:-6TTHKC4+4JTODJ1,N#)_='/WO;K7GFJZ;;:IH]QJ%
MGH6KB>[U'3Y)A>V[^8_E3*6/EX^4+&""V/FZ<XJ+Q!H;2V_CT6NBS&2YC@^Q
M&.S;YW$:@E/EZAE'(]!0!Z:]]:1726LEU EP_P!R)I ';Z#J>A_*F_VC9"=8
M/MEOYS.46/S5W%@,D 9Z@$<5YUXB2^NM4O7@T;4$V:MIUT&AM687,2-%NE+$
M<%0"NQ<$;22#DX@DT=TM=1FBT:Y2X_X2N"ZB9;-M_DB2(LX(7[N!)T]_7D [
M;Q/XE30+6%X_LTUP]S;PF!Y]KA9)5CW!<$G&[/;IUK:>WBDGCG9 98P0C]"
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M6\L;/9+/:O#O9#*&!# '(#*.?Y4 =#J>MZ=H[VJ7]W% UU+Y4(=@-S8R>O8
M9)JR;VU6[6T:YA%RPR(3(-Y'KMZUSWC*WF>?P[=16DUREIJJ2S+#&794,4J9
MP.VYE^G6N;FTK5+G0]3T:6TN5UEM<^UVUYY3;-AG5UE$@&T;8\KC.?EVXY&0
M#TMW6-&=V"HHRS$X 'K7+OXULY[G0VTY[:YT_4KF:![GSL>5LCD?.,8P?+ZD
MC@YKJ2,C!Z5Y9I.FW/\ 9W@FRN](NQ]@U"?[6LEHQ5?W<RACQ@C<Z8/3GV.
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M$?9"DKQ-<;U"9 )!4 X'H.] '9Q>*83XFO=.N'M(;.&T@N(KHW Q+YK2+CG
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MQI_8EO-_:MO@_<>7</*QZ!Q)(/3*^E=O0 4444 %%%% !1110 4444 %%%%
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MKQO:!=.NX[4Z'#;PR2(9/+9)')5Y.0&"E>IYZ#- ':O<0QRK$\T:R/\ =0L
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M2 <' ]CP:\U5+I_$^E7']C:A;I;Z[>&>);21D"R13*)3(0=P<E3\IV*" 0,
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MM>(TM@WS0%8=[X"X ^5\\<=#S5BZLKVQN=5:TTF[_LN+Q);W<UM%:L!+;"!
MS(F/G E4,0N<[2: .NM/$UQJ$FNQVD%DS:;<1112/=XBF5T1]Q8+\O#],'D=
M:WY+RVB?9)<0H^X+M9P#D]!]3CBO+=6LGO=.\;-;:/?,MW?V=Q:K]@D!DPD.
MYE4KG(*MGC/6G^)M&^UGQ]+#HMQ+/<6UN;-UL7+/($.2AV]0VW)'I[4 >H27
M-O#(D<L\222<(K. 6^@[TR^N'M;">XBC65XHRX1GVAL#.,X./RKS3Q6(;O5_
M$%A<1Z@UIJEI:)).FFSS_9RI9OEV(V#@@[6VD,<\UZ!<2VS^&9)+%-]L]H3
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MAV&N-</X&OBVE-<W#Z>P;3TD.78IS&&7GU&1SZ4 :L=]9RP//'=0/"AP\BR
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MKZA'\[W \NLK0;6TO=.@-_::LNNV%A-;W\<UILC8LF'+.$ F#. R_,QYSZT
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M.5**XV@(N=Q56 QQP#T]/5510J@!0, #L* $,B*ZH74,W12>309$#!2Z@DX
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MR>5"I/+M@M@?@I/X5YCHP>UAT&.YMV_L"WU+4HIHWC)CAS*WV8LI'$>W(!/
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M8Q $5XR6!+R;/FA*$$9;LH'04 >A:?IRV =FN)[J>0 //<,"[ 9P.   ,G@
M=3ZU-:7EO?6_GVLJRQ%F0.IR"58J?U!%>5>%K.UM_P#A!IUBVW$SW<%VS9+-
M&4DVH^?X=VS /&2,=:ZSX:06]KX12VCM1;SPSSI.GDF,AA*^ >!GC'X8H ["
MHHK>*%Y7C7#2MN=B223T[_RKS#Q;<QG7K^2.WGBN[/4].;S##))(T>^/<T;
M82/#,"!G)W9QG!JZE:V@A\37\<9^V0>(K66TDYWHI^S;V3T! D#$=@0>G !Z
M3XAUL>']+%\UL\Z>?#"51@-OF2+&#SV!85J$D*2!D]AZUY#KD\-SIVN1:G;N
M^N0Z[!+ 3"S.;7[3%Y;1D _)Y?7'&<YY//K%WY3V$WG8$)C._=QQCG- !92S
MSV4$MU;&UG= 9("X?RV[KN'!QZBIZ\DT"SL[Q? 4.I1+)&-#N([N.?.W<!#A
M9 >.H?@^A]*[/X=.[> M*61G+QQM&0Y.Y0K$ '//0"@#J*Y5_&J)87%V=-F
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MKZJJ(%50JJ,  8 %>86V@:3-XD\/:;,+N\T_^R;I!]O)#N/.B:(-@#' 8J"
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M^!8[5D>(I8H_'VE))=-'')I5\)5\\J.#%M/7@_?P>O!]* .UHKROP>T5M>>
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M,57DGYR=WXYXKR[0I+2XC^'E]?3B4D7D1GEE+$O@E5+9Y8D<#J: /7:*\_\
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MEHH *,"BB@#,TK2)-/FN+BYU"XO[F8X\V=44I&"2J*$4# W'GJ>YX&-.BB@
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M*ELG/(!ZA3)IH[>"2:9PD4:EW8]% &2:Y_QUJ%UIGA::ZM6D15F@%Q+'G=%
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MQ6TTYCFE\.QO&C3L Y'VD-A<X(  [<=>] 'H%A>1ZCIUK>PAA%<Q),@88(#
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M.RINR RJW"DY/RXSQ699:DMYH_A=I;YKAT\5W$8:68NP4-<A 23GA=N,]L4
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M3R8]K\.-@PWU]:XC5I[K1==AEL+F[N['6[7[%;9N9)4@NADHX)8X5EW$D?\
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M+W4?#UQ-+%<7+R+--''$R$*3@')(R "<G.: /3+MK73[.6\>W!6WC+_NXP6
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M6(+GR2C9'"@?,!Z4 =O:16=_:P7AT\1-(!,$N( DB$\G<#R&]:G6QM$38EK
MJ;@^T1@#<.A^OO7FND2WVMQ>![>XUK4HQJ.A32W+07)1Y)%$!#9Z[LNW/],U
MU_BR^CLX]*@:[E@:ZOEB4)+Y0EPCMM>3JB_+G(Y.  #F@#=-I;?:OM?V>+[1
MMV^;L&_'IGK6;I%SI.MZ?=26EHH@>66UG1X A=D8HX8=QD$<UPNA>)9[M?#F
MG7VIL;:YO-1AEN%N2&=HI6$,1D!#<KDCD%M@ZY.8/#VJQVLFFZ3]O=-.N]=U
M1)K@7!#.RR.8D,@.06R6ZY;;[G(!W6@G2]6TORXXC=0V$\EHAO(?G0QG:1\W
M)QC&>IQSSS6F-.B.J_VC*?,G6(PPY'$2$@L![DA<G_9'ISY=ISE;>SM++5KJ
M..;Q==VTS0W)W21LLS89NI)VKSU[]>:TIKN9]4U31W\4OIEYI<UNMF;AW>6:
M'RXR&*[U$Q=O,4Y!.>.N* /271)$9'561AAE89!'H:JS6VFVNGLLT%K%90 R
M%611&@')..@[UQ+ZI?V?B"9+RYD^S7$UVMGJ5O<,\491')BF@/"E-APP!!V<
M\DUC:AJ.H_8/[*U.*XBN!>Z4+MUNVN+>:W>XQYL;,<J'*X*G' '6@#U:WD66
MWC=(VC1AE59=I [<=OI38K.U@F>>*VACED^^Z( S?4]ZXOQ/J32^*+C1;G74
MT6)M-6:SG>1H]TA=P[!@ZABF(SM.1@GC%03ZEJ5EJ]I-=W,VH:>\ME ]S:3-
M"]M,P08DM\X9)"X/<KOQV% '::<UA+'.;*&*(^:5N$6,*PD[AQZ\CZ@@C((-
M3I8VD=JUJEK MNP(,2Q@(<]>.E<UICR)\3O$$,>3;-86<T@["4F5?S*JOY"L
M#Q+X@:VURY>VU:6-K35["WE22Y\M8U<Q[T6,<.I5R2S=,\?=X /0CI]D8S&;
M.W*''RF,8X&!QCL.*IZS?:9H=FNIWMN"L;QPJ\<.YEW,%4>PRP]N:X*\O+Z*
M'7]136+\O8>);:"W3[2?+$3FV#(5Z,I$C<'('48.:@\2:FFJ:!XE>_OI(;NP
MUN&W2V^T%%2%9HMA*9PP9<OD@]>#P, '=ZI8&[U*STZ*]-M9R1RRW-I%;J1<
M*&3(+]5R6P<#Y@3TZUO5Q'B75;BST75]=M'*H+B"S\].?+MUE"RR#W!>7G_9
M![5D>+;W4M*C\4P:=J-V+*+14O8Y?M#.UO.7< *Y).&50<9[<8S0!V,'AM$\
M5:AK=Q)!<"ZCA1(FM^83%OPP8D\G>>PZ"M:*&T:5KF&.$R,2K2HHR<'!!/U&
M/PJO8::MI92P&[O+D3LSL\\Y9AN'(5A@J/0#IGC%>8>'M5BL_#?A*PDU7[)9
MWL5P+B>6YDP)U*[(RX<%,@R'&1DK0!Z1)>Z9IWB"VL!;".^U%9)%DCAP'" %
MMS>O(K4V+N9MHW,,$XZBO/(S<0:QX-#:F-8GCM]1"76W;Y^ NWN<\8&[/.,]
MZI:9J<^J:#%J]OXL)NWTJ<W=C&6+B8)N+%2Y\HHX(X4 Y ]* /0KZ'3;+2KF
M2XLH6M(U,LD:P!@=HSG:!R>*++^S]6T6WGBM8FLKR);A8Y(AA@X# E>F><UY
MW&^H0V^C7$>KWM[%JN@3RW\5Q/YB+MA0K(H_A^9MIQUSSD\TW3;W4M$L=);3
M;BZNI)_",EVMK+(71IHEA\O:G1?OD87&>^3S0!Z>;.U,D<AMH=\8 1M@R@'0
M#TJ!-*MX[VZN$4;+S!N(64%7< *'^NT 'U"CTKC+>\N6N_#<NGZG=7-KJFF3
M27A:<OC;&K+,N3\AWMMXP/FZ<#&9HFI:K;6?A.^BO[V]N]2T"XFFAGG:1998
MXXF0A>@.6(R.3GG- 'HEUHUI=62V/E1QV6\-)!&@59,'.TX[9'([].F<Z%<)
MX-O1J=U8:E;^*$O5N+'-Q8@LY\SY27(+GRB#E2  #G&.!4/B4W4OB;7[==5U
M""&#P^MY''!<M&$E#RC<,<_P+QT/?- ';C3; $$65L,'<,1+P?7I4L-M!;;O
M(@CBW'+;$"Y/OBO.CKEP;B1[K4Y(EN?"L5V 9R@\\ELLG/!^[T]J339[G6K[
M2H9=8O\ R;CPNMS)Y%TR9E#("^5.0V2><_7N* /0;E;2U$NH26ZF2-"S2)%N
M<@#M@9/%0:3+IVJZ=!K%G;QB/48$FWM$%=T901N]>#T-<!HU_?O#X1NYM2NY
MY-8T2=[Q)9BR.RQ1L&"?=4@D\@ G/.:JZ VI:5HO@RZTB^O+Q[K1V^T6,DID
MBVI;;D95Z)B0(G&,[L')H [S7O#,6K:*=-M&M[%&N8;ARMN&#&.19 , KU*
M$^E:,OV'2[#8\4,4#$((HXP [,<;0HZDD]*\ZM]2DOO#=QK%EXN,TDFB322V
ML3L7654W>8<N?*96RI  !SC' JW:P3Q>(? S2WUY=Q7D<]W(US,9 )A;*%VY
MZ##2' [DF@#OA9VJV!M5LXOL^W_CW$:[3WQMZ4RT>QOK.)[=(W@C;"+LQY;*
M<8P?ND$$8[5R3:C?6GC:+[4TUSIUS?F"WN+6Z;$+^21Y$T)XQP6##/8G%7?#
M3R+XT\96ZY^RI=6TB#L)&MTWX_)3^- '6$ C!Y%5X["SAMVMXK2!(6.6C6,!
M2?<=*\\O?$)C\2VLEOJ\OE_\) ;*<37.T!!$P:,0_=V @'><,3[$$PVMW?Q&
MSOCJ]_)(/%4VG[)+@E#!YLB["O0X &">1C@T =]?:E8:#]AA>)HUO+E;:%88
MOEWMTSC@#BIG%E<ZA+:R6\<DRPH\A>,$;"S;02?=6./:O,WU6/5M-\.ZI?7[
MKJ(\2".XMVN"%A*R2*(S&3@84+SC)ZYY-=!J^I3VMG8WZR/%:ZMK,45Q.C;3
M';8*QD-U4.43GC'FGH: .RCLK6*3S([:%'QMW+& <>F?2G6]K;VD9CMH(H4)
M+%8T"C)ZG KS76KS5;-M;LX-3O$L[75]-CMKCSB77S7C$L1<Y+ !LX.?OXZ5
MZ%:Z;'::7]A-S=S1@-^]FN&:7!)/W\[N,X!SG % %"UU+2M=OEC%@\ZM"TD-
MW);!HI45MIVOSCD]#@D<C(YK9CABAC\N*)$C_NJH _*O+?#-S;6G@SP;:?;[
MB)KV"63RS>/%'($3G=)G*!<@A5ZGMP2%T#Q.=4L_#]GK>M/;PW6C/(+I;GR3
M+<JP5LN"/F5<-C/.XD@X% 'I::?91V[6\=G;I QW&-8E"D^N,8J&W2SN;B51
MIYC:SD$:/+ %!X#9C/=><9'<&N*U'4;[3[FSNC>7.J:5%#9I--;W!BN(6+\2
MM$,+(DF1GOUP*JZIJ.H1V7B;R]5O(VMO$=G#"ZS<I&_V;<@_V?WC\=.: /2&
MM+9[I;IK>(W"C:LI0;P/0'K5.]U6WL'O)+BVN=EG;>>\ZP%E*G.54CJPV9(^
ME>>:])>Z?:^.3;ZQJ:_V/'#=68-XY\MVCW$$DY921]UB5Y/%;>KW4YU_Q9:M
M=2M;#P]'.L+/E$9C.&(';(5?RH Z^TDM-3TBWECB5K.Y@5TC=!C8R@@$=.AZ
M4\6%F!$!:08A&(QY8^3Z>GX5YI'J330:?HMSKR:+&?#UK-93O(T>Z0A@[ AU
M#%<1G:<C!Z8)KI_&%S=VOPNU.[BOY5O(=-,HNH@86+A,[@.JY/..W2@#IKBS
MMKM56YMX9@O($J!L?G4P&!@5YEX@N+_2Y/%MO:ZI?ML\.KJ,1:X9FCG!F!9.
M?E!V+\HPO'2GZUKKO?Z^EEK$@5/"_P!KC\FYSLF!D.]>>#@+G';ZT >@G3K$
MJRFRMR&.XCREY/KTZ\U2%YI;>(WTG[*/MQMQ=LQ@&TJK!0=W<@GCTKD+:WN+
MCQ#;6,FLZK]GO- ^V3!;QP?-5D 92#E.&.0N <#.><YFB>9XDO\ 0)M1U2[M
MYKCPJLLUQ;3^2[-YBDMN'(YY/;UXXH ]26TMENFNEMXA<,-K2A!O(]">M,.G
M63!P;.W(<[F!B7YCZGCGJ:\QLM<U'4+73=-UW71I4EQHWGP7<K-"9I/,=2^0
MZ L$$3[3D?.>*UK*._O?%LMO)KE_<?9M'L;Q!%(84FFWR@L4[*VQ<KTY^F #
ML[4:?<3W/V>WB)0^3+(L8P3W3/?' /;MU! 1CI]MJ-O"T$45PZ%8'\L#.!RJ
MGU YQZ9QT..(T234&^%7AM]/GC^WS^7(\4TS0_:G.YY(_,7E&)W'/J,'J:35
M=2>[^'^FW]LEY%>PZS D<5T^^5)1=^6\>[)W  NN<\K0!WZ6-I&LJI:P*LQW
M2!8P Y]3Z_C3X+>"UB$5O#'#&.0D:A1^0JGIAM#<ZC]FU)KQ_M/[Z-K@2"W?
M:H\L#^ 8 .WU)/>M&@""2SM9I/,EMH7DQMW,@)QZ9I$L+.-T=+2!63[A6, K
M]..*L44 0+8VB"8):P*)CNE C \P^K>OXTGV&TQ$/LL&(3NB'ECY#ZKZ?A5B
MB@"![&TDCBC>U@9(2#$IC!"$="!V_"D^P6>(Q]D@_=C:G[L?*/0<<58HH JC
M3K)0NVTMU*G*E8E^4^HXX-<[IW@MK9[=;Z\M;V*VD62.5K!$N696# O+D[CD
M9)"J3^)KK** "F"*,;<(HVG*\=#[?F:?10!#]DMO->3[/%YD@VNVP98>A/>F
M?V=9$Y^QV^=NS_5+]WICITJS10!6?3[*2*.)[.W:.([HU:($(?4#'%22VT$[
MQO-!'(T9RC.@)4^HSTJ6B@");:!?*VP1CR1B/"#Y!TP/2I:** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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ML:Q\0^%+B."[MT2*+6&54N)+%XDNF;[H+L@!)[ GGM6YN=M&W2R!W-OEGV%
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MQ7)Q:C?V_B"2TU%IYH;F2\6SO8+DO#*$#GR9(S_JW0*1D#!VGN:H^#&N;-?
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M#87.GZOY#6[R$[X00%3RNA\Q3D-UR>#QB@#K;F]TSP]'8VQB6VCNKA;:"."
M[/,;H/E&%[\G%6)M/TYKM;Z:TM3<KA5N'C7>.> &(SU->;2:BVN:7X=UBZNY
M1=MXE6&6V\S"1;99%$93H" %.>ISG.#BNG^(2;]'TS]]-$/[8L0QCD*9!G0<
MX_SG![4 ='+IMA/?17LUE;27<(Q%.\2F1!_LL1D?A4<FCZ7(9&DTZS8R,))"
MT"G<PZ,>.3[UPVHZU?RZ1XPO;>_F@OM#FQ91!\JT:Q(Z;E_C\PEADYZ\8(S7
M1^-#++\.-=D8R03#2YI"(W*LC",G&1[B@"KK-EINKW[Z-I[VMMJ)6._F$MAY
ML-S$"5 D^[O&<'AL@J/H=+P_X<AT1[B<0Z?%<7"JL@T^S%M$0N2/ER23\QY)
M].E<;/:F37RMKJ-W"8O"_F+-#+E]PD)'S')P#V]L=.*(/$&HZ[#'9RZS%I=V
MVAVE]!.\OEYDD5B\NWHX!"@J>/SH [W4K+2%CN+^_L+>7$6)9&MA(YC'.#@$
MD#KBJ4/B?P_JEM9H9MUMJ("VQN;62.*XW#(52ZA22.@[U<NW=_#4[RNKN;-B
MSJI4,=G) /(^E>5R_;;7X9>!+VZN(+K3X9=/<:?%$8YIF^4(%<LVXJ2&*A1G
M!Y% 'K0TG35$(&GV@$!S"!"O[L_[/''X4G]CZ7]F:V_LVS\AG\PQ>0NTMZXQ
MC/O7#W6OW">([.6VU.22!]?>PF+N$4((GW1"/D$*R@[S@Y]0:KV>H:M&;"]?
M6;R9CXGGTYHW9=C0>9*H!  Y 5<'MB@#LM._L'7([V:VL;>11,UK<F2U"EGC
M."K!AD@'UJY;Z/96VIOJ$-O%'.T(@!2-5P@[<#)Z#KTQQCG/ >&-28>*+[2K
MN2:TM9=8O9+:6-\+=3!SNB8C[N%PP'\7K\I![+Q5>BRTVV NY;=[B]@@01 ;
MI2SC]V&)&S< 1NSD#..<4 9NOV%A!XMT_6=6:"6VEC&EQ6TEH9<R2R*58MR%
MY&.1W/-:T$FB:UJ-W +2&>YTQOLTAFML&/>@.U2PZ%2.G!!KA6U*XO\ 0X8[
MJX$SVGBZ&W3][YA6,7"[1N(!;&2,GDXKJ/#?_(Y>,O\ K\M__26*@#8MX--M
MM7,%OIR0W*VZMYT=KM79G:%\P#&1C[N>!CBI5T?3%9673K0,DAE4B!<JYZL.
M.I]:X[Q5J>I6FK^)([;4KB%(/#3WD*KMQ%*K2?,,COM'7/MBIM'EO?\ A*$T
M^?4[RXM[S1([MQ)( 4DWA24( VY![>E &M93>'-6\S2X--@DMID-R UE^XG
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M2L;\<C:^P<=F]JH^#]1U2_F_LK4I[E;_ $J>1KXNPS(K@- #@8P5?/'>(^M
M'0:7!X?UGP[:26-C9R:3,!-!']F"I[,$(X/X9J\^DZ;(MN'T^T86QS #"I\H
M^J\?+^%>9^#[S4-)T?P88+NXN(;W3+C?9MMV9CC#IMP,@YR,Y.<_2KMMJ&I:
MMX:35X]>C\F\TB9YH8IRSM,$W;DPH\HJ<J0..1WY(!UTR>')-8.ES6-I)=ZC
M"URRM:!EG1"H+,VW:V"R]3GFKTFB:3*93)I=DYFC$4I:W0[T'13QR/;I7 :=
M9-<ZGX)MX]0N8B_A^X+31.ID&1:G )!QU':C2/$FIZS8^']/N;]8;B]TEYQ<
M&;R&FF5PN00IR5'S%1@'=SP* .^&A:.()H!I5B(9T5)8Q;IMD5>%##'('8'I
M4L>EZ?%.\\=C;)-)&(WD6%0S(.BDXY'M7&6+:SJ'BFSTZY\1SM&FD0W4DEDD
M:)-*)BI894_*P7GZ\$"MOQ%J<]OK_A[2A(\%MJ,\R33(=I.R(LL8;L6/<<_*
M0.M &I'HFE0V<MG%IEFEM* LD*P*$<#H"N,$55;3M%N;NZL5TNV$Z6JQ.[6(
MV>4^X! Q7##Y3E0>.,CFN,?4]=EO;73#JUU%$OB.731<(J;YH/LSRC)*GYE;
MY<C^[R":N7FH:UI=SXLM+;5'N)-/T2VFM7O#& LA$P9R0 ,G8"<\9]J .T@M
M[;1M'CMXD86MG $5%3<=BKT  Y.!T J/2['3+>W6YTZP@M5N$#_);B)B#S\P
MP"#ST/>N5\[6=FNWUMJ&H0Z7'I:R6HG5-ZW.URY^=2V  G^SDMCVJ07>K:G?
M:;;-K5Y!%/X:%X_D[ ?.R@W9*D\Y_P#U<T =U:Z7I]C,\MI8VT$DF2[Q1*I;
M)R<D#G)YJA:C0(-<N=*MK*WBOV@\^94M=@>-F(R6QALMG/)YZUPE]XIU.X\&
M1:A%JDBZE%X934GCC"QJDA4D2L?XLE2!'MQUSC(KI;&;S_B9YI()?0(F..F?
M.;- '0)H6CQ_9]FE6*_9\^1MMT'E9Z[>.,^U0W'AO2)]+N-.33K.*WN$"2(E
MNF"H.1QC''49'!YK*NKRYU+QG?Z$;R:QBM]-CN;=XB%9W=W5GYZA-JC!X^8Y
M!XQ@>'M3USQ-J6C"\U6[L5N-$COI8K98U#2"8#<,J3M8<D>AXQ0!Z.D,<<"P
M*@\I5"!3R,8QBJ-EH&C:;(LECI-A:R*" T%NB$ ]>0.]9OB?5FT_4-!LVG-M
M:ZC>&":X!VD8C=E0-_"690,]>N.3D9<5[=+XET[PY-K$US;2PW<WVI,1O(Z.
MFR'<.I17.2.25&>X(!UEGI>GZ=O^Q6-M;;_O>3$J9^N![G\ZCMM#TFRM[BWM
M=+LH(+G/GQQ6ZJLN>#N &&_&N!LM4UW4[W0M/N-7N8%EN]1LY9X4C5KE("0D
M@RIPQQSCCJ0!QAT&K:Y8Z'%J][J,]Q:Z-J\]K>/@#[5:*YC\UL#[R$@G&,A&
MSF@#LFT?P[:M%9-I.G1+<)Y*1_94"NJY;9TQZMM^I[&K9T;2FD:1M-LR[1>2
MS&!<F/\ N$X^[[=*X_Q5/=K\,=1U?S93<F5+ZT#'F+$JM$H]#@+D>I(Z5TGB
MF^_L_P /RS"\>S=I(HDECC#L6>15"J"0,MG:"2 ,Y[4 69M T:XBM8YM)L)(
M[0YMU>V0B'_<&/E_"GRZ-I<[W#S:;9R/<J%G9X%)E Z!LCYA]:\_EUO6%M=0
MMTU.6![;Q-:V2;765A#)Y&Y"S+EL&1N>O;)%2RZ_J.EZE>:/+J4\D!\06]BM
MW-M\R**6W64KD #ELJ#CC?["@#KK5/#VKWE[!%86LL]B!8SB2T **5#>7\R\
MKA@<#CFIKOPYI5U:Q6IL;9(([A+D*L*_?7H1QP>V1SC(XK$\'PBW\2^,8O.D
MEVZC%AI&W-@VT6 3WQTYYXYK,U77=3DTOQAJ,%Y);7VA716UMA]UD6-' 9?X
MO,RPS[C&"* .N\0W.D6NAWDVN113:="GF7"20>< H.<E #D9'IVJ4Z)H\MI-
M;MI=DUM<X::(VZ;9<  ;AC!P .OI7FWB(2/9?$J2:><-_9\6(9),JFZW+%0/
M8YZ>]:6K:[J?AJ]UY%OYKJ*+2;:]4SA3Y#/-)&[+A?NA5#8(/W?K0!W$^AZ3
M=:='IUQI=E+8QXV6TD"M&F.F%(P,4^YTG3KQ(4NK"UG2 8B62%6$8QCY<CCC
MCBN$UR\UC3]%U.[M/$*&-WLGMTAD%PT0>94<EV7E'!R!V(.#CBNPN!<Z#X8O
MIH[BYU&XMH9IXS<[2[L S!?E &.@''2@"Y<Z7I]Z]N]U8VT[VS;H&EB5C$?5
M<CY3]*@_L;1K.)94TJS06T3*GEVJY1.ZJ ,X/H.M<MI9U36K9)[3Q)&(=0TP
MM'Y<WFNL_&)E^4!0,X9,8Z=*?HVL7VN>'9;X7%Q:W%A8/;W(!!Q>+D29# C*
M%>.,'S/84 =%;66BG2[.[ATN".W@7[3;)]CVM#D9RJ;<JV.P&:K6&G^']9\.
M++IEC9+I^H0*5*VB@/&>1E"/Q (Z]JYW1-:O-:GTC2[N_FA+^'(-0,L;!7GE
M?AFSWVX!QT._D$8K'\+ZG=S>'_#F@07J6?F>'TN()3/Y1:3)4D':=VP!3MZ?
M-SGL >I16=O#81V*Q*;9(A$(V&X; ,8.>O%5X]#TB$QF+2K%#$ACC*VZ#8AZ
MJ.. ?2O/[Z_UUDU_/B*<O8^'H+^.2U1%C:;$V6 *D[&,:G'OUQ6DNLW.MWVI
MV4NLG2)[2PM;FWD7&/G4L\I4_?4$;<'@8]3F@#K!X?T94C0:18!8E*Q@6R (
M,YP..!GG%+?:7H\HN;N_L+%]T6V>6>%#NC7G#$CE1UYX%<B^KZEJNJ:JEMJT
M&GSZ9?Q($ED(S#M1L-%M^;S-S '.0<8Z<Z?CV:1=/T>W7/D7>LV<%Q[QF0$@
M^Q*J#]<4 :DL6C:A/8V4^FQS;(S<VPFLB4B"D#()7"-\PP.#CZ58CT/2(7B>
M+2[)&A#"-EMT!0'KCCC/>N>UV_U"#Q?]D@OYHK=]#NK@1JJ$)*CQ!7&5/.&/
M7(]JS_"^HZH=5\+_ &K5+B[35M!:ZGCF"[5E3R,,N ,?ZQL^M '8QZ'I$2PK
M'I5B@@<R0A;=!Y;'JR\<'W%1RZ9HU@U[J;:9:)++&3=31VH,DJ]2&P-S?3FL
M;Q9J$^B:KI6HR75PNE2F2TNXH_X7=28G'?.X;/JX]*R_#>H:IJ.G3V.IW$_V
M_1X[B'4<L,2R'_5'H 04^;@#&10!U.DVFA7MAINIZ=868@,(ELY%ME0HCC(V
M\97(/3BICX?T7RU0Z18;$9V5?LR8!;[Q''4X&?7'->>^&]0NM%TSPGOU:865
MUX9EGE65%:. PQP%750 > [9&>:CO=6U&32]?LWU&Y,3^%A?1NTH$IEQ)F3Y
M?N;@H.P$@#ICF@#T>#2;*/5WU:**(7$D(A\R-%!*<'DCEN@QGH!QCG,E]I.F
MZF\+W^GVMVT#;XC/"KF-O5<C@_2N&-_>37,?AZUU46CIHT-S:SRW.QC(Q<,W
MW2'";4^4X&&YSQBS=:IJFE:Q9K/?-=1:SIPBM"@Q&MZ,9V]PKAMW/0(U '8W
M.EZ?>7$=Q=6-M/-&,))+$K,HSG )&1SS22Z1IL\TTTVGVDDLZ>7*[PJ6D7^Z
MQ(Y'L:XS4;_4I]5U?1K;6H["YTRW@D@N+F;:6!7<TK)MQ("05(R ,<8)S5[P
M\=1U#Q5KC7.LW;0:=?*D5LJHL;*]M&Q5OES@,Y(Y!XYS0!>U^PTFVTMXX[.T
M@O)[>2RM&CMMT@RC$J@4;L!0QP/2I/!]AI]MX9TY[.&W.ZTCC:>.#RC*%&,D
M$!AGDX/0DUF^*;;SO&_@_P#TB>/,]R,1O@<6[G/U[?2LJ'Q!JMQH&GZ_%<R_
M;9-:^QW%@<;/+-P8C%M[,JX;=UR"3P<4 =M::#H^GNC6>E6-NT>[88;=$*[O
MO8P.,X&?7%-E\.Z)-81V,NCZ>]G&^]+=K9#&K>H7& >>M<!?7FMIX1\8:ROB
M*_6XTV>]AMT58M@5"-I(V=1C&1C@^O-:&J'58M>URP37M06%-&74(R/+W)+N
ME7Y3MX7Y5./;ZY .Q6#2QK.X6ULNI+#\LGD@2&/IA6QDJ. 0#QD>HK0K@]2U
M&ZGTSP!JV?\ 3;F]MED*C&Y9H'\P8]/XO^ CTKO* "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH KWEC::A!Y%[;17$08,$E0, PZ'GN/6H7T;2Y(K>.33K1TMG\
MR!6A4B)O[R\<'D\BL7Q;=:E#J'AZVL-1DLUOKYK:8I&CDKY$KY&X'!!08[>H
M/2LI=1\07D^IV]GJ]O'/HMU##*;IE42H(XV=Y$$9/S[GP590,# X.0#K[;4-
M/U9KZUAD2?[-(;>YC9#A6*@[3D<\,/;FEM](TRSM9+:WL+6&"5=DD:1*%=<8
MVD8Y&#C%<3'?26.K>*_)NS;2SZ]:PKLC#O)NMX,H@/ 9@",G@<GM5*74=5U*
MVTR.YU&YBDA\5/9$Q^7N:-0Y4/\ +M)7 [8XR<GF@#M[/3/#SW4]O:Z79++9
MH+5PMH%V(RAM@.W!4A@<#CGUJ2X\,Z#=VUK;7&BZ?+;VAS;Q/;(5B_W1C _"
MN/UG7M:M8/%GV?4V5]/U*RBMF:&,[8Y1#N4C;R/WC<]>G-37>LZ[IJ>+;6&]
M>]ET\VLEO)-'&)$67&\ *H#$ ,5!!).!S0!VR:=8Q7SWT=G;I>2*$>=8P)&4
M= 6ZD>U)/I]C<WD%U/:6\MS;Y,,KQAGCSUVD\C\*Q] ;5I=:U=KJXNI-+1HU
ML1<0K&S90%S]T,<-P"?4^F:RM:NKJR^(+727-R\=MH%Q<K:)MVNRR)\N"I/.
M!SUX% '4-H>DOJZZLVF69U)5VB[,*^:!C&-V,].*(=%TFUU.;4X--LXK^<8E
MN4A59'^K8R>U<KIVMZIY_@^Z-\;VWUV$_:8MB!8V\DRATP 0 05P2>"._)N^
M.!<&7PVD%[<6PDUB*-_*V_,-KD9R#G!4'T_2@#3TF/P_<3W\FEVUIYL,[V]T
MT<&PB0A693P,YW*3C@YJS_8.D?V6VE_V79?V>YRUJ(%\HG.<[<8Z\UY\;O4-
M*D\2:G9:A)$L7BBWB>W$:%)ED6UC;<2">C\;2,$=ZV8-5UO5[^ZN++4+6VBT
M_5S:3V\SC!B5@I4KY9;<P(93NZD=N* -F^TWPOHFG375YIVG6MHKK)++]F4*
MK*,*Q('&!P#VJ.WB\/7NN:>ULD"7=E%));(+?RW"'Y7() ^7YQD#N0357XH?
M\DQ\1?\ 7F]2ZC/JFEZ)J=_?:E8PB*T46MREHW[ESD,2I9BQ)V8&>2!Q0!OW
MFGV6HHB7MK#<+&V]!*@;:WJ,]#[U4OK71;)+.XN[*V46TB16K"V#&%G(50F
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M'6PZ%I%NUJT&EV41M,BW*0*/)SUV8'RY]JISVOAOPPEUJ;V5E8BZ=4N)X[8
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M2J+_ -\"NI=%D0HZAE88*D9!H Y.:_\  LJPVT\6FLNG*&CC>TXME;H0"OR
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M[0FTBGLRI2:16W@,?]6JE&##MD'H<5W&G6MS:6[1W5_+>N9&822HBD GA<*
M,#\Z ,W5=&\,6VCI+J>DZ<-/TQ3+&'M59+=1R2JX./7@5JH+6^BMKH(DJC$T
M#LOW<J0&&>AVL1]":\ZU#7-0ETK7].UA[F*Y?1[Z6%=L;VMT@'RR0R*,C:I
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M7:&4.=W'.T'O5*UU[Q%JLVB6(U+['+/=:A8W%Q%;HPE,&X+*H8$ DKDCIG-
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M.L]NCM%O4D_,A*L,GK@@BN$TO5+K6KCX=ZC>LK74Z732LJX!;R2"<=LXK=\
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MK&RMKR._@4-,,A;B/^'<!@-CL3TK?2-(XUC10J*-H5> ![5Y;X2UC4M#\/\
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M#2[6\CO([-#=1*4CFD)D>-3U"EB2H/M56W\'^'K62*2WTFWB>'?Y3("#'O\
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M9C+XW))OW$9P" ,5K:WJT\'B'0]%@E-O_:1G9YU4%E$2!MJ[@1DE@>0>%/U
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M0V<DG!![<C@5TGAS4]=U1M(U226U;2]0M/,D0NN4D*AE$6!DC&X$,2>,^HH
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M4B>4QV[CAC*&7DC*CD=15G0?$-Y<^)'TS5&GM;KRYG2VDA7RIT#KLD@E4?,
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M60YRY(/+'<V2<D[CZFI]/TJSTM9Q9Q&,3RM/+EV;<[=6Y)Y-684:.)4>5I6
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M[&:V$-GJC65U',55&C1MCGH6$A^\O.,$#'>NUH **** "BBB@ HHHH ****
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MZOR;EXAE$AD?( S@DDKCL #QQ73^%M8N]5AU*"^2/[3IU_)9O)&I590H5E<
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M73YI0H96E;:^]$8@A>HP1G.#ZU+X9CGB\=^+5N)Q,W^AX?8%)'EMUQQGZ8H
M["BN/U?4+VS^(-J!=L+"+1KJZDMUCSN*20Y[]<' ]/QJ*R\3ZF5\*7\Y@EM/
M$ "M%&F#;NT1E3:<_, %*MGOR,=* .UJO!?6ES//!;W,,LUN0LR1N&:,GH&
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M''//J..,UGW_ (JU1--\2ZC9_963P_(8Y(9(R#<>7$LDASN^3(8A>O(R<YP
M#L+VSAU"SEM+@,895VN$<H<>S @@^X-8USX>T&[>;3YW+WDS1W;G[4PN,QD!
M) P.X!2, CCKZFJOCC4KN+X=ZAJ.FSM;3&W5U<IEE5L9'7@X/7M4.H:QJ=CX
MBO;0?8'>'1'O(YC;,&+J^-I^?[O'0$?6@"+7?!L2VL$>CVD[-+JUO?79^UMN
M/EE=S LWWR%'(Y)')[U-XF\,-<Z7%;Z=;22RRZG;7EU(9]LCK&Z%CO)!SM7
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M(Y97D65F 4G#$XR !QCH*I1>!M"BTLZ?Y-T\7F1R*\E[,TD9C.4V.6W*%/0
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MJ03SP<CWXS+;Q3XIF\/>'M6<Z0!K4MK&L8@D_=>8C%B3OYY (''<>] '2_\
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MX075(]4>VFN?L4_F-!&4C;Y6QA6)(XQW/-<K9^*=5\+Z7I)U.*TN=-FT1[J
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MHI%<;1A?,R<,<#![D#!R*A\-^(;W4M<O]-O!"ZP6EM<QS1P/%N\SS PVL22
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M6RDO'0+Y<27-T\JP1_W$#$[5X'Y#T%+>Z)IM]K+7(GD@U!K;R9OL\VUY8<G
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M,P[B$8Y)R2,-VZCBN7T[Q?JNIWVD1016:B^FN8[B!D8RV8B)Y?YN^ .@Y84
M;MEX6L+&.%(GN7%M UO:^;+O-O&V,JA/L ,G)P,9Q35\):<FE:5IJ/<K;:7(
MDMJ!+RA083)[@ D8/XYK(TKQ=J%]%X5DEAM0-7N+F"<(K#;Y:2L"OS<9\H9!
MSUI+'Q;J=QK%M8R)9-]JLKFX1HD<I&\3H OF9Q*,/R5Q@C\@#<O?#&GWM]<W
M;>=%)>0BWNQ#)M6XC&<!Q[ D9&#@XSBK5QHNGW5SIT\MLADTYR]K@8$9*E<
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MY7S8FGLA8,L;!5$ SA0,<8W-SUY^E4[KPK:P644EHMS+<V6G26-HGF#_ %;
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M@YPK ,><$''05=U#Q=>VFKP1HEJ]K)J-O9^6J,SA)57YV<':C!F^X03@9[\
M&YX=TA-'T^5?(BAGNKB6[N$B.5$DC%B >^!@9P,XS@4V]\-V%[J$U\3/#/<0
M"VN3!)L$\0SA6^F3AAAAD\UQNM>)/%$WA#Q1J$$VG6L>G-=VRM'$[2DQD!6!
M+8'&[UP<'VKH;WQ#?:)X@2TU9[7[#-8RSP3Q0,K-+'R\>"Y_A^8#O@^G(!>N
M_"FEW5SY^R:%OL7V K!*44P\X4J..,G'IGZ4V/PEIB2VSL)95M[%M.5)'W*;
M=L91ACG.U>3SQ]:M_:[ZT\.->W=LLU_%:F:2WMP0&<+G8N2>_ KE[7Q=JUVY
M: Z=/ -&_M)I8XW(CD(.(F^?OC/8X!XXH TX/ >CP:-=:3YE_+9W$)MRDUV\
MGEPGK&A8G:O3ISP.>!7211^5"D6YG"J%W-R3]:Y*U\5W\]SI"F"UVW^A2:F0
M24VR+Y7R[B2 I\P\D<8K.F\;ZK;V.NOY=E--8:*FJ1.(9$C<GS-R\MEE_=\,
M" <T ;EIX$T.SM;NSCCN6L;B.2+[))<NT,*R AQ&F<)G)Z=,G&,TZ+P3I<,I
MF6;4#.;>.V,S7DA;9&Y=._4$FJ5YKGB"QMHFG;2A)/%-/&(XI)&VJB%4V!@6
MY9MSY   X&ZJT'BK6]5GTR+3XM/@^WZ$-4#3H\GEOE/EP&&1\^.WKVP0#7O?
M!6DZA!(+C[0;E[E;O[;'*8YUF"! RLN,?* N ,8[5LV%A#IMFEM 9&5<DO+(
M7=R>I9CR2:X6U\7:A>:EH>J/-'!IT_AR;5+BU6(L<J82V#N'.&(!QQSP<\:=
MMXGU/SO#CW$5H;?7XB8O+5LV\GE&50QR=ZE002 O(]^ #7O/"FC7XU47-FK_
M -JK&MV<_P"LV#"_3&!^537&D6=_J5AJ?F2":S5UMS$XV@. &XQ@Y 'TQQ7#
M_P#"2Z[J_AW0)[X64-MKM];VNRU#AT7,C2 DGHRQ[>.1N/L:Z#5?$\NE>);?
M29/(LH)C"MM+<0,8[@EL.BR A4<+T4CDX]: 'GP-HDVG6,$,EW']BEDEM;JW
MNF26,R$EP'7DJQ)R#G]!6E;^'+&UU2VU&$SK/;V[6R9E+ QLP9MV>6)8 EB<
MY[]:S;&[>T^(FI:,O_'K<6$6H*O9)#(\;X_WL(?KD]S2WNOZA-J>MV.DK:B7
M2+>.5Q<(S><[JS!!@C:,*/FYY;IQR 6=/\(:5I>JRWUI]J022M-]E^TN;=)&
M^\ZQYV@G)_/BMZN)TGQ7J_B'6;6+38K&&RFTVSU,FX5S((Y6<,G! W (<'I[
M'/';4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110!EZIH-IJUY8W<TEQ%<63,8I(
M)2APPPRG'8C'OQP15'3_  9INEOIK6DUXO\ 9R2I;!I=X42$;AR#GHOTQ[G+
MO%/B%O#T-I/(/*M))"L]XT#S1VXVY4NJD$ GC=T'?K69-XIUBZCFBT6RMKZ\
MM;."XD6-@T<[R*6V(^\;5P.&.X<]..0!]]X:V:)%X2M=.>YT>X#&>ZGG7]P#
M('(Q]XL<L5(Z'&>*Z]$6-%1%"JHP !@ 5S,.O:MJ<MZVEVEMML+N.UG@N&(=
MR51Y"&!PNT2<<')4],BJ4GB_4(K.[F,-L6MM?BTL@*P#QN\:[NO##S/<<4 :
M,/@W3+-K1XI[N..QNI+R!#-E(W??NX(^[B1^/]KV&"+PCIKVT0CNKIXO[0.J
M(RR*<S$EMV=O(R2<=.:STU[7+Z7Q"OV32S9:7/-;NDA<M*! DB^W5\'U'TYJ
MZ1JVK7NM>'8+.2RL[.Y\.F\%JMN2B/F$ ###@;L#T&>N> #H!X2TQM/U:PN!
M+<VNJRM-<QRL.78 $J0 1T7ITP"*73?"]KINJ+J7VN_NKM;86OF7,Y;,88L
M0  3D]?Z\U0T'Q+?:O%80R1V\6H">>+480K$0>4=K;>>I+1X)ZA\]L5I^*]7
MN-!\*:GJUK%%+-9V[S*DI(4[1GG% &7=:-?W?Q#>_ N[:Q.E"U^TPR1C<_F%
MBN#ENA'..O0U+=^ M#NXY(0ES;P26 TZ2&WG9$>%=VT$=R-S8/OSFLO4?%^N
MZ/<:I;WME8,\>D3:K9M$[[<1$!XWSR3\RX(P#GH*NVGB#6;C4[/2IET^*\O;
M9[Z-T5W2*%1&-K D%G+R'H0,"@#8TWP_:Z9J5U?0SW+S7,4<4OFR;@1&"%[9
MR,GOSGZ5A7_AZ.ST&W\(6EB\VDWBF!KBYNQ_HZY!"JI.XD*"5V]"H)[FH[;Q
MI?2Q:5<S6MO! ^IR:5J/WF\F969%9#D?*SJHY'&\=:LWVL7!E\/33V=C<0WV
MJM% [QG=$GERE)%R3\Q5#SQP_2@#J"8K2W2-/*C4 1Q*QVKGHJBN$\.Z%K5M
M<6S2+K5C,DHDN?-OHIK23+;G"+EG(.6QD*1G.<CFOK&J3>(K7PWJ\:6PL&\0
MQ1P*4)E"K(Z;]V<<E3\N.A'/%;EGXDUG4[BUN=/TQ)],FNI;>0DA6B5&9!+N
M+\C<G*[<C=U..0"Q;>!]*M+FSFCEO2ME<R7-M$;@[(F<,& ']T[VX.>N.G%,
ML/ VD6/V)[2YO_\ 0H9;>V/VHL(XWQE #Q@;1C/ISG%<[)XHU[5-"TJ6Y2RM
MK;5]233_ /1F?S5 F<2<G@ I&0,<@G/TW]5\3'2/$5KHY^SV,,HA%M)<0L(K
M@ER'C20$*CJH&%/7(Q0!9C\(:8-+T>SAGNUCTD@V<T<^'1=I3;N'4%21_6BR
M\%Z;ITE@UM->+]@FFF@5IMX5I<[_ +P.1\Q_//7FHK.\>S^(E]HR?\>MSIZ:
M@J]DD$C(^/3=\A^H)ZDT[QG?:C8V^D#3KF.!KC5+:WE+QE\JS].&'ISZC(XH
M ?%X,TV&"RB26[!L[N6\A<3;65Y-WF#( X;>_'OQBI8/">FV\Q\OSA:_:OMH
MLRX,*SYW;P,9'S?-C.W/.,UCW_C*\MM)UK6;>&WEL=&NS;W$15A)*$V^:RG.
M%QN. 0<[>HSQV32*L1E)^0+N)]J .?G\'64OA[5-(6>?9?S/<F20AC',S;]X
MX'1P&QTXJQ=:&-9MW_M%YX6N+8VMW!#(#'*G.1R"<')P1AL'M69;^*=0;08/
M$TMM;'0Y=/EOY%0D30*J;T'4AR5SG &".]*GB74X;_1K>Z@M'&LVLDEN8MP\
MF58Q)L<DG<I7/S #E>G/ !J1Z,)/$D6J2H$2RM6M;.(<X#%2[_CL0 >@/K@3
M7^A6U]J5MJ0DFMK^W1HDN(& 8QM@LA!!##(!Y'!&1BN4TKQ=X@U-/#;_ &?3
M$&NV3S1_ZP^0ZJK9//S @GY>#[TMGXQUS4ET."VM-/2YU#[;'(\C.422W<H2
M .2IQG&<]L]Z .@3PWI=G?:3/%)) U@DD-K&)!AO,P7SD98G;DG.>,^M:5_8
M+?+#_I$\#PRB5)(6 (.".<@@C#'@BN!;5YM>NO"-U>VD-OJ5KKUQ93B/YE#Q
MP3JVTGG:< __ *JW-,\2ZC>,VGSI:QZO#J36L\2HVU8@-XD'S9PT>T@],L![
MT 3S^!-(E%J\,EY9W5L\KK=6DYBE;S6WR!B."&8YQC [8J2Z\%Z5<7\%[')>
MVLT< MG-K=/'Y\0.0LA!RW)//7D\UMWAN193&R$9N@A,0E!VEL< X/2N*L/'
M[SW.CFZ\B*UOM-DN)2(FW0W" EHC\V/X)??]V10!K:KX-T75KN]CGFN(O[0M
M5AN+:"XV+*B<*VT<\!L<<=,]JOVNC6>GZS<WT=W.+N^B2)EDD#;EC!VD C)(
MW-SSUYS6)+JFI1^((;:>STZ/4#H4UU]I$19HW5XP8^N=F6Z9Y*@\5@V,VJ7]
MW\/M0:6UEU2ZTJ=S<2Q$##10M\P!RQR2>" <]J .OM_!NF6UKID$<EV!ILTD
MUNXFPP+[MZDC&0=Q_P :;I5E)-K=UXDU33(]-NOLPM%#3+(PB5F8LS+Q@Y&!
MVQSUP+?A76)=?\-6>I7$213RAUD2,DJ&5RAQGG&5)%2^)+EK/PQJMTMO#<>3
M:2R&&<920!22K#N".* ,GQ/IU[JFL^&9[*.9H+6\>>:X@DC!C4PN@(W'GEAP
M >,U<?PGI[?9#YEPKVUZ;\2!QNDG((+OQSPQ&.!CC' QAOXEUD3166FVFFQ*
M-#344,@?:IZ; JXX[#GCWQBNJT34?[8T'3M3\OR_MEK%<;,YV[U#8S^- %.[
M\*Z?>7M]<%IXQJ$:Q7T4;X2Y4# W#&0=ORY4@D<&K=WHMA>WVG7DT"F?3F9K
M8C@)N7:1CTQC\0#VK#E\2:Q<WUQ_9&F+=VUI?BTG0X5F V^8X<N "N[.TJ<A
M>HSQ&OBV[C\26=C<1VWD75S=0$1!F,0B5F4F0':Q(3E  5W 'I0!J:AX6TO4
M;O4+N_#RK?68L[B-V 0Q*6('3((+,<YSS["JMOX+TB3,]Q<7FI++8FQ)N;@N
MLD#<X., _7KWSGFJ+ZIJ6O>%AJ#6EF^CZEIDTY4D^9!E-T8.20^03G &".]0
M^"]8U")?#FC745L;:YT%+J!HMV]/+$2D,3P<B0'@#&".>M &FO@73?[$N-)E
MO-3N+>95C+7%T9'2,$$(I/W1D#IR<#)X%7KO2'&NZ?K-N3)<V\+VLP8@&6%R
MI/H-P9%(Z#EAWJ37]8_L:PAE5%>:XNH;2$,<+OD<("?89S[XQ5"ZU37-/B9;
MN/3U+7JPQ7 +8:(KG<(L[B^X;0@8D]?:@"W'X?MK6[BOMUS=RVIE>VCE=3Y1
MD^\%. >>G).!TJ30-(_L>QE1V5[FZN)+NY=>ADD;) ]@,*/917,+X]G7P_8:
ME>11V<,MQ<V]Q>-;R20PO%(T:[U!#('*DY)PN,'KFK5QXHUFX%U'HNGP7US9
M10/+&C I.\B!RJ/O 4;2,,0P.?;D UHO#%M!+<RP7E[%+<7OVYG5UXEV>6>"
MN,%<#!!' [U=TBQLM.T_[-8,#$))&9@P),C.6<G'&=Q;([=,#I5U6+1AMI4D
M9VGM[5P5GXGU"*PTX6>FZ; ][KMUITBH&5 RM,?,XZDF(D^I- &]!X.T^W6R
M5+B[Q9WLE]%EU_ULF[<3\O(/F/Q_M?3$\/AC3XM*U/37\V>VU)Y9+E96!R9?
MOXP!C.?PIOA?6+K5[&\^W1PK=6=[-9R& $(Y1L!@"21D$<9-4O%OB.^T&*YE
MMDM2MO82W>V0-(\K)SMVJ057'5SD D4 7[S0=+N;?3[+<8)=-VRV;Q2 20[1
MMR,YR,'!R"#GFHW\,:9>V,2)-,5-XFHF>-U+33*05<G&#T7@<8 &,#%8C""]
M^(#SM F+KPWN=64'<#+T/KUK5^'O_)./#?\ V#;?_P!%B@#5ET>QFUNVUB2$
M&]MX7@CDST5B"?Y<>F3ZUGP^#]-M]<GU2"2\C,\OVB6U2X86[S<?O#'TW< ^
MF0#C-8NN>+M:TY_$[V]M8-#H<45QB0N6F1D+,O& IP.#SCT.>+,_B;5K/4=5
MLKB#3VD@T^._MF\TQHJL[(5D9CSC;G(QGI@4 68O >DP/ (IKY+:WO/MT%JM
MP1%#*=V=HZ@$L3C..>,<UH:9I30ZSJ6LW  N;T1Q*F<^7#&#M7/J2SL<?W@.
M<9/):MXLU>72-8CM988+BPU.SMO/^S.GF1S-%GY&;*G]X1G)R!QC.1K77B/6
MWN+Z+2=.COGTVYBMKB, )YQ*([E6+C9A9,@$-G&,]Z +^I>$M,OM8.KO/>6L
MYB$5P;:Y:)+B-<D+(!U R>>#@]:CF\(:9?VVHK]HN3#JLT5S-Y<BX8H%V;3C
M@81.GI]<YRZ]KE[_ ,)%_H>EM9:7//;NDA<M*! DB^W\>#ZCZ<U+[QA>:5X3
MM=0M;2PBBCT1-0%NB,VXA03&JJ<QH!QO.1R!VH Z7^P;%]1C>:ZFG>&?[;';
MR.I"28*[P,9 Y/&<9.<9JI:>!]+LKBRFAGOA]AFDFM$-P=D)<$,H']WYCP<_
MEQ5:T$;?%2YF2-5,NA0,Q Y/[Z3KZ\5H^+-9O-"T>.\LH()I&N[>W*S,0,22
MK'V[_-0!&?!>E-X9_L"0W+V8E,T;&7$D4F\ON1Q@@AB2#[XZ<5IZ5I<6DVIA
MCGN;AV.YY[J4R2.>G)/L!P.*YRXU_P 1I)>:=:V5G=:M8VZSRI$I\N4NS[$!
M9P4RJ<L=PR>G%//BVX'B2/2+B.'3YY3&8(+M&_TE60,_ER@["RL2I7D_+GN*
M +(\#Z4MTEPDU\ACOGU")%N6"1S.&WE1Z'>Q(]^,5);^#M/M8-.ACGN]FG74
MEY;@NIQ(^_<3\O(/F/Q_M>PQ@V?C377M](U*[L;#^S;W4GTV187<RQMYSQ(X
MSQMRH!'7G.>PN6GB[5+J*VU=-,\S0I4FDED7 >!$#%7R7^?.W!4*"">^* -'
M1-/FN-9NO$.HZ4NGW\\"6@B\U9'$:,S9++QR6'X*/H-6]TX7DT$RW5Q;RP[@
MK0E>0V,@A@01P.HKG)]:\0OX;FU>&.PCMYM)>]AD +-!)M#JA&?W@*D_,-O*
M].:I-XMOM(TO1DO[BWB-W81R)?7,#^3+,0,1,X;$;8YW,<'/&,8H V'\#:/M
MMT@-U:I#9&PV03%1)#UVMZX))S[GJ#BD;P+I(>PD@FU"VEL[5;,26]VZ-+ .
MD;D<D#MT(SP1735AZ]J]WI%_H^U8?L-W="UN)'4EHF=3Y9'(&"X"_P# A0!'
M=>#].N_[5#R7"IJELEI<QHRA?*4,%5>..&8?C],:,EC9ZCHDVFR/]IM)87M9
M"'&67!1@2._4?6N?\/>*KW7$CA M1>)>S17"+&P40H-RR+EL_,'A(/\ TTZ'
M%9%IKFISV_AG["MAIR7FM7MM<0PP$HWE_:.>&'4Q[CZDY]00#IK3PQ81W4=S
M!?7<DUO:-I^\S!R$)!(.0?FR%/M@=J6T\(V-B=)-O<72G2;9[6T^=3MC8*"#
ME>3A5Z_W?KGDM&U2]T&:^-M!:?V=/XIDLY$P0X\UU4,N.!@D<8.>>E>E2,4C
M9E ) ) )QG\: .>;P9I0\-VNBE[D6UC(LUK,)<2P.I)#*P'49/7/!(JUHVD:
M=I-S=7-M>2SSZFRSN\T^_P TJBKN4=/NJ.@_3%<_:^);G6&NM*OX+21)M&-Z
M3"C;%))5D#$E95&1AUX.#Q6;X>C077PSD"+YAT*52V.2/)@XS^)H U['PU/>
MZ]XH;5(;J+3M0NXI%B\R,QW"+#&A# $L/F0Y'&1C.>E:%SX(TJZNY[AI;U/.
MO([XQQW+*BSIM^< ="=HS^F*T?$&KC0]'DOO+\QA)%"B9QEY)%C7/MEAGVKG
M=1\2^)-*M+F6XTJWVI>VD%O-(?+69)I%1OD#.592W4G!R#CM0!L+X2T[^Q]5
MTJ5KB:UU1Y9+A7<9W2?>*D 8_I5+4=-:\O;&RO['.E:9-'>C4KNY5C)(H; Q
MU!W$9)P,9 JE=>*==M-.\2$VUE->:'-&SB-'VRP-&LA(&[(95+=\';VSQ+XF
MU^1?"VN:A!;V&H:=;6Z%8[A"R3$@,V>2&7:R8]R?2@#H];CNYM"OXK!$DNY(
M'6)7D* L00/F'(^HKF/#F@WT,J1R#7+>Q$;13VNIW<,Z2*5P GEEB.<<DC@8
MP<\3W/B758->UN#R;%=-T>**XG=BYE>)D=F"@<;AL[\?T6W\3ZB+K0!<P6IB
MUV%F@\O<#!*(O-"L<G>"H(W #D=.> "6'P!HT<444LM_<1Q6,NGJLURQ MY
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M <UU5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQ69BS%"5Y)'OA1]!L0:C;W&DQ:FI(MI(!< D<A"N[I]*YFW\6W$T'AZ]NK2
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M)(\F1P..@RG\JYK1M6NO#]QJ9@L[9M/F\4-:2?.5=3*8T!50,8!8$Y///3N
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M/#*7,\!QY@82L=A(ZD?=S6G=>(O$-O;:H\6BK<&UM!=0/MDB25AG?#AANW
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MND P 1P3D\96V\5ZAJ$*PVFB/'JJV'VV:RNY?**99D6,';R6,;X)  &">N*
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MWC<L(QY-QD9P,Y(STJPWB&\M[4'2M-M+22;Q*;&Y!F9A(=WS.#MX+8YXX'Z
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MR/<^@4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MD8R.3SB:]\9C1+DQZ[9"U1K"6^BDAE\T,(@#(ARJX8!E(Z@^HH ZD !0H
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M:.S' SR>* .HN?!<5S;:I;MJ%PJ:CJ$6H2$(N5DC,94+Q]W]TG7)Z\\U!>^
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M96:W4TFGZ?<&YLK9P,1-\VT%NK*NX[0>G&2<"M'0-%70-.>RCN9)T:>6?=(
M"#([.PX[;F.*Q(M?BU'6]$N+?3$,]]HTM[:SRSE=BGRB8V4 ]=Z?-ST/%:/@
MO5;[6_!^F:GJ"1+<74"RGRF)!W 'I@8Z].?J: ([OPC!<7FJRQ7D]O#J\8CO
MX$ (DPNS<I(RK%?E)'8#H>:9>^#;:YGU-H;RXM8M1T]=/F@B5"FQ0ZJ1D9!
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MJ!OUG14W*614>/IS&RHN0?3.<XQBRZS?^'O$?C2_L]+^WVMJUO/<@W6QDC$
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M4GPV,C>"+<RJ5?[5=@KOW;?])EXSWQTS2_$0?\4GO!8,E]9E2"1UN8P?T)%
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M[R\GLUCGG:)2T<;2*ZEH\F-@O7 (YX)&* +,5@FL>,8-4ETV\MCI,<MLL]P
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M]RKV^L7%MJ$6H3W\%W%&N8VF),B%3D,AST/H.>*T5\-2?VKI.HRZG--/IZS
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MQM9+6TDDB **X"EFQ]Y\*!G@=>.:T]"TL:'H-AI2S-,EG D"2,N"54!1G'?
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M?#*1T*J<'=G(Z=ZUH/&DT]\U@=-CANVL)KR*)[G+)Y;*"DH"_(WSJ>-W?\0
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MR&Q^-TDCLG-@R++J3:7=[Y0/LLX) !P/F4D  CKN7IG@ -/\%MIXT0+J6_\
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M*'QHAMYTN;$P7\6HG3?LXDWJTGEB7(8+G;Y9W?=SP1B@#4T+13HW]H9N?/\
MMEY)=G]WMV,^,@<GCBL:/P/)%?V]RNM3[;;4YM1B0PH3F57#*S=6_P!80#V
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MJ[FQT&64=1UI;SP0MRC74.I36NLF^^WK?Q1CB39Y>W8<@IY8"[2??.:DD\9
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MWB/6H8-,O&NK&XEM+>]MH"]O<&-B[/'@Y!! #,H."<\CUH @OO S7L^H7/\
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M-!>/4ED_L?3WL8PUO_K%;9\Q^;J/+7]?7B]HWATZ3X230/MLCA(7A%Q&OEN
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M!)@4>=$2A Z_*1Y:\\]3T[=9110 4444 %%%% !1110 4444 %%%% !1110
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M%HWWH@!93\WR/@@@-C(SW!%20>-$F6Q$FF7-L^H#=9+<2Q)]H78K_*=W!^;
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MWKPW9OSJ/VV-<,LYE,C,HYP,%E YX/>I]/\ !UCI]]J\D;-]DU! BVHX6$%
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M1B4PJ1N(.0O7U*D#/I0!/14-K,]Q9PS2P/;R21JS0R$%HR1DJ<$C(Z<'%34
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MR2)TUQ6E(?:(3YC3#.5=90H!.",X'%>A7-\L$%VT,;W4]M'O-O"09&X)"C)
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M?S)"!N#.0T"C!\P%?F;/R@+P<FJ6OSVM]/XTN!J,S>3H-O=6NR\=0LVV<AD
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M@GFN>U2\:>R\6QO/)#K=M*KZ(J.5<Q^4A@\H=PSA@P'4D@^E>I4F!D' R.]
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M&C-N**6QC)'/K0!Y3KPBN[SQR5UB^2\LT@GTQ(;Z0%93 &38@;#;GP-N".<
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MTOP]:V%O<)-#:2O=8\\16JQ1-CH-@S^I)]\  :T<<<,2Q1(J1H,*JC  ] *
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MZ]3ZU':6T4LLL=O$DDW^M=4 +_[Q[_C3!IUB(Q&+.W"!=@7REQMSG&,=,\T
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***Q;Z_NX/%F
MD64<BBUN8;AI$V<EDV;3G_@1H VJ*Y?3-4U&7QA=V.I&ZM%*.]I;/%&8IHU8
M+O61223R"5;!&_I@5U% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !117.^)]4U71XHKJT:S\B2YM;8)+$S-NEF6,MD.!@!@0,<X/- '1
M5F7>MP6=R\#VFHR,N,M#922*<C/#!2#5F&2Y@L'DOW@:6/>S/$"B%03@X8G'
M&,\]<USWA/Q<VO6=I/<JB_;8@\ CA<?,!^]0YS]PD+N. 23@<4 :7_"26W_/
MAJW_ (+IO_B:/^$DMO\ GPU;_P %TW_Q-,;6+F[\37.BZ?Y*&RMXY[J>9"X!
MD+!$501SA&).>..#GBTU]<V&B7-[J42&6W65V6W!(=5)VD#D@E0">N"30!!_
MPDEM_P ^&K?^"Z;_ .)H_P"$DMO^?#5O_!=-_P#$U1TWQ3&NGB\U:ZA19(8K
MC$=K(OV='&,R$YP-P;#' P,] 36K::[87VI7&GVSS/<6S,DW^CR!$8!207*[
M<X=2!GD'(H @_P"$DMO^?#5O_!=-_P#$T?\ "26W_/AJW_@NF_\ B:H6WB&\
MU/1KW6;.;3[6QCDFCMVO <2>6Q0NS[@$4LIQP<#![X&=JGC:;3[K7!]KTM(M
M/M8;FW27.ZYWJQV!@_4E0 0#]X<&@#H/^$DMO^?#5O\ P73?_$T?\));?\^&
MK?\ @NF_^)K)NO%-S#KR6,UQ8Z;%)IJ7BB[C+.'9BICP'7)&.W-:OB+6I?#_
M (4NM5F2)IK>$,ZY.S=P"1W(&2<=3C% "_\ "26W_/AJW_@NF_\ B:/^$DMO
M^?#5O_!=-_\ $TNB:S_:*F&8C[2%\X;(F56A9F$;\YQN"YQG/!Z= S2-5N[[
M7M=LIQ (=/GCBB*(0S!HDDRQ)(_BQP.U #O^$DMO^?#5O_!=-_\ $T?\));?
M\^&K?^"Z;_XFIG\0:8EVML]SM=I6A5BC;#(JEBF_&W< #QGL?0U6'B_1#")?
MM4FTM"@'V>3),O\ J\#;G#=C^'6@!_\ PDEM_P ^&K?^"Z;_ .)H_P"$DMO^
M?#5O_!=-_P#$TZ+Q/I4\$<L<\C"3S<(()-Z^6X23<NW*[6(!R!5;Q+KD^C7N
MBQ)-9P0W]TUO+-<J2(\122 _>4=4QSZT 3_\));?\^&K?^"Z;_XFC_A)+;_G
MPU;_ ,%TW_Q-1V_B2SB@MQ?7T$DDXC=);:%_+,<LA2%CUV[C@<GKGM4MUXCT
MZ);B-;O9*D4SB0V[NG[KA\8'S;2>0#GKZ'  G_"26W_/AJW_ (+IO_B:/^$D
MMO\ GPU;_P %TW_Q-9DGB>:*?5!-=VT=K;:=9W<5U]ED8 RM*I+(&R1^[! X
MQGDFM"+Q7IKWUS:2_:(7AOQ8*SP/M>4HK@ @8&=V.3V]Q0 __A)+;_GPU;_P
M73?_ !-'_"26W_/AJW_@NF_^)I?[>AN-7@TZS.^1EFDE9D8!$B<(P XR2QP.
MW#'G&#7B\5Z9!HT5_>:@CQLCRM-%;2* BL5+%3DJ!T)/H3] "?\ X22V_P"?
M#5O_  73?_$T?\));?\ /AJW_@NF_P#B:G_M:*[::#3I%EN4#[=R-Y;,A 9=
M^,9R0.O?H<&HX-2GUKP_::AHQA1KN-9$:Y4L(P1D[E!!)'3&1SWH 9_PDEM_
MSX:M_P""Z;_XFC_A)+;_ )\-6_\ !=-_\3618>*-5OS:6 MK6/4GANYI'(9H
M66"41 H,@X<L&&3P,]>*<OB75+NQT36K*WM6TS46ME-NX8SXFQE@P.!LW$E<
M'(5CD4 :O_"26W_/AJW_ (+IO_B:/^$DMO\ GPU;_P %TW_Q-9.H>+;C1;_6
M1?/87$%AIS7_ )-LQ6:/!(5&!)W;L?> &.XY%61JNMRZC<Z-$-/74H8(+KS9
M$?RO+D+J1M#9)#1D=1PP/;% %W_A)+;_ )\-6_\ !=-_\31_PDEM_P ^&K?^
M"Z;_ .)J7P]>7NH:+%=7WV<RR,^UK=2J.@8A& ))^90&Z]Z9+XFTJ'4)[)YI
M1/;D++_H\A5"0"H+;<9.1@9Y/ R: &_\));?\^&K?^"Z;_XFC_A)+;_GPU;_
M ,%TW_Q-.M?$^D7EW':0W+&XD>2,(87!#Q@%U.1@$ @X/4$$9%1KXCL3>2$W
MJB 6T$RQM;2*_P"]=E1MQZACA0H&00<]: '?\));?\^&K?\ @NF_^)H_X22V
M_P"?#5O_  73?_$TZZ\3Z390>?<W+Q1CERT+CRQO*9<8RHW C)P.">@-5;GQ
M(/\ A(](T^S99(;F>>"=S"^ 8XV)"O\ =R&7!'/<=C0!8_X22V_Y\-6_\%TW
M_P 31_PDEM_SX:M_X+IO_B:6\UB0:C=V%H(_-M+,74S2*6 W;A&N 1UV.3SP
M /7(CTO5KN^\$6FLR"!;JXL$N]JH=BEHP^,9R1SCK0 __A)+;_GPU;_P73?_
M !-'_"26W_/AJW_@NF_^)K'@\4ZC;Z3X=U74([66SU<V\<GD(R-;O,!LZLV]
M=Q"GH1G/-6]9U;6H-,U#4=-6P\BS\UP+E7)E$8PR#:1M)97&[G^'@T 7?^$D
MMO\ GPU;_P %TW_Q-'_"26W_ #X:M_X+IO\ XFLN]\7SVSZC.+9$MM+-JMVD
M@)D)EVE@"#@;%=3T.3D<=:N#4=<A\216,\-E);74$TL(BW*\!0J!YC$D,#O'
M( P?7K0!8_X22V_Y\-6_\%TW_P 31_PDEM_SX:M_X+IO_B:IZ5X@N98-;-U+
M87;:;-Y2/9':)#L5MA4LQ5MS;>O/MTI7O/$=OK5C;S-IDEO<2,&2.-_-"*A)
M?); RP4=.-X'/6@"W_PDEM_SX:M_X+IO_B:/^$DMO^?#5O\ P73?_$U3@U#Q
M'_:E[ILL6FO,+5+B"6,.$B+.5V2 DENA((VYP>!2V.LZI'::@U^MG/<17)MK
M46JLBS,$!/WBW .X$]MC4 6_^$DMO^?#5O\ P73?_$T?\));?\^&K?\ @NF_
M^)JKIGB26?3O#5W>1QH-:MX\>6" D[1&7')^Z0K =P0.N>.CH QO^$DMO^?#
M5O\ P73?_$T?\));?\^&K?\ @NF_^)K9HH QO^$DMO\ GPU;_P %TW_Q-'_"
M26W_ #X:M_X+IO\ XFMFB@#&_P"$DMO^?#5O_!=-_P#$T?\ "26W_/AJW_@N
MF_\ B:V:* ,;_A)+;_GPU;_P73?_ !-'_"26W_/AJW_@NF_^)K9HH QO^$DM
MO^?#5O\ P73?_$T?\));?\^&K?\ @NF_^)K9HH QO^$DMO\ GPU;_P %TW_Q
M-'_"26W_ #X:M_X+IO\ XFMFB@#&_P"$DMO^?#5O_!=-_P#$T?\ "26W_/AJ
MW_@NF_\ B:V:* ,;_A)+;_GPU;_P73?_ !-'_"26W_/AJW_@NF_^)K9HH QO
M^$DMO^?#5O\ P73?_$T?\));?\^&K?\ @NF_^)K9HH QO^$DMO\ GPU;_P %
MTW_Q-'_"26W_ #X:M_X+IO\ XFMFB@#&_P"$DMO^?#5O_!=-_P#$T?\ "26W
M_/AJW_@NF_\ B:V:* ,;_A)+;_GPU;_P73?_ !-'_"26W_/AJW_@NF_^)K9H
MH QO^$DMO^?#5O\ P73?_$T?\));?\^&K?\ @NF_^)K9HH QO^$DMO\ GPU;
M_P %TW_Q-'_"26W_ #X:M_X+IO\ XFMFB@#&_P"$DMO^?#5O_!=-_P#$T?\
M"26W_/AJW_@NF_\ B:V:* ,;_A)+;_GPU;_P73?_ !-'_"26W_/AJW_@NF_^
M)K9HH QO^$DMO^?#5O\ P73?_$T?\));?\^&K?\ @NF_^)K9HH QO^$DMO\
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M'ZX&,G'(KHZ* .6@\(S_ -G:+87NHQSVVD")H8X[<Q^9)$N(V?+MD @-@8Y
MY[5:O=%U-[>PM]/U*UAAM5&]+FS:;S7&,,<2)T(SCGGGL*WZ* .:NO"0O)+K
MSKP&*_-N]\OE8,KPD<J<_*&"J",'@<8ZU-;Z5KL6H7-R^L6#B4-M']G,&7@[
M%+>:<JI.< #//(R:WZ* ,2'0&^W27US/$]S.T)N/)A,:.(MQ08+$@AFSG)X
M%7FL6;5FOS*"RV_D0J5_U9+9<]><XCX_V/>KM% &+HVF:O8W$LFH:I:7:R99
MO)LC"S/Q@LQD;( &  !33X6L;C3+:UO=\TT(<F:.1XBSR'=(WRL.K<XR:W**
M .4M?"OV*R\+Z1$[O;:,RSR3MG]XRQ,B@9)QEG+8S@!<=Q75T44 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
&444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>37
<FILENAME>exhibit1033-bochk_facili021.jpg
<TEXT>
begin 644 exhibit1033-bochk_facili021.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MY)4MU^7.2/:O7K;Q9HU[JRZ99W,ES<')S#!(\8QUS(%V#\Z -NBBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MP"15Q(9-I?)P>G;..>E<SX?\9>(KOPCX$:XO9<ZWJ$T-_J!4;E"R,$C'&%+
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MP$A<E<;_ # -P&,#C(QT]JVY]1U&'P1J^I/>75K?1Z3-/;Q22JY<I"KB=?\
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M8O\ &@#I:*YK^Q/$_P#T-W_E-B_QH_L3Q/\ ]#=_Y38O\: .EHKFO[$\3_\
M0W?^4V+_ !H_L3Q/_P!#=_Y38O\ &@#I:*YK^Q/$_P#T-W_E-B_QH_L3Q/\
M]#=_Y38O\: .EHKFO[$\3_\ 0W?^4V+_ !H_L3Q/_P!#=_Y38O\ &@#I:*YK
M^Q/$_P#T-W_E-B_QH_L3Q/\ ]#=_Y38O\: .EHKFO[$\3_\ 0W?^4V+_ !H_
ML3Q/_P!#=_Y38O\ &@#I:*YK^Q/$_P#T-W_E-B_QH_L3Q/\ ]#=_Y38O\: .
MEHKFO[$\3_\ 0W?^4V+_ !H_L3Q/_P!#=_Y38O\ &@#I:*YK^Q/$_P#T-W_E
M-B_QH_L3Q/\ ]#=_Y38O\: .EHKFO[$\3_\ 0W?^4V+_ !H_L3Q/_P!#=_Y3
M8O\ &@#I:*YK^Q/$_P#T-W_E-B_QH_L3Q/\ ]#=_Y38O\: .EHKFO[$\3_\
M0W?^4V+_ !H_L3Q/_P!#=_Y38O\ &@#I:*YK^Q/$_P#T-W_E-B_QH_L3Q/\
M]#=_Y38O\: .EHKFO[$\3_\ 0W?^4V+_ !H_L3Q/_P!#=_Y38O\ &@#I:*YK
M^Q/$_P#T-W_E-B_QH_L3Q/\ ]#=_Y38O\: .EHKFO[$\3_\ 0W?^4V+_ !H_
ML3Q/_P!#=_Y38O\ &@#I:*YK^Q/$_P#T-W_E-B_QH_L3Q/\ ]#=_Y38O\: .
MEHKFO[$\3_\ 0W?^4V+_ !H_L3Q/_P!#=_Y38O\ &@#I:*YK^Q/$_P#T-W_E
M-B_QH_L3Q/\ ]#=_Y38O\: .EHKFO[$\3_\ 0W?^4V+_ !H_L3Q/_P!#=_Y3
M8O\ &@#I:*YK^Q/$_P#T-W_E-B_QH_L3Q/\ ]#=_Y38O\: .EHKFO[$\3_\
M0W?^4V+_ !H_L3Q/_P!#=_Y38O\ &@#I:*YK^Q/$_P#T-W_E-B_QH_L3Q/\
M]#=_Y38O\: .EHKFO[$\3_\ 0W?^4V+_ !H_L3Q/_P!#=_Y38O\ &@#I:*YK
M^Q/$_P#T-W_E-B_QH_L3Q/\ ]#=_Y38O\: .EHKFO[$\3_\ 0W?^4V+_ !H_
ML3Q/_P!#=_Y38O\ &@#I:*YK^Q/$_P#T-W_E-B_QH_L3Q/\ ]#=_Y38O\: .
MEHKFO[$\3_\ 0W?^4V+_ !H_L3Q/_P!#=_Y38O\ &@#I:*YK^Q/$_P#T-W_E
M-B_QH_L3Q/\ ]#=_Y38O\: .EHKFO[$\3_\ 0W?^4V+_ !H_L3Q/_P!#=_Y3
M8O\ &@#I:*YK^Q/$_P#T-W_E-B_QH_L3Q/\ ]#=_Y38O\: .EHKFO[$\3_\
M0W?^4V+_ !H_L3Q/_P!#=_Y38O\ &@#I:*YK^Q/$_P#T-W_E-B_QH_L3Q/\
M]#=_Y38O\: .EHKFO[$\3_\ 0W?^4V+_ !H_L3Q/_P!#=_Y38O\ &@#I:*YK
M^Q/$_P#T-W_E-B_QH_L3Q/\ ]#=_Y38O\: .EHKFO[$\3_\ 0W?^4V+_ !H_
ML3Q/_P!#=_Y38O\ &@#I:*YK^Q/$_P#T-W_E-B_QH_L3Q/\ ]#=_Y38O\: .
MEHKFO[$\3_\ 0W?^4V+_ !H_L3Q/_P!#=_Y38O\ &@#I:*YK^Q/$_P#T-W_E
M-B_QH_L3Q/\ ]#=_Y38O\: .EHKFO[$\3_\ 0W?^4V+_ !H_L3Q/_P!#=_Y3
M8O\ &@#I:*YK^Q/$_P#T-W_E-B_QH_L3Q/\ ]#=_Y38O\: .EHKFO[$\3_\
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MA<CRR2 >G4E6XZ\'BN<\,Z1K&E6=O%>>'-)^UZ9;F&&]@D7?=$+M&WY08]V
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M!P#U'/% "W7B?1K+51IEQ>JMZ3'^Y",Q_>-M4\#@$\9Z#O0?$^CB<P_:SO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M'.^)/$$FA:GH:O+:Q6-Y<R0W,DX(**L,D@(;( Y0#D'K3[BZ\+:U;:=JT\FG
MWT4<Q-E.<28EP<[.IW#:3@<C;GM47BFQNI]2\.WUO:/=1:??M-.D97<$,,B!
M@"1G#.O3FL%-$U73[[[9#I+/!?:S->2QP&+S[5&A$8*EF"J7*DL5.0'..<F@
M#K9/$NAPQ6\LFKV2I<QF6$F=?WB#JR\\BJ%SXC9];\-QZ=-:W.FZKYVZ5<L2
M$C+@JP..HYX-<UX=T+6+*3PB+K2)D&F&^6=C+&VSS"=A'S9.?S]<50/A/7[S
M1O#]@MK<V$MM<Z@\LX>)A")&D,>0&^93N4$#L2.* .TGN-(N-7TK5;._T[[3
M<.;=)9'+-/%M):.+# 9R%;H1P>,U>A\3Z%<7<5I!J]E)/,[1QQI,I+,N<@8/
M48/Y'TKG[F/6M6MO"4\^@R6ES9ZBLUY"DD16%1#(A*D-RN7& .<=N*SH]#U=
M;.)?[(F$@\5/J+#?%GR#*S;_ +W]TCCK[4 =M-K^D6]P+>?4K6*0R&("24*"
MXZH">"W(^7K5F\O[6P1'NITB#ML0$\NV"<*.I. 3@=@:\VL<QWL;7&EZHVCV
M^MSW]M<PK%)'N9W7<7$F\IEV;&S/(&2!SU_B:/4'O-&>STYKJ&.Y8SR0^6)X
M5,;*"A<@#).UB#G!./6@"W<>*= M+:&YN-9L8X9XS-$[3KAT'5ASR!ZTB>*_
M#TDYA36]/:0;\J+A3C8H=N_93D^@KC?#V@ZO:OX1CO-'F1=.DOEN&:2-P@D)
MV-][)!S]?6KYTK58['QP8M%BFN+ZX:6RCNO+:.X7R(X\$;O56X;'7WH Z<^(
M]&6UGN7U.UCA@95E:20+L+<J#GIG(QZ]J?;Z_I%U%=RP:G:21V9Q<.LJXBXS
M\Q[#'>O/=2T+7;VU\5K'HU](=3M;,0?:)H=[LC'>& ?:IYS@<8_*K?B?3;J2
MY\4SR6%PL%_:6$-FR2QJTDZ2/A0"W4%TX. <$9[T =Q%KNDSO/&FHVWF6Z[Y
MXVD"O$O'+*>5'(Y([BH_^$DT40F5M4M$43K;G?*%(E;&$(/(8Y''O7#7-IJ.
MJV^M&'3-0MM>NVM;L0W02".=+:1#L1HY'VD]"2W\0[#BS?Z1=:EI375KX8N[
M6ZN-1L)9X[FX22:18959F8F0C 4$#G)].E '5CQ=X=*!QK5CM,WD ^>O^LX^
M7_QY?S'J*MW6L:;97,=O<WL$,TC*BJ[@?,W"CV)/3/7M7#:]H6KWEOXZ6WTJ
M5WU/[.+0[XQYNR-5/5N,$'KBI[C2+]]?U>TOM N=2T_5+B.Z@G%V%BB(2-2L
MR;Q]TQ@@J&SQZ4 =4/$^A&[6U&L61G:?[.L8F4DR\?)UZ\CC\*9:>*=)O+C4
MH4NE4Z?<"WF+<9<A#QZ\N%'J>E<C=Z'J[V&N)'I,QEN/$EO?0X>/+PH\!+9W
M<<1OP>>GK5F;1+V23Q+:W6EWS6][JD5[!<VEPB.H$<*AT.[(9&C)P1R!QG.*
M .VMKZUO+4W-O.DD(+ N#P"I(8'T(((/IBJ%KXJ\/WMY'9VNM6$UQ*C/'''.
MK%U'4C!YQ@_AS4?A6#5;;1VBU>3S9UGD\N5HU1Y(]WRLZKP'(ZX_'!S7$>&-
M,EUCPQX72&R>+^S]5EO'N2% VK)+D*0<DL2%QZ9ST&0#NX/%.@73.+?6;&4Q
MH9&V3J<*'V$]>F[CZU(WB'1TLWNY-2MD@CE$+N\@4)(>B-GHW(X//(KB[?P]
MK,?@VR1-.:.]L=<?4'M6>,&XB^TO(%#!BN=K*1DCE0*U3X7.MWOBB>\BDM;3
M6+:"W2-\;PT:M^]P"<'+*!W^3Z4 ;FM:Q;V.GWNW4[&SN881)YEX?W<8;(5F
M&0<$@CKSBJOBWQ''X?\ #VHW45S:K?6]H]Q%',"P;:#C(!! )&T'(Y/?I6%J
M.CZ]J'PPU2"]M1/X@O[7RI(HG7&X*% #,0 ."W7@L:KZWINN>9XRACTBXO(M
M<TX+9R1O'^Y<0&,Q.&88^;Y@1D?,>] '8?V]86MG:2:A>V]O)-%&Y#MM W<#
M/H"> 3WXK-\8>*5T#2I9+2XM3?1RPH89@6X=U7'!&#@DC/7'0USTFCZFNHW,
M%_X=NM3T_5+2W38EXJ+ Z)L:.9=X!3C=E=W4\&H=1T;7XM'\1Z*NCSWCWFI1
MWMK=121['CWQ':=S@AE";>>P'- '>:[KEEX>TJ34+YRL*LJ# R69B H_,UBQ
M^,K:V\2ZM9ZG?V%OI\$-I):S,=A;S?,SDDX/W!R .O-6O&MA>:KX0NK>RMFF
MN2\,JPAE#-LE1R 2<9PI[USNM:/J^HMXVDCT>?=JFC0VMH&>++2!9@5/S<8,
MB\].#@G% ';7.LZ;9W2VUQ?013,4&QGQ@N<(#Z;CP,]3TJ'3_$&GZGJVHZ;;
M2[KBP<),.GS$ \>H&X<^]</XATK7]0CU"&+0YR&^P2PM#)"GG>6Z,_FDL"SK
MA@!]W&#UYKI]"L[^T\5^(Y;BQDCMKZ:&XAGWH5.((XRN <Y!4]L8[T 7IM9M
MK35KM+G5=.BMK:U6::)VVRPY8_.[%L!", 9'4'FI[#7-*U2XEM['4+:YFB57
M=(I Q53T./2N7\1:3J=WKVOS6VG2RPW7AXV4+AT >;=(=O+ C[XY.!UJ71M+
MU"W\4:1<R:=)#;0Z"+.1RR824.AVX#9Z*>0,4 =-J&KZ?I2!K^\AMUP6S(V,
M*.K'T R.3P,U0CD\-:3K%Q)&;"VU"^>/SY%P'E9N$#-ZG' /7M6)X@T^_3Q7
M/<MHUWJ^E:C81VDD=M="(Q,C2'#J74,C"3D\XQTYK)UO0];D6\L[;06$44VG
M26QLY(ECE2)HB^XLP=F7:R@-Q@ ]: ._FUC3H+U+.6]@2X=Q&L;. 2Y&0O\
MO$<@=36)X=\70W\D]EJ=Y8Q:B-0N;2&&,[#(L3LH(4DG)"D]>Q]*HZ5::K::
MM?Z;?Z!]LMY]4.H6U^[1M%&K$-\P)W"1,87 /0<@<UGQ:'JZVD"_V3,)!XJD
MU%AOCR(#(Y#_ 'O[K#CK[4 >@W5W;V40EN9DB0D*"QZD] /4^PJD_B+1TLXK
MPZE;&WF5FCD5P0P7[QX[+W/;OBLOQ7;ZG'J&AZOIUD]^NGW$C3V<;JKNCQE-
MR;B 67/0D9!-96IV&ISRVBVOAL6UM/:W:NMJ84EADD92%D;<,*V"S%"26 Y/
M< ZZ;6=-MQ&9;V%5D575MV058X4Y'8G@'OVHDUC38;]+&2]@2YD;8L;. 2V,
M[?\ >QSCKCFO/DT+7H]'T=[*RO;'6+72;6U<.\4EM<["P:&9-QP!RP8<X<X.
M>*T++1[Z/7+FPU+0KB\A_M5M0M-0^U_Z.BF3S 63?D.F2H 4YP.0,F@#J]9U
M^PT+[&+Z78;RX6WB'JQY)/H  363I'BZ"74]4L-5O;&">'4S96B@[#*OEQNO
M!)RQ+D>_%3^+[*]NDT6>RM'NFLM4BN98HV56*!74D;B!QN'>N:O=#UB73_$2
M)I$QFN]?M;V#$D?SQ1M;EFSNXQY3\'!Z<<T =U+K&FP7T=E+>P)<R.(UC9P"
M7(R%_P!XCG'7%6+J[M[* S7,R11Y"[F.,DG  ]23P!WKA;71[Y==O+'4=!N+
MVWDU,W]K?_:_W$:E@XWIO!#H>!A3G Y R:VO%MIJ37>@ZE86KWJ:=?&:XM$9
M0TB-&\>Y=Q ++OS@D9YH /#OB@:E#K4]Y<6H@LM3>SADB!4,H2,@$$DE\N1C
MU&,5%J?C"WM-2T*2"^L6TB]DG2XN&/W#'&S<-G .Y<$$9[=:YR32-?5KS4H=
M&NCY?B!M1%F+E(I+B![80G:ROPZDDX)&<=>:T?[&GAO]!U:UT">WAAO[BZN;
M8RK).#)"4\Q\N06+8)VL>/?- '03>,-#B32I$OX9XM3E,5M+$P9&(5F))' Q
MM(^O%:UU>6]G&KW$JQAFVKGJQQG '4G )X]#7!)X;U.PGT[4(=/:0?\ "0SZ
MC):1N@:&*2&2,=6"YR0Q )^\<9Q71^+=-;4K6Q2-+])(KGS$NK"15EM6V. ^
M&X8<[2N#D-TH BU*'P=.T>LZ@FFN98]PNG _>1CNQ[H,CD\#-:T^LZ58-%%/
M?6T.X)L!<  ,<)[ $\#U/ KA5TSQ%;W=K<ZOHTVK17FFK9W45A<+ 8Y%DD(+
M)O52KK)\V"0"#VJW9:5J6D:GJ.FR>'([_3-16V:W971H+8QQ)&8Y Y#;5,88
M$ DY]: .O;7-*2.61M1ME2*<6TC&0 )*<80^C'<O!]1ZTP>(]$.H_P!GC5K,
MWF]H_($RE]RKN88SU"\FN)UG1];V>)K&VT>>X%]J]I?P3))&$:-3;[A\S AA
MY3<$8QWJ]-X?U+4%\>0K:M:/JP LYY&3#?Z,L?.TD@;@PY[&@#J[?7-*NA<&
M'4+=A;())OW@&Q""0QS_  D X/0X-9>E>(VU/QEJ>E126\MG;6<%PC(I#AG:
M0%6R?1%(X'#=ZYF_T;5==T"\N(?#<^GZRL,*,+R]$AN!',DAA1M[?NSM89;'
MWAQC-;NCQZA<^.K[5YM(NK*TN=,MX5:=H\B1))200KD]'% %K6O%=M93:EIM
MI+&=5M+!KP)*I*<!BH.",YVGH>*L>'_$ECK-C;@7MJ]^+6*>YAB<9CW*">,\
M#.1[5B^(-,U23Q)J]Q:Z=+<P7N@_8XY(W0!95:4[2&8'GS%P>G7.*RKCPSK-
M[#:VD5G):9\*S:8TS.FV*=O+PIVL3CY6Y (H [5O$VAI!<S/JUFD5LH>9GE"
MA%/W6.>QP<'H>U+_ ,))HIMI+A=4M6ABD>)W20,%9>6''H""?05P^I:1J6N>
M$]9(\*W5IK,VF/8YN+Q96D8D';&QD(\L')RVWJ,#K6OK]GJ,.O:;JMMH]W?6
M)LWM9[2TN%AFA9F5@WWU5A\NTC=V![4 6;KQG::=XH:VO]1T^'1WTZ.[AN6?
M&YF<KC=NPPPN1@5OQ:OITUZME%?6\ER\(G6)) 6:,]' '5??I7)6NBSZ/X@@
MN(M +6!T8626UNZ.(F$C-Y9W,."& STX/3BJDOAG4= \-^%AI]Q$-:L M@6R
M2KQS<.H[D(0L@]HO>@#O([^TGL3>PW4+6VTGSMPV #J2?08K/M=>LX=%L[O4
M-4L9&E@\UKB#(B=0!EUR3A.1R3CD<\UH16T=AIB6UO$QB@A$<<8/) & .>]>
M;0>&];@\(:)#!:7UEK=AI0MU>-XI(I'Z&"9"Q5D; .[MSR.A /2;W4+/3;;[
M1?74-M#N"^9*X49)P!D]R>U5+;Q+H=[;75Q;:M930VC;;ATF4B,]LG/&>WK6
M)\1?,/PZO?.C5Y<V^]$Z,WG1Y SV^M9VMZ/J=SJFK:YI^D!S+:VEL+:98]\Q
MCG+O(%8[=R*1LW=U] ,@'37VO6ATI[FSU6P@*W"0&2Y.55]PS&5R#O(. .N2
M.*I>,O%*^']'GEM+BU-]$\0\F8%AAW"X.",$@DC/7'0US%QH6MR:/XFMTT>[
M9[W5[2\M_-GB9G1?LY8D[\ CRFR.G0#/9=6TG7_[+\4:2NC7%X^H:BE]:W,<
MD01D+1'8VY@0RA,=,8 H ]$OM0L],M3<WUS%;0 A3)*P502< 9/J>*A.M:8K
MWB&_MPUDH>Z!<9A4C(+_ -T8YYI-8TR'7="O-,N5*QW<#1-ZID=>.X//U%<;
MIWAWQ%)JFG:CJ/EA]0ME@UJ-7RJ^20T17UW8<-[2'TH V+/Q? GB'6-.U6]L
M;>.WN88;,D[#*)(U< Y)R<N!D8'3UK<N=8TVSNH[6YO8(II&5%1W RS?='L3
MV'?M7#:[H6KW<7C86^E2R/J,UJUH0\8\T1I&">6XP5/7%3R:1?MK^K6=_H%Q
MJ-CJ-W'=V]R+O;#%A4&V9-X.4:,$%0V>/2@#JH_$^A2W<=I%K%D]Q+*T*1K,
MI+..JCGKP>/8^E:%S=06<#3W,R11 @%G.!DG 'U)( '?->?'0]7^QRJ-(F\Q
MO%2ZB 'BR8!*K%_O?W0>.OM70^,+/49AHU]I]LUY_9VH)<SVB,JM+'L=#MW$
M LN\, 2,X]<4 ,T+Q;%?7>KQWMW9I%;ZFMC:NN4\PM'&P4[B?GW.5QQR.E;@
MU?3BERPO8"+:0138<9C<XPI'8G(P.IR/6N"N=(UF9-:O$T6Y7=K]GJ<,)>+?
M+%&L <##X#?NVX)&?6F7ND>(9+_5-4AT:XXUJ#4$MOM21O<0BT$+JK*_#@DG
MD@$KC)H [F6+1?%>DM%*EKJ5@[X9& =-Z-T([$$=#TJ6/5M+2Z33X[NW6;)C
M2%6 Y4<J.V0.H'(%5/#5HEO97$R:5)IINIVG>&:7S)68@ M(0S#<<=B>,=\B
MN4L_#FKOH.E:#=6LBW&G:PMV;_<I22-9FEW@YSN8':1C.6.>.: .RL_$6C:A
M??8K/5+.XN<.WE13*S84[6.!Z$X-37NL:;IT@2\O8(&..)' P"< GT!/ )ZG
MBL?P;I]U80:M]LL6MI)]5NKB/>4)>.1]RGY2>V.#SQ6==6FIVOBG6HY-!_M?
M3=82$QN6C,<+(FPI*KD'9D;LJ&ZGC- '47&L:;:W2VUQ>P1S,RIM9P,,WW0?
M0GL#U[57G\3Z%:W+6T^L64<Z2K"T;3+E7.,*1G@\C\QZUR6H>'M7GTOQ=H3V
MCS_VQ=&>TO0R[$#JB_-DY!C*9Z<@#'-1:YX?U>YMO&T<&F332:C]E6T??&#-
ML15)Y;C!!ZXH [&#Q+ID^L:CIBW*K-IZ*]P7.U5R"3R?0 $GIS]:GBUW2YHI
MI([Z%A ZQR@-\R,V-H(ZY.1@=\\5QVM:'K=Y>>*A963@ZA#9S6LK2JJ,T7+1
M-AMP)QC.,8/6G/I!U:PGNI?#6JZ=<3R0"247JM=J8RQ$BMO8%4)XR<D%OEZ
M@'22^*]'CO\ 3K-;M))-0:00E3D?)D-D]L,-N.N?H:NQZQILU_\ 8([V!KK#
M$1!QEMIPV/7!X..G>N/LM,\11:CX:O+ZV:\:TGO8Y94$<3^7)_JY9%R "0,M
MMR<GIGBJ6C>'=5?2X]'OM'N(=2T^">&WUB2\WP_,C(LD:[RP9LC(V@#GGH*
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MRKD9!R#]0>0:M44 4M.TBPTE&2QMEBW8W-DLS8Z98Y)Q5VBB@ HHHH ****
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M@*X(X;$;Y/3/UJGIMIJX\0Z%=SZ'=VT5I=7PGBB2,0PB3<0R8.Y@WWB><D\
M=* .YM]?T:ZG$%OJUC-*8S,$CN$9B@ZM@'I[TFB:[I_B&P^VZ;<)-!O=,J1G
MY6*Y([9QD9[$5PWAW1KZR@\#+)ID\+V,MT;O]UCR@Z.!DCKDE>F??I73>!+6
M[L/#$=A>V<MM-;S3*?,QA\RNP*X)R,$<T ;3:KIZ7HLFO[9;HY_<F50_ R?E
MSGIS]*AA\0:-<EQ!JUA*8T\Q]EPC;4W%=QP>!N!&?45RV@6][;3MI&J^'YIY
M;74Y[R'47"-"5=W<2 YW!]KE-H&?PZ9EMH>I6_@"T-OI$IO[/5'NIK0'RI9X
M?M#OM5LCG:RL.>J@=: /08]7TV6R:]CU"U>U5MAF692@;.,9SC.>,>M<]I?B
MN74[6^E%UI4/D:P+&&1Y3Y<T?[L_*<\R$,0 .,XK&FT^XANM+U[3?#^H16J:
MF;F^LYI-]Q+NA:(3%"YY4D<9R0,XZ57DTS4I=-U/&CW<9F\407\2E%RT(>%F
M? )QPC=>: .[T[7]-U74;^QL[J.2XL9/*F0,,AMJDX'H-P&?7BB/Q!IDNOW&
MB)=1_;K>))9(]PR V[ ]SA23Z CUK,\/6UW9^)_$XGLYDAN[R.Y@N#C8Z^1$
MF!SG.4;C';W%8WB70]8O]7\4P6,$J?VKHD5O;W0("+(AFW*QSD9WJ.G?V- '
M:VFIV&H.Z6=[;7#1@%Q#*KE0>A.#QFEO-1L=.0/>WEO;(<X::0(#CKUKFK.T
MN=3\6:1K*6,^GQVFG2V]TDJ;"SNT96(?W@NUSD<<C!.3B6^AO++QZFJ26LUU
MIDVF&T_<IYAAE$A8Y4<X<$#([H,XH V;O7='L #>:K8V^8_-'G7")E,@;N3T
MR0,^XJY-/#;0M-/*D42C+.[!5'U)KSO0/#-WINI>%;>_L6FBM-.O8IF9 Z0F
M62-HXR>APH9>,CCWKH?'B,_A^'RHYI;E+ZVE@CA"LS.DJO\ =)&\ *25R,@'
MD=0 :Z:]H\C!4U:Q9C((@!<)G>3@+UZD\8ZU*=5TX).YO[4+;N(YF\Y<1N<8
M5N>#R.#ZBO.IK:2\T_4I[;3M2.I'6++5;FVEM?)9HTDC'[H;B&^6(G[V2<^H
M%3SP:O\ VAKMZGA^Z:*YU>RN(V=$:1(UAC5I$7=RZE>_3WP10!W+:[I"6T=R
M^JV2P2EECD-P@5BN=P!SR1@Y],4)KND2-;JFJV3-<!3"%N%/F!ON[>><X.,=
M:\^M]'U():1W&D7I$7BI[]C*JN?)97^<[21U9<X[],X-3>)--U2:^U&&ST*X
M6&/4-/G@-HD82XCC>(LS$D'<NUE"C   //6@#NCK^C+<K;-JUB)WF\A8C<)N
M,F =@&<[N1QUY%1VGB32;V^U&SAO83+IS;;G+@;/E!)Z]!D9/0'BN(U'2+Z6
MP\5>7I5QY]WK=I<V^(OF>-#;EF!]O+D_R1F;5=*UI[CQ5]CTV>4S:A9ZC!B0
M1K<QQ)!NC#9!5CY;#MT'K0!W46KZ;/:2746H6LEO$VR259E*HWH3G /(X]ZE
MM+RUO[=;BSN8KB!LA9(G#J<'!Y'O7GU]I]Q+;Q:]I?AS5(G74(;F]M9[DK=7
M2+$\9(_>'!7>I W ML^F>M\,6EO;6%Q-;Z7<:<MW<M<-%<R%I69@ 7;+-M)(
MZ9]^"30!H?VIIYOA8_;K;[620(/-7?D#)^7.>G-1V^MZ5=W?V2VU.SFN<,?)
MCG5GPIPW .>"0#Z5PUOH>JRZ!9:#<6TRZC9ZV+S[=CY&C^T&4RA_5D8KMZY)
MR,<UO>#=.:T;6I;BP:"675;F>)Y(MI>-R"&!]#CIUXYH V)=3C@U>6&:^T^.
MVBM?-DC>7$R'=]X@G 3'<]ZEL]9TO4)W@LM1M+F:-%D>.&9795;H2 > >QKE
MM>L+N;Q7J5Q'93R0R>'Y+59%CR&E+DA/KC\*QFT#5I;;3+:QM)K2X'A2?3S,
M4V"*Y81;5)[<HYST_,4 =7_PE$<WC2QT:SGLKBWGLYYY'BDW.C1M& #@X .\
M_P#?)K4&O:.4N'&JV.VV4-.WVA,1 ]"W/ ^M<')8ZMK%QI*VVBWFFR1Z#>:?
M))*JJMO,ZQ!,$'E05."/P[X;)ILVJ>%-4)\+:E::PNB3:=NN)S(&9EP(XAO(
M9=PSNP ./? !W+^)M!C6X:36].5;8@3EKI!Y6>F[GC..]2W6O:/9 F[U:Q@
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MXBD*0J%)^L;=../<53@TK4+/X8:?(]G):ZSX>;[1 )2H\QD+;D!!/RNA9/\
M@0H ]&ANK>Y,H@GBE,3F.0(X;8PZJ<=#[5#_ &II_P!N%C]NMOM9) @\U=^0
M,GY<YZ<U'H]G)9:9%'/@W+DRW!'0RN2S8]LD@>P%<-;Z'JLN@6>@W%M,NHV>
MMB\^W8^1H_M!E,H?U9&*[>N2<C'- '00>)IM5\17FG:1-ISKI]Q'%<I+(2\B
M%0SLA4\;=P&"""01D5NW6JZ?93)#=WUM!*^-J2RJI;)P, GN>/K6)X=@N(?$
M_BF::VFBBNKR*6"1T($BK!&A(_X$IZUSWCFPU;4)=>MK31[AQ/8P"&:V5/\
M2"CLQ61F.1MS\JC&=QZ]@#MI]?T:UG,%QJUA%*)%B,<EPBL';HN">I["I1JV
MG,]TBZA:EK3FY43+F'O\_/R_C7GWB#2+^_@\=M#I-P9M2L[=+0&,9D=4((!'
M'#8[XXR,UL:WI5Q)XKM);$ 6VN6_V;4XV^5O+C^8/CKDJ7B/_71/2@#K9]0L
MK:Q^VSW<$5H%#^>\@5-IZ'<3C%16NKZ9?/<I::C:7#6K;;@13*QA/HV#\O0]
M?2L+XD@?\*U\0C (%C)Q^%86O>'+W5[W4-0T2Q:V/]C"T$4B^1]HD$JR"/MP
M%1EW=/WG!X- ';KKVCM \RZK8F*-Q&[BX3"N>BDYX)["D7Q!HKPI,FKV#1.2
M$<7"%6(.TX.?7CZ\5PFL::=9\-ZG=6OAC4[:]NVM(Y4O)#)+,(YE<C!=AM5=
MW)QG.!6CXHTR^_M)KS0(;F&\-HBB(P![2^!=R8I5Q\A!)._(QO/7I0!V$NJ:
M?#>):2WUM'<N0JPM*H=B>@ SG)J&37]&BN5MI-6L4G:;R!&UP@8R<?)C.=W(
MXZ\BN(O]#U6YT;Q/H$EK,UWJ&IFZLKQ1F,(S(RN6_A,>W&#@_(,9S4>M:-?3
M0>-/)TR=Y;V_M)+8K%S*L:P@D'V*/UQ[=10!Z97+:OXGDCUY]"TNXTU=0CM/
MM)%Y)A6.[ C^4Y4D G.#@8.#6Q9:N+W5;_3_ +'=0-:"-A),@"3*X."G.>"I
M!R!R*R?)N$^),UZUK/\ 8_[)6#SQ&2ID$K,5_(CV[=: +EKXBL8=*MKC5M8T
MA))4=_,AN0(F"DY*ECR !R?8U8_X2/0_,CC_ +9T_?)*(47[2F6<@$*.>3@C
MCW%<+H6B7D<7@F*\TF8+9/>"Z62'(B#A@F?8Y'3/O1K&AW<^G>-88=)F=K[4
M;62V40_ZU$6 $CV!C?K_ %% 'H5CJFGZF)387UM="%_+E\B57V-Z'!X/M1=Z
MII]@Z)>7UM;N^-JRRJA.3@8R?7BL/1[6:+QWKUW]EEBM+FUM%AD,9579/,W#
MZ@,O^16;J.GWT>K^+(KBPFO;76;.-+-HUW+E8V0Q-_<^8[@3A?F/.: .JGUO
M2K6[%I<:G9Q7)=$$,DZJY9_NC!.<G!P.^*OUPWA_0KFQ\61_;[9K@0:#969O
M7CRLD\3N7P3SGE#G^HKN: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MNDV[<[<YSC&>/KQ7":]H=U?7&L:A!I]Q):7VH:8Z6Y@;<WDR*9I2A&1E,+R
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M<.< 2!1D[@..<YSF@#JK+5K#4+6RN+:ZB=+V+SK<;@&D3 .0.O (SZ5=K@?
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ML:&<_9ID,;RQNQ22+YAU96!'^TJUZ%I%DVG:7%!(5:?F2=U'#RL2SL/JQ)H
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M98&B=I'E81C# ')++CZB@#T]55%"JH55&  , "EID*ND$:R-N<* S>IQS3Z
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ME=H+&ZN"AF^ZB7#1._T*D$UC^$H+(MJ.HV,&HQ+?2))*U]"8"\@7:2(RJ[>
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M!';?:&GB6$C(D9P%.>G->7)#?:7#YT>FZDFE6OB&ZDE@MK,[UB=3LD2-E^9
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MQ@Y H ]'6:)G9%D0LOWE##(^M$<L<R;XI%=?53D5Y?!9SJ+VTD6YN=,N+"Y
MNDLV2^LM\BEHG&,2Y)R.,G8>H.3U7@O[>B:I%?0VSLMRI6_MH#"MY^[4;RAZ
M,  IQQD<=#0!I:KX@MM/@U,0F.XO=/M/M<EMYFT[<,1DX.,[&[56_L^R\3V^
MFZJ\EQ:WJVP=6M+ID>-9 K%#C@@X7J.P-<WKUF(?$_BN4Z=,[WF@HMM-':LX
M9P)PP# '#?,@QG)R*R_[*O(2J:'8S6U[<>$I(C(L#1[KD%-H9L#]Y]_&3D<T
M >FZ?;VMK"T5JYDPQ\QVE,CEO]IB22>!U[ "K+R)&,R.J #.6..*XWP<FFWF
MI2:K96FJVT[6B6]Q'=VOV9$*G*IMV*'898;AG XSR*@\66VE3?$/PX-4M(IX
M);&^619(?,5L& KN&#D#)QGC)]: .X::)$#O(BJ1D$L ,=:/-C\T1>8OF$9"
M9Y(]<5Y1I?AF,7?A2QU/2Y)[-6U%5CGMV<16SMF".0D<?+C"MT/N*L2Z;>S:
M/J.F_9)8_$4>MB:SN!"0/+\Y2DBOC 18?D(SP%*]\$ ]/,L8E$1D42$9"9Y(
M]<4"6,RM$)%,BC)0'D#Z5P.DB&77+K3]:TB]DU>'69+RUN!!($:(L?+D$P&W
M:L9VE2?X<8.:SM#LYKSR89X-6A\5:>+D&1[?RX=[AAYAE" 2(Q*D#<3G''&0
M >E3+%>P3VHFZJ4?RV&Y<C]#6%I%[;Z5K-GX1LXM]I;::9(IS.&95C=(Q&1C
ML&'.<\5Q$%I<:AX9N9M'M-9MO$]MI$EI(DUOY"JQ RH<(HD8L"5()QG.1GFW
M*NFZAKDEQ9:7J5K8R^&;BUD:#3Y(Y(SN0B,97[X ; ]1CF@#TZ.6.9=T4B.O
MJK T/+'&5$DBKN.%W'&3Z"N6\%B_CEU.*]CMY@CQ>7J,%N8!=C;_ !1G@.N
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MTN+[3KFW*Z=)&'P8@[(NW(P%;WP.3WK5UK3-.LM=NM,N],O8]!U"P6.T&FV
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MQ5&@E7D $X+%/QQ7*S646Z[U 6;_ &V/Q=%)'-Y+;U@,D>]E.,["N_)'!&:
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MU.0P(]/RI-/TJ+3\OY]S<S$;3-<R[VQZ#L!] ,]ZOT4 %%%% !1110 4444
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M^ VT^APP/XU/7!?#FY@;4/%-M;V=] @U,2 W4#(3FWA!W$_QD@L<\\Y[UWM
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MTD5?,$XSE>&*]%+9W8P/PJ[HFNP:XEVT%O<0FUN&MI5F"@B13A@,$YQZ^XH
MC3PMHT:P*EH0(+EKN(><_P LS9W/][J<MS[GU-/N/#>DW;Z@T]IO.H(([O,C
MXF4# 4C/3!(_$^M8Y^(&G+,!)I^IQVPOCI\MV\*^5%,&V ,=V<%N,@$<C.*O
MKXKM#JUO8-:WB&YN)K:"5T4+))$I+ #.[&%;!(P<=>1D OPZ-86^HB_CA870
M@%N)#(S'RP<A>3TSS]:;?:'INHW2W-S;;IQ&8?,5V1FC/)1BI&Y?]DY%<S>?
M$,?V#+J5AH>HR1K*(1+,J)&'\_R",[\DAN>.OKUQ>U#QU::;)J23Z7J9.F11
M3WA1(R(HW#'=G?SC:<@9/H#S0!MQZ/80ZG_:,=N$N_)%N'5B (QR$VYQ@'G&
M*RO$FA76LZMH$T2PFVL+MKB?=.\;D&)T&S:.H+@]1TI-9\;Z1H;SBX9W2V\O
M[0T10^4'Q@E2P9N""=H/!IDOCBQANM3B>PU#RM,9Q>7(C4Q1 1"4$G=D@J1C
M ZD9QD4 :,WAG1KB*VCEL(V%M*TT1).X.V=S%LY);)SDG.><TVT\*Z)826DE
MI8) UF7:W\MV C+_ 'L#..>_L .@JWI^H_V@)"+6:$)MVF0H1(",AE*L016!
M-XJL-)EU^ZF35)19W<$%Q&0KK&SJ@4QKG[IW*3WR3Q0!J7/A;1+N:YFFL$,E
MS(DLQ#,N]TQM8X/4;5_[Y'H*=/X9T:Z74%N;%)UU$*+M969Q+M&%R">V!@]L
M4NDZ]#JUY?V?V6YM;JQ=%EBN N<.NY6!5B"",]\C!R!5#4?&ECI8UDW%G>_\
M2A8Y+C:J<QOG#KE^5X.>G0^E %J+PGH<%E;V<5B$@MYQ<1!9'!$HZ.3G)8#@
M$DXJU+H>G37CW<EN6E>1)7!D;8SIC:Q3.TD8&#CC ]*HZMXLM-&@GGN+2\DA
M@\@220JC@&5MJCALD@D9XZ,.N:K+KR3Z]91R6.L6UX]I<R1VDAC5) CHIW ,
M1NY7:<XPQYH OKX7T=(XXUM"%CNC>(/.?B8DDOU^]DDY]SZUE>(?" N[:"+2
MK>%-^JPZA=^;<2+O*,"Q! 8[B !GCH.>*ATSQ4FL:?X5OKNWO[.74Y284A=?
M+<^2[X?YLE=H..,[E' JW:>.;&ZN+6/[!J$45Q>RZ>)Y(T"+.A8%#AB>=C8(
M!'J0: +FH^%=-U#3&L6A"I)<+</(69I#(N,/NSDL   23C XXQ6EJ6FVFKV$
MMC?PB:VE&'C+$!AZ'!K&_P"$SL#-:+';7<L-W>26,$Z*NQY4+!ARV0/D?DCG
M:<=LZNHZK!IKVL3J\MQ=R^5;P1XW2,%+'&2  %4DDGMZXH $T?3X]4_M);9?
MMOE+"9B26*#. >>2,GD\\GUJ+4?#^E:M=17-]9I--'&T2L21E&ZJ<'YAP#@Y
MYYKGO$'C%O\ A%;VZTR"Y2[M[V*QN(V"![=VE13G+8Y5P5()'(/3-7]1NYO"
M7@[5M607UZ8(Y+M+>[F5VB&W.S=GE003U8\G!/ H O0>&-'M6A:WLQ"8;8VD
M?ER.NV$_P#!Z< _4"HCX/T$I9I_9R 641A@*NP*1GK'D')3_ &3D>U<_<>)K
MS3?%UW//;:E/:KHD=V]E%Y9,1$D@9_O!?NJ.-Q)[>E:^I^.=(TVU-P3).BVJ
M7CB(H&6%LE6PS L<*QPN3QTY&0":?P3X;N;2QMI=(@,5@NVV R#&O=00<D'N
M#P:T8='L+;4GU&&W"73Q+"SJS8*+G:N,XP,G QQD^M5]7\0V>C^&Y==D66>R
MCB$Q,"@L4.,$ D>M4;GQE:6:,+BQO(;@"1Q;2F*.1HT(&\;G P<\#.3SQP:
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M.-I;T3:0+WR+B,/!YODD 2KD9VXS@-^/6@"O!X=TJVDL)(;78VGQ&&T_>/\
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MHI$;R*:)G:*1$$>^(@@<JJC##&0#[58MM!U"VN/$TR36F[59!+!O4N(R(5B
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH ***A>[AC<H[X8=1@T 3457^W6_P#ST_\ '31]NM_^>G_C
MIH L457^W6__ #T_\=-'VZW_ .>G_CIH L457^W6_P#ST_\ '31]NM_^>G_C
MIH L457^W6__ #T_\=-'VZW_ .>G_CIH L457^W6_P#ST_\ '31]NM_^>G_C
MIH L457^W6__ #T_\=-'VZW_ .>G_CIH L457^W6_P#ST_\ '31]NM_^>G_C
MIH L457^W6__ #T_\=-'VZW_ .>G_CIH L457^W6_P#ST_\ '31]NM_^>G_C
MIH L457^W6__ #T_\=-'VZW_ .>G_CIH L457^W6_P#ST_\ '31]NM_^>G_C
MIH L457^W6__ #T_\=-'VZW_ .>G_CIH L457^W6_P#ST_\ '31]NM_^>G_C
MIH L457^W6__ #T_\=-'VZW_ .>G_CIH L457^W6_P#ST_\ '31]NM_^>G_C
MIH L457^W6__ #T_\=-'VZW_ .>G_CIH L457^W6_P#ST_\ '31]NM_^>G_C
MIH L457^W6__ #T_\=-'VZW_ .>G_CIH L457^W6_P#ST_\ '31]NM_^>G_C
MIH L457^W6__ #T_\=-'VZW_ .>G_CIH L457^W6_P#ST_\ '31]NM_^>G_C
MIH L457^W6__ #T_\=-'VZW_ .>G_CIH L457^W6_P#ST_\ '31]NM_^>G_C
MIH L457^W6__ #T_\=-'VZW_ .>G_CIH L457^W6_P#ST_\ '31]NM_^>G_C
MIH L457^W6__ #T_\=-'VZW_ .>G_CIH L457^W6_P#ST_\ '31]NM_^>G_C
MIH L457^W6__ #T_\=-'VZW_ .>G_CIH L457^W6_P#ST_\ '31]NM_^>G_C
MIH L457^W6__ #T_\=-'VZW_ .>G_CIH L457^W6_P#ST_\ '31]NM_^>G_C
MIH L457^W6__ #T_\=-'VZW_ .>G_CIH L457^W6_P#ST_\ '31]NM_^>G_C
MIH L457^W6__ #T_\=-'VZW_ .>G_CIH L457^W6_P#ST_\ '31]NM_^>G_C
MIH L457^W6__ #T_\=-'VZW_ .>G_CIH L457^W6_P#ST_\ '31]NM_^>G_C
MIH L457^W6__ #T_\=-'VZW_ .>G_CIH L457^W6_P#ST_\ '31]NM_^>G_C
MIH L457^W6__ #T_\=-'VZW_ .>G_CIH L457^W6_P#ST_\ '31]NM_^>G_C
MIH L457^W6__ #T_\=-'VZW_ .>G_CIH L457^W6_P#ST_\ '31]NM_^>G_C
MIH L457^W6__ #T_\=-'VZW_ .>G_CIH L457^W6_P#ST_\ '31]NM_^>G_C
MIH L457^W6__ #T_\=-'VZW_ .>G_CIH L457^W6_P#ST_\ '31]NM_^>G_C
MIH L457^W6__ #T_\=-'VZW_ .>G_CIH L457^W6_P#ST_\ '31]NM_^>G_C
MIH L457^W6__ #T_\=-3JP=0RG((R* %HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH *YCQ+/J4$<O]DVL5Q>N0L8G?9&O'WF(YP,=
MN2<?6NGKC_&>MOH&GW5]#97-[.,+#;V\32,[D<9 Z#N3_6@#G_ OBO4O$+:O
M9:S8PVNH:7<>1,8"3&^<],D^GKW%2:%XR_MWQIJVCP0*MG8P1NDQ!W2EN=P[
M;2",>O7O6!X>^V:WX;U33M)T^^TN[DD6>ZO-7MC']KDD;,GR@]"%(X/ ('O5
M/PW9^)-)^)'B;4=2A6>-+*-I&M;5U6YVQC:L.3C(Q@C/6@#U<YP<=>U<!HGC
M'6=9U[Q%II?3;4:3<I;I*\$C><7=D7(#C;R!Z]:Z[0]5.LZ);:DUG<61F0L8
M+A=KI@D<C\,CV(KRKP]I<#^./%=YJEKJ$$1U.&[LIA;3;9/+E9C@*,-D8'.>
MN10!Z=:ZW';6ME%KMU8V6IW&5\@S!=[!MOR!CE@>,?45=?5=/C2Y=[ZV5;5@
MLY,H'E$] W/!Y'7UKB/&EI=>*_ ZZUI]I<6^I:;<F\L4DB*RD1N1RIY&X#<!
M_NU6\<Z=K \*Z1J$=K-+<PZI#J.HP6J[W]< $'=L^51D=%!(XH [J37M'ALE
MO9=4LX[5G,8F>=57>.JY)Z\'CK4?_"3:&;6]N5U:S>&Q'^DLDP;ROKC_ ":\
MR\::3%<?#^_ET:#5[QM2U*.Z=9[9@SMCYF6,("!P.<8/:K;:==S^-O'HMK&X
M$-[HZPVK>2RI*XA"[5)&"<\4 =OI'C+1M7T2'55O8(897V!9)5W*23M4CLQ
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P!FP_WG_,?X5:10B*@Z*,#-.HH **** "BBB@ HHHH **** "BBB@ HHHH
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M\>G3V5J$,MW?2&.WB!QN*J68D]E !R>>W!S7.WGC>4I:)8V!^U'5UTR[AE<
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M26]K;?:9ILA%VY(VH3PTG!.WCCZBLG4)IF\9:U$EW<K WAY)U19W 1]\HW*
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MUMIEZR3^%6MD::RD0-,"Q"?,H^;TS^%=UX6,?_"+Z8([>2W"VZ*8Y(3$P8*
M<JP!'.>HH TQ/"T[0"5#*HR8PPW >N*07$#-M$T9;:6P&&< X)^F:\QMQ(_B
MG1[AM'O[>.+5K];J'[%*ZJLB2@.TA!WASM;Y3L4$#L#47AG2!9)X'E72+B"=
M+B[2[<V3JRQLDH42';PI.S&>.E 'J@GA*AA+&5)V@[A@GTIY( ))P!U)KAM
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M)(EE2:-HV. ZL""<XZ_6L/QJQ7PO/_Q+Y+Y?-AW11J[$+YJY<JGS,%^\5'4
MCO7!36,D\.HPRZ;?SJWBFSNXV?3W7,)$&]P O ^5\]QWY/(!ZRL\+Q&594:-
M<Y<,"!CKS65HFO'6+_6+;R8T73[E8%DCE\P2AHTD#=!CAP,<].M<%=6MSIVI
M:H;32KH:+%XAMKF>W@M'"O!]F169$ ^=1* Q"@_=S73>#41==\5R0V<]O;W%
M_'/"9+9X5D!MXP6&X#/S!LT =9+/#",RRQQC_;8#VHDGAA9%EEC1G.$#, 6/
MH/6O/]<L=$NOB5?1:OIRW<,NA1DI]F,NYO-D'  /SXX!Z^E<WJFFZM#X/ETF
M\TV^?54\-PQBXC@DG,SJ7/E!AE$*'&3]YB1@\#(![+YT6YE\U,H,L-PX^M-^
MTP>8D?GQ[Y!E%WC+#V'>N(UO3[B/Q%;7NF6Y6/Q' -/OLKL=" 768@\Y$?FC
M!YSLSTK(\30.NHW\-IH]Y";74-,DC-O9R2B:)'BRZL 555&Y=B8/!)SDB@#N
M=%U_^U+G5+>>*.VDLK]K-%$V[S<1H^X9 [/TYQCK3M.UM[[7M9TR2V6(:<8@
M)!)N\P.F[)&!MQZ<UP&J>'UU"/Q7;C2Y1KESJJ3Z9<M;,&C'EPA9%EQA55E;
M.#V([@&YK<&IG4?%\MG8WLH,^G2E(X#FYACVF58RPVN=H(QSGIWH ](BFBGC
M$D,B2(>C(P(_,5D?V_L\67&BSPQQ1164=VMP9OO;W9-I! P<J>YSD53\(PV#
M/J.HZ?#J*)?2))(UY 8-\@7:2L95<<!03CDCOBLG7]+T^Y\=W,NM:2][83:,
MD,>;1IE:02R$J, X?:PQT//'>@#N?-C\SR_,3>.=N[G\J5'210R,&4]"IR*\
MU&BZSX=TCPOJL423:W%:)I5XKD$NL@ 0EN_ER!,G^[OKT+3K"#3--M[&W7$,
M$8C7WP.I]SU- &-J'BZVACM)=/$5[%+J<>G2LLV/+9GVDC@[L'(QQTK?6>%H
M3,LL9B&<N&&T8Z\UY6=-,>EM8MI%T&7Q9YTJK9/M: W#.&R%PR;#G(R #BGS
MVUYIO]K-9Z9?+IEOXC2YEM[:T.7MS;*I:-"N' EPQ !^Z30!ZG'(DL:R1NKH
MPR&4Y!_&N?;Q%?/XHO=#M=,ADDM;:.Z\Q[HH'5RP  V'!RA]NG-.\(VEE;:;
M<R:?%>QVUU=/<#[7&8V8L!N81E5**3GC YR>]<[=V\,OQ+U>>]AU=+1]+@@2
M>TCN4#.'D+ -$.2 R_G0!U>@^(K37M$&J1A[>-7>*5)R 8G1BK D''!!Y!Q6
MIYT7EK)YB;&^ZVX8/T->5Z#8ZSI>G^'C?6$_]B6>J706$V_[U;=E86\LL:C.
M0Q))QD;@QY!-+<:$Q>T\W39I=.D\4&XMH?LK-Y5LT1#DKCY$:3<<' (/H: /
M41<P'9B>,[\;<./FSG&/K@_E2BX@9I%6:,M']\!AE/KZ5P%MX9M%\7>)$L='
MAMVCL;7^S)6L]L4<R+*-R-MVY4E.1S4>C:?+=MX,,-A/:WEA"\.K":!E^3R2
MKHY(P^Z7:PY.>6H ]#%Q"Q4":,EON@,.?I2-=6Z1B1YXE0G:&+@ GTS7EPT3
M6M&:VEL=,,H\-:@\-FNT9N[:X(^4'L(UD7GU0^E:&MV"Z1JUE:W]M?W&BS::
MULTME9^?BX9R9"Z!&(\P$<@=10!Z&\T4;!7E16.,!F )SP*?7GFE>';'_A.H
MEN-'F>W@T6U6*2\@,FV6.1R,R$;3(J[.<Y]Z]#H **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MCD=&,)X9<_(2 3M8J02,GGIQ7.^)6N4^)?A)K6&*67[+?_++*8QC$7<*W\J
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M)E\@*2 -N1\U '77E_9Z>D;WEU#;K)(L2&5PNYV.%49ZDGM5BO-/$&J76OZ
M]\LZQVMOXCM[06VP'*QWD:%B>H8L,^FW QGFMO\ MO4X=?U70I[A/MCO!)IC
M"(#= ^0Q(_B*%9,]. O0F@#L**XB[\2:E;:_:Q1SQ3VTNL#3W6./,:(8B>6.
M#YH89.W*@<'!JI;^)M?\RWN9[JT> ^(9-)>!+8KNCWL@;=N)!& ?S_  ]"HK
MD])UG4]8M8-:@N;9+'[7/#/:2+R(T=XUVD<^8653@\8;&,C)IZ9KWB74].L=
M9LX;:2TOK"2<0SNB!)2F^)4(.2,@JV[![\<B@#N**YGPGKS:R][%--<+<VPC
M$UG=V_E3V[D'.['#*<?*PR#@\FK'B'5+O3=1\/I;NOEWNH"UF5ESE3%(^0>Q
MR@_,T ;U%< _B?7#'&D,]J'/B-]++R0%LQ $@\,.>.?7VIUKXKU,2II-Q-$]
MY)KDFF+=B+:!&L7G;MN<;\?*.V><'H0#M;2_L[XSBTNH9_(E,,OE.&V. "5.
M.AP1Q[U6N-%MKK5X-2FDN6D@3:D/GN(<@DAC'G:6&>"1Z>@QPNE:K=:-?ZS:
M>89KC4/$YM!,%52!]CC<'!(7<0FWTR<X[5?FU7Q;%?Z3I<MS8V\U[>7, F,(
MD?RUA:2-V4, 'XY4<' /0XH [RBHX%E2WC6:19)0H#NJ[0S8Y(&3CGMFN,MO
M$FIOXETRU$\$]M?W-Y 7CCS"GE!BFQCAF8!</U7)(!&* .WHKSW0_$NO7;>&
M9[VZM7BU>>ZMI(HK?;L,:RLK@ECS^[QCI@^V3H:-KVJ7ET-%NYXQK%K?R)>;
M(@%-LHW+(J]@RO$.O5CZ8H [*BJNI7JZ;I5Y?NC.MM \Q1>K!5)P/RKE;7Q!
MJOVCPN\LT4T'B"!MP2,#[-)Y)E4H>Z8!!W9/0Y[4 =0NK:<^H_V>M[ ;S!;R
M!(-Y Z\>V1GTR*N5QWPYMW?PO'<7,HGD^VWI1FC&Y";F4,0>O-3^));Y?%OA
M2WMKYX()[B?S8U4$/M@<C.?QX]\]A0!HV%KIE_K4OB&QOOM,K1?8F,4BM'M1
MB=O ZABW?/:MFO,M%U'4M)<2PSPFRNO%5Y9RVYB^8AYI/FWYX(('&/7\-O2M
M<UO6);/4K1(AILEY+!<1RE%"1J[(I4@[O,W*N01@Y(&.,@&\-+L;'5+K6IKB
M?S'7DW%RQBA7 !V*3M3.T9(I\'B#1;J6**WU>PFDE.(TCN48N>O !YJ[/_Q[
MR_[A_E7!?#47\O@?PVMU:60TV.P\Q9?.+.)%*["05 7C?T)H ]!J*YN(;.UE
MN;F5(H(4,DDCG"HH&22>P KSY/'&I6"S7-WY=[ -!FU7=$FR-Y(V48B)PQC(
M?@L,G ()!K8U2]UW3O#^JZBNH:?<Q+I+W<&^'GS54LV%! ,1&W&22">2: .C
MCU2PFNUM(KR![EX?M"Q+("QCR!OQ_=Y'/O4EG>6VH6<5W9SQW%M*NZ.6-@RL
M/4$5R%O+-<^/]*G#(L\OAN5MQ7*AC+">F1QGMFLW2-8U;6KGP+<27P@%]8W$
M\\,,2A"ZA,$ ^SD>U ';OHMM)K:ZK))<O,B!4B:=S"AY&X1YVAL,1G&<&I[O
M4K*PAFFN[N&".!/,E:1P B^I]!7+Z/KVJ7=W_8EW<1C6+6_D2[*1 *;8#<LB
MKV#*T8Z\,Q],5DVFN7\/P?U#Q/"T7]HS_:+MS-'O4GS&4+C(^ZBJH_W1UH ]
M(I'941G8@*HR2>PKCM1US6[O4M8M-$2(3Z5)"NR8H(Y=R+(Q<D[E&UL J."I
M//0/A\1W:^,5TK4&DL_-G=;97A#07<0C)'ERCI(",E6(X!P.] '6HZ2QK)&R
MNC %64Y!'J#3JY;PI<R+KGBC2.MO87ZM!Z*LL22E1[!F8_C5O6M4N['Q'X<M
M(77R-0N9H9U9<G"P22 @]CE!^% &]17GT?B;7[@Z9!#<VB/<ZY>Z:\DEN6.R
M(3;&P& S^[&?4^E+IOBS5WU*'P[?20_;SJT]BU]%%M5XXX!,&"DD!R&5<<@<
MGGI0!Z!17GTOBG74F_L]9+47%OKZ:9).T!*RQ/&)%; 888!@"._;&>.A\*:E
M?7\6K6^H2QS3:?J,EH)DCV>8H5&!(SP</C\* .@JO9W]GJ,32V5U#<Q*[1EX
MG#*&!P1D=P:YWQ-+?+XJ\*06U\\$,]W.)4500^+>1AG/TZ>^>PKG-(U'4M)D
M>:">'['<^*[FSEMVBR6$DKC=OSP0<<8]?P /3:*XW3-<UO6)K74;-(AIS7TU
MO<1S%%"QJ[1@J0=WF;E7((P<D#'!/94 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 8#>"]!:[
M-R;.3S#=F^&+F4*LY!!<+NP,Y.0!@YYS4B>$=%CBAB6VE"0WC7T8^U2\3DDE
M_O<Y+,<'CDT77BK3;-Y6E,OV6&X6UFNPN8HI20 K'.>K*"<8!."1SAT_B:Q@
MO%@VSNGVI;)IXX]T:3-C"$]>X&0, G!(- %<^"= -RTXM)5)NA>^6EU*L8G!
MSY@0-M#9Y) YKH:Q5\3V,EY!!%%<R+<22PP3K'F.62,'<H.>/NMR< X.#3+3
MQ;IEZFDO#YY355D:V8Q]=BEF!'4'"F@!8O"&AP&W\JUE46URUW HN9<1RMNR
M0-V /G;Y>GS'CDU'<>"M NK&6SFLG:*6Z-Z3]HEWK.>LBONW*?\ =(JFGQ"T
M9[ 7_P!GU(6;.L:SFR?86:7R@N<==W4>_KQ5FY\9Z=:6,EU/;WT8AB,]Q$\.
MV2"(,R[V4D'!V,1C)(&0* -JPL+;3;..TM$*0QYP&8L22<DEB222>222352_
M\.Z;J6IVVHW,<YN[962&2.ZEC*!L;@ K <X&?I67<^/M%MC>'%Y+#9B)KB:.
MW8QQI(,J^>ZX(.1^&<&K]_XFL=/FF219Y$MY(X[F2&/<L#2$;0W?^)3P#@$$
MX!H C?P=H4EE/:M9$K/.ES)+Y\GG-*I!5_-W;]PP,'/%(O@S04)*VDH)NUO3
MBZEYG48#_>Z\?B>3S3KGQ;I=K?PVTKR!9;H62S@ QB<]$/.<YXSC&>,YXJ_?
MZG!I[6\<@>2>YD,<$,8!>1@I8XR0!@ DDD#B@"@_A'19&E9K:8F6\6^?_2I1
MF=<;7^]U&U>.G JYINBV&D/=/80M#]JF:>9?-=E,C'+,%)(7/L!7/Z]XQ"^&
M6O=)29IOM\5A,I0![=VF2-PP)^]AN.HY!Z<UKQSCP_HEQ>:C>7<\*OYBB= T
MD88@+'\OWL$X!.>O)[T 7;W3+:_FAFF\Y980PC>*=XR V,CY2,@X'7TJ@OA+
M1$9C'9M'NLQ8$)/(H\@9P@ ; ZGD<\GFH)O&>EVT<IN8[N*2&^CL)8?)+LDL
MFTIG;D8(=3D$]?7BFMXVTR.RN+J2"]C%K>)9W$;P[6AD?;L+ GA3O7YNG/.*
M %G\">'+B)HI;&0QM:+9.@NI0'A7.U6 ;YBN3@G)'8U<?PQI,DUU*T$IDN[5
M;.=OM,OSQ#.%^]_M-R.>3SS5V&^CFU"YLT23?;JA=R!M^;) !SUXZ>X]16=>
M^*]-L&G:8R_9;:=;>YNE7,4$C8P&.<_Q+D@$#/)'. #4LK.#3[*"SME*P0((
MXU9RQ"@8 R22?QK.N_"^D7TNI27%O([:G"MO=_Z1(!+&,@+@-@#YFZ8ZGUK'
MN+_4-7\:7^AP37MA%9VMO/'/"L9&]GDR6!SE2(PH&.YZ<$:=UKKKXM@\/):7
M \^RDN3=)MPF'11@$]MQSD>G7G !)-X6TB>4RO;R!VMQ;2%;B1?-B'19,-\X
M&3][/4^IJS_8FGC6(]56WVWD< MU='95\L$D*5!VG!)QD<9.*YGP/XO6_P!#
MT*VU-[EM0O+-IOM,L.V.9EY< \#(!!Z8].E;5CXKTR_U.WL(VD62Z@:XM6=1
MMN(UQDJ0>VX'!P<'.* -/4+"UU2PGL;V$36TZ%)(V) 8?AS5/_A'-*:UNK>:
MV-REW$(9S<R-,TD8SA2S$G R>,]23U-97B+5+S_A)])T& 7<,-[#<227%ML#
M@H$ P2>@+Y/'8=1D59L?$UDD>G037$\RW+_98=0>,+'<S*""!CH25;' !QP3
MQ0!>T7P_IWA^W:#3HI55L9,L[S-@=!N<DX&3@9P,GUJ74M'LM6:U-[&[FTF%
MQ#ME=-L@R WRD9ZGKZUP\FM:NFCW<O\ :<YDA\4QV08JF6@-Q&A0_+TPQZ8/
MO75WGBO3;%IVF,OV6VG6WN;I5S%#(V,!CG/\2Y(! SR1S@ +OPEHE[K8UB:S
M/VW"J[I,Z+*%^Z)$4A7QVW UC>)O!-O<0SW.D61%_<WUM<S#[2RQ,8YD=GV$
M[-Y5",@9.>O6M.X\8Z=:QWTDL5THL;N.SN/D&4=]NP]?NG>OS=.?8X-<URTM
MX)4EFO[00WMM;M-;QALN[(53)! 4[E!) X;CF@!][X-T/4KBZN+JTE+W;QRS
MH+F159TV[7VJVT,-JC<!G QG%/N_"6BWW]H_:;:5_P"T0BW?^E2CS GW>C<8
M]L56NO&^DVEU>021WN+*YCMKF46S;(6<+M))_A^=>1ZYZ<U/J7B[3-+:\\_S
MWCLGBCNI(H]XA>3&P$#DD[EZ XW#.* )-6\*Z1K;VDE];RM-: B&:.XDBE4'
MJ-Z,&(..03S3+SPAH=].LTEH\<@MOLA-O/)"'A_YYL$8!E'8'.*TKO4;>QL/
MMERQCB^4 %2&+,0%7'J20,>IK$;QQI4:S^8ERDEO=Q6EQ&44F%Y<>66(;&UM
MPPP)'KB@#=L;*WTZQ@LK5"EO @CC4L6VJ!@#))-4KCPYI-W>W=W<68DEO(!;
MW(9V*2H,@!DSM)PQ&<9P2,TZYUVTM9)XY5D#12I".!^\D<;@B\]<$$YQ@<GC
MFLQ?'>CLL.!=F62]>P,*P%V2=5+E#MR/NC(()![4 :VGZ+8Z8^^W20R>6L(D
MFF>5@@Z*&<D@<T_5=*L];T^2PU")I;:0@NBR,F<'(Y4@]0*P;CQQ!]ETZ:SL
M+N8W>HG3WC90CP2+NW*P)'.%.,<=\UKVNNVUY>>1!%.Z>=);^>%!3S(\[U/.
M0001R!G'&: ([CPOI-U)J$DT$KMJ%NMK='[3+^]B&0%/S<?>;I_>/K56X\#>
M'KKSO.LI6$T4<4H%U, ZQ_<) ;EEP,-][WK2OM7@LKI+18IKF[>)IA;P %_+
M4@%N2 !D@=<G/&>:YW5_%8ND\.?V1]HFL]8N61IX %?8L4C%1N(*MN0 YZ -
MWH U)O!F@S^?YMI*QGN([EV^U2AO-C ".#NRI  '&.!3G\(:(^M_VP;1A>G9
MO99Y LI7[I= VUR.Q8$\#TJ?[2-!TNTAO[R>]N'<01.R+YMPYR0,# S@')X&
M 2<<U@^'?$LF[7VU*:Y<QZTUG:PRJBR#]S&WEC&%X)<YSC&3G'- '9$!E*L
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M(K273K;[7< 7O]GQWLR"-ON%1E@ .1G/2B?QAX?M_L_FZI"#<0+<Q  DO$Q
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M);FVNKJXE9E61TE25\84GG;M&>@QZ5M?\))I#6D-U%>K-#,C21F!6E+(N-S
M*"=HR,GIR/6H;SQ?X?L(X'N-5MPL\!N(BI+^9&,98;<Y'(H P=4\):O?6_BB
M.-K%3J]W;SPEIG^01K$I#?)U/E]O7VK#U6Y$WBC7%C?0I(FN(!<6%WJ#VTDT
MD2(5.P(Q?YL $8W!0""!SZ/#K%A<7@M8IBTI+A<1MM8H<, V-I(/!P>#535M
M<L-)U?2K6X@E>XU"5XHGC@9]H6-G)) /]W&/?/0&@"+Q'I-SXC\,B"W=;.]W
MPW4/GKO5)4=7"N!U&1@U N@W>K>'-0T[78M/@:]B,1CT\$I'P<.&8 ELG(XX
MP/J=,Z]I8O4M#=J)7E,"$J=C2#DH'QM+<'Y<YX/'%3:EJECH]I]JU&ZCMH-Z
MIYDAP-S' 'XDT <U?^%=4N?"^FQ)>VTFNV=RE\\TZ$PSS8*NK <["K,H[@ >
ME/GT'6;QM#GG33(I;+4?MDT4#,$5?*>/:IV98_/G) ]/>M6V\6:#=VUW<0:E
M"\=I(L<_!#(S$!1M(R=Q(Q@<YXS3CXGT<11R&\PLEU]C ,;@B?\ YYD8RK<C
M@XH YW_A$M86(.CV/GQ^('U:-3*^UD8,"I.S(8!O0CBK=GX6NX/%RZVHMK-F
MEF-V;25]M[&01&)(B H=<J=V2?E[YXZ>*\@GNI[:-R9;?;YJ[2-N1D<XP>/2
MJEUK^EV5Y]EN+M4E#1HWRL51I#A S 84L>!DC- %"_T:^3Q=;^(-.:"1OL;6
M5Q;SR,@*;]ZLK!6P0<@C'(/M69;^#[W3XO#<5K);2+IM]/>W)D=DWM*LH8(
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 <9#8WMIKOC."!(6N=1B2[LA<#,<A\D1%6]0&09'HX]:C
M\-:=JFG>(+K5-2LVM;:72K>*22:Z1RDD32E\A>%'S@@+A0/3I7:M&CNCLBLR
M'*DCE3C''X421I*FR1%=3@[6&1QS0!SG@.PGL/"<(N$:.2XGGN_+88*"65Y%
M!'8X89'KFNEHHH YWQ3I]]=W.@75C;BX-AJ(N)8_,"$H8I(\@GC@N#],USTO
MA_66L[Q!IS[Y/$T6IH/-CYA62-B?O=<(>/<5UVL>(++1+C3H+KS"]_/Y$6R-
MF (4L2<#T4_YS61H?B^&:^O['5[VUCNTU26RMD12F]0%V@Y)^8Y/4\D<4 4-
M+T'4K36)[*]T&TN[4:E)?VVIR3*=@>0RX,9^;S%+$ CCH<^NUXXT^\U;P9J6
MGZ? 9[JXCV1IO51G(Y)) Q6C)K>FQ7\=C)=HMQ))Y2 YPSXSL#=-V.=N<X[5
MF>+M:U#18M):P-KF\U*"R?SXF?:)#C<,,O(H P/&6C>(-<&L6]MI@:&ZT^-+
M9EN$B(D5F++*0<MU&T9*C)Z$YJY?Z1JUUJOB6Z73V"ZAHL5I#B5.95\[(Z]/
MWHY]C[9OV?B2XB\6WVA:BUI(EO8K?&\@!C6-2Q4I("S;3QN!SR,\#%:!\4Z(
MMI=74FHQ10VJ+).TN4V(PRK8(!P<'![XXH Y@:+K=K=6$\6F&;?H']FRKYZ+
MY,H((+9/*GGE<GCI4GAG0]6T_5?#LMY8&..R\/C3YW$J,%E!C/8Y(Q&>0.XK
M3UWQ9;Q^&?$%WHE[:S7VE6CW#(REP,*S#(!&0=I (...^*V;+4H+EQ;B0-=+
M$DDJ*I^7<,C)Z#/- ')>&M!U*PN8+#4M!M)%L;B22#5VF5]ZDL5*I]Y9,-M/
M;J<GI6UXKTZ\O1HUQ96_VAK#4H[J2)7569 CJ=NX@9^<'DCH:MW&K6]MKK03
M:K:111633RVS+B10& \PMG 4 XQCJ<YXIVG>)-&U:Y6WL-1@N)F@%PJH?O1G
M'S#U'(SZ9YH YF^\.Q/I7B>YU*>/37U2=;J#<XS;/%&@1\C@ONCWG&?3FNC\
M-6]W#HL,VHJJZE=_Z1=A1P)& ^7Z* JCV44:X^A(+>36HK:4V[&XA\V'S6C*
MCF0#!(VYY;MD<U+<^(-)M(4FFOHA$T0G\Q2641'I(2,@)_M' ]Z .0\3Z+X@
MU*^U)8=-66'[797%J\=PD2ND;QM('&06?Y6QNX  Q@]6W?A_6IM-UV)=-;S;
MS7[>_B FCP8D: L<[NO[IN/<>^.KOO%>@Z;++%=ZK;1R11K-(N[)5&SAB!VX
M)SZ#-%]XJT'39'CN]4MHY$B$[+NR1&>C8';O]!GI0!B76EFX\?QR65Q$;.[A
M675( <GS(&'E'CH23@YZB/':MWQ1H47B;PQJ.BS2&-;R$QB0#.QNJG'?! -1
M&[\.>'TFNT^QVBW?^E3S0Q@!P?\ EJY4=.?O-Q[U:N]>TNQD5+F]BCSLRQR5
M7><)N8<+N/ SC/:@# U.UU[6_"$N@36'V>[NK?[)<WAE1H%4C:[H =YR,X!4
M<GG'6JS^'+[3[W7+:ST[[39:AI=O8VSF5 L9C21,2 D'&'!^4-P#6E=>+["6
MSUU8-0CT^33)/(>ZNX6,:OM5LXXW#YP,9YZCBM>^UO3=,<I>WD<150\A(.(U
M)P&<CA 2" 6P.#Z4 <S:^'K_ $S65$5O)<6L'AZ/34GWH#)(A/8MD9&.?6L2
M*RU73!X8L[33I)=7L-!^R7D4-S#O1#Y:@X<[2"T;$$'^'D=J[F_\5Z#IDT\-
MYJMM%+ BO*A;)16S@G'0<'GM2:[8>'9[3^T]<LK&>"U0O]HN(5D\M.YR0<#N
M>U ',Z!IUSI^HZ9J>FZ7='3HM+.DO9/-&9K=XI#AL[MC \@D-V7CKA=!\*ZC
MHFI^&0UOYD%C:7J3R(Z[8WGD20*H)!(7:5SCT_#K(-7TI)?L-O,B/#;+.(4C
M(VPXX8#'3C ^F.U49_$MC;W-U<MJD#V=OIXNWMHX6:95R3YF0?ND8 &WMG-
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M8&0V J[#U(^]TXKJ)=3T+6-'D:66&ZTZ67[+(&0LCN6V[",<_,=N/7BJ":W
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M81B#QD@G/'6@#FO[ UFUOY;^WL T5_K#7=Q;1RHDT,?D"(%7)PK%ERQ4YPV
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M_P!#<1W//^J8XP&]#R/S%5%\06-O-J4E[K.G?9H+E(%"G:86*K^[<EB"Y8Y
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MS9AXX8DC$;<CU%,'A_6SX,U*"&P,6H#6Y=1A@>94^T)]J\Y5WHQVDJ ,DC!
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M8ZD-.&J69O3(8A;B92^\+N*XSG('.*TJ "BBB@ HHHH **** "BBB@ HHHH
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M!4D'YC6O9:%);>)?#LL&A-:Z?;V=ZLB%U<0-,\;*&RQ))VMG&0"<9(YKN:*
M,GQ1%=S^%]3AL;*"]NGMW6.VG *2DC[I!X/T-<8-%U"ZN]?>\TG5S;WZ6#QS
M"XB2X5XV.7&UL*R'#@ 8PN.^*])HH PO"D&JV^E2QZO)YTHN'\J=HUCDEBXV
MM(J\!^OIT&0#FN3U"T;4==\?Z9%IS74U[:6\$9PNW<T+ ;B3\H!(;/MQSQ7I
M-4[;2K*TU"ZOX(BMS=[?/?>QW[1@<$XX' H YOP]H]WIOBK5);FUDD@-A901
M7;!3YK1"0/CG(^\O45CZ!HFJVDGA W.DSI_9[WYN"2A\KS"VSHW.<]LX[UZ1
M10!YEI&G:_H*Z'J']BW-S':OJ$%Q9QO'YJ+//YD<B L%/"@$9R WUK<&EW4?
MB?PS/!HZVEE:6EVDJ0; EOYAC*+@'K\ISM!&:[&FN@DC9&SAA@[6(/YCD4 >
M6>$=+GU7PIX%EM+ POI8>Y>>0!593$Z[ 1R=[,I/LISS@&[X<T[6K?6]+OKK
M0[JW2/1)K.9%:$1PR[XV"1HK\)\I"]SQGUKO=-TVTTBPBL;"'R;6$8CC#$A1
MZ#)/%6Z ,#P/976F^!]%L+ZW:WNK:TCAEC8@E648/()!KF;_ ,/:O<Z-XG\/
MO:R/)J>HM<VE\K+L5'9&!8YR&CVXQCG:N,]O1:* .9\-:?<VNN^)KBZLGB6Z
MU!9[>5]I\Q!!&F1@DCE6ZXZ^].\6:;+J L3 =0@GAD>2*^L2I>W?;@;D;AU;
M)!&#VZ=1TE% 'G/]G^(8;F&YN]),]Q=>'OL$GV0HJ13AF.""W (;^'/0@=JL
M^&]'U&WUS0);W2I8H[;PZEE*[F-@DP9#MX8]E/(XZ5WM% ' >%M(O;>XLK#5
MM!N6NM+FD:/5)+O? RG< Z+OR'8-@C: ,GGL:L.CZE8_"_3?,M&M-:T K-;"
M1U/FNA(*@J3\LBLR>OS=.E>DU1N]&TV_U"TO[NSBFNK,DV\CKDQDXSC\A^5
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M59%YP2H?..N">]>D44 ><S>'=1_M6*^2PE:"X\2)J1@RO[B);<QEV!/5G^;
MR>1WS4,NCZY;23:A%I-U,D'B">]-I'.L4D\$D13>A##Y@23M)&>?6O3** ,C
MPY9QVFFNT6F/IPN)GG,$LF^3<QR6<AF&XG).">OKFN6U+1-5D@\::4UB]TNN
M9DLKG<NQ2T*Q[7R<KL*!NG(Z9/%>@44 <GX7TJ[L/$?B"6[MI-DTEL8+J3:?
M.$<"QLW!)'(;KCK76444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%9Z:FL^MRZ;  S6T:R
M7+D\)OSL4>YVD^PQZBGG48KB*X&FSVUW<0?>B68'!_NG&=I.#UH NT54TS4;
M?5],M]0M&+03H'7(P1Z@CL0<@CU%6Z .6\:KN;PY@9(UNW/Z/6"V@ZM/H%YX
M>FM9?MIUK[9!J QL,9N1-YN[/#!<KMZY [<UV=W9:/:7_P#;%X8H9OE EFF*
MH" 0#@G;NP6&<9P35F75-/@B66:_M8XWC,JL\R@,@ZL"3T]Z . UK1M1NH?%
MD::7/*+W5[&>!=@Q+'']GWMR>@\I^O7CUI^NZ-J=VWC$VNG3N+M["6W  7SO
M**%]N2.0%QSC/:N]74K%Y((UO;9GG7?"HE4F1?51GD>XJ:&XAN Q@FCE",48
MHP;:PZ@X[^U '+QV$U_XYOKF[TZ9=/N]&BM6\T J6\R5F0X)_A<>W49IG@C3
M[ZWAF&H2B8:>SZ;92YR7AC<_.?\ :.%5O>+/>M[5O[)O(&TG5)K<K=C9]GDF
M"-("> .0>H[5BW6N)I^J+X9T"/3Q=V]H)TMYI=BL-V!$,<AB QS@XXX.<@ 7
MQ/HM]=:SIM_IJ*7D273[TD@8MI!DOSU*LH('^T?6J&D:%J=AX4U6QO8VFDMK
M:;3M/ .YI+<;O+/LS HI_P"N8-=3JVMZ?H=M#/J5S' DTT<";F W.[!0!GZY
M/H 3VK-L/%,,^NZKI]Y)9VT=M-#%:N9Q_I'F1AQC.,GGH,_C0!BZ/8:EIVK^
M'+N73;EHHO#_ -BGV;<PRAHB0PSG^%L8SG%4_#.BZC81^ XYM-FA;3K2XBO#
MM&(F= !D@\Y8=L^IKT":_LK>YBMIKN".XEXCB>0!G^@)R>AJ666.")I9I%CC
M099W. !ZDF@#D_%MMJ-SJMNEKIDL\$EA<PFYM]GF*[;,1DL1M1@"21SE1R.^
M-HNE:A'<Z3+=Z1<((/"XL9-Z*Q$P*_)P3U"GVYP>>*[LZQI@MY+@ZE9^3$VR
M23SUVHV,X)S@'!!I9M6TVVB$L^H6D49C\T.\RJ"F0-V2>F2.>G(H X/^R=5T
M[P?X/O;.,6^O:=;P:?)%-_&LBK&ZG'4*P63_ +9GUKL-1T=V\'W>BZ;,896L
M7MK>5CRK%"JL3ZYYS3;F/P[#JT6N7<MDEZ+?$5S+,!^ZSU&3C'SD;A_>QGFM
M'^T++[:++[7;_:B-P@\P;R.N=N<T <=9:7?ZC?>&;AK"73Y-*LIH+M9  "S1
MJ@C4@_,NX;LCCY1W.*HZ#I>IPQ^ DN](N8CI-K+!=%U5A&WDJ@(P3D%@<8^O
M KOXM0LIY9(H;RWDDB!,B)*I*8X.0#Q3(]6TV6!IX]0M'A5Q&TBS*5#'HN<]
M>1Q0!YSI^F:SI%IH=W)HVH7%O;/J$%S:6LOES1B:<21R* ZAAA0",\;O8UKZ
M9H L_%6BF+0WMM-@TJY@\MB)! \DT;JI))YVJV<$@$XSBNEOO$VC:?I4^I3:
MC;&UA?RF>.56_>9QLX/WLGI5LZKIPEAB-_:B2< Q)YRYD!Z;1GG.#TH YKQP
MR)JGA!Y(&F5=9R45-Q_X]YN0.^.O'/''-8,V@:IIUU)K5IIEU-9OK<MZVFVT
MOE3")X!%YB_,/FW MMR#AN<'(KI-4U#1=9>[-O=64NI:'(7C-Q=M%%#-LZL5
M/0!\$X.,D>M=#/J%G:&);J[MX'EX19)0NX^V>O)H XF+0PNN>&Y[?0)[:R2>
M\GGCF;S&B,J8W/EFY9LD@$XSSWI)=&U<:[.NDO=6UM=3W(N(+I T4!,;JMS!
M)U4D[<IS]YN!C-=K<ZKIUDS+=W]K 4V[A+,JXSP,Y/?M3YK^SMIHX9[N"*63
M 1'D"LV3@8!///% '$:5I6H31^#5FT^:RGT&-EO&(&T@0&+8A'WP[;6X[+S@
MX%5?#NBZC8P>!DETR:%K!KK[7\H_=;T8#.#SDE>F?>O2:JRZE8PR2Q2WMM')
M$N^17E4%%]2,\#D<T 0:+JO]LZ8MX;.YLVWNCP7 &]&5BI!VDCMV-</<:5J<
MO@77+)=,N3=7&MO<PQ%1EXVNA*&'./N@GDY[5WT=[IT44:QW-JD?E&1 LB@>
M6.K#_9'KTH35-/DM_M"7]JT&_P OS%F4KNZ;<YQGD<4 <S9Z?*/$OBR\ETZ3
MR[I(#;2-&,R%82I [@@G'..M9>A:->V;^ O/TR5#IFERP79\L'R9"D8QQUR4
M;D9_6NV&N:241QJED5?[I^T)AOFV\<_WN/KQ4T>HV,MQ);QWMN\T0)DC652R
M '!)&<B@#!\$6%W9>"X;&YADM+E'N!M<#*!I792,<=&!K!TK1-4?2/".FW-E
M+;7NA70>ZN>JLB1NA*-_%YFY>.O)S@CGN(]7TR9V2+4;1W6+SBJSJ2(_[_7[
MOOTJA:^([75[6PN](O+&6WGN3&QEFVEE ;[@&<L2%(!QP<T 4_ >G2Z=X;6*
MZL3:W0N;EF#J Q5YW=3D=<J5_P BL^UMK^VUW5]-O] ?4+>]U%;^UO3L:%1M
M3&_)W!D*<8!S@8KL!?V9O39"[@-V!N, D&_'KMSGN*+>_L[N1X[:[@F>/[ZQ
MR!BOU Z4 <!#H.K2^'[?0+BVE6^M=;%X+_C8T?VDS&4-G[Q4E-O7)Z8YJIK6
MG26GPY\>27-@T,DUS=W$32( 7C?;A@??'0\\5ZBS!%+,0% R23P!69J":-KN
MG_V?=SP7%K>J0(UGQYRCJ!M()'!SB@#BO$WAG4-<N[_4-&LC:D:7';"&51%]
MI=9TE\O'H%1DR>/WG!(S4GB72+_7!K^I6=A<Q_:O#TFG);R(%>:=B2N1G^#)
M&X\?.<$BNXMM2TUY(K6WU"VEE928XQ<!W8*<$]23@@@GU!K+UOQ-'INJZ186
M[6L\MY?+:S(9OWD0*,V[:/\ =[XZB@#(UFRO7ETV.ST63R'TZ>)YK=(UECD9
M8P(V+$;4(7DCGY%&1WK>&M/U73]0\,7%UI5TB0^'A83\H3#*IC/S -T(4XQD
M^U=Q_:-C]K>T^V6_VE%+-#YJ[U'J5SD#FL^]\6:#8+$TVK69,LL<2JDZDDR'
MY>_3&3GT!- ''>'M*UC2$\+7EQI]P8+..]M[JV507A,L@9) H/S#"X.,D;OK
M3['P[?V6JZ#-)8R&W36KZ_:, ,+6*5)!&#[[F4X&<$GTKOAJ5B;M;07MN;EA
ME8?-7>1C/"YSTYK)T'Q&-1M;J34/LUG)%J,]DB^;PYC<J,$XR3C.,4 8V@RR
MZ#I<<5]HUTWVC7;CRR$4B!9IW,<AR>!AP..1GI7<5F0WL3RW#WT^G!8;OR;=
MDF!*DJN%;/W9"6(P.Q'K5F'4K&XM7NH+VVEMXR0\R2JR*1UR0<#% %JBJBZI
MI[PO,E];-$GWW$RE5YQR<\<\5/;W$%W"LUM-'-$V=KQL&4X.#@CW% $E%-DD
M2*-I)'5$499F. !ZDU7CU*QEM&NX[VV>V4D-,LJE 1URV<4 6J*J?VKIWDPS
M?;[7RIVVQ/YRXD/HISR?I3WOK2,3%[J!1!CS<R >7GIN]/QH L453&JZ<8(I
MQJ%KY,P8QR><NUP 2<'/. "3]#0VK::ME'>MJ%J+23[DYF78WT;.#T/Y4 7*
M*J3ZII]L@>>_M8D,?FAI)E4%./FY/3D<^]5Y_$.DV^I6-@]]!]IOD,EN@D'S
MJ,?,.>AR /7/% &G15>"_L[F9X;>[@EEC^^D<@9EYQR!TYI]S=6]G"9KJ>*"
M('!>5PH_,T 2T55DU.PAACFEOK9(I5+1NTJA7 &XD'/(P"?H*L1R)-$DL3J\
M;J&5U.0P/0@]Q0 ZBLB_\3Z)IVG3WT^IVI@@VARDJL=S'"KUZD]*N'5=.$L,
M1O[423@&)?.7,@/3:,\YQVH MT5F6GB#2KZ]O[2WO87FL&VW #CY#@$]^V1D
M]CQ5B/5=.E@6>._M7A:3RED692I?.-H.>N>W6@"W15!-;TF18F35+)EFD,41
M%PA#N.JCGEO8<U/+?V4%U':S7<$=Q+_JXGD =_H"<GH: +%%4_[5TXW"6_\
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M[,=L8QT]#21)(UDC=6C8!E93D$'N#Z57CU*PE@DGCO;9X8O]9(LJE4^IS@4
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MELX2>ZAB8@$"20*2"0!U]R!]30!YUKFFW\^E?$*S&DW<DFH8FM,0[ED)MHD
M!&?F#*WTQGTJ]>VET=2\41WFG7-W:ZOI\2612!F'$;*T+<?NSN;<"V!\YYX-
M=AJVL6&B67VO4+E((2ZQJ78#<S'  ]\FLVR\3Q3^(-4T^Y-K!#:_9_L\WG@^
M?YJL1U &?EX S0!Q\GAZ[BDU2*]L9+RY_P"$4ALC<"W+B:Y42A@&QR3N3G_
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MUP2,X*[#CV'I76Y &<C'7-9]UKVE6FE7.J2W]O\ 8K92TLJR!E7';@]?;WH
MR-<AN4\;>&[]+2>>VABNX97A3=Y;.(]I;T'R-S_C7,:-I-S;6WA)_P"R[F*X
MM]:O)KEOLS!DC<7 5F..AWQ_Y!QUB^*X/^$C%B[6L>GMIXO5O#.,$F39M/8<
M^YK<N+VTM%1KFZAA60[4,D@4,?09ZT <%X0TZ3[1I=OJVBZHNKZ095:]ED;[
M.=P(:1&SA]^0=N."23C%>B5 ][:1SB![J%9B0HC,@#$G) QUYP?R-3T %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:M/I>H21VOBN6Y??9,6,+B3#A0O*DNI.T8&?8X]42:.3:%D4EEW  \D>M/H
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BJ7]HQOJ[:="N^6*(2SG.!$K$A?J25/'H"3VS3
MN==>'Q-;:+%:I*UQ:37"R^=@!HVC!0C!QGS!S^E &S1533=1@U2R6Z@W!2S(
MR-PT;JQ5E;W# @_2K= '(^-+&.]U7PJ7L7N5CU0M*5@,@2,PRJ=Q .%+% <\
M'BN3_L>.WL9Y;?1ITG@\5QRVY2Q<-';^<C,4^7(CP9#QQR?6O6'=8UW.P5?4
MG I6=5&68 8SR: /-I=/9KWQ5&@O=.$VLV\]M<QV+.@988_G*E<.F]"&_/(Z
MT^Q74'O?![76E^0\&I7IF:TMY/)(:.8"7!&45V8$!O[WI7HV0>]+0!Y9H$!D
MAMSJ&G:U+XBTJ&Y6>/R/)CE+*P8B8( XD."/F)R0>V:SO(U:2VOO[$L+Z":X
M\,QP0HMG) J.CMF(,PSO"D@,QR2<CV],UC7?[*O])M1 LPU"[%J6$F#$2CN#
MC'(PA':KUM<3NMPUW#';B.9D0B4/N0?=8\#:3Z=O6@#S]/L%_P"*)KJRT>ZC
MLI?#KV[!]-DC&X."(R"O4#(Q[8%5]#TB&:\\'C4M'E>.'PPUO<B>R<JL@\C"
M/E>ORR8!].*]).H6JZE'IYF3[7)"TZQ \[%*J3],L!_^JI_,3!.]< 9//2@#
MR2PGDTK1?!KW]K>.T6DW%K-:3V4[JG^K7+*B,RMQMY7!4MR.,]UX)M=/LO!6
MGV=C,+FW@A\IY# 8B[CABR$ @YSP>?K5K4="L]0OHM2^V7=K<",0^=:W)0.F
M<A2/NGDG'&>>M:-K!;V4*6\)P.6&]RS,2<DDDY)R>M 'EVCZ0CVO@N&ZT>?9
M;ZEJ'G)+9.!'$WG[-P*\*2R8SP<BNO\  $#6N@W5L;::VCCU*\\F*2%H]L1G
M=DV@@?+M(QCBNJIN]-^S<N_&=N><4 >6Z.&?Q%H5P^CWUM /[1ANK=K*5EBW
ML&P[L"9-Q!.<[>@'O'X3T<62^ V_LB>"<6US#?,UFZD I@+*2O R!@-Z#%>C
MG7M,$1E^V1&,78LMP/!F+!=@]3N./P/I5V79*K0&0JSJ1\K[6QTR,<CZT <3
MX:T::RUN;0I+9/[*T6X:ZL7P.?.!*)]8]TP^AC-6O$VGPWGC?PO)-I[7,*"Z
M$S_9S(BJ8QM#G! !/0'O6_I>F6VC69M+:2::0_O&>YG:665L 99FR3P /8 5
M#X;UP>(-#M]1, MWF,@\GS-Y7:[)UP,_=].] 'GNE:2MGI_AF:'2+B&[@\17
M&YQ9.KQVQ:X"Y.W*Q[6C]N14^C*\OB?0)_[(O;6(2:A#<P-9RE8O,;<!)(P.
M_<06W9V] /?U#>A;:&7//&?3K1YB>7YF]=F,[L\8^M 'D>EI/I/A_P +&ZTW
M4H;"U2YM]06'3R[QSDKLD,91BRX#KN4'[_7K6C:^&-*;Q'X=M'T:YFTM-,NX
M_P#3K9G #2QM&LA*X7@.55L;>F 17I>]=H;<,'H<]:@GU"TM[BTMY9T66\<I
M N>9"%+G'X*3G_&@#SDQFQ_MG.CW30R>*$F1A:2E8U\J/]]L4 R*'4CC(R03
MTJ&S@NH](L+<V.H?N/%KS8:S<;83+(P? 7 7# Y' S7JM-WKOV;AN],\T <G
MX_LTO;+1E:RDN@FKVKN(X&E*QA_G)V@X7&<^U<_J^E6=OKNHZ+?:;J*:3>6\
M*Z<NF68>,;<EHPP0^4V_Y@<J.<Y&*],#JS,JL"5X(!Z4"1&)"NI(.#@]* //
M_L=W%XQC:.$W]I/>XN;6\M6WV[>04,T<V,-&5&T@Y&20#GBN?\(Z-#=Z)X(O
M=$M?(U6!7-W=^25_<^4Z[78CY@6\O:.>!D<"O8'!=&57*$C 9<9'N,U0T/2[
M30]&@TRRE=K:U7RT\QPQ4#L3[>] 'FVFV%UJ&@%;6VUFV\66.E3VC&:#R465
MDP3YH0"7<X#*=S'G=ZU;U.VT_P 0>!M;ETKPY?0:@=&-J\<MK)$0R@E8@C !
MV!+?,H/IGFO19]1L[::TBEN$62[D,<"YY=@I8@?\!4FK&]=VW<,^F?\ /K0!
M@6-YHIUNRCBT^6&_EL289GLFB AW9,>XJ,'(W;#@]\5T-4;R[TZR5=2N98U&
M5@24MGEV "K[EL#CK@>E2QS7+:A-"]NBVRQHT<PER78EMP*XXQ@<YYS[4 6:
M*:KHP)5E(!P2#TI5=6)"L"1UP>E "T44T.C%@&4E3@@'I0 ZBC--5U?.U@V#
M@X.<&@!U%-5T==RL&'J#FH+V_M=.MQ/=S+%&9$B!8]79@J@>Y) H LT56CFN
M6U">%[=%MD1&CF$N2['=N!7'&,#G/.?:IQ(C*6#J5'4@\"@!U%(&5B0&!(X.
M#TH9U0 LP4$XY..: %HI&=5^\P'U-*2 ,G@4 %%5;S4;2PM5N;F=$A=TC5B>
M&9V"J!ZDD@51T_7/MNO:OI<EN(?[/:$"3S,^;YBEAQ@8Z>] &Q132ZJRJ6 9
MN@)Y-+O7=MW#=Z9YH 6BLFYUIK;Q3I^BFVRM[;S3K/YGW?+* KMQW\P<Y[5J
M*ZL6"L"5." >E #J*:KJX)5@P!P<'/-9?B'6QH?AK4-9BA6[%E"\QC$FW<%&
M2,X./RH UJ*;&_F1H^,;@#BA75B0K D8) - #J*;YB;2V]< 9)ST%+O79OW#
M;C.[/&* %HIID01^874)C.XGC\Z&=%QN91GID]: '44W>N_9N&[KMSS4%W-<
MPFW^SVZ3!YE24M+L\M#G+#@[CG''&<]: +-%-#J6*A@6'49Y%9>HZTVGZ[HV
MF_9O,74I)8_-\S'EE(V?ICG.W'44 :U%-#J6*AAN')&>13LCUH **JV=Q/)8
MK-?0QVLN6#HLP=5PQ ^; ZC!Z<9Q4TTGE0LZ[2V/E#-M#'L,T 245E^&]9'B
M'PWI^L" P"\A681%MVS/;.!FM-G5%+.P51U). * %HIK.BC+,H&,Y)[5FZMK
M']GW-A9PQ+->7\CQP(\FQ,JC.2S ' PN. >2* -2BJMA<S7%G ]W;?9+MXPT
MEL9%<QGN,C@CWJSO7=MW#=Z9Y_SR* %HIJNC+N5E*CN#Q1YB>7YF]=F,[L\8
M^M #J*R/#^MG7+:\E:V^SM;7DUH5$F\,8VV[LX'6M8NH<(6&XC(&>30 M%)O
M7=MW#=Z9YI&=4QN8+G@9.,T .HHR/6FEU#*I8!FZ GDT .HK'U_7?[#2Q80"
M<W-[!:%?,VE!+($WXP<X)Z?K6Q0 44U75U#*P93T(.14%_?VNF6,MY>3+%!$
M,N['IV ^I/ % %FBBD5U8D*P.TX.#T- "T4U71CA6!. >#V-.H **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH X6*+4DU7X@QV61J<J12V))QUMML9'MYB./J#5#PZUE-XL\,W-
MEIMU;E=&N+>Z9[.1"DFZ [)&*_>R'Y)Z_6O0FLX6O4N]NV=%*;U.-RG^$^HS
MS[?B:ED3?&R;F7<,;E."/I0!R_@B.13XCE.?(FURY:#T*@*K8_X&K_K755%;
M6T-I;1V]O&(XHQM51V%2T <GXN:(ZOH<,]C++'(TX^T"!YTB.P#:8U!!9@2
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M42Q-&0ZXSPP&1@@@]#FN&E@U&+Q1.=,6.\^T7%UL\^W,=Q83>4X$@DZ/"Q
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MX\&WP90\;V$G##K\A[&O/M%T>PDB\-ZAI=H%']AR+J[K$0)E,*!%DR/F;?R
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M8!'*4B)D#>:F =_'3DD8//%4M4UM=+U/2+-K9Y!J5PUNL@8 1D1N_(ZG(0T
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M8$]SPAZ5JT %%%% !1110 45E>(];7P]HLNI-;/<+&Z*41@#\S!<Y/H2*U:
M"BBB@ HHHH **KVLUQ,9_M%J;?9*4CS(&\Q!C#\=,\\'GBK% !1110 445C:
MKKLEE??V?8V+7U^+9KLP+((R8U8+@$\;B3P#@<')% &S16'I7B"75YXY+;3I
M#ITC31B[\U<J\3E"&3L"5;!!/3G%;E !14#7ENE[%9M*HN98VE2/N54J&/T!
M9?SJ>@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MM% 'FFN6,&BZS"-)@M+FVA%N#I,J$2 &9F$EJ_/S;F)9<8P!TXKI?'-C)/H
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M"(<@D\'CD UV%% 'D6JV]J4\4ZC''B\@U^RDLY,$,B@6RL4';A9 <=E(/2M
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M%P,")OEVH,@\'/8>J5GZOK-KHMM'-<EV::58((8QEYI&^ZBCU//7  !)( H
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MFD9I70!?+R&[GG;GG'':O0J* /*/"NHVXURREAE,=K<^'Y"X(<GS5=#^^D.
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M,VGK<M\GGY^;S<]>8_+YSU=Z]!J![N,2S01D2W,40E,"D;L'<%Z\#)5@,^E
M'DIGF7P9X?N4EMKV6#0HA/IEV2KS#&&,#]5G!4C&#GCI6G)-;:AXHO;+5[J_
MLM8CU".?3TA@_>/" A01OM(V?>#C./O9ZYKTFUEDGM(9I8'MY)(U9X7(+1DC
M)4D$@D=.#BI: .3MUD/Q9OVBSY T6W$^.F_SI=F??&^J.KO;2>+]6M/$)"6$
MFFQ'37<X4,"_F[#VER8^GS8 Q78VMC#://(F6EG??+(WWG.,#\   !5F@#R[
M0]/EU+Q+HEMXE,DM]_PC\4EQ&\S+^_652"0"/G &3^)K?^(/D!?#IN9GB@;6
M(HY665HQL*29!((XX'TKLJR]9T1-9DTYWN9H?L-TMV@C"_,Z@@!L@\88],4
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MC@%Q/Y2Q7!P!*'/&>V1EEV\#FO6*Q;S09YM8?4;36;VR>6)(I8XUB=&"EB"
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M^K:0=6:!'O[J"V0L)[>';MN5./E<E2<?[I'4UIT <7\5)HHO EP))%4FZM2
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MHGCW-] N[)],UQ_B0:?-+XZN+:?:]MI%I+9&&8IMD5)2A4 C)!VX^OO7KU%
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MA#  7DQV7) S]30!/12 Y .,>QI: "BHXYHIFD$<BN8VV/@YVM@'!]\$5)0
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M'YV4%&!.20,\YK7U'S=,U?P8DUW-%/=:C,UQ$;EMK%X)6*8S@JK;0/3 KN"
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M)+QV\TJD9'!;A@2W(P>M;GA9+\Z@-!O7NW.@32,]S)(V;I7_ -02V?G^1FW
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M#.9$#(YC;:Z]=K8!P??!!_&@#S'Q)+%/J7C%AJMTHM= AN[=8KYT6.;$Y#*
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M>RC:X99 ?+.YD /'(.=O'!S7JS1H[*S(K%3E21G!]J1HHW;<T:EL8R1SCTH
MX>PBM-6^(FO"34KF2*UALKB".*_D5%)67<0%;&",<=.:P-$NAJ%MX%BN-6NG
M6ZDOXY\7S@S!1)C<0V2>G/7WKUC8F2=JY/4XZTGE1C'[M./:@#RFQUZ*TT7P
M\]_JR/IR:CJ%M-'/=A3*B/(L67=@&V@+PS<Y!Y(KMO T;1^$[7S-374I6+L]
MPMV;D'+'"AR3G:N <<9!/>JUS$NO>(KF"PO+BQN]( BF22WCD@E$H# [3R3A
M1SQC)'.:NZ--96.L7F@Q),;U(DO9YFC1$DWY0$!<#_EGC&.W<\T <5I>NVT_
MBK17AU6007=QJ$%PDUT?.8@DJ) ,!"",(N,A1UZU#X7N%9? \[:I=32ZD;NW
MNC)>N_FH$D(&"V,@JO(YSWYKUCRH^?D7DYZ=Z9) K1,L>(W((5U4$J?49XH
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M*]6%O +@W AC$Q&TR;1N(],]:4PQ'S,QH?,&'RH^;C'/K0!YL=233[C2H?\
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M*<R.B %S[D=: /.M<UG4]'AM[WP[=W&H176A7-VZRR&8!HU0QS*"3@DN1M&
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M[;W!A7YF]3QR?>@#@]0O=0OM<U/3HM7,5['J]NL+17JQI':[8S(A3=DM@O\
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MTCG:=+6!9F789%C 8KZ9]*IQVVF0W#Z5%I:)%+%YS[;4"%N<8)QM+=\=<<T
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M[1;FX7;-,(5#RCT8XR1]:2/2-,A:!HM.M$:#/DE8%!CSUV\<?A0!SOPQ$?\
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M>X>,$(TL08J#U )['N.] '!:-?WVJZCX$N]1D#W<EOJ :55"^8!M59 .GS*
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MFK*L8?SV5]Z!IQ\H"A5<Y7ID#IS78R+H'A:*.86MO8I/*ELK0V_5G8!5^4<
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M5B@ HHHH **** "BD!!Z$'MQ4%Q>P6UQ;02EP]RYCBVQLP)"ECD@87A3R<4
M6**** "BJ<^JV=MJEIILTI6[NU=H$V,0X09;G&!@>IJY0 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M;"0.PD*DA478-C(0002<@'.3S6];WGA^76H+E$BCU*Y3R899;=HI)D +;4+
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M%!W;&(ZC:<X]/:@#G]-\0:K/IO@[6DO&N/[:G$-Y:;5V+OC=SLP,KY93'7D
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MZE>.,^WO6O0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MVYM]+M4^S?ZC]V#Y7^YG[OX5+=Z)IE]=?:KFRBDFV>6SD??3.=K?WESS@Y%
M')V6O:GXC;4DCU(:+<V5K:7 1XE=5\R,2NSAN2O+)P1C:3UZ0:OXAU:SL_%S
MQ:@RMINHVL=L3''E4D2 LI^7D9D;KS[UV%[X=T;4M2@U&\TRUGO+< 1321@L
MH!R!GV/(ST/-49M*\+:UK>H0S65E=:C''%]L5X\G:<^7N['[I]\#'2@#E_$6
MLZ[:#QG<VVL31+HWD36L0AB*D-&'9&RN2I)/<'WJ?6/$6J^&M0\00R:@UW%!
M8VEU&]PB*+<RS/$Y&U1\@"AN<D8/)KKI?#FC3K>++IT#K>A1<J1Q,%&%##N
M.![5(=#TQIYIWLHI)9X!;RM(-WF1#^!L]5Y/!]3ZT <=K=YXETC2M0N!K4!4
MW%B;4+LE=%DF6-PQ\M048'(QSD'G%4/$=YJBZ5XKTV75[J5;*ZL3%,5C639*
MR;D.U0"O)[9YP217;6_A'P]:::VG6^D6L5FTBRM"J85G4Y4GUP0,>F!BIY?#
MVD3B]$UA#)]N55NMXW><%^[NSUQV]* .=N=9U'3?%4=G?SW8T^6ZA@M;R%8Y
M(F8HH,4X"[D=F)(8<<J..<[?B:^DLK"V\F[-M+/=Q0KLC#O+EN8TSP&(!Y/
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MY.!T&:AF\$Z"]E=6\>FVX-S;BVD>4-(6C!R%))R0,^OIZ4 6_%/_ "*.M?\
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MQ\N0P(P3P:JW_A/0=3NI[F]TR":6X54G)! E"_=W '#8[$]*V$18T5$4*JC
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MNN2VXGDY!W<\=^>M &"NJZ]8ZI8Z'J-[;>;J%](L-U$5:1(%B,@5AL"^82,
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M @XH Y>_\5:H-"UW7K2;']DZF]K]@\M2LL<;JC G&[>P)8$$#E>#SF'6-?\
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M>3PV1R?6@#D=,N)]:\=Z-J4DT\"W?AW[2UJ0A5-[Q%DY7./7G/'4#BO0 ,#
MZ51.CV)U9=4\DB]2+R5D$C#$><[<9QC(!QCM5Z@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M2/M,EZ\!C<VGV1F6=XU6 <[0 P"@>H H YC3_$VN32Z)+-/:%-9T66_2(6Y
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MJ0F2)<@*3N_VFYZG<>>:CN?!6AW=]!>203K/#"MN6CNI$\Z->B2 ,/,7V;-
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M+6ZCGF6X>-YI&N'\R0QD%,L#G (R .,Y]36K/<V]C;>;<W$<,*[5,DSA1DD
M9)[DD#ZF@#D=?\3:EIFJ2"WDMY8(;^SMFB1"VU)G16,C' 5_G!51GC!(P>*=
MYXHU^V_MF[\ZQ-MIFM061A%NVZ6*3R!][?P1YQ.<')'05T-]X,T34+N[N;B"
M??=R133".ZE16DCV['VJP 8;5Y'/%.E\(:--!>P/#.8[VY2ZG47,@WRIMVM]
M[C&Q.!Q\HH RV\0:K;ZSJFASR6_]H&6%M,(A($D$AP6(W?,4*R;L$< 'C-=@
M,@#)R?6L&UT^[O?$8U34]/MK<V"RV]DR3>:\B.RY=CM&W(1?EYZMS6_0!PL'
MB77+W4+*&W%NDTNIW%I=6CP%VMH(]^V7(8=0J<G@^8,#CE;/Q7JLMAHD\AMB
MUWKEQILX$1 ,:-.%8<\-^Z7U')J#2?"VKPWJR2QW5E<"Y:>6>WUF5K:0M(7;
M; >/FR?E( &>I[] /!6B"Z6X$-P&2\-\B"ZE"1S'=N95W87)9B0.#F@#)LO$
MVJ3>(M.LS+:RP7[7B>9%$3%&8C\FQB07XX;C&<X(Q5?2/$'B&\\-:=K%Y?Z:
M@U"2.(0QVS[U^9PWE_,V]B ,+C P220#G=MO!.A6<]M-!!<(]K)));@7<NV(
MR9W!1NP%.<X'%/'@[11H]GI:PSI:V4PGMMMU('B?GE7W;A]YAUZ$T <[;>*]
M=N[?140VD4UUK%WIDYD@).(A-M; ? /[H9&2">A%02:YKE[%HL;7T44R>(YM
M-N'BAPLZQK*58KGC[BDC/7\JZF#P;HEM) \,$ZF"[>]B_P!)D(69]P9L%N^Y
MN.GS'UI3X/T8V_DF"?;]M.H BYD#"<YRX8-D9W-D XY- &#<^,-070[SQ# (
MFL[/4VLY+,Q_.\:S"%FW9X?/S 8QC QGFM+P[J.N:KJ^J-<W5D+*QOYK3RH[
M9@\@"H5.XN<8W'/!S[=M$>%])6[FG6W8":=;F6$2-Y3S+@B0IG;NR >G) /4
M9I^FV6DZ3J%W;6DRK=WCM>30O<%W8\*7"L20/NCCCI0!7\7:G?:+H3:I9F,Q
MVLJ27:O&6)M]P\PK@C!"Y;OTK&LO%-_=ZWJ>D+-!YXNXOL$GD_++;G.]OO<E
M3',,\#Y5]:ZU7LM6TXF.2&ZL[F,KN1@Z2*>#R.".M5K70-+LKBRGM[1$ELK4
MV<##JD1V_+_XX/U]30!Q6LZWJ\EAK:17,%M):>(K.S$D$."\3FWR&R3D_O""
M>X&.*@U34=4T+5_&VK64]MNLHK*:9982WGXC.5&&&W(SSSV].>SF\):/<0:A
M#)!*4U"X2YN/](D!,J;=KJ=V5(V)]W'W159_#7AS47U>SW&=[M(XM0B6]<MM
M480, V5X!],\]: *.H^)=2=?%$VFM G]@ ?N9D)^T$1"5LG/R@AMHQW!/(XJ
MG=^,M2_L[Q1>6PA1=/TB#4K198B2"\<CE'YY^X!QCJ:Z6X\+:5=7,]Q)#)ON
M8EAN@LSA;E%& ) #AN"1D\D'!XXJ/5/"&C:Q<7,UW!*3=6OV2=8[AXTEC&[
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MVZ,!E^[M;D8[DGG)H YR3QAK2V=YY:6WG6NO6VF@S0,N^*7R3DJ&^5AYOZ=
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ML!0J,\;<AL*N0$()]JZ"/P?ID6MR:JC7:33.LL\$=PZP32@#$C1@[2W _(4
M9UK=:C%XI\2Z+ICVZ,D=M>VWVA6:.,REA(" 0<$QEN#U8FNQKE[GPO+?0:W.
MUQ+;7VJF("2"=HV@CC^X R\]=S$#KN(SCFNG12J*I8L0,9/4T +1110 4444
M %%%,BFBN$WPRI(F2NY&!&0<$<>AXH ?1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%1RSQ0*&FE2-68*"[  DG '/<F@"2BBB@ HHHH ****
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ML38QN 50"V"1N;)&3@\FH$\+:;%<S,9)S;S7?VY[1Y 8C/D-OQC=]X!L9VY
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MXMHH=7%Y/:R[F+1+Y2JYD'0L")(\#C[QYXYLV>OZJVMZ?I-_IT%K<W5C<7#
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MX?L]%D@E%I8E#:%9W62 J,*4D!W @<=>E &%?^)]?T;3K>76;9+5 9UN+V"
MSI$5*^2TB*Q*(RDEL$X('(!S4LWB76[^74%T*"WN'TYX%8,4\J<-&DC'>7!4
M%7^4A3R,\]!NGPOIWD10JUVHCBDB+"Z<M(KX+[R22Q.!R>1V(JO+X)T*34HK
MY;:6&5(DA9(+B2..:-!A%D12 X XP0>..E &!?>*=?M3K=R)+ VVE:Q;V9B^
MSMNEBD\C/S;_ )6'G$YP<XZ"M?PY<ZA<>*_%45U>":WMKN**&/R\;%,$;@ Y
MZ?,>W)Y]JN3^$-(N8K^*6*<I?W*75R!<.-\B;=IX/&-B<# ^45=M=%LK/5KS
M4X$D6ZO OGGS6*N54*&VYVYPJC.,\4 <MJ7B_4(M'\0:W9K ;;1+QK=[5T):
M9(]OF'=GY6^8[>,<#.<\7],U/7-1\6ZM:?:+*/3].N(E*?9F\R5'A#XW;\*0
M6'.#GT'?1E\+Z5->7-RT+C[6Z27,2R,(YG7&UF3.">!GUP,YJU9Z/9V&I7VH
M0+(+B^96N"TK,&*J%7 )P,  <8H YW7([N;XD>'X4N(E@>QO28WAW X, .?F
M&<@_ASUS531?$VHRZ?X1 CLHH]1N+BTECB@*JBQ)*4V#=\O^J48Y_"NFEL-*
MO/$<%XTV[5+&)E1$N"#'&Y&<H#C!VCDCM52W\%:);75O<117(:UN7NK=?M4F
MR%WW;MJ[L '>V1T.: .;T'7]:M]'T*6XNX;K^T-<N;*4R0D,$$EP<@AL#_5@
M#C '%3S>*M<,06%K$2?\)$=*W/ Q'E8X; ?[P[^OMUK?;P9HQLS:K%<1Q_:S
M>H8[J0&*8LS%D.[Y,EFX&!\QJK/X;\+Z<88KB;[,TE^+V(2W[J7N>@89;D^W
M?ODT 49=<\3/)J%C81VUWJ&E&%)CY:QQ3LR+(Q.Z3<@VM@8!P0>O2MSQ+JEY
MI6F0W=I:S3IYRBX^SQ^;)'$0<NJ9^8@XX&>"3@XIFI>%-%O=5.L722Q7 C"3
MO%<O$DR+R!*JD!U'/WL\<=*OSVUGK5M:SQW#-&CB>">VFP,[2N05.&&&/!R#
MF@#E8?%E_JPAM-%GM[RXDL&O$N8HALD_>,B#8[J5 *X89)!XXJQ;ZYX@U:2^
MLK-;"SU33[6WDEAF)DC>>0%BNY3D(-N,@$Y^F#-J?ACPJC:='=2_8;B)W%M+
M'?/;S.9&W.NY6#-N8Y(]35R[\&Z)>7T%XUO+%+#"+?\ T>XDB62(=(Y I =1
MZ'- &)JWBW5;&T\6RPFS9M(:W:W)C)#+(BL0WS<_>.",5H0:CKU]XQU;38+J
MPAL]/-N_S6S.[K(CDC.\ $$#G]!5K4_!FBZO<7DUW#.?ML:1W,<=S(B2A?ND
MJI R!QGKT]!5ZUT*RLM1O+^ 3BYO$1)G:=VW!!A>"3@@$\]: .*TO6]8U23P
M1*+FWM5O5NGGAA@Q&612!@;LXP3@9Z\\\5K:7XAU6YNY=&N7M1K-OJ)BF"0D
M)]EQO64+N)^9-JYR<.<=JU(/!^C6UMIL$,,RIICL]KBYDRF[.X$[LLISR#D4
MW1=/NIM5N-=U73K:RU"6!+58XIO.*QJS-R^U<Y+=,<!1[T %_J]R_BJW\/6<
MB02/8R7KSNF_A75%51D=V))]!COD<_8^+==U:XT.UB^Q6LMV]];73- T@66W
M;;N3YQE203@]/4XYZ[4-$L]2N[6\E61+NUW"&>&0HZAN&7(Z@X'!R. >H%4%
MTGP]%J>G11S1Q7NGK(+:%;HAUW_?)7.6)ZDG)[T -\.^()[[P4NLZ@B&:)9_
M.$"D!C$[J2H).,[,XSWK,M?$^JLOA>[F^S/;>($V[$C.;:1H3*F#GYUPI#9Q
MSR,=*Z'2++2M(@;1K"1?W>Z5K=IS(ZAV+$D$DX+$GTYJI8:#H6F7EO9VSA9H
M(Y'M;5K@L8$;AC&A/ YQGL#@8!Q0!6\$ZEK6MZ/!JVISV1BN(SL@MX&0HRNP
M)W%CD$ <8X]36:WC'4#H47B2)86L#JGV)[3RSY@B^T>0&#9^_NPV,8P<=>:Z
M?P_8Z9IVBP6^C2"33QN,3+.91R23AB3D9SWJ&/POI45U).D+A9+G[6T'F-Y7
MGYSYFS.,Y&?3/.,\T 9-OK^JG5]3T2XDM1J45Y"+0K"0KVL@W;R"W) 28'D#
M*#UIMMK^NZI=+<:;:Q&RCU*6RG678 L:.T9<-OW;]RAMNWD''7FNE;2[)]8C
MU8P*;Z.!K=9NXC+!B/S'\_6LZ/PAH\.MS:M%%/'//)YLL:7,@A>7_GH8L["_
M3G'49Z\T 5/!FI:WK6GC4M2N+(P.TT2PP6[(P9)G3=N+G@A>F/QKD]=N-1NO
M#GC475VL\=OK5O%"ACV[ #:L #GI\WIUR>]>BZ1H]GH=@+*P61+<.\@5Y&?#
M,Q9N6)/))/XU1N_!^C7K:@9H9\:A*DURB7,BJ[IMPV V ?D3)&,[1F@##G\6
M:II5WK-C>&VN9K>ZLH;:2*(QC_26VX92_.T@_P 0SP,CK70:'/K,D]_%JT$:
M1QR*;60%0\D9'.]59@"&!&0>1C@<TRZ\(Z-?'4_M=L\XU....Z$DK$.$^Y@9
M^4CL1@YYJYI&C6NBVI@MFN)-QRTMS.\TC8Z99R3@=AT% '-V_B?4F\3Z;9NU
MK-:WMU=VY,*'8GE!F3;(<;FPF&P" 21D8JK9>,=6N;*^46['6;6W22;2GMRD
MR$N S1DMME3&=I!Y( )^; W8/!.AVUU;W$4-PKV]Q)<P+]KEV1/)G?M7=@*=
MQ)&,'-//A;2(+;]XUQMAA6))I+I]\,:,' #YR &5223DX&3@4 8EKXSDU V5
MKI\XNI;R>= XM_+EA$2*61XY&7$@+#/L,@4V'4/$DOBCPQ;:E+!:R2PWC7-O
M$H9',;1A6X8X)5^F3M)/6M1O#/AO7[ M')]I_P!+-S]MM;HB43A0A82(<@[0
M%P.,#&*O_P#",:7OTZ013"33BY@?[1)N^?&_>=V7W$ G=G)'- &5X6\2W.KZ
MC+8Z@1:ZA#!ON-/E@,;QMNQNC;)$D78,/QZX%?4O%6HBQ\4:CIXMQ%X?D9&M
MY4)-P$B663+9^7(8A<#J,G.<#H=.\/V&F3130"9Y(8/LT+32M(8XL@[ 2<XR
MHZ\\#TJ.Z\+Z5=WMU<RPN#>*JW<:R,J7 7A=Z@X/''N.#D<4 <_$)-5^(\@F
M:*2PGT*)S;30;LH\KY4Y.,G SQVQBI/&7B;4=!CU"6Q:U=;&Q6Z$'EEW8[F!
M\SH$3:O!SDG. =N*Z1=%LUUUM9"R_;6@%N6\UMOE@DA=N<=23TSS5+5O!^C:
MU<W4][!,SW=L+6X$=Q)&LL8S@,JD D;FP3TS0!SVO^)M?L;CQ4UG+8+#HME#
M>QK);LS2 K(S(3O'79U_2K]_XFOM+UV:WNO(-K=V!GTP+&0[SJ<-$QW8).Y"
MN ,Y/I6E-X0T>=-126.X==1MTMKK=<R'S(U! !.[(X9N1R<G-12Z5<:AK=E#
M=Z= NF:5*MQ:7#S^9)+)Y94?*5^7;N;DDDE5]3@ ROB-<7]IX 59)PKS3VUO
M?3P H%B>15D(Y) (..O0TGQ,C_L[P,+S38UBOM/N+9M/$2X*N9438H'8JQ4C
MN#797=I;WUI+:7<*36\R%)(Y%RK*>H(K&@TS0QJ5O:&]^U75E^\@M)[PRM#C
M@-L)R2,\,V2,\&@#CIM2UG06\;ZSIKV9MK'51-<6LT+%IU%M!N"N&&TXZ<')
MJWJ5_/IE]\1-1M4@::WT^VG"7$9=&VPR'# $9R!CK742:#HCZO<*[?Z1>,MW
M/:?:#MF*;5$ACSR!A >,' SFGW7A72KUM6:>*9O[6B6&\ G<"1 " .#\O!(X
MQUH P]=\4ZG8O>0VRP0R0:2M[:"2,L+V;+ Q* 1TPHP.<R#TYL1ZWK-_?ZAI
MEL]K;WVG6,%Q(9("5DFE#D+MW<(-F#R22>HQS3U;PU?S>(&FCM;Q[;[-%;P3
MV6L2VK*J;CB4 _-RQP>>.WKM)X8M#%!<W\\[7T=I]FGNDG9&ECZE7(QN Y^8
M\]3QDT 86E>*=;\2:CI::>]E96UYI$6I$3V[2.I,@5DR' ((S@\?0]M#PWXE
MN=3UJ73K\BUOHHG>6PE@*,,. KQ/DK)'C/([D=,X&K8:1HYO;?6=/VDI:BTA
M>"8F(0@\*%!VX!'IVJ#3K+0;)K2\M[V.4(&LK226[\P)N8;HD)/))0#')^7'
M;% '-7\FLVWB_P 87>BSV44MO8V<S+=0LXEVK,=N0R[<X///TJS'XMUO7+>>
M30+%//M[:UG\F;;M8RQB0JS%U*C:V 0#R#UZ5TEYX:TV]OKB[E282742PW*I
M,RK.BYPKJ#@@;F_ D'CBH;_P?HVH:K'J4L$L=PL8A?[/</$LT8Z)(JD!U'H<
M^G2@"E::SJVLS7D^FR644%AJ(M)H;@'YHU"F1MXZ-\QV\8X&>O&>_C'4#H2>
M)(EA:P_M3[$]H8SY@B^T>1N#9^_NPV,8P<=>:VKGPWH%MK9UJ8M;3W$L8=?M
M3QPSRC C+1[@KOT R"<X[XJ>/POI45U).D+A9+D7;0>8WE&?.?,V9QG(!],C
M.,\T <M<>*?$44%]=K+IQCL]>CTWRC;N/,C=XD!W;_E(\S/0YQ5A_%FJ:?=:
MGIUW]GN;J'4;6TMYHHO+!$Z!N59\9'S ?,,\5NR>$-(EM[F!HYS'<WBWTH^T
M/S.I4ANO'*J<#C@<47?@_1;]=36[MGF&IE&N=TS_ #,@ 1EY^4C P5QTH Q[
MO7O$>E6<DFHV#F!+S:T]K$)9EM2A(D:)6/(<!3C/'('IHW'B9;/P&/$"S6]Z
M?(1UE@!6*1F(4$ G(7)Y!.1S5JW\+V%K;010RWPDAD,JSO=R/*S%=OS,Q)88
MXP<@<<<"K2Z'IHT-M%-HC:<T1B:!LD,IZY)Y).2<]<T <KK&N^*M'LKR>2"T
M$0GM%MI)T 9A),L<BE4D.,;@0WO@@]:SO%6JZQ+X0\>:;=75NTNGVXVSPP%-
M\<D.XKMW'!'(SGIVKJ(O ^BQ:6VG%;R6 O&^9KV5W'EMNC4,6R%4@$*.*6X\
M-^']3FUJTE=II;](QJ,*W;;BH!"9 ;*@@$<8S@T 4A?7\NO:QIFG-8PW]E9P
MSRW#6V/M,C[]@(#9V*J 'DGYN,8YSM+\7:UX@O;)[-K.SLYM(@U1TEMVDD&7
M(>,$. <A3AL?@>W4W/AO3[J[6[?[0ER(/LSS1SNK219SL8@\\YP>HR<$9-26
MWA_3;35$U&WA:*=+5;- DC!%A4Y5 F=H /M0!S:^*=5C\*0^+7-C+IDFF27K
MVHRLB-L#QHK<AN-P8G'(R/2I;C6/$EDEU+.MC':-#$UO<7&%(D:1590D;N7&
MU@5QR6PO.0:NVOA;PUH1>(*(H+PM#':W%TS0@R?>2.-FVKNR>%'?'2DA\ Z#
M#I<FG"*[>W8H8_,O97:#8P9!$Q;* , ?EQT&<XH Y;4]8U'5XK>&41I<V'BJ
M"U@DDB(ROE!U9U!Z_O.0",X[4[6M4U.YLKS2M7-O-<Z9KNF*MS;QF-94DFB=
M?E).&&2#SZ5UO_"%:(!<8BN0\]REVTGVN4L)D4*L@);AL 9/?OFIY_"^E7-F
M;::*5E:Y2[=_.8/),A!5V8')P57 Z#:!C Q0!D0>(-<U*^,VFVD364&J265P
MDNQ0(T<QNX;?NWY&X#;@@X]ZZ:Q2]2*07TT,LAE<H88R@$98[002<D#&3WK,
MC\(:/%KDFKQQ3I<2N)98TN)!#)(.DC1@["W Y(Z@'KS2Z3%8Z"UQ92ZFGG7-
MR\Z03W1=DW8^5=YW$9!./4G% &Y12*RNH92&4C((.012T %%%% !14=Q<06D
M#SW,T<,*#+R2,%51ZDG@4]65T5T8,K#((.010 M%4CK.E@D'4K,$?]-U_P :
MMHZ21K)&RNC %64Y!![@T .HHHH **** "BBB@ HJ'[7;?:Q:?:(OM)0R"'>
M-^P$ MMZXR0,^]34 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MM$*\A'4$;U'/7U]*F;PYHNIS75Y$=\-^ EVD$W[FYV?*-P'!QC:<8R!@Y'%
M'.:MXOUR&+Q-=6)L%M](LX+Z))K=RTJ,C.4;#C!^7&>WI5F^\7ZEHE[JL>H+
M:3QQ:;'?V_DHT>PO(8]CDL=PSM.[Y>_%;$_AO1]5;6LS22C4D%K?K'/P0HP$
MX^Z0&(XP>:EG\*Z7=W,T]VDEP9[+[!*DKY5X>3M(]<DG/7GK0!E76L^*=.AU
M"6?2A<0Q^2\#PQJ92I;$P\I9&+%5^88(ST[<[/AK5TUS1DOH[RWNT:1U$D,;
M1C 8@!E8Y5@, @]ZK67@_3["Q^RPW&HMAD9)I;QY)(PARJJS$X4>G0]\UJZ=
MIMOID,D=NIS+*TTKL<M)(QRS'W/MQ0!R6L^+=5TZW\7/$MFS:-Y#6^^)L.KH
M&(;YN3SU&/I46O\ BK7M.G\4O:G3O(T2WANE62!RTJLK,R$AP ?EX;'X5N:K
MX,T?6+B^FNQ<XOHECNHX[AT24+]TD ]0.,_X"FOX8T758-4<3RSPZK$MM=%+
MDL)%CRH7/8CY@<'/7/- &1?WDEAXYUZ^MOLR31^';>1#<OLBW"6?&]AT%-G\
M5ZZMGXF-K%;S3Z.D-Q&9;5T,T3(6<;"^0V%;'3L".];U[X0TK4I+M[P3S&[L
MULILRD;HE)9>F,$,2<CG)IUEHND:)J%S=BXD^TW<21S-=7;/Y@7(!(8XSSC-
M &)%XRN[G6]2TZVELY \,$NDRB%MLV\A6W?/\P0LI.,<'VJE?F]'BGQA),]C
M<Q6ND6LJP7%J70[?M#J,;_[PR?7CIBNHTWPYH-LFEM86\)&DH\5HR-N\H. &
MY]34X\/V/]IW]^WFO+?PK!<JSY1XU#!5QVQN;IZT 9.G>(;V_P!8TJRGCMOL
M]_HAOW"H=RR Q@@$DC;^\/&,\=:?\-_^2:^'/^O"+_T&GV/A31-)O[0Q75T+
MR&S>VM_-O69Q!E<@ GD+A>V!QWK0T6#2M'T>PT_3[J,V:CR;0-,'W;<_*IS\
MV #ZG@^E '%:QJ+Z7X@\:ZCJ"6U]9V6GV<@M9(,AN9C&,EB!A\$G!]<#%:^K
M>(]8T2_GL9C9SO)I4]_;3+"RJLD.W>C+O.5.]<$$'KUK;D\,Z;->ZG<SH\QU
M.%8+N.1LI)&H8*NWM@,W3UIB>%=/%K+!(]S-YEJ;(22S%G2 ]45NV>,GJ<#)
M.!@ ?X:N-5O=)AO=4EM&-S%'-$EM$R>6&0$JQ+'<<D\\?2L77_%.HZ5J<BP_
M9)+>*]L[=HE1G8+,ZJQ=\@(WSC:O)(&>AXZ73DL[*T@TZUN%=;>,1HID#,%4
M8 /?@5EW_@K1M1NKRXG6Z#7DL4\RQ74B*9(MNQ\ X##8HS[4 85YXKUZU.L7
M(.GFUTO68+)H_(??+%)Y'\6_"L/.SG!!QT'>\WB/58-6U;1IS9C45EA.F8A;
M;+#(<;F&_+%"K[L$<+GO6A-X.TN>WOX':Y,=]<I=W \X_-*FW:<]1CRTX']T
M>]);:?<ZAXF75=2TV&V.G+-;V<GG"1Y5<KF0X V\*..3\S?B 6?%-Y>:=X/U
MB\L>;RWL9I(<#/SJA(./KVKGHM-T]_@XJG!C;2?M9N,_/YOE[_.W==^[YMW7
M-=R0""",@]JPAX2TM;,Z>!.-,+;OL'FGR>N=N.NW/\&=O;&.* .'T*X\1ZEJ
M]I>V<EE#J\_A:SFF>\A9UD??*<$*RXR>^>/0]M31]6;Q#XL\,ZPD*V\U[X=N
M92I&X*QDM^.V0#^E=7>>';&]U'[<6N(;AK?[+(T$I3S(LD[#CIR3@C!&>M*/
M#UA'J-I?0*\$MI:M:0+$VU(XCMRH7I_"O_?(H Y?2?%=W)H?AAY([*Q34Q/Y
MMP(RL$+("50#<,%L$\G^$]S4VC^*=8U%=#LKF.VM=0U."XNF;R&"QQ1E5 "E
MLDMO# YZ=J9JOA.6S32+/2[2_ETVR24+]DU(P7$;N1W) 9<;NISR*T(= @AT
M^TN-9OIX[BSF:2TN9KL-+;A@ 4,A #YYR"".0.=H- &3%XOUZ]GTRQMTT^"\
MEU*\TRY>2%V3?#'(XD0!@=IV@[3ZD9[UH6WB:^C\50Z)JCP6DS2;8P]LX2\0
M19+0R;B-V_JAY '?K6JGAK2FDT^:'S ;":2XA9)2<R2!M[L?XBP=LY_O5,?#
M]DUZES(T\@2Y-VD3R91)L$;@.W!/&<9.<9YH SO'UY?6/A&XN-/N1;S":!"Y
M3<=KRHA Y&.&Z_\ ZQ4O/$>JG_A(EL39F308D,BRQ-BY?RA*P'S?("I '7G)
MY P>DU;2K36]+FTZ]1FMYL;@CE6!!# @CD$$ _A5";PGIDT\\Q%PINH%M[L+
M.V+F-00!)W)P2-W!P<9Q0!HZ=>KJ>D6E_"IC6Z@29%<<J&4$ _G7#Z?XN\1M
M:Z%JMXFFR6&H:BVGS0P1.LB$R.B2!BQ&,J,KCWSZ=[#-;M&Z6S1R" ^64B8'
M8P'W?8].*Y7P=X8DLM%LUU:&=;BUNI[B."257C1GD<AQM)YVOW/!)P.] #=(
M\0:_K0T[4;2S@&E7R2,SR!08."8SQ)E^1AEVJ>>V*Y_4-5\1:W\-;/6+NYT^
M*.^ETYUA@MWRNZYC# L7Y!RO&.F1[UU]IX3T71+J:[MY;BV25W=86NV\B)WS
MN:.,G:K')Z#N<8S2Q>%]&G\-VV@PS2OIUJT;1I'<9*[&#(-W7A@#^% &9-K-
M[;R>)UTF'3XYM'5)KD&W*_;)C$)&)PWRY7:H)W'/J!@KI_B+6]=U\6^GO86]
MD=/LM1'VBW=Y-DQ?<APX&<)P>W3!ZC:NO"^G7EY<74GGK)=P"WN_+D*"Y09
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M<^THOV_^T507#;5GW%MP!X W,QQT.>>U)=>"M'O;:]@G2X87EV+UW$S*\<X
M D1A@H0% X]/<T 9%YXGU[1]/CFUJR6UB6XFCFO(8#.L<8 ,4CQHY*@Y.[DX
MV]@P(<_B;7-0%S%H-O:7ES9V]O(Q4J8KAY$W\,9%*H5Z-AOTP=V/PU:0Q0+#
M<WR21!P9C<,\DF_;NWEL[ONKUZ8&,8JI)X$T)KFUFAAN+4V]NEKMM;F2)984
M^['(%/S@>_K0!K:C=7$&AW=W;1;[F.V>6.+KEPI(''7GBN3\*26L?PE@U5X(
M]0>YL#>7WFD9N9"I:0,2#DYRO/3 ' %=T    , = *P1X2TZ."ZM;5[FTL[L
ML9[6"7$;;OO8!SLSDYV;>M &#8^(]0NM-LM/\/6"1RKHMO?0QS$2C;)N$2,2
MZ=H_F(SU'XLU'Q1XEA;61&FFVSZ=HT.IF*2-I3O82EXBRN >8L!A^1[;UYX*
MT:[;3W1+JTDL(!;026=U)"XA&/W992"5X'6I9_">F3O?,1,@OK-;&9$DPI@4
M, @';AFY'/S&@#'G\3ZYJ+7JZ!812S626[-#*5Q(9$60J6+J5&UL [3R#]*%
MU[Q!+JGB$)+I,=GH[])T9#(&MQ*NZ3=A,,PRV"",\#'.C+X(T>6]AN_]+CFC
M@2WD\JZ>,7$:_=64*0' ]^W!R*FN?#FCI;ZV]Z6^S:JO^G^=-A"-@3.>-N%
M'&.E '*:MKUYJGAKQMIMZL3I;:%]ICE6!HMWF139^5B3@&/@\=?Q/>Z7_P @
MBR_ZX)_Z"*QE\%:.\5YF2]E^WV2V5Q(]X[F6(;L9)/7#L,^AXQ6_;6ZVMK%;
MH6*1($4L<G X&30!Q-]IEA:_$SPQ:0V<"6ZZ9>J(P@Q@&$#ZU9NM6U6">_TG
MPOIT#_V.L$:P.%"OE0VW<778-I !P>1[8K?N-"M+G7K769&F^V6L;Q1$/A55
ML;AMZ'.T=?2JNH^$=*U+6!JLHN8KEHQ%-]GN7B6X0=%D52 X&3U]<=* ,?\
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MYSD*?0^GKS0!)%J6H'Q1H=AJ=EIPGNM-N))FB!=HY$:(,J.?X#OY&/X17/\
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MU@\/KJ4 A5D9=FU2C,20V<K\P"XYXKI;_P +:7=3WEU(TT'VJR%G<"*8HC1
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M 8Y)Y-2T %%(S!5+,0 !DD]J2.1)HDEB=7C<!E93D,#T(/<4 .HHHH ****
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MU+4;N-RB22S7/F2*$(94R1P <'ID\9)H L:)J]_=:_K.DZ@EMYEB()(Y+<,
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MU3%DGY@>."6.?>@#C_#?B>\T+P_H,.H16[Z>?#1OX_)#>8OD1Q;@Q)P=P?/
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M='6">[VZ29#:AG4_?!#!OEYX)% '0UQGB>.<^/?"[V0MUNVAO562920HV)U
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MLK>5(^4BPH7"#' .,GW)H M4444 %%%% !1110 4444 %%%% !1110 4444
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M7S%?:A-8:O+-<VNNQ+YSR"-X1@AH44'+1C'). 3V/)H ]TK$O_%%IIWBC3-
MF@N#<:BKM#*H4QC8"2#SD=/3O7F/B4O<>+?'D?VNY$%MI"7,$<=PZHLFQ#N
M!QUY].:BO=1U-M3^'&H6\/V_4_[*FD1)'P97\GN?4_K0![=17*_#[4M/U;PK
M#>6.\2NQ%VDC%G2;^)3GH,G@<  C %=50 4444 %%%% !1110 4444 %%%%
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MD_OK1_9LG]]:TZ* ,S^S9/[ZT?V;)_?6M.B@#,_LV3^^M:,2E(D0]5 %.HH
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MX_Y<GX_"@#2M/%.AWTEZEOJ4+-9 -.#E=BGHW(&5..",@TV3Q;H4,4\D^H+
M()D@F69&C:-WQL#*P!&<C!Q@US7B/PMJ?B*\NM3M[=+*Y33X[>".X=2)G6X2
M?#;"<)^["^OSMP.Z:AHNI:GH,SQ^%[;3KV:ZLGDBCGC>1UAF61BSC (P"%'7
MGMF@#J(O%.CSQ)+%=,Z-CE89/ERY0;OE^7+*P&<9P:FFU_2X+L6TMVJR&80;
MBK;!*1D(7QM#'(^4G/(]:Y[Q+H>I7VMC4-)BN+2_2*)([N.=/*E4.2T4\9/S
M* 200"?F.#ZT9O"VJS:+K'AR2'=!>ZH;R&_$BX2-YEE.X9W;UPP&!@_+R.<
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MXK2T#Q!:^(K>YGM8KA$@N)(#YT+)DHQ4GY@.ZGCJ.^#7)Z5X>UNUL?"D5Q8
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M.4REWMY3*4VAVR=K*N<$\8.,9H ]-HK,2!=%TB[>74+J54$D[3W)$C(,9.
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MJ<J2V_BJWM8@TW(A9X=R<GE=KMU[&@#TI75F8*P)4X8 ]#C//X$4ZO+'U/\
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M"&_=KSDCKQZ/7P8;.71IM,U#[/-IPN%=YH1+YPG8/*2 5PQ90P/('H17544
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M:10$5BI8J<E0.A)]"?H 3_\ "26W_/AJW_@NF_\ B:/^$DMO^?#5O_!=-_\
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MC[P QW'(JR-5UN74;G1HAIZZE#!!=>;(C^5Y<A=2-H;)(:,CJ.&![8H N_\
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M7!J.N0^)(K&>&RDMKJ":6$1;E> H5 \QB2&!WCD 8/KUH L?\));?\^&K?\
M@NF_^)H_X22V_P"?#5O_  73?_$U3TKQ!<RP:V;J6PNVTV;RD>R.T2'8K;"I
M9BK;FV]>?;I2O>>([?6K&WF;3)+>XD8,D<;^:$5"2^2V!E@HZ<;P.>M %O\
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M (FC_A)+;_GPU;_P73?_ !-;-% &-_PDEM_SX:M_X+IO_B:/^$DMO^?#5O\
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M5[:)M.EVPF0Y;'R9[D#)X!(]*Z^&430QRJKJ'4,%=2K#/J#R#[4^B@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K)\0Z-)KEA#:QW*VY
MCNX+G<T6_/E2+(!C<.I4#-:U% &3XBT>;7-'-G#>?991+%,LACWJ3&ZN%9<C
M<IVX(R.*RM*\*7VDZ]<:C!JD BO'\VZMA:':')!8PDN?+WX!;.[)&>.W5T4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
L !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>38
<FILENAME>exhibit1033-bochk_facili022.jpg
<TEXT>
begin 644 exhibit1033-bochk_facili022.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MY)4MU^7.2/:O7K;Q9HU[JRZ99W,ES<')S#!(\8QUS(%V#\Z -NBBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MP"15Q(9-I?)P>G;..>E<SX?\9>(KOPCX$:XO9<ZWJ$T-_J!4;E"R,$C'&%+
M8SC/!QSS7KBZ58B8SO:027+)Y;SO$OF./0G'-*FE:=%9&SCL+5+5CDP+"H0_
M\!QB@#AK_6M5M?'.M>'[:YFDTY-#-]YV<O93Y8 ;^X( ;#9_+BDTK5_$.E^*
M-/\ "OB-YKF22:22RU2%=B7L2QNQ20#A74A>.X'Y]VNF6"6\MNEE;+#-_K(Q
M$H5_J,8-3^3%B,>4G[HYC^4?(<$<>G!(_&@#S;PYXIGOO NI>*/$FH7=E+#<
MRQRQ6PQ]@"MM"^7@[B."=P8\^E7?B-K=_I'PEFUC2[^:*\CCMVCN=H#-N=%)
M*G(Y!/';-=G/I&FW,KRW&GVDLCXW/)"K%L=,DCFI+JQM+VW\B[M8+B'C]W+&
M'7CIP>* .,TSQ7)J-]J\$D5U:ZUI4$ACT:5^;A0,I)N&?,W8 R.F<'/!K D\
M4ZU'\&H?&":F\FMM(K>5M!C=C-L,'EX],CCYLC.:]/.EZ>;N.Z-A:_:8U"I-
MY*[U Z '&0*!I>GBY^TBQM1/OW^;Y*[MWKG&<^] '#:QJ7BK2-0F\0VHFO=*
MAV)J&C  R0J8T=I(FZEE+'*YY'3VA@\2ZAJ'B7PCI,=U/#I.IZ:U\UT>)+I\
M9$08_=P,,<8.#VKT6.V@AEDEBAC224YD=5 +GU)[TR6PLY[=+>:T@D@3!6-X
MP57'3 / Q0!Q=_XB6#3?%D^DZG=2W.A1>:]O<IE(G16<IN/+JX&.I([$<8G\
M=Z]>6WPHO=>TV62SN_LL5Q$PQNC+%>#G@\,1S71W&@Z9<V,MB;.*.UF8-/%$
M@19O9L#D'OZ]#QD5<N;.UO+<V]U;0SPG&8Y4#+QTX/% '.:WJDEG\/[N>*\9
M-171Y;N)]WS[DBSO_!BOMR!7)7NK>)_^$ \-Z_IE_-+>Q:<-1O8&P1>HOE%U
M/'!P['Y<>GI7I"Z+I2APNF60#IY; 0+\R?W3QR..E20Z;8VYC,-E;1F-"B;(
ME&U3U P.![4 >?IXFU+4_B7X;CBNIX=&U33YKE+0J$+*JY5FXR"<D]>F/>F>
M$-2U76/!>MZE=ZM=M/97EZD95@,J@^0'CH/U[YKT-]-L)+F.Y>RMFGC7:DIB
M4LH] <9 I(=+T^WMY;>&QM8X9<F2-(5"OGU &#0!Y@=:UI?@4?%0UB[_ +3:
MP$A<E<;_ # -P&,#C(QT]JVY]1U&'P1J^I/>75K?1Z3-/;Q22JY<I"KB=?\
M@38(Z= 17:?V5IWV'[#]@M?LG7R/)7R_^^<8IBZ+I2*ZKIED Z>6X$"_,G]T
M\<CVH \ZTOQ-KD%W\/0EY)??V[9[]0MY%5BN(U;SE(&5P2<CH>@ ->IU6M=.
ML;'/V2SM[?("GR8E3@=N!5F@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#GH]1OO^%A3Z
M6\ZM8C3$N4C$8!5S*5)+=3P*S[B'Q+::_I:/XC\U;RZ9I+1+*,(D*@LP#8W8
M'RIGKE@:TUTF^'CM]9(M_L3:>MH!YC>9N$A?.W;C'..M7$L)F\22ZE,4,4=J
MMO;*#RNYBTA/UVQC_@- &E1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%8>H:7KMS>R2V7B/[';MC;!]BCDV\#/S$Y.3D_
MC0!N4C*KJ590RG@@C(-<W_8GB?\ Z&[_ ,IL7^-']B>)_P#H;O\ RFQ?XT 7
MY?"_A^=]\VA:9(_]Y[2,G]15RTTVQT]=ME96UL,8Q#$J?R%8G]B>)_\ H;O_
M "FQ?XT?V)XG_P"AN_\ *;%_C0!TM%<U_8GB?_H;O_*;%_C1_8GB?_H;O_*;
M%_C0!TM%<U_8GB?_ *&[_P IL7^-']B>)_\ H;O_ "FQ?XT =+17-?V)XG_Z
M&[_RFQ?XT?V)XG_Z&[_RFQ?XT =+17-?V)XG_P"AN_\ *;%_C1_8GB?_ *&[
M_P IL7^- '2T5S7]B>)_^AN_\IL7^-']B>)_^AN_\IL7^- '2T5S7]B>)_\
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M_8GB?_H;O_*;%_C0!TM%<U_8GB?_ *&[_P IL7^-']B>)_\ H;O_ "FQ?XT
M=+17-?V)XG_Z&[_RFQ?XT?V)XG_Z&[_RFQ?XT =+17-?V)XG_P"AN_\ *;%_
MC1_8GB?_ *&[_P IL7^- '2T5S7]B>)_^AN_\IL7^-']B>)_^AN_\IL7^- '
M2T5S7]B>)_\ H;O_ "FQ?XT?V)XG_P"AN_\ *;%_C0!TM%<U_8GB?_H;O_*;
M%_C1_8GB?_H;O_*;%_C0!TM%<U_8GB?_ *&[_P IL7^-']B>)_\ H;O_ "FQ
M?XT =+17-?V)XG_Z&[_RFQ?XT?V)XG_Z&[_RFQ?XT =+17-?V)XG_P"AN_\
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M?_H;O_*;%_C1_8GB?_H;O_*;%_C0!TM%<U_8GB?_ *&[_P IL7^-']B>)_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% #6=$!+LJ@#))..*<2!U.*\PU^Y&N?#[QKJ5RBR,D]Q:P!AGRXX6
M"#'IEE9L^K>PQT]MJ5[?Z]>^&]<L;9-]H+J"2UE9@8]VT@D@$.IP01Z@C&*
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M/I2AE8D*P)4X.#T-</!XH.K67A:]N-*M7:[U6:T)DSF"2,3KYB C()\INN"
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M%QE7)7D@8*G@YK-N=1GF\5^$M=OH;>*&73[RY C!,D:>6C[6/\7![8YSQWH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MF7JV.(U)*RDC(;CC .3G^M79=<TR"\BM);R-)I7$:!L@%R,A,] Q'(7.2.U
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MRJA/R'(VXQDD@\<<4 9X\'V4>N7&I6]Y?6T=TRO=64,@$$[J  S+C(.  =I
M..0:AN/ UE<7,\G]HZC%%+?IJ/V>-T").I4[AE">2HR"2/0"M&S\4Z%J%U!;
M6>JVL\T^_P I8WSOVD[@/4C!X]!GI3+[Q7I&GZ?>7DER6CM8'N'"(Q+(O!*\
M?,,\9'% %>3P;8S:9K5A+=7CPZO.;B8[U#(Y"C*$*,?<7KGI]:KW'@+3KQ=1
M^UWVHSR7XA:25I55DDB^Y*FU1M<8'3CCIR<Z;>)](BM89[B\2%9(A,0^?D0G
M&YN/E7/&3@5F7^O:E;^(=;L(C:^5::0E];EHF)WEI 0WS<C]V.F.M "ZCIMQ
M9:))I:6M]KTFI*]O/<74D>%!4@&3[N$]D7/4XR>=[2]/ATG2K73[?/E6T2Q*
M6.2<#&2>Y/4GUK*L/%-DOA[2[W5;N&">YL8KJ48.U RKECUVIDXR>/>I)?$^
MG#5]0TG[0L-Q9VR3R2RJ1&@;?C)X! V$GGVSF@".?P?I\\^HGSKE+74W62]L
MT9?*F8  DY7(W!0&P1G%7;'1(=/UC4M2CN+AY=0*-+&Y78I1=J[<*".!W)J.
M#7+.#1["YO-1@F:>V6;SH4(65=H+2*HR0G(.>V1DTMSXGT.S\H3ZK:J9H?M$
M8$@8O'Q\R@=1R.G7- #]1T2'4M2TR^DN+B.73I6EA6,KM+,C(=V5.?E9AQCK
M6;#X+LX+>Q@6^OBEEJ#ZC'DQY,KERV?D^[F1^/?V%;]I=V]]:0W=I,DUO,@>
M.2,Y5U(R"#5:?6]-M;H6T]Y%'*76,@GA7;[JEN@8Y& 3DY&* ,*V^'^F6[68
M-YJ$T%F9Q#!+(A01S??C.%!*\]SGMG'%/L? MG92Z:3J>HW,.FI)%:P3O&R)
M$ZA2A^0%A@ #))]ZU5\2:*VJC2UU.V:^,AB\A7!;>%W%<>NWFKMU>6]E$)+F
M41JS!%SR68]  .2?8<T <Y9> M-M=+N-*FO-1O=,DA:WBM+J<,EO&PP53 !X
M' +$D#H15"T\-3VGC*WBN)M2U*P.C3V;W5VRD@M)&0F5"_PJWS8SZG.*Z1_$
MVAQ6D5U+JMI'!+(T2,\@7+KG<N#T(P<CMCFG6GB+2+_33J%IJ$,]J)#%OC.?
MGSC9CKN]L9H Q(_A]8"&.*XU+4[E(].ETL"61!_H\@4%?E0<C:,-UXY)I[>
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MV5I=Q3%][P2/,8V3<V20RKNP3D<XX->@PZ9I]O;2V\%C;103$F6)(557SUW
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MW:'2M.;3WT\V%J;*0$/;F%?+;/7*XP:C&@Z.(VC&DV(1MFY1;I@[1A<C'8
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M3S"=X7.W9SG;GMBHU\$RQPPP)JO[B#5VU2)&MP2I9W<H2&&1ESSZ <=<MN?
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MWN8+6:VM?LL7DK!YHVNXR6)? &.<#TK/3P!<"VEBDUO<9='.D-MLU51'SA@
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M787]J0BAG/G+\H)QD\\#((^HK@]%L&EU".PUK1]5DU"PU">YCNL'[,ZNSGS
MXX.4?!3DD\$8Y$.C^'TB\!Z>OV*]TS4UO'_TJWL29H2)9&1F0KEX\$#'3YNV
M. #N;G6K>UFL7+QR65Y*(([B-P0LISM![8)&W/K@=^-*21(HVDD=411EF8X
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M$)-F0 Q#*3CN5]Z[;0/LTL5W>VNF3V"W<_G.+B,QR2OM +E#RO0#G!.,X[D
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M/#5YK.D:%X=NX+U);"[U66REL3 !A7GE^</][<",GMCMQFM.T\5:I<Z+X?\
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M#>!;\H+622TD1)2T9D 5B,'Y5;\L4Z3QIHL444CRW'[V\DL45;61F,Z!BR8
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M/:>+L6FF1P+=JR2K&S ;6Y8*,_(#W"XS39/&6C0VQFEFF0K>+8R1F!R\<S$
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M:V9Y]-A8R,LDD*DN ,@D=>1C]* (]3TNRUFQ:SU"W6>W9E;:21AE((((Y!!
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MKB73X&@M,S/B-"!E1R>#A>QZ#T%8?C3Q.UCH]R=*N)TN;:\MX)9HH0\:,\B
MHQ((!*OVZ$CD$X-RX\3Z;I=UKMQ>:C=-#8"'SX3:G;;[@<;2%RP;J220/44
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MOX?TB/3K48A1G95!)"[F+8&23@9]:J6W@SP]:/"]OIB1M )!$5=@8P_W@O/
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MC-:-)&56X08)*$]>"#CKCGIS6O0 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!P*^&[J?0/$?A
MV*=;>\?4GU"SED!*L&E6="?50X*'OQ[C.Z]WK,7AV^N=6M;6*[:$I#:6DIE#
MO@@ ,57)8D #''J>:Z# R#@9'0T$ D$@$@Y'M0!E^&-*;0O"VE:4[!Y+.TBA
M=AT+*H!(]LYK5HHH :X8QL$8*Y!VDC.#7GVG^%?$L=]:WUZNG272Z3<6%S+]
MJ=FFD=HV$G,? )0_+T4'C/2O0Z* .)T[0K_1I?#-Y?R6,5KHFC26=W*9R #M
MB^<94#:!"222.OM4W@S3(8KS4[VSNTN=)-PZZ9Y>"D:/AY=C#@J9,@>FS%=>
MZ+(C(ZAE88*D9!'I2(B11K'&JHBC"JHP /0"@# \4Z1J%_+I&H:6T+7FEWGV
MA89W*I,I1HV7< =IVN<'!YKG+GPAKTXO;P1:7]K_ +:&J6]O+*TD4BFW$+1N
M=@QQN(8 \XXKO)+B5+Z"W6TE>.1'9IU*[(R,8#9.<G)Q@'H<XJQ0!Q]QH&JW
M4&B.MGI=I):ZHM]/;V\A"(@C9-JL$&]OFSDA?3M5*#PYX@37M+U74&TZ0V%[
M=2RW+7#[G@D5PN%*83:& V@X."<]SWM'48- '&>&;&UN/$VJZKIE_%=Z,[^=
M;B)@T:W,BCSF5AP1A5/'0R2#UKH- O+^_P!)2?4[:&WNB[JRP2%XV 8@,I(!
M((P>GZ5H111P1+%#&D<:C"HB@ ?0"GT <)K?A36-1_X2L0"R U;[-]G+S,-O
ME@!M^$.,XXQFG:YX3U75Y?%10VD:ZMIUO;VY:5B5DC,A^;Y> =_49Z=*[FJ]
MI<2W*2F6TEMBDKQJ)2IWJ#@.,$\'J,X/J* ./NO#VN?\)'/J<>GZ)=QZC#&M
MQ%=NS&UD0$;D.S]XN",J=N2.HS5^ST/4K74_$LY6U:+48XEML2D'*1>7\PVX
M7/7C-:VBZU%K<=X\4$T)M+N2T=9=N2R8R1@D8YXYK3H XE?#6L6WAOP?!"EG
M+?Z"\7F1M.RQRA8'A.'V$C[V[[O;%8][IFJ:++H:W*6DD]QXLENXUCF;!62&
MX;!)7@\^_;I7IU0S6EM<NCSV\4K1G*%T#%3[9Z4 <9<^$=29Y-1@%K]NEUN+
M4W@>5EC")&(@FX*?FVC<3CJ2/>FZCX0U:^O-;NDEM(IIM0L]0LCYC%2]NJ#;
M(-O 8H>F<9]J[NB@#A=>\):GK<>M7BI:PWU_:VUI'"TQ*(D<AD+,P7DDL0 !
MT YYXV].TJ^M_&&KZK.L MKVVMHHPDA9PT?F9R-H&#YG'/:M^B@#G+W2-0A\
M91:_8"&='L?L4]O+(8\8<NCJ<'N6!'H0>V*S-%\'WVBZGX>>-K>2VL+:\2X;
MS"&,EQ(DAV+M^Z"I')'!%==>W$MK )(K26Z8NB^7$5! + %OF(& #D^PJQ0!
MGZY9-J.C7-FMK;77G *T%T2(Y%R-P) ..,X.#@XKD5\(ZS9V=E]DE6=;#5UO
M;.TO+MF,<'DF,Q^:5)X+LPR#@8&:[ZB@#@5\'W\]A>6NJ6-C<QW&JS7P,-T\
M<D.\?*T;A05<'WY!/TJOI=OK.G>-5LY7BU*_C\.Q)++-,5W-Y\F"3M^8=B<
MGKCG%>C55FCL+67[=-'!'*2L?GE0&)8A5&[KR2!0!PEIX%U+P]/8#3;?2M5M
MQIT-C<)J&4*/&6(D0A6X.]LKQT'-6]2\)ZM<Q^*XH?L6W5M*AL;=MY0*R)(I
M+*%(4?O. ,]*[JB@#BKKPMJ%QK=KJ4"0V-["]N#>6URP\V!=OF12IM DS\X4
MGID'C'-?_A$=861KU&M!=P:\^JV\?FL4EC=#&R,=ORMM)P<$9Q7>T4 <-?\
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M'# L1G.#Q7H=1R7$,4T43R*LDI(C4GEL#)Q^% ',_$HX^&OB+_KQD_E5;5M
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M3WLMU')*T2YN6WL4(5N%/ ! R/2NXHH X/1O"FMZ9_PC<DGV!Y--DO%G F<
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M:9@D=N448W$\1Y(_V>E>KC804&TA>"H[=\5EZ-H@TA]28W'GB_NVNV#)C8S
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MT >16%U:6VEV:VM\4C7QE*@VW! :,RN<'GYAC!YS6B+UX==OH9IX;RVF:_\
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MWMQXIM;^R55M+^W^R:JK'!\M3O0X[G_61GVD]J -R?7=+M6B6>_@C,NS9N;
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M5)P&V%3G'!J;6="U+Q)<:C?QV4MC)-X?N-.$4[INDEEY .TD84@\_P"WQWH
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MHJ2R;V.Y5SM!&<8&3CTR?6KE%% !1110 4U4169E4!F.6(')/3FG44 %%%%
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M(,?(6!R.3G!'!XK1U#5S;:A#IMK;BYOY89+A8S)L41H5!);!QDLH QSGT!H
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MV\]%9 P!R&4_>'\+9Z\5TL<2>'-!N98+:\N?+#SBUCD:9]QY,<>>V> .@]J
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M$?@ =?17'6OC&ZU34O# L;)%L]6MIKB3S9,2)Y>T%< $<%_7G':NQH ****
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M!@]ABKK:_,OC9/#WV*/8UB;W[29SD*'"%=FWKD^M:T5Y:SR>7#<PR2; ^U)
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M7Y[>*2T@M;Q981*\WE+M616)&Q]O!.".G'%=#>ZK%#I=[=V;P74EM$[^6)@
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MX!09?A?E&!T';% &#;>(/$<?A72-<O':[M[^&&>X73K,&6U0Q9+!23O&\KG
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M[2;W3+[79KK[.8]0OS=Q>4Y8J#'&F&RHY_=YXSU]J@U+1M43Q?:Z_I;6LO\
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M1QMX;][TZ?+U.>(&\&ZY"$O;5],:_@U6[O(X+AG:&6*<DLC';E6'!! /(]Z
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M:M8P>%HY6LC_ &1=7$TQ65_G619%&WY.H\S/..GO7<4 %%%% !1110 4444
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MH\SBZM-4O8+Q?FW1 I<;5<]N=A /L10!ZE?3SVUE+-;6CW<R#*0(ZJ7/H"Q
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M4QTM+J:SDBG,(D>UWJS*V,E,YVDCIG.*AT+5H]>T"PU:&-HH[R!)U1SRH89
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M"5=Y-Q$0.[Y?N$;CD9/3K4UCKVN:CXGN].CL;."WLUMI9O.E8R;)58D  8W
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M2%P<9.2  #_%UXYRO#&JS:/#>:='!%]MO-?O47RHR8T"C<S!,@GH.,CKUXY
M/2:*XE_$WB;SM)L/['L[:_OFNH_])E;9F(95P%R0K#!P>1G'O6CXUU#4],\)
M&ZLIH8;KS[:-V*E@ \J(VWD?WNO^0 =+17(WOBB_CBUZ2RAMIO[!1?M*.&4W
M#^6)7"'/R84C!.[)XXQDU=4\=S16VI7.GVL3)9:=;ZA''<9#W:R[L*F.A&T#
M.&RS 8'< [BFNZ1HSR,JHHR68X %<E?>)]8$U[;Z7I:75WIZP^?;@$^:[J&*
M*Y("84C!(.3Q@8S7-^+;S4-1T+Q_;WSP26MBL2V\7E8*9CCD!SDC(W')]?3I
M0!ZG17'7'C"]TJ\UFUU*UMVDLX[22W^SLV&^T2-$JMD=0Z\D#D'I45_XI\0Z
M;&_G:1"RF_M+:"XD)B699G"'Y,L592>YP<@^U ';450B.K#1F,RV?]J!&PL9
M8PELG;UP<$8SZ<]:Y2P\?&>XT8W0@AMK_3Y)Y6V-N@GC!W1'G'\$OO\ NF'O
M0!W'F()!&77>06"YY('?'XB@NBLJLRAF^Z">3]*Y%]4OU\16MO<:?I\>HOHD
M]R+DH6:)@\8,?7.S+#/S<E>U<]8W&J:A<?#W4W:UFU2ZTV=S-(A48:&-OFQD
MGDDX&,^U 'J--21) 2CJP!*G:<X(ZBLGPMK,NO\ ARUU&>%(9I"Z2(A)4.CL
MAP3SC*DBN9MO$]Y;6<'V+2=.ADNO$-QITJHY5=P:3,G"\EBA)/O0!WU%>?W7
MB?7+BTM(T:TMKJ/Q"NF7+(C,DBCY@5^8$ C&1SWYK37Q-JMW>YTW3/M5I%J#
M6,X"E6 5MCRAB<85@?EP20,YR<4 =;17#6_C'5S97.H75E8K;1W\FF1I%([2
M-/\ :!"AZ8V\DGOQQUJ>Z\5:OI=I=3:GIC0VT-U'&+]8&9/)923(T08L K#:
M>>X;ID4 =E4,5M%#-+,H/F2D%V)R3CH/8#T]SZFN1MM=U._\5Z!%#>V$EA=V
M%S<.;=2Z2[)(E#*V[NK\>ASG/:]XFO\ 4[76_#5M8W$,45Y?/%.'C+%@()'
MX(XROYX^A .D5T?.QE;!P<'.#Z4ZO-/#NJWFA;XX;6T_LVY\3W=DR@D2*7E?
M:5 X ! &/?M6]9^)M5U*YM;BPTL7&FSW,MN[8*M$J%E$I8G!!9>5 R-W?!H
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MWO8F3>ZQ0*L8PP.W+EY,<'&!GV(!NZ%I$>@Z%9:3#-)-#9PK#&\N-Q51@9P
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MJ%Y;S6&F?:-->^EM)2%VM&J.R&7<3@C<GW<9P>O:NLH **** "BBB@ HHHH
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M68A5S@' R1S6%_PF<.G^)]8@U:[2'3K>UM9X";=U9!(9 Q?J0!M7)( &><4
M:5QX1L;BPCM?/NH]M\NH/*C+OEG5PX9LJ1U X  P .G%:.K:5;:UHMWI5[O:
MWNH6AE*G#8(P2#V-1ZAK^EZ43]MNA$H"EWV,RQACA2[ $(">A8@5+J>K6&C6
MHNM1NDMX"ZQAWZ;F. /S(H S6\)V\EU/=2:A?R33V'V"1W9"3'DG/W/O98^W
M/3%56\"V*RV$UMJ.IVD]I:I9&6VG"-/"OW4D^7!QS@@ C)YJ^WBS1%L/MQO#
M]FVL[/Y,A\M58J6<;<HH((RV!P?2LO5_$5S-XA;1-,N&MI%L#>+<_8WG1F+
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MXZD  X(!QR#5[7=!M?$%I#!<R30R6\ZW%O<0,%DAD7HRD@CH2,$$$$\5J44
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MTZ"-$O+NS>-(V?@.5X!;],UFI8:S;>(=2U0Z9]HAU:PBB:W\]-UO)'O 5B2
M4(?DKG!!X/6NQHH Y[3O#TVG?#Z'PZ)Q+/%IWV3S3G!;9MS],_I6-HNDZS;:
MKH-U=:8R)8Z&]A*%GC8^83$1CGH?*;\Q[X[JB@#S#3/#&NZ/9Z"\FAV^IK%I
M2Z=>6;W"*8F5B1(I.593N((Z]/I7;7-A+%X0FTZULX5E^QM#';VV$C4E<!5S
M@!1GVXK9HH \S7PAJ,_A[PQIUOI,>F:EIIMO/U/?&&41@"0(4)9]V",-@'/-
M7+CPKJL^C:YX<DAWP:AJ;7<-^)%Q'&\JRL&&=V]2& P"#\O(YQZ!10!Q8T;4
M_LGC>/[$0VJR.UI^\3YP;=(AGGCYD)Y['\*5M&U6"3PCJ45J9'TJV>VNK,2(
M&(>-%+*2=I*L@[C()[\5V=% '"R>$M0'A_4);81IJTFKMK-G$[?+')N&$)''
MS*"&QQEVZ]:MZ%X5O-)U^^>2Y\W3I,74>3\WVN1=DS^PPN[TS*WI77T4 >?>
M'/#^J:?I]OI]_P"';$SZ7;O!#J22HS7 V%%* \HS#&[)'?KGCI_"%C<Z7X.T
M?3KR'RKFTLXH)5W!AN10I((ZCBMJB@#SJ7P_KZ226D6FI)$OB1=46X-PH5XC
M('( Z[AR#D#VS5>UTNY\0:7XDT:.U*QS>(W=KLLNV-4DC=CC.[=A2!QC)'/6
MO3:JV>FV.G>=]BM(+?SG,DOE1A=[GJQQU/O0!D^+M.O=0L=/:PA$\MIJ-O=-
M$7"EU1\L 3QG'K7/7?A?5[C2?$^@O;K)#K5TUQ#>"52L D"[@P)#90J=N <_
M+TKT&B@# \8Z5=ZMX2NK&Q02W),3HCOMW[)%?&3W(4U@:OH>LZB_C!UTXJ=6
MT>*SMQYR$>8%F!!YX'[U>?8^V>^HH \^E\/ZK'K%T9?#]GJMCJ<$ ;[3,@^R
MR)&$974YWH< _+DYSQS6]XQTR\U+PXEE86_G2B[M9=@94&V.9)&ZGT0@#UQ7
M1T4 <3K>CZE_PE4U_%H=KK.GZA9QVTL,\RQFW9"_)W AD82'(&3QT-7;72;V
MW\;1W8LT2P32$L@\1545P^["IG(7' KJ:* /.?#V@Z_8-X1BN=+5(]$MI[:>
M07*'S,HJJR#T.WO@^N.I;I_A764TKPG92VK0/81745S*LJ'RO,C9%9<-SRP/
M%>D44 >?:/I'B&.;P=#=Z3'"NAI);W$RW"%)%\GRU= .<' ." 1^M;^NV%Z_
MB30=5M;5KF*Q-PLT<;JKXD0 $;B <$<\_G7144 >=ZAH,NE^&9)8Y[>#7?[5
MDU6QA+\"623 AXY(97V,1QER:[G3+(:=IL%KO\QD7YY".9'/+,?<L2?QITNG
M6,]]!?36=O)=VX(AG>(%XP>NUB,C/M5F@#SRP\/:W;0Z!:RZ>"FFZW<7;RK.
MA#Q/Y^& )!_Y;+QUX;VS"_AO78"+^+2XKIX-:N[LV,LZ+Y\$V<%6R0'7@X/O
MS7I-% &9H=I]ATO']FV]@SNTIM;;!"DG/)& 6/4GID]^IX)?"6H2^$]:TN7P
M[$VI7UY=3VUW++$%@\V1F1]ZDN&7(/ ZCK7J%% '#VNA:UH^H:@SH=8CU'3+
M>V>4R*K+-$C(2X8_<?=NR,D'/'-/\.>&K[0==L \;3VEIH,.G?:=Z_/(C$G"
MDYQZ?Y-=K10!Y]#X9UG_ (0BVM%@6+4+'6&U)('D7;.HNFF"%@3C*MCGHP].
M:TI/"[:W?^(;N_@>TAU:PBL1 S*779O/F':2,Y<8P3C;[UU]% '!Z9X5UP:Q
MINIZC<1--=6RKK**V59XBK0[/H=P/KD^M+;Z!J,&OW]M<Z#8ZA8W-^;V#4)I
M%/DY(8JT9&2RD':1QTY&*[NB@#G?".GWFG0:JMY;& W&IW-U'EU;<DCEEZ$X
M..HK+\0Z'JE]K'B*:VLR\5[H']GP-YB#=+F4\@G('[P<^Q]L]M10!R6EZ5J,
M'BK3[V:S:.WBT5;.1S(AQ*'5L8!SC /-6[^PO9?'FCZC':LUG;6=S!++O48:
M1HBO!.2/W9S]17144 >=:?X?U^V.@6;::GE:5K-S<O.;A<212"?:RCKQYHR#
M@Y]1S3V\/:R=+EA%@WF'Q,NIA?-CY@%P),_>ZX&,>M>A44 5;6>ZEGNEN+/R
M(XY-L#^:'\Y-H.[ ^[R2,'TSWJU110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !115:6]BBD*,&R/04 6:*J?VC#Z
M/^5']HP^C_E0!;HJI_:,/H_Y4?VC#Z/^5 %NBJG]HP^C_E1_:,/H_P"5 %NB
MJG]HP^C_ )4?VC#Z/^5 %NBJG]HP^C_E1_:,/H_Y4 6Z*J?VC#Z/^5']HP^C
M_E0!;HJI_:,/H_Y4?VC#Z/\ E0!;HJI_:,/H_P"5']HP^C_E0!;HJI_:,/H_
MY4?VC#Z/^5 %NBJG]HP^C_E1_:,/H_Y4 6Z*J?VC#Z/^5']HP^C_ )4 6Z*J
M?VC#Z/\ E1_:,/H_Y4 6Z*J?VC#Z/^5']HP^C_E0!;HJI_:,/H_Y4?VC#Z/^
M5 %NBJG]HP^C_E1_:,/H_P"5 %NBJG]HP^C_ )4?VC#Z/^5 %NBJG]HP^C_E
M1_:,/H_Y4 6Z*J?VC#Z/^5']HP^C_E0!;HJI_:,/H_Y4?VC#Z/\ E0!;HJI_
M:,/H_P"5']HP^C_E0!;HJI_:,/H_Y4?VC#Z/^5 %NBJG]HP^C_E1_:,/H_Y4
M 6Z*J?VC#Z/^5']HP^C_ )4 6Z*J?VC#Z/\ E1_:,/H_Y4 6Z*J?VC#Z/^5'
M]HP^C_E0!;HJI_:,/H_Y4?VC#Z/^5 %NBJG]HP^C_E1_:,/H_P"5 %NBJG]H
MP^C_ )4?VC#Z/^5 %NBJG]HP^C_E1_:,/H_Y4 6Z*J?VC#Z/^5']HP^C_E0!
M;HJI_:,/H_Y4?VC#Z/\ E0!;HJI_:,/H_P"5']HP^C_E0!;HJI_:,/H_Y4?V
MC#Z/^5 %NBJG]HP^C_E1_:,/H_Y4 6Z*J?VC#Z/^5']HP^C_ )4 6Z*J?VC#
MZ/\ E1_:,/H_Y4 6Z*J?VC#Z/^5']HP^C_E0!;HJI_:,/H_Y4?VC#Z/^5 %N
MBJG]HP^C_E1_:,/H_P"5 %NBJG]HP^C_ )4?VC#Z/^5 %NBJG]HP^C_E1_:,
M/H_Y4 6Z*J?VC#Z/^5']HP^C_E0!;HJI_:,/H_Y4?VC#Z/\ E0!;HJI_:,/H
M_P"5']HP^C_E0!;HJI_:,/H_Y4?VC#Z/^5 %NBJG]HP^C_E1_:,/H_Y4 6Z*
MJ?VC#Z/^5']HP^C_ )4 6Z*J?VC#Z/\ E1_:,/H_Y4 6Z*J?VC#Z/^5']HP^
MC_E0!;HJI_:,/H_Y591@Z*XZ,,B@!U%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !7,>)4U.6.6+2)8(+IR%$\Z%UB&.6V_P 1[ 9[
M^V*Z>N/\9WVJ:?I]U+HVG/?Z@V$AB5E !(^\Q)' _7B@#B_"WC+5+72O$[^*
MI(IAH4YC-W @438S\H' SG'I]X5L^#?$;>)(?M<VI6@N'02_V9;LK&WC;[N\
MGYBV",G@9.,5S*:)KOB+P#K7A^;P_P#V*6C5X6FNEF>[GW^8S.P P25&3C^+
MT&*DTS0]9_X2;3?$"Z9)"^FZ +62"1@AN+@!OW8.>1T^;IT_  ]-(R",X]Z\
MST3Q1JE_XD\56.H:X;6UTFX6*W=88MS;F90&RO)X XQUKN]#O+^^T2VNM4L#
M87LB$RVV_?L.3W'J,'\<5Y_X:\'RS^,O%=SK6CLMM?723V,\J*Q4J[-N')*G
ME3VH WXM5U2T\6Z+H]_K=L99()VGMOLC!KK&[:ZL!M7@ D9]1SGBTOQ$\+L5
M U)L&Z^R%C;2A4E_NL2N%_'T/H:SM:TK49_BSX>U:&RE>PM+:6.:=<85F5@.
M,Y/4=!WKB9_"/B)_"&H62Z/<&YF\1_;T3<G,./O9W8_#K0!ZIJGBW1-&DN$O
M;PJ;8(UQLB=Q"'.%+E0=N3ZT7_BW1-,O[:QNKQA<W41E@CCADD\U0"?E*J03
MQT'-<#XXT+Q#K=_XCAL]!_T>XM(1;W$#1H;AE*L?-).YB,$!>G'/8UH?V/JQ
M\:^"]2;3+A;;3].>*Z;*DQN8F4#@\\XZ9ZT ==;^+M#N]$@UB"^5[*>00Q,$
M;<\A. @3&XMGMBL37?&5K-H]C=Z/KD%F'U);662>TD?)&=\1&W*L??'3KWKB
M+#PCXHL/!.CR1:9(=0TG63?-9,Z@S1G!R#G&?\371^--*O\ 7?#FF?V7X<FM
M9?[8CO9H,1J^ K;G?:<;B2.Y)H Z[4_%^AZ1+/'>WNPVS1K<,L;NL!?[F]@"
M%S[UDGQ!J"_%E- $ZMILFE_:PFP9#[BO#=<<?K7)>-_#_B/7)O%$-IH&V&=;
M8VTMNT:?:=K L9.0SL!D '@8/?!K=LM)U3_A:=AJ\FG3Q62:*MJ\C%3MER6V
MG!/YCB@#2\=^*V\,/HXEE>UL;RY,=U>I&',"A<C ((R3W(/ /!ITGB<:-H>H
MZ[<7ZZKH\<2/:S6R!G8G<&5BG&<[>< #/J#G0\0I)<3VMG/H_P#:>D3QRB\3
M:K>604V-M)R?XN!SW[5P/_"OKRVT7QE:Z';SPZ=J$,8L;.X?#,Z\L0&.5'8;
ML$]^ #0!W5AXPT^?1M,N[HRQ7-]"'2W%M)O=@@9]BE=S*,_>''O5'6OB'I.G
M^';#5[%GO8M0G6"V:.)RNXG!W<9! !^7J<8 ZXQ;BQUZ6W\'11^'GVVMOY5U
M-NB%Q!B,+A6+?(K'.2/FP.,&N?M_!_B*+X9:)IS:3-]MTW6ENI8-Z;GC!;)7
MYL'[PZXH ]/NO%NBV1Q<W3Q$1+-(&@D!A1CM#2#;E 3_ 'L=_0U%?^-M TV_
MN;&YO)!=6T/VB2)+:1R(^#N&U2",'.1T&?0UQ][X?O\ _A/=7NK_ $&^U'2-
M<MH5*6]R$,3HH79( ZC'7G)'/&>:6Z\.ZI'XVURZ@TN7[%-X>:PMV1@P,N%P
MHR<XXQDT =?:>-_#U]>V%I;:AODOU+6K>4X27 R0'(V[AW&<CH>:L_\ "3Z/
M_:(L?M@\TW'V7=L;9YV-WE[\;=^.V<]NM>;:;X9UV"'X>))I4ZG299S>\K^Z
M#,,=^>.>,U=\->%[NQU.]TK6M"N[R-=6.H6=\MT5@&3D.RAQ\P_W223@\<T
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M-BACF;&"ZA,C&<CH>W:N]H **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "MRW_P"/:+_<'\JPZW+?_CVB_P!P?RH DHHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH *@DM(97+LI+'KS4]% %;[!;_W3
M^='V"W_NG\ZLT4 5OL%O_=/YT?8+?^Z?SJS10!6^P6_]T_G1]@M_[I_.K-%
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M^='V"W_NG\ZLT4 5OL%O_=/YT?8+?^Z?SJS10!6^P6_]T_G1]@M_[I_.K-%
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M<K<D&X\Q(@K\KP0'4;?8\T[4/&FK:>NOB31+5GT6%+J;;?':\#*S?*?+SO\
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MEM(!*B'*.5)S@#IL7'T/7-167@./3!I4EAJMU!=:="]L)PB$S0NVXHZD8X8
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M1BKKM '#\$$].0,UUM<UIW@^+3G\/E+^9UT2V>V@5D7]XC*JG=[X5>F*Z6@
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M,5LT4 1P0Q6T$<$*+'%&H1$48"J!@ 5)110 55DTZRF%P)+2%Q<D&?<@/F8
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M%B,ABN H+9SC'OQ5;P3>W=Y+XD%VUSF'6)(HX[B3>8E$41VC!(VY)(QZT =
M=,L6U Z@UK$;PQ>29BOS%.NW/I[5'9:+IFFJ5L[&"!2NS"(  G]T>B^PXK$@
MUO\ M"U\1ZC(;G[%I\LUG'';-M<B)?WC@Y'S;MP'/ 08Y)K/O-7FNKKPGIEK
M'J9T_4K1YGE2X"3,!$NW+[PV1NW,>YQC/(H WH_!_AV!"+?1=/C;RY(U/V<$
M*KCY@!V!]!BM#2M-@T?2[;3[5=L%NFQ!C  ]AV'MVJG<7_\ 8-K969COM0E\
MIAYS;<D1KDM(YVJ">/3)/UQF+X[M;A=._L_2M2OGU'3SJ%LD*Q@L@* @[G #
M#>.O'H2< @&S_P (_H_]M'6?[,M/[3(Q]J\H>9TQU]<<9].*?%HNFP7KWL-C
M ERSF0N%QER,%O\ >(X+=2*P8?B!97L6G'3M,U*\DU&VEN((XTC5OW3!9$;<
MX"LI;!SQQP2< U/^$C37-8\&ZAIL]W%:7L]U'-;N2ARD,F4D7.,JZ_F* -+P
MSX6725N9+Z"UDNI+^XO$DC8L%\UV;N!\P#;=W7'Y5IR>'=&FM;RUETRU>"]?
MS+F-XP5F;^\P/4\#GKP/2LG2?$=E]E*P1ZA+<7&I7-M';W$BM)YB,Q< [L+&
MNTXYX& .2!4\GBZ..PCN3I.I*S1SR/%)$(S$(3AMS,0O)(V\_-U'&30!>C\-
MZ-!:6UK#IMO##;;O(6)=GE[OO8(Y&>_KWK1AABMX8X88TCBC4*B(N%51P  .
M@KA9/$T__"76M]I]OJ6HV5WH0O([*W91UD4A]KL%!VG'7/85./$,6I^)O"VH
MV-[.NF7VGWDSQLQ53L\K!9>@9=S"@#IXM%TR&^:]BL8$N'<R%U3'SD8+_P"\
M1P3U(J2TTNQL;BXGM;6*&6X;?,Z#!D;U;U/ YK$L?%VFZW?Q:9#]HC-Y;-/;
MS(ZG<HQG[K$HV"#A@./H15OPMK$FL:9/]HP;NRNYK*X*C 9XV*[@.VX;6QVS
MB@#1O=,L=2\G[=:07'D2"6+S4#;'P1N&>AP355/#FC(D2)IMLJQ3FYC4)PDI
MZN/1N3SUY-4K?Q;;SZG;V'V&\CENHYY+82*JF01-M;Y2V5SG*[@ 1Z55TOQU
M:ZJ=-,.E:BD>I6\D]F\@C'FE!EDQOR&QZX!P>: -B#P[HUKK$NKP:7:1ZC-G
MS+E(@';/7)]^_K6G6%IGBJUU:QTNZMK2[ U"1T6-P@>'9NW&0;N "N#C)R0.
M];M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %<19^"]4M)-)B&IVAM-+U.:]@
M7[.V]TD$N58[L9'FD9'IGVKMZYZT\27&K6MQ?:-IPO+&&1XUE:?RVN"A(;RA
MM((R" 6*Y(].: ,VV\'7T%EI5N;RV;[#K$VIE@C?.)&E.SKQCSCS_LCCFF:9
MX-U2RU?2[ZXU2UG:REN2\GV9O-N%E[NV_P"\  .F !^%:%KXSM-0O=$%G&LE
MAJMO/.ERTFTQ&+;N5E(ZY;!YX(-7M4UMM.U71+1;=98]3N&@\T28\LB)Y <8
M^8'81U'6@#G--\"ZA:KH=M<ZE:R66DK/"BI;L'EBD4KR=W#8/4<<=\\2:7X.
MUBQ;PY#+JMI+:Z"[K ?LS"26(Q-&JM\V 0K8R/3..U=;:W$[I<M=Q10".5E0
MK-O#(.C'@;2?3G'K5@2(8_,#J4QG=GC'KF@#C8O!E_#86$::A;+<V>LS:FCF
M%F1A*9<H1N!X\XX.?X1ZU;TGP[K&D7UQ;1:M ^A2W,ETL+6Y\]"[%VC#[L;-
MQ)R5S@D>]=,)8VC$BNI1L88'@YZ<TGVB'*#SH\O]WYA\WT]: .)T_P $ZM86
M^@V']JVCV.B7IGMBUNWFO%LD0(QW8R!)C(ZX!QV.SXAT*_O]2TS5M(O8;;4-
M/\Q%%Q$9(I8Y N]6 ((Y12"#U'O70TC.J(7=@J@9))P!0!S;>'M0BUVTUR"^
MAEOUM&M+I98RL<J%]X*X)*[6S@<Y!P3GFJVE^#I=&U+2KFVN8G2RM;J)U="#
M+)/(LKOP3M&Y>G/!Z\5U@EC9%<.I5OND'@_2D$T1B\T2)Y>,[]PQCZT <(WP
M_N)O"EEH-U-8W"VML8H;@Q,DEO+DD31L#D$9'RYYP.15V7P9<B'7K""_4Z=K
M@S<^:A,L;-&(Y&4]#N51UQM///2MG0-<.MC4MUNL/V*]>T^67>) JJ=P.!UW
M=*M7.JV\%VUBDD;W_P!G:X6 O@E00,D\X!)QT]?2@#"NO"=Q)=Z[);W$$<.I
M:7'IT2%23$$$@#'GG_6GCCH.>:K1^$-3LKL7-AJ%JK7&F1:?>)-"S*WEA@DB
M88$'YF!!XYZUO^'=:37_  _IVJ"-87O+:.X,&_<4##.,\9^N*TUEC=F5'5F0
MX8 Y*_6@#SZX^'NJ3Z&FE-K%H\(T1=+!DM6/E,JE?,C&_@L" W?Y1]*TK[P7
M<ZC<ZH;C48UAU/38;2?RH2'22/>5=#NX&7S@Y^[UYK7\2Z\_A^ULYUM!<_:;
MR*T ,NS:TC!5/0\9//\ 6DM/$._Q(V@7MH;:^^S?:XBDGF1RQA@IPV 002,@
M@=>,T 9-YX8U_6M :SUC6K4WL,D4MI/:VI15DB<.KNI8[B2HR!@ 9Q5_1M$U
M.U\1ZAK&H7=I(U[;00M#;PLH4QE^0Q8\'>>W_P!?H%EC=F5'5F0X8 Y(/O2"
M:(])4.,=&'?I0!QNN>#=3U:_U"9-4M1%<3VL\'GVS.\'DNC&,$,/D8INX&<L
M:6X\':A/8:K;_;;8-?:O#J8?RV^3RS$=F,\Y\D<_[1XXKL//AQ&?-3$GW/F'
MS?3UIQEC!(+J".N3TH X>\\$:I)::OIUIJ=JEAJ&H)J*^= SR0R>:DCJ"& *
MEER.A&<>XU]5\+MJWA^YL9;ORKR6Z%XETB9V2I(&C.W/(4*BXSR!70AT) #
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M6NXVT6YU#[=M*'S4!E$K1 YP07!^;J 2,9YJ?6/!%IK.JZA=3SL+>^LOL\L
M''F@,JS9_O!78?EZ"NH26.1F5'5BAPP!S@^]()HCTE0].C#OTH Y>]\*W[:1
MH_V#5%CUC2Y#.+J:+>D[LK"7>H(X?<QX/!QBIGT'5;G5M#U&[O[:2:PDEDF5
M(F57\Q-FU!D[0!SR3D^F:Z'SX?W?[U/WGW/F'S?3UI3+&"0748Z\]* ,OQ+I
M5WK&E"VL[M+>19XY3YB%HY55@3&X!!*L!@\UST/@G489D8ZA9LBZT-5"I;LF
M/W>PQCYC@<\'MCOGCM@Z$X#*3C/7M2+-$\8D21&0G 8,"">G6@#BY/!.H"X>
M_MM0MX[^+6'U.V9HF9,/'Y;Q.,Y(*Y^8>O2MKPYHMYI$^KS7EU!.VH7AN]L,
M101DHB$9+'/W!Z58M-;2YUC4[)H?*ALDA<7+.-DHD#'CTQM_6M165ERI!![@
MT <E8:)/9VWB7100@U&XGNK69@2NV<?,#[JY;CT*^O$MMX9O8+OPQ-]JMV71
MK1[9QL;,VY%3(_NXV XYZX]ZT/$^O#P[HTE^L*7#HR#R3+L)#.%R.#G&X&K\
M=Q/]MNHYH8H[:)$:.4399\YW;EQ\H&!SDYYZ8H S-<T6^U+5-,NK:\@CAM3)
MYMO<0F1)"P&UP P^9<'&?[QKD-*TN]\.^*O"^CI=V=S<66AW%N796C5AYD.T
M=20V%S[[3TZCTAIX40NTJ!0=I8L  ?3ZTYY8X]N]U7<<+N.,GT% 'G<>EOX?
M\9>%].LIX)9H['4'E,V4#O++$YZ9VY8L0.>%(]ZV+7P=+8W&@R0W43?V=<W-
MW<%D(,\DX??MY^4 R$@<\ #WKI(M1M)]1N;"*='N;94::,')0/G;GW^4G'T]
M:G26.169)$95)!(8$ B@#B?^$*U."**ZL]3MHM3MM4N=0@=X6:)EG+;XG7()
M&&Z@]@:NZCX:UC4;BRGFU:VD*031W$4EL3%N?;B2-=_#* 5&2>&/<G.[?:M!
M9_9XT*S7%S-Y$$2M]Y]I8Y/8!06)]!W. ;;3*&,:O&9MN1&6Q_\ 7Q^% '):
M5X3U31WTF>&_LY;BSTE=,??"RJ0I!5QAB<C;R._J*=#X(6VFT2**X5K+3K.Y
MM95<'?-Y^W>V1P.5)_X%VQ71:9J46IV\CQ@I)#*T$\3=8Y%ZJ?T(/<$'O5IY
M8XBHDD5-QPNXXR?04 <YX>TO6M LH[75-8M[O3[&+R[<QVQ29U POF'<0Q X
MPH&3S[53T;3=:TF"&6W$*2:CJLU[?02QEBL<C<*&!PK*FW.<Y(P*Z]Y8X_OR
M*O3J<=>!5/6=2&D:/=WVQ)'@A>58GDV>9M!.T'!YX]* .7TWP;JUCJ>F7TNJ
M6=Q+8M<[G:V827(EQR[;_O# '3 'Y4NG>%+G0[3PV\]] \/A^&82LL39E5D(
MR ,XP.<<YKK-,O/[1TFSOO+\O[3 DVS.=NY0<9[]:J'5Y+F+4FTVW2X:SW1@
MR2^6LDRC)3=@X Z%NQR,<&@#'\):?:2:KJVO6+S-87TN^T21"@7<JF5T# $!
MW4$Y[J2.M=;6#J?B">VU!-,L+.*[U)K1[OR7N/*4JK*NT-M/S$MQD <')%;B
M,S1JS(48@$J3G!]* '4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ",-RE<D9&.*X
M;P3(?"/A"+0=4@N!=Z:TD:B*!W^TIO9D>/ .[((XZ@YSBNZHH \FTWPL=)3P
MI%X@T\36_P#Q,);N-H3-%"\S*Z(V 1ZCGC(X[5;T[2[K3!X3@-K<K:Q:Y=S0
M1&)V-M:M'.(@_'R#YT&#TW =J].I&8*I9B H&23VH \J=/[/T2\D^SW,,<7B
MMKE(!:2%9H]V>552Q3 + JK<J.*2VBMEM%O--0W%N^OB]U:VBLY$>.!@VP%&
M17=%?:_W>H8@<&NXU-=$UZWTV<ZJ$W7!%C<VEWL+2[64A"#AC@.".>AK4L-.
MBL$;;)--*^-\T\A=VQTY[ 9/ P.3ZF@#S36-(:0ZC+%92R:3/K^GSVL26[':
M%:/[1(J@953SD\ X8]^=#6=+_LK7(VT.RB>"-K57TF2S(C=1*7$D$BC".K,S
M$<CC)QUKT&XN8+.WDN+F:.&"-=SR2,%51ZDG@4+<P-:"Z$T9MRGF"7<-NW&=
MV>F,<YH EKF_&D@BTRQ+6,MTGV^'<4C>008.1(R)RX! XZ9()Z5O6MU;WUK'
M=6D\<]O*NZ.6-@RN/4$=13UEC:5XE=3(@!90>5STR* /);73O.BTJVN=,NY$
M@\57+GSK)U MW68Y(V@!"63/;G!J:VCGTQX"=.N1H-MXDNGGMX[5\+$R-Y3A
M .8Q(=W (!P>U>KU7@OK2ZN+BWM[J&6:W(6:-'#-&3R P'0_6@#F/ 420CQ$
M(K2:VADUB6:)9+=H@R,B?,H8#C(/2HM2MX[?XDI?2V,CQR:.\:3I;,X$@D!P
M6 .#M]?H*[2B@#R/0=*N;.T\''3[":TU)M"N;>YF-LR%9?+CV"5L<893C=Z<
M5M^!X;.YO+*\%KJ]OJMK9?9;Q+FV\F-#P2I8(HE.X9!!;C)R,\]K)JNGQ2W,
M3WULLEK%YUPAE&8DY.YA_".#R?2K,4L<\*31.LD<BAD=3D,#R"#Z4 <A\28F
MGT;2XDAN9?\ B;VDCBVC=F6-95+M\@R,#G-8ESIVIMXPU"Y\,)?E;C1IH9;F
M_63$4W_+%8I)?F^\22H.WOUKTVB@#S?3[-+NY\,W-K82VRVVGS0ZO%);LN4\
ML 1."/G;S.1UZ,>_.19^'+&+P)X,9]#87IN[(7V;-O-VH&#>9\N=HR1SQ@XZ
M5Z_10!YO?:5!9WWB?2[K2F^Q3V$2:0L%N615",#''M&%<2'=C@\@]N$OO#&H
M%M,BN;874VLZ2NDZQ,%#;)%4,)B>Y \X9[G8*]&\V/SO)WKYFW=LSSCIG'I0
MTL:RI$SJ)'!*J3RV.N!0!YM]@UV3P%=74VGR'5K1(;$QPH/,G@@F'FE 1_RT
M ? Z$;>.:J:II^F7^B7%_IUEJLZW>IZ?)()[)H^4F7>4C"*5Q&/F8#!QC)P:
M]7HH Y7Q#HUE;>'H+/31_9:"XC:&2UM!(D3!BX+Q@<Q[B<],;LY'6KG@YKH^
M'4%Y8P6DRSS K;JRQR?O&/F(K<A6R6 /KZ5IQ:KI\]^]A%?6[W:*6:!9 7 !
MP3CKP>#Z&K= ' 3074/CH36\0OK:?4!Y]M<VK+);-Y.SSHI>ACVX!!R,D@')
MQ6/H,;P/X,LVTZ\6?3=2O([D_8Y L(9)POS;<;3N7D9'(SCBO5Z* /*-%\/H
MUOH'V;39+?7[/6)9+JX,#1NEOYLI8,Y RK(5 &2#D8Z'$EK:7*6NI6C6QU&P
METFZ,4TMFR75NS$'R)1C$A).5.,_*3SG)]3JG#JVFW%T;6'4+26X&<Q),I?C
MKP#GB@#SRQWP7&GQ:SIUU+83>'(+:U!M'D6.< B:-E"DJS#9U R%QVJ/0H)K
M=? DQTR\\^VT">"<?9WC8,$BVHS$#:25?&?PKTN"^M+J>X@M[J&66W8+,D;A
MC&QY 8#H?8TQM4T]9KJ%KVW$MI&);A/,&84.2&8?PC@\GTH \HLX/-CEVZ5>
M1V]QX6DM_(_L^4*DJD%8B67+N,D;CU)..N*VI_#EI8^ ]+U[3=,A@U?2HH=0
M;=#Y<DK)&%E1R1G+)N'/?![5Z+#-%<01SPR+)%(H='0Y#*1D$'N,51U+1;?5
M;BUEN9KH);DGR(YV2*7..)%!PX&!P??U- #-!LVMM.,TT(BN[QVN;@8&0[\[
M3Z[1A<_[-<GK MV\5ZS8>(-)O;VSU"W@73W@@DD!VYW1AT_U;;\-DE>H.>*]
M HH \QU>RN[FT\8V%Y9SOK%S,)=(F2-FR/+00^7)CY=DBL3R,9+'KFJ&OZ-Y
MMKX[=M,DFOF^S/:RQVC$O*(D#/$0O7>.2OIS7KM% 'D?C*PM;:'QL+73_)L9
MM AD!6W*1O,KRDG.,%P"GOTJUJVE6MM>ZSJ.BZ---ILNC>5>6UO&\7VF8RC:
M2  S.J>86Q\V#@\FO0-?TRTUC0KS3]0F>*SGC*SLKA?D[\D<#WJ>VO;1].M[
MF.]CGMI @CN ZE9-Q 4@C@Y)'3UH \IU2U>YLO%<8L;R9+B[TZYMRNG21A\&
M,.R+MR,!3[X')[U:U_2HUT_XA65CI4@@N+2W:UAAM&V22^602@"X+9VYQ[5Z
MO10!YGK<,5[XAU2QUFWU=[:_CMWTV2SM=X8*H^02;"8F$@+9)4#=G(J[!!>6
MWCB*6"/[;;37\AFBN;9EFLW\IE,J2XP\1 Q@_P!X '/ [NXN(;6WDN+B:.&&
M,;GDD8*JCU)/ H@GBN;>.>"19(95#HZ'(92,@@]QB@#G?'@O#X;#6EO+<Q)=
MV[WD$*EGEMA(IE4*.6RH.1W&1WKB=8MH[U_&%SIVEW)@F73+F-EL9$\SRI,R
M%05&6"]AS7KE5+O5=.L)4CO+^UMY'&56:94+?0$\T >:ZV'O[3XB26>GWI6^
MTZ 6Q^QR*9V\MU.T;<DY(XZ]^E;.O:?<6FOV.J:1 -^MP?V7=D*%9/E+QS8/
M4H!)D=P1Z5V]O<P7<(FMIXYHFZ/&X93^(JFFC6Z:W+JK374LSJ D<D[-%%Q@
ME$)PI(')'OZG(!<M;6"RM(;6VC6*"%!'&BC 50, "O.M$C:ZM?L5SI=XGBVQ
MENV6[>&1(][[P)?-QL=6!4!<GMP-N1Z510!Y):V5EJ7AF]E.G:RNK0:+-9W5
MO<66Q0Q7[G$8\YBXRI!8]3QGG0.A:?8CP/?Q:)A!-F]:.R9GWFT= 9 %W9W[
M02>^,UZ710!Y1J>GAO!WC2W73)V:36S+;Q"S<EP?)^=%V\CA^1[UJ:[87+>)
M[\Z#:O#<2^&9X+::*$QH)BX*+NP &[CTKT.HH;F"Y\SR)HY?*<QR;'#;''53
MCH1Z4 >5W$ O_#VI:EH%AK2:C]ABM[JVEM?L_P BRJSQ!0BAY-GF %<\'&>1
M70: UG/\1;R]TZQGAL[C1[=1(;*2%&=9)<@[E R%*C\/:NYHH Y'QO9QW-]X
M:DNK1KBP@U%FNAY1D54-O*H+@ _+N90<\<\US_\ PBSP>&=6O+"T2#[!JKZI
MHL,J;!&B*I9 #]Q'(EXXP&!KT:\OK33K<W%[=0VT((!DF<(N3T&3W-5M5T6W
MU@VXN9KI8X6):&&=HTF!&"LB@_.OL>* (/#D!&GMJ$UOY-UJ+_:ID( 9=P 1
M6]U0*I]P:YO6;58?'FI73Z?*_P!HT$1Q3QVK.#(KR[AN .&VLHYY.0!FNUN+
MRVM#"+FXBA,T@BB\Q@N]SG"C/4G!X]J2ZOK2Q\G[7=0P>=(L47F.%WNQP%7/
M4D]J /+=/TJ[M8-!&D6,UIJ,WA2>WEE%NT9%SLA\L2,1PP97QNZ8-;_@J*PN
M]0CU&WM-6MKV.Q%K=1W5K]G2,@@A#\BB1@=V&!.!GD9Y[2&\MKF:>&"XBDDM
MW$<R(P)C8@, P['!!_&IZ .,^(\33Z9H\2PW4H&L6DL@MHW9EC60%VR@R,#O
M6'=:;JC>+-5N/"Z7Y6YT6:)[J_63]W<#/DK%)+\W4DD [1UZUZ?10!YO:V<=
MY<^'[FRT^6VBM],GAU6*2V9<J8U"Q."/F829('/1CWYRK7PY81>"?!#/H9%X
M;FR%_P#Z&WF82-E;S?ESM&<'/&#CI7KM% 'F6H:2ELOB[2)=+<":W0:(((#M
M"B(!$B(&$9906ZC&[=TYJ76/"M[<7J6<MNLR^(-+6QU2Y5 1%-$,B8^Y5I #
M_>5*](HH \TFM];G\#OJEUILHU1&MK>YM[>-3+);P2CS0BD8.XB1@O1E*C%5
M=1TW2[RP@O=/LM3N(+K7+*>7[19,GW6 D98@BE1M W-@ ^IYKU6B@#E/$>CV
MEMHEC:Z81I?E72&"2WLQ)%$0'(\Q /\ 5\D=L%@<BK_A!KEO#-L;NPBL9P\H
M:&$$1G]XWSH&Y"M]X ] P%:S7ELMZEDUQ$+J2-I$A+#>R @%@.N 2.?>IJ /
M)?$*2RZ=XKL=1TR[GU5]3BGLW2S>7S+</%Y>QE4@;0&!&>I/][F3Q58&Y7X@
MK%IMQ(;NQM# %M'/FR /G;\O+#*YQR*]6HH \YUVRL-*UJSW:=<Q>'KRTE5S
M86'G!;ARN3)'L8Y=1C=C.1@]:KBTM+#4)-)UO2=5O-(N]*@MM/+0R3NFTOOB
M9D&8Y#E#NX^Z.?EKTZJYOK1;];$W4(O&C,BP;QO* @%MO7&2.?>@#S;6M,OT
MOO&*:;ILZW]U8VK6S)$Q\Q5#"5%EQC<1E>N22*=X@L$U$:W>:38RC3I_#DT$
ML"VK+YMQ_P L5$>,EU&X=,C('I7I]% 'G=KI5MIOB?P7<VMDEM!/;W*S8BV%
MKAH8R"^1G>5C?KSP:FAAN[?QU'-;Q_;;6;4)#+%<6S)-9/Y3*98Y>C1$ #!_
MO  Y&!V]U:0WL(BG3< P=2#@JP.00>Q%3$$H5W$$C&X=1[T <KX7CD/BOQC<
MKG[)+?PK'Z%TMXPY'XX'U4UA?$6-[J;5;2/3;IYI-"E$%Q';23>8^6/E+@%4
M8$*23R<KC&*]"M;6&SMU@MT"1@DXZDDG))/4DDDDGDDU-0!Y1JVF6^J7/B>X
METB:9IO#< A:6R?+W $W3*_ZP;D_VAD4^]>60:U%K-A=W"WN@Q)ISFT>4;A&
M_FIPIV/O()S@G _NUZI10!E^&0P\+:2KQR1NMG$K)*A1E(0 @@X(.:X..RED
M^"?B#39K9[B_1M1B>)8R[M,9I"I  )).Y2/J*]*N[NVL+26[O)X[>WB7=)+*
MP54'J2>E)%:0174MS$NUY\&3:>'(& Q'K@ 9] /08 ./@MH)/B58W;6+%?[%
MQY[6K8$OF(0"Q& VT'C.<5V]%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<
M%9>*M7EU*W@,UK,EWIMU=),D1,(DB= /+.0SIA^2<9(R#BN](!&#R*Y<>"=&
MTZV233K.?S[6":*T4W<C!%<#* ,V-N0, \#'% &)IGB7Q*Q\,7%W-82P:_8L
MX1+9E-M,(/-!)W_.IPP(XQQ@T[0?$_B*9O"-YJ$EE-9^((-KPPP%&MY/),H8
M,6.X':P(P,<=:UO#/AK^R/"^EI<VTDFIV6GBV"M/Y@1MH#;,G !*]>...!Q2
M^#?"ZZ1X<T:&_BD_M"QM!!\TYD6-L .4YP,XZ]0..!Q0!@>&]2NM.\-^$HH!
M 8;S6+FVE#QY8#=<,"ISP?DQT/6M[1=8U36K6RUJ&XLH].EFG2:WE!4HBLRI
MM;^_N4;@>,$XZ<WX?".C6]M86\4$PBL+AKJV7[3(=DK;LM][G[[<'(^8T6OA
M#1+/4;B]@M75[AWDDB,[F'>XPSB(G8&()!(&>3ZF@#DW\1ZE?V=]8W;PSPW7
MAR>]\V*,K'O&%/E$X+1D/P6&3C()!JWX<U+6=/N?#6G7DUK<Z?J>F;HEBA*/
M;-'&AP3N.\$-C.!S]<5N6?@C0+%H3#:S'R;9[-!+=2R 0MC,>&8Y7@8'0=L5
M<L?#NG:<J"!)B8X?L\323N[11\?*A8DJ.!TYX'H* .'\(:Q?+X3\,Z'IJE;A
M]%%UY@5&/!"J,,P&,GGOTZ9S6OJM_J-H?!^I7<4,.I37RV%[' ^Y")$?>H/<
M!T5AZ;?K6G+X$\/RV&G68M9XH]-!6T>&[E26%3U42!@V#Z9JU-H45QJ&EDHD
M=EI9,EO$.=TNPH"?959OJ3GC'(!1\?W%Y:^%C+8W36TAO+6-F5025>=$8?DU
M<OJ6HZKH6J^-=5LKBWW60LI9ED@+>?B( CAAMR,^O;TY]#U72[/6M.DL+^(R
M6\A4LJNR$%6#*0RD$$$ @@]JS9O!VB7$.HQ36\[IJ*HET#=2_O @PO.[CCTZ
M]Z ,R[U[6[R_U6/188BVEW<<#1S% DBE$=RS%@R_*YVD#&5YSG V/%6MMX>\
M.W&HHBO(K1Q1A_NAY'6-2WL"P)]A4=QX/T6YUE=5DMY?M>U4D9+B15G"_=\U
M0V),?[0-:>HZ=9ZOIT^GW\"3VDZ%)(WZ,/Z?7M0!PE]+J&E>+/%-U]IAN+F#
MPY#-$TL'R_*]P<,H(R,@^G!'7'-^WUC7]0U[3].M;NRMH9=(AOW9K4N=Q<!E
M'S@8(S@]O?MK1^#-&3[262\E>YM!93/+>S.SPY)VDEO]H\]>:MVGAW3;'4(+
MZ"*5;B"U%G&S7$C 1 Y"X)P>>YYH YFR\5ZS<Z9:^(TMD?1Y+>:>>)BBL@56
M9!&0Q+-E=K CW&,8J2_U'Q ?"%WK$>I6:PS:+)=QM&G[R*?9O'E]F3;GD\Y
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M91M&5'E^H/-:$MAXJU;PAJ>F:G#ID5W-826D9@G9DE=D*^8Q* H/]D!NIYH
MT)_%>E:="HN;F63RK>&:>41$^6DA*H[X'&2#TZ8)X%,T^_O)/'FMZ=+<-):0
M6=I-#&54>6SM,&P0,G.Q>I-<[KWA3Q)JVFW5A_H$D$FG00VXDN'403)G>=H0
MA]W&&."O/'7/1Z=I>HP^,=3U:Y2W6WN[.V@41REF#QF0MP5''[S@^W2@"_/K
MEG!?-:'S7D1XDD,<981M(<(&QTS^G?%9FG^-+*\AN998+F#R]0;3X4>([II
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\&7EGJ%U<2ZE$Z:K&\[$$"$EW*Y_=LDH"_*!C=M]* /0+FSM;Q56ZMH9U4Y
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M+#5-1N]'T'4X[NX_MR36?LM]:&9BNWS&$L9CS@!$&X'&0%![G.UX*MX(]?\
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MKNJ,2"/OX-0B\MK7^SK!O$\E_#=75T]O+]I:&#8$4E#+N9GV%_E ;DY!/R9
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M%JR<RR^8=$DD %PX!Q-&!\H.,>W0]:[6@ HHHH **** "BBB@ HHHH ****
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MP;05S@C/3D#. :/XWO=1D\/-?Z+%;:?K\!-M*EUYC))Y9DV.NT  J&P03TY
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M?E#*5SAURP89 X'.<U'JOB(ZE83Z;)8HL=[X>EU$/YN2I 4;,;1_?!SGMTH
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MCJ>H'- '5"PLU@6 6D A4Y6,1C:#[#%-_L^W_M,:@4'VA83"K8 VJ2"1TSU
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M'&,9P0>"<'(YZGT"@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[+C(R*V?%_BA/#^E22VUQ9M?)+"OV>9N2'<+T!!S@DCZ&ND9@JEF(  R2>U
M'-:EX-AU>SU&.]OIGNK^W2UEN41598D)8*HP0.6))YY/L +6M>'!KMK-:75Z
MYM;BV^SSPF)65AS\ZY'ROSP>GL<#%D>(M$-M/<_VM8^1 JM+(9U"HK?=).>
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M$5H+>*('.QF*E0!G/SMG/%:FH>$(-<MKM[V^N6N;JWC@6=4$;1(KB084CJ6
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M -YAW;WZU=LK*UTZSBL[*WBM[:(;8XHD"JH]@* .4^*.X^!)PA ;[99[21D
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M0<''3O5L[58IHEMXA'.S-*FP8D+?>)'?/>LV#PEX=M=.ETZ#1+".RE<220+
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MB\E!L  C_N?[O ^7IQ0!Q6M>+;[2[CQ3<P7AFM;>QT^:UWHNV#SWD1GZ D
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MABR)&!$IQP &9O7@<XS3[?5_$&HW.C:=)J\]L9-3U#3I;F&*/-PD*2;)!E2
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M.3;^#;Z&STR WUNQLM9EU0L(V&\.TK;.O&/-//L.*FT7PKJ.EV\NCRZI#/H
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M@#O8Y8Y=WER(^T[3M8'!]*$FBD#%)48(<-M8':?0UY L7]JV=Y+IH^R^(1H
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M.,98<YZ?RIPD0D .I+<C!ZUPMAH^EW_Q%U"ZET4&V-A9O;O/8LB"5'E)(W*
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MUYMHELMSK<5KJUKJXUNQU.>X21;;;"Z,SXD\X)RAC8#86SP!C@8])H ****
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M(((47)VL 0#R#Z<$=<<V+W7]0TWQ#J.HRW#2VEEX;34!:! %+9DW 'MG8.:
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M)QD9/I0!:HKG/#%]J\E_K.F:M+#=-I\Z)'>0Q>6)0\8?:RY(#+D9P>A%='0
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MN=HP3@8R2".<G.:9'X0T6/27TQK>66!V5RTUS))*&4Y0B1F+@J1Q@\=J@O\
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M;%BK)(@D0LI(((/&001]10!SEW:ZA!K=[XJ6QB6>#3!:0VTUPJ>:?,WL6<9
M X ZGKP*Z>TF>XLH)Y(6@DDC5VB;JA(R5/N.E+NAM_)ARD>X[(D&!G )P!]
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MMGKL[3173./]'\Q%5PZGD[=N5QG/ ..M=59ZS;WNLZCI<<<RSV B:4NH"L)
MQ7:<\_=/I3]9U6#0]&O-4N8Y7@M(FFD6)06VJ,G )':@#G=9\%G5=9;]Z%TJ
M^T_[)J4>?GE\LYA(/K\[Y/H *J7'A?7)/!UBDLEI>:[;745Y,LW$-TR+LV$X
M.,ICG!^89KN(I!-"DJY"NH89]Z?0!Q$^AZE<KH]Q'H5CI\D.K)>W%O;2)PBQ
MLF68!0[G<.V,#K7;T44 >?CPOJL-QJ$EA!)9PWEM=+=67V@/;RS/]R2($YC)
MR2W0>QZTH\/:_$=.DM8(([BU\-RZ:'E=61;@^65)'.4S&>W<<=:[R66."%YI
M75(XU+.[' 4#J347VH_VB;3[-/@1>;Y^T>7UQMSG.[OC'2@#@1X9UZ1=?=K&
M)&U/0DLE#7IE<3#S1\Q(QC]X.G  X':MK3](U&'Q1I%_+;!;>WT9K&4^8I(D
M+QMP.X_=GGW'%7;;Q5#>W5K':Z9J4]M=<Q7L<*F J"06+;OE''< D'(!YQOT
M 9GB*UGOO#6IV=K&'N+BUEAC4L%&YE*C)/0<U@#2-8MM0\+W\%E%*]C82V-S
M$\X387$6'!P<J#$??D<=JZ&_UFWT[4],L)HYC)J,K0PNB@J&5&<[CGCA3ZU?
MD;9&SA6;:"=J]3["@#@O#OAK6M-D\(B[M8<:7;W45RT<P;!D*[<9QG[O/UXS
M1=>&]8EL-8A2T4O=>((-1B_>KCRD:%CGT;]T>/<<]<=AHFKV^O:+::K:+(MO
M=1B2,2##8]QDU?H X>[\.7=W?>)3=Z6MU9ZE=6TB1_: C[8XU4LK @JX*[EY
M].13--\/Z[:ZMH4]V\MY!8/>?O)Y5:98I !&K'H[#')]QR:[NLN77[./5].T
MT"21[])7AE0 QXC +9.?<=J *G@S3+S1_#,-C?1K'/'-.Q"N&&'E=Q@CV8?B
M#6?KWAN_U7Q!?/%Y:V6H:+)ILDWF8>%BS$,%Q\WW_4=*Z^B@#D-/T34[J_\
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MMOJDA!F17D,FTH5SO!8@-N Q@]L'N*** "BBB@ HHHH **** "BBB@ HHHH
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M 4R,B+ ^<$<_3M7,6NJ7>E_\).8K@W=K_;=F+S78CM,D+E1*,K\JF-0$)3&
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MM'VCR8_/QM\S:-V/3/7% 'F6H:L^E7WBVXCN/)M_[<LTO)U!/DPFWA#,=I!
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MC,LEO%%%-)RT@C'S'L6Q@G\ZR_#/AV'PYH5OINZ*X:&/RS.(0C2+VW<G/YT
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M4D.H3RW#2':'C>1_,)7 QPQR,@T 1WWC :=J6L6D]H"+%;/RF1R3,UP[1JI
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M'M3I=8TR&W>>74;1(4<QO(TRA5<=5)SP1Z5P6H^&=<MI=0_LV$-#IE^-7TI
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M^Q7M\\X9 ?*202A"=I/!+K_^KFM[1M#O=/\ $]_;F,#1$N#J-H<])I00Z8]
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MRCLM,N+2Y\Q$58G/DX4'=\R_(V"/\<=_0 4444 %%%% !1110 4444 %%%%
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MK:6YN'V11(7=L$X4=3@<UR7AG6]0GUW^SM8>YBO&MI)D7:CVUT@=<2PR*,X
M8 JW(W#KU-;5A.?'.NJ;ZX\A?#RR" E=F6:93VR/N@\'.>^.* .VL[N"_LK>
M\M9/,M[B-98GP1N5AD'!YZ&IJ\MTK6M4\/:1I++=27MNWA.2_2T>- J20I#M
M"E0&P0Y!R375>'IM6GU""ZFU6UN],O+$2QQB0.YD!'SH1&OR$, 0<X./>@#6
MNM?TRSU'^SY[@K=F/S1"(W9BF<%A@<C)QFK5C?VFI6JW5C<Q7,#$@21.&&0<
M$9'<'M7'ZDMVWQ>LA92P1R_V#/DS1EQCSX^P8=\=ZP_#>HSV$.L6#W)@U63Q
M(R736R!UNG==Y2#=@)\BC.[)7#<DD4 >J53O-4LM/N+."ZF\N2\E\F ;2=[X
M)QD#C@$\^E<%::[KMW;Z%$VJ2123:[>:=.ZQQL7CC$^T\KC</+7D  ]P>E4=
M3UG4ET?2IYEFU:[TWQ/<01* JRW"QQW 4' "[L8' Y]* /5Z@O;RWT^RFO+J
M3R[>!#)(^"=JCDG YJAX;NAJ&AV]\NIMJ*7*^:LQ14 S_"% & .F#DC')S7&
MW>MZ@\&LZ=J[7,4LNFWTEMM5'M;N,#*O&ZC<I53@JW][//6@#T.VN(KNUAN8
M'WPS(LD;8(RI&0>?:H]0U"UTK3Y[^]E\JUMT,DLFTG:HZG YKS[3]7O]%B@A
MFUG;9MX7-\'N(5*6LD>Q00% 9EP_())..M,U#4]2GT3QSIM]--)##X?6XB%P
M(Q(&DBG#9V# !\L''.,_@ #OHM9T^?4DT^.XW7;VWVI8]C#,60-V<8ZD<=:O
MUQ6G?\E TG_L7&_]&Q5VM !1110 4444 %%%% !1110 4444 %%%% !1110
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ML5K]A^P_9H?LGE^5Y&P;-F,;=O3&.,5D^*-<N=#M].:VLS<M=W\%J?F VAV
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M:-<;FV@9 &0#D=2!UXJ.?Q=HD&GK?_:S):FU6\,D,3.$@;I(V!\J\'KZ'T.
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M;C@?O.V>E)K_ (4U;7-0U66,PVHN=*M[>"1GW%9XIFE&X ?=)8#/7@\5W=%
M'&ZSI_B7Q'X-U*RNK*PM+VYB6*.*.Y+KD'+,S[!@>@ ./7GBA)#>ZAXI\:Z?
M;6T3->6%K"6DDPL1:.0988Y')Z>GOFO0:@CL;2&ZDNHK6!+B7_62K& [_4]3
M0!Q%_P"![VYDO+*"5([-] BTN&X9LN)(V9@S+C[O(SSZU870M1U#1+F'5?#.
MA1RR+'%+!;2G%PH=2S;PBE, $J.?FQDCK7;44 <UX?L-;T:T@LY'-Y;-=2'?
M=7)::WM]OR*6P?,;<,<G@'J<5TM%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !114;3Q(Q5I%!'8F@"2BHOM,'_ #U3\Z/M,'_/5/SH EHJ
M+[3!_P ]4_.C[3!_SU3\Z ):*B^TP?\ /5/SH^TP?\]4_.@"6BHOM,'_ #U3
M\Z/M,'_/5/SH EHJ+[3!_P ]4_.C[3!_SU3\Z ):*B^TP?\ /5/SH^TP?\]4
M_.@"6BHOM,'_ #U3\Z/M,'_/5/SH EHJ+[3!_P ]4_.C[3!_SU3\Z ):*B^T
MP?\ /5/SH^TP?\]4_.@"6BHOM,'_ #U3\Z/M,'_/5/SH EHJ+[3!_P ]4_.C
M[3!_SU3\Z ):*B^TP?\ /5/SH^TP?\]4_.@"6BHOM,'_ #U3\Z/M,'_/5/SH
M EHJ+[3!_P ]4_.C[3!_SU3\Z ):*B^TP?\ /5/SH^TP?\]4_.@"6BHOM,'_
M #U3\Z/M,'_/5/SH EHJ+[3!_P ]4_.C[3!_SU3\Z ):*B^TP?\ /5/SH^TP
M?\]4_.@"6BHOM,'_ #U3\Z/M,'_/5/SH EHJ+[3!_P ]4_.C[3!_SU3\Z ):
M*B^TP?\ /5/SH^TP?\]4_.@"6BHOM,'_ #U3\Z/M,'_/5/SH EHJ+[3!_P ]
M4_.C[3!_SU3\Z ):*B^TP?\ /5/SH^TP?\]4_.@"6BHOM,'_ #U3\Z/M,'_/
M5/SH EHJ+[3!_P ]4_.C[3!_SU3\Z ):*B^TP?\ /5/SH^TP?\]4_.@"6BHO
MM,'_ #U3\Z/M,'_/5/SH EHJ+[3!_P ]4_.C[3!_SU3\Z ):*B^TP?\ /5/S
MH^TP?\]4_.@"6BHOM,'_ #U3\Z/M,'_/5/SH EHJ+[3!_P ]4_.C[3!_SU3\
MZ ):*B^TP?\ /5/SH^TP?\]4_.@"6BHOM,'_ #U3\Z/M,'_/5/SH EHJ+[3!
M_P ]4_.C[3!_SU3\Z ):*B^TP?\ /5/SH^TP?\]4_.@"6BHOM,'_ #U3\Z/M
M,'_/5/SH EHJ+[3!_P ]4_.C[3!_SU3\Z ):*B^TP?\ /5/SH^TP?\]4_.@"
M6BHOM,'_ #U3\Z/M,'_/5/SH EHJ+[3!_P ]4_.C[3!_SU3\Z ):*B^TP?\
M/5/SH^TP?\]4_.@"6BHOM,'_ #U3\Z/M,'_/5/SH EHJ+[3!_P ]4_.C[3!_
MSU3\Z ):*B^TP?\ /5/SH^TP?\]4_.@"6BHOM,'_ #U3\Z/M,'_/5/SH EHJ
M+[3!_P ]4_.C[3!_SU3\Z ):*B^TP?\ /5/SH^TP?\]4_.@"6BHOM,'_ #U3
M\Z/M,'_/5/SH EHJ+[3!_P ]4_.I 0P!!R#T- "T444 %%%% !1110 4444
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MZ<CU%=1XD>:Q\6IJUA/:ZG;W#6<%WIDN/-!PIBDA/7'S9R.^<@CH >PT444
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MS&JVOBF;6A<6,>C/:0C_ $9;J67<KD8+D*N,\D#G@9]: *_BZVU^*"YOM/\
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M%VYSP?F/)P>:O^&]$U_0<Z8US8R:/#-));R#=]H*,Q81L"-HP6QN!.0.@/(
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M[7 9=J," %(SG)R3P,<5.J*@(50N3DX&.:XW69H4^(UC'+=-'%)HUYYB^>5
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MI:/JDTZ26BQW%JD12.-PV09 <D3<D'N0.>@- '9M<PI<QVS2*)Y%9T3/+*N
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M7D_A._L=2UK0HY->MO[0M#<B['VLI+?N6^0F/(8XP6PP^7H 1G'K% !1110
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M0=HRHB1)'7(3=ER=J@(O.3GFH8?%.L:M)X6>WD@M1=ZG>6ETAA8A_)2< X+
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MQ)&,#!X!Y]*HZEXQNH-.U[5K.WAELM#N##<1/GS)@BJTA5LX7 8X!!SMZC/
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MN+';]I2*QF?R]PRO*H<Y'/&:TM.U*RU>QCOM/N8[FVE'R21G(.."/8@\$=J
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M5'EG:45E4_-TSEQQ5^@#S"#P_P"(G$TLNCR))/X=DT]U-U%A9^P50=JIZ!<
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M8]S)<MIUH9Y&5GE,"[F9?NDG&21V]*#I6G%+A#I]J4N#F=3"N)3_ +7'/XT
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MRV5MQ_A#DJ!GKCVJMX3U"?7_ .Q]1?Q$@FN(98]0TU7<N9-OS+MW?NC&P/(
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MR'0='MPP@TFQB#!@VRW1<[OO9P.^!GUJ1=(TQ&B9=.M%,2E(R(5&Q3U XX%
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MVL3HS,K1PJI5F^\00.IP,^N* ,CQIJ[Z-I-I/YQM[:6_@@NK@''DPLV&;/\
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M63U*\<'Z5=H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M9N4D8_YZMSZX^E $FG^,3J$-I"M@$U.XN;FV-LT_R(T#%9&\S;RO Q\N3N'
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ML"]E+'[1]IM5,,R%2-AB!  YSUSGVXH73&\-^!Y-.TR.>Y>UM'6!(RN]FP2
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MPV]SHAFB;8-B,+@84*5&?O94,1USD [S5]632H+<M'YD]U<);01[L!I&]3V
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MH; 6AD\O:-PSP">]9*>%]?DL]2E73[M(D\:C5G@,9#7%IN^\H_B]=O7CITH
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M:17&-Q?&XG:2"F>X&.N.=TCPOK-M!X>9M%O(Y8/%4E[.?LY!6 [<.3CIC^5
M'I?C?Q]:>$; RPFSOKQ)HXY;+[4$E17. V ">XZBMZ[\1:)822QWFL:?;O%@
M2+-<HA3/3()XS7BVM>&_$ \/^)M&;1+Z[O[GQ(-0AN(XMR20$C#!^F0 1CJ,
M^F:U_%7A_4K_ ,5>-[N+2+J6.]T-+:TD\@G?+\N54XZ]/R]J /6+?5M-O+R6
MSMM0M9[J$!I88IE9T!Z$J#D4U=:TIUN&34[-A;#,Y$ZGRADC+<_+R".?0UY5
MI'AS68_$^E/;V%S9@>#5T]K@PE%CN^N"<=0><^M-\.>'KT^"+F.\TG68=;LM
M$N=+V2HHA<,#M5-HS)DX.><<Y/3(!ZI!X@T:ZDDCM]7L)I(XO/=8[E&*Q_WR
M >%]^E5_#GBG2?%5G+=:3=1SQQRM&=K#/#%0Q'4 [21GJ*\T\'>'=4L/%/@Z
M:72;FWAMM!>UNG,)54F+,=K''7OGW]ZZCX0Z;J&B>!(=)U.PGM+JUGE#B50
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M+(SLQMY^N1]*[>O)?#FC:I;^,O!%S-IMW'!9>'%L[F1H6"Q3!<;2?P^E>M4
M<?X7\?66NW.I6E\UGI]Y::G-IT4+70+7!CQ\R@@'G/0 UTSZE817R64E[;)=
MOC; TJAVSGHN<GH?R->*W/A#6[S0O$6C1Z9<PW^H^*6OK6X,9")!O_UI?H,!
M6XSGD8'-;=OX=U!_'FNVNL66K2VUUJ<&I6%U:A/))0#:'<C*[, 8SR < \9
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M5R?((*1-MPQ..F/Y>U>]T <Y-XTT@:UJ&BVUW!+J=G;&9H3* "V"=GJ6PI)
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M^J^(-(T39_:>HV]J7&X"5\?+D#<?098#)XR1ZUHJRMG:P.#@X/>O+-1LVO\
MX]6B274HCE\.L^S9&P4>81M 9#QGYN<G/?'%<[X7\5ZMHWPLT'4#J%S-/K.N
M?99I91&?(5I9"[*2!\S8ZN2![8H ]VHKROQ!KWC+1K70H9+R.WNKOQ$MB"R1
M2&2U<Y3S !@.!@':1^N:]%T:SO['34@U+4VU*Y#L3<M"L18%B0-J\<# ]\4
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MDF-\+YVM@Y&?7D _A56#PQHMO=W%U'I\7GW, MYW;+>;&  $;).1@ <UK44
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M6UC^T"5#D>43\T+$8//'((SR.,UZ76+>:_)'JD]A8V$E]-:K"]RJ2*A1)68
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M)P./6@"Q1110 4457N9KB*2V6"T:=9)=DK!POE)@G><]>0!@<\^U %BBBB@
MHHI&)"DA2Q Z#O0 M%9?A[6D\0:'!J:0/ LQ<>6Y!*[79>2./X:U* "BBB@
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M<<@3#=YPS_SVYCZ?-QQWKO4T2)/$TVN_:9S/+:I:F([?+"*S,,<9SEF[UJ4
M>7+IFL6^F>&;[4+1[O4+_3SI.HI(N2&==T<DG^Z5PQZ_,?2GVEGK2>"M21+2
M7^U-$M)=-M7C7;)/M.6D3W:,1X/7<6KTE+FWDGD@CGB>:/&^-7!9<],CM4M
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M)E8NSYY)8GJ222?K63I_A*PTU;..&:Y>"Q+FRAD966U+ K\G&3@,P&XM@'%
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MZ;C\Q+ $D \@<##+'P?I^G:M->VUQ?)%+,UP;'[0?LPE8Y+A/4GG&<9YQG%
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MZ]&O;5;ZQGM'>1%FC:,O&VUE!&,@]C[UB7'@VQNW>:>ZNVN9+BWN)+@% [M
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MO#(DH1X9D555XV !4@*H[]/<UKZ7IB:5:>2MQ<W+LVZ2>YDWR2'&,D\#H ,
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M65WJ"0,[R16AGW06[OG<T:$<=3P<@9.!3'\$:8_AJQT/SKQ8=/=9+.X24+-
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MID:'E+<MO"\]#DA/I&M9&B^&M7L;/P1!/:@'2$E2[*RJ=NZ(H"O//)S]/RH
MZN+Q#I4VH1V*76)Y5=XMT;*LH3[Q1R-KX[X)IEMXGT>[NX+:"\W2W$7GP@Q.
M!+'_ 'U8C!7IR#CD>HKD]"T:YT+2DM]=T324MM'MI5_M;>"TT00KD +N0E?O
M'/8XSGBAH.FWDEKI=EJ6FW$1DTJ33+*[2]AF2%'C!)"KACPB@$YQ@>I) /0+
M/7],O[[[%;W):X,/GHC1LGF1YQO0L '7)'*Y'(]15N\O+>PMFN+J41Q A<GG
M))   ')))  '))KE_"6EZC;&V&J^']+L[FS@\@WMNZNT_093"@HIQD@G.<<=
MZT/%VDWNJZ?9/IY0W5C?0WJ1.VU9MC<H3VR"<'U H EE\6Z';VLUQ/?"&."=
M+>82QNK1R-C:&4C*YR,$C'-:&GZA;:I9)=VCL\+EE!>-D.5)4Y5@".0>U<3K
M?AG4]2FU74H+,I/?3Z=MMGD0$);3"1F8@E<G)  )Z#U.._!R 2"/8]J ,A_%
M.BQZN^E->?Z:CK&\8B<["READXP 0#R3BF/XNT.-;AI+WRQ;VWVM]\+KF'_G
MHN5^=?=<CI6:= O;O5_%PE0P6VKVL<$$X8$@B-D)(!R.6R/IVK)30-9N_"VI
M65UX;TNTU(Z7-8)<P2(S7#.FT%3@%$)^8@G/3CB@#I&\:Z K3*;V0O%$)RBV
MTI9HSGYT 7+KP<E<@8YQ5JX\2:3:V,=Z]WOMI(/M*O#&\O[K&?,.T$A<'J>*
MQ(=)U-/$-O?&R;R8]#-DW[Q,^;N5L=>G'6L/3_"^N:3#HKOHEEJJ+H\&F7EK
M/.J^4\1;#JQ!!4[V!'7IQVH Z?Q/XHM].\-ZC<V%XC7<=@UW"R0M,H7:2C-M
MX"D@X)('!]#5S2M?M+P16<D['45LHKJ:/RF'RL/O XP03GIZ'TKE;SPWKEG_
M ,)%:V.GVMQ:ZQIB6\0AD6)+61(3%L"G_EF>",=.01WJ75=*EGF\.6\%W!;Z
MND7V"^ACDW,;5X\R#C!!&P%6/ /UH [>SNX;^SAN[9B\$R!XV*E=RGD'! -8
MUUXW\.65U+;7&II')%.+>7,;[8G(! =L84'<,$D YZUOJJH@1%"JHP !@ 5Y
MM-IUUKMQ\0=#@M=RWUY%#]H9EV19M806(SDD#D8!R?3K0!V)\5Z(NJR:8;X"
M\B?RY$\M\1G87^9L84;03DG'%/B\3:/+)<1_;!&]O +B03QM%^Z/1QN W+QC
M(R*PCX9O;N7QG:R*;>#6($AMK@N&(Q!Y1) .>O/T]*SI?#>M:QX=NH9M#TG2
M=62!$CN8G#^?(DB2 9505B)CY!R>>G'(!K>)O%:P^&M6N=&N@M_IYB\V.>W9
M60.PQE' /()P<8X-;%UXETBR34GN+LQKIH5KO,3_ +H,,@GCD8!Y&16#K=EK
M_B'P?J4$NCV]G?7*Q(D"W"N25<$EGP!CT')_/BCXF\.Z[?-XLAL;&.6/7-/B
MCCD>=4\IU5E*L.?4$$<=>: -?QSXH&A>&M7EL;D+J-I;&5?]':54)SMW8&%S
MCC<:UKWQ#IFF8%[=>5C8)'\MBD9<X7>P!5,G^\1UKCM9\/>(Y;3Q?8V]C#<1
MZ_$)(9?M('D2>2L;1MD9(^0$$#OSBK,WA_51KVI&70=+U.QU;RI2]S(I^R2+
M&D;*RE?WB?(&&,<Y'&<T =[63!XFT>ZN!!#>;G9))$/E.%D6-MKE&QA\$@':
M3UK6KSW2]#\21:YHNI7]A"9+1+R*Y:.Z&UO,*E3&F,*N%QC@Y//J0#IK'QCH
M6IR0QV5\9FG@:XAVP28E1<;MAVX8C(RHR1GI5FT\0:9?6=C=VUP98+]_+MG6
M)_WC8)]..%8Y.!P:Y/0O#VJZ9#X+6ZME1='M9HKQ_-7"ED"@CGD<9^E7?"VE
MK%X@U6:VNHI]'AG9[%8SD1R3!7F /0@'D8Z>8XH ZVXG2VMY)Y Y1%W$(A=O
MP !)KD?"WB:758]*OKR_*+J]KOAL7LV7;*%WGRY,#<H3USDC(/:NNN=_V67R
MXS(^P[4! )..G/%<+8>']:T[1?!)6Q6:ZT13#<P"=5W P&/<K=" 2#CKB@#H
MI?&.@0V]O/)?XCN))88OW,A+/'NWKC;G(V,,8Y(P,U@Z[X[#^'_$<VB&6.YT
MNT6=)Y[5]C%DWC 8 ?=*]>N3QQ4&F^'-<MGT(W%E%_H6MWM[+Y<ZL/+F\_:1
MG'/[T<>@/?BG^(/#>LWB^-+>UM8I8]:MXEMY#,%PXC$9# ].F<^E '4VWB72
M+HWBQW@W62JTX>-DPK9VL-P&Y3@X*Y!QQ4,OC#0H(IY)[[R1!/';S+-"Z-&[
MXV!E*@@'(P2,>]<[XA\,ZQK.J:K<6L$</G:?9I;F=U*M-!<--L< GY3D+GZ_
MB7VB:GJ6B,\?AJQTV\DO;*62&"5&9UAF61BS@ '@$*.?PSP =II^H6VJ627E
MH[/ Y8*7C9#D$J<JP!'(/456O?$&EZ?<"&ZNO+/F)$S^6Q1'?&U6<#:I.1@$
MCJ/45I@Y .,>U<,_A_4HO$>J1R:'IFIZ=J5RMTEW<LNZV.U%*LA4EP"@9<?3
M(Z@ Z.+Q-I,UU+:QW+M<17 M7B\B3<LA4L!C;_=!.>F.<T^?Q#I=M>QVDUUL
MEDF\A&,;;#+C.S?C;NQ_#G-<]=:/JR>+8/$]G9)]H+FSN+8L@\RTZB3=G_6!
MN1[';[U#IWA_4K/6KJVN=#TV\LGU&2_M]2E=2\0>0R;2A&=ZDD*P.,8/;! -
MVV\9:!=M*(-0#>4'+GRG !5Q&5R5QNW$#;U.1@<BH[WQ+ITMFS6^K"S>*]AM
M93);,65V9<1LC %=X( )_O U@CPUK9\'3VL,44.I0ZR^J6\<L@*2C[49U1BN
M<9!Q[&KNM6.MZYX? ?28;6Z>_M)S;K.KL%BE1V+/P"2$P ,]!SSP =&-9L&O
MQ9+*YF,AB&(G*;PI8KOQMR "<9[5':>(-+O;];*"YW7#Q&:-6C91+&" 61B
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M@?O8)XW>A%6K^:^T#6(4>YO;_2(9K6W:>.]8W%K(SC'FH<"5'WJ"W) )X.*
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MT%VYP\H"H-V5QGC^(=>O>LS0_$-U)#X'\S4Y)KFX-VES$UQDS%8Y-H89Z[E
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MG3[6>8+L$DL*LVWTR1G'M56#2KO^VGO;R_6>WC)^QVRP!!!D $ELG<<9 /&
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MV_Y\-6_\%TW_ ,31_P ));?\^&K?^"Z;_P")K9HH QO^$DMO^?#5O_!=-_\
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/ 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>39
<FILENAME>exhibit1033-bochk_facili023.jpg
<TEXT>
begin 644 exhibit1033-bochk_facili023.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MY)4MU^7.2/:O7K;Q9HU[JRZ99W,ES<')S#!(\8QUS(%V#\Z -NBBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MP"15Q(9-I?)P>G;..>E<SX?\9>(KOPCX$:XO9<ZWJ$T-_J!4;E"R,$C'&%+
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MP$A<E<;_ # -P&,#C(QT]JVY]1U&'P1J^I/>75K?1Z3-/;Q22JY<I"KB=?\
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MEQ]G-Q8ZC+>+J*N?.DC=F)0C'<,%(R1A01V  .SHHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBL/4-+UVYO9);+Q']CMVQ
MM@^Q1R;>!GYB<G)R?QH W*1E5U*LH93P01D&N;_L3Q/_ -#=_P"4V+_&C^Q/
M$_\ T-W_ )38O\: +\OA?P_.^^;0M,D?^\]I&3^HJY::;8Z>NVRLK:V&,8AB
M5/Y"L3^Q/$__ $-W_E-B_P :/[$\3_\ 0W?^4V+_ !H Z6BN:_L3Q/\ ]#=_
MY38O\:/[$\3_ /0W?^4V+_&@#I:*YK^Q/$__ $-W_E-B_P :/[$\3_\ 0W?^
M4V+_ !H Z6BN:_L3Q/\ ]#=_Y38O\:/[$\3_ /0W?^4V+_&@#I:*YK^Q/$__
M $-W_E-B_P :/[$\3_\ 0W?^4V+_ !H Z6BN:_L3Q/\ ]#=_Y38O\:/[$\3_
M /0W?^4V+_&@#I:*YK^Q/$__ $-W_E-B_P :/[$\3_\ 0W?^4V+_ !H Z6BN
M:_L3Q/\ ]#=_Y38O\:/[$\3_ /0W?^4V+_&@#I:*YK^Q/$__ $-W_E-B_P :
M/[$\3_\ 0W?^4V+_ !H Z6BN:_L3Q/\ ]#=_Y38O\:/[$\3_ /0W?^4V+_&@
M#I:*YK^Q/$__ $-W_E-B_P :/[$\3_\ 0W?^4V+_ !H Z6BN:_L3Q/\ ]#=_
MY38O\:/[$\3_ /0W?^4V+_&@#I:*YK^Q/$__ $-W_E-B_P :/[$\3_\ 0W?^
M4V+_ !H Z6BN:_L3Q/\ ]#=_Y38O\:/[$\3_ /0W?^4V+_&@#I:*YK^Q/$__
M $-W_E-B_P :/[$\3_\ 0W?^4V+_ !H Z6BN:_L3Q/\ ]#=_Y38O\:/[$\3_
M /0W?^4V+_&@#I:*YK^Q/$__ $-W_E-B_P :/[$\3_\ 0W?^4V+_ !H Z6BN
M:_L3Q/\ ]#=_Y38O\:/[$\3_ /0W?^4V+_&@#I:*YK^Q/$__ $-W_E-B_P :
M/[$\3_\ 0W?^4V+_ !H Z6BN:_L3Q/\ ]#=_Y38O\:/[$\3_ /0W?^4V+_&@
M#I:*YK^Q/$__ $-W_E-B_P :/[$\3_\ 0W?^4V+_ !H Z6BN:_L3Q/\ ]#=_
MY38O\:/[$\3_ /0W?^4V+_&@#I:*YK^Q/$__ $-W_E-B_P :/[$\3_\ 0W?^
M4V+_ !H Z6BN:_L3Q/\ ]#=_Y38O\:/[$\3_ /0W?^4V+_&@#I:*YK^Q/$__
M $-W_E-B_P :/[$\3_\ 0W?^4V+_ !H Z6BN:_L3Q/\ ]#=_Y38O\:/[$\3_
M /0W?^4V+_&@#I:*YK^Q/$__ $-W_E-B_P :/[$\3_\ 0W?^4V+_ !H Z6BN
M:_L3Q/\ ]#=_Y38O\:/[$\3_ /0W?^4V+_&@#I:*YK^Q/$__ $-W_E-B_P :
M/[$\3_\ 0W?^4V+_ !H Z6BN:_L3Q/\ ]#=_Y38O\:/[$\3_ /0W?^4V+_&@
M#I:*YK^Q/$__ $-W_E-B_P :/[$\3_\ 0W?^4V+_ !H Z6BN:_L3Q/\ ]#=_
MY38O\:/[$\3_ /0W?^4V+_&@#I:*YK^Q/$__ $-W_E-B_P :/[$\3_\ 0W?^
M4V+_ !H Z6BN:_L3Q/\ ]#=_Y38O\:/[$\3_ /0W?^4V+_&@#I:*YK^Q/$__
M $-W_E-B_P :/[$\3_\ 0W?^4V+_ !H Z6BN:_L3Q/\ ]#=_Y38O\:/[$\3_
M /0W?^4V+_&@#I:*YK^Q/$__ $-W_E-B_P :/[$\3_\ 0W?^4V+_ !H Z6BN
M:_L3Q/\ ]#=_Y38O\:/[$\3_ /0W?^4V+_&@#I:*YK^Q/$__ $-W_E-B_P :
M/[$\3_\ 0W?^4V+_ !H Z6BN:_L3Q/\ ]#=_Y38O\:/[$\3_ /0W?^4V+_&@
M#I:*YK^Q/$__ $-W_E-B_P :/[$\3_\ 0W?^4V+_ !H Z6BN:_L3Q/\ ]#=_
MY38O\:/[$\3_ /0W?^4V+_&@#I:*YK^Q/$__ $-W_E-B_P :/[$\3_\ 0W?^
M4V+_ !H Z6BN:_L3Q/\ ]#=_Y38O\:/[$\3_ /0W?^4V+_&@#I:*YK^Q/$__
M $-W_E-B_P :/[$\3_\ 0W?^4V+_ !H Z6BN:_L3Q/\ ]#=_Y38O\:/[$\3_
M /0W?^4V+_&@#I:*YK^Q/$__ $-W_E-B_P :/[$\3_\ 0W?^4V+_ !H Z6BN
M:_L3Q/\ ]#=_Y38O\:/[$\3_ /0W?^4V+_&@#I:*YK^Q/$__ $-W_E-B_P :
MZ"V26*UBCGF\Z94 >7:%WMCDX'3/I0!+1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !17C^HVT=
MS%XK-I>W'_"06NN#^S$%TY=6*0$!4SRIRP/&,9[#B_-;337'CV\TJ2>?6;&9
MFTX+<.QC9K1 =JYP?F+@ @C(]J /4:.U>?V,5EJGB'3!HDGF:3=Z7,NJ1HYP
M#\GE%_27)DY/S<'/2I_",$\EH;35D=#H"2V#3N2GG'M+NX/^J"-GUD;TH ["
MSN)KC3XKB>SEMIF3<UL[*S(?[N02N?QJKH&LQ>(-%@U.&&2%)BX$<N-R[7*G
M."1U7UKS?PWJL2V/@Z+7YU_L>;29!YERV8WO-R_+(3QNV;L;NY/?%5-'U&TL
MO#_ARWU2X\C09(KV%I9HB\:S^?E!)GH2F[:3[]Z /7[VY%E8SW1B>40QM(4C
MQN8 9P,D#/U-9<GB6%/!0\3BUG>W^P"^,*%=^PIOQR0,@>]<)Y]I:SW&DZ[>
MW,]E_8B#2)]0^5IVS)YC9X_>X\K'\6/J:VX5:Y^! C@5I)&\.>6$4$L6^SXV
MX]<\8H [:VG%S:PSJ"!*BN >V1FI:\VTG2+&_P!:M$TJXEFTV\T>1-5,=RTB
M>9^[$1SD[9/]9TY 'TK4\&1WMS(D.I0LLV@HVG>81@3R9'[P?6,1G/K(P[4
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@92/FSALYSCM6G10!3L--BL6GD$DDUQ<,&FGEQN<@8'0   #H !U/4FKE%%
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MIT5[./NJBLF2Q[!<YZGM0!"O@RRAUJ;4+6]U"VBN&5[FQBF @G90%#,I!(.
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M:M::%I-SJ=^SK:VR%Y&2-G( ]@":N@Y ([T 9,ME);>$7L+6R02)9&&.UMV
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M=MI(!)]^BCZ#H:;'(DL:21NKQN RLIR&!Z$&G4 %%%% !1110 4444 %%%%
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M:EX@N=!CFUJ\C2]\,?:YQ;.J9FS#E@0,@_,?Y=,BO0)]+T^Y:W:XL+64VQS
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M+:..39OWQN6D/]X9 7!R!@^M4H=4N;Z+^R(]:ATF2VT:TGLYGF*#E#NEQTD
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MYM.L[[3WO[:Y:59 RH@=U8#E2%.1Z@=CQ70Z[N_X1O4AM9W-K(H$:$EB5(P
M,GKVKFM"\++JWAG1#K;F58-)-HML8#"R>9$J2;\DDL%!7H.IXZ8 -%?%XBN;
M".^T^2!-1M9+FS,;^8S[$WM&PP-K[3D $@X//'.;?^-[N7PC-K.DV]E*A-L(
MYEN]Z?O9 C X3AUR,J1W]L5HVOA*:.+3UNM4:=],MI(+&80['0LFS>YR=SA>
M,@*.3QTQ4N? ,5W#JK-=Q07>HI;B22UMA&A>&3S%D9-QW,3@$Y'  H MZIXN
M?1[I(KS3PD9GM[=G\_!=I65<Q*5^=5++D\=^.*9J'C5;,WKPZ>]Q!9ZA%ILS
M"4*_FR;,$*1RN94&<COQQS7U#P/=:A/?R-KKJ+R:UN&!ME8K) 4( .?N$IG;
MV))SR0<.X@U)_$VIW-O)-%>_:MT-M=Z$\R2&-0B.)E*H <9!)RNX]* .FN/&
M*QWWE6^G3W4"7BV<SPAF>-S@%@H4@HI."=P(P3@@<WM?U]]$FTR&/3Y;N34+
MDVT8215"OY;N,Y[80U3MO"UY9:W=75IK<T&G7L_VFXL!$K?O2!N*2'E5; R,
M>N",U!XUCN9=1\+"T$F^+5A*\@MVE6-/(F7+8Z#+ =1UH KIX_E9(86T*==1
M.IG2YK8SIB.7RS(IW=U91G.*L7'C:2W1S_8]Q+):R117L$+&22)W5&8(%4B3
M:'4GD=\9Q3Y/!I>ZM[L7ZBZ75/[4G?R,B601&(*!N^50AQU)XSZYDD\+7<?B
M&\U#3];GL[34&5[VT$*MO=5";D<\QDJJ@\'IG@\T 4+SQ_)9I?W4FA7']G:=
M?_8[RY\],QCY/G"=6'SC([#UY T+GQ:+37+;3[BQ,:7-[]CB9I0)&.PL)!'C
M_5DJ5W9Z]JQ-)T.?6G\4V-V[PZ=<ZR97BDM65IHPD7W7) VL4P< ]#@C/&A)
MX(G?4/M UJ01KJW]J(AMU+!BI4H6)Y !PO' XYP* %T_Q+:0+>)!8S1W<^M2
M6*027!;S9MH9FR<[%V@G Z!>!DXI?!,MS)J7BM;H.KQZOM$;3F4(/L\)PK'M
MR2!@8ST%-F\#/(DLD>JF*]&K-JMM.L'$4C+M*,I;YE*Y!Y!YZTX>'=:TQ=1N
M-/U@->ZA?QW4G^B+LX1$9<%CA2$'.21VR: -G7]=M_#]A'=W)18Y)DA\R5]D
M:%C@%VP=J^^.I%<SJ.HZ@_C#PU<V]H[336E^/LJW?[I]K1A6W=,$$D,%SANE
M=;JEE-?VZ10SQQ@/F198?-25,$%&7(R#G/7L*P=,\$II%WI4MI>*D>G+=!(?
M(.S]^X<A?F^55P J\X'<T )_PF_F>'K/5X=-813VLMPYGF$:1F,@&/?@Y<G.
MT8YVD\5!%?+JGCK0+N&2X2UO]!N)_*,C 8+VY4X!P& 8\CGWIMMX FM;:P@C
MUI]MM:W%HW^C ADF;<64$G:XZ9YR.,5?TSPG-IMWHMQ_:8F;2]-;3U#6^/,5
MMGS'#<8\M>/K0 WX>L]Q\/\ 2S-++([QN&=G)8_.P^]G.?>L'P9XHN=/T'P]
M:ZA87!L[Z62VCU%YPY,V]RH9?O8(4@,3U'('6NQ\-:*?#V@6VE&Y^T"W# 2>
M7L)!8GD9/K6;IO@X65MIUE<7HN;'3;AKBUB\G:V\[L;VR0VW>V,!><>E "Z9
MXP75-0T^*'3IVLM0C>2"[0,P4 ;AY@V@(&'(.3Z'!J]J.K'^TFT6TMOM-V;4
MW,J^>80D9)4?, 3N8AL8_NGD<9I^'/"]YX>,=JNN3W&DVV1:6;PJK1*<X5I!
MRZJ#P,#MUP*FO_#L\OB:+7M/U'[)<_9OLEPCP^:DT08LO&1M8$M@\]>0: .:
M\*^*I+/P)H,"0R7^H'24NY%>1LLO0?,%8EF(.,\<')%:UUXZ1+1I[/2;RX>&
MVBN9[8HR3H'&0@3:<R #)4E>V">U:R\ W>DVVCG2_$$EM>:?9_89)FM5=+B$
M'(!0G@@Y((/<]:O3>$[R/6O[1TS7[FS:>".&]5X4E^T;,[7!/W'P2,X(Z<<4
M 5M2\>/8#6I$T::6WT@127#M,J$QNN[<JD9R!_"<=#R*M2>,ELKO4[?4]/DM
M6L[>*ZC"R"0S)([(HX^ZVY<8R1R.:BU'P4U_#XCA_M+9'K44<39A+&)439P2
MWS$CU[T_5/!BZU>ZA/>WQ"WNGQV3+#'L:,QNSK(K;CR&;/3L/Q  >-!$UU#=
MZ9/%/'+!#;E=QBN7F.U0KLJ\@_>XX'/-1>&);M_&WBR.[5HRAM-L8N&E09C8
MY4D# /I@<T^Y\(7^IZ,+;5/$,US?0S13VMW';K&(9(VW*VP$AB3UR>1TQ5_1
MM!NM.UG4M4N]16ZFOUA$B);^4BF-2 0-S'G/<T 9DOB^YL-:\0K?V\(L--^S
M1PB*0F21Y?NC!4#+%E'7 QWYK7L==:;7[C0[VU%M?1VZW2;)/,26(DKD-@'(
M88(([CKFL[5O!$6K76LO+?RQP:HD!9$0;HI8>4D5CZ$ XQU'7'%:=AHKPZN^
MKWURES?FV6U#QP^4BQABQPNYCDD\\]A@#N <OJ>LW>@^-O$5Y!:37L-OHUM=
M20FYVJBJ\^\J#G!(4<  '')%:VL>-(])A^U-9,UD(X)/-DE$9E$K8Q$N#O*C
M!89&,CK4FI>%)-1O];N?MZQC5--73V7R,^6HW_,#NY/[UOT_'.OO $][!=P_
MVVR1W5I;V[C[,&*F$Y4J2W"D\E?7G(H U9/$[0ZGK-A+9;9["&.>%?-_X^ED
MR%V\<?,NWOS^=5[SQE]FNI(X=-FNDM[E+6Y-ON=T=MN2JA?F5=PR<@\'CCF_
M>>'+>^US2]6EFD^T6*-&V  )U.T@./9U5AZ$537PM=VVOWE[8:W/;6%]*)[J
MR$*MND"A24<\IN"C/!]B#0!!X[EFMXM!FMQ,T@UBW7RHI=GF [OE/(!' ZT0
M>.$S<6E[ITEIJL%XEF;5I-ZLSH9%8.HY4HK'ID;2,5KZ_HIUJVM52Y^SS6EU
M'=PN4WKO0\!ER,@Y/0@^]96H>"A?QS7(U*2WUE[R.]2^BB&(Y(T\M0$)(*;"
MP().=QYYH (?&GFQ1Q/ILT%^]Q+"L,V]481@$R*^S)0AEP=O5L8&#B.'QK<W
M4NEV\&@72W6H0W$BQ7,@B\MH656!R,X.X$,!R"#BI;[PIJ%Y%870\02QZU92
MO(EZ+=2A#J%:,Q9QL( XSG(SFK0\.7)UC2M3DU0S3V,,\;&2'_6F4J6/##:!
ML7 ';N>M %[P_K,?B#0;/58X7A6X3<8G()0@D$9'7!!YK&L?&PU"XT40Z=(U
MOK E:UE$HW!8^I=2!C(Y !/H<5I^'](;PWX<BTX2F\-N'*LJ!"^6+8P21GG'
M6N+\(VVI0WEI+#*[2EB;BWO-"D@:$.VZ0"8E5SGGY1AB!QW !L:7XIAMK#3W
MBTR6&UO=6N+&1I;HN89O-D&3G/#,I  . 64=*T[GQ0('2(6RF:>>:*V!D;:Z
MQ<.[$*2HSQP#R1VYJ!/!B-X2U#09[TN+J>:X2X2+:T,CRF4,!D\JYR/H*FU?
MPJ;R#2FTS49-.O=+)%M<",2@J5VLKJ<;@0!W!R <T 4H?&MS=2Z7;PZ!=+=:
MA%<,L5Q((O+:%@&!)&=IW A@.01QVK;T'61K_AZVU6" Q-.A/DR-]UP2I4D9
M[@C.*I?\(Y=-J^E:E+JAFGL(IT8R0_ZUI=N3P1M V# ';N>M6_#>BGP_H4&F
M&Y^T"$N1)Y>S.YBW3)]30!S^B>,M0GTC0[S4K"!5U6[DMA+%.2L+9?8""@Z[
M-H/KC/6M'2?%HU6$&.T195U"6QFC\_=Y?E@EG)V\C !'^\O(S447@I5\'R^'
M9-1E:(2&2UG6,*]N1)YB$>K*V.>,XZ"KNG>%;#3-;N]2M]P%Q;QP>1_ NT;2
MP]V58P?]P4 9]MXW^U/;O!I-S+:7=K)<V\\>2,*NX"3*@)N7D<GTX-)IOC6?
M4CIZ_P!D& ZEIC:A9&2X!#[0A9&P#M_UBX/.1G@'BGZ/X1OM(L6TU=?FGTV*
M-HK*WD@7,*D$ ,X.9 H. ..V<X%.T_P>UC+H!.H"1-'T][!5\C!E1@@W$[N#
MB-?U_  JZ%XPOKC2_"T^IV,2C6XUQ<QS?*DACWA2"HP6P0!D],9Z9W;;7[-[
M83WL]M9K)+(D'FS@>:JMMWC..#C(Z\$>M<Q>Z#]C\)V'@HO?W<^R-;.]AMBB
MVWE,NQV<9"LN-W)RV"!U KKGT32Y;:VMYM/M9HK9!'"LL2OL4 # R..@_*@#
MB]2U -XC\2SZX"NFZ-!;7$3P7+K)%C>^5  RSX (STP.16Y>^+9-,N)[6_TT
M17*V$E_ JS[EE2/'F)NVC#C(XP1SUZT7?@Z+4;GQ";ZZ\RUUJ"."2%(]K1A%
M8*5;)Y^;/3J!3_\ A%6O")-8OOMDZ6$MA')'#Y6$DP'8C)RYVKSP.#QS0!%-
MXR6$KC3Y'#Z.VK)MD&2J[<H<C@_..<]JU- U6ZUFP6\N--:RBE1)(-TRN9$9
M V>/NX)Q@^E8$7@:\"QFXUWS7CTF32ABT"KY;;?FQNSN&T=\'VZ5U&DV3:;I
M%G8-*)C;0I#Y@7;N"@ '&3CI0!@:!+)XM\/3:E+<SPI?7$JQ^3(4:.W20HJJ
M1RI8)DL.?F.",#%31)7\.G7C]KN;G2ENTATV.ZN#(QEV@.BNY)*[^,DG&U^P
MJSIF@7]AX<NO#EG>O8^7/*UM>+%O_<22%P!R,,-Q3UXR.H-7+'PRQM&M-=N;
M76+50@@MY;"-(XMN>0O.3R![8XZF@#(\*&YU/_A*[2YU5YKE-3Q'/&_^I)MX
M2/+'90Q.!T/?.3G6T'6&\2^!;?4I5,4MQ;,)A$Q7;(N5?:1R/F4XIFF>&K#P
MF=8O=+L(FGOIO-CA@MUCV_(JB($=%RN[G !8FK/A_0&T/P?:Z*LZF6* H\VW
M(,C9+-C(XW,3B@#F_!OBM[7P[X<M-5MI(HI]$%VEZ\P<N(DC,A8=1PX(.3GG
M.#6W!XL:2YTF.;3S"FL0M)8.9L[F";PD@Q\C%>>-PX(STS6MO R16^AVT]ZL
M]MI>GRZ>8S!M\^.144Y.[@X0=/?\+.F>$VL_['2\OS>1:.K+9 Q;&&4V N<G
M<0A(R O4G% #-.\9)J4?AZ2.P=5UJWDFC'F#,91=VT\8.?7-4K;X@&31;;5[
MO2OL-A=.D4-Q<W2A Y9E.\@'8!M'S$8)8#WI^E>![G2Y=%QK1DAT<3):QFU
MS&ZX <[N2!W&,XZ#K5W3_"\^G>&+/18]0BE2W=BYFM=R3QMNRCINY'S>O84
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MW0BU:"20) 9-D8SN)P#@=,URVH:,XTWQ4;?1I_/DUZVN+0I9MN,:FW+,F%Z
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M,4$9BC59)U7#J,#"[OFQQ@' H ]2HK'\,WK:IHL.I?;Q=I=YE38H"Q D_(.
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M026Q9$N%N@3*^XRKC#ELY9A@8))Z#TJ.X\*Z)>0:A!<V"31:@XDNED=F$C@
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M#!<_O+QK+RF11(LBDA@5SQC:Q/L,]*VZ "BBB@ HHHH **** "BBB@ HHHH
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M'..<9KMJ* /+=2L;KPU9:+976H:3!?+J=Y?075Q(\$0#L[%?,YVL?. VD'<
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MRGMC(\8E0H73&X C'&01^E0:/ID>BZ-9:7#+++#:0I!&\V-Y51@9P ,X [4
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MZX.5!\MF&#@DUZ/10!Y6VE:.][X7MH9[NZTJXU&[8?:247RG@?Y54!<1;S@
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M<=<<5E^$[F'PMJ'B#2M:F6TEN-5GOK:><[([F*4@C:YX+#E2O48%=X2%!)(
M'))I(Y$EC62-U=& 964Y!!Z$&@#D-<N8Y_%G@Z95=$^V7)RZ[>#;R*"1V!)
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M*;R\%OX\UJYO(DNO#[WUJ+I4&Y@_DQB.3'\<:L"& Z$@G(!%>J1E&C4QE2A
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M,66$P5Y53<F/E&"P.#UYY%=&GB745O\ 5=*G2U74X+J%+- C;9H)?NR$;LG
M$N<=/+/6M!/"=@L\[&6X:VGN_MLEHS Q&;(;=TW?> ;&<9'2H;33Y=2\5#6K
M_23926,<MK;.\JNTRLP^?Y2<#"\9Y^=N!W &^-K[4=/T6UETZYC@EDU&T@=F
MC+91YT0@?,,=?RR.,Y'+W>IZAX;UOQKJMG#9.MJ;.:Z5E9?-'E#=M /RD\G)
M)],'K7>ZUH]MKNG&RNFE1/,CE5XFVNCHX=6!YY#**R[OP787L6KQ375Z4U5(
MTN?WBY(0;5P2N1QU/>@"O?>)-7DO=0CT73%O!IUU';S1' :7*H[E7+@)A9!C
M(.<'IFJ_Q6BCD^'MX7A64K<6I4, >?M$8XSZ]/QK2F\'6$VMR:H+N_BEG5%N
MXH9]D5WM& 9% Y...,9'!XJ]K^A6WB/2FTZ[FGCMW=';R6 )*,&7D@_Q*#^%
M ''!_L'Q4TM?[.&BQ7-C.B(A7;J$@VMM(3A2@!(+<G.!5NV\::E))/$\%F\H
MT=]23R]XC5T8 Q[\D2#YA\ZX!P:WF\*V-SJ46H:A-<W]S#$\,+7#@")7&'VJ
M@4 D<9QG'>J-MX!TVV2)5O=28Q6#Z<A><'$#8^7&,<8&#CZYH S8O$.HZI$M
MCJEK9&#4] ?4(Q"&)0@(&5MW!!\P$<#&,<]:F^'&KOJOAC2H[5X?L=C86UO,
M&4^:9A$I/&>%P5P2.>2.,$ZJ^#[-&M&6[O UKI[:=&=R?ZEMN<_+U^1>?;ZT
MFF^#K#2+F"XLKF\B>*R2Q8!U EC083?\O+*. W7'XT ="RAE*L 5(P0>]>0V
M$<MM\(H18M#;B77/+E_=9WJ=1V8X(XQP1W''%>K6=F;/3H;,7-Q,8HQ&)YWW
MRM@8W,2.3[XK"C\$6$6@)HJWE]]D2Z%V/G3=Y@E\WKMZ;_FQ_3B@"#Q=Y_AS
MP'K%YI!MK2]*F:66.# >1L!G W<,?4D_C6-JMQJ>D>-=>O[%;![J#P]!<S-)
M&RK(4DN#@*#G)"XR2<8'6NXU;2;;6M&N=+O3(T%Q&8Y"K;6^H(Z'O6;+X2M)
MY[R:6]OGDO+$6$S,ZDF(%C_=X.7?GW]A@ S;CQ9JEZLZZ#IJW%Q;V<%RT,G_
M "T:52PCW;EV<#[Q!&3TXYM^.P+CX9^(&F@"DZ5._EO@E&\HGZ9![BED\#Z>
MUU:W,-[J5K/!;):2/;7/EFXB3[JR8'.,G!&#R>:U]5TBWU?1+G2)6DBM;B$P
M2"$@'RR,%1D'''% 'G4A%AJ_@:X_LP:- [I"]]'L_P!(9XB%@8)V8\Y;@%?6
MN@_X32Y.DVFOI! ^D7&H_8C& ?-1#,85DW9P?G )7'0]<CG57PE9/+ISWEU=
MWRZ:RR6D4[J$C=1A6PJKN8#H6SBE@\(Z=;R$(\_V/[7]M6R+ PK-NW;@,;A\
MWS;<[<\XH YV[\7^(X=#\1:NEII?V?2)+J+RV:3>YBQM/I@C.?PK8CUK6&UR
M+0Y1I\=]-!+>K(JNZ) K(JJ1E2SEG.2"!A>G.*G?P?8R:-J^E/<W;6VJRR2W
M/S+NR_W]IV\ _P#ZJM7GAZWN[JPO?M-S#?V2-'%=Q%0Y1@-RL"I4@X!QCJ,C
M% '/V?C2]NAH\LUO;VT%S=W&FW98%O)N8]X7!R,HQ0]?8=^':+XTN-1T>.\G
M2!);<W+W\:1M^[CA_NY.<L&C(SU#>U;<_A72;G0!HLL!:S\T3$%OF:02>86)
M]2V23[FK%OH6G6VH:G>QVZ^=J0076>0X5=HX^E './XG\11Z;<:E_9,#67]E
MO?1RD[1'(J[A&WS$N"N<, O3ISQO^'[O4[W3$O-36T3ST26%;;=\J,@.&W=\
MD].V*S;/P+IUCIESIL=]J;V<L#V\<4USO6VB88*QY''' )R0. 1706-HEA86
M]G&[ND$:QJTF-Q &!G ':@#F[+Q/?W6D6WB(P6QT.:VFN9 I(FA15+(>N')
M.0 ,$]3BHX_%.I)+H)N+>U:+7(':W$>X&"41>:JN<G>"H8;@%Y'3GB]I?@S3
M-)DE$$MV]FS.T=C+-NMX2^=VQ,< [FX)(&3C&:DL?"5E81VL4=Q=R1V4;Q62
MRNK?958;?D.W)POR@MN(''<T 8FA>,=8OSX?EN[.S,6M:=)=116Y8.DB*C8)
M8X(8-Z<8ZFJ=UXU>_P#!>OWK0Z==R65FKW&G74#QO$_S;XY8V))' P> >?2N
MAM_!6GVT&E0QW-YY>EVTEK;@NO$;J%()V\G '/M2W?@NPO[6]AO+J\G>\M5L
MY9V9!(85).W(4=V/)&?>@""]\4R6GBF/1I#!9^:T0MOM,3!;M6QO\N3(4.O(
MV'DX]^,BQ\4ZM8:%=ZCJ4J7$2ZS<VDL\5F["UBC>1=[(K$E<H@X^[NR2:Z>X
M\-6UY-NNKJZGB,\-P8'*;#)%MVM]W(Y120" <=,$BHX/"MM:/*UI?7]N9+U[
M["2J55WW;P RD;278X.><>@H EBUV*+PD^O7$T$\,5J]R\EH=R.B@ME.>X%9
ML'B345U'0[>[BM?+URW=X'B5C]GE6/S-K9/SKMSR-O*].>-NQT6PT_11I,4(
M:SVNK1OR'#DEL]N2QXZ<U4TWPO9Z;]DV3W4PL8FALA.ZM]G0@#"\9/  RV3@
M8SR<@&-\/[,W>BQZIJ MKB\2\OA%.(2LB9N9 _S%CP=HXXP !SBJ]QXPUR&*
M^NEM-/,%EK2::\99]TBNT:A@W12#(">#GVQSU6AZ+!H&G?8;::>2'S))1YQ!
M(9W+MR .K,3^-9TO@VQFM;RW:[O-EW?IJ$F&3/G*RL,?+P,HG'M]<@&:_C&^
ML;C4-/OX;5[Z'4+6QMWA#+&YN I4L"2?ERV>><<8S4>L^,]4T9=<M7M;2:]T
MY+:>-QN2.:*9]G3)*L&##KSP?:MBZ\&Z;?2ZG)<R7,C:@\4KG>%,<D6/+="
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MP\5N54@LJ_*2>?[P8#'8 ]ZT*@L;.'3["WLK==L%O&L48]%48'\JGH ****
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MA:W+0Q.LPD$R  AN -IYY7G'K0!B^+O%/]F6B+IMR/M2ZA:VTO\ H[.@\R5
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M:]:)+BY:8VS?Z2R8E=_W038,9R#GIS7HFJ^+(=)OA#<64X@^TP6OGL0H=Y2
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MT,>T[8^>-S?G4'A?Q8R6&JRW5S/=6Z:O]ATZ*; NCNVA4D!P5^8L1OPVT9-
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M6FE:7=WR7%I!>K.C1JGDR,5W?,P/&#D=>.!74T %%%% !1110 4444 %%%%
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M,D9J6[\96GEZ=-IA@O;>YU,:?+()L>6<L"P !W<H>X]>:Z!;VU>U-TMS"UN
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M[&6W8):-NF4JHR &)! 0< '-3>%-.M6U+5M>M%N4M=0E#V\<\;1[057S'5&
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MAU9/FX'R#)&*QM<T7[3/XK0Z).X;PW#;6:_9GE E59_D1L'<P+IR#_6O4**
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M21&1H7A51G:1G+INB/X'M7IM5Y[^SMKFWMI[J&.>Y8K!$[@-(0"2%'4X )H
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M5VMYT*2*DC(64]1E2"/SJMJN@Z=K>D_V7J,+S6>4)3SG4DJ05RRD,<$ ]>U
M''^,M5NM6T'QW8V\ZV\.DZ>\;J8PQF+P&1B<]!M8 8QR">1Q3K[6]=@EUFVL
MKRUABT[1(+^'=;%R6(ERK?-R#Y0Y]_QKH;_P9H>I37$US;3%[FV^RW!2ZE3S
MX\$ 2;6&\@$X+9//6I3X4T=FNF-O,3=6JV<Q^U2_/"N<+][C[S<CGD^M &-I
M^NZS-K<-K-/:LE]HK:C"H@($#AD&W[V6'[P>G3MG%4=*\0Z]JL?A*"&ZM+;^
MUM&DNY6%KN*2((?NC<!C]X>.V.]=5'X9TJ*X@N$AF$L%H;*-OM,ORPG&5^][
M#GKP.:9:^%-&L6L&MK>6,Z?;M;6N+F7]U&V,J/F_V5Z^@]* .?T?Q1J>HCP7
M+.+8#5%G%T%B.=Z1L<J<_*"5Z?K61JOBO5+CPGXBAENIM.UFUTJ6XDM7@"E2
M/XX7'#Q'IG)(R.YX[>U\)Z-9#31;VTJ#3"YM!]IE/E[P0W5N<@GKGK2+X2T4
M6DEJ]J\T#VK66V:>23; V-R LQ(!P.GH/04 9+7NOMXLBT6#4[6.W33H[QI9
M+3<[?O=K+]X#E1C/;T-4;'Q-J]U?PVK7<3I>Z3<W:7,,0\M9(W0 PEL%DQ)U
M8<X!!(-=5:^&]+L[]+V&&;[2EO\ 90\ES+)F+.=I#,0>><GFJMAX+T#39K66
MULY%:TC>*#=<RN$C?&4 9B-ORC"]!C@"@#G?#^K:I'IG@"*6Z2=-4MLSO)%F
M0$6I<$-GU'/&36CHNN:G>7<NCW=P@U6TU"1+@I$ #; !T<+Z,KQCK]XGTQ6K
M:>$M%LAIHM[:51IA8V@-U*WE97:1RW(V_+@Y ' K1CTVSBU2?4DMT6\GB2&2
M4=61"Q4?^/']/04 <OH.NZYK;Z5JL,<8TJ\\SSTE*#RQSL\L@EBP(PP8>N,8
MQ3/B5+(-,T6U8D6%YK5K;W_8&!F.5;_9+!0?8X[UM:?X2T72M4FU&RM&BGE=
MI"HF<QJ[?>98R=BL<G) !Y/J:T[^PM-4L9K*^MX[BUF7;)%(,JPH ;=6-I<-
M:O/&FZVE$D#' V-@KQ]02/QKSOP5J6I:=8^$[;SX&T_49;R P^5AHRGFR!M^
M>?N$8QC!]LGO+/0K.QV^6UW)L!"?:+N679QCY=['!QD9Z\]:K6_A'1+5-/2&
MUD5=.=Y+4&YE(C9P0W5N<AF&#GJ: .=T[Q1J\^IV]N;BVF2[TJYO$F6$^2)(
MW0#RN59H\2=6ZX!!P:2Q\0:^/#&@ZO?75N\6KM:"5XK;8+)'C)9B2Q!RVP9(
M 7=W%;EKX&\/V1MS;VDR&WBD@A_TN8^7&^-R#+\+P,#H,<8JEKWA8G1M(TS2
MK%9M/L)0WV8W\L$BJ$94\N4$L,;NF1D<9[$ IV_B;6UCM;>[5&>^U2>SM)HH
M0C/!&KL)/G;:68(,=!U(!&!1?>(/$.CZ?#)J\+)"DDZW%W90B=HE&TPO)$"<
M*5)W[<X(&" :OVG@RUN]'EL=9BGEMWE2:&"74);A[=UZ,LS$.&^AP.W4UJ#P
MOI:001(EP@@22-66ZE#,KXW[FW9<G:.6R>* +EM>*^CPWQE2=&MQ-YD/*R#;
MG*^Q[5R-GXIU22P\*ZNSPR6NO2+"]NL?_'N9(V="I')V[<-GKU&WI7;6]O#:
M6T5M;QK%!"@CCC48"J!@ >P%9EEX8TG3WC:UMF18G=X8_-<I"SYW%%)PF<MT
M QDXQDT 9O@J_P!:UG35U34KRU>*1IHA!#;%-K),Z;MQ8]0O3'X^J7,U\?BA
M8VR7KI9_V3/,8 @VEA-$,^N<'\.W4UN:5I%EHEB++3XGBMP[.$:5Y,%B6;EB
M3R23^--N]$L+[4K?49XG^UV\;Q1RQS.A"L02#M(R,JIYS@@$<T >>^"]8U'1
M]"\(Q22Q2Z?>6$Y,"PX>,Q+O!#9Y)Y&,>GX]+X=U;7=5ETK4)$A.E:A:>:X8
MH#'(5#((MI)9<;@=W/ /J*T[3PGHMC_9HM[61!I@<6@^TRD1!AAA@MSD>N:3
M1_"6BZ!<R3Z;:- 7W83SG:./<<G8C$JF3UV@4 9?CA)WOO"BVTB13G6,)(Z;
MPI^SS\XR,_G5.S\1:T9)]*O;NV-Y:ZJ;)IX(2)+F,P"9?+0Y42?,N[/R@!C7
M6ZGI-GJ\<"WD;L;>430O'(T;1N 0&#*01P2/H352?PKH]Q%;H]M(&MYVN8Y8
MYY$D$C AF+JP8D@D')Y'% '*)XSU;_A%]+U6[BEBMY!=)>75K;B4P/')L1GC
MR3Y9"L6*YP<<@5?E\0:NVKZC!IXL[UET.&]L_+7;YLCLX W$X(.T$=.OXUL0
M>#]%M;=(+:WG@B3S@JQ74JC$K!I!PW0D X[=L5(_A71GFDE^RNC26J69\N>1
M (4.550& 7!)P1@T 0>%-<76[>\;[3,\D$_EM!=6_DSV_P BG9(N ,YR01P0
M1UQ52\UK4;S5]?T_39HK:32+6*5?,CWB:1U=@&_V,*!Q@Y)YXKH++3+73WG>
M!&\V=@TLDCL[N0 HR22>  *K7OA[3-0O6O)X7%P\/V>1XIGC,D><[6VD;AR>
MO3)]30!R-M?W'B'Q9X/U+S#!#?:+<7)MF0,%W&W++SUSNQG_ !KIO$.J?V%8
M6$=LL41NKR"QB)7Y(MYQG ] " /7%6VT+3FU.TU'R&6YM(C# 4E=51#C*A =
MN#M7MV%2:MI-CKFFRZ?J5NMQ:RXW(Q(Z'(((Y!! ((Y% &'=WFLZ>T-I<:C:
M.\]\4A,29N7@\MF "8V^9N4Y) 4(">#6##JUUKD7@._O507+:O<QOM7 )2&Y
M3.,G&=N>M=5_PA^BFVM8#!.3:S&>*;[7+YPD*[23+NWG*\<G&..@I;?P?H=H
MEFD%H\:V5P]U;JMQ)B.1\[B!NZ'<W'3D\<T 9^A:IJVOV6G:S!>6T5C=M,LM
MNR?-& 6$>P]W!4;@W'7 &*I:#XIU348_!DL[0_\ $XMIGNE6/ W(FX%>>.?K
M6_I_A31M+U.;4+.U:*:5VD*B9S&KM]YEC)V*QYR0 >3ZFHK/P7H5A<6L]M:S
M(]HSM;9NI2(=_P!X*"V O^R./:@#F/#-]=6WAK3+2TN$B:YO]1RB)OG?;<2D
M; 1MP"1N+8 &!G)%.T?7-6UW5O!EW)=B!;[2KBYGMXXQL:13",\\_P 9[\5T
MJ>#-"C2T6.UE3[)+++ 5NI0RF4YD&=V2K'DJ>#Z4^U\(:'9)IRVUH\8TW>+7
M;<290-C<N=WS+\J\'(X''% '/:3XJU"\&CZ=*\,5UJ%_J$+SQ18"I;R./E4D
MC<<+US_$>:C/BK7FEM[%9+1+B/7VTF:9H"1*GDF57 W#!QM!'KG&*Z9?".BI
M9Q6J6LBI%<M=Q,+B3?',Q)9E?=N&2S9 .#D^M2OX9TEUM%:V?_1;DW<1$\@/
MG'.78ALL?F/WL]: *OA/4[W4;/4(]0DCEGL=0FM/-1-GF*I&"5R<'!'Y52OM
M<U*ZU'Q'::;-%;R:+;QR*LD>X3R.AD^;N$P .,'.>>,5OZ;I%EI/VG[%&Z?:
MIFN)MTKOND;JWS$XSCM4%[X<TO4+V2\G@?SY8?(F:.9X_-CY^5PI 8<GKZGU
M- '*6MY/K_C7PSJ'F&&WO= FN3:N@8*'>V+(<]<YQGVKJ=>NWTO28S:2V]L3
M-#"N]"<*SA2L:J#E]N0HQC.,\5,VAZ<VK6^J>2ZW=O"8(F25U58R02NP';C*
MKV["GZMH]CK=FMK?Q-)&LBRH4D:-D=3E65E(((/<&@#BU\5:Z]G"J/!',/$)
MTIVG@W,8\9!(5@-PXSC@^U.D\2:[:Z/J5Y+<0RIHNKFWO72WP9;3",S@9X95
MDSZ$*>*Z)/!FA1G*6DH/VL7W%U+_ *\# ?[W7^?4U%>Z-/8PW4.A6-NYU29V
MOI+NZ<A"R;3($(8-P -OR@X SZ &AH]Y+J!O+OSEDLVG*6FT#E%^5CGOEP^/
M8#UK)N]9U&]UO7-,TV>.VDTJTBE4R1[Q-)('8!O]@! .,')/(QST-A90:;IU
MM8VJ!+>VB6*)1V51@#\A5.^\/:;J%\;V>%Q<-";=Y(IGC,D><[&VD;ADGKTR
M<=30!R%MJ-SXB\3^"]3$AMXK[2+FY:V*!@N?LY89/7.[&?3ZUZ#'&D,211(J
M1H JHHP% Z #L*SVT'36U*SU#R&6XLHC#;E)758T.,J$!VX.U>W85I4 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 <!X@\77LNA>(GLH[JPDTG4(;8381O,!,.X8YZB4].<8Y
M!XKHX?%FFRB_\P7%O)8R1QRQ3Q%')DQY>T=]Q.![]<5A:GX1U>YM?$EI;R6)
MAU2_AO8GDD=64J(0RL I_P">/&,YW=L<KJ_@_5-3OM<NHY[."2[-E-9EBT@6
M6W8L!(NT95B<<'I0!IMXYT>/S%E^TQSQ7D5E+!Y)=TDDQLSMR,$$$$$YZ=>*
M:WCO2HTN&FM]0B^RW*VUUOMB/L[-MVE^VT[U.1G@U4N] U[4M-LQ<1:1;W,.
MHVUT\5L[B,+$X<X8IDLWN ![\Y@U7PEJ]];>*HHVLE.L7,$T):9_D$:1J=WR
M=3Y>>,]?:@#5\>7]WI?A*>]LKJ2WFBF@^:-0Q*M,BL,$'J&/3FHY/'FDPVVI
MS3PW\+::%>YAEMBDBQMG;(%/5.#R.F#G&*O>*=(N->\-7&GP/%%<.T4BER=F
MY)%?!(&<';C.._2L^ZM+.RO=1\0>)Y[&UAN;2/3FC:;,2Q[F)W.P7)9I".@P
M /4T ;\>H1RZBUBJ2>8L"SLV 5"L2 ,YZG:WY&L;4O&^E:7<:C#/'>L=.6-[
MMX[9BL2/G#D_W1@YQ^&<'">!]*ETOP[%]HGEN))?N22KA_(7Y801U!\L*3_M
M%O6L_6O"FJ:D?%ZPO9JFM645K 7E;*%5=26 7_;SQGI0!N:CXFL---WY@GE2
MRC66\DA3<+=""06YR> 3A02!R1@BJ9\51RZYJ.FK;7 M[6PCN_MD(#AEDWX*
M@$DCY..#D]L<FE)X9U:.[UYK9[-H=<MD282R-FWE$7E%EPOSJ5"G!V\CWX?;
M>%;W2]4F:P>V>RDT>#3E$SL)%:'S IX4@@B09/;'0YX +=IXFL8=!T^:.2]U
M OIZWN?+4S-#M'[QP,#)ST').< X-27_ (STBPLS>.\LELD,=Q-+&G^IB?[K
M,#@].< $@<D"L/3O"OB+0VT6ZTZ;39;BVTF+2[R&XD<1LL9RLB,%SG);Y2!D
M'KWJU/X<UVW\13ZA92:5=PWT,27?VZ-@T4B+M\R,*""",90D<CK0!T]]J=II
MVGF^N)<0#:%*C<7+$!0H'4DD  =217%R^))HK[QJ=1N]2L[*PM+=T"1(TMMN
M60LR;00>@.3GWZ5T/BG0KG6M#BM[*X2*]M;B"[MWE'R&2)PP#@=CC!QTS6#J
M'A;7]5@\5&<:;!+K>GQ6L:)<.XB95=22QC&1\^>G;'O0!TS:]:QW9M$2XG>,
MPI,\:@^69#A-PSGGKD @5FQ^/M%>YABVWJ1RWC6(N'M76)9PQ78S$<$D8']*
MJZCX5OM0UFUU)%M;.]MW@V7UO.ZR^4I4R1.NT"13A@-QXW=!CG(T'2[CQ%I&
MHV)-LM@OB6XN'E60F0B.Z,@4+MP,E0,[NA- &UH_B"6VFU\:C<3W7E:Y]BM$
M"+N^:*)E08 &,LW)_$UH)XPTUUL6"7(%W>/8+F,#RYT+!D<YP#E6P>0<<9R*
MR)/#6OQ_VHUK-9 7FLK?M$9W430>6B-$S!,KDH#P"#T/&<YUYI$.B^$=2T35
M+VR@N[^]N+K24M20YF,GFQA%./F5RO _/G@ [&7Q#:1/)&4E,JW!MD0!097"
M[R%)., =22 ,8Z\56M?%NF:C:V[V)GGGN6E1+>- )5:,XDR&( VG ))QDC&<
MC.=JGA;4FT[19=.FLY=4TZ5I9%O%/DW1D!\W=@$J2S%@0#@]J)- UR'6M+UV
MU_LTWD,$UM=6>YHH?*D9&_=N%)W*47DK\W/W>!0!;\!:E=:KX/MKV]GDFG>>
MY4R2J%8A9Y%7(  !  '3M5F#Q7IL\]D@\Y8K_=]BN&3]W<E020I'.< D9 W
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MK:9P;R#:P5)8]H4L"5^;)(VT .\1ZU=:1XOT)$>[EM+BWNC+:6\(D,C($VD
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M8;<MC&[+!B.1DJ"!GFNAKB_%?B;PX]R_A_4]5M8(QLDO5=N2H(81@>K8&?\
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ME6U)(E92O1<<-MZ FFZS<Z8MA\1I-(O(UB:SM9('M)\*6V,/D*G&,]AQD^]
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M2'(QE"Y!)ZG/7!K6L]-LKGQ3H6DW.J7][:G1IR#/=/&\VV>,QL0&!SMR0>I
MR>E 'I]-D8I&S*C.0"0JXRWL,X%*QVJ6P3@9P!S7E?A'6K5_$^BSP7I%K=Z5
M=&599"TAD62(CSVX!E +DC V@D<CF@#L=/\ &5IJ*>'GCL[I4UQ7:!FVXCVH
MSD/SG.%[9'O725Y/X8N8!IWPP4S1[AYX(W#@^1(,?F0/K7K% !1110 4444
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MN\2320,7C9"'1BK## '@@B@#E;GP[J.H7GCB!8&M%U:UCAM+MF3!(A*=%)8
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M6"#+?-C QD<9SS5Z@#A-4TK73I.B:HMB;K48+LWFH6,%QY3/YD;(RH^0"4#
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M[JTM[VW>WN[>*X@<8:.5 ZL/<'@U6M=#TFQF6:TTNRMY47:KPVZ(P'H"!TH
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M+F %MJ]%P25P/3G)YKTNLV#P[HEK=?:K?1]/BN YD\V.V16W'JV0,Y/K6E0
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M---=16/]DS17\XDEA@FF0;H$V9E)4G:"7"@8SGMCFJ<G@ZXE\/>)-);4XO\
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M+?0YM\NI6KV8CL6RRJD 8QX7H"C\CT]ZT+W2U_MGQ.D5GJ-G9W$.FM!-8V;
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MWN5M=HVJTC2@X.,_P@YH ZL&QUG38Y$:.YM)U62.1&R&'!5E(_ @CV(JT!@
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MP?-#9/RY4# /-9EYXB\41>&/$NMIJ-B!I<]W!'!]B)#^6X"MG?QP",<]<^U
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M22 % G/.01].^,&DB\3V4R%1#<K=?:FLQ:,@$C2JN\@<[2-OS;L[<=Z )?\
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M]CJLEK)>0EWM)?-@99&0HV"IY4C(()!!X(/(JD/"6BK$D8MI=J7AOP/M4O\
MKR22_P![KDDXZ<U5MM=AN=4T<7,MY:7%Q82W'V8JHA91LW,S<\KD8PW1CFK$
M'BS3IYK2/9<HM]"TUE(T7RW*J-QV8R<[>0" 2.0.#0 ^S\):)I^L3:K:69BN
MIG:5\2OY>]N&<1YV!CSE@,\GU-;5<[I'C32]9N+"*VCNT74(&GM99H"B2A<;
M@#Z@$'^5=%0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M>YN;;5+A[F7>RAHW8@Y0JHQ@@$9S@BKMAHBVFH'4+BZFO+[R%MA-*%!$8.<
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MB2"XR'FD?8(3D9&"5^?&"#TXQ5+6O&EYH(UFWN=/@EO+'3?[2AV3%8YH@2K
M_*2K*1TYSD=.UM/!-O+H4^D:GJNHZE!)&L4;W#H'A52"NTJHRP*J=S9.5%27
MW@ZWU2RU"*_O[J:>^LQ8R7($:NL.22% 7:"222<>GH, $(\1:HU_JNFRV5M#
M<P:>E];.DQ=2C%UPWRC# IGC(YKD='TV'=\-M9EMH5U*ZVK+<1DEIE-E*V7]
M6+$DGGKUKNW\,1OJESJ!U"\\^XL%L&P(\!%+$,!L^]EF]N>E10>$+:WMO#\"
MW]X4T(C[-GR\N!&8@'^3GY6(XQ0!FZ3XCC1I+2VTRVM;V\UJYM%1)"49T4N\
MS' ))"DXQR2![A]UK?B%-;\.6<UG;6AN[NYCG0R[Q(L<;E64CHK !L'G. >A
MS--X#LY;61$U*_BN?[1?4X+M"@D@F;.[;\N"I!(*L#D&KDOA:.9M,FDU*^:\
ML)VG%T2F^4LA1@PV[0"IQ\H&,#&* */Q*16\$7#&,.\=S:L@/8_:(QP>W4C\
M:AD\:W>F7]_IVLZ;#%>Q?9VMA:S-*DZSR>4O.P,"&!S\IXY /2NCUS1X->TB
M;3KF26..4HV^(@,K*P=2,@C@J.H-9M]X.L=5M;Y-1N+B>YO$B1KI2$DC$;;H
M_+VC"[6);OR><CB@#&U7Q1K\=NB1V"VS#5[.U6XD5U2XBD=<E0P#*>JG(/J,
MYXEUCQO>:+%KOVC3[<S:5Y$H03-^^@DZR#Y<_*0_&/X#S6E+X1^U:2MI>ZUJ
M-U<K<0W"7K^6)$:)@R84)LP".ZG.3FKMSX;T^\UBVU2X5I;B"U>U^8_+(K8Y
M8=R!N _WV]: *5[XH-JYV0I+'-=1VEK(A9O,D:,R,<*"=H4'IG)!''6JL?BZ
M]'E6EUI<EM?S7$T4.Z*1DDCC4-YH4+OP=RC:0,'//&39D\$Z<WA2RT"*>[@C
ML622UNHI/WT4BDD."01GDYR,8)%-O/!JWMG:>;K6I#5+28SQ:FK1B8,5VD;=
MNS:5X*[<<>N30!4C\6:W-=:19'0HK:\U".Y)6YG91&T) SC9DJP8,._8@=:W
M/#.LMX@\.VFIO ())@P>(-N"LK%6P<#(RIQ5=?"\8U'3+]]2OI+FP290[E#Y
MIEQN9_EZ_*, 8 Q@#%6] T6+P]H\6FP3SSQ1,[*\VW=\S%C]T =2>U &;X6O
M6UJZUK49LGRM0FL;<?\ /..(A#CT+,&8GZ#L*J^"K>.?2M<M9MTL7]LWL>)'
M+':)" ,DYXK4T72GT6_U6%%)M+VZ>]B<?P.X&]#_ ,"!8'_:([<R:5HZ>'K6
M^\B6ZNS<7,EV4DV;O,D;)"X"@#)[]/6@"IX,U2?4M%FCNG,ES87MQ822'K)Y
M4A4,?<J%)]\UR/BG4-0U+P_XU@ODMW@T^^@BM@F=R\0..O?YSS[^E=SX:T8Z
M)I'D2,KW,TTMU<NO0RRN7;'L"V![ 5GZAX)M-0_ME6U"^AAU:2.6>*,QX5T"
M#<N4)Y$:YR2.N,9H @?QE<6-SJ]KJ5C$EQ926BPBWE:19?M#%(P?ER"&!S@'
MCH#TK5T/5+_4+B_@O=/>W%NZB&XV,J7"L,Y <!@0<@CZ'/-4[_P58ZI-JTEW
M=WCG4XH(Y-K*OE&$EHW0A<A@Q)SDC/:M/1]*ETN!EN=3N]1G? :>ZV!L#H $
M55'4]LG/)H P-1\3WFD^*M:%V(CI.G:3'?;4SYARTH/L23&![5'JGC'5])T[
M5KN30_,BL[,74<Q,D4;G.&C.] =PX((&"#_#6QJ/A2QU35;J]N99REY8_8+F
MV!7RY8\N1GC<"/,;H1V]*H'P,LWAZ[T:^U[5KR&>'[.LDSQ[XHN/E!"8).!E
MF!/% "SZ_P"(+?6[#2I=*T]9[Y+F2%Q>.558]F-W[OJ=_;/3\:JZ3XTO[\Z!
M-<Z9;PVNK32VN4N"[QS1K(2<;0"I,3 <YY!]JW[G04NM9TW5'O;D3V$,L48
M3:_F;=Q8;>ORKTP*S[3P5:V=OH\":A?,NE74EW#N\O+,X<$-A.1^\?ICK[4
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MF[&NRT4L<;MM639(KE">VX*5_&@"M8^*!=>+M5L&N+<:=9V$-UYC1M&T99I
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M]B'F1Q>1O/+<?ZIN#R<BNBT6QO8/&'B*]GLWBM;S[,8)&=#OV(5;@$D<^HH
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M+7F+:K<:%)XKNQ?2_-K\%LSSR_)!&\=N&?)!V@;L9Q@9'%6]3GURP6"%-?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M3=\Q/(/EM@CMS[5/9>,8KZVM%CLW34;F[GLQ:.X^22$L)"7&1M&WJ <Y''-
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MU673+.348AB.Z:%3*H]FQFB70='G6[672K)Q>,K7(:!3YQ'0OQ\Q&!C-8?\
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M;N'@(;!.T?>/.,\XK87QU9W&EV5W9P&26[LOMRV\L@C8)TVYYRQ.0!TX/(H
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MHWW?(&"C(P<<XQ4,_@RXN/#WB+26U2,#6;B6;S1:G]SO !&-_P W3KD5UU%
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MF716FVYM<&59%*X^_P $ ]><GTZ5V%%% !1110 4444 %%%% !1110 4444
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M[F(9DA60%T'NN<B@"Q1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MV\(U*^L5,-O:[=N9#N!8L<@_+Q@=,9()K7U7Q'KD5[J5K9"%;VUO;6WMK62
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MCLY7@WP7(*@LAD'W)=VX ' ( QDGC,7Q-KGV6#RGL$ED\22Z8[?9FVF,,X#
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M %%%% !1110 4444 %%%% '&V'B,Q^-?$FF:GK4,-M9BW^RI,T49'F1EF.2
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M4* ?E7(7D@GG..!21^$=1U&RT.RU=H(ETBWEA\ZWD+&<M"80P! VC:Q8C/7
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M9"\EP]HDGEG8TR*6:,'U !]N"!R,4:/XHTW7;AXK#[4X7S,R/:R(@*/L9=S
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MGH@TZ%C(VY9!YOS,-OW?WHZ$GBHY_#6JZE?:9)>+:0PQZ1<Z?<^3.S,K2^6
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M3QQ@D#)SFI+#QA<3:W#87=DBF>TN+G; _F-$T+JIC)'RLQ#@_*>#P1WH ZT
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M01_>)?H.@!/.,4 =N%4,6 &3U.*6N)B\:ZC<^&M/U<:9;VPO+66Y"R7!DY4
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MB@! J@Y"@$]\4M%% !BBBB@ HQ110 FT;BV!D]Z6BB@ HHHH **** "BBB@
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MKJTDB<Q%YMZHZ%BKHX(R.Q4=.M2ZGX;U_6&O87MTM9[KPPE@UQ$RB%;G)+(
M#N"\XSCI7:ZAKVGZ6+MKR62-;2W^U3N('95CR1G(!!^Z<@<@<]*OQ2)-"DL9
MRCJ&4^H- '#W^F:GK5W;:G_9<UG+:Z/=6LL#,F9990@6-2&P54J3DD#D8[X=
MH.D:E::SX7EFTV2&*ST%[*Y??'B.4F$A>&R?]6W(R.E=S10!S?B&RO+GQ)X8
MN;:TDF@L[N66X=64>6K02(#@D$_,PZ9KG+'0M7AT[0HVTF9);;Q'<7TXWQ?+
M"[3D-PW/$J<#GKZ5WNHZA:Z3IUQJ%[(8[6W0R2N$+;5'). ">*GBE2:%)8SE
M'4,I]0>E &!XUL+S4-!C6QMFN9H+ZTN?)1E5G6.='8 L0,X4]2*YG6=$UF]M
MO&9BT>;S=3FM'M1YD67")&&YW\8*MUQ[5Z16;9Z_IM_J!L;:=GF\MI5_=.%=
M%;:2K$;6 .!P3U% '(R:/?G7]5L[_0+C4;'4;M+NWN?M86&+"H-LL>\'*,@(
M*AL\=,5T'CBRN]3\$:SI]A;-<7=U:20Q1JRKEF4@<L0 /QKH** .3GT%;/P9
MJ']D:#9+J=SIXB>TDC0),RJV%<#Y3]YNIP<]:YJZT'Q%<SZW=6NF70DF&G7<
M"WL\69VMY"[Q-M8A2>,8&WITKU&B@#AM=M=0USPS=26WAN2TN[F\LY&A=H1/
M((IHV9G(;;PJ8'S$\=JBUK1M6NV\>"'39G&J:9';V9WQ@2N(I%(Y;C!<=<=Z
M[ZD) (!(!/3WH Y*QTZ_B\91WDVG.;*XT6&UD<NF(G1Y&97&[)R'&, CK3/!
M>DW-A/>032++9:7(]CIC Y(A)#D$_P"S\D?_ &R/K757EG;ZA93V=W"LUM.A
MCEC<9#*1@@T6=E;:=9Q6EG!'!;Q+MCCC7"J/84 <UXSL]0N[[PW-8Z=/>+8Z
MFMU/Y3QKM01R+_&RY.7'%1>)5US7-)E2QT>>![2:WN8XKB=(VNRD@=HU9'.S
MA>IQR1Z$UV (89!!'M4%E>P7\#36Y<HLCQG?&R'<K%3PP!QD'GH>U '#7FD7
M=W80ZE9>'+JUN/[5M+N>WFN$>YF6(X+$F0KPN !NS@?05'JFAZ]-+XG^R:>Y
M>XOK/4;8FX5$G$2P[HMP;<K$Q,,X Z'->BU76]@?4);$%_/CC65@8V"[6) P
MV,$Y4\ Y% '!WVD76H6,-Y:^&+JUGEU6QN+F.XN$DF=(9 69B9",!1@#.3CH
M.*[J_24Z5=):P12S&%Q'#+]QVP<*WL3UJU67'XBTR:&>6*:1U@O!92[8)"5F
M)4;2-N<?.O/3GK0!Y_\ V)K\\&HL=#NU>[\,MIX1Y8 %G^;"*JOM5?F &.,#
MGGK:U?PSK6IK-;VEF]J9?#!T]96= JS;@=APQ., C(&.:]*JM>7UO8P>=.S[
M/,2/Y(V<[F8*.%!/4CGMU- '$[->O?$=OJ<6@W5@W]C26):22$B&9I(R#\KD
ME1M8Y [=.:U)]-O-*\8V&HVEG)<Z8FF-I_E0E=T#!U96PQ&00-IQZ+VZ=710
M!YYX>\+ZCI&L>'!/8L]O:VM^)7#(5MS/,DB1]<G"@KD C\*Z+QOI]WJGA&\M
M;& SW):*1(@P4OLE1R 20,X4]370$A022 !R2:6@#SS6M'U?49/&DD>CS9U3
M18;6T#219:0+,"I^?C!D7GIP>3BF7&CZE_:U]#?>'KG5-/U6W@ "W@1('6,(
MR3+O&5R-V5#=3P:[Z_OK?3+">^NW,=M;H9)7"%MJCDG !/%26\\=U;17$+;H
MI4#HV,9!&10!P[Z%JR>(VFTS[7:0W%Q(+R*9DDMRIB91<1')9'^Z,#KDY&.:
M=X-TN\B.FQ:KX>FMK[2K<VWVZ6[\V-QM"GR1O) ;:"057&,<UW54KC5;2UGG
MAF:16@M_M,A$+L!'DC.0,$\'@<^U &#XCT:__P"$HT7Q-ID/VF6P66WN+3<%
M:6&0#)0L0-RD X) //(JAJ>AWFO^+X]0ALI+.!=)N;4W$X56$TFT(0 23M ;
MGWX/-=-;^(M+NYM.AAN2SZE;FZM!Y3@21  ELD8'#+P>>1Q6I0!Y@=$U34/"
M%_:S>%KB#68M'FT])I;U95E9TVA8<R'"$@,=P7& .>UK6/#NLZE<WB6EDUN)
M?#R6<<CN@7SE<MY9VMD CC(&.37HM5M0O[;2]/N+^\D,=M;QF25PA;:HY)P
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MC)+XH@U!,/%EH%DB8O\ >]$;@\^U=QIVLV.JRW$5I)(9+?;YB20O&0&&5.&
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M7,>3P,[>_&<9KH:* /./$_A_4]:C\1ZA9Z;.&O\ 3;>SBM'9%>9TD=R[9;
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MXKP[XR(F9 !T;G)';-=S<:K9VNIV>G32E;J\W^0FQB'VC+<XP,#U-,U6^TZ
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MR[A@?>RV[.<Y'XT <]I_B+6EN;;0KV^$C-J=Y9I?R,L+7"Q*I12P0@,=[ X
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M=A=O)&JH<.AB"L"03D;VX/'3BM"#P_I]MK4>J06T,4T5I]C0QQA2(]P;:3W
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M\<>#(LL:AEW*2 P)..>#QBNYGT+2KE8%FT^W<0*4BR@^13U4?[)XR.AQ4O\
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M]M/AYJFI6MT(;V#3I+A)H5!&]8RV0&!X)'<=*NW?A?0;\68N]'L9_L8Q;>9
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MA8HRKO!5EW,/O$'/2M/3M!GL/$M_JK7PFCN[:"W\MHL./*WX8ONP2=YSP.U
M$VM:V=("8LY9]T4DK29"1HJ 9#.> QW *._/3!K+'C>.XDLH]/TF]NWO=+_M
M.##1H#'\G!RW!^<?_7JWKGA^ZU75;*\@U!(8X(9HGAE@\U3OV_.OS#:XP0"<
M\,>.:SM&\&WVDRZ5(=5@F.GZ.=*4?9"N\90A_O\ _3->._/([ %R#Q5;:Q:6
M2Z;;3W$M_8"^$0<1-'"V ,MGAB20,=P>1C-9?A*^N;[P-X5CFNIGGN8EN+B:
M20E_+C^9B6/7+;%/LQI^D^![_0I-(GL-7@^T6>G+IEP9;0LD\2G<C!0X*L"3
MW(.36CX8\+/H6E6]C=W:7HM[-;1"(C&-N6+'&3][*@_[@H (/&-M,=*E:UF2
MRU9BEC<DC$C;2RAAGY=ZJ2OZX/%3>'/$K^(X_/BTF[MK0^8%GG:/!=)&1EPK
M$Y^7.>GO5#3O!DEG9:/IUQ?I<6.C3^=9J82)#M5EC#MNP0H<] ,X'3G.KX8T
M6;P_HBZ=-=)<E9I91(D1C_UDC/C&X]"Q'6@#D_%OB'49])\<V<<4MHNE6(:"
MY@G*OO,9<-E2",\<>W/7%;R^,;:VEU"#4;2XLVL;:*ZS(R'SHW+*I&#P2RD8
M..H_"OK/@RYU-O$BPZI'!!KEJD$BM;%VB94*;@=XR,'ICKW[4:IX*DUB]OYK
MK40B7>FQ66(82K1O&[2+(&+'^)LXQV'- #V\=V, O!=1>2UM) GF&56@?S6V
MJ?-'  /WL]/?(S;N/%,=M';QRVPCO9UF=()9T0%(VVEMY.,-E2OJ&'3!Q''H
MNNS:8T&J:Q97LQ*JRFPVPR1C.X/'O.2V>3G P,#KG+@\!7>DK8SZ%JT=E=VC
MSJJ26YEMS#*X8PA-X(52JD8;L>QP #;?Q1;GP1/XGCMYQ!'9R7?D2KLD&U22
MI'8Y!%9%FH;P+'KVN:O?QSSV8NY[FVED"6X9=WR1IE=J ]U.<9.:ZE;$2Z4U
MC?O]L66-HYRZX$@;.X8[#DC'85S:^$=1A\)7/A:'58GTV6V>TAEG@+30PLI7
M;D, Y . <#H,YH ?<>-++3].4Q[[^2"RCNI0K".1T8'!1'P68[6(7Z>HS'>?
M$"WM1J4BZ3?26VG"%[F;**!'(H8. 6R>#G&,\'IQF1O">HV.J07NAZTEIFSB
ML[J.XM?.658\['7#+M<!F'<<CCBH=2\$7-_;^)(1JJ*NLQ0Q!GMRS1"-=N2=
MXW$CGM0!=U7QI8Z7<W$?E-<+:31PW/E.ID0N%/RQYW. '4G'0'C." Q?&3R3
MZHL6@:G+%IDTL,[Q"-B62-9 %4-EBVX 8]LX[(/#6K6VO7E[I^MI;V>HLDE[
M;-:[F$BH$+Q-N&PLJJ.0V,9I&\)7C:9XFM%U<1/K-PUPDT4!5H"8T3'WOF&(
MQZ=30!E^*_$AOO!OBZ"W::SU#2K?+/;W'0LNY2KJ0>Q!!QR.]=G>V9O[ V_V
MB: ,4)DA<H^ P) 8<C(&,CL:Y*Y\"7MW9:_;OJMI&-8M(K=EAL2J0E%*Y5?,
MZ8/3/7OVKM8@ZQ(LC*S@ ,5& 3[#F@#AO#EE+?:_XCB?4M3"Z=JL2VP-]*P6
M,1Q.4(+$,"2P.<]:U+;QO9W=_:06UM)<17BR&WE@='R4!.&&?DW ':3U[X/%
M6]"T"XTC5=;O9;R*==3N1<[%A*&,A%3&=QSPH["J>@>&=6T%!8QZW'+I-OO^
MQP-:XD0'.U'?=\R+G@  G YXY *UM\0!<Z7IVI?V!J*V>HR6\5K(6B^=I<CI
MOR,8[CN.W-/?QXL,5W)<:+>Q+8WJ6=Z2\9$)<IM88;Y@1(AXZ<T0>#+J#PKX
M?T4:G$3I%Q!-YQMC^]$1R!MW\9]<GZ4V^\%W=Y::_ -4A3^UKZ&[W?92?*\L
M1C;]_P";/E+SQU- &M;>(XKW6Y].MH3*;:<V]PPD&Z)O+WAF3J$/ ![D],<U
M)K>N'1PN+.68&*29I,A(T5,9#.> QW *._/3%9\OA-KKQ'9ZQ<SV_P!HM)VD
MCGA@,<S1E2/)9MWS)DYY'8#'>I]=\/76K:K9WD&H)#'#!-"\,L'FJ?,V_O%^
M8;7&" 3GACQ0!5/C:.:2TCT_2;V[>\TL:G#AHT#1G;P<MP?G'_UZFB\56VKV
MEFNFV\]Q)?:>+\1B01-'"PXRV>&)) QW4\C&:IZ1X.OM+ETR0ZK!*;'1_P"R
M@/LA7<,KA_O_ .P.._/([1:5X(O]#DTF>PU>#S[334TRX\VT+)/$ARC!0X*L
M"3W(.: +7@K4I!\,=)U*]EFGD73Q-*\C%G?"Y))/4U#X2BN?$GA2TUO4;Z\6
M]U&/[0OV>X>-+=6Y150':=HQRP.3G.>E;'AG0VT'PM8Z+/<)=BUA$)D$6P./
M=<G^=4M$\.ZEX=LQI>GZG VE1L?LR3VY:6!"2=@8. P&>,C('7- "MX@;2K2
MXM/)GU.XTBTBDU"2-@&.5)X!/S.0I;''!'.3BJ]WX\MXGN/L6F7=]'#IL>J"
M6)HU62!]V&&Y@<X0\$9_G4TWA6XCU/4[NPU$1+JELD%VL\7F'<BE%D4@CG:<
M$$8. ?8USX(:&2[2ROHX;6718]'AB: L8T3?ARVX;C\YXP.@H DUGQ)'>:1J
M$&EQ3SRIIGVQWBE\IHD=6,>#G.\[6(''3DC(S2T360L?AZ*2&^N-0?P[]J5V
MN,12X$6X,-W+Y8?,1P">>:>G@F_LWD>PU>!#=:9'I]ZLMJ663RU*I(F'!5L,
M0021^56].\(W%E>Z-/)J,4J:=I3::56W*F4'9\^=YP?W:\8/4T 5-*\2G5K7
MP;=ZA9W4-SJF9(C!/B(,;=G.\!OF&,X!!P0#Q6@GC.T==/N?LTO]G:C<FUM;
ML%2&DR0N5SD*Q4A3],XS533O!E[8VOA>W?5895T%CM(M"OFIY31 'YS@[6))
MYR>PI;#P2UG86&DO?)+I6G7@N[6,Q$2#:Q9$9MV"%8]< D #UR /L/',5[+I
MV[2KV"VOKR:Q2>1H\+-&9/E(#$X/E-R..E:.B^(XM=D)M(2UM^\'G+(&V,C!
M2CKU1CDD#T';I63;>"[NWL]*MSJD+?8-6EU/=]E(\SS#*2GW^,><W//0<5;T
MOPH;+Q$NMS3VYN_L[P3O;0&(W62I5I1N(++MP#_M'ITH G.I/?>-GT>-F6"P
MM$NI]IP7DD9@BGV 1B1WROIS!#XTMFOTM;FRN;9I;2>[C60#S/+B(#;T^\I.
MX$#N/0\5*=->P\<2:NBL;?4+..UF*C.R2-F*$^Q#L,]BH]:R-/\  VJ6,VG3
M?V]"\UC!=0"7[%AY?.*'S')<Y<% 2>_H.M '1:'K:ZY;BYAA MGB26*=)5D2
M0-G@$?Q#'([9'6N0\7>(=1N-&\<6B12V:Z3;KY%S!.5?<4#YRI!&<CCVYZUT
MF@>&$T35+_4%-O&]ZD8EAM(C%"77=F7;DX9MPSC^Z.O6J&L^"[G4SXECAU2*
M"#7(8T=6MB[1,J!,@[QD8'3'7OVH M_\)C;6TVIP:C9W%D]A##/B1D/FQRLR
M(1AL EE(P2,<5;T;Q%%K%]?68@:.:TV$NKB2.17!(*N.#C!!'4'Z@UEZKX+E
MUF^U.XN=2$8O;""T'D0E6B>*1I$D!+'/S-G&.PYK:T6SU>VA8ZSJ<-]<$!5,
M%MY" #OMW-ECW.<<# '< KR^)!]JD2UT^ZO((+M+.>6 !C'(V,G;U*KN&X]N
M>N#B*/Q9"==M-+FLIX&O)9X8&DP&8Q DL4/(1@K%6YSCMD5#;>&=1T_7KZXL
M=86+2[^X%U<6K6^Z19, -Y<FX;0VT9RIQSC&<BG:^"K^WU6QO'UF&46>H3W8
M+6A\R595=2KOOY*A\*<  *!@T 7+3QM8W.CG5_+(TXQJZ3+(K99F"B-AGY),
ML 0>!GKP<7M%\0Q:Q>7UH(&CFLRFYE<21R*X)!1QP>A!'4$?2N>D^'2W:WLE
MQ?1P7EW:I%+<6,'E>;,DBR)<.NX@N&4?F>>1CIM%M-6MH6.L:E#>W! 4&"W\
ME !WVEF^8YY.<=, =P#'U3QU%IDFLAM)O9(M':/[7*K1X".H;>HW9/!SCKP>
MG&;/_"6;+K5+6;2+]+JQMX[E8$"R//&Y95*A2>=R$$'IUJGJO@RYU./Q1&-3
MBC77$C3_ (]BQ@"($_OC=D#VI=9\'WVJWNIW::NEM)>Z?#9#R[<_+Y<C/D_/
MRK;V4KQP>M #KCQU!:V&K7+V,LATFX2&\$,JNJ*P5O,#9&5 ;YNXP>.*W[?4
M!<:G<V:1$K;HC-,&!4LV3M^H !/LR^M<T--A\-G5[W6KA;NTU<Q0O;6FG2$!
MA&(]H5"YVD+CIQGKTK6\(:,^A^&;.SF>62XV!I7F8,^<  ,1U*J%7/HHH YE
M_$MSX>\0^+IY;+4=0T^TF@DE:.4,+6,P*SE5=LXR2VU1Z^U;6H>.=.LGE,:-
M=10211SF%U+KY@4@JF=S@!U)QT!XS@@)>^$[BZO->V:@D=GKB(ERGDDR(!&(
MVV-NQRH[C@\\]*2/PKJ&GZW=3Z1K"6FF7I1KFT:VWLK*BINB?<-I*JH.0W3-
M %JVU*2U\:W&A2.SQ3V0O[<L<E,/LD3/IDH1Z;B.@ $=YXDFLO&#:9-;JFGP
MZ:][-<EQP P&<>@ /US[<R6^FO=>.)M<92L-O8_88,C!<L^^1OI\J 'OANV,
MIJOA?^U-=:^>Z5;:?3I-.NK<Q9,D;'.5;(VGJ.AX]* '6GBJ&>_TRUGLYK8:
MK"TUB[D$2!5#%6 ^ZVT[L<C /.1BM^N9TSPM/;R:*=0OTNQHL;):LL.QF)3R
MPSG<02$R.,9))]JZ:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#G=:\66VFZ7?WEDL5Z]A=1
M6MQ$)=NQG*#K@Y(\Q3CZCK6^LL;ABCJP4D,0<X(Z@UY9J^GM%I?C6T72KK[1
M<:Q;SQ&&S<^9"?LQ)5E7D91R0#Q@YQ4FIV-U9WGBD:/I=RMGYVG7!@M;7:)X
MU/[X1@KM9MH&1SG&#UH ]/BECFC$D4BR(>C*<@_C09H@X0RH')VA=PR3C./R
MKG/"$%A_Q,-0TY-06*]E61VO(#!ND"[25C*KMX"Y..3Z]:XJ[T6$Z=J\BZ--
M]H'BF&:%ELGWB'S82[(0N=FT29(XZT >KB>%HVD$J%%SN8,,#'7)H$\+(KK+
M&4?[K!AAOI7F=W FF7_B*.WT2<V#ZI82QK%:2B),*FZ4(@'F!6495>I'--M=
M)&IZ!JVD36=['=RZY++I]S+9M']G8D2).#M 4 @G'&2=IY- 'H]Y<S10*]G'
M#._FHC!YM@"E@&.<'D D@=^E6&FB5@K2H&+;0"PSGKCZUYI<A[SP-IT4FC7,
M6I6FLVK72+:.Q:1;E3+.IV_,K ,VX=CBJ>NZ/'+;>-Y8](G:X;4[:6S=+-RY
MPD&YXB%S]Y7R5]* /5A/"0Q$J$*VT_,.#Z?6G&6,!B74!!EN?N_6O+/$&C$_
M\)Q;:9I,JP3:?9RP1PVC*DDB&0OLXP7QLZ<]*C\3)_;"^.);72[Z6.^T2V6U
M)L)!YTBF;H"N=P++UY[].: /5#<P*'+31@(0&)8?*3V/I4M>::GH>GR^)-;*
M:*7M9O#ZX_T)BDD^Z7_9P9-K#_:YK9N(M5N/A'%%9Q7!U/\ LN(&)@4E9@J[
MTPPX8@,.>YH ZU;F!T+K-&R@[2P8$ ^GUJ"_U2RTNPGO;RYCBMX%W.Q;IZ#Z
MGH!WKA(K'0=7TK5[@:7J]Q'J,$5K/!=69@S)R$ 01C!7/,@!"@#DXXHW-A>M
M\/O$6C7NG3W6LVLBF6Z%JQ^WA2I65#CYB$ 4J,D%2* /46GA4H&E0&0X0%A\
MQ]O6E,T2N$:5 Q.T L,DXSCZXKS35H;>\US4K'4[#6/[.U"& Z:;.R)&%',>
M=A,+!P6Y*@;LDC%4M4T=1!XLN(](G:\&LV<UI(MF[/@"WWO&0N>JR9*]<'-
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M^*,2JL5SY:M+;^8&:(D="1UQTSWKD;RRM'^(/AR>#32+>.QNP9!9L$C=FA*
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MI,=U)<+;O^]G%R\1F<Q-*,8?9G;G@'IU /49J32==L]9>\BM]Z7%E+Y-Q!(
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M&JW>IQQ/]KO$6.=FE=E=5SM&TG:,9/0=S67H][>3>-/$EE/<O+;6RVK01L%
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M5Y20BD\L0,G'X U)0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MSA59U.>\:FN<\)3_ &&Q\#26%X[7-[I]U&\+7)*2%4W(NPG:,,.P'4^IKV#
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M4#>;+#L0KY/SA7#-O5AM/4YZ#%<2V<>F^-=5N-3U1FT^_GAC:VOW+0QM'$.
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MF*')/!/.:]298ILJP1]IZ$ X/^-+\C.1\I8#D=P* /*?#?B!;J'PK!KVH_\
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M)P3%/I443@'!*M& >?H:Q[;PWHUU\1]?TZ33+06@TJU*1I"JB,LTH++@?*W
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M/4+;^T+,6=ZL1CQ<*$**S H<,%.,KCB@ UK4+S2?A?<ZCI[1K=6NE>=&T@R
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M5IY4+PPGJJG9ST'+9/'6M2?0([G5-+U%[VZ\_3HY(X\;,/O #%AMZ\#IB@#
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M:C+JUP(V&4 'E7 P3R0!@<#/ %=%9^,Y[FWM[:6UCCU.2]NK-A&KRQ@P$AG
M W$'Y>./O=>.;=KX(L[--,CCU&_,6FW;W5LC-&0I<."I^3)4"1_?GKP,1R^
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M6^;;NQGM714 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M:SAEMI(T55D+0^9YK*0<JQRN.@"GOS0!WU4[+3++39;AK2(1O=2&:;YR=[\
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M@VH6]Q<A-DT2*&?&UB00&!P0#BKC^+8;>Y%M=Z?=P3R6;WMO&=A,R)C>H.[
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M/HFERVD=K)I]L\$<GFI&\0(#YSOP?XL\YZYJ*Y\-Z'>W4UU=:18S3S!1+))
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M.IRR$+!$\,\&,K<(2K*K>RNH8?CZFLQ/ B1^#H=$34)/M%M<1W-O>.NXH\3
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M?Q59:*;8%;JTFN5G\S[OEL@*[<=_,'.>U #]%M=9@A9M:U"VN[@@*OV:W,*
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MS&=0G7<3Q^= 'E_A&TFF%G9^;IE_;M:M:SB*SN(9K:-URP^=BD>6 RH5<X&
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M&Q@N"=X;@'.0371:YI<\/BNVU+2K7?'KEL=.O9$09CZNDQ^B^8.>IV"NWHH
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MBXDXBX^1OF^<#:N-V<8K9H **** "BBB@ HHHH **** "BBB@ HHHH ****
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MV5XB1(JG')4@_7!QG%91TG6YO%5QK-U;6<WD*8=+C-P=MNA^_(PV<R-[= ,
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MBBB@ HHHH 9-#%<0M#/$DL3##(ZA@1[@TVWMK>SA$-M!%!$.B1(%4?@*EHH
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M&!SGMC'KST% 'HO]I1_\\VH_M*/_ )YM7!67CS3M0O-+M([+4$;58VDM&=4
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MH_\ GFU']I1_\\VK-HH TO[2C_YYM1_:4?\ SS:LVB@#2_M*/_GFU']I1_\
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M"1ZXP:3P5X/N?#?B#4KBWC>RTFYA3%@T_FJL^?F9#V7' SR<\@8%>J_9H/\
MGDGY4?9H/^>2?E0!B45M_9H/^>2?E1]F@_YY)^5 &)16W]F@_P">2?E1]F@_
MYY)^5 &)16W]F@_YY)^5'V:#_GDGY4 8E%;?V:#_ )Y)^5'V:#_GDGY4 8E%
M;?V:#_GDGY4?9H/^>2?E0!B45M_9H/\ GDGY4?9H/^>2?E0!B45M_9H/^>2?
ME1]F@_YY)^5 &)16W]F@_P">2?E1]F@_YY)^5 &)16W]F@_YY)^5'V:#_GDG
MY4 8E%;?V:#_ )Y)^5'V:#_GDGY4 8E%;?V:#_GDGY4?9H/^>2?E0!B45M_9
MH/\ GDGY4?9H/^>2?E0!B45M_9H/^>2?E1]F@_YY)^5 &)16W]F@_P">2?E1
M]F@_YY)^5 &)16W]F@_YY)^5'V:#_GDGY4 8E%;?V:#_ )Y)^5'V:#_GDGY4
M 8E%;?V:#_GDGY4?9H/^>2?E0!B45M_9H/\ GDGY4?9H/^>2?E0!B45M_9H/
M^>2?E1]F@_YY)^5 &)16W]F@_P">2?E1]F@_YY)^5 &)16W]F@_YY)^5'V:#
M_GDGY4 8E%;?V:#_ )Y)^5'V:#_GDGY4 8E%;?V:#_GDGY4?9H/^>2?E0!B4
M5M_9H/\ GDGY4?9H/^>2?E0!B45M_9H/^>2?E1]F@_YY)^5 &)16W]F@_P">
M2?E1]F@_YY)^5 &)16W]F@_YY)^5'V:#_GDGY4 8E%;?V:#_ )Y)^5'V:#_G
MDGY4 8E%;?V:#_GDGY4?9H/^>2?E0!B45M_9H/\ GDGY4?9H/^>2?E0!B45M
M_9H/^>2?E1]F@_YY)^5 &)16W]F@_P">2?E1]F@_YY)^5 &)16W]F@_YY)^5
M'V:#_GDGY4 8E%;?V:#_ )Y)^5'V:#_GDGY4 8E%;?V:#_GDGY4?9H/^>2?E
M0!B45M_9H/\ GDGY4?9H/^>2?E0!B45M_9H/^>2?E1]F@_YY)^5 &)16W]F@
M_P">2?E1]F@_YY)^5 &)6Y;_ /'M%_N#^5)]F@_YY)^52 !0 !@#H* %HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M)YK8K+MO$6E7=Y!:PW69;A6: F-E68+][RV(VOCK\I/'/2M2@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@#EM,M9-,\>^(9)%)34XK>YMR/XC&AC=!GN,(?\ @?UKG=*\%ZMI
MNFP:E:6L%OXAL[VXF4&1=EW;RRL[0NPS_"1@D<,HQQFO261'*EE5BIRN1G!]
M13J .&UZVF74=7UK4;-(M,?0&M)1/,H&_<S%3M)(4AL9'/M6=IEKJ2CR+[29
MVU"?2&T^VN/ML,J[54GHH4@$XRQ!Z*.,\]IJNN:?8N]K<QRSG8K3QQ0F79&[
M%0SJ,G:2".AZ'L#5G3]&TO20XTW3;.S$AR_V:!8]WUV@9H Y*Q\.:JESH7FV
MPC2T\/R:;,YD4[96\K!&#RO[L\^XXZXHMX5UB;PSHUJUE)::MINFBVMKVRO
M&CD557#@X#Q,5!*X;@=,GCTBB@#GO%&C:AK/A9;6":+^T89+>Y4ME8Y)(I%?
M:?125Q[9K.O]#U#4KO6]7^R-!/=Z/_9L-JTBEBV78LQ!*@9< <DX!]<5V5%
M&?H,$]IX?T^UN8O+G@MHXI%W _,J@'!';BLF+3+]?B3<ZPUMBPDTN.S63>N=
MZR.Y.W.<88#Z]JZ:D5U8L%8$J<-@]#Z4 <!K/AS6+R#Q?'!9@G5+JVDM295
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MN# MN QC'.<UW-%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MK?2WRZ?:"\E79)<"%?,=?0MC)'M31HNE"V2V&F68MXW\Q(O(7:K?W@,8!]Z
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MV6)(\#+-D?(#0!EZ/=S>*?$GB#[1<7$5AI=T+&WMX)FBW.$#/(Y4@G)8 #.
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M?[4OH[NZ8Y9H8?*C4=@JEF(]R2<D^F ,?2?#.H:/J-REOK"_V+-=/=BT-O\
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MQYL8<E2 Q(R(VYZ9'XU!:^"M0MM3L;PZU#)]CO[B[4O9GS)5E5P5D??R5#
M@# 4#'HZR\&W.G6F@J^J12+H]W/=DK:-F42"0%<;SC E;US@<4 :.F>*H]4L
MK.>.RECEN+R2S>W=EWPO'NW[\<<;#^8]:Z&N2\,V5G>^(-2\2V2W26MXJ"*.
M>)HLR8 ED", 1N"1+R.3&3WR>MH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH @FO;6W;;-<PQ
MME5P\@!R<X'/K@X^E+-=VUO)''-<11O*=L:NX!<^@!ZUYKK.FZ9?>*O&UK<Z
M3]LGGTVV$*I:F0^85F PP&%8G;R2.F<\<,DTN\BN+C1O$ECJVH17MC:1Q3V4
M>]'>.,!T9P,QGS 7#$@?,3F@#TTW=LLX@-Q$)2<",N-V<9QCZ<TV*^M)H7FB
MNH)(DY=UD!5?J>U<%%H-E-J?CB6\T:X828,$J6I\Q@;58Y#"Y7EB=XR.23[U
M4DM_$(C1YX7U&TL]3LYYKI+)H9KRW"MD/#CYFC8QME1SC@9&* /2DO+62W6X
M2YA:%B L@<%22<8!Z=>*=!<07*%X)HY5#%28V# $=1QWKS'7=%FN?[;NX=.N
M9;&\U;39K> 6KEMR.GGRA,94%1@D@9VGKGGIO"]I]C\4^*5BLI;:TEG@D@_T
M=HXWQ"JL5X /(P<>E '2O>VL3NDES"CH-SJT@!4>I].HK-\0:\FC^'+_ %2V
M\BZDM;22Z2$S;?,5%)." ?3TK'\5:+=3:]97EC:B9=0MY=*O_E!"PN-RR'/4
M(588[[\5C?V1JR_#C7K2^M)I;VUTVXTBR"1EWG10RK(H S\_[O/^YF@#T&RO
MH;V$-'+&T@53(B."4)&<'TI\%W;70<V]Q%,$.UO+<-M/H<=*\RU;1M0DFU2'
M0=/GMI;GPTD*LMNT*O,'8E"Q  <J2.3D9KH]/@:^\:6&KV%G<65FFEO!=I-;
MM#N8NAB3:P&2F).1P,X[T =+=SSPSV:PK;E)9MDOFRE"%VL?D&#N;('''&?2
MI8[NVEG>".XB>9/OQJX++]1U%<WXLMGEUWPG/%:2S&WU,O))' S^5&8)5))
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M(9;FW,7FJT$0W 8 ZJV1C(QS@UC:S8:3=>/O$<%_I7VSSM$M]J):F4EB\X[
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M=A-((Y1A..2&9>G3\*O65CO\9Q/=:;.]I>:!#;%WMFV;E=]Z.2/E.UAP<9H
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MP)$\#0!RKRBZO,E1M#-]IEZ#L*K?"P_:_ 5O>W.)+^]FGEOV<?,TWF,&#?0
M+CL !0!V<4L<T22Q.LD;@,KH<A@>A![T^N0ANYSJM]X:T*6&RBTFPADA+1AP
M[.7"KC^XHC ..>>HQSC6OB_7M=B2:SEM;".70%U,*]N9&63<P*Y+#*G;P<=/
MS !Z)/<0VMO)<7$L<,,:EGDD8*J@=R3T%01:I83RVT45Y \ES#]H@57!,D?'
MSJ.X^9>?<5Q0\27OB;2M0@ADCLS#H4%[+\F[S))XW;;S_  O;D[NHQR:#J5_
M'%X8TN&6*.WG\,&=7$69$D00 ')."/GZ8[=Z .YFO+:VGMX)[B..6Y<I"C,
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MY;:N[2_:K:)X8\-\H1RI88[Y*K^5:%%% !1110 4444 %%%% !1110 4444
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M;]S,]O-&XPT<BG#*>V>G0D$$$5-J6HV^DZ?+>W180QXSM4L220  !W)('XT
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M!9W2WMI'<(DD:N/N2+M9><8([&O-]7\3ZG9:CXP@3Q"Z7>GO"-+LC#"[7#M
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M97U@EW!%<X>\-EY;(!()58JP*YXP0<^PSTYK:H **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *YS7+7Q)<ZI"^GQ:3
M)8P@.L=W-(I:7^\0J$<=AGKSUQCHZ* .3U7PS=ZI+=->)8WJ7NFI9S0S,RI$
MZEF+Q\'@E@>Q'EKSZ:<=OK=A:):6K6=U';V,<<4ES(ZR2SKP2Y .%( .1DYS
MQ6S10!BZ9I,L>MWFMWD<$-Y=6\-NT5NY=0L9<@EBJEB2Y'08 %;5%% &&^BM
M?Z]<7FIV]M+;)$L5H!(Q9!DER1@ %CMZ$_<%<TO@O68/"^J^'[=M/6REU 7-
M@IF?]Q%YRRF,_)ZAL8_O>W/H-5_/G_M$V_V1_L_E!_M.]=I;.-FW.<XYSC%
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M*V7;"NL7GEC! V&0E<9[8KKWD1,;W5=QVC)QD^E#R)& 7=5!(4%CCDG 'YT
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M(/ (X7'S ?O4.<_<)"[C@$DX'% &E_PDEM_SX:M_X+IO_B:/^$DMO^?#5O\
MP73?_$TQM8N;OQ-<Z+I_DH;*WCGNIYD+@&0L$15!'.$8DYXXX.>+37US8:)<
MWNI1(9;=979;<$AU4G:0.2"5 )ZX)- $'_"26W_/AJW_ (+IO_B:/^$DMO\
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MR/*TT5M(H"*Q4L5.2H'0D^A/T )_^$DMO^?#5O\ P73?_$T?\));?\^&K?\
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MQ@%U.1@$ @X/4$$9%1KXCL3>2$WJB 6T$RQM;2*_[UV5&W'J&.%"@9!!SUH
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MV_Y\-6_\%TW_ ,31_P ));?\^&K?^"Z;_P")K9HH QO^$DMO^?#5O_!=-_\
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M,L^5*"1E!.[C&0<5-8^$KJQO[%EU.-[*QO;BZAA:V/F8F#[D+[\'!D;!V],
MYZUU5% &!-H\R^(=1NX6 CU.QCMW<KN\J2,R8)&1D$2'_OGWJ/3_  _J=EH%
MIHQU:V>WMK(6JLMDRL^(]BEOWA^N!C)QR*Z.B@#EH/",_P#9VBV%[J,<]MI
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M<99RV,X 7'<5U=%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
910 4444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>40
<FILENAME>exhibit1033-bochk_facili024.jpg
<TEXT>
begin 644 exhibit1033-bochk_facili024.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MY)4MU^7.2/:O7K;Q9HU[JRZ99W,ES<')S#!(\8QUS(%V#\Z -NBBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MP"15Q(9-I?)P>G;..>E<SX?\9>(KOPCX$:XO9<ZWJ$T-_J!4;E"R,$C'&%+
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MP$A<E<;_ # -P&,#C(QT]JVY]1U&'P1J^I/>75K?1Z3-/;Q22JY<I"KB=?\
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MKW%C96R6LK7")!&-\\Y&T22M@= 3@<\G)/ % '44444 %%%% !1110 4444
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M_P IL7^- '2T5S7]B>)_^AN_\IL7^-']B>)_^AN_\IL7^- '2T5S7]B>)_\
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M_8GB?_H;O_*;%_C0!TM%<U_8GB?_ *&[_P IL7^-']B>)_\ H;O_ "FQ?XT
M=+17-?V)XG_Z&[_RFQ?XT?V)XG_Z&[_RFQ?XT =+17-?V)XG_P"AN_\ *;%_
MC1_8GB?_ *&[_P IL7^- '2T5S7]B>)_^AN_\IL7^-']B>)_^AN_\IL7^- '
M2T5S7]B>)_\ H;O_ "FQ?XT?V)XG_P"AN_\ *;%_C0!TM%<U_8GB?_H;O_*;
M%_C1_8GB?_H;O_*;%_C0!TM%<U_8GB?_ *&[_P IL7^-']B>)_\ H;O_ "FQ
M?XT =+17-?V)XG_Z&[_RFQ?XT?V)XG_Z&[_RFQ?XT =+17-?V)XG_P"AN_\
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M?_H;O_*;%_C1_8GB?_H;O_*;%_C0!TM%<U_8GB?_ *&[_P IL7^-']B>)_\
MH;O_ "FQ?XT =+17-?V)XG_Z&[_RFQ?XT?V)XG_Z&[_RFQ?XT =+17-?V)XG
M_P"AN_\ *;%_C1_8GB?_ *&[_P IL7^- '2T5S7]B>)_^AN_\IL7^-']B>)_
M^AN_\IL7^- '2T5S7]B>)_\ H;O_ "FQ?XT?V)XG_P"AN_\ *;%_C0!TM%<U
M_8GB?_H;O_*;%_C1_8GB?_H;O_*;%_C0!TM%<U_8GB?_ *&[_P IL7^-=!;)
M+%:Q1SS>=,J /+M"[VQR<#IGTH EHHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ K \0>*HO#XDEETS4;JV@3S+JXM8U
M9+=/5LL"<#DA02!R>V=^N1\7^(]$C\SP]J&I0VOVJ(BZ+$Y6%N"HQ_$PR!Z
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MRO(#C<I.<.%)YQP![4 >KT5XOJ5_"+'Q5#;WT:0-'IL]L+)W2+F0JY0Y^;@
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M(MFUQ%.XN[N*T0Q*"%>1@JELD8&36E7)>/YHHM/T?S)$3_B=6+?,<<"923]
M.376@@C(Y% &1J'B"'3M=TO2)+2ZDFU(R"&2,)L&Q=S;LL"./8UKUQ&HWD&K
M_$GP_'8OYSZ3)>"]4*08=T*A<Y'0[Q@]#SZ&N:T/5;.;7-(FBNI(K:\T^_2X
M5W;SMX>,@3N, R %SC *#/)'- 'KE%>1>&TA6/P5MG=[G4-$GCO \S.96"1E
M0P)ZAMV/3FG:'KD#IX+=;J>:>+0[J.\6$DR&5(X?D;UD!W8!Y!/O0!ZW17C%
MOJ5NUKJ MKS9;7/A5I$\J5\F9<\O(,;Y1D!FP#DX(KH+C2;?3/".E>*=+66:
MYL1%?W(\YI/M,?EA9A@DC(7+ #^)!0!Z/167H%L\.F^?-&8[B\D:YE0]4+G(
M4_[HPOX9[UJ4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 &0#C/6C-<9XZ\,6&JZ?/*L!DUV?
M;%IUQN(DMY/X60CE54@NV.H!SG@5F:@IU/5/'*WS%VTNPACLY#P8286E,B?W
M6+D<C^X/2@#T:CIS7 7-S+J47PWU2Y!%W<W$;R\D#+V<K,,=.O\ *F:UJU]<
M^*-<<Z>E_IGAVVBD:S:?9YLCJ9&?&TARJ !5.!G)SG! !Z""#T(/TI:Y"36(
MXO$OA>[L<BRUZ&1'7& <1>;$^.Q"JR_1AGH,=?0 4444 %%%% !1110 4444
M %%%% !1110 5E#1 /%)UW[2^\V@M/)VC;M#;LYZYR?R[5JT4 91T13XI77?
MM+[UM#:>3M&W:6#9SUSD#\*T;B)IK:6))7A9T*B2/&Y"1U&01D=>14E% %#2
M=,&EVAB:ZGNYW;?-<SD;Y6P!D[0!T ' ' %7Z** ,OQ#HJ>(-&ETR2XD@CE9
M&9XP"WRL&&,\=5%::@A0&.3CDXQFEHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** *MQ80W%U;W1REQ;
MD^7(O7:<;E/JIP,CV!Z@&K5%% !1110!E:OHSZG/:7,&I7=C<6I;8\&Q@P8
M$,KJP/3KU'.#R:LZ?IZV"2%IY+B>5@TL\H4,Y  '"@ 8  P!^N:N44 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M V**Q_MUQ_ST_P#'11]NN/\ GI_XZ* -BBL?[=<?\]/_ !T4?;KC_GI_XZ*
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M>GVOB76)+.WO?#UK+9W0N#%OG8,)F5NAE!\O Y([#DUZD40G)52?4BD:.(E
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M9MF&4@' 'F#L<[6Z8JW>>"K2]AUB)[^]5=5N8KF?88_E:,(%"_)P,1IUSTK
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M5\/%V2QU.:X>ZV,09%ACWB,GT8D9'<*1T)JUK_AO2H](OKJWM(8#'8W"&.)
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MCNYX_$EIKOV>.U$S %#.JI'Y><%&A.[./5NV:KWMS)!%KNH+JUZ)K'Q1;0P
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MCFTT;O,DB#L%0H7P8_+V,'"<8SG.<^DT %%%% !1110 4444 %%%% !1110
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M>:6.>[4*'C/$:E02Q<98<< <\\5B#5M0/C.]U31-+2\:YT"SNS!-<^5P7F.
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M)HDD"L&7>H.#ZC/>O/WU/4K3QKK=_I.EQWKMH]E<R0277E<;IR0IVMEB  .
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M1P,X;^YR3D_GD<[HVMW.@W6K;;%);";Q,;1Y3<$/&9?+12J[3N 8C.2.O&:
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MRJD@';C(!Q]*P)/A]:3>'KW29KV5_M%Z]_%<A LMM,S[RT9'0@DX^O>NQHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MNZ1&]NCZI9*]R%,"F=<RAB I7GG)( QUS0!6_P"$DMO^?#5O_!=-_P#$T?\
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MII()+G='<AXA&C;2V\@#O^A]* )/^$DMO^?#5O\ P73?_$T?\));?\^&K?\
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M'_"26W_/AJW_ (+IO_B:-&U;4;Z_O+34-,BLVMDC;=%=><&+[OE^ZN"  ?\
M@0J[>ZOING21QWVH6ML\G*+-,J%N0. 3SR0/Q% %+_A)+;_GPU;_ ,%TW_Q-
M'_"26W_/AJW_ (+IO_B:LOKFDQM(KZI9H8RJN&G4;2QVJ#SW(('N,4L^IPQW
MMM:QW%FTDDYADCDN KC"%\*N#N;[IV\?*2<\<@%7_A)+;_GPU;_P73?_ !-'
M_"26W_/AJW_@NF_^)JZ-6TYHY)%O[8I'C>PE&%STS]<<>M9NN^*;'2-"?4H9
M[6Y)C$D*"X"B520,J1G/7\>E $O_  DEM_SX:M_X+IO_ (FC_A)+;_GPU;_P
M73?_ !-7=0U&.P^S1D;Y[J8001YQN;!8\]@%5F/L*JZ+K,FK3:I&]JL(L;QK
M3(EW[R%5MWW1CAAZT ,_X22V_P"?#5O_  73?_$T?\));?\ /AJW_@NF_P#B
M:S_^$LO!::Q>_P!CB2VTJYDAG$-SNE944,S*I4 \-G&[/!K2DUJ2XCA;2+9+
M[S[=;A"9?+3:Y&PEL' (#G."?EZ<T -_X22V_P"?#5O_  73?_$T?\));?\
M/AJW_@NF_P#B:I6?BR2]2S@33O+U.XEN8C;2385# VV0[PIRN[: <<[ATYIC
M^+Y6TW3]7M=*>;2KDPK)*9@LL9E8( (\'=M9@#\P[XS0!H?\));?\^&K?^"Z
M;_XFC_A)+;_GPU;_ ,%TW_Q-.75;P>(TTV;3@EO+#)+%<I/N/R%0=Z8&W.[C
M!.<<XJCJGB+4[.TN+RST6.ZM(!(3(]V(BVUBN%&TY)*G'U7UX +G_"26W_/A
MJW_@NF_^)H_X22V_Y\-6_P#!=-_\34=WKM]9:M96\^DXLKN<6RW"W +K(5+?
MZO;]SY2-V<]\8YIMGK>IR:RME?Z1%9PM!).)OM@D*JI4?,NT!2=WJ>A]* )O
M^$DMO^?#5O\ P73?_$T?\));?\^&K?\ @NF_^)JK;^+89M/U+4'M7BM-/N_)
ME=VY\O8C^;C' PX.#S@$]>*Z.@#&_P"$DMO^?#5O_!=-_P#$T?\ "26W_/AJ
MW_@NF_\ B:V:* ,;_A)+;_GPU;_P73?_ !-'_"26W_/AJW_@NF_^)K9HH QO
M^$DMO^?#5O\ P73?_$T?\));?\^&K?\ @NF_^)K9HH QO^$DMO\ GPU;_P %
MTW_Q-'_"26W_ #X:M_X+IO\ XFMFB@#&_P"$DMO^?#5O_!=-_P#$T?\ "26W
M_/AJW_@NF_\ B:V:* ,;_A)+;_GPU;_P73?_ !-'_"26W_/AJW_@NF_^)K9H
MH QO^$DMO^?#5O\ P73?_$T?\));?\^&K?\ @NF_^)K9HH QO^$DMO\ GPU;
M_P %TW_Q-'_"26W_ #X:M_X+IO\ XFMFB@#&_P"$DMO^?#5O_!=-_P#$T?\
M"26W_/AJW_@NF_\ B:V:* ,;_A)+;_GPU;_P73?_ !-'_"26W_/AJW_@NF_^
M)K9HH QO^$DMO^?#5O\ P73?_$T?\));?\^&K?\ @NF_^)K9HH QO^$DMO\
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MK<>:[M"CHJYV; "P /&X#FKT.CZAHVAM:Z*ML\Z+'!!]HF*B."-0B_,$;YL
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
$* /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>41
<FILENAME>zlab-20231231_g1.jpg
<TEXT>
begin 644 zlab-20231231_g1.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X1#H17AI9@  34T *@    @ ! $[  (
M   *   (2H=I  0    !   (5)R=  $    4   0S.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $II;F<@66%N
M9P  !9 #  (    4   0HI $  (    4   0MI*1  (    #-C@  )*2  (
M   #-C@  .H<  <   @,   (E@     <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0        $" P0%!@<("0H+_\0
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M7'@CPQ=2F2?0;!G/5O(49_*HO^%?^$_^@!8_]^JZ*BIY8]C95ZRVD_O9SO\
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M_"G/!W_/E<?^!3_XT44G"+=VBHXO$0CRQFTO4W_#?A'2?"<-Q'HL,D2W#!I
M\K/D@8'6M'4].M]7TNXT^^4O;W"%)%5BI(/N***JR2L92J3E/G;U[G'_ /"G
M/!W_ #Y7'_@4_P#C4EM\)/"5I=17$-G.)(7#H3<N<$'([T45/LX=C=XW$M6=
M1_>SMJ***LY HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
*HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>42
<FILENAME>zlab-20231231_g10.jpg
<TEXT>
begin 644 zlab-20231231_g10.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !T 0H# 2(  A$! Q$!_\0
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MBB@ HHHH **2D/ Q0 ZBHUQNJ2@ HHHH **** "BBB@ HHHH **** "BBB@
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MA9)- X[DK'+&5<^RN#Z9. ?OC1=%L/#^GV^G:;:PV%C;KY<-M FQ$4< *O8
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M-2$7)RV/5M3\6_:/A]=^(_#GEZ^GV"2^T\0L9%NR(R\6T@$G<0!@#/-?$O\
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M:=/=)$EVF0&;=YL: =I!+S\M>Z7NF6E[>VEQ/#%-<6LAE@:09:)S&4)7ZHS
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MX+C;@8/F8VJJ@;.]:'CKP+)XHU#1=4T_5I=&UG17E:VNDA6=-LB!7CD0_>#
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M^(UE8CT*UZ<O6G44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
4% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>43
<FILENAME>zlab-20231231_g11.jpg
<TEXT>
begin 644 zlab-20231231_g11.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !& +D# 2(  A$! Q$!_\0
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MLHNT,0V/8"O1KBTBN8S'*BR*P*E>Q!_G18:;;:?:06]M"D-O%&L<<<8VJB@
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H,T44 +M!I0,444 %+110 E+110 4E%% "TE%% !MI:** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>44
<FILENAME>zlab-20231231_g12.jpg
<TEXT>
begin 644 zlab-20231231_g12.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X0+H17AI9@  34T *@    @ ! $[  (
M   *   !2H=I  0    !   !5)R=  $    4   "S.H<  <   $,    /@
M   <Z@    $
M
M
M
M
M
M2FEN9R!986YG   %D ,  @   !0   *BD 0  @   !0   *VDI$  @    ,U
M,0  DI(  @    ,U,0  ZAP !P   0P   &6     !SJ     0
M
M
M
M
M
M                                       R,#(T.C Q.C(Y(#$T.C,U
M.C(Y #(P,C0Z,#$Z,CD@,30Z,S4Z,CD   !* &D ;@!G "  60!A &X 9P
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M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BK_P  1" +,!6H# 2(  A$! Q$!_\0
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M_FO^-2T4 1><_P#S[2_FO^-'G/\ \^TOYK_C4M% $7G/_P ^TOYK_C1YS_\
M/M+^:_XU+10!%YS_ //M+^:_XT><_P#S[2_FO^-2T4 1><__ #[2_FO^-'G/
M_P ^TOYK_C4M% $7G/\ \^TOYK_C1YS_ //M+^:_XU+10!%YS_\ /M+^:_XT
M><__ #[2_FO^-2T4 1><_P#S[2_FO^-'G/\ \^TOYK_C4M% $7G/_P ^TOYK
M_C1YS_\ /M+^:_XU+10!%YS_ //M+^:_XT><_P#S[2_FO^-2T4 1><__ #[2
M_FO^-'G/_P ^TOYK_C4M% $7G/\ \^TOYK_C1YS_ //M+^:_XU+10!%YS_\
M/M+^:_XT><__ #[2_FO^-2T4 1><_P#S[2_FO^-'G/\ \^TOYK_C4M% $7G/
M_P ^TOYK_C1YS_\ /M+^:_XU+10!%YS_ //M+^:_XT><_P#S[2_FO^-2T4 1
M><__ #[2_FO^-'G/_P ^TOYK_C4M% $7G/\ \^TOYK_C1YS_ //M+^:_XU+1
M0!%YS_\ /M+^:_XT><__ #[2_FO^-2T4 1><_P#S[2_FO^-'G/\ \^TOYK_C
M4M% $7G/_P ^TOYK_C1YS_\ /M+^:_XU+10!%YS_ //M+^:_XT><_P#S[2_F
MO^-2T4 1><__ #[2_FO^-'G/_P ^TOYK_C4M% $7G/\ \^TOYK_C1YS_ //M
M+^:_XU+10!%YS_\ /M+^:_XT><__ #[2_FO^-2T4 1><_P#S[2_FO^-'G/\
M\^TOYK_C4M% $7G/_P ^TOYK_C1YS_\ /M+^:_XU+10!%YS_ //M+^:_XT><
M_P#S[2_FO^-2T4 1><__ #[2_FO^-'G/_P ^TOYK_C4M% $7G/\ \^TOYK_C
M1YS_ //M+^:_XU+10!%YS_\ /M+^:_XT><__ #[2_FO^-2T4 1><_P#S[2_F
MO^-'G/\ \^TOYK_C4M% $7G/_P ^TOYK_C1YS_\ /M+^:_XU+10!%YS_ //M
M+^:_XT><_P#S[2_FO^-2T4 1><__ #[2_FO^-'G/_P ^TOYK_C4M% $7G/\
M\^TOYK_C1YS_ //M+^:_XU+10!%YS_\ /M+^:_XT><__ #[2_FO^-2T4 1><
M_P#S[2_FO^-'G/\ \^TOYK_C4M% $7G/_P ^TOYK_C1YS_\ /M+^:_XU+10!
M%YS_ //M+^:_XT><_P#S[2_FO^-2T4 1><__ #[2_FO^-'G/_P ^TOYK_C4M
M% $7G/\ \^TOYK_C1YS_ //M+^:_XU+10!%YS_\ /M+^:_XT><__ #[2_FO^
M-2T4 1><_P#S[2_FO^-'G/\ \^TOYK_C4M% $7G/_P ^TOYK_C1YS_\ /M+^
M:_XU+10!%YS_ //M+^:_XT><_P#S[2_FO^-2T4 1><__ #[2_FO^-'G/_P ^
MTOYK_C4M% $7G/\ \^TOYK_C1YS_ //M+^:_XU+10!%YS_\ /M+^:_XT><__
M #[2_FO^-2T4 1><_P#S[2_FO^-'G/\ \^TOYK_C4M% $7G/_P ^TOYK_C1Y
MS_\ /M+^:_XU+10!%YS_ //M+^:_XT><_P#S[2_FO^-2T4 1><__ #[2_FO^
M-'G/_P ^TOYK_C4M% $7G/\ \^TOYK_C1YS_ //M+^:_XU+10!%YS_\ /M+^
M:_XT><__ #[2_FO^-2T4 1><_P#S[2_FO^-'G/\ \^TOYK_C4M% $7G/_P ^
MTOYK_C1YS_\ /M+^:_XU+10!%YS_ //M+^:_XT><_P#S[2_FO^-2T4 1><__
M #[2_FO^-'G/_P ^TOYK_C4M% $7G/\ \^TOYK_C1YS_ //M+^:_XU+10!%Y
MS_\ /M+^:_XT><__ #[2_FO^-2T4 1><_P#S[2_FO^-'G/\ \^TOYK_C4M%
M$7G/_P ^TOYK_C1YS_\ /M+^:_XU+10!%YS_ //M+^:_XT><_P#S[2_FO^-2
MT4 1><__ #[2_FO^-'G/_P ^TOYK_C4M% $7G/\ \^TOYK_C1YS_ //M+^:_
MXU+10!%YS_\ /M+^:_XT><__ #[2_FO^-2T4 1><_P#S[2_FO^-'G/\ \^TO
MYK_C4M% $7G/_P ^TOYK_C1YS_\ /M+^:_XU+10!%YS_ //M+^:_XT><_P#S
M[2_FO^-2T4 1><__ #[2_FO^-'G/_P ^TOYK_C4M% $7G/\ \^TOYK_C1YS_
M //M+^:_XU+10!%YS_\ /M+^:_XT><__ #[2_FO^-2T4 1><_P#S[2_FO^-'
MG/\ \^TOYK_C4M% $7G/_P ^TOYK_C1YS_\ /M+^:_XU+10!%YS_ //M+^:_
MXT><_P#S[2_FO^-2T4 1><__ #[2_FO^-'G/_P ^TOYK_C4M% $7G/\ \^TO
MYK_C1YS_ //M+^:_XU+10!%YS_\ /M+^:_XT><__ #[2_FO^-2T4 1P3+<0K
M*@(5LXSUZU)533/^0;%^/\S5N@ JI;_\A*\_X!_*K=5+?_D)7G_ /Y4 6Z**
M* "BN8UKQ8\5Y?:7H5M]KOK2V::XD,@2.V&,C)(.6[[0*32?$]Z;K2K#6M,>
M&748=T%W#*LD4C+'O.[A2IP"<8H ZBBN4\4>,KO0]6ATW2-"N-:N7A\Z5('(
M\I<X4G"MUP?3I6#=?$_7;%$>]\#7=NDDBQJTMR5!8]!DQ]: /2:*R]=U^U\.
MZ3]MU'=EF$<<,7S-+(>B+TR:SI?%5UI<]E_PD>EKI]M>N(XYX[GS1%(>0LGR
MC:3CJ-P]Z .EHK,U_7[/PYI9O;\LP+".**,9>5ST51ZUFR^*KK2Y[+_A(]+7
M3[:]<1QSQW/FB*0\A9/E&TG'4;A[T =+1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 5-,_Y!L7X_S-6ZJ:9_R#8O
MQ_F:MT %5+?_ )"5Y_P#^56ZJ6__ "$KS_@'\J +=%%% 'D?BV'5O!/BK5=:
MM[4WFD:S"8YR.L3%<<^F#R.Q!QUKN_"VH:5XA\/Z9<6<R7#6*IP"0T,GEE#D
M?1F'/K5B\U*WU+0-:6#.;59[>56 X8)S^'(KSEM'7PCXM\)W_AZ5H!K)CBN[
M0'*L#LWMCT^8GV(X]@#UJ.VAAGFFCC"R3L&D;NQ  'Z#I_C7*:Y_Q.?B+HFD
M+\T&FHVIW(!XW#Y8OQ!R?H:["N0\##^T[K6?$KY/]I71CMR1_P L(OD7'U.<
M_2@#"\:S->?%[PKICG,,.+G:>A;<W/\ Y#%;OQ3MTG^&^IEQDQ^6Z'T(D7^A
M(_&L7QS;G3_B=X6UR08MF<6CR'HAW'&?^^S^1K7^*UT(/AY>Q 9DNI(H8U R
M2Q<''Y*: .*.J3Z]XI^']O=L7"VT=PV[^)PS L??]U^M=Q\4[=)_AOJ9<9,?
MENA]")%_H2/QKC]0T63POXB\!WMR-L<<4=G.YZ)(220?QD;\C76_%:Z$'P\O
M8@,R74D4,:@9)8N#C\E- &OX,OI=2\$Z3=7!+2O;*'8]6(&"?QQFMNLGPKIK
MZ/X3TRPE&)(+=!(/1L98?F36M0 4A(526(  R2>U+2$!E(8 @C!![T 1_:[?
M_GO%_P!]BC[7;_\ />+_ +[%'V2W_P">$7_? H^R6_\ SPB_[X% !]KM_P#G
MO%_WV*/M=O\ \]XO^^Q1]DM_^>$7_? H^R6__/"+_O@4 'VNW_Y[Q?\ ?8H^
MUV__ #WB_P"^Q1]DM_\ GA%_WP*/LEO_ ,\(O^^!0 ?:[?\ Y[Q?]]BC[7;_
M //>+_OL4?9+?_GA%_WP*/LEO_SPB_[X% !]KM_^>\7_ 'V*/M=O_P ]XO\
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M;_\ />+_ +[%'V2W_P">$7_? H^R6_\ SPB_[X% !]KM_P#GO%_WV*/M=O\
M\]XO^^Q1]DM_^>$7_? H^R6__/"+_O@4 'VNW_Y[Q?\ ?8H^UV__ #WB_P"^
MQ1]DM_\ GA%_WP*/LEO_ ,\(O^^!0 ?:[?\ Y[Q?]]BC[7;_ //>+_OL4?9+
M?_GA%_WP*/LEO_SPB_[X% !]KM_^>\7_ 'V*/M=O_P ]XO\ OL4?9+?_ )X1
M?]\"C[);_P#/"+_O@4 'VNW_ .>\7_?8H^UV_P#SWB_[[%'V2W_YX1?]\"C[
M);_\\(O^^!0 ?:[?_GO%_P!]BC[7;_\ />+_ +[%'V2W_P">$7_? H^R6_\
MSPB_[X% !]KM_P#GO%_WV*/M=O\ \]XO^^Q1]DM_^>$7_? H^R6__/"+_O@4
M 'VNW_Y[Q?\ ?8H^UV__ #WB_P"^Q1]DM_\ GA%_WP*/LEO_ ,\(O^^!0 ?:
M[?\ Y[Q?]]BC[7;_ //>+_OL4?9+?_GA%_WP*/LEO_SPB_[X% !]KM_^>\7_
M 'V*/M=O_P ]XO\ OL4?9+?_ )X1?]\"C[);_P#/"+_O@4 'VNW_ .>\7_?8
MH^UV_P#SWB_[[%'V2W_YX1?]\"C[);_\\(O^^!0 ?:[?_GO%_P!]BC[7;_\
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MW_Y[Q?\ ?8H^UV__ #WB_P"^Q1]DM_\ GA%_WP*/LEO_ ,\(O^^!0 ?:[?\
MY[Q?]]BC[7;_ //>+_OL4?9+?_GA%_WP*/LEO_SPB_[X% !]KM_^>\7_ 'V*
M/M=O_P ]XO\ OL4?9+?_ )X1?]\"C[);_P#/"+_O@4 'VNW_ .>\7_?8H^UV
M_P#SWB_[[%'V2W_YX1?]\"C[);_\\(O^^!0 ?:[?_GO%_P!]BC[7;_\ />+_
M +[%'V2W_P">$7_? H^R6_\ SPB_[X% !]KM_P#GO%_WV*/M=O\ \]XO^^Q1
M]DM_^>$7_? H^R6__/"+_O@4 'VNW_Y[Q?\ ?8H^UV__ #WB_P"^Q1]DM_\
MGA%_WP*/LEO_ ,\(O^^!0 ?:[?\ Y[Q?]]BC[7;_ //>+_OL4?9+?_GA%_WP
M*/LEO_SPB_[X% !]KM_^>\7_ 'V*/M=O_P ]XO\ OL4?9+?_ )X1?]\"C[);
M_P#/"+_O@4 'VNW_ .>\7_?8H^UV_P#SWB_[[%'V2W_YX1?]\"C[);_\\(O^
M^!0 ?:[?_GO%_P!]BC[7;_\ />+_ +[%'V2W_P">$7_? H^R6_\ SPB_[X%
M!]KM_P#GO%_WV*/M=O\ \]XO^^Q1]DM_^>$7_? H^R6__/"+_O@4 'VNW_Y[
MQ?\ ?8H^UV__ #WB_P"^Q1]DM_\ GA%_WP*/LEO_ ,\(O^^!0 ?:[?\ Y[Q?
M]]BC[7;_ //>+_OL4?9+?_GA%_WP*/LEO_SPB_[X% !]KM_^>\7_ 'V*/M=O
M_P ]XO\ OL4?9+?_ )X1?]\"C[);_P#/"+_O@4 2 AE!4@@C(([TM( %4!0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"IIG_(-B_'^9JW
M533/^0;%^/\ ,U;H *J6_P#R$KS_ (!_*K=5+?\ Y"5Y_P  _E0!;HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH J:9_R#8OQ_F:MU4TS_ )!L7X_S-6Z "JEO
M_P A*\_X!_*K=5+?_D)7G_ /Y4 6Z*** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@"IIG_ "#8OQ_F:MU4TS_D&Q?C_,U;H *J6_\
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M*=KN\#2WL#>5<Z=-%<02+P48.%X/T8_E6+XOC-O\:_"]Y)D12Q"%3C^(,_\
M\6M;_P 4IEA^&^J;SRXC11ZDR+0!RNOZ^_BO4?!>E/\ \>^H"*\O(UZ.<X*_
M0%7_ ,BNE^*=KN\#2WL#>5<Z=-%<02+P48.%X/T8_E7#VEA+I?C#X?RW0*K)
M8I&./XBSG'_D5:[WXI3+#\-]4WGEQ&BCU)D6@#<\.ZI_;7AO3]1( :Y@5W Z
M!L?,/SS6E6!X&M9++P)H\,PPXM58CTW?-C]:WZ "BBD==Z,N2N1C(/(H 6BJ
MGV _\_=S_P!_*/L!_P"?NY_[^4 6Z*J?8#_S]W/_ '\H^P'_ )^[G_OY0!;H
MJI]@/_/W<_\ ?RC[ ?\ G[N?^_E %NBJGV _\_=S_P!_*/L!_P"?NY_[^4 6
MZ*J?8#_S]W/_ '\H^P'_ )^[G_OY0!;HJI]@/_/W<_\ ?RC[ ?\ G[N?^_E
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MNY_[^4 6Z*J?8#_S]W/_ '\H^P'_ )^[G_OY0!;HJI]@/_/W<_\ ?RC[ ?\
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M1]@/_/W<_P#?RI&6Z*J?8#_S]W/_ '\H^P'_ )^[G_OY0!;HJI]@/_/W<_\
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MN=M153[ ?^?NY_[^4?8#_P _=S_W\KS#L+=%5/L!_P"?NY_[^4?8#_S]W/\
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MNY_[^4?8#_S]W/\ W\H MT54^P'_ )^[G_OY1]@/_/W<_P#?R@"W153[ ?\
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MP"64;%YZ?-]:ZRB@!  J@*  !@ =J6BB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"IIG_ "#8
MOQ_F:MU4TS_D&Q?C_,U;H *J6_\ R$KS_@'\JMU4M_\ D)7G_ /Y4 6Z***
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MU>-Q2JRY(?"B</1Y%S2W84445YQU!1110 4444 %%%% !1110 4444 %%%%
M!1110!D^(_#EEXFTMK.^7##F*91\T3>H_J.]>$ZEINK>#/$*H[-!<PMOAGCZ
M./[P/<'T_ U]&5D>)/#=EXFTMK.^7##F&91\T3>H]O4=Z]#"8MT7R3UBSEKT
M/:>]'<S?!7C6W\4V7ER[8=1B7][#GAA_>7V]NU=37SGJ.G:MX+\0JCLT%S V
M^&9/NN/[P]0?3\#7L?@KQI;>*;+9)MAU&)?WL.?O?[2^W\JO%X107M:6L7^
MJ%?F]R>YU-%%%>8=84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M!4TS_D&Q?C_,U;JIIG_(-B_'^9JW0 54M_\ D)7G_ /Y5;JI;_\ (2O/^ ?R
MH MT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !117GGQ-\9_V;:MHFFR$7DR
M_OY%/^J0]OJ?T'U%;4:,JTU")%2HJ<>9G,_$KQG_ &S>G2=.D_T&V?\ >.IX
MF<?^RCMZGGTK;^%_@SRD3Q!J<8WN,VD;#[H_YZ'Z]OS]*YKX>^#6\1:E]LOH
M_P#B6VS?/G_EJW9/IZ__ %Z]R50JA5 "@8  Z5Z>+K1H4_JU+YG'0INI+VL_
MD+1117C'>%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 9'B
M3PW9>)]+:TO5VNN3#,H^:)O4>WJ.]>%7]AJW@OQ$%=FM[J!M\4R?=<>H]0?3
M\#7T96/XE\-67B?2VM+U=KKDPS ?-$WJ/;U'>O0P>+=%\D]8LY:]#VGO1W,_
MP7XTMO%-CLDVPZA$O[Z'/WO]I?;^5=17SG?6.K>"_$05V:WNH&WQ3)]UQZCU
M!]/P->R^#/&=MXIL=K[8=0B7]]#GK_M+[?RJ\9A%!>UI:Q?X"H5^;W)[G3T4
M45YAUA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 5-,_Y!L7X_S-6ZJ:
M9_R#8OQ_F:MT %5+?_D)7G_ /Y5;JI;_ /(2O/\ @'\J +=%%% %/4]5LM'L
MGNM1N(X(U4D;W52^!G R1D^U-TO6=/UFU2?3KN&=64,5CD5BF1T;!.#7FEYJ
M\$/Q+\1P>)"JRFR:+3&F'RH-F<*3T+>OKD5V5EX<MKB;PWK4$445U:0CS9 ,
M-+&T#+@X')#%3S[T =/4#7MJEZEF]S"MU(I=(#( [*.I"]2/>HM6U2WT;2YK
MZ[)\N)>%499V/ 4#N2< ?6O,]'BU!?C?;RZP^;RXL&F>,'*PY!Q&/]T #W.3
MWH ]7)"J2Q  &23VJI9ZQIFH3/%8:C:74B??2"=7*_4 \5Q?Q$U*6[U[0O"D
M3M'%J4ZO>%3@M%NQMSZ'#?D*L?$BQ&F^$XM7TA$M;O1I(WMWB7;M0L%*<?P_
M-R/:@#MR0JDL0 !DD]JJ6>L:9J$SQ6&HVEU(GWT@G5ROU /%>>^*O$C>)&\*
MZ+:LT,&N>5/>!20?+)&4S]0V?H*UOB18C3?"<6KZ0B6MWHTD;V[Q+MVH6"E.
M/X?FY'M0!W%%4M%U)-8T.RU&,;5NH%EV_P!TD9(_ \5=H **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBJ>K:K:Z+I<U_?R
M;(85R?5CV ]S32;=D)M)79D^,_%</A;1FE!5KV8%;:(]S_>/L/\  5XOH>CZ
MAXQ\1^5O=Y)7,ES<-SL7/+'^@INL:KJ/C+Q)YI1I)YW$=O G.Q<\*/ZGZFO;
M?!_A:#PMHRVZX>ZEP]Q+_>;T'L.WY]Z]SW<!1_OR/.UQ-3^ZC4TS3+71]-AL
M;"/RX(5PH[GU)]2>M6Z**\-MMW9Z*22L@HHHI#"BBB@ HHHH **** "BBB@
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M(5;HH J?9[S_ )_?_(0H^SWG_/[_ .0A5NB@"I]GO/\ G]_\A"C[/>?\_O\
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MW_R$*/L]Y_S^_P#D(5;HH J?9[S_ )_?_(0H^SWG_/[_ .0A5NB@"I]GO/\
MG]_\A"C[/>?\_O\ Y"%6Z* *GV>\_P"?W_R$*/L]Y_S^_P#D(5;HH J?9[S_
M )_?_(0H^SWG_/[_ .0A5NB@"I]GO/\ G]_\A"C[/>?\_O\ Y"%6Z* *GV>\
M_P"?W_R$*/L]Y_S^_P#D(5;HH J?9[S_ )_?_(0H^SWG_/[_ .0A5NB@#G/$
MGA)/$VG_ &>^N1O3F*41#=&?\/45XK=VFK^"_$05BUM=V[;HY$^ZX]1Z@_\
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M *GV>\_Y_?\ R$*/L]Y_S^_^0A5NB@"I]GO/^?W_ ,A"C[/>?\_O_D(5;HH
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M ,A"C[/>?\_O_D(5;HH 1 0BAFW,!R<8R:6BB@ HHHH **** "BBB@ HHHH
M**** "BBB@"IIG_(-B_'^9JW533/^0;%^/\ ,U;H *J6_P#R$KS_ (!_*K=5
M+?\ Y"5Y_P  _E0!;HHHH 0@,I# $$8(/>EHHH **** "BBB@ HHHH ****
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M#)'S2RXYD?N3_3VK6K+&8IUYZ?"MBZ%'V<==PHHHKB.@**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#$
M\4>%[+Q3IAM[H;)DR8)P/FC;^H]17AMQ;ZOX+\1@$M;7ENVY'7[KKZCU4_\
MUJ^C:P_%/A:S\4Z8;>Z'ESIDP3@?-&?Z@]Q7HX/%^Q]R>L6<M>AS^]'<@\'>
M,+7Q5I^1MAOH@//@ST_VE]5/Z=/KT=?.4\&K^"_$8!+6UY;MN1UY5U]1ZJ?_
M *U>U>#_ !A:>*M/W+MAO8@//M\]/]I?53^G3ZO&83V?[RGK%_@*A7Y_<GN=
M'1117FG6%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110!4TS_D&Q?C_,U;JIIG_(-B_'^9JW0
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJ/\ B8>EM_X]0!;HJI_Q,/2V_P#'J/\ B8>EM_X]0!;HJI_Q,/2V_P#'J/\
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MFA>*50Z.I5E/0@]10B)%&L<:JB* JJHP !V H YK5?%M]I/B'[$_AG4[NQV
MB]LHS-DD=-@'&#QUS[57EL;KQ9XETN_N;":PTW2G::,7("S3RG&/ER=JC&>>
M3Z5U]% '(>.O#EWJ3Z;K6C()-2TB82I$3CSTR"4SZ\<?CZU5\4B\\<:;;Z)I
MMC?6D,TJ27MQ>6[0B%%.=HW#YVSC[N1[UW-% '%^,/"<TMMH^H>'H@;W0G0P
M0$X\V)<93/K\HQ^/K47BD7GCC3;?1--L;ZTAFE22]N+RW:$0HISM&X?.V<?=
MR/>NYHH BM;:*SLX;6W7;%!&L:+Z*!@#\A4M%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !7FGQ/\9_98FT'2Y?WTBXNY%/W%/\'U/?V^M='XY\7)X7
MTC]P5;4+@%8$/.WU<CT'ZG\:\?\ #/A^[\7^(?)+OM9C+=7!YV@GD_4GI7JX
M'#QM[>K\*.+$57_#ANS<^''@S^W;[^TM1C/]GVS?*I'$SCM]!W_+UKVRH+&R
MM]-L(;.SC$<$*!$4=A4]<F*Q$L14YGMT-Z-)4HV"BBBN4V"BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** ,#Q9X3L_%6F^5-B*ZC!,%P
M!RA]#Z@]Q7B!&K^#/$?\5K>VS<'JKK_[,IKZ.K \6^$K/Q5IOE38BNHP3!<
M<H?0^JGTKT<'C/9?NZFL7^!R5Z'/[T=Q/"/BZT\5:=YD6(KN,#S[?/*GU'JI
MKH*^<2-7\&>(_P"*UO;9OJKK_P"S*:]J\*>--/\ $]FFV1(+X#$MLS<Y]5]1
M_+O3Q>#]G^\IZQ?X!0K\_NSW.DHHHKS3K"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@"IIG_(-B_'^9JW533/^0;%^/\
M,U;H *J6_P#R$KS_ (!_*K=5+?\ Y"5Y_P  _E0!;HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L_7-9M= T>;4+UL1
MQ#A0>7;LH]S5Z65(87EF<)'&I9F8X"@<DFO!/'/BV3Q3K&+<LMA;DK A_B/=
MR/4_H/QKLPF&>(G;HMS"O65*/F9][=ZEXS\3[RIEN[N0)%&IX0=E'H /ZFO<
M_"OANW\,:*EG#AYF^:>;',C_ . Z 5@_#GP9_8-A_:&HQC^T;E>%(YA3^[]3
MW_*NXK?'8E3?LJ?PHSP]%Q]^6["BBBO,.L**** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@# \6^$K/Q5IWE38BNHP3!< <
MH?0^H/I7C.M^"M=\.,9;FU9X4.1<VY+(/?/5?QQ7T+17=A\;4H+EW78YZN'A
M4UV9X5H7Q,UW1]L5S(-1MQQLN#\P'L_7\\UZ3H7Q&T'6ML;S_8;EN/*N2%!/
MLW0_H?:GZ[\.]!US=)]G^Q7)_P"6UL N3[KT/\_>O-=>^&.N:1NELT&I6XYW
M0#YP/=.OY9KM_P!CQ7]V7]?(Y_W]'S1[F#D9'(HKYYT7QCKWAM_*M;I_*0X-
MM< L@]L'E?PQ7I&A?%C2K_;%K$;:?,>-_P!^,_CU'XC\:Y:V7UJ>L=5Y?Y&U
M/%4YZ/1G?45%;W,%W L]I-'/$XRLD;!E/XBI:\[8Z@HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MZ 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MIG_(-B_'^9JW533/^0;%^/\ ,U;H *J6_P#R$KS_ (!_*K=5+?\ Y"5Y_P
M_E0!;HHHH :[I%&TDC*B*"S,QP !W)H1TEC62-E=& 964Y!![@UYU?ZQ/XC\
M4^(M)EO)K2STFS<QV\$AC:X;;RS,.2HZ8''(K7TC2]1TZ?P_<:?J%Y+I]Q'L
MO+6=S,J?N&965FR5&X =<<@4 =A17+Z[I^O>(-3DLK#4I=%TVW5=]Q"A\VX<
MC.%/&% (Y'?([5RL%YXA\!^.M,TK5-6FUG2M6D$44EP275B0O4DD$%ESS@@]
MCT /4J*Y'QSXDNM+?3='T=U34]6G$,<A&?)3(!?'KSQ^/I53Q0+SP3I=OKFG
M7U]>1V\J)?07=PTJS(QQN&X_(V2,;<#GI0!W-%<9XN\72PVNCV/AZ51>ZZZ"
MWF*Y\J)L?O,>OS#'X^E0^*!>>"=+M]<TZ^OKR.WE1+Z"[N&E69&.-PW'Y&R1
MC;@<]* .YHJ*TNHKVSANK9M\,\:R1MZJPR#^1J6@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHJ&\O(+"REN[N18H(5+N[=@*:3;L@,WQ/XBMO#.BR7MP0TGW88L\R/V'T[
MD^E>%6\&I^,_%&W)FO+R3<[D?*@[GV4#_"I_%7B.Z\7:]YP1A$#Y=K;CD@$^
MG=CW_+M7KG@/P@GAC2=]P%;4+D S-_<'9 ?;OZG\*]R*C@*/,_C9YK;Q-2R^
M%&SH.B6OA[1X=/LA\D8RSGK(QZL?<UHT45X<I.3N]ST4DE9!1112&%%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !137D2-=TC*@]6.*I3:]I-O_KM1M5/IYH)_(5,IQC\3L7&$I?"KE^BL";Q
MOH,/2\,A](XF/ZXQ6?-\1]-3_46MS(?]H*H_F:YI8S#QWFCIC@<3+:#_ ".O
MHK@)OB5*?^/?347WDE+?H *SYOB#K,O^K%M#_N1D_P R:YY9IAH[._R.F.4X
MJ6Z2^?\ D>GT5Y!-XMUV?[^HR+_N )_("JGGZMJ/_+6\NL_[3O7.\XI[0@W_
M %\SICDM3><TOZ^1['->VMM_Q\7,,7^_(%_G6?-XJT.#[^I0G_KF2_\ Z#FO
M,X?#&M7'^KTVX&?[Z[/YXK0A\!:Y+]^*&'_KI*#_ .@YJ?[0Q4_X=+\_^ /^
MSL)#^)6_+_@G6S>/]$B_U;3S?[D6/YD5GS?$JW7/V?3I7]/,D"_R!JE#\-KM
MO^/B_AC_ .N:%OYXK0A^&UDN/M%]/)_N*%_GFCGS.>R2^[_@AR953W;?W_I8
MS)OB1?M_Q[V=O'_OEF_J*SYO'6NR_=N4B'I'$O\ 7-=G#X#T*+[\$LW^_*?Z
M8K0A\-:-;X\O3;<X_OIN_GFCZKCY_%4M_7D'US+X?!2O\O\ -GEDOB#6;DX?
M4;HY[+(5S^ IBZ=JU\P9;2\G/][RV;]:]EBMX8!B"&.,>B*!_*I*/[)E+^)4
M;_KU#^V(Q_ATTOZ]#R.'P;KT_2P9!ZR.J_S.:T(?AWJTF#+-:Q#T+DG]!7IE
M%;1RG#K>[,99QB7LDC@X?AIWN-3_  CA_J3_ $K0A^'>DQ\RS74I]"X _05U
ME%=,<OPL=H'++,<5+>9AP^#=!@Z6 <^LCLWZ9Q6A#H^FV_\ J-/MHSZK"N?S
MQ5RBNF-"E#X8I?(YI5ZL_BDW\P "C"C '84UXTE0I(BNIZJPR#3J*U,3%O/"
M.B7N2]BD;'^*'Y/T'%8-Y\-H6R;"^=/19E#?J,?RKN**Y*F"P]3XH+\OR.RG
MCL32^&;_ #_,\IO/ VMVN2D*7*CO"^?T.#68LFJZ-+@-=V39Z?,F?P[U[337
MC25"DB*ZGJK#(-<$\HA>]*33_KT/1AG-2UJL$U_7J>7V?CW6;; F>*Z4?\]4
MP?S&*WK/XD6CX%]92PGNT3!Q^N*VKSPCHE[DO8I$Q_BA^3]!Q6#>?#:%LFPO
MW3T69 WZC'\JCV.8T?@ES+^N_P#F7[;+:_QQY7_7;_(WX?$>@ZM"83=V[K(,
M-%<#;N]L-P:YW6_A7HVJ*T^DN=/F;D"/YXF_X#V_ _A6)>>!M;M<E($N5'>%
M\_H<&LQ9=5T:7 :[LFST^9,_AWK6EG&*PK_>0:]/^#H1/)\-B%^ZJ)_UY&+K
MG@?7O#S&6>U::!#D7-OEE'N>Z_B!5S0OB5KVC;8YIAJ%LO'EW!RP'L_7\\UT
MMGX]UFVP)GBNE'_/5,'\QBJNHS^%O$&7U'29=.N6_P"7BR8<GU*G /Y9]Z]Z
MCQ'@\0N3$JWR_K\SQZV0XRB^:CKZ,Z[0OB3H.L[8YIOL%R>/+N#A2?9^GYX/
MM77 AE!4Y!Y!'>OGC4?"S09DTJ^AU&'L!F.4?\ ;K_P$FDT;Q=KOAN3RK2ZD
M6-#AK:<;D^FT]/PQ7H+"4,3'GPE1/YGG2JUJ#Y<1!KY'T117GVA?%K3+W;%K
M4+6$QX\Q<O&?ZC]?K7>6MW;WMNL]G/'/$WW9(V#*?Q%>?5H5*3M-6.B%2$U[
MK):***Q- HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HIDL\4";YY4C7^\[ #]:R+KQ?H=ID-?
M)*WI""^?Q''ZUG.K3I_')(TA2J5/@BWZ&U17%7?Q(M4R+*QEE]#*P0?IFL6[
M^(.L3Y%N(+8=BB;C_P"/9_E7#4S/#0V=_0[Z>58J>ZMZGI]4[K5M/L<_:[V"
M(C^%I!G\NM>23ZOJ^IOLEN[F<M_RS5C@_P# 1Q4]KX3UN\QY>GR(#WEPG\ZY
M'FLYZ4:;?]>1V+*84U>O42_KS.ZN_'VBV^1"TUR?^F<>!^;8K%NOB3.V196$
M:>C3.6_08_G45K\-[V3!O+R&$>D:ES_2MJU^'NDPX-S)/<GN"VU?TY_6B^95
MNT5_7JQVRNCWD_Z]$<?=>,]<NL@WAA4_PPJ%_7K^M44MM5U=]RQ7=XW]XAG_
M %KUBTT#2;+'V;3X%(Z,4W-^9YK1Z=*/[,JU-:U2_P#7F+^U:5/2A22_KR_S
M.=\$Z9=Z5H<D-_"89'G,@4D$XVJ.WT-=%117L4J:I4U".R/%K576J.I+=A11
M16ID%%%% !1110 4444 %%%% !1110!4TS_D&Q?C_,U;JIIG_(-B_'^9JW0
M54M_^0E>?\ _E5NJEO\ \A*\_P" ?RH MT444 >?>/\ P&=1DF\0Z)=&QU*&
M%C+R0LRA2#TZ';QZ$<'UI/ ?CTW4D'A[Q#;'3]2CB58"PPLZ[1MQGH2.1V/;
MTJY>>+8K>/Q!I>ONUG*IF6SDGC*)-$5^7:V,$YXZ\^]8LL$?BW7O")T6/SET
MA8YKR^5?D4+M(BW?Q'*G@9QGZT >H5Q5Q9_\)7\1+2Z4;M-\/;AYHZ2W+8RH
M/<+A2??BJWC3XBZ;I5^-$AO)(I2<7=S NYK=>ZK_ +9'&?X>O7BH-/\ BAX7
MM+2WTS0+2\EDR(K:V6+;O9CP"2>Y/)Y/.>: *WBO+_'3PTC@F,6ZLOUW2_X"
MNC^)V/\ A6^KY_N)_P"C%JCX_P!%NFOM'\3Z=;M/<:3,&G@CY:2+()V^I'/Y
MU#XTU*'QEHD6@>%YUO9KZ5#.\0RMO$K;BTA_A.0/E.#0!QFDF23QGX!68,5&
MG(5R.^^7'Z!:]'^)V/\ A6^KY_N)_P"C%K)\7^%Y-.C\/ZQHMNUPWA\HDD*#
M+R0+C.!W(P?^^C3O&FI0^,M$BT#PO.M[-?2H9WB&5MXE;<6D/\)R!\IP: -S
MX?%C\/M&\S.?LX'/IDX_2NCJMIUC%IFF6UC;_P"JMHEB3Z*,?TJS0 4CDA&*
MKN8#@9QFEHH J?:;O_GR/_?T4?:;O_GR/_?T5;HH J?:;O\ Y\C_ -_11]IN
M_P#GR/\ W]%6Z* *GVF[_P"?(_\ ?T4?:;O_ )\C_P!_15NB@"I]IN_^?(_]
M_11]IN_^?(_]_15NB@"I]IN_^?(_]_11]IN_^?(_]_15NB@"I]IN_P#GR/\
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M+1\"^LY83W:-@X_7%:T\SPT]W;U.>IE6*ALK^AU/VF[_ .?(_P#?T4?:;O\
MY\C_ -_152S\4:-?8$-_$&/\,AV']<5JJP905((/0CO7?"I":O!W/.G3G3=I
MIKU*OVF[_P"?(_\ ?T4?:;O_ )\C_P!_15NBK(*GVF[_ .?(_P#?T4?:;O\
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M3'*A1@#C@C!I8(8[:WC@A7;'&H1%SG  P!3Z* "BBB@ HHHH **** "BBB@
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M^";5IF'>60G]!@5T%%=D,#AH;07Y_F<4\?B9[S?Y?D5K;3;&SQ]DLX(<=TC
M/YU9HHKK45%62..4G)W;"BBBF(**** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH *9-#%<1-%<1I+&W5'4,#^!I]% '(ZQ\/;"^W2:9,^G
MSGG"C?&3_NGI^!'TK@=9\/>(- W/>:?]IME_Y>+0EE ]QU'X\5[9163P^&G_
M !*:?X/[U;\;G3#%XFG_  ZC7XK[F?/46K6LG5RA]&%:ECJMS:_-I][)&/\
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MU8<V5T=DY/\ KT1P=UXJUN\R)-0E4'^&([/_ $'%10:+K&I/OBLKF8M_&RD
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MW_Y"5Y_P#^56ZJ6__(2O/^ ?RH MT444 %%%% !1110 4444 %%%% !1110
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M %5K</\ [VT?U-=D,+0A\,%]QQ3Q5>I\4W]YU"JJ*%0!0.@ QBEKBY/B ?\
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M?] ^'\J .,_X375_[\/_ '[H_P"$VU?^]#_W[KL_^$;T?_GPB_(TG_"-:/\
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M^$[U3_GE:_\ ?#?_ !5'_"=ZI_SQM?\ OAO_ (JNI_X1/1/^?$?]_'_QI/\
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M4_QJ)O#6L+UL)?PP?Y&@#U!9$?[CJWT.:=7D[:'JJ==.N?PB)_E3?L>IP_\
M+M=Q_P#;-A0!ZU17DOVG4X?^6UW'_P "84JZUJB=-1NOQF8_UH ]9HKRQ?$F
ML)TOYOQ(/\ZE7Q9K:]+TGZQH?Z4 >G45YNOC/65ZS1M]8A_2I5\<ZJO5;9OK
M&?Z&@#T.BN!7Q[J ^_:VQ^@8?UJ9?']P/OV,9^DA']* .CUGPUI&OQ[=4LHY
M6QA90-KK]&'/X=*\XUWX0W4.Z7P_="Y3J()R%<?1NA_'%=2OQ!'\>F_E/_\
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M8II\1Z0/^8A#^==U/"4*?PP1Y]3&8BI\4V:2(L:A8U"J.@48 I:RSXFT<?\
M+_'^1_PII\4Z*/\ E^3_ +Y;_"NHY36HK'/BS1!_R_#_ +]O_A33XNT0?\ON
M?^V3_P"% &U16&?&&BC_ )>F/_;)O\*0^,M&'_+=S_VR:@#=HK /C31Q_P M
M)3_VS--/C;2!WG/_ &S_ /KT =#17.'QQI(_AN#_ -LQ_C33XZTH?\L[H_\
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MQ-_.O60 !@# ]J* /+X_"VLR_=L7'^\RK_,U:C\$ZN_WA#'_ +TG^&:]&HH
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M %>LPM_O0$?U-6J>7O[3_'_(GFQ7;^OO,=-6TI_O:E$G^]'+_1*LQW>CR?\
M,=LU_P!Z.8?^TZG?X.:L/]7J-DW^]O']#5=_A!X@7[MSI[_25_ZI3^KX%[3?
M]?(7M<2OLEN--)DZ>(M-'U9Q_-:M1Z=I<G3Q-I ^MP!_.L)_A3XF3[L=J_\
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M?44LG.CQ6TMS@[1<R,JC\@<_3CZUSOPV\0ZAXG\,S:AJKH\WVMT4(@554*I
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M"TX?ZRYN6^A4?TK>_M.T_P">W_CI_P */[3M/^>W_CI_PH R4\%:.GWDF?\
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M\]O_ !T_X4 6J*J_VG:?\]O_ !T_X4?VG:?\]O\ QT_X4 6J*J_VG:?\]O\
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M]O\ QT_X4?VG:?\ /;_QT_X4 6J*J_VG:?\ /;_QT_X4?VG:?\]O_'3_ (4
M6J*J_P!IVG_/;_QT_P"%']IVG_/;_P =/^% %JBJO]IVG_/;_P =/^%']IVG
M_/;_ ,=/^% %JBJO]IVG_/;_ ,=/^%']IVG_ #V_\=/^% %JBJO]IVG_ #V_
M\=/^%']IVG_/;_QT_P"% %JBJO\ :=I_SV_\=/\ A1_:=I_SV_\ '3_A0!:H
MJK_:=I_SV_\ '3_A1_:=I_SV_P#'3_A0!:HJK_:=I_SV_P#'3_A1_:=I_P ]
MO_'3_A0!:HJK_:=I_P ]O_'3_A1_:=I_SV_\=/\ A0!:HJK_ &G:?\]O_'3_
M (4?VG:?\]O_ !T_X4 6J*J_VG:?\]O_ !T_X4?VG:?\]O\ QT_X4 6J*J_V
MG:?\]O\ QT_X4?VG:?\ /;_QT_X4 6J*J_VG:?\ /;_QT_X4?VG:?\]O_'3_
M (4 6J*J_P!IVG_/;_QT_P"%']IVG_/;_P =/^% %JBJO]IVG_/;_P =/^%'
M]IVG_/;_ ,=/^% %JBJO]IVG_/;_ ,=/^%']IVG_ #V_\=/^% %JBJO]IVG_
M #V_\=/^%']IVG_/;_QT_P"% %JBJO\ :=I_SV_\=/\ A1_:=I_SV_\ '3_A
M0!:HJK_:=I_SV_\ '3_A1_:=I_SV_P#'3_A0!:HJK_:=I_SV_P#'3_A1_:=I
M_P ]O_'3_A0!:HJK_:=I_P ]O_'3_A1_:=I_SV_\=/\ A0!:HJK_ &G:?\]O
M_'3_ (4?VG:?\]O_ !T_X4 6J*J_VG:?\]O_ !T_X4?VG:?\]O\ QT_X4 6J
M*J_VG:?\]O\ QT_X4?VG:?\ /;_QT_X4 6J*J_VG:?\ /;_QT_X4?VG:?\]O
M_'3_ (4 6J*J_P!IVG_/;_QT_P"%']IVG_/;_P =/^% %JBJO]IVG_/;_P =
M/^%']IVG_/;_ ,=/^% %JBJO]IVG_/;_ ,=/^%']IVG_ #V_\=/^% %JBJO]
MIVG_ #V_\=/^%']IVG_/;_QT_P"% %JBJO\ :=I_SV_\=/\ A1_:=I_SV_\
M'3_A0!:HJK_:=I_SV_\ '3_A1_:=I_SV_P#'3_A0!:J-X(I/]9$C_P"\H-0_
MVG:?\]O_ !T_X4?VG:?\]O\ QT_X4 -?2--D_P!9I]J_^] I_I5=_#.A2??T
M73V]S:I_A5K^T[3_ )[?^.G_  H_M.T_Y[?^.G_"K4Y+9D\J?0S7\%^&Y/O:
M+9C_ '8@/Y57?X?>%I/O:1$/]UW'\C6U_:=I_P ]O_'3_A1_:=I_SV_\=/\
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M>N64'D95<5WE[I]GJ4 @U&T@NX0VX1SQ!USZX(Z\U7L_#^C:=<"XT_2+&UF
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M&!Z444 &!Z48'I110 8'I1@>E%% !@>E&!Z444 &!Z48'I110 8'I1@>E%%
M!@>E&!Z444 &!Z48'I110 8'I1@>E%% !@>E&!Z444 &!Z48'I110 8'I1@>
ME%% !@>E&!Z444 &!Z48'I110 8'I1@>E%% !@>E&!Z444 &!Z48'I110 8'
MI1@>E%% !@>E&!Z444 &!Z48'I110 8'I1@>E%% !@>E&!Z444 &!Z48'I11
M0 8'I1@>E%% !@>E&!Z444 &!Z48'I110 8'I1@>E%% !@>E&!Z444 &!Z48
M'I110 8'I1@>E%% !@>E&!Z444 &!Z48'I110 8'I1@>E%% !@>E&!Z444 &
M!Z48'I110 8'I1@>E%% !@>E&!Z444 &!Z48'I110 8'I1@>E%% !@>E&!Z4
M44 &!Z48'I110 8'I1@>E%% !@>E&!Z444 &!Z48'I110 4444 %%%% !111
M0 4444 %%%% !1110 4444 5-,_Y!L7X_P S5NJFF?\ (-B_'^9JW0 54M_^
M0E>?\ _E5NJEO_R$KS_@'\J +=%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %3
M3/\ D&Q?C_,U;JIIG_(-B_'^9JW0 54M_P#D)7G_  #^56ZJ6_\ R$KS_@'\
MJ +=%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MOX?S% $WVNW_ .>\7_?8H^UV_P#SWB_[[%'V2W_YX1?]\"C[);_\\(O^^!0
M?:[?_GO%_P!]BC[7;_\ />+_ +[%'V2W_P">$7_? H^R6_\ SPB_[X% !]KM
M_P#GO%_WV*/M=O\ \]XO^^Q1]DM_^>$7_? H^R6__/"+_O@4 'VNW_Y[Q?\
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M //>+_OL4?:[?_GO%_WV*/LEO_SPB_[X%'V2W_YX1?\ ? H /M=O_P ]XO\
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M 'P* #[7;_\ />+_ +[%'VNW_P">\7_?8H^R6_\ SPB_[X%'V2W_ .>$7_?
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M //>+_OL4?9+?_GA%_WP*/LEO_SPB_[X% !]KM_^>\7_ 'V*/M=O_P ]XO\
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M+_O@4 'VNW_Y[Q?]]BC[7;_\]XO^^Q1]DM_^>$7_ 'P*/LEO_P \(O\ O@4
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M //>+_OL4?:[?_GO%_WV*/LEO_SPB_[X%'V2W_YX1?\ ? H /M=O_P ]XO\
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M %%%% !1110 4444 5-,_P"0;%^/\S5NJFF?\@V+\?YFK= !52W_ .0E>?\
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M9/#GBK34T_5 "T9B)V28&<#)/;)!!(.*[>.*.'=Y4:IN8LVU<9)ZD^]<+<6
MUWXT07<"[H-$M L\G8RMN*H".X#Y_"@#:UKQ-+!X@M/#^BQ13ZG<J9':8GR[
M>,?Q,!R3Z#CZTR#Q'=V'BJ+0?$(M_,NXS)9W=NA1)<=4*LQ*M^)SD5S'@Z1K
MWXS^*+F8[GA1H5SSA0ZK_)12_&&5K27PW>PDK-;WA9&!Z?=/]!0!U'B'7]5@
MOETOPOIBZA?[!),\K[8;=3G;N.1DG!P,YXS6#IGC[6K'Q5!H7C;2X+*6[(6W
MN+8G8Q)P.I.03QUX/45WZQ1I(\B1JKR$%V"X+8&!D]^*X7QC8#Q%X_\ #>F0
M+O-@S7MVW:./*X!(Z%BF* .C\4^);?PQI(N98S//,XBMK=3AI9#T'L/4UF:G
MXAUKPQ;6NH>(H[*6PED6.Y^R1NKVI;H<EB'7/!.%^E<_X[D:Y^+'A*RD.88W
M68*>F[S/3_@ KIOB1&LGPZUA7&0(0WXAU(_44 =,CK(BO&P96&593D$>M+7-
M?#NYDNOA[H\DI+,(-F2>RL5'Z 5TM !1110 4444 %%%% !1110!QGC3QIJ/
MAFXLXK;2-T=U.(1=3R+MSGG"J<].YQ]*[.O.?B__ ,>>@_\ 827^5>C4 <->
M>)O%^I/+/X0T.UET^-BL=Q>R8-SC^)%W+A?0GK5SP/XW_P"$J2ZM;VT-CJED
M<3P'..N,C/(Y&"#TXKJXHDAB2*%%CC10J(@P% Z #L*X/P-I_P!L\9^(_$T0
MQ:74QM[5L<2A2-[CVRHP?K0!U7B74Y-(\.W=W;C-R$\NW7^]*Q"H/?YB*S=2
MU/7X5ATS0+6#4-1AA4W=W='9"C8]%QECUP,8&/6GZQ_Q,O&&CZ8.8K0-J,X_
MW?DB'_?3$_\  :V=2U"/3+"2[EBN)E3JEM"TKGZ*HS0!R7A;QKJEYXGN/#GB
MC3HK/4HT,D;6^?+D4?4GMR#GUZ5V%Y/-;VK26UK)=R#[L4;*I)^K$ "O.?!W
MB#2?$OQ*O]1N5DM=2\K[/9VLR8(C7ECG^_UR.PSUYKTV@#D_ _BZ[\5MJAO+
M*.S^QSB)8E8LPZYW'H3D=@*ZLD*I+$  9)/:O.OA1_Q^>*/^PD?YM74>,KB6
M/PX]G:MMN=2D2QA([&0X)_!=Q_"@"E:>)KF#PH^M744EY)?73_V=:1* [HS$
M1(,#NJ[B3G@GTQ6#JGC/QQX<1-0UWP]8_P!F;P)/L\A9XP?5MQ'XXQFO0H+*
MWM[:V@CB79:J%AR,[,+M&/0X)'T)K ^(EPD7@6_A*F26[46T$2C+22.<* /7
MO^% &@WB734\*_\ "0M,18>0)MV/FP?X<?WL\8]:Q1X@\2-X:_X2,6=D+3R_
MM T\JYG,'7=YF<;MO.W;^-<A\0K.7PW\)-$T1F^?SE$Q!X)"LS#W&X_I7J\=
ME&FEK8MS$(1">,97;B@"@OB73Y/"HU^%GDLVB\Q JY=CG 0#^]N^7'K7(ZGX
MK\?Z=:/JLGAJR33D&]X3*7F1/4D-Z=?EX[U!\%9?M7@^[M;A%DC@O=R!AG'"
ML./9AD>]=UXBOH--\-:A=W9 BCMWSGOD8 _$D#\: &>&O$%KXGT&#4[(,J29
M#1MUC8=5/^>F*P?&GC34?#-Q9Q6VD;H[J<0BZGD7;G/.%4YZ=SCZ5/\ #70I
M_#_@BV@O%*7$[-<2(>J%L8!]\ 9]\UB_%_\ X\]!_P"PDO\ *@#T:BBB@ HH
MHH **** "BBB@ HHHH KWUQ/;6K26EG)>2_PQ(ZKGZEB !_G%<YX$\6W7BVV
MU&>[M([3[-<^2D2L6(&,_,>YSZ 5U=><_"#_ (\]>_["3?RH ZOQ)KMSI206
MVDV#:CJ=V2(+<,%4 8W.S=E&1^) KD;GQ]XG\,:E;+XUT6UBL+AMHN+(D[/K
MECDCKCC/:O1O*C\X3>6OFA=H?;\V,YQGTKB?BC;MJ^DZ=H-J-][J%XOEJ!G:
MJ@EW/L ?UH [A65T#HP96&00<@BN>&N3+K.LSNSMINFI';K#'&&,UP?F8 ]<
M_,B@=,FM6>:#0]!>60XM[&W)))_A1?\ ZU4?"-E+9^&;9KH?Z7=;KNY/?S)#
MO(/TSC\* .6UOQ;XXT&W_M6^T#3QI88>9%'*SS1*3QN8''MD BNZTO48=6TF
MUU"USY-S$LJ;AR 1G!]ZX+XF>+[6"Q?09;6^BCNG6.>\:V(1$R"Q3=C>>.W'
MO7;Z"=//A^Q_L5U>P$"K R]U Q^?K[YH YSQ=XTU'P]J>G6D&D?NKVY6$74\
MH*GY@#A%.>AX)(^E=G7G/Q7_ ./SPO\ ]A(?S6O1J ,75;^Z'B+2=,L)/+,S
M/<73!0V(4&,<]-SLHSUZUCZGXC\3WM]<0^#M&M[BWM7,4EW>R;4D<'#*@# G
M!XSG&<U?\/\ _$R\1ZUK!Y19186Q]$B^^1[&1F_[YKH(HHX(Q'#&L: DA47
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M+'(S@'D8]*]$K@?'>GCQ%XN\.:- "SP2M>7+#_EE""!DGMD@@>]=]0 4444
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MWMW<Q65G-=7#;8H(VD<^B@9/Z"N83Q!J=AX2T^>XM9-1UK4<M!:(%3[V6 )
MP%12 2?ZU:\8_P"F6MCHB<MJMTL4@ Y$*_/(?^^5Q_P*M\PQF1)#&F]%*HVT
M94'&0#V!P/R% 'G%_P".O%_A>X@N/%NA6@TV9]AELF)9#[G<1GV(&<=:[+6_
M$VGZ)X:;6YY/,MBBM$$ZS%A\H'U_ES6+\4/]*\(C2+>/S;W4[B*"V0==P<,3
M] %.3VS7,_$NU^PVG@O00^Z!95B;T;RQ&@./HQH ZF]U_P 1:/H<>NZK:V36
M8VO<V<"/YT$;$#.\MAR,C(VCOS6SJ'B&VL_#Z:K;*]ZLZI]EBAY:=G^ZH^N?
MP&?2E\4QK-X0UB.095K&;(_X :YKX2R?;/A[9BX59#:SR+$6 )7D\CT/S$?2
M@"CJGC'QWH$(U+6/#EB-,##S%AE+21@^K!B!]=N*[6SU^QO?#<>N0NWV1X?-
MZ?,/5<=VSQCUJCX\NXK3P/J@E7>UQ UM%&!DO)(-J@#N<G/X5+X,T:3P_P"#
MM.TV?'G0Q$R '.&9BS#\"Q% '-:UXI\<Z59OJQT"P33(_G>%I&:=$]6(.![X
M!Q78Z%K$.OZ%::I:JR17*;@K=5.<$?@0:Y'XE>,8M*TBZTC[)>;[M/(DN?LY
M\I$<?,0QP';:3P#UZD8KI?")TO\ X1/3UT&7S;%(@L;]R1][(['.<CUH V:*
M** "BBB@"IIG_(-B_'^9JW533/\ D&Q?C_,U;H *J6__ "$KS_@'\JMU4M_^
M0E>?\ _E0!;HHHH **** "O/=+./C]K.>^EKC_R#7H#H)(V1MP# @[6*G\".
M1]:YZ/P#X>BU(ZA';7*WI.3<C4+CS#]6WY- &]<W,%G:R7-W*D,,2[GD<X"C
MU)KD[/4+#Q#J<.KZG?6L5E;,6T^TDF4,6Z><X)X;^Z.P.>IXZ#6M!T[Q%9"T
MUB!I[<.'\L2N@)'KM(S^-8/_  JKP9_T!O\ R:F_^+H T-8\3VD7AW4KK2;F
M.[FM\0IY3;E,SX"+GH3EAD#I6AH^GQ:'H%K8AQLM80KR$]2!\S$GU.3^-5[/
MPKHNGZ=;V-G9"*VMK@7,48D<XE'1B2<GZ'(Z>@K5DC26)HY5#HZE64C((/44
M 06M]8ZG:F6RNK>[@.07AD61?<9'%<3\.=,BM]?\3W^F\:5<702UV#Y'V[BQ
M7V!; (X_*MB#X<>%+>5I(=)"E_O+Y\I5OJN[!'MBNDAABMX4AMXTBB085$4*
MJCT '2@#F/B;_P DWU?_ *YI_P"C%K1\),!X'T1B0 -.@R<]/W:U)K7AO3/$
M48BUB*:>(?\ +(7,L:'G.2JL 3[D4NG^&],TO3)M/LHIDM)D*-$UU*X"D$$+
MN8[>I^[B@"CX.!O+.\UR0'?JURTR9ZB%?DB'_?*[O^!59\0^(H-$BBB5HGO[
MD[+:"20*"?[S'L@ZD_@.:U;:WBM+6*VMD$<,*".-!_"H& /RK U;P#X;US47
MOM5T]KFYD #.US*.!T  ; 'L* &Z5<:+H%E<75[K5G-=W#>=>733*#(W8 9X
M4#A5'\ZYS68/[(^,6B:\P(L=3B^S-(5QMD*D*#GIG*=??TK<A^%_@^">.:+1
MP'C8,I-S*1D'(X+8-='J&G6FJV3VFHVZ7$#_ 'D<<?7V/O0!Q/Q:$FHZ3IF@
MV0WWNHWJA$']U0<D^P)'ZUW-G;)96,%K%]R"-8UX[ 8'\JI:?X=TO3+HW-K;
ML;@IY?G33/-(%_NAG)('L.*O7-NEU;O!*9%1Q@F*5HV'T92"/P- '!?#T_\
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MVDMH?A73M-DQYEO JR8Z;SRWZDUK444 %%%% !1110 4444 %%%% 'G/Q?\
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M3;"&RL8A%;P($C0$G:![GD_4UCZIX'\.ZSJAU'4=.$EX<9F2:2-C@8&=K#L
M* .>\3:7!J'Q6\.R::!]NM]TU\R#[D2XV%_KR!]:] JEIFCZ?HT+1:9:1VZN
M<N5&6<^K,>2?J:GO+2*^M'MIS*(Y  WE2M$W7/#*01^!]J //_A1_P ?GBC_
M +"1_FU='/\ \37Q_;Q#F'1K<S/QQYTN54?@@8_\"%2:3X)T'0[PW6DVLUM*
M3EBMY,0_^\I?#?B#6M;:?;6EQ=3V\>V6[D$DSEBQ=@H4=3P  !@<4 .OKZUT
MVREN[^=(+>)=SR.< #_/:N8TZ[L-7U./7-8O;6(1 C3[-YE!@4_\M'&?]8P[
M?PCCKFMK7/#FE^)+>.#6K=KB*)MRH)G09]3M(S^-8G_"JO!G_0&_\FIO_BZ
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** *FF?\@V+\?YFK=5-,_Y!L7X_S-6Z "JEO_R$KS_@'\JMU4M_^0E>
M?\ _E0!;HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH J:9_P @V+\?YFK=5-,_
MY!L7X_S-6Z "JEO_ ,A*\_X!_*K=5+?_ )"5Y_P#^5 %NBBB@ HHHH ****
M"BBB@ HHHH **Q]8\6Z'H-PL&JWZ02LNX($9VQZD*#C\:SO^%E>$O^@M_P"2
MTO\ \36T:%62O&+:]"'4@G9M'4T5RW_"RO"7_06_\EI?_B:/^%E>$O\ H+?^
M2TO_ ,33^KUOY']S%[6G_,OO.IHKEO\ A97A+_H+?^2TO_Q-'_"RO"7_ $%O
M_):7_P")H^KUOY']S#VM/^9?>=317+?\+*\)?]!;_P EI?\ XFC_ (65X2_Z
M"W_DM+_\31]7K?R/[F'M:?\ ,OO.IK'UWQ'%H5Q96[6%]?3WK.(HK.-7;Y0"
M2<L,#FC1_%NAZ]<-!I5^D\JKN*%&1L>H# 9_"M"2RBDU*"^;/FP121)Z8<H3
M^/R#]:RE&4':2LRU)25T8K^+)XHVDD\,:VB*"S,R0  #N3YM-\*>-['Q@UQ_
M9EE?11VX&^6X1%0D_P (PQR>_P#D5S7Q)UZ[U*^@\%>'OWEY>D"Z9?X$Z[2>
MW')]OK78Z'H]AX0\,I:0D)!:QF2:8CECC+.?R_+ J1FQ2,2JDA2Q R%'4_G7
M&KXYO[GPW-XAT[01/I4>]@SWFR9T0D,X381@8/5L\5MV?B.#4/#,&MV-K=7,
M4Z;EAA0&3J01@D#@@CK0 OAK6+S7-+>ZU#2+C295F:,07!.Y@,8;D#@Y].U:
MLKF.)W6-I&520B8RQ]!D@9^I%87@[Q2GB_1I-1BM6M46=H51GW$X .>@QUZ5
MOT <:WQ)M%\0?V&="UG^TLX^SB*(GIG.?,QC'.<XKK;:5Y[=));>2W=ADQ2E
M2R^QVDC\B:\YP/\ AH?I_P N.?\ R'7I= !163XE\16?A;0Y-2O]S(I")&@^
M:1ST4?Y[5C:KXUOO#ILIO$.AK;65W((O.@N_-:)CR R[%[ G@GH: )M8\;+I
M/B?3=&;2[EFOYQ$EP[!(\9 )7J6QD<<5U-><?$NYCL_&'@NXG)$<5W*[$ DX
M#1= .2?:K5]\3)]'OX1KOAF^T_3IGVI=R."?Q0#CUQG/M0!WM9NN:P=#L'O&
MT^\O(8U9Y3:A"8U'<AF4G\,]*T(Y$EB62)@Z.H96!R"#T-4];_Y%_4/^O63_
M - - &-X;\<V_BKY]*T?5#;A]CW,J1+&A_[^9/4= :Z>N"^#0 \ +@=;J3/O
MTKO: ,>?6KV+Q;;:2FC7,EI-"9'U$']W&PS\IX]@.H//3O6Q7+KXU5_'%OX;
M.EW4+S1M)Y\Y" J Q!51G(.TCG%0ZAX_@T[Q=;Z'<Z9=Q^<KMY[@?, K$;%&
M2^2NT=.M '745Q$_Q%FTO7+6S\1:!<:5:7AQ!=RSJ^>GWE7A>HR,DC--U;XB
MW.CM%=WGAJ]CT>60(M\\BJV/7RL9'J,D9H ZC7]3N=(T6>]L=-FU.>/&VU@/
MS/D@>A/&<\ U:LIWNK"WN)H'MY)8E=X7^]&2,E3[CI6-XH\6Q>&M%.I?8+F^
MAVJP>$ (H8@#<QZ9R.@/44FKZUJ?_"#_ -K:-:PFXDM!<8FE^6$%-Q/3YB/3
MC- &_'*DJEHG5U#%25.1D'!'U!!'X4ZN#^&&H:K-X0L3=V<1LV\^1KYKO+LQ
ME<DE-O'.>=WO6G)XKU*ZL9=0T#0&U&P3=LF>Z$33@=6C7:21P<9QGM0!U-07
MMT;.T>=;>>Y*](H%#.WT!('ZUD^'O%VF>(_#[ZO;.8880WVA9< PE1DY]L<Y
M]*J6_BK4M1TY]4TC03<Z<,F-Y+D1S3J,Y9(]IXXXRP)XH L>#O%:>+]+N+Z*
MT>T2&Y:W"2/N9L*K9/''WL8YZ5T%>=_!9Q)X0OW7HVIR$9_ZYQUZ)0 44$A5
M)8X Y)/:L-_&>@1N5;4 2#@[8G(_,#%9SJTZ?QR2]6:0I5*GP1;]%<W**P?^
M$V\/_P#00_\ (,G_ ,31_P )MX?_ .@A_P"09/\ XFL_K5#^=?>C7ZIB/^?;
M^YF]16#_ ,)MX?\ ^@A_Y!D_^)H_X3;P_P#]!#_R#)_\31]:H?SK[T'U3$?\
M^W]S-ZBL'_A-O#__ $$/_(,G_P 31_PFWA__ *"'_D&3_P")H^M4/YU]Z#ZI
MB/\ GV_N9O56O[J2RM&FBLKB]9?^65OLWD>OS,H/YYK*_P"$V\/_ /00_P#(
M,G_Q-;%I>6]_:K<6<JRQ/T9:N%:E4=H23]&9SHU::O.+7JCG?#WQ TGQ%K$V
MEPPW=G>P@DPWD:HS8Z@88\CN*Z.ZF>WMGEBMI;IUZ0Q%0S?3<0/S(KR;Q3X7
MO=4\6>(M:T&1X]4TJXMY(U0\R+Y"$@?[0QGWY'I7<>!_&$'B[11*=L=]!A+J
M#IM;^\!Z'_$=JU,B70O%R>(+R>"UT;5(%MI6AGFN$C5(G R5.'))Z= >H[<U
MT-<SX094G\3,Y"JNM2DDG  \J*JMOXWO-4TB\U?0]%6[TZU9QOEN_*DE"C+%
M4V'MZD&@#L**P]+\6Z=J?A$^(5+PVB1N\JN/F3;G</<\<>O%9>H>,M5T_P -
MC7G\.K)8-&)5"7H,JHP&TNNS '(Z%L4 =A7.^+_%R^$M--W)IUS=KP-T>%12
M3@!F/3\ :O:]K]KH%FDMRKRS3R"&WMHAF2>0]%4?UK@_BGJ>K'P2\&IZ,EM%
M/+'MFAN_.V,#G:XVKC@'D9% 'I-E<_;-/M[G;L\Z)9-N<[<C.,_C4]<Q>^)K
M7POX-TRZND>:2:*&&"!" TCE!@9/0>]0WWC.[T/5=.M?$6D):P:@_EQ7%O=^
M<$?CA@47'4=,_C0!UM%9FNZ_::!:1RW0DEEFD$5O;0KNDG<]%45S^M^-]5\-
MV/VW6O#31VK?*KP7JR%7/0,-HQGU!- '9T5!97/VS3[>YV[/.B63;G.W(SC/
MXUQ'Q>\03Z-X32ULW,<VH2&(NIP1&!EL?7('T)H VW\;Z=)>RVFDV][K$L)Q
M*=/A#I&?0N2%S^-.G\:Z;96K2:K#=Z=(,;8+N((TF2!A#G:QYZ!N.O2K7A71
M8?#_ (9LM/@C"%(@93C!:0C+$^^?Z"IM>T:WU_19]/N@ )%^1RN3&XY5A[@_
MX4 :-%8^L^(HM*O+33X('O-2O"?(M8R%R!U9F/"J/7]*S;OQG+HFLVUCXGTU
M;"*[.V"\@N/.A+>C$JI7KZ?IS0!U5%<MXM\<1^%);:.;3;B<7$HC68L$B&>O
MS<G('MVZU2UWXA7.A[+N3PW>/H[2!/MS2*A/N(R,X/;=MS0!VU%<;JWCVXM;
M)]0T;P_<ZIID2!Y;T2B)-O<H""7 [D#'O5N[\<VL'@V'Q';V-W=VTL>_;$!^
M[P<$,2>.>.,]* .GHK@Y?B1>2:)#J>E^&+N^@\D27,B2[4AXR0&VY? ZD# _
M.NC\.^*=/\2Z"-5LW\N)<B99.#"P&2#^'.?2@#9HKF;?Q1J.JZ?+J/A_1!>6
M*DB)YKKR7N #@F-=AXR#C<5S5OPUXKT_Q/IDEW:%H6@;9<0385X6]_;KS[4
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MO6Q;>'KF2>*;7]6DU1H6#Q1")8858=&V#)8@],D@>F: .06ZV_M!#[46"S6
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MZI_SWM/^^V_^)KT"B@#S_P#X0/5/^>]I_P!]M_\ $T?\('JG_/>T_P"^V_\
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M\IP.#S[@TV3P3K#^,U\2C7[47:1^4L7]FGR]F",$>;GOUS0!G>$_^2R>*_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 5-,_P"0;%^/\S5NJFF?\@V+\?YFK= !5>6QMIY"\L>YCU.XBK%%
M %3^S+/_ )X_^/'_ !H_LRS_ .>/_CQ_QJW10!4_LRS_ .>/_CQ_QH_LRS_Y
MX_\ CQ_QJW10!4_LRS_YX_\ CQ_QH_LRS_YX_P#CQ_QJW10!4_LRS_YX_P#C
MQ_QH_LRS_P">/_CQ_P :MT4 5/[,L_\ GC_X\?\ &C^S+/\ YX_^/'_&K=%
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M^>/_ (\?\:MT4 5/[,L_^>/_ (\?\:/[,L_^>/\ X\?\:MT4 5/[,L_^>/\
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IS+/_ )X_^/'_ !H_LRS_ .>/_CQ_QJW10 V.-(8PD8VJ.@IU%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>45
<FILENAME>zlab-20231231_g2.jpg
<TEXT>
begin 644 zlab-20231231_g2.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X0+H17AI9@  34T *@    @ ! $[  (
M   *   !2H=I  0    !   !5)R=  $    4   "S.H<  <   $,    /@
M   <Z@    $
M
M
M
M
M
M2FEN9R!986YG   %D ,  @   !0   *BD 0  @   !0   *VDI$  @    ,U
M,P  DI(  @    ,U,P  ZAP !P   0P   &6     !SJ     0
M
M
M
M
M
M                                       R,#(T.C Q.C(Y(#$T.C Y
M.C Y #(P,C0Z,#$Z,CD@,30Z,#DZ,#D   !* &D ;@!G "  60!A &X 9P
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M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BK_P  1" &: B0# 2(  A$! Q$!_\0
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M WXR[#N:I>%_#L6B68=ANN9!EG(Y'M6]7S^,Q7M9<L=D?<Y5EWU:'M*GQ/\
M 1G$<;2-]V-2S?05\L>/]:?7?'%_-NW6\4FV#GM7T%\0M?7PWX+N[QF(,H,
MQURPQ7RPF=N7.6)))/>IPL=Y'J59=#OO@I_R6#1/^V__ *3R5]95\F_!3_DL
M&B?]M_\ TGDKZRK#&?Q%Z'5A?@?J%%%%<9UA1110 4444 %%%% !1110 45S
M7BCQK9>'!Y1_?76,B(&N5'Q;N P,FC%4_O;C753PE:I'FBM#SJV9X2A/DG+7
M[ST^BLK0/$5EXAL1/929(X=#U4UJUSRBXOEEN=U.I&I%3@[IA1114EA1110
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MW>1WGP4_Y+!HG_;?_P!)Y*^LJ^3?@I_R6#1/^V__ *3R5]95YV,_B+T._"_
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M?\E@T3_MO_Z3R5]95Y>,_B+T/2POP/U"BBBN,ZPHHHH **** "BBB@ HHHH
MSM7T*PUJ#R[Z%7/9\<K7,Q?"O18KCS?,G;G.TD8KMZ*VA7JP5HRLCDJX+#UI
M<]2";*UAIUKIEJ+>QA2&,=0HQD^M4]5\.:=K,ZRWT"R.B[02.U:M%0IR4N9/
M4WE2IRAR.*MV(;2UBLK2.V@7;'&NU1Z"LRX\+:7=:DU]-;JT[,&+8[ULT4*<
MHNZ82I4YI1DKI$<UO%<6YAGC62-A@JPR#7+77PWT.YN#*8V3G.U<8KK:*<*L
MZ?PNQ%7#T:W\2*9G:3H5AHL16QMT1B,,X'S-]35F]L+;4;<P7D*RQGLPSBK%
M%2Y2;YF]2XTX1AR):=CB9?A9HDMUYV^9><[%(Q74:7H]EH]L(;&!8QW('+?6
MKU%:3KU*BM*5S&E@\/1DY4X),****Q.H" P((R#UKDM6^'&BZK=>>0]N2<E8
M< &NMHK2G4G3=X.QA6P]*O'EJQNCGCX)T<Z3%8& >7&VX'')-:UOIMM;Z?\
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M)Y*^LJ^3?@I_R6#1/^V__I/)7UE7EXS^(O0]+"_ _4****XSK"BBB@ HHHH
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M92/QKZIKY2^!O_)45_Z]C_.OJVN7%_Q#KPW\,****XSI"BBB@ HHHH ****
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M*_M"_P#(EVO_ %W/\J^:E^X/I73A?X1S8K^(>A? W_DJ*_\ 7L?YU]6U\I?
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MZN%ARPYNYYN*E>=NP'/ 7EF.%'J>U?2/P5^&T>AZ4FO:O"#J-R-R(X_U _\
MKUX%X:?3(O$UK-KREK&([V .,L.17T$OQ^\-(H587 48 ##BC$\[7+!!A^1/
MFDSUBBO)S^T#X< R(G/_  ,4W_AH/P[_ ,^\G_?8K@]C4[';[:GW/6J*\D/[
M0GAX#_CWD/\ P,4S_AH;P_\ \^DO_?8_PH]A4[![:GW/7B 1@C(KYU^//@"#
M2)O^$JTN,102OB[11PSL>#[5U;?M#Z".EC,?^!C_  K'\2_''P[X@T&YTV?2
MI769#MW.,!L<&MJ,*M.:=C*I.E.-FSPBNX^$'B67P[X_MHO,VVEZ=L_/' XK
MA8P53#<G)I2[1O')&Q5U=2".W->E**E%Q9Y\).,DT?=RL'0,O((R*^2_C3_R
M5F\_Z]TKZ@\,WZZGX:LKE3G="H)]P*^7_C3_ ,E9O/\ KW2O.PBM4:/0Q.M,
MX27_ %;?2OJCX&_\D_3_ *Z?TKY7E_U;?2OJCX&_\D_3_KI_2NC%_P ,Y\+\
M9Z+-_J'_ -TU\7^-O^2A:W_U\5]H3?ZA_P#=-?%_C;_DH6M_]?%88/XF;XKX
M48;]!_O"OL#X6_\ ).]._P!T_P Z^/WZ#_>%?8'PM_Y)WIW^Z?YUKC/@1CA/
MB9U]%%%>8>B%%%% 'G_QL_Y)C>?]=$_K7R@GW:^K_C9_R3&\_P"NB?UKY03[
MM>K@_P"&SS<5\:.H^&?_ "5+1?\ ?;^5?8R_='TKXY^&?_)4M%_WV_E7V,OW
M1]*Y\9\:]#?"_ >3?M"_\B7:_P#7<_RKYJ7[@^E?2O[0O_(EVO\ UW/\J^:E
M^X/I73A?X1S8K^(>A? W_DJ*_P#7L?YU]6U\I? W_DJ*_P#7L?YU]6URXO\
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M*45.-F?"*MNSP5(X*L,$?44^*66WN$N+:1HIXSE)%/(KW[XI?!,ZE-+K?A%
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MJ.GW&J_VC83VFZ)=OFKC/->Z4\1;VCL*A?V:N%%%%8&P4444 %%%% !1110
M4444 %%%% !1110 4444 %?-/QE\5:WI/C>6#3KV2&/:QVAC7TM7R]\;M%U>
M\\=22V.EW5S'L;YXDR*ZL+9U-3"O?DT/4= U:^N?V?[/49YV:[:V+-)GDG)K
MRCX6>+M>U#XI:5:WE_)+!)(X="Q(/!KT_0+>>U_9SLX;N!X)DM2&CD&&7YCU
MKQ?X0?\ )7=&_P"NLG\C6].*M4^9E4;4H(^P****\X[ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
*%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>46
<FILENAME>zlab-20231231_g3.jpg
<TEXT>
begin 644 zlab-20231231_g3.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !_ 8T# 2(  A$! Q$!_\0
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M_P"AJM_^^9/_ (FC_AHSX<_]#1;_ /?$W_Q-?"SV-5GTVK_U]Q7_ #ZC^/\
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M1E[J^'YD]%(*6OT,^2/D#]IE_P#BZ!_Z\XO_ &:O*O/KTS]I[_DJ!_Z\XO\
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M] Q$VL-4:[,^S88A$JH@")BK--C^Z/I3J_L3R/YU>X44M%,04E%% !111F@
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MSEV^S_P/D?H>4\85L#"-'%1YX+K]K_@GP#17V+J'[,G@F^'[F*^L3ZP73/\
M^A[JH-^RCX1'_+]JW_?Z/_XBOAY<!YIWA_X$_P#(^RCQIE<MU+_P'_)L^2:9
MOKZY_P"&3?"7_/[JO_?V/_XW1_PR;X3_ .?W5?\ O['_ /&ZG_47-N\/O?\
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M?%/X3Z;\4-),<@%GJD"_Z-?!?F7_ &6_O)7P[XN\-ZEX-UZZT?6+;[/<V_\
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M?^&A/'__ $,=Q_WYB_\ C=>7)/4_GUC_ &MF7_/^?_@3_P R/[(P/_0/3_\
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M?(/^17A_\,2;S*^V/V:?^20:/_UTN/\ T?)7PYY]?;_[,/\ R1G1_P#?N/\
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>MZUV/X5^E4?:JC%8CXO(_%L5]6=>3PE^7^]N?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>47
<FILENAME>zlab-20231231_g4.jpg
<TEXT>
begin 644 zlab-20231231_g4.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X0+H17AI9@  34T *@    @ ! $[  (
M   *   !2H=I  0    !   !5)R=  $    4   "S.H<  <   $,    /@
M   <Z@    $
M
M
M
M
M
M2FEN9R!986YG   %D ,  @   !0   *BD 0  @   !0   *VDI$  @    ,X
M.   DI(  @    ,X.   ZAP !P   0P   &6     !SJ     0
M
M
M
M
M
M                                       R,#(T.C R.C Y(#$V.C0Y
M.C4P #(P,C0Z,#(Z,#D@,38Z-#DZ-3    !* &D ;@!G "  60!A &X 9P
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M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BK_P  1" #9 JD# 2(  A$! Q$!_\0
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4&BB@"K=7!M\%
MEW+W/I4L;I*H="&'8^E.D4.I5AD$8Q6#=&?1)?/B#26I/SH.JTTK@=!15:RO
M8+ZW66V<,I[9Z?6IP^>@.,XI,!U**2E% !1110 4444 %%%% !1110 &DSQ0
M:;_#0 A.!G'7C%59[L1R>3"=TF>@[55U;5ULMMO%^\NY>(T'\ZFTRP\A/-G^
M:>3YF/I5;$HOIG:-WWN]/I "!SUI:DH**,\TF>M !2<49H#9[4K/N/4!UI:,
MXHH$%+FD!!HHN@%HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %!HHH 0C-1L@=2'P
MP/!!%2FFT!8Y+5-*OM&E;4M!RR]9K<GAQZBM+0/$]EKL.(7\JX3B2!N&4ULD
M9X_3UKA/%W@Z:28ZSX>D-M?Q<D+_ !XK2%I:&;=COMU*#7F/AKXG S'3_$D1
MMKF([2[<;J]$M;JWO(1-;RJZ,,@J<T5*<J>^Q491D6J*9GD4ZLKEV%HI**$T
MQ"TA.**:1^=%T@0[=1NIG3DFLJ3687OQ:6)\^4?>V]$IK4-#7+=?4"LC7]<@
MT2P,TWS32#$48_B;L*36=:M?#^F-=WTP! X&>7/I7'^%(+OQAK3>(=54K:QM
MBTA/;W_E6B@[79+DD=)X;TR9MVK:F,W<_*JW_+-?2NB3GD\9['M3E4 <4M0W
M<=A:*0]*:<8^M(8XD9J.:>*",O*ZHH&22>E<UXK\9V/ABU8R.);@CY8U/(KQ
M;Q!XUU?7Y"9;@PVY/$8/:NNAA95C&551/:-3^(>@Z8Q22Z61AV2N=G^,VF(Q
M\FW=P.]>+E>=Y.3[FC@=L>P%>I'+Z,5[QRO$3Z'LD?QGL&/SVCBMC3_BGH%X
MP1YC"Q_OUX$3R,Y7ZB@@-TS]0:'@*3V!5I+<^J;+5++4(PUG<)*/535O/-?+
M6FZUJ.DW"RZ?=/&5Y.3UKUKP9\4(=3VVNL8AGR%$A_B->?B,%*F[QU.FG6B]
MSTS=2@YJ%&$B@J<@C.1W%/3ID=.U<&VYN/HI*3IW_"@!U%-)]P*:77NP_.C4
M+HDHJ+S8Q_RT3\Z/-C/21?P846EV"Z):;FDSN'!S^-(![FCU#0>#2TT4&CT
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MPUQ(/W:L/NCUKW:U:.%A8X:<749@>&_A-/>QQW.M/Y2MR(P.:[VT^&_AVV0
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MG(\R3G?0TAXX\0?]!!OUH_X3CQ#_ -!!JUA\*/$?/R1D#U/_ -:C_A5'B/\
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M]<6_E7S(W^M;_?-?3?BG_D5[[_KBW\J^9&_UI_WS7IY;\+.7$=&>I_!4YEU
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M\T?,4\B?1R*]AU+X-64LC2:=<& GHM<]/\&]71SY-TKCU->C]<HRW.;V-1'
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M +13<TAD ZD#ZFF _-)CBF[T/\2_G2[T_O+^=)V'9ABE Q2>8G]]?SHWJ>C
M_C25EN*UAU-ZTN>*8'4M@,,_6F"'D4<T9I"V.I _&BX+R%YHIOF+_?7\Z#(G
M]]?SHN/4=BC%,\U/[Z_G1YBGHR_G1H'O#L<BG8J/-.WC^\/SIZ"U'8HQ3=XS
MU%.!!'!S0 N:,TE% "T444 1O&KG)[4HXI^** "BBB@ HHHH **** "BBB@
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M+D=:]+4Y-:85-0LS',6GB),<:!2T5TGG6"BBB@8M%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1BBB@ HHHH
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MK%,'S8)'.:?6R5E8YK\WO7W%ZT8H%%, Q1BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ I#2TAH **** #GM1S2BB@!***
=* "BBB@ HHHH **** "EI*6@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>48
<FILENAME>zlab-20231231_g5.jpg
<TEXT>
begin 644 zlab-20231231_g5.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" != -X# 2(  A$! Q$!_\0
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M;7Q)HMMJEF9!9W"ET:9"C%02,X/8X_(YKXZN&NOB7\0',6[S]7OB$.,^6I.
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M[?)'S^81D\WH-*]DO3=GO?Q,Q_PKOQ/D?\PRY_\ 135\P_ O_DK/A[_?G_\
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M"5Z]#V'2O2PV!6&QKKSJ*SO9>I\WBLQEBL!'#0INZM=^G^9]&?L[?\DML_\
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M3EC5>@ IU%.[)44G=(3'M1M%+12*"BBB@ HHHH **** "BBB@ HHHH ****
C"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>49
<FILENAME>zlab-20231231_g6.jpg
<TEXT>
begin 644 zlab-20231231_g6.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" "- 68# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z:[K&C.
M[!449+,< #UI2P4$DX ZFORX_;:_;0N?BMJ5[X%\$WTEOX(MG,5[?P,5;5Y%
M)#*"/^7<'H/^6F,G*XSK3INH[(ZL/AYXF?+';JSZ ^/O_!2'PK\/[RXT7P%9
MQ^-M9B+1RZ@92FFP,.P<<SD'LF%_V\C%?$_Q"_;)^,7Q(FE-[XVO]'M'X%CX
M?8Z?&@] T9$A'^\[5XM77_#GX1^,_B[J+V7@[PW?:_-&=LLEN@$,)X.))6(1
M#@@X9@3VKU(TH4U<^HIX6AAU>WS?]:&!JGB#5M<D,FIZK?:E(>KWMU),Q^I8
MDU<T7QWXG\-LK:/XFUO1V4@@Z=J4]N>.GW'%?2.D_P#!,_XSZG;++-)X5TEF
M&3!?ZI*9%]CY4$B_DQK,\4?\$Y_C7X;M7F@TS1O$07DIHVI@OC'83I%GZ#FJ
M]I3[HOZQAWIS(B^&/_!0;XN_#^XB34]4A\;:6K?/::U&!+M]$N$ <'W</]*^
M^OV=_P!LKP-^T(J:?:R/X>\5A-TFA:BZ[WQU:"0<3*.O&& Y*K7Y!>(O#FK>
M$=9GTC7-,O-&U2W_ -;97T#0RH#G!*L <'!P>A[51@GEM;B&XMYI+>XA=98I
MH7*21NIRK*P(*L" 00<@BLYT(36FAC6P-&LKQ5GW1_0+17QY^PW^V5+\885\
M"^-)U_X32TA+V=^0%&JPH/F) X$RCE@.&7Y@.& ^PZ\N<'3?*SY:M1G0FX3W
M"BBBH,0HHHH **** "BBB@ HHHH **** "BBB@ JKJ6I6^CZ?<7UW((;:W0R
M2.W90,U:KR_]H:_EM? \$$;;5NKV..3W4*SX_P"^E7\J\G-L=_9N K8M*[@F
MTO/I^)Z&7X7Z[BJ>';LI.WRZGEWC3XR:[XFO)1:7<VDZ:"1'#;OL<KZNXY)]
M@<?7K7&_VQ?*PG^W7(8GB7SFSG_>S7?? GPK9^(O%-S/?1+<0V$(D6&095I&
M.%)'<  \>N/2OI)H8Y(C$R*T9&TH1D$>F*_$\KX=S'BF@\RQ6+<>9NVCEL_\
M245>Z21^FX[.,'D558*AAT[)7UMO\G=VZL^</ /QLU30+R*VUFYDU+2F(5Y)
MCNEA']X-U8#N#GV]_H^*5)HTDC8/&X#*RG((/0BOEKXP>&;7PKXVGM[*,0VL
M\27*0J,+'N)!4>V5)]LX[5[A\%]1DU+X<Z493N:'?;@_[*.0OY+@?A7TW!^8
MXVECJ^28Z?.Z=VG>_P +2:OO9W35]CQ.(\'AJF%I9GA8\JG:ZVW5UIWTL^YW
M%%%%?KA^>A1110 4444 %%%% !1110 4444 %%%% !1110!\B_\ !1CX]3?#
M7X8VW@W1KAX->\5B2*6:)BK6]BN!,P(Z,Y98QTX,A!RM?EATX%>[?MO?$&3X
MA_M,>+Y?-66ST>8:):A3D(MOE9!]?.,U>0>$?"]]XX\6:+X<TP ZAJ][#8P$
MKD*\CA Q']T9R?8&O9HQ4((^RP=)4*"OUU9]"?L:_L?W'[0NJRZ_X@::P\!Z
M?-Y<K1$I+J,PY,,3?PHO&]QR,A5YR4_5CPMX3T;P1H-IHOA_2[71])M5V0V=
MG$(XT'?@=R>2>I))/-4_AWX$TKX8^!]$\*:)%Y.EZ3:I:P@_>; Y=CW9FRS'
MN6)KHJ\VK5=1^1\UBL3+$3OTZ(****P.(\Y^-WP#\'_'[PN^C^*=.625%;['
MJ< "W=DY_BBDQQSC*G*MC# U^/\ \=O@AK_P ^(-WX7UT"< >=8ZC$A6*]MR
M2%D4=CP0RYRK C)&"?W&KYG_ ."@'P<M_B=\!=2UB&WWZ[X35]6LY57+>2H'
MVF/Z-&I;']Z-/2NNA5<9<KV9ZN!Q4J4U3D_=?X'Y.Z%KNH^%]<T_6='O)-/U
M;3YTNK2ZB.&BE0Y5O?GJ#P1D'@FOVZ^ OQ:L_CA\)_#_ (PM%2&2^@VW=LC9
M%O<H=LT?K@.#@GJI4]Z_#>OO[_@E7\0I!=>.? L\@,6V+6[.,DY!XAN#CT_X
M]NG<GUKJQ,.:'-V/5S*BITN?K$_0JBO-/VC_ (L7?P/^#/B'QM8Z=#JUUIAM
M@EG<2F-)/-N8H3E@"1@2$].U?$O_  ]8\5_]$]T;_P &4O\ \;K@A1G45XH\
M&CA*U>/-36GJ?I+17EO[,OQBN_CU\&=%\;7VFPZ1<W\MU&UG;RF1$\FXDA!#
M$ G(CST[UX3^U-^W9KO[/OQ8D\(:=X2T_6;=;""\^U75Y)$^9"X*[54C V=<
M]Z2IRE)P6Y$</4G4=**U1]D45\C?LM_M]6'QQ\82>%/$^DVOA76[D;M+,-RT
ML-X0"6BRRC;)@;@/X@&[C!^N:F4)0=I$5:,Z,N6HK,***^;OVQOVJM5_9CC\
M)/IGA^SU[^VFNUD%W<O#Y7DB'&-JG.?-/Y"E&+F^5"ITY59J$-V?2-%?FK<_
M\%7O%=O;RR_\*]T8[$+8_M*7L,_\\Z_2+3KHWNGVMPRA6FB60J.@R <5<Z<J
M=N8UK8:KA[.HK7+%%?GMX\_X*;^)_"'CKQ)H,/@32;F'2M3NK!)I-0E5I%BE
M:,,0$X)"YQ[UZK^R-^VIK7[2/Q!U7P[J7A>PT.&STQK]9[6[>5F82QIM(91@
M?O"<^U4Z,XKF:T-)X*O"'M)+3U1]:4445@<(5Y%^T@W_ !3.DKZWN?\ R&_^
M->NUXU^TE=1?V3HUL)%,_P!H:0Q[AN"[",X],FOC^+Y*.1XF_9?^E(^BX>BY
M9I1MW?Y,S?V:TSJ'B!O2* ?F7_PKW>OESX7?$>W^'G]JO+8RWTEX(0@C<(%V
M;\Y)_P!X=!V-=BO[2LGF_-X>7R_:\.?_ $"OC.%^)LIRS**.&Q5;EFG*ZY9.
MUY2:V36Q])GN29ACLPJ5J%.\=+.Z7V5W9B_M%)M\<V;?WM.C_P#1DM>C? .0
M-\.X!_=N9A_X]G^M>,?$[QS;^/M7L[^"UELS%;"%XY6#<AF.01U'S>U>N?L\
MW,<G@F>!9%,L5Y(63<-P!52"1Z=?RKS^'\51Q'%M>O0E>$U*S[_"^OH=F;X>
MK1X?I4JL;2BU?\4>HT445^YGY:%%9?B;Q1H_@O0[K6=>U2TT?2K5=\]Y?3+%
M%&/=F./\:^-?BA_P5%\*:'<2VG@3PY=^*W4X_M"_<V-LWNBE6D8?[RI_6M(T
MY3^%'12P]6M_#C<^WJ*_+C4O^"HGQ5N+HM8:%X1L[?/$4UG<S-C_ 'A<+_*N
MM\%_\%5-;@N8T\7>!;&\MC]^XT.Z>&1?I%+N#?BXK9X:H=;R[$)7M^)^C5%>
M5?!']ISX?_M 6LA\*ZO_ ,3.%-]QH]^GD7D(XY*$X=1D#>A9<\9S7:?$3QC#
M\._A_P")_%=S;R7EOH6EW6J26\1 >588FD**3P"0N!GUKG<6GRM:G!*G.,N1
MJS.AHKX6_P"'K'AG_H0=8_\  R'_  KZ0_9K_:#L?VDO U_XET_1[K1(;34I
M---O=RK(S,D44F\%>,$2@?@:N5*<5>2-JF%K4H\TXV1ZS12%@H))P!U-?'GQ
M%_X*9>!?!OC'4=$TC0M0\56MD_DMJMG/'';RR D,(]W+J#QOZ-R1D8)F,)3T
MBC.E1J5G:FKGV)17PNO_  56\-,P5?A_K+,QP%6\A))]!Q7TB?B[XI7P;X5U
MR7P ^G76O7"6XTG4M46*XM&D(\GS=L; %ADE1RO /.0*E2G'=%5</4H*]16/
M5Z*^</&7[9EEX1T]ISX5NKN6/5KW2Y8EO%79Y#A5ESM/$GSX'_3-O2BA4YOH
M<3J074_)SQAJC:YXPU_4WYDOM2N;MR/[TDSN?U:O</V ]#BUO]JKPBTR[TL8
M[N\"D9^9;>15/X%P?PKQ'QGI9T/QGXATP];'4[JT/UCF=#^JU[5^P3KT6@_M
M5>#1-)Y<=\+NRR3@%GMI"H_%E4?4BO6J?PW;L?>5[^PE;L_R/V&HHHKQ#X@H
MZYKFG>&='O-6U:^M]-TRSB:>YO+J01Q0QJ,LS,>  *\%^#7[</@#XU?$[4_!
MFF&XL)UYTB[OAY:ZLJKF3RU/*,,%@C?,R#=@88+\K_\ !2[Q1\35\;6FA:RO
MV/X;3!9M)%CN\F\E4 O]I;O,C9(0_*%VLN3N(^+K"_N=*O[6^LKB6TO;65)X
M+B!RDD4BD,KJPY!! ((]*[Z>'4H7;W/>P^7PJ4N>3U>WD?T U5U33H-8TV[L
M+I!);74+P2H1D,C*58?D37S;^Q?^UU:_'[PZ- \030VOQ TR'-S$H"+J,(P/
MM,0]>0'4?=8Y "LM?2>I:A;Z1IUU?7<@AM;6)YY9&Z*B@LQ/T -<<HN#LSQJ
ME.=&?)):GX &SFTYC:7!S<6Y,,O^\O#?J#7T[_P3AU9M-_:BTV!3QJ&E7MHW
MT"K-_.$5\R27TNI2/>7"[9[EC-(OHS'<1^9KZ9_X)R:6^I?M2:5,JY6PTN]N
MF/H"BQ?SF%>Q5^"5S[+%?P)W[,^Z/V_O^32?'7UT_P#].%M7X^5^P?[?W_)I
M/CKZZ?\ ^G"VK\?*PPOP/U.'*_X#]?T1^NO_  3K_P"32?"/_7UJ?_IPN*^+
MO^"DW_)S\_\ V!++_P!"EK[1_P""=?\ R:3X1_Z^M3_].%Q7Q=_P4F_Y.?G_
M .P)9?\ H4M9T_X\OF<^'_W^I\_S/EZ&:6VGBG@ED@GA=98IHF*/&ZD%65AR
M&! ((Y!%?K%^Q+^UM#\>/#?_  C?B.XCB\?:5"#-D!!J4 P/M"#IN!(#J.A(
M( # #\FJU?"OBK5O _B33M?T&^ETS6-.F$]M=0GYD8>W0@C(*G@@D$$$UU5:
M:J1L>IBL/'$PY7OT/WSK\_O^"L'_ ![_  O_ -_4_P"5K7TQ^RS^TOI'[27@
M,7\0BL/$VGA8M8TE6YAD(.)$SR8GP2I]F4G*FOF?_@K!_P >_P +_P#?U/\
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MIRMZ6BOS3/S3/JD'G$8K?D2^=V_R/D[X":?::I\=/AS:7P!M9O$>G*ZMT?\
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M%6K7&J:UJ=YK&I7!W2WE_<//*_U9B3@=AT'050KZ2^&O_!/OXO\ Q FADO\
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M\'S1I+X_DSV']A?_ )-;\&_[]_\ ^E]Q6-_P4&_Y-QOO^PE9_P#HRMG]A?\
MY-;\&_[]_P#^E]Q6-_P4&_Y-QOO^PE9_^C*7_+[YC_Y<_+]#SW]I#_DP?P'_
M ->VC?\ H@5S_P"V1_R9K\'?]W3_ /TV25T'[2'_ "8/X#_Z]M&_]$"L3]KZ
M,S?L?_!>,#<6.FKCUSILE:PW7JS&>S]$?;_AS8?#VEF/_5_98MOTV#%?+O\
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M** "BBB@ HHHH **** /G+]NWX>W7BWX*MKVE!EUOPG=+K%O)&,N(U!$N/8
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9HHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>50
<FILENAME>zlab-20231231_g7.jpg
<TEXT>
begin 644 zlab-20231231_g7.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !J 1H# 2(  A$! Q$!_\0
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M-U"UU".-MC/:S+*%;T)4]:-6KBNEH:E%(#FEH&%%(:3=@$T -+<>GI48*KW
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MEF1E1@0Q.&"[< FOL3XS_%S3?@KX#OO$NJ*UPL9$-M:1D"2YG;B.)3[G))[
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M8E8A<\;G7)[#-?I9\3?COX-\#_#L^(KS7[&6PO[61].^SSK(U^P7A80#\_)
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MXK_PQM\'5(QX(M1SD?OYL?\ H=>B^ _ASX?^&>DG2_#ED=.T\MO%L)Y)$4X
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00 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>51
<FILENAME>zlab-20231231_g8.jpg
<TEXT>
begin 644 zlab-20231231_g8.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" "E .0# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z*** "B
MBB@ HHHH **** "BBB@ HHIK-M% !NIGF-[ USDGC_1UUZ71_MD8U&-%D:V8
MX?:1G(]>.U;J,6Z?-Z'I6$:T)2<8R5UT*G&5.W.G9EG<:3<11FLK5M>MM'A2
M6[GCMTDF2!&?H78X Z^O\C70ES;&4I1@N:3->EJ%)B_;;CJ#U]JE!I%)W%HH
MHH&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%)0 S<W
M'3%<UXY\91>#?#USJ-PH)C^5%_OL> !_/Z UNRS,N<C(P#@=<=Z^7_C9X^/B
M;Q)_9EM+NLM/^\W\+RC[Q'T!*C\:Y,56]C2YD>OE6 GF&)5-?"MSS77-2NM1
MU@WTT[F[:1IFF4X8L3G.>O'0 =J]5^'_ ,==:T>,6VJH^J6'0W/2:/W(_B'T
MQ7CMW)NFK5T1TNTE&2TR#<VX_>7T_P#U5^%YIC,9EM>>-H-^:/V/%97A\3AE
M3E%:'V?H/B[3/$UF+C3KI)U(SM!^9?\ >7J*\ ^-'BB7Q/XIM=(MV'V33Y2S
M,N0K3XY/7H.0/<GK7,:/<7>B77VZPD:SN\8,L1QGZCH?RI]G<";6($NE_?%R
M&=?N,3U)SWSSUK]$X6XLH9I'EQ7NS_ _FWC'#U<#-8?#ROW?8]_^$OBY_$OA
MU(+F7?J-FJP3,>K8Z-_0^X-=]O//%?-_AG5V\'^)DO@W^C2-Y-P$Z%/4>^>:
M^AX;H7$2RQLK(4W@C^('H1_GO7W]11;YJ;T.;)L;+%8=*I\:W+U%%%9GT(44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <#\7?$=YX
M=\":A>6%O)<7+?N,QG!C#?Q_05\@L[O_ *WKDL3ZD]?UR?QK[GUC1X-9TVXM
M;@;XID:-U]0?\*^.O&GA9O"OB*YTR\?:L3$K,/XT/W"!^A]P:B6#^M1Y$?HG
M"F(HI3HR7O/7Y''W3?Z3C_8W4ZTOC:W$5S$,O')AD[,/[I]ZCUBWDL;S!Q-^
MZ_@K<^'^B_VIJ#WW$MI9<[<?ZR8^OKM[_45^9<18+ZEAJE6LM%^)^E8B5.G2
MYFST:'30;:(X/S=:2UL%^VVX*Y&[=S6Q9;6V12<*O3'6I;>T*WEN<5_-%'.Z
MF6UO9QV[GXCFN6NM5E-ZWW*EU9@1^6%PO\Z]4^%.K7%YI3VLT;$VC;$E/3;_
M '?PQ^HKC%TM[R2&!1_I$IVJ.V[W]J]<T/18M%TQ($+ 9W'IECZGCZ?E7]*\
M&9W7S>G*;^%:-^?D?%T\N6%KN:TN;E%%%?J1Z@4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 0,NX$=*\9^/WP_;7=+&MV$7F:E9J3
MM/)>+^)1[@Y(_'K7M''%5IK5+A&1QD$'CZUO1J>SES'3A,1+"5XU(GP!Y-_K
M7B6PTRS19+NZ*PJ$/&"3\WTVC/X&OJJQ^#-IH_A_3[;3K@)=10CS"5^29O\
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MXR14E% #3&/6D\H4^BE;J W;[T;/<TZBF 4444 %%%% !1110 4444 %%%%
M!1110 4444 59+SR8C(^U$VE@S-@9 /!/;IUI([X3*KQ,KQD%MZ\@@=LY_\
MU?C7$?'F/RO@;\12CNA7PYJ!7:<;<6LF,'J.>?K7Y6?\$]_VF/$O[.-OH\OC
MCS&^#?C#49K"'66+.NEZFA3<6;^$2 J64]5^=<"-P0#]E:@6X8[LI\P_A'/Z
M]*K1ZD9H(IT:%H759!(C;E*'H01ZCD'_ /77Q)^R=&DO_!0']JG**I1[!=RC
M!.02<_7% 'W7547FU09"$X).X%>V<\XQQ_7TJU7P?^T,=O\ P5"_9Q3 .[2+
MX%B!G(BN\'TR,F@#[PJM]KP45OE9ESG:=OT![GVJS7PW_P %8XQ%\$?!17^+
MQE8*>!TVS$\XSSQQTX% 'W$K9&:KR7RQK\S(A/=CQSG'/<\=*?$Q:.,]VZUY
MG^T!^S?X0_:4\+6/A[QC_:!TVSO5OT73[GR&:15=1N;:25PYX]A0!Z;]KB_O
MK^8JM_:+(J^8JA^X##'7&!W/Y<_C7Q9>?\$I?@58V[SSW/B6W@C1I9)9M:*(
MBCDY)3 P.I/N>V*^=/V4/V4?!GQH_:AU#QGX(M]8M_@MX*O8TL+[4[TRRZYJ
M4,@D651@8A#8?'4@1 X,C", _6VJ7VYBS8"LHR R_-T.#QZ^P[U=K\_/C99S
M_L+_ +3EI\8])AD;X4>/)UTOQA:0QEHK"Z+[A=8!. 6,LF /O&5?^6BX /T#
MJHM^&9%P 6('S<>W\^,'%4_^$DL5T4ZNU[;_ -EI!]K>]WCR?(V;_,#9QMV_
M-GTYZ<U\*_L_Z3=_MM?M):A\<M=@(^&'A-WTOP1IES$5^T3J5W7KIP, C=@_
MQ&-?^6/(!^@-5)+X1KG*GG&,X.<9VX/?'J1UJW7Y=0?LU>$/VFO^"C7Q]TCQ
M<VI6]MI%O8WUL^D7(MI/,,%NIW-M.0=Q_$T ?IZMR&;Y2I3H7R>OY8_6GK(S
M+D!3_NG/ZU\/:E_P2G\ Z3;S7W@+QKXW\%>)HP7M=3@U3S,2=O-4(K,OLK*?
M>NV_84^./C'XAZ'XW\"_$>:&[\?^ M5;2+R^B(VWT1W".8XX+;HY,X XV' W
M4 ?6%0F;:@=L!<#)/&.Y/Y5-7RU_P4 ^,E_\+_@1<:-X<=I_&OC2Y7P_HD$(
M/FM+*RAW7!ZI'G!Z!G3J,@@'TS]L?Y?W9RWMR!TSC.<<CZ4S^T'1E\P1IN#;
M06P>.@Y]1D]. *^"?V#;?5/V9?C-XX_9O\4:BM_"EI%XD\/WA0QQW"21JMTJ
M@\<.,8QP8Y3VKWWXS?LSZ1X_^)EEXPMO#'A^ZU6/0=3M&U"]A7[1]KD6W6RD
MWE2<1".;![;^,4 >_?;"Q(" <L%); ; Y]^N>W;-6J^4?A;^SK\0/ WQ.^'V
MKZQXL;Q+H'AK1+O1[>UN)?WL$+16XC+XA'VB;>DJ&8E5\N&$;=SNQ^KJ "BB
MB@ HHHH X#X_<? OXD?]BUJ1_P#)62OAS_@F_P#!_P -?'3]@OQ+X1\4V/V[
M2]0\07:, WSP.L5OLEB)R%D4@$'!Z8(*Y6ON'X\MYWP/^(2C($GAV_0;5+')
MMI.,#KU%?*__  2!ADL/V5;Z*8>3*WB*[<1R*0VTQ0 ''UH J_LE?%GQ%\ ?
MB7)^S-\7+E;BYM5W^#O$39$>I6A+!83N8X8* %7)(VR(2<*6F_9+D+?M_P#[
M5)1<;IK %B<KP""/KS7M/[7G[+FE_M-?#^*U,_\ 97C'26-WX?\ $$)V2V5R
M"I W 9V,43.,?=4@@@8^6O\ @FK=>.+[]I#XZ7_Q(MI--\9R0:=#J<#P^7OE
M0R1;QSM.0JMN!(;=\HH _2FOA']HJ/R_^"G7[.-W,1%"-,U! YY!_<W>/IU'
MYBONZOD;]N[X#^+/'UCX,^(_PT5)?B9\/[_[;86>-WVR E#)!U7D;<A2?F7>
M!R00 ?6^ZOAW_@K$P?X)^ XF95GD\:6 1/[S>7,<#^=6/"O_  5:^%L>EK;?
M$+3]>^'WBZUC U'1+[2KB1HY0/F$95"2,_\ /0)7GWVCQ=_P4.^/O@36CX7U
M'PG\#O!-\NJQMK$?E7&KW:.K*JQD_,K>6%RHPBF4,^YE50#]%XX]L:CLO2D^
MT;=V2 !_>&!],]ZF Q7S?^W)^TU_PS'\&I]9LHVG\4ZH7T_1H-A95G*[FE?_
M &8U!)]> * /(/VROBIK_P >/B18?LQ?#*[*:KJD8N/%^N0EF33+ 89H6 Q\
MS*58C.<M'&,&0E?K[X5_"OPY\&_ .C^#_"UB-/T32[=8(8QC<^/O2.0!EV)9
MF;J2Q-?F_P#L9_M1?!']G/P+>:GXDO\ Q!K?Q)\3S'4?$6J+H,SLTK$OY*/C
M.U"Y8G."Y8C P!].^&?^"F_P8\5>(M)T2PF\0"^U2[BL[=;C1I8E\R1E5=S'
M@#+#F@#ZUKCOB9\+?#_Q8\"ZUX2\1VK7>C:M;-:W$:L%95.,,AQPRL%<'^\H
M/.!78TA&: /R(BU3XSW5K%^PW+'<+?)J7DS>+4W[3X8V"?(4\XQD?>Z$6_6O
MU,^&_P ,=!^$_@;1/"/ARW>TT/1[9;6U@9]Q" <ECCYBQRQ)ZEB>,U\A1Q/_
M ,/:IL!@G_"OL%@!@_O!QC'7 '&*^Z: "OR[7X_VW[//_!1?X_ZK)X0\3^-?
M[2M;&U%MX5L5O)83]GMWWN-ZX7C'UK]1*^#OV=_-A_X*9?M%,Z-&CZ39;25/
MS$1VW"[@"W.?RH J>(O^"I*ZAJUMX2\%_!GQO>_$+5$']F:)XAMH[,2#G$F%
M9Y'0;7)P #L;YE&6'J7[$/[/_B;X.>'?%WBGXB3P7/Q$\<:L^MZNMLP9+0Y=
MEB##@L/,=B ,?,%&0N:TOVROV78_VBO ^G:AH%T^D_$GPS(NH^&=9C<QO'<*
MP?R7<=$=D4[CRCA6SC(,?[&_[2TWQN\-ZAH'C+3)/#_Q6\+N+77])G00DLOR
M+<Q*/X6(8$+G8V5^Z4R ?2C7'++G:PXS@GD\XQWXK\X-:^-O@3XI?\%#KG6_
M&OC+0]!\&?"FV:RTF/4+](A?:LQ*RR*C?W&$@SZP0GHYQ]9?M??&\_ +X ^)
MO$\ +Z^MJUII,2?,SWDH\N)@O4JIS(W?:A&02"/)_P!DO]@_X>>'?@;X9;XA
M^ ]%\2^-=2MFU'4[W6+1;F023,7$9+@G*HRJ>^0>>: /(/V]OCA\.)-4^'/Q
ME^&OQ#\,ZWXZ\!:HIETW3=5B>6_L9'420_+N+#.1W^6:4]J_0CP;XNTOQ]X3
MTGQ)HMU]MTC5K:*]LYE)&Z.1 R$XZ9!''8\=J\PU+]A[X#ZEIMS9'X5^%[83
MHR>?;:9$DT>>Z.%RI!Y&/Y9%>(?\$[?$VK_#N7QY^SWXJD>36/ >HRG2IYQM
M-UILS;T**>3M)#X["X0<;3D ^W&M5;(W. <?*#QQCM^ X_Q-3444 %%%% !1
M110!#-:QW$31R#?&PVLK $%>X(/8]/I38;""WC*)$BH>2JH "?7 '7_"K%0M
M(WED JLG09!(!ZXQWXH 7[.OJPYW=>_^?PJ-M/@,S2[ )6&TR* &(],CG_\
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M(?#9OM-7Q/<)>W^E)<DV NP&#W,<1'R2R!EWL#AO+7@<Y]':U1F+9*EAABN
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M7#DEI9Y2 7/)P.@ZXSS7I-(!BEH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>52
<FILENAME>zlab-20231231_g9.jpg
<TEXT>
begin 644 zlab-20231231_g9.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" "= 18# 2(  A$! Q$!_\0
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MBK+JNKW]W,P RQ67R1^2Q 5ZU^V3X0N?'7[+OQ,T>SC,MU)HLT\4:]7:'$P
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M0^&?[+.M+I<[6M[X@NH=#$\;$.D4H9IL?6.-U_X'7@X[+E3QZPU+:5K>5_\
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M_1-O7L9M_P BN'_;OY'-A?\ >9?,_,C]J349=5_:4^*5S,3YC>);]>>P6=D
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MO_86_P#:,M++?^13/TD&(_WI?(_:?]H;_DW[XD_]BQJ7_I+)7\[Y_P"/=O\
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)44 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647762098576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - USD ($)<br> $ in Billions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Feb. 21, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38205<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ZAI LAB LIMITED<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">E9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-1144595<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">4560 Jinke Road<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Bldg. 1, Fourth Floor Pudong<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Shanghai<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">CN<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">201210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">86 21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">6163 2588<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The registrant intends to file a definitive proxy statement pursuant to Regulation 14A within 120 days of the end of the fiscal year ended December 31, 2023. Portions of such definitive proxy statement are incorporated by reference into Part III of this Annual Report on Form 10-K.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001704292<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=dei_AdrMember', window );">American Depositary Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">American Depositary Shares, each representing 10 Ordinary Shares, par value $0.000006 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ZLAB<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">758,101,320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Ordinary Shares, par value $0.000006 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">9688<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">992,087,430<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=dei_AdrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=dei_AdrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647759335984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_AuditInformationAbstract', window );"><strong>Audit Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">185<span></span>
</td>
<td class="text">1113<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">KPMG LLP<span></span>
</td>
<td class="text">Deloitte Touche Tohmatsu Certified Public Accountants LLP<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Short Hills, New Jersey<span></span>
</td>
<td class="text">Shanghai, the People&#8217;s Republic of  China<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_AuditInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Audit Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_AuditInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647755120256">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 790,151,000<span></span>
</td>
<td class="nump">$ 1,008,470,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">16,300,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable (net of allowance for credit loss of $17 and $11 as of December&#160;31, 2023 and 2022, respectively)</a></td>
<td class="nump">59,199,000<span></span>
</td>
<td class="nump">39,963,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLossCurrent', window );">Notes receivable</a></td>
<td class="nump">6,134,000<span></span>
</td>
<td class="nump">8,608,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories, net</a></td>
<td class="nump">44,827,000<span></span>
</td>
<td class="nump">31,621,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepayments and other current assets</a></td>
<td class="nump">22,995,000<span></span>
</td>
<td class="nump">35,674,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">939,606,000<span></span>
</td>
<td class="nump">1,124,336,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash, non-current</a></td>
<td class="nump">1,113,000<span></span>
</td>
<td class="nump">803,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term investments</a></td>
<td class="nump">9,220,000<span></span>
</td>
<td class="nump">6,431,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_PrepaymentsForEquipment', window );">Prepayments for equipment</a></td>
<td class="nump">111,000<span></span>
</td>
<td class="nump">1,396,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">53,734,000<span></span>
</td>
<td class="nump">57,863,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">14,844,000<span></span>
</td>
<td class="nump">19,512,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_LandUseRightsNetNoncurrent', window );">Land use rights, net</a></td>
<td class="nump">3,069,000<span></span>
</td>
<td class="nump">6,892,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">13,389,000<span></span>
</td>
<td class="nump">1,511,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepositsAssetsNoncurrent', window );">Long-term deposits</a></td>
<td class="nump">1,209,000<span></span>
</td>
<td class="nump">1,396,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">1,036,295,000<span></span>
</td>
<td class="nump">1,220,140,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">112,991,000<span></span>
</td>
<td class="nump">65,974,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current operating lease liabilities</a></td>
<td class="nump">7,104,000<span></span>
</td>
<td class="nump">7,050,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">82,972,000<span></span>
</td>
<td class="nump">66,818,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">203,067,000<span></span>
</td>
<td class="nump">139,842,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeNoncurrent', window );">Deferred income</a></td>
<td class="nump">28,738,000<span></span>
</td>
<td class="nump">21,360,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Non-current operating lease liabilities</a></td>
<td class="nump">8,047,000<span></span>
</td>
<td class="nump">13,343,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">325,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">240,177,000<span></span>
</td>
<td class="nump">174,545,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 20)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Ordinary shares (par value of $0.000006 per share; 5,000,000,000 shares authorized, 977,151,270 and 962,455,850 shares issued as of December&#160;31, 2023 and 2022, respectively; 972,239,070 and 960,219,570 shares issued and outstanding as of December&#160;31, 2023 and 2022, respectively)</a></td>
<td class="nump">6,000<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">2,975,302,000<span></span>
</td>
<td class="nump">2,893,120,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(2,195,980,000)<span></span>
</td>
<td class="num">(1,861,360,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="nump">37,626,000<span></span>
</td>
<td class="nump">25,685,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonValue', window );">Treasury stock (at cost, 4,912,200 and 2,236,280 shares as of December&#160;31, 2023 and 2022, respectively)</a></td>
<td class="num">(20,836,000)<span></span>
</td>
<td class="num">(11,856,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders&#8217; equity</a></td>
<td class="nump">796,118,000<span></span>
</td>
<td class="nump">1,045,595,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders&#8217; equity</a></td>
<td class="nump">$ 1,036,295,000<span></span>
</td>
<td class="nump">$ 1,220,140,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income excluding obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481174/470-10-25-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost excluding accrued interest, after allowance for credit loss, of financing receivable classified as current. Excludes net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479344/326-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -SubTopic 210<br> -Topic 954<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480632/954-210-45-5<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481520/505-30-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.30)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_LandUseRightsNetNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Land use rights, net noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_LandUseRightsNetNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_PrepaymentsForEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepayments for equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_PrepaymentsForEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647759342560">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Accounts receivable, allowance for credit loss</a></td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, par value (in dollars per share)</a></td>
<td class="nump">$ 0.000006<span></span>
</td>
<td class="nump">$ 0.000006<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Ordinary shares, shares authorized (in shares)</a></td>
<td class="nump">5,000,000,000<span></span>
</td>
<td class="nump">5,000,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ordinary shares, shares issued (in shares)</a></td>
<td class="nump">977,151,270<span></span>
</td>
<td class="nump">962,455,850<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ordinary shares, shares outstanding (in shares)</a></td>
<td class="nump">972,239,070<span></span>
</td>
<td class="nump">960,219,570<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock (in shares)</a></td>
<td class="nump">4,912,200<span></span>
</td>
<td class="nump">2,236,280<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479344/326-20-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647756214032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenue, net</a></td>
<td class="nump">$ 266,719,000<span></span>
</td>
<td class="nump">$ 212,672,000<span></span>
</td>
<td class="nump">$ 144,105,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer', window );">Collaboration revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,368,000<span></span>
</td>
<td class="nump">207,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">266,719,000<span></span>
</td>
<td class="nump">215,040,000<span></span>
</td>
<td class="nump">144,312,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of sales</a></td>
<td class="num">(95,816,000)<span></span>
</td>
<td class="num">(74,018,000)<span></span>
</td>
<td class="num">(52,239,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="num">(265,868,000)<span></span>
</td>
<td class="num">(286,408,000)<span></span>
</td>
<td class="num">(573,306,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="num">(281,608,000)<span></span>
</td>
<td class="num">(258,971,000)<span></span>
</td>
<td class="num">(218,831,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfIntangibleAssets', window );">Gain on sale of intellectual property</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(366,573,000)<span></span>
</td>
<td class="num">(404,357,000)<span></span>
</td>
<td class="num">(700,064,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">39,797,000<span></span>
</td>
<td class="nump">14,582,000<span></span>
</td>
<td class="nump">2,190,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign currency (loss) gain</a></td>
<td class="num">(14,850,000)<span></span>
</td>
<td class="num">(56,403,000)<span></span>
</td>
<td class="nump">4,661,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="nump">7,006,000<span></span>
</td>
<td class="nump">3,113,000<span></span>
</td>
<td class="num">(10,201,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Loss before income tax and share of loss from equity method investment</a></td>
<td class="num">(334,620,000)<span></span>
</td>
<td class="num">(443,065,000)<span></span>
</td>
<td class="num">(703,414,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Share of loss from equity method investment</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(221,000)<span></span>
</td>
<td class="num">(1,057,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (334,620,000)<span></span>
</td>
<td class="num">$ (443,286,000)<span></span>
</td>
<td class="num">$ (704,471,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Loss per share &#8212; basic (in dollars per share)</a></td>
<td class="num">$ (0.35)<span></span>
</td>
<td class="num">$ (0.46)<span></span>
</td>
<td class="num">$ (0.76)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Loss per share &#8212; diluted (in dollars per share)</a></td>
<td class="num">$ (0.35)<span></span>
</td>
<td class="num">$ (0.46)<span></span>
</td>
<td class="num">$ (0.76)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average shares used in calculating net loss per ordinary share &#8212; basic (in shares)</a></td>
<td class="nump">966,394,130<span></span>
</td>
<td class="nump">958,067,140<span></span>
</td>
<td class="nump">929,921,120<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average shares used in calculating net loss per ordinary share &#8212;diluted (in shares)</a></td>
<td class="nump">966,394,130<span></span>
</td>
<td class="nump">958,067,140<span></span>
</td>
<td class="nump">929,921,120<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482014/830-20-35-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481956/830-20-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481926/830-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481839/830-10-45-17<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482916/730-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482517/912-730-25-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue from collaborative arrangement. Excludes revenue from contract with customer under Topic 606.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479402/808-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -SubTopic 10<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479428/808-10-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647759354880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (334,620)<span></span>
</td>
<td class="num">$ (443,286)<span></span>
</td>
<td class="num">$ (704,471)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss), net of tax of nil:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustments</a></td>
<td class="nump">11,941<span></span>
</td>
<td class="nump">49,330<span></span>
</td>
<td class="num">(9,121)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (322,679)<span></span>
</td>
<td class="num">$ (393,956)<span></span>
</td>
<td class="num">$ (713,592)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647764221680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Loss (Parenthetical) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1', window );">Other comprehensive (loss) income, tax</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647762285328">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Shareholders' Equity - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Ordinary shares</div></th>
<th class="th"><div>Additional paid in capital</div></th>
<th class="th"><div>Accumulated deficit</div></th>
<th class="th"><div>Accumulated other comprehensive income (loss)</div></th>
<th class="th"><div>Treasury Stock</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">878,110,260<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="nump">$ 1,169,345<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 1,897,467<span></span>
</td>
<td class="num">$ (713,603)<span></span>
</td>
<td class="num">$ (14,524)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of ordinary shares upon vesting of restricted shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,054,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of ordinary shares upon vesting of restricted shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of shares options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,353,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of share options</a></td>
<td class="nump">7,417<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">7,417<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of ordinary shares upon follow-on public offering, net of issuance cost (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,164,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of ordinary shares upon follow-on public offering, net of issuance cost</a></td>
<td class="nump">818,036<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">818,035<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Issuance of ordinary shares in connection with collaboration and license arrangement (Note 16) (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,681,820<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Issuance of ordinary shares in connection with collaboration and license arrangement (Note 16)</a></td>
<td class="nump">62,250<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">62,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_IssuanceCostAdjustment', window );">Issuance cost adjustment for secondary listing</a></td>
<td class="nump">65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Receipt of shares netted to satisfy tax withholding obligations related to share-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(382,930)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Receipt of shares netted to satisfy tax withholding obligations related to share-based compensation</a></td>
<td class="num">(4,279)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (4,279)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">40,714<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,714<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(704,471)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(704,471)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation</a></td>
<td class="num">(9,121)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,121)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">955,363,980<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2021</a></td>
<td class="nump">1,379,956<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
<td class="nump">2,825,948<span></span>
</td>
<td class="num">(1,418,074)<span></span>
</td>
<td class="num">(23,645)<span></span>
</td>
<td class="num">$ (4,279)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Ending balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(382,930)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of ordinary shares upon vesting of restricted shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,940,680<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of ordinary shares upon vesting of restricted shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of shares options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,151,190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of share options</a></td>
<td class="nump">5,870<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">5,870<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Receipt of shares netted to satisfy tax withholding obligations related to share-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,853,350)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Receipt of shares netted to satisfy tax withholding obligations related to share-based compensation</a></td>
<td class="num">(7,577)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (7,577)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">61,302<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61,302<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(443,286)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(443,286)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation</a></td>
<td class="nump">$ 49,330<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,330<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2022</a></td>
<td class="nump">960,219,570<span></span>
</td>
<td class="nump">962,455,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2022</a></td>
<td class="nump">$ 1,045,595<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
<td class="nump">2,893,120<span></span>
</td>
<td class="num">(1,861,360)<span></span>
</td>
<td class="nump">25,685<span></span>
</td>
<td class="num">$ (11,856)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Ending balance (in shares) at Dec. 31, 2022</a></td>
<td class="num">(2,236,280)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,236,280)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of ordinary shares upon vesting of restricted shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,178,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of ordinary shares upon vesting of restricted shares</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of shares options (in shares)</a></td>
<td class="nump">6,516,920<span></span>
</td>
<td class="nump">6,516,920<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of share options</a></td>
<td class="nump">$ 2,548<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">2,548<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Receipt of shares netted to satisfy tax withholding obligations related to share-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,675,920)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Receipt of shares netted to satisfy tax withholding obligations related to share-based compensation</a></td>
<td class="num">(8,980)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (8,980)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">79,634<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79,634<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(334,620)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(334,620)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation</a></td>
<td class="nump">$ 11,941<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,941<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2023</a></td>
<td class="nump">972,239,070<span></span>
</td>
<td class="nump">977,151,270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2023</a></td>
<td class="nump">$ 796,118<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
<td class="nump">$ 2,975,302<span></span>
</td>
<td class="num">$ (2,195,980)<span></span>
</td>
<td class="nump">$ 37,626<span></span>
</td>
<td class="num">$ (20,836)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Ending balance (in shares) at Dec. 31, 2023</a></td>
<td class="num">(4,912,200)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,912,200)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481089/718-20-55-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481089/718-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_IssuanceCostAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance cost adjustment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_IssuanceCostAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647762913072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Shareholders' Equity (Parenthetical)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Issuance costs</a></td>
<td class="nump">$ 839<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647758916432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (334,620)<span></span>
</td>
<td class="num">$ (443,286)<span></span>
</td>
<td class="num">$ (704,471)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Allowance for credit loss</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventory write-down</a></td>
<td class="nump">973<span></span>
</td>
<td class="nump">477<span></span>
</td>
<td class="nump">1,368<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization expenses</a></td>
<td class="nump">9,029<span></span>
</td>
<td class="nump">8,227<span></span>
</td>
<td class="nump">6,487<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TangibleAssetImpairmentCharges', window );">Impairment of property and equipment</a></td>
<td class="nump">57<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_AmortizationOfDeferredIncome', window );">Amortization of deferred income</a></td>
<td class="num">(3,383)<span></span>
</td>
<td class="num">(2,602)<span></span>
</td>
<td class="num">(521)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">79,634<span></span>
</td>
<td class="nump">61,302<span></span>
</td>
<td class="nump">40,714<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_NoncashResearchAndDevelopmentExpenses', window );">Noncash research and development expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">62,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Share of loss from equity method investment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">221<span></span>
</td>
<td class="nump">1,057<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiGainLoss', window );">(Gain) loss from fair value changes of equity investment with readily determinable fair value</a></td>
<td class="num">(2,789)<span></span>
</td>
<td class="nump">8,952<span></span>
</td>
<td class="nump">14,617<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss on disposal of property and equipment</a></td>
<td class="nump">159<span></span>
</td>
<td class="nump">560<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_GainLossOnDisposalOfLandUseRights', window );">Gain on disposal of land use right</a></td>
<td class="num">(408)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_NonCashLeaseExpenses', window );">Noncash lease expenses</a></td>
<td class="nump">8,708<span></span>
</td>
<td class="nump">8,350<span></span>
</td>
<td class="nump">6,119<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfIntangibleAssets', window );">Gain from sale of intellectual property</a></td>
<td class="num">(10,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized', window );">Foreign currency remeasurement loss (gain)</a></td>
<td class="nump">14,850<span></span>
</td>
<td class="nump">56,403<span></span>
</td>
<td class="num">(10,679)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(20,040)<span></span>
</td>
<td class="nump">4,330<span></span>
</td>
<td class="num">(42,319)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInNotesReceivableCurrent', window );">Notes receivable</a></td>
<td class="nump">2,352<span></span>
</td>
<td class="num">(1,976)<span></span>
</td>
<td class="num">(7,335)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(14,907)<span></span>
</td>
<td class="num">(15,382)<span></span>
</td>
<td class="num">(7,174)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepayments and other current assets</a></td>
<td class="nump">12,246<span></span>
</td>
<td class="num">(19,258)<span></span>
</td>
<td class="num">(7,086)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_IncreaseDecreaseInLongTermDeposits', window );">Long-term deposits</a></td>
<td class="nump">187<span></span>
</td>
<td class="num">(527)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_IncreaseDecreaseInValueAddedTaxesReceivable', window );">Value added tax recoverable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">22,781<span></span>
</td>
<td class="num">(1,717)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">36,803<span></span>
</td>
<td class="num">(53,773)<span></span>
</td>
<td class="nump">63,522<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities', window );">Other current liabilities</a></td>
<td class="nump">19,810<span></span>
</td>
<td class="nump">7,392<span></span>
</td>
<td class="nump">30,142<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_IncreaseDecreaseInOperatingLeaseLiabilities', window );">Operating lease liabilities</a></td>
<td class="num">(8,351)<span></span>
</td>
<td class="num">(8,455)<span></span>
</td>
<td class="num">(5,385)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred income</a></td>
<td class="nump">11,181<span></span>
</td>
<td class="num">(1,379)<span></span>
</td>
<td class="nump">11,149<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities', window );">Other non-current Liabilities</a></td>
<td class="nump">325<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by (used in) operating activities</a></td>
<td class="num">(198,178)<span></span>
</td>
<td class="num">(367,642)<span></span>
</td>
<td class="num">(549,231)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireShortTermInvestments', window );">Purchase of short-term investments</a></td>
<td class="num">(134,000)<span></span>
</td>
<td class="num">(260,274)<span></span>
</td>
<td class="num">(445,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments', window );">Proceeds from maturity of short-term investments</a></td>
<td class="nump">117,700<span></span>
</td>
<td class="nump">705,274<span></span>
</td>
<td class="nump">743,902<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Purchase of investment in equity investee</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(30,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(7,212)<span></span>
</td>
<td class="num">(24,585)<span></span>
</td>
<td class="num">(18,295)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from the sale of property and equipment</a></td>
<td class="nump">122<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Acquisition of intangible assets</a></td>
<td class="num">(1,279)<span></span>
</td>
<td class="num">(399)<span></span>
</td>
<td class="num">(653)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfIntangibleAssets', window );">Proceeds from sale of intellectual property</a></td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_ProceedsFromDisposalOfLandUseRights', window );">Proceeds from disposal of land use right</a></td>
<td class="nump">3,893<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash (used in) provided by investing activities</a></td>
<td class="num">(10,776)<span></span>
</td>
<td class="nump">420,016<span></span>
</td>
<td class="nump">249,957<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercises of stock options</a></td>
<td class="nump">2,369<span></span>
</td>
<td class="nump">5,870<span></span>
</td>
<td class="nump">7,417<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from issuance of ordinary shares upon public offerings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">818,875<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payment of public offering costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,837)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Taxes paid related to settlement of equity awards</a></td>
<td class="num">(8,802)<span></span>
</td>
<td class="num">(7,600)<span></span>
</td>
<td class="num">(4,253)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash (used in) provided by financing activities</a></td>
<td class="num">(6,433)<span></span>
</td>
<td class="num">(1,730)<span></span>
</td>
<td class="nump">820,202<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash</a></td>
<td class="num">(2,622)<span></span>
</td>
<td class="num">(6,274)<span></span>
</td>
<td class="nump">1,116<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net (decrease) increase in cash, cash equivalents and restricted cash</a></td>
<td class="num">(218,009)<span></span>
</td>
<td class="nump">44,370<span></span>
</td>
<td class="nump">522,044<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash, cash equivalents and restricted cash &#8212; beginning of the year</a></td>
<td class="nump">1,009,273<span></span>
</td>
<td class="nump">964,903<span></span>
</td>
<td class="nump">442,859<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash, cash equivalents and restricted cash &#8212; end of the year</a></td>
<td class="nump">791,264<span></span>
</td>
<td class="nump">1,009,273<span></span>
</td>
<td class="nump">964,903<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental disclosure on non-cash investing and financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1', window );">Payables for purchase of property and equipment</a></td>
<td class="nump">2,474<span></span>
</td>
<td class="nump">5,269<span></span>
</td>
<td class="nump">2,568<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_NonCashPayablesForIntangibleAssets', window );">Payables for acquisition of intangible assets</a></td>
<td class="nump">11,516<span></span>
</td>
<td class="nump">163<span></span>
</td>
<td class="nump">191<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_NonCashPayablesForTreasuryStock', window );">Payables for treasury stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use asset acquired under operating leases</a></td>
<td class="nump">3,668<span></span>
</td>
<td class="nump">14,801<span></span>
</td>
<td class="nump">2,183<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_ReceivableRecognizedForDisposalOfPropertyAndEquipment', window );">Receivables for disposal of property and equipment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">64<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flow information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">790,151<span></span>
</td>
<td class="nump">1,008,470<span></span>
</td>
<td class="nump">964,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash, non-current</a></td>
<td class="nump">1,113<span></span>
</td>
<td class="nump">803<span></span>
</td>
<td class="nump">803<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Total cash and cash equivalents and restricted cash</a></td>
<td class="nump">$ 791,264<span></span>
</td>
<td class="nump">$ 1,009,273<span></span>
</td>
<td class="nump">$ 964,903<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 321<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479536/321-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain (loss) from foreign currency transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-6<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481956/830-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481926/830-20-50-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossUnrealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInNotesReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period of amounts due within one year (or one business cycle) from note holders for outstanding loans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInNotesReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483080/330-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of fixed assets that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from maturities, prepayments, calls and collections of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from disposal of asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -SubTopic 210<br> -Topic 954<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480632/954-210-45-5<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TangibleAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The charge against earnings resulting from the aggregate write down of tangible assets from their carrying value to their fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TangibleAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_AmortizationOfDeferredIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization of deferred income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_AmortizationOfDeferredIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_GainLossOnDisposalOfLandUseRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) On Disposal Of Land Use Rights</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_GainLossOnDisposalOfLandUseRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_IncreaseDecreaseInLongTermDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase decrease in long term deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_IncreaseDecreaseInLongTermDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_IncreaseDecreaseInOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) in operating lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_IncreaseDecreaseInOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_IncreaseDecreaseInValueAddedTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase decrease in value added taxes receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_IncreaseDecreaseInValueAddedTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_NonCashLeaseExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non-cash lease expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_NonCashLeaseExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_NonCashPayablesForIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non-cash payables for intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_NonCashPayablesForIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_NonCashPayablesForTreasuryStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non cash payables for treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_NonCashPayablesForTreasuryStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_NoncashResearchAndDevelopmentExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncash research and development expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_NoncashResearchAndDevelopmentExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_ProceedsFromDisposalOfLandUseRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Disposal Of Land Use Rights</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_ProceedsFromDisposalOfLandUseRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_ReceivableRecognizedForDisposalOfPropertyAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Receivable Recognized For Disposal Of Property And Equipment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_ReceivableRecognizedForDisposalOfPropertyAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647858979920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Principal Activities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Organization and Principal Activities</a></td>
<td class="text">Organization and Principal Activities <div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Zai Lab Limited was incorporated on March 28, 2013 in the Cayman Islands as an exempted company with limited liability under the Companies Act of the Cayman Islands (as amended). Zai Lab Limited and its subsidiaries (collectively referred to as the &#8220;Company&#8221;) are focused on discovering, developing, and commercializing products that address medical conditions with significant unmet needs in the areas of oncology, autoimmune disorders, infectious disease, and neuroscience.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company&#8217;s principal operations and geographic markets are in Greater China. The Company has a substantial presence in Greater China and the United States. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">As of December&#160;31, 2023, the Company&#8217;s significant operating subsidiaries were as follows: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.596%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.237%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name of Company</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Place of<br/>Incorporation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Date of<br/>Incorporation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Percentage of<br/>Ownership</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Principal Activities</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Zai Lab (Hong Kong) Limited</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hong Kong</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April 29, 2013</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating company for business development and R&amp;D activities and commercialization of innovative medicines and device</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Zai Lab (Shanghai) Co., Ltd.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mainland<br/>China</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">January 6, 2014</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Development and commercialization of innovative medicines and devices</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Zai Lab (AUST) Pty. Ltd.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Australia</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 10, 2014</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical trial activities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Zai Lab (Suzhou) Co., Ltd.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mainland<br/>China</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">November 30, 2015</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Development and commercialization of innovative medicines</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Zai Biopharmaceutical (Suzhou) Co., Ltd.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mainland<br/>China</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June 15, 2017</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Development and commercialization of innovative medicines</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Zai Lab (US) LLC</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">United<br/>States</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April 21, 2017</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating company for business development, R&amp;D activities and certain business activities, including legal, compliance and communication functions of the Company</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Zai Lab International Trading (Shanghai) Co., Ltd.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mainland<br/>China</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">November 6, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercialization of innovative medicines and devices</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Zai Auto Immune (Hong Kong) Limited</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hong Kong</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">November 4, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating company for business development and R&amp;D activities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Zai Lab (Taiwan) Limited</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Taiwan</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 10, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercialization of innovative medicines and devices</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Zai Lab Trading (Suzhou) Co., Ltd.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mainland<br/>China</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">October 27, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercialization of innovative medicines and devices</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480424/946-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480424/946-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//810/tableOfContent<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647762892448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(a) Basis of Presentation </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#8220;U.S. GAAP&#8221;). Significant accounting policies followed by the Company in the preparation of the accompanying consolidated financial statements are summarized below. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Effective as of March 30, 2022, the Company subdivided each of its issued and unissued ordinary shares into ten ordinary shares (the &#8220;Share Subdivision&#8221;). Following the Share Subdivision, the Company&#8217;s authorized share capital became $30,000 divided into 5,000,000,000 shares with a par value of $0.000006 per share. The numbers of issued and unissued ordinary shares and per share data as disclosed elsewhere in these consolidated financial statements and notes thereto are presented on a basis after taking into account the effects of the Share Subdivision and have been retrospectively adjusted, where applicable. In connection with the Share Subdivision, the conversion ratio of its ADSs to ordinary shares changed from one ADS to one ordinary share to a new ratio of one ADS to ten ordinary shares (the &#8220;ADS Ratio Change&#8221;). The Share Subdivision and ADS Ratio Change did not result in any change to the number of outstanding ADSs of the Company. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> In 2022, the Company began to separately present foreign currency (loss) gain on the consolidated statements of operations. This amount was previously included in other income (expense), net. Additionally, the Company began to provide a breakdown of other income (expense), net in Note 17.  The Company also began to separately present the amount of foreign currency remeasurement loss (gain) on the consolidated statements of cash flows. This amount was previously included in changes in other current liabilities. This change did not have any impact on net cash used in operating activities. Corresponding amounts in the prior periods of the consolidated financial statements have been presented to conform to the current period presentation.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(b) Principles of Consolidation</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The consolidated financial statements include the accounts of Zai Lab Limited and its subsidiaries, which are wholly owned. All intercompany transactions and balances are eliminated upon consolidation.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(c) Use of Estimates </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Areas where management uses subjective judgment include, but are not limited to, accrual of rebates, recognition of research and development expenses to the appropriate financial reporting period based on actual services performed, fair value of share-based compensation expenses, and recoverability of deferred tax assets. These estimates, judgments, and assumptions can affect the reported amounts of assets and liabilities as of the date of the financial statements as well as the reported amounts of revenues and expenses during the periods presented. Actual results could differ from these estimates. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(d) Foreign Currency Translation </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The functional currency of Zai Lab Limited, Zai Lab (Hong Kong) Limited, Zai Lab (US) LLC, and Zai Auto Immune (Hong Kong) Limited are the U.S. dollar (&#8220;$&#8221;). The Company&#8217;s subsidiaries in mainland China determined their functional currency to be the Chinese Renminbi (&#8220;RMB&#8221;). The Company&#8217;s subsidiary in Australia determined its </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">functional currency to be the Australian dollar (&#8220;A$&#8221;). The Company&#8217;s subsidiary in Taiwan determined its functional currency to be the Taiwan dollar (&#8220;TWD&#8221;). The determination of the respective functional currency is based on the criteria of Accounting Standard Codification (&#8220;ASC&#8221;) 830, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Foreign Currency Matters</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">. The Company uses the U.S. dollar as its reporting currency. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Assets and liabilities are translated from each entity&#8217;s functional currency to the reporting currency at the exchange rate on the balance sheet date. Equity amounts are translated at historical exchange rates. Revenues, expenses, gains, and losses are translated using the average rate for the period presented. The resulted foreign currency translation adjustments are recorded as a component of other comprehensive loss in the consolidated statements of comprehensive loss, and the accumulated foreign currency translation adjustments are recorded as a component of accumulated other comprehensive income (loss) in the consolidated statements of shareholders&#8217; equity.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Monetary assets and liabilities denominated in currencies other than the applicable functional currencies are translated into the functional currencies at the prevailing rates of exchange at the balance sheet date.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Non-monetary assets and liabilities are translated into the applicable functional currencies at historical exchange rates. Transactions in currencies other than the applicable functional currencies during the year are converted into the functional currencies at the applicable rates of exchange prevailing at the transaction dates. Transaction gains and losses are recognized in the consolidated statements of operations. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(e) Cash, Cash Equivalents, and Restricted Cash </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Cash and Cash Equivalents </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company considers all highly liquid investments purchased with original maturities of three months or less to be cash equivalents. Cash and cash equivalents consist primarily of cash on hand, demand deposits, and highly liquid investments with maturity of less than three months and are stated at cost, which approximates fair value. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Restricted Cash </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Restricted cash mainly consists of bank deposits held as collateral for issuances of letters of credit. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(f) Short-Term Investments </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Short-term investments are time deposits with original maturities between three months and one year. Short-term investments are stated at cost, which approximates fair value. Interest earned is included in interest income. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(g) Accounts Receivable </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company&#8217;s accounts receivable arise from product sales and represent amounts due from its customers. From January 1, 2020, the Company adopted the ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Credit Losses, Measurement of Credit Losses on Financial Instruments. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Accounts receivable are recorded at the amounts net of allowances for credit losses. The allowance for credit losses reflects the Company&#8217;s current estimate of credit losses expected to be incurred over the life of the receivables. The Company considers various factors in establishing, monitoring, and adjusting its allowance for credit losses including the aging of receivables and aging trends, customer creditworthiness, and specific exposures related to particular customers. The Company also monitors other risk factors and forward-looking information, such as country-specific risks and economic factors that may affect a debtor&#8217;s ability to pay in establishing and adjusting its allowance for credit losses. Accounts receivable are written off when deemed uncollectible.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(h) Notes Receivable </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Notes receivable is equal to contractual amounts owed from signed, secured promissory notes issued from customers to the Company. The Company considers the notes receivable to be fully collectible. Accordingly, no allowance for credit loss has been established as of December&#160;31, 2023 and 2022.   </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(i) Inventories </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Inventories are stated at the lower of cost or net realizable value, with cost determined on a weighted average basis. The Company periodically reviews the composition of inventory and shelf life of inventory to identify obsolete, slow-moving, or otherwise non-saleable items. The Company will record a write-down to its net realizable value in cost of sales in the period that the decline in value is first identified. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(j) Prepayments for Equipment </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The prepayments for equipment purchase are recorded in long-term prepayments considering the prepayments are all related to property and equipment. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(k) Property and Equipment </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Property and equipment are stated at cost, less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the respective assets as follows:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Useful life</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Office equipment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Electronic equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.25-3 years</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vehicles</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Laboratory equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Manufacturing equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leasehold improvements</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">lesser of useful life or lease term</span></td></tr></table></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Construction in progress represents property and equipment under construction and pending installation and is stated at cost less impairment losses, if any. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(l) Leases</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company leases facilities for its offices, research and development center, and manufacturing facilities in mainland China, Hong Kong, and the United States. On January 1, 2019, the Company adopted the ASC 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> using the modified retrospective transition approach by applying the new standard to all leases existing at the date of initial application and not restating historical periods before the adoption date. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company assessed whether an arrangement contains a lease at inception. The Company&#8217;s leases are all classified as operating leases with fixed lease payments, or minimum payments, as contractually stated in the lease agreements. The Company&#8217;s leases do not contain any material residual value guarantees or material restrictive covenants.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%"> </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Operating leases are included in operating lease right-of-use assets and operating lease liabilities in the consolidated balance sheets. Operating lease liabilities that become due within one year of the balance sheet date are classified as current operating lease liabilities. Operating lease expense is recognized on a straight-line basis over the lease term.  </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">At the commencement date of a lease, the Company recognizes a lease liability for future fixed lease payments and a right-of-use (&#8220;ROU&#8221;) asset representing the right to use the underlying asset during the lease term. The lease liability is initially measured as the present value of the future fixed lease payments that will be made over the lease term. The lease term includes periods for which the Company is reasonably certain that the renewal options will be exercised and the termination options will not be exercised. The Company uses its incremental borrowing rate based on the information available at the commencement date in determining the lease liabilities as the Company&#8217;s leases generally do not provide an implicit rate. The incremental borrowing rate is reevaluated upon a lease modification. The Company considered information available at the adoption date of ASC 842 to determine the incremental borrowing rate for leases in existence as of this date.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The ROU asset is measured at the amount of the lease liability with adjustments, if applicable, for lease prepayments made prior to or at lease commencement, initial direct costs incurred by the Company, and lease incentives. Under ASC 842, land use rights agreements are also considered to be operating lease contracts.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company elected to apply each of the practical expedients described in ASC 842 which allow companies (i) not to reassess prior conclusions on whether any expired or existing contracts are or contain a lease, lease classification, and initial direct costs upon adoption of ASC 842, (ii) combine lease and non-lease components for all underlying assets groups, and (iii) not recognize ROU assets or lease liabilities for short term leases. A short-term lease is a lease that, at the commencement date, has a lease term of 12 months or less and does not include an option to purchase the underlying asset that the lessee is reasonably certain to exercise.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(m) Land Use Rights </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">All land in mainland China is subject to government or collective ownership. Land use rights can be purchased for a specified period of time. The purchase price of land use rights represents the operating lease prepayments under ASC 842 and is recorded as land use rights on the consolidated balance sheet, which is amortized over the remaining lease term.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company acquired land use rights in 2019 for a term of 30 years from the local Bureau of Land and Resources in Suzhou for the purpose of constructing and operating the research center and biologics manufacturing facility in Suzhou. In 2023, the Company returned a portion of the land use rights and received cash in an amount equal to the respective portion of the original acquisition cost.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(n) Long-Term Deposits </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Long-term deposits represent amounts paid in connection with the Company&#8217;s long-term lease agreements. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(o) Intangible Assets </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Intangible assets mainly consist of capitalized sales-based milestone fees and externally purchased software. Sales-based milestone fees are capitalized based on contract terms upon achievement of the sales levels and are amortized over the estimated remaining useful life of the related product, which is generally based on expected patent life, the contractual period of the underlying license agreement, and expected commercial benefits of the products. Externally purchased software are amortized over <span style="-sec-ix-hidden:f-496">three</span> to five years on a straight-line basis. As of December&#160;31, 2023, the intangible assets, net consist of $11.2 million capitalized sales-based milestone fees and $2.2 million software. As of December&#160;31, 2022, the intangible assets, net consist of $1.5 million software. Amortization expenses for 2023, 2022, and 2021 were $0.7 million, $0.5 million, and $0.5 million, respectively. Amortization expenses of the Company&#8217;s intangible assets are expected to be approximately $3.1 million, $2.9 million, $2.7 million, $2.5 million, and $2.3 million, and nil for 2024, 2025, 2026, 2027, 2028, and thereafter, respectively. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(p) Impairment of Long-Lived Assets </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company evaluates long-lived assets, which includes intangible assets, tangible assets, and ROU assets for impairment whenever events or changes in circumstances indicate that the carrying value of these assets may not be recoverable. Recoverability of these assets is measured by comparison of the carrying amount of the related asset group to its future undiscounted cash flows. The Company measures the amount of impairment, if any, based on the difference between the carrying value and the estimated fair value of the impaired asset group. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(q) Fair Value Measurements </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company applies ASC topic 820 (&#8220;ASC 820&#8221;), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Fair Value Measurements and Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">, in measuring fair value. ASC 820 defines fair value, establishes a framework for measuring fair value, and requires disclosures to be provided on fair value measurement. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">ASC 820 establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows: </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Level 1 &#8212; Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Level 2 &#8212; Include other inputs that are directly or indirectly observable in the marketplace. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Level 3 &#8212; Unobservable inputs which are supported by little or no market activity. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">ASC 820 describes three main approaches to measuring the fair value of assets and liabilities: (i) market approach; (ii) income approach; and (iii) cost approach. The market approach uses prices and other relevant information generated from market transactions involving identical or comparable assets or liabilities. The income approach uses valuation techniques to convert future amounts to a single present value amount. The measurement is based on the value indicated by current market expectations about those future amounts. The cost approach is based on the amount that would currently be required to replace an asset. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Equity investments with readily determinable fair value are measured using level 1 inputs and were $9.2 million and $6.4 million as of December&#160;31, 2023 and 2022, respectively. The unrealized gains and losses from fair value changes are recognized in other income (expense), net in the consolidated statements of operations. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Financial instruments of the Company primarily include cash, cash equivalents and restricted cash, short-term investments, accounts receivable, notes receivable, prepayments, and other current assets, accounts payable, and other current liabilities. As of December&#160;31, 2023 and 2022, the carrying values of cash and cash equivalents, short-term investments, accounts receivable, prepayments, and other current assets, accounts payable, and other current liabilities approximated their fair values due to the short-term maturity of these instruments, and the carrying value of notes receivable and restricted cash approximated their fair value based on the nature of the assessment of the ability to recover these amounts. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(r) Revenue Recognition</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In 2018, the Company adopted ASC Topic 606 (&#8220;ASC 606&#8221;), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">. Under ASC 606, the Company recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration expected to be received in exchange for those goods or services. To determine revenue recognition for arrangements that the Company determines are within the scope of ASC 606, the Company performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price, including variable consideration, if any; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the Company satisfies a performance </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">obligation. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration to which it is entitled in exchange for the goods or services it transfers to the customer. Once a contract is determined to be within the scope of ASC 606 at contract inception, the Company reviews the contract to determine which performance obligations it must deliver and which of these performance obligations are distinct. The Company recognizes as revenue the amount of the transaction price that is allocated to each performance obligation when that performance obligation is satisfied or as it is satisfied.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company&#8217;s revenue is mainly from product sales. The Company recognizes revenue from product sales when the Company has satisfied the performance obligation by transferring control of the product to the customers. Control of the product generally transfers to the customers when the delivery is made and when title and risk of loss transfers to the consumers. Cost of sales mainly consists of the acquisition cost of products, the manufacturing cost of products, royalty fees, and amortization of sales-based milestone payments. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company has applied the practical expedients under ASC 606 with regard to assessment of financing component and concluded that there is no significant financing component given that the period between delivery of goods and payment is generally one year or less. The Company&#8217;s product revenues were mainly generated from the sale of ZEJULA (niraparib), OPTUNE (Tumor Treating Fields), QINLOCK (ripretinib), NUZYRA (omadacycline), and VYVGART (efgartigimod) to customers. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In mainland China, the Company sells the products to distributors, who ultimately sell the products to health care providers. Based on the nature of the arrangements, the performance obligations are satisfied upon the delivery of the products to distributors. Rebates are offered to distributors, consistent with pharmaceutical industry practices. The estimated amount of unpaid or unbilled rebates are recorded as a reduction of revenue, if any. Estimated rebates are determined based on contracted rates and sales volumes and to a lesser extent, distributor inventories. The Company regularly reviews the information related to these estimates and adjusts the amount accordingly. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In Hong Kong, the Company sells the products to customers, which are typically healthcare providers such as oncology centers. The Company utilizes a third party for warehousing services. Based on the nature of the arrangements, the Company has determined that it is a principal in the transaction since the Company is primarily responsible for fulfilling the promise to provide the products to the customers, maintains inventory risk until delivery to the customers, and has latitude in establishing the price. Revenue was recognized at the amount to which the Company expected to be entitled in exchange for the sale of the products, which is the sales price agreed with the customers. Consideration paid to the third party is recognized in operating expenses. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company didn&#8217;t recognize any contract assets and contract liabilities as of December&#160;31, 2023 and 2022.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(s) Collaborative Arrangements </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company analyzes its collaboration arrangements to assess whether such arrangements involve joint operating activities performed by parties that are both active participants in the activities and exposed to significant risks and rewards dependent on the commercial success of such activities and therefore within the scope of ASC Topic 808, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Collaborative Arrangements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> (ASC 808). This assessment is performed throughout the life of the arrangement based on changes in the responsibilities of all parties in the arrangement. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">For collaboration arrangements within the scope of ASC 808 that contain multiple elements, the Company first determines which elements of the collaboration are deemed to be within the scope of ASC 808 and which elements of the collaboration are more reflective of a vendor-customer relationship and therefore within the scope of ASC 606. For </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">elements of collaboration arrangements that are accounted pursuant to ASC 808, an appropriate recognition method is determined and applied consistently. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(t) Research and Development Expenses </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Elements of research and development expenses primarily include (i) payroll and other related costs of personnel engaged in research and development activities; (ii) in-licensed patent rights fees of exclusive development rights of products granted to the Company; (iii) costs related to pre-clinical testing of the Company&#8217;s technologies under development and clinical trials such as payments to contract research organizations (&#8220;CROs&#8221;) and contract manufacturing organizations (&#8220;CMOs&#8221;), investigators, and clinical trial sites that conduct its clinical studies; (iv) costs to develop the product candidates, including raw materials and supplies, product testing, depreciation, and facility-related expenses; and (v) other research and development expenses. Research and development expenses are charged to expense as incurred and have no alternative future uses. Liabilities related to third-party research and development expenses are primarily included in accounts payable on the consolidated balance sheet.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company has acquired rights to develop and commercialize product candidates. Upfront payments that relate to the acquisition of a new product compound, as well as pre-commercial milestone payments, are immediately expensed as acquired in-process research and development in the period in which they are incurred, provided that the new product compound did not also include processes or activities that would constitute a &#8220;business&#8221; as defined under U.S. GAAP. Milestone payments made to third parties subsequent to regulatory approval which meet the capitalization criteria would be capitalized as intangible assets and amortized over the estimated remaining useful life of the related product, which is generally based on expected patent life, the contractual period of the underlying license agreement, and expected commercial benefits of the products. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(u) Deferred Income </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Deferred income mainly consists of deferred income from government grants and the upfront payments received from Huizheng.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Government grants consist of cash subsidies received by the Company&#8217;s subsidiaries in mainland China from local governments. Grants received as incentives for conducting business in certain local districts with no performance obligation or other restriction as to the use are recognized as other income when cash is received. Grants received with government specified performance obligations are recognized as other income when all the obligations have been fulfilled. If such obligations are not satisfied, the Company may be required to refund the subsidy. The grant received before the fulfillment of specified performance obligation is recorded in deferred income. The Company had $2.1 million and $0.9 million of government grants in deferred income as of December&#160;31, 2023 and 2022, respectively. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In March 2020, the Company entered into an exclusive promotion agreement with Huizheng so that the Company could leverage Hanhui&#8217;s infrastructure to optimize an anticipated future commercial launch of NUZYRA in mainland China. In exchange for exclusive promotion rights in mainland China, Huizheng agreed to pay the Company non-creditable upfront payments of RMB230.0 million, of which RMB90.0 million was paid in April 2020, RMB70.0 million in 2022, and RMB70.0 million in 2023. The Company is amortizing the upfront payments through the end of the contract term. The Company had $26.7 million and $20.5 million in deferred income related to the upfront payments as of December&#160;31, 2023 and 2022, respectively.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(v) Comprehensive Loss </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Comprehensive loss is defined as the changes in equity of the Company during a period from transactions and other events and circumstances excluding transactions resulting from investments by owners and distributions to owners. For each of the periods presented, the Company&#8217;s comprehensive loss includes net loss and foreign currency translation adjustments, which are presented in the consolidated statements of comprehensive loss. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(w) Share-Based Compensation </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company grants share options and non-vested restricted shares to eligible employees, non-employees, and directors and accounts for these share-based awards in accordance with ASC 718, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Compensation-Stock Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company estimates the fair value of stock options using the Black-Scholes option-pricing model. The grant-date fair value of non-vested restricted shares is the market value of the underlying stock on the award&#8217;s grant date. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> The Company has elected to use the straight-line method to recognize compensation expenses for share awards with graded vesting based on service conditions, subject to the minimum amount of cumulative compensation expense recognized is not less than the portion of the award vested to date. For share-based awards with service conditions only, the Company recognizes expenses (i) immediately at grant date if no vesting conditions are required; or (ii) using a straight-line method over the requisite service period, which is the vesting period, if vesting conditions are required. For share-based awards containing performance conditions, the Company recognizes expenses based on the estimated number of the performance-based awards expected to vest using the graded vesting attribution method. The Company accounts for the effect of forfeitures as they occur.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(x) Income Taxes </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Income tax expense includes (i) deferred tax expense, which generally represents the net change in the deferred tax asset or liability balance during the year plus any change in valuation allowances; (ii) current tax expense, which represents the amount of tax currently payable to or receivable from a taxing authority; and (iii) non-current tax expense, which represents the increases and decreases in amounts related to uncertain tax positions from prior periods and not settled with cash or other tax attributes.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company recognizes deferred tax assets and liabilities for temporary differences between the financial statement and income tax bases of assets and liabilities, which are measured using enacted tax rates and laws that will be in effect when the differences are expected to reverse. A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company evaluates its uncertain tax positions using the provisions of ASC 740, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">, which requires that realization of an uncertain income tax position be recognized in the financial statements. The benefit to be recorded in the financial statements is the amount most likely to be realized assuming a review by tax authorities having all relevant information and applying current conventions. It is the Company&#8217;s policy to recognize interest and penalties related to unrecognized tax benefits, if any, as a component of income tax expense. No unrecognized tax benefits and related interest and penalties were recorded in any of the periods presented. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(y) Loss Per Share </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Basic loss per ordinary share is computed by dividing net loss attributable to ordinary shareholders by weighted average number of ordinary shares outstanding during the period. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Diluted loss per ordinary share reflects the potential dilution that could occur if securities were exercised or converted into ordinary shares. The Company had stock options and non-vested restricted shares, which could potentially dilute basic loss per share in the future. To calculate the number of shares for diluted loss per share, the effect of the stock options and non-vested restricted shares is computed using the treasury stock method. The computation of diluted loss per share does not assume exercise or conversion of securities that would have an anti-dilutive effect. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(z) Segment Information </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In accordance with ASC 280, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Segment Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">, the Company&#8217;s chief operating decision maker, the Chief Executive Officer, reviews the consolidated results when making decisions about allocating resources and assessing performance of the Company as a whole and therefore, the Company has only one operating and reportable segment.  </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(aa) Concentration of Risks</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Concentration of Customers </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">One customer accounted for 10% or more of revenue, with $59.4 million, $52.5 million, and $40.6 million in 2023, 2022, and 2021, respectively.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Concentration of Suppliers</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following suppliers accounted for 10% or more of research and development expenses and inventory purchases ($ in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">E</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">165,431&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66,650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">*  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Represents less than 10% of research and development expenses and inventory purchases for the period.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Concentration of Credit Risk </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Financial instruments that are potentially subject to significant concentration of credit risk consist of cash and cash equivalents, short-term investments, accounts receivable, and notes receivable. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The carrying amounts of cash and cash equivalents and short-term investments represent the maximum amount of loss due to credit risk. As of December&#160;31, 2023 and 2022, all of the Company&#8217;s cash and cash equivalents and short-term investments were held by major financial institutions located in mainland China and international financial institutions outside of mainland China which management believes are of high credit quality and continually monitors the credit worthiness of these financial institutions.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Accounts receivable are typically unsecured and are derived from product sales and collaborative arrangements. The Company manages credit risk of accounts receivable through ongoing monitoring of the outstanding balances and limits the amount of credit extended based upon payment history and credit worthiness. Historically, the Company has collected receivables from customers within the credit terms with no significant credit losses incurred. One customer accounted for 10% or more of accounts receivable, with $7.8 million and $9.3 million as of December&#160;31, 2023 and 2022, respectively.  </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Certain accounts receivable balances may be settled in the form of notes receivable. As of December&#160;31, 2023, notes receivable represented bank acceptance promissory notes that are non-interest bearing and due within six months. Notes receivable were used to collect the receivables based on an administrative convenience, given these notes are readily </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">convertible to be known amounts of cash. In accordance with the sales agreements, whether to use cash or bank acceptance promissory notes to settle the receivables is at the Company&#8217;s discretion, and this selection does not impact the agreed contractual purchase prices. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Foreign Currency Risk </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">RMB is not a freely convertible currency. The State Administration of Foreign Exchange, under the authority of the People&#8217;s Bank of China, controls the conversion of RMB into foreign currencies. The value of RMB is subject to changes in central government policies and to international economic and political developments affecting supply and demand in the China Foreign Exchange Trading System market. The cash and cash equivalents of the Company included aggregated amounts of $25.1 million and $45.5 million, which were denominated in RMB, as of December&#160;31, 2023 and 2022, respectively, representing 3% and 5% of the cash and cash equivalents as of December&#160;31, 2023 and 2022, respectively. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(ab) Recent Accounting Pronouncements </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In December 2023, the FASB issued ASU No. 2023-09, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Improvements to Income Tax Disclosures </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(Topic 740). The ASU requires disaggregated information about a reporting entity&#8217;s effective tax rate reconciliation as well as additional information on income taxes paid. The ASU is effective on a prospective basis for annual periods beginning after December 15, 2024. Early adoption is permitted. This ASU will result in the required additional disclosures being included in the consolidated financial statements, once adopted. The Company is currently evaluating the impact of this ASU and expects to adopt it for the year ending December 31, 2025.</span></div>The Company has not adopted any new accounting standards in 2023 that have a material impact on the Consolidated Financial Statements.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647762948608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash and Cash Equivalents<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Cash and Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsDisclosureTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text">Cash and Cash Equivalents <div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following table presents the Company&#8217;s cash and cash equivalents ($ in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">789,051&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,007,423&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents (i)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,047&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">790,151&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,008,470&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Denominated in:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">US$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">762,436&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">957,824&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RMB (ii)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25,093&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45,486&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hong Kong dollar (&#8220;HK$&#8221;)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,974&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,378&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Australian dollar (&#8220;A$&#8221;)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Taiwan dollar (&#8220;TW$&#8221;)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">184&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">790,151&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,008,470&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:17.57pt">Cash equivalents represent short-term and highly liquid investments in a money market fund. </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</span>Certain cash and bank balances denominated in RMB were deposited with banks in mainland China. The conversion of these RMB denominated balances into foreign currencies is subject to the rules and regulations of foreign exchange control promulgated by the Chinese government.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for cash and cash equivalent footnotes, which may include the types of deposits and money market instruments, applicable carrying amounts, restricted amounts and compensating balance arrangements. Cash and equivalents include: (1) currency on hand (2) demand deposits with banks or financial institutions (3) other kinds of accounts that have the general characteristics of demand deposits (4) short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only investments maturing within three months from the date of acquisition qualify.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647763083968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restricted Cash, Non-Current<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAbstract', window );"><strong>Restricted Cash [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_RestrictedCashNonCurrentTextBlock', window );">Restricted Cash, Non-Current</a></td>
<td class="text">Restricted Cash, Non-Current<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company&#8217;s restricted cash balance were $1.1 million and $0.8 million as of December&#160;31, 2023 and 2022, respectively, and consisted of long-term bank deposits held as collateral for issuance of letters of credit. These deposits will be released when the related letters of credit are settled by the Company.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_RestrictedCashNonCurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restricted cash, non-current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_RestrictedCashNonCurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647762894032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Short-Term Investments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestmentsAbstract', window );"><strong>Short-Term Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_ShortTermInvestmentTextBlock', window );">Short-Term Investments</a></td>
<td class="text">Short-Term InvestmentsShort-term investments are primarily comprised of time deposits with original maturities between three months and one year. The short-term investments balance were $16.3 million and nil as of December&#160;31, 2023 and 2022, respectively. No allowance for credit loss was recorded as of December 31, 2023.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_ShortTermInvestmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Short-term investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_ShortTermInvestmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647763072016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories, Net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventories, Net</a></td>
<td class="text">Inventories, Net<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following table presents the Company&#8217;s inventories, net ($ in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">22,702&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">12,156&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Raw materials</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">17,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">19,029&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Work in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,470&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">436&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inventories, net</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">44,827&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">31,621&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company writes down inventory for any excess or obsolete inventories or when the Company believes that the net realizable value of inventories is less than the carrying value. The Company recorded write-downs in inventory, which were included in cost of sales of $1.0 million, $0.5 million, and $1.4 million in 2023, 2022, and 2021, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//330/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647762944128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Investments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTextBlock', window );">Long-Term Investments</a></td>
<td class="text">Long-Term Investments In July 2021, the Company made an equity investment in MacroGenics Inc. (&#8220;MacroGenics&#8221;), a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer, in a private placement with total contributions of $30,000 and obtained 958,467 newly issued common shares of MacroGenics at $31.30 per share. The Company recorded this investment at acquisition cost and subsequently measured it at fair value, with the changes in fair value recognized in other income (expenses), net in the consolidated statements of operations. The equity investments with readily determinable fair value are measured using level 1 inputs and were $9.2 million and $6.4 million as of December&#160;31, 2023 and 2022, respectively. The Company recognized a fair value gain of $2.8 million in 2023, and losses of $9.0 million and $14.6 million in 2022 and 2021, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//320/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Topic 321<br> -Publisher FASB<br> -URI https://asc.fasb.org//321/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Topic 325<br> -Publisher FASB<br> -URI https://asc.fasb.org//325/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647762962016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment, Net</a></td>
<td class="text">Property and Equipment, Net <div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following table presents the components of the Company&#8217;s property and equipment, net ($ in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Office equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,047&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">977&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Electronic equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">9,161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,416&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Vehicle</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">202&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Laboratory equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">20,140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">18,726&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Manufacturing equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">17,680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">17,055&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">11,371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">11,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">24,272&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">24,251&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-weight:400;line-height:114%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">83,870&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">79,927&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(30,136)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(22,064)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">53,734&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">57,863&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Depreciation expense was $8.4 million, $7.7 million, and $6.0 million for 2023, 2022, and 2021, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//360/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647762889216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company leases facilities for its offices, research and development center, and manufacturing facilities in mainland China, Hong Kong, Taiwan, and the United States. Lease terms vary based on the nature of operations and market dynamics; however, all leased facilities are classified as operating leases with remaining lease terms between <span style="-sec-ix-hidden:f-627">one</span> and five years. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following table presents operating lease costs ($ in thousands). Total lease expense related to short-term leases was insignificant for those periods presented.</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating fixed lease cost</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,691&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,774&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6,263&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents operating cash flows related to leases ($ in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash paid for amounts included in measurement of lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,317&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,084&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,840&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-cash operating lease liabilities arising from obtaining operating right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,668&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,801&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The maturities of lease liabilities in accordance with ASC Topic 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> in each of the next five years and thereafter were as follows ($ in thousands): </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.778%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.022%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended<br/>December 31, 2023</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,444&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5,143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,811&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">822&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">15,611&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(460)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Present value of minimum operating lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">15,151&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Weighted-average remaining lease terms and discount rates are as follows: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.051%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.962%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Weighted-average remaining lease term</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2.5 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2.6 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Weighted-average discount rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647763919680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue</a></td>
<td class="text">Revenue<span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:139%"> </span><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Product Revenue</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company&#8217;s product revenue is derived from the sales of its commercial products primarily in mainland China. The table below presents the Company&#8217;s net product revenue ($ in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Product revenue &#8212; gross</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">298,911&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">234,009&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">190,180&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Less: Rebates and sales returns</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(32,192)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(21,337)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(46,075)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Product revenue &#8212; net</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">266,719&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">212,672&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">144,105&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Sales rebates are offered to distributors in mainland China, and the amounts are recorded as a reduction of revenue. Estimated rebates are determined based on contracted rates, sales volumes, and level of distributor inventories. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following table presents the Company&#8217;s net revenue by product ($ in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">ZEJULA</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">168,843&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">145,194&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">93,579&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">OPTUNE</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">46,969&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">47,321&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">38,903&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">QINLOCK</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">19,240&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">14,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">11,620&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">NUZYRA</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">21,656&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">VYVGART</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10,011&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Product revenue &#8212; net</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">266,719&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">212,672&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">144,105&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-9<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-15<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org//606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647762916176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Tax</a></td>
<td class="text">Income Tax<div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Cayman Islands </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Zai Lab Limited, ZLIP Holding Limited, Zai Auto Immune Limited, and Zai Anti Infectives Limited are incorporated in the Cayman Islands. Under the current laws of the Cayman Islands, Zai Lab Limited, ZLIP Holding Limited, Zai Auto Immune Limited, and Zai Anti Infectives Limited are not subject to tax on income or capital gain. Additionally, the Cayman Islands does not impose a withholding tax on payments of dividends to shareholders. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">British Virgin Islands Taxation </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">ZL Capital Limited is incorporated in the British Virgin Islands. Under the current laws of the British Virgin Islands, ZL Capital Limited is not subject to income tax. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Australia </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Zai Lab (AUST) Pty. Ltd. is incorporated in Australia and is subject to corporate income tax at a rate of 30%. Zai Lab (AUST) Pty. Ltd. had no taxable income for the periods presented; therefore, no provision for income taxes is required. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">United States </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Zai Lab (US) LLC is incorporated in the United States and is subject to U.S. federal corporate income tax at a rate of 21%. Zai Lab (US) LLC is also subject to state income tax in Delaware. Zai Lab (US) LLC had no taxable income for the periods presented; therefore, no provision for income taxes is required. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Taiwan </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Zai Lab (Taiwan) Limited is incorporated in Taiwan and is subject to corporate income tax at a rate of 20%. Zai Lab (Taiwan) Limited had no taxable income for the periods presented; therefore, no provision for income taxes is required. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Hong Kong </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Zai Lab (Hong Kong) Limited, ZL China Holding Two Limited, Zai Auto Immune (Hong Kong) Limited, and Zai Anti Infectives (Hong Kong) Limited are incorporated in Hong Kong. Companies registered in Hong Kong are subject to Hong Kong profits tax on the taxable income as reported in their respective statutory financial statements adjusted in accordance with relevant Hong Kong tax laws. Under the two-tiered profits tax rates regime in Hong Kong, the first HK$2 million of profits of the qualifying group entity will be taxed at 8.25%, and profits above HK$2 million will be taxed at </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">16.5%. In 2023, 2022, and 2021, Zai Lab (Hong Kong) Limited, ZL China Holding Two Limited, Zai Auto Immune (Hong Kong) Limited, and Zai Anti Infectives (Hong Kong) Limited did not make any provisions for Hong Kong profit tax as there were no assessable profits derived from or earned in Hong Kong for any of the periods presented. Under the Hong Kong tax law, Zai Lab (Hong Kong) Limited, ZL China Holding Two Limited, Zai Auto Immune (Hong Kong) Limited, and Zai Anti Infectives (Hong Kong) Limited are exempted from income tax on its foreign-derived income, and there are no withholding taxes in Hong Kong on remittance of dividends. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">People&#8217;s Republic of China</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Under EIT Law, the statutory income tax rate is 25%, and the EIT rate will be reduced to 15% for state-encouraged High and New Technology Enterprises (&#8220;HNTE&#8221;). Zai Lab (Shanghai) Co., Ltd., first obtained a HNTE certificate in 2018 and began to enjoy the preferential tax rate of 15% from 2018 to 2020 and further extended the certificate in 2021 effective for 2021 to 2023. Zai Lab International Trading (Shanghai) Co., Ltd., Zai Lab (Suzhou) Co., Ltd., Zai Biopharmaceutical (Suzhou) Co., Ltd., and Zai Lab Trading (Suzhou) Co., Ltd. are subject to the statutory rate of 25%. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">No provision for income taxes has been required to be accrued because the Company is in a cumulative loss position for the periods presented. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following table presents loss (income) before income taxes ($ in thousands): </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cayman Islands</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(16,792)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19,454&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28,401&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">British Virgin Islands</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mainland China</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">253,274&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">290,056&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">340,865&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hong Kong</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53,425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">243,400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92,869&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79,620&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89,374&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Australia</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(260)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,758&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Taiwan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">772&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">989&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">671&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">334,620&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">443,286&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">704,471&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Reconciliations of the differences between the Chinese statutory income tax rate and the Company&#8217;s effective income tax rate are as follows: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Statutory income tax rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax-exempted income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2.08&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development super deduction</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-deductible expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2.83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2.31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5.78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior year tax filing adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effect of different tax rate of subsidiary operation in other jurisdictions</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2.85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4.60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preferential tax rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7.12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6.26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4.30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expiration of deductible qualified donation </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(23.89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(21.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10.90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following table presents the principal components of deferred tax assets and liabilities ($ in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:58.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.932%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation of property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">131&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and experimental capitalization</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30,429&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22,476&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,422&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,787&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">707&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Government grants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,354&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,378&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Qualified donation</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22,992&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,947&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,967&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,738&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net operating loss carry forwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">295,313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">241,397&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(357,956)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(284,072)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total Deferred tax assets</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,826&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,738&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,826)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3,738)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets, net</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">ASC 740,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%"> Income Taxes,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> provides for the recognition of deferred tax assets if realization of such assets is more likely than not. The Company&#8217;s ability to realize deferred tax assets depends on its ability to generate sufficient taxable income within the carry forward periods provided for in the tax law. In assessing the need for any additional valuation allowance for 2023, the Company considered all available evidence both positive and negative, including potential for prudent and feasible tax planning strategies, recent losses, and forecasts of future profitability. As of December&#160;31, 2023 and 2022, the Company determined that the deferred tax assets on temporary differences and net operating loss carry forwards related to certain subsidiaries will not be realized, and as such it has fully provided the corresponding valuation allowance.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following table presents that movement of the valuation allowance on deferred tax assets ($ in thousands): </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance as of January 1,</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(284,072)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(189,684)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(73,884)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(94,388)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance as of December 31,</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(357,956)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(284,072)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">As of December&#160;31, 2023 and 2022, the Company had net operating loss carry forwards of $1,804.9 million and $1,483.2 million, respectively. As of December&#160;31, 2023, net operating loss carryforwards related to the Company&#8217;s subsidiaries in mainland China, Hong Kong, Taiwan, the United States, and Australia and were $1,492.0 million, $51.0 million, $2.1 million, $256.0 million, and $3.8 million, respectively. Net operating loss carryforwards in mainland China and Taiwan expire through 2033 and those in Hong Kong, the United States, and Australia do not expire.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Uncertainties exist with respect to how the current income tax law in mainland China applies to the Company&#8217;s overall operations, and more specifically, with regard to tax residency status. The EIT Law includes a provision specifying that legal entities organized outside of mainland China will be considered residents for Chinese income tax purposes if the place of effective management or control is within mainland China. The implementation rules to the EIT Law provide that non-resident legal entities will be considered Chinese residents if substantial and overall management and control over the manufacturing and business operations, personnel, accounting, and properties occurs within mainland China. Despite the present uncertainties resulting from the limited Chinese tax guidance on the issue, the Company does not believe that the legal entities organized outside of mainland China within the Company should be treated as residents for EIT Law purposes. If the Chinese tax authorities subsequently determine that the Company and its subsidiaries registered outside of mainland China should be deemed resident enterprises, the Company and its subsidiaries registered outside of mainland China will be subject to Chinese income taxes, at a rate of 25%. The Company is not subject to any other uncertain tax position. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">According to the PRC Tax Administration and Collection Law, the statute of limitation is three years if the underpayment of taxes is due to computational errors made by the taxpayer or the withholding agent. The statute of limitation is extended to five years under special circumstances where the underpayment of taxes is more than RMB0.1 million. In the case of transfer pricing issues, the statute of limitation is 10 years. There is no statute of limitation in the case of tax evasion. The income tax returns of the Company&#8217;s PRC subsidiary for the years from 2014 to 2023 are open to examination by the PRC tax authorities.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">For Hong Kong income tax purposes, the statute of limitations is six years after the relevant year of assessment. This can be extended to 10 years in the case of fraud of willful evasion of taxes. There are no provisions that govern the time limit for tax collection.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">For U.S. federal income tax purposes, the statute of limitations is generally 3 years after the due date of the return, or 3 years after the date the return was actually filed, whichever is later. The statute of limitations does not apply to fraud or tax evasion. Also, the statute of limitations is indefinite if no tax return is filed. For state income tax purpose, the statute of limitations is generally 4 years from the return filing date or due date for California, Kentucky, and New Jersey, subject to certain exceptions (e.g., fraud, failure to file).</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//740/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-21<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482526/740-270-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647759863504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Current Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_OtherCurrentLiabilitiesDisclosureTextBlock', window );">Other Current Liabilities</a></td>
<td class="text">Other Current Liabilities <div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following table presents the Company&#8217;s other current liabilities ($ in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued payroll</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33,711&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31,689&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued professional service fee</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,080&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payables for purchase of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,474&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,269&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued rebate to distributors</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16,926&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,443&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax payables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16,988&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13,283&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Others (i)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,353&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,054&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82,972&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66,818&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span>Others mainly include accrued travel, business-related expenses, and other payables to employee.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_OtherCurrentLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other current liabilities disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_OtherCurrentLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647762862784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loss Per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Loss Per Share</a></td>
<td class="text">Loss Per Share <div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following table presents the computation of the basic and diluted net loss per share ($ in thousands, except share and per share data):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss attributable to ordinary shareholders</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(334,620)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(443,286)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(704,471)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average number of ordinary shares - basic and diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">966,394,130</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">958,067,140</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">929,921,120</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss per share-basic and diluted</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.35)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.46)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.76)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">As a result of the Company&#8217;s net loss for 2023, 2022, and 2021, share options and non-vested restricted shares outstanding in the respective periods were excluded from the calculation of diluted loss per share as their inclusion would have been anti-dilutive.</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share options</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104,584,050</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91,181,420</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81,015,590</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-vested restricted shares</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31,279,600</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33,433,890</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,567,360</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647763048528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text">Related Party Transactions <div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company incurred research and development expenses for product research and development services provided by MEDx (Suzhou) Translational Medicine Co., Ltd (&#8220;MEDx&#8221;), over which an immediate family member of its Chief Executive Officer and Chairperson of the Board held significant influence. The Company incurred development expenses with MEDx of insignificant amount in 2023, and $0.4 million and $0.7 million in 2022 and 2021, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647763031712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Share-Based Compensation</a></td>
<td class="text">Share-Based Compensation <div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company has adopted equity incentive plans, pursuant to which the Company grants share options, SARs, restricted and unrestricted shares, and share units, performance awards, and other awards that are convertible into or otherwise based on ordinary shares to employees and directors of the Company as well as to certain advisors and service providers. In March 2015, the Board of Directors of the Company approved such an Equity Incentive Plan (the &#8220;2015 Plan&#8221;). In August 2017, in connection with the completion of the Company&#8217;s initial public offering on Nasdaq (the &#8220;IPO&#8221;), the Board of Directors approved the 2017 Equity Incentive Plan (the &#8220;2017 Plan&#8221;). No new equity-based awards would be granted under the 2015 Plan subsequent to the IPO; new equity-based awards would be granted under the 2017 Plan. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company adopted the 2022 Equity Incentive Plan (the &#8220;2022 Plan&#8221;), which became effective in June 2022 following required approvals from the Company&#8217;s shareholders and Board of Directors. No new equity-based awards will be made under the 2017 Plan as of the effective date of the 2022 Plan. The initial aggregate number of shares available for issuance under the 2022 Plan was 97,908,743 ordinary shares. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> The share options granted under the equity incentive plans described above have a contractual term of ten years. Share options granted since April 2023 generally vest ratably over a four-year period, and share options granted prior to April 2023 generally vest ratably over a five-year period, with 25% or 20% of the awards vesting on each anniversary of the grant date, respectively, subject to continued employment/service with the Company on the vesting date. The restricted shares granted generally vest ratably over a specified period on the anniversary of the grant date, subject to continued employment/service with the Company on the vesting date. The shares underlying restricted share grants represent shares not yet vested until they have met related consideration or vesting requirements, which are generally continued employment/service to the Company or satisfaction of specified performance conditions. The restricted shares will be released from the restrictions once they vest. Upon termination of the award holders&#8217; service with the Company for any reason, any shares that are outstanding and not yet vested will be immediately forfeited unless otherwise set forth in an agreement between the Company and the award holder.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Before November 2023, upon each settlement date of the share awards, shares were generally withheld to cover the required withholding tax, which was based on the value of a share on the settlement date as determined by the closing price of the ADSs on the trading day of the applicable settlement date. The remaining shares after the withholding were delivered to the recipient. The amount remitted to the tax authorities for employee tax obligations was reflected as a financing activity on the consolidated statements of cash flows. These shares withheld by the Company as a result of the net settlement were accounted for as treasury stock and considered issued but not outstanding. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Stock Option Activity</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following table presents a summary of option activity and related information in 2023: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of<br/>options </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted<br/>average exercise<br/>price<br/>($)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted<br/>average<br/>remaining<br/>contractual term (years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Aggregate<br/>intrinsic value <br/>($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding at December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91,181,420</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.05&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.89</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">115,969&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24,102,740</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6,516,920)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4,183,190)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding at December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104,584,050</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.97</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83,424&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vested and exercisable as of December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58,695,320</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.93</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83,266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The aggregate intrinsic value of stock options exercised during 2023, 2022, and 2021 was $20.3 million, $14.3 million, and $170.4 million, respectively. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Stock Option Valuation Assumptions</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following table presents the assumptions used to estimate the fair values of the share options granted: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.993%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk-free rate of return</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.5%-4.7%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.4%-4.0%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.9%-1.4%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6, 6.25,or 6.5</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.5 </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6, 6.25 or 6.5</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated volatility rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected dividend rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0%</span></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Options granted are measured based on grant-date fair value using the Black-Scholes option pricing model. The weighted-average grant-date fair value per share for options granted during 2023, 2022, and 2021 were $2.21, $2.74, and $12.60 per share, respectively. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Non-Vested Restricted Shares Activity</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following table summarized the Company&#8217;s non-vested restricted share activity in 2023: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Numbers<br/>of non-vested<br/>restricted shares </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted<br/>average<br/>remaining<br/>contractual term (years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Aggregate<br/>intrinsic value <br/>($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-vested as of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33,433,890</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.55</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102,642&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,001,740</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8,178,500)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,977,530)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-vested as of December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31,279,600</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.75</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85,487&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> The grant-date fair value of restricted shares is the fair value of the underlying stock on the award&#8217;s grant date. The weighted-average grant-date fair value per share for restricted shares granted in 2023, 2022, and 2021 were $3.18, $3.71, and $10.55 per share, respectively. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Stock-Based Compensation Expenses</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following table presents the share-based compensation expense which has been reported in the Company&#8217;s consolidated statements of operations ($ in thousands): </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48,017&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38,118&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23,194&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31,617&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23,184&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79,634&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61,302&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40,714&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div>As of December&#160;31, 2023, there was unrecognized share-based compensation expense related to unvested share options and unvested restricted shares of $104.2 million and $104.1 million, respectively, which the Company expects to recognize over a weighted-average period of 3.05 years and 2.75 years, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//718/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647763019504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>License and Collaboration Agreements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_LicensesAndCollaborativeArrangementDisclosureTextBlock', window );">License and Collaboration Agreements</a></td>
<td class="text">License and Collaboration Agreements <div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company may enter into collaboration agreements with third parties to license intellectual property. These agreements may require the Company to make upfront payments and payments related to certain future development, regulatory, and sales-based milestones as well as certain royalties at tiered percentage rates on annual sales of the licensed products in the licensed territory. These agreements generally remain in effect, unless earlier terminated, until the expiration of the last-to-expire royalty term for the last licensed product. The royalty terms generally continue until the latest of: (i) the expiration of the last-to-expire valid claim with respect to licensed patent rights; (ii) the expiration of market or regulatory exclusivity; or (iii) or a specified period of time, generally around ten years, after the date of the first commercial sale of the licensed product. These agreements also contain customary provisions for termination by either party, including in the event of a material breach by the other party that remains uncured; by us for convenience upon a specified notice period; for certain bankruptcy, insolvency, or other similar events; and by its partners upon challenge of their licensed patent rights. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Payments under these agreements generally become due and payable upon the achievement of such milestones or sales. These commitments are not recorded as liabilities on the consolidated balance sheet because the achievement and timing of these milestones are not fixed and determinable. The following is a description of the Company&#8217;s significant license and collaboration agreements as of December&#160;31, 2023, including milestone fees incurred in 2023, 2022, and 2021. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;text-decoration:underline">Significant License and Collaboration Arrangements</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">License and Collaboration Agreement with GSK (Niraparib) </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In September 2016, the Company entered into a collaboration, development, and license agreement with Tesaro, Inc., a company later acquired by GSK, pursuant to which the Company obtained an exclusive sublicense under certain patents and know-how of GSK to develop, manufacture, and commercialize GSK&#8217;s proprietary PARP inhibitor, niraparib, for the diagnosis and prevention of any human diseases or conditions (other than prostate cancer) in mainland China, Hong Kong, and Macau. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company recorded development milestone fees into research and development expenses of $4.0 million in 2022. The Company recorded sales-based milestone fees of $12.0 million and $8.0 million in 2023 and 2021, respectively. The Company may be required to pay an additional aggregate amount of up to $16.0 million in development, regulatory, and sales-based milestones as well as certain royalties at tiered percentages rates ranging from mid- to high-teens on annual net sales of the licensed products in the licensed territories.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">License and Collaboration Agreement with NovoCure (Tumor Treating Fields)</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In September 2018, the Company entered into a license and collaboration agreement with NovoCure, pursuant to which it obtained an exclusive license under certain patents and know-how of NovoCure to develop and commercialize any Tumor Treating Fields treatment or delivery system, including the device branded as OPTUNE, in all human therapeutic and preventative uses in the field of oncology in Greater China. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company may be required to pay an additional aggregate amount of up to $68.0 million in development, regulatory, and sales-based milestones as well as certain royalties at tiered percentage rates ranging from low- to mid-teens on annual net sales of the licensed products in the licensed territory. The Company will purchase licensed products exclusively from NovoCure at NovoCure&#8217;s fully burdened manufacturing cost. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">License and Collaboration Agreement with Deciphera (Ripretinib)</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In June 2019, the Company entered into a license agreement with Deciphera, pursuant to which it obtained an exclusive license under certain patents and know-how of Deciphera to develop and commercialize products containing ripretinib in the field of the prevention, prophylaxis, treatment, cure, or amelioration of any disease or medical condition in humans in Greater China. The Company will purchase licensed products exclusively from Deciphera.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company recorded development milestone fees into research and development expenses of $5.0 million in 2021.  The Company may be required to pay an additional aggregate amount of up to $173.0 million in development, regulatory, and sales-based milestones as well as certain royalties at tiered percentage rates ranging from low- to high-teens on annual net sales of the licensed products in the licensed territory.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">License and Collaboration Agreement with Novo Holdings (Omadacycline)</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In April 2017, the Company entered into a license and collaboration agreement with Paratek Bermuda Ltd. (&#8220;Paratek&#8221;), a subsidiary of Paratek (which was subsequently acquired by Gurnet Point Capital and Novo Holdings A/S), pursuant to which the Company obtained both an exclusive license under certain patents and know-how of Paratek and an exclusive sub-license under certain intellectual property that Paratek licensed from Tufts University to develop, manufacture, and commercialize products containing omadacycline as an active ingredient in the field of all human therapeutic and preventative uses other than biodefense in Greater China.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company recorded development milestone fees into research and development expenses of $6.0 million in 2021. The Company may be required to pay an additional aggregate amount of up to $40.5 million in development, regulatory, and sales-based milestones as well as certain royalties at tiered percentages rates ranging from low- to mid-teens on annual net sales of licensed products in the licensed territory. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Collaboration and License Agreement with argenx (Efgartigimod)</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In January 2021, the Company entered into a collaboration and license agreement with argenx BV (&#8220;argenx&#8221;) pursuant to which the Company obtained an exclusive license under certain patients and know-how of argenx to develop and commercialize products containing efgartigimod as an active ingredient in all human and animal uses for any </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">preventative or therapeutic indications in Greater China. The Company will purchase licensed products exclusively from argenx.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Pursuant to the collaboration and license agreement, the Company and argenx entered into a share issuance agreement. The Company issued as an upfront payment to argenx of 5,681,820 ordinary shares of the Company. In determining the fair value of the ordinary shares at closing, the Company considered the closing price of the ordinary shares on the closing date and included a lack of marketability discount because the shares were subject to certain restrictions. The fair value of the shares on the closing date was determined to be $62.3 million in the aggregate. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company recorded development milestone fees into research and development expense of $100.0 million in 2021. The Company may be required to pay certain royalties at tiered percentages rates ranging from mid-teen to low-twenties on annual net sales of the licensed products in the licensed territory.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">License and Collaboration Agreement with Amgen (Bemarituzumab)</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In December 2017, the Company entered into a license and collaboration agreement with Five Prime Therapeutics, Inc. (a company later acquired by Amgen), pursuant to which it obtained an exclusive license under certain patents and know-how of Five Prime to develop and commercialize products containing Five Prime&#8217;s proprietary afucosylated FGFR2b antibody known as bemarituzumab (FPA144) as an active ingredient in the treatment or prevention of any disease or condition in humans in Greater China.  The Company will purchase licensed products exclusively from Amgen.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company may be required to pay an additional aggregate amount of up to $37.0 million in development and regulatory milestones as well as certain royalties at tiered percentage rates ranging from high-teens to low twenties on annual net sales of the licensed product in the licensed territory. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Under the terms of the agreement, provided that the Company enrolls and treats a specified number of patients in the bemarituzumab FPA144-004 study in mainland China, the Company is eligible to receive a low single-digit percentage quarterly royalty, on a licensed product-by-licensed product basis on net sales of all licensed product outside of the licensed territory until the tenth (10th) anniversary of the first commercial sale of each such licensed product outside of the licensed territory. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">License and Collaboration Agreement with Innoviva (SUL-DUR)</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In April 2018, the Company entered into a license and collaboration agreement with Entasis Therapeutics Holdings Inc. (&#8220;Entasis&#8221;), a wholly owned subsidiary of Innoviva, Inc. (&#8220;Innoviva&#8221;), pursuant to which it obtained an exclusive license under certain patents and know-how of Entasis to develop and commercialize products containing Entasis&#8217;s proprietary compounds known as durlobactam with Sulbactam (the combination, SUL-DUR) with the possibility of developing and commercializing a combination of such compounds with Imipenem in all human diagnostic, prophylactic, and therapeutic uses in Greater China, Korea, Vietnam, Thailand, Cambodia, Laos, Malaysia, Indonesia, the Philippines, Singapore, Australia, New Zealand, and Japan. The Company&#8217;s rights to develop and commercialize the licensed products are limited to the lead product (Sulbactam) until such lead product receives initial FDA approval in the United States. The Company will purchase licensed products exclusively from Innoviva.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company recorded development milestone fees into research and development expenses of $3.0 million in 2023. The Company may be required to pay an additional aggregate amount of up to $88.6 million in development and sales-based milestones as well as certain royalties at tiered percentage rates ranging from high single digits to low-teens on annual net sales of the licensed products in the licensed territory. The Company is also responsible for a portion of the costs of the global pivotal Phase III ATTACK clinical trial of SUL-DUR outside of the licensed territory.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">License Agreement with BMS (Repotrectinib)</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In July 2020, the Company entered into an exclusive license agreement with Turning Point Therapeutics, Inc. (a company later required by BMS) pursuant to which the Company received an exclusive license to develop and commercialize products containing repotrectinib as an active ingredient in all human therapeutic indications in Greater China. The Company will purchase licensed products exclusively from BMS.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company recorded development milestone fees into research and development expenses of $5.0 million in each of 2023 and 2021. The Company may be required to pay an additional aggregate amount of up to $141.0 million in development, regulatory, and sales-based milestones as well as certain royalties at tiered percentage rates ranging from mid- to high-teens on annual net sales of the licensed product in the licensed territory. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Collaboration and License Agreement with BMS (Adagrasib)</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In May 2021, the Company entered into a collaboration and license agreement with Mirati Therapeutics, Inc. (&#8220;Mirati&#8221;) (a company later acquired by BMS) pursuant to which the Company obtained the right to research, develop, manufacture, and exclusively commercialize adagrasib in all indications in Greater China, with Mirati retaining exclusive rights for the development, manufacturing, and commercialization of adagrasib outside of Greater China and certain co-commercialization, manufacture, and development rights in Greater China. The Company will purchase licensed products exclusively from BMS.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company recorded development milestone fees of $10.0 million in 2022 and an upfront payment of $65.0 million in 2021. The Company may be required to pay an additional aggregate amount of up to $263.0 million in development, regulatory, and sales-based milestones as well as certain royalties at tiered percentage rates ranging from high-teens to low-twenties on annual net sales of the licensed product in the licensed territory.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">License Agreement with BMS (Xanomeline-Trospium)</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In November 2021, the Company entered into a license agreement with Karuna Therapeutics, Inc. (a company later acquired by BMS), pursuant to which the Company obtained an exclusive license to develop, manufacture, and commercialize xanomeline-trospium (KarXT) in Greater China.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company recorded an upfront payment of $35.0 million and development milestone fees of $10.0 million into research and development expenses in 2021 and 2022, respectively. The Company may be required to pay an additional aggregate amount of up to $142.0 million in development, regulatory, and sales-based milestones as well as certain royalties at tiered percentage rates ranging from low- to high-teens on annual net sales of the licensed products in Greater China.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Collaboration and License Agreement with Pfizer (Tisotumab Vedotin)</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In September 2022, the Company entered into a collaboration and license agreement with Seagen Inc. (a company later acquired by Pfizer Inc. (&#8220;Pfizer&#8221;), pursuant to which the Company and Seagen agreed to collaboratively develop and commercialize tisotumab vedotin (TIVDAK). Under the agreement, the Company obtained an exclusive license to develop and commercialize TIVDAK in Greater China.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company recorded an upfront payment of $30.0 million into research and development expenses in 2022. The Company may be required to pay an additional aggregate amount of up to $263.0 million in development, regulatory, and sales-based milestone payments as well as certain royalties at tiered percentage rates ranging from mid-teens to low-twenties on annual net sales of the licensed products in Greater China. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The agreement will remain in effect, unless earlier terminated, until the expiration of the last-to-expire royalty term for the last licensed product. The agreement contains customary provisions for termination by either party, including in the event of a material breach by the other party that remains uncured, by the Company for convenience, for certain bankruptcy events, and by Seagen upon a challenge of the licensed patent rights.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;text-decoration:underline">Other License and Collaboration Arrangements That Are Not Individually Significant</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company recorded an upfront payment of $10.0&#160;million in 2023 for other license and collaboration agreements that are not individually significant. The Company may be required to pay an additional aggregate amount of up to $2,202.1 million in development, regulatory, and sales-based milestones as well as certain royalties at tiered percentage rates on annual net sales under such agreements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_LicensesAndCollaborativeArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Licenses and collaborative arrangement disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_LicensesAndCollaborativeArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647763051664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Income (Expenses), Net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock', window );">Other Income (Expenses), Net</a></td>
<td class="text">Other Income (Expenses), Net <div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following table presents the Company&#8217;s other income (expenses), net ($ in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Government grants</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,433&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,471&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,113&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gain (Loss) on equity investments with readily determinable fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,789&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8,952)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(14,617)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Others miscellaneous gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,784&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">594&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">303&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,006&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,113&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10,201)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the components of non-operating income or non-operating expense, including, but not limited to, amounts earned from dividends, interest on securities, gain (loss) on securities sold, equity earnings of unconsolidated affiliates, gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647762082864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restricted Net Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_RestrictedNetAssetsAbstract', window );"><strong>Restricted net assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedAssetsDisclosureTextBlock', window );">Restricted Net Assets</a></td>
<td class="text">Restricted Net Assets<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company&#8217;s ability to pay dividends may depend on the Company receiving distributions of funds from its Chinese subsidiaries. Relevant Chinese laws and regulations permit payments of dividends by the Company&#8217;s Chinese subsidiaries only out of its retained earnings, if any, as determined in accordance with Chinese accounting standards and regulations. The results of operations reflected in the consolidated financial statements prepared in accordance with U.S. GAAP differ from those reflected in the statutory financial statements of the Company&#8217;s Chinese subsidiaries.  </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In accordance with the Company Law of the People&#8217;s Republic of China, a domestic enterprise is required to provide statutory reserves of at least 10% of its annual after-tax profit until such reserve has reached 50% of its respective registered capital based on the enterprise&#8217;s Chinese statutory accounts. A domestic enterprise may provide discretionary surplus reserve, at the discretion of the Board of Directors, from the profits determined in accordance with the enterprise&#8217;s Chinese statutory accounts. The aforementioned reserves can only be used for specific purposes and are not distributable as cash dividends. The Company&#8217;s Chinese subsidiaries were established as domestic enterprises and therefore are subject to the above-mentioned restrictions on distributable profits. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">No appropriation to statutory reserves was made during the years ended December&#160;31, 2023, 2022, and 2021 because the Chinese subsidiaries had substantial losses during such periods. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">As a result of these Chinese laws and regulations, subject to the limits discussed above that require annual appropriations of 10% of after-tax profit to be set aside, prior to payment of dividends, as a general reserve fund, the Company&#8217;s Chinese subsidiaries are restricted in their ability to transfer out a portion of their net assets. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Foreign exchange and other regulation in mainland China may further restrict the Company&#8217;s subsidiaries in mainland China from transferring out funds in the form of dividends, loans, and advances. As of December&#160;31, 2023 and </span></div>2022, amounts restricted were the paid-in capital of the Company&#8217;s subsidiaries in mainland China, which were $506.0 million and $456.0 million, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for assets that are restricted in their use, generally by contractual agreements or regulatory requirements. This would include, but not limited to, a description of the restricted assets and the terms of the restriction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_RestrictedNetAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restricted net assets .</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_RestrictedNetAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647762862784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Defined Contribution Plans<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock', window );">Employee Defined Contribution Plans</a></td>
<td class="text">Employee Defined Contribution Plans<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Full time employees of the Company in mainland China participate in a government mandated defined contribution plan, pursuant to which certain pension benefits, medical care, employee housing fund, and other welfare benefits are provided to employees. Chinese labor regulations require that the Company&#8217;s subsidiaries in China mainland make contributions to the government for these benefits primarily based on certain percentages of the employees&#8217; salaries subject to certain caps and other government requirements. The total amounts for such employee benefits, which were expensed as incurred, were $25.8 million, $23.6 million, and $17.6 million for 2023, 2022, and 2021, respectively.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company&#8217;s employees who are U.S. taxpayers and who meet certain age and service requirements are eligible to participate in a broad-based, defined contribution retirement plan which is qualified under Section 401 of the Internal Revenue Code (&#8220;the 401(k) plan&#8221;). The Company makes a matching contribution equal to 100% in 2023 and 50% in 2022 and 2021 of the first 5% of the employee&#8217;s elective contributions under the plan, up to 5.0% of an employee&#8217;s eligible compensation. Contributions made by the Company vest 100% upon contribution. The total amounts for such employee benefits, which were expensed as incurred, were $1.0 million, $0.5 million, and insignificant in 2023, 2022, and 2021, respectively. </span></div>The Company also provides required Mandatory Provident Fund contribution for its full-time employees located in Hong Kong and provides social benefits contribution for its full-time employees located in Taiwan. The total amounts for these contributions, which were expensed as incurred, was $0.2 million, $0.2 million, and insignificant in 2023, 2022, and 2021, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of an entity's employee compensation and benefit plans, excluding share-based compensation and including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, life insurance, severance, health care, unemployment and other benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 710<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//710/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 712<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//712/tableOfContent<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 715<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//715/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647756130224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(a)&#160;&#160;&#160;&#160;Purchase Commitments</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company&#8217;s commitments related to purchase of property and equipment contracted but not yet reflected in the consolidated financial statements were $1.2 million as of December&#160;31, 2023 and were expected to be incurred within one year. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(b)&#160;&#160;&#160;&#160;Legal Proceedings</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company is not currently a party to any material legal proceedings. Each quarter, the Company evaluates whether there have been any developments in legal proceedings that would require an accrual. In accordance with the accounting guidance for contingencies, the Company will accrue for losses that are both probable and reasonably estimable. The Company will record any legal and other third-party costs related to its legal contingencies as incurred.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">(c)       Indemnifications</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In the normal course of business, the Company enters into agreements that indemnify others for certain liabilities that may arise in connection with a transaction or certain events and activities. If the indemnified party were to make a successful claim pursuant to the terms of the indemnification, the Company may be required to reimburse the loss. These indemnifications are generally subject to various restrictions and limitations. The Company&#8217;s exposure under these agreements is unknown because it involves claims that may be made against the Company in the future but have not yet </span></div>been made. To date, the Company has not paid any claims or been required to defend any action related to its indemnification obligations.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//450/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480327/954-440-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647763135040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text">Subsequent Events <div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In February 2024, the Company entered into certain debt arrangements with the Bank of China, SPD Bank, and Ningbo Bank to support its working capital needs in mainland China.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Bank of China Working Capital Loan Facility</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">On February 5, 2024, the Company entered into an uncommitted facility letter with the Bank of China (Hong Kong) Limited (the &#8220;BOC HK&#8221;) pursuant to which the BOC HK will provide standby letters of credit for loans of up to $100.0 million for a term of one year. In connection with this agreement, the Company paid a one-time, non-refundable fee of $0.7 million. On February 6, 2024, upon the Company&#8217;s application, the BOC HK provided a standby letter of credit in favor of the Bank of China Pudong Development Zone Branch (the &#8220;BOC Pudong Branch&#8221;) for $50.0&#160;million which are or may become payable by the Company&#8217;s wholly-owned subsidiary, Zai Lab (Shanghai) Co., Ltd. (&#8220;Zai Lab Shanghai&#8221;), and Zai Lab Shanghai subsequently entered into a working capital loan contract with the BOC Pudong Branch on February 7, 2024 for a loan of RMB340.0&#160;million (approximately $47.8&#160;million). The working capital loan has a one-year term and is subject to a floating interest rate of approximately 2.95% initially, and is subject to adjustment every six months.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">SPD Bank Working Capital Loan Facility</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">On February 6, 2024, the Company entered into a maximum-amount guarantee contract with the Shanghai Pudong Development Bank Co., Ltd. Zhangjiang Hi-Tech Park Sub-branch (the &#8220;SPD Bank&#8221;) pursuant to which the Company will guarantee working capital loans of up to RMB300.0&#160;million (approximately $42.0&#160;million) from SPD Bank to Zai Lab Shanghai over a three-year period. To date, Zai Lab Shanghai has entered into a working capital loan contract with SPD Bank under this debt facility for RMB50.0&#160;million (approximately $7.0&#160;million). The working capital loan has a one-year term and is subject to a fixed interest rate of 3.45%.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Ningbo Bank Working Capital Loan Facility</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">On February 6, 2024, the Company&#8217;s wholly-owned subsidiary, Zai Lab (Suzhou) Co., Ltd. (&#8220;Zai Lab Suzhou&#8221;), entered into a maximum credit contract with Bank of Ningbo Co., Ltd. Suzhou Sub-branch (&#8220;Ningbo Bank&#8221;) as well as an Electronic Commercial Draft Discounting Master Agreement and Online Working Capital Loan Master Agreement (collectively, the &#8220;Ningbo Bank Agreements&#8221;). The Ningbo Bank Agreements permit Zai Lab Suzhou to utilize, including through discounting or working capital loan agreements and subject to the terms and conditions in related master agreements, up to RMB230.3&#160;million (approximately $32.4&#160;million), of which the Company is authorized to utilize up to RMB160.0&#160;million (approximately $22.5&#160;million). In connection with the arrangements described in the Ningbo Bank Agreements, Zai Lab Suzhou agreed to pledge interests in certain real property it owns in Suzhou. To date, Zai Lab Suzhou has not entered into any discounting arrangements or working capital loans under this Ningbo Bank working capital loan facility.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647763080656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule I &#8212; Condensed Financial Information of Registrant<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract', window );"><strong>Condensed Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock', window );">Schedule I &#8212; Condensed Financial Information of Registrant</a></td>
<td class="text"><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Schedule I &#8212; Condensed Financial Information of Registrant</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Zai Lab Limited</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Information of Parent Company</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Balance Sheets</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands of $, except for number of shares and per share data)</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">565,981&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">944,649&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepayments and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,203&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">573,404&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">954,852&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investment in subsidiaries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">224,954&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93,363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">798,358</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,048,215</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liabilities and shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,240&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,620&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,240&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,620&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2,240</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2,620</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ordinary shares (par value of $0.000006 per share; 5,000,000,000 shares authorized, 977,151,270 and 962,455,850 shares issued as of December&#160;31, 2023 and 2022, respectively; 972,239,070 and 960,219,570 shares issued and outstanding as of December&#160;31, 2023 and 2022, respectively)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,975,302&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,893,120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,195,980)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,861,360)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated other comprehensive income</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37,626&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25,685&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Treasury stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(20,836)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(11,856)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total shareholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">796,118</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,045,595</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total liabilities and shareholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">798,358</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,048,215</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Schedule I &#8212; Condensed Financial Information of Registrant</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Zai Lab Limited </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Information of Parent Company</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Statements of Operations and Comprehensive Loss</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands of $)</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(82)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(178)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(16,958)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(19,773)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(12,074)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Loss from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(17,040)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(19,951)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(12,080)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30,840&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,857&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,881&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,029&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8,678)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(18,173)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Profit (Loss) before income tax and equity in loss of subsidiaries</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17,829</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(15,772)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(28,372)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity in loss of subsidiaries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(352,449)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(427,514)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(676,099)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(334,620)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(443,286)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(704,471)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive income (loss), net of tax of nil:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,941&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49,330&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(9,121)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(322,679)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(393,956)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(713,592)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Schedule I &#8212; Condensed Financial Information of Registrant</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Zai Lab Limited </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Information of Parent Company </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Statements of Cash Flows</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands of $)</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(334,620)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(443,286)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(704,471)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjustments to reconcile net loss to net cash provided by (used in) operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of deferred income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(234)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(312)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,217&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,724&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,435&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity in loss of subsidiaries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">352,449&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">427,514&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">676,099&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss from fair value changes of equity investment of readily determinable fair value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,789)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,952&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,617&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepayments and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,780&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7,839)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(439)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(379)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,648&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(376)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by (used in) operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20,658&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(9,521)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(11,447)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchases of short-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(260,274)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(445,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proceeds from maturity of short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">705,274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">743,902&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchase of investment in equity investee</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(30,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investment in subsidiaries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(392,893)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(80,942)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(884,342)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash (used in) provided by investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(392,893)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">364,058&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(615,440)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proceeds from exercises of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,369&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,870&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,418&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proceeds from issuance of ordinary shares upon public offerings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">818,875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payment of public offering costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,692)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employee taxes paid related to settlement of equity awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8,802)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7,600)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4,253)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash (used in) provided by financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6,433)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,730)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">820,348&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effect of foreign exchange rate changes on cash and cash equivalent</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">773&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net (decrease) increase in cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(378,668)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">352,807&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">194,234&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents-beginning of the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">944,649&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">591,842&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">397,608&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents-end of the year</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">565,981&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">944,649&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">591,842&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Schedule I &#8212; Condensed Financial Information of Registrant</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Zai Lab Limited </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Information of Parent Company</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;Schedule I has been provided pursuant to the requirements of Rule 12-04(a) and 5-04(c) of Regulation S-X, which require condensed financial information as to the financial position, changes in financial position and results of operations of a parent company as of the same dates and for the same periods for which audited consolidated financial statements have been presented when the restricted net assets of consolidated subsidiaries exceed 25 percent of consolidated net assets as of the end of the most recently completed fiscal year. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;The condensed financial information has been prepared using the same accounting policies as set out in the consolidated financial statements except that the equity method has been used to account for investments in its subsidiaries. For the parent company, Zai Lab Limited records its investments in subsidiaries under the equity method of accounting as prescribed in ASC 323, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments-Equity Method and Joint Ventures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Such investments are presented on the Condensed Balance Sheets as &#8220;Investment in subsidiaries&#8221;. Ordinarily under the equity, an investor in an equity method investee would cease to recognize its share of the losses of an investee once the carrying value of the investment has been reduced to nil absent an undertaking by the investor to provide continuing support and fund losses. For the purpose of this Schedule I, the parent company has continued to reflect its share, based on its proportionate interest, of the losses of subsidiaries regardless of the carrying value of the investment even though the parent company is not obligated to provide continuing support or fund losses. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. The footnote disclosures provide certain supplemental information relating to the operations of the Company and, as such, these statements should be read in conjunction with the notes to the accompanying consolidated financial statements. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;As of December&#160;31, 2023 and 2022, there were no material contingencies, significant provisions of long-term obligations, mandatory dividend or redemption requirements of redeemable stocks or guarantees of Zai Lab Limited.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for condensed financial information, including the financial position, cash flows, and the results of operations of the registrant (parent company) as of the same dates or for the same periods for which audited consolidated financial statements are being presented. Alternatively, the details of this disclosure can be reported by the specific parent company taxonomy elements, indicating the appropriate date and period contexts in an instance document.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.5-04(Schedule I))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480922/205-10-S99-6<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647763100080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (334,620)<span></span>
</td>
<td class="num">$ (443,286)<span></span>
</td>
<td class="num">$ (704,471)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647758637504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=zlab_RafaelAmadoMember', window );">Rafael Amado [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MtrlTermsOfTrdArrTextBlock', window );">Material Terms of Trading Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">On December 15, 2023, Rafael Amado, the Company&#8217;s President and Head of Global Oncology Research and Development, adopted a new written Rule 10b5-1 trading arrangement (as defined in Item 408 of Regulation S-K), for the sale of up to 94,500 of the Company&#8217;s ADSs, each representing ten of the Company&#8217;s ordinary shares. This Rule 10b5-1 trading arrangement is scheduled to terminate no later than December 16, 2024.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndName', window );">Name</a></td>
<td class="text">Rafael Amado<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndTitle', window );">Title</a></td>
<td class="text">President and Head of Global Oncology Research and Development<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrAdoptionDate', window );">Adoption Date</a></td>
<td class="text">December 15, 2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrDuration', window );">Arrangement Duration</a></td>
<td class="text">367 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrSecuritiesAggAvailAmt', window );">Aggregate Available</a></td>
<td class="nump">94,500<span></span>
</td>
<td class="nump">94,500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MtrlTermsOfTrdArrTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MtrlTermsOfTrdArrTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrAdoptionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrAdoptionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrDuration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph C<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrDuration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrIndName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrIndName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrIndTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrIndTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrSecuritiesAggAvailAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrSecuritiesAggAvailAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=zlab_RafaelAmadoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=zlab_RafaelAmadoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647762262016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">Basis of Presentation <div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#8220;U.S. GAAP&#8221;). Significant accounting policies followed by the Company in the preparation of the accompanying consolidated financial statements are summarized below. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Effective as of March 30, 2022, the Company subdivided each of its issued and unissued ordinary shares into ten ordinary shares (the &#8220;Share Subdivision&#8221;). Following the Share Subdivision, the Company&#8217;s authorized share capital became $30,000 divided into 5,000,000,000 shares with a par value of $0.000006 per share. The numbers of issued and unissued ordinary shares and per share data as disclosed elsewhere in these consolidated financial statements and notes thereto are presented on a basis after taking into account the effects of the Share Subdivision and have been retrospectively adjusted, where applicable. In connection with the Share Subdivision, the conversion ratio of its ADSs to ordinary shares changed from one ADS to one ordinary share to a new ratio of one ADS to ten ordinary shares (the &#8220;ADS Ratio Change&#8221;). The Share Subdivision and ADS Ratio Change did not result in any change to the number of outstanding ADSs of the Company. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> In 2022, the Company began to separately present foreign currency (loss) gain on the consolidated statements of operations. This amount was previously included in other income (expense), net. Additionally, the Company began to provide a breakdown of other income (expense), net in Note 17.  The Company also began to separately present the amount of foreign currency remeasurement loss (gain) on the consolidated statements of cash flows. This amount was previously included in changes in other current liabilities. This change did not have any impact on net cash used in operating activities. Corresponding amounts in the prior periods of the consolidated financial statements have been presented to conform to the current period presentation.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text">Principles of Consolidation<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The consolidated financial statements include the accounts of Zai Lab Limited and its subsidiaries, which are wholly owned. All intercompany transactions and balances are eliminated upon consolidation.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text">Use of Estimates The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Areas where management uses subjective judgment include, but are not limited to, accrual of rebates, recognition of research and development expenses to the appropriate financial reporting period based on actual services performed, fair value of share-based compensation expenses, and recoverability of deferred tax assets. These estimates, judgments, and assumptions can affect the reported amounts of assets and liabilities as of the date of the financial statements as well as the reported amounts of revenues and expenses during the periods presented. Actual results could differ from these estimates.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Translation</a></td>
<td class="text">Foreign Currency Translation <div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The functional currency of Zai Lab Limited, Zai Lab (Hong Kong) Limited, Zai Lab (US) LLC, and Zai Auto Immune (Hong Kong) Limited are the U.S. dollar (&#8220;$&#8221;). The Company&#8217;s subsidiaries in mainland China determined their functional currency to be the Chinese Renminbi (&#8220;RMB&#8221;). The Company&#8217;s subsidiary in Australia determined its </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">functional currency to be the Australian dollar (&#8220;A$&#8221;). The Company&#8217;s subsidiary in Taiwan determined its functional currency to be the Taiwan dollar (&#8220;TWD&#8221;). The determination of the respective functional currency is based on the criteria of Accounting Standard Codification (&#8220;ASC&#8221;) 830, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Foreign Currency Matters</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">. The Company uses the U.S. dollar as its reporting currency. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Assets and liabilities are translated from each entity&#8217;s functional currency to the reporting currency at the exchange rate on the balance sheet date. Equity amounts are translated at historical exchange rates. Revenues, expenses, gains, and losses are translated using the average rate for the period presented. The resulted foreign currency translation adjustments are recorded as a component of other comprehensive loss in the consolidated statements of comprehensive loss, and the accumulated foreign currency translation adjustments are recorded as a component of accumulated other comprehensive income (loss) in the consolidated statements of shareholders&#8217; equity.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Monetary assets and liabilities denominated in currencies other than the applicable functional currencies are translated into the functional currencies at the prevailing rates of exchange at the balance sheet date.</span></div>Non-monetary assets and liabilities are translated into the applicable functional currencies at historical exchange rates. Transactions in currencies other than the applicable functional currencies during the year are converted into the functional currencies at the applicable rates of exchange prevailing at the transaction dates. Transaction gains and losses are recognized in the consolidated statements of operations.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Cash, Cash Equivalents and Restricted Cash</a></td>
<td class="text">Cash, Cash Equivalents, and Restricted Cash <div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Cash and Cash Equivalents </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company considers all highly liquid investments purchased with original maturities of three months or less to be cash equivalents. Cash and cash equivalents consist primarily of cash on hand, demand deposits, and highly liquid investments with maturity of less than three months and are stated at cost, which approximates fair value. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Restricted Cash </span></div>Restricted cash mainly consists of bank deposits held as collateral for issuances of letters of credit.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_ShortTermInvestmentsPolicyPolicyTextBlock', window );">Short-term Investments</a></td>
<td class="text">Short-Term Investments Short-term investments are time deposits with original maturities between three months and one year. Short-term investments are stated at cost, which approximates fair value. Interest earned is included in interest income.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Accounts Receivable</a></td>
<td class="text">Accounts Receivable <div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company&#8217;s accounts receivable arise from product sales and represent amounts due from its customers. From January 1, 2020, the Company adopted the ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Credit Losses, Measurement of Credit Losses on Financial Instruments. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Accounts receivable are recorded at the amounts net of allowances for credit losses. The allowance for credit losses reflects the Company&#8217;s current estimate of credit losses expected to be incurred over the life of the receivables. The Company considers various factors in establishing, monitoring, and adjusting its allowance for credit losses including the aging of receivables and aging trends, customer creditworthiness, and specific exposures related to particular customers. The Company also monitors other risk factors and forward-looking information, such as country-specific risks and economic factors that may affect a debtor&#8217;s ability to pay in establishing and adjusting its allowance for credit losses. Accounts receivable are written off when deemed uncollectible.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_NotesReceivablePolicyTextBlock', window );">Notes Receivable</a></td>
<td class="text">Notes Receivable Notes receivable is equal to contractual amounts owed from signed, secured promissory notes issued from customers to the Company.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text">Inventories Inventories are stated at the lower of cost or net realizable value, with cost determined on a weighted average basis. The Company periodically reviews the composition of inventory and shelf life of inventory to identify obsolete, slow-moving, or otherwise non-saleable items. The Company will record a write-down to its net realizable value in cost of sales in the period that the decline in value is first identified.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_PrepaymentsForEquipmentPolicyPolicyTextBlock', window );">Prepayments for Equipment</a></td>
<td class="text">Prepayments for Equipment The prepayments for equipment purchase are recorded in long-term prepayments considering the prepayments are all related to property and equipment.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text">Property and Equipment <div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Property and equipment are stated at cost, less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the respective assets as follows:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Useful life</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Office equipment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Electronic equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.25-3 years</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vehicles</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Laboratory equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Manufacturing equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leasehold improvements</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">lesser of useful life or lease term</span></td></tr></table></div>Construction in progress represents property and equipment under construction and pending installation and is stated at cost less impairment losses, if any.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company leases facilities for its offices, research and development center, and manufacturing facilities in mainland China, Hong Kong, and the United States. On January 1, 2019, the Company adopted the ASC 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> using the modified retrospective transition approach by applying the new standard to all leases existing at the date of initial application and not restating historical periods before the adoption date. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company assessed whether an arrangement contains a lease at inception. The Company&#8217;s leases are all classified as operating leases with fixed lease payments, or minimum payments, as contractually stated in the lease agreements. The Company&#8217;s leases do not contain any material residual value guarantees or material restrictive covenants.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%"> </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Operating leases are included in operating lease right-of-use assets and operating lease liabilities in the consolidated balance sheets. Operating lease liabilities that become due within one year of the balance sheet date are classified as current operating lease liabilities. Operating lease expense is recognized on a straight-line basis over the lease term.  </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">At the commencement date of a lease, the Company recognizes a lease liability for future fixed lease payments and a right-of-use (&#8220;ROU&#8221;) asset representing the right to use the underlying asset during the lease term. The lease liability is initially measured as the present value of the future fixed lease payments that will be made over the lease term. The lease term includes periods for which the Company is reasonably certain that the renewal options will be exercised and the termination options will not be exercised. The Company uses its incremental borrowing rate based on the information available at the commencement date in determining the lease liabilities as the Company&#8217;s leases generally do not provide an implicit rate. The incremental borrowing rate is reevaluated upon a lease modification. The Company considered information available at the adoption date of ASC 842 to determine the incremental borrowing rate for leases in existence as of this date.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The ROU asset is measured at the amount of the lease liability with adjustments, if applicable, for lease prepayments made prior to or at lease commencement, initial direct costs incurred by the Company, and lease incentives. Under ASC 842, land use rights agreements are also considered to be operating lease contracts.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company elected to apply each of the practical expedients described in ASC 842 which allow companies (i) not to reassess prior conclusions on whether any expired or existing contracts are or contain a lease, lease classification, and initial direct costs upon adoption of ASC 842, (ii) combine lease and non-lease components for all underlying assets groups, and (iii) not recognize ROU assets or lease liabilities for short term leases. A short-term lease is a lease that, at the commencement date, has a lease term of 12 months or less and does not include an option to purchase the underlying asset that the lessee is reasonably certain to exercise.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_LandUseRightsPolicyPolicyTextBlock', window );">Land Use Rights</a></td>
<td class="text">Land Use Rights <div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">All land in mainland China is subject to government or collective ownership. Land use rights can be purchased for a specified period of time. The purchase price of land use rights represents the operating lease prepayments under ASC 842 and is recorded as land use rights on the consolidated balance sheet, which is amortized over the remaining lease term.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company acquired land use rights in 2019 for a term of 30 years from the local Bureau of Land and Resources in Suzhou for the purpose of constructing and operating the research center and biologics manufacturing facility in Suzhou. In 2023, the Company returned a portion of the land use rights and received cash in an amount equal to the respective portion of the original acquisition cost.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_LongTermDepositsPolicyPolicyTextBlock', window );">Long-term Deposits</a></td>
<td class="text">Long-Term Deposits Long-term deposits represent amounts paid in connection with the Company&#8217;s long-term lease agreements.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsFiniteLivedPolicy', window );">Intangible Assets</a></td>
<td class="text">Intangible Assets Intangible assets mainly consist of capitalized sales-based milestone fees and externally purchased software. Sales-based milestone fees are capitalized based on contract terms upon achievement of the sales levels and are amortized over the estimated remaining useful life of the related product, which is generally based on expected patent life, the contractual period of the underlying license agreement, and expected commercial benefits of the products. Externally purchased software are amortized over <span style="-sec-ix-hidden:f-496">three</span> to five years on a straight-line basis.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-Lived Assets</a></td>
<td class="text">Impairment of Long-Lived Assets The Company evaluates long-lived assets, which includes intangible assets, tangible assets, and ROU assets for impairment whenever events or changes in circumstances indicate that the carrying value of these assets may not be recoverable. Recoverability of these assets is measured by comparison of the carrying amount of the related asset group to its future undiscounted cash flows. The Company measures the amount of impairment, if any, based on the difference between the carrying value and the estimated fair value of the impaired asset group.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements <div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company applies ASC topic 820 (&#8220;ASC 820&#8221;), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Fair Value Measurements and Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">, in measuring fair value. ASC 820 defines fair value, establishes a framework for measuring fair value, and requires disclosures to be provided on fair value measurement. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">ASC 820 establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows: </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Level 1 &#8212; Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Level 2 &#8212; Include other inputs that are directly or indirectly observable in the marketplace. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Level 3 &#8212; Unobservable inputs which are supported by little or no market activity. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">ASC 820 describes three main approaches to measuring the fair value of assets and liabilities: (i) market approach; (ii) income approach; and (iii) cost approach. The market approach uses prices and other relevant information generated from market transactions involving identical or comparable assets or liabilities. The income approach uses valuation techniques to convert future amounts to a single present value amount. The measurement is based on the value indicated by current market expectations about those future amounts. The cost approach is based on the amount that would currently be required to replace an asset. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Equity investments with readily determinable fair value are measured using level 1 inputs and were $9.2 million and $6.4 million as of December&#160;31, 2023 and 2022, respectively. The unrealized gains and losses from fair value changes are recognized in other income (expense), net in the consolidated statements of operations. </span></div>Financial instruments of the Company primarily include cash, cash equivalents and restricted cash, short-term investments, accounts receivable, notes receivable, prepayments, and other current assets, accounts payable, and other current liabilities. As of December&#160;31, 2023 and 2022, the carrying values of cash and cash equivalents, short-term investments, accounts receivable, prepayments, and other current assets, accounts payable, and other current liabilities approximated their fair values due to the short-term maturity of these instruments, and the carrying value of notes receivable and restricted cash approximated their fair value based on the nature of the assessment of the ability to recover these amounts.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text">Revenue Recognition<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In 2018, the Company adopted ASC Topic 606 (&#8220;ASC 606&#8221;), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">. Under ASC 606, the Company recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration expected to be received in exchange for those goods or services. To determine revenue recognition for arrangements that the Company determines are within the scope of ASC 606, the Company performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price, including variable consideration, if any; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the Company satisfies a performance </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">obligation. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration to which it is entitled in exchange for the goods or services it transfers to the customer. Once a contract is determined to be within the scope of ASC 606 at contract inception, the Company reviews the contract to determine which performance obligations it must deliver and which of these performance obligations are distinct. The Company recognizes as revenue the amount of the transaction price that is allocated to each performance obligation when that performance obligation is satisfied or as it is satisfied.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company&#8217;s revenue is mainly from product sales. The Company recognizes revenue from product sales when the Company has satisfied the performance obligation by transferring control of the product to the customers. Control of the product generally transfers to the customers when the delivery is made and when title and risk of loss transfers to the consumers. Cost of sales mainly consists of the acquisition cost of products, the manufacturing cost of products, royalty fees, and amortization of sales-based milestone payments. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company has applied the practical expedients under ASC 606 with regard to assessment of financing component and concluded that there is no significant financing component given that the period between delivery of goods and payment is generally one year or less. The Company&#8217;s product revenues were mainly generated from the sale of ZEJULA (niraparib), OPTUNE (Tumor Treating Fields), QINLOCK (ripretinib), NUZYRA (omadacycline), and VYVGART (efgartigimod) to customers. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In mainland China, the Company sells the products to distributors, who ultimately sell the products to health care providers. Based on the nature of the arrangements, the performance obligations are satisfied upon the delivery of the products to distributors. Rebates are offered to distributors, consistent with pharmaceutical industry practices. The estimated amount of unpaid or unbilled rebates are recorded as a reduction of revenue, if any. Estimated rebates are determined based on contracted rates and sales volumes and to a lesser extent, distributor inventories. The Company regularly reviews the information related to these estimates and adjusts the amount accordingly. </span></div>In Hong Kong, the Company sells the products to customers, which are typically healthcare providers such as oncology centers. The Company utilizes a third party for warehousing services. Based on the nature of the arrangements, the Company has determined that it is a principal in the transaction since the Company is primarily responsible for fulfilling the promise to provide the products to the customers, maintains inventory risk until delivery to the customers, and has latitude in establishing the price. Revenue was recognized at the amount to which the Company expected to be entitled in exchange for the sale of the products, which is the sales price agreed with the customers. Consideration paid to the third party is recognized in operating expenses.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementAccountingPolicy', window );">Collaborative Arrangements</a></td>
<td class="text">Collaborative Arrangements <div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company analyzes its collaboration arrangements to assess whether such arrangements involve joint operating activities performed by parties that are both active participants in the activities and exposed to significant risks and rewards dependent on the commercial success of such activities and therefore within the scope of ASC Topic 808, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Collaborative Arrangements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> (ASC 808). This assessment is performed throughout the life of the arrangement based on changes in the responsibilities of all parties in the arrangement. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">For collaboration arrangements within the scope of ASC 808 that contain multiple elements, the Company first determines which elements of the collaboration are deemed to be within the scope of ASC 808 and which elements of the collaboration are more reflective of a vendor-customer relationship and therefore within the scope of ASC 606. For </span></div>elements of collaboration arrangements that are accounted pursuant to ASC 808, an appropriate recognition method is determined and applied consistently.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Expenses</a></td>
<td class="text">Research and Development Expenses <div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Elements of research and development expenses primarily include (i) payroll and other related costs of personnel engaged in research and development activities; (ii) in-licensed patent rights fees of exclusive development rights of products granted to the Company; (iii) costs related to pre-clinical testing of the Company&#8217;s technologies under development and clinical trials such as payments to contract research organizations (&#8220;CROs&#8221;) and contract manufacturing organizations (&#8220;CMOs&#8221;), investigators, and clinical trial sites that conduct its clinical studies; (iv) costs to develop the product candidates, including raw materials and supplies, product testing, depreciation, and facility-related expenses; and (v) other research and development expenses. Research and development expenses are charged to expense as incurred and have no alternative future uses. Liabilities related to third-party research and development expenses are primarily included in accounts payable on the consolidated balance sheet.</span></div>The Company has acquired rights to develop and commercialize product candidates. Upfront payments that relate to the acquisition of a new product compound, as well as pre-commercial milestone payments, are immediately expensed as acquired in-process research and development in the period in which they are incurred, provided that the new product compound did not also include processes or activities that would constitute a &#8220;business&#8221; as defined under U.S. GAAP. Milestone payments made to third parties subsequent to regulatory approval which meet the capitalization criteria would be capitalized as intangible assets and amortized over the estimated remaining useful life of the related product, which is generally based on expected patent life, the contractual period of the underlying license agreement, and expected commercial benefits of the products.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_DeferredIncomePolicyTextBlock', window );">Deferred Income</a></td>
<td class="text">Deferred Income <div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Deferred income mainly consists of deferred income from government grants and the upfront payments received from Huizheng.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Government grants consist of cash subsidies received by the Company&#8217;s subsidiaries in mainland China from local governments. Grants received as incentives for conducting business in certain local districts with no performance obligation or other restriction as to the use are recognized as other income when cash is received. Grants received with government specified performance obligations are recognized as other income when all the obligations have been fulfilled. If such obligations are not satisfied, the Company may be required to refund the subsidy. The grant received before the fulfillment of specified performance obligation is recorded in deferred income. The Company had $2.1 million and $0.9 million of government grants in deferred income as of December&#160;31, 2023 and 2022, respectively. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In March 2020, the Company entered into an exclusive promotion agreement with Huizheng so that the Company could leverage Hanhui&#8217;s infrastructure to optimize an anticipated future commercial launch of NUZYRA in mainland China. In exchange for exclusive promotion rights in mainland China, Huizheng agreed to pay the Company non-creditable upfront payments of RMB230.0 million, of which RMB90.0 million was paid in April 2020, RMB70.0 million in 2022, and RMB70.0 million in 2023. The Company is amortizing the upfront payments through the end of the contract term. The Company had $26.7 million and $20.5 million in deferred income related to the upfront payments as of December&#160;31, 2023 and 2022, respectively.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive Loss</a></td>
<td class="text">Comprehensive Loss Comprehensive loss is defined as the changes in equity of the Company during a period from transactions and other events and circumstances excluding transactions resulting from investments by owners and distributions to owners. For each of the periods presented, the Company&#8217;s comprehensive loss includes net loss and foreign currency translation adjustments, which are presented in the consolidated statements of comprehensive loss.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationRelatedCostsPolicyTextBlock', window );">Share-Based Compensation</a></td>
<td class="text">Share-Based Compensation <div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company grants share options and non-vested restricted shares to eligible employees, non-employees, and directors and accounts for these share-based awards in accordance with ASC 718, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Compensation-Stock Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company estimates the fair value of stock options using the Black-Scholes option-pricing model. The grant-date fair value of non-vested restricted shares is the market value of the underlying stock on the award&#8217;s grant date. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> The Company has elected to use the straight-line method to recognize compensation expenses for share awards with graded vesting based on service conditions, subject to the minimum amount of cumulative compensation expense recognized is not less than the portion of the award vested to date. For share-based awards with service conditions only, the Company recognizes expenses (i) immediately at grant date if no vesting conditions are required; or (ii) using a straight-line method over the requisite service period, which is the vesting period, if vesting conditions are required. For share-based awards containing performance conditions, the Company recognizes expenses based on the estimated number of the performance-based awards expected to vest using the graded vesting attribution method. The Company accounts for the effect of forfeitures as they occur.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes <div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Income tax expense includes (i) deferred tax expense, which generally represents the net change in the deferred tax asset or liability balance during the year plus any change in valuation allowances; (ii) current tax expense, which represents the amount of tax currently payable to or receivable from a taxing authority; and (iii) non-current tax expense, which represents the increases and decreases in amounts related to uncertain tax positions from prior periods and not settled with cash or other tax attributes.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company recognizes deferred tax assets and liabilities for temporary differences between the financial statement and income tax bases of assets and liabilities, which are measured using enacted tax rates and laws that will be in effect when the differences are expected to reverse. A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized. </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company evaluates its uncertain tax positions using the provisions of ASC 740, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Income Taxes</span>, which requires that realization of an uncertain income tax position be recognized in the financial statements. The benefit to be recorded in the financial statements is the amount most likely to be realized assuming a review by tax authorities having all relevant information and applying current conventions. It is the Company&#8217;s policy to recognize interest and penalties related to unrecognized tax benefits, if any, as a component of income tax expense.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Loss Per Share</a></td>
<td class="text">Loss Per Share <div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Basic loss per ordinary share is computed by dividing net loss attributable to ordinary shareholders by weighted average number of ordinary shares outstanding during the period. </span></div>Diluted loss per ordinary share reflects the potential dilution that could occur if securities were exercised or converted into ordinary shares. The Company had stock options and non-vested restricted shares, which could potentially dilute basic loss per share in the future. To calculate the number of shares for diluted loss per share, the effect of the stock options and non-vested restricted shares is computed using the treasury stock method. The computation of diluted loss per share does not assume exercise or conversion of securities that would have an anti-dilutive effect.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Information</a></td>
<td class="text">Segment Information <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In accordance with ASC 280, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Segment Reporting</span>, the Company&#8217;s chief operating decision maker, the Chief Executive Officer, reviews the consolidated results when making decisions about allocating resources and assessing performance of the Company as a whole and therefore, the Company has only one operating and reportable segment.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Risks</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Concentration of Credit Risk </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Financial instruments that are potentially subject to significant concentration of credit risk consist of cash and cash equivalents, short-term investments, accounts receivable, and notes receivable. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The carrying amounts of cash and cash equivalents and short-term investments represent the maximum amount of loss due to credit risk. As of December&#160;31, 2023 and 2022, all of the Company&#8217;s cash and cash equivalents and short-term investments were held by major financial institutions located in mainland China and international financial institutions outside of mainland China which management believes are of high credit quality and continually monitors the credit worthiness of these financial institutions.</span></div>Accounts receivable are typically unsecured and are derived from product sales and collaborative arrangements. The Company manages credit risk of accounts receivable through ongoing monitoring of the outstanding balances and limits the amount of credit extended based upon payment history and credit worthiness. Historically, the Company has collected receivables from customers within the credit terms with no significant credit losses incurred. <div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Certain accounts receivable balances may be settled in the form of notes receivable. As of December&#160;31, 2023, notes receivable represented bank acceptance promissory notes that are non-interest bearing and due within six months. Notes receivable were used to collect the receivables based on an administrative convenience, given these notes are readily </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">convertible to be known amounts of cash. In accordance with the sales agreements, whether to use cash or bank acceptance promissory notes to settle the receivables is at the Company&#8217;s discretion, and this selection does not impact the agreed contractual purchase prices. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Foreign Currency Risk </span></div>RMB is not a freely convertible currency. The State Administration of Foreign Exchange, under the authority of the People&#8217;s Bank of China, controls the conversion of RMB into foreign currencies. The value of RMB is subject to changes in central government policies and to international economic and political developments affecting supply and demand in the China Foreign Exchange Trading System market.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text">Recent Accounting Pronouncements <div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In December 2023, the FASB issued ASU No. 2023-09, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Improvements to Income Tax Disclosures </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(Topic 740). The ASU requires disaggregated information about a reporting entity&#8217;s effective tax rate reconciliation as well as additional information on income taxes paid. The ASU is effective on a prospective basis for annual periods beginning after December 15, 2024. Early adoption is permitted. This ASU will result in the required additional disclosures being included in the consolidated financial statements, once adopted. The Company is currently evaluating the impact of this ASU and expects to adopt it for the year ending December 31, 2025.</span></div>The Company has not adopted any new accounting standards in 2023 that have a material impact on the Consolidated Financial Statements.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementAccountingPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for collaborative arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementAccountingPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationRelatedCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationRelatedCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480981/942-825-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//830/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480091/360-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482338/360-10-05-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-25<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-19<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsFiniteLivedPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 920<br> -SubTopic 350<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483256/920-350-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 920<br> -SubTopic 350<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483256/920-350-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 920<br> -SubTopic 350<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483256/920-350-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsFiniteLivedPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483489/210-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 330<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482105/912-330-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//330/tableOfContent<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483080/330-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483080/330-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 270<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482989/270-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481569/310-20-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481569/310-20-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481569/310-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483044/730-10-05-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_DeferredIncomePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_DeferredIncomePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_LandUseRightsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Land use rights.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_LandUseRightsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_LongTermDepositsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long term deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_LongTermDepositsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_NotesReceivablePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Notes receivable policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_NotesReceivablePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_PrepaymentsForEquipmentPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepayments for equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_PrepaymentsForEquipmentPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_ShortTermInvestmentsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Short term investments policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_ShortTermInvestmentsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647763060112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Principal Activities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock', window );">Schedule of Significant Operating Subsidiaries</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">As of December&#160;31, 2023, the Company&#8217;s significant operating subsidiaries were as follows: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.596%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.237%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name of Company</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Place of<br/>Incorporation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Date of<br/>Incorporation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Percentage of<br/>Ownership</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Principal Activities</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Zai Lab (Hong Kong) Limited</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hong Kong</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April 29, 2013</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating company for business development and R&amp;D activities and commercialization of innovative medicines and device</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Zai Lab (Shanghai) Co., Ltd.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mainland<br/>China</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">January 6, 2014</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Development and commercialization of innovative medicines and devices</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Zai Lab (AUST) Pty. Ltd.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Australia</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 10, 2014</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical trial activities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Zai Lab (Suzhou) Co., Ltd.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mainland<br/>China</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">November 30, 2015</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Development and commercialization of innovative medicines</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Zai Biopharmaceutical (Suzhou) Co., Ltd.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mainland<br/>China</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June 15, 2017</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Development and commercialization of innovative medicines</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Zai Lab (US) LLC</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">United<br/>States</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April 21, 2017</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating company for business development, R&amp;D activities and certain business activities, including legal, compliance and communication functions of the Company</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Zai Lab International Trading (Shanghai) Co., Ltd.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mainland<br/>China</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">November 6, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercialization of innovative medicines and devices</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Zai Auto Immune (Hong Kong) Limited</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hong Kong</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">November 4, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating company for business development and R&amp;D activities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Zai Lab (Taiwan) Limited</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Taiwan</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 10, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercialization of innovative medicines and devices</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Zai Lab Trading (Suzhou) Co., Ltd.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mainland<br/>China</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">October 27, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercialization of innovative medicines and devices</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the key aspects of a subsidiary (partnership, corporation, or other entity) of the limited liability company or limited partnership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647763910560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_PropertyAndEquipmentEstimatedUsefulLivesTableTextBlock', window );">Summary of Estimated Useful Lives of Property and Equipment</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Property and equipment are stated at cost, less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the respective assets as follows:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Useful life</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Office equipment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Electronic equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.25-3 years</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vehicles</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Laboratory equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Manufacturing equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leasehold improvements</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">lesser of useful life or lease term</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueConcentrationOfRiskTextBlock', window );">Schedule of Concentration of Suppliers</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following suppliers accounted for 10% or more of research and development expenses and inventory purchases ($ in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">E</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">165,431&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66,650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">*  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Represents less than 10% of research and development expenses and inventory purchases for the period.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueConcentrationOfRiskTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of all significant concentrations of risk, including credit risk and market risk, arising from all financial instruments (as defined), whether from an individual counterparty or groups of counterparties. The disclosure concerning concentrations of risk may consist of the following information: (1) for concentrations of credit risk disclosure may include: (a) information about the (shared) activity, region, or economic characteristic that identifies the concentration, (b) the maximum amount of loss due to credit risk that, based on the gross fair value of the financial instrument, the entity would incur if parties to the financial instruments that make up the concentration failed completely to perform according to the terms of the contracts and the collateral or other security, if any, for the amount due proved to be of no value to the entity, (c) the policy of requiring collateral or other security to support financial instruments subject to credit risk, information about the entity's access to that collateral or other security, and the nature and a brief description of the collateral or other security supporting those financial instruments, and (d) the policy of entering into master netting arrangements to mitigate the credit risk of financial instruments, information about the arrangements for which the entity is a party, and a brief description of the terms of those arrangements, including the extent to which they would reduce the entity's maximum amount of loss due to credit risk and (2) for disclosure of quantitative information about the market risks of financial instruments that is consistent with the way the company manages or adjusts those risks, disclosure may include: (a) more details about current positions and perhaps activity during the period, (b) the hypothetical effects on comprehensive income (or net assets), or annual income, of several possible changes in market prices, (c) a gap analysis of interest rate re-pricing or maturity dates, (d) the duration of the financial instruments, (e) the entity's value at risk from derivatives and from other positions at the end of the reporting period and the average value at risk during the year, or (f) other ways of reporting quantitative information as internally developed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-21<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-23<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-20<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueConcentrationOfRiskTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_PropertyAndEquipmentEstimatedUsefulLivesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Property and equipment estimated useful lives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_PropertyAndEquipmentEstimatedUsefulLivesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647763218720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash and Cash Equivalents (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Cash and Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock', window );">Schedule of Cash and Cash Equivalents</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following table presents the Company&#8217;s cash and cash equivalents ($ in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">789,051&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,007,423&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents (i)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,047&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">790,151&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,008,470&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Denominated in:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">US$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">762,436&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">957,824&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RMB (ii)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25,093&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45,486&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hong Kong dollar (&#8220;HK$&#8221;)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,974&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,378&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Australian dollar (&#8220;A$&#8221;)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Taiwan dollar (&#8220;TW$&#8221;)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">184&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">790,151&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,008,470&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:17.57pt">Cash equivalents represent short-term and highly liquid investments in a money market fund. </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</span>Certain cash and bank balances denominated in RMB were deposited with banks in mainland China. The conversion of these RMB denominated balances into foreign currencies is subject to the rules and regulations of foreign exchange control promulgated by the Chinese government.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647859516048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventory</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following table presents the Company&#8217;s inventories, net ($ in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">22,702&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">12,156&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Raw materials</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">17,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">19,029&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Work in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,470&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">436&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inventories, net</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">44,827&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">31,621&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483489/210-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647758904224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following table presents the components of the Company&#8217;s property and equipment, net ($ in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Office equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,047&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">977&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Electronic equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">9,161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,416&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Vehicle</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">202&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Laboratory equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">20,140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">18,726&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Manufacturing equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">17,680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">17,055&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">11,371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">11,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">24,272&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">24,251&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-weight:400;line-height:114%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">83,870&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">79,927&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(30,136)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(22,064)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">53,734&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">57,863&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647756007600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_SupplementalInformationRelatedToLeasesTableTableTextBlock', window );">Summary of Supplemental Information Related to Leases</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following table presents operating lease costs ($ in thousands). Total lease expense related to short-term leases was insignificant for those periods presented.</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating fixed lease cost</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,691&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,774&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6,263&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Summary of Cash Flow Information Related to Leases</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents operating cash flows related to leases ($ in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash paid for amounts included in measurement of lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,317&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,084&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,840&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-cash operating lease liabilities arising from obtaining operating right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,668&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,801&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Summary of Maturities of Lease Liabilities</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The maturities of lease liabilities in accordance with ASC Topic 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> in each of the next five years and thereafter were as follows ($ in thousands): </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.778%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.022%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended<br/>December 31, 2023</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,444&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5,143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,811&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">822&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">15,611&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(460)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Present value of minimum operating lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">15,151&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_SummaryOfWeightedAverageRemainingLeaseTermsAndDiscountRatesTableTextBlock', window );">Summary of Weighted-Average Remaining Lease Terms and Discount Rates</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Weighted-average remaining lease terms and discount rates are as follows: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.051%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.962%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Weighted-average remaining lease term</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2.5 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2.6 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Weighted-average discount rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_SummaryOfWeightedAverageRemainingLeaseTermsAndDiscountRatesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Summary of weighted average remaining lease terms and discount rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_SummaryOfWeightedAverageRemainingLeaseTermsAndDiscountRatesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_SupplementalInformationRelatedToLeasesTableTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Summary of supplemental information related to leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_SupplementalInformationRelatedToLeasesTableTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647844969168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_NetRevenueTableTextBlock', window );">Schedule of Net Product Sales</a></td>
<td class="text">The table below presents the Company&#8217;s net product revenue ($ in thousands):<div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Product revenue &#8212; gross</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">298,911&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">234,009&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">190,180&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Less: Rebates and sales returns</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(32,192)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(21,337)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(46,075)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Product revenue &#8212; net</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">266,719&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">212,672&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">144,105&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Disaggregation of Net Revenue</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following table presents the Company&#8217;s net revenue by product ($ in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">ZEJULA</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">168,843&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">145,194&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">93,579&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">OPTUNE</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">46,969&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">47,321&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">38,903&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">QINLOCK</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">19,240&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">14,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">11,620&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">NUZYRA</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">21,656&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">VYVGART</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10,011&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Product revenue &#8212; net</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">266,719&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">212,672&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">144,105&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_NetRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net revenue</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_NetRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647756007728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of Loss (Income) Before Income Taxes</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following table presents loss (income) before income taxes ($ in thousands): </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cayman Islands</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(16,792)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19,454&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28,401&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">British Virgin Islands</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mainland China</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">253,274&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">290,056&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">340,865&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hong Kong</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53,425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">243,400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92,869&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79,620&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89,374&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Australia</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(260)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,758&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Taiwan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">772&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">989&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">671&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">334,620&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">443,286&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">704,471&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Reconciliations</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Reconciliations of the differences between the Chinese statutory income tax rate and the Company&#8217;s effective income tax rate are as follows: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Statutory income tax rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax-exempted income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2.08&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development super deduction</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-deductible expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2.83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2.31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5.78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior year tax filing adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effect of different tax rate of subsidiary operation in other jurisdictions</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2.85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4.60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preferential tax rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7.12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6.26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4.30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expiration of deductible qualified donation </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(23.89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(21.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10.90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Components of Deferred Tax Assets and Liabilities</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following table presents the principal components of deferred tax assets and liabilities ($ in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:58.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.932%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation of property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">131&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and experimental capitalization</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30,429&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22,476&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,422&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,787&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">707&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Government grants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,354&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,378&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Qualified donation</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22,992&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,947&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,967&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,738&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net operating loss carry forwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">295,313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">241,397&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(357,956)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(284,072)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total Deferred tax assets</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,826&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,738&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,826)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3,738)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets, net</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SummaryOfValuationAllowanceTextBlock', window );">Schedule of Movement of Valuation Allowance</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following table presents that movement of the valuation allowance on deferred tax assets ($ in thousands): </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance as of January 1,</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(284,072)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(189,684)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(73,884)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(94,388)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance as of December 31,</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(357,956)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(284,072)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 12<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfValuationAllowanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfValuationAllowanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647763086704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Current Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock', window );">Schedule of Other Current Liabilities</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following table presents the Company&#8217;s other current liabilities ($ in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued payroll</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33,711&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31,689&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued professional service fee</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,080&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payables for purchase of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,474&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,269&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued rebate to distributors</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16,926&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,443&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax payables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16,988&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13,283&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Others (i)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,353&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,054&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82,972&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66,818&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span>Others mainly include accrued travel, business-related expenses, and other payables to employee.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other current liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647763026288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loss Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Summary of Basic and Diluted Net Loss Per Share</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following table presents the computation of the basic and diluted net loss per share ($ in thousands, except share and per share data):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss attributable to ordinary shareholders</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(334,620)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(443,286)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(704,471)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average number of ordinary shares - basic and diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">966,394,130</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">958,067,140</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">929,921,120</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss per share-basic and diluted</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.35)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.46)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.76)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Summary of Anti-Dilutive Shares Excluded from Calculation of Diluted Loss Per Share</a></td>
<td class="text"><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share options</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104,584,050</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91,181,420</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81,015,590</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-vested restricted shares</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31,279,600</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33,433,890</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,567,360</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647761362496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of Option Activity</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following table presents a summary of option activity and related information in 2023: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of<br/>options </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted<br/>average exercise<br/>price<br/>($)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted<br/>average<br/>remaining<br/>contractual term (years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Aggregate<br/>intrinsic value <br/>($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding at December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91,181,420</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.05&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.89</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">115,969&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24,102,740</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6,516,920)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4,183,190)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding at December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104,584,050</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.97</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83,424&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vested and exercisable as of December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58,695,320</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.93</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83,266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Assumptions Used to Estimate Fair Values of Share Options Granted</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following table presents the assumptions used to estimate the fair values of the share options granted: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.993%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk-free rate of return</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.5%-4.7%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.4%-4.0%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.9%-1.4%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6, 6.25,or 6.5</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.5 </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6, 6.25 or 6.5</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated volatility rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected dividend rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock', window );">Summary of Non-vested Restricted Share Activity</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following table summarized the Company&#8217;s non-vested restricted share activity in 2023: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Numbers<br/>of non-vested<br/>restricted shares </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted<br/>average<br/>remaining<br/>contractual term (years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Aggregate<br/>intrinsic value <br/>($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-vested as of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33,433,890</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.55</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102,642&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,001,740</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8,178,500)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,977,530)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-vested as of December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31,279,600</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.75</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85,487&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Allocation of Compensation Expense Related to Options</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following table presents the share-based compensation expense which has been reported in the Company&#8217;s consolidated statements of operations ($ in thousands): </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48,017&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38,118&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23,194&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31,617&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23,184&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79,634&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61,302&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40,714&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Subparagraph (c)<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647859499216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Income (Expenses), Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock', window );">Schedule of Other Income (Expense), Net</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following table presents the Company&#8217;s other income (expenses), net ($ in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Government grants</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,433&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,471&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,113&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gain (Loss) on equity investments with readily determinable fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,789&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8,952)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(14,617)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Others miscellaneous gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,784&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">594&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">303&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,006&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,113&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10,201)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647759333024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule I &#8212; Condensed Financial Information of Registrant (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract', window );"><strong>Condensed Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfCondensedBalanceSheetTableTextBlock', window );">Condensed Balance Sheets</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Balance Sheets</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands of $, except for number of shares and per share data)</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">565,981&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">944,649&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepayments and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,203&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">573,404&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">954,852&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investment in subsidiaries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">224,954&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93,363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">798,358</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,048,215</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liabilities and shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,240&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,620&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,240&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,620&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2,240</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2,620</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ordinary shares (par value of $0.000006 per share; 5,000,000,000 shares authorized, 977,151,270 and 962,455,850 shares issued as of December&#160;31, 2023 and 2022, respectively; 972,239,070 and 960,219,570 shares issued and outstanding as of December&#160;31, 2023 and 2022, respectively)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,975,302&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,893,120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,195,980)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,861,360)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated other comprehensive income</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37,626&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25,685&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Treasury stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(20,836)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(11,856)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total shareholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">796,118</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,045,595</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total liabilities and shareholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">798,358</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,048,215</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedStatementOfComprehensiveIncomeTableTextBlock', window );">Condensed Statements of Operations and Comprehensive Loss</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Statements of Operations and Comprehensive Loss</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands of $)</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(82)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(178)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(16,958)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(19,773)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(12,074)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Loss from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(17,040)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(19,951)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(12,080)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30,840&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,857&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,881&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,029&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8,678)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(18,173)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Profit (Loss) before income tax and equity in loss of subsidiaries</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17,829</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(15,772)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(28,372)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity in loss of subsidiaries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(352,449)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(427,514)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(676,099)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(334,620)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(443,286)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(704,471)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive income (loss), net of tax of nil:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,941&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49,330&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(9,121)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(322,679)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(393,956)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(713,592)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock', window );">Condensed Statements of Cash Flows</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Statements of Cash Flows</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands of $)</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(334,620)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(443,286)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(704,471)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjustments to reconcile net loss to net cash provided by (used in) operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of deferred income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(234)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(312)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,217&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,724&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,435&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity in loss of subsidiaries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">352,449&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">427,514&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">676,099&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss from fair value changes of equity investment of readily determinable fair value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,789)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,952&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,617&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepayments and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,780&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7,839)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(439)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(379)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,648&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(376)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by (used in) operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20,658&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(9,521)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(11,447)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchases of short-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(260,274)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(445,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proceeds from maturity of short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">705,274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">743,902&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchase of investment in equity investee</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(30,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investment in subsidiaries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(392,893)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(80,942)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(884,342)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash (used in) provided by investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(392,893)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">364,058&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(615,440)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proceeds from exercises of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,369&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,870&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,418&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proceeds from issuance of ordinary shares upon public offerings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">818,875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payment of public offering costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,692)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employee taxes paid related to settlement of equity awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8,802)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7,600)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4,253)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash (used in) provided by financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6,433)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,730)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">820,348&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effect of foreign exchange rate changes on cash and cash equivalent</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">773&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net (decrease) increase in cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(378,668)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">352,807&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">194,234&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents-beginning of the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">944,649&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">591,842&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">397,608&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents-end of the year</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">565,981&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">944,649&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">591,842&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedStatementOfComprehensiveIncomeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of condensed statement of comprehensive income (loss) including, but not limited to, statements of comprehensive income (loss) of consolidated entities and consolidation eliminations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 04<br> -Paragraph (a)<br> -Publisher SEC<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedStatementOfComprehensiveIncomeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfCondensedBalanceSheetTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 04<br> -Paragraph (a)<br> -Publisher SEC<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfCondensedBalanceSheetTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of condensed cash flow statement, including, but not limited to, cash flow statements of consolidated entities and consolidation eliminations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 04<br> -Paragraph (a)<br> -Publisher SEC<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfCondensedCashFlowStatementTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647762186784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Principal Activities (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=zlab_ZaiLabHongKongLimitedMember', window );">Zai Lab (Hong Kong) Limited</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems', window );"><strong>Subsidiary Of Limited Liability Company Or Limited Partnership [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest', window );">Percentage of Ownership</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=zlab_ZaiLabShanghaiCompanyLimitedMember', window );">Zai Lab (Shanghai) Co., Ltd.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems', window );"><strong>Subsidiary Of Limited Liability Company Or Limited Partnership [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest', window );">Percentage of Ownership</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=zlab_ZaiLabAUSTPtyLtdMember', window );">Zai Lab (AUST) Pty. Ltd.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems', window );"><strong>Subsidiary Of Limited Liability Company Or Limited Partnership [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest', window );">Percentage of Ownership</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=zlab_ZaiLabSuzhouCompanyLimitedMember', window );">Zai Lab (Suzhou) Co., Ltd.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems', window );"><strong>Subsidiary Of Limited Liability Company Or Limited Partnership [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest', window );">Percentage of Ownership</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=zlab_ZaiBiopharmaceuticalSuzhouCompanyLimitedMember', window );">Zai Biopharmaceutical (Suzhou) Co., Ltd.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems', window );"><strong>Subsidiary Of Limited Liability Company Or Limited Partnership [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest', window );">Percentage of Ownership</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=zlab_ZaiLabUSLLCMember', window );">Zai Lab (US) LLC</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems', window );"><strong>Subsidiary Of Limited Liability Company Or Limited Partnership [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest', window );">Percentage of Ownership</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=zlab_ZaiLabInternationalTradingShanghaiCompanyLimitedMember', window );">Zai Lab International Trading (Shanghai) Co., Ltd.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems', window );"><strong>Subsidiary Of Limited Liability Company Or Limited Partnership [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest', window );">Percentage of Ownership</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=zlab_ZaiAutoImmuneHongKongLimitedMember', window );">Zai Auto Immune (Hong Kong) Limited</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems', window );"><strong>Subsidiary Of Limited Liability Company Or Limited Partnership [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest', window );">Percentage of Ownership</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=zlab_ZaiLabTaiwanLimitedMember', window );">Zai Lab (Taiwan) Limited</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems', window );"><strong>Subsidiary Of Limited Liability Company Or Limited Partnership [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest', window );">Percentage of Ownership</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=zlab_ZaiLabTradingSuzhouCoLtdMember', window );">Zai Lab Trading (Suzhou) Co., Ltd.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems', window );"><strong>Subsidiary Of Limited Liability Company Or Limited Partnership [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest', window );">Percentage of Ownership</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of units or percentage investment held in the subsidiary by the limited liability company or limited partnership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=zlab_ZaiLabHongKongLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=zlab_ZaiLabHongKongLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=zlab_ZaiLabShanghaiCompanyLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=zlab_ZaiLabShanghaiCompanyLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=zlab_ZaiLabAUSTPtyLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=zlab_ZaiLabAUSTPtyLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=zlab_ZaiLabSuzhouCompanyLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=zlab_ZaiLabSuzhouCompanyLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=zlab_ZaiBiopharmaceuticalSuzhouCompanyLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=zlab_ZaiBiopharmaceuticalSuzhouCompanyLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=zlab_ZaiLabUSLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=zlab_ZaiLabUSLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=zlab_ZaiLabInternationalTradingShanghaiCompanyLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=zlab_ZaiLabInternationalTradingShanghaiCompanyLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=zlab_ZaiAutoImmuneHongKongLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=zlab_ZaiAutoImmuneHongKongLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=zlab_ZaiLabTaiwanLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=zlab_ZaiLabTaiwanLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=zlab_ZaiLabTradingSuzhouCoLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=zlab_ZaiLabTradingSuzhouCoLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647752791872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Additional Information (Details)<br> $ / shares in Units, &#165; in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="6">12 Months Ended</th>
<th class="th" colspan="1">45 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 30, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th"><div>Mar. 29, 2022</div></th>
<th class="th">
<div>Apr. 30, 2020 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>segment </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>CNY (&#165;) </div>
<div>segment</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>CNY (&#165;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1', window );">Share Subdivision ratio</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_CommonStockAuthorizedShareCapital', window );">Ordinary shares, authorized share capital</a></td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Ordinary shares, shares authorized (in shares) | shares</a></td>
<td class="nump">5,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, par value (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.000006<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.000006<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.000006<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_AmericanDepositaryShareToCommonStockConversionRatio', window );">ADS to ordinary shares conversion ratio</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestCurrent', window );">Allowance for credit loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_LandUseRightsLeaseTerm', window );">Land use rights lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Finite-lived intangible assets, Amortization expense, year one</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Finite-lived intangible assets, Amortization expense, year two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Finite-lived intangible assets, Amortization expense, year three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Finite-lived intangible assets, Amortization expense, year four</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Finite-lived intangible assets, Amortization expense, year five</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Finite-lived intangible assets, Amortization expense, after year five</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeNoncurrent', window );">Deferred income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,738,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,360,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense', window );">Unrecognized tax benefits and related interest and penalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 266,719,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">212,672,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">144,105,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Aggregate amount of cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">790,151,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,008,470,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">964,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_CNY', window );">RMB</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Aggregate amount of cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,093,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,486,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk | One Customer | Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_LenderConcentrationRiskMember', window );">Debtor Concentration Risk | One Customer | Accounts Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=zlab_ForeignCurrencyRiskMember', window );">Foreign Currency Risk | Cash and Cash Equivalents | RMB</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Aggregate amount of cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_EquitySecuritiesWithReadilyDeterminableFairValueAmount', window );">Equity investments with readily determinable fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_GrantMember', window );">Government Grants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeNoncurrent', window );">Deferred income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=zlab_HuizhengMember', window );">Huizheng</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_CollaborativeArrangementRightsAndObligationsPaymentOfUpFrontFeesForLicenseAgreement', window );">Upfront payment | &#165;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 90.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 70.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 70.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 230.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=zlab_HuizhengMember', window );">Huizheng | Collaborative Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeNoncurrent', window );">Deferred income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember', window );">Software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember', window );">Software | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember', window );">Software | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=zlab_CapitalizedSalesBasedMilestoneFeesMember', window );">Capitalized Sales Based Milestone Fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480833/946-310-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(5)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481058/954-310-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-21<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-20<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-18<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income excluding obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481174/470-10-25-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount excluding accrued interest, of allowance for credit loss on financing receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479344/326-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB TOPIC 4.C)<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteStockSplitConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_AmericanDepositaryShareToCommonStockConversionRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>American Depositary Share to Common Stock, Conversion Ratio</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_AmericanDepositaryShareToCommonStockConversionRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_CollaborativeArrangementRightsAndObligationsPaymentOfUpFrontFeesForLicenseAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment of upfront fees for license agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_CollaborativeArrangementRightsAndObligationsPaymentOfUpFrontFeesForLicenseAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_CommonStockAuthorizedShareCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common stock authorized share capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_CommonStockAuthorizedShareCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_EquitySecuritiesWithReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity securities with readily determinable fair value amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_EquitySecuritiesWithReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_LandUseRightsLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Land use rights lease term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_LandUseRightsLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_SignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Significant accounting policies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_SignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_CNY">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_CNY</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=zlab_OneCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=zlab_OneCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_LenderConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_LenderConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=zlab_ForeignCurrencyRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=zlab_ForeignCurrencyRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=zlab_CashAndCashEquivalentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=zlab_CashAndCashEquivalentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_GrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_GrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=zlab_HuizhengMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=zlab_HuizhengMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=zlab_CollaborativeAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=zlab_CollaborativeAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=zlab_CapitalizedSalesBasedMilestoneFeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=zlab_CapitalizedSalesBasedMilestoneFeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647755975056">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Property and Equipment (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember', window );">Office equipment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=zlab_ElectronicEquipmentMember', window );">Electronic equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life</a></td>
<td class="text">1 year 3 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=zlab_ElectronicEquipmentMember', window );">Electronic equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember', window );">Vehicles</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life</a></td>
<td class="text">4 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=zlab_LaboratoryEquipmentMember', window );">Laboratory equipment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ManufacturingFacilityMember', window );">Manufacturing equipment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=zlab_ElectronicEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=zlab_ElectronicEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=zlab_LaboratoryEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=zlab_LaboratoryEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ManufacturingFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ManufacturingFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647763367360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Concentration of Suppliers (Details) - Research and Development Expenses - Supplier Concentration Risk<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=zlab_ResearchAndDevelopmentExpensesMember', window );">E</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_ResearchAndDevelopmentExpensesAndTheInventoryPurchases', window );">Research and development expenses and inventory purchases</a></td>
<td class="nump">$ 165,431<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=zlab_ResearchAndDevelopmentExpensesMember', window );">F</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_ResearchAndDevelopmentExpensesAndTheInventoryPurchases', window );">Research and development expenses and inventory purchases</a></td>
<td class="nump">$ 66,650<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481027/954-310-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_ResearchAndDevelopmentExpensesAndTheInventoryPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Research and development expenses and the inventory purchases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_ResearchAndDevelopmentExpensesAndTheInventoryPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=zlab_ResearchAndDevelopmentExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=zlab_ResearchAndDevelopmentExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_MajorSuppliersAxis=zlab_SupplierEMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_MajorSuppliersAxis=zlab_SupplierEMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_MajorSuppliersAxis=zlab_SupplierFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_MajorSuppliersAxis=zlab_SupplierFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647754247296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cash and Cash Equivalents (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsLineItems', window );"><strong>Cash And Cash Equivalents [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="nump">$ 789,051<span></span>
</td>
<td class="nump">$ 1,007,423<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">1,100<span></span>
</td>
<td class="nump">1,047<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">790,151<span></span>
</td>
<td class="nump">1,008,470<span></span>
</td>
<td class="nump">$ 964,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_USD', window );">US$</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsLineItems', window );"><strong>Cash And Cash Equivalents [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">762,436<span></span>
</td>
<td class="nump">957,824<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_CNY', window );">RMB</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsLineItems', window );"><strong>Cash And Cash Equivalents [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">25,093<span></span>
</td>
<td class="nump">45,486<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_HKD', window );">Hong Kong dollar (&#8220;HK$&#8221;)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsLineItems', window );"><strong>Cash And Cash Equivalents [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">1,974<span></span>
</td>
<td class="nump">4,378<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_AUD', window );">Australian dollar (&#8220;A$&#8221;)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsLineItems', window );"><strong>Cash And Cash Equivalents [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">587<span></span>
</td>
<td class="nump">598<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_TWD', window );">Taiwan dollar (&#8220;TW$&#8221;)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsLineItems', window );"><strong>Cash And Cash Equivalents [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 61<span></span>
</td>
<td class="nump">$ 184<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480555/946-210-45-21<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 210<br> -Topic 946<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480555/946-210-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_USD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_USD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_CNY">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_CNY</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_HKD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_HKD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_AUD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_AUD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_TWD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_TWD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647759333024">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Restricted Cash, Non-Current (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAbstract', window );"><strong>Restricted Cash [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash, non-current</a></td>
<td class="nump">$ 1,113<span></span>
</td>
<td class="nump">$ 803<span></span>
</td>
<td class="nump">$ 803<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -SubTopic 210<br> -Topic 954<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480632/954-210-45-5<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647763806256">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Short-Term Investments (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems', window );"><strong>Schedule of Held-to-Maturity Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">$ 16,300,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossExcludingAccruedInterest', window );">Allowance for credit loss</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems', window );"><strong>Schedule of Held-to-Maturity Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MaturityOfTimeDeposits', window );">Original maturities of time deposits</a></td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems', window );"><strong>Schedule of Held-to-Maturity Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MaturityOfTimeDeposits', window );">Original maturities of time deposits</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossExcludingAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding accrued interest, of allowance for credit loss on investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479344/326-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossExcludingAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MaturityOfTimeDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of customer deposits, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Industry Guide<br> -Number 3<br> -Section V<br> -Paragraph D-E<br> -Publisher SEC<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MaturityOfTimeDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (aaa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647756245328">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventories, Net - Schedule of Inventory (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">$ 22,702<span></span>
</td>
<td class="nump">$ 12,156<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">17,655<span></span>
</td>
<td class="nump">19,029<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work in progress</a></td>
<td class="nump">4,470<span></span>
</td>
<td class="nump">436<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories, net</a></td>
<td class="nump">$ 44,827<span></span>
</td>
<td class="nump">$ 31,621<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480581/330-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480581/330-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480581/330-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647762919200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories, Net - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductionRelatedImpairmentsOrCharges', window );">Inventory write-down</a></td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="nump">$ 1.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductionRelatedImpairmentsOrCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nonrecurring impairment charges related to the write-off of production-related equipment and inventory. This tag is used when an Entity charges this cost to cost of goods sold.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductionRelatedImpairmentsOrCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647752665568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Investments (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_EquityAndCostMethodInvestmentsLineItems', window );"><strong>Equity And Cost Method Investments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiGainLoss', window );">Gains (losses) on equity investments with readily determinable fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,789<span></span>
</td>
<td class="num">$ (8,952)<span></span>
</td>
<td class="num">$ (14,617)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=zlab_MacroGenicsIncMember', window );">MacroGenics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_EquityAndCostMethodInvestmentsLineItems', window );"><strong>Equity And Cost Method Investments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Issuance of common stock (in shares)</a></td>
<td class="nump">958,467<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Issue price per share (in dollars per share)</a></td>
<td class="nump">$ 31.30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_EquityAndCostMethodInvestmentsLineItems', window );"><strong>Equity And Cost Method Investments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_EquitySecuritiesWithReadilyDeterminableFairValueAmount', window );">Equity investments with readily determinable fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,200<span></span>
</td>
<td class="nump">6,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=zlab_MacroGenicsIncMember', window );">MacroGenics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_EquityAndCostMethodInvestmentsLineItems', window );"><strong>Equity And Cost Method Investments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_CapitalContributionsCommitment', window );">Capital contribution commitment</a></td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiGainLoss', window );">Gains (losses) on equity investments with readily determinable fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,800<span></span>
</td>
<td class="num">$ (9,000)<span></span>
</td>
<td class="num">$ (14,600)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 321<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479536/321-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_CapitalContributionsCommitment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capital contribution commitment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_CapitalContributionsCommitment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_EquityAndCostMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity and cost method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_EquityAndCostMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_EquitySecuritiesWithReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity securities with readily determinable fair value amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_EquitySecuritiesWithReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=zlab_MacroGenicsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=zlab_MacroGenicsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=zlab_MacroGenicsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=zlab_MacroGenicsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647762355616">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and Equipment, Net - Summary of Property and Equipment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 83,870<span></span>
</td>
<td class="nump">$ 79,927<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation</a></td>
<td class="num">(30,136)<span></span>
</td>
<td class="num">(22,064)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">53,734<span></span>
</td>
<td class="nump">57,863<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember', window );">Office equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">1,047<span></span>
</td>
<td class="nump">977<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=zlab_ElectronicEquipmentMember', window );">Electronic equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">9,161<span></span>
</td>
<td class="nump">7,416<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember', window );">Vehicle</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">199<span></span>
</td>
<td class="nump">202<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=zlab_LaboratoryEquipmentMember', window );">Laboratory equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">20,140<span></span>
</td>
<td class="nump">18,726<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=zlab_ManufacturingEquipmentMember', window );">Manufacturing equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">17,680<span></span>
</td>
<td class="nump">17,055<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">11,371<span></span>
</td>
<td class="nump">11,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 24,272<span></span>
</td>
<td class="nump">$ 24,251<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=zlab_ElectronicEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=zlab_ElectronicEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=zlab_LaboratoryEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=zlab_LaboratoryEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=zlab_ManufacturingEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=zlab_ManufacturingEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647758595264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expenses</a></td>
<td class="nump">$ 8.4<span></span>
</td>
<td class="nump">$ 7.7<span></span>
</td>
<td class="nump">$ 6.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647759326400">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Additional Information (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lease</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm', window );">Operating lease remaining lease term</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lease</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm', window );">Operating lease remaining lease term</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRemainingLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647758614160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Operating Lease Cost (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating fixed lease cost</a></td>
<td class="nump">$ 8,691<span></span>
</td>
<td class="nump">$ 8,774<span></span>
</td>
<td class="nump">$ 6,263<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647763937856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Cash Flow Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Cash paid for amounts included in measurement of lease liabilities</a></td>
<td class="nump">$ 9,317<span></span>
</td>
<td class="nump">$ 8,084<span></span>
</td>
<td class="nump">$ 5,840<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Non-cash operating lease liabilities arising from obtaining operating right-of-use assets</a></td>
<td class="nump">$ 3,668<span></span>
</td>
<td class="nump">$ 14,801<span></span>
</td>
<td class="nump">$ 2,183<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647761305392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Maturities of Lease Liabilities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2024</a></td>
<td class="nump">$ 7,444<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2025</a></td>
<td class="nump">5,143<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2026</a></td>
<td class="nump">1,811<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2027</a></td>
<td class="nump">822<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2028</a></td>
<td class="nump">391<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">15,611<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(460)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of minimum operating lease payments</a></td>
<td class="nump">$ 15,151<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647763924560">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Weighted-Average Remaining Lease Terms and Discount Rates (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term</a></td>
<td class="text">2 years 6 months<span></span>
</td>
<td class="text">2 years 7 months 6 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.40%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647758582416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Summary of Product Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_RevenueFromContractWithCustomersExcludingAssessedTaxBeforeAdjustmentsForRebatesAndSalesReturns', window );">Product revenue &#8212; gross</a></td>
<td class="nump">$ 298,911<span></span>
</td>
<td class="nump">$ 234,009<span></span>
</td>
<td class="nump">$ 190,180<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_RevenueFromContractWithCustomersExcludingAssessedTaxAdjustmentsForRebatesAndSalesReturns', window );">Less: Rebates and sales returns</a></td>
<td class="num">(32,192)<span></span>
</td>
<td class="num">(21,337)<span></span>
</td>
<td class="num">(46,075)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenue &#8212; net</a></td>
<td class="nump">$ 266,719<span></span>
</td>
<td class="nump">$ 212,672<span></span>
</td>
<td class="nump">$ 144,105<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_RevenueFromContractWithCustomersExcludingAssessedTaxAdjustmentsForRebatesAndSalesReturns">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue from contract with customers excluding assessed tax, adjustments for rebates and sales return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_RevenueFromContractWithCustomersExcludingAssessedTaxAdjustmentsForRebatesAndSalesReturns</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_RevenueFromContractWithCustomersExcludingAssessedTaxBeforeAdjustmentsForRebatesAndSalesReturns">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue from contract with customers excluding assessed tax, before adjustments for rebates and sales return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_RevenueFromContractWithCustomersExcludingAssessedTaxBeforeAdjustmentsForRebatesAndSalesReturns</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647762293968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Disaggregation of Net Revenue by Product (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenue &#8212; net</a></td>
<td class="nump">$ 266,719<span></span>
</td>
<td class="nump">$ 212,672<span></span>
</td>
<td class="nump">$ 144,105<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=zlab_ZejulaMember', window );">ZEJULA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenue &#8212; net</a></td>
<td class="nump">168,843<span></span>
</td>
<td class="nump">145,194<span></span>
</td>
<td class="nump">93,579<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=zlab_OptuneMember', window );">OPTUNE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenue &#8212; net</a></td>
<td class="nump">46,969<span></span>
</td>
<td class="nump">47,321<span></span>
</td>
<td class="nump">38,903<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=zlab_QinlockMember', window );">QINLOCK</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenue &#8212; net</a></td>
<td class="nump">19,240<span></span>
</td>
<td class="nump">14,957<span></span>
</td>
<td class="nump">11,620<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=zlab_NuzyraMember', window );">NUZYRA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenue &#8212; net</a></td>
<td class="nump">21,656<span></span>
</td>
<td class="nump">5,200<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=zlab_VyvgartMember', window );">VYVGART</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenue &#8212; net</a></td>
<td class="nump">$ 10,011<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=zlab_ZejulaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=zlab_ZejulaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=zlab_OptuneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=zlab_OptuneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=zlab_QinlockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=zlab_QinlockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=zlab_NuzyraMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=zlab_NuzyraMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=zlab_VyvgartMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=zlab_VyvgartMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647755739232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Taxable income</a></td>
<td class="num">$ (334,620,000)<span></span>
</td>
<td class="num">$ (443,286,000)<span></span>
</td>
<td class="num">$ (704,471,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carry forwards</a></td>
<td class="nump">1,804,900,000<span></span>
</td>
<td class="nump">1,483,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CN', window );">Mainland China</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Taxable income</a></td>
<td class="num">(253,274,000)<span></span>
</td>
<td class="num">(290,056,000)<span></span>
</td>
<td class="num">(340,865,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carry forwards</a></td>
<td class="nump">1,492,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_HK', window );">Hong Kong</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Taxable income</a></td>
<td class="num">(4,483,000)<span></span>
</td>
<td class="num">(53,425,000)<span></span>
</td>
<td class="num">(243,400,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carry forwards</a></td>
<td class="nump">51,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_TW', window );">Taiwan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Taxable income</a></td>
<td class="num">(772,000)<span></span>
</td>
<td class="num">(989,000)<span></span>
</td>
<td class="num">(671,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carry forwards</a></td>
<td class="nump">2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Taxable income</a></td>
<td class="num">(92,869,000)<span></span>
</td>
<td class="num">(79,620,000)<span></span>
</td>
<td class="num">(89,374,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carry forwards</a></td>
<td class="nump">256,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_AU', window );">Australia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Taxable income</a></td>
<td class="num">(14,000)<span></span>
</td>
<td class="nump">260,000<span></span>
</td>
<td class="num">(1,758,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carry forwards</a></td>
<td class="nump">3,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=zlab_ZaiLabAUSTPtyLtdMember', window );">Zai Lab (AUST) Pty. Ltd.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Taxable income</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=zlab_ZaiLabUSLLCMember', window );">Zai Lab (US) LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Taxable income</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=zlab_ZaiLabTaiwanLimitedMember', window );">Zai Lab (Taiwan) Limited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Taxable income</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=zlab_ZaiLabHongKongAndZlChinaHoldingTwoAndZaiAutoImmuneHongKongAndZaiAntiInfectivesHongKongLimitedMember', window );">Zai Lab (Hong Kong) and ZL China Holding Two and Zai Auto Immune (Hong Kong) and Zai Anti Infectives (Hong Kong) Limited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Taxable income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_WithholdingTaxesRemittanceOfDividends', window );">Withholding taxes on remittance of dividends</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_IncomeTaxDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income tax disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_IncomeTaxDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_WithholdingTaxesRemittanceOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of withholding taxes on remittance of dividends.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_WithholdingTaxesRemittanceOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CN">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CN</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_HK">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_HK</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_TW">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_TW</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_AU">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_AU</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=zlab_ZaiLabAUSTPtyLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=zlab_ZaiLabAUSTPtyLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=zlab_ZaiLabUSLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=zlab_ZaiLabUSLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=zlab_ZaiLabTaiwanLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=zlab_ZaiLabTaiwanLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=zlab_ZaiLabHongKongAndZlChinaHoldingTwoAndZaiAutoImmuneHongKongAndZaiAntiInfectivesHongKongLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=zlab_ZaiLabHongKongAndZlChinaHoldingTwoAndZaiAutoImmuneHongKongAndZaiAntiInfectivesHongKongLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647762300336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax - Loss (Income) Before Income Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss (income) before income taxes</a></td>
<td class="nump">$ 334,620<span></span>
</td>
<td class="nump">$ 443,286<span></span>
</td>
<td class="nump">$ 704,471<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_KY', window );">Cayman Islands</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss (income) before income taxes</a></td>
<td class="num">(16,792)<span></span>
</td>
<td class="nump">19,454<span></span>
</td>
<td class="nump">28,401<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_VG', window );">British Virgin Islands</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss (income) before income taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CN', window );">Mainland China</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss (income) before income taxes</a></td>
<td class="nump">253,274<span></span>
</td>
<td class="nump">290,056<span></span>
</td>
<td class="nump">340,865<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_HK', window );">Hong Kong</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss (income) before income taxes</a></td>
<td class="nump">4,483<span></span>
</td>
<td class="nump">53,425<span></span>
</td>
<td class="nump">243,400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss (income) before income taxes</a></td>
<td class="nump">92,869<span></span>
</td>
<td class="nump">79,620<span></span>
</td>
<td class="nump">89,374<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_AU', window );">Australia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss (income) before income taxes</a></td>
<td class="nump">14<span></span>
</td>
<td class="num">(260)<span></span>
</td>
<td class="nump">1,758<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_TW', window );">Taiwan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss (income) before income taxes</a></td>
<td class="nump">$ 772<span></span>
</td>
<td class="nump">$ 989<span></span>
</td>
<td class="nump">$ 671<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_IncomeTaxDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income tax disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_IncomeTaxDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_KY">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_KY</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_VG">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_VG</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CN">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CN</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_HK">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_HK</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_AU">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_AU</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_TW">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_TW</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647759003056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax - Reconciliation of the Effective Income Tax Rate (Details) - Mainland China<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory income tax rate</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome', window );">Tax-exempted income</a></td>
<td class="nump">0.19%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Share-based compensation</a></td>
<td class="num">(2.08%)<span></span>
</td>
<td class="num">(1.40%)<span></span>
</td>
<td class="num">(0.92%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch', window );">Research and development super deduction</a></td>
<td class="nump">7.11%<span></span>
</td>
<td class="nump">2.51%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense', window );">Non-deductible expenses</a></td>
<td class="num">(2.83%)<span></span>
</td>
<td class="num">(2.31%)<span></span>
</td>
<td class="num">(5.78%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes', window );">Prior year tax filing adjustment</a></td>
<td class="nump">1.32%<span></span>
</td>
<td class="nump">6.33%<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Effect of different tax rate of subsidiary operation in other jurisdictions</a></td>
<td class="nump">0.02%<span></span>
</td>
<td class="num">(2.85%)<span></span>
</td>
<td class="num">(4.60%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_EffectiveIncomeTaxRateReconciliationAtPreferentialTaxRate', window );">Preferential tax rate</a></td>
<td class="num">(7.12%)<span></span>
</td>
<td class="num">(6.26%)<span></span>
</td>
<td class="num">(4.30%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCharitableContributions', window );">Expiration of deductible qualified donation</a></td>
<td class="nump">2.28%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Changes in valuation allowance</a></td>
<td class="num">(23.89%)<span></span>
</td>
<td class="num">(21.02%)<span></span>
</td>
<td class="num">(10.90%)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCharitableContributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to charitable contributions expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCharitableContributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income (loss) exempt from income taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_EffectiveIncomeTaxRateReconciliationAtPreferentialTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective income tax rate reconciliation at preferential tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_EffectiveIncomeTaxRateReconciliationAtPreferentialTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_IncomeTaxesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_IncomeTaxesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CN">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CN</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647755945392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Tax - Components of Deferred Tax Assets and Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment', window );">Depreciation of property and equipment, net</a></td>
<td class="nump">$ 131<span></span>
</td>
<td class="nump">$ 98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_DeferredTaxAssetsResearchAndExperimentalCapitalization', window );">Research and experimental capitalization</a></td>
<td class="nump">30,429<span></span>
</td>
<td class="nump">22,476<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Share-based compensation</a></td>
<td class="nump">3,422<span></span>
</td>
<td class="nump">1,787<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="nump">707<span></span>
</td>
<td class="nump">1,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_DeferredTaxAssetsGovernmentGrants', window );">Government grants</a></td>
<td class="nump">467<span></span>
</td>
<td class="nump">189<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_DeferredTaxAssetsDeferredRevenue', window );">Deferred revenue</a></td>
<td class="nump">4,354<span></span>
</td>
<td class="nump">3,378<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_DeferredTaxAssetsPublicWelfareDonations', window );">Qualified donation</a></td>
<td class="nump">22,992<span></span>
</td>
<td class="nump">12,947<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_DeferredTaxAssetsLeasingArrangements', window );">Lease liability</a></td>
<td class="nump">2,967<span></span>
</td>
<td class="nump">3,738<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carry forwards</a></td>
<td class="nump">295,313<span></span>
</td>
<td class="nump">241,397<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less: valuation allowance</a></td>
<td class="num">(357,956)<span></span>
</td>
<td class="num">(284,072)<span></span>
</td>
<td class="num">$ (189,684)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Total Deferred tax assets</a></td>
<td class="nump">2,826<span></span>
</td>
<td class="nump">3,738<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements', window );">Right-of-use assets</a></td>
<td class="num">(2,826)<span></span>
</td>
<td class="num">(3,738)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Deferred tax assets, net</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesLeasingArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_DeferredTaxAssetsDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_DeferredTaxAssetsDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_DeferredTaxAssetsGovernmentGrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets government grants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_DeferredTaxAssetsGovernmentGrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_DeferredTaxAssetsLeasingArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Leasing Arrangements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_DeferredTaxAssetsLeasingArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_DeferredTaxAssetsPublicWelfareDonations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets public welfare donations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_DeferredTaxAssetsPublicWelfareDonations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_DeferredTaxAssetsResearchAndExperimentalCapitalization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Research And Experimental Capitalization</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_DeferredTaxAssetsResearchAndExperimentalCapitalization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647758578208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax - Movement of Valuation Allowance (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_DeferredTaxAssetsValuationAllowanceRollForward', window );"><strong>Deferred Tax Assets, Valuation Allowance [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Balance as of January 1,</a></td>
<td class="num">$ (284,072)<span></span>
</td>
<td class="num">$ (189,684)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Additions</a></td>
<td class="num">(73,884)<span></span>
</td>
<td class="num">(94,388)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Balance as of December 31,</a></td>
<td class="num">$ (357,956)<span></span>
</td>
<td class="num">$ (284,072)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_DeferredTaxAssetsValuationAllowanceRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Valuation Allowance</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_DeferredTaxAssetsValuationAllowanceRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647756223184">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Current Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued payroll</a></td>
<td class="nump">$ 33,711<span></span>
</td>
<td class="nump">$ 31,689<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Accrued professional service fee</a></td>
<td class="nump">7,520<span></span>
</td>
<td class="nump">4,080<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_PayablesForPurchaseOfPropertyAndEquipmentCurrent', window );">Payables for purchase of property and equipment</a></td>
<td class="nump">2,474<span></span>
</td>
<td class="nump">5,269<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_AccruedRebateToDistributorsCurrent', window );">Accrued rebate to distributors</a></td>
<td class="nump">16,926<span></span>
</td>
<td class="nump">8,443<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrentAndNoncurrent', window );">Tax payables</a></td>
<td class="nump">16,988<span></span>
</td>
<td class="nump">13,283<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_OtherPayablesCurrentLiabilities', window );">Others</a></td>
<td class="nump">5,353<span></span>
</td>
<td class="nump">4,054<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Total</a></td>
<td class="nump">$ 82,972<span></span>
</td>
<td class="nump">$ 66,818<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_AccruedRebateToDistributorsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accrued rebate payable to distributors.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_AccruedRebateToDistributorsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_OtherPayablesCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other payables current liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_OtherPayablesCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_PayablesForPurchaseOfPropertyAndEquipmentCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payables for purchase of property and equipment current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_PayablesForPurchaseOfPropertyAndEquipmentCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647858963136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loss Per Share - Computation of Basic and Diluted Net Loss Per Share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss attributable to ordinary shareholders &#8212; basic</a></td>
<td class="num">$ (334,620)<span></span>
</td>
<td class="num">$ (443,286)<span></span>
</td>
<td class="num">$ (704,471)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Net loss attributable to ordinary shareholders &#8212; diluted</a></td>
<td class="num">$ (334,620)<span></span>
</td>
<td class="num">$ (443,286)<span></span>
</td>
<td class="num">$ (704,471)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_WeightedAverageNumberOfShareOutstandingBasicAndDilutedAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of ordinary shares - basic (in shares)</a></td>
<td class="nump">966,394,130<span></span>
</td>
<td class="nump">958,067,140<span></span>
</td>
<td class="nump">929,921,120<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average number of ordinary shares - diluted (in shares)</a></td>
<td class="nump">966,394,130<span></span>
</td>
<td class="nump">958,067,140<span></span>
</td>
<td class="nump">929,921,120<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share &#8212; basic (in dollars per share)</a></td>
<td class="num">$ (0.35)<span></span>
</td>
<td class="num">$ (0.46)<span></span>
</td>
<td class="num">$ (0.76)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share &#8212; diluted (in dollars per share)</a></td>
<td class="num">$ (0.35)<span></span>
</td>
<td class="num">$ (0.46)<span></span>
</td>
<td class="num">$ (0.76)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-5<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-11<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-40<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-40<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-40<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_WeightedAverageNumberOfShareOutstandingBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average number of share outstanding basic and diluted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_WeightedAverageNumberOfShareOutstandingBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647755223568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loss Per Share - Anti-Dilutive Shares Excluded from Calculation of Diluted Loss Per Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Share options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive shares excluded from calculation of diluted loss per share</a></td>
<td class="nump">104,584,050<span></span>
</td>
<td class="nump">91,181,420<span></span>
</td>
<td class="nump">81,015,590<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=zlab_NonVestedRestrictedSharesMember', window );">Non-vested restricted shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive shares excluded from calculation of diluted loss per share</a></td>
<td class="nump">31,279,600<span></span>
</td>
<td class="nump">33,433,890<span></span>
</td>
<td class="nump">9,567,360<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=zlab_NonVestedRestrictedSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=zlab_NonVestedRestrictedSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647880357584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expense</a></td>
<td class="nump">$ 265,868<span></span>
</td>
<td class="nump">$ 286,408<span></span>
</td>
<td class="nump">$ 573,306<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_LimitedLiabilityCompanyMember', window );">MEDx (Suzhou) Translational Medicine Co., Ltd.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expense</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482916/730-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482517/912-730-25-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_LimitedLiabilityCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_LimitedLiabilityCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647753012032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Additional Information (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Aggregate intrinsic value of stock options exercised</a></td>
<td class="nump">$ 20.3<span></span>
</td>
<td class="nump">$ 14.3<span></span>
</td>
<td class="nump">$ 170.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Share options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Options granted contractual term</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant-date fair value of options granted (in dollars per share)</a></td>
<td class="nump">$ 2.21<span></span>
</td>
<td class="nump">$ 2.74<span></span>
</td>
<td class="nump">$ 12.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized compensation expense related to unvested share options granted</a></td>
<td class="nump">$ 104.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Recognized over a weighted-average period</a></td>
<td class="text">3 years 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Share options | Since April 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Share options | Since April 2023 | Tranche one</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Share options | Since April 2023 | Tranche two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Share options | Since April 2023 | Tranche three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Share options | Since April 2023 | Tranche four</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Share options | Prior to April 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Share options | Prior to April 2023 | Tranche one</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Share options | Prior to April 2023 | Tranche two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Share options | Prior to April 2023 | Tranche three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Share options | Prior to April 2023 | Tranche four</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Share options | Prior to April 2023 | Tranche five</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=zlab_NonVestedRestrictedSharesMember', window );">Non-vested restricted shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant-date fair value of non-option awards granted (in dollars per share)</a></td>
<td class="nump">$ 3.18<span></span>
</td>
<td class="nump">$ 3.71<span></span>
</td>
<td class="nump">$ 10.55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unrecognized share-based compensation</a></td>
<td class="nump">$ 104.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Recognized over a weighted-average period</a></td>
<td class="text">2 years 9 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=zlab_TwoThousandTwentyTwoEquityIncentivePlanMember', window );">Two Thousand Twenty Two Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">97,908,743<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=zlab_April2023AndLaterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=zlab_April2023AndLaterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=zlab_ShareBasedPaymentArrangementTrancheFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=zlab_ShareBasedPaymentArrangementTrancheFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=zlab_PriorToApril2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=zlab_PriorToApril2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=zlab_ShareBasedPaymentArrangementTrancheFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=zlab_ShareBasedPaymentArrangementTrancheFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=zlab_NonVestedRestrictedSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=zlab_NonVestedRestrictedSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=zlab_TwoThousandTwentyTwoEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=zlab_TwoThousandTwentyTwoEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647755617056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Option Activity (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of options</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, beginning balance (in shares)</a></td>
<td class="nump">91,181,420<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">24,102,740<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(6,516,920)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited (in shares)</a></td>
<td class="num">(4,183,190)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, ending balance (in shares)</a></td>
<td class="nump">104,584,050<span></span>
</td>
<td class="nump">91,181,420<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted average exercise price ($)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, beginning balance (in dollars per share)</a></td>
<td class="nump">$ 3.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share)</a></td>
<td class="nump">3.36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share)</a></td>
<td class="nump">0.39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited (in dollars per share)</a></td>
<td class="nump">6.68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, ending balance (in dollars per share)</a></td>
<td class="nump">$ 3.14<span></span>
</td>
<td class="nump">$ 3.05<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Additional Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Number of options, Vested and exercisable (in shares)</a></td>
<td class="nump">58,695,320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted average exercise price, Vested and exercisable (in dollars per share)</a></td>
<td class="nump">$ 2.11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining contractual term, Outstanding</a></td>
<td class="text">5 years 11 months 19 days<span></span>
</td>
<td class="text">5 years 10 months 20 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contractual term, Vested and exercisable</a></td>
<td class="text">3 years 11 months 4 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value, Outstanding</a></td>
<td class="nump">$ 83,424<span></span>
</td>
<td class="nump">$ 115,969<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate intrinsic value, Vested and exercisable</a></td>
<td class="nump">$ 83,266<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647762357120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Assumptions Used to Estimate Fair Values of Share Options Granted (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Share options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk-free rate of return, minimum</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="nump">1.40%<span></span>
</td>
<td class="nump">0.90%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free rate of return, maximum</a></td>
<td class="nump">4.70%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">1.40%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Estimated volatility rate</a></td>
<td class="nump">70.00%<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=zlab_ShareBasedPaymentArrangementOptionBatchOneMember', window );">Share options, batch one</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=zlab_ShareBasedPaymentArrangementOptionBatchTwoMember', window );">Share options, batch two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">6 years 3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years 3 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=zlab_ShareBasedPaymentArrangementOptionBatchThreeMember', window );">Share options, batch three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">6 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years 6 months<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=zlab_ShareBasedPaymentArrangementOptionBatchOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=zlab_ShareBasedPaymentArrangementOptionBatchOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=zlab_ShareBasedPaymentArrangementOptionBatchTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=zlab_ShareBasedPaymentArrangementOptionBatchTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=zlab_ShareBasedPaymentArrangementOptionBatchThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=zlab_ShareBasedPaymentArrangementOptionBatchThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647763806384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Non-vested Restricted Share Activity (Details) - Non-Vested Restricted Shares - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward', window );"><strong>Numbers of non-vested restricted shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Non-vested, Beginning balance (in shares)</a></td>
<td class="nump">33,433,890<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">9,001,740<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="num">(8,178,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares)</a></td>
<td class="num">(2,977,530)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Non-vested, Ending balance (in shares)</a></td>
<td class="nump">31,279,600<span></span>
</td>
<td class="nump">33,433,890<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Weighted average remaining contractual term (years)</a></td>
<td class="text">2 years 9 months<span></span>
</td>
<td class="text">3 years 6 months 18 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested', window );">Aggregate intrinsic value ($ in thousands)</a></td>
<td class="nump">$ 85,487<span></span>
</td>
<td class="nump">$ 102,642<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Intrinsic value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=zlab_NonVestedRestrictedSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=zlab_NonVestedRestrictedSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647755612400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation expense</a></td>
<td class="nump">$ 79,634<span></span>
</td>
<td class="nump">$ 61,302<span></span>
</td>
<td class="nump">$ 40,714<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, general and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation expense</a></td>
<td class="nump">48,017<span></span>
</td>
<td class="nump">38,118<span></span>
</td>
<td class="nump">23,194<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation expense</a></td>
<td class="nump">$ 31,617<span></span>
</td>
<td class="nump">$ 23,184<span></span>
</td>
<td class="nump">$ 17,520<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647753515344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>License and Collaboration Agreements (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_CollaborativeArrangementRightsAndObligationsSpecifiedRoyaltyTerm', window );">Specified royalty term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 265,868<span></span>
</td>
<td class="nump">$ 286,408<span></span>
</td>
<td class="nump">$ 573,306<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments', window );">Maximum additional milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,202,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=zlab_GlaxoSmithKlineMember', window );">GSK</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_CollaborativeArrangementRightsAndObligationsSalesBasedMilestonePayment', window );">Sales-based milestone payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments', window );">Maximum additional milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=zlab_NovocureLimitedMember', window );">Novocure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments', window );">Maximum additional milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=zlab_DecipheraPharmaceuticalsLLCMember', window );">Deciphera</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments', window );">Maximum additional milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">173,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=zlab_GurnetPointCapitalAndNovoHoldingsASMember', window );">Novo Holdings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments', window );">Maximum additional milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=zlab_ArgenxBvMember', window );">argenx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross', window );">Issuance of ordinary shares in connection with collaboration and license arrangement (in shares)</a></td>
<td class="nump">5,681,820<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_CollaborativeArrangementRightsAndObligationsPaymentOfUpFrontFeesForLicenseAgreement', window );">Upfront payment</a></td>
<td class="nump">$ 62,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=zlab_AmgenMember', window );">Amgen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_CollaborativeArrangementRightsAndObligationsSpecifiedRoyaltyTerm', window );">Specified royalty term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments', window );">Maximum additional milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=zlab_InnovivaInc.Member', window );">Innoviva</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments', window );">Maximum additional milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=zlab_BMSMember', window );">BMS | Repotrectinib</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments', window );">Maximum additional milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">141,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=zlab_BMSMember', window );">BMS | Adagrasib</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments', window );">Maximum additional milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">263,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_CollaborativeArrangementRightsAndObligationsPaymentOfUpFrontFeesForLicenseAgreement', window );">Upfront payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_CollaborativeArrangementRightsAndObligationsDevelopmentMilestonePayment', window );">Development milestone payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=zlab_BMSMember', window );">BMS | Xanomeline-Trospium</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments', window );">Maximum additional milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">142,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=zlab_PfizerIncMember', window );">Pfizer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments', window );">Maximum additional milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">263,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=zlab_OtherCounterpartiesMember', window );">Other counterparties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_CollaborativeArrangementRightsAndObligationsPaymentOfUpFrontFeesForLicenseAgreement', window );">Upfront payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember', window );">Collaborative Arrangement, Transaction with Party to Collaborative Arrangement | GSK</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember', window );">Collaborative Arrangement, Transaction with Party to Collaborative Arrangement | Deciphera</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember', window );">Collaborative Arrangement, Transaction with Party to Collaborative Arrangement | Novo Holdings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember', window );">Collaborative Arrangement, Transaction with Party to Collaborative Arrangement | argenx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember', window );">Collaborative Arrangement, Transaction with Party to Collaborative Arrangement | Innoviva</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember', window );">Collaborative Arrangement, Transaction with Party to Collaborative Arrangement | BMS | Repotrectinib</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember', window );">Collaborative Arrangement, Transaction with Party to Collaborative Arrangement | BMS | Xanomeline-Trospium</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">$ 35,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember', window );">Collaborative Arrangement, Transaction with Party to Collaborative Arrangement | Pfizer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482916/730-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482517/912-730-25-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_CollaborativeArrangementRightsAndObligationsDevelopmentMilestonePayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Rights and Obligations, Development Milestone Payment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_CollaborativeArrangementRightsAndObligationsDevelopmentMilestonePayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount represents the additional milestone payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_CollaborativeArrangementRightsAndObligationsPaymentOfUpFrontFeesForLicenseAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment of upfront fees for license agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_CollaborativeArrangementRightsAndObligationsPaymentOfUpFrontFeesForLicenseAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_CollaborativeArrangementRightsAndObligationsSalesBasedMilestonePayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Rights and Obligations, Sales-Based Milestone Payment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_CollaborativeArrangementRightsAndObligationsSalesBasedMilestonePayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_CollaborativeArrangementRightsAndObligationsSpecifiedRoyaltyTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Rights and Obligations, Specified Royalty Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_CollaborativeArrangementRightsAndObligationsSpecifiedRoyaltyTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=zlab_GlaxoSmithKlineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=zlab_GlaxoSmithKlineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=zlab_NovocureLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=zlab_NovocureLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=zlab_DecipheraPharmaceuticalsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=zlab_DecipheraPharmaceuticalsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=zlab_GurnetPointCapitalAndNovoHoldingsASMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=zlab_GurnetPointCapitalAndNovoHoldingsASMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=zlab_ArgenxBvMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=zlab_ArgenxBvMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=zlab_AmgenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=zlab_AmgenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=zlab_InnovivaInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=zlab_InnovivaInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=zlab_BMSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=zlab_BMSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=zlab_RepotrectinibMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=zlab_RepotrectinibMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=zlab_AdagrasibMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=zlab_AdagrasibMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=zlab_XanomelineTrospiumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=zlab_XanomelineTrospiumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=zlab_PfizerIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=zlab_PfizerIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=zlab_OtherCounterpartiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=zlab_OtherCounterpartiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>135
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647755543296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Income (Expenses), Net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_GovernmentAssistanceNonoperatingIncome', window );">Government grants recognized</a></td>
<td class="nump">$ 2,433<span></span>
</td>
<td class="nump">$ 11,471<span></span>
</td>
<td class="nump">$ 4,113<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiGainLoss', window );">Gain (Loss) on equity investments with readily determinable fair value</a></td>
<td class="nump">2,789<span></span>
</td>
<td class="num">(8,952)<span></span>
</td>
<td class="num">(14,617)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingGainsLosses', window );">Others miscellaneous gain</a></td>
<td class="nump">1,784<span></span>
</td>
<td class="nump">594<span></span>
</td>
<td class="nump">303<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Total</a></td>
<td class="nump">$ 7,006<span></span>
</td>
<td class="nump">$ 3,113<span></span>
</td>
<td class="num">$ (10,201)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 321<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479536/321-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7,9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_GovernmentAssistanceNonoperatingIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Government Assistance, Nonoperating Income</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_GovernmentAssistanceNonoperatingIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>136
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647763090560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restricted Net Assets (Details) - Mainland China - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_RestrictedNetAssetsLineItems', window );"><strong>Restricted net assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_StatutoryReserves', window );">Statutory reserves</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries', window );">Restricted amount by subsidiaries</a></td>
<td class="nump">$ 506,000,000.0<span></span>
</td>
<td class="nump">$ 456,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of restricted net assets of consolidated and unconsolidated subsidiaries as of the end of the most recently completed fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(3)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_RestrictedNetAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restricted net assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_RestrictedNetAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_StatutoryReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Statutory reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_StatutoryReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CN">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CN</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>137
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647755913984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Defined Contribution Plans (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanNameAxis=zlab_MainlandChinaGovernmentPlanMember', window );">Mainland China Government Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanDisclosureLineItems', window );"><strong>Defined Contribution Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Defined contribution plan expense</a></td>
<td class="nump">$ 25.8<span></span>
</td>
<td class="nump">$ 23.6<span></span>
</td>
<td class="nump">$ 17.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanNameAxis=zlab_A401kPlanMember', window );">401(k) Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanDisclosureLineItems', window );"><strong>Defined Contribution Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Defined contribution plan expense</a></td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch', window );">Employer matching contribution percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_DefinedContributionPlanEmployerMatchingContributionPercentOfEmployeeContribution', window );">Percentage of employee contribution that the employer matches</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanNameAxis=zlab_MandatoryProvidentFundMember', window );">Mandatory Provident Fund</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanDisclosureLineItems', window );"><strong>Defined Contribution Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Defined contribution plan expense</a></td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | 401(k) Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanDisclosureLineItems', window );"><strong>Defined Contribution Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent', window );">Percentage of employees eligible compensation the employer matches</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 70<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480794/715-70-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 70<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480794/715-70-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage employer matches of the employee's percentage contribution matched.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_DefinedContributionPlanEmployerMatchingContributionPercentOfEmployeeContribution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Contribution Plan, Employer Matching Contribution, Percent Of Employee Contribution</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_DefinedContributionPlanEmployerMatchingContributionPercentOfEmployeeContribution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=zlab_MainlandChinaGovernmentPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=zlab_MainlandChinaGovernmentPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=zlab_A401kPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=zlab_A401kPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=zlab_MandatoryProvidentFundMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=zlab_MandatoryProvidentFundMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>138
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647763554368">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_PropertyPlantAndEquipmentMember', window );">Property and Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecordedUnconditionalPurchaseObligationDueInNextRollingTwelveMonths', window );">Purchase obligation to be incurred within one year</a></td>
<td class="nump">$ 1.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-4<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecordedUnconditionalPurchaseObligationDueInNextRollingTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the fixed and determinable portion of the unrecorded unconditional purchase obligation maturing in the next rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecordedUnconditionalPurchaseObligationDueInNextRollingTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_PropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_PropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>139
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647761204048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events (Details) - Subsequent Event<br> &#165; in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Feb. 07, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 06, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 05, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 27, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 27, 2024 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Feb. 07, 2024 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Feb. 06, 2024 </div>
<div>CNY (&#165;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsMaximumExposure', window );">Maximum guarantor obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 300.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_GuarantorObligationTerm', window );">Guarantor obligation term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Bank of China Working Capital Loan Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFeeAmount', window );">Debt instrument fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Bank of China Working Capital Loan Facility | Loans Payable | Zai Lab Shanghai</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument term</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Loan amount</a></td>
<td class="nump">$ 47.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 340.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">2.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_DebtInstrumentVariableInterestRateAdjustmentPeriod', window );">Floating interest rate adjustment period</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Bank of China Working Capital Loan Facility | Standby Letters of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of credit outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">SPD Bank Working Capital Loan Facility | Loans Payable | Zai Lab Shanghai</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Loan amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.0<span></span>
</td>
<td class="nump">&#165; 50.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.45%<span></span>
</td>
<td class="nump">3.45%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Ningbo Bank Working Capital Loan Facility | Loans Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">160.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Ningbo Bank Working Capital Loan Facility | Loans Payable | Zai Lab Suzhou</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 230.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFeeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the fee that accompanies borrowing money under the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFeeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteeObligationsMaximumExposure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum potential amount of future payments (undiscounted) the guarantor could be required to make under the guarantee or each group of similar guarantees before reduction for potential recoveries under recourse or collateralization provisions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteeObligationsMaximumExposure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_DebtInstrumentVariableInterestRateAdjustmentPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Variable Interest Rate, Adjustment, Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_DebtInstrumentVariableInterestRateAdjustmentPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_GuarantorObligationTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Guarantor Obligation, Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_GuarantorObligationTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=zlab_BankOfChinaWorkingCapitalLoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=zlab_BankOfChinaWorkingCapitalLoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=zlab_ZaiLabShanghaiCo.Ltd.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=zlab_ZaiLabShanghaiCo.Ltd.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_StandbyLettersOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_StandbyLettersOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=zlab_SPDBankWorkingCapitalLoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=zlab_SPDBankWorkingCapitalLoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=zlab_NingboBankWorkingCapitalLoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=zlab_NingboBankWorkingCapitalLoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=zlab_ZaiLabSuzhouCompanyLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=zlab_ZaiLabSuzhouCompanyLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>140
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647752827392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule I &#8212; Condensed Financial Information of Registrant - Condensed Balance Sheets (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 790,151<span></span>
</td>
<td class="nump">$ 1,008,470<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 964,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepayments and other current assets</a></td>
<td class="nump">22,995<span></span>
</td>
<td class="nump">35,674<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">939,606<span></span>
</td>
<td class="nump">1,124,336<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">1,036,295<span></span>
</td>
<td class="nump">1,220,140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">82,972<span></span>
</td>
<td class="nump">66,818<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">203,067<span></span>
</td>
<td class="nump">139,842<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">240,177<span></span>
</td>
<td class="nump">174,545<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Ordinary shares (par value of $0.000006 per share; 5,000,000,000 shares authorized, 977,151,270 and 962,455,850 shares issued as of December&#160;31, 2023 and 2022, respectively; 972,239,070 and 960,219,570 shares issued and outstanding as of December&#160;31, 2023 and 2022, respectively)</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">2,975,302<span></span>
</td>
<td class="nump">2,893,120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(2,195,980)<span></span>
</td>
<td class="num">(1,861,360)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="nump">37,626<span></span>
</td>
<td class="nump">25,685<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonValue', window );">Treasury stock</a></td>
<td class="num">(20,836)<span></span>
</td>
<td class="num">(11,856)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders&#8217; equity</a></td>
<td class="nump">796,118<span></span>
</td>
<td class="nump">1,045,595<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,379,956<span></span>
</td>
<td class="nump">$ 1,169,345<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders&#8217; equity</a></td>
<td class="nump">$ 1,036,295<span></span>
</td>
<td class="nump">$ 1,220,140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract', window );"><strong>Stockholders' equity, par value and number of shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, par value (in dollars per share)</a></td>
<td class="nump">$ 0.000006<span></span>
</td>
<td class="nump">$ 0.000006<span></span>
</td>
<td class="nump">$ 0.000006<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Ordinary shares, shares authorized (in shares)</a></td>
<td class="nump">5,000,000,000<span></span>
</td>
<td class="nump">5,000,000,000<span></span>
</td>
<td class="nump">5,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ordinary shares, shares issued (in shares)</a></td>
<td class="nump">977,151,270<span></span>
</td>
<td class="nump">962,455,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ordinary shares, shares outstanding (in shares)</a></td>
<td class="nump">972,239,070<span></span>
</td>
<td class="nump">960,219,570<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember', window );">Parent Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 565,981<span></span>
</td>
<td class="nump">$ 944,649<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepayments and other current assets</a></td>
<td class="nump">7,423<span></span>
</td>
<td class="nump">10,203<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">573,404<span></span>
</td>
<td class="nump">954,852<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investment in subsidiaries</a></td>
<td class="nump">224,954<span></span>
</td>
<td class="nump">93,363<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">798,358<span></span>
</td>
<td class="nump">1,048,215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">2,240<span></span>
</td>
<td class="nump">2,620<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">2,240<span></span>
</td>
<td class="nump">2,620<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">2,240<span></span>
</td>
<td class="nump">2,620<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Ordinary shares (par value of $0.000006 per share; 5,000,000,000 shares authorized, 977,151,270 and 962,455,850 shares issued as of December&#160;31, 2023 and 2022, respectively; 972,239,070 and 960,219,570 shares issued and outstanding as of December&#160;31, 2023 and 2022, respectively)</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">2,975,302<span></span>
</td>
<td class="nump">2,893,120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(2,195,980)<span></span>
</td>
<td class="num">(1,861,360)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="nump">37,626<span></span>
</td>
<td class="nump">25,685<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonValue', window );">Treasury stock</a></td>
<td class="num">(20,836)<span></span>
</td>
<td class="num">(11,856)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders&#8217; equity</a></td>
<td class="nump">796,118<span></span>
</td>
<td class="nump">1,045,595<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders&#8217; equity</a></td>
<td class="nump">$ 798,358<span></span>
</td>
<td class="nump">$ 1,048,215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract', window );"><strong>Stockholders' equity, par value and number of shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, par value (in dollars per share)</a></td>
<td class="nump">$ 0.000006<span></span>
</td>
<td class="nump">$ 0.000006<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Ordinary shares, shares authorized (in shares)</a></td>
<td class="nump">5,000,000,000<span></span>
</td>
<td class="nump">5,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ordinary shares, shares issued (in shares)</a></td>
<td class="nump">977,151,270<span></span>
</td>
<td class="nump">962,455,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ordinary shares, shares outstanding (in shares)</a></td>
<td class="nump">972,239,070<span></span>
</td>
<td class="nump">960,219,570<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481520/505-30-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.30)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>141
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647752796768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule I &#8212; Condensed Financial Information of Registrant - Condensed Statements of Operations and Comprehensive Loss (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating Expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="num">$ (265,868,000)<span></span>
</td>
<td class="num">$ (286,408,000)<span></span>
</td>
<td class="num">$ (573,306,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(366,573,000)<span></span>
</td>
<td class="num">(404,357,000)<span></span>
</td>
<td class="num">(700,064,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">39,797,000<span></span>
</td>
<td class="nump">14,582,000<span></span>
</td>
<td class="nump">2,190,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="nump">7,006,000<span></span>
</td>
<td class="nump">3,113,000<span></span>
</td>
<td class="num">(10,201,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Loss before income tax and share of loss from equity method investment</a></td>
<td class="num">(334,620,000)<span></span>
</td>
<td class="num">(443,065,000)<span></span>
</td>
<td class="num">(703,414,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(334,620,000)<span></span>
</td>
<td class="num">(443,286,000)<span></span>
</td>
<td class="num">(704,471,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss) , net of tax of nil:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1', window );">Other comprehensive (loss) income, tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustments</a></td>
<td class="nump">11,941,000<span></span>
</td>
<td class="nump">49,330,000<span></span>
</td>
<td class="num">(9,121,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">(322,679,000)<span></span>
</td>
<td class="num">(393,956,000)<span></span>
</td>
<td class="num">(713,592,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember', window );">Parent Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating Expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="num">(82,000)<span></span>
</td>
<td class="num">(178,000)<span></span>
</td>
<td class="num">(6,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="num">(16,958,000)<span></span>
</td>
<td class="num">(19,773,000)<span></span>
</td>
<td class="num">(12,074,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(17,040,000)<span></span>
</td>
<td class="num">(19,951,000)<span></span>
</td>
<td class="num">(12,080,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">30,840,000<span></span>
</td>
<td class="nump">12,857,000<span></span>
</td>
<td class="nump">1,881,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="nump">4,029,000<span></span>
</td>
<td class="num">(8,678,000)<span></span>
</td>
<td class="num">(18,173,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Loss before income tax and share of loss from equity method investment</a></td>
<td class="nump">17,829,000<span></span>
</td>
<td class="num">(15,772,000)<span></span>
</td>
<td class="num">(28,372,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_IncomeLossFromEquityMethodInvestmentsNetOfTax', window );">Equity in loss of subsidiaries</a></td>
<td class="num">(352,449,000)<span></span>
</td>
<td class="num">(427,514,000)<span></span>
</td>
<td class="num">(676,099,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(334,620,000)<span></span>
</td>
<td class="num">(443,286,000)<span></span>
</td>
<td class="num">(704,471,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss) , net of tax of nil:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1', window );">Other comprehensive (loss) income, tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustments</a></td>
<td class="nump">11,941,000<span></span>
</td>
<td class="nump">49,330,000<span></span>
</td>
<td class="num">(9,121,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (322,679,000)<span></span>
</td>
<td class="num">$ (393,956,000)<span></span>
</td>
<td class="num">$ (713,592,000)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482916/730-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482517/912-730-25-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_IncomeLossFromEquityMethodInvestmentsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income (loss) from equity method investments, net of tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_IncomeLossFromEquityMethodInvestmentsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>142
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140647755040992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule I &#8212; Condensed Financial Information of Registrant - Condensed Statements of Cash Flows (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from Operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (334,620)<span></span>
</td>
<td class="num">$ (443,286)<span></span>
</td>
<td class="num">$ (704,471)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash provided by (used in) operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_AmortizationOfDeferredIncome', window );">Amortization of deferred income</a></td>
<td class="num">(3,383)<span></span>
</td>
<td class="num">(2,602)<span></span>
</td>
<td class="num">(521)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">79,634<span></span>
</td>
<td class="nump">61,302<span></span>
</td>
<td class="nump">40,714<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiGainLoss', window );">Loss from fair value changes of equity investment of readily determinable fair value</a></td>
<td class="num">(2,789)<span></span>
</td>
<td class="nump">8,952<span></span>
</td>
<td class="nump">14,617<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepayments and other current assets</a></td>
<td class="nump">12,246<span></span>
</td>
<td class="num">(19,258)<span></span>
</td>
<td class="num">(7,086)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities', window );">Other current liabilities</a></td>
<td class="nump">19,810<span></span>
</td>
<td class="nump">7,392<span></span>
</td>
<td class="nump">30,142<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by (used in) operating activities</a></td>
<td class="num">(198,178)<span></span>
</td>
<td class="num">(367,642)<span></span>
</td>
<td class="num">(549,231)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireShortTermInvestments', window );">Purchase of short-term investments</a></td>
<td class="num">(134,000)<span></span>
</td>
<td class="num">(260,274)<span></span>
</td>
<td class="num">(445,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments', window );">Proceeds from maturity of short-term investments</a></td>
<td class="nump">117,700<span></span>
</td>
<td class="nump">705,274<span></span>
</td>
<td class="nump">743,902<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Purchase of investment in equity investee</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(30,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash (used in) provided by investing activities</a></td>
<td class="num">(10,776)<span></span>
</td>
<td class="nump">420,016<span></span>
</td>
<td class="nump">249,957<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercises of stock options</a></td>
<td class="nump">2,369<span></span>
</td>
<td class="nump">5,870<span></span>
</td>
<td class="nump">7,417<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from issuance of ordinary shares upon public offerings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">818,875<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payment of public offering costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,837)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Taxes paid related to settlement of equity awards</a></td>
<td class="num">(8,802)<span></span>
</td>
<td class="num">(7,600)<span></span>
</td>
<td class="num">(4,253)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash (used in) provided by financing activities</a></td>
<td class="num">(6,433)<span></span>
</td>
<td class="num">(1,730)<span></span>
</td>
<td class="nump">820,202<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash</a></td>
<td class="num">(2,622)<span></span>
</td>
<td class="num">(6,274)<span></span>
</td>
<td class="nump">1,116<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net (decrease) increase in cash, cash equivalents and restricted cash</a></td>
<td class="num">(218,009)<span></span>
</td>
<td class="nump">44,370<span></span>
</td>
<td class="nump">522,044<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash, cash equivalents and restricted cash &#8212; beginning of the year</a></td>
<td class="nump">1,009,273<span></span>
</td>
<td class="nump">964,903<span></span>
</td>
<td class="nump">442,859<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash, cash equivalents and restricted cash &#8212; end of the year</a></td>
<td class="nump">791,264<span></span>
</td>
<td class="nump">1,009,273<span></span>
</td>
<td class="nump">964,903<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember', window );">Parent Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from Operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(334,620)<span></span>
</td>
<td class="num">(443,286)<span></span>
</td>
<td class="num">(704,471)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash provided by (used in) operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_AmortizationOfDeferredIncome', window );">Amortization of deferred income</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(234)<span></span>
</td>
<td class="num">(312)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">3,217<span></span>
</td>
<td class="nump">3,724<span></span>
</td>
<td class="nump">3,435<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_zlab_IncomeLossFromEquityMethodInvestmentsNetOfTax', window );">Equity in loss of subsidiaries</a></td>
<td class="nump">352,449<span></span>
</td>
<td class="nump">427,514<span></span>
</td>
<td class="nump">676,099<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiGainLoss', window );">Loss from fair value changes of equity investment of readily determinable fair value</a></td>
<td class="num">(2,789)<span></span>
</td>
<td class="nump">8,952<span></span>
</td>
<td class="nump">14,617<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepayments and other current assets</a></td>
<td class="nump">2,780<span></span>
</td>
<td class="num">(7,839)<span></span>
</td>
<td class="num">(439)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities', window );">Other current liabilities</a></td>
<td class="num">(379)<span></span>
</td>
<td class="nump">1,648<span></span>
</td>
<td class="num">(376)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by (used in) operating activities</a></td>
<td class="nump">20,658<span></span>
</td>
<td class="num">(9,521)<span></span>
</td>
<td class="num">(11,447)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireShortTermInvestments', window );">Purchase of short-term investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(260,274)<span></span>
</td>
<td class="num">(445,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments', window );">Proceeds from maturity of short-term investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">705,274<span></span>
</td>
<td class="nump">743,902<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Purchase of investment in equity investee</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(30,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates', window );">Investment in subsidiaries</a></td>
<td class="num">(392,893)<span></span>
</td>
<td class="num">(80,942)<span></span>
</td>
<td class="num">(884,342)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash (used in) provided by investing activities</a></td>
<td class="num">(392,893)<span></span>
</td>
<td class="nump">364,058<span></span>
</td>
<td class="num">(615,440)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercises of stock options</a></td>
<td class="nump">2,369<span></span>
</td>
<td class="nump">5,870<span></span>
</td>
<td class="nump">7,418<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from issuance of ordinary shares upon public offerings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">818,875<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payment of public offering costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,692)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Taxes paid related to settlement of equity awards</a></td>
<td class="num">(8,802)<span></span>
</td>
<td class="num">(7,600)<span></span>
</td>
<td class="num">(4,253)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash (used in) provided by financing activities</a></td>
<td class="num">(6,433)<span></span>
</td>
<td class="num">(1,730)<span></span>
</td>
<td class="nump">820,348<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">773<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net (decrease) increase in cash, cash equivalents and restricted cash</a></td>
<td class="num">(378,668)<span></span>
</td>
<td class="nump">352,807<span></span>
</td>
<td class="nump">194,234<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash, cash equivalents and restricted cash &#8212; beginning of the year</a></td>
<td class="nump">944,649<span></span>
</td>
<td class="nump">591,842<span></span>
</td>
<td class="nump">397,608<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash, cash equivalents and restricted cash &#8212; end of the year</a></td>
<td class="nump">$ 565,981<span></span>
</td>
<td class="nump">$ 944,649<span></span>
</td>
<td class="nump">$ 591,842<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 321<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479536/321-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of or advances to an entity that is related to it but not strictly controlled (for example, an unconsolidated subsidiary, affiliate, and joint venture or equity method investment) or the acquisition of an additional interest in a subsidiary (controlled entity).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from maturities, prepayments, calls and collections of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_AmortizationOfDeferredIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization of deferred income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_AmortizationOfDeferredIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zlab_IncomeLossFromEquityMethodInvestmentsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income (loss) from equity method investments, net of tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zlab_IncomeLossFromEquityMethodInvestmentsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zlab_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>144
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MTPZ7:R4A"&\ OZ\,B(S]C3];/)PE+_\!4$L#!!0    ( (J"6U@<WY->%P,
M .H(   8    >&PO=V]R:W-H965T<R]S:&5E=#0N>&ULK991;YLZ%,>_BL6=
MIE9J"S@!DBY!:E--V\/5HF6]]^%J#PZ<!*O&YMHFZ>ZGWS&D*&E(VSLM#\$V
MY_S]_YECS&2K](,I "QY+(4T4Z^PMKKV?9,54#)SI2J0>&>E=,DL=O7:-Y4&
MEC=)I?!I$,1^R;CTTDDS-M?I1-56< ES34Q=EDS_N 6AME,O])X&OO)U8=V
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M:F^/VP<CU\U]ZJTT1E;-UY7@N5 6 +_?26GV#W: [@Y__B]02P,$%     @
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MA9G7=#,LID!H _P_Y5RM!WJ!ICR+_@%02P,$%     @ BH);6%60SWMY @
MK@8  !@   !X;"]W;W)K<VAE971S+W-H965T-RYX;6RM5=]/VS 0_E<L;YI
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MWJGU-73YG#F^7$GCOV3=^EY$E.1+8U75@3&"2M3MR!\[';8 X?D>0-0!HN>
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MSBC1;7=L#:L:WR]FRF+W\=,2?RB@G0/NSY6R&\,=T/^BTC]02P,$%     @
MBH);6.G_E<BJ"@  E&   !@   !X;"]W;W)K<VAE971S+W-H965T."YX;6S-
MG5N3FS@:AO\*Y9W:35>-8W3@E.WNJHD-3"YV-I6>V;W8V@L:J]ML,'@ =R?_
M?@6FC76P#,F7S-RD?9">3^C])."5<*Z?R^ICO6&LL3YM\Z*^F6V:9O=FL:C3
M#=LF]>MRQPK^S4-9;9.&OZT>%_6N8LFZJ[3-%]BVW<4VR8K9[77WV?OJ]KK<
M-WE6L/>55>^WVZ3Z_);EY?/-#,U>/OB0/6Z:]H/%[?4N>61WK/EM][[B[Q9'
MRCK;LJ+.RL*JV,/-["?T)J9>6Z$K\:^,/=<GKZWV4.[+\F/[YMWZ9F:W+6(Y
M2YL6D? _3VS)\KPE\7;\WD-GQYAMQ=/7+_2H.WA^,/=)S99E_N]LW6QN9O[,
M6K.'9)\W'\KGGUE_0$[+2\N\[OZUGONR]LQ*]W53;OO*O 7;K#C\33[U'7%2
M 9$S%7!? <L5W#,52%^!2!6P=Z8"[2M0N<*Y8W#Z"HY4@9YKDMM7<.5C<,Y4
M\/H*G?J+0^]VTJR2)KF]KLIGJVI+<UK[HM.WJ\T5R8HV%>^:BG^;\7K-[;(L
MZC+/UDG#UM9=P__P/&MJJWRP[C9)Q39EOF95_3<K_'V?-9^MN?7;W<IZ]<.5
M]8.5%=:OFW)?)\6ZOEXTO#4M<Y'VD=\>(N,SD7\MFR375%N:J_VS6F<%'S16
MW39/%W=E!ORT7F?M*$AR:Y=DZ_8HTF27Z1L37F"EZ7Z[S[O.X_F?I5FC@43C
M(66S8965EEL^KVS: ?_$> /Y>V:]RLNZOM+@XPO]S&>H>L\[[*XITX]B_07/
MEF/*X&/*X Y(SP#?LL>L*++BD<\!>5*DO&F\#P]R7%E)8ZU8^MHBZ$<+V]C6
M)8:1WTZ^;^I=DK*;&>^%FE5/;';[U[\@U_Z[+ET.,+>#M1/OTZWO^0C9V.6Q
MGT[S C)L" F+(&$Q$$S(#7+,#3(Q-\;DPX'IG4B(D!L0ZH@"+M5R4HF5AN0'
M'G4]L5RHEIM[B+@V$<M%FG*(.IB*Q6)CIWQAE]-CE]..3LYT^;LB;4<X'X6\
MG[M75^V<UHUV>?;^SX<RSRU^#G].JO5_=5)0R*$)"5M!PD)(6 0)BX%@0BHY
MQU1RC*/W75WONT'+S_ZE>)ZU]CM^X?C$ZJ8=W/Q[_EE396E[TNI+G)P%=)EE
M##TULQQETL>V0QU;GO(A@X:0L @2%@/!A*1QCTGC?KNDT26*JV@KJ;ITE5E9
MUOTB(S0>U%0Q(6$Q$$P0TSN*Z1G%##^Q*LWJ3LQ>PW+77BU?'-Y&[M3A[2GR
M(4P<0I7Q#1DUA(1%D+ 8"":DA'],"7]:2KQDA"X+?$4XCR+IXFOI7QR^8S"A
ML=E3Y8*$Q4 P0:[@*%?P==/Q [\$+)_G_-5N?Y]G*2_XP"H^0?]H%:QIJV4O
MB+2LFTOCWMB:J>,^4'1W/.3R82\G"&34$!(60<)B()B02,@>K"'[NZ:2UB.R
MU=MWY-O$E>:,OIQP9R?EQ#F4=(\8FH]ZJMZ@M!B*)BI^8@:B+U:\]<G*HN@M
MY.>LV?#W>9[<EU5R<)6+M<63@!7\7)%455(\=EZB]>J7LF$6<J\N327FQDV=
M2WJ:,)FX/"&P/)> A@U!:1$H+8:BB=DU^(;(;!Q^V^S29I1J#KH8._+]1%_,
M=$4RCA2:>V"R^J"^(!1-5']P!I'9&GPG7%4DZ__MZZ93\*&LK)IQ]==M/N19
M=[>H59.H&L@6H;D14SVG$1%#T(@1*"V&HHF2#\XD,KI5MQ]8RK)=<W(SR2\+
MVIO_IK1J/JSKA\]6DWSJAGMK578N ;^0>$P.MYP5.ZR*M,7;^O-VT7'=+8_P
M>> P+UPZIX :FJ"T%2@M!*5%H+2XIYV.HSGQ<4"&^5-,L<&Q1&;+\CNDF#:M
M5 -R3K$7R+,1I,NW J6%H+0(E!;W-.]L]XK9,EB5R.Q5WDV16/40J>TA*DL,
MZ?VMQ@4-08-&H+08BB9*/!B8R.Q@_L)O/-N5<JVDJJ\X]VQ*/22+"NG>K4!I
MX=B#B$##QE T4=;!A$1F%S(J*Y8]\IN$?56Q(N63.K\%J//SHU>U$.<!PHK0
MD+[?"I06@M*B<1T20P4591[,2V1V+\-B/7)C"=*J#NI&(M6.#!R'N"3PE=M#
M4$,2E!:!TF(HFKCU:/ DL=F3E!)D3%)@U1=$Q L"1_88L>HQ2D56&A;VL1-0
M7SI#:PK.$46^[4GG\DA7$A-7WOP2:UIGN";"@^>'S9[?5PXY,WWR9BY(V@J4
M%H+2(E!:C%6STWB#A4\V^^'ON+T(PV[]@Z2M0&DA*"T"I<50-#&E!B<0CW0"
MO\4V(W/LR1FF&H HH+:K7 " A@U!:1$H+8:BB<DS>(K8["F";S?"JC<EKP_T
M14SK Y<IH?G )HL*:M!!T411!Q</FUV\+]]V9 9/'NZJK><@!Z% D1O4B@.E
M1:"T&(HF9L;@V&&S8S=I]Q%6W3/']Y31?'G[X"A0:&[Z9-E 73@HFBC;X,)A
MLPOW)UCY,;=P\LP Z@B"TD)06@1*B['&K42^0XAS[LYDL 2QV1+\@Y9^L,9(
M\QQ/WN1H;OSDA %U%D%I$2@MQNKN4+%[Q6P9G$5L=A:G+/U@U?AS$;&Q+#&D
ML;8:%S0$#1J!TF(HFOCHV> -$K,W:%KZ(1J7C5*"?=D$-,>8*BHH+1Q[$!%H
MV!B*)LHZ&)3$;%!.7?KI<:<S" T(D2\#S5$G"PUJ-8+2(J*:@YH.B:&"BC(/
M1B,Q[PX<[T-CK>KJ!KW M3$*'.4&0%L44\?QY?U\*W.;)\L*Z@F"TF(HFJC^
MR7/#9D_0O*ZC5USSL*_-50R4QX;5@O*Z#E%]/NP'!,F;A4--07X]Z[;/#LMS
ML ;IN+Z\K*-IW!SQ*V17?\%#!J.,F(VRKQU/FBU;&!,7R];GTMR.R1,IZ*8X
M4%H$2HO']+"H_>"G$><[+MH04(\-E+8"I86@M B4%D/1Q)0:C#CR#1_SO>35
MF&-/SC#5O?.1YZM/AX.&#4%I$2@MAJ*)R3/8@<1L!X(OVO3Q#![N\G*1%5'-
M*>5\#^JM@=)B*)HHZN"_D8D/!H]>M"&JA>8ZR WDJZWEV((K<U,GCV10?PR4
M%D/11-$'&XU<V* W93VF9YT.0>S(6Z66FE**O*HWIH)"<],GRP9JC4'1Q)\(
M&JPQ:K;&_@3K,>863CW'@])6H+00E!:!TF*JVVWH>L[IE"KFV.#34;-/]P>M
MQU#-UC=?V:&[-#=^<L* VGV@M B4%E/5316[5\R6P>ZC9KMORGH,50T[+W")
M_"B..>)DB4<%#4&#1J"T&(HF2CQX>M3LZ9G68ZC&1R.$NLHEH#G&9%%!M^F-
M/8@(-&P,11-E/?F]0;.Q.'4]AJJ[YQ *J/PHCCGJ9*%!;4106D15XT_3(3%4
M4%'FP4.D%_;DC?:/B59U=2M=X&%, EM9C]$6]9"#L%QT96[S9%E![3Y06@Q%
M$]4?[#YZ8=^=<3U&K[BZKXZ?,!&2[_<TY>3E&$T1''B.NAM"4W#>KODIUW^1
MIB3Q7.S*@TX'M'UR9CF&#A88O?#+>E\YG#3[J&B ,)9-S:6Y'9/G4="=:J"T
M")06C^GA@_:+DY];;W^O_Q])]9CQ&YB</?"J]FN/#]WJ\!/XAS=-N>M^@?V^
M;)IRV[W<L&3-JK8 __ZA+)N7-^V/NA__(X+;_P-02P,$%     @ BH);6&ZW
M .!$ @  T00  !@   !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q]5-]OVC 0
M_E<LK]I::2(0:&E9B%3:3NM#)536[6':@TD.8N'8J>\"[7\_VX&,3<!+?'>^
M[[L?N7.R,7:%!0"QMU)I'/."J!I%$68%E ([I@+M;A;&EH*<:I<15A9$'D"E
MBN)N]RHJA=0\38)M:M/$U*2DAJEE6)>EL.\34&8SYCV^,SS+94'>$*5))98P
M WJIIM9I4<N2RQ(T2J.9A<68W_9&DX'W#PX_)&QP3V:^DKDQ*Z\\YF/>]0F!
M@HP\@W#'&NY *4_DTGC=<O(VI ?NRSOVKZ%V5\M<(-P9]5/F5(SY-6<Y+$2M
MZ-ELOL&VGDO/EQF%X<LVC>_PAK.L1C+E%NPR**5N3O&V[<,>((Z/ .(M( YY
M-X%"EO>"1)I8LV'6>SLV+X12 ]HE)[7_*3.R[E8Z'*5W1J-1,A<$.9N1.US'
M"9E9L%DA+!1&Y6#Q$WMXK26]L_.I,VHJ@&0FU 4[8U*S[X6I4>@<DXA<3IXY
MRK;Q)TW\^$C\7LR>C.-#]J!SR/\EB%PQ;47QKJ))?)+Q'K(.Z_<^L[@;]]C+
M[)Z=GUV<X.VWG>H'WOX1WK8YH3=DLM7_O?EU.T>R;LY^'^I#PSXXS.YW;X25
MR&#,W7(AV#7P]..'WE7WRXG<!VWN@U/LZ2-B+70&+#-(!_]2@Q\&O%_D=7K=
MOTFB]7[0:&_,2K#+L$SH.&M-S<2UUG9?;YLQ_>O>+/N3L$NID2E8.&BW,[SD
MS#8+U"ADJC"T<T-N!8)8N#<'K'=P]PMC:*?X .TKEOX!4$L#!!0    ( (J"
M6UADLQ__PPL  /T[   9    >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;+6;
M:W/;-A:&_PK'[722F2@F+KRECF<2L>EVIMUFXK3[F:8@BUN*5$G*E_WU>T#*
M @D<@')6FP^Q+B\@OK@</#@@KQ[JYJ]V(T3G/6[+JGU_L>FZW;O+RS;?B&W6
MOJUWHH)OUG6SS3IXV]Q=MKM&9*N^T+:\I+X?7FZSHKJXONH_^]Q<7]7[KBPJ
M\;GQVOUVFS5/'T59/[R_(!?/'WPI[C:=_.#R^FJ7W8D;T?VQ^]S N\MC+:MB
M*ZJVJ"NO$>OW%Q_(NS2DLD"O^+,0#^WHM2>MW-;U7_+-+ZOW%[Z\(E&*O)-5
M9/#G7BQ%6<J:X#K^/E1Z<?Q-67#\^KGV3[UY,'.;M6)9E_\J5MWF_45\X:W$
M.MN7W9?ZX1_B8"B0]>5UV?;_>P\'K7_AY?NVJ[>'PG %VZ(:_F:/AX88%2"A
MI0 ]%*!Z 6XIP X%V*D%^*$ [UMFL-*W0YIUV?554S]XC51#;?)%WYA]:;!?
M5++?;[H&OBV@7'>]K*NV+HM5UHF5=]/!'^C4KO7JM;?,VHWW"09&ZRV\/VY2
M[]7WK[WOO:+ROF[J?9M5J_;JLH-KD#5=YH??^SC\'K7\'J'>;W75;5KOIVHE
M5M,*+N'BCP[HLX./U%EC*O*W'B-O/.I3AES0\O3B%"F>GEZ<.-RP8W^POCYF
MZP_9Z.N^T==-O?5@@C=95U1WPPPIND*@K3[4RO%:9?!XU^ZR7+R_@.C0BN9>
M7%S_\!T)_1^Q%CMG9>F9*INT)C^V)G?5?OU/")QEW:(M-I2,^I(R.MY?+QCC
M(?6O+N_'C8'H.&<T#J>Z%-%%/N<1.>HF%H*CA< Y(#ZL_@U18)B470VA-J^K
MO"B%5QV\R4_EZUR.G'T+TQAF*#9LWF&M$)QSW)RSLO1,E4T:/3PV>N@<-Q]*
MF(%9E0L/5E8O;\2JL ^DH:IPU/':T%B:"J(-'D3AX^,F.EJ(G!9^J>YAS-3-
MD_?0%)U8K.J'"KOZR/CE)&+:]9L:'D6: U-#6!CC'N*CA]CI(170MWF1#810
MK;QL6S==\9_A _$(\-/BX3 V7?DTT6R9HIA2W9<I"GD<X;Z2HZ_$W3?;758T
M<D[+=7;7R-G:/?4.Q=_[8B>_P5PEQK4$VN4N38D6SU*78N*&^(HA?/=T&7<+
M. +N$DW31Z*\W@J4$GSC,B#\QOK(PV0T]*GF"9,%U!)YR8B-B-/7S29KQ$)B
MY<H#(W*X]1Y10\2XA"@)&=<-F;*0,-.0*>-^1+C%$56.J'M!A,5#KA,R9&9-
MONG'W$K< __WH\XYJ0YU.P;7<EZ2(I*0TL V"!4X$2=)#)TE1U^_*/;P)"<3
MS*NMZ#:U'(SW8EA)47-LWIPIH52/Y(B(^($E8! %,L1-,J]^ACW<ZY&W-400
M[SXK]\++-UEU)WIF/SA65F$[T<GNSE9%^00]W8D&=A'9+0"$J@%M#X[,O"C6
M8R@BBY/ &,ZFBO"0V%I%L1%Q4L#UK[(Y(.:LBG97MUGYLG!ZJ'QR58%AT!0%
MH3&F3=%HM9F:4PQ"W! B>UPW5TI3 'E>(_>SJ"D3)1;<CW57ILKPY)),+2DF
M(6XH>0X_I8"8ZHXU)D_$D6D#4;' <&*J0D)L_:/@A+CII.^??BY"Y_21IZ@Z
M4<J,QAYZZWD<HNY,JE@0'_[I_DR=8<XEF3I3>$+<?/*I;D1Q5WGY'E;Q*G^"
M^+&%'MLW?7)@"$*O[F1 0LV9A$%XK/?*$I$%(?>9[L^405.%D:7[J((6ZKMW
MVH>H.=TMM:V C9:<9661W1:E?>=$G4STTJW366M+SU7;M&D5-U$W-WW(\WHO
M-ZQ [Z*XEZL-VH(FY"RH[W-]I" ZSI@^$;#:.&6V>4X5,]$Y9NK$K!43:BC3
ME\$EHEJ0)-(S"9@L8BRP&%&$1-V$]+PEM*20J$DN"\(37]]BH+J Q?JBC^DB
M$ED8EBH4HFX4^MR(7?8T9$3D1*V[C6@.L:H[S&#4'P(AE')]LX[(H)-H$.OV
M$!VL4*'%GF(:.L<TU=U"8AK0&JS[A<4,PBZQT5.F"+9%^@X74UDV[E3!"W7#
MRY\]F6:K%6R=NNRQSUO=0Y2US9]9'EDB$MBMQSI_([(%B6RH216Z4#>Z'&,:
MC#VK"Q,T6!CK2]H2D2T"%NEIEQ31A1!4J,6* A?J!I??)Q-FM,ZAGDR^($E,
MC-XQ91%+C)!@JIA/N,V1 A;J!I;?CPOX0)9SGA"F &XDNB=,QH- -X7((!Q:
MPC53@,+<695T/HO"S+P'(42?$TM$MB LTK8Z*5X;MRR@3.$ <^/ ,-ZJNEH\
MC[E?W?W#S*6<T4 W98IT)'!*IF84#; 9&GA.M0/?WQ<RO-T^>:\.>??7IY_7
MH"@0DTC?XF!"%D8AU^<6)@QX @1DL3PZDGK9F=2073C!XWD/I<Y[*O7_.)9B
MBF'8#,/LFWPC(Q7L&MM-W73#BJ_R-GB#8FC"N+EOQ(0R;1IQ?= @0LZ#<8U3
MAPICF!MC/C=U+L3J,&2V6;=O9&;J97X1R"%19-HU=9$?(&X1'6>);UE_F*(=
MYJ:=<7>.<F^PM9PDY 0>Q.?99UZ2(I(%\^T=J<"'N<%G[.WTW!I#&">B1-\1
M83+*@UA?8S$=B6EB6V05"S$W"TV'*2Q4QV3."[PBB$0-I_.I'$3"+/X4&3$W
M&7W(X<IA$W$XF2FJ+JON"IG^M6^4&)9RH3HN+#$92PRH0%1A8/'%%1QQ-QQ-
M^^W%"3B.H Z2?T-D>J<Y)5-S"IBX&YBFYEZ6_^4(.\6)O@5!5(:QD^&)*WCB
M)\*3 J8Q1IT*%AR#)S_2$RE+1,>I[Q/CU@TD>\.3Q'9JPQ4Y\9>1T[JHLBH_
MP>!9R>FLM:7GJFW:I*,[>N:R/^.Y(1Y%DQ?M</C5=G7^%Q"X#'9XLYJT0UFH
MQS5$%<21,3U,5<1M:0:NL(F_!)N*MMWWMZ& N[I9P>AIGH"?,FA8;[^#D+[;
MWY9%#E_#5A&&%>[:I!XCSLU*4D02DSB.+"LP5^S$9]AIR.7U2^[4C9?7+;Y"
M\7EDFI>DB 2@@MGZ4!$3=Q/3U^Q1R#Q1L?(:4?9W5G:U!ZMM5XIGJP<NS!ZR
M!K^-DB/$$\?ZC0)+3!:%^D*68C).K<NPPB?NQJ>9@'YRO$/.PT+.C%4+.S:+
MC), 1!93G]HPGRN8XFZ8^@D&9MYWW_IP0B8>A\-W#S;]HX/XJF^4-T/3R*Z^
M!T!YSE?#Y.V:(I?#0GZ/M@<"330TF!*3A>:V!Y$10BR)ZD A6.!&,-GWKU8B
M;V3*[;7,4O6OY*[G?W,?8#?]D-CW]4B-"#EG1JA&9 &E/K><1 2*TP(WIRU/
MMNG]\%T,NY\?O5MQ5U25G!$PBN1VXTED#=H()GX!H2;4N#D/$28A3XR#5$3'
M.8T#2WHO4% 7N*'N&UI!R&.;&?\FDT4)H:%^0Q6B0]LI181:.TW]*\@+W)!W
ML]_MAL .C ZPGI>U/"J74:#/>4KC([(%ZZ>&Q>"L&'C6VM)SU39M=(6!P0P&
M#J<P;7^#[NZ;4A0!0H-<#YY+1!50G1E3K*[ =OMK,+KW>X8&QRZS;]C*!U@&
M+= W0$M,%AH3"!$EMKO;%?X%L_BG+'9-?YO)TX#RJ*%Y\D,D>JX<D]C60X5]
M@1O[^F>F%O5Z(??G?9<,72:/</;52C2CPX'^F KO,>P,,=1/!1 5X;&O'X8B
M,EA(;1%/45_@IKXOQWLAAF[[MMOO@MF,V!*1Z M ZJQF:E"!7I!\6TA?#^N8
MW-+#!!P>N[/<$!PX6?+%P?N<M:7GJFWZ<(4BQ]!-CGU:1(X/'1K0QRM,>HL2
MGQBGM8@.0"#F!@XB0@ !8LN4APH'0S<.?IG2SIOQD2?J#$$\0G2^0U3&+07I
MC&AJ2)%=Z":[K[4<_[FMMT[E^<.O1),>1% .T>$HAPA1E+L</1>Y%<U=_WQI
MZ_4W<@P/&!X_/3[#^J%_<E/[_"-YEPY/HJIJA@=C?\L: /H6 OH:JO3?1K!(
M-L.SIL.;KM[U3U_>UEU7;_N7&Y'!:B %\/VZKKOG-_('CD_\7O\74$L#!!0
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MRM1J?"O0S@ZO=<*E>.0^13)F$RUD) J>L1$E3%@!YJQCT149=*(*]MS#AB_
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MT4' M+_R^X55A;MFSY3%2[M[3/%?$F@Z@._G2MEZ00Z:_UW#_P%02P,$%
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MMV*'F"WO")88X*H&1*1-5Q,^$D1<LH^(.[@'YK*T624+8&WWQQQ311.0R(#
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M::EX)\!>?CM(WN&SO]"S)LH:$Q!IXP ^BL>VVN19\NSDR.;"X6>UJR<[IT1
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M>!:7A=;N$+5UTAY;QSF*<:3 FQD4K*(L):<&5K0K9/1^*JP>")I,R,,.?J.
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MFS7]5U"[ /)OE++'B=N@_U/-_@502P,$%     @ BH);6+V^1J2B @  ^@4
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ME+CFK71WNOL;]_5,/%ZAI0U/Z'K?,8N@:*W3]3Z8&-1"]6_^L._#4<!I^H,
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MB<#TJ[07G&["^EII1\LP'"OZ^Z#Q#F1?:^T.@D\P_,^6WP!02P,$%     @
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M-%]E#L!% 0_?^[JCCAL??D>S# P=8-V"_ AV-X"QGX!%#!ZE,)6&!U%@\2-
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M>F?#@0.JO>-:P\AM<Z^LI*'#M!GF]%N RCK0][64IC=L@/V/QNP[4$L#!!0
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MF%()B6"N-AO/LJ=>8 ]D9[D3?:\315MQ>KD!2[1862CKO<59Y4;\4]NU[HZ
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M_4'K][)%=;]V$ X7>-28K7]U2^WD2YI8)2A]LT+EI>L<SZ-P,!<O+N :X7C
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M>XQ OD&.]N5,%(KDC"M\>$'E2HPCUJ4Y!A*UL91_^C6($_RY(+4JY1D+#:T
M;JC#NGQ&:,H-#S7*W/2PD_D.49;.<]$;4[V[JM-TUWD#.XRQ-#HQ.2O\B(F?
MJ5Q9[@S8QLCFRZQCGH(?QU3S.!-TB/]>IKQ5LE'^(?.:] >3= AT#@ -IO/Q
M13N-!\G9*)C3K?,%D'0.#-DGM&?=8[#V?W,"G@,^:T,0_($2P3A<M,,9HH>;
MJ)+#=F(3]"99Z6F'#$X>><QKCA6N>QX$$V1[Y7W0'UZYNCMX/(]V3K8_F^>Q
M"TFU0%W92?7#9+CW,PJ'_5^3:?\I*P9%S2FEG,IKK>R/Y&&2OG]05)518V=-
MC>X_&HQ&OKRGES2/YW9/BIP8CCQ'DV9"/D*YS%$/NJR:R2(+0-;8F.W>:Y9>
M709 /L9[4:1$[H0EJ; @F&T+6\\D)RDZE?M_?DGE65E3<O ON, 88_+.-3^E
MBW<_@_%83$C5ZZ4=S9W+%PC_% 13-Z@D-HU=RYPP2)BZ(N+DP0<B-3.:7J;P
MC+A95-N1]913U)9>HW%ZY@(TE6[$U/5@Z'3EVD.1)>*5-2DE;)\B][EPHNJL
M2'F+0RQ;IYVJ&S5XR'3BYFAJ&F8/93\B5R-))Y]V_4@E76XC?AH;]@2@VXT$
M])@9PO-Z)6.D+NZ*:'94ET2_W#,_+DN3YRH->,1=YQ0H[;"8*F0V5 P7/*F;
M#_!8.'XSC2*X%_6>>^-FG7((\D"*%J9^Y-@(379;USII4@"MT659JX-$VKPI
M72IX^KWJTND?\JVV'&KHE\@O:<*#<"1(GHF6!P[7FMI[&0JCU=YL@)-6#9"P
MCA4R(3H,$$A[E4#'>7,VOWFJ#@"W]UKDM" =UXF"3W0A0OIHQI/!_]-AC>?V
M9FN/8Y#Q;^\5&0W:>G7OD9>_/$3G-KOU'A?.?F@64M=DK!LHN[#[\O6:/URX
M2J!2S55=DR^O48CX+W@.9L3,#_N?[^ZI.+%*\2RA!8V:1LS^G3N7*\T;MP2-
M%[\5S(JZ:N:>*%<,]F82*EONFKH9VR&-;R?Z\W"$;N[[@),\==-9(U:$68X]
MYLLA*W6BVL9U5O(0'0'*\_<GN6>LYT[DZT_O!UUNY?+>-08E,P-=YB7*,&K?
M8^*9H[%\1I'#@6.39;/*6?G4\H,#84=U+TMFAO&V-X90 +)N.G>8V,@->H.;
MIH%S"FMFX.-F=LT#-_HZC0?I#Q*NXQCRAB-J!S$<BK_MO48ZDFR>4 PKOM0/
MGB&YJE338?JWB#S%PA[77V7>.315*SG%6M\7&A4?ZF]E99W0!04H"OA&F:WY
M&YOX]S.]=V0,16N>.SC7I?>2S+_3)<2,VW!RNMC[G. /J,-UJ]1EC!ZIA2(L
M\;CAU$36#RB0CBR6/O6X56(+P*:\Q[17.J4.9[O1\491:L3)5.S:)V*O]SD.
MU5/<6WO=VGTGO4I+\YR<&F9;:2H,"5ARTW-G>LP,.HT^^I#"J_+W:W+<]_B>
M2OQHU*G4=NKE\HFF1L;F&I7\C_"[.OZ^"]H77?] >:#PN_\UA$=F]1"KPO=1
M*ES3JRQ2$OZAAZ>&F6$K51?AL>_;+GM?'F;*KOG[2K@[52#N(\3V;OL)YY7[
M<K%;[K[__$G2FPC85:VP=1#.)F?"NF\JW8_*%/P=X])4E<GX<J, U)86X/G*
MF*KY00>T'[:^^U]02P,$%     @ BH);6!UXF+[C @  ,@8  !D   !X;"]W
M;W)K<VAE971S+W-H965T,C(N>&ULG55=;YLP%/TK5VRJ5@D5,"2A;1*I'YLV
M:=.JMML>ICT8N E6C4UMLS3_?M>0I)G41MI>P!_WG'N.S;U,5]H\V!K1P5,C
ME9T%M7/M6139LL:&VQ/=HJ*=A38-=S0UR\BV!GG5@QH9L3@>1PT7*IA/^[4;
M,Y_JSDFA\,: [9J&F_4E2KV:!4FP7;@5R]KYA6@^;?D2[]!]:V\,S:(=2R4:
M5%9H!087L^ B.;O,?'P?\%W@RNZ-P3LIM'[PDT_5+(B]()18.L_ Z?4;KU!*
M3T0R'C><P2ZE!^Z/M^P?>N_DI> 6K[3\(2I7SX(\@ H7O)/N5J\^XL;/R/.5
M6MK^":LA-HL#*#OK=+,!DX)&J.'-GS;GL ?(7P.P#8#UNH=$O<IK[OA\:O0*
MC(\F-C_HK?9H$B>4OY0[9VA7$,[-O[H:#5QUQJ!R\%GP0DCA!-IIY(C>!T7E
MANIRH&*O4"4,OFCE:@OO5875WP01Z=J)8UMQE^P@XS66)Y F(;"8I0?XTIW9
MM.=+#YK=,PG7PI92V\X@_+PHK#/TE?QZR?I G+U,["OGS+:\Q%E I6'1_,9@
M?O0F&<?G!V1G.]G9(?9_NZ/_I(+[&F&A)16I4$MPO) (O1?E+! *KG33<K4^
M>I.S9')N0?=4Y89*[E&]>PM"$49WEJO*'I\!720V!85O+],_&%R4I>FP@I:O
M#:6&- TG2>*#QOGI\Z[1"[2^"W )_FQ%25(181*.6 Q9&.<QW/"UEVS)@X&V
M,V5-I0IZX=$M&K<&D@+XV(FV\7I9F$TR&(5L_)S(8,$=@M-0"?H41-$Y;2PD
MX_"4C2$/LRR%>_[DY0ZY_$Z>0Y*&+$^A/UMR+XZ)-QVE7MDH@WOM2'?.PM,)
M@_$XS)/<Q[ST741[==R@6?;=RD*I.^6&DMZM[AKBQ= 'GL.';OJ%FZ50%B0N
M"!J?3$8!F*%##1.GV[XK%-I1C^F'-35U-#Z ]A=:N^W$)]C])N9_ %!+ P04
M    " "*@EM8JTH-&IT#  #>!P  &0   'AL+W=O<FMS:&5E=',O<VAE970R
M,RYX;6R556UOVS80_BL'=2@2@(E>+;_4-I"D+39@+8)F6S$,^T!+9XLH16HD
M%:?_?D?*5I(M,;8/$M_NGGMYCL?E7IMOMD%T\-!*95=1XURWB&-;-=AR>ZD[
M5'2RU:;ECI9F%]O.(*^#4BOC+$G*N.5"1>MEV+LUZZ7NG10*;PW8OFVY^7Z-
M4N]741H=-[Z(7>/\1KQ>=GR'=^A^[6X-K>(1I18M*BNT H/;5725+JX++Q\$
M?A.XMT_FX"/9:/W-+WZJ5U'B'4*)E?,(G(9[O$$I/1"Y\=<!,QI->L6G\R/Z
MQQ [Q;+A%F^T_"IJUZRB600U;GDOW1>]_Q$/\4P\7J6E#7_8#[)Y$D'56Z?;
M@S)YT HUC/SAD(<G"K/7%+*#0A;\'@P%+]]SQ]=+H_=@O#2A^4D(-6B3<T)Y
M4NZ<H5-!>F[]L[86;M' 7<,-+F-'F/XDK@[ZUX-^]HI^FL$GK5QCX8.JL7X.
M$),SHT?9T:/K["3B>ZPN(4\99$F6G\#+QPCS@)>_@O>!&R74[DF4\,?5QCI#
M!?'G2P$/<,7+</Z2+&S'*UQ%= LLFGN,UF_?I&7R[H2SQ>AL<0K]/]#Q?_3A
MEP9AJR7=/,H .+Z1",%KY2PX.JQTV_6.APNBMV&+:EQ4P%4-M9"]PQH4]0;I
M@3L"M@'X[ <0BL1U;TG2,L"'"CMW./7*C[(UU>7Y GY';H8B :(8VPT)'&GV
MO\S_4OC<MVBXTV8!GX]VN7-&;/K!?Z=!FUHH:B&#@4;+&HV%LSPO6)DEYW!6
M%#G+9B7-IDG!BFEZ3C:5IOLS('\-EY4\X?=D;(>@^N /I> YMH6+%Q(R+TN6
MSPN6Y@G,)S.6E%.6%C3/YFR>I2S-DD?GQT1<_!OH++G,)^=^*,HP3&FXHH"I
MWUGJ*T=.;H@FKKZ_?3/+TND[^\@(=>60P)#&C 5PGT9VR+WN/+4V["NM+N[1
M>KN$3AFM_/00)O5KZTC*UTE@%KU0AZ%I^AB$KBWLD3"):ME[&K=&MT,5<5GU
M<JRB8W3_J!D>2DX8PB> T-7WNI<U-,0";!"I1RLG+H(Z6;T\62=WS^)+B>;)
MK&#)A%@@ F8I*X@$&I)TPB9SXN-4](2?3>>L3!+(<U;0-R.5.9L0L7F9O'2Q
MXR<]ERIV%UX62Q>J5VYHO^/N^'A=#3W[47QX^3YQLQ,4A,0MJ5(13"(PPVLR
M+)SN0@??:$?O09@V] "C\0)TOM7:'1?>P/BDK_\&4$L#!!0    ( (J"6U@P
MJ?:!Y@(  (P&   9    >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;)U5VV[:
M0!#]E9%318F$,!B21@D@!9*JE8J*DK1]J/JPV&.\RE[<W36&?GUGU\2E$D%*
M7^R]G#E[9KQS/*JU>;8%HH.-%,J.H\*Y\CJ.;5J@9+:K2U2TDVLCF:.I6<6V
M-,BR$"1%G/1ZE[%D7$6345A;F,E(5TYPA0L#MI*2F>T4A:['43]Z67C@J\+Y
MA7@R*MD*']%]+1>&9G'+DG&)RG*MP& ^CF[[U].AQP? -XZUW1N#SV2I];.?
M?,K&4<\+0H&I\PR,7FN<H1">B&3\VG%&[9$^<'_\POXAY$ZY+)G%F1;?>>:*
M<705088YJX1[T/5'W.5SX?E2+6QX0MU@!P1.*^NTW 63 LE5\V:;71WV JYZ
MKP0DNX DZ&X."BKOF&.3D=$U&(\F-C\(J89H$L>5_RB/SM NIS@W>4#!'&:P
M8,9MX<DP95FHEQW%CO@]*DYW7-.&*WF%JY_ 7"M76+A7&6;_$L0DK%67O*B;
M)D<9[S#MPJ#?@:27#([P#=IL!X%O\.9LX<?MTCI#LY^'$F]HAX=I?>-<VY*E
M.(ZH,RR:-4:3TY/^9>_FB.AA*WIXC/V-G^A_N>"I0)AI63*U!:[2RAC"^6R8
M20M@*J/+OJ8F+JDE'>"&;,&B!?(%*(W.JM2]CO8EX2FA";GF=#=@N87Y_=T&
MSAZKWX6NSALM)(ZT, %SS'A*VDE1MP.?709GIR=72=*[\5%AV+\Y[X!>HX&Z
MX.%,X%)2'"4(.9-<;$&B7!) Y\"=A5G!,8?[#::5MP+XDN<DR@2ULX)Q4Z*Q
MY!0$=U2,J68F@P)%!I:O%"<PHURXRD6%*L7NX9(=K%+-7=$D[+6H?3XF=15H
MPR7O!#7O>MTA=;L0P;B:A??M0@--P@8-J#VH\"4&?Q/;[J$K%^\YA$2S"CYH
M(?5'-V;1KK96>]LXS%]XX]-S9E:4 0C,*91T741@&N]K)DZ7P6^6VI%[A6%!
MOPLT'D#[N=;N9>(/:'] DS]02P,$%     @ BH);6!@UR$_T"0  YQD  !D
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M;"]W;W)K<VAE971S+W-H965T,CDN>&ULM5;;;N,V$/T50GO!+N#JYC@)$MM
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M33P(2+$2F21M_E[^F=&\^,FG;'*\[LV^1=$5Z'43ECVU7(I2H#T6,N;EH?_
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M#!G@?JFUVTWH@.$-NOP+4$L#!!0    ( (J"6UBOQ%?:=P0  $,*   9
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M4O17,TWY&!P>H^<TC47 *)YN/15%%LA],Q&U/" [YNQ!N5>;A;G-0JK,!7_
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M\JHI]H)Q<_#K<4-;M4BR9)\E*D._"U3$R8 ]M5F.JK0MK':1K3GSC42_"_R
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M8DQC'BYXU:XN7>41&B_)[JB'Q<1^Q')BBSF!W$K;/,O-TZB0RCX]NJX:)6X
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M:&5E=#,U+GAM;*T]:W/;1I)_!>5+;=E5%"W1S\2)JV393KQK)S[+SM;NU7T
MP2$Y,0@P&$ R\^NOG_, 0$CVWE:M(Y*8F9Z>GGYWX\?KNOGLML:TV9==6;F?
M[FS;=O_#_?NNV)I=[N;UWE3PR[IN=GD+'YO-?;=O3+ZB0;OR_N+T]/']76ZK
M.\]_I._>-\]_K+NVM)5YWV2NV^WRYO#"E/7U3W?.[N@7'^QFV^(7]Y__N,\W
MYM*TG_;O&_ATW\^RLCM3.5M766/6/]TY/_OAQ0,:0$_\;LVUB_[.<"O+NOZ,
M']ZL?KISBA"9TA0M3I'#?Z[,A2E+G G@^%,FO>/7Q('QWSK[:]H\;&:9.W-1
ME_^TJW;[TYVG=[*56>==V7ZHKW\QLJ%'.%]1EX[^S:[YV4</[V1%Y]IZ)X,!
M@IVM^+_Y%T%$-.#IZ9$!"QFP(+AY(8+R9=[FSW]LZNNLP:=A-OR#MDJC 3A;
MX:E<M@W\:F%<^_R23R.KU]FEW51V;8N\:K/SHJB[JK75)GM?E[:PQF5W]:][
M/]YO86F<X'XAR[S@919'ECE;9._JJMVZ[%6U,JMT@OL LP=\H8"_6$S.^-(4
M\^S!V2Q;G"X>3,SWP"/B <WWX,A\8SO^G_.E:QL@G/\=VS'/]W!\/KQ-/[A]
M7IB?[L!U<::Y,G>>_^V_SAZ?/IN ]J&']N'4[,]?Y,XZ/+3W.'?5YDCB8T!^
MPS39QZW)BKIR@(95WII5MK957A4V+S,'CQBXE*W+MOF5R9;&5!GL;Y\W\)S%
M6U;4S0J>-D#([3;[-+^<9QM3F28ORP/^;/8X91[0O6\L3+XOD<3^]E]/%XO3
M9S3JY_/S]_3Y[-F]>4*=\6 ]JW5= H>!F9>'K(4-7-2[?5X=$";\R##R_F"_
M^!7.0L_@/#?O%W8HO,O^A<L@0YMGK]9K0XPERPF1[_*FV&8/3HDN%[,$%-<M
M5_;* OUG)H>GX'$+$UOG.L1(M<JZ2CX #@$&N)=N"^O",U5;9RW@NO_#75Q
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MP0?@]W4-C$@^X +^O>+/_P]02P,$%     @ BH);6,(5/>7^ P  X@H  !D
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M;71.KFU[.?P:A*91$JT[53'G<3_19;1Y9]:N ^+*X":CZZ-A0CGXF1G5QL8
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MQ!+8]_.C'9%4:,IV%%C(=:-<IY?>VD^;\TYD?\*[477+32F4!8E+2HU/QL,
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M4SC5?='1Y.A0;_U\-%3;7MIAB(RGXPB^'B;/B_DPO^^YW@IIH,6:7..K8A*
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MM*193G9Z>844DH*C>[8J4!TOQII S=0XZ0 N6H#@%0 _@&M1Z5S!SU6*Z7.
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M_S@4@18_.(QOW\VYWO&UF#CX,+10S\*9OG]'(^_B"/M@8!\<0Y_>X3M,ZT*
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M68P:J[:#M!,C=TW57DF#%:H9;K'I"F4/X/Y&2M-/[ 5#&Y_^!5!+ P04
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M;XT>KEY#QZJEO^[,E,7ER3<7N*T*[2;@^UPIN^FX#;;WW\O_ 5!+ P04
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MKSH$_<I9H$!PK9LE5YN3%\.,#5Y9T"&ZV$;'IV>C_+-Y23L$TZVEB[7]$?Q
M;KJ7 %1';&8$WM72?S+_8?!.K] HLKR#A>$^=A87>0Z,Q<6 01$SEL,[ZC30
M^ZBM[0/9&G^WPFTHX JM:X+@M7 U^ XEY(8<ZM"0<4).<RX,K+ALD9@'PPOH
M#>.+LZP//5;$YVS0[Z[5DM-L29V"*Z0D8.%#,@(4<'910)[F<*\=ES"(J?=!
M'G3U6!IG*>L?JG/RS* -FD5H0Q9*W2K7>76_NN]TEYW!GXYW;?(3-PNA+$B<
M$S0]'9Q%8+K6TTV<7@:[S[2CYA&&-=T%&G^ ]N=:N]W$!]CW_^D?4$L#!!0
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M7+XLI=/ ZW4Y,HBC7+E9"JJG'HH=E?HT#7E J]'K3Y[>]O\^QVTQ#&*T)PI
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M8][4'O->G,:E^"V)'\24Q&D9I?/X/A$D*@I15QI4F7B[23#)4J$,AW; SN%
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MU7ZHYD(U"M4\J.9#M0"J,:@60C6.TN3PM94 4U\)^/EI'K0  -5<J$9-10'
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MK$Y!U42+O#QYS(4VYYARF)J3(TB[P-Q/A-";B3W,U&?1R7]02P,$%     @
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ML@:TOY#2;"?V@/:U3GX!4$L#!!0    ( (J"6UC\>C T!@0  )$9   9
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M1FB .5G@3<(?Z.Z.E((\R3>C"2L^P6Y?ZXLSSC:,T[0$BW$:9_MO_%H:T0!
M]Q< NP38AP*<$N <"G!+@%LXLY=2^( PQY-13G<@E]6"36X49A9H(3_.Y'5_
MY+DX&@L<GTPQ6P&<S4&Q\=>/3;S%"<DX ^>(<!PG[ +\"9X?$3@_NP!G(,[
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MBN YR66!.+Z@E+\-Y")[]2_,Y']02P,$%     @ BH);6$PDWEHS @  [ 4
M !D   !X;"]W;W)K<VAE971S+W-H965T-30N>&ULK51-;]LP#/TK@E8,+=#&
M7VE:9+:!-L:P'38$R;H=AAT4FXF%RI(G*7'W[R?)CN%N;I%#+Y8H\3V*SR3C
M1LA'50)H]%0QKA)<:EW//4_E)51$340-W-QLA:R(-J;<>:J60 H'JI@7^O[,
MJPCE.(W=V5*FL=AK1CDL)5+[JB+RSSTPT20XP,>#%=V5VAYX:5R3':Q!/]1+
M:2RO9REH!5Q1P9&$;8+O@GD667_G\)U"HP9[9#/9"/%HC<]%@GW[(&"0:\M
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MTFBHY(HH:VW8[*#(38$V:EAFRSA%9=XR@\-HFDJ%G6^@!+G,EJ#1E @U.9@
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M2P:#D8Y(.!MT$\5K:PQ+KK3-V&&I_QP@#$#OKSA7NXDYH/L7I7\ 4$L#!!0
M   ( (J"6U@:&29 3 0  )T8   9    >&PO=V]R:W-H965T<R]S:&5E=#4X
M+GAM;+69:V^C.!2&_XK%CE:M-"V7$))TDTAM8&>[FDK5=+K[V8638-78&=LD
MTW^_!E(""64:K?NE 7/>Q^8]^-KIEHMGF0(H]#.C3,ZL5*GUE6W+.(4,RTN^
M!J:?++G(L-*W8F7+M0"<E**,VI[C!':&";/FT[+L7LRG/%>4,+@72.99AL7+
M#5"^G5FN]5KPC:Q25138\^D:K^ !U./Z7N@[NZ8D) ,F"6=(P')F7;M7D3LL
M!&7$/P2VLG&-BE=YXORYN+E-9I93M @HQ*I 8/VS@0506I!T.W[LH%9=9R%L
M7K_2_RQ?7K_,$Y:PX/1?DJAT9HTME, 2YU1]X]N_8/="90-C3F7Y%VVKV)$.
MCG.I>+83ZQ9DA%6_^.?.B(9 <[H%WD[@'0J"-P2#G6!P*/#?$/@[@?]>P7 G
M*%_=KMZ]-"[$"L^G@F^1**(UK;@HW2_5VB_"B@_E00G]E&B=FG_E;'7Q'42&
M;MD&I-+?@)+H+ 2%"97GZ (]/H3H[-,Y^H1L)%,L0"+"T",C2G[6A?KZ>\IS
MB5DBI[;232K =KRK_J:JWGNC>A?=<:92B2*60-*A7_Q"[_4 ;.U%;8CW:LB-
MUTO\.Z>7:.!^1I[CN5T-ZI>'$-?R08<\?+_<ZY!'[Y>[/68,ZJ]C4/(&;_"B
M'SE1+^B:)6C!I4)WH%*>-#^5KI173+^;68Q\5W*-8YA9>FB3(#9@S7__S0V<
M/[KL-@D+3<(B0[!68OPZ,7X???Y%3P&ZFU(N)>A>JD=<J%)%&KUX2U2*BMF#
MT!<]>"K=RPG#3Q30$A.!-ICFT)6_WJI/S5\%&Y6P8M;:S+W1>#*U-\V\' ==
MC"=#KQT5=42Y?N".ZK"6E</:RF&OE7<X%OP+,!)W?LR]XE/-, D+3<(B0[!6
M!H(Z \$'C#*!R<28A(4F89$A6"LQHSHQH]ZN<2MECED,B"]1S+-,#S-Z01(_
MHS,]ZU=K@?.NU%34H-%1)\.Q'XS:_7G16_FIIIN$189@+=/'M>GC7YH.:"V(
M]GT-HO*Y=#SAE&(A]Z6=YE?T2</\@7LY.+"^MPFG6F\2%AF"M:R?U-9/>JW_
M"AN@J&O5=],K/'6T,0D+3<(B0["6^ZZSWXLX'S 1[*"&<F.4%AJE1:9H[?0T
MMHIN;_>(S"TQ^VLZ.6?N\83C.<[!(K,C*O /HR)3+6M[[.T]]O[/:K1??;)O
M)FFA45IDBM;.PW[CZW[$SM<UNO4U2@N-TB)3M'9Z]MM?MW__N\!KHC#5JU*F
M!'G*RT/'8HE*RN1TYN9X^SAPG,/^O^BO^&333=(B4[2VZ?N-LMN_4_[00X?^
MND_N.L/C8X?Q\8QP''4Q.?HDHJXPUP\:<96A=N,8-@.Q*L^_I?XL<Z:J \BZ
MM#YCORY/E@_*%\79>WF\N\=4!_=W6*R*)%!8:J1S.=)-$]59>'6C^+H\['WB
M2O&LO$QU,D 4 ?KYDG/U>E-44/]'8OX?4$L#!!0    ( (J"6UAW&D2E4P0
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M':#N+QB33R=ZGM[]?S+]'U!+ P04    " "*@EM8Y72E380"  "L!@  &0
M 'AL+W=O<FMS:&5E=',O<VAE970V,"YX;6RM55M/VS 8_2M6AB8FL>9*BU@:
MJ25,XX&I K$]3'MPDZ^-A6,'VVWAW^^SDV8M*XP'7A)?SCG^+LY)NI'J7E<
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M2). ZTLA]&YB-NC^/O$_4$L#!!0    ( (J"6UBK7K[)V@(  +X'   9
M>&PO=V]R:W-H965T<R]S:&5E=#8S+GAM;*U5VV[;, S]%<$KAA98ZFO2K$L,
M-,F*%5B'HEVWAV$/BDW'0FW)D^2D^_M1LN/FUJ />TETX3DDCVARM!+R2>4
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MP,!D,RV:C1:5[9]SH;$;VV6. Q:D,<#[3 B]WA@'W<B._P%02P,$%     @
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MZ WX?,&YVD[T_=%>_]%?4$L#!!0    ( (J"6U@#BKTH50(   @&   9
M>&PO=V]R:W-H965T<R]S:&5E=#8U+GAM;*U4;6O;,!#^*T*#L<$:OZ7)Z&Q#
MFC VZ""DV_IA[(-B7V)16_(D)6[^_4ZR8]+BA [VQ=9)]SRZY^YT<2/5HRX
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MCZ;7E*AV[K2&D;5[NFMI<!"X98&C&I1UP/.-E.9HV&G0#__T+U!+ P04
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MIF1)\R) W7_B7+X.B@]H3I5G_P%02P,$%     @ BH);6()#" Q5!   )A
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M)?!052,M>)-V&W0R+B%R24A_)8$?A)8#W5T.#RSPY>5PVJ$F; (5EGQA;Z!
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MC#)5*$:'&$L\'G*V1EQ;*S8],&(:M J?Y/K:'R17NT3AY/B6"8%FP-'#$G-
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MI>KI@6L#M3]G3&XF^H#F7\+X#U!+ P04    " "*@EM8D?TF^N@"   <"@
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MTD(HC:)HICB>%L<[<5^K/@&4E$A:"*51%,V44@_97>M@<O:[:F_B=&%+<W9
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MJG>8H48 BF:&61L!OMT(Z)??#KQAL-?1^Z& V@E0&D713+7V)@6<?%8 =EH
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M-505MSGKNCF!W5Y][UL;:@"@:&;HM0$0V V _S3Q^@C;JR=>3\FJ7.RI->M
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M)4OSXHK@F'#=0'U?,";W+WJ ZIYT^A]02P,$%     @ BH);6&Z?$"XJ!
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M"C@!I@SD_1FE8CM0#ZA/Z(>_ %!+ P04    " "*@EM8E?RL0G(#   9"P
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M1$H6O,)_AZ3&OV?D*V=G:Y *=V[P(XI$#PV 7&KO%^J!G%R!HD4I3UO CWZ
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MX1+RW#!I/W[5I$[S3@/<'C^RO[?BM9A[(N&2Y]]HJK*I,W)0"@NRRM4MWWR
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M+4=7B"]3%G)*T9QR4I_1"J(S,E7(Z'7V 32W:SPKFA70L!E0Z*0"1;-#7RL
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M)\: "S4&H#0.I0D4S5;4& ,N;0P<WV!"@SI+0B^+:C&!+D2@:';\C3G@TN;
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MN_1B.LL%[36 T@2*9LMJ?(B@)[T& =36@-(XE"90-%M18VL$=*_!2=D1ZE!
M:1Q*$T&S!>+PKT2!<1X"VGF 9\?OGOU++ZBS9-">!2A-H&BVM+4+^O6D9R'
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M883)H:I67$V,G)7-:20-MKIRF&'V@K(&^'TBI5E/[ ;U_U#\'U!+ P04
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M[;+4TQ&D,=#W"R%PNS$.^GF;_@502P,$%     @ BH);6&L\%%CZ P  1!0
M !D   !X;"]W;W)K<VAE971S+W-H965T.#4N>&ULO5C;;N,V$/T50ET4"=!:
M%U\WM0ULS-WM @U@;+#M0]$'6AK;1"C1)6D[ ?KQ)2E9EAQ9=@IN7R21G#GD
M.=20@QGON7B2:P"%GE.6R8FW5FISY_LR7D-*9(=O(-,C2RY2HG13K'RY$4 2
MZY0R/PJ"@9\2FGG3L>V;B^F8;Q6C&<P%DMLT)>+E'AC?3[S0.W1\I:NU,AW^
M=+PA*W@$]6TS%[KEER@)32&3E&=(P'+B?0CO<#@P#M;B=PI[6?E&ALJ"\R?3
M^)),O,"L"!C$RD 0_=K!#!@S2'H=?Q>@7CFG<:Q^'] _6?*:S()(F''V!TW4
M>N*-/)3 DFR9^LKWOT)!J&_P8LZD?:)];CL,/!1OI>)IX:Q7D-(L?Y/G0HB*
M@R;:[! 5#M&I0^^,0[=PZ%[KT"L<>E:9G(K5 1-%IF/!]T@8:XUF/JR8UEO3
MIYG9]T<E]"C5?FKZ,=TP_@* ,"SU4()F/%."+K9V5^:,9!+=8%"$,GF+?D;?
M'C&Z>7>+WB&:H0?*F#:38U_II1A /RZFO<^GC<Y,&T;H04^TENACED!2!_ U
MAY)(="!R'[4B8H@[J!O^A*(@ZC8L:':]>]3@CJ]W#UO8=,MMZ5J\WAF\!QVQ
M6GN]'6N:$?29[T!D.MR4W9(FO5OQS.EQ)S<DAHFGCP<)8@?>],<?PD'P2Y-6
M+L&P([":CKU2QYY%[Y[=ES-_-<)4QHS+K0#TYV_:!GU1D,J_FJ3MN936)1AV
M!%:3ME]*VV_]10_2QE5I-T9:>-:WDH0F*7/(OH4T5])N&O4[H[&_JTK48-3M
M#.I&^+51.*P8U2@-2DJ#5DJ](+QYNCT;8JW.;_T/7()A1V UT8:E:,/O'V)#
ME]*Z!,..P&K2CDII1^Y#+(<<5@/C)+Y&KT(GZ/1/PNLU2M <6^]++N];N12)
MAM#)BXKUI;8Z804BUM>;3C6;..708=!"JL'D-:L+1C5B87!,H8)6:O-R[8@O
M$1PRJAH_M29*/^ P7.@ S;E3T+3.X(3-[#HS?-&L3KN2.887<I0L(8J+%S07
M?$<3DYU\VF9)(Z-6J+<&N%,T[ JM+F-TE#'Z_N=G,8<K?5VB85=H=7V/F738
MGDK_IT.TP*R?D=%I_%UAA NC*T[2\)C4AJV)G8Z\9YIN4_0/NI"QM..\^;=P
MFKNZ0JMK>,Q>P_[_$':M*?*;]76)AEVAU?4]IM)A>R[=?"E*!(RNZ(*9ZS$U
MX4>*Z_'*FW%PW<UXE1F^:)9S]ROEE13$RI:II":PS51>H"A[RU+8!UL .NF_
M-R4R6[8YPN3UM0<B5C23B,%20P:=H=X\D9>L\H;B&UO$67"E>&H_UT 2$,9
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MRBN@9J_@8U;5S^(?*/(;505U!Z T!TIC4!J'TEPHS4/1='U6[@ %NP,4Z@Y
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M;BKLA9V@3U65E6LJ;\K](VWSD_W<)N(994RL\UCB=W)VAZHP ++5=CQBZ5$
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M N[8-@KK^DM.A.5 <@B"AJ&K[P@1""55(SG C'3JCIC5W1&-%-'%F&T%$"<
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M465](?)-=7CWD N19]7/-:,Q*Q1 _K_,<_%RH1[0'AC/_P%02P,$%     @
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MD%5?BX=?^-&A^@:3(BOKO\[#4>O.G.105L7NV%C>P2[-F__QXS$0K0;(&VB
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MKP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ BH);6)E<G",0!@
MG"<  !,              ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"
M% ,4    " "*@EM8ZD][R]<(   :.P  &               @($-"   >&PO
M=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ BH);6 .R>4.J @
MB@<  !@              ("!&A$  'AL+W=O<FMS:&5E=',O<VAE970R+GAM
M;%!+ 0(4 Q0    ( (J"6U@=OB3(^@8  %<>   8              " @?H3
M  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4    " "*@EM8'-^3
M7A<#  #J"   &               @($J&P  >&PO=V]R:W-H965T<R]S:&5E
M=#0N>&UL4$L! A0#%     @ BH);6#E\DNRL!0  SQ<  !@
M ("!=QX  'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0    ( (J"
M6UCOS%UY%0,  *H)   8              " @5DD  !X;"]W;W)K<VAE971S
M+W-H965T-BYX;6Q02P$"% ,4    " "*@EM859#/>WD"  "N!@  &
M        @(&D)P  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%
M  @ BH);6.G_E<BJ"@  E&   !@              ("!4RH  'AL+W=O<FMS
M:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( (J"6UANMP#@1 (  -$$   8
M              " @3,U  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"
M% ,4    " "*@EM89+,?_\,+  #].P  &0              @(&M-P  >&PO
M=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( (J"6UC<U,@Z#@4
M (,-   9              " @:=#  !X;"]W;W)K<VAE971S+W-H965T,3$N
M>&UL4$L! A0#%     @ BH);6-^-#CQ/*0  %H8  !D              ("!
M[$@  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4    " "*@EM8
MC4W_? 0#  "U!@  &0              @(%R<@  >&PO=V]R:W-H965T<R]S
M:&5E=#$S+GAM;%!+ 0(4 Q0    ( (J"6UB]OD:DH@(  /H%   9
M      " @:UU  !X;"]W;W)K<VAE971S+W-H965T,30N>&UL4$L! A0#%
M  @ BH);6*Q++E.5 @  XP4  !D              ("!AG@  'AL+W=O<FMS
M:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4    " "*@EM8U9$1 BH#  #;!@
M&0              @(%2>P  >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+
M 0(4 Q0    ( (J"6UC3?+3OS@,  %,(   9              " @;-^  !X
M;"]W;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @ BH);6-AP6V]"
M P  " <  !D              ("!N((  'AL+W=O<FMS:&5E=',O<VAE970Q
M."YX;6Q02P$"% ,4    " "*@EM8#]78O'8$   K"@  &0
M@($QA@  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( (J"
M6U@,,(9>S@,  '0(   9              " @=Z*  !X;"]W;W)K<VAE971S
M+W-H965T,C N>&UL4$L! A0#%     @ BH);6-*99K_X#@  Y"H  !D
M         ("!XXX  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"% ,4
M    " "*@EM8'7B8ON,"   R!@  &0              @($2G@  >&PO=V]R
M:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( (J"6UBK2@T:G0,  -X'
M   9              " @2RA  !X;"]W;W)K<VAE971S+W-H965T,C,N>&UL
M4$L! A0#%     @ BH);6#"I]H'F @  C 8  !D              ("! *4
M 'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4    " "*@EM8&#7(
M3_0)  #G&0  &0              @($=J   >&PO=V]R:W-H965T<R]S:&5E
M=#(U+GAM;%!+ 0(4 Q0    ( (J"6UBBD ,9X@X  %0_   9
M  " @4BR  !X;"]W;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%     @
MBH);6+?@IQ_6 @  % 8  !D              ("!8<$  'AL+W=O<FMS:&5E
M=',O<VAE970R-RYX;6Q02P$"% ,4    " "*@EM8IB*GMC4%   K#0  &0
M            @(%NQ   >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4
M Q0    ( (J"6U@:)WW"7 0  (\*   9              " @=K)  !X;"]W
M;W)K<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @ BH);6*_$5]IW!
M0PH  !D              ("!;<X  'AL+W=O<FMS:&5E=',O<VAE970S,"YX
M;6Q02P$"% ,4    " "*@EM8O5[Z$"$&  #.$   &0              @($;
MTP  >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( (J"6UCC
MM9--,PL  &0>   9              " @7/9  !X;"]W;W)K<VAE971S+W-H
M965T,S(N>&UL4$L! A0#%     @ BH);6+EN$P5> @  @@8  !D
M     ("!W>0  'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( (J"6UC=U>BH% ,  + &   9              "
M@109 0!X;"]W;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%     @ BH);
M6"#97(N7 @  CP4  !D              ("!7QP! 'AL+W=O<FMS:&5E=',O
M<VAE970S.2YX;6Q02P$"% ,4    " "*@EM81690PR$#  "D!@  &0
M        @($M'P$ >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0
M   ( (J"6UC6Q2*>4 0  #\+   9              " @84B 0!X;"]W;W)K
M<VAE971S+W-H965T-#$N>&UL4$L! A0#%     @ BH);6&,1WF%< P  T@<
M !D              ("!#"<! 'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6Q0
M2P$"% ,4    " "*@EM8@04A<AT&   +#P  &0              @(&?*@$
M>&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    ( (J"6UB27"<=
M\ (  "T&   9              " @?,P 0!X;"]W;W)K<VAE971S+W-H965T
M-#0N>&UL4$L! A0#%     @ BH);6.T^,!5F P  M@<  !D
M ("!&C0! 'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q02P$"% ,4    " "*
M@EM83(,]BPH%  !)#   &0              @(&W-P$ >&PO=V]R:W-H965T
M<R]S:&5E=#0V+GAM;%!+ 0(4 Q0    ( (J"6UA</]AVY (   L&   9
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M970U,2YX;6Q02P$"% ,4    " "*@EM8PU.11+("  "Y!P  &0
M    @('_7@$ >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4 Q0    (
M (J"6UC\>C T!@0  )$9   9              " @>AA 0!X;"]W;W)K<VAE
M971S+W-H965T-3,N>&UL4$L! A0#%     @ BH);6$PDWEHS @  [ 4  !D
M             ("!)68! 'AL+W=O<FMS:&5E=',O<VAE970U-"YX;6Q02P$"
M% ,4    " "*@EM8C/$TQ-\"  "@"P  &0              @(&/: $ >&PO
M=V]R:W-H965T<R]S:&5E=#4U+GAM;%!+ 0(4 Q0    ( (J"6UAR(R87DP(
M .@&   9              " @:5K 0!X;"]W;W)K<VAE971S+W-H965T-38N
M>&UL4$L! A0#%     @ BH);6%3XRF5X @  EP8  !D              ("!
M;VX! 'AL+W=O<FMS:&5E=',O<VAE970U-RYX;6Q02P$"% ,4    " "*@EM8
M&ADF0$P$  "=&   &0              @($><0$ >&PO=V]R:W-H965T<R]S
M:&5E=#4X+GAM;%!+ 0(4 Q0    ( (J"6UAW&D2E4P0  $L9   9
M      " @:%U 0!X;"]W;W)K<VAE971S+W-H965T-3DN>&UL4$L! A0#%
M  @ BH);6.5TI4V$ @  K 8  !D              ("!*WH! 'AL+W=O<FMS
M:&5E=',O<VAE970V,"YX;6Q02P$"% ,4    " "*@EM8@(708"$"  !]!@
M&0              @('F? $ >&PO=V]R:W-H965T<R]S:&5E=#8Q+GAM;%!+
M 0(4 Q0    ( (J"6UCVB\@P<0(  (D&   9              " @3Y_ 0!X
M;"]W;W)K<VAE971S+W-H965T-C(N>&UL4$L! A0#%     @ BH);6*M>OLG:
M @  O@<  !D              ("!YH$! 'AL+W=O<FMS:&5E=',O<VAE970V
M,RYX;6Q02P$"% ,4    " "*@EM8OP-$8]\"   *"   &0
M@('WA $ >&PO=V]R:W-H965T<R]S:&5E=#8T+GAM;%!+ 0(4 Q0    ( (J"
M6U@#BKTH50(   @&   9              " @0V( 0!X;"]W;W)K<VAE971S
M+W-H965T-C4N>&UL4$L! A0#%     @ BH);6!;$7UOI @  8 @  !D
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M=#<P+GAM;%!+ 0(4 Q0    ( (J"6UB%#UKX7P0  ,\2   9
M  " @3VB 0!X;"]W;W)K<VAE971S+W-H965T-S$N>&UL4$L! A0#%     @
MBH);6*@_2M"] @  )P<  !D              ("!TZ8! 'AL+W=O<FMS:&5E
M=',O<VAE970W,BYX;6Q02P$"% ,4    " "*@EM86^4N$ 4#  #B"   &0
M            @(''J0$ >&PO=V]R:W-H965T<R]S:&5E=#<S+GAM;%!+ 0(4
M Q0    ( (J"6UA*HB_+DP,  /@,   9              " @0.M 0!X;"]W
M;W)K<VAE971S+W-H965T-S0N>&UL4$L! A0#%     @ BH);6,*_\@ L P
M,0P  !D              ("!S; ! 'AL+W=O<FMS:&5E=',O<VAE970W-2YX
M;6Q02P$"% ,4    " "*@EM8D?TF^N@"   <"@  &0              @($P
MM $ >&PO=V]R:W-H965T<R]S:&5E=#<V+GAM;%!+ 0(4 Q0    ( (J"6UAL
M7;1)B@@  ,I3   9              " @4^W 0!X;"]W;W)K<VAE971S+W-H
M965T-S<N>&UL4$L! A0#%     @ BH);6*IG=/Z@!   ,Q4  !D
M     ("!$, ! 'AL+W=O<FMS:&5E=',O<VAE970W."YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( (J"6UB_U!([*@,  !L)   9              "
M@;?: 0!X;"]W;W)K<VAE971S+W-H965T.#,N>&UL4$L! A0#%     @ BH);
M6*GLWY&( @  >P<  !D              ("!&-X! 'AL+W=O<FMS:&5E=',O
M<VAE970X-"YX;6Q02P$"% ,4    " "*@EM8:SP46/H#  !$%   &0
M        @('7X $ >&PO=V]R:W-H965T<R]S:&5E=#@U+GAM;%!+ 0(4 Q0
M   ( (J"6UBW(*]=-P(  .@$   9              " @0CE 0!X;"]W;W)K
M<VAE971S+W-H965T.#8N>&UL4$L! A0#%     @ BH);6 .-SDH5!P  &DH
M !D              ("!=N<! 'AL+W=O<FMS:&5E=',O<VAE970X-RYX;6Q0
M2P$"% ,4    " "*@EM8Z]LI\],)   &4P  &0              @('"[@$
M>&PO=V]R:W-H965T<R]S:&5E=#@X+GAM;%!+ 0(4 Q0    ( (J"6UA5C7D
M'P8  #P>   9              " @<SX 0!X;"]W;W)K<VAE971S+W-H965T
M.#DN>&UL4$L! A0#%     @ BH);6'%W23?B"0  SCD  !D
M ("!(O\! 'AL+W=O<FMS:&5E=',O<VAE970Y,"YX;6Q02P$"% ,4    " "*
M@EM8])BIEFL#  #,%@  #0              @ $["0( >&PO<W1Y;&5S+GAM
M;%!+ 0(4 Q0    ( (J"6UB7BKL<P    !,"   +              "  =$,
M @!?<F5L<R\N<F5L<U!+ 0(4 Q0    ( (J"6U@L)IARV08  !T[   /
M          "  ;H- @!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " "*@EM8
MYN*DT* "   %-0  &@              @ ' % ( >&PO7W)E;',O=V]R:V)O
M;VLN>&UL+G)E;'-02P$"% ,4    " "*@EM8PH ,:SH"  !H,P  $P
M        @ &8%P( 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     8@!B .4:
(   #&@(    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>145
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>146
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>148
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>274</ContextCount>
  <ElementCount>398</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>114</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>6</UnitCount>
  <MyReports>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/ConsolidatedStatementsofOperations</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - Consolidated Statements of Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/ConsolidatedStatementsofComprehensiveLoss</Role>
      <ShortName>Consolidated Statements of Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - Consolidated Statements of Comprehensive Loss (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/ConsolidatedStatementsofComprehensiveLossParenthetical</Role>
      <ShortName>Consolidated Statements of Comprehensive Loss (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Statement - Consolidated Statements of Shareholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/ConsolidatedStatementsofShareholdersEquity</Role>
      <ShortName>Consolidated Statements of Shareholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Statement - Consolidated Statements of Shareholders' Equity (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/ConsolidatedStatementsofShareholdersEquityParenthetical</Role>
      <ShortName>Consolidated Statements of Shareholders' Equity (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Organization and Principal Activities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/OrganizationandPrincipalActivities</Role>
      <ShortName>Organization and Principal Activities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Cash and Cash Equivalents</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/CashandCashEquivalents</Role>
      <ShortName>Cash and Cash Equivalents</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Restricted Cash, Non-Current</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/RestrictedCashNonCurrent</Role>
      <ShortName>Restricted Cash, Non-Current</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Short-Term Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/ShortTermInvestments</Role>
      <ShortName>Short-Term Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Inventories, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/InventoriesNet</Role>
      <ShortName>Inventories, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Long-Term Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/LongTermInvestments</Role>
      <ShortName>Long-Term Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Property and Equipment, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/PropertyandEquipmentNet</Role>
      <ShortName>Property and Equipment, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/Revenue</Role>
      <ShortName>Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Income Tax</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/IncomeTax</Role>
      <ShortName>Income Tax</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Other Current Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/OtherCurrentLiabilities</Role>
      <ShortName>Other Current Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Loss Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/LossPerShare</Role>
      <ShortName>Loss Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/RelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Share-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/ShareBasedCompensation</Role>
      <ShortName>Share-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - License and Collaboration Agreements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/LicenseandCollaborationAgreements</Role>
      <ShortName>License and Collaboration Agreements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - Other Income (Expenses), Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/OtherIncomeExpensesNet</Role>
      <ShortName>Other Income (Expenses), Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Restricted Net Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/RestrictedNetAssets</Role>
      <ShortName>Restricted Net Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Employee Defined Contribution Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/EmployeeDefinedContributionPlans</Role>
      <ShortName>Employee Defined Contribution Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - Schedule I ??? Condensed Financial Information of Registrant</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrant</Role>
      <ShortName>Schedule I ??? Condensed Financial Information of Registrant</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>9954471 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://zailab.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>9954472 - Disclosure - Organization and Principal Activities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/OrganizationandPrincipalActivitiesTables</Role>
      <ShortName>Organization and Principal Activities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://zailab.com/role/OrganizationandPrincipalActivities</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>9954473 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/SummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://zailab.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>9954474 - Disclosure - Cash and Cash Equivalents (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/CashandCashEquivalentsTables</Role>
      <ShortName>Cash and Cash Equivalents (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://zailab.com/role/CashandCashEquivalents</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>9954475 - Disclosure - Inventories, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/InventoriesNetTables</Role>
      <ShortName>Inventories, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://zailab.com/role/InventoriesNet</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>9954476 - Disclosure - Property and Equipment, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/PropertyandEquipmentNetTables</Role>
      <ShortName>Property and Equipment, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://zailab.com/role/PropertyandEquipmentNet</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>9954477 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://zailab.com/role/Leases</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>9954478 - Disclosure - Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/RevenueTables</Role>
      <ShortName>Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://zailab.com/role/Revenue</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>9954479 - Disclosure - Income Tax (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/IncomeTaxTables</Role>
      <ShortName>Income Tax (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://zailab.com/role/IncomeTax</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>9954480 - Disclosure - Other Current Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/OtherCurrentLiabilitiesTables</Role>
      <ShortName>Other Current Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://zailab.com/role/OtherCurrentLiabilities</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>9954481 - Disclosure - Loss Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/LossPerShareTables</Role>
      <ShortName>Loss Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://zailab.com/role/LossPerShare</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>9954482 - Disclosure - Share-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/ShareBasedCompensationTables</Role>
      <ShortName>Share-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://zailab.com/role/ShareBasedCompensation</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>9954483 - Disclosure - Other Income (Expenses), Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/OtherIncomeExpensesNetTables</Role>
      <ShortName>Other Income (Expenses), Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://zailab.com/role/OtherIncomeExpensesNet</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>9954484 - Disclosure - Schedule I ??? Condensed Financial Information of Registrant (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantTables</Role>
      <ShortName>Schedule I ??? Condensed Financial Information of Registrant (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrant</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>9954485 - Disclosure - Organization and Principal Activities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/OrganizationandPrincipalActivitiesDetails</Role>
      <ShortName>Organization and Principal Activities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://zailab.com/role/OrganizationandPrincipalActivitiesTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>9954486 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>9954487 - Disclosure - Summary of Significant Accounting Policies - Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>9954488 - Disclosure - Summary of Significant Accounting Policies - Concentration of Suppliers (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/SummaryofSignificantAccountingPoliciesConcentrationofSuppliersDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Concentration of Suppliers (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>9954489 - Disclosure - Cash and Cash Equivalents (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/CashandCashEquivalentsDetails</Role>
      <ShortName>Cash and Cash Equivalents (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://zailab.com/role/CashandCashEquivalentsTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>9954490 - Disclosure - Restricted Cash, Non-Current (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/RestrictedCashNonCurrentDetails</Role>
      <ShortName>Restricted Cash, Non-Current (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://zailab.com/role/RestrictedCashNonCurrent</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>9954491 - Disclosure - Short-Term Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/ShortTermInvestmentsDetails</Role>
      <ShortName>Short-Term Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://zailab.com/role/ShortTermInvestments</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>9954492 - Disclosure - Inventories, Net - Schedule of Inventory (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/InventoriesNetScheduleofInventoryDetails</Role>
      <ShortName>Inventories, Net - Schedule of Inventory (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>9954493 - Disclosure - Inventories, Net - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/InventoriesNetAdditionalInformationDetails</Role>
      <ShortName>Inventories, Net - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>9954494 - Disclosure - Long-Term Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/LongTermInvestmentsDetails</Role>
      <ShortName>Long-Term Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://zailab.com/role/LongTermInvestments</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>9954495 - Disclosure - Property and Equipment, Net - Summary of Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails</Role>
      <ShortName>Property and Equipment, Net - Summary of Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>9954496 - Disclosure - Property and Equipment, Net - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/PropertyandEquipmentNetAdditionalInformationDetails</Role>
      <ShortName>Property and Equipment, Net - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>9954497 - Disclosure - Leases - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/LeasesAdditionalInformationDetails</Role>
      <ShortName>Leases - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>9954498 - Disclosure - Leases - Operating Lease Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/LeasesOperatingLeaseCostDetails</Role>
      <ShortName>Leases - Operating Lease Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>9954499 - Disclosure - Leases - Cash Flow Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/LeasesCashFlowInformationDetails</Role>
      <ShortName>Leases - Cash Flow Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>9954500 - Disclosure - Leases - Maturities of Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails</Role>
      <ShortName>Leases - Maturities of Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>9954501 - Disclosure - Leases - Weighted-Average Remaining Lease Terms and Discount Rates (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/LeasesWeightedAverageRemainingLeaseTermsandDiscountRatesDetails</Role>
      <ShortName>Leases - Weighted-Average Remaining Lease Terms and Discount Rates (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>9954502 - Disclosure - Revenue - Summary of Product Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/RevenueSummaryofProductRevenueDetails</Role>
      <ShortName>Revenue - Summary of Product Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>9954503 - Disclosure - Revenue - Disaggregation of Net Revenue by Product (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/RevenueDisaggregationofNetRevenuebyProductDetails</Role>
      <ShortName>Revenue - Disaggregation of Net Revenue by Product (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>9954504 - Disclosure - Income Tax - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/IncomeTaxAdditionalInformationDetails</Role>
      <ShortName>Income Tax - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>9954505 - Disclosure - Income Tax - Loss (Income) Before Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/IncomeTaxLossIncomeBeforeIncomeTaxesDetails</Role>
      <ShortName>Income Tax - Loss (Income) Before Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>9954506 - Disclosure - Income Tax - Reconciliation of the Effective Income Tax Rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRateDetails</Role>
      <ShortName>Income Tax - Reconciliation of the Effective Income Tax Rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>9954507 - Disclosure - Income Tax - Components of Deferred Tax Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/IncomeTaxComponentsofDeferredTaxAssetsandLiabilitiesDetails</Role>
      <ShortName>Income Tax - Components of Deferred Tax Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>9954508 - Disclosure - Income Tax - Movement of Valuation Allowance (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/IncomeTaxMovementofValuationAllowanceDetails</Role>
      <ShortName>Income Tax - Movement of Valuation Allowance (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>9954509 - Disclosure - Other Current Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/OtherCurrentLiabilitiesDetails</Role>
      <ShortName>Other Current Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://zailab.com/role/OtherCurrentLiabilitiesTables</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>9954510 - Disclosure - Loss Per Share - Computation of Basic and Diluted Net Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/LossPerShareComputationofBasicandDilutedNetLossPerShareDetails</Role>
      <ShortName>Loss Per Share - Computation of Basic and Diluted Net Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>9954511 - Disclosure - Loss Per Share - Anti-Dilutive Shares Excluded from Calculation of Diluted Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/LossPerShareAntiDilutiveSharesExcludedfromCalculationofDilutedLossPerShareDetails</Role>
      <ShortName>Loss Per Share - Anti-Dilutive Shares Excluded from Calculation of Diluted Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>9954512 - Disclosure - Related Party Transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/RelatedPartyTransactionsDetails</Role>
      <ShortName>Related Party Transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://zailab.com/role/RelatedPartyTransactions</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>9954513 - Disclosure - Share-Based Compensation - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/ShareBasedCompensationAdditionalInformationDetails</Role>
      <ShortName>Share-Based Compensation - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>9954514 - Disclosure - Share-Based Compensation - Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/ShareBasedCompensationOptionActivityDetails</Role>
      <ShortName>Share-Based Compensation - Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>9954515 - Disclosure - Share-Based Compensation - Assumptions Used to Estimate Fair Values of Share Options Granted (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/ShareBasedCompensationAssumptionsUsedtoEstimateFairValuesofShareOptionsGrantedDetails</Role>
      <ShortName>Share-Based Compensation - Assumptions Used to Estimate Fair Values of Share Options Granted (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>9954516 - Disclosure - Share-Based Compensation - Non-vested Restricted Share Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/ShareBasedCompensationNonvestedRestrictedShareActivityDetails</Role>
      <ShortName>Share-Based Compensation - Non-vested Restricted Share Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>9954517 - Disclosure - Share-Based Compensation - Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/ShareBasedCompensationCompensationExpenseDetails</Role>
      <ShortName>Share-Based Compensation - Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>9954518 - Disclosure - License and Collaboration Agreements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/LicenseandCollaborationAgreementsDetails</Role>
      <ShortName>License and Collaboration Agreements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://zailab.com/role/LicenseandCollaborationAgreements</ParentRole>
      <Position>82</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>9954519 - Disclosure - Other Income (Expenses), Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/OtherIncomeExpensesNetDetails</Role>
      <ShortName>Other Income (Expenses), Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://zailab.com/role/OtherIncomeExpensesNetTables</ParentRole>
      <Position>83</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>9954520 - Disclosure - Restricted Net Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/RestrictedNetAssetsDetails</Role>
      <ShortName>Restricted Net Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://zailab.com/role/RestrictedNetAssets</ParentRole>
      <Position>84</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>9954521 - Disclosure - Employee Defined Contribution Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/EmployeeDefinedContributionPlansDetails</Role>
      <ShortName>Employee Defined Contribution Plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://zailab.com/role/EmployeeDefinedContributionPlans</ParentRole>
      <Position>85</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>9954522 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://zailab.com/role/CommitmentsandContingencies</ParentRole>
      <Position>86</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>9954523 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://zailab.com/role/SubsequentEvents</ParentRole>
      <Position>87</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>9954524 - Disclosure - Schedule I ??? Condensed Financial Information of Registrant - Condensed Balance Sheets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails</Role>
      <ShortName>Schedule I ??? Condensed Financial Information of Registrant - Condensed Balance Sheets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>9954525 - Disclosure - Schedule I ??? Condensed Financial Information of Registrant - Condensed Statements of Operations and Comprehensive Loss (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofOperationsandComprehensiveLossDetails</Role>
      <ShortName>Schedule I ??? Condensed Financial Information of Registrant - Condensed Statements of Operations and Comprehensive Loss (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="zlab-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>9954526 - Disclosure - Schedule I ??? Condensed Financial Information of Registrant - Condensed Statements of Cash Flows (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails</Role>
      <ShortName>Schedule I ??? Condensed Financial Information of Registrant - Condensed Statements of Cash Flows (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>90</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" isDefinitelyFs="true" isUsgaap="true" original="zlab-20231231.htm">zlab-20231231.htm</File>
    <File>zlab-20231231.xsd</File>
    <File>zlab-20231231_cal.xml</File>
    <File>zlab-20231231_def.xml</File>
    <File>zlab-20231231_lab.xml</File>
    <File>zlab-20231231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>zlab-20231231_g1.jpg</File>
    <File>zlab-20231231_g10.jpg</File>
    <File>zlab-20231231_g11.jpg</File>
    <File>zlab-20231231_g12.jpg</File>
    <File>zlab-20231231_g2.jpg</File>
    <File>zlab-20231231_g3.jpg</File>
    <File>zlab-20231231_g4.jpg</File>
    <File>zlab-20231231_g5.jpg</File>
    <File>zlab-20231231_g6.jpg</File>
    <File>zlab-20231231_g7.jpg</File>
    <File>zlab-20231231_g8.jpg</File>
    <File>zlab-20231231_g9.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="3">http://fasb.org/srt/2023</BaseTaxonomy>
    <BaseTaxonomy items="980">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="45">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
    <BaseTaxonomy items="10">http://xbrl.sec.gov/ecd/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>151
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "zlab-20231231.htm": {
   "nsprefix": "zlab",
   "nsuri": "http://zailab.com/20231231",
   "dts": {
    "inline": {
     "local": [
      "zlab-20231231.htm"
     ]
    },
    "schema": {
     "local": [
      "zlab-20231231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/currency/2023/currency-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "zlab-20231231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "zlab-20231231_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "zlab-20231231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "zlab-20231231_pre.xml"
     ]
    }
   },
   "keyStandard": 341,
   "keyCustom": 57,
   "axisStandard": 33,
   "axisCustom": 1,
   "memberStandard": 46,
   "memberCustom": 59,
   "hidden": {
    "total": 10,
    "http://xbrl.sec.gov/ecd/2023": 1,
    "http://fasb.org/us-gaap/2023": 5,
    "http://xbrl.sec.gov/dei/2023": 4
   },
   "contextCount": 274,
   "entityCount": 1,
   "segmentCount": 114,
   "elementCount": 755,
   "unitCount": 6,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2023": 980,
    "http://xbrl.sec.gov/dei/2023": 45,
    "http://xbrl.sec.gov/ecd/2023": 10,
    "http://fasb.org/srt/2023": 3
   },
   "report": {
    "R1": {
     "role": "http://zailab.com/role/CoverPage",
     "longName": "0000001 - Document - Cover Page",
     "shortName": "Cover Page",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://zailab.com/role/AuditInformation",
     "longName": "0000002 - Document - Audit Information",
     "shortName": "Audit Information",
     "isDefault": "false",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:AuditorFirmId",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:AuditorFirmId",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://zailab.com/role/ConsolidatedBalanceSheets",
     "longName": "0000003 - Statement - Consolidated Balance Sheets",
     "shortName": "Consolidated Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-12",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-12",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://zailab.com/role/ConsolidatedBalanceSheetsParenthetical",
     "longName": "0000004 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c-12",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-12",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R5": {
     "role": "http://zailab.com/role/ConsolidatedStatementsofOperations",
     "longName": "0000005 - Statement - Consolidated Statements of Operations",
     "shortName": "Consolidated Statements of Operations",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://zailab.com/role/ConsolidatedStatementsofComprehensiveLoss",
     "longName": "0000006 - Statement - Consolidated Statements of Comprehensive Loss",
     "shortName": "Consolidated Statements of Comprehensive Loss",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R7": {
     "role": "http://zailab.com/role/ConsolidatedStatementsofComprehensiveLossParenthetical",
     "longName": "0000007 - Statement - Consolidated Statements of Comprehensive Loss (Parenthetical)",
     "shortName": "Consolidated Statements of Comprehensive Loss (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1",
       "us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R8": {
     "role": "http://zailab.com/role/ConsolidatedStatementsofShareholdersEquity",
     "longName": "0000008 - Statement - Consolidated Statements of Shareholders' Equity",
     "shortName": "Consolidated Statements of Shareholders' Equity",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c-15",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-15",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://zailab.com/role/ConsolidatedStatementsofShareholdersEquityParenthetical",
     "longName": "0000009 - Statement - Consolidated Statements of Shareholders' Equity (Parenthetical)",
     "shortName": "Consolidated Statements of Shareholders' Equity (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c-11",
      "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-11",
      "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://zailab.com/role/ConsolidatedStatementsofCashFlows",
     "longName": "0000010 - Statement - Consolidated Statements of Cash Flows",
     "shortName": "Consolidated Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ProvisionForDoubtfulAccounts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "unique": true
     }
    },
    "R11": {
     "role": "http://zailab.com/role/OrganizationandPrincipalActivities",
     "longName": "0000011 - Disclosure - Organization and Principal Activities",
     "shortName": "Organization and Principal Activities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://zailab.com/role/SummaryofSignificantAccountingPolicies",
     "longName": "0000012 - Disclosure - Summary of Significant Accounting Policies",
     "shortName": "Summary of Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://zailab.com/role/CashandCashEquivalents",
     "longName": "0000013 - Disclosure - Cash and Cash Equivalents",
     "shortName": "Cash and Cash Equivalents",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CashAndCashEquivalentsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CashAndCashEquivalentsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://zailab.com/role/RestrictedCashNonCurrent",
     "longName": "0000014 - Disclosure - Restricted Cash, Non-Current",
     "shortName": "Restricted Cash, Non-Current",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "zlab:RestrictedCashNonCurrentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "zlab:RestrictedCashNonCurrentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://zailab.com/role/ShortTermInvestments",
     "longName": "0000015 - Disclosure - Short-Term Investments",
     "shortName": "Short-Term Investments",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "zlab:ShortTermInvestmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "zlab:ShortTermInvestmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://zailab.com/role/InventoriesNet",
     "longName": "0000016 - Disclosure - Inventories, Net",
     "shortName": "Inventories, Net",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://zailab.com/role/LongTermInvestments",
     "longName": "0000017 - Disclosure - Long-Term Investments",
     "shortName": "Long-Term Investments",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InvestmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InvestmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://zailab.com/role/PropertyandEquipmentNet",
     "longName": "0000018 - Disclosure - Property and Equipment, Net",
     "shortName": "Property and Equipment, Net",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://zailab.com/role/Leases",
     "longName": "0000019 - Disclosure - Leases",
     "shortName": "Leases",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://zailab.com/role/Revenue",
     "longName": "0000020 - Disclosure - Revenue",
     "shortName": "Revenue",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://zailab.com/role/IncomeTax",
     "longName": "0000021 - Disclosure - Income Tax",
     "shortName": "Income Tax",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://zailab.com/role/OtherCurrentLiabilities",
     "longName": "0000022 - Disclosure - Other Current Liabilities",
     "shortName": "Other Current Liabilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "zlab:OtherCurrentLiabilitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "zlab:OtherCurrentLiabilitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://zailab.com/role/LossPerShare",
     "longName": "0000023 - Disclosure - Loss Per Share",
     "shortName": "Loss Per Share",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://zailab.com/role/RelatedPartyTransactions",
     "longName": "0000024 - Disclosure - Related Party Transactions",
     "shortName": "Related Party Transactions",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://zailab.com/role/ShareBasedCompensation",
     "longName": "0000025 - Disclosure - Share-Based Compensation",
     "shortName": "Share-Based Compensation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://zailab.com/role/LicenseandCollaborationAgreements",
     "longName": "0000026 - Disclosure - License and Collaboration Agreements",
     "shortName": "License and Collaboration Agreements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "zlab:LicensesAndCollaborativeArrangementDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "zlab:LicensesAndCollaborativeArrangementDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://zailab.com/role/OtherIncomeExpensesNet",
     "longName": "0000027 - Disclosure - Other Income (Expenses), Net",
     "shortName": "Other Income (Expenses), Net",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherNonoperatingIncomeAndExpenseTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherNonoperatingIncomeAndExpenseTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://zailab.com/role/RestrictedNetAssets",
     "longName": "0000028 - Disclosure - Restricted Net Assets",
     "shortName": "Restricted Net Assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RestrictedAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RestrictedAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://zailab.com/role/EmployeeDefinedContributionPlans",
     "longName": "0000029 - Disclosure - Employee Defined Contribution Plans",
     "shortName": "Employee Defined Contribution Plans",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://zailab.com/role/CommitmentsandContingencies",
     "longName": "0000030 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://zailab.com/role/SubsequentEvents",
     "longName": "0000031 - Disclosure - Subsequent Events",
     "shortName": "Subsequent Events",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrant",
     "longName": "0000032 - Disclosure - Schedule I \u2014 Condensed Financial Information of Registrant",
     "shortName": "Schedule I \u2014 Condensed Financial Information of Registrant",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R34": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c-10",
      "name": "ecd:NonRule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-10",
      "name": "ecd:NonRule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://zailab.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "longName": "9954471 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://zailab.com/role/OrganizationandPrincipalActivitiesTables",
     "longName": "9954472 - Disclosure - Organization and Principal Activities (Tables)",
     "shortName": "Organization and Principal Activities (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://zailab.com/role/SummaryofSignificantAccountingPoliciesTables",
     "longName": "9954473 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "zlab:PropertyAndEquipmentEstimatedUsefulLivesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "zlab:PropertyAndEquipmentEstimatedUsefulLivesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://zailab.com/role/CashandCashEquivalentsTables",
     "longName": "9954474 - Disclosure - Cash and Cash Equivalents (Tables)",
     "shortName": "Cash and Cash Equivalents (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://zailab.com/role/InventoriesNetTables",
     "longName": "9954475 - Disclosure - Inventories, Net (Tables)",
     "shortName": "Inventories, Net (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://zailab.com/role/PropertyandEquipmentNetTables",
     "longName": "9954476 - Disclosure - Property and Equipment, Net (Tables)",
     "shortName": "Property and Equipment, Net (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://zailab.com/role/LeasesTables",
     "longName": "9954477 - Disclosure - Leases (Tables)",
     "shortName": "Leases (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "zlab:SupplementalInformationRelatedToLeasesTableTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "zlab:SupplementalInformationRelatedToLeasesTableTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://zailab.com/role/RevenueTables",
     "longName": "9954478 - Disclosure - Revenue (Tables)",
     "shortName": "Revenue (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "zlab:NetRevenueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "zlab:NetRevenueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://zailab.com/role/IncomeTaxTables",
     "longName": "9954479 - Disclosure - Income Tax (Tables)",
     "shortName": "Income Tax (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://zailab.com/role/OtherCurrentLiabilitiesTables",
     "longName": "9954480 - Disclosure - Other Current Liabilities (Tables)",
     "shortName": "Other Current Liabilities (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "44",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://zailab.com/role/LossPerShareTables",
     "longName": "9954481 - Disclosure - Loss Per Share (Tables)",
     "shortName": "Loss Per Share (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "45",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://zailab.com/role/ShareBasedCompensationTables",
     "longName": "9954482 - Disclosure - Share-Based Compensation (Tables)",
     "shortName": "Share-Based Compensation (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "46",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://zailab.com/role/OtherIncomeExpensesNetTables",
     "longName": "9954483 - Disclosure - Other Income (Expenses), Net (Tables)",
     "shortName": "Other Income (Expenses), Net (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "47",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantTables",
     "longName": "9954484 - Disclosure - Schedule I \u2014 Condensed Financial Information of Registrant (Tables)",
     "shortName": "Schedule I \u2014 Condensed Financial Information of Registrant (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "48",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "srt:ScheduleOfCondensedBalanceSheetTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "srt:ScheduleOfCondensedBalanceSheetTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://zailab.com/role/OrganizationandPrincipalActivitiesDetails",
     "longName": "9954485 - Disclosure - Organization and Principal Activities (Details)",
     "shortName": "Organization and Principal Activities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "c-51",
      "name": "us-gaap:SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-51",
      "name": "us-gaap:SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
     "longName": "9954486 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)",
     "shortName": "Summary of Significant Accounting Policies - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "c-61",
      "name": "us-gaap:StockholdersEquityNoteStockSplitConversionRatio1",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-61",
      "name": "us-gaap:StockholdersEquityNoteStockSplitConversionRatio1",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://zailab.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails",
     "longName": "9954487 - Disclosure - Summary of Significant Accounting Policies - Property and Equipment (Details)",
     "shortName": "Summary of Significant Accounting Policies - Property and Equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "c-64",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "zlab:PropertyAndEquipmentEstimatedUsefulLivesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-64",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "zlab:PropertyAndEquipmentEstimatedUsefulLivesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://zailab.com/role/SummaryofSignificantAccountingPoliciesConcentrationofSuppliersDetails",
     "longName": "9954488 - Disclosure - Summary of Significant Accounting Policies - Concentration of Suppliers (Details)",
     "shortName": "Summary of Significant Accounting Policies - Concentration of Suppliers (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "c-89",
      "name": "zlab:ResearchAndDevelopmentExpensesAndTheInventoryPurchases",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueConcentrationOfRiskTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-89",
      "name": "zlab:ResearchAndDevelopmentExpensesAndTheInventoryPurchases",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueConcentrationOfRiskTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://zailab.com/role/CashandCashEquivalentsDetails",
     "longName": "9954489 - Disclosure - Cash and Cash Equivalents (Details)",
     "shortName": "Cash and Cash Equivalents (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "c-12",
      "name": "us-gaap:Cash",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-12",
      "name": "us-gaap:Cash",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://zailab.com/role/RestrictedCashNonCurrentDetails",
     "longName": "9954490 - Disclosure - Restricted Cash, Non-Current (Details)",
     "shortName": "Restricted Cash, Non-Current (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "c-12",
      "name": "us-gaap:RestrictedCashNoncurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R55": {
     "role": "http://zailab.com/role/ShortTermInvestmentsDetails",
     "longName": "9954491 - Disclosure - Short-Term Investments (Details)",
     "shortName": "Short-Term Investments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "c-12",
      "name": "us-gaap:ShortTermInvestments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-12",
      "name": "us-gaap:DebtSecuritiesHeldToMaturityAllowanceForCreditLossExcludingAccruedInterest",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "unique": true
     }
    },
    "R56": {
     "role": "http://zailab.com/role/InventoriesNetScheduleofInventoryDetails",
     "longName": "9954492 - Disclosure - Inventories, Net - Schedule of Inventory (Details)",
     "shortName": "Inventories, Net - Schedule of Inventory (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "c-12",
      "name": "us-gaap:InventoryFinishedGoodsNetOfReserves",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-12",
      "name": "us-gaap:InventoryFinishedGoodsNetOfReserves",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R57": {
     "role": "http://zailab.com/role/InventoriesNetAdditionalInformationDetails",
     "longName": "9954493 - Disclosure - Inventories, Net - Additional Information (Details)",
     "shortName": "Inventories, Net - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ProductionRelatedImpairmentsOrCharges",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ProductionRelatedImpairmentsOrCharges",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R58": {
     "role": "http://zailab.com/role/LongTermInvestmentsDetails",
     "longName": "9954494 - Disclosure - Long-Term Investments (Details)",
     "shortName": "Long-Term Investments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EquitySecuritiesFvNiGainLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-110",
      "name": "us-gaap:StockIssuedDuringPeriodSharesAcquisitions",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "unique": true
     }
    },
    "R59": {
     "role": "http://zailab.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails",
     "longName": "9954495 - Disclosure - Property and Equipment, Net - Summary of Property and Equipment (Details)",
     "shortName": "Property and Equipment, Net - Summary of Property and Equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "c-12",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-12",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R60": {
     "role": "http://zailab.com/role/PropertyandEquipmentNetAdditionalInformationDetails",
     "longName": "9954496 - Disclosure - Property and Equipment, Net - Additional Information (Details)",
     "shortName": "Property and Equipment, Net - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:Depreciation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:Depreciation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R61": {
     "role": "http://zailab.com/role/LeasesAdditionalInformationDetails",
     "longName": "9954497 - Disclosure - Leases - Additional Information (Details)",
     "shortName": "Leases - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "c-108",
      "name": "us-gaap:LesseeOperatingLeaseRemainingLeaseTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-108",
      "name": "us-gaap:LesseeOperatingLeaseRemainingLeaseTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R62": {
     "role": "http://zailab.com/role/LeasesOperatingLeaseCostDetails",
     "longName": "9954498 - Disclosure - Leases - Operating Lease Cost (Details)",
     "shortName": "Leases - Operating Lease Cost (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "zlab:SupplementalInformationRelatedToLeasesTableTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "zlab:SupplementalInformationRelatedToLeasesTableTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R63": {
     "role": "http://zailab.com/role/LeasesCashFlowInformationDetails",
     "longName": "9954499 - Disclosure - Leases - Cash Flow Information (Details)",
     "shortName": "Leases - Cash Flow Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R64": {
     "role": "http://zailab.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails",
     "longName": "9954500 - Disclosure - Leases - Maturities of Lease Liabilities (Details)",
     "shortName": "Leases - Maturities of Lease Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "c-12",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-12",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R65": {
     "role": "http://zailab.com/role/LeasesWeightedAverageRemainingLeaseTermsandDiscountRatesDetails",
     "longName": "9954501 - Disclosure - Leases - Weighted-Average Remaining Lease Terms and Discount Rates (Details)",
     "shortName": "Leases - Weighted-Average Remaining Lease Terms and Discount Rates (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "c-12",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "zlab:SummaryOfWeightedAverageRemainingLeaseTermsAndDiscountRatesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-12",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "zlab:SummaryOfWeightedAverageRemainingLeaseTermsAndDiscountRatesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R66": {
     "role": "http://zailab.com/role/RevenueSummaryofProductRevenueDetails",
     "longName": "9954502 - Disclosure - Revenue - Summary of Product Revenue (Details)",
     "shortName": "Revenue - Summary of Product Revenue (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "zlab:RevenueFromContractWithCustomersExcludingAssessedTaxBeforeAdjustmentsForRebatesAndSalesReturns",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "zlab:RevenueFromContractWithCustomersExcludingAssessedTaxBeforeAdjustmentsForRebatesAndSalesReturns",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R67": {
     "role": "http://zailab.com/role/RevenueDisaggregationofNetRevenuebyProductDetails",
     "longName": "9954503 - Disclosure - Revenue - Disaggregation of Net Revenue by Product (Details)",
     "shortName": "Revenue - Disaggregation of Net Revenue by Product (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-126",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "unique": true
     }
    },
    "R68": {
     "role": "http://zailab.com/role/IncomeTaxAdditionalInformationDetails",
     "longName": "9954504 - Disclosure - Income Tax - Additional Information (Details)",
     "shortName": "Income Tax - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-12",
      "name": "us-gaap:OperatingLossCarryforwards",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "unique": true
     }
    },
    "R69": {
     "role": "http://zailab.com/role/IncomeTaxLossIncomeBeforeIncomeTaxesDetails",
     "longName": "9954505 - Disclosure - Income Tax - Loss (Income) Before Income Taxes (Details)",
     "shortName": "Income Tax - Loss (Income) Before Income Taxes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-147",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "unique": true
     }
    },
    "R70": {
     "role": "http://zailab.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRateDetails",
     "longName": "9954506 - Disclosure - Income Tax - Reconciliation of the Effective Income Tax Rate (Details)",
     "shortName": "Income Tax - Reconciliation of the Effective Income Tax Rate (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "c-153",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-153",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R71": {
     "role": "http://zailab.com/role/IncomeTaxComponentsofDeferredTaxAssetsandLiabilitiesDetails",
     "longName": "9954507 - Disclosure - Income Tax - Components of Deferred Tax Assets and Liabilities (Details)",
     "shortName": "Income Tax - Components of Deferred Tax Assets and Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "c-12",
      "name": "us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-12",
      "name": "us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R72": {
     "role": "http://zailab.com/role/IncomeTaxMovementofValuationAllowanceDetails",
     "longName": "9954508 - Disclosure - Income Tax - Movement of Valuation Allowance (Details)",
     "shortName": "Income Tax - Movement of Valuation Allowance (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "c-13",
      "name": "us-gaap:DeferredTaxAssetsValuationAllowance",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfValuationAllowanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "unique": true
     }
    },
    "R73": {
     "role": "http://zailab.com/role/OtherCurrentLiabilitiesDetails",
     "longName": "9954509 - Disclosure - Other Current Liabilities (Details)",
     "shortName": "Other Current Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "c-12",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-12",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R74": {
     "role": "http://zailab.com/role/LossPerShareComputationofBasicandDilutedNetLossPerShareDetails",
     "longName": "9954510 - Disclosure - Loss Per Share - Computation of Basic and Diluted Net Loss Per Share (Details)",
     "shortName": "Loss Per Share - Computation of Basic and Diluted Net Loss Per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R75": {
     "role": "http://zailab.com/role/LossPerShareAntiDilutiveSharesExcludedfromCalculationofDilutedLossPerShareDetails",
     "longName": "9954511 - Disclosure - Loss Per Share - Anti-Dilutive Shares Excluded from Calculation of Diluted Loss Per Share (Details)",
     "shortName": "Loss Per Share - Anti-Dilutive Shares Excluded from Calculation of Diluted Loss Per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "c-173",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-173",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R76": {
     "role": "http://zailab.com/role/RelatedPartyTransactionsDetails",
     "longName": "9954512 - Disclosure - Related Party Transactions (Details)",
     "shortName": "Related Party Transactions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "76",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-179",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "unique": true
     }
    },
    "R77": {
     "role": "http://zailab.com/role/ShareBasedCompensationAdditionalInformationDetails",
     "longName": "9954513 - Disclosure - Share-Based Compensation - Additional Information (Details)",
     "shortName": "Share-Based Compensation - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "77",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R78": {
     "role": "http://zailab.com/role/ShareBasedCompensationOptionActivityDetails",
     "longName": "9954514 - Disclosure - Share-Based Compensation - Option Activity (Details)",
     "shortName": "Share-Based Compensation - Option Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "78",
     "firstAnchor": {
      "contextRef": "c-13",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "unique": true
     }
    },
    "R79": {
     "role": "http://zailab.com/role/ShareBasedCompensationAssumptionsUsedtoEstimateFairValuesofShareOptionsGrantedDetails",
     "longName": "9954515 - Disclosure - Share-Based Compensation - Assumptions Used to Estimate Fair Values of Share Options Granted (Details)",
     "shortName": "Share-Based Compensation - Assumptions Used to Estimate Fair Values of Share Options Granted (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "79",
     "firstAnchor": {
      "contextRef": "c-183",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-183",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R80": {
     "role": "http://zailab.com/role/ShareBasedCompensationNonvestedRestrictedShareActivityDetails",
     "longName": "9954516 - Disclosure - Share-Based Compensation - Non-vested Restricted Share Activity (Details)",
     "shortName": "Share-Based Compensation - Non-vested Restricted Share Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "80",
     "firstAnchor": {
      "contextRef": "c-203",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-205",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "unique": true
     }
    },
    "R81": {
     "role": "http://zailab.com/role/ShareBasedCompensationCompensationExpenseDetails",
     "longName": "9954517 - Disclosure - Share-Based Compensation - Compensation Expense (Details)",
     "shortName": "Share-Based Compensation - Compensation Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "81",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R82": {
     "role": "http://zailab.com/role/LicenseandCollaborationAgreementsDetails",
     "longName": "9954518 - Disclosure - License and Collaboration Agreements (Details)",
     "shortName": "License and Collaboration Agreements (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "82",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "zlab:CollaborativeArrangementRightsAndObligationsSpecifiedRoyaltyTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "zlab:CollaborativeArrangementRightsAndObligationsSpecifiedRoyaltyTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R83": {
     "role": "http://zailab.com/role/OtherIncomeExpensesNetDetails",
     "longName": "9954519 - Disclosure - Other Income (Expenses), Net (Details)",
     "shortName": "Other Income (Expenses), Net (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "83",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "zlab:GovernmentAssistanceNonoperatingIncome",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "zlab:GovernmentAssistanceNonoperatingIncome",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R84": {
     "role": "http://zailab.com/role/RestrictedNetAssetsDetails",
     "longName": "9954520 - Disclosure - Restricted Net Assets (Details)",
     "shortName": "Restricted Net Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "84",
     "firstAnchor": {
      "contextRef": "c-153",
      "name": "zlab:StatutoryReserves",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "zlab:StatutoryReserves",
       "zlab:StatutoryReserves",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-153",
      "name": "zlab:StatutoryReserves",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "zlab:StatutoryReserves",
       "zlab:StatutoryReserves",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R85": {
     "role": "http://zailab.com/role/EmployeeDefinedContributionPlansDetails",
     "longName": "9954521 - Disclosure - Employee Defined Contribution Plans (Details)",
     "shortName": "Employee Defined Contribution Plans (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "85",
     "firstAnchor": {
      "contextRef": "c-243",
      "name": "us-gaap:DefinedContributionPlanCostRecognized",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-243",
      "name": "us-gaap:DefinedContributionPlanCostRecognized",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R86": {
     "role": "http://zailab.com/role/CommitmentsandContingenciesDetails",
     "longName": "9954522 - Disclosure - Commitments and Contingencies (Details)",
     "shortName": "Commitments and Contingencies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "86",
     "firstAnchor": {
      "contextRef": "c-255",
      "name": "us-gaap:UnrecordedUnconditionalPurchaseObligationDueInNextRollingTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-255",
      "name": "us-gaap:UnrecordedUnconditionalPurchaseObligationDueInNextRollingTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R87": {
     "role": "http://zailab.com/role/SubsequentEventsDetails",
     "longName": "9954523 - Disclosure - Subsequent Events (Details)",
     "shortName": "Subsequent Events (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "87",
     "firstAnchor": {
      "contextRef": "c-262",
      "name": "us-gaap:GuaranteeObligationsMaximumExposure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-262",
      "name": "us-gaap:GuaranteeObligationsMaximumExposure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R88": {
     "role": "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails",
     "longName": "9954524 - Disclosure - Schedule I \u2014 Condensed Financial Information of Registrant - Condensed Balance Sheets (Details)",
     "shortName": "Schedule I \u2014 Condensed Financial Information of Registrant - Condensed Balance Sheets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "88",
     "firstAnchor": {
      "contextRef": "c-12",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-268",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfCondensedBalanceSheetTableTextBlock",
       "us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "unique": true
     }
    },
    "R89": {
     "role": "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofOperationsandComprehensiveLossDetails",
     "longName": "9954525 - Disclosure - Schedule I \u2014 Condensed Financial Information of Registrant - Condensed Statements of Operations and Comprehensive Loss (Details)",
     "shortName": "Schedule I \u2014 Condensed Financial Information of Registrant - Condensed Statements of Operations and Comprehensive Loss (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "89",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-270",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:CondensedStatementOfComprehensiveIncomeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "unique": true
     }
    },
    "R90": {
     "role": "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails",
     "longName": "9954526 - Disclosure - Schedule I \u2014 Condensed Financial Information of Registrant - Condensed Statements of Cash Flows (Details)",
     "shortName": "Schedule I \u2014 Condensed Financial Information of Registrant - Condensed Statements of Cash Flows (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "90",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-270",
      "name": "zlab:AmortizationOfDeferredIncome",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfCondensedCashFlowStatementTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zlab-20231231.htm",
      "unique": true
     }
    }
   },
   "tag": {
    "zlab_A401kPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "A401kPlanMember",
     "presentation": [
      "http://zailab.com/role/EmployeeDefinedContributionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "401(k) Plan",
        "label": "401(k) Plan [Member]",
        "documentation": "401(k) Plan"
       }
      }
     },
     "auth_ref": []
    },
    "country_AU": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "AU",
     "presentation": [
      "http://zailab.com/role/IncomeTaxAdditionalInformationDetails",
      "http://zailab.com/role/IncomeTaxLossIncomeBeforeIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Australia",
        "label": "AUSTRALIA"
       }
      }
     },
     "auth_ref": []
    },
    "currency_AUD": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/currency/2023",
     "localname": "AUD",
     "presentation": [
      "http://zailab.com/role/CashandCashEquivalentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Australian dollar (\u201cA$\u201d)",
        "label": "Australia, Dollars"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of significant accounting policies",
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Accounts Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r739"
     ]
    },
    "us-gaap_AccountsReceivableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsReceivableMember",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts Receivable",
        "label": "Accounts Receivable [Member]",
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold."
       }
      }
     },
     "auth_ref": [
      "r682"
     ]
    },
    "us-gaap_AccountsReceivableNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsReceivableNet",
     "crdr": "debit",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts receivable",
        "label": "Accounts Receivable, after Allowance for Credit Loss",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business."
       }
      }
     },
     "auth_ref": [
      "r622",
      "r681",
      "r745",
      "r1008"
     ]
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsReceivableNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts receivable (net of allowance for credit loss of $17 and $11 as of December\u00a031, 2023 and 2022, respectively)",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
       }
      }
     },
     "auth_ref": [
      "r287",
      "r288"
     ]
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedProfessionalFeesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/OtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://zailab.com/role/OtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued professional service fee",
        "label": "Accrued Professional Fees, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "zlab_AccruedRebateToDistributorsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "AccruedRebateToDistributorsCurrent",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/OtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://zailab.com/role/OtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued rebate to distributors",
        "label": "Accrued Rebate To Distributors Current",
        "documentation": "Amount of accrued rebate payable to distributors."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://zailab.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: accumulated depreciation",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r192",
      "r550"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedBalanceSheets",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated other comprehensive income",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r34",
      "r35",
      "r103",
      "r197",
      "r546",
      "r571",
      "r572"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated other comprehensive income (loss)",
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r11",
      "r35",
      "r467",
      "r470",
      "r502",
      "r567",
      "r568",
      "r853",
      "r854",
      "r855",
      "r864",
      "r865",
      "r866"
     ]
    },
    "zlab_AdagrasibMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "AdagrasibMember",
     "presentation": [
      "http://zailab.com/role/LicenseandCollaborationAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adagrasib",
        "label": "Adagrasib [Member]",
        "documentation": "Adagrasib"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional 402(v) Disclosure",
        "label": "Additional 402(v) Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r794"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapitalCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedBalanceSheets",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid in Capital, Common Stock",
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital."
       }
      }
     },
     "auth_ref": [
      "r95"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid in capital",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r433",
      "r434",
      "r435",
      "r587",
      "r864",
      "r865",
      "r866",
      "r987",
      "r1015"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation, Amount",
        "label": "Adjustment to Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r800"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation:",
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r800"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote",
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r800"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment To PEO Compensation, Footnote",
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r800"
     ]
    },
    "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation",
     "crdr": "debit",
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Receipt of shares netted to satisfy tax withholding obligations related to share-based compensation",
        "label": "Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation",
        "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r70",
      "r71",
      "r399"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
     "crdr": "debit",
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofShareholdersEquityParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance costs",
        "label": "Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs",
        "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r129"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:",
        "verboseLabel": "Adjustments to reconcile net loss to net cash provided by (used in) operating activities:",
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AdrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AdrMember",
     "presentation": [
      "http://zailab.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "American Depositary Shares",
        "label": "ADR [Member]",
        "documentation": "American Depositary Receipt (or American Depositary Share, ADS)."
       }
      }
     },
     "auth_ref": [
      "r757"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Amount",
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r764",
      "r776",
      "r786",
      "r812"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined",
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r767",
      "r779",
      "r789",
      "r815"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Adjustments to Compensation",
        "label": "All Adjustments to Compensation [Member]"
       }
      }
     },
     "auth_ref": [
      "r800"
     ]
    },
    "currency_AllCurrenciesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/currency/2023",
     "localname": "AllCurrenciesDomain",
     "presentation": [
      "http://zailab.com/role/CashandCashEquivalentsDetails",
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Currencies [Domain]",
        "label": "All Currencies [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Executive Categories",
        "label": "All Executive Categories [Member]"
       }
      }
     },
     "auth_ref": [
      "r807"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Individuals",
        "label": "All Individuals [Member]"
       }
      }
     },
     "auth_ref": [
      "r771",
      "r780",
      "r790",
      "r807",
      "r816",
      "r820",
      "r828"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Trading Arrangements",
        "label": "All Trading Arrangements [Member]"
       }
      }
     },
     "auth_ref": [
      "r826"
     ]
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation expense",
        "label": "Share-Based Payment Arrangement, Expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r428",
      "r436"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "crdr": "credit",
     "presentation": [
      "http://zailab.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts receivable, allowance for credit loss",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r198",
      "r289",
      "r315"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://zailab.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "zlab_AmericanDepositaryShareToCommonStockConversionRatio": {
     "xbrltype": "pureItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "AmericanDepositaryShareToCommonStockConversionRatio",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ADS to ordinary shares conversion ratio",
        "label": "American Depositary Share to Common Stock, Conversion Ratio",
        "documentation": "American Depositary Share to Common Stock, Conversion Ratio"
       }
      }
     },
     "auth_ref": []
    },
    "zlab_AmgenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "AmgenMember",
     "presentation": [
      "http://zailab.com/role/LicenseandCollaborationAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amgen",
        "label": "Amgen [Member]",
        "documentation": "Five Prime Therapeutics Incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "zlab_AmortizationOfDeferredIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "AmortizationOfDeferredIncome",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      },
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of deferred income",
        "label": "Amortization Of Deferred Income",
        "documentation": "Amortization of deferred income."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AmortizationOfIntangibleAssets",
     "crdr": "debit",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Amortization expenses",
        "label": "Amortization of Intangible Assets",
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r56",
      "r60"
     ]
    },
    "us-gaap_AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries",
     "crdr": "debit",
     "presentation": [
      "http://zailab.com/role/RestrictedNetAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted amount by subsidiaries",
        "label": "Amount of Restricted Net Assets for Consolidated and Unconsolidated Subsidiaries",
        "documentation": "Amount of restricted net assets of consolidated and unconsolidated subsidiaries as of the end of the most recently completed fiscal year."
       }
      }
     },
     "auth_ref": [
      "r221"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://zailab.com/role/LossPerShareAntiDilutiveSharesExcludedfromCalculationofDilutedLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive shares excluded from calculation of diluted loss per share",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r255"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://zailab.com/role/LossPerShareAntiDilutiveSharesExcludedfromCalculationofDilutedLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities [Axis]",
        "label": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "presentation": [
      "http://zailab.com/role/LossPerShareAntiDilutiveSharesExcludedfromCalculationofDilutedLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://zailab.com/role/LossPerShareAntiDilutiveSharesExcludedfromCalculationofDilutedLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities, Name [Domain]",
        "label": "Antidilutive Securities, Name [Domain]",
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "zlab_April2023AndLaterMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "April2023AndLaterMember",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Since April 2023",
        "label": "April 2023 And Later [Member]",
        "documentation": "April 2023 And Later"
       }
      }
     },
     "auth_ref": []
    },
    "zlab_ArgenxBvMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "ArgenxBvMember",
     "presentation": [
      "http://zailab.com/role/LicenseandCollaborationAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "argenx",
        "label": "Argenx BV [Member]",
        "documentation": "Argenx BV [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "presentation": [
      "http://zailab.com/role/LicenseandCollaborationAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r461"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedBalanceSheets",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Assets",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r142",
      "r193",
      "r222",
      "r262",
      "r277",
      "r281",
      "r312",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r462",
      "r464",
      "r476",
      "r542",
      "r627",
      "r739",
      "r752",
      "r888",
      "r889",
      "r997"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://zailab.com/role/ConsolidatedBalanceSheets",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets",
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedBalanceSheets",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r186",
      "r201",
      "r222",
      "r312",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r462",
      "r464",
      "r476",
      "r739",
      "r888",
      "r889",
      "r997"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://zailab.com/role/ConsolidatedBalanceSheets",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current assets",
        "label": "Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "zlab_AuditInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "AuditInformationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Audit Information [Abstract]",
        "documentation": "Audit Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://zailab.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Firm ID",
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r758",
      "r759",
      "r772"
     ]
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorLocation",
     "presentation": [
      "http://zailab.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Location",
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r758",
      "r759",
      "r772"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorName",
     "presentation": [
      "http://zailab.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Name",
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r758",
      "r759",
      "r772"
     ]
    },
    "us-gaap_AwardDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AwardDateAxis",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Date [Axis]",
        "label": "Award Date [Axis]",
        "documentation": "Information by date or year award under share-based payment arrangement is granted."
       }
      }
     },
     "auth_ref": [
      "r955",
      "r956",
      "r957",
      "r958",
      "r959",
      "r960",
      "r961",
      "r962",
      "r963",
      "r964",
      "r965",
      "r966",
      "r967",
      "r968",
      "r969",
      "r970",
      "r971",
      "r972",
      "r973",
      "r974",
      "r975",
      "r976",
      "r977",
      "r978",
      "r979",
      "r980"
     ]
    },
    "us-gaap_AwardDateDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AwardDateDomain",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Date [Domain]",
        "label": "Award Date [Domain]",
        "documentation": "Date or year award under share-based payment arrangement is granted."
       }
      }
     },
     "auth_ref": [
      "r955",
      "r956",
      "r957",
      "r958",
      "r959",
      "r960",
      "r961",
      "r962",
      "r963",
      "r964",
      "r965",
      "r966",
      "r967",
      "r968",
      "r969",
      "r970",
      "r971",
      "r972",
      "r973",
      "r974",
      "r975",
      "r976",
      "r977",
      "r978",
      "r979",
      "r980"
     ]
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise Price",
        "label": "Award Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r823"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value as of Grant Date",
        "label": "Award Grant Date Fair Value"
       }
      }
     },
     "auth_ref": [
      "r824"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r819"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing, How MNPI Considered",
        "label": "Award Timing, How MNPI Considered [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r819"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Method",
        "label": "Award Timing Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r819"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Considered",
        "label": "Award Timing MNPI Considered [Flag]"
       }
      }
     },
     "auth_ref": [
      "r819"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Disclosure",
        "label": "Award Timing MNPI Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r819"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Predetermined",
        "label": "Award Timing Predetermined [Flag]"
       }
      }
     },
     "auth_ref": [
      "r819"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://zailab.com/role/ShareBasedCompensationAdditionalInformationDetails",
      "http://zailab.com/role/ShareBasedCompensationAssumptionsUsedtoEstimateFairValuesofShareOptionsGrantedDetails",
      "http://zailab.com/role/ShareBasedCompensationNonvestedRestrictedShareActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Axis]",
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Securities",
        "label": "Award Underlying Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r822"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r821"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures",
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r820"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table",
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r820"
     ]
    },
    "zlab_BMSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "BMSMember",
     "presentation": [
      "http://zailab.com/role/LicenseandCollaborationAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "BMS",
        "label": "BMS [Member]",
        "documentation": "BMS"
       }
      }
     },
     "auth_ref": []
    },
    "zlab_BankOfChinaWorkingCapitalLoanFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "BankOfChinaWorkingCapitalLoanFacilityMember",
     "presentation": [
      "http://zailab.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bank of China Working Capital Loan Facility",
        "label": "Bank of China Working Capital Loan Facility [Member]",
        "documentation": "Bank of China Working Capital Loan Facility"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of Presentation",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": []
    },
    "country_CN": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "CN",
     "presentation": [
      "http://zailab.com/role/IncomeTaxAdditionalInformationDetails",
      "http://zailab.com/role/IncomeTaxLossIncomeBeforeIncomeTaxesDetails",
      "http://zailab.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRateDetails",
      "http://zailab.com/role/RestrictedNetAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Mainland China",
        "label": "CHINA"
       }
      }
     },
     "auth_ref": []
    },
    "currency_CNY": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/currency/2023",
     "localname": "CNY",
     "presentation": [
      "http://zailab.com/role/CashandCashEquivalentsDetails",
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RMB",
        "label": "China, Yuan Renminbi"
       }
      }
     },
     "auth_ref": []
    },
    "zlab_CapitalContributionsCommitment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "CapitalContributionsCommitment",
     "crdr": "credit",
     "presentation": [
      "http://zailab.com/role/LongTermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capital contribution commitment",
        "label": "Capital Contributions Commitment",
        "documentation": "Capital contribution commitment."
       }
      }
     },
     "auth_ref": []
    },
    "zlab_CapitalizedSalesBasedMilestoneFeesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "CapitalizedSalesBasedMilestoneFeesMember",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capitalized Sales Based Milestone Fees",
        "label": "Capitalized Sales Based Milestone Fees [Member]",
        "documentation": "Capitalized Sales Based Milestone Fees"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Cash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Cash",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/CashandCashEquivalentsDetails": {
       "parentTag": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://zailab.com/role/CashandCashEquivalentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash",
        "label": "Cash",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r544",
      "r598",
      "r621",
      "r739",
      "r752",
      "r848"
     ]
    },
    "zlab_CashAndCashEquivalentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "CashAndCashEquivalentMember",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents",
        "label": "Cash And Cash Equivalent [Member]",
        "documentation": "Cash and cash equivalent."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalents [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
       "weight": 1.0,
       "order": 1.0
      },
      "http://zailab.com/role/CashandCashEquivalentsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://zailab.com/role/CashandCashEquivalentsDetails",
      "http://zailab.com/role/ConsolidatedBalanceSheets",
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails",
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Aggregate amount of cash and cash equivalents",
        "totalLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r40",
      "r189",
      "r701"
     ]
    },
    "us-gaap_CashAndCashEquivalentsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsDisclosureTextBlock",
     "presentation": [
      "http://zailab.com/role/CashandCashEquivalents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents",
        "label": "Cash and Cash Equivalents Disclosure [Text Block]",
        "documentation": "The entire disclosure for cash and cash equivalent footnotes, which may include the types of deposits and money market instruments, applicable carrying amounts, restricted amounts and compensating balance arrangements. Cash and equivalents include: (1) currency on hand (2) demand deposits with banks or financial institutions (3) other kinds of accounts that have the general characteristics of demand deposits (4) short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only investments maturing within three months from the date of acquisition qualify."
       }
      }
     },
     "auth_ref": [
      "r189",
      "r544"
     ]
    },
    "us-gaap_CashAndCashEquivalentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsLineItems",
     "presentation": [
      "http://zailab.com/role/CashandCashEquivalentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash And Cash Equivalents [Line Items]",
        "label": "Cash and Cash Equivalents [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash, Cash Equivalents and Restricted Cash",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits."
       }
      }
     },
     "auth_ref": [
      "r41",
      "r141"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash, cash equivalents and restricted cash \u2014 beginning of the year",
        "periodEndLabel": "Cash, cash equivalents and restricted cash \u2014 end of the year",
        "totalLabel": "Total cash and cash equivalents and restricted cash",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r40",
      "r116",
      "r219"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net (decrease) increase in cash, cash equivalents and restricted cash",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r116"
     ]
    },
    "us-gaap_CashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/CashandCashEquivalentsDetails": {
       "parentTag": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://zailab.com/role/CashandCashEquivalentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash equivalents",
        "label": "Cash Equivalents, at Carrying Value",
        "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r848",
      "r1007"
     ]
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental disclosure on non-cash investing and financing activities",
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changed Peer Group, Footnote",
        "label": "Changed Peer Group, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r798"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://zailab.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://zailab.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Domain]",
        "label": "Class of Stock [Domain]",
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r168",
      "r194",
      "r195",
      "r196",
      "r222",
      "r244",
      "r245",
      "r252",
      "r254",
      "r260",
      "r261",
      "r312",
      "r336",
      "r338",
      "r339",
      "r340",
      "r343",
      "r344",
      "r361",
      "r362",
      "r364",
      "r365",
      "r366",
      "r476",
      "r578",
      "r579",
      "r580",
      "r581",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r599",
      "r613",
      "r637",
      "r660",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r835",
      "r859",
      "r867"
     ]
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Amount",
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r799"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Name",
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r799"
     ]
    },
    "zlab_CollaborativeAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "CollaborativeAgreementMember",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Agreement",
        "label": "Collaborative Agreement [Member]",
        "documentation": "Collaborative Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CollaborativeArrangementAccountingPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CollaborativeArrangementAccountingPolicy",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangements",
        "label": "Collaborative Arrangement, Accounting Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for collaborative arrangements."
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "zlab_CollaborativeArrangementRightsAndObligationsDevelopmentMilestonePayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "CollaborativeArrangementRightsAndObligationsDevelopmentMilestonePayment",
     "crdr": "credit",
     "presentation": [
      "http://zailab.com/role/LicenseandCollaborationAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Development milestone payment",
        "label": "Collaborative Arrangement, Rights and Obligations, Development Milestone Payment",
        "documentation": "Collaborative Arrangement, Rights and Obligations, Development Milestone Payment"
       }
      }
     },
     "auth_ref": []
    },
    "zlab_CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments",
     "crdr": "debit",
     "presentation": [
      "http://zailab.com/role/LicenseandCollaborationAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum additional milestone payments",
        "label": "Collaborative Arrangement, Rights and Obligations, Maximum Additional Milestone Payments",
        "documentation": "The amount represents the additional milestone payments."
       }
      }
     },
     "auth_ref": []
    },
    "zlab_CollaborativeArrangementRightsAndObligationsPaymentOfUpFrontFeesForLicenseAgreement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "CollaborativeArrangementRightsAndObligationsPaymentOfUpFrontFeesForLicenseAgreement",
     "crdr": "debit",
     "presentation": [
      "http://zailab.com/role/LicenseandCollaborationAgreementsDetails",
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Upfront payment",
        "label": "Collaborative Arrangement, Rights and Obligations, Payment Of Up front Fees For License Agreement",
        "documentation": "Payment of upfront fees for license agreement."
       }
      }
     },
     "auth_ref": []
    },
    "zlab_CollaborativeArrangementRightsAndObligationsSalesBasedMilestonePayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "CollaborativeArrangementRightsAndObligationsSalesBasedMilestonePayment",
     "crdr": "credit",
     "presentation": [
      "http://zailab.com/role/LicenseandCollaborationAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sales-based milestone payment",
        "label": "Collaborative Arrangement, Rights and Obligations, Sales-Based Milestone Payment",
        "documentation": "Collaborative Arrangement, Rights and Obligations, Sales-Based Milestone Payment"
       }
      }
     },
     "auth_ref": []
    },
    "zlab_CollaborativeArrangementRightsAndObligationsSpecifiedRoyaltyTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "CollaborativeArrangementRightsAndObligationsSpecifiedRoyaltyTerm",
     "presentation": [
      "http://zailab.com/role/LicenseandCollaborationAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Specified royalty term",
        "label": "Collaborative Arrangement, Rights and Obligations, Specified Royalty Term",
        "documentation": "Collaborative Arrangement, Rights and Obligations, Specified Royalty Term"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember",
     "presentation": [
      "http://zailab.com/role/LicenseandCollaborationAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement, Transaction with Party to Collaborative Arrangement",
        "label": "Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member]",
        "documentation": "Collaborative arrangement transaction between parties to collaborative arrangement."
       }
      }
     },
     "auth_ref": [
      "r986"
     ]
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "presentation": [
      "http://zailab.com/role/LicenseandCollaborationAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r461"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "presentation": [
      "http://zailab.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and contingencies (Note 20)",
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r85",
      "r543",
      "r612"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]",
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://zailab.com/role/CommitmentsandContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r128",
      "r327",
      "r328",
      "r683",
      "r881"
     ]
    },
    "zlab_CommonStockAuthorizedShareCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "CommonStockAuthorizedShareCapital",
     "crdr": "credit",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares, authorized share capital",
        "label": "Common Stock Authorized Share Capital",
        "documentation": "Common stock authorized share capital."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockMember",
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://zailab.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r742",
      "r743",
      "r744",
      "r746",
      "r747",
      "r748",
      "r749",
      "r864",
      "r865",
      "r987",
      "r1013",
      "r1015"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://zailab.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails",
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares, par value (in dollars per share)",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://zailab.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails",
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares, shares authorized (in shares)",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r94",
      "r613"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://zailab.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares, shares issued (in shares)",
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://zailab.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://zailab.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares, shares outstanding (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "periodEndLabel": "Ending balance (in shares)",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r94",
      "r613",
      "r633",
      "r1015",
      "r1016"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedBalanceSheets",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares (par value of $0.000006 per share; 5,000,000,000 shares authorized, 977,151,270 and 962,455,850 shares issued as of December\u00a031, 2023 and 2022, respectively; 972,239,070 and 960,219,570 shares issued and outstanding as of December\u00a031, 2023 and 2022, respectively)",
        "label": "Common Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r94",
      "r545",
      "r739"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure",
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r804"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Net Income",
        "label": "Compensation Actually Paid vs. Net Income [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r803"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Other Measure",
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r805"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return",
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r802"
     ]
    },
    "us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock",
     "presentation": [
      "http://zailab.com/role/EmployeeDefinedContributionPlans"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Employee Defined Contribution Plans",
        "label": "Compensation and Employee Benefit Plans, Other than Share-Based Compensation [Text Block]",
        "documentation": "The entire disclosure of an entity's employee compensation and benefit plans, excluding share-based compensation and including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, life insurance, severance, health care, unemployment and other benefit plans."
       }
      }
     },
     "auth_ref": [
      "r130",
      "r131",
      "r132"
     ]
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee defined contribution plan",
        "label": "Retirement Benefits [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CompensationRelatedCostsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CompensationRelatedCostsPolicyTextBlock",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-Based Compensation",
        "label": "Compensation Related Costs, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofComprehensiveLoss",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofOperationsandComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Comprehensive loss",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r203",
      "r205",
      "r211",
      "r538",
      "r555"
     ]
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Comprehensive Loss",
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for comprehensive income."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComputerSoftwareIntangibleAssetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComputerSoftwareIntangibleAssetMember",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Software",
        "label": "Computer Software, Intangible Asset [Member]",
        "documentation": "Collection of computer programs and related data that provide instructions to a computer, for example, but not limited to, application program, control module or operating system, that perform one or more particular functions or tasks."
       }
      }
     },
     "auth_ref": [
      "r700",
      "r878",
      "r879"
     ]
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskBenchmarkDomain",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesConcentrationofSuppliersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Benchmark [Domain]",
        "label": "Concentration Risk Benchmark [Domain]",
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r50",
      "r78",
      "r79",
      "r286",
      "r682"
     ]
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesConcentrationofSuppliersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Benchmark [Axis]",
        "label": "Concentration Risk Benchmark [Axis]",
        "documentation": "Information by benchmark of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r50",
      "r78",
      "r79",
      "r286",
      "r573",
      "r682"
     ]
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskByTypeAxis",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesConcentrationofSuppliersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Type [Axis]",
        "label": "Concentration Risk Type [Axis]",
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r50",
      "r78",
      "r79",
      "r286",
      "r682",
      "r840"
     ]
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration of Risks",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for credit risk."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r160"
     ]
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskLineItems",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesConcentrationofSuppliersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk [Line Items]",
        "label": "Concentration Risk [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r682"
     ]
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskPercentage1",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration risk percentage",
        "label": "Concentration Risk, Percentage",
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r50",
      "r78",
      "r79",
      "r286"
     ]
    },
    "us-gaap_ConcentrationRiskTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskTable",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesConcentrationofSuppliersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk [Table]",
        "label": "Concentration Risk [Table]",
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r48",
      "r50",
      "r51",
      "r78",
      "r139",
      "r682"
     ]
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskTypeDomain",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesConcentrationofSuppliersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Type [Domain]",
        "label": "Concentration Risk Type [Domain]",
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r50",
      "r78",
      "r79",
      "r286",
      "r682"
     ]
    },
    "srt_CondensedBalanceSheetStatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "CondensedBalanceSheetStatementTable",
     "presentation": [
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Condensed Balance Sheet Statement [Table]",
        "label": "Condensed Balance Sheet Statement [Table]",
        "documentation": "Disclosure of information about condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations."
       }
      }
     },
     "auth_ref": [
      "r169",
      "r226",
      "r836"
     ]
    },
    "srt_CondensedBalanceSheetStatementsCaptionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "CondensedBalanceSheetStatementsCaptionsLineItems",
     "presentation": [
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Condensed Balance Sheet Statements Captions [Line Items]",
        "label": "Condensed Balance Sheet Statements, Captions [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r170",
      "r226",
      "r836"
     ]
    },
    "srt_CondensedCashFlowStatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "CondensedCashFlowStatementTable",
     "presentation": [
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Condensed Cash Flow Statement [Table]",
        "label": "Condensed Cash Flow Statement [Table]",
        "documentation": "Disclosure of information about condensed cash flow statement, including, but not limited to, cash flow statements of consolidated entities and consolidation eliminations."
       }
      }
     },
     "auth_ref": [
      "r170",
      "r226",
      "r836"
     ]
    },
    "srt_CondensedCashFlowStatementsCaptionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "CondensedCashFlowStatementsCaptionsLineItems",
     "presentation": [
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Condensed Cash Flow Statements Captions [Line Items]",
        "label": "Condensed Cash Flow Statements, Captions [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r170",
      "r226",
      "r836"
     ]
    },
    "srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Condensed Financial Information Disclosure [Abstract]",
        "label": "Condensed Financial Information Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock",
     "presentation": [
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrant"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule I \u2014 Condensed Financial Information of Registrant",
        "label": "Condensed Financial Information of Parent Company Only Disclosure [Text Block]",
        "documentation": "The entire disclosure for condensed financial information, including the financial position, cash flows, and the results of operations of the registrant (parent company) as of the same dates or for the same periods for which audited consolidated financial statements are being presented. Alternatively, the details of this disclosure can be reported by the specific parent company taxonomy elements, indicating the appropriate date and period contexts in an instance document."
       }
      }
     },
     "auth_ref": [
      "r184",
      "r226",
      "r836"
     ]
    },
    "srt_CondensedIncomeStatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "CondensedIncomeStatementTable",
     "presentation": [
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofOperationsandComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Condensed Income Statement [Table]",
        "label": "Condensed Income Statement [Table]",
        "documentation": "Disclosure of information about condensed income statement including, but not limited to, income statements of consolidated entities and consolidation eliminations."
       }
      }
     },
     "auth_ref": [
      "r170",
      "r226",
      "r836"
     ]
    },
    "srt_CondensedIncomeStatementsCaptionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "CondensedIncomeStatementsCaptionsLineItems",
     "presentation": [
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofOperationsandComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Condensed Income Statements Captions [Line Items]",
        "label": "Condensed Income Statements, Captions [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r170",
      "r226",
      "r836"
     ]
    },
    "srt_CondensedStatementOfComprehensiveIncomeTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "CondensedStatementOfComprehensiveIncomeTableTextBlock",
     "presentation": [
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Condensed Statements of Operations and Comprehensive Loss",
        "label": "Condensed Statement of Comprehensive Income [Table Text Block]",
        "documentation": "Tabular disclosure of condensed statement of comprehensive income (loss) including, but not limited to, statements of comprehensive income (loss) of consolidated entities and consolidation eliminations."
       }
      }
     },
     "auth_ref": [
      "r844",
      "r863"
     ]
    },
    "srt_ConsolidatedEntitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ConsolidatedEntitiesAxis",
     "presentation": [
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofOperationsandComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidated Entities [Axis]",
        "label": "Consolidated Entities [Axis]",
        "documentation": "Information by consolidated entity or group of entities."
       }
      }
     },
     "auth_ref": [
      "r172",
      "r226",
      "r462",
      "r463",
      "r464",
      "r465",
      "r510",
      "r693",
      "r845",
      "r846",
      "r847",
      "r887",
      "r890",
      "r891"
     ]
    },
    "srt_ConsolidatedEntitiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ConsolidatedEntitiesDomain",
     "presentation": [
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofOperationsandComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidated Entities [Domain]",
        "label": "Consolidated Entities [Domain]",
        "documentation": "Entity or group of entities consolidated into reporting entity."
       }
      }
     },
     "auth_ref": [
      "r172",
      "r226",
      "r462",
      "r463",
      "r464",
      "r465",
      "r510",
      "r693",
      "r845",
      "r846",
      "r847",
      "r887",
      "r890",
      "r891"
     ]
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConsolidationPolicyTextBlock",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Principles of Consolidation",
        "label": "Consolidation, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r709"
     ]
    },
    "us-gaap_ConstructionInProgressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConstructionInProgressMember",
     "presentation": [
      "http://zailab.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Construction in progress",
        "label": "Construction in Progress [Member]",
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostOfRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostOfRevenue",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Cost of sales",
        "label": "Cost of Revenue",
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r108",
      "r222",
      "r312",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r476",
      "r888"
     ]
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostsAndExpensesAbstract",
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Expenses",
        "label": "Costs and Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_CounterpartyNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "CounterpartyNameAxis",
     "presentation": [
      "http://zailab.com/role/LicenseandCollaborationAgreementsDetails",
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name [Axis]",
        "label": "Counterparty Name [Axis]",
        "documentation": "Information by name of counterparty. A counterparty is the other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution."
       }
      }
     },
     "auth_ref": [
      "r182",
      "r224",
      "r225",
      "r348",
      "r363",
      "r508",
      "r706",
      "r708"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover [Abstract]",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CreditFacilityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CreditFacilityAxis",
     "presentation": [
      "http://zailab.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Facility [Axis]",
        "label": "Credit Facility [Axis]",
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CreditFacilityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CreditFacilityDomain",
     "presentation": [
      "http://zailab.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Facility [Domain]",
        "label": "Credit Facility [Domain]",
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": []
    },
    "srt_CurrencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "CurrencyAxis",
     "presentation": [
      "http://zailab.com/role/CashandCashEquivalentsDetails",
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Currency [Axis]",
        "label": "Currency [Axis]",
        "documentation": "Information by currency."
       }
      }
     },
     "auth_ref": [
      "r992"
     ]
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://zailab.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CustomerConcentrationRiskMember",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer Concentration Risk",
        "label": "Customer Concentration Risk [Member]",
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r286"
     ]
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://zailab.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Axis]",
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r91",
      "r92",
      "r143",
      "r145",
      "r226",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r489",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r860"
     ]
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "presentation": [
      "http://zailab.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loan amount",
        "label": "Debt Instrument, Face Amount",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r82",
      "r345",
      "r489",
      "r719",
      "r720"
     ]
    },
    "us-gaap_DebtInstrumentFeeAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentFeeAmount",
     "crdr": "debit",
     "presentation": [
      "http://zailab.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument fee",
        "label": "Debt Instrument, Fee Amount",
        "documentation": "Amount of the fee that accompanies borrowing money under the debt instrument."
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "presentation": [
      "http://zailab.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest rate",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r346"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://zailab.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Name [Domain]",
        "label": "Debt Instrument, Name [Domain]",
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r226",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r489",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r860"
     ]
    },
    "us-gaap_DebtInstrumentTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentTerm",
     "presentation": [
      "http://zailab.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument term",
        "label": "Debt Instrument, Term",
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "zlab_DebtInstrumentVariableInterestRateAdjustmentPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "DebtInstrumentVariableInterestRateAdjustmentPeriod",
     "presentation": [
      "http://zailab.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Floating interest rate adjustment period",
        "label": "Debt Instrument, Variable Interest Rate, Adjustment, Period",
        "documentation": "Debt Instrument, Variable Interest Rate, Adjustment, Period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossExcludingAccruedInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtSecuritiesHeldToMaturityAllowanceForCreditLossExcludingAccruedInterest",
     "crdr": "credit",
     "presentation": [
      "http://zailab.com/role/ShortTermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Allowance for credit loss",
        "label": "Debt Securities, Held-to-Maturity, Allowance for Credit Loss, Excluding Accrued Interest",
        "documentation": "Amount, excluding accrued interest, of allowance for credit loss on investment in debt security measured at amortized cost (held-to-maturity)."
       }
      }
     },
     "auth_ref": [
      "r877"
     ]
    },
    "zlab_DecipheraPharmaceuticalsLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "DecipheraPharmaceuticalsLLCMember",
     "presentation": [
      "http://zailab.com/role/LicenseandCollaborationAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deciphera",
        "label": "Deciphera Pharmaceuticals L L C [Member]",
        "documentation": "Deciphera Pharmaceuticals L L C [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredIncomeNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedBalanceSheets",
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred income",
        "label": "Deferred Income, Noncurrent",
        "documentation": "Amount of deferred income excluding obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r837"
     ]
    },
    "zlab_DeferredIncomePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "DeferredIncomePolicyTextBlock",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred Income",
        "label": "Deferred Income [Policy Text Block]",
        "documentation": "Deferred income."
       }
      }
     },
     "auth_ref": []
    },
    "zlab_DeferredTaxAssetsDeferredRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "DeferredTaxAssetsDeferredRevenue",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/IncomeTaxComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://zailab.com/role/IncomeTaxComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred revenue",
        "label": "Deferred Tax Assets Deferred Revenue",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred revenue."
       }
      }
     },
     "auth_ref": []
    },
    "zlab_DeferredTaxAssetsGovernmentGrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "DeferredTaxAssetsGovernmentGrants",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/IncomeTaxComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://zailab.com/role/IncomeTaxComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Government grants",
        "label": "Deferred Tax Assets Government Grants",
        "documentation": "Deferred tax assets government grants."
       }
      }
     },
     "auth_ref": []
    },
    "zlab_DeferredTaxAssetsLeasingArrangements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "DeferredTaxAssetsLeasingArrangements",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/IncomeTaxComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://zailab.com/role/IncomeTaxComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease liability",
        "label": "Deferred Tax Assets, Leasing Arrangements",
        "documentation": "Deferred Tax Assets, Leasing Arrangements"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/IncomeTaxComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://zailab.com/role/IncomeTaxComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Deferred tax assets, net",
        "label": "Deferred Tax Assets, Net",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r983"
     ]
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/IncomeTaxComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://zailab.com/role/IncomeTaxComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Deferred tax assets",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r983"
     ]
    },
    "us-gaap_DeferredTaxAssetsNetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsNetAbstract",
     "presentation": [
      "http://zailab.com/role/IncomeTaxComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax assets:",
        "label": "Deferred Tax Assets, Net [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/IncomeTaxComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://zailab.com/role/IncomeTaxComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net operating loss carry forwards",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r984"
     ]
    },
    "us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsPropertyPlantAndEquipment",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/IncomeTaxComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://zailab.com/role/IncomeTaxComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation of property and equipment, net",
        "label": "Deferred Tax Assets, Property, Plant and Equipment",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment."
       }
      }
     },
     "auth_ref": []
    },
    "zlab_DeferredTaxAssetsPublicWelfareDonations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "DeferredTaxAssetsPublicWelfareDonations",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/IncomeTaxComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://zailab.com/role/IncomeTaxComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Qualified donation",
        "label": "Deferred Tax Assets Public Welfare Donations",
        "documentation": "Deferred tax assets public welfare donations."
       }
      }
     },
     "auth_ref": []
    },
    "zlab_DeferredTaxAssetsResearchAndExperimentalCapitalization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "DeferredTaxAssetsResearchAndExperimentalCapitalization",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/IncomeTaxComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://zailab.com/role/IncomeTaxComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and experimental capitalization",
        "label": "Deferred Tax Assets, Research And Experimental Capitalization",
        "documentation": "Deferred Tax Assets, Research And Experimental Capitalization"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/IncomeTaxComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://zailab.com/role/IncomeTaxComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r984"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/IncomeTaxComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://zailab.com/role/IncomeTaxComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r984"
     ]
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/IncomeTaxComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://zailab.com/role/IncomeTaxComponentsofDeferredTaxAssetsandLiabilitiesDetails",
      "http://zailab.com/role/IncomeTaxMovementofValuationAllowanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: valuation allowance",
        "negatedPeriodStartLabel": "Balance as of January 1,",
        "negatedPeriodEndLabel": "Balance as of December 31,",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r449"
     ]
    },
    "zlab_DeferredTaxAssetsValuationAllowanceRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "DeferredTaxAssetsValuationAllowanceRollForward",
     "presentation": [
      "http://zailab.com/role/IncomeTaxMovementofValuationAllowanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred Tax Assets, Valuation Allowance [Roll Forward]",
        "label": "Deferred Tax Assets, Valuation Allowance [Roll Forward]",
        "documentation": "Deferred Tax Assets, Valuation Allowance"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilitiesAbstract",
     "presentation": [
      "http://zailab.com/role/IncomeTaxComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax liabilities:",
        "label": "Deferred Tax Liabilities, Gross [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxLiabilitiesLeasingArrangements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilitiesLeasingArrangements",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/IncomeTaxComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://zailab.com/role/IncomeTaxComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Right-of-use assets",
        "label": "Deferred Tax Liabilities, Leasing Arrangements",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r984"
     ]
    },
    "us-gaap_DefinedContributionPlanCostRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedContributionPlanCostRecognized",
     "crdr": "debit",
     "presentation": [
      "http://zailab.com/role/EmployeeDefinedContributionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined contribution plan expense",
        "label": "Defined Contribution Plan, Cost",
        "documentation": "Amount of cost for defined contribution plan."
       }
      }
     },
     "auth_ref": [
      "r387"
     ]
    },
    "us-gaap_DefinedContributionPlanDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedContributionPlanDisclosureLineItems",
     "presentation": [
      "http://zailab.com/role/EmployeeDefinedContributionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined Contribution Plan Disclosure [Line Items]",
        "label": "Defined Contribution Plan Disclosure [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r387"
     ]
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercent",
     "presentation": [
      "http://zailab.com/role/EmployeeDefinedContributionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of employees eligible compensation the employer matches",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay",
        "documentation": "Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan."
       }
      }
     },
     "auth_ref": []
    },
    "zlab_DefinedContributionPlanEmployerMatchingContributionPercentOfEmployeeContribution": {
     "xbrltype": "percentItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfEmployeeContribution",
     "presentation": [
      "http://zailab.com/role/EmployeeDefinedContributionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of employee contribution that the employer matches",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent Of Employee Contribution",
        "documentation": "Defined Contribution Plan, Employer Matching Contribution, Percent Of Employee Contribution"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatch",
     "presentation": [
      "http://zailab.com/role/EmployeeDefinedContributionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employer matching contribution percentage",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Match",
        "documentation": "Percentage employer matches of the employee's percentage contribution matched."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedContributionPlanTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedContributionPlanTable",
     "presentation": [
      "http://zailab.com/role/EmployeeDefinedContributionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined Contribution Plan [Table]",
        "label": "Defined Contribution Plan [Table]",
        "documentation": "Disclosure of information about defined contribution pension plans or defined contribution other postretirement plans, separately for pension plans and other postretirement benefit plans."
       }
      }
     },
     "auth_ref": [
      "r387"
     ]
    },
    "us-gaap_DepositsAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DepositsAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term deposits",
        "label": "Deposits Assets, Noncurrent",
        "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r849"
     ]
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Depreciation",
     "crdr": "debit",
     "presentation": [
      "http://zailab.com/role/PropertyandEquipmentNetAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Depreciation expenses",
        "label": "Depreciation",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r61"
     ]
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DepreciationDepletionAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation and amortization expenses",
        "label": "Depreciation, Depletion and Amortization",
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r266"
     ]
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisaggregationOfRevenueLineItems",
     "presentation": [
      "http://zailab.com/role/RevenueDisaggregationofNetRevenuebyProductDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disaggregation of Revenue",
        "label": "Disaggregation of Revenue [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r377",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisaggregationOfRevenueTable",
     "presentation": [
      "http://zailab.com/role/RevenueDisaggregationofNetRevenuebyProductDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disaggregation of Revenue [Table]",
        "label": "Disaggregation of Revenue [Table]",
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r377",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "presentation": [
      "http://zailab.com/role/RevenueTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Disaggregation of Net Revenue",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r893"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-Based Compensation",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r397",
      "r401",
      "r429",
      "r430",
      "r432",
      "r735"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement [Abstract]",
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://zailab.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Annual Report",
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r758",
      "r759",
      "r772"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://zailab.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Financial Statement Error Correction [Flag]",
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r758",
      "r759",
      "r772",
      "r808"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://zailab.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Period Focus",
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://zailab.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Year Focus",
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://zailab.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Information [Line Items]",
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://zailab.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Information [Table]",
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://zailab.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://zailab.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Transition Report",
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r793"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://zailab.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://zailab.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Documents Incorporated by Reference",
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r755"
     ]
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Earnings Per Share [Abstract]",
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofOperations",
      "http://zailab.com/role/LossPerShareComputationofBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss per share \u2014 basic (in dollars per share)",
        "verboseLabel": "Net loss per share \u2014 basic (in dollars per share)",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r212",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r241",
      "r244",
      "r252",
      "r253",
      "r254",
      "r258",
      "r473",
      "r474",
      "r539",
      "r556",
      "r713"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofOperations",
      "http://zailab.com/role/LossPerShareComputationofBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss per share \u2014 diluted (in dollars per share)",
        "verboseLabel": "Net loss per share \u2014 diluted (in dollars per share)",
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r212",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r244",
      "r252",
      "r253",
      "r254",
      "r258",
      "r473",
      "r474",
      "r539",
      "r556",
      "r713"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss Per Share",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r46"
     ]
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://zailab.com/role/LossPerShare"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss Per Share",
        "label": "Earnings Per Share [Text Block]",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r240",
      "r255",
      "r256",
      "r257"
     ]
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r991"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "calculation": {
      "http://zailab.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRateDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://zailab.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Effective income tax rate",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r443"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "calculation": {
      "http://zailab.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://zailab.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statutory income tax rate",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)."
       }
      }
     },
     "auth_ref": [
      "r223",
      "r443",
      "r457"
     ]
    },
    "zlab_EffectiveIncomeTaxRateReconciliationAtPreferentialTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "EffectiveIncomeTaxRateReconciliationAtPreferentialTaxRate",
     "calculation": {
      "http://zailab.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://zailab.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferential tax rate",
        "label": "Effective Income Tax Rate Reconciliation At Preferential Tax Rate",
        "documentation": "Effective income tax rate reconciliation at preferential tax rate."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "calculation": {
      "http://zailab.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://zailab.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in valuation allowance",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r982",
      "r985"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
     "calculation": {
      "http://zailab.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://zailab.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of different tax rate of subsidiary operation in other jurisdictions",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile."
       }
      }
     },
     "auth_ref": [
      "r982",
      "r985"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpense",
     "calculation": {
      "http://zailab.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://zailab.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-deductible expenses",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses."
       }
      }
     },
     "auth_ref": [
      "r982",
      "r985"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCharitableContributions": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCharitableContributions",
     "calculation": {
      "http://zailab.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://zailab.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expiration of deductible qualified donation",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Charitable Contributions, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to charitable contributions expense."
       }
      }
     },
     "auth_ref": [
      "r982",
      "r985"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "calculation": {
      "http://zailab.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://zailab.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent",
        "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r982",
      "r985"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes",
     "calculation": {
      "http://zailab.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://zailab.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prior year tax filing adjustment",
        "label": "Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense."
       }
      }
     },
     "auth_ref": [
      "r982",
      "r985"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsResearch",
     "calculation": {
      "http://zailab.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://zailab.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Research and development super deduction",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit."
       }
      }
     },
     "auth_ref": [
      "r982",
      "r985"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationTaxExemptIncome",
     "calculation": {
      "http://zailab.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://zailab.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Tax-exempted income",
        "label": "Effective Income Tax Rate Reconciliation, Tax Exempt Income, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income (loss) exempt from income taxes."
       }
      }
     },
     "auth_ref": [
      "r982",
      "r985"
     ]
    },
    "zlab_ElectronicEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "ElectronicEquipmentMember",
     "presentation": [
      "http://zailab.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails",
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Electronic equipment",
        "label": "Electronic Equipment [Member]",
        "documentation": "Electronic equipment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/OtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://zailab.com/role/OtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued payroll",
        "label": "Employee-related Liabilities, Current",
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recognized over a weighted-average period",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r431"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "crdr": "debit",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized share-based compensation",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r981"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "crdr": "debit",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized compensation expense related to unvested share options granted",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r981"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://zailab.com/role/LossPerShareAntiDilutiveSharesExcludedfromCalculationofDilutedLossPerShareDetails",
      "http://zailab.com/role/ShareBasedCompensationAdditionalInformationDetails",
      "http://zailab.com/role/ShareBasedCompensationAssumptionsUsedtoEstimateFairValuesofShareOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share options",
        "label": "Employee Stock Option [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://zailab.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://zailab.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line Two",
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://zailab.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://zailab.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Country",
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://zailab.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://zailab.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r754"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://zailab.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Common Stock, Shares Outstanding",
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://zailab.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Current Reporting Status",
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityDomain",
     "presentation": [
      "http://zailab.com/role/IncomeTaxAdditionalInformationDetails",
      "http://zailab.com/role/LongTermInvestmentsDetails",
      "http://zailab.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity [Domain]",
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://zailab.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r754"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://zailab.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://zailab.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r754"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://zailab.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://zailab.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Interactive Data Current",
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r833"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://zailab.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Public Float",
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://zailab.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r754"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://zailab.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Shell Company",
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r754"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://zailab.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Small Business",
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r754"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://zailab.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r754"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://zailab.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Voluntary Filers",
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://zailab.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Well-known Seasoned Issuer",
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r834"
     ]
    },
    "zlab_EquityAndCostMethodInvestmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "EquityAndCostMethodInvestmentTable",
     "presentation": [
      "http://zailab.com/role/LongTermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity And Cost Method Investment [Table]",
        "label": "Equity And Cost Method Investment [Table]",
        "documentation": "Equity and cost method investment."
       }
      }
     },
     "auth_ref": []
    },
    "zlab_EquityAndCostMethodInvestmentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "EquityAndCostMethodInvestmentsLineItems",
     "presentation": [
      "http://zailab.com/role/LongTermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity And Cost Method Investments",
        "label": "Equity And Cost Method Investments [Line Items]",
        "documentation": "Equity and cost method investments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Component [Domain]",
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r183",
      "r207",
      "r208",
      "r209",
      "r227",
      "r228",
      "r229",
      "r231",
      "r237",
      "r239",
      "r259",
      "r313",
      "r314",
      "r367",
      "r433",
      "r434",
      "r435",
      "r453",
      "r454",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r502",
      "r567",
      "r568",
      "r569",
      "r587",
      "r660"
     ]
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "EquityMethodInvesteeNameDomain",
     "presentation": [
      "http://zailab.com/role/LongTermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment, Name [Domain]",
        "label": "Investment, Name [Domain]",
        "documentation": "Name of investment including named security. Excludes entity that is consolidated."
       }
      }
     },
     "auth_ref": [
      "r309",
      "r310",
      "r311"
     ]
    },
    "us-gaap_EquitySecuritiesFvNiGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquitySecuritiesFvNiGainLoss",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/OtherIncomeExpensesNetDetails": {
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 2.0
      },
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 5.0
      },
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows",
      "http://zailab.com/role/LongTermInvestmentsDetails",
      "http://zailab.com/role/OtherIncomeExpensesNetDetails",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "(Gain) loss from fair value changes of equity investment with readily determinable fair value",
        "netLabel": "Gains (losses) on equity investments with readily determinable fair value",
        "terseLabel": "Gain (Loss) on equity investments with readily determinable fair value",
        "negatedLabel": "Loss from fair value changes of equity investment of readily determinable fair value",
        "label": "Equity Securities, FV-NI, Gain (Loss)",
        "documentation": "Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI)."
       }
      }
     },
     "auth_ref": [
      "r557",
      "r875"
     ]
    },
    "zlab_EquitySecuritiesWithReadilyDeterminableFairValueAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "EquitySecuritiesWithReadilyDeterminableFairValueAmount",
     "crdr": "debit",
     "presentation": [
      "http://zailab.com/role/LongTermInvestmentsDetails",
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity investments with readily determinable fair value",
        "label": "Equity Securities With Readily Determinable Fair Value Amount",
        "documentation": "Equity securities with readily determinable fair value amount."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Valuation Assumption Difference, Footnote",
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r801"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneous Compensation Analysis",
        "label": "Erroneous Compensation Analysis [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r764",
      "r776",
      "r786",
      "r812"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneously Awarded Compensation Recovery",
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r761",
      "r773",
      "r783",
      "r809"
     ]
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Executive Category:",
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r807"
     ]
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "presentation": [
      "http://zailab.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset Class [Domain]",
        "label": "Asset Class [Domain]",
        "documentation": "Class of asset."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByAssetClassAxis",
     "presentation": [
      "http://zailab.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset Class [Axis]",
        "label": "Asset Class [Axis]",
        "documentation": "Information by class of asset."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r77"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://zailab.com/role/LongTermInvestmentsDetails",
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r353",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r475",
      "r514",
      "r515",
      "r516",
      "r719",
      "r720",
      "r731",
      "r732",
      "r733"
     ]
    },
    "us-gaap_FairValueConcentrationOfRiskTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueConcentrationOfRiskTextBlock",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Concentration of Suppliers",
        "label": "Fair Value, Concentration of Risk [Table Text Block]",
        "documentation": "Tabular disclosure of all significant concentrations of risk, including credit risk and market risk, arising from all financial instruments (as defined), whether from an individual counterparty or groups of counterparties. The disclosure concerning concentrations of risk may consist of the following information: (1) for concentrations of credit risk disclosure may include: (a) information about the (shared) activity, region, or economic characteristic that identifies the concentration, (b) the maximum amount of loss due to credit risk that, based on the gross fair value of the financial instrument, the entity would incur if parties to the financial instruments that make up the concentration failed completely to perform according to the terms of the contracts and the collateral or other security, if any, for the amount due proved to be of no value to the entity, (c) the policy of requiring collateral or other security to support financial instruments subject to credit risk, information about the entity's access to that collateral or other security, and the nature and a brief description of the collateral or other security supporting those financial instruments, and (d) the policy of entering into master netting arrangements to mitigate the credit risk of financial instruments, information about the arrangements for which the entity is a party, and a brief description of the terms of those arrangements, including the extent to which they would reduce the entity's maximum amount of loss due to credit risk and (2) for disclosure of quantitative information about the market risks of financial instruments that is consistent with the way the company manages or adjusts those risks, disclosure may include: (a) more details about current positions and perhaps activity during the period, (b) the hypothetical effects on comprehensive income (or net assets), or annual income, of several possible changes in market prices, (c) a gap analysis of interest rate re-pricing or maturity dates, (d) the duration of the financial instruments, (e) the entity's value at risk from derivatives and from other positions at the end of the reporting period and the average value at risk during the year, or (f) other ways of reporting quantitative information as internally developed."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r80",
      "r139",
      "r140"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://zailab.com/role/LongTermInvestmentsDetails",
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 1",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r353",
      "r380",
      "r385",
      "r475",
      "r514",
      "r731",
      "r732",
      "r733"
     ]
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurements",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://zailab.com/role/LongTermInvestmentsDetails",
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r353",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r514",
      "r515",
      "r516",
      "r719",
      "r720",
      "r731",
      "r732",
      "r733"
     ]
    },
    "us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestCurrent",
     "crdr": "credit",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Allowance for credit loss",
        "label": "Financing Receivable, Allowance for Credit Loss, Excluding Accrued Interest, Current",
        "documentation": "Amount excluding accrued interest, of allowance for credit loss on financing receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r877"
     ]
    },
    "us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLossCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLossCurrent",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Notes receivable",
        "label": "Financing Receivable, Excluding Accrued Interest, after Allowance for Credit Loss, Current",
        "documentation": "Amortized cost excluding accrued interest, after allowance for credit loss, of financing receivable classified as current. Excludes net investment in lease."
       }
      }
     },
     "auth_ref": [
      "r877"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets useful life",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "crdr": "debit",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-lived intangible assets, Amortization expense, after year five",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "crdr": "debit",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-lived intangible assets, Amortization expense, year one",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "crdr": "debit",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-lived intangible assets, Amortization expense, year five",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "crdr": "debit",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-lived intangible assets, Amortization expense, year four",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "crdr": "debit",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-lived intangible assets, Amortization expense, year three",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "crdr": "debit",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-lived intangible assets, Amortization expense, year two",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "documentation": "Information by major type or class of finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r321",
      "r322",
      "r323",
      "r324",
      "r524",
      "r525"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r59"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsNet",
     "crdr": "debit",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets, net",
        "label": "Finite-Lived Intangible Assets, Net",
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r122",
      "r524"
     ]
    },
    "zlab_ForeignCurrencyRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "ForeignCurrencyRiskMember",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign Currency Risk",
        "label": "Foreign Currency Risk [Member]",
        "documentation": "foreign currency risk."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency (loss) gain",
        "label": "Gain (Loss), Foreign Currency Transaction, before Tax",
        "documentation": "Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction."
       }
      }
     },
     "auth_ref": [
      "r478",
      "r479",
      "r480",
      "r481",
      "r657"
     ]
    },
    "us-gaap_ForeignCurrencyTransactionGainLossUnrealized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForeignCurrencyTransactionGainLossUnrealized",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Foreign currency remeasurement loss (gain)",
        "label": "Unrealized Gain (Loss), Foreign Currency Transaction, before Tax",
        "documentation": "Amount, before tax, of unrealized gain (loss) from foreign currency transaction."
       }
      }
     },
     "auth_ref": [
      "r118",
      "r635",
      "r750",
      "r989",
      "r990",
      "r1014"
     ]
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign Currency Translation",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy."
       }
      }
     },
     "auth_ref": [
      "r477"
     ]
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r768",
      "r780",
      "r790",
      "r816"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount",
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r768",
      "r780",
      "r790",
      "r816"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r768",
      "r780",
      "r790",
      "r816"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery, Explanation of Impracticability",
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r768",
      "r780",
      "r790",
      "r816"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r768",
      "r780",
      "r790",
      "r816"
     ]
    },
    "zlab_GainLossOnDisposalOfLandUseRights": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "GainLossOnDisposalOfLandUseRights",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Gain on disposal of land use right",
        "label": "Gain (Loss) On Disposal Of Land Use Rights",
        "documentation": "Gain (Loss) On Disposal Of Land Use Rights"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainLossOnDispositionOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GainLossOnDispositionOfIntangibleAssets",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 5.0
      },
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows",
      "http://zailab.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gain on sale of intellectual property",
        "negatedTerseLabel": "Gain from sale of intellectual property",
        "label": "Gain (Loss) on Disposition of Intangible Assets",
        "documentation": "Amount of gain (loss) on sale or disposal of intangible assets."
       }
      }
     },
     "auth_ref": [
      "r857"
     ]
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Loss on disposal of property and equipment",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofOperationsandComprehensiveLossDetails": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofOperationsandComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "General and administrative",
        "label": "General and Administrative Expense",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r109",
      "r639"
     ]
    },
    "zlab_GlaxoSmithKlineMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "GlaxoSmithKlineMember",
     "presentation": [
      "http://zailab.com/role/LicenseandCollaborationAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "GSK",
        "label": "GlaxoSmithKline [Member]",
        "documentation": "GSK [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "zlab_GovernmentAssistanceNonoperatingIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "GovernmentAssistanceNonoperatingIncome",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/OtherIncomeExpensesNetDetails": {
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://zailab.com/role/OtherIncomeExpensesNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Government grants recognized",
        "label": "Government Assistance, Nonoperating Income",
        "documentation": "Government Assistance, Nonoperating Income"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GrantMember",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Government Grants",
        "label": "Grant [Member]",
        "documentation": "Award of money not required to be repaid."
       }
      }
     },
     "auth_ref": [
      "r894"
     ]
    },
    "us-gaap_GuaranteeObligationsMaximumExposure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GuaranteeObligationsMaximumExposure",
     "crdr": "credit",
     "presentation": [
      "http://zailab.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum guarantor obligation",
        "label": "Guarantor Obligations, Maximum Exposure, Undiscounted",
        "documentation": "Maximum potential amount of future payments (undiscounted) the guarantor could be required to make under the guarantee or each group of similar guarantees before reduction for potential recoveries under recourse or collateralization provisions."
       }
      }
     },
     "auth_ref": [
      "r335"
     ]
    },
    "zlab_GuarantorObligationTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "GuarantorObligationTerm",
     "presentation": [
      "http://zailab.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Guarantor obligation term",
        "label": "Guarantor Obligation, Term",
        "documentation": "Guarantor Obligation, Term"
       }
      }
     },
     "auth_ref": []
    },
    "zlab_GurnetPointCapitalAndNovoHoldingsASMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "GurnetPointCapitalAndNovoHoldingsASMember",
     "presentation": [
      "http://zailab.com/role/LicenseandCollaborationAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Novo Holdings",
        "label": "Gurnet Point Capital And Novo Holdings A/S [Member]",
        "documentation": "Gurnet Point Capital And Novo Holdings A/S"
       }
      }
     },
     "auth_ref": []
    },
    "country_HK": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "HK",
     "presentation": [
      "http://zailab.com/role/IncomeTaxAdditionalInformationDetails",
      "http://zailab.com/role/IncomeTaxLossIncomeBeforeIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hong Kong",
        "label": "HONG KONG"
       }
      }
     },
     "auth_ref": []
    },
    "currency_HKD": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/currency/2023",
     "localname": "HKD",
     "presentation": [
      "http://zailab.com/role/CashandCashEquivalentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hong Kong dollar (\u201cHK$\u201d)",
        "label": "Hong Kong, Dollars"
       }
      }
     },
     "auth_ref": []
    },
    "zlab_HuizhengMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "HuizhengMember",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Huizheng",
        "label": "Huizheng [Member]",
        "documentation": "Huizheng"
       }
      }
     },
     "auth_ref": []
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://zailab.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ICFR Auditor Attestation Flag",
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r758",
      "r759",
      "r772"
     ]
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment of Long-Lived Assets",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r127"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "presentation": [
      "http://zailab.com/role/IncomeTaxAdditionalInformationDetails",
      "http://zailab.com/role/IncomeTaxLossIncomeBeforeIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Taxable income",
        "negatedTerseLabel": "Loss (income) before income taxes",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r104",
      "r150",
      "r262",
      "r276",
      "r280",
      "r282",
      "r540",
      "r553",
      "r715"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      },
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofOperationsandComprehensiveLossDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofOperations",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofOperationsandComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss before income tax and share of loss from equity method investment",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments."
       }
      }
     },
     "auth_ref": [
      "r262",
      "r276",
      "r280",
      "r282",
      "r558",
      "r715"
     ]
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromEquityMethodInvestments",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 3.0
      },
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows",
      "http://zailab.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share of loss from equity method investment",
        "negatedLabel": "Share of loss from equity method investment",
        "label": "Income (Loss) from Equity Method Investments",
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss)."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r105",
      "r149",
      "r267",
      "r308",
      "r552"
     ]
    },
    "zlab_IncomeLossFromEquityMethodInvestmentsNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "IncomeLossFromEquityMethodInvestmentsNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofOperationsandComprehensiveLossDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 2.0
      },
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofOperationsandComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Equity in loss of subsidiaries",
        "negatedLabel": "Equity in loss of subsidiaries",
        "label": "Income Loss From Equity Method Investments Net Of Tax",
        "documentation": "Income (loss) from equity method investments, net of tax."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidated statements of operations",
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location",
        "label": "Income Statement Location [Axis]",
        "documentation": "Information by location in the income statement."
       }
      }
     },
     "auth_ref": [
      "r325",
      "r326",
      "r644"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location",
        "label": "Income Statement Location [Domain]",
        "documentation": "Location in the income statement."
       }
      }
     },
     "auth_ref": [
      "r326",
      "r644"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Disclosure [Abstract]",
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "zlab_IncomeTaxDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "IncomeTaxDisclosureLineItems",
     "presentation": [
      "http://zailab.com/role/IncomeTaxAdditionalInformationDetails",
      "http://zailab.com/role/IncomeTaxLossIncomeBeforeIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Disclosure [Line Items]",
        "label": "Income Tax Disclosure [Line Items]",
        "documentation": "Income tax disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "zlab_IncomeTaxDisclosureTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "IncomeTaxDisclosureTable",
     "presentation": [
      "http://zailab.com/role/IncomeTaxAdditionalInformationDetails",
      "http://zailab.com/role/IncomeTaxLossIncomeBeforeIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Disclosure [Table]",
        "label": "Income Tax Disclosure [Table]",
        "documentation": "Income tax disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://zailab.com/role/IncomeTax"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax",
        "label": "Income Tax Disclosure [Text Block]",
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information."
       }
      }
     },
     "auth_ref": [
      "r223",
      "r439",
      "r444",
      "r446",
      "r451",
      "r455",
      "r458",
      "r459",
      "r460",
      "r583"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      },
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofOperationsandComprehensiveLossDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofOperations",
      "http://zailab.com/role/IncomeTaxAdditionalInformationDetails",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofOperationsandComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income tax expense",
        "verboseLabel": "Provision for income taxes",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r152",
      "r166",
      "r238",
      "r239",
      "r268",
      "r442",
      "r456",
      "r559"
     ]
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r206",
      "r440",
      "r441",
      "r446",
      "r447",
      "r450",
      "r452",
      "r577"
     ]
    },
    "zlab_IncomeTaxesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "IncomeTaxesLineItems",
     "presentation": [
      "http://zailab.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes [Line Items]",
        "label": "Income Taxes [Line Items]",
        "documentation": "Income taxes."
       }
      }
     },
     "auth_ref": []
    },
    "zlab_IncomeTaxesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "IncomeTaxesTable",
     "presentation": [
      "http://zailab.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes [Table]",
        "label": "Income Taxes [Table]",
        "documentation": "Income taxes."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsPayable",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 22.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Increase (Decrease) in Accounts Payable",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accounts receivable",
        "label": "Increase (Decrease) in Accounts Receivable",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 25.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred income",
        "label": "Increase (Decrease) in Deferred Revenue",
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r696"
     ]
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInInventories",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 18.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Inventories",
        "label": "Increase (Decrease) in Inventories",
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "zlab_IncreaseDecreaseInLongTermDeposits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "IncreaseDecreaseInLongTermDeposits",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Long-term deposits",
        "label": "Increase Decrease In Long Term Deposits",
        "documentation": "Increase decrease in long term deposits."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInNotesReceivableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInNotesReceivableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Notes receivable",
        "label": "Increase (Decrease) in Notes Receivable, Current",
        "documentation": "The increase (decrease) during the reporting period of amounts due within one year (or one business cycle) from note holders for outstanding loans."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in operating assets and liabilities:",
        "label": "Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "zlab_IncreaseDecreaseInOperatingLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "IncreaseDecreaseInOperatingLeaseLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 24.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities",
        "label": "Increase Decrease In Operating Lease Liabilities",
        "documentation": "Increase (decrease) in operating lease liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOtherCurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOtherCurrentLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 7.0
      },
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 23.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other current liabilities",
        "label": "Increase (Decrease) in Other Current Liabilities",
        "documentation": "Amount of increase (decrease) in current liabilities classified as other."
       }
      }
     },
     "auth_ref": [
      "r856"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 26.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other non-current Liabilities",
        "label": "Increase (Decrease) in Other Noncurrent Liabilities",
        "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 6.0
      },
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 19.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepayments and other current assets",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "zlab_IncreaseDecreaseInValueAddedTaxesReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "IncreaseDecreaseInValueAddedTaxesReceivable",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 21.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Value added tax recoverable",
        "label": "Increase Decrease In Value Added Taxes Receivable",
        "documentation": "Increase decrease in value added taxes receivable."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Individual:",
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r771",
      "r780",
      "r790",
      "r807",
      "r816",
      "r820",
      "r828"
     ]
    },
    "zlab_InnovivaInc.Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "InnovivaInc.Member",
     "presentation": [
      "http://zailab.com/role/LicenseandCollaborationAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Innoviva",
        "label": "Innoviva, Inc. [Member]",
        "documentation": "Innoviva, Inc."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r826"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r760",
      "r832"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Adopted",
        "label": "Insider Trading Policies and Procedures Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r760",
      "r832"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted",
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r760",
      "r832"
     ]
    },
    "us-gaap_IntangibleAssetsFiniteLivedPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IntangibleAssetsFiniteLivedPolicy",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible Assets",
        "label": "Intangible Assets, Finite-Lived, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r520",
      "r521",
      "r522",
      "r524",
      "r710"
     ]
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets, net",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r58"
     ]
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventories",
        "label": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryDisclosureTextBlock",
     "presentation": [
      "http://zailab.com/role/InventoriesNet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventories, Net",
        "label": "Inventory Disclosure [Text Block]",
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory."
       }
      }
     },
     "auth_ref": [
      "r317"
     ]
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/InventoriesNetScheduleofInventoryDetails": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://zailab.com/role/InventoriesNetScheduleofInventoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finished goods",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale."
       }
      }
     },
     "auth_ref": [
      "r121",
      "r703"
     ]
    },
    "us-gaap_InventoryNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryNet",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      },
      "http://zailab.com/role/InventoriesNetScheduleofInventoryDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedBalanceSheets",
      "http://zailab.com/role/InventoriesNetScheduleofInventoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventories, net",
        "totalLabel": "Inventories, net",
        "label": "Inventory, Net",
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r200",
      "r702",
      "r739"
     ]
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryPolicyTextBlock",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventories",
        "label": "Inventory, Policy [Policy Text Block]",
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost."
       }
      }
     },
     "auth_ref": [
      "r156",
      "r188",
      "r199",
      "r317",
      "r318",
      "r320",
      "r519",
      "r711"
     ]
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryRawMaterialsNetOfReserves",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/InventoriesNetScheduleofInventoryDetails": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://zailab.com/role/InventoriesNetScheduleofInventoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Raw materials",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process."
       }
      }
     },
     "auth_ref": [
      "r121",
      "r705"
     ]
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryWorkInProcessNetOfReserves",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/InventoriesNetScheduleofInventoryDetails": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://zailab.com/role/InventoriesNetScheduleofInventoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Work in progress",
        "label": "Inventory, Work in Process, Net of Reserves",
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing."
       }
      }
     },
     "auth_ref": [
      "r121",
      "r704"
     ]
    },
    "us-gaap_InventoryWriteDown": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryWriteDown",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventory write-down",
        "label": "Inventory Write-down",
        "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels."
       }
      }
     },
     "auth_ref": [
      "r319"
     ]
    },
    "us-gaap_InvestmentIncomeInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentIncomeInterest",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofOperations",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofOperationsandComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest income",
        "label": "Investment Income, Interest",
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities."
       }
      }
     },
     "auth_ref": [
      "r110",
      "r265"
     ]
    },
    "us-gaap_InvestmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentTextBlock",
     "presentation": [
      "http://zailab.com/role/LongTermInvestments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Term Investments",
        "label": "Investment [Text Block]",
        "documentation": "The entire disclosure for investment."
       }
      }
     },
     "auth_ref": [
      "r842",
      "r843",
      "r874"
     ]
    },
    "us-gaap_InvestmentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment in subsidiaries",
        "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures",
        "documentation": "Amount of investment in equity method investee and investment in and advance to affiliate."
       }
      }
     },
     "auth_ref": [
      "r850"
     ]
    },
    "zlab_IssuanceCostAdjustment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "IssuanceCostAdjustment",
     "crdr": "credit",
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance cost adjustment for secondary listing",
        "label": "Issuance Cost Adjustment",
        "documentation": "Issuance cost adjustment"
       }
      }
     },
     "auth_ref": []
    },
    "country_KY": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "KY",
     "presentation": [
      "http://zailab.com/role/IncomeTaxLossIncomeBeforeIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cayman Islands",
        "label": "CAYMAN ISLANDS"
       }
      }
     },
     "auth_ref": []
    },
    "zlab_LaboratoryEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "LaboratoryEquipmentMember",
     "presentation": [
      "http://zailab.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails",
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Laboratory equipment",
        "label": "Laboratory Equipment [Member]",
        "documentation": "Laboratory equipment."
       }
      }
     },
     "auth_ref": []
    },
    "zlab_LandUseRightsLeaseTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "LandUseRightsLeaseTerm",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Land use rights lease term",
        "label": "Land Use Rights Lease Term",
        "documentation": "Land use rights lease term."
       }
      }
     },
     "auth_ref": []
    },
    "zlab_LandUseRightsNetNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "LandUseRightsNetNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Land use rights, net",
        "label": "Land Use Rights Net Noncurrent",
        "documentation": "Land use rights, net noncurrent."
       }
      }
     },
     "auth_ref": []
    },
    "zlab_LandUseRightsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "LandUseRightsPolicyPolicyTextBlock",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Land Use Rights",
        "label": "Land Use Rights, Policy [Policy Text Block]",
        "documentation": "Land use rights."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseCostTableTextBlock",
     "presentation": [
      "http://zailab.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Cash Flow Information Related to Leases",
        "label": "Lease, Cost [Table Text Block]",
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income."
       }
      }
     },
     "auth_ref": [
      "r994"
     ]
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseholdImprovementsMember",
     "presentation": [
      "http://zailab.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leasehold improvements",
        "label": "Leasehold Improvements [Member]",
        "documentation": "Additions or improvements to assets held under a lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "us-gaap_LeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease",
        "label": "Leases [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://zailab.com/role/IncomeTaxAdditionalInformationDetails",
      "http://zailab.com/role/LongTermInvestmentsDetails",
      "http://zailab.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Legal Entity [Axis]",
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LenderConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LenderConcentrationRiskMember",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debtor Concentration Risk",
        "label": "Lender Concentration Risk [Member]",
        "documentation": "Reflects the percentage that borrowings or credit lines from one or more lenders is to a specified benchmark, such as total debt, segment debt. Risk is the materially adverse effects from loss of financing arrangements with a particular lender."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeLeaseDescriptionLineItems",
     "presentation": [
      "http://zailab.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Lease",
        "label": "Lessee, Lease, Description [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r495"
     ]
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeLeaseDescriptionTable",
     "presentation": [
      "http://zailab.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee Lease Description [Table]",
        "label": "Lessee, Lease, Description [Table]",
        "documentation": "Disclosure of information about lessee's leases."
       }
      }
     },
     "auth_ref": [
      "r495"
     ]
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeLeasesPolicyTextBlock",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Leases [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee."
       }
      }
     },
     "auth_ref": [
      "r494"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://zailab.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Maturities of Lease Liabilities",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r995"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://zailab.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://zailab.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total lease payments",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r501"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://zailab.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Thereafter",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r501"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://zailab.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r501"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://zailab.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r501"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://zailab.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r501"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://zailab.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r501"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://zailab.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r501"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://zailab.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: imputed interest",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r501"
     ]
    },
    "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseRemainingLeaseTerm",
     "presentation": [
      "http://zailab.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease remaining lease term",
        "label": "Lessee, Operating Lease, Remaining Lease Term",
        "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r993"
     ]
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://zailab.com/role/Leases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Operating Leases [Text Block]",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r490"
     ]
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LettersOfCreditOutstandingAmount",
     "crdr": "credit",
     "presentation": [
      "http://zailab.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Letters of credit outstanding",
        "label": "Letters of Credit Outstanding, Amount",
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedBalanceSheets",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r222",
      "r312",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r463",
      "r464",
      "r465",
      "r476",
      "r611",
      "r714",
      "r752",
      "r888",
      "r997",
      "r998"
     ]
    },
    "us-gaap_LiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAbstract",
     "presentation": [
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities",
        "label": "Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedBalanceSheets",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities and shareholders\u2019 equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r146",
      "r548",
      "r739",
      "r861",
      "r876",
      "r988"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://zailab.com/role/ConsolidatedBalanceSheets",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities and shareholders\u2019 equity",
        "label": "Liabilities and Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedBalanceSheets",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r187",
      "r222",
      "r312",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r463",
      "r464",
      "r465",
      "r476",
      "r739",
      "r888",
      "r997",
      "r998"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://zailab.com/role/ConsolidatedBalanceSheets",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current liabilities",
        "label": "Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "zlab_LicensesAndCollaborativeArrangementDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "LicensesAndCollaborativeArrangementDisclosureTextBlock",
     "presentation": [
      "http://zailab.com/role/LicenseandCollaborationAgreements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "License and Collaboration Agreements",
        "label": "Licenses And Collaborative Arrangement Disclosure [Text Block]",
        "documentation": "Licenses and collaborative arrangement disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LimitedLiabilityCompanyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LimitedLiabilityCompanyMember",
     "presentation": [
      "http://zailab.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "MEDx (Suzhou) Translational Medicine Co., Ltd.",
        "label": "Limited Liability Company [Member]",
        "documentation": "Legal form of business company offering limited liability to its owners (denoted by L.L.C. or LLC in the U.S.)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://zailab.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum borrowing capacity",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility."
       }
      }
     },
     "auth_ref": [
      "r22"
     ]
    },
    "us-gaap_LoansPayableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LoansPayableMember",
     "presentation": [
      "http://zailab.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loans Payable",
        "label": "Loans Payable [Member]",
        "documentation": "Borrowing supported by a written promise to pay an obligation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://zailab.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "zlab_LongTermDepositsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "LongTermDepositsPolicyPolicyTextBlock",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Deposits",
        "label": "Long Term Deposits, Policy [Policy Text Block]",
        "documentation": "Long term deposits."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermInvestments",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term investments",
        "label": "Long-Term Investments",
        "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle)."
       }
      }
     },
     "auth_ref": [
      "r190"
     ]
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongtermDebtTypeAxis",
     "presentation": [
      "http://zailab.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Term Debt, Type [Axis]",
        "label": "Long-Term Debt, Type [Axis]",
        "documentation": "Information by type of long-term debt."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongtermDebtTypeDomain",
     "presentation": [
      "http://zailab.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Term Debt, Type [Domain]",
        "label": "Long-Term Debt, Type [Domain]",
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r63"
     ]
    },
    "us-gaap_LossContingenciesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LossContingenciesLineItems",
     "presentation": [
      "http://zailab.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss Contingencies [Line Items]",
        "label": "Loss Contingencies [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r329",
      "r330",
      "r331",
      "r334",
      "r882",
      "r883"
     ]
    },
    "us-gaap_LossContingenciesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LossContingenciesTable",
     "presentation": [
      "http://zailab.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss Contingencies [Table]",
        "label": "Loss Contingencies [Table]",
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations."
       }
      }
     },
     "auth_ref": [
      "r329",
      "r330",
      "r331",
      "r334",
      "r882",
      "r883"
     ]
    },
    "zlab_MacroGenicsIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "MacroGenicsIncMember",
     "presentation": [
      "http://zailab.com/role/LongTermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MacroGenics",
        "label": "MacroGenics Inc [Member]",
        "documentation": "Macro Genics Inc.."
       }
      }
     },
     "auth_ref": []
    },
    "zlab_MainlandChinaGovernmentPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "MainlandChinaGovernmentPlanMember",
     "presentation": [
      "http://zailab.com/role/EmployeeDefinedContributionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Mainland China Government Plan",
        "label": "Mainland China Government Plan [Member]",
        "documentation": "Mainland China Government Plan"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MajorCustomersAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MajorCustomersAxis",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer [Axis]",
        "label": "Customer [Axis]",
        "documentation": "Information by name or description of a single external customer or a group of external customers."
       }
      }
     },
     "auth_ref": [
      "r286",
      "r726",
      "r893",
      "r1009",
      "r1010"
     ]
    },
    "zlab_MajorSuppliersAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "MajorSuppliersAxis",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesConcentrationofSuppliersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Major Suppliers [Axis]",
        "label": "Major Suppliers [Axis]",
        "documentation": "Major suppliers."
       }
      }
     },
     "auth_ref": []
    },
    "zlab_MajorSuppliersDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "MajorSuppliersDomain",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesConcentrationofSuppliersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Major Suppliers [Domain]",
        "label": "Major Suppliers [Domain]",
        "documentation": "Major Suppliers."
       }
      }
     },
     "auth_ref": []
    },
    "zlab_MandatoryProvidentFundMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "MandatoryProvidentFundMember",
     "presentation": [
      "http://zailab.com/role/EmployeeDefinedContributionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Mandatory Provident Fund",
        "label": "Mandatory Provident Fund [Member]",
        "documentation": "Mandatory Provident Fund"
       }
      }
     },
     "auth_ref": []
    },
    "zlab_ManufacturingEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "ManufacturingEquipmentMember",
     "presentation": [
      "http://zailab.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Manufacturing equipment",
        "label": "Manufacturing Equipment [Member]",
        "documentation": "Manufacturing equipment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ManufacturingFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ManufacturingFacilityMember",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Manufacturing equipment",
        "label": "Manufacturing Facility [Member]",
        "documentation": "Structure used in the manufacturing of goods."
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "us-gaap_MaturityOfTimeDeposits": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MaturityOfTimeDeposits",
     "presentation": [
      "http://zailab.com/role/ShortTermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Original maturities of time deposits",
        "label": "Maturity of Time Deposits",
        "documentation": "Period of time between issuance and maturity of customer deposits, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r88"
     ]
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MaximumMember",
     "presentation": [
      "http://zailab.com/role/EmployeeDefinedContributionPlansDetails",
      "http://zailab.com/role/LeasesAdditionalInformationDetails",
      "http://zailab.com/role/ShortTermInvestmentsDetails",
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum",
        "label": "Maximum [Member]",
        "documentation": "Upper limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r330",
      "r331",
      "r332",
      "r333",
      "r391",
      "r518",
      "r566",
      "r603",
      "r604",
      "r666",
      "r668",
      "r670",
      "r671",
      "r673",
      "r694",
      "r695",
      "r717",
      "r723",
      "r734",
      "r741",
      "r892",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1004"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measure:",
        "label": "Measure [Axis]"
       }
      }
     },
     "auth_ref": [
      "r799"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Measure Name"
       }
      }
     },
     "auth_ref": [
      "r799"
     ]
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MinimumMember",
     "presentation": [
      "http://zailab.com/role/LeasesAdditionalInformationDetails",
      "http://zailab.com/role/ShortTermInvestmentsDetails",
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum",
        "label": "Minimum [Member]",
        "documentation": "Lower limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r330",
      "r331",
      "r332",
      "r333",
      "r391",
      "r518",
      "r566",
      "r603",
      "r604",
      "r666",
      "r668",
      "r670",
      "r671",
      "r673",
      "r694",
      "r695",
      "r717",
      "r723",
      "r734",
      "r741",
      "r892",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1004"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MNPI Disclosure Timed for Compensation Value",
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]"
       }
      }
     },
     "auth_ref": [
      "r819"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Material Terms of Trading Arrangement",
        "label": "Material Terms of Trading Arrangement [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r827"
     ]
    },
    "srt_NameOfMajorCustomerDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "NameOfMajorCustomerDomain",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer [Domain]",
        "label": "Customer [Domain]",
        "documentation": "Single external customer or group of external customers."
       }
      }
     },
     "auth_ref": [
      "r286",
      "r726",
      "r893",
      "r1009",
      "r1010"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Named Executive Officers, Footnote",
        "label": "Named Executive Officers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r800"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash (used in) provided by financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r218"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash (used in) provided by investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r218"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      },
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by (used in) operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r117",
      "r118"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from operating activities",
        "verboseLabel": "Cash flows from Operating activities:",
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 1.0
      },
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://zailab.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofOperationsandComprehensiveLossDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows",
      "http://zailab.com/role/ConsolidatedStatementsofComprehensiveLoss",
      "http://zailab.com/role/ConsolidatedStatementsofOperations",
      "http://zailab.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofOperationsandComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net loss",
        "terseLabel": "Net loss",
        "label": "Net Income (Loss)",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r106",
      "r118",
      "r151",
      "r185",
      "r202",
      "r204",
      "r209",
      "r222",
      "r230",
      "r232",
      "r233",
      "r234",
      "r235",
      "r238",
      "r239",
      "r250",
      "r262",
      "r276",
      "r280",
      "r282",
      "r312",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r474",
      "r476",
      "r554",
      "r636",
      "r658",
      "r659",
      "r715",
      "r750",
      "r888"
     ]
    },
    "us-gaap_NetIncomeLossAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLossAbstract",
     "presentation": [
      "http://zailab.com/role/LossPerShareComputationofBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Numerator:",
        "label": "Net Income (Loss) Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "crdr": "credit",
     "presentation": [
      "http://zailab.com/role/LossPerShareComputationofBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loss attributable to ordinary shareholders \u2014 basic",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r216",
      "r232",
      "r233",
      "r234",
      "r235",
      "r241",
      "r242",
      "r251",
      "r254",
      "r262",
      "r276",
      "r280",
      "r282",
      "r715"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "crdr": "credit",
     "presentation": [
      "http://zailab.com/role/LossPerShareComputationofBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loss attributable to ordinary shareholders \u2014 diluted",
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r216",
      "r243",
      "r246",
      "r247",
      "r248",
      "r249",
      "r251",
      "r254"
     ]
    },
    "zlab_NetRevenueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "NetRevenueTableTextBlock",
     "presentation": [
      "http://zailab.com/role/RevenueTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Net Product Sales",
        "label": "Net Revenue [Table Text Block]",
        "documentation": "Net revenue"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recent Accounting Pronouncements",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "zlab_NingboBankWorkingCapitalLoanFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "NingboBankWorkingCapitalLoanFacilityMember",
     "presentation": [
      "http://zailab.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ningbo Bank Working Capital Loan Facility",
        "label": "Ningbo Bank Working Capital Loan Facility [Member]",
        "documentation": "Ningbo Bank Working Capital Loan Facility"
       }
      }
     },
     "auth_ref": []
    },
    "zlab_NonCashLeaseExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "NonCashLeaseExpenses",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Noncash lease expenses",
        "label": "Non Cash Lease Expenses",
        "documentation": "Non-cash lease expenses."
       }
      }
     },
     "auth_ref": []
    },
    "zlab_NonCashPayablesForIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "NonCashPayablesForIntangibleAssets",
     "crdr": "debit",
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payables for acquisition of intangible assets",
        "label": "Non Cash Payables For Intangible Assets",
        "documentation": "Non-cash payables for intangible assets."
       }
      }
     },
     "auth_ref": []
    },
    "zlab_NonCashPayablesForTreasuryStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "NonCashPayablesForTreasuryStock",
     "crdr": "credit",
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payables for treasury stock",
        "label": "Non Cash Payables For Treasury Stock",
        "documentation": "Non cash payables for treasury stock."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-GAAP Measure Description",
        "label": "Non-GAAP Measure Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r799"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-NEOs",
        "label": "Non-NEOs [Member]"
       }
      }
     },
     "auth_ref": [
      "r768",
      "r780",
      "r790",
      "r807",
      "r816"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r797"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount",
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r796"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO",
        "label": "Non-PEO NEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r807"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted",
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r827"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated",
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r827"
     ]
    },
    "zlab_NonVestedRestrictedSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "NonVestedRestrictedSharesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://zailab.com/role/LossPerShareAntiDilutiveSharesExcludedfromCalculationofDilutedLossPerShareDetails",
      "http://zailab.com/role/ShareBasedCompensationAdditionalInformationDetails",
      "http://zailab.com/role/ShareBasedCompensationNonvestedRestrictedShareActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-vested restricted shares",
        "verboseLabel": "Non-Vested Restricted Shares",
        "label": "Non Vested Restricted Shares [Member]",
        "documentation": "Non-vested restricted shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1",
     "crdr": "debit",
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payables for purchase of property and equipment",
        "label": "Noncash or Part Noncash Acquisition, Fixed Assets Acquired",
        "documentation": "The amount of fixed assets that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r43",
      "r44"
     ]
    },
    "zlab_NoncashResearchAndDevelopmentExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "NoncashResearchAndDevelopmentExpenses",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Noncash research and development expenses",
        "label": "Noncash Research And Development Expenses",
        "documentation": "Noncash research and development expenses."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NonvestedRestrictedStockSharesActivityTableTextBlock",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Non-vested Restricted Share Activity",
        "label": "Nonvested Restricted Stock Shares Activity [Table Text Block]",
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock shares."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "zlab_NotesReceivablePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "NotesReceivablePolicyTextBlock",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Notes Receivable",
        "label": "Notes Receivable [Policy Text Block]",
        "documentation": "Notes receivable policy."
       }
      }
     },
     "auth_ref": []
    },
    "zlab_NovocureLimitedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "NovocureLimitedMember",
     "presentation": [
      "http://zailab.com/role/LicenseandCollaborationAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Novocure",
        "label": "Novocure Limited [Member]",
        "documentation": "Novocure limited."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NumberOfOperatingSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NumberOfOperatingSegments",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of operating segments",
        "label": "Number of Operating Segments",
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues."
       }
      }
     },
     "auth_ref": [
      "r869"
     ]
    },
    "us-gaap_NumberOfReportableSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NumberOfReportableSegments",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of reportable segments",
        "label": "Number of Reportable Segments",
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements."
       }
      }
     },
     "auth_ref": [
      "r869"
     ]
    },
    "zlab_NuzyraMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "NuzyraMember",
     "presentation": [
      "http://zailab.com/role/RevenueDisaggregationofNetRevenuebyProductDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "NUZYRA",
        "label": "Nuzyra [Member]",
        "documentation": "Nuzyra [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OfficeEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OfficeEquipmentMember",
     "presentation": [
      "http://zailab.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails",
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Office equipment",
        "label": "Office Equipment [Member]",
        "documentation": "Tangible personal property used in an office setting. Examples include, but are not limited to, computers, copiers and fax machine."
       }
      }
     },
     "auth_ref": []
    },
    "zlab_OneCustomerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "OneCustomerMember",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "One Customer",
        "label": "One Customer [Member]",
        "documentation": "One Customer"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofOperationsandComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Expenses:",
        "label": "Operating Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0,
       "order": 1.0
      },
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofOperationsandComprehensiveLossDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofOperations",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofOperationsandComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss from operations",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r262",
      "r276",
      "r280",
      "r282",
      "r715"
     ]
    },
    "us-gaap_OperatingLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://zailab.com/role/LeasesOperatingLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating fixed lease cost",
        "label": "Operating Lease, Cost",
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability."
       }
      }
     },
     "auth_ref": [
      "r496",
      "r738"
     ]
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://zailab.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Present value of minimum operating lease payments",
        "label": "Operating Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r492"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current operating lease liabilities",
        "label": "Operating Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r492"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-current operating lease liabilities",
        "label": "Operating Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r492"
     ]
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://zailab.com/role/LeasesCashFlowInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash paid for amounts included in measurement of lease liabilities",
        "label": "Operating Lease, Payments",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r493",
      "r497"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease right-of-use assets",
        "label": "Operating Lease, Right-of-Use Asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r491"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://zailab.com/role/LeasesWeightedAverageRemainingLeaseTermsandDiscountRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average discount rate",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "documentation": "Weighted average discount rate for operating lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r500",
      "r738"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://zailab.com/role/LeasesWeightedAverageRemainingLeaseTermsandDiscountRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average remaining lease term",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r499",
      "r738"
     ]
    },
    "us-gaap_OperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://zailab.com/role/IncomeTaxAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net operating loss carry forwards",
        "label": "Operating Loss Carryforwards",
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "zlab_OptuneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "OptuneMember",
     "presentation": [
      "http://zailab.com/role/RevenueDisaggregationofNetRevenuebyProductDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "OPTUNE",
        "label": "Optune [Member]",
        "documentation": "Optune"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Organization and principal activities",
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "presentation": [
      "http://zailab.com/role/OrganizationandPrincipalActivities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Organization and Principal Activities",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure."
       }
      }
     },
     "auth_ref": [
      "r89",
      "r137",
      "r574",
      "r575"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofComprehensiveLoss",
      "http://zailab.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofOperationsandComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency translation adjustments",
        "verboseLabel": "Foreign currency translation",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r10",
      "r138"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofComprehensiveLoss",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofOperationsandComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other comprehensive income (loss), net of tax of nil:",
        "terseLabel": "Other comprehensive income (loss) , net of tax of nil:",
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossTaxPortionAttributableToParent1",
     "crdr": "debit",
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofComprehensiveLossParenthetical",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofOperationsandComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive (loss) income, tax",
        "label": "Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent",
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) attributable to parent entity."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r10",
      "r138"
     ]
    },
    "zlab_OtherCounterpartiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "OtherCounterpartiesMember",
     "presentation": [
      "http://zailab.com/role/LicenseandCollaborationAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other counterparties",
        "label": "Other Counterparties [Member]",
        "documentation": "Other Counterparties"
       }
      }
     },
     "auth_ref": []
    },
    "zlab_OtherCurrentLiabilitiesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "OtherCurrentLiabilitiesDisclosureTextBlock",
     "presentation": [
      "http://zailab.com/role/OtherCurrentLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Current Liabilities",
        "label": "Other Current Liabilities Disclosure [Text Block]",
        "documentation": "Other current liabilities disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherCurrentLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherCurrentLiabilitiesTableTextBlock",
     "presentation": [
      "http://zailab.com/role/OtherCurrentLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Other Current Liabilities",
        "label": "Other Current Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of other current liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherIncomeAndExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherIncomeAndExpensesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Income and Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      },
      "http://zailab.com/role/OtherCurrentLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedBalanceSheets",
      "http://zailab.com/role/OtherCurrentLiabilitiesDetails",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other current liabilities",
        "totalLabel": "Total",
        "label": "Other Liabilities, Current",
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r739"
     ]
    },
    "us-gaap_OtherLiabilitiesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilitiesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Liabilities Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other non-current liabilities",
        "label": "Other Liabilities, Noncurrent",
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "us-gaap_OtherNonoperatingGainsLosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherNonoperatingGainsLosses",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/OtherIncomeExpensesNetDetails": {
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://zailab.com/role/OtherIncomeExpensesNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Others miscellaneous gain",
        "label": "Other Nonoperating Gains (Losses)",
        "documentation": "Amount of gain (loss) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r111"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherNonoperatingIncomeAndExpenseTextBlock",
     "presentation": [
      "http://zailab.com/role/OtherIncomeExpensesNet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Income (Expenses), Net",
        "label": "Other Nonoperating Income and Expense [Text Block]",
        "documentation": "The entire disclosure for the components of non-operating income or non-operating expense, including, but not limited to, amounts earned from dividends, interest on securities, gain (loss) on securities sold, equity earnings of unconsolidated affiliates, gain (loss) on sales of business, interest expense and other miscellaneous income or expense items."
       }
      }
     },
     "auth_ref": [
      "r214",
      "r215"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0,
       "order": 4.0
      },
      "http://zailab.com/role/OtherIncomeExpensesNetDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofOperations",
      "http://zailab.com/role/OtherIncomeExpensesNetDetails",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofOperationsandComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other income (expense), net",
        "totalLabel": "Total",
        "verboseLabel": "Other income (expense), net",
        "label": "Other Nonoperating Income (Expense)",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r112"
     ]
    },
    "zlab_OtherPayablesCurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "OtherPayablesCurrentLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/OtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://zailab.com/role/OtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Others",
        "label": "Other Payables Current Liabilities",
        "documentation": "Other payables current liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Performance Measure, Amount",
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r799"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount",
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r766",
      "r778",
      "r788",
      "r814"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Amount",
        "label": "Outstanding Recovery Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r769",
      "r781",
      "r791",
      "r817"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r769",
      "r781",
      "r791",
      "r817"
     ]
    },
    "srt_OwnershipAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "OwnershipAxis",
     "presentation": [
      "http://zailab.com/role/OrganizationandPrincipalActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ownership [Axis]",
        "label": "Ownership [Axis]",
        "documentation": "Information by name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment."
       }
      }
     },
     "auth_ref": []
    },
    "srt_OwnershipDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "OwnershipDomain",
     "presentation": [
      "http://zailab.com/role/OrganizationandPrincipalActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ownership [Domain]",
        "label": "Ownership [Domain]",
        "documentation": "Name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment."
       }
      }
     },
     "auth_ref": []
    },
    "srt_ParentCompanyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ParentCompanyMember",
     "presentation": [
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofOperationsandComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Parent Company",
        "label": "Parent Company [Member]",
        "documentation": "Registrant with controlling financial interest in one or more subsidiaries. Controlling interest in subsidiary includes, but is not limited to, primary beneficiary of variable interest entity (VIE). Controlling interest in subsidiary excludes broker-dealer with controlling financial interest in subsidiary but control is likely to be temporary."
       }
      }
     },
     "auth_ref": [
      "r226"
     ]
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r795"
     ]
    },
    "zlab_PayablesForPurchaseOfPropertyAndEquipmentCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "PayablesForPurchaseOfPropertyAndEquipmentCurrent",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/OtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://zailab.com/role/OtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payables for purchase of property and equipment",
        "label": "Payables For Purchase Of Property And Equipment Current",
        "documentation": "Payables for purchase of property and equipment current."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsOfStockIssuanceCosts",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payment of public offering costs",
        "negatedTerseLabel": "Payment of public offering costs",
        "label": "Payments of Stock Issuance Costs",
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Taxes paid related to settlement of equity awards",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r217"
     ]
    },
    "us-gaap_PaymentsToAcquireEquityMethodInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireEquityMethodInvestments",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of investment in equity investee",
        "negatedTerseLabel": "Purchase of investment in equity investee",
        "label": "Payments to Acquire Equity Method Investments",
        "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence."
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireIntangibleAssets",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Acquisition of intangible assets",
        "label": "Payments to Acquire Intangible Assets",
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill."
       }
      }
     },
     "auth_ref": [
      "r115"
     ]
    },
    "us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireInterestInSubsidiariesAndAffiliates",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Investment in subsidiaries",
        "label": "Payments to Acquire Interest in Subsidiaries and Affiliates",
        "documentation": "The cash outflow associated with the acquisition of or advances to an entity that is related to it but not strictly controlled (for example, an unconsolidated subsidiary, affiliate, and joint venture or equity method investment) or the acquisition of an additional interest in a subsidiary (controlled entity)."
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of property and equipment",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r115"
     ]
    },
    "us-gaap_PaymentsToAcquireShortTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireShortTermInvestments",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of short-term investments",
        "label": "Payments to Acquire Short-Term Investments",
        "documentation": "The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term."
       }
      }
     },
     "auth_ref": [
      "r114"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Issuers, Footnote",
        "label": "Peer Group Issuers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r798"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Total Shareholder Return Amount",
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r798"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Actually Paid Compensation Amount",
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r797"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO",
        "label": "PEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r807"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Name",
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r800"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Total Compensation Amount",
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r796"
     ]
    },
    "zlab_PfizerIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "PfizerIncMember",
     "presentation": [
      "http://zailab.com/role/LicenseandCollaborationAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pfizer",
        "label": "Pfizer Inc [Member]",
        "documentation": "Pfizer Inc"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Axis]",
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r955",
      "r956",
      "r957",
      "r958",
      "r959",
      "r960",
      "r961",
      "r962",
      "r963",
      "r964",
      "r965",
      "r966",
      "r967",
      "r968",
      "r969",
      "r970",
      "r971",
      "r972",
      "r973",
      "r974",
      "r975",
      "r976",
      "r977",
      "r978",
      "r979",
      "r980"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Domain]",
        "label": "Plan Name [Domain]",
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r955",
      "r956",
      "r957",
      "r958",
      "r959",
      "r960",
      "r961",
      "r962",
      "r963",
      "r964",
      "r965",
      "r966",
      "r967",
      "r968",
      "r969",
      "r970",
      "r971",
      "r972",
      "r973",
      "r974",
      "r975",
      "r976",
      "r977",
      "r978",
      "r979",
      "r980"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedBalanceSheets",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepayments and other current assets",
        "label": "Prepaid Expense and Other Assets, Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r852"
     ]
    },
    "zlab_PrepaymentsForEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "PrepaymentsForEquipment",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepayments for equipment",
        "label": "Prepayments For Equipment",
        "documentation": "Prepayments for equipment."
       }
      }
     },
     "auth_ref": []
    },
    "zlab_PrepaymentsForEquipmentPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "PrepaymentsForEquipmentPolicyPolicyTextBlock",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepayments for Equipment",
        "label": "Prepayments For Equipment, Policy [Policy Text Block]",
        "documentation": "Prepayments for equipment."
       }
      }
     },
     "auth_ref": []
    },
    "zlab_PriorToApril2023Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "PriorToApril2023Member",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prior to April 2023",
        "label": "Prior To April 2023 [Member]",
        "documentation": "Prior To April 2023"
       }
      }
     },
     "auth_ref": []
    },
    "zlab_ProceedsFromDisposalOfLandUseRights": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "ProceedsFromDisposalOfLandUseRights",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from disposal of land use right",
        "label": "Proceeds From Disposal Of Land Use Rights",
        "documentation": "Proceeds From Disposal Of Land Use Rights"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceInitialPublicOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceInitialPublicOffering",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of ordinary shares upon public offerings",
        "label": "Proceeds from Issuance Initial Public Offering",
        "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from maturity of short-term investments",
        "label": "Proceeds from Maturities, Prepayments and Calls of Short-Term Investments",
        "documentation": "The cash inflow from maturities, prepayments, calls and collections of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r114"
     ]
    },
    "us-gaap_ProceedsFromSaleOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromSaleOfIntangibleAssets",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from sale of intellectual property",
        "label": "Proceeds from Sale of Intangible Assets",
        "documentation": "The cash inflow from disposal of asset without physical form usually arising from contractual or other legal rights, excluding goodwill."
       }
      }
     },
     "auth_ref": [
      "r113"
     ]
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from the sale of property and equipment",
        "label": "Proceeds from Sale of Property, Plant, and Equipment",
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r113"
     ]
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromStockOptionsExercised",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from exercises of stock options",
        "label": "Proceeds from Stock Options Exercised",
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r16"
     ]
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://zailab.com/role/LicenseandCollaborationAgreementsDetails",
      "http://zailab.com/role/RevenueDisaggregationofNetRevenuebyProductDetails",
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Axis]",
        "label": "Product and Service [Axis]",
        "documentation": "Information by product and service, or group of similar products and similar services."
       }
      }
     },
     "auth_ref": [
      "r283",
      "r523",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r698",
      "r724",
      "r740",
      "r841",
      "r884",
      "r885",
      "r893",
      "r1009"
     ]
    },
    "us-gaap_ProductionRelatedImpairmentsOrCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProductionRelatedImpairmentsOrCharges",
     "crdr": "debit",
     "presentation": [
      "http://zailab.com/role/InventoriesNetAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventory write-down",
        "label": "Production Related Impairments or Charges",
        "documentation": "Nonrecurring impairment charges related to the write-off of production-related equipment and inventory. This tag is used when an Entity charges this cost to cost of goods sold."
       }
      }
     },
     "auth_ref": [
      "r107"
     ]
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://zailab.com/role/LicenseandCollaborationAgreementsDetails",
      "http://zailab.com/role/RevenueDisaggregationofNetRevenuebyProductDetails",
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Domain]",
        "label": "Product and Service [Domain]",
        "documentation": "Product or service, or a group of similar products or similar services."
       }
      }
     },
     "auth_ref": [
      "r283",
      "r523",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r698",
      "r724",
      "r740",
      "r841",
      "r884",
      "r885",
      "r893",
      "r1009"
     ]
    },
    "zlab_PropertyAndEquipmentEstimatedUsefulLivesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "PropertyAndEquipmentEstimatedUsefulLivesTableTextBlock",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Estimated Useful Lives of Property and Equipment",
        "label": "Property And Equipment Estimated Useful Lives [Table Text Block]",
        "documentation": "Property and equipment estimated useful lives."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property Plant And Equipment",
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://zailab.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails",
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Lived Tangible Asset [Axis]",
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "presentation": [
      "http://zailab.com/role/PropertyandEquipmentNet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and Equipment, Net",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r124",
      "r161",
      "r164",
      "r165"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://zailab.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment, gross",
        "label": "Property, Plant and Equipment, Gross",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r125",
      "r191",
      "r551"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://zailab.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails",
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Line Items]",
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentMember",
     "presentation": [
      "http://zailab.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and Equipment",
        "label": "Property, Plant and Equipment [Member]",
        "documentation": "Physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      },
      "http://zailab.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedBalanceSheets",
      "http://zailab.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Property and equipment, net",
        "label": "Property, Plant and Equipment, Net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r541",
      "r551",
      "r739"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and Equipment",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r161",
      "r164",
      "r549"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://zailab.com/role/PropertyandEquipmentNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Property and Equipment",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://zailab.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails",
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Lived Tangible Asset [Domain]",
        "label": "Long-Lived Tangible Asset [Domain]",
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Useful life",
        "label": "Property, Plant and Equipment, Useful Life",
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProvisionForDoubtfulAccounts",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Allowance for credit loss",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r213",
      "r316"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure",
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r795"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure, Table",
        "label": "Pay vs Performance [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r795"
     ]
    },
    "zlab_QinlockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "QinlockMember",
     "presentation": [
      "http://zailab.com/role/RevenueDisaggregationofNetRevenuebyProductDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "QINLOCK",
        "label": "Qinlock [Member]",
        "documentation": "Qinlock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "zlab_RafaelAmadoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "RafaelAmadoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rafael Amado [Member]",
        "documentation": "Rafael Amado"
       }
      }
     },
     "auth_ref": []
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeAxis",
     "presentation": [
      "http://zailab.com/role/EmployeeDefinedContributionPlansDetails",
      "http://zailab.com/role/LeasesAdditionalInformationDetails",
      "http://zailab.com/role/ShortTermInvestmentsDetails",
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Axis]",
        "label": "Statistical Measurement [Axis]",
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r330",
      "r331",
      "r332",
      "r333",
      "r379",
      "r391",
      "r424",
      "r425",
      "r426",
      "r517",
      "r518",
      "r566",
      "r603",
      "r604",
      "r666",
      "r668",
      "r670",
      "r671",
      "r673",
      "r694",
      "r695",
      "r717",
      "r723",
      "r734",
      "r741",
      "r744",
      "r880",
      "r892",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1004"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeMember",
     "presentation": [
      "http://zailab.com/role/EmployeeDefinedContributionPlansDetails",
      "http://zailab.com/role/LeasesAdditionalInformationDetails",
      "http://zailab.com/role/ShortTermInvestmentsDetails",
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Domain]",
        "label": "Statistical Measurement [Domain]",
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r330",
      "r331",
      "r332",
      "r333",
      "r379",
      "r391",
      "r424",
      "r425",
      "r426",
      "r517",
      "r518",
      "r566",
      "r603",
      "r604",
      "r666",
      "r668",
      "r670",
      "r671",
      "r673",
      "r694",
      "r695",
      "r717",
      "r723",
      "r734",
      "r741",
      "r744",
      "r880",
      "r892",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1004"
     ]
    },
    "zlab_ReceivableRecognizedForDisposalOfPropertyAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "ReceivableRecognizedForDisposalOfPropertyAndEquipment",
     "crdr": "debit",
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Receivables for disposal of property and equipment",
        "label": "Receivable Recognized For Disposal Of Property And Equipment",
        "documentation": "Receivable Recognized For Disposal Of Property And Equipment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReceivablesPolicyTextBlock",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts Receivable",
        "label": "Receivable [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable."
       }
      }
     },
     "auth_ref": [
      "r870",
      "r871",
      "r872",
      "r873"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r761",
      "r773",
      "r783",
      "r809"
     ]
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://zailab.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party, Type [Domain]",
        "label": "Related Party, Type [Domain]",
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "auth_ref": [
      "r386",
      "r506",
      "r507",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r632",
      "r634",
      "r665"
     ]
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionLineItems",
     "presentation": [
      "http://zailab.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transaction [Line Items]",
        "label": "Related Party Transaction [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r640",
      "r641",
      "r644"
     ]
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transactions [Abstract]",
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://zailab.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party, Type [Axis]",
        "label": "Related Party, Type [Axis]",
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "auth_ref": [
      "r386",
      "r506",
      "r507",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r632",
      "r634",
      "r665",
      "r996"
     ]
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://zailab.com/role/RelatedPartyTransactions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transactions",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r503",
      "r504",
      "r505",
      "r507",
      "r509",
      "r584",
      "r585",
      "r586",
      "r642",
      "r643",
      "r644",
      "r663",
      "r664"
     ]
    },
    "zlab_RepotrectinibMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "RepotrectinibMember",
     "presentation": [
      "http://zailab.com/role/LicenseandCollaborationAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Repotrectinib",
        "label": "Repotrectinib [Member]",
        "documentation": "Repotrectinib"
       }
      }
     },
     "auth_ref": []
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "presentation": [
      "http://zailab.com/role/LicenseandCollaborationAgreementsDetails",
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name [Domain]",
        "label": "Counterparty Name [Domain]",
        "documentation": "Named other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution."
       }
      }
     },
     "auth_ref": [
      "r224",
      "r225",
      "r348",
      "r363",
      "r508",
      "r707",
      "r708"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofOperationsandComprehensiveLossDetails": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      },
      "http://zailab.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofOperations",
      "http://zailab.com/role/LicenseandCollaborationAgreementsDetails",
      "http://zailab.com/role/RelatedPartyTransactionsDetails",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofOperationsandComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Research and development",
        "terseLabel": "Research and development expense",
        "label": "Research and Development Expense",
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r438",
      "r1005"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpenseMember",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development",
        "label": "Research and Development Expense [Member]",
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and Development Expenses",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process."
       }
      }
     },
     "auth_ref": [
      "r437"
     ]
    },
    "zlab_ResearchAndDevelopmentExpensesAndTheInventoryPurchases": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "ResearchAndDevelopmentExpensesAndTheInventoryPurchases",
     "crdr": "debit",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesConcentrationofSuppliersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development expenses and inventory purchases",
        "label": "Research and development expenses and the inventory purchases",
        "documentation": "Research and development expenses and the inventory purchases."
       }
      }
     },
     "auth_ref": []
    },
    "zlab_ResearchAndDevelopmentExpensesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "ResearchAndDevelopmentExpensesMember",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesConcentrationofSuppliersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and Development Expenses",
        "label": "Research And Development Expenses [Member]",
        "documentation": "Research and development expenses."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date:",
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r762",
      "r774",
      "r784",
      "r810"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date",
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r763",
      "r775",
      "r785",
      "r811"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement does not require Recovery",
        "label": "Restatement Does Not Require Recovery [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r770",
      "r782",
      "r792",
      "r818"
     ]
    },
    "us-gaap_RestrictedAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedAssetsDisclosureTextBlock",
     "presentation": [
      "http://zailab.com/role/RestrictedNetAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted Net Assets",
        "label": "Restricted Assets Disclosure [Text Block]",
        "documentation": "The entire disclosure for assets that are restricted in their use, generally by contractual agreements or regulatory requirements. This would include, but not limited to, a description of the restricted assets and the terms of the restriction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestrictedCashAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedCashAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash, non-current",
        "label": "Restricted Cash [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "zlab_RestrictedCashNonCurrentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "RestrictedCashNonCurrentTextBlock",
     "presentation": [
      "http://zailab.com/role/RestrictedCashNonCurrent"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted Cash, Non-Current",
        "label": "Restricted Cash Non Current [Text Block]",
        "documentation": "Restricted cash, non-current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedCashNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      },
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedBalanceSheets",
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows",
      "http://zailab.com/role/RestrictedCashNonCurrentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash, non-current",
        "label": "Restricted Cash, Noncurrent",
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r155",
      "r849",
      "r858"
     ]
    },
    "zlab_RestrictedNetAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "RestrictedNetAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted net assets",
        "label": "Restricted net assets",
        "documentation": "Restricted net assets ."
       }
      }
     },
     "auth_ref": []
    },
    "zlab_RestrictedNetAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "RestrictedNetAssetsLineItems",
     "presentation": [
      "http://zailab.com/role/RestrictedNetAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Restricted net assets",
        "label": "Restricted Net Assets [Line Items]",
        "documentation": "Restricted net assets."
       }
      }
     },
     "auth_ref": []
    },
    "zlab_RestrictedNetAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "RestrictedNetAssetsTable",
     "presentation": [
      "http://zailab.com/role/RestrictedNetAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted Net Assets [Table]",
        "label": "Restricted Net Assets [Table]",
        "documentation": "Restricted net assets ."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedBalanceSheets",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated deficit",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r129",
      "r547",
      "r570",
      "r572",
      "r582",
      "r614",
      "r739"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated deficit",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r183",
      "r227",
      "r228",
      "r229",
      "r231",
      "r237",
      "r239",
      "r313",
      "r314",
      "r433",
      "r434",
      "r435",
      "r453",
      "r454",
      "r466",
      "r468",
      "r469",
      "r471",
      "r472",
      "r567",
      "r569",
      "r587",
      "r1015"
     ]
    },
    "us-gaap_RetirementPlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetirementPlanNameAxis",
     "presentation": [
      "http://zailab.com/role/EmployeeDefinedContributionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retirement Plan Name [Axis]",
        "label": "Retirement Plan Name [Axis]",
        "documentation": "Information by name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans."
       }
      }
     },
     "auth_ref": [
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r734",
      "r838",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r901",
      "r902",
      "r903",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915",
      "r916",
      "r917",
      "r918",
      "r919",
      "r920",
      "r921",
      "r922",
      "r923",
      "r924",
      "r925",
      "r926",
      "r927",
      "r928",
      "r929",
      "r930",
      "r931",
      "r932",
      "r933",
      "r934",
      "r935",
      "r936",
      "r937",
      "r938",
      "r939",
      "r940",
      "r941",
      "r942",
      "r943",
      "r944",
      "r945",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950",
      "r951",
      "r952",
      "r953",
      "r954"
     ]
    },
    "us-gaap_RetirementPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetirementPlanNameDomain",
     "presentation": [
      "http://zailab.com/role/EmployeeDefinedContributionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retirement Plan Name [Domain]",
        "label": "Retirement Plan Name [Domain]",
        "documentation": "Name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans."
       }
      }
     },
     "auth_ref": [
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r734",
      "r838",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r901",
      "r902",
      "r903",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915",
      "r916",
      "r917",
      "r918",
      "r919",
      "r920",
      "r921",
      "r922",
      "r923",
      "r924",
      "r925",
      "r926",
      "r927",
      "r928",
      "r929",
      "r930",
      "r931",
      "r932",
      "r933",
      "r934",
      "r935",
      "r936",
      "r937",
      "r938",
      "r939",
      "r940",
      "r941",
      "r942",
      "r943",
      "r944",
      "r945",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950",
      "r951",
      "r952",
      "r953",
      "r954"
     ]
    },
    "us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaboration revenue",
        "label": "Revenue from Collaborative Arrangement, Excluding Revenue from Contract with Customer",
        "documentation": "Amount of revenue from collaborative arrangement. Excludes revenue from contract with customer under Topic 606."
       }
      }
     },
     "auth_ref": [
      "r154",
      "r986"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue from Contract with Customer [Abstract]",
        "label": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 1.0
      },
      "http://zailab.com/role/RevenueSummaryofProductRevenueDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofOperations",
      "http://zailab.com/role/RevenueDisaggregationofNetRevenuebyProductDetails",
      "http://zailab.com/role/RevenueSummaryofProductRevenueDetails",
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product revenue, net",
        "netLabel": "Revenue",
        "totalLabel": "Product revenue \u2014 net",
        "verboseLabel": "Product revenue \u2014 net",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise."
       }
      }
     },
     "auth_ref": [
      "r263",
      "r264",
      "r275",
      "r278",
      "r279",
      "r283",
      "r284",
      "r286",
      "r376",
      "r377",
      "r523"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerMember",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue",
        "label": "Revenue from Contract with Customer Benchmark [Member]",
        "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation."
       }
      }
     },
     "auth_ref": [
      "r286",
      "r839"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "presentation": [
      "http://zailab.com/role/Revenue"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue",
        "label": "Revenue from Contract with Customer [Text Block]",
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts."
       }
      }
     },
     "auth_ref": [
      "r167",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r378"
     ]
    },
    "zlab_RevenueFromContractWithCustomersExcludingAssessedTaxAdjustmentsForRebatesAndSalesReturns": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "RevenueFromContractWithCustomersExcludingAssessedTaxAdjustmentsForRebatesAndSalesReturns",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/RevenueSummaryofProductRevenueDetails": {
       "parentTag": "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://zailab.com/role/RevenueSummaryofProductRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: Rebates and sales returns",
        "label": "Revenue From Contract With Customers, Excluding Assessed Tax, Adjustments For Rebates And Sales Returns",
        "documentation": "Amount of revenue from contract with customers excluding assessed tax, adjustments for rebates and sales return."
       }
      }
     },
     "auth_ref": []
    },
    "zlab_RevenueFromContractWithCustomersExcludingAssessedTaxBeforeAdjustmentsForRebatesAndSalesReturns": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "RevenueFromContractWithCustomersExcludingAssessedTaxBeforeAdjustmentsForRebatesAndSalesReturns",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/RevenueSummaryofProductRevenueDetails": {
       "parentTag": "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://zailab.com/role/RevenueSummaryofProductRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product revenue \u2014 gross",
        "label": "Revenue From Contract With Customers, Excluding Assessed Tax, Before Adjustments For Rebates And Sales Returns",
        "documentation": "Amount of revenue from contract with customers excluding assessed tax, before adjustments for rebates and sales return."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueRecognitionPolicyTextBlock",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue Recognition",
        "label": "Revenue [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources."
       }
      }
     },
     "auth_ref": [
      "r638",
      "r697",
      "r712"
     ]
    },
    "us-gaap_Revenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Revenues",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total revenues",
        "label": "Revenues",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r210",
      "r222",
      "r263",
      "r264",
      "r275",
      "r278",
      "r279",
      "r283",
      "r284",
      "r286",
      "r312",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r476",
      "r540",
      "r888"
     ]
    },
    "us-gaap_RevenuesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenuesAbstract",
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenues",
        "label": "Revenues [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows",
      "http://zailab.com/role/LeasesCashFlowInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right-of-use asset acquired under operating leases",
        "verboseLabel": "Non-cash operating lease liabilities arising from obtaining operating right-of-use assets",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r498",
      "r738"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Adopted",
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r827"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Terminated",
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r827"
     ]
    },
    "zlab_SPDBankWorkingCapitalLoanFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "SPDBankWorkingCapitalLoanFacilityMember",
     "presentation": [
      "http://zailab.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SPD Bank Working Capital Loan Facility",
        "label": "SPD Bank Working Capital Loan Facility [Member]",
        "documentation": "SPD Bank Working Capital Loan Facility"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "presentation": [
      "http://zailab.com/role/LossPerShareAntiDilutiveSharesExcludedfromCalculationofDilutedLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities."
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "presentation": [
      "http://zailab.com/role/LossPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Anti-Dilutive Shares Excluded from Calculation of Diluted Loss Per Share",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities."
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "us-gaap_ScheduleOfCashAndCashEquivalentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfCashAndCashEquivalentsTable",
     "presentation": [
      "http://zailab.com/role/CashandCashEquivalentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule Of Cash And Cash Equivalents [Table]",
        "label": "Schedule of Cash and Cash Equivalents [Table]",
        "documentation": "Schedule of cash and cash equivalent balances. This table excludes restricted cash balances."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock",
     "presentation": [
      "http://zailab.com/role/CashandCashEquivalentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Cash and Cash Equivalents",
        "label": "Schedule of Cash and Cash Equivalents [Table Text Block]",
        "documentation": "Tabular disclosure of the components of cash and cash equivalents."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "presentation": [
      "http://zailab.com/role/LicenseandCollaborationAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table]",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r461"
     ]
    },
    "srt_ScheduleOfCondensedBalanceSheetTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ScheduleOfCondensedBalanceSheetTableTextBlock",
     "presentation": [
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Condensed Balance Sheets",
        "label": "Condensed Balance Sheet [Table Text Block]",
        "documentation": "Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations."
       }
      }
     },
     "auth_ref": [
      "r844",
      "r863"
     ]
    },
    "srt_ScheduleOfCondensedCashFlowStatementTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ScheduleOfCondensedCashFlowStatementTableTextBlock",
     "presentation": [
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Condensed Statements of Cash Flows",
        "label": "Condensed Cash Flow Statement [Table Text Block]",
        "documentation": "Tabular disclosure of condensed cash flow statement, including, but not limited to, cash flow statements of consolidated entities and consolidation eliminations."
       }
      }
     },
     "auth_ref": [
      "r844",
      "r863"
     ]
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://zailab.com/role/IncomeTaxTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Components of Deferred Tax Assets and Liabilities",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r136"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://zailab.com/role/LossPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Summary of Basic and Diluted Net Loss Per Share",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r868"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://zailab.com/role/IncomeTaxTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Reconciliations",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Allocation of Compensation Expense Related to Options",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "presentation": [
      "http://zailab.com/role/LongTermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment, Name [Axis]",
        "label": "Investment, Name [Axis]",
        "documentation": "Information by name of investment including named security. Excludes entity that is consolidated."
       }
      }
     },
     "auth_ref": [
      "r309",
      "r310",
      "r311"
     ]
    },
    "us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfHeldToMaturitySecuritiesLineItems",
     "presentation": [
      "http://zailab.com/role/ShortTermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Held-to-Maturity Securities [Line Items]",
        "label": "Schedule of Held-to-Maturity Securities [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307"
     ]
    },
    "us-gaap_ScheduleOfHeldToMaturitySecuritiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfHeldToMaturitySecuritiesTable",
     "presentation": [
      "http://zailab.com/role/ShortTermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Securities, Held-to-Maturity [Table]",
        "label": "Debt Securities, Held-to-Maturity [Table]",
        "documentation": "Disclosure of information about investment in debt security measured at amortized cost (held-to-maturity)."
       }
      }
     },
     "auth_ref": [
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307"
     ]
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "presentation": [
      "http://zailab.com/role/IncomeTaxTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Loss (Income) Before Income Taxes",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions."
       }
      }
     },
     "auth_ref": [
      "r862"
     ]
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "presentation": [
      "http://zailab.com/role/InventoriesNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Inventory",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r100",
      "r101",
      "r102"
     ]
    },
    "us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
     "presentation": [
      "http://zailab.com/role/OtherIncomeExpensesNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Other Income (Expense), Net",
        "label": "Schedule of Other Nonoperating Income (Expense) [Table Text Block]",
        "documentation": "Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://zailab.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails",
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule Of Property Plant And Equipment [Table]",
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "presentation": [
      "http://zailab.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule Of Related Party Transactions By Related Party [Table]",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r84",
      "r640",
      "r641",
      "r644"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationAdditionalInformationDetails",
      "http://zailab.com/role/ShareBasedCompensationAssumptionsUsedtoEstimateFairValuesofShareOptionsGrantedDetails",
      "http://zailab.com/role/ShareBasedCompensationNonvestedRestrictedShareActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r398",
      "r400",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Option Activity",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r15",
      "r68"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Assumptions Used to Estimate Fair Values of Share Options Granted",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock",
     "presentation": [
      "http://zailab.com/role/OrganizationandPrincipalActivitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Significant Operating Subsidiaries",
        "label": "Schedule of Subsidiary of Limited Liability Company or Limited Partnership, Description [Table Text Block]",
        "documentation": "Tabular disclosure of the key aspects of a subsidiary (partnership, corporation, or other entity) of the limited liability company or limited partnership."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipTable",
     "presentation": [
      "http://zailab.com/role/OrganizationandPrincipalActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule Of Subsidiary Of Limited Liability Company Or Limited Partnership [Table]",
        "label": "Schedule of Subsidiary of Limited Liability Company or Limited Partnership [Table]",
        "documentation": "This table describes the key aspects of a subsidiary (partnership, corporation, or other entity) of the Limited Liability Company (LLC) or Limited Partnership (LP)."
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://zailab.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r753"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://zailab.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r756"
     ]
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://zailab.com/role/IncomeTaxAdditionalInformationDetails",
      "http://zailab.com/role/IncomeTaxLossIncomeBeforeIncomeTaxesDetails",
      "http://zailab.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRateDetails",
      "http://zailab.com/role/RestrictedNetAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Domain]",
        "label": "Geographical [Domain]",
        "documentation": "Geographical area."
       }
      }
     },
     "auth_ref": [
      "r171",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r284",
      "r285",
      "r600",
      "r601",
      "r602",
      "r667",
      "r669",
      "r672",
      "r674",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r699",
      "r725",
      "r744",
      "r893",
      "r1009"
     ]
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Information",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for segment reporting."
       }
      }
     },
     "auth_ref": [
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r284",
      "r716"
     ]
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SellingGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Selling, general and administrative",
        "label": "Selling, General and Administrative Expense",
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc."
       }
      }
     },
     "auth_ref": [
      "r109"
     ]
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Selling, general and administrative",
        "label": "Selling, General and Administrative Expenses [Member]",
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      },
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r735"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationNonvestedRestrictedShareActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Forfeited (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r418"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationNonvestedRestrictedShareActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r416"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average grant-date fair value of non-option awards granted (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r416"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationNonvestedRestrictedShareActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Non-vested, Beginning balance (in shares)",
        "periodEndLabel": "Non-vested, Ending balance (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r413",
      "r414"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationNonvestedRestrictedShareActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average remaining contractual term (years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms",
        "documentation": "Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationNonvestedRestrictedShareActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Vested (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r417"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationAssumptionsUsedtoEstimateFairValuesofShareOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected dividend rate",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r425"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationAssumptionsUsedtoEstimateFairValuesofShareOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Estimated volatility rate",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r424"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationAssumptionsUsedtoEstimateFairValuesofShareOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk-free rate of return, maximum",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum",
        "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationAssumptionsUsedtoEstimateFairValuesofShareOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk-free rate of return, minimum",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum",
        "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationAdditionalInformationDetails",
      "http://zailab.com/role/ShareBasedCompensationAssumptionsUsedtoEstimateFairValuesofShareOptionsGrantedDetails",
      "http://zailab.com/role/ShareBasedCompensationNonvestedRestrictedShareActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r398",
      "r400",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationNonvestedRestrictedShareActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Numbers of non-vested restricted shares",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares authorized (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r737"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Disclosures",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average exercise price, Vested and exercisable (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r407"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate intrinsic value of stock options exercised",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares."
       }
      }
     },
     "auth_ref": [
      "r420"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Forfeited (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r411"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r409"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average grant-date fair value of options granted (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology."
       }
      }
     },
     "auth_ref": [
      "r419"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate intrinsic value, Outstanding",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding, beginning balance (in shares)",
        "periodEndLabel": "Outstanding, ending balance (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r405",
      "r406"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of options",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding, beginning balance (in dollars per share)",
        "periodEndLabel": "Outstanding, ending balance (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r405",
      "r406"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average exercise price ($)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of options, Vested and exercisable (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number",
        "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r422"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://zailab.com/role/ShareBasedCompensationAdditionalInformationDetails",
      "http://zailab.com/role/ShareBasedCompensationAssumptionsUsedtoEstimateFairValuesofShareOptionsGrantedDetails",
      "http://zailab.com/role/ShareBasedCompensationNonvestedRestrictedShareActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Domain]",
        "label": "Award Type [Domain]",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercised (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r410"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forfeited (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated."
       }
      }
     },
     "auth_ref": [
      "r411"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Granted (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r409"
     ]
    },
    "us-gaap_ShareBasedCompensationAwardTrancheOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationAwardTrancheOneMember",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tranche one",
        "label": "Share-Based Payment Arrangement, Tranche One [Member]",
        "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationAwardTrancheThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationAwardTrancheThreeMember",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tranche three",
        "label": "Share-Based Payment Arrangement, Tranche Three [Member]",
        "documentation": "Third portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationAwardTrancheTwoMember",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tranche two",
        "label": "Share-Based Payment Arrangement, Tranche Two [Member]",
        "documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period."
       }
      }
     },
     "auth_ref": []
    },
    "zlab_ShareBasedPaymentArrangementOptionBatchOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "ShareBasedPaymentArrangementOptionBatchOneMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://zailab.com/role/ShareBasedCompensationAssumptionsUsedtoEstimateFairValuesofShareOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share options, batch one",
        "label": "Share-Based Payment Arrangement, Option, Batch One [Member]",
        "documentation": "Share-Based Payment Arrangement, Option, Batch One"
       }
      }
     },
     "auth_ref": []
    },
    "zlab_ShareBasedPaymentArrangementOptionBatchThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "ShareBasedPaymentArrangementOptionBatchThreeMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://zailab.com/role/ShareBasedCompensationAssumptionsUsedtoEstimateFairValuesofShareOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share options, batch three",
        "label": "Share-Based Payment Arrangement, Option, Batch Three [Member]",
        "documentation": "Share-Based Payment Arrangement, Option, Batch Three"
       }
      }
     },
     "auth_ref": []
    },
    "zlab_ShareBasedPaymentArrangementOptionBatchTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "ShareBasedPaymentArrangementOptionBatchTwoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://zailab.com/role/ShareBasedCompensationAssumptionsUsedtoEstimateFairValuesofShareOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share options, batch two",
        "label": "Share-Based Payment Arrangement, Option, Batch Two [Member]",
        "documentation": "Share-Based Payment Arrangement, Option, Batch Two"
       }
      }
     },
     "auth_ref": []
    },
    "zlab_ShareBasedPaymentArrangementTrancheFiveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "ShareBasedPaymentArrangementTrancheFiveMember",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tranche five",
        "label": "Share-Based Payment Arrangement, Tranche Five [Member]",
        "documentation": "Share-Based Payment Arrangement, Tranche Five"
       }
      }
     },
     "auth_ref": []
    },
    "zlab_ShareBasedPaymentArrangementTrancheFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "ShareBasedPaymentArrangementTrancheFourMember",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tranche four",
        "label": "Share-Based Payment Arrangement, Tranche Four [Member]",
        "documentation": "Share-Based Payment Arrangement, Tranche Four"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting percentage",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage",
        "documentation": "Percentage of vesting of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r955"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested",
     "crdr": "debit",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationNonvestedRestrictedShareActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate intrinsic value ($ in thousands)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested",
        "documentation": "Intrinsic value of nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options granted contractual term",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r736"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationAssumptionsUsedtoEstimateFairValuesofShareOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected term (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r423"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "crdr": "debit",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate intrinsic value, Vested and exercisable",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable."
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average remaining contractual term, Outstanding",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average remaining contractual term, Vested and exercisable",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r422"
     ]
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharesIssuedPricePerShare",
     "presentation": [
      "http://zailab.com/role/LongTermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issue price per share (in dollars per share)",
        "label": "Shares Issued, Price Per Share",
        "documentation": "Per share or per unit amount of equity securities issued."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation",
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Receipt of shares netted to satisfy tax withholding obligations related to share-based compensation (in shares)",
        "label": "Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation",
        "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShortTermDebtTypeAxis",
     "presentation": [
      "http://zailab.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-Term Debt, Type [Axis]",
        "label": "Short-Term Debt, Type [Axis]",
        "documentation": "Information by type of short-term debt arrangement."
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShortTermDebtTypeDomain",
     "presentation": [
      "http://zailab.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-Term Debt, Type [Domain]",
        "label": "Short-Term Debt, Type [Domain]",
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing."
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "zlab_ShortTermInvestmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "ShortTermInvestmentTextBlock",
     "presentation": [
      "http://zailab.com/role/ShortTermInvestments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-Term Investments",
        "label": "Short Term Investment [Text Block]",
        "documentation": "Short-term investment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShortTermInvestments",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedBalanceSheets",
      "http://zailab.com/role/ShortTermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term investments",
        "label": "Short-Term Investments",
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current."
       }
      }
     },
     "auth_ref": [
      "r147",
      "r148",
      "r851"
     ]
    },
    "us-gaap_ShortTermInvestmentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShortTermInvestmentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-Term Investments [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "zlab_ShortTermInvestmentsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "ShortTermInvestmentsPolicyPolicyTextBlock",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term Investments",
        "label": "Short Term Investments, Policy [Policy Text Block]",
        "documentation": "Short term investments policy."
       }
      }
     },
     "auth_ref": []
    },
    "zlab_SignificantAccountingPoliciesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "SignificantAccountingPoliciesLineItems",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Significant Accounting Policies [Line Items]",
        "label": "Significant Accounting Policies [Line Items]",
        "documentation": "Significant accounting policies."
       }
      }
     },
     "auth_ref": []
    },
    "zlab_SignificantAccountingPoliciesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "SignificantAccountingPoliciesTable",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Significant Accounting Policies [Table]",
        "label": "Significant Accounting Policies [Table]",
        "documentation": "Significant accounting policies."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Significant Accounting Policies",
        "label": "Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r119",
      "r220"
     ]
    },
    "us-gaap_StandbyLettersOfCreditMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StandbyLettersOfCreditMember",
     "presentation": [
      "http://zailab.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Standby Letters of Credit",
        "label": "Standby Letters of Credit [Member]",
        "documentation": "An irrevocable undertaking (typically by a financial institution) to guarantee payment of a specified financial obligation."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r886",
      "r1011",
      "r1012"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://zailab.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Axis]",
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r168",
      "r194",
      "r195",
      "r196",
      "r222",
      "r244",
      "r245",
      "r252",
      "r254",
      "r260",
      "r261",
      "r312",
      "r336",
      "r338",
      "r339",
      "r340",
      "r343",
      "r344",
      "r361",
      "r362",
      "r364",
      "r365",
      "r366",
      "r476",
      "r578",
      "r579",
      "r580",
      "r581",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r599",
      "r613",
      "r637",
      "r660",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r835",
      "r859",
      "r867"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Components [Axis]",
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r32",
      "r183",
      "r207",
      "r208",
      "r209",
      "r227",
      "r228",
      "r229",
      "r231",
      "r237",
      "r239",
      "r259",
      "r313",
      "r314",
      "r367",
      "r433",
      "r434",
      "r435",
      "r453",
      "r454",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r502",
      "r567",
      "r568",
      "r569",
      "r587",
      "r660"
     ]
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://zailab.com/role/IncomeTaxAdditionalInformationDetails",
      "http://zailab.com/role/IncomeTaxLossIncomeBeforeIncomeTaxesDetails",
      "http://zailab.com/role/IncomeTaxReconciliationoftheEffectiveIncomeTaxRateDetails",
      "http://zailab.com/role/RestrictedNetAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Axis]",
        "label": "Geographical [Axis]",
        "documentation": "Information by geographical components."
       }
      }
     },
     "auth_ref": [
      "r171",
      "r181",
      "r284",
      "r285",
      "r600",
      "r601",
      "r602",
      "r667",
      "r669",
      "r672",
      "r674",
      "r680",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r699",
      "r725",
      "r744",
      "r893",
      "r1009"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementLineItems",
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Line Items]",
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r227",
      "r228",
      "r229",
      "r259",
      "r523",
      "r576",
      "r599",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r613",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r623",
      "r624",
      "r625",
      "r626",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r634",
      "r638",
      "r639",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r660",
      "r745"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Cash Flows [Abstract]",
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidated balance sheets",
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidated statements of comprehensive loss",
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Stockholders' Equity [Abstract]",
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementTable",
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Table]",
        "label": "Statement [Table]",
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed."
       }
      }
     },
     "auth_ref": [
      "r227",
      "r228",
      "r229",
      "r259",
      "r523",
      "r576",
      "r599",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r613",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r623",
      "r624",
      "r625",
      "r626",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r634",
      "r638",
      "r639",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r660",
      "r745"
     ]
    },
    "zlab_StatutoryReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "StatutoryReserves",
     "crdr": "credit",
     "presentation": [
      "http://zailab.com/role/RestrictedNetAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statutory reserves",
        "label": "Statutory Reserves",
        "documentation": "Statutory reserves."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Price or TSR Estimation Method",
        "label": "Stock Price or TSR Estimation Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r765",
      "r777",
      "r787",
      "r813"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "presentation": [
      "http://zailab.com/role/LongTermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock (in shares)",
        "label": "Stock Issued During Period, Shares, Acquisitions",
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions."
       }
      }
     },
     "auth_ref": [
      "r93",
      "r94",
      "r129"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of ordinary shares upon follow-on public offering, net of issuance cost (in shares)",
        "label": "Stock Issued During Period, Shares, New Issues",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r93",
      "r94",
      "r129",
      "r578",
      "r660",
      "r676"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesOther": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesOther",
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of ordinary shares in connection with collaboration and license arrangement (Note 16) (in shares)",
        "label": "Stock Issued During Period, Shares, Other",
        "documentation": "Number of shares of stock issued attributable to transactions classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of ordinary shares upon vesting of restricted shares (in shares)",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r93",
      "r94",
      "r129"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationGross",
     "presentation": [
      "http://zailab.com/role/LicenseandCollaborationAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of ordinary shares in connection with collaboration and license arrangement (in shares)",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, before Forfeiture",
        "documentation": "Number, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://zailab.com/role/ShareBasedCompensationOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise of shares options (in shares)",
        "negatedLabel": "Exercised (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r93",
      "r94",
      "r129",
      "r410"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of ordinary shares upon follow-on public offering, net of issuance cost",
        "label": "Stock Issued During Period, Value, New Issues",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r93",
      "r94",
      "r129",
      "r587",
      "r660",
      "r676",
      "r751"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueOther",
     "crdr": "credit",
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of ordinary shares in connection with collaboration and license arrangement (Note 16)",
        "label": "Stock Issued During Period, Value, Other",
        "documentation": "Value of shares of stock issued attributable to transactions classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures",
     "crdr": "credit",
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of ordinary shares upon vesting of restricted shares",
        "label": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures",
        "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r129"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "crdr": "credit",
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise of share options",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "documentation": "Value of stock issued as a result of the exercise of stock options."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r32",
      "r129"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedBalanceSheets",
      "http://zailab.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total shareholders\u2019 equity",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r94",
      "r97",
      "r98",
      "r120",
      "r615",
      "r633",
      "r661",
      "r662",
      "r739",
      "r752",
      "r861",
      "r876",
      "r988",
      "r1015"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://zailab.com/role/ConsolidatedBalanceSheets",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shareholders\u2019 equity",
        "label": "Equity, Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteStockSplitConversionRatio1": {
     "xbrltype": "pureItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityNoteStockSplitConversionRatio1",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share Subdivision ratio",
        "label": "Stockholders' Equity Note, Stock Split, Conversion Ratio",
        "documentation": "Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract",
     "presentation": [
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stockholders' equity, par value and number of shares",
        "label": "Stockholders' Equity, Number of Shares, Par Value and Other Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventLineItems",
     "presentation": [
      "http://zailab.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event [Line Items]",
        "label": "Subsequent Event [Line Items]",
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
       }
      }
     },
     "auth_ref": [
      "r488",
      "r512"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://zailab.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event",
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r488",
      "r512"
     ]
    },
    "us-gaap_SubsequentEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTable",
     "presentation": [
      "http://zailab.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event [Table]",
        "label": "Subsequent Event [Table]",
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued."
       }
      }
     },
     "auth_ref": [
      "r488",
      "r512"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://zailab.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type [Axis]",
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r488",
      "r512"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://zailab.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type [Domain]",
        "label": "Subsequent Event Type [Domain]",
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r488",
      "r512"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Events [Abstract]",
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://zailab.com/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Events",
        "label": "Subsequent Events [Text Block]",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r511",
      "r513"
     ]
    },
    "us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems",
     "presentation": [
      "http://zailab.com/role/OrganizationandPrincipalActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsidiary Of Limited Liability Company Or Limited Partnership [Line Items]",
        "label": "Subsidiary of Limited Liability Company or Limited Partnership [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest",
     "presentation": [
      "http://zailab.com/role/OrganizationandPrincipalActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of Ownership",
        "label": "Subsidiary of Limited Liability Company or Limited Partnership, Ownership Interest",
        "documentation": "The number of units or percentage investment held in the subsidiary by the limited liability company or limited partnership."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SummaryOfValuationAllowanceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SummaryOfValuationAllowanceTextBlock",
     "presentation": [
      "http://zailab.com/role/IncomeTaxTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Movement of Valuation Allowance",
        "label": "Summary of Valuation Allowance [Table Text Block]",
        "documentation": "Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "zlab_SummaryOfWeightedAverageRemainingLeaseTermsAndDiscountRatesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "SummaryOfWeightedAverageRemainingLeaseTermsAndDiscountRatesTableTextBlock",
     "presentation": [
      "http://zailab.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Weighted-Average Remaining Lease Terms and Discount Rates",
        "label": "Summary Of Weighted Average Remaining Lease Terms And Discount Rates [Table Text Block]",
        "documentation": "Summary of weighted average remaining lease terms and discount rates."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental disclosure of cash flow information",
        "label": "Supplemental Cash Flow Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "zlab_SupplementalInformationRelatedToLeasesTableTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "SupplementalInformationRelatedToLeasesTableTableTextBlock",
     "presentation": [
      "http://zailab.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Supplemental Information Related to Leases",
        "label": "Supplemental Information Related To Leases Table [Table Text Block]",
        "documentation": "Summary of supplemental information related to leases."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplierConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SupplierConcentrationRiskMember",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesConcentrationofSuppliersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplier Concentration Risk",
        "label": "Supplier Concentration Risk [Member]",
        "documentation": "Reflects the percentage that purchases in the period from one or more significant suppliers is to cost of goods or services, as defined by the entity, such as total cost of sales or services, product line cost of sales or services, segment cost of sales or services. Risk is the materially adverse effects of loss of a material supplier or a supplier of critically needed goods or services."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "zlab_SupplierEMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "SupplierEMember",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesConcentrationofSuppliersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "E",
        "label": "Supplier E [Member]",
        "documentation": "Supplier E"
       }
      }
     },
     "auth_ref": []
    },
    "zlab_SupplierFMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "SupplierFMember",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesConcentrationofSuppliersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "F",
        "label": "Supplier F [Member]",
        "documentation": "Supplier F."
       }
      }
     },
     "auth_ref": []
    },
    "country_TW": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "TW",
     "presentation": [
      "http://zailab.com/role/IncomeTaxAdditionalInformationDetails",
      "http://zailab.com/role/IncomeTaxLossIncomeBeforeIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Taiwan",
        "label": "TAIWAN"
       }
      }
     },
     "auth_ref": []
    },
    "currency_TWD": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/currency/2023",
     "localname": "TWD",
     "presentation": [
      "http://zailab.com/role/CashandCashEquivalentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Taiwan dollar (\u201cTW$\u201d)",
        "label": "Taiwan, New Dollars"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tabular List, Table",
        "label": "Tabular List [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r806"
     ]
    },
    "us-gaap_TangibleAssetImpairmentCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TangibleAssetImpairmentCharges",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment of property and equipment",
        "label": "Tangible Asset Impairment Charges",
        "documentation": "The charge against earnings resulting from the aggregate write down of tangible assets from their carrying value to their fair value."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r126"
     ]
    },
    "us-gaap_TaxesPayableCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TaxesPayableCurrentAndNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://zailab.com/role/OtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://zailab.com/role/OtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax payables",
        "label": "Taxes Payable",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes."
       }
      }
     },
     "auth_ref": [
      "r92",
      "r144",
      "r1006"
     ]
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Amount",
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r798"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Vs Peer Group",
        "label": "Total Shareholder Return Vs Peer Group [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r805"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangement:",
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r826"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangements, by Individual",
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "auth_ref": [
      "r828"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://zailab.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adoption Date",
        "label": "Trading Arrangement Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r829"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Arrangement Duration",
        "label": "Trading Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r830"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r828"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title",
        "label": "Trading Arrangement, Individual Title"
       }
      }
     },
     "auth_ref": [
      "r828"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Available",
        "label": "Trading Arrangement, Securities Aggregate Available Amount"
       }
      }
     },
     "auth_ref": [
      "r831"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Termination Date",
        "label": "Trading Arrangement Termination Date"
       }
      }
     },
     "auth_ref": [
      "r829"
     ]
    },
    "us-gaap_TreasuryStockCommonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockCommonMember",
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Treasury Stock",
        "label": "Treasury Stock, Common [Member]",
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "us-gaap_TreasuryStockCommonShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockCommonShares",
     "presentation": [
      "http://zailab.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://zailab.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Treasury stock (in shares)",
        "negatedPeriodStartLabel": "Beginning balance (in shares)",
        "negatedPeriodEndLabel": "Ending balance (in shares)",
        "label": "Treasury Stock, Common, Shares",
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "us-gaap_TreasuryStockCommonValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockCommonValue",
     "crdr": "debit",
     "calculation": {
      "http://zailab.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://zailab.com/role/ConsolidatedBalanceSheets",
      "http://zailab.com/role/ScheduleICondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Treasury stock (at cost, 4,912,200 and 2,236,280 shares as of December\u00a031, 2023 and 2022, respectively)",
        "negatedLabel": "Treasury stock",
        "label": "Treasury Stock, Common, Value",
        "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r64",
      "r65"
     ]
    },
    "zlab_TwoThousandTwentyTwoEquityIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "TwoThousandTwentyTwoEquityIncentivePlanMember",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Two Thousand Twenty Two Equity Incentive Plan",
        "label": "Two Thousand Twenty Two Equity Incentive Plan [Member]",
        "documentation": "Two Thousand Twenty Two Equity Incentive Plan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TypeOfArrangementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TypeOfArrangementAxis",
     "presentation": [
      "http://zailab.com/role/LicenseandCollaborationAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r461"
     ]
    },
    "country_US": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "US",
     "presentation": [
      "http://zailab.com/role/IncomeTaxAdditionalInformationDetails",
      "http://zailab.com/role/IncomeTaxLossIncomeBeforeIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "United States",
        "label": "UNITED STATES"
       }
      }
     },
     "auth_ref": []
    },
    "currency_USD": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/currency/2023",
     "localname": "USD",
     "presentation": [
      "http://zailab.com/role/CashandCashEquivalentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "US$",
        "label": "United States of America, Dollars"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Security Market Price Change",
        "label": "Underlying Security Market Price Change, Percent"
       }
      }
     },
     "auth_ref": [
      "r825"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense",
     "crdr": "debit",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized tax benefits and related interest and penalties",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense",
        "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return."
       }
      }
     },
     "auth_ref": [
      "r445"
     ]
    },
    "us-gaap_UnrecordedUnconditionalPurchaseObligationDueInNextRollingTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecordedUnconditionalPurchaseObligationDueInNextRollingTwelveMonths",
     "crdr": "credit",
     "presentation": [
      "http://zailab.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchase obligation to be incurred within one year",
        "label": "Unrecorded Unconditional Purchase Obligation, Due in Next Rolling 12 Months",
        "documentation": "Amount of the fixed and determinable portion of the unrecorded unconditional purchase obligation maturing in the next rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Use of Estimates",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r53",
      "r54",
      "r157",
      "r158",
      "r162",
      "r163"
     ]
    },
    "country_VG": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "VG",
     "presentation": [
      "http://zailab.com/role/IncomeTaxLossIncomeBeforeIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "British Virgin Islands",
        "label": "VIRGIN ISLANDS, BRITISH"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "crdr": "credit",
     "presentation": [
      "http://zailab.com/role/IncomeTaxMovementofValuationAllowanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Additions",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset."
       }
      }
     },
     "auth_ref": [
      "r448"
     ]
    },
    "us-gaap_VehiclesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VehiclesMember",
     "presentation": [
      "http://zailab.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails",
      "http://zailab.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Vehicles",
        "terseLabel": "Vehicle",
        "label": "Vehicles [Member]",
        "documentation": "Equipment used primarily for road transportation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VestingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VestingAxis",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting [Axis]",
        "label": "Vesting [Axis]",
        "documentation": "Information by vesting schedule of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r955",
      "r956",
      "r957",
      "r958",
      "r959",
      "r960",
      "r961",
      "r962",
      "r963",
      "r964",
      "r965",
      "r966",
      "r967",
      "r968",
      "r969",
      "r970",
      "r971",
      "r972",
      "r973",
      "r974",
      "r975",
      "r976",
      "r977",
      "r978",
      "r979",
      "r980"
     ]
    },
    "us-gaap_VestingDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VestingDomain",
     "presentation": [
      "http://zailab.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting [Domain]",
        "label": "Vesting [Domain]",
        "documentation": "Vesting schedule of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r955",
      "r956",
      "r957",
      "r958",
      "r959",
      "r960",
      "r961",
      "r962",
      "r963",
      "r964",
      "r965",
      "r966",
      "r967",
      "r968",
      "r969",
      "r970",
      "r971",
      "r972",
      "r973",
      "r974",
      "r975",
      "r976",
      "r977",
      "r978",
      "r979",
      "r980"
     ]
    },
    "zlab_VyvgartMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "VyvgartMember",
     "presentation": [
      "http://zailab.com/role/RevenueDisaggregationofNetRevenuebyProductDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "VYVGART",
        "label": "vyvgart [Member]",
        "documentation": "vyvgart"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofOperations",
      "http://zailab.com/role/LossPerShareComputationofBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average shares used in calculating net loss per ordinary share \u2014diluted (in shares)",
        "verboseLabel": "Weighted average number of ordinary shares - diluted (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r243",
      "r254"
     ]
    },
    "zlab_WeightedAverageNumberOfShareOutstandingBasicAndDilutedAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDilutedAbstract",
     "presentation": [
      "http://zailab.com/role/LossPerShareComputationofBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Denominator:",
        "label": "Weighted Average Number Of Share Outstanding Basic And Diluted [Abstract]",
        "documentation": "Weighted average number of share outstanding basic and diluted."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://zailab.com/role/ConsolidatedStatementsofOperations",
      "http://zailab.com/role/LossPerShareComputationofBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average shares used in calculating net loss per ordinary share \u2014 basic (in shares)",
        "verboseLabel": "Weighted average number of ordinary shares - basic (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r241",
      "r254"
     ]
    },
    "zlab_WithholdingTaxesRemittanceOfDividends": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "WithholdingTaxesRemittanceOfDividends",
     "crdr": "debit",
     "presentation": [
      "http://zailab.com/role/IncomeTaxAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Withholding taxes on remittance of dividends",
        "label": "Withholding Taxes Remittance Of Dividends",
        "documentation": "Amount of withholding taxes on remittance of dividends."
       }
      }
     },
     "auth_ref": []
    },
    "zlab_XanomelineTrospiumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "XanomelineTrospiumMember",
     "presentation": [
      "http://zailab.com/role/LicenseandCollaborationAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Xanomeline-Trospium",
        "label": "Xanomeline-Trospium [Member]",
        "documentation": "Xanomeline-Trospium"
       }
      }
     },
     "auth_ref": []
    },
    "zlab_ZaiAutoImmuneHongKongLimitedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "ZaiAutoImmuneHongKongLimitedMember",
     "presentation": [
      "http://zailab.com/role/OrganizationandPrincipalActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Zai Auto Immune (Hong Kong) Limited",
        "label": "Zai Auto Immune Hong Kong Limited [Member]",
        "documentation": "Zai Auto Immune Hong Kong Limited [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "zlab_ZaiBiopharmaceuticalSuzhouCompanyLimitedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "ZaiBiopharmaceuticalSuzhouCompanyLimitedMember",
     "presentation": [
      "http://zailab.com/role/OrganizationandPrincipalActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Zai Biopharmaceutical (Suzhou) Co., Ltd.",
        "label": "Zai Biopharmaceutical Suzhou Company Limited [Member]",
        "documentation": "Zai Biopharmaceutical (Suzhou) company limited."
       }
      }
     },
     "auth_ref": []
    },
    "zlab_ZaiLabAUSTPtyLtdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "ZaiLabAUSTPtyLtdMember",
     "presentation": [
      "http://zailab.com/role/IncomeTaxAdditionalInformationDetails",
      "http://zailab.com/role/OrganizationandPrincipalActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Zai Lab (AUST) Pty. Ltd.",
        "label": "Zai Lab A U S T Pty Ltd [Member]",
        "documentation": "Zai Lab (AUST) Pty., Ltd."
       }
      }
     },
     "auth_ref": []
    },
    "zlab_ZaiLabHongKongAndZlChinaHoldingTwoAndZaiAutoImmuneHongKongAndZaiAntiInfectivesHongKongLimitedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "ZaiLabHongKongAndZlChinaHoldingTwoAndZaiAutoImmuneHongKongAndZaiAntiInfectivesHongKongLimitedMember",
     "presentation": [
      "http://zailab.com/role/IncomeTaxAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Zai Lab (Hong Kong) and ZL China Holding Two and Zai Auto Immune (Hong Kong) and Zai Anti Infectives (Hong Kong) Limited",
        "label": "Zai Lab (Hong Kong) and ZL China Holding Two and Zai Auto Immune (Hong Kong) and Zai Anti Infectives (Hong Kong) Limited [Member]",
        "documentation": "Zai Lab (Hong Kong) and ZL China Holding Two and Zai Auto Immune (Hong Kong) and Zai Anti Infectives (Hong Kong) Limited [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "zlab_ZaiLabHongKongLimitedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "ZaiLabHongKongLimitedMember",
     "presentation": [
      "http://zailab.com/role/OrganizationandPrincipalActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Zai Lab (Hong Kong) Limited",
        "label": "Zai Lab Hong Kong Limited [Member]",
        "documentation": "Zai Lab (Hong Kong) Limited."
       }
      }
     },
     "auth_ref": []
    },
    "zlab_ZaiLabInternationalTradingShanghaiCompanyLimitedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "ZaiLabInternationalTradingShanghaiCompanyLimitedMember",
     "presentation": [
      "http://zailab.com/role/OrganizationandPrincipalActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Zai Lab International Trading (Shanghai) Co., Ltd.",
        "label": "Zai Lab International Trading Shanghai Company Limited [Member]",
        "documentation": "Zai Lab International Trading Shanghai Company Limited."
       }
      }
     },
     "auth_ref": []
    },
    "zlab_ZaiLabShanghaiCo.Ltd.Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "ZaiLabShanghaiCo.Ltd.Member",
     "presentation": [
      "http://zailab.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Zai Lab Shanghai",
        "label": "Zai Lab (Shanghai) Co., Ltd. [Member]",
        "documentation": "Zai Lab (Shanghai) Co., Ltd."
       }
      }
     },
     "auth_ref": []
    },
    "zlab_ZaiLabShanghaiCompanyLimitedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "ZaiLabShanghaiCompanyLimitedMember",
     "presentation": [
      "http://zailab.com/role/OrganizationandPrincipalActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Zai Lab (Shanghai) Co., Ltd.",
        "label": "Zai Lab Shanghai Company Limited [Member]",
        "documentation": "Zai Lab (Shanghai) company limited."
       }
      }
     },
     "auth_ref": []
    },
    "zlab_ZaiLabSuzhouCompanyLimitedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "ZaiLabSuzhouCompanyLimitedMember",
     "presentation": [
      "http://zailab.com/role/OrganizationandPrincipalActivitiesDetails",
      "http://zailab.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Zai Lab (Suzhou) Co., Ltd.",
        "verboseLabel": "Zai Lab Suzhou",
        "label": "Zai Lab Suzhou Company Limited [Member]",
        "documentation": "Zai Lab (Suzhou) company limited."
       }
      }
     },
     "auth_ref": []
    },
    "zlab_ZaiLabTaiwanLimitedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "ZaiLabTaiwanLimitedMember",
     "presentation": [
      "http://zailab.com/role/IncomeTaxAdditionalInformationDetails",
      "http://zailab.com/role/OrganizationandPrincipalActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Zai Lab (Taiwan) Limited",
        "label": "Zai Lab (Taiwan) Limited [Member]",
        "documentation": "Zai lab (taiwan) limited [Member]."
       }
      }
     },
     "auth_ref": []
    },
    "zlab_ZaiLabTradingSuzhouCoLtdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "ZaiLabTradingSuzhouCoLtdMember",
     "presentation": [
      "http://zailab.com/role/OrganizationandPrincipalActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Zai Lab Trading (Suzhou) Co., Ltd.",
        "label": "Zai Lab Trading (Suzhou) Co., Ltd. [Member]",
        "documentation": "Zai Lab Trading (Suzhou) Co., Ltd."
       }
      }
     },
     "auth_ref": []
    },
    "zlab_ZaiLabUSLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "ZaiLabUSLLCMember",
     "presentation": [
      "http://zailab.com/role/IncomeTaxAdditionalInformationDetails",
      "http://zailab.com/role/OrganizationandPrincipalActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Zai Lab (US) LLC",
        "label": "Zai Lab U S L L C [Member]",
        "documentation": "Zai Lab (US) LLC."
       }
      }
     },
     "auth_ref": []
    },
    "zlab_ZejulaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://zailab.com/20231231",
     "localname": "ZejulaMember",
     "presentation": [
      "http://zailab.com/role/RevenueDisaggregationofNetRevenuebyProductDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ZEJULA",
        "label": "Zejula [Member]",
        "documentation": "Zejula"
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482338/360-10-05-4"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "15",
   "Paragraph": "12",
   "Subparagraph": "(f)(2)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481410/810-10-15-12"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "940",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c),(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2A"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Subparagraph": "(c)",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SAB TOPIC 4.C)",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-4"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.20)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.21)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.24)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.25)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.30)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-16"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-21"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "((a)(1),(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481549/505-30-45-1"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-4"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b),(f(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-8"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-22"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.17)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "825",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480981/942-825-50-1"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "985",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Industry Guide",
   "Number": "3",
   "Section": "V",
   "Paragraph": "D-E",
   "Publisher": "SEC"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//205/tableOfContent"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.2(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.7,9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r117": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r118": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r119": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//235/tableOfContent"
  },
  "r120": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2"
  },
  "r121": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480581/330-10-S99-2"
  },
  "r122": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r123": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r124": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//360/tableOfContent"
  },
  "r125": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r126": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-2"
  },
  "r127": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480091/360-10-S99-2"
  },
  "r128": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//440/tableOfContent"
  },
  "r129": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r130": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "710",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//710/tableOfContent"
  },
  "r131": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "712",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//712/tableOfContent"
  },
  "r132": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "715",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//715/tableOfContent"
  },
  "r133": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r134": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r135": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r136": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r137": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//810/tableOfContent"
  },
  "r138": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19"
  },
  "r139": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21"
  },
  "r140": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-23"
  },
  "r141": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r142": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r143": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r144": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r145": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r146": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r147": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r148": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r149": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r150": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r151": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "210",
   "Topic": "946",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-20"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "SubTopic": "10",
   "Topic": "808",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479428/808-10-45-3"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "SubTopic": "210",
   "Topic": "954",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480632/954-210-45-5"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "270",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482989/270-10-45-6"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "808",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//606/tableOfContent"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "04",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "04",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column B",
   "Publisher": "SEC"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column C",
   "Publisher": "SEC"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column D",
   "Publisher": "SEC"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column E",
   "Publisher": "SEC"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column F",
   "Publisher": "SEC"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column G",
   "Publisher": "SEC"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column H",
   "Publisher": "SEC"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column I",
   "Publisher": "SEC"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "29",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "4",
   "Subsection": "08",
   "Paragraph": "(m)",
   "Subparagraph": "(1)(iii)",
   "Publisher": "SEC"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.5-04(Schedule I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480922/205-10-S99-6"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 6.B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-5"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(3)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//260/tableOfContent"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-11"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-4"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481664/323-10-45-1"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//330/tableOfContent"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-1"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-2"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-4"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-3"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-4"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-10"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-15"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-9"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "70",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480794/715-70-50-1"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//718/tableOfContent"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483044/730-10-05-1"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//740/tableOfContent"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//830/tableOfContent"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481839/830-10-45-17"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482014/830-20-35-1"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481956/830-20-45-1"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481926/830-20-50-1"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//842-20/tableOfContent"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-1"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//850/tableOfContent"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481435/852-10-45-14"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//855/tableOfContent"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "330",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482105/912-330-50-1"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "920",
   "SubTopic": "350",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483256/920-350-50-1"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "920",
   "SubTopic": "350",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483256/920-350-50-1"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "920",
   "SubTopic": "350",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483256/920-350-50-4"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "928",
   "SubTopic": "340",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "33",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "33",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "35A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "35A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(3)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-1"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-2"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-21"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(5)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-6"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481058/954-310-45-1"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Subparagraph": "(b)",
   "SubTopic": "20",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-38"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-16"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-21"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482785/280-10-55-47"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d-3"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii",
   "Section": "6"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-11"
  },
  "r837": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "470",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481174/470-10-25-2"
  },
  "r838": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "SubTopic": "20",
   "Topic": "715",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r839": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18"
  },
  "r840": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "SubTopic": "825",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B"
  },
  "r841": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4H",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H"
  },
  "r842": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Topic": "321",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//321/tableOfContent"
  },
  "r843": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Topic": "325",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//325/tableOfContent"
  },
  "r844": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "04",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r845": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "(a)",
   "Subparagraph": "(4)(i)",
   "Publisher": "SEC"
  },
  "r846": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "(a)",
   "Subparagraph": "(4)(iv)",
   "Publisher": "SEC"
  },
  "r847": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "(a)",
   "Subparagraph": "(4)(iv)",
   "Publisher": "SEC"
  },
  "r848": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r849": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r850": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r851": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r852": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r853": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r854": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r855": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r856": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r857": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r858": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
  },
  "r859": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r860": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r861": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r862": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r863": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3"
  },
  "r864": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r865": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r866": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r867": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55"
  },
  "r868": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r869": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-18"
  },
  "r870": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-2"
  },
  "r871": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-1"
  },
  "r872": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-2"
  },
  "r873": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-4"
  },
  "r874": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//320/tableOfContent"
  },
  "r875": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-4"
  },
  "r876": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r877": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1"
  },
  "r878": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r879": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r880": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10"
  },
  "r881": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//450/tableOfContent"
  },
  "r882": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4"
  },
  "r883": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r884": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r885": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r886": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-3"
  },
  "r887": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r888": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r889": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r890": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r891": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r892": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r893": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r894": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r895": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r896": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r897": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(10)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r898": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r899": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r900": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r901": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r902": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r903": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r904": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(8)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r905": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r906": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r907": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r908": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r909": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r910": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r911": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r912": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r913": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r914": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(8)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r915": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r916": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r917": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r918": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r919": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r920": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r921": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r922": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r923": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r924": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r925": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r926": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r927": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r928": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r929": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r930": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r931": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r932": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r933": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r934": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r935": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r936": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r937": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r938": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r939": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r940": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r941": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(q)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r942": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-2"
  },
  "r943": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3"
  },
  "r944": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3"
  },
  "r945": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r946": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r947": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r948": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r949": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r950": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r951": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r952": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r953": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r954": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-8"
  },
  "r955": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r956": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r957": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r958": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r959": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r960": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r961": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r962": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r963": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r964": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r965": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r966": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r967": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r968": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r969": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r970": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r971": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r972": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r973": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r974": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r975": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r976": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r977": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r978": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r979": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r980": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r981": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r982": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r983": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r984": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-6"
  },
  "r985": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r986": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1"
  },
  "r987": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r988": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r989": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481956/830-20-45-1"
  },
  "r990": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481926/830-20-50-1"
  },
  "r991": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "230",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r992": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479424/830-30-S99-1"
  },
  "r993": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3"
  },
  "r994": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r995": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6"
  },
  "r996": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
  },
  "r997": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r998": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r999": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B"
  },
  "r1010": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
  },
  "r1011": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-15"
  },
  "r1012": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-16"
  },
  "r1013": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r1014": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r1015": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r1016": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>152
<FILENAME>0001628280-24-007235-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-24-007235-xbrl.zip
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M!?&&3/B;3R$E-\J"!Y73"H$I2^9)?2*- A'S"0*YTB\$IASDS7U@+?7!OY"
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MT>5#98G!;H&Z@!23T.+7(*ZD7*]?' :;7(/ SZ@(-U8+6/%K 3J:T8:<J=R
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MP6 >\&:WZFDH'$A$W2($==QLP_,M)L('SDHDV6;SRU7@E;R"0H'29J2D/BM
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M=?B0=EG-R\EW&8WFK]_!<+[+KLKJ\JK[ZW>3$_B+W_FW[U^^_?5#UE;_ _?
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M**B3F^GJG6WVYV*U 9UK6;+W6L8R1BTJ)0$/,7@I2A2HY(=LAQH;,O4EZK=
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M9YTM=U&5!6(2F/8(TV+)-E";A(_GZ9A@&WYX<T5'P&4',[+[P(-GQ?JN@L'
M.IHAR.3]$ P;Q!DQ+N%]UH&O0!P4Q1\GW"HNV=O%AMGWHS,3UNE>X4I\<#^O
MRF7(^P-L0%"52QIOT0XNG"ZL/I^([PS+Z4CCA*]1Q9^2.2(Q+83==\H8L"N\
M@#QDAS\%]4 "AB4XS715,T"6O 6'/]';'X+R&0'\W'7=46H2<(.^3<<2POJ"
M093S\/"ZX$*[F+!LVG,&/Z,F+[6?T;8/$(J/J]I8A!96ET1H2]R+U&;8A@KG
MDG("#S<ORA6. E1 *30<WEA]$.$)H\F/XKBV74AHO1^%N_T:Y=N+P]=YD'S%
M0PM()>YXHY$MWTJ$VQZ@0BJH)(33EL47X)(Y?9'20P.AG,J'Q5I#FD8_>(>&
MT1031UDK1X/";"JY%:2B$:?LAA)K<;!W5,Q)C^()2O$VM7A ]<QH9P4[\BHG
MX>$[IZA9FHIM5$?+\3P(<R45(C&%'7U\TA!:*HR__YZIF@E@V:;W.<P(4]83
M;G^\W-Y)UZH73T^5NK+2'5FD_5-O\U#AT!.GXX$#F7<NP.W2,5.6(>IRT^VM
M^E?L2W7(SG;;.R(Z3H]YXV(:UX!YZQF(NU\/F9\0D0!O3;%60YFHWK/!M:#G
M%]01RT$.'DB]1[#[,8HPOTE0;="TD&1P'I:QY8A_R?#JM? <AJ9W!TT[5#&D
M(8^5EN()]N6)UT'G6#48 IY)D2I\<UE=E]2K9/@6;YE)KJBV>UEEZBCQ!3#D
M^Z-Q3([@J?(PG"6Z_@COE+)HM#S%YD)(1NK>P1(&=V*8.\>9'.8'^Z$8 4[W
M-QVJ(A.-ZX",+R%^/H(F?<1^"XH-12W5?&CC7NLQE8F'T']PH#97];I$^+Y9
M"XK2DHQ3>E!3KZL90CXO>2?Z;I2=]J4Y1R3X4K9@$5:O'XB&)#5J*MB,(LW:
M3)3MBDXDP:?&(,9]JM]S3 E;SV5S?@6S[Q]U\Y&@>'84QM^W+G[$"WCL*47P
MKAC1"Y9S!6O=U;2+L)KJU["B5)1)4:H%!F2>\AB$\%/PWA-@:[FU5$D-K,BW
M*7X9A#I%) 7V* JBELDX^FW;5.V\\G3G* @%)D/$:W 'R3^)]!X8S@PSBPC8
M7!5A@,4YS[S:\,1E,.B^-LWE>CX@ ^@J\,.%. O9#:02WE4DF,=$W=RX5=Q2
ML#\2S)?Y;#PC! G9$J'3-_->+:&5GB0%F/G,RR4<S*;L]28:$]"]2PW#OR:$
M*\Y$T#KWTR%[JI+K[ 63X"Z%N<('"O4"5DF)C\;X%6HSOVWGER1)8K9E_*VC
MG!>6<#3"5# M" 6J(S[GD!MZV6=]Y<"!C3;N=HI]8*HL/R=X"(7;-6?7U*+2
M(6RO]CF4*89D6X.XH0;,.-4-1\ G,J';!,]GX6!'%V'![[=\K8>); KI"P'4
M(?TQ/.9&U4I-U/^439W+K/S7">T1_L!K656<%<L9!;%%I3(,($PNYSDH2(6-
M;A'3>>4[W.2*MWR/9P6U0F9"H!\M.L')Q\Q,CM;XZ3FMIC<]UJ%$E@^.9'AY
MZ"0>)XS;B)CW@=C4:>>NMX+=@/K+RJR:^\,Q-:*8@S'B/_@>/..R@2Q=2=5G
MB! @%#RTP#&W"*= #@L45B7!\C*C V7TY.'9 WS<+?;Z=?4A\-T[$E07,+BE
M1#<+N/@HO%A.OH>(,^E=%.CABNL1=]+3LC,E>$E3ENY$_:KH1"1H7F^Z'8?/
M^;2TEQQ'HGT$2C)I#.OWH$SK&+O$K.WT-BRU([+RSR5J.6%.+>W\W*,<C6E/
M"==DBEU/%39UU(INL4)S>U?EMA8Q ^9B*#%<'RJ'Q9*XMCX^KN%R%%<3M?D
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M6U;</0K$>L0$XYZXCLY&)^!,[C7O<6"BICY%YX#ZE&#= T8]6][ZI>!<H:E
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M]"O-DTAP)P?,5G;J Q)3IW 72B:N$]9! @SJCEVY5IN/U8E]%3E1OX\ %M
MWX5 9:%:;0LOAF%A=YG#=!Q,"JG, $>X%&1R,4 ?A&XT[Z'\7<,6,PG%J,?]
M%I^;++E1@/O(TV,J;TF(6&-;FNVRM4]4+<A,7$)\G=0-CO;6157)13,)/,U:
MX2>K?IL>\??OI/S*>D\._9_V\,HYY7 ?)0FO"0)Q+40L2+[^/!^ZME+^B&LB
M0G@NU-7!WR1HW#( ,$+>ZAXE@0(IN/!YZ( A..!.=$!Z2YV$!*2O4CB @S"
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MCDAY:$<H0KDL._%!4>$J[NFT:%6E"38Z5&0=R.5<KV-^>Y8J'G09-!PNR6-
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M\58XL ?GX'3[/IQ&/ASL[J-O>QB_O7GGR2A^W8<]K;W'1?.;$] :]DR3KT*
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M+E.)_OGA[8M_X+\_?WCS^F__'U!+ P04    " "+@EM8PZP[O"=$   5'@(
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M)2-RTEQ>PKG$!OL(RC*.H^2*E!QH5\?4N:'1X/$A#&A-C*-Q&(AKYMF5RN1
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MTPT9<VP_46<X+YT9?U>6H<&CLSBM29D4I#=1,\,&E)Z83/<JC?;NH&91P81
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MA).]U Z.$B\S.AAW!AG/%#(P=(C<17S<*\6H23/"@6(DN0AT0%2)9S#FC$0
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M7 '=1657IV:V6'KF@N>B3NBU.FM\Q&HN>6I NL:5+]$W*SE.T6[-*A10.:)
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M@">:(E0-WA8!@HNO!,RWNB@&W4BVQ!05+"U%D4,T%9B/K3 ZGO3QI-_+8_%
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M?&P>?K3SK@ZD=UC?:QXWU[6+?W,69/=PO/,.\;;2"X[T"T"TGMP%3BL(3N.
M^&K'DBSVZXYBRQ,G#AQFMK4'[]L].%SI=8=F0TJRG)R[OAOQ2_>>.Q<^L&/?
M[7J\%88\^A+R7NQ=NCV>O!%(X69W13S5#R??><GA^?QZQ'&C?O^2@Q2^!8D
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M\IVS/V-WM,0)5W%..O8+&_GHQ-V0_QG#36?W>,(XU0MLXH(?M3#T8T]Y-[H
MD 9Q<OPI3[29_^VZ1S&QWT3PS?7[JG+Y4C#_G-FN!^!;URK: 7?<2#]U8N.
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MA\@[JF^YKB!K60%QNXKK#E&G3K7<0)<UIE$TI"A;J1KI<U/#WQ:^(]NTX#7
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MFZ\,["=_Z0)4 )"37],(S>'(FW$'_N3Z\8SO8\^9_!)P25.%I[XG>3+Y+<"
MVRR<^KXOF#?YG9QS.?GMD(TGOT*1-O6= "X"LV3Z>T6*4S\$'/-VI[\6?\S8
M1\CYMZGO!K/@$X'"X5/W/[C>U H>,K<+.<?=QPG4F$(A1W("(X+J!R$'/X?
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M 4#F@4ZPQVD;4)Y'IU(!*-$JF\L[G8>23GERE5DA<Z0L)Y:O5+E/,N\)$.&
M(,=]A90DNNDH2+)1$!!X@H9_AS$F!;N40\TBE4JM3Y@T(S^1*%PK6<+].0(
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MDDC(+A^#-EAJ5MO!NF>UM3#B, ^6S54Z/;U,X<6L JLL1!J[-8) R[:Y)Q5
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MYE+:4'JU)1.NB13%L2$>E0(:=4]F PUZP F[F;D0&;9,4-B^N@X7Y3K.M'J
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M,!84U_7 !0XPS]$S;'G=,;Y:%C(TD56R)_*@W/6"O9+Q2VEH"+ >^DO6=0<
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M_NSL>=0&Y08'3WSD#-J[VI(;[6%NM-A4Y?("@03PWW*QPK#PV,,%)#SLZWI
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M*2L+RS)O3'S^/)I391/T,N<CD+@H)+A7(-4@2N!-:K.<[KV]C=8_X_6QNW=
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M#^]-1["4]*&LL.U/UH+?? (T'3@8[9 R3=$.VO1A/,:HCRN/!I#OTW+<N]O
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M%T[XXG0Z!D Z]DC?U[7$D_5CSU-!V9AP&,VYQJV#0Y!0$ IWE6'J"\M2I3&
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M&;"(NRF%3<R<)&1"J#UIXL5[NI+=<K("4^?(8F:J!KS1)<%EI7Z@-:V,:[_
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M/7%H:HC^F$Y)JNL-OTVY*:4TGUVBCX8)>']LKN^[%=7]^PC *(X6+<L\DY;
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MQ4+*OORL<BG9/*>!Z'&-2E>APV)3> !/E_"H0[[)H[:KQF5&OY>5E-L1+^D
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MSKZ]6E(CGI?@X J$EIPR)1OPF9W(650RR-6%$MF1$13KILEXS1X:J6%[4W]
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MYHX?FZ-6TS=JWF:)#<&S2(IZK-=X1'>(4,L=%C D#[3'=RL9/>M^ Y7"?1#
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M.+J>^SH7!#K8Q\9A,RDYH;QSLXU[XE#W'I(A_10AHGQ<1-D60R;3Q;P=WDF
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MD3OUU-EEE!FVV<GE$46[@%3>H(3ITI<#/7!"'3O'9&J'[FT-#3_0,0D?8G(
MM$*#4:<]J>/7A:X"_(2&+3=BY^;1_)SK=]2)&XW^V'2$,4L02,JMDS*WV>44
M<+![EM0NM% >6"Z%1&ML@@VH1):!]4UP3PS8*VP./@FPX!%7S $+L 0L+<!C
M()(<#>3^IY'N!JX@0YCL:JK!KR7DR_>P\(.%W6F?J*[;>TGCQ;M:#B;IS>$&
MQEZM(:_BY.N6(@[[J4A<^^!8AX@1AHFO9ED-],(B\E%NS-.ISD<_,<2B1M&Y
M#<;IMII?ZJ@DB@ (Q(UD(:BHHZLJPF%U05I0GRO[!J$\D?"Y&'<9?(1"_29
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M!L>T M2Q$REB< @:FP- 04M<8DT[^\!^1Z6^Q%SJ!6V7A"U[33_#SR1:4'Z
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M[8V3\2U&9NI2?CNB_/:G2_GMX48RE81+\OBR?82RJ$M;PG2#%*0B:;2X(NO
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M99+O=7BD$.DO/BPI6$82!@D0-4HZX0O!ET$.<(1"##4G\ZQH4W-(Z8+ZG6]
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MD8 PFMF/WSXI9J]>/+% SO"=WQ*%87(HKN[=/9 H7U;*QS#%0K,BT\6':HR
MX"R4,RW4D<*5J:(2J.&RS4\H*Q%X>1'L*C,'I#T+-KI& ^2"P3_I;#![-H0
ML"\@! DD<!AG$ %J8#1IEF-"R+$?>X;<;T$[&?*Y4;9V=L-%C'G7ELND]C[9
M/Q;18]]+8G9==ILCN54^H:+$FT.J[PG</-6RPU9+QTWGW':C[9.F+Y/MMWC/
M<7L5I/BO-'TBWT^ ]3!;PG N*K:0;&$1NE!=UXHZ%0:6#KQ&N& 683')I8)%
M!ML)&A 7F9[0R4Y0; 4(XU=RDA<E8#]0*/EB$#_((&IITMU!^HRF/X/GO?@(
M)]03XTV+G,@-4I+1V*.J 9#Q;;Q!%C#\929.R$OB4-*>QQ^[B)C>%]EWF101
M>]_(,E]\YQ,:ISL?^83>]9D_7JC1$<XWB%(O?<:GW@X5476B4GODBA0,/:BW
MC@LZ#Y&=O,S&!\S&R!5$RFWT5*?Y<<B.,1GX)=(_I;4:T0M&[$8CN@QRUQ\,
MH[S,S8?J3$K$GI(,4F^RC:LP+ Y= X:[,$GG]#Y@6I;=$A%5)3.LDF#6 "RJ
M0U3EONR^T\[PR$"..L.D@\Q/8W7QHT\W&_=EUR!M$#&\!UD0 ,42_6^4$(5B
M+[/37&;E9+/"4;V?@X7WH[GKL7/0C(FB>[V?J%KH0T9=&0J:F>\>U"!UF:H/
MF*J1?$W OIBRG:%>(C3XA7WI(QTUG#2%2^&9;[T'RW8R!ZEW[PC@INHW95TC
M6W#9("\3%'LO$W6Z@ DQZX.W:GSZD_S2BK'_8QMWH/IV@0D33/C1!2;\;[6/
MDL.(B<R(<5 "*1#M*;L.&!*HB%HUZVK.DK^FDC2X<D/X%M#Z70M6"=U OSVQ
M:@9H) B5#1>IZ?_YK/\\D%7.'6FL@1(.!-8-,7(MPD-)13)($O6DRX:.S)A1
M#0 N*65:/\&9%C&2'&1-.\,BL1$(VP,:VM.&?Q3'5R(P!ZT\5)7/*&C[58.-
M4L3Q7P.0 C@?JO%CW%:W>)]SJST_!RT\$#(.37#J@W-SU W$N!%FG529MOW>
M>5*N+?8DFZW?E<!:QUUDNZ2E,$)/!VRAU*BE,DB;X)_;$N8(A7*P<4Y:NN(V
MJR 6D:DN(]D+"V+:+ VP-/"?XU:]%*ZF:M,'5NPTDX?M1/CMA"I^GXT@&^ <
MS0XN(7QQMS1*3:G(@VT+)0]OU".(\ )TPD,*L(W.I-[_R>'2$<6D6*E))M@F
MCVC15PBB,8_G[S^OW:8/_ 8$\4 94'/-(L'MN2.;7-.&QWC% -@FQN%0DCFC
M@W1N5O%GE9>I(W8F1*%2HRZUNY.#8C[>=E8_@OMR@Z 4-\BS>>%98(':91X#
MDU]GVP:-MBH/1Y>J$E'3:+6A$O9]FZQM_R^IX?@'>[/]U[K=IB#@23[2\7/G
M>#DG7L7:P/]Y]K>??GAR/7N^.OR8D  /DH#8SR&C[\=F:9\$2E0+UFHLR1+N
M_*7ZM9YEWO3AM *<JKG!@LGLZ8N7T'>V$@'>Z,UBEK!J1 \TJ=J:5T'%7K)J
MM:.#;57YY_>WIW/ U*&5%RSHH(X&0#V2\+R-<R2W%":JEO;C6+DV# \)&1:6
M&S4&\>F-,_(:+(6BS?1FCRP/KX?C;$JP3A^HKO8IG4'/TW'*+/9EN?$+<TDD
M9.#LHT4.RPPIQ0;:<W8[]T%Y,]! \T\K@IJ [['WWCCADCR?[X*;DYLN_S7,
M\AI@9N-N2F;E>>@<?4)G IF((VTG;- )3H>$V918D&5 80A1_+5%!QADN>\=
MFS5RQ<1K@'/>W%L,57+.[X7C[R(O.#5A^0V*AL!5&(;R[;V+[_:MT+  ^^W\
M%RX 6-E>[W'>LP(]Z;;[[T&Y$SU,4/.] K-$KW];EZR+.4W]B!*SN!.8;MP/
MH2Y&H+6AWA0UNXQFW9'')-I/\&'DI#&-%YIF2NR!;^Y6('SL6.3T>O:$=Y0.
M#MA?M[1/CRE95FXVVS<,)SXK_"Y-R =.R:G8"=[%OZ6?4;\QN =G&UF)T=>U
MB0//)[\P6_L$64[>N?,#X$]@<C::773P :5N'UM];-Z.1@7BK#$OB+?C]?0E
MPZY"-5 Q233F-NF"2] [K3W<&,/ L%&T:FYZ729J'M%(T9!4F]NRZM( B5VB
M#,G*U.;*^@<VFS_J!/AM?>U/YNP3PUIJ!,8O ]1@%4B&[.RP;,IW#NS%L@)W
M _KV82?NR%T%0.666D='E'_1T %B'19\3XN#R*'UX#K#LPE]0;/T6$-@7K6W
M$*AYH[,=!!5_"YN+8D;%\->[Z>&_GCWU"\MO!0R("MZ;3A,CY;S=#G8@>>0+
M,(E^=C: 11)7A5V#LHL. YO/-*+MB98YZ"/ :TLKPW+7^.%<$'SYKJWOB)^,
MA&GAV[1LO/&G=Z*X&]LI?  -=#_^#,.F81:2YR6%QVDG+QQI-\]W1DV]:CCF
MX#LB=D>YN'!!OK_%I"T<)FOJ=XA3U) ]O@MGEF1]"F*F&,\G+V(KC+X!0PS"
M[C7U@^B;;8'!S7L)KE%AEB)ZR2+.JQ?,] 9V4]S]94O.WW+9(=D4>AT30V;I
MX](6'1ASB!!<MR=#=*EY4<WK\5G7O#ZEDX4Z?X"K!0L\VZ[?@IT,5B74T4>G
M,3.#2.X5U[LP?/&56)1JKSY[=!%M^MNAT@O^EO(.LI&1D8^:9(!13"&#<"<D
MNREG-YR%QCU?K8&6A)(ML/O.\.R*)VG5+K9]G,T";I7>E=UB7<0",EEA!AC"
MFZ[<4!<[D[\?SMQVT=?-E)VF0OKXJ-&9_7[EV?_G_Z>(LNW=P<&;EY"_Y.PB
M@4UXN:>P+TRE:?$@,'G0@:Y]@]KJQ\DKZ>T+/Z5J%70Q[AK7 =R<Z;3Q"3BV
M"L<E)C )@X&I-&!N['W(Z.( 51-TE3]%.Q^Z(^\A>8IQ\R2*GM$*I.-0D![A
M$66@<JZ^#UD"]92>YG!>W[0:O9"9J0;R\"$1"_V,6B6(C,]$#I]MB+!6)78H
ML4'HAXMUL5E=>:5"]>W]@_O_@U"VKELVD+"'>[PXO O5RK>X"\5L^@%'Z^WC
M(MJG&]0 M/>B0(]>1@PA5R:C(4@=%%!Y\L\-[IH- G)O@7L=$=-R99R[S*E@
M#P.>(HR..ZAU^="P7V-7"JG2:$D AW9,5"9:EQ$'?&&MG$Y4U^[*>DAU(X!>
M7C,E(0K&8\-'B]YW]AX!E%CA=6C@@9 %<K-M[?:D[<5PAE>( .IFT;Z!OYL+
M]?9IH-N8F]8<AZQ-Y 86^9"UF*VJQCO'%88G#7G O+<>')-],M['VW5^X7Y
MRDT\?<3T!3P*+@@RT/$=RBZ4,\%9$0VL^W6+G_EG]6YN!:LV& =M<O,7TR0*
M_ +G%O88F/&V60K97=6:'_7!- "3VF;:_,-QTMX*!X6\FE\ O(//S8%YFSN6
M)M$%^]K='SSW7([Q$1[ISQS$R%!425:? DHZ<2D/_%'623!R6E ('^KQZ\T
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MR-[V6^^@W%6]":7WG ZI0%88.5YS@.^[@C(+H;98<8YB-9;E+/"49X$.?\V
M#=&"3Q(>)T3DV#@Q4NPAYO_:0<X<WSIY6R$YRJ"P$'=BH[5NVMF@6L:$'SH:
MH>O9,]8B'0M00'"FY^(40(WJ5H"#B0&4&! KJMY J!&UN6JW!(BBZ/ZN:FM]
M";,V)FY:$.*%H943B)Z%WXG^<%UTT!TM523+,W@'*17_27)0AT16H/4H&&9*
M[C1^W7L(5=\V(3!B'66(YI!_'NLZT C%N\YT;UH>42D;XY0V>/*IMV ;/H-3
MH:&V#U@!<"DK NW35AN'TH&/&VD.A WGYC-&J;C$W":0/,T J]6EJ)IZ$6#:
ML)=-A4"/(;:B&%NZGW;*#ANLSVCV-1^E*P#79YCFV(27T:KI  B[ 8TZ_VR<
MK@_V"FMS7773HF>J3^UW K(^,VFOS<(NV_OF'EB>;@%PA2#NANV5?4N._>O
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MPOP\PAMEAY;>=N_PDE^A_8J6IA.EFR1-A&"J94#6QLD3QC*._:B<JDN*A*:
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MF7>HI =-OV/IQ",-'LH"-L*/CRZZ+*XR83-F$M/,$QKV,UM8T=M<SYZ%;NO
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MA7!A&OIX6W"U[4/#\Z&#!MQX.IL@TT.L#_L=XE!;LM\#M@T6VR[H1U88VI]
M[4([TT(7*N8H@U]Y618G6Q9H/7M7_6M+Q1KT=-%7@=FA)8/9OD[85("8HALX
MQ<A"U<8D7S ])YTO@&$U"]V#8Z:0175701]A)&E=3%&'G)DW#3@@@^B,\)X8
MS_E@XL;;&^_7JKPWM [=9XGZ,=F^C%+QBM>(2W'T:\V_:#,F44MAAW8H&-MJ
M(Q3@!$M-N0L6.]?X;$*5G"-8/U,+3!,9$B2&/#'#$1=PZC(;DA^'K[?5,Q0M
MY%*5X*>BFJUF=8KL#?%! ;B H 7*?KBEO$_M TZ- Z4X1I@MQ\<#WA!YF@9E
MC@D5E(^FJO/H\:=1NWK\!3-IL>H(([S\E,/B588:DR8$"74_A.^<#Z??N\5V
MP'[HDEKMRP'S?05_J^!PWG\'%C9!82J'N;V^;1IW?JFJGVD= X\)XG&02:09
M).S NMA0!1G!F[J= WV3*Y?8#AX"W3>E?QB_GF>?_;?_S\]GWVZI,(2\!;#3
MG_IUNYH]DT&>O82\"6)&$,A05AT-HQR1?VG+;@G_\:TW0JCIP'49Z#F KF]M
MN_?FQY7=@IA8TGRTR3(/KD26CMK[;=N;M:K;8-4!<V5@Y_R.;7?T\YO.L<NF
MO%FZ2( / IZ?4!,[W&_*OL(93',MO " )08,S-%T!DJT<@:8F)9J\7Z75X2X
M)(!.CZG"!I,' ^2C=I$.FMH=[NJ$I4PC*:V=5=-O.\R@)8 CL^);>5IWAB?=
M:Z)[$<9/VJWP7V&+V@I@CU !,'&%QE1%'%5SF;"L501-XF_=ZY!, A)_BL@H
MA\+VA@ PPN!%*AG=G;#Y"BHDG01=48&G!\V23(NT^FQNW9);?NDLL* &V0M%
MC%Z,=X)*2F(*62T>C#ZEN/3@F$++5AN.9F)5N)X;FZYG$:RI<]"5@.0F!]\=
M'B1^[9&.DJC2#5#D0&PI2P53C07''/;7W!%7"L_!F/;#HO(9R.+_Y$_5;A>2
M>E#J6R+_"^1H:V;8,H@!VR\8#1+/0#&[F0+6M*OQU-C,]5.6]N$VT#6X8YR]
M\:M/7NBV;7$UHF2RX"$"#B% ?-:(84&043C34'6)CS3"C <+ LL<JM*!VPI,
M7#^[J0!F*X0R\H24)?3#ZSK A3&4$V6VRGI_I',I06,)^NLO+B7HAYO_>=4.
M;K%NB/0-5F392!%).66"BP8^#U ]FBUL5[&4GOQFX?1J."\8O<QIN+!'<$]N
MFPJJ.]0/RF$1^24@Y54-6R[:QE6.;6=A>E)+MC;%FY%V<./(2VH!5#5FX4(T
MYO@X<&4P;=Z<5+#*O;E@;=5F]F/9+\M_*D7<7V'?_AW^Y\W0+MYY)XW"+V_&
M0]T!31N!C7-R95AQALH!*KBM(;AL;K!,UPH=FSF<S<EL1O?A?O2G$'18-4FA
MWHI0SBK)M"AOZ4"MG#JO;7?C5^N_XJ(?7,KJ@B9JH+A@L)0**)^;KKT?UF?G
MM/T\>DT9/'HA@5"&XQH]!G4+& \%-:I2J+MPM!?MK<8K@8"T,,*6V(M$'A3,
MDDVG1EZ3!O^IYQ1'\ZN5#UXX.E%7R%P(<1JTR24PI5=4M* M\@;7JB197\PK
M!SL!6ZX(+U8*A:O$]?VN']RF!P[N6X&YL-B']F3;^]G-B:Z!3;AD8]R\<BK5
MM D<SB_+(639"-(NGA)*FS[T[F\/7!2!1MS58&TF-9R)[[@$6TTY6A_E4QY7
M+F;L\=24AI07L3Y&VIS\]KR,+1DW#0CZO.%V>GWLR"?UWQ[H7M,W"\DU[J<Q
M(*@863#BA/[=S>E>4S [<>+XPVRY7V0U'&8QU37]HPVI$*R_<&46 !KEO.7F
MMK+KX!0-V)@4B,Z,TIG ;)5)/-K,'O40<VIV AZ-"SX0.&QOO5L  'J'9-)5
M#2S6#<@M[)@@JFMW93WLS%_$IFJSI@!6U ,@>OFKD;ROV6-V.X6MUMFL,7"K
MJ-,2X?*G6T!E)T=#8>=**':8;P6F2+=:;&=B>0-N8CB[ _4M5O1_:46-\Z@>
M5NR,DT8'ZDB;SJ#)\O2C]ST2'774@81' MDDGI2H_2&WDWCW4(\9<\+OV4F:
MB;,I1[B) \14VZ%#M1V02,F_>O)TSX+L%89WE.F3RNGH;@&J0SX#YR!X.<<G
M!"ON]F9IF]6,*WG1=K<M]:E0>L1[NC<MT_R$%$P15J?U6BRDCOI0I'R5=.O=
M0GUQVY!SF=#MYZH8G*$I..B/C%75W+5UW$XFYB0,OS4HWZ3-LN(=F43:U;R$
M)::6AQD-)"5$U@=C)PAP,".+TG(-<N5VN%[I$@B4;R"V:1"+5SM!O(_-&J/]
MP-^YX<RVC(:_.B+O5;0[-I'R8'L0SN%=Q*^2IO;]]I&H8 &+Y3TH0&=I+CK*
M!"W90R)U/0*24GN30GC$((]Y8,_,>H628&R-=5-0-LCOB75UVRO\=<+LDYHY
MAJ6IBU3OA"T\KHP%0MA+/?Y4^ F)8XF&70*&B&R(#FS,SU'RHKVKJ)4&,K1H
M4'_9^DE>5A=6HA-/5SAW+&X5FN(@ ((?]]'Q5(-]\E:(S-% 30[<:3PXA"YO
M34L_7^(R@2>;P&T#V17D:S'=XT/I;[!"O8G2NTMS?_)74GF9 !3;8W\PI:T&
MCL^:+P1<LUN ,@SW1,$0-:E+*/%3@S6+-\.%J_"D<^^\%44-ZWM7ODM..&@Y
MO&B_GW@"THZNH7Q?&$2 GX[-IKJQW9T8@@  B_SWD.KT^^N.&$#+>=>6%\;T
MDZLDBZJ#0?Z"FPZL%'X> V$-!];F!)1$''S-R@]<YNQT.XUT=GS07<.L**.$
MX4<-7 )2F5E*E.UW%1,)R!%(+@R'6I=Y.QV58MN]0\<?U% HV.:>.K*$VP9:
M8;ZY@ 8.@ 8>G35HX+)O'MPJQ$7YJ9(HKE/ #D0IS*1U$!A._'*HYM#@B#['
MB%BJ8(PFW.@[/OV>@$CD["G<I*UGW;9V4>"@=2HX1^4W3UM4+YR]4DW[)XO!
M\&%$CT+O@#^ Z!&>[-(E<=+E9(HBK#/)Y%9P9*(\&20;;UP+ 'W&<BWXC#5A
M(<: RZJ_W6)Y9BPD[1XN)-U/*$E'U.('M:2CT@ Q3^#R/<<*3^\24O7^@6G.
MK#IKD6 (M#?@J"SR)X7^E^)M<P-5 V_3N 8E3!^0/2Y"S0N#*E/Z*&:_M'Z1
MSF#=@']O1#.'W2W!=OB*NF],5286X#9E_# !A$E=>A.NL,ZV7AHXNW<VMIT!
M:R@8-S,_M!C4D>7)/;?<_\\*Q(=)6X;:;HG(V:28B%\J4),SS"GVPVAY+:[G
MQ:6Q5B2<,YFMMF=> )5RL%,+:-WXU]@<'P"'PN@!9"K0HX,O9;N)(@ 8?AM5
M!<V31W  /^-#:#U@]4JS[NBHS!<7$6>X ,S,(A0UB4\^'K4]8U5$[Y^^O*"7
M+O62D_4O@AP[B/#ZC0_JZMX2Z"IC"P-Q"W64AE(IV)%[G6$"OT_:F.GPZC)[
MO[;[%.J[2S<G7Q>4539.58,KKG]?AO^DPU]NO#D3W(KF>0SO#C1/-415#E1<
M Q\0\%L48644)@CK@)6]][O&7;6KU=D=LA$+DC\\_U8V6[ JC[]X_ A->=0&
M5TZ>IA0]^I%IWL_^\@_OYW?]EEG'*./F+Z6=K-B=X\_7'B7G&7 S 87+X^#<
MZ@8"V)MJTRY'P",45&:P.E.2^XO,JT9_OBA[Z@M,K.BYS9[@RUOP!<%^NW=F
MAKSCCY4&<"])@2[V8D?G/ L_!3"405#D'>,<*BKU=[![@834A4&\W-YHF]B#
M>M,<8[;V417M4V8 M(RX_H<4"_@U2(('GRS1<H^Q)U;KB_ G9"^:MKGJX&#M
MI!.1 6!KV"[D:E)7 +Q$X\?BBK*=K;==T%C%3?851QYT_(>CFAZ4SWQJG^.6
M#ES3?,07*8)X L[L7S'BJ?-N7>E#]GXM,(PR7D0""HLYG"D$)0IPR>$FY&Z?
M59^GO82+EF(6%[S;L)C9/RW\#_F7H\_ L\;$/1<Y"Q-?00G-W0BJT_5DT0EP
MIRZW?SH_FR#)UP0/F^,M?UM_WUA-7-GIQX\RZK+;.."*!:EN*<%J"&D8DV.F
M8[N85MMZ!1N)PI&(9-FOE+,#=OV<:43TD2R0\%;44VA1C2G"-T\+3C9F<+]%
M! B(P%5YUW:AOY'T908PJ\+VL(R@HS:9L.>^3.OVSO'T1\$3X;*MA947A;0;
M)'3J'5S8Q[O^QXU0IE*?VIUH!! 0E <8R$:AP35H;,]W/FSLAW:#AB$D$"Q1
M.SU5VUE,:#9I,O66)D=BQY62(-AJAPAM;0P=H_7:4;/.!8UW>GB74!."H;SA
M#!*:O:T_I+%$&JRJX8R55AR<=FV\O(22IXUET''0K2*1S&7(3UUD$_4B80-U
MX.G ?]0HXF?">=5(6W#O+L:3G-'S;[6[3-;I@,78>4TAW][F# '.5QT0J?@1
MOUH2U>DM^(.:F;G,U(EF"HL9\7D?ZA;(=#LN<EQFXV0@4< *$'N 2D,A$$ S
M.6C[A&BDA1@7^ 0BR93]:<P+2(= .H\O()U_JZT5<@<"EH]8C1(Z H[U$P<"
M+C#LSC3@3T)VOZ:1W @IE5SCH+0)^5DN:K;*V9?&EJ.,"T>CG$36+DXJ;$6=
M*@?R?E5&!2UFN>+ *!7B-FQPPJF2=NFCPS>#7B?DBK585*("P(?UPP[C%QB_
M4.IN+X(#Y P";5P8'##D/>%R, 4FTF7Y!(JP2&:4T\#(H]C1HB62F5^V_AU7
M.QH#<QM)C;B:4[,@S<:IP"6D M^Y5$]RG.:%2]VQ^TPYCO:^"4_-2B.BZ1=K
M?Q$S81G+ B[*6\"*V/2:O/N==^EE +9]EM@*,M91WD<$Q4SR)TGQ(.D@4?&1
M!&.L51?TQ?!IX=8Z.DAOXF"]06'B<#DD#-;4O J%BHC4'9,M]\\W%T&-C9&(
MA*\KBZO\CBCQ>*W((-\S*47"-AHX1??PCF;Q2&?+_Z/2.)$.)T'*>3(0 "E:
M+R/-CAE_,"E.R!R7>A7UU"B1/"F,FM$-1<Q7F<"OD>2AVLRWW@)1?2:R714R
M)7/*'M<"=IIG#%;$2GMN9]C;((0:4%W$/HQ3&*@FS5"12DS,>D=JP7;2[DID
M%US"<&$TZD>V <9!-"WX3\3NI%A<%!(6Y.1?$5:Y@+/K#=6'=K,GAL7:&XO/
MF _TQ[^^><),H)\#2Z#&NB+.S3]S'2F_V[MJ -VWQ"TD]R*2H5CH!)#"C;MI
MD88,!@V/2>1,#Q I*%PR*YC(Y5$TKAN T5X_OO[V!Y&Q&U\:+2V9#J(D\__=
M ?:%OHL;CF&L)=&0D>!]!VRTLZ^_^ ]X@#_Z_X,II:1GV4/C__ULY\J.&3QA
MZ/S MS<.=R,=^T11%8BH108 K3(+?B'3>(-U;^$ZV0C#-*T(;>"']PQ$*\![
M0 <$;SM6TA9>N$5=]CU2(A4S'R,A*R5_D78>^H\;6$:]+DXY'/P0>V]FPYYG
M=5L:7AJ8 4[[<B(+'%+1_<8B*/#=$[\MG7LHU88-I,+)8+BZ@$FUC1F":6JL
M9%(6HQ;$)F%HE+4N"'47L__S_,<?7C[]>\%RW31\__CO?WS_Y/7;2'@W$M.]
MA[[5>\S@$25K78?' J1!&7P\1!=VSH\4RSTJ:7#T4%9['AJC\=0OB7,:U2YQ
MWV_0T((D]Z1J*#75W@.F-[(H>/:2Z355'6-E^22.N,K)I :N*_81C&."I@96
M/CU00NP1   KZ2J8*-TGG+E&; G?'(Q1-=]&V!NE#\/"D"4BLR*LEKJ$K*V?
MC;Z'^""52;-/7O9(I8R]7AQ,+3#'06P:2!/;J:RU=;JMORA.5/98LP.>]UW.
M[*A[A>D<B F:G:EXVW5>A+>6T9_4>R4.<3 'Y!YHR=T/Y,H'9A4*G/!>20(?
M2;#/=X:SFL\#OPZ HM9?8<?K['KV5_\:,)^\\=BW@N@'MU*R(<E!0D_,[LE
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M#<(Y=49\JY&>XO67<0C7/%^#>F(B%;[/-68N^^1;"0PP&AE,WE@;A?\&;TY
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M?55!GJ*I+ML]^#?!]+LI;]HNYEUTF^YR:O0?H\C\JNY6PTX: %/L(!UI<D#
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M/"6</(IAB0J6O6#CM3& A%Z9VSC-W.V$ER&XRY$Y1?5D3]Q\'Y$)>3D8#EV
M3=SQ3:];3.@,7#OA\YA'&R]:QK1>*TF":96%1R\5^0^^"MTA1E[!E75M!SJV
MC"CG:.)^:H1S.\MST/BA:A"FG!PI"),9C("X.&EGLMAJ+^@ $3_H2/U%B)//
MCB#BITJ3IL3=UG8,LX"6[VH;HG6J+X+'1Y +'B5"!F%K-'$D!@ABYBK55(H-
MN+XM(M?9NI-ATDIIUA9T3;?>:F]M03*XA.QJ!MF6=NGQ#45 D#77]![**Z^-
M06OJV4@]I!J01#%4BKJD[A'NGIW 6[[[P8/( 0&!J7.5:?RVE;VCK*,5ZTK6
M*(+/4&5+1^N1(']@Z%W/\-V#0_=,,K:-&\7DKTXQ@[[;#)Q48#P%ZQ)!$AF:
MYOPP$I0ND7FFU],N<NDQI/W"RCPU*8&1@_V0C.&P,_,L1# )ZWF&?]_46^B]
M\^,34)F<%0\J [>5\;C@[_NZ\Z@KV1 @AW%(>+1E3/+"R/+)F9+0-X01I61X
M"[8Y+<LBV[4GR8*N@J(&U3O0).I4E">*R?)&KN=/8/+*,!QM8SQ.=UU08BP-
MK1-U3@:1=I)/9':T-'"!&E0:U6W=7W&N#X#Z,=6$QRWXJG;.F3"QUJHLKA<\
M939QX\N/:97,_R 7LIUXJ8=-D-0)V!SYE?E,VTN>VW%+$'Z*TDS BL1.27H6
MO*P", H[.1Q#M!H]>80856:5 MWP7R'F"WN_:9N'UZHJ3BGUX*Z%J07C6(0:
M(NW;0XP!2)I*XD$Y,==EO;Y8_*V^J1J?7]?PVMK_%:#CNC**E'4L:;_D?/@F
MW>F$")DRW'I2-4B@:JIGTIH[)EP:YIG2;O)6<@<(#?<*RKB+2*5+Z<=&A"'[
MJ]'UE"+.*6&72=>?[(XF'K(KIGIZ3&V;"Y%_7\5</O9+O3H[3_*[L%0$M#+.
MQ%4I(%Y(RB?>A[[KSVV-^(Q]K^5!!<7*)C8\' H'H9V(2"<\5:T_.0$Z(&[B
M,V4]^MC)I]]UZ%]GW1,)^V+J0[)IS'-$=>X(H[[;'-D5I%:Y4HV9,8P9\\;0
M98N.92X?\ES*X!RL.4R"!K?9P-X5X_PL:C;2^508DP.S&%Q< <R5U&6;Y-U3
MF>L/W*KQD69;*&R?#CW$@IJCRC*:XO,PIL/Y,9!<NB*=SN:22S7AB\S.*V84
M11-*)[Z28"8\[0T%KY3M,UTZ#8=4&$0I00[G=D__9.R%B>!)Q+C 21;U=CF^
M -E+O_!Z$=LBO/3V]!EB!B=10'"G#I>%-Q0%L_JIXVK+?$5"<\O#A,1%(;+B
MZES+ /C$0L?5A<=IBDN:,%$5TC"Q;C8$="*7>5?W3K]]G2G-LTXK&Z'ZCMXW
M>!+PYF/#QCO,/IN-/JPT /8VQ83*[&>W/.SF?:'KCD+7X_M"U[L;C]&Y+^3X
ME0B, *T3#64UNNS*D<KX5K QME5K95"Q?+;M=<LDBKMJPI)&%MT,.\8(LG10
MS\1U4IX7^0EJZ.='ZF&1'W3GQ00?](PF;@=GZ.C"0-Z@(C^%\\>:)TI4TXLD
MBP[Q/LA; SGKGF"$4*E0ZK)=1YHU&K7=7"(M?"P)&_VHQ+ *@;7_<39_,447
M8IAVI9*HE*?;;N6_*"$8XI_UKHK==[98(QLNX>\\]NQL%= IEZ3-9N)K]NFL
MDD&.(>W02!:6[?&Q[K?(D4-+P:<)J83D/K-]H 32_5Z)QI-(PMW(=*Z"C[\M
M.S_,*=Y,/EKU7DH_E 2KDK*F(P&)5&DL3$VM610^HT*A../8U"S8#CY&-]7<
M=:F7+\?:R?VK^]#DT<]N\SR+#8OQS-&:I8NE!>&I^1DMX/6P3ZK5R7'L#5E-
M()J*&4E<2G ZXR?,TZ;VN&C*KFMOJ9>(*$2<H;\5=BK*B%%[$+E_VJ4)NR4A
MF;.YDG2?LKM^W-@C" 4GWNUH8L/B0X Q789"#@:>3-0 IY$JNGR?M XC=1$I
M^R168Z49(4&/ 6#L3>W?*0+\#3+XYQ?J33-\^[32Y*$XM\"+[A"PK>TC^/9H
M\*#I]1"*_FN03*<B"TK/'L@-"TG3Z_2#M^4M"A]#(]Z+^"LK ??6I&M/B1]*
M9VH=+?5!XETC:?A+Y%.]%^2H;^R[5M9*_(7W.QJGG8+O6[I\#WQ?LL1ZI?IG
M1+&LG+?T&)50AJ>'][H*']NRX9R<R&BY"4ZIV2([\YR3F_(!)$GF'N"9-<OD
MVHTV )6J8 6H=AB=K#6I5_G;V=)WI-W(<D7<A\K<IFD9<Y8PR-U7:',P&;2D
M*3^^P*C[WHE*'-W@#)LYM5M_=N%MT34YKQTLYV8AOJ/9C>+<.!=ASW)8182:
M;F\HOFSA$$=2@(H^Y-'9GX]A8B21@Y;)AO%%WQ_Z/>!MN0$Q?<A8%<,;\"D1
M#Q'=H&.2"T,'%"E\Q-,GSSI(8AIS[INW2/'&3@#*2 U]GHN:?JJ8E."'5GLJ
MV<K,F9^/!G +JW*NC'=Z9AZ3^5YZ-*L6>MQ!+BLD82@*O,-9+]AQ/-%3G',(
MS=;>M&]SRG87NR;I  <@\Y(>ZD*J1QPNJ*%VU$L:0D=\.V01A;15FFF43O>V
M[,!DJIK+SJM(X$V[JB00%O11GN4MP(Y_[;TWB%7*[.IVE9GD&'LMX#7=W.2B
MFMC.](].@W?.+BQ*@N(=FSZQ$]*1%"SAL.VIRLK)4FC;DPO##D_,]43&&IUZ
MN.?;+1=G(%48X0MY"2JK,V5#B76R<>ABAT@V]R4%&4S8&-8QW%^\3]U?*_./
MEK<X5G &TI5?XPMA.I2]0??[+,G7ND92Z4K3;H,3;-(,UP0I>TQ(ERPXO/*S
M5WJ\6WKD<_B2=Q'-(<T(DHK9@I<='C@1=)SS-M1? V^:;>H\O[#I:T\KB=A:
MKMZ]0&0T)53>GM12?ZX]],^O2@0GX8U%[]&=(9@+?XU9O3C_D+K44V<G>B6"
MF>+-J37KWP0]?+%P+^('Y@ GVHN@+5S12H57S)RX57P:^'S,!A&OKN29 <&,
M<A [I(#<%Z_:VS2L3)YB)5!]1L^E*0"QJN!XC;#5<@4"'",&HLUCPDFI3"GU
MZ5BS(-0#N7X:X6#Y7_+Y&&^(;,?HY\//WM?2[JBE/;FOI;U_+8WV&TXB8[R(
MD[\I13J( #C!?"\/[!U7EW6_M5+104H[NE-'CH"KO,S5:3Y,[N7<KM*IUIZ$
ME"BX&1L&D)<^;9T%J:.LRC'_YCQ!U4H\AV*KCWS\#%$YI^UV2FT>$7U^NC!!
M;YOV]B%N&3?A<Y[AQ>+O[6UU8SFTN9]$V7>9=?_+Q7RLD>:D=Q$ ]?+ W.>2
M96E'.R2GF;?XF$XZGSKN2:(.0LX63,X9'U[&@Q0I$TWAA<'"P:U9D,D)SZ"6
MM]TSTTQ,H631SW3^O8K4[MS>D[T0A,^XS,[62^,4:I:A_Z5F__B.H^,BA1>;
M]-07\GTM1[#8=#83SIMUW:^V3$>!/$\U>53IWVSKB4R72V!P4.;99-<ANJE-
M3:#Z!6R)DDQ&"(5Y]=(R2E(@DD[&4\?/UA]C@0/VWP17U*<4M^G<IT@D>=FJ
M?X<=[.:3=Z%F*"R-LFD%2<R#2VJO[N: $H@F+/6HQAS&\1-:4I*%H).4#OJK
MM<&5'I.58$M35BR\-=)3&51K8JF)<E(-0>%;/N" 9VT?1G^IQ7[.B66I_#.S
MV2]'<Z(@ +PB'004H %,0-J*^R2Y1Y2FF[Q^!B(GA.O'L;L)-6/Z^UI 7E;I
M:F:_S &NJ$_<1G^E:2,^>:I*._0FS^@WG6B<45]KS$9J%L6I'M_7:"<]I!.J
MY@KCR"&4TPC*(RE.A4]N<LCGK7$=H:TWYLA)UT\J>DG#UM+[=,R'F_<$B4F^
MH]7R# ]]UO:<\:&.6Y_EP!5>MKP0S$,1*0AG"(7Q 94UF;O986%)C$VV"C=&
M)W@?^IN)[:(X0M]C+-9HG(#/-PY7KI9U:V.1W/TDF;'R2(3 "E)V[%J0RT?E
M>VFIL/)G%^ZESN'N_-#N[.EV^&KQI5K&-5]!>KT1OIUB$BOD,7UQ%$=/U+NW
MFF;]K&Q6_X>"_'(:!*UD<0DKYH@\7"VY2W@50'A+E$]A'!0KE+C>&N\]^NU"
MK0CZ$;*+'?JE(P@V>$@1,J@L* [FCKVJYTI^<Z_B2 WJ<8K"8[^* :U\H88[
MS-13N2H;1O&O@;K=A%!TZIUA0WUY[YI3SSBDK;CE:R*MC"_Z2?]@C&5'WXRV
M9&ST?@Z_X+.9FJN(T@L)ZWEL+T3ET@&,5>C5L/W<2Y563M[MUC^[71US&]PH
M$Y8';QSG)'&T#4*2=6<X"NRAR3&KJI-F;I<K-F'9.VM*'G4K,'6!HE*=!O-_
MGCS3UZQP]W!;;?;_^>F?L[E_^/C+/VSRH6/]YZ?Z(K__$-*Y>?S9Q><T%ZK<
MV1[*[?[P<%F52&18A92Y^=..FX,1:YJP@JZO]Z$U4#=PVMT";PI^2MTY+?BB
M_,$##;]XB#JGD[_&2G%"KQ*M)@*.K$528$S\R@4SWML^I(9C:Z",=9_+^F8B
MV)E+K;CTAQ'^)W>I[XH<^J?W&_Y#;?BL1\PI7J9^5=:/X1TLR01C$07-S$ON
M;ZIP&.Y7\8.M8D=-,[L!L:.1,8O/2M=,WRY4I_-@M"]RS9T4;'(28<*<&1B6
M'1^V$99+LE32PE))1W;!?=&0BX:?GG71\/[TONOIA<"*@X7Z-(/GW$G(4RB%
M&%,%[Q:J/L43[ZWQ!UK/ZW+4E7U(N\;:AI,R ME,2X$5F5,%<PJ.M>V:ZF"D
M(!O4L.J9^(5HQEA8/D8R'& KR.TDELQ''T6D]H0,U6ONUB,@JD35(U45@W[2
M#.2U#W[[^=*/LO1E5>OWBX+_FG8Q#MN]RE6=UM#(+WA3E\X#HSO\F!.&4&.J
M Z%-6AP- MKO18(G!U>G4G7 5?>" G*MCN'SX9TA.?)<!4CVC'Z>(/KX?0L(
M9U<_N*N-1EXOZU%FG6R&Z_<0)?8+9PO$;0_8,EK.M^94!5.'H]'06=BFXL!G
MR+2E1X]>7PDY+'TWG2EV.IIITE@3Z^W=W3IH#G;K(3489_#9(:X\ONC]%V5*
M[-U<[^MAN2700].T!'LU*G_.3]CYN>+$1D_T_7*,DD;;KMXE\P%*OHBJE>3A
M)N&7#D'CH=\+J)3HNBD!$-X,RD=22](A<(E3T^3%HMZGUC813!S9"E0[NGH5
MU5YL&(+\FC.!40?)GK^- B%,[LFFA;(^X*<6F"FTTF06]6Q9<F63S@\D66^D
MB8ZAY(*UA*RC5HZTH),*A]E7$_P)YL4U[T8#Z=H]=&",NH$7>/1"Z WD0!T[
MJ3!O+QW]>49'<>):.!QZAP7K]Q&:,?^CZ%WV!*?A\FZ$IS4CQEE6?+#"0R]1
M]^F.OOG%(I**I:AOWGBTJJZ'!!TT$;P1/MD,AGJ=>(EQ<>F]7(1SNZ*L&D?'
MYF>ICXF?HGZ7</?,0:S@O# .2YS4KD6?$2'F!.,0 0_4&@NO-84F;=21&[I.
M:BWDQ%7VLPR'YIRZ@70V.0*M0 XSXJ'XOX=>_N!HJC%N^CO2A5K5*JN6X;W8
M;9L?4SQ+MU?M3J<R/U=T1MI]I7UM$2]R9G?P3WH9)?#SWW;S4/L8=?PQ&B8I
MB=>[:Q6%.WE?=1/E<@^/@>+ND2VW.77T+,MKQFWG8$#'L(GV\BB]\TCXO9&]
M)Z /-3T082@_A4+&8/_8>]=;B-\QK?33IDL+_=9D>P3"-+]7$VFL?7=(<$BG
MOB63G/IU5(3#I!=6S*U;84A&3H"\NS&IM3)]VW9OI3^V$$]&NR%=+C3&=V=7
M"_TV[;J';Z9TS$>9Y$8%I=.9>^3[HW[Y(ZV^^#'R/LQ]%OA:QL-#<EUE1Y56
M=:P!NX/>'8W&FAW18\C&B,3H@&/V#%=<@0/2D:E/PN2,LS<*'! &FJZ]"MXZ
ME? ]ZD[;OY,Z%^VZBF1JO#A;F#HY6QD.998J6KR5V4<G2:)PKMONFJ#2%9,]
MILKC -F^LX%,"%C!E!",= 10^=\\/M3W\:B,+T%MS1 KM;(1MX=1!A48KZQ8
M,J\G,,6X"J0O]<(QG^8=?(<QR,L4$Q-BQNC SN1SL#X 04UYJ0#GY,(X&9KM
MBFK*9HJY<L/X;'9HXM%WQ^<9R]R%GWQ;N7^0$:F-M)F350Q70\?N?[P$QKBZ
M,?+PA%VOQ:C;W[)=9U9__)T33!^+94_WK<K**[(@N90M#)(^;"@71^9\2ZE(
MW\^JNM8]Z6-?T%M-=N>WP?6!&H!WH<L>B1*E^Y[]ZI!IV*5W3!2,R5HR&-_(
M/W)\>"Z9H_=YM=T\Y"%KJ+Y/'W9?RKRCE/G969<R_Z CZTZ';'?IAEGG .[(
M1;"$DY)1BHQ=;CW:+MTWI@X6;\\':0 .X$<[[\@-S$ZL9$B<( ,[0W]57R-P
M$J]GFJA,VC2%%_6>#NY=Z.!2 VAJ6L>M&P3E5X(DS/G#_T= ^\TGW+7KX)Z<
M(FR6>(E>#4FG*IVI&5;$JKDJM?,MQ"95<QD.0^,]F<5U?5W1J#D/P#?5R8M1
MS#1N0#;IZ**[8@9GM,R_VU!9Q'M>B6B 5\T8:56DY=>[L(S(@@"!"$\:3X9'
M./U6LW[AS) L50ZAJ^11MIY3JY8);I<@D5NXVO$"Q=;JLEX%0[,W 93GR)(8
M>:?@)N\BX$JJ2K-O<KI8PO;P$5C'C^7LOT%^Z&$*C\7IDN[RNQR_S4SG5H_P
MWG5RAKTM&2NBVEZRHH;VN2I%';825->&KA_@F,I.4L;JATY\1.V,!^^_SV!U
M0RM=,00,RSUG2K@#V0X_/..^&HW<E>NG&UC!5CRD$@8J?\ZA(*U;P8K=5IH1
M%%-8..09DVI9!F_27O5(19D11:M3$0>-%[=:XZ %QM)E)Z.5(8",G$+VY6E>
M=#6BA,M@$G4I_T%R72A@W+Y%+&TL7#:%P_I-M>BH'%AUY^?'&,?6J6H/*CBY
M=/J#K*(E?6=2P@NS7)JZ#UWN(YE9RU;XOP%ISO@PR3FRWK\DXR2;Z>RU +^N
M5+$2Q!5(+M7<\KT>NC(F0&CG$9S!>-6=U%<D?\;5>5-NI\BD3YWF,<'U4;D;
M68EPA5_66HM71KCIK0*<4V3GS"AZDQ*-9#M^;/"XUWMAJ%K0#1/%"3^Y5L&C
M>A_#IDIF@\@7NN$2+U7MK]JU5!+@K*O8MON7!/S)S([AZP\F7W3Z!4DC\)I5
M&&]8WIP&K:69>J]$4/C&6E -.^U2R]7IEM6AQ6VW;_>\LH\_\WITS#VYKYS4
MF^T#QTR2\E6 .Z]:>X;^["7D1J&T_,!-\;NJ,D55F@!)8@DB)<$-N&]5O]"]
MTO,5M0X7RB4(*M9Q>D7!CDIA?!V/5>RN11N3,M7QT326PY%UH&RJ[" W['55
M$H-R);WBM3!XD8)=PL&6M1.-<L,S=E#WG$&"T'0)B 5P,\%.M&O- 88W?P>&
MOX_%:)&O!]Y=5:;ZMKQ54O#^R'IPF?'GH=]S=B5^4H"V42RB>0NN#G#YNDW,
M;D5-FXP>4:T37LKTY_K1[VG6=</.# UY-VPO;=4]F1WS%8<+CZ@Z[0<ER1^B
M*RJ6Y)B=NLEXB5V[:ZP;-VT$WX!$*^[XFKF+PCP"*4.YH.Q*=79$N<'MM$AU
MGGQ5+K<'^U#N*BN>DD=[*=BJT54-/IV]+&SR6%PU$-+X,41R6WQ(5"19]M(
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M,2/0ROQ?=QJYFK;2XH':/#:$=1\/XI(H#G>T&B:/@?*:"UGCL08L9=4V[0Y
M%L'L4OU..4PR91QE=2?2:?/GW:F_[MI+D%3H<5(Z,#C]BVV]I .H%-GT#9H+
M01KP_2?_6"1DBHZUAZH#FNQREP>F,+M"]&.%A_8 R>1#$6/)/%)ITU5C7%*[
M]V4VCC3UOYQ10^E35GYFA2\6+\"EMZXI'J6R#RL.$I,*@6ET;@%D@.^@,Q+^
MB.=XVBA2^3QH$T0IEBE]UQ.BKG02S\X'>3-O.&AJA%*42\D$S8@'9[RSTTC5
MS5$X4'9Z^U@P#C.:W=6VX9B"49 V6D -1PY +/_DQ#+TS"M**Z57BK.31 "Y
M\6W(9=?1N)VX:U2U4U;_L#ZMTH/5S;&?IK?2D2XK'2R^QF,JTM*VLVYS!DVH
M#*/E\^IGS8Q4-AZX(S@3,T!QB=^XFWE</>B4GO.?*[#) MQ#)(7KRD^V6)SV
MV*LKY^+UT!%!&^-:W^*"9TXH_H@!X^1S_?2,')T!/U4P,;[U0IV-;$;B*\O$
M>#%OH?X_LV/[&A"4QU]]^2E;_NA5?*=ZE<^&_57;D4OW"2*\1T___H_OGN&/
MCY\^P,5P75U"(#>983F#R<4J$"^A_08*]!=D;X/1_OL__OV+BR\?T?=^?/WO
MCR\>/?(,RNZ2*/M^Z!CYJ9>$V]ET561U:AW>>$#*/I$^PZTSAHIG"H@L?'AJ
MH"\V=SQC[FCJ%3EROM+'Q:NNGWN47-VL,1.1I7U/CGEF?MR94R:^G#&4@"@9
M3[0.ZKMG1M/:56%R1PN?T:KK&0L3P;Z1D(HG@T^(&33IE1^[,"^YD<X=M8);
MA'_SN3B[@^UAVX)63V^+Q!=^=]:X7W_EVB4[O@72*W?^QCO)GW_WV^Y6($&_
M\LZCMQB_W_@6_'#WWOM<<\GW>4I&UUR2<DH'X8R5@W*.(C'-/"_RR9"@/](6
M>^@SQZT,@1YY4B(:EF9YR$\;PG'LM@>TN;"+66=2P.U,4'QVY_Z?5;BR5<CD
MJEI?HC'B6B)\BLYL*4?\TFS0T87&9;MK[C!!,X@/9WSN+P1P+80\"@.S0R2D
M86 \-CNM@8X%A0W!A8/^LA%1]"._KA&"6/F#&T[=OPUQLPK4LB2,'D.,@4<P
M]^L>\8\&"9X=3F$A3L^[;[AYEYX7$84RWPE:/L.@.W9#?#=]QU3G+IXLAO;D
M+RV@1!,3@J7G6$KC5/NLMCWX]D 89[MBLS[$D;^>3_Z1(W%?8N(2TY=G76+Z
M:%*A?V^W:^*7D# ;[1TP,)OJEBJCP@1$[F1/O<17\GDDIX8>[2?&.\!I-6PQ
M9+:=Q ^#G_EQYY;EG)HCSZ"#<E"Y,X6Z4G+MH_DBP8AF>TAF97'3,K1)N+DH
MM2&4W.KON:NUU<9N/'R6GWDLP"++$O6W2;.%VO%@FG;4;;76,L8>;CLJ1UK#
MZ_M6G T03)=-0R4=R'E0::(2C;&&&RA@-6RH^:?$II*\2+4677MJ=3#1C0W)
M-E!::AV.JD06]!$T#?Q$D4<Y>FC=LU5MZ(HXM(.C%F,'DR3YZA"\-'MY%'-6
M^T72G])G4L*2V7#I@0!=[Z_677G+-;=L*=PJ'6R;T*U$&&M]0ECL:K3&D"31
MIDNF!#=]PYZE;0Z,C _7R; 2=UU[22]KV8+NY+DW5+D3OT:L7F1-CPH'%S9R
M0Y[3+N".#VTH^?01U@3;CAB 5^9NZN/92]%(VPT)8^TK%N?DX87?H6DIET0I
MB(U^O:*H\9*GR9#QDOMCAJDM-7ABU\K!T5"JE^=QDY3[9=01Z%A>5I CLT[.
M"1<" Y0'^^G6L1(W0!@.]:[N>5&F/@S&<:J^L7Y.0^MIVB74TSJGR,M>&K.^
ME\K E5O4O1MC9&JCT8U_MPCN-Z(MT95#7J?BW4@>"OU!4B]\3)Q%BA-+3IQT
MV^I[3HP,BW;JR<AT0Z<VBRS-MBY54P]=-5'D+:X$_4.^7#2<PL(^GH[(.D_?
MP(#)<-#6;J,<C89J[O301R\6STAQEHT%N/*#M2&;0L5M4E:G;]"[10,4R;@K
MA+KA[8F_6U4VL[>V%EOJTY0:HDHSM,NM@)UE/J>MNB3.>5G[*P$\C]>*<0$
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M,R]L$2@12%:;A#'$>NL/F-TT?$HR1\>(7V-AX92MF $M\XR-,A3':J(@=:C
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MBEQE\?<B!7I6ZC86%J8L(C\)M!NT(E%WJE!E5IT2_+&KZMUR"(O+%41^'#K
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M+$*4O-XBH!Q(<9T2P2!E!/G-3D4??2_@5?G?9;>FL>H:\M-N*;<TQ4P8]4Q
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M-HU.A+6M^HP+8@I_75>$$K#DNT[>.1KV9W0JHR40!X&O[+^T%!/0_'+@,QV
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MK@52T-#<76C.;5>?U@/2'RIR-XP.872(>W V-FO->[=W#@)RK7:M<>\>C<.
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M\M0=&A8X(F7'<M/,M740 [&?OE'AQI>,:B)P:@>SJB/@9=A5.WF1BQ<#U@W
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M2E"%]#PO/<Z;*YJ4]N(%8E7.RWR:JTU9@NBU!BM?I3EQ4#T6:1:'*G.X3XY
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M$38FUL*KFI''AMS=DU#;SHXEH=XYW72+M+5OI;(E:I$E>]BFR8H:KZ/GK#*
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M.Y'3L!WG*>QV@YRUD-/M&>1L*7*<C5O1'HB_:W_R=>3T8E8 :$(\C82=X.C
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M<B"J!O*P$L#J9W /9OP/]&*@M6LYMH1L3@),S!]/K"MAP<.\L: $?UB<B$,
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MG$\Z"V(?G<.7P,5YH81)(0I5;2!5 HPNX<VP545I\%AD)$!8UUB7 8L\*NX
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MT38$; 7$>/N/,UQE/:"<DA.^:@+>6N2W&6263J7!+>X4V-"_L,X,O74V?$A
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M9(_(@O5QZW<>+([A0!H^I,9@R4;.]$!N=W9%7>8%R1<UF*\X%C50U>DSL4X
M#2I2L+RAT(&='YP56Z]H9CGUJ$/;S+LI>A,60_:HI5:9RB))A?#?D>JC5;!M
M^>2D&H8K8:8#%S>CPU ;:U&"H<8[E,DRUX]KY\X\SYET>MV&/=?O^W,4"O*
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ML  $_!EP)SV91$A]XT+$EUB9; AF?8(Q?HO";]&\%[^%X[C&<7%GQ\6_[\S
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M%<XA PT@CMQ!9J ! H4".>PD=.O&2;CO3D+7. F-D[#,#KK(#JJBVH?*'W6
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ML)SM<%S/P=A?N.3G!56UV[SO)Y<UQWD]N4IV<1=T-Q0]_^G//-#AR1]PMP:
M$OBO[.]*6P_:5HJDQ@P7.>4BI\Y)N S[IN'SP?GME?/;_[*<F__?@6<OZ32<
MX7*&RQDN)4O3!X1SW"OGN#^<R0Q]U7^SWKQ&& UGN9SE7A3+;?R$<)Y[Y3SW
MNQ-:PC<2>\^<WW)^R_GM,ED:/1V<UUXYK_V'X[J.-1>^.4VD8'!FRYGM13';
M9H\'Y[97SFV_$=\3[OO";W[LPND0A?\,^ISM<K;+V>XR68YT3CC_O7+^^SB!
M%0"J@L )?1Y XYR7<][5C.RF3PCGN5?.<W]S)C/B"G_W8\^*0I^[&3C7Y5QW
MA2Q'.".<[UXYWWT@$0F$?SA!-.,LE[-<SG*7R=+L\>#<=N?K\>8X67,<6%I#
M[4\UWOYTC_:G_VTY.!9&^.;,G8C8E=K6*"U:_U?8CI_8$NC.]RC[I4UX\E*N
MQP@^H#V"+JTCCRGUC:'92,N:8=]4M[?+.7K[ME8U-Z&MSG!RP3XM[)JL"3W6
MO%EXP6H#IL^^EF3V[?^J(@'TWN@';>U%^X$A9U@0RJV37L8$A\ _Q&/7F13+
M.[\XP3P4WOW7PV]_$[Y]>Q"%QQFV!_N_CNN&HO#]/T7A-K8=T)CI+X6OGSX4
MA^J>6FHB-(7S/7PK;)R?'SS?^Q[/X<X3 4=-P(]_X/Y-;N2>X%ES6*=-G \)
M09&>7^T>%?'3FX'4&\G&X*^_+-UF%Z'Y$:EY1#X*GXCKX^@*X<F/)S/\SVQN
M16$LW"&+FCIKI\3"%GO)T;"\YYGEL!;A#\1?8/,KJZ/D4$T<:F$HLOZQNR^!
M>QH"AUNP+0/.=S<#]6>=:PGG9EO;^4,%!B$#@Y!EE7.(XZ+I?06@'/%%6D Z
M %=MJBT=KYW--8[26Z3$N@_P)<_4+/C+3>E&GE([V6<CE0T;R?7_=K,N5<*A
M<P4OP*^6:WD3 DH+(:# 6-0L^$0F9#XF@:#*U ?<7<&/[ZMV>_FTTXXB=?LE
ME$T,HW$^P?G[H?P=]VO(^7LWSYJZPM]SWRXR]OL%87</A2E8/6B?_I-802A\
MAH?9E\3WU6[S?5C^!>Q QY<O)J*WXZ\A<]';&=$+VZ5ST=O-HS;<*GKO_/DB
M(#,<3?]"A&]^>/$B>-AM$3SLO@@>=EL$#W,1W.VW4+@([HX(AOTRN CNYEDS
MMXK@QYD%$MC'$M$P"6D*G_\=.]%;)5&LTC^5S"K@A[H[AQJ 8?)#W<E#K2G;
M]6HKG E?7/_UTO5II$.']6E<_@7L0,>7WWU]FFX"%[V=$;VX7[+$96\W#]N@
M-_KNX_#>:M4#_%!VY% .,$N0'\HN'DI%D;#OQHS8L4N$KP*U9)6/>#QMXH5+
M9_.K!SKQG#X+=>7.2GWZSJQ (;"\B#.:CC :NF_J5LN;UWFF=9Y?;N1FJCSU
M)JH\!WI_>#UUGJKYO]/"J-IU44+5@M#3XXJ^UI-/O2)%[R>U M>G*N,_]BAV
M-8_Y:O2.E685TI>]7S@>E78>?>E&*EZ/^GY;W^8?1)A9+T2PL-0#W@!?R0+T
MS6$M;XB_2?']QDDN;\AR>=<WDVY[&(]#QW:LP(%UOF-$HO=[OR'[5TT=W@JK
M:*(\F-C+SPZ7G')^EF<F"I.EP+?KA_!96.*))]03SQP4$W3J33.G'K$FLW06
M^!MU[CEL>Z-7_P8_$.!YCF\+9)/C'F]:7+M'C1K\=)J!(GL%H:!=W531JW+-
M1'B'I<]PFN!=W3=&KR4ZE3PN?-^'&PI^' #=*'HK7B< 74-<[]1R GP:4,5R
M70$6!N2 G\+7"UA+R.Z7WR*5C2E-$P!4V/^<CF'LLKUV\#]Y7B'^ C]J? OA
M]T 1I#L&;%Z=:";\WG_L"\_$@X>[[AN>#+*@,,\9](*-+G5)V&_]4;?<T"\Y
M[_:_XC!B&QXQ5H[!IPKP@%\') I\"@(*2,%:+.!/O <]@L@,@!!.2$$'VV^3
M<!(X8[@CD!LM?T%Y9Y7@,XQA.XLKPYO!S0,?" X+H#"@KS(FQ!/P<U#ZV?,=
M8O<%>-U7D*EX$&'+GT$[L7&]],5%6/:+0UY% 8##5HSHA)M,X%@&I"X=5E#N
MPS\P4 ![3%&4G)+TIDMOY=DB15. )@0>L5<BV#Y;]4\\?OB;E"QTN=D#$*GX
M:"L,XX#RY40F5=T]ZP^@'.R));P"JR0=Q"_C2)1\E "4W!1\$5 6M(]L;Q+-
M*MVBXF!AL,]"?$ZBK[S[W7.R*%#X7GCW<'=[_^M[L;C%B4A!'@.<T .Z8AUE
MX+N"_X([DY$[H!H?/F8#ZQ-!J"+KAZV#<T'9JD!"-%D<D++TE'Q-GW&7/(,^
M7?Y(OW@.F.816'/RZ@=_".\425;?"PZ  B7V6[KL.18;$QJE7B T OKNP;/E
M.7\FG#4AU1,H\3;H[NRJ,#FZ<-SP@+(7$A)])VGE]'_^ESR4/J;]G%+@4G5
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MB!Y,)_PCW/C8E&@[WV#'^L0B*5?7@Q1G)]UFYP-WAJZK+SRBYE?X<?9NY">
MRX-;B7B8+0&D<X2'VX&E@#H')V^"I_+9HKH4V[TY'FIV"FPGG(!QF-RSVCLN
M$9EJ'_EJ7BPWMJ+L2646@1"'J4WL/'L@ R=HP<&R'20],C^;H(C.F2#5D5\)
MV%CPWY5'H.!#ZRLQRJRB@57A3?Z!JC+HQB\)X@L'":B-] .:%N ]SL1303&O
MRBG2 OH;]( 7_7?G%[MWR!DG0!S:WD+XS0*]*&CA:^T2QE1?I"_">-2<O@AZ
M0^:Q!Y]3APT!^QB%J)5^;<$IHT(N\!F# TD1X+%/K&-VKZJH2G@G8'7IL7ZP
M*AV7OD[M(/JH2:::,I%D11^$=_+[Q)'">!<[6R'>MWB*Z<.1CV:,++ES!>X+
MSWJG@)KLO?CN2R)6J,!VJ*4/ M-UP6RDW 9LV'\Q194:C.AO<LE/X5^Q_9R<
M+;H=V2LFY]+:L$.V#VM' \]R\9\HQ4 O0(6[<-!2';D"&UZUXQCG?64*#CQ'
M1!936%W"3LH71Q$C)AR!VBV@C2PLM#+6EE9Z ^077I$EKF^;#^MT@,D[4;K+
MF]G*<K#@2L(TRN8P3>L#+NUF_I\3D9J<T,DD0"L9).H$?LO C-[A]!\1Y2I@
M?J!_MJHKOS5"XC:DYRZFIGCF;JO,),L]'JA\6 $ZYU"G FW"]1=4;TRIE*I(
M\("0-OP(_8E#'T(U](7UECD/J4EO3:+\IOZ20^+=W8_[\#W;DO2G0)5X"G^)
MJ0-C]?>_X>]19WD!0>?'X:ZMM9"M4TNI+X"=E+Q!ZL2')5:^GIF3": RD[.,
M@KG^EXA9?!MJ]04OS@0^3I3F@OL&R$"?CN_7%Y)]!7[*]K7B;BY[H)C/)G=#
M%6W4 ./QJ.3^19;5O@3V@>OBD4D,+LK481^IFIBP\E0M3AA_G6/5KQ3?;-/!
M E4:S8VD31]U91W"5YCL+A6G8 ZA3H*6@XO>X163((42/K0$/G@0)B1(#-<-
MY[8(X8B&3FX(=2LD"ERN_;"5P3U3S:>-UL!.M7GJNZ#B4-4F\52!P3;'AO0%
MHQ/= 1D9406U[8#9SZ!,;]BI?V0P2$!A$S3[F%X+.Y5\FH2RX/EK_L]TKU9]
MGDL<J?;I>L(U9P>T[)8%*!5LRHK\",S_(,5C8D1DBGGVU#+. ;^A#_9HC@"-
MW^7N<G8GL+_1T@\MU+A36Q_VAKD"2"X6X.-%#.@&OBO0IFZA2'5[7'\:5'0"
M^P8TV>B-AOF<)+P:)N(%.%_ =FB^XK);9=P)B2JSZS1PD2\ZVV:V0.2WQ'EA
MKH)?X'QE,I(Z"*AVEQ],O'&.LX+3Z8T%O%8%;K;.["F =RQD\=D^V6DT;?U6
MQ>W;)LDH=JFTARO0GK2+K*02ESA3/_-R-H'C2FKWT?T.'V1-,I7>*&UEO*E1
M9DN3>=*,$(0-[F-8NO.I) @==+IAZ+[E/N3:V_G-9Y9\MJ5J;[3<DQH6]I_
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M*)3%R ?'0KGATD(,[9!-FS&T!A.U-S*DMH"$Y[B5 ..;#\M:3<$6FDN@ZH1
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MD3_YX\$*[H/'R(J(_7=\:'[/1)V1<AYA;&=,&Y>C'&<Y9F\D]>GNK'<"6OM
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M=+7\IGKYZ*UG'\Y]5.DRQC,V"*H.V(/\[!Q8D=K,V9$O8^KCF<\.E>N_1#A
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M_>F6WGKVIWQ#$^.D]M'$H<I#T 5*PB6\K5C'<;33!]8DD+ %HC$4-8D#Z>*
M=%*.- 1E05=%M60\8U?;U'5%6W@D+GSX+ K/Q"-8K8]:@V7/'<\)(Q9'Y3Z#
M%I_3'<VZV.[^C>TM'-;;I9W=][QB2-R0Q>%!C)];A:T$U X-XDB(PGCNP!!-
M7>:(NC1$G8='T:BM(1IJ"Q!U#:&ROUF.)P 4,,R X09L_^.Z9!+%V (H\!>P
MUDZW[^O@.6U0D\#MQ9$1]]XG)TP;*=U/OWJ1Y3T[8Y=@_G]4.^ ]P(!W^7QP
MGKIY :#:H4WLA:JM6>@#F6>A7S2BCL&GMB-*:1NB.MU)OR(F< ^%:>#/!7^]
MG5D''1$7E2IWF(MBPP##I&V=]YS/IZJM3:B]D3H<B@-=/5SIYUF:W8?>FOIQ
M1.SA,"M)$]7!>JT(Q]X58N^4?&_0&^D2F%%#K<W8N[)$C*_8#8:$43*KE?L^
MVFM4;+<IOGHOL(T8X&1'--W8VL=T".J)*>IF6ZH).8I.Z>QH#$8XU$T3!\;!
M-2(<1FV$T:FX$<;<1-ELB^>5=[P\5<?+;F>L?/$#^*<G3.(@(-[D37CG@LK\
M7GBV'*_+'J(.LK6C^(&2_;U+MO<I@ 6RVZ>^W5\)<#JR1Z.I@4DEIS%8YWD\
MRZ#CZ*KJZCDBO(92;S3 ?-@&O(\<7EW2R8X)*KDWTL3A<#V-A;?&.P%*[J,9
M"1(/CO".L&2D]_MW$=Z=V=/&+L+ZT9Q7W-[;P5HH +_[GK_L)MXS+6Z(]9RB
M5))HSUT'%P"E'1ZHAK&$T591EM>U'8ZE=F+I2 &L9E&ET8Q 13HD;Y<GVM1+
MM!E3[315<R+K9SZ&&W-YW2P9ATWA%N8DFODV_#YU17;9\7+%,>J*)SR/3*>-
M,QTO!L+DDR:9><-^!T8."7]S/#\ J*3>Z5O/7KX+FT#\&P52[M*N'?H>#D (
MJ6 @*0WX='C:1?<A7=4/U&9,#\'DUU11&J[WP^>8OD),7P*?UC%%214U^1I2
ME%JM\7W-M;S$GW5%GBR9>[+.ET:5<)W$,OR5>&3J1#5*,89&VTHQ.(!.FT%U
M,(),CJ"+1M#1>9 NM0U!U^"E>KP.5]2EG\XJA[.6X;']J#97"\RS,EII&._G
M[-F(K'4$X7Q5I04=1#APVN!1:<@7HJM@B(I2$X6"W-^Q&QG?2435ABX78%VQ
M\[/B285=WK^ 4M>:B"+5VJL.V(I7#+JJBL5AJ!NP.(]B--#WE*.N^Z@[#:\;
M8B1&$[6#>BT>'76\'.R\Y6"M5NEHTM*"!$F*4F+D"V,K="9L[H'CQA&QF_ %
M=22PI1[-[U4O-J_"6;?]>.R2RV3:#R2@SLBM>JJRD75_M@(/R!&FM_G$@)KQ
M:2GGT_IVYUK#"_D5ST[9,HS>2.JKZYDHC8;QMZ&F _X2CO\5E;D!W)E[PG_/
M=6P^B(:$)T!;U]'Y"> G8*/Z?O@),.0]3T#CHLA0\ 3H'3L!U^#;_ ?]![%O
M+%B5]4R80AP*<4@P)BK ,B>Q2ZLRL&21A4]1<0:R.YX5O!U%@VZ)T[2#C&?C
M>6?[NE77DU8/> J.6X:-[_%\3(+[:7+.Z9D/[^,HC&"_@4[5' D%KJ">9KUK
M"TT89LW5:KV1.1R*JJF)LKKNYFU),@<_(DT?$>V,F!N<:+F-'>DAC@DV1&FH
MB[+&#\G5'))S,N9M?HXFE]O8(3'@D"BF:"JR*)<$#%MR2+@#_3@.]/,OL*V_
MHH3[);+ @H/_VL[+Z*_P1_KKN14\.QX+%2G AX_&&.D=/S@1'(A)E?00/R(?
MA%O7%:(9$3S*+$),-5TVD4)J%>4Q!]N*++2PX**0('^BL2\+&(PPA<N\B6.Y
M\'+P <T1$F9@H0EC0CPA(%'@APLRP?%6[IM@V?^*0[A.%%YG!.YL+1:P<J2B
M*%CP6+@@C-T(EX0K9*FPC_$8:.N$R"VCF17!K2? ! 7@'.S&.(OI-SH'6I5$
M09$4I2\ ^X3U1[Z [RPH[ZSWR/H$9#3(J&#!CL=X(?RK+V0<:]M62F6AD=9L
M[A,0S)I,_#FLYHT:P?#F0%,DLT=G5#WCT,N%%:3TK;*9_8V421ZN85NC=/K(
MAX"X=)39QU?'CF;P,E1"%ZYB3/N#E%]BC6$%(*TV7G)"DF\BL#S ;HPW^C(Q
MBG_B>E%H.H9EZOIX/#5T2=,,TS2FIBU-==D8ZV--'IO_(ZN@>297S8+T)18@
MO6_& ;'^N+&F\(X?+/?5>@N1UQ31"% LTGTKR1S/!G)]4/2, XW^.@Z0>:V_
MQ ;$&\=D7@FQ]5(T_[?E"-^LL?#-F3N(S2H'='BVU=X5C]%CS@GAG-W!@0S(
MC'@A<BH:S6WWN[RCG-Z/X1XV?8._O*_,'F')5";FIYVZ/&'IKK4(R8?T+Q]3
M>>IX= 'THH_)S1(6@?A>T?@HK-G7.?3[$H-_HL8D3TZ^[L-7OZQ_/C#ZLJ:4
M?B7UY=+/-]U*5OJ247[)IEMM_ER3AA>^*&WKK7;HHUNM6WFP]KLSYS,8E<[;
M/XD5")^!5]O")S(AJ),)JBPNV5"'T*7@-:B:P=1N@H&"5RD#9.?;7@VY%$ZN
M.N22ZYR]\]NB9\VHZV @<6>1!,_</7>1@F'R(@4.NE,7*9@2+U+@J#MUD8(I
M7T*10N.Y]M33< Z(L#;HDR6W3=H4G8Y?H1W1J0O5^HG_V9^1??W^I;3#[)+/
M*$?6D_7SP0_P&;=1%#CCF+I-GOP'*P U6J[1+L!4#NDU<KYE;TO#V:6KG&_5
M6F_D.>[NX.G:!Q]67+5M:_/1Q>NO;*C#V@BI" =VN#3LE83CJ*OZ$&.H@WI
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M3.08?@Y8,OVJ=IZ"/.R-!KHH#S51XHD*'?%M%'9[_?#IO='!S?UYX*"%@#E
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M DRM-](T552,0WS['$!M!-!I.-"@-](E3=3T]4SGDP/HHG3#<@@4VGGA$)^
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MFNW,K ^(#=MNDT#P60#2>Q9<3&;G5OV^'GU*ZOOI[R%3IN_'D06/L[]Z:5D
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M<T\&W>@:B9WT=C9+%F86J!UC0CSLK;>PL/^BX]&NS(%-TR)H'\3?^X]]X9F
M?FBY[AM^36@'22L'>M+Z#^>]OTOZ-M*K_G9[^Y!V;NPOG9+BQ>DI85W@X,[C
MMV+&1=IPD:TQTYRBU0;2N]\7NPZ&]-3B.&)X<WC<:IO UF_MY^F4M<T46/M)
MUOR3U6H@BR]2+HS'\#X.R@5BP:]0X00Z.&$8)WTYP=A@_X M!Y(!.PMG0";L
M<@DRLJYILM3@XNOW+VN<.(+S._-=;(R)G>VC-Q3']-/'!5@H((]!70_A43]P
MG^6E'O9 L GVL7^%I<(QS@P4*6<(P]XH(MZ:?;+V<N\*#48?\2/AD5$*'YT#
M]@L%)&(+?[_VP_*VAU8<S7P&,/HT 5@1\DR VP1;F?VESD"!H;*!HG3(-EH4
MOD?)=YL]E2[SCCVSV@R  @'UW@B0))78>$(*I.W 8 2N_!K98(3\3>CZP_Q]
M:K^#T1L-\!72_ZV_2H("RMTL;#$OO.!P23P>6W?G@01T=8>\'MC<]P%5,&TZ
MT3*_Y_J;F+T1[3HI2</UEUB0@+T(ZYO*3B3E"%6.-WZ9W4$ GFDA.TEF>B.[
M<$/R.B.L36O%YONLJRW3K_%2[.4;D*1O:]*JV!+&5!I3@TF(K#_P=%%()1*!
MGBE">5R6>K=V\NB3<ND%CPK\<)%U$[;L?\4A/% 4V"M8"V N$S2;^\)7#U_$
M(VQW*02V'.Y)QI $*GE2#GK[Z9$:$:MDG6"F')(G\.?PN@1_*.S!2-5MQ_Z6
M*BR6]XE0BQP>3U?_Y!=@ML)):S)27>J-8/6[&"GMUBQX(-<RXASPSIN$QZG>
M6=Y#>."KTH<)=W3G<]GQM!&WJ]? J:/'!L>VQ6Y$53"0W0Q*J:7*:$8I'$?8
M$IGZ^"D,E_-3.Z?/X(E<UUS&Y!F6 B\?,J4/CW7"2'!;X09PCNE4PLF;\ YX
M5OA>>,;47]]+#V[.K HL"@F8=:?&74)>-*>,!SNKPR->L%.W^Y:D"S.5V$=^
M1MNN@P!_1WXNB!>2]R) /^H+MS9K&X[:\8:76 0^"D_D?N@NLOU7JL)NN2T^
M%74C0=;[PE)C;#@>_E;R4,68O1(\8XU8 5#"PK;\-!4"*2>\0\J]KT Z.FUP
MBJV:*Y..P3C,J9C,DLQZS3LDO=ED^3A0_D[U?WAQ;#WO4<+0-=#V[WC++.DC
MS^/H ZG@$>'"9X>$K3',S0C'#U#V.;Z='9Z:ME(BSX#^<"%RF?28IB_';I_^
ME*)MI<7[5D=M:TWZ<5V3?FELQ"9#7B\9!Z&7C(-XR,U,VA"X<.N]K'F](S,@
MJEGSR:G+#.,X.;15QC&@IN2 @8CRZA4,-#C$P*.(#=S-=>DTIB#-JHH">!-K
MDK?W'ULN.@N8>4UPE(1'%QG# 2PL^U*.P*3N$?@])/?3SV$$FDV$IE$*/K4$
M].HZZ.%RW,7L!CL<5ZT'\\;#B.].H5[BZ*F"_I07X_B2W'&%+BB0>?^.'=3=
M8/76,Y-\P+'GUA^ V)2PHO"OV'ZF=V..<@M,I_F" 9U-#*%F"5T0+-$/Z&F:
M9P<-?D\2*Z@@W%@T+QN&P^0H??]GFHNXX2+V&)MUN:9_WVAR;5H/"&0"X&(_
M2K0+L/'B(/5H,"D%9YR.,F&V4H%",?X<N,2_$G]32IZ4TXC".([HJ4=QG<Z0
MB7P1V4\0XR 07,28$3<@$__9<])=1<E(/5=)L#-+SLP6FHA4,-X"'X0V4B(G
M 7M?ZCYDHA;,RL3"G$3X:$ G#:#B]X@*M :GEE,P]:DZ?\.N0^8&3V682U<@
M)L.4Z8"9=# .7&AGPVJLG\G^47T_K HFL&/VQ5*FL>Q&!H[7 .:=C-,Y "!A
MKO+TL9=V3.F/M@J\BA^["&]XFX!9O=$R(?KK;+[:E(]6,7V[+M/_PM3NNT3K
M?BH(S5O/IO]TF1&R42DJ"4/I)6&HY$E"^BBA<//]@AQZ:>!)WQ9X:I%\00F2
M%F_B5*>4+.N:D"ALZ8]>^#*IJ6?GN$+=#&6)=!X1"B ;1]$$65SD+\LN@K6A
M.<7Q."#3YDDR6C+IR":@B8&"12C7!VY6]J81VH?,$)UA/@D1?A /+AH[V2I^
M_/9KQ770\$O6T+"X -0A=RET/!UE)1U%V9R.PA-+>&))2]ZEV<22S?D-)78_
M?*IN,1)*K]'9-1M%TYDDT7;>G/%4;U5$W%:5$90WLZ*65<:\_=GI-<O/??K'
MI^4'I_=<,L70LY88!&4/<<)<%:>66P!'%[1WO+R0&O.(+FPK +GFVS0G@#XB
MH\#C73;PT<#0=@JK4ZN#Y1N[IG+]9D7PDN&15[EU3<O3$ZGIMJJ"X.10@$9N
M.J6;UKF8P>T&ZPCUKD3[38-P-.\!E@NV6W: -AR.W$PJ$B<UQ<G/Q#\=4,N+
MH3OQ?8$M24A$;;*^P!(;,CMK95%PMYD31GY >_$MW12LR!^)1286C%!TSB=&
M)'KKU]\32QR9O6:AH9HN<9HP\65?--IP3^P8@P&'5%H-$$0%^X%%4O/L&32&
M Y0&=#HG6LV^1UB@(?'NPT<!F<'2D4'0Z(*S.ZRP=I&8.3:LR22>Q\F&-K34
MXCW+EIU&9%A8:??ZJ2<A26M)0"80BH*NS77]#6B$P=5-_@=8GY_Z=YUL(_ ;
M1L=H9GFIUR8)N9><MI*S2E, HE+3K> .PQB3!6L!N-,#@\3/CE#RFY(CN9_;
MN47;LD4=4E'S]&[F.S9N$[EW[]-6?E7T:QP(B(+;Z8V@M K2](OJ^"@\9!T?
M!? D/R^$,BA0EE^(,=Y5OINX,?]D!Z!ZJ/DBW&"D=OC/"F>WGHW_0;'X8KE(
MFA\$5%]G O0J_YZYQ')/6$F>KUZ2YXMW$07\4RC<C(F2_)'L!_LYQ@:ECK'!
M=L?8&;:OG(O0%Z>^I!42=4W]*VJZ>/H<%+R"Y;K JIYG[AMP/G@Y/* O)%4)
M%G$ ?  -$QH; GX&+P9,9&Y%P'@HCZ0&3D"( ,PTFL&_ \'%UA',;J)Y!R0G
M6E_(Z+GZ%5M4&&&N 28;NV]9\@2 ";B1C;/JYRSR0=U8"4HW+Y\N.EDKO1M;
M&>.NA3734 .F.4>IMCGQPR@+[V(LY6<21\RC(=7T_S.QHG((K)_G2Q7QE+L4
M7I?"B+J%WU*<4>B.+>^/#$["C+A4\YV@Z1=AZCZU!S ;E 7K*82HU4JQ&1#;
MB2Y#2$VK"BF:6/@X WOOB03SK_EIVUYVH@]+9,"PI#X([WR#MQ8*][[8\#U2
M('EG]!HM<2^J?<(J<GQN9,)C$KUBEM4:5\/,4E0,^\*6A]1D>VFQLP#WI9ZS
M<"EWS4F_9@;A91R/Y[HZW \R(2#90*G>'*O42XZ$OGXD;M.TI/R>>VIB>G<R
MM]8*1%(B!#D10$D("7-8 53M>!()H>4FD?F I*F=J4_)CI,?XU&:Q&"> >U
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M2W8<8-0^%QB#WDA=%5XTL'_, 3QG)?-G]-\$OH>1I1HHV_<5VQ7(J "TP7&
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MS*((<5TSC)*P'BPT3V*96K(PC%>C"7RYB*$3>J:"*09(8"OX#37KG;.@(WH
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MU43P63KJ%QM8N8V&(?:+_O4RHW^]\XC^Q5+6+=U<_R6 B:<AF6PK$:V1=X\
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MH_(F-T(0[GQ\9IYNF)3U-+GWJ]$_,Z7WT5)^([L5UM**2P % H@:&*ZU(DX
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ME1_9G*9RNQM0I"C;S,PHVF>^E#ZZ8"85$BSU_V(W\Q@;8B\02AZBI"%>\)+
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M_60.7,0)6.P![P+X?H+KY)7?TJ )&M)&%C2+[/2$X7L#2R2K\4@6FJ&JX '
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M%YFI5X8^N\=+V0/LZ\?@ I:ARC) L0>=M"JCP6YP-"4<SMVLQ"JOIG+5+!)
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M02.WWQAW.MTR/+0G[@]:BT E1. <+WJ#QKC;[:CMX<%IF;4,U#*0T?;Y#&0
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MMC7=4Q2Z7+%FX!_4!NT%L-,6OT+I[-0#=NJH[>'!JK4V8G=F",J1<9571JI
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MEL7]I$@XB>F3N#P''B+Z&FC&6Y/\D&R/?I/ OTO"JIL^O5>7-RW^>7)F.M[
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M/QB6;DT-W53N/?B E$6UUP*W,%K&OS&K0KFS9K *:3=S72.-YV2Z;A9[)W2
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MW('IPRO6_ >X=<$_(F?W%%Z@&Y8R]SU@D6CT R7ST8<';6?-\\Q=T/NNL F
MFJ _; NF#Z;#,TP:_RM'<^RU;M+:=$^!_R+J/2P%TXE0?V,'%U>A<]'"A=+
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M-SZM\.C".H+_#MT8$Y_\QCYH@<@A(@<(KFILN][:1^/XA O83<8<F8AT\=T
M[@'\RA@=H4CYAP^Z.DB3P7K29 D1=B@\(D*OE!XAA,5-%T+0"3<FQ<WQC\B1
M)I-';OIF E]QY4C>R-*8)"/>.\Y [MC1K24227C<\.L9TS'R+W*\X1M)U+@9
M F.K(QD29%W-K2IHJXIMK32WLJW3@D5M##OY-E?K6CJ<=:6T#BIZ.YB4U*ZZ
M["W;NGH[;=M*^KMMHM[M2A?W,TW7QF]C'/$(A>#-W#%,E(*]<FRJ!PU1]E/Z
MP)R9KVO2%T^_EBY0;U*:[\67]%?K_25>9[G^R#5T Z^# &3!KR^X',4@:7P
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M<WV33U]P2ER<PR8F(T"*O*YQ/#%Q$B8FNF%B(D9&SS4G>UH_KA^OI=]O;AZ
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MNH\=8'F*S!X -F@VAJK2DSNM;6+E:H!5$V!Y2L4^ -9J#+N]KMP<5("#G5E
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MTJ>C+/?I_#:R]3?XU]2;F</_#U!+ P04    " "+@EM8'61E3RX8  !X'@$
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M7.+ JKH9N)4(E9_@7//\2W.>6AS5BWZJSHIN'2!:>.\G$I#D))AY?F<39EI
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MDI7VS!6PRF-TZ"TV3W%M!&Q,KM'VO+C*^/8R:9?^/.KZY=5*MNC)+BN7@,M
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MU_L?*U]O/6:QI30'Z%.S1G*V"A.1;5!\=:K5BGH:+$(D"P7.9X.V9*ZQ];;
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M88H")3FO[D4BZ,(&:6BM]&87F6X-81.6N1^#97N4U:.[@H<44DV7JWO'ZD;
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M]P@2G-,VB5ADT:T+,.Y&M)-.^+Z;=T!^[V)9,RK71YI8955PUM#K8&MC_ZS
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M(-[3")[;9$3M#?L>B&?+;1VQ5GX[5R;()_SNP&8.27--(D?C14:!LTK*$)J
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MIR[  75&FFXK= L01T-]/5'?UP3371,^^:^O$\Y\F(>++(/E^L-5H)1%3BA
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M39?*W 94Q<U^(Y##;^[=.;I/>"4!5][,-X,S7ACNN2?.X0NS:':L%2/*XW^
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MHH!W<4H%+MF8"5.EU#\NAL0B/H+0G4@>F'.USYD>1UUVCP<>4%MV8:$'+?D
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M"];&S&,VH=V+N-_X3\"J[7:V=RC9]YUX4(IV^'NU.SHD%&Q_8*=$@1VPUDH
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M&06ISD,?R;9ERB_];+$&1Z !@BC55,"5@@ X2X>F:_;,*<6\M7?;8=>Q]E<
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MK_VD:/C9XK6?S;Z/I^?+ 02C;**PT6G"EL5_.B@T:BZ08"//F9>L?.V&^*V
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MJ&<1PY 9?+EH9HNO,+N\>Q?4<.J3B()P74H[=1E.XATE,3NF9?0@DJZL4ZV
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MB6!GY<".[VK]Q^67@.;A?_Z/_P902P,$%     @ BX);6#15-K_I&@  /#<
M !0   !Z;&%B+3(P,C,Q,C,Q7V<Q+FIP9^UX!UA36Y?V0<!01$0)*")10.F$
M7@(D>A$1O(C42+]T E*D1EI$1:I$0%!!B#0!0;A*KU% 0$!1JH!(DRX02B!
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M$S$&P[S.^[OWO??#_?#>^^D^>SW[PUYK[_W\UUI/6>0?Y&6 V4!'7P< @4!
M\.4%D.<!+0!,0?%ONQ3*RT9UE8J*DI**EIKZRE5Z6GIZ.EHZ.@9&5F8&1A9&
M.CIF#F:6:VSL[.ST3)Q<'&Q<K&SL;/]^! 2^?(>2BH:*BH:-@8Z![?]:R.T
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MOM6UF?1M0H-21K"/#DBLC5W6T<UG2OV>P>.*/';- 4XN+42'WRNI8J.0VL@
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M/,N'O*IV?]4DKK+N77T:IZFE,\2BCO.1;R][1V(UM(]178HR-<]99WA(,-S
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MC@]?_+7-D/NWV8G/;#?#SQ:]N03?^N0F<ZJ&Z+]8<MR[-SJSG6>ZK*O*+QW
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MZ$7CCFI?BQCBFUGH3%10O[K,BT=/1)PX]X\O#*?B=-$DV??MGCG+HHY?ESR
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M6"L"+1?*P4AK0Z@2THK-AF $(!^S/BPHEA%0_B(%4&!5YO1_ %!+ P04
M" "+@EM8_B_=R)_'   _0P$ %0   'IL86(M,C R,S$R,S%?9S$R+FIP9^R\
M!UP4V;(PWB0Q$ 1!,JB (&F0()D1$!"0)#E+EBQYB(,BHD0!!0%EE)R1+%DD
M*Y)S9LB9(0[#,/,?]M[=O=]]>__?>WOWIO?9<'Y4%]55?4[7J7"Z3F-'L#/
M164%)04 #P\/>(G[ ;"S^,OR$#L; %!5!;@  #@+$.)) /@XZ#P X"F'V@&$
M.!@/]ZO]]MWI7X * / [5QD!8AR.!'<NC6L X^J?J'X< *!LYVQ[Q<#<V18
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MCC2[>ZITN7>_D_3>0O*QSHBN?\8"-\WDA_2>^TM9PU5Y\XOZI\2T_7M%LK$
MV?[TTY9J\GC#EK>#RUQA:^XLGS&BP<T'3Z:6\\7?JARWH\X1_Z2<0\-=2?5Q
MN4@1,^V8)#JXT[:QXF?7T<<8BSJ_SQB1GZZ8SQ=_]1=79/ZJSIP_J7,!3IT[
M_V/5^?>H<GZ!2[-O8 @%C3N!6V]9C-$5&Q]^*2I*XGI^+E[6%E_=C]N-U%];
M_-@LU$ON%3"^$WA$B__9O9VI]#:#MK9(0CPJX-6P=VR^QNV0>:_E7/&DQ8U
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M5\\=-PVPJ.-T&\G=&C]UHV3T^H@G;<+AQZ4M:%G]]-<BFC^K=E"VWN(A1]5
MKSSU(I/YO_I]PC]N$^3?<G7_N&;J@Q!IA8Y6%*3:E5#X"& P\N#5EP<H6$^
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M$Y_#6HG_IX00S7@O22*"*@X@P*%S#U).A)QVX?MX5/OIHUT*O]O'>48%\"1
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M.4^4BN13JUGCS2UK77;%,I+@&64%.XK4Y(\=T[" D9/G32Q@/WO[A.BAW&R
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M+0C6,S/$%G_HZ]17&Z-J)PY['?;*?$_*X89-:31B>:>!>WS3&_W-0)4+]KD
M:@*EQBB6_E?]6CR0EAAR'. I4?0*CIX&@=\THG>-#J"4O"SXJ"Y]=:_(X.AA
MZ@+);E*IR3HUWT1=+@9N%)/Z;WHR'1ZTYD^+IA<MT0),H?LM]GEG-+2?D,M*
M#/MSR=IO>TNN]+\3L<NL4V[X&^XT_\F_@PO^O>S#_/+\M"?=)1\5Y4=1!98E
M*YE$7I^,(?]-D0:5IH(]&V[2HTO\&%KMRK7^_7R5HA?\$>$,YUAZ,Q\UO._>
MQ6GSA!0XS&'W5)L95=6?D>^@NRK_RP0L$JU!')2[QEQH<@2OO/4!)]N4L-</
MEMO>8#O4NX,% !N7'CVJ75^5N_*E]73"M@5*[,B4#YYP%0>>D^S/3SW-RFZX
MM+L;"*+E^^?:PZ8,HH\Y"/:I.PR18..:1J/++P)LKMY$,D.5Q\J13FXC(I6]
MBJO79+% 3HOM?JVGV6Q_Y?ZBW;YD?33"WJP?0]0ZZ7^WQC]<@M;B,"8<UD\=
M[@T_<=NZNC4EO/>4L TN5CC6/XN)/$."">C8JML&L[<X&2Y7.T5)?[,DM()>
MC'!&HWKW[WF:P;4K]Q<>H!;QH[=SIH<QI-WLX6J#Y7K33.6#'>"=GCP*+!!
MWQ_\.6GBD\#ME]$'\X28UZMENB^_WN"UO=Z9]7;(5_9&( ?,$"UM?65*J,3O
MSE=8SG<G0Z216EDC_977#75"Q[M(9K#RRG+A*H1'"OSLPBZZZ_R;=57U,)<=
M=-C%H_B.DNE[=Q..BTNR3[C4_]*FF2BQIXHQ.$W^#:-\\V^9O&N4FBI\0ZPQ
M;^'Q?^R'<E@_/>8KR'BB<<_M@P(P]X3?[L$S"0?(3(A7&_U3^:Y'P&<JU-_[
MGJQ]P%_O@YW!L5>>$P-9=E%=&YK(S3Z-3FF,"^ZFHNO0:QJ0C7[0Q[M3[?GN
M^QQ9Q$BD^ES'"?>K@4!>AT,?([;*8M.62WZ!3FTK)F4[Z#LHHX&E>*Y7OA,'
M7V[32>+I)T5'^(,SYDWM*V;;M"-K6]$)UVNY M1-$213QL,BE9O0A=AX5R3G
MW%Z!B<1LY8MRDDL6O!>Q -.WIR=B+GW5#:4K_4/E*K0G]FX81K5Q361+IMSK
M?AX^ON12Y3L.)^K+W*\' KF1SW:Y'SJM:^SMI$U,)]ONX5>6_7_LO7=<$UW;
M+CJ(B@T0Z34(* @BTD1JL-!4B$COTIN B/02% 'I @H"TGL)2.\$:4$0D-Y[
M)Y2$&B#EC-\^YWN?L_>[]_G]WMWW>?Z8))/,NN^U[KG+=<VLK-D)4+X[4570
M@V:O &DJ*@DO4#C8Q.%AK?;#2-R1#<[>S2R*@\3O9TZ\Y,,+K\!'7R^W];F;
M=^RS4ZMC@YJX*7F"E&9=WAX[!-3RCOYV+X$/BDT:052#.EJ@=R[HV$6N#J6^
M\!K^^#)TYCI[@PJ=>49&(#F&[F2QW6SYHZW^S[<2F0]>[)DJT.G0_/Y_,^T_
M5XH%N?GY-G3GGI/G%=6GTMI4)>Q5,HE(?7!8!<?]!T ^&C#KK(Y<<!G[< FJ
MD3I0FQN:3AUJLQY$2Z,Q'W :61RZ-YD:(B$8;6U*YQ>D(WAR15NU+Z)R,OS=
MV^L:$WS-?ZXFH&1&*=F+B28K[H_XVKJ]A5*/#0]",UT0MG&>IZJ$!@OXQ4_6
MNVACQ<&-NO*K%@T-T.ENZ+J.0P.DV,C<(:!#UO+E5_S%'A<0_6CEXUD<2("Q
MDM*A*C^\HR#^8,5=0DZFG[,O_G;U67@?7Q^Q)[2S%O=9DL'+62[B=NIO:K26
M8!.;21/E\'(#=S_9&^@7>P,?R<','W5U-5]/[ER%K,#U)<OYZV] ZHD7CD7J
M#*J%D/MEDNA4"%ICM<O& 440C8*>,-CS.]CK(AW*3(R>P# "GZCG! 8=&KC3
M)Q:M4EE3]51\B#[:1?<PD\63'N8AOC0/HP:B-O%:L(5A/ F8HSB,8XC'V/H]
MQ?=Q5F-F*CU<&))?N^!?W&F&,[2#O9$=7OZ1O+6%>MVK2PR (+P<Z(M$0B\O
M.'SMDRP1"N1Q9IBE1(R>WWL>37BLS'@@B?!V.FNCC;LYG&,ZHW>1</[<6SH=
MB[OW;1S.'1.MZ;"XA!V)8S\%>X=['7T0B_+W;.[*S=!DO8Q0M+JZMO+BYV_)
MDY?X,KZ^_^\Q R)!3-CP<;^A8DS'M/K07>B[7!!/199B#EM.WR9:].7V>K9$
M8&.)Z^LXFOUB"CW,T4<QRC[/7$+..'QYX7?<<UF4.@YK/*Y@@<'9DH!KB?"
MTV$D:_+=]@5PERK3)/0T86](O[(HV3!]WU0_3@K14]*3._,3I $Y+ZY"G^SW
MN#=+4376J3CX];R9W9V973+S13W"A8\FV:=>KFR\E>AP-T*1K%/8IXR,N -O
M3NP^I3ZG-1.H<]%SHXE ]27%["5"/S%Q=Q#?TPWE0-\;HQ73>0H2"%J*/28$
M&AK"$//21*_[(G'_%1O\";8"V5CV%75OJ_-U_Z]<SA..A>JW6S"5QC;WV.[<
M)QXSZRN/X33OD=$G0UI=+C[\C9*W2M!-2.<LT2NYM%F+8%TNGBV0C>MK9Q$_
M/,N(/0]MO3X&-]3.>]EUZ=.#-26O7=%YV2=/G5URCUD"Z]_&#3R?(P'Z.>5V
M=6+U6MM%2="WV\^([.@^XD")PD2CM!\%[-#H4A?.JQH/%]J5S?ESSQIB#PZ@
MXJ\#^'CXUP&@<Q/F<^NK\W]J\+=KC)O\WN(#Q=*NC8Y=-6D##7HEV)3@K)\6
M]$]!E4)&6FU39;GA]%0K -H^DO%X1'PT8E_:,+#6=LPM\")!C0*M(364CW^C
M7/>6?PC'-=NYQE=\;6?AQ>[MM[N^++;")]38(@,DN[V[Y$4QMPUO!2:B]<T:
M?JNO-J]VUMP'NYPUIF]L@'7HX,6?M T"F.L#M\L/(QZ>XRXH=.3&,(LO4]XK
M+%*I:)Q&6V\OI^XC+IN<0\?K0BUV-4D 72_C/OI$1^(P63_U1ZY+R2E_A*#]
M</7\G_M1(]-@/DOOK KU#A@+O(0L@6:;3?LH(6.Y>@<N4!3&+,&OGV@>(BFS
M[TM,O!<J: E$:D0M&VBGG.EWP%A&&L2"QK18W#54[T[0GLXK00\'W]-1LE@B
M 26/7[L;\X_LB/ ,W7@.#^(N)P$/VA7.AQ79P9H$!!+"X*RW0$,U1]&CW>JT
M B/E?EJ?Y?D3EJGZU:J6+Y(:[2+ G&;FV7"K4#TG_F#),Z*D==KX%6O0^S'W
M*Z=1ZRBT@5LJY>;@^<-#VZ@LNZM^M<6]H1NY<:;I \1<]F>#]-!*IT<L@RWZ
M-W(NZ2IQ4^U9@I!#0)\O,_#,(Y:.S(R,.8VUXK47@=!W/*_5$$\2>U5/ NG4
M]9D#_X6Y'?3_N/.]\1<( =#_^[12[8U_GUSC+]C_+]VIM[;CX!QX6P32^XU[
M(YO0=TNLR)V4BD5&7HL/$_KEBJ'SXI P+\IB[0[II)5-K7NW\ 9@83)26B"6
M.G\91 @6#>T+)C#Y\9+O%W=Y7'E,[&E\=B,DFR.W;,0X<\&(4:5S2%S:1M?U
M$:<@"?")A#_!V/==PP4;QG;7#CEN7R8!W7QC@5 ,?3.!?R9YCOK:AJ[P>LS#
M8-SVA2C(N]7]XO:XEDL'N4[H7ZWH-W&?%[QN9F+='U=UK1\>22#&%KLU<"GP
M)\NND+"ZY5[MELOV-S8?'H=#:5'K^E+N/_(G*0OMHE$;<9T@SN*X3]0:MIV]
M@A<W?7\8Y;&(*[8 ZR?U0.2K<^SQHL2F!Z^>';G)N*$-1P^.?0K#)KL[G([-
MBI2A&+)_$]9:0FMWGUO-W@+:_J9%QH]BA2 PO?4*\<ILMPB17AUU6JIXU>]A
M;GZ<U4 E'X]X $RO:_7+^NSYI*#ARN>R+R9D2,!B#Y$>[  E7C1WCA"\I08-
M7>Y>Q9PBLUTU==B?67HE=>]+<3_\YO98^[#J,/H"@C/R NIQR)FH3LT*=<.D
MI/_@$UI/DPU@Y7T3)0X+W.7*(&ZTO$'OMJEI?DM:P;!:P:5:3NKWUEZ9)R]W
MA7KJRFL!KM4%S4=<?6IN^[86Y/M@6$@MITA34JX@H9WH(')ZV32BEY^UBX)G
M8%\;N]6K8SF%FJTRF52\MW@L]*-XTLKDG?0WI\A MCRH?['DRKY.2Y)T>JP.
MG%;YX'A["Z$C(4'S4-;B-;*WK-C'/'W2VG6WTY?KQ3%>OMVSB.5\N<]DQN"V
MB3M6BIX"*XYPP)SJ)7&X1SM*[\3R_H$[E@=@T9Y_\:=HLY  :]-;<(:291)P
M=KH6%VV6P!#G\@L^>9V,Z!KM@F5]$<LU,3%#LS'^!OJ)(/!P<K[HT?D]=;<#
MW4SR QX2P#]:A;D3[!2!49%D7_Y$ JZ_4[IIJ>.6>>073VW[96#BC@D<;?Z^
M%NM8ZYI\\N&C+%>+^6Z[UE-! \V7ZT[N;V'8+U8$^U%$1;)<'\2RM/IC))J)
M8J_P65? G1]*^?<S3^]D'12J(]&_3":&UM<58TQ&HY>U9\Z/WA&NF^:D:"BC
M7A*QUP?[A )Q@\(!C:+! >AKDRH%NH^(52?3T)DO2@<%,1Y)BF$[)AWPZ7/(
M3\5?+75MMI/^),D>F5EZP43C,/RVY:2/7/_\CV]3AASSL^3[Y,<CC=7!;[V?
M>;*XUG"G6TPI+;AH9F%S(E/=]"Q(@)LHP5G+ KOE3P*T[%^3@!T'R-"HQ=V*
MZY@?OB@ZK-:&CP;<<XB_@$^33'X-Z+AE'Q:[0$8"XO3=%P;AS[3T9+SS)$X*
M[2U.@J C=53F31D-$S!FM-"1523TR PR*JX-NV9_C8 ^5CK-$MI-H];(:0AA
M^A59(*N[T)"ZY94\BV\PZB$!Y%:Y-Z,*U-Y4,:JFK-PD6OG+WE,U4 LC6!+*
M3IEUH+T%*@L1+$*-/L&$82OBPQH;_"V$RL#/S_"*#6A"H3,.H@UO/ 1!^DPL
MGBR-*@;&LG[QR-@6.AV%=];BP1Z 9U++]O7L#KW)AMT'/Z .BG8R-3G2K,9I
MU1 A+="1V7IX/1-DZ/=9$1]Y%V(A3'U[8/4$')IGOL1)C> G>%T;Z/ 34<UU
M^K['CA8G->3[]';0"S:E!Q5W?/4520 +L,2#C:L C3G/#;[<(*8-0N>%1D N
M_V=9&5Z<CC?'NZSVH[>G+L1]4V0R])01K/!IKKD$G DFC8J<>(W@1(13$$Y@
MF$PB+:43T0_UYW/QZ?]]7 GAV 23>4K[CYTTJLO@@?9$OU$B00BG3@(N1E:2
M "AX@%\\7J"1V#J 7&.W!_?B8D\O/_G3K)IP0D?6 F\Q1\#[NDC ;#8)N 2=
M%QE!KLY#=P9(0* [?$Q*AT".0.Z,91%_#,#7V)W ]NW ZUE,@CUT;QH\JA_4
MDP)62=E%D.H^K$_=I.0EOCLD 4>;+^ MT"P2\%MNEHA+H^(FTLI:$[V5P/:!
M$$RB/61O!'IZ* #RT@_>*F!G?"!'[;QX[@DE CF(D)ILR$/!7P9U24!*-'RV
M5 E_LPYUM "J,*LWP2F]C3JA: 4S_@"\13(+_EL.K$_W^W"JKO =\%N_-;#E
MI YQ'WJT70_%*>[#CS%ANV*IF @;$K WSXB69W/'WSQ!%D&.=L""K_3G,^$N
M*!I.\-J$S[. (UIM$1K%VT+GF?N1JRW07R0@ G@#P7RSF]T'6_B1@)-]>(MS
MH1>8^&?+B>*C)*!%.!/>]P$.5E$6&$YAW^D8 SM=1W;X2PKAU%R=MB?_[4 Q
M>(M+ 0EX,TDDI&*+JXDT#HQ$'PWBB1,6--,' P42D$H/#GT2;T,.XI,/:"WB
M<C4! ^^()](B=(B>$Z 02J+X,*A-((,$]($&FG4@@N,*M4'N+2"/L'_T.>'4
M#F#'R^!I]I$@ ?1*>%ZO7#P6](,F5A(06IQ+I)&E)?HH$?#P?U/Z]#&HE(8$
MP$U I?'@%WL@[$IA2#UJA6,UD9@4._A>RR 1YT3DKX/C'E? CK$@EBOYH_3C
M&GP/3*C1?QJ"P_YPI %*\H:=SB-Q!6]P1\\A?B-C!')JM!$OGHN%%W\,7](!
MC6/O(:T@*YC@%U.-^WV>!4=T/MHTAZI<('[AQS^ H'*(H)!#\8R9"P.LN2E(
M%6B;INJ<K!AA?#N>>#:7!%BF7=!!':)VQKKD(BF?-,D.1LU6U4$4- AV]S#G
M\D_CRZD+ IY7MRX3*1]'%4F2@/&\,R>X117'C'F_TJ@U.TML7/BT([M?J<0^
M?>@L]0KD#5'T(#P*_;S:WREXJJX::M1Z\ISB29- OT'V;E31*VCVLR:N 4A.
M.O7"&-$55?W.56O]1J$O&Q@8CV<NCS!F.4L,/"#8D-<963^#U^=-I)Z^0BZ^
M0!"2"-UYK.N<XJNJ\^P.\.4^J(H&WNXF9N1[XZL;^+OPZ#3JYWHTQ,5"7RK;
MX:6M](W\4;5:/!?OL88?*A_TWSNCSB1@\AX=&5I3)X:0JQ%,-#!"D8 SID_J
M1O*2Q5E+.JR@(_ZR5J&[[=B;WY.%5O#*T-YL$P9[^X']U"(;>#;@Y4J_@EZ4
MM?3J8?4U@PQDF[!M% X[)*&9B4'^LE2A<SJH.O_3PRK4&A-</\$'_EJ.$&Z]
M?ATRX"\E:]VJKXCDF'[1)6G I"<_@=XW[9L?:%@TPCURI5KW@;Z]HY'W_@T]
MJK\.@J(?*FFCP7LY+4-)@+F&4-16U&SI9U\VEO7,4(32O)>;<+XBO8129%;=
MSH>#:_3%%9/OAI7Y63$R=_'M;B<2[8W8,#BM;M&:AZA\YL&C'WCJ>2/9U3 Q
MP1=CDQM>KZII(/,Q8B]E.V 0_7E7Y!6<U^K;.LKVGJ04G[ /4ZD!9Y0)]OTG
M(ZS7$,;W?'M-S/7#&F]ZG2M.GJ>F:[8:?$SE''OH)ESFJU.]P/]EM=4F4C7P
M-#?C5Q)2/6K96)TCJF!\ZJ(#4]9'/[WK\;8<<QC[RM]X[P4'Z5?ZC5^'3-F<
M9@HY\4H46$B$I^ZW5 H-W?O(Q&?[WX^+[Z1$5.(RGO:1H]T2;IWY,W\IX(2-
MI8M7<U"W674ZW?&29:S[_$PC%(8-BH9?<!'5;Y*,G'>+QNU#WQ6B$;8.@^I@
M*"*[B>)S0S_G4FMO(B&[L@6>PXJ(%[>(D!5/A>K@RJ3#:<K 5D>BA%$:43!T
MO!+G7J :X"K&L#AX8W)_\: 8A]8'L^+7B%P""3#!YB2[/X'LT53]N<[X3224
M!I=D,=1KWZW,$^DU.M^;RD$Y/;27JD!&1K0^0!3"+MM4>>R^Q>E&[E*N@J"U
MYXG/@ZRHXX]_\IA9HH]2%O7QQT?'HZXR-R[!K]"L#G68\?MH6,5P=:2;/R^0
M.L=T)JZL+Z0"]$XA+%$)?RNW78J/!,2#K*G) "^0MRR>5^2RT',5WHT!>^-$
MI!M<V )WMN%;8#8+!!S4=:T[6/XTR($>_D2V?,)U*T)VI_L(97; =,9WZ@@Q
M4+#@#>CAKT%81,6[&1<2\.I/IB7[W6\XC^V(@0:!=6%2F"@VN(C@@W=+9Y(
MP(3([R^E+_!53F90^H$;? Y$_.TO(!SKTXABY(T_)7B#KU@3=X*JS$81I?^T
M1*N-N,!G'_I+=0E$RT&KM\R%"(>W<A?.RE: 11F9B><C_YY1LX@])VT+X@\X
M\I3%%A>PG@-?@A,[_*6E!$*A5TVJOB&/3DE :4[JQVN'@X-$8BI8>6="YZ.B
MMJ5UVTF ;^*CQ=.F$1 US2KZ2Q<(!,C)-6W9@G4S"AXA!B;&+0>'8PG<;PI?
M!0L/>YTDO4'CA65N);TG9G>=P\FG3D<:_X>N9D/_XE1K<+]M.L]X<I+ZQ)[3
MD" ZDJA:?_U>W'*=0-B0'[_'FVX!)YZC7NE'?Z8H$40-BS.Q4<_C!;+7?QM$
M]H@RL^XW$UU'8>0?4_JKBX.NM;V(TA@MB$Q'V":^6%5'5H..::4"\*Y))6)
M+V/QB-(VJV;)[F!:[/YP_/+4U#GQM@SC@JQ>@,&Z.Y-YJHCI<L!.7(=]J67!
MI0.0/Z^\Q#KJ/Y2055+'E<ZCGR%R)X12J[]P#.,G(9VC GEXTV'>KO6J>X>%
MXUDW%8D!^[GKLQ3B%U]/Y&2>J]G^GA^--*1>-=).QI2TQNG:?UUM<IZQO0N]
M@4(GPC?IX U_V+[086**TN=9C_(V_>YC=ZGDH:1>F;S(=KE)'6"H#O[.1Z4
MI.8KCYT6:PAC)_@Q7DS)FZJ 1_VT#F6Z8^$NU6;6&[9EN-3'P3L;VJN$CEE\
MN1Y,(E=5/U']X%Z0R8N<XIU^#I=<']9ZGWN%^:T7MN/6#(G63/@(5R_W%A)
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M5A&R^'QW4\FIK00QL.U.WESW' R.:B7B>21>];X'1 72_AJ^E0;ZX:+&XN,
M@E40@K@U CU\\CV5>:OOI(=!"Y0Q!R%\UFPX?\,WM9W^(-&H][L'KS)[+O1P
MD 0@U#@N]Z/PY9]!YW]DV.5C,0 VNH>%3_/#\\!^!,@[(>WS> GEC\#H'I)A
MN.X;33"+=_'QD #1>0OXI8/^-QGVC*AC5W/PLP'>GEGNMH=MTYY1[BGHX^]
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MC+F9,^MG#YZ<=\)@OV3(7L-'3!21VQVP _I1N.T$O,\)#Z*50,@_=,NS=?E
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MIZWZ-[XE>KWO]\W_VO,Z$_>%C(GBNTPJBKYD#DF'6MBA*L[X])5'[XJHTK?
MUV3WY;YR$L49PWV,4^@&C4U-75V%GW6\8!"^M=5X0I4L-0P)1&21@!9FEK6C
M\^XBC/5WZG6?.7\K,?4'#NG(TA>AUXQQY@J)Q,$G]D,A#SRO%(1PJ/5')Z-B
M[I-C$;*73E1AK76N^(U"P>$B#:FTZX]$SG-:5XN'8"6(*DTE),!PD 0H"MIZ
M*!$?)U,3?XR0@!-!&P"KENF<:R/"+OM^UE#*0'_9W4SI9=IB+K-@'YL6N[O1
M\)9CYH"/>&X$3)WF(F^<VT4Z_C=D;X3W[E%W":-A]:"%<J->(?SVI53KC7YV
M*"7=?''7MR6$>MGH3#N+\BZ/7<GU<V-W+K]\:7&TX'^?4A0U,1P5FO:[P2'[
MAZ7@^&4GYU=J'3QSKKR<*5(8K]"U!M4%ITV55T6WTPT0&NJQW57O4NVB=,S'
ME="ZQL+?.;BP)"!HOY/1\[M58[UC/^I+,\_;VQKTJ;<C/$\?M<1\0R0GT 1,
M"L>2@/)$8/V.CT*>A[?N]RKL]8J8P>=._ +UNA/"=(U?6D5?>]_S?EL<LZ)W
MO<KS^KMM=J5N.LL'3NT?(8C72.9/$OX!'*73'5V^5$QP#:/(D-='7N=3781_
MQ>JCN&FGOIS]?9XZ &_@O:!J;5C>]#T2=2JBO$ 3/#,9\GK<,7C[RDL_5\2"
MT]5)G/G#>/7:B&S^ATK7OC&S81AEFYK>UT*#D;NRN%4B4H,$/(RK,V'V<)#1
MFD_87_G\Z.;C3UU>W"7/3ETA$8!F4Q/6."%3I< 0E=W+^4AL1)@G=![H/O>Y
M].R[U+F5:K%DM5F] 4%75MD9U5]F"E-W%;TAS@,-*=THJ:#"ETU71QT%-RUK
M;DX?O#B-TZW5J(;<,G\O8>UD?(#6MTIVREIW.V1XHGW9H\WFXL_F@Z.TRYK_
M4:*@[\*MML?/T WH;P^J2/!=T)")*>CXL'_\8 I^_:"XH 8>!N8)M6TXNL+D
MY&H:5:M:C7?CG9$5^?250)Z7C63\U/3=&S-<V!LCZ<[V<],<,RO22KLK]0V^
MI14!!9R=O.P7^TQ&,_JA2V2Y)&"T"'YRH3"Z+?J6;K3Z4X;KBN=5?D)?J$ C
M &<_:NSP2 G"<$V.Z[N1M$[UN:J;;LH4AA8IGGTO+JS4;3T\%)10K6VLN1\Z
M<_,+,5344#4HE5""!9.8GC\\8]UM83@+12UI2,]1<\5EO=T!5TV0K.BA]"3V
MUYTW)0'/N B+1 \M$O#N^;FW(^(X,7:IF<M:0^+H/)_UQQ^4Z.MBO]4RK2>G
M4:E1IQ?U"'5,;*6&<V)(0/C;27M/(8H3\?8$AW#X-9=!#E2ENX3$97M[GNT8
MJ8[LT'9F-[D?BBIR+0T=D^TLT! _@?&J;/;VD-)']!]TA!U$NJ8G3W-S^F>'
M./C(AVY&9P0F<WDF*#ZVD;<Z9.;TLZJ%4GIT@!&+#<K/,K;-?UE%$_#]9V.W
M!97R(I,L4@J-[O7A)0$W8MOA!SW00WU@WVX%T?!PG:&QT%BY)V=BRC=EA$=>
M+Q1 5+/%#+!GIK14X!_E)T-:JZLW)%2N*'496K\-_@ )NWI+3)9#5K0U3NI5
M0=E7[H?+0>[*5 NS1GB"#7G$$%YGD2#5?Z G(VZ1^(9RY^+GALZ4K*!]]"YV
MIJ[G<MLARTZ0AD%(0]+K\,&+U"<Q2 ](KN&)BP8N](12HE4_<'K\#-_6K.1.
MM#_TFCS>OL>Q8K+D$IX\Y7*@S7:)D;'6FOD,^@=89OPO'-STE]J2-AG%*V3W
M%*ZY'3X?=S2UI9R0C%F[]4,Z@(Q#F?/U<.E\R=4)7.KC*/7R*PDW;H00]]6D
M\D'H=2%/AN;,I >M@L+:JPR_Y/%'D%5#>"LS)3)"QCQ7B9@A/6+!?%H3/7IL
MOIM&6<+B,:B.Z6G_ICVAN+:=>S4L?\FHMN^^EN3ZU.*Z4;)G'T@H<7N_X9L\
MR*Y&FE:Q5S15PF?/=[SVM2%/*,.>SUQX>KJ$F2\/ZNK0(#>:5APX'G@70Z\5
MO\SFDD*X163'/DL,*O5-M[^K9%\X-E?6UH:2XHA,6&6+I,[#2PH%2C6PL$G%
M!QW\-"]KJJZSI;=^F?0#8*,=9779IK)-G;@W$;5USO3.%RG8A0J+1&6#-U7<
M+J/I1(Z4SV0;%?]Q<-+_*GOT:O<1^9145!Q?U_O9L*M0_;A08 D/69B<O68O
MM9Q\\,$-.AZC=#5<[G#J:5#W6^AK<_(]!/PJ&I:IFZD__A/N_9JH55ED?5[I
MATQ*%\"3,OS31Y8$1.^@H <GJ2=TE;,5Z@WYW(H('L\+RYZ&!S^V$H&]B*<H
M#A%,VZ=ICU3Y<F)/=$OYA.3MA$VU!5$<X&O??WM[OJGL_?;P4:N,/<\KZ7SF
M\[7PD)(5#WX'*1Z1Z0T1E)/#M5VCHR#"F=C$F?XBVH>8Y>2PNJWR*DWW/@J[
MW=E?O\\Q'X3HM.O0>,X8)^?H'H]ZR+LKK_*+AF,*U"B. ETF^D(:7$VM[R"H
M@S=C53]Z1EPI$S6\[3O^O9E*DIL"$NCD(7(O23E).P'<:KS+HSO#L4P@-J>'
M2Z%P48M,^ZHL:)B! "IN0_1BS:FTIW!A^#6F.6%@GZ+$\#D%;'[+$4+CX3>H
M5:D8*?V9U]SUQ<47T#.4+SU.._2C/E1@G:VS/-=ZN1E%GS3IFEV$\$E'/1JE
MSYTKV4R?VY*3/>,DU77_L# Z:/I;U?S8-D_TCN%L1\DQ#<@A2\9(P#YC&O7#
M(I.KL],/;B:9YZHL3YL8%3A>8LIZNM<YA3U2E"0>..A(FI, 6BC[[ PDD?W.
MN;*/B]R_?&0^0)[+E![_/N=@WR;'&:^1!,/XQ5(NZL\9&DW+C:EW4KS\<2[I
M+&T?<X$<(W:9,!MB@5D-K1@:/)"_K&C&:_&5N?FG;-F#LP&A6XNA]]T]U0L<
MS7HJG6.\8G<,!=O]1_W$'KB?V0YX7'%9)CD<45-P1MK_&,]';J^/%?ON\7ZP
M]>2V.BQ_*C]ZPLRGW@.%O<L6NW;_9) 3RSX=')KQV^>A(+Z[YE><N]N:^@V4
M)O^O)]4++M&&J( L^]EP(E_MUVT/]73#O4"J0OSG%WC3+X@;F.E-GJ*1H\#H
M=^M'L'TZLB&/8)/AETU&0BTG9AN,IV=C94JJ6%TE)VN6++ZQ75D-'Z%*6-RR
M0[4_MS&^-S!7%K<96%U3Q6M^[;54["<8NX>L@CN:SI:[,[J@X0/CRQK!=^]B
M9T/G?<Q?RB@LD@#*]4]W]E[V>+M-9T8)^"NOZ>;PD6=B82$.>.&LL 1ST3[1
MCPC$T'SVIWV.UJ$1J]P%=OM6AI&ZX(^997$M>@S2J66*&X?9=6QQUT=E: -/
M=*"+M2RK"Z@/15F201)Z[U.2&OI@.* X:>&Q/6\KPM30XL(CO^M#44//*9Y%
MEG$UO&+6M=13>\!14=GC(UT;@Y[?CN+)*K]PSR*EJUUI[=S;BO^$SW5X#'8D
M1@4YWEZH&I!0<KW_P0C&M=7KV9+?I[8*>;*)[O43(@&HE  28'J#J+4V1-9J
M[)'4?A+;#?T@)JWW%C=6Y,Y8]G)J$1?M?H?Q=TJE2S-1@@1\R+^#<'*@C,RW
M<):AN(\.#]^59.+<7ZBKR5 V4TY7B!1[GO?Q+AV5/U5+#93<E@2\PJ9^Q*M>
M;<\>ZI@9+FU+5YY9G.2_ZU=!-NP1KQ&KC-F:GJ[IZ83=F88W"ES-DR6:"4B\
M&#K :;.+RE<&/!\R#52=GNX?OW1/EI'9?)2<B>D@%PW!BF"#HG*HS"HH\WJA
MT\=<D*-!6I 5(I*?/H]Z]CUF6[?XIN9&W.^*8K_03#&RGQX&'779JR';,I(+
M$5("LD_$1!1'CG>7U ]XJSE71[/=&&-[G.P&#/1_NG.>EBIV9:467@5*)#'N
M'\52K^&?((<<M9\:/>TZE4TN^OF>VUAW]93P1OK*P4KC/7])*#FN;J?=H8"U
MFV^3B+H?8J9]N[78G>/#DMN9NK*'^;?E 8O8B0;TO!+>SR.3V*)T7.G*(5(3
M!Z6232YTJ!W*>LJDO&EQGQ=CA,*D7=).N5D;T!*%,%*XL10_"B,DVU[SWPYO
M>QQ 7E>\H.;!.T@?4.#1A^)@>SPD/DNM2P*LG,[ RCOU%BF&JVEPB\PE#]]W
MS<Q,3%Q8,(HK8& +WVS98MJ_S^-[L8CZ8_Q%QG=.\_P6<5L*%31\W2K<W_C(
M1Y'S\BR4"T;B,@(DX.+E9PK!GVY.1R51X)P)F]@H_78.3BRWASWQFK"UA: ,
MLH)2IC#A%[N[9T+'5L/6)&[T.O92KPDEGJ=?3-$IM5==F.+]P_*[1ZQ1Z\8E
M[)]MLQ%A+E<_//3HT''D._,>%P^+;<DT"4QY>B_LEWQAO/FWL^2GDTV&7J/<
M^;@2U(EKYD:9A]U/L276&=I;GM&R*I3KH\N+C0\PVB:5'G+;(_,,RG.-4^^"
MG%N^+XX'*36Z&W,U!:AB1M+=W>1#I=U[O9=>4K=]@K( UD$-#^P7?,]3JG6*
M9"50LKI&!&M!5W,$*#I2Q(9\1)VMZ:NBZZ3SV[@V/!D=77KIU;S<[Y]H@M']
M]A8>.A=F(T27W;8Y>NWZ1F"IOR_FO.^>+I*1!"SV/2 !WV-( #\(C_[)@P0%
M9@UA#G8#^GH_/84P;9&%J?EF &25OM>#MKW:6+!JR+J^(G)P<U3NR>,BW7?A
M>%1M7QK]\.@W/"<)B)+U)K:HXO/("[$WZUVR>1@F5 /LI)+'N2Z__J%)%M';
M,ZZHM"!?K+B*FN'%=&2_:A+O=S#[7N.0L= 96XZ.D^0NOM]GM^_$#[VONER2
MR&CCB[PG^LUZH"8U]-Y6X;J46X"=Q,P&8]AR'O-$P45WN6;(B+]TH.5;JG!F
M78NK;RX4>]C'WBDOZMW<REG/9Z]K93,-'Z58>4EMB.],>_L3H;<2\.BWL1Z5
MX*;#3Y[4>042@-:"7!A_:CV?9%4'67<W*-Z&P44>-03L]T(O <N52 ;<XH-J
MXG#3;S%L=A"'A7I7G]@3&.M7-F^+,P)U P=,K@XW1Y]7]L6Z7.M*"N:D^0;Q
MFFNZZ=$T<IGQMV5E4ZATKNYJ@[T9#2UGJ>K8C,<6JM'MY.)@7_ FO-3(N%F^
MD%S(E1R26M)D0_X-ZQXA#J&V\W+-8E':+G'4IG&52<L_]K^O(+GFP1.5[>:Z
M"J4'S]Q>"PDXO ;IL>_/(V?40M9Q< V\[;XH4RXJVSYXCO+C<W.V_:G-3%FO
M$;G<!2CMS*SAH[DMEIF%F>%?+XQF?E;RO'[=Y7^7ER)\E;G'!$3K^&<-2@A[
MBL]Z"H&E^\I-QQP=BDZG*W47,B(OM+WN*$WC"51H9I:4 5%>),8Z,G?4]2F"
MT:B4Q:_$[K+82WPQV2JP%QT]M>2BL^.CXNRR4()3\I'[+CLD?#P:+_J^?[+$
MM.*J7J02,SO\M@,KC*6Z?=K$^ .D3+?M]HC:@&K%>?)1FTYHX'.<QO4F+"1,
MG)EHFUVG'COF^&GQV$^3;-C6C_N;1Z(3%3KDBM?[#M[J.$!;^BM!GN?3 PIN
MWO25M%&91\55^7<2YMGY!7YN-4M(2,"JF$*8+PXQO+KJ(6.A([FX3EG2#J7H
M8[PFTTW#?9HCG^7WS'X@,_1^];%Z@9,#6.QK3E(UY-DD@F4\\Y\NQ,[W,=J6
MKI^$G3'U4-E=6KR_E)+&=A66JS^!94#F3Q@K9>.<5%F",M97:J,/V\]8^/?Z
M=M[GZ/A^("AC/\M4<>1/RQ#VBF/CP6_I:^JBZ$[HD^T1O@&=:'.MF&<4KQNJ
MI"R.V@'/@_BHRAZAML,)B4BQ0F]HU=7OAI.TY3QSUK??B/I[,NV7/"ZF0'EY
M8!G#&B0SY2_+7*M<[J8^MKS :9$RSOENQ^C@/[EP1=^!;A(=>EO"8,LB/R"3
M)W[Y'5-MBOQD_&O*2DV,G^E/V1,=2V-O[&6B$I(</HHF 6OJSRG2GO(_N-PM
M<#92_/8O+T#R9HTTDM9C99=Q2$9VOMMI<]/QHU'IW@ILY]P5X>C?;_PJ9U18
M5&G;16Y'UWVQ,/W4?'#6G4XZZVYY9U=T1DP;ANX2L.I#N\CD8YKU\_Z'2:/)
MFLB%,RX5A]QC>\<LU0O)#S=02IJ#)MU-#2G2!E83K/;U;\9D7J<GI3Y9]6.V
M+2I$H&?T0@6M#G*J'][U2?NEN3CKB3_WZBD(^6 ?[RI*!BM5BE1#=B><OBC-
MA:*(Y^1IT"S(CUGU,8,M7KZ5/ZM:^ER]ELV%PC>?9UV3W_"ZLE" $^IP3]S.
M],U$5UTV+QC;XU)*#J_M4%1!\;A+GM51*-K VB2Z&,.<7%^G+5IF40KL\Z:M
MW=]X+1",<T'8^G%BY:H+ZL7T>\:9JUQ1\6=,Y37P1HRRDBCV3@KW J.I<3V9
M*BF?^#W K9VUP'H#K%VW4^W:,9#0.S)&:4_S#2=1C@K=;=$=*BW^618IN2D-
MO@(Y);(XL"YQ\2 /3GF)[S^3S4Q/M5M:BP^W.H1>F%"2"ST/6Q/X"KMJY\9Q
M;7"UIC)6?:22K8+A([W<H>X9^6;-%V2\)\,E?]9_U1];"^FVJWY*YT_U6&"O
M$[[S!86_5/U+..':(Q8G!?Z("LL''?*R[YKQ@8 GR-HB&TSFO3_>D3%(UZ>\
M9SUF66:F1UT[I>C[D1FEOUF)I+4]X0U*,DB!B8QE5#R0^J7KD^8+CQ</PSXB
M"+1P*U=']30.;7.]'Z<P^M%*NT^F!GLU*HJ],[IY+^7R[T?;[RQUD_H;2EG(
MHS)9@ TG5Q) 8W/"YK5=:&\Q8FX_-=X<M?J ]:IH0Q5;>'A$)E*\/,\C:**O
M=;U@4F"F:"/5,I1#WPU>EXE.;;8>B&\7+IJY.L+]R5*_XU44CJS8?OYVZBN<
MM]4=>HM[Y9VE#,"7I5U9ZE]* _Y\&RG"V)EW%X8JHZAT(^[>W6-@?JK")%?$
M].Y@,G3KU<$IZRPEJOCAUJ%2<,_Z'K46RJV/Z:! 3J8^=+#Y).V+>V4;I0/=
M2XN&&,H"8/N-"TZSZ4I_%I@. RJV[OEX_FY[YL\VGQ!V%W^91IYMI'(AE6U=
MVZF0_<P/L4ZB>V"653+M\,?['#@*^K$U_38I8J!M@7XAC\ZM&@%7C6\TN*OV
MT;@OBTP5""ZT\NF-E=.*79[:4\G=:#:?-N%FMPD8<+"A*)"-"1D@ ?.T@Z,/
MXGM*E=]W$'Y"O+E+>]_(VI!;_>M/N/]SM5N@[VUY5-1$K_>Z?10^P-A_C2<B
MNAIH#J@,36V.5!JI7<.3SZ]5<N<I.;RISEJ:BGBX^ NJ/1LKSSHJ<5=OXJ>+
M._^C*T]KEUS\,X<2ES8/+E-?W7B]<9)\4*2M_<L 5A%C><4@]]M<"NMIYG?)
M#8\U<02%&I;^4\4(I^U6:_!N6[%_-+HBG"@. O%+A3]2]\^3@)_Y2%P=\'M$
M!F;+&.PJ@+BY(EV+P%[R5*U]UN<?EO)A.4A^79]%+I4A.$U_+)A5T/32+NW0
MNSUAWJ$EHKAQ7TO=G=1<@['Q\0L(1/&Y7^HA; OJ_2&\O&MOI+PN#<>(Q=V,
MU***S-93[N0\H",[ASB(S+6S+*NKKO=?8@Q2B/;M4*)OPTL.<E6/XF'P'&RV
MH='9RC$YI<F:4I.7!D DE'\L8!X5*+AL>WW@8?QI]VJ75E-A_5EOLSIET] 9
MNJ 9L5 >)DV%2P6R #L?^5=<$@G@F=4A <6V?QX45>'#T^P!>6PF3ZX6P"L+
M=:N\63G?*-JF_K'R8T[*=3 Q!/XJ35^5Y"\BDUMZL4YD'11K%'&0Z[H5,V#!
MUR\^5'SFTX/+M9$SN=L+_GRX^ZS=TCUOY-TW1@5%K/,"_92#";OUR#DMZS8Y
MKH#'H7Q?,KQ/8\LF+O)<NDC<X^B4BL51V6M/S @\U44@/BE=X>..H,#D,9'O
M%E$:-,NQCHHS-@V_/:RM_03TCHI$4L@#K\@V^<CJM#K"TO0,C8S1VBY&4Q+)
MGF\'^40D7I[W>'Y?"]);VV-%O1D5KG^SH3F,74VH7"S0N>IA%I_D^K=<$_B3
MJ>!Y>,!<BF1&?[/'F$BLRRUF"N[W8^+]&RRN.846AXD1=8;R),"3S?G@4&Z?
MK VO?\U.2BTA;9SRJ"YBX\,#PC %S^D9);113W*9GNX/>\:I]^(1'IOG*78+
M].'!;QM%UJ8F)DMK;BT?#S[;4V8\3?\6\W^Q]Y91<45MNN A$"0XP9T (0D6
MW*L@! L!8K@E 8*[:R$)+@$"!/>@A01W@KM+4K@$#5"%%E!43:6[5Z_^ONZ>
MF77O73.SUMP?^U^=.ON<L_<C>[_[?0FJUBN-%@IG6WX\C'_91Q2I$Q,V^248
MC"O/3-<]C0%HMF,)(/5%Z$_\)DBHNZ?M:O(U9ZNSNC.SIR.;]L=MSRV/N+XZ
MT2-<+XCJ#&CI&VS<T<705;6A!K4M=1GD]WC<+&TQB] !NDS\-4&OP+B2J4([
M+)<:9\2KI5M:H&GUFXI>;NC4ST%KIZ\][ +*Y!>JN)R-J$>.80G+6O!KM<27
M I:/LTQ+-'JP'[K=8S8<19?32_');E-\;^%3S=*S">P<,(JRN^%U_EOU"< %
M<*8":?\YD?@_+A=7K'\7ZR"V9N7DO:G!:[@3B,,&*WQZ-#;[5F3<Z$,@WT[V
ML> N!CC;9T,'\O*:(/!LO42-I:^6EZ^T1^:I)(FMV2YB?9K0-"@MW$QC7I6:
M2;O>BHP:+MS#@A2J9W0_'<V"_DB6/T33(Y7WUM4.1;\EZ]/7M!B/J-^=R<X*
M%-QM"&"=^ ,576"ZMA,)WU#Z*IO0PHJES,1!<(S"-PS0,]T'R\J?8P&)3:]*
MKC9U#T&$L7W'$;4V)4<)Y=F\7-E-TPO=XOOS>93S8.#'VM?8T/IRMVM[<8+(
M,3 _JTK2<6^4C- 'K@0UKC2 >\8NMSUVR';8Z["0*3_H]XM#:7,!%Q]=2H2$
M>HANZX0]%)#N-JE,JO+;)QST /\)QAG' ";-QHX_KLC##\T:Y]S.&M.X?R80
ML="3)$:7L RB]N:2UFX$E01@]FE/#A\?)QC_]*%[K\;Z*X>4\22;"(M"Y@C3
M&U>MF^0V,JMD+U8> 5JE1\^DE(%HI\Y@\D8IFB#K53"YWIZI8VU=8^2?C-IA
M?]#652;JAMP T("@[P=P3IXZ#W&%O6BB1Q,VR@=4=&* 3MO<9+W53X6I<Y(3
M#I9_$3-K]I;U^>3>JSUBMJLWU>4:'.\#E+@"<21Q^;18;/A-E:OG:\^K9]];
M0U-#1&UY[_]Q&WQ%Q#J#,Z92O-O^8,:LM:V]+DZM-M&]L#6A-#V50,WH[H4*
M/!8#>)W32$2]FNY%4\R)MMU;9VKYFJ_;H^)$1O;;*%;8(SXNP&<& B]M9<
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M  [X?.2,4%U=H^JAH<,=CK<*[*>K#5B6A4321=$%.N1$;6==YC<$W4WDI"7
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M\P+GL^MTFST&^(^,TVQK#)H:UHC2J@^BFGK0HTXK++Y!+[6//,LAT6*P@2O
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MYYI('7NNRE=(0UOR8$HDB0:I&8/B 6.->Y*7<47/++O+]A&K"W>+#11O?_2
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M_$S$)O3SL0MYY6EQJ\0ZJ:)Q<X=AI@"3*M^VKR-(ID-4_5X&2_Y[Q&' U_U
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MQR(<DI)_ K9W#4WI,,!FYB(6":TZ3CD,LKCAH-1U.5I8YV&M+?OM@DG_'7G
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MC,=RT@,JOP=,%D?^B&21_082$S3)383DZ5=.Y#L.:6X>?;-@JQF_ GGZAV5
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M[>N5,#]M\*?F6E=K3Q^E30W\&DL9IMG/"<?5X'TBV<2?-P3%4*A$=W-20Y2
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M2(-#W\+GPV+3U[;4O8F6ML?9TO2O:P!=6><9LTC@-X@"TI_U;R=GZ'[L!V,
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MR5Z*,W<3W?LV ZH,YQ('#=M!];)YRYL3\D5'Y\?/:S859Y>#MMT6;9TGX@@
MN;ALN]*8M8@T^CWK[I?+N>(5>Q($P,94QD]95?LBLV:_&Z0.KL>Y&YM%K;DG
M'#@>^?HC0+'^[;@U2^P^H^)77BZ2/L_CZ)8!EE6M\B3]RFR&JX]<'><*5LWH
M="<5LB8_Y+UQK1C1\-,,T@D"FC$I^=:R;:5GF]FY.E1&VQUZ,0%_V*8QE8\T
MVB(0PO#35WO%-AE13*WW7]&Y7T@U'<S(+%0P!B;K%6^U/3R_(<7$1C*HI:3
M9%F=>C/8Z^$R)=@AFN_V5(Q$\.N)A W/\1[#E-FW"BO[*),A=V]W4WF'.=(
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M^0ZY*B0P:[' *6[NUI+Y?:B0V4]V&O)&3E^,5CN]JBQBJGQEP"(C>?A6BA@
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MJ_@P+0PC?,3@/G,\"^[Q5R$:0&;YO)'Q&%J ?Q"$H1:/4GE+K'_8[/^XIIL
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MR=9OU';S\FYFP?-LB%9N>%H:;!\E.LRM0(D;"L$#*W_>>R:S7%U2V!4@/+R
M':WTA*K*5:F_6JST/+-'M^LD/'ID#73?\&^DHG\<!=-.5;%57NN4;&U^E-PX
MO^,#&<_'4T6S3<V?;!( GZ JV,.'L5VM58Q)EX:ZG;,<S(.B.FN: ,0Q7>Y
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MVH:KBL"("OD79IZ$RLZ7EJ5[J.( !KR@/^OLBOE;QYKJL[V(MB73-ED$Y>[
M*P+@RJ&H=Z9I4%IES$/I^Y!PX+9'"[+XVQ']5&AV3\T[XDQ:/8*!;+L=#E0:
M+K<Z6"+*:IJ!"QQB^+-<6]%>*\P[I?T%ZRM69"IX^O$2AD5)FPQNJ1;3M/9O
M>=DIP5JC:6/IDF_$PSTG%7+MF?=LXZ'=,NCV=$;[*B?QY(Z.+ <"0 C;]!6<
M6EU;5^> ]M)^--7+LA%%?9;CVGL]\>N)JK\AYE#*U*X]_9X, 1 )JVHJKV.N
MJ$$Z';*QX TMOO^X?V__8H6@G IJ%7\^,%Y27#K2^T)/#O2<=^XD<W,"O 2A
M.O5%ER/XJ1VY&RMA3;*EHM ZO'I7+6-$42*<?X5"WCP^&-%3P_\D5;[_G5[$
M@8P1;T:I!"4OZEVC(+ZM@P7:0?7!0=BLOJ+RH5;BI1FJY/$$'GW]![K)@74*
MJ1F-3EB5+KAVKU9@;_M:F>'7^Q]B59WAZRN%ZGE.17.UE<[8;Y^&0IUM\M5T
MI[)X=2/&AB08?JC2U;#1Y30^PB&B3DWMYR/-)M#MT,\M#/@HB0 &7TKWO-KB
MK [MC)R2@6(;5(3Q'"BB$S*7V[0&6<R&:V"7CM>UL(+!?:?;+K)!M2K2/,D%
MY>S<GMVYAKJ>*D18ATI7_^5$6:5C2NU$%>_EX9%MJFKO^N6&H8449['_8!-=
M_7/HN;(?D48>F8I_WBIR?#^@79NS,73@ =S);=MFQ9<0 '-W8VSA<U23X;8F
MH6$S_#^]4 5)6]'92D:/X\K$<[5TH2IQ ?^)\X80G3?]E_/"2!$+>:@S/] R
M3!_=\R\E(6%\J!GK+-$_J_O?9F165X<,7TQ>TPWA9K:."7R%3\8UL?HCOHS<
M]@-1M0H[OGV[S7N38C"J(HNOQW'H@9I+8)U\LJI%,%7/&E(F40J8X#(W0#NQ
MO,G2%V_I<=%C8!<5ZX$ X5'&M3Z.%1_>92*.O%2.KM?\B/_YU6PQHL@W4=[^
MBQ1DR5J@U'XC<_/2J0<F3,:^DG-="NA(>\W&BXL*;M1_WT^@!U'L?^_@(63Y
M7?['6&.5*5NQUND"NS0:>6:(,3RZ=OA!#*ER2_S>C:54&,L* 4!W:IAADO79
M7E*LLVFG5>5(P_<PB "P45?_<17=H=_:[R6K-TN>A./)=AN@DEJKD RY=77$
M8I(W3U#8 ;69.-?CO1S6J=C9$KJJ@_X'G?$1*L1T$!E*$_7:X&U$.7EWPLL5
M_>G?Q,PJ]'A&/E:/%CM9FO39U_4J?'A%L2?A6.*Z5!5[6V3Q%QJ1_SD8Z?.$
MRVE98$"T _EK5\DO78JDQ35*,0P[_+A<GO C" >9HVX*%*?8Z>G.ZZ\S#Y>+
MP-5A47$ECH["J)R&IH3<VFJ'X:]=B1*9<["K,.\ZV ?]T>^+WX^TK&]Q[P$3
MS#I8U.+]!_@K8+:"=RGW(*^;:&"=1A.P-2W0Q@?]*WJAUTZ@DK--%-/XF787
MVW&_V"ECR6OS9P8H5#D[36];K0"+XX>K'63@EQ1N/\>]D3_#$V63S5=V%6Q?
MF(4P;<Y&,>ERN>3I:7VG >0.*?FH9 '-SH]G-$H3=P[TD)=TR\HXFO601UWS
MZ>U\$O(:]2+9/4I%U.?Q/8C%C_)@(]TI54/FT>37CM\@8;#K3J=6<.[$&/"D
MS5>UDNDK\V.A=KO93\(KE,EYF9B W!7EAU4N$S_:1S1OMF8@#RR86@PY'F7S
MU7T1;0G D:[9KI*/=M$9_NQ."[[%!:W',\Y2?U%D/XS0G.!RB;,,6 NXU1"N
M,5C>=VOJZ4C17(@$$T!8;3%-B-XS*O?1G2]V.X/X$@T>O3>DM]][1-7?']-K
MCT&@ FT0ZQG <X]#<Z38&.-.$;M7\SD'CDT@N?(#PX\5ET!:S)-2Y'%&VC4-
M9MP;Z14WG>\P,UN9UU['>FV3ILK>,;00M7T8R)^J?DAP<;3^SJ;7A<6T[Q$^
M]C,<%0N_+=\(+)*Z$4%O^C;%#MR^&,^ML0:7Q*+FIIJ0GS3 AE9!NO=>JLZ9
M> T4^V;[\Y'M&DZI>-C>C/)^)_HE_?'8?E)K$WMN9+U0M#15GO'+*OJHZ9#Z
M#24:35]9]CVP6XFAHY?$#K0S_0@LF;Z_E;!?[)^ RSU7ZUL^\\MF@LQ!?FL_
MI:"0V7XUNG>KL1(OGR=_V-;+[2EXX$$OY < +^0CQJJ&&_/PK 0 UQED/7>O
M) *&'0H!GO1QA$L>AQ( [NB.\[M$WAE<3$2:#OBG/ZFT",*_KP1CE%GW0-N4
M)Z08I].X!MFSD=/U^<,5R#3P@*)UYHC'U^LD]VB\>N 5$T;AML>>EI)/:,;O
M;D8 = X<W28.?@A2[/\QW;,1A?]!'$SG[GDMSSXJ_MH6NC#HG%7N)[0S*A.3
M?IH@R'AV<*YW('HVM(>*"F F +JUAQ S3HLP"^$ID-IRI[_]X P5ED/CY#X!
M\#7)_O>C!51RTA9M-AS\[W7N&,1KMV=-;WP9FV>.^,$$@%G7$7JL8B?I7XJ]
MX><WT2'X"P5K1I$E<;F]?G#^#C)%@6\N^F'-7%AR_Q'<0->PO6\OWNGQN^+4
M_([^D?;<O--"2N*Z-QC/5GHL^5RX'84T"HU$67T96?2#,]-,(1'H,R5GRD^,
ME'?X?FL&>!;#J/'V.CC'S[4!T20Q7^2Z9<@X:E#/^,7GK3+D\J5U8^+J4G@%
M9J;,-&Q7I]G'*RS"J67<MG )P+WH( 5*;T1;(JXO_T%M)/XH8OB*@\)+:&87
MV9/.? 8[9": Q"2NDSM+:^0*V'[:NDO;7P9GZ;(-%UM<[WAJ:C!C\&W(S-#D
M08^SZIM71^B?)RH?3PNB<C-L)_H*C>WT8P:N$>,$+3:+M?!$>G?K=D#(218H
MF^RB"4?"%H*ND53@B6H>7M#3Q^)VNSMGT^WZ.Z&J+-):L0^DK,P#J3U'\EF0
M.*DUG03)YYX0VD:NM0"RQH??(EVRROP/-KRC?T+'DJ_76,T)WF)7U(A7O1(D
MQQ$ZW'B+2,@%Y]_[B\V]V0NO,2P_.:#O8I937M@9&WCS,:LFLV8HM&AD\1<M
M?QGR1'>!X[4V.M'WYG__P=J(%H8R.L!"W,1+\!KCP819NOSF1B#OC?L[TAOD
M1(_AZ4)SR.*HRE]TYTS&OKWM_=8ZI"1S'M)>-D=U,"ANVS3H,',XS'?2+W6K
M/@6029KM^\Y.KC#-."W@5L7,+<K27%NT;W_^Q0\Y[2.FCYT+&D+=\'INU5\R
M+O1O !F\>#ZB<@*H_24XF(>3H&.8SEQW4C*7;Z3#585Z.I'?^'0\N!U#M;"[
MS>.-%[$+^C&;B9MH(C23#Q  1K43O*CKVJY>UD6QR"_$/?MMO_T<Q9LY[$"0
MDY-E7&],I@T&LAG3X>_"W8Y.NCHU5>,7-ND?X9=\J#D!,9RRM_H4TO+\VJQ7
M%Q CL88Q[Z5Q7/Z 3%AV;'9K-C.,8O!-&]N+;H&%#*WX:MM/U-]8D^1TY8S>
M)R4 4&;DF-R16SB)HHF=Q-(WVT]I1-MB8/>$N[:I;P4;F) S >[,16C*FGR^
M%[J@F?QH'PGN'M@DQ32+WG(C $@99O V$!H"8* ^_?![":V%3NGD9OZAO!UR
M1_'DOK<W+?[P+0'0W"%VSL+:1@#LK@J?'4!:H\UU/OO9P0?,;M 'BH*78=$*
M@*"''\ZO%@N),%QM%!I2N;+AK3 V5K5)^S$J40R$9R( *+MPPET@&GS0O9H1
MZ^%LC_<T4_UW6-E8)B+X1Y(]1?-E="(_R-VJBW[-P9W4U@BI#/\V:>OK.3#
M1@,.C@ ^DN2Y'5^GC.MF!7IXW(CZB<[FS5?J2//GFN<:.G3]['ZEGCB.A:9(
MR(Z^$V1]"KQ&>V6F)!=3"$Z0GJ(,A#>CDL[%B>AC6$\TESM*]E*Q5N9@^_HC
M##<!H#^C=IPY2\3!O=^?5VB$)IT9P\%KT<002G/DO!:AMM)!# 666T^M,_K.
M/Q$ 4Q(X1&33PB=[Q#X.9J/QQRJ#I^>WG9!XK9 SBI/6QF:\\:]3Q\=$&"8
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MQO9H/R!LYKHZ6:0< RFZELV4?4'9?CR;W"]ZYS2NSI)^;IY-:UZJ=ZKP,B<
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M7 81UI':N%A3^R?7WTC;>%JFOT!_QNM@4*%R-^KV>H&[W_UWFOJJCW>':R?
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MY>\W:,5LLR@AP[B.^@_6B+)/SQ.; (++F+-4(*G,J W_NR;-<^'8W*2(YV;
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MPKS-A?WUOC7RSA([Q*B[V33-F3#[0W[M2GXO9IZ&*Q>C9?P%0A-002OX>TQ
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MS&513V</KENE5G]G4TAU(=3-<&5677OQ#FP; I+0,G'SF/;<<<\V'Z42XD^
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MRD74"MI+UHXOSVA!B*J*]1\WHJ,OUS96)U],J'W"P291/0,[!7>>4B'[=I0
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MDM]E27_+?%4C(=ESA)_^/*?35^$KY A3;,- X_6:ET&FED/B+1:Y6.7P52;
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M3<^_?_X_LHG^_T  F>/_!E!+ P04    " "+@EM8*"P<UU,J  !++0  %
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M']3,;J,GS-3$8&&0#A?B'+.)O+LE42)!U#!R&GGUS\33<-4((U@L<T8"40*
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M6KW=<LO;T[JUUS_$Q=#SO62.OF,ARO)$](0;FJ>V&(Y7 +N7#=,$:BX2: E
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M>7D 2$GY9_F?<B5)^]W7_Y7K/P])<4EI17%)17$%+@E916D%11GQ__ ><04
M=\ ;< 6X  O _D_IMZ:3L;D%!OHJBHEY!XC:._DX.(LZ^GB)@>U]Q21$Q<4
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M&1[ED,=0GI&Q'A;@Z6&7"<"P6NF#" $,)XC7B=:8 $P6X!FUGA& U7=V&02
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M?,67$0&#%;M2^6A9:- <_1>*F6ZZV=7IEJ3G5P5&Y;L8-8$CI !6 D$KM'(
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MD:M:;Q %8JN:T;N7NKFSH##I[:5?[?N(W!IVJ(3>K-2X<329;X J=::4M@9
MY%R5KLECE;]&8#&'N.3Y_SF1U!?R$ .&4P%222M.[OD?EKX&LW:6#3YR[UI_
M^.B\95O)O'[_U^.5QQP"^0G#)-I0*4UWP"'!,%..ZO='MR3%#L0[;I>-1@TS
M+2\*% 3Q+1#E+B(G[9)X;BN(N6C9L#YL)) E:8#/78[64@[RCEB)B\K)8CZ-
M"G2=3IP=/WEI\;LNJB$7)!JY;D/^QLDP>5,[.RS3KNM%A\Q%J#749TEK24LZ
M//;-%E12L.%8VG4V:XQ:XAN#DW' KFY.F#2U> ^\Y[!PZ*23H2+&T%^@IW"
M+W*M<>.JXT=B&><VP/3,0S%A+&!7<U='FD;+R#!32F.86L_#*+1P4[]=V,X&
MGI501WOL:(V";G!(HH+.[,L#$4[W.P38-U$1ND/Q.]UE+DTA"]T#B\.L+P.B
M3U"7^&P/#+=^#AL^?=\2VS&,"UR"9(F!MJ&@#TW$*%%YF0"TQ(;K% ,7J?R
M0$8#FJ\[CF=%!""50R"0D^TXV^#7FMGN4VD8H]5FFXV9!4V]M7];L\0'BKO
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MVKJOK=_:VCLZN[I[!H>&1T;'QB?P<_/$A<6EY975-?+VSN[>_N^#/X=_N4
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ML7$:W'4\'\+OZB.CO3MS?] <(4W,1:S58I39-.>,MW *JW^?EN')0$LR7/S
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MV4\I[DI#R4DZF#ABL O\]'4](@JY5( Z\#XD [\O_B(##U):1LE B"\9Z"O
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MST)__4Y5GI$[ A=(TWH19ZYZB0%%6;NV::WVR6IK>-YAU4F_+I@</C08O<]
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M:[_7-S:W< >'1\<G?_"G9_^X*  JBO^C_Y3KPE\N2FIJ*FJZ?UP4E*_^5;A
M37-%AI;C@1&=@P_GU=MOZ+D>)N4AOC,(RQKO<S_S'66\*"*W? WW#^T_R/YK
M8.'_([+_"_;_N&8 9BJ*OY-'=0%0 \Y-\F/%@/RL;V5;M)L5<&NE_'!L@0-7
M[:/GCUY>JNCCTP.\M9F;C[FJPNITSHRC!J%^!&VB)WYEGX>@^ANSTGDW*K%$
M>T0]V+EHF+,PSP^Q$AS=>U^$W7!>"<6'13J"$BY+X.>7R0"G/23;W=(9T9K
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M8%*(EQA$)$U!N'>H%= \4IM_Z5PL.88RCV?NC'2%B@L/=XP%['.7JF.\]E1
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MDDY?GS!Z)'-QUBZ-#W,=.2,%DR3!54K'(LZG.L=&-?S?B>7' EYR346%/9+
M@AC<J,Z$4H65.'9'H%ZOSOAET?.C9U-_9/?JK"^9W\Y(]YZ3+GS'WW1NLD2*
M]U_P2!DN'F(U[3P%SMD,N[@W%+FXZ4JJ51OL([LE#3+OEF(DC? BZ-4@BS%H
MP++=RVH3JSK[4V>%1>+'=3)PF2BQ\ 47R_OBXK?='-4TOSGL#?@B[YR:Q%%\
M?LE6YJ6H:HJH@RG)=V2@Y6I$(KPHR'= AC?$VRSS(+UD\VQ0(A,,/[12.Q"
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M&-]U64\%3E4B<P6_001/Q0N3?ZX@827Z)_7\S.1E(V^)5XD'13.%;:B<A(S
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M8[11/BDXJO*6IG19T0U0:'_G+ZTE'5SI3U"&TW_^N/K_T='D?P!02P,$%
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M<U1(O5E4;?C#^O'8P5_(V .V*],0@5$7F=FUZKH="9N\8PG\ ^H9SD3]5JQ
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M6]%6W/ ^27'UQT_X#SA!*9Z8L, !VE(,I@#O!9!&D+_YYRP%D-1$69VP_J(
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M$>82FP F'+L0!6$(XX!0R&C(N$L"W^5:<W9,YTN;V*V<@'2" MI*:G;^:#0
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M'29;DWM9)\RVA\/XV-FZ "-3;/"RY'P;>?1>12)]XLK\ZOYVRXN'%6>NX]*
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MN)O8EH67FT=>?.7E2GA<8(PBF!"?0T2I)QG!"V#D8(\&U!%AJ'\G\:SYI9'
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MOE[CHE3N4$T(I&D$Y+R?@B;E+G: )S?,A]VJR@M"+Z] !P1HD=@^!6HL9G3
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M<!R*(#!R+=3H<VGSO!4/W#6BYP7(M[*;+>0Z@.NMZY9AG)@A?MXBMR?N%>B
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MVV64L>+[5U/F+X\OH-1\'I\W_[C/-Z_R]U57Q2:AQ D1(S!)(@J1H!&,0Y=
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M/MG)S.MRGZ+/U^7>IT?F>*#WG&W6_$9<6/6X^<HI1R%2*WL4^0E$G$<PQE1
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M '%$.8QC+PT"PADWJ.QZTOC<2*\1SV#VGH*E06XW0# RI362*0\L&R([A<*
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M^/KY[6M2_.._RNH?J@_RG&_(2N4C>T]H'=ZR+SE!(Y&F"?1"+X8HHSXDB1?
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MP>W(U)J @RJ-H]&B+IA,E7'7U6H!_EN-S/W R)CGC'8"J*M<TK<),VV.:2?
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M("^A-(0D]84R'K 'E=G 84C]@,B )US*Y6:](2M#GT-W="NQLIUCO)UQK^<
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M3/Y:$!UY,@:3,:E+XUJP#GT;5X_GNL_'KZ60+ZO/F11+9<5$::RT(A83"E&
M$$Q3@6$HTI 3%C+?3@R:3#HWD7<4(01>*EK!2A'KJFM'!W,SN><:R9%E7&]_
MC@6H:0:?^Q!UV)#C&*+1NW!TIIQ)ZXUC$,S[;9QXU][5>O?Z?%#'Q="U>O3B
MW$2&DMK@M=36@EP73T0M%'BO--O56N>Q+D!%O+DS]1BGR\[3JR :W5URA,X8
M-6QZ81CD$CT>;3(7Z%E&NB[/\P\-4Q%N\DW&LU7E0/TNV$N1;3)=ID^'"@I>
MU_5[>GZIPY%NY0=2Y$J!*=7"UDV[WTX/4.7@!#&/*,44ADFH#"S&8HC]*((L
M2;S(BQ'W4JOKXQ%IG9MTZ5(*=J0.2I<:<XG-%)F9+-S(,F_@FEGK/!.@Z4A5
M&I/2236L"2 _5,RFF')<AYOV87Q4NVL9^SB6?LR@X*S*0<&0^(3#-/&D%\1>
M$'&KHJNV!,Q-N*M]DHSC8-M"[M:Q-@3(.3K4- _3>]0.T9O8D[:=?I8>M$-P
MAGK.CL:QMU7O"WY3%)]R?I]M5D8NK^.WYB9J*J+,S= #""[;H,.Y'UD^W!>D
MRDWKM#99 $5G]IKQ%[("_<!8&:"G,1AD?1X,-9GI>9J%KMUYYHDK>HO]<KD+
MS2^'76ANZ\8SMR^;<D-RO<!_$=G#XT;PFU<E(1[$AS]$P;)2W!49$\L8"\EH
M@"'&B0<1PABF<8Q@C"3SA/01963Y7-U$?M^08F.F?DQ$O<UF.N1AO'W5(7ZA
M3M>'+-=J)Z!D53EY=$LROEZM2%$"110H-1!#VI--\'4$E'N() +&?I46PX1.
MC68P9A'"A*8\0K3Y.C[DAD5Q9_MMM!Q,]&6(ZK__E)^%F>H\PX4>^41UT,_N
MMFU@M_>MM/R#!@#0(@ J"!SWMYMNS5PVNYN ZND[WTVW%"?;X$TXO4LU:>FA
M!*7<Q] C,H"(!1Y,O52W3_5BSD1(>2BMVZ<>33,W2Z86*U5?0L Z=+HX1*Z2
M^3,5T5O1VS6 =+,EW5Y"=V[,R]%%ZR22< Z"RT[.7"D6?LT+P?0+_%?=.HM7
M_0S(ZDY]18]JJENZRAZJ>=Z_B$^Y#BGZ5C?7V@N]BZ7G<3_P(2:^DB(BD3!E
MRC8* XG3***^87,;IU3-3>BTU(/UEOS&JYCE[*4HU#[[/=L\*NUVG8NJ%[.=
M.'*SE&;2:_(%&EG8[?@!>PR![:+M6%H Q93.&=5L@88OX >@YLJ=''0*LB.Q
MZ8:F2:6L4Q@/A;+;P8?)<'4</*WK!-<F02KB44(C/X:^D (B'"8P#:,8QHQC
M1L((,;O.A$<SS$VVWC9=(&MG@&4CC&/\S(3@5:B,+-!JVNJT=H<)9A=9=R1F
MCL>?5&2<9>]P^Y]_T/[*:'>A4$7#&%X9[;\UMWVYH^X_S"^.#H"X?'$T'(.1
M=V'GCLA5X,YY?@==$AT,-=DET6D6NI=$9YZP3^1\EVW>;@I!WJVY6#(6$B]-
M(XA2W9TEQ AB+V$PQ-)3IZ(?IH*;YFYV!Y[;QM.T 4T<T-29)VCN@=6_\ZZ!
M8.S3SXQ[J\3+4ZP.RK7<&VBR],I3Y'<S*D_^?FA!\1O.U7*6=^MR0U;_-WNN
MOB:41C@A-(4R% %$'.OZG2&%D<=C'*A_4F%4.:Y_FKEMQ*9$=D.JKCRIB06*
M6LN=V8/LY7WJ!J^1=^U0J :4$^]#XHIJXB>'G;B8>!]KQ[7$>Y\>4.BD6/,7
MMKDMOHOB-6--%R-&$^+%(8S4V0L1DQP2YC$=/A$G"L0D\HQ"]\]-,+<MW]!8
M-3UKR+2*M3\+9/\^=P'/R#M\ #)VM4]ZV+^F^,FI8:>K?M+#U%[YD[[GAGF6
M#@/!=QEE+!:)1[& 7NI3B"))(4EY !,9R)@R+T5VZ3AG9YK;YOZ\+JM4M#HT
MP<[1=!Y.,X>3$Y#&/L0;&G<8.:YD9@R&(U?4^7DF=4E=9/?0-77YA<%U7[NE
M9#_KA=+^[?43R?*E[Q/JQX&$ D?Z)I @2#U/Z?PX$C+%H4?CQ++*Z_G9YB8;
MCHH<M^1:EVSM0=A,5#C#;70/V1G(P&\UK6[+KE[&Q%V1U9ZYIBZI>IGM$P54
M#5YR5UR^?$?J:*C/62X^J9^52Z5?D"#U$R@D(A %0E]B(021)U-.&4M9:.2J
MLYMV;C+E? GU$K3$@]\T^:"BWT$5^A-K<=GR& ?AT6_)SH*[L$372;WZ\V"-
M4+S^Q&0_O)+]>0!,RMKWO'UM_<<Z)4P7*O13DH1IG&B)A+2&DT(<QCY$<2"8
MQ)2E9G?K/7/,308=5C5L\A^OJ/RX@_.R[](!2".+D0'X7%'S\0@!!Q4?=V/^
MH'J/1TR=K_9X_*B]&O)=/.@!_R36#P5Y?LS4L(UZ'7K2#R(<0TITES$O508,
MB1%D/.1!&*7,"WU3K>/L+'/;X%T*+RO>%FA>UAN<8#3R_K:#QTH3N,C^%0?_
M^;$G.^<OLM<]UB\_/#@^;ALN_4VLE++ WZW+MG'6S@GG8Q)%<<P@(R*$B$<!
MQ$G ((K"-$JC* T]J][JAO/.31B<R\VR#JHS MW,G3$"E*.;%IVLMH9D4-$\
MJ/O@D @]&\3<Q>T9S3IU-)\-%"=B_*Q>'^I6?17EIK)B;FBY*0C;&+OZCMZ<
MT3[H4 =^:^ESZM0[R[TS5][Q#!,[\,ZR>.RV.__H-0E"#WGV#\'OR1^_B%S(
M;%/6EK?ZP9W(R:HJ!I7KHI]"?3N;)B-LZ3$4A#ZA4!!2^>W4@4H\!$/"?#^1
MC$ILU2_\"EKF=LAV60$;\@>@#3/5W7C1G!=9PT3UP^>6NR%I0<,6T$P 3;0L
M(PNJO1515(.6CT7K'-0_W/)2+4G+C?L<2 >8.LWX&4;)#\CSN0JRT]D]UPUI
M[YSXDN79T\M3DXN2L"2@(B601-K?Z#.A_L92&,28IK[@,<5&N95'(\]-)#;$
MF;L=]G&Z[&H8S/W(DJ>ARW$?J)/<7N%-V!]O,@_"23:Z7H/3#PQ3=NZ*];,H
M-F]W:GTV:D_K1I'/6IOZ*C9+$L8B)HC".(H2B!@54.V_!!)?"![Z4:+^ST:;
MZ9ML;GNSI;4Z]41+Z +D8F.GC?0BG,:I"#B/H9)J$414_2WU? $Y%=@GL?!B
MKA!>;\AJ8H2W4_ZS(VRFT+G";62YV9*Y !6A%7(?=LA][4'.6A\S@<21PM4[
MU:0:E0G3ARJ3T3M7Q(W\4E<!^_XHQ&:_G_E2$!$&881AP'P/HBBED(12R6N.
M4AI)2ICG60>,G)]O;C)Z%\S0T PJHCNQ5777A"$1(CVH7]:['&,YNN/V6AB'
MA8)<!L=%#$C/+-,'?UQF^634A\%K VMDL4?!7U;B5IZNM5/E>3=5NV[8)GO-
M-F\'G5:P'X4I%S'D2EF!" L,*:7:6@M3F>*(!9A:U=.ZFJ2YB:GO+T]/NE+#
M6C8E_$!+MV7UK>L7RTP;FG8)1I9N%ZMZU8PLMHLR2JL=]]"ZJ@IV/4'35A!S
M!N!1M3%W(]N7PJC*(W[XHV!U%57#4AC[;\U-[AD6(KV$1;_,N@Z&D65/19CS
M@JSG61Y4$.-@J,D*8IQFH5L0X\P3=KOK'_J/F^<B6VFN;W0A9_7Q-R[46$8L
M%3B! B42(H_[$">ILJ>4TB+2T,<L,@IM[9MD;MOR>Z95_(I8H*DUVYB],/9O
M45?@C+U9MX@ 12.HB+SLH38'B3<QG77-U+'!VIMM6M"NEW F(-2R3C]9B3-?
M_5\ETGK?G42XF5#?BCFC9UVW+RY_>?M"_K8NWJU(63>B2^+(#[%@4#)!(")>
M#$D4JH."41_%./9X$+GI8GPT]]S$8V\?WE*7:*_H!Q4#@SH*VBR,F<$V$MPC
M"URG2#OL?7P6L]%;(!_//)-.R&<A,6^(?'Z( ?I<4XG[FRB%>O%1R<WWXE6L
MUI7?O8E'*)><14GB40E#[&&($.60QDD*N4@8%Q@%L85V9S3EW(196[&\:*BN
M;HSXCFX@&L(M]!LS[ U40N>(CBRO6C!;@BN-IT-R&Q/E'DP+U=$YJ!,IDL9?
MZK\[4B^M@.I5-LU&FD[UM.)L3Q&U>W-@;HJ:8!DE82P90Y#'^M(@(3'$(:.0
MRB#R8XHYMRS7K :=F^S5-%EFD&AHS#0^6X9'%HV]O-IG<G28<Y6FH8><-@>C
MP\11@D7W=P-O[MIKP%NI1_NX6O^^2Z/P? ][4<Q@%*5(;:\X@:E &/J,RY %
MA'-N%!=@,MG<MMWNUGHM@:865.2:I&+8 VVV65W!-_(FO@(Y^WLP TA<W7#U
M337MW94!TT>W4B;O#!,AM5FV_9;C*%"&D8A@('B5NZ*$AD\95%8496D:LS"T
M\@'M#S\W,5%39R<*#@ SV_S#81C;WUV[6<;8W:=Y=K2?#P:?= >?9NQPSYYY
M:N"M\/W3PY?\.7N?E6P7R&%S07QJ@-EMQ^JF]#Y[TIV%OGR]^P0TN:MU^6):
M<K(?K_Z]Z@RJL;=L#TJ.BTX:03+\OOGDJ-->/?<Q=G0+W?OPP/N9=2&RA_R=
M;H26L[?[@N2E$A?9.O\3R7)==?47(=4S]^2/I1]*/TT\ B5+M2<S]B#A3.J\
MTC01OM+KJ57Q68NYYR8I&M(!:V@'/ZGOO_P9/"C"+>]A+!; \!YF'%A'EBJ:
M-O"3IN[G!6CA;7D '29TRW)-OLX+=7@18P^:JXL8BYFGO8BQA^3H(F; $%?'
M$+_0,N,9*=YNY6=U2&T$_YP1FJVRS9N.I"/YVVW1_.*.%)M<B8O'[+F.JB=<
M8$%P"!$32L1%40HQ2R*8A%$8\"B. V25.N^&K+E)OY8K<"O!CB_]KX8!L&4-
M-+R!VV+[RPY[=KD1CA?;T&\R^1*.[6%I5V^]MWKKOM5;#UN]:R*3'8#M/CKY
M&J)^5(2R R![HI1=C#XP:[B.HR^;XD#W:W6*_"7;/#ZN5[JINSI[SG0*I\@3
M)! $!@3K J)4"7GDI]!/8T9DY',:Q<M</%2C6B06#Z3'2#2DM6@XHFH\,:&H
M%R5X)MFN+LIF#4JQV:RV_EF=,*MS9[5Q8NG&&KQZ9E)[U,68*,^V9F%1%4#I
MT+X %[))'*;?7HFBJ]3<H61,F[9[)5A'*;W7CC=,K+X74NBNZ&JVVH7X56RV
MWF9&D\272BNF."80A8S -%#Z,4I2D:9>'!)F5:NQ;[*Y:;TMK57=*%)1:]A=
MU0A:,[GF"K"19=<6*RV[:D*KR@"C./I-,'$DB7JGFE3:F#!]*%&,WAGH1R19
M\6>R>A'O-/FY&E*+HEOY+2O_=^< #UC,,&8<$DJHCH5$D"8AAE0)$B\-%'EF
MI0*L9IV;'.G:7WMTUP;9\_,J4U18>A&-X#?T'[H&=619H^D%%<&+8SPUT:/F
MTEJAY<IE:#3GM,Y"&QB.W(16+P\34*U5JJO&M4<N)UZ"8R^ 3#(!$9>!$D=!
M *,8)3'&*4MCJV"#$W/,3?AT2+23,*?P,Y,G5Z(RLO3H4#>*<M+#O2-I<&J&
M2?=^#XN'.[WOT6'[6JDP.B3IKEB_9ESP7]Y^K1K4?,QRDC-E)C5)\FK"9:)T
M#!)) <, *>V#*>.%Q)3")/1"G!!,*:,V=<[,I[:2 A-4/=.:>!7H_M-+6=6[
M_1D\-USHC"?9<@#(E@4[:6&Q*F9"9!RL1Y8M&N8JA/&N ^Y/O[:0;XD'-Y=A
MMA8\]H@YDD<6$T\JINP!.91> T88E%;VNF8OA6B\YFWB-F=,\C2$VCL-D;:?
MTBCQ(.8$^:%DG HC7>7\%'-355HBK1*93D'7+V'< #*V)&GHV]["#2@)<.:[
MLLGJNA*DR;*X&K!6-:'NDK5Z^+^0G'7JS2F3L7HH/TB^ZGMRH.DERE*(SX*4
MXKTH69%5Y8L^;[M<QA*%#+,04JHK_"9(0.(%#"IU3.=@^2%7@[V*@JZ-#;'^
M&6V^V>Z\(UHAFE1+@^P"JH;&F3NDQC;4*DH7H*)U 3K4.NX4:@F-*RONPFS3
M6G1FK!]9=X:O#>XGIF12W60EY^_6^4:I7$(I7J+<!2#OG)T$I<SS< +#-)80
M(2X@QM2#'D)8Q%S&*6.6;<4LII^;,M6AODIJWJ/?NL68S3J8R:'QT!U9+/4"
M.UYD_'6XN6L[9C/YU-W'!@!SH@G9D%&N"VBZ7]^PO[]DA6A[FWS*MV%6==.3
M&RFS548VHEQ&,0XBDF!(4IQ"%/,48AI12,,0BR168B[VVF F,T$WA(P!,4PC
M"[Q=2RZ0Y:#L$#XL3LEJ4<QDWFA 3QJ?5.JPL(:!76<FA7F7ATHT[KAP'Z$T
M!$/'T4E6)/R0R*0A()V+2AHTUC"Y^$ULB-(A^0=2Y$K\EHWG(@IH@BF6NAU,
M!%%*&,21[T,N?812'_M):J7@G9YF;HK<#6,O3R]U/"87,F.99:.2,VB:B:SK
M,1I9*+4$@I9"A^V=S$!P)%7.3#*IW.AG]% R7'AZ@"?\^^.ZV-R+XFEWF._L
MBM3CG$G.(6)(EQ?Q/$B$[M+&4>Q3A"5*N+%#O&^FN4F BE:HB06=OJ,6CN!>
M6 V<Y:[ &ED45&2" YS,S#!+S"Q\Z*ZPF\B57G]K&XUAMB78E3_=!(M>MWKO
M --YUTWXV'.R&[TP0%Y^5EKVKZ7XECT\MGVR#_N^RS"@$9,A#'RIE";B"X@3
M',((^6GHQ\3C1!I+S<OSS4UV:HJ!(AG4-%L(  -L#42G6\3&]KCO@[4 -:G@
MM^:_PR2I 9 6\M0MH!-)U0K8%P5L49'M2IZ:8]$K50V&F4ZVFO.T)V$M7K.3
MLVS]DF^*M^7__'4I!?<I]F-(I/0@XIZ$).$4RIBGDF(A)36R/W=#SDU:OE.V
M/LG!IU+]U#2_KP-0OSP<QO;8WOR;OWZY^0H^??]\\_7]]^OWY3&3/=5JFH=K
MZ[#YQ\XP[ PUR?8[)KW=82=^<VW1A@]/SZOUFQ#?1?&:Z1YSIQ+;;E85T'5H
M^+9!^)THLK5ZKMR4G403S#R))(>Q#*GVBE.8)IA#+&C@1S+A"E6[D(+1:)U?
M,,*.]CI%9<=56UP:?-ME!#?-J(96<'"]\F9^K%FLYNCV[X6><\UB\OK>DCQG
M&[+2?"W S9/>XA/UH!MI!9P7?W!-YP^J!S$2W.=+1(PUX8!*AOQO]^NOZ_Q.
MK+^*M9[^8VY?S;!OD+EI<(K8E\;QI42UHAK>?;@%7]7_[XGUC^OU)E]O;(H<
M]D+9+X2=HCBR$+4$<(SZAR9(#:N!V#OR='4031C<JX5H],+ &(QS?=2;:S*<
M)!'S4@F#""FC+Z$$X@2%$ >2BP QF8K$YM+QPGQSDR<MN97*L*75,J+B L1F
M&IQ#X$86(2VE"U#1N@_="->3ALBXBGZX,-NT@0YFK!_%-!B^=GWF<<ZK!KZZ
MA(O:K1^J\DG+*/1HJ#XC99V&2J;("$.,J ]C3T:^'V%.0L\F+_'2A%9"98)L
MQ'L]!UAU$G'U%BFUGMC0_:__@@,_^<^FWM3PQ.63\)O)&Y>@CNVW/T#R0S]J
M5Z4T]T$Q0G[SR>E^6+)S'_-]F<^][]F;-7="%'\JUB_/U4;ZOMLWWS;YS=/&
MU+"Y,,SL5!%%+JCH!;4 Z5 ,OHG-2Y$W?@QSJ^82DI?M&H<@CJV67(^?E1UC
MB,P@2^;2V)/9,H9,=JT9TU?LY$)9;):WOS?5-M^OGTB6+T,IU/\D"#(O1!"%
M"8.I+N-&HC06E DF*#41%B?&GIMPV)('?JL)-+RA/@5;_Z:_$HR1-[D%#L:;
MN8?COA-?O=8Y[=6_=EOXU(B3;-D>5MHMVO?(X#RVG=M3&1N->_07D0N9;;0-
M4MYN'D5Q_TCRT\[2G:,M08&'D=K-H<<91+[:W(1("F7 1""8+SC'=O=<#JF;
MW\U6RPUXKYC14<(ZHZ?(Z$OEQ*N8L\Z%<[:69G;(#UJ?L>_=N\[4RF9I5ZIA
MK%Z<!:AX QO%W%X5W+WW1\NT<PV\NS0\9Y1-G:/G&M(3"7S.IQ@F]MNP^#NQ
MK=N;*:4QC!'7G72\2*?OH51"PI" <>![H>0QQLQ()^N=96[:F6[\ 9[5/JY\
M/*#R[@3_":BF%?R4Y8"O5RM2=)[YV4XLG\::$8Q%B"/(=(-!).,84D04ZE3&
M&-$DP22R.RRO1GN:8T_7H5K]&,S-#K6K<1SY>-HF$RD"ZW-G 2H:W1TOO1 X
M.BA.SS&IR.]E\U!X]S\\3 S?JN^;Z"SNJDQ%%2!Z*W\M1540>>D'OA^E+((B
MX!@BX0F(F1(6'*<B]05.0N[;B./>V>8FEK?$@I6FMHY.AFL)=:@R&="JM!]K
M,]'@#,&Q+>TM>$V!FF\M>CJ"OJ+6G; P L61T.B?:U+A8<3VH1 Q>VF@3F<2
MVO1U767Y"%[U<"PK-U_W]SJ\Z>MZ\U>QV04^5?<#363E,@ZQ%RM['J91&$"D
M6ZKCU&.0"QI'C!./1%9EBB>A>F["[=>\V-()6-=<%$U,:Z?+S4O#>Z,LK6N6
MP$-!<O532[UHDF_$4,^:V\J/+)0OAL!N>045LXLFFED7DB\WZK<;\*9TYQV?
M"V=7(C]D25SID9/0/*U>.N4R'.FYDTX^[*B[857:ASI'JT2J;AGXD$4H"6,$
M69H0[<,0D/H40Q;&H1^'"?(#HTS\RU/-[5#Y_O+TU/1.+#,%N<Q8%>&U90 \
M-QS8G1D]8)L)>C<0CBR==T2"ELI12O!?!L.17.R9:%)A=IGA0PED\(9]7$H=
MV*(;>]3NU[)\>:IDT?M,2J$[ HL!\?=VH\Y-8M34@RWY8$<_V#&P&!"1;XEV
MOQP9%^BQO766&(\0M#\,NT&Q+Y93318*,PR";F3,P!$&YJ*>3DO:&0N_O.T>
M:6R)2A/;-B_:T5?JQD4?"[&MC?9-&99?R!_9T\O3,B1I*B(J82@(@H@1#^+0
MX]#'(DEX0 62H56+\8D(GYLDU:1"J6@%A2)2JV!%%;2V $\UP989J5.MOYD"
M-\=5G=!8W[O/[W"M&ZB<-.IKZWW7"JXC\\M%W05.([ K4*DQ6( O%SX5^[36
MB=?-59;K5&1/F_0Z\6(<Y<!./?\ ';TH-&TW.5F]E5EIKXV?>7]NIX6B<YV+
M]4MY(%H:NBW4['. &2C4#K :6W7NAVD,3?D"*,-TXG.#3J?]7F!K3\^]]*RC
M1MZ=%)2O8K,,XR@,411!Z2<4(HH1I&G,(0]Y$+%48BI2F[2S"_-9280)LLY.
MM/->@+SGEG80R&;:GD/H1A80YQI[C]C-^S068S7T/ICMQ_;T/LWZQ;;>9UZ;
MV#!N[AT^_"$*EI6B_)37Y3RJFXM/.NXZ+S-6J3E+)7)\/R$<1M171K% 2*>F
M^!#YJ4\3SR<I-2I+.271<U-Q;AX>BJJU LA:.L%K90OIZPE]$[2]R!8->Y97
MV9-\"B/;QR,M\/QMX]O6&-ZRKILTU,POP);SVGR>@4$\8*%^M#%L0_(_AR$\
M8!&<&<%#YK9/DGSW4FA/\MO-'UFY]&4H$QPS2(G $$GA0>+A  8L)#PE?AP$
M1M5=#@>>VU'1T@9^T]19Y$;NH=4OJ:_!8&1I:LJ^54KD*5ZOR(?<&VZR9,A3
M3'0S(4_^?G#C]D\Y6S\)G0UR\TJRE2XV>*_K.3VM\VZ!A/?9ZF4C^#+!)&8D
M2&"<QJ':G7X <1H%4,9"^+%' \ZM:B]94S"W;;S-ZR";.HNQ*M>X6>MUR'(=
MF-(MHK+-^> U-]8=W2V7RTR1&W411I8C&O^:>/"3)O]GL&5 KT+- NCRL #O
M+X _I,_[, #=M7NWG'_JKN_#X#G1_'W@0/9>^?N"*P7I_4M15\ W],7OOS4W
M8=6U5%H:S=WN!XA<=K8/!V-DH7%?$*Y#WJSPL'*IGV9]D"/]8*C)W.>G6>@Z
MS<\\8;?7N,B6'_)-MGF[X5PM<OE._?6VN%__GB^]2 8DE0'D,I40I;HKN:_[
M2Q$2<4EB2HAGLC-[YIC;%JW)! V="Z I53@"3:O95NT#M'_/.H)I[/NQ(0@9
M;UX##'IVL7J[WL7J+[M=W#?F)-O9@*EV7YL\.J#JLW8FW#\]?,F?LW=YR0O^
M<44>C,L]GWQ[;CNWHA+<9T_Z9/GR]>Z3KFQ29@H@4SV_!ZG+A^WU((V\;_OP
M ;]I8EU5:^Y%8EB9YM-#3E>?N9>EO<+,_4\.Z&AV5XCGIN'LQW6QK<MZNFT4
MX@*A&*4P0)Q Q!(,4UVJV6=>FD:)D)Y90UCKF><F#3JT ZE.)\M"S?;(]TN(
M4?$<67!TH?S8A=)1-S0KF"WZHHT%]T0=T@Z_8-$RX*I7VA!\>KNF60TX7?^T
M(7SN=5(;-,"/B33X<YT>F7/=V(:IO]ZO]8^:"R3MK?GZ4E68]X5'?>Z%,":<
M0H3"!*8QDI"1@-$H"5(>&YEV4Q,^MW.FIDJ'%ZS;R^6:E:J$F]B17Q48JGS1
MI655H<F^"3-O]1Q7>N03T&7H0>?K: '0CG+]XVU<@@9A 6H8YA.&8+MP,PE%
M,";[GRH<P78Q7(<D6,]_;7O$=Z1\5-/I_^@3^)6L]'E<=6=;"LSBU/,YE"+6
M'6DB#@F-/,A12-4Q%W%F>9B9S#JWDZ@E&MQ*H.D%-U5+._67#N5-/SM#]=QN
M%0R/#]?8CBW[6UC7#:QD"*Q7] 8T@,EYG[^^.7]0SSX#&,[WWS-Y>6@EZ[Q4
M%@"OQ.>AL9H2'R4Q"2%-?"67 N9#RG ($681"25+96!52J]OLKF)H[LBRUGV
MO!)EW4&U0[EM?>D>A,UDCBO<1A8U>V0.<JX,J.A\&1EG)9I[IIJXYO)EIH^+
M*!N\,\"[6\=3W),_WF<E6ZW+ET+4IVD2XY1Z(H(A8QRB.$XA)=KM$B*,?.G)
M* J,/;GG9IF;T&@BB71BS8Y2.YVE'U4#+ZT+K$86%*/#9.%E=0'71![5!C:=
M[,:WQ+KRIE["H==S>O;EZ;RDE^C?\XA>?-A.$K(FI';Y[NM?EY)*73]-*"TI
MC2&*/ XQ9QZDV*>QB!CWO-A$\'4'G9N<^_;E%[-MNH=,O_ :RN_82LUCEI,%
M^.L+R<$WD3]E.<VNWW*GF.VY66X?K_64]E\['65ON$GVW"D&VBUV\G?V45WO
M&ZEZ7Y"\S+1H_2:>U\5FZ?DRP9Q'D 3(5SO,]R%FNH&.1$&(D8Q3;G1)W#?)
MW'9<2R?8$0IJ2LVCNLX"VK\Q7<$T\D8=@)!55-<E" :%=9T==+*XKDML=0.[
M+CX[/++KKA!\4SSE@P*[]EZ>V\[=BUO2E HUZY-N764?U;6/4O^V=0+0R'OV
M/#:C1'2=A.&J@*[]$2>/YSK)T*EPKM,/#K#W_Y)M'G6.A%HPI3Z+\IMXRC8;
MHBB^E>^SUXR+G)=+&J:A%Z0I#*E4QC\-/(BE%\,DD:G/N<^))XR-?Z,IY[;K
M.T1K@TU[$7-0;"G7/D7>TFYA\9K!;^ E< [JR)*BBV=%,-A1K&^,WH\&IH4O
MP3FH$SD6ZH+X^IO\W>*S=>5YL$*MUPUA-M)T/@DKSO8<%'9O#LU.NZ\.V^KC
M>D\V1A+Y[,MS$\ =\H"FSS9/[1";R\K6U;",+$)/9:T9HS0@>^T,$E<DL1V.
M.'$NVQF&CE/:SCTX[(KV4\X*W??HO:C_^REO2KV7=^2MOFMA-!0^%C 5NA=B
M3"7$F$@8L4"$+,%!B(TVM_&,<]OL+7G@N:;/[H;V,L#]FW\4V$86!BVMX*>6
MVI]U+:$MD'<7@+2^J34&Q]%U[>7Y)KVS-6;_\.+6_,7!K<S;W/<J8*Z\>=D\
MK@O=>F9)(X9B3XF4)$T"B"0*89J&D2Y[SFB*/<Y#JZXP/7/-3:+<[I7?*!?-
M?P'94CP\(+H/<C-)XPC(L:]..L4S%G5P<0EVE#KMZWT)#G=]NL_.-'7?[4LL
MG^BC??&5X;<TGW*Y+I[J=MO5F8E)*+&,",1<ZGJ0*8=*:D0P0*'/4Y\@)HV$
M1]\D<Y,:VSN(#J%V<0V]D)K?TUP#U%3W-#88#;JI.0?"53<U1X-.?E-SCJU3
M-S5GGQW@^OU,<OYKTWY5%Z7]JDBN;GHW2XX#/PY#'=T58X@82R$F7$(IPR#U
MU;_]U"A0],(\<]ONFE+PTK99MJD]?0E0 P^N&YA&WNP50KI[<DVF+C,-=H2Z
MP<K"0>L&LXF\LJ>^+I!O*7;E?KV,2:_/M>?UZ1RMEWG8\ZX:/#ZT"-'="UUE
M[.-J339+X7LRD()"/]'A8 GS(19!"M.01UY$1!RF1FVB3HX^-UG8E-6I*005
MB;;UAKK8759UKD)D9+%G \: TD(GF+ZBJ%!WM(G+"9U@Y+B0T*F'!O9ZK[K1
M?1=JLU>5]3^^?LW^1+)<EP-<2JF#U ,,PX!X$(4"04*]"";42Q&1D?286.95
M=79^;]&IO6=.HR\VK;_8HYG'^WI_TO3]7)<EU:L&I.[)5=>A9X_Z[J#*B1%U
MC\:LZFE<:?3Z]A 4@O!L]0;:6(XJ>7PW@F7G];X54Q8D\66BU@EA"1$-"4PI
M1U!$ @64!"*B2*W89NJ%VHR\/IJJ$ORDUT>4/^L;VJ.E**=>"YZF8: C,:-
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MXC!1<[MY%$6G%]HN7\_R\[\\T(R^_XI8T*%V+TUVA,_?'!U'W[_!A)-N ',
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M>Q7\D_JR\H>,KD2M?]X\K8M-]H_J:VL4U+\*4E3!F4NF2\0+7]FI'DH@0G$
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MY>.Z5)^WI_19A@-A9B-X!'<:RM "@Q^TR#]J<-]5X%899;O)L^IKYC%NF.T
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MZF=M2Q,7/CM2X+3FV?$#;DOO6U)^OUUQ_1]]#/!,EGK"WM*RVLTO*"$TH)S
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MD(9<0A&B@)$@C+E9A-]0)W.;>;6,H!72,NQO$$[#TZ(K01K[<,@6'_N#H $
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MB&:1VC.E&62,Q0&)$.(2V=A-!GW.C>3^UCI22LLC5!-\S:PFSZB-3(>MM,I
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MUD.U0LE7N3&C/J<M/68#PTD9,JN7K^"E3N.?E%YUCXL@83&-==XYR?7!1Q)
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M]K*X^_N[1<("1B,>PC".,$0)$9!P%D(B>!0D:4AP:)1CH]OHW,SW.U+\3E:
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M$T,ZBS$I75X+UC%W7MW>.2+M?A\?U9_^Z]_:?U'_HQ/S_=>__7]02P,$%
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ML2PV'-UO$&J9PI,5S8;EBLBL&;&I=*:2&AA+"E*L??=PB)9^!C9U * JPAX
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M[[ \SU_]]U%2AGKPCIB5<^ ADV"I(HFSG($'06GM*OYGDMAOZJ KN]:AF@:
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MPGI$1\$#YX3C,0[2"\]<[5X]%<GO-Y75'6Y?4*G#P?-B%%RBW*#HO+0,Z89
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MWBKKG\,- XO?QM/9?+S\<3?T=YH>?LKZE<=OL+R<I>UY:)*SC&8\$^446GA
M@5MG!9$R<>$X9Z%Z8?\+LM?OPYYNCNIA8F,0ON.&Y<VV_Q7#]CQ>CCSC 2S#
M.$FO3I. P7]I8^\]TY*G3&7UUO\'2.EW?$AW<&PG\\%9W$/[P0@7!>>2"-"!
M2.$3QE*JU/IG=$H\E2[5CT%J6;GNAI!T;^9J*&0 */L=EEN1N9!1<1\U";[,
M_?+9$<NS(=F)S'SR%K]=&4T/"&B&FE=5$7:Z@ =P?-WV/[E]5?2K7XSCB OJ
MLY>,"!TC,A'+,Y <T76%[*.(CHK:*=B]A#1#RZNZJFXO\ '8E%TFWHXG-TM(
M(Q>\MHE38D(94JJ3(=Y(3;BQZ-8!?CO4#CH/D-(,.:\J5U]#Z / SM^@C*.$
M=/8-8X<+^/WF*L#\/#]Z[+'>&)DGJA2/)$&97<&M1($%1ISSY96C$%#]O'H6
M@<UP]JH2^MTI:+CHV^REQR^.F-;,14])-*5!A2V]4Y-B1,6@K/"4VNHU],\D
ML1D"7]7-0)=*>CT/>1YT!EOYS@]8:/>>Y_&'=_2LYPDNZK<360-RU0GY46>U
M^Z$G,28'8(GRMKR=!T]"F5*KLJ,*P[LR=*)V/<OS2*P;]DEEC K.$*K*&(T$
MAMB0/&%&>VHI9RR+ROR>$/9U9:.Z1,?Q:/ Y<A_ Z=BD(R&ZG^.2$(GE726\
MA?7O=[)SBOEL/"?1@20RF$B"E)QP7?J'>1I=JGW#V9[JP703Z1R>+ZSA0=14
M'^+Y\.4P*F#UM\D: ^G_W*R3?W<2FLU7WU@NY^-PLRP=@+[.UDVS1A!S3J:X
M("JA0^R8)DX9E!852LD0*,C:^=H79;!?4_[2^&VX??J'T@!.CSURN6MCRR,8
M28,CPNDRRSF72QH>"*"]<CHZJ60'330.D3.8#C^=V_M:.AEV\\6C 4?59HS/
M6.FE JH7;=;8#+!HG4264!IK\%))Y1"PW! G#0!7%O)KCZZ.'4/'C3H;&6=%
MRIX194JN7U%;>@1:DE3*H 4/N7KC]1;DOK+([1G(>XYK7%.GKR<#M<JT/>Q9
M7-%\[OGTCDSF4WS4-Y-'^BD'G[S/+I.0RM02(\J\72=(=NC04>F##;7O5AL1
MUKYC^V:1KV5KC%+@4=E,28X:B-2<$RN#)$IDKKFD3*3:0Y8>4C 8PU4)"X^;
MMI\L[P'$"G?4KR52S.YL6G;KV??Q8B0#]T&Q3,#3C!XO_N)C4L0$DT'0*&SU
M_HU'"1H(ED[0]"'0M!;[ #"TP\/;V94?3T<I"B5$>: &I:M;S"B>("/)PH$'
MZ;2L[E[M)60@F&FOZ-TRA-92'P!TMKI,_@;E=G$4K*5.>TUX1#=.ED%/GAN,
MC07^64;))*]]0_*(B'XA4T&QAWMYGB#E <#DP!"Z#3.*!YVY*Y7&0A&,.S*Q
M26M"'0I(:NU3]3G;1PGJ]Q:C/GSJ27\ 4-H=.+?A(DDN7:! 0D:I2.X5QJJX
M*R*$$).U/E2OM-Q/2;\IT?K@J2#O :"FP;2X6\OJE? T&.(<T%(#XXAC*+!L
MI!#<E7?7M8'4F+A^'[UW8)@ZT<H X+:G5_*&$:<$ X4'MW::$XG_*3,!@#"6
MJ8Q*9\5B97@=)*;?I_#UX51'Z@. SUW0\1$M[P?\XV+$-*-*2T64!K-^+..R
M#,3&;(R*X&BH[58_IF(@Y1T5P_?3!#P B.S>RG^8/DZ/?9Y-)N]G\S_]/(V4
M<A(D0AY4LJ614NERI#T!9Z-/' /95+L#WC-)'$B<?R(B'K^ ZTP] T#?FV/#
M)1AHZJCP1&MT"&4 7TQX)B)*Q;V(%FUY=QF $^NZ.RSK[@X(SQGY\1RMG(RP
MZU7%$.ZE^;+20?AHTJ71&H(,FGC0Z" X'3%<I99P(5B*6C)??<35B2-'NWQ.
M]V*8:JF!P2#I\/02JE,P0!E!4U]\PV+F-3J(+#&9(^,^5D]8MALAT^5CNQ?#
M51U]M.W'^*D+>[4>W?7V9HYF=[/ BK//L%C.QW%UIXX_=E9DN*HA0WEF&"]O
M"O>.8H2;HB<QEUX=D 0)LI0J(N\6F?>*UK_5;DET[[WX7M8:OIA^!^#H'6!X
M-4"S$;\T&A^\"B1IF8AD3A(?8B"*&? :,-*O_NZO+<V]=PCL&\[=:'>X:%YO
MW]4WSZ]779C>?8=Y'"_*H_ 4I>,A$Y89.CM0FI2 -B129RA(C=NX=KWU\ZGL
MO=]@WXBMI<'A8G2U)_<SF,N$4*,H22P4?YQ28GV*1!D>I%0^>N%?T,2>CM N
MFQ;VC=!*^ALN0-=;\'?X<_6MQ8@QFY,SB= L/9&>2V(#LL8$S3'QS$T'=8M-
M*.N]JV#?4&RCJ>'B;[7![IDR ;(K4]PL%_IV4V6';K?0X*/&(^$E_<[GH:_+
M)H)]HZ^%GH8+ODVZM=QACYBVF5J!<9V-F4BN)7$Y&\*4BU'E(-%A?DG#MZ*J
M_R:#?>/N5!4-%W2KG;1FR$I*2_N@TB1&$6E%)HY9W%1.>Y=-%$R\4)1R3U3_
M'0K[AMR)"NH1<>71T:@PXJ<1RE">^W?6HXP2L-E&XD)D1):B#,=57'5Y=UD:
M+7:'USY^PG3D\_MO4=@Y7&I)=P@F:65-2SDI"N2K_UXFCA99(?;Q"[<-&6'U
MQA"FBY4>1]I19PVW!*TO\IBH(YY*0Y(#RRRG"E+MVJ=3Z.R_Y>'+&:ZNU=CV
M@N9KQ1+TV[VV^ RKDL.OLZ8<AVC!4,Z)U I%7)))0:&_8" *%#('H+6!VX+<
M_ELIOAA^7TJI@YC[ML7LU]F!FOX5KV&7U\^ 4E^,E_ %YM_&$=;NR6>(LXOI
MZE-6GLK(:!-1%>@,!Q&(E.B?N 2,<."2XYX'$6L7[G3-4_]-'?O8"_W#8P N
MRDX[<9#&LAAQCP=*9.EJX!G/) D [BU+AM>>Z'I"X[Y_BCN:TP4_ -2\;&,J
M+B+(X#G)J[ITC ))"%(3:]&32CY[)E^JR5^//<[^*>Y]A@N<0?0./%J;FE).
MJLS<Y9DE(AT&OU9J1URD6E@;+3(YN(KA?XHKHFIJ:5GH^6Y::0SWXW)5I2 8
M80VQKOCYR>!6,648EO8^4\J8HYWD1I]?,,S^>>Y]3E?!0(!TN#[5VA"H"64N
MA$2'!E:)$%NJGZPO/?Q!N]I-V=K5"_-_BFN=.@JI4S#\$&0]M _KK!7C4TN]
M6&.Q%VW&>*2SE XT>XKNE<]E_()5I76LR!CT9CP5LRT38ZJ?'B_09:Q1MN#^
M6FO[UF(QPBT&(@M+N%>ED:KSQ'O+B56N1'E!"%_[R40;>@?RLK :SD[*_-30
MY>OIN/C&+R[?3V9_UIWU<?>A7;6DW4]U?8-WM] =_HP%&CF+!-4NB*0*D9AT
M((9Z#9)Z;E1G;0;WT%,A^5<^\]-\]FV,DOOUQQ\+!/[T_';"]!E&X-]PG\"]
M!)SQI:F)),F7X3<TXD90*I HHI?&L1AY[5G*SZ=R,*:L'8+VI R[5-< \HH/
MDZ)&,+3N1A)A92YOW!C:6X&_.%!29<]4];S?@,;(=*WMH_GHYXA^ +AY<+:7
M*YEI'$_@ 4M?9\^5I@DA*TLUL;&T_%*Z3-XM@N#.)Y%-$))VZ;]5XJ/?5]@O
MC.+>@3" S;!B;8'Z?3^;OYW=A&6^F9S%.+M9C9-.7"C%*!$QE(UM>)EW;PB>
M2R%9YT0*M3V88_3T:V+[1\NL(]4- (9EB/D4?^3'W^;C);R=_3D=R0 ,_Z>)
MD@'#-\D\<4E9PJ1UVG+>P0W&8RKZM8>#@UQ+-0T :&\!5X[CE0KQSQ/87!N>
M796KP7^LZY@8ITDDSXD6R1'T9PSQ-CH2)#";2^:=UYZ3U82N?EM9# Z,U54Y
M 'A^]=.+<9C V6*!@KVZ]N-YD?B;2S^_@,4HYNRUYHP EP;%50KL+&4D@_,T
M9:5<]9:LQRGJMT_%X"!947U]/UG8WD7G^>V&@K5@1\HSR6A&KQLH&OU@(WK=
MD1'JN5-!&2?U3O7N@8<+QU;IMVG$8+!55QL#L'$'BH<M[@"=I2 \6T N!!KI
MD#CA0FN=F96VFZ<,IQ5[=U96.!C<5517W[;L=Q0B2NPS:A*)N$0?X2U\@\GL
M>C6%XGMAJKR;Y4QA5)2(SB&AJ^ %<8:67Y2F'D4E=^= 'C!JC9;KMWW#8%#6
MD7X&8.;N)?D>Q;^^F_P-EI=E_.LWV A_9$V66CI&1"X#-%U0N(V\+L/:/.,Q
M*A=KCQ-J1%B_+1T& \_NE#F(]R]K1KY O)FO9/7^V^_CO_KQ=)76C]J(:+0G
MP<15LUY.?.E,:2@#GO'_BM:&YC%Z^FWS,#A$5E/=<-X3WI)_/OWB)W">490H
MO.6/3Q._'A:U.@]&5AB-,;TAW$I)I+8HL! E43)[]#JRQA^HC,MFE/7<$6)P
M$.U G[U:S96O<L_4V_'B>K;PD_/\T4\3BO+S^.*RG +)>N'1[#-61J-'3XD5
MK+0!$C0D:FP2NI$?^>12/?>#& S@.E!,_U;QUC,N OQ82H'O'&&5C,E&12(M
M+]0'0.ED0= [!MQ)W" Q30.51Y_><].(86&JM?@'$(?L[HOQ.H?T ;6ZE:Q<
MC+B./$?!43ZNC)]"6^P%8&B/=CA*II7.M=V]AJ3UW#UB,)#L4J/]V[M;[@Z_
M[KOE^X_I'/QD_ ]((Q2>Q[ *B#<6?8>L&/$V>Z)Q)U(1.)75VT@\A[Z>^T8,
M#KF=Z78X\'W\@.=.F)NZ\?L"=1>#D:[L3^6(3#(03U,B628#!K25N?:SI^;4
M]=SF87#0[4BO W 0'G-V6T6$<H?QM]5H,,,\)!$U<3QG='JT(H%&13+3W":6
M--,=Y"F?I&MHDXCJ8.))Z+54T"!RCX^Y^GVVA"V6UJ?$<A2B\]2;TNBO)+-<
MP/T+P1$3RXPE)[/VW<]9VT_;T(86O1#\*BAJH!"\+7 ;E[DBI2N;< *]#JK*
M,RX@P6&<9XP5I?5DQNW6.>ZV"!K:)*,7 MNI*ADHPC[-X=J/TVT)QR:K<#9=
MC^O=1&X9,#P+$;D+&B,WP)T4T%TAV>(6,C%G%&?GT&M"Z=#F%+T0)JLKL?^\
M]F,F/\ZF%Q@77;V%58ZAW"HA#TIEHL#A[M,A$:L8<N5"\CDQ#;N#APZUJWUR
MK:$-#*J*JR[D/40 K7K<G24,SK[Z[]L. TJ-24!S35B, D5G,! 3H$K9F@N<
M,09<GHBD@XL.;:+/2T"JC@8&>I+>!D&?_(\52]%8$$)1XF@,& %!)CZP0+2R
MDE%F(G.U[X6?)&IH0WI>.#X]136#S(BL6]&MXYR/8Q_&DU5F:<0SY5*@34Y4
MX#;B1A(GF2+:LN14T$:9[C%W@+BA3>5Y(>S54%7?!:M'A+>ZB]SF2S@>N,T:
MD2(DD9*7A+D4Z&:&*(2C6D=_XEEZ<-&AC=QYB;.TC@8&:=UNXYC/@*'V#8R4
MCES+8 CC$ M#GCB= D%F= XJH]6NW;?C2:(&-V[GA<Q9&]T,$FPK^UPJOA^;
M:!4E*U$S<4$Q--%>$NN](X)Y;;U)#&SM)@K/H6]PXW=>\D1MK[$!H+%Y@XF1
M4=GZ;#S)@FM2O%02%*6D?!6833J&VMG?YM3UFPI^^68S72CM=#C.<*MU"<?U
MDX+]@BSCS4/BN.&\SL@A;FION"+.,:IY BVK#[-_/I7]7HN]=$NM6NH:@'W$
M>/VVYV'\[YOQ'+Y<SN;+DI3<?N;"(4A;9E48@7Z(])J38-#]%2@4;] /D;1V
MT-N(L$&VX*J&CMWN+]55-8@T'XHO J35,ZO?_'+SN&5UW[+F]VR:WOC)9'&>
M5PPO=QA.B8-0 CET9:(*E#<PSGID6"C#.'K(U9. +4D>9,NMSE#[@NH=HCT]
M]')0TF29%QC+N23Q6$)/*3C!B8\6\"LJT%@[XFY*VR!]S1>SJC44-@S#NLO9
M@]=8N.WN'V2)0+/2,1&3W<J+%L25XX-11T'SJ 7U78/Q('7]5AST#<<Z2AL&
M(+>.@CWO Q\PIT2PWAH@.DI6=ILC%O](4@"1=4#!5D](/H.\?HL5>CS!:ZIM
MB*?UHQ<U6BH62[,[GTQA*"OBLW)$:%/:B>%W=BM@ZEO&DUY'=5;7T+=!;*6B
M@=K!1SPEE21ZN8F I$"D8;:DM0PQW&>? ?\.M8=#/$U5OZ4-O5N]5DKJ^WYY
MFYU#KZ6Y\2BO$(@SMEPTQ4P\\T"$99FZH'6PS:K]&BS6;ZG""V&I$\D/X-AL
M+KX1L* \1$Y$8,A9<I$$@0+,@8+*+AJJ.A@9VY"Z?HL:7MB@=:2TX5ZJO!]/
M_33N%V2R65-.47+2Z]+#&/U4QC5A6@!XIA3+M0/>YU/9;Q[FI2]5:JEK /;Q
M@>]09D:=7Q>M+=Y]AWD<([<CIH$E)S)A LV\] $9DASM?W0^&QE+75&7_MT^
MH@9YF5(-%<?<N]8J&ACF;H>3?2B3Y_WDTTV8C.-Y1KK*1%J(,;#@'>$I<R)S
MZ8T-/A)!DX18BHID[:=&C8D;Y-7(2V"PGLJ&@,5-S+X9UO=P5IY,&D*BE@C(
MCD@=*7&)NU*N9 0(9R74?MQ[C)Y!7G9TAKA:BAE&'F7#S6>8K#IZS+[Z[W\;
M+R_+<$B4W?O9_$ G8\.UM%Q2PE?]G,"6-CE<$*V-YSYE%F-7Y0S/I760EQ]=
MP[-3A0ZG<4QSZ8XH5T&G!(1#><I +2>.EU^BC!BJ215-;:/9G+I!WH9TA=&.
ME#: ,/H=>AL1H[UWW^.EGU[ 9T3[^:H;7OE_N>/YYB?K[8ER'$?<"^4;9]/T
M\ M;/_EA&B<W9>O>)K[^.I_=7)=NW^-%G$V7X^D-I$U9)SK?(RT#<.8]R0Q0
M,:[,L)(QDBRCH9"D8ZYV6-0_U_V:^,["_/X%^RPX#<!M;B6;3Q@IE(*5W5+^
MC<2VM;#6S AE@.K%H$(90='?RZ6R*@7"-0.J RO%!94WV\MRV.^YU-G&&C!,
M!G"*O:B!D<@^<PZ%X2WZG5DK8K-Q1,B80W""V50[C3RXDZFS0H-A;J N(7+R
M]KE>[6H4V'SY^C:1#XZ+<C;3F$N+95^"-YN(HCFPH%UDJG8T/KA-U%G5Q#_'
M)GH.1%INHG?3.LFI6VEO)AW=7[-.TYY8L? ]F2UNYG"GG!@Y:*T3D6A RHQU
M0P+H2(3A5#+)2S%R!]NB#<W]%G5T"O474^4 XI -G^?S3WB>;/ZR*KY;]QU_
M/_X.:5T"M2G)2VQ$A5 N.T^<I+P4?FKB4A:$.Q_Q^R;J5'N [@ED]GO%^;(X
MVLU;=:S4O@O<-H,;-OV'%N]G\T?U>H9#$IHQ(D B.U:78:P\$M 6E,^&4=6L
MONWIM?J]Q^P%:%UH87B@^EKBY9OYC]7]V4AR,!P/$&*DQ5,E)4<"!8["XH)G
M&7''-.O$\\1"_5Y2#@E.I\M_  ?KJMKS//^Q6.^%\[#TXVFY/;A-NR"#^YL.
M_1A%[9+5N$\29U!F9@D2G"[\.I,=BU+&VH64+<CM-Z?=ZT'[4DKNVS;>MY8L
MPQHNIF6"![)V7^)\^TKHP0,AK0SG3*,/D421+$7KKVD@TMA$P7J:E&ID,4]:
MOM^,<']VM'M=#<"Z?KFYOIZL D _N17UAVF>S:_6&KZ5(F?40F"26&2/R) 8
M"3P'$H3GVEH7DJV=M&U(6K_UZ)W%SUTH9@!XVR2Y=E);9\LW?C[_@5MYU8IW
M!,''Z*4OQ:.X<;41I5^6(*"4-N HJ%#[2KL18?V&PIU 8D_:IJY^!@"ZARG5
M^Q9M(Q>5YP$PCG*R#'P+Y:X[.R(H4&]HD$G43L <HJ7G9E O *TJ6A@ FEXT
MB0\TT0#*$)6$02?"2_1K&2-,9"=-R!%#N7_V>Y[N7NN\D$$=)%JJE1W\ZR^/
ME/<1O[#ZUNH[Y5]]AOQ3^?V/SQ_N/O\??HS;ZR]Q=K7^X//YA4<O>_4)?IH^
MS<?HW5_[R5;1Y /:%^,K5-]3@4^#3_WEGM9=+C8?_@!V;>F&[TN8)D@_M[-#
MV\N^0>W/)N.TQFVAX9Z-\[P)E/SDSEN]]U%MBLZ5QSHT:EU>223BF32$X5E.
ML_,2/=C*!J8*X6VM>"LB[L/,KZC,7R<EK0:&LRR3(YKJ4DXM+0E,2P)9EZ&<
MPOG=M&:_@MS#0[_N[<OC>==6]XJ):IY--7O\Y>;JRL]_S/*7\<5TG,>Q-*Y9
MCZS (^D32B>>:),;?G)+NWP*_95L\^-E[@&:D_?E:C"'DI02EA%+8P%&%#Y:
M#9+7;DU[F)K6Z:-CDKW?!Q),9EGE\@"O-/VPI>F'0\93R#2@D^^J'S+-*.O7
MXE5"R:/447VE#,\X%4_9/TI4G&*,#GQ22^/3A+Y*QN9 SN862LQ8:D(RQ.B(
MAY!WG#B%00'E2DCA0A:^ML$Y3E$W.<1]YV]&WGDP@D1.T1D EHAC7*)'8$+T
MU*O<2;5^(^+Z+ZNIA)EF*<2VZAF>!7J4S[J==GR"#3KX62VM4#,:*]FAG;S&
MW2T($^4MM":&FC)#CS+$4C1$6(E:8N6:MK;]V4])RYO;_9*\1W.B-H,6D61?
MAGPX3TEP>+(:8;)UQK&DFTUK?'*I?DU'!37OW+/6E.SP[,3>'ORG!$T'>_FW
M")&>I*V2;=BWT/T5/7JT-G!%E$34R!#*@,VD21+.@(_,U&^N<HR>5G9BSP??
M UDY*KEU0"*4 \]H2JP,0++V/G('>+HV*Z8\MDK/EY2U%/W 1E23ZO#,P];@
M]M_A).=AYQ-:FH1C]%0R!K=+_-A3KB-9T!RX)H$&A(ABDCAG)='6N7*][)R$
MRK;@"#GMY[H]^NA[W)J@G5:0"%A; G#IB+-X=F:A(OY7VE"]7^TQ>OJU&[4P
M\7A.6R4-#,]RW$Y";^E7[/N8EC;D2<HJ&I+=,\9I;S6%0)A-D4B.8 G**Q(C
MQ:,F4^ZJWYA7]"$>?^26&VPC6!T%L0F9DM&60??.$QZ"399+B9YQ9YP-R$RT
MT?@^\]!&SL.S"K=5J7ZK*O5$Q^+01[6T#HTHK&0A#DY=N$,/6,Z32X!G0-$V
M_DJ<5Y$$6?J2)Z-HZ&!HQG&B*O2UW+_ OD.0@LDA,@2Y5AGA+BGQO+35]@D%
M@'M'F]H>UW/HZ]?>U,7/GF:6W>AI>&9I]6CC-/]D_2_;NB1[UJ]D8]8??0<(
MC&HEGA<!P]%87@ 84\)1=%FS=B9[R#JKROOI(05MK<='6"P 'CZWV;HW%($B
MTI(B.>"9*X/0Q ;J"?64.L-=R,96Y^\81?U:B!;:WS4'%04_/ -P.Z#^I-N1
MK=GV;2Y#]E!0[>YC]=FE*_&;V70%A=*$\\W-8CF[@OG6R''-8\Z<Q R42)<=
ML9DR(KQ/P26:@JP=\S<DK7V1_=%EMF[]HLP2STEB$708S:= K(\6CTYCM3"<
MI>IMW)O2UO?%2GT,/2["[T!+PS,V'Z;X1_CJOY^63[W]QZU3J7NIJ);\V'SZ
MGHR92\D&9D-I^U/ZSP5!0BGPB2%%JE7PEM7V08Z0TSX9\NBC[X%J73 \B4R"
MD 8/W$")DPI(Y$"3I(HI7;O+[S%Z^DZ/U,'$XS1))0T,SU2<+R]AOKEROGU4
M?NI3@P,?U?9]01,*:STJ*&MM+;(O&T]1KW:%GECZ1^A,7(J<4"H-SU9#\K6;
M*CQ-5:L[VP,"WGMC((*7,5*B'2#6'?K@P89,C&(L!YD">OB-;G";K]ES57Y=
M0#RXU>U([L.S,1]GB])$=M6(_[0KFJU_W_INYA ME4S(.S^?8O1ZM\A6A9#/
M#E87\PIQPASB) ,C(+EWTG&I3.TRCT.TM&[[OO.Y6T#5UABN/!Z&J3QFI88X
M&SQA1N2,;K,*M'9CSH/$]&LYJN#@48/T*H(?GH783.\H?>9^?)W[Z0(%M7H@
M>U*ZY,!GM<Z?-*&Q6D)E_V+WB3:CDM4189,YAJ4&0V'GC"=1J22B4R:FZKV=
MGJ"I?0IE_^?O.Q!U!..RD"274U%*J4@ T$2;Z"@-.=CJ#5F>05[?B92*V'F<
M0>E&2<.S20>&*YU@D8Z-:6I3O/HT?96LT;URS_/V8ALPK&:!K<@)A9S;D4SW
M=8\ZZZ0-$$26(U(H0ZR@@N#?' W1^.!K>S[M*&YKR1JO_NOVZEMOTP0+2M-,
MA//H[C-/RVSG0+3G6?+,:?TT>4N2^[5X+XC/77OXDJH>GHW\.([(,)27?K,)
M?F>V;L5Q=C$'.+TB[\D/;1L#/H_J036L2)X%:40D,G+\A0E&G!"*4&L\X]3+
MP&K;TEX;5JPR)1N%+<X>:.P;G,WGI3OFH9(1H;3"'11Q(S/T<SS'F$CP1 2+
M,;%,9<C-GB2=MOX_0S^)Y\#M07+K!50V/'.XRNBM+PO>?;]>\7]B[>&!3ZJ1
M2G^"OIJ9]/52I;)KL]H=KFCB61@EB,T,<:7P[/,)@(@D09N<$VJ[BRSZ08I:
M-]0IG_[[;#J[+5_97>D>XSYP*CP#DE4(B'%9V@>")SJ A<243K9ZSZ'&U T@
MW5X'-8^ZVW2CH.$9H?L'I;BW-Z,%3DJC/?Z8:L^Q#U#6TO;LO*>]6^3^JB9E
MZR4U).92*J^E)9[J3)3*V;J0+8W->N\?6:1>M\[UY^X[)6,67DMG\90L=]G6
M(A^@-.$074[ @ZK?V/UILOHQ'565?KAI9QUE#,]:O$-;,/L!\!9R:3F_JHH:
MAYOR@:4L^R33\>1GMK0CSZ.Y5IN9K>!^U;1R.9[ON+%;3=?Q),H"@;!*L&9I
M2JV)(-%9!4)G,/7G<#4GKW4#FH=+W6KC5YBB/I8K#:P.VZ^7?KH_27F_>1QN
M%VIP<[*0</-$K8BW>.@*Q:/S5&A3_;UK1?)[;F+3$2(?=;3I2=\G&\MO, ^S
MCOINS:ZNQNL'>*OTT:JY&$Q/[01X[./:=N!J2FD]^WB[WMG.>OOP*(,592)
M3!H/Y029V-)8V#F/CG>064$'^[XY@15LY-.+;44<R7L7=2(8W3CT(40@3H A
M7%I5O)<4NS@PGD%A[Y:N(VSML75=Z6UXOM^7F[" _[[!#WGW[=1D_://:-VU
M]!A-M=KQ["QR'RM$IC'TM\1Q!$PI]B>.1DIH7(&*N>QKOX8]1$O[T38//W?K
MRHE'SU6(A$F(I>\<QS,X.\)9CMHAI]+6SKT=)*;OD2(5</!X=$T-P0_06L1+
M2#<3^(!6,96$6;J[.-B:&C#+G^%B7,1X6BO $U9I:W%:\M72)BWFR]'1E<_S
MIQ68BT/MIS_.IY-]36(@)Q^2 !)8Z>5"A2-!&D>R .:,T.":>1!(SM:&QK_=
M;^8ZE+;WK$ZE8.O)1ID *4TB(653!OA08B/SY:K)@@G<T%"],6I[LONQE3W@
M\[%3]K(J'Z#M;=3+O?N>]"_;F[ZO'O40N1;H I#$%"^MP4NR1#'"4Q11R>28
MKOU\L+L>];_ZQ7AQGG<6^+'^=2N2R30#=88P&W%_.IJ)%[A)'&>4^^REWVW?
MVIKG9I0-MD?]<U"R:]$Z4,H01H-MEYGL\J(B")_1 $N'ME\ZHTOFCQ.5)#5)
M:W2 :[\,.49/OP/G.H)5-04, $Q_+. \OULLQWC,PV*DI+(A14DL;@@BT9L@
M03-)0&3#7'+.R-KOG!]2T.^LMHX TT+( X#(^]D<T']8/Z&,#]\Z3-/JKY.5
MAA:/]H+FAL4R:9&6J<A: GJ#RA(JF3#> 675)R.<3&R_<]$[ M[+J&X &-T_
M#N+1#,2=[Z^9'N4@*$LJD119Z4*2*0DQ:((\NJ"255!]J%H;>OL=E=[5F?I2
M"NP1K(>:C"_VNZ4A*N-0H(1#MAC+.TJ\MI8 CXE)P83B.V=Q\S[N^Y=LA"S]
M2I#5H;0'8/ ^0P3<!6$"CTQWZ8<@%-*OF;"E<U-$89DR*,,FQJ724/WMPF%J
M&D'*O!)(519^WZ;H]QEZH_>\[+(2A:!"4_1+G<.PV!I%' V!%,$QQQ5+M)G]
M.;Y.(X385X*0VG(=@*6YZVV_RX?UFB&^\9A-A8\<(K%24J*8EU9R'T'5GFM_
MB)9&&'*O!$-5!=^WC?DTA^O-:TP,1NY:#^\_@ZW(3%NJ2'*EQP\%5@KI(C&@
M9)0N1AYM(XOSG%6;93[I*P%/MT(?@#DZV,UZEZ\R<@/W0L!XP&0BF2S%!8EC
M!$N5,B+)S&IG0IO2U@QRKRW;WHEF!H"X=</D=9_D7588LZ"#H22*5%)Y.9#
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M1 ,#R!RN&"F5LSML>":-UQ9(1G<+Y<43\65BB.1":.%5-+ZV?WR E'ZS@Q4
M55/4@T!,:;ES?CO#?<75W;7@;WYY,\??=U@,0*GA,95T16F@2CWQEJ%/SYD
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ML2S),KS8H!@UM:*[HI8VE/\SC(QX#G:KCXQXOOY[]A+._]Q0?O9]O!B9X'*
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M*Z7.VIM<^]GG,TGLU^AU!I7FD&RMMP' <MVG#.9?9GGYIR\3"![PN,D]!*.
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M8KYL)N*HXEX91@1SI>N<L,2RR GZEX9'$:FJ'A[TI6W<QI*5D/*@]\40BFG
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MO7SVW>2 \)1+VAA* I0@S6?\JK0ZB &=*"8Y.E#57>O^Y+5R'53?AQA:5PW
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M3A&<G'7G:*YUX@RD3 22+W?9@9/@ _H23EMA!&/0\T#<;?U6/:L:!^4!--*
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MO.1@N>G!+\%9="4-X<&IT@_ $6OQN$ZAU 9PK6*_-@K]</*0@/%:]^ROTX<
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M$TV3(=+AL>%5IH2E%)(((>?[=G4\\#_%1.,U#9516&L35(%$*WLBO"R <%\
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M7&=C7,-U;#]%X\+F?=@ZZ&EE&^UA@&Y9FKN"8!-GO7,L>,*EQX!9Y4""\)0
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M!8SO/[%?I+HW3J<A54D4FJ#5G9KN<SC/A2%)*@R3B,R#@EQ"CM. ?'*!@?+
MZRS]='^+&.WY3J?:ZXY4?0/91?=U=E9SN&WZ<ZZ4M91ZAZP(.;[(3T2)U\@;
MEH2E7C-9VAKMDJ6!/*#3\J@(" VX3,O+L8_]M'^\+FY-:P E0(P2D+3YU7'(
MU_08MNV@@TF18$UIZ3=,^R6J<^OXD@:J'"!-=)._M[/O0)V@1)C3%4SK_DKK
M54S];/V<X9O]&>>_=]-^UBUN;M<4;/R/1UE=^/X>%]_[\*#JV+DQ)EBO%,(2
M_ N.P<G445&$-7@9."4?\:"CB(,,X(M-K\Y3A!>UJ6U2I>*>OVRR-6A&=X^
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MVVQ.^<(%=_<9[]J/Y8[_OU!+ P04    " "+@EM8X'_?74@$  #V$@  '
M 'IL86(M,C R,S$R,S%X,3!K>&5X>#,R,2YH=&WE6&UOVS80_KY?P3E8Z@"6
M+<EV8LM.@"!I@6)%6S0=BNW+0(DGBXA$JB251/OU/5)27NHD=;&D2;<@,"0=
MC^3S/,>[DY:9*?*#90:4'?RR_-7SR+%,J@*$(8D":H"12G.Q(I\8Z%/B>>VH
M(UG6BJ\R0T(_G)!/4IWR,]K8#3<Y''3S+$?-_7+D%EG&DM4'2\;/"&?[/<[F
M$((?LEG(II-).)_'"<QFL_EXS@)_O$O_#GKHBL,;'VWJ'/9[!1=>!G;]:#(M
MS>*<,Y-%@>__UG/C#I:I% 874^C<7#9SK,]$U0HG,[*,@A!G,G!A/)KSE8@<
MOEXS53<\D;E4T9;O_A;6XJ6TX'D=O?C("]#D+9R3#[*@XL5 4Z$]#8JGS4#-
M_P'<(R[B;L^;_>_A/#D7T.$)0@OBY47&8V[(.!P&-Q%LMO<$F0?U1)L_ F5X
MRA-JN!0DKHG)@+Q77"2\I#EY>0%)9?@9D'<IC@)U)\#G NA]I71%<5TC23 C
M?PQ/AD=#<@*) QB,I_[@V6,XU.20R=*>Z/(:G [$W-\E,G5*G5 54P':>W>1
M0TT.$V,MH>^'FT;BHT.<W KQM2")%*)%=,Y-YO <"E%AV'V 4BJ$(L@KJ0H2
M^-[O))7*#:F!*@*"(3G'D$ 1@]K>"G;]Q3@8V PWM@S\13EY0V/RAA?<TMBW
MGMM;LS#T%T>R**FHW5VPV.F(>E@6PHU8&#S.XIM)0*@F*<^1G4OZ,<(JQ0W'
M1:A@>/J3C(H58 DI"JZUE0K_[4B&]89DH #)ODYNHUS'[8"\'F",XE9-1DG_
M3ZQ..^2X&I"CC$.ZGEVZL&XE&I#$I2>\*+]]K"T>^F^/S0#MU+D5-3D5\ASY
M6<'VUG2V(!LG]Y(RAE"]'%(3A7M=NN<8M,)$GGWR1,>N'SQ2O&^R_$U>@NEP
M/+%$?$1!V@.?5GE>8V(HRMS&X&5<*OA<<06V1]%6J2O=^W2'8&((IGVV<ZGN
M511?1G K<3 ?3U#,^<+%]W]!T/!Y"LH%YNNBZ2HPT1N*K@R?.H$ZM2E7*'>I
M0%MA!]9,\YR@&^X&RP :2E1:#YQ7R@7%M@2?XX2,NZFMBCBJRINXD"4HMZ;^
M*I,,O[,<WM*.WNMC:)Q#9XZE8J \U""GI8:HNU@PKLN<UA$7CDGGM&@GBZ4Q
MLHALAWQFDUY"\[85<:'6F*^:YZ'?-- &MVE8MW)K'CK3R+!UVV0VG/MWF_UA
M<*?M@:8=N2TWVT9F-,JSWQOW.H<VI**PO"#!S4;91MD:.;*\_AKQ ^,_F""D
M8PS5ICB\@EA55-5-+Q+NN5YD\M4;3<O-0\%^BH2SO3796VCW>TMEO\3['4K[
M%G#O7G;:$^4.7(F09<X9L5@7/PUO/XRKGX:1.WK _SLM_7O>OG?6R1FY*O)
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M:6%R:65S;&ES=#(P,C,N:'1M4$L! A0#%     @ BX);6/,2'X*L @  + @
M !\              ( !304  &5X,C,Q+6-O;G-E;G1L971T97)F<F]M:W!M
M9RYH=&U02P$"% ,4    " "+@EM8[R"C\N "   ["0  '@
M@ $V"   97@R,S(M8V]N<V5N=&QE='1E<F9R;VUD96PN:'1M4$L! A0#%
M  @ BX);6*G:%?UB$@  <F,  !X              ( !4@L  &5X.3<Q+7IL
M86)X9&]D9'AF<F%N:V-O;7!E+FAT;5!+ 0(4 Q0    ( (N"6U@\U*7H67$
M -[' 0 <              "  ? =  !E>&AI8FET,3 S,RUB;V-H:U]F86-I
M;&DN:'1M4$L! A0#%     @ BX);6,.L.[PG1   %1X" !X
M ( !@X\  &5X:&EB:70T-2UD97-C<FEP=&EO;F]F<V5C+FAT;5!+ 0(4 Q0
M   ( (N"6UCUT3W3=&8# *%#(0 1              "  >;3  !Z;&%B+3(P
M,C,Q,C,Q+FAT;5!+ 0(4 Q0    ( (N"6U@=9&5/+A@  '@> 0 1
M      "  8DZ! !Z;&%B+3(P,C,Q,C,Q+GAS9%!+ 0(4 Q0    ( (N"6UC]
M6K@([2<  /:+ 0 5              "  >92! !Z;&%B+3(P,C,Q,C,Q7V-A
M;"YX;6Q02P$"% ,4    " "+@EM8$QKNHVIX  #A!@4 %0
M@ $&>P0 >FQA8BTR,#(S,3(S,5]D968N>&UL4$L! A0#%     @ BX);6#15
M-K_I&@  /#<  !0              ( !H_,$ 'IL86(M,C R,S$R,S%?9S$N
M:G!G4$L! A0#%     @ BX);6.!E=_'/'   (QX  !4              ( !
MO@X% 'IL86(M,C R,S$R,S%?9S$P+FIP9U!+ 0(4 Q0    ( (N"6UAJ(@NQ
M>0\  "<0   5              "  < K!0!Z;&%B+3(P,C,Q,C,Q7V<Q,2YJ
M<&=02P$"% ,4    " "+@EM8_B_=R)_'   _0P$ %0              @ %L
M.P4 >FQA8BTR,#(S,3(S,5]G,3(N:G!G4$L! A0#%     @ BX);6%4S&KC\
M70  YVT  !0              ( !/@,& 'IL86(M,C R,S$R,S%?9S(N:G!G
M4$L! A0#%     @ BX);6"@L'-=3*@  2RT  !0              ( !;&$&
M 'IL86(M,C R,S$R,S%?9S,N:G!G4$L! A0#%     @ BX);6&^I<0/2-P
MS4   !0              ( !\8L& 'IL86(M,C R,S$R,S%?9S0N:G!G4$L!
M A0#%     @ BX);6,/ON]T-$0  /A(  !0              ( !]<,& 'IL
M86(M,C R,S$R,S%?9S4N:G!G4$L! A0#%     @ BX);6%[Z[IHB/P  (T$
M !0              ( !--4& 'IL86(M,C R,S$R,S%?9S8N:G!G4$L! A0#
M%     @ BX);6$-HP'6*'@  AQ\  !0              ( !B!0' 'IL86(M
M,C R,S$R,S%?9S<N:G!G4$L! A0#%     @ BX);6()?V:>C'0  2Q\  !0
M             ( !1#,' 'IL86(M,C R,S$R,S%?9S@N:G!G4$L! A0#%
M  @ BX);6*KH*\AD+0  V2\  !0              ( !&5$' 'IL86(M,C R
M,S$R,S%?9SDN:G!G4$L! A0#%     @ BX);6/N1&4O-6 $ [$P. !4
M         ( !KWX' 'IL86(M,C R,S$R,S%?;&%B+GAM;%!+ 0(4 Q0    (
M (N"6UB(S"%,8<\  *56"0 5              "  :_7" !Z;&%B+3(P,C,Q
M,C,Q7W!R92YX;6Q02P$"% ,4    " "+@EM8ZT3G-64'  #A'P  '
M        @ %#IPD >FQA8BTR,#(S,3(S,7@Q,&MX97AX,S$Q+FAT;5!+ 0(4
M Q0    ( (N"6UA<U<;780<  .H?   <              "  >*N"0!Z;&%B
M+3(P,C,Q,C,Q>#$P:WAE>'@S,3(N:'1M4$L! A0#%     @ BX);6.!_WUU(
M!   ]A(  !P              ( !?;8) 'IL86(M,C R,S$R,S%X,3!K>&5X
M>#,R,2YH=&U02P$"% ,4    " "+@EM8MCAL8TL$   X$@  '
M    @ '_N@D >FQA8BTR,#(S,3(S,7@Q,&MX97AX,S(R+FAT;5!+!08
..'  < )0'  "$OPD    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>153
<FILENAME>zlab-20231231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2023"
  xmlns:currency="http://xbrl.sec.gov/currency/2023"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2023"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xmlns:zlab="http://zailab.com/20231231">
    <link:schemaRef xlink:href="zlab-20231231.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dei:AdrMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-21</instant>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dei:AdrMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-21</instant>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">zlab:RafaelAmadoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">zlab:RafaelAmadoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">zlab:RafaelAmadoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">zlab:ZaiLabHongKongLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">zlab:ZaiLabShanghaiCompanyLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">zlab:ZaiLabAUSTPtyLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">zlab:ZaiLabSuzhouCompanyLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">zlab:ZaiBiopharmaceuticalSuzhouCompanyLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">zlab:ZaiLabUSLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">zlab:ZaiLabInternationalTradingShanghaiCompanyLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">zlab:ZaiAutoImmuneHongKongLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">zlab:ZaiLabTaiwanLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">zlab:ZaiLabTradingSuzhouCoLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
        </entity>
        <period>
            <startDate>2022-03-30</startDate>
            <endDate>2022-03-30</endDate>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
        </entity>
        <period>
            <instant>2022-03-30</instant>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
        </entity>
        <period>
            <startDate>2022-03-29</startDate>
            <endDate>2022-03-29</endDate>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">zlab:ElectronicEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">zlab:ElectronicEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">zlab:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ManufacturingFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c-71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">zlab:CapitalizedSalesBasedMilestoneFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:HuizhengMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:HuizhengMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c-82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:HuizhengMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:HuizhengMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:HuizhengMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">zlab:CollaborativeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:HuizhengMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">zlab:CollaborativeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">zlab:OneCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">zlab:OneCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">zlab:OneCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">zlab:ResearchAndDevelopmentExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="zlab:MajorSuppliersAxis">zlab:SupplierEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">zlab:ResearchAndDevelopmentExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="zlab:MajorSuppliersAxis">zlab:SupplierFMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">zlab:OneCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:LenderConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">zlab:OneCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:LenderConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CNY</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">zlab:CashAndCashEquivalentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">zlab:ForeignCurrencyRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CNY</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">zlab:CashAndCashEquivalentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">zlab:ForeignCurrencyRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CNY</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">zlab:CashAndCashEquivalentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">zlab:ForeignCurrencyRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CNY</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">zlab:CashAndCashEquivalentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">zlab:ForeignCurrencyRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CNY</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CNY</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:HKD</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:HKD</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:AUD</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:AUD</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:TWD</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:TWD</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">zlab:MacroGenicsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-31</instant>
        </period>
    </context>
    <context id="c-110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">zlab:MacroGenicsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-31</endDate>
        </period>
    </context>
    <context id="c-111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">zlab:MacroGenicsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-31</instant>
        </period>
    </context>
    <context id="c-112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">zlab:MacroGenicsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">zlab:MacroGenicsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">zlab:MacroGenicsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">zlab:ElectronicEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">zlab:ElectronicEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">zlab:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">zlab:ManufacturingEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">zlab:ManufacturingEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">zlab:ZejulaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">zlab:ZejulaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">zlab:ZejulaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">zlab:OptuneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">zlab:OptuneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">zlab:OptuneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">zlab:QinlockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">zlab:QinlockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">zlab:QinlockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">zlab:NuzyraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">zlab:NuzyraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">zlab:NuzyraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">zlab:VyvgartMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">zlab:VyvgartMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">zlab:VyvgartMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">zlab:ZaiLabAUSTPtyLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">zlab:ZaiLabUSLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">zlab:ZaiLabTaiwanLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">zlab:ZaiLabHongKongAndZlChinaHoldingTwoAndZaiAutoImmuneHongKongAndZaiAntiInfectivesHongKongLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">zlab:ZaiLabHongKongAndZlChinaHoldingTwoAndZaiAutoImmuneHongKongAndZaiAntiInfectivesHongKongLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">zlab:ZaiLabHongKongAndZlChinaHoldingTwoAndZaiAutoImmuneHongKongAndZaiAntiInfectivesHongKongLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:KY</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:KY</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:KY</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:VG</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:VG</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:VG</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:HK</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:HK</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:HK</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:TW</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:TW</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:TW</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:HK</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:TW</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-174">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">zlab:NonVestedRestrictedSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">zlab:NonVestedRestrictedSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">zlab:NonVestedRestrictedSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:LimitedLiabilityCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:LimitedLiabilityCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:LimitedLiabilityCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">zlab:TwoThousandTwentyTwoEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-183">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-184">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">zlab:April2023AndLaterMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-185">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">zlab:PriorToApril2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-186">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">zlab:April2023AndLaterMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">zlab:April2023AndLaterMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-188">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">zlab:April2023AndLaterMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">zlab:ShareBasedPaymentArrangementTrancheFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-189">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">zlab:April2023AndLaterMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-190">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">zlab:PriorToApril2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-191">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">zlab:PriorToApril2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-192">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">zlab:PriorToApril2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">zlab:ShareBasedPaymentArrangementTrancheFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-193">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">zlab:PriorToApril2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-194">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">zlab:PriorToApril2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">zlab:ShareBasedPaymentArrangementTrancheFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-195">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-196">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-197">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">zlab:ShareBasedPaymentArrangementOptionBatchOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-198">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">zlab:ShareBasedPaymentArrangementOptionBatchTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-199">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">zlab:ShareBasedPaymentArrangementOptionBatchThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-200">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">zlab:ShareBasedPaymentArrangementOptionBatchOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">zlab:ShareBasedPaymentArrangementOptionBatchTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">zlab:ShareBasedPaymentArrangementOptionBatchThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">zlab:NonVestedRestrictedSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">zlab:NonVestedRestrictedSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">zlab:NonVestedRestrictedSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">zlab:NonVestedRestrictedSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">zlab:NonVestedRestrictedSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:GlaxoSmithKlineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:GlaxoSmithKlineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:GlaxoSmithKlineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:GlaxoSmithKlineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:NovocureLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-220">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:DecipheraPharmaceuticalsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:DecipheraPharmaceuticalsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:GurnetPointCapitalAndNovoHoldingsASMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:GurnetPointCapitalAndNovoHoldingsASMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-224">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:ArgenxBvMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="c-225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:ArgenxBvMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:AmgenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:AmgenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:InnovivaInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:InnovivaInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:BMSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">zlab:RepotrectinibMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:BMSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">zlab:RepotrectinibMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-232">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:BMSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">zlab:RepotrectinibMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-233">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:BMSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">zlab:AdagrasibMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-234">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:BMSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">zlab:AdagrasibMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-235">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:BMSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">zlab:AdagrasibMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-236">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:BMSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">zlab:XanomelineTrospiumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-237">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:BMSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">zlab:XanomelineTrospiumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-238">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:BMSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">zlab:XanomelineTrospiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-239">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:PfizerIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-240">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:PfizerIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-241">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">zlab:OtherCounterpartiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-242">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-243">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">zlab:MainlandChinaGovernmentPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-244">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">zlab:MainlandChinaGovernmentPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-245">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">zlab:MainlandChinaGovernmentPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-246">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">zlab:A401kPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-247">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">zlab:A401kPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-248">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">zlab:A401kPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-249">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">zlab:A401kPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-250">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">zlab:A401kPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-251">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">zlab:A401kPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-252">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">zlab:MandatoryProvidentFundMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-253">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">zlab:MandatoryProvidentFundMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-254">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">zlab:MandatoryProvidentFundMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-255">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-256">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">zlab:BankOfChinaWorkingCapitalLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-05</instant>
        </period>
    </context>
    <context id="c-257">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">zlab:BankOfChinaWorkingCapitalLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-05</startDate>
            <endDate>2024-02-05</endDate>
        </period>
    </context>
    <context id="c-258">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">zlab:BankOfChinaWorkingCapitalLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-05</instant>
        </period>
    </context>
    <context id="c-259">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">zlab:BankOfChinaWorkingCapitalLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-06</instant>
        </period>
    </context>
    <context id="c-260">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">zlab:BankOfChinaWorkingCapitalLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">zlab:ZaiLabShanghaiCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-07</instant>
        </period>
    </context>
    <context id="c-261">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">zlab:BankOfChinaWorkingCapitalLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">zlab:ZaiLabShanghaiCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-07</startDate>
            <endDate>2024-02-07</endDate>
        </period>
    </context>
    <context id="c-262">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-06</instant>
        </period>
    </context>
    <context id="c-263">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-06</startDate>
            <endDate>2024-02-06</endDate>
        </period>
    </context>
    <context id="c-264">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">zlab:SPDBankWorkingCapitalLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">zlab:ZaiLabShanghaiCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-27</instant>
        </period>
    </context>
    <context id="c-265">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">zlab:SPDBankWorkingCapitalLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">zlab:ZaiLabShanghaiCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-06</startDate>
            <endDate>2024-02-27</endDate>
        </period>
    </context>
    <context id="c-266">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">zlab:NingboBankWorkingCapitalLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">zlab:ZaiLabSuzhouCompanyLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-06</instant>
        </period>
    </context>
    <context id="c-267">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">zlab:NingboBankWorkingCapitalLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-06</instant>
        </period>
    </context>
    <context id="c-268">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-269">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-270">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-271">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-272">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-273">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-274">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="cny">
        <measure>iso4217:CNY</measure>
    </unit>
    <unit id="segment">
        <measure>zlab:segment</measure>
    </unit>
    <dei:AmendmentFlag contextRef="c-1" id="f-36">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="c-1" id="f-37">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-38">0001704292</dei:EntityCentralIndexKey>
    <dei:DocumentFiscalYearFocus contextRef="c-1" id="f-39">2023</dei:DocumentFiscalYearFocus>
    <ecd:TrdArrDuration contextRef="c-8" id="f-49">P367D</ecd:TrdArrDuration>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-71" id="f-496">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm contextRef="c-107" id="f-627">P1Y</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-181" decimals="-5" id="f-850" unitRef="usd">0</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:DefinedContributionPlanCostRecognized contextRef="c-247" decimals="-5" id="f-1005" unitRef="usd">0</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized contextRef="c-254" decimals="-5" id="f-1006" unitRef="usd">0</us-gaap:DefinedContributionPlanCostRecognized>
    <dei:DocumentType contextRef="c-1" id="f-1">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="c-1" id="f-2">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-3">2023-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="c-1" id="f-4">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport contextRef="c-1" id="f-5">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c-1" id="f-6">001-38205</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c-1" id="f-7">ZAI LAB LIMITED</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-8">E9</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-9">98-1144595</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-10">4560 Jinke Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c-1" id="f-11">Bldg. 1, Fourth Floor Pudong</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-12">Shanghai</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry contextRef="c-1" id="f-13">CN</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-14">201210</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-15">86 21</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-16">6163 2588</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-2" id="f-17">American Depositary Shares, each representing 10 Ordinary Shares, par value $0.000006 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-2" id="f-18">ZLAB</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-2" id="f-19">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="c-3" id="f-20">Ordinary Shares, par value $0.000006 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-3" id="f-21">9688</dei:TradingSymbol>
    <dei:EntityWellKnownSeasonedIssuer contextRef="c-1" id="f-22">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="c-1" id="f-23">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="c-1" id="f-24">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c-1" id="f-25">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c-1" id="f-26">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c-1" id="f-27">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-28">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag contextRef="c-1" id="f-29">true</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="c-1" id="f-30">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:EntityShellCompany contextRef="c-1" id="f-31">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat contextRef="c-4" decimals="-8" id="f-32" unitRef="usd">2700000000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-5" decimals="INF" id="f-33" unitRef="shares">992087430</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-6" decimals="INF" id="f-34" unitRef="shares">758101320</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock contextRef="c-1" id="f-35">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;The registrant intends to file a definitive proxy statement pursuant to Regulation 14A within 120 days of the end of the fiscal year ended December 31, 2023. Portions of such definitive proxy statement are incorporated by reference into Part III of this Annual Report on Form 10-K.&lt;/span&gt;&lt;/div&gt;</dei:DocumentsIncorporatedByReferenceTextBlock>
    <ecd:MtrlTermsOfTrdArrTextBlock contextRef="c-7" id="f-40">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;On December 15, 2023, Rafael Amado, the Company&#x2019;s President and Head of Global Oncology Research and Development, adopted a new written Rule 10b5-1 trading arrangement (as defined in Item 408 of Regulation S-K), for the sale of up to 94,500 of the Company&#x2019;s ADSs, each representing ten of the Company&#x2019;s ordinary shares. This Rule 10b5-1 trading arrangement is scheduled to terminate no later than December 16, 2024.&lt;/span&gt;&lt;/div&gt;</ecd:MtrlTermsOfTrdArrTextBlock>
    <ecd:TrdArrAdoptionDate contextRef="c-8" id="f-41">December 15, 2023</ecd:TrdArrAdoptionDate>
    <ecd:TrdArrIndName contextRef="c-8" id="f-42">Rafael Amado</ecd:TrdArrIndName>
    <ecd:TrdArrIndTitle contextRef="c-8" id="f-43">President and Head of Global Oncology Research and Development</ecd:TrdArrIndTitle>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c-8" id="f-44">true</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:TrdArrSecuritiesAggAvailAmt contextRef="c-9" decimals="INF" id="f-45" unitRef="shares">94500</ecd:TrdArrSecuritiesAggAvailAmt>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="c-10" id="f-46">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="c-10" id="f-47">false</ecd:NonRule10b51ArrTrmntdFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="c-10" id="f-48">false</ecd:Rule10b51ArrTrmntdFlag>
    <dei:AuditorFirmId contextRef="c-1" id="f-50">185</dei:AuditorFirmId>
    <dei:AuditorFirmId contextRef="c-11" id="f-51">1113</dei:AuditorFirmId>
    <dei:AuditorName contextRef="c-1" id="f-52">KPMG LLP</dei:AuditorName>
    <dei:AuditorLocation contextRef="c-1" id="f-53">Short Hills, New Jersey</dei:AuditorLocation>
    <dei:AuditorName contextRef="c-11" id="f-54">Deloitte Touche Tohmatsu Certified Public Accountants LLP</dei:AuditorName>
    <dei:AuditorLocation contextRef="c-11" id="f-55">Shanghai, the People&#x2019;s Republic of China</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-12" decimals="-3" id="f-56" unitRef="usd">790151000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-13" decimals="-3" id="f-57" unitRef="usd">1008470000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments contextRef="c-12" decimals="-3" id="f-58" unitRef="usd">16300000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments contextRef="c-13" decimals="-3" id="f-59" unitRef="usd">0</us-gaap:ShortTermInvestments>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="c-12" decimals="-3" id="f-60" unitRef="usd">17000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="c-13" decimals="-3" id="f-61" unitRef="usd">11000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-12" decimals="-3" id="f-62" unitRef="usd">59199000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-13" decimals="-3" id="f-63" unitRef="usd">39963000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLossCurrent contextRef="c-12" decimals="-3" id="f-64" unitRef="usd">6134000</us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLossCurrent>
    <us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLossCurrent contextRef="c-13" decimals="-3" id="f-65" unitRef="usd">8608000</us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLossCurrent>
    <us-gaap:InventoryNet contextRef="c-12" decimals="-3" id="f-66" unitRef="usd">44827000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="c-13" decimals="-3" id="f-67" unitRef="usd">31621000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-12" decimals="-3" id="f-68" unitRef="usd">22995000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-13" decimals="-3" id="f-69" unitRef="usd">35674000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-12" decimals="-3" id="f-70" unitRef="usd">939606000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-13" decimals="-3" id="f-71" unitRef="usd">1124336000</us-gaap:AssetsCurrent>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-12" decimals="-3" id="f-72" unitRef="usd">1113000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-13" decimals="-3" id="f-73" unitRef="usd">803000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:LongTermInvestments contextRef="c-12" decimals="-3" id="f-74" unitRef="usd">9220000</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments contextRef="c-13" decimals="-3" id="f-75" unitRef="usd">6431000</us-gaap:LongTermInvestments>
    <zlab:PrepaymentsForEquipment contextRef="c-12" decimals="-3" id="f-76" unitRef="usd">111000</zlab:PrepaymentsForEquipment>
    <zlab:PrepaymentsForEquipment contextRef="c-13" decimals="-3" id="f-77" unitRef="usd">1396000</zlab:PrepaymentsForEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-12" decimals="-3" id="f-78" unitRef="usd">53734000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-13" decimals="-3" id="f-79" unitRef="usd">57863000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-12" decimals="-3" id="f-80" unitRef="usd">14844000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-13" decimals="-3" id="f-81" unitRef="usd">19512000</us-gaap:OperatingLeaseRightOfUseAsset>
    <zlab:LandUseRightsNetNoncurrent contextRef="c-12" decimals="-3" id="f-82" unitRef="usd">3069000</zlab:LandUseRightsNetNoncurrent>
    <zlab:LandUseRightsNetNoncurrent contextRef="c-13" decimals="-3" id="f-83" unitRef="usd">6892000</zlab:LandUseRightsNetNoncurrent>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-12" decimals="-3" id="f-84" unitRef="usd">13389000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-13" decimals="-3" id="f-85" unitRef="usd">1511000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DepositsAssetsNoncurrent contextRef="c-12" decimals="-3" id="f-86" unitRef="usd">1209000</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:DepositsAssetsNoncurrent contextRef="c-13" decimals="-3" id="f-87" unitRef="usd">1396000</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:Assets contextRef="c-12" decimals="-3" id="f-88" unitRef="usd">1036295000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-13" decimals="-3" id="f-89" unitRef="usd">1220140000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="c-12" decimals="-3" id="f-90" unitRef="usd">112991000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-13" decimals="-3" id="f-91" unitRef="usd">65974000</us-gaap:AccountsPayableCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-12" decimals="-3" id="f-92" unitRef="usd">7104000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-13" decimals="-3" id="f-93" unitRef="usd">7050000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c-12" decimals="-3" id="f-94" unitRef="usd">82972000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c-13" decimals="-3" id="f-95" unitRef="usd">66818000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-12" decimals="-3" id="f-96" unitRef="usd">203067000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-13" decimals="-3" id="f-97" unitRef="usd">139842000</us-gaap:LiabilitiesCurrent>
    <us-gaap:DeferredIncomeNoncurrent contextRef="c-12" decimals="-3" id="f-98" unitRef="usd">28738000</us-gaap:DeferredIncomeNoncurrent>
    <us-gaap:DeferredIncomeNoncurrent contextRef="c-13" decimals="-3" id="f-99" unitRef="usd">21360000</us-gaap:DeferredIncomeNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-12" decimals="-3" id="f-100" unitRef="usd">8047000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-13" decimals="-3" id="f-101" unitRef="usd">13343000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-12" decimals="-3" id="f-102" unitRef="usd">325000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-13" decimals="-3" id="f-103" unitRef="usd">0</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="c-12" decimals="-3" id="f-104" unitRef="usd">240177000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-13" decimals="-3" id="f-105" unitRef="usd">174545000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies contextRef="c-12" id="f-106" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-13" id="f-107" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-13"
      decimals="INF"
      id="f-108"
      unitRef="usdPerShare">0.000006</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-12"
      decimals="INF"
      id="f-109"
      unitRef="usdPerShare">0.000006</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c-13"
      decimals="INF"
      id="f-110"
      unitRef="shares">5000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c-12"
      decimals="INF"
      id="f-111"
      unitRef="shares">5000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="c-12"
      decimals="INF"
      id="f-112"
      unitRef="shares">977151270</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="c-13"
      decimals="INF"
      id="f-113"
      unitRef="shares">962455850</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-12"
      decimals="INF"
      id="f-114"
      unitRef="shares">972239070</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-13"
      decimals="INF"
      id="f-115"
      unitRef="shares">960219570</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="c-12" decimals="-3" id="f-116" unitRef="usd">6000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-13" decimals="-3" id="f-117" unitRef="usd">6000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-12" decimals="-3" id="f-118" unitRef="usd">2975302000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-13" decimals="-3" id="f-119" unitRef="usd">2893120000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-12" decimals="-3" id="f-120" unitRef="usd">-2195980000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-13" decimals="-3" id="f-121" unitRef="usd">-1861360000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-12" decimals="-3" id="f-122" unitRef="usd">37626000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-13" decimals="-3" id="f-123" unitRef="usd">25685000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockCommonShares
      contextRef="c-12"
      decimals="INF"
      id="f-124"
      unitRef="shares">4912200</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares
      contextRef="c-13"
      decimals="INF"
      id="f-125"
      unitRef="shares">2236280</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonValue contextRef="c-12" decimals="-3" id="f-126" unitRef="usd">20836000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:TreasuryStockCommonValue contextRef="c-13" decimals="-3" id="f-127" unitRef="usd">11856000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:StockholdersEquity contextRef="c-12" decimals="-3" id="f-128" unitRef="usd">796118000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-13" decimals="-3" id="f-129" unitRef="usd">1045595000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-12" decimals="-3" id="f-130" unitRef="usd">1036295000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-13" decimals="-3" id="f-131" unitRef="usd">1220140000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-3" id="f-132" unitRef="usd">266719000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-14" decimals="-3" id="f-133" unitRef="usd">212672000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-11" decimals="-3" id="f-134" unitRef="usd">144105000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer contextRef="c-1" decimals="-3" id="f-135" unitRef="usd">0</us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer>
    <us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer contextRef="c-14" decimals="-3" id="f-136" unitRef="usd">2368000</us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer>
    <us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer contextRef="c-11" decimals="-3" id="f-137" unitRef="usd">207000</us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer>
    <us-gaap:Revenues contextRef="c-1" decimals="-3" id="f-138" unitRef="usd">266719000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-14" decimals="-3" id="f-139" unitRef="usd">215040000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-11" decimals="-3" id="f-140" unitRef="usd">144312000</us-gaap:Revenues>
    <us-gaap:CostOfRevenue contextRef="c-1" decimals="-3" id="f-141" unitRef="usd">95816000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c-14" decimals="-3" id="f-142" unitRef="usd">74018000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c-11" decimals="-3" id="f-143" unitRef="usd">52239000</us-gaap:CostOfRevenue>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-1" decimals="-3" id="f-144" unitRef="usd">265868000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-14" decimals="-3" id="f-145" unitRef="usd">286408000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-11" decimals="-3" id="f-146" unitRef="usd">573306000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-1" decimals="-3" id="f-147" unitRef="usd">281608000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-14" decimals="-3" id="f-148" unitRef="usd">258971000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-11" decimals="-3" id="f-149" unitRef="usd">218831000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:GainLossOnDispositionOfIntangibleAssets contextRef="c-1" decimals="-3" id="f-150" unitRef="usd">10000000</us-gaap:GainLossOnDispositionOfIntangibleAssets>
    <us-gaap:GainLossOnDispositionOfIntangibleAssets contextRef="c-14" decimals="-3" id="f-151" unitRef="usd">0</us-gaap:GainLossOnDispositionOfIntangibleAssets>
    <us-gaap:GainLossOnDispositionOfIntangibleAssets contextRef="c-11" decimals="-3" id="f-152" unitRef="usd">0</us-gaap:GainLossOnDispositionOfIntangibleAssets>
    <us-gaap:OperatingIncomeLoss contextRef="c-1" decimals="-3" id="f-153" unitRef="usd">-366573000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-14" decimals="-3" id="f-154" unitRef="usd">-404357000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-11" decimals="-3" id="f-155" unitRef="usd">-700064000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest contextRef="c-1" decimals="-3" id="f-156" unitRef="usd">39797000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest contextRef="c-14" decimals="-3" id="f-157" unitRef="usd">14582000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest contextRef="c-11" decimals="-3" id="f-158" unitRef="usd">2190000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="c-1" decimals="-3" id="f-159" unitRef="usd">-14850000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="c-14" decimals="-3" id="f-160" unitRef="usd">-56403000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="c-11" decimals="-3" id="f-161" unitRef="usd">4661000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-1" decimals="-3" id="f-162" unitRef="usd">7006000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-14" decimals="-3" id="f-163" unitRef="usd">3113000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-11" decimals="-3" id="f-164" unitRef="usd">-10201000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-1" decimals="-3" id="f-165" unitRef="usd">-334620000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-14" decimals="-3" id="f-166" unitRef="usd">-443065000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-11" decimals="-3" id="f-167" unitRef="usd">-703414000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-168" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-14" decimals="-3" id="f-169" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-11" decimals="-3" id="f-170" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-1" decimals="-3" id="f-171" unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-14" decimals="-3" id="f-172" unitRef="usd">-221000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-11" decimals="-3" id="f-173" unitRef="usd">-1057000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-174" unitRef="usd">-334620000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-14" decimals="-3" id="f-175" unitRef="usd">-443286000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-11" decimals="-3" id="f-176" unitRef="usd">-704471000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-177"
      unitRef="usdPerShare">-0.35</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-178"
      unitRef="usdPerShare">-0.35</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-14"
      decimals="2"
      id="f-179"
      unitRef="usdPerShare">-0.46</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-14"
      decimals="2"
      id="f-180"
      unitRef="usdPerShare">-0.46</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-11"
      decimals="2"
      id="f-181"
      unitRef="usdPerShare">-0.76</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-11"
      decimals="2"
      id="f-182"
      unitRef="usdPerShare">-0.76</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="0" id="f-183" unitRef="shares">966394130</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="0" id="f-184" unitRef="shares">966394130</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-14" decimals="0" id="f-185" unitRef="shares">958067140</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-14" decimals="0" id="f-186" unitRef="shares">958067140</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-11" decimals="0" id="f-187" unitRef="shares">929921120</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-11" decimals="0" id="f-188" unitRef="shares">929921120</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-189" unitRef="usd">-334620000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-14" decimals="-3" id="f-190" unitRef="usd">-443286000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-11" decimals="-3" id="f-191" unitRef="usd">-704471000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-14" decimals="INF" id="f-192" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-11" decimals="INF" id="f-193" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-1" decimals="INF" id="f-194" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-1" decimals="-3" id="f-195" unitRef="usd">11941000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-14" decimals="-3" id="f-196" unitRef="usd">49330000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-11" decimals="-3" id="f-197" unitRef="usd">-9121000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-1" decimals="-3" id="f-198" unitRef="usd">-322679000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-14" decimals="-3" id="f-199" unitRef="usd">-393956000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-11" decimals="-3" id="f-200" unitRef="usd">-713592000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-15"
      decimals="INF"
      id="f-201"
      unitRef="shares">878110260</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-15" decimals="-3" id="f-202" unitRef="usd">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-16" decimals="-3" id="f-203" unitRef="usd">1897467000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-17" decimals="-3" id="f-204" unitRef="usd">-713603000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-18" decimals="-3" id="f-205" unitRef="usd">-14524000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-19" decimals="-3" id="f-206" unitRef="usd">1169345000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c-20"
      decimals="INF"
      id="f-207"
      unitRef="shares">2054500</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-20" decimals="-3" id="f-208" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-21" decimals="-3" id="f-209" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-11" decimals="-3" id="f-210" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-20"
      decimals="INF"
      id="f-211"
      unitRef="shares">12353400</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-20" decimals="-3" id="f-212" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-21" decimals="-3" id="f-213" unitRef="usd">7417000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-11" decimals="-3" id="f-214" unitRef="usd">7417000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-11" decimals="-3" id="f-215" unitRef="usd">839000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-20"
      decimals="INF"
      id="f-216"
      unitRef="shares">57164000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-20" decimals="-3" id="f-217" unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-21" decimals="-3" id="f-218" unitRef="usd">818035000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-11" decimals="-3" id="f-219" unitRef="usd">818036000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="c-20"
      decimals="INF"
      id="f-220"
      unitRef="shares">5681820</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodValueOther contextRef="c-20" decimals="-3" id="f-221" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther contextRef="c-21" decimals="-3" id="f-222" unitRef="usd">62250000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther contextRef="c-11" decimals="-3" id="f-223" unitRef="usd">62250000</us-gaap:StockIssuedDuringPeriodValueOther>
    <zlab:IssuanceCostAdjustment contextRef="c-21" decimals="-3" id="f-224" unitRef="usd">65000</zlab:IssuanceCostAdjustment>
    <zlab:IssuanceCostAdjustment contextRef="c-11" decimals="-3" id="f-225" unitRef="usd">65000</zlab:IssuanceCostAdjustment>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="c-22"
      decimals="INF"
      id="f-226"
      unitRef="shares">382930</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-22" decimals="-3" id="f-227" unitRef="usd">4279000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-11" decimals="-3" id="f-228" unitRef="usd">4279000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-21" decimals="-3" id="f-229" unitRef="usd">40714000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-11" decimals="-3" id="f-230" unitRef="usd">40714000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss contextRef="c-23" decimals="-3" id="f-231" unitRef="usd">-704471000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-11" decimals="-3" id="f-232" unitRef="usd">-704471000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-24" decimals="-3" id="f-233" unitRef="usd">-9121000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-11" decimals="-3" id="f-234" unitRef="usd">-9121000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-25"
      decimals="INF"
      id="f-235"
      unitRef="shares">955363980</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-25" decimals="-3" id="f-236" unitRef="usd">6000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-26" decimals="-3" id="f-237" unitRef="usd">2825948000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-27" decimals="-3" id="f-238" unitRef="usd">-1418074000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-28" decimals="-3" id="f-239" unitRef="usd">-23645000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="c-29"
      decimals="INF"
      id="f-240"
      unitRef="shares">382930</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity contextRef="c-29" decimals="-3" id="f-241" unitRef="usd">-4279000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-30" decimals="-3" id="f-242" unitRef="usd">1379956000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c-31"
      decimals="INF"
      id="f-243"
      unitRef="shares">1940680</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-31" decimals="-3" id="f-244" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-32" decimals="-3" id="f-245" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-14" decimals="-3" id="f-246" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-31"
      decimals="INF"
      id="f-247"
      unitRef="shares">5151190</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-31" decimals="-3" id="f-248" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-32" decimals="-3" id="f-249" unitRef="usd">5870000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-14" decimals="-3" id="f-250" unitRef="usd">5870000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="c-33"
      decimals="INF"
      id="f-251"
      unitRef="shares">1853350</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-33" decimals="-3" id="f-252" unitRef="usd">7577000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-14" decimals="-3" id="f-253" unitRef="usd">7577000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-32" decimals="-3" id="f-254" unitRef="usd">61302000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-14" decimals="-3" id="f-255" unitRef="usd">61302000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss contextRef="c-34" decimals="-3" id="f-256" unitRef="usd">-443286000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-14" decimals="-3" id="f-257" unitRef="usd">-443286000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-35" decimals="-3" id="f-258" unitRef="usd">49330000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-14" decimals="-3" id="f-259" unitRef="usd">49330000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-36"
      decimals="INF"
      id="f-260"
      unitRef="shares">962455850</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-36" decimals="-3" id="f-261" unitRef="usd">6000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-37" decimals="-3" id="f-262" unitRef="usd">2893120000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-38" decimals="-3" id="f-263" unitRef="usd">-1861360000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-39" decimals="-3" id="f-264" unitRef="usd">25685000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="c-40"
      decimals="INF"
      id="f-265"
      unitRef="shares">2236280</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity contextRef="c-40" decimals="-3" id="f-266" unitRef="usd">-11856000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-13" decimals="-3" id="f-267" unitRef="usd">1045595000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c-41"
      decimals="INF"
      id="f-268"
      unitRef="shares">8178500</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-41" decimals="-3" id="f-269" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-42" decimals="-3" id="f-270" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-1" decimals="-3" id="f-271" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-41"
      decimals="INF"
      id="f-272"
      unitRef="shares">6516920</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-41" decimals="-3" id="f-273" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-42" decimals="-3" id="f-274" unitRef="usd">2548000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-1" decimals="-3" id="f-275" unitRef="usd">2548000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="c-43"
      decimals="INF"
      id="f-276"
      unitRef="shares">2675920</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-43" decimals="-3" id="f-277" unitRef="usd">8980000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-1" decimals="-3" id="f-278" unitRef="usd">8980000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-42" decimals="-3" id="f-279" unitRef="usd">79634000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-1" decimals="-3" id="f-280" unitRef="usd">79634000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss contextRef="c-44" decimals="-3" id="f-281" unitRef="usd">-334620000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-282" unitRef="usd">-334620000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-45" decimals="-3" id="f-283" unitRef="usd">11941000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-1" decimals="-3" id="f-284" unitRef="usd">11941000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-46"
      decimals="INF"
      id="f-285"
      unitRef="shares">977151270</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-46" decimals="-3" id="f-286" unitRef="usd">6000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-47" decimals="-3" id="f-287" unitRef="usd">2975302000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-48" decimals="-3" id="f-288" unitRef="usd">-2195980000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-49" decimals="-3" id="f-289" unitRef="usd">37626000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="c-50"
      decimals="INF"
      id="f-290"
      unitRef="shares">4912200</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity contextRef="c-50" decimals="-3" id="f-291" unitRef="usd">-20836000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-12" decimals="-3" id="f-292" unitRef="usd">796118000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-293" unitRef="usd">-334620000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-14" decimals="-3" id="f-294" unitRef="usd">-443286000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-11" decimals="-3" id="f-295" unitRef="usd">-704471000</us-gaap:NetIncomeLoss>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="c-1" decimals="-3" id="f-296" unitRef="usd">6000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="c-14" decimals="-3" id="f-297" unitRef="usd">1000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="c-11" decimals="-3" id="f-298" unitRef="usd">10000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:InventoryWriteDown contextRef="c-1" decimals="-3" id="f-299" unitRef="usd">973000</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown contextRef="c-14" decimals="-3" id="f-300" unitRef="usd">477000</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown contextRef="c-11" decimals="-3" id="f-301" unitRef="usd">1368000</us-gaap:InventoryWriteDown>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-1" decimals="-3" id="f-302" unitRef="usd">9029000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-14" decimals="-3" id="f-303" unitRef="usd">8227000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-11" decimals="-3" id="f-304" unitRef="usd">6487000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:TangibleAssetImpairmentCharges contextRef="c-1" decimals="-3" id="f-305" unitRef="usd">57000</us-gaap:TangibleAssetImpairmentCharges>
    <us-gaap:TangibleAssetImpairmentCharges contextRef="c-14" decimals="-3" id="f-306" unitRef="usd">0</us-gaap:TangibleAssetImpairmentCharges>
    <us-gaap:TangibleAssetImpairmentCharges contextRef="c-11" decimals="-3" id="f-307" unitRef="usd">0</us-gaap:TangibleAssetImpairmentCharges>
    <zlab:AmortizationOfDeferredIncome contextRef="c-1" decimals="-3" id="f-308" unitRef="usd">-3383000</zlab:AmortizationOfDeferredIncome>
    <zlab:AmortizationOfDeferredIncome contextRef="c-14" decimals="-3" id="f-309" unitRef="usd">-2602000</zlab:AmortizationOfDeferredIncome>
    <zlab:AmortizationOfDeferredIncome contextRef="c-11" decimals="-3" id="f-310" unitRef="usd">-521000</zlab:AmortizationOfDeferredIncome>
    <us-gaap:ShareBasedCompensation contextRef="c-1" decimals="-3" id="f-311" unitRef="usd">79634000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-14" decimals="-3" id="f-312" unitRef="usd">61302000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-11" decimals="-3" id="f-313" unitRef="usd">40714000</us-gaap:ShareBasedCompensation>
    <zlab:NoncashResearchAndDevelopmentExpenses contextRef="c-1" decimals="-3" id="f-314" unitRef="usd">0</zlab:NoncashResearchAndDevelopmentExpenses>
    <zlab:NoncashResearchAndDevelopmentExpenses contextRef="c-14" decimals="-3" id="f-315" unitRef="usd">0</zlab:NoncashResearchAndDevelopmentExpenses>
    <zlab:NoncashResearchAndDevelopmentExpenses contextRef="c-11" decimals="-3" id="f-316" unitRef="usd">62250000</zlab:NoncashResearchAndDevelopmentExpenses>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-1" decimals="-3" id="f-317" unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-14" decimals="-3" id="f-318" unitRef="usd">-221000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-11" decimals="-3" id="f-319" unitRef="usd">-1057000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:EquitySecuritiesFvNiGainLoss contextRef="c-1" decimals="-3" id="f-320" unitRef="usd">2789000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss contextRef="c-14" decimals="-3" id="f-321" unitRef="usd">-8952000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss contextRef="c-11" decimals="-3" id="f-322" unitRef="usd">-14617000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="c-1" decimals="-3" id="f-323" unitRef="usd">-159000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="c-14" decimals="-3" id="f-324" unitRef="usd">-560000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="c-11" decimals="-3" id="f-325" unitRef="usd">-29000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <zlab:GainLossOnDisposalOfLandUseRights contextRef="c-1" decimals="-3" id="f-326" unitRef="usd">408000</zlab:GainLossOnDisposalOfLandUseRights>
    <zlab:GainLossOnDisposalOfLandUseRights contextRef="c-14" decimals="-3" id="f-327" unitRef="usd">0</zlab:GainLossOnDisposalOfLandUseRights>
    <zlab:GainLossOnDisposalOfLandUseRights contextRef="c-11" decimals="-3" id="f-328" unitRef="usd">0</zlab:GainLossOnDisposalOfLandUseRights>
    <zlab:NonCashLeaseExpenses contextRef="c-1" decimals="-3" id="f-329" unitRef="usd">8708000</zlab:NonCashLeaseExpenses>
    <zlab:NonCashLeaseExpenses contextRef="c-14" decimals="-3" id="f-330" unitRef="usd">8350000</zlab:NonCashLeaseExpenses>
    <zlab:NonCashLeaseExpenses contextRef="c-11" decimals="-3" id="f-331" unitRef="usd">6119000</zlab:NonCashLeaseExpenses>
    <us-gaap:GainLossOnDispositionOfIntangibleAssets contextRef="c-1" decimals="-3" id="f-332" unitRef="usd">10000000</us-gaap:GainLossOnDispositionOfIntangibleAssets>
    <us-gaap:GainLossOnDispositionOfIntangibleAssets contextRef="c-14" decimals="-3" id="f-333" unitRef="usd">0</us-gaap:GainLossOnDispositionOfIntangibleAssets>
    <us-gaap:GainLossOnDispositionOfIntangibleAssets contextRef="c-11" decimals="-3" id="f-334" unitRef="usd">0</us-gaap:GainLossOnDispositionOfIntangibleAssets>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized contextRef="c-1" decimals="-3" id="f-335" unitRef="usd">-14850000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized contextRef="c-14" decimals="-3" id="f-336" unitRef="usd">-56403000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized contextRef="c-11" decimals="-3" id="f-337" unitRef="usd">10679000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-1" decimals="-3" id="f-338" unitRef="usd">20040000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-14" decimals="-3" id="f-339" unitRef="usd">-4330000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-11" decimals="-3" id="f-340" unitRef="usd">42319000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInNotesReceivableCurrent contextRef="c-1" decimals="-3" id="f-341" unitRef="usd">-2352000</us-gaap:IncreaseDecreaseInNotesReceivableCurrent>
    <us-gaap:IncreaseDecreaseInNotesReceivableCurrent contextRef="c-14" decimals="-3" id="f-342" unitRef="usd">1976000</us-gaap:IncreaseDecreaseInNotesReceivableCurrent>
    <us-gaap:IncreaseDecreaseInNotesReceivableCurrent contextRef="c-11" decimals="-3" id="f-343" unitRef="usd">7335000</us-gaap:IncreaseDecreaseInNotesReceivableCurrent>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c-1" decimals="-3" id="f-344" unitRef="usd">14907000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c-14" decimals="-3" id="f-345" unitRef="usd">15382000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c-11" decimals="-3" id="f-346" unitRef="usd">7174000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-1" decimals="-3" id="f-347" unitRef="usd">-12246000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-14" decimals="-3" id="f-348" unitRef="usd">19258000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-11" decimals="-3" id="f-349" unitRef="usd">7086000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <zlab:IncreaseDecreaseInLongTermDeposits contextRef="c-1" decimals="-3" id="f-350" unitRef="usd">-187000</zlab:IncreaseDecreaseInLongTermDeposits>
    <zlab:IncreaseDecreaseInLongTermDeposits contextRef="c-14" decimals="-3" id="f-351" unitRef="usd">527000</zlab:IncreaseDecreaseInLongTermDeposits>
    <zlab:IncreaseDecreaseInLongTermDeposits contextRef="c-11" decimals="-3" id="f-352" unitRef="usd">8000</zlab:IncreaseDecreaseInLongTermDeposits>
    <zlab:IncreaseDecreaseInValueAddedTaxesReceivable contextRef="c-1" decimals="-3" id="f-353" unitRef="usd">0</zlab:IncreaseDecreaseInValueAddedTaxesReceivable>
    <zlab:IncreaseDecreaseInValueAddedTaxesReceivable contextRef="c-14" decimals="-3" id="f-354" unitRef="usd">-22781000</zlab:IncreaseDecreaseInValueAddedTaxesReceivable>
    <zlab:IncreaseDecreaseInValueAddedTaxesReceivable contextRef="c-11" decimals="-3" id="f-355" unitRef="usd">1717000</zlab:IncreaseDecreaseInValueAddedTaxesReceivable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-1" decimals="-3" id="f-356" unitRef="usd">36803000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-14" decimals="-3" id="f-357" unitRef="usd">-53773000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-11" decimals="-3" id="f-358" unitRef="usd">63522000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities contextRef="c-1" decimals="-3" id="f-359" unitRef="usd">19810000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities contextRef="c-14" decimals="-3" id="f-360" unitRef="usd">7392000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities contextRef="c-11" decimals="-3" id="f-361" unitRef="usd">30142000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <zlab:IncreaseDecreaseInOperatingLeaseLiabilities contextRef="c-1" decimals="-3" id="f-362" unitRef="usd">-8351000</zlab:IncreaseDecreaseInOperatingLeaseLiabilities>
    <zlab:IncreaseDecreaseInOperatingLeaseLiabilities contextRef="c-14" decimals="-3" id="f-363" unitRef="usd">-8455000</zlab:IncreaseDecreaseInOperatingLeaseLiabilities>
    <zlab:IncreaseDecreaseInOperatingLeaseLiabilities contextRef="c-11" decimals="-3" id="f-364" unitRef="usd">-5385000</zlab:IncreaseDecreaseInOperatingLeaseLiabilities>
    <us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="c-1" decimals="-3" id="f-365" unitRef="usd">11181000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="c-14" decimals="-3" id="f-366" unitRef="usd">-1379000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="c-11" decimals="-3" id="f-367" unitRef="usd">11149000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities contextRef="c-1" decimals="-3" id="f-368" unitRef="usd">325000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities contextRef="c-14" decimals="-3" id="f-369" unitRef="usd">0</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities contextRef="c-11" decimals="-3" id="f-370" unitRef="usd">0</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="-3" id="f-371" unitRef="usd">-198178000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-14" decimals="-3" id="f-372" unitRef="usd">-367642000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-11" decimals="-3" id="f-373" unitRef="usd">-549231000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireShortTermInvestments contextRef="c-1" decimals="-3" id="f-374" unitRef="usd">134000000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:PaymentsToAcquireShortTermInvestments contextRef="c-14" decimals="-3" id="f-375" unitRef="usd">260274000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:PaymentsToAcquireShortTermInvestments contextRef="c-11" decimals="-3" id="f-376" unitRef="usd">445000000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments contextRef="c-1" decimals="-3" id="f-377" unitRef="usd">117700000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments contextRef="c-14" decimals="-3" id="f-378" unitRef="usd">705274000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments contextRef="c-11" decimals="-3" id="f-379" unitRef="usd">743902000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments contextRef="c-1" decimals="-3" id="f-380" unitRef="usd">0</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments contextRef="c-14" decimals="-3" id="f-381" unitRef="usd">0</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments contextRef="c-11" decimals="-3" id="f-382" unitRef="usd">30000000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-1" decimals="-3" id="f-383" unitRef="usd">7212000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-14" decimals="-3" id="f-384" unitRef="usd">24585000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-11" decimals="-3" id="f-385" unitRef="usd">18295000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="c-1" decimals="-3" id="f-386" unitRef="usd">122000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="c-14" decimals="-3" id="f-387" unitRef="usd">0</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="c-11" decimals="-3" id="f-388" unitRef="usd">3000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="c-1" decimals="-3" id="f-389" unitRef="usd">1279000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="c-14" decimals="-3" id="f-390" unitRef="usd">399000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="c-11" decimals="-3" id="f-391" unitRef="usd">653000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:ProceedsFromSaleOfIntangibleAssets contextRef="c-1" decimals="-3" id="f-392" unitRef="usd">10000000</us-gaap:ProceedsFromSaleOfIntangibleAssets>
    <us-gaap:ProceedsFromSaleOfIntangibleAssets contextRef="c-14" decimals="-3" id="f-393" unitRef="usd">0</us-gaap:ProceedsFromSaleOfIntangibleAssets>
    <us-gaap:ProceedsFromSaleOfIntangibleAssets contextRef="c-11" decimals="-3" id="f-394" unitRef="usd">0</us-gaap:ProceedsFromSaleOfIntangibleAssets>
    <zlab:ProceedsFromDisposalOfLandUseRights contextRef="c-1" decimals="-3" id="f-395" unitRef="usd">3893000</zlab:ProceedsFromDisposalOfLandUseRights>
    <zlab:ProceedsFromDisposalOfLandUseRights contextRef="c-14" decimals="-3" id="f-396" unitRef="usd">0</zlab:ProceedsFromDisposalOfLandUseRights>
    <zlab:ProceedsFromDisposalOfLandUseRights contextRef="c-11" decimals="-3" id="f-397" unitRef="usd">0</zlab:ProceedsFromDisposalOfLandUseRights>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-1" decimals="-3" id="f-398" unitRef="usd">-10776000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-14" decimals="-3" id="f-399" unitRef="usd">420016000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-11" decimals="-3" id="f-400" unitRef="usd">249957000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-1" decimals="-3" id="f-401" unitRef="usd">2369000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-14" decimals="-3" id="f-402" unitRef="usd">5870000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-11" decimals="-3" id="f-403" unitRef="usd">7417000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering contextRef="c-1" decimals="-3" id="f-404" unitRef="usd">0</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering contextRef="c-14" decimals="-3" id="f-405" unitRef="usd">0</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering contextRef="c-11" decimals="-3" id="f-406" unitRef="usd">818875000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c-1" decimals="-3" id="f-407" unitRef="usd">0</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c-14" decimals="-3" id="f-408" unitRef="usd">0</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c-11" decimals="-3" id="f-409" unitRef="usd">1837000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-1" decimals="-3" id="f-410" unitRef="usd">8802000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-14" decimals="-3" id="f-411" unitRef="usd">7600000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-11" decimals="-3" id="f-412" unitRef="usd">4253000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-1" decimals="-3" id="f-413" unitRef="usd">-6433000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-14" decimals="-3" id="f-414" unitRef="usd">-1730000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-11" decimals="-3" id="f-415" unitRef="usd">820202000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="c-1" decimals="-3" id="f-416" unitRef="usd">-2622000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="c-14" decimals="-3" id="f-417" unitRef="usd">-6274000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="c-11" decimals="-3" id="f-418" unitRef="usd">1116000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-1" decimals="-3" id="f-419" unitRef="usd">-218009000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-14" decimals="-3" id="f-420" unitRef="usd">44370000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-11" decimals="-3" id="f-421" unitRef="usd">522044000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="c-13" decimals="-3" id="f-422" unitRef="usd">1009273000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="c-30" decimals="-3" id="f-423" unitRef="usd">964903000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="c-19" decimals="-3" id="f-424" unitRef="usd">442859000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="c-12" decimals="-3" id="f-425" unitRef="usd">791264000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="c-13" decimals="-3" id="f-426" unitRef="usd">1009273000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="c-30" decimals="-3" id="f-427" unitRef="usd">964903000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 contextRef="c-1" decimals="-3" id="f-428" unitRef="usd">2474000</us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1>
    <us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 contextRef="c-14" decimals="-3" id="f-429" unitRef="usd">5269000</us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1>
    <us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 contextRef="c-11" decimals="-3" id="f-430" unitRef="usd">2568000</us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1>
    <zlab:NonCashPayablesForIntangibleAssets contextRef="c-1" decimals="-3" id="f-431" unitRef="usd">11516000</zlab:NonCashPayablesForIntangibleAssets>
    <zlab:NonCashPayablesForIntangibleAssets contextRef="c-14" decimals="-3" id="f-432" unitRef="usd">163000</zlab:NonCashPayablesForIntangibleAssets>
    <zlab:NonCashPayablesForIntangibleAssets contextRef="c-11" decimals="-3" id="f-433" unitRef="usd">191000</zlab:NonCashPayablesForIntangibleAssets>
    <zlab:NonCashPayablesForTreasuryStock contextRef="c-1" decimals="-3" id="f-434" unitRef="usd">0</zlab:NonCashPayablesForTreasuryStock>
    <zlab:NonCashPayablesForTreasuryStock contextRef="c-14" decimals="-3" id="f-435" unitRef="usd">2000</zlab:NonCashPayablesForTreasuryStock>
    <zlab:NonCashPayablesForTreasuryStock contextRef="c-11" decimals="-3" id="f-436" unitRef="usd">26000</zlab:NonCashPayablesForTreasuryStock>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-1" decimals="-3" id="f-437" unitRef="usd">3668000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-14" decimals="-3" id="f-438" unitRef="usd">14801000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-11" decimals="-3" id="f-439" unitRef="usd">2183000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <zlab:ReceivableRecognizedForDisposalOfPropertyAndEquipment contextRef="c-1" decimals="-3" id="f-440" unitRef="usd">0</zlab:ReceivableRecognizedForDisposalOfPropertyAndEquipment>
    <zlab:ReceivableRecognizedForDisposalOfPropertyAndEquipment contextRef="c-14" decimals="-3" id="f-441" unitRef="usd">64000</zlab:ReceivableRecognizedForDisposalOfPropertyAndEquipment>
    <zlab:ReceivableRecognizedForDisposalOfPropertyAndEquipment contextRef="c-11" decimals="-3" id="f-442" unitRef="usd">0</zlab:ReceivableRecognizedForDisposalOfPropertyAndEquipment>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-12" decimals="-3" id="f-443" unitRef="usd">790151000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-13" decimals="-3" id="f-444" unitRef="usd">1008470000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-30" decimals="-3" id="f-445" unitRef="usd">964100000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-12" decimals="-3" id="f-446" unitRef="usd">1113000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-13" decimals="-3" id="f-447" unitRef="usd">803000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-30" decimals="-3" id="f-448" unitRef="usd">803000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="c-12" decimals="-3" id="f-449" unitRef="usd">791264000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="c-13" decimals="-3" id="f-450" unitRef="usd">1009273000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="c-30" decimals="-3" id="f-451" unitRef="usd">964903000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="c-1" id="f-452">Organization and Principal Activities &lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Zai Lab Limited was incorporated on March 28, 2013 in the Cayman Islands as an exempted company with limited liability under the Companies Act of the Cayman Islands (as amended). Zai Lab Limited and its subsidiaries (collectively referred to as the &#x201c;Company&#x201d;) are focused on discovering, developing, and commercializing products that address medical conditions with significant unmet needs in the areas of oncology, autoimmune disorders, infectious disease, and neuroscience.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The Company&#x2019;s principal operations and geographic markets are in Greater China. The Company has a substantial presence in Greater China and the United States. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;As of December&#160;31, 2023, the Company&#x2019;s significant operating subsidiaries were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:28.596%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:27.237%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Name of Company&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Place of&lt;br/&gt;Incorporation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Date of&lt;br/&gt;Incorporation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Percentage of&lt;br/&gt;Ownership&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Principal Activities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Zai Lab (Hong Kong) Limited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Hong Kong&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;April 29, 2013&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating company for business development and R&amp;amp;D activities and commercialization of innovative medicines and device&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Zai Lab (Shanghai) Co., Ltd.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Mainland&lt;br/&gt;China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;January 6, 2014&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Development and commercialization of innovative medicines and devices&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Zai Lab (AUST) Pty. Ltd.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Australia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December 10, 2014&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Clinical trial activities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Zai Lab (Suzhou) Co., Ltd.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Mainland&lt;br/&gt;China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;November 30, 2015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Development and commercialization of innovative medicines&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Zai Biopharmaceutical (Suzhou) Co., Ltd.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Mainland&lt;br/&gt;China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;June 15, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Development and commercialization of innovative medicines&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Zai Lab (US) LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;United&lt;br/&gt;States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;April 21, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating company for business development, R&amp;amp;D activities and certain business activities, including legal, compliance and communication functions of the Company&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Zai Lab International Trading (Shanghai) Co., Ltd.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Mainland&lt;br/&gt;China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;November 6, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercialization of innovative medicines and devices&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Zai Auto Immune (Hong Kong) Limited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Hong Kong&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;November 4, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating company for business development and R&amp;amp;D activities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Zai Lab (Taiwan) Limited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Taiwan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December 10, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercialization of innovative medicines and devices&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Zai Lab Trading (Suzhou) Co., Ltd.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Mainland&lt;br/&gt;China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;October 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercialization of innovative medicines and devices&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock contextRef="c-1" id="f-453">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;As of December&#160;31, 2023, the Company&#x2019;s significant operating subsidiaries were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:28.596%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:27.237%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Name of Company&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Place of&lt;br/&gt;Incorporation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Date of&lt;br/&gt;Incorporation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Percentage of&lt;br/&gt;Ownership&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Principal Activities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Zai Lab (Hong Kong) Limited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Hong Kong&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;April 29, 2013&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating company for business development and R&amp;amp;D activities and commercialization of innovative medicines and device&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Zai Lab (Shanghai) Co., Ltd.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Mainland&lt;br/&gt;China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;January 6, 2014&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Development and commercialization of innovative medicines and devices&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Zai Lab (AUST) Pty. Ltd.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Australia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December 10, 2014&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Clinical trial activities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Zai Lab (Suzhou) Co., Ltd.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Mainland&lt;br/&gt;China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;November 30, 2015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Development and commercialization of innovative medicines&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Zai Biopharmaceutical (Suzhou) Co., Ltd.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Mainland&lt;br/&gt;China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;June 15, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Development and commercialization of innovative medicines&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Zai Lab (US) LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;United&lt;br/&gt;States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;April 21, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating company for business development, R&amp;amp;D activities and certain business activities, including legal, compliance and communication functions of the Company&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Zai Lab International Trading (Shanghai) Co., Ltd.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Mainland&lt;br/&gt;China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;November 6, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercialization of innovative medicines and devices&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Zai Auto Immune (Hong Kong) Limited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Hong Kong&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;November 4, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating company for business development and R&amp;amp;D activities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Zai Lab (Taiwan) Limited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Taiwan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December 10, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercialization of innovative medicines and devices&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Zai Lab Trading (Suzhou) Co., Ltd.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Mainland&lt;br/&gt;China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;October 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercialization of innovative medicines and devices&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock>
    <us-gaap:SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest contextRef="c-51" decimals="2" id="f-454" unitRef="number">1</us-gaap:SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest>
    <us-gaap:SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest contextRef="c-52" decimals="2" id="f-455" unitRef="number">1</us-gaap:SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest>
    <us-gaap:SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest contextRef="c-53" decimals="2" id="f-456" unitRef="number">1</us-gaap:SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest>
    <us-gaap:SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest contextRef="c-54" decimals="2" id="f-457" unitRef="number">1</us-gaap:SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest>
    <us-gaap:SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest contextRef="c-55" decimals="2" id="f-458" unitRef="number">1</us-gaap:SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest>
    <us-gaap:SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest contextRef="c-56" decimals="2" id="f-459" unitRef="number">1</us-gaap:SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest>
    <us-gaap:SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest contextRef="c-57" decimals="2" id="f-460" unitRef="number">1</us-gaap:SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest>
    <us-gaap:SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest contextRef="c-58" decimals="2" id="f-461" unitRef="number">1</us-gaap:SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest>
    <us-gaap:SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest contextRef="c-59" decimals="2" id="f-462" unitRef="number">1</us-gaap:SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest>
    <us-gaap:SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest contextRef="c-60" decimals="2" id="f-463" unitRef="number">1</us-gaap:SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c-1" id="f-464">Summary of Significant Accounting Policies &lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%"&gt;(a) Basis of Presentation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#x201c;U.S. GAAP&#x201d;). Significant accounting policies followed by the Company in the preparation of the accompanying consolidated financial statements are summarized below. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Effective as of March 30, 2022, the Company subdivided each of its issued and unissued ordinary shares into ten ordinary shares (the &#x201c;Share Subdivision&#x201d;). Following the Share Subdivision, the Company&#x2019;s authorized share capital became $30,000 divided into 5,000,000,000 shares with a par value of $0.000006 per share. The numbers of issued and unissued ordinary shares and per share data as disclosed elsewhere in these consolidated financial statements and notes thereto are presented on a basis after taking into account the effects of the Share Subdivision and have been retrospectively adjusted, where applicable. In connection with the Share Subdivision, the conversion ratio of its ADSs to ordinary shares changed from one ADS to one ordinary share to a new ratio of one ADS to ten ordinary shares (the &#x201c;ADS Ratio Change&#x201d;). The Share Subdivision and ADS Ratio Change did not result in any change to the number of outstanding ADSs of the Company. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt; In 2022, the Company began to separately present foreign currency (loss) gain on the consolidated statements of operations. This amount was previously included in other income (expense), net. Additionally, the Company began to provide a breakdown of other income (expense), net in Note 17.  The Company also began to separately present the amount of foreign currency remeasurement loss (gain) on the consolidated statements of cash flows. This amount was previously included in changes in other current liabilities. This change did not have any impact on net cash used in operating activities. Corresponding amounts in the prior periods of the consolidated financial statements have been presented to conform to the current period presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%"&gt;(b) Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The consolidated financial statements include the accounts of Zai Lab Limited and its subsidiaries, which are wholly owned. All intercompany transactions and balances are eliminated upon consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%"&gt;(c) Use of Estimates &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Areas where management uses subjective judgment include, but are not limited to, accrual of rebates, recognition of research and development expenses to the appropriate financial reporting period based on actual services performed, fair value of share-based compensation expenses, and recoverability of deferred tax assets. These estimates, judgments, and assumptions can affect the reported amounts of assets and liabilities as of the date of the financial statements as well as the reported amounts of revenues and expenses during the periods presented. Actual results could differ from these estimates. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%"&gt;(d) Foreign Currency Translation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The functional currency of Zai Lab Limited, Zai Lab (Hong Kong) Limited, Zai Lab (US) LLC, and Zai Auto Immune (Hong Kong) Limited are the U.S. dollar (&#x201c;$&#x201d;). The Company&#x2019;s subsidiaries in mainland China determined their functional currency to be the Chinese Renminbi (&#x201c;RMB&#x201d;). The Company&#x2019;s subsidiary in Australia determined its &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;functional currency to be the Australian dollar (&#x201c;A$&#x201d;). The Company&#x2019;s subsidiary in Taiwan determined its functional currency to be the Taiwan dollar (&#x201c;TWD&#x201d;). The determination of the respective functional currency is based on the criteria of Accounting Standard Codification (&#x201c;ASC&#x201d;) 830, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%"&gt;Foreign Currency Matters&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;. The Company uses the U.S. dollar as its reporting currency. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Assets and liabilities are translated from each entity&#x2019;s functional currency to the reporting currency at the exchange rate on the balance sheet date. Equity amounts are translated at historical exchange rates. Revenues, expenses, gains, and losses are translated using the average rate for the period presented. The resulted foreign currency translation adjustments are recorded as a component of other comprehensive loss in the consolidated statements of comprehensive loss, and the accumulated foreign currency translation adjustments are recorded as a component of accumulated other comprehensive income (loss) in the consolidated statements of shareholders&#x2019; equity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Monetary assets and liabilities denominated in currencies other than the applicable functional currencies are translated into the functional currencies at the prevailing rates of exchange at the balance sheet date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Non-monetary assets and liabilities are translated into the applicable functional currencies at historical exchange rates. Transactions in currencies other than the applicable functional currencies during the year are converted into the functional currencies at the applicable rates of exchange prevailing at the transaction dates. Transaction gains and losses are recognized in the consolidated statements of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%"&gt;(e) Cash, Cash Equivalents, and Restricted Cash &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%"&gt;Cash and Cash Equivalents &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The Company considers all highly liquid investments purchased with original maturities of three months or less to be cash equivalents. Cash and cash equivalents consist primarily of cash on hand, demand deposits, and highly liquid investments with maturity of less than three months and are stated at cost, which approximates fair value. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%"&gt;Restricted Cash &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Restricted cash mainly consists of bank deposits held as collateral for issuances of letters of credit. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%"&gt;(f) Short-Term Investments &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Short-term investments are time deposits with original maturities between three months and one year. Short-term investments are stated at cost, which approximates fair value. Interest earned is included in interest income. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%"&gt;(g) Accounts Receivable &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The Company&#x2019;s accounts receivable arise from product sales and represent amounts due from its customers. From January 1, 2020, the Company adopted the ASU 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%"&gt;Credit Losses, Measurement of Credit Losses on Financial Instruments. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Accounts receivable are recorded at the amounts net of allowances for credit losses. The allowance for credit losses reflects the Company&#x2019;s current estimate of credit losses expected to be incurred over the life of the receivables. The Company considers various factors in establishing, monitoring, and adjusting its allowance for credit losses including the aging of receivables and aging trends, customer creditworthiness, and specific exposures related to particular customers. The Company also monitors other risk factors and forward-looking information, such as country-specific risks and economic factors that may affect a debtor&#x2019;s ability to pay in establishing and adjusting its allowance for credit losses. Accounts receivable are written off when deemed uncollectible.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%"&gt;(h) Notes Receivable &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Notes receivable is equal to contractual amounts owed from signed, secured promissory notes issued from customers to the Company. The Company considers the notes receivable to be fully collectible. Accordingly, no allowance for credit loss has been established as of December&#160;31, 2023 and 2022.   &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%"&gt;(i) Inventories &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Inventories are stated at the lower of cost or net realizable value, with cost determined on a weighted average basis. The Company periodically reviews the composition of inventory and shelf life of inventory to identify obsolete, slow-moving, or otherwise non-saleable items. The Company will record a write-down to its net realizable value in cost of sales in the period that the decline in value is first identified. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%"&gt;(j) Prepayments for Equipment &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The prepayments for equipment purchase are recorded in long-term prepayments considering the prepayments are all related to property and equipment. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%"&gt;(k) Property and Equipment &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Property and equipment are stated at cost, less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the respective assets as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.566%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:27.234%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Useful life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Office equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Electronic equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.25-3 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Vehicles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Laboratory equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Manufacturing equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;lesser of useful life or lease term&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Construction in progress represents property and equipment under construction and pending installation and is stated at cost less impairment losses, if any. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%"&gt;(l) Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The Company leases facilities for its offices, research and development center, and manufacturing facilities in mainland China, Hong Kong, and the United States. On January 1, 2019, the Company adopted the ASC 842, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt; using the modified retrospective transition approach by applying the new standard to all leases existing at the date of initial application and not restating historical periods before the adoption date. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The Company assessed whether an arrangement contains a lease at inception. The Company&#x2019;s leases are all classified as operating leases with fixed lease payments, or minimum payments, as contractually stated in the lease agreements. The Company&#x2019;s leases do not contain any material residual value guarantees or material restrictive covenants.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Operating leases are included in operating lease right-of-use assets and operating lease liabilities in the consolidated balance sheets. Operating lease liabilities that become due within one year of the balance sheet date are classified as current operating lease liabilities. Operating lease expense is recognized on a straight-line basis over the lease term.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;At the commencement date of a lease, the Company recognizes a lease liability for future fixed lease payments and a right-of-use (&#x201c;ROU&#x201d;) asset representing the right to use the underlying asset during the lease term. The lease liability is initially measured as the present value of the future fixed lease payments that will be made over the lease term. The lease term includes periods for which the Company is reasonably certain that the renewal options will be exercised and the termination options will not be exercised. The Company uses its incremental borrowing rate based on the information available at the commencement date in determining the lease liabilities as the Company&#x2019;s leases generally do not provide an implicit rate. The incremental borrowing rate is reevaluated upon a lease modification. The Company considered information available at the adoption date of ASC 842 to determine the incremental borrowing rate for leases in existence as of this date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The ROU asset is measured at the amount of the lease liability with adjustments, if applicable, for lease prepayments made prior to or at lease commencement, initial direct costs incurred by the Company, and lease incentives. Under ASC 842, land use rights agreements are also considered to be operating lease contracts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The Company elected to apply each of the practical expedients described in ASC 842 which allow companies (i) not to reassess prior conclusions on whether any expired or existing contracts are or contain a lease, lease classification, and initial direct costs upon adoption of ASC 842, (ii) combine lease and non-lease components for all underlying assets groups, and (iii) not recognize ROU assets or lease liabilities for short term leases. A short-term lease is a lease that, at the commencement date, has a lease term of 12 months or less and does not include an option to purchase the underlying asset that the lessee is reasonably certain to exercise.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%"&gt;(m) Land Use Rights &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;All land in mainland China is subject to government or collective ownership. Land use rights can be purchased for a specified period of time. The purchase price of land use rights represents the operating lease prepayments under ASC 842 and is recorded as land use rights on the consolidated balance sheet, which is amortized over the remaining lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The Company acquired land use rights in 2019 for a term of 30 years from the local Bureau of Land and Resources in Suzhou for the purpose of constructing and operating the research center and biologics manufacturing facility in Suzhou. In 2023, the Company returned a portion of the land use rights and received cash in an amount equal to the respective portion of the original acquisition cost.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%"&gt;(n) Long-Term Deposits &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Long-term deposits represent amounts paid in connection with the Company&#x2019;s long-term lease agreements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%"&gt;(o) Intangible Assets &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Intangible assets mainly consist of capitalized sales-based milestone fees and externally purchased software. Sales-based milestone fees are capitalized based on contract terms upon achievement of the sales levels and are amortized over the estimated remaining useful life of the related product, which is generally based on expected patent life, the contractual period of the underlying license agreement, and expected commercial benefits of the products. Externally purchased software are amortized over &lt;span style="-sec-ix-hidden:f-496"&gt;three&lt;/span&gt; to five years on a straight-line basis. As of December&#160;31, 2023, the intangible assets, net consist of $11.2 million capitalized sales-based milestone fees and $2.2 million software. As of December&#160;31, 2022, the intangible assets, net consist of $1.5 million software. Amortization expenses for 2023, 2022, and 2021 were $0.7 million, $0.5 million, and $0.5 million, respectively. Amortization expenses of the Company&#x2019;s intangible assets are expected to be approximately $3.1 million, $2.9 million, $2.7 million, $2.5 million, and $2.3 million, and nil for 2024, 2025, 2026, 2027, 2028, and thereafter, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%"&gt;(p) Impairment of Long-Lived Assets &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The Company evaluates long-lived assets, which includes intangible assets, tangible assets, and ROU assets for impairment whenever events or changes in circumstances indicate that the carrying value of these assets may not be recoverable. Recoverability of these assets is measured by comparison of the carrying amount of the related asset group to its future undiscounted cash flows. The Company measures the amount of impairment, if any, based on the difference between the carrying value and the estimated fair value of the impaired asset group. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%"&gt;(q) Fair Value Measurements &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The Company applies ASC topic 820 (&#x201c;ASC 820&#x201d;), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%"&gt;Fair Value Measurements and Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;, in measuring fair value. ASC 820 defines fair value, establishes a framework for measuring fair value, and requires disclosures to be provided on fair value measurement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;ASC 820 establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Level 1 &#x2014; Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Level 2 &#x2014; Include other inputs that are directly or indirectly observable in the marketplace. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Level 3 &#x2014; Unobservable inputs which are supported by little or no market activity. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;ASC 820 describes three main approaches to measuring the fair value of assets and liabilities: (i) market approach; (ii) income approach; and (iii) cost approach. The market approach uses prices and other relevant information generated from market transactions involving identical or comparable assets or liabilities. The income approach uses valuation techniques to convert future amounts to a single present value amount. The measurement is based on the value indicated by current market expectations about those future amounts. The cost approach is based on the amount that would currently be required to replace an asset. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Equity investments with readily determinable fair value are measured using level 1 inputs and were $9.2 million and $6.4 million as of December&#160;31, 2023 and 2022, respectively. The unrealized gains and losses from fair value changes are recognized in other income (expense), net in the consolidated statements of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Financial instruments of the Company primarily include cash, cash equivalents and restricted cash, short-term investments, accounts receivable, notes receivable, prepayments, and other current assets, accounts payable, and other current liabilities. As of December&#160;31, 2023 and 2022, the carrying values of cash and cash equivalents, short-term investments, accounts receivable, prepayments, and other current assets, accounts payable, and other current liabilities approximated their fair values due to the short-term maturity of these instruments, and the carrying value of notes receivable and restricted cash approximated their fair value based on the nature of the assessment of the ability to recover these amounts. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%"&gt;(r) Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;In 2018, the Company adopted ASC Topic 606 (&#x201c;ASC 606&#x201d;), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;. Under ASC 606, the Company recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration expected to be received in exchange for those goods or services. To determine revenue recognition for arrangements that the Company determines are within the scope of ASC 606, the Company performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price, including variable consideration, if any; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the Company satisfies a performance &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;obligation. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration to which it is entitled in exchange for the goods or services it transfers to the customer. Once a contract is determined to be within the scope of ASC 606 at contract inception, the Company reviews the contract to determine which performance obligations it must deliver and which of these performance obligations are distinct. The Company recognizes as revenue the amount of the transaction price that is allocated to each performance obligation when that performance obligation is satisfied or as it is satisfied.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The Company&#x2019;s revenue is mainly from product sales. The Company recognizes revenue from product sales when the Company has satisfied the performance obligation by transferring control of the product to the customers. Control of the product generally transfers to the customers when the delivery is made and when title and risk of loss transfers to the consumers. Cost of sales mainly consists of the acquisition cost of products, the manufacturing cost of products, royalty fees, and amortization of sales-based milestone payments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The Company has applied the practical expedients under ASC 606 with regard to assessment of financing component and concluded that there is no significant financing component given that the period between delivery of goods and payment is generally one year or less. The Company&#x2019;s product revenues were mainly generated from the sale of ZEJULA (niraparib), OPTUNE (Tumor Treating Fields), QINLOCK (ripretinib), NUZYRA (omadacycline), and VYVGART (efgartigimod) to customers. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;In mainland China, the Company sells the products to distributors, who ultimately sell the products to health care providers. Based on the nature of the arrangements, the performance obligations are satisfied upon the delivery of the products to distributors. Rebates are offered to distributors, consistent with pharmaceutical industry practices. The estimated amount of unpaid or unbilled rebates are recorded as a reduction of revenue, if any. Estimated rebates are determined based on contracted rates and sales volumes and to a lesser extent, distributor inventories. The Company regularly reviews the information related to these estimates and adjusts the amount accordingly. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;In Hong Kong, the Company sells the products to customers, which are typically healthcare providers such as oncology centers. The Company utilizes a third party for warehousing services. Based on the nature of the arrangements, the Company has determined that it is a principal in the transaction since the Company is primarily responsible for fulfilling the promise to provide the products to the customers, maintains inventory risk until delivery to the customers, and has latitude in establishing the price. Revenue was recognized at the amount to which the Company expected to be entitled in exchange for the sale of the products, which is the sales price agreed with the customers. Consideration paid to the third party is recognized in operating expenses. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The Company didn&#x2019;t recognize any contract assets and contract liabilities as of December&#160;31, 2023 and 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%"&gt;(s) Collaborative Arrangements &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The Company analyzes its collaboration arrangements to assess whether such arrangements involve joint operating activities performed by parties that are both active participants in the activities and exposed to significant risks and rewards dependent on the commercial success of such activities and therefore within the scope of ASC Topic 808, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%"&gt;Collaborative Arrangements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt; (ASC 808). This assessment is performed throughout the life of the arrangement based on changes in the responsibilities of all parties in the arrangement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;For collaboration arrangements within the scope of ASC 808 that contain multiple elements, the Company first determines which elements of the collaboration are deemed to be within the scope of ASC 808 and which elements of the collaboration are more reflective of a vendor-customer relationship and therefore within the scope of ASC 606. For &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;elements of collaboration arrangements that are accounted pursuant to ASC 808, an appropriate recognition method is determined and applied consistently. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%"&gt;(t) Research and Development Expenses &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Elements of research and development expenses primarily include (i) payroll and other related costs of personnel engaged in research and development activities; (ii) in-licensed patent rights fees of exclusive development rights of products granted to the Company; (iii) costs related to pre-clinical testing of the Company&#x2019;s technologies under development and clinical trials such as payments to contract research organizations (&#x201c;CROs&#x201d;) and contract manufacturing organizations (&#x201c;CMOs&#x201d;), investigators, and clinical trial sites that conduct its clinical studies; (iv) costs to develop the product candidates, including raw materials and supplies, product testing, depreciation, and facility-related expenses; and (v) other research and development expenses. Research and development expenses are charged to expense as incurred and have no alternative future uses. Liabilities related to third-party research and development expenses are primarily included in accounts payable on the consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The Company has acquired rights to develop and commercialize product candidates. Upfront payments that relate to the acquisition of a new product compound, as well as pre-commercial milestone payments, are immediately expensed as acquired in-process research and development in the period in which they are incurred, provided that the new product compound did not also include processes or activities that would constitute a &#x201c;business&#x201d; as defined under U.S. GAAP. Milestone payments made to third parties subsequent to regulatory approval which meet the capitalization criteria would be capitalized as intangible assets and amortized over the estimated remaining useful life of the related product, which is generally based on expected patent life, the contractual period of the underlying license agreement, and expected commercial benefits of the products. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%"&gt;(u) Deferred Income &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Deferred income mainly consists of deferred income from government grants and the upfront payments received from Huizheng.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Government grants consist of cash subsidies received by the Company&#x2019;s subsidiaries in mainland China from local governments. Grants received as incentives for conducting business in certain local districts with no performance obligation or other restriction as to the use are recognized as other income when cash is received. Grants received with government specified performance obligations are recognized as other income when all the obligations have been fulfilled. If such obligations are not satisfied, the Company may be required to refund the subsidy. The grant received before the fulfillment of specified performance obligation is recorded in deferred income. The Company had $2.1 million and $0.9 million of government grants in deferred income as of December&#160;31, 2023 and 2022, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;In March 2020, the Company entered into an exclusive promotion agreement with Huizheng so that the Company could leverage Hanhui&#x2019;s infrastructure to optimize an anticipated future commercial launch of NUZYRA in mainland China. In exchange for exclusive promotion rights in mainland China, Huizheng agreed to pay the Company non-creditable upfront payments of RMB230.0 million, of which RMB90.0 million was paid in April 2020, RMB70.0 million in 2022, and RMB70.0 million in 2023. The Company is amortizing the upfront payments through the end of the contract term. The Company had $26.7 million and $20.5 million in deferred income related to the upfront payments as of December&#160;31, 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%"&gt;(v) Comprehensive Loss &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Comprehensive loss is defined as the changes in equity of the Company during a period from transactions and other events and circumstances excluding transactions resulting from investments by owners and distributions to owners. For each of the periods presented, the Company&#x2019;s comprehensive loss includes net loss and foreign currency translation adjustments, which are presented in the consolidated statements of comprehensive loss. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%"&gt;(w) Share-Based Compensation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The Company grants share options and non-vested restricted shares to eligible employees, non-employees, and directors and accounts for these share-based awards in accordance with ASC 718, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%"&gt;Compensation-Stock Compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The Company estimates the fair value of stock options using the Black-Scholes option-pricing model. The grant-date fair value of non-vested restricted shares is the market value of the underlying stock on the award&#x2019;s grant date. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt; The Company has elected to use the straight-line method to recognize compensation expenses for share awards with graded vesting based on service conditions, subject to the minimum amount of cumulative compensation expense recognized is not less than the portion of the award vested to date. For share-based awards with service conditions only, the Company recognizes expenses (i) immediately at grant date if no vesting conditions are required; or (ii) using a straight-line method over the requisite service period, which is the vesting period, if vesting conditions are required. For share-based awards containing performance conditions, the Company recognizes expenses based on the estimated number of the performance-based awards expected to vest using the graded vesting attribution method. The Company accounts for the effect of forfeitures as they occur.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%"&gt;(x) Income Taxes &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Income tax expense includes (i) deferred tax expense, which generally represents the net change in the deferred tax asset or liability balance during the year plus any change in valuation allowances; (ii) current tax expense, which represents the amount of tax currently payable to or receivable from a taxing authority; and (iii) non-current tax expense, which represents the increases and decreases in amounts related to uncertain tax positions from prior periods and not settled with cash or other tax attributes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The Company recognizes deferred tax assets and liabilities for temporary differences between the financial statement and income tax bases of assets and liabilities, which are measured using enacted tax rates and laws that will be in effect when the differences are expected to reverse. A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The Company evaluates its uncertain tax positions using the provisions of ASC 740, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;, which requires that realization of an uncertain income tax position be recognized in the financial statements. The benefit to be recorded in the financial statements is the amount most likely to be realized assuming a review by tax authorities having all relevant information and applying current conventions. It is the Company&#x2019;s policy to recognize interest and penalties related to unrecognized tax benefits, if any, as a component of income tax expense. No unrecognized tax benefits and related interest and penalties were recorded in any of the periods presented. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%"&gt;(y) Loss Per Share &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Basic loss per ordinary share is computed by dividing net loss attributable to ordinary shareholders by weighted average number of ordinary shares outstanding during the period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Diluted loss per ordinary share reflects the potential dilution that could occur if securities were exercised or converted into ordinary shares. The Company had stock options and non-vested restricted shares, which could potentially dilute basic loss per share in the future. To calculate the number of shares for diluted loss per share, the effect of the stock options and non-vested restricted shares is computed using the treasury stock method. The computation of diluted loss per share does not assume exercise or conversion of securities that would have an anti-dilutive effect. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%"&gt;(z) Segment Information &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;In accordance with ASC 280, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%"&gt;Segment Reporting&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;, the Company&#x2019;s chief operating decision maker, the Chief Executive Officer, reviews the consolidated results when making decisions about allocating resources and assessing performance of the Company as a whole and therefore, the Company has only one operating and reportable segment.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%"&gt;(aa) Concentration of Risks&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%"&gt;Concentration of Customers &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;One customer accounted for 10% or more of revenue, with $59.4 million, $52.5 million, and $40.6 million in 2023, 2022, and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%"&gt;Concentration of Suppliers&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The following suppliers accounted for 10% or more of research and development expenses and inventory purchases ($ in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.142%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;E&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;165,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;F&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;66,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;*  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Represents less than 10% of research and development expenses and inventory purchases for the period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%"&gt;Concentration of Credit Risk &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Financial instruments that are potentially subject to significant concentration of credit risk consist of cash and cash equivalents, short-term investments, accounts receivable, and notes receivable. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The carrying amounts of cash and cash equivalents and short-term investments represent the maximum amount of loss due to credit risk. As of December&#160;31, 2023 and 2022, all of the Company&#x2019;s cash and cash equivalents and short-term investments were held by major financial institutions located in mainland China and international financial institutions outside of mainland China which management believes are of high credit quality and continually monitors the credit worthiness of these financial institutions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Accounts receivable are typically unsecured and are derived from product sales and collaborative arrangements. The Company manages credit risk of accounts receivable through ongoing monitoring of the outstanding balances and limits the amount of credit extended based upon payment history and credit worthiness. Historically, the Company has collected receivables from customers within the credit terms with no significant credit losses incurred. One customer accounted for 10% or more of accounts receivable, with $7.8 million and $9.3 million as of December&#160;31, 2023 and 2022, respectively.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Certain accounts receivable balances may be settled in the form of notes receivable. As of December&#160;31, 2023, notes receivable represented bank acceptance promissory notes that are non-interest bearing and due within six months. Notes receivable were used to collect the receivables based on an administrative convenience, given these notes are readily &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;convertible to be known amounts of cash. In accordance with the sales agreements, whether to use cash or bank acceptance promissory notes to settle the receivables is at the Company&#x2019;s discretion, and this selection does not impact the agreed contractual purchase prices. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%"&gt;Foreign Currency Risk &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;RMB is not a freely convertible currency. The State Administration of Foreign Exchange, under the authority of the People&#x2019;s Bank of China, controls the conversion of RMB into foreign currencies. The value of RMB is subject to changes in central government policies and to international economic and political developments affecting supply and demand in the China Foreign Exchange Trading System market. The cash and cash equivalents of the Company included aggregated amounts of $25.1 million and $45.5 million, which were denominated in RMB, as of December&#160;31, 2023 and 2022, respectively, representing 3% and 5% of the cash and cash equivalents as of December&#160;31, 2023 and 2022, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%"&gt;(ab) Recent Accounting Pronouncements &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;In December 2023, the FASB issued ASU No. 2023-09, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%"&gt;Improvements to Income Tax Disclosures &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;(Topic 740). The ASU requires disaggregated information about a reporting entity&#x2019;s effective tax rate reconciliation as well as additional information on income taxes paid. The ASU is effective on a prospective basis for annual periods beginning after December 15, 2024. Early adoption is permitted. This ASU will result in the required additional disclosures being included in the consolidated financial statements, once adopted. The Company is currently evaluating the impact of this ASU and expects to adopt it for the year ending December 31, 2025.&lt;/span&gt;&lt;/div&gt;The Company has not adopted any new accounting standards in 2023 that have a material impact on the Consolidated Financial Statements.</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c-1" id="f-465">Basis of Presentation &lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#x201c;U.S. GAAP&#x201d;). Significant accounting policies followed by the Company in the preparation of the accompanying consolidated financial statements are summarized below. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Effective as of March 30, 2022, the Company subdivided each of its issued and unissued ordinary shares into ten ordinary shares (the &#x201c;Share Subdivision&#x201d;). Following the Share Subdivision, the Company&#x2019;s authorized share capital became $30,000 divided into 5,000,000,000 shares with a par value of $0.000006 per share. The numbers of issued and unissued ordinary shares and per share data as disclosed elsewhere in these consolidated financial statements and notes thereto are presented on a basis after taking into account the effects of the Share Subdivision and have been retrospectively adjusted, where applicable. In connection with the Share Subdivision, the conversion ratio of its ADSs to ordinary shares changed from one ADS to one ordinary share to a new ratio of one ADS to ten ordinary shares (the &#x201c;ADS Ratio Change&#x201d;). The Share Subdivision and ADS Ratio Change did not result in any change to the number of outstanding ADSs of the Company. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt; In 2022, the Company began to separately present foreign currency (loss) gain on the consolidated statements of operations. This amount was previously included in other income (expense), net. Additionally, the Company began to provide a breakdown of other income (expense), net in Note 17.  The Company also began to separately present the amount of foreign currency remeasurement loss (gain) on the consolidated statements of cash flows. This amount was previously included in changes in other current liabilities. This change did not have any impact on net cash used in operating activities. Corresponding amounts in the prior periods of the consolidated financial statements have been presented to conform to the current period presentation.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:StockholdersEquityNoteStockSplitConversionRatio1
      contextRef="c-61"
      decimals="INF"
      id="f-466"
      unitRef="number">10</us-gaap:StockholdersEquityNoteStockSplitConversionRatio1>
    <zlab:CommonStockAuthorizedShareCapital contextRef="c-62" decimals="INF" id="f-467" unitRef="usd">30000</zlab:CommonStockAuthorizedShareCapital>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c-62"
      decimals="INF"
      id="f-468"
      unitRef="shares">5000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-62"
      decimals="INF"
      id="f-469"
      unitRef="usdPerShare">0.000006</us-gaap:CommonStockParOrStatedValuePerShare>
    <zlab:AmericanDepositaryShareToCommonStockConversionRatio
      contextRef="c-63"
      decimals="INF"
      id="f-470"
      unitRef="number">1</zlab:AmericanDepositaryShareToCommonStockConversionRatio>
    <zlab:AmericanDepositaryShareToCommonStockConversionRatio
      contextRef="c-61"
      decimals="INF"
      id="f-471"
      unitRef="number">10</zlab:AmericanDepositaryShareToCommonStockConversionRatio>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="c-1" id="f-472">Principles of Consolidation&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The consolidated financial statements include the accounts of Zai Lab Limited and its subsidiaries, which are wholly owned. All intercompany transactions and balances are eliminated upon consolidation.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="c-1" id="f-473">Use of Estimates The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Areas where management uses subjective judgment include, but are not limited to, accrual of rebates, recognition of research and development expenses to the appropriate financial reporting period based on actual services performed, fair value of share-based compensation expenses, and recoverability of deferred tax assets. These estimates, judgments, and assumptions can affect the reported amounts of assets and liabilities as of the date of the financial statements as well as the reported amounts of revenues and expenses during the periods presented. Actual results could differ from these estimates.</us-gaap:UseOfEstimates>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="c-1" id="f-474">Foreign Currency Translation &lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The functional currency of Zai Lab Limited, Zai Lab (Hong Kong) Limited, Zai Lab (US) LLC, and Zai Auto Immune (Hong Kong) Limited are the U.S. dollar (&#x201c;$&#x201d;). The Company&#x2019;s subsidiaries in mainland China determined their functional currency to be the Chinese Renminbi (&#x201c;RMB&#x201d;). The Company&#x2019;s subsidiary in Australia determined its &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;functional currency to be the Australian dollar (&#x201c;A$&#x201d;). The Company&#x2019;s subsidiary in Taiwan determined its functional currency to be the Taiwan dollar (&#x201c;TWD&#x201d;). The determination of the respective functional currency is based on the criteria of Accounting Standard Codification (&#x201c;ASC&#x201d;) 830, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%"&gt;Foreign Currency Matters&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;. The Company uses the U.S. dollar as its reporting currency. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Assets and liabilities are translated from each entity&#x2019;s functional currency to the reporting currency at the exchange rate on the balance sheet date. Equity amounts are translated at historical exchange rates. Revenues, expenses, gains, and losses are translated using the average rate for the period presented. The resulted foreign currency translation adjustments are recorded as a component of other comprehensive loss in the consolidated statements of comprehensive loss, and the accumulated foreign currency translation adjustments are recorded as a component of accumulated other comprehensive income (loss) in the consolidated statements of shareholders&#x2019; equity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Monetary assets and liabilities denominated in currencies other than the applicable functional currencies are translated into the functional currencies at the prevailing rates of exchange at the balance sheet date.&lt;/span&gt;&lt;/div&gt;Non-monetary assets and liabilities are translated into the applicable functional currencies at historical exchange rates. Transactions in currencies other than the applicable functional currencies during the year are converted into the functional currencies at the applicable rates of exchange prevailing at the transaction dates. Transaction gains and losses are recognized in the consolidated statements of operations.</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy contextRef="c-1" id="f-475">Cash, Cash Equivalents, and Restricted Cash &lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%"&gt;Cash and Cash Equivalents &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The Company considers all highly liquid investments purchased with original maturities of three months or less to be cash equivalents. Cash and cash equivalents consist primarily of cash on hand, demand deposits, and highly liquid investments with maturity of less than three months and are stated at cost, which approximates fair value. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%"&gt;Restricted Cash &lt;/span&gt;&lt;/div&gt;Restricted cash mainly consists of bank deposits held as collateral for issuances of letters of credit.</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <zlab:ShortTermInvestmentsPolicyPolicyTextBlock contextRef="c-1" id="f-476">Short-Term Investments Short-term investments are time deposits with original maturities between three months and one year. Short-term investments are stated at cost, which approximates fair value. Interest earned is included in interest income.</zlab:ShortTermInvestmentsPolicyPolicyTextBlock>
    <us-gaap:ReceivablesPolicyTextBlock contextRef="c-1" id="f-477">Accounts Receivable &lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The Company&#x2019;s accounts receivable arise from product sales and represent amounts due from its customers. From January 1, 2020, the Company adopted the ASU 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%"&gt;Credit Losses, Measurement of Credit Losses on Financial Instruments. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Accounts receivable are recorded at the amounts net of allowances for credit losses. The allowance for credit losses reflects the Company&#x2019;s current estimate of credit losses expected to be incurred over the life of the receivables. The Company considers various factors in establishing, monitoring, and adjusting its allowance for credit losses including the aging of receivables and aging trends, customer creditworthiness, and specific exposures related to particular customers. The Company also monitors other risk factors and forward-looking information, such as country-specific risks and economic factors that may affect a debtor&#x2019;s ability to pay in establishing and adjusting its allowance for credit losses. Accounts receivable are written off when deemed uncollectible.&lt;/span&gt;&lt;/div&gt;</us-gaap:ReceivablesPolicyTextBlock>
    <zlab:NotesReceivablePolicyTextBlock contextRef="c-1" id="f-478">Notes Receivable Notes receivable is equal to contractual amounts owed from signed, secured promissory notes issued from customers to the Company.</zlab:NotesReceivablePolicyTextBlock>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestCurrent contextRef="c-12" decimals="INF" id="f-479" unitRef="usd">0</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestCurrent>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestCurrent contextRef="c-13" decimals="INF" id="f-480" unitRef="usd">0</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestCurrent>
    <us-gaap:InventoryPolicyTextBlock contextRef="c-1" id="f-481">Inventories Inventories are stated at the lower of cost or net realizable value, with cost determined on a weighted average basis. The Company periodically reviews the composition of inventory and shelf life of inventory to identify obsolete, slow-moving, or otherwise non-saleable items. The Company will record a write-down to its net realizable value in cost of sales in the period that the decline in value is first identified.</us-gaap:InventoryPolicyTextBlock>
    <zlab:PrepaymentsForEquipmentPolicyPolicyTextBlock contextRef="c-1" id="f-482">Prepayments for Equipment The prepayments for equipment purchase are recorded in long-term prepayments considering the prepayments are all related to property and equipment.</zlab:PrepaymentsForEquipmentPolicyPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="c-1" id="f-483">Property and Equipment &lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Property and equipment are stated at cost, less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the respective assets as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.566%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:27.234%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Useful life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Office equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Electronic equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.25-3 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Vehicles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Laboratory equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Manufacturing equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;lesser of useful life or lease term&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Construction in progress represents property and equipment under construction and pending installation and is stated at cost less impairment losses, if any.</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <zlab:PropertyAndEquipmentEstimatedUsefulLivesTableTextBlock contextRef="c-1" id="f-484">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Property and equipment are stated at cost, less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the respective assets as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.566%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:27.234%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Useful life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Office equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Electronic equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.25-3 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Vehicles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Laboratory equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Manufacturing equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;lesser of useful life or lease term&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</zlab:PropertyAndEquipmentEstimatedUsefulLivesTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-64" id="f-485">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-65" id="f-486">P1Y3M</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-66" id="f-487">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-67" id="f-488">P4Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-68" id="f-489">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-69" id="f-490">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="c-1" id="f-491">Leases&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The Company leases facilities for its offices, research and development center, and manufacturing facilities in mainland China, Hong Kong, and the United States. On January 1, 2019, the Company adopted the ASC 842, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt; using the modified retrospective transition approach by applying the new standard to all leases existing at the date of initial application and not restating historical periods before the adoption date. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The Company assessed whether an arrangement contains a lease at inception. The Company&#x2019;s leases are all classified as operating leases with fixed lease payments, or minimum payments, as contractually stated in the lease agreements. The Company&#x2019;s leases do not contain any material residual value guarantees or material restrictive covenants.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Operating leases are included in operating lease right-of-use assets and operating lease liabilities in the consolidated balance sheets. Operating lease liabilities that become due within one year of the balance sheet date are classified as current operating lease liabilities. Operating lease expense is recognized on a straight-line basis over the lease term.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;At the commencement date of a lease, the Company recognizes a lease liability for future fixed lease payments and a right-of-use (&#x201c;ROU&#x201d;) asset representing the right to use the underlying asset during the lease term. The lease liability is initially measured as the present value of the future fixed lease payments that will be made over the lease term. The lease term includes periods for which the Company is reasonably certain that the renewal options will be exercised and the termination options will not be exercised. The Company uses its incremental borrowing rate based on the information available at the commencement date in determining the lease liabilities as the Company&#x2019;s leases generally do not provide an implicit rate. The incremental borrowing rate is reevaluated upon a lease modification. The Company considered information available at the adoption date of ASC 842 to determine the incremental borrowing rate for leases in existence as of this date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The ROU asset is measured at the amount of the lease liability with adjustments, if applicable, for lease prepayments made prior to or at lease commencement, initial direct costs incurred by the Company, and lease incentives. Under ASC 842, land use rights agreements are also considered to be operating lease contracts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The Company elected to apply each of the practical expedients described in ASC 842 which allow companies (i) not to reassess prior conclusions on whether any expired or existing contracts are or contain a lease, lease classification, and initial direct costs upon adoption of ASC 842, (ii) combine lease and non-lease components for all underlying assets groups, and (iii) not recognize ROU assets or lease liabilities for short term leases. A short-term lease is a lease that, at the commencement date, has a lease term of 12 months or less and does not include an option to purchase the underlying asset that the lessee is reasonably certain to exercise.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <zlab:LandUseRightsPolicyPolicyTextBlock contextRef="c-1" id="f-492">Land Use Rights &lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;All land in mainland China is subject to government or collective ownership. Land use rights can be purchased for a specified period of time. The purchase price of land use rights represents the operating lease prepayments under ASC 842 and is recorded as land use rights on the consolidated balance sheet, which is amortized over the remaining lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The Company acquired land use rights in 2019 for a term of 30 years from the local Bureau of Land and Resources in Suzhou for the purpose of constructing and operating the research center and biologics manufacturing facility in Suzhou. In 2023, the Company returned a portion of the land use rights and received cash in an amount equal to the respective portion of the original acquisition cost.&lt;/span&gt;&lt;/div&gt;</zlab:LandUseRightsPolicyPolicyTextBlock>
    <zlab:LandUseRightsLeaseTerm contextRef="c-70" id="f-493">P30Y</zlab:LandUseRightsLeaseTerm>
    <zlab:LongTermDepositsPolicyPolicyTextBlock contextRef="c-1" id="f-494">Long-Term Deposits Long-term deposits represent amounts paid in connection with the Company&#x2019;s long-term lease agreements.</zlab:LongTermDepositsPolicyPolicyTextBlock>
    <us-gaap:IntangibleAssetsFiniteLivedPolicy contextRef="c-1" id="f-495">Intangible Assets Intangible assets mainly consist of capitalized sales-based milestone fees and externally purchased software. Sales-based milestone fees are capitalized based on contract terms upon achievement of the sales levels and are amortized over the estimated remaining useful life of the related product, which is generally based on expected patent life, the contractual period of the underlying license agreement, and expected commercial benefits of the products. Externally purchased software are amortized over &lt;span style="-sec-ix-hidden:f-496"&gt;three&lt;/span&gt; to five years on a straight-line basis.</us-gaap:IntangibleAssetsFiniteLivedPolicy>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-72" id="f-497">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-73" decimals="-5" id="f-498" unitRef="usd">11200000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-74" decimals="-5" id="f-499" unitRef="usd">2200000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-75" decimals="-5" id="f-500" unitRef="usd">1500000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-1" decimals="-5" id="f-501" unitRef="usd">700000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-14" decimals="-5" id="f-502" unitRef="usd">500000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-11" decimals="-5" id="f-503" unitRef="usd">500000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths contextRef="c-12" decimals="-5" id="f-504" unitRef="usd">3100000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo contextRef="c-12" decimals="-5" id="f-505" unitRef="usd">2900000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree contextRef="c-12" decimals="-5" id="f-506" unitRef="usd">2700000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour contextRef="c-12" decimals="-5" id="f-507" unitRef="usd">2500000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive contextRef="c-12" decimals="-5" id="f-508" unitRef="usd">2300000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive contextRef="c-12" decimals="INF" id="f-509" unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="c-1" id="f-510">Impairment of Long-Lived Assets The Company evaluates long-lived assets, which includes intangible assets, tangible assets, and ROU assets for impairment whenever events or changes in circumstances indicate that the carrying value of these assets may not be recoverable. Recoverability of these assets is measured by comparison of the carrying amount of the related asset group to its future undiscounted cash flows. The Company measures the amount of impairment, if any, based on the difference between the carrying value and the estimated fair value of the impaired asset group.</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="c-1" id="f-511">Fair Value Measurements &lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The Company applies ASC topic 820 (&#x201c;ASC 820&#x201d;), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%"&gt;Fair Value Measurements and Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;, in measuring fair value. ASC 820 defines fair value, establishes a framework for measuring fair value, and requires disclosures to be provided on fair value measurement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;ASC 820 establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Level 1 &#x2014; Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Level 2 &#x2014; Include other inputs that are directly or indirectly observable in the marketplace. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Level 3 &#x2014; Unobservable inputs which are supported by little or no market activity. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;ASC 820 describes three main approaches to measuring the fair value of assets and liabilities: (i) market approach; (ii) income approach; and (iii) cost approach. The market approach uses prices and other relevant information generated from market transactions involving identical or comparable assets or liabilities. The income approach uses valuation techniques to convert future amounts to a single present value amount. The measurement is based on the value indicated by current market expectations about those future amounts. The cost approach is based on the amount that would currently be required to replace an asset. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Equity investments with readily determinable fair value are measured using level 1 inputs and were $9.2 million and $6.4 million as of December&#160;31, 2023 and 2022, respectively. The unrealized gains and losses from fair value changes are recognized in other income (expense), net in the consolidated statements of operations. &lt;/span&gt;&lt;/div&gt;Financial instruments of the Company primarily include cash, cash equivalents and restricted cash, short-term investments, accounts receivable, notes receivable, prepayments, and other current assets, accounts payable, and other current liabilities. As of December&#160;31, 2023 and 2022, the carrying values of cash and cash equivalents, short-term investments, accounts receivable, prepayments, and other current assets, accounts payable, and other current liabilities approximated their fair values due to the short-term maturity of these instruments, and the carrying value of notes receivable and restricted cash approximated their fair value based on the nature of the assessment of the ability to recover these amounts.</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <zlab:EquitySecuritiesWithReadilyDeterminableFairValueAmount contextRef="c-76" decimals="-5" id="f-512" unitRef="usd">9200000</zlab:EquitySecuritiesWithReadilyDeterminableFairValueAmount>
    <zlab:EquitySecuritiesWithReadilyDeterminableFairValueAmount contextRef="c-77" decimals="-5" id="f-513" unitRef="usd">6400000</zlab:EquitySecuritiesWithReadilyDeterminableFairValueAmount>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="c-1" id="f-514">Revenue Recognition&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;In 2018, the Company adopted ASC Topic 606 (&#x201c;ASC 606&#x201d;), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;. Under ASC 606, the Company recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration expected to be received in exchange for those goods or services. To determine revenue recognition for arrangements that the Company determines are within the scope of ASC 606, the Company performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price, including variable consideration, if any; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the Company satisfies a performance &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;obligation. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration to which it is entitled in exchange for the goods or services it transfers to the customer. Once a contract is determined to be within the scope of ASC 606 at contract inception, the Company reviews the contract to determine which performance obligations it must deliver and which of these performance obligations are distinct. The Company recognizes as revenue the amount of the transaction price that is allocated to each performance obligation when that performance obligation is satisfied or as it is satisfied.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The Company&#x2019;s revenue is mainly from product sales. The Company recognizes revenue from product sales when the Company has satisfied the performance obligation by transferring control of the product to the customers. Control of the product generally transfers to the customers when the delivery is made and when title and risk of loss transfers to the consumers. Cost of sales mainly consists of the acquisition cost of products, the manufacturing cost of products, royalty fees, and amortization of sales-based milestone payments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The Company has applied the practical expedients under ASC 606 with regard to assessment of financing component and concluded that there is no significant financing component given that the period between delivery of goods and payment is generally one year or less. The Company&#x2019;s product revenues were mainly generated from the sale of ZEJULA (niraparib), OPTUNE (Tumor Treating Fields), QINLOCK (ripretinib), NUZYRA (omadacycline), and VYVGART (efgartigimod) to customers. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;In mainland China, the Company sells the products to distributors, who ultimately sell the products to health care providers. Based on the nature of the arrangements, the performance obligations are satisfied upon the delivery of the products to distributors. Rebates are offered to distributors, consistent with pharmaceutical industry practices. The estimated amount of unpaid or unbilled rebates are recorded as a reduction of revenue, if any. Estimated rebates are determined based on contracted rates and sales volumes and to a lesser extent, distributor inventories. The Company regularly reviews the information related to these estimates and adjusts the amount accordingly. &lt;/span&gt;&lt;/div&gt;In Hong Kong, the Company sells the products to customers, which are typically healthcare providers such as oncology centers. The Company utilizes a third party for warehousing services. Based on the nature of the arrangements, the Company has determined that it is a principal in the transaction since the Company is primarily responsible for fulfilling the promise to provide the products to the customers, maintains inventory risk until delivery to the customers, and has latitude in establishing the price. Revenue was recognized at the amount to which the Company expected to be entitled in exchange for the sale of the products, which is the sales price agreed with the customers. Consideration paid to the third party is recognized in operating expenses.</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:CollaborativeArrangementAccountingPolicy contextRef="c-1" id="f-515">Collaborative Arrangements &lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The Company analyzes its collaboration arrangements to assess whether such arrangements involve joint operating activities performed by parties that are both active participants in the activities and exposed to significant risks and rewards dependent on the commercial success of such activities and therefore within the scope of ASC Topic 808, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%"&gt;Collaborative Arrangements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt; (ASC 808). This assessment is performed throughout the life of the arrangement based on changes in the responsibilities of all parties in the arrangement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;For collaboration arrangements within the scope of ASC 808 that contain multiple elements, the Company first determines which elements of the collaboration are deemed to be within the scope of ASC 808 and which elements of the collaboration are more reflective of a vendor-customer relationship and therefore within the scope of ASC 606. For &lt;/span&gt;&lt;/div&gt;elements of collaboration arrangements that are accounted pursuant to ASC 808, an appropriate recognition method is determined and applied consistently.</us-gaap:CollaborativeArrangementAccountingPolicy>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="c-1" id="f-516">Research and Development Expenses &lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Elements of research and development expenses primarily include (i) payroll and other related costs of personnel engaged in research and development activities; (ii) in-licensed patent rights fees of exclusive development rights of products granted to the Company; (iii) costs related to pre-clinical testing of the Company&#x2019;s technologies under development and clinical trials such as payments to contract research organizations (&#x201c;CROs&#x201d;) and contract manufacturing organizations (&#x201c;CMOs&#x201d;), investigators, and clinical trial sites that conduct its clinical studies; (iv) costs to develop the product candidates, including raw materials and supplies, product testing, depreciation, and facility-related expenses; and (v) other research and development expenses. Research and development expenses are charged to expense as incurred and have no alternative future uses. Liabilities related to third-party research and development expenses are primarily included in accounts payable on the consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;The Company has acquired rights to develop and commercialize product candidates. Upfront payments that relate to the acquisition of a new product compound, as well as pre-commercial milestone payments, are immediately expensed as acquired in-process research and development in the period in which they are incurred, provided that the new product compound did not also include processes or activities that would constitute a &#x201c;business&#x201d; as defined under U.S. GAAP. Milestone payments made to third parties subsequent to regulatory approval which meet the capitalization criteria would be capitalized as intangible assets and amortized over the estimated remaining useful life of the related product, which is generally based on expected patent life, the contractual period of the underlying license agreement, and expected commercial benefits of the products.</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <zlab:DeferredIncomePolicyTextBlock contextRef="c-1" id="f-517">Deferred Income &lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Deferred income mainly consists of deferred income from government grants and the upfront payments received from Huizheng.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Government grants consist of cash subsidies received by the Company&#x2019;s subsidiaries in mainland China from local governments. Grants received as incentives for conducting business in certain local districts with no performance obligation or other restriction as to the use are recognized as other income when cash is received. Grants received with government specified performance obligations are recognized as other income when all the obligations have been fulfilled. If such obligations are not satisfied, the Company may be required to refund the subsidy. The grant received before the fulfillment of specified performance obligation is recorded in deferred income. The Company had $2.1 million and $0.9 million of government grants in deferred income as of December&#160;31, 2023 and 2022, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;In March 2020, the Company entered into an exclusive promotion agreement with Huizheng so that the Company could leverage Hanhui&#x2019;s infrastructure to optimize an anticipated future commercial launch of NUZYRA in mainland China. In exchange for exclusive promotion rights in mainland China, Huizheng agreed to pay the Company non-creditable upfront payments of RMB230.0 million, of which RMB90.0 million was paid in April 2020, RMB70.0 million in 2022, and RMB70.0 million in 2023. The Company is amortizing the upfront payments through the end of the contract term. The Company had $26.7 million and $20.5 million in deferred income related to the upfront payments as of December&#160;31, 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;</zlab:DeferredIncomePolicyTextBlock>
    <us-gaap:DeferredIncomeNoncurrent contextRef="c-78" decimals="-5" id="f-518" unitRef="usd">2100000</us-gaap:DeferredIncomeNoncurrent>
    <us-gaap:DeferredIncomeNoncurrent contextRef="c-79" decimals="-5" id="f-519" unitRef="usd">900000</us-gaap:DeferredIncomeNoncurrent>
    <zlab:CollaborativeArrangementRightsAndObligationsPaymentOfUpFrontFeesForLicenseAgreement contextRef="c-80" decimals="-5" id="f-520" unitRef="cny">230000000</zlab:CollaborativeArrangementRightsAndObligationsPaymentOfUpFrontFeesForLicenseAgreement>
    <zlab:CollaborativeArrangementRightsAndObligationsPaymentOfUpFrontFeesForLicenseAgreement contextRef="c-81" decimals="-5" id="f-521" unitRef="cny">90000000</zlab:CollaborativeArrangementRightsAndObligationsPaymentOfUpFrontFeesForLicenseAgreement>
    <zlab:CollaborativeArrangementRightsAndObligationsPaymentOfUpFrontFeesForLicenseAgreement contextRef="c-82" decimals="-5" id="f-522" unitRef="cny">70000000</zlab:CollaborativeArrangementRightsAndObligationsPaymentOfUpFrontFeesForLicenseAgreement>
    <zlab:CollaborativeArrangementRightsAndObligationsPaymentOfUpFrontFeesForLicenseAgreement contextRef="c-83" decimals="-5" id="f-523" unitRef="cny">70000000</zlab:CollaborativeArrangementRightsAndObligationsPaymentOfUpFrontFeesForLicenseAgreement>
    <us-gaap:DeferredIncomeNoncurrent contextRef="c-84" decimals="-5" id="f-524" unitRef="usd">26700000</us-gaap:DeferredIncomeNoncurrent>
    <us-gaap:DeferredIncomeNoncurrent contextRef="c-85" decimals="-5" id="f-525" unitRef="usd">20500000</us-gaap:DeferredIncomeNoncurrent>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock contextRef="c-1" id="f-526">Comprehensive Loss Comprehensive loss is defined as the changes in equity of the Company during a period from transactions and other events and circumstances excluding transactions resulting from investments by owners and distributions to owners. For each of the periods presented, the Company&#x2019;s comprehensive loss includes net loss and foreign currency translation adjustments, which are presented in the consolidated statements of comprehensive loss.</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:CompensationRelatedCostsPolicyTextBlock contextRef="c-1" id="f-527">Share-Based Compensation &lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The Company grants share options and non-vested restricted shares to eligible employees, non-employees, and directors and accounts for these share-based awards in accordance with ASC 718, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%"&gt;Compensation-Stock Compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The Company estimates the fair value of stock options using the Black-Scholes option-pricing model. The grant-date fair value of non-vested restricted shares is the market value of the underlying stock on the award&#x2019;s grant date. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt; The Company has elected to use the straight-line method to recognize compensation expenses for share awards with graded vesting based on service conditions, subject to the minimum amount of cumulative compensation expense recognized is not less than the portion of the award vested to date. For share-based awards with service conditions only, the Company recognizes expenses (i) immediately at grant date if no vesting conditions are required; or (ii) using a straight-line method over the requisite service period, which is the vesting period, if vesting conditions are required. For share-based awards containing performance conditions, the Company recognizes expenses based on the estimated number of the performance-based awards expected to vest using the graded vesting attribution method. The Company accounts for the effect of forfeitures as they occur.&lt;/span&gt;&lt;/div&gt;</us-gaap:CompensationRelatedCostsPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="c-1" id="f-528">Income Taxes &lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Income tax expense includes (i) deferred tax expense, which generally represents the net change in the deferred tax asset or liability balance during the year plus any change in valuation allowances; (ii) current tax expense, which represents the amount of tax currently payable to or receivable from a taxing authority; and (iii) non-current tax expense, which represents the increases and decreases in amounts related to uncertain tax positions from prior periods and not settled with cash or other tax attributes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The Company recognizes deferred tax assets and liabilities for temporary differences between the financial statement and income tax bases of assets and liabilities, which are measured using enacted tax rates and laws that will be in effect when the differences are expected to reverse. A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized. &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The Company evaluates its uncertain tax positions using the provisions of ASC 740, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%"&gt;Income Taxes&lt;/span&gt;, which requires that realization of an uncertain income tax position be recognized in the financial statements. The benefit to be recorded in the financial statements is the amount most likely to be realized assuming a review by tax authorities having all relevant information and applying current conventions. It is the Company&#x2019;s policy to recognize interest and penalties related to unrecognized tax benefits, if any, as a component of income tax expense.</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense contextRef="c-14" decimals="INF" id="f-529" unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense contextRef="c-1" decimals="INF" id="f-530" unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense contextRef="c-11" decimals="INF" id="f-531" unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="c-1" id="f-532">Loss Per Share &lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Basic loss per ordinary share is computed by dividing net loss attributable to ordinary shareholders by weighted average number of ordinary shares outstanding during the period. &lt;/span&gt;&lt;/div&gt;Diluted loss per ordinary share reflects the potential dilution that could occur if securities were exercised or converted into ordinary shares. The Company had stock options and non-vested restricted shares, which could potentially dilute basic loss per share in the future. To calculate the number of shares for diluted loss per share, the effect of the stock options and non-vested restricted shares is computed using the treasury stock method. The computation of diluted loss per share does not assume exercise or conversion of securities that would have an anti-dilutive effect.</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="c-1" id="f-533">Segment Information &lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;In accordance with ASC 280, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%"&gt;Segment Reporting&lt;/span&gt;, the Company&#x2019;s chief operating decision maker, the Chief Executive Officer, reviews the consolidated results when making decisions about allocating resources and assessing performance of the Company as a whole and therefore, the Company has only one operating and reportable segment.</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="c-1"
      decimals="INF"
      id="f-534"
      unitRef="segment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:NumberOfOperatingSegments
      contextRef="c-1"
      decimals="INF"
      id="f-535"
      unitRef="segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-86" decimals="-5" id="f-536" unitRef="usd">59400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-87" decimals="-5" id="f-537" unitRef="usd">52500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-88" decimals="-5" id="f-538" unitRef="usd">40600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:FairValueConcentrationOfRiskTextBlock contextRef="c-1" id="f-539">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The following suppliers accounted for 10% or more of research and development expenses and inventory purchases ($ in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.142%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;E&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;165,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;F&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;66,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;*  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Represents less than 10% of research and development expenses and inventory purchases for the period.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueConcentrationOfRiskTextBlock>
    <zlab:ResearchAndDevelopmentExpensesAndTheInventoryPurchases contextRef="c-89" decimals="-3" id="f-540" unitRef="usd">165431000</zlab:ResearchAndDevelopmentExpensesAndTheInventoryPurchases>
    <zlab:ResearchAndDevelopmentExpensesAndTheInventoryPurchases contextRef="c-90" decimals="-3" id="f-541" unitRef="usd">66650000</zlab:ResearchAndDevelopmentExpensesAndTheInventoryPurchases>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="c-1" id="f-542">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%"&gt;Concentration of Credit Risk &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Financial instruments that are potentially subject to significant concentration of credit risk consist of cash and cash equivalents, short-term investments, accounts receivable, and notes receivable. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The carrying amounts of cash and cash equivalents and short-term investments represent the maximum amount of loss due to credit risk. As of December&#160;31, 2023 and 2022, all of the Company&#x2019;s cash and cash equivalents and short-term investments were held by major financial institutions located in mainland China and international financial institutions outside of mainland China which management believes are of high credit quality and continually monitors the credit worthiness of these financial institutions.&lt;/span&gt;&lt;/div&gt;Accounts receivable are typically unsecured and are derived from product sales and collaborative arrangements. The Company manages credit risk of accounts receivable through ongoing monitoring of the outstanding balances and limits the amount of credit extended based upon payment history and credit worthiness. Historically, the Company has collected receivables from customers within the credit terms with no significant credit losses incurred. &lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Certain accounts receivable balances may be settled in the form of notes receivable. As of December&#160;31, 2023, notes receivable represented bank acceptance promissory notes that are non-interest bearing and due within six months. Notes receivable were used to collect the receivables based on an administrative convenience, given these notes are readily &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;convertible to be known amounts of cash. In accordance with the sales agreements, whether to use cash or bank acceptance promissory notes to settle the receivables is at the Company&#x2019;s discretion, and this selection does not impact the agreed contractual purchase prices. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%"&gt;Foreign Currency Risk &lt;/span&gt;&lt;/div&gt;RMB is not a freely convertible currency. The State Administration of Foreign Exchange, under the authority of the People&#x2019;s Bank of China, controls the conversion of RMB into foreign currencies. The value of RMB is subject to changes in central government policies and to international economic and political developments affecting supply and demand in the China Foreign Exchange Trading System market.</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:AccountsReceivableNet contextRef="c-91" decimals="-5" id="f-543" unitRef="usd">7800000</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet contextRef="c-92" decimals="-5" id="f-544" unitRef="usd">9300000</us-gaap:AccountsReceivableNet>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-93" decimals="-5" id="f-545" unitRef="usd">25100000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-94" decimals="-5" id="f-546" unitRef="usd">45500000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-95" decimals="2" id="f-547" unitRef="number">0.03</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-96" decimals="2" id="f-548" unitRef="number">0.05</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c-1" id="f-549">Recent Accounting Pronouncements &lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;In December 2023, the FASB issued ASU No. 2023-09, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%"&gt;Improvements to Income Tax Disclosures &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;(Topic 740). The ASU requires disaggregated information about a reporting entity&#x2019;s effective tax rate reconciliation as well as additional information on income taxes paid. The ASU is effective on a prospective basis for annual periods beginning after December 15, 2024. Early adoption is permitted. This ASU will result in the required additional disclosures being included in the consolidated financial statements, once adopted. The Company is currently evaluating the impact of this ASU and expects to adopt it for the year ending December 31, 2025.&lt;/span&gt;&lt;/div&gt;The Company has not adopted any new accounting standards in 2023 that have a material impact on the Consolidated Financial Statements.</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsDisclosureTextBlock contextRef="c-1" id="f-550">Cash and Cash Equivalents &lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The following table presents the Company&#x2019;s cash and cash equivalents ($ in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;789,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,007,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents (i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;790,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,008,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Denominated in:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;762,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;957,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;RMB (ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;25,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;45,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Hong Kong dollar (&#x201c;HK$&#x201d;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Australian dollar (&#x201c;A$&#x201d;)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Taiwan dollar (&#x201c;TW$&#x201d;)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;790,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,008,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:17.57pt"&gt;Cash equivalents represent short-term and highly liquid investments in a money market fund. &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(ii)&lt;/span&gt;Certain cash and bank balances denominated in RMB were deposited with banks in mainland China. The conversion of these RMB denominated balances into foreign currencies is subject to the rules and regulations of foreign exchange control promulgated by the Chinese government.</us-gaap:CashAndCashEquivalentsDisclosureTextBlock>
    <us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock contextRef="c-1" id="f-551">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The following table presents the Company&#x2019;s cash and cash equivalents ($ in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;789,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,007,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents (i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;790,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,008,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Denominated in:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;762,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;957,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;RMB (ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;25,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;45,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Hong Kong dollar (&#x201c;HK$&#x201d;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Australian dollar (&#x201c;A$&#x201d;)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Taiwan dollar (&#x201c;TW$&#x201d;)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;790,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,008,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:17.57pt"&gt;Cash equivalents represent short-term and highly liquid investments in a money market fund. &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(ii)&lt;/span&gt;Certain cash and bank balances denominated in RMB were deposited with banks in mainland China. The conversion of these RMB denominated balances into foreign currencies is subject to the rules and regulations of foreign exchange control promulgated by the Chinese government.</us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock>
    <us-gaap:Cash contextRef="c-12" decimals="-3" id="f-552" unitRef="usd">789051000</us-gaap:Cash>
    <us-gaap:Cash contextRef="c-13" decimals="-3" id="f-553" unitRef="usd">1007423000</us-gaap:Cash>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-12" decimals="-3" id="f-554" unitRef="usd">1100000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-13" decimals="-3" id="f-555" unitRef="usd">1047000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-12" decimals="-3" id="f-556" unitRef="usd">790151000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-13" decimals="-3" id="f-557" unitRef="usd">1008470000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-97" decimals="-3" id="f-558" unitRef="usd">762436000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-98" decimals="-3" id="f-559" unitRef="usd">957824000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-99" decimals="-3" id="f-560" unitRef="usd">25093000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-100" decimals="-3" id="f-561" unitRef="usd">45486000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-101" decimals="-3" id="f-562" unitRef="usd">1974000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-102" decimals="-3" id="f-563" unitRef="usd">4378000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-103" decimals="-3" id="f-564" unitRef="usd">587000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-104" decimals="-3" id="f-565" unitRef="usd">598000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-105" decimals="-3" id="f-566" unitRef="usd">61000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-106" decimals="-3" id="f-567" unitRef="usd">184000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-12" decimals="-3" id="f-568" unitRef="usd">790151000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-13" decimals="-3" id="f-569" unitRef="usd">1008470000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <zlab:RestrictedCashNonCurrentTextBlock contextRef="c-1" id="f-570">Restricted Cash, Non-Current&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The Company&#x2019;s restricted cash balance were $1.1 million and $0.8 million as of December&#160;31, 2023 and 2022, respectively, and consisted of long-term bank deposits held as collateral for issuance of letters of credit. These deposits will be released when the related letters of credit are settled by the Company.&lt;/span&gt;&lt;/div&gt;</zlab:RestrictedCashNonCurrentTextBlock>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-12" decimals="-5" id="f-571" unitRef="usd">1100000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-13" decimals="-5" id="f-572" unitRef="usd">800000</us-gaap:RestrictedCashNoncurrent>
    <zlab:ShortTermInvestmentTextBlock contextRef="c-1" id="f-573">Short-Term InvestmentsShort-term investments are primarily comprised of time deposits with original maturities between three months and one year. The short-term investments balance were $16.3 million and nil as of December&#160;31, 2023 and 2022, respectively. No allowance for credit loss was recorded as of December 31, 2023.</zlab:ShortTermInvestmentTextBlock>
    <us-gaap:MaturityOfTimeDeposits contextRef="c-107" id="f-574">P3M</us-gaap:MaturityOfTimeDeposits>
    <us-gaap:MaturityOfTimeDeposits contextRef="c-108" id="f-575">P1Y</us-gaap:MaturityOfTimeDeposits>
    <us-gaap:ShortTermInvestments contextRef="c-12" decimals="-3" id="f-576" unitRef="usd">16300000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments contextRef="c-13" decimals="INF" id="f-577" unitRef="usd">0</us-gaap:ShortTermInvestments>
    <us-gaap:DebtSecuritiesHeldToMaturityAllowanceForCreditLossExcludingAccruedInterest contextRef="c-12" decimals="INF" id="f-578" unitRef="usd">0</us-gaap:DebtSecuritiesHeldToMaturityAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:InventoryDisclosureTextBlock contextRef="c-1" id="f-579">Inventories, Net&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The following table presents the Company&#x2019;s inventories, net ($ in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;22,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;12,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;17,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;19,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Work in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;44,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;31,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The Company writes down inventory for any excess or obsolete inventories or when the Company believes that the net realizable value of inventories is less than the carrying value. The Company recorded write-downs in inventory, which were included in cost of sales of $1.0 million, $0.5 million, and $1.4 million in 2023, 2022, and 2021, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="c-1" id="f-580">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The following table presents the Company&#x2019;s inventories, net ($ in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;22,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;12,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;17,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;19,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Work in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;44,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;31,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryFinishedGoodsNetOfReserves contextRef="c-12" decimals="-3" id="f-581" unitRef="usd">22702000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves contextRef="c-13" decimals="-3" id="f-582" unitRef="usd">12156000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves contextRef="c-12" decimals="-3" id="f-583" unitRef="usd">17655000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves contextRef="c-13" decimals="-3" id="f-584" unitRef="usd">19029000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves contextRef="c-12" decimals="-3" id="f-585" unitRef="usd">4470000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves contextRef="c-13" decimals="-3" id="f-586" unitRef="usd">436000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryNet contextRef="c-12" decimals="-3" id="f-587" unitRef="usd">44827000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="c-13" decimals="-3" id="f-588" unitRef="usd">31621000</us-gaap:InventoryNet>
    <us-gaap:ProductionRelatedImpairmentsOrCharges contextRef="c-1" decimals="-5" id="f-589" unitRef="usd">1000000.0</us-gaap:ProductionRelatedImpairmentsOrCharges>
    <us-gaap:ProductionRelatedImpairmentsOrCharges contextRef="c-14" decimals="-5" id="f-590" unitRef="usd">500000</us-gaap:ProductionRelatedImpairmentsOrCharges>
    <us-gaap:ProductionRelatedImpairmentsOrCharges contextRef="c-11" decimals="-5" id="f-591" unitRef="usd">1400000</us-gaap:ProductionRelatedImpairmentsOrCharges>
    <us-gaap:InvestmentTextBlock contextRef="c-1" id="f-592">Long-Term Investments In July 2021, the Company made an equity investment in MacroGenics Inc. (&#x201c;MacroGenics&#x201d;), a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer, in a private placement with total contributions of $30,000 and obtained 958,467 newly issued common shares of MacroGenics at $31.30 per share. The Company recorded this investment at acquisition cost and subsequently measured it at fair value, with the changes in fair value recognized in other income (expenses), net in the consolidated statements of operations. The equity investments with readily determinable fair value are measured using level 1 inputs and were $9.2 million and $6.4 million as of December&#160;31, 2023 and 2022, respectively. The Company recognized a fair value gain of $2.8 million in 2023, and losses of $9.0 million and $14.6 million in 2022 and 2021, respectively.</us-gaap:InvestmentTextBlock>
    <zlab:CapitalContributionsCommitment contextRef="c-109" decimals="-3" id="f-593" unitRef="usd">30000000</zlab:CapitalContributionsCommitment>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="c-110"
      decimals="INF"
      id="f-594"
      unitRef="shares">958467</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c-111"
      decimals="2"
      id="f-595"
      unitRef="usdPerShare">31.30</us-gaap:SharesIssuedPricePerShare>
    <zlab:EquitySecuritiesWithReadilyDeterminableFairValueAmount contextRef="c-76" decimals="-5" id="f-596" unitRef="usd">9200000</zlab:EquitySecuritiesWithReadilyDeterminableFairValueAmount>
    <zlab:EquitySecuritiesWithReadilyDeterminableFairValueAmount contextRef="c-77" decimals="-5" id="f-597" unitRef="usd">6400000</zlab:EquitySecuritiesWithReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesFvNiGainLoss contextRef="c-112" decimals="-5" id="f-598" unitRef="usd">2800000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss contextRef="c-113" decimals="-5" id="f-599" unitRef="usd">-9000000.0</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss contextRef="c-114" decimals="-5" id="f-600" unitRef="usd">-14600000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="c-1" id="f-601">Property and Equipment, Net &lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The following table presents the components of the Company&#x2019;s property and equipment, net ($ in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Office equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Electronic equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;9,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Vehicle&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Laboratory equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;20,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;18,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Manufacturing equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;17,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;17,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;11,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;11,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;24,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;24,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;83,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;79,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(30,136)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(22,064)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;53,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;57,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Depreciation expense was $8.4 million, $7.7 million, and $6.0 million for 2023, 2022, and 2021, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="c-1" id="f-602">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The following table presents the components of the Company&#x2019;s property and equipment, net ($ in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Office equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Electronic equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;9,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Vehicle&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Laboratory equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;20,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;18,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Manufacturing equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;17,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;17,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;11,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;11,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;24,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;24,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;83,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;79,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(30,136)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(22,064)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;53,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;57,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-64" decimals="-3" id="f-603" unitRef="usd">1047000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-115" decimals="-3" id="f-604" unitRef="usd">977000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-116" decimals="-3" id="f-605" unitRef="usd">9161000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-117" decimals="-3" id="f-606" unitRef="usd">7416000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-67" decimals="-3" id="f-607" unitRef="usd">199000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-118" decimals="-3" id="f-608" unitRef="usd">202000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-68" decimals="-3" id="f-609" unitRef="usd">20140000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-119" decimals="-3" id="f-610" unitRef="usd">18726000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-120" decimals="-3" id="f-611" unitRef="usd">17680000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-121" decimals="-3" id="f-612" unitRef="usd">17055000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-122" decimals="-3" id="f-613" unitRef="usd">11371000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-123" decimals="-3" id="f-614" unitRef="usd">11300000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-124" decimals="-3" id="f-615" unitRef="usd">24272000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-125" decimals="-3" id="f-616" unitRef="usd">24251000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-12" decimals="-3" id="f-617" unitRef="usd">83870000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-13" decimals="-3" id="f-618" unitRef="usd">79927000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c-12" decimals="-3" id="f-619" unitRef="usd">30136000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c-13" decimals="-3" id="f-620" unitRef="usd">22064000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-12" decimals="-3" id="f-621" unitRef="usd">53734000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-13" decimals="-3" id="f-622" unitRef="usd">57863000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation contextRef="c-1" decimals="-5" id="f-623" unitRef="usd">8400000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-14" decimals="-5" id="f-624" unitRef="usd">7700000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-11" decimals="-5" id="f-625" unitRef="usd">6000000.0</us-gaap:Depreciation>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="c-1" id="f-626">Leases&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The Company leases facilities for its offices, research and development center, and manufacturing facilities in mainland China, Hong Kong, Taiwan, and the United States. Lease terms vary based on the nature of operations and market dynamics; however, all leased facilities are classified as operating leases with remaining lease terms between &lt;span style="-sec-ix-hidden:f-627"&gt;one&lt;/span&gt; and five years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The following table presents operating lease costs ($ in thousands). Total lease expense related to short-term leases was insignificant for those periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.142%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Operating fixed lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents operating cash flows related to leases ($ in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.142%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash paid for amounts included in measurement of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Non-cash operating lease liabilities arising from obtaining operating right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The maturities of lease liabilities in accordance with ASC Topic 842, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt; in each of the next five years and thereafter were as follows ($ in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:81.778%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.022%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Year Ended&lt;br/&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;15,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(460)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Present value of minimum operating lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;15,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Weighted-average remaining lease terms and discount rates are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:69.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.962%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Weighted-average remaining lease term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2.5 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2.6 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm contextRef="c-108" id="f-628">P5Y</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <zlab:SupplementalInformationRelatedToLeasesTableTableTextBlock contextRef="c-1" id="f-629">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The following table presents operating lease costs ($ in thousands). Total lease expense related to short-term leases was insignificant for those periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.142%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Operating fixed lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</zlab:SupplementalInformationRelatedToLeasesTableTableTextBlock>
    <us-gaap:OperatingLeaseCost contextRef="c-1" decimals="-3" id="f-630" unitRef="usd">8691000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c-14" decimals="-3" id="f-631" unitRef="usd">8774000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c-11" decimals="-3" id="f-632" unitRef="usd">6263000</us-gaap:OperatingLeaseCost>
    <us-gaap:LeaseCostTableTextBlock contextRef="c-1" id="f-633">&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents operating cash flows related to leases ($ in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.142%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash paid for amounts included in measurement of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Non-cash operating lease liabilities arising from obtaining operating right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeasePayments contextRef="c-1" decimals="-3" id="f-634" unitRef="usd">9317000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments contextRef="c-14" decimals="-3" id="f-635" unitRef="usd">8084000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments contextRef="c-11" decimals="-3" id="f-636" unitRef="usd">5840000</us-gaap:OperatingLeasePayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-1" decimals="-3" id="f-637" unitRef="usd">3668000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-14" decimals="-3" id="f-638" unitRef="usd">14801000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-11" decimals="-3" id="f-639" unitRef="usd">2183000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="c-1" id="f-640">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The maturities of lease liabilities in accordance with ASC Topic 842, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt; in each of the next five years and thereafter were as follows ($ in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:81.778%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.022%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Year Ended&lt;br/&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;15,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(460)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Present value of minimum operating lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;15,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c-12" decimals="-3" id="f-641" unitRef="usd">7444000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="c-12" decimals="-3" id="f-642" unitRef="usd">5143000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree contextRef="c-12" decimals="-3" id="f-643" unitRef="usd">1811000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour contextRef="c-12" decimals="-3" id="f-644" unitRef="usd">822000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive contextRef="c-12" decimals="-3" id="f-645" unitRef="usd">391000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive contextRef="c-12" decimals="-3" id="f-646" unitRef="usd">0</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="c-12" decimals="-3" id="f-647" unitRef="usd">15611000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="c-12" decimals="-3" id="f-648" unitRef="usd">460000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability contextRef="c-12" decimals="-3" id="f-649" unitRef="usd">15151000</us-gaap:OperatingLeaseLiability>
    <zlab:SummaryOfWeightedAverageRemainingLeaseTermsAndDiscountRatesTableTextBlock contextRef="c-1" id="f-650">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Weighted-average remaining lease terms and discount rates are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:69.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.962%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Weighted-average remaining lease term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2.5 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2.6 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</zlab:SummaryOfWeightedAverageRemainingLeaseTermsAndDiscountRatesTableTextBlock>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-12" id="f-651">P2Y6M</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-13" id="f-652">P2Y7M6D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-12" decimals="3" id="f-653" unitRef="number">0.030</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-13" decimals="3" id="f-654" unitRef="number">0.034</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:RevenueFromContractWithCustomerTextBlock contextRef="c-1" id="f-655">Revenue&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:139%"&gt; &lt;/span&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%"&gt;Product Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The Company&#x2019;s product revenue is derived from the sales of its commercial products primarily in mainland China. The table below presents the Company&#x2019;s net product revenue ($ in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.142%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Product revenue &#x2014; gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;298,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;234,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;190,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Less: Rebates and sales returns&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(32,192)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(21,337)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(46,075)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Product revenue &#x2014; net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;266,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;212,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;144,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Sales rebates are offered to distributors in mainland China, and the amounts are recorded as a reduction of revenue. Estimated rebates are determined based on contracted rates, sales volumes, and level of distributor inventories. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The following table presents the Company&#x2019;s net revenue by product ($ in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.142%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;ZEJULA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;168,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;145,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;93,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;OPTUNE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;46,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;47,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;38,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;QINLOCK&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;19,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;14,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;11,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;NUZYRA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;21,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;VYVGART&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;10,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Product revenue &#x2014; net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;266,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;212,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;144,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <zlab:NetRevenueTableTextBlock contextRef="c-1" id="f-656">The table below presents the Company&#x2019;s net product revenue ($ in thousands):&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.142%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Product revenue &#x2014; gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;298,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;234,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;190,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Less: Rebates and sales returns&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(32,192)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(21,337)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(46,075)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Product revenue &#x2014; net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;266,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;212,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;144,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</zlab:NetRevenueTableTextBlock>
    <zlab:RevenueFromContractWithCustomersExcludingAssessedTaxBeforeAdjustmentsForRebatesAndSalesReturns contextRef="c-1" decimals="-3" id="f-657" unitRef="usd">298911000</zlab:RevenueFromContractWithCustomersExcludingAssessedTaxBeforeAdjustmentsForRebatesAndSalesReturns>
    <zlab:RevenueFromContractWithCustomersExcludingAssessedTaxBeforeAdjustmentsForRebatesAndSalesReturns contextRef="c-14" decimals="-3" id="f-658" unitRef="usd">234009000</zlab:RevenueFromContractWithCustomersExcludingAssessedTaxBeforeAdjustmentsForRebatesAndSalesReturns>
    <zlab:RevenueFromContractWithCustomersExcludingAssessedTaxBeforeAdjustmentsForRebatesAndSalesReturns contextRef="c-11" decimals="-3" id="f-659" unitRef="usd">190180000</zlab:RevenueFromContractWithCustomersExcludingAssessedTaxBeforeAdjustmentsForRebatesAndSalesReturns>
    <zlab:RevenueFromContractWithCustomersExcludingAssessedTaxAdjustmentsForRebatesAndSalesReturns contextRef="c-1" decimals="-3" id="f-660" unitRef="usd">32192000</zlab:RevenueFromContractWithCustomersExcludingAssessedTaxAdjustmentsForRebatesAndSalesReturns>
    <zlab:RevenueFromContractWithCustomersExcludingAssessedTaxAdjustmentsForRebatesAndSalesReturns contextRef="c-14" decimals="-3" id="f-661" unitRef="usd">21337000</zlab:RevenueFromContractWithCustomersExcludingAssessedTaxAdjustmentsForRebatesAndSalesReturns>
    <zlab:RevenueFromContractWithCustomersExcludingAssessedTaxAdjustmentsForRebatesAndSalesReturns contextRef="c-11" decimals="-3" id="f-662" unitRef="usd">46075000</zlab:RevenueFromContractWithCustomersExcludingAssessedTaxAdjustmentsForRebatesAndSalesReturns>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-3" id="f-663" unitRef="usd">266719000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-14" decimals="-3" id="f-664" unitRef="usd">212672000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-11" decimals="-3" id="f-665" unitRef="usd">144105000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="c-1" id="f-666">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The following table presents the Company&#x2019;s net revenue by product ($ in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.142%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;ZEJULA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;168,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;145,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;93,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;OPTUNE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;46,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;47,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;38,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;QINLOCK&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;19,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;14,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;11,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;NUZYRA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;21,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;VYVGART&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;10,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Product revenue &#x2014; net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;266,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;212,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;144,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-126" decimals="-3" id="f-667" unitRef="usd">168843000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-127" decimals="-3" id="f-668" unitRef="usd">145194000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-128" decimals="-3" id="f-669" unitRef="usd">93579000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-129" decimals="-3" id="f-670" unitRef="usd">46969000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-130" decimals="-3" id="f-671" unitRef="usd">47321000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-131" decimals="-3" id="f-672" unitRef="usd">38903000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-132" decimals="-3" id="f-673" unitRef="usd">19240000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-133" decimals="-3" id="f-674" unitRef="usd">14957000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-134" decimals="-3" id="f-675" unitRef="usd">11620000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-135" decimals="-3" id="f-676" unitRef="usd">21656000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-136" decimals="-3" id="f-677" unitRef="usd">5200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-137" decimals="-3" id="f-678" unitRef="usd">3000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-138" decimals="-3" id="f-679" unitRef="usd">10011000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-139" decimals="-3" id="f-680" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-140" decimals="-3" id="f-681" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-3" id="f-682" unitRef="usd">266719000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-14" decimals="-3" id="f-683" unitRef="usd">212672000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-11" decimals="-3" id="f-684" unitRef="usd">144105000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c-1" id="f-685">Income Tax&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%"&gt;Cayman Islands &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Zai Lab Limited, ZLIP Holding Limited, Zai Auto Immune Limited, and Zai Anti Infectives Limited are incorporated in the Cayman Islands. Under the current laws of the Cayman Islands, Zai Lab Limited, ZLIP Holding Limited, Zai Auto Immune Limited, and Zai Anti Infectives Limited are not subject to tax on income or capital gain. Additionally, the Cayman Islands does not impose a withholding tax on payments of dividends to shareholders. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%"&gt;British Virgin Islands Taxation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;ZL Capital Limited is incorporated in the British Virgin Islands. Under the current laws of the British Virgin Islands, ZL Capital Limited is not subject to income tax. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%"&gt;Australia &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Zai Lab (AUST) Pty. Ltd. is incorporated in Australia and is subject to corporate income tax at a rate of 30%. Zai Lab (AUST) Pty. Ltd. had no taxable income for the periods presented; therefore, no provision for income taxes is required. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%"&gt;United States &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Zai Lab (US) LLC is incorporated in the United States and is subject to U.S. federal corporate income tax at a rate of 21%. Zai Lab (US) LLC is also subject to state income tax in Delaware. Zai Lab (US) LLC had no taxable income for the periods presented; therefore, no provision for income taxes is required. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%"&gt;Taiwan &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Zai Lab (Taiwan) Limited is incorporated in Taiwan and is subject to corporate income tax at a rate of 20%. Zai Lab (Taiwan) Limited had no taxable income for the periods presented; therefore, no provision for income taxes is required. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%"&gt;Hong Kong &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Zai Lab (Hong Kong) Limited, ZL China Holding Two Limited, Zai Auto Immune (Hong Kong) Limited, and Zai Anti Infectives (Hong Kong) Limited are incorporated in Hong Kong. Companies registered in Hong Kong are subject to Hong Kong profits tax on the taxable income as reported in their respective statutory financial statements adjusted in accordance with relevant Hong Kong tax laws. Under the two-tiered profits tax rates regime in Hong Kong, the first HK$2 million of profits of the qualifying group entity will be taxed at 8.25%, and profits above HK$2 million will be taxed at &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;16.5%. In 2023, 2022, and 2021, Zai Lab (Hong Kong) Limited, ZL China Holding Two Limited, Zai Auto Immune (Hong Kong) Limited, and Zai Anti Infectives (Hong Kong) Limited did not make any provisions for Hong Kong profit tax as there were no assessable profits derived from or earned in Hong Kong for any of the periods presented. Under the Hong Kong tax law, Zai Lab (Hong Kong) Limited, ZL China Holding Two Limited, Zai Auto Immune (Hong Kong) Limited, and Zai Anti Infectives (Hong Kong) Limited are exempted from income tax on its foreign-derived income, and there are no withholding taxes in Hong Kong on remittance of dividends. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%"&gt;People&#x2019;s Republic of China&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Under EIT Law, the statutory income tax rate is 25%, and the EIT rate will be reduced to 15% for state-encouraged High and New Technology Enterprises (&#x201c;HNTE&#x201d;). Zai Lab (Shanghai) Co., Ltd., first obtained a HNTE certificate in 2018 and began to enjoy the preferential tax rate of 15% from 2018 to 2020 and further extended the certificate in 2021 effective for 2021 to 2023. Zai Lab International Trading (Shanghai) Co., Ltd., Zai Lab (Suzhou) Co., Ltd., Zai Biopharmaceutical (Suzhou) Co., Ltd., and Zai Lab Trading (Suzhou) Co., Ltd. are subject to the statutory rate of 25%. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;No provision for income taxes has been required to be accrued because the Company is in a cumulative loss position for the periods presented. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The following table presents loss (income) before income taxes ($ in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.142%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cayman Islands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(16,792)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;19,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;28,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;British Virgin Islands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Mainland China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;253,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;290,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;340,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Hong Kong&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;53,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;243,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;92,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;79,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;89,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Australia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(260)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Taiwan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;334,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;443,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;704,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Reconciliations of the differences between the Chinese statutory income tax rate and the Company&#x2019;s effective income tax rate are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.142%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Statutory income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Tax-exempted income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development super deduction&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Non-deductible expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(5.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior year tax filing adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effect of different tax rate of subsidiary operation in other jurisdictions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Preferential tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(7.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expiration of deductible qualified donation &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(23.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(21.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(10.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effective income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The following table presents the principal components of deferred tax assets and liabilities ($ in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.232%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.932%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation of property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and experimental capitalization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;30,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;22,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Government grants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Qualified donation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;22,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net operating loss carry forwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;295,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;241,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(357,956)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(284,072)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total Deferred tax assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2,826)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3,738)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;ASC 740,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%"&gt; Income Taxes,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt; provides for the recognition of deferred tax assets if realization of such assets is more likely than not. The Company&#x2019;s ability to realize deferred tax assets depends on its ability to generate sufficient taxable income within the carry forward periods provided for in the tax law. In assessing the need for any additional valuation allowance for 2023, the Company considered all available evidence both positive and negative, including potential for prudent and feasible tax planning strategies, recent losses, and forecasts of future profitability. As of December&#160;31, 2023 and 2022, the Company determined that the deferred tax assets on temporary differences and net operating loss carry forwards related to certain subsidiaries will not be realized, and as such it has fully provided the corresponding valuation allowance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The following table presents that movement of the valuation allowance on deferred tax assets ($ in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Balance as of January 1,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(284,072)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(189,684)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(73,884)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(94,388)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Balance as of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(357,956)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(284,072)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;As of December&#160;31, 2023 and 2022, the Company had net operating loss carry forwards of $1,804.9 million and $1,483.2 million, respectively. As of December&#160;31, 2023, net operating loss carryforwards related to the Company&#x2019;s subsidiaries in mainland China, Hong Kong, Taiwan, the United States, and Australia and were $1,492.0 million, $51.0 million, $2.1 million, $256.0 million, and $3.8 million, respectively. Net operating loss carryforwards in mainland China and Taiwan expire through 2033 and those in Hong Kong, the United States, and Australia do not expire.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Uncertainties exist with respect to how the current income tax law in mainland China applies to the Company&#x2019;s overall operations, and more specifically, with regard to tax residency status. The EIT Law includes a provision specifying that legal entities organized outside of mainland China will be considered residents for Chinese income tax purposes if the place of effective management or control is within mainland China. The implementation rules to the EIT Law provide that non-resident legal entities will be considered Chinese residents if substantial and overall management and control over the manufacturing and business operations, personnel, accounting, and properties occurs within mainland China. Despite the present uncertainties resulting from the limited Chinese tax guidance on the issue, the Company does not believe that the legal entities organized outside of mainland China within the Company should be treated as residents for EIT Law purposes. If the Chinese tax authorities subsequently determine that the Company and its subsidiaries registered outside of mainland China should be deemed resident enterprises, the Company and its subsidiaries registered outside of mainland China will be subject to Chinese income taxes, at a rate of 25%. The Company is not subject to any other uncertain tax position. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;According to the PRC Tax Administration and Collection Law, the statute of limitation is three years if the underpayment of taxes is due to computational errors made by the taxpayer or the withholding agent. The statute of limitation is extended to five years under special circumstances where the underpayment of taxes is more than RMB0.1 million. In the case of transfer pricing issues, the statute of limitation is 10 years. There is no statute of limitation in the case of tax evasion. The income tax returns of the Company&#x2019;s PRC subsidiary for the years from 2014 to 2023 are open to examination by the PRC tax authorities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;For Hong Kong income tax purposes, the statute of limitations is six years after the relevant year of assessment. This can be extended to 10 years in the case of fraud of willful evasion of taxes. There are no provisions that govern the time limit for tax collection.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;For U.S. federal income tax purposes, the statute of limitations is generally 3 years after the due date of the return, or 3 years after the date the return was actually filed, whichever is later. The statute of limitations does not apply to fraud or tax evasion. Also, the statute of limitations is indefinite if no tax return is filed. For state income tax purpose, the statute of limitations is generally 4 years from the return filing date or due date for California, Kentucky, and New Jersey, subject to certain exceptions (e.g., fraud, failure to file).&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-141" decimals="INF" id="f-686" unitRef="usd">0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-141" decimals="INF" id="f-687" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-142" decimals="INF" id="f-688" unitRef="usd">0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-142" decimals="INF" id="f-689" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-143" decimals="INF" id="f-690" unitRef="usd">0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-143" decimals="INF" id="f-691" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-144" decimals="INF" id="f-692" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-145" decimals="INF" id="f-693" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-146" decimals="INF" id="f-694" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-144" decimals="INF" id="f-695" unitRef="usd">0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-145" decimals="INF" id="f-696" unitRef="usd">0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-146" decimals="INF" id="f-697" unitRef="usd">0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <zlab:WithholdingTaxesRemittanceOfDividends contextRef="c-144" decimals="INF" id="f-698" unitRef="usd">0</zlab:WithholdingTaxesRemittanceOfDividends>
    <zlab:WithholdingTaxesRemittanceOfDividends contextRef="c-146" decimals="INF" id="f-699" unitRef="usd">0</zlab:WithholdingTaxesRemittanceOfDividends>
    <zlab:WithholdingTaxesRemittanceOfDividends contextRef="c-145" decimals="INF" id="f-700" unitRef="usd">0</zlab:WithholdingTaxesRemittanceOfDividends>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="INF" id="f-701" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-14" decimals="INF" id="f-702" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-11" decimals="INF" id="f-703" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock contextRef="c-1" id="f-704">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The following table presents loss (income) before income taxes ($ in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.142%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cayman Islands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(16,792)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;19,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;28,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;British Virgin Islands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Mainland China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;253,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;290,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;340,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Hong Kong&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;53,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;243,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;92,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;79,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;89,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Australia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(260)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Taiwan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;334,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;443,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;704,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-147" decimals="-3" id="f-705" unitRef="usd">16792000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-148" decimals="-3" id="f-706" unitRef="usd">-19454000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-149" decimals="-3" id="f-707" unitRef="usd">-28401000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-150" decimals="-3" id="f-708" unitRef="usd">0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-151" decimals="-3" id="f-709" unitRef="usd">-2000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-152" decimals="-3" id="f-710" unitRef="usd">-2000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-153" decimals="-3" id="f-711" unitRef="usd">-253274000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-154" decimals="-3" id="f-712" unitRef="usd">-290056000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-155" decimals="-3" id="f-713" unitRef="usd">-340865000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-156" decimals="-3" id="f-714" unitRef="usd">-4483000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-157" decimals="-3" id="f-715" unitRef="usd">-53425000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-158" decimals="-3" id="f-716" unitRef="usd">-243400000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-159" decimals="-3" id="f-717" unitRef="usd">-92869000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-160" decimals="-3" id="f-718" unitRef="usd">-79620000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-161" decimals="-3" id="f-719" unitRef="usd">-89374000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-162" decimals="-3" id="f-720" unitRef="usd">-14000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-163" decimals="-3" id="f-721" unitRef="usd">260000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-164" decimals="-3" id="f-722" unitRef="usd">-1758000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-165" decimals="-3" id="f-723" unitRef="usd">-772000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-166" decimals="-3" id="f-724" unitRef="usd">-989000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-167" decimals="-3" id="f-725" unitRef="usd">-671000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-726" unitRef="usd">-334620000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-14" decimals="-3" id="f-727" unitRef="usd">-443286000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-11" decimals="-3" id="f-728" unitRef="usd">-704471000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="c-1" id="f-729">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Reconciliations of the differences between the Chinese statutory income tax rate and the Company&#x2019;s effective income tax rate are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.142%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Statutory income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Tax-exempted income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development super deduction&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Non-deductible expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(5.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior year tax filing adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effect of different tax rate of subsidiary operation in other jurisdictions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Preferential tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(7.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expiration of deductible qualified donation &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(23.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(21.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(10.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effective income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="c-153"
      decimals="INF"
      id="f-730"
      unitRef="number">0.25</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="c-154"
      decimals="INF"
      id="f-731"
      unitRef="number">0.25</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="c-155"
      decimals="INF"
      id="f-732"
      unitRef="number">0.25</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxExemptIncome contextRef="c-153" decimals="4" id="f-733" unitRef="number">-0.0019</us-gaap:EffectiveIncomeTaxRateReconciliationTaxExemptIncome>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxExemptIncome contextRef="c-154" decimals="4" id="f-734" unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationTaxExemptIncome>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxExemptIncome contextRef="c-155" decimals="4" id="f-735" unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationTaxExemptIncome>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="c-153" decimals="4" id="f-736" unitRef="number">-0.0208</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="c-154" decimals="4" id="f-737" unitRef="number">-0.0140</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="c-155" decimals="4" id="f-738" unitRef="number">-0.0092</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch contextRef="c-153" decimals="4" id="f-739" unitRef="number">-0.0711</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch contextRef="c-154" decimals="4" id="f-740" unitRef="number">-0.0251</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch contextRef="c-155" decimals="4" id="f-741" unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense contextRef="c-153" decimals="4" id="f-742" unitRef="number">-0.0283</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense contextRef="c-154" decimals="4" id="f-743" unitRef="number">-0.0231</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense contextRef="c-155" decimals="4" id="f-744" unitRef="number">-0.0578</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes contextRef="c-153" decimals="4" id="f-745" unitRef="number">0.0132</us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes contextRef="c-154" decimals="4" id="f-746" unitRef="number">0.0633</us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes contextRef="c-155" decimals="4" id="f-747" unitRef="number">0.0150</us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential contextRef="c-153" decimals="4" id="f-748" unitRef="number">0.0002</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential contextRef="c-154" decimals="4" id="f-749" unitRef="number">-0.0285</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential contextRef="c-155" decimals="4" id="f-750" unitRef="number">-0.0460</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <zlab:EffectiveIncomeTaxRateReconciliationAtPreferentialTaxRate contextRef="c-153" decimals="4" id="f-751" unitRef="number">-0.0712</zlab:EffectiveIncomeTaxRateReconciliationAtPreferentialTaxRate>
    <zlab:EffectiveIncomeTaxRateReconciliationAtPreferentialTaxRate contextRef="c-154" decimals="4" id="f-752" unitRef="number">-0.0626</zlab:EffectiveIncomeTaxRateReconciliationAtPreferentialTaxRate>
    <zlab:EffectiveIncomeTaxRateReconciliationAtPreferentialTaxRate contextRef="c-155" decimals="4" id="f-753" unitRef="number">-0.0430</zlab:EffectiveIncomeTaxRateReconciliationAtPreferentialTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCharitableContributions contextRef="c-153" decimals="4" id="f-754" unitRef="number">0.0228</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCharitableContributions>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCharitableContributions contextRef="c-154" decimals="4" id="f-755" unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCharitableContributions>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCharitableContributions contextRef="c-155" decimals="4" id="f-756" unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCharitableContributions>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c-153" decimals="4" id="f-757" unitRef="number">-0.2389</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c-154" decimals="4" id="f-758" unitRef="number">-0.2102</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c-155" decimals="4" id="f-759" unitRef="number">-0.1090</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-153" decimals="4" id="f-760" unitRef="number">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-154" decimals="4" id="f-761" unitRef="number">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-155" decimals="4" id="f-762" unitRef="number">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="c-1" id="f-763">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The following table presents the principal components of deferred tax assets and liabilities ($ in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.232%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.932%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation of property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and experimental capitalization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;30,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;22,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Government grants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Qualified donation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;22,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net operating loss carry forwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;295,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;241,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(357,956)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(284,072)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total Deferred tax assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2,826)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3,738)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment contextRef="c-12" decimals="-3" id="f-764" unitRef="usd">131000</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment contextRef="c-13" decimals="-3" id="f-765" unitRef="usd">98000</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <zlab:DeferredTaxAssetsResearchAndExperimentalCapitalization contextRef="c-12" decimals="-3" id="f-766" unitRef="usd">30429000</zlab:DeferredTaxAssetsResearchAndExperimentalCapitalization>
    <zlab:DeferredTaxAssetsResearchAndExperimentalCapitalization contextRef="c-13" decimals="-3" id="f-767" unitRef="usd">22476000</zlab:DeferredTaxAssetsResearchAndExperimentalCapitalization>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="c-12" decimals="-3" id="f-768" unitRef="usd">3422000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="c-13" decimals="-3" id="f-769" unitRef="usd">1787000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities contextRef="c-12" decimals="-3" id="f-770" unitRef="usd">707000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities contextRef="c-13" decimals="-3" id="f-771" unitRef="usd">1800000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <zlab:DeferredTaxAssetsGovernmentGrants contextRef="c-12" decimals="-3" id="f-772" unitRef="usd">467000</zlab:DeferredTaxAssetsGovernmentGrants>
    <zlab:DeferredTaxAssetsGovernmentGrants contextRef="c-13" decimals="-3" id="f-773" unitRef="usd">189000</zlab:DeferredTaxAssetsGovernmentGrants>
    <zlab:DeferredTaxAssetsDeferredRevenue contextRef="c-12" decimals="-3" id="f-774" unitRef="usd">4354000</zlab:DeferredTaxAssetsDeferredRevenue>
    <zlab:DeferredTaxAssetsDeferredRevenue contextRef="c-13" decimals="-3" id="f-775" unitRef="usd">3378000</zlab:DeferredTaxAssetsDeferredRevenue>
    <zlab:DeferredTaxAssetsPublicWelfareDonations contextRef="c-12" decimals="-3" id="f-776" unitRef="usd">22992000</zlab:DeferredTaxAssetsPublicWelfareDonations>
    <zlab:DeferredTaxAssetsPublicWelfareDonations contextRef="c-13" decimals="-3" id="f-777" unitRef="usd">12947000</zlab:DeferredTaxAssetsPublicWelfareDonations>
    <zlab:DeferredTaxAssetsLeasingArrangements contextRef="c-12" decimals="-3" id="f-778" unitRef="usd">2967000</zlab:DeferredTaxAssetsLeasingArrangements>
    <zlab:DeferredTaxAssetsLeasingArrangements contextRef="c-13" decimals="-3" id="f-779" unitRef="usd">3738000</zlab:DeferredTaxAssetsLeasingArrangements>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c-12" decimals="-3" id="f-780" unitRef="usd">295313000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c-13" decimals="-3" id="f-781" unitRef="usd">241397000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-12" decimals="-3" id="f-782" unitRef="usd">357956000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-13" decimals="-3" id="f-783" unitRef="usd">284072000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet contextRef="c-12" decimals="-3" id="f-784" unitRef="usd">2826000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet contextRef="c-13" decimals="-3" id="f-785" unitRef="usd">3738000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements contextRef="c-12" decimals="-3" id="f-786" unitRef="usd">2826000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements contextRef="c-13" decimals="-3" id="f-787" unitRef="usd">3738000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="c-12" decimals="-3" id="f-788" unitRef="usd">0</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="c-13" decimals="-3" id="f-789" unitRef="usd">0</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:SummaryOfValuationAllowanceTextBlock contextRef="c-1" id="f-790">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The following table presents that movement of the valuation allowance on deferred tax assets ($ in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Balance as of January 1,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(284,072)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(189,684)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(73,884)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(94,388)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Balance as of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(357,956)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(284,072)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SummaryOfValuationAllowanceTextBlock>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-13" decimals="-3" id="f-791" unitRef="usd">284072000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-30" decimals="-3" id="f-792" unitRef="usd">189684000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="c-1" decimals="-3" id="f-793" unitRef="usd">73884000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="c-14" decimals="-3" id="f-794" unitRef="usd">94388000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-12" decimals="-3" id="f-795" unitRef="usd">357956000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-13" decimals="-3" id="f-796" unitRef="usd">284072000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:OperatingLossCarryforwards contextRef="c-12" decimals="-5" id="f-797" unitRef="usd">1804900000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c-13" decimals="-5" id="f-798" unitRef="usd">1483200000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c-168" decimals="-5" id="f-799" unitRef="usd">1492000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c-169" decimals="-5" id="f-800" unitRef="usd">51000000.0</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c-170" decimals="-5" id="f-801" unitRef="usd">2100000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c-171" decimals="-5" id="f-802" unitRef="usd">256000000.0</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c-172" decimals="-5" id="f-803" unitRef="usd">3800000</us-gaap:OperatingLossCarryforwards>
    <zlab:OtherCurrentLiabilitiesDisclosureTextBlock contextRef="c-1" id="f-804">Other Current Liabilities &lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The following table presents the Company&#x2019;s other current liabilities ($ in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued payroll&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;33,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;31,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued professional service fee&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Payables for purchase of property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued rebate to distributors&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Tax payables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Others (i)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;82,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;66,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(i)&lt;/span&gt;Others mainly include accrued travel, business-related expenses, and other payables to employee.</zlab:OtherCurrentLiabilitiesDisclosureTextBlock>
    <us-gaap:OtherCurrentLiabilitiesTableTextBlock contextRef="c-1" id="f-805">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The following table presents the Company&#x2019;s other current liabilities ($ in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued payroll&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;33,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;31,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued professional service fee&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Payables for purchase of property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued rebate to distributors&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Tax payables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Others (i)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;82,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;66,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(i)&lt;/span&gt;Others mainly include accrued travel, business-related expenses, and other payables to employee.</us-gaap:OtherCurrentLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-12" decimals="-3" id="f-806" unitRef="usd">33711000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-13" decimals="-3" id="f-807" unitRef="usd">31689000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="c-12" decimals="-3" id="f-808" unitRef="usd">7520000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="c-13" decimals="-3" id="f-809" unitRef="usd">4080000</us-gaap:AccruedProfessionalFeesCurrent>
    <zlab:PayablesForPurchaseOfPropertyAndEquipmentCurrent contextRef="c-12" decimals="-3" id="f-810" unitRef="usd">2474000</zlab:PayablesForPurchaseOfPropertyAndEquipmentCurrent>
    <zlab:PayablesForPurchaseOfPropertyAndEquipmentCurrent contextRef="c-13" decimals="-3" id="f-811" unitRef="usd">5269000</zlab:PayablesForPurchaseOfPropertyAndEquipmentCurrent>
    <zlab:AccruedRebateToDistributorsCurrent contextRef="c-12" decimals="-3" id="f-812" unitRef="usd">16926000</zlab:AccruedRebateToDistributorsCurrent>
    <zlab:AccruedRebateToDistributorsCurrent contextRef="c-13" decimals="-3" id="f-813" unitRef="usd">8443000</zlab:AccruedRebateToDistributorsCurrent>
    <us-gaap:TaxesPayableCurrentAndNoncurrent contextRef="c-12" decimals="-3" id="f-814" unitRef="usd">16988000</us-gaap:TaxesPayableCurrentAndNoncurrent>
    <us-gaap:TaxesPayableCurrentAndNoncurrent contextRef="c-13" decimals="-3" id="f-815" unitRef="usd">13283000</us-gaap:TaxesPayableCurrentAndNoncurrent>
    <zlab:OtherPayablesCurrentLiabilities contextRef="c-12" decimals="-3" id="f-816" unitRef="usd">5353000</zlab:OtherPayablesCurrentLiabilities>
    <zlab:OtherPayablesCurrentLiabilities contextRef="c-13" decimals="-3" id="f-817" unitRef="usd">4054000</zlab:OtherPayablesCurrentLiabilities>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c-12" decimals="-3" id="f-818" unitRef="usd">82972000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c-13" decimals="-3" id="f-819" unitRef="usd">66818000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:EarningsPerShareTextBlock contextRef="c-1" id="f-820">Loss Per Share &lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The following table presents the computation of the basic and diluted net loss per share ($ in thousands, except share and per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.142%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net loss attributable to ordinary shareholders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(334,620)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(443,286)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(704,471)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average number of ordinary shares - basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;966,394,130&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;958,067,140&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;929,921,120&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net loss per share-basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;As a result of the Company&#x2019;s net loss for 2023, 2022, and 2021, share options and non-vested restricted shares outstanding in the respective periods were excluded from the calculation of diluted loss per share as their inclusion would have been anti-dilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.142%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;104,584,050&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;91,181,420&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;81,015,590&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Non-vested restricted shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;31,279,600&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;33,433,890&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9,567,360&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c-1" id="f-821">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The following table presents the computation of the basic and diluted net loss per share ($ in thousands, except share and per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.142%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net loss attributable to ordinary shareholders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(334,620)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(443,286)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(704,471)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average number of ordinary shares - basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;966,394,130&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;958,067,140&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;929,921,120&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net loss per share-basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted contextRef="c-1" decimals="-3" id="f-822" unitRef="usd">-334620000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c-1" decimals="-3" id="f-823" unitRef="usd">-334620000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c-14" decimals="-3" id="f-824" unitRef="usd">-443286000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted contextRef="c-14" decimals="-3" id="f-825" unitRef="usd">-443286000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted contextRef="c-11" decimals="-3" id="f-826" unitRef="usd">-704471000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c-11" decimals="-3" id="f-827" unitRef="usd">-704471000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="0" id="f-828" unitRef="shares">966394130</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="0" id="f-829" unitRef="shares">966394130</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-14" decimals="0" id="f-830" unitRef="shares">958067140</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-14" decimals="0" id="f-831" unitRef="shares">958067140</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-11" decimals="0" id="f-832" unitRef="shares">929921120</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-11" decimals="0" id="f-833" unitRef="shares">929921120</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-834"
      unitRef="usdPerShare">-0.35</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-835"
      unitRef="usdPerShare">-0.35</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-14"
      decimals="2"
      id="f-836"
      unitRef="usdPerShare">-0.46</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-14"
      decimals="2"
      id="f-837"
      unitRef="usdPerShare">-0.46</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-11"
      decimals="2"
      id="f-838"
      unitRef="usdPerShare">-0.76</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-11"
      decimals="2"
      id="f-839"
      unitRef="usdPerShare">-0.76</us-gaap:EarningsPerShareBasic>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="c-1" id="f-840">&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.142%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;104,584,050&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;91,181,420&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;81,015,590&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Non-vested restricted shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;31,279,600&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;33,433,890&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9,567,360&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-173" decimals="0" id="f-841" unitRef="shares">104584050</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-174" decimals="0" id="f-842" unitRef="shares">91181420</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-175" decimals="0" id="f-843" unitRef="shares">81015590</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-176" decimals="0" id="f-844" unitRef="shares">31279600</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-177" decimals="0" id="f-845" unitRef="shares">33433890</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-178" decimals="0" id="f-846" unitRef="shares">9567360</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="c-1" id="f-847">Related Party Transactions &lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The Company incurred research and development expenses for product research and development services provided by MEDx (Suzhou) Translational Medicine Co., Ltd (&#x201c;MEDx&#x201d;), over which an immediate family member of its Chief Executive Officer and Chairperson of the Board held significant influence. The Company incurred development expenses with MEDx of insignificant amount in 2023, and $0.4 million and $0.7 million in 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-179" decimals="-5" id="f-848" unitRef="usd">400000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-180" decimals="-5" id="f-849" unitRef="usd">700000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="c-1" id="f-851">Share-Based Compensation &lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The Company has adopted equity incentive plans, pursuant to which the Company grants share options, SARs, restricted and unrestricted shares, and share units, performance awards, and other awards that are convertible into or otherwise based on ordinary shares to employees and directors of the Company as well as to certain advisors and service providers. In March 2015, the Board of Directors of the Company approved such an Equity Incentive Plan (the &#x201c;2015 Plan&#x201d;). In August 2017, in connection with the completion of the Company&#x2019;s initial public offering on Nasdaq (the &#x201c;IPO&#x201d;), the Board of Directors approved the 2017 Equity Incentive Plan (the &#x201c;2017 Plan&#x201d;). No new equity-based awards would be granted under the 2015 Plan subsequent to the IPO; new equity-based awards would be granted under the 2017 Plan. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The Company adopted the 2022 Equity Incentive Plan (the &#x201c;2022 Plan&#x201d;), which became effective in June 2022 following required approvals from the Company&#x2019;s shareholders and Board of Directors. No new equity-based awards will be made under the 2017 Plan as of the effective date of the 2022 Plan. The initial aggregate number of shares available for issuance under the 2022 Plan was 97,908,743 ordinary shares. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt; The share options granted under the equity incentive plans described above have a contractual term of ten years. Share options granted since April 2023 generally vest ratably over a four-year period, and share options granted prior to April 2023 generally vest ratably over a five-year period, with 25% or 20% of the awards vesting on each anniversary of the grant date, respectively, subject to continued employment/service with the Company on the vesting date. The restricted shares granted generally vest ratably over a specified period on the anniversary of the grant date, subject to continued employment/service with the Company on the vesting date. The shares underlying restricted share grants represent shares not yet vested until they have met related consideration or vesting requirements, which are generally continued employment/service to the Company or satisfaction of specified performance conditions. The restricted shares will be released from the restrictions once they vest. Upon termination of the award holders&#x2019; service with the Company for any reason, any shares that are outstanding and not yet vested will be immediately forfeited unless otherwise set forth in an agreement between the Company and the award holder.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Before November 2023, upon each settlement date of the share awards, shares were generally withheld to cover the required withholding tax, which was based on the value of a share on the settlement date as determined by the closing price of the ADSs on the trading day of the applicable settlement date. The remaining shares after the withholding were delivered to the recipient. The amount remitted to the tax authorities for employee tax obligations was reflected as a financing activity on the consolidated statements of cash flows. These shares withheld by the Company as a result of the net settlement were accounted for as treasury stock and considered issued but not outstanding. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%"&gt;Stock Option Activity&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The following table presents a summary of option activity and related information in 2023: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.354%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.085%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Number of&lt;br/&gt;options &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Weighted&lt;br/&gt;average exercise&lt;br/&gt;price&lt;br/&gt;($)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Weighted&lt;br/&gt;average&lt;br/&gt;remaining&lt;br/&gt;contractual term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Aggregate&lt;br/&gt;intrinsic value &lt;br/&gt;($ in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outstanding at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;91,181,420&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.89&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;115,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;24,102,740&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6,516,920)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4,183,190)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outstanding at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;104,584,050&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.97&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;83,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Vested and exercisable as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;58,695,320&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.93&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;83,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The aggregate intrinsic value of stock options exercised during 2023, 2022, and 2021 was $20.3 million, $14.3 million, and $170.4 million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%"&gt;Stock Option Valuation Assumptions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The following table presents the assumptions used to estimate the fair values of the share options granted: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:55.415%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.993%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Risk-free rate of return&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.5%-4.7%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.4%-4.0%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.9%-1.4%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6, 6.25,or 6.5&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.5 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6, 6.25 or 6.5&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Estimated volatility rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;70%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;65%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;65%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected dividend rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Options granted are measured based on grant-date fair value using the Black-Scholes option pricing model. The weighted-average grant-date fair value per share for options granted during 2023, 2022, and 2021 were $2.21, $2.74, and $12.60 per share, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%"&gt;Non-Vested Restricted Shares Activity&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The following table summarized the Company&#x2019;s non-vested restricted share activity in 2023: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.142%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Numbers&lt;br/&gt;of non-vested&lt;br/&gt;restricted shares &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Weighted&lt;br/&gt;average&lt;br/&gt;remaining&lt;br/&gt;contractual term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Aggregate&lt;br/&gt;intrinsic value &lt;br/&gt;($ in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Non-vested as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;33,433,890&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.55&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;102,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9,001,740&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(8,178,500)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2,977,530)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Non-vested as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;31,279,600&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.75&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;85,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt; The grant-date fair value of restricted shares is the fair value of the underlying stock on the award&#x2019;s grant date. The weighted-average grant-date fair value per share for restricted shares granted in 2023, 2022, and 2021 were $3.18, $3.71, and $10.55 per share, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%"&gt;Stock-Based Compensation Expenses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The following table presents the share-based compensation expense which has been reported in the Company&#x2019;s consolidated statements of operations ($ in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.142%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;48,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;38,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;23,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;31,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;23,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;79,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;61,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;40,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;As of December&#160;31, 2023, there was unrecognized share-based compensation expense related to unvested share options and unvested restricted shares of $104.2 million and $104.1 million, respectively, which the Company expects to recognize over a weighted-average period of 3.05 years and 2.75 years, respectively.</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c-182"
      decimals="INF"
      id="f-852"
      unitRef="shares">97908743</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="c-183" id="f-853">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-184" id="f-854">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-185" id="f-855">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="c-186"
      decimals="INF"
      id="f-856"
      unitRef="number">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="c-187"
      decimals="INF"
      id="f-857"
      unitRef="number">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="c-188"
      decimals="INF"
      id="f-858"
      unitRef="number">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="c-189"
      decimals="INF"
      id="f-859"
      unitRef="number">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="c-190"
      decimals="INF"
      id="f-860"
      unitRef="number">0.20</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="c-191"
      decimals="INF"
      id="f-861"
      unitRef="number">0.20</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="c-192"
      decimals="INF"
      id="f-862"
      unitRef="number">0.20</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="c-193"
      decimals="INF"
      id="f-863"
      unitRef="number">0.20</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="c-194"
      decimals="INF"
      id="f-864"
      unitRef="number">0.20</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="c-1" id="f-865">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The following table presents a summary of option activity and related information in 2023: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.354%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.085%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Number of&lt;br/&gt;options &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Weighted&lt;br/&gt;average exercise&lt;br/&gt;price&lt;br/&gt;($)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Weighted&lt;br/&gt;average&lt;br/&gt;remaining&lt;br/&gt;contractual term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Aggregate&lt;br/&gt;intrinsic value &lt;br/&gt;($ in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outstanding at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;91,181,420&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.89&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;115,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;24,102,740&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6,516,920)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4,183,190)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outstanding at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;104,584,050&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.97&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;83,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Vested and exercisable as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;58,695,320&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.93&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;83,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-13"
      decimals="INF"
      id="f-866"
      unitRef="shares">91181420</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-13"
      decimals="2"
      id="f-867"
      unitRef="usdPerShare">3.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-14" id="f-868">P5Y10M20D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c-13" decimals="-3" id="f-869" unitRef="usd">115969000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="c-1" decimals="INF" id="f-870" unitRef="shares">24102740</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-871"
      unitRef="usdPerShare">3.36</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c-1" decimals="INF" id="f-872" unitRef="shares">6516920</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-873"
      unitRef="usdPerShare">0.39</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="c-1" decimals="INF" id="f-874" unitRef="shares">4183190</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-875"
      unitRef="usdPerShare">6.68</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-12"
      decimals="INF"
      id="f-876"
      unitRef="shares">104584050</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-12"
      decimals="2"
      id="f-877"
      unitRef="usdPerShare">3.14</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-1" id="f-878">P5Y11M19D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c-12" decimals="-3" id="f-879" unitRef="usd">83424000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
      contextRef="c-12"
      decimals="INF"
      id="f-880"
      unitRef="shares">58695320</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="c-12"
      decimals="2"
      id="f-881"
      unitRef="usdPerShare">2.11</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1 contextRef="c-1" id="f-882">P3Y11M4D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="c-12" decimals="-3" id="f-883" unitRef="usd">83266000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="c-1" decimals="-5" id="f-884" unitRef="usd">20300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="c-14" decimals="-5" id="f-885" unitRef="usd">14300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="c-11" decimals="-5" id="f-886" unitRef="usd">170400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="c-1" id="f-887">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The following table presents the assumptions used to estimate the fair values of the share options granted: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:55.415%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.993%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Risk-free rate of return&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.5%-4.7%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.4%-4.0%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.9%-1.4%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6, 6.25,or 6.5&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.5 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6, 6.25 or 6.5&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Estimated volatility rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;70%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;65%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;65%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected dividend rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum contextRef="c-183" decimals="3" id="f-888" unitRef="number">0.035</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum contextRef="c-183" decimals="3" id="f-889" unitRef="number">0.047</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum contextRef="c-195" decimals="3" id="f-890" unitRef="number">0.014</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum contextRef="c-195" decimals="3" id="f-891" unitRef="number">0.040</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum contextRef="c-196" decimals="3" id="f-892" unitRef="number">0.009</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum contextRef="c-196" decimals="3" id="f-893" unitRef="number">0.014</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-197" id="f-894">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-198" id="f-895">P6Y3M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-199" id="f-896">P6Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-195" id="f-897">P6Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-200" id="f-898">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-201" id="f-899">P6Y3M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-202" id="f-900">P6Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c-183" decimals="2" id="f-901" unitRef="number">0.70</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c-195" decimals="2" id="f-902" unitRef="number">0.65</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c-196" decimals="2" id="f-903" unitRef="number">0.65</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c-183" decimals="2" id="f-904" unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c-195" decimals="2" id="f-905" unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c-196" decimals="2" id="f-906" unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-183"
      decimals="2"
      id="f-907"
      unitRef="usdPerShare">2.21</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-195"
      decimals="2"
      id="f-908"
      unitRef="usdPerShare">2.74</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-196"
      decimals="2"
      id="f-909"
      unitRef="usdPerShare">12.60</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock contextRef="c-1" id="f-910">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The following table summarized the Company&#x2019;s non-vested restricted share activity in 2023: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.142%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Numbers&lt;br/&gt;of non-vested&lt;br/&gt;restricted shares &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Weighted&lt;br/&gt;average&lt;br/&gt;remaining&lt;br/&gt;contractual term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Aggregate&lt;br/&gt;intrinsic value &lt;br/&gt;($ in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Non-vested as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;33,433,890&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.55&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;102,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9,001,740&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(8,178,500)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2,977,530)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Non-vested as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;31,279,600&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.75&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;85,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-203"
      decimals="INF"
      id="f-911"
      unitRef="shares">33433890</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms contextRef="c-204" id="f-912">P3Y6M18D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested contextRef="c-203" decimals="-3" id="f-913" unitRef="usd">102642000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-205"
      decimals="INF"
      id="f-914"
      unitRef="shares">9001740</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-205"
      decimals="INF"
      id="f-915"
      unitRef="shares">8178500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-205"
      decimals="INF"
      id="f-916"
      unitRef="shares">2977530</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-206"
      decimals="INF"
      id="f-917"
      unitRef="shares">31279600</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms contextRef="c-205" id="f-918">P2Y9M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested contextRef="c-206" decimals="-3" id="f-919" unitRef="usd">85487000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-205"
      decimals="2"
      id="f-920"
      unitRef="usdPerShare">3.18</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-204"
      decimals="2"
      id="f-921"
      unitRef="usdPerShare">3.71</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-207"
      decimals="2"
      id="f-922"
      unitRef="usdPerShare">10.55</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="c-1" id="f-923">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The following table presents the share-based compensation expense which has been reported in the Company&#x2019;s consolidated statements of operations ($ in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.142%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;48,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;38,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;23,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;31,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;23,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;79,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;61,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;40,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-208" decimals="-3" id="f-924" unitRef="usd">48017000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-209" decimals="-3" id="f-925" unitRef="usd">38118000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-210" decimals="-3" id="f-926" unitRef="usd">23194000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-211" decimals="-3" id="f-927" unitRef="usd">31617000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-212" decimals="-3" id="f-928" unitRef="usd">23184000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-213" decimals="-3" id="f-929" unitRef="usd">17520000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-1" decimals="-3" id="f-930" unitRef="usd">79634000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-14" decimals="-3" id="f-931" unitRef="usd">61302000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-11" decimals="-3" id="f-932" unitRef="usd">40714000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions contextRef="c-214" decimals="-5" id="f-933" unitRef="usd">104200000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions contextRef="c-206" decimals="-5" id="f-934" unitRef="usd">104100000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c-183" id="f-935">P3Y18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c-205" id="f-936">P2Y9M</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <zlab:LicensesAndCollaborativeArrangementDisclosureTextBlock contextRef="c-1" id="f-937">License and Collaboration Agreements &lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The Company may enter into collaboration agreements with third parties to license intellectual property. These agreements may require the Company to make upfront payments and payments related to certain future development, regulatory, and sales-based milestones as well as certain royalties at tiered percentage rates on annual sales of the licensed products in the licensed territory. These agreements generally remain in effect, unless earlier terminated, until the expiration of the last-to-expire royalty term for the last licensed product. The royalty terms generally continue until the latest of: (i) the expiration of the last-to-expire valid claim with respect to licensed patent rights; (ii) the expiration of market or regulatory exclusivity; or (iii) or a specified period of time, generally around ten years, after the date of the first commercial sale of the licensed product. These agreements also contain customary provisions for termination by either party, including in the event of a material breach by the other party that remains uncured; by us for convenience upon a specified notice period; for certain bankruptcy, insolvency, or other similar events; and by its partners upon challenge of their licensed patent rights. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Payments under these agreements generally become due and payable upon the achievement of such milestones or sales. These commitments are not recorded as liabilities on the consolidated balance sheet because the achievement and timing of these milestones are not fixed and determinable. The following is a description of the Company&#x2019;s significant license and collaboration agreements as of December&#160;31, 2023, including milestone fees incurred in 2023, 2022, and 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;text-decoration:underline"&gt;Significant License and Collaboration Arrangements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%"&gt;License and Collaboration Agreement with GSK (Niraparib) &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;In September 2016, the Company entered into a collaboration, development, and license agreement with Tesaro, Inc., a company later acquired by GSK, pursuant to which the Company obtained an exclusive sublicense under certain patents and know-how of GSK to develop, manufacture, and commercialize GSK&#x2019;s proprietary PARP inhibitor, niraparib, for the diagnosis and prevention of any human diseases or conditions (other than prostate cancer) in mainland China, Hong Kong, and Macau. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The Company recorded development milestone fees into research and development expenses of $4.0 million in 2022. The Company recorded sales-based milestone fees of $12.0 million and $8.0 million in 2023 and 2021, respectively. The Company may be required to pay an additional aggregate amount of up to $16.0 million in development, regulatory, and sales-based milestones as well as certain royalties at tiered percentages rates ranging from mid- to high-teens on annual net sales of the licensed products in the licensed territories.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%"&gt;License and Collaboration Agreement with NovoCure (Tumor Treating Fields)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;In September 2018, the Company entered into a license and collaboration agreement with NovoCure, pursuant to which it obtained an exclusive license under certain patents and know-how of NovoCure to develop and commercialize any Tumor Treating Fields treatment or delivery system, including the device branded as OPTUNE, in all human therapeutic and preventative uses in the field of oncology in Greater China. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The Company may be required to pay an additional aggregate amount of up to $68.0 million in development, regulatory, and sales-based milestones as well as certain royalties at tiered percentage rates ranging from low- to mid-teens on annual net sales of the licensed products in the licensed territory. The Company will purchase licensed products exclusively from NovoCure at NovoCure&#x2019;s fully burdened manufacturing cost. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%"&gt;License and Collaboration Agreement with Deciphera (Ripretinib)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;In June 2019, the Company entered into a license agreement with Deciphera, pursuant to which it obtained an exclusive license under certain patents and know-how of Deciphera to develop and commercialize products containing ripretinib in the field of the prevention, prophylaxis, treatment, cure, or amelioration of any disease or medical condition in humans in Greater China. The Company will purchase licensed products exclusively from Deciphera.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The Company recorded development milestone fees into research and development expenses of $5.0 million in 2021.  The Company may be required to pay an additional aggregate amount of up to $173.0 million in development, regulatory, and sales-based milestones as well as certain royalties at tiered percentage rates ranging from low- to high-teens on annual net sales of the licensed products in the licensed territory.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%"&gt;License and Collaboration Agreement with Novo Holdings (Omadacycline)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;In April 2017, the Company entered into a license and collaboration agreement with Paratek Bermuda Ltd. (&#x201c;Paratek&#x201d;), a subsidiary of Paratek (which was subsequently acquired by Gurnet Point Capital and Novo Holdings A/S), pursuant to which the Company obtained both an exclusive license under certain patents and know-how of Paratek and an exclusive sub-license under certain intellectual property that Paratek licensed from Tufts University to develop, manufacture, and commercialize products containing omadacycline as an active ingredient in the field of all human therapeutic and preventative uses other than biodefense in Greater China.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The Company recorded development milestone fees into research and development expenses of $6.0 million in 2021. The Company may be required to pay an additional aggregate amount of up to $40.5 million in development, regulatory, and sales-based milestones as well as certain royalties at tiered percentages rates ranging from low- to mid-teens on annual net sales of licensed products in the licensed territory. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%"&gt;Collaboration and License Agreement with argenx (Efgartigimod)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;In January 2021, the Company entered into a collaboration and license agreement with argenx BV (&#x201c;argenx&#x201d;) pursuant to which the Company obtained an exclusive license under certain patients and know-how of argenx to develop and commercialize products containing efgartigimod as an active ingredient in all human and animal uses for any &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;preventative or therapeutic indications in Greater China. The Company will purchase licensed products exclusively from argenx.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Pursuant to the collaboration and license agreement, the Company and argenx entered into a share issuance agreement. The Company issued as an upfront payment to argenx of 5,681,820 ordinary shares of the Company. In determining the fair value of the ordinary shares at closing, the Company considered the closing price of the ordinary shares on the closing date and included a lack of marketability discount because the shares were subject to certain restrictions. The fair value of the shares on the closing date was determined to be $62.3 million in the aggregate. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The Company recorded development milestone fees into research and development expense of $100.0 million in 2021. The Company may be required to pay certain royalties at tiered percentages rates ranging from mid-teen to low-twenties on annual net sales of the licensed products in the licensed territory.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%"&gt;License and Collaboration Agreement with Amgen (Bemarituzumab)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;In December 2017, the Company entered into a license and collaboration agreement with Five Prime Therapeutics, Inc. (a company later acquired by Amgen), pursuant to which it obtained an exclusive license under certain patents and know-how of Five Prime to develop and commercialize products containing Five Prime&#x2019;s proprietary afucosylated FGFR2b antibody known as bemarituzumab (FPA144) as an active ingredient in the treatment or prevention of any disease or condition in humans in Greater China.  The Company will purchase licensed products exclusively from Amgen.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The Company may be required to pay an additional aggregate amount of up to $37.0 million in development and regulatory milestones as well as certain royalties at tiered percentage rates ranging from high-teens to low twenties on annual net sales of the licensed product in the licensed territory. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Under the terms of the agreement, provided that the Company enrolls and treats a specified number of patients in the bemarituzumab FPA144-004 study in mainland China, the Company is eligible to receive a low single-digit percentage quarterly royalty, on a licensed product-by-licensed product basis on net sales of all licensed product outside of the licensed territory until the tenth (10th) anniversary of the first commercial sale of each such licensed product outside of the licensed territory. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%"&gt;License and Collaboration Agreement with Innoviva (SUL-DUR)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;In April 2018, the Company entered into a license and collaboration agreement with Entasis Therapeutics Holdings Inc. (&#x201c;Entasis&#x201d;), a wholly owned subsidiary of Innoviva, Inc. (&#x201c;Innoviva&#x201d;), pursuant to which it obtained an exclusive license under certain patents and know-how of Entasis to develop and commercialize products containing Entasis&#x2019;s proprietary compounds known as durlobactam with Sulbactam (the combination, SUL-DUR) with the possibility of developing and commercializing a combination of such compounds with Imipenem in all human diagnostic, prophylactic, and therapeutic uses in Greater China, Korea, Vietnam, Thailand, Cambodia, Laos, Malaysia, Indonesia, the Philippines, Singapore, Australia, New Zealand, and Japan. The Company&#x2019;s rights to develop and commercialize the licensed products are limited to the lead product (Sulbactam) until such lead product receives initial FDA approval in the United States. The Company will purchase licensed products exclusively from Innoviva.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The Company recorded development milestone fees into research and development expenses of $3.0 million in 2023. The Company may be required to pay an additional aggregate amount of up to $88.6 million in development and sales-based milestones as well as certain royalties at tiered percentage rates ranging from high single digits to low-teens on annual net sales of the licensed products in the licensed territory. The Company is also responsible for a portion of the costs of the global pivotal Phase III ATTACK clinical trial of SUL-DUR outside of the licensed territory.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%"&gt;License Agreement with BMS (Repotrectinib)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;In July 2020, the Company entered into an exclusive license agreement with Turning Point Therapeutics, Inc. (a company later required by BMS) pursuant to which the Company received an exclusive license to develop and commercialize products containing repotrectinib as an active ingredient in all human therapeutic indications in Greater China. The Company will purchase licensed products exclusively from BMS.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The Company recorded development milestone fees into research and development expenses of $5.0 million in each of 2023 and 2021. The Company may be required to pay an additional aggregate amount of up to $141.0 million in development, regulatory, and sales-based milestones as well as certain royalties at tiered percentage rates ranging from mid- to high-teens on annual net sales of the licensed product in the licensed territory. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%"&gt;Collaboration and License Agreement with BMS (Adagrasib)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;In May 2021, the Company entered into a collaboration and license agreement with Mirati Therapeutics, Inc. (&#x201c;Mirati&#x201d;) (a company later acquired by BMS) pursuant to which the Company obtained the right to research, develop, manufacture, and exclusively commercialize adagrasib in all indications in Greater China, with Mirati retaining exclusive rights for the development, manufacturing, and commercialization of adagrasib outside of Greater China and certain co-commercialization, manufacture, and development rights in Greater China. The Company will purchase licensed products exclusively from BMS.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The Company recorded development milestone fees of $10.0 million in 2022 and an upfront payment of $65.0 million in 2021. The Company may be required to pay an additional aggregate amount of up to $263.0 million in development, regulatory, and sales-based milestones as well as certain royalties at tiered percentage rates ranging from high-teens to low-twenties on annual net sales of the licensed product in the licensed territory.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%"&gt;License Agreement with BMS (Xanomeline-Trospium)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;In November 2021, the Company entered into a license agreement with Karuna Therapeutics, Inc. (a company later acquired by BMS), pursuant to which the Company obtained an exclusive license to develop, manufacture, and commercialize xanomeline-trospium (KarXT) in Greater China.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The Company recorded an upfront payment of $35.0 million and development milestone fees of $10.0 million into research and development expenses in 2021 and 2022, respectively. The Company may be required to pay an additional aggregate amount of up to $142.0 million in development, regulatory, and sales-based milestones as well as certain royalties at tiered percentage rates ranging from low- to high-teens on annual net sales of the licensed products in Greater China.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%"&gt;Collaboration and License Agreement with Pfizer (Tisotumab Vedotin)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;In September 2022, the Company entered into a collaboration and license agreement with Seagen Inc. (a company later acquired by Pfizer Inc. (&#x201c;Pfizer&#x201d;), pursuant to which the Company and Seagen agreed to collaboratively develop and commercialize tisotumab vedotin (TIVDAK). Under the agreement, the Company obtained an exclusive license to develop and commercialize TIVDAK in Greater China.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The Company recorded an upfront payment of $30.0 million into research and development expenses in 2022. The Company may be required to pay an additional aggregate amount of up to $263.0 million in development, regulatory, and sales-based milestone payments as well as certain royalties at tiered percentage rates ranging from mid-teens to low-twenties on annual net sales of the licensed products in Greater China. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The agreement will remain in effect, unless earlier terminated, until the expiration of the last-to-expire royalty term for the last licensed product. The agreement contains customary provisions for termination by either party, including in the event of a material breach by the other party that remains uncured, by the Company for convenience, for certain bankruptcy events, and by Seagen upon a challenge of the licensed patent rights.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;text-decoration:underline"&gt;Other License and Collaboration Arrangements That Are Not Individually Significant&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The Company recorded an upfront payment of $10.0&#160;million in 2023 for other license and collaboration agreements that are not individually significant. The Company may be required to pay an additional aggregate amount of up to $2,202.1 million in development, regulatory, and sales-based milestones as well as certain royalties at tiered percentage rates on annual net sales under such agreements.&lt;/span&gt;&lt;/div&gt;</zlab:LicensesAndCollaborativeArrangementDisclosureTextBlock>
    <zlab:CollaborativeArrangementRightsAndObligationsSpecifiedRoyaltyTerm contextRef="c-1" id="f-938">P10Y</zlab:CollaborativeArrangementRightsAndObligationsSpecifiedRoyaltyTerm>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-215" decimals="-5" id="f-939" unitRef="usd">4000000</us-gaap:ResearchAndDevelopmentExpense>
    <zlab:CollaborativeArrangementRightsAndObligationsSalesBasedMilestonePayment contextRef="c-216" decimals="-5" id="f-940" unitRef="usd">12000000.0</zlab:CollaborativeArrangementRightsAndObligationsSalesBasedMilestonePayment>
    <zlab:CollaborativeArrangementRightsAndObligationsSalesBasedMilestonePayment contextRef="c-217" decimals="-5" id="f-941" unitRef="usd">8000000.0</zlab:CollaborativeArrangementRightsAndObligationsSalesBasedMilestonePayment>
    <zlab:CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments contextRef="c-218" decimals="-5" id="f-942" unitRef="usd">16000000.0</zlab:CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments>
    <zlab:CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments contextRef="c-219" decimals="-5" id="f-943" unitRef="usd">68000000.0</zlab:CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-220" decimals="-5" id="f-944" unitRef="usd">5000000.0</us-gaap:ResearchAndDevelopmentExpense>
    <zlab:CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments contextRef="c-221" decimals="-5" id="f-945" unitRef="usd">173000000.0</zlab:CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-222" decimals="-5" id="f-946" unitRef="usd">6000000.0</us-gaap:ResearchAndDevelopmentExpense>
    <zlab:CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments contextRef="c-223" decimals="-5" id="f-947" unitRef="usd">40500000</zlab:CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross
      contextRef="c-224"
      decimals="INF"
      id="f-948"
      unitRef="shares">5681820</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross>
    <zlab:CollaborativeArrangementRightsAndObligationsPaymentOfUpFrontFeesForLicenseAgreement contextRef="c-224" decimals="-5" id="f-949" unitRef="usd">62300000</zlab:CollaborativeArrangementRightsAndObligationsPaymentOfUpFrontFeesForLicenseAgreement>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-225" decimals="-5" id="f-950" unitRef="usd">100000000.0</us-gaap:ResearchAndDevelopmentExpense>
    <zlab:CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments contextRef="c-226" decimals="-5" id="f-951" unitRef="usd">37000000.0</zlab:CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments>
    <zlab:CollaborativeArrangementRightsAndObligationsSpecifiedRoyaltyTerm contextRef="c-227" id="f-952">P10Y</zlab:CollaborativeArrangementRightsAndObligationsSpecifiedRoyaltyTerm>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-228" decimals="-5" id="f-953" unitRef="usd">3000000.0</us-gaap:ResearchAndDevelopmentExpense>
    <zlab:CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments contextRef="c-229" decimals="-5" id="f-954" unitRef="usd">88600000</zlab:CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-230" decimals="-5" id="f-955" unitRef="usd">5000000.0</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-231" decimals="-5" id="f-956" unitRef="usd">5000000.0</us-gaap:ResearchAndDevelopmentExpense>
    <zlab:CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments contextRef="c-232" decimals="-5" id="f-957" unitRef="usd">141000000.0</zlab:CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments>
    <zlab:CollaborativeArrangementRightsAndObligationsDevelopmentMilestonePayment contextRef="c-233" decimals="-5" id="f-958" unitRef="usd">10000000.0</zlab:CollaborativeArrangementRightsAndObligationsDevelopmentMilestonePayment>
    <zlab:CollaborativeArrangementRightsAndObligationsPaymentOfUpFrontFeesForLicenseAgreement contextRef="c-234" decimals="-5" id="f-959" unitRef="usd">65000000.0</zlab:CollaborativeArrangementRightsAndObligationsPaymentOfUpFrontFeesForLicenseAgreement>
    <zlab:CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments contextRef="c-235" decimals="-5" id="f-960" unitRef="usd">263000000.0</zlab:CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-236" decimals="-5" id="f-961" unitRef="usd">35000000.0</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-237" decimals="-5" id="f-962" unitRef="usd">10000000.0</us-gaap:ResearchAndDevelopmentExpense>
    <zlab:CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments contextRef="c-238" decimals="-5" id="f-963" unitRef="usd">142000000.0</zlab:CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-239" decimals="-5" id="f-964" unitRef="usd">30000000.0</us-gaap:ResearchAndDevelopmentExpense>
    <zlab:CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments contextRef="c-240" decimals="-5" id="f-965" unitRef="usd">263000000.0</zlab:CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments>
    <zlab:CollaborativeArrangementRightsAndObligationsPaymentOfUpFrontFeesForLicenseAgreement contextRef="c-241" decimals="-5" id="f-966" unitRef="usd">10000000</zlab:CollaborativeArrangementRightsAndObligationsPaymentOfUpFrontFeesForLicenseAgreement>
    <zlab:CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments contextRef="c-12" decimals="-5" id="f-967" unitRef="usd">2202100000</zlab:CollaborativeArrangementRightsAndObligationsMaximumAdditionalMilestonePayments>
    <us-gaap:OtherNonoperatingIncomeAndExpenseTextBlock contextRef="c-1" id="f-968">Other Income (Expenses), Net &lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The following table presents the Company&#x2019;s other income (expenses), net ($ in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.142%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Government grants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gain (Loss) on equity investments with readily determinable fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(8,952)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(14,617)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Others miscellaneous gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(10,201)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OtherNonoperatingIncomeAndExpenseTextBlock>
    <us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock contextRef="c-1" id="f-969">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The following table presents the Company&#x2019;s other income (expenses), net ($ in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.142%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Government grants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gain (Loss) on equity investments with readily determinable fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(8,952)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(14,617)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Others miscellaneous gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(10,201)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock>
    <zlab:GovernmentAssistanceNonoperatingIncome contextRef="c-1" decimals="-3" id="f-970" unitRef="usd">2433000</zlab:GovernmentAssistanceNonoperatingIncome>
    <zlab:GovernmentAssistanceNonoperatingIncome contextRef="c-14" decimals="-3" id="f-971" unitRef="usd">11471000</zlab:GovernmentAssistanceNonoperatingIncome>
    <zlab:GovernmentAssistanceNonoperatingIncome contextRef="c-11" decimals="-3" id="f-972" unitRef="usd">4113000</zlab:GovernmentAssistanceNonoperatingIncome>
    <us-gaap:EquitySecuritiesFvNiGainLoss contextRef="c-1" decimals="-3" id="f-973" unitRef="usd">2789000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss contextRef="c-14" decimals="-3" id="f-974" unitRef="usd">-8952000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss contextRef="c-11" decimals="-3" id="f-975" unitRef="usd">-14617000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:OtherNonoperatingGainsLosses contextRef="c-1" decimals="-3" id="f-976" unitRef="usd">1784000</us-gaap:OtherNonoperatingGainsLosses>
    <us-gaap:OtherNonoperatingGainsLosses contextRef="c-14" decimals="-3" id="f-977" unitRef="usd">594000</us-gaap:OtherNonoperatingGainsLosses>
    <us-gaap:OtherNonoperatingGainsLosses contextRef="c-11" decimals="-3" id="f-978" unitRef="usd">303000</us-gaap:OtherNonoperatingGainsLosses>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-1" decimals="-3" id="f-979" unitRef="usd">7006000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-14" decimals="-3" id="f-980" unitRef="usd">3113000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-11" decimals="-3" id="f-981" unitRef="usd">-10201000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:RestrictedAssetsDisclosureTextBlock contextRef="c-1" id="f-982">Restricted Net Assets&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The Company&#x2019;s ability to pay dividends may depend on the Company receiving distributions of funds from its Chinese subsidiaries. Relevant Chinese laws and regulations permit payments of dividends by the Company&#x2019;s Chinese subsidiaries only out of its retained earnings, if any, as determined in accordance with Chinese accounting standards and regulations. The results of operations reflected in the consolidated financial statements prepared in accordance with U.S. GAAP differ from those reflected in the statutory financial statements of the Company&#x2019;s Chinese subsidiaries.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;In accordance with the Company Law of the People&#x2019;s Republic of China, a domestic enterprise is required to provide statutory reserves of at least 10% of its annual after-tax profit until such reserve has reached 50% of its respective registered capital based on the enterprise&#x2019;s Chinese statutory accounts. A domestic enterprise may provide discretionary surplus reserve, at the discretion of the Board of Directors, from the profits determined in accordance with the enterprise&#x2019;s Chinese statutory accounts. The aforementioned reserves can only be used for specific purposes and are not distributable as cash dividends. The Company&#x2019;s Chinese subsidiaries were established as domestic enterprises and therefore are subject to the above-mentioned restrictions on distributable profits. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;No appropriation to statutory reserves was made during the years ended December&#160;31, 2023, 2022, and 2021 because the Chinese subsidiaries had substantial losses during such periods. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;As a result of these Chinese laws and regulations, subject to the limits discussed above that require annual appropriations of 10% of after-tax profit to be set aside, prior to payment of dividends, as a general reserve fund, the Company&#x2019;s Chinese subsidiaries are restricted in their ability to transfer out a portion of their net assets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Foreign exchange and other regulation in mainland China may further restrict the Company&#x2019;s subsidiaries in mainland China from transferring out funds in the form of dividends, loans, and advances. As of December&#160;31, 2023 and &lt;/span&gt;&lt;/div&gt;2022, amounts restricted were the paid-in capital of the Company&#x2019;s subsidiaries in mainland China, which were $506.0 million and $456.0 million, respectively.</us-gaap:RestrictedAssetsDisclosureTextBlock>
    <zlab:StatutoryReserves contextRef="c-155" decimals="INF" id="f-983" unitRef="usd">0</zlab:StatutoryReserves>
    <zlab:StatutoryReserves contextRef="c-154" decimals="INF" id="f-984" unitRef="usd">0</zlab:StatutoryReserves>
    <zlab:StatutoryReserves contextRef="c-153" decimals="INF" id="f-985" unitRef="usd">0</zlab:StatutoryReserves>
    <us-gaap:AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries contextRef="c-168" decimals="-5" id="f-986" unitRef="usd">506000000.0</us-gaap:AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries>
    <us-gaap:AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries contextRef="c-242" decimals="-5" id="f-987" unitRef="usd">456000000.0</us-gaap:AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries>
    <us-gaap:CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock contextRef="c-1" id="f-988">Employee Defined Contribution Plans&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Full time employees of the Company in mainland China participate in a government mandated defined contribution plan, pursuant to which certain pension benefits, medical care, employee housing fund, and other welfare benefits are provided to employees. Chinese labor regulations require that the Company&#x2019;s subsidiaries in China mainland make contributions to the government for these benefits primarily based on certain percentages of the employees&#x2019; salaries subject to certain caps and other government requirements. The total amounts for such employee benefits, which were expensed as incurred, were $25.8 million, $23.6 million, and $17.6 million for 2023, 2022, and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The Company&#x2019;s employees who are U.S. taxpayers and who meet certain age and service requirements are eligible to participate in a broad-based, defined contribution retirement plan which is qualified under Section 401 of the Internal Revenue Code (&#x201c;the 401(k) plan&#x201d;). The Company makes a matching contribution equal to 100% in 2023 and 50% in 2022 and 2021 of the first 5% of the employee&#x2019;s elective contributions under the plan, up to 5.0% of an employee&#x2019;s eligible compensation. Contributions made by the Company vest 100% upon contribution. The total amounts for such employee benefits, which were expensed as incurred, were $1.0 million, $0.5 million, and insignificant in 2023, 2022, and 2021, respectively. &lt;/span&gt;&lt;/div&gt;The Company also provides required Mandatory Provident Fund contribution for its full-time employees located in Hong Kong and provides social benefits contribution for its full-time employees located in Taiwan. The total amounts for these contributions, which were expensed as incurred, was $0.2 million, $0.2 million, and insignificant in 2023, 2022, and 2021, respectively.</us-gaap:CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock>
    <us-gaap:DefinedContributionPlanCostRecognized contextRef="c-243" decimals="-5" id="f-989" unitRef="usd">25800000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized contextRef="c-244" decimals="-5" id="f-990" unitRef="usd">23600000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized contextRef="c-245" decimals="-5" id="f-991" unitRef="usd">17600000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
      contextRef="c-246"
      decimals="INF"
      id="f-992"
      unitRef="number">1</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
      contextRef="c-247"
      decimals="INF"
      id="f-993"
      unitRef="number">0.50</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
      contextRef="c-248"
      decimals="INF"
      id="f-994"
      unitRef="number">0.50</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch>
    <zlab:DefinedContributionPlanEmployerMatchingContributionPercentOfEmployeeContribution
      contextRef="c-248"
      decimals="INF"
      id="f-995"
      unitRef="number">0.05</zlab:DefinedContributionPlanEmployerMatchingContributionPercentOfEmployeeContribution>
    <zlab:DefinedContributionPlanEmployerMatchingContributionPercentOfEmployeeContribution
      contextRef="c-246"
      decimals="INF"
      id="f-996"
      unitRef="number">0.05</zlab:DefinedContributionPlanEmployerMatchingContributionPercentOfEmployeeContribution>
    <zlab:DefinedContributionPlanEmployerMatchingContributionPercentOfEmployeeContribution
      contextRef="c-247"
      decimals="INF"
      id="f-997"
      unitRef="number">0.05</zlab:DefinedContributionPlanEmployerMatchingContributionPercentOfEmployeeContribution>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent
      contextRef="c-249"
      decimals="INF"
      id="f-998"
      unitRef="number">0.050</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent
      contextRef="c-250"
      decimals="INF"
      id="f-999"
      unitRef="number">0.050</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent
      contextRef="c-251"
      decimals="INF"
      id="f-1000"
      unitRef="number">0.050</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
    <us-gaap:DefinedContributionPlanCostRecognized contextRef="c-246" decimals="-5" id="f-1001" unitRef="usd">1000000.0</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized contextRef="c-248" decimals="-5" id="f-1002" unitRef="usd">500000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized contextRef="c-252" decimals="-5" id="f-1003" unitRef="usd">200000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized contextRef="c-253" decimals="-5" id="f-1004" unitRef="usd">200000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c-1" id="f-1007">Commitments and Contingencies&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%"&gt;(a)&#160;&#160;&#160;&#160;Purchase Commitments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The Company&#x2019;s commitments related to purchase of property and equipment contracted but not yet reflected in the consolidated financial statements were $1.2 million as of December&#160;31, 2023 and were expected to be incurred within one year. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%"&gt;(b)&#160;&#160;&#160;&#160;Legal Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;The Company is not currently a party to any material legal proceedings. Each quarter, the Company evaluates whether there have been any developments in legal proceedings that would require an accrual. In accordance with the accounting guidance for contingencies, the Company will accrue for losses that are both probable and reasonably estimable. The Company will record any legal and other third-party costs related to its legal contingencies as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%"&gt;(c)       Indemnifications&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;In the normal course of business, the Company enters into agreements that indemnify others for certain liabilities that may arise in connection with a transaction or certain events and activities. If the indemnified party were to make a successful claim pursuant to the terms of the indemnification, the Company may be required to reimburse the loss. These indemnifications are generally subject to various restrictions and limitations. The Company&#x2019;s exposure under these agreements is unknown because it involves claims that may be made against the Company in the future but have not yet &lt;/span&gt;&lt;/div&gt;been made. To date, the Company has not paid any claims or been required to defend any action related to its indemnification obligations.</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:UnrecordedUnconditionalPurchaseObligationDueInNextRollingTwelveMonths contextRef="c-255" decimals="-5" id="f-1008" unitRef="usd">1200000</us-gaap:UnrecordedUnconditionalPurchaseObligationDueInNextRollingTwelveMonths>
    <us-gaap:SubsequentEventsTextBlock contextRef="c-1" id="f-1009">Subsequent Events &lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;In February 2024, the Company entered into certain debt arrangements with the Bank of China, SPD Bank, and Ningbo Bank to support its working capital needs in mainland China.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%"&gt;Bank of China Working Capital Loan Facility&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;On February 5, 2024, the Company entered into an uncommitted facility letter with the Bank of China (Hong Kong) Limited (the &#x201c;BOC HK&#x201d;) pursuant to which the BOC HK will provide standby letters of credit for loans of up to $100.0 million for a term of one year. In connection with this agreement, the Company paid a one-time, non-refundable fee of $0.7 million. On February 6, 2024, upon the Company&#x2019;s application, the BOC HK provided a standby letter of credit in favor of the Bank of China Pudong Development Zone Branch (the &#x201c;BOC Pudong Branch&#x201d;) for $50.0&#160;million which are or may become payable by the Company&#x2019;s wholly-owned subsidiary, Zai Lab (Shanghai) Co., Ltd. (&#x201c;Zai Lab Shanghai&#x201d;), and Zai Lab Shanghai subsequently entered into a working capital loan contract with the BOC Pudong Branch on February 7, 2024 for a loan of RMB340.0&#160;million (approximately $47.8&#160;million). The working capital loan has a one-year term and is subject to a floating interest rate of approximately 2.95% initially, and is subject to adjustment every six months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%"&gt;SPD Bank Working Capital Loan Facility&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;On February 6, 2024, the Company entered into a maximum-amount guarantee contract with the Shanghai Pudong Development Bank Co., Ltd. Zhangjiang Hi-Tech Park Sub-branch (the &#x201c;SPD Bank&#x201d;) pursuant to which the Company will guarantee working capital loans of up to RMB300.0&#160;million (approximately $42.0&#160;million) from SPD Bank to Zai Lab Shanghai over a three-year period. To date, Zai Lab Shanghai has entered into a working capital loan contract with SPD Bank under this debt facility for RMB50.0&#160;million (approximately $7.0&#160;million). The working capital loan has a one-year term and is subject to a fixed interest rate of 3.45%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%"&gt;Ningbo Bank Working Capital Loan Facility&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;On February 6, 2024, the Company&#x2019;s wholly-owned subsidiary, Zai Lab (Suzhou) Co., Ltd. (&#x201c;Zai Lab Suzhou&#x201d;), entered into a maximum credit contract with Bank of Ningbo Co., Ltd. Suzhou Sub-branch (&#x201c;Ningbo Bank&#x201d;) as well as an Electronic Commercial Draft Discounting Master Agreement and Online Working Capital Loan Master Agreement (collectively, the &#x201c;Ningbo Bank Agreements&#x201d;). The Ningbo Bank Agreements permit Zai Lab Suzhou to utilize, including through discounting or working capital loan agreements and subject to the terms and conditions in related master agreements, up to RMB230.3&#160;million (approximately $32.4&#160;million), of which the Company is authorized to utilize up to RMB160.0&#160;million (approximately $22.5&#160;million). In connection with the arrangements described in the Ningbo Bank Agreements, Zai Lab Suzhou agreed to pledge interests in certain real property it owns in Suzhou. To date, Zai Lab Suzhou has not entered into any discounting arrangements or working capital loans under this Ningbo Bank working capital loan facility.&lt;/span&gt;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-256" decimals="-5" id="f-1010" unitRef="usd">100000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm contextRef="c-257" id="f-1011">P1Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentFeeAmount contextRef="c-258" decimals="-5" id="f-1012" unitRef="usd">700000</us-gaap:DebtInstrumentFeeAmount>
    <us-gaap:LettersOfCreditOutstandingAmount contextRef="c-259" decimals="-5" id="f-1013" unitRef="usd">50000000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-260" decimals="-5" id="f-1014" unitRef="cny">340000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-260" decimals="-5" id="f-1015" unitRef="usd">47800000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentTerm contextRef="c-261" id="f-1016">P1Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-260"
      decimals="4"
      id="f-1017"
      unitRef="number">0.0295</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <zlab:DebtInstrumentVariableInterestRateAdjustmentPeriod contextRef="c-261" id="f-1018">P6M</zlab:DebtInstrumentVariableInterestRateAdjustmentPeriod>
    <us-gaap:GuaranteeObligationsMaximumExposure contextRef="c-262" decimals="-5" id="f-1019" unitRef="cny">300000000</us-gaap:GuaranteeObligationsMaximumExposure>
    <us-gaap:GuaranteeObligationsMaximumExposure contextRef="c-262" decimals="-5" id="f-1020" unitRef="usd">42000000</us-gaap:GuaranteeObligationsMaximumExposure>
    <zlab:GuarantorObligationTerm contextRef="c-263" id="f-1021">P3Y</zlab:GuarantorObligationTerm>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-264" decimals="-5" id="f-1022" unitRef="cny">50000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-264" decimals="-5" id="f-1023" unitRef="usd">7000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentTerm contextRef="c-265" id="f-1024">P1Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-264"
      decimals="4"
      id="f-1025"
      unitRef="number">0.0345</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-266" decimals="-5" id="f-1026" unitRef="cny">230300000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-266" decimals="-5" id="f-1027" unitRef="usd">32400000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-267" decimals="-5" id="f-1028" unitRef="cny">160000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-267" decimals="-5" id="f-1029" unitRef="usd">22500000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock contextRef="c-1" id="f-1030">&lt;div style="margin-top:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Schedule I &#x2014; Condensed Financial Information of Registrant&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Zai Lab Limited&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Financial Information of Parent Company&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Condensed Balance Sheets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(in thousands of $, except for number of shares and per share data)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Current assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;565,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;944,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepayments and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;573,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;954,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investment in subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;224,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;93,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;798,358&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1,048,215&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Liabilities and shareholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Current liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2,240&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2,620&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Shareholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Ordinary shares (par value of $0.000006 per share; 5,000,000,000 shares authorized, 977,151,270 and 962,455,850 shares issued as of December&#160;31, 2023 and 2022, respectively; 972,239,070 and 960,219,570 shares issued and outstanding as of December&#160;31, 2023 and 2022, respectively)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additional paid-in capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,975,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,893,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accumulated deficit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2,195,980)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,861,360)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive income&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;37,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;25,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Treasury stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(20,836)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(11,856)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total shareholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;796,118&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1,045,595&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total liabilities and shareholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;798,358&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1,048,215&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Schedule I &#x2014; Condensed Financial Information of Registrant&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Zai Lab Limited &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Financial Information of Parent Company&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Condensed Statements of Operations and Comprehensive Loss&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(in thousands of $)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.142%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Operating Expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(82)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(178)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(16,958)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(19,773)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(12,074)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Loss from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(17,040)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(19,951)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(12,080)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;30,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(8,678)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(18,173)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Profit (Loss) before income tax and equity in loss of subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;17,829&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(15,772)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(28,372)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity in loss of subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(352,449)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(427,514)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(676,099)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(334,620)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(443,286)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(704,471)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other comprehensive income (loss), net of tax of nil:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Foreign currency translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;49,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(9,121)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(322,679)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(393,956)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(713,592)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Schedule I &#x2014; Condensed Financial Information of Registrant&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Zai Lab Limited &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Financial Information of Parent Company &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Condensed Statements of Cash Flows&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(in thousands of $)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.142%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash flows from operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(334,620)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(443,286)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(704,471)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Adjustments to reconcile net loss to net cash provided by (used in) operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization of deferred income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(234)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(312)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity in loss of subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;352,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;427,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;676,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Loss from fair value changes of equity investment of readily determinable fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2,789)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in operating assets and liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepayments and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(7,839)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(439)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(379)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(376)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net cash provided by (used in) operating activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(9,521)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(11,447)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash flows from investing activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Purchases of short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(260,274)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(445,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Proceeds from maturity of short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;705,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;743,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Purchase of investment in equity investee&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(30,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investment in subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(392,893)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(80,942)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(884,342)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net cash (used in) provided by investing activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(392,893)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;364,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(615,440)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash flows from financing activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Proceeds from exercises of stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Proceeds from issuance of ordinary shares upon public offerings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;818,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Payment of public offering costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,692)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Employee taxes paid related to settlement of equity awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(8,802)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(7,600)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4,253)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net cash (used in) provided by financing activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6,433)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,730)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;820,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effect of foreign exchange rate changes on cash and cash equivalent&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net (decrease) increase in cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(378,668)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;352,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;194,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents-beginning of the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;944,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;591,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;397,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents-end of the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;565,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;944,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;591,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Schedule I &#x2014; Condensed Financial Information of Registrant&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Zai Lab Limited &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Financial Information of Parent Company&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Notes &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.&#160;&#160;&#160;&#160;Schedule I has been provided pursuant to the requirements of Rule 12-04(a) and 5-04(c) of Regulation S-X, which require condensed financial information as to the financial position, changes in financial position and results of operations of a parent company as of the same dates and for the same periods for which audited consolidated financial statements have been presented when the restricted net assets of consolidated subsidiaries exceed 25 percent of consolidated net assets as of the end of the most recently completed fiscal year. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.&#160;&#160;&#160;&#160;The condensed financial information has been prepared using the same accounting policies as set out in the consolidated financial statements except that the equity method has been used to account for investments in its subsidiaries. For the parent company, Zai Lab Limited records its investments in subsidiaries under the equity method of accounting as prescribed in ASC 323, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments-Equity Method and Joint Ventures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Such investments are presented on the Condensed Balance Sheets as &#x201c;Investment in subsidiaries&#x201d;. Ordinarily under the equity, an investor in an equity method investee would cease to recognize its share of the losses of an investee once the carrying value of the investment has been reduced to nil absent an undertaking by the investor to provide continuing support and fund losses. For the purpose of this Schedule I, the parent company has continued to reflect its share, based on its proportionate interest, of the losses of subsidiaries regardless of the carrying value of the investment even though the parent company is not obligated to provide continuing support or fund losses. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.&#160;&#160;&#160;&#160;Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. The footnote disclosures provide certain supplemental information relating to the operations of the Company and, as such, these statements should be read in conjunction with the notes to the accompanying consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.&#160;&#160;&#160;&#160;As of December&#160;31, 2023 and 2022, there were no material contingencies, significant provisions of long-term obligations, mandatory dividend or redemption requirements of redeemable stocks or guarantees of Zai Lab Limited.&lt;/span&gt;&lt;/div&gt;</us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock>
    <srt:ScheduleOfCondensedBalanceSheetTableTextBlock contextRef="c-1" id="f-1031">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Condensed Balance Sheets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(in thousands of $, except for number of shares and per share data)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Current assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;565,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;944,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepayments and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;573,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;954,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investment in subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;224,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;93,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;798,358&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1,048,215&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Liabilities and shareholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Current liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2,240&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2,620&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Shareholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Ordinary shares (par value of $0.000006 per share; 5,000,000,000 shares authorized, 977,151,270 and 962,455,850 shares issued as of December&#160;31, 2023 and 2022, respectively; 972,239,070 and 960,219,570 shares issued and outstanding as of December&#160;31, 2023 and 2022, respectively)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additional paid-in capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,975,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,893,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accumulated deficit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2,195,980)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,861,360)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive income&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;37,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;25,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Treasury stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(20,836)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(11,856)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total shareholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;796,118&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1,045,595&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total liabilities and shareholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;798,358&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1,048,215&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</srt:ScheduleOfCondensedBalanceSheetTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-268" decimals="-3" id="f-1032" unitRef="usd">565981000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-269" decimals="-3" id="f-1033" unitRef="usd">944649000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-268" decimals="-3" id="f-1034" unitRef="usd">7423000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-269" decimals="-3" id="f-1035" unitRef="usd">10203000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-268" decimals="-3" id="f-1036" unitRef="usd">573404000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-269" decimals="-3" id="f-1037" unitRef="usd">954852000</us-gaap:AssetsCurrent>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures contextRef="c-268" decimals="-3" id="f-1038" unitRef="usd">224954000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures contextRef="c-269" decimals="-3" id="f-1039" unitRef="usd">93363000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:Assets contextRef="c-268" decimals="-3" id="f-1040" unitRef="usd">798358000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-269" decimals="-3" id="f-1041" unitRef="usd">1048215000</us-gaap:Assets>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c-268" decimals="-3" id="f-1042" unitRef="usd">2240000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c-269" decimals="-3" id="f-1043" unitRef="usd">2620000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-268" decimals="-3" id="f-1044" unitRef="usd">2240000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-269" decimals="-3" id="f-1045" unitRef="usd">2620000</us-gaap:LiabilitiesCurrent>
    <us-gaap:Liabilities contextRef="c-268" decimals="-3" id="f-1046" unitRef="usd">2240000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-269" decimals="-3" id="f-1047" unitRef="usd">2620000</us-gaap:Liabilities>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-269"
      decimals="INF"
      id="f-1048"
      unitRef="usdPerShare">0.000006</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-268"
      decimals="INF"
      id="f-1049"
      unitRef="usdPerShare">0.000006</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c-268"
      decimals="INF"
      id="f-1050"
      unitRef="shares">5000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c-269"
      decimals="INF"
      id="f-1051"
      unitRef="shares">5000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="c-268"
      decimals="INF"
      id="f-1052"
      unitRef="shares">977151270</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="c-269"
      decimals="INF"
      id="f-1053"
      unitRef="shares">962455850</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-268"
      decimals="INF"
      id="f-1054"
      unitRef="shares">972239070</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-269"
      decimals="INF"
      id="f-1055"
      unitRef="shares">960219570</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="c-268" decimals="-3" id="f-1056" unitRef="usd">6000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-269" decimals="-3" id="f-1057" unitRef="usd">6000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-268" decimals="-3" id="f-1058" unitRef="usd">2975302000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-269" decimals="-3" id="f-1059" unitRef="usd">2893120000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-268" decimals="-3" id="f-1060" unitRef="usd">-2195980000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-269" decimals="-3" id="f-1061" unitRef="usd">-1861360000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-268" decimals="-3" id="f-1062" unitRef="usd">37626000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-269" decimals="-3" id="f-1063" unitRef="usd">25685000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockCommonValue contextRef="c-268" decimals="-3" id="f-1064" unitRef="usd">20836000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:TreasuryStockCommonValue contextRef="c-269" decimals="-3" id="f-1065" unitRef="usd">11856000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:StockholdersEquity contextRef="c-268" decimals="-3" id="f-1066" unitRef="usd">796118000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-269" decimals="-3" id="f-1067" unitRef="usd">1045595000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-268" decimals="-3" id="f-1068" unitRef="usd">798358000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-269" decimals="-3" id="f-1069" unitRef="usd">1048215000</us-gaap:LiabilitiesAndStockholdersEquity>
    <srt:CondensedStatementOfComprehensiveIncomeTableTextBlock contextRef="c-1" id="f-1070">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Condensed Statements of Operations and Comprehensive Loss&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(in thousands of $)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.142%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Operating Expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(82)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(178)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(16,958)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(19,773)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(12,074)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Loss from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(17,040)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(19,951)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(12,080)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;30,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(8,678)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(18,173)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Profit (Loss) before income tax and equity in loss of subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;17,829&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(15,772)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(28,372)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity in loss of subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(352,449)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(427,514)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(676,099)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(334,620)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(443,286)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(704,471)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other comprehensive income (loss), net of tax of nil:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Foreign currency translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;49,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(9,121)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(322,679)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(393,956)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(713,592)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</srt:CondensedStatementOfComprehensiveIncomeTableTextBlock>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-270" decimals="-3" id="f-1071" unitRef="usd">82000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-271" decimals="-3" id="f-1072" unitRef="usd">178000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-272" decimals="-3" id="f-1073" unitRef="usd">6000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-270" decimals="-3" id="f-1074" unitRef="usd">16958000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-271" decimals="-3" id="f-1075" unitRef="usd">19773000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-272" decimals="-3" id="f-1076" unitRef="usd">12074000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingIncomeLoss contextRef="c-270" decimals="-3" id="f-1077" unitRef="usd">-17040000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-271" decimals="-3" id="f-1078" unitRef="usd">-19951000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-272" decimals="-3" id="f-1079" unitRef="usd">-12080000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest contextRef="c-270" decimals="-3" id="f-1080" unitRef="usd">30840000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest contextRef="c-271" decimals="-3" id="f-1081" unitRef="usd">12857000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest contextRef="c-272" decimals="-3" id="f-1082" unitRef="usd">1881000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-270" decimals="-3" id="f-1083" unitRef="usd">4029000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-271" decimals="-3" id="f-1084" unitRef="usd">-8678000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-272" decimals="-3" id="f-1085" unitRef="usd">-18173000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-270" decimals="-3" id="f-1086" unitRef="usd">17829000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-271" decimals="-3" id="f-1087" unitRef="usd">-15772000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-272" decimals="-3" id="f-1088" unitRef="usd">-28372000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <zlab:IncomeLossFromEquityMethodInvestmentsNetOfTax contextRef="c-270" decimals="-3" id="f-1089" unitRef="usd">-352449000</zlab:IncomeLossFromEquityMethodInvestmentsNetOfTax>
    <zlab:IncomeLossFromEquityMethodInvestmentsNetOfTax contextRef="c-271" decimals="-3" id="f-1090" unitRef="usd">-427514000</zlab:IncomeLossFromEquityMethodInvestmentsNetOfTax>
    <zlab:IncomeLossFromEquityMethodInvestmentsNetOfTax contextRef="c-272" decimals="-3" id="f-1091" unitRef="usd">-676099000</zlab:IncomeLossFromEquityMethodInvestmentsNetOfTax>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-270" decimals="-3" id="f-1092" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-271" decimals="-3" id="f-1093" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-272" decimals="-3" id="f-1094" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss contextRef="c-270" decimals="-3" id="f-1095" unitRef="usd">-334620000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-271" decimals="-3" id="f-1096" unitRef="usd">-443286000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-272" decimals="-3" id="f-1097" unitRef="usd">-704471000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-270" decimals="INF" id="f-1098" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-271" decimals="INF" id="f-1099" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-272" decimals="INF" id="f-1100" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-270" decimals="-3" id="f-1101" unitRef="usd">11941000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-271" decimals="-3" id="f-1102" unitRef="usd">49330000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-272" decimals="-3" id="f-1103" unitRef="usd">-9121000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-270" decimals="-3" id="f-1104" unitRef="usd">-322679000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-271" decimals="-3" id="f-1105" unitRef="usd">-393956000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-272" decimals="-3" id="f-1106" unitRef="usd">-713592000</us-gaap:ComprehensiveIncomeNetOfTax>
    <srt:ScheduleOfCondensedCashFlowStatementTableTextBlock contextRef="c-1" id="f-1107">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Condensed Statements of Cash Flows&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(in thousands of $)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.142%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash flows from operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(334,620)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(443,286)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(704,471)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Adjustments to reconcile net loss to net cash provided by (used in) operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization of deferred income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(234)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(312)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity in loss of subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;352,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;427,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;676,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Loss from fair value changes of equity investment of readily determinable fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2,789)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in operating assets and liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepayments and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(7,839)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(439)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(379)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(376)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net cash provided by (used in) operating activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(9,521)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(11,447)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash flows from investing activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Purchases of short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(260,274)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(445,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Proceeds from maturity of short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;705,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;743,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Purchase of investment in equity investee&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(30,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investment in subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(392,893)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(80,942)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(884,342)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net cash (used in) provided by investing activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(392,893)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;364,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(615,440)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash flows from financing activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Proceeds from exercises of stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Proceeds from issuance of ordinary shares upon public offerings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;818,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Payment of public offering costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,692)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Employee taxes paid related to settlement of equity awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(8,802)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(7,600)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4,253)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net cash (used in) provided by financing activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6,433)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,730)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;820,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effect of foreign exchange rate changes on cash and cash equivalent&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net (decrease) increase in cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(378,668)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;352,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;194,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents-beginning of the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;944,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;591,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;397,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents-end of the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;565,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;944,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;591,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</srt:ScheduleOfCondensedCashFlowStatementTableTextBlock>
    <us-gaap:NetIncomeLoss contextRef="c-270" decimals="-3" id="f-1108" unitRef="usd">-334620000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-271" decimals="-3" id="f-1109" unitRef="usd">-443286000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-272" decimals="-3" id="f-1110" unitRef="usd">-704471000</us-gaap:NetIncomeLoss>
    <zlab:AmortizationOfDeferredIncome contextRef="c-270" decimals="-3" id="f-1111" unitRef="usd">0</zlab:AmortizationOfDeferredIncome>
    <zlab:AmortizationOfDeferredIncome contextRef="c-271" decimals="-3" id="f-1112" unitRef="usd">-234000</zlab:AmortizationOfDeferredIncome>
    <zlab:AmortizationOfDeferredIncome contextRef="c-272" decimals="-3" id="f-1113" unitRef="usd">-312000</zlab:AmortizationOfDeferredIncome>
    <us-gaap:ShareBasedCompensation contextRef="c-270" decimals="-3" id="f-1114" unitRef="usd">3217000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-271" decimals="-3" id="f-1115" unitRef="usd">3724000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-272" decimals="-3" id="f-1116" unitRef="usd">3435000</us-gaap:ShareBasedCompensation>
    <zlab:IncomeLossFromEquityMethodInvestmentsNetOfTax contextRef="c-270" decimals="-3" id="f-1117" unitRef="usd">-352449000</zlab:IncomeLossFromEquityMethodInvestmentsNetOfTax>
    <zlab:IncomeLossFromEquityMethodInvestmentsNetOfTax contextRef="c-271" decimals="-3" id="f-1118" unitRef="usd">-427514000</zlab:IncomeLossFromEquityMethodInvestmentsNetOfTax>
    <zlab:IncomeLossFromEquityMethodInvestmentsNetOfTax contextRef="c-272" decimals="-3" id="f-1119" unitRef="usd">-676099000</zlab:IncomeLossFromEquityMethodInvestmentsNetOfTax>
    <us-gaap:EquitySecuritiesFvNiGainLoss contextRef="c-270" decimals="-3" id="f-1120" unitRef="usd">2789000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss contextRef="c-271" decimals="-3" id="f-1121" unitRef="usd">-8952000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss contextRef="c-272" decimals="-3" id="f-1122" unitRef="usd">-14617000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-270" decimals="-3" id="f-1123" unitRef="usd">-2780000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-271" decimals="-3" id="f-1124" unitRef="usd">7839000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-272" decimals="-3" id="f-1125" unitRef="usd">439000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities contextRef="c-270" decimals="-3" id="f-1126" unitRef="usd">-379000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities contextRef="c-271" decimals="-3" id="f-1127" unitRef="usd">1648000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities contextRef="c-272" decimals="-3" id="f-1128" unitRef="usd">-376000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-270" decimals="-3" id="f-1129" unitRef="usd">20658000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-271" decimals="-3" id="f-1130" unitRef="usd">-9521000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-272" decimals="-3" id="f-1131" unitRef="usd">-11447000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireShortTermInvestments contextRef="c-270" decimals="-3" id="f-1132" unitRef="usd">0</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:PaymentsToAcquireShortTermInvestments contextRef="c-271" decimals="-3" id="f-1133" unitRef="usd">260274000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:PaymentsToAcquireShortTermInvestments contextRef="c-272" decimals="-3" id="f-1134" unitRef="usd">445000000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments contextRef="c-270" decimals="-3" id="f-1135" unitRef="usd">0</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments contextRef="c-271" decimals="-3" id="f-1136" unitRef="usd">705274000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments contextRef="c-272" decimals="-3" id="f-1137" unitRef="usd">743902000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments contextRef="c-270" decimals="-3" id="f-1138" unitRef="usd">0</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments contextRef="c-271" decimals="-3" id="f-1139" unitRef="usd">0</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments contextRef="c-272" decimals="-3" id="f-1140" unitRef="usd">30000000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates contextRef="c-270" decimals="-3" id="f-1141" unitRef="usd">392893000</us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates>
    <us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates contextRef="c-271" decimals="-3" id="f-1142" unitRef="usd">80942000</us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates>
    <us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates contextRef="c-272" decimals="-3" id="f-1143" unitRef="usd">884342000</us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-270" decimals="-3" id="f-1144" unitRef="usd">-392893000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-271" decimals="-3" id="f-1145" unitRef="usd">364058000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-272" decimals="-3" id="f-1146" unitRef="usd">-615440000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-270" decimals="-3" id="f-1147" unitRef="usd">2369000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-271" decimals="-3" id="f-1148" unitRef="usd">5870000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-272" decimals="-3" id="f-1149" unitRef="usd">7418000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering contextRef="c-270" decimals="-3" id="f-1150" unitRef="usd">0</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering contextRef="c-271" decimals="-3" id="f-1151" unitRef="usd">0</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering contextRef="c-272" decimals="-3" id="f-1152" unitRef="usd">818875000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c-270" decimals="-3" id="f-1153" unitRef="usd">0</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c-271" decimals="-3" id="f-1154" unitRef="usd">0</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c-272" decimals="-3" id="f-1155" unitRef="usd">1692000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-270" decimals="-3" id="f-1156" unitRef="usd">8802000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-271" decimals="-3" id="f-1157" unitRef="usd">7600000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-272" decimals="-3" id="f-1158" unitRef="usd">4253000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-270" decimals="-3" id="f-1159" unitRef="usd">-6433000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-271" decimals="-3" id="f-1160" unitRef="usd">-1730000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-272" decimals="-3" id="f-1161" unitRef="usd">820348000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="c-270" decimals="-3" id="f-1162" unitRef="usd">0</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="c-271" decimals="-3" id="f-1163" unitRef="usd">0</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="c-272" decimals="-3" id="f-1164" unitRef="usd">773000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-270" decimals="-3" id="f-1165" unitRef="usd">-378668000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-271" decimals="-3" id="f-1166" unitRef="usd">352807000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-272" decimals="-3" id="f-1167" unitRef="usd">194234000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="c-269" decimals="-3" id="f-1168" unitRef="usd">944649000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="c-273" decimals="-3" id="f-1169" unitRef="usd">591842000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="c-274" decimals="-3" id="f-1170" unitRef="usd">397608000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="c-268" decimals="-3" id="f-1171" unitRef="usd">565981000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="c-269" decimals="-3" id="f-1172" unitRef="usd">944649000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="c-273" decimals="-3" id="f-1173" unitRef="usd">591842000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
